-DOCSTART- X X O

Phenotypic JJ O
analysis NN O
demonstrates VBZ O
that IN O
trio NN B-NP
and CC O
Abl NNP B-NP
cooperate VBP O
in IN O
regulating JJ O
axon NN O
outgrowth NN O
in IN O
the DT O
embryonic JJ O
central JJ O
nervous JJ O
system NN O
( -LRB- O
CNS NNP O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
measured VBD O
electromyograms NNS O
( -LRB- O
EMG) NN O
of IN O
the DT O
alae NN O
nasi NN O
to TO O
determine VB O
the DT O
relationship NN O
between IN O
their PRP$ O
activity NN O
and CC O
timing NN O
to TO O
contraction NN O
of IN O
the DT O
rib NN O
cage NN O
muscles NNS O
and CC O
diaphragm NN O
during IN O
obstructive JJ O
apnea NN O
in IN O
nine CD O
patients NNS O
. . O

-DOCSTART- X X O

However RB O
the DT O
precise JJ O
function NN O
of IN O
DNA-PK JJ B-NP
in IN O
DNA NNP O
double-strand JJ O
break NN O
repair NN O
is VBZ O
not RB O
known VBN O
. . O

-DOCSTART- X X O

The DT O
COR JJ B-NP
biosynthetic JJ O
gene NN O
cluster NN O
in IN O
P. NNP O
syringae NN O
pv. . O
glycinea NN O
PG4180 . O
is VBZ O
encoded VBN O
by IN O
a DT O
32-kb JJ O
region NN O
which WDT O
contains VBZ O
both DT O
the DT O
structural JJ O
and CC O
regulatory JJ O
genes NNS O
needed VBN O
for IN O
COR JJ B-NP
synthesis NN O
. . O

-DOCSTART- X X O

FEurea NNP O
was VBD O
also RB O
measured VBN O
during IN O
stable JJ O
graft NN O
function NN O
, , O
7-14 CD O
days NNS O
prior RB O
to TO O
allograft VB O
dysfunction NN O
. . O

-DOCSTART- X X O

On IN O
the DT O
other JJ O
hand NN O
hypokalemia NN O
, , O
induced VBN O
by IN O
diuretics NNS O
, , O
may MD O
also RB O
be VB O
accompanied VBN O
by IN O
a DT O
significant JJ O
depletion NN O
of IN O
total JJ O
body NN O
K NNP O
, , O
bringing VBG O
about IN O
more JJR O
general JJ O
consequences NNS O
. . O

-DOCSTART- X X O

We PRP O
present RB O
here RB O
the DT O
complete JJ O
primary JJ O
structure NN O
of IN O
human JJ B-NP
gp330 CD I-NP
, , O
the DT O
human JJ O
variant NN O
of IN O
the DT O
principal JJ O
kidney NN O
autoantigen NN O
causing VBG O
Heymann NNP O
membranous JJ O
glomerulonephritis NN O
in IN O
rats NNS O
. . O

-DOCSTART- X X O

A DT O
series NN O
of IN O
deletion NN O
mutants NNS O
was VBD O
expressed VBN O
transiently RB O
in IN O
two CD O
human JJ O
hepatocytes NNS O
, , O
HepG2 NNP O
and CC O
PLC NNP O
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

The DT O
P-ITIM-compelled JJ B-NP
multi-phosphoprotein JJ I-NP
complex JJ I-NP
binds NNS O
to TO O
and CC O
activates NNS O
SHP-2 NN B-NP
, , O
which WDT O
in IN O
turn NN O
dephosphorylates VBZ O
SHIP NNP B-NP
and CC O
Shc NNP B-NP
and CC O
probably RB O
other JJ O
substrates NNS O
. . O

-DOCSTART- X X O

cDNA NN O
cloning NN O
and CC O
transcriptional JJ O
properties NNS O
of IN O
a DT O
novel NN O
GC NNP B-NP
box-binding JJ I-NP
protein NN I-NP
, , O
BTEB2 NN B-NP
. . O

-DOCSTART- X X O

Of IN O
81 CD O
girls NNS O
cured VBD O
from IN O
the DT O
bacteriuria NNS O
24 CD O
recurred VBN O
, , O
5 CD O
with IN O
a DT O
symptomatic JJ O
pyelonephritis NN O
and CC O
3 CD O
with IN O
cystitis NN O
. . O

-DOCSTART- X X O

Partial JJ O
hepatectomy NN O
in IN O
metastatic JJ O
Wilms NNP O
' POS O
tumor NN O
. . O

-DOCSTART- X X O

MRS NNS O
allowed VBD O
the DT O
differentiation NN O
of IN O
the DT O
following VBG O
metabolites NNS O
in IN O
5 CD O
patients NNS O
: : O
N-acetyl-aspartate NNP O
( -LRB- O
NAA NNP O
) -RRB- O
, , O
creatine JJ O
and CC O
phosphocreatine JJ O
, , O
phosphorylcholine NN O
and CC O
glycerophosphorylcholine NN O
, , O
beta JJ O
- : O
and CC O
gamma-glutamate NN O
( -LRB- O
GLU) NNP O
. . O

-DOCSTART- X X O

Studies NNS O
of IN O
fetal JJ O
maturity NN O

-DOCSTART- X X O

A DT O
comparison NN O
of IN O
the DT O
rate NN O
of IN O
recovery NN O
and CC O
time NN O
for IN O
detection NN O
of IN O
mycobacteria NNS O
from IN O
clinical JJ O
specimens NNS O
of IN O
the DT O
newly RB O
developed VBN O
Mycobacteria NNP O
Growth NNP O
Indicator NNP O
Tube NNP O
( -LRB- O
MGIT NN O
) -RRB- O
, , O
the DT O
biphasic JJ O
Septi-Chek NNP O
, , O
and CC O
the DT O
egg-based JJ O
Ogawa NNP O
medium NN O
was VBD O
made VBN O
. . O

-DOCSTART- X X O

A DT O
clinical JJ O
study NN O
. . O

-DOCSTART- X X O

Thirty-five CD O
pts NNS O
were VBD O
transplanted VBN O
for IN O
constitutional JJ O
disease NN O
: : O
Fanconi NNP O
anemia NN O
( -LRB- O
FA NNP O
) -RRB- O
( -LRB- O
26 CD O
pts NNS O
) -RRB- O
, , O
Dyskeratosis NNP O
congenita NN O
( -LRB- O
2 CD O
pts VBZ O
) -RRB- O
, , O
Blackfan-Diamond NNP O
erythroblastopenia NN O
( -LRB- O
2 CD O
pts VBZ O
) -RRB- O
, , O
Glanzmann NNP O
thrombasthenia NN O
( -LRB- O
1 CD O
pt NN O
) -RRB- O
, , O
osteopetrosis NN O
( -LRB- O
1 CD O
pt NN O
) -RRB- O
and CC O
Gaucher NNP O
's POS O
disease NN O
( -LRB- O
1 CD O
pt NN O
) -RRB- O
. . O

-DOCSTART- X X O

Using VBG O
the DT O
same JJ O
approach NN O
we PRP O
have VBP O
shown VBN O
that IN O
hFIRE RB B-NP
binds VBZ O
the DT O
stimulatory JJ O
proteins NNS O
Sp1 . B-NP
and CC O
Sp3 JJ B-NP
in IN O
addition NN O
to TO O
CBF. NNP B-NP

-DOCSTART- X X O

Cellular NNP O
fractionation NN O
and CC O
Percoll NNP O
gradient NN O
centrifugation NN O
combined VBN O
with IN O
immunoblotting JJ O
show NN O
that IN O
p67 DT B-NP
cofractionates NNS O
with IN O
nuclei JJ O
and CC O
is VBZ O
enriched VBN O
in IN O
resistant JJ O
structure NN O
that WDT O
is VBZ O
insoluble JJ O
in IN O
2 CD O
M NNP O
NaCl NNP O
, , O
25 CD O
mM NNS O
lithium NN O
3,5'-diiodosalicylate JJ O
, , O
and CC O
1 CD O
% NN O
Triton NN O
but CC O
is VBZ O
soluble JJ O
in IN O
8 CD O
M NNP O
urea NN O
. . O

-DOCSTART- X X O

Gene NNP O
expression NN O
is VBZ O
in IN O
part NN O
controlled VBN O
by IN O
chromatin NN O
remodeling VBG O
factors NNS O
and CC O
the DT O
acetylation NN O
state NN O
of IN O
nucleosomal JJ B-NP
histones NNS I-NP
. . O

-DOCSTART- X X O

Corticosteroid NNP O
treatment NN O
before IN O
, , O
during IN O
, , O
or CC O
after IN O
fludarabine NN O
treatment NN O
in IN O
patients NNS O
with IN O
alkylator-resistant JJ O
, , O
low-grade JJ O
lymphoid JJ O
malignancies NNS O
who WP O
have VBP O
not RB O
received VBN O
PCP NNP O
prophylaxis NNS O
is VBZ O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
opportunistic JJ O
pulmonary JJ O
infections NNS O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
demonstrate VBP O
that IN O
several JJ O
genes NNS O
associated VBN O
with IN O
NHEJ NNP O
perform VB O
essential JJ O
functions NNS O
in IN O
the DT O
repair NN O
of IN O
endonuclease-induced JJ O
DSBs NNS O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

The DT O
primary JJ O
structure NN O
of IN O
cholesterol NN B-NP
esterase NN I-NP
displayed VBD O
no DT O
significant JJ O
homology NN O
with IN O
other JJ O
lipases NNS B-NP
, , O
although IN O
the DT O
putative JJ O
lipid JJ O
interfacial JJ O
recognition NN O
site NN O
of IN O
G-X-S-X-G NNP O
is VBZ O
present JJ O
in IN O
the DT O
cholesterol NN B-NP
esterase NN I-NP
sequence NN I-NP
. . O

-DOCSTART- X X O

Subtype- NNS O
and CC O
response NN O
element-dependent JJ O
differences NNS O
in IN O
transactivation NN O
by IN O
peroxisome DT B-NP
proliferator-activated JJ I-NP
receptors NNS I-NP
alpha NN I-NP
and CC I-NP
gamma NN I-NP
. . O

-DOCSTART- X X O

Monoclonal NNP O
antibodies NNS O
to TO O
the DT O
hapten JJ O
phenyloxazolone NN O
were VBD O
raised VBN O
7 CD O
days NNS O
after IN O
immunization NN O
in IN O
mice NNS O
of IN O
six CD O
strains NNS O
( -LRB- O
BALB/c NNP O
, , O
C57BL-Igha NNP O
, , O
DBA2 NNP O
, , O
RF NNP O
, , O
A/J NNP O
, , O
and CC O
CE) NNP O
. . O

-DOCSTART- X X O

Although IN O
the DT O
QT NNP O
duration NN O
was VBD O
higher JJR O
( -LRB- O
p NN O
= SYM O
0.0001 CD O
) -RRB- O
at IN O
night NN O
, , O
the DT O
beat-to-beat JJ O
variability NN O
of IN O
this DT O
interval NN O
was VBD O
lower JJR O
: : O
in IN O
the DT O
time NN O
domain NN O
( -LRB- O
decreased VBN O
standard JJ O
deviation NN O
, , O
p NN O
= SYM O
0.0005 CD O
) -RRB- O
, , O
in IN O
the DT O
frequency NN O
domain NN O
( -LRB- O
decreased VBN O
low-frequency NN O
power NN O
of IN O
the DT O
spectra NN O
, , O
p NN O
= SYM O
0.004 CD O
) -RRB- O
, , O
and CC O
the DT O
chaotic JJ O
domain NN O
(tighter NN O
clustering NN O
of IN O
the DT O
points NNS O
in IN O
the DT O
Poincare NNP O
plots NNS O
) -RRB- O
. . O

-DOCSTART- X X O

J. NNP O

-DOCSTART- X X O

We PRP O
have VBP O
earlier RB O
proposed VBN O
that IN O
CG NNP O
rich JJ O
sequences NNS O
resembling VBG O
CpG NNP O
islands NNS O
, , O
which WDT O
are VBP O
associated VBN O
with IN O
many JJ O
imprinted JJ O
genes NNS O
and CC O
often RB O
subject JJ O
to TO O
parental-specific JJ O
methylation NN O
, , O
could MD O
act VB O
as IN O
a DT O
common JJ O
imprinting NN O
element NN O
. . O

-DOCSTART- X X O

Electrophoretic JJ O
mobility-shift JJ O
assays NNS O
showed VBD O
a DT O
rapid JJ O
induction NN O
of IN O
nuclear JJ O
proteins NNS O
that WDT O
bound VBD O
to TO O
the DT O
consensus NN B-NP
kappa NN I-NP
B NNP I-NP
motif NN I-NP
. . O

-DOCSTART- X X O

The DT O
thalamic IN O
SD NNP O
was VBD O
regularly RB O
triggered VBN O
by IN O
short JJ O
( -LRB- O
0.02-0.05 CD O
s VBZ O
) -RRB- O
high-frequency CC O
( -LRB- O
200-500 CD O
Hz NN O
) -RRB- O
ES NNPS O
of IN O
the DT O
parietal NN O
cortical JJ O
surface NN O
. . O

-DOCSTART- X X O

Genetic JJ O
analysis NN O
places NNS O
CWH43 VBG B-NP
upstream RB O
of IN O
the DT O
BCK2 NNP B-NP
branch NN O
of IN O
the DT O
PKC1 NNP B-NP
signalling NN O
pathway NN O
, , O
since IN O
cwh43 CD B-NP
mutations NNS O
were VBD O
synthetic JJ O
lethal JJ O
with IN O
pkc1 DT B-NP
deletion NN O
, , O
whereas IN O
the DT O
cwh43 JJ B-NP
defects NNS O
could MD O
be VB O
rescued VBN O
by IN O
overexpression NN O
of IN O
BCK2 NNP B-NP
and CC O
not RB O
by IN O
high-copy-number JJ O
expression NN O
of IN O
genes NNS O
encoding VBG O
downstream JJ O
proteins NNS O
of IN O
the DT O
PKC1 NNP B-NP
pathway NN O
However RB O
, , O
unlike IN O
BCK2 NNP B-NP
, , O
whose WP$ O
disruption NN O
in IN O
a DT O
cln3 NN B-NP
mutant NN I-NP
resulted VBD O
in IN O
growth NN O
arrest NN O
in IN O
G( JJ O
1 CD O
) -RRB- O
, , O
no DT O
growth NN O
defect NN O
was VBD O
observed VBN O
in IN O
a DT O
double JJ O
cwh43 CD B-NP
cln3 CD B-NP
mutants NNS I-NP
. . O

-DOCSTART- X X O

Expression NN O
of IN O
the DT O
E2 JJ B-NP
protein NN I-NP
resulted VBD O
in IN O
rapid JJ O
repression NN O
of IN O
HPV NNP B-NP
E6 NNP I-NP
and CC O
E7 NNP B-NP
expression NN O
, , O
followed VBD O
approximately RB O
12 CD O
h NN O
later RB O
by IN O
profound JJ O
inhibition NN O
of IN O
cellular JJ O
DNA NNP O
synthesis NN O
. . O

-DOCSTART- X X O

Peak NNP O
reactive NN O
hyperemia NN O
( -LRB- O
mL.min-1.100 JJ O
mL-1 NN O
) -RRB- O
was VBD O
determined VBN O
in IN O
the DT O
calf NN O
and CC O
forearm NN O
immediately RB O
before IN O
and CC O
after IN O
12 CD O
weeks NNS O
of IN O
training NN O
. . O

-DOCSTART- X X O

The DT O
hematopoietic JJ O
form NN O
of IN O
PTPN6 NNP B-NP
transcript NN I-NP
is VBZ O
initiated VBN O
at IN O
a DT O
downstream NN O
promoter NN O
separated VBN O
by IN O
7 CD O
kb NN O
from IN O
the DT O
first JJ O
. . O

-DOCSTART- X X O

Reversal NN O
of IN O
biliary JJ O
sphincter NN O
spasm NN O
with IN O
low JJ O
dose NN O
glucagon NN B-NP
during IN O
operative JJ O
cholangiography NN O
. . O

-DOCSTART- X X O

In IN O
ten CD O
other JJ O
endotoxin-albumin-treated JJ O
pigs NNS O
PGE1 . O
infusion NN O
( -LRB- O
0.25 CD O
micrograms NNS O
X NNP O
kg-1 CD O
X NNP O
min-1 NN O
) -RRB- O
was VBD O
begun VBN O
after IN O
established VBN O
pulmonary NN O
and CC O
cardiovascular JJ O
dysfunction NN O
, , O
for IN O
closer JJR O
mimicking NN O
of IN O
clinical JJ O
use NN O
. . O

-DOCSTART- X X O

In IN O
particular JJ O
, , O
MF NNP O
males NNS O
receiving VBG O
either CC O
a DT O
5.0-mg/kg JJ O
CDP NNP O
dose NN O
or CC O
a DT O
3.0-mg/kg JJ O
RO NNP O
dose NN O
explored VBD O
the DT O
object NN O
more RBR O
often RB O
than IN O
MM NNP O
males NNS O
.(ABSTRACT VBP O
TRUNCATED JJ O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

A DT O
single JJ O
HD NNP O
session NN O
using VBG O
cellulose JJ O
triacetate NN O
or CC O
polysulfone NN O
membrane NN O
significantly RB O
increased VBD O
water NN O
content NN O
both CC O
at IN O
forearm NN O
and CC O
lower JJR O
leg NN O
( -LRB- O
p<0.05 VB O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
the DT O
yeast NN O
two-hybrid JJ O
assays RB O
, , O
PNRC NNP B-NP
interacted VBD O
with IN O
the DT O
orphan JJ O
receptors NNS O
SF1 . B-NP
and CC O
ERRalpha1 PRP B-NP
in IN O
a DT O
ligand-independent JJ O
manner NN O
. . O

-DOCSTART- X X O

Further RB O
, , O
we PRP O
will MD O
review VB O
our PRP$ O
evaluation NN O
of IN O
the DT O
survival NN O
rate NN O
and CC O
prognostic JJ O
factors NNS O
for IN O
9,262 CD O
patients NNS O
from IN O
1981 CD O
to TO O
1996 CD O
. . O

-DOCSTART- X X O

The DT O
results NNS O
were VBD O
subjected VBN O
to TO O
analysis NN O
of IN O
23 CD O
autopsies NNS O
carried VBD O
out RP O
in IN O
children NNS O
dying VBG O
of IN O
intoxication NN O
with IN O
Amanita NNP O
phalloides NNS O
. . O

-DOCSTART- X X O

Microscopic NNP O
examination NN O
of IN O
these DT O
colonies NNS O
showed VBD O
a DT O
high JJ O
percentage NN O
of IN O
histiocytes NNS O
identical JJ O
to TO O
those DT O
seen VBN O
in IN O
the DT O
patient NN O
's POS O
bone NN O
marrow NN O
. . O

-DOCSTART- X X O

Additional JJ O
genetic JJ O
analyses NNS O
described VBN O
herein RB O
suggest VBP O
that IN O
Skb1 NNP B-NP
is VBZ O
a DT O
component NN O
of IN O
the DT O
morphology NN O
control NN O
branch NN O
of IN O
the DT O
Ras NNP B-NP
signaling VBG O
cascade NN O
in IN O
S. NNP O
pombe NN O
and CC O
that IN O
it PRP O
positively RB O
modulates VBZ O
Shk1 NNP B-NP
function NN O
. . O

-DOCSTART- X X O

Transient NNP O
transfection NN O
assays VBZ O
indicated VBN O
that IN O
the DT O
(-4551)UCP1-CAT JJ O
construct VB O
, , O
containing VBG O
the DT O
5'-regulatory JJ O
region NN O
of IN O
the DT O
rat NN B-NP
ucp-1 JJ I-NP
gene NN I-NP
, , O
was VBD O
activated VBN O
by IN O
PPARalpha NNP B-NP
co-transfection NN O
in IN O
a DT O
dose-dependent JJ O
manner NN O
and CC O
this DT O
activation NN O
was VBD O
potentiated VBN O
by IN O
Wy NNP O
14,643 CD O
and CC O
retinoid JJ B-NP
X NNP I-NP
receptor NN I-NP
alpha NN I-NP
. . O

-DOCSTART- X X O

Idealized NNP O
versus NN O
realized VBD O
overall JJ O
treatment NN O
times NNS O
. . O

-DOCSTART- X X O

Serum NNP B-NP
C3 NNP I-NP
was VBD O
measured VBN O
in IN O
1,282 CD O
school NN O
children NNS O
with IN O
abnormal JJ O
urinary JJ O
findings NNS O
between IN O
1980 CD O
and CC O
1997 CD O
. . O

-DOCSTART- X X O

Tc-99m JJ O
HMPAO NNP O
brain NN O
SPECT NN O
compared VBN O
to TO O
CT NNP O
and CC O
EEG NNP O
after IN O
seizures NNS O
in IN O
childhood NN O
. . O

-DOCSTART- X X O

The DT O
adenovirus NN B-NP
E1B NN I-NP
19,000-molecular-weight JJ I-NP
( -LRB- I-NP
19K IN I-NP
) -RRB- I-NP
protein NN I-NP
is VBZ O
a DT O
potent JJ O
inhibitor NN O
of IN O
apoptosis NN O
and CC O
cooperates NNS O
with IN O
E1A NNP B-NP
to TO O
transform VB O
primary JJ O
rodent NN O
cells NNS O
. . O

-DOCSTART- X X O

Subclones NNS O
of IN O
R15 NNP O
which WDT O
reverted VBD O
to TO O
kappa VB B-NP
light JJ I-NP
chain NN I-NP
production NN O
contained VBD O
genomic JJ O
deletions NNS O
of IN O
R15ns NNP O
and/or CC O
the DT O
surrounding VBG O
intron NN O
. . O

-DOCSTART- X X O

Region-specific NNP O
enhancers NNS O
near IN O
two CD O
mammalian JJ B-NP
homeo NN I-NP
box NN I-NP
genes NNS I-NP
define VB O
adjacent JJ O
rostrocaudal NN O
domains NNS O
in IN O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

-DOCSTART- X X O

Cells NNP O
were VBD O
cotransfected VBN O
with IN O
this DT O
plasmid NN O
, , O
and CC O
the DT O
appropriate JJ O
responder NN O
plasmids NNS O
and CC O
clonies NNS O
were VBD O
selected VBN O
on IN O
the DT O
basis NN O
of IN O
their PRP$ O
resistance NN O
to TO O
Geneticin NNP O
(via IN O
the DT O
neomycin NN B-NP
aminoglycoside IN I-NP
phosphotransferase JJ I-NP
gene NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

To TO O
clone JJ O
cDNAs NNS O
for IN O
the DT O
beta JJ O
subunit NN O
of IN O
rabbit NN B-NP
eIF-2B NN I-NP
, , O
amino IN O
acid NN O
sequence NN O
data NNS O
was VBD O
first JJ O
obtained VBN O
and CC O
used VBN O
to TO O
design VB O
redundant JJ O
oligonucleotide JJ O
primers NNS O
for IN O
use NN O
in IN O
PCR. NNP O

-DOCSTART- X X O

Deletion NNP O
analysis NN O
of IN O
the DT O
3.5kb JJ O
DNA NN O
fragment NN O
revealed VBD O
that IN O
the DT O
region NN O
between IN O
-125 PRP$ O
to TO O
+1 CD O
, , O
containing VBG O
a DT O
single JJ O
Sp1 NNP B-NP
binding NN I-NP
site NN I-NP
, , O
is VBZ O
essential JJ O
for IN O
transcription NN O
of IN O
the DT O
embigin NN B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

By IN O
applying VBG O
a DT O
sufficiently RB O
strong JJ O
crusher NN O
gradient NN O
in IN O
the DT O
EPI NNP O
pulse NN O
sequence NN O
, , O
the DT O
temporal JJ O
variation NN O
induced VBN O
by IN O
SSFP NNP O
disturbance NN O
can MD O
be VB O
suppressed VBN O
due JJ O
to TO O
diffusion NN O
. . O

-DOCSTART- X X O

The DT O
cdc42W97R JJ B-NP
temperature-sensitive JJ I-NP
allele NN I-NP
in IN O
S. NNP O
cerevisiae NNS O
displayed VBD O
the DT O
same JJ O
cell-division-cycle NN O
arrest NN O
phenotype NN O
( -LRB- O
large JJ O
, , O
round JJ O
unbudded JJ O
cells NNS O
) -RRB- O
as IN O
the DT O
cdc42-1ts JJ B-NP
mutant NN I-NP
. . O

-DOCSTART- X X O

Wolf-Hirschhorn JJ O
syndrome NN O
( -LRB- O
WHS) NN O
is VBZ O
a DT O
malformation NN O
syndrome NN O
associated VBN O
with IN O
a DT O
hemizygous JJ O
deletion NN O
of IN O
the DT O
distal JJ O
short JJ O
arm NN O
of IN O
chromosome NN O
4 CD O
( -LRB- O
4p16.3 CD O
) -RRB- O
. . O

-DOCSTART- X X O

To TO O
address VB O
this DT O
question NN O
with IN O
respect NN O
to TO O
skeletal JJ O
muscle NN O
, , O
we PRP O
have VBP O
examined VBN O
the DT O
effects NNS O
of IN O
the DT O
Providence NNP O
mutation NN O
in IN O
cultured JJ O
muscle NN O
cells NNS O
, , O
after IN O
adoptive VBG O
gene NN O
transfer NN O
to TO O
adult NN O
mice NNS O
, , O
and CC O
in IN O
two CD O
infants NNS O
homozygous JJ O
for IN O
spectrin NN B-NP
Providence NNP I-NP
. . O

-DOCSTART- X X O

Adenovirus-mediated NNP O
gene NN O
transfer NN O
of IN O
MMAC1/PTEN NNP B-NP
to TO O
glioblastoma NNP O
cells NNS O
inhibits VBZ O
S NNP O
phase NN O
entry NN O
by IN O
the DT O
recruitment NN O
of IN O
p27Kip1 NNS B-NP
into IN O
cyclin NN B-NP
E/CDK2 NN I-NP
complexes NNS O
. . O

-DOCSTART- X X O

Increasing VBG O
insulin NN B-NP
sensitivity NN O
in IN O
type NN O
I PRP O
diabetic JJ O
patients NNS O
should MD O
alert VB O
clinicians NNS O
to TO O
the DT O
possibility NN O
of IN O
glucocorticoid JJ O
deficiency NN O
. . O

-DOCSTART- X X O

Experiment NN O
B NNP O
: : O
Clinical NNP O
, , O
biochemical JJ O
, , O
and CC O
histological JJ O
variables NNS O
were VBD O
measured VBN O
over IN O
a DT O
12-day JJ O
period NN O
after IN O
the DT O
zymosan NN O
had VBD O
been VBN O
given VBN O
. . O

-DOCSTART- X X O

Lesions NNS O
of IN O
this DT O
kind NN O
resemble VB O
those DT O
in IN O
vitamin NN O
A-deficient JJ O
chickens NNS O
and CC O
are VBP O
the DT O
first JJ O
to TO O
be VB O
induced VBN O
by IN O
excess JJ O
vitamin NN O
E. NNP O

-DOCSTART- X X O

Spinophilin NNP B-NP
, , O
a DT O
novel JJ O
protein NN B-NP
phosphatase NN I-NP
1 CD I-NP
binding JJ I-NP
protein NN I-NP
localized VBN O
to TO O
dendritic JJ O
spines NNS O
. . O

-DOCSTART- X X O

The DT O
Htf9-a NNP B-NP
gene NN I-NP
encodes VBZ O
the DT O
RanBP1 NNP B-NP
protein NN I-NP
, , O
a DT O
major JJ O
partner NN O
of IN O
the DT O
Ran NNP B-NP
GTPase NNP I-NP
. . O

-DOCSTART- X X O

Membrane NNP O
extraction NN O
has VBZ O
been VBN O
interfaced VBN O
with IN O
gas NN O
chromatography NN O
and CC O
mass NN O
spectroscopy NN O
for IN O
the DT O
analysis NN O
of IN O
volatile JJ O
organics NNS O
in IN O
water NN O
. . O

-DOCSTART- X X O

More JJR O
than IN O
80 CD O
% NN O
appropriate JJ O
lever NN O
responding VBG O
was VBD O
established VBN O
after IN O
27 CD O
, , O
38 CD O
and CC O
44 CD O
daily JJ O
training NN O
sessions NNS O
with IN O
DN-2327 NN O
, , O
diazepam NN O
and CC O
PTZ NNP O
, , O
respectively RB O
, , O
as IN O
the DT O
training NN O
drug NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
have VBP O
investigated VBN O
the DT O
effects NNS O
of IN O
SDZ NNP O
ENA NNP O
713 CD O
on IN O
spatial JJ O
learning VBG O
deficits NNS O
in IN O
aged JJ O
rats NNS O
. . O

-DOCSTART- X X O

One CD O
of IN O
the DT O
major JJ O
transcripts NNS O
encodes VBZ O
MEQ NNP B-NP
, , O
a DT O
339-amino-acid JJ O
bZIP NN B-NP
protein NN I-NP
which WDT O
is VBZ O
homologous JJ O
to TO O
the DT O
Jun/Fos NNP B-NP
family NN O
of IN O
transcription NN O
factors NNS O
. . O

-DOCSTART- X X O

An DT O
identical JJ O
polypeptide NN O
was VBD O
detected VBN O
by IN O
Western JJ O
blot NN O
analysis NN O
of IN O
K1F NNP O
virions NNS O
. . O

-DOCSTART- X X O

The DT O
predictive JJ O
value NN O
of IN O
the DT O
remotely NN O
sensed VBD O
map NN O
based VBN O
on IN O
NDVI NNP O
data NNS O
appears VBZ O
to TO O
be VB O
better JJR O
than IN O
that DT O
from IN O
forecast NN O
indices NNS O
based VBN O
only RB O
on IN O
climatic JJ O
data NNS O
. . O

-DOCSTART- X X O

The DT O
concentration NN O
of IN O
vitamin NN O
B1 NNP O
, , O
B2 NN O
and CC O
B6 NNS O
are VBP O
found VBN O
to TO O
be VB O
9.96 CD O
, , O
9.92 CD O
and CC O
3.01 CD O
mg NN O
, , O
respectively RB O
in IN O
240 CD O
mg NN O
of IN O
capsule NN O
powder NN O
of IN O
a DT O
standard JJ O
company NN O
( -LRB- O
name NN O
has VBZ O
not RB O
been VBN O
disclosed VBN O
due JJ O
to TO O
secrecy NN O
purpose NN O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
shown VBN O
that IN O
the DT O
human JJ O
cell NN O
MRC NNP O
closely RB O
resembles VBZ O
the DT O
murine NN O
cell NN O
MRC NNP O
, , O
in IN O
both DT O
its PRP$ O
protein NN O
composition NN O
and CC O
its PRP$ O
fractionation NN O
and CC O
chromatographic JJ O
profile NN O
. . O

-DOCSTART- X X O

Red NNP O
blood NN O
cell NN O
binding NN O
of IN O
99mTc-EC NNP O
and CC O
131I-OIH CD O
was VBD O
6.1 CD O
% NN O
and CC O
20 CD O
% NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

To TO O
identify VB O
the DT O
GRK6 NNP B-NP
homologue NN I-NP
on IN O
chromsome DT O
13 CD O
, , O
several JJ O
sets NNS O
of IN O
closely-spaced JJ O
primers NNS O
were VBD O
designed VBN O
based VBN O
on IN O
the DT O
GRK6 NNP B-NP
cDNA NN I-NP
sequence NN I-NP
and CC O
then RB O
used VBD O
to TO O
amplify VB O
human JJ O
genomic JJ O
DNA NN O
by IN O
PCR. VBG O

-DOCSTART- X X O

During IN O
the DT O
burst NN O
period NN O
( -LRB- O
approximately RB O
5-10 JJ O
min NN O
) -RRB- O
, , O
local JJ O
blood NN O
H2O2 IN O
concentrations NNS O
and CC O
xanthine NN B-NP
oxidase NN I-NP
activities NNS O
were VBD O
highly RB O
correlated VBN O
( -LRB- O
r NN O
= SYM O
0.999 CD O
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
mutant NN O
also RB O
functions VBZ O
in IN O
vivo NN O
as IN O
a DT O
trans-acting JJ O
dominant JJ O
negative JJ O
regulator NN O
: : O
the DT O
transcriptional JJ O
inducibility NN O
of IN O
the DT O
HIV NN B-NP
long RB I-NP
terminal JJ I-NP
repeat NN I-NP
( -LRB- O
which WDT O
contains VBZ O
two CD O
potential JJ O
NF-kappa NNP B-NP
B NNP I-NP
binding NN I-NP
sites NNS I-NP
) -RRB- O
by IN O
phorbol NN O
ester NN O
( -LRB- O
PMA NNP O
) -RRB- O
is VBZ O
inhibited VBN O
when WRB O
it PRP O
is VBZ O
co-transfected VBN O
into IN O
CD4+ NNP B-NP
T NNP O
cells NNS O
with IN O
the DT O
delta NN O
SP NNP O
mutant NN O
. . O

-DOCSTART- X X O

We PRP O
demonstrate VBP O
that IN O
the DT O
WRM-1 JJ B-NP
protein NN I-NP
binds NNS O
to TO O
LIT-1 NNP B-NP
in IN O
vivo RB O
and CC O
that DT O
WRM-1 NN B-NP
can MD O
activate VB O
the DT O
LIT-1 JJ B-NP
protein NN I-NP
kinase NN I-NP
when WRB O
coexpressed VBN O
in IN O
vertebrate JJ O
tissue NN O
culture NN O
cells NNS O
. . O

-DOCSTART- X X O

To TO O
assess VB O
the DT O
safety NN O
of IN O
the DT O
angiotensin NN B-NP
converting VBG I-NP
enzyme JJ I-NP
inhibitor NN O
enalapril VBD O
a DT O
multicenter NN O
, , O
open JJ O
, , O
randomized JJ O
, , O
prazosin-controlled JJ O
trial NN O
was VBD O
designed VBN O
comparing VBG O
the DT O
incidence NN O
and CC O
severity NN O
of IN O
symptomatic JJ O
hypotension NN O
on IN O
the DT O
first JJ O
day NN O
of IN O
treatment NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
report VBP O
the DT O
cloning NN O
and CC O
sequencing NN O
of IN O
several JJ O
overlapping JJ O
cDNAs NNS O
encoding VBG O
approximately RB O
4.1 CD O
kb NN O
of IN O
the DT O
human JJ B-NP
homologue NN I-NP
of IN I-NP
Wnt-5A. PRP$ I-NP

-DOCSTART- X X O

Furthermore RB O
, , O
we PRP O
demonstrate VBP O
that IN O
in IN O
myeloid JJ O
and CC O
B NNP O
cell NN O
extracts NNS O
, , O
PU.1 NNP B-NP
forms VBZ O
a DT O
novel NN O
, , O
specific JJ O
, , O
more RBR O
slowly RB O
migrating JJ O
complex JJ O
( -LRB- O
PU-SF NN B-NP
) -RRB- O
when WRB O
binding VBG O
the DT O
GM-CSF NNP B-NP
receptor NN I-NP
alpha NN I-NP
promoter NN O
PU.1 NNP B-NP
site NN O
. . O

-DOCSTART- X X O

Cytokine NNP O
inducibility NN O
of IN O
VCAM1 NNP B-NP
in IN O
endothelial JJ O
cells NNS O
utilizes VBZ O
the DT O
interaction NN O
of IN O
heterodimeric JJ O
p50/p65 IN B-NP
proteins NNS O
with IN O
IRF-1 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
cases NNS O
with IN O
terminal NN O
forces NNS O
of IN O
left VBN O
ventricular JJ O
activation NN O
in IN O
the DT O
same JJ O
direction NN O
as IN O
the DT O
delta JJ O
wave NN O
, , O
superiorly RB O
and CC O
to TO O
the DT O
left NN O
at IN O
-60 DT O
degrees NNS O
or CC O
inferiorly JJ O
and CC O
to TO O
the DT O
right NN O
at IN O
+120 CD O
degrees NNS O
, , O
forming VBG O
a DT O
single JJ O
deflection NN O
of IN O
over IN O
0,12 CD O
seconds NNS O
' POS O
duration NN O
, , O
are VBP O
the DT O
result NN O
of IN O
delayed VBN O
activation NN O
of IN O
the DT O
anterior JJ O
or CC O
posterior JJ O
fascicle NN O
of IN O
the DT O
left JJ O
bundle NN O
after IN O
a DT O
long JJ O
delay NN O
. . O

-DOCSTART- X X O

Manifestation NNP O
of IN O
superfluidity NN O
in IN O
an DT O
evolving VBG O
bose-einstein NN O
condensed VBN O
Gas NNP O
We PRP O
study VBP O
the DT O
generation NN O
of IN O
excitations NNS O
due JJ O
to TO O
an DT O
"impurity NN O
" `` O
( -LRB- O
static JJ O
perturbation NN O
) -RRB- O
placed VBN O
into IN O
an DT O
oscillating NN O
Bose-Einstein NNP O
condensed VBD O
gas NN O
in IN O
the DT O
time-dependent NN O
trapping NN O
field NN O
. . O

-DOCSTART- X X O

By IN O
sequencing NN O
of IN O
exonuclease NN B-NP
III NNP I-NP
deletion NN O
clones NNS O
an DT O
open JJ O
reading NN O
frame NN O
of IN O
405 CD O
nucleotides NNS O
was VBD O
found VBN O
coding NN O
for IN O
a DT O
protein NN O
of IN O
135 CD O
amino IN O
acids NNS O
with IN O
a DT O
molecular JJ O
mass NN O
of IN O
15 CD O
kDa NN O
. . O

-DOCSTART- X X O

The DT O
c-raf-1 NN B-NP
proto-oncogene NN I-NP
is VBZ O
the DT O
cellular JJ B-NP
homologue NN I-NP
of IN I-NP
v-raf NN I-NP
, , O
the DT O
oncogene NN O
of IN O
the DT O
acutely NN O
transforming VBG O
retrovirus NN O
3611-MSV. . O

-DOCSTART- X X O

Furthermore RB O
, , O
we PRP O
detect VBP O
hCoch-5B2 NN B-NP
on IN O
three CD O
overlapping JJ O
YACs NNS O
, , O
two CD O
of IN O
which WDT O
also RB O
contain VBP O
one CD O
of IN O
the DT O
markers NNS O
linked VBN O
to TO O
DFNA9 VB B-NP
. . O
mCoch-5B2 '' B-NP
was VBD O
genetically RB O
mapped VBN O
in IN O
the DT O
mouse NN O
to TO O
chromosome NN O
12 CD O
, , O
in IN O
a DT O
region NN O
of IN O
homologous JJ O
synteny NN O
with IN O
human JJ O
14q11.2-q13 CD O
, , O
which WDT O
contains VBZ O
the DT O
asp1 NN B-NP
( -LRB- O
audiogenic JJ B-NP
seizure NN I-NP
prone JJ I-NP
) -RRB- O
locus NN O
in IN O
the DT O
mouse NN O
. . O

-DOCSTART- X X O

Reasons NNS O
are VBP O
given VBN O
for IN O
suggesting VBG O
that IN O
tiapamil NN O
warrants NNS O
further JJ O
clinical JJ O
evaluation NN O
, , O
after IN O
which WDT O
it PRP O
may MD O
join VB O
the DT O
more RBR O
established VBN O
calcium NN O
antagonists NNS O
as IN O
a DT O
valuable JJ O
therapeutic JJ O
agent NN O
. . O

-DOCSTART- X X O

Histopathologic NN O
studies NNS O
displaying VBG O
spongiform NN O
changes NNS O
in IN O
the DT O
gray JJ O
matter NN O
, , O
neuronal JJ O
loss NN O
, , O
and CC O
atrogliosis NN O
confirmed VBD O
the DT O
clinical JJ O
diagnosis NN O
of IN O
Creutzfeldt-Jakob NNP O
disease NN O
. . O

-DOCSTART- X X O

Its PRP$ O
activity NN O
was VBD O
twice RB O
that IN O
of IN O
a DT O
construct VB O
where WRB O
the DT O
CAT NNP B-NP
gene NN I-NP
was VBD O
driven VBN O
by IN O
the DT O
H-2Kb JJ B-NP
5' JJ I-NP
enhancer NN I-NP
region NN I-NP
( -LRB- O
H2TF1/KBF1 UH B-NP
site NN O
) -RRB- O
and CC O
comparable JJ O
to TO O
that DT O
of IN O
pRSVCAT NN O
construct VB B-NP
carrying VBG I-NP
the DT I-NP
strong JJ I-NP
Rous JJ I-NP
sarcoma NN I-NP
virus NN I-NP
LTR NNP I-NP
enhancer NN I-NP
. . O

-DOCSTART- X X O

The DT O
dipper NN O
( -LRB- O
RONF NNP O
of IN O
BP NNP O
( -LRB- O
or CC O
HR NNP O
) -RRB- O
> , O
or CC O
= SYM O
10 CD O
% NN O
2. . O

-DOCSTART- X X O

I. NN O

-DOCSTART- X X O

Nonsuicidal JJ O
mortality NN O
in IN O
late-life JJ O
depression NN O
. . O

-DOCSTART- X X O

However RB O
, , O
both DT O
peptides NNS O
1-49 . O
and CC O
63-87 CD O
bound VBN O
to TO O
PDE NNP B-NP
alpha/beta NN I-NP
in IN O
a DT O
solid-phase JJ O
binding NN O
assay NN O
. . O

-DOCSTART- X X O

SETTING NN O
: : O
A DT O
private JJ O
office-based JJ O
fertility NN O
program NN O
. . O

-DOCSTART- X X O

The DT O
consensus NN O
mammalian JJ O
ER NNP O
stress NN O
response NN O
element NN O
( -LRB- O
ERSE NN O
) -RRB- O
conserved VBN O
among IN O
grp JJ B-NP
promoters NNS I-NP
consists VBZ O
of IN O
a DT O
tripartite JJ O
structure NN O
CCAAT(N9)CCACG NNP O
, , O
with IN O
N NNP O
being VBG O
a DT O
strikingly RB O
GC-rich JJ O
region NN O
of IN O
9 CD O
bp NN O
. . O

-DOCSTART- X X O

Further RB O
, , O
we PRP O
find VBP O
that IN O
the DT O
BMI1 JJ B-NP
protein NN I-NP
can MD O
also RB O
interact VB O
with IN O
itself PRP O
. . O

-DOCSTART- X X O

These DT O
data NNS O
suggest VBP O
that IN O
certain JJ O
of IN O
the DT O
nuclear JJ O
protein NN O
import NN O
functions NNS O
of IN O
NTF2 NN B-NP
and CC O
Ran/TC4 NNP B-NP
are VBP O
closely RB O
linked VBN O
and CC O
that IN O
NTF2 NNP B-NP
may MD O
serve VB O
to TO O
modulate VB O
a DT O
transport NN O
step NN O
involving VBG O
Ran/TC4 NNP B-NP
. . O

-DOCSTART- X X O

Because IN O
controlled-release NN O
niacin NN O
seems VBZ O
to TO O
be VB O
more RBR O
potent JJ O
than IN O
crystalline NN O
niacin NN O
, , O
product NN O
substitution NN O
without IN O
dose NN O
adjustment NN O
should MD O
be VB O
avoided VBN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
the DT O
gene NN O
encoding JJ O
transcription NN B-NP
factor NN I-NP
cyclic NN I-NP
adenosine NN I-NP
3', IN I-NP
5'-monophosphate JJ I-NP
(cAMP NNS I-NP
) -RRB- I-NP
response NN I-NP
element-binding JJ I-NP
protein NN I-NP
( -LRB- O
CREB NN B-NP
) -RRB- O
: : O
regulation NN O
by IN O
follicle-stimulating VBG B-NP
hormone-induced JJ I-NP
cAMP JJ O
signaling NN O
in IN O
primary JJ O
rat NN O
Sertoli NNP O
cells NNS O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
the DT O
therapeutic JJ O
effectiveness NN O
of IN O
membrane NN O
and CC O
centrifugation NN O
plasmapheresis NN O

-DOCSTART- X X O

To TO O
investigate VB O
the DT O
effect NN O
of IN O
hyperthyroidism NN O
on IN O
the DT O
pattern NN O
and CC O
time NN O
course NN O
of IN O
O2 DT O
uptake JJ O
(VO2 NN O
) -RRB- O
following VBG O
the DT O
transition NN O
from IN O
rest NN O
to TO O
exercise VB O
, , O
six CD O
patients NNS O
and CC O
six CD O
healthy JJ O
subjects NNS O
performed VBN O
cycle NN O
exercise NN O
at IN O
an DT O
average JJ O
work NN O
rate NN O
( -LRB- O
WR NN O
) -RRB- O
of IN O
18 CD O
and CC O
20 CD O
W NNP O
respectively RB O
. . O

-DOCSTART- X X O

88 CD O
, , O
3739-3743 JJ O
) -RRB- O
) -RRB- O
. . O

-DOCSTART- X X O

CHIEF JJ O
OUTCOME NNP O
MEASURES NNP O
: : O
Endoluminal JJ O
release NN O
of IN O
prostacyclin NN O
(6-Keto-PGF1 JJ O
alpha NN O
) -RRB- O
and CC O
thromboxane NN O
B2 NN O
( -LRB- O
TxB2 NN O
) -RRB- O
, , O
patency NN O
, , O
EC NNP O
coverage NN O
and CC O
cell NN O
identity NN O
. . O

-DOCSTART- X X O

Seasonal JJ O
variation NN O
of IN O
the DT O
cadmium NN O
content NN O
of IN O
Murex NNP O
trunculus NN O
in IN O
a DT O
non-cadmium JJ O
polluted JJ O
environment NN O
. . O

-DOCSTART- X X O

However RB O
, , O
electron NN O
microscopy NN O
revealed VBD O
that IN O
while IN O
sec4 CD B-NP
mutant JJ I-NP
cells NNS O
accumulate VBP O
secretory JJ O
vesicles NNS O
, , O
ypt31/32 CD B-NP
mutant JJ I-NP
cells NNS O
accumulate VBP O
aberrant JJ O
Golgi NNP O
structures NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
Grap NNP B-NP
is VBZ O
associated VBN O
with IN O
a DT O
Ras NNP B-NP
guanine NNP I-NP
nucleotide JJ I-NP
exchange NN I-NP
factor NN I-NP
mSos1 NNS B-NP
, , O
primarily RB O
through IN O
its PRP$ O
N-terminal JJ B-NP
SH3 NNP I-NP
domain NN I-NP
. . O

-DOCSTART- X X O

This DT O
regimen NNS O
may MD O
be VB O
considered VBN O
front-line JJ O
therapy NN O
when WRB O
autologous JJ O
stem NN O
cell NN O
transplantation NN O
is VBZ O
not RB O
feasible JJ O
and CC O
when WRB O
a DT O
rapid JJ O
response NN O
is VBZ O
particularly RB O
important JJ O
. . O

-DOCSTART- X X O

To TO O
investigate VB O
this DT O
issue NN O
, , O
we PRP O
used VBD O
a DT O
recognition NN O
task NN O
in IN O
which WDT O
two CD O
strings NNS O
of IN O
letters NNS O
are VBP O
presented VBN O
sequentially RB O
. . O

-DOCSTART- X X O

Comparison NN O
to TO O
the DT O
murine NN O
homologues NNS O
of IN O
these DT O
molecules NNS O
reveals VBZ O
a DT O
high JJ O
degree NN O
of IN O
conservation NN O
between IN O
the DT O
products NNS O
of IN O
one CD O
of IN O
these DT O
genes NNS O
, , O
Fc NNP B-NP
gamma NNP I-NP
RIIb NNP I-NP
, , O
and CC O
the DT O
murine NN B-NP
beta JJ I-NP
gene NN I-NP
in IN O
primary JJ O
sequence NN O
, , O
splicing NN O
pattern NN O
, , O
and CC O
tissue NN O
distribution NN O
. . O

-DOCSTART- X X O

A DT O
rabbit NN O
antiserum NN O
raised VBN O
against IN O
a DT O
unique JJ O
( -LRB- O
V3 JJ O
domain NN O
) -RRB- O
bacterially RB O
expressed VBD O
PKC NNP B-NP
theta DT I-NP
fragment NN I-NP
immunoprecipitated VBD O
specifically RB O
an DT O
82-kDa JJ O
protein NN O
from IN O
Jurkat NNP O
cell NN O
lysates NNS O
. . O

-DOCSTART- X X O

Hematological JJ O
parameters NNS O
( -LRB- O
leukocyte NN O
, , O
neutrophil JJ O
and CC O
platelet NN O
counts NNS O
) -RRB- O
and CC O
liver NN O
function NN O
tests NNS O
were VBD O
determined VBN O
by IN O
standard JJ O
procedures NNS O
. . O

-DOCSTART- X X O

( -LRB- O
1993 CD O
) -RRB- O
8 CD O
, , O
94-99 CD O
) -RRB- O
. . O

-DOCSTART- X X O

It PRP O
would MD O
seem VB O
that IN O
caution NN O
should MD O
be VB O
exercised VBN O
in IN O
using VBG O
HPL NNP B-NP
values NNS O
as IN O
an DT O
index NN O
of IN O
placental JJ O
function NN O
in IN O
anaemic JJ O
women NNS O
. . O

-DOCSTART- X X O

No DT O
IORT NN O
related VBN O
mortality NN O
has VBZ O
been VBN O
observed VBN O
. . O

-DOCSTART- X X O

Characterization NNP O
of IN O
a DT O
tonB-phoA JJ B-NP
gene NN O
fusion NN O
suggests VBZ O
that IN O
the DT O
amino-terminal JJ O
41 CD O
amino IN O
acids NNS O
of IN O
TonB NNP B-NP
are VBP O
sufficient JJ O
to TO O
promote VB O
export NN O
of IN O
the DT O
fusion NN O
protein NN O
and CC O
presumably RB O
TonB NNP B-NP
as RB O
well RB O
. . O

-DOCSTART- X X O

Characterization NNP O
of IN O
a DT O
unique JJ O
protein NN O
component NN O
of IN O
yeast NN B-NP
RNase NNP I-NP
MRP NNP I-NP
: : O
an DT O
RNA-binding JJ O
protein NN O
with IN O
a DT O
zinc-cluster NN O
domain NN O
. . O

-DOCSTART- X X O

This DT O
raises VBZ O
the DT O
possibility NN O
that IN O
recombination NN O
occurred VBD O
between IN O
corresponding JJ O
LTR NNP O
and CC O
vif JJ B-NP
loci NNS I-NP
of IN O
the DT O
quasi-species NNS O
present NN O
in IN O
the DT O
isolates NNS O
described VBD O
here RB O
. . O

-DOCSTART- X X O

2. . O

-DOCSTART- X X O

The DT O
antihypertensive JJ O
action NN O
corresponds VBZ O
to TO O
those DT O
of IN O
established VBN O
diuretics NNS O
. . O

-DOCSTART- X X O

The DT O
aromatic JJ B-NP
hydrocarbon NN I-NP
receptor NN I-NP
( -LRB- O
AHR NN B-NP
) -RRB- O
is VBZ O
a DT O
ligand-activated JJ O
transcription NN O
factor NN O
that WDT O
regulates VBZ O
the DT O
expression NN O
of IN O
several JJ O
drug-metabolizing JJ O
enzymes NNS O
and CC O
has VBZ O
been VBN O
implicated VBN O
in IN O
immunosuppression NN O
, , O
teratogenesis NN O
, , O
cell-specific JJ O
hyperplasia NN O
, , O
and CC O
certain JJ O
types NNS O
of IN O
malignancies NNS O
and CC O
toxicities NNS O
. . O

-DOCSTART- X X O

The DT O
metalloproteinase NN B-NP
mediating VBG O
Met NNP B-NP
cleavage NN O
was VBD O
specifically RB O
inhibited VBN O
by IN O
the DT O
tissue NN B-NP
inhibitor NN I-NP
of IN I-NP
metalloproteinases NNS I-NP
( -LRB- I-NP
TIMP)-3 NN I-NP
, , O
but CC O
not RB O
by IN O
TIMP-1 NN B-NP
or CC O
TIMP-2 NN B-NP
. . O

-DOCSTART- X X O

METHODS NNS O
AND CC O
RESULTS NNS O
: : O
The DT O
effect NN O
of IN O
prolonged JJ O
nitrate JJ O
therapy NN O
between IN O
2 CD O
days NNS O
and CC O
6 CD O
weeks NNS O
during IN O
healing VBG O
after IN O
infarction NN O
on IN O
serial JJ O
parameters NNS O
of IN O
ventricular JJ O
remodeling NN O
(scar NN O
expansion NN O
, , O
scar NN O
thinning NN O
, , O
ventricular JJ O
dilation NN O
, , O
and CC O
hypertrophy NN O
) -RRB- O
and CC O
function NN O
( -LRB- O
asynergy NN O
or CC O
akinesis NN O
plus CC O
dyskinesis NN O
and CC O
ejection NN O
fraction NN O
) -RRB- O
by IN O
serial JJ O
two-dimensional JJ O
echocardiography NN O
, , O
hemodynamics NNS O
, , O
postmortem NN O
topography NN O
( -LRB- O
computerized JJ O
planimetry NN O
, , O
geometric JJ O
maps NNS O
, , O
and CC O
radiographs NNS O
) -RRB- O
, , O
and CC O
collagen NN B-NP
content NN O
( -LRB- O
hydroxyproline NN O
) -RRB- O
was VBD O
studied VBN O
in IN O
64 CD O
instrumented JJ O
dogs NNS O
randomized VBD O
2 CD O
days NNS O
after IN O
left JJ O
anterior JJ O
descending VBG O
coronary JJ O
artery NN O
ligation NN O
to TO O
various JJ O
nitrate JJ O
regimens NNS O
( -LRB- O
n NN O
= SYM O
32 CD O
) -RRB- O
over IN O
the DT O
first JJ O
2 CD O
weeks NNS O
( -LRB- O
subgroup NN O
1 CD O
: : O
2 CD O
% NN O
transdermal NN O
nitroglycerin NN O
at IN O
8 CD O
AM NNP O
and CC O
4 CD O
PM NNP O
, , O
n NN O
= SYM O
6 CD O
; : O
subgroup NN O
2 CD O
: : O
2 CD O
% NN O
transdermal NN O
nitroglycerin NN O
plus CC O
2.6 CD O
mg NN O
of IN O
sustained-release NN O
oral JJ O
nitroglycerin NN O
at IN O
8 CD O
AM NNP O
, , O
3 CD O
PM NNP O
, , O
and CC O
10 CD O
PM NNP O
, , O
n RB O
= SYM O
5 CD O
; : O
subgroup NN O
3 CD O
: : O
oral JJ O
isosorbide NN O
dinitrate NN O
, , O
30 CD O
mg NN O
at IN O
8 CD O
AM NNP O
and CC O
4 CD O
PM NNP O
, , O
n RB O
= SYM O
11 CD O
) -RRB- O
or CC O
6 CD O
weeks NNS O
( -LRB- O
subgroup NN O
4 CD O
: : O
isosorbide NN O
dinitrate NN O
, , O
n NN O
= SYM O
10 CD O
) -RRB- O
and CC O
in IN O
matching VBG O
controls NNS O
( -LRB- O
n NN O
= SYM O
32 CD O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
found VBN O
that IN O
pro-IGF-2 NN B-NP
can MD O
initially RB O
form VB O
two CD O
disulfide JJ O
isomers NNS O
that WDT O
undergo VBP O
rearrangement NN O
to TO O
a DT O
single JJ O
conformation NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
primate JJ O
vs. CC O
rodent JJ O
promoter NN O
selectivity NN O
mediated VBN O
by IN O
the DT O
TBP-TAF NN B-NP
I PRP B-NP
complex NN O
is VBZ O
likely JJ O
to TO O
be VB O
the DT O
result NN O
of IN O
cumulative JJ O
subtle JJ O
differences NNS O
between IN O
individual JJ O
subunits NNS O
that WDT O
lead VBP O
to TO O
species-specific JJ O
properties NNS O
of IN O
RNA NNP B-NP
polymerase NN I-NP
I PRP I-NP
transcription NN O
. . O

-DOCSTART- X X O

The DT O
structure NN O
and CC O
expression NN O
of IN O
the DT O
murine NN B-NP
gene NN I-NP
encoding JJ I-NP
granulocyte-macrophage JJ I-NP
colony NN I-NP
stimulating NN I-NP
factor NN I-NP
: : O
evidence NN O
for IN O
utilisation NN O
of IN O
alternative JJ O
promoters NNS O
. . O

-DOCSTART- X X O

Central NNP O
treatment NN O
unit NN O
saves VBZ O
nurses NNS O
, , O
adds VBZ O
income NN O
, , O
improves VBZ O
care NN O
. . O

-DOCSTART- X X O

The DT O
QCS NNP O
appears VBZ O
comparable JJ O
with IN O
the DT O
MMSE NNP O
and CC O
is VBZ O
quicker JJR O
to TO O
administer VB O
. . O

-DOCSTART- X X O

A DT O
positive JJ O
FTA-ABS-19S-IgM JJ B-NP
test NN O
indicates VBZ O
the DT O
necessity NN O
of IN O
treatment NN O
. . O

-DOCSTART- X X O

Uterine NNP O
contractions NNS O
began VBD O
with IN O
a DT O
mean JJ O
latency NN O
of IN O
62 CD O
min NN O
in IN O
the DT O
PGF2 NNP O
alpha NN O
infused VBD O
women NNS O
, , O
in IN O
controls NNS O
uterine JJ O
activity NN O
remained VBD O
unchanged JJ O
. . O

-DOCSTART- X X O

The DT O
implication NN O
of IN O
Rac NNP B-NP
and CC O
Cdc42 NNP B-NP
was VBD O
analyzed VBN O
in IN O
transient NN O
transfection NN O
experiments NNS O
using VBG O
either DT O
constitutively RB O
active JJ O
( -LRB- O
V12 NN O
) -RRB- O
or CC O
dominant-interfering JJ O
( -LRB- O
N17 NN O
) -RRB- O
mutants NNS O
. . O

-DOCSTART- X X O

The DT O
evolutionary JJ O
significance NN O
of IN O
the DT O
similarities NNS O
of IN O
intron NN O
secondary JJ O
structures NNS O
and CC O
open JJ O
reading NN O
frames NNS O
of IN O
the DT O
ND3 NNP B-NP
, , I-NP
4 CD I-NP
and CC I-NP
ATPase NNP I-NP
6 CD I-NP
genes NNS I-NP
is VBZ O
discussed VBN O
, , O
including VBG O
the DT O
possible JJ O
separate JJ O
evolution NN O
of IN O
structural JJ O
and CC O
coding JJ O
sequences NNS O
. . O

-DOCSTART- X X O

Procedures NNS O
with IN O
perfected JJ O
method NN O

-DOCSTART- X X O

A DT O
case NN O
of IN O
functioning VBG O
parathyroid NN O
carcinoma NN O
with IN O
hypereninemic JJ O
hypertension NN O
. . O

-DOCSTART- X X O

The DT O
study NN O
was VBD O
performed VBN O
in IN O
a DT O
class NN O
100 CD O
laminar NN O
flow NN O
clean JJ O
bench NN O
in IN O
order NN O
to TO O
minimize VB O
particulate NN O
contamination NN O
from IN O
extraneous JJ O
sources NNS O
. . O

-DOCSTART- X X O

The DT O
sequence NN O
of IN O
LZ321 NNP B-NP
matched VBD O
that IN O
of IN O
RREB1 NNP B-NP
, , O
a DT O
transcription NN O
factor NN O
that WDT O
bound VBD O
to TO O
a DT O
Ras NNP B-NP
responsive JJ I-NP
element NN I-NP
( -LRB- O
RRE VB B-NP
) -RRB- O
very RB O
different JJ O
from IN O
the DT O
sequence NN O
with IN O
which WDT O
we PRP O
isolated VBD O
LZ321 NNP B-NP
. . O

-DOCSTART- X X O

Phosphorylation NNP O
at IN O
Ser(670 NNP O
) -RRB- O
impairs VBZ O
the DT O
ability NN O
of IN O
GRK2 NNP B-NP
to TO O
phosphorylate VB O
both DT O
soluble JJ O
and CC O
membrane-incorporated JJ O
receptor NN O
substrates NNS O
and CC O
dramatically RB O
attenuates VBZ O
Gbetagamma-mediated JJ B-NP
activation NN O
of IN O
this DT O
enzyme NN O
. . O

-DOCSTART- X X O

The DT O
longest JJS O
S1-S2 JJ O
interval NN O
at IN O
which WDT O
S2 NNP O
failed VBD O
to TO O
capture VB O
( -LRB- O
effective JJ O
refractory JJ O
period NN O
) -RRB- O
was VBD O
longer RB O
by IN O
5.5 CD O
+/ NNS O
- : O
8.2 CD O
msec NN O
at IN O
twice JJ O
threshold NN O
( -LRB- O
0.05 CD O
less JJR O
than IN O
p NN O
less JJR O
than IN O
0.10 CD O
) -RRB- O
and CC O
5.5 CD O
+/ NN O
- : O
3.5 CD O
msec NN O
at IN O
5 CD O
times NNS O
threshold NN O
stimulation NN O
( -LRB- O
p NN O
less JJR O
than IN O
0.01 CD O
) -RRB- O
when WRB O
the DT O
basic JJ O
drive NN O
and CC O
extrastimuli NNS O
were VBD O
delivered VBN O
to TO O
separate VB O
sites NNS O
. . O

-DOCSTART- X X O

Using VBG O
lasers NNS O
, , O
PRK NNP O
involves VBZ O
reshaping VBG O
the DT O
cornea NN O
so RB O
that IN O
its PRP$ O
refractive JJ O
power NN O
is VBZ O
increased VBN O
. . O

-DOCSTART- X X O

Inhibition NN O
of IN O
Raf-1 NNP B-NP
signaling VBG O
by IN O
a DT O
monoclonal JJ O
antibody NN O
, , O
which WDT O
interferes VBZ O
with IN O
Raf-1 NNP B-NP
activation NN O
and CC O
with IN O
Mek NNP B-NP
substrate JJ O
binding NN O
. . O

-DOCSTART- X X O

Laparoscopic JJ O
examination NN O
1 CD O
year NN O
after IN O
surgery NN O
revealed VBD O
an DT O
enlarged VBN O
, , O
thin-walled JJ O
, , O
and CC O
fluid-filled JJ O
uterine NN O
segment NN O
cranial NN O
to TO O
the DT O
midcornus NN O
occlusion NN O
sites NNS O
in IN O
all DT O
animals NNS O
. . O

-DOCSTART- X X O

NBSII NNP O
is VBZ O
essential JJ O
for IN O
ribosome-stimulated JJ O
activity NN O
. . O

-DOCSTART- X X O

Gel NNP O
shift NN O
and CC O
southwestern JJ O
experiments NNS O
revealed VBN O
nuclear JJ O
proteins NNS O
of IN O
43 CD O
kDa NN O
and CC O
30 CD O
kDa NN O
in IN O
GC NNP O
and CC O
fish NN O
cells NNS O
, , O
respectively RB O
, , O
that IN O
bind NN O
specifically RB O
to TO O
the DT O
tGH NN B-NP
CRE RB O
, , O
suggesting VBG O
the DT O
involvement NN O
of IN O
CRE-binding-protein/activating-transcription-factor-l-related JJ B-NP
peptides NNS O
in IN O
cAMP JJ O
response NN O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
such JJ O
mutations NNS O
lead VBP O
to TO O
a DT O
dramatic JJ O
transition NN O
in IN O
chromatin NN O
structure NN O
: : O
the DT O
DNase NN B-NP
I PRP I-NP
hypersensitive VBP I-NP
region NN I-NP
is VBZ O
replaced VBN O
by IN O
two CD O
stable JJ O
, , O
sequence-positioned JJ O
nucleosomes NNS O
. . O

-DOCSTART- X X O

Two CD O
measures NNS O
of IN O
sensory JJ O
inhibition NN O
were VBD O
employed VBN O
, , O
S2/S1 NNP O
x NNP O
100 CD O
amplitude NN O
ratio NN O
and CC O
S1-S2 JJ O
amplitude NN O
difference NN O
. . O

-DOCSTART- X X O

The DT O
transcriptional JJ O
start NN O
site NN O
, , O
identified VBN O
by IN O
primer JJ O
extension NN O
and CC O
S1 JJ B-NP
nuclease NN I-NP
assay NN O
, , O
is VBZ O
34 CD O
nt JJ O
upstream RB O
of IN O
the DT O
translation NN O
initiation NN O
codon NN O
. . O

-DOCSTART- X X O

The DT O
clinical JJ O
effects NNS O
of IN O
valproate NN O
and CC O
ethosuximide NN O
can MD O
be VB O
related VBN O
to TO O
this DT O
differential JJ O
modulation NN O
of IN O
thalamocortical DT O
excitability NN O
. . O

-DOCSTART- X X O

Central NNP O
projections NNS O
of IN O
gastric JJ O
afferent JJ O
vagal NN O
inputs NNS O
. . O

-DOCSTART- X X O

Like IN O
Mdm2 NNP B-NP
, , O
MdmX NNP B-NP
is VBZ O
able JJ O
to TO O
bind NN O
p53 NN B-NP
and CC O
inhibit VB O
p53 NN B-NP
transactivation NN O
; : O
however RB O
, , O
the DT O
ability NN O
of IN O
MdmX NNP B-NP
to TO O
degrade VB O
p53 NN B-NP
has VBZ O
yet RB O
to TO O
be VB O
examined VBN O
. . O

-DOCSTART- X X O

The DT O
structure NN O
of IN O
the DT O
mAR NN B-NP
ORF NN O
was VBD O
confirmed VBN O
by IN O
sequence NN O
analysis NN O
of IN O
mAR NN B-NP
cDNA NN O
fragments NNS O
, , O
which WDT O
were VBD O
obtained VBN O
by IN O
PCR NNP O
amplification NN O
of IN O
mouse NN O
testis NN O
cDNA NN O
, , O
using VBG O
mAR NN B-NP
specific JJ O
primers NNS O
. . O

-DOCSTART- X X O

Transforming VBG B-NP
growth NN I-NP
factor-beta NN I-NP
( -LRB- O
TGF-beta NN B-NP
) -RRB- O
inhibits VBZ O
cell NN O
cycle NN O
progression NN O
, , O
in IN O
part NN O
through IN O
up-regulation NN O
of IN O
gene NN O
expression NN O
of IN O
the DT O
p21(WAF1/Cip1 NN B-NP
) -RRB- O
( -LRB- O
p21 NN B-NP
) -RRB- O
cell NN O
cycle NN O
inhibitor NN O
. . O

-DOCSTART- X X O

Decreased JJ O
plasma NN O
level NN O
of IN O
antithrombin JJ B-NP
III NNP I-NP
was VBD O
assumed VBN O
to TO O
be VB O
one CD O
of IN O
the DT O
major JJ O
factors NNS O
underlying VBG O
hypercoagulable JJ O
state NN O
in IN O
nephrotic JJ O
syndrome NN O
. . O

-DOCSTART- X X O

In IN O
both DT O
RAW NNP O
cells NNS O
and CC O
the DT O
microglia NNS O
cell NN O
line NN O
EOC20 NNP O
, , O
two CD O
IFN-gamma-activated JJ B-NP
transcription NN O
factors NNS O
, , O
STAT-1alpha NNP B-NP
and CC O
IRF-1 NNP B-NP
, , O
bind VBP O
the DT O
GAS NNP B-NP
and CC O
IRF NNP B-NP
elements NNS I-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

All DT O
patients NNS O
received VBD O
marrow JJ O
from IN O
HLA-identical JJ B-NP
sibling NN O
donors NNS O
, , O
underwent JJ O
similar JJ O
myeloablative JJ O
regimens NNS O
, , O
and CC O
had VBD O
similar JJ O
pretreatment NN O
characteristics NNS O
. . O

-DOCSTART- X X O

Immunoblot NNP O
analyses NNS O
revealed VBD O
that IN O
the DT O
loss NN O
of IN O
activator NN O
function NN O
coincides VBZ O
with IN O
selective JJ O
removal NN O
of IN O
the DT O
C-terminal JJ B-NP
domain NN I-NP
( -LRB- I-NP
CTD)-hyperphosphorylated JJ I-NP
RNAP NNP I-NP
IIO NNP I-NP
along IN O
with IN O
NC2 NNP B-NP
. . O

-DOCSTART- X X O

In IN O
bell NN O
pepper NN O
, , O
a DT O
gene NN O
encoding VBG O
a DT O
major JJ O
plastid-lipid NN O
associated VBN O
protein NN O
is VBZ O
expressed VBN O
as IN O
both DT O
partially RB O
and CC O
totally RB O
spliced JJ O
transcripts NNS O
( -LRB- O
respectively RB O
PAP2 NNP B-NP
and CC O
PAP1 NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Aggregation NNP O
in IN O
washed VBN O
platelets NNS O
from IN O
rats NNS O
with IN O
diabetes NN O
was VBD O
enhanced VBN O
. . O

-DOCSTART- X X O

The DT O
authors NNS O
investigate VB O
in IN O
a DT O
group NN O
of IN O
211 CD O
children NNS O
aged VBN O
2-6 CD O
years NNS O
, , O
incl RB O
. . O
in IN O
particular JJ O
a DT O
group NN O
of IN O
33 CD O
2-year-old JJ O
ones NNS O
, , O
in IN O
1990 CD O
and CC O
checked VBN O
in IN O
1991 CD O
at IN O
two CD O
sites NNS O
in IN O
Bratislava--a NNP O
town NN O
with IN O
a DT O
varying VBG O
concentration NN O
of IN O
NOX NNP O
, , O
SO2 NNP O
, , O
dustiness NN O
and CC O
dust NN O
fallout--their JJ O
influence NN O
on IN O
the DT O
incidence NN O
, , O
type NN O
and CC O
course NN O
of IN O
relapsing VBG O
respiratory JJ O
disease NN O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
DaunoXome NNP O
has VBZ O
an DT O
improved VBN O
pharmacokinetic JJ O
profile NN O
compared VBN O
with IN O
free JJ O
daunorubicin NN O
, , O
and CC O
is VBZ O
well RB O
tolerated VBN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
zincon-loaded JJ O
resin NN O
was VBD O
applied VBN O
to TO O
the DT O
selective JJ O
concentration NN O
of IN O
trace NN O
amounts NNS O
of IN O
chalcophile NN O
elements NNS O
in IN O
natural JJ O
water NN O
samples NNS O
prior RB O
to TO O
neutron POS O
activation NN O
analysis NN O
. . O

-DOCSTART- X X O

The DT O
NH( NNP O
2)-terminus NNP O
of IN O
all DT O
three CD O
proteins NNS O
contains VBZ O
a DT O
POZ NN O
domain NN O
, , O
a DT O
conserved JJ O
120 CD O
amino NN O
acid NN O
motif NN O
involved VBN O
in IN O
transcriptional JJ O
repression NN O
and CC O
protein NN O
dimerization NN O
. . O

-DOCSTART- X X O

Recognition NNP O
of IN O
DNA NNP O
by IN O
single-chain JJ O
derivatives NNS O
of IN O
the DT O
phage NN O
434 CD O
repressor NN O
: : O
high JJ O
affinity NN O
binding NN O
depends VBZ O
on IN O
both DT O
the DT O
contacted VBN O
and CC O
non-contacted JJ O
base NN O
pairs NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
absence NN O
of IN O
Mg2+ NNP O
, , O
the DT O
extent NN O
of IN O
destabilization NN O
of IN O
tRNAPhe DT B-NP
is VBZ O
greater JJR O
but CC O
appears VBZ O
to TO O
be VB O
confined VBN O
to TO O
internal JJ O
regions NNS O
of IN O
the DT O
acceptor NN O
and CC O
T NNP O
psi NNS O
C NNP O
helices NNS O
, , O
as IN O
evidenced VBN O
by IN O
the DT O
selectively JJ O
enhanced JJ O
exchange NN O
rates NNS O
for IN O
imino NN O
protons NNS O
associated VBN O
with IN O
these DT O
base NN O
pairs NNS O
. . O

-DOCSTART- X X O

The DT O
carboxyl-terminal JJ O
75 CD O
amino IN O
acids NNS O
of IN O
the DT O
two CD O
proteins NNS O
contain VBP O
the DT O
bHLH NN O
motif NN O
and CC O
differ VBP O
from IN O
each DT O
other JJ O
by IN O
only JJ O
three CD O
conservative JJ O
amino IN O
acid NN O
changes NNS O
, , O
while IN O
the DT O
amino-terminal JJ O
portions NNS O
are VBP O
markedly RB O
divergent JJ O
from IN O
each DT O
other JJ O
. . O

-DOCSTART- X X O

A DT O
Drosophila NNP O
subobscura NN O
genomic JJ O
fragment NN O
containing VBG O
all DT O
the DT O
exons NNS O
and CC O
the DT O
late JJ O
and CC O
early JJ O
promotors NNS O
in IN O
the DT O
Sxl NNP B-NP
gene NN I-NP
of IN I-NP
D. NNP I-NP
melanogaster NN I-NP
was VBD O
isolated VBN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
of IN O
the DT O
transient-transfection NN O
assay NN O
showed VBD O
that IN O
the DT O
Sp1 NNP B-NP
binding JJ I-NP
element NN I-NP
located VBN O
in IN O
the DT O
core NN O
region NN O
( -LRB- O
positions NNS O
--64 NN O
to TO O
+1 CD O
) -RRB- O
of IN O
the DT O
alpha2-integrin NN B-NP
promoter NN I-NP
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
the DT O
alpha2-integrin NN B-NP
promoter NN I-NP
activity NN O
and CC O
its PRP$ O
downregulation NN O
by IN O
Erb-B2 NNP B-NP
. . O

-DOCSTART- X X O

These DT O
observations NNS O
suggest VBP O
that IN O
the DT O
AF-1 JJ O
region NN O
of IN O
PPARalpha NNP B-NP
is VBZ O
partially RB O
silenced VBN O
by IN O
corepressor JJ O
proteins NNS O
, , O
which WDT O
might MD O
interact VB O
in IN O
a DT O
phosphorylation-dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

Insertion NN O
of IN O
alternatively RB O
spliced VBN O
exon NN O
W NNP O
into IN O
CREB NNP B-NP
mRNA NN I-NP
during IN O
spermatogenesis NN O
results NNS O
in IN O
a DT O
polycistronic JJ O
RNA NNP O
that IN O
encodes VBZ O
two CD O
novel NN O
internally RB O
translated VBD O
CREB NNP B-NP
repressor NNP I-NP
isoforms VBZ I-NP
called VBN O
I-CREBs NNP B-NP
, , O
consisting VBG O
of IN O
the DT O
carboxy-terminal JJ O
DNA-binding NN O
domain NN O
devoid JJ O
of IN O
the DT O
transactivation NN O
domains VBZ O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
BRCA1 NN I-NP
promoter NN I-NP
also RB O
contains VBZ O
a DT O
conserved JJ O
E2F NN B-NP
site NN I-NP
and CC O
is VBZ O
similarly RB O
regulated VBN O
by IN O
E2F1 NNP B-NP
and CC O
Rb NNP B-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
studies NNS O
described VBN O
in IN O
this DT O
report NN O
, , O
we PRP O
have VBP O
identified VBN O
two CD O
potential JJ O
Ets NNS B-NP
binding VBG O
sites NNS O
, , O
EBS1 NNP B-NP
and CC O
EBS2 NNP B-NP
, , O
which WDT O
are VBP O
conserved VBN O
in IN O
both DT O
the DT O
human JJ O
and CC O
murine JJ O
interleukin-2 JJ B-NP
enhancers NNS O
. . O

-DOCSTART- X X O

An DT O
enhancement NN O
of IN O
benign JJ O
liver NN O
tumors NNS O
( -LRB- O
tumorigenic JJ O
effect NN O
) -RRB- O
was VBD O
observed VBN O
only RB O
in IN O
CF1 NNP O
male NN O
mice NNS O
( -LRB- O
17/56 CD O
at IN O
the DT O
only RB O
tested VBN O
dose NN O
: : O
400 CD O
ppm NN O
vs. FW O

-DOCSTART- X X O

Stamps NNP O
in IN O
cardiology NN O
: : O
de FW O
Musset NNP O
sign NN O
. . O

-DOCSTART- X X O

268 CD O
, , O
6858-6861 CD O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
the DT O
transcriptional JJ O
activator NN O
CREM NNP B-NP
is VBZ O
highly RB O
expressed VBN O
in IN O
postmeiotic JJ O
cells NNS O
. . O

-DOCSTART- X X O

For IN O
more RBR O
detailed JJ O
mapping NN O
, , O
we PRP O
constructed VBD O
mouse NN O
A9 IN O
cells NNS O
containing VBG O
STFs NNP O
derived VBD O
from IN O
human JJ O
chromosome NN O
2 CD O
tagged VBN O
with IN O
pSTneo NN O
at IN O
different JJ O
regions NNS O
in IN O
2q31-qter JJ O
. . O

-DOCSTART- X X O

We PRP O
therefore RB O
propose VBP O
that IN O
PRR2 NNP B-NP
, , O
and CC O
not RB O
PVR NNP B-NP
, , O
is VBZ O
the DT O
true JJ O
human JJ O
homolog NN O
of IN O
MPH. NNP B-NP

-DOCSTART- X X O

Cbl NNP B-NP
is VBZ O
a DT O
signaling VBG O
molecule NN O
with IN O
multiple JJ O
functional JJ O
domains NNS O
: : O
an DT O
SH2 NNP B-NP
domain NN I-NP
which WDT O
binds VBZ O
phosphotyrosine NN O
residues NNS O
, , O
a DT O
RING NNP O
finger NN O
domain NN O
which WDT O
acts VBZ O
as IN O
a DT O
ubiquitin NN B-NP
ligase NN I-NP
, , O
a DT O
proline-rich JJ O
region NN O
which WDT O
serves VBZ O
as IN O
a DT O
docking NN O
site NN O
for IN O
SH3-containing JJ B-NP
proteins NNS I-NP
, , O
phosphotyrosine NN O
residues NNS O
which WDT O
serve VBP O
as IN O
docking VBG O
sites NNS O
for IN O
SH2-containing JJ B-NP
proteins NNS I-NP
such JJ O
a DT O
CrkL NNP B-NP
and CC O
the DT O
p85 NN B-NP
subunit NN I-NP
of IN O
PI NNP B-NP
3-kinase CD I-NP
, , O
and CC O
a DT O
nuclear JJ O
localization NN O
signal NN O
. . O

-DOCSTART- X X O

No DT O
interaction NN O
with IN O
epidural JJ O
anesthesia NN O
was VBD O
observed VBN O
. . O

-DOCSTART- X X O

Region NN O
I PRP O
includes VBZ O
the DT O
two CD O
cysteine-cysteine JJ O
zinc NN O
fingers NNS O
that WDT O
comprise VBP O
a DT O
DNA-binding JJ O
domain NN O
which WDT O
typifies VBZ O
all DT O
members NNS O
of IN O
the DT O
superfamily NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
to TO O
Phase NNP O
III NNP O
, , O
which WDT O
has VBZ O
a DT O
single JJ O
study NN O
design--the , O
controlled VBN O
, , O
randomized VBD O
, , O
double-blind JJ O
study--Phase NN O
IV NNP O
requires VBZ O
different JJ O
designs NNS O
for IN O
each DT O
of IN O
the DT O
many JJ O
different JJ O
questions NNS O
. . O

-DOCSTART- X X O

This DT O
bound JJ O
[3H]iloprost NN O
with IN O
high JJ O
affinity NN O
and CC O
stimulated VBD O
cAMP JJ O
production NN O
when WRB O
exposed VBN O
to TO O
agonist VB O
. . O

-DOCSTART- X X O

Juvenile NNP O
idiopathic JJ O
inflammatory NN O
myopathies NNS O
: : O
the DT O
value NN O
of IN O
magnetic JJ O
resonance NN O
imaging NN O
in IN O
the DT O
detection NN O
of IN O
muscle NN O
involvement NN O
. . O

-DOCSTART- X X O

The DT O
methods NNS O
used VBN O
were VBD O
the DT O
AOAC NNP O
method NN O
of IN O
dilution NN O
and CC O
heating NN O
; : O
the DT O
addition NN O
of IN O
mercuric NN O
chloride NN O
, , O
charcoal NN O
, , O
and CC O
Carrez NNP O
reagents NNS O
at IN O
2 CD O
different JJ O
pH NN O
values NNS O
; : O
and CC O
direct JJ O
analysis NN O
of IN O
sample NN O
supernatants NNS O
with IN O
no DT O
treatment NN O
( -LRB- O
control NN O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
review NN O
of IN O
156 CD O
patients NNS O
younger JJR O
than IN O
40 CD O
treated VBN O
at IN O
our PRP$ O
Department NNP O
between IN O
1960 CD O
and CC O
1991 CD O
with IN O
transitional JJ O
cell NN O
carcinoma NN O
of IN O
the DT O
bladder NN O
revealed VBD O
that IN O
89.1 CD O
% NN O
had VBD O
superficial JJ O
( -LRB- O
Ta/T1 NN O
) -RRB- O
disease NN O
and CC O
the DT O
remaining VBG O
10.9 CD O
% NN O
presented VBN O
with IN O
invasive JJ O
disease NN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
the DT O
Asp NNP O
but CC O
not RB O
the DT O
Ala NNP O
gB NNP B-NP
mutation NN O
resulted VBD O
in IN O
an DT O
increase NN O
in IN O
the DT O
steady-state JJ O
expression NN O
of IN O
gB NN B-NP
at IN O
the DT O
plasma NN O
membrane NN O
( -LRB- O
PM) NNP O
in IN O
U373 NNP O
cells NNS O
. . O

-DOCSTART- X X O

Large JJ O
volumes NNS O
of IN O
bone NN O
marrow NN O
may MD O
be VB O
required VBN O
for IN O
certain JJ O
types NNS O
of IN O
autologous JJ O
bone NN O
marrow NN O
transplants NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
dauricine NN O
and CC O
verapamil NN O
have VBP O
a DT O
salutary JJ O
effect NN O
in IN O
extracorporeal JJ O
circulation NN O
. . O

-DOCSTART- X X O

For IN O
evaluation NN O
of IN O
the DT O
model NN O
, , O
simulations NNS O
of IN O
physiological JJ O
excitation NN O
and CC O
of IN O
pathologies NNS O
( -LRB- O
Wolff-Parkinson-White JJ O
syndrome NN O
, , O
complete JJ O
AV-block NN O
, , O
inferior JJ O
wall NN O
ischaemia NN O
) -RRB- O
were VBD O
examined VBN O
. . O

-DOCSTART- X X O

For IN O
rotating VBG O
stimuli NNS O
presented VBN O
to TO O
the DT O
dominant JJ O
eye NN O
, , O
this DT O
class NN O
of IN O
neurons NNS O
responded VBD O
best RB O
to TO O
rotation NN O
of IN O
the DT O
visual JJ O
world NN O
about IN O
an DT O
axis NN O
oriented VBN O
near IN O
the DT O
horizontal JJ O
plane NN O
and CC O
approximately RB O
45 CD O
degrees NNS O
azimuth NN O
. . O

-DOCSTART- X X O

The DT O
incidence NN O
of IN O
the DT O
variability NN O
of IN O
the DT O
free JJ O
PSA/total JJ B-NP
PSA NNP B-NP
ratio NN O
on IN O
the DT O
early JJ O
diagnosis NN O
of IN O
prostate NN O
cancer NN O

-DOCSTART- X X O

A DT O
TAAATA NNP O
sequence NN O
is VBZ O
present JJ O
26 CD O
nt NN O
upstream RB O
from IN O
the DT O
major JJ O
CAP NNP O
site NN O
, , O
and CC O
within IN O
the DT O
5'-flanking JJ O
region NN O
there EX O
are VBP O
several JJ O
putative JJ O
transcription NN O
factor NN O
binding VBG O
sites NNS O
. . O

-DOCSTART- X X O

Iris NNP O
binding NN O
and CC O
bioavailability NN O
. . O

-DOCSTART- X X O

The DT O
dopamine NN B-NP
D1 IN I-NP
dopamine NN I-NP
receptor NN I-NP
antagonist NN O
SCH NNP O
23390 CD O
dose NN O
dependently RB O
( -LRB- O
7.5-30 CD O
micrograms/kg JJ O
s.c. NN O
) -RRB- O
antagonized VBN O
the DT O
stimulant NN O
locomotor NN O
effect NN O
on IN O
both DT O
drugs NNS O
but CC O
did VBD O
not RB O
prevent VB O
their PRP$ O
antiimmobility NN O
effect NN O
on IN O
the DT O
behavioral JJ O
despair NN O
test NN O
. . O

-DOCSTART- X X O

Neither DT O
symptoms NNS O
, , O
virions NNS O
, , O
nor CC O
viral JJ O
RNA NNP O
was VBD O
detectable JJ O
in IN O
plants NNS O
inoculated VBN O
with IN O
this DT O
mutant JJ O
or CC O
a DT O
mutant JJ O
with IN O
a DT O
frameshift NN O
mutation NN O
in IN O
the DT O
coat NN B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Chromaffin NNP O
cells NNS O
transfected VBN O
with IN O
a DT O
plasmid NN O
with IN O
the DT O
entire JJ O
coding NN O
sequence NN O
of IN O
c-Rabphilin3a JJ B-NP
inserted VBN O
in IN O
the DT O
antisense NN O
orientation NN O
inhibited VBD O
secretion NN O
of IN O
co-expressed JJ O
GH NNP B-NP
by IN O
approximately RB O
30 CD O
% NN O
. . O

-DOCSTART- X X O

A DT O
sequence-ready JJ O
3-Mb JJ O
PAC NNP O
contig NN O
covering VBG O
16 CD O
breakpoints NNS O
of IN O
the DT O
Wilms NNP B-NP
tumor/anirida VBD I-NP
region NN I-NP
of IN O
human JJ O
chromosome NN O
11p13 CD O
. . O

-DOCSTART- X X O

Compression NN O
of IN O
pulmonary JJ O
artery NN O
and CC O
right JJ O
ventricular JJ O
outflow NN O
tract NN O
by IN O
aneurysm NN O
of IN O
ascending VBG O
aorta NN O
. . O

-DOCSTART- X X O

High JJ O
expression NN O
of IN O
p51A NN B-NP
( -LRB- O
TAp63gamma NNP B-NP
) -RRB- O
in IN O
the DT O
skeletal JJ O
muscle NN O
tissue NN O
drove VBD O
us PRP O
to TO O
investigate VB O
a DT O
differentiation-inducible JJ O
myoblastic JJ O
cell NN O
line NN O
which WDT O
showed VBD O
increased VBN O
p51A DT B-NP
expression NN O
after IN O
differentiation NN O
induction NN O
. . O

-DOCSTART- X X O

Nosographic JJ O
problems NNS O

-DOCSTART- X X O

Since IN O
UmuD NNP B-NP
protein NN I-NP
is VBZ O
proteolytically RB O
processed VBN O
to TO O
an DT O
active JJ O
form NN O
( -LRB- O
UmuD*) NNP B-NP
in IN O
a DT O
RecA*-dependent JJ B-NP
fashion NN O
, , O
and CC O
MucA NNP B-NP
shares NNS O
extensive JJ O
amino IN O
acid NN O
homology NN O
with IN O
UmuD NNP B-NP
, , O
we PRP O
examined VBD O
whether IN O
MucA NNP B-NP
is VBZ O
similarly RB O
processed VBN O
in IN O
the DT O
cell NN O
, , O
using VBG O
antiserum NN O
against IN O
a DT O
LacZ'-'MucA JJ B-NP
fusion NN O
protein NN O
. . O

-DOCSTART- X X O

Changes NNS O
in IN O
BHR NNP O
were VBD O
found VBN O
to TO O
correlate VB O
significantly RB O
with IN O
changes NNS O
in IN O
the DT O
levels NNS O
of IN O
24 CD O
h NN O
mean JJ O
SO2 NNP O
, , O
NO2 NNP O
and CC O
smoke NN O
; : O
48 CD O
h NN O
mean JJ O
NO2 NN O
and CC O
smoke NN O
; : O
24 CD O
h NN O
lag NN O
NO2 NN O
; : O
although IN O
the DT O
effect NN O
was VBD O
only RB O
small JJ O
, , O
accounting VBG O
for IN O
approximately RB O
10 CD O
% NN O
of IN O
the DT O
variability NN O
in IN O
within-subject JJ O
BHR NN O
between IN O
visits NNS O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
domains NNS O
mediating VBG O
transcription NN O
activation NN O
, , O
repression NN O
, , O
and CC O
inhibition NN O
in IN O
the DT O
paired-related JJ B-NP
homeobox NN I-NP
protein NN I-NP
, , O
Prx2 NNP B-NP
( -LRB- O
S8 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Where WRB O
the DT O
resonator NN O
has VBZ O
two CD O
holes NNS O
, , O
these DT O
terms NNS O
should MD O
be VB O
somewhat RB O
modified VBN O
: : O
A DT O
is VBZ O
the DT O
combined JJ O
area NN O
of IN O
the DT O
two CD O
holes NNS O
, , O
L NNP O
is VBZ O
16/3pi CD O
r NN O
( -LRB- O
~1.7r NN O
) -RRB- O
for IN O
a DT O
simple JJ O
hole NN O
in IN O
a DT O
thin-walled JJ O
vessel NN O
and CC O
r NN O
is VBZ O
the DT O
radius NN O
of IN O
one CD O
hole NN O
( -LRB- O
Seto NNP O
, , O
1971 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
most RBS O
distal JJ O
active JJ O
site NN O
in IN O
TIGA NNP B-NP
is VBZ O
created VBN O
by IN O
excision NN O
of IN O
a DT O
66-bp JJ O
intron NN O
. . O

-DOCSTART- X X O

GeneCalling NNP O
analysis NN O
was VBD O
successful JJ O
in IN O
detecting VBG O
members NNS O
of IN O
complex JJ O
metabolic JJ O
pathways NNS O
and CC O
uncovering VBG O
novel JJ O
genes NNS O
that WDT O
were VBD O
either RB O
coincidentally RB O
regulated VBN O
or CC O
directly RB O
involved VBN O
in IN O
such JJ O
pathways NNS O
. . O

-DOCSTART- X X O

Wingless/Wnt NNP B-NP
signaling NN O
directs VBZ O
cell-fate JJ O
choices NNS O
during IN O
embryonic JJ O
development NN O
. . O

-DOCSTART- X X O

Patients NNS O
with IN O
the DT O
chronic NN O
photosensitivity NN O
dermatitis NN O
with IN O
actinic JJ O
reticuloid JJ O
syndrome NN O
have VBP O
high JJ O
total JJ O
serum NN O
IgE NNP B-NP
concentrations NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
cognate NN O
binding JJ O
protein NN O
is VBZ O
present JJ O
in IN O
both DT O
rat NN O
and CC O
human NN O
( -LRB- O
HeLa NNP O
) -RRB- O
cell NN O
nuclear JJ O
extracts NNS O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
stimulation NN O
of IN O
the DT O
entopeduncular JJ O
nucleus NN O
( -LRB- O
EP NNP O
) -RRB- O
on IN O
the DT O
jaw-opening NN O
reflex NN O
( -LRB- O
JOR NN O
) -RRB- O
was VBD O
studied VBN O
in IN O
the DT O
cat NN O
anesthetized VBN O
with IN O
sodium NN O
pentobarbital NN O
. . O

-DOCSTART- X X O

We PRP O
cloned VBD O
the DT O
BamHI-F JJ B-NP
fragment NN I-NP
from IN O
the DT O
left JJ O
end NN O
of IN O
Ad4 NNP O
in IN O
pUC13-1 NN O
between IN O
the DT O
SalI NNP B-NP
and CC O
BamHI NNP B-NP
sites NNS I-NP
in IN O
order NN O
to TO O
carry VB O
out RP O
the DT O
structural JJ O
analysis NN O
of IN O
the DT O
E1A JJ B-NP
region NN I-NP
of IN I-NP
Ad4 NNP I-NP
. . O

-DOCSTART- X X O

The DT O
objective NN O
of IN O
this DT O
research NN O
was VBD O
to TO O
determine VB O
if IN O
ergotamine NN O
, , O
an DT O
ergopeptine JJ O
alkaloid JJ O
isolated VBN O
from IN O
Neotyphodium-infected JJ O
grasses NNS O
and CC O
associated VBN O
with IN O
toxicoses NNS O
in IN O
livestock NN O
, , O
altered VBN O
plasma NN O
concentrations NNS O
of IN O
reproductive JJ O
hormones NNS O
in IN O
follicular JJ O
phase NN O
heifers NNS O
and CC O
in IN O
cows NNS O
given VBN O
a DT O
progestin NN O
implant NN O
. . O

-DOCSTART- X X O

The DT O
following VBG O
parameters NNS O
were VBD O
measured VBN O
: : O
onset VBN O
time NN O
(time JJ O
interval NN O
from IN O
injection NN O
to TO O
maximal JJ O
or CC O
total JJ O
block NN O
) -RRB- O
, , O
T125/75 DT O
(time NN O
for IN O
T1 NNP O
to TO O
reach VB O
25 CD O
% NN O
or CC O
75 CD O
% NN O
of IN O
control NN O
) -RRB- O
, , O
TOF70 DT O
(time NN O
for IN O
TOF NNP O
ratio NN O
to TO O
reach VB O
70 CD O
% NN O
of IN O
control NN O
) -RRB- O
, , O
heart NN O
rate NN O
and CC O
blood NN O
pressure NN O
. . O

-DOCSTART- X X O

Ectopic NNP O
Xbra NNP B-NP
can MD O
induce VB O
Xegr-1 JJ B-NP
transcription NN O
by IN O
an DT O
indirect JJ O
mechanism NN O
that WDT O
appears VBZ O
to TO O
operate VB O
via IN O
primary JJ O
activation NN O
of IN O
fibroblast JJ B-NP
growth NN I-NP
factor NN I-NP
secretion NN O
. . O

-DOCSTART- X X O

For IN O
example NN O
, , O
the DT O
presence NN O
of IN O
two CD O
related JJ O
genes NNS O
, , O
b NN B-NP
and CC O
b' JJ B-NP
, , O
in IN O
the DT O
cyanobacterium NN O
suggests VBZ O
that IN O
its PRP$ O
ATP NNP B-NP
synthase NN I-NP
is VBZ O
a DT O
complex NN O
of IN O
nine CD O
polypeptides NNS O
, , O
and CC O
that IN O
it PRP O
may MD O
have VB O
single JJ O
copies NNS O
of IN O
related VBN O
b NN B-NP
and CC O
b' JJ B-NP
proteins NNS I-NP
rather RB O
than IN O
two CD O
copies NNS O
of IN O
identical JJ O
b NN B-NP
subunits NNS I-NP
as IN O
found VBN O
in IN O
the DT O
E. NNP O
coli NNS O
enzyme VBD O
.4+off . O

-DOCSTART- X X O

DDD(R NNP O
) -RRB- O
pacing NN O
with IN O
automatic JJ O
mode NN O
switch NN O
in IN O
patients NNS O
with IN O
paroxysmal JJ O
atrial JJ O
fibrillation NN O
following VBG O
AV NNP O
nodal NN O
ablation NN O
. . O

-DOCSTART- X X O

These DT O
events NNS O
were VBD O
only RB O
weakly RB O
stimulated VBN O
by IN O
the DT O
activated JJ B-NP
PDGF NNP I-NP
alpha-receptor NN I-NP
. . O

-DOCSTART- X X O

These DT O
results NNS O
establish VBP O
that IN O
the DT O
DNA NN O
fragment NN O
we PRP O
have VBP O
isolated VBN O
contains VBZ O
the DT O
human JJ B-NP
gp130 CD I-NP
promoter NN I-NP
and CC O
that DT O
interleukin-6 NN B-NP
type NN I-NP
cytokines NNS I-NP
may MD O
influence VB O
the DT O
activity NN O
of IN O
this DT O
promoter NN O
via IN O
activated VBN O
STATs NNP B-NP
. . O

-DOCSTART- X X O

Only RB O
53 CD O
% NN O
of IN O
all DT O
injuries NNS O
and CC O
12.5 CD O
% NN O
of IN O
serious JJ O
injuries NNS O
involved VBN O
children NNS O
, , O
and CC O
in IN O
contrast NN O
to TO O
the DT O
1950s NNS O
and CC O
early JJ O
1960s NNS O
, , O
young JJ O
adults NNS O
appear VBP O
at IN O
greatest JJS O
risk NN O
in IN O
the DT O
1980s CD O
. . O

-DOCSTART- X X O

Three CD O
simple JJ O
methods NNS O
of IN O
detecting VBG O
malnutrition NN O
on IN O
medical JJ O
wards NNS O
. . O

-DOCSTART- X X O

We PRP O
also RB O
show VBP O
that IN O
an DT O
internal JJ O
fragment NN O
of IN O
U24 NNP B-NP
methylation NN I-NP
guide NN I-NP
snoRNA NN I-NP
, , O
encompassing VBG O
the DT O
upstream JJ O
antisense NN O
element NN O
and CC O
the DT O
D' NNP O
and CC O
C' FW O
box NN O
motifs NNS O
, , O
can MD O
support VB O
the DT O
site-specific JJ O
methylation NN O
of IN O
rRNA NNP O
. . O

-DOCSTART- X X O

The DT O
gap NN B-NP
protein NN O
knirps NNS B-NP
mediates VBZ O
both DT O
quenching NN O
and CC O
direct JJ O
repression NN O
in IN O
the DT O
Drosophila NNP O
embryo NN O
. . O

-DOCSTART- X X O

An DT O
infant NN O
of IN O
8 CD O
months NNS O
with IN O
congenital JJ O
glaucoma NN O
and CC O
hemophilia NN O
A DT O
lost VBN O
one CD O
eye NN O
due JJ O
to TO O
haemorrhages NNS O
after IN O
trabeculotomy NN O
in IN O
an DT O
eye NN O
hospital NN O
. . O

-DOCSTART- X X O

Encapsulation NN O
of IN O
sodium NN O
fluorescein NN O
for IN O
dye JJ O
release NN O
studies NNS O
. . O

-DOCSTART- X X O

Ethanol NNP O
preference NN O
in IN O
strains NNS O
of IN O
rats NNS O
selectively RB O
bred VBD O
for IN O
behavioral VBG O
characteristics NNS O
. . O

-DOCSTART- X X O

Incubation NNP O
of IN O
HeLa NNP O
cell NN O
cytoplasmic JJ O
extracts NNS O
with IN O
a DT O
purified VBN O
recombinant NN O
glutathione NN B-NP
S-transferase-raf JJ I-NP
fusion NN O
protein NN O
in IN O
the DT O
presence NN O
of IN O
ATP NNP O
released VBD O
active JJ O
NF-kappa NNP B-NP
B NNP I-NP
that WDT O
could MD O
be VB O
detected VBN O
by IN O
electrophoretic JJ O
gel NN O
mobility NN O
shift NN O
assay NN O
. . O

-DOCSTART- X X O

Both DT O
the DT O
p38 NNS B-NP
kinase NN I-NP
inhibitor NN O
SB205380 . O
( -LRB- O
SB NNP O
) -RRB- O
and CC O
cotransfection NN O
of IN O
a DT O
dominant-negative JJ O
mutant NN O
of IN O
p38 DT B-NP
kinase NN I-NP
reduced VBD O
IL-1beta JJ B-NP
stimulation NN O
of IN O
the DT O
hBNP NN B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Recent JJ O
geological JJ O
studies NNS O
focusing VBG O
on IN O
the DT O
Davie NNP O
Fracture NNP O
Zone NNP O
of IN O
the DT O
Mozambique NNP O
Channel NNP O
offer NN O
a DT O
resolution NN O
to TO O
this DT O
situation NN O
, , O
by IN O
suggesting VBG O
the DT O
presence NN O
of IN O
a DT O
land-bridge NN O
from IN O
the DT O
mid-Eocene NN O
to TO O
the DT O
early JJ O
Miocene NNP O
, , O
an DT O
interval NN O
that WDT O
matches VBZ O
the DT O
ages NNS O
of IN O
Madagascar NNP O
's POS O
mammalian JJ O
groups NNS O
. . O

-DOCSTART- X X O

On IN O
the DT O
basis NN O
of IN O
8 CD O
cases NNS O
, , O
the DT O
authors NNS O
report VBP O
different JJ O
clinical JJ O
pictures NNS O
all DT O
caused VBN O
by IN O
cardiac JJ O
toxicity NN O
of IN O
5FU. VBG O

-DOCSTART- X X O

The DT O
immunoprofile NN O
of IN O
60 CD O
adult NN O
patients NNS O
of IN O
pulmonary JJ O
tuberculosis NN O
was VBD O
studied VBN O
and CC O
compared VBN O
with IN O
22 CD O
normal JJ O
controls NNS O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
long-term JJ O
use NN O
of IN O
raloxifene NN O
, , O
a DT O
selective JJ O
estrogen NN B-NP
receptor NN I-NP
modulator NN O
, , O
on IN O
thyroid DT O
function NN O
test NN O
profiles NNS O
. . O

-DOCSTART- X X O

Module NNP O
2 CD O
of IN O
RifA NNP B-NP
lacks VBZ O
a DT O
beta-ketoacyl JJ B-NP
:acyl NN I-NP
carrier NN I-NP
protein NN I-NP
reductase NN I-NP
(KR NN O
) -RRB- O
domain NN O
and CC O
the DT O
one CD O
in IN O
module NN O
3 CD O
has VBZ O
an DT O
apparently RB O
inactive JJ O
NADPH NNP B-NP
binding NN I-NP
motif NN I-NP
, , O
similar JJ O
to TO O
one CD O
found VBN O
in IN O
the DT O
Er NNP B-NP
PKS NNP I-NP
, , O
while IN O
the DT O
other JJ O
eight CD O
KR NNP B-NP
domains NNS I-NP
of IN O
the DT O
Rf NNP B-NP
PKS NNP I-NP
should MD O
be VB O
functional JJ O
. . O

-DOCSTART- X X O

Synergy NNP O
between IN O
interferon-gamma NN B-NP
and CC O
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
in IN O
transcriptional JJ O
activation NN O
is VBZ O
mediated VBN O
by IN O
cooperation NN O
between IN O
signal NN B-NP
transducer NN I-NP
and CC I-NP
activator NN I-NP
of IN I-NP
transcription NN I-NP
1 CD I-NP
and CC O
nuclear JJ B-NP
factor NN I-NP
kappaB. . I-NP

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
In IN O
the DT O
results NNS O
of IN O
this DT O
study NN O
, , O
SDB NNP O
, , O
even RB O
snoring VBG O
, , O
was VBD O
independently RB O
associated VBN O
with IN O
hypertension NN O
in IN O
both DT O
men NNS O
and CC O
women NNS O
. . O

-DOCSTART- X X O

Transfection NN O
of IN O
both DT O
Calu-6 NNP O
and CC O
JEG-3 JJ O
cells NNS O
with IN O
a DT O
PKA NNP B-NP
expression NN O
vector NN O
resulted VBD O
in IN O
a DT O
10-fold JJ O
induction NN O
of IN O
human JJ B-NP
renin NN I-NP
transcriptional JJ O
activity NN O
in IN O
constructs NNS O
containing VBG O
the DT O
native JJ O
or CC O
consensus NN O
CRE NNP O
and CC O
5-fold JJ O
activation NN O
in IN O
a DT O
construct VB O
containing VBG O
a DT O
nonfunctional JJ O
CRE. NNP O

-DOCSTART- X X O

In IN O
renal JJ O
vein NN O
thrombosis NN O
, , O
similar JJ O
pattern NN O
to TO O
acute JJ O
tubular JJ O
necrosis NN O
was VBD O
found VBN O
but CC O
RI NNP O
venography NN O
was VBD O
helpful JJ O
. . O

-DOCSTART- X X O

Restricted VBN O
expression NN O
of IN O
a DT O
novel NN O
murine NN B-NP
atonal-related VBD I-NP
bHLH JJ I-NP
protein NN I-NP
in IN O
undifferentiated JJ O
neural JJ O
precursors NNS O
. . O

-DOCSTART- X X O

Oligo-[alpha]-deoxynucleotides NNS O
can MD O
be VB O
derived VBN O
by IN O
stabilizing VBG O
( -LRB- O
intercalating NN O
) -RRB- O
agents NNS O
or CC O
reactive JJ O
groups NNS O
( -LRB- O
cleaving VBG O
reagents NNS O
, , O
cross-linkers NNS O
... : O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
two CD O
cis-acting JJ O
elements NNS O
direct JJ O
the DT O
first JJ O
zygotic JJ O
expression NN O
of IN O
Kr NNP B-NP
in IN O
a DT O
striped JJ O
subpattern NN O
within IN O
the DT O
central JJ O
region NN O
of IN O
the DT O
blastoderm NN O
embryo NN O
. . O

-DOCSTART- X X O

For IN O
capsules NNS O
containing VBG O
only RB O
the DT O
drug NN O
, , O
the DT O
value NN O
of IN O
T50 DT O
increased VBN O
as IN O
the DT O
particle NN O
size NN O
of IN O
the DT O
drug NN O
decreased VBN O
. . O

-DOCSTART- X X O

Its PRP$ O
prognostic JJ O
impact NN O
is VBZ O
superior JJ O
to TO O
the DT O
T1/2 NN O
one CD O
( -LRB- O
RR NN O
= SYM O
2.9 CD O
; : O
p NN O
= SYM O
0.0010 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Previous JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
the DT O
21- CD O
or CC O
the DT O
72-bp JJ O
repeat NN O
transcriptional JJ O
control NN O
elements NNS O
enhance VB O
the DT O
efficiency NN O
of IN O
SV40 JJ O
DNA NNP O
replication NN O
in IN O
vivo NN O
, , O
provided VBN O
either DT O
of IN O
these DT O
repeats NNS O
is VBZ O
located VBN O
near IN O
the DT O
end NN O
of IN O
the DT O
core NN O
replication NN O
origin NN O
containing VBG O
the DT O
17-bp JJ O
A DT O
+ NN O
T-containing NN O
sequence NN O
. . O

-DOCSTART- X X O

ER NNP O
and CC O
DR NN O
were VBD O
significantly RB O
correlated VBN O
with IN O
MIB-1 JJ B-NP
LI NNP O
( -LRB- O
P<0.01 NNP O
and CC O
P<0.05 CD O
, , O
respectively RB O
) -RRB- O
, , O
but CC O
RI NNP O
and CC O
Td/Te NNP O
were VBD O
not RB O
. . O

-DOCSTART- X X O

D. NNP O
, , O
and CC O
Long NNP O
, , O
C. NNP O

-DOCSTART- X X O

A DT O
lead NN O
phthalocyanin NN O
method NN O
for IN O
the DT O
demonstration NN O
of IN O
acid NN B-NP
hydrolases NNS I-NP
in IN O
plant NN O
and CC O
animal NN O
tissues NNS O
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
describe VBP O
the DT O
three-dimensional JJ O
structure NN O
of IN O
the DT O
enzyme NN O
from IN O
Escherichia NNP O
colidetermined . O
and CC O
refined JJ O
to TO O
2.0 CD O
A DT O
resolution NN O
. . O

-DOCSTART- X X O

cDNA NN O
cloning NN O
, , O
sequencing NN O
and CC O
chromosome NN O
mapping NN O
of IN O
a DT O
non-erythroid JJ B-NP
spectrin NN I-NP
, , O
human JJ B-NP
alpha-fodrin NN I-NP
. . O

-DOCSTART- X X O

In IN O
serial JJ O
recall NN O
from IN O
short-term JJ O
memory NN O
, , O
repeated VBN O
items NNS O
are VBP O
recalled VBN O
well RB O
when WRB O
close NN O
together RB O
( -LRB- O
repetition NN O
facilitation NN O
) -RRB- O
, , O
but CC O
not RB O
when WRB O
far RB O
apart RB O
( -LRB- O
repetition NN O
inhibition NN O
; : O
the DT O
Ranschburg NNP O
effect NN O
) -RRB- O
. . O

-DOCSTART- X X O

Posterior NNP O
osteophytes NNS O
around IN O
the DT O
posterior JJ O
edges NNS O
of IN O
vertebral JJ O
body NN O
resulted VBD O
in IN O
intervertebral JJ O
insufficiency NN O
, , O
and CC O
corresponded VBD O
to TO O
hypertrophic JJ O
spur NN O
in IN O
osteochondrosis NN O
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

Nuclear NNP O
extracts NNS O
from IN O
Sertoli NNP O
cells NNS O
were VBD O
found VBN O
to TO O
cause VB O
an DT O
E-box NNP O
gel NNP O
shift NN O
when WRB O
the DT O
cells NNS O
were VBD O
stimulated VBN O
to TO O
differentiate JJ O
in IN O
culture NN O
, , O
but CC O
not RB O
under IN O
basal JJ O
conditions NNS O
. . O

-DOCSTART- X X O

The DT O
combination NN O
of IN O
ICP47 NNP B-NP
and CC O
US11 NNP B-NP
rendered VBD O
fibroblasts NNS O
negative JJ O
for IN O
surface NN B-NP
class NN I-NP
I PRP I-NP
MHC RB I-NP
and CC O
allowed VBD O
a DT O
class NN B-NP
I PRP I-NP
MHC-low JJ I-NP
population NN O
of IN O
T NNP O
cells NNS O
to TO O
be VB O
sorted VBN O
by IN O
flow NN O
cytometry NN O
. . O

-DOCSTART- X X O

The DT O
recovery NN O
of IN O
adults NNS O
schistosomes NNS O
by IN O
extracorporeal JJ O
filtration NN O
. . O

-DOCSTART- X X O

Biochemical NNP O
studies NNS O
and CC O
studies NNS O
of IN O
cells NNS O
expressing VBG O
mutant JJ O
IL-2 JJ B-NP
receptors NNS I-NP
indicate VBP O
that IN O
IL-2-induced JJ B-NP
tyrosine NN B-NP
kinase NN I-NP
activation NN O
initiates VBZ O
a DT O
complex JJ O
signaling NN O
cascade NN O
. . O

-DOCSTART- X X O

Serum NN O
levels NNS O
of IN O
angiotensin NN B-NP
converting VBG I-NP
enzyme NN I-NP
were VBD O
well RB O
maintained VBN O
. . O

-DOCSTART- X X O

We PRP O
tested VBD O
the DT O
effects NNS O
of IN O
antifungal JJ O
drugs NNS O
on IN O
adherence NN O
of IN O
Candida NNP O
albicans NNS O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Portions NNS O
of IN O
the DT O
3'-coding JJ O
and CC O
3'-untranslated JJ O
regions NNS O
were VBD O
found VBN O
to TO O
be VB O
missing VBG O
from IN O
the DT O
7.2- CD B-NP
and CC I-NP
4.8-kb JJ I-NP
topo NN I-NP
II NNP I-NP
alpha NN I-NP
mRNAs NNS I-NP
by IN O
Northern JJ O
blot NN O
analysis NN O
. . O

-DOCSTART- X X O

An DT O
analogue NN O
of IN O
calcium NN O
, , O
strontium NN O
chloride NN O
Sr NN O
89 CD O
is VBZ O
rapidly RB O
cleared VBN O
from IN O
the DT O
blood NN O
after IN O
i PRP$ O
.v. NNP O
injection NN O
. . O

-DOCSTART- X X O

These DT O
mutants NNS O
, , O
assayed VBN O
by IN O
injection NN O
into IN O
Xenopus NNP O
oocyte NNP O
nuclei NNS O
, , O
delimit VB O
the DT O
promoter NN O
to TO O
36 CD O
bp NN O
of IN O
DNA NNP O
upstream RB O
of IN O
the DT O
cap NN O
site NN O
and CC O
73 CD O
bp NN O
of IN O
the DT O
untranslated JJ O
mRNA NN O
leader NN O
. . O

-DOCSTART- X X O

( -LRB- O
3 CD O
) -RRB- O
With IN O
the DT O
exception NN O
of IN O
the DT O
anteroposterior JJ O
direction NN O
of IN O
layers NNS O
II--II CC O
I PRP O
and CC O
the DT O
mediolateral JJ O
direction NN O
of IN O
layer NN O
IV NNP O
, , O
the DT O
vertical JJ O
conductivity NN O
of IN O
the DT O
cortex NN O
was VBD O
always RB O
greater JJR O
than IN O
either DT O
of IN O
the DT O
horizontal JJ O
conductivities NNS O
. . O

-DOCSTART- X X O

Acad NNP O
. . O

-DOCSTART- X X O

To TO O
obtain VB O
information NN O
on IN O
the DT O
functional JJ O
role NN O
of IN O
the DT O
Rac1/p38/MAPKAPK-2 NNP B-NP
pathway NN O
in IN O
RA NNP O
signaling NN O
, , O
the DT O
effects NNS O
of IN O
pharmacological JJ O
inhibition NN O
of IN O
p38 NNS B-NP
on IN O
RA-induced JJ O
gene NN O
transcription NN O
and CC O
cell NN O
differentiation NN O
were VBD O
determined VBN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
The DT O
MC/UA NNP O
ratio NN O
improves VBZ O
the DT O
sensitivity NN O
for IN O
the DT O
prediction NN O
of IN O
poor JJ O
perinatal JJ O
outcome NN O
when WRB O
it PRP O
is VBZ O
combined VBN O
with IN O
the DT O
NST. NNP O

-DOCSTART- X X O

Evolution NN O
of IN O
cytomegalovirus NN O
antibodies NNS O
of IN O
maternal JJ O
origin NN O
and CC O
acquired VBD O
, , O
throughout IN O
the DT O
first JJ O
year NN O
of IN O
life NN O

-DOCSTART- X X O

The DT O
sequence NN O
contained VBD O
five CD O
repeats NNS O
of IN O
the DT O
hypothetical JJ O
leucine NN O
zipper NN O
motif NN O
: : O
one CD O
is VBZ O
in IN O
the DT O
N-terminal JJ O
globular JJ O
domain NN O
, , O
and CC O
four CD O
are VBP O
in IN O
the DT O
central JJ O
alpha-helical JJ O
stalk NN O
. . O

-DOCSTART- X X O

Zta NNP B-NP
stimulated VBD O
the DT O
HAT NNP B-NP
activity NN O
of IN O
CBP NNP B-NP
that WDT O
had VBD O
been VBN O
partially RB O
purified VBN O
or CC O
immunoprecipitated VBN O
from IN O
mammalian JJ O
cells NNS O
as RB O
well RB O
as IN O
from IN O
affinity-purified JJ O
, , O
baculovirus JJ O
expressed VBD O
CBP. . B-NP

-DOCSTART- X X O

Previous JJ O
studies NNS O
using VBG O
partial JJ O
sequences NNS O
have VBP O
suggested VBN O
the DT O
potential NN O
of IN O
26S CD B-NP
or CC O
large-subunit JJ B-NP
( -LRB- O
LSU) NN B-NP
rDNA NN O
for IN O
phylogeny NN O
retrieval NN O
at IN O
taxonomic JJ O
levels NNS O
comparable JJ O
to TO O
those DT O
investigated VBN O
with IN O
18S DT B-NP
rDNA NNP I-NP
. . O

-DOCSTART- X X O

P53 DT B-NP
mutations NNS I-NP
also RB O
offer VBP O
new JJ O
approaches NNS O
to TO O
the DT O
study NN O
of IN O
the DT O
origins NNS O
of IN O
mutations NNS O
in IN O
human JJ O
cancer NN O
. . O

-DOCSTART- X X O

Due JJ O
to TO O
significant JJ O
homology NN O
to TO O
the DT O
C-terminus NN O
of IN O
the DT O
Mutator NNP B-NP
transposase NN I-NP
this DT O
alternative JJ O
gene NN O
product NN O
was VBD O
named VBN O
Trap NNP B-NP
( -LRB- O
transposon-associated JJ B-NP
protein NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
novel NN O
serine NN B-NP
kinase NN I-NP
activated VBN O
by IN O
rac1/CDC42Hs-dependent JJ B-NP
autophosphorylation NN O
is VBZ O
related VBN O
to TO O
PAK65 VB B-NP
and CC O
STE20 VB B-NP
. . O

-DOCSTART- X X O

CYP51P1 NNP B-NP
is VBZ O
96.5 CD O
% NN O
identical JJ O
to TO O
the DT O
human JJ B-NP
CYP51 NNP I-NP
coding NN O
sequence NN O
and CC O
is VBZ O
not RB O
interrupted VBN O
with IN O
introns NNS O
but CC O
has VBZ O
six CD O
in-frame JJ O
stop NN O
codons NNS O
resulting VBG O
from IN O
point NN O
mutations NNS O
. . O

-DOCSTART- X X O

IgE-binding JJ B-NP
proteins NNS I-NP
of IN O
Psocoptera NNP O
were VBD O
determined VBN O
by IN O
immunoblotting JJ O
experiments NNS O
. . O

-DOCSTART- X X O

174 CD O
, , O
233-247 CD O
) -RRB- O
and CC O
Serrate NNP O
( -LRB- O
Serrate1 NNP O
and CC O
2 CD O
; : O
Myat NNP O
, , O
A. NN O
, , O
Henrique NNP O
, , O
D. NNP O
, , O
Ish-Horowicz NNP O
, , O
D. NNP O
and CC O
Lewis NNP O
, , O
J. NNP O
, , O
1996 CD O
. . O

-DOCSTART- X X O

A DT O
new JJ O
technique NN O
for IN O
the DT O
identification NN O
of IN O
phases NNS O
contained VBN O
within IN O
a DT O
polymer NN O
blend NN O
is VBZ O
described VBN O
in IN O
this DT O
paper NN O
. . O

-DOCSTART- X X O

Our PRP$ O
studies NNS O
indicate VBP O
no DT O
single JJ O
trans-acting JJ O
factor NN O
is VBZ O
absolutely RB O
essential JJ O
for IN O
enhancer NN O
activity NN O
, , O
and CC O
that IN O
the DT O
enhancer NN O
activity NN O
of IN O
MerI NNP B-NP
is VBZ O
mediated VBN O
via IN O
a DT O
combinatorial JJ O
and CC O
additive JJ O
mechanism NN O
. . O

-DOCSTART- X X O

We PRP O
recently RB O
reported VBD O
the DT O
cloning NN O
and CC O
sequencing NN O
of IN O
the DT O
alpha NN B-NP
7 CD I-NP
integrin NN I-NP
chain NN I-NP
and CC O
its PRP$ O
regulated JJ O
expression NN O
during IN O
the DT O
development NN O
of IN O
skeletal NN O
muscle NN O
( -LRB- O
Song NNP O
et NNP O
al NN O
. . O

-DOCSTART- X X O

A DT O
structural JJ O
model NN O
for IN O
Vpu NNP B-NP
is VBZ O
proposed VBN O
in IN O
which WDT O
the DT O
membrane NN O
anchor NN O
precedes VBZ O
a DT O
region NN O
comprising VBG O
two CD O
amphipathic JJ O
alpha-helices NNS O
of IN O
opposed JJ O
polarity NN O
, , O
joined VBN O
by IN O
a DT O
strongly RB O
acidic JJ O
turn NN O
that WDT O
protrudes VBZ O
into IN O
the DT O
cytoplasm NN O
and CC O
contains VBZ O
the DT O
CK-2 JJ B-NP
phosphorylation NN I-NP
sites NNS I-NP
. . O

-DOCSTART- X X O

Primer JJ O
extension NN O
analysis NN O
and CC O
subcloning NN O
of IN O
the DT O
virJ-phoA JJ B-NP
fusion NN O
indicate VBP O
that IN O
the DT O
acetosyringone-inducible JJ O
promoter NN O
lies VBZ O
directly RB O
upstream RB O
of IN O
the DT O
virJ NN B-NP
structural JJ I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
A DT O
discriminant JJ O
function NN O
predicting VBG O
surgery NN O
outcome NN O
( -LRB- O
seizure-free JJ O
vs. NN O
non-seizure-free JJ O
) -RRB- O
was VBD O
computed VBN O
separately RB O
for IN O
samples NNS O
of IN O
patients NNS O
with IN O
left JJ O
( -LRB- O
n NN O
= SYM O
79 CD O
) -RRB- O
and CC O
right JJ O
( -LRB- O
n NN O
= SYM O
62 CD O
) -RRB- O
temporal JJ O
lobectomy NN O
( -LRB- O
LATL NNP O
, , O
RATL NNP O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
porcine NN O
model NN O
of IN O
diffuse NN O
axonal JJ O
injury NN O
, , O
developed VBN O
with IN O
information NN O
from IN O
these DT O
physical JJ O
models NNS O
and CC O
earlier JJR O
in IN O
vitro NN O
tissue NN O
modeling JJ O
studies NNS O
, , O
is VBZ O
used VBN O
to TO O
correlate VB O
histologic NN O
and CC O
radiologic JJ O
evidence NN O
of IN O
axonal JJ O
injury NN O
to TO O
predicted VBN O
regions NNS O
of IN O
injury NN O
from IN O
the DT O
experimental JJ O
and CC O
theoretical JJ O
analysis NN O
. . O

-DOCSTART- X X O

Control NNP O
of IN O
ovulation NN O
in IN O
mares NNS O
in IN O
the DT O
early JJ O
breeding NN O
season NN O
with IN O
ovarian JJ O
steroids NNS O
and CC O
prostaglandin NN O
. . O

-DOCSTART- X X O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
the DT O
response NN O
properties NNS O
of IN O
the DT O
human JJ O
visual JJ O
cortex NN O
to TO O
chromatic JJ O
stimuli NNS O
using VBG O
magnetoencephalography NN O
( -LRB- O
MEG) NNP O
. . O

-DOCSTART- X X O

3. . O

-DOCSTART- X X O

The DT O
root-mean-square JJ O
deviation NN O
of IN O
bond NN O
lengths NNS O
from IN O
the DT O
ideal JJ O
values NNS O
is VBZ O
0.02 CD O
A. NN O

-DOCSTART- X X O

Sugar NNP O
analysis NN O
was VBD O
performed VBN O
on IN O
alpha-TM NNS B-NP
to TO O
investigate VB O
a DT O
possible JJ O
biosynthetic JJ O
mechanism NN O
for IN O
part-time JJ O
PGs NNS O
. . O

-DOCSTART- X X O

4 CD O
. . O

-DOCSTART- X X O

Prevalence NN O
of IN O
rheumatic JJ O
diseases NNS O
in IN O
a DT O
rural JJ O
population NN O
in IN O
western JJ O
India NNP O
: : O
a DT O
WHO-ILAR NN O
COPCORD NNP O
Study NNP O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
clonidine NN O
3 CD O
micrograms/kg NN O
produces VBZ O
sedation NN O
comparable JJ O
to TO O
diazepam VB O
0.2 CD O
mg/kg NN O
and CC O
also RB O
attenuates VBZ O
the DT O
intubation NN O
response NN O
without IN O
increasing VBG O
the DT O
incidence NN O
of IN O
complications NNS O
. . O

-DOCSTART- X X O

The DT O
Saccharomyces NNP O
cerevisiae NN O
targets NNS O
of IN O
rapamycin NN O
, , O
TOR1 NNP B-NP
and CC O
TOR2 NNP B-NP
, , O
signal NN O
activation NN O
of IN O
cell NN O
growth NN O
in IN O
response NN O
to TO O
nutrient JJ O
availability NN O
. . O

-DOCSTART- X X O

Gene NNP O
structure NN O
and CC O
precursor NN O
processing NN O
. . O

-DOCSTART- X X O

Blood NN O
and CC O
whole-brain JJ O
mercury NN O
concentrations NNS O
were VBD O
determined VBN O
in IN O
pups NNS O
on IN O
PN NNP O
0 CD O
( -LRB- O
birth NN O
) -RRB- O
and CC O
PN NNP O
21 CD O
( -LRB- O
weaning NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
blood NN O
pressures NNS O
in IN O
43 CD O
subjects NNS O
were VBD O
compared VBN O
during IN O
rapid JJ O
weight NN O
loss NN O
and CC O
at IN O
identical JJ O
weights NNS O
during IN O
post-fast JJ O
weight NN O
gain NN O
( -LRB- O
Study NNP O
A) NNP O
. . O

-DOCSTART- X X O

Mol NNP O
. . O

-DOCSTART- X X O

Arg-130 JJ O
, , O
Gly-132 JJ O
and CC O
Lys-167 JJ O
are VBP O
conserved VBN O
in IN O
all DT O
members NNS O
of IN O
the DT O
type NN B-NP
IB NNP I-NP
topoisomerase NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

The DT O
maximal JJ O
rise NN O
in IN O
plasma NN O
adrenaline NN O
was VBD O
of IN O
similar JJ O
magnitude NN O
in IN O
all DT O
three CD O
groups NNS O
but CC O
a DT O
lower JJR O
plasma NN O
glucose NN O
was VBD O
required VBN O
to TO O
stimulate VB O
this DT O
hormonal JJ O
response NN O
in IN O
the DT O
'unaware JJ O
' POS O
patients NNS O
, , O
in IN O
whom WP O
the DT O
plasma NN O
adrenaline NN O
concentration NN O
was VBD O
lower JJR O
at IN O
the DT O
time NN O
of IN O
the DT O
reaction NN O
. . O

-DOCSTART- X X O

PATIENTS--125 DT O
women NNS O
consulting VBG O
the DT O
general JJ O
practitioner NN O
for IN O
symptomatic JJ O
bacterial JJ O
vaginosis NN O
. . O

-DOCSTART- X X O

Promoter NNP O
activity NN O
of IN O
the DT O
proliferating-cell JJ B-NP
nuclear JJ I-NP
antigen JJ I-NP
gene NN I-NP
is VBZ O
associated VBN O
with IN O
inducible JJ O
CRE-binding JJ B-NP
proteins NNS I-NP
in IN O
interleukin JJ B-NP
2-stimulated JJ I-NP
T NNP O
lymphocytes NNS O
. . O

-DOCSTART- X X O

The DT O
mutation NN O
also RB O
preferentially RB O
limits NNS O
( -LRB- O
compared VBN O
with IN O
total JJ O
protein NN O
synthesis NN O
) -RRB- O
translation NN O
of IN O
an DT O
induced JJ O
gene NN O
that WDT O
depends VBZ O
on IN O
five CD O
AGA NNP O
codons NNS O
, , O
i IN O
.e NN O
. . O
, , O
the DT O
lambda NN B-NP
cI IN I-NP
repressor NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
inhibition NN O
of IN O
MAPK NNP B-NP
activity NN O
by IN O
MAPK NNP B-NP
kinase NN I-NP
inhibitor NN O
( -LRB- O
PD JJ O
98059 CD O
) -RRB- O
or CC O
by IN O
overexpression NN O
of IN O
kinase-deficient JJ O
MAPKs NNP B-NP
activated VBD O
basal JJ O
and CC O
GnRH-A-stimulated JJ B-NP
GnRHR-Luc JJ B-NP
activity NN O
. . O

-DOCSTART- X X O

For IN O
the DT O
first JJ O
, , O
short-term JJ O
( -LRB- O
concurrent JJ O
) -RRB- O
TAL NN O
, , O
two CD O
different-flavored JJ O
stimuli NNS O
were VBD O
presented VBN O
at IN O
the DT O
same JJ O
time NN O
, , O
one CD O
associated VBN O
with IN O
simultaneous JJ O
intragastric JJ O
administration NN O
of IN O
an DT O
aversive JJ O
product NN O
, , O
hypertonic JJ O
NaCl NNP O
, , O
and CC O
the DT O
other JJ O
with IN O
saline NN O
. . O

-DOCSTART- X X O

Heterodimerization NNP B-NP
mutant JJ I-NP
RXR NNP I-NP
failed VBD O
to TO O
alter VB O
GFP-VDR JJ B-NP
and CC O
nlsGFP-VDR JJ B-NP
distribution NN O
or CC O
activity NN O
. . O

-DOCSTART- X X O

Smectic-A NNP O
ordering VBG O
at IN O
a DT O
liquid-vapor NN O
interface NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
demonstrate VBP O
that IN O
the DT O
entire JJ O
E3L JJ B-NP
gene NN I-NP
is VBZ O
required VBN O
for IN O
pathogenesis NN O
in IN O
the DT O
mouse NN O
model NN O
. . O

-DOCSTART- X X O

Parelaphostrongylus NNP O
odocoilei NNP O
is VBZ O
redescribed VBN O
from IN O
worms NNS O
collected VBN O
from IN O
the DT O
type NN O
host NN O
( -LRB- O
Odocoileus NNP O
hemionus NN O
columbianus NN O
) -RRB- O
in IN O
California NNP O
, , O
as RB O
well RB O
as IN O
material NN O
from IN O
experimentally RB O
infected VBN O
mule NN O
deer NNS O
( -LRB- O
O. NNP O
h NN O
. . O
heminus NN O
) -RRB- O
in IN O
Alberta NNP O
. . O

-DOCSTART- X X O

Particle NNP O
bombardment NN O
of IN O
barley NN O
aleurone NN O
with IN O
a DT O
B22EL8 CD B-NP
promoter-GUS JJ I-NP
( -LRB- O
beta-glucuronidase NN B-NP
) -RRB- O
construct VB O
demonstrates VBZ O
that IN O
the DT O
promoter NN O
( -LRB- O
3 CD O
kb NN O
) -RRB- O
is VBZ O
active JJ O
in IN O
developing VBG O
barley NN O
grains NNS O
. . O

-DOCSTART- X X O

They PRP O
elicit VBD O
similar JJ O
regional JJ O
cerebral NN O
blood NN O
flow NN O
(rCBF IN O
) -RRB- O
patterns NNS O
, , O
even RB O
though IN O
sign NN O
language NN O
is VBZ O
dependent JJ O
on IN O
spatial JJ O
information NN O
. . O

-DOCSTART- X X O

First RB O
, , O
a DT O
GATA-1 JJ B-NP
motif NN I-NP
was VBD O
found VBN O
to TO O
bind NN O
nuclear JJ O
factor( NN O
s VBZ O
) -RRB- O
, , O
presumably RB O
the DT O
GATA-1 JJ B-NP
factor NN I-NP
, , O
present JJ O
in IN O
K-562 JJ O
cell NN O
extracts NNS O
and CC O
in IN O
living VBG O
K-562 JJ O
cells NNS O
. . O

-DOCSTART- X X O

There EX O
was VBD O
a DT O
direct JJ O
proportional JJ O
relationship NN O
between IN O
the DT O
spiral NN O
artery NN O
flow NN O
and CC O
the DT O
pressure NN O
difference NN O
between IN O
the DT O
spiral NN O
artery NN O
and CC O
the DT O
amniotic JJ O
fluid NN O
; : O
the DT O
pressure NN O
difference NN O
per IN O
flow NN O
( -LRB- O
the DT O
resistance NN O
of IN O
the DT O
cotyledonary JJ O
unit NN O
) -RRB- O
was VBD O
found VBN O
to TO O
be VB O
1--3 JJ O
mm CD O
Hg NNP O
. . O
ml-1 '' O
. . O
min NN O
(8--24kPa NNP O
. . O
ml-1 NN O
. . O
s PRP O
) -RRB- O
. . O

-DOCSTART- X X O

Truncations NNS O
from IN O
Hip NNP B-NP
's POS O
N NNP O
terminus NN O
resulted VBD O
in IN O
an DT O
apparent JJ O
loss NN O
of IN O
Hip NNP B-NP
homo-oligomerization NN O
, , O
but CC O
these DT O
mutants NNS O
retained VBD O
association NN O
with IN O
hsp70 CD B-NP
and CC O
were VBD O
recovered VBN O
in IN O
receptor NN O
complexes NNS O
. . O

-DOCSTART- X X O

3. . O

-DOCSTART- X X O

The DT O
rate NN O
of IN O
collagen NN B-NP
synthesis NN O
in IN O
normal JJ O
scar NN O
was VBD O
approximately RB O
constant JJ O
between IN O
6 CD O
months NNS O
and CC O
20 CD O
years NNS O
after IN O
the DT O
initial JJ O
wounding NN O
, , O
but CC O
in IN O
both DT O
hypertrophic JJ O
scar NN O
and CC O
keloid VBD O
the DT O
rate NN O
was VBD O
initially RB O
approximately RB O
twice JJ O
that IN O
in IN O
normal JJ O
scar NN O
, , O
and CC O
2-3 CD O
years NNS O
after IN O
wounding VBG O
it PRP O
fell VBD O
to TO O
approximately RB O
the DT O
same JJ O
level NN O
as IN O
in IN O
normal JJ O
scar NN O
. . O

-DOCSTART- X X O

W. NNP O
, , O
and CC O
Touster NNP O
, , O
O. NNP O

-DOCSTART- X X O

There EX O
was VBD O
a DT O
57 CD O
% NN O
reduction NN O
in IN O
IGF NNP B-NP
IR NNP I-NP
mRNA NN I-NP
levels NNS O
in IN O
clone NN O
CA9 IN O
after IN O
confluence NN O
compared VBN O
with IN O
clone NN O
ME10 CD O
. . O

-DOCSTART- X X O

Uncertainty NN O
exists VBZ O
about IN O
the DT O
function NN O
of IN O
these DT O
potential JJ O
isoforms NNS O
of IN O
the DT O
Cbfa1 NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
RTI40 NNP B-NP
gene NN I-NP
spans VBZ O
35 CD O
kilobase NN O
pairs NNS O
; : O
it PRP O
contains VBZ O
6 CD O
exons NNS O
and CC O
at IN O
least JJS O
6 CD O
rat NN O
Identifier NN O
repetitive JJ O
elements NNS O
. . O

-DOCSTART- X X O

The DT O
characteristics NNS O
of IN O
a DT O
simple JJ O
apparatus NN O
for IN O
clinical JJ O
use NN O
to TO O
measure VB O
DEOAEs NNP O
are VBP O
described VBN O
together RB O
with IN O
typical JJ O
examples NNS O
of IN O
emissions NNS O
. . O

-DOCSTART- X X O

During IN O
seed NN O
maturation NN O
, , O
the DT O
transcriptional JJ O
activity NN O
of IN O
napin NN B-NP
genes NNS I-NP
is VBZ O
regulated VBN O
by IN O
developmental JJ O
signals NNS O
involving VBG O
the DT O
transcriptional JJ B-NP
activator NN I-NP
ABI3 . I-NP
and CC O
abscisic JJ O
acid NN O
( -LRB- O
ABA NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
isomerization NN O
of IN O
the DT O
pre-existing JJ O
closed JJ O
complex NN O
to TO O
an DT O
open JJ O
promoter NN O
form NN O
, , O
as IN O
judged VBN O
by IN O
the DT O
local JJ O
denaturation NN O
of IN O
promoter NN O
DNA NN O
which WDT O
rendered VBD O
sequences NNS O
from IN O
+5 CD O
to TO O
-10 JJ O
reactive NN O
towards IN O
KMnO4 NNP O
, , O
was VBD O
shown VBN O
to TO O
be VB O
fully RB O
dependent JJ O
on IN O
NifA NNP B-NP
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
product NN O
exhibits NNS O
91 CD O
% NN O
amino IN O
acid NN O
identity NN O
to TO O
the DT O
murine NN B-NP
voltage-gated JJ I-NP
potassium NN I-NP
channel NN I-NP
protein NN I-NP
Kv1.7 CC I-NP
(Kcna7 NN O
) -RRB- O
, , O
which WDT O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
the DT O
repolarization NN O
of IN O
cell NN O
membranes NNS O
. . O

-DOCSTART- X X O

Elective JJ O
replacement NN O
of IN O
the DT O
aortic JJ O
root NN O
in IN O
Marfan NNP O
's POS O
syndrome NN O
. . O

-DOCSTART- X X O

Their PRP$ O
main JJ O
representatives NNS O
are VBP O
the DT O
American JJ O
diagnostic JJ O
and CC O
statistical JJ O
manual NN O
of IN O
mental JJ O
disorders NNS O
, , O
DSM-III NNP O
, , O
its PRP$ O
revised VBN O
version NN O
DSM-III-R NN O
and CC O
the DT O
new JJ O
international JJ O
classification NN O
of IN O
mental JJ O
disorders NNS O
iCD-10 JJ O
. . O

-DOCSTART- X X O

Time NN O
for IN O
action NN O
on IN O
hepatitis NN O
B NNP O
immunisation NN O
. . O

-DOCSTART- X X O

Kramer NNP O
Hamburg NNP O
1988 CD O
, , O
ISBN NNP O
: : O
3 CD O
926952 CD O
07 CD O
5 CD O
) -RRB- O
, , O
the DT O
syndromatic NN O
day-to-day JJ O
shifting VBG O
of IN O
the DT O
psychopathological JJ O
features NNS O
with IN O
manic JJ O
, , O
depressive JJ O
and CC O
several JJ O
mixed JJ O
states NNS O
has VBZ O
a DT O
well-defined JJ O
time NN O
structure NN O
, , O
as IN O
in IN O
25 CD O
patients NNS O
studied VBN O
and CC O
reported VBN O
on IN O
in IN O
this DT O
paper NN O
. . O

-DOCSTART- X X O

Internal NNP O
controls NNS O
over IN O
the DT O
volume NN O
of IN O
milk NN O
suckled VBN O
do VBP O
not RB O
appear VB O
until IN O
infant NN O
rats NNS O
are VBP O
about IN O
2 CD O
weeks NNS O
of IN O
age NN O
at IN O
which WDT O
time NN O
gastric JJ O
distension NN O
, , O
milk NN O
, , O
systemic JJ O
dehydration NN O
, , O
and CC O
intestinal JJ B-NP
hormone NN I-NP
cholecystokinin NN I-NP
suppress NN O
milk NN O
intake IN O
derived VBN O
through IN O
suckling NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
WR-3689 NNP O
, , O
WR-109342 NNP O
, , O
and CC O
WR-168643 CD O
were VBD O
used VBN O
with IN O
per IN O
os NNS O
administration NN O
to TO O
determine VB O
hematopoietic JJ O
lethality NN O
. . O

-DOCSTART- X X O

Isolation NNP O
and CC O
characterization NN O
of IN O
human JJ O
orthologs NNS O
of IN O
yeast NN O
CCR4-NOT JJ B-NP
complex JJ O
subunits NNS O
. . O

-DOCSTART- X X O

The DT O
paper NN O
calls VBZ O
for IN O
standardized JJ O
question NN O
formats NNS O
and CC O
a DT O
centralized JJ O
body NN O
to TO O
monitor VB O
changes NNS O
in IN O
these DT O
parameters NNS O
of IN O
sexual JJ O
behaviour NN O
. . O

-DOCSTART- X X O

A DT O
long-term JJ O
follow-up JJ O
study NN O
of IN O
a DT O
children NNS O
's POS O
psychiatric JJ O
day NN O
treatment NN O
center NN O
. . O

-DOCSTART- X X O

Risk NN O
factors NNS O
for IN O
atherosclerosis NN O
related VBN O
to TO O
nutrition NN O
are VBP O
hypercholesterolemia NN O
, , O
hyperglycemia-diabetes NNS O
, , O
and CC O
for IN O
hypertension NN O
, , O
obesity NN O
, , O
high JJ O
salt NN O
intake NN O
, , O
and CC O
excessive JJ O
use NN O
of IN O
alcohol NN O
. . O

-DOCSTART- X X O

We PRP O
demonstrate VBP O
that IN O
the DT O
recently RB O
proposed VBN O
synthetic JJ O
imaging NN O
technique NN O
[J. . O

-DOCSTART- X X O

We PRP O
compared VBD O
the DT O
quantities NNS O
collected VBN O
with IN O
both DT O
pollen NN O
traps NNS O
during IN O
February NNP O
, , O
March NNP O
and CC O
April NNP O
1988 CD O
and CC O
1989 CD O
. . O

-DOCSTART- X X O

Of IN O
the DT O
CSF NNP O
tested VBD O
, , O
24 CD O
stimulated VBD O
oxygen NN O
consumption NN O
above IN O
our PRP$ O
cut NN O
off RP O
, , O
and CC O
8 CD O
did VBD O
not RB O
( -LRB- O
0.84 CD O
+/ NN O
- : O
0.34 CD O
, , O
n RB O
= SYM O
24 CD O
compared VBN O
with IN O
the DT O
rate NN O
of IN O
0.27 CD O
+/ NNS O
- : O
0.1 CD O
mumol/min/g NN O
dry JJ O
wt NN O
, , O
respectively RB O
; : O
SD NNP O
n RB O
= SYM O
8 CD O
) -RRB- O
at IN O
180 CD O
minutes NNS O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
here RB O
on IN O
an DT O
eight-year-old JJ O
boy NN O
who WP O
first RB O
developed VBD O
acute JJ O
intravascular JJ O
hemolysis NN O
following VBG O
therapy NN O
with IN O
amphotericin NN O
B NNP O
( -LRB- O
AmB NN O
) -RRB- O
and CC O
subsequently RB O
a DT O
delayed VBN O
hemolytic NN O
transfusion NN O
reaction NN O
due JJ O
to TO O
alloantibodies NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
no DT O
significant JJ O
difference NN O
in IN O
either CC O
the DT O
Valsalva NNP O
ratio NN O
or CC O
delta JJ O
SBP NNP O
was VBD O
found VBN O
between IN O
diabetic JJ O
patients NNS O
and CC O
controls NNS O
. . O

-DOCSTART- X X O

The DT O
PDSS NNP O
identified VBD O
17 CD O
( -LRB- O
94 CD O
% NN O
) -RRB- O
of IN O
the DT O
women NNS O
diagnosed VBD O
with IN O
major JJ O
postpartum NN O
depression NN O
, , O
the DT O
EPDS NNP O
identified VBD O
14 CD O
of IN O
these DT O
women NNS O
( -LRB- O
78 CD O
% NN O
) -RRB- O
, , O
and CC O
the DT O
BDI-II NNP O
identified VBD O
10 CD O
of IN O
the DT O
18 CD O
women NNS O
( -LRB- O
56 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

One CD O
ORF NNP O
extends VBZ O
from IN O
nucleotides NNS O
415 CD O
to TO O
1620 CD O
, , O
encodes VBZ O
402 CD O
amino IN O
acids NNS O
, , O
and CC O
is VBZ O
preceded VBN O
by IN O
a DT O
ribosome-binding JJ O
site NN O
. . O

-DOCSTART- X X O

Blood NN B-NP
coagulation NN I-NP
Factor NNP I-NP
X NNP I-NP
and CC O
its PRP$ O
activated JJ O
form NN O
Factor NNP B-NP
Xa NNP I-NP
play VBP O
an DT O
essential JJ O
role NN O
in IN O
the DT O
midphase NN O
of IN O
the DT O
clotting NN O
cascade NN O
. . O

-DOCSTART- X X O

On IN O
a DT O
national JJ O
level NN O
, , O
undiscounted JJ O
costs NNS O
are VBP O
expected VBN O
to TO O
increase VB O
up RP O
to TO O
approximately RB O
DF1 VB O
42 CD O
million CD O
annually RB O
during IN O
the DT O
first JJ O
40 CD O
years NNS O
after IN O
introduction NN O
of IN O
the DT O
preventative JJ O
strategy NN O
. . O

-DOCSTART- X X O

Reduction NN O
of IN O
p53 NN B-NP
protein NN I-NP
was VBD O
detected VBN O
after IN O
1 CD O
day NN O
of IN O
OM NNP B-NP
treatment NN O
and CC O
reached VBD O
maximal JJ O
suppression NN O
of IN O
10-20 CD O
% NN O
of IN O
control NN O
after IN O
3 CD O
days NNS O
in IN O
H3922 NN O
and CC O
40 CD O
% NN O
of IN O
control NN O
after IN O
4 CD O
days NNS O
in IN O
MCF-7 JJ O
cells NNS O
. . O

-DOCSTART- X X O

This DT O
seems VBZ O
to TO O
take VB O
place NN O
in IN O
the DT O
same JJ O
nuclear JJ O
compartment NN O
as IN O
normal JJ O
cis NNPS O
splicing NN O
and CC O
proceeds NNS O
through IN O
Y-branched JJ O
intermediates NNS O
analogous JJ O
to TO O
the DT O
lariats NNS O
formed VBN O
in IN O
cis NN O
splicing NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
E6010 PRP B-NP
may MD O
be VB O
of IN O
clinical JJ O
value NN O
in IN O
the DT O
treatment NN O
of IN O
coronary JJ O
occlusion NN O
. . O

-DOCSTART- X X O

We PRP O
determined VBD O
their PRP$ O
N-terminal JJ O
amino JJ O
acid NN O
sequence NN O
and CC O
found VBD O
that IN O
these DT O
polypeptides NNS O
were VBD O
CotT NNP B-NP
, , O
YeeK NNP B-NP
, , O
YxeE NNP B-NP
, , O
CotF NNP B-NP
, , O
YrbA NNP B-NP
( -LRB- O
31 CD O
and CC O
45 CD O
kDa NN O
) -RRB- O
, , O
and CC O
SpoIVA NNP B-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
determination NN O
of IN O
diacetyl NN O
, , O
2,3-pentanedione CD O
and CC O
acetoin NN O
was VBD O
performed VBN O
in IN O
two CD O
steps NNS O
. . O

-DOCSTART- X X O

The DT O
same JJ O
pattern NN O
of IN O
firing NN O
was VBD O
seen VBN O
with IN O
saccades NNS O
in IN O
light NN O
and CC O
in IN O
complete JJ O
darkness NN O
. . O

-DOCSTART- X X O

The DT O
critical JJ O
obstacle NN O
in IN O
modeling VBG O
psychiatric JJ O
disorders NNS O
has VBZ O
been VBN O
limited VBN O
information NN O
about IN O
their PRP$ O
origin NN O
and CC O
underlying VBG O
neural JJ O
mechanisms NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
both DT O
the DT O
distinct JJ O
DNA NNP O
binding NN O
properties NNS O
of IN O
PMLRAR NNP B-NP
homodimers NNS I-NP
and CC O
the DT O
sequestration NN O
of IN O
RXR NNP B-NP
by IN O
PMLRARs NNS B-NP
may MD O
contribute VB O
to TO O
the DT O
molecular JJ O
mechanisms NNS O
which WDT O
underlie VBP O
the DT O
pathogenesis NN O
of IN O
APL. NNP O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Patients NNS O
' POS O
attainment NN O
of IN O
TGB NNP O
monotherapy NN O
was VBD O
associated VBN O
with IN O
their PRP$ O
achievement NN O
of IN O
positive JJ O
changes NNS O
of IN O
varying VBG O
degree NN O
on IN O
psychological JJ O
tests NNS O
. . O

-DOCSTART- X X O

Sixtieth JJ O
anniversary NN O
of IN O
Angiotensin NNP B-NP
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
we PRP O
found VBD O
that IN O
the DT O
transactivation NN O
mediated VBN O
by IN O
the DT O
p68c-ets-1 JJ B-NP
pr NN I-NP
p55erg NN B-NP
through IN O
the DT O
Polyomavirus NNP B-NP
enhancer NN I-NP
sequence NN I-NP
is VBZ O
specifically RB O
inhibited VBN O
by IN O
the DT O
p46kDaPax-QNR NN B-NP
in IN O
transient NN O
transfection NN O
assay NN O
. . O

-DOCSTART- X X O

SCAN NNP B-NP
boxes NNS O
are VBP O
found VBN O
in IN O
eight CD O
other JJ O
genes NNS O
in IN O
the DT O
GenBank NNP O
database NN O
, , O
five CD O
of IN O
which WDT O
are VBP O
also RB O
in IN O
the DT O
Kruppel NNP B-NP
family NN I-NP
of IN O
zinc NN B-NP
finger NN I-NP
proteins VBZ I-NP
lacking VBG O
KRAB NNP B-NP
A NNP I-NP
and CC I-NP
B NNP I-NP
domains NNS O
and CC O
thereby RB O
define VB O
a DT O
new JJ O
subclass NN O
of IN O
zinc NN B-NP
finger NN I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Since IN O
blood NN O
serotonin NN O
is VBZ O
primarily RB O
produced VBN O
peripherally RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
some DT O
aspect NN O
of IN O
peripheral JJ O
serotonin NN O
metabolism NN O
is VBZ O
abnormal JJ O
in IN O
major JJ O
depression NN O
. . O

-DOCSTART- X X O

Partial JJ O
albinism NN O
and CC O
immunodeficiency NN O
: : O
ultrastructural JJ O
study NN O
of IN O
haemophagocytosis NN O
and CC O
bone NN O
marrow NN O
erythroblasts NNS O
in IN O
one CD O
case NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Twenty-two CD O
patients NNS O
( -LRB- O
30 CD O
% NN O
) -RRB- O
showed VBD O
ST-segment NNP O
depression NN O
during IN O
AEM NNP O
and CC O
34 CD O
( -LRB- O
49 CD O
% NN O
) -RRB- O
on IN O
ExT. NNP O

-DOCSTART- X X O

Enhanced VBN O
quantum NN O
correlations NNS O
in IN O
bound JJ O
higher-order NN O
solitons NNS O
Quantum NNP O
effects NNS O
in IN O
N-bound JJ O
solitons NNS O
can MD O
be VB O
drastically RB O
enhanced JJ O
compared VBN O
to TO O
the DT O
fundamental JJ O
soliton NN O
. . O

-DOCSTART- X X O

Acute NNP O
intoxication NN O
with IN O
cypermethrin NN O
( -LRB- O
NRDC NNP O
149 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Whereas WRB O
the DT O
sequence NN O
of IN O
alpha-actinin NN B-NP
( -LRB- O
Noegel NNP O
, , O
A. NNP O
, , O
W. NNP O

-DOCSTART- X X O

Overall RB O
, , O
it PRP O
appears VBZ O
that IN O
prenatal JJ O
exposure NN O
to TO O
androgen-based DT O
synthetic JJ O
progestin NN O
exerted VBD O
a DT O
masculinizing JJ O
and/or NN O
defeminizing VBG O
influence NN O
on IN O
human NN O
behavioral NN O
development NN O
, , O
whereas IN O
prenatal JJ O
exposure NN O
to TO O
natural JJ O
progesterone NN O
and CC O
progesterone-based JJ O
synthetic JJ O
progestin NN O
had VBD O
a DT O
feminizing JJ O
and/or NN O
demasculinizing VBG O
influence NN O
, , O
particularly RB O
among IN O
female JJ O
subjects NNS O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
In IN O
an DT O
acute JJ O
canine CD O
model NN O
of IN O
progressive JJ O
LCX NNP O
coronary NN O
stenosis NN O
, , O
CFR NNP O
was VBD O
impaired VBN O
in IN O
both DT O
ischemic JJ O
and CC O
remote JJ O
nonischemic JJ O
regions NNS O
in IN O
association NN O
with IN O
mild JJ O
to TO O
moderate VB O
ischemic-induced DT O
regional JJ O
myocardial JJ O
dysfunction NN O
. . O

-DOCSTART- X X O

Parathyroid NNP B-NP
hormone NN I-NP
responses NNS O
of IN O
cyclic JJ O
AMP-, JJ O
serum NN O
- : O
and CC O
phorbol NN O
ester-responsive JJ O
reporter NN O
genes NNS O
in IN O
osteoblast-like JJ O
UMR-106 NNP O
cells NNS O
. . O

-DOCSTART- X X O

Genome NNP O
timeline NN O
. . O

-DOCSTART- X X O

The DT O
" `` O
Ulm NNP O
Zucker NNP O
Uhr NNP O
System NNP O
" '' O
comprises VBZ O
a DT O
microdialysis NN O
probe NN O
, , O
a DT O
biosensor NN O
( -LRB- O
Glucosensor NNP O
Unitec NNP O
Ulm NNP O
s.c. NN O
) -RRB- O
, , O
a DT O
sender NN O
transferring NN O
telemetrically RB O
the DT O
glucose NN O
concentrations NNS O
, , O
and CC O
a DT O
receiving VBG O
indicator NN O
. . O

-DOCSTART- X X O

Previous JJ O
work NN O
has VBZ O
shown VBN O
that IN O
glucose JJ O
repression NN O
of IN O
PRB1 NNP B-NP
transcription NN O
is VBZ O
not RB O
mediated VBN O
by IN O
HXK2 NNP B-NP
or CC O
by IN O
the DT O
SNF1 NNP B-NP
, , O
SNF4 NNP B-NP
, , O
and CC O
SNF6 CD B-NP
genes NNS I-NP
( -LRB- O
C. NNP O

-DOCSTART- X X O

Our PRP$ O
objective NN O
was VBD O
to TO O
find VB O
possible JJ O
predictors NNS O
for IN O
the DT O
expression NN O
and CC O
progression NN O
of IN O
LJM NNP O
and CC O
to TO O
evaluate VB O
the DT O
relationship NN O
between IN O
LJM NNP O
and CC O
other JJ O
long-term JJ O
complications NNS O
of IN O
insulin-dependent JJ B-NP
diabetes NN O
mellitus NN O
. . O

-DOCSTART- X X O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
we PRP O
developed VBD O
a DT O
system NN O
of IN O
transient JJ O
transfection NN O
of IN O
rat NN O
adipocytes NNS O
with IN O
constructs NNS O
containing VBG O
glyceraldehyde-3-phosphate NN B-NP
dehydrogenase NN I-NP
( -LRB- O
GAPDH) NNP B-NP
and CC O
fatty JJ B-NP
acid NN I-NP
synthetase NN I-NP
( -LRB- O
FAS NNP B-NP
) -RRB- O
promoters NNS O
fused VBN O
to TO O
gene NN B-NP
reporter NN I-NP
CAT. . I-NP

-DOCSTART- X X O

Comparison NN O
of IN O
this DT O
gene NN O
with IN O
the DT O
available JJ O
databases NNS O
reveals VBZ O
very RB O
significant JJ O
homology NN O
to TO O
the DT O
ETS NNP B-NP
factor NN I-NP
PE-1 NN B-NP
and CC O
probable JJ O
near-identity NN O
with IN O
the DT O
recently RB O
cloned VBN O
factor NN O
ERF. . B-NP

-DOCSTART- X X O

Eight CD O
of IN O
these DT O
suppressors NNS O
for IN O
into IN O
two CD O
complementation NN O
groups NNS O
, , O
designated VBN O
KCS1 NN B-NP
and CC O
KCS2 NN B-NP
. . O

-DOCSTART- X X O

Also RB O
, , O
the DT O
absence NN O
of IN O
PdNi NNP O
between IN O
the DT O
segments NNS O
reduces VBZ O
the DT O
heat NN O
production NN O
of IN O
the DT O
seed NN O
. . O

-DOCSTART- X X O

Further JJ O
analysis NN O
of IN O
the DT O
CAP59 NNP B-NP
locus NN I-NP
of IN I-NP
Cryptococcus NNP I-NP
neoformans NNS I-NP
: : O
structure NN O
defined VBN O
by IN O
forced JJ O
expression NN O
and CC O
description NN O
of IN O
a DT O
new JJ O
ribosomal NN B-NP
protein-encoding NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
results NNS O
showed VBD O
a DT O
significant JJ O
group NN O
effect NN O
only RB O
on IN O
the DT O
active JJ O
task NN O
. . O

-DOCSTART- X X O

Localization NN O
of IN O
the DT O
porcine NN O
enzyme NN O
in IN O
the DT O
endoplasmic JJ O
reticulum NN O
is VBZ O
consistent JJ O
with IN O
immuno-electron-microscopic JJ O
studies NNS O
using VBG O
pig NN O
hepatocytes NNS O
. . O

-DOCSTART- X X O

International NNP O
efforts NNS O
are VBP O
now RB O
being VBG O
made VBN O
to TO O
standardize VB O
haemolytic JJ O
test NN O
conditions NNS O
and CC O
the DT O
present JJ O
study NN O
is VBZ O
meant VBN O
as IN O
a DT O
contribution NN O
to TO O
this DT O
. . O

-DOCSTART- X X O

The DT O
DFA NNP O
slide NN O
prepared VBD O
from IN O
the DT O
ThinPrep NNP O
Test NNP O
and CC O
the DT O
conventional JJ O
DFA NNP O
sample NN O
prepared VBD O
from IN O
the DT O
endocervical JJ O
swab NN O
were VBD O
evaluated VBN O
independently RB O
. . O

-DOCSTART- X X O

We PRP O
suggest VBP O
that IN O
the DT O
responses NNS O
to TO O
types NNS B-NP
I PRP I-NP
and CC I-NP
II NNP I-NP
collagen NN I-NP
were VBD O
caused VBN O
by IN O
a DT O
cross-reaction NN O
with IN O
type NN B-NP
III NNP I-NP
collagen NN I-NP
peptides NNS O
. . O

-DOCSTART- X X O

The DT O
ventricular JJ O
demand NN O
pacemaker NN O
( -LRB- O
VVI NN O
) -RRB- O
was VBD O
implanted VBN O
three CD O
years NNS O
ago RB O
and CC O
because IN O
of IN O
further JJ O
impairment NN O
of IN O
cardiac JJ O
performance NN O
an DT O
av-sequential JJ O
pacemaker NN O
( -LRB- O
DDD NNP O
) -RRB- O
was VBD O
used VBN O
to TO O
restore VB O
atrio-ventricular JJ O
synchronisation NN O
. . O

-DOCSTART- X X O

Individual NNP O
and CC O
combined VBN O
effects NNS O
of IN O
fumonisin NN B-NP
B1 IN I-NP
present JJ O
in IN O
Fusarium NNP O
moniliforme NN O
culture NN O
material NN O
and CC O
diacetoxyscirpenol NN O
or CC O
ochratoxin NN O
A DT O
in IN O
turkey NN O
poults NNS O
. . O

-DOCSTART- X X O

This DT O
C-terminal JJ O
domain NN O
contains VBZ O
several JJ O
YxxI/L NN O
motifs NNS O
reminiscent JJ O
of IN O
LMP2A NNP B-NP
and CC O
a DT O
putative JJ O
TRAF NN B-NP
binding NN I-NP
site NN I-NP
as IN O
in IN O
LMP1 NNP B-NP
. . O

-DOCSTART- X X O

Muscle NN O
and CC O
liver NN O
biopsies NNS O
demonstrated VBD O
the DT O
same JJ O
anomalies NNS O
, , O
again RB O
without IN O
branching NN B-NP
enzyme NN I-NP
deficiency NN O
in IN O
the DT O
liver NN O
. . O

-DOCSTART- X X O

The DT O
1031-bp JJ B-NP
wild-type JJ I-NP
HIT1 NNP I-NP
DNA NNP I-NP
which WDT O
contained VBD O
an DT O
open JJ O
reading NN O
frame NN O
encoding VBG O
a DT O
protein NN O
of IN O
164 CD O
amino IN O
acids NNS O
and CC O
the DT O
AGG NNP B-NP
arginine IN I-NP
tRNA DT I-NP
gene NN I-NP
complemented VBN O
all DT O
hit1-1 NN B-NP
mutant JJ I-NP
phenotypes NNS I-NP
, , O
indicating VBG O
that IN O
the DT O
mutant JJ O
phenotypes NNS O
were VBD O
caused VBN O
by IN O
the DT O
deletion NN O
of IN O
these DT O
genes NNS O
. . O

-DOCSTART- X X O

Heterotrimeric NNP O
guanine CD B-NP
nucleotide-binding JJ I-NP
proteins NNS I-NP
(G-proteins NNS O
) -RRB- O
function NN O
as IN O
signal NN O
transducers NNS O
for IN O
a DT O
variety NN O
of IN O
hormone-coupled JJ O
enzyme NN O
and CC O
ion NN O
transport NN O
systems NNS O
in IN O
eukaryotic JJ O
cells NNS O
. . O

-DOCSTART- X X O

Mibefradil NNP O
( -LRB- O
Ro NNP O
40-5967 CD O
) -RRB- O
is VBZ O
a DT O
novel NN O
nondihydropyridine NN O
calcium NN O
antagonist NN O
. . O

-DOCSTART- X X O

The DT O
recombinant NN O
containing VBG O
the DT O
full-length JJ O
polyhedrin NN B-NP
leader NN O
sequence NN O
gave VBD O
levels NNS O
of IN O
N NNP B-NP
mRNA NN I-NP
comparable JJ O
to TO O
those DT O
of IN O
AcNPV NNP B-NP
polyhedrin NN I-NP
mRNA NN I-NP
. . O

-DOCSTART- X X O

Four CD O
of IN O
12 CD O
patients NNS O
( -LRB- O
33 CD O
% NN O
) -RRB- O
were VBD O
initially RB O
diagnosed VBN O
as IN O
having VBG O
a DT O
benign JJ O
disease NN O
( -LRB- O
false-negatives NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Using VBG O
reporter NN O
gene NN O
constructs NNS O
driven VBN O
by IN O
the DT O
CD4 NNP B-NP
promoter NN I-NP
, , O
we PRP O
report VBP O
that IN O
HHV-6 NNP O
can MD O
efficiently RB O
transactivate VB O
such JJ O
genetic JJ O
elements NNS O
. . O

-DOCSTART- X X O

Removal NNP O
of IN O
ink4a DT B-NP
dramatically RB O
reduces VBZ O
the DT O
lymphoid NN O
and CC O
neurological JJ O
defects NNS O
seen VBN O
in IN O
bmi-1-deficient JJ B-NP
mice NNS O
, , O
indicating VBG O
that IN O
ink4a NN B-NP
is VBZ O
a DT O
critical JJ O
in IN O
vivo JJ O
target NN O
for IN O
Bmi-1 NN B-NP
. . O

-DOCSTART- X X O

In IN O
fifty CD O
non JJ O
selected VBN O
ductal NN O
carcinomas NNS O
of IN O
the DT O
breast NN O
we PRP O
found VBD O
that IN O
a DT O
marked JJ O
tumoral JJ O
inflammatory NN O
infiltrate NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.025 CD O
) -RRB- O
, , O
perinodal JJ O
tumoral JJ O
infiltrate NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
, , O
sinus IN O
catarrh NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.05 CD O
) -RRB- O
, , O
follicular JJ O
hyperplasia NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.025 CD O
) -RRB- O
, , O
mixed JJ O
pattern NN O
in IN O
lymph NN O
nodes NNS O
( -LRB- O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
and CC O
with IN O
54 CD O
years NNS O
of IN O
age NN O
or CC O
younger JJR O
( -LRB- O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
correlated VBN O
significantly RB O
with IN O
lymph NN O
node NN O
metastases NNS O
and/or CC O
high JJ O
histologic NN O
grade NN O
. . O

-DOCSTART- X X O

The DT O
herpesvirus NN B-NP
entry NN I-NP
mediator NN I-NP
C NNP I-NP
( -LRB- O
HveC NNP B-NP
) -RRB- O
, , O
previously RB O
known VBN O
as IN O
poliovirus NN B-NP
receptor-related JJ I-NP
protein NN I-NP
1 CD I-NP
( -LRB- O
PRR1 NN B-NP
) -RRB- O
, , O
and CC O
the DT O
herpesvirus NN B-NP
Ig-like NN I-NP
receptor NN I-NP
( -LRB- O
HIgR NN B-NP
) -RRB- O
are VBP O
the DT O
bona NN O
fide NN O
receptors NNS O
employed VBN O
by IN O
herpes NNS O
simplex JJ O
virus-1 NN O
and CC O
-2 NN O
( -LRB- O
HSV-1 NN O
and CC O
-2 NN O
) -RRB- O
for IN O
entry NN O
into IN O
the DT O
human JJ O
cell NN O
lines NNS O
most RBS O
frequently RB O
used VBN O
in IN O
HSV NNP O
studies NNS O
. . O

-DOCSTART- X X O

Spinal JJ O
injuries NNS O
in IN O
a DT O
multiple JJ O
trauma NN O
patient NN O
. . O

-DOCSTART- X X O

Creatinine NNP O
and CC O
creatine JJ B-NP
phosphokinase NN I-NP
( -LRB- O
CPK) NNP B-NP
. . O

-DOCSTART- X X O

The DT O
glyoxysomal NN O
and CC O
plastid NN O
molecular JJ O
chaperones NNS O
( -LRB- O
70-kDa JJ B-NP
heat NN I-NP
shock NN I-NP
protein NN I-NP
) -RRB- O
of IN O
watermelon NN O
cotyledons NNS O
are VBP O
encoded VBN O
by IN O
a DT O
single JJ O
gene NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
cross-resistance NN O
between IN O
fluoroquinolones NNS O
was VBD O
shown VBN O
for IN O
both DT O
enterococci NNS O
and CC O
MRSA NNP O
. . O

-DOCSTART- X X O

Furthermore RB O
we PRP O
elucidate VBD O
the DT O
subtle JJ O
highly RB O
anisotropic JJ O
interchain NN O
correlations NNS O
and CC O
reveal VB O
the DT O
detailed JJ O
atomic JJ O
structure NN O
of IN O
the DT O
low-temperature JJ O
( -LRB- O
8x2 NN O
) -RRB- O
phase NN O
. . O

-DOCSTART- X X O

With IN O
stimulation NN O
beyond IN O
the DT O
theta-range JJ O
three CD O
phenomena NNS O
occurred VBD O
: : O
shift NN O
of IN O
the DT O
burst NN O
frequencies NNS O
to TO O
higher JJR O
or CC O
lower JJR O
harmonics NNS O
of IN O
stimulation NN O
frequencies NNS O
; : O
complex JJ O
interactions NNS O
of IN O
basic JJ O
background NN O
frequency NN O
with IN O
rhythm NN O
of IN O
stimulation NN O
( -LRB- O
"beating JJ O
" '' O
) -RRB- O
; : O
return NN O
to TO O
background NN O
theta-burst JJ O
frequency NN O
in IN O
spite NN O
of IN O
continuing VBG O
stimulation NN O
( -LRB- O
"escape NN O
" '' O
) -RRB- O
. . O

-DOCSTART- X X O

Incorporation NN O
of IN O
this DT O
information NN O
in IN O
the DT O
data NNS O
brought VBD O
about IN O
a DT O
revised VBN O
five-year JJ O
survival NN O
estimate NN O
of IN O
55 CD O
percent NN O
. . O

-DOCSTART- X X O

Our PRP$ O
previous JJ O
studies NNS O
demonstrated VBD O
that IN O
the DT O
promyelocytic JJ O
leukemia NN O
gene NN O
, , O
PML NNP B-NP
which WDT O
involved VBD O
in IN O
the DT O
15;17 CD O
translocation NN O
in IN O
acute JJ O
promyelocytic JJ O
leukemia NN O
( -LRB- O
APL) NNP O
is VBZ O
a DT O
growth NN O
and CC O
transformation NN O
suppressor NN O
. . O

-DOCSTART- X X O

These DT O
characteristics NNS O
add VBP O
to TO O
the DT O
suitability NN O
of IN O
NM441 NNP O
as IN O
an DT O
effective JJ O
prodrug NN O
of IN O
NM394 NNP O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
cDNA NN O
clones NNS O
encoding VBG O
human JJ O
gamma NN O
revealed VBD O
an DT O
open JJ O
reading NN O
frame NN O
predicting VBG O
a DT O
protein NN O
of IN O
299 CD O
amino IN O
acids NNS O
( -LRB- O
approximately RB O
32 CD O
kDa NN O
) -RRB- O
, , O
half PDT O
the DT O
size NN O
of IN O
the DT O
bovine NN O
gamma NN O
subunit NN O
. . O

-DOCSTART- X X O

DISCUSSION NN O
: : O
The DT O
higher JJR O
absolute JJ O
knee NN O
extension NN O
strength NN O
measures NNS O
of IN O
leg NN O
and CC O
the DT O
similar JJ O
extension NN O
strength NN O
of IN O
the DT O
trunk NN O
in IN O
the DT O
obese NN O
sample NN O
compared VBN O
to TO O
the DT O
lean JJ O
might MD O
be VB O
explained VBN O
by IN O
the DT O
training NN O
effect NN O
of IN O
weight NN O
bearing NN O
and CC O
support NN O
of IN O
a DT O
larger JJR O
body NN O
mass NN O
. . O

-DOCSTART- X X O

Measuring VBG O
the DT O
dim JJ O
light NN O
melatonin NN O
onset NN O
( -LRB- O
DLMO NNP O
) -RRB- O
is VBZ O
a DT O
useful JJ O
and CC O
practical JJ O
way NN O
to TO O
assess VB O
circadian JJ O
phase NN O
position NN O
in IN O
humans NNS O
. . O

-DOCSTART- X X O

A DT O
survey NN O
of IN O
children NNS O
with IN O
HBsAg NNP B-NP
markers NNS I-NP
related VBN O
to TO O
their PRP$ O
parents NNS O
HBV IN O
markers NNS O
. . O

-DOCSTART- X X O

Rv NN O
was VBD O
7.7 CD O
+/ CD O
- : O
1.4 CD O
mmHg.ml-1.min.100 CD O
g-1 NN O
and CC O
Cv NNP O
was VBD O
0.59 CD O
+/ NNS O
- : O
0.25 CD O
ml/mmHg NN O
, , O
tau VBD O
v NN O
calculated VBN O
from IN O
the DT O
product NN O
of IN O
Rv NNP O
and CC O
Cv NNP O
was VBD O
4.20 CD O
+/ CD O
- : O
1.58 CD O
s PRP O
and CC O
from IN O
the DT O
ratio NN O
of IN O
delta JJ O
V NNP O
to TO O
delta JJ O
Q NN O
was VBD O
4.95 CD O
+/ CD O
- : O
1.53 CD O
s PRP O
( -LRB- O
P NNP O
= SYM O
NS NNS O
) -RRB- O
at IN O
a DT O
mean JJ O
Pel NNP O
of IN O
17.6 CD O
+/ NNS O
- : O
3.7 CD O
mmHg NN O
. . O
delta NN O
V NNP O
was VBD O
also RB O
produced VBN O
by IN O
changing VBG O
Pv NNP O
; : O
the DT O
average JJ O
tau NN O
v NN O
( -LRB- O
1.95 CD O
+/ NN O
- : O
0.37 CD O
s PRP O
) -RRB- O
, , O
was VBD O
shorter JJR O
than IN O
that IN O
with IN O
changes NNS O
in IN O
flow NN O
. . O

-DOCSTART- X X O

Peripheral JJ O
neuropathy NN O
in IN O
the DT O
cherry-red JJ O
spot-myoclonus NN O
syndrome NN O
( -LRB- O
sialidosis NN O
type NN O
I PRP O
) -RRB- O
. . O

-DOCSTART- X X O

For IN O
O3 CD O
, , O
the DT O
correlation NN O
between IN O
personal JJ O
exposures NNS O
and CC O
ambient JJ O
levels NNS O
was VBD O
weakest JJS O
in IN O
the DT O
winter NN O
for IN O
residential JJ O
microenvironments NNS O
( -LRB- O
rs NNS O
= SYM O
0.05 CD O
, , O
p NN O
> NN O
0.05 CD O
) -RRB- O
, , O
and CC O
was VBD O
strongest JJS O
in IN O
the DT O
summer NN O
for IN O
outdoor JJ O
near-roadway NN O
microenvironments NNS O
( -LRB- O
rs NNS O
= SYM O
0.91 CD O
, , O
p NN O
< NN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
" `` O
Gregg JJ O
phenomenon NN O
" '' O
implies VBZ O
that DT O
myocardial JJ O
function NN O
and CC O
oxygen NN O
consumption NN O
( -LRB- O
MVO2 IN O
) -RRB- O
increase NN O
when WRB O
coronary JJ O
perfusion NN O
is VBZ O
enhanced VBN O
within IN O
or CC O
above IN O
the DT O
autoregulatory JJ O
range NN O
. . O

-DOCSTART- X X O

Pollinosis NNP O
in IN O
the DT O
U.A.R. NNP O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
the DT O
PRP20 NNP B-NP
gene NN I-NP
is VBZ O
identical JJ O
to TO O
the DT O
yeast NN B-NP
SRM1 JJ I-NP
gene NN I-NP
( -LRB- O
Clark NNP O
and CC O
Sprague JJ O
1989 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Transcriptional NNP O
activation NN O
of IN O
the DT O
proopiomelanocortin NN B-NP
gene NN I-NP
by IN O
cyclic JJ B-NP
AMP-responsive JJ I-NP
element NN I-NP
binding JJ I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

After IN O
discharge NN O
, , O
he PRP O
was VBD O
finally RB O
given VBN O
a DT O
diagnosis NN O
of IN O
PCH NNP O
because IN O
a DT O
Donath-Landsteiner NNP O
test NN O
was VBD O
positive JJ O
. . O

-DOCSTART- X X O

Human JJ O
forearm NN O
was VBD O
used VBN O
as IN O
a DT O
dummy JJ O
ear NN O
and CC O
the DT O
electrode NN O
HN-5 . O
was VBD O
fixed VBN O
thereon RB O
, , O
and CC O
a DT O
sound JJ O
stimulus NN O
of IN O
90dBnHL NNP O
was VBD O
delivered VBN O
by IN O
the DT O
earphone NN O
(NC-3 NN O
) -RRB- O
. . O

-DOCSTART- X X O

However RB O
, , O
their PRP$ O
stability NN O
was VBD O
low JJ O
as IN O
already RB O
reported VBN O
for IN O
the DT O
ARS NNS O
in IN O
S. NNP O
occidentalis NNP O
. . O

-DOCSTART- X X O

When WRB O
gene NN O
conversion NN O
is VBZ O
initiated VBN O
by IN O
a DT O
double-strand JJ O
break NN O
( -LRB- O
DSB) NNP O
, , O
any DT O
nonhomologous JJ O
DNA NN O
that WDT O
may MD O
be VB O
present JJ O
at IN O
the DT O
ends NNS O
must MD O
be VB O
removed VBN O
before IN O
new JJ O
DNA NN O
synthesis NN O
can MD O
be VB O
initiated VBN O
. . O

-DOCSTART- X X O

MRI NNP O
visualization NN O
of IN O
proteoglycan NN O
depletion NN O
in IN O
articular JJ O
cartilage NN O
via IN O
intravenous JJ O
administration NN O
of IN O
Gd-DTPA. NNP O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
GC-rich JJ O
sequences NNS O
could MD O
confer VB O
Sp1-dependent JJ B-NP
transactivation NN O
to TO O
a DT O
heterologous JJ O
prolactin NN B-NP
minimal JJ I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Neuronal JJ O
activity NN O
of IN O
58 CD O
dopaminergic NN O
( -LRB- O
DA NNP O
) -RRB- O
and CC O
200 CD O
non-dopaminergic JJ O
( -LRB- O
non-DA JJ O
) -RRB- O
neurons NNS O
in IN O
the DT O
ventral JJ O
tegmental JJ O
area NN O
(VTA NNP O
) -RRB- O
of IN O
female NN O
monkeys NNS O
was VBD O
recorded VBN O
, , O
and CC O
correlation NN O
to TO O
bar VB O
press NN O
feeding NN O
, , O
sensory JJ O
stimulation NN O
and CC O
change VB O
in IN O
motivation NN O
was VBD O
investigated VBN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
required VBN O
for IN O
correct JJ O
expression NN O
of IN O
both DT O
genes NNS O
. . O

-DOCSTART- X X O

Cloning VBG O
the DT O
cDNA NN O
for IN O
a DT O
new JJ O
human JJ B-NP
zinc NN I-NP
finger NN I-NP
protein NN I-NP
defines VBZ O
a DT O
group NN O
of IN O
closely RB O
related VBN O
Kruppel-like NNP B-NP
transcription NN I-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

Recently RB O
, , O
we PRP O
and CC O
other JJ O
laboratories NNS O
have VBP O
identified VBN O
a DT O
family NN O
of IN O
caveolin-related JJ B-NP
proteins NNS I-NP
; : O
caveolin NN B-NP
has VBZ O
been VBN O
re-termed VBN O
caveolin-1 NN B-NP
. . O

-DOCSTART- X X O

Six CD O
cDNAs NNS O
represent VBP O
human JJ O
homologs NNS O
of IN O
genes NNS O
known VBN O
in IN O
other JJ O
species NNS O
, , O
namely RB O
, , O
mouse NN B-NP
HSPE71 NNP I-NP
, , O
Rat NNP B-NP
RhoGAP NNP I-NP
protein NN I-NP
, , O
S NNP B-NP
cerevisiae NN I-NP
leucyl NN I-NP
tRNA IN I-NP
synthetase NN I-NP
and CC O
S NNP B-NP
cerevisiae JJ I-NP
chromosome NN I-NP
II NNP I-NP
ORF NNP I-NP
YBLO44W. . I-NP

-DOCSTART- X X O

The DT O
hepatic JJ O
isoform NN O
of IN O
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase JJ B-NP
( -LRB- O
PF2K/Fru-2,6-BPase JJ B-NP
) -RRB- O
is VBZ O
transcriptionally RB O
stimulated VBN O
by IN O
glucocorticoids NNS O
, , O
whereas IN O
insulin NN B-NP
blocks NNS O
this DT O
stimulatory JJ O
effect NN O
. . O

-DOCSTART- X X O

I. NN O

-DOCSTART- X X O

Such JJ O
simple JJ O
injuries NNS O
may MD O
however RB O
be VB O
accompanied VBN O
by IN O
far RB O
reaching VBG O
consequences NNS O
. . O

-DOCSTART- X X O

The DT O
132-bp JJ B-NP
PHO8p JJ I-NP
fragment NN I-NP
, , O
connected VBN O
at IN O
position NN O
-281 NN O
of IN O
the DT O
5' JJ O
upstream JJ O
region NN O
of IN O
a DT O
HIS5'-'lacZ NN B-NP
fused VBN O
gene NN O
, , O
could MD O
sense VB O
Pi NNP O
signals NNS O
in IN O
vivo NN O
, , O
but CC O
a DT O
20-bp JJ O
synthetic NN O
oligonucleotide NN O
having VBG O
the DT O
same JJ O
sequence NN O
from IN O
-544 PRP$ O
to TO O
-525 CD O
of IN O
the DT O
PHO8p JJ B-NP
DNA NN I-NP
could MD O
not RB O
. . O

-DOCSTART- X X O

In IN O
resume NN O
response NN O
to TO O
treatment NN O
with IN O
usual JJ O
regimens NNS O
, , O
doxycycline NN O
plus CC O
streptomycin NN O
of IN O
doxycycline NN O
rifampicin NN O
is VBZ O
good JJ O
, , O
being VBG O
however RB O
time NN O
elapsed VBD O
until IN O
pain NN O
ceases NNS O
of IN O
mean JJ O
length NN O
in IN O
hospital NN O
stay VB O
shorter JJR O
in IN O
the DT O
group NN O
receiving VBG O
doxycycline NN O
plus CC O
streptomycin NN O
. . O

-DOCSTART- X X O

Having VBG O
demonstrated VBN O
proper JJ O
localization NN O
of IN O
GFP-calmodulin NNP B-NP
in IN O
budding VBG O
yeast NN O
, , O
we PRP O
examined VBD O
the DT O
localization NN O
of IN O
a DT O
fusion NN O
between IN O
GFP NNP B-NP
and CC O
calmodulin NN B-NP
( -LRB- O
GFP-Camlp NN B-NP
) -RRB- O
in IN O
fission NN O
yeast NN O
, , O
where WRB O
calmodulin NN B-NP
had VBD O
not RB O
been VBN O
localized VBN O
by IN O
any DT O
method NN O
. . O

-DOCSTART- X X O

Fourteen CD O
eyes NNS O
( -LRB- O
38.9 CD O
% NN O
) -RRB- O
developed VBN O
DLK NNP O
after IN O
an DT O
epithelial NN O
defect NN O
, , O
representing VBG O
an DT O
odds NNS O
ratio NN O
of IN O
13 CD O
times NNS O
. . O

-DOCSTART- X X O

Each DT O
subject NN O
was VBD O
injected VBN O
in IN O
the DT O
antecubital JJ O
vein NN O
with IN O
7 CD O
mg/kg NN O
of IN O
sodium NN O
fluorescein NN O
( -LRB- O
25 CD O
% NN O
solution NN O
) -RRB- O
and CC O
measurements NNS O
were VBD O
taken VBN O
1 CD O
hr NN O
postinjection NN O
at IN O
4.5 CD O
mm CD O
and CC O
7.5 CD O
mm CD O
from IN O
the DT O
retina NN O
. . O

-DOCSTART- X X O

Such JJ O
tetranucleotides NNS O
are VBP O
common JJ O
in IN O
promoter NN O
regions NNS O
, , O
particularly RB O
in IN O
activating VBG B-NP
transcription NN I-NP
factor/cyclic NN I-NP
AMP IN B-NP
response NN I-NP
element-binding JJ I-NP
protein NN I-NP
( -LRB- O
ATF/CREB NN B-NP
) -RRB- O
and CC O
E-box NNP O
motifs NNS O
, , O
suggesting VBG O
that IN O
PIF NNP B-NP
may MD O
modulate VB O
the DT O
transcription NN O
of IN O
many JJ O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
long JJ O
terminal NN O
repeat NN O
is VBZ O
590 CD O
bp NN O
in IN O
length NN O
, , O
with IN O
the DT O
U3 NNP O
region NN O
containing VBG O
consensus NN O
sequences NNS O
likely JJ O
to TO O
be VB O
involved VBN O
in IN O
viral JJ O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

A DT O
pathogenetic JJ O
relation NN O
with IN O
the DT O
Eisenmenger NNP O
's POS O
syndrome NN O
is VBZ O
discussed VBN O
. . O

-DOCSTART- X X O

The DT O
PHO5 NNP B-NP
gene NN I-NP
is VBZ O
activated VBN O
by IN O
the DT O
Pho4p NNP B-NP
transcription NN I-NP
factor NN I-NP
, , O
which WDT O
itself PRP O
is VBZ O
negatively RB O
regulated VBN O
through IN O
phosphorylation NN O
by IN O
the DT O
products NNS O
of IN O
PHO80 CD B-NP
and CC O
PHO85 CD B-NP
. . O

-DOCSTART- X X O

This DT O
deletion NN O
disrupts VBZ O
the DT O
PU.1 NNP B-NP
Ets NNP B-NP
domain NN I-NP
. . O

-DOCSTART- X X O

Basal NNP O
urinary JJ O
17-hydroxycorticoid JJ O
( -LRB- O
17-OHCS) JJ O
values NNS O
were VBD O
elevated VBN O
in IN O
9/12 CD O
patients NNS O
and CC O
low JJ O
dose NN O
dexamethasone NN O
suppression NN O
test NN O
favoured VBD O
Cushing NNP O
's POS O
syndrome NN O
in IN O
8/9 CD O
patients NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
cross-over NN O
controlled VBD O
study NN O
, , O
five CD O
male JJ O
volunteers NNS O
donated VBD O
one CD O
unit NN O
of IN O
red JJ O
cells NNS O
by IN O
MCS NNP O
and CC O
one CD O
unit NN O
of IN O
whole JJ O
blood NN O
by IN O
the DT O
conventional JJ O
manual NN O
method NN O
, , O
3 CD O
months NNS O
apart RB O
. . O

-DOCSTART- X X O

D. NNP O

-DOCSTART- X X O

1 CD O
. . O

-DOCSTART- X X O

1995 CD O
. . O

-DOCSTART- X X O

Although IN O
immunoglobulin NN B-NP
and CC O
CRP NNP B-NP
concentration NN O
increased VBD O
, , O
anemia NN O
obviously RB O
improved VBN O
with IN O
hemoglobin NN B-NP
levels NNS O
increasing VBG O
from IN O
4.8 CD O
g/dl NN O
to TO O
8.5 CD O
g/dl NN O
without IN O
any DT O
side NN O
effects NNS O
. . O

-DOCSTART- X X O

These DT O
data NNS O
also RB O
demonstrate VBP O
that IN O
insulin NN B-NP
and CC O
TPA NNP O
activate JJ O
MBP/MAP2 CD B-NP
kinase NN O
activity NN O
by IN O
de NNP O
novo , O
phosphorylation NN O
of IN O
threonine CD O
and CC O
tyrosine NN O
residues NNS O
via IN O
a DT O
very RB O
similar JJ O
pathway NN O
. . O

-DOCSTART- X X O

100 CD O
and CC O
51 CD O
p NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
obtained VBD O
with IN O
[F304]R2 NNP B-NP
indicate VBP O
that IN O
structural JJ O
changes NNS O
in IN O
E. NNP B-NP
coli NNS I-NP
R2 IN I-NP
in IN O
the DT O
vicinity NN O
of IN O
this DT O
helix NN O
distortion NN O
can MD O
influence VB O
the DT O
catalytic JJ O
activity NN O
of IN O
the DT O
holoenzyme NN O
. . O

-DOCSTART- X X O

This DT O
result NN O
is VBZ O
consistent JJ O
with IN O
the DT O
previous JJ O
observation NN O
that WDT O
expression NN O
of IN O
the DT O
hsp70 CD B-NP
genes NNS I-NP
in IN I-NP
T. NNP I-NP
brucei NN I-NP
is VBZ O
mainly RB O
controlled VBN O
at IN O
the DT O
posttranscriptional JJ O
level NN O
. . O

-DOCSTART- X X O

The DT O
cloned VBD O
rRNA NNP O
operon NNP O
was VBD O
transcribed VBN O
in IN O
vitro NN O
by IN O
using VBG O
purified VBN B-NP
RNA NNP I-NP
polymerase NN I-NP
of IN I-NP
Escherichia NNP I-NP
coli NNS I-NP
. . O

-DOCSTART- X X O

To TO O
test VB O
whether IN O
Cd JJ O
exposure NN O
would MD O
increase VB O
Ca JJ O
release NN O
from IN O
bone NN O
during IN O
pregnancy NN O
and CC O
lactation NN O
in IN O
relation NN O
to TO O
the DT O
etiological JJ O
mechanism NN O
of IN O
Itai-Itai NNP O
disease NN O
, , O
virgin JJ O
female NN O
mice NNS O
with IN O
45Ca DT O
prelabeled JJ O
skeletons NNS O
( -LRB- O
15 CD O
microCi/mouse NN O
) -RRB- O
were VBD O
subjected VBN O
to TO O
one CD O
round NN O
of IN O
pregnancy/lactation NN O
and CC O
were VBD O
exposed VBN O
to TO O
a DT O
Ca-deficient JJ O
diet NN O
containing VBG O
0, JJ O
5 CD O
, , O
or CC O
25 CD O
ppm NN O
Cd NN O
or CC O
25 CD O
ppm NN O
Pb NN O
for IN O
32 CD O
days NNS O
, , O
from IN O
conception NN O
until IN O
Lactation NNP O
Day NNP O
14 CD O
. . O

-DOCSTART- X X O

G-box NNP B-NP
binding NN I-NP
factors NNS I-NP
( -LRB- O
GBFs NNS B-NP
) -RRB- O
constitute VBP O
a DT O
family NN O
of IN O
plant NN O
DNA-binding JJ O
proteins NNS O
that WDT O
bind VBP O
to TO O
the DT O
G-box NNP O
motif NN O
, , O
a DT O
regulatory JJ O
cis NN O
element NN O
present NN O
in IN O
many JJ O
plant NN O
genes NNS O
with IN O
a DT O
palindromic JJ O
DNA NNP O
motif NN O
of IN O
CACGTG. NNP O

-DOCSTART- X X O

Anovulatory JJ O
cycles NNS O
with IN O
an DT O
apparently RB O
normal JJ O
level NN O
of IN O
blood NN O
prolactin NN B-NP
. . O

-DOCSTART- X X O

Cardiovascular NNP O
drug NN O
use NN O
and CC O
hospitalizations NNS O
attributable JJ O
to TO O
type NN O
2 CD O
diabetes NN O
. . O

-DOCSTART- X X O

Renal NNP O
cell NN O
carcinoma NN O
induced VBN O
Coombs NNP O
negative JJ O
autoimmune NN O
hemolytic NN O
anemia NN O
and CC O
severe JJ O
thrombocytopenia NN O
responsive JJ O
to TO O
nephrectomy NN O
. . O

-DOCSTART- X X O

The DT O
c-Jun JJ B-NP
delta-domain JJ I-NP
inhibits NNS O
neuroendocrine JJ O
promoter NN O
activity NN O
in IN O
a DT O
DNA NN O
sequence NN O
- : O
and CC O
pituitary-specific JJ O
manner NN O
. . O

-DOCSTART- X X O

Finally RB O
, , O
antisense JJ O
mediated JJ O
reduction NN O
of IN O
Elk-1 NNP B-NP
in IN O
GH4 NNP O
cells NNS O
decreased VBN O
insulin-increased JJ B-NP
prolactin NN B-NP
gene NN I-NP
expression NN O
and CC O
confirmed VBD O
the DT O
requirement NN O
for IN O
Elk-1 NNP B-NP
for IN O
insulin-increased JJ B-NP
prolactin NN B-NP
gene NN I-NP
expression NN O
. . O

-DOCSTART- X X O

Smooth JJ O
pursuit NN O
gain NN O
and CC O
the DT O
percentage NN O
of IN O
total JJ O
eye NN O
movement NN O
due JJ O
to TO O
various JJ O
saccadic JJ O
subtypes NNS O
were VBD O
computed VBN O
using VBG O
infrared VBD O
oculography NN O
and CC O
computerized JJ O
pattern NN O
recognition NN O
software NN O
. . O

-DOCSTART- X X O

Mitoxantrone NNP O
plus CC O
ara-C NN O
is VBZ O
an DT O
active JJ O
combination NN O
with IN O
great JJ O
promise NN O
for IN O
the DT O
therapy NN O
of IN O
previously RB O
untreated JJ O
patients NNS O
with IN O
AML. NNP O

-DOCSTART- X X O

During IN O
an DT O
observation NN O
period NN O
of IN O
12 CD O
weeks NNS O
after IN O
halving JJ O
atenolol NN O
from IN O
a DT O
mean JJ O
dose NN O
of IN O
82 CD O
mg NN O
to TO O
41 CD O
mg NN O
, , O
no DT O
significant JJ O
changes NNS O
in IN O
systolic JJ O
and CC O
diastolic JJ O
blood NN O
pressure NN O
or CC O
in IN O
response NN O
rate NN O
( -LRB- O
defined VBN O
as IN O
a DT O
diastolic JJ O
blood NN O
pressure NN O
of IN O
95 CD O
mm CD O
Hg NN O
or CC O
less JJR O
) -RRB- O
were VBD O
observed VBN O
. . O

-DOCSTART- X X O

Diet NNP O
imbalances NNS O
and CC O
aflatoxicosis NN O

-DOCSTART- X X O

WBC NNP O
differential JJ O
( -LRB- O
SEG NNP O
, , O
BAND NNP O
, , O
LYMPH NNP O
, , O
MONO NNP O
, , O
EOSINO NNP O
, , O
BASO NNP O
) -RRB- O
usually RB O
showed VBD O
log-normal JJ O
distribution NN O
. . O

-DOCSTART- X X O

Recombinant JJ O
protein NN O
encoded VBN O
by IN O
ESX NNP B-NP
( -LRB- O
for IN O
epithelial-restricted JJ B-NP
with IN I-NP
serine JJ I-NP
box NN I-NP
) -RRB- O
exhibits VBZ O
Ets-like JJ B-NP
DNA NNP O
binding NN O
specificity NN O
in IN O
electrophoretic JJ O
mobility NN O
shift NN O
assays IN O
and CC O
, , O
in IN O
transient NN O
transfection NN O
assays VBZ O
, , O
transactivates NNS O
Ets-responsive JJ B-NP
promoter NN I-NP
elements NNS I-NP
including VBG O
that DT O
found VBN O
in IN O
the DT O
HER2/neu NNP B-NP
oncogene NNP O
. . O

-DOCSTART- X X O

Two CD O
adjacent JJ O
, , O
highly RB O
homologous JJ B-NP
endoglucanase NN I-NP
genes NNS I-NP
, , O
celD NNS B-NP
and CC O
celE NN B-NP
from IN O
Fibrobacter NNP O
succinogenes VBZ O
S85 NNP O
, , O
which WDT O
were VBD O
separated VBN O
by IN O
an DT O
AT-rich JJ O
223-nucleotide JJ O
intergenic JJ O
region NN O
were VBD O
characterized VBN O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
this DT O
region NN O
showed VBD O
it PRP O
contained VBD O
five CD O
potential JJ O
copies NNS O
of IN O
the DT O
sterol NN O
regulatory JJ O
element NN O
( -LRB- O
SRE-1 NN O
) -RRB- O
( -LRB- O
Smith NNP O
, , O
J.R. NNP O
, , O
Osborne NNP O
, , O
T.F. NNP O
, , O
Brown NNP O
, , O
M.S. NNP O
, , O
Goldstein NNP O
, , O
J.L. NNP O
, , O
and CC O
Gil NNP O
, , O
G. NNP O

-DOCSTART- X X O

Fetal NNP O
PaO2 NNP O
fell VBD O
somewhat RB O
during IN O
the DT O
recovery NN O
stages NNS O
in IN O
both DT O
NIT NNP O
and CC O
control NN O
groups NNS O
. . O

-DOCSTART- X X O

It PRP O
also RB O
showed VBD O
which WDT O
amino IN O
acid NN O
residues NNS O
would MD O
contact VB O
an DT O
extended JJ O
TATA NNP O
box NN O
with IN O
a DT O
B NNP B-NP
recognition NN I-NP
element NN I-NP
, , O
and CC O
evolutionary JJ O
conservation NN O
of IN O
the DT O
TBP-TFB-DNA NNP B-NP
complex JJ O
orientation NN O
between IN O
two CD O
archaeal JJ O
organisms NNS O
with IN O
widely RB O
different JJ O
optimal NN O
temperature NN O
for IN O
growth NN O
( -LRB- O
37 CD O
and CC O
100 CD O
degrees NNS O
C NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
average JJ O
progression NN O
was VBD O
11.6 CD O
( -LRB- O
SD NNP O
9.0) CD O
. . O

-DOCSTART- X X O

Result NN O
were VBD O
as RB O
followed VBN O
: : O
1 CD O
) -RRB- O
Early RB O
cancer-like JJ O
advanced JJ O
cancers NNS O
were VBD O
consisted VBN O
of IN O
133 CD O
lesions NNS O
, , O
of IN O
which WDT O
128 CD O
lesions NNS O
(96.2 IN O
% NN O
) -RRB- O
had VBD O
peptic JJ O
ulcer NN O
in IN O
cancerous JJ O
lesion NN O
( -LRB- O
73 CD O
lesions NNS O
were VBD O
active JJ O
stage NN O
and CC O
55 CD O
lesions NNS O
were VBD O
scarring JJ O
stage NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
unexpected JJ O
prevalence NN O
of IN O
c-myc JJ B-NP
and CC O
alpha-tubulin NN B-NP
in IN O
the DT O
S-phase JJ O
library NN O
is VBZ O
supported VBN O
by IN O
Northern JJ O
analysis NN O
of IN O
RNA NNP O
from IN O
phase-synchronous JJ O
cells NNS O
. . O

-DOCSTART- X X O

A DT O
spectrophotometric JJ O
method NN O
for IN O
the DT O
microdetermination NN O
of IN O
periodate NN O
. . O

-DOCSTART- X X O

Eleven CD O
of IN O
the DT O
12 CD O
exons NNS O
have VBP O
complete JJ O
sequence NN O
homology NN O
with IN O
the DT O
RBM-1 JJ B-NP
sequence NN I-NP
. . O

-DOCSTART- X X O

Polyoma NNP O
virus NN O
in IN O
urine NN O
during IN O
pregnancy NN O
. . O

-DOCSTART- X X O

Using VBG O
probes NNS O
from IN O
these DT O
regions NNS O
, , O
rearrangements NNS O
have VBP O
been VBN O
identified VBN O
in IN O
each DT O
of IN O
nine CD O
cases NNS O
of IN O
t( JJ O
8;21 CD O
) -RRB- O
AML NNP O
examined VBD O
. . O

-DOCSTART- X X O

The DT O
delta JJ O
G NNP O
values NNS O
of IN O
these DT O
regions NNS O
were VBD O
higher JJR O
, , O
i IN O
.e NN O
. . O
potential JJ O
secondary JJ O
structural JJ O
elements NNS O
were VBD O
fewer JJR O
, , O
than IN O
in IN O
TIR NN O
of IN O
genes NNS O
from IN O
E. NNP O
coli NNS O
. . O

-DOCSTART- X X O

In IN O
each DT O
patient NN O
, , O
MBF NNP O
was VBD O
quantified VBN O
in IN O
the DT O
three CD O
major JJ O
vascular JJ O
territories NNS O
: : O
the DT O
left JJ O
anterior NN O
descending VBG O
and CC O
left RB O
circumflex JJ O
coronary JJ O
artery NN O
territories NNS O
and CC O
the DT O
right JJ O
coronary JJ O
artery NN O
( -LRB- O
control NN O
region NN O
) -RRB- O
territory NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
99mTc-HL91 NNP O
is VBZ O
a DT O
potent JJ O
marker NN O
of IN O
myocardial JJ O
viability NN O
when WRB O
used VBN O
during IN O
the DT O
early JJ O
acute JJ O
phase NN O
after IN O
reperfusion NN O
. . O

-DOCSTART- X X O

The DT O
community-acquired JJ O
bacteremia NN O
was VBD O
mainly RB O
due JJ O
to TO O
E. NNP O
coli NNS O
. . O

-DOCSTART- X X O

The DT O
benzo-pyrone JJ O
drug NN O
Venalot NNP O
had VBD O
a DT O
considerable JJ O
effect NN O
in IN O
reducing VBG O
the DT O
protein NN O
concentration NN O
in IN O
the DT O
air NN O
spaces NNS O
and CC O
the DT O
interstitial JJ O
tissue NN O
, , O
and CC O
of IN O
the DT O
oedema NN O
in IN O
the DT O
latter NN O
. . O

-DOCSTART- X X O

The DT O
brains NNS O
were VBD O
bisected VBN O
and CC O
T1 NNP O
and CC O
T2 NNP O
relaxation NN O
times NNS O
were VBD O
determined VBN O
for IN O
the DT O
right NN O
and CC O
left VBD O
hemispheres NNS O
by IN O
MR NNP O
spectroscopy NN O
immediately RB O
after IN O
dissection NN O
. . O

-DOCSTART- X X O

The DT O
exact JJ O
function NN O
of IN O
IP-30 DT B-NP
is VBZ O
not RB O
yet RB O
known VBN O
, , O
but CC O
it PRP O
may MD O
play VB O
a DT O
role NN O
in IN O
gamma-interferon NN B-NP
mediated VBN O
immune JJ O
reactions NNS O
. . O

-DOCSTART- X X O

Finally RB O
, , O
gel JJ O
shift NN O
assays IN O
showed VBD O
that DT O
ORF2 NNP O
was VBD O
able JJ O
to TO O
bind NN O
to TO O
promoter NN O
fragment NN O
566-888 CD O
. . O

-DOCSTART- X X O

In IN O
normal JJ O
B NNP O
cells NNS O
stimulated VBN O
by IN O
LPS NNP O
or CC O
IL-4 NNP B-NP
, , O
new JJ O
complexes NNS O
appear VBP O
that IN O
bind NN O
to TO O
C/EBP NNP B-NP
and CC O
NF-IL-4 NNP B-NP
elements NNS I-NP
, , O
respectively RB O
, , O
located VBN O
within IN O
the DT O
-125/-101 JJ O
region NN O
. . O

-DOCSTART- X X O

Phylogenetic JJ O
analysis NN O
using VBG O
a DT O
neighbor-joining NN O
algorithm NN O
showed VBD O
closest JJS O
similarity NN O
of IN O
the DT O
horse NN B-NP
mu NN I-NP
chain-encoding NN I-NP
constant JJ I-NP
region NN I-NP
gene NN I-NP
to TO O
human JJ O
and CC O
dog NN O
sequences NNS O
. . O

-DOCSTART- X X O

Progressive JJ O
immunodeficiency NN O
in IN O
a DT O
patient NN O
with IN O
IgA NNP B-NP
deficiency NN O

-DOCSTART- X X O

Mouse NN O
embryo NN O
cells NNS O
( -LRB- O
C57BL/6 NNS O
, , O
H-2b JJ O
) -RRB- O
transformed VBN O
by IN O
the DT O
E1A NNP B-NP
and CC O
E1B NNP B-NP
genes NNS O
of IN O
adenovirus JJ O
type NN O
5 CD O
( -LRB- O
Ad5E1 NN O
MEC NNP O
) -RRB- O
are VBP O
highly RB O
immunogenic JJ O
. . O

-DOCSTART- X X O

The DT O
major JJ O
open JJ O
reading NN O
frame NN O
of IN O
the DT O
cDNA NN O
predicts VBZ O
a DT O
protein NN O
of IN O
59 CD O
kD NN O
, , O
with IN O
a DT O
leucine NN O
zipper NN O
situated VBN O
adjacent JJ O
to TO O
an DT O
myc-related JJ B-NP
motif NN I-NP
that WDT O
has VBZ O
been VBN O
proposed VBN O
to TO O
assume VB O
a DT O
helix-loop-helix NN O
structure NN O
. . O

-DOCSTART- X X O

Evidence NN O
from IN O
four CD O
areas--sensory JJ O
deprivation NN O
, , O
enriched JJ O
environments NNS O
, , O
nervous JJ O
system NN O
plasticity NN O
, , O
and CC O
sensitive JJ O
periods NNS O
of IN O
neurodevelopment--suggests NNS O
that IN O
sensory JJ O
stimulation NN O
programs NNS O
are VBP O
potentially RB O
beneficial JJ O
for IN O
STR NNP O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
limb NN O
defects NNS O
, , O
oligodactyly RB O
and CC O
syndactyly RB O
, , O
have VBP O
been VBN O
traced VBN O
to TO O
improper JJ O
differentiation NN O
of IN O
the DT O
apical JJ O
ectodermal JJ O
ridge NN O
( -LRB- O
AER NNP O
) -RRB- O
and CC O
shortening NN O
of IN O
the DT O
anteroposterior JJ O
limb NN O
axis NN O
. . O

-DOCSTART- X X O

Donehower NNP O
and CC O
H. NNP O

-DOCSTART- X X O

Children NNS O
with IN O
repeated VBN O
proteinuria NN O
during IN O
follow-up JJ O
tend VBP O
to TO O
have VB O
a DT O
higher JJR O
incidence NN O
of IN O
pathologic NN O
findings NNS O
on IN O
the DT O
i NN O
.v.-pyelogram NN O
. . O

-DOCSTART- X X O

The DT O
translated VBN O
sequence NN O
of IN O
the DT O
FLI NNP B-NP
LRR NNP I-NP
associated JJ I-NP
protein NN I-NP
( -LRB- O
FLAP NNP B-NP
) -RRB- O
encodes VBZ O
a DT O
novel JJ O
protein NN O
not RB O
represented VBN O
in IN O
the DT O
data NN O
base NN O
. . O

-DOCSTART- X X O

In IN O
two CD O
separate JJ O
studies NNS O
, , O
specimens NNS O
of IN O
saliva NN O
from IN O
57 CD O
individuals NNS O
over IN O
the DT O
age NN O
of IN O
65 CD O
years NNS O
( -LRB- O
mean JJ O
age NN O
, , O
76.7 CD O
years NNS O
) -RRB- O
and CC O
37 CD O
persons NNS O
under IN O
the DT O
age NN O
of IN O
40 CD O
years NNS O
( -LRB- O
mean JJ O
age NN O
, , O
28.8 CD O
years NNS O
) -RRB- O
were VBD O
examined VBN O
for IN O
concentrations NNS O
of IN O
IgA NNP B-NP
as IN O
functions NNS O
of IN O
volume NN O
, , O
total JJ O
protein NN O
, , O
and CC O
electrolyte JJ O
conductivity NN O
; : O
some DT O
were VBD O
also RB O
tested VBN O
for IN O
IgG NNP B-NP
and CC O
IgM NNP B-NP
content NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
plant NN B-NP
malate NN I-NP
synthases NNS I-NP
, , O
the DT O
extension NN O
is VBZ O
probably RB O
involved VBN O
in IN O
routing VBG O
to TO O
the DT O
microbodies NNS O
, , O
since IN O
it PRP O
contains VBZ O
the DT O
potential NN O
peroxisomal NN O
targeting VBG O
signal NN O
, , O
Ser-Arg/Lys-Leu NNP O
, , O
at IN O
the DT O
carboxy NN O
terminus NN O
. . O

-DOCSTART- X X O

In IN O
agreement NN O
with IN O
this DT O
model NN O
, , O
elimination NN O
of IN O
the DT O
ADAM13 NNPS B-NP
cytoplasmic JJ I-NP
domain NN I-NP
increased VBD O
developmental JJ O
alterations NNS O
attributable JJ O
to TO O
ADAM13 DT B-NP
proteolytic JJ O
activity NN O
. . O

-DOCSTART- X X O

The DT O
strangulated JJ O
intestinal JJ O
pathologies NNS O
of IN O
horses NNS O
are VBP O
accompanied VBN O
by IN O
a DT O
local JJ O
activation NN O
of IN O
the DT O
neutrophils NNS O
, , O
that WDT O
can MD O
be VB O
revealed VBN O
by IN O
measuring VBG O
the DT O
tissular JJ O
enzymatic JJ O
activity NN O
of IN O
the DT O
granulocytic JJ O
enzyme NN O
myeloperoxidase NN B-NP
( -LRB- O
MPO NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
two CD O
redox NN O
centers NNS O
in IN O
the DT O
protein NN O
, , O
FAD NN O
and CC O
a DT O
[4Fe4S]+2 NN O
,+1 IN O
cluster NN O
, , O
are VBP O
present JJ O
in IN O
a DT O
64-kDa JJ O
monomer NN O
. . O

-DOCSTART- X X O

Failure NN O
to TO O
demonstrate VB O
a DT O
major JJ O
anti-inflammatory JJ O
effect NN O
with IN O
alpha NN O
tocopherol NN O
supplementation NN O
( -LRB- O
400 CD O
IU/day NN O
) -RRB- O
in IN O
normal JJ O
subjects NNS O
. . O

-DOCSTART- X X O

The DT O
flanking NN O
open JJ O
reading NN O
frames NNS O
in IN O
pARGC2 NN O
showed VBD O
no DT O
homologies NNS O
to TO O
arginine VB O
biosynthetic JJ O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
interaction NN O
of IN O
different JJ O
protein NN O
systems NNS O
with IN O
microtubules NNS O
is VBZ O
a DT O
critical JJ O
step NN O
in IN O
the DT O
cellular JJ O
function NN O
of IN O
these DT O
organelles NNS O
. . O

-DOCSTART- X X O

SHBG NNP B-NP
concentrations NNS O
in IN O
women NNS O
were VBD O
also RB O
significantly RB O
higher JJR O
at IN O
T-2 JJ O
and CC O
T-3 JJ O
when WRB O
compared VBN O
to TO O
T-1 DT O
values NNS O
. . O

-DOCSTART- X X O

Chromosome-specific JJ O
STSs NNP O
for IN O
27 CD O
telomeres NNS O
were VBD O
identified VBN O
from IN O
the DT O
196 CD O
TYACs NNS O
. . O

-DOCSTART- X X O

The DT O
two CD O
yeast NN B-NP
pheromone NN I-NP
receptors NNS I-NP
, , O
the DT O
a DT B-NP
and CC I-NP
alpha-factor NN I-NP
receptors NNS I-NP
, , O
share NN O
many JJ O
functional JJ O
similarities NNS O
: : O
both DT O
G NNP B-NP
protein-coupled JJ I-NP
receptors NNS I-NP
couple NN O
to TO O
the DT O
same JJ O
downstream NN O
signal NN O
transduction NN O
pathway NN O
, , O
and CC O
both DT O
receptors NNS O
undergo VBP O
feedback NN O
regulation NN O
involving VBG O
increased VBN O
phosphorylation NN O
on IN O
their PRP$ O
C-terminal JJ O
domains NNS O
in IN O
response NN O
to TO O
ligand VB O
challenge NN O
. . O

-DOCSTART- X X O

Heart NN O
rate NN O
and CC O
oxygen NN O
consumption NN O
increased VBD O
75+/-4 CD O
bpm NN O
and CC O
26.3+/-1.4 CD O
ml JJ O
O2/kg JJ O
x NN O
min(-1 NN O
) -RRB- O
from IN O
supine NN O
resting VBG O
values NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

It PRP O
also RB O
produces VBZ O
an DT O
NH2 NNP O
terminus NN O
that IN O
corresponds NNS O
to TO O
an DT O
equivalent JJ O
NH2 NNP O
terminus NN O
on IN O
the DT O
processed JJ O
matrix NN O
form NN O
of IN O
the DT O
similar JJ O
alpha1(XI NN B-NP
) -RRB- I-NP
chain NN I-NP
, , O
thus RB O
suggesting VBG O
physiological JJ O
significance NN O
. . O

-DOCSTART- X X O

To TO O
determine VB O
the DT O
transactivation NN O
potential NN O
of IN O
each DT O
of IN O
the DT O
four CD O
Ahr NNP B-NP
Sp1 NNP B-NP
sites NNS I-NP
, , O
we PRP O
fused VBD O
the DT O
Ahr NNP B-NP
promoter NN I-NP
to TO O
a DT O
luciferase NN B-NP
( -LRB- O
LUC) NNP B-NP
reporter NN O
gene NN O
and CC O
transfected VBD O
the DT O
construct VB O
into IN O
the DT O
Drosophila NNP O
cell NN O
line NN O
Schneider-2 NNP O
, , O
which WDT O
contains VBZ O
no DT O
Sp1 NNP B-NP
or CC O
Sp1-like JJ B-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

Based VBN O
on IN O
the DT O
results NNS O
of IN O
this DT O
analysis NN O
, , O
we PRP O
also RB O
predict VBP O
that IN O
the DT O
budding VBG B-NP
yeast NN I-NP
arsenate NN I-NP
resistance NN I-NP
protein NN I-NP
Acr2 NNP B-NP
and CC O
the DT O
ORF NNP B-NP
Ygr203w NNP I-NP
encode JJ O
protein NN O
phosphatases NNS O
with IN O
catalytic JJ O
properties NNS O
similar JJ O
to TO O
that DT O
of IN O
the DT O
Cdc25 NNP B-NP
family NN I-NP
. . O

-DOCSTART- X X O

However RB O
, , O
in IN O
7 CD O
patients NNS O
with IN O
normal JJ O
CT NN O
results NNS O
the DT O
latter JJ O
method NN O
showed VBD O
areas NNS O
of IN O
cerebral JJ O
activity NN O
anatomically RB O
correlated VBD O
with IN O
neurological JJ O
signs NNS O
or CC O
vascular JJ O
lesions NNS O
. . O

-DOCSTART- X X O

Signal NNP O
transduction NN O
in IN O
fibroblasts NNS O
stably RB O
transformed VBN O
by IN O
[Val12]Ras--the DT O
activities NNS O
of IN O
extracellular-signal-regulated JJ B-NP
kinase NN I-NP
and CC O
Jun NNP B-NP
N-terminal JJ I-NP
kinase NN I-NP
are VBP O
only RB O
moderately RB O
increased VBN O
, , O
and CC O
the DT O
activity NN O
of IN O
the DT O
delta-inhibitor NN O
of IN O
c-Jun NN B-NP
is VBZ O
not RB O
alleviated VBN O
. . O

-DOCSTART- X X O

Avian NNP B-NP
EMILIN NNP I-NP
was VBD O
extracted VBN O
from IN O
19-day-old JJ O
embryonic JJ O
chick NN O
aortas NNS O
and CC O
associated VBN O
blood NN O
vessels NNS O
and CC O
purified VBN O
by IN O
ion-exchange JJ O
chromatography NN O
and CC O
gel NN O
filtration NN O
. . O

-DOCSTART- X X O

Asymptomatic JJ O
ischaemia NN O
during IN O
daily JJ O
life NN O
in IN O
stable JJ O
coronary JJ O
artery NN O
disease NN O
: : O
relevant JJ O
or CC O
redundant JJ O
? . O

-DOCSTART- X X O

Individual JJ O
intolerance NN O
to TO O
betaxolol NN O
will MD O
continue VB O
to TO O
occur VB O
and CC O
care VB O
is VBZ O
always RB O
required VBN O
when WRB O
patients NNS O
with IN O
cardiac JJ O
or CC O
respiratory JJ O
dysfunction NN O
are VBP O
exposed VBN O
to TO O
any DT O
beta-antagonist NN O
. . O

-DOCSTART- X X O

DESIGN NNP O
: : O
Prospective JJ O
case NN O
study NN O
( -LRB- O
Canadian NNP O
Task NNP O
Force NNP O
classification NN O
II-2 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Peak JJ O
insulin NN B-NP
response NN O
to TO O
glucose NN O
infusion NN O
declined VBD O
from IN O
Groups NNP O
1 CD O
to TO O
3 CD O
( -LRB- O
51 CD O
+/ NN O
- : O
14 CD O
, , O
42.4 CD O
+/ CD O
- : O
31 CD O
, , O
20.4 CD O
+/ NN O
- : O
6.8 CD O
microU/ml NN O
, , O
respectively RB O
) -RRB- O
with IN O
Group NNP O
3 CD O
exhibiting NN O
a DT O
significantly RB O
decreased VBN O
mean JJ O
peak NN O
level NN O
compared VBN O
to TO O
the DT O
other JJ O
groups NNS O
. . O

-DOCSTART- X X O

Chemical NNP O
structure NN O
of IN O
antibiotic JJ O
SF-837 NNS O
. . O

-DOCSTART- X X O

Reexamination NN O
of IN O
the DT O
cdc4-1 NN B-NP
mutant JJ I-NP
revealed VBD O
that IN O
, , O
in IN O
addition NN O
to TO O
being VBG O
defective JJ O
in IN O
the DT O
onset NN O
of IN O
S NNP O
phase NN O
, , O
it PRP O
is VBZ O
also RB O
defective JJ O
in IN O
G( NNP O
2 CD O
)/M NNP O
transition NN O
when WRB O
released VBN O
from IN O
hydroxyurea-induced JJ O
S-phase JJ O
arrest NN O
. . O

-DOCSTART- X X O

Structure NN O
and CC O
regulation NN O
of IN O
the DT O
luteinizing VBG B-NP
hormone NN I-NP
receptor NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Unconventional JJ O
mRNA NN O
processing NN O
in IN O
the DT O
expression NN O
of IN O
two CD O
calcineurin NN B-NP
B NNP I-NP
isoforms VBZ I-NP
in IN O
Dictyostelium NN O
. . O

-DOCSTART- X X O

T1 NNP O
and CC O
T2 DT O
values NNS O
were VBD O
calculated VBN O
from IN O
guinea NN O
pig NN O
brain NN O
in IN O
vivo JJ O
at IN O
0.5 CD O
T. NNP O

-DOCSTART- X X O

A DT O
chest-X JJ O
ray NN O
film NN O
showed VBD O
infiltrative JJ O
shadows NNS O
in IN O
the DT O
right JJ O
middle NN O
and CC O
lower JJR O
lung NN O
fields NNS O
, , O
but CC O
a DT O
chest NN O
CT NN O
scan NN O
showed VBD O
an DT O
abnormal JJ O
lung NN O
density NN O
in IN O
the DT O
right NN O
lower JJR O
lobe NN O
. . O

-DOCSTART- X X O

Plasma NNP B-NP
insulin NN I-NP
responses NNS O
to TO O
glucose VB O
in IN O
femoral JJ O
, , O
hepatic JJ O
, , O
and CC O
pancreatic JJ O
veins NNS O
in IN O
dogs NNS O
. . O

-DOCSTART- X X O

The DT O
reading NN O
achievement NN O
of IN O
students NNS O
with IN O
learning VBG O
disabilities NNS O
who WP O
received VBD O
reading NN O
instruction NN O
through IN O
the DT O
DISTAR NN O
program NN O
was VBD O
compared VBN O
to TO O
that DT O
of IN O
similar JJ O
students NNS O
using VBG O
basal JJ O
reader NN O
materials NNS O
. . O

-DOCSTART- X X O

SM NNP B-NP
binds NNS O
RNA NNP O
in IN O
vitro NN O
, , O
suggesting VBG O
that IN O
sequence NN O
- : O
or CC O
structure-specific JJ O
mRNA NN O
interactions NNS O
might MD O
mediate VB O
SM NNP B-NP
specificity NN O
. . O

-DOCSTART- X X O

Stress-induced JJ O
suppression NN O
of IN O
the DT O
prolactin NN B-NP
afternoon NN O
surge NN O
in IN O
ovariectomized JJ O
, , O
estrogen-treated JJ O
rats NNS O
and CC O
the DT O
nocturnal JJ O
surge NN O
in IN O
pseudopregnant JJ O
rats NNS O
are VBP O
accompanied VBN O
by IN O
an DT O
increase NN O
in IN O
median JJ O
eminence NN O
dihydroxyphenylacetic JJ O
acid NN O
concentrations NNS O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
kinase NN O
assays VBZ O
on IN O
isolated VBN O
microvilli NNS O
and CC O
microvillar NN O
fractions NNS O
enriched VBD O
in IN O
the DT O
putative JJ O
signal NN O
transduction NN O
particle NN O
showed VBD O
a DT O
high JJ O
specific JJ O
activity NN O
of IN O
tyrosine NN B-NP
kinase NN I-NP
activity NN O
compared VBN O
to TO O
that DT O
of IN O
membranes NNS O
from IN O
EGF NNP B-NP
receptor-overexpressing JJ I-NP
A431 IN O
cells NNS O
maximally RB O
activated VBN O
by IN O
EGF. NNP B-NP

-DOCSTART- X X O

Among IN O
these DT O
, , O
four CD O
patients NNS O
had VBD O
the DT O
AIDS NNP O
syndrome NN O
, , O
while IN O
42 CD O
individuals NNS O
were VBD O
HIV NNP O
carriers NNS O
. . O

-DOCSTART- X X O

Carcinogenic NNP O
action NN O
of IN O
groundnut NN O
meal NN O
containing VBG O
aflatoxin NN O
in IN O
rats NNS O
. . O

-DOCSTART- X X O

The DT O
UASB NNP O
reactors NNS O
treated VBD O
a DT O
VFA NN O
mixture NN O
( -LRB- O
with IN O
an DT O
acetate NN O
:propionate JJ O
:butyrate JJ O
ratio NN O
of IN O
5:3:2 CD O
on IN O
COD JJ O
basis NN O
) -RRB- O
or CC O
acetate NN O
as IN O
the DT O
sole JJ O
substrate NN O
at IN O
different JJ O
COD NNP O
:sulfate NN O
ratios NNS O
. . O

-DOCSTART- X X O

The DT O
initial JJ O
oral JJ O
administration NN O
of IN O
the DT O
1 CD O
and CC O
2 CD O
mg/kg JJ O
doses NNS O
of IN O
enoximone NN O
improved VBN O
central JJ O
hemodynamic JJ O
parameters NNS O
with IN O
apparent JJ O
preferential JJ O
reduction NN O
of IN O
limb NN O
vascular JJ O
resistance NN O
and CC O
augmentation NN O
of IN O
blood NN O
flow NN O
to TO O
the DT O
limb NN O
region NN O
( -LRB- O
peripheral JJ O
musculoskeletal NN O
system NN O
) -RRB- O
. . O

-DOCSTART- X X O

Copyright NNP O
1999 CD O
Academic NNP O
Press NNP O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
phosphorylation NN O
on IN O
receptor NN O
desensitization NN O
was VBD O
assessed VBN O
using VBG O
receptor NN O
mutants NNS O
expressed VBN O
in IN O
COS NNP O
cells NNS O
or CC O
Chinese JJ O
hamster NN O
lung NN O
fibroblasts NNS O
. . O

-DOCSTART- X X O

For IN O
il8ra NN B-NP
, , O
it PRP O
is VBZ O
formed VBN O
from IN O
two CD O
exons NNS O
, , O
whereas IN O
for IN O
il8rb NN B-NP
, , O
seven CD O
distinct JJ O
neutrophil JJ O
mRNAs NNS O
are VBP O
formed VBN O
by IN O
alternative JJ O
splicing NN O
of IN O
11 CD O
exons NNS O
. . O

-DOCSTART- X X O

By IN O
deletion NN O
analysis NN O
, , O
we PRP O
identified VBD O
the DT O
regions NNS O
of IN O
c-Jun JJ B-NP
encoding NN O
transformation NN O
and CC O
transactivation NN O
functions NNS O
. . O

-DOCSTART- X X O

Several JJ O
waveforms NNS O
of IN O
both DT O
the DT O
somatosensory NN O
( -LRB- O
N20 NNP O
, , O
P/N NNP O
30 CD O
, , O
and CC O
P200 CD O
) -RRB- O
and CC O
the DT O
brainstem NN O
auditory-evoked JJ O
response NN O
( -LRB- O
I PRP O
, , O
III NNP O
, , O
IV NNP O
, , O
and CC O
V NNP O
) -RRB- O
demonstrated VBD O
shorter JJR O
( -LRB- O
p NN O
less JJR O
than IN O
0.05 CD O
) -RRB- O
latencies RBR O
in IN O
growth-retarded JJ O
fetuses NNS O
relative JJ O
to TO O
normal-sized JJ O
fetuses NNS O
. . O

-DOCSTART- X X O

Interactions NNS O
were VBD O
also RB O
detected VBN O
between IN O
full-length JJ O
HSF1 NNP B-NP
and CC O
the DT O
small JJ O
subunit NN O
( -LRB- O
gamma NN O
) -RRB- O
of IN O
TFIIA NNP B-NP
. . O

-DOCSTART- X X O

Pyknotic JJ O
osteocytes NNS O
increased VBN O
at IN O
12 CD O
h NN O
( -LRB- O
p NN O
less JJR O
than IN O
0.01 CD O
) -RRB- O
and CC O
2 CD O
days NNS O
( -LRB- O
p NN O
less JJR O
than IN O
0.001 CD O
) -RRB- O
of IN O
ischemia NN O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
indicated VBN O
that IN O
both DT O
human JJ O
and CC O
murine JJ O
genes NNS O
encode VBD O
approximately RB O
6-kb JJ O
transcripts NNS O
. . O

-DOCSTART- X X O

ALT NNP B-NP
( -LRB- O
alanine NN B-NP
aminotransferase NN I-NP
) -RRB- O
and CC O
Hb NNP B-NP
( -LRB- O
hemoglobin NN B-NP
) -RRB- O
appeared VBD O
to TO O
be VB O
predictive JJ O
for IN O
efficacy NN O
. . O

-DOCSTART- X X O

Maternal JJ O
behavior NN O
was VBD O
assessed VBN O
using VBG O
observational JJ O
techniques NNS O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
timepidium NN O
bromide NN O
( -LRB- O
TB NNP O
; : O
anticholinergic JJ O
agent NN O
) -RRB- O
, , O
acetylcholine JJ O
(ACh NN O
) -RRB- O
and CC O
neostigmine NN O
( -LRB- O
Neost NN O
) -RRB- O
on IN O
gastric NNP O
and CC O
duodenal JJ O
blood NN O
flow NN O
distribution NN O
were VBD O
studied VBN O
by IN O
the DT O
use NN O
of IN O
131I-labeled JJ O
macroaggregated JJ O
human JJ O
serum NN O
albumin NN O
( -LRB- O
MAA NNP B-NP
) -RRB- O
in IN O
rabbits NNS O
. . O

-DOCSTART- X X O

Nucleotide NNP O
sequence NN O
of IN O
the DT O
gag NN B-NP
gene NN I-NP
and CC O
gag-pol JJ B-NP
junction NN O
of IN O
feline NN O
leukemia NN O
virus NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
reduced VBD O
metabolism NN O
to TO O
cotinine VB O
from IN O
the DT O
proliposomes NNS O
and CC O
MP NNP O
was VBD O
apparently RB O
responsible JJ O
for IN O
the DT O
sustained VBN O
plasma NN O
nicotine JJ O
levels NNS O
. . O

-DOCSTART- X X O

D. NNP O

-DOCSTART- X X O

BCR-ABL JJ B-NP
expression NN O
confers NNS O
cross-resistance NN O
to TO O
multiple JJ O
genotoxic JJ O
anticancer NN O
drugs NNS O
by IN O
inhibition NN O
of IN O
the DT O
apoptotic JJ O
response NN O
to TO O
DNA NNP O
damage NN O
in IN O
association NN O
with IN O
cell NN O
cycle NN O
arrest NN O
at IN O
the DT O
G2-M JJ O
restriction NN O
point NN O
. . O

-DOCSTART- X X O

In IN O
area NN O
CA1 NNP O
of IN O
the DT O
hippocampus NN O
, , O
numbers NNS O
of IN O
normal JJ O
neurons NNS O
were VBD O
increased VBN O
11- CD O
to TO O
14-fold JJ O
by IN O
MK-801 JJ O
treatment NN O
( -LRB- O
p NN O
< JJ O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Considering VBG O
these DT O
two CD O
facts NNS O
together RB O
, , O
we PRP O
propose VBP O
that IN O
vasectomy NN O
may MD O
lead VB O
to TO O
decrease VB O
in IN O
the DT O
incidence NN O
of IN O
prostatic JJ O
tumors NNS O
- : O
a DT O
disease NN O
that WDT O
claims VBZ O
nearly RB O
22,000 CD O
lives NNS O
each DT O
year NN O
in IN O
the DT O
United NNP O
States NNPS O
alone RB O
. . O

-DOCSTART- X X O

At IN O
least JJS O
one CD O
such JJ O
complex NN O
is VBZ O
eliminated VBN O
by IN O
preincubating VBG O
the DT O
nuclear JJ O
extract VB O
with IN O
an DT O
antibody NN O
with IN O
broad JJ O
cross-reactivity NN O
with IN O
Ets-1 JJ B-NP
and CC O
Ets-2 JJ B-NP
proteins NNS I-NP
, , O
thus RB O
confirming VBG O
that IN O
an DT O
ETS NNP B-NP
transcription NN I-NP
factor( NN I-NP
s VBZ I-NP
) -RRB- I-NP
recognizes VBZ O
the DT O
-12 NN O
motif NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Peripheral JJ O
kappa NN B-NP
receptor NN I-NP
agonists NNS O
may MD O
provide VB O
a DT O
new JJ O
therapeutic JJ O
approach NN O
for IN O
the DT O
treatment NN O
of IN O
functional JJ O
dyspepsia NN O
. . O

-DOCSTART- X X O

Checking NNP O
for IN O
patient JJ O
compliance NN O
, , O
samples NNS O
( -LRB- O
n NN O
= SYM O
10 CD O
) -RRB- O
with IN O
a DT O
FK NNP O
I PRP O
concentration NN O
of IN O
0 CD O
ng/mL NNS O
were VBD O
re-analyzed VBN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
support VBP O
an DT O
in IN O
vivo JJ O
interaction NN O
between IN O
Nck NNP B-NP
and CC O
CKI-gamma2 NNP B-NP
and CC O
suggest VB O
that IN O
CKI-gamma2 NNP B-NP
could MD O
be VB O
involved VBN O
in IN O
signaling VBG O
pathways NNS O
downstream IN O
of IN O
RTKs NNP B-NP
. . O

-DOCSTART- X X O

4-Hydroxyproline JJ O
assays NNS O
were VBD O
performed VBN O
to TO O
determine VB O
collagen NN B-NP
content NN O
. . O

-DOCSTART- X X O

The DT O
biological JJ O
basis NN O
for IN O
the DT O
changes NNS O
in IN O
CNAPs NNS O
produced VBN O
by IN O
CS2 NNP O
is VBZ O
under IN O
investigation NN O
. . O

-DOCSTART- X X O

Non-suppressed JJ O
thyroidal JJ O
radioactive JJ O
iodine NN O
uptake NN O
(RAIU) NN O
in IN O
thyrotoxic JJ O
phase NN O
in IN O
a DT O
case NN O
of IN O
subacute JJ O
thyroiditis NN O
with IN O
thyroid-stimulating JJ O
antibodies NNS O
( -LRB- O
TSAb NN O
) -RRB- O
. . O

-DOCSTART- X X O

Blotting VBG O
analysis NN O
of IN O
intestinal JJ O
RNA NNP O
and CC O
hybridization NN O
of IN O
the DT O
blots NNS O
with IN O
carboxy NN O
apoB NN B-NP
cDNA NN O
probes NNS O
produced VBD O
a DT O
single JJ O
15-kb JJ O
hybridization NN O
band NN O
whereas IN O
hybridization NN O
with IN O
amino DT O
terminal NN O
probes NNS O
produced VBD O
two CD O
hybridization NN O
bands NNS O
of IN O
15 CD O
and CC O
8 CD O
kb NN O
. . O

-DOCSTART- X X O

The DT O
temporal JJ O
expression NN O
of IN O
CRAlBP NNP B-NP
is VBZ O
similar JJ O
to TO O
IRBP NNP B-NP
while IN O
bFGF PRP B-NP
is VBZ O
not RB O
expressed VBN O
until IN O
after IN O
photoreceptor NN O
differentiation NN O
is VBZ O
complete JJ O
. . O

-DOCSTART- X X O

Several JJ O
components NNS O
in IN O
cytokine JJ O
signaling NN O
remain VBP O
unidentified JJ O
. . O

-DOCSTART- X X O

Virgin NNP O
, , O
P. NNP O

-DOCSTART- X X O

Kudzu NNP O
extract VB O
shows VBZ O
potential JJ O
for IN O
moderating JJ O
alcohol NN O
abuse NN O
. . O

-DOCSTART- X X O

Serum NNP O
IgG NNP B-NP
and CC O
IgA NNP B-NP
level NN O
were VBD O
decreased VBN O
. . O

-DOCSTART- X X O

A DT O
novel NN O
zinc NN O
finger-containing NN O
RNA-binding JJ O
protein NN O
conserved VBN O
from IN O
fruitflies NNS O
to TO O
humans NNS O
. . O

-DOCSTART- X X O

High-affinity NNP O
binding NN O
was VBD O
also RB O
observed VBN O
with IN O
recombinant JJ B-NP
SH2 NNP I-NP
domains VBZ I-NP
from IN O
v-src JJ B-NP
and CC O
v-fps NNS B-NP
, , O
raising VBG O
the DT O
possibility NN O
of IN O
protein-protein NN O
interactions NNS O
between IN O
various JJ O
members NNS O
of IN O
the DT O
cytoplasmic JJ B-NP
PTK NNP I-NP
family NN I-NP
. . O

-DOCSTART- X X O

Youssoufian NNP O
, , O
A. NN O

-DOCSTART- X X O

Since IN O
1988 CD O
Modulit-SZ-20 NNP O
has VBZ O
been VBN O
tested VBN O
for IN O
localization NN O
of IN O
nephroliths NNS O
and CC O
ureteroliths NNS O
. . O

-DOCSTART- X X O

Lactate NNP O
, , O
pyruvate JJ O
and CC O
actual JJ O
pH NNS O
values NNS O
in IN O
the DT O
venous JJ O
blood NN O
of IN O
newborn JJ O
calves NNS O

-DOCSTART- X X O

The DT O
dermatoglyphic JJ O
pattern NN O
demostrates VBZ O
a DT O
distal JJ O
triradius NN O
and CC O
small JJ O
whorl NN O
abnormalities NNS O
. . O

-DOCSTART- X X O

The DT O
MI NNP O
site NN O
is VBZ O
predictive JJ O
of IN O
hemodynamic JJ O
left JJ O
ventricular JJ O
dysfunction NN O
both DT O
at IN O
rest NN O
and CC O
during IN O
exercise NN O
: : O
anterior JJ O
MIs NNS O
are VBP O
more RBR O
impaired JJ O
than IN O
inferior JJ O
MIs NNS O
. . O

-DOCSTART- X X O

The DT O
median NN O
survival NN O
time NN O
was VBD O
18 CD O
months NNS O
. . O

-DOCSTART- X X O

Biology NNP O
of IN O
Anopheles NNP O
quadrimaculatus NNP O
under IN O
field NN O
conditions NNS O
in IN O
central JJ O
Florida NNP O
. . O

-DOCSTART- X X O

This DT O
transformation NN O
suppression NN O
by IN O
Rb NNP B-NP
was VBD O
further RB O
shown VBN O
to TO O
be VB O
due JJ O
to TO O
transcriptional JJ O
repression NN O
of IN O
neu NN B-NP
using VBG O
Rb NNP B-NP
expressing VBG O
effector NN O
plasmid NN O
and CC O
neu NN B-NP
promoter-chloramphenicol NN O
acetyltransferase NN B-NP
reporter NN O
gene NN O
. . O

-DOCSTART- X X O

Collectively RB O
, , O
a DT O
unique JJ O
mechanism NN O
involving VBG O
NF-ATp NNP B-NP
appears VBZ O
to TO O
regulate VB O
the DT O
cell NN O
type-specific JJ O
and CC O
activation-dependent JJ O
expression NN O
of IN O
the DT O
SCM-1 JJ B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

In IN O
seven CD O
patients NNS O
( -LRB- O
7.8 CD O
% NN O
) -RRB- O
with IN O
new JJ O
Q-waves NNS O
and CC O
a DT O
pathologic NN O
CK-MB NN B-NP
profile NN O
( -LRB- O
group NN O
II NNP O
) -RRB- O
troponin FW B-NP
T NNP I-NP
reached VBD O
median JJ O
levels NNS O
of IN O
10.47 CD O
micrograms/l JJ O
(quartile JJ O
6.34-12.50 JJ O
micrograms/l NN O
) -RRB- O
( -LRB- O
P NNP O
< , O
0.001 CD O
I PRP O
vs IN O
II NNP O
) -RRB- O
. . O

-DOCSTART- X X O

EMG-based JJ O
measures NNS O
of IN O
fatigue NN O
during IN O
a DT O
repetitive JJ O
squat JJ O
exercise NN O
. . O

-DOCSTART- X X O

Southern JJ O
blot NN O
analysis NN O
revealed VBN O
that IN O
CCaMK NNP B-NP
is VBZ O
encoded VBN O
by IN O
a DT O
single JJ O
gene NN O
. . O

-DOCSTART- X X O

A DT O
fine-structure JJ O
radiation NN O
hybrid NN O
map NN O
for IN O
the DT O
region NN O
that WDT O
extends VBZ O
from IN O
D8S520 NNP B-NP
( -LRB- O
distal NN O
) -RRB- O
to TO O
D8S1759 CD B-NP
( -LRB- O
proximal NN O
) -RRB- O
was VBD O
prepared VBN O
, , O
followed VBN O
by IN O
construction NN O
of IN O
a DT O
single JJ O
, , O
integrated JJ O
YAC/BAC NNP O
contig NN O
for IN O
the DT O
interval NN O
. . O

-DOCSTART- X X O

Messenger NNP O
RNA NNP O
for IN O
the DT O
Ad2 NNP B-NP
DNA NNP I-NP
binding JJ I-NP
protein NN I-NP
: : O
DNA NN O
sequences NNS O
encoding VBG O
the DT O
first JJ O
leader NN O
and CC O
heterogenity NN O
at IN O
the DT O
mRNA NN O
5' JJ O
end NN O
. . O

-DOCSTART- X X O

All DT O
rights NNS O
reserved VBN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
were VBD O
not RB O
obtained VBN O
using VBG O
either DT O
preimmune JJ O
sera NN O
or CC O
antiserum NN O
specific NN O
for IN O
the DT O
luminal JJ O
portion NN O
of IN O
the DT O
glycoprotein NN O
precursor NN O
. . O

-DOCSTART- X X O

The DT O
fz-1 JJ B-NP
and CC O
fz-2 JJ B-NP
genes NNS I-NP
are VBP O
widely RB O
expressed VBN O
in IN O
rat NN O
tissues NNS O
with IN O
the DT O
highest JJS O
steady-state NN O
levels NNS O
of IN O
mRNA NN O
in IN O
kidney NN O
, , O
liver NN O
, , O
heart NN O
, , O
uterus NN O
, , O
and CC O
ovary JJ O
. . O
fz-1 JJ B-NP
and CC I-NP
-2 RB I-NP
mRNA JJ I-NP
levels NNS O
were VBD O
greater JJR O
in IN O
neonatal JJ O
than IN O
in IN O
corresponding JJ O
adult NN O
tissues NNS O
. . O

-DOCSTART- X X O

Mean JJ O
concentration NN O
of IN O
insulin NN B-NP
in IN O
maternal JJ O
plasma NN O
across IN O
all DT O
sampling JJ O
times NNS O
was VBD O
higher JJR O
in IN O
ethanol NN O
treated VBN O
animals NNS O
. . O

-DOCSTART- X X O

Triaxiality NN O
in IN O
the DT O
proton-neutron NN O
interacting VBG O
boson NN O
model NN O
: : O
Perturbed JJ O
O(6 NNS O
) -RRB- O
symmetry NN O
with IN O
application NN O
to TO O
the DT O
mass NN O
A NN O

-DOCSTART- X X O

Role NNP O
of IN O
distinct JJ O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
pathways NNS O
and CC O
cooperation NN O
between IN O
Ets-2 NNP B-NP
, , O
ATF-2 NNP B-NP
, , O
and CC O
Jun NNP B-NP
family NN I-NP
members NNS I-NP
in IN O
human JJ B-NP
urokinase-type NN I-NP
plasminogen NN I-NP
activator NN I-NP
gene NN I-NP
induction NN O
by IN O
interleukin-1 JJ B-NP
and CC O
tetradecanoyl JJ O
phorbol NN O
acetate NN O
. . O

-DOCSTART- X X O

Comparative JJ O
volumetric JJ O
analysis NN O
is VBZ O
defined VBN O
as IN O
the DT O
difference NN O
between IN O
mean JJ O
corpuscular JJ O
erythrocyte NN O
volume NN O
in IN O
peripheral JJ O
blood NN O
(MCVB NN O
) -RRB- O
diluted VBN O
in IN O
urine NN O
supernatant NN O
after IN O
centrifugation NN O
and CC O
mean JJ O
corpuscular JJ O
volume NN O
of IN O
urinary JJ O
erythrocytes NNS O
(MCVU) RB O
. . O

-DOCSTART- X X O

To TO O
assess VB O
whether IN O
thallium-201 DT O
thallous NN O
chloride NN O
( -LRB- O
Tl NN O
) -RRB- O
can MD O
detect VB O
childhood NN O
tumors NNS O
and CC O
whether IN O
diagnostic JJ O
effectiveness NN O
improves VBZ O
with IN O
combined VBN O
blood NN O
flow NN O
imaging VBG O
, , O
28 CD O
children NNS O
( -LRB- O
1.0-18.6 CD O
years NNS O
) -RRB- O
were VBD O
studied VBN O
using VBG O
single JJ O
photon NN O
emission NN O
computed VBN O
tomography NN O
( -LRB- O
SPECT) NNP O
: : O
Tl NNP O
( -LRB- O
1.3-1.8 CD O
mCi NN O
intravenously RB O
) -RRB- O
, , O
followed VBD O
in IN O
13 CD O
of IN O
the DT O
patients NNS O
by IN O
technetium-99m-hexamethylpropyleneamine JJ O
oxime NN O
(99mTc-HMPAO : O
; : O
8-18 CD O
mCi JJ O
intravenously NN O
) -RRB- O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
tobacco NN O
mRNA NN O
using VBG O
the DT O
ACBF NNP B-NP
cDNA NN I-NP
as IN O
probe NN O
showed VBD O
that IN O
while IN O
ACBF NNP B-NP
mRNA NN I-NP
was VBD O
present JJ O
in IN O
all DT O
tissues NNS O
examined VBN O
, , O
the DT O
highest JJS O
transcript NN O
accumulation NN O
occurred VBD O
in IN O
stem NN O
tissues NNS O
. . O

-DOCSTART- X X O

When WRB O
PCR NNP O
was VBD O
used VBN O
to TO O
amplify VB O
agar NN O
cultures NNS O
which WDT O
do VBP O
not RB O
express VB O
the DT O
fimbriae NNS O
, , O
the DT O
switch NN O
region NN O
was VBD O
OFF VBN O
only RB O
. . O

-DOCSTART- X X O

We PRP O
therefore RB O
investigated VBD O
whether IN O
the DT O
promoter NN O
activity NN O
of IN O
the DT O
mouse NN B-NP
TRH NNP I-NP
gene NN I-NP
is VBZ O
directly RB O
regulated VBN O
by IN O
RA NNP O
using VBG O
a DT O
transient NN O
transfection NN O
assay NN O
into IN O
CV-1 JJ O
cells NNS O
. . O

-DOCSTART- X X O

Sin4 NNP B-NP
and CC O
Srb10 NNP B-NP
, , O
components NNS O
of IN O
specific JJ O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
sub-complexes NNS I-NP
that WDT O
are VBP O
required VBN O
for IN O
Ssn6-Tup1 JJ B-NP
repression NN O
activity NN O
, , O
are VBP O
found VBN O
to TO O
be VB O
required VBN O
for IN O
Sfl1 JJ B-NP
repression NN O
function NN O
. . O

-DOCSTART- X X O

Functional NNP O
PET NNP O
scanning NN O
in IN O
the DT O
preoperative JJ O
assessment NN O
of IN O
cerebral JJ O
arteriovenous JJ O
malformations NNS O
. . O

-DOCSTART- X X O

The DT O
MEE NN O
was VBD O
significantly RB O
greater JJR O
than IN O
the DT O
BEE NN O
and CC O
significantly RB O
less JJR O
than IN O
the DT O
calculated JJ O
energy NN O
expenditure NN O
. . O

-DOCSTART- X X O

Differences NNS O
were VBD O
not RB O
found VBN O
in IN O
colons NNS O
by IN O
SEM. VBG O

-DOCSTART- X X O

The DT O
human JJ O
RIL NNP B-NP
gene NN I-NP
: : O
mapping NN O
to TO O
human JJ O
chromosome NN O
5q31.1 CD O
, , O
genomic JJ O
organization NN O
and CC O
alternative NN O
transcripts NNS O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
indicated VBD O
that IN O
p35 PRP B-NP
is VBZ O
a DT O
trans-dominant JJ O
factor NN O
that WDT O
facilitates VBZ O
AcMNPV NNP O
growth NN O
in IN O
a DT O
cell NN O
line-specific JJ O
manner NN O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
remarkable JJ O
differences NNS O
in IN O
the DT O
expression NN O
patterns NNS O
of IN O
MTB-Zf JJ B-NP
mRNA NN I-NP
and CC O
two CD O
other JJ O
hybridizable JJ O
mRNAs NNS O
of IN O
5kb JJ O
and CC O
8.5 CD O
kb NN O
when WRB O
human JJ O
brain NN O
and CC O
primary JJ O
brain NN O
tumors NNS O
were VBD O
compared VBN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
recently RB O
shown VBN O
that IN O
induced JJ O
expression NN O
of IN O
a DT O
CDK NNP B-NP
target NN O
site-deficient NN O
mutant JJ O
, , O
Op18-S25A NNP B-NP
,S38A NNP O
, , O
blocks NNS O
human JJ O
cell NN O
lines NNS O
during IN O
G2/M NNP O
transition NN O
. . O

-DOCSTART- X X O

ATF6 NNP B-NP
, , O
a DT O
basic-leucine NN B-NP
zipper NN I-NP
protein NN I-NP
, , O
was VBD O
isolated VBN O
by IN O
binding JJ O
to TO O
SRF NNP B-NP
and CC O
in IN O
particular JJ O
to TO O
its PRP$ O
transcriptional JJ O
activation NN O
domain NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
provide VBP O
strong JJ O
evidence NN O
that IN O
conserved VBN O
interhelical JJ O
packing NN O
interactions NNS O
in IN O
the DT O
gp41 JJ B-NP
core NN I-NP
are VBP O
important JJ O
determinants NNS O
of IN O
HIV-1 PRP$ O
entry NN O
and CC O
its PRP$ O
inhibition NN O
. . O

-DOCSTART- X X O

Natl NNP O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
NF-kappa NNP B-NP
B NNP I-NP
activation NN O
was VBD O
observed VBN O
in IN O
these DT O
cells NNS O
after IN O
PMA NNP O
stimulation NN O
. . O

-DOCSTART- X X O

From IN O
our PRP$ O
own JJ O
investigations NNS O
on IN O
phantoms NNS O
, , O
the DT O
smallest JJS O
signal-to-noise JJ O
ratio NN O
( -LRB- O
delta NN O
S NNP O
min/delta NN O
R) NN O
was VBD O
obtained VBN O
which WDT O
determines VBZ O
the DT O
minimal JJ O
contrast NN O
, , O
given VBN O
the DT O
film NN O
properties NNS O
( -LRB- O
film NN O
response NN O
S NNP O
, , O
film NN O
gradient NN O
gamma NN O
) -RRB- O
and CC O
the DT O
amount NN O
of IN O
scatter NN O
. . O

-DOCSTART- X X O

We PRP O
functionally RB O
characterised VBD O
AtXPO1 NNP B-NP
by IN O
its PRP$ O
interaction NN O
with IN O
NESs NNP O
of IN O
animal NN O
and CC O
plant NN O
proteins NNS O
, , O
which WDT O
is VBZ O
inhibited VBN O
by IN O
the DT O
cytotoxin NN O
leptomycin NN O
B NNP O
( -LRB- O
LMB) NN O
, , O
and CC O
also RB O
by IN O
its PRP$ O
interaction NN O
with IN O
the DT O
small JJ B-NP
GTPase NNP I-NP
Ran1 NNP B-NP
in IN O
the DT O
yeast NN O
two-hybrid JJ O
system NN O
. . O

-DOCSTART- X X O

The DT O
use NN O
of IN O
self-measured JJ O
blood NN O
pressure NN O
determinations NNS O
in IN O
assessing VBG O
dynamics NNS O
of IN O
drug NN O
compliance NN O
in IN O
a DT O
study NN O
with IN O
amlodipine NN O
once RB O
a DT O
day NN O
, , O
morning NN O
versus NN O
evening NN O
. . O

-DOCSTART- X X O

We PRP O
propose VBP O
that IN O
unc-37 NN B-NP
may MD O
be VB O
regulated VBN O
by IN O
unc-4. PRP$ B-NP

-DOCSTART- X X O

The DT O
gag-myc JJ B-NP
proteins NNS O
encoded VBN O
by IN O
these DT O
variants NNS O
efficiently RB O
localized VBN O
to TO O
the DT O
cell NN O
nucleus NN O
. . O

-DOCSTART- X X O

From IN O
the DT O
supposition NN O
that IN O
there EX O
exists VBZ O
a DT O
possible JJ O
connection NN O
between IN O
certain JJ O
psychopathological JJ O
symptoms NNS O
, , O
and/or CC O
syndromes NNS O
( -LRB- O
e NN O
.g. NNP O
, , O
hallucinations NNS O
) -RRB- O
and CC O
regional JJ O
cerebral JJ O
dysfunction NN O
, , O
patients NNS O
suffering VBG O
from IN O
auditory JJ O
and CC O
tactile JJ O
hallucinations NNS O
were VBD O
investigated VBN O
, , O
in IN O
a DT O
symptom-oriented JJ O
study NN O
, , O
using VBG O
the DT O
method NN O
of IN O
technetium-99m-Hexamethyl-propylenamine JJ O
Oxime NNP O
(99m-Tc-HMPAO)-Single NNP O
Photon NNP O
Emission NNP O
Computed NNP O
Tomography NNP O
( -LRB- O
SPECT) NNP O
and CC O
compared VBN O
with IN O
normal JJ O
controls NNS O
. . O

-DOCSTART- X X O

A DT O
novel NN O
alternative NN O
spliced VBD O
variant JJ O
of IN O
the DT O
transcription NN O
factor NN O
AP2alpha NNP B-NP
is VBZ O
expressed VBN O
in IN O
the DT O
murine NN O
ocular JJ O
lens NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
end NN O
of IN O
a DT O
linearized JJ O
DNA NN O
fragment NN O
can MD O
initiate VB O
new JJ O
DNA NNP O
synthesis NN O
by IN O
BIR NNP O
in IN O
which WDT O
the DT O
newly RB O
synthesized VBN O
DNA NN O
is VBZ O
displaced VBN O
and CC O
subsequently RB O
forms NNS O
circles NNS O
by IN O
NHEJ. NNP O

-DOCSTART- X X O

From IN O
the DT O
deduced VBN O
amino IN O
acid NN O
sequence NN O
, , O
a DT O
molecular JJ O
weight NN O
of IN O
38,549 CD O
was VBD O
calculated VBN O
for IN O
the DT O
ADH NNP B-NP
subunit NN I-NP
. . O

-DOCSTART- X X O

Nine CD O
months NNS O
after IN O
the DT O
end NN O
of IN O
the DT O
vaccination NN O
anti-HBsAg JJ B-NP
levels NNS O
had VBD O
dropped VBN O
to TO O
9 CD O
+/ CD O
- : O
4 CD O
IU/1 NN O
( -LRB- O
M NNP O
+/ NNP O
- : O
SE) NNP O
, , O
with IN O
a DT O
geometric JJ O
mean NN O
of IN O
5 CD O
IU/1 NNP O
, , O
in IN O
the DT O
nine CD O
remaining VBG O
evaluable JJ O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
point NN O
mutation NN O
Asp-316-->Asn NNP O
in IN O
the DT O
C-terminus NN O
of IN O
p38 NNS B-NP
, , O
analogous JJ O
to TO O
the DT O
ERK2 NN B-NP
( -LRB- O
extracellular-signal-regulated JJ B-NP
kinase NN I-NP
2 CD I-NP
) -RRB- O
sevenmaker NN B-NP
mutation NN O
, , O
dramatically RB O
decreases VBZ O
its PRP$ O
binding NN O
to TO O
MKP-1 JJ B-NP
and CC O
substantially RB O
compromises VBZ O
its PRP$ O
stimulatory JJ O
effect NN O
on IN O
the DT O
catalytic JJ O
activity NN O
of IN O
this DT O
phosphatase NN O
. . O

-DOCSTART- X X O

Cortical NNP O
somatosensory NN O
evoked VBN O
potentials NNS O
to TO O
median JJ O
nerve NN O
stimulation NN O
revealed VBD O
significantly RB O
delayed VBN O
peak JJ O
latencies NNS O
of IN O
N20 NNP O
, , O
P20 NNP O
, , O
P25 CD O
, , O
and CC O
N26 NNP O
, , O
although IN O
N16 DT O
latency RB O
was VBD O
normal JJ O
. . O

-DOCSTART- X X O

The DT O
results NNS O
suggest VBP O
that IN O
proenzyme NN O
processing NN O
is VBZ O
not RB O
essential JJ O
for IN O
secretion NN O
of IN O
PC2 NNP B-NP
, , O
but CC O
peptides NNS O
containing VBG O
mutations NNS O
that WDT O
affect VBP O
the DT O
ability NN O
of IN O
the DT O
propeptide NN O
( -LRB- O
and CC O
cleavage JJ O
sites NNS O
) -RRB- O
to TO O
fold VB O
within IN O
the DT O
catalytic JJ O
pocket NN O
are VBP O
not RB O
transferred VBN O
beyond IN O
the DT O
early JJ O
stages NNS O
of IN O
the DT O
secretory NN O
pathway NN O
. . O

-DOCSTART- X X O

Cloning NNP O
, , O
sequence NN O
analysis NN O
, , O
and CC O
expression NN O
of IN O
the DT O
gene NN B-NP
encoding VBG I-NP
formaldehyde JJ I-NP
dismutase NN I-NP
from IN I-NP
Pseudomonas NNP I-NP
putida VBD I-NP
F61 NNP I-NP
. . O

-DOCSTART- X X O

The DT O
IGFBP-1 JJ B-NP
IRS NNP B-NP
and CC O
PEPCK NNP B-NP
IRS NNP B-NP
both DT O
bind VBP O
the DT O
alpha NN O
and CC O
beta JJ O
forms NNS O
of IN O
hepatic JJ B-NP
nuclear JJ I-NP
factor NN I-NP
3 CD I-NP
( -LRB- O
HNF-3 NN B-NP
) -RRB- O
, , O
although IN O
the DT O
latter NN O
does VBZ O
so RB O
with IN O
a DT O
sixfold-lower NN O
relative JJ O
affinity NN O
. . O

-DOCSTART- X X O

Free JJ O
protein NN B-NP
S NNP I-NP
deficiency NN O
in IN O
acute JJ O
ischemic JJ O
stroke NN O
. . O

-DOCSTART- X X O

This DT O
domain NN O
encompasses VBZ O
the DT O
region NN O
of IN O
ARP-1/COUP-TFII JJ B-NP
corresponding JJ O
to TO O
helices NNS O
3 CD O
to TO O
12 CD O
in IN O
the DT O
recently RB O
published VBN O
crystal NN O
structure NN O
of IN O
other JJ O
members NNS O
of IN O
the DT O
nuclear JJ B-NP
receptor NN I-NP
superfamily NN I-NP
. . O

-DOCSTART- X X O

When WRB O
medical JJ O
aid NN O
was VBD O
sought VBN O
a DT O
false JJ O
history NN O
was VBD O
given VBN O
and CC O
the DT O
true JJ O
nature NN O
of IN O
the DT O
child NN O
's POS O
illness NN O
, , O
heat NN O
stroke NN O
, , O
was VBD O
not RB O
determined VBN O
until IN O
after IN O
death NN O
. . O

-DOCSTART- X X O

BACKGROUND. . O

-DOCSTART- X X O

To TO O
test VB O
the DT O
role NN O
of IN O
myb JJ B-NP
family NN I-NP
members NNS I-NP
in IN O
progression NN O
through IN O
the DT O
cell NN O
cycle NN O
, , O
we PRP O
comicroinjected VBD O
c-myc JJ B-NP
and CC O
myb JJ B-NP
expression NN O
vectors NNS O
into IN O
serum-deprived JJ O
quiescent JJ O
SMCs NNS O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Ultrasound NNP O
biomicroscopy NN O
is VBZ O
a DT O
useful JJ O
tool NN O
for IN O
the DT O
evaluation NN O
of IN O
APVR NNP O
, , O
which WDT O
is VBZ O
difficult JJ O
by IN O
ordinary JJ O
methods NNS O
. . O

-DOCSTART- X X O

Like IN O
the DT O
human JJ O
gene NN O
, , O
the DT O
Drosophila NNP O
gene NN O
encodes VBZ O
at IN O
least JJS O
three CD O
isoforms NNS O
of IN O
full JJ B-NP
length NN I-NP
dystrophin-like JJ I-NP
proteins NNS I-NP
( -LRB- O
dmDLP1 NN B-NP
, , O
dmDLP2 . B-NP
and CC O
dmDLP3 JJ B-NP
,) JJ O
, , O
regulated VBN O
by IN O
different JJ O
promoters NNS O
located VBN O
at IN O
the DT O
5' JJ O
end NN O
of IN O
the DT O
gene NN O
, , O
and CC O
a DT O
smaller JJR O
product NN O
regulated VBN O
by IN O
an DT O
internal JJ O
promoter NN O
( -LRB- O
dmDp186 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
the DT O
case NN O
of IN O
a DT O
patient NN O
presenting VBG O
a DT O
second JJ O
hepatocellular JJ O
carcinoma NN O
13 CD O
years NNS O
after IN O
resection NN O
of IN O
a DT O
first JJ O
tumor NN O
of IN O
the DT O
same JJ O
type NN O
is VBZ O
reported VBN O
. . O

-DOCSTART- X X O

The DT O
equation NN O
for IN O
mean JJ O
trabecular JJ O
number NN O
passed VBN O
the DT O
test NN O
, , O
whereas IN O
the DT O
validity NN O
of IN O
the DT O
equations NNS O
for IN O
mean JJ O
trabecular JJ O
separation NN O
and CC O
Tb.Wi NN O
appeared VBD O
limited VBN O
. . O

-DOCSTART- X X O

The DT O
performances NNS O
of IN O
two CD O
tests NNS O
, , O
the DT O
ProstAsure JJ O
index NN O
and CC O
the DT O
percent NN O
free JJ O
PSA NNP B-NP
test NN O
, , O
were VBD O
evaluated VBN O
in IN O
detecting VBG O
cancer NN O
. . O

-DOCSTART- X X O

But CC O
if IN O
one CD O
equalizes VBZ O
the DT O
upper JJ O
limits NNS O
of IN O
normal JJ O
for IN O
both DT O
markers NNS O
to TO O
a DT O
common JJ O
95 CD O
% NN O
specificity NN O
, , O
the DT O
tumour-indicating JJ O
sensitivity NN O
of IN O
CA NNP B-NP
19-9 CD I-NP
clearly RB O
surpasses NNS O
that IN O
of IN O
CA NNP B-NP
50 CD I-NP
. . O

-DOCSTART- X X O

For IN O
economical JJ O
reasons NNS O
, , O
we PRP O
could MD O
not RB O
send VB O
a DT O
questionnaire NN O
to TO O
all DT O
the DT O
35,779 CD O
individuals NNS O
, , O
but CC O
based VBN O
the DT O
investigation NN O
on IN O
a DT O
SRS NNP O
of IN O
4,000 CD O
men NNS O
, , O
post-stratified JJ O
in IN O
a DT O
high-risk JJ O
and CC O
a DT O
low-risk JJ O
group NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
over IN O
a DT O
wide JJ O
range NN O
of IN O
arterial JJ O
dimensions NNS O
, , O
results NNS O
obtained VBD O
with IN O
caliper NN O
estimates NNS O
of IN O
luminal JJ O
area NN O
and CC O
diameter NN O
are VBP O
comparable JJ O
to TO O
those DT O
obtained VBN O
with IN O
videodensitometry NN O
using VBG O
the DT O
XR-70 NNP O
system NN O
. . O

-DOCSTART- X X O

Oncogenic NNP O
activation NN O
of IN O
RET NNP B-NP
is VBZ O
detected VBN O
in IN O
human JJ O
papillary NN O
thyroid VBD O
tumours NNS O
and CC O
in IN O
multiple JJ O
endocrine NN O
neoplasia NN O
type NN O
2 CD O
syndromes NNS O
. . O

-DOCSTART- X X O

Evasion NNP O
of IN O
host NN O
immunity NN O
by IN O
Toxocara NNP O
canis NNS O
infective JJ O
larvae NN O
is VBZ O
mediated VBN O
by IN O
the DT O
nematode JJ O
surface NN O
coat NN O
, , O
which WDT O
is VBZ O
shed VBN O
in IN O
response NN O
to TO O
binding NN O
by IN O
host NN O
antibody NN O
molecules NNS O
or CC O
effector NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
proteins NNS O
show VBP O
strong JJ O
homology NN O
to TO O
an DT O
ABA-inducible JJ B-NP
glycine-rich JJ I-NP
protein NN I-NP
from IN O
maize NN O
embryos NNS O
and CC O
to TO O
the DT O
mammalian JJ B-NP
RNA-binding JJ I-NP
protein NN I-NP
A1 IN I-NP
of IN O
the DT O
heterogeneous JJ O
nuclear JJ O
ribonucleoprotein NN O
complex NN O
involved VBN O
in IN O
pre-mRNA JJ O
splicing NN O
. . O

-DOCSTART- X X O

Reactive JJ O
mesothelial NN O
cells NNS O
, , O
usually RB O
seen VBN O
as IN O
exfoliated JJ O
cells NNS O
, , O
were VBD O
consistently RB O
strongly RB O
positive JJ O
for IN O
alpha NN B-NP
1-antichymotrypsin JJ I-NP
and CC O
more RBR O
variably RB O
for IN O
alpha NN B-NP
1-antitrypsin JJ I-NP
and CC O
lysozyme NN B-NP
. . O

-DOCSTART- X X O

However RB O
, , O
all DT O
pathophysiologic NN O
assessments NNS O
reported VBD O
to TO O
date NN O
have VBP O
been VBN O
carried VBN O
out RP O
during IN O
or CC O
immediately RB O
after IN O
IVOX DT O
utilization NN O
. . O

-DOCSTART- X X O

The DT O
wet JJ O
and CC O
dry JJ O
methods NNS O
of IN O
the DT O
HA NNP O
synthesis NN O
are VBP O
considered VBN O
. . O

-DOCSTART- X X O

In IN O
agreement NN O
with IN O
other JJ O
authors NNS O
, , O
we PRP O
recommend VBP O
the DT O
procedure NN O
as IN O
a DT O
safe JJ O
one CD O
, , O
providing VBG O
satisfactory JJ O
results NNS O
. . O

-DOCSTART- X X O

In IN O
several JJ O
steps NNS O
we PRP O
converted VBD O
the DT O
retinoid JJ O
specific JJ O
response NN O
element NN O
of IN O
the DT O
human JJ B-NP
retinoic NN I-NP
acid NN I-NP
receptor NN I-NP
beta NN I-NP
promoter NN I-NP
into IN O
the DT O
vitamin NN O
D/retinoic JJ O
acid NN O
response NN O
element NN O
of IN O
the DT O
human JJ B-NP
osteocalcin NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

The DT O
plasmid NN O
was VBD O
found VBN O
to TO O
confer VB O
drug NN O
resistance NN O
specifically RB O
to TO O
LMB. NNP O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
at IN O
least JJS O
some DT O
chloroplast-like JJ B-NP
tRNA NN I-NP
genes NNS I-NP
in IN O
wheat NN O
mtDNA NNS O
are VBP O
transcribed VBN O
, , O
with IN O
transcripts NNS O
undergoing VBG O
processing NN O
, , O
post-transcriptional JJ O
modification NN O
and CC O
3'-CCA JJ O
addition NN O
, , O
to TO O
produce VB O
mature JJ O
tRNAs NNS O
that WDT O
may MD O
participate VB O
in IN O
mitochondrial JJ O
protein NN O
synthesis NN O
. . O

-DOCSTART- X X O

Immunologic NNP O
tolerance NN O
in IN O
rats NNS O
during IN O
13 CD O
weeks NNS O
of IN O
inhalation NN O
exposure NN O
to TO O
trimellitic JJ O
anhydride NN O
. . O

-DOCSTART- X X O

Rat NNP B-NP
cholesterol NN I-NP
side-chain NN I-NP
cleavage NN I-NP
cytochrome NN I-NP
P-450 JJ I-NP
(P-450scc JJ O
) -RRB- O
gene NN O
. . O

-DOCSTART- X X O

Almost RB O
every DT O
image NN O
that WDT O
appears VBZ O
during IN O
a DT O
therapy NN O
session NN O
reveals VBZ O
a DT O
symbolic JJ O
nature NN O
, , O
but CC O
the DT O
very JJ O
concept NN O
of IN O
symbol NN O
is VBZ O
not RB O
free JJ O
from IN O
ambiguity NN O
some DT O
positions NNS O
originated VBP O
in IN O
different JJ O
areas NNS O
of IN O
investigation NN O
are VBP O
mentioned VBN O
, , O
ending VBG O
with IN O
a DT O
description NN O
of IN O
the DT O
traits NNS O
that IN O
, , O
according VBG O
to TO O
the DT O
writer NN O
, , O
bestow RB O
a DT O
symbolic JJ O
character NN O
to TO O
images NNS O
. . O

-DOCSTART- X X O

A DT O
trend NN O
was VBD O
observed VBN O
toward IN O
increased VBN O
graft NN O
half-life NN O
in IN O
era NN O
2 CD O
( -LRB- O
p NN O
= SYM O
NS NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Human NNP B-NP
CD38 NNPS I-NP
, , O
a DT O
leukocyte NN O
receptor NN O
and CC O
ectoenzyme NN O
, , O
is VBZ O
a DT O
member NN O
of IN O
a DT O
novel NN O
eukaryotic JJ O
gene NN O
family NN O
of IN O
nicotinamide JJ B-NP
adenine NN I-NP
dinucleotide+-converting NN I-NP
enzymes NNS I-NP
: : O
extensive JJ O
structural JJ O
homology NN O
with IN O
the DT O
genes NNS O
for IN O
murine NN B-NP
bone NN I-NP
marrow NN I-NP
stromal JJ I-NP
cell NN I-NP
antigen NN I-NP
1 CD I-NP
and CC O
aplysian JJ B-NP
ADP-ribosyl NNP I-NP
cyclase NN I-NP
. . O

-DOCSTART- X X O

Juvenile NNP O
angiofibromas NNS O
. . O

-DOCSTART- X X O

Mutation NN O
of IN O
the DT O
HNF3 CD B-NP
element NN I-NP
significantly RB O
reduced VBD O
promoter NN O
activity NN O
in IN O
HepG2 NNP O
cells NNS O
, , O
whereas IN O
this DT O
element NN O
in IN O
isolation NN O
conferred VBN O
HNF3beta NNP B-NP
responsiveness NN O
to TO O
a DT O
heterologous JJ O
promoter NN O
. . O

-DOCSTART- X X O

Patients NNS O
adopt VBP O
new JJ O
sets NNS O
based VBN O
partly RB O
on IN O
the DT O
original JJ O
topic NN O
and CC O
partly RB O
on IN O
their PRP$ O
own JJ O
personal JJ O
idiosyncratic JJ O
concerns NNS O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
PET NNP O
revealed VBD O
wide JJ O
variations NNS O
in IN O
CBF NNP O
between IN O
regions NNS O
during IN O
isoflurane NN O
anaesthesia NN O
, , O
particularly RB O
in IN O
comparison NN O
with IN O
propofol JJ O
anaesthesia NN O
, , O
while IN O
rCMRO2 NNP O
decreased VBD O
globally RB O
in IN O
a DT O
dose-dependent JJ O
manner NN O
during IN O
both DT O
isoflurane NN O
and CC O
propofol NN O
anaesthesia NN O
. . O

-DOCSTART- X X O

Long NNP O
chain NN O
acyl-CoA NN O
esters NNS O
are VBP O
important JJ O
intermediates NNS O
in IN O
degradation NN O
and CC O
synthesis NN O
of IN O
fatty JJ O
acids NNS O
, , O
as RB O
well RB O
as IN O
having VBG O
important JJ O
functions NNS O
in IN O
regulation NN O
of IN O
intermediary NN O
metabolism NN O
and CC O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

Buchstein NNP O
, , O
L.-L. . O

-DOCSTART- X X O

The DT O
model NN O
of IN O
the DT O
complex NN O
provides VBZ O
a DT O
rationale NN O
for IN O
conserved VBN O
ITAM NNP B-NP
residues NNS O
, , O
substrate JJ O
specificity NN O
, , O
and CC O
suggests VBZ O
that IN O
substrate JJ O
binds NNS O
only RB O
the DT O
active JJ O
conformation NN O
of IN O
the DT O
Src NNP B-NP
family NN I-NP
tyrosine NN I-NP
kinase NN I-NP
, , O
unlike IN O
the DT O
ATP NNP O
cofactor NN O
, , O
which WDT O
can MD O
bind NN O
the DT O
inactive JJ O
form NN O
. . O

-DOCSTART- X X O

Sucrose-specific JJ O
signalling NN O
represses VBZ O
translation NN O
of IN O
the DT O
Arabidopsis NNP B-NP
ATB2 NNP I-NP
bZIP NN I-NP
transcription NN I-NP
factor NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

This DT O
is VBZ O
probably RB O
because RB O
, , O
in IN O
vivo NN O
, , O
some DT O
bacteria NNS O
( -LRB- O
perhaps RB O
dormant JJ O
forms NNS O
) -RRB- O
are VBP O
not RB O
entirely RB O
dependent JJ O
upon IN O
urease NN B-NP
for IN O
survival NN O
. . O

-DOCSTART- X X O

Our PRP$ O
aim NN O
was VBD O
to TO O
evaluate VB O
this DT O
technique NN O
by IN O
cross-calibrating VBG O
the DT O
DXA NNP O
method NN O
with IN O
the DT O
carcass NN O
chemical NN O
analysis NN O
in IN O
a DT O
heterogeneous JJ O
population NN O
of IN O
nondiabetic JJ O
Wistar NNP O
and CC O
diabetic JJ O
GK NN O
rats NNS O
( -LRB- O
21 CD O
animals NNS O
were VBD O
used VBN O
for IN O
precision NN O
error NN O
and CC O
reproducibility NN O
determinations NNS O
and CC O
26 CD O
were VBD O
used VBN O
for IN O
accuracy NN O
studies NNS O
) -RRB- O
. . O

-DOCSTART- X X O

There EX O
was VBD O
a DT O
highly RB O
significant JJ O
decrease NN O
in IN O
serum NN B-NP
eosinophil NN I-NP
cationic JJ I-NP
protein NN I-NP
in IN O
patients NNS O
with IN O
elevated JJ O
AGA. . B-NP

-DOCSTART- X X O

The DT O
prototype NN O
now RB O
structures NNS O
oncology-related JJ O
information NN O
available JJ O
on IN O
the DT O
Internet NNP O
and CC O
also RB O
places VBZ O
resources NNS O
maintained VBN O
locally RB O
at IN O
users NNS O
' POS O
disposal NN O
. . O

-DOCSTART- X X O

Ischaemia NNP O
and CC O
reperfusion NN O
injury NN O
in IN O
the DT O
kidney NN O
: : O
current JJ O
status NN O
and CC O
future JJ O
direction NN O
. . O

-DOCSTART- X X O

As IN O
to TO O
the DT O
side NN O
effects NNS O
of IN O
SISO NNP O
, , O
cylindruria NN O
with IN O
aggravation NN O
of IN O
microscopic JJ O
hematuria NN O
and CC O
elevations NNS O
of IN O
GOT NNP B-NP
, , O
GPT NNP B-NP
and CC O
A1-P NNP B-NP
were VBD O
observed VBN O
each DT O
one CD O
of IN O
them PRP O
, , O
respectively RB O
. . O

-DOCSTART- X X O

From IN O
1981 CD O
to TO O
1989 CD O
, , O
a DT O
total NN O
of IN O
26 CD O
women NNS O
with IN O
locally RB O
or CC O
regionally RB O
advanced JJ O
carcinoma NN O
of IN O
the DT O
uterine NN O
cervix NN O
were VBD O
treated VBN O
with IN O
radiotherapy JJ O
(RT NN O
) -RRB- O
and CC O
pelvic JJ O
regional JJ O
hyperthermia NN O
( -LRB- O
HT) NNP O
, , O
in IN O
the DT O
Divisions NNS O
of IN O
Radiation NNP O
Oncology NNP O
at IN O
the DT O
University NNP O
of IN O
Utah NNP O
Medical NNP O
Center NNP O
( -LRB- O
UU) NNP O
and CC O
the DT O
Kenneth NNP O
Norris NNP O
Jr NNP O
Cancer NNP O
Hospital NNP O
of IN O
the DT O
University NNP O
of IN O
Southern NNP O
California NNP O
( -LRB- O
USC NNP O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
proteins NNS O
were VBD O
detected VBN O
by IN O
an DT O
antibody NN O
which WDT O
recognizes VBZ O
the DT O
N-terminus NNP O
of IN O
SRK3 NNP B-NP
and CC O
, , O
in IN O
an DT O
F2 NNP O
progeny NN O
segregating VBG O
for IN O
the DT O
S3 JJ B-NP
haplotype NN I-NP
, , O
were VBD O
only RB O
expressed VBN O
in IN O
plants NNS O
possessing VBG O
the DT O
S3 JJ B-NP
haplotype NN I-NP
. . O

-DOCSTART- X X O

Like IN O
other JJ O
IAPs NNS B-NP
, , O
ch-IAP1 CC B-NP
contains VBZ O
the DT O
N-terminal JJ B-NP
baculovirus NN I-NP
IAP NNP I-NP
repeats NNS I-NP
and CC O
C-terminal JJ O
RING VBG O
finger NN O
motifs NNS O
. . O

-DOCSTART- X X O

Mutations NNS O
in IN O
Saccharomyces NNP O
cerevisiae NNS O
that IN O
block NN O
meiotic JJ O
prophase NN O
chromosome NN O
metabolism NN O
and CC O
confer VB O
cell NN O
cycle NN O
arrest NN O
at IN O
pachytene NN O
identify VBP O
two CD O
new JJ O
meiosis-specific JJ B-NP
genes NNS I-NP
SAE1 . I-NP
and CC O
SAE3 PRP B-NP
. . O

-DOCSTART- X X O

Following VBG O
EGF NNP B-NP
or CC O
NGF NNP B-NP
stimulation NN O
of IN O
the DT O
v-CrkPC12 JJ O
cells NNS O
, , O
the DT O
v-Crk JJ B-NP
protein NN O
itself PRP O
became VBD O
tyrosine NN O
phosphorylated VBN O
within IN O
1 CD O
min NN O
. . O

-DOCSTART- X X O

Enzymatic JJ O
and CC O
chemical JJ O
structure NN O
probing NN O
revealed VBN O
mainly RB O
the DT O
conserved VBN O
terminal NN O
part NN O
(termed JJ O
3'C JJ O
) -RRB- O
of IN O
the DT O
DI9c NNP O
3' CD O
UTR NN O
containing VBG O
distinctive JJ O
RNA NNP O
motifs NNS O
, , O
i IN O
.e NN O
. . O
, , O
a DT O
stable JJ O
stem-loop NN O
, , O
SL NNP O
I PRP O
, , O
near IN O
the DT O
RNA NNP O
3' CD O
terminus NN O
and CC O
a DT O
considerably RB O
less RBR O
stable JJ O
stem-loop NN O
, , O
SL NNP O
II NNP O
, , O
that WDT O
forms VBZ O
the DT O
5' JJ O
portion NN O
of IN O
3'C. VBG O

-DOCSTART- X X O

Attention NN O
is VBZ O
devoted VBN O
in IN O
particular JJ O
to TO O
the DT O
action NN O
of IN O
thermoregulating DT O
nervous JJ O
and CC O
hormonal JJ O
mechanisms NNS O
. . O

-DOCSTART- X X O

ES NNPS O
cells NNS O
in IN O
which WDT O
the DT O
gene NN O
for IN O
the DT O
erythroid JJ O
transcription NN O
factor NN O
GATA-1 NN B-NP
has VBZ O
been VBN O
disrupted VBN O
fail VBP O
to TO O
produce VB O
mature JJ O
erythroid NN O
cells NNS O
either CC O
in IN O
vivo JJ O
or CC O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Acidic NNP O
carboxyl-terminal JJ O
domain NN O
of IN O
gene NN B-NP
2.5 CD I-NP
protein NN I-NP
of IN I-NP
bacteriophage NN I-NP
T7 . I-NP
is VBZ O
essential JJ O
for IN O
protein-protein NN O
interactions NNS O
. . O

-DOCSTART- X X O

Three CD O
of IN O
these DT O
positions NNS O
are VBP O
novel JJ O
in IN O
that IN O
they PRP O
had VBD O
not RB O
been VBN O
identified VBN O
to TO O
be VB O
important JJ O
for IN O
binding JJ O
PC NN O
by IN O
previous JJ O
crystallographic JJ O
analysis NN O
. . O

-DOCSTART- X X O

Three CD O
transcriptional JJ O
control NN O
elements NNS O
within IN O
300 CD O
base NN O
pairs NNS O
of IN O
the DT O
5'-flanking JJ O
region NN O
of IN O
the DT O
rat NN B-NP
glucagon NN I-NP
gene NN I-NP
interact NN O
with IN O
regulatory JJ O
cellular JJ O
proteins NNS O
and CC O
direct JJ O
transcription NN O
only RB O
in IN O
glucagon-producing JJ B-NP
islet NN O
cells NNS O
. . O

-DOCSTART- X X O

Fusion NNP O
proteins NNS O
were VBD O
isolated VBN O
by IN O
affinity NN O
chromatography NN O
on IN O
APTG-Sepharose NNP O
. . O

-DOCSTART- X X O

(99m)Tc JJ O
Ethyl NNP O
Cysteinate NNP O
Dimer NNP O
stable NN O
during IN O
6h NN O
has VBZ O
contributed VBN O
to TO O
develop VB O
ictal JJ O
studies NNS O
to TO O
evaluate VB O
the DT O
location NN O
of IN O
partial JJ O
seizure NN O
. . O

-DOCSTART- X X O

A DT O
less RBR O
common JJ O
and CC O
much RB O
more RBR O
perplexing JJ O
circumstance NN O
occurs VBZ O
when WRB O
evaluating VBG O
patients NNS O
with IN O
sarcoidosis NN O
established VBN O
for IN O
several JJ O
years NNS O
present JJ O
with IN O
evidence NN O
of IN O
progressive JJ O
or CC O
chronic JJ O
pulmonary JJ O
involvement NN O
and CC O
dyspnea NN O
. . O

-DOCSTART- X X O

The DT O
training NN O
programs NNS O
had VBD O
a DT O
duration NN O
of IN O
30 CD O
days NNS O
, , O
5 CD O
days/week NN O
, , O
and CC O
was VBD O
performed VBN O
on IN O
a DT O
motor-driven JJ O
treadmill NN O
. . O

-DOCSTART- X X O

The DT O
avian JJ O
carcinoma NN O
virus NN O
MH2 NNP O
contains VBZ O
a DT O
hybrid JJ O
gene NN O
delta JJ B-NP
gag-mht NN I-NP
with IN O
a DT O
contiguous JJ O
open JJ O
reading NN O
frame NN O
of IN O
2682 CD O
base NN O
pairs NNS O
as RB O
well RB O
as IN O
v-myc JJ B-NP
and CC O
avian JJ O
helper NN O
virus-related JJ O
sequences NNS O
. . O
delta NN B-NP
gag NN I-NP
is VBZ O
a DT O
partial JJ O
retroviral NN B-NP
core NN I-NP
protein NN I-NP
gene NN I-NP
while IN O
v-mht JJ B-NP
and CC O
v-myc JJ B-NP
are VBP O
cell-drived JJ O
sequences NNS O
. . O

-DOCSTART- X X O

The DT O
recent JJ O
concept NN O
of IN O
a DT O
bioartificial JJ O
organ NN O
is VBZ O
an DT O
attempt NN O
to TO O
avoid VB O
such JJ O
disadvantages NNS O
. . O

-DOCSTART- X X O

The DT O
pressure NN O
measurements NNS O
under IN O
steady JJ O
flow NN O
conditions NNS O
showed VBD O
that IN O
the DT O
hemodynamic JJ O
performance NN O
( -LRB- O
including VBG O
pressure NN O
gradient NN O
and CC O
effective JJ O
orifice NN O
area NN O
) -RRB- O
of IN O
SPAB NNP O
is VBZ O
superior JJ O
to TO O
that DT O
of IN O
its PRP$ O
stented JJ O
counterpart NN O
, , O
especially RB O
in IN O
the DT O
smaller JJR O
sizes NNS O
. . O

-DOCSTART- X X O

Cerebral JJ O
blood NN O
flow NN O
was VBD O
measured VBN O
using VBG O
the DT O
iv NN O
method NN O
of IN O
133-Xe JJ O
CBF NNP O
determination NN O
and CC O
AVDO2 DT O
was VBD O
measured VBN O
using VBG O
systemic JJ O
arterial-jugular JJ O
venous JJ O
oxygen NN O
content NN O
differences NNS O
. . O

-DOCSTART- X X O

Possible JJ O
consequences NNS O
of IN O
such JJ O
binder NN O
distribution NN O
through IN O
powder NN O
aggregates NNS O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

Bile NNP O
salts NNS O
, , O
hormonal JJ O
control NN O
, , O
and CC O
the DT O
male JJ O
disadvantage NN O
. . O

-DOCSTART- X X O

The DT O
fusion NN O
gene NN O
cassette NN O
was VBD O
placed VBN O
under IN O
the DT O
control NN O
of IN O
a DT O
vaccinia NN B-NP
virus NN I-NP
early JJ I-NP
promoter NN I-NP
and CC O
cloned VBD O
in IN O
a DT O
host-restricted JJ O
fowlpox NN O
viral NN O
vector NN O
. . O

-DOCSTART- X X O

We PRP O
describe VBP O
a DT O
novel NN O
stat-related JJ B-NP
factor NN I-NP
, , O
p93 NN B-NP
, , O
that DT O
is VBZ O
found VBN O
in IN O
EGF-treated JJ B-NP
A431 JJ O
cell NN O
extracts NNS O
but CC O
appears VBZ O
to TO O
be VB O
absent JJ O
in IN O
bovine JJ B-NP
fibroblast JJ I-NP
growth NN I-NP
factor NN I-NP
( -LRB- O
bFGF) NN B-NP
, , O
IFN-gamma NNP B-NP
, , O
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
( -LRB- O
TNF-alpha NNP B-NP
) -RRB- O
, , O
and CC O
untreated JJ O
cells NNS O
. . O
p93 NN B-NP
appears VBZ O
to TO O
be VB O
antigenically RB O
related VBN O
to TO O
stat91 VB B-NP
. . O
p185c-neu+ '' B-NP
, , O
EGFr+ NNP B-NP
( -LRB- O
M1 NNP B-NP
) -RRB- O
, , O
and CC O
p185c-neu- DT B-NP
kinase NN O
inactive JJ O
, , O
EGFr+ JJ B-NP
( -LRB- O
NEN757 NN B-NP
) -RRB- O
expressing VBG O
cells NNS O
undergo VBP O
different JJ O
mitotic JJ O
responses NNS O
to TO O
EGF. NNP B-NP

-DOCSTART- X X O

Phosphorylated JJ O
tyrosine NN O
residues NNS O
were VBD O
subsequently RB O
identified VBN O
by IN O
sequencing VBG O
the DT O
separated JJ O
phosphopeptides NNS O
by IN O
matrix NN O
assisted VBN O
laser NN O
desorption IN O
ionization NN O
mass NN O
spectrometry NN O
( -LRB- O
MALDI-MS NNP O
) -RRB- O
and CC O
Edman NNP O
degradation NN O
. . O

-DOCSTART- X X O

Superovulation NNP O
with IN O
intrauterine NN O
insemination NN O
( -LRB- O
SO-IUI) NNP O
has VBZ O
been VBN O
suggested VBN O
as IN O
an DT O
alternative NN O
to TO O
gamete VB O
intrafallopian JJ O
transfer NN O
( -LRB- O
GIFT) NNP O
, , O
despite IN O
the DT O
absence NN O
of IN O
controlled JJ O
or CC O
comparative JJ O
trials NNS O
. . O

-DOCSTART- X X O

One CD O
of IN O
the DT O
repeating JJ O
domains NNS O
( -LRB- O
Yheb1 NN B-NP
) -RRB- O
, , O
consisting VBG O
of IN O
67 CD O
amino IN O
acids NNS O
, , O
was VBD O
cloned VBN O
from IN O
the DT O
E. NNP O
coli NNS O
chromosome NN O
and CC O
purified VBN O
by IN O
metal NN O
chelating VBG O
chromatography NN O
. . O

-DOCSTART- X X O

Assessment NNP O
of IN O
two CD O
anion-exchange JJ O
resins NNS O
for IN O
direct JJ O
use NN O
in IN O
the DT O
screening NN O
method NN O
for IN O
urinary JJ O
porphobilinogen NN O
. . O

-DOCSTART- X X O

A DT O
previously RB O
developed VBN O
kinetic JJ O
model NN O
was VBD O
used VBN O
to TO O
identify VB O
major JJ O
chemical NN O
reaction NN O
pathways NNS O
involving VBG O
PAH NNP O
in IN O
the DT O
afterburner NN O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
the DT O
p21-activated JJ B-NP
kinase NN I-NP
( -LRB- O
PAK) NNP B-NP
by IN O
a DT O
human JJ B-NP
Gbeta NN I-NP
-like JJ I-NP
WD-repeat JJ O
protein NN O
, , O
hPIP1 NN B-NP
. . O

-DOCSTART- X X O

Activation NN O
of IN O
HIV-1 NN O
requires VBZ O
the DT O
binding NN O
of IN O
host NN O
cell NN O
transcription NN O
factors NNS O
to TO O
cis NNPS O
elements NNS O
in IN O
the DT O
proviral JJ O
long JJ O
terminal NN O
repeat NN O
( -LRB- O
LTR NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
the DT O
ratios NNS O
of IN O
the DT O
areas NNS O
under IN O
the DT O
concentration-time NN O
curves NNS O
in IN O
CSF NNP O
and CC O
serum NN O
, , O
the DT O
overall JJ O
penetration NN O
of IN O
rifampicin NN O
into IN O
CSF NNP O
was VBD O
0.13-0.42 CD O
( -LRB- O
median NN O
= SYM O
0.22 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Adaptability NN O
of IN O
Nippostrongylus NN O
brasiliensis NN O
( -LRB- O
Travassos NNP O
, , O
1914 CD O
) -RRB- O
to TO O
lead VB O
contamination NN O

-DOCSTART- X X O

In IN O
early JJ O
midgestation NN O
embryos VBD O
it PRP O
is VBZ O
expressed VBN O
in IN O
telencephalic NN O
, , O
diencephalic NN O
and CC O
mesencephalic NN O
regions NNS O
but CC O
from IN O
day NN O
11.75 CD O
of IN O
gestation NN O
its PRP$ O
expression NN O
disappears VBZ O
from IN O
dorsal JJ O
telencephalon NN O
and CC O
is VBZ O
confined VBN O
to TO O
diencephalic JJ O
and CC O
mesencephalic JJ O
regions NNS O
. . O

-DOCSTART- X X O

A DT O
child NN O
presumed VBN O
to TO O
have VB O
the DT O
21-hydroxylase JJ B-NP
deficiency NN O
form NN O
of IN O
congenital JJ O
adrenal JJ O
hyperplasia NN O
was VBD O
studied VBN O
extensively RB O
as IN O
an DT O
infant NN O
. . O

-DOCSTART- X X O

The DT O
size NN O
and CC O
the DT O
predicted VBN O
N-terminal JJ O
sequence NN O
of IN O
the DT O
mouse NN O
protein NN O
were VBD O
confirmed VBN O
experimentally RB O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
found VBN O
that IN O
Nopp140 DT B-NP
binds NNS O
primarily RB O
to TO O
the DT O
CK2 NNP B-NP
regulatory JJ I-NP
subunit NN I-NP
, , I-NP
beta NN I-NP
. . O

-DOCSTART- X X O

Further RB O
, , O
more RBR O
recent JJ O
communications NNS O
suggest VBP O
that IN O
liver NN O
disease NN O
led VBD O
to TO O
a DT O
differential JJ O
alteration NN O
of IN O
the DT O
cytochrome NN B-NP
P-450s NNS I-NP
with IN O
regard NN O
to TO O
protein NN O
content NN O
and CC O
activity NN O
. . O

-DOCSTART- X X O

Alignment NNP O
of IN O
the DT O
rat NN B-NP
and CC I-NP
human JJ I-NP
WIN IN I-NP
cDNAs NNS I-NP
and CC O
their PRP$ O
comparison NN O
with IN O
mouse NN O
genomic JJ O
sequence NN O
revealed VBD O
that IN O
the DT O
WIN NNP B-NP
DNA NNP I-NP
binding NN I-NP
domain NN I-NP
is VBZ O
encoded VBN O
by IN O
four CD O
exons NNS O
, , O
two CD O
of IN O
which WDT O
( -LRB- O
exons NNS O
4 CD O
and CC O
6 CD O
) -RRB- O
are VBP O
alternatively RB O
spliced VBN O
to TO O
generate VB O
at IN O
least JJS O
three CD O
classes NNS O
of IN O
mRNA NN O
transcripts NNS O
. . O

-DOCSTART- X X O

25 CD O
patients NNS O
received VBD O
20 CD O
mgs NNS O
of IN O
hyoscine NN O
N-butyl NN O
bromide NN O
and CC O
the DT O
rest NN O
5 CD O
mgs NNS O
propinoxate NN O
, , O
i IN O
.v. NNP O
plus CC O
diazepam NN O
. . O

-DOCSTART- X X O

The DT O
activity NN O
of IN O
plasminogen NN B-NP
activator NN I-NP
has VBZ O
been VBN O
measured VBN O
in IN O
tissue NN O
sections NNS O
with IN O
the DT O
aid NN O
of IN O
a DT O
modified VBN O
Todd NNP O
technique NN O
. . O

-DOCSTART- X X O

DESIGN NNP O
, , O
SETTING VBG O
AND CC O
SUBJECTS NNS O
: : O
The DT O
analysis NN O
is VBZ O
based VBN O
on IN O
data NNS O
collected VBN O
in IN O
the DT O
first JJ O
two CD O
rounds NNS O
of IN O
the DT O
nationally RB O
representative JJ O
Ghana NNP O
Living NNP O
Standards NNP O
Survey NNP O
, , O
held VBD O
in IN O
1987/88 CD O
( -LRB- O
GLSS-I) NNP O
and CC O
1988/89 CD O
( -LRB- O
GLSS-II NN O
) -RRB- O
, , O
with IN O
both DT O
surveys NNS O
covering VBG O
approximately RB O
3000 CD O
households NNS O
. . O

-DOCSTART- X X O

Moclobemide NNP O
is VBZ O
a DT O
well-tolerated JJ O
alternative NN O
antidepressant JJ O
, , O
but CC O
there EX O
is VBZ O
a DT O
need NN O
for IN O
prospective JJ O
controlled VBN O
trials NNS O
to TO O
evaluate VB O
its PRP$ O
long-term JJ O
efficacy NN O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analyses NNS O
were VBD O
used VBN O
to TO O
examine VB O
the DT O
regulated JJ O
expression NN O
of IN O
the DT O
cys-14+ JJ B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

We PRP O
propose VBP O
that IN O
, , O
while IN O
Y PRP O
. . O
lipolytica '' O
CEN NNP O
DNA NNP O
is VBZ O
essential JJ O
for IN O
plasmid NN O
maintenance NN O
, , O
this DT O
function NN O
can MD O
be VB O
supplied VBN O
by IN O
several JJ O
sub-fragments NNS O
which WDT O
, , O
together RB O
, , O
form VB O
the DT O
active JJ O
chromosomal NN O
centromere NN O
. . O

-DOCSTART- X X O

These DT O
three CD O
groups NNS O
were VBD O
further RB O
examined VBN O
with IN O
regard NN O
to TO O
the DT O
modulation NN O
of IN O
discharge NN O
rate NN O
i IN O
) -RRB- O
during IN O
motor NN O
activity NN O
in IN O
W, JJ O
ii NNS O
) -RRB- O
at IN O
the DT O
transitional JJ O
phase NN O
from IN O
SS NNP O
to TO O
paradoxical JJ O
sleep NN O
( -LRB- O
PS) NNP O
, , O
iii NN O
) -RRB- O
during IN O
rapid JJ O
eye NN O
movements NNS O
( -LRB- O
REMs) NNP O
in IN O
PS NNP O
, , O
and CC O
iv) NN O
following VBG O
electrical JJ O
stimulation NN O
of IN O
the DT O
midbrain NN O
reticular NN O
formation NN O
( -LRB- O
MRF NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Normal JJ O
dogs NNS O
were VBD O
exposed VBN O
to TO O
either DT O
10 CD O
, , O
15 CD O
, , O
or CC O
30 CD O
Gy NNP O
of IN O
X NNP O
rays NNS O
to TO O
a DT O
single JJ O
hemisphere NN O
and CC O
the DT O
gross JJ O
and CC O
histopathologic NN O
changes NNS O
were VBD O
evaluated VBN O
qualitatively RB O
. . O

-DOCSTART- X X O

The DT O
characterization NN O
of IN O
fly NN O
receptors NNS O
with IN O
features NNS O
similar JJ O
to TO O
mammalian JJ B-NP
glycoprotein NN I-NP
hormone NN I-NP
receptors NNS I-NP
allows VBZ O
a DT O
better JJR O
understanding NN O
of IN O
the DT O
evolution NN O
of IN O
this DT O
unique JJ O
group NN O
of IN O
GPCRs NNP B-NP
and CC O
future JJ O
elucidation NN O
of IN O
their PRP$ O
ligand NN O
signaling VBG O
mechanisms NNS O
. . O

-DOCSTART- X X O

In IN O
summary NN O
, , O
the DT O
only JJ O
treatment-related JJ O
effect NN O
noted VBD O
in IN O
this DT O
study NN O
was VBD O
hydrocarbon NN O
nephropathy NN O
in IN O
male JJ O
rats NNS O
, , O
which WDT O
is VBZ O
not RB O
considered VBN O
relevant JJ O
for IN O
human JJ O
health NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
deletion NN O
of IN O
two CD O
potential JJ O
Ste11 NNP B-NP
recognition NN I-NP
sites NNS I-NP
in IN O
the DT O
fus1 NN B-NP
promoter NN I-NP
region NN O
abolished VBD O
transcription NN O
, , O
and CC O
expression NN O
could MD O
be VB O
restored VBN O
when WRB O
we PRP O
inserted VBD O
a DT O
different JJ O
Ste11 NNP B-NP
site NN I-NP
from IN O
the DT O
mat1-P JJ B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

PRIP NNP B-NP
contains VBZ O
two CD O
LXXLL NNP O
signature NN O
motifs NNS O
. . O

-DOCSTART- X X O

BPN NNP O
can MD O
be VB O
experimentally RB O
produced VBN O
by IN O
intratracheal JJ O
inoculation NN O
of IN O
microorganisms NNS O
in IN O
high JJ O
concentrations NNS O
and CC O
ventilator-associated JJ O
BPN NNP O
by IN O
ventilating VBG O
baboons NNS O
with IN O
oleic-acid JJ O
lung NN O
injury NN O
. . O

-DOCSTART- X X O

Coexpression NNP O
of IN O
a DT O
dominant JJ B-NP
negative JJ I-NP
c-jun NN I-NP
antagonized CC O
the DT O
ras-dependent JJ B-NP
stimulation NN O
of IN O
the DT O
92-kDa JJ B-NP
gelatinase NN I-NP
B NNP I-NP
promoter-driven JJ O
CAT NN B-NP
reporter NN I-NP
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
safety NN O
of IN O
design NN O
4 CD O
was VBD O
assured VBN O
as RB O
long JJ O
as IN O
all DT O
patients NNS O
received VBD O
three CD O
courses NNS O
of IN O
chemotherapy NN O
, , O
which WDT O
is VBZ O
unusual JJ O
in IN O
phase NN O
I PRP O
studies NNS O
in IN O
Japan NNP O
. . O

-DOCSTART- X X O

The DT O
plants NNS O
were VBD O
then RB O
brought VBN O
to TO O
our PRP$ O
Houston NNP O
laboratory NN O
where WRB O
they PRP O
were VBD O
measured VBN O
and CC O
analyzed VBN O
for IN O
lignin NN O
and CC O
protein NN O
content NN O
and CC O
for IN O
phenylalanine NN B-NP
ammonia-lyase NN I-NP
( -LRB- O
PAL NNP B-NP
) -RRB- O
and CC O
peroxidase JJ B-NP
activities NNS O
. . O

-DOCSTART- X X O

Activation NN O
of IN O
tyrosine NN B-NP
kinase-containing NN I-NP
receptors NNS I-NP
, , O
heterotrimeric JJ B-NP
G NNP I-NP
proteins NNS I-NP
, , O
and CC O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
enhanced VBD O
the DT O
activities NNS O
of IN O
both DT O
MEK NNP B-NP
isoforms VBZ I-NP
in IN O
293 CD O
and CC O
PC12 CD O
cells NNS O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Transpulmonary JJ O
stable JJ O
air NN O
microbubbles NNS O
bound VBN O
to TO O
a DT O
galactose NN O
carrier NN O
represent VBP O
a DT O
useful JJ O
and CC O
safe JJ O
contrast NN O
agent NN O
in IN O
case NN O
of IN O
an DT O
insufficient JJ O
native JJ O
signal NN O
in IN O
transcranial JJ O
Doppler NNP O
investigation NN O
. . O

-DOCSTART- X X O

Specifically RB O
, , O
we PRP O
engineered VBN O
two CD O
chimeras NNS O
in IN O
which WDT O
the DT O
N-terminal JJ O
lobe NN O
of IN O
the DT O
SH1 NNP B-NP
domain NN I-NP
of IN O
c-Abl NN B-NP
was VBD O
swapped VBN O
with IN O
that DT O
of IN O
v-Src JJ B-NP
. . O

-DOCSTART- X X O

Although IN O
IL-6 NNP B-NP
can MD O
activate VB O
ERK-1 JJ B-NP
in IN O
HepG2 CD O
cells NNS O
, , O
STAT3 NNP B-NP
transactivation NN O
and CC O
Ser(727 NN O
) -RRB- O
phosphorylation NN O
were VBD O
not RB O
reduced VBN O
by IN O
using VBG O
the DT O
MAP NNP B-NP
kinase/ERK NN I-NP
kinase NN B-NP
( -LRB- O
MEK NNP B-NP
) -RRB- O
inhibitor VBP O
PD98059 CD O
or CC O
by IN O
overexpression NN O
of IN O
dominant-negative JJ O
Raf NNP B-NP
. . O

-DOCSTART- X X O

Mean JJ O
disposition NN O
constants NNS O
( -LRB- O
+/ NN O
- : O
SD NN O
) -RRB- O
were VBD O
obtained VBN O
from IN O
individualized JJ O
fits NNS O
( -LRB- O
V1 NNS O
: : O
0.398 CD O
+/ CD O
- : O
0.336 CD O
LITER/KG NNP O
, , O
Vdarea NN O
: : O
2.53 CD O
+/ CD O
- : O
0.72 CD O
liter/kg NN O
, , O
alpha NN O
: : O
0.316 CD O
+/ CD O
- : O
0.294 CD O
min NN O
-1 NN O
, , O
beta NN O
: : O
0.00204 CD O
+/ CD O
- : O
0.00262 CD O
min NN O
-1 NN O
, , O
k2 VBD O
: : O
0.0305 CD O
+/ CD O
- : O
0.0101 CD O
min NN O
-1 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Clinical NNP O
trials NNS O
bring VBP O
informations NNS O
for IN O
pharmacology NN O
and CC O
epidemiology NN O
. . O

-DOCSTART- X X O

The DT O
peptides NNS O
are VBP O
generated VBN O
in IN O
the DT O
cytosol NN O
, , O
then RB O
translocated VBN O
across IN O
the DT O
membrane NN O
of IN O
the DT O
endoplasmic JJ O
reticulum NN O
by IN O
the DT O
transporter NN B-NP
associated VBN I-NP
with IN I-NP
antigen NN I-NP
processing NN I-NP
( -LRB- O
TAP JJ B-NP
) -RRB- O
. . O

-DOCSTART- X X O

An DT O
in IN O
vitro NN O
'glass JJ O
stomach NN O
' '' O
( -LRB- O
containing VBG O
various JJ O
volumes NNS O
of IN O
hydrochloric JJ O
acid NN O
[HCl] NN O
and CC O
ammonium NN O
chloride NN O
[NH4Cl] NN O
) -RRB- O
was VBD O
used VBN O
to TO O
evaluate VB O
the DT O
means NNS O
of IN O
increasing VBG O
'gastric JJ O
' POS O
pH NN O
to TO O
that DT O
of IN O
the DT O
NH4+-->NH3 JJ O
transition NN O
that WDT O
occurs VBZ O
significantly RB O
at IN O
pH DT O
9.24 CD O
. . O

-DOCSTART- X X O

Northern JJ O
analyses NNS O
further RB O
confirm VBP O
that IN O
the DT O
expression NN O
of IN O
endogenous JJ O
alpha-ENaC JJ B-NP
gene NN I-NP
in IN O
salivary JJ O
Pa-4 JJ O
cells NNS O
is VBZ O
suppressed VBN O
by IN O
an DT O
ectopic JJ O
HMGI-C JJ B-NP
overexpression NN O
. . O

-DOCSTART- X X O

Finally RB O
, , O
we PRP O
demonstrated VBD O
that IN O
although IN O
the DT O
DNA-binding JJ O
domain NN O
of IN O
c-myb NN B-NP
is VBZ O
required VBN O
for IN O
both DT O
the DT O
differentiation NN O
block NN O
and CC O
the DT O
shift NN O
in IN O
cell NN O
cycle NN O
after IN O
PMA NNP O
treatment NN O
, , O
phosphorylation NN O
by IN O
casein NN B-NP
kinase NN I-NP
II NNP I-NP
and CC O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
at IN O
positions NNS O
11 CD O
and CC O
12 CD O
or CC O
532 CD O
of IN O
c-myb NN B-NP
, , O
respectively RB O
, , O
are VBP O
not RB O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
RXR NNP B-NP
and CC O
VDR NNP B-NP
transactivated VBD O
selectively RB O
from IN O
VDRE-linked JJ O
templates NNS O
exclusively RB O
as IN O
a DT O
heterodimeric JJ O
complex NN O
, , O
since IN O
neither DT O
receptor NN O
alone RB O
enhanced VBN O
transcription NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Assays NNP O
of IN O
APRE-luciferase NNP O
reporter NN O
plasmids NNS O
transfected VBD O
into IN O
HepG2 CD O
cells NNS O
show VBP O
that IN O
a DT O
mutated JJ O
APRE NNP O
that IN O
binds NNS O
only RB O
BPi NNP B-NP
functions NNS O
as IN O
an DT O
IL-1 NN B-NP
alpha NN I-NP
inducible JJ O
enhancer NN O
, , O
whereas IN O
a DT O
mutated JJ O
APRE NNP O
that IN O
binds NNS O
only RB O
BPc NNP B-NP
does VBZ O
not RB O
. . O

-DOCSTART- X X O

Compared VBN O
with IN O
controls NNS O
, , O
patients NNS O
in IN O
the DT O
unmedicated JJ O
state NN O
had VBD O
low JJ O
smooth JJ O
pursuit NN O
gain NN O
, , O
had VBD O
a DT O
higher JJR O
rate NN O
of IN O
corrective JJ O
catch-up NN O
saccades NNS O
, , O
and CC O
tended VBD O
to TO O
spend VB O
less JJR O
time NN O
engaged VBN O
in IN O
the DT O
tracking NN O
task NN O
. . O

-DOCSTART- X X O

Epstein-Barr NNP B-NP
virus NN I-NP
nuclear JJ I-NP
antigen NN I-NP
2 CD I-NP
exerts VBZ O
its PRP$ O
transactivating NN O
function NN O
through IN O
interaction NN O
with IN O
recombination NN B-NP
signal NN I-NP
binding JJ I-NP
protein NN I-NP
RBP-J NN I-NP
kappa NN I-NP
, , O
the DT O
homologue NN O
of IN O
Drosophila NNP B-NP
Suppressor NNP I-NP
of IN I-NP
Hairless NNP I-NP
. . O

-DOCSTART- X X O

The DT O
three-dimensional JJ O
structure NN O
of IN O
the DT O
E. NNP O
coli NNS O
CR VBD O
domain NN O
indicates VBZ O
that IN O
this DT O
sequence NN O
conservation NN O
is VBZ O
likely JJ O
to TO O
result VB O
in IN O
a DT O
conserved JJ O
structural JJ O
motif NN O
. . O

-DOCSTART- X X O

Co-expression NN O
of IN O
PLD1 NNP B-NP
in IN O
COS-7 JJ O
cells NNS O
with IN O
the DT O
two CD O
recombinant JJ B-NP
CK2 NNP I-NP
subunits NNS I-NP
, , O
alpha NN O
or CC O
beta JJ O
, , O
suggests VBZ O
that IN O
the DT O
association NN O
of IN O
PLD1 NNP B-NP
with IN O
the DT O
kinase NN O
is VBZ O
through IN O
the DT O
beta JJ O
subunit NN O
. . O

-DOCSTART- X X O

Despite IN O
this DT O
dependency NN O
, , O
however RB O
, , O
a DT O
B. NNP B-NP
japonicum NN I-NP
fixK NN I-NP
mutant NN I-NP
did VBD O
not RB O
have VB O
the DT O
phenotypic JJ O
characteristics NNS O
of IN O
B. NNP B-NP
japonicum NNP I-NP
fixL NN I-NP
and CC O
fixJ NN B-NP
mutants NNS I-NP
: : O
the DT O
fixK NN B-NP
mutant NN I-NP
was VBD O
neither DT O
Fix NNP O
- : O
in IN O
symbiosis NN O
with IN O
soybean NN O
plants NNS O
nor CC O
defective JJ O
in IN O
anaerobic JJ O
respiration NN O
with IN O
nitrate JJ O
as IN O
the DT O
terminal NN O
electron NN O
acceptor NN O
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
amino IN O
acid JJ O
sequence NN O
of IN O
Pst1p NNP B-NP
possessed VBD O
high JJ O
sequence NN O
homology NN O
with IN O
the DT O
Sin3 NNP B-NP
family NN I-NP
of IN O
proteins NNS O
, , O
known VBN O
for IN O
their PRP$ O
interaction NN O
with IN O
histone NN B-NP
deacetylases NNS I-NP
. . O

-DOCSTART- X X O

This DT O
selective JJ O
squelching NN O
activity NN O
suggests VBZ O
that IN O
GRIM NNP B-NP
can MD O
interact VB O
with IN O
an DT O
essential JJ O
component NN O
of IN O
the DT O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
transcription NN O
machinery NN O
. . O

-DOCSTART- X X O

The DT O
S. NNP B-NP
typhimurium NN I-NP
aspartyl/asparaginyl NN I-NP
beta-hydroxylase NN I-NP
homologue NN I-NP
( -LRB- O
designated VBN O
lpxO NN B-NP
) -RRB- O
was VBD O
cloned VBN O
into IN O
pBluescriptSK NN O
and CC O
expressed VBD O
in IN O
Escherichia NNP O
coli NNS O
K-12 NN O
, , O
which WDT O
does VBZ O
not RB O
contain VB O
lpxO. . B-NP

-DOCSTART- X X O

Translation NN O
of IN O
mok NN B-NP
is VBZ O
tightly RB O
regulated VBN O
by IN O
Sok NNP B-NP
RNA NNP I-NP
, , O
and CC O
Sok NNP B-NP
RNA NNP I-NP
thus RB O
regulates VBZ O
hok NN B-NP
translation NN O
indirectly RB O
through IN O
mok NN B-NP
. . O

-DOCSTART- X X O

In IN O
this DT O
work NN O
, , O
we PRP O
determined VBD O
the DT O
sequences NNS O
of IN O
eight CD O
VirF-binding NNP B-NP
sites NNS I-NP
from IN O
four CD O
different JJ O
genes NNS O
, , O
by IN O
DNase NNP B-NP
I PRP I-NP
or CC O
hydroxyl JJ O
radical JJ O
footprinting NN O
. . O

-DOCSTART- X X O

Treatment NNP O
with IN O
ACE NNP B-NP
inhibitors NNS O
after IN O
acute JJ O
myocardial JJ O
infarction NN O

-DOCSTART- X X O

One-hour PRP$ O
O3 CD O
, , O
NO2 NNP O
, , O
and CC O
SO2 JJ O
personal JJ O
exposures NNS O
were VBD O
measured VBN O
using VBG O
samplers NNS O
developed VBN O
in IN O
our PRP$ O
laboratory NN O
, , O
while IN O
short-term JJ O
PM2.5 CD O
, , O
CO NNP O
, , O
and CC O
VOCs NNP O
exposures NNS O
were VBD O
measured VBN O
using VBG O
currently RB O
available JJ O
monitors NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
UV NN O
resistance NN O
is VBZ O
only RB O
minimally RB O
restored VBN O
, , O
and CC O
mutant JJ O
cells NNS O
remain VBP O
sensitive JJ O
to TO O
gamma NNP O
radiation NN O
. . O

-DOCSTART- X X O

Diagnostic JJ O
importance NN O
of IN O
determining VBG O
leucine NN B-NP
aminotransferase NN I-NP
activity NN O
in IN O
acute JJ O
pancreatitis NN O

-DOCSTART- X X O

Synchronous JJ O
multicentric JJ O
giant JJ O
cell NN O
tumour NN O
: : O
a DT O
case NN O
report NN O
with IN O
review NN O
of IN O
literature NN O
. . O

-DOCSTART- X X O

Lysates NNS O
of IN O
COS NNP O
cells NNS O
transfected VBN O
with IN O
modified VBN B-NP
hGrzB NN I-NP
cDNA NN I-NP
were VBD O
able JJ O
to TO O
hydrolyze VB O
tert-butyloxycarbonyl-Ala-Ala-Asp-thiobenzyl JJ O
ester NN O
( -LRB- O
Boc-Ala-Ala-Asp-SBzl NNP O
) -RRB- O
, , O
whereas IN O
lysates NNS O
transfected VBN O
with IN O
unmodified JJ B-NP
hGrzB NN I-NP
cDNA NN I-NP
were VBD O
inactive JJ O
. . O

-DOCSTART- X X O

The DT O
POU-specific JJ B-NP
domain NN O
of IN O
Pit-1 NNP B-NP
is VBZ O
essential JJ O
for IN O
sequence-specific JJ O
, , O
high JJ O
affinity NN O
DNA NN O
binding NN O
and CC O
DNA-dependent JJ O
Pit-1-Pit-1 NNP B-NP
interactions NNS O
. . O

-DOCSTART- X X O

3 LS O
) -RRB- O
The DT O
progress NN O
of IN O
fibrinolysis NN O
was VBD O
observed VBN O
by IN O
serial JJ O
collection NN O
of IN O
middle JJ O
ear NN O
fluid NN O
in IN O
the DT O
same JJ O
side NN O
ear NN O
of IN O
5 CD O
cases NNS O
out IN O
of IN O
17 CD O
cases NNS O
having VBG O
much JJ O
activity NN O
for IN O
fibrin NN B-NP
degradation NN O
, , O
and CC O
lowering VBG O
of IN O
fibrinolytic JJ O
activity NN O
was VBD O
revealed VBN O
in IN O
4 CD O
out IN O
of IN O
these DT O
5 CD O
cases NNS O
as IN O
the DT O
result NN O
. . O

-DOCSTART- X X O

In IN O
lyzozyme NN B-NP
activity NN O
there RB O
was VBD O
periodicity NN O
in IN O
three CD O
groups NNS O
but CC O
not RB O
in IN O
the DT O
youngest JJS O
foals NNS O
. . O

-DOCSTART- X X O

Alternative JJ O
roles NNS O
of IN O
these DT O
DNA NNP O
motifs NNS O
as IN O
activators NNS O
of IN O
early JJ O
mRNA NN O
transcription NN O
and CC O
as IN O
an DT O
initiator NN O
element NN O
for IN O
late JJ O
mRNA NN O
transcription NN O
help VBP O
explain VB O
how WRB O
polyomavirus NN O
gene NN O
expression NN O
is VBZ O
regulated VBN O
during IN O
lytic JJ O
growth NN O
and CC O
provides VBZ O
a DT O
model NN O
for IN O
cellular JJ O
transcription NN O
during IN O
development NN O
. . O

-DOCSTART- X X O

The DT O
Mer1 NNP B-NP
protein NN I-NP
contains VBZ O
the DT O
KH NNP O
motif NN O
found VBD O
in IN O
some DT O
RNA-binding JJ O
proteins NNS O
, , O
and CC O
RNA NNP O
gel NNP O
mobility NN O
shift NN O
assays RB O
demonstrate VBP O
that IN O
Mer1 NNP B-NP
binds NNS O
specifically RB O
to TO O
MER2 NNP B-NP
RNA NNP I-NP
. . O

-DOCSTART- X X O

Collectively RB O
, , O
these DT O
studies NNS O
suggest VBP O
that IN O
the DT O
major JJ O
EGF-stimulated JJ B-NP
mitotic JJ O
growth NN O
pathways NNS O
may MD O
not RB O
be VB O
absolutely RB O
linked VBN O
to TO O
the DT O
stat91 NN B-NP
signaling VBG O
pathways NNS O
and CC O
that IN O
such JJ O
transcription NN O
complexes NNS O
are VBP O
more RBR O
complex JJ O
than IN O
previously RB O
reported VBN O
. . O

-DOCSTART- X X O

A DT O
procaryotic JJ O
regulatory JJ O
factor NN O
with IN O
a DT O
histone NN B-NP
H1-like JJ I-NP
carboxy-terminal JJ I-NP
domain NN I-NP
: : O
clonal JJ O
variation NN O
of IN O
repeats NNS O
within IN O
algP NN B-NP
, , O
a DT O
gene NN O
involved VBN O
in IN O
regulation NN O
of IN O
mucoidy NN O
in IN O
Pseudomonas NNP O
aeruginosa NN O
. . O

-DOCSTART- X X O

Innervation NN O
of IN O
reticular JJ O
papillae NN O
in IN O
sheep NN O
and CC O
goats NNS O
. . O

-DOCSTART- X X O

The DT O
monkeys NNS O
had VBD O
been VBN O
administered VBN O
a DT O
common JJ O
lead NN O
isotope NN O
"mix NN O
" '' O
at IN O
the DT O
rate NN O
of IN O
about IN O
1300 CD O
micrograms NNS O
Pb/kg JJ O
body NN O
wt/day NN O
from IN O
age NN O
10 CD O
months NNS O
until IN O
the DT O
start NN O
of IN O
the DT O
study NN O
. . O

-DOCSTART- X X O

Previous JJ O
studies NNS O
showed VBD O
that IN O
a DT O
palindromic JJ O
sequence NN O
located VBN O
at IN O
-159 DT O
base NN O
pairs NNS O
is VBZ O
essential JJ O
for IN O
induction NN O
of IN O
cutinase JJ B-NP
gene NN I-NP
in IN O
Fusarium NNP O
solani JJ O
f NN O
. . O
sp. NN O
pisi FW O
( -LRB- O
Nectria NNP O
haematococca VBD O
mating VBG O
type NN O
VI NN O
) -RRB- O
by IN O
the DT O
hydroxy JJ O
fatty NN O
acids NNS O
from IN O
plant NN O
cutin NN O
and CC O
that IN O
a DT O
50-kDa JJ O
nuclear JJ O
protein NN O
binds NNS O
to TO O
a DT O
promoter NN O
that WDT O
contains VBZ O
this DT O
element NN O
. . O

-DOCSTART- X X O

In IN O
cells NNS O
co-expressing JJ O
high JJ O
levels NNS O
of IN O
the DT O
p38(MAPK) JJ B-NP
kinase NN O
( -LRB- O
MKK3 CD B-NP
) -RRB- O
together RB O
with IN O
the DT O
p38(MAPK) NN B-NP
, , O
a DT O
significant JJ O
inhibition NN O
of IN O
mitogen-induced JJ O
cyclin NN B-NP
D1 IN I-NP
expression NN O
was VBD O
observed VBN O
. . O

-DOCSTART- X X O

ANL-7535 DT O
. . O

-DOCSTART- X X O

Restriction NNP O
analysis NN O
of IN O
the DT O
isolated VBN O
genomic JJ O
clones NNS O
indicated VBD O
that IN O
the DT O
endogenous JJ O
sequences NNS O
abutting VBG O
the DT O
3' JJ O
ends NNS O
of IN O
the DT O
94-A NNP O
and CC O
94-K JJ O
transgenes NNS O
are VBP O
separated VBN O
by IN O
less JJR O
than IN O
20 CD O
kb NN O
, , O
providing VBG O
strong JJ O
support NN O
for IN O
the DT O
single JJ O
integration NN O
model NN O
. . O

-DOCSTART- X X O

Phylogenetic JJ O
analysis NN O
of IN O
yeast NN O
, , O
invertebrate JJ O
, , O
and CC O
multiple JJ O
mammalian JJ O
isoforms NNS O
of IN O
SNF4 NNP B-NP
shows VBZ O
that IN O
the DT O
gene NN O
duplication NN O
likely RB O
occurred VBD O
early RB O
in IN O
the DT O
metazoan NN O
lineage NN O
, , O
as IN O
the DT O
protein NN O
products NNS O
of IN O
the DT O
different JJ O
loci NNS O
are VBP O
relatively RB O
divergent JJ O
. . O

-DOCSTART- X X O

The DT O
delta JJ O
mean JJ O
VAF NNP O
and CC O
delta JJ O
mean JJ O
SABP NNP O
indicated VBD O
varied VBN O
mean JJ O
values NNS O
of IN O
VAF NNP O
and CC O
SABP NNP O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Gel NNP O
mobility NN O
shift NN O
analyses NNS O
reveal VBP O
that IN O
FRTL-5 DT O
thyroid NN O
cell NN O
nuclear JJ O
extracts NNS O
form VBP O
a DT O
specific JJ O
protein/DNA NN O
complex NN O
with IN O
this DT O
region NN O
, , O
which WDT O
is VBZ O
prevented VBN O
by IN O
the DT O
TTF-1 JJ B-NP
binding JJ I-NP
element NN I-NP
from IN O
the DT O
TG NNP B-NP
promoter NN I-NP
; : O
FRT NNP O
and CC O
BRL NNP O
cell NN O
nuclear JJ O
extracts NNS O
do VBP O
not RB O
have VB O
TTF-1 JJ B-NP
and CC O
do VBP O
not RB O
form VB O
this DT O
complex NN O
. . O

-DOCSTART- X X O

Thallium-201 DT O
scintigraphy NN O
after IN O
dipyridamole NN O
infusion NN O
with IN O
low JJ O
level NN O
exercise NN O
. . O

-DOCSTART- X X O

Dominant-negative JJ O
upf1 IN B-NP
mutations NNS O
were VBD O
isolated VBN O
following VBG O
in IN O
vitro NN O
mutagenesis NN O
of IN O
a DT O
plasmid NN O
containing VBG O
the DT O
UPF1 NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Such JJ O
saturation NN O
often RB O
occurs VBZ O
for IN O
several JJ O
recording NN O
sweeps NNS O
after IN O
large JJ O
amplitude NN O
signals NNS O
such JJ O
as IN O
eye NN O
blinks NNS O
are VBP O
rejected VBN O
. . O

-DOCSTART- X X O

To TO O
define VB O
the DT O
molecular JJ O
mechanism NN O
regulating VBG O
FGFR-1 JJ B-NP
gene NN I-NP
expression NN O
in IN O
proliferating VBG O
myoblasts NNS O
and CC O
post-mitotic JJ O
muscle NN O
fibers NNS O
, , O
we PRP O
have VBP O
isolated VBN O
and CC O
partially RB O
characterized VBD O
the DT O
avian NN O
FGFR-1 JJ B-NP
gene NN I-NP
promoter NN O
. . O

-DOCSTART- X X O

Men NNS O
and CC O
women NNS O
entering VBG O
psychotherapy NN O
more RBR O
often RB O
had VBD O
negative JJ O
Wish NNP O
elements NNS O
than IN O
others NNS O
. . O

-DOCSTART- X X O

Serum NN B-NP
prolactin NN I-NP
and CC O
oestradiol JJ O
levels NNS O
at IN O
different JJ O
stages NNS O
of IN O
puberty NN O
. . O

-DOCSTART- X X O

The DT O
sequence NN O
of IN O
three CD O
of IN O
them PRP O
revealed VBD O
pure JJ O
CAG NNP O
stretches NNS O
. . O

-DOCSTART- X X O

PCC NNP O
6803 CD O
mutant JJ O
impaired VBN O
in IN O
cytochrome NN B-NP
c NN I-NP
maturation NN O
. . O

-DOCSTART- X X O

Seroconversion NN O
after IN O
hepatitis NN O
B NNP O
vaccination NN O
. . O

-DOCSTART- X X O

On IN O
day NN O
1 CD O
at IN O
3500 CD O
m NN O
, , O
RI NNP O
showed VBD O
a DT O
significant JJ O
fall NN O
in IN O
body NN O
weight NN O
( -LRB- O
BW) NN O
with IN O
respect NN O
to TO O
SL NNP O
but CC O
AI NNP O
maintained VBD O
it PRP O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
CBP/p300 DT B-NP
potentiated JJ O
HS2-mediated JJ O
transactivation NN O
. . O

-DOCSTART- X X O

Using VBG O
lasers NNS O
in IN O
diabetic NN O
wound NN O
healing NN O
. . O

-DOCSTART- X X O

Protein NNP O
metabolism NN O
disorders NNS O
in IN O
burns NNS O

-DOCSTART- X X O

RNA NNP O
unwinding JJ O
in IN O
U4/U6 DT B-NP
snRNPs NNS O
requires VBZ O
ATP NNP O
hydrolysis NN O
and CC O
the DT O
DEIH-box NNP O
splicing NN O
factor NN O
Brr2 NNP B-NP
. . O

-DOCSTART- X X O

Preface NNP O
and CC O
acknowledgements VBD O
. . O

-DOCSTART- X X O

G-CSF NNP B-NP
( -LRB- O
10 CD O
microg/kg NN O
) -RRB- O
was VBD O
started VBN O
on IN O
day NN O
+1 . O
and CC O
all DT O
patients NNS O
engrafted VBN O
within IN O
a DT O
median JJ O
day NN O
number NN O
of IN O
12 CD O
( -LRB- O
range NN O
, , O
10-22 CD O
) -RRB- O
until IN O
leukocytes NNS O
>1.0 CD O
x NN O
10(9 CD O
)/l NN O
and CC O
a DT O
median JJ O
day NN O
number NN O
of IN O
56 CD O
( -LRB- O
range NN O
, , O
10-180 CD O
) -RRB- O
until IN O
platelets NNS O
>20.0 VBP O
x NN O
10(9 CD O
)/l NN O
( -LRB- O
ie NN O
platelet NN O
transfusion NN O
independence NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
present JJ O
study NN O
indicates VBZ O
that IN O
the DT O
high-dose JJ O
5-fluorouracil JJ O
regimen NNS O
shows VBZ O
weak JJ O
activity NN O
in IN O
advanced JJ O
pancreatic JJ O
cancer NN O
which WDT O
seems VBZ O
comparable JJ O
to TO O
gemcitabine VB O
. . O

-DOCSTART- X X O

At IN O
D28 CD O
, , O
149 CD O
of IN O
386 CD O
patients NNS O
( -LRB- O
49 CD O
% NN O
) -RRB- O
had VBD O
had VBN O
episodes NNS O
of IN O
automatic JJ O
mode NN O
switch NN O
prompted VBN O
by IN O
atrial JJ O
arrhythmias NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
rates NNS O
of IN O
a-factor NN B-NP
receptor NN I-NP
endocytosis NN O
and CC O
consequent JJ O
vacuolar JJ O
turnover NN O
depend VBP O
on IN O
the DT O
available JJ O
level NN O
of IN O
ubiquitin NN B-NP
in IN O
the DT O
cell NN O
. . O

-DOCSTART- X X O

Early RB O
diagnosis NN O
and CC O
early JJ O
surgical JJ O
division NN O
of IN O
the DT O
biliary JJ O
tract NN O
and CC O
pancreatic JJ O
duct NN O
is VBZ O
recommended VBN O
for IN O
children NNS O
with IN O
AAPBD. NNP O

-DOCSTART- X X O

This DT O
approach NN O
allowed VBD O
examination NN O
of IN O
baseline NN O
factors NNS O
as RB O
well RB O
as IN O
the DT O
effect NN O
of IN O
change NN O
in IN O
mileage NN O
, , O
the DT O
occurrence NN O
of IN O
a DT O
musculoskeletal NN O
problem NN O
, , O
or CC O
the DT O
occurrence NN O
of IN O
another DT O
health NN O
problem NN O
on IN O
the DT O
rate NN O
of IN O
dropout NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
the DT O
results NNS O
suggest VBP O
that IN O
N NNP O
region NN O
diversity NN O
at IN O
V( NNP B-NP
D)J NNP B-NP
junctions NNS O
within IN O
rearranged JJ O
immunoglobulin NN B-NP
and CC O
T NNP B-NP
cell NN I-NP
receptor NN I-NP
gene NN I-NP
loci NNS I-NP
can MD O
only RB O
be VB O
introduced VBN O
after IN O
the DT O
generation NN O
of IN O
RAG-catalyzed JJ B-NP
DNA NNP O
double-strand NN O
breaks NNS O
, , O
i IN O
.e NN O
. . O
during IN O
the DT O
DNA NN O
end NN O
joining VBG O
phase NN O
of IN O
the DT O
V( NNP B-NP
D)J NNP B-NP
recombination NN O
reaction NN O
. . O

-DOCSTART- X X O

The DT O
pra2 JJ B-NP
gene NN I-NP
encodes VBZ O
a DT O
pea NN B-NP
( -LRB- I-NP
Pisum IN I-NP
sativum NN I-NP
) -RRB- I-NP
small JJ I-NP
GTPase NN I-NP
belonging VBG O
to TO O
the DT O
YPT/rab JJ B-NP
family NN O
, , O
and CC O
its PRP$ O
expression NN O
is VBZ O
down-regulated JJ O
by IN O
light NN O
, , O
mediated VBN O
by IN O
phytochrome NN B-NP
. . O

-DOCSTART- X X O

To TO O
directly RB O
address VB O
this DT O
issue NN O
, , O
we PRP O
used VBD O
a DT O
tetracycline-regulated JJ O
system NN O
in IN O
human JJ O
U2OS NNP O
osteosarcoma NN O
cells NNS O
and CC O
thus RB O
found VBD O
that DT O
BCL6 NNP B-NP
mediates NNS O
growth NN O
suppression NN O
associated VBN O
with IN O
impaired JJ O
S NNP O
phase NN O
progression NN O
and CC O
apoptosis NN O
. . O

-DOCSTART- X X O

To TO O
explore VB O
the DT O
effect NN O
of IN O
persistent JJ O
cardiomegaly NN O
on IN O
cardiovascular JJ O
function NN O
, , O
groups NNS O
of IN O
newborn JJ O
rats NNS O
inhaled VBN O
up RP O
to TO O
500 CD O
ppm NN O
CO NNP O
for IN O
33 CD O
days NNS O
, , O
after IN O
which WDT O
development NN O
continued VBD O
in IN O
ambient JJ O
air NN O
. . O

-DOCSTART- X X O

Cutaneous JJ O
melanoma NN O
and CC O
bilateral JJ O
retinoblastoma NN O
. . O

-DOCSTART- X X O

This DT O
complex NN O
was VBD O
eliminated VBN O
by IN O
mutation NN O
of IN O
either DT O
half-site JJ O
, , O
and CC O
it PRP O
was VBD O
supershifted VBN O
by IN O
antibodies NNS O
against IN O
chicken NN B-NP
ovalbumin NN I-NP
upstream RB I-NP
promoter-transcription NN I-NP
factor NN I-NP
( -LRB- O
COUP-TF) NN B-NP
. . O

-DOCSTART- X X O

The DT O
material NN O
then RB O
was VBD O
cut VBN O
with IN O
a DT O
diamond NN O
saw VBD O
into IN O
sheets NNS O
of IN O
8 CD O
x NN O
10 CD O
x NN O
3 CD O
mm CD O
, , O
and CC O
the DT O
upper JJ O
surface NN O
was VBD O
polished VBN O
by IN O
colloidal JJ O
SiO2 NNP O
and/or CC O
covered VBN O
with IN O
a DT O
carbon-titanium NN O
( -LRB- O
C:Ti NN O
) -RRB- O
layer NN O
( -LRB- O
3.3 CD O
microm NN O
) -RRB- O
using VBG O
the DT O
plasma-enhanced JJ O
physical JJ O
vapor NN O
deposition NN O
method NN O
. . O

-DOCSTART- X X O

We PRP O
present RB O
here RB O
a DT O
statistical JJ O
technique NN O
we PRP O
developed VBD O
to TO O
identify VB O
the DT O
sequence NN O
elements NNS O
that WDT O
may MD O
be VB O
responsible JJ O
for IN O
this DT O
cell NN O
cycle NN O
regulation NN O
. . O

-DOCSTART- X X O

From IN O
the DT O
comparison NN O
of IN O
the DT O
nod NN B-NP
box NN I-NP
sequences NNS I-NP
of IN O
( -LRB- O
brady NN O
)rhizobia NN O
with IN O
a DT O
more JJR O
divergent JJ O
nod NN B-NP
box NN I-NP
from IN O
Azorhizobium NNP O
caulinodans NNS O
, , O
we PRP O
now RB O
propose VBP O
a DT O
modular JJ O
build-up NN O
of IN O
the DT O
nod NN B-NP
box NN I-NP
with IN O
the DT O
sequence NN O
A-T-C-N9-G-A-T NN O
as IN O
the DT O
binding JJ O
target NN O
of IN O
the DT O
NodD NNP B-NP
protein NN I-NP
( -LRB- O
the DT O
NodD NN B-NP
box NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
dip NN O
also RB O
occurred VBD O
during IN O
prednisone NN O
and CC O
vitamin NN O
D NNP O
treatment NN O
, , O
but CC O
did VBD O
not RB O
occur VB O
when WRB O
calcium NN O
was VBD O
added VBN O
to TO O
prednisone NN O
, , O
although IN O
the DT O
baseline NN O
value NN O
was VBD O
lower JJR O
at IN O
the DT O
start NN O
of IN O
combined VBN O
treatment NN O
with IN O
prednisone NN O
and CC O
calcium NN O
. . O

-DOCSTART- X X O

Highly NNP O
conserved VBD O
regions NNS O
called VBD O
src JJ B-NP
homology NN I-NP
2 CD I-NP
and CC O
3 CD O
( -LRB- O
SH2 NNP B-NP
and CC O
SH3 NNP B-NP
) -RRB- O
, , O
comprising VBG O
amino IN O
acid NN O
residues NNS O
88 CD O
to TO O
250 CD O
, , O
are VBP O
believed VBN O
to TO O
modulate VB O
the DT O
protein-tyrosine NN B-NP
kinase NN I-NP
activity NN O
present NN O
in IN O
the DT O
carboxy-terminal JJ O
halves NNS O
of IN O
the DT O
src JJ B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Acanthamoeba NNP B-NP
myosin NN I-NP
I PRP I-NP
heavy JJ I-NP
chain NN I-NP
kinase NN I-NP
( -LRB- O
MIHCK) NNP B-NP
phosphorylates VBZ O
the DT O
heavy JJ O
chains NNS O
of IN O
amoeba DT B-NP
myosins NNS I-NP
I PRP I-NP
, , O
increasing VBG O
their PRP$ O
actin-activated JJ B-NP
ATPase NNP B-NP
activities NNS O
. . O

-DOCSTART- X X O

Two CD O
different JJ O
genes NNS O
( -LRB- O
polA NNS B-NP
and CC O
polB NN B-NP
) -RRB- O
encoding NN O
family NN B-NP
B NNP I-NP
DNA NNP I-NP
polymerases NNS I-NP
were VBD O
cloned VBN O
from IN O
the DT O
organism NN O
by IN O
PCR NNP O
using VBG O
degenerated VBD O
primers NNS O
based VBN O
on IN O
the DT O
two CD O
conserved JJ O
motifs NNS O
( -LRB- O
motif NN O
A DT O
and CC O
B) NNP O
. . O

-DOCSTART- X X O

The DT O
polypeptide NN O
encoded VBN O
by IN O
the DT O
cDNA NN O
contained VBD O
450 CD O
amino IN O
acids NNS O
with IN O
a DT O
calculated JJ O
M(r NN O
) -RRB- O
of IN O
52,057 CD O
, , O
and CC O
showed VBD O
significant JJ O
homology NN O
with IN O
human JJ O
and CC O
mouse NN B-NP
CAD NN I-NP
( -LRB- O
22 CD O
% NN O
identity NN O
) -RRB- O
. . O

-DOCSTART- X X O

Cytokine-mediated JJ O
I PRP B-NP
kappa VBD I-NP
B NNP I-NP
alpha NN I-NP
reappearance NN O
was VBD O
completely RB O
blocked VBN O
by IN O
the DT O
protein NN O
synthesis NN O
inhibitor NN O
cycloheximide NN O
. . O

-DOCSTART- X X O

NGF NN B-NP
also RB O
induced VBD O
a DT O
synthetic JJ O
promoter NN O
with IN O
repeated VBN O
Sp1 NNP B-NP
sites NNS I-NP
linked VBD O
to TO O
a DT O
core NN O
promoter NN O
, , O
and CC O
a DT O
plasmid NN O
regulated VBN O
by IN O
a DT O
chimeric JJ O
transactivator NN O
in IN O
which WDT O
the DT O
Gal4 NNP B-NP
DNA NNP I-NP
binding NN I-NP
domain NN I-NP
is VBZ O
fused VBN O
to TO O
the DT O
Sp1 NNP B-NP
transactivation NN I-NP
domain NN I-NP
, , O
indicating VBG O
that IN O
this DT O
transactivation NN O
domain NN O
is VBZ O
regulated VBN O
by IN O
NGF. NNP B-NP

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
UvrA NNP B-NP
is VBZ O
involved VBN O
in IN O
triplet NN O
repeat NN O
instability NN O
in IN O
cells NNS O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
, , O
therefore RB O
, , O
that IN O
in IN O
the DT O
absence NN O
of IN O
E1A NNP B-NP
, , O
E4orf4 NNP B-NP
is VBZ O
sufficient JJ O
by IN O
itself PRP O
to TO O
trigger VB O
a DT O
p53-independent JJ B-NP
apoptosis NN O
pathway NN O
that WDT O
may MD O
operate VB O
independently RB O
of IN O
the DT O
known VBN O
zVAD-inhibitable JJ O
caspases NNS B-NP
, , O
and CC O
that WDT O
may MD O
involve VB O
an DT O
as RB O
yet RB O
uncharacterized JJ O
mechanism NN O
. . O

-DOCSTART- X X O

The DT O
nucleotide JJ O
sequence NN O
of IN O
the DT O
gene NN O
encoding VBG O
this DT O
product NN O
was VBD O
determined VBN O
and CC O
the DT O
amino JJ O
acid NN O
sequence NN O
deduced VBN O
. . O

-DOCSTART- X X O

Evidence NN O
for IN O
Gcr1p/Gcr2p NNP B-NP
interaction NN O
has VBZ O
been VBN O
presented VBN O
earlier RBR O
and CC O
is VBZ O
now RB O
supported VBN O
by IN O
the DT O
isolation NN O
of IN O
mutations NNS O
in IN O
Gcr1p NNP B-NP
suppressing NN O
gcr2 NN B-NP
, , O
as IN O
assessed VBN O
by IN O
growth NN O
and CC O
enzyme JJ O
assay NN O
. . O

-DOCSTART- X X O

Mammalian NNP O
ribonucleotide NN B-NP
reductase NN I-NP
shows VBZ O
S-phase JJ O
specific JJ O
expression NN O
and CC O
consists VBZ O
of IN O
two CD O
non-identical JJ O
subunits NNS O
, , O
proteins VBZ B-NP
R1 DT I-NP
( -LRB- O
large JJ O
subunit NN O
) -RRB- O
and CC O
R2 NNP B-NP
( -LRB- O
small JJ O
subunit NN O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
analyzed VBD O
the DT O
effects NNS O
of IN O
light NN O
on IN O
tubulin NN B-NP
mRNA NN I-NP
abundance NN O
in IN O
Arabidopsis NNP O
seedlings NNS O
using VBG O
RNA NNP O
gel NNP O
blot NN O
hybridizations NNS O
and CC O
gene-specific JJ O
probes NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
suggested VBN O
that IN O
death NN O
of IN O
S. NNP O
mansoni NNS O
cercariae NNS O
during IN O
penetration NN O
of IN O
mammalian JJ O
host NN O
skin NN O
is VBZ O
probably RB O
due JJ O
to TO O
exhaustion NN O
of IN O
their PRP$ O
energy NN O
reserves NNS O
. . O

-DOCSTART- X X O

Recent JJ O
research NN O
on IN O
lipolysis NN O
. . O

-DOCSTART- X X O

Instead RB O
, , O
HBx NNP B-NP
is VBZ O
shown VBN O
to TO O
activate VB O
the DT O
cyclin NN B-NP
A DT I-NP
promoter NN I-NP
, , O
induce VB O
cyclin NN B-NP
A-cyclin-dependent NN I-NP
kinase NN B-NP
2 CD I-NP
complexes NNS O
, , O
and CC O
promote VB O
cycling NN O
of IN O
growth-arrested JJ O
cells NNS O
into IN O
G1 NNP O
through IN O
a DT O
pathway NN O
involving VBG O
activation NN O
of IN O
Src NNP B-NP
tyrosine NN I-NP
kinases NNS I-NP
. . O

-DOCSTART- X X O

Fifty-seven CD O
per IN O
cent NN O
of IN O
the DT O
primary JJ O
patients NNS O
reporting VBG O
mild JJ O
symptoms NNS O
had VBD O
abnormal JJ O
levels NNS O
of IN O
leucocytes NNS O
in IN O
their PRP$ O
CSF. NNP O

-DOCSTART- X X O

The DT O
PRP4 NNP B-NP
protein NN I-NP
of IN I-NP
Saccharomyces NNP I-NP
cerevisiae NN I-NP
is VBZ O
an DT O
essential JJ O
part NN O
of IN O
the DT O
U4/U6 NNP B-NP
snRNP NN O
, , O
a DT O
component NN O
of IN O
the DT O
mRNA NN O
splicing NN O
apparatus NN O
. . O

-DOCSTART- X X O

Binding NNP O
of IN O
transformed VBN O
Ah PRP B-NP
receptor NN I-NP
complex NN I-NP
to TO O
a DT O
dioxin NN O
responsive JJ O
transcriptional JJ O
enhancer NN O
: : O
evidence NN O
for IN O
two CD O
distinct JJ O
heteromeric JJ O
DNA-binding JJ O
forms NNS O
. . O

-DOCSTART- X X O

Characterization NN O
of IN O
the DT O
chromosome NN O
19 CD O
breakpoint NN O
region NN O
revealed VBD O
that IN O
the DT O
transcription NN B-NP
factor-encoding NN I-NP
USF2 NNP I-NP
gene NN I-NP
is VBZ O
affected VBN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
dangerous JJ O
to TO O
label VB O
such JJ O
conditions NNS O
as IN O
'inappropriate JJ O
' '' O
secretion NN O
of IN O
ADH NNP B-NP
since IN O
the DT O
maintenance NN O
of IN O
circulating VBG O
volume NN O
is VBZ O
at IN O
least JJS O
as IN O
important JJ O
a DT O
physiological JJ O
requirement NN O
as IN O
the DT O
defence NN O
of IN O
tonicity NN O
. . O

-DOCSTART- X X O

Using VBG O
a DT O
simulated JJ O
cough NN O
machine NN O
, , O
we PRP O
analyzed VBD O
the DT O
effect NN O
of IN O
adding VBG O
tensio-active JJ O
liquids NNS O
as IN O
sol JJ O
phase NN O
simulant NN O
on IN O
the DT O
clearance NN O
of IN O
gel NNP O
mucus NN O
simulant NN O
by IN O
cough NN O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
4 CD O
weeks NNS O
of IN O
cyclosporin NN O
A DT O
( -LRB- O
7 CD O
mg/kg NN O
per IN O
day NN O
) -RRB- O
( -LRB- O
CyA NNS O
) -RRB- O
on IN O
the DT O
survival NN O
of IN O
vascularized VBN O
osteochondral JJ O
grafts NNS O
between IN O
rat NN O
strains NNS O
[DA IN O
( -LRB- O
donor NN O
) -RRB- O
and CC O
Lewis NNP O
( -LRB- O
recipient NN O
) -RRB- O
] SYM O
and CC O
the DT O
presence NN O
and CC O
significance NN O
of IN O
host NN O
immune JJ O
tolerance NN O
and CC O
graft NN O
antigen NN O
modulation NN O
after IN O
cessation NN O
of IN O
immunosuppression NN O
have VBP O
been VBN O
examined VBN O
. . O

-DOCSTART- X X O

Insulin NNP B-NP
binding NN O
to TO O
the DT O
alpha-subunit NN O
of IN O
its PRP$ O
receptor NN O
stimulates VBZ O
the DT O
receptor NN B-NP
tyrosine NN I-NP
kinase NN I-NP
to TO O
phosphorylate VB O
the DT O
beta-subunit NN O
and CC O
several JJ O
endogenous JJ O
protein NN O
substrates NNS O
, , O
including VBG O
pp120/HA4 NNS B-NP
, , O
a DT O
liver-specific JJ O
plasma NN O
membrane NN O
glycoprotein NN O
of IN O
M(r NNP O
) -RRB- O
20,000 CD O
. . O

-DOCSTART- X X O

The DT O
second JJ O
intron NN O
is VBZ O
the DT O
smallest JJS O
of IN O
all PDT O
the DT O
introns NNS O
( -LRB- O
116 CD O
bp NN O
) -RRB- O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
our PRP$ O
recent JJ O
findings NNS O
on IN O
the DT O
Tc52 NNP B-NP
encoding VBG I-NP
gene NN I-NP
underline IN O
the DT O
interest NN O
of IN O
genetic JJ O
manipulation NN O
of IN O
T. NNP O
cruzi NN O
, , O
not RB O
only RB O
making VBG O
it PRP O
possible JJ O
to TO O
use VB O
more RBR O
closely RB O
an DT O
in IN O
vitro NN O
approach NN O
to TO O
find VB O
out RP O
how WRB O
genes NNS O
function VBP O
, , O
but CC O
also RB O
to TO O
obtain VB O
'attenuated JJ O
' '' O
strains NNS O
that WDT O
could MD O
be VB O
used VBN O
in IN O
the DT O
development NN O
of IN O
vaccinal JJ O
strategies NNS O
. . O

-DOCSTART- X X O

The DT O
promoter NN O
for IN O
HMG-CoA NNP B-NP
synthase NN I-NP
contains VBZ O
two CD O
binding JJ O
sites NNS O
for IN O
the DT O
sterol NN B-NP
regulatory JJ I-NP
element-binding JJ I-NP
proteins NNS I-NP
( -LRB- O
SREBPs NNS B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Using VBG O
the DT O
same JJ O
electrical JJ O
analog NN O
, , O
we PRP O
present VBP O
an DT O
analysis NN O
that WDT O
allows VBZ O
calculation NN O
of IN O
these DT O
parameters NNS O
, , O
as RB O
well RB O
as IN O
the DT O
corner NN O
frequency NN O
of IN O
the DT O
network NN O
( -LRB- O
f1 NN O
) -RRB- O
, , O
without IN O
need NN O
for IN O
similar JJ O
assumptions NNS O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
a DT O
similar JJ O
fusion NN O
protein NN O
( -LRB- O
hGH-LDLR-DAF17 NN B-NP
, , O
abbreviated JJ O
HLD NN B-NP
) -RRB- O
containing VBG O
a DT O
fragment NN O
of IN O
the DT O
serine/threonine-rich JJ O
domain NN O
of IN O
the DT O
LDL NN B-NP
receptor NN I-NP
( -LRB- O
LDLR NNP B-NP
) -RRB- O
in IN O
place NN O
of IN O
the DT O
DAF-derived NNP B-NP
serine/threonine-rich JJ I-NP
sequences NNS I-NP
, , O
does VBZ O
not RB O
become VB O
GPI NNP O
anchored VBN O
. . O

-DOCSTART- X X O

Of IN O
concern NN O
is VBZ O
the DT O
high JJ O
, , O
unexplained JJ O
prevalence NN O
of IN O
BV NNP O
among IN O
African-American JJ O
women NNS O
, , O
who WP O
are VBP O
also RB O
at IN O
extremely RB O
high JJ O
risk NN O
for IN O
preterm NN O
birth NN O
. . O

-DOCSTART- X X O

The DT O
RAG-2 NNP B-NP
gene NN I-NP
encodes VBZ O
a DT O
component NN O
of IN O
the DT O
V( NNP B-NP
D)J NNP I-NP
recombinase NN I-NP
which WDT O
is VBZ O
essential JJ O
for IN O
the DT O
assembly NN O
of IN O
antigen NN O
receptor NN O
genes NNS O
in IN O
B NNP O
and CC O
T NNP O
lymphocytes NNS O
. . O

-DOCSTART- X X O

Cell-free JJ O
extracts NNS O
of IN O
E. NNP O
coli NNS O
( -LRB- O
fpg JJ B-NP
mutY NN B-NP
) -RRB- O
harboring VBG O
pYSB10 RB O
possess VBP O
an DT O
enzymatic JJ O
activity NN O
that IN O
cleaves NNS O
a DT O
34-mer NN O
oligonucleotide NN O
containing VBG O
a DT O
single JJ O
8-oxoG NN O
opposite IN O
a DT O
cytosine NN O
(8-OxoG/C JJ O
) -RRB- O
. . O

-DOCSTART- X X O

Magnification-corrected JJ O
planimetry NN O
of IN O
the DT O
parapapillary NN O
region NN O
was VBD O
performed VBN O
according VBG O
to TO O
Littmann NNP O
's POS O
method NN O
in IN O
312 CD O
unselected JJ O
eyes NNS O
with IN O
chronic JJ O
primary JJ O
open-angle JJ O
glaucoma NN O
and CC O
in IN O
125 CD O
normal JJ O
eyes NNS O
of IN O
an DT O
age NN O
- : O
and CC O
refraction-matched JJ O
control NN O
group NN O
using VBG O
optic JJ O
disk NN O
photographs NNS O
. . O

-DOCSTART- X X O

Both DT O
merR NN B-NP
genes NNS I-NP
consist VBP O
of IN O
a DT O
408 CD O
bp NN O
ORF IN O
coding VBG O
for IN O
135 CD O
amino IN O
acids NNS O
. . O

-DOCSTART- X X O

The DT O
1.3-kb JJ O
DNA NN O
, , O
when WRB O
placed VBN O
upstream RB O
of IN O
the DT O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
gene NN I-NP
, , O
was VBD O
shown VBN O
to TO O
be VB O
functionally RB O
active JJ O
. . O

-DOCSTART- X X O

Polar JJ O
effects NNS O
of IN O
transposon NN O
insertions NNS O
demonstrated VBD O
that IN O
all DT O
of IN O
these DT O
mRNAs NNS O
arose VBD O
from IN O
a DT O
single JJ O
promoter NN O
region NN O
, , O
where WRB O
transcription NN O
initiated VBN O
80 CD O
bp JJ O
5' JJ O
to TO O
nifH. . B-NP

-DOCSTART- X X O

Here RB O
, , O
we PRP O
identify VBP O
the DT O
analytical JJ O
form NN O
of IN O
the DT O
PDF NN O
of IN O
one CD O
such JJ O
measure NN O
, , O
the DT O
order NN O
parameter NN O
in IN O
the DT O
low JJ O
temperature NN O
phase NN O
of IN O
the DT O
2D NNP O
XY NNP O
model NN O
. . O

-DOCSTART- X X O

The DT O
determination NN O
of IN O
antithrombin JJ B-NP
III NNP I-NP
( -LRB- O
AT NN B-NP
III NNP I-NP
) -RRB- O
and CC O
its PRP$ O
clinical JJ O
significance NN O

-DOCSTART- X X O

With IN O
this DT O
study NN O
, , O
a DT O
total NN O
of IN O
13 CD O
operators NNS O
for IN O
the DT O
glp NN B-NP
regulon NN I-NP
have VBP O
been VBN O
characterized VBN O
. . O

-DOCSTART- X X O

Southern JJ O
zoo NN O
blot NN O
analysis NN O
indicated VBN O
that IN O
ZNF236 NNP B-NP
is VBZ O
conserved VBN O
in IN O
the DT O
genomes NNS O
of IN O
all DT O
mammalian JJ O
species NNS O
tested VBN O
, , O
but CC O
not RB O
in IN O
yeast NN O
. . O

-DOCSTART- X X O

3. . O

-DOCSTART- X X O

This DT O
alternative JJ O
splice NN O
acceptor NN O
site NN O
is VBZ O
also RB O
used VBN O
by IN O
a DT O
biologically RB O
active JJ O
provirus NN O
with IN O
an DT O
efficiency NN O
of IN O
approximately RB O
5 CD O
% NN O
compared VBN O
with IN O
the DT O
upstream JJ O
site NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
the DT O
effect NN O
of IN O
the DT O
antibiotic JJ O
lasalocid NN O
on IN O
the DT O
rumen NNS O
anaerobic JJ O
fungus NN O
Neocallimastix NNP O
frontalis IN O
RK NNP O
21 CD O
was VBD O
examined VBN O
. . O

-DOCSTART- X X O

4 CD O
382 CD O
new JJ O
mothers NNS O
were VBD O
examined VBN O
retrospectively RB O
with IN O
the DT O
enzyme-linked JJ O
immunosorbent JJ O
assay NN O
( -LRB- O
ELISA NNP O
) -RRB- O
for IN O
IgG NNP B-NP
activity NN O
to TO O
cytomegalovirus NN O
( -LRB- O
CMV) NNP O
during IN O
pregnancy NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
a DT O
dose-dependent JJ O
activity NN O
of IN O
lysine NN B-NP
vasopressin NN I-NP
on IN O
the DT O
EEG NNP O
, , O
which WDT O
might MD O
be VB O
similar JJ O
to TO O
that DT O
observed VBN O
in IN O
animal NN O
and CC O
man NN O
after IN O
administration NN O
of IN O
nicotine JJ O
. . O

-DOCSTART- X X O

However RB O
, , O
elimination NN O
of IN O
the DT O
kinase NN O
activity NN O
of IN O
DCAMKL1 NNP B-NP
has VBZ O
no DT O
detectable JJ O
effect NN O
on IN O
its PRP$ O
microtubule NN O
polymerization NN O
activity NN O
. . O

-DOCSTART- X X O

Sequencing NN O
and CC O
restriction NN O
enzyme NN O
analysis NN O
demonstrated VBN O
that IN O
this DT O
single-copy JJ O
gene NN O
contains VBZ O
11 CD O
exons NNS O
and CC O
spans VBZ O
9596 CD O
base NN O
pairs NNS O
. . O

-DOCSTART- X X O

The DT O
anaesthetic JJ O
management NN O
of IN O
41 CD O
patients NNS O
who WP O
underwent VBD O
cardiac JJ O
transplantation NN O
during IN O
a DT O
40 CD O
month NN O
period NN O
at IN O
Clinica NNP O
Puerta NNP O
de IN O
Hierro NNP O
is VBZ O
reviewed VBN O
. . O

-DOCSTART- X X O

In IN O
uraemic JJ O
patients NNS O
, , O
similar JJ O
maximum NN O
serum NN O
concentrations NNS O
were VBD O
found VBN O
after IN O
a DT O
single JJ O
7.5 CD O
mg/kg NN O
iv FW O
dose NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
unit NN O
housing NN O
of IN O
a DT O
compact JJ O
cyclotron NN O
and CC O
positron NN O
emission NN O
CT NNP O
( -LRB- O
PET NN O
) -RRB- O
, , O
positron NN O
emitting NN O
gas NN O
such JJ O
as IN O
15O CD O
, , O
11C CD O
, , O
C15O2 NNP O
, , O
C15O NNP O
etc FW O
. . O
is VBZ O
supplied VBN O
from IN O
a DT O
cyclotron NN O
to TO O
a DT O
PET NN O
room NN O
through IN O
a DT O
transportation NN O
pipe NN O
with IN O
an DT O
appropriate JJ O
shield NN O
to TO O
reduce VB O
positron NN O
annihilation NN O
radiation NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
describe VBP O
the DT O
cloning NN O
and CC O
initial JJ O
characterization NN O
of IN O
IPP NNP B-NP
, , O
a DT O
novel NN O
human NN O
gene NN O
that WDT O
predicts VBZ O
a DT O
kelch NN B-NP
family NN I-NP
protein NN I-NP
homologous RB O
to TO O
the DT O
mouse NN B-NP
Ipp NNP I-NP
gene NN I-NP
, , O
a DT O
previously RB O
described VBN O
kelch JJ B-NP
family NN I-NP
member NN I-NP
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
identifies VBZ O
a DT O
ras-associating NN B-NP
(RA)-like JJ O
domain NN O
in IN O
the DT O
N-termini NN O
of IN O
band NN B-NP
4.1/JEF IN I-NP
domains NNS I-NP
and CC O
in IN O
the DT O
Grb7/10/14 NNP B-NP
adapter NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

Sleeping VBG O
position NN O
and CC O
sudden JJ O
infant NN O
death NN O
syndrome NN O
( -LRB- O
SIDS NNP O
) -RRB- O
: : O
effect NN O
of IN O
an DT O
intervention NN O
programme NN O
to TO O
avoid VB O
prone JJ O
sleeping NN O
. . O

-DOCSTART- X X O

Statistical NNP O
conservation NN O
laws NNS O
in IN O
turbulent JJ O
transport NN O
. . O

-DOCSTART- X X O

Characterization NN O
and CC O
targeted JJ O
disruption NN O
of IN O
murine NN B-NP
Nup50 NNP I-NP
, , O
a DT O
p27( JJ B-NP
Kip1)-interacting JJ B-NP
component NN O
of IN O
the DT O
nuclear JJ O
pore NN O
complex NN O
. . O
p27( JJ B-NP
Kip1 NNP B-NP
) -RRB- O
is VBZ O
a DT O
member NN O
of IN O
the DT O
Cip-Kip NNP B-NP
family NN O
of IN O
cyclin-dependent JJ B-NP
kinase NN I-NP
( -LRB- O
Cdk NN B-NP
) -RRB- O
inhibitors VBZ O
that DT O
binds NNS O
to TO O
cyclin-Cdk JJ B-NP
complexes NNS O
and CC O
inhibits VBZ O
their PRP$ O
catalytic JJ O
activity NN O
in IN O
response NN O
to TO O
antiproliferative JJ O
stimuli NNS O
. . O
p27( NN B-NP
Kip1 NNP B-NP
) -RRB- O
is VBZ O
regulated VBN O
by IN O
several JJ O
posttranscriptional JJ O
mechanisms NNS O
, , O
including VBG O
subcellular JJ O
localization NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
identified VBN O
the DT O
gene NN O
encoding VBG O
sigma NN B-NP
E NNP I-NP
using VBG O
a DT O
genetic JJ O
screen NN O
designed VBN O
to TO O
isolate VB O
trans-acting JJ O
mutations NNS O
that IN O
abolish VB O
expression NN O
from IN O
either DT O
htrA NN B-NP
or CC O
rpoHP3 CD B-NP
, , O
two CD O
promoters NNS O
recognized VBD O
uniquely RB O
by IN O
sigma NN B-NP
E-containing NN I-NP
RNA NNP B-NP
polymerase NN I-NP
. . O

-DOCSTART- X X O

Based VBN O
on IN O
these DT O
results NNS O
, , O
it PRP O
has VBZ O
been VBN O
concluded VBN O
that IN O
an DT O
IPFSA NN O
can MD O
promote VB O
the DT O
healing JJ O
process NN O
in IN O
the DT O
avascular JJ O
zone NN O
of IN O
a DT O
torn JJ O
meniscus NN O
in IN O
rabbits NNS O
and CC O
that DT O
systemic JJ O
vascularity NN O
to TO O
the DT O
synovium NN O
or CC O
the DT O
meniscus NN O
is VBZ O
not RB O
essential JJ O
for IN O
healing NN O
to TO O
occur VB O
. . O

-DOCSTART- X X O

Biomass NNP O
growth NN O
monitoring NN O
using VBG O
pressure NN O
drop NN O
in IN O
a DT O
cocurrent NN O
biofilter NN O

-DOCSTART- X X O

Inspection NNP O
of IN O
X NNP B-NP
. . I-NP
tropicalis NNS I-NP
, , I-NP
mouse NN I-NP
and CC I-NP
human JJ I-NP
U6 IN I-NP
DNA NNP I-NP
upstream RB I-NP
sequences NNS I-NP
revealed VBD O
the DT O
presence NN O
of IN O
a DT O
TATA NNP O
box NN O
as RB O
well RB O
as IN O
of IN O
the DT O
proximal JJ O
and CC O
enhancer NN O
(octamer NN O
motif NN O
) -RRB- O
elements NNS O
contained VBN O
in IN O
snRNA DT O
genes NNS O
transcribed VBN O
by IN O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
. . O

-DOCSTART- X X O

When WRB O
expressed VBN O
in IN O
thymidine NN B-NP
kinase-deficient JJ I-NP
L NNP O
cells NNS O
or CC O
3T3 CD O
cells NNS O
, , O
C/EBPalpha NNP B-NP
is VBZ O
detected VBN O
in IN O
a DT O
protein NN O
complex NN O
which WDT O
binds VBZ O
to TO O
the DT O
E2F NNP B-NP
binding NN I-NP
sites NNS I-NP
found VBD O
in IN O
the DT O
promoters NNS O
of IN O
the DT O
genes NNS O
for IN O
E2F-1 JJ B-NP
and CC O
dihydrofolate JJ B-NP
reductase NN I-NP
( -LRB- O
DHFR NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Phenylalanine NNP O
and CC O
tyrosine NN O
levels NNS O
were VBD O
higher JJR O
in IN O
those DT O
who WP O
received VBD O
Vamin NNP O
9 CD O
glucose NN O
but CC O
55 CD O
% NN O
of IN O
infants NNS O
given VBN O
Vamin NNP O
Infant NNP O
had VBD O
tyrosine NN O
levels NNS O
below IN O
the DT O
lower JJR O
limit NN O
of IN O
the DT O
target NN O
range NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Neurodevelopmental JJ O
assessment NN O
at IN O
1 CD O
year NN O
is VBZ O
predictive JJ O
of IN O
school NN O
performance NN O
and CC O
outcome NN O
in IN O
the DT O
adolescent JJ O
period NN O
. . O

-DOCSTART- X X O

Phenotypic JJ O
responses NNS O
of IN O
additional JJ O
mutants NNS O
, , O
including VBG O
exo1 JJ B-NP
, , O
srs2 JJ B-NP
, , O
rad5 CD B-NP
, , O
and CC O
rdh54 CD B-NP
strains NNS O
, , O
suggest VBP O
roles NNS O
in IN O
recombinational JJ O
repair NN O
, , O
but CC O
not RB O
in IN O
NHEJ. NNP O

-DOCSTART- X X O

Although IN O
hSSTR5 PRP B-NP
displays VBZ O
approximately RB O
75 CD O
% NN O
sequence NN O
identity NN O
with IN O
rat NN B-NP
SSTR5 NNP I-NP
, , O
the DT O
two CD O
receptors NNS O
display VBP O
significantly RB O
different JJ O
pharmacological JJ O
profiles NNS O
, , O
especially RB O
with IN O
respect NN O
to TO O
their PRP$ O
binding JJ O
affinities NNS O
for IN O
the DT O
SST NNP B-NP
analogue NN O
SMS NNP O
201-995 CD O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
IL-1-stimulated JJ B-NP
, , O
Rho-dependent JJ B-NP
cytoskeletal NN O
reorganization NN O
may MD O
cluster NN O
signaling VBG O
molecules NNS O
in IN O
specific JJ O
architectures NNS O
that WDT O
are VBP O
necessary JJ O
for IN O
persistent JJ O
cell NN O
activation NN O
in IN O
chronic NN O
inflammatory NN O
disease NN O
. . O

-DOCSTART- X X O

Deletion NNP O
mutants NNS O
of IN O
the DT O
human JJ B-NP
CHOP NNP I-NP
promoter NN I-NP
identify VBP O
a DT O
region NN O
comprising VBG O
nucleotides NNS O
-75 . O
to TO O
-104 DT O
required VBN O
for IN O
both DT O
constitutive JJ O
and CC O
ER-stress-inducible JJ O
expression NN O
. . O

-DOCSTART- X X O

Anderson NNP O
Hospital NNP O
and CC O
Tumor NNP O
Institute NNP O
at IN O
Houston NNP O
during IN O
a DT O
30-year JJ O
interval NN O
( -LRB- O
1944 CD O
to TO O
1974 CD O
) -RRB- O
, , O
with IN O
a DT O
minimum NN O
of IN O
ten CD O
years NNS O
of IN O
follow-up NN O
, , O
we PRP O
determined VBD O
that IN O
the DT O
major JJ O
prognostic JJ O
factor NN O
of IN O
survival NN O
was VBD O
the DT O
number NN O
of IN O
positive JJ O
nodes NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
concluded VBN O
that IN O
the DT O
atherogenic JJ O
process NN O
includes VBZ O
stimulation NN O
of IN O
collagen NN B-NP
and CC O
elastin JJ B-NP
synthesis NN O
. . O

-DOCSTART- X X O

The DT O
absolute JJ O
CD4 NNP B-NP
count NN O
of IN O
patients NNS O
with IN O
de NNP O
novo , O
IBD NNP O
was VBD O
210-700 CD O
cells/ml NN O
at IN O
the DT O
time NN O
of IN O
IBD. NNP O

-DOCSTART- X X O

Four CD O
of IN O
these DT O
fibroblast JJ O
clones NNS O
were VBD O
infected VBN O
with IN O
a DT O
retrovirus NN O
containing VBG O
the DT O
cDNA NN B-NP
encoding NN I-NP
myoD NN I-NP
and CC O
a DT O
puromycin NN O
selection NN O
marker NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
demonstrates VBZ O
the DT O
feasibility NN O
and CC O
potential JJ O
usefulness NN O
of IN O
syngeneic NN O
BM NNP O
Txp NNP O
in IN O
myeloma NN O
. . O

-DOCSTART- X X O

Results NNS O
obtained VBD O
from IN O
the DT O
tritium NN O
test NN O
and CC O
direct JJ O
chemical NN O
analysis NN O
were VBD O
compared VBN O
. . O

-DOCSTART- X X O

The DT O
levels NNS O
of IN O
soluble JJ O
L-selectin NNP B-NP
and CC O
ICAM-1 NNP B-NP
in IN O
the DT O
serum NN O
were VBD O
determined VBN O
by IN O
the DT O
ELISA NNP O
method NN O
. . O

-DOCSTART- X X O

Within IN O
the DT O
last JJ O
few JJ O
years NNS O
, , O
the DT O
WWW NNP O
has VBZ O
grown VBN O
enormously RB O
. . O

-DOCSTART- X X O

Characterization NNP O
of IN O
insertion NN O
mutations NNS O
in IN O
the DT O
Saccharomyces NNP B-NP
cerevisiae NN I-NP
MSH1 . I-NP
and CC O
MSH2 JJ B-NP
genes NNS I-NP
: : O
evidence NN O
for IN O
separate JJ O
mitochondrial NN O
and CC O
nuclear JJ O
functions NNS O
. . O

-DOCSTART- X X O

These DT O
cells NNS O
also RB O
showed VBD O
an DT O
increase NN O
in IN O
cyclin NN B-NP
A DT I-NP
and CC O
cyclin NN B-NP
A- NNP I-NP
and CC I-NP
E-associated NNP I-NP
kinase NN I-NP
activities NNS O
characteristic JJ O
of IN O
S NNP O
phase NN O
induction NN O
. . O

-DOCSTART- X X O

Obtaining VBG O
kidney NN O
cells NNS O
from IN O
a DT O
beagle NN O
puppy NN O
( -LRB- O
RPB-1 NN O
) -RRB- O
and CC O
the DT O
establishment NN O
of IN O
a DT O
cryopreservation NN O
bank NN O

-DOCSTART- X X O

During IN O
each DT O
step NN O
of IN O
the DT O
pulse NN O
infusion IN O
the DT O
osteocalcin JJ B-NP
responses NNS O
to TO O
changes NNS O
in IN O
CaI NNP O
in IN O
general JJ O
were VBD O
parallel RB O
to TO O
the DT O
changes NNS O
in IN O
PTH NNP B-NP
( -LRB- O
r NN O
= SYM O
0.462 CD O
; : O
P NNP O
= SYM O
0.02 CD O
) -RRB- O
and CC O
were VBD O
inversely RB O
correlated VBN O
to TO O
CaI NNP O
( -LRB- O
r NN O
= SYM O
-0.562 : O
; : O
P NNP O
= SYM O
0.003 CD O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
data NNS O
suggest VBP O
that IN O
overexpression NN O
of IN O
MT NNP B-NP
potentiates VBZ O
the DT O
growth NN O
of IN O
MCF7 CD O
cells NNS O
, , O
whereas IN O
downregulation NN O
of IN O
MT NNP B-NP
elicits NNS O
antiproliferative JJ O
effects NNS O
. . O

-DOCSTART- X X O

The DT O
induction NN O
by IN O
dexamethasone NN O
of IN O
rat NN B-NP
liver NN I-NP
CYP3A1 IN I-NP
differs NNS O
from IN O
classical JJ O
glucocorticoid NN O
gene NN O
regulation NN O
in IN O
part NN O
because IN O
both DT O
glucocorticoids NNS O
and CC O
antiglucocorticoids NNS O
such JJ O
as IN O
pregnenolone JJ O
16 CD O
alpha-carbonitrile JJ O
(PCN) NNP O
induce VB O
CYP3A1 PRP B-NP
through IN O
transcriptional JJ O
gene NN O
activation NN O
. . O

-DOCSTART- X X O

A DT O
pharmacokinetic JJ O
interaction NN O
between IN O
LY354740 CD O
and CC O
diazepam NN O
, , O
leading VBG O
to TO O
the DT O
lowering VBG O
of IN O
the DT O
plasma NN O
level NN O
of IN O
free JJ O
diazepam NN O
, , O
was VBD O
also RB O
demonstrated VBN O
. . O

-DOCSTART- X X O

Also RB O
, , O
in IN O
patients NNS O
with IN O
MYD NNP O
, , O
there EX O
was VBD O
a DT O
significant JJ O
decrease NN O
in IN O
arterial JJ O
PO2 NN O
from IN O
the DT O
seated VBN O
posture NN O
to TO O
the DT O
supine JJ O
posture NN O
, , O
without IN O
a DT O
significant JJ O
change NN O
in IN O
the DT O
arterial JJ O
PCO2 NN O
. . O

-DOCSTART- X X O

The DT O
animals NNS O
were VBD O
followed VBN O
over IN O
a DT O
1- JJ O
to TO O
6-h JJ O
posttraumatic JJ O
course NN O
, , O
and CC O
processed VBD O
for IN O
the DT O
LM NNP O
and CC O
TEM NNP O
visualization NN O
of IN O
HRP. NNP B-NP

-DOCSTART- X X O

Glucose JJ O
consumption NN O
of IN O
the DT O
human JJ O
brain NN O
under IN O
the DT O
influence NN O
of IN O
intravenous JJ O
infusions NNS O
of IN O
glucose NN O
, , O
glucagon NN B-NP
and CC O
glucose-insulin NN O

-DOCSTART- X X O

The DT O
lowest JJS O
PaCO2 NN O
values NNS O
were VBD O
significantly RB O
lower JJR O
in IN O
MCE NNP O
than IN O
in IN O
the DT O
F NNP O
, , O
W, NNP O
and CC O
D NNP O
( -LRB- O
F NNP O
+ , O
W NNP O
+ NNP O
D) NNP O
group NN O
or CC O
controls NNS O
. . O

-DOCSTART- X X O

The DT O
psychosomatic JJ O
approach NN O
to TO O
temporomandibular JJ O
arthrosis NN O

-DOCSTART- X X O

Detection NNP O
of IN O
sinusoidal JJ O
gratings NNS O
by IN O
pattern-specific JJ O
detectors NNS O
: : O
further JJ O
evidence NN O
for IN O
the DT O
correlation NN O
principle NN O
in IN O
human JJ O
vision NN O
. . O

-DOCSTART- X X O

Left VBN O
ventricle NN O
to TO O
coronary JJ O
sinus IN O
fistula NN O
. . O

-DOCSTART- X X O

No DT O
other JJ O
transcripts NNS O
of IN O
different JJ O
length NN O
could MD O
be VB O
detected VBN O
after IN O
prolonged JJ O
exposure NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
and CC O
sequenced VBN O
cDNA NN O
sequences NNS O
corresponding JJ O
to TO O
two CD O
novel NN O
genes NNS O
that WDT O
map VBP O
to TO O
Xq28 VB O
. . O

-DOCSTART- X X O

The DT O
vaccinia NN O
virus NN O
D6R DT B-NP
open JJ O
reading NN O
frame NN O
encodes VBZ O
the DT O
small JJ O
subunit NN O
of IN O
the DT O
heterodimeric JJ O
vaccinia NN B-NP
virus NN I-NP
early RB I-NP
transcription NN I-NP
factor NN I-NP
(VETF NN O
) -RRB- O
that WDT O
activates VBZ O
transcription NN O
of IN O
early JJ B-NP
genes NNS I-NP
in IN O
vitro NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
used VBN O
nuclear JJ O
magnetic JJ O
resonance NN O
( -LRB- O
NMR NN O
) -RRB- O
to TO O
obtain VB O
the DT O
structure NN O
of IN O
an DT O
RNA NNP O
"kissing NN O
" `` O
hairpin NN O
complex JJ O
formed VBN O
between IN O
the DT O
HIV-2 NN O
TAR NN O
hairpin NN O
loop NN O
and CC O
a DT O
hairpin NN O
with IN O
a DT O
complementary JJ O
loop NN O
sequence NN O
. . O

-DOCSTART- X X O

Xnr3 PRP B-NP
is VBZ O
transcriptionally RB O
activated VBN O
by IN O
wnt JJ B-NP
signaling NN O
during IN O
gastrulation NN O
in IN O
the DT O
Xenopus NNP O
embryo NN O
. . O

-DOCSTART- X X O

Renal NNP O
dysplasia NN O
with IN O
multisystem JJ O
malformation--a JJ O
study NN O
of IN O
9 CD O
cases NNS O
. . O

-DOCSTART- X X O

Brome NNP B-NP
mosaic NN I-NP
virus NN I-NP
polymerase-like JJ I-NP
protein NN B-NP
2a DT I-NP
is VBZ O
directed VBN O
to TO O
the DT O
endoplasmic JJ O
reticulum NN O
by IN O
helicase-like JJ B-NP
viral JJ B-NP
protein NN I-NP
1a VBD I-NP
. . O

-DOCSTART- X X O

Mutations NNS O
abolishing NN O
MalK NNP B-NP
function NN O
not RB O
only RB O
result VB O
in IN O
inability NN O
to TO O
transport VB O
maltose JJ O
but CC O
also RB O
cause VB O
constitutive JJ O
expression NN O
of IN O
the DT O
maltose NN B-NP
regulon NN I-NP
. . O

-DOCSTART- X X O

The DT O
D. NNP O
discoideum NN O
proteins NNS O
were VBD O
entirely RB O
conserved VBN O
over IN O
the DT O
four CD O
regions NNS O
known VBN O
to TO O
be VB O
important JJ O
for IN O
GTP NNP O
binding NN O
and CC O
all DT O
contained VBD O
the DT O
C-terminal JJ O
CAAX NNP O
aa JJ O
motifs NNS O
shared VBN O
by IN O
other JJ O
Rho NNP B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

The DT O
lack NN O
of IN O
chronically RB O
depressed JJ O
LCBF NN O
( -LRB- O
after IN O
1 CD O
day NN O
) -RRB- O
may MD O
be VB O
related VBN O
to TO O
the DT O
quick JJ O
structural JJ O
repair NN O
of IN O
endothelium NN O
. . O

-DOCSTART- X X O

Functional JJ O
uncoupling NN O
of IN O
the DT O
Janus NNP B-NP
kinase NN I-NP
3-Stat5 CD I-NP
pathway NN O
in IN O
malignant JJ O
growth NN O
of IN O
human JJ O
T NNP O
cell NN O
leukemia NN O
virus NN O
type NN O
1-transformed JJ O
human JJ O
T NNP O
cells NNS O
. . O

-DOCSTART- X X O

We PRP O
used VBD O
event-related JJ O
functional JJ O
magnetic JJ O
resonance NN O
imaging NN O
( -LRB- O
fMRI NN O
) -RRB- O
during IN O
a DT O
cued JJ O
spatial-attention NN O
task NN O
to TO O
dissociate VB O
brain NN O
activity NN O
related VBN O
to TO O
attentional JJ O
control NN O
from IN O
that DT O
related VBN O
to TO O
selective JJ O
processing NN O
of IN O
target NN O
stimuli NNS O
. . O

-DOCSTART- X X O

A DT O
V1 NNP B-NP
mutant NN I-NP
generated VBD O
in IN O
vivo RB O
with IN O
11 CD O
of IN O
the DT O
14 CD O
N-terminal JJ O
amino IN O
acids NNS O
altered VBN O
, , O
was VBD O
viable JJ O
and CC O
produced VBN O
symptoms NNS O
typical JJ O
of IN O
a DT O
wild-type JJ O
infection NN O
. . O

-DOCSTART- X X O

These DT O
observations NNS O
suggest VBP O
that IN O
clr4+ JJ B-NP
and CC O
rik1+ JJ B-NP
must MD O
play VB O
a DT O
role NN O
in IN O
the DT O
assembly NN O
of IN O
Swi6p NNP B-NP
into IN O
a DT O
transcriptionally NN O
silent JJ O
, , O
inaccessible JJ O
chromatin NN O
structure NN O
at IN O
fission NN O
yeast NN O
centromeres NNS O
which WDT O
is VBZ O
required VBN O
to TO O
facilitate VB O
interactions NNS O
with IN O
spindle NN O
microtubules NNS O
and CC O
to TO O
ensure VB O
normal JJ O
chromosome NN O
segregation NN O
. . O

-DOCSTART- X X O

The DT O
gene NN O
sequence NN O
predicts VBZ O
a DT O
150,825 CD O
mol NN O
wt IN O
apoprotein NN O
of IN O
1363 CD O
amino IN O
acids NNS O
having VBG O
an DT O
N-terminal JJ O
hydrophobic JJ O
signal NN O
sequence NN O
of IN O
17 CD O
amino IN O
acids NNS O
, , O
19 CD O
potential JJ O
N-linked JJ O
glycosylation NN O
sites NNS O
, , O
a DT O
hydrophobic JJ O
anchor NN O
sequence NN O
of IN O
approximately RB O
17 CD O
amino IN O
acids NNS O
near IN O
the DT O
C NNP O
terminus NN O
, , O
and CC O
a DT O
hydrophilic JJ O
cysteine-rich JJ O
C NNP O
terminus NN O
of IN O
35 CD O
amino IN O
acids NNS O
. . O

-DOCSTART- X X O

Likewise RB O
, , O
epidural JJ O
morphine NN O
does VBZ O
not RB O
modify VB O
the DT O
intraoperative JJ O
metabolic JJ O
and CC O
hormonal JJ O
responses NNS O
. . O

-DOCSTART- X X O

Omitting VBG O
part NN O
of IN O
the DT O
experimental JJ O
NOE-derived JJ O
distances NNS O
results NNS O
in IN O
reduced JJ O
restraint NN O
violations NNS O
and CC O
lower JJR O
R NN O
factors NNS O
but CC O
impairs NNS O
structural JJ O
convergence NN O
in IN O
the DT O
rMD NNP O
refinement NN O
. . O

-DOCSTART- X X O

Cell NNP O
cycle NN O
regulatory JJ O
components NNS O
have VBP O
been VBN O
largely RB O
conserved VBN O
in IN O
eukaryotes NNS O
; : O
however RB O
, , O
orthologs NNS O
of IN O
neither DT O
CAK1 NNP B-NP
nor CC O
csk1 MD B-NP
have VB O
been VBN O
identified VBN O
in IN O
other JJ O
species NNS O
to TO O
date NN O
. . O

-DOCSTART- X X O

Within IN O
any DT O
cell NN O
line NN O
, , O
several JJ O
Tcfs NNS B-NP
and CC O
TLEs NNS B-NP
are VBP O
co-expressed JJ O
. . O

-DOCSTART- X X O

In IN O
marked JJ O
contrast NN O
to TO O
the DT O
previously RB O
published VBN O
human JJ B-NP
CD6 IN I-NP
sequence NN I-NP
, , O
the DT O
mouse NN O
sequence NN O
predicts VBZ O
a DT O
long JJ O
cytoplasmic JJ O
tail NN O
that WDT O
is VBZ O
not RB O
closely RB O
related VBN O
to TO O
other JJ O
proteins NNS O
and CC O
possesses NNS O
two CD O
proline-rich JJ O
motifs NNS O
containing VBG O
the DT O
SH3-domain JJ B-NP
binding JJ I-NP
consensus NN I-NP
sequence NN I-NP
, , O
three CD O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
phosphorylation NN I-NP
site NN I-NP
motifs NNS I-NP
, , O
nine CD O
casein NNS B-NP
kinase-2 JJ I-NP
phosphorylation NN I-NP
site NN I-NP
motifs NNS I-NP
, , O
and CC O
a DT O
serine-threonine-rich JJ O
motif NN O
repeated VBD O
three CD O
times NNS O
. . O

-DOCSTART- X X O

Divergent NNP O
regions NNS O
of IN O
the DT O
posterior NN O
left VBD O
hemisphere RB O
used VBN O
for IN O
decoding NN O
and CC O
storage NN O
of IN O
information NN O
emerged VBD O
in IN O
each DT O
working VBG O
memory NN O
versus IN O
control NN O
task NN O
comparison NN O
. . O

-DOCSTART- X X O

Among IN O
the DT O
different JJ O
epithelial NN O
cell NN O
lines NNS O
tested VBN O
, , O
only RB O
RTS3b JJ O
cells NNS O
allowed VBN O
an DT O
expression NN O
pattern NN O
similar JJ O
to TO O
that DT O
observed VBD O
in IN O
naturally RB O
infected VBN O
benign JJ O
condylomas NNS O
. . O

-DOCSTART- X X O

Evidence NN O
for IN O
involvement NN O
of IN O
proteins NNS O
HU NNP B-NP
and CC O
RpoS NNP B-NP
in IN O
transcription NN O
of IN O
the DT O
osmoresponsive JJ O
proU NN B-NP
operon NN I-NP
in IN O
Escherichia NNP O
coli NNS O
. . O

-DOCSTART- X X O

Detonation-traumatic JJ O
load NN O
during IN O
military JJ O
service NN O

-DOCSTART- X X O

Deletion NNP O
of IN O
CDC5 NNP B-NP
was VBD O
lethal JJ O
and CC O
resulted VBD O
in IN O
a DT O
dumbbell-shaped JJ O
terminal NN O
morphology NN O
, , O
with IN O
the DT O
nuclei JJ O
almost RB O
divided VBN O
but CC O
still RB O
connected VBN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
pathway NN O
to TO O
Fc NNP B-NP
epsilonRI-mediated JJ I-NP
MEK/ERK NNP B-NP
and CC O
ERK NNP B-NP
activation NN O
can MD O
apparently RB O
bypass VB O
Ras NNP B-NP
and CC O
Raf-1 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
starting VBG O
dose NN O
was VBD O
8 CD O
mg/m2 CD O
administered VBN O
intravenously RB O
( -LRB- O
IV NNP O
) -RRB- O
as IN O
a DT O
short JJ O
infusion NN O
daily RB O
for IN O
5 CD O
days NNS O
, , O
repeated VBD O
every DT O
3 CD O
weeks NNS O
with IN O
dose NN O
adjustments NNS O
depending VBG O
on IN O
patient NN O
tolerance NN O
. . O

-DOCSTART- X X O

The DT O
related VBN O
adhesion NN B-NP
focal JJ I-NP
tyrosine NN I-NP
kinase NN I-NP
is VBZ O
tyrosine-phosphorylated JJ O
after IN O
beta1-integrin JJ B-NP
stimulation NN O
in IN O
B NNP O
cells NNS O
and CC O
binds NNS O
to TO O
p130cas NNS B-NP
. . O

-DOCSTART- X X O

The DT O
cerebellar NN O
cortical JJ O
vessels NNS O
: : O
they PRP O
are VBP O
compared VBN O
to TO O
the DT O
cerebral NN O
vessels NNS O
. . O

-DOCSTART- X X O

We PRP O
present VBP O
the DT O
case NN O
of IN O
a DT O
patient NN O
who WP O
presented VBD O
an DT O
unusually RB O
large JJ O
mucoid JJ O
cyst NN O
measuring VBG O
38 CD O
x NN O
25 CD O
mm CD O
in IN O
an DT O
uncommon JJ O
localization NN O
, , O
the DT O
right JJ O
maxillary NN O
. . O

-DOCSTART- X X O

Twenty CD O
male JJ O
volunteers NNS O
were VBD O
studied VBN O
during IN O
almokalant NN O
infusion NN O
aiming VBG O
at IN O
plasma NN O
concentrations NNS O
( -LRB- O
Cpl NN O
) -RRB- O
of IN O
20 CD O
, , O
50 CD O
, , O
100 CD O
, , O
and CC O
150 CD O
nmol/l NN O
. . O

-DOCSTART- X X O

A DT O
significant JJ O
difference NN O
in IN O
the DT O
distribution NN O
of IN O
antibodies NNS O
to TO O
thyroglobulin VB B-NP
and CC O
thyroid VB B-NP
peroxidase NN I-NP
was VBD O
found VBN O
in IN O
subgroup NN O
2. . O

-DOCSTART- X X O

Protein NNP B-NP
kinase NN I-NP
C NNP I-NP
( -LRB- O
PKC NNP B-NP
) -RRB- O
activation NN O
after IN O
treatment NN O
of IN O
human JJ O
neuroblastoma NN O
SK-N-BE( JJ O
2)C JJ O
cells NNS O
with IN O
phorbol JJ O
12-myristate JJ O
13-acetate JJ O
( -LRB- O
PMA NNP O
) -RRB- O
was VBD O
found VBN O
to TO O
enhance VB O
transcription NN O
of IN O
the DT O
human JJ O
dopamine NN B-NP
beta-hydroxylase NN I-NP
( -LRB- O
DBH) NN B-NP
in IN O
those DT O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
originally RB O
embryonic JJ B-NP
gamma-globin NN I-NP
locus NN I-NP
duplicated VBN O
and CC O
acquired VBN O
a DT O
novel NN O
( -LRB- O
fetal NN O
) -RRB- O
pattern NN O
of IN O
expression NN O
in IN O
a DT O
defined VBN O
time NN O
period NN O
( -LRB- O
55-40 CD O
million CD O
years NNS O
ago IN O
) -RRB- O
during IN O
primate JJ O
phylogeny NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
i-leader JJ B-NP
protein NN I-NP
is VBZ O
a DT O
viral JJ O
gene NN O
product NN O
of IN O
unknown JJ O
function NN O
and CC O
high JJ O
stability NN O
that WDT O
is VBZ O
made VBN O
in IN O
large JJ O
quantities NNS O
at IN O
intermediate JJ O
times NNS O
of IN O
productive JJ O
infection NN O
.(ABSTRACT NN O
TRUNCATED JJ O
AT WDT O
400 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

The DT O
Pi NNP O
signals NNS O
are VBP O
conveyed VBN O
to TO O
PHO8 VB B-NP
by IN O
binding NN O
of IN O
PHO4 NNP B-NP
protein NN I-NP
, , O
a DT O
positive JJ O
regulatory JJ O
factor NN O
, , O
to TO O
a DT O
promoter NN O
region NN O
of IN O
PHO8 DT B-NP
( -LRB- O
PHO8p NN B-NP
) -RRB- O
under IN O
the DT O
influence NN O
of IN O
the DT O
PHO NNP B-NP
regulatory JJ O
circuit NN O
. . O

-DOCSTART- X X O

Mutational JJ O
analysis NN O
of IN O
the DT O
IME2 NNP B-NP
UAS NNP I-NP
reveals VBZ O
two CD O
critical JJ O
sequence NN O
elements NNS O
: : O
a DT O
G+C-rich JJ O
sequence NN O
( -LRB- O
called VBN O
URS1 NNP O
) -RRB- O
, , O
previously RB O
identified VBN O
at IN O
many JJ O
meiotic JJ O
genes NNS O
, , O
and CC O
a DT O
newly RB O
described VBN O
element NN O
, , O
the DT O
T4C NNP O
site NN O
, , O
that IN O
we PRP O
found VBD O
at IN O
a DT O
subset NN O
of IN O
meiotic JJ O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
authors NNS O
recommend VBP O
in IN O
cases NNS O
with IN O
an DT O
elevated JJ O
transaminase NN O
serum NN O
activity NN O
more RBR O
frequent JJ O
check-up NN O
examinations NNS O
to TO O
avoid VB O
missing VBG O
of IN O
a DT O
relapse NN O
, , O
and CC O
to TO O
examine VB O
repeatedly RB O
IgM RB B-NP
anti-HAV JJ B-NP
as IN O
in IN O
protracted JJ O
forms NNS O
of IN O
hepatitis NN O
IgM NNP B-NP
anti-HAV CC B-NP
may MD O
persist VB O
even RB O
when WRB O
the DT O
transaminase NN O
activity NN O
is VBZ O
normal JJ O
. . O

-DOCSTART- X X O

Effects NNS O
were VBD O
studied VBN O
of IN O
extremely RB O
high-frequency JJ O
electromagnetic JJ O
radiation NN O
( -LRB- O
EHF NN O
EMR NN O
) -RRB- O
on IN O
indices NNS O
for IN O
the DT O
immune JJ O
and CC O
endocrine JJ O
systems NNS O
in IN O
a DT O
series NN O
of IN O
48 CD O
patients NNS O
presenting VBG O
with IN O
hyperplastic JJ O
processes NNS O
in IN O
endometrium NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
hyperaemia NN O
on IN O
thallium-201 DT O
redistribution NN O
in IN O
normal JJ O
canine NN O
myocardium NN O
. . O

-DOCSTART- X X O

After IN O
dialysis NN O
online RB O
, , O
lactate NN O
was VBD O
converted VBN O
by IN O
means NNS O
of IN O
lactate NN B-NP
oxidase NN I-NP
immobilized VBD O
to TO O
porous JJ O
glass NN O
, , O
and CC O
the DT O
depletion NN O
of IN O
oxygen NN O
was VBD O
registered VBN O
by IN O
means NNS O
of IN O
a DT O
Clark NNP O
electrode NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
show VBP O
that IN O
both DT O
Sp1 NNP B-NP
and CC O
Sp3 NNP B-NP
transcription NN I-NP
factors NNS I-NP
upregulate JJ O
HGF NNP B-NP
promoter NN I-NP
activity NN O
by IN O
binding NN O
to TO O
the DT O
Sp1 NNP B-NP
binding NN I-NP
site NN I-NP
at IN O
position NN O
-318 . O
to TO O
-303 JJ O
bp NN O
in IN O
the DT O
HGF NNP B-NP
gene NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Hepatitis NNP O
B NNP O
markers NNS O
in IN O
Lancashire NNP O
police NN O
officers NNS O
. . O

-DOCSTART- X X O

Xa4 NNP B-NP
is VBZ O
a DT O
dominantly RB O
inherited VBN O
rice NN O
gene NN O
that WDT O
confers VBZ O
resistance NN O
to TO O
Philippine NNP O
race NN O
1 CD O
of IN O
the DT O
bacterial JJ O
blight NN O
pathogen NN O
Xanthomonas NNP O
oryzae NNP O
pv. VBD O
oryzae NNS O
in IN O
rice NN O
. . O

-DOCSTART- X X O

Screening NN O
of IN O
human JJ O
cDNA NN O
libraries NNS O
has VBZ O
identified VBN O
two CD O
different JJ O
5'-termini NNS O
and CC O
alternatively RB O
spliced JJ O
forms NNS O
of IN O
the DT O
human JJ B-NP
Fli-1 NN I-NP
gene NN I-NP
( -LRB- O
Fli-1b JJ B-NP
) -RRB- O
, , O
suggesting VBG O
the DT O
possible JJ O
existence NN O
of IN O
two CD O
independent JJ O
promoters NNS O
. . O

-DOCSTART- X X O

Consistent NNP O
with IN O
an DT O
effect NN O
on IN O
transcription NN O
, , O
p21 PRP B-NP
was VBD O
localized VBN O
in IN O
nuclei NNS O
of IN O
transfected JJ O
cells NNS O
. . O

-DOCSTART- X X O

When WRB O
yeast NN O
cells NNS O
reach VBP O
a DT O
critical JJ O
size NN O
in IN O
late JJ O
G1 IN O
they PRP O
simultaneously RB O
start VBP O
budding VBG O
, , O
initiate VB O
DNA NNP O
synthesis NN O
, , O
and CC O
activate JJ O
transcription NN O
of IN O
a DT O
set NN O
of IN O
genes NNS O
that WDT O
includes VBZ O
G1 NNP B-NP
cyclins NNS I-NP
CLN1 NN B-NP
, , O
CLN2 NN B-NP
, , O
and CC O
many JJ O
DNA NNP O
synthesis NN O
genes NNS O
. . O

-DOCSTART- X X O

After IN O
a DT O
1-h JJ O
rest NN O
( -LRB- O
for IN O
T2 DT O
return NN O
to TO O
baseline NN O
) -RRB- O
, , O
subjects VBZ O
repeated VBN O
the DT O
5-min JJ O
protocol NN O
, , O
followed VBN O
by IN O
a DT O
final JJ O
MRI/MRS. . O

-DOCSTART- X X O

Use NNP O
of IN O
ELISAs NNP O
for IN O
the DT O
diagnosis NN O
of IN O
canine CD O
atopy NN O
. . O

-DOCSTART- X X O

A DT O
single JJ O
dose NN O
of IN O
Cef NNP O
was VBD O
administered VBN O
intravenously RB O
to TO O
11 CD O
patients NNS O
with IN O
autoimmune JJ O
diseases NNS O
and CC O
varying VBG O
degrees NNS O
of IN O
renal NN O
impairment NN O
( -LRB- O
Group NNP O
I PRP O
CLCR VBP O
less JJR O
than IN O
50 CD O
ml/min NN O
, , O
Group NNP O
II NNP O
CLCR NN O
greater JJR O
than IN O
50 CD O
ml/min NN O
) -RRB- O
. . O

-DOCSTART- X X O

Postheparin NNP O
lipoprotein NN B-NP
lipase NN I-NP
, , O
measured VBN O
using VBG O
fat JJ O
emulsion NN O
as IN O
substrate NN O
, , O
also RB O
was VBD O
significantly RB O
greater JJR O
in IN O
female JJ O
rats NNS O
compared VBN O
with IN O
males NNS O
. . O

-DOCSTART- X X O

The DT O
results NNS O
obtained VBN O
demonstrate VBP O
the DT O
applicability NN O
of IN O
countercurrent NN O
chromatography NN O
to TO O
the DT O
determination NN O
of IN O
ultratrace JJ O
elements NNS O
. . O

-DOCSTART- X X O

Clinical NNP O
evidence NN O
provides VBZ O
tentative JJ O
suggestions NNS O
on IN O
( -LRB- O
a DT O
) -RRB- O
possible JJ O
additional JJ O
risk NN O
of IN O
cigarette NN O
smoking NN O
( -LRB- O
b NN O
) -RRB- O
avoidance NN O
of IN O
venography NN O
( -LRB- O
c NN O
) -RRB- O
avoidance NN O
of IN O
varicose NN O
vein NN O
surgery NN O
. . O

-DOCSTART- X X O

However RB O
, , O
using VBG O
wet JJ O
weight/dry NN O
weight NN O
methodology NN O
, , O
we PRP O
found VBD O
that DT O
administration NN O
of IN O
U74006F NNP O
significantly RB O
reduced VBD O
water NN O
content NN O
in IN O
the DT O
right JJ O
hippocampus NN O
( -LRB- O
contralateral NN O
to TO O
the DT O
site NN O
of IN O
injury NN O
) -RRB- O
compared VBN O
to TO O
saline-treated JJ O
animals NNS O
( -LRB- O
p NN O
less JJR O
than IN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
authors NNS O
suggest VBP O
that IN O
alprazolam NN O
may MD O
have VB O
enhanced VBN O
specificity NN O
for IN O
a DT O
subpopulation NN O
of IN O
benzodiazepine NN B-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

Transcription NNP O
start VB O
sites NNS O
of IN O
sal NN B-NP
and CC O
salR NN B-NP
genes NNS I-NP
were VBD O
determined VBN O
to TO O
lie VB O
30 CD O
- : O
and CC O
24-bp JJ O
upstream RB O
of IN O
the DT O
respective JJ O
initiation NN O
codons NNS O
and CC O
separated VBN O
from IN O
each DT O
other JJ O
by IN O
78 CD O
nucleotides NNS O
. . O

-DOCSTART- X X O

Henry NNP O
Quastler NNP O
brought VBD O
experience NN O
from IN O
an DT O
actual JJ O
x-ray NN O
treatment NN O
, , O
and CC O
Dr. NNP O

-DOCSTART- X X O

( -LRB- O
4 CD O
) -RRB- O
Expression NN O
in IN O
different JJ O
sites NNS O
in IN O
the DT O
central JJ O
nervous JJ O
system NN O
is VBZ O
driven VBN O
by IN O
separable JJ O
elements NNS O
widely RB O
dispersed VBN O
throughout IN O
8 CD O
kb NN O
3' CD O
of IN O
the DT O
gene NN O
. . O

-DOCSTART- X X O

The DT O
virus NN O
must MD O
progress VB O
past IN O
the DT O
immediate-early JJ O
phase NN O
and CC O
express VB O
an DT O
early JJ B-NP
gene NN I-NP
product( NN I-NP
s VBZ I-NP
) -RRB- I-NP
for IN O
activation NN O
of IN O
cyclin NN B-NP
E NNP I-NP
expression NN O
. . O

-DOCSTART- X X O

The DT O
software NN O
is VBZ O
in IN O
BASIC NNP O
adapted VBD O
for IN O
the DT O
Hewlett-Packard NNP O
calculators NNS O
HP-9845B : O
and CC O
HP-85A. PRP$ O

-DOCSTART- X X O

Genealogical JJ O
analysis NN O
suggested VBN O
mainly RB O
a DT O
mother-to-offspring NN O
transmission NN O
of IN O
this DT O
STLV-1 NN O
. . O

-DOCSTART- X X O

Patients NNS O
commonly RB O
considered VBN O
the DT O
external JJ O
frame NN O
cumbersome JJ O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
tail NN O
deviated VBN O
ipsilaterally RB O
in IN O
cats NNS O
with IN O
a DT O
hemisection NN O
, , O
and CC O
the DT O
tail NN O
was VBD O
ventroflexed VBN O
in IN O
cats NNS O
with IN O
a DT O
transection NN O
. . O

-DOCSTART- X X O

Peak NNP O
plasma NN O
ACTH NNP B-NP
responses NNS O
were VBD O
not RB O
significantly RB O
different JJ O
between IN O
control NN O
and CC O
patient NN O
groups NNS O
. . O

-DOCSTART- X X O

We PRP O
demonstrate VBP O
inhibition IN O
of IN O
2-deoxyglucose JJ O
uptake NN O
in IN O
isolated JJ O
primary JJ O
rat NN O
adipocytes NNS O
and CC O
3T3-L1 JJ O
adipocytes NNS O
pretreated VBN O
with IN O
U73122 NNP O
. . O

-DOCSTART- X X O

In IN O
this DT O
report NN O
we PRP O
describe VBP O
the DT O
structure NN O
and CC O
DNA NNP O
sequence NN O
of IN O
transcriptional JJ O
control NN O
regions NNS O
from IN O
both DT O
human JJ B-NP
and CC I-NP
Wistar-rat NNP I-NP
single JJ I-NP
copy NN I-NP
EGF NNP I-NP
genes NNS I-NP
and CC O
their PRP$ O
functional JJ O
analysis NN O
in IN O
epithelial NN O
cell NN O
cultures NNS O
. . O

-DOCSTART- X X O

Along IN O
with IN O
these DT O
species NNS O
, , O
F. NNP O
graminearum NN O
group NN O
2 CD O
( -LRB- O
ZON NNP O
, , O
DON NNP O
and/or CC O
3AcDON NNP O
or CC O
15AcDON NNP O
) -RRB- O
; : O
F. NNP O
chlamydosporum NN O
; : O
F. NNP O
acuminatum NN O
(type-A NNP O
trichothecene NN O
derivatives NNS O
) -RRB- O
; : O
and CC O
F. NNP O
semitectum NN O
were VBD O
often RB O
found VBN O
to TO O
be VB O
associated VBN O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
observed VBN O
that IN O
muscle NN O
infarction NN O
in IN O
the DT O
IPC NN O
( -LRB- O
24 CD O
+/ NN O
- : O
2 CD O
% NN O
) -RRB- O
and CC O
preischemic JJ O
LMK NN O
( -LRB- O
21 CD O
+/ NN O
- : O
2 CD O
% NN O
) -RRB- O
groups NNS O
were VBD O
smaller JJR O
( -LRB- O
P NNP O
< NN O
0.05 CD O
) -RRB- O
than IN O
that IN O
in IN O
the DT O
control NN O
( -LRB- O
42 CD O
+/ NN O
- : O
2 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
characteristic JJ O
feature NN O
is VBZ O
their PRP$ O
tendency NN O
to TO O
form VB O
homo- NNS O
and/or CC O
heterodimeric JJ O
complexes NNS O
. . O

-DOCSTART- X X O

Copyright NNP O
1999 CD O
Academic NNP O
Press NNP O
. . O

-DOCSTART- X X O

Methodological NNP O
considerations NNS O
limiting VBG O
causal JJ O
assertions NNS O
permissible JJ O
with IN O
nonexperimental JJ O
data NNS O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

Skytthe NNP O
, , O
and CC O
K. NNP O

-DOCSTART- X X O

S-phase-promoting JJ O
cyclin-dependent NN B-NP
kinases NNS I-NP
( -LRB- O
Cdks NNS B-NP
) -RRB- O
and CC O
the DT O
kinase NN O
Dbf4-Cdc7 CC B-NP
then RB O
act VB O
to TO O
initiate VB O
replication NN O
. . O

-DOCSTART- X X O

The DT O
cleft JJ O
walls NNS O
are VBP O
lined VBN O
with IN O
highly RB O
conserved VBN O
residues NNS O
and CC O
NADP NNP O
is VBZ O
bound VBN O
along IN O
one CD O
wall NN O
. . O

-DOCSTART- X X O

Non-specific JJ O
immunological JJ O
abnormalities NNS O
were VBD O
detected VBN O
in IN O
8 CD O
of IN O
the DT O
13 CD O
patients NNS O
in IN O
whom WP O
they PRP O
were VBD O
looked VBN O
for IN O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
To TO O
assess VB O
laboratory NN O
practice NN O
in IN O
the DT O
examination NN O
of IN O
blood NN O
films NNS O
for IN O
malarial JJ O
parasites NNS O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
GRF1 NNP B-NP
and CC O
GRF2 NNP B-NP
can MD O
form VB O
homo- NNS O
and CC O
hetero-oligomers NNS O
via IN O
their PRP$ O
DH NNP B-NP
domains NNS I-NP
, , O
that IN O
mutational JJ O
inactivation NN O
of IN O
oligomer NN O
formation NN O
by IN O
GRF1 NNP B-NP
is VBZ O
associated VBN O
with IN O
impaired JJ O
biological JJ O
and CC O
signaling VBG O
activities NNS O
, , O
and CC O
that IN O
in IN O
293T JJ O
cells NNS O
GRF1 IN B-NP
mediates NNS O
at IN O
least JJS O
two CD O
pathways NNS O
for IN O
Raf NNP B-NP
activation NN O
: : O
one CD O
a DT O
constitutive JJ O
signal NN O
that WDT O
is VBZ O
mainly RB O
Ras-dependent NNP B-NP
, , O
and CC O
one CD O
an DT O
ionomycin-induced JJ O
signal NN O
that IN O
cooperates NNS O
with IN O
the DT O
constitutive JJ O
signal NN O
without IN O
further JJ O
augmenting VBG O
the DT O
level NN O
of IN O
GTP-Ras NNP B-NP
. . O

-DOCSTART- X X O

These DT O
results NNS O
extend VBP O
our PRP$ O
knowledge NN O
of IN O
this DT O
SNF2-like JJ B-NP
family NN I-NP
member NN I-NP
and CC O
suggest VB O
a DT O
role NN O
for IN O
PASG NNP B-NP
in IN O
leukemogenesis NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
absence NN O
of IN O
c-fos JJ B-NP
gene NN I-NP
expression NN O
, , O
c-Fos JJ B-NP
protein NN I-NP
appears VBZ O
to TO O
be VB O
replaced VBN O
by IN O
proteins NNS O
of IN O
Fos NNP B-NP
family NN I-NP
( -LRB- O
Fra-1 NNP B-NP
) -RRB- O
and CC O
ATF NNP B-NP
family NN I-NP
( -LRB- O
ATF-2 NNP B-NP
and CC O
ATFa NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

To TO O
elucidate VB O
the DT O
molecular JJ O
mechanism NN O
by IN O
which WDT O
the DT O
Ras NNP B-NP
signaling VBG O
pathway NN O
activates NNS O
a DT O
cell-type-specific JJ O
gene NN O
, , O
we PRP O
have VBP O
used VBN O
the DT O
pituitary-specific JJ B-NP
rat NN I-NP
prolactin NN I-NP
(rPRL NN O
) -RRB- O
promoter NN O
as IN O
a DT O
target NN O
of IN O
oncogenic JJ B-NP
Ras NNP I-NP
and CC O
Raf NNP B-NP
in IN O
GH4 DT O
rat NN O
pituitary JJ O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
results NNS O
indicate VBP O
that IN O
expression NN O
of IN O
proU NN B-NP
in IN O
E. NNP O
coli NNS O
is VBZ O
directed VBN O
from IN O
two CD O
promoters NNS O
, , O
one CD O
( -LRB- O
P2 NN O
) -RRB- O
characterized VBN O
earlier RB O
by IN O
other JJ O
workers NNS O
with IN O
the DT O
start NN O
site NN O
of IN O
transcription NN O
60 CD O
nucleotides NNS O
upstream RB O
of IN O
the DT O
initiation NN O
codon NN O
of IN O
the DT O
first JJ O
structural JJ O
gene NN O
( -LRB- O
proV NN B-NP
) -RRB- O
, , O
and CC O
the DT O
other JJ O
( -LRB- O
P1 NN O
) -RRB- O
situated VBN O
250 CD O
nucleotides NNS O
upstream RB O
of IN O
proV NN B-NP
. . O

-DOCSTART- X X O

Coexpression NNP O
of IN O
CREB-binding JJ B-NP
protein NN I-NP
( -LRB- O
CBP)/p300 NN B-NP
with IN O
TReP-132 NNP B-NP
has VBZ O
an DT O
additive JJ O
effect NN O
on IN O
promoter NN O
activity NN O
, , O
and CC O
the DT O
proteins NNS O
were VBD O
demonstrated VBN O
to TO O
interact VB O
physically RB O
. . O

-DOCSTART- X X O

Thirty CD O
minutes NNS O
after IN O
reperfusion NN O
, , O
lung NN O
lymph NN O
flow NN O
( -LRB- O
QL NN O
) -RRB- O
increased VBN O
from IN O
4.3 CD O
to TO O
8.3 CD O
ml/30 CD O
minutes NNS O
( -LRB- O
p NN O
less JJR O
than IN O
0.05 CD O
) -RRB- O
, , O
lymph/plasma JJR O
protein NN O
ratio NN O
was VBD O
unchanged JJ O
from IN O
0.6 CD O
, , O
and CC O
the DT O
lymph JJ O
protein NN O
clearance NN O
increased VBD O
from IN O
2.6 CD O
to TO O
4.6 CD O
ml/30 CD O
minutes NNS O
( -LRB- O
p NN O
less JJR O
than IN O
0.05 CD O
) -RRB- O
, , O
data NNS O
consistent JJ O
with IN O
increased VBN O
microvascular JJ O
permeability NN O
. . O

-DOCSTART- X X O

The DT O
shift NN O
from IN O
complex JJ O
I PRP O
to TO O
complex JJ O
II NNP O
seen VBN O
only RB O
in IN O
SCM-1-producer NNP B-NP
T NNP O
cell NN O
lines NNS O
upon IN O
activation NN O
was VBD O
completely RB O
suppressed VBN O
by IN O
cyclosporin NN O
A. NN O

-DOCSTART- X X O

Database NNP O
searches NNS O
revealed VBD O
a DT O
50-63 CD O
% NN O
similarity NN O
and CC O
34-42 CD O
% NN O
identity NN O
with IN O
several JJ O
families NNS O
of IN O
serine NN B-NP
proteases NNS I-NP
, , O
in IN O
particular JJ O
the DT O
trypsin-like JJ B-NP
proteases NNS I-NP
, , O
members NNS O
of IN O
the DT O
glandular JJ B-NP
kallikrein NN I-NP
family NN I-NP
( -LRB- O
including VBG O
prostate-specific JJ B-NP
antigen NN I-NP
, , O
nerve NN B-NP
growth NN I-NP
factor NN I-NP
gamma NN I-NP
, , O
and CC O
epidermal JJ B-NP
growth NN I-NP
factor-binding JJ I-NP
protein NN I-NP
) -RRB- O
and CC O
the DT O
activators NNS O
for IN O
the DT O
kringle JJ B-NP
family NN I-NP
proteins NNS I-NP
( -LRB- O
including VBG O
the DT O
human JJ B-NP
tissue NN I-NP
plasminogen NN I-NP
activator NN I-NP
and CC O
human JJ B-NP
hepatocyte NN I-NP
growth NN I-NP
factor NN I-NP
activator NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

No DT O
bafilomycin-sensitive JJ O
ATPase NNP B-NP
is VBZ O
detected VBN O
in IN O
a DT O
vacuolar JJ O
fraction NN O
. . O

-DOCSTART- X X O

The DT O
kinase NN O
domains VBZ O
encoded VBN O
in IN O
the DT O
COOH-terminal JJ O
moiety NN O
are VBP O
94 CD O
% NN O
conserved VBN O
; : O
the DT O
NH2-terminal JJ O
moieties NNS O
are VBP O
approximately RB O
65 CD O
% NN O
homologous RB O
, , O
suggesting VBG O
this DT O
region NN O
may MD O
encode VB O
sequences NNS O
conferring VBG O
differential JJ O
regulation NN O
of IN O
the DT O
two CD O
kinases NNS O
. . O

-DOCSTART- X X O

From IN O
this DT O
asymmetry NN O
, , O
we PRP O
suggested VBD O
previously RB O
that IN O
GCN4 NNP B-NP
interacts VBZ O
with IN O
nonequivalent NN O
and CC O
possibly RB O
overlapping VBG O
half-sites NNS O
( -LRB- O
ATGAC NNP O
and CC O
ATGAG NNP O
) -RRB- O
that WDT O
have VBP O
different JJ O
affinities NNS O
. . O

-DOCSTART- X X O

The DT O
essential JJ O
questions NNS O
about IN O
hepatitis NNP O
C NNP O

-DOCSTART- X X O

DRAP27 NN B-NP
is VBZ O
recognized VBN O
by IN O
CD9 DT B-NP
antibodies NNS I-NP
. . O

-DOCSTART- X X O

YACs NNS O
selected VBN O
from IN O
our PRP$ O
contig NN O
will MD O
be VB O
the DT O
starting VBG O
point NN O
for IN O
the DT O
cloning NN O
of IN O
the DT O
LGMD2B NNP B-NP
gene NN I-NP
and CC O
thereby RB O
establish VB O
the DT O
biological JJ O
basis NN O
for IN O
this DT O
form NN O
of IN O
muscular JJ O
dystrophy NN O
and CC O
its PRP$ O
relationship NN O
with IN O
the DT O
other JJ O
limb-girdle NN O
muscular JJ O
dystrophies NNS O
. . O

-DOCSTART- X X O

Starches NNS O
had VBD O
no DT O
effect NN O
. . O

-DOCSTART- X X O

The DT O
tensile JJ O
strengths NNS O
of IN O
an DT O
adhesive JJ O
luting NN O
resin NN O
' POS O
Panavia NNP O
EX' NNP O
to TO O
the DT O
bovine NN O
dentin NN O
decreased VBD O
significantly RB O
by IN O
the DT O
zinc NN O
iontophoresis NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
renal JJ O
sympathetic JJ O
activity NN O
was VBD O
measured VBN O
in IN O
a DT O
separate JJ O
group NN O
of IN O
rats NNS O
. . O

-DOCSTART- X X O

In IN O
humans NNS O
, , O
there EX O
was VBD O
a DT O
statistically RB O
significant JJ O
decrease NN O
of IN O
TEWL NNP O
on IN O
both DT O
forearm NN O
and CC O
thigh NN O
in IN O
CS-treated JJ O
patients NNS O
compared VBN O
to TO O
non-CS-treated JJ O
patients NNS O
and CC O
controls NNS O
( -LRB- O
p NN O
less JJR O
than IN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Southern JJ O
hybridization NN O
of IN O
genomic JJ O
DNA NN O
from IN O
WT NNP O
and CC O
Lp/Lp NNP B-NP
embryos VBD O
failed VBN O
to TO O
identify VB O
specific JJ O
rearrangements NNS O
at IN O
or CC O
near IN O
the DT O
Nhlh1 NNP B-NP
locus NN I-NP
, , O
and CC O
Northern NNP O
RNA NNP O
blotting VBG O
and CC O
RT-PCR NNP O
evaluation NN O
of IN O
Nhlh1 NN B-NP
mRNA NNS I-NP
expression NN O
indicated VBD O
that IN O
both DT O
the DT O
levels NNS O
and CC O
types NNS O
of IN O
Nhlh1 NNP B-NP
mRNAs NNS I-NP
produced VBD O
in IN O
WT NNP O
and CC O
Lp/Lp NNP B-NP
embryos NNS O
were VBD O
indistinguishable JJ O
. . O

-DOCSTART- X X O

Mutations NNS O
of IN O
the DT O
human JJ B-NP
PTEN NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

MGF NNP B-NP
is VBZ O
a DT O
novel JJ O
member NN O
of IN O
the DT O
cytokine-regulated JJ B-NP
transcription NN I-NP
factor NN I-NP
gene NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

One CD O
month NN O
after IN O
administration NN O
of IN O
131I CD O
, , O
the DT O
29 CD O
cats NNS O
evaluated VBN O
were VBD O
clinically RB O
improved VBN O
, , O
and CC O
24 CD O
(83 CD O
% NN O
) -RRB- O
of IN O
the DT O
29 CD O
cats NNS O
evaluated VBN O
had VBD O
normal JJ O
serum NN O
T4 IN O
concentrations NNS O
, , O
3 CD O
cats NNS O
( -LRB- O
10 CD O
% NN O
) -RRB- O
remained VBD O
hyperthyroxinemic JJ O
, , O
and CC O
2 CD O
cats NNS O
( -LRB- O
7 CD O
% NN O
) -RRB- O
were VBD O
hypothyroxinemic JJ O
. . O

-DOCSTART- X X O

Csk NN B-NP
(C-terminal JJ O
Src JJ B-NP
kinase NN I-NP
) -RRB- O
is VBZ O
a DT O
protein NN B-NP
tyrosine NN I-NP
kinase NN I-NP
that WDT O
phosphorylates VBZ O
Src NNP B-NP
family NN I-NP
member NN I-NP
C-terminal JJ I-NP
tails NNS I-NP
, , O
resulting VBG O
in IN O
downregulation NN O
of IN O
Src NNP B-NP
family NN O
members NNS O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
of IN O
enoyl-ACP JJ B-NP
reductase NN I-NP
mRNA NN I-NP
steady-state NN O
levels NNS O
during IN O
seed NN O
development NN O
suggests VBZ O
that IN O
the DT O
increase NN O
in IN O
enzyme JJ O
activity NN O
during IN O
the DT O
phase NN O
of IN O
storage NN O
lipid JJ O
accumulation NN O
is VBZ O
regulated VBN O
at IN O
the DT O
level NN O
of IN O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

Lung NNP O
transplantation NN O
is VBZ O
warranted VBN O
for IN O
stable JJ O
, , O
ventilator-dependent JJ O
recipients NNS O
. . O

-DOCSTART- X X O

A DT O
new JJ O
myocyte-specific JJ B-NP
enhancer-binding JJ I-NP
factor NN I-NP
that WDT O
recognizes VBZ O
a DT O
conserved JJ O
element NN O
associated VBN O
with IN O
multiple JJ O
muscle-specific JJ O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
magnesium NN O
content NN O
in IN O
leukocytes NNS O
could MD O
not RB O
be VB O
estimated VBN O
because IN O
of IN O
interaction NN O
between IN O
the DT O
ion NN O
and CC O
the DT O
Percoll NN O
( -LRB- O
R NN O
) -RRB- O
media NNS O
. . O

-DOCSTART- X X O

The DT O
need NN O
for IN O
such JJ O
guidelines NNS O
is VBZ O
clear JJ O
on IN O
both DT O
clinical JJ O
and CC O
scientific JJ O
grounds NNS O
. . O

-DOCSTART- X X O

This DT O
activity NN O
creates VBZ O
a DT O
4-bp JJ O
staggered JJ O
cut NN O
with IN O
3' JJ O
OH NNP O
overhangs NNS O
within IN O
a DT O
specific JJ O
sequence NN O
of IN O
the DT O
21S NNP B-NP
rRNA NNP I-NP
gene NN I-NP
of IN O
omega JJ O
- : O
strains NNS O
. . O

-DOCSTART- X X O

Herewith IN O
C. NNP O
psittaci NNS O
could MD O
be VB O
diagnosed VBN O
in IN O
all DT O
positive JJ O
samples NNS O
. . O

-DOCSTART- X X O

Chem NNP O
. . O

-DOCSTART- X X O

Is VBZ O
it PRP O
time NN O
for IN O
a DT O
wine NN O
trial NN O
? . O

-DOCSTART- X X O

Three CD O
patients NNS O
treated VBD O
with IN O
amphotericin RB O
B NNP O
, , O
single JJ O
course NN O
as RB O
well RB O
as IN O
multiple JJ O
courses NNS O
, , O
and CC O
other JJ O
antifungal JJ O
agents NNS O
( -LRB- O
hydroxystilbamidine JJ O
and CC O
miconazole JJ O
) -RRB- O
have VBP O
all DT O
relapsed VBN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
to TO O
Torpedo NNP O
, , O
where WRB O
only RB O
a DT O
single JJ O
transcript NN O
is VBZ O
seen VBN O
, , O
the DT O
mouse NN O
expresses VBZ O
several JJ O
mRNAs NNS O
encoding VBG O
different JJ O
isoforms NNS O
. . O

-DOCSTART- X X O

Latex JJ O
products NNS O
( -LRB- O
gloves NNS O
, , O
balloons NNS O
, , O
and CC O
condoms NNS O
) -RRB- O
directly RB O
bound JJ O
IgE NN B-NP
from IN O
all DT O
four CD O
patients NNS O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
infantile JJ O
undernutrition NN O
on IN O
adult NN O
sucrose NN O
solution NN O
consumption NN O
in IN O
the DT O
rat NN O
. . O

-DOCSTART- X X O

The DT O
transcriptional JJ O
activity NN O
of IN O
P-450( JJ B-NP
11 CD I-NP
beta NN I-NP
) -RRB- I-NP
gene NN I-NP
was VBD O
studied VBN O
with IN O
an DT O
in IN O
vitro NN O
transcription NN O
system NN O
using VBG O
nuclear JJ O
extracts NNS O
prepared VBN O
from IN O
bovine JJ O
adrenal JJ O
cortex NN O
. . O

-DOCSTART- X X O

Appl NNP O
. . O

-DOCSTART- X X O

These DT O
include VBP O
urinalysis NNP O
, , O
chest NN O
X-P NNP O
, , O
ECG NNP O
, , O
hematological JJ O
examinations NNS O
( -LRB- O
RBC NNP O
, , O
WBC NNP O
, , O
Ht NNP O
, , O
Hb NNP B-NP
, , O
PLT NNP O
and CC O
ESR NNP O
) -RRB- O
and CC O
biochemical JJ O
tests NNS O
( -LRB- O
AST NN B-NP
, , O
ALT NNP B-NP
, , O
ALP NNP B-NP
, , O
gamma NN B-NP
GTP NNP I-NP
, , O
LDH NNP B-NP
, , O
CPK NNP B-NP
, , O
Chol NNP O
, , O
T-Bil NNP O
, , O
TP NNP O
, , O
Alb NNP B-NP
, , O
TG NNP O
, , O
BUN NNP O
, , O
Cr NNP O
, , O
Glu NNP O
, , O
Na NNP O
, , O
K NNP O
, , O
Ca MD O
, , O
P NNP O
and CC O
CRP NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
challenge VBP O
each DT O
of IN O
55 CD O
consecutive JJ O
ragweed NN O
( -LRB- O
RW)-allergic JJ O
patients NNS O
with IN O
hay NN O
fever NN O
and CC O
with IN O
graded JJ O
increasing VBG O
doses NNS O
of IN O
ragweed NN O
extract VB O
to TO O
investigate VB O
the DT O
frequency NN O
and CC O
relationship NN O
between IN O
the DT O
early JJ O
( -LRB- O
ER NN O
) -RRB- O
, , O
late JJ O
( -LRB- O
LPR NN O
) -RRB- O
, , O
and CC O
rechallenge JJ O
reactions NNS O
(RCRs NNS O
) -RRB- O
to TO O
nasal JJ O
challenge NN O
. . O

-DOCSTART- X X O

The DT O
5' JJ O
ends NNS O
of IN O
the DT O
P NNP B-NP
and CC O
O NNP B-NP
gene NN I-NP
mRNAs NNS I-NP
are VBP O
separated VBN O
by IN O
109 CD O
nucleotide JJ O
pairs NNS O
in IN O
the DT O
DNA NNP O
template NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
thus RB O
cloned VBN O
two CD O
yeast NN O
homologs NNS O
of IN O
mammalian JJ B-NP
p220 NN I-NP
. . O

-DOCSTART- X X O

A DT O
phase NN O
II NNP O
clinical JJ O
trial NN O
on IN O
MDS NNP O
was VBD O
conducted VBN O
in IN O
a DT O
cooperative JJ O
study NN O
with IN O
orally RB O
administrable JJ O
ara-C NN O
analogue NN O
, , O
PLAC NNP O
, , O
which WDT O
is VBZ O
resistant JJ O
to TO O
cytidine VB B-NP
deaminase NN I-NP
and CC O
had VBD O
shown VBN O
an DT O
anti-tumor JJ O
activity NN O
on IN O
various JJ O
experimental JJ O
tumors NNS O
by IN O
oral JJ O
route NN O
. . O

-DOCSTART- X X O

The DT O
arrangement NN O
of IN O
amino DT O
acids NNS O
in IN O
the DT O
helix NN O
1 CD O
and CC O
helix NN O
2 CD O
regions NNS O
is VBZ O
quite RB O
similar JJ O
to TO O
those DT O
of IN O
Mxi NNP B-NP
and CC O
Mad NNP B-NP
, , O
but CC O
different JJ O
from IN O
those DT O
of IN O
E2F-1 JJ B-NP
and CC O
DP-1 JJ B-NP
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
mutants NNS O
are VBP O
deficient JJ O
in IN O
production NN O
of IN O
the DT O
O-antigen JJ B-NP
polymerase NN I-NP
and CC O
were VBD O
termed VBN O
rfc JJ B-NP
mutants NNS I-NP
. . O

-DOCSTART- X X O

The DT O
program NN O
for IN O
myogenic JJ O
differentiation NN O
is VBZ O
subject JJ O
to TO O
negative JJ O
control NN O
by IN O
several JJ O
peptide NN O
growth NN O
factors NNS O
and CC O
by IN O
the DT O
products NNS O
of IN O
mutationally RB O
activated VBN O
ras NNS B-NP
oncogenes NNS I-NP
, , O
which WDT O
persistently RB O
activate VBP O
intracellular JJ O
cascades NNS O
normally RB O
triggered VBN O
by IN O
specific JJ O
growth NN O
factors NNS O
. . O

-DOCSTART- X X O

The DT O
p58 NN B-NP
( -LRB- O
PITSLRE NNP B-NP
beta NN I-NP
1 CD I-NP
) -RRB- O
protein NN O
kinase NN O
( -LRB- O
PK) NNP O
is VBZ O
a DT O
member NN O
of IN O
a DT O
large JJ O
supergene NN O
family NN O
related VBN O
to TO O
the DT O
master NN B-NP
mitotic JJ I-NP
protein NN I-NP
kinase NN I-NP
, , O
p34cdc2 NN B-NP
. . O

-DOCSTART- X X O

By IN O
a DT O
combination NN O
of IN O
alternative JJ O
promoter NN O
usage NN O
and CC O
exon JJ O
splicing NN O
, , O
each DT O
ROR NNP B-NP
gene NN I-NP
generates VBZ O
several JJ O
isoforms NNS O
that WDT O
differ VBP O
only RB O
in IN O
their PRP$ O
amino JJ O
terminus NN O
. . O

-DOCSTART- X X O

Despite IN O
this DT O
loss NN O
, , O
YEpFAS1 NNP B-NP
is VBZ O
still RB O
able JJ O
to TO O
complement VB O
a DT O
fas1 NN B-NP
mutation NN O
at IN O
the DT O
enoyl NN B-NP
reductase NN I-NP
domain NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
a DT O
site NN O
of IN O
PDGF-induced JJ B-NP
tyrosine NN O
phosphorylation NN O
was VBD O
mapped VBN O
to TO O
Tyr NNP O
138 CD O
in IN O
the DT O
SH3 NNP B-NP
domain NN I-NP
; : O
Tyr NNP O
138 CD O
is VBZ O
exposed VBN O
on IN O
the DT O
SH3 NNP B-NP
peptide NN I-NP
binding NN I-NP
surface NN I-NP
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
showed VBD O
that IN O
the DT O
5-hydroxytryptamine JJ O
(5-HT) JJ O
content NN O
in IN O
platelets NNS O
was VBD O
: : O
( -LRB- O
1 CD O
) -RRB- O
increased VBN O
in IN O
the DT O
subgroup NN O
of IN O
anti-social JJ O
alcoholics NNS O
; : O
( -LRB- O
2 CD O
) -RRB- O
transiently RB O
and CC O
differently RB O
altered VBN O
in IN O
alcoholics NNS O
compared VBN O
to TO O
opiate VB O
addicts NNS O
; : O
and CC O
( -LRB- O
3 LS O
) -RRB- O
lowered VBN O
in IN O
drinking NN O
alcoholics NNS O
and CC O
normal JJ O
in IN O
alcoholics NNS O
who WP O
were VBD O
drinking VBG O
as RB O
well RB O
as IN O
smoking NN O
( -LRB- O
that WDT O
may MD O
occur VB O
via IN O
MAO-B NNP B-NP
inhibition NN O
by IN O
smoke NN O
) -RRB- O
. . O

-DOCSTART- X X O

Recently RB O
, , O
we PRP O
reported VBD O
that DT O
SMRT NNP B-NP
also RB O
directly RB O
associates NNS O
with IN O
LAZ3(BCL-6 NN B-NP
) -RRB- O
, , O
a DT O
POZ/Zn NNP O
finger NN O
transcriptional JJ O
repressor NN O
involvedin IN O
the DT O
pathogenesis NN O
of IN O
non-Hodgkin JJ O
lymphomas NNS O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
activating VBG B-NP
transcription NN I-NP
factor-1 NN I-NP
and CC O
the DT O
cAMP JJ B-NP
response NN I-NP
element-binding JJ I-NP
protein NN I-NP
by IN O
Ca2+/calmodulin-dependent JJ B-NP
protein NN I-NP
kinases NNS I-NP
type NN I-NP
I PRP I-NP
, , I-NP
II NNP I-NP
, , I-NP
and CC I-NP
IV. NNP I-NP

-DOCSTART- X X O

Accordingly RB O
, , O
constitutive JJ O
downregulation NN O
of IN O
expression NN O
of IN O
accessory JJ O
molecules NNS O
of IN O
the DT O
MHC NNP B-NP
class NN I-NP
I PRP I-NP
pathway NN I-NP
can MD O
reveal VB O
differences NNS O
between IN O
H2 JJ B-NP
class NN I-NP
I PRP I-NP
alleles RB I-NP
in IN O
antigen JJ O
presentation NN O
not RB O
encountered VBN O
when WRB O
the DT O
expression NN O
levels NNS O
are VBP O
augmented VBN O
. . O

-DOCSTART- X X O

Cross-sectional JJ O
studies NNS O
continue VBP O
to TO O
dominate VB O
. . O

-DOCSTART- X X O

The DT O
tau NNS O
v NN O
at IN O
rest NN O
was VBD O
4.06 CD O
+/ CD O
- : O
2.16 CD O
s PRP O
and CC O
decreased VBD O
to TO O
2.44 CD O
+/ CD O
- : O
1.07 CD O
s PRP O
( -LRB- O
P NNP O
< NN O
0.05 CD O
) -RRB- O
at IN O
1 CD O
Hz NN O
and CC O
to TO O
1.81 CD O
+/ NNS O
- : O
0.4 CD O
s PRP O
at IN O
5 CD O
Hz NNP O
. . O

-DOCSTART- X X O

The DT O
cDNA NN O
contains VBZ O
a DT O
reading NN O
frame NN O
for IN O
a DT O
145-amino-acid JJ O
protein NN O
and CC O
it PRP O
lacks VBZ O
the DT O
UGA NNP O
codons NNS O
, , O
which WDT O
have VBP O
been VBN O
found VBN O
in IN O
the DT O
reading NN O
frame NN O
of IN O
the DT O
mouse NN B-NP
MCS NNP I-NP
cDNA NN I-NP
and CC O
have VBP O
been VBN O
presumed VBN O
to TO O
encode VB O
the DT O
selenocysteine NN O
in IN O
the DT O
amino JJ O
terminal NN O
of IN O
the DT O
deduced JJ O
mouse NN O
amino IN O
acid NN O
sequence NN O
. . O

-DOCSTART- X X O

It PRP O
differed VBD O
significantly RB O
by IN O
country NN O
( -LRB- O
from IN O
2.4 CD O
% NN O
in IN O
the DT O
United NNP O
Kingdom NNP O
to TO O
24.7 CD O
% NN O
in IN O
Portugal NNP O
) -RRB- O
and CC O
by IN O
transmission NN O
category NN O
( -LRB- O
2.7 CD O
% NN O
among IN O
homo/bisexuals NNS O
, , O
5.8 CD O
% NN O
among IN O
injecting VBG O
drug NN O
users NNS O
, , O
13.6 CD O
% NN O
among IN O
heterosexual JJ O
subgroup NN O
1 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
results NNS O
showed VBD O
differential JJ O
activation NN O
of IN O
each DT O
parahippocampal JJ O
region NN O
during IN O
verbal JJ O
memory NN O
tasks NNS O
in IN O
which WDT O
the DT O
side NN O
activated VBD O
shifted VBN O
depending VBG O
on IN O
the DT O
nature NN O
of IN O
the DT O
task NN O
employed VBN O
; : O
an DT O
increase NN O
in IN O
rCBF NN O
in IN O
the DT O
left JJ O
parahippocampal NN O
gyrus NN O
was VBD O
associated VBN O
with IN O
retrieval JJ O
strategy NN O
of IN O
non-matching JJ O
, , O
and CC O
an DT O
increase NN O
in IN O
rCBF NN O
in IN O
the DT O
right JJ O
parahippocampal NN O
gyrus NN O
was VBD O
associated VBN O
with IN O
retrieval JJ O
strategy NN O
of IN O
matching VBG O
. . O

-DOCSTART- X X O

Cells NNP O
were VBD O
co-infected JJ O
simultaneously RB O
with IN O
IBV NNP O
, , O
the DT O
recombinant NN O
FPV NN O
( -LRB- O
rFPV NN O
) -RRB- O
containing VBG O
the DT O
D-RNA JJ O
sequence NN O
and CC O
a DT O
second JJ O
rFPV NN O
expressing VBG O
T7 DT B-NP
RNA NNP I-NP
polymerase NN I-NP
for IN O
the DT O
initial JJ O
expression NN O
of IN O
the DT O
D-RNA NNP O
transcript NN O
, , O
subsequently RB O
rescued VBN O
by IN O
helper NN O
IBV. . O

-DOCSTART- X X O

The DT O
more RBR O
sustained JJ O
effect NN O
of IN O
cyclofenil NN O
on IN O
prolactin NN B-NP
secretion NN O
with IN O
a DT O
reduced JJ O
frequency NN O
of IN O
relapse NN O
, , O
and CC O
the DT O
lower JJR O
oestradiol JJ O
level NN O
, , O
which WDT O
might MD O
indicate VB O
a DT O
reduced VBN O
risk NN O
of IN O
thromboembolism NN O
, , O
suggest VBP O
that IN O
this DT O
drug NN O
has VBZ O
some DT O
advantage NN O
over IN O
bromocriptine NN O
in IN O
the DT O
inhibition NN O
of IN O
postpartum NN O
lactation NN O
. . O

-DOCSTART- X X O

Epithelial NNP O
cell-specific JJ O
activation NN O
is VBZ O
achieved VBN O
by IN O
the DT O
cooperative JJ O
interaction NN O
of IN O
apparently RB O
ubiquitous JJ O
transcriptional JJ O
factors NNS O
. . O

-DOCSTART- X X O

This DT O
set NN O
of IN O
genetic JJ O
and CC O
physical JJ O
interactions NNS O
suggests VBZ O
a DT O
role NN O
for IN O
yeast NN O
RNA-binding JJ O
proteins NNS O
in IN O
transcriptional JJ O
regulation NN O
. . O

-DOCSTART- X X O

A DT O
new JJ O
B-cell-specific JJ O
enhancer NN O
element NN O
has VBZ O
been VBN O
identified VBN O
3' IN O
of IN O
E4 NNP B-NP
and CC O
the DT O
octamerlike JJ O
motifs NNS O
in IN O
the DT O
human JJ B-NP
immunoglobulin NN I-NP
heavy-chain JJ I-NP
gene NN I-NP
enhancer NN I-NP
. . O

-DOCSTART- X X O

Electrically RB O
induced VBD O
undulations NNS O
and CC O
their PRP$ O
competition NN O
with IN O
electrically RB O
induced VBN O
convection NN O
in IN O
cholesteric JJ O
liquid JJ O
crystals NNS O
. . O

-DOCSTART- X X O

A DT O
visibly JJ O
distinct JJ O
muscular JJ O
hypertrophy NN O
( -LRB- O
mh NN O
) -RRB- O
, , O
commonly RB O
known VBN O
as IN O
double JJ O
muscling NN O
, , O
occurs VBZ O
with IN O
high JJ O
frequency NN O
in IN O
the DT O
Belgian JJ O
Blue NNP O
and CC O
Piedmontese NNP O
cattle NNS O
breeds NNS O
. . O

-DOCSTART- X X O

The DT O
LS NN B-NP
gene NN I-NP
promoter NN I-NP
sequence NN I-NP
has VBZ O
homology RB O
with IN O
Escherichia NNP O
coli NNS O
promoter NN O
sequences NNS O
; : O
its PRP$ O
terminator NN O
sequence NN O
is VBZ O
capable JJ O
of IN O
forming VBG O
a DT O
stem-and-loop JJ O
structure NN O
. . O

-DOCSTART- X X O

In IN O
pituitary JJ O
GH3 JJ O
cells NNS O
, , O
vitamin NN O
D NNP O
increases VBZ O
the DT O
levels NNS O
of IN O
PRL NNP B-NP
transcripts NNS I-NP
and CC O
stimulates NNS O
the DT O
PRL NNP B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Present NNP O
investigation NN O
was VBD O
undertaken VBN O
to TO O
elucidate VB O
what WP O
pharmacokinetic JJ O
parameters NNS O
in IN O
animal NN O
experiment NN O
could MD O
be VB O
of IN O
more JJR O
predictable JJ O
for IN O
human JJ O
clinical JJ O
trial NN O
of IN O
beta-blocking JJ O
agents NNS O
. . O

-DOCSTART- X X O

Association NNP O
of IN O
Smads NNP B-NP
with IN O
lymphoid JJ B-NP
enhancer NN I-NP
binding NN I-NP
factor NN I-NP
1/T WDT I-NP
cell-specific JJ B-NP
factor NN I-NP
mediates NNS O
cooperative JJ O
signaling VBG O
by IN O
the DT O
transforming VBG B-NP
growth NN I-NP
factor-beta NN I-NP
and CC O
wnt NN B-NP
pathways NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
univariate JJ O
models NNS O
of IN O
either DT O
fixed VBN O
or CC O
time NN O
dependent JJ O
covariates NNS O
, , O
many JJ O
variables NNS O
were VBD O
significantly RB O
associated VBN O
with IN O
risk NN O
of IN O
progression NN O
to TO O
AIDS NNP O
( -LRB- O
T4 DT O
cell NN O
count NN O
, , O
T4/T8 DT O
ratio NN O
, , O
blastogenic JJ O
responses NNS O
to TO O
phytohemagglutinin VB B-NP
, , O
concanavalin VB B-NP
A DT I-NP
, , O
and CC O
pokeweed VBD B-NP
mitogen NN I-NP
, , O
serum NN B-NP
IgA NNP I-NP
, , O
appearance NN O
of IN O
p24 DT B-NP
antigen NN I-NP
, , O
and CC O
the DT O
development NN O
of IN O
oral JJ O
hairy JJ O
leukoplakia NN O
, , O
thrush NN O
, , O
or CC O
herpes NNS O
zoster NN O
) -RRB- O
. . O

-DOCSTART- X X O

But CC O
, , O
when WRB O
mated VBN O
males NNS O
built VBN O
nests NNS O
in IN O
the DT O
absence NN O
of IN O
young JJ O
, , O
T NNP O
levels NNS O
were VBD O
higher JJR O
than IN O
in IN O
all DT O
other JJ O
conditions NNS O
, , O
though IN O
only RB O
for IN O
early JJ O
broods NNS O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
At IN O
short JJ O
dwell VBP O
times NNS O
, , O
uncorrected JJ O
( -LRB- O
whole JJ O
plasma NN O
) -RRB- O
D/P NNP O
and CC O
Cp NNP O
of IN O
urea NN O
values NNS O
were VBD O
higher JJR O
than IN O
the DT O
corrected VBN O
( -LRB- O
plasma NN O
water NN O
) -RRB- O
values NNS O
by IN O
5.7%-5.9 CD O
% NN O
. . O

-DOCSTART- X X O

The DT O
AmyI NNP B-NP
specific JJ O
3'-UTR NN O
is VBZ O
characterized VBN O
by IN O
the DT O
absence NN O
of IN O
IR NNP O
sequences NNS O
and CC O
the DT O
presence NN O
of IN O
a DT O
putative JJ O
'AATAAA JJ O
' '' O
polyadenylation NN O
signal NN O
. . O

-DOCSTART- X X O

The DT O
atf1+ JJ B-NP
gene NN I-NP
of IN I-NP
Schizosaccharomyces NNP I-NP
pombe NN I-NP
encodes VBZ O
a DT O
bZIP NN B-NP
transcription NN I-NP
factor NN I-NP
with IN O
strong JJ O
homology NN O
to TO O
the DT O
mammalian JJ B-NP
factor NN I-NP
ATF-2 NNP I-NP
. . O

-DOCSTART- X X O

Cotransfection NN O
experiments NNS O
revealed VBD O
that IN O
both DT O
hGATA-4 JJ B-NP
and CC O
PMA/A23187 JJ O
stimulation NN O
are VBP O
necessary JJ O
for IN O
the DT O
IL-5 NNP B-NP
promoter NN I-NP
activation NN O
. . O

-DOCSTART- X X O

( -LRB- O
5 CD O
) -RRB- O
. . O

-DOCSTART- X X O

1 CD O
. . O

-DOCSTART- X X O

Mortality NN O
rates NNS O
were VBD O
not RB O
different JJ O
( -LRB- O
chi2 NN O
: : O
0.0298 CD O
, , O
p NN O
> JJ O
0.5 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Cox NNP O
proportional JJ O
hazard NN O
analysis NN O
identified VBN O
dialysis NN O
modality NN O
and CC O
pre-dialysis DT O
UV NN O
of IN O
less JJR O
than IN O
1,000 CD O
ml/m2 CD O
per IN O
24 CD O
h NN O
as IN O
the DT O
only JJ O
significant JJ O
risk NN O
factors NNS O
for IN O
UV NN O
survival NN O
. . O

-DOCSTART- X X O

The DT O
sequence NN O
of IN O
the DT O
25-kDa JJ O
chain NN O
of IN O
the DT O
alpha NN O
subunit NN O
was VBD O
found VBN O
in IN O
a DT O
cDNA NN O
clone NN O
, , O
and CC O
the DT O
amino JJ O
acid NN O
sequence NN O
deduced VBN O
from IN O
the DT O
cDNA NN O
establishes VBZ O
the DT O
complete JJ O
amino NN O
acid NN O
sequence NN O
of IN O
the DT O
25-kDa JJ O
chain NN O
. . O

-DOCSTART- X X O

The DT O
Gastrointestinal NNP O
Tumor NNP O
Study NNP O
Group NNP O
( -LRB- O
GITSG) NNP O
protocol NN O
GI-7175 . O
randomized VBD O
227 CD O
patients NNS O
between IN O
1975 CD O
and CC O
1980 CD O
following VBG O
complete JJ O
surgical JJ O
resection NN O
of IN O
stages NNS O
B2 JJ O
and CC O
C NNP O
rectal JJ O
adenocarcinoma NN O
to TO O
four CD O
treatment NN O
arms NNS O
: : O
( -LRB- O
1 CD O
) -RRB- O
no DT O
adjuvant JJ O
therapy NN O
, , O
( -LRB- O
2 CD O
) -RRB- O
chemotherapy NN O
only RB O
, , O
( -LRB- O
3 CD O
) -RRB- O
radiotherapy NN O
only RB O
, , O
and CC O
( -LRB- O
4 CD O
) -RRB- O
radiotherapy NN O
and CC O
chemotherapy NN O
( -LRB- O
combined JJ O
modality NN O
) -RRB- O
. . O

-DOCSTART- X X O

Cell NNP O
lines NNS O
expressing VBG O
single JJ O
amino JJ O
acid NN O
substitutions NNS O
of IN O
the DT O
carboxyl-terminal JJ O
asparagine NN O
of IN O
CD2 NNP B-NP
are VBP O
incapable JJ O
of IN O
avidity NN O
regulation NN O
by IN O
TCR NNP B-NP
signaling VBG O
, , O
PMA NNP O
treatment NN O
, , O
or CC O
elevation NN O
of IN O
intracellular JJ O
cAMP JJ O
levels NNS O
, , O
demonstrating VBG O
that IN O
each DT O
of IN O
these DT O
stimuli NNS O
utilizes VBZ O
a DT O
common JJ O
structural JJ O
element NN O
for IN O
regulating VBG O
CD2 NNP B-NP
avidity NN O
. . O

-DOCSTART- X X O

Iomazenil-SPECT NNP O
revealed VBD O
a DT O
highly RB O
significant JJ O
increase NN O
in IN O
the DT O
benzodiazepine NN B-NP
receptor NN I-NP
uptake NN O
in IN O
all DT O
studied VBN O
cortical JJ O
regions NNS O
except IN O
temporal JJ O
cortices NNS O
. . O

-DOCSTART- X X O

The DT O
WEB2 NNP B-NP
gene NN I-NP
encodes VBZ O
a DT O
1,522-amino-acid JJ O
protein NN O
with IN O
homology NN O
to TO O
nucleic JJ B-NP
acid-dependent NN I-NP
ATPases NNS I-NP
. . O

-DOCSTART- X X O

Increasing VBG O
the DT O
height NN O
of IN O
the DT O
agar NN O
column NN O
overlying VBG O
the DT O
SN NNP O
fabric NN O
diminished VBN O
the DT O
inhibitory JJ O
effect NN O
of IN O
SN NNP O
on IN O
microbial JJ O
growth NN O
. . O

-DOCSTART- X X O

Biochem NNP O
. . O

-DOCSTART- X X O

When WRB O
expressed VBN O
in IN O
Escherichia NNP O
coli NNS O
, , O
SH-PTP2 JJ B-NP
displays NNS O
tyrosine-specific JJ B-NP
phosphatase NN I-NP
activity NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
hypothesized VBN O
this DT O
occurs VBZ O
through IN O
antagonism NN O
of IN O
PML/RAR NNP B-NP
alpha NN B-NP
actions NNS O
in IN O
these DT O
leukemic JJ O
cells NNS O
. . O

-DOCSTART- X X O

Fli-1 NN B-NP
is VBZ O
a DT O
proto-oncogene NN O
which WDT O
is VBZ O
rearranged VBN O
in IN O
tumors NNS O
induced VBN O
by IN O
three CD O
different JJ O
retroviruses NNS O
, , O
Cas-Br-E NNP O
, , O
F-MuLV NNP O
, , O
and CC O
10A1 CD O
. . O

-DOCSTART- X X O

Routine NNP O
imaging NN O
modalities NNS O
revealed VBD O
a DT O
total NN O
of IN O
79 CD O
metastases NNS O
. . O

-DOCSTART- X X O

Cervical JJ O
CT NNP O
revealed VBD O
an DT O
irregular JJ O
low JJ O
density NN O
at IN O
the DT O
periphery NN O
of IN O
the DT O
cervical JJ O
vertebra NN O
from IN O
the DT O
C2 NNP O
to TO O
C4 VB O
level NN O
. . O

-DOCSTART- X X O

Human JJ B-NP
myotonic JJ I-NP
dystrophy JJ I-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
DMPK) NNP B-NP
is VBZ O
a DT O
member NN O
of IN O
a DT O
novel JJ O
class NN O
of IN O
multidomain JJ O
protein NN O
kinases NNS O
that WDT O
regulate VB O
cell NN O
size NN O
and CC O
shape NN O
in IN O
a DT O
variety NN O
of IN O
organisms NNS O
. . O

-DOCSTART- X X O

Sequential JJ O
immunoprecipitation NN O
showed VBD O
all DT O
detectable JJ O
p53 NN B-NP
to TO O
be VB O
of IN O
the DT O
PAb246+ JJ B-NP
class NN O
in IN O
each DT O
LPV-transformed JJ O
cell NN O
line NN O
, , O
suggesting VBG O
that IN O
the DT O
stable JJ O
p53 NN B-NP
was VBD O
indeed RB O
wild JJ O
type NN O
. . O

-DOCSTART- X X O

Increased VBN O
platelet-derived JJ B-NP
growth NN I-NP
factor NN I-NP
production NN O
and CC O
intimal JJ O
thickening NN O
during IN O
healing NN O
of IN O
Dacron NNP O
grafts NNS O
in IN O
a DT O
canine NN O
model NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
the DT O
NES NNP B-NP
mutant JJ I-NP
proteins NNS I-NP
appeared VBD O
to TO O
have VB O
altered VBN O
interactions NNS O
with IN O
the DT O
splicing NN O
complex NN O
, , O
binding JJ O
more RBR O
tightly RB O
to TO O
SC35 VB B-NP
in IN O
co-immunoprecipitation NN O
assays VBZ O
. . O

-DOCSTART- X X O

The DT O
results NNS O
of IN O
these DT O
studies NNS O
indicate VBP O
that IN O
EHV-1 JJ B-NP
gp13 NN I-NP
is VBZ O
the DT O
structural JJ O
homolog NN O
of IN O
herpes PRP$ B-NP
simplex JJ I-NP
virus NN I-NP
glycoprotein NN I-NP
C NNP I-NP
and CC O
further JJ O
suggest VBP O
that IN O
the DT O
epitope-containing NN O
N-terminal JJ O
amino IN O
acid NN O
sequences NNS O
of IN O
the DT O
herpesvirus NN B-NP
gC-like JJ I-NP
glycoproteins NNS I-NP
have VBP O
undergone VBN O
more RBR O
extensive JJ O
evolutionary JJ O
divergence NN O
than IN O
the DT O
C-terminal JJ O
sequences NNS O
. . O

-DOCSTART- X X O

Previously RB O
, , O
a DT O
cDNA NN O
( -LRB- O
GT2 NNP B-NP
) -RRB- O
encoding VBG O
this DT O
protein NN O
was VBD O
isolated VBN O
from IN O
a DT O
mouse NN O
3T3-L1 JJ O
adipocyte NN O
library NN O
and CC O
was VBD O
sequenced VBN O
. . O

-DOCSTART- X X O

By IN O
RT-PCR NNP O
, , O
different JJ O
levels NNS O
of IN O
E75 DT B-NP
expression NN O
can MD O
be VB O
detected VBN O
in IN O
the DT O
epidermis NN O
, , O
nerve NN O
cord NN O
and CC O
the DT O
eyestalk NN O
of IN O
early JJ O
pre-molt JJ O
shrimp NN O
. . O

-DOCSTART- X X O

The DT O
chromosomal NN O
location NN O
of IN O
these DT O
YACs NNS O
was VBD O
verified VBN O
using VBG O
FISH NNP O
, , O
which WDT O
also RB O
demonstrated VBD O
their PRP$ O
nonchimeric JJ O
nature NN O
. . O

-DOCSTART- X X O

There EX O
is VBZ O
no DT O
indication NN O
from IN O
these DT O
experiments NNS O
that IN O
linker NN B-NP
histones NNS I-NP
bind VBP O
fundamentally RB O
differently RB O
to TO O
5 CD B-NP
S NNP I-NP
and CC O
bulk NN O
nucleosomes NNS O
. . O

-DOCSTART- X X O

Gas NNP O
chromatographic JJ O
analysis NN O
of IN O
headspace NN O
samples NNS O
of IN O
alkalinized DT O
vaginal JJ O
discharges NNS O
indicated VBD O
the DT O
presence NN O
of IN O
trimethylamine NN O
in IN O
all DT O
11 CD O
samples NNS O
with IN O
the DT O
fishy NN O
odor NN O
but CC O
not RB O
in IN O
the DT O
other JJ O
samples NNS O
. . O

-DOCSTART- X X O

The DT O
transcription NN O
start NN O
site NN O
was VBD O
identified VBN O
by IN O
primer JJ O
extension NN O
analysis NN O
and CC O
over IN O
800 CD O
bp NN O
of IN O
5' JJ O
flanking NN O
DNA NN O
was VBD O
sequenced VBN O
. . O

-DOCSTART- X X O

PURPOSE NNP O
: : O
To TO O
evaluate VB O
the DT O
effect NN O
of IN O
adding VBG O
a DT O
pulsating VBG O
bristle JJ O
action NN O
to TO O
the DT O
established JJ O
oscillating/rotating JJ O
action NN O
of IN O
the DT O
Braun NNP O
Oral-B NNP O
Ultra NNP O
Plaque NNP O
Remover NNP O
( -LRB- O
D9 NNP O
) -RRB- O
on IN O
plaque NN O
removal NN O
. . O

-DOCSTART- X X O

The DT O
high JJ O
degree NN O
of IN O
sequence NN O
conservation NN O
together RB O
with IN O
the DT O
ability NN O
to TO O
direct VB O
nucleolar JJ O
protein NN O
transport NN O
supports VBZ O
the DT O
hypothesis NN O
that IN O
MAK16 NNP B-NP
proteins VBZ I-NP
play VB O
a DT O
key JJ O
role NN O
in IN O
the DT O
biogenesis NN O
of IN O
60S CD B-NP
subunits NNS I-NP
. . O

-DOCSTART- X X O

NO2 JJ O
pollution NN O
on IN O
major JJ O
trunk NN O
roads NNS O
frequently RB O
exceeded VBD O
British JJ O
and CC O
European NNP O
Union NNP O
air NN O
quality NN O
standards NNS O
, , O
while IN O
particle NN O
pollution NN O
was VBD O
lower JJR O
. . O

-DOCSTART- X X O

The DT O
human JJ O
RFC-1 NN B-NP
gene NN I-NP
differs NNS O
from IN O
the DT O
mouse NN O
and CC O
hamster NN O
genes NNS O
both CC O
in IN O
terms NNS O
of IN O
the DT O
total JJ O
number NN O
of IN O
exons NNS O
and CC O
in IN O
regard NN O
to TO O
alternatives NNS O
of IN O
exon NN O
1 CD O
which WDT O
encode VBP O
5' JJ O
end NN O
heterogeneity NN O
. . O

-DOCSTART- X X O

The DT O
recombinant JJ B-NP
L/F-transferase NN I-NP
is VBZ O
as RB O
active JJ O
as IN O
the DT O
previously RB O
purified VBN O
wild JJ O
type NN O
enzyme NN O
and CC O
contains VBZ O
no DT O
detectable JJ O
RNA NNP O
component NN O
. . O

-DOCSTART- X X O

AST NN B-NP
activity NN O
in IN O
PMNs NNP O
was VBD O
significantly RB O
low JJ O
, , O
approximately RB O
2 CD O
% NN O
of IN O
that DT O
observed VBN O
in IN O
HPLFs NNP O
. . O

-DOCSTART- X X O

Intraspinal NNP O
and CC O
mediastinal JJ O
foregut NN O
cyst NN O
compressing VBG O
the DT O
spinal JJ O
cord NN O
. . O

-DOCSTART- X X O

The DT O
H5 CD B-NP
mutants NNS I-NP
were VBD O
: : O
DH5 FW B-NP
( -LRB- O
all DT O
amino IN O
acids NNS O
in IN O
D NNP O
configuration NN O
) -RRB- O
and CC O
H5F NNP B-NP
( -LRB- O
where WRB O
all DT O
His PRP$ O
are VBP O
replaced VBN O
by IN O
Phe NNP O
at IN O
positions NNS O
3 CD O
, , O
7 CD O
, , O
8 CD O
, , O
15 CD O
, , O
18 CD O
, , O
19 CD O
, , O
21 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Accordingly RB O
, , O
infection NN O
of IN O
IFN-pretreated JJ B-NP
HeLa NNP O
S3 NNP O
cells NNS O
with IN O
an DT O
E3L-deficient JJ O
VV NN O
( -LRB- O
VVDeltaE3L NNP O
) -RRB- O
resulted VBD O
in IN O
increased JJ O
phosphorylation NN O
levels NNS O
of IN O
both DT O
PKR NNP B-NP
and CC O
eIF2alpha NN B-NP
. . O

-DOCSTART- X X O

The DT O
human JJ O
sequence NN O
contains VBZ O
the DT O
element NN O
TGACTCT NN O
that WDT O
also RB O
is VBZ O
found VBN O
in IN O
a DT O
murine NN B-NP
ras-responsive JJ I-NP
enhancer NN I-NP
. . O

-DOCSTART- X X O

GAGA NNP B-NP
factor NN I-NP
is VBZ O
known VBN O
to TO O
remodel VB O
the DT O
chromatin NN O
structure NN O
in IN O
concert NN O
with IN O
nucleosome-remodeling JJ B-NP
factor NN I-NP
NURF NN B-NP
in IN O
a DT O
Drosophila NNP O
embryonic NN O
S150 NN O
extract VB O
. . O

-DOCSTART- X X O

After IN O
30 CD O
weeks NNS O
of IN O
amifostine JJ O
therapy NN O
, , O
the DT O
morphology NN O
of IN O
the DT O
MDS NNP O
switched VBD O
to TO O
a DT O
chronic NN O
myelomonocytic JJ O
leukemia NN O
( -LRB- O
CMML)-like JJ O
appearance NN O
, , O
with IN O
continuously RB O
increasing VBG O
leukocytes NNS O
, , O
so RB O
that IN O
we PRP O
discontinued VBN O
amifostine JJ O
therapy NN O
for IN O
1 CD O
month NN O
to TO O
exclude VB O
a DT O
possible JJ O
side NN O
effect NN O
of IN O
amifostine JJ O
. . O

-DOCSTART- X X O

A DT O
gene NN O
with IN O
a DT O
high JJ O
degree NN O
of IN O
sequence NN O
identity NN O
with IN O
mammalian JJ B-NP
ADP-ribosylation NN I-NP
factors NNS I-NP
( -LRB- O
ARFs NN B-NP
) -RRB- O
, , O
believed VBD O
to TO O
be VB O
important JJ O
in IN O
vesicular JJ O
transport NN O
, , O
was VBD O
identified VBN O
. . O

-DOCSTART- X X O

Theophylline NNP O
QID NNP O
, , O
TID NNP O
, , O
BID NNP O
and CC O
now RB O
QD NNP O
? . O
A DT O
report NN O
on IN O
24-hour JJ O
dosing NN O
with IN O
slow-release NN O
theophylline NN O
formulations NNS O
with IN O
emphasis NN O
on IN O
analyses NNS O
of IN O
data NNS O
used VBN O
to TO O
obtain VB O
Food NNP O
and CC O
Drug NNP O
Administration NNP O
approval NN O
for IN O
Theo-24 NNP O
. . O

-DOCSTART- X X O

We PRP O
anticipated VBD O
SNS NNP O
function NN O
after IN O
CVA NNP O
to TO O
be VB O
asymmetric JJ O
and CC O
selected VBN O
null JJ O
hypotheses NNS O
of IN O
bilaterally RB O
symmetric JJ O
SSR NNP O
latencies NNS O
and CC O
amplitudes NNS O
irrespective NN O
of IN O
side NN O
of IN O
stimulation NN O
and/or CC O
recording NN O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
demonstrate VBP O
that IN O
the DT O
BSMV NNP B-NP
coat NN I-NP
protein NN I-NP
is VBZ O
the DT O
sole JJ O
translation NN O
product NN O
of IN O
the DT O
genomic JJ B-NP
RNA NNP I-NP
beta NN I-NP
, , O
whereas IN O
sgRNA DT B-NP
beta NN I-NP
1 CD I-NP
serves VBZ O
as IN O
a DT O
messenger NN O
for IN O
translation NN O
of IN O
the DT O
beta JJ B-NP
b NN I-NP
protein NN I-NP
, , O
and CC O
sgRNA DT B-NP
beta JJ I-NP
2 CD I-NP
functions NNS O
as IN O
a DT O
messenger NN O
for IN O
translation NN O
of IN O
beta JJ B-NP
c NNS I-NP
and CC O
beta JJ B-NP
d NN I-NP
and CC O
the DT O
newly RB O
discovered VBN O
beta NN B-NP
d CC I-NP
' POS I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Without IN O
a DT O
team NN O
, , O
there EX O
is VBZ O
little JJ O
hope NN O
for IN O
fetal NN O
survival NN O
; : O
mortality NN O
will MD O
be VB O
80-100 CD O
% NN O
. . O

-DOCSTART- X X O

The DT O
RNA NNP O
, , O
whether IN O
antisense NN O
, , O
ribozyme NN O
, , O
or CC O
RNA NNP O
aptamer NN O
, , O
must MD O
be VB O
efficiently RB O
transcribed VBN O
, , O
stabilized VBN O
against IN O
rapid JJ O
degradation NN O
, , O
folded JJ O
correctly RB O
, , O
and CC O
directed VBD O
to TO O
the DT O
part NN O
of IN O
the DT O
cell NN O
where WRB O
it PRP O
can MD O
be VB O
most RBS O
effective JJ O
. . O

-DOCSTART- X X O

Recurrent JJ O
infections NNS O
, , O
episodic JJ O
lymphopenia NN O
and CC O
impaired VBN O
cellular JJ O
immunity NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
report NN O
, , O
we PRP O
describe VBP O
a DT O
patient NN O
with IN O
renal JJ O
cell NN O
carcinoma NN O
who WP O
experienced VBD O
ventricular JJ O
tachycardia NN O
while IN O
undergoing VBG O
treatment NN O
with IN O
high-dose JJ O
bolus JJ O
IL-2 NN B-NP
. . O

-DOCSTART- X X O

We PRP O
report VBP O
the DT O
cloning NN O
of IN O
the DT O
ade1 JJ B-NP
gene NN I-NP
on IN O
a DT O
4.4 CD B-NP
kb NN I-NP
Sau3A NNP I-NP
insert NN I-NP
in IN O
the DT O
yeast NN O
shuttle NN O
vector VBN O
pWH5 RB O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
secretion NN O
of IN O
chitinolytic JJ O
enzymes NNS O
by IN O
cultured JJ O
L. NNP O
major JJ O
parasites NNS O
is VBZ O
inhibited VBN O
by IN O
blood NN O
or CC O
hemoglobin NN B-NP
, , O
and CC O
hence RB O
these DT O
enzymes NNS O
are VBP O
apparently RB O
absent JJ O
from IN O
the DT O
blood-fed JJ O
infected JJ O
flies NNS O
, , O
where WRB O
the DT O
cardiac NN O
valve NN O
appears VBZ O
undamaged JJ O
. . O

-DOCSTART- X X O

Oral JJ O
hypoglycemic JJ O
agents NNS O

-DOCSTART- X X O

Identification NN O
and CC O
characterization NN O
of IN O
a DT O
yeast NN O
gene NN O
encoding VBG O
the DT O
U2 NNP B-NP
small JJ I-NP
nuclear JJ I-NP
ribonucleoprotein NN I-NP
particle NN I-NP
B" JJ I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Nature NN O
of IN O
the DT O
thermopower NN O
in IN O
bipolar JJ O
semiconductors NNS O
. . O

-DOCSTART- X X O

Overexpression NNP O
of IN O
SNURF NNP B-NP
in IN O
cultured JJ O
mammalian JJ O
cells NNS O
enhanced VBN O
not RB O
only RB O
androgen NN O
, , O
glucocorticoid NN O
, , O
and CC O
progesterone NN B-NP
receptor-dependent JJ I-NP
transactivation NN O
but CC O
also RB O
basal JJ O
transcription NN O
from IN O
steroid-regulated JJ O
promoters NNS O
. . O

-DOCSTART- X X O

Usher NNP O
syndrome NN O
1C . O
( -LRB- O
USH1C NNP O
) -RRB- O
is VBZ O
a DT O
congenital JJ O
condition NN O
manifesting VBG O
profound JJ O
hearing NN O
loss NN O
, , O
the DT O
absence NN O
of IN O
vestibular JJ O
function NN O
, , O
and CC O
eventual JJ O
retinal JJ O
degeneration NN O
. . O

-DOCSTART- X X O

On IN O
the DT O
basis NN O
of IN O
these DT O
findings NNS O
we PRP O
suggest VBP O
that IN O
the DT O
acceptor NN O
peptide NN O
binds VBZ O
the DT O
transferase NN O
in IN O
a DT O
beta-like JJ O
conformation NN O
and CC O
that DT O
penultimate NN O
residue JJ O
side NN O
chain NN O
steric JJ O
interactions NNS O
may MD O
play VB O
a DT O
role NN O
in IN O
determining VBG O
extent NN O
that IN O
a DT O
given VBN O
Ser NN O
or CC O
Thr NNP O
is VBZ O
glycosylated VBN O
. . O

-DOCSTART- X X O

A DT O
higher JJR O
median JJ O
proportion NN O
of IN O
spirochaetes NNS O
was VBD O
observed VBN O
in IN O
sites NNS O
after IN O
diagnosis NN O
of IN O
loss NN O
of IN O
attachment NN O
. . O

-DOCSTART- X X O

Copyright NNP O
1998 CD O
Academic NNP O
Press NNP O
. . O

-DOCSTART- X X O

Although IN O
cDNA NNS O
encoding VBG O
a DT O
human JJ B-NP
phagocyte NN I-NP
formyl IN I-NP
peptide-binding JJ I-NP
protein NN I-NP
has VBZ O
been VBN O
reported VBN O
recently RB O
( -LRB- O
Boulay NNP O
, , O
F. NNP O
, , O
Tardif NNP O
, , O
M. NNP O
, , O
Brouchon NNP O
, , O
L. NNP O
, , O
and CC O
Vignais NNP O
, , O
P. NNP O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
PVB NNP O
therapy NN O
is VBZ O
not RB O
sufficient JJ O
to TO O
cure VB O
the DT O
cases NNS O
with IN O
choriocarcinoma NN O
element NN O
or CC O
bulky JJ O
metastasis NN O
. . O

-DOCSTART- X X O

For IN O
large JJ O
breasts NNS O
( -LRB- O
> NN O
70 CD O
mm CD O
) -RRB- O
the DT O
use NN O
of IN O
X-ray NN O
sets NNS O
such JJ O
as IN O
the DT O
IGE NNP O
DMR NNP O
, , O
which WDT O
automatically RB O
select VBP O
the DT O
beam NN O
quality NN O
for IN O
each DT O
breast NN O
, , O
resulted VBD O
in IN O
lower JJR O
doses NNS O
compared VBN O
with IN O
sets NNS O
using VBG O
manual JJ O
tube NN O
potential NN O
selection NN O
. . O

-DOCSTART- X X O

Deletion NNP O
mutagenesis NN O
of IN O
the DT O
promoter NN O
indicated VBD O
that IN O
a DT O
positive JJ O
regulatory JJ O
element NN O
( -LRB- O
PRE JJ O
) -RRB- O
was VBD O
likely JJ O
to TO O
exist VB O
downstream NN O
of IN O
the DT O
UL94 NNP B-NP
mRNA NNS I-NP
start VBP I-NP
site NN I-NP
, , O
while IN O
a DT O
negative JJ O
regulatory JJ O
element NN O
( -LRB- O
NRE NNP O
) -RRB- O
was VBD O
present JJ O
upstream RB O
of IN O
the DT O
TATA NNP O
box NN O
. . O

-DOCSTART- X X O

An DT O
ERp60-like JJ B-NP
protein NN I-NP
from IN O
the DT O
filarial NN O
parasite NN O
Dirofilaria NNP O
immitis NN O
has VBZ O
both DT O
transglutaminase NN O
and CC O
protein NN O
disulfide NN O
isomerase NN O
activity NN O
. . O

-DOCSTART- X X O

Fos/Jun NNP B-NP
bound VBD O
to TO O
an DT O
unacetylated JJ O
nucleosome JJ O
with IN O
only RB O
a DT O
4- JJ O
to TO O
5-fold JJ O
reduction NN O
in IN O
DNA NNP O
binding NN O
affinity NN O
compared VBN O
with IN O
naked JJ O
DNA NN O
. . O

-DOCSTART- X X O

The DT O
extent NN O
of IN O
myocardial JJ O
ischemia NN O
in IN O
the DT O
coronary JJ O
sinus NN O
study NN O
was VBD O
significantly RB O
correlated VBN O
to TO O
the DT O
coronary JJ O
diameters NNS O
of IN O
the DT O
proximal JJ O
and CC O
middle JJ O
segments NNS O
of IN O
the DT O
Ramus NNP O
interventricularis NN O
anterior NN O
and CC O
the DT O
middle JJ O
segment NN O
of IN O
the DT O
Ramus NNP O
circumflexus NN O
( -LRB- O
r NN O
= SYM O
0.87 CD O
, , O
p NN O
< NN O
0.02 CD O
) -RRB- O
. . O

-DOCSTART- X X O

S1 JJ B-NP
nuclease JJ I-NP
analysis NN O
of IN O
the DT O
RNA NNP O
from IN O
a DT O
number NN O
of IN O
QT6-LD NNP O
clones NNS O
gave VBD O
similar JJ O
results NNS O
, , O
indicating VBG O
that IN O
the DT O
LD NNP O
population NN O
was VBD O
composed VBN O
of IN O
viruses NNS O
with IN O
similar JJ O
but CC O
not RB O
identical JJ O
deletion NN O
endpoints NNS O
. . O

-DOCSTART- X X O

The DT O
prevalence NN O
of IN O
ocular/adnexal JJ O
SCC NNP O
was VBD O
significantly RB O
greater JJR O
for IN O
all DT O
hair NN O
colors NNS O
when WRB O
compared VBN O
with IN O
bay NN O
, , O
brown JJ O
, , O
or CC O
black JJ O
( -LRB- O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

ZNS NNS O
, , O
in IN O
the DT O
mmolar JJ O
range NN O
, , O
scavenged JJ O
hydroxyl NN O
and CC O
nitric JJ O
oxide NN O
radicals NNS O
in IN O
a DT O
dose-dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

The DT O
three CD O
more JJR O
slower RBR O
migrating VBG O
Stat5B NNP B-NP
bands NNS O
observed VBD O
in IN O
response NN O
to TO O
GH NNP B-NP
contain VB O
phosphorylated VBN O
tyrosyl NN O
residues NNS O
. . O

-DOCSTART- X X O

During IN O
the DT O
1st JJ O
week NN O
of IN O
treatment NN O
all DT O
subjects NNS O
received VBD O
either DT O
mianserin JJ O
30 CD O
mg NN O
or CC O
clomipramine VB O
75 CD O
mg NN O
once RB O
daily RB O
. . O

-DOCSTART- X X O

EMBO NNP O
( -LRB- O
Eur NNP O
. . O

-DOCSTART- X X O

When WRB O
stratifying VBG O
FLM NNP O
values NNS O
< RB O
34 CD O
and CC O
> RB O
34 CD O
wks NNS O
' POS O
gestation NN O
, , O
again RB O
no DT O
difference NN O
was VBD O
found VBN O
in IN O
mean JJ O
difference NN O
of IN O
L/S NNP O
and CC O
LB NNP O
before IN O
and CC O
after IN O
34 CD O
wks NNS O
. . O

-DOCSTART- X X O

Are VBP O
there EX O
any DT O
lessons NNS O
to TO O
be VB O
learnt NN O
? . O

-DOCSTART- X X O

The DT O
other JJ O
five CD O
from IN O
within IN O
the DT O
SRO NNP O
may MD O
provide VB O
an DT O
entrance NN O
point NN O
for IN O
the DT O
cloning NN O
of IN O
candidate NN O
genes NNS O
for IN O
neuroblastoma NN O
. . O

-DOCSTART- X X O

Three CD O
distinct JJ O
human JJ B-NP
HDACs NNS I-NP
are VBP O
homologous JJ O
to TO O
RPD3 VB B-NP
, , O
a DT O
yeast NN O
transcriptional JJ O
regulator NN O
. . O

-DOCSTART- X X O

The DT O
vaccine NN O
was VBD O
at IN O
least JJS O
80 CD O
% NN O
efficacious JJ O
against IN O
Chlamydia NNP O
and CC O
Campylobacter NNP O
spp NN O
and CC O
appeared VBD O
to TO O
be VB O
protective JJ O
. . O

-DOCSTART- X X O

The DT O
RPC31 NNP B-NP
gene NN I-NP
encoding VBG O
the DT O
C31 NNP B-NP
subunit NN I-NP
of IN I-NP
Saccharomyces NNP I-NP
cerevisiae NN I-NP
RNA NNP I-NP
polymerase NN I-NP
C NNP I-NP
( -LRB- I-NP
III NNP I-NP
) -RRB- I-NP
has VBZ O
been VBN O
isolated VBN O
, , O
starting VBG O
from IN O
a DT O
C-terminal JJ O
fragment NN O
cloned VBD O
on IN O
a DT O
lambda NN O
gt11 IN O
library NN O
. . O

-DOCSTART- X X O

Slowly RB O
adapting VBG O
type NN O
I PRP O
mechanoreceptor MD O
discharge VB O
as IN O
a DT O
function NN O
of IN O
dynamic JJ O
force NN O
versus JJ O
dynamic JJ O
displacement NN O
of IN O
glabrous JJ O
skin NN O
of IN O
raccoon NN O
and CC O
squirrel NN O
monkey JJ O
hand NN O
. . O

-DOCSTART- X X O

The DT O
goal NN O
of IN O
this DT O
investigation NN O
was VBD O
to TO O
determine VB O
whether IN O
BMIPP NNP O
uptake NN O
can MD O
be VB O
used VBN O
to TO O
differentiate JJ O
viable JJ O
myocardium NN O
from IN O
scar NN O
tissue NN O
soon RB O
after IN O
coronary JJ O
thrombolysis NN O
for IN O
acute JJ O
myocardial JJ O
infarction NN O
. . O

-DOCSTART- X X O

IRIS/GAS NNP B-NP
DNA NNP O
also RB O
formed VBD O
a DT O
number NN O
of IN O
specific JJ O
complexes NNS O
with IN O
constitutively RB O
expressed VBN O
factors NNS O
, , O
none NN O
of IN O
which WDT O
were VBD O
affected VBN O
by IN O
the DT O
above JJ O
Abs NN O
. . O

-DOCSTART- X X O

Recovery NNP O
rates NNS O
of IN O
energy NN O
level NN O
and CC O
intracellular JJ O
pH NNS O
during IN O
stimulation NN O
at IN O
100Hz CD O
were VBD O
greater JJR O
than IN O
those DT O
observed VBN O
during IN O
stimulation NN O
at IN O
30Hz NNP O
. . O

-DOCSTART- X X O

The DT O
data NNS O
obtained VBD O
included VBN O
1 CD O
) -RRB- O
the DT O
mean JJ O
frequency NN O
of IN O
abnormal JJ O
teased JJ O
myelinated JJ O
fibers NNS O
and CC O
its PRP$ O
upper JJ O
limit NN O
value NN O
of IN O
95 CD O
% NN O
confidence NN O
interval NN O
, , O
and CC O
2 CD O
) -RRB- O
the DT O
mean JJ O
densities NNS O
of IN O
total NN O
, , O
large JJ O
and CC O
small JJ O
myelinated JJ O
fibers NNS O
and CC O
of IN O
unmyelinated JJ O
fibers NNS O
and CC O
their PRP$ O
lower JJR O
limit NN O
value NN O
of IN O
95 CD O
% NN O
confidence NN O
interval NN O
for IN O
each DT O
decade NN O
. . O

-DOCSTART- X X O

The DT O
yield NN O
of IN O
endocervical JJ O
cells NNS O
and CC O
the DT O
incidence NN O
of IN O
dysplasia NN O
was VBD O
determined VBN O
for IN O
both DT O
the DT O
prenatal NN O
and CC O
the DT O
postpartum NN O
Pap NNP O
smears VBZ O
performed VBN O
for IN O
this DT O
group NN O
of IN O
patients NNS O
. . O

-DOCSTART- X X O

Others NNS O
as IN O
for IN O
example NN O
C-11 NN O
labeled VBN O
short JJ O
chain NN O
fatty NN O
acids NNS O
are VBP O
on IN O
the DT O
horizon NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
the DT O
BR-C NN B-NP
early JJ I-NP
gene NN I-NP
directly RB O
activates VBZ O
late JJ B-NP
gene NN I-NP
transcription NN O
by IN O
interacting VBG O
with IN O
late JJ B-NP
gene NN I-NP
cis-acting JJ O
regulatory JJ O
elements NNS O
and CC O
that IN O
this DT O
interaction NN O
is VBZ O
responsible JJ O
for IN O
the DT O
temporal JJ O
linkage NN O
of IN O
early JJ O
and CC O
late JJ O
ecdysone-induced JJ O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

We PRP O
tested VBD O
the DT O
hypothesis NN O
that IN O
PEH NNP O
is VBZ O
associated VBN O
with IN O
reductions NNS O
in IN O
TPR NNP O
and CC O
sympathetic JJ O
nerve NN O
activity NN O
( -LRB- O
SNA NNP O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
short JJ O
conserved JJ O
motif NN O
is VBZ O
required VBN O
for IN O
repressor NN O
domain NN O
function NN O
in IN O
the DT O
myeloid-specific JJ O
transcription NN O
factor NN O
CCAAT/enhancer-binding JJ B-NP
protein NN I-NP
epsilon NN I-NP
. . O

-DOCSTART- X X O

Purified VBN O
fER NN B-NP
exhibited VBN O
a DT O
distribution NN O
constant JJ O
( -LRB- O
KD NN O
) -RRB- O
for IN O
17 CD O
beta-estradiol NN O
of IN O
0.45 CD O
nM. . O

-DOCSTART- X X O

However RB O
, , O
strains NNS O
in IN O
which WDT O
both DT O
of IN O
the DT O
two CD O
most RBS O
highly RB O
related VBN O
genes NNS O
, , O
DdPIK1 NNP B-NP
and CC O
DdPIK2 NNP B-NP
, , O
were VBD O
disrupted VBN O
showed VBD O
both DT O
growth NN O
and CC O
developmental JJ O
defects NNS O
, , O
while IN O
double JJ O
knockouts NNS O
of IN O
DdPIK1 NNP B-NP
and CC O
DdPIK3 NNP B-NP
and CC O
DdPIK2 NNP B-NP
and CC O
DdPIK3 NNP B-NP
appear VBP O
to TO O
be VB O
lethal JJ O
. . O

-DOCSTART- X X O

The DT O
exon NN O
sequences NNS O
determined VBN O
from IN O
genomic JJ O
DNA NN O
sequencing NN O
showed VBD O
some DT O
differences NNS O
when WRB O
compared VBN O
to TO O
the DT O
published VBN O
rat NN B-NP
GLUT2 IN I-NP
cDNA NN I-NP
. . O

-DOCSTART- X X O

This DT O
integration NN O
results NNS O
in IN O
the DT O
production NN O
of IN O
MMTV/mdr3 NNP B-NP
fusion NN I-NP
transcripts NNS I-NP
that WDT O
originate VBP O
from IN O
the DT O
antisense NN O
5'LTR IN B-NP
of IN O
the DT O
provirus NN O
. . O

-DOCSTART- X X O

This DT O
surface NN O
in IN O
specimens NNS O
from IN O
unfertilized JJ O
eggs NNS O
is VBZ O
almost RB O
flat JJ O
. . O

-DOCSTART- X X O

These DT O
results NNS O
are VBP O
discussed VBN O
in IN O
the DT O
context NN O
of IN O
a DT O
model NN O
of IN O
the DT O
myogenic JJ O
lineage NN O
that WDT O
is VBZ O
based VBN O
on IN O
the DT O
expression NN O
of IN O
desmin NN B-NP
. . O

-DOCSTART- X X O

Characterization NNP O
of IN O
a DT O
DEAD NN B-NP
box NN I-NP
ATPase/RNA NNP I-NP
helicase NN B-NP
protein NN O
of IN O
Arabidopsis NNP O
thaliana NN O
. . O

-DOCSTART- X X O

The DT O
host NN O
range NN O
( -LRB- O
HR NN O
) -RRB- O
of IN O
poliovirus NN O
is VBZ O
thought VBN O
to TO O
be VB O
primarily RB O
determined VBN O
by IN O
a DT O
cell NN O
surface NN O
molecule NN O
that WDT O
functions VBZ O
as IN O
poliovirus NN B-NP
receptor NN I-NP
( -LRB- O
PVR NN B-NP
) -RRB- O
, , O
since IN O
it PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
transgenic JJ O
mice NNS O
are VBP O
made VBN O
poliovirus JJ O
sensitive JJ O
by IN O
introducing VBG O
the DT O
human JJ B-NP
PVR NNP I-NP
gene NN I-NP
into IN O
the DT O
genome NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
paper NN O
, , O
the DT O
authors NNS O
used VBN O
measured VBN O
weight NN O
for IN O
1,259 CD O
white JJ O
women NNS O
aged VBN O
65-74 CD O
years NNS O
from IN O
the DT O
Epidemiologic NNP O
Follow-up NNP O
Study NNP O
of IN O
the DT O
First NNP O
National NNP O
Health NNP O
and CC O
Nutrition NNP O
Examination NNP O
Survey NNP O
to TO O
examine VB O
the DT O
effect NN O
of IN O
overweight JJ O
on IN O
coronary JJ O
heart NN O
disease NN O
incidence NN O
( -LRB- O
mean JJ O
length NN O
of IN O
follow-up JJ O
, , O
14 CD O
years NNS O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
to TO O
the DT O
reciprocal JJ O
effects NNS O
of IN O
Gab1 NNP B-NP
and CC O
Gab2 NNP B-NP
in IN O
mediating VBG O
Elk-1 NNP B-NP
induction NN O
, , O
these DT O
two CD O
molecules NNS O
have VBP O
a DT O
similar JJ O
function NN O
in IN O
extracellular JJ B-NP
signal-regulated JJ I-NP
kinase NN I-NP
activation NN O
induced VBN O
by IN O
either DT O
oncogenic JJ O
Ras NNP B-NP
or CC O
growth NN O
factor NN O
stimulation NN O
. . O

-DOCSTART- X X O

We PRP O
were VBD O
able JJ O
to TO O
demonstrate VB O
a DT O
significant JJ O
statistical JJ O
interaction NN O
effect NN O
between IN O
gender NN O
and CC O
globulin NN B-NP
protein NN I-NP
concentration NN O
on IN O
Vu NNP O
( -LRB- O
p NN O
= SYM O
0.022 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
NS-2 JJ B-NP
isoforms NNS I-NP
were VBD O
resolved VBN O
at IN O
a DT O
pI JJ O
value NN O
close RB O
to TO O
5.5 CD O
as IN O
three CD O
groups NNS O
of IN O
unevenly JJ O
phosphorylated JJ O
polypeptides NNS O
, , O
each DT O
composed VBN O
of IN O
at IN O
least JJS O
two CD O
protein NN O
species NNS O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
isobarin NN O
on IN O
electrocardiographic JJ O
indices NNS O
in IN O
hypertensive JJ O
disease NN O

-DOCSTART- X X O

TAAG NNP O
sites NNS O
that WDT O
serve VBP O
as IN O
functional DT O
late JJ O
promoters NNS O
in IN O
OpMNPV NNP O
were VBD O
found VBN O
to TO O
mediate JJ O
transcription NN O
initiation NN O
at IN O
only RB O
basal JJ O
levels NNS O
in IN O
the DT O
context NN O
of IN O
the DT O
AcMNPV NNP O
genome NN O
, , O
suggesting VBG O
that IN O
late JJ O
promoter NN O
activation NN O
may MD O
be VB O
virus NN O
specific NN O
within IN O
the DT O
family NN O
Baculoviridae NNP O
. . O

-DOCSTART- X X O

The DT O
carboxyl NN O
globular JJ O
domain NN O
was VBD O
found VBN O
to TO O
be VB O
encoded VBN O
by IN O
six CD O
exons NNS O
which WDT O
appear VBP O
to TO O
delineate VB O
its PRP$ O
structural JJ O
subdomains NNS O
. . O

-DOCSTART- X X O

Fus3p NNP B-NP
and CC O
Kss1p NNP B-NP
together RB O
increase VB O
the DT O
expression NN O
of IN O
CLN3 NN B-NP
and CC O
PCL2 NN B-NP
genes NNS I-NP
that WDT O
promote VBP O
budding VBG O
, , O
and CC O
Kss1p NNP B-NP
inhibits VBZ O
the DT O
MAP NNP B-NP
kinase NN I-NP
cascade NN O
. . O

-DOCSTART- X X O

Measurement NN O
of IN O
the DT O
spectral JJ O
sensitivity NN O
and CC O
the DT O
ERG NNP O
can MD O
thus RB O
help VB O
in IN O
the DT O
diagnosis NN O
of IN O
these DT O
three CD O
hereditary JJ O
diseases NNS O
. . O

-DOCSTART- X X O

On IN O
both DT O
indocyanine JJ O
green JJ O
video NN O
and CC O
fluorescein NN O
angiography NN O
, , O
hypofluorescent JJ O
lesions NNS O
were VBD O
almost RB O
the DT O
same JJ O
size NN O
as IN O
the DT O
light JJ O
yellow JJ O
area NN O
and CC O
the DT O
dark JJ O
yellow JJ O
center NN O
of IN O
a DT O
placoid NN O
lesion NN O
. . O

-DOCSTART- X X O

Possibility NN O
of IN O
using VBG O
gynecologic NN O
nurses NNS O
in IN O
the DT O
independently RB O
administered VBN O
health NN O
centers NNS O

-DOCSTART- X X O

Platelet NN O
count NN O
and CC O
plasma NN O
volume NN O
were VBD O
significantly RB O
higher JJR O
in IN O
group NN O
A DT O
than IN O
in IN O
group NN O
B NNP O
throughout IN O
pregnancy NN O
. . O

-DOCSTART- X X O

The DT O
complexity NN O
of IN O
some DT O
of IN O
the DT O
reports NNS O
of IN O
VACURG NNP O
studies NNS O
has VBZ O
led VBN O
some DT O
to TO O
believe VB O
that IN O
this DT O
group NN O
was VBD O
opposed VBN O
to TO O
estrogens NNS O
, , O
but CC O
that DT O
is VBZ O
not RB O
true JJ O
. . O

-DOCSTART- X X O

Mycobacterium NNP O
tuberculosis NN O
inhibits VBZ O
IFN-gamma NNP B-NP
transcriptional JJ O
responses NNS O
without IN O
inhibiting VBG O
activation NN O
of IN O
STAT1 NNP B-NP
. . O

-DOCSTART- X X O

Upstream NN O
of IN O
the DT O
afa-3 JJ B-NP
gene NN I-NP
cluster NN I-NP
, , O
a DT O
1.2-kb JJ O
region NN O
was VBD O
found VBN O
to TO O
be VB O
96 CD O
% NN O
identical JJ O
to TO O
the DT O
RepFIB NNP B-NP
sequence NN I-NP
of IN O
one CD O
of IN O
the DT O
enterotoxigenic JJ O
E. NNP O
coli NNS O
plasmids NNS O
( -LRB- O
P307 CD O
) -RRB- O
, , O
suggesting VBG O
a DT O
common JJ O
ancestor NN O
plasmid NN O
. . O

-DOCSTART- X X O

Maintenance NN O
metabolizable-energy NN O
( -LRB- O
ME) NN O
requirement NN O
averaged VBD O
31.0 CD O
kcal/kg JJ O
body NN O
wt NN O
. . O

-DOCSTART- X X O

The DT O
secondary JJ O
end NN O
points NNS O
included VBD O
creatine JJ B-NP
kinase NN I-NP
peak NN O
, , O
ventricular JJ O
fibrillation/tachycardia NN O
within IN O
the DT O
first JJ O
24 CD O
hours NNS O
, , O
death NN O
and CC O
congestive JJ O
heart NN O
failure NN O
within IN O
the DT O
30-day JJ O
follow-up NN O
, , O
and CC O
30-day JJ O
left JJ O
ventricular JJ O
ejection NN O
fraction NN O
. . O

-DOCSTART- X X O

The DT O
contribution NN O
of IN O
reviewers NNS O
and CC O
editors NNS O
to TO O
the DT O
scientific JJ O
work NN O
of IN O
the DT O
authors NNS O

-DOCSTART- X X O

Comparisons NNS O
of IN O
defective JJ O
HTLV-I JJ O
proviruses NNS O
predict VBP O
the DT O
mode NN O
of IN O
origin NN O
and CC O
coding NN O
potential NN O
of IN O
internally RB O
deleted VBN O
genomes NNS O
. . O

-DOCSTART- X X O

When WRB O
proper JJ O
controls NNS O
were VBD O
used VBN O
, , O
the DT O
psychophysical JJ O
data NNS O
and CC O
computer NN O
simulation NN O
gave VBD O
remarkably RB O
comparable JJ O
results NNS O
. . O

-DOCSTART- X X O

The DT O
phosphoprotein NN B-NP
pUL69 IN I-NP
of IN O
human JJ O
cytomegalovirus NN O
( -LRB- O
HCMV) NNP O
, , O
which WDT O
is VBZ O
a DT O
herpesvirus NN O
of IN O
considerable JJ O
medical JJ O
importance NN O
in IN O
immunosuppressed JJ O
patients NNS O
and CC O
newborns NNS O
, , O
has VBZ O
previously RB O
been VBN O
identified VBN O
as IN O
an DT O
early-late JJ B-NP
viral JJ I-NP
protein NN I-NP
that WDT O
can MD O
stimulate VB O
several JJ O
viral JJ O
and CC O
cellular JJ O
promoters NNS O
and CC O
thus RB O
exerts VBZ O
a DT O
rather RB O
broad JJ O
activation NN O
pattern NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
acute JJ O
exposure NN O
to TO O
cold JJ O
on IN O
pulmonary JJ O
arterial JJ O
blood NN O
pressure NN O
in IN O
awake JJ O
rats NNS O
. . O

-DOCSTART- X X O

RNase NN B-NP
protection NN O
analysis NN O
reveals VBZ O
a DT O
10-fold JJ O
increase NN O
in IN O
the DT O
expression NN O
of IN O
SCD2 NNP B-NP
mRNA NNS I-NP
during IN O
3T3-L1 JJ O
preadipocyte NN O
differentiation NN O
. . O

-DOCSTART- X X O

The DT O
response NN O
sequences NNS O
were VBD O
localized VBN O
between IN O
-67 JJ O
and CC O
+30 CD O
in IN O
the DT O
simian JJ O
cytomegalovirus NN O
IE94 IN B-NP
promoter NN I-NP
and CC O
upstream RB O
of IN O
position NN O
+9 CD O
in IN O
the DT O
HCMV NNP B-NP
IE68 IN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

The DT O
expression NN O
of IN O
Scmh1 NNP B-NP
and CC O
rae28/mph1 NNP B-NP
is VBZ O
well RB O
correlated VBN O
in IN O
most JJS O
tissues NNS O
of IN O
embryos NN O
. . O

-DOCSTART- X X O

Retinoic NNP O
acid NN O
, , O
which WDT O
inhibits VBZ O
the DT O
progression NN O
of IN O
certain JJ O
cancers NNS O
, , O
repressed VBN O
v-src-induced JJ B-NP
MMP-1 NNP B-NP
transcription NN O
. . O

-DOCSTART- X X O

Untransformed JJ O
3T3 JJ O
cells NNS O
carry VBP O
abundant JJ O
1.9 CD O
kb NN O
Hox NNP B-NP
1.3 CD I-NP
RNA NNP O
, , O
whereas IN O
the DT O
methylcholanthrene-transformed JJ O
MB66 NNP O
and CC O
LTK- NNP O
cells NNS O
or CC O
3T3 CD O
cells NNS O
transformed VBN O
by IN O
the DT O
oncogenes NNS O
src NN B-NP
, , O
fos NNS B-NP
or CC O
SV40 CD B-NP
T NNP I-NP
antigen NN I-NP
express VBP O
only RB O
low JJ O
levels NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
it PRP O
is VBZ O
also RB O
established VBN O
that IN O
serine NN O
phosphorylation NN O
of IN O
STAT5a NNP B-NP
transactivation NN O
domain NN O
, , O
via IN O
the DT O
MAPK NNP B-NP
pathway NN O
, , O
is VBZ O
a DT O
means NN O
of IN O
modifying VBG O
GH-induced JJ B-NP
transcriptional JJ O
activation NN O
. . O

-DOCSTART- X X O

Blood NN O
pressure NN O
was VBD O
controlled VBN O
long JJ O
term NN O
( -LRB- O
with/without IN O
diuretics/beta-adrenoreceptor NN O
blocking VBG O
drugs NNS O
) -RRB- O
in IN O
sixteen CD O
out IN O
of IN O
nineteen CD O
patients NNS O
with IN O
mild-moderate JJ O
hypertension NN O
. . O

-DOCSTART- X X O

This DT O
may MD O
be VB O
another DT O
example NN O
of IN O
the DT O
principle--less JJ O
is VBZ O
more JJR O
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
amino-acid JJ O
sequence NN O
includes VBZ O
an DT O
N-terminal JJ O
signal NN O
sequence NN O
of IN O
27 CD O
amino IN O
acids NNS O
, , O
a DT O
27 CD O
amino-acid JJ O
pro-region JJ O
, , O
a DT O
251 CD O
amino-acid JJ O
catalytic JJ O
domain NN O
typical JJ O
of IN O
a DT O
serine NN B-NP
protease NN I-NP
with IN O
trypsin-like JJ B-NP
specificity NN O
, , O
and CC O
a DT O
C-terminal JJ O
hydrophobic JJ O
extension NN O
which WDT O
is VBZ O
predicted VBN O
to TO O
function NN O
as IN O
a DT O
membrane NN O
anchor NN O
. . O

-DOCSTART- X X O

Phenotypic NNP O
and CC O
molecular JJ O
analyses NNS O
of IN O
patients NNS O
with IN O
partial JJ O
chromosome NN O
21 CD O
monosomy NN O
enabled VBD O
us PRP O
to TO O
define VB O
a DT O
region NN O
, , O
spanning VBG O
2.4 CD O
Mb NNP O
between IN O
D21S190 CD B-NP
and CC O
D21S226 NNP B-NP
, , O
associated VBN O
with IN O
arthrogryposis NN O
, , O
mental JJ O
retardation NN O
, , O
hypertonia NN O
, , O
and CC O
several JJ O
facial JJ O
anomalies NNS O
. . O

-DOCSTART- X X O

Relation NN O
between IN O
circulating VBG O
immune JJ O
complexes NNS O
and CC O
serum NN B-NP
ferritin NN I-NP
in IN O
hemosiderosis NN O
of IN O
different JJ O
etiologies NNS O

-DOCSTART- X X O

The DT O
zinc NN B-NP
finger NN I-NP
protein NN I-NP
A20 NNP I-NP
is VBZ O
a DT O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
( -LRB- O
TNF) NNP B-NP
- : O
and CC O
interleukin NN B-NP
1 CD I-NP
( -LRB- O
IL-1)-inducible JJ B-NP
protein NN O
that WDT O
negatively RB O
regulates VBZ O
nuclear JJ B-NP
factor-kappa NN I-NP
B NNP I-NP
( -LRB- O
NF-kappaB)-dependent NN B-NP
gene NN O
expression NN O
. . O

-DOCSTART- X X O

Treatments NNS O
were VBD O
two CD O
adrenocorticotrophin IN B-NP
(ACTH) JJ O
preparations NNS O
given VBN O
intramuscularly JJ O
at IN O
2.2 CD O
U/kg NNP O
, , O
one CD O
of IN O
the DT O
ACTH NNP B-NP
preparations NNS O
given VBN O
intramuscularly RB O
at IN O
1 CD O
U/kg NN O
and CC O
a DT O
synthetic JJ O
polypeptide NN O
with IN O
ACTH-like JJ B-NP
activity NN O
(tetracosactrin NNP O
, , O
cosyntropin NN O
) -RRB- O
given VBN O
intravenously RB O
at IN O
5 CD O
micrograms/kg NN O
. . O

-DOCSTART- X X O

The DT O
deviation NN O
site NN O
is VBZ O
equivalent JJ O
to TO O
the DT O
exon NN O
1/exon IN O
2 CD O
splice NN O
site NN O
of IN O
the DT O
mouse NN O
C-subunit NN O
. . O

-DOCSTART- X X O

The DT O
liver-specific JJ O
sequence NN O
contains VBZ O
unique JJ O
consensus NN O
sites NNS O
for IN O
phosphorylation NN O
by IN O
cyclic JJ B-NP
AMP-dependent JJ I-NP
protein NN I-NP
kinase NN I-NP
and CC O
by IN O
protein NN B-NP
kinase NN I-NP
C. NNP I-NP

-DOCSTART- X X O

Seizure NN O
recurrence NN O
( -LRB- O
HR NNP O
1.30 CD O
; : O
95 CD O
% NN O
CI NNP O
= SYM O
0.84 CD O
, , O
2.01 CD O
) -RRB- O
and CC O
antiepileptic JJ O
drug NN O
treatment NN O
( -LRB- O
HR NNP O
0.97 CD O
; : O
95 CD O
% NN O
CI NNP O
= SYM O
0.67 CD O
, , O
1.38 CD O
) -RRB- O
did VBD O
not RB O
influence NN O
mortality NN O
rate NN O
. . O

-DOCSTART- X X O

Fas NNP B-NP
( -LRB- O
APO-1/CD95 NN B-NP
) -RRB- O
, , O
which WDT O
is VBZ O
a DT O
member NN O
of IN O
the DT O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
receptor NN I-NP
superfamily NN I-NP
, , O
is VBZ O
a DT O
cell NN O
surface NN O
receptor NN O
that WDT O
induces VBZ O
apoptosis NN O
. . O

-DOCSTART- X X O

Soft NNP O
independent JJ O
modelling NN O
of IN O
class NN O
analogy NN O
( -LRB- O
SIMCA NNP O
) -RRB- O
is VBZ O
applied VBN O
to TO O
identify VB O
near-infrared JJ O
( -LRB- O
NIR NN O
) -RRB- O
spectra NN O
of IN O
ten CD O
excipients NNS O
used VBN O
in IN O
the DT O
pharmaceutical JJ O
industry NN O
. . O

-DOCSTART- X X O

Implantation NN O
is VBZ O
contraindicated VBN O
for IN O
severe JJ O
dysplasia NN O
of IN O
the DT O
cochlea NN O
and CC O
for IN O
the DT O
recently RB O
described VBN O
variety NN O
of IN O
x-linked JJ O
deafness NN O
with IN O
deficient JJ O
bone NN O
at IN O
the DT O
fundus NN O
of IN O
the DT O
internal JJ O
auditory NN O
meatus NN O
. . O

-DOCSTART- X X O

The DT O
RsmA NNP B-NP
- : I-NP
mutant JJ I-NP
, , O
like IN O
its PRP$ O
parent NN O
, , O
produces VBZ O
N-(3-oxohexanoyl)-L-homoserine JJ O
lactone NN O
( -LRB- O
HSL) NNP O
, , O
a DT O
starvation/cell NN O
density-sensing JJ O
signal NN O
required VBN O
for IN O
extracellular JJ O
enzyme NN O
production NN O
. . O

-DOCSTART- X X O

The DT O
101st JJ O
annual JJ O
meeting NN O
of IN O
the DT O
Japanese JJ O
Ophthalmological NNP O
Society NNP O
. . O

-DOCSTART- X X O

In IN O
patients NNS O
in IN O
which WDT O
these DT O
criteria NNS O
were VBD O
not RB O
met VBN O
only RB O
the DT O
reproducibility NN O
of IN O
the DT O
VO2 NNP O
obtained VBD O
in IN O
both DT O
the DT O
P-MET NNP O
and CC O
the DT O
C-MET NN O
indicated VBD O
that IN O
the DT O
maximal JJ O
VO2 NN O
for IN O
these DT O
4 CD O
patients NNS O
had VBD O
been VBN O
reached VBN O
. . O

-DOCSTART- X X O

In IN O
conclusion NN O
, , O
ORCA3 NNP B-NP
regulates VBZ O
jasmonate-responsive JJ O
expression NN O
of IN O
the DT O
Str NNP B-NP
gene NN I-NP
via IN O
direct JJ O
interaction NN O
with IN O
the DT O
JERE. NNP O

-DOCSTART- X X O

Pseudotumor NN O
form NN O
of IN O
pulmonary JJ O
nocardia NN O
infection NN O
( -LRB- O
Nocardia NN O
nova NN O
) -RRB- O
in IN O
a DT O
renal JJ O
transplant NN O
patient NN O

-DOCSTART- X X O

Deoxyuridine-suppression NN O
test NN O
and CC O
bone NN O
marrow NN O
culture NN O
for IN O
the DT O
diagnosis NN O
of IN O
macrocytic JJ O
refractory JJ O
anaemias NNS O
. . O

-DOCSTART- X X O

A DT O
computerized JJ O
database NN O
of IN O
veterans NNS O
discharged VBN O
from IN O
the DT O
military JJ O
after IN O
1967 CD O
was VBD O
selected VBN O
as IN O
the DT O
source NN O
because IN O
it PRP O
contains VBZ O
about IN O
50 CD O
% NN O
of IN O
the DT O
total JJ O
Vietnam NNP O
era NN O
veteran JJ O
population NN O
, , O
is VBZ O
reasonably RB O
unbiased JJ O
, , O
and CC O
provides VBZ O
a DT O
feasible JJ O
method NN O
for IN O
identifying VBG O
twins NNS O
. . O

-DOCSTART- X X O

Keys NNP O
can MD O
be VB O
used VBN O
for IN O
identifying VBG O
species NNS O
from IN O
the DT O
European JJ O
part NN O
of IN O
the DT O
USSR NNP O
and CC O
north-eastern JJ O
Kazakhstan NNP O
. . O

-DOCSTART- X X O

To TO O
initiate VB O
our PRP$ O
analysis NN O
of IN O
factors NNS O
required VBN O
for IN O
eIF-2 JJ B-NP
alpha NN I-NP
expression NN O
, , O
selected VBN O
a DT O
CAP-proximal JJ O
element NN O
shown VBN O
by IN O
in IN O
vivo JJ O
methylation NN O
protection NN O
analysis NN O
to TO O
bind NN O
a DT O
potential JJ O
regulatory JJ O
factor NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
monaural JJ O
middle JJ O
ear NN O
destruction NN O
on IN O
postnatal JJ O
development NN O
of IN O
mouse NN O
inferior JJ O
colliculus NN O
. . O

-DOCSTART- X X O

The DT O
specificity NN O
and CC O
sensitivity NN O
of IN O
this DT O
method NN O
( -LRB- O
limit NN O
of IN O
detection NN O
in IN O
plasma NN O
0.025 CD O
micrograms/mL NN O
and CC O
< NN O
or CC O
= SYM O
0.0125 CD O
micrograms/mL NN O
for IN O
febantel NN O
and CC O
its PRP$ O
metabolites NNS O
, , O
respectively RB O
) -RRB- O
were VBD O
sufficiently RB O
high JJ O
to TO O
enable VB O
us PRP O
to TO O
characterize VB O
the DT O
time NN O
course NN O
of IN O
the DT O
drug NN O
in IN O
the DT O
plasma NN O
after IN O
oral JJ O
administration NN O
of IN O
therapeutic JJ O
doses NNS O
to TO O
sheep. MD O

-DOCSTART- X X O

MATERIALS NNS O
AND CC O
METHODS NNS O
: : O
A DT O
seven-wavelength JJ O
frequency-domain JJ O
photon NN O
migration NN O
probe NN O
was VBD O
used VBN O
to TO O
perform VB O
noninvasive JJ O
NIR NN O
measurements NNS O
in IN O
the DT O
breasts NNS O
of IN O
28 CD O
healthy JJ O
women NNS O
, , O
both DT O
pre JJ O
- : O
and CC O
postmenopausal JJ O
, , O
aged JJ O
18-64 CD O
years NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
targeted VBN O
to TO O
peroxisomes NNS O
when WRB O
expressed VBN O
in IN O
mammalian JJ O
cells NNS O
and CC O
yeast NN O
. . O

-DOCSTART- X X O

All DT O
except IN O
the DT O
last JJ O
two CD O
interventions NNS O
are VBP O
physical JJ O
treatments NNS O
that WDT O
create VBP O
a DT O
wound-tissue JJ O
environment NN O
conducive NN O
to TO O
healing NN O
. . O

-DOCSTART- X X O

Consistent NN O
with IN O
our PRP$ O
observation NN O
that IN O
AP-1 NN B-NP
binding NN O
does VBZ O
not RB O
contribute VB O
to TO O
c-Jun JJ B-NP
coactivation NN O
is VBZ O
the DT O
observation NN O
that IN O
the DT O
activation NN O
of IN O
PU.1 NNP B-NP
by IN O
c-Jun NN B-NP
is VBZ O
blocked VBN O
by IN O
overexpression NN O
of IN O
c-Fos NNS B-NP
. . O

-DOCSTART- X X O

In IN O
a DT O
series NN O
of IN O
papers NNS O
, , O
the DT O
staging NN O
system NN O
for IN O
melanoma NN O
was VBD O
critically RB O
analyzed VBN O
, , O
and CC O
many JJ O
shortcomings NNS O
were VBD O
identified VBN O
. . O

-DOCSTART- X X O

The DT O
levels NNS O
of IN O
products NNS O
expressed VBN O
from IN O
these DT O
chimeric JJ O
cDNAs NNS O
in IN O
COS NNP O
cells NNS O
were VBD O
assessed VBN O
by IN O
activity NN O
assay NN O
and CC O
by IN O
metabolic JJ O
labeling NN O
of IN O
the DT O
proteins NNS O
followed VBN O
by IN O
immunoprecipitation NN O
and CC O
SDS-PAGE. NNP O

-DOCSTART- X X O

The DT O
leucine NN O
zipper IN O
region NN O
of IN O
ATF NNP B-NP
proteins NNS I-NP
is VBZ O
also RB O
similar JJ O
to TO O
that DT O
of IN O
the DT O
AP-1/c-jun JJ B-NP
family NN O
of IN O
transcription NN O
factors NNS O
, , O
whose WP$ O
DNA-binding JJ O
site NN O
differs NNS O
from IN O
the DT O
ATF-binding JJ B-NP
site NN O
at IN O
a DT O
single JJ O
position NN O
. . O

-DOCSTART- X X O

Immunoblotting NNP O
with IN O
antiphosphotyrosine DT O
antibody NN O
showed VBD O
that IN O
many JJ O
yeast NN O
proteins NNS O
, , O
including VBG O
the DT O
p34CDC28 NNS B-NP
kinase NN I-NP
, , O
became VBD O
phosphorylated VBN O
at IN O
tyrosine NN O
in IN O
cells NNS O
expressing VBG O
v-src JJ B-NP
. . O

-DOCSTART- X X O

AIMS NNP O
: : O
We PRP O
postulated VBD O
that IN O
perhexiline NN O
, , O
a DT O
novel JJ O
anti-ischaemic JJ O
agent NN O
with IN O
an DT O
oxygen-sparing NN O
metabolic JJ O
effect NN O
in IN O
the DT O
myocardium NN O
(via IN O
inhibition NN O
of IN O
carnitine JJ B-NP
palmitoyltransferase-1 NN I-NP
) -RRB- O
and CC O
no DT O
adverse JJ O
haemodynamic JJ O
effects NNS O
, , O
may MD O
improve VB O
symptomatic JJ O
status NN O
in IN O
elderly JJ O
patients NNS O
with IN O
severe JJ O
aortic JJ O
stenosis NN O
. . O

-DOCSTART- X X O

Developmentally-regulated JJ O
interaction NN O
of IN O
a DT O
transcription NN O
factor NN O
complex NN O
containing VBG O
CDP/cut NN B-NP
with IN O
the DT O
early JJ B-NP
histone NN I-NP
H3 . I-NP
gene NN I-NP
promoter NN I-NP
of IN I-NP
the DT I-NP
sea NN I-NP
urchin IN I-NP
Tetrapygus NNP I-NP
niger NN I-NP
is VBZ O
associated VBN O
with IN O
changes NNS O
in IN O
chromatin NN O
structure NN O
and CC O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
group NN O
of IN O
patients NNS O
, , O
the DT O
mean JJ O
LH NNP B-NP
( -LRB- O
9.3 CD O
+/ NN O
- : O
5.9 CD O
IU/l NN O
) -RRB- O
and CC O
sex-hormone NN B-NP
binding NN I-NP
globulin NN I-NP
( -LRB- O
SHBG NN B-NP
) -RRB- O
( -LRB- O
54.5 CD O
+/ NN O
- : O
22.9 CD O
nmol/l NN O
) -RRB- O
concentrations NNS O
were VBD O
significantly RB O
greater JJR O
than IN O
those DT O
of IN O
five CD O
normal JJ O
control NN O
subjects NNS O
( -LRB- O
4.7 CD O
+/ NN O
- : O
1.11 CD O
IU/l NN O
and CC O
26.0 CD O
+/ NNS O
- : O
7.0 CD O
nmol/l NN O
respectively RB O
) -RRB- O
. . O

-DOCSTART- X X O

Structural JJ O
organization NN O
of IN O
the DT O
human JJ B-NP
Elk1 NNP I-NP
gene NN I-NP
and CC O
its PRP$ O
processed VBN O
pseudogene NN B-NP
Elk2 NNP I-NP
. . O

-DOCSTART- X X O

Prematurely RB O
inactivating VBG O
p42 DT B-NP
MAPK NNP I-NP
in IN O
egg NN O
extracts NNS O
resulted VBD O
in IN O
a DT O
corresponding JJ O
hastening NN O
of IN O
the DT O
first JJ O
mitosis NN O
. . O

-DOCSTART- X X O

Anxiogenic JJ O
effects NNS O
of IN O
pentagastrin VBG O
in IN O
patients NNS O
with IN O
social JJ O
phobia NN O
and CC O
healthy JJ O
controls NNS O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
a DT O
putative JJ O
chromosomal NN O
replication NN O
origin NN O
from IN O
Helicobacter NNP O
pylori NN O
and CC O
its PRP$ O
interaction NN O
with IN O
the DT O
initiator NN B-NP
protein NN I-NP
DnaA NNP I-NP
. . O

-DOCSTART- X X O

Sub-inhibitory JJ O
and CC O
post-antibiotic JJ O
effects NNS O
of IN O
spiramycin NN O
and CC O
erythromycin NN O
on IN O
Staphylococcus NNP O
aureus NN O
. . O

-DOCSTART- X X O

Because IN O
the DT O
variation NN O
in IN O
the DT O
carbohydrate NN O
content NN O
of IN O
human JJ O
milk NN O
is VBZ O
very RB O
small JJ O
, , O
a DT O
more RBR O
simple JJ O
alternative JJ O
approach NN O
would MD O
be VB O
to TO O
include VB O
only RB O
an DT O
average JJ O
carbohydrate NN O
value NN O
for IN O
an DT O
estimate NN O
of IN O
energy NN O
content NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
suggested VBN O
that IN O
biliary JJ O
secretion NN O
of IN O
both DT O
TBZ NNP O
and CC O
FBZ NNP O
and CC O
their PRP$ O
metabolites NNS O
may MD O
contribute VB O
to TO O
this DT O
recycling NN O
. . O

-DOCSTART- X X O

Hyperlipemia NNP O
has VBZ O
been VBN O
recently RB O
described VBN O
in IN O
children NNS O
with IN O
migraine JJ O
, , O
being VBG O
suggested VBN O
that IN O
this DT O
alteration NN O
is VBZ O
in IN O
the DT O
base NN O
of IN O
the DT O
disease NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
A DT O
thorough JJ O
understanding NN O
of IN O
malignant JJ O
fibrous JJ O
histiocytoma NN O
( -LRB- O
MFH) NNP O
, , O
the DT O
most RBS O
common JJ O
subtype NN O
of IN O
soft JJ O
tissue NN O
sarcoma NN O
, , O
will MD O
lead VB O
to TO O
improved JJ O
histologic-specific JJ O
protocols NNS O
. . O

-DOCSTART- X X O

Using VBG O
yeast NN O
two-hybrid JJ O
screening NN O
, , O
we PRP O
isolated VBD O
histone NN B-NP
H3 . I-NP
as IN O
an DT O
interacting JJ O
factor NN O
of IN O
CIA NNP B-NP
. . O

-DOCSTART- X X O

Elevated VBN O
total JJ O
serum NN O
calcium NN O
to TO O
a DT O
level NN O
of IN O
11.9 CD O
+/ NNS O
- : O
0.2 CD O
mg/dl NN O
( -LRB- O
p NN O
less JJR O
than IN O
0.001 CD O
compared VBN O
to TO O
control NN O
group NN O
) -RRB- O
developed VBN O
in IN O
the DT O
gentamicin/1,25( JJ O
OH)2 NNP O
vitamin NN O
D3 IN O
group NN O
on IN O
day NN O
4 CD O
, , O
2 CD O
days NNS O
prior RB O
to TO O
pronounced VBN O
structural JJ O
damage NN O
, , O
and CC O
continued VBD O
to TO O
be VB O
elevated VBN O
through IN O
day NN O
7. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
steroid NN O
resistant JJ O
rejection NN O
following VBG O
renal JJ O
transplantation NN O
: : O
benefits NNS O
and CC O
risks NNS O
of IN O
OKT3 JJ B-NP
therapy NN O
. . O

-DOCSTART- X X O

SETTING NNP O
: : O
University NNP O
research NN O
laboratory NN O
. . O

-DOCSTART- X X O

Binding NNP O
of IN O
C/EBPs NNS B-NP
to TO O
all DT O
three CD O
spi NN B-NP
2.3 CD I-NP
3' CD I-NP
UTR NN I-NP
repressor NN I-NP
sites NNS I-NP
, , O
although IN O
rather RB O
weak JJ O
, , O
was VBD O
confirmed VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assays VBZ O
that IN O
otherwise RB O
failed VBN O
to TO O
reveal VB O
specific JJ O
interactions NNS O
with IN O
other JJ O
liver NN O
nuclear JJ O
proteins NNS O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Despite IN O
the DT O
fact NN O
that IN O
biochemical JJ O
estimates NNS O
of IN O
bone NN O
turnover NN O
indicate VBP O
that IN O
( -LRB- O
short-term JJ O
) -RRB- O
administration NN O
of IN O
rhGH NNP B-NP
and CC O
IGF-I NNP B-NP
stimulates NNS O
bone NN O
metabolism NN O
in IN O
non-osteoporotic JJ O
older JJR O
people NNS O
, , O
no DT O
significant JJ O
changes NNS O
have VBP O
been VBN O
observed VBN O
in IN O
bone NN O
mineral NN O
density NN O
at IN O
the DT O
proximal JJ O
femur NN O
. . O

-DOCSTART- X X O

Our PRP$ O
studies NNS O
suggest VBP O
that IN O
the DT O
helicase NN B-NP
assembly NN O
protein NN O
is VBZ O
responsible JJ O
for IN O
loading VBG O
T4 NNP B-NP
gene NN I-NP
41 CD I-NP
helicase NN I-NP
specifically RB O
at IN O
replication NN O
forks NNS O
, , O
and CC O
that IN O
its PRP$ O
binding NN O
sites NNS O
for IN O
each DT O
arm NN O
must MD O
hold VB O
more JJR O
than IN O
six CD O
, , O
but CC O
not RB O
more JJR O
than IN O
12 CD O
nucleotides NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
strongly RB O
suggest VBP O
that IN O
HSV-1 JJ O
infection NN O
inhibits VBZ O
host NN O
cell NN O
splicing NN O
through IN O
the DT O
action NN O
of IN O
ICP27 NN B-NP
. . O

-DOCSTART- X X O

Sci NNS O
. . O

-DOCSTART- X X O

In IN O
our PRP$ O
initial JJ O
studies NNS O
, , O
we PRP O
treated VBD O
MCF-7 JJ O
cells NNS O
with IN O
paclitaxel NN O
, , O
which WDT O
results VBZ O
in IN O
the DT O
arrest NN O
of IN O
cells NNS O
in IN O
G1 NNP O
with IN O
4n JJ O
DNA NN O
content NN O
( -LRB- O
pseudo NN O
G1 NNP O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
GTP/GDP NNP O
exchange NN O
assay NN O
was VBD O
used VBN O
to TO O
assess VB O
the DT O
potential JJ O
role NN O
of IN O
Ras NNP B-NP
in IN O
the DT O
pathway NN O
leading VBG O
to TO O
ERK NNP B-NP
phosphorylation NN O
; : O
DADLE NNP O
failed VBD O
to TO O
stimulate VB O
GTP/GDP NNP O
exchange NN O
in IN O
comparison NN O
to TO O
PMA. NNP O

-DOCSTART- X X O

Copyright NNP O
1999 CD O
Academic NNP O
Press NNP O
. . O

-DOCSTART- X X O

The DT O
remaining VBG O
77 CD O
nucleotides NNS O
at IN O
the DT O
3' JJ O
end NN O
of IN O
domain NN O
II NNP O
and CC O
all DT O
of IN O
domains NNS O
III NNP O
( -LRB- O
655 NN O
nucleotides NNS O
) -RRB- O
and CC O
IV NNP O
( -LRB- O
770 CD O
nucleotides NNS O
) -RRB- O
are VBP O
not RB O
present JJ O
in IN O
DIssE NNP B-NP
RNA NNP I-NP
. . O

-DOCSTART- X X O

Changes NNS O
in IN O
tension NN O
were VBD O
monitored VBN O
isometrically RB O
on IN O
spiral JJ O
strips NNS O
of IN O
freshly RB O
obtained VBN O
bovine NN O
basilar NN O
arteries NNS O
. . O

-DOCSTART- X X O

The DT O
preparative JJ O
regimen NNS O
consisted VBD O
of IN O
fractionated JJ O
total JJ O
body NN O
irradiation NN O
( -LRB- O
TBI NNP O
) -RRB- O
and CC O
cyclophosphamide NN O
( -LRB- O
CY NN O
) -RRB- O
. . O

-DOCSTART- X X O

Consistent NNP O
with IN O
the DT O
large JJ O
pocket NN O
of IN O
Rb NNP B-NP
binding NN O
to TO O
TAF(II)250 CD B-NP
, , O
the DT O
large JJ O
pocket NN O
domains NNS O
of IN O
both DT O
p107 NNS B-NP
and CC O
p130 PRP B-NP
are VBP O
able JJ O
to TO O
bind NN O
to TO O
TAF(II)250 CD B-NP
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
the DT O
derived VBN O
amino IN O
acid JJ O
sequence NN O
with IN O
that DT O
of IN O
the DT O
HCMV NNP B-NP
UL99 NNP I-NP
gene NN I-NP
product NN I-NP
reveals VBZ O
34.8 CD O
% NN O
identity NN O
in IN O
an DT O
overlap NN O
of IN O
66 CD O
amino IN O
acids NNS O
. . O

-DOCSTART- X X O

Fentanyl NNP O
citrate NN O
( -LRB- O
0.1 CD O
mL NN O
) -RRB- O
and CC O
2H5-fentanyl JJ O
( -LRB- O
internal JJ O
standard NN O
, , O
0.05 CD O
mL NN O
, , O
100 CD O
mg/L NN O
) -RRB- O
were VBD O
extracted VBN O
with IN O
Toxi-A JJ O
tubes NNS O
( -LRB- O
Toxi-Lab NNP O
, , O
Irvine NNP O
, , O
CA NNP O
) -RRB- O
and CC O
analyzed VBN O
by IN O
gas NN O
chromatography-mass NN O
spectrometry NN O
. . O

-DOCSTART- X X O

O5257 CD B-NP
shows NNS O
homology NN O
with IN O
the DT O
SAS2 NNP B-NP
protein NN I-NP
and CC O
another DT O
hypothetical JJ O
protein NN O
from IN O
yeast NN O
. . O

-DOCSTART- X X O

Cotransfection NN O
of IN O
expression NN O
plasmids NNS O
encoding VBG O
the DT O
protein NN B-NP
kinase NN I-NP
A DT I-NP
inhibitor NN O
, , O
or CC O
an DT O
inactive JJ O
protein NN B-NP
kinase NN I-NP
A DT I-NP
( -LRB- O
PKA NN B-NP
) -RRB- O
catalytic JJ O
beta JJ O
subunit NN O
, , O
inhibited VBD O
both DT O
forskolin NN O
and CC O
PACAP NNP B-NP
activation NN O
of IN O
chromogranin NN B-NP
A DT I-NP
transcription NN O
, , O
revealing VBG O
that IN O
PACAP-induced NNP B-NP
trans-activation NN O
is VBZ O
highly RB O
dependent JJ O
on IN O
PKA. NNP B-NP

-DOCSTART- X X O

The DT O
uap100 CD B-NP
cis-acting NN O
, , O
up-promoter JJ O
, , O
constitutive JJ O
mutation NN O
is VBZ O
a DT O
duplication NN O
that WDT O
comprises VBZ O
two CD O
GATA NNP O
sites NNS O
and CC O
suppresses NNS O
weakly RB O
the DT O
AREA NN B-NP
zinc NN I-NP
finger NN I-NP
mutation NN I-NP
but CC O
does VBZ O
not RB O
alleviate VB O
the DT O
need NN O
for IN O
functional JJ O
UAY NNP B-NP
and CC O
AREA NNP B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

With IN O
BCPP NNP O
protocol NN O
, , O
12 CD O
achieved VBD O
a DT O
complete JJ O
response NN O
, , O
11 CD O
evidenced VBN O
a DT O
75 CD O
% NN O
response NN O
, , O
and CC O
7 CD O
displayed VBD O
a DT O
50 CD O
% NN O
response NN O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
tilmicosin NN O
administration NN O
in IN O
the DT O
feed NN O
at IN O
400 CD O
mg/kg NN O
and CC O
an DT O
injection NN O
therapy NN O
of IN O
clinically RB O
diseased JJ O
pigs NNS O
with IN O
long-acting JJ O
oxytetracycline NN O
( -LRB- O
Terramycine NN O
LA NNP O
) -RRB- O
at IN O
20 CD O
mg/kg NN O
bodyweight NN O
were VBD O
compared VBN O
. . O

-DOCSTART- X X O

In IN O
7 CD O
men NNS O
and CC O
1 CD O
woman NN O
who WP O
died VBD O
suddenly RB O
the DT O
functionally RB O
important JJ O
areas NNS O
of IN O
myocardium NN O
in IN O
the DT O
sino-auricular JJ O
area NN O
and CC O
the DT O
subendocardial JJ O
layers NNS O
of IN O
left JJ O
ventricle NN O
were VBD O
obtained VBN O
by IN O
necropsy NN O
no DT O
more JJR O
than IN O
3 CD O
h NN O
after IN O
death NN O
, , O
and CC O
then RB O
prepared VBD O
for IN O
study NN O
by IN O
electron NN O
microscopy NN O
. . O

-DOCSTART- X X O

Pyridostigmine NN O
pretreatment NN O
was VBD O
supplemented VBN O
by IN O
therapy NN O
with IN O
two CD O
doses NNS O
of IN O
an DT O
antidotal JJ O
combination NN O
( -LRB- O
A,TM,B) NNP O
consisting VBG O
of IN O
0.05 CD O
mg/kg NN O
atropine NN O
, , O
2.24 CD O
mg/kg NN O
TMB-4 NN O
, , O
and CC O
0.4 CD O
mg/kg NN O
benactyzine NN O
which WDT O
assured VBD O
survival NN O
in IN O
five CD O
of IN O
six CD O
animals NNS O
following VBG O
three CD O
separate JJ O
exposures NNS O
to TO O
10 CD O
LD50 CD O
soman NN O
. . O

-DOCSTART- X X O

Electrophoretic NNP O
mobility NN O
shift NN O
assays IN O
and CC O
DNase NNP B-NP
I PRP I-NP
protection NN O
analyses NNS O
revealed VBD O
that IN O
FP NNP B-NP
I PRP I-NP
was VBD O
bound VBN O
by IN O
the DT O
transcription NN O
factor NN O
PU.1/Spi-1 NN B-NP
. . O

-DOCSTART- X X O

Motilin NNP B-NP
serum NN O
levels NNS O
were VBD O
measured VBN O
for IN O
one CD O
hour NN O
. . O

-DOCSTART- X X O

Parameters NNS O
of IN O
sperm JJ O
quality NN O
were VBD O
evaluated VBN O
before IN O
and CC O
after IN O
freezing/thawing VBG O
. . O

-DOCSTART- X X O

Comment NN O
on IN O
" `` O
Critical JJ O
behavior NN O
of IN O
a DT O
binary JJ O
mixture NN O
of IN O
protein NN O
and CC O
salt NN O
water NN O
" '' O

-DOCSTART- X X O

Site-directed JJ O
mutagenesis NN O
was VBD O
conducted VBN O
to TO O
investigate VB O
the DT O
functional JJ O
significance NN O
of IN O
this DT O
element NN O
and CC O
the DT O
3' JJ O
minus-strand NN O
terminal NN O
sequence NN O
" `` O
3'-OH-CCCUAU JJ O
, , O
" '' O
which WDT O
contains VBZ O
the DT O
minus-strand JJ O
3'-end JJ O
sequence NN O
" '' O
3'-OH-CC(1-2 JJ O
)( JJ O
A/U)( NNP O
A/U)( NNP O
A/U)" NNP O
found VBD O
in IN O
all DT O
carmovirus NN O
RNAs NNS O
. . O

-DOCSTART- X X O

Characterization NNP O
of IN O
a DT O
nuclear JJ B-NP
deformed JJ I-NP
epidermal NN I-NP
autoregulatory NN I-NP
factor-1 NN I-NP
( -LRB- O
DEAF-1)-related JJ B-NP
( -LRB- O
NUDR) NNP B-NP
transcriptional , O
regulator NN O
protein NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
family NN O
visits NNS O
on IN O
the DT O
blood NN O
pressure NN O
and CC O
heart NN O
rate NN O
of IN O
patients NNS O
in IN O
the DT O
coronary-care JJ O
unit NN O
. . O

-DOCSTART- X X O

Prospects NNS O
of IN O
chemosterilant NN O
and CC O
genetic JJ O
control NN O
of IN O
rodents NNS O
. . O

-DOCSTART- X X O

Neurological JJ O
toxicity NN O
occurred VBD O
in IN O
8/219 CD O
patients NNS O
treated VBN O
with IN O
fludarabine NN O
( -LRB- O
FAMP) NNP O
, , O
30 CD O
mg/m2 CD O
per IN O
day NN O
and CC O
cytosine NN O
arabinoside NN O
( -LRB- O
Ara-C) NNP O
, , O
0.5 CD O
g/m2 NN O
per IN O
hour NN O
for IN O
2-6 CD O
hours NNS O
for IN O
5 CD O
days NNS O
, , O
for IN O
new JJ O
or CC O
relapsed JJ O
acute JJ O
leukemia NN O
or CC O
myelodysplasia NN O
. . O

-DOCSTART- X X O

Paclitaxel NNP O
caused VBD O
a DT O
rapid JJ O
and CC O
transient JJ O
increase NN O
in IN O
c-Jun JJ B-NP
NH2-terminal JJ I-NP
kinase NN I-NP
( -LRB- O
JNK) NNP B-NP
activity NN O
, , O
a DT O
proposed VBN O
mediator NN O
of IN O
stress NN O
activation NN O
pathways NNS O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
the DT O
Hox NNP B-NP
genes NNS I-NP
egl-5 WDT B-NP
and CC O
mab-5 NN B-NP
is VBZ O
reduced VBN O
in IN O
lin-49 JJ B-NP
and CC O
lin-59 JJ B-NP
mutants NNS I-NP
, , O
suggesting VBG O
lin-49 JJ B-NP
and CC O
lin-59 JJ B-NP
regulate VB O
HOM-C NNP B-NP
gene NN I-NP
expression NN O
in IN O
C. NNP O
elegans NNS O
as IN O
the DT O
trx-G JJ B-NP
genes NNS I-NP
do VBP O
in IN O
Drosophila NNP O
. . O
lin-49 '' B-NP
and CC O
lin-59 JJ B-NP
transgenes NNS I-NP
are VBP O
expressed VBN O
widely RB O
throughout IN O
C. NNP O
elegans NNS O
animals NNS O
. . O

-DOCSTART- X X O

In IN O
cotransfection NN O
assays RB O
, , O
a DT O
small JJ O
fragment NN O
of IN O
Sin NNP B-NP
retaining VBG O
the DT O
Src-SH3-binding JJ B-NP
site NN O
and CC O
one CD O
tyrosine-containing NN O
motif NN O
induced VBN O
c-Src JJ B-NP
activation NN O
as IN O
measured VBN O
by IN O
a DT O
transcriptional JJ O
reporter NN O
. . O

-DOCSTART- X X O

TFIIB NNP B-NP
and CC O
VDR NNP B-NP
can MD O
also RB O
interact VB O
directly RB O
, , O
and CC O
these DT O
factors NNS O
synergize VBP O
to TO O
mediate VB O
transactivation NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
269 CD O
mice NNS O
from IN O
a DT O
( -LRB- O
Mus NNP O
spretus NN O
x NN O
C57BL/6J)F1 IN O
x NN O
C57BL/6J IN O
interspecific JJ O
backcross NN O
were VBD O
also RB O
used VBN O
to TO O
order VB O
marker NN O
loci NNS O
and CC O
calculate VB O
intergene NN O
distances NNS O
for IN O
this DT O
region NN O
. . O

-DOCSTART- X X O

Reduced VBN O
concentrations NNS O
of IN O
antithrombin JJ B-NP
III NNP I-NP
, , O
plasminogen NN B-NP
, , O
( -LRB- O
free JJ O
) -RRB- O
protein NN B-NP
S NNP I-NP
, , O
and CC O
protein NN B-NP
C NNP I-NP
were VBD O
found VBN O
in IN O
some DT O
patients NNS O
but CC O
were VBD O
not RB O
associated VBN O
with IN O
either DT O
thrombosis NN O
or CC O
lupus NN O
anticoagulant NN O
. . O

-DOCSTART- X X O

Three CD O
RasV12 CD B-NP
mutants NNS I-NP
( -LRB- O
S35 CD B-NP
, , O
G37 NNP B-NP
, , O
and CC O
C40 NNP B-NP
) -RRB- O
which WDT O
differ VBP O
by IN O
their PRP$ O
ability NN O
to TO O
bind NN O
to TO O
Ras NNP B-NP
effectors NNS I-NP
( -LRB- O
Raf NNP B-NP
, , O
Ral-GEFs NNP B-NP
, , O
and CC O
the DT O
p110 JJ B-NP
subunit NN I-NP
of IN I-NP
PI NNP I-NP
3-kinase CD I-NP
, , O
respectively RB O
) -RRB- O
were VBD O
able JJ O
to TO O
induce VB O
sustained VBN O
NR NNP O
cell NN O
proliferation NN O
, , O
although IN O
none NN O
of IN O
these DT O
mutants NNS O
was VBD O
reported VBN O
to TO O
transform VB O
NIH NNP O
3T3 CD O
cells NNS O
. . O

-DOCSTART- X X O

A DT O
possible JJ O
correlation NN O
between IN O
mandibular JJ O
growth NN O
retardation NN O
and CC O
palatal NN O
clefting NN O
is VBZ O
discussed VBN O
. . O

-DOCSTART- X X O

Total JJ O
cross NN O
sections NNS O
for IN O
electron JJ O
scattering NN O
by IN O
CO2 NNP O
molecules NNS O
in IN O
the DT O
energy NN O
range NN O
400-5000 CD O
eV NN O
. . O

-DOCSTART- X X O

However RB O
, , O
depending VBG O
upon IN O
the DT O
promoter NN O
context NN O
, , O
we PRP O
observed VBD O
cooperative JJ O
interactions NNS O
between IN O
the DT O
two CD O
domains NNS O
to TO O
confer VB O
high JJ O
DNA-binding NN O
affinity NN O
and CC O
specificity NN O
. . O

-DOCSTART- X X O

This DT O
experience NN O
would MD O
recommend VB O
consideration NN O
of IN O
home NN O
nutritional JJ O
support NN O
in IN O
patients NNS O
with IN O
systemic JJ O
scleroderma NN O
when WRB O
the DT O
disease NN O
is VBZ O
relatively RB O
stable JJ O
and CC O
no DT O
major JJ O
organ NN O
failure NN O
is VBZ O
present JJ O
. . O

-DOCSTART- X X O

Adult-onset NNP O
parkinsonism NN O
has VBZ O
appeared VBN O
in IN O
several JJ O
previously RB O
unaffected JJ O
members NNS O
in IN O
families NNS O
with IN O
DRD NNP O
suggesting VBG O
that IN O
this DT O
may MD O
be VB O
an DT O
additional JJ O
phenotypical JJ O
expression NN O
of IN O
the DT O
disease NN O
. . O

-DOCSTART- X X O

Production NN O
of IN O
VT NNP O
was VBD O
also RB O
examined VBN O
retrospectively RB O
in IN O
32 CD O
E. NNP O
coli NNS O
strains NNS O
of IN O
serotype NN O
O26 IN O
:H11 DT O
isolated VBN O
from IN O
children NNS O
with IN O
diarrhoea NN O
; : O
eight CD O
( -LRB- O
25 CD O
% NN O
) -RRB- O
of IN O
them PRP O
produced VBD O
moderate JJ O
to TO O
high JJ O
levels NNS O
of IN O
verotoxin NN B-NP
1 CD I-NP
despite IN O
several JJ O
years NNS O
storage NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

The DT O
5'-flanking JJ O
region NN O
of IN O
the DT O
gene NN O
, , O
approximately RB O
1.1 CD O
kbp NN O
long JJ O
, , O
had VBD O
no DT O
known VBN O
regulatory JJ O
elements NNS O
for IN O
transcription NN O
such JJ O
as IN O
TATA NNP O
, , O
GC NNP O
, , O
and CC O
CCAAT NN O
boxes NNS O
. . O

-DOCSTART- X X O

The DT O
Molteno NNP O
implant NN O
is VBZ O
an DT O
effective JJ O
procedure NN O
in IN O
the DT O
treatment NN O
of IN O
complicated JJ O
and CC O
refractory JJ O
cases NNS O
of IN O
glaucoma NN O
in IN O
high-risk JJ O
eyes NNS O
. . O

-DOCSTART- X X O

Two CD O
of IN O
the DT O
three CD O
groups NNS O
were VBD O
submitted VBN O
to TO O
two CD O
different JJ O
levels NNS O
of IN O
hypoxia NN O
( -LRB- O
FiO2 NNP O
= SYM O
0.05 CD O
, , O
group NN O
F5 IN O
and CC O
FiO2 IN O
= SYM O
0.1 CD O
, , O
group NN O
F10 IN O
) -RRB- O
and CC O
the DT O
third JJ O
to TO O
normoxia DT O
( -LRB- O
FiO2 NNP O
= SYM O
0.21 CD O
, , O
group NN O
F21 NN O
) -RRB- O
in IN O
a DT O
thermoneutral JJ O
and CC O
controlled JJ O
environment NN O
. . O

-DOCSTART- X X O

Genotype-phenotype JJ O
correlations NNS O
in IN O
male JJ O
patients NNS O
with IN O
a DT O
partial JJ O
nullisomy NN O
of IN O
the DT O
X NNP O
chromosome NN O
have VBP O
suggested VBN O
that IN O
at IN O
least JJS O
one CD O
locus NN O
involved VBN O
in IN O
MRX NNP O
is VBZ O
on IN O
Xp22.3 CD O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
now RB O
completed VBN O
the DT O
primary JJ O
structure NN O
of IN O
fibrillin NNS B-NP
, , O
elucidated VBD O
the DT O
exon/intron NN O
organization NN O
of IN O
the DT O
gene NN O
and CC O
derived VBN O
a DT O
physical JJ O
map NN O
of IN O
the DT O
genetic JJ O
locus NN O
. . O

-DOCSTART- X X O

The DT O
deduced JJ O
amino JJ O
acid NN O
sequence NN O
of IN O
PutR NNP B-NP
( -LRB- O
154 CD O
amino IN O
acid JJ O
residues NNS O
) -RRB- O
showed VBD O
homology NN O
to TO O
the DT O
small JJ O
regulatory JJ O
proteins NNS O
Lrp NNP B-NP
, , O
BkdR NNP B-NP
, , O
and CC O
AsnC. NNP B-NP

-DOCSTART- X X O

NF-kappaB NNP B-NP
only RB O
partially RB O
mediates NNS O
Epstein-Barr NNP B-NP
virus NN I-NP
latent JJ I-NP
membrane NN I-NP
protein NN I-NP
1 CD I-NP
activation NN O
of IN O
B NNP O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
mammalian JJ O
UPR NNP O
is VBZ O
mediated VBN O
by IN O
the DT O
cis-acting JJ O
ER NNP O
stress NN O
response NN O
element NN O
consisting VBG O
of IN O
19 CD O
nt NN O
(CCAATN(9)CCACG) NN O
, , O
the DT O
CCACG JJ O
part NN O
of IN O
which WDT O
is VBZ O
considered VBN O
to TO O
provide VB O
specificity NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
dietary NN O
lipids NNS O
on IN O
whole-body JJ O
retention NN O
and CC O
organ NN O
distribution NN O
of IN O
organic JJ O
and CC O
inorganic JJ O
mercury NN O
in IN O
mice NNS O
. . O

-DOCSTART- X X O

This DT O
region NN O
shows VBZ O
46 CD O
% NN O
identity NN O
with IN O
the DT O
calmodulin-binding JJ B-NP
region NN I-NP
of IN O
rat NN B-NP
brain NN I-NP
Ca2+/calmodulin-dependent JJ I-NP
protein NN I-NP
kinase NN I-NP
II NNP I-NP
and CC O
32 CD O
% NN O
identity NN O
with IN O
the DT O
equivalent JJ O
region NN O
of IN O
chicken NN B-NP
smooth JJ I-NP
muscle NN I-NP
myosin JJ I-NP
light NN I-NP
chain NN I-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

Copyright NNP O
1998 CD O
Academic NNP O
Press NNP O
. . O

-DOCSTART- X X O

We PRP O
identified VBD O
clones NNS O
of IN O
Chlamydomonas NNP O
genomic JJ O
DNA NN O
that WDT O
rescued VBD O
the DT O
Ca( NNP O
2+)-dependent JJ O
axonemal NN O
microtubule NN O
severing JJ O
defect NN O
of IN O
fa1 CD B-NP
mutants NNS I-NP
. . O

-DOCSTART- X X O

STUDY NNP O
SELECTION NNP O
: : O
Not RB O
applicable JJ O
. . O

-DOCSTART- X X O

Sequence NN O
and CC O
deletion NN O
analysis NN O
of IN O
the DT O
recombination NN B-NP
enhancement NN I-NP
gene NN I-NP
( -LRB- O
ref NN B-NP
) -RRB- O
of IN O
bacteriophage NN O
P1 NNS O
: : O
evidence NN O
for IN O
promoter-operator NN O
and CC O
attenuator-antiterminator NN O
control NN O
. . O

-DOCSTART- X X O

Viral JJ B-NP
protein NN I-NP
U NNP I-NP
(Vpu NNP O
) -RRB- O
is VBZ O
a DT O
protein NN O
encoded VBN O
by IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( -LRB- O
HIV-1 NN O
) -RRB- O
that WDT O
promotes VBZ O
the DT O
degradation NN O
of IN O
the DT O
virus NN O
receptor NN O
, , O
CD4 NNP B-NP
, , O
and CC O
enhances VBZ O
the DT O
release NN O
of IN O
virus NN O
particles NNS O
from IN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
overall JJ O
objective JJ O
response NN O
rate NN O
( -LRB- O
RR NN O
) -RRB- O
was VBD O
50 CD O
% NN O
[95 CD O
% NN O
confidence NN O
interval NN O
( -LRB- O
CI) NNP O
= SYM O
29-71 CD O
% NN O
] SYM O
including VBG O
four CD O
complete JJ O
responses NNS O
and CC O
eight CD O
partial JJ O
responses NNS O
. . O

-DOCSTART- X X O

SH3A NNP B-NP
competes VBZ O
with IN O
the DT O
SH3 JJ B-NP
domains NNS I-NP
of IN O
Grb2 NNP B-NP
in IN O
binding NN O
to TO O
mSos1 VB B-NP
, , O
and CC O
the DT O
intersectin-mSos1 JJ B-NP
complex NN O
can MD O
be VB O
separated VBN O
from IN O
Grb2 NNP B-NP
by IN O
sucrose DT O
gradient JJ O
centrifugation NN O
. . O

-DOCSTART- X X O

Both DT O
oligonucleotide NNP O
cross-competition NN O
and CC O
antibody NN O
supershift NN O
experiments NNS O
established VBN O
that IN O
the DT O
double-strand JJ O
binding JJ O
protein NN O
is VBZ O
equivalent JJ O
to TO O
Sp1 VB B-NP
. . O

-DOCSTART- X X O

Epithelial NNP O
cells NNS O
had VBD O
abnormal JJ O
and CC O
accelerated VBN O
exfoliation NN O
which WDT O
resulted VBD O
in IN O
multifocal JJ O
epithelial JJ O
defects NNS O
. . O

-DOCSTART- X X O

Influenza NNP O
virus-induced VBD O
NF-kappaB-dependent JJ B-NP
gene NN I-NP
expression NN O
is VBZ O
mediated VBN O
by IN O
overexpression NN O
of IN O
viral JJ O
proteins NNS O
and CC O
involves VBZ O
oxidative JJ O
radicals NNS O
and CC O
activation NN O
of IN O
IkappaB NNP B-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

This DT O
demonstrates VBZ O
a DT O
relative JJ O
independence NN O
of IN O
the DT O
given VBN O
synchronizer NN O
of IN O
rhythmicity NN O
at IN O
a DT O
tissue NN O
level NN O
from IN O
any DT O
influence NN O
of IN O
the DT O
higher JJR O
regulatory JJ O
center NN O
. . O

-DOCSTART- X X O

Since IN O
nearly RB O
all DT O
transformants NNS O
involving VBG O
homeologous JJ O
DNAs NNP O
carried VBD O
a DT O
single JJ O
recombinant JJ O
plasmid NN O
in IN O
both DT O
Pms NNP B-NP
+ NNP I-NP
and CC O
Pms NNP B-NP
- : I-NP
strains NNS O
, , O
stable JJ O
heteroduplex JJ O
DNA NN O
appears VBZ O
less RBR O
likely JJ O
than IN O
for IN O
homologous JJ O
DNAs NNP O
. . O

-DOCSTART- X X O

Western JJ O
and CC O
immunocytochemical JJ O
analysis NN O
implied VBN O
that IN O
PREB JJ B-NP
accumulates NNS O
specifically RB O
in IN O
GH3 JJ O
cell NN O
nuclei NNS O
. . O

-DOCSTART- X X O

Coronary JJ O
arteries NNS O
were VBD O
found VBN O
in IN O
the DT O
biopsy JJ O
tissue NN O
of IN O
30 CD O
( -LRB- O
76 CD O
% NN O
) -RRB- O
of IN O
the DT O
39 CD O
patients NNS O
who WP O
formed VBD O
the DT O
study NN O
group NN O
. . O

-DOCSTART- X X O

Cotransfection NN O
of IN O
a DT O
junB NN B-NP
stimulated VBD O
the DT O
basal JJ O
activity NN O
of IN O
the DT O
alpha NN B-NP
2( JJ I-NP
I PRP I-NP
) -RRB- I-NP
collagen NN I-NP
promoter NN I-NP
93-fold JJ O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Anesthesia NNP O
was VBD O
induced VBN O
by IN O
droperidol NN O
0.2 CD O
mg.kg-1 NN O
, , O
fentanyl NN O
50 CD O
micrograms NNS O
, , O
thiamylal DT O
150-250 CD O
mg NN O
, , O
and CC O
succinylcholine NN O
1 CD O
mg.kg-1 NN O
, , O
and CC O
maintained VBD O
with IN O
nitrous JJ O
oxide NN O
and CC O
O2 NNP O
( -LRB- O
67:33 NN O
) -RRB- O
supplemented VBN O
with IN O
repeated VBN O
i IN O
.v. NNP O
doses NNS O
of IN O
fentanyl NN O
( -LRB- O
within IN O
15 CD O
micrograms.kg-1 NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
this DT O
system NN O
, , O
enhancers NNS O
act VBP O
primarily RB O
to TO O
increase VB O
the DT O
probability NN O
of IN O
rapid JJ O
and CC O
efficient JJ O
transcription NN O
complex JJ O
formation NN O
and CC O
initiation NN O
. . O

-DOCSTART- X X O

( -LRB- O
i NN O
) -RRB- O
p60 VBZ B-NP
bound VBN O
fast-migrating JJ O
, , O
underprocessed JJ O
wild-type JJ B-NP
ICP22 NN I-NP
and CC O
ICP22 NN B-NP
lacking VBG O
the DT O
carboxyl-terminal JJ O
24 CD O
amino IN O
acids NNS O
but CC O
not RB O
ICP22 IN B-NP
lacking VBG O
the DT O
carboxyl-terminal JJ O
40 CD O
amino IN O
acids NNS O
, , O
whereas IN O
the DT O
previously RB O
identified VBN O
cellular JJ B-NP
protein NN I-NP
p78 NN I-NP
( -LRB- O
R NN O
. . O

-DOCSTART- X X O

This DT O
group NN O
showed VBD O
the DT O
presence NN O
of IN O
bacteria NNS O
infiltrated VBN O
at IN O
the DT O
dentinal JJ O
tubules NNS O
coronally RB O
and CC O
into IN O
the DT O
root NN O
canals NNS O
. . O

-DOCSTART- X X O

Hydroxyl NNP O
radical JJ O
footprinting NN O
of IN O
DNA NNP O
complexes NNS O
of IN O
the DT O
ets NNS B-NP
domain NN I-NP
of IN O
PU.1 NNP B-NP
and CC O
its PRP$ O
comparison NN O
to TO O
the DT O
crystal NN O
structure NN O
. . O

-DOCSTART- X X O

The DT O
generation NN O
of IN O
dorso-ventral JJ O
polarity NN O
during IN O
Drosophila NNP O
embryogenesis NN O
is VBZ O
regulated VBN O
by IN O
the DT O
action NN O
of IN O
12 CD O
maternally RB O
expressed VBN O
gene NN O
products NNS O
, , O
the DT O
dorsal JJ B-NP
group NN I-NP
. . O

-DOCSTART- X X O

Immunoblot NNP O
analysis NN O
of IN O
purified VBN O
and CC O
protease-digested JJ O
intracellular JJ O
mature JJ O
virus NN O
( -LRB- O
IMV) NNP O
and CC O
extracellular JJ O
enveloped JJ O
virus NN O
( -LRB- O
EEV NN O
) -RRB- O
showed VBD O
that IN O
the DT O
A36R JJ B-NP
proteins NNS I-NP
were VBD O
present JJ O
on IN O
the DT O
surface NN O
of IN O
EEV NNP O
with IN O
type NN O
II NNP O
membrane NN O
topology NN O
, , O
but CC O
were VBD O
absent JJ O
from IN O
IMV. NNP O

-DOCSTART- X X O

To TO O
prevent VB O
section NN O
wrinkles NNS O
usually RB O
encountered VBN O
with IN O
the DT O
use NN O
of IN O
coated JJ O
single-hole JJ O
grids NNS O
, , O
a DT O
simple JJ O
method NN O
was VBD O
developed VBN O
. . O

-DOCSTART- X X O

Both DT O
v-Myb JJ B-NP
and CC O
c-Myb JJ B-NP
bind NN O
specifically RB O
to TO O
delta JJ B-NP
E3 NN I-NP
. . O

-DOCSTART- X X O

After IN O
at IN O
least JJS O
one CD O
year NN O
follow-up NN O
, , O
argon NN O
laser NN O
showed VBD O
a DT O
statistically RB O
significant JJ O
effect NN O
( -LRB- O
p NN O
less JJR O
of IN O
0,01 CD O
; : O
Kolmogorow-Smirnov JJ O
test NN O
) -RRB- O
on IN O
the DT O
stabilization NN O
or CC O
the DT O
amelioration NN O
of IN O
visual JJ O
acuity NN O
compared VBN O
with IN O
the DT O
non JJ O
treated VBN O
group NN O
. . O

-DOCSTART- X X O

Relationship NN O
between IN O
age-associated JJ O
endocrine NN O
deficiencies NNS O
and CC O
muscle NN O
function NN O
in IN O
elderly JJ O
women NNS O
: : O
a DT O
cross-sectional JJ O
study NN O
. . O

-DOCSTART- X X O

Intensity NNP O
variations NNS O
from IN O
the DT O
variable JJ O
TR NN O
were VBD O
removed VBN O
, , O
and CC O
the DT O
data NNS O
were VBD O
evaluated VBN O
for IN O
correlation NN O
with IN O
the DT O
lateralized JJ O
stimulus NN O
. . O

-DOCSTART- X X O

Improvement NN O
of IN O
some DT O
pharmaceutical JJ O
properties NNS O
of IN O
clofibrate NN O
by IN O
cyclodextrin NN O
complexation NN O
. . O

-DOCSTART- X X O

We PRP O
assessed VBD O
cardiovascular JJ O
variables NNS O
and CC O
blood NN O
O2 IN O
contents NNS O
in IN O
order NN O
to TO O
characterize VB O
O2 NNP O
transport NN O
in IN O
ponies NNS O
during IN O
treadmill NN O
exercise NN O
. . O

-DOCSTART- X X O

In IN O
HepG2 CD O
cells NNS O
, , O
SREBP-1c JJ B-NP
mRNA NN I-NP
and CC O
precursor JJ O
protein NN O
levels NNS O
were VBD O
induced VBN O
by IN O
treatment NN O
with IN O
22( JJ O
R)-hydroxycholesterol NN O
and CC O
9-cis-retinoic JJ O
acid NN O
, , O
confirming VBG O
that IN O
endogenous JJ O
LXR-RXR JJ B-NP
activation NN O
can MD O
induce VB O
endogenous JJ B-NP
SREBP-1c JJ I-NP
expression NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
sought VBD O
to TO O
determine VB O
the DT O
specific JJ O
effect NN O
of IN O
HIV NNP B-NP
protease NN I-NP
inhibitors NNS O
on IN O
patient JJ O
weight NN O
. . O

-DOCSTART- X X O

E1 JJ B-NP
recognition NN O
sequences NNS O
in IN O
the DT O
bovine NN O
papillomavirus NN O
type NN O
1 CD O
origin NN O
of IN O
DNA NNP O
replication NN O
: : O
interaction NN O
between IN O
half DT O
sites NNS O
of IN O
the DT O
inverted JJ O
repeats NNS O
. . O

-DOCSTART- X X O

Phase NN O
I PRP O
study VBP O
of IN O
5-fluorouracil NN O
and CC O
leucovorin NN O
by IN O
a DT O
14-day JJ O
circadian NN O
infusion NN O
in IN O
metastatic JJ O
adenocarcinoma NN O
patients NNS O
. . O

-DOCSTART- X X O

Although IN O
polyubiquitin NN B-NP
chains NNS I-NP
linked VBD O
through IN O
Lys( JJ O
29 CD O
) -RRB- O
of IN O
ubiquitin NN B-NP
have VBP O
been VBN O
implicated VBN O
in IN O
the DT O
targeting VBG O
of IN O
certain JJ O
substrates NNS O
to TO O
proteasomes NNS O
, , O
the DT O
signaling VBG O
properties NNS O
of IN O
these DT O
chains NNS O
are VBP O
poorly RB O
understood VBN O
. . O

-DOCSTART- X X O

B NNP B-NP
and CC O
C1 NNP B-NP
fusions NNS I-NP
with IN O
yeast NN B-NP
GAL4 NNP I-NP
DNA-binding NNP I-NP
and CC I-NP
transcriptional JJ I-NP
activation NN I-NP
domains NNS I-NP
were VBD O
also RB O
found VBN O
to TO O
interact VB O
when WRB O
synthesized VBN O
and CC O
assayed VBN O
in IN O
yeast NN O
. . O

-DOCSTART- X X O

Deletion NNP O
analysis NN O
of IN O
the DT O
7.3-kb JJ B-NP
GATA-2 NNP I-NP
promoter NN I-NP
region NN I-NP
revealed VBD O
that IN O
a DT O
1.1-kb JJ O
DNA NN O
sequence NN O
is VBZ O
critical JJ O
for IN O
expression NN O
of IN O
GATA-2 NNP B-NP
in IN O
neurons NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
verified VBD O
that IN O
PI NNP B-NP
3-kinase JJ I-NP
associates NNS O
with IN O
the DT O
CD4:p56lck NNP B-NP
complex NN B-NP
as IN O
judged VBN O
by IN O
the DT O
presence NN O
of IN O
PI NNP O
3-phosphate CD O
generated VBD O
from IN O
anti-CD4 DT B-NP
immunoprecipitates NNS O
and CC O
detected VBN O
by IN O
high-pressure JJ O
liquid JJ O
chromatographic JJ O
analysis NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
UNC-4 JJ B-NP
expression NN O
in IN O
the DT O
VA NNP O
motor NN O
neurons NNS O
specifies VBZ O
the DT O
wild-type JJ O
pattern NN O
of IN O
presynaptic JJ O
input NN O
. . O

-DOCSTART- X X O

Transesophageal NNP O
echocardiography NN O
risk NN O
factors NNS O
for IN O
stroke NN O
in IN O
nonvalvular JJ O
atrial JJ O
fibrillation NN O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
in IN O
VDR-mediated JJ B-NP
transcriptional JJ O
activation NN O
, , O
1,25( CD O
OH)2D3 CD O
binding NN O
to TO O
VDR NNP B-NP
alters IN O
the DT O
conformation NN O
of IN O
the DT O
ligand NN O
binding NN O
domain NN O
such JJ O
that IN O
it PRP O
: : O
( -LRB- O
i FW O
) -RRB- O
engages VBZ O
in IN O
strong JJ O
heterodimerization NN O
with IN O
RXR NNP B-NP
to TO O
facilitate VB O
VDRE NNP O
binding NN O
, , O
( -LRB- O
ii NNS O
) -RRB- O
influences VBZ O
the DT O
RXR NNP B-NP
ligand NN I-NP
binding NN I-NP
domain NN I-NP
such JJ O
that IN O
it PRP O
is VBZ O
resistant JJ O
to TO O
the DT O
binding NN O
of IN O
9-cis DT O
RA NNP O
but CC O
active JJ O
in IN O
recruiting VBG O
coactivator NN O
to TO O
its PRP$ O
AF-2 JJ O
and CC O
( -LRB- O
iii NN O
) -RRB- O
presents VBZ O
the DT O
AF-2 JJ O
region NN O
in IN O
VDR NNP B-NP
for IN O
coactivator NN O
association NN O
. . O

-DOCSTART- X X O

Second JJ O
, , O
overexpression IN O
of IN O
RIM11 NNP B-NP
can MD O
suppress VB O
an DT O
ime1 JJ B-NP
missense NN O
mutation NN O
( -LRB- O
ime1-L321F NN B-NP
) -RRB- O
but CC O
not RB O
an DT O
ime1 JJ B-NP
deletion NN O
. . O

-DOCSTART- X X O

Nimodipine NNP O
( -LRB- O
5 CD O
micrograms/kg NN O
) -RRB- O
followed VBN O
by IN O
infusion NN O
of IN O
0.75 CD O
microgram/kg/min NN O
lowered VBD O
the DT O
blood NN O
pressure NN O
by IN O
10 CD O
% NN O
in IN O
both DT O
normotensive JJ O
and CC O
hypertensive JJ O
rats NNS O
; : O
the DT O
same JJ O
dose NN O
schedule NN O
of IN O
nifedipine NN O
did VBD O
not RB O
lower JJR O
MAP. . O

-DOCSTART- X X O

Using VBG O
unidirectional JJ O
PCR NN O
we PRP O
isolated VBD O
a DT O
361-bp JJ O
5' JJ O
promoter NN O
region NN O
and CC O
delineated VBD O
the DT O
intronic JJ O
/ NN O
exonic JJ O
boundaries NNS O
which WDT O
include VBP O
a DT O
non-coding JJ O
exon NN O
1 CD O
, , O
a DT O
single JJ O
intron NN O
, , O
and CC O
a DT O
coding NN O
exon NN O
2 CD O
, , O
a DT O
structure NN O
that WDT O
is VBZ O
typical JJ O
of IN O
genes NNS O
of IN O
the DT O
RNase NN B-NP
A DT I-NP
superfamily NN I-NP
. . O

-DOCSTART- X X O

Results NNS O
of IN O
these DT O
studies NNS O
indicate VBP O
that IN O
binding NN O
of IN O
biotin NN O
to TO O
the DT O
protein NN O
results NNS O
in IN O
protection NN O
of IN O
regions NNS O
of IN O
the DT O
central JJ O
domain NN O
in IN O
the DT O
vicinity NN O
of IN O
the DT O
active JJ O
site NN O
and CC O
the DT O
C-terminal JJ O
domain NN O
from IN O
chemical NN O
cleavage NN O
. . O

-DOCSTART- X X O

The DT O
family NN O
histories NNS O
were VBD O
obtained VBN O
from IN O
the DT O
parents NNS O
. . O

-DOCSTART- X X O

The DT O
structure NN O
of IN O
the DT O
murine NN B-NP
Dtk NNP I-NP
gene NN I-NP
has VBZ O
been VBN O
determined VBN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
demonstrate VBP O
that IN O
oleosin NNP B-NP
gene NN I-NP
transcription NN O
is VBZ O
regulated VBN O
in IN O
a DT O
tissue-specific JJ O
and CC O
temporally RB O
regulated JJ O
manner NN O
and CC O
clearly RB O
indicate VBP O
that IN O
oleosin JJ B-NP
protein NN I-NP
expression NN O
is VBZ O
co-ordinated VBN O
primarily RB O
at IN O
the DT O
transcriptional JJ O
level NN O
. . O

-DOCSTART- X X O

Allergic NNP O
field NN O
: : O
how WRB O
to TO O
detect VB O
it PRP O
? . O

-DOCSTART- X X O

The DT O
actual JJ O
placement NN O
of IN O
the DT O
lesions NNS O
was VBD O
determined VBN O
after IN O
mapping NN O
of IN O
the DT O
GPi NNP O
by IN O
microrecording VBG O
, , O
using VBG O
stimulation NN O
to TO O
identify VB O
the DT O
sensorimotor NN O
region NN O
and CC O
its PRP$ O
somatotopic JJ O
organization NN O
. . O

-DOCSTART- X X O

The DT O
0.018-inch JJ O
FloWire NNP O
provides VBZ O
a DT O
high-fidelity NN O
continuous JJ O
Doppler NNP O
signal NN O
. . O

-DOCSTART- X X O

Mutational JJ O
analysis NN O
of IN O
yeast NN B-NP
CEG1 IN I-NP
demonstrated VBN O
that IN O
four CD O
of IN O
the DT O
five CD O
conserved JJ O
motifs NNS O
are VBP O
essential JJ O
for IN O
capping VBG B-NP
enzyme JJ I-NP
function NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Purified VBN O
phosphorylated JJ O
PhoP NNP B-NP
( -LRB- O
PhoPP NNP B-NP
) -RRB- O
had VBD O
a DT O
half-life NN O
of IN O
approximately RB O
2.5 CD O
h NN O
, , O
which WDT O
was VBD O
reduced VBN O
to TO O
about IN O
15 CD O
min NN O
by IN O
addition NN O
of IN O
the DT O
same JJ O
molar JJ O
amount NN O
of IN O
*PhoR NN B-NP
( -LRB- O
the DT O
cytoplasmic JJ O
region NN O
of IN O
PhoR NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

It PRP O
spans VBZ O
20 CD O
kilobases NNS O
, , O
consists VBZ O
of IN O
7 CD O
exons NNS O
and CC O
6 CD O
introns NNS O
, , O
and CC O
contains VBZ O
a DT O
TATA NNP O
motif NN O
24 CD O
nucleotides NNS O
upstream RB O
of IN O
the DT O
transcriptional JJ O
start NN O
site NN O
. . O

-DOCSTART- X X O

A DT O
survey NN O
of IN O
274 CD O
late JJ O
detected VBD O
cases NNS O
of IN O
CDH NNP O
born VBN O
in IN O
the DT O
years NNS O
1970--74 CD O
is VBZ O
presented VBN O
. . O

-DOCSTART- X X O

This DT O
distinct JJ O
biochemical JJ O
difference NN O
between IN O
STAT5A NNP B-NP
and CC O
STAT5B NNP B-NP
was VBD O
confirmed VBN O
with IN O
purified VBN O
activated JJ O
STAT5 NNPS B-NP
recombinant JJ I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Enoxacin NNP O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
an DT O
effective JJ O
well NN O
tolerated VBN O
and CC O
convenient JJ O
treatment NN O
for IN O
gonorrhoea NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
Tax1 NNPS B-NP
activates VBZ O
CArG-mediated JJ O
transcription NN O
without IN O
mitogenic JJ O
signals NNS O
through IN O
interaction NN O
with IN O
a DT O
CArG-binding JJ B-NP
factor NN I-NP
, , O
p67SRF. . B-NP

-DOCSTART- X X O

In IN O
5 CD O
cases NNS O
, , O
combined VBN O
sensitization NN O
to TO O
mercury NN O
and CC O
other JJ O
metal NN O
salts NNS O
, , O
particularly RB O
gold JJ O
sodium NN O
thiosulfate NN O
( -LRB- O
GST NNP O
) -RRB- O
and CC O
palladium NN O
chloride NN O
( -LRB- O
PDC NNP O
) -RRB- O
, , O
was VBD O
observed VBN O
. . O

-DOCSTART- X X O

Amongst IN O
53 CD O
"inoperable JJ O
" '' O
( -LRB- O
T4 NNP O
, , O
N0 NNP O
, , O
N1 NNP O
, , O
T. NNP O
, , O
N2 NNP O
, , O
N3 NNP O
) -RRB- O
cases NNS O
, , O
5 CD O
( -LRB- O
10 CD O
% NN O
) -RRB- O
had VBD O
a DT O
positive JJ O
scan NN O
and CC O
5 CD O
a DT O
doubtful JJ O
scan NN O
. . O

-DOCSTART- X X O

Acyclovir NNP O
( -LRB- O
3 CD O
% NN O
ointment NN O
) -RRB- O
used VBN O
topically RB O
one CD O
to TO O
five CD O
times NNS O
a DT O
day NN O
on IN O
acute JJ O
ocular JJ O
HSV NN O
infection NN O
gave VBD O
beneficial JJ O
results NNS O
as IN O
measured VBN O
by IN O
a DT O
reduction NN O
in IN O
corneal JJ O
involvement NN O
, , O
conjunctivitis NN O
, , O
iritis NN O
, , O
and CC O
corneal JJ O
clouding NN O
. . O

-DOCSTART- X X O

The DT O
efficiency NN O
of IN O
transfections NNS O
was VBD O
normalized JJ O
relative JJ O
to TO O
the DT O
net JJ O
amount NN O
of IN O
CAT NN B-NP
plasmid NN O
actually RB O
transfected VBN O
into IN O
recipient NN O
cells NNS O
, , O
determined VBN O
by IN O
a DT O
modified JJ O
Southern JJ O
hybridization NN O
procedure NN O
. . O

-DOCSTART- X X O

Initial JJ O
computer NN O
based VBN O
similarity NN O
searches NNS O
identified VBN O
human JJ B-NP
retinoblastoma NN I-NP
binding JJ I-NP
protein NN I-NP
1 CD I-NP
( -LRB- O
RBP-1 NN B-NP
) -RRB- O
, , O
Drosophila NNP B-NP
melanogaster NN I-NP
male NN I-NP
specific JJ I-NP
lethal-3 NN I-NP
( -LRB- O
Msl-3 NN B-NP
) -RRB- O
, , O
S. NNP B-NP
pombe VBD I-NP
altered VBN I-NP
polarity-13 JJ I-NP
( -LRB- O
Alp13 IN B-NP
) -RRB- O
and CC O
S. NNP B-NP
cerevisiae NN I-NP
Eaf3p NNP I-NP
, , O
a DT O
component NN O
of IN O
the DT O
yeast NN B-NP
NuA4 NNP I-NP
HAT NNP B-NP
complex NN O
( -LRB- O
Galarneau NNP O
et NNP O
al NN O
. . O
, , O
2000 CD O
. . O

-DOCSTART- X X O

These DT O
aa JJ O
residues NNS O
correspond VBP O
to TO O
codons NNS O
59 CD O
and CC O
108 CD O
in IN O
the DT O
P. NNP B-NP
falciparum NN I-NP
DHFR NNP I-NP
active JJ I-NP
site NN I-NP
in IN O
which WDT O
similar JJ O
aa JJ O
substitutions NNS O
( -LRB- O
Cys NNS O
Arg-59 : O
and CC O
Ser JJ O
Asn-108 CC O
) -RRB- O
are VBP O
associated VBN O
with IN O
pyrimethamine NN O
resistance NN O
. . O

-DOCSTART- X X O

Short-term JJ O
growth NN O
: : O
rhythms NNS O
, , O
chaos NN O
, , O
or CC O
noise NN O
? . O

-DOCSTART- X X O

Sequences NNS O
homologous JJ O
to TO O
the DT O
consensus NN O
TUF-binding NN B-NP
UAS NNP I-NP
boxes NNS I-NP
are VBP O
present JJ O
in IN O
the DT O
5' JJ O
flanking NN O
regions NNS O
of IN O
both DT O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
gene NN B-NP
atp6 VBD I-NP
, , O
encoding VBG O
subunit NN O
6 CD O
of IN O
the DT O
mitochondrial JJ O
F0-ATPase JJ B-NP
complex NN O
, , O
has VBZ O
been VBN O
characterized VBN O
from IN O
both DT O
the DT O
normal JJ O
( -LRB- O
fertile JJ O
) -RRB- O
and CC O
Ogura NNP O
( -LRB- O
male-sterile JJ O
) -RRB- O
radish NN O
cytoplasms NNS O
in IN O
order NN O
to TO O
determine VB O
if IN O
previously RB O
identified VBN O
atp6 IN B-NP
transcriptional JJ O
differences NNS O
could MD O
play VB O
a DT O
role NN O
in IN O
cytoplasmic JJ O
male JJ O
sterility NN O
. . O

-DOCSTART- X X O

The DT O
expression NN O
of IN O
CAPL, NNP B-NP
a DT O
second JJ O
protein NN O
involved VBN O
in IN O
calcium NN O
metabolism NN O
, , O
was VBD O
only RB O
moderately RB O
elevated VBN O
in IN O
the DT O
doxorubicin-resistant JJ O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
reconstituted VBD O
enzyme JJ O
binds NNS O
DNA NN O
with IN O
an DT O
affinity NN O
that WDT O
is VBZ O
approximately RB O
20-fold JJ O
lower JJR O
than IN O
that DT O
of IN O
the DT O
intact JJ O
topo70 NN B-NP
. . O

-DOCSTART- X X O

In IN O
late JJ O
October NNP O
, , O
1974 CD O
, , O
Staphylococcus NNP O
aureus NN O
postoperative NN O
wound NN O
infection NN O
was VBD O
recorded VBN O
in IN O
a DT O
nonhuman JJ O
primate JJ O
( -LRB- O
Macaca JJ O
mulatta NN O
) -RRB- O
which WDT O
had VBD O
recently RB O
undergone IN O
surgical JJ O
operation NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
in IN O
vivo JJ O
function NN O
of IN O
Gle2p NNP B-NP
is VBZ O
strictly RB O
coupled VBN O
to TO O
the DT O
short JJ O
GLEBS NNP B-NP
within IN O
Nup116p NNP B-NP
which WDT O
links VBZ O
this DT O
putative JJ O
mRNA NN O
transport NN O
factor NN O
to TO O
the DT O
nuclear JJ O
pores NNS O
. . O

-DOCSTART- X X O

Seminal JJ O
prolactin NN B-NP
levels NNS O
were VBD O
significantly RB O
elevated VBN O
in IN O
all DT O
infertile JJ O
males NNS O
. . O

-DOCSTART- X X O

The DT O
recruitment NN O
of IN O
constitutively RB O
phosphorylated JJ O
p185(neu NN B-NP
) -RRB- O
and CC O
the DT O
activated JJ O
mitogenic JJ O
pathway NN O
proteins VBZ O
to TO O
this DT O
membrane-microfilament NN O
interaction NN O
site NN O
provides VBZ O
a DT O
physical JJ O
model NN O
for IN O
integrating VBG O
the DT O
assembly NN O
of IN O
the DT O
mitogenic JJ O
pathway NN O
with IN O
the DT O
transmission NN O
of IN O
growth NN O
factor NN O
signal NN O
to TO O
the DT O
cytoskeleton NN O
. . O

-DOCSTART- X X O

The DT O
pattern NN O
of IN O
net JJ B-NP
RNA NNP I-NP
expression NN O
in IN O
adult NN O
mouse NN O
tissues NNS O
is VBZ O
different JJ O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
capsaicin NN O
on IN O
hexobarbital-anesthetized JJ O
rats NNS O

-DOCSTART- X X O

A DT O
physical JJ O
and CC O
genetic JJ O
map NN O
covering VBG O
the DT O
entire JJ O
RP12 NNP B-NP
candidate NN I-NP
gene NN I-NP
region NN I-NP
was VBD O
constructed VBN O
. . O

-DOCSTART- X X O

In IN O
both DT O
immortalized JJ O
and CC O
normal JJ O
diploid JJ O
human JJ O
cells NNS O
, , O
wt IN O
AAV DT O
targeted JJ O
integration NN O
to TO O
ch-19 CD O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
found VBN O
that IN O
both DT O
versions NNS O
of IN O
the DT O
brief JJ O
SL&amp;shy;ASIA NNP O
had VBD O
similar JJ O
correlations NNS O
to TO O
the DT O
target NN O
variables NNS O
as IN O
the DT O
full JJ O
scale NN O
SL&amp;shy;ASIA NNP O
. . O

-DOCSTART- X X O

These DT O
operons NNS O
encode VBP O
subunits NNS O
of IN O
photosystems NNS B-NP
I PRP I-NP
( -LRB- O
psa NN B-NP
) -RRB- O
and CC O
II NNP O
( -LRB- O
psb NN B-NP
) -RRB- O
, , O
the DT O
cytochrome NN B-NP
bGf NN I-NP
complex NN I-NP
( -LRB- O
pet NN B-NP
) -RRB- O
, , O
the DT O
plastid NN O
NAD( NNP B-NP
P)H NNP I-NP
dehydrogenase NN I-NP
( -LRB- O
ndh NN B-NP
) -RRB- O
, , O
and CC O
the DT O
unidentified JJ O
open JJ O
reading NN O
frame NN O
ycf9 VBD B-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
dominant JJ B-NP
negative JJ I-NP
Rac NNP I-NP
( -LRB- O
N17Rac1 NN B-NP
) -RRB- O
inhibited VBN O
JNK NNP B-NP
activation NN O
by IN O
Galpha12 NNP B-NP
in IN O
HEK293 CD O
cells NNS O
as RB O
well RB O
as IN O
three CD O
other JJ O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

A DT O
major JJ O
feature NN O
of IN O
this DT O
genomic JJ O
sequence NN O
is VBZ O
the DT O
presence NN O
of IN O
a DT O
first JJ O
intron NN O
( -LRB- O
Il NNP O
) -RRB- O
, , O
215 CD O
bp NN O
long JJ O
, , O
located VBN O
48 CD O
bp NN O
downstream NN O
of IN O
the DT O
translation NN O
start NN O
ATG NNP O
codon NN O
. . O

-DOCSTART- X X O

We PRP O
reviewed VBN O
the DT O
different JJ O
published VBN O
cases NNS O
of IN O
acute JJ O
high JJ O
dose NN O
methotrexate NN O
neurotoxicity NN O
and CC O
the DT O
different JJ O
underlying VBG O
mechanisms NNS O
. . O

-DOCSTART- X X O

The DT O
expected JJ O
products NNS O
of IN O
the DT O
cloned VBN O
bph NN B-NP
genes NNS I-NP
, , O
except IN O
bphA3 CD B-NP
, , O
were VBD O
observed VBN O
in IN O
E. NNP O
coli NNS O
in IN O
an DT O
in IN O
vitro NN O
transcription-translation NN O
system NN O
. . O

-DOCSTART- X X O

The DT O
immunoreactive JJ O
antithrombin NN B-NP
III NNP I-NP
increased VBD O
significantly RB O
while IN O
the DT O
increase NN O
in IN O
antithrombin JJ B-NP
III NNP I-NP
activity NN O
was VBD O
insignificant JJ O
in IN O
20 CD O
male JJ O
Caucasian JJ O
Danes NNP O
upon IN O
3 CD O
weeks NNS O
supplementation NN O
of IN O
the DT O
diet NN O
with IN O
10 CD O
ml JJ O
daily JJ O
of IN O
a DT O
cod NN O
liver NN O
oil NN O
concentrate NN O
. . O

-DOCSTART- X X O

Only RB O
the DT O
27-kDa JJ O
protein NN O
was VBD O
detected VBN O
after IN O
N-glycosidase JJ B-NP
treatment NN O
, , O
indicating VBG O
that IN O
PLP-H NNP B-NP
is VBZ O
a DT O
glycoprotein NN O
. . O

-DOCSTART- X X O

These DT O
observed JJ O
changes NNS O
were VBD O
not RB O
found VBN O
when WRB O
assessing VBG O
NPY NNP B-NP
level NN O
in IN O
plasma NN O
fluid NN O
. . O

-DOCSTART- X X O

In IN O
three CD O
other JJ O
patients NNS O
the DT O
electrophysiologic JJ O
characteristics NNS O
of IN O
atrioventricular JJ O
conduction NN O
prevented VBD O
a DT O
demonstration NN O
of IN O
these DT O
differences NNS O
. . O

-DOCSTART- X X O

These DT O
sequence NN O
differences NNS O
are VBP O
reflected VBN O
in IN O
differences NNS O
in IN O
gene NN O
expression NN O
in IN O
three CD O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

The DT O
cumulative JJ O
dose NN O
to TO O
nursing VBG O
staff NN O
for IN O
the DT O
week NN O
after IN O
treatment NN O
was VBD O
dependent JJ O
on IN O
patient JJ O
mobility NN O
and CC O
was VBD O
estimated VBN O
at IN O
0.08 CD O
mSv NN O
for IN O
a DT O
self-caring JJ O
patient NN O
to TO O
6.3 CD O
mSv NN O
for IN O
a DT O
totally RB O
helpless JJ O
patient NN O
( -LRB- O
1840 CD O
MBq/group NN O
A) NN O
. . O

-DOCSTART- X X O

The DT O
analysis NN O
consisted VBD O
of IN O
1 CD O
) -RRB- O
fitting VBG O
first RB O
- : O
and CC O
second-order NN O
autoregressive JJ O
models NNS O
( -LRB- O
AR1 NN O
and CC O
AR2 NN O
) -RRB- O
and CC O
2 CD O
) -RRB- O
obtaining VBG O
the DT O
power NN O
spectra NN O
of IN O
the DT O
data NNS O
by IN O
fast-Fourier JJ O
transform VB O
. . O

-DOCSTART- X X O

Of IN O
921 CD O
specimens NNS O
, , O
95 CD O
yielded VBD O
non-albicans NNS O
species NNS O
, , O
mainly RB O
from IN O
patients NNS O
with IN O
low JJ O
CD4 NNP B-NP
lymphocyte NN O
counts NNS O
and CC O
extensive JJ O
previous JJ O
azole JJ O
exposure NN O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
experiments NNS O
suggest VBP O
that IN O
GnSE JJ B-NP
response NN I-NP
elements NNS I-NP
interact NN O
, , O
in IN O
these DT O
two CD O
regions NNS O
, , O
with IN O
GATA NNP B-NP
- : I-NP
and CC I-NP
LIM-related JJ I-NP
factors NNS I-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

Hamdija NNP O
Karamehmedovic NNP O
; : O
Ibn NNP O
al-Nefis NNS O
, , O
" '' O
Mudzez NNP O
al-Kanum" JJ O
, , O
Republicki NNP O
zavod VBD O
za FW O
zdravstvenu FW O
zastitu FW O
Sarajevo NNPS O
, , O
1961 CD O
, , O
1-219 CD O
; : O
Mr NNP O
ph NN O
Samuel NNP O
Elazar NNP O
, , O
Ajnija NNP O
Omanic NNP O
: : O
" `` O
Bibliografija NNP O
medicinskih JJ O
djela NN O
u IN O
SR NNP O
BiH NNP O
do VBP O
1895 CD O
." NNS O
Medicinska NNP O
knjiga VBD O
Beograd-Zagreb NNP O
1984 CD O
; : O
Besides IN O
, , O
the DT O
great JJ O
contribution NN O
in IN O
bibliography NN O
was VBD O
given VBN O
by IN O
dr NN O
Lujo NNP O
Taler NNP O
, , O
prof NN O
. . O
dr NN O
. . O

-DOCSTART- X X O

Patients NNS O
randomized VBD O
into IN O
the DT O
active JJ O
treatment NN O
groups NNS O
A30 IN O
( -LRB- O
n NN O
= SYM O
49 CD O
) -RRB- O
and CC O
A60 NNP O
( -LRB- O
n NN O
= SYM O
48 CD O
) -RRB- O
received VBD O
topical JJ O
treatment NN O
with IN O
3.0 CD O
% NN O
diclofenac NN O
in IN O
2.5 CD O
% NN O
hyaluronan NN O
gel JJ O
0.5 CD O
g NN O
twice RB O
daily RB O
for IN O
30 CD O
or CC O
60 CD O
days NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Human NNP B-NP
PDNP3 NNP I-NP
is VBZ O
expressed VBN O
in IN O
glioma NN O
cells NNS O
, , O
prostate NN O
, , O
and CC O
uterus NN O
, , O
but CC O
not RB O
in IN O
the DT O
alimentary JJ O
tract NN O
. . O

-DOCSTART- X X O

13 CD O
:961-969 CD O
, , O
1993 CD O
) -RRB- O
suggested VBD O
that IN O
T NNP B-NP
antigen NN I-NP
could MD O
mediate VB O
transcriptional JJ O
activation NN O
through IN O
interaction NN O
with IN O
the DT O
TATA-binding JJ B-NP
protein NN I-NP
, , O
as RB O
well RB O
as IN O
upstream RB O
bound VBN O
transcription NN O
factors NNS O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
a DT O
putative JJ O
infC-rpmI-rplT JJ B-NP
operon NN O
flanked VBN O
by IN O
long JJ O
inverted JJ O
repeats NNS O
in IN O
Mycoplasma NNP O
fermentans NNS O
( -LRB- O
incognitus JJ O
strain NN O
) -RRB- O
. . O

-DOCSTART- X X O

IgE NNP B-NP
antibody NN I-NP
to TO O
twelve CD O
common JJ O
food NN O
and CC O
inhalant NN O
allergens NNS O
was VBD O
measured VBN O
by IN O
enzyme-linked JJ O
immunosorbent JJ O
assay NN O
( -LRB- O
ELISA NNP O
) -RRB- O
in IN O
the DT O
sera NN O
of IN O
thirteen DT O
atopic NN O
patients NNS O
with IN O
one CD O
or CC O
more JJR O
allergic JJ O
disorders NNS O
( -LRB- O
asthma NN O
occurring VBG O
in IN O
eleven CD O
; : O
rhinitis NN O
in IN O
ten CD O
; : O
eczema NN O
in IN O
six CD O
; : O
urticaria NNP O
in IN O
four CD O
; : O
mouth NN O
and CC O
gastro-intestinal JJ O
symptoms NNS O
in IN O
six CD O
) -RRB- O
, , O
of IN O
twelve CD O
non-atopic JJ O
patients NNS O
with IN O
various JJ O
clinical JJ O
symptoms NNS O
( -LRB- O
asthma NN O
in IN O
four CD O
; : O
rhinitis NN O
in IN O
four CD O
; : O
eczema NN O
in IN O
one CD O
; : O
urticaria NN O
in IN O
two CD O
; : O
mouth NN O
and CC O
gastro-intestinal JJ O
symptoms NNS O
in IN O
four CD O
) -RRB- O
and CC O
sixteen CD O
cord NN O
blood NN O
sera NN O
. . O

-DOCSTART- X X O

Analysis NNP O
of IN O
1 CD O
Mb NN O
of IN O
published VBN O
sequence NN O
from IN O
the DT O
region NN O
of IN O
conserved VBN O
synteny NN O
on IN O
human JJ O
chromosome NN O
5q31-q33 CC O
identified VBD O
45 CD O
gene NN O
candidates NNS O
, , O
including VBG O
35 CD O
expressed VBN O
genes NNS O
in IN O
the DT O
human JJ B-NP
IL-4 NN I-NP
cytokine NN I-NP
gene NN I-NP
cluster NN O
. . O

-DOCSTART- X X O

These DT O
p21-E2F JJ B-NP
complexes NNS O
, , O
while IN O
present JJ O
in IN O
young JJ O
G1 NNP O
cells NNS O
at IN O
very RB O
low JJ O
levels NNS O
, , O
were VBD O
elevated VBN O
in IN O
senescent JJ O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
delta NN O
Mo NNP O
+ NNP O
SV NNP O
tumor NN O
DNAs NN O
from IN O
B-lineage JJ O
tumors NNS O
were VBD O
typically RB O
rearranged VBN O
at IN O
the DT O
immunoglobulin NN B-NP
gene NN I-NP
loci NNS I-NP
and CC O
contained VBD O
germ NN O
line NN O
configurations NNS O
of IN O
the DT O
T-cell NN B-NP
receptor NN I-NP
beta JJ I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Earlier JJR O
reports NNS O
have VBP O
localized VBN O
mutations NNS O
which WDT O
affect VBP O
the DT O
processing NN O
and CC O
transport NN O
of IN O
herpes PRP$ O
simplex JJ O
virus NN O
1 CD O
glycoproteins NNS O
to TO O
a DT O
region NN O
located VBN O
between IN O
the DT O
genes NNS O
specifying VBG O
glycoprotein NN B-NP
B NNP I-NP
and CC O
the DT O
major JJ O
viral NN O
DNA-binding NN O
protein NN O
( -LRB- O
beta JJ B-NP
8 CD I-NP
) -RRB- O
. . O

-DOCSTART- X X O

Magnetic JJ O
force NN O
and CC O
torque NN O
at IN O
1.5 CD O
T NNP O
did VBD O
not RB O
dislodge VB O
the DT O
GF NN O
or CC O
result NN O
in IN O
perforation NN O
of IN O
canine CD O
IVC NNP O
by IN O
the DT O
GF. NNP O

-DOCSTART- X X O

The DT O
rec8( JJ B-NP
+ NN I-NP
) -RRB- I-NP
, , O
rec10( JJ B-NP
+ NN I-NP
) -RRB- I-NP
, , O
and CC O
rec11( JJ B-NP
+ NN I-NP
) -RRB- I-NP
genes NNS I-NP
of IN I-NP
the DT I-NP
fission NN I-NP
yeast NN I-NP
Schizosaccharomyces NNP I-NP
pombe VBD I-NP
exhibit NN O
similar JJ O
specificities NNS O
for IN O
meiotic JJ O
recombination NN O
and CC O
rec8( JJ B-NP
+ NN I-NP
) -RRB- I-NP
is VBZ O
required VBN O
for IN O
sister NN O
chromatid NN O
cohesion NN O
and CC O
homolog NN O
pairing NN O
. . O

-DOCSTART- X X O

The DT O
formation NN O
of IN O
a DT O
D-loop NN O
is VBZ O
an DT O
essential JJ O
step NN O
in IN O
DNA NNP O
double-strand JJ O
break NN O
repair NN O
through IN O
recombination NN O
. . O

-DOCSTART- X X O

Using VBG O
a DT O
set NN O
of IN O
sera NN O
for IN O
which WDT O
full JJ O
chlamydial NN O
micro-immunofluorescence NN O
results NNS O
suggested VBD O
a DT O
clear JJ O
diagnosis NN O
, , O
we PRP O
have VBP O
evaluated VBN O
the DT O
Chlamydia NNP O
Spot-IF NNP O
test NN O
( -LRB- O
bioMerieux NN O
) -RRB- O
, , O
which WDT O
allows VBZ O
a DT O
comparison NN O
of IN O
titres NNS O
to TO O
Chlamydia NNP B-NP
trachomatis NN I-NP
and CC I-NP
C. NNP I-NP
psittaci NNS I-NP
antigens NNS I-NP
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
DMIPP NNP O
detects VBZ O
regionally RB O
hypoperfused VBN O
myocardium NN O
, , O
in IN O
which WDT O
agreement NN O
between IN O
MBF NNP O
and CC O
fatty JJ O
acid NN O
uptake NN O
deteriorates NNS O
. . O

-DOCSTART- X X O

The DT O
majority NN O
of IN O
putative JJ O
TSC2 NN B-NP
mutations NNS I-NP
were VBD O
found VBN O
in IN O
sporadic JJ O
rather RB O
than IN O
TSC2-linked JJ B-NP
families NNS O
. . O

-DOCSTART- X X O

None NN O
of IN O
the DT O
10 CD O
sequences NNS O
has VBZ O
hitherto VBN O
been VBN O
recognized VBN O
as IN O
part NN O
of IN O
the DT O
p53 NN B-NP
signaling VBG O
pathway NN O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
the DT O
genes NNS O
coding VBG O
for IN O
mouse NN O
and CC O
human JJ O
p36 NNS B-NP
( -LRB- O
annexin NN B-NP
II NNP I-NP
) -RRB- O
and CC O
mouse NN O
, , O
rat NN O
and CC O
human JJ O
p35 FW B-NP
( -LRB- O
annexin NN B-NP
I PRP I-NP
) -RRB- O
and CC O
pigeon NN O
cp35 IN B-NP
( -LRB- O
an DT O
annexin NN B-NP
I-related JJ I-NP
protein NN I-NP
) -RRB- O
shows VBZ O
strong JJ O
genomic JJ O
structural JJ O
conservation NN O
supporting VBG O
the DT O
hypothesis NN O
that IN O
these DT O
genes NNS O
had VBD O
a DT O
common JJ O
ancestor NN O
. . O

-DOCSTART- X X O

Now RB O
: : O
pleasure NN O
in IN O
work NN O

-DOCSTART- X X O

Mammalian NNP O
homologues NNS O
of IN O
the DT O
Polycomb-group NNP B-NP
gene NN I-NP
Enhancer NNP B-NP
of IN I-NP
zeste NN I-NP
mediate JJ O
gene NN O
silencing NN O
in IN O
Drosophila NNP O
heterochromatin NN O
and CC O
at IN O
S. NNP O
cerevisiae NN O
telomeres VBZ O
. . O

-DOCSTART- X X O

Xanthoepocin NNP O
, , O
a DT O
new JJ O
antibiotic JJ O
from IN O
Penicillium NNP O
simplicissimum JJ O
IFO5762 NN O
. . O

-DOCSTART- X X O

Additionally RB O
, , O
VAHS NNP O
is VBZ O
often RB O
associated VBN O
with IN O
fatal JJ O
infectious JJ O
mononucleosis NN O
( -LRB- O
IM) NNP O
. . O

-DOCSTART- X X O

273 CD O
, , O
27420-27429 CD O
) -RRB- O
a DT O
putative JJ O
peroxisome JJ O
proliferator-activated JJ O
receptor NN O
response NN O
element NN O
( -LRB- O
PPRE NNP O
) -RRB- O
is VBZ O
present JJ O
from IN O
-458 CD O
to TO O
-474 CD O
. . O

-DOCSTART- X X O

In IN O
T NNP O
cells NNS O
these DT O
two CD O
signal NN O
pathways NNS O
are VBP O
critical JJ O
for IN O
interleukin-2 JJ B-NP
production NN O
. . O

-DOCSTART- X X O

A DT O
plasma NN O
cell-rich JJ O
infiltrate NN O
was VBD O
present JJ O
in IN O
the DT O
connective JJ O
tissue NN O
cores NNS O
of IN O
the DT O
papillae NN O
. . O

-DOCSTART- X X O

Peptide NNP O
competition NN O
studies NNS O
have VBP O
localized VBN O
a DT O
cyclin NN B-NP
A DT I-NP
interaction NN I-NP
site NN I-NP
to TO O
a DT O
Lys381Lys382Leu383Met384Phe385 CD O
sequence NN O
within IN O
C-terminal JJ O
negative JJ O
regulatory JJ O
domain NN O
of IN O
human JJ B-NP
p53 NN I-NP
. . O

-DOCSTART- X X O

While IN O
some DT O
still RB O
automatically RB O
refuse VB O
all DT O
patients NNS O
with IN O
positive JJ O
mediastinoscopy NN O
, , O
most JJS O
authors NNS O
still RB O
remain VBP O
very RB O
interventionistic JJ O
for IN O
N2 JJ O
patients NNS O
selected VBD O
on IN O
very RB O
accurate JJ O
criteria NNS O
that WDT O
are VBP O
analyzed VBN O
above RB O
. . O

-DOCSTART- X X O

A DT O
yeast NN O
mitochondrial JJ O
translation NN O
initiation NN O
codon NN O
mutation NN O
affecting VBG O
the DT O
gene NN O
for IN O
cytochrome NN B-NP
oxidase NN I-NP
subunit NN I-NP
III NNP I-NP
( -LRB- O
COX3 NN B-NP
) -RRB- O
was VBD O
partially RB O
suppressed VBN O
by IN O
a DT O
spontaneous JJ O
nuclear JJ O
mutation NN O
. . O

-DOCSTART- X X O

Patients NNS O
with IN O
endocarditis NN O
or CC O
vascular JJ O
infection NN O
were VBD O
more RBR O
frequently RB O
immunocompromised VBN O
and CC O
older JJR O
than IN O
those DT O
with IN O
acute JJ O
Q NN O
fever NN O
. . O

-DOCSTART- X X O

MEASURES NNP O
: : O
SF-36 NNP O
questionnaires NNS O
were VBD O
completed VBN O
by IN O
patients NNS O
at IN O
both DT O
initial JJ O
and CC O
discharge NN O
examinations NNS O
. . O

-DOCSTART- X X O

Hormonal JJ O
replacement NN O
therapy NN O
for IN O
women NNS O
with IN O
a DT O
personal JJ O
history NN O
of IN O
breast NN O
cancer NN O
? . O

-DOCSTART- X X O

Mutant JJ O
beta2-adrenergic JJ B-NP
receptors NNS I-NP
with IN O
a DT O
Tyr-to-Phe JJ O
substitution NN O
at IN O
Tyr-350 CD O
do VBP O
not RB O
display VB O
agonist-induced JJ O
desensitization NN O
, , O
Src NNP B-NP
recruitment NN O
, , O
or CC O
Src NNP B-NP
activation NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
disruption NN O
of IN O
pcr1 DT B-NP
reduced JJ O
expression NN O
of IN O
fbp1 CD B-NP
, , O
a DT O
glucose-repressible JJ O
gene NN O
negatively RB O
regulated VBN O
by IN O
PKA. NNP B-NP

-DOCSTART- X X O

This DT O
B-box NN O
is VBZ O
not RB O
present JJ O
in IN O
ETS1 NNP B-NP
, , O
ETS2 NNP B-NP
, , O
PEA3 CD B-NP
or CC O
PU.1 CD B-NP
and CC O
these DT O
proteins NNS O
were VBD O
unable JJ O
to TO O
form VB O
ternary JJ O
complexes NNS O
with IN O
SRF NNP B-NP
and CC O
Egrl-SREs NNP B-NP
or CC O
c-fos JJ B-NP
SRE. . O

-DOCSTART- X X O

Excretion NNP O
of IN O
radiopharmaceuticals NNS O
into IN O
breast NN O
milk NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
concluded VBN O
that IN O
the DT O
drinking NN O
ampules NNS O
of IN O
VP-16-213 NN O
can MD O
be VB O
replaced VBN O
with IN O
the DT O
new JJ O
oral JJ O
capsules NNS O
with IN O
a DT O
recommended VBN O
initial JJ O
dose NN O
of IN O
100-130 CD O
mg/m2 CD O
given VBN O
in IN O
5-day JJ O
courses NNS O
every DT O
21-28 CD O
days NNS O
. . O

-DOCSTART- X X O

Deletion NNP O
of IN O
the DT O
region NN O
from IN O
amino DT O
acid NN O
residues NNS O
2-67 CC O
in IN O
E1A NNP B-NP
, , O
which WDT O
has VBZ O
been VBN O
postulated VBN O
to TO O
interact VB O
with IN O
p300/CBP JJ B-NP
, , O
also RB O
abolished VBD O
the DT O
inhibitory JJ O
effect NN O
of IN O
E1A NNP B-NP
, , O
whereas IN O
deletion NN O
of IN O
the DT O
region NN O
from IN O
residues NNS O
120 CD O
to TO O
140 CD O
had VBD O
no DT O
effect NN O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
both DT O
the DT O
v-Ras JJ B-NP
- : O
and CC O
PC-PLC-transformed JJ B-NP
cells NNS O
to TO O
be VB O
insensitive JJ O
to TO O
stimulation NN O
with IN O
platelet-derived JJ B-NP
growth NN I-NP
factor NN I-NP
( -LRB- O
PDGF NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
it PRP O
was VBD O
found VBN O
that IN O
the DT O
Shb-overexpressing NN B-NP
cells NNS O
extended VBN O
neurites NNS O
in IN O
response NN O
to TO O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
. . O

-DOCSTART- X X O

Tre NNP O
during IN O
exercise NN O
at IN O
35 CD O
W NNP O
at IN O
23 CD O
degrees NNS O
C NN O
correlated JJ O
r NN O
= SYM O
-70 FW O
with IN O
Vo2max NNP O
and CC O
r NN O
= SYM O
0.80 CD O
with IN O
Tre NNP O
during IN O
exercise NN O
in IN O
heat NN O
. . O

-DOCSTART- X X O

Should MD O
we PRP O
use VB O
thiazide DT O
diuretics NNS O
in IN O
hypertensive JJ O
patients NNS O
with IN O
non-insulin-dependent JJ O
diabetes NN O
mellitus NN O
? . O

-DOCSTART- X X O

The DT O
University NNP O
of IN O
North NNP O
Carolina NNP O
caries NNS O
risk NN O
assessment NN O
was VBD O
conducted VBN O
between IN O
1986 CD O
and CC O
1989 CD O
with IN O
5000 CD O
children NNS O
initially RB O
in IN O
grades NNS O
1 CD O
and CC O
5 CD O
from IN O
low JJ O
fluoride NN O
sites NNS O
in IN O
South NNP O
Carolina NNP O
and CC O
Maine NNP O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
cells NNS O
for IN O
10 CD O
min NN O
with IN O
TNF-alpha NNP B-NP
resulted VBD O
in IN O
activation NN O
of IN O
p44/42 DT B-NP
MAPK NNP O
, , O
p38 VBD B-NP
, , O
and CC O
JNK. NNP B-NP

-DOCSTART- X X O

In IN O
phase NN O
II NNP O
studies NNS O
, , O
MDL NNP O
72,974A NNP O
is VBZ O
proving VBG O
to TO O
be VB O
a DT O
useful JJ O
adjunct NN O
to TO O
conventional JJ O
therapy NN O
. . O

-DOCSTART- X X O

A DT O
derived VBN O
RA-resistant JJ O
line NN O
, , O
NT2/D1-R1 NNP O
, , O
is VBZ O
deficient JJ O
in IN O
this DT O
activity NN O
and CC O
is VBZ O
co-resistant JJ O
to TO O
cisplatin VB O
. . O

-DOCSTART- X X O

Phenacetin NNP O
nephritis NN O

-DOCSTART- X X O

Both DT O
claR NN B-NP
and CC O
car NN B-NP
are VBP O
expressed VBN O
as IN O
monocistronic JJ O
transcripts NNS O
; : O
the DT O
level NN O
of IN O
transcript NN O
declined VBD O
rapidly RB O
after IN O
48h JJ O
in IN O
complex JJ O
media NNS O
, , O
but CC O
low JJ O
sustained VBN O
levels NNS O
of IN O
both DT O
transcripts NNS O
were VBD O
observed VBN O
in IN O
defined VBN O
GSPG NNP O
medium NN O
until IN O
96h JJ O
. . O
claR NN B-NP
and CC O
car NN B-NP
were VBD O
not RB O
significantly RB O
expressed VBN O
in IN O
mutants NNS O
disrupted VBD O
in IN O
the DT O
ccaR NN B-NP
gene NN I-NP
, , O
a DT O
regulatory JJ O
gene NN O
that WDT O
controls VBZ O
positively RB O
clavulanic JJ O
acid NN O
and CC O
cephamycin NN O
biosynthesis NN O
. . O

-DOCSTART- X X O

Experiments NNS O
were VBD O
performed VBN O
without IN O
polarization NN O
or CC O
with IN O
cathodic JJ O
and CC O
anodic JJ O
polarization NN O
of IN O
the DT O
adsorbent NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
Sp1 NNP B-NP
binding NN I-NP
site NN I-NP
can MD O
function VB O
as IN O
a DT O
distinct JJ O
TGF-beta JJ B-NP
responsive JJ I-NP
element NN I-NP
for IN O
TGF-beta JJ B-NP
mediated JJ O
promoter NN O
expression NN O
and CC O
Sp1 NNP B-NP
per IN O
se NN O
can MD O
mediate VB O
this DT O
response NN O
. . O

-DOCSTART- X X O

A DT O
positive JJ O
correlation NN O
was VBD O
also RB O
established VBN O
between IN O
the DT O
level NN O
of IN O
FP9C NNP B-NP
binding NN O
and CC O
the DT O
degree NN O
of IN O
cell NN O
differentiation NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

In IN O
another DT O
patient NN O
, , O
IRPF NNP O
recurred VBD O
in IN O
the DT O
ureter NN O
of IN O
a DT O
living NN O
related VBN O
renal JJ O
graft NN O
6 CD O
months NNS O
after IN O
transplantation NN O
. . O

-DOCSTART- X X O

Similar JJ O
to TO O
the DT O
D NNP B-NP
, , O
B/B NNP B-NP
' POS B-NP
and CC O
E NNP B-NP
proteins NNS I-NP
, , O
the DT O
F NNP B-NP
and CC O
G NNP B-NP
proteins VBZ I-NP
do VB O
not RB O
possess VB O
any DT O
of IN O
the DT O
known VBN O
RNA NNP O
binding NN O
motifs NNS O
, , O
suggesting VBG O
that IN O
other JJ O
types NNS O
of IN O
RNA-protein NNP O
interactions NNS O
occur VBP O
in IN O
the DT O
snRNP JJ O
core NN O
. . O

-DOCSTART- X X O

Ultrasound-guided JJ O
fine-needle JJ O
aspiration NN O
biopsy NN O
( -LRB- O
US-FNAB) NNP O
revealed VBD O
normal-looking JJ O
squamous JJ O
cells NNS O
. . O

-DOCSTART- X X O

In IN O
EGF NNP B-NP
receptor-mediated JJ I-NP
signaling NN O
, , O
the DT O
protein NN B-NP
kinase NN I-NP
PKB/Akt NN I-NP
and CC O
the DT O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
c-Jun NN I-NP
N-terminal JJ I-NP
kinase NN I-NP
, , O
but CC O
not RB O
extracellular JJ B-NP
signal-regulated JJ I-NP
kinase NN I-NP
2 CD I-NP
, , O
function NN O
downstream NN O
of IN O
phosphatidylinositol NN B-NP
3-kinase JJ I-NP
( -LRB- O
PI JJ B-NP
3-kinase NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

Blockade NNP O
of IN O
T NNP O
cell NN O
activation NN O
using VBG O
a DT O
surface-linked JJ O
single-chain JJ O
antibody NN O
to TO O
CTLA-4 DT B-NP
( -LRB- O
CD152 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Complementary JJ O
DNA NNP O
libraries NNS O
from IN O
liver NN O
and CC O
ovary NN O
of IN O
an DT O
immature JJ O
female NN O
channel NN O
catfish NN O
were VBD O
screened VBN O
with IN O
a DT O
homologous JJ B-NP
ERalpha NNP I-NP
cDNA NN I-NP
probe NN O
. . O

-DOCSTART- X X O

Examination NN O
of IN O
the DT O
Coomassie-stained JJ O
gels NNS O
revealed VBD O
that IN O
the DT O
capsid-like JJ O
particles NNS O
composed VBN O
of IN O
the DT O
N11-VP1 JJ B-NP
protein NN O
did VBD O
not RB O
contain VB O
any DT O
host-derived JJ O
histones NNS B-NP
. . O

-DOCSTART- X X O

Here RB O
we PRP O
show VBP O
that IN O
one CD O
nudF NN B-NP
suppressor NN I-NP
also RB O
suppresses VBZ O
hs NNS O
- : O
mutations NNS O
in IN O
nudA NN B-NP
, , O
nudC JJ B-NP
, , O
and CC O
nudG JJ B-NP
and CC O
deletions NNS O
in IN O
nudA NN B-NP
and CC O
nudF NN B-NP
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
potential JJ O
induction NN O
of IN O
this DT O
gene NN O
rearrangement NN O
by IN O
E1A NNP B-NP
gene NN I-NP
therapy NN O
is VBZ O
unlikely JJ O
to TO O
be VB O
clinically RB O
significant JJ O
in IN O
the DT O
treatment NN O
of IN O
advanced JJ O
malignant JJ O
disease NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
Bry1/Skn7 PRP B-NP
can MD O
influence VB O
the DT O
expression NN O
of IN O
MCB- NNP O
and CC O
SCB-driven NNP O
gene NN O
expression NN O
in IN O
budding VBG O
yeast NN O
, , O
perhaps RB O
including VBG O
genes NNS O
involved VBN O
in IN O
cell NN O
wall NN O
metabolism NN O
, , O
via IN O
a DT O
two-component JJ O
signal NN O
transduction NN O
pathway NN O
which WDT O
activates VBZ O
Bry1/Skn7 CD B-NP
in IN O
response NN O
to TO O
an DT O
unidentified JJ O
signal NN O
. . O

-DOCSTART- X X O

Buspirone NNP O
therapy NN O
for IN O
Type NNP O
A DT O
behavior NN O
, , O
hostility NN O
, , O
and CC O
perceived VBN O
stress NN O
in IN O
cardiac JJ O
patients NNS O
. . O

-DOCSTART- X X O

When WRB O
furA RB B-NP
alone RB O
was VBD O
introduced VBN O
into IN O
the DT O
Delta(furA-katG NNP O
) -RRB- O
mutant JJ O
, , O
survival NN O
in IN O
mouse NN O
lungs NNS O
was VBD O
moderately RB O
increased VBN O
, , O
suggesting VBG O
that IN O
FurA NNP B-NP
could MD O
regulate VB O
genes NNS O
, , O
other JJ O
than IN O
katG NN B-NP
, , O
that WDT O
are VBP O
involved VBN O
in IN O
pathogenesis NN O
. . O

-DOCSTART- X X O

The DT O
resulting VBG O
threshold NN O
elevation NN O
curves NNS O
fell VBD O
into IN O
a DT O
small JJ O
number NN O
of IN O
distinct JJ O
groups NNS O
, , O
suggesting VBG O
the DT O
existence NN O
of IN O
discrete JJ O
spatial JJ O
frequency NN O
mechanisms NNS O
in IN O
human JJ O
central JJ O
vision NN O
. . O

-DOCSTART- X X O

Through IN O
interactions NNS O
with IN O
the DT O
pre-mRNA JJ O
and CC O
the DT O
CTD NNP O
domain NN O
of IN O
the DT O
Polymerase NNP B-NP
II NNP I-NP
, , O
SR NNP B-NP
proteins NNS I-NP
have VBP O
been VBN O
shown VBN O
to TO O
regulate VB O
alternative JJ O
splicing NN O
. . O

-DOCSTART- X X O

Electrophoretic NNP O
mobility NN O
shift NN O
analysis NN O
of IN O
protein-DNA NN O
complexes NNS O
formed VBD O
with IN O
nuclear JJ O
proteins NNS O
isolated VBN O
from IN O
I3C-treated JJ O
and CC O
-untreated JJ O
cells NNS O
, , O
in IN O
combination NN O
with IN O
supershift NN O
assays IN O
using VBG O
Sp1 NNP B-NP
antibodies NNS I-NP
, , O
demonstrated VBD O
that IN O
the DT O
Sp1-binding JJ B-NP
site NN I-NP
in IN O
the DT O
CDK6 NNP B-NP
promoter NN I-NP
forms NNS O
a DT O
specific JJ O
I3C-responsive JJ O
DNA-protein NNP O
complex NN O
that WDT O
contains VBZ O
the DT O
Sp1 NNP B-NP
transcription NN I-NP
factor NN I-NP
. . O

-DOCSTART- X X O

However RB O
, , O
C/EBP NNP B-NP
beta NN I-NP
stimulated VBD O
transcription NN O
primarily RB O
through IN O
the DT O
cAMP-responsive JJ O
element NN O
( -LRB- O
CRE) NNP O
, , O
which WDT O
maps NNS O
between IN O
positions NNS O
-77 JJ O
to TO O
-94 VB O
, , O
but CC O
not RB O
at IN O
the DT O
more JJR O
5'-binding JJ O
sites NNS O
. . O

-DOCSTART- X X O

The DT O
observed VBD O
alterations NNS O
in IN O
lung NN O
functions NNS O
in IN O
these DT O
subjects NNS O
indicate VBP O
that IN O
individuals NNS O
performing VBG O
heavy JJ O
continuous JJ O
exercise NN O
are VBP O
more RBR O
likely JJ O
to TO O
be VB O
affected VBN O
by IN O
lower JJR O
O3 IN O
levels NNS O
. . O

-DOCSTART- X X O

A DT O
personal JJ O
view NN O
of IN O
future NN O
trends NNS O
in IN O
the DT O
field NN O
of IN O
immunoassay NN O
concludes VBZ O
this DT O
review NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
admit VBP O
that IN O
a DT O
ribosome JJ O
scanning NN O
mechanism NN O
of IN O
the DT O
MP NNP B-NP
gene NN I-NP
expression NN O
from IN O
I( JJ O
2 CD O
) -RRB- O
sgRNA NN O
operates VBZ O
concurrently RB O
. . O

-DOCSTART- X X O

22.6 CD O
% NN O
of IN O
patients NNS O
were VBD O
found VBN O
to TO O
be VB O
positive JJ O
at IN O
histology NN O
in IN O
the DT O
corpus JJ O
mucosa NN O
; : O
all DT O
but CC O
one CD O
of IN O
these DT O
patients NNS O
had VBD O
elevated VBN O
circulating VBG O
IgG NNP B-NP
to TO O
H. NNP O
pylori FW O
( -LRB- O
Group NN O
C NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Concerning VBG O
the DT O
practical JJ O
approach NN O
in IN O
a DT O
clinical JJ O
setting NN O
, , O
it PRP O
has VBZ O
to TO O
be VB O
pointed VBN O
out RP O
that IN O
with IN O
these DT O
diseases NNS O
a DT O
hepatitis NN O
C NNP O
infection NN O
has VBZ O
to TO O
be VB O
considered VBN O
and CC O
testing VBG O
for IN O
hepatitis NN B-NP
C NNP I-NP
antibodies NNS I-NP
and CC O
, , O
if IN O
positive JJ O
, , O
hepatitis NN B-NP
C-RNA NNP I-NP
is VBZ O
indicated VBN O
. . O

-DOCSTART- X X O

In IN O
order NN O
to TO O
investigate VB O
the DT O
effect NN O
of IN O
the DT O
local JJ O
direct JJ O
action NN O
of IN O
danazol NN O
upon IN O
endometriosis NN O
, , O
intravaginal JJ O
and CC O
intrauterine JJ O
application NN O
were VBD O
tried VBN O
. . O

-DOCSTART- X X O

80 CD O
bp JJ O
) -RRB- O
surrounding VBG O
the DT O
site NN O
of IN O
transcription NN O
initiation NN O
. . O

-DOCSTART- X X O

BCR-ABL JJ B-NP
elicits NNS O
transformation NN O
of IN O
both DT O
fibroblast JJ O
and CC O
hematopoietic JJ O
cells NNS O
and CC O
blocks NNS O
apoptosis NN O
following VBG O
cytokine NN O
deprivation NN O
in IN O
various JJ O
factor-dependent JJ O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
transcriptional JJ B-NP
transactivator NN I-NP
( -LRB- O
Tas NNP B-NP
) -RRB- O
of IN O
simian JJ O
foamy NN O
virus NN O
type NN O
1 CD O
strongly RB O
augments VB O
gene NN O
expression NN O
directed VBN O
by IN O
both DT O
the DT O
promoter NN O
in IN O
the DT O
viral JJ O
long JJ O
terminal NN O
repeat NN O
and CC O
the DT O
newly RB O
discovered VBN O
internal JJ O
promoter NN O
located VBN O
within IN O
the DT O
env NN B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
nt JJ O
sequence NN O
was VBD O
carried VBN O
out RP O
on IN O
three CD O
out IN O
of IN O
the DT O
more JJR O
than IN O
15 CD O
of IN O
these DT O
regions NNS O
present RB O
in IN O
the DT O
mouse NN O
genome NN O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
site-specific JJ O
integration NN O
of IN O
the DT O
ITR-flanked JJ O
DNA NN O
was VBD O
also RB O
detected VBN O
by IN O
PCR NNP O
amplification NN O
of IN O
the DT O
ITR-aavs1 NNP B-NP
junction NN I-NP
in IN O
transduced VBN O
human JJ O
fibroblasts NNS O
. . O

-DOCSTART- X X O

Finally RB O
, , O
we PRP O
demonstrate VBP O
that IN O
animals NNS O
carrying VBG O
a DT O
snf NN B-NP
mutation NN O
that WDT O
converts VBZ O
SNF NNP B-NP
from IN O
a DT O
bifunctional JJ O
protein NN O
to TO O
a DT O
U1 NNP B-NP
snRNP-specific JJ I-NP
protein NN I-NP
are VBP O
viable JJ O
. . O

-DOCSTART- X X O

For IN O
this DT O
interaction NN O
, , O
the DT O
C-terminal JJ O
part NN O
of IN O
Sp1 NNP B-NP
and CC O
the DT O
N NNP O
terminus NN O
of IN O
E2F1 NNP B-NP
, , O
a DT O
domain NN O
also RB O
present JJ O
in IN O
E2F2 JJ B-NP
and CC O
E2F3 JJ B-NP
but CC O
absent JJ O
in IN O
E2F4 NNP B-NP
and CC O
E2F5 NNP B-NP
, , O
were VBD O
essential JJ O
. . O

-DOCSTART- X X O

To TO O
gain VB O
additional JJ O
insights NNS O
into IN O
this DT O
novel NN O
apoptotic JJ O
checkpoint NN O
, , O
we PRP O
have VBP O
now RB O
characterized VBN O
the DT O
mouse NN B-NP
survivin NN I-NP
locus NN I-NP
. . O

-DOCSTART- X X O

Since IN O
RIP140 NNP B-NP
generally RB O
down-regulates VBZ O
receptor NN O
activity NN O
in IN O
mammalian JJ O
cells NNS O
and CC O
specifically RB O
down-regulates JJ O
coactivation NN O
mediated VBN O
by IN O
SRC-1 JJ B-NP
, , O
we PRP O
propose VBP O
a DT O
model NN O
in IN O
which WDT O
RIP140 PRP B-NP
indirectly RB O
regulates VBZ O
nuclear JJ B-NP
receptor NN I-NP
AF-2 JJ I-NP
activity NN O
by IN O
competition NN O
for IN O
coactivators NNS O
such JJ O
as IN O
SRC-1 NN B-NP
. . O

-DOCSTART- X X O

We PRP O
constructed VBD O
a DT O
stable JJ O
, , O
doubly RB O
transfected VBN O
cell NN O
line NN O
( -LRB- O
TIS-10 NN O
) -RRB- O
carrying VBG O
a DT O
chromosomally RB O
integrated VBN O
ptetO7-CMV-L JJ B-NP
reporter NN O
construct VB O
and CC O
expressing VBG O
the DT O
TetR-KRAB NNP B-NP
protein NN O
. . O

-DOCSTART- X X O

Value NN O
of IN O
bone NN O
scintigraphy NN O
with IN O
Tc99MDP NNP O
in IN O
the DT O
early JJ O
diagnosis NN O
of IN O
mobilization NN O
of IN O
the DT O
total JJ O
hip NN O
prosthesis NN O

-DOCSTART- X X O

The DT O
isolation NN O
of IN O
crt5-262 NN B-NP
, , O
an DT O
additional JJ O
cdc NN B-NP
allele NN I-NP
of IN O
POL1/CDC17 CD B-NP
, , O
suggests VBZ O
for IN O
the DT O
first JJ O
time NN O
that IN O
directly RB O
blocking VBG O
DNA NNP O
replication NN O
can MD O
provide VB O
a DT O
signal NN O
to TO O
induce VB O
the DT O
DNA NN O
damage NN O
response NN O
. . O
crt2 VBD B-NP
mutants NNS I-NP
show VB O
a DT O
defect NN O
in IN O
basal NN O
level NN O
expression NN O
of IN O
RNR1-lacZ JJ B-NP
reporter NN O
constructs NNS O
. . O

-DOCSTART- X X O

Mouse NN B-NP
GRK6-C JJ I-NP
displays NNS O
none NN O
of IN O
these DT O
motifs NNS O
. . O

-DOCSTART- X X O

CTDK1 NNP B-NP
and CC O
CTDK2 NNP B-NP
also RB O
differ VBP O
in IN O
their PRP$ O
protein NN O
substrate NN O
specificity NN O
. . O

-DOCSTART- X X O

Protease NNP O
digestion NN O
and CC O
alkaline NN O
extraction NN O
of IN O
microsomes NNS O
containing VBG O
labeled VBN O
mutant JJ O
proteins NNS O
further RB O
showed VBD O
that IN O
segment NN O
3 CD O
was VBD O
sufficient JJ O
for IN O
stable JJ O
membrane NN O
anchoring NN O
of IN O
the DT O
glycoproteins NNS O
, , O
indicating VBG O
that IN O
this DT O
segment NN O
may MD O
specify VB O
the DT O
transmembrane NN O
domain NN O
of IN O
the DT O
gB NN B-NP
glycoprotein NN I-NP
. . O

-DOCSTART- X X O

87 CD O
, , O
7270-7274 CD O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
properties NNS O
prompted VBD O
us PRP O
to TO O
investigate VB O
Ets-1 JJ B-NP
expression NN O
in IN O
32 CD O
human JJ O
astroglial NN O
tumors NNS O
of IN O
WHO WP O
grades NNS O
I-IV NNP O
and CC O
to TO O
correlate VB O
the DT O
data NNS O
with IN O
the DT O
expression NN O
pattern NN O
of IN O
VEGF NNP B-NP
, , O
Flt-1 NNP B-NP
, , O
and CC O
KDR. NNP B-NP

-DOCSTART- X X O

The DT O
CydDC NNP B-NP
system NN I-NP
appears VBZ O
to TO O
be VB O
the DT O
first JJ O
prokaryotic JJ O
example NN O
of IN O
a DT O
heterodimeric JJ B-NP
ABC NNP I-NP
transport NN I-NP
system NN I-NP
in IN O
which WDT O
each DT O
polypeptide NN O
contains VBZ O
both DT O
hydrophobic JJ O
and CC O
ATP-binding JJ O
domains NNS O
. . O

-DOCSTART- X X O

Older JJR O
females NNS O
had VBD O
lumbar NN O
( -LRB- O
0.6 CD O
+/ NN O
- : O
1.3 CD O
) -RRB- O
and CC O
TB NNP O
( -LRB- O
1.1 CD O
+/ NN O
- : O
1.1 CD O
) -RRB- O
BMD NNP O
Z NN O
scores NNS O
greater JJR O
than IN O
0 CD O
( -LRB- O
both DT O
, , O
p NN O
< NN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Mutation NN O
of IN O
the DT O
distal JJ O
E2F NNP B-NP
binding NN I-NP
site NN I-NP
in IN O
the DT O
cdc25A JJ B-NP
promoter NN I-NP
abolished VBD O
E2-induced JJ B-NP
repression NN O
, , O
whereas IN O
mutation NN O
of IN O
the DT O
proximal JJ O
E2F NNP B-NP
site NN I-NP
or CC O
the DT O
E2 NNP B-NP
site NN I-NP
had VBD O
no DT O
effect NN O
. . O

-DOCSTART- X X O

Psychopathological NNP O
, , O
vegetative NN O
, , O
and CC O
vital JJ O
parameters NNS O
were VBD O
assessed VBN O
every DT O
hour NN O
. . O

-DOCSTART- X X O

The DT O
mitochondrial JJ B-NP
tyrosyl-tRNA NN I-NP
synthetase NN I-NP
of IN O
Podospora NNP O
anserina NN O
is VBZ O
a DT O
bifunctional JJ O
enzyme JJ O
active JJ O
in IN O
protein NN O
synthesis NN O
and CC O
RNA NNP O
splicing NN O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
the DT O
central JJ O
nonconserved JJ O
region NN O
of IN O
the DT O
large JJ O
subunit NN O
is VBZ O
not RB O
essential JJ O
for IN O
function NN O
and CC O
likely JJ O
acts NNS O
as IN O
a DT O
spacer NN O
between IN O
the DT O
conserved VBN O
N- NNP O
and CC O
C-terminal JJ O
regions NNS O
. . O

-DOCSTART- X X O

Surprisingly RB O
, , O
apo-iso-1-cytochrome JJ B-NP
c NN I-NP
is VBZ O
absent JJ O
in IN O
cyc3 CD B-NP
- : I-NP
strains NNS O
, , O
although IN O
apo-iso-2-cytochrome JJ B-NP
c NN I-NP
is VBZ O
present JJ O
at IN O
approximately RB O
the DT O
same JJ O
level NN O
at IN O
which WDT O
holo-iso-2-cytochrome NN B-NP
c NN I-NP
is VBZ O
found VBN O
in IN O
CYC3+ JJ B-NP
strains NNS O
. . O

-DOCSTART- X X O

An DT O
exception NN O
is VBZ O
the DT O
Bcl-6 NNP B-NP
gene NN I-NP
, , O
encoding VBG O
a DT O
transcription NN O
factor NN O
, , O
which WDT O
was VBD O
found VBN O
to TO O
be VB O
mutated VBN O
in IN O
normal JJ O
human JJ O
memory NN O
B NNP O
cells NNS O
. . O

-DOCSTART- X X O

Serum NNP O
PRL NNP B-NP
concentrations NNS O
significantly RB O
increased VBD O
after IN O
MCP NNP O
administration NN O
in IN O
normal JJ O
women NNS O
, , O
hyperprolactinemic JJ O
patients NNS O
with IN O
normal JJ O
sella NN O
and CC O
patients NNS O
with IN O
microadenoma NN O
, , O
but CC O
not RB O
in IN O
macroadenoma NN O
patients NNS O
with IN O
and CC O
without IN O
suprasellar JJ O
expansion NN O
( -LRB- O
SSE) NNP O
. . O

-DOCSTART- X X O

These DT O
include VBP O
not RB O
only RB O
antioxidants NNS O
, , O
N-methyl-D-aspartate NN B-NP
receptor NN I-NP
antagonists NNS O
, , O
inhibitors NNS O
of IN O
glutamate NN O
release NN O
, , O
calcium NN O
channel NN O
blockers NNS O
, , O
polyamine NN O
antagonists NNS O
, , O
and CC O
nitric JJ B-NP
oxide NN I-NP
synthase NN I-NP
inhibitors NNS O
, , O
but CC O
cannabinoids NNS O
, , O
aspirin NN O
, , O
melatonin NN O
, , O
and CC O
vitamin NN O
B-12 NN O
. . O

-DOCSTART- X X O

In IN O
conclusion NN O
, , O
ANH NNP O
had VBD O
no DT O
negative JJ O
effects NNS O
on IN O
the DT O
endocrine NN O
stress NN O
response NN O
during IN O
orthopedic JJ O
surgery NN O
under IN O
epidural JJ O
anesthesia NN O
. . O

-DOCSTART- X X O

Calculation NNP O
of IN O
energy NN O
levels NNS O
, , O
E1 NNP O
transition NN O
amplitudes NNS O
, , O
and CC O
parity NN O
violation NN O
in IN O
francium NN O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
confirmed VBN O
that IN O
ADAMTS-1 NNP B-NP
was VBD O
up-regulated JJ O
in IN O
both DT O
metaphyseal NN O
( -LRB- O
14- CD O
to TO O
35-fold JJ O
) -RRB- O
and CC O
diaphyseal JJ O
( -LRB- O
4.2-fold JJ O
) -RRB- O
bone NN O
1 CD O
h NN O
after IN O
PTH-(1-38 DT B-NP
) -RRB- I-NP
injection NN O
and CC O
returned VBD O
to TO O
control VB O
levels NNS O
by IN O
24 CD O
h NN O
. . O

-DOCSTART- X X O

The DT O
findings NNS O
in IN O
the DT O
human JJ O
multiple NN O
myeloma NN O
cell NN O
lines NNS O
represent VBP O
the DT O
first JJ O
examples NNS O
of IN O
B NNP O
cells NNS O
with IN O
downregulated JJ O
PU.1 JJ B-NP
expression NN O
and CC O
apparently RB O
contradict JJ O
observations NNS O
in IN O
the DT O
murine NN O
system NN O
in IN O
which WDT O
PU.1 NNP B-NP
is VBZ O
expressed VBN O
and CC O
active JJ O
in IN O
plasmacytoma NN O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

The DT O
STP1 NNP B-NP
locus NN I-NP
is VBZ O
located VBN O
on IN O
chromosome NN O
IV NNP O
close RB O
to TO O
at IN O
least JJS O
two CD O
other JJ O
genes NNS O
involved VBN O
in IN O
RNA NNP O
splicing NN O
: : O
PRP3 NNP B-NP
and CC O
SPP41 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
highly RB O
correlated JJ O
frequencies NNS O
provided VBD O
strong JJ O
evidence NN O
of IN O
a DT O
medium-frequency NN O
pattern NN O
generator NN O
which WDT O
may MD O
remain VB O
operative JJ O
beyond IN O
the DT O
neonatal JJ O
period NN O
. . O

-DOCSTART- X X O

Pancreatic JJ O
expression NN O
of IN O
the DT O
glucagon NN B-NP
gene NN I-NP
depends VBZ O
on IN O
multiple JJ O
transcription NN O
factors NNS O
interacting VBG O
with IN O
at IN O
least JJS O
three CD O
DNA NN O
control NN O
elements NNS O
: : O
G1 NNP O
, , O
the DT O
upstream JJ O
promoter NN O
element NN O
, , O
and CC O
G2 NNP O
and CC O
G3 NNP O
, , O
two CD O
enhancer-like JJ O
sequences NNS O
. . O

-DOCSTART- X X O

Before IN O
and CC O
6 CD O
and CC O
12 CD O
months NNS O
after IN O
H. NNP O
pylori NN O
eradication NN O
the DT O
patients NNS O
were VBD O
evaluated VBN O
for IN O
fasting VBG O
gastrinemia NN O
and CC O
pepsinogen NN B-NP
I PRP I-NP
, , O
basal JJ O
and CC O
peak JJ O
acid NN O
output NN O
, , O
and CC O
detailed JJ O
histological JJ O
assessment NN O
including VBG O
the DT O
ECL NNP O
cell NN O
proliferative NN O
patterns NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
CARP NNP B-NP
is VBZ O
a DT O
YB-1 JJ B-NP
associated JJ I-NP
factor NN I-NP
and CC O
represents VBZ O
the DT O
first JJ O
identified VBN O
cardiac-restricted JJ O
downstream IN O
regulatory JJ O
gene NN O
in IN O
the DT O
homeobox NN O
gene NN O
Nkx2-5 : B-NP
pathway NN O
and CC O
may MD O
serve VB O
as IN O
a DT O
negative JJ O
regulator NN O
of IN O
HF-1-dependent JJ B-NP
pathways NNS O
for IN O
ventricular JJ O
muscle NN O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

Structure NN O
and CC O
chromosomal NN O
localization NN O
of IN O
the DT O
human JJ O
gene NN O
of IN O
the DT O
phosphotyrosyl NN B-NP
phosphatase NN I-NP
activator NN I-NP
( -LRB- O
PTPA NNP B-NP
) -RRB- O
of IN O
protein NN B-NP
phosphatase NN I-NP
2A. . I-NP

-DOCSTART- X X O

This DT O
article NN O
expands VBZ O
the DT O
analysis NN O
of IN O
a DT O
numeric JJ O
example NN O
included VBD O
in IN O
the DT O
SAS NNP O
GLM NNP O
procedure NN O
to TO O
cover VB O
several JJ O
crucial JJ O
statistical JJ O
aspects NNS O
relevant JJ O
to TO O
ANCOVA NNP O
, , O
and CC O
to TO O
highlight VB O
the DT O
meaning NN O
of IN O
the DT O
statistical JJ O
results NNS O
obtained VBD O
. . O

-DOCSTART- X X O

The DT O
PEP4 NNP B-NP
gene NN I-NP
was VBD O
isolated VBN O
from IN O
a DT O
genomic JJ O
DNA NNP O
library NN O
by IN O
complementation NN O
of IN O
the DT O
pep4-3 NN B-NP
mutation NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
panretinal JJ O
photocoagulation NN O
offers VBZ O
a DT O
highly RB O
effective JJ O
means NNS O
of IN O
dealing VBG O
with IN O
early JJ O
and CC O
moderately RB O
advanced JJ O
cases NNS O
of IN O
angle NN O
neovascularization NN O
. . O

-DOCSTART- X X O

Bilateral JJ O
renal JJ O
oncocytoma NN O
in IN O
a DT O
Greyhound JJ O
dog NN O
. . O

-DOCSTART- X X O

The DT O
E. NNP O
multilocularis/Mongolian JJ O
gerbil NN O
system NN O
can MD O
replace VB O
the DT O
natural JJ O
canid NN O
hosts NNS O
as IN O
a DT O
new JJ O
way NN O
to TO O
obtain VB O
infective JJ O
eggs NNS O
and CC O
to TO O
analyze VB O
host-parasite JJ O
interactions NNS O
. . O

-DOCSTART- X X O

The DT O
Fugu NNP O
rubripes NNS O
( -LRB- O
Fugu NNP O
) -RRB- O
gene NN O
fragment NN O
was VBD O
used VBN O
to TO O
isolate VB O
the DT O
GH NNP B-NP
gene NN I-NP
from IN O
a DT O
Fugu NNP O
genomic JJ O
library NN O
. . O

-DOCSTART- X X O

For IN O
the DT O
first JJ O
time NN O
also RB O
a DT O
genomic JJ O
sequence NN O
for IN O
a DT O
red JJ B-NP
algal NN I-NP
lhc NN I-NP
gene NN I-NP
is VBZ O
presented VBN O
. . O

-DOCSTART- X X O

Comparison NN O
with IN O
the DT O
data NNS O
of IN O
clinical JJ O
development NN O
and CC O
hemodynamic JJ O
results NNS O

-DOCSTART- X X O

Despite IN O
a DT O
lowering VBG O
of IN O
her PRP$ O
plasma NN O
ACTH NNP B-NP
concentration NN O
during IN O
therapy NN O
with IN O
valproic JJ O
acid NN O
, , O
the DT O
patient NN O
's POS O
tumour NN O
showed VBD O
no DT O
evidence NN O
of IN O
regression NN O
while IN O
she PRP O
was VBD O
taking VBG O
the DT O
drug NN O
. . O

-DOCSTART- X X O

2. . O

-DOCSTART- X X O

The DT O
D443N NNP B-NP
substitution NN I-NP
is VBZ O
an DT O
activating NN O
mutation NN O
that WDT O
increases VBZ O
the DT O
activity NN O
of IN O
SCAP NNP B-NP
and CC O
renders VBD O
it PRP O
resistant JJ O
to TO O
inhibition NN O
by IN O
25-hydroxycholesterol JJ O
. . O

-DOCSTART- X X O

Transcriptional NNP O
modulation NN O
of IN O
the DT O
anti-apoptotic JJ B-NP
protein NN I-NP
BCL-XL NNP I-NP
by IN O
the DT O
paired JJ B-NP
box NN I-NP
transcription NN I-NP
factors NNS I-NP
PAX3 JJ B-NP
and CC O
PAX3/FKHR. NNP B-NP

-DOCSTART- X X O

In IN O
this DT O
case NN O
myogenic JJ O
factors NNS O
are VBP O
not RB O
initially RB O
expressed VBN O
and CC O
these DT O
migratory JJ O
cells NNS O
are VBP O
characterized VBN O
by IN O
the DT O
expression NN O
of IN O
the DT O
paired-box NN B-NP
gene NN O
Pax3 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
fecal JJ O
excretion NN O
is VBZ O
found VBN O
to TO O
be VB O
only RB O
one CD O
third JJ O
of IN O
that DT O
measured VBN O
in IN O
urine NN O
. . O

-DOCSTART- X X O

Forty-five CD O
per IN O
cent NN O
of IN O
the DT O
dose NN O
was VBD O
excreted VBN O
as IN O
methyldopa NN O
as IN O
opposed VBN O
to TO O
18 CD O
% NN O
normally RB O
seen VBN O
after IN O
oral JJ O
methyldopa NN O
dosages NNS O
. . O

-DOCSTART- X X O

Standing VBG O
values NNS O
: : O
placebo NN O
114/79 CD O
; : O
BHT-933 CD O
92/67 CD O
. . O

-DOCSTART- X X O

In IN O
cases NNS O
in IN O
which WDT O
it PRP O
was VBD O
identified VBN O
, , O
insulitis NNS O
affected VBD O
23 CD O
% NN O
of IN O
islets NNS O
containing VBG O
insulin NN B-NP
, , O
but CC O
affected VBD O
only RB O
1 CD O
% NN O
of IN O
islets NNS O
which WDT O
were VBD O
insulin NN B-NP
deficient NN O
, , O
thus RB O
supporting VBG O
the DT O
concept NN O
that IN O
insulitis NN O
represents VBZ O
an DT O
immunologically RB O
mediated JJ O
destruction NN O
of IN O
insulin NN B-NP
secreting NN O
B NNP O
cells NNS O
. . O

-DOCSTART- X X O

Proteins NNS O
PBP-1 JJ B-NP
and CC O
PBP-2 JJ B-NP
bind NN O
to TO O
two CD O
of IN O
the DT O
three CD O
promoter NN O
elements NNS O
in IN O
the DT O
trypanosomatid JJ O
Leptomonas NNP O
seymouri NN O
. . O

-DOCSTART- X X O

The DT O
vicinity NN O
of IN O
large JJ O
industrial JJ O
emissions NNS O
of IN O
lead NN O
, , O
where WRB O
mean JJ O
Pb-B NNP O
concentrations NNS O
were VBD O
usually RB O
twice RB O
as RB O
high JJ O
as IN O
in IN O
rural JJ O
areas NNS O
of IN O
the DT O
Katowice NNP O
voivodship NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
BCR NNP B-NP
ligation NN O
initiates VBZ O
a DT O
PI NNP B-NP
3-kinase/Akt/GSK-3 JJ I-NP
signaling NN O
pathway NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
a DT O
new JJ O
positive JJ O
inotropic NN O
agent NN O
( -LRB- O
OPC-8212 NNP O
) -RRB- O
on IN O
intracellular JJ O
potential JJ O
of IN O
isolated VBN O
canine CD O
ventricular JJ O
papillary NN O
muscle NN O

-DOCSTART- X X O

At IN O
the DT O
same JJ O
acoustic JJ O
power NN O
, , O
the DT O
rate NN O
of IN O
chloride NN O
formation NN O
with IN O
20 CD O
kHz NN O
ultrasound NN O
was VBD O
greater JJR O
when WRB O
a DT O
probe NN O
with IN O
a DT O
larger JJR O
tip NN O
area NN O
was VBD O
used VBN O
, , O
but CC O
significantly RB O
less JJR O
than IN O
the DT O
rate NN O
with IN O
900 CD O
kHz NN O
. . O

-DOCSTART- X X O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
demonstrating VBG O
specificity NN O
at IN O
the DT O
level NN O
of IN O
the DT O
energy NN O
coupling VBG O
proteins NNS O
of IN O
the DT O
PTS. NNP O

-DOCSTART- X X O

As IN O
expected VBN O
, , O
the DT O
QOLS-N NNP O
had VBD O
a DT O
lower JJR O
correlation NN O
with IN O
physical JJ O
health NN O
( -LRB- O
r NN O
= SYM O
0.24 CD O
, , O
p NN O
< NN O
0.000 CD O
) -RRB- O
and CC O
self-reported JJ O
symptoms NNS O
( -LRB- O
r NN O
= SYM O
-0.20 FW O
, , O
p NN O
< NN O
0.001 CD O
) -RRB- O
, , O
and CC O
a DT O
higher JJR O
correlation NN O
with IN O
mental JJ O
health NN O
( -LRB- O
r NN O
= SYM O
0.52 CD O
, , O
p NN O
< NN O
0.000 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Like IN O
pimethixene NN O
and CC O
cyproheptadine NN O
, , O
WA VBD O
335 PRP O
has VBZ O
no DT O
distinct JJ O
antagonistic JJ O
qualities NNS O
against IN O
bradykinin NN B-NP
. . O

-DOCSTART- X X O

Additional JJ O
simulations NNS O
account VBP O
for IN O
interactions NNS O
of IN O
spatial JJ O
frequency NN O
with IN O
stimulus NN O
duration NN O
, , O
effects NNS O
of IN O
adaptation NN O
, , O
and CC O
properties NNS O
of IN O
residual JJ O
traces NNS O
, , O
as IN O
opposed VBN O
to TO O
visual JJ O
persistence NN O
. . O

-DOCSTART- X X O

A DT O
DNA NNP O
fragment NN O
that WDT O
complements VBZ O
the DT O
uvs-2 JJ B-NP
mutation NN O
was VBD O
subcloned VBN O
by IN O
monitoring VBG O
its PRP$ O
ability NN O
to TO O
transform VB O
the DT O
uvs-2 JJ B-NP
mutant JJ I-NP
to TO O
MMS NNP O
resistance NN O
. . O

-DOCSTART- X X O

Back-ground JJ O
factors NNS O
which WDT O
affect VBP O
the DT O
outcome NN O
of IN O
steroid JJ O
withdrawal NN O
therapy NN O
in IN O
patients NNS O
with IN O
chronic JJ O
type NN O
B NN O
hepatitis--statistical JJ O
evaluation NN O
of IN O
the DT O
importance NN O
of IN O
the DT O
mode NN O
of IN O
HBV NNP O
transmission NN O

-DOCSTART- X X O

Effect NN O
of IN O
food NN O
on IN O
hemodynamics NNS O
. . O

-DOCSTART- X X O

PTP1-lacZ JJ B-NP
studies NNS O
indicate VBP O
that IN O
PTP1 NNP B-NP
is VBZ O
spatially RB O
localized VBN O
to TO O
prestalk VB O
and CC O
anterior-like JJ O
cell NN O
types NNS O
. . O

-DOCSTART- X X O

Morphologic NNP O
evidence NN O
that WDT O
rhe VBD O
renal JJ O
calyx NN O
and CC O
pelvis NN O
control NN O
ureteric JJ O
activity NN O
in IN O
the DT O
rabbit NN O
. . O

-DOCSTART- X X O

Human JJ B-NP
alcohol NN I-NP
dehydrogenase NN I-NP
( -LRB- O
ADH) NNP B-NP
exists VBZ O
as IN O
a DT O
heterogeneous JJ O
group NN O
of IN O
isozymes NNS O
capable JJ O
of IN O
oxidizing VBG O
a DT O
wide JJ O
variety NN O
of IN O
aliphatic JJ O
and CC O
aromatic JJ O
alcohols NNS O
. . O

-DOCSTART- X X O

We PRP O
reviewed VBN O
81 CD O
patients NNS O
with IN O
dementia NNP O
and CC O
autopsy JJ O
findings NNS O
of IN O
Alzheimer NNP O
's POS O
disease NN O
( -LRB- O
AD NN O
) -RRB- O
to TO O
identify VB O
patients NNS O
with IN O
seizures NNS O
or CC O
myoclonus NN O
after IN O
onset NN O
of IN O
dementia NN O
. . O

-DOCSTART- X X O

The DT O
second JJ O
system NN O
( -LRB- O
VacFix NNP O
) -RRB- O
uses VBZ O
a DT O
0.15 CD O
mm CD O
thick JJ O
plastic JJ O
bag NN O
loosely RB O
filled VBN O
with IN O
1 CD O
mm CD O
polysterol NN O
spheres NNS O
. . O

-DOCSTART- X X O

Expression NN O
in IN O
all DT O
lines NNS O
was VBD O
decreased VBN O
by IN O
the DT O
inclusion NN O
of IN O
regions NNS O
further RB O
upstream RB O
, , O
and CC O
extinguished VBN O
by IN O
the DT O
inclusion NN O
of IN O
the DT O
first JJ O
intron NN O
. . O

-DOCSTART- X X O

U. . O

-DOCSTART- X X O

A DT O
Laboratory NNP O
Manual NNP O
, , O
2nd NNP O
ed VBD O
. . O

-DOCSTART- X X O

A DT O
protein NN O
which WDT O
promotes VBZ O
DNA NNP O
strand NN O
transfer NN O
between IN O
linear NN O
double-stranded JJ O
M13mp19 IN O
DNA NNP O
and CC O
single-stranded JJ O
viral JJ O
M13mp19 CC O
DNA NNP O
has VBZ O
been VBN O
isolated VBN O
from IN O
recA JJ B-NP
- : I-NP
E.coli NNS O
. . O

-DOCSTART- X X O

We PRP O
speculate VBP O
that IN O
the DT O
enhancing VBG O
effect NN O
of IN O
glucose NN O
and CC O
galactose NN O
on IN O
fructose NN O
absorption NN O
may MD O
be VB O
due JJ O
to TO O
activation NN O
of IN O
the DT O
fructose JJ B-NP
carrier NN I-NP
. . O

-DOCSTART- X X O

The DT O
nutraceuticals NNS O
of IN O
specific JJ O
vitamins NNS O
, , O
minerals NNS O
, , O
phytoestrogens NNS O
, , O
and CC O
essential JJ O
fatty JJ O
acid NN O
supplementations NNS O
are VBP O
a DT O
vital JJ O
component NN O
of IN O
the DT O
risk NN O
reduction NN O
health NN O
program NN O
. . O

-DOCSTART- X X O

An DT O
scrR NN B-NP
promoter NN I-NP
fragment NN I-NP
, , O
which WDT O
dose NN O
not RB O
contain VB O
a DT O
sequence NN O
resembling NN O
OB NNP B-NP
, , O
was VBD O
not RB O
shifted VBN O
by IN O
the DT O
fusion NN O
protein NN O
. . O

-DOCSTART- X X O

We PRP O
screened VBD O
an DT O
A. NN O
thaliana DT O
cDNA JJ O
library NN O
, , O
whose WP$ O
inserts NNS O
are VBP O
under IN O
the DT O
control NN O
of IN O
the DT O
galactose-inducible JJ O
GAL10 NNP B-NP
promoter NN I-NP
, , O
for IN O
cDNAs NNS O
which WDT O
enabled VBD O
YDH8 CD O
cells NNS O
to TO O
grow VB O
at IN O
the DT O
restrictive JJ O
temperature NN O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
we PRP O
have VBP O
reevaluated VBN O
the DT O
age-related JJ O
changes NNS O
in IN O
serum NN B-NP
leptin NN I-NP
levels NNS O
and CC O
their PRP$ O
relationship NN O
with IN O
adiposity NN O
and CC O
androgen NN O
levels NNS O
in IN O
a DT O
large JJ O
group NN O
of IN O
community NN O
dwelling NN O
men NNS O
. . O

-DOCSTART- X X O

While IN O
reviewing VBG O
gastric JJ O
specimens NNS O
from IN O
215 CD O
baboons NNS O
, , O
we PRP O
found VBD O
diffuse JJ O
giant JJ O
mucosal NN O
folds VBZ O
in IN O
2 CD O
specimens NNS O
and CC O
multiple JJ O
giant JJ O
mucosal NN O
nodules NNS O
in IN O
another DT O
3. . O

-DOCSTART- X X O

Morphologically RB O
, , O
corrugation NN O
of IN O
the DT O
internal JJ O
elastic JJ O
lamina NN O
of IN O
vessels NNS O
was VBD O
often RB O
observed VBN O
in IN O
the DT O
vehicle-treated JJ O
group NN O
, , O
but CC O
was VBD O
not RB O
prominent JJ O
in IN O
the DT O
GLNVA-treated JJ O
groups NNS O
or CC O
healthy JJ O
controls NNS O
. . O

-DOCSTART- X X O

Transcripts NNS O
initiating VBG O
at IN O
the DT O
CAGT NN O
motif NN O
( -LRB- O
proximal JJ O
transcripts NNS O
) -RRB- O
were VBD O
abolished VBN O
by IN O
deletion NN O
of IN O
the DT O
proximal JJ O
TATA JJ O
box NN O
located VBN O
at IN O
-29 DT O
relative JJ O
to TO O
CAGT. NNP O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
the DT O
MMF NNP O
lesion NN O
is VBZ O
secondary JJ O
to TO O
intramuscular JJ O
injection NN O
of IN O
aluminium NN O
hydroxide-containing JJ O
vaccines NNS O
, , O
shows VBZ O
both DT O
long-term JJ O
persistence NN O
of IN O
aluminium NN O
hydroxide NN O
and CC O
an DT O
ongoing JJ O
local JJ O
immune JJ O
reaction NN O
, , O
and CC O
is VBZ O
detected VBN O
in IN O
patients NNS O
with IN O
systemic JJ O
symptoms NNS O
which WDT O
appeared VBD O
subsequently RB O
to TO O
vaccination NN O
. . O

-DOCSTART- X X O

Advisory NNP O
Committee NNP O
report NN O
recommends VBZ O
that IN O
US PRP O
make VBP O
amends NNS O
for IN O
human JJ O
radiation NN O
experiments NNS O
. . O

-DOCSTART- X X O

An DT O
evaluation NN O
of IN O
a DT O
positive JJ O
control NN O
for IN O
platelet NN O
neutralization NN O
procedure NN O
testing NN O
with IN O
seven CD O
commercial JJ O
activated VBN O
partial JJ O
thromboplastin IN B-NP
time NN O
reagents NNS O
. . O

-DOCSTART- X X O

Transmission NNP O
of IN O
mutans NNS O
streptococci NNS O
to TO O
infants NNS O
following VBG O
short JJ O
term NN O
application NN O
of IN O
an DT O
iodine-NaF JJ O
solution NN O
to TO O
mothers NNS O
' POS O
dentition NN O
. . O

-DOCSTART- X X O

Glycoprotein NNP O
biosynthesis NN O
in IN O
Saccharomyces NNP O
cerevisiae NNS O
: : O
ngd29 CD B-NP
, , O
an DT O
N-glycosylation NN O
mutant JJ O
allelic NN O
to TO O
och1 VB B-NP
having VBG O
a DT O
defect NN O
in IN O
the DT O
initiation NN O
of IN O
outer JJ O
chain NN O
formation NN O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
erythrosine FW O
( -LRB- O
Red JJ O
3 CD O
) -RRB- O
, , O
rose VBD O
bengal NN O
B NN O
( -LRB- O
Red JJ O
105 CD O
) -RRB- O
and CC O
thyroidectomy NN O
on IN O
the DT O
development NN O
of IN O
thyroid DT O
tumor NN O
were VBD O
examined VBN O
in IN O
male JJ O
Wistar NNP O
rats NNS O
treated VBN O
with IN O
N-bis(2-hydroxypropyl JJ O
)nitrosamine NN O
( -LRB- O
DHPN) NNP O
. . O

-DOCSTART- X X O

The DT O
region NN O
surrounding VBG O
the DT O
ZNF35 CD B-NP
zinc NN I-NP
finger NN I-NP
protein NN I-NP
gene NN I-NP
on IN O
3p21 CD O
is VBZ O
of IN O
particular JJ O
interest NN O
, , O
as IN O
this DT O
region NN O
of IN O
chromosome NN O
3 CD O
is VBZ O
frequently RB O
involved VBN O
in IN O
rearrangements NNS O
and/or CC O
deletions NNS O
associated VBN O
with IN O
various JJ O
human JJ O
tumors NNS O
including VBG O
lung NN O
and CC O
renal JJ O
carcinoma NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
no DT O
change NN O
in IN O
the DT O
level NN O
of IN O
either DT O
p53 NN B-NP
or CC O
activation NN O
of IN O
mdm2 JJ B-NP
protein NN I-NP
by IN O
p53 NN B-NP
was VBD O
observed VBN O
in IN O
hamster NN O
UV61 IN O
cells NNS O
after IN O
UV NN O
exposure NN O
. . O

-DOCSTART- X X O

Complete JJ O
activation NN O
of IN O
signal NN B-NP
transducer NN I-NP
and CC I-NP
activator NN I-NP
of IN I-NP
transcription NN I-NP
1 CD I-NP
(STAT1 NN O
) -RRB- O
requires VBZ O
phosphorylation NN O
at IN O
both DT O
Y701 NNP O
and CC O
a DT O
conserved VBN O
PMS(727)P NNP O
sequence NN O
. . O

-DOCSTART- X X O

On IN O
the DT O
basis NN O
of IN O
experiments NNS O
with IN O
mutant JJ O
virus NN O
and CC O
transfection NN O
with IN O
isolated VBN O
genes NNS O
, , O
the DT O
herpes NNS B-NP
simplex JJ I-NP
virus NN I-NP
immediate-early JJ I-NP
gene NN I-NP
product NN O
ICP4 . B-NP
is VBZ O
known VBN O
to TO O
positively RB O
regulate VB O
the DT O
transcription NN O
of IN O
viral JJ B-NP
early JJ I-NP
and CC I-NP
late JJ I-NP
genes NNS I-NP
and CC O
negatively RB O
regulate VB O
expression NN O
from IN O
its PRP$ O
own JJ O
promoter NN O
. . O

-DOCSTART- X X O

Alcohol NN O
abuse NN O
and CC O
treatment NN O
resistance NN O
in IN O
skin NN O
disease NN O
. . O

-DOCSTART- X X O

The DT O
first JJ O
270 CD O
bp NN O
of IN O
the DT O
promoter NN O
region NN O
were VBD O
sequenced VBN O
and CC O
found VBN O
to TO O
contain VB O
a DT O
CATAA NNP O
box NN O
rather RB O
than IN O
a DT O
TATAA NNP O
box NN O
and CC O
several JJ O
DNA NNP O
motifs NNS O
found VBD O
in IN O
activation NN O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
reduced JJ O
expression NN O
caused VBN O
by IN O
multimerization NN O
of IN O
UAS2 NNP O
in IN O
the DT O
native JJ O
promoter NN O
was VBD O
observed VBN O
only RB O
in IN O
the DT O
presence NN O
of IN O
ADR1 NNP B-NP
. . O

-DOCSTART- X X O

One CD O
child NN O
, , O
recently RB O
fed VBN O
, , O
vomited VBN O
a DT O
small JJ O
amount NN O
of IN O
breast NN O
milk NN O
after IN O
a DT O
short JJ O
period NN O
of IN O
crying VBG O
and CC O
apparently RB O
had VBD O
a DT O
laryngospasm NN O
, , O
shown VBN O
by IN O
a DT O
sudden JJ O
drop NN O
in IN O
the DT O
PtcO2 NNP O
level NN O
without IN O
any DT O
other JJ O
signs NNS O
of IN O
discomfort NN O
. . O

-DOCSTART- X X O

The DT O
central JJ O
venous JJ O
O2 DT O
saturation NN O
test NN O
in IN O
acute JJ O
pulmonary JJ O
fat JJ O
embolism NN O
. . O

-DOCSTART- X X O

Sequence DT O
comparisons NNS O
reveal VBP O
that IN O
the DT O
P. NNP B-NP
woesei NN I-NP
GTP-binding JJ I-NP
protein NN I-NP
is VBZ O
strikingly RB O
related VBN O
in IN O
sequence NN O
to TO O
eubacterial JJ B-NP
FtsZ NN I-NP
and CC O
is VBZ O
marginally RB O
more JJR O
similar JJ O
to TO O
eukaryotic JJ B-NP
tubulins NNS I-NP
than IN O
are VBP O
bacterial JJ B-NP
FtsZ JJ I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Cross-talk NN O
between IN O
transcription NN O
factors NNS O
NF-kappa NNP B-NP
B NNP I-NP
and CC O
C/EBP NNP B-NP
in IN O
the DT O
transcriptional JJ O
regulation NN O
of IN O
genes NNS O
. . O

-DOCSTART- X X O

FDP-1 NN O
( -LRB- O
200 CD O
micrograms.kg-1 NN O
) -RRB- O
of IN O
intracoronary JJ O
injection NN O
increased VBD O
collateral NN O
flow NN O
, , O
reduced VBD O
systemic JJ O
artery NN O
resistance NN O
, , O
and CC O
coronary JJ O
systolic JJ O
pressure NN O
in IN O
infarcted JJ O
region NN O
and CC O
the DT O
area NN O
of IN O
infarction NN O
decreased VBN O
from IN O
28.9 CD O
+/ CD O
- : O
1.3 CD O
% NN O
to TO O
15.3 CD O
+/ NNS O
- : O
1.2 CD O
% NN O
( -LRB- O
P NNP O
< NNP O
0.01 CD O
, , O
n RB O
= SYM O
6 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Heterologous NNP O
hybridization NN O
with IN O
a DT O
rps12 NN B-NP
gene NN I-NP
specific JJ O
probe NN O
from IN O
Euglena NNP O
has VBZ O
revealed VBN O
the DT O
presence NN O
of IN O
rps12 CD B-NP
homologous JJ I-NP
sequences NNS I-NP
within IN O
the DT O
inverted JJ O
repeat NN O
of IN O
Spirodela NNP O
chloroplast NN O
DNA NN O
on IN O
the DT O
fragment NN B-NP
BamHI-V. . I-NP

-DOCSTART- X X O

In IN O
6 CD O
patients NNS O
( -LRB- O
9 CD O
kidneys NNS O
) -RRB- O
irrigation NN O
with IN O
Solution NNP O
G NNP O
in IN O
the DT O
renal JJ O
pelvis NN O
was VBD O
performed VBN O
for IN O
the DT O
dissolution NN O
of IN O
their PRP$ O
infectious JJ O
stones NNS O
. . O

-DOCSTART- X X O

Derepression NNP O
of IN O
RAR NNP B-NP
signaling VBG O
by IN O
expressing VBG O
a DT O
dominant-negative JJ O
corepressor NN O
resulted VBD O
in IN O
embryos NNS O
that WDT O
exhibited VBD O
phenotypes NNS O
similar JJ O
to TO O
those DT O
treated VBN O
by IN O
RA. NNP O

-DOCSTART- X X O

Within IN O
the DT O
final JJ O
11 CD O
amino IN O
acids NNS O
there EX O
are VBP O
5 CD O
aromatic JJ O
, , O
2 CD O
basic JJ O
, , O
and CC O
no DT O
acidic NN O
residues NNS O
and CC O
it PRP O
has VBZ O
been VBN O
proposed VBN O
that IN O
these DT O
residues NNS O
stack NN O
with IN O
and CC O
electrostatically RB O
interact NN O
with IN O
the DT O
kinked JJ O
DNA NN O
at IN O
the DT O
site NN O
of IN O
a DT O
pyrimidine NN O
dimer NN O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
of IN O
cDNAs NNS O
encoding VBG O
alpha-subunits NNS O
of IN O
guanine CD B-NP
nucleotide-binding JJ I-NP
regulatory JJ I-NP
proteins NNS I-NP
(G-proteins NNS O
) -RRB- O
has VBZ O
revealed VBN O
the DT O
existence NN O
of IN O
nine CD O
species NNS O
of IN O
alpha-subunits NNS O
. . O

-DOCSTART- X X O

In IN O
all DT O
cases NNS O
, , O
a DT O
large JJ O
fraction NN O
of IN O
soluble JJ O
Al NNP O
became VBD O
insoluble JJ O
in IN O
the DT O
stomach NN O
after IN O
ingestion NN O
. . O

-DOCSTART- X X O

The DT O
prominent JJ O
fracture NN O
of IN O
women NNS O
older JJR O
than IN O
75 CD O
years NNS O
is VBZ O
the DT O
hip NN O
fracture NN O
( -LRB- O
type NN O
II NNP O
osteoporosis NN O
) -RRB- O
. . O

-DOCSTART- X X O

Under IN O
anaerobic JJ O
conditions NNS O
( -LRB- O
a DT O
50-day JJ O
experiment NN O
) -RRB- O
these DT O
organisms NNS O
degraded VBD O
15-18 CD O
% NN O
of IN O
the DT O
TEM NNP O
, , O
20-25 CD O
% NN O
of IN O
some DT O
alkanes NNS O
, , O
and CC O
15-18 CD O
% NN O
of IN O
selected VBN O
polycyclic NN O
aromatic JJ O
hydrocarbons NNS O
. . O

-DOCSTART- X X O

They PRP O
cause VBP O
temporary JJ O
disability NN O
, , O
invalidity NN O
and CC O
mortality NN O
of IN O
a DT O
great JJ O
part NN O
of IN O
the DT O
productive JJ O
population NN O
, , O
significantly RB O
damaging VBG O
the DT O
economic JJ O
status NN O
of IN O
the DT O
country NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
wild-type JJ O
and CC O
mutated JJ O
DNA NN O
templates NNS O
were VBD O
used VBN O
as IN O
probes NNS O
in IN O
DNase NN B-NP
I PRP I-NP
protection NN O
experiments NNS O
to TO O
determine VB O
sites NNS O
of IN O
protein-DNA NN O
interaction NN O
. . O

-DOCSTART- X X O

CONCLUSIONS--Postlumbar NN O
puncture NN O
headache NN O
may MD O
be VB O
mediated VBN O
by IN O
the DT O
release NN O
of IN O
substance NN B-NP
P NNP I-NP
triggered VBD O
by IN O
lumbar NN O
puncture NN O
, , O
in IN O
patients NNS O
predisposed VBD O
to TO O
headache NN O
by IN O
a DT O
hypersensitivity NN O
to TO O
substance NN B-NP
P. NNP I-NP

-DOCSTART- X X O

They PRP O
are VBP O
found VBN O
to TO O
have VB O
several JJ O
advantages NNS O
over IN O
the DT O
conventional JJ O
indices NNS O
of IN O
skewness NN O
and CC O
kurtosis NN O
( -LRB- O
square JJ O
root NN O
of IN O
b1 JJ O
and CC O
b2 JJ O
) -RRB- O
and CC O
no DT O
serious JJ O
drawbacks NNS O
. . O

-DOCSTART- X X O

Second JJ O
, , O
CGGA-containing JJ O
sequences NNS O
placed VBN O
at IN O
-88 NNS O
in IN O
the DT O
delta NN B-NP
MTV-CAT JJ I-NP
reporter NN I-NP
plasmid VBD O
conferred VBN O
insulin NN B-NP
responsiveness NN O
to TO O
the DT O
mammary JJ B-NP
tumor NN I-NP
virus NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Hemorrheological NNP O
evaluation NN O
and CC O
proposed VBD O
pharmacological JJ O
uses NNS O
. . O

-DOCSTART- X X O

Stimulation NN O
of IN O
the DT O
endosteal JJ O
bone NN O
formation NN O
rate NN O
was VBD O
mainly RB O
impaired VBN O
in IN O
D-depleted JJ O
rats NNS O
, , O
resulting VBG O
in IN O
trabecular JJ O
bone NN O
loss NN O
, , O
which WDT O
, , O
in IN O
-D JJ O
mother NN O
rats NNS O
, , O
was VBD O
associated VBN O
with IN O
decreased VBN O
bone NN O
ash NN O
and CC O
total JJ O
bone NN O
calcium NN O
. . O

-DOCSTART- X X O

Biochemical JJ O
status NN O
was VBD O
examined VBN O
using VBG O
erythrocyte NN O
enzyme NN O
function NN O
and CC O
blood NN O
vitamin NN O
levels NNS O
. . O

-DOCSTART- X X O

The DT O
proliferative JJ O
potential NN O
of IN O
the DT O
pilocytic JJ O
astrocytoma NN O
: : O
the DT O
relation NN O
between IN O
MIB-1 JJ B-NP
labeling NN O
and CC O
clinical JJ O
and CC O
neuro-radiological JJ O
follow-up NN O
. . O

-DOCSTART- X X O

The DT O
aim NN O
of IN O
our PRP$ O
study NN O
was VBD O
to TO O
determine VB O
whether IN O
exercise NN O
training NN O
can MD O
augment VB O
left VBN O
ventricular RP O
diastolic VB O
filling VBG O
at IN O
rest NN O
and CC O
during IN O
exercise NN O
in IN O
patients NNS O
with IN O
ischemic JJ O
cardiomyopathy NN O
and CC O
whether IN O
any DT O
correlation NN O
exists VBZ O
between IN O
changes NNS O
in IN O
diastolic JJ O
filling NN O
and CC O
changes NNS O
in IN O
exercise NN O
tolerance NN O
. . O

-DOCSTART- X X O

There EX O
is VBZ O
an DT O
overall JJ O
functional JJ O
similarity NN O
between IN O
IL-6 NN B-NP
and CC O
c-fos JJ B-NP
promoters NNS I-NP
, , O
since IN O
transfection NN O
of IN O
excess JJ O
amounts NNS O
of IN O
either DT O
promoter NN O
DNA NN O
into IN O
intact JJ O
HeLa NNP O
cells NNS O
modulates VBZ O
the DT O
function NN O
of IN O
the DT O
heterologous JJ O
promoter NN O
construct VB O
. . O

-DOCSTART- X X O

Detailed VBN O
comparison NN O
of IN O
the DT O
sequences NNS O
of IN O
cp35 CD B-NP
and CC O
human JJ B-NP
calpactin NN I-NP
II NNP I-NP
shows VBZ O
that IN O
the DT O
only JJ O
substantial JJ O
sequence NN O
dissimilarity NN O
is VBZ O
a DT O
domain NN O
encoding VBG O
amino IN O
acids NNS O
between IN O
residues NNS O
20 CD O
and CC O
40 CD O
which WDT O
includes VBZ O
a DT O
tyrosine NN O
phosphorylation NN O
site NN O
in IN O
the DT O
human JJ O
molecule NN O
, , O
along IN O
with IN O
other JJ O
residues NNS O
of IN O
possible JJ O
physiological JJ O
significance NN O
. . O

-DOCSTART- X X O

Power NN O
deposition NN O
by IN O
inverse-bremsstrahlung NN O
is VBZ O
modeled VBN O
with IN O
a DT O
scheme NN O
based VBN O
on IN O
Gaussian NNP O
quadrature NN O
to TO O
accommodate VB O
a DT O
deposition NN O
rate NN O
whose WP$ O
spatial JJ O
variation NN O
is VBZ O
highly RB O
nonuniform NN O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
malaria NN O
vectors NNS O
Anopheles NNP O
funestus NN O
and CC O
An DT O
. . O
gambiae NN O
have VBP O
both DT O
become VB O
more RBR O
abundant JJ O
during IN O
the DT O
1970s NNS O
and CC O
1980s NNS O
and CC O
sporozoite-positive JJ O
specimens NNS O
of IN O
both DT O
have VBP O
been VBN O
found VBN O
. . O

-DOCSTART- X X O

Expression NNP O
of IN O
Msx-1 NNP B-NP
and CC O
Msx-2 NNP B-NP
has VBZ O
been VBN O
studied VBN O
during IN O
development NN O
of IN O
the DT O
osteoblast JJ O
phenotype NN O
, , O
but CC O
the DT O
role NN O
of IN O
Dlx NNP B-NP
in IN O
this DT O
context NN O
and CC O
in IN O
the DT O
regulation NN O
of IN O
bone-expressed JJ O
genes NNS O
is VBZ O
unknown JJ O
. . O

-DOCSTART- X X O

The DT O
salt NN O
sensitivity NN O
of IN O
the DT O
interaction NN O
indicated VBD O
that IN O
two CD O
ion NN O
pairs NNS O
are VBP O
involved VBN O
in IN O
the DT O
association NN O
of IN O
Zn2+ JJ O
(NC-F1 JJ O
) -RRB- O
with IN O
polynucleotide NN O
, , O
whereas IN O
one CD O
ion NN O
pair NN O
is VBZ O
found VBN O
in IN O
the DT O
metal-free JJ O
peptide-nucleic JJ O
acid NN O
complex NN O
. . O

-DOCSTART- X X O

The DT O
overall JJ O
rate NN O
of IN O
biohydrogenation NN O
of IN O
C18:2 NNP O
was VBD O
14.3 CD O
% NN O
/h NN O
, , O
but CC O
declined VBD O
1.2 CD O
% NN O
/h NN O
for IN O
each DT O
percentage NN O
unit NN O
increase NN O
in IN O
C18:2 NNP O
added VBD O
to TO O
the DT O
substrate NN O
. . O

-DOCSTART- X X O

Transient NNP O
thyrotoxicosis NN O
in IN O
primary JJ O
anti-phospholipid JJ O
syndrome NN O
. . O

-DOCSTART- X X O

The DT O
highest JJS O
TTX NN B-NP
content NN O
is VBZ O
10.0 CD O
microg/g NN O
in IN O
N. NNP O
livescens NNS O
. . O

-DOCSTART- X X O

The DT O
BUR NNP O
was VBD O
set VBN O
at IN O
20/min CD O
and CC O
the DT O
IT NNP O
at IN O
.5 CD O
seconds NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
to TO O
elucidate VB O
the DT O
possible JJ O
mechanism NN O
of IN O
action NN O
of IN O
EM NNP O
, , O
we PRP O
examined VBD O
the DT O
effect NN O
of IN O
the DT O
drug NN O
on IN O
the DT O
expression NN O
of IN O
neutrophil JJ O
adhesion NN O
molecules NNS O
such JJ O
as IN O
L-selectin NNP B-NP
and CC O
Mac-1 NNP B-NP
. . O

-DOCSTART- X X O

It PRP O
contains VBZ O
31 CD O
exons NNS O
and CC O
a DT O
high JJ O
proportion NN O
of IN O
class NN O
0 CD O
introns NNS O
, , O
alternative JJ O
splicing NN O
of IN O
which WDT O
results NNS O
in IN O
significant JJ O
levels NNS O
of IN O
variant JJ O
transcripts NNS O
that WDT O
maintain VBP O
the DT O
original JJ O
open JJ O
reading NN O
frame NN O
of IN O
MRP NNP B-NP
mRNA NN I-NP
. . O

-DOCSTART- X X O

This DT O
nuclear/organellar JJ O
gene NN O
transfer NN O
event NN O
is VBZ O
strikingly RB O
similar JJ O
to TO O
the DT O
experimentally NN O
accessible JJ O
process NN O
of IN O
nuclear JJ O
integration NN O
of IN O
introduced VBN O
heterologous JJ O
DNA NN O
. . O

-DOCSTART- X X O

Under IN O
control NN O
conditions NNS O
, , O
pretreatment NN O
with IN O
lithium NN O
during IN O
7 CD O
days NNS O
did VBD O
not RB O
modify VB O
the DT O
hyperlocomotion NN O
produced VBN O
by IN O
d-amphetamine NN O
. . O

-DOCSTART- X X O

This DT O
article NN O
describes VBZ O
a DT O
program NN O
that WDT O
resulted VBD O
in IN O
a DT O
75-percent JJ O
reduction NN O
of IN O
inventory NN O
over IN O
a DT O
five-year JJ O
interval NN O
. . O

-DOCSTART- X X O

Risk NN O
ratios NNS O
decreased VBN O
with IN O
increasing VBG O
age NN O
and CC O
increased VBD O
with IN O
number NN O
of IN O
breast NN O
biopsies NNS O
, , O
family NN O
history NN O
of IN O
breast NN O
cancer NN O
, , O
estrogen NN O
use NN O
, , O
time NN O
between IN O
screenings NNS O
, , O
no DT O
comparison NN O
with IN O
previous JJ O
mammograms NNS O
, , O
and CC O
the DT O
radiologist NN O
's POS O
tendency NN O
to TO O
call VB O
mammograms NNS O
abnormal JJ O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
relative JJ O
substrate NN O
specificity NN O
of IN O
RSK3 NNP B-NP
differed VBD O
from IN O
that DT O
reported VBN O
for IN O
other JJ O
isoforms NNS O
. . O

-DOCSTART- X X O

Fosinopril NNP O
decreased VBD O
blood NN O
pressure NN O
from IN O
174/101 CD O
mm CD O
Hg NNP O
to TO O
149/88 CD O
mm CD O
Hg NNP O
in IN O
patients NNS O
with IN O
diastolic JJ O
hypertension NN O
and CC O
from IN O
182/8 CD O
6 CD O
mm CD O
Hg NNP O
to TO O
151/8 CD O
0 CD O
mm CD O
Hg NNP O
in IN O
patients NNS O
with IN O
ISH. NNP O

-DOCSTART- X X O

Loss NN O
of IN O
pRb NN B-NP
or CC O
p107 VB B-NP
binding JJ O
results NNS O
in IN O
the DT O
loss NN O
of IN O
transforming VBG O
activity NN O
. . O

-DOCSTART- X X O

Influence NN O
of IN O
huanglian JJ O
used VBN O
in IN O
combination NN O
with IN O
huangqin NN O
and CC O
gancao NN O
on IN O
the DT O
erythrocytic JJ O
osmotic JJ O
fragilitas NNS O
of IN O
experimental JJ O
glucose-6-phosphate JJ B-NP
dehydrogenase NN I-NP
deficiency NN O
in IN O
rats NNS O
] IN O
OBJECTIVE CD O
: : O
To TO O
study VB O
the DT O
influence NN O
of IN O
common JJ O
combination NN O
of IN O
Huanglian( NNP O
Coptis NNP O
chinensis NN O
) -RRB- O
on IN O
the DT O
erythrocytic JJ O
osmotic JJ O
fragilitas NNS O
of IN O
glucose-6-phosphate JJ B-NP
dehydrogenase( JJ I-NP
G6PD NN B-NP
) -RRB- O
deficiency NN O
in IN O
rats NNS O
. . O

-DOCSTART- X X O

Comparison NNP O
of IN O
Healon NNP O
and CC O
Amvisc NNP O
. . O

-DOCSTART- X X O

2,4- CD O
and CC O
2,6-toluenediamine CD O
in IN O
hydrolysed JJ O
plasma NN O
and CC O
urine NN O
after IN O
test-chamber NN O
exposure NN O
of IN O
humans NNS O
to TO O
2,4- CD O
and CC O
2,6-toluene CD O
diisocyanate NN O
. . O

-DOCSTART- X X O

Interaction NN O
between IN O
the DT O
tobacco NN O
DNA-binding NN O
activity NN O
CBF NNP B-NP
and CC O
the DT O
cyt-1 JJ B-NP
promoter NN I-NP
element NN I-NP
of IN O
the DT O
Agrobacterium NNP O
tumefaciens NNS O
T-DNA NNP O
gene NN O
T-CYT JJ B-NP
correlates NNS O
with IN O
cyt-1 NN B-NP
directed VBN O
gene NN O
expression NN O
in IN O
multiple JJ O
tobacco NN O
tissue NN O
types NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
repetitive JJ O
GAA NNP O
sequences NNS O
enhance VB O
splicing NN O
by IN O
binding VBG O
a DT O
protein NN O
complex NN O
containing VBG O
a DT O
sequence-specific JJ O
RNA NNP O
binding JJ O
protein NN O
and CC O
a DT O
general JJ O
splicing NN O
activator NN O
that IN O
, , O
in IN O
turn NN O
, , O
recruit NN O
additional JJ O
SR JJ B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Organization NNP O
of IN O
exons NNS O
suggests VBZ O
that IN O
, , O
similar JJ O
to TO O
the DT O
human JJ B-NP
VEGF NNP I-NP
gene NN I-NP
, , O
alternative JJ O
splicing NN O
generates VBZ O
the DT O
120-, JJ O
164-, JJ O
and CC O
188-amino JJ O
acid NN O
isoforms VBZ O
, , O
but CC O
does VBZ O
not RB O
predict VB O
a DT O
fourth JJ O
VEGF NN B-NP
isoform VBP I-NP
corresponding JJ O
to TO O
human JJ B-NP
VEGF206 NNS I-NP
. . O

-DOCSTART- X X O

The DT O
papers NNS O
provide VBP O
a DT O
broad JJ O
perspective NN O
of IN O
MPAs NNP O
and CC O
include VB O
social JJ O
, , O
economic JJ O
, , O
cultural JJ O
, , O
biological JJ O
and CC O
statistical JJ O
components NNS O
. . O

-DOCSTART- X X O

The DT O
great JJ O
cardiac NN O
vein NN O
flow NN O
became VBD O
zero CD O
due JJ O
to TO O
the DT O
cardiac NN O
arrest NN O
and CC O
remained VBD O
at IN O
zero CD O
for IN O
a DT O
moment NN O
( -LRB- O
dead JJ O
time NN O
) -RRB- O
after IN O
the DT O
initiation NN O
of IN O
reperfusion NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
These DT O
results NNS O
suggest VBP O
that IN O
histamine-2 NN B-NP
receptor NN I-NP
activation NN O
mechanisms NNS O
may MD O
not RB O
be VB O
involved VBN O
in IN O
postoperative JJ O
IL-6 NN B-NP
synthesis NN O
. . O

-DOCSTART- X X O

LAC9 PRP B-NP
is VBZ O
a DT O
DNA-binding JJ O
protein NN O
that WDT O
regulates VBZ O
transcription NN O
of IN O
the DT O
lactose-galactose JJ B-NP
regulon NN I-NP
in IN O
Kluyveromyces NNP O
lactis NN O
. . O

-DOCSTART- X X O

Some DT O
cells NNS O
were VBD O
excited VBN O
, , O
others NNS O
inhibited VBD O
by IN O
, , O
and CC O
only RB O
some DT O
were VBD O
directionally RB O
sensitive JJ O
to TO O
the DT O
optomotor NN O
stimulus NN O
. . O

-DOCSTART- X X O

The DT O
molecular JJ O
event( NN O
s VBZ O
) -RRB- O
underlying VBG O
the DT O
functional JJ O
specificities NNS O
of IN O
these DT O
receptors NNS O
( -LRB- O
in IN O
regulating VBG O
the DT O
expression NN O
of IN O
their PRP$ O
native JJ O
target NN O
genes NNS O
) -RRB- O
is VBZ O
a DT O
very RB O
important JJ O
issue NN O
that WDT O
remains VBZ O
poorly RB O
understood VBN O
. . O

-DOCSTART- X X O

For IN O
Thermus DT O
strain NN O
ZO5 IN B-NP
dihydroorotase NN I-NP
( -LRB- O
DHOase NN B-NP
; : O
encoded VBN O
by IN O
pyrC NNS B-NP
) -RRB- O
, , O
the DT O
highest JJS O
similarity NN O
scores NNS O
( -LRB- O
about IN O
40 CD O
% NN O
identity NN O
) -RRB- O
were VBD O
obtained VBN O
with IN O
DHOases NNS B-NP
from IN O
B. NNP O
caldolyticus NN O
and CC O
Bacillus NNP O
subtilis NNS O
. . O

-DOCSTART- X X O

This DT O
difference NN O
between IN O
SP-1 JJ B-NP
and CC O
SP-2 JJ B-NP
peptides NNS I-NP
was VBD O
not RB O
due JJ O
to TO O
their PRP$ O
differential JJ O
uptake NN O
by IN O
cell NN O
, , O
since IN O
approximately RB O
100 CD O
times NNS O
more RBR O
SP-2 JJ B-NP
peptide NN I-NP
could MD O
be VB O
found VBN O
in IN O
cytoplasmic JJ O
extracts NNS O
than IN O
SP-1 JJ B-NP
peptide NN I-NP
in IN O
experiments NNS O
using VBG O
radiolabeled JJ O
peptides NNS O
. . O

-DOCSTART- X X O

The DT O
product NN O
of IN O
one CD O
gene NN O
, , O
Bv80 CD B-NP
, , O
has VBZ O
a DT O
single JJ O
divergent JJ O
copy NN O
of IN O
a DT O
sequence NN O
of IN O
149 CD O
amino NN O
acids NNS O
( -LRB- O
approx NN O
. . O

-DOCSTART- X X O

The DT O
sequences NNS O
at IN O
-10 JJ O
and CC O
-35 DT O
relative JJ O
to TO O
the DT O
transcriptional JJ O
starting VBG O
site NN O
showed VBD O
55 CD O
% NN O
homology NN O
with IN O
the DT O
consensus NN O
sequences NNS O
of IN O
the DT O
Escherichia NNP B-NP
coli NNS I-NP
sigma NN I-NP
70-type JJ I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

The DT O
two CD O
ORFs NNP O
had VBD O
significant JJ O
similarity NN O
with IN O
the DT O
putative JJ O
replication NN O
protein NN O
from IN O
plasmid JJ O
pTiK12 NN O
of IN O
Thiobacillus DT O
intermedius NN O
and CC O
other JJ O
CoIE2-related JJ O
plasmids NNS O
. . O

-DOCSTART- X X O

A DT O
clinical JJ O
double-blind JJ O
trial NN O
of IN O
topical JJ O
miconazole NN O
and CC O
clotrimazole NN O
against IN O
superficial JJ O
fungal JJ O
infections NNS O
and CC O
erythrasma NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Systemic JJ O
factors NNS O
that WDT O
increase NN O
bone NN O
mineral NN O
density NN O
appear VBP O
to TO O
be VB O
involved VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
ossification NN O
of IN O
the DT O
posterior JJ O
longitudinal JJ O
ligament NN O
, , O
and CC O
these DT O
factors NNS O
may MD O
be VB O
activated VBN O
after IN O
middle JJ O
age NN O
. . O

-DOCSTART- X X O

FdsR NN B-NP
purified VBN O
to TO O
homogeneity NN O
after IN O
overexpression NN O
of IN O
fdsR NN B-NP
in IN O
E. NNP O
coli NNS O
is VBZ O
a DT O
130 CD O
kDa NN O
homotetramer NN O
binding NN O
to TO O
the DT O
fds NNS B-NP
control VBP O
region NN O
located VBN O
between IN O
the DT O
fdsR NN B-NP
and CC O
fdsG JJ B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

Surgical JJ O
methods NNS O
in IN O
the DT O
treatment NN O
of IN O
rhinophyma NN O
. . O

-DOCSTART- X X O

The DT O
adeno-associated JJ O
virus NN O
type NN O
2 CD O
( -LRB- O
AAV-2 NN O
) -RRB- O
Rep78/Rep68 NNPS B-NP
regulatory JJ O
proteins NNS O
are VBP O
pleiotropic JJ O
effectors NNS O
of IN O
viral JJ O
and CC O
cellular JJ O
DNA NN O
replication NN O
, , O
of IN O
cellular JJ O
transformation NN O
by IN O
viral JJ O
and CC O
cellular JJ O
oncogenes NNS O
, , O
and CC O
of IN O
homologous JJ O
and CC O
heterologous JJ O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
here RB O
that IN O
Spb1p NNP B-NP
is VBZ O
able JJ O
to TO O
bind NN O
[( IN O
3 CD O
)H]AdoMet NN O
in IN O
vitro NN O
, , O
suggesting VBG O
that IN O
it PRP O
is VBZ O
a DT O
novel NN O
methylase NN O
, , O
whose WP$ O
possible JJ O
substrates NNS O
will MD O
be VB O
discussed VBN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
suggest VBP O
that IN O
weight NN O
gain NN O
or CC O
increased VBN O
caloric JJ O
intake NN O
, , O
in IN O
contrast NN O
to TO O
its PRP$ O
large JJ O
effect NN O
on IN O
peripheral JJ O
thyroid JJ O
function NN O
, , O
has VBZ O
relatively RB O
little JJ O
effect NN O
on IN O
CNS NNP B-NP
TRH NNP I-NP
activity NN O
. . O

-DOCSTART- X X O

Hematopoietic NNP B-NP
progenitor NN I-NP
kinase NN I-NP
1 CD I-NP
( -LRB- O
HPK1 NN B-NP
) -RRB- O
is VBZ O
a DT O
member NN O
of IN O
the DT O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
kinase NN I-NP
kinase NN I-NP
kinase NN I-NP
( -LRB- O
MAP4K) NNP B-NP
family NN O
and CC O
an DT O
upstream JJ O
activator NN O
of IN O
the DT O
c-Jun JJ B-NP
N-terminal JJ I-NP
kinase NN I-NP
( -LRB- O
JNK) NNP B-NP
signaling VBG O
cascade NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
the DT O
outcome NN O
of IN O
patients NNS O
with IN O
uterine NNP O
MMMT NNP O
is VBZ O
mainly RB O
influenced VBN O
by IN O
the DT O
initial JJ O
stage NN O
and CC O
the DT O
type NN O
of IN O
epithelial JJ O
component NN O
. . O

-DOCSTART- X X O

Increased VBN O
susceptibility NN O
of IN O
aphasics NNS O
to TO O
a DT O
distractor NN O
task NN O
in IN O
the DT O
recall NN O
of IN O
verbal JJ O
commands NNS O
. . O

-DOCSTART- X X O

We PRP O
hypothesized VBD O
that IN O
conjugated VBN O
estrogens NNS O
, , O
which WDT O
contain VBP O
several JJ O
vasoactive JJ O
estrogenic JJ O
compounds NNS O
, , O
may MD O
favorably RB O
influence VB O
the DT O
vasomotor NN O
response NN O
to TO O
acetylcholine NN O
in IN O
men NNS O
. . O

-DOCSTART- X X O

Calcium NNP O
bilirubinate JJ O
crystals NNS O
were VBD O
seen VBN O
in IN O
gallbladder NN O
bile NN O
or CC O
wall NN O
scrapings NNS O
of IN O
7 CD O
of IN O
8 CD O
TPN NNP O
animals NNS O
but CC O
in IN O
none NN O
of IN O
the DT O
controls NNS O
( -LRB- O
P NNP O
less RBR O
than IN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Alcohol NN O
and CC O
stomach NN O
diseases NNS O

-DOCSTART- X X O

In IN O
our PRP$ O
case NN O
the DT O
development NN O
of IN O
the DT O
tumor NN O
at IN O
the DT O
posterior JJ O
side NN O
of IN O
the DT O
prostate NN O
, , O
the DT O
lack NN O
of IN O
PSA NNP B-NP
immunoreactivity NN O
and CC O
the DT O
presence NN O
of IN O
mucinous JJ O
glands NNS O
, , O
sometimes RB O
"endocervical-like" JJ O
, , O
could MD O
suggest VB O
an DT O
origin NN O
from IN O
embryonic JJ O
mullerian JJ O
remnants NNS O
in IN O
the DT O
prostatic JJ O
utricle NN O
rather RB O
than IN O
urogenital JJ O
sinus NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
DNA-binding NN O
and CC O
transcriptional JJ O
activation NN O
functions NNS O
of IN O
human NN B-NP
Fli-1 NN I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

The DT O
second JJ O
patient NN O
was VBD O
successfully RB O
treated VBN O
with IN O
intravenous JJ O
prostaglandin NN O
F2 NN O
alpha NN O
( -LRB- O
PGF2 JJ O
alpha NN O
) -RRB- O
. . O

-DOCSTART- X X O

Base NN O
substitutions NNS O
within IN O
this DT O
NFIL-6 NN B-NP
site NN I-NP
resulted VBN O
in IN O
virtual JJ O
elimination NN O
of IN O
LPS-induced JJ O
IL-1 NN B-NP
beta NN I-NP
gene NN I-NP
transcription NN O
. . O

-DOCSTART- X X O

Different JJ O
clinical JJ O
variants NNS O
of IN O
the DT O
empty JJ O
sella NN O
turcica NN O
syndrome NN O
are VBP O
demonstrated VBN O
, , O
including VBG O
variants NNS O
resultant VBP O
from IN O
substitution NN O
therapy NN O
of IN O
thyroid NN O
hypofunction NN O
, , O
from IN O
dopamine NN O
agonist JJ O
therapy NN O
for IN O
hyperprolactinemic JJ O
hypogonadism NN O
, , O
from IN O
radiotherapy NN O
of IN O
hypophyseal NN O
adenoma NN O
. . O

-DOCSTART- X X O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
association NN O
of IN O
TBP NNP B-NP
with IN O
the DT O
TATA NNP O
box NN O
may MD O
be VB O
regulated VBN O
, , O
directly RB O
or CC O
indirectly RB O
, , O
by IN O
a DT O
substrate NN O
of IN O
Snf1 NNP B-NP
. . O

-DOCSTART- X X O

Site-directed JJ O
mutagenesis NN O
of IN O
the DT O
T4 NNP B-NP
endonuclease NN I-NP
V NNP I-NP
gene NN I-NP
: : O
role NN O
of IN O
lysine-130 NN O
. . O

-DOCSTART- X X O

Simulations NNS O
of IN O
velocities NNS O
, , O
vorticity NN O
, , O
pressure NN O
and CC O
certain JJ O
stress NN O
values NNS O
were VBD O
developed VBN O
by IN O
a DT O
computer NN O
and CC O
displayed VBD O
for IN O
man-machine NN O
interaction NN O
. . O

-DOCSTART- X X O

Together RB O
, , O
these DT O
results NNS O
implicate VBP O
Fal1p NNP B-NP
in IN O
the DT O
18S NNP B-NP
rRNA NNP I-NP
maturation NN O
pathway NN O
rather RB O
than IN O
in IN O
translation NN O
initiation NN O
. . O

-DOCSTART- X X O

Heliox NNP O
improves VBZ O
pulsus NN O
paradoxus NN O
and CC O
peak NN O
expiratory NN O
flow NN O
in IN O
nonintubated JJ O
patients NNS O
with IN O
severe JJ O
asthma NN O
. . O

-DOCSTART- X X O

Both DT O
DMP2 NNP B-NP
and CC O
DMP3 NNP B-NP
are VBP O
closely RB O
localized VBN O
on IN O
mouse NN O
chromosome NN O
5q21 CD O
, , O
corresponding JJ O
to TO O
human JJ O
chromosome NN O
4q21 CD O
. . O

-DOCSTART- X X O

A DT O
kinetic JJ O
model NN O
for IN O
99mTc-DMSA NNS O
in IN O
the DT O
rat NN O
. . O

-DOCSTART- X X O

Together RB O
with IN O
the DT O
up-regulation NN O
of IN O
the DT O
cAMP JJ B-NP
response NN I-NP
element NN I-NP
modulator NN I-NP
protein NN I-NP
( -LRB- O
CREM) JJ B-NP
mRNA NN O
and CC O
protein NN O
levels NNS O
demonstrated VBD O
previously RB O
in IN O
CREB NNP B-NP
mutant JJ I-NP
mice NNS O
, , O
we PRP O
suggest VBP O
that IN O
the DT O
up-regulation NN O
of IN O
CREB NNP B-NP
beta NN I-NP
may MD O
also RB O
contribute VB O
to TO O
compensation NN O
within IN O
the DT O
CREB/ATF NNP B-NP
family NN O
of IN O
transcription NN O
factors NNS O
, , O
when WRB O
CREB NNP B-NP
delta NN I-NP
and CC O
CREB NNP B-NP
alpha NN I-NP
are VBP O
absent JJ O
. . O

-DOCSTART- X X O

The DT O
transition NN O
from IN O
expression NN O
of IN O
early JJ O
meiotic JJ O
genes NNS O
to TO O
expression NN O
of IN O
middle NN O
sporulation-specific JJ O
genes NNS O
occurs VBZ O
at IN O
about IN O
the DT O
time NN O
that IN O
cells NNS O
exit NN O
from IN O
pachytene NN O
and CC O
form VB O
the DT O
meiosis NN O
I PRP O
spindle VBP O
. . O

-DOCSTART- X X O

Mutations NNS O
away RB O
from IN O
splice NN O
site NN O
recognition NN O
sequences NNS O
might MD O
cis-modulate VB O
alternative JJ O
splicing NN O
of IN O
goat NN O
alpha NN B-NP
s1-casein JJ I-NP
transcripts NNS I-NP
. . O

-DOCSTART- X X O

Fig1p VB B-NP
and CC O
Fig2p VB B-NP
are VBP O
likely JJ O
to TO O
act VB O
at IN O
the DT O
cell NN O
surface NN O
as IN O
Fig1 NNP B-NP
: : O
: : O
beta-gal JJ B-NP
and CC O
Fig2 VB B-NP
::beta-gal JJ O
fusion NN B-NP
proteins VBZ I-NP
localize VBN O
to TO O
the DT O
periphery NN O
of IN O
mating VBG O
cells NNS O
. . O

-DOCSTART- X X O

There EX O
is VBZ O
little JJ O
supportive JJ O
evidence NN O
that IN O
ACE NNP B-NP
inhibitors NNS O
( -LRB- O
captopril NN O
or CC O
enalapril NN O
) -RRB- O
are VBP O
teratogenic JJ O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
PVB NNP O
therapy NN O
is VBZ O
not RB O
sufficient JJ O
to TO O
cure VB O
the DT O
cases NNS O
with IN O
choriocarcinoma NN O
element NN O
or CC O
bulky JJ O
metastasis NN O
. . O

-DOCSTART- X X O

Evaluation NN O
of IN O
gamma-glutamyl NN B-NP
transpeptidase NN I-NP
in IN O
myocardial JJ O
infarction NN O
. . O

-DOCSTART- X X O

The DT O
yjr041c JJ B-NP
delta JJ I-NP
haploid JJ O
cells NNS O
gave VBD O
rise NN O
to TO O
microcolonies NNS O
comprising VBG O
about IN O
20 CD O
to TO O
50 CD O
cells NNS O
. . O

-DOCSTART- X X O

Mean IN O
latency RB O
periods NNS O
were VBD O
29.6 CD O
among IN O
insulators NNS O
, , O
35.4 CD O
among IN O
dock NN O
workers NNS O
, , O
43.7 CD O
in IN O
a DT O
heterogeneous JJ O
group NN O
defined VBD O
as IN O
various JJ O
, , O
46.4 CD O
in IN O
non-shipbuilding JJ O
industry NN O
workers NNS O
, , O
49.4 CD O
in IN O
shipyard NN O
workers NNS O
, , O
51.7 CD O
among IN O
women NNS O
with IN O
a DT O
history NN O
of IN O
domestic JJ O
exposure NN O
to TO O
asbestos NN O
, , O
and CC O
56.2 CD O
in IN O
people NNS O
employed VBN O
in IN O
maritime NN O
trades NNS O
. . O

-DOCSTART- X X O

7-Nitroindazole JJ O
(7NI) NNP O
, , O
a DT O
relatively RB O
selective JJ O
neuronal JJ O
nitric JJ B-NP
oxide NN I-NP
synthase NN I-NP
( -LRB- O
nNOS NNS B-NP
) -RRB- O
inhibitor NN O
. . O
was VBD O
intraperitoneally RB O
administered VBN O
to TO O
the DT O
guinea NN O
pigs NNS O
30 CD O
minutes NNS O
before IN O
the DT O
onset NN O
of IN O
local JJ O
anoxia NNS O
. . O

-DOCSTART- X X O

New NNP O
protein-free JJ O
products NNS O
for IN O
diet NN O
therapy NN O
in IN O
chronic NN O
renal NN O
insufficiency NN O

-DOCSTART- X X O

The DT O
human JJ O
protein NN O
binds NNS O
most RBS O
strongly RB O
to TO O
the DT O
SH3 NNP B-NP
domain NN I-NP
from IN O
the DT O
abl JJ B-NP
proto-oncogene NN I-NP
. . O

-DOCSTART- X X O

Like IN O
troponin FW B-NP
Cs NNPS I-NP
and CC O
calmodulins VBD B-NP
, , O
PfCPK NNP B-NP
also RB O
contains VBZ O
four CD O
EF JJ O
hand NN O
calcium-binding JJ O
motifs NNS O
. . O

-DOCSTART- X X O

Roller NNP O
pumps NNS O
, , O
coronary JJ O
suction NN O
and CC O
an DT O
open JJ O
cardiotomy NN O
reservoir NN O
were VBD O
used VBN O
. . O

-DOCSTART- X X O

Our PRP$ O
data NNS O
indicate VBP O
that IN O
the DT O
various JJ O
subunits NNS O
of IN O
the DT O
human JJ O
P-TEFb NN B-NP
complex NN O
may MD O
play VB O
distinct JJ O
roles NNS O
at IN O
multiple JJ O
stages NNS O
to TO O
mediate VB O
Tat NNP B-NP
activation NN O
of IN O
HIV-1 PRP$ O
transcription NN O
elongation NN O
. . O

-DOCSTART- X X O

The DT O
organelles NNS O
synthesize VBP O
their PRP$ O
own JJ O
set NN O
of IN O
Fe/S NNP B-NP
proteins NNS I-NP
, , O
and CC O
they PRP O
initiate VBP O
the DT O
generation NN O
of IN O
extramitochondrial JJ B-NP
Fe/S NNP I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Orlistat NNP O
is VBZ O
a DT O
specific JJ O
lipase NN B-NP
inhibitor NN O
that WDT O
impairs VBZ O
fat JJ O
absorption NN O
, , O
thereby RB O
reducing VBG O
fat JJ O
uptake NN O
. . O

-DOCSTART- X X O

ORF3 CD O
encodes VBZ O
a DT O
putative JJ O
periplasmic JJ B-NP
c-type JJ I-NP
cytochrome NN I-NP
with IN O
a DT O
molecular JJ O
mass NN O
of IN O
94 CD O
, , O
000 CD O
Da NNP O
and CC O
contains VBZ O
seven CD O
c-heme-binding JJ O
motifs NNS O
but CC O
shows VBZ O
no DT O
sequence NN O
homology NN O
to TO O
occ VB B-NP
or CC O
ORF1 CD O
. . O

-DOCSTART- X X O

The DT O
rat NN O
anococcygeus NN O
muscle NN O
was VBD O
used VBN O
in IN O
postsynaptic JJ O
studies NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
camptothecin NN O
resistance NN O
in IN O
CEM/DOX NNP O
cells NNS O
is VBZ O
due JJ O
to TO O
different JJ O
mechanism( NN O
s VBZ O
) -RRB- O
than IN O
topoisomerase NN B-NP
- : O
or CC O
P-glycoprotein-associated JJ B-NP
multidrug NN O
resistance NN O
. . O

-DOCSTART- X X O

Because IN O
of IN O
gut NN O
fermentation NN O
, , O
a DT O
substantial JJ O
portion NN O
( -LRB- O
16-80 CD O
% NN O
) -RRB- O
of IN O
N NNP O
is VBZ O
absorbed VBN O
as IN O
ammonia NN O
N NNP O
( -LRB- O
NH3N) NNP O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
PMA-, NNP O
PDGF-, NNP B-NP
and CC O
serum-induced JJ O
GHR NNP B-NP
proteolysis NN O
was VBD O
associated VBN O
with IN O
substantial JJ O
decreases NNS O
in IN O
GH-induced JJ B-NP
activation NN O
of IN O
Janus NNP B-NP
kinase-2 NN I-NP
, , O
which WDT O
were VBD O
also RB O
prevented VBN O
by IN O
IC3 NNP O
. . O

-DOCSTART- X X O

The DT O
centromeric JJ O
dodeca-satellite JJ O
of IN O
Drosophila NNP O
forms NNS O
altered VBD O
DNA NNP O
structures NNS O
in IN O
vitro NN O
in IN O
which WDT O
its PRP$ O
purine-rich JJ O
strand JJ O
(G-strand JJ O
) -RRB- O
forms NNS O
stable JJ O
fold-back JJ O
structures NNS O
, , O
while IN O
the DT O
complementary JJ O
C-strand NN O
remains VBZ O
unstructured JJ O
. . O

-DOCSTART- X X O

The DT O
Aspergillus NNP B-NP
uvsH NNP I-NP
gene NN I-NP
encodes VBZ O
a DT O
product NN O
homologous NN O
to TO O
yeast NN B-NP
RAD18 NNS I-NP
and CC O
Neurospora NNP B-NP
UVS-2 NNP I-NP
. . O

-DOCSTART- X X O

These DT O
data NNS O
also RB O
suggest VBP O
the DT O
existence NN O
of IN O
a DT O
mechanism NN O
by IN O
which WDT O
regulatory JJ O
subunits NNS O
modulate VBP O
the DT O
PI NNP B-NP
3-kinase-mediated JJ I-NP
signals NNS O
, , O
independent JJ O
of IN O
the DT O
kinase NN O
activity NN O
, , O
possibly RB O
through IN O
subcellular JJ O
localization NN O
of IN O
the DT O
catalytic JJ O
subunit NN O
or CC O
interaction NN O
with IN O
additional JJ O
signaling NN O
molecules NNS O
. . O

-DOCSTART- X X O

A DT O
continuous-flow JJ O
BIPAP NNP O
system NN O
consists VBZ O
of IN O
a DT O
high-flow JJ O
CPAP NNP O
system NN O
, , O
a DT O
reservoir NN O
bag NN O
, , O
and CC O
a DT O
pneumatically RB O
controlled VBN O
membrane NN O
valve NN O
in IN O
the DT O
expiratory NN O
limb NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
demonstrates VBZ O
that IN O
the DT O
exposure NN O
to TO O
sulphur NN O
mustard NN O
results NNS O
in IN O
very RB O
low JJ O
androgen NN O
levels NNS O
and CC O
hypo-responsiveness NN O
to TO O
GnRH VB B-NP
in IN O
the DT O
first JJ O
five CD O
weeks NNS O
and CC O
normalization NN O
by IN O
the DT O
twelfth JJ O
week NN O
after IN O
injury NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
study NN O
we PRP O
prospectively RB O
compared VBN O
side NN O
effects NNS O
occurring VBG O
in IN O
12 CD O
patients NNS O
after IN O
the DT O
first JJ O
administration NN O
of IN O
low-dose JJ O
OKT3 NNS O
( -LRB- O
0.5 CD O
mg NN O
twice RB O
daily RB O
) -RRB- O
induction NN O
therapy NN O
with IN O
those DT O
in IN O
10 CD O
patients NNS O
who WP O
were VBD O
treated VBN O
with IN O
a DT O
conventional JJ O
dose NN O
of IN O
OKT3 JJ O
( -LRB- O
5 CD O
mg JJ O
daily NN O
) -RRB- O
for IN O
acute JJ O
rejection NN O
. . O

-DOCSTART- X X O

Plasma NNP B-NP
prolactin NN I-NP
concentrations NNS O
during IN O
incubation NN O
, , O
25.8 CD O
+/ NNS O
- : O
2.3 CD O
ng/ml NN O
, , O
decreased VBD O
to TO O
baseline NN O
levels NNS O
, , O
10.8 CD O
+/ NN O
- : O
1.9 CD O
ng/ml NN O
, , O
within IN O
24 CD O
hr NN O
after IN O
nestbox NN O
removal NN O
. . O

-DOCSTART- X X O

Our PRP$ O
findings NNS O
suggest VBP O
that IN O
resting VBG O
Tl-201 DT O
scintigraphy NN O
has VBZ O
limited VBN O
value NN O
in IN O
the DT O
detection NN O
of IN O
coronary JJ O
artery NN O
disease NN O
in IN O
patients NNS O
with IN O
Hurler NNP O
syndrome NN O
. . O

-DOCSTART- X X O

Also RB O
, , O
residues NNS O
273 CD O
to TO O
287 CD O
, , O
which WDT O
are VBP O
identical JJ O
in IN O
sequence NN O
to TO O
a DT O
15-amino-acid JJ O
segment NN O
near IN O
the DT O
carboxy NN O
terminus NN O
of IN O
the DT O
simian JJ B-NP
foamy NN I-NP
virus NN I-NP
transcriptional JJ I-NP
activator NN I-NP
Taf NNP I-NP
, , O
can MD O
independently RB O
enhance VB O
the DT O
activity NN O
of IN O
the DT O
minimal JJ O
activator NN O
region NN O
. . O

-DOCSTART- X X O

The DT O
side NN O
effect NN O
of IN O
pulmonary JJ O
fibrosis NN O
occurs VBZ O
in IN O
20 CD O
to TO O
30 CD O
percent NN O
of IN O
patients NNS O
receiving VBG O
this DT O
drug NN O
. . O

-DOCSTART- X X O

Of IN O
the DT O
47 CD O
women NNS O
with IN O
AGCUS NNP O
, , O
16 CD O
had VBD O
intraepithelial JJ O
or CC O
invasive JJ O
neoplasms NNS O
( -LRB- O
34 CD O
% NN O
; : O
95 CD O
% NN O
confidence NN O
interval NN O
, , O
21-49 CD O
% NN O
) -RRB- O
, , O
including VBG O
9 CD O
low JJ O
or CC O
high JJ O
grade NN O
squamous JJ O
intraepithelial JJ O
lesions NNS O
, , O
1 CD O
adenocarcinoma NN O
in IN O
situ NN O
of IN O
the DT O
cervix NN O
, , O
3 CD O
adenocarcinomas NNS O
of IN O
the DT O
cervix NN O
, , O
2 CD O
adenocarcinomas NNS O
of IN O
the DT O
endometrium NN O
and CC O
1 CD O
adenoid JJ O
basal NN O
cell NN O
carcinoma NN O
of IN O
the DT O
cervix NN O
. . O

-DOCSTART- X X O

Thus RB O
in IN O
this DT O
study NN O
we PRP O
used VBD O
in IN O
vitro NN O
methods NNS O
to TO O
directly RB O
evaluate VB O
whether IN O
isolated VBN O
human JJ O
saphenous JJ O
vein NN O
segments NNS O
respond VBP O
to TO O
vasoconstrictor VB O
agents NNS O
at IN O
arterial JJ O
pressure NN O
levels NNS O
. . O

-DOCSTART- X X O

Genomic JJ O
Southern JJ O
blot NN O
analysis NN O
suggests VBZ O
that IN O
the DT O
human JJ O
haploid JJ O
genome NN O
contains VBZ O
a DT O
single JJ O
Gs NNP B-NP
alpha NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
facilitation NN O
started VBD O
preceding VBG O
the DT O
onset NN O
of IN O
electromyographic JJ O
activity NN O
of IN O
the DT O
masseter NN O
muscle NN O
. . O

-DOCSTART- X X O

Reactivation NN O
of IN O
hepatitis NN O
B NNP O
virus NN O
replication NN O
is VBZ O
a DT O
rare JJ O
event NN O
during IN O
the DT O
natural JJ O
history NN O
of IN O
chronic JJ O
hepatitis NN O
B. NNP O

-DOCSTART- X X O

SETTING--Hospital JJ O
laboratories NNS O
in IN O
the DT O
United NNP O
States NNPS O
submitting VBG O
pneumococcal JJ O
isolates NNS O
to TO O
the DT O
CDC NNP O
between IN O
October NNP O
1 CD O
, , O
1991 CD O
, , O
and CC O
September NNP O
30 CD O
, , O
1992 CD O
. . O

-DOCSTART- X X O

To TO O
determine VB O
whether IN O
transcription NN O
of IN O
orfX NNP O
and CC O
vfr RB B-NP
are VBP O
controlled VBN O
by IN O
the DT O
same JJ O
mechanisms NNS O
that IN O
control NN O
transcription NN O
of IN O
the DT O
region NN O
of IN O
the DT O
divergent JJ O
ORF NN O
( -LRB- O
dorf NN O
) -RRB- O
and CC O
of IN O
crp JJ B-NP
, , O
we PRP O
compared VBD O
the DT O
vfr-orfX JJ B-NP
and CC O
crp-dorf JJ B-NP
intergenic JJ O
regions NNS O
. . O

-DOCSTART- X X O

Cotransfection NN O
with IN O
C/EBPbeta NNP B-NP
and CC O
GATA-1 JJ B-NP
expression NN O
vectors NNS O
produced VBN O
a DT O
5-fold JJ O
increase NN O
compared VBN O
with IN O
cotransfection NN O
with IN O
the DT O
C/EBPbeta NNP B-NP
or CC O
GATA-1 JJ B-NP
expression NN O
vectors NNS O
individually RB O
. . O

-DOCSTART- X X O

Eighteen CD O
patients NNS O
with IN O
advanced JJ O
epidermoid JJ O
carcinoma NN O
of IN O
the DT O
head NN O
and CC O
neck NN O
were VBD O
entered VBN O
into IN O
a DT O
phase NN O
II NNP O
trial NN O
of IN O
N-Methylformamide NNP O
( -LRB- O
NMF) NN O
, , O
800 CD O
mg/M2 CD O
IV NNP O
daily JJ O
for IN O
5 CD O
days NNS O
every DT O
4 CD O
weeks NNS O
. . O

-DOCSTART- X X O

Total JJ O
body NN O
water NN O
and CC O
distribution NN O
space NN O
of IN O
Na24 NNP O
in IN O
women NNS O
with IN O
various JJ O
body NN O
weight NN O

-DOCSTART- X X O

Transient NNP O
cotransfection NN O
analyses NNS O
indicate VBP O
that IN O
the DT O
cooperative JJ O
association NN O
of IN O
NF-IL-6 NNP B-NP
and CC O
RelA NNP B-NP
with IN O
the DT O
IL-8 NN B-NP
promoter NN I-NP
results NNS O
in IN O
synergistic JJ O
transcriptional JJ O
activation NN O
. . O

-DOCSTART- X X O

Sera NN O
from IN O
33 CD O
newborn JJ O
infants NNS O
with IN O
gestational JJ O
ages NNS O
ranging VBG O
from IN O
27 CD O
to TO O
41 CD O
weeks NNS O
were VBD O
tested VBN O
by IN O
radioimmunoassay NN O
for IN O
IgG NNP B-NP
antibodies NNS O
to TO O
surface VB O
antigens NNS O
of IN O
group NN O
B NN O
streptococci NNS O
( -LRB- O
GBS NNP O
) -RRB- O
types NNS O
Ia NNP O
, , O
Ib NNP O
, , O
II NNP O
and CC O
III NNP O
. . O

-DOCSTART- X X O

On IN O
average NN O
, , O
rCMRglc JJ O
values NNS O
were VBD O
23 CD O
% NN O
below IN O
control NN O
values NNS O
for IN O
all DT O
regions NNS O
studied VBD O
, , O
with IN O
the DT O
greatest JJS O
differences NNS O
in IN O
posterior JJ O
brain NN O
regions NNS O
(visual JJ O
association NN O
cortex NN O
, , O
primary JJ O
visual JJ O
cortex NN O
, , O
and CC O
parietal NN O
cortex NN O
) -RRB- O
and CC O
thalamus NN O
. . O

-DOCSTART- X X O

The DT O
NF1 NNP B-NP
family NN I-NP
members NNS O
and CC O
HNF4 NNP B-NP
interacted VBD O
with IN O
overlapping VBG O
sequences NNS O
of IN O
the DT O
L-II JJ O
element NN O
, , O
wherein WRB O
the DT O
5' JJ O
half-site NN O
was VBD O
more RBR O
critical JJ O
for IN O
NF1 NNP B-NP
binding NN O
, , O
and CC O
the DT O
3' JJ O
site NN O
was VBD O
more RBR O
important JJ O
for IN O
HNF4 NNP B-NP
binding NN O
. . O

-DOCSTART- X X O

VP4 DT B-NP
differentially RB O
regulates VBZ O
TRAF2 NN B-NP
signaling VBG O
, , O
disengaging VBG O
JNK NNP B-NP
activation NN O
while IN O
directing VBG O
NF-kappa NNP B-NP
B NN I-NP
to TO O
effect VB O
rotavirus-specific JJ O
cellular JJ O
responses NNS O
. . O

-DOCSTART- X X O

From IN O
the DT O
autopsy NN O
findings NNS O
, , O
in IN O
5 CD O
out IN O
of IN O
the DT O
remaining VBG O
23 CD O
expired VBD O
patients NNS O
, , O
Legionella NNP O
pneumonia NN O
seemed VBD O
to TO O
be VB O
successfully RB O
treated VBN O
, , O
but CC O
other JJ O
disease NN O
or CC O
other JJ O
bacterial JJ O
pneumonia NN O
put VBD O
an DT O
end NN O
to TO O
the DT O
patients NNS O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
a DT O
prevalence NN O
of IN O
eating VBG O
disorders NNS O
of IN O
5.9 CD O
% NN O
( -LRB- O
lifetime NN O
prevalence NN O
of IN O
10 CD O
% NN O
) -RRB- O
, , O
irrespective JJ O
of IN O
gender NN O
and CC O
type NN O
of IN O
diabetes NN O
; : O
4.1 CD O
% NN O
of IN O
the DT O
whole JJ O
sample NN O
reported VBD O
intentional JJ O
insulin NN B-NP
undertreatment NN O
or CC O
omission NN O
. . O

-DOCSTART- X X O

NER NNP O
was VBD O
also RB O
measured VBN O
by IN O
a DT O
plasmid NN O
host NN O
cell NN O
re-activation NN O
assay NN O
using VBG O
a DT O
vector NN O
containing VBG O
a DT O
luciferase NN B-NP
reporter NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Also RB O
, , O
like IN O
TUB NNP B-NP
, , O
it PRP O
has VBZ O
a DT O
wider JJR O
pattern NN O
of IN O
tissue NN O
expression NN O
than IN O
either DT O
TULP1 NNP B-NP
or CC O
TULP2 NNP B-NP
. . O

-DOCSTART- X X O

Moist JJ O
healing NN O
versus IN O
wet-to-dry JJ O
. . O

-DOCSTART- X X O

Despite IN O
the DT O
same JJ O
decreases NNS O
or CC O
increases NNS O
in IN O
MAP NNP O
, , O
RSNA NNP O
was VBD O
attenuated VBN O
after IN O
15 CD O
and CC O
30 CD O
min NN O
of IN O
propofol NN O
infusion NN O
in IN O
both DT O
groups NNS O
compared VBN O
with IN O
control NN O
( -LRB- O
P NNP O
< NN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Acute JJ O
morphine NN O
treatment NN O
did VBD O
not RB O
increase VB O
the DT O
locomotor NN O
activity NN O
of IN O
mice NNS O
withdrawn VBN O
for IN O
1 CD O
day NN O
, , O
after IN O
withdrawal NN O
for IN O
3 CD O
days NNS O
the DT O
increase NN O
was VBD O
similar JJ O
to TO O
that DT O
in IN O
controls NNS O
, , O
and CC O
after IN O
5 CD O
days NNS O
the DT O
increase NN O
was VBD O
clearly RB O
larger JJR O
than IN O
in IN O
controls NNS O
. . O

-DOCSTART- X X O

A DT O
significant JJ O
and CC O
specific JJ O
reduction NN O
in IN O
binaural JJ O
peak NN O
amplitude NN O
and CC O
area NN O
of IN O
the DT O
echo-evoked JJ O
middle-latency NN O
component NN O
Pa NNP O
was VBD O
observed VBN O
. . O

-DOCSTART- X X O

Non-dialyzable JJ O
transfer NN B-NP
factor NN I-NP

-DOCSTART- X X O

Stress NNP O
thallium-201 DT O
myocardial JJ O
imaging NN O
was VBD O
used VBN O
in IN O
two CD O
angina-free JJ O
patients NNS O
with IN O
severe JJ O
congestive JJ O
heart NN O
failure NN O
to TO O
identify VB O
clinically RB O
silent JJ O
areas NNS O
of IN O
ischemic JJ O
myocardium NN O
and CC O
to TO O
distinguish VB O
between IN O
scar NN O
and CC O
reversibly RB O
ischemic JJ O
myocardium NN O
as IN O
a DT O
cause NN O
for IN O
akinesia NN O
of IN O
left JJ O
ventricular JJ O
wall NN O
segments NNS O
. . O

-DOCSTART- X X O

The DT O
6.5-kb JJ O
genomic JJ O
fragment NN O
contains VBZ O
the DT O
complete JJ O
coding NN O
region NN O
of IN O
MyoD NNP B-NP
, , O
distributed VBN O
over IN O
three CD O
exons NNS O
, , O
plus CC O
2.3 CD O
kb NN O
of IN O
5'-noncoding JJ O
sequence NN O
and CC O
1.4 CD O
kb NN O
of IN O
3'-noncoding JJ O
sequence NN O
. . O

-DOCSTART- X X O

These DT O
observations NNS O
demonstrate VBP O
that IN O
KSR NNP B-NP
is VBZ O
capable JJ O
of IN O
uncoupling VBG O
the DT O
MAP NNP B-NP
kinase NN I-NP
activation NN O
from IN O
its PRP$ O
target NN O
phosphorylation NN O
, , O
and CC O
thus RB O
provide VB O
a DT O
novel NN O
mechanism NN O
for IN O
modulating VBG O
the DT O
Ras-MAP NNP B-NP
kinase NN B-NP
signaling VBG O
pathway NN O
. . O

-DOCSTART- X X O

Since IN O
1985 CD O
the DT O
combination NN O
of IN O
chlorambucil NN O
( -LRB- O
10 CD O
mg JJ O
daily JJ O
, , O
initially RB O
for IN O
six CD O
weeks NNS O
, , O
then RB O
alternating VBG O
fortnights NNS O
for IN O
12 CD O
weeks NNS O
) -RRB- O
and CC O
interferon-alpha NN B-NP
2b IN I-NP
( -LRB- O
Schering-Plough NNP O
; : O
2 CD O
x NN O
10(6 CD O
) -RRB- O
U/m2 IN O
three CD O
times NNS O
weekly RB O
by IN O
subcutaneous JJ O
injection NN O
for IN O
18 CD O
weeks NNS O
) -RRB- O
has VBZ O
been VBN O
compared VBN O
in IN O
a DT O
randomised JJ O
trial NN O
with IN O
chlorambucil NN O
alone RB O
in IN O
previously RB O
untreated JJ O
patients NNS O
with IN O
stage NN O
III NNP O
or CC O
IV NNP O
follicular JJ O
lymphoma NN O
. . O

-DOCSTART- X X O

Correlation NN O
of IN O
alpha NN O
activity NN O
between IN O
the DT O
frontal JJ O
and CC O
occipital JJ O
cortex NN O
. . O

-DOCSTART- X X O

Nonetheless RB O
, , O
the DT O
majority NN O
were VBD O
located VBN O
within IN O
three CD O
short JJ O
sequences NNS O
at IN O
the DT O
N NNP O
terminus NN O
, , O
middle NN O
, , O
and CC O
C NNP O
terminus NN O
that WDT O
are VBP O
phylogenetically RB O
conserved VBN O
among IN O
all DT O
known VBN O
eubacterial NN O
and CC O
chloroplast JJ O
versions NNS O
of IN O
this DT O
protein NN O
. . O

-DOCSTART- X X O

All DT O
other JJ O
cysts NNS O
showed VBD O
a DT O
unilocular JJ O
, , O
purely RB O
cystic JJ O
pattern NN O
, , O
with IN O
homogeneous JJ O
fluids NNS O
, , O
although IN O
the DT O
T2 NN O
relaxation NN O
times NNS O
of IN O
four CD O
lesions NNS O
overlapped IN O
those DT O
of IN O
odontogenic JJ O
keratocysts NNS O
. . O

-DOCSTART- X X O

Recombinant NNP B-NP
caspases NNS I-NP
are VBP O
typically RB O
produced VBN O
in IN O
Escherichia NNP O
coli NNS O
expression NN O
systems NNS O
with IN O
the DT O
attendant JJ O
problems NNS O
of IN O
solubilization NN O
, , O
re-folding NN O
and CC O
activation NN O
of IN O
the DT O
protease NN O
. . O

-DOCSTART- X X O

Nuclear NNP O
runoff NN O
assays VBD O
show NN O
that IN O
complementation NN O
by IN O
HPV16 CD B-NP
E7 NNS I-NP
restores VBZ O
the DT O
ability NN O
of IN O
the DT O
E1A NNP B-NP
mutants NNS I-NP
to TO O
stimulate VB O
early JJ B-NP
gene NN I-NP
expression NN O
at IN O
the DT O
level NN O
of IN O
transcription NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
deferoxamine NN O
B NNP O
on IN O
the DT O
blood NN O
sugar NN O
behavior NN O
in IN O
intravenous JJ O
glucose NN O
loading NN O
in IN O
healthy JJ O
persons NNS O

-DOCSTART- X X O

Constructs NNS O
containing VBG O
fragments NNS O
of IN O
the DT O
upstream JJ O
region NN O
of IN O
the DT O
cytotactin NN B-NP
gene NN I-NP
fused VBN O
to TO O
a DT O
promoterless JJ O
gene NN O
for IN O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
were VBD O
transiently RB O
transfected VBN O
into IN O
chicken NN O
embryo NN O
fibroblasts NNS O
to TO O
define VB O
functional JJ O
promoter NN O
sequences NNS O
. . O

-DOCSTART- X X O

Like IN O
the DT O
human JJ B-NP
erythrocyte NN I-NP
P4.2 NN I-NP
, , O
mouse NN B-NP
erythrocyte NN I-NP
P4.2 NNP I-NP
contains VBZ O
regions NNS O
strikingly RB O
homologous JJ O
with IN O
the DT O
transglutaminase NN O
( -LRB- O
TGase NN O
) -RRB- O
proteins VBZ O
although IN O
it PRP O
too RB O
most RBS O
likely JJ O
lacks VBZ O
TGase DT O
crosslinking JJ O
activity NN O
. . O

-DOCSTART- X X O

The DT O
rate NN O
for IN O
Arm NN O
III NNP O
( -LRB- O
CAF NN O
therapy NN O
) -RRB- O
was VBD O
61.5 CD O
% NN O
( -LRB- O
32/52 CD O
) -RRB- O
, , O
a DT O
little RB O
higher JJR O
than IN O
that IN O
for IN O
the DT O
other JJ O
two CD O
. . O

-DOCSTART- X X O

Mutating VBG O
this DT O
sequence NN O
eliminated VBD O
complex JJ O
formation NN O
and CC O
markedly RB O
reduced VBN O
basal NN O
and CC O
cAMP-dependent JJ O
promoter NN O
activity NN O
of IN O
transfected VBN O
reporter NN O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
induction NN O
of IN O
the DT O
composite JJ O
H-PK/Tag NNP B-NP
and CC O
SV-PK/Tag NNP B-NP
transgenes NNS O
by IN O
a DT O
carbohydrate-rich JJ O
diet NN O
in IN O
the DT O
liver NN O
was VBD O
similar JJ O
to TO O
that DT O
of IN O
the DT O
endogenous JJ B-NP
L-PK NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

For IN O
routine JJ O
medical JJ O
applications NNS O
, , O
no RB O
sophisticated JJ O
adjustment NN O
of IN O
the DT O
CHESS NNP O
pulse NN O
is VBZ O
needed VBN O
, , O
as IN O
reported VBN O
in IN O
previous JJ O
methods NNS O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
report VBP O
the DT O
cloning NN O
of IN O
the DT O
hemF NN B-NP
gene NN I-NP
, , O
encoding VBG O
the DT O
aerobic JJ O
coproporphyrinogen NN B-NP
III NNP I-NP
oxidase NN I-NP
from IN I-NP
Escherichia NNP I-NP
coli NNS I-NP
, , O
by IN O
functional JJ O
complementation NN O
of IN O
a DT O
Saccharomyces NNP B-NP
cerevisiae NN I-NP
HEM13 IN I-NP
mutant JJ I-NP
. . O

-DOCSTART- X X O

Efficacy NN O
of IN O
probiotic JJ O
feed NN O
additives NNS O
: : O
guidelines NNS O
for IN O
the DT O
evaluation NN O
of IN O
the DT O
efficiency NN O
of IN O
microorganisms NNS O
in IN O
dogs NNS O
, , O
cats NNS O
, , O
and CC O
horses NNS O
] SYM O
Probiotic JJ O
microorganisms NNS O
are VBP O
frequently RB O
in IN O
use NN O
as IN O
feed NN O
additives NNS O
for IN O
farm NN O
and CC O
pet JJ O
animals NNS O
. . O

-DOCSTART- X X O

We PRP O
analyzed VBD O
the DT O
contribution NN O
of IN O
the DT O
three CD O
different JJ O
types NNS O
of IN O
UV-inducible JJ O
mitogen-activated JJ B-NP
protein NN I-NP
( -LRB- I-NP
MAP NNP I-NP
) -RRB- I-NP
kinases FW I-NP
( -LRB- O
ERK NN B-NP
, , O
JNK/SAPK NNP B-NP
, , O
and CC O
p38 NNS B-NP
) -RRB- O
to TO O
the DT O
activation NN O
of IN O
the DT O
murine NN O
uPA NN B-NP
promoter NN O
by IN O
UV. NNP O

-DOCSTART- X X O

Mean JJ O
total JJ O
homocysteine NN O
( -LRB- O
tHcy NN O
) -RRB- O
was VBD O
21.1 CD O
+/-9.5 CD O
micromol/L NNS O
and CC O
median JJ O
concentration NN O
was VBD O
19 CD O
micromol/L NN O
. . O

-DOCSTART- X X O

To TO O
facilitate VB O
the DT O
characterization NN O
of IN O
NF-E2 JJ B-NP
functions NNS O
in IN O
human NN O
cells NNS O
, , O
we PRP O
isolated VBD O
cDNAs IN O
encoding VBG O
two CD O
members NNS O
of IN O
the DT O
small JJ B-NP
Maf NNP I-NP
family NN I-NP
, , O
MafK NNP B-NP
and CC O
MafG. NNP B-NP

-DOCSTART- X X O

In IN O
this DT O
first-person JJ O
account NN O
, , O
the DT O
author NN O
chronicles VBZ O
her PRP$ O
experience NN O
of IN O
being VBG O
mentally RB O
ill JJ O
and CC O
homeless JJ O
in IN O
New NNP O
York NNP O
and CC O
New NNP O
Jersey NNP O
in IN O
the DT O
early JJ O
1980s CD O
. . O

-DOCSTART- X X O

Pharmacokinetics NNP O
of IN O
skin NN O
penetration NN O
. . O

-DOCSTART- X X O

Dmyd NNP B-NP
clone NN O
encodes VBZ O
a DT O
polypeptide NN O
of IN O
332 CD O
amino IN O
acids NNS O
with IN O
82 CD O
% NN O
identity NN O
to TO O
MyoD NNP B-NP
in IN O
the DT O
41 CD O
amino IN O
acids NNS O
of IN O
the DT O
putative JJ O
helix-loop-helix NN O
region NN O
and CC O
100 CD O
% NN O
identity NN O
in IN O
the DT O
13 CD O
amino IN O
acids NNS O
of IN O
the DT O
basic JJ O
domain NN O
proposed VBN O
to TO O
contain VB O
the DT O
essential JJ O
recognition NN O
code NN O
for IN O
muscle-specific JJ O
gene NN O
activation NN O
. . O

-DOCSTART- X X O

Enterotoxin NN O
production NN O
by IN O
staphylococci NNS O
isolated VBN O
from IN O
foods NNS O
in IN O
France NNP O
. . O

-DOCSTART- X X O

Binding VBG O
sites NNS O
were VBD O
mapped VBN O
for IN O
each DT O
factor NN O
. . O

-DOCSTART- X X O

The DT O
majority NN O
of IN O
these DT O
cells NNS O
were VBD O
also RB O
OKT4 CD B-NP
positive JJ O
( -LRB- O
helper/inducer NN O
T NNP O
lymphocytes VBZ O
) -RRB- O
, , O
while IN O
the DT O
minority NN O
were VBD O
OKT8 CD B-NP
positive JJ O
( -LRB- O
suppressor/cytotoxic JJ O
T NN O
lymphocytes NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Toxicological JJ O
effects NNS O
of IN O
dietary NN O
Maillard NNP O
reaction NN O
products NNS O
in IN O
the DT O
rat NN O
. . O

-DOCSTART- X X O

All DT O
relapses NNS O
occurred VBD O
within IN O
the DT O
first JJ O
year NN O
and CC O
were VBD O
confined VBN O
to TO O
patients NNS O
with IN O
PS NNP O
II NNP O
disease NN O
and CC O
four CD O
or CC O
more JJR O
sites NNS O
of IN O
involvement NN O
. . O

-DOCSTART- X X O

These DT O
patients NNS O
developed VBD O
severe JJ O
diabetic NN O
symptoms NNS O
including VBG O
glucose NNP O
intolerance NN O
, , O
weight NN O
loss NN O
, , O
impaired VBN O
energy NN O
utilization NN O
, , O
and CC O
nerve NN O
and CC O
brain NN O
disorders NNS O
that WDT O
were VBD O
refractory JJ O
to TO O
insulin NN B-NP
. . O

-DOCSTART- X X O

BCV NNP B-NP
mRNAs NNS I-NP
5 CD I-NP
and CC I-NP
5-1 CD I-NP
appear VBP O
to TO O
be VB O
used VBN O
for IN O
the DT O
synthesis NN O
of IN O
the DT O
12.7- CD O
and CC O
9.5-kDa JJ O
proteins NNS O
, , O
respectively RB O
, , O
which WDT O
demonstrates VBZ O
a DT O
pattern NN O
of IN O
expression NN O
strikingly RB O
different JJ O
from IN O
that DT O
utilized VBN O
by IN O
MHV. NNP O

-DOCSTART- X X O

Consistent NN O
with IN O
this DT O
observation NN O
, , O
introduction NN O
of IN O
Smad JJ B-NP
sites NNS I-NP
into IN O
a DT O
TGFbeta-insensitive JJ B-NP
LEF1/TCF NN B-NP
target NN O
gene NN O
confers VBZ O
cooperative JJ O
TGFbeta NN B-NP
and CC O
Wnt NNP B-NP
responsiveness NN O
to TO O
the DT O
promoter NN O
. . O

-DOCSTART- X X O

Recombinant NNP O
vaccinia NN O
viruses NNS O
that WDT O
express VBP O
the DT O
bacteriophage NN B-NP
T3 IN I-NP
RNA NNP I-NP
polymerase NN I-NP
( -LRB- O
VV-T3pol JJ B-NP
) -RRB- O
or CC O
the DT O
Escherichia NNP B-NP
coli NNS I-NP
lac NN I-NP
repressor NN I-NP
( -LRB- O
VV-lacI JJ B-NP
) -RRB- O
under IN O
control NN O
of IN O
the DT O
early-late JJ B-NP
vaccinia NN I-NP
promoter NN I-NP
P7.5 . I-NP
were VBD O
constructed VBN O
. . O

-DOCSTART- X X O

Tritiated NNP O
1,24,25-trihydroxyvitamin CD O
D3 . O
was VBD O
synthesized VBN O
biologically RB O
and CC O
used VBD O
as IN O
tracer NN O
to TO O
monitor VB O
the DT O
recovery NN O
of IN O
endogenous JJ O
metabolite NN O
during IN O
isolation NN O
from IN O
serum NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
examines VBZ O
LEIBNIZ NNP O
' POS O
idea NN O
of IN O
Veterinary JJ O
medicine NN O
in IN O
a DT O
biographical JJ O
context NN O
. . O

-DOCSTART- X X O

Using VBG O
the DT O
conflict NN O
drinking NN O
test NN O
as IN O
a DT O
model NN O
, , O
we PRP O
studied VBD O
in IN O
rats NNS O
the DT O
effect NN O
of IN O
the DT O
nonselective JJ O
beta-adrenoceptor NN B-NP
blockers NNS O
pindolol NN O
and CC O
cyanopindolol NN O
which WDT O
bind VBP O
to TO O
5-HT1A JJ B-NP
and CC I-NP
5-HT1B JJ I-NP
receptors NNS I-NP
, , O
and CC O
of IN O
the DT O
selective JJ O
beta NN B-NP
1- . I-NP
and CC I-NP
beta JJ I-NP
2-adrenoceptor JJ I-NP
antagonists NNS O
betaxolol , O
and CC O
ICI NNP O
118,551 CD O
, , O
respectively RB O
, , O
which WDT O
have VBP O
a DT O
negligible JJ O
affinity NN O
for IN O
5-HT JJ B-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

Rewarding VBG O
properties NNS O
of IN O
methylphenidate NN O
: : O
sensitization NN O
by IN O
prior JJ O
exposure NN O
to TO O
the DT O
drug NN O
and CC O
effects NNS O
of IN O
dopamine NN B-NP
D1- . I-NP
and CC I-NP
D2-receptor JJ I-NP
antagonists NNS O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
Children NNS O
with IN O
attention-deficit/hyperactivity NN O
disorder NN O
( -LRB- O
ADHD NN O
; : O
n RB O
= SYM O
282 CD O
) -RRB- O
, , O
all DT O
subtypes NNS O
, , O
ages NNS O
6 CD O
to TO O
12 CD O
years NNS O
, , O
were VBD O
randomized VBN O
to TO O
placebo VB O
( -LRB- O
n RB O
= SYM O
90 CD O
) -RRB- O
, , O
immediate-release JJ O
methylphenidate NN O
( -LRB- O
IR NNP O
MPH) NNP O
3 CD O
times NNS O
a DT O
day NN O
(tid CC O
; : O
dosed VBN O
every DT O
4 CD O
hours NNS O
; : O
n RB O
= SYM O
97 CD O
) -RRB- O
, , O
or CC O
OROS NNP O
MPH NNP O
once RB O
a DT O
day NN O
(qd NN O
; : O
n RB O
= SYM O
95 CD O
) -RRB- O
in IN O
a DT O
double-blind JJ O
, , O
28-day JJ O
trial NN O
. . O

-DOCSTART- X X O

The DT O
possibility NN O
to TO O
use VB O
this DT O
method NN O
for IN O
common JJ O
diagnostic JJ O
problems NNS O
is VBZ O
indicated VBN O
. . O

-DOCSTART- X X O

Female JJ O
Wistar NNP O
rats NNS O
receiving VBG O
alcohol NN O
( -LRB- O
5 CD O
% NN O
) -RRB- O
in IN O
drinking NN O
water NN O
during IN O
lactation NN O
( -LRB- O
N NNP O
= SYM O
7 CD O
) -RRB- O
were VBD O
compared VBN O
to TO O
normal JJ O
controls NNS O
fed VBN O
ad NN O
libitum NN O
( -LRB- O
N NNP O
= SYM O
6 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Eph NNP B-NP
receptors NNS I-NP
and CC O
their PRP$ O
membrane-associated JJ O
ephrin NN B-NP
ligands VBZ I-NP
regulate VB O
cell-cell NN O
interactions NNS O
during IN O
development NN O
. . O

-DOCSTART- X X O

Vk8/Jk2 NNP B-NP
and CC O
Vk1/Jk5 DT B-NP
rearrangements NNS O
encoded VBD O
the DT O
respective JJ O
L NNP B-NP
chain NN I-NP
V-regions NNS I-NP
. . O

-DOCSTART- X X O

An DT O
analysis NN O
of IN O
the DT O
c-kit NN B-NP
5' IN I-NP
flanking VBG I-NP
region NN I-NP
using VBG O
the DT O
bacterial JJ B-NP
chloramphenicol NN I-NP
acetyltransferase NN I-NP
gene NN I-NP
( -LRB- O
CAT JJ B-NP
assay NN O
) -RRB- O
in IN O
human JJ O
erythroleukemia NN O
HEL NNP O
cells NNS O
, , O
which WDT O
express VBP O
the DT O
endogenous JJ O
c-kit NN B-NP
mRNA NN I-NP
at IN O
high JJ O
levels NNS O
, , O
showed VBD O
that IN O
a DT O
region NN O
from IN O
-180 PRP$ O
to TO O
-22 DT O
is VBZ O
important JJ O
for IN O
the DT O
expression NN O
of IN O
the DT O
c-kit JJ B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Following VBG O
immunization NN O
of IN O
transgenic JJ O
mice NNS O
, , O
hybrid JJ O
molecules NNS O
were VBD O
isolated VBN O
from IN O
B NNP O
cell NN O
DNA NN O
which WDT O
contained VBD O
the DT O
transgene NN O
recombined VBD O
with IN O
the DT O
endogenous JJ B-NP
IgH NNP I-NP
locus NN I-NP
. . O

-DOCSTART- X X O

( -LRB- O
LH NNP B-NP
P NNP O
< NNP O
0.05 CD O
, , O
LH/FSH NNP B-NP
P NNP O
< JJ O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

None NN O
of IN O
the DT O
19 CD O
women NNS O
with IN O
probable JJ O
RA NNP O
and CC O
100 CD O
of IN O
the DT O
116 CD O
women NNS O
with IN O
definite JJ O
RA NNP O
met VBD O
the DT O
1987 CD O
criteria NNS O
. . O

-DOCSTART- X X O

In IN O
response NN O
to TO O
the DT O
need NN O
for IN O
better JJR O
quantitative JJ O
estimates NNS O
of IN O
the DT O
regional JJ O
distribution NN O
of IN O
the DT O
active JJ O
bone NN O
marrow NN O
organ NN O
in IN O
infants NNS O
and CC O
children NNS O
, , O
a DT O
method NN O
using VBG O
various JJ O
anatomical JJ O
data NNS O
has VBZ O
been VBN O
developed VBN O
. . O

-DOCSTART- X X O

Thus RB O
the DT O
Hi-RARE NNP O
represents VBZ O
a DT O
new JJ O
type NN O
of IN O
RA NNP O
response NN O
element NN O
with IN O
a DT O
role NN O
in IN O
the DT O
modulation NN O
of IN O
the DT O
expression NN O
of IN O
MHC NNP B-NP
class NN I-NP
1 CD I-NP
family NN O
genes NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
strongly RB O
suggest VBP O
that IN O
activation NN O
of IN O
the DT O
beta JJ O
origin NN O
by IN O
a DT O
distant JJ O
replication NN O
enhancer NN O
element NN O
requires VBZ O
a DT O
small JJ O
target NN O
sequence NN O
essential JJ O
for IN O
initiator NN O
protein-mediated JJ O
DNA NNP O
looping NN O
. . O

-DOCSTART- X X O

Three CD O
experiments NNS O
using VBG O
20 CD O
microM NNS O
2-(hydroxyamino)-1-methyl-6-phenylimidazo[4,5-b]pyridine JJ O
(N-OH-PhIP NN O
) -RRB- O
were VBD O
performed VBN O
to TO O
induce VB O
mutations NNS O
in IN O
the DT O
dihydrofolate NN B-NP
reductase NN I-NP
( -LRB- O
DHFR NN B-NP
) -RRB- O
gene NN O
of IN O
a DT O
hemizygous JJ O
Chinese JJ O
hamster NN O
ovary NN O
( -LRB- O
CHO NNP O
) -RRB- O
cell NN O
line NN O
( -LRB- O
UA21 NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
UL3 NNP B-NP
ORF NNP I-NP
of IN O
204 CD O
amino IN O
acids NNS O
shows VBZ O
significant JJ O
homology NN O
to TO O
UL3 DT B-NP
( -LRB- O
nuclear JJ O
phosphoprotein NN O
) -RRB- O
of IN O
HSV-1 NN O
( -LRB- O
62 CD O
% NN O
) -RRB- O
and CC O
PRV NNP O
( -LRB- O
53 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Immunogenicity NN O
tested VBN O
in IN O
experiments NNS O
on IN O
guinea NN O
pigs NNS O
and CC O
rabbits NNS O
was VBD O
not RB O
reduced VBN O
and CC O
corresponded VBN O
to TO O
that DT O
of IN O
the DT O
reference NN O
STI-1 JJ O
vaccine NN O
. . O

-DOCSTART- X X O

Supportive VB O
therapy NN O
with IN O
xenogenous JJ O
peptides NNS O
in IN O
patients NNS O
with IN O
metastatic JJ O
breast NN O
cancer NN O
undergoing VBG O
aggressive JJ O
chemotherapy NN O
( -LRB- O
modified JJ O
AC-protocol NN O
) -RRB- O
: : O
a DT O
prospective JJ O
, , O
randomized VBN O
double-blind JJ O
study NN O

-DOCSTART- X X O

The DT O
inactive JJ O
X NNP O
allele NN O
, , O
however RB O
, , O
is VBZ O
hypermethylated VBN O
in IN O
leukocytes NNS O
, , O
presumably RB O
reflecting VBG O
early JJ O
X NNP O
inactivation IN O
events NNS O
that WDT O
become VBP O
important JJ O
for IN O
gene NN O
dosage NN O
in IN O
expressing VBG O
lineages NNS O
. . O

-DOCSTART- X X O

Development NNP O
of IN O
neural JJ O
control NN O
of IN O
alimentary JJ O
motor NN O
function NN O
in IN O
the DT O
vertebrates NNS O
. . O

-DOCSTART- X X O

Cell NNP O
rounding NN O
was VBD O
abrogated VBN O
by IN O
expression NN O
of IN O
either DT O
kinase-dead JJ O
forms NNS O
of IN O
US3 NNP B-NP
PK NNP I-NP
or CC O
a DT O
mutant JJ O
protein NN O
lacking VBG O
the DT O
acidic NN O
cluster NN O
in IN O
the DT O
kinase NN O
regulatory JJ O
domain NN O
. . O

-DOCSTART- X X O

The DT O
genes NNS O
expressed VBN O
during IN O
the DT O
embryonic JJ O
(zeta NN O
) -RRB- O
or CC O
fetal NN O
and CC O
adult NN O
stage NN O
( -LRB- O
alpha NN B-NP
2 CD I-NP
and CC O
alpha NN B-NP
1 CD I-NP
) -RRB- O
can MD O
be VB O
modified VBN O
by IN O
point NN O
mutations NNS O
which WDT O
affect VBP O
either CC O
the DT O
processing-translation NN O
of IN O
mRNA NN O
or CC O
make VB O
the DT O
polypeptide NN O
chains NNS O
extremely RB O
unstable JJ O
. . O

-DOCSTART- X X O

Acoustic-property NN O
measurements NNS O
of IN O
the DT O
oxide NN O
superconductor NN O
BaPb1-xBixO3 CC O
by IN O
the DT O
sphere-resonance NN O
method NN O
. . O

-DOCSTART- X X O

Rabbit NN B-NP
KCC1 NNP I-NP
( -LRB- O
rbKCC1 NN B-NP
) -RRB- O
and CC O
rat NN B-NP
KCC1 NNS I-NP
( -LRB- O
rtKCC1 NN B-NP
) -RRB- O
were VBD O
cloned VBN O
by IN O
screening VBG O
rabbit NN O
kidney NN O
and CC O
rat NN O
brain NN O
cDNA NN O
libraries NNS O
using VBG O
homologous JJ O
cDNA NN O
probes NNS O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
these DT O
findings NNS O
demonstrate VBP O
that IN O
ZNF76 NNP B-NP
and CC O
ZNF143 CD B-NP
are VBP O
two CD O
members NNS O
of IN O
a DT O
same JJ O
family NN O
of IN O
transactivator NN O
proteins NNS O
. . O

-DOCSTART- X X O

This DT O
model NN O
system NN O
exploits VBZ O
the DT O
polyomavirus NN O
late JJ O
transcription NN O
termination NN O
and CC O
polyadenylation NN O
signals NNS O
, , O
which WDT O
are VBP O
sufficiently RB O
weak JJ O
to TO O
allow VB O
the DT O
production NN O
of IN O
many JJ O
multigenome-length JJ O
primary JJ O
transcripts NNS O
with IN O
repeating VBG O
introns NNS O
, , O
exons NNS O
, , O
and CC O
poly( NN O
A DT O
) -RRB- O
sites NNS O
. . O

-DOCSTART- X X O

The DT O
disorders NNS O
are VBP O
accompanied VBN O
by IN O
consistent JJ O
, , O
but CC O
similarly RB O
reversible JJ O
, , O
electroencephalographic JJ O
changes NNS O
. . O

-DOCSTART- X X O

Electronic JJ O
structure NN O
and CC O
optical JJ O
properties NNS O
of IN O
the DT O
B12O2 NNP O
crystal NN O
. . O

-DOCSTART- X X O

Basic NNP B-NP
helix-loop-helix , I-NP
proteins VBZ I-NP
can MD O
act VB O
at IN O
the DT O
E-box NN O
within IN O
the DT O
serum JJ O
response NN O
element NN O
of IN O
the DT O
c-fos JJ B-NP
promoter NN I-NP
to TO O
influence VB O
hormone-induced JJ O
promoter NN O
activation NN O
in IN O
Sertoli NNP O
cells NNS O
. . O

-DOCSTART- X X O

Recent JJ O
developments NNS O
in IN O
the DT O
study NN O
of IN O
growth NN O
factors NNS O
: : O
GRF NNP B-NP
and CC O
somatomedins NNS B-NP
. . O

-DOCSTART- X X O

Phenotypic NNP O
screening NN O
of IN O
mutations NNS O
in IN O
Pmr1 NNP B-NP
, , O
the DT O
yeast NN B-NP
secretory NN I-NP
pathway NN I-NP
Ca2+/Mn2+-ATPase JJ I-NP
, , O
reveals VBZ O
residues NNS O
critical JJ O
for IN O
ion NN O
selectivity NN O
and CC O
transport NN O
. . O

-DOCSTART- X X O

IV. . O

-DOCSTART- X X O

Routine NNP O
and CC O
default NN O
retrieval NN O
home NN O
visits NNS O
were VBD O
given VBN O
to TO O
ensure VB O
maximal JJ O
drug NN O
compliance NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
an DT O
unmodified JJ O
threonine CD O
at IN O
position NN O
169 CD O
in IN O
Cdc28 DT B-NP
is VBZ O
important JJ O
for IN O
interaction NN O
with IN O
G1 NNP B-NP
cyclins NNS I-NP
. . O

-DOCSTART- X X O

These DT O
alterations NNS O
occurred VBD O
at IN O
both DT O
the DT O
mRNA NN O
and CC O
protein NN O
levels NNS O
but CC O
did VBD O
not RB O
significantly RB O
affect VB O
the DT O
subcellular JJ O
distribution NN O
of IN O
any DT O
of IN O
the DT O
four CD O
isoforms NNS O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
chronic JJ O
hepatitis NN O
B NNP O
with IN O
interferon NN B-NP
: : O
experience NN O
in IN O
western JJ O
countries NNS O
. . O

-DOCSTART- X X O

Phenazopyridine-induced JJ O
hemolytic JJ O
anemia NN O
in IN O
a DT O
patient NN O
with IN O
G6PD JJ B-NP
deficiency NN O
. . O

-DOCSTART- X X O

The DT O
novel NN O
gene NN O
spans VBZ O
16.7 CD O
kb NN O
of IN O
genomic JJ O
sequence NN O
and CC O
it PRP O
is VBZ O
formed VBN O
of IN O
11 CD O
exons NNS O
and CC O
10 CD O
intervening NN O
introns NNS O
. . O

-DOCSTART- X X O

Overexpression NNP O
of IN O
a DT O
HIF-1alpha NNP B-NP
construct VB O
with IN O
deletions NNS O
of IN O
the DT O
basic JJ O
domain NN O
and CC O
carboxy NN O
terminus NN O
blocked VBD O
reporter NN O
gene NN O
activation NN O
by IN O
endogenous JJ O
HIF-1 NN B-NP
in IN O
hypoxic JJ O
cells NNS O
. . O

-DOCSTART- X X O

With IN O
rats NNS O
fed VBN O
on IN O
the DT O
Zn-sufficient JJ O
diet NN O
, , O
NaFe3+EDTA NNP O
and CC O
Na2EDTA NNP O
similarly RB O
increased VBD O
the DT O
absorption NN O
, , O
urinary JJ O
excretion NN O
and CC O
retention NN O
of IN O
Zn NNP O
but CC O
to TO O
a DT O
lesser JJR O
extent NN O
. . O

-DOCSTART- X X O

The DT O
requirement NN O
for IN O
an DT O
essential JJ O
interaction NN O
between IN O
NPH NNP B-NP
I PRP I-NP
and CC O
H4L NNP B-NP
provides VBZ O
an DT O
explanation NN O
for IN O
the DT O
observed JJ O
restriction NN O
of IN O
transcription NN O
termination NN O
to TO O
early RB O
viral JJ O
genes NNS O
. . O

-DOCSTART- X X O

Other JJ O
clinicopathological JJ O
features NNS O
have VBP O
no DT O
definite JJ O
influence NN O
in IN O
survival NN O
expectancy NN O
. . O

-DOCSTART- X X O

One CD O
day NN O
postoperatively RB O
, , O
the DT O
mononuclear JJ O
leukocyte NN O
beta NN B-NP
2-receptor JJ I-NP
density NN O
decreased VBD O
maximally RB O
by IN O
45 CD O
+/ NNS O
- : O
11 CD O
% NN O
in IN O
the DT O
enflurane NN O
patients NNS O
, , O
and CC O
by IN O
53 CD O
+/ NNS O
- : O
6 CD O
% NN O
in IN O
the DT O
neurolept NN O
patients NNS O
. . O

-DOCSTART- X X O

A DT O
direct JJ O
statistically NN O
reliable JJ O
correction NN O
of IN O
decrease NN O
of IN O
the DT O
enzymes NNS O
with IN O
the DT O
initial JJ O
state NN O
of IN O
the DT O
patients NNS O
has VBZ O
been VBN O
established VBN O
in IN O
an DT O
analysis NN O
of IN O
25 CD O
patients NNS O
aged VBN O
from IN O
18 CD O
to TO O
60 CD O
years NNS O
in IN O
prosthesis NN O
of+ IN O
the DT O
mitral JJ O
valve NN O
(n-9 CC O
) -RRB- O
and CC O
closed VBD O
mitral JJ O
commissurotomy NN O
(n-16 CD O
) -RRB- O
. . O

-DOCSTART- X X O

However RB O
, , O
it PRP O
was VBD O
observed VBN O
that IN O
storage NN O
time NN O
affected VBN O
significantly RB O
the DT O
biochemical JJ O
changes NNS O
occurring VBG O
in IN O
the DT O
constituents NNS O
of IN O
carrots NNS O
exposed VBN O
to TO O
gamma-irradiation NN O
. . O

-DOCSTART- X X O

Partial JJ O
proteolysis NN O
of IN O
cell NN O
surface-iodinated JJ O
B-G NNP B-NP
molecules NNS I-NP
generates VBZ O
extremely RB O
similar JJ O
patterns NNS O
of IN O
spots NNS O
, , O
both DT O
within IN O
and CC O
between IN O
haplotypes NNS O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
demonstrate VBP O
the DT O
ability NN O
of IN O
oligonucleotides NNS O
containing VBG O
the DT O
C4T JJ O
sequence NN O
to TO O
confer VB O
heat NN O
shock NN O
inducibility NN O
on IN O
the DT O
reporter NN O
gene NN O
and CC O
show NN O
that IN O
the DT O
presence NN O
of IN O
two CD O
such JJ O
elements NNS O
produces VBZ O
more JJR O
than IN O
additive JJ O
effects NNS O
on IN O
induction NN O
. . O

-DOCSTART- X X O

An DT O
X-linked JJ O
zinc NN B-NP
finger NN I-NP
gene NN I-NP
mapping NN O
to TO O
Xq21.1-q21.3 CD O
closely RB O
related VBN O
to TO O
ZFX NNP B-NP
and CC O
ZFY NNP B-NP
: : O
possible JJ O
origins NNS O
from IN O
a DT O
common JJ O
ancestral JJ O
gene NN O
. . O

-DOCSTART- X X O

Promoter NNP O
activity NN O
was VBD O
assayed VBN O
by IN O
transient JJ O
transfection NN O
of IN O
luciferase NN B-NP
reporter NN I-NP
constructs NNS I-NP
containing VBG O
nested VBN O
deletions NNS O
of IN O
the DT O
upstream JJ O
sequence NN O
in IN O
the DT O
human JJ O
RPE NN O
cell NN O
lines NNS O
ARPE19 . O
and CC O
D407 JJ O
, , O
as RB O
well RB O
as IN O
in IN O
the DT O
SK-Mel-28 JJ O
and CC O
HeLa NNP O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
an DT O
essential JJ O
role NN O
of IN O
the DT O
binding NN O
of IN O
HNF-4 NNP B-NP
and/or CC O
HNF-4-related JJ B-NP
nuclear JJ I-NP
factors NNS I-NP
to TO O
the DT O
6 CD O
beta NN O
A-A NNP O
site NN O
on IN O
the DT O
basal NN O
transcriptional JJ O
activation NN O
of IN O
the DT O
CYP3A2 NNP B-NP
gene NN I-NP
in IN O
liver NN O
cells NNS O
. . O

-DOCSTART- X X O

A DT O
vascular JJ O
component NN O
to TO O
impotence NN O
was VBD O
shown VBN O
to TO O
be VB O
common JJ O
in IN O
those DT O
with IN O
neurological JJ O
impairment NN O
, , O
and CC O
may MD O
alter VB O
management NN O
. . O

-DOCSTART- X X O

Bandwidth NNP O
of IN O
auditory JJ O
units NNS O
in IN O
the DT O
chick NN O
forebrain IN O
( -LRB- O
field NN O
L/Hv NN O
complex JJ O
) -RRB- O
was VBD O
measured VBN O
with IN O
isointensity NN O
tone NN O
stimuli NNS O
. . O

-DOCSTART- X X O

The DT O
promoter NN O
of IN O
this DT O
methyltransferase NN O
gene NN O
lacks VBZ O
an DT O
identifiable JJ O
TATA NNP O
box NN O
but CC O
is VBZ O
characterized VBN O
by IN O
a DT O
CpG NNP O
island NN O
which WDT O
begins VBZ O
approximately RB O
723 CD O
nucleotides NNS O
upstream RB O
of IN O
the DT O
major JJ O
transcriptional JJ O
start NN O
site NN O
and CC O
extends VBZ O
through IN O
exon NN O
1 CD O
and CC O
into IN O
the DT O
first JJ O
intron NN O
. . O

-DOCSTART- X X O

Three CD O
patients NNS O
with IN O
Mirizzi NNP O
type NN O
II NNP O
syndrome NN O
and CC O
two CD O
patients NNS O
with IN O
Mirizzi NNP O
type NN O
I PRP O
syndrome NN O
were VBD O
treated VBN O
laparoscopically RB O
. . O

-DOCSTART- X X O

The DT O
pregnancies NNS O
were VBD O
terminated VBN O
at IN O
19 CD O
and CC O
12 CD O
weeks NNS O
of IN O
gestation NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
treatment NN O
with IN O
glucocorticoids NNS O
and CC O
immunosuppressants NNS O
resulted VBD O
in IN O
a DT O
more JJR O
noticeable JJ O
decrease NN O
in IN O
the DT O
levels NNS O
of IN O
T3 NNP O
and CC O
E-RCF. NNP B-NP

-DOCSTART- X X O

Rapid NNP O
, , O
sensitive JJ O
gas NN O
chromatographic JJ O
analysis NN O
of IN O
8-methoxypsoralen JJ O
in IN O
human JJ O
plasma NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Sixty-one CD O
percent NN O
of IN O
the DT O
patients NNS O
had VBD O
damage NN O
within IN O
7 CD O
years NNS O
of IN O
onset NN O
( -LRB- O
mean JJ O
3.8 CD O
yrs NNS O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
concluded VBD O
that IN O
HFV NNP O
can MD O
achieve VB O
values NNS O
of IN O
CO2 NNP O
elimination NN O
close RB O
to TO O
the DT O
estimated VBN O
metabolic JJ O
CO2 NN O
production NN O
in IN O
normal JJ O
unintubated JJ O
subjects NNS O
over IN O
short JJ O
periods NNS O
of IN O
time NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
characterized VBN O
21 CD O
mutations NNS O
in IN O
the DT O
type NN B-NP
VII NNP I-NP
collagen NN I-NP
gene NN I-NP
( -LRB- O
COL7A1 NNP B-NP
) -RRB- O
encoding VBG O
the DT O
anchoring NN O
fibrils NNS O
, , O
18 CD O
of IN O
which WDT O
were VBD O
not RB O
previously RB O
reported VBN O
, , O
in IN O
patients NNS O
from IN O
15 CD O
unrelated JJ O
families NNS O
with IN O
recessive JJ O
dystrophic JJ O
epidermolysis NN O
bullosa NN O
( -LRB- O
RDEB NNP O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
case NN O
of IN O
heterotopic JJ O
gastric JJ O
mucosa NN O
( -LRB- O
pyloric JJ O
gland NN O
) -RRB- O
in IN O
the DT O
wall NN O
of IN O
the DT O
gallbladder NN O
was VBD O
reported VBN O
. . O

-DOCSTART- X X O

Ribosome DT O
association NN O
of IN O
GCN2 JJ B-NP
protein NN I-NP
kinase NN I-NP
, , O
a DT O
translational JJ O
activator NN O
of IN O
the DT O
GCN4 NNP B-NP
gene NN I-NP
of IN O
Saccharomyces NNS O
cerevisiae NNS O
. . O

-DOCSTART- X X O

These DT O
segments NNS O
may MD O
represent VB O
pseudogenes NNS O
. . O

-DOCSTART- X X O

Corresponding VBG O
oligonucleotides NNS O
were VBD O
used VBN O
to TO O
screen VB O
a DT O
rat NN O
liver NN O
cDNA NN O
library NN O
constructed VBN O
in IN O
the DT O
plasmid NN O
cloning NN O
vector NN O
, , O
pcDV. . O

-DOCSTART- X X O

Extracellular JJ B-NP
regulated JJ I-NP
kinases NNS I-NP
( -LRB- I-NP
ERK) NNP I-NP
1 CD I-NP
and CC O
ERK2 NNP B-NP
are VBP O
authentic JJ O
substrates NNS O
for IN O
the DT O
dual-specificity NN B-NP
protein-tyrosine NN I-NP
phosphatase NN I-NP
VHR. . I-NP

-DOCSTART- X X O

The DT O
model NN O
therefore RB O
predicts VBZ O
that IN O
1 CD O
) -RRB- O
on-line JJ O
calculation NN O
of IN O
airway NN O
dead JJ O
space NN O
and CC O
end-expired JJ O
lung NN O
volume NN O
can MD O
be VB O
made VBN O
by IN O
the DT O
addition NN O
of IN O
an DT O
oxygen NN O
sine-wave NN O
perturbation NN O
component NN O
to TO O
the DT O
mean JJ O
FIO2 CD O
; : O
and CC O
( -LRB- O
2 CD O
) -RRB- O
QS/QT NN O
can MD O
be VB O
measured VBN O
from IN O
the DT O
resultant NN O
oxygen NN O
perturbation NN O
sine-wave JJ O
amplitudes NNS O
in IN O
the DT O
expired VBN O
gas NN O
and CC O
in IN O
arterial NN O
and CC O
mixed-venous JJ O
blood NN O
and CC O
is VBZ O
independent JJ O
of IN O
the DT O
mean JJ O
blood NN O
oxygen NN O
partial JJ O
pressure NN O
and CC O
oxyhemoglobin NN B-NP
saturation NN O
values NNS O
. . O

-DOCSTART- X X O

An DT O
anoerxiant NN O
, , O
mazindol NN O
suppresses NNS O
food NN O
intake NN O
by IN O
1 CD O
) -RRB- O
stimulating NN O
beta-adrenergic JJ B-NP
receptors NNS I-NP
, , O
2 CD O
) -RRB- O
inhibiting VBG O
the DT O
feeding VBG O
center NN O
and CC O
, , O
3 CD O
) -RRB- O
stimulating VBG O
the DT O
satiety NN O
center NN O
in IN O
the DT O
hypothalamus NN O
. . O

-DOCSTART- X X O

When WRB O
patients NNS O
were VBD O
admitted VBN O
within IN O
one CD O
week NN O
of IN O
the DT O
onset NN O
of IN O
dark JJ O
urine NN O
, , O
45 CD O
% NN O
were VBD O
found VBN O
to TO O
be VB O
shedding VBG O
HAV NNP O
, , O
whereas IN O
only RB O
11 CD O
% NN O
of IN O
specimens NNS O
obtained VBD O
from IN O
patients NNS O
admitted VBN O
during IN O
the DT O
second JJ O
week NN O
contained VBD O
virus NN O
. . O

-DOCSTART- X X O

Positive JJ O
effects NNS O
of IN O
radioactive JJ O
therapy NN O
in IN O
Guarapari NNP O

-DOCSTART- X X O

Nevertheless RB O
, , O
lower JJR O
doses NNS O
which WDT O
alone RB O
were VBD O
lacking VBG O
in IN O
activity NN O
( -LRB- O
100-250 CD O
mg/kg NN O
B1 NNP O
and CC O
B6 NNP O
, , O
1-2.5 CD O
mg/kg NN O
B12 CD O
p.o NN O
. . O
) -RRB- O
dose-dependently RB O
potentiated VBD O
the DT O
antinociceptive JJ O
of IN O
diclofenac. NN O

-DOCSTART- X X O

Escherichia NNP O
coli NNS O
strains NNS O
carrying VBG O
recA730 CD B-NP
( -LRB- O
or CC O
other JJ O
recA* JJ B-NP
alleles NNS I-NP
) -RRB- O
exhibit VBP O
dramatic JJ O
increases NNS O
in IN O
SOS-dependent JJ O
spontaneous JJ O
mutator NN O
activity NN O
. . O

-DOCSTART- X X O

On IN O
the DT O
contrary JJ O
i NN O
.v. VBD O
administration NN O
of IN O
calcitonin NN B-NP
increased VBD O
intrapyloric JJ O
pressure NN O
via IN O
vagal JJ O
nerves NNS O
in IN O
atropinized JJ O
or CC O
gallaminized JJ O
animals NNS O
. . O

-DOCSTART- X X O

Overall RB O
, , O
free-chlorine JJ O
treatments NNS O
( -LRB- O
0.3 CD O
or CC O
1.0 CD O
mg/L NN O
) -RRB- O
showed VBD O
significantly RB O
lower JJR O
heterotrophic JJ O
plate NN O
numbers NNS O
than IN O
those DT O
without IN O
free JJ O
chlorine NN O
. . O

-DOCSTART- X X O

The DT O
curse NN O
of IN O
the DT O
Pharaohs NNP O
. . O

-DOCSTART- X X O

The DT O
enigma NN O
of IN O
aging VBG O
bone NN O
loss NN O
. . O

-DOCSTART- X X O

In IN O
both DT O
cell NN O
types NNS O
, , O
insulin NN B-NP
led VBD O
to TO O
a DT O
dose-dependent NN O
increase NN O
in IN O
the DT O
association NN O
of IN O
tyrosine NN B-NP
phosphorylated VBN I-NP
IRS-1 NNP I-NP
with IN O
the DT O
SH2 NNP B-NP
domain NN I-NP
of IN O
the DT O
p85 VBG B-NP
regulatory JJ I-NP
subunit NN I-NP
of IN O
PI-3 JJ B-NP
kinase NN I-NP
, , O
and CC O
also RB O
increased VBD O
the DT O
amount NN O
of IN O
PI NNP B-NP
kinase NN I-NP
activity NN O
detected VBD O
in IN O
anti-IRS-1 JJ B-NP
immunoprecipitates NNS O
. . O

-DOCSTART- X X O

Twelve CD O
(92 CD O
% NN O
) -RRB- O
showed VBD O
cognitive JJ O
dysfunction NN O
including VBG O
impairments NNS O
in IN O
memory NN O
, , O
attention NN O
, , O
and CC O
affective JJ O
disturbances NNS O
( -LRB- O
anxiety NN O
, , O
depression NN O
, , O
irritability NN O
, , O
and CC O
poor JJ O
frustration NN O
tolerance NN O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
effects NNS O
were VBD O
antagonized VBN O
by IN O
prior JJ O
administration NN O
of IN O
1-(2-methoxyphenyl)-4-[-(2-phthalimido JJ O
)butyl]piperazine NN O
) -RRB- O
( -LRB- O
0.5 CD O
mg/kg NN O
, , O
i.p. NN O
) -RRB- O
. . O

-DOCSTART- X X O

Transcription NNP O
initiation NN O
from IN O
this DT O
region NN O
was VBD O
also RB O
detected VBN O
in IN O
vivo NN O
, , O
when WRB O
the DT O
cloned VBN O
rRNA NNP O
gene NN O
cluster NN O
was VBD O
present JJ O
on IN O
a DT O
multi-copy JJ O
plasmid NN O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
dopamine NN O
and CC O
of IN O
dopamine NN B-NP
D2 NN I-NP
receptor NN I-NP
blocker NN O
haloperidol NN O
on IN O
the DT O
activity NN O
of IN O
carotid NN O
chemoreceptors NNS O
were VBD O
studied VBN O
in IN O
24 CD O
anesthetized VBN O
, , O
paralyzed JJ O
and CC O
artificially RB O
ventilated VBD O
newborn JJ O
kittens NNS O
aged VBN O
0-17 CD O
days NNS O
. . O

-DOCSTART- X X O

DNMT2 NNP B-NP
binds NNS O
AdoHcy NNP O
in IN O
the DT O
same JJ O
conformation NN O
as IN O
confirmed VBN O
m( NN B-NP
5)C IN I-NP
MTases NNS I-NP
and CC O
, , O
while IN O
DNMT2 NNP B-NP
shares NNS O
all DT O
sequence NN O
and CC O
structural JJ O
features NNS O
with IN O
m( JJ B-NP
5)C JJ I-NP
MTases NNS I-NP
, , O
it PRP O
has VBZ O
failed VBN O
to TO O
demonstrate VB O
detectable JJ O
transmethylase NN O
activity NN O
. . O

-DOCSTART- X X O

The DT O
standardized JJ O
incidence NN O
in IN O
Europeans NNS O
has VBZ O
risen VBN O
significantly RB O
to TO O
4.7/10(5 CD O
)/year NN O
from IN O
3.4/10(5 CD O
)/year NN O
in IN O
the DT O
1970s NNS O
( -LRB- O
chi NN O
2 CD O
= SYM O
8.1 CD O
, , O
p RB O
less JJR O
than IN O
0.005 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Multiple JJ O
aortic JJ O
thrombi NN O
associated VBN O
with IN O
protein NN B-NP
C NNP I-NP
and CC O
S NNP B-NP
deficiency NN O
. . O

-DOCSTART- X X O

The DT O
practice NN O
of IN O
measuring VBG O
of IN O
AChE NNP B-NP
levels NNS O
in IN O
acute JJ O
poisoning NN O
is VBZ O
limited VBN O
. . O

-DOCSTART- X X O

M. NNP O
, , O
Adrich NNP O
, , O
Z. NNP O
, , O
Fournet NNP O
, , O
B. NNP O
, , O
Capon NNP O
, , O
C. NNP O
, , O
Bonicel NNP O
, , O
J. NNP O

-DOCSTART- X X O

Confocal NNP O
fluorescent JJ O
microscopy NN O
analysis NN O
demonstrated VBN O
that IN O
WT NNP O
, , O
VaI NNP O
, , O
and CC O
VaII NNP O
all DT O
distribute VBP O
equally RB O
to TO O
the DT O
cell NN O
surface NN O
while NN O
, , O
as IN O
expected VBN O
, , O
a DT O
WT NNP O
mutant NN O
lacking VBG O
the DT O
two CD O
C-terminal JJ O
valine NN O
residues NNS O
does VBZ O
not RB O
. . O

-DOCSTART- X X O

The DT O
amount NN O
of IN O
ERCC1 NNP B-NP
detectable NN O
by IN O
immunoblotting NN O
is VBZ O
reduced VBN O
in IN O
group NN O
1 CD O
, , O
group NN O
4 CD O
and CC O
XP-F NNP O
extracts NNS O
. . O

-DOCSTART- X X O

Letter NNP O
: : O
Ballistocardiography NN O
. . O

-DOCSTART- X X O

Metabolic NNP O
studies NNS O
of IN O
tetrabenazine NN O
, , O
a DT O
psychotropic JJ O
drug NN O
in IN O
animals NNS O
and CC O
man NN O
. . O

-DOCSTART- X X O

Gene NNP O
transcripts NNS O
are VBP O
detected VBN O
on IN O
tissues NNS O
such JJ O
as IN O
bovine JJ O
liver NN O
, , O
kidney NN O
, , O
lung NN O
, , O
and CC O
brain NN O
. . O

-DOCSTART- X X O

Plasma NNP B-NP
enteroglucagon NN I-NP
was VBD O
measured VBN O
before IN O
and CC O
during IN O
three CD O
hours NNS O
after IN O
a DT O
standard JJ O
meal NN O
in IN O
21 CD O
untreated JJ O
adult NN O
patients NNS O
with IN O
suspected JJ O
coeliac JJ O
disease NN O
who WP O
all PDT O
had VBD O
villous JJ O
atrophy NN O
of IN O
the DT O
small JJ O
intestinal JJ O
mucosa NN O
and CC O
malabsorption NN O
, , O
and CC O
in IN O
nine CD O
control NN O
subjects NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
report NN O
, , O
we PRP O
establish VBP O
that IN O
the DT O
heteromeric JJ O
CCAAT-binding JJ B-NP
factor NN I-NP
CBF NN B-NP
is VBZ O
the DT O
major JJ O
component NN O
of IN O
the DT O
C1-binding JJ B-NP
factor NN I-NP
( -LRB- O
C1F NN B-NP
) -RRB- O
in IN O
human JJ O
cells NNS O
. . O

-DOCSTART- X X O

This DT O
growth-inhibitory JJ O
effect NN O
was VBD O
suppressed VBN O
by IN O
the DT O
mpk1 JJ B-NP
delta NN I-NP
mutation NN O
, , O
suggesting VBG O
that IN O
hyperactivation NN O
of IN O
the DT O
Mpk1 NNP B-NP
pathway NN O
is VBZ O
toxic JJ O
to TO O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
PAX8 NNP I-NP
gene NN I-NP
generates VBZ O
at IN O
least JJS O
five CD O
different JJ O
alternatively NN O
spliced VBD O
transcripts NNS O
encoding VBG O
different JJ O
PAX8 NNS B-NP
isoforms NNS I-NP
. . O

-DOCSTART- X X O

The DT O
use NN O
of IN O
specific JJ O
somatic JJ O
cell NN O
hybrids NNS O
have VBP O
allowed VBN O
us PRP O
to TO O
locate VB O
the DT O
YAC NNP O
contig NN O
telomeric NN O
to TO O
the DT O
D3F15S2 NNP B-NP
locus NN I-NP
, , O
in IN O
a DT O
region NN O
which WDT O
is VBZ O
frequently RB O
deleted VBN O
in IN O
lung NN O
carcinomas NNS O
. . O

-DOCSTART- X X O

Characterization NNP O
of IN O
Chlamydomonas NNP O
reinhardtii NNP O
zygote-specific JJ O
cDNAs NNS O
that IN O
encode JJ O
novel NN O
proteins NNS O
containing VBG O
ankyrin IN B-NP
repeats NNS O
and CC O
WW NNP O
domains NNS O
. . O

-DOCSTART- X X O

Subsequent JJ O
analysis NN O
revealed VBN O
that IN O
MyD88 CD B-NP
possesses NNS O
a DT O
unique JJ O
modular JJ O
structure NN O
, , O
which WDT O
consists VBZ O
of IN O
an DT O
N-terminal JJ O
"death NN O
domain NN O
, , O
" '' O
similar JJ O
to TO O
the DT O
intracellular JJ O
segments NNS O
of IN O
TNF NN B-NP
receptor NN I-NP
1 CD I-NP
and CC O
Fas NNP B-NP
, , O
and CC O
a DT O
C-terminal JJ O
region NN O
related VBN O
to TO O
the DT O
cytoplasmic JJ O
domains NNS O
of IN O
the DT O
Drosophila NNP B-NP
morphogen NN I-NP
Toll NNP I-NP
and CC O
vertebrate JJ O
interleukin-1 JJ B-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

Role NNP O
of IN O
zinc-finger JJ B-NP
proteins NNS I-NP
Sp1 . I-NP
and CC O
zif268/egr-1 JJ B-NP
in IN O
transcriptional JJ O
regulation NN O
of IN O
the DT O
human JJ B-NP
synaptobrevin NN I-NP
II NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
GvpE NNP B-NP
protein NN I-NP
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
gas NN O
vesicles NNS O
synthesis NN O
in IN O
halophilic JJ O
archaea NN O
has VBZ O
been VBN O
identified VBN O
as IN O
the DT O
transcriptional JJ O
activator NN O
for IN O
the DT O
promoter NN O
located VBN O
upstream RB O
of IN O
the DT O
gvpA NNP B-NP
gene NN I-NP
encoding VBG O
the DT O
major JJ O
gas NN O
vesicle NN O
structural JJ O
protein NN O
GvpA. . B-NP

-DOCSTART- X X O

Experience NN O
in IN O
using VBG O
the DT O
Romashka-1 JJ O
laser NN O
surgical JJ O
unit NN O
in IN O
treating VBG O
suppurative NN O
wounds NNS O

-DOCSTART- X X O

At IN O
a DT O
cutoff NN O
point NN O
for IN O
KISA NNP O
% NN O
of IN O
100 CD O
, , O
280 CD O
of IN O
281 CD O
participants NNS O
(99.6 VBP O
% NN O
) -RRB- O
were VBD O
correctly RB O
classified VBN O
. . O

-DOCSTART- X X O

The DT O
AP-1 NNP B-NP
recruited VBD O
by IN O
ARF1.GTP NN B-NP
is VBZ O
released VBN O
from IN O
the DT O
Golgi NNP O
membrane NN O
by IN O
treatment NN O
with IN O
1 CD O
M NNP O
Tris-HCl NNP O
( -LRB- O
pH NN O
7 CD O
) -RRB- O
or CC O
upon IN O
reincubation NN O
at IN O
37 CD O
degreesC NN O
, , O
whereas IN O
AP-1 NNP B-NP
recruited VBD O
with IN O
GTPgammaS NNP O
or CC O
by IN O
a DT O
constitutively RB O
active JJ O
point NN O
mutant NN O
, , O
ARF1( NNP B-NP
Q71L) NNP I-NP
, , O
remains VBZ O
membrane NN O
bound VBN O
after IN O
either DT O
treatment NN O
. . O

-DOCSTART- X X O

In IN O
K562 NNP O
cells NNS O
, , O
using VBG O
the DT O
bicistronic JJ O
vector NN O
, , O
selection NN O
with IN O
colchicine NN O
led VBN O
to TO O
at IN O
least JJS O
20-fold JJ O
higher JJR O
expression NN O
of IN O
the DT O
MDR1 NNP B-NP
gene NN I-NP
product NN I-NP
than IN O
did VBD O
selection NN O
with IN O
G418 PRP O
, , O
suggesting VBG O
that IN O
the DT O
stringent JJ O
MDR1 NNP B-NP
selection NN O
system NN O
is VBZ O
very RB O
efficient JJ O
for IN O
obtaining VBG O
overexpression NN O
of IN O
foreign JJ O
genes NNS O
. . O

-DOCSTART- X X O

A DT O
surge NN O
in IN O
the DT O
rate NN O
of IN O
ascorbyl NN O
radical JJ O
production NN O
, , O
directly RB O
correlated VBN O
with IN O
oxyradical JJ O
stress NN O
and CC O
an DT O
abrupt JJ O
fall NN O
in IN O
superoxide NN B-NP
dismutase NN I-NP
activity NN O
in IN O
the DT O
granuloma NN O
, , O
indicates VBZ O
'switching JJ O
on IN O
' '' O
of IN O
a DT O
free JJ O
radical-dependent JJ O
machinery NN O
for IN O
the DT O
formation NN O
of IN O
granuloma NN O
after IN O
vasectomy NN O
. . O

-DOCSTART- X X O

The DT O
vaccine NN O
was VBD O
highly RB O
immunogenic JJ O
, , O
since IN O
111 CD O
of IN O
113 CD O
patients NNS O
(98 VBD O
% NN O
) -RRB- O
produced VBN O
anti-HBs JJ B-NP
( -LRB- O
10 CD O
mIU/ml NN O
or CC O
more JJR O
) -RRB- O
. . O

-DOCSTART- X X O

Papillomavirus NN O
type NN O
16 CD O
oncogenes NNS O
downregulate JJ O
expression NN O
of IN O
interferon-responsive JJ B-NP
genes NNS O
and CC O
upregulate JJ O
proliferation-associated JJ O
and CC O
NF-kappaB-responsive JJ B-NP
genes NNS O
in IN O
cervical JJ O
keratinocytes NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
show VBP O
that IN O
a DT O
combination NN O
of IN O
Pfu NNP B-NP
exo(-) NN I-NP
at IN O
the DT O
primer JJ O
extension NN O
step NN O
and CC O
Taq NNP B-NP
at IN O
the DT O
PCR NN O
amplification IN O
step NN O
is VBZ O
ideal JJ O
for IN O
in IN O
vivo JJ O
DNA NN O
analysis NN O
and CC O
DNA NN O
damage NN O
mapping NN O
using VBG O
LMPCR. . O

-DOCSTART- X X O

KU-1257 CC O
also RB O
significantly RB O
accelerated VBD O
the DT O
healing NN O
of IN O
acetic JJ O
acid-induced JJ O
duodenal JJ O
ulcers NNS O
as RB O
well RB O
as IN O
famotidine JJ O
and CC O
roxatidine JJ O
acetate NN O
. . O

-DOCSTART- X X O

Prolongation NN O
of IN O
prothrombin NN B-NP
time NN O
was VBD O
not RB O
due JJ O
to TO O
depletion NN O
of IN O
vitamin NN O
K-dependent JJ O
coagulation NN O
factors NNS O
or CC O
manifest JJ O
fibrinolysis NN O
, , O
but CC O
due JJ O
to TO O
the DT O
presence NN O
of IN O
circulating VBG O
fibrinogen NN B-NP
fibrinmonomer-FDP JJ I-NP
complexes NNS O
. . O

-DOCSTART- X X O

Clostridium NNP O
botulinum NN O
in IN O
marine NN O
sediment NN O

-DOCSTART- X X O

Upstream NNP B-NP
stimulatory JJ I-NP
factor NN I-NP
USF NNP B-NP
is VBZ O
a DT O
human JJ O
transcriptional JJ O
activation NN O
factor NN O
, , O
which WDT O
uses VBZ O
a DT O
basic/helix-loop-helix/ JJ O
leucin NN O
zipper NN O
( -LRB- O
b/HLH/Z NN O
) -RRB- O
motif NN O
to TO O
homodimerize VB O
and CC O
recognize VB O
specific JJ O
sequences NNS O
in IN O
the DT O
promoter NN O
region NN O
of IN O
both DT O
nuclear JJ O
and CC O
viral JJ O
genes NNS O
transcribed VBN O
by IN O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
. . O

-DOCSTART- X X O

Fusion NN O
of IN O
mouse NN B-NP
CD8+ IN I-NP
class NN B-NP
I PRP I-NP
MHC-restricted JJ I-NP
T NNP O
cells NNS O
with IN O
the DT O
BW5147 NNP O
thymoma NN O
invariably RB O
yields VBZ O
CD8- DT B-NP
hybridomas NNS O
in IN O
which WDT O
RNA NNP O
transcribed VBD O
from IN O
the DT O
CD8 NN B-NP
alpha NN I-NP
( -LRB- O
Lyt-2 NN B-NP
) -RRB- O
gene NN O
is VBZ O
undetectable JJ O
. . O

-DOCSTART- X X O

Consistent NN O
with IN O
this DT O
hypothesis NN O
, , O
alpha1-PDX JJ B-NP
prevents VBZ O
cleavage NN O
of IN O
BMP-4 NNP B-NP
in IN O
an DT O
oocyte NN O
translation NN O
assay NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
we PRP O
cloned VBD O
the DT O
cDNA NN O
of IN O
AD1 NNP B-NP
Ag NNP I-NP
from IN O
a DT O
rat NN O
basophilic NN O
leukemia NN O
2H3 IN O
cDNA DT O
library NN O
. . O

-DOCSTART- X X O

Several JJ O
sequences NNS O
resembling VBG O
binding JJ O
sites NNS O
for IN O
liver- NNS O
and CC O
fat JJ O
body-specific JJ O
transcription NN O
factors NNS O
were VBD O
identified VBN O
within IN O
1 CD O
kb NN O
upstream RB O
and CC O
downstream RB O
of IN O
the DT O
gene NN O
. . O

-DOCSTART- X X O

Root NNP O
surface NN O
caries NNS O
incidence NN O
in IN O
the DT O
groups NNS O
inoculated VBN O
with IN O
A. NN O
viscosus NN O
and CC O
A. NN O
viscosus NN O
plus CC O
S. NNP O
sobrinus NNPS O
did VBD O
not RB O
differ VB O
. . O

-DOCSTART- X X O

The DT O
prgX JJ B-NP
gene NN I-NP
is VBZ O
adjacent JJ O
to TO O
prgQ VB B-NP
which WDT O
provides VBZ O
the DT O
promoter NN O
for IN O
prgB NN B-NP
expression NN O
. . O

-DOCSTART- X X O

Frequency NN O
of IN O
recurrence NN O
of IN O
fibroids NNS O
after IN O
myomectomy NN O
has VBZ O
been VBN O
evaluated VBN O
in IN O
145 CD O
women NNS O
( -LRB- O
median NN O
age NN O
38 CD O
years NNS O
, , O
range NN O
21-52 CD O
) -RRB- O
who WP O
underwent IN O
myomectomy NN O
. . O

-DOCSTART- X X O

There EX O
is VBZ O
a DT O
good JJ O
correlation NN O
between IN O
the DT O
occurrence NN O
in IN O
any DT O
particular JJ O
vascular JJ O
segment NN O
of IN O
the DT O
transient JJ O
contractile JJ O
response NN O
and CC O
intrinsic JJ O
tone NN O
as IN O
assessed VBN O
by IN O
relaxation NN O
to TO O
papaverine NN O
( -LRB- O
10(-6 CD O
) -RRB- O
M NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
antimicrobial JJ O
of IN O
choice NN O
for IN O
initial JJ O
prophylactic JJ O
therapy NN O
among IN O
asymptomatic JJ O
pregnant JJ O
women NNS O
exposed VBN O
to TO O
Bacillus NNP O
anthracis NNPS O
is VBZ O
ciprofloxacin CD O
, , O
500 CD O
mg NN O
twice RB O
a DT O
day NN O
for IN O
60 CD O
days NNS O
. . O

-DOCSTART- X X O

Nickel NNP O
release NN O
from IN O
tools NNS O
on IN O
the DT O
Swedish JJ O
market NN O
. . O

-DOCSTART- X X O

There EX O
was VBD O
no DT O
correlation NN O
between IN O
starting VBG O
platelet-associated VBN O
IgG NNP B-NP
levels NNS O
or CC O
changes NNS O
in IN O
platelet-associated JJ O
IgG NNP B-NP
levels NNS O
with IN O
therapy NN O
and CC O
the DT O
increment NN O
in IN O
the DT O
patient NN O
's POS O
platelet NN O
count NN O
. . O

-DOCSTART- X X O

In IN O
a DT O
rat NN O
model NN O
of IN O
SAH NNP O
, , O
we PRP O
assessed VBD O
BBB NNP O
changes NNS O
by IN O
means NNS O
of IN O
the DT O
quantitative JJ O
[14C]-alpha-aminoisobutyric JJ O
acid NN O
technique NN O
. . O

-DOCSTART- X X O

BAG-1 NN B-NP
also RB O
prevented VBN O
growth NN O
arrest NN O
following VBG O
UV-irradiation-induced JJ O
genotoxic JJ O
injury NN O
without IN O
interfering VBG O
with IN O
accumulation NN O
of IN O
p53 NN B-NP
protein NN I-NP
or CC O
p21(waf-1 NN B-NP
) -RRB- O
expression NN O
. . O

-DOCSTART- X X O

During IN O
the DT O
last JJ O
three CD O
days NNS O
of IN O
the DT O
study NN O
, , O
mean VBP O
urine NN O
osmolality NN O
( -LRB- O
Uosm NN O
) -RRB- O
and CC O
free JJ O
water NN O
reabsorption NN O
(TCH2O NN O
) -RRB- O
increased VBN O
significantly RB O
: : O
[formula NN O
: : O
see VB O
text] NN O
. . O

-DOCSTART- X X O

[(OP)2Cu] JJ O
+ NNS O
also RB O
detected VBD O
protections NNS O
in IN O
the DT O
C NNP O
alpha-helix NN O
, , O
the DT O
interdomain JJ O
hinge NN O
, , O
and CC O
beta-strands NNS O
2-7. . O

-DOCSTART- X X O

The DT O
gene NN O
, , O
from IN O
the DT O
initiator NN O
methionine NN O
to TO O
the DT O
polyadenylation NN O
site NN O
, , O
is VBZ O
contained VBN O
within IN O
13 CD O
244 CD O
basepairs NNS O
and CC O
contains VBZ O
19 CD O
exons NNS O
. . O

-DOCSTART- X X O

To TO O
study VB O
structural JJ O
diversity NN O
of IN O
the DT O
three CD O
homologous JJ O
loci NNS O
encoding VBG O
a DT O
KN1-like JJ B-NP
homeobox NN I-NP
protein NN I-NP
in IN O
the DT O
hexaploid JJ O
wheat NN O
genome NN O
, , O
we PRP O
isolated VBD O
clones NNS O
from IN O
a DT O
cDNA JJ O
library NN O
of IN O
young JJ O
spikes NNS O
of IN O
Japanese JJ O
common JJ O
wheat NN O
cultivar NN O
' POS O
Norin NNP O
26' CD O
. . O

-DOCSTART- X X O

Controversy NNP O
exists VBZ O
regarding VBG O
both DT O
the DT O
natural JJ O
life NN O
cycle NN O
for IN O
this DT O
parasite NN O
as RB O
well RB O
as IN O
the DT O
species NN O
identity NN O
of IN O
opossum NN O
Sarcocystis NNP O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
report VBP O
that IN O
components NNS O
of IN O
the DT O
Ras/Raf/MAPK NNP B-NP
pathway NN O
are VBP O
constitutively RB O
activated VBN O
in IN O
these DT O
lck-transformed JJ B-NP
immature JJ O
thymoblasts NNS O
. . O
p56(lck NN B-NP
) -RRB- O
utilizes VBZ O
Shc NNP B-NP
and CC O
Grb2 NNP B-NP
adaptors NNS I-NP
to TO O
mediate VB O
activation NN O
of IN O
p21(ras NNS B-NP
) -RRB- O
in IN O
the DT O
thymoblast JJ O
lines NNS O
by IN O
promoting VBG O
tyrosine FW O
phosphorylation NN O
of IN O
the DT O
Shc JJ B-NP
protein NN I-NP
and CC O
constitutive JJ O
interaction NN O
between IN O
Shc NNP B-NP
and CC O
Grb2 NNP B-NP
. . O

-DOCSTART- X X O

Unfractionated JJ O
heparin NN O
( -LRB- O
UFH) NNP O
given VBN O
at IN O
a DT O
dose NN O
of IN O
0.3 CD O
mg NN O
x NN O
kg-1 NN O
bolus NN O
+ VBD O
0.3 CD O
mg NN O
x NN O
kg-1 NN O
x NN O
h-1 NN O
infusion NN O
did VBD O
not RB O
improve VB O
the DT O
incidence NN O
of IN O
reperfusion NN O
or CC O
lower JJR O
the DT O
incidence NN O
of IN O
reocclusion NN O
. . O

-DOCSTART- X X O

The DT O
quantification NN O
limit NN O
was VBD O
50 CD O
ng/ml NN O
for IN O
each DT O
of IN O
PHT NNP O
, , O
m-HPPH JJ O
and CC O
p-HPPH. PRP$ O

-DOCSTART- X X O

Plasma NNP B-NP
hemopexin NN I-NP
homeostasis NN O
during IN O
the DT O
acute JJ O
phase NN O
response NN O
. . O

-DOCSTART- X X O

Our PRP$ O
aim NN O
was VBD O
to TO O
check VB O
whether IN O
, , O
during IN O
PG-DS NNP O
administration NN O
, , O
serum JJ O
lipase NN B-NP
activity NN O
changes NNS O
simultaneously RB O
with IN O
serum NN O
amylase NN B-NP
activity NN O
, , O
and CC O
, , O
if IN O
so RB O
, , O
what WP O
the DT O
reason NN O
is VBZ O
for IN O
the DT O
detected VBN O
change NN O
. . O

-DOCSTART- X X O

Cytokines NNS O
and CC O
steroid NN O
hormones NNS O
use VBP O
different JJ O
sets NNS O
of IN O
signal NN O
transduction NN O
pathways NNS O
, , O
which WDT O
seem VBP O
to TO O
be VB O
unrelated JJ O
. . O

-DOCSTART- X X O

This DT O
is VBZ O
the DT O
most RBS O
northern JJ O
and CC O
, , O
at IN O
the DT O
same JJ O
time NN O
largest JJS O
, , O
Q NN O
fever NN O
epidemic JJ O
recorded VBN O
in IN O
Germany NNP O
over IN O
the DT O
last JJ O
28 CD O
years NNS O
. . O

-DOCSTART- X X O

Genetic JJ O
analysis NN O
of IN O
the DT O
role NN O
of IN O
herpes NNS B-NP
simplex JJ I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
glycoprotein NN I-NP
K NNP I-NP
in IN O
infectious JJ O
virus NN O
production NN O
and CC O
egress NN O
. . O

-DOCSTART- X X O

The DT O
5' JJ O
half NN O
of IN O
the DT O
EWS NNP B-NP
gene NN I-NP
has VBZ O
recently RB O
been VBN O
described VBN O
to TO O
be VB O
fused VBN O
to TO O
the DT O
3' JJ O
regions NNS O
of IN O
genes NNS O
encoding VBG O
the DT O
DNA-binding JJ O
domain NN O
of IN O
several JJ O
transcriptional JJ O
regulators NNS O
, , O
including VBG O
ATF1 NNP B-NP
, , O
FLI-1 NNP B-NP
, , O
and CC O
ERG NNP B-NP
, , O
in IN O
several JJ O
human JJ O
tumors NNS O
. . O

-DOCSTART- X X O

We PRP O
used VBD O
high-resolution JJ O
ultrasound NN O
to TO O
characterize VB O
postprandial JJ O
antral JJ O
excursion NN O
characteristics NNS O
in IN O
15 CD O
healthy JJ O
volunteers NNS O
. . O

-DOCSTART- X X O

Multivariable JJ O
logistic JJ O
regression NN O
showed VBD O
that IN O
mean JJ O
blood NN O
glucose NN O
level NN O
for IN O
the DT O
first JJ O
2 CD O
days NNS O
( -LRB- O
p NN O
= SYM O
0.002 CD O
) -RRB- O
, , O
obesity NN O
( -LRB- O
p NN O
< JJ O
0.002 CD O
) -RRB- O
, , O
and CC O
use NN O
of IN O
the DT O
internal JJ O
mammary NN O
artery NN O
( -LRB- O
p NN O
< JJ O
0.02 CD O
) -RRB- O
were VBD O
all DT O
independent JJ O
predictors NNS O
of IN O
deep JJ O
wound NN O
infection NN O
. . O

-DOCSTART- X X O

Fine JJ O
tangled JJ O
pili NNS O
expressed VBN O
by IN O
Haemophilus NNP O
ducreyi NNS O
are VBP O
a DT O
novel JJ O
class NN O
of IN O
pili NNS O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
The DT O
RRM NN O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
common JJ O
and CC O
best RB O
characterized VBN O
RNA-binding JJ O
motifs NNS O
. . O

-DOCSTART- X X O

Serum NN O
levels NNS O
of IN O
total NN O
and CC O
specific JJ B-NP
immunoglobulin NN I-NP
E NNP I-NP
( -LRB- O
IgE NN B-NP
) -RRB- O
have VBP O
been VBN O
determined VBN O
by IN O
radioimmunoassays NNP O
in IN O
sixty-nine CD O
allergic JJ O
subjects NNS O
. . O

-DOCSTART- X X O

The DT O
largest JJS O
one NN O
probably RB O
corresponds VBZ O
to TO O
the DT O
precursor JJ O
form NN O
of IN O
PS2 NNP B-NP
in IN O
E. NNP O
coli NNS O
. . O

-DOCSTART- X X O

The DT O
identification NN O
of IN O
SRP54sc NNP B-NP
and CC O
SRP54sp NNP B-NP
provides VBZ O
the DT O
first JJ O
evidence NN O
for IN O
SRP NNP B-NP
related JJ O
proteins NNS O
in IN O
yeast NN O
. . O

-DOCSTART- X X O

Urease NN B-NP
activity NN O
, , O
judged VBN O
as IN O
the DT O
amount NN O
of IN O
ammonia NN O
production NN O
from IN O
urea NN O
, , O
could MD O
be VB O
measured VBN O
at IN O
25 CD O
ng NN O
per IN O
tube NN O
( -LRB- O
S/N NNP O
= SYM O
1.5 CD O
) -RRB- O
with IN O
Jack NNP B-NP
bean NN I-NP
meal NN I-NP
urease NN I-NP
. . O

-DOCSTART- X X O

In IN O
a DT O
previous JJ O
study NN O
of IN O
transforming VBG B-NP
growth NN I-NP
factor-beta1-mediated JJ I-NP
inhibition NN O
of IN O
the DT O
cyclin NN B-NP
A DT I-NP
promoter NN I-NP
, , O
we PRP O
mapped VBD O
the DT O
inhibitory JJ O
effect NN O
to TO O
the DT O
ATF NNP B-NP
site NN I-NP
; : O
in IN O
the DT O
present JJ O
study NN O
of IN O
IFN-gamma NNP B-NP
treatment NN O
, , O
functional JJ O
analysis NN O
by IN O
transient NN O
transfection NN O
showed VBD O
that IN O
inhibition NN O
of IN O
the DT O
cyclin NN B-NP
A DT I-NP
promoter NN I-NP
persisted VBD O
despite IN O
mutation NN O
of IN O
the DT O
ATF NNP B-NP
, , O
NF-Y NNP B-NP
, , O
or CC O
CDE NNP O
elements NNS O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
GCNF NNP B-NP
binds NNS O
to TO O
one CD O
of IN O
the DT O
two CD O
DRO NNP O
sequences NNS O
in IN O
the DT O
Prm1 NNP B-NP
promoter NN I-NP
, , O
and CC O
to TO O
the DT O
DRO NNP O
sequence NN O
in IN O
the DT O
Prm2 NNP B-NP
promoter NN I-NP
in IN O
a DT O
specific JJ O
manner NN O
. . O

-DOCSTART- X X O

From IN O
1977 CD O
to TO O
1985 CD O
, , O
42 CD O
patients NNS O
with IN O
squamous JJ O
cell NN O
carcinoma NN O
of IN O
the DT O
anal NN O
canal NN O
were VBD O
treated VBN O
with IN O
mitomycin NN O
C NNP O
( -LRB- O
15 CD O
mg/m2 NN O
) -RRB- O
and CC O
5-fluorouracil JJ O
( -LRB- O
750 CD O
mg/m2 NN O
) -RRB- O
on IN O
day NN O
1 CD O
, , O
5-FU JJ O
( -LRB- O
750 CD O
mg/m2/d NN O
) -RRB- O
alone RB O
on IN O
days NNS O
2 CD O
to TO O
5 CD O
, , O
and CC O
radiation NN O
therapy NN O
( -LRB- O
3000 CD O
cGy NN O
) -RRB- O
on IN O
days NNS O
7 CD O
to TO O
28 CD O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
choline NN O
magnesium NN O
trisalicylate NN O
on IN O
prostacyclin NN O
production NN O
by IN O
isolated JJ O
vascular JJ O
tissue NN O
of IN O
the DT O
rat NN O
. . O

-DOCSTART- X X O

The DT O
magnitude NN O
of IN O
all DT O
four CD O
parameters NNS O
increased VBN O
in IN O
an DT O
exponential JJ O
fashion NN O
with IN O
increasing VBG O
sperm NN O
number NN O
up IN O
to TO O
400 CD O
x NN O
10(6 CD O
) -RRB- O
per IN O
ejaculate NN O
. . O

-DOCSTART- X X O

In IN O
HMEC NNP O
stably RB O
transfected VBD O
with IN O
an DT O
ER NN B-NP
mutant NN I-NP
containing VBG O
a DT O
deletion NN O
in IN O
the DT O
second JJ O
zinc NN O
finger NN O
of IN O
the DT O
DNA-binding JJ O
domain NN O
, , O
E NNP O
and CC O
HT NNP O
had VBD O
different JJ O
effects NNS O
on IN O
EBBP NNP B-NP
gene NN I-NP
expression NN O
; : O
EBBP NNP B-NP
regulation NN O
by IN O
E NNP O
was VBD O
dramatically RB O
reduced VBN O
while IN O
the DT O
effects NNS O
of IN O
HT NNP O
were VBD O
augmented VBN O
. . O

-DOCSTART- X X O

6 CD O
h NN O
after IN O
ingestion NN O
of IN O
aspirin NN O
on IN O
day NN O
1 CD O
to TO O
day NN O
14 CD O
, , O
both DT O
TX NNP O
and CC O
PGI2 NNP O
levels NNS O
also RB O
significantly RB O
decreased VBD O
( -LRB- O
p NN O
< JJ O
0.0001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

NF-kappaB NNP B-NP
DNA-protein NNP O
binding NN O
and CC O
ICAM-1 JJ B-NP
promoter NN I-NP
activity NN O
were VBD O
enhanced VBN O
by IN O
IL-1beta JJ B-NP
and CC O
these DT O
effects NNS O
were VBD O
inhibited VBN O
by IN O
tyrphostin NN O
23 CD O
, , O
but CC O
not RB O
by IN O
PD NNP O
98059 CD O
or CC O
SB NNP O
203580 CD O
. . O

-DOCSTART- X X O

In IN O
murine NN O
cells NNS O
, , O
FPGS NNP B-NP
expression NN O
is VBZ O
controlled VBN O
by IN O
two CD O
promoters NNS O
that IN O
, , O
as IN O
we PRP O
show VBP O
here RB O
, , O
vary VBP O
substantially RB O
in IN O
their PRP$ O
efficiency NN O
, , O
at IN O
least JJS O
in IN O
the DT O
context NN O
of IN O
a DT O
reporter NN O
gene NN O
assay NN O
. . O

-DOCSTART- X X O

Quantitative JJ O
measurement NN O
of IN O
antigamma DT B-NP
globulin NN I-NP
factors NNS I-NP
( -LRB- O
rheumatoid NN B-NP
factors NNS I-NP
) -RRB- O
using VBG O
laser-nephelometry NN O
in IN O
comparison NN O
with IN O
the DT O
latex JJ O
agglutination NN O
test NN O
and CC O
the DT O
Waaler-Rose NNP O
test NN O

-DOCSTART- X X O

The DT O
complete JJ O
nucleotide JJ O
sequence NN O
of IN O
odontoglossum NN O
ringspot NN O
virus NN O
( -LRB- O
Cy-1 JJ O
strain NN O
) -RRB- O
genomic JJ O
RNA NNP O
. . O

-DOCSTART- X X O

The DT O
B. NNP B-NP
aphidicola NN I-NP
argS-rrn JJ I-NP
DNA NN I-NP
fragments NNS I-NP
from IN O
endosymbionts NNS O
from IN O
seven CD O
species NNS O
of IN O
aphids NNS O
had VBD O
promoter NN O
activities NNS O
in IN O
E. NNP O
coli NNS O
which WDT O
ranged VBD O
from IN O
6 CD O
to TO O
135 CD O
% NN O
of IN O
that DT O
observed VBN O
with IN O
a DT O
comparable JJ O
DNA NN O
fragment NN O
of IN O
E. NNP B-NP
coli NNS I-NP
rrnB. . I-NP

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
These DT O
principally RB O
structural JJ O
studies NNS O
support VBP O
the DT O
hypothesis NN O
that IN O
the DT O
thrombus NN O
is VBZ O
a DT O
self-sustaining JJ O
entity NN O
that WDT O
may MD O
have VB O
significance NN O
in IN O
the DT O
pathophysiologic NN O
mechanism NN O
of IN O
abdominal JJ O
aortic JJ O
aneurysms NNS O
. . O

-DOCSTART- X X O

The DT O
authors NNS O
report VBP O
about IN O
the DT O
exeresis NN O
of IN O
a DT O
pyelonephrictic NN O
left VBN O
small JJ O
kidney NN O
with IN O
laparoscopic NN O
surgery NN O
. . O

-DOCSTART- X X O

AMPK NNP B-NP
is VBZ O
a DT O
heterotrimer NN O
composed VBN O
of IN O
a DT O
catalytic JJ O
subunit NN O
( -LRB- O
alpha NN O
) -RRB- O
and CC O
two CD O
regulatory JJ O
subunits NNS O
( -LRB- O
beta NN O
and CC O
gamma NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
genes NNS O
encoding VBG O
these DT O
carotenoids NNS O
in IN O
E. NNP O
herbicola CC O
Eho13 NNP O
are VBP O
clustered VBN O
in IN O
a DT O
7 CD O
kb JJ O
DNA NN O
fragment NN O
. . O

-DOCSTART- X X O

Genetic JJ O
diagnosis NN O
of IN O
respiratory JJ O
diseases NNS O

-DOCSTART- X X O

Whereas IN O
mutant JJ B-NP
6C4 CD I-NP
specified VBN O
a DT O
wild-type-size JJ B-NP
Pol NNP I-NP
protein NN I-NP
, , O
we PRP O
detected VBD O
no DT O
full-length JJ B-NP
Pol JJ I-NP
protein NN I-NP
in IN O
7E4-infected JJ O
cell NN O
extracts NNS O
. . O

-DOCSTART- X X O

Incidence NNP O
of IN O
beta-thalassemia NN O
carriers NNS O
and CC O
those DT O
deficient JJ O
in IN O
erythrocyte NN B-NP
glucose-6-phosphate JJ I-NP
dehydrogenase NN I-NP
in IN O
the DT O
greater JJR O
Buenos NNP O
Aires NNPS O
area NN O

-DOCSTART- X X O

These DT O
transcripts NNS O
directed VBD O
the DT O
synthesis NN O
of IN O
three CD O
proteins NNS O
: : O
the DT O
virus NN B-NP
trans-activator NN I-NP
protein NN I-NP
( -LRB- O
EIAV JJ B-NP
Tat NNPS I-NP
) -RRB- O
encoded VBN O
by IN O
ORF NNP O
S1 NNP O
, , O
a DT O
protein NN O
of IN O
unknown JJ O
function NN O
encoded VBN O
by IN O
ORF NNP O
S2 NNP O
, , O
and CC O
the DT O
virus NN O
envelope NN B-NP
glycoprotein NN I-NP
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
because IN O
SB203580 PRP O
had VBD O
no DT O
effect NN O
of IN O
TNF- NNP B-NP
or CC O
ceramide-induced JJ O
apoptosis NN O
, , O
our PRP$ O
results NNS O
strongly RB O
argue VBP O
against IN O
a DT O
role NN O
for IN O
p38 DT B-NP
MAPK NNP I-NP
in IN O
the DT O
induction NN O
of IN O
TNF-- NNP B-NP
or CC O
ceramide-induced JJ O
apoptosis NN O
. . O

-DOCSTART- X X O

YACs NNS O
, , O
BACs NNP O
, , O
cosmids NNS O
, , O
and CC O
STSs NNS O
are VBP O
defined VBN O
to TO O
aid VB O
in IN O
further JJ O
study NN O
of IN O
this DT O
gene NN O
. . O

-DOCSTART- X X O

This DT O
chimera NN O
transduced VBN O
IL-4-specific JJ B-NP
signals NNS O
in IN O
response NN O
to TO O
IL-2 DT B-NP
binding NN O
and CC O
dramatically RB O
enhanced JJ O
type NN O
2 CD O
responses NNS O
( -LRB- O
IL-4 NN B-NP
, , O
IL-5 NNP B-NP
, , O
and CC O
immunoglobulin NN B-NP
E NN I-NP
production NN O
) -RRB- O
upon IN O
in IN O
vitro NN O
TCR NNP B-NP
stimulation NN O
or CC O
in IN O
vivo JJ O
antigen JJ O
challenge NN O
. . O

-DOCSTART- X X O

We PRP O
previously RB O
demonstrated VBD O
that IN O
AKT2 NNP B-NP
, , O
a DT O
member NN O
of IN O
protein NN B-NP
kinase NN I-NP
B NNP I-NP
family NN I-NP
, , O
is VBZ O
activated VBN O
by IN O
a DT O
number NN O
of IN O
growth NN O
factors NNS O
via IN O
Ras NNP B-NP
and CC O
PI NNP B-NP
3-kinase JJ I-NP
signaling NN O
pathways NNS O
. . O

-DOCSTART- X X O

This DT O
demonstrates VBZ O
the DT O
presence NN O
of IN O
a DT O
PKC-dependent JJ B-NP
pathway NN O
which WDT O
functions VBZ O
independently RB O
from IN O
Lck NNP B-NP
in IN O
MAP NNP B-NP
kinase NN I-NP
activation NN O
. . O

-DOCSTART- X X O

Finally RB O
, , O
transfection NN O
of IN O
Grb10 DT B-NP
genes NNS I-NP
with IN O
specific JJ O
mutations NNS O
in IN O
their PRP$ O
SH2 JJ B-NP
domains NNS I-NP
induces VBZ O
apoptosis NN O
in IN O
HTC-IR NNP O
and CC O
COS-7 JJ O
cells NNS O
. . O

-DOCSTART- X X O

Physical JJ O
map NN O
of IN O
the DT O
genome NN O
of IN O
sonchus RB O
yellow JJ O
net JJ O
virus NN O
, , O
a DT O
plant NN O
rhabdovirus NN O
with IN O
six CD O
genes NNS O
and CC O
conserved VBN O
gene NN O
junction NN O
sequences NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
an DT O
untested JJ O
argument NN O
that IN O
conventional JJ O
beta-adrenoceptor NN B-NP
antagonists NNS O
possess VBP O
unwanted JJ O
metabolic JJ O
effects NNS O
that WDT O
may MD O
counter VB O
some DT O
of IN O
their PRP$ O
potential JJ O
cardiac NN O
benefits NNS O
. . O

-DOCSTART- X X O

An DT O
11.5-kb JJ O
intron NN O
is VBZ O
found VBN O
at IN O
the DT O
end NN O
of IN O
transmembrane NN O
6 CD O
, , O
and CC O
the DT O
rest NN O
of IN O
the DT O
ORF NNP O
is VBZ O
in IN O
exon NN O
3. . O

-DOCSTART- X X O

To TO O
assay VB O
for IN O
sequences NNS O
that WDT O
could MD O
potentially RB O
regulate VB O
Xenopus NNP B-NP
proenkephalin NN I-NP
expression NN O
, , O
we PRP O
transfected VBD O
constructs NNS O
that WDT O
contained VBD O
upstream RB O
genomic JJ O
sequences NNS O
linked VBN O
to TO O
the DT O
CAT NN B-NP
reporter NN I-NP
gene NN I-NP
into IN O
various JJ O
eukaryotic JJ O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
also RB O
conceivable JJ O
that IN O
elevated JJ O
insulin NN B-NP
levels NNS O
may MD O
cause VB O
hypertriglyceridaemia NN O
and CC O
possibly RB O
other JJ O
abnormalities NNS O
of IN O
lipid JJ O
metabolism NN O
. . O

-DOCSTART- X X O

To TO O
quantify VB O
the DT O
normal JJ O
coupling NN O
patterns NNS O
, , O
fresh JJ O
cadaveric JJ O
human JJ O
lumbar NN O
spine NN O
specimens NNS O
( -LRB- O
L1-S1 JJ O
) -RRB- O
were VBD O
used VBN O
. . O

-DOCSTART- X X O

Deletion NNP O
mutations NNS O
were VBD O
constructed VBN O
, , O
removing VBG O
residues NNS O
2-30 CD O
, , O
31-60 CD O
, , O
61-90 CD O
, , O
and CC O
49-78 CD O
of IN O
the DT O
N-terminal JJ O
cytoplasmic JJ O
domain NN O
, , O
as RB O
well RB O
as IN O
a DT O
missense NN O
mutation NN O
of IN O
a DT O
dileucine NN O
motif NN O
. . O

-DOCSTART- X X O

Indigenous JJ O
microbial JJ O
flora NNS O
and CC O
the DT O
large JJ O
intestine NN O
in IN O
tadpoles NNS O
. . O

-DOCSTART- X X O

3 CD O
patients NNS O
with IN O
acute JJ O
leukaemia NN O
, , O
HLA NNP B-NP
antibodies NNS O
and CC O
thrombocytopenia DT O
refractory JJ O
to TO O
random JJ O
donor NN O
platelet NN O
transfusions NNS O
were VBD O
treated VBN O
with IN O
high-dose JJ O
i NN O
.v. NNP O
immunoglobulin NN B-NP
. . O

-DOCSTART- X X O

Plasma NNP B-NP
renin NN I-NP
activity NN O
in IN O
end-stage NN O
kidney NN O
disease NN O
. . O

-DOCSTART- X X O

Computer NNP O
system NN O
trains VBZ O
employees NNS O
to TO O
meet VB O
JCAHO NNP O
safety NN O
ED VBN O
requirements NNS O
. . O

-DOCSTART- X X O

All DT O
of IN O
this DT O
region NN O
is VBZ O
part NN O
of IN O
a DT O
prominent JJ O
CpG NNP O
island NN O
that WDT O
may MD O
be VB O
acting VBG O
as IN O
an DT O
extended JJ O
, , O
enhancer-independent JJ O
promoter NN O
. . O

-DOCSTART- X X O

One CD O
function NN O
of IN O
p53 NN B-NP
is VBZ O
in IN O
regulating JJ O
cell NN O
cycle NN O
check-point NN O
control NN O
after IN O
DNA NNP O
damage NN O
. . O

-DOCSTART- X X O

100 CD O
. . O

-DOCSTART- X X O

In IN O
patients NNS O
autografted VBN O
in IN O
CR1 NNP O
, , O
the DT O
transplant-related JJ O
mortality NN O
( -LRB- O
TRM NN O
) -RRB- O
was VBD O
15 CD O
+/ NN O
- : O
4 CD O
% NN O
, , O
the DT O
relapse NN O
incidence NN O
( -LRB- O
RI NNP O
) -RRB- O
was VBD O
58 CD O
+/ NN O
- : O
5 CD O
% NN O
, , O
the DT O
leukaemia-free JJ O
survival NN O
( -LRB- O
LFS NNP O
) -RRB- O
was VBD O
36 CD O
+/ NNS O
- : O
5 CD O
% NN O
and CC O
the DT O
overall JJ O
survival NN O
was VBD O
47 CD O
+/ NN O
- : O
5 CD O
% NN O
at IN O
3 CD O
years NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
H19 NNP B-NP
and CC O
IGF2 NNP B-NP
lie VBP O
within IN O
a DT O
larger JJR O
imprinted JJ O
domain NN O
, , O
and CC O
the DT O
gene NN O
specificity NN O
of IN O
H19 NNP B-NP
epimutation NN O
has VBZ O
been VBN O
a DT O
persistent JJ O
question NN O
. . O

-DOCSTART- X X O

Antibiotics NNPS O
and CC O
CDCA-mediation NNP O
are VBP O
essential JJ O
for IN O
symptomatic JJ O
therapy NN O
. . O

-DOCSTART- X X O

The DT O
effectiveness NN O
and CC O
pathogenetic JJ O
expediency NN O
of IN O
correcting JJ O
disorders NNS O
of IN O
lipid JJ O
metabolism NN O
in IN O
atherosclerosis NN O
with IN O
enterosorbents NNS O
is VBZ O
substantiated VBN O
. . O

-DOCSTART- X X O

Adaptive JJ O
effects NNS O
of IN O
repeated VBN O
immersion NN O
exposure NN O
on IN O
the DT O
human JJ O
body NN O

-DOCSTART- X X O

The DT O
human JJ O
cDNA NN O
was VBD O
cloned VBN O
and CC O
sequenced VBN O
; : O
it PRP O
was VBD O
shown VBN O
to TO O
have VB O
an DT O
open JJ O
reading NN O
frame NN O
encoding VBG O
a DT O
296-amino-acid JJ O
protein NN O
in IN O
which WDT O
could MD O
be VB O
identified VBN O
four CD O
peptides NNS O
previously RB O
identified VBN O
by IN O
micro-sequencing JJ O
purified JJ O
protein NN O
. . O

-DOCSTART- X X O

Dipetalonema NNP O
( -LRB- O
Acanthocheilonema NN O
) -RRB- O
didelphis VBZ O
sp. VBD O
n NN O
. . O

-DOCSTART- X X O

The DT O
promyelocytic JJ B-NP
leukemia NN I-NP
protein NN I-NP
interacts NNS O
with IN O
Sp1 NNP B-NP
and CC O
inhibits VBZ O
its PRP$ O
transactivation NN O
of IN O
the DT O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
receptor NN I-NP
promoter NN O
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
characterize VBP O
TCR/CD48 PRP B-NP
and CC O
TCR/CD28 DT B-NP
costimulation NN O
in IN O
T NNP O
cells NNS O
expressing VBG O
Lck NNP B-NP
Src NNP B-NP
homology NN I-NP
3 CD I-NP
( -LRB- O
SH3 NN B-NP
) -RRB- O
mutants NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
it PRP O
appears VBZ O
that IN O
moxalactam NN O
is VBZ O
a DT O
reliable JJ O
and CC O
useful JJ O
antibiotic JJ O
for IN O
the DT O
treatment NN O
of IN O
complicated JJ O
urinary JJ O
tract NN O
infections NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
second JJ O
, , O
37 CD O
students NNS O
were VBD O
given VBN O
trimethoprim/sulphamethoxazole NN O
( -LRB- O
160 CD O
mg NN O
TMP-SMX NNP O
800 CD O
mg NN O
) -RRB- O
, , O
38 CD O
TMP NNP O
( -LRB- O
200 CD O
mg NN O
) -RRB- O
, , O
and CC O
in IN O
35 CD O
a DT O
placebo NN O
was VBD O
given VBN O
b.i.d NN O
. . O
for IN O
five CD O
days NNS O
. . O

-DOCSTART- X X O

The DT O
infection NN O
of IN O
cells NNS O
with IN O
Moloney NNP O
murine NN O
leukemia NN O
virus NN O
(M-MuLV NN O
) -RRB- O
causes VBZ O
an DT O
increase NN O
in IN O
specific JJ O
cellular JJ O
gene NN O
products NNS O
, , O
including VBG O
the DT O
major JJ B-NP
histocompatibility NN I-NP
complex NN I-NP
( -LRB- I-NP
MHC NNP I-NP
) -RRB- I-NP
class NN I-NP
I PRP I-NP
antigens VBD I-NP
. . O

-DOCSTART- X X O

Apparent JJ O
Buschke-Loewenstein NNP O
tumour NN O
of IN O
the DT O
penis NN O
. . O

-DOCSTART- X X O

The DT O
orthologs NNS O
of IN O
the DT O
Y( JJ B-NP
1 CD I-NP
) -RRB- I-NP
and CC O
Y( JJ B-NP
2 CD I-NP
) -RRB- I-NP
subtypes NNS I-NP
display VBP O
high JJ O
amino IN O
acid NN O
sequence NN O
identities NNS O
between IN O
pig NN O
, , O
human JJ O
, , O
and CC O
mouse NN O
(92%-94 NN O
% NN O
) -RRB- O
, , O
whereas IN O
the DT O
Y( JJ B-NP
4 CD I-NP
) -RRB- I-NP
, , O
Y(5 PRP B-NP
) -RRB- I-NP
, , O
and CC O
y( JJ B-NP
6 CD I-NP
) -RRB- I-NP
subtypes NNS I-NP
display VBP O
lower JJR O
identities NNS O
( -LRB- O
76 CD O
%-87 NN O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Enhanced VBN O
phospholipid JJ O
hydrolysis NN O
with IN O
free JJ O
fatty JJ O
acid NN O
and CC O
thromboxane NN O
accumulation NN O
, , O
increased VBD O
release NN O
of IN O
excitatory JJ O
amino IN O
acids NNS O
, , O
and CC O
decreased VBD O
tissue NN O
magnesium NN O
levels NNS O
may MD O
each DT O
serve VB O
to TO O
worsen VB O
secondary JJ O
tissue NN O
damage NN O
and CC O
diminish JJ O
neurologic NN O
recovery NN O
after IN O
spinal JJ O
cord NN O
injury NN O
associated VBN O
with IN O
acute JJ O
alcohol NN O
intoxication NN O
. . O

-DOCSTART- X X O

With IN O
six CD O
reports NNS O
in IN O
the DT O
literature NN O
that WDT O
show VBP O
there EX O
is VBZ O
an DT O
order NN O
to TO O
melanoma NN O
nodal NN O
metastases NNS O
and CC O
that IN O
the DT O
SLN NNP O
histology NN O
is VBZ O
reflective JJ O
of IN O
the DT O
histology NN O
of IN O
the DT O
remainder NN O
of IN O
the DT O
nodal NN O
basin NN O
, , O
the DT O
more RBR O
conservative JJ O
SLN JJ O
biopsy NN O
can MD O
be VB O
performed VBN O
to TO O
adequately RB O
stage VB O
nodally RB O
the DT O
patient NN O
with IN O
melanoma NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
a DT O
double JJ O
mutant NN O
( -LRB- O
E482A,D489A NN O
) -RRB- O
which WDT O
removed VBD O
negative JJ O
charges NNS O
along IN O
one CD O
side NN O
of IN O
the DT O
helix NN O
had VBD O
negligible JJ O
effects NNS O
on IN O
fusion NN O
activity NN O
. . O

-DOCSTART- X X O

Escherichia NNP O
coli NNS O
cells NNS O
expressing VBG O
a DT O
mutant JJ B-NP
glyV NN I-NP
( -LRB- O
glycine NN B-NP
tRNA NN I-NP
) -RRB- O
gene NN O
have VBP O
a DT O
UVM-constitutive JJ O
phenotype NN O
: : O
implications NNS O
for IN O
mechanisms NNS O
underlying VBG O
the DT O
mutA NNS B-NP
or CC O
mutC JJ B-NP
mutator NN I-NP
effect NN O
. . O

-DOCSTART- X X O

Synthetic JJ O
studies NNS O
on IN O
furan JJ O
derivatives NNS O
by IN O
the DT O
wittig NN O
reaction NN O

-DOCSTART- X X O

Positive JJ O
linear NN O
correlations NNS O
were VBD O
found VBN O
when WRB O
the DT O
AUC(0-12 NN O
) -RRB- O
( -LRB- O
r NN O
= SYM O
0.68 CD O
; : O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
, , O
the DT O
maximum NN O
plasma NN O
concentration NN O
( -LRB- O
r NN O
= SYM O
0.34 CD O
; : O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
, , O
the DT O
minimum NN O
plasma NN O
concentration NN O
( -LRB- O
r NN O
= SYM O
0.55 CD O
; : O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
, , O
and CC O
the DT O
elimination NN O
t1/2 IN O
( -LRB- O
r NN O
= SYM O
0.46 CD O
; : O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
were VBD O
regressed VBN O
with IN O
age NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
social JJ O
learning NN O
theory NN O
of IN O
depression NN O
, , O
developed VBN O
by IN O
Lewinsohn NNP O
, , O
is VBZ O
described VBN O
. . O

-DOCSTART- X X O

Intramolecular NNP O
interaction NN O
is VBZ O
believed VBN O
to TO O
result VB O
in IN O
the DT O
formation NN O
of IN O
MxA NNP B-NP
monomers NNS I-NP
, , O
whereas IN O
intermolecular JJ O
interaction NN O
may MD O
induce VB O
the DT O
formation NN O
of IN O
large JJ B-NP
MxA NNP I-NP
oligomers NNS I-NP
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
a DT O
Het- NNP B-NP
mutation NN O
in IN O
Anabaena NNP O
sp. VBD O
strain NN O
PCC NNP O
7120 CD O
implicates VBZ O
a DT O
secondary JJ O
metabolite NN O
in IN O
the DT O
regulation NN O
of IN O
heterocyst NN O
spacing NN O
. . O

-DOCSTART- X X O

He PRP O
presented VBD O
with IN O
left NN O
lower JJR O
abdominal NN O
pain NN O
and CC O
hematoma NN O
after IN O
a DT O
fall NN O
. . O

-DOCSTART- X X O

To TO O
this DT O
end NN O
we PRP O
generated VBD O
a DT O
detailed JJ O
physical JJ O
map NN O
of IN O
the DT O
genomic JJ O
region NN O
spanning NN O
between IN O
sequence-tagged JJ O
site NN O
markers NNS O
D16S518 . B-NP
and CC O
D16S516 CD B-NP
. . O

-DOCSTART- X X O

The DT O
kinetics NNS O
of IN O
erythromycin NN O
( -LRB- O
E. NNP O
) -RRB- O
was VBD O
studied VBN O
in IN O
16 CD O
patients NNS O
with IN O
different JJ O
degrees NNS O
of IN O
impairment NN O
of IN O
renal JJ O
function NN O
after IN O
a DT O
single JJ O
intravenous JJ O
dose NN O
. . O

-DOCSTART- X X O

Lasting JJ O
paraplegia NN O
caused VBN O
by IN O
loss NN O
of IN O
lumbar NN O
spinal JJ O
cord NN O
interneurons NNS O
in IN O
rats NNS O
: : O
no DT O
direct JJ O
correlation NN O
with IN O
motor NN O
neuron NN O
loss NN O
. . O

-DOCSTART- X X O

Some DT O
CHOP-C/EBP JJ B-NP
heterodimers NNS O
apparently RB O
bind VBP O
to TO O
alternative JJ O
DNA NNP O
sequence NN O
and CC O
thereby RB O
regulate VB O
the DT O
transcription NN O
of IN O
other JJ O
genes NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
addition NN O
of IN O
the DT O
recombinant JJ B-NP
NF-YA NNP I-NP
subunit NN I-NP
restores NNS O
NF-Y JJ B-NP
binding NN O
. . O

-DOCSTART- X X O

The DT O
specificity NN O
of IN O
the DT O
transcriptional JJ O
activation NN O
by IN O
ISGF3 NNP B-NP
is VBZ O
mediated VBN O
by IN O
specific JJ O
elements NNS O
termed VBD O
IFN-stimulatory JJ B-NP
response NN I-NP
element NN I-NP
( -LRB- O
ISRE NN B-NP
) -RRB- O
located VBN O
in IN O
the DT O
promoter NN O
region NN O
of IN O
IFN-inducible JJ B-NP
genes NNS O
. . O

-DOCSTART- X X O

Clinical NNP O
development NN O
of IN O
interleukin-10 NN B-NP
. . O

-DOCSTART- X X O

The DT O
system NN O
consists VBZ O
of IN O
a DT O
microcomputer NN O
and CC O
six CD O
laboratory NN O
analyzers NNS O
: : O
a DT O
blood NN O
gas NN O
analyzer NN O
, , O
a DT O
flame NN O
photometer NN O
, , O
a DT O
plasma NN O
osmotic JJ O
pressure NN O
meter NN O
, , O
a DT O
chloride NN O
ion NN O
titrator NN O
, , O
a DT O
blood NN O
sugar NN O
analyzer NN O
, , O
and CC O
a DT O
hemoglobin NN B-NP
concentration NN O
and CC O
saturation NN O
meter NN O
. . O

-DOCSTART- X X O

Of IN O
these DT O
, , O
23 CD O
( -LRB- O
13.6 CD O
% NN O
) -RRB- O
were VBD O
due JJ O
to TO O
GIB NNP O
( -LRB- O
Upper NNP O
GIB NNP O
= SYM O
19 CD O
, , O
Lower NNP O
GIB NNP O
= SYM O
4) CD O
. . O

-DOCSTART- X X O

Saturated NNP O
fatty JJ O
acids NNS O
induce VB O
a DT O
1.6-fold JJ O
increase NN O
in IN O
transcription NN O
activity NN O
, , O
whereas IN O
a DT O
large JJ O
family NN O
of IN O
unsaturated JJ O
fatty JJ O
acids NNS O
repress VBP O
OLE1 NNP B-NP
transcription NN O
as RB O
much RB O
as IN O
60-fold JJ O
. . O

-DOCSTART- X X O

A DT O
third JJ O
GEF NNP B-NP
, , O
GRP3 JJ B-NP
(KIAA0846 NNS O
) -RRB- O
, , O
activated VBD O
both DT O
Ras NNP B-NP
and CC O
Rap1 NNP B-NP
and CC O
shared VBD O
significant JJ O
sequence NN O
homology NN O
with IN O
the DT O
calcium NN O
- : O
and CC O
diacylglycerol-activated JJ O
GE NNP B-NP
Fs NNP I-NP
, , O
GRP1 NNP B-NP
and CC O
GRP2 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
time-dependent NN O
changes NNS O
in IN O
measured VBN O
facility NN O
of IN O
outflow NN O
or CC O
"washout IN O
phenomenon NN O
" `` O
appeared VBD O
to TO O
result VB O
from IN O
the DT O
gradual JJ O
dissolution NN O
of IN O
the DT O
hyaluronidase-sensitive JJ B-NP
component NN O
of IN O
the DT O
barriers NNS O
to TO O
aqueous JJ O
outflow NN O
in IN O
the DT O
canine CD O
eye NN O
. . O

-DOCSTART- X X O

Melioidosis NNP O
in IN O
Sika NNP O
deer , O
( -LRB- O
Cervus NNP O
nippon NN O
nippon NN O
) -RRB- O
. . O

-DOCSTART- X X O

Many JJ O
human JJ O
malignant JJ O
cells NNS O
lack VBP O
methylthioadenosine JJ B-NP
phosphorylase NN I-NP
( -LRB- O
MTAP NNP B-NP
) -RRB- O
enzyme NN O
activity NN O
. . O

-DOCSTART- X X O

We PRP O
propose VBP O
2 CD O
separate JJ O
PAI-1 NN B-NP
inductory NN O
pathways NNS O
for IN O
PMA NNP O
and CC O
IL-1alpha NNP B-NP
in IN O
HepG2 NNP O
, , O
both DT O
involving VBG O
protein NN B-NP
tyrosine NN I-NP
kinase NN I-NP
activation NN O
; : O
the DT O
serum-induced JJ O
signaling NN O
pathway NN O
may MD O
( -LRB- O
partially RB O
) -RRB- O
overlap NN O
with IN O
the DT O
PMA-activated JJ O
protein NN B-NP
kinase NN I-NP
C/mitogen-activated JJ I-NP
protein NN B-NP
kinase NN I-NP
kinase NN I-NP
pathway NN O
, , O
leading VBG O
to TO O
c-Jun JJ B-NP
homodimer NN I-NP
binding NN O
to TO O
the DT O
PAI-1 NN B-NP
TRE. . O

-DOCSTART- X X O

Crude JJ O
drugs NNS O
from IN O
aquatic JJ O
plants NNS O
. . O

-DOCSTART- X X O

These DT O
data NNS O
show VBP O
that IN O
tyrosine NN O
phosphorylation NN O
by IN O
FES NNP B-NP
affects VBZ O
the DT O
interaction NN O
of IN O
BCR NNP B-NP
with IN O
multiple JJ O
signaling VBG O
partners NNS O
and CC O
suggest VBP O
a DT O
general JJ O
role NN O
for IN O
BCR NNP B-NP
in IN O
non-receptor JJ O
protein-tyrosine NN B-NP
kinase NN I-NP
regulation NN O
and CC O
signal NN O
transduction NN O
. . O

-DOCSTART- X X O

Replication NNP O
regions NNS O
from IN O
plant-pathogenic JJ O
Pseudomonas NNP O
syringae NN O
plasmids NNS O
are VBP O
similar JJ O
to TO O
ColE2-related JJ O
replicons NNS O
. . O

-DOCSTART- X X O

Comparison NNP O
of IN O
dose NN O
volume NN O
histograms NNS O
revealed VBD O
that IN O
the DT O
6-field JJ O
plan NN O
spared VBD O
relatively RB O
more JJR O
heart NN O
whereas IN O
the DT O
8-field JJ O
plan NN O
spared VBD O
relatively RB O
more JJR O
lung NN O
. . O

-DOCSTART- X X O

STUDY NNP O
OBJECTIVE VBP O
: : O
to TO O
characterize VB O
gas NN O
exchange NN O
and CC O
cardiopulmonary JJ O
performance NN O
during IN O
maximal JJ O
progressive JJ O
arm NN O
crank NN O
exercise NN O
. . O

-DOCSTART- X X O

The DT O
most RBS O
frequent JJ O
abnormality NN O
was VBD O
GH NNP B-NP
deficiency NN O
( -LRB- O
six CD O
cases NNS O
) -RRB- O
, , O
followed VBN O
by IN O
gonadotropin NN B-NP
( -LRB- O
four CD O
cases NNS O
) -RRB- O
, , O
cortisol FW O
( -LRB- O
four CD O
cases NNS O
) -RRB- O
, , O
and CC O
TSH NNP B-NP
( -LRB- O
one NN O
case NN O
) -RRB- O
, , O
whereas IN O
four CD O
patients NNS O
showed VBD O
high JJ O
serum NN B-NP
PRL NN I-NP
values NNS O
. . O

-DOCSTART- X X O

The DT O
nramp2 JJ B-NP
gene NN I-NP
is VBZ O
comprised VBN O
of IN O
17 CD O
exons NNS O
and CC O
spans NNS O
more JJR O
than IN O
36 CD O
kb NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
In IN O
lung NN O
protective JJ O
strategy NN O
, , O
positive JJ O
end-expiratory NN O
pressure NN O
( -LRB- O
PEEP NN O
) -RRB- O
slightly RB O
higher JJR O
than IN O
the DT O
Pflex NNP O
( -LRB- O
the DT O
airway NN O
pressure NN O
corresponding JJ O
to TO O
the DT O
lower JJR O
inflection NN O
point NN O
( -LRB- O
LIP NNP O
) -RRB- O
on IN O
the DT O
inspiratory NN O
pressure-volume NN O
(P-V) JJ O
curve NN O
measured VBN O
with IN O
ZEEP NNP O
) -RRB- O
is VBZ O
generally RB O
recommended VBN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
a DT O
constant JJ O
magnetic JJ O
field NN O
on RP O
different JJ O
models NNS O
of IN O
carcinogenesis NN O

-DOCSTART- X X O

Similarly RB O
, , O
beta JJ B-NP
adrenoceptors NNS I-NP
blockade NN O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
of IN O
value NN O
in IN O
achieving VBG O
continence NN O
in IN O
a DT O
small JJ O
group NN O
of IN O
patients NNS O
. . O

-DOCSTART- X X O

Effectively RB O
, , O
the DT O
upstream RB O
, , O
housekeeping-type NN O
promoter NN O
responds NNS O
to TO O
FIXK NNP B-NP
and CC O
positively RB O
regulates VBZ O
the DT O
downstream NN O
, , O
sigma NN B-NP
54-type JJ I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Km NNP O
values NNS O
of IN O
the DT O
uncoupled JJ O
enzymes NNS O
IIGlc . B-NP
for IN O
glucose NN O
ranged VBD O
from IN O
0.5 CD O
to TO O
2.5 CD O
mM NN O
, , O
2 CD O
orders NNS O
of IN O
magnitude NN O
higher JJR O
than IN O
the DT O
value NN O
of IN O
normal JJ O
IIGlc NN B-NP
. . O

-DOCSTART- X X O

Disruption NN O
of IN O
PML NNP B-NP
subnuclear JJ I-NP
domains NNS I-NP
by IN O
the DT O
acidic NN B-NP
IE1 IN I-NP
protein NN I-NP
of IN O
human JJ O
cytomegalovirus NN O
is VBZ O
mediated VBN O
through IN O
interaction NN O
with IN O
PML NNP B-NP
and CC O
may MD O
modulate VB O
a DT O
RING NNP O
finger-dependent NN O
cryptic VBD O
transactivator NN O
function NN O
of IN O
PML. NNP B-NP

-DOCSTART- X X O

The DT O
fate NN O
of IN O
ochratoxin NN O
A DT O
during IN O
malting NN O
and CC O
brewing NN O
. . O

-DOCSTART- X X O

To TO O
further RB O
investigate VB O
the DT O
role NN O
of IN O
PKR NNP B-NP
in IN O
transcriptional JJ O
signaling NN O
, , O
we PRP O
expressed VBD O
the DT O
wild JJ B-NP
type NN I-NP
human JJ I-NP
PKR NN I-NP
and CC O
a DT O
catalytically RB O
inactive JJ O
dominant JJ O
negative JJ O
PKR NN B-NP
mutant NN I-NP
in IN O
the DT O
murine NN O
pre-B JJ O
lymphoma NN O
70Z/3 IN O
cells NNS O
. . O

-DOCSTART- X X O

Consistent NNP O
with IN O
other JJ O
experiments NNS O
with IN O
these DT O
compounds NNS O
, , O
cocaine NN O
was VBD O
the DT O
most JJS O
potent JJ O
of IN O
the DT O
group NN O
. . O

-DOCSTART- X X O

Atrial JJ O
dissociation NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
envisaged VBN O
that IN O
the DT O
WHOQOL-BREF NN O
will MD O
be VB O
most RBS O
useful JJ O
in IN O
studies NNS O
that WDT O
require VBP O
a DT O
brief JJ O
assessment NN O
of IN O
quality NN O
of IN O
life NN O
, , O
for IN O
example NN O
, , O
in IN O
large JJ O
epidemiological JJ O
studies NNS O
and CC O
clinical JJ O
trials NNS O
where WRB O
quality NN O
of IN O
life NN O
is VBZ O
of IN O
interest NN O
. . O

-DOCSTART- X X O

Hepatitis NNP B-NP
B NNP I-NP
immune JJ I-NP
globulins NNS I-NP
and CC O
HIV NNP B-NP
antibodies NNS I-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
spontaneous JJ O
abortion NN O
group NN O
, , O
the DT O
levels NNS O
of IN O
PAPP-A NNP B-NP
were VBD O
significantly RB O
lower JJR O
than IN O
in IN O
normal JJ O
pregnancy NN O
but CC O
higher JJR O
than IN O
in IN O
non-pregnant JJ O
controls NNS O
. . O

-DOCSTART- X X O

The DT O
gene NN O
encoding JJ O
rat NN O
peptidylglycine NN B-NP
alpha-amidating NN I-NP
monooxygenase NN I-NP
( -LRB- O
PAM NNP B-NP
) -RRB- O
contains VBZ O
26 CD O
protein-coding NN O
exons NNS O
. . O

-DOCSTART- X X O

Whether IN O
this DT O
lack NN O
of IN O
preferential JJ O
repair NN O
has VBZ O
to TO O
be VB O
explained VBN O
by IN O
a DT O
defect NN O
in IN O
repair NN O
or CC O
in IN O
general JJ O
transcription NN O
is VBZ O
unclear JJ O
at IN O
present NN O
. . O

-DOCSTART- X X O

MUS81 NNP B-NP
encodes VBZ O
a DT O
novel NN O
helix-hairpin-helix NN B-NP
protein NN I-NP
involved VBN O
in IN O
the DT O
response NN O
to TO O
UV- NNP O
and CC O
methylation-induced JJ O
DNA NN O
damage NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

All DT O
possessed VBD O
cutaneous JJ O
receptive JJ O
fields NNS O
on IN O
the DT O
distal JJ O
segments NNS O
of IN O
digits NNS O
2 CD O
, , O
3 CD O
, , O
or CC O
4 CD O
. . O

-DOCSTART- X X O

A DT O
GT-rich JJ O
sequence NN O
binding NN O
the DT O
transcription NN B-NP
factor NN I-NP
Sp1 NNP I-NP
is VBZ O
crucial JJ O
for IN O
high JJ O
expression NN O
of IN O
the DT O
human JJ B-NP
type NN I-NP
VII NNP I-NP
collagen NN I-NP
gene NN I-NP
( -LRB- O
COL7A1 NNP B-NP
) -RRB- O
in IN O
fibroblasts NNS O
and CC O
keratinocytes NNS O
. . O

-DOCSTART- X X O

Using VBG O
in IN O
vivo DT O
genomic JJ O
dimethyl NN O
sulfate NN O
and CC O
KMnO4 NNP O
footprinting NN O
, , O
we PRP O
showed VBD O
that IN O
the DT O
promoter NN O
region NN O
is VBZ O
differentially RB O
protected VBN O
, , O
depending VBG O
upon IN O
which WDT O
holoenzyme NN O
is VBZ O
bound VBN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
these DT O
cDNAs NNS O
belong VBP O
to TO O
a DT O
novel NN O
GST NNP B-NP
class NN O
hereby RB O
designated VBN O
Kappa NNP O
, , O
with IN O
the DT O
rat NN B-NP
GST NNP I-NP
subunit NN I-NP
13 CD I-NP
gene NN I-NP
designated VBN O
rGSTK1 NNS B-NP
and CC O
the DT O
human JJ O
gene NN O
being VBG O
called VBN O
hGSTK1 NN B-NP
. . O

-DOCSTART- X X O

At IN O
onset NN O
of IN O
first JJ O
post-weaning JJ O
estrus NN O
, , O
sows VBZ O
received VBN O
either CC O
an DT O
intravulval JJ O
injection NN O
of IN O
3.75 CD O
mg NN O
of IN O
prostaglandin NN O
analogue NN O
( -LRB- O
PGF NN O
) -RRB- O
or CC O
, , O
served VBN O
as IN O
a DT O
non-injected JJ O
control NN O
( -LRB- O
CON NN O
) -RRB- O
. . O

-DOCSTART- X X O

Tbx6 DT B-NP
maps NNS O
to TO O
chromosome NN O
7 CD O
and CC O
does VBZ O
not RB O
appear VB O
to TO O
be VB O
linked VBN O
to TO O
any DT O
known VBN O
mutation NN O
. . O

-DOCSTART- X X O

Before IN O
therapy NN O
was VBD O
started VBN O
, , O
trabecular VBG O
bone NN O
alterations NNS O
could MD O
be VB O
observed VBN O
which WDT O
were VBD O
typical JJ O
for IN O
Paget NNP O
's POS O
disease NN O
of IN O
bone NN O
as IN O
there EX O
were VBD O
bulky JJ O
trabeculare NN O
, , O
increased VBD O
remodelling VBG O
surfaces NNS O
and CC O
giant JJ O
osteoclasts NNS O
. . O

-DOCSTART- X X O

Contraindications NNS O
to TO O
adenosine JJ O
and CC O
drug NN O
interactions NNS O
are VBP O
noted VBN O
in IN O
this DT O
article NN O
. . O

-DOCSTART- X X O

The DT O
extent NN O
of IN O
the DT O
odontoblast JJ O
process NN O
in IN O
human JJ O
dentin NN O
. . O

-DOCSTART- X X O

On IN O
transfer NN O
from IN O
glucose NN O
, , O
succinate JJ O
, , O
malate JJ O
, , O
or CC O
glycerol NN O
medium NN O
to TO O
citrate VB O
medium NN O
, , O
the DT O
Cit NNP O
+ NNP O
Escherichia NNP O
coli NNS O
strains NNS O
showed VBD O
a DT O
delay NN O
of IN O
36 CD O
to TO O
48 CD O
h NN O
before IN O
growth NN O
. . O

-DOCSTART- X X O

Additionally RB O
, , O
the DT O
members NNS O
of IN O
this DT O
family NN O
display NN O
strong JJ O
sequence NN O
homologies NNS O
between IN O
their PRP$ O
larger JJR O
C-terminal JJ O
effector NN O
binding/oligomerization NN O
domains VBZ O
. . O

-DOCSTART- X X O

Long-term JJ O
ambulatory JJ O
measurement NN O
of IN O
transcutaneous JJ O
arterial NN O
CO2 IN O
pressure NN O
(PCO2 IN O
) -RRB- O
offers VBZ O
an DT O
opportunity NN O
to TO O
test VB O
directly RB O
the DT O
co-occurrence NN O
of IN O
panic NN O
and CC O
hyperventilation NN O
under IN O
natural JJ O
conditions NNS O
. . O

-DOCSTART- X X O

An DT O
association NN O
was VBD O
found VBN O
between IN O
zafirlukast NN O
plasma NN O
concentrations NNS O
and CC O
increases NNS O
in IN O
PC8SRaw NNP O
10 CD O
h NN O
after IN O
treatment NN O
( -LRB- O
p NN O
= SYM O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Most JJS O
interestingly RB O
, , O
although IN O
the DT O
effector NN O
plasmid NN O
containing VBG O
the DT O
ICP27 NN B-NP
gene NN I-NP
had VBD O
little JJ O
effect NN O
on IN O
its PRP$ O
own JJ O
, , O
two CD O
different JJ O
and CC O
marked VBN O
effects NNS O
depending VBG O
on IN O
the DT O
target NN O
were VBD O
observed VBN O
when WRB O
ICP27 PRP B-NP
was VBD O
combined VBN O
with IN O
ICP4 NNP B-NP
or CC O
ICP0 NNP B-NP
or CC O
both DT O
. . O

-DOCSTART- X X O

Water NNP O
pair NN O
and CC O
three-body JJ O
potential NN O
of IN O
spectroscopic JJ O
quality NN O
from IN O
Ab CD O
initio NN O
calculations NNS O

-DOCSTART- X X O

Because IN O
the DT O
wa-2 NN B-NP
mutation NN I-NP
was VBD O
mapped VBN O
previously RB O
to TO O
the DT O
vicinity NN O
of IN O
the DT O
EGF/TGF-alpha NN B-NP
receptor NN I-NP
( -LRB- O
EGFR NN B-NP
) -RRB- O
gene NN O
on IN O
mouse NN O
chromosome NN O
11 CD O
, , O
we PRP O
hypothesized VBD O
that IN O
the DT O
wa-2 NN B-NP
phenotype NN I-NP
might MD O
result VB O
from IN O
a DT O
defect NN O
in IN O
either CC O
the DT O
expression NN O
or CC O
activity NN O
of IN O
EGFR NNP B-NP
, , O
or CC O
both DT O
. . O

-DOCSTART- X X O

4 CD O
) -RRB- O
Mutation NN O
of IN O
the DT O
three CD O
extracellular JJ O
cysteine NN O
residues NNS O
of IN O
GFKAR NNP B-NP
beta NN I-NP
indicated VBD O
that IN O
the DT O
two CD O
conserved JJ O
cysteine NN O
residues NNS O
( -LRB- O
C305 . O
and CC O
C385 PRP O
) -RRB- O
, , O
located VBN O
between IN O
two CD O
transmembrane NN O
segments NNS O
, , O
form VBP O
a DT O
solvent-accessible JJ O
disulfide NN O
bond NN O
. . O

-DOCSTART- X X O

R NN O
of IN O
the DT O
chest NN O
wall NN O
was VBD O
maximum JJ O
( -LRB- O
35.6 CD O
cmH2O.L- : O
1.sec-1 CD O
+/ CD O
- : O
2.2 CD O
SE NNP O
) -RRB- O
at IN O
0.2 CD O
Hz-10 CD O
ml NN O
and CC O
decreased VBD O
with IN O
increasing VBG O
f NN O
and CC O
VT NN O
, , O
although IN O
the DT O
VT NNP O
effect NN O
diminished VBD O
at IN O
the DT O
higher JJR O
f NN O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
the DT O
predicted VBN O
amino IN O
acid NN O
sequence NN O
with IN O
that DT O
of IN O
the DT O
Drosophila NNP B-NP
virilis NN I-NP
gene NN I-NP
shows VBZ O
that IN O
several JJ O
blocks NNS O
of IN O
amino DT O
acid NN O
sequence NN O
have VBP O
been VBN O
very RB O
highly RB O
conserved VBN O
. . O

-DOCSTART- X X O

The DT O
N-terminal JJ O
exon1 NN O
had VBD O
no DT O
homology NN O
at IN O
the DT O
amino JJ O
acid NN O
level NN O
with IN O
NGFI-B NNP B-NP
, , O
the DT O
mammalian JJ O
homologue NN O
. . O

-DOCSTART- X X O

Although IN O
RAD17 NNP B-NP
, , O
RAD24 NNP B-NP
and CC O
MEC3 NNP B-NP
are VBP O
not RB O
required VBN O
for IN O
cell NN O
cycle NN O
arrest NN O
when WRB O
S NNP O
phase NN O
is VBZ O
inhibited VBN O
by IN O
hydroxyurea NN O
( -LRB- O
HU) NNP O
, , O
they PRP O
do VBP O
contribute VB O
to TO O
the DT O
viability NN O
of IN O
yeast NN O
cells NNS O
grown VBN O
in IN O
the DT O
presence NN O
of IN O
HU NNP O
, , O
possibly RB O
because IN O
they PRP O
are VBP O
required VBN O
for IN O
the DT O
repair NN O
of IN O
HU-induced JJ O
DNA NNP O
damage NN O
. . O

-DOCSTART- X X O

Single NNP O
oblique-view NN O
mammography NN O
for IN O
periodic JJ O
screening NN O
for IN O
breast NN O
cancer NN O
in IN O
women NNS O
. . O

-DOCSTART- X X O

Nicotinic NNP B-NP
receptor NN I-NP
antagonists NNS O
mecamylamine NN O
( -LRB- O
0.5 CD O
and CC O
1 CD O
mg/kg NN O
) -RRB- O
and CC O
hexamethonium NN O
( -LRB- O
5 CD O
and CC O
10 CD O
mg/kg NN O
) -RRB- O
reduced VBD O
the DT O
response NN O
induced VBN O
by IN O
nicotine JJ O
( -LRB- O
0.25 CD O
mg/kg NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
matrix NN O
of IN O
the DT O
CBs NNP O
contains VBZ O
the DT O
diagnostic JJ O
protein NN O
p80-coilin NN B-NP
, , O
which WDT O
is VBZ O
colocalized VBN O
with IN O
the DT O
U7 NNP B-NP
small JJ I-NP
nuclear JJ I-NP
ribonucleoprotein NN I-NP
( -LRB- O
snRNP NN O
) -RRB- O
, , O
whereas IN O
the DT O
attached VBN O
and CC O
embedded VBN O
B-snurposomes NNS O
contain VBP O
splicing NN O
snRNPs NNS O
. . O

-DOCSTART- X X O

Tritium NNP O
concentrations NNS O
in IN O
environmental JJ O
water NN O
samples NNS O
were VBD O
found VBN O
to TO O
be VB O
determined VBN O
within IN O
an DT O
accuracy NN O
of IN O
10 CD O
% NN O
by IN O
this DT O
method NN O
when WRB O
Vi/Vf NNP O
was VBD O
14-25 CD O
. . O

-DOCSTART- X X O

The DT O
results NNS O
of IN O
this DT O
study NN O
suggest VBP O
that IN O
in IN O
patients NNS O
with IN O
syndrome NN O
X NNP O
, , O
myocardial JJ O
ischemia NN O
frequently RB O
develops VBZ O
during IN O
daily JJ O
life NN O
; : O
silent JJ O
ischemia NN O
is VBZ O
an DT O
important JJ O
component NN O
of IN O
this DT O
syndrome NN O
; : O
and CC O
increased VBD O
oxygen NN O
demand NN O
in IN O
the DT O
presence NN O
of IN O
impaired JJ O
coronary JJ O
vasodilatory JJ O
capacity NN O
is VBZ O
not RB O
the DT O
only JJ O
cause NN O
of IN O
myocardial JJ O
ischemia NN O
. . O

-DOCSTART- X X O

Two CD O
patients NNS O
with IN O
Ewing NNP O
's POS O
sarcoma NN O
relapsed VBN O
( -LRB- O
1 CD O
patient NN O
with IN O
both DT O
local JJ O
and CC O
distant JJ O
failure NN O
) -RRB- O
at IN O
26 CD O
and CC O
58 CD O
months NNS O
and CC O
were VBD O
again RB O
rendered VBN O
disease-free JJ O
with IN O
surgery NN O
, , O
total JJ O
body NN O
irradiation NN O
and CC O
further JJ O
chemotherapy NN O
. . O

-DOCSTART- X X O

When WRB O
single-point JJ O
mutation NN O
was VBD O
introduced VBN O
to TO O
each DT O
GC JJ O
box NN O
, , O
EBS NNP B-NP
, , O
and CC O
GT NNP O
box NN O
in IN O
PFP9a20 NNP B-NP
, , O
at IN O
least JJS O
3-fold JJ O
less JJR O
CAT NN B-NP
activity NN O
was VBD O
observed VBN O
in IN O
CTLL-R8 JJ O
cells NNS O
. . O

-DOCSTART- X X O

Thirty-three CD O
percent NN O
had VBD O
elevated VBN O
titers NNS O
( -LRB- O
above IN O
1:20 CD O
dilution NN O
) -RRB- O
. . O

-DOCSTART- X X O

Both DT O
the DT O
inactive JJ O
domain NN B-NP
II NNP I-NP
P68 CD I-NP
mutant NN I-NP
and CC O
the DT O
deletion NN O
mutant NN O
lacking VBG O
aa JJ O
91-243 CD O
were VBD O
less JJR O
inhibitory JJ O
to TO O
growth NN O
in IN O
yeast NN O
due JJ O
to TO O
the DT O
reduced VBN O
ability NN O
to TO O
phosphorylate VB O
initiation NN B-NP
factor NN I-NP
2 CD I-NP
alpha NN I-NP
in IN O
vivo NN O
. . O

-DOCSTART- X X O

As IN O
the DT O
mechanism NN O
of IN O
the DT O
intractability NN O
, , O
cell NN O
function NN O
involved VBN O
in IN O
the DT O
defense NN O
against IN O
infection NN O
was VBD O
evaluated VBN O
. . O

-DOCSTART- X X O

IV. . O

-DOCSTART- X X O

After IN O
5-h JJ O
thermal JJ O
induction NN O
of IN O
cells NNS O
carrying VBG O
the DT O
runaway JJ O
recombinant NN O
pBS1 NNS O
, , O
protein NN B-NP
B2 NN I-NP
constituted VBD O
40 CD O
% NN O
of IN O
the DT O
soluble JJ O
protein NN O
fraction NN O
of IN O
the DT O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
highest JJS O
concentration NN O
of IN O
respirable JJ O
mineral NN O
fibres NNS O
was VBD O
found VBN O
during IN O
the DT O
overhaul NN O
of IN O
a DT O
truck NN O
with IN O
asbestos NN O
insulation NN O
; : O
respirable JJ O
fibre JJ O
concentration NN O
reached VBD O
the DT O
value NN O
of IN O
5 CD O
f/cm3 CD O
, , O
and CC O
total JJ O
dust NN O
concentration-the DT O
value NN O
of IN O
about IN O
80 CD O
mg/m3 CD O
. . O

-DOCSTART- X X O

By IN O
contrast NN O
, , O
footprint NN O
II NNP O
at IN O
position NN O
-125 . O
is VBZ O
common JJ O
to TO O
both DT O
HeLa NNP O
and CC O
GH3 NNP O
cell NN O
extracts NNS O
and CC O
overlies NNS O
a DT O
15-base-pair JJ O
sequence NN O
found VBD O
in IN O
all DT O
members NNS O
of IN O
the DT O
growth NN B-NP
hormone NN I-NP
gene NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

Unlike IN O
LANA1 NNP B-NP
, , O
LANA2 NNP B-NP
does VBZ O
not RB O
elicit VB O
a DT O
serologic JJ O
response NN O
from IN O
patients NNS O
with IN O
KS NNP O
, , O
PEL NNP O
, , O
or CC O
CD NNP O
as IN O
measured VBN O
by IN O
Western JJ O
blot NN O
hybridization NN O
. . O

-DOCSTART- X X O

CD4 NNP B-NP
degradation NN O
mediated VBN O
by IN O
Vpu NNP B-NP
does VBZ O
not RB O
require VB O
the DT O
ER NNP O
chaperone NN O
calnexin NN B-NP
and CC O
is VBZ O
dependent JJ O
on IN O
an DT O
intact JJ O
ubiquitin-conjugating JJ B-NP
system NN O
. . O

-DOCSTART- X X O

The DT O
revaluation NN O
at IN O
the DT O
end NN O
of IN O
the DT O
study NN O
showed VBD O
a DT O
good JJ O
compliance NN O
for IN O
the DT O
proposed VBN O
diet NN O
scheme NN O
by IN O
children NNS O
, , O
but CC O
a DT O
poor JJ O
compliance NN O
by IN O
their PRP$ O
families NNS O
. . O

-DOCSTART- X X O

Cytostatic JJ O
activity NN O
of IN O
some DT O
essential JJ O
oils NNS O
against IN O
HEp-2 JJ O
cells NNS O
. . O

-DOCSTART- X X O

Excess NNP O
recombinant NN B-NP
PTB NNP I-NP
squelches VBZ O
the DT O
splicing NN O
switch NN O
and CC O
reestablishes NNS O
exon RB O
skipping VBG O
as IN O
the DT O
predominant JJ O
splicing NN O
pathway NN O
. . O

-DOCSTART- X X O

Among IN O
women NNS O
, , O
plasma NN B-NP
factor NN I-NP
VII:Ag NNP I-NP
was VBD O
inversely RB O
associated VBN O
with IN O
income NN O
. . O

-DOCSTART- X X O

Recently RB O
, , O
we PRP O
demonstrated VBD O
that IN O
platelet-derived JJ B-NP
growth NN I-NP
factor NN I-NP
( -LRB- I-NP
PDGF)-beta NN I-NP
receptor NN I-NP
stimulation NN O
, , O
but CC O
not RB O
various JJ O
other JJ O
growth NN O
factors NNS O
, , O
inhibits VBZ O
transcription NN O
of IN O
alpha1D-, JJ B-NP
but CC O
not RB O
alpha1A DT B-NP
- : O
or CC O
alpha1B-ARs NNS B-NP
, , O
resulting VBG O
in IN O
reduced VBN O
norepinephrine-mediated JJ O
SMC NNP O
growth NN O
. . O

-DOCSTART- X X O

( -LRB- O
A DT O
short JJ O
account NN O
of IN O
Karl NNP O
Touton NNP O
's POS O
life NN O
is VBZ O
also RB O
included VBN O
. . O
) -RRB- O
After IN O
reviewing VBG O
the DT O
historical JJ O
development NN O
of IN O
the DT O
concept NN O
of IN O
giant JJ O
cells NNS O
and CC O
current JJ O
interpretations NNS O
of IN O
their PRP$ O
nature NN O
, , O
the DT O
unitarian NN O
view NN O
of IN O
polykaryons NNS O
now RB O
favored VBN O
by IN O
workers NNS O
in IN O
the DT O
field NN O
is VBZ O
extended VBN O
to TO O
include VB O
also RB O
the DT O
" `` O
xanthelasmatic JJ O
giant JJ O
cell NN O
" '' O
of IN O
Touton NNP O
, , O
whose WP$ O
characteristic JJ O
appearance NN O
is VBZ O
determined VBN O
merely RB O
by IN O
the DT O
presence NN O
of IN O
demonstrable JJ O
lipid NN O
in IN O
the DT O
cytoplasm NN O
. . O

-DOCSTART- X X O

After IN O
birth NN O
, , O
there EX O
was VBD O
a DT O
significantly RB O
higher JJR O
increase NN O
of IN O
IgA NNP B-NP
and CC O
IgM NNP B-NP
anti-M. . I-NP
leprae NNS I-NP
antibody NN I-NP
activity NN O
in IN O
sera NN O
taken VBN O
3-6 CD O
months NNS O
after IN O
birth NN O
from IN O
babies NNS O
of IN O
Group NNP O
1 CD O
compared VBN O
to TO O
Group NNP O
2 CD O
, , O
but CC O
the DT O
IgA NNP B-NP
and CC O
IgM NNP B-NP
activity NN O
in IN O
sera NN O
taken VBN O
after IN O
6 CD O
months NNS O
of IN O
age NN O
showed VBD O
the DT O
same JJ O
increase NN O
in IN O
the DT O
two CD O
groups NNS O
. . O

-DOCSTART- X X O

Serum NN O
estriol NN O
levels NNS O
during IN O
beta-receptor NN B-NP
agonist JJ O
infusion NN O
in IN O
the DT O
third JJ O
trimester NN O
of IN O
pregnancy NN O
. . O

-DOCSTART- X X O

These DT O
tiny JJ O
premature JJ O
infants NNS O
also RB O
received VBD O
PN NNP O
for IN O
significantly RB O
longer JJR O
periods NNS O
of IN O
time NN O
, , O
and CC O
the DT O
longer RB O
the DT O
infusions NNS O
were VBD O
administered VBN O
the DT O
greater JJR O
was VBD O
the DT O
risk NN O
of IN O
cholestasis NN O
developing VBG O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
sae1-1 JJ B-NP
and CC O
sae3-1 JJ B-NP
mutations NNS I-NP
each DT O
confer VBP O
a DT O
distinct JJ O
defect NN O
in IN O
meiotic JJ O
recombination NN O
. . O
sae1-1 NN B-NP
produces VBZ O
recombinants NNS O
but CC O
very RB O
slowly RB O
and CC O
ultimately RB O
to TO O
less JJR O
than IN O
half PDT O
the DT O
wild-type JJ O
level NN O
; : O
sae3-1 JJ B-NP
makes VBZ O
persistent JJ O
hyper-resected JJ O
meiotic JJ O
double-strand NN O
breaks NNS O
and CC O
has VBZ O
a DT O
severe JJ O
defect NN O
in IN O
formation NN O
of IN O
recombinants NNS O
. . O

-DOCSTART- X X O

Patients NNS O
in IN O
the DT O
mucinous JJ O
cyst NN O
group NN O
had VBD O
significantly RB O
lower JJR O
CA NNP B-NP
125 CD I-NP
cystic JJ O
fluid NN O
levels NNS O
compared VBN O
with IN O
women NNS O
with IN O
endometriomas NNS O
and CC O
dermoids NNS O
( -LRB- O
P&lt JJ O
;0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
brains NNS O
were VBD O
processed VBN O
according VBG O
to TO O
the DT O
tetramethylbenzidine NN O
( -LRB- O
TMB) NNP O
protocol NN O
of IN O
Mesulam NNP O
( -LRB- O
'78 CD O
) -RRB- O
and CC O
studied VBD O
with IN O
darkfield NN O
microscopy NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
WT1 DT B-NP
target NN I-NP
gene NN I-NP
expression NN O
in IN O
stably NN O
transfected VBD O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

Amniotic JJ O
fluid NN O
ionic JJ O
concentration NN O
in IN O
response NN O
to TO O
chronic JJ O
fetal NN B-NP
vasopressin NN I-NP
infusion NN O
. . O

-DOCSTART- X X O

The DT O
genomic JJ O
organization NN O
in IN O
this DT O
region NN O
is VBZ O
similar JJ O
to TO O
the DT O
neural-restricted JJ O
family NN O
members NNS O
, , O
Hel-N1 NNP B-NP
( -LRB- O
ELAVL2 NN B-NP
) -RRB- O
and CC O
mHuD NN B-NP
( -LRB- O
Elavl4 NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
The DT O
biodistribution NN O
of IN O
111In JJ O
IgG NNP B-NP
is VBZ O
similar JJ O
to TO O
that DT O
of IN O
99mTc-HMPAO-labeled JJ O
leukocytes NNS O
. . O

-DOCSTART- X X O

Since IN O
it PRP O
is VBZ O
often RB O
necessary JJ O
to TO O
resort VB O
to TO O
thoracotomy NN O
as IN O
a DT O
final JJ O
step NN O
in IN O
making VBG O
such JJ O
a DT O
diagnosis NN O
, , O
we PRP O
have VBP O
sought VBN O
a DT O
procedure NN O
that WDT O
is VBZ O
simpler JJR O
while IN O
capable JJ O
of IN O
providing VBG O
the DT O
same JJ O
information NN O
. . O

-DOCSTART- X X O

On IN O
the DT O
optic JJ O
tentacle-gonadal JJ O
axis NN O
in IN O
the DT O
control NN O
of IN O
the DT O
male-phase JJ O
ovotestis NN O
in IN O
the DT O
slug NN O
( -LRB- O
Ariolimax JJ O
californicus NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
inhibitor JJ O
GF-109203X NNP O
abolished VBD O
the DT O
activation NN O
by IN O
phorbol NN O
ester NN O
and CC O
inhibited VBD O
the DT O
effect NN O
of IN O
CCK NNP B-NP
by IN O
78 CD O
% NN O
but CC O
had VBD O
no DT O
effect NN O
on IN O
EGF-activated JJ B-NP
MAPK NNP B-NP
activity NN O
. . O

-DOCSTART- X X O

These DT O
morphological JJ O
changes NNS O
are VBP O
associated VBN O
with IN O
a DT O
marked JJ O
induction NN O
of IN O
P450arom NNP B-NP
gene NN I-NP
expression NN O
. . O

-DOCSTART- X X O

DNase NN B-NP
I PRP I-NP
protection NN O
analysis NN O
as RB O
well RB O
as IN O
oligonucleotide JJ O
competition NN O
experiments NNS O
indicate VBP O
that IN O
this DT O
binding NN O
is VBZ O
sequence NN O
specific JJ O
. . O

-DOCSTART- X X O

METHOD NNP O
: : O
After IN O
eligibility NN O
, , O
patients NNS O
were VBD O
randomly RB O
allocated VBN O
in IN O
one CD O
of IN O
the DT O
following VBG O
groups NNS O
: : O
M NNP O
= SYM O
methylprednisolone NN O
30 CD O
mg.kg-1 NN O
over IN O
1 CD O
hour NN O
, , O
followed VBN O
by IN O
5.4 CD O
mg.kg-1.h-1 NN O
for IN O
23 CD O
hours NNS O
, , O
N NNP O
= SYM O
nimodipine JJ O
0.015 CD O
mg.kg-1.h-1 NN O
over IN O
2 CD O
hours NNS O
followed VBN O
by IN O
0.03 CD O
mg.kg-1.h-1 NN O
for IN O
7 CD O
days NNS O
, , O
MN NNP O
or CC O
P. NNP O

-DOCSTART- X X O

We PRP O
have VBP O
shown VBN O
previously RB O
that DT O
EGF NN B-NP
receptor NN I-NP
activation NN O
stimulates NNS O
gastrin VBG B-NP
gene NN O
expression NN O
through IN O
a DT O
GC-rich JJ O
element NN O
called VBD O
gERE. . O

-DOCSTART- X X O

To TO O
determine VB O
cis-acting JJ O
elements NNS O
controlling VBG O
the DT O
rat NN O
B-50/GAP-43 JJ B-NP
gene NN O
expression NN O
, , O
the DT O
genomic JJ O
DNA NNP O
encoding NN O
exon NN O
1 CD O
and CC O
the DT O
5' JJ O
flanking NN O
sequence NN O
was VBD O
isolated VBN O
. . O

-DOCSTART- X X O

Any DT O
opacity NN O
on IN O
a DT O
chest NN O
radiograph NN O
has VBZ O
a DT O
wide JJ O
differential JJ O
diagnosis NN O
. . O

-DOCSTART- X X O

Levels NNP O
of IN O
p53 NN B-NP
were VBD O
substantially RB O
increased VBN O
by IN O
E1A JJ B-NP
expression NN O
during IN O
adenovirus JJ O
infection NN O
. . O

-DOCSTART- X X O

This DT O
pathway NN O
has VBZ O
been VBN O
reported VBN O
to TO O
mediate JJ O
heterodimer NN O
interactions NNS O
with IN O
the DT O
proapoptotic JJ O
regulator NN O
, , O
Bad NNP B-NP
. . O

-DOCSTART- X X O

We PRP O
sought VBD O
to TO O
test VB O
whether IN O
a DT O
prolonged JJ O
infusion NN O
of IN O
magnesium NN O
sulfate NN O
( -LRB- O
MgSO( JJ O
4 CD O
) -RRB- O
; : O
40 CD O
mmol/24 CD O
hours NNS O
) -RRB- O
would MD O
normalize VB O
QT NNP O
interval NN O
variability NN O
in IN O
patients NNS O
with IN O
compensated JJ O
heart NN O
failure NN O
. . O

-DOCSTART- X X O

Long-term JJ O
follow-up NN O
of IN O
kidney NN O
donors NNS O
: : O
a DT O
longitudinal JJ O
study NN O
. . O

-DOCSTART- X X O

Gore NNP O
& CC O
Associates NNPS O
, , O
Inc. NNP O
) -RRB- O
standard JJ O
wall NN O
graft NN O
segments NNS O
varying VBG O
in IN O
length NN O
from IN O
4 CD O
to TO O
12 CD O
cm NN O
. . O

-DOCSTART- X X O

This DT O
report NN O
describes VBZ O
the DT O
isolation NN O
and CC O
recombinant JJ O
expression NN O
of IN O
a DT O
cDNA NN O
clone NN O
encoding VBG O
HER4 NNP B-NP
, , O
the DT O
fourth JJ O
member NN O
of IN O
the DT O
human JJ B-NP
epidermal NN I-NP
growth NN I-NP
factor NN I-NP
receptor NN I-NP
( -LRB- O
EGFR NNP B-NP
) -RRB- O
family NN O
. . O

-DOCSTART- X X O

Precision NNP O
of IN O
data NNS O
from IN O
models NNS O
of IN O
sodium NN O
kinetics NNS O
in IN O
hemodialysis NN O

-DOCSTART- X X O

Cytochrome NNP B-NP
bd VBD I-NP
biosynthesis NN O
in IN O
Escherichia NNP O
coli NNS O
: : O
the DT O
sequences NNS O
of IN O
the DT O
cydC NN B-NP
and CC O
cydD NN B-NP
genes NNS I-NP
suggest VBP O
that IN O
they PRP O
encode VBP O
the DT O
components NNS O
of IN O
an DT O
ABC NNP B-NP
membrane NN I-NP
transporter NN I-NP
. . O

-DOCSTART- X X O

We PRP O
exposed VBD O
Dorper-cross NNP O
ewes VBZ O
at IN O
approximately RB O
120-135 CD O
days NNS O
of IN O
gestation NN O
to TO O
a DT O
hot JJ O
( -LRB- O
40 CD O
degrees NNS O
C NN O
, , O
60 CD O
% NN O
relative JJ O
humidity NN O
) -RRB- O
and CC O
a DT O
cold JJ O
( -LRB- O
4 CD O
degrees NNS O
C NN O
, , O
90 CD O
% NN O
relative JJ O
humidity NN O
) -RRB- O
environment NN O
and CC O
to TO O
treadmill VB O
exercise NN O
( -LRB- O
2.1 CD O
km/h NN O
, , O
5 CD O
degrees NNS O
gradient NN O
) -RRB- O
and CC O
measured VBN O
fetal NN O
lamb NN O
and CC O
ewe JJ O
body NN O
temperatures NNS O
using VBG O
previously RB O
implanted VBN O
abdominal JJ O
radiotelemeters NNS O
. . O

-DOCSTART- X X O

Amino-terminal JJ O
polymorphisms NNS O
of IN O
the DT O
human JJ B-NP
beta NN I-NP
2-adrenergic JJ I-NP
receptor NN I-NP
impart NN O
distinct JJ O
agonist-promoted JJ O
regulatory JJ O
properties NNS O
. . O

-DOCSTART- X X O

A DT O
brief JJ O
discussion NN O
for IN O
the DT O
relationship NN O
among IN O
these DT O
formulas NNS O
is VBZ O
given VBN O
. . O

-DOCSTART- X X O

The DT O
embryology NN O
of IN O
the DT O
vertebral NN O
column NN O
is VBZ O
reviewed VBN O
briefly NN O
, , O
and CC O
the DT O
origin NN O
of IN O
each DT O
anomaly NN O
of IN O
the DT O
C2 NNP O
vertebra NN O
is VBZ O
traced VBN O
to TO O
one CD O
of IN O
the DT O
two CD O
early JJ O
stages NNS O
in IN O
development NN O
as IN O
follows VBZ O
: : O
1 CD O
) -RRB- O
the DT O
formation NN O
of IN O
the DT O
mesenchymal NN O
vertebra NN O
or CC O
2 CD O
) -RRB- O
its PRP$ O
induction NN O
to TO O
cartilage NN O
. . O

-DOCSTART- X X O

Visualization NNP O
of IN O
the DT O
cells NNS O
by IN O
phase NN O
contrast NN O
microscopy NN O
indicated VBD O
that IN O
murine NN B-NP
PKCepsilon NNP I-NP
expression NN O
in IN O
the DT O
presence NN O
of IN O
glycerol NN O
resulted VBD O
in IN O
a DT O
significant JJ O
increase NN O
in IN O
the DT O
number NN O
of IN O
yeast NN O
cells NNS O
exhibiting VBG O
very RB O
small JJ O
buds NNS O
. . O

-DOCSTART- X X O

12 CD O
per IN O
cent NN O
was VBD O
observed VBN O
with IN O
the DT O
use NN O
of IN O
tetracycline NN O
and CC O
4-epianhydrotetracycline JJ O
in IN O
doses NNS O
of IN O
1000 CD O
and CC O
100gamma CD O
per IN O
embryo NN O
respectively RB O
. . O

-DOCSTART- X X O

Bodily NNP O
referents NNS O
and CC O
the DT O
experience NN O
of IN O
affect VB O
. . O

-DOCSTART- X X O

We PRP O
studied VBD O
about IN O
the DT O
histological JJ O
findings NNS O
of IN O
the DT O
kidneys NNS O
including VBG O
of IN O
the DT O
infiltrated JJ O
macrophages NNS O
in IN O
one CD O
hour NN O
post-transplantation NN O
kidney NN O
biopsies NNS O
( -LRB- O
one CD O
hour NN O
biopsies NNS O
) -RRB- O
and CC O
re-biopsies NNS O
on IN O
11 CD O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
lbc NN I-NP
oncogene IN I-NP
product NN I-NP
is VBZ O
a DT O
guanine NNP B-NP
nucleotide JJ I-NP
exchange NN I-NP
factor NN I-NP
that WDT O
specifically RB O
activates VBZ O
the DT O
Rho NNP B-NP
small JJ I-NP
GTP NNP I-NP
binding JJ I-NP
protein NN I-NP
, , O
thus RB O
resulting VBG O
in IN O
biologically RB O
active JJ O
, , O
GTP-bound JJ O
Rho NNP B-NP
, , O
which WDT O
in IN O
turn NN O
mediates NNS O
actin IN B-NP
cytoskeletal NN O
reorganization NN O
, , O
gene NN O
transcription NN O
, , O
and CC O
entry NN O
into IN O
the DT O
mitotic JJ O
S NNP O
phase NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
There EX O
were VBD O
no DT O
significant JJ O
differences NNS O
in IN O
the DT O
mean JJ O
serum NN O
vitamin NN O
A DT O
, , O
E NNP O
concentrations NNS O
and CC O
vitamin NN O
E/cholesterol NNP O
ratio NN O
between IN O
pregnant JJ O
women NNS O
with IN O
normal JJ O
hemoglobin NN B-NP
and CC O
hemoglobinopathies NNS O
, , O
while IN O
confounding VBG O
variables NNS O
that WDT O
might MD O
affect VB O
serum NN O
vitamin NN O
levels NNS O
i IN O
.e NN O
. . O
maternal JJ O
age NN O
, , O
gravida NN O
, , O
BMI NNP O
, , O
gestational JJ O
age NN O
, , O
hematocrit NN O
, , O
hemoglobin NN B-NP
, , O
mean VBP O
corpuscular JJ O
hemoglobin NN B-NP
concentration NN O
and CC O
blood NN O
group NN O
were VBD O
not RB O
different JJ O
. . O

-DOCSTART- X X O

These DT O
data NNS O
indicate VBP O
that IN O
SB NNP O
203580 CD O
sensitive JJ O
p38 NNS B-NP
MAP NNP I-NP
kinases NNS I-NP
are VBP O
not RB O
involved VBN O
in IN O
okadaic JJ O
acid NN O
mediated VBN O
increases NNS O
in IN O
TRE NNP O
DNA NNP O
binding NN O
and CC O
transactivation NN O
. . O

-DOCSTART- X X O

Evidence NN O
for IN O
a DT O
role NN O
of IN O
Smad6 NNP B-NP
in IN O
chick NN O
cardiac NN O
development NN O
. . O

-DOCSTART- X X O

The DT O
overall JJ O
response NN O
rate NN O
including VBG O
CR NNP O
and CC O
PR NNP O
was VBD O
23.5 CD O
% NN O
( -LRB- O
4/17 CD O
) -RRB- O
. . O

-DOCSTART- X X O

After IN O
5,850 CD O
C14 IN O
BP NNP O
, , O
the DT O
decrease NN O
in IN O
Acer NNP O
stands VBZ O
could MD O
be VB O
attributed VBN O
to TO O
fire VB O
as IN O
suggested VBN O
by IN O
the DT O
strong JJ O
increase NN O
in IN O
Betula NNP O
and CC O
by IN O
the DT O
delayed JJ O
expansion NN O
of IN O
Pinus NNP O
cembra NN O
. . O

-DOCSTART- X X O

4.7 CD O
+/ NN O
- : O
0.6 CD O
micromol NN O
. . O
kg-1 NN O
. . O
min-1 NN O
) -RRB- O
but CC O
was VBD O
not RB O
changed VBN O
by IN O
training NN O
. . O

-DOCSTART- X X O

RET/PTC NNP B-NP
oncogenes NNP O
, , O
generated VBN O
by IN O
chromosomal JJ O
rearrangements NNS O
in IN O
papillary NN O
thyroid NN O
carcinomas NNS O
, , O
are VBP O
constitutively RB O
activated VBN O
versions NNS O
of IN O
proto-RET NN B-NP
, , O
a DT O
gene NN O
coding NN O
for IN O
a DT O
receptor-type JJ B-NP
tyrosine NN I-NP
kinase NN I-NP
( -LRB- O
TK) NN B-NP
whose WP$ O
ligand NN O
is VBZ O
still RB O
unknown JJ O
. . O

-DOCSTART- X X O

Diclofenac NNP O
sodium NN O
: : O
blood NN O
concentration NN O
of IN O
the DT O
slow-release NN O
form NN O
and CC O
influence NN O
on IN O
the DT O
metabolism NN O
of IN O
kallikrein NN B-NP
. . O

-DOCSTART- X X O

The DT O
unc-101 JJ B-NP
, , O
sli-1 JJ B-NP
, , O
and CC O
rok-1 JJ B-NP
genes NNS I-NP
encode VBP O
a DT O
distinct JJ O
set NN O
of IN O
negative JJ O
regulators NNS O
of IN O
vulval JJ O
differentiation NN O
. . O

-DOCSTART- X X O

Optimized NNP O
USF NNP B-NP
and CC O
MYC NNP B-NP
DNA-binding NNP O
sites NNS O
, , O
which WDT O
differ VBP O
in IN O
the DT O
nucleotides NNS O
bordering VBG O
the DT O
hexanucleotide NN O
box NN O
displace NN O
the DT O
E-C4 NNP B-NP
factor NN I-NP
in IN O
competition NN O
assays . O
but CC O
with IN O
lesser JJR O
efficiency NN O
than IN O
the DT O
E-C4 NNP B-NP
site NN I-NP
itself PRP O
. . O

-DOCSTART- X X O

DESIGN NNP O
: : O
Intradermally NNP O
injected VBD O
human JJ O
squamous JJ O
cell NN O
carcinoma NN O
cells NNS O
were VBD O
grown VBN O
to TO O
40 CD O
to TO O
80 CD O
mm3 CD O
in IN O
athymic JJ O
nude JJ O
mice NNS O
and CC O
irradiated JJ O
with IN O
675-nm JJ O
light NN O
( -LRB- O
75 CD O
J/cm2 NN O
, , O
75 CD O
mW/cm2 NN O
) -RRB- O
24 CD O
hours NNS O
after IN O
the DT O
intraperitoneal JJ O
injection NN O
of IN O
SiPc NNP O
IV NNP O
( -LRB- O
1.0 CD O
mg/kg NN O
) -RRB- O
. . O

-DOCSTART- X X O

There EX O
are VBP O
two CD O
regulatory JJ O
regions NNS O
between IN O
the DT O
US3 NNP B-NP
and CC O
the DT O
US6 NNP B-NP
transcription NN I-NP
units NNS I-NP
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
predicted VBN O
M3 IN O
ORF NNP O
is VBZ O
a DT O
functional JJ O
gene NN O
that WDT O
encodes VBZ O
an DT O
abundant JJ O
secreted JJ O
protein NN O
which WDT O
is VBZ O
a DT O
candidate NN O
for IN O
interacting VBG O
with IN O
host NN O
cellular JJ O
receptors NNS O
or CC O
cytokines NNS O
. . O

-DOCSTART- X X O

The DT O
protein NN O
encoded VBN O
by IN O
the DT O
NF2 NNP B-NP
gene NN I-NP
has VBZ O
a DT O
similarity NN O
to TO O
ezrin VB B-NP
, , O
radixin NN B-NP
and CC O
moesin NN B-NP
( -LRB- O
ERM NN B-NP
) -RRB- O
proteins VBZ O
that DT O
link NN O
membrane NN O
proteins VBZ O
to TO O
the DT O
cytoskeleton NN O
. . O

-DOCSTART- X X O

80 CD O
v-ets-encoded JJ B-NP
amino-acids NNS O
located VBN O
immediately RB O
after IN O
the DT O
v-myb/v-ets NNS B-NP
junction NN O
are VBP O
not RB O
found VBN O
in IN O
P54/56c-ets NNS B-NP
, , O
the DT O
translation NN O
product NN O
of IN O
the DT O
c-ets NNS B-NP
proto-oncogene NN I-NP
, , O
nor CC O
in IN O
a DT O
set NN O
of IN O
cellular JJ O
proteins NNS O
of IN O
64 CD O
, , O
62 CD O
, , O
and CC O
60 CD O
kDa NN O
related VBN O
to TO O
but CC O
distinct JJ O
from IN O
P54/56c-ets NNS B-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
translocation NN O
of IN O
G1 NNP B-NP
to TO O
the DT O
Golgi NNP O
was VBD O
not RB O
observed VBN O
when WRB O
G1 NNP B-NP
was VBD O
coexpressed VBN O
with IN O
NSm NNP B-NP
, , O
although IN O
NSm NNP B-NP
itself PRP O
was VBD O
still RB O
detected VBN O
in IN O
the DT O
Golgi NNP O
. . O

-DOCSTART- X X O

In IN O
this DT O
technique NN O
, , O
the DT O
posterior JJ O
wall NN O
of IN O
the DT O
neopharynx NN O
consists VBZ O
only RB O
of IN O
the DT O
prevertebral JJ O
tissue NN O
, , O
while IN O
the DT O
flap NN O
forms VBZ O
the DT O
anterior JJ O
and CC O
lateral JJ O
walls NNS O
. . O

-DOCSTART- X X O

These DT O
data NNS O
may MD O
indicate VB O
redundancy NN O
between IN O
members NNS O
of IN O
the DT O
NGFI-B/Nurr1/Nor1 JJ B-NP
subfamily NN O
and CC O
could MD O
explain VB O
why WRB O
no DT O
phenotypic NN O
disturbances NNS O
have VBP O
yet RB O
been VBN O
found VBN O
in IN O
mice NNS O
in IN O
which WDT O
the DT O
NGFI-B NNP B-NP
gene NN I-NP
has VBZ O
been VBN O
inactivated VBN O
. . O

-DOCSTART- X X O

Activation NN O
of IN O
the DT O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
MAPK) NNP B-NP
pathway NN O
enhances VBZ O
long-range JJ O
transactivation NN O
by IN O
the DT O
beta-globin NN B-NP
locus NN I-NP
control NN I-NP
region NN I-NP
(LCR NN O
) -RRB- O
( -LRB- O
W. NN O

-DOCSTART- X X O

The DT O
gp41 CD B-NP
peptide NN I-NP
( -LRB- I-NP
Glu-Leu-Asp-Lys-Trp-Ala NNP I-NP
) -RRB- I-NP
fused VBN O
to TO O
the DT O
C-terminus NN O
of IN O
Sj NNP B-NP
GST NNP I-NP
forms VBZ O
a DT O
loop NN O
stabilized VBN O
by IN O
symmetry-related JJ O
GSTs NNP B-NP
. . O

-DOCSTART- X X O

The DT O
testes NNS O
of IN O
8 CD O
specimens NNS O
of IN O
Triturus NNP O
marmoratus NN O
were VBD O
collected VBN O
during IN O
each DT O
month NN O
of IN O
1987 CD O
and CC O
processed VBN O
for IN O
electron NN O
microscopy NN O
and CC O
light NN O
microscopy JJ O
demonstration NN O
of IN O
testosterone NN O
( -LRB- O
T NNP O
) -RRB- O
following VBG O
the DT O
ABC NNP B-NP
(avidin-biotin NNP O
peroxidase NN B-NP
complex NN I-NP
) -RRB- O
method NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
apoptosis NN O
in IN O
hematopoietic JJ O
cells NNS O
is VBZ O
the DT O
end NN O
result NN O
of IN O
a DT O
conflict NN O
between IN O
death NN O
and CC O
survival NN O
signals NNS O
, , O
rather RB O
than IN O
a DT O
simple JJ O
death NN O
by IN O
default NN O
. . O

-DOCSTART- X X O

Changes NNS O
in IN O
testicular JJ O
testosterone NN O
and CC O
acid NN O
and CC O
alkaline NN B-NP
phosphatase NN I-NP
activity NN O
in IN O
testis NN O
and CC O
accessory JJ O
sex NN O
organs NNS O
after IN O
induction NN O
of IN O
varicocele NN O
in IN O
Noble NNP O
rats NNS O
. . O

-DOCSTART- X X O

The DT O
reconstituted VBD O
RNA NNP B-NP
polymerases NNS I-NP
containing VBG O
the DT O
mutant JJ O
alpha NN O
subunits NNS O
were VBD O
examined VBN O
for IN O
their PRP$ O
response NN O
to TO O
transcription NN O
activation NN O
by IN O
cAMP-CRP JJ B-NP
and CC O
the DT O
rrnBP1 JJ B-NP
UP NNP I-NP
element NN I-NP
. . O

-DOCSTART- X X O

Changes NNS O
in IN O
the DT O
greater JJR O
omentum NN O
of IN O
mice NNS O
of IN O
different JJ O
strains NNS O
after IN O
intraperitoneal JJ O
immunization NN O
with IN O
sheep NN O
erythrocytes NNS O
. . O

-DOCSTART- X X O

In IN O
patients NNS O
, , O
750 CD O
mL NN O
of IN O
saline NN O
lowered VBD O
DL(CO NNP O
) -RRB- O
(-8 CD O
% NN O
, , O
P<0.01 CD O
versus JJ O
baseline NN O
) -RRB- O
, , O
D( JJ O
M NNP O
) -RRB- O
(-10 CD O
% NN O
, , O
P<0.01 CD O
versus JJ O
baseline NN O
) -RRB- O
, , O
aldosterone RB O
(-29 CD O
% NN O
, , O
P<0.01 CD O
versus JJ O
baseline NN O
) -RRB- O
, , O
renin FW B-NP
(-52 CD O
% NN O
, , O
P<0.01 NNP O
versus JJ O
baseline NN O
) -RRB- O
, , O
and CC O
hematocrit NN O
(-6 NN O
% NN O
, , O
P<0.05 CD O
versus JJ O
baseline NN O
) -RRB- O
and CC O
increased VBD O
V( JJ O
C NN O
) -RRB- O
( -LRB- O
20 CD O
% NN O
, , O
P<0.01 CD O
versus JJ O
baseline NN O
) -RRB- O
, , O
without IN O
changing VBG O
rap NN O
and CC O
wpp NN O
. . O

-DOCSTART- X X O

Reversible JJ O
pressure-induced JJ O
amorphization NN O
in IN O
solid JJ O
C70 NN O
: : O
Raman NNP O
and CC O
photoluminescence NN O
study NN O
. . O

-DOCSTART- X X O

Mean NNP O
CD4 NNP B-NP
percentages NNS O
were VBD O
lower JJR O
postpartum FW O
( -LRB- O
21.9 CD O
+/ RB O
- : O
3.4 CD O
) -RRB- O
than IN O
prepartum NN O
( -LRB- O
45.1 CD O
+/ NN O
- : O
6.7 CD O
) -RRB- O
in IN O
all DT O
five CD O
patients NNS O
studied VBD O
, , O
although IN O
proliferative JJ O
responses NNS O
to TO O
the DT O
mitogens NNS B-NP
phytohemagglutinin NN I-NP
and CC I-NP
pokeweed NN I-NP
were VBD O
unchanged JJ O
during IN O
the DT O
study NN O
period NN O
. . O

-DOCSTART- X X O

Significance NN O
of IN O
the DT O
determination NN O
of IN O
vascular JJ O
tonus NN O
in IN O
the DT O
differential JJ O
diagnosis NN O
of IN O
rheumatic JJ O
and CC O
arteriosclerotic JJ O
lesions NNS O
of IN O
the DT O
heart NN O
and CC O
vessels NNS O
in IN O
middle-aged JJ O
and CC O
elderly JJ O
persons NNS O
with IN O
fibrillation NN O
arrhythmia NN O

-DOCSTART- X X O

Under IN O
control NN O
conditions NNS O
and CC O
in IN O
the DT O
presence NN O
of IN O
3 CD O
micromol/kg JJ O
MIB NNP O
and CC O
VER NNP O
the DT O
maximal JJ O
effect NN O
of IN O
noradrenaline NN O
was VBD O
reached VBN O
at IN O
0.1 CD O
micromol/kg NN O
whereas IN O
in IN O
the DT O
presence NN O
of IN O
10 CD O
micromol/kg JJ O
MIB NNP O
and CC O
VER NNP O
it PRP O
was VBD O
reached VBN O
at IN O
a DT O
dose NN O
of IN O
1 CD O
micromol/kg NN O
. . O

-DOCSTART- X X O

The DT O
highly RB O
conserved JJ O
region NN O
of IN O
U6 DT B-NP
snRNA NN I-NP
has VBZ O
a DT O
structural JJ O
similarity NN O
with IN O
the DT O
catalytic JJ O
domain NN O
of IN O
the DT O
negative JJ O
strand NN O
of IN O
the DT O
satellite NN O
RNA NN O
of IN O
tobacco NN O
ring NN O
spot NN O
virus NN O
[(-)sTRSV] RB O
, , O
suggesting VBG O
that IN O
the DT O
highly RB O
conserved VBN O
region NN O
of IN O
U6 DT B-NP
snRNA NN I-NP
forms VBZ O
the DT O
catalytic JJ O
center NN O
. . O

-DOCSTART- X X O

By IN O
computed VBN O
homology NN O
search NN O
, , O
we PRP O
noticed VBD O
significant JJ O
similarities NNS O
between IN O
US3 NNP B-NP
PK NNP I-NP
and CC O
p21-activated JJ B-NP
kinase NN I-NP
( -LRB- O
PAK) NNP B-NP
, , O
which WDT O
is VBZ O
activated VBN O
by IN O
the DT O
Cdc42 NNP B-NP
or CC O
Rac. NNP B-NP

-DOCSTART- X X O

Drosophila NNP B-NP
melanogaster NN I-NP
casein NN I-NP
kinase NN I-NP
II NNP I-NP
( -LRB- O
DmCKII NN B-NP
) -RRB- O
is VBZ O
composed VBN O
of IN O
catalytic JJ O
( -LRB- O
alpha NN O
) -RRB- O
and CC O
regulatory JJ O
( -LRB- O
beta NN O
) -RRB- O
subunits NNS O
associated VBN O
as IN O
an DT O
alpha2beta2 NN O
heterotetramer NN O
. . O

-DOCSTART- X X O

Inhibition NN O
of IN O
DNA NNP B-NP
topoisomerase NN I-NP
II NNP I-NP
alpha NN I-NP
gene NN I-NP
expression NN O
by IN O
the DT O
p53 NN B-NP
tumor NN I-NP
suppressor NN I-NP
. . O

-DOCSTART- X X O

Vav NNP B-NP
and CC O
Dbl NNP B-NP
are VBP O
members NNS O
of IN O
a DT O
novel JJ O
class NN O
of IN O
oncogene JJ O
proteins NNS O
that WDT O
share VBP O
significant JJ O
sequence NN O
identity NN O
in IN O
a DT O
approximately RB O
250-amino-acid JJ O
domain NN O
, , O
designated VBN O
the DT O
Dbl NNP B-NP
homology NN I-NP
domain NN I-NP
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
Levels NNP O
of IN O
sIL-2R NN B-NP
were VBD O
measured VBN O
simultaneously RB O
in IN O
plasma NN O
and CC O
pleural JJ O
fluid NN O
in IN O
111 CD O
patients NNS O
with IN O
pleural JJ O
effusions NNS O
of IN O
unknown JJ O
causes NNS O
. . O

-DOCSTART- X X O

The DT O
LIF NNP B-NP
appeared VBD O
to TO O
be VB O
released VBN O
by IN O
the DT O
patient NN O
's POS O
peripheral JJ O
blood NN O
lymphocytes NNS O
when WRB O
cultured VBN O
with IN O
optimal JJ O
doses NNS O
of IN O
propranolol NN O
. . O

-DOCSTART- X X O

This DT O
regulation NN O
is VBZ O
mediated VBN O
by IN O
several JJ O
kinases NNS O
that WDT O
phosphorylate VBP O
specific JJ O
residues NNS O
in IN O
the DT O
different JJ O
functional JJ O
domains NNS O
of IN O
the DT O
p53 NN B-NP
molecule NN I-NP
. . O

-DOCSTART- X X O

In IN O
group NN O
I PRP O
during IN O
the DT O
pain NN O
free JJ O
period NN O
26 CD O
of IN O
81 CD O
patients NNS O
had VBD O
positive JJ O
thallium-201 DT O
scans NNS O
, , O
whereas IN O
20 CD O
patients NNS O
had VBD O
an DT O
abnormal JJ O
ECG NN O
at IN O
that DT O
time NN O
; : O
during IN O
angina DT O
18 CD O
patients NNS O
had VBD O
transient JJ O
ECG JJ O
changes NNS O
. . O

-DOCSTART- X X O

We PRP O
examined VBD O
the DT O
contribution NN O
of IN O
the DT O
M-MuLV NNP B-NP
enhancers NNS I-NP
to TO O
the DT O
transcriptional JJ O
activity NN O
and CC O
pathogenesis NN O
of IN O
M-MuLV NNP O
by IN O
constructing VBG O
LTRs NNS O
containing VBG O
heterologous JJ O
enhancer NN O
elements NNS O
. . O

-DOCSTART- X X O

Acute NN O
respiratory JJ O
distress NN O
syndrome NN O
. . O

-DOCSTART- X X O

Serum NNP O
creatinine CD B-NP
kinase NN I-NP
activity NN O
was VBD O
7,800-17,500 CD O
U/l NNP O
, , O
making VBG O
acute JJ O
muscle NN O
damage NN O
likely JJ O
, , O
probably RB O
rhabdomyolysis NN O
. . O

-DOCSTART- X X O

Fetal NNP O
arterial NN O
and CC O
sagittal NN O
sinus IN O
pH RB O
, , O
base JJ O
excess NN O
, , O
po2 NN O
, , O
and CC O
oxygen NN O
saturation NN O
decreased VBD O
, , O
and CC O
hydrogen NN O
ion NN O
concentrations NNS O
and CC O
pco2 NN O
increased VBN O
during IN O
asphyxia DT O
alone JJ O
and CC O
asphyxia NN O
plus CC O
isoflurane-oxygen NN O
. . O

-DOCSTART- X X O

For IN O
the DT O
most JJS O
part NN O
, , O
only RB O
aerobic JJ O
microbial JJ O
degradation NN O
systems NNS O
have VBP O
been VBN O
reported VBN O
so RB O
far RB O
. . O

-DOCSTART- X X O

This DT O
is VBZ O
mediated VBN O
by IN O
vascular JJ O
remodeling NN O
, , O
an DT O
active JJ O
process NN O
that IN O
results NNS O
in IN O
a DT O
change NN O
in IN O
the DT O
geometry NN O
of IN O
the DT O
blood NN O
vessel NN O
. . O

-DOCSTART- X X O

Although IN O
cardiac JJ O
output NN O
decreased VBD O
slightly RB O
with IN O
PCF NN O
, , O
hemodynamic JJ O
changes NNS O
due JJ O
to TO O
PCF NNP O
were VBD O
unlikely JJ O
to TO O
account VB O
for IN O
the DT O
observed JJ O
fall NN O
in IN O
PaO2 NNP O
. . O

-DOCSTART- X X O

Swarming VBG O
of IN O
Moraxella NNP O

-DOCSTART- X X O

Two CD O
patient JJ O
groups NNS O
were VBD O
studied VBN O
: : O
Type NNP O
I--with NNP O
a DT O
new JJ O
ePTFE NN O
graft NN O
; : O
and CC O
Type NNP O
II--with NNP O
thrombectomy NN O
and/or CC O
revision NN O
of IN O
a DT O
previously RB O
placed VBN O
ePTFE JJ O
graft NN O
. . O

-DOCSTART- X X O

As IN O
a DT O
quantitative JJ O
index NN O
of IN O
cochlear JJ O
function NN O
, , O
2f1-f2 JJ O
distortion-product NN O
otoacoustic JJ O
emissions NNS O
( -LRB- O
DPOAEs NNS O
) -RRB- O
were VBD O
monitored VBN O
systematically RB O
over IN O
time NN O
in IN O
three CD O
groups NNS O
of IN O
rabbits NNS O
, , O
with IN O
each DT O
group NN O
experiencing VBG O
a DT O
unique JJ O
paradigm NN O
that IN O
incorporated JJ O
repeated VBN O
exposure NN O
to TO O
the DT O
low-frequency NN O
tone NN O
. . O

-DOCSTART- X X O

Quasidiatomic JJ O
study NN O
of IN O
Ly- NNP O
alpha NN O
-producing NN O
H2 IN O
+-Ne JJ O
collisions NNS O
at IN O
keV NN O
energies NNS O
. . O

-DOCSTART- X X O

Detailed VBN O
analysis NN O
of IN O
the DT O
predicted VBN O
amino IN O
acid NN O
sequence NN O
revealed VBD O
sequence NN O
elements NNS O
which WDT O
are VBP O
conserved VBN O
in IN O
many JJ O
DNA NNP B-NP
and CC I-NP
RNA NNP I-NP
polymerases NNS I-NP
. . O

-DOCSTART- X X O

139La CD O
NQR NNP O
relaxation NN O
and CC O
microSR NN O
study NN O
of IN O
Zn-doping JJ O
effects NNS O
in IN O
La2CuO4 NNP O
. . O

-DOCSTART- X X O

Our PRP$ O
study NN O
investigated VBD O
the DT O
hypothesis NN O
that IN O
the DT O
combination NN O
of IN O
a DT O
high JJ O
NaCl JJ O
diet NN O
and CC O
social JJ O
isolation NN O
stress NN O
would MD O
increase VB O
systolic JJ O
blood NN O
pressure NN O
( -LRB- O
SBP NNP O
) -RRB- O
and CC O
endogenous JJ O
sodium NN O
pump NN O
ligands VBZ O
( -LRB- O
SPL) NNP O
, , O
ouabainlike JJ O
compound NN O
( -LRB- O
OLC NNP O
) -RRB- O
, , O
and CC O
marinobufagenin FW O
( -LRB- O
MBG) NN O
. . O

-DOCSTART- X X O

Percentage NN O
incremental JJ O
18-OHB JJ O
responses NNS O
to TO O
metoclopramide VB O
were VBD O
greater JJR O
( -LRB- O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
in IN O
the DT O
subjects NNS O
after IN O
5 CD O
days NNS O
on IN O
a DT O
200-meq JJ O
sodium NN O
intake IN O
than IN O
after IN O
5 CD O
days NNS O
on IN O
a DT O
10-meq JJ O
sodium NN O
intake NN O
. . O

-DOCSTART- X X O

PURPOSE NNP O
: : O
Second JJ O
malignant JJ O
neoplasms NNS O
( -LRB- O
SMNs NNS O
) -RRB- O
are VBP O
a DT O
rare JJ O
occurrence NN O
after IN O
the DT O
successful JJ O
treatment NN O
of IN O
childhood NN O
cancer NN O
. . O

-DOCSTART- X X O

A DT O
p53 NN B-NP
cDNA NN I-NP
deletion NN O
mutant NN O
( -LRB- O
delta JJ O
pro FW O
AE) NNP O
, , O
which WDT O
lacks VBZ O
this DT O
entire JJ O
proline-rich JJ O
domain NN O
( -LRB- O
deleted VBN O
for IN O
amino DT O
acids NNS O
62-91 CD O
) -RRB- O
, , O
was VBD O
created VBN O
and CC O
characterized VBN O
for IN O
a DT O
variety NN O
of IN O
p53 NN B-NP
functions NNS O
. . O

-DOCSTART- X X O

Candidate NN O
factors NNS O
have VBP O
been VBN O
identified VBN O
by IN O
the DT O
observation NN O
that IN O
changes NNS O
in IN O
glucocorticoid JJ O
induction NN O
parameters NNS O
in IN O
CV-1 JJ O
cells NNS O
could MD O
be VB O
reproduced VBN O
by IN O
varying VBG O
the DT O
cellular JJ O
levels NNS O
of IN O
coactivators NNS O
[transcriptional JJ O
intermediary NN B-NP
factor NN I-NP
2 CD I-NP
( -LRB- O
TIF2 NN B-NP
) -RRB- O
, , O
steroid NN B-NP
receptor NN I-NP
coactivator NN I-NP
1 CD I-NP
( -LRB- O
SRC-1 NN B-NP
) -RRB- O
, , O
and CC O
amplified JJ B-NP
in IN I-NP
breast NN I-NP
cancer NN I-NP
1 CD I-NP
( -LRB- O
AIB1 NNP B-NP
)] NNP O
, , O
comodulator NN O
[CREB-binding JJ O
protein NN B-NP
( -LRB- O
CBP)] NN B-NP
, , O
or CC O
corepressor NN O
[silencing NN O
mediator NN B-NP
for IN I-NP
retinoid JJ I-NP
and CC I-NP
thyroid-hormone JJ I-NP
receptors NNS I-NP
( -LRB- O
SMRT) NNP B-NP
] , O
without IN O
concomitant NN O
increases NNS O
in IN O
GR CD B-NP
. . O

-DOCSTART- X X O

The DT O
pyridostigmine NN O
inhibited VBD O
AChE NNP B-NP
recovered VBD O
only RB O
in IN O
the DT O
100 CD O
mumol NN O
kg-1 NN O
kg NN O
oxime NN O
groups NNS O
at IN O
the DT O
end NN O
of IN O
the DT O
experiment NN O
. . O

-DOCSTART- X X O

We PRP O
compared VBN O
retrospectively RB O
the DT O
efficacy NN O
of IN O
granulocyte NN B-NP
colony NN I-NP
stimulating NN I-NP
factor NN I-NP
(G-CSF NNP O
) -RRB- O
alone RB O
with IN O
chemotherapy NN O
plus CC O
G-CSF NNP B-NP
in IN O
mobilizing VBG O
CD34-positive JJ B-NP
cells NNS O
in IN O
patients NNS O
with IN O
malignant JJ O
lymphoma NN O
. . O

-DOCSTART- X X O

Activation NN O
of IN O
the DT O
receptor NN O
induces VBZ O
Ret NNP B-NP
phosphorylation NN O
that WDT O
leads VBZ O
the DT O
survival-promoting JJ O
effects NNS O
. . O

-DOCSTART- X X O

Adenovirus NNP O
infection NN O
of IN O
hepatoma NN O
cells NNS O
inhibited VBN O
transcription NN O
of IN O
the DT O
phosphoenolpyruvate JJ B-NP
carboxykinase NN I-NP
( -LRB- O
GTP NNP O
) -RRB- O
(EC JJ O
4.1.1.32 CD B-NP
) -RRB- O
( -LRB- O
PEPCK) NN B-NP
gene NN O
and CC O
virtually RB O
eliminated VBD O
transcription NN O
of IN O
a DT O
chimeric JJ O
gene NN O
which WDT O
contained VBD O
the DT O
PEPCK NN B-NP
promoter NN I-NP
linked VBN O
to TO O
the DT O
structural JJ O
gene NN O
for IN O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
( -LRB- O
CAT NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Circulating VBG O
immune JJ O
complexes NNS O
were VBD O
determined VBN O
by IN O
the DT O
method NN O
of IN O
phagocytosis NN O
and CC O
immunofluorescence NN O
. . O

-DOCSTART- X X O

LCCH1 NNP B-NP
was VBD O
identical JJ O
to TO O
the DT O
Rdl NNP B-NP
gene NN I-NP
, , O
a DT O
known VBN O
GABA NNP B-NP
receptor NN I-NP
subunit NN I-NP
gene NN I-NP
from IN O
D. NNP O
melanogaster NN O
, , O
whereas IN O
LCCH2 NNP B-NP
and CC O
LCCH3 NNP B-NP
were VBD O
novel JJ O
D. NNP O
melanogaster NN O
sequences NNS O
that WDT O
exhibited VBD O
structural JJ O
similarity NN O
to TO O
other JJ O
members NNS O
of IN O
the DT O
ligand-gated JJ B-NP
chloride NN I-NP
channel NN I-NP
gene NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

In IN O
this DT O
report NN O
, , O
we PRP O
investigated VBD O
whether IN O
the DT O
cleavage NN O
of IN O
the DT O
RRKR NNP O
motif NN O
of IN O
MT-MMP1 NNP B-NP
by IN O
Golgi-associated NNP B-NP
furin NN I-NP
is VBZ O
analogous JJ O
to TO O
a DT O
similar JJ O
enzyme NN O
activation NN O
mechanism NN O
observed VBD O
with IN O
stromelysin-3 JJ B-NP
. . O

-DOCSTART- X X O

Lifestyle NN O
characteristics NNS O
were VBD O
ascertained VBN O
by IN O
a DT O
self-administered JJ O
questionnaire NN O
. . O

-DOCSTART- X X O

The DT O
oxalate NN B-NP
oxidase NN I-NP
method NN O
results NNS O
in IN O
a DT O
mean JJ O
and CC O
reference NN O
interval NN O
for IN O
oxalate NN O
excretion NN O
that WDT O
are VBP O
comparable JJ O
with IN O
those DT O
by IN O
isotope DT O
dilution NN O
, , O
gas-chromatographic JJ O
, , O
colorimetric JJ O
, , O
and CC O
other JJ O
enzymic JJ O
procedures NNS O
. . O

-DOCSTART- X X O

Normal JJ O
replication NN O
of IN O
DNA NNP B-NP
A NNP I-NP
still RB O
carrying VBG O
the DT O
AC3 NNP B-NP
ORF NNP I-NP
mutation NN O
was VBD O
found VBN O
in IN O
extracts NNS O
from IN O
these DT O
plants NNS O
. . O

-DOCSTART- X X O

Kohtz NNP O
, , O
J. NNP O

-DOCSTART- X X O

These DT O
data NNS O
are VBP O
discussed VBN O
in IN O
the DT O
context NN O
of IN O
the DT O
pathogenesis NN O
and CC O
differential JJ O
diagnosis NN O
of IN O
EEC NNP O
. . O

-DOCSTART- X X O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
fibrinogen NN B-NP
gamma NN I-NP
chain NN I-NP
region NN I-NP
Gly190-Val202 JJ I-NP
functions NNS O
as IN O
a DT O
minimal JJ O
recognition NN O
sequence NN O
for IN O
the DT O
leukocyte NN O
integrin NN O
CD11b/CD18 NNS B-NP
. . O

-DOCSTART- X X O

OBJECTIVE VBP O
: : O
The DT O
audiologic NN O
presentation NN O
of IN O
vestibular JJ O
schwannoma NN O
(VS NNP O
) -RRB- O
associated VBN O
with IN O
neurofibromatosis NN O
type NN O
2 CD O
( -LRB- O
NF2 NN O
) -RRB- O
has VBZ O
not RB O
been VBN O
well RB O
characterized VBN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
the DT O
NMDA-receptor NN B-NP
antagonist NN O
( -LRB- O
+/-)-CPP NNP O
on IN O
the DT O
conditioned-reflex JJ O
activation NN O
of IN O
an DT O
operant NN O
reaction NN O
in IN O
the DT O
brain NN O
electrical JJ O
self-stimulation NN O
test NN O
in IN O
rats NNS O

-DOCSTART- X X O

Treatment NNP O
with IN O
H7 PRP O
did VBD O
not RB O
affect VB O
IL-4R-mediated JJ B-NP
immediate JJ O
signaling VBG O
events NNS O
such JJ O
as IN O
tyrosine NN O
phosphorylation NN O
of IN O
Jak1 NNP B-NP
, , O
Jak3 NNP B-NP
, , O
insulin NN B-NP
receptor NN I-NP
substrate NN I-NP
( -LRB- I-NP
IRS)-1 NNP I-NP
and CC O
IRS-2 NNP B-NP
, , O
or CC O
tyrosine NN O
phosphorylation NN O
and CC O
DNA NNP O
binding NN O
of IN O
Stat6 NNP B-NP
. . O

-DOCSTART- X X O

( -LRB- O
1982 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Vasodilation NNP O
in IN O
congestive JJ O
heart NN O
failure NN O
is VBZ O
an DT O
established VBN O
therapeutic JJ O
principal NN O
. . O

-DOCSTART- X X O

The DT O
translational JJ O
product NN O
of IN O
UL26.5 DT B-NP
is VBZ O
infected-cell JJ B-NP
protein NN I-NP
35c JJ I-NP
,d NN I-NP
( -LRB- O
ICP35c JJ B-NP
,d NN I-NP
) -RRB- O
( -LRB- O
F. NNP O

-DOCSTART- X X O

Minor NNP O
changes NNS O
within IN O
the DT O
transmembrane NN O
domains VBZ O
( -LRB- O
TMs) NN O
sometimes RB O
produced VBD O
major JJ O
effects NNS O
and CC O
more JJR O
drastic JJ O
changes NNS O
in IN O
the DT O
TMs NNP O
ablated VBD O
surface NN O
expression NN O
entirely RB O
. . O

-DOCSTART- X X O

Mammalian JJ O
chromosome NN O
ends NNS O
contain VBP O
long JJ O
arrays NNS O
of IN O
TTAGGG NNP O
repeats NNS O
that WDT O
are VBP O
complexed VBN O
to TO O
a DT O
telomere JJ O
specific JJ O
protein NN O
, , O
the DT O
TTAGGG NNP B-NP
repeat NN I-NP
binding NN I-NP
factor NN I-NP
, , O
TRF1 NNP B-NP
. . O

-DOCSTART- X X O

HPV-16 CD O
MARs NNS O
are VBP O
context NN O
dependent JJ O
transcriptional JJ O
enhancers NNS O
, , O
and CC O
activated JJ O
expression NN O
of IN O
HPV-16 CD O
oncogenes NNS O
dependent JJ O
on IN O
chromosomal NN O
integration NN O
may MD O
positively RB O
select VB O
tumorigenic JJ O
cells NNS O
during IN O
the DT O
multistep JJ O
etiology NN O
of IN O
cervical JJ O
cancer NN O
. . O

-DOCSTART- X X O

Vancomycin NNP O
and CC O
tetracycline VBP O
eliminated VBN O
toxin NN O
in IN O
stools NNS O
and CC O
delayed VBN O
death NN O
. . O

-DOCSTART- X X O

The DT O
duration NN O
of IN O
naloxone NN O
appears VBZ O
to TO O
be VB O
dose-related JJ O
, , O
statistically RB O
significant JJ O
up RB O
to TO O
approximately RB O
1.5 CD O
hr NN O
. . O

-DOCSTART- X X O

Reconstruction NNP O
time NN O
for IN O
a DT O
64 CD O
x NN O
64 CD O
matrix NN O
is VBZ O
approximately RB O
45 CD O
s/transaxial JJ O
slice NN O
. . O

-DOCSTART- X X O

The DT O
immediate JJ O
and CC O
remote JJ O
results NNS O
of IN O
surgical JJ O
treatment NN O
of IN O
renal JJ O
adenocarcinomas NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
MCMI-II NNP O
I PRP O
group NN O
profile NN O
was VBD O
significantly RB O
lower JJR O
in IN O
magnitude NN O
compared VBN O
with IN O
the DT O
MCMI-II NNP O
. . O

-DOCSTART- X X O

The DT O
impairment NN O
of IN O
the DT O
nocturnal JJ O
secretion NN O
was VBD O
related VBN O
to TO O
the DT O
subjects NNS O
' POS O
age NN O
and CC O
, , O
for IN O
the DT O
GH NNP B-NP
secretory NN O
pattern NN O
only RB O
, , O
also RB O
to TO O
the DT O
MMSE NNP O
score NN O
. . O

-DOCSTART- X X O

Earlier JJR O
nonoptical JJ O
methods NNS O
probably RB O
did VBD O
not RB O
include VB O
the DT O
portion NN O
of IN O
the DT O
film NN O
that IN O
contained VBN O
mucus NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
report VBP O
that DT O
point NN O
mutations NNS O
of IN O
the DT O
Abd-B NNP B-NP
gene NN I-NP
in IN O
trans NNS O
suppress VBP O
the DT O
Fab-7 NNP B-NP
phenotype NN I-NP
in IN O
a DT O
pairing-dependent JJ O
manner NN O
and CC O
thus RB O
represent VB O
a DT O
type NN O
of IN O
transvection NN O
. . O

-DOCSTART- X X O

The DT O
glucose JJ O
effect NN O
on IN O
the DT O
pyruvate JJ B-NP
kinase NN I-NP
gene NN I-NP
is VBZ O
reversibly RB O
antagonized VBN O
by IN O
agents NNS O
increasing VBG O
intracellular JJ O
cAMP. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
report VBP O
the DT O
isolation NN O
of IN O
a DT O
new JJ O
spindle NN O
checkpoint NN O
gene NN O
, , O
mph1 CD B-NP
( -LRB- O
Mps1p-like JJ B-NP
pombe NN I-NP
homolog NN I-NP
) -RRB- O
, , O
in IN O
the DT O
fission NN O
yeast NN O
Schizosaccharomyces NNP O
pombe VBD O
, , O
that WDT O
is VBZ O
required VBN O
for IN O
checkpoint NN O
activation NN O
in IN O
response NN O
to TO O
spindle VB O
defects NNS O
. . O
mph1 NN B-NP
functions VBZ O
upstream RB O
of IN O
mad2 JJ B-NP
, , O
a DT O
previously RB O
characterized VBN O
component NN O
of IN O
the DT O
spindle NN O
checkpoint NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
measurements NNS O
of IN O
shielded VBN O
and CC O
unshielded VBN O
syringes NNS O
containing VBG O
99mTc-labelled JJ O
radiopharmaceuticals NNS O
were VBD O
carried VBN O
out RP O
. . O

-DOCSTART- X X O

The DT O
well-trained JJ O
group NN O
was VBD O
measured VBN O
once RB O
in IN O
the DT O
respiration NN O
chamber NN O
for IN O
36 CD O
h NN O
according VBG O
to TO O
the DT O
same JJ O
protocol NN O
. . O

-DOCSTART- X X O

PtdIns( NNP B-NP
4,5)P2 CD I-NP
synthesis NN O
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
is VBZ O
only RB O
moderately RB O
affected VBN O
even RB O
in IN O
fab1Delta JJ B-NP
mutants NNS I-NP
. . O

-DOCSTART- X X O

Protein NNP O
sequencing NN O
, , O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
, , O
and CC O
immunoblot NN O
analyses NNS O
identify VBP O
p54 NN B-NP
and CC O
p47/48 VBD B-NP
as IN O
members NNS O
of IN O
the DT O
hepatocyte NN B-NP
nuclear JJ I-NP
factor NN I-NP
3 CD I-NP
( -LRB- O
HNF3 JJ B-NP
[forkhead] NN O
) -RRB- O
family NN O
of IN O
transcription NN O
factors NNS O
. . O
p54 NN B-NP
belongs VBZ O
to TO O
the DT O
subfamily NN O
of IN O
HNF3 JJ B-NP
beta JJ I-NP
proteins NNS I-NP
, , O
while IN O
p47/48 VBG B-NP
binding JJ O
activity NN O
includes VBZ O
HNF3 JJ B-NP
gamma NN I-NP
. . O

-DOCSTART- X X O

The DT O
TCR NNP B-NP
beta NN I-NP
enhancer NN I-NP
was VBD O
active JJ O
on IN O
both DT O
the DT O
minimal JJ B-NP
simian NN I-NP
virus NN I-NP
40 CD I-NP
promoter NN I-NP
and CC O
a DT O
TCR NNP B-NP
beta NN I-NP
variable JJ I-NP
gene NN I-NP
promoter NN I-NP
in IN O
both DT O
TCR NNP B-NP
alpha/beta NN I-NP
+ NN O
and CC O
TCR NNP B-NP
gamma/delta NNP I-NP
+ VBZ O
T NNP O
cells NNS O
. . O

-DOCSTART- X X O

Fibrosis NNP O
of IN O
the DT O
adjacent JJ O
myocardium NN O
was VBD O
seen VBN O
in IN O
five CD O
cases NNS O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
T3R NNP B-NP
can MD O
repress VB O
or CC O
activate VB O
transcription NN O
while IN O
tethered JJ O
to TO O
the DT O
LBD NNP O
of IN O
GAL4-RXR NNP B-NP
and CC O
that DT O
heterodimerization NN O
can MD O
occur VB O
in IN O
vivo NN O
without IN O
stabilization NN O
by IN O
hormone NN O
response NN O
elements NNS O
. . O

-DOCSTART- X X O

Surprisingly RB O
, , O
in IN O
adult NN O
animals NNS O
, , O
the DT O
suprabasal JJ O
expression NN O
of IN O
dnRXR NN B-NP
alpha NN I-NP
significantly RB O
reduced VBD O
the DT O
ability NN O
of IN O
topically RB O
applied VBN O
tRA NN O
to TO O
stimulate VB O
proliferation NN O
of IN O
undifferentiated JJ O
keratinocytes NNS O
in IN O
the DT O
basal JJ O
layer NN O
of IN O
epidermis NN O
. . O

-DOCSTART- X X O

A DT O
third-order NN O
polynominal JJ O
fit NN O
showed VBD O
a DT O
good JJ O
correlation NN O
for IN O
the DT O
parameter NN O
Q* NNP O
and CC O
MTT NNP O
, , O
whereas IN O
T NNP O
and CC O
SImax NNP O
were VBD O
found VBN O
to TO O
have VB O
a DT O
poor JJ O
correlation NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
demonstrate VBP O
the DT O
extensive JJ O
homology NN O
in IN O
sequence NN O
among IN O
light JJ O
chains NNS O
of IN O
IgM NNP B-NP
kappa NN I-NP
autoantibodies NNS I-NP
and CC O
indicate VBP O
that IN O
a DT O
particular JJ O
V NNP B-NP
kappa NN I-NP
germ NN I-NP
line NN I-NP
gene NN I-NP
, , O
kappa NN B-NP
IIIb NNP I-NP
, , O
is VBZ O
expressed VBN O
as IN O
a DT O
phylogenetic JJ O
response NN O
to TO O
certain JJ O
self NN O
antigens NNS O
or CC O
as IN O
part NN O
of IN O
a DT O
selection NN O
process NN O
by IN O
which WDT O
these DT O
autoimmune JJ O
responses NNS O
are VBP O
regulated VBN O
. . O

-DOCSTART- X X O

The DT O
aim NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
influence NN O
of IN O
long JJ O
term NN O
intravenous JJ O
administration NN O
of IN O
naftidrofuryl NN O
( -LRB- O
Dusodril-Lipha JJ O
Arzn NN O
) -RRB- O
twice RB O
daily RB O
in IN O
a DT O
dose NN O
of IN O
200 CD O
mg NN O
in IN O
continuous JJ O
, , O
4-hour JJ O
infusion NN O
in IN O
500 CD O
ml CD O
0.9 CD O
% NN O
NaCl NNP O
to TO O
the DT O
patients NNS O
suffering VBG O
from IN O
a DT O
peripheral JJ O
arterial NN O
occlusive JJ O
disease NN O
( -LRB- O
PAOD NN O
) -RRB- O
in IN O
a DT O
clinical JJ O
condition NN O
with IN O
special JJ O
attention NN O
paid VBN O
to TO O
transcutaneous JJ O
partial JJ O
oxygen NN O
pressure NN O
measurements NNS O
(tcPO2 IN O
) -RRB- O
and CC O
rheographic JJ O
parameters NNS O
. . O

-DOCSTART- X X O

We PRP O
concluded VBD O
that IN O
RXR-gamma NNP B-NP
induced VBD O
terminal JJ O
differentiation NN O
in IN O
SCC NNP O
lines NNS O
, , O
suggesting VBG O
a DT O
potential JJ O
tumor NN O
suppressor NN O
function NN O
for IN O
this DT O
transcription NN O
factor NN O
. . O

-DOCSTART- X X O

A DT O
very RB O
large JJ O
PC NN O
LAN NNP O
as IN O
the DT O
basis NN O
for IN O
a DT O
hospital NN O
information NN O
system NN O
. . O

-DOCSTART- X X O

After IN O
institution NN O
of IN O
insulin NN B-NP
treatment NN O
, , O
diabetic JJ O
control NN O
was VBD O
improved VBN O
as IN O
demonstrated VBN O
by IN O
decreasing VBG O
levels NNS O
of IN O
HbA1 NNP B-NP
. . O

-DOCSTART- X X O

Both DT O
parameters NNS O
were VBD O
determined VBN O
in IN O
an DT O
individual JJ O
eye NN O
by IN O
applying VBG O
the DT O
dye NN O
first RB O
by IN O
iontophoresis NN O
and CC O
then RB O
by IN O
intravitreal JJ O
injection NN O
, , O
which WDT O
allows VBZ O
the DT O
influence NN O
of IN O
fluorescein NN O
glucuronide NN O
on IN O
the DT O
fluorophotometric JJ O
measurements NNS O
to TO O
be VB O
excluded VBN O
. . O

-DOCSTART- X X O

Phase NN O
I PRP O
clinical JJ O
trial NN O
with IN O
a DT O
combination NN O
of IN O
methotrexate NN O
and CC O
mitomycin NN O
C. NNP O

-DOCSTART- X X O

A DT O
total NN O
of IN O
114 CD O
animals NNS O
were VBD O
infected VBN O
by IN O
E. NNP O
coli NNS O
O2:K1:H4 NNP O
by IN O
the DT O
hematogenic JJ O
route NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
These DT O
results NNS O
suggest VBP O
that IN O
, , O
by IN O
interacting VBG O
with IN O
cellular JJ O
transcription NN O
factors NNS O
and CC O
cofactors NNS O
, , O
vIRF-2 NN B-NP
may MD O
modulate VB O
the DT O
expression NN O
of IN O
the DT O
early JJ O
inflammatory NN O
genes NNS O
and CC O
potentially RB O
deregulate VB O
the DT O
immune JJ O
system NN O
. . O

-DOCSTART- X X O

AIMS NNP O
: : O
The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
assess VB O
static JJ O
and CC O
dynamic JJ O
bone NN O
changes NNS O
in IN O
patients NNS O
suffering VBG O
from IN O
rickets NNS O
. . O

-DOCSTART- X X O

The DT O
homeodomain NN B-NP
transcription NN I-NP
factor NN I-NP
CDP/cut IN B-NP
interacts NNS O
with IN O
the DT O
cell NN O
cycle NN O
regulatory JJ O
element NN O
of IN O
histone NN B-NP
H4 IN I-NP
genes NNS I-NP
packaged VBN O
into IN O
nucleosomes NNS O
. . O

-DOCSTART- X X O

K. NNP O
, , O
Weiss NNP O
, , O
M. NNP O

-DOCSTART- X X O

Thus RB O
, , O
IF-laser NNP O
therapy NN O
has VBZ O
a DT O
certain JJ O
antioxidative JJ O
effect NN O
by IN O
increasing VBG O
SOD JJ B-NP
activity NN O
in IN O
RA NNP O
patients NNS O
' POS O
blood NN O
cells NNS O
and CC O
reducing VBG O
the DT O
production NN O
of IN O
highly RB O
reactive JJ O
oxygen NN O
and CC O
nitrogen JJ O
forms NNS O
. . O

-DOCSTART- X X O

During IN O
hexamethylene NN O
bisactamide NN O
( -LRB- O
HMBA)-induced JJ O
differentiation NN O
of IN O
murine NN O
erythroleukemia NN O
( -LRB- O
MEL NNP O
) -RRB- O
cells NNS O
erythroid VBN O
genes NNS O
are VBP O
transcriptionally RB O
activated VBN O
while IN O
c-myb JJ B-NP
and CC O
several JJ O
other JJ O
nuclear JJ O
proto-oncogenes NNS O
are VBP O
down-regulated JJ O
. . O

-DOCSTART- X X O

We PRP O
now RB O
report VBP O
identification NN O
and CC O
analysis NN O
of IN O
transcriptional JJ O
activities NNS O
mediated VBN O
by IN O
three CD O
cis-acting JJ O
sites NNS O
within IN O
a DT O
90-bp JJ O
portion NN O
of IN O
the DT O
rDNA NNP O
enhancer NN O
designated VBD O
the DT O
modulator NN O
region NN O
. . O

-DOCSTART- X X O

In IN O
human JJ O
WI38 IN O
cells NNS O
, , O
the DT O
E1B NNP B-NP
19K CD I-NP
gene NN I-NP
mutant JJ I-NP
viruses NNS O
had VBD O
a DT O
substantial JJ O
growth NN O
advantage NN O
over IN O
the DT O
wild-type JJ O
virus NN O
, , O
yielding VBG O
500-fold-higher JJ O
titers NNS O
. . O

-DOCSTART- X X O

The DT O
N-terminal JJ O
sequence NN O
of IN O
the DT O
extracellular JJ B-NP
MEP20 NNP I-NP
, , O
TKVAS NNP B-NP
, , O
was VBD O
found VBN O
at IN O
aa JJ O
194-198 CD O
within IN O
the DT O
ORF. NNP O

-DOCSTART- X X O

Furthermore RB O
, , O
mutations NNS O
in IN O
element NN O
II NNP O
result NN O
in IN O
changes NNS O
in IN O
the DT O
RNA NNP O
structure NN O
near IN O
element NN O
III NNP O
, , O
consistent JJ O
with IN O
a DT O
long-range JJ O
interaction NN O
that WDT O
may MD O
promote VB O
translation NN O
. . O

-DOCSTART- X X O

( -LRB- O
We PRP O
observed VBD O
a DT O
ferritin JJ B-NP
value NN O
as RB O
high JJ O
as IN O
47 CD O
mg/L NN O
in IN O
one CD O
patient NN O
. . O
) -RRB- O
Results NNS O
with IN O
all PDT O
these DT O
kits NNS O
did VBD O
not RB O
inter-compare JJ O
well RB O
for IN O
ferritin NN B-NP
concentrations NNS O
greater JJR O
than IN O
300 CD O
micrograms/L NN O
, , O
a DT O
finding VBG O
that IN O
casts NNS O
further JJ O
doubt NN O
on IN O
the DT O
controversial JJ O
use NN O
of IN O
serum NN B-NP
ferritin NN I-NP
measurement NN O
in IN O
cases NNS O
of IN O
iron NN O
overload NN O
. . O

-DOCSTART- X X O

A. NN O

-DOCSTART- X X O

We PRP O
propose VBP O
that IN O
U73 NNP B-NP
is VBZ O
involved VBN O
in IN O
methylation NN O
of IN O
the DT O
G1739 NNP O
residue NN O
of IN O
the DT O
human JJ B-NP
28S CD I-NP
rRNA NN I-NP
. . O

-DOCSTART- X X O

Animals NNS O
were VBD O
divided VBN O
into IN O
six CD O
equal JJ O
groups NNS O
as IN O
follows VBZ O
: : O
( -LRB- O
1 CD O
) -RRB- O
no DT O
oral JJ O
drug NN O
( -LRB- O
water NN O
) -RRB- O
, , O
no DT O
hemodilution NN O
, , O
no DT O
IV NNP O
drug NN O
( -LRB- O
saline NN O
) -RRB- O
; : O
( -LRB- O
2 CD O
) -RRB- O
oral JJ O
water NN O
, , O
hemodilution NN O
, , O
IV NNP O
saline NN O
; : O
( -LRB- O
3 CD O
) -RRB- O
oral JJ O
water NN O
, , O
no DT O
hemodilution NN O
, , O
IV NNP O
propranolol NN O
; : O
( -LRB- O
4 CD O
) -RRB- O
oral JJ O
water NN O
, , O
hemodilution NN O
, , O
IV NNP O
propranolol NN O
; : O
( -LRB- O
5 CD O
) -RRB- O
oral JJ O
propranolol NN O
, , O
no DT O
hemodilution NN O
, , O
IV NNP O
saline NN O
; : O
and CC O
( -LRB- O
6 CD O
) -RRB- O
oral JJ O
propranolol NN O
, , O
hemodilution NN O
, , O
IV NNP O
saline NN O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
4 CD O
highly RB O
conserved VBN O
regions NNS O
to TO O
vertebrate JJ B-NP
Hsp90 IN I-NP
exclusively RB O
and CC O
27 CD O
amino IN O
acids NNS O
conserved VBN O
among IN O
but CC O
differing VBG O
between IN O
Hsp90 CD B-NP
alpha NN I-NP
and CC O
Hsp90 CD B-NP
beta JJ I-NP
sequences NNS I-NP
. . O

-DOCSTART- X X O

Four CD O
newborns NNS O
in IN O
this DT O
group NN O
became VBD O
HBsAg JJ B-NP
carriers NNS O
. . O

-DOCSTART- X X O

It PRP O
tends VBZ O
to TO O
be VB O
higher JJR O
between IN O
frazioni NNS O
of IN O
the DT O
same JJ O
community NN O
than IN O
between IN O
communities NNS O
. . O

-DOCSTART- X X O

In IN O
previous JJ O
studies NNS O
, , O
we PRP O
showed VBD O
that IN O
the DT O
nuclear JJ O
import NN O
of IN O
SREBP-2 NNP B-NP
occurs VBZ O
via IN O
the DT O
direct JJ O
interaction NN O
of IN O
importin VBG B-NP
beta NN I-NP
with IN O
the DT O
HLH-Zip NNP O
domain NN O
. . O

-DOCSTART- X X O

Ftz NNP B-NP
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
influences VBZ O
Ftz-F1 JJ B-NP
activity NN O
by IN O
interacting NN O
with IN O
its PRP$ O
AF-2 JJ O
domain NN O
in IN O
a DT O
manner NN O
that WDT O
mimics VBZ O
a DT O
nuclear JJ O
receptor NN O
coactivator NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
In IN O
the DT O
majority NN O
of IN O
patients NNS O
with IN O
severe JJ O
ulcerative JJ O
colitis NN O
, , O
circulating VBG O
concentrations NNS O
of IN O
NOX NNP O
are VBP O
increased VBN O
at IN O
presentation NN O
and CC O
fall NN O
promptly RB O
during IN O
parenteral JJ O
steroid JJ O
therapy NN O
, , O
irrespective NN O
of IN O
clinical JJ O
outcome NN O
. . O

-DOCSTART- X X O

A DT O
cDNA NN O
for IN O
human JJ B-NP
microfibril-associated JJ I-NP
glycoprotein-2 NN I-NP
( -LRB- O
MAGP-2 NN B-NP
) -RRB- O
was VBD O
used VBN O
to TO O
screen VB O
a DT O
human JJ O
leukocyte NN O
genomic JJ O
DNA NNP O
library NN O
in IN O
EMBL-3 NN O
vector NN O
. . O

-DOCSTART- X X O

They PRP O
are VBP O
transduced VBN O
through IN O
TM NNP O
to TO O
the DT O
cytoplasmic JJ O
portion NN O
( -LRB- O
cytoloops NNS O
and CC O
the DT O
C-terminal JJ O
tail NN O
) -RRB- O
of IN O
the DT O
receptor NN O
and CC O
then RB O
, , O
transferred VBN O
to TO O
cytoplasmic JJ O
signaling NN O
molecules NNS O
, , O
such JJ O
as IN O
G NNP B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Primary JJ O
TJRs NNS O
were VBD O
clinically RB O
evaluated VBN O
for IN O
degree NN O
of IN O
osteoarthrosis NN O
. . O

-DOCSTART- X X O

It PRP O
produced VBD O
extrapyramidal JJ O
disturbances NNS O
in IN O
nearly RB O
every DT O
subject NN O
, , O
the DT O
most RBS O
common JJ O
being VBG O
akathisia NN O
and CC O
the DT O
most RBS O
severe JJ O
, , O
in IN O
the DT O
case NN O
of IN O
one CD O
individual NN O
, , O
being VBG O
acute JJ O
dystonia NN O
. . O

-DOCSTART- X X O

Electron NNP O
microscopy NN O
of IN O
pH DT O
7.5-treated JJ O
TMV NNP O
particles NNS O
incubated VBN O
in IN O
SPN-treated JJ B-NP
wheatgerm NN O
extract VB O
or CC O
rabbit VB O
reticulocyte NN O
lysate NN O
, , O
showed VBD O
that IN O
approximately RB O
10 CD O
% NN O
of IN O
virions NNS O
complexed VBN O
with IN O
one CD O
ribosome JJ O
and CC O
approximately RB O
10 CD O
% NN O
with IN O
two CD O
bound JJ O
ribosomes NNS O
, , O
confirming VBG O
that IN O
omega JJ O
at IN O
least JJS O
had VBD O
been VBN O
uncoated VBN O
. . O

-DOCSTART- X X O

The DT O
absorbance NN O
of IN O
the DT O
eluent JJ O
was VBD O
monitored VBN O
at IN O
254 CD O
nm NN O
. . O

-DOCSTART- X X O

All DT O
patients NNS O
studied VBD O
were VBD O
pregnant JJ O
women NNS O
and CC O
their PRP$ O
delivered VBN O
children NNS O
. . O

-DOCSTART- X X O

Using VBG O
this DT O
oligonucleotide NNP O
as IN O
a DT O
probe NN O
, , O
an DT O
8-kilobase JJ O
HindIII NNP B-NP
fragment NN O
of IN O
genomic JJ O
DNA NNP O
was VBD O
isolated VBN O
and CC O
subjected VBN O
to TO O
Sanger NNP O
dideoxy JJ O
DNA NNP O
sequencing NN O
. . O

-DOCSTART- X X O

The DT O
Rep NNP B-NP
proteins VBZ I-NP
of IN O
adeno-associated JJ O
virus NN O
type NN O
2 CD O
( -LRB- O
AAV NN O
) -RRB- O
are VBP O
known VBN O
to TO O
bind NN O
to TO O
Rep NNP B-NP
recognition NN I-NP
sequences NNS I-NP
( -LRB- O
RRSs NNS B-NP
) -RRB- O
in IN O
the DT O
AAV NNP O
inverted VBD O
terminal NN O
repeats NNS O
( -LRB- O
ITRs NNS O
) -RRB- O
, , O
the DT O
AAV NNP B-NP
p5 NN I-NP
promoter NN I-NP
, , O
and CC O
the DT O
preferred VBN O
AAV NNP O
integration NN O
site NN O
in IN O
human JJ O
chromosome NN O
19 CD O
, , O
called VBN O
AAVS1 NNP O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
noteworthy JJ O
that IN O
under IN O
more JJR O
physiological JJ O
conditions NNS O
mimicking VBG O
the DT O
cellular JJ O
GDP/GTP NNP O
ratio NN O
, , O
Raf NNP B-NP
enhances VBZ O
the DT O
GEF-stimulated JJ B-NP
GDP/GTP NNP O
exchange NN O
on IN O
Ha-Ras NNP B-NP
, , O
in IN O
agreement NN O
with IN O
the DT O
sequestration NN O
of IN O
Ras.GTP NNP B-NP
by IN O
Raf NNP B-NP
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
show VBP O
that IN O
HNF-4 NNP B-NP
, , O
a DT O
member NN O
of IN O
the DT O
steroid NN B-NP
hormone NN I-NP
receptor NN I-NP
superfamily NN I-NP
, , O
binds VBZ O
the DT O
AF-1 JJ B-NP
site NN I-NP
on IN O
the DT O
apoB NN B-NP
promoter NN I-NP
and CC O
through IN O
it PRP O
activates VBZ O
transcription NN O
in IN O
transient NN O
transfection NN O
assays VBZ O
in IN O
both DT O
liver NN O
and CC O
non-liver JJ O
cell NN O
lines NNS O
, , O
HepG2 NNP O
and CC O
HeLa NNP O
, , O
respectively RB O
. . O

-DOCSTART- X X O

In IN O
Cos NNP O
7 CD O
cells NNS O
transfected VBN O
with IN O
oCRF1var JJ B-NP
, , O
cAMP JJ O
accumulation NN O
was VBD O
only RB O
observed VBN O
at IN O
the DT O
highest JJS O
concentration NN O
of IN O
oCRF NN B-NP
utilized VBN O
( -LRB- O
100 CD O
nM NN O
) -RRB- O
. . O

-DOCSTART- X X O

Usefulness NNP O
of IN O
glucocorticoids NNS O
in IN O
the DT O
treatment NN O
of IN O
congestive JJ O
heart NN O
failure NN O

-DOCSTART- X X O

Plasma NNP B-NP
renin NN I-NP
activity NN O
in IN O
essential JJ O
arterial NN O
hypertension NN O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
, , O
cytokine NN O
- : O
or CC O
hypoxia-induced JJ O
up-regulation NN O
of IN O
Fas NNP B-NP
expression NN O
is VBZ O
associated VBN O
with IN O
RTC NNP O
apoptosis NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
Reg1-Glc7 NNP B-NP
phosphatase NN O
is VBZ O
a DT O
cytoplasmic JJ O
component NN O
of IN O
the DT O
machinery NN O
responsible JJ O
for IN O
returning VBG O
Snf1 NNP B-NP
kinase NN I-NP
activity NN O
to TO O
its PRP$ O
basal JJ O
level NN O
and CC O
reestablishing VBG O
glucose JJ O
repression NN O
. . O

-DOCSTART- X X O

To TO O
explore VB O
further RB O
the DT O
role NN O
of IN O
the DT O
carboxyl-terminal JJ O
domain NN O
in IN O
determining VBG O
the DT O
cell NN O
cycle NN O
function NN O
of IN O
CDC34 NNP B-NP
, , O
we PRP O
constructed VBD O
and CC O
characterized VBD O
genes NNS O
encoding VBG O
chimeric JJ B-NP
E2s JJ I-NP
incorporating NN O
sequences NNS O
from IN O
CDC34 NNP B-NP
and CC O
the DT O
related JJ O
but CC O
functionally RB O
distinct JJ O
E2 NN B-NP
RAD6 IN B-NP
( -LRB- O
UBC2 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
F9 NNP O
, , O
which WDT O
is VBZ O
a DT O
prototype NN O
of IN O
embryonal JJ O
carcinoma NN O
cells NNS O
expressing VBG O
hst RB B-NP
, , O
the DT O
expression NN O
of IN O
hst JJ B-NP
gene NN I-NP
is VBZ O
positively RB O
regulated VBN O
by IN O
a DT O
downstream NN O
octamer NN O
motif NN O
that WDT O
functions VBZ O
as IN O
an DT O
enhancer NN O
. . O

-DOCSTART- X X O

Only RB O
viable JJ O
bacteria NNS O
at IN O
a DT O
high JJ O
concentration NN O
induced VBN O
purulent JJ O
otitis NN O
media NNS O
, , O
which WDT O
was VBD O
culture NN O
positive JJ O
in IN O
58 CD O
% NN O
of IN O
the DT O
cases NNS O
on IN O
day NN O
4 CD O
. . O

-DOCSTART- X X O

The DT O
law NN O
and CC O
the DT O
chiropractor NN O
. . O

-DOCSTART- X X O

A DT O
distinct JJ O
5'-sequence NN O
in IN O
clone NN O
hMIWC2 NN O
suggested VBD O
an DT O
alternative JJ O
upstream JJ O
transcription NN O
initiation IN O
site NN O
. . O

-DOCSTART- X X O

98 CD O
, , O
93-98 CD O
) -RRB- O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
pre3-2 NN B-NP
mutation NN I-NP
strengthened VBD O
phenotypes NNS O
induced VBN O
by IN O
other JJ O
20 CD B-NP
S NNP I-NP
proteasomal NN I-NP
mutations NNS I-NP
, , O
indicating VBG O
that IN O
the DT O
peptidylglutamyl NN O
peptide-hydrolyzing NN O
activity NN O
has VBZ O
to TO O
fulfill VB O
some DT O
rescue NN O
functions NNS O
. . O

-DOCSTART- X X O

A DT O
mammalian JJ O
protein NN O
called VBN O
RFX NNP B-NP
or CC O
NF-X NNP B-NP
binds NNS O
to TO O
the DT O
X NNP O
box NN O
( -LRB- O
or CC O
X1 JJ O
box NN O
) -RRB- O
in IN O
the DT O
promoters NNS O
of IN O
a DT O
number NN O
of IN O
major JJ B-NP
histocompatibility NN I-NP
( -LRB- I-NP
MHC NNP I-NP
) -RRB- I-NP
class NN I-NP
II NNP I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

This DT O
result NN O
suggests VBZ O
that IN O
the DT O
target NN O
protein NN O
specificity NN O
of IN O
E2s NNP B-NP
can MD O
be VB O
altered VBN O
by IN O
the DT O
addition NN O
of IN O
appropriate JJ O
C-terminal JJ O
extensions NNS O
, , O
thus RB O
providing VBG O
a DT O
way NN O
to TO O
modify VB O
the DT O
selectivity NN O
of IN O
the DT O
ubiquitin NN B-NP
system NN O
. . O

-DOCSTART- X X O

This DT O
pattern NN O
of IN O
expression NN O
and CC O
differential JJ O
processing NN O
suggests VBZ O
a DT O
role NN O
for IN O
inrpk1 NN B-NP
in IN O
some DT O
aspect NN O
of IN O
SD NNP O
photoperiodic-induced JJ O
flowering NN O
in IN O
morning NN O
glory NN O
. . O

-DOCSTART- X X O

Co-expression NN O
of IN O
a DT O
gag-TRalpha NN B-NP
fusion NN O
protein NN O
in IN O
AEV-transformed JJ O
cells NNS O
and CC O
addition NN O
of IN O
ligand NN O
derepresses NNS O
CAII NNP B-NP
transcription NN O
. . O

-DOCSTART- X X O

A DT O
400-bp JJ O
fragment NN O
( -LRB- O
bp NN O
-339 CC O
through IN O
+71 CD O
) -RRB- O
of IN O
the DT O
CD22 NNP B-NP
promoter NN I-NP
region NN I-NP
was VBD O
subcloned VBN O
into IN O
a DT O
pGEM-chloramphenicol JJ O
acetyltransferase NN B-NP
vector NN O
and CC O
after IN O
transfection NN O
into IN O
B NNP O
and CC O
T NNP O
cells NNS O
was VBD O
found VBN O
to TO O
be VB O
active JJ O
in IN O
both DT O
B NNP O
and CC O
T NNP O
cells NNS O
. . O

-DOCSTART- X X O

Five CD O
RNA NNP O
transcripts NNS O
of IN O
about IN O
1.2 CD O
to TO O
1.7 CD O
kilobases NNS O
were VBD O
mapped VBN O
to TO O
a DT O
part NN O
of IN O
the DT O
genome NN O
of IN O
insect NN O
iridescent NN O
virus NN O
type NN O
6 CD O
( -LRB- O
Chilo NNP O
iridescent NN O
virus NN O
; : O
CIV NNP O
) -RRB- O
between IN O
genome NN O
coordinates NNS O
0.832 CD O
and CC O
0.856 CD O
within IN O
the DT O
EcoRI NNP B-NP
DNA NNP I-NP
fragment NN I-NP
F. NNP I-NP

-DOCSTART- X X O

Cutting VBG O
the DT O
intraorbital JJ O
nerves NNS O
produced VBD O
a DT O
temporary JJ O
retrieval JJ O
impairment NN O
that WDT O
was VBD O
indistinguishable JJ O
from IN O
that DT O
produced VBN O
by IN O
intramystacial JJ O
lidocaine NN O
injection NN O
. . O

-DOCSTART- X X O

The DT O
comparisons NNS O
of IN O
swimming VBG O
performance NN O
before IN O
and CC O
after IN O
treatments NNS O
with IN O
deltamethrin NN O
have VBP O
shown VBN O
a DT O
significant JJ O
effect NN O
on IN O
locomotory JJ O
ability NN O
of IN O
rainbow NN O
trout NN O
which WDT O
at IN O
the DT O
end NN O
of IN O
strong JJ O
exposure NN O
( -LRB- O
e NN O
.g NN O
. . O

-DOCSTART- X X O

Increased VBN O
trabecular JJ O
spacing NN O
, , O
such JJ O
as IN O
it PRP O
occurs VBZ O
in IN O
osteoporosis NN O
, , O
reduces VBZ O
the DT O
spatial JJ O
field NN O
inhomogeneity NN O
and CC O
thus RB O
prolongs VBZ O
T2* NNP O
, , O
which WDT O
has VBZ O
been VBN O
shown VBN O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Decidual/trophoblast NNP B-NP
prolactin-related JJ I-NP
protein NN I-NP
: : O
characterization NN O
of IN O
gene NN O
structure NN O
and CC O
cell-specific JJ O
expression NN O
. . O

-DOCSTART- X X O

RMR NNP O
was VBD O
positively RB O
correlated VBN O
with IN O
TEF NNP O
( -LRB- O
r NN O
= SYM O
0.613 CD O
, , O
p NN O
< NN O
0.01 CD O
) -RRB- O
and CC O
net JJ O
TEF NN O
( -LRB- O
r NN O
= SYM O
0.648 CD O
, , O
p NN O
< NN O
0.005 CD O
) -RRB- O
in IN O
the DT O
luteal NN O
but CC O
not RB O
the DT O
follicular JJ O
phase NN O
. . O

-DOCSTART- X X O

Nine CD O
individuals NNS O
who WP O
were VBD O
stable JJ O
after IN O
1 CD O
month NN O
of IN O
therapy NN O
at IN O
low JJ O
dosage NN O
were VBD O
randomized VBN O
to TO O
a DT O
further JJ O
month NN O
of IN O
therapy NN O
at IN O
low JJ O
or CC O
high JJ O
dosage NN O
, , O
during IN O
which WDT O
one CD O
of IN O
four CD O
at IN O
high JJ O
dosage NN O
had VBD O
a DT O
partial JJ O
response NN O
, , O
and CC O
none NN O
of IN O
five CD O
at IN O
low JJ O
dosage NN O
manifested VBN O
response NN O
. . O

-DOCSTART- X X O

Bile NNP O
reflux NN O
demonstrated VBN O
by IN O
99m NNP O
Tc NNP O
disofenin NN O
. . O

-DOCSTART- X X O

The DT O
mode NN O
of IN O
action NN O
is VBZ O
often RB O
suggested VBN O
as IN O
an DT O
explanation NN O
for IN O
the DT O
different JJ O
slopes NNS O
of IN O
concentration-effect JJ O
curves NNS O
. . O

-DOCSTART- X X O

Two CD O
full-length JJ O
clones NNS O
( -LRB- O
pBCH1 NN O
and CC O
pBCH2 NN O
) -RRB- O
were VBD O
isolated VBN O
. . O

-DOCSTART- X X O

In IN O
dehydrated JJ O
animals NNS O
at IN O
Ta NNP O
38 CD O
degrees NNS O
C NN O
, , O
Tb NNP O
and CC O
EWL NNP O
were VBD O
both DT O
significantly RB O
altered VBN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.001 CD O
) -RRB- O
from IN O
the DT O
normally RB O
hydrated JJ O
state NN O
and CC O
were VBD O
measured VBN O
at IN O
39.9 CD O
+/ NNS O
- : O
0.2 CD O
degree NN O
C NNP O
and CC O
0.84 CD O
+/ NNS O
- : O
0.09 CD O
W NNP O
. . O
kg-1 CD O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
optimum JJ O
cooling NN O
rate NN O
from IN O
RT NNP O
to TO O
5 CD O
degrees NNS O
C NN O
resulting VBG O
in IN O
maximum NN O
survival NN O
of IN O
human JJ O
spermatozoa NNS O
was VBD O
found VBN O
to TO O
be VB O
0.5 CD O
to TO O
1 CD O
degree NN O
per IN O
minute NN O
when WRB O
cooled VBN O
from IN O
RT NNP O
to TO O
5 CD O
degrees NNS O
C NN O
and CC O
subsequently RB O
frozen-thawed JJ O
in IN O
liquid JJ O
nitrogen NN O
( -LRB- O
LN2 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Methylprednisolone NNP O
and CC O
U-74006F NNP O
were VBD O
equally RB O
effective JJ O
at IN O
preventing VBG O
neurological JJ O
dysfunction NN O
compared VBN O
to TO O
the DT O
control NN O
group NN O
( -LRB- O
p NN O
less JJR O
than IN O
0.01 CD O
) -RRB- O
; : O
U-78517F NN O
was VBD O
slightly RB O
less RBR O
effective JJ O
than IN O
U-74006F NNP O
and CC O
methylprednisolone NN O
but CC O
was VBD O
significantly RB O
better JJR O
than IN O
vehicle NN O
in IN O
preventing VBG O
neurological JJ O
dysfunction NN O
. . O

-DOCSTART- X X O

Comparison NN O
between IN O
the DT O
Ricketts NNP O
and CC O
Bimler NNP O
therapeutic JJ O
technics NNS O
in IN O
the DT O
treatment NN O
of IN O
cases NNS O
of IN O
class NN O
II NNP O
, , O
division NN O
I PRP O
mmalocclusion MD O

-DOCSTART- X X O

Transfection NNP O
assays VBZ O
using VBG O
the DT O
first JJ O
600 CD O
bp NN O
of IN O
the DT O
upstream JJ O
nucleotide JJ O
sequences NNS O
indicated VBD O
that IN O
a DT O
region NN O
from IN O
-75 PRP$ O
to TO O
-120 DT O
was VBD O
necessary JJ O
for IN O
the DT O
ALDH2 NNP B-NP
gene NN I-NP
expression NN O
, , O
and CC O
especially RB O
NF-Y/CP1 JJ B-NP
binding JJ O
site NN O
from IN O
-92 JJ O
to TO O
-96 DT O
(CCAAT JJ O
box NN O
) -RRB- O
is VBZ O
important JJ O
in IN O
the DT O
expression NN O
of IN O
the DT O
gene NN O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
five CD O
of IN O
13 CD O
evaluable JJ O
patients NNS O
undergoing VBG O
allogeneic DT O
sibling JJ O
BM NNP O
or CC O
PBSC NNP O
transplantation NN O
for IN O
MM NNP O
between IN O
1990 CD O
and CC O
1997 CD O
who WP O
met VBD O
the DT O
criteria NNS O
for IN O
adjuvant JJ O
alpha-IFN JJ B-NP
therapy NN O
. . O

-DOCSTART- X X O

Hepatocyte NNP B-NP
growth NN I-NP
factor NN I-NP
( -LRB- O
HGF NN B-NP
) -RRB- O
is VBZ O
an DT O
inducible JJ O
cytokine NN O
that WDT O
is VBZ O
essential JJ O
for IN O
the DT O
normal JJ O
growth NN O
and CC O
development NN O
of IN O
various JJ O
tissues NNS O
, , O
such JJ O
as IN O
the DT O
liver NN O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
To TO O
summarise VB O
quantitatively RB O
the DT O
association NN O
between IN O
moderate JJ O
alcohol NN O
intake NN O
and CC O
biological JJ O
markers NNS O
of IN O
risk NN O
of IN O
coronary JJ O
heart NN O
disease NN O
and CC O
to TO O
predict VB O
how WRB O
these DT O
changes NNS O
would MD O
lower VB O
the DT O
risk NN O
. . O

-DOCSTART- X X O

( -LRB- O
1991 CD O
) -RRB- O
EMBO NNP O
J. NNP O

-DOCSTART- X X O

Teratospermia NNP O
is VBZ O
therefore RB O
an DT O
important JJ O
factor NN O
in IN O
evaluating VBG O
fertilization NN O
capacity NN O
. . O

-DOCSTART- X X O

Genetic JJ O
polymorphisms NNS O
in IN O
the DT O
5'-flanking JJ O
region NN O
change NN O
transcriptional JJ O
regulation NN O
of IN O
the DT O
human JJ B-NP
cytochrome NN I-NP
P450IIE1 NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Basal NNP O
JNK NNP B-NP
MAPK NNP I-NP
kinase NN I-NP
activity NN O
was VBD O
also RB O
specifically RB O
induced VBN O
by IN O
deltaEGFR NN B-NP
, , O
which WDT O
correlated VBD O
with IN O
increased JJ O
phosphorylation NN O
of IN O
a DT O
54-kDa JJ B-NP
JNK2 JJ I-NP
protein NN I-NP
observed VBD O
in IN O
deltaEGFR-containing JJ B-NP
cells NNS O
. . O

-DOCSTART- X X O

Isolation NNP O
and CC O
properties NNS O
of IN O
Drosophila NNP B-NP
melanogaster NN I-NP
ferritin--molecular JJ I-NP
cloning NN O
of IN O
a DT O
cDNA NN O
that WDT O
encodes VBZ O
one CD O
subunit NN O
, , O
and CC O
localization NN O
of IN O
the DT O
gene NN O
on IN O
the DT O
third JJ O
chromosome NN O
. . O

-DOCSTART- X X O

The DT O
single-copy JJ O
U20 NNP B-NP
sequence NN I-NP
is VBZ O
located VBN O
on IN O
the DT O
same JJ O
DNA NN O
strand NN O
as IN O
the DT O
nucleolin NN B-NP
mRNA NN I-NP
. . O

-DOCSTART- X X O

Maximum NNP O
baroreceptor NN O
activity NN O
measured VBD O
at IN O
140 CD O
mm CD O
Hg NNP O
and CC O
the DT O
slope NN O
of IN O
the DT O
pressure-activity NN O
curve NN O
were VBD O
reduced VBN O
in IN O
atherosclerotic JJ O
( -LRB- O
n NN O
= SYM O
15 CD O
) -RRB- O
compared VBN O
with IN O
normal JJ O
( -LRB- O
n NN O
= SYM O
13 CD O
) -RRB- O
rabbits VBZ O
( -LRB- O
425 CD O
+/ NN O
- : O
34 CD O
versus JJ O
721 CD O
+/ NNS O
- : O
30 CD O
spikes NNS O
per IN O
second JJ O
and CC O
6.2 CD O
+/ NN O
- : O
0.6 CD O
versus NN O
10.8 CD O
+/ NNS O
- : O
0.8 CD O
spikes NNS O
per IN O
second NN O
per IN O
mm CD O
Hg NNP O
, , O
respectively RB O
, , O
P NNP O
< JJ O
.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
effective JJ O
use NN O
of IN O
superoxide NN B-NP
dismutase NN I-NP
from IN O
human JJ O
erythrocytes NNS O
in IN O
the DT O
late JJ O
stages NNS O
of IN O
experimental JJ O
influenza NN O
infection NN O

-DOCSTART- X X O

EMT NNP B-NP
was VBD O
localized VBN O
to TO O
chromosome NN O
5q31-32 CD O
, , O
a DT O
region NN O
that WDT O
contains VBZ O
the DT O
genes NNS O
for IN O
several JJ O
growth NN O
factors NNS O
and CC O
receptors NNS O
as RB O
well RB O
as IN O
early RB O
activation NN O
genes NNS O
, , O
particularly RB O
those DT O
involved VBN O
in IN O
the DT O
hematopoietic JJ O
system NN O
. . O

-DOCSTART- X X O

Both DT O
purH NNS B-NP
and CC O
purD VBN B-NP
genes NNS I-NP
constitute VBP O
a DT O
single JJ O
operon NN O
and CC O
are VBP O
coregulated VBN O
in IN O
expression NN O
by IN O
purines NNS O
as IN O
other JJ O
purine NN B-NP
genes NNS I-NP
are VBP O
. . O

-DOCSTART- X X O

Fluorescence NNP O
in IN O
situ FW O
hybridization NN O
was VBD O
used VBN O
to TO O
investigate VB O
the DT O
physical JJ O
distribution NN O
and CC O
revealed VBD O
that IN O
both DT O
retrotransposon NN O
families NNS O
are VBP O
present JJ O
on IN O
all DT O
sugar NN O
beet IN O
chromosomes NNS O
and CC O
largely RB O
excluded VBN O
from IN O
chromosomal NN O
regions NNS O
harbouring VBG O
the DT O
18S-5.8S-25S CD B-NP
rRNA NNP O
genes NNS O
. . O

-DOCSTART- X X O

Application NNP O
of IN O
the DT O
method NN O
using VBG O
an DT O
11-year JJ O
microseismicity NN O
record NN O
revealed VBD O
systematic JJ O
spatial JJ O
and CC O
temporal JJ O
changes NNS O
in IN O
the DT O
slip NN O
rate NN O
that WDT O
were VBD O
synchronous JJ O
with IN O
earthquake NN O
activity NN O
and CC O
other JJ O
independent JJ O
measures NNS O
of IN O
fault-zone JJ O
slip NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
we PRP O
have VBP O
identified VBN O
the DT O
major JJ O
open JJ O
reading NN O
frame NN O
( -LRB- O
RF4 NNP O
; : O
2.3 CD O
kb NN O
) -RRB- O
as IN O
being VBG O
essential JJ O
for IN O
activation NN O
, , O
and CC O
we PRP O
have VBP O
shown VBN O
that IN O
the DT O
NF NNP B-NP
kappa NN I-NP
B NNP I-NP
, , O
SP1 NNP B-NP
, , O
and CC O
TATA NNP O
box NN O
motifs NNS O
in IN O
the DT O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
LTR NNP I-NP
are VBP O
all DT O
required VBN O
for IN O
full JJ O
induction NN O
of IN O
the DT O
promoter NN O
by IN O
the DT O
HHV-6-encoded JJ B-NP
transactivator NN I-NP
. . O

-DOCSTART- X X O

Two CD O
conserved JJ O
motifs NNS O
, , O
W89RKRRY94 NNP O
and CC O
P156KKIKP161 NNP O
, , O
seemed VBD O
to TO O
act VB O
as IN O
nuclear JJ O
addressing VBG O
signals NNS O
. . O

-DOCSTART- X X O

All DT O
testosterone NN O
treatments NNS O
raised VBD O
plasma NN O
testosterone NN O
concentrations NNS O
above IN O
control NN O
and CC O
pretreatment NN O
levels NNS O
(testosterone , O
and CC O
synovex NN O
+ NN O
testosterone NN O
> IN O
synovex NN O
> NN O
control NN O
; : O
all DT O
P NNP O
< JJ O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
educational JJ O
program NN O
was VBD O
the DT O
significant JJ O
factor NN O
that WDT O
influenced VBD O
the DT O
change NN O
of IN O
concern NN O
trajectories NNS O
, , O
and CC O
the DT O
recurrent/non-recurrent JJ O
factor NN O
influenced VBD O
the DT O
change NN O
of IN O
concern NN O
only RB O
in IN O
pamphlet NN O
group NN O
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

Evidence NN O
that IN O
the DT O
AT1A NNP B-NP
receptor NN I-NP
activates NNS O
transcription NN B-NP
factor-Stat91 NN I-NP
and/or CC O
a DT O
related JJ O
protein NN O
. . O

-DOCSTART- X X O

The DT O
full-length JJ O
cDNA NN O
was VBD O
cloned VBN O
and CC O
sequenced VBN O
, , O
and CC O
the DT O
inferred JJ O
amino JJ O
acid NN O
sequence NN O
was VBD O
found VBN O
to TO O
encode VB O
a DT O
novel JJ O
protein NN O
, , O
which WDT O
we PRP O
named VBD O
cystatin NN B-NP
M NNP I-NP
, , O
with IN O
40 CD O
% NN O
homology NN O
to TO O
human JJ B-NP
family NN I-NP
2 CD I-NP
cystatins NNS I-NP
and CC O
similar JJ O
overall JJ O
structure NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
oxyR NN B-NP
mutants NNS I-NP
are VBP O
locked VBN O
on IN O
for IN O
Ag43 DT B-NP
expression NN O
, , O
whereas IN O
dam JJ B-NP
mutants NNS I-NP
are VBP O
locked VBN O
off RP O
for IN O
Ag43 DT B-NP
expression NN O
. . O

-DOCSTART- X X O

GH NNP B-NP
induced VBD O
rapid JJ O
tyrosine NN O
phosphorylation NN O
of IN O
a DT O
protein NN O
at IN O
approximately RB O
93 CD O
kDa NN O
in IN O
normal JJ O
fibroblasts NNS O
, , O
and CC O
Western NNP O
blotting VBG O
with IN O
STAT-specific JJ B-NP
antibodies NNS I-NP
revealed VBD O
STAT5 CD B-NP
activation NN O
( -LRB- O
phosphorylation NN O
) -RRB- O
by IN O
GH. NNP O

-DOCSTART- X X O

A DT O
retrospective JJ O
study NN O
of IN O
clozapine NN O
and CC O
electroencephalographic JJ O
abnormalities NNS O
in IN O
schizophrenic JJ O
patients NNS O
. . O

-DOCSTART- X X O

While IN O
working VBG O
on IN O
the DT O
toxicity NN O
of IN O
war NN O
gases NNS O
. . O
he PRP O
formulated VBD O
' '' O
Haber NNP O
's POS O
rule NN O
' '' O
, , O
also RB O
known VBN O
as IN O
C NNP O
x NN O
T= IN O
constant JJ O
in IN O
order NN O
to TO O
characterize VB O
the DT O
toxicity NN O
of IN O
an DT O
inhalant NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
regulation NN O
conferred VBD O
on IN O
a DT O
reporter NN O
gene NN O
in IN O
Drosophila NNP O
by IN O
three CD O
closely RB O
related VBN O
sequences NNS O
demonstrates VBZ O
that IN O
even RB O
subtle JJ O
sequence NN O
changes NNS O
within IN O
an DT O
E NNP O
box NN O
or CC O
flanking NN O
bases NNS O
have VBP O
dramatic JJ O
consequences NNS O
on IN O
the DT O
overall JJ O
repertoire NN O
of IN O
proteins NNS O
that WDT O
can MD O
bind NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Two CD O
putative JJ O
ATP-binding NNP O
domains NNS O
were VBD O
identified VBN O
, , O
one CD O
in IN O
the DT O
amino-terminal JJ O
half NN O
of IN O
the DT O
argA-encoded JJ B-NP
protein NN I-NP
and CC O
the DT O
other JJ O
in IN O
the DT O
carboxy-terminal JJ O
half NN O
. . O

-DOCSTART- X X O

Previously RB O
, , O
we PRP O
identified VBD O
two CD O
human JJ B-NP
SMC NNP I-NP
family NN I-NP
proteins VBZ I-NP
, , O
hCAP-C JJ B-NP
and CC O
hCAP-E JJ B-NP
, , O
which WDT O
form VBP O
a DT O
heterodimeric JJ O
complex JJ O
(hCAP-C-hCAP-E) NN O
in IN O
the DT O
cell NN O
. . O

-DOCSTART- X X O

There EX O
were VBD O
no DT O
major JJ O
postoperative JJ O
complications NNS O
and CC O
at IN O
follow-up NN O
of IN O
the DT O
13 CD O
patients NNS O
at IN O
10 CD O
to TO O
26 CD O
months NNS O
after IN O
operation NN O
the DT O
results NNS O
were VBD O
satisfactory JJ O
. . O

-DOCSTART- X X O

The DT O
interleukin-2 NN B-NP
receptor NN I-NP
alpha NN I-NP
( -LRB- O
IL-2R JJ B-NP
alpha NN I-NP
) -RRB- O
chain NN O
gene NN O
contains VBZ O
a DT O
sequence NN O
similar JJ O
to TO O
the DT O
immunoglobulin NN B-NP
( -LRB- I-NP
Ig NNP I-NP
) -RRB- I-NP
kappa NN I-NP
(kappa NN O
) -RRB- O
enhancer NN O
NF-kappa NNP B-NP
B NNP I-NP
binding NN I-NP
site NN I-NP
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
a DT O
short JJ O
( -LRB- O
70 CD O
bp NN O
) -RRB- O
intron NN O
near IN O
the DT O
N-terminus NNP O
of IN O
the DT O
atX JJ B-NP
gene NN I-NP
was VBD O
predicted VBN O
that IN O
contains VBZ O
the DT O
canonical JJ O
GT NNP O
and CC O
AG NNP O
dinucleotides NNS O
at IN O
its PRP$ O
5' JJ O
- : O
and CC O
3'-splicing JJ O
junctions NNS O
. . O

-DOCSTART- X X O

In IN O
accordance NN O
with IN O
Ann NNP O
Arbor NNP O
classification NN O
, , O
we PRP O
observed VBD O
12 CD O
CS NNP O
IA NNP O
( -LRB- O
21.3 CD O
% NN O
) -RRB- O
, , O
2 CD O
CS NNP O
IB NNP O
( -LRB- O
3.5 CD O
% NN O
) -RRB- O
, , O
14 CD O
CS NNP O
IIA NNP O
( -LRB- O
25.4 CD O
% NN O
) -RRB- O
and CC O
27 CD O
CS NNP O
IIB NNP O
( -LRB- O
49.7 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

HL NNP B-NP
is VBZ O
hypothesized VBN O
to TO O
directly RB O
couple JJ O
HDL NNP B-NP
lipid VBD O
metabolism NN O
to TO O
tissue/cellular JJ O
lipid JJ O
metabolism NN O
. . O

-DOCSTART- X X O

The DT O
analysis NN O
of IN O
the DT O
organization NN O
of IN O
the DT O
sequence NN O
of IN O
the DT O
human JJ O
ABP/DAO NNP B-NP
gene NN O
reveals VBZ O
that IN O
the DT O
2.4-kilobase JJ O
messenger NN O
RNA NNP O
is VBZ O
transcribed VBN O
from IN O
two CD O
close JJ O
origins NNS O
identifying VBG O
the DT O
proximal JJ O
promoter NN O
. . O

-DOCSTART- X X O

Several JJ O
DNA NNP O
clones NNS O
were VBD O
obtained VBN O
by IN O
this DT O
procedure NN O
, , O
one CD O
of IN O
which WDT O
, , O
clone RB O
18 CD O
, , O
is VBZ O
reported VBN O
and CC O
characterized VBN O
here RB O
. . O

-DOCSTART- X X O

Immunoprecipitation NNP O
of IN O
cell NN O
lysates NNS O
with IN O
anti-phosphotyrosine JJ B-NP
and CC O
immunoblotting JJ O
showed VBD O
phosphorylated JJ O
forms NNS O
of IN O
the DT O
mitogenic JJ O
pathway NN O
proteins VBZ O
Shc NNP B-NP
and CC O
MAPK NNP B-NP
in IN O
addition NN O
to TO O
p185(neu) VB B-NP
, , O
suggesting VBG O
that IN O
the DT O
Ras NNP B-NP
to TO O
MAPK NNP B-NP
mitogenic JJ O
pathway NN O
is VBZ O
activated VBN O
. . O

-DOCSTART- X X O

The DT O
sequence NN O
immediately RB O
upstream RB O
of IN O
the DT O
translation NN O
start NN O
site NN O
was VBD O
G NNP O
+ NNP O
C NNP O
rich JJ O
( -LRB- O
greater JJR O
than IN O
75 CD O
% NN O
) -RRB- O
and CC O
contained VBD O
a DT O
consensus NN O
CCAAT NN O
sequence NN O
despite IN O
the DT O
absence NN O
of IN O
a DT O
TATA NNP O
box NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
latter NN O
, , O
the DT O
cells NNS O
and CC O
adjacent JJ O
matrix NN O
had VBD O
several JJ O
characteristics NNS O
of IN O
fibrocartilage NN O
, , O
including VBG O
chondrocytes NNS O
. . O

-DOCSTART- X X O

Radiation NNP O
sensitivity NN O
of IN O
rats NNS O
irradiated VBN O
in IN O
a DT O
condition NN O
of IN O
hypoxia NN O

-DOCSTART- X X O

When WRB O
the DT O
opioid NN O
antagonist NN O
was VBD O
administered VBN O
to TO O
animals NNS O
24 CD O
hr NN O
after IN O
termination NN O
of IN O
single JJ O
or CC O
multiple JJ O
exposures NNS O
to TO O
restraint NN O
, , O
NALT-induced JJ O
increases NNS O
in IN O
basal NN O
plasma NN B-NP
LH NNP I-NP
were VBD O
significantly RB O
attenuated VBN O
in IN O
the DT O
chronically NN O
stressed VBD O
rats NNS O
compared VBN O
to TO O
animals NNS O
subjected VBN O
to TO O
stress VB O
only RB O
once RB O
or CC O
not RB O
at IN O
all DT O
.(ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

Analysis NN O
of IN O
exon NN O
2 CD O
of IN O
the DT O
factor NN B-NP
IX NNP I-NP
gene NN I-NP
revealed VBD O
a DT O
C-->T NN O
mutation NN O
in IN O
codon NN O
10 CD O
of IN O
the DT O
propeptide JJ O
region NN O
, , O
resulting VBG O
in IN O
the DT O
substitution NN O
of IN O
alanine NN O
by IN O
valine NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
to TO O
the DT O
restricted VBN O
tissue NN O
expression NN O
of IN O
gonadotropin NNP B-NP
and CC O
TSH NNP B-NP
receptors NNS I-NP
in IN O
gonads NNS O
and CC O
thyroid VBD O
, , O
respectively RB O
, , O
LGR4 NNP B-NP
is VBZ O
expressed VBN O
in IN O
diverse JJ O
tissues NNS O
including VBG O
ovary NN O
, , O
testis NN O
, , O
adrenal JJ O
, , O
placenta NN O
, , O
thymus NN O
, , O
spinal JJ O
cord NN O
, , O
and CC O
thyroid VBD O
, , O
whereas IN O
LGR5 DT B-NP
is VBZ O
found VBN O
in IN O
muscle NN O
, , O
placenta NN O
, , O
spinal JJ O
cord NN O
, , O
and CC O
brain NN O
. . O

-DOCSTART- X X O

We PRP O
now RB O
show VBP O
that IN O
purified VBN O
recombinant JJ O
c-sis/PDGF NN B-NP
can MD O
induce VB O
this DT O
binding NN O
activity NN O
which WDT O
we PRP O
have VBP O
termed VBN O
SIF NNS B-NP
, , O
for IN O
sis-inducible JJ B-NP
factor NN I-NP
. . O

-DOCSTART- X X O

Antinuclear JJ O
antibodies NNS O
, , O
rheumatoid NN B-NP
factor NN I-NP
and CC O
C-reactive JJ B-NP
protein NN I-NP
in IN O
serum NN O
of IN O
normal JJ O
women NNS O
using VBG O
oral JJ O
contraceptives NNS O
. . O

-DOCSTART- X X O

The DT O
relationship NN O
between IN O
donor NN O
status NN O
for IN O
antibody NN O
to TO O
hepatitis NNP B-NP
B NNP I-NP
core NN I-NP
antigen NN I-NP
and CC O
the DT O
occurrence NN O
of IN O
non-A JJ O
, , O
non-B JJ O
posttransfusion NN O
hepatitis NN O
in IN O
the DT O
recipient NN O
was VBD O
prospectively RB O
studied VBN O
in IN O
112 CD O
patients NNS O
undergoing VBG O
open-heart JJ O
surgery NN O
who WP O
were VBD O
followed VBN O
for IN O
6.5 CD O
months NNS O
after IN O
surgery NN O
. . O

-DOCSTART- X X O

Both DT O
control NN O
and CC O
Mn-exposed JJ O
quail NN O
accumulated VBN O
5 CD O
to TO O
10 CD O
times NNS O
more JJR O
Mn NN O
in IN O
their PRP$ O
livers NNS O
than IN O
similarly RB O
treated VBN O
rodents NNS O
. . O

-DOCSTART- X X O

These DT O
data NNS O
suggested VBD O
that IN O
mutant JJ B-NP
PS1 NNP I-NP
may MD O
cause VB O
disease NN O
as IN O
a DT O
result NN O
of IN O
reduction NN O
in IN O
PS1 NNP B-NP
function NN O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
pretreatment NN O
with IN O
the DT O
non-competitive JJ O
NMDA NN O
antagonist NN O
( -LRB- O
+)MK-801 CD O
on IN O
the DT O
behavioral JJ O
alterations NNS O
induced VBN O
by IN O
repeated VBN O
restraint NN O
stress NN O
were VBD O
investigated VBN O
. . O

-DOCSTART- X X O

MsEPV NNP O
genes NNS O
with IN O
putative JJ O
functions NNS O
in IN O
prevention NN O
and CC O
repair NN O
of IN O
DNA NNP O
damage NN O
include VBP O
a DT O
complete JJ O
base NN O
excision NN O
repair NN O
pathway NN O
(uracil NN O
DNA NNP B-NP
glycosylase NN I-NP
, , O
AP NNP B-NP
endonuclease NN I-NP
, , O
DNA NNP B-NP
polymerase NN I-NP
beta NN I-NP
, , O
and CC O
an DT O
NAD+-dependent JJ B-NP
DNA NN I-NP
ligase NN I-NP
) -RRB- O
, , O
a DT O
photoreactivation NN O
repair NN O
pathway NN O
( -LRB- O
cyclobutane NN B-NP
pyrimidine NN I-NP
dimer NN I-NP
photolyase NN I-NP
) -RRB- O
, , O
a DT O
LINE-type JJ B-NP
reverse NN I-NP
transcriptase NN I-NP
, , O
and CC O
a DT O
mutT JJ B-NP
homologue NN I-NP
. . O

-DOCSTART- X X O

In IN O
isolated VBN O
olfactory JJ O
cilia NNS O
certain JJ O
odorants NNS O
elicit NN O
a DT O
rapid JJ O
and CC O
transient JJ O
cAMP JJ O
response NN O
, , O
terminated VBN O
by IN O
a DT O
concerted JJ O
process NN O
which WDT O
requires VBZ O
the DT O
action NN O
of IN O
two CD O
protein NN O
kinases NNS O
, , O
protein NN B-NP
kinase NN I-NP
A DT I-NP
( -LRB- O
PKA NN B-NP
) -RRB- O
and CC O
a DT O
receptor-specific JJ B-NP
kinase NN I-NP
( -LRB- O
GRK3 CD B-NP
) -RRB- O
( -LRB- O
Schleicher NNP O
, , O
S. NNP O
, , O
Boekhoff NNP O
, , O
I. NN O

-DOCSTART- X X O

Two CD O
hundred CD O
and CC O
eighty-three CD O
patients NNS O
, , O
217 CD O
females NNS O
( -LRB- O
median NN O
age NN O
24 CD O
years NNS O
, , O
range NN O
0.5-73 CD O
) -RRB- O
and CC O
66 CD O
males NNS O
( -LRB- O
median JJ O
age NN O
20 CD O
years NNS O
, , O
range NN O
0.75-72 NN O
) -RRB- O
, , O
were VBD O
examined VBN O
. . O

-DOCSTART- X X O

Pneumatic JJ O
dilation NN O
of IN O
the DT O
lower JJR O
esophageal NN O
sphincter NN O
was VBD O
accomplished VBN O
by IN O
endoscopic JJ O
visualization NN O
and CC O
positioning NN O
of IN O
a DT O
modified VBN O
polyurethane NN O
dilator NN O
(90 IN O
F NN O
diameter NN O
) -RRB- O
without IN O
fluoroscopy NN O
in IN O
17 CD O
consecutive JJ O
patients NNS O
with IN O
advanced JJ O
symptomatic JJ O
achalasia NN O
. . O

-DOCSTART- X X O

The DT O
organotins NNS O
. . O

-DOCSTART- X X O

A DT O
series NN O
of IN O
mutations NNS O
were VBD O
constructed VBN O
within IN O
the DT O
E2 NN B-NP
open JJ O
reading NN O
frame NN O
which WDT O
delete JJ O
various JJ O
regions NNS O
of IN O
the DT O
conserved JJ O
DNA NNP O
binding NN O
and CC O
transactivation NN O
domains NNS O
as RB O
well RB O
as IN O
the DT O
internal JJ O
hinge NN O
region NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
indicate VBP O
that IN O
chromatic JJ O
processing NN O
in IN O
areas NNS O
V1 . O
and CC O
V2 PRP O
is VBZ O
normal JJ O
after IN O
V4 NNP O
lesions NNS O
and CC O
, , O
together RB O
with IN O
the DT O
behavioural JJ O
evidence NN O
, , O
that IN O
these DT O
areas NNS O
are VBP O
sufficient JJ O
for IN O
some DT O
basic JJ O
aspects NNS O
of IN O
colour NN O
perception NN O
. . O

-DOCSTART- X X O

The DT O
non-major JJ B-NP
histocompatibility NN I-NP
complex NN I-NP
( -LRB- O
MHC)-encoded JJ B-NP
CD1 NN B-NP
family NN I-NP
has VBZ O
recently RB O
emerged VBN O
as IN O
a DT O
new JJ O
antigen-presenting JJ O
system NN O
that WDT O
is VBZ O
distinct JJ O
from IN O
either DT O
MHC NNP B-NP
class NN I-NP
I PRP I-NP
or CC I-NP
class NN I-NP
II NNP I-NP
molecules NNS I-NP
. . O

-DOCSTART- X X O

Doxazosin NNP O
produced VBD O
increases NNS O
in IN O
both DT O
mean JJ O
and CC O
maximum JJ O
urinary JJ O
flow NN O
rates NNS O
of IN O
1.01 CD O
ml/s NNS O
and CC O
3.2 CD O
ml/s NNS O
respectively RB O
, , O
compared VBN O
with IN O
0.21 CD O
ml/s NNS O
and CC O
2.2 CD O
ml/s NNS O
on IN O
placebo NN O
. . O

-DOCSTART- X X O

We PRP O
determined VBD O
the DT O
complete JJ O
nucleotide JJ O
sequence NN O
of IN O
the DT O
gypsy NN B-NP
element NN I-NP
present NN O
at IN O
the DT O
forked JJ B-NP
locus NN I-NP
of IN O
Drosophila NNP O
melanogaster NN O
in IN O
the DT O
f1 JJ O
allele NN O
. . O

-DOCSTART- X X O

Cloning NNP O
and CC O
nucleotide JJ O
sequence NN O
analysis NN O
reveals VBZ O
that IN O
BUR6 NNP B-NP
encodes VBZ O
a DT O
homolog NN O
of IN O
DRAP1 NNP B-NP
( -LRB- O
also RB O
called VBN O
NC2alpha NNP B-NP
) -RRB- O
, , O
a DT O
mammalian JJ O
repressor NN O
of IN O
basal JJ O
transcription NN O
. . O

-DOCSTART- X X O

The DT O
ATF/CRE NNP B-NP
site NN O
is VBZ O
also RB O
essential JJ O
for IN O
CD4 NNP B-NP
promoter NN I-NP
activation NN O
by IN O
forskolin NN O
, , O
an DT O
activator NN O
of IN O
adenylate JJ B-NP
cyclase NN I-NP
. . O

-DOCSTART- X X O

They PRP O
are VBP O
growth-inhibited VBN O
by IN O
TGF-beta1 NNP B-NP
. . O

-DOCSTART- X X O

Chronic JJ O
active JJ O
hepatitis NN O
and CC O
cirrhosis NN O
of IN O
the DT O
liver NN O
. . O

-DOCSTART- X X O

Colonization NNP O
increased VBD O
with IN O
level NN O
of IN O
care NN O
: : O
from IN O
9 CD O
per IN O
cent NN O
in IN O
independent JJ O
residents NNS O
of IN O
apartments NNS O
to TO O
60 CD O
per IN O
cent NN O
in IN O
patients NNS O
on IN O
an DT O
acute JJ O
hospital NN O
ward NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.0001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Interaction NN O
of IN O
the DT O
v-rel JJ B-NP
protein NN I-NP
with IN O
an DT O
NF-kappa NNP B-NP
B NNP I-NP
DNA NNP I-NP
binding NN I-NP
site NN I-NP
. . O

-DOCSTART- X X O

CVO2 DT O
saturation NN O
is VBZ O
a DT O
reliable JJ O
and CC O
sensitive JJ O
method NN O
for IN O
detecting VBG O
blood NN O
loss NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
Saccharomyces NNP B-NP
cerevisiae NN I-NP
actin NN I-NP
intron IN I-NP
a DT O
silent JJ O
branch NN O
point-like JJ O
sequence NN O
( -LRB- O
UACUAAG NNP O
) -RRB- O
is VBZ O
located VBN O
7 CD O
nt NN O
upstream RB O
of IN O
the DT O
canonical JJ O
sequence NN O
. . O

-DOCSTART- X X O

PrRP NNP B-NP
rapidly RB O
and CC O
transiently RB O
activated VBN O
extracellular JJ B-NP
signal-regulated JJ I-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
ERK) NN B-NP
in IN O
both DT O
types NNS O
of IN O
cells NNS O
. . O

-DOCSTART- X X O

Reversible JJ O
topology NN O
of IN O
a DT O
bifunctional JJ O
transmembrane NN O
protein NN O
depends VBZ O
upon IN O
the DT O
charge NN O
balance NN O
around IN O
its PRP$ O
transmembrane NN O
domain NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
documented VBN O
previously RB O
that IN O
glucocorticoid JJ O
hormones NNS O
modulate VBP O
the DT O
posttranslational JJ O
localization NN O
of IN O
cell NN O
surface NN O
mouse NN O
mammary JJ O
tumor NN O
virus NN O
( -LRB- O
MMTV NNP O
) -RRB- O
glycoproteins NNS O
in IN O
the DT O
viral-infected JJ O
M1.54 CD O
rat NN O
HTC NNP O
hepatoma NN O
cell NN O
line NN O
. . O

-DOCSTART- X X O

Spodoptera NN O
frugiperda NN O
( -LRB- O
Sf9 PRP O
) -RRB- O
cells NNS O
have VBP O
proved VBN O
a DT O
suitable JJ O
cell NN O
system NN O
in IN O
which WDT O
to TO O
study VB O
this DT O
association NN O
and CC O
to TO O
produce VB O
recombinant JJ B-NP
CR3 JJ I-NP
, , O
and CC O
we PRP O
show VBP O
here RB O
that IN O
another DT O
lepidopteran JJ O
cell NN O
line NN O
, , O
Trichoplusia NNP O
niTN-5B1-4 NN O
( -LRB- O
High-Five JJ O
) -RRB- O
cells NNS O
, , O
allows VBZ O
the DT O
recovery NN O
of IN O
large JJ O
amounts NNS O
of IN O
functional JJ B-NP
recombinant JJ I-NP
CR3 NNP I-NP
. . O

-DOCSTART- X X O

Using VBG O
the DT O
standard NN O
scoring NN O
, , O
children NNS O
with IN O
full JJ O
scale NN O
IQ NNP O
< NNP O
or CC O
= SYM O
84 CD O
on IN O
the DT O
Wechsler NNP O
Preschool NNP O
and CC O
Primary JJ O
Scale NNP O
of IN O
Intelligence NNP O
at IN O
age NN O
4-5 CD O
years NNS O
were VBD O
poorly RB O
identified VBN O
( -LRB- O
sensitivity NN O
54 CD O
% NN O
) -RRB- O
from IN O
the DT O
composite JJ O
S-B NNP O
IV NNP O
score NN O
at IN O
age NN O
3. . O

-DOCSTART- X X O

To TO O
clarify VB O
the DT O
mechanisms NNS O
that WDT O
regulate VB O
transcription NN O
of IN O
the DT O
GTP NNP B-NP
cyclohydrolase NN I-NP
I PRP I-NP
gene NN I-NP
and CC O
to TO O
generate VB O
multiple JJ O
species NNS O
of IN O
mRNA NN O
, , O
we PRP O
isolated VBD O
genomic JJ O
DNA NNP O
clones NNS O
for IN O
the DT O
human JJ O
and CC O
mouse NN O
GTP NNP B-NP
cyclohydrolase NN I-NP
I PRP I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

Perception NN O
of IN O
sweetness NN O
cannot MD O
be VB O
used VBN O
to TO O
accurately RB O
meter VB O
the DT O
metabolizable JJ O
energy NN O
or CC O
nutritive JJ O
value NN O
of IN O
a DT O
food NN O
. . O

-DOCSTART- X X O

When WRB O
labeled VBN O
by IN O
the DT O
described VBN O
method NN O
, , O
99mTc VBG O
on IN O
DTPA NNP O
coupled VBN O
antibodies NNS O
shows VBZ O
instability NN O
in IN O
serum NN O
but CC O
superior JJ O
stability NN O
than IN O
99mTc CD O
on IN O
antibodies NNS O
without IN O
the DT O
attached VBN O
DTPA. . O

-DOCSTART- X X O

The DT O
crystal NN O
structure NN O
of IN O
the DT O
yeast NN O
Phe-tRNAPhe DT B-NP
ternary JJ I-NP
complex JJ I-NP
with IN O
Thermus DT O
aquaticus NN O
EF-Tu-GDPNP NNP B-NP
( -LRB- O
Phe-TC NNP B-NP
) -RRB- O
has VBZ O
previously RB O
been VBN O
determined VBN O
as IN O
one CD O
representative NN O
of IN O
this DT O
general JJ O
yet RB O
highly RB O
discriminating VBG O
complex JJ O
formation NN O
. . O

-DOCSTART- X X O

U.S.A. NN O

-DOCSTART- X X O

Human NNP B-NP
plastin NN I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

Role NNP O
of IN O
the DT O
CCAAT/enhancer NNP B-NP
binding NN I-NP
protein-alpha NN I-NP
transcription NN I-NP
factor NN I-NP
in IN O
the DT O
glucocorticoid JJ O
stimulation NN O
of IN O
p21waf1/cip1 JJ B-NP
gene NN O
promoter NN O
activity NN O
in IN O
growth-arrested JJ O
rat NN O
hepatoma NN O
cells NNS O
. . O

-DOCSTART- X X O

We PRP O
also RB O
demonstrate VBP O
that IN O
a DT O
p110RB1 JJ B-NP
mutant NN I-NP
, , O
which WDT O
is VBZ O
refractory JJ O
to TO O
cell NN O
cycle NN O
phosphorylation NN O
but CC O
intact JJ O
in IN O
E1a/large JJ B-NP
T NNP B-NP
antigen-binding JJ I-NP
properties NNS O
, , O
represses VBZ O
EIIaE NNP B-NP
with IN O
50- CD O
to TO O
80-fold JJ O
greater JJR O
efficiency NN O
than IN O
wild-type JJ B-NP
p110RB1 NNS I-NP
. . O

-DOCSTART- X X O

For IN O
the DT O
target NN O
stimuli NNS O
, , O
P3 DT O
amplitude NN O
and CC O
latency RB O
were VBD O
negatively RB O
correlated VBN O
and CC O
most RBS O
tightly RB O
coupled VBN O
over IN O
the DT O
frontal-central JJ O
and CC O
right JJ O
medial/lateral JJ O
recording NN O
sites NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
characterized VBN O
a DT O
new JJ O
cDNA NN O
, , O
33k-6 CD O
, , O
potentially RB O
encoding VBG O
a DT O
tobacco NN B-NP
33 CD I-NP
kDa NN I-NP
chloroplast NN I-NP
RNP NNP I-NP
( -LRB- I-NP
cp33 NN I-NP
) -RRB- I-NP
homologue NN I-NP
. . O

-DOCSTART- X X O

Though IN O
it PRP O
has VBZ O
been VBN O
established VBN O
that IN O
skinfold NN O
anthropometry NN O
has VBZ O
severe JJ O
limitations NNS O
as IN O
a DT O
method NN O
of IN O
deriving VBG O
total JJ O
body NN O
fat JJ O
( -LRB- O
TBF) NN O
, , O
the DT O
possibility NN O
that IN O
the DT O
problem NN O
might MD O
be VB O
related VBN O
more JJR O
to TO O
the DT O
assumptions NNS O
implicit JJ O
in IN O
densitometry NN O
has VBZ O
to TO O
be VB O
addressed VBN O
. . O

-DOCSTART- X X O

Gene NNP B-NP
GPR NNP I-NP
51 CD I-NP
was VBD O
localized VBN O
by IN O
radiation NN O
hybrid NN O
mapping NN O
to TO O
chromosome NN O
9 CD O
, , O
4.81 CD O
cR NN O
from IN O
the DT O
WI-8684 NNP O
marker NN O
, , O
and CC O
proximal JJ O
to TO O
the DT O
hereditary JJ B-NP
sensory JJ I-NP
neuropathy NN I-NP
type NN I-NP
1 CD I-NP
locus NN I-NP
. . O

-DOCSTART- X X O

A) NNP O
During IN O
O2-ischemia NNP O
both DT O
extracellular JJ O
[ NN O
K+ IN O
] NN O
and CC O
change NN O
of IN O
pH NNS O
in IN O
the DT O
subepicardium NN O
are VBP O
significantly RB O
less JJR O
than IN O
in IN O
the DT O
midmyocardium NN O
. . O

-DOCSTART- X X O

Some DT O
of IN O
these DT O
physiological JJ O
responses NNS O
are VBP O
regulated JJ O
via IN O
activation NN O
of IN O
transcription NN O
factors NNS O
such JJ O
as IN O
activator NN B-NP
protein NN I-NP
1 CD I-NP
( -LRB- O
AP-1 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
1.6-kb JJ O
cDNA NN O
( -LRB- O
CBF-A NNP B-NP
) -RRB- O
encoding VBG O
285 CD O
amino IN O
acids NNS O
( -LRB- O
aa JJ O
) -RRB- O
was VBD O
obtained VBN O
, , O
and CC O
a DT O
beta-galactosidase JJ B-NP
fusion NN I-NP
protein NN I-NP
, , O
bacterially RB O
produced VBN O
from IN O
the DT O
cDNA NN O
, , O
bound VBN O
to TO O
DNA NN O
fragments NNS O
containing VBG O
several JJ O
CArG NNP O
boxes NNS O
. . O

-DOCSTART- X X O

Alveoli-capillary NNP O
diffusion NN O
. . O

-DOCSTART- X X O

Interobserver NNP O
agreement NN O
of IN O
the DT O
Nottingham NNP O
histologic NN O
grading NN O
scheme NN O
for IN O
infiltrating NN O
duct NN O
carcinoma NN O
breast NN O
. . O

-DOCSTART- X X O

To TO O
determine VB O
the DT O
role NN O
of IN O
the DT O
transmembrane JJ O
region NN O
of IN O
HN NNP B-NP
on IN O
fusion-promoting NN O
activity NN O
, , O
mutant JJ B-NP
HN NNP I-NP
proteins NNS I-NP
were VBD O
expressed VBN O
and CC O
their PRP$ O
biological JJ O
activities NNS O
examined VBN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
transgene NN O
expression NN O
directed VBN O
by IN O
both DT O
the DT O
human JJ O
and CC O
mouse NN B-NP
Rb JJ I-NP
promoters NNS I-NP
is VBZ O
restricted VBN O
to TO O
a DT O
subset NN O
of IN O
tissues NNS O
in IN O
which WDT O
Rb NNP B-NP
is VBZ O
normally RB O
expressed VBN O
during IN O
embryogenesis NN O
. . O

-DOCSTART- X X O

The DT O
cDNA NN O
is VBZ O
predicted VBN O
to TO O
encode VB O
a DT O
polypeptide NN O
of IN O
298 CD O
amino IN O
acids NNS O
that WDT O
is VBZ O
homologous JJ O
to TO O
the DT O
Y-box NN B-NP
( -LRB- I-NP
inverted JJ I-NP
CCAAT NN I-NP
) -RRB- I-NP
family NN I-NP
of IN I-NP
DNA-binding JJ I-NP
transcription NN I-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

RAP NNP B-NP
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
a DT O
useful JJ O
vaccine NN O
target NN O
site NN O
, , O
and CC O
RIP NNP B-NP
and CC O
inhibitory JJ O
AIPs NNS B-NP
as IN O
therapeutic JJ O
molecules NNS O
to TO O
prevent VB O
and CC O
suppress VB O
S. NNP O
aureus NN O
infections NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
both DT O
RAR NNP B-NP
- : O
and CC O
RXR-specific JJ B-NP
ligands NNS O
increase NN O
CaSki NNP O
number NN O
by IN O
> NNS O
or CC O
= SYM O
20 CD O
% NN O
. . O

-DOCSTART- X X O

Tight-binding JJ O
band NN O
structure NN O
calculations NNS O
for IN O
beta-MNX JJ O
( -LRB- O
M NNP O
= SYM O
Zr NNP O
, , O
X NNP O
= SYM O
Cl NNP O
, , O
Br NNP O
; : O
M NNP O
= SYM O
Hf NNP O
, , O
X NNP O
= SYM O
Cl NNP O
) -RRB- O
, , O
ZrCl NNP O
, , O
and CC O
Y( NNP O
2)C( NNP O
2)Br( JJ O
2 CD O
) -RRB- O
are VBP O
reported VBN O
. . O

-DOCSTART- X X O

On IN O
the DT O
basis NN O
of IN O
the DT O
physical JJ O
interactions NNS O
between IN O
Sxl NNP B-NP
and CC O
Snf NNP B-NP
, , O
we PRP O
present VBP O
a DT O
model NN O
for IN O
Sxl NNP B-NP
splicing NN O
regulation NN O
. . O

-DOCSTART- X X O

It PRP O
thus RB O
seems VBZ O
likely JJ O
that IN O
genistein NN O
affects VBZ O
a DT O
common JJ O
pathway NN O
downstream NN O
of IN O
these DT O
signals NNS O
. . O

-DOCSTART- X X O

LiF NNP O
thermoluminescence NN O
dosimeters NNS O
( -LRB- O
TLD NN O
) -RRB- O
in IN O
chip NN O
form NN O
were VBD O
placed VBN O
onto IN O
1 CD O
eyelid NN O
, , O
the DT O
skin NN O
over IN O
the DT O
thyroid NN O
, , O
and CC O
the DT O
patient NN O
's POS O
clothes NNS O
covering VBG O
the DT O
region NN O
of IN O
breasts NNS O
and CC O
ovaries NNS O
of IN O
female JJ O
patients NNS O
and CC O
the DT O
testicles NNS O
of IN O
male JJ O
patients NNS O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
from IN O
these DT O
observations NNS O
that IN O
the DT O
cTnC JJ B-NP
3'Ile JJ I-NP
element NN I-NP
is VBZ O
a DT O
composite JJ O
enhancer NN O
that WDT O
functions VBZ O
through IN O
the DT O
combined VBN O
interactions NNS O
of IN O
at IN O
least JJS O
five CD O
regulatory JJ O
elements NNS O
and CC O
their PRP$ O
cognate JJ O
binding JJ O
factors NNS O
: : O
three CD O
or CC O
four CD O
E-boxes NNS O
, , O
a DT O
MEF-2 JJ B-NP
site NN I-NP
, , O
and CC O
a DT O
MEF-3 JJ B-NP
site NN I-NP
. . O

-DOCSTART- X X O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
secreted JJ O
, , O
truncated JJ O
receptor NN O
encoded VBN O
by IN O
the DT O
2.6-kb JJ B-NP
c-erbB NN I-NP
transcript NN I-NP
can MD O
bind NN O
to TO O
TGF NNP B-NP
alpha NN I-NP
and CC O
may MD O
play VB O
an DT O
important JJ O
growth-regulatory JJ O
function NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
paper NN O
we PRP O
review VBP O
evidence NN O
on IN O
smoking NN O
and CC O
lung NN O
cancer NN O
among IN O
Latinos NNS O
, , O
including VBG O
findings NNS O
from IN O
several JJ O
unpublished JJ O
studies NNS O
and CC O
technical JJ O
reports NNS O
. . O

-DOCSTART- X X O

Although IN O
several JJ O
large JJ O
waterborne JJ O
outbreaks NNS O
occurred VBD O
during IN O
the DT O
past JJ O
decade NN O
, , O
most JJS O
were VBD O
in IN O
small JJ O
communities NNS O
. . O

-DOCSTART- X X O

Uptake NNP O
of IN O
colicins NNS B-NP
required VBN O
different JJ O
domains NNS O
in IN O
TonB NNP B-NP
, , O
for IN O
colicin NN B-NP
B NNP I-NP
and CC I-NP
M NNP I-NP
around IN O
residue JJ O
160 CD O
and CC O
for IN O
colicin JJ B-NP
Ia NNP I-NP
, , O
a DT O
domain NN O
closer RBR O
to TO O
the DT O
C-terminal JJ O
end NN O
. . O

-DOCSTART- X X O

A DT O
phase NN O
II NNP O
study NN O
of IN O
interferon-alpha NN B-NP
, , O
interleukin-2 JJ B-NP
and CC O
5-fluorouracil JJ O
in IN O
advanced JJ O
renal JJ O
carcinoma NN O
: : O
clinical JJ O
data NNS O
and CC O
laboratory NN O
evidence NN O
of IN O
protease NN O
activation NN O
. . O

-DOCSTART- X X O

Most JJS O
significantly RB O
, , O
the DT O
cyclin NN B-NP
E-Cdk2 NNP I-NP
complex NN O
is VBZ O
maximally RB O
active JJ O
at IN O
the DT O
G1/S NNP O
transition NN O
, , O
and CC O
overexpression IN O
of IN O
cyclin NN B-NP
E NNP I-NP
decreases VBZ O
the DT O
time NN O
it PRP O
takes VBZ O
the DT O
cell NN O
to TO O
complete JJ O
G1 NNP O
and CC O
enter VB O
S NNP O
phase NN O
. . O

-DOCSTART- X X O

In IN O
static JJ O
conditions NNS O
, , O
body NN O
sway NN O
was VBD O
assessed VBN O
using VBG O
a DT O
conventional JJ O
force NN O
platform NN O
with IN O
eyes NNS O
open JJ O
and CC O
with IN O
eyes NNS O
closed VBN O
. . O

-DOCSTART- X X O

Antiserum NNP O
raised VBD O
against IN O
rat NN B-NP
liver NN I-NP
S6 IN I-NP
kinase NN I-NP
specifically RB O
immunoprecipitates VBZ O
the DT O
purified VBN O
32P-labeled JJ O
H4 IN O
hepatoma NN O
insulin-stimulated JJ O
S6 NNP B-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

In IN O
vitro NN O
, , O
SHIP NNP B-NP
catalyzes VBZ O
the DT O
conversion NN O
of IN O
the DT O
phosphoinositide NN B-NP
3-kinase JJ I-NP
( -LRB- O
PI3K) JJ B-NP
product NN O
phosphatidylinositol NN O
3,4 CD O
, , O
5-trisphosphate JJ O
( -LRB- O
PIP3 NN O
) -RRB- O
into IN O
phosphatidylinositol NN O
3,4-bisphosphate NN O
. . O

-DOCSTART- X X O

Diabetic JJ O
osteopathy NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
, , O
taken VBN O
together RB O
, , O
suggest VBP O
that IN O
CRF NNP B-NP
produces VBZ O
its PRP$ O
behavioral JJ O
activating NN O
and CC O
anxiogenic JJ O
effects NNS O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
by IN O
increasing VBG O
the DT O
activity NN O
of IN O
LC NNP O
noradrenergic JJ O
neurons NNS O
. . O

-DOCSTART- X X O

SN-38 DT O
rebound NN O
concentrations NNS O
were VBD O
observed VBN O
in IN O
many JJ O
courses NNS O
at IN O
about RB O
0.5 CD O
to TO O
1 CD O
hour NN O
following VBG O
the DT O
end NN O
of IN O
the DT O
i FW O
.v. NNP O
infusion NN O
, , O
which WDT O
is VBZ O
suggestive JJ O
of IN O
enterohepatic JJ O
recycling NN O
. . O

-DOCSTART- X X O

The DT O
S3 JJ B-NP
protein NN I-NP
also RB O
contains VBZ O
a DT O
DNA NN O
repair NN O
activity NN O
, , O
efficiently RB O
processing VBG O
8-oxoguanine CD O
residues NNS O
in IN O
DNA NNP O
via IN O
an DT O
N-glycosylase/apurinic-apyrimidinic NNP B-NP
( -LRB- B-NP
AP NNP I-NP
) -RRB- I-NP
lyase NN I-NP
activity NN O
. . O

-DOCSTART- X X O

The DT O
orf2 JJ O
gene NN O
product NN O
is VBZ O
a DT O
protein NN O
of IN O
79 CD O
amino IN O
acids NNS O
with IN O
characteristics NNS O
similar JJ O
to TO O
those DT O
of IN O
the DT O
Tat NNPS B-NP
( -LRB- O
transactivator NN B-NP
) -RRB- O
proteins VBZ O
of IN O
the DT O
ungulate JJ O
lentiviruses NNS O
. . O

-DOCSTART- X X O

This DT O
finding NN O
is VBZ O
of IN O
importance NN O
because IN O
it PRP O
completes VBZ O
an DT O
explanation NN O
for IN O
central JJ O
near-location JJ O
errors NNS O
in IN O
the DT O
partial-report NN O
bar-probe NN O
task NN O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
JEA2 NNP O
cells NNS O
with IN O
interleukin JJ B-NP
( -LRB- I-NP
IL)-7 : I-NP
induces VBZ O
CBLB NNP B-NP
phosphorylation NN O
as RB O
well RB O
. . O

-DOCSTART- X X O

Plasmid NNP O
pNK21 NN O
, , O
in IN O
which WDT O
2.05-kb JJ O
sequence NN O
covering VBG O
the DT O
region NN O
encoding VBG O
the DT O
nitrilase NN B-NP
was VBD O
was VBD O
placed VBN O
under IN O
the DT O
control NN O
of IN O
the DT O
lac NN B-NP
promoter NN I-NP
, , O
directed VBD O
overproduction IN O
of IN O
enzymatically RB B-NP
active JJ I-NP
nitrilase NN I-NP
in IN O
response NN O
to TO O
addition NN O
of IN O
isopropyl NN O
beta-D-thiogalactopyranoside NN O
in IN O
Escherichia NNP O
coli NNS O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Elevation NNP O
of IN O
TBARS NNP O
and CC O
decrease VB O
of IN O
GSH NNP O
show VBP O
the DT O
presence NN O
of IN O
oxidative JJ O
stress NN O
during IN O
the DT O
PFD NNP O
treatment NN O
with IN O
hemodiafilter NN O
SG3 NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
of IN O
interest NN O
that IN O
, , O
aside RB O
from IN O
starvation NN O
, , O
the DT O
nutrition NN O
catastrophes NNS O
of IN O
the DT O
past NN O
, , O
including VBG O
scurvy JJ O
(vitamin NN O
C NNP O
deficiency NN O
) -RRB- O
resulting VBG O
from IN O
lack NN O
of IN O
fresh JJ O
vegetables NNS O
and CC O
fruit NN O
and CC O
beriberi NN O
(vitamin NN O
B1 JJ O
deficiency NN O
) -RRB- O
from IN O
consumption NN O
of IN O
polished JJ O
rice NN O
, , O
are VBP O
forgotten VBN O
and CC O
only RB O
of IN O
interest NN O
as IN O
history NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
overexpression NN O
of IN O
the DT O
DREB2A NNP B-NP
cDNA NN I-NP
induced VBD O
weak JJ O
expression NN O
of IN O
the DT O
target NN O
genes NNS O
under IN O
unstressed JJ O
conditions NNS O
and CC O
caused VBN O
growth NN O
retardation NN O
of IN O
the DT O
transgenic JJ O
plants NNS O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
, , O
c-Src JJ B-NP
phosphorylated JJ O
FAK NNP B-NP
Tyr-925 CD I-NP
in IN O
a DT O
glutathione NN B-NP
S-transferase-FAK JJ I-NP
C-terminal JJ O
domain NN O
fusion NN O
protein NN O
, , O
whereas IN O
FAK NNP O
did VBD O
not RB O
. . O

-DOCSTART- X X O

The DT O
aetiology NN O
and CC O
management NN O
of IN O
diabetic NN O
impotence NN O
is VBZ O
well-documented JJ O
; : O
the DT O
effects NNS O
of IN O
diabetes NNS O
on IN O
female JJ O
sexuality NN O
are VBP O
not RB O
so RB O
clear JJ O
. . O

-DOCSTART- X X O

The DT O
percentage NN O
distribution NN O
of IN O
types NNS O
of IN O
fixation NN O
disparity NN O
curves NNS O
was VBD O
found VBN O
to TO O
be VB O
similar JJ O
to TO O
some DT O
previous JJ O
studies NNS O
, , O
with IN O
a DT O
higher JJR O
prevalence NN O
of IN O
Type NNP O
I PRP O
curve NN O
( -LRB- O
64.3 CD O
% NN O
) -RRB- O
, , O
followed VBN O
by IN O
Type JJ O
II NNP O
( -LRB- O
28.6 CD O
% NN O
) -RRB- O
and CC O
Type NNP O
III NNP O
( -LRB- O
7.1 CD O
% NN O
) -RRB- O
curves NNS O
. . O

-DOCSTART- X X O

Reading VBG O
disability NN O
in IN O
twins NNS O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
amount NN O
of IN O
blood NN O
loss NN O
prior JJ O
to TO O
time NN O
of IN O
injection NN O
was VBD O
4.5 CD O
units NNS O
( -LRB- O
a DT O
range NN O
of IN O
3 CD O
to TO O
10 CD O
units NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Several JJ O
of IN O
the DT O
drugs NNS O
used VBN O
in IN O
the DT O
management NN O
of IN O
MAC NNP O
have VBP O
been VBN O
associated VBN O
with IN O
significant JJ O
drug NN O
interactions NNS O
involving VBG O
the DT O
cytochrome NN B-NP
P450 . I-NP
( -LRB- O
CYP NNP B-NP
) -RRB- O
enzyme NN O
system NN O
. . O

-DOCSTART- X X O

Therapy NNP O
and CC O
prevention NN O
of IN O
irreversible JJ O
shock NN O
with IN O
pharmacological JJ O
doses NNS O
of IN O
some DT O
corticosteroids NNS O

-DOCSTART- X X O

Suppression NN O
of IN O
the DT O
cka1 JJ B-NP
delta NN I-NP
cka2-8 CC I-NP
mutant JJ I-NP
phenotype NN O
occurs VBZ O
by IN O
interaction NN O
of IN O
CKB1 NNP B-NP
with IN O
the DT O
defective JJ O
, , O
cka2-8-encoded JJ B-NP
, , O
catalytic JJ O
subunit NN O
. . O

-DOCSTART- X X O

Reduced VBN O
glutathione NN O
in IN O
whole JJ O
blood NN O
decreases VBZ O
within IN O
a DT O
blood NN O
Se NNP O
range NN O
of IN O
1.01 CD O
to TO O
2.28 CD O
micrograms NNS O
in IN O
the DT O
high JJ O
Se JJ O
area NN O
. . O

-DOCSTART- X X O

Promoter NNP O
elements NNS O
and CC O
transcriptional JJ O
control NN O
of IN O
the DT O
mouse NN B-NP
acetylcholinesterase NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
authors NNS O
report VBP O
two CD O
cases NNS O
of IN O
orbital NN O
cavernous JJ O
hemangioma NN O
diagnosed VBN O
by IN O
Tc-99m JJ O
RBC NNP O
SPECT. . O

-DOCSTART- X X O

250 CD O
, , O
302-311] CD O
. . O

-DOCSTART- X X O

Arterial JJ O
compliance NN O
measurements NNS O
using VBG O
intraarterial JJ O
pulse NN O
contour NN O
analysis NN O
and CC O
a DT O
modified VBN O
Windkessel NNP O
model NN O
were VBD O
carried VBN O
out RP O
in IN O
19 CD O
patients NNS O
with IN O
isolated JJ O
systolic JJ O
hypertension NN O
( -LRB- O
> NN O
or CC O
= SYM O
160/< CD O
or CC O
= SYM O
90 CD O
mm CD O
Hg JJ O
) -RRB- O
and CC O
compared VBN O
to TO O
measurements NNS O
in IN O
29 CD O
patients NNS O
with IN O
essential JJ O
hypertension NN O
( -LRB- O
diastolic JJ O
blood NN O
pressure NN O
[BP] IN O
> NN O
or CC O
= SYM O
95 CD O
mm CD O
Hg NN O
) -RRB- O
and CC O
47 CD O
normotensive JJ O
control NN O
subjects NNS O
. . O

-DOCSTART- X X O

The DT O
relationship NN O
between IN O
CSF NNP B-NP
somatostatin NN I-NP
and CC O
peripheral JJ O
thyroid NN O
hormones NNS O
was VBD O
assessed VBN O
in IN O
11 CD O
affectively RB O
ill JJ O
patients NNS O
before RB O
and CC O
during IN O
carbamazepine NN O
treatment NN O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
the DT O
requirement NN O
for IN O
CREM/ICER NNP B-NP
and CC O
Rad6B NNP B-NP
proteins VBZ I-NP
in IN O
spermatogenesis NN O
, , O
we PRP O
determined VBD O
expression NN O
of IN O
Cdc34 NNP B-NP
, , O
Rad6B NNP B-NP
, , O
CREM/ICER NNP B-NP
isoforms VBZ O
, , O
and CC O
the DT O
Skp1-Cullin-F-box NNP B-NP
ubiquitin NNP B-NP
protein NN O
ligase NN O
subunits NNS O
Cul-1 NNP B-NP
and CC O
Cul-2 NNP B-NP
, , O
which WDT O
are VBP O
associated VBN O
with IN O
Cdc34 NNP B-NP
activity NN O
during IN O
murine NN O
testicular JJ O
development NN O
. . O

-DOCSTART- X X O

Since IN O
the DT O
early JJ O
1900s CD O
, , O
a DT O
genetic JJ O
hypothesis NN O
has VBZ O
been VBN O
suggested VBN O
. . O

-DOCSTART- X X O

Kettin NNP B-NP
is VBZ O
a DT O
large JJ O
modular JJ O
protein NN O
associated VBN O
with IN O
thin JJ O
filaments NNS O
in IN O
the DT O
Z-disc JJ O
region NN O
of IN O
insect NN O
muscles NNS O
. . O

-DOCSTART- X X O

This DT O
is VBZ O
the DT O
first JJ O
description NN O
of IN O
an DT O
integron NN O
located VBN O
on IN O
a DT O
composite JJ O
transposon NN O
. . O

-DOCSTART- X X O

By IN O
means NNS O
of IN O
early JJ O
detection NN O
and CC O
correction NN O
of IN O
the DT O
possible JJ O
causes NNS O
, , O
the DT O
goal NN O
of IN O
increasing VBG O
therapeutic JJ O
efficacy NN O
can MD O
be VB O
achieved VBN O
. . O

-DOCSTART- X X O

Mutations NNS O
in IN O
the DT O
beta-galactosidase NN B-NP
gene NN I-NP
result NN O
in IN O
the DT O
lysosomal JJ O
storage NN O
disorders NNS O
GM1-gangliosidosis . O
and CC O
Morquio NNP O
B NNP O
syndrome NN O
. . O

-DOCSTART- X X O

Angiographic NNP O
follow-up NN O
was VBD O
obtained VBN O
in IN O
92 CD O
% NN O
of IN O
patients NNS O
with IN O
a DT O
primary JJ O
success NN O
of IN O
angioplasty NN O
. . O

-DOCSTART- X X O

Electron NNP O
microscopic NN O
visualization NN O
of IN O
the DT O
general JJ O
population NN O
of IN O
active JJ O
genes NNS O
in IN O
flies NNS O
overexpressing VBG O
hnRNP JJ B-NP
proteins NNS I-NP
also RB O
indicated VBD O
that IN O
the DT O
great JJ O
majority NN O
of IN O
genes NNS O
seemed VBD O
normal JJ O
in IN O
terms NNS O
of IN O
cotranscriptional JJ O
RNA NNP O
processing VBG O
events NNS O
, , O
although IN O
there EX O
were VBD O
a DT O
few JJ O
abnormalities NNS O
consistent JJ O
with IN O
rare JJ O
exon-skipping JJ O
events NNS O
. . O

-DOCSTART- X X O

ESR NNP O
spectra NN O
of IN O
Er3+ NNP O
in IN O
SmB6 NNP O
single JJ O
crystals NNS O
: : O
Dynamic NNP O
Jahn-Teller NNP O
effect NN O
in IN O
a DT O
mixed-valence NN O
compound NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
2127-bp JJ O
cDNA NN O
encodes VBZ O
a DT O
functional JJ O
feline NN O
L/B/K-type JJ B-NP
ALP NNP I-NP
expressed VBD O
on IN O
cell NN O
surfaces NNS O
via IN O
phosphatidylinositol-glycan JJ O
linkage NN O
. . O

-DOCSTART- X X O

Inhibition NN O
of IN O
endogenous JJ B-NP
Cdk2 NNP I-NP
by IN O
dominant JJ B-NP
negative JJ I-NP
Cdk2 NN I-NP
attenuated VBN O
phosphorylation NN O
of IN O
Thr447 NNP O
, , O
Thr490 CD O
and CC O
Thr497 CD O
, , O
but CC O
had VBD O
no DT O
effect NN O
upon IN O
Ser581 NNP O
modification NN O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
excessive JJ O
bleeding NN O
after IN O
cardiopulmonary JJ O
bypass NN O
was VBD O
based VBN O
on IN O
an DT O
algorithm NN O
using VBG O
point-of-care JJ O
testing NN O
with IN O
whole JJ O
blood NN B-NP
prothrombin NN I-NP
time NN O
, , O
activated VBN O
partial JJ O
thromboplastin IN B-NP
time NN O
, , O
heparinase NN B-NP
activated VBN O
clotting NN O
time NN O
, , O
and CC O
platelet NN O
count NN O
. . O

-DOCSTART- X X O

The DT O
high JJ O
prevalence NN O
of IN O
atrial JJ O
septal JJ O
defect NN O
in IN O
tetralogy NN O
of IN O
Fallot NNP O
is VBZ O
cited VBN O
as IN O
a DT O
possible JJ O
analogy NN O
because IN O
right JJ O
ventricular JJ O
pressure NN O
is VBZ O
high JJ O
and CC O
right JJ O
ventricular JJ O
compliance NN O
is VBZ O
low JJ O
from IN O
birth NN O
. . O

-DOCSTART- X X O

Experience NN O
in IN O
a DT O
Kenya NNP O
district NN O
hospital NN O

-DOCSTART- X X O

Moreover RB O
, , O
we PRP O
studied VBD O
the DT O
relationship NN O
between IN O
initial JJ O
percentage NN O
of IN O
bone NN O
marrow NN O
plasma NN O
cells NNS O
and CC O
prognosis NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
larger JJR O
cDNA NN O
clones NNS O
demonstrates VBZ O
that IN O
there EX O
are VBP O
at IN O
least JJS O
two CD O
isoforms NNS O
of IN O
RIP14 NNP B-NP
that WDT O
differ VBP O
in IN O
the DT O
N-terminal JJ O
( -LRB- O
A DT O
and CC O
B) NNP O
and CC O
hinge NN O
( -LRB- O
D) NNP O
domains VBZ O
. . O

-DOCSTART- X X O

The DT O
entire JJ O
coding NN O
region NN O
of IN O
an DT O
ovine JJ B-NP
endometrial JJ I-NP
oxytocin NN I-NP
receptor NN I-NP
( -LRB- O
OTR NN B-NP
) -RRB- O
cDNA NN O
was VBD O
generated VBN O
by IN O
PCR NNP O
, , O
subcloned VBD O
into IN O
the DT O
SV40 JJ B-NP
major JJ I-NP
late JJ I-NP
promoter NN I-NP
expression NN O
vector NN O
pSVLJ NN O
and CC O
transiently RB O
expressed VBN O
in IN O
Cos-7 NNP O
cells NNS O
. . O

-DOCSTART- X X O

Copyright NNP O
1999 CD O
Academic NNP O
Press NNP O
. . O

-DOCSTART- X X O

Critical JJ O
review NN O
of IN O
tests NNS O
for IN O
the DT O
HBs NNP B-NP
antigen NN I-NP
in IN O
the DT O
detection NN O
of IN O
infectious JJ O
blood NN O

-DOCSTART- X X O

Disease-free JJ O
interval NN O
was VBD O
greater JJR O
in IN O
node-negative JJ O
Lx NN O
patients NNS O
for IN O
both DT O
T1 NNP O
( -LRB- O
P NNP O
less RBR O
than IN O
0.007 CD O
) -RRB- O
and CC O
T2 NNP O
( -LRB- O
P NNP O
less RBR O
than IN O
0.05 CD O
) -RRB- O
presentations NNS O
. . O

-DOCSTART- X X O

Allergen-stimulated DT O
levels NNS O
of IN O
PGD2 NNP O
were VBD O
1274 CD O
+/ NNS O
- : O
565 CD O
versus NN O
1468 CD O
+/ NNS O
- : O
679 CD O
after IN O
prednisone NN O
; : O
likewise RB O
, , O
allergen-stimulated DT O
5-HETE JJ O
levels NNS O
were VBD O
95 CD O
+/ NNS O
- : O
21 CD O
versus NN O
82 CD O
+/ NNS O
- : O
21 CD O
; : O
those DT O
of IN O
LTE4 NNP O
were VBD O
54 CD O
+/ NNS O
- : O
20 CD O
versus NN O
91 CD O
+/ NN O
- : O
51 CD O
; : O
and CC O
those DT O
of IN O
15-HETE JJ O
were VBD O
63 CD O
+/ NNS O
- : O
19 CD O
versus NN O
60 CD O
+/ NNS O
- : O
25 CD O
. . O

-DOCSTART- X X O

To TO O
confirm VB O
the DT O
data NNS O
obtained VBN O
using VBG O
the DT O
HPLC-ESI-MS NNP O
procedure NN O
, , O
fractions NNS O
of IN O
the DT O
glycosides NNS O
from IN O
four CD O
berries NNS O
were VBD O
separated VBN O
, , O
hydrolyzed JJ O
, , O
silylated JJ O
and CC O
the DT O
sugars NNS O
were VBD O
analyzed VBN O
using VBG O
gas NN O
chromatography-mass NN O
spectrometry NN O
. . O

-DOCSTART- X X O

Usefulness NN O
of IN O
computerized JJ O
tomography NN O
in IN O
hemodialysis NN O
patients NNS O
. . O

-DOCSTART- X X O

Prevalence NNP O
of IN O
use NN O
, , O
claims VBZ O
volume NN O
, , O
and CC O
expenditures NNS O
were VBD O
compared VBN O
for IN O
cisapride NN O
, , O
proton NN O
pump NN O
inhibitors NNS O
, , O
histamine-2 NN B-NP
receptor NN I-NP
antagonists NNS O
, , O
and CC O
the DT O
prokinetic JJ O
agent NN O
metoclopramide VBN O
during IN O
these DT O
periods NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
quasiparticle NN O
scattering NN O
rate NN O
tau(-1 NN O
) -RRB- O
is VBZ O
such JJ O
that IN O
Planck NNP O
's POS O
over IN O
2pi/tau CD O
approximately RB O
6t( JJ O
perpendicular JJ O
) -RRB- O
, , O
implying VBG O
that IN O
kappa NN O
- : O
( -LRB- O
BEDT-TTF)2Cu(NCS)( JJ O
2 CD O
) -RRB- O
meets VBZ O
the DT O
criterion NN O
used VBD O
to TO O
identify VB O
interlayer NN O
incoherence NN O
. . O

-DOCSTART- X X O

The DT O
deduced JJ O
gene NN O
product NN O
was VBD O
found VBN O
to TO O
have VB O
significant JJ O
sequence NN O
similarity NN O
to TO O
the DT O
yeast NN B-NP
and CC I-NP
prokaryotic JJ I-NP
RNA NNP I-NP
polymerase NN I-NP
subunits NNS I-NP
involved VBN O
with IN O
subunit NN O
assembly NN O
. . O

-DOCSTART- X X O

In IN O
two CD O
of IN O
these DT O
nine CD O
patients NNS O
, , O
a DT O
decrease NN O
in IN O
dyskinesia NN O
score NN O
was VBD O
observed VBN O
without IN O
a DT O
concomitant NN O
worsening VBG O
of IN O
parkinsonian NN O
symptoms NNS O
, , O
whereas IN O
in IN O
the DT O
remaining VBG O
seven CD O
, , O
full JJ O
parkinsonian NN O
akinesia NN O
followed VBD O
THDL NNP O
administration NN O
. . O

-DOCSTART- X X O

A DT O
proposed JJ O
method NN O
. . O

-DOCSTART- X X O

A DT O
clinical JJ O
trial NN O
of IN O
a DT O
new JJ O
mitomycin NN O
C NNP O
derivative JJ O
, , O
KW-2083 JJ O
(7-N-(p-hydroxyphenyl)-mitomycin JJ O
C NNP O
) -RRB- O

-DOCSTART- X X O

Complexities NNS O
in IN O
the DT O
host-pathogen NN O
interactions NNS O
during IN O
actual JJ O
infection NN O
with IN O
Gram-negative NNP O
bacteria NNS O
may MD O
account VB O
for IN O
the DT O
difficulties NNS O
in IN O
demonstrating VBG O
this DT O
phenomena NNS O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

6,320 CD O
cells/mm3 NN O
, , O
respectively RB O
; : O
P NNP O
less RBR O
than IN O
.005 CD O
) -RRB- O
; : O
twelve CD O
(86 CD O
% NN O
) -RRB- O
of IN O
the DT O
14 CD O
inmates NNS O
who WP O
developed VBD O
AIDS NNP O
had VBD O
counts NNS O
of IN O
less JJR O
than IN O
5,000 CD O
cells/mm3 NNS O
, , O
compared VBN O
with IN O
only RB O
six CD O
( -LRB- O
14 CD O
% NN O
) -RRB- O
of IN O
the DT O
42 CD O
controls NNS O
( -LRB- O
P NNP O
less RBR O
than IN O
.00001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
new JJ O
model NN O
for IN O
objective JJ O
assessment NN O
of IN O
cervical JJ O
ripening NN O
: : O
the DT O
effect NN O
of IN O
prostaglandin NN O
E2 NN O
and CC O
prelabor NN O
contractility NN O
. . O

-DOCSTART- X X O

Insulin-secreting JJ B-NP
islet-cell NN O
tumours NNS O
of IN O
the DT O
pancreas NNS O
. . O

-DOCSTART- X X O

Suprapubic NNP O
and CC O
intravesical JJ O
methods NNS O

-DOCSTART- X X O

The DT O
use NN O
of IN O
ALAD NNP B-NP
activity NN O
and CC O
EP NNP O
as IN O
cumulative JJ O
lead NN O
exposure NN O
indicators NNS O
is VBZ O
suggested VBN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
The DT O
present JJ O
study NN O
showed VBD O
it PRP O
is VBZ O
possible JJ O
to TO O
use VB O
a DT O
modified VBN O
Stroop NNP O
task NN O
as IN O
a DT O
measure NN O
of IN O
implicit JJ O
processing NN O
of IN O
alcohol NN O
stimuli NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
rapid JJ O
light-mediated JJ O
increase NN O
of IN O
CPRF NNP B-NP
proteins NNS I-NP
was VBD O
insensitive JJ O
to TO O
transcriptional JJ O
inhibitors NNS O
, , O
suggesting VBG O
that IN O
a DT O
post-transcriptional JJ O
mechanism NN O
controls VBZ O
CPRF NNP B-NP
accumulation NN O
. . O

-DOCSTART- X X O

43 CD O
% NN O
, , O
6/14 CD O
; : O
P NNP O
= SYM O
0.013 CD O
) -RRB- O
, , O
whereas IN O
, , O
in IN O
RCC NNP O
samples NNS O
with IN O
VHL NNP B-NP
methylation NN O
or CC O
mutation NN O
, , O
the DT O
frequency NN O
of IN O
3p14-p21 CD O
LOH NNP O
did VBD O
not RB O
differ VB O
from IN O
that DT O
of IN O
sp25-p26 DT O
( -LRB- O
72 CD O
% NN O
, , O
18/25 CD O
vs. CC O

-DOCSTART- X X O

One CD O
patient NN O
had VBD O
chronic JJ O
dysphoria NN O
and CC O
one CD O
encephalopatia NN O
toxica NN O
. . O

-DOCSTART- X X O

A DT O
single JJ O
clone NN O
, , O
which WDT O
was VBD O
conserved VBN O
and CC O
had VBD O
near-perfect JJ O
homology NN O
to TO O
eight CD O
human/rodent NN O
expressed VBD O
sequence NN O
tags NNS O
, , O
was VBD O
used VBN O
as IN O
template JJ O
for IN O
5' JJ O
and CC O
3' JJ O
rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends NNS O
and CC O
SPICE NNP O
( -LRB- O
system NN O
for IN O
polymerase NN O
chain NN O
reaction NN O
amplification NN O
of IN O
cDNA JJ O
ends NNS O
) -RRB- O
reactions NNS O
to TO O
obtain VB O
the DT O
3.6-kb JJ O
cDNA NN O
, , O
LGL2 NNP B-NP
( -LRB- O
Genbank NNP B-NP
, , I-NP
AF JJ I-NP
110195 CD I-NP
) -RRB- O
encoding VBG O
a DT O
deduced JJ O
polypeptide NN O
(lgl2 NN O
) -RRB- O
of IN O
963 CD O
amino IN O
acids NNS O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
dimethyl NN O
sulfoxide NN O
on IN O
cooling VBG O
rates NNS O
of IN O
unrestrained JJ O
rats NNS O
. . O

-DOCSTART- X X O

The DT O
GIS NNP O
software NN O
program NN O
, , O
ArcView NNP O
, , O
was VBD O
used VBN O
for IN O
spatial JJ O
analysis NN O
and CC O
distance NN O
calculations NNS O
. . O
chi2 NN O
Tests NNS O
were VBD O
used VBN O
to TO O
compare VB O
the DT O
distribution NN O
of IN O
the DT O
characteristics NNS O
between IN O
intersection NN O
and CC O
midblock NN O
collisions NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
analyzed VBN O
the DT O
role NN O
of IN O
the DT O
HU NNP B-NP
protein NN I-NP
in IN O
invertasome JJ O
assembly NN O
when WRB O
the DT O
enhancer NN O
is VBZ O
located VBN O
at IN O
variable JJ O
positions NNS O
close JJ O
to TO O
one CD O
of IN O
the DT O
recombination NN O
sites NNS O
. . O

-DOCSTART- X X O

The DT O
likelihood NN O
of IN O
death NN O
was VBD O
more JJR O
than IN O
3 CD O
times NNS O
higher JJR O
among IN O
patients NNS O
in IN O
the DT O
ERA-II JJ O
group NN O
( -LRB- O
mortality NN O
risk NN O
ratio NN O
3.82 CD O
[95 CD O
% NN O
CI NNP O
1.48 CD O
% NN O
to TO O
9.84] CD O
, , O
p NN O
= SYM O
0.006 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
show VBP O
that IN O
the DT O
nucleotide JJ O
in IN O
the DT O
middle NN O
of IN O
the DT O
anticodon NN O
( -LRB- O
i FW O
.e FW O
. . O
, , O
psi FW O
35 CD O
) -RRB- O
also RB O
contributes VBZ O
to TO O
the DT O
suppressor NN O
efficiency NN O
displayed VBN O
by IN O
cytoplasmic JJ B-NP
tRNA(Tyr NN I-NP
) -RRB- I-NP
. . O

-DOCSTART- X X O

Similarly RB O
, , O
an DT O
increase NN O
in IN O
CAT JJ B-NP
expression NN O
from IN O
the DT O
same JJ O
construct VB O
( -LRB- O
pBLCAT-ENDOA NN O
) -RRB- O
was VBD O
also RB O
observed VBN O
in IN O
7AQS2.1 CD O
cells NNS O
. . O

-DOCSTART- X X O

Although IN O
the DT O
occurrence NN O
of IN O
any DT O
ventricular JJ O
ectopic NN O
activity NN O
, , O
as IN O
detected VBN O
by IN O
either RB O
or CC O
both DT O
methods NNS O
, , O
was VBD O
common JJ O
, , O
the DT O
incidence NN O
was VBD O
significantly RB O
higher JJR O
( -LRB- O
P NNP O
less RBR O
than IN O
0.001 CD O
) -RRB- O
in IN O
patients NNS O
with IN O
coronary JJ O
heart NN O
disease NN O
(86 WDT O
percent NN O
; : O
77/90 CD O
) -RRB- O
, , O
as IN O
compared VBN O
to TO O
that DT O
in IN O
normal JJ O
subjects NNS O
( -LRB- O
40 CD O
percent NN O
; : O
12/30 CD O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
8-oxoguanine CD B-NP
DNA NNP I-NP
glycosylases NNS I-NP
, , O
hOgg1 NNS B-NP
( -LRB- O
human NN O
) -RRB- O
and CC O
mOgg1 JJ B-NP
( -LRB- O
murine NN O
) -RRB- O
, , O
are VBP O
homologous JJ O
to TO O
each DT O
other JJ O
and CC O
to TO O
yeast NN B-NP
Ogg1 NNP I-NP
. . O

-DOCSTART- X X O

Model JJ O
experiments NNS O
on IN O
pheasants NNS O
using VBG O
single JJ O
doses NNS O
of IN O
the DT O
insecticide NN O
( -LRB- O
Lindane NNP O
) -RRB- O
the DT O
herbicide NN O
( -LRB- O
Terbutryn NNP O
) -RRB- O
a DT O
mineral JJ O
fertilizer NN O
( -LRB- O
calcium NN O
ammonium NN O
nitrate NN O
) -RRB- O
and CC O
the DT O
fungicide NN O
( -LRB- O
HCB) NNP O
. . O

-DOCSTART- X X O

The DT O
main JJ O
side-effects NNS O
were VBD O
myelosuppression CD O
, , O
mucositis NN O
and CC O
peripheral JJ O
neuropathy NN O
, , O
which WDT O
were VBD O
all DT O
common JJ O
and CC O
often RB O
severe JJ O
. . O

-DOCSTART- X X O

Repression NN O
was VBD O
strictly RB O
dependent JJ O
on IN O
the DT O
presence NN O
of IN O
upstream RB O
Oshox1 JJ B-NP
binding NN O
sites NNS O
in IN O
the DT O
reporter NN O
gene NN O
constructs NNS O
and CC O
a DT O
function NN O
of IN O
the DT O
N-terminal JJ O
region NN O
of IN O
Oshox1 NNP B-NP
, , O
preceding VBG O
the DT O
homeodomain NN B-NP
. . O

-DOCSTART- X X O

Experimental JJ O
studies NNS O
and CC O
clinical JJ O
application NN O
of IN O
plasma NN B-NP
ACTH NNP I-NP
radioimmunoassay NN O
kit NN O
without IN O
extraction NN O
process NN O

-DOCSTART- X X O

Defects NNS O
in IN O
RT6 NNP B-NP
expression NN O
coincide NN O
with IN O
increased VBN O
susceptibility NN O
in IN O
animal NN O
models NNS O
for IN O
insulin-dependent NN B-NP
diabetes NNS O
mellitus JJ O
and CC O
other JJ O
autoimmune JJ O
diseases NNS O
. . O

-DOCSTART- X X O

By IN O
cloning VBG O
genes NNS O
encoding VBG O
benzene-degradative JJ O
enzymes NNS O
, , O
we PRP O
found VBD O
that DT O
strain NN O
JS150 PRP O
also RB O
carries VBZ O
genes NNS O
for IN O
a DT O
toluene/benzene-2-monooxygenase NN B-NP
. . O

-DOCSTART- X X O

Thus RB O
G17 PRP B-NP
targets VBZ O
the DT O
c-fos JJ B-NP
promoter NN I-NP
CArG NNP I-NP
sequence NN I-NP
via IN O
Rho NNP B-NP
A-dependent NNP I-NP
pathways NNS O
, , O
and CC O
Rho NNP B-NP
A NNP I-NP
appears VBZ O
to TO O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
the DT O
trophic JJ O
action NN O
of IN O
G17 NN B-NP
. . O

-DOCSTART- X X O

By IN O
contrast NN O
with IN O
ama-1 NN B-NP
, , O
rpc-1 NN B-NP
was VBD O
not RB O
deleted VBN O
by IN O
mDf4 CD O
or CC O
larger JJR O
deficiencies NNS O
examined VBD O
, , O
indicating VBG O
that IN O
these DT O
genes NNS O
are VBP O
no RB O
closer JJR O
than IN O
150 CD O
kb NN O
. . O

-DOCSTART- X X O

Dual JJ O
signal NN O
peptides NNS O
mediate VBP O
the DT O
signal NN B-NP
recognition NN I-NP
particle/Sec-independent JJ I-NP
insertion NN O
of IN O
a DT O
thylakoid JJ O
membrane NN O
polyprotein NN O
, , O
PsbY NNP B-NP
. . O

-DOCSTART- X X O

The DT O
three CD O
respective JJ O
time NN O
control NN O
groups NNS O
( -LRB- O
C5 NNP O
, , O
C10 NNP O
, , O
and CC O
C15 NNP O
) -RRB- O
were VBD O
injected VBN O
with IN O
saline NN O
solution NN O
. . O

-DOCSTART- X X O

Next JJ O
, , O
to TO O
examine VB O
the DT O
regulation NN O
mechanism NN O
of IN O
CD44/ERM NNP B-NP
interaction NN O
in IN O
vivo NN O
, , O
we PRP O
reexamined VBD O
the DT O
immunoprecipitated JJ O
CD44/ERM NNP B-NP
complex NN O
from IN O
BHK NNP O
cells NNS O
and CC O
found VBD O
that IN O
it PRP O
contains VBZ O
Rho-GDP NNP B-NP
dissociation NN I-NP
inhibitor NN I-NP
( -LRB- O
GDI) NNP B-NP
, , O
a DT O
regulator NN O
of IN O
Rho NNP B-NP
GTPase NNP I-NP
. . O

-DOCSTART- X X O

Ten CD O
patients NNS O
( -LRB- O
aged VBN O
28-76 CD O
years NNS O
) -RRB- O
with IN O
a DT O
terminal JJ O
jejunostomy NN O
located VBN O
within IN O
the DT O
first JJ O
meter NN O
of IN O
jejunum NN O
were VBD O
treated VBN O
by IN O
infusion NN O
of IN O
an DT O
elemental JJ O
diet NN O
into IN O
the DT O
distal JJ O
small JJ O
bowel NN O
( -LRB- O
IEDDSB NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
goals NNS O
of IN O
these DT O
experiments NNS O
were VBD O
to TO O
determine VB O
whether IN O
lactational JJ O
anestrus NN O
would MD O
be VB O
prolonged VBN O
by IN O
a DT O
48-h JJ O
fast JJ O
at IN O
days NNS O
13 CD O
and CC O
14 CD O
postpartum NN O
( -LRB- O
pp RP O
) -RRB- O
and CC O
, , O
if IN O
so RB O
, , O
to TO O
determine VB O
whether IN O
this DT O
effect NN O
could MD O
be VB O
reversed VBN O
by IN O
treatment NN O
with IN O
the DT O
Ob NNP B-NP
protein NN I-NP
leptin NN B-NP
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
In IN O
patients NNS O
with IN O
necrotising JJ O
fasciitis NN O
the DT O
arterial NN O
PO2 NN O
rose VBD O
about IN O
7-fold JJ O
whereas IN O
the DT O
arterial NN O
PCO2 NN O
increased VBD O
only RB O
slightly RB O
during IN O
exposure NN O
to TO O
2.5 CD O
absolute JJ O
atmospheres NNS O
( -LRB- O
ATA NNP O
) -RRB- O
of IN O
oxygen NN O
. . O

-DOCSTART- X X O

Being VBG O
implicated VBN O
in IN O
insulin NN B-NP
and CC O
GK JJ B-NP
gene NN I-NP
regulations NNS O
as IN O
a DT O
common JJ O
transcription NN O
factor NN O
, , O
IPF1/STF-1/PDX-1 NN B-NP
is VBZ O
likely JJ O
to TO O
play VB O
an DT O
essential JJ O
role NN O
in IN O
maintaining VBG O
normal JJ O
beta-cell JJ O
functions NNS O
. . O

-DOCSTART- X X O

MATERIAL NNP O
AND CC O
METHODS NNP O
: : O

-DOCSTART- X X O

Finally RB O
, , O
synthetic JJ O
peptides NNS O
corresponding JJ O
to TO O
the DT O
mutant JJ O
proteins NNS O
were VBD O
assessed VBN O
for IN O
the DT O
ability NN O
to TO O
act VB O
as IN O
substrates NNS O
for IN O
PR NNP B-NP
. . O

-DOCSTART- X X O

As IN O
an DT O
approach NN O
to TO O
the DT O
determination NN O
of IN O
structure-function NN O
relationships NNS O
in IN O
the DT O
PRP4 NNP B-NP
protein NN I-NP
, , O
we PRP O
have VBP O
isolated VBN O
more JJR O
than IN O
fifty CD O
new JJ O
alleles NNS O
of IN O
the DT O
PRP4 NNP B-NP
gene NN I-NP
through IN O
random JJ O
and CC O
site-directed JJ O
mutagenesis NN O
, , O
and CC O
have VBP O
analyzed VBN O
the DT O
phenotypes NNS O
of IN O
many JJ O
of IN O
them PRP O
. . O

-DOCSTART- X X O

Brainstem NNP O
auditory NN O
evoked VBZ O
potential JJ O
responses NNS O
( -LRB- O
BAEPs NNS O
) -RRB- O
were VBD O
recorded VBN O
from IN O
CZ-A1 NNP O
and CC O
CZ-A2 JJ O
scalp NN O
regions NNS O
in IN O
23 CD O
hypertensive NN O
and CC O
14 CD O
normotensive JJ O
subjects NNS O
. . O

-DOCSTART- X X O

Although IN O
the DT O
Gly252Arg NNP O
substitution NN O
observed VBD O
in IN O
UM:JG5 DT O
is VBZ O
non-conservative JJ O
, , O
it PRP O
was VBD O
not RB O
possible JJ O
to TO O
distinguish VB O
whether IN O
it PRP O
is VBZ O
a DT O
mutation NN O
or CC O
a DT O
polymorphism NN O
. . O

-DOCSTART- X X O

Phosphorylation NNP O
of IN O
the DT O
ras NNS B-NP
GTPase-activating JJ B-NP
protein NN I-NP
( -LRB- O
GAP NNP B-NP
) -RRB- O
by IN O
the DT O
p93c-fes NNS B-NP
protein-tyrosine NN B-NP
kinase NN I-NP
in IN O
vitro NN O
and CC O
formation NN O
of IN O
GAP-fes NNP B-NP
complexes NNS O
via IN O
an DT O
SH2 NNP B-NP
domain-dependent NN O
mechanism NN O
. . O

-DOCSTART- X X O

This DT O
resulted VBD O
in IN O
a DT O
shift NN O
of IN O
C1/C2 NNP O
, , O
so RB O
that IN O
the DT O
effect NN O
of IN O
collagen NN B-NP
was VBD O
more RBR O
pronounced JJ O
( -LRB- O
maximal JJ O
increase NN O
of IN O
C1/C2 NNP O
= SYM O
134 CD O
% NN O
) -RRB- O
than IN O
ADP NNP O
( -LRB- O
maximal JJ O
increase NN O
of IN O
C1/C2 NNP O
= SYM O
79 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

ZF87 PRP B-NP
specifically RB O
binds VBZ O
the DT O
ME1a1 NNP O
element NN O
with IN O
higher JJR O
affinity NN O
than IN O
the DT O
ME1a2 NNP O
element NN O
. . O

-DOCSTART- X X O

Structure NN O
of IN O
the DT O
connective JJ O
stroma NN O
of IN O
the DT O
epididymis NN O
in IN O
the DT O
zebu NN O

-DOCSTART- X X O

These DT O
data NNS O
suggest VBP O
that IN O
multiple JJ O
genetic JJ O
recombination NN O
among IN O
bacteriophages NNS O
with IN O
different JJ O
immunities NNS O
took VBD O
place NN O
to TO O
generate VB O
the DT O
prophage NN O
VT1-Sakai NNP O
. . O

-DOCSTART- X X O

Transient-expression NNP O
assay NN O
analysis NN O
of IN O
subclones NNS O
of IN O
pPstI-G JJ O
localized VBN O
the DT O
trans-active JJ O
factor NN O
to TO O
a DT O
3.0-kilobase JJ B-NP
XbaI JJ I-NP
fragment NN I-NP
. . O

-DOCSTART- X X O

Concentrations NNS O
of IN O
platelet NN O
nitrite JJ O
and CC O
total JJ O
nitrate/nitrite NN O
were VBD O
determined VBN O
using VBG O
simple JJ O
and CC O
sensitive JJ O
nitrate/nitrite JJ O
fluorometric JJ O
assay NN O
techniques NNS O
. . O

-DOCSTART- X X O

Using VBG O
a DT O
GTP-dependent NNP O
, , O
brefeldin NN O
A-sensitive NN O
in IN O
vitro NN O
AP-1 NN B-NP
binding NN O
assay NN O
, , O
we PRP O
have VBP O
determined VBN O
here RB O
the DT O
parameters NNS O
of IN O
the DT O
AP-1 NNP B-NP
binding NN O
reaction NN O
. . O

-DOCSTART- X X O

By IN O
using VBG O
methanol-0.15 CD O
M NNP O
borate NN O
buffer NN O
of IN O
pH DT O
8.0, JJ O
cate-chol-O-methyltransferase NN B-NP
activity NN O
might MD O
be VB O
assayed VBN O
. . O

-DOCSTART- X X O

Replacement NNP O
of IN O
Val20-Leu21 NNP O
with IN O
Ala-Ala NNP O
produced VBD O
a DT O
dimeric JJ B-NP
RII NNP I-NP
beta JJ I-NP
protein NN I-NP
that IN O
binds NNS O
AKAP75 IN B-NP
approximately RB O
4 CD O
% NN O
as IN O
avidly RB O
as IN O
wild-type JJ B-NP
RII NNP I-NP
beta NN I-NP
. . O

-DOCSTART- X X O

Plasmodium NN O
vivax NN O
malaria NN O
. . O

-DOCSTART- X X O

Postcontrast NNP O
images NNS O
were VBD O
also RB O
acquired VBN O
in IN O
the DT O
sagittal NN O
( -LRB- O
six CD O
patients NNS O
) -RRB- O
and CC O
coronal JJ O
( -LRB- O
three CD O
patients NNS O
) -RRB- O
planes NNS O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
death NN O
assays VBZ O
with IN O
transient JJ O
overexpression NN O
of IN O
deletion NN O
constructs NNS O
of IN O
both DT O
isoforms NNS O
using VBG O
beta-galactosidase JJ B-NP
as RB O
a DT O
reporter NN O
gene NN O
in IN O
MCF7 CD O
cells NNS O
suggest VBP O
the DT O
following VBG O
: : O
1 LS O
) -RRB- O
the DT O
nucleotide JJ O
binding JJ O
domain NN O
may MD O
act VB O
as IN O
a DT O
negative JJ O
regulator NN O
of IN O
the DT O
killing NN O
activity NN O
of IN O
DEFCAP NNP B-NP
; : O
2 CD O
) -RRB- O
the DT O
LRR/CARD NNP B-NP
represents VBZ O
a DT O
putative JJ O
constitutively RB O
active JJ O
inducer NN O
of IN O
apoptosis NN O
; : O
3 CD O
) -RRB- O
the DT O
killing NN O
activity NN O
of IN O
LRR/CARD NNP B-NP
is VBZ O
inhibitable JJ O
by IN O
benzyloxycarbonyl-Val-Ala-Asp NN O
( -LRB- O
OMe)-fluoromethyl NNP O
ketone NN O
and CC O
to TO O
a DT O
lesser JJR O
extent NN O
by IN O
Asp-Glu-Val-Asp NNP O
( -LRB- O
OMe)-fluoromethyl NN O
ketone NN O
; : O
and CC O
4 CD O
) -RRB- O
the DT O
CARD NNP B-NP
is VBZ O
critical JJ O
for IN O
killing VBG O
activity NN O
of IN O
DEFCAP. NNP B-NP

-DOCSTART- X X O

Here RB O
, , O
we PRP O
provide VBP O
direct JJ O
evidence NN O
that IN O
the DT O
meiotic JJ O
defect NN O
caused VBN O
by IN O
either DT O
unregulated JJ O
cAPK NN B-NP
activity NN O
or CC O
unregulated JJ O
ran1+ JJ B-NP
kinase NN I-NP
activity NN O
is VBZ O
due JJ O
to TO O
inability NN O
to TO O
induce VB O
transcription NN O
of IN O
the DT O
mei2+ JJ B-NP
gene NN I-NP
, , O
which WDT O
is VBZ O
required VBN O
for IN O
meiotic JJ O
initiation NN O
. . O

-DOCSTART- X X O

Sailer NNP O
, , O
K. NNP O

-DOCSTART- X X O

As IN O
tat NN B-NP
itself PRP O
dramatically RB O
increases VBZ O
HIV-1 PRP$ O
gene NN O
expression NN O
, , O
it PRP O
too RB O
is VBZ O
presumably RB O
regulated VBN O
in IN O
the DT O
latent JJ O
state NN O
, , O
and CC O
may MD O
also RB O
be VB O
activated VBN O
by IN O
mitogenic JJ O
stimulation NN O
. . O

-DOCSTART- X X O

The DT O
CBS-1 NNP B-NP
gene NN I-NP
was VBD O
mapped VBN O
to TO O
human JJ O
chromosome NN O
10p12 CD O
between IN O
markers NNS O
WI-8535 : B-NP
and CC O
WI-4724 NNP B-NP
, , O
and CC O
is VBZ O
tightly RB O
linked VBN O
to TO O
the DT O
two CD O
STRP NNP O
markers NNS O
of IN O
D10S1789 CD B-NP
and CC O
D10S550 CD B-NP
. . O

-DOCSTART- X X O

We PRP O
have VBP O
previously RB O
described VBN O
the DT O
partial JJ O
purification NN O
of IN O
Ap4A DT B-NP
hydrolase NN I-NP
from IN O
S. NNP O
pombe NN O
[ IN O
Robinson NNP O
, , O
de NNP O
la NNP O
Pena NNP O
and CC O
Barnes NNP O
( -LRB- O
1993 CD O
) -RRB- O
Biochim NNP O
. . O

-DOCSTART- X X O

Together RB O
, , O
these DT O
results NNS O
indicate VBP O
that IN O
YTS1 PRP B-NP
is VBZ O
a DT O
bifunctional JJ O
protein NN O
active JJ O
in IN O
both DT O
splicing NN O
and CC O
protein NN O
synthesis NN O
. . O

-DOCSTART- X X O

The DT O
first JJ O
operon NN O
, , O
orf1-tolQRA NNP O
, , O
is VBZ O
iron NN O
regulated VBN O
throughout IN O
growth NN O
, , O
but CC O
iron-regulated JJ O
expression NN O
of IN O
tolB NN B-NP
and CC O
oprL NN B-NP
fusions NNS I-NP
occurs VBZ O
only RB O
in IN O
late JJ O
log NN O
phase NN O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
IFI16 NNP I-NP
gene NN I-NP
is VBZ O
a DT O
member NN O
of IN O
an DT O
interferon-inducible JJ B-NP
family NN O
of IN O
mouse NN O
and CC O
human JJ O
genes NNS O
closely RB O
linked VBN O
on IN O
syntenic JJ O
regions NNS O
of IN O
chromosome NN O
1 CD O
. . O

-DOCSTART- X X O

Late JJ O
results NNS O
in IN O
the DT O
treatment NN O
of IN O
urotuberculosis NN O

-DOCSTART- X X O

Methylation NNP O
interference NN O
analysis NN O
established VBN O
at IN O
single JJ O
nucleotide JJ O
resolution NN O
that WDT O
purified VBD O
recombinant JJ O
Fos NNP B-NP
and CC O
Jun NNP B-NP
proteins VBZ I-NP
bind NN O
in IN O
a DT O
sequence-specific JJ O
manner NN O
to TO O
the DT O
AP-1 NN B-NP
sites NNS I-NP
within IN O
the DT O
VDRE NNP O
and CC O
OC NNP B-NP
box NN I-NP
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
p18 NN I-NP
gene NN I-NP
spans VBZ O
at IN O
least JJS O
7.5 CD O
kb NN O
and CC O
is VBZ O
composed VBN O
of IN O
three CD O
exons NNS O
, , O
two CD O
of IN O
which WDT O
encode VBP O
the DT O
p18 NNS B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Partial JJ O
characterization NN O
of IN O
the DT O
CCAAT NN O
box NN O
in IN O
the DT O
promoter NN O
of IN O
the DT O
hLGFBP-1 JJ B-NP
gene NN I-NP
: : O
interaction NN O
with IN O
negatively RB O
acting VBG O
transcription NN O
factors NNS O
in IN O
decidualized JJ O
human JJ O
endometrial NN O
stromal JJ O
cells NNS O
. . O

-DOCSTART- X X O

These DT O
cDNAs NNS O
were VBD O
found VBN O
to TO O
be VB O
derived VBN O
from IN O
the DT O
3"-untranslated JJ O
region NN O
( -LRB- O
3"-UTR JJ O
) -RRB- O
of IN O
the DT O
methyl-CpG-binding JJ B-NP
protein NN I-NP
2 CD I-NP
gene NN I-NP
( -LRB- O
MeCP2 CD B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Carotid NNP O
body NN O
chemoreceptor NN O
activity NN O
as IN O
recorded VBN O
from IN O
the DT O
petrosal NN O
ganglion NN O
in IN O
cats NNS O
. . O

-DOCSTART- X X O

The DT O
NF-kappaB/Rel NNP B-NP
transcription NN O
factors NNS O
participate VBP O
in IN O
the DT O
activation NN O
of IN O
immune JJ O
system NN O
regulatory JJ O
genes NNS O
and CC O
viral JJ B-NP
early JJ I-NP
genes NNS I-NP
including VBG O
the DT O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
long JJ I-NP
terminal NN I-NP
repeat NN I-NP
. . O

-DOCSTART- X X O

BK-induced JJ B-NP
translocation NN O
and CC O
overexpression NN O
of IN O
PKC NNP B-NP
isoforms VBZ I-NP
as RB O
well RB O
as IN O
coexpression NN O
of IN O
inactive JJ O
or CC O
constitutively RB O
active JJ O
mutants NNS O
of IN O
different JJ O
PKC NNP B-NP
isozymes NNS I-NP
provided VBD O
evidence NN O
for IN O
a DT O
role NN O
of IN O
the DT O
diacylglycerol-sensitive JJ O
PKCs NNP B-NP
alpha NN I-NP
and CC I-NP
epsilon NN I-NP
in IN O
BK NNP B-NP
signaling VBG O
toward IN O
MAPK. NNP B-NP

-DOCSTART- X X O

Clinical NNP O
trial NN O
endpoints NNS O
based VBN O
on IN O
magnitude NN O
of IN O
reduction NN O
in IN O
HIV-1 PRP$ O
RNA NNP O
levels NNS O
provide VBP O
an DT O
important JJ O
complement NN O
to TO O
endpoints NNS O
based VBN O
on IN O
percentage NN O
of IN O
patients NNS O
achieving VBG O
complete JJ O
virologic NN O
suppression NN O
. . O

-DOCSTART- X X O

The DT O
expression NN O
of IN O
cor14b NN B-NP
was VBD O
strongly RB O
impaired VBN O
in IN O
the DT O
barley NN O
albino IN O
mutant JJ O
an DT O
, , O
suggesting VBG O
the DT O
involvement NN O
of IN O
a DT O
plastidial JJ O
factor NN O
in IN O
the DT O
control NN O
of IN O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

Pulse NN O
monitors NNS O
in IN O
outpatient JJ O
dental JJ O
anaesthesia NN O
. . O

-DOCSTART- X X O

Synthesis NNP O
of IN O
2-( JJ O
2'-thiazolyl JJ O
) -RRB- O
alkanebenzimidazoles--potential JJ O
anthelmintics NNS O

-DOCSTART- X X O

Wild JJ O
type NN O
MEKK1 IN B-NP
enhances NNS O
promoter NN O
activity NN O
and CC O
the DT O
activity NN O
can MD O
be VB O
inhibited VBN O
by IN O
dominant JJ O
negative JJ O
MEKK1 NNS B-NP
, , O
MEK1 NNP B-NP
, , O
MEK7 NNP B-NP
, , O
MEK3 NNP B-NP
, , O
p38/RK NN B-NP
, , O
and CC O
c-Jun NN B-NP
. . O

-DOCSTART- X X O

Our PRP$ O
current JJ O
study NN O
aims VBZ O
at IN O
clarifying VBG O
the DT O
role NN O
of IN O
myristoylation NN O
in IN O
caveolar JJ O
targeting VBG O
using VBG O
well-characterized JJ O
acylation NN O
mutants NNS O
of IN O
two CD O
model JJ O
proteins NNS O
, , O
namely RB O
Gi1 NNP B-NP
alpha NN I-NP
and CC O
c-Src NN B-NP
. . O

-DOCSTART- X X O

Immunoprecipitation NNP O
of IN O
spinophilin NN B-NP
or CC O
neurabin NN B-NP
from IN O
crude JJ O
brain NN O
extracts NNS O
selectively RB O
coprecipitated VBN O
PP1gamma( JJ B-NP
1 CD I-NP
) -RRB- I-NP
over IN O
PP1beta NNP B-NP
. . O

-DOCSTART- X X O

Most RBS O
important JJ O
, , O
after IN O
all DT O
, , O
is VBZ O
not RB O
the DT O
ionization NN O
technique NN O
but CC O
the DT O
stage NN O
with IN O
a DT O
47.1 CD O
% NN O
five-year JJ O
survival NN O
rate NN O
in IN O
T1N0 NNP O
as IN O
compared VBN O
to TO O
T2N0 VB O
with IN O
28.6 CD O
% NN O
and CC O
T1N1 NNP O
with IN O
19.4 CD O
% NN O
. . O

-DOCSTART- X X O

The DT O
encoded VBD O
Arabidopsis NNP B-NP
U3 IN I-NP
snRNAs NNS I-NP
can MD O
be VB O
folded VBN O
into IN O
a DT O
secondary JJ O
structure NN O
which WDT O
is VBZ O
more RBR O
similar JJ O
to TO O
that DT O
of IN O
U3 JJ B-NP
RNAs NNS I-NP
from IN O
lower JJR O
eukaryotes NNS O
rather RB O
than IN O
from IN O
metazoa NN O
. . O

-DOCSTART- X X O

Cytokinetics NNS O
of IN O
the DT O
Krebs NNP O
2 CD O
carcinoma NN O
. . O

-DOCSTART- X X O

We PRP O
investigated VBD O
whether IN O
two CD O
WT1 JJ B-NP
splice NN I-NP
variants VBZ I-NP
lacking VBG O
or CC O
including VBG O
a DT O
three-amino-acid JJ O
(KTS NNS O
) -RRB- O
insertion NN O
between IN O
the DT O
third JJ O
and CC O
fourth JJ O
zinc NN O
finger NN O
in IN O
the DT O
DNA-binding JJ O
domain NN O
could MD O
repress VB O
the DT O
IR NNP B-NP
promoter NN I-NP
in IN O
vitro NN O
. . O

-DOCSTART- X X O

These DT O
back RB O
mutations NNS O
led VBD O
to TO O
a DT O
modest JJ O
decrease NN O
in IN O
kinase NN O
activity NN O
, , O
decreased VBD O
tumorigenic JJ O
potential NN O
in IN O
chickens NNS O
, , O
and CC O
an DT O
unexpected JJ O
increase NN O
in IN O
transforming VBG O
activity NN O
in IN O
rat NN O
cells NNS O
. . O

-DOCSTART- X X O

Plasma NNP O
NE NNP O
and CC O
E NNP O
increased VBD O
to TO O
significantly RB O
higher JJR O
values NNS O
after IN O
15 CD O
min NN O
in IN O
the DT O
young JJ O
subjects NNS O
: : O
1.68 CD O
+/ CD O
- : O
0.18 CD O
vs. NN O

-DOCSTART- X X O

E. NNP O
granulosus NN O
infection NN O
has VBZ O
been VBN O
confirmed VBN O
in IN O
25 CD O
patients NNS O
( -LRB- O
20.6 CD O
% NN O
) -RRB- O
, , O
in IN O
16 CD O
cases NNS O
by IN O
finding VBG O
parasite JJ O
protoscoleces NNS O
or CC O
hooks NNS O
and CC O
in IN O
nine CD O
cases NNS O
by IN O
detection NN O
of IN O
an DT O
antigen JJ O
specific NN O
for IN O
E. NNP B-NP
granulosus NNP I-NP
, , I-NP
antigen NN I-NP
5 CD I-NP
( -LRB- O
Ag5 IN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Transcription NN O
of IN O
FN NNP B-NP
promoter-chloramphenicol JJ I-NP
acetyltransferase NN B-NP
fusion NN O
genes NNS O
carrying VBG O
the DT O
base NN O
substitution NN O
in IN O
one CD O
or CC O
more JJR O
of IN O
these DT O
G-rich JJ O
sequences NNS O
both DT O
in IN O
vivo JJ O
and CC O
in IN O
vitro NN O
revealed VBD O
that IN O
the DT O
base NN O
substitution NN O
in IN O
any DT O
G-rich JJ O
sequence NN O
results NNS O
in IN O
reduction NN O
of IN O
promoter NN O
activity NN O
, , O
although IN O
the DT O
downstream NN O
GC NN O
box NN O
( -LRB- O
GCd NN O
) -RRB- O
plays VBZ O
a DT O
primary JJ O
role NN O
. . O

-DOCSTART- X X O

Teboroxime NNP O
is VBZ O
a DT O
new JJ O
boronic JJ O
acid NN O
adduct NN O
of IN O
technetium NN O
dioxime NN O
( -LRB- O
BATO NNP O
) -RRB- O
compound NN O
that WDT O
demonstrates VBZ O
favorable JJ O
characteristics NNS O
in IN O
preliminary JJ O
studies NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
our PRP$ O
conclusion NN O
that IN O
Sonoclot NNP O
coagulation NN O
analysis NN O
is VBZ O
unlikely JJ O
to TO O
identify VB O
patients NNS O
with IN O
prolonged JJ O
bleeding NN O
time NN O
in IN O
whom WP O
platelet NN O
count NN O
and CC O
other JJ O
coagulation NN O
factors NNS O
are VBP O
normal JJ O
. . O

-DOCSTART- X X O

The DT O
single JJ O
copy NN O
flotillin-1 NN B-NP
gene NN I-NP
is VBZ O
located VBN O
at IN O
6p21.3 CD O
in IN O
the DT O
MHC NNP B-NP
class NN I-NP
I PRP I-NP
region NN I-NP
and CC O
consists VBZ O
of IN O
13 CD O
exons NNS O
over IN O
15 CD O
kb NN O
. . O

-DOCSTART- X X O

Low NNP O
plasma NN O
glucose NN O
concentrations NNS O
that WDT O
may MD O
or CC O
may MD O
not RB O
be VB O
sufficiently RB O
low JJ O
to TO O
result VB O
in IN O
symptoms NNS O
can MD O
be VB O
observed VBN O
as IN O
a DT O
concomitant NN O
of IN O
several JJ O
diverse JJ O
diseases NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
patients NNS O
with IN O
DPX NNP O
should MD O
be VB O
observed VBN O
for IN O
the DT O
potential JJ O
occurrence NN O
of IN O
an DT O
associated JJ O
condition NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
TNF NNP B-NP
, , O
IL-1 NNP B-NP
, , O
and CC O
IL-6 NN B-NP
on IN O
the DT O
proliferation NN O
of IN O
human JJ O
Tenon NNP O
's POS O
capsule NN O
fibroblasts NNS O
in IN O
tissue NN O
culture NN O
. . O

-DOCSTART- X X O

Previous JJ O
analysis NN O
of IN O
this DT O
motif NN O
in IN O
the DT O
lactose NN B-NP
permease NN I-NP
( -LRB- O
A DT O
. . O

-DOCSTART- X X O

Several JJ O
reports NNS O
assert VBP O
that IN O
prolactin NN B-NP
affects VBZ O
the DT O
delta NN O
5 CD O
and CC O
delta JJ O
4 CD O
pathways NNS O
through IN O
its PRP$ O
effect NN O
on IN O
the DT O
activity NN O
of IN O
3beta-hydroxysteroid JJ B-NP
dehydrogenase NN I-NP
( -LRB- O
3beta-OHSD JJ B-NP
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
decrease NN O
was VBD O
also RB O
found VBN O
of IN O
the DT O
levels NNS O
of IN O
total JJ O
cholesterol NN O
and CC O
LDL-cholesterol NNP B-NP
. . O

-DOCSTART- X X O

Low NNP O
serum NN B-NP
C3 IN I-NP
values NNS O
were VBD O
observed VBN O
in IN O
all DT O
11 CD O
children NNS O
at IN O
some DT O
stage NN O
of IN O
their PRP$ O
illness NN O
. . O

-DOCSTART- X X O

In IN O
spite NN O
of IN O
the DT O
presence NN O
of IN O
a DT O
physician NN O
, , O
the DT O
real JJ O
pathology NN O
of IN O
an DT O
indian JJ O
population NN O
of IN O
Colombie NNP O
is VBZ O
not RB O
very RB O
well RB O
known VBN O
. . O

-DOCSTART- X X O

During IN O
chordotonal JJ O
organ NN O
development NN O
, , O
the DT O
3' JJ O
enhancer NN O
directs VBZ O
expression NN O
in IN O
proneural JJ O
clusters NNS O
; : O
whereas IN O
successive JJ O
modular JJ O
enhancers NNS O
located VBN O
in IN O
the DT O
5' JJ O
region NN O
drive NN O
tissue-specific JJ O
expression NN O
in IN O
chordotonal JJ O
organ NN O
precursors NNS O
in IN O
the DT O
embryo NN O
and CC O
larval JJ O
leg NN O
, , O
wing NN O
and CC O
antennal JJ O
imaginal JJ O
discs NNS O
. . O

-DOCSTART- X X O

Is VBZ O
conventional JJ O
sperm JJ O
analysis NN O
of IN O
any DT O
use NN O
? . O
The DT O
computerised VBN O
records NNS O
of IN O
867 CD O
couples NNS O
were VBD O
used VBN O
to TO O
investigate VB O
the DT O
prognostic JJ O
significance NN O
of IN O
semen NNS O
volume NN O
, , O
motility NN O
, , O
density NN O
and CC O
morphology NN O
. . O

-DOCSTART- X X O

Antisense NNP O
oligonucleotides VBZ O
complementary JJ O
to TO O
the DT O
5' JJ O
end NN O
of IN O
PKC-zeta NNP B-NP
mRNA CD I-NP
sequences NNS I-NP
significantly RB O
reduced VBD O
the DT O
collagen NN B-NP
lattice-stimulated JJ O
alpha2 NNS O
and CC O
MMP-1 JJ B-NP
mRNA NN I-NP
levels NNS O
. . O

-DOCSTART- X X O

The DT O
most RBS O
valid JJ O
method NN O
was VBD O
the DT O
AXB NNP O
bearing NN O
with IN O
the DT O
cephalometric JJ O
clinical JJ O
diagnosis NN O
a DT O
90.91 CD O
% NN O
concordance NN O
. . O

-DOCSTART- X X O

However RB O
, , O
coligation NN O
of IN O
Fc NNP B-NP
gamma NNP I-NP
RIIB1 NNP I-NP
with IN O
B NNP B-NP
cell NN I-NP
Ag RB I-NP
receptors JJ I-NP
(BCR NN O
) -RRB- O
inhibits VBZ O
BCR-mediated JJ B-NP
signaling NN O
by IN O
a DT O
mechanism NN O
that WDT O
may MD O
involve VB O
recruitment NN O
of IN O
phosphatases NNS B-NP
SHP-1 JJ I-NP
, , O
SHP-2 JJ B-NP
, , O
and CC O
the DT O
SH2 NNP B-NP
containing VBG I-NP
inositol NN I-NP
5'phosphatase JJ I-NP
( -LRB- O
SHIP NN B-NP
) -RRB- O
to TO O
the DT O
phosphorylated JJ O
Fc NNP B-NP
gamma NN I-NP
RIIB1 IN I-NP
immunoreceptor NN I-NP
tyrosine-based JJ I-NP
inhibitory JJ I-NP
motif NN I-NP
. . O

-DOCSTART- X X O

The DT O
slope NN O
of IN O
QD NNP O
versus IN O
QEMF NNP O
for IN O
the DT O
four CD O
tubes NNS O
was VBD O
near JJ O
unity NN O
. . O

-DOCSTART- X X O

The DT O
sequence NN O
of IN O
the DT O
127 CD B-NP
residue JJ I-NP
NrfF NNP I-NP
polypeptide NN I-NP
, , I-NP
M(r NNP I-NP
) -RRB- I-NP
14,522 CD I-NP
, , O
is VBZ O
strikingly RB O
similar JJ O
to TO O
the DT O
CcI2 JJ B-NP
protein NN I-NP
of IN O
R. NNP O
capsulatus NN O
, , O
especially RB O
in IN O
the DT O
putative JJ O
haem-binding NN O
motif NN O
, , O
RCPQCQNQN.(ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
400 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

When WRB O
cotransfected VBN O
with IN O
the DT O
HIV NNP B-NP
LTR NNP I-NP
CAT NNP B-NP
into IN O
CV-1 JJ O
cells NNS O
, , O
both CC O
the DT O
pCD41 JJ B-NP
and CC O
pGD41 JJ B-NP
clones NNS O
trans-activated VBD O
the DT O
HIV NNP B-NP
LTR. NNP I-NP

-DOCSTART- X X O

From IN O
this DT O
comparison NN O
of IN O
aa JJ O
sequences NNS O
, , O
the DT O
ATPK7 JJ B-NP
protein NN I-NP
is VBZ O
considered VBN O
to TO O
be VB O
a DT O
member NN O
of IN O
a DT O
novel NN O
subfamily NN O
of IN O
Ser/Thr NNP B-NP
PKs NNP I-NP
in IN O
plants NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
very RB O
probable JJ O
that IN O
this DT O
change NN O
was VBD O
due JJ O
to TO O
mechanical JJ O
effects NNS O
induced VBN O
by IN O
injecting VBG O
a DT O
hypertonic JJ O
solution NN O
of IN O
MT-141 NNP O
at IN O
a DT O
rate NN O
of IN O
70--130 CD O
ml/dog NN O
. . O

-DOCSTART- X X O

Both DT O
viruses NNS O
express VBP O
the DT O
mil NN B-NP
/raf IN O
oncogene NNP O
product NN O
as IN O
a DT O
gag-fusion NN B-NP
polyprotein NN O
, , O
while IN O
the DT O
myc JJ B-NP
oncogene NN O
of IN O
MH2 NNP O
is VBZ O
expressed VBN O
via IN O
a DT O
subgenomic JJ O
mRNA NN O
. . O

-DOCSTART- X X O

Transmural NNP O
metabolic JJ O
heterogeneity NN O
at IN O
high JJ O
cardiac JJ O
work NN O
states NNS O
. . O

-DOCSTART- X X O

A DT O
flow NN O
probe NN O
for IN O
direct JJ O
measurement NN O
of IN O
blood NN O
flow NN O
of IN O
the DT O
mitral JJ O
valve NN O
was VBD O
devised VBN O
. . O

-DOCSTART- X X O

Liver NN O
disease NN O
and CC O
HCV NN O
infection NN O
after IN O
transplantation NN O
of IN O
organs NNS O
from IN O
hepatitis NN B-NP
C NNP I-NP
antibody NN I-NP
positive JJ O
donors NNS O
. . O

-DOCSTART- X X O

To TO O
investigate VB O
whether IN O
the DT O
two CD O
RPG-boxes NNS B-NP
mediate JJ O
transcription NN O
activation NN O
of IN O
both DT O
the DT O
L46 NNP B-NP
and CC O
S24 NNP B-NP
gene NN I-NP
, , O
two CD O
experimental JJ O
strategies NNS O
were VBD O
followed VBN O
: : O
cloning NN O
of IN O
the DT O
respective JJ O
genes NNS O
on IN O
multicopy JJ O
vectors NNS O
and CC O
construction NN O
of IN O
fusion NN O
genes NNS O
. . O

-DOCSTART- X X O

Electrophoretic NNP O
mobility NN O
shift NN O
assays VBZ O
demonstrated VBN O
that IN O
sequences NNS O
within IN O
this DT O
region NN O
bind NN O
members NNS O
of IN O
the DT O
Sp1 NNP B-NP
family NN I-NP
of IN I-NP
transcription NN I-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

To TO O
date NN O
, , O
6 CD O
mammalian JJ O
GRKs NNP B-NP
have VBP O
been VBN O
identified VBN O
by IN O
molecular JJ O
cloning NN O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
To TO O
report VB O
a DT O
case NN O
of IN O
fulminant JJ O
neuropathy NN O
with IN O
severe JJ O
quadriparesis NN O
associated VBN O
with IN O
vincristine JJ O
chemotherapy NN O
. . O

-DOCSTART- X X O

The DT O
1.5-Mb JJ O
region NN O
was VBD O
covered VBN O
by IN O
137 CD O
cosmids NNS O
with IN O
a DT O
minimum JJ O
overlap JJ O
set NN O
of IN O
52 CD O
cosmids NNS O
assigned VBN O
to TO O
17 CD O
bins NNS O
and CC O
9 CD O
contigs NNS O
. . O

-DOCSTART- X X O

Homodimers NNS O
of IN O
RIP60 NNP B-NP
( -LRB- O
replication NN B-NP
initiation-region JJ I-NP
protein NN I-NP
60 CD I-NP
kDA NN I-NP
) -RRB- O
purified VBN O
from IN O
nuclear JJ O
extract VB O
bind NN O
two CD O
ATT-rich NNP O
sites NNS O
in IN O
oribeta NNP O
and CC O
foster VB O
the DT O
formation NN O
of IN O
a DT O
twisted JJ O
720 CD O
bp JJ O
DNA NNP O
loop NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
age NN O
on IN O
glucose NN O
, , O
reducing VBG O
sugars NNS O
and CC O
plasma NN B-NP
insulin NN I-NP
in IN O
blood NN O
of IN O
milk-fed JJ O
calves NNS O
. . O

-DOCSTART- X X O

Principal JJ O
component NN O
analysis NN O
using VBG O
psychosocial JJ O
factors NNS O
in IN O
women NNS O
showed VBD O
two CD O
psychosocial JJ O
structures NNS O
, , O
i IN O
.e NN O
. . O
the DT O
second JJ O
principal NN O
( -LRB- O
high JJ O
SOC NN O
, , O
high JJ O
lifestyle NN O
, , O
and CC O
low JJ O
stress NN O
) -RRB- O
and CC O
the DT O
4th JJ O
principal JJ O
components NNS O
( -LRB- O
high JJ O
supernatural JJ O
HLC NNP O
, , O
and CC O
high JJ O
PHLC NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Availability NN O
of IN O
a DT O
less JJR O
palatable JJ O
diet NN O
( -LRB- O
chow NN O
) -RRB- O
following VBG O
presentation NN O
of IN O
palatable JJ O
diets NNS O
will MD O
not RB O
result VB O
in IN O
diminished JJ O
caloric JJ O
intake NN O
, , O
body NN O
weight NN O
, , O
obesity NN O
and CC O
hyperinsulinemia NN O
. . O

-DOCSTART- X X O

Type NNP O
II NNP O
neuroleptanalgesia NN O
in IN O
odonto-stomatology NN O

-DOCSTART- X X O

In IN O
addition NN O
, , O
there EX O
was VBD O
an DT O
increase NN O
in IN O
the DT O
amount NN O
of IN O
p120 DT B-NP
Ras-specific NNP I-NP
GTPase-activating JJ B-NP
protein NN I-NP
( -LRB- O
GAP NNP B-NP
) -RRB- O
and CC O
GAP-associated JJ B-NP
p190 NN O
. . O

-DOCSTART- X X O

Jornvall NNP O
, , O
B. NNP O

-DOCSTART- X X O

Copyright NNP O
1998 CD O
Academic NNP O
Press NNP O
. . O

-DOCSTART- X X O

Three CD O
modern JJ O
hematology NN O
analyzers NNS O
( -LRB- O
Abbott NNP O
Cell-Dyn NNP O
3000 CD O
, , O
Coulter NNP O
STKS NNP O
, , O
and CC O
Sysmex NNP O
NE-8000 . O
) -RRB- O
with IN O
high JJ O
throughput NN O
and CC O
5-part JJ O
differential JJ O
capability NN O
were VBD O
evaluated VBN O
using VBG O
a DT O
protocol NN O
designed VBN O
by IN O
a DT O
quality NN O
team NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
prostaglandin NN O
E2 NNS O
on IN O
experimental JJ O
atherosclerosis NN O
. . O

-DOCSTART- X X O

The DT O
tro NN B-NP
operon NN I-NP
is VBZ O
flanked VBN O
by IN O
a DT O
Holliday NNP B-NP
structure NN I-NP
DNA NNP I-NP
helicase NN I-NP
homolog NN O
(upstream NN O
) -RRB- O
and CC O
two CD O
ORFs NNS O
representing VBG O
a DT O
purine NN B-NP
nucleoside JJ I-NP
phosphorylase NN I-NP
homolog NN O
and CC O
tpp15 CD B-NP
, , O
a DT O
previously RB O
characterized VBN O
gene NN O
encoding VBG O
a DT O
membrane NN O
lipoprotein NN O
( -LRB- O
downstream NN O
) -RRB- O
. . O

-DOCSTART- X X O

However RB O
, , O
a DT O
few JJ O
sites NNS O
in IN O
the DT O
genomes NNS O
of IN O
EC NNP O
cells NNS O
permit VBP O
M-MuLVneo JJ B-NP
delta NN I-NP
Enh NNP I-NP
proviral JJ O
expression NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
been VBN O
developing VBG O
a DT O
digital JJ O
fluoroscopic JJ O
imaging NN O
system NN O
to TO O
replace VB O
the DT O
portal JJ O
films NNS O
that WDT O
are VBP O
currently RB O
used VBN O
to TO O
verify VB O
patient JJ O
positioning NN O
during IN O
radiotherapy NN O
treatments NNS O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
unlike IN O
PAK65 NNP B-NP
, , O
HPK1 NNP B-NP
does VBZ O
not RB O
contain VB O
the DT O
small JJ B-NP
GTPase NNP I-NP
Rac1/Cdc42-binding NNP B-NP
domain NN O
and CC O
does VBZ O
not RB O
bind NN O
to TO O
either DT O
Rac1 NNP B-NP
or CC O
Cdc42 NNP B-NP
, , O
suggesting VBG O
that IN O
HPK1 NNP B-NP
. . O
activation NN O
is VBZ O
Rac1/Cdc42-independent NNP B-NP
. . O

-DOCSTART- X X O

Transformations NNS O
with IN O
circular JJ O
plasmids NNS O
yielded VBD O
slowly RB O
and CC O
irregularly RB O
growing VBG O
geneticin-resistant JJ O
mycelia NNS O
in IN O
which WDT O
1 CD O
% NN O
of IN O
nuclei JJ O
contained VBN O
plasmid NN O
sequences NNS O
. . O

-DOCSTART- X X O

Using VBG O
a DT O
combined VBN O
pharmacokinetic-pharmacodynamic JJ O
model NN O
, , O
the DT O
impact NN O
of IN O
various JJ O
factors NNS O
on IN O
the DT O
effective JJ O
bioavailability NN O
and CC O
on IN O
its PRP$ O
estimation NN O
, , O
using VBG O
the DT O
intravenous-to-oral JJ O
dose NN O
ratio NN O
required VBN O
to TO O
produce VB O
the DT O
same JJ O
area NN O
under IN O
the DT O
response NN O
time NN O
curve NN O
after IN O
acute JJ O
administration NN O
, , O
are VBP O
explored VBN O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
in IN O
anesthetized JJ O
, , O
paralyzed JJ O
cats NNS O
, , O
the DT O
visual JJ O
evoked JJ O
potential JJ O
(VEP NN O
) -RRB- O
was VBD O
dependent JJ O
only RB O
on IN O
magnitude NN O
of IN O
delta JJ O
C NNP O
at IN O
each DT O
pattern NN O
transition NN O
, , O
and CC O
was VBD O
independent JJ O
of IN O
the DT O
starting VBG O
or CC O
ending VBG O
contrast NN O
level NN O
. . O

-DOCSTART- X X O

Plasmid NNP O
pSP64E6E7 IN O
which WDT O
contains VBZ O
the DT O
reading NN O
frames NNS O
of IN O
both DT O
E6 NNP B-NP
and CC O
E7 NNP B-NP
was VBD O
constructed VBN O
in IN O
order NN O
to TO O
study VB O
the DT O
expression NN O
of IN O
both DT O
proteins NNS O
in IN O
a DT O
coupled VBN O
transcription/rabbit NN O
reticulocyte NN O
translation NN O
system NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
FOP-FGFR1-expressing JJ B-NP
cells NNS O
show VBP O
constitutive JJ O
phosphorylation NN O
of IN O
the DT O
positive JJ O
regulator NN O
of IN O
translation NN O
p70S6 NNS B-NP
kinase NN I-NP
; : O
this DT O
phosphorylation NN O
is VBZ O
inhibited VBN O
by IN O
PI3-kinase JJ B-NP
and CC O
mTOR JJ B-NP
( -LRB- O
mammalian JJ B-NP
target NN I-NP
of IN I-NP
rapamycin NN I-NP
) -RRB- O
inhibitors NNS O
. . O

-DOCSTART- X X O

As IN O
a DT O
test NN O
of IN O
this DT O
hypothesis NN O
, , O
we PRP O
predicted VBD O
that IN O
mice NNS O
which WDT O
have VBP O
altered VBN O
expression NN O
of IN O
class NN O
I PRP O
gene NN O
products NNS O
, , O
the DT O
beta2-microglobulin NN B-NP
knockout NN O
mice NNS O
, , O
[beta2m(-/-)] JJ B-NP
, , O
would MD O
develop VB O
Fe NNP O
overload NNP O
. . O

-DOCSTART- X X O

The DT O
synthesis NN O
of IN O
endo-adduct NN O
[4aS,5S,8R,8aR IN O
,SS]-9d JJ O
resulting VBG O
from IN O
cycloaddition NN O
on IN O
the DT O
substituted VBN O
C( JJ O
2)-C(3 JJ O
) -RRB- O
double JJ O
bond NN O
was VBD O
achieved VBN O
in IN O
a DT O
chemo- NNS O
and CC O
diastereoselective JJ O
way NN O
from IN O
quinone NN O
1d CC O
in IN O
the DT O
presence NN O
of IN O
ZnBr( JJ O
2 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Mad3 NNP B-NP
and CC O
Mad4 NNP B-NP
: : O
novel NN O
Max-interacting NNP B-NP
transcriptional VBD O
repressors NNS O
that IN O
suppress NN O
c-myc JJ B-NP
dependent JJ O
transformation NN O
and CC O
are VBP O
expressed VBN O
during IN O
neural JJ O
and CC O
epidermal JJ O
differentiation NN O
. . O

-DOCSTART- X X O

This DT O
polypeptide NN O
includes VBZ O
the DT O
first JJ O
three CD O
zinc NN O
fingers NNS O
of IN O
the DT O
TFIIIA NNP B-NP
DNA NNP I-NP
binding NN I-NP
domain NN I-NP
. . O

-DOCSTART- X X O

Transcription NN O
of IN O
eukaryotic JJ O
tRNA NN O
genes NNS O
is VBZ O
dependent JJ O
on IN O
the DT O
A- NNP O
and CC O
B-Box NNP O
internal JJ O
control NN O
regions NNS O
( -LRB- O
ICRs NNS O
) -RRB- O
and CC O
the DT O
upstream JJ O
transcription NN O
modulatory JJ O
region NN O
. . O

-DOCSTART- X X O

This DT O
dose NN O
of IN O
Na3 JJ O
citrate NN O
produced VBD O
no DT O
clinical JJ O
symptoms NNS O
suggestive VBP O
of IN O
hypocalcaemia NN O
in IN O
these DT O
subjects NNS O
, , O
even RB O
though IN O
the DT O
use NN O
of IN O
acid-citrate-dextrose NN O
, , O
NIH NNP O
formula NN O
A DT O
(ACD-A NN O
) -RRB- O
under IN O
identical JJ O
conditions NNS O
has VBZ O
been VBN O
reported VBN O
to TO O
reduce VB O
significantly RB O
the DT O
level NN O
of IN O
total JJ O
calcium NN O
in IN O
serum NN O
, , O
and CC O
concomitantly RB O
increase VB O
the DT O
number NN O
or CC O
reactions NNS O
occurring VBG O
in IN O
donors NNS O
. . O

-DOCSTART- X X O

A DT O
multivariant JJ O
study NN O
of IN O
pituitary JJ O
adenoma NN O
, , O
obtainment NN O
of IN O
two CD O
logistic JJ O
regression NN O
equations NNS O
as IN O
an DT O
auxiliary JJ O
support NN O
in IN O
the DT O
diagnosis NN O
of IN O
these DT O
tumors NNS O
. . O

-DOCSTART- X X O

APL NNP O
patients NNS O
showed VBD O
a DT O
low JJ O
, , O
yet RB O
variable JJ O
, , O
level NN O
of IN O
JEM-1 JJ B-NP
mRNA NN I-NP
in IN O
bone NN O
marrow NN O
. . O

-DOCSTART- X X O

The DT O
cDNA NN O
clones NNS O
encode VBP O
a DT O
polypeptide NN O
of IN O
657 CD O
amino IN O
acids NNS O
with IN O
a DT O
bHLH NN O
( -LRB- O
basic-helix-loop-helix NN O
) -RRB- O
domain NN O
, , O
characteristic NN O
of IN O
a DT O
large JJ O
family NN O
of IN O
transcription NN O
factors NNS O
, , O
and CC O
a DT O
PAS NNP B-NP
( -LRB- O
Per-Arnt-Sim NNP B-NP
) -RRB- O
domain NN O
in IN O
the DT O
amino-terminal JJ O
half NN O
region NN O
. . O

-DOCSTART- X X O

Nedocromil NN O
sodium NN O
shifted VBD O
the DT O
severity NN O
of IN O
the DT O
early JJ O
allergic JJ O
reaction NN O
( -LRB- O
EAR NN O
) -RRB- O
from IN O
mean JJ O
-34.8 CD O
% NN O
to TO O
-6.9 CD O
% NN O
and CC O
inhibited VBD O
the DT O
later RB O
allergic JJ O
reaction NN O
( -LRB- O
LAR NN O
) -RRB- O
from IN O
-30.5 DT O
% NN O
to TO O
+0.4 CD O
% NN O
( -LRB- O
p NN O
less JJR O
than IN O
0.005 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Values NNS O
of IN O
K1 NNP O
and CC O
Vd NNP O
were VBD O
significantly RB O
increased VBN O
in IN O
the DT O
tumour JJ O
tissue NN O
. . O

-DOCSTART- X X O

The DT O
binding NN O
of IN O
PTB NNP B-NP
was VBD O
antagonistic JJ O
to TO O
the DT O
binding NN O
of IN O
U2AF NNP B-NP
to TO O
the DT O
enhancer-located JJ O
pyrimidine NN O
tract NN O
. . O

-DOCSTART- X X O

Similar JJ O
tissue-specific JJ O
patterns NNS O
are VBP O
observed VBN O
with IN O
a DT O
fusion NN O
between IN O
the DT O
caufliflower NN B-NP
mosaic NN I-NP
virus NN I-NP
35S DT I-NP
RNA NNP I-NP
promotor NN I-NP
and CC O
the DT O
GUS NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
results NNS O
obtained VBD O
show NN O
that WDT O
expression NN O
of IN O
the DT O
gene NN O
is VBZ O
low JJ O
at IN O
23 CD O
degrees NNS O
C NN O
and CC O
is VBZ O
induced VBN O
rapidly RB O
at IN O
37 CD O
degrees NNS O
C. NNP O

-DOCSTART- X X O

The DT O
effects NNS O
on IN O
survival NN O
of IN O
adjuvant JJ O
treatments NNS O
, , O
including VBG O
pre NN O
- : O
or CC O
postoperative JJ O
systemic JJ O
or CC O
postoperative JJ O
intra-arterial JJ O
chemotherapy NN O
, , O
are VBP O
currently RB O
under IN O
evaluation NN O
. . O

-DOCSTART- X X O

Malformations NNS O
of IN O
the DT O
regenerating VBG O
optic JJ O
tectum NN O
of IN O
larvae NNS O
of IN O
the DT O
Egyptian JJ O
toad NN O
, , O
Bufo NNP O
regularis NNP O
Reuss NNP O
. . O

-DOCSTART- X X O

To TO O
be VB O
a DT O
nurse NN O
. . O

-DOCSTART- X X O

Chronic NNP O
granulocytic JJ O
leukemia NN O
in IN O
children NNS O
. . O

-DOCSTART- X X O

Charcot NNP O
joints NNS O
. . O

-DOCSTART- X X O

Recombinant NNP B-NP
apoA-I JJ I-NP
protein NN I-NP
recovered VBD O
from IN O
the DT O
soluble JJ O
fraction NN O
of IN O
the DT O
bacterial JJ O
cell NN O
pellet NN O
was VBD O
purified VBN O
to TO O
greater JJR O
than IN O
95 CD O
% NN O
homogeneity NN O
by IN O
reversed-phase NN O
high-performance NN O
liquid JJ O
chromatography NN O
. . O

-DOCSTART- X X O

Kaposi NNP O
's POS O
sarcoma-associated JJ O
herpesvirus/human NN O
herpesvirus-8 CC O
ORF50 CD B-NP
gene NN O
product NN O
contains VBZ O
a DT O
potent JJ O
C-terminal JJ O
activation NN O
domain NN O
which WDT O
activates VBZ O
gene NN O
expression NN O
via IN O
a DT O
specific JJ O
target NN O
sequence NN O
. . O

-DOCSTART- X X O

Competition NN O
and CC O
methylation NN O
interference NN O
assays VBZ O
showed VBN O
that IN O
the DT O
binding JJ O
site NN O
for IN O
the DT O
novel NN O
factor NN O
was VBD O
limited VBN O
to TO O
nucleotides NNS O
in IN O
the DT O
3' JJ O
half NN O
of IN O
the DT O
kappa NN B-NP
B NNP I-NP
site NN I-NP
. . O

-DOCSTART- X X O

Both DT O
proteins VBZ O
share NN O
sequence NN O
similarity NN O
with IN O
the DT O
myelin-associated JJ B-NP
glycoprotein NN I-NP
, , O
an DT O
adhesion NN O
molecule NN O
of IN O
oligodendrocytes NNS O
and CC O
Schwann NNP O
cells NNS O
that WDT O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
process NN O
of IN O
myelination NN O
, , O
raising VBG O
the DT O
important JJ O
question NN O
of IN O
whether IN O
myelin-associated JJ B-NP
glycoprotein NN I-NP
is VBZ O
also RB O
a DT O
sialic JJ B-NP
acid-binding JJ I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

By IN O
24 CD O
h NN O
, , O
there EX O
was VBD O
no DT O
significant JJ O
difference NN O
in IN O
FFA JJ O
levels NNS O
from IN O
shams NNS O
. . O

-DOCSTART- X X O

As IN O
much JJ O
thrombin NN B-NP
was VBD O
formed VBN O
during IN O
cardiopulmonary JJ O
bypass NN O
( -LRB- O
measured VBN O
by IN O
the DT O
prothrombin NN B-NP
activation NN I-NP
fragment NN I-NP
F1 IN I-NP
+ NN I-NP
2 CD I-NP
and CC O
thrombin-antithrombin NN B-NP
complexes NNS O
) -RRB- O
as IN O
in IN O
normal JJ O
patients NNS O
, , O
showing VBG O
that IN O
factor NN B-NP
XII NNP I-NP
was VBD O
not RB O
necessary JJ O
for IN O
thrombin DT B-NP
generation NN O
. . O

-DOCSTART- X X O

The DT O
phosphatase JJ O
active JJ O
site NN O
is VBZ O
located VBN O
within IN O
residues NNS O
367-374 CD O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
antibody NN O
binding NN O
to TO O
the DT O
same JJ O
two CD O
determinants NNS O
was VBD O
also RB O
inhibited VBN O
when WRB O
ZAP-70 CD B-NP
or CC O
the DT O
SH2 NNP B-NP
domains VBZ I-NP
bound VBN O
to TO O
the DT O
zeta NN O
chain NN O
or CC O
to TO O
a DT O
2pY-ITAM. JJ B-NP

-DOCSTART- X X O

These DT O
extrachromosomal JJ O
copies NNS O
can MD O
be VB O
isolated VBN O
as IN O
covalently RB O
closed VBN O
molecules NNS O
with IN O
lengths NNS O
around IN O
3mu CD O
. . O

-DOCSTART- X X O

After IN O
multivariate JJ O
analysis NN O
, , O
TWA NNP O
correlated VBD O
with IN O
age NN O
( -LRB- O
P NNP O
= SYM O
0.02 CD O
) -RRB- O
and CC O
LV NNP O
function NN O
( -LRB- O
P NNP O
= SYM O
0.002 CD O
) -RRB- O
and CC O
occurred VBD O
more RBR O
often RB O
in IN O
patients NNS O
after IN O
nonanterior JJ O
MI NNP O
( -LRB- O
P NNP O
= SYM O
0.03 CD O
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
cDNA NN O
corresponded VBD O
to TO O
FGF-binding JJ B-NP
protein NN I-NP
( -LRB- O
FGF-BP) NN B-NP
, , O
a DT O
secreted JJ O
protein NN O
previously RB O
shown VBN O
to TO O
bind NN O
acidic NN O
and CC O
basic JJ B-NP
FGF NN I-NP
and CC O
to TO O
modulate VB O
their PRP$ O
activities NNS O
. . O

-DOCSTART- X X O

Electrophoretic NNP O
mobility-shift JJ O
assays IN O
using VBG O
oligonucleotides NNS O
derived VBN O
from IN O
these DT O
sites NNS O
demonstrated VBD O
formation NN O
of IN O
specific JJ O
DNA-protein NNP O
complexes NNS O
. . O

-DOCSTART- X X O

For IN O
the DT O
P NNP B-NP
transcript NN I-NP
from IN O
phage NN O
with IN O
the DT O
G(-) JJ O
orientation NN O
, , O
full JJ O
termination NN O
activity NN O
required VBD O
both DT O
the DT O
region NN O
containing VBG O
the DT O
stem-loop JJ O
structure NN O
and CC O
upstream RB O
sequences NNS O
. . O

-DOCSTART- X X O

One CD O
day NN O
after IN O
injection NN O
48 CD O
% NN O
of IN O
the DT O
injected JJ O
activity NN O
was VBD O
in IN O
the DT O
skeleton NN O
, , O
9.3 CD O
% NN O
in IN O
the DT O
liver NN O
, , O
3 CD O
% NN O
in IN O
the DT O
kidneys NNS O
and CC O
4.4 CD O
% NN O
in IN O
the DT O
rest NN O
of IN O
the DT O
organs NNS O
. . O

-DOCSTART- X X O

Of IN O
these DT O
four CD O
PP2C JJ B-NP
genes NNS I-NP
, , O
the DT O
expression NN O
of IN O
the DT O
PP2Cbeta NNP B-NP
gene NN I-NP
has VBZ O
been VBN O
reported VBN O
to TO O
be VB O
tissue-specific JJ O
and CC O
development-dependent JJ O
. . O

-DOCSTART- X X O

Combined VBN O
chemotherapy NN O
with IN O
VM NNP O
26 CD O
and CC O
BCNU NNP O
for IN O
recurrent JJ O
malignant JJ O
gliomas NNS O
after IN O
operation NN O
and CC O
irradiation NN O
. . O

-DOCSTART- X X O

Administration NNP O
of IN O
FR NNP O
34235 CD O
reduced VBD O
aortic JJ O
blood NN O
pressure NN O
and CC O
increased VBD O
cardiac JJ O
output NN O
in IN O
anesthetized JJ O
dogs NNS O
with IN O
an DT O
ameroid-induced JJ O
coronary JJ O
artery NN O
occlusion NN O
. . O

-DOCSTART- X X O

Alternative JJ O
immune JJ B-NP
globulin NN I-NP
preparation NN O
when WRB O
standard JJ O
immune JJ B-NP
serum NN I-NP
globulin NN I-NP
is VBZ O
not RB O
available JJ O
. . O

-DOCSTART- X X O

Two CD O
sibs NNS O
with IN O
identical JJ O
features NNS O
of IN O
short-limbed JJ O
dwarfism NN O
, , O
a DT O
normal JJ O
skull NN O
and CC O
face NN O
and CC O
normal JJ O
intelligence NN O
are VBP O
described VBN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
a DT O
high JJ O
sugar NN O
intake NN O
on IN O
some DT O
metabolic JJ O
and CC O
regulatory JJ O
indicators NNS O
in IN O
young JJ O
men NNS O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
putative JJ O
constitutively JJ O
active JJ O
forms NNS O
of IN O
DdMEK1 NNP B-NP
in IN O
a DT O
ddmek1 JJ B-NP
null JJ O
background NN O
is VBZ O
capable JJ O
, , O
at IN O
least JJS O
partially RB O
, , O
of IN O
complementing VBG O
the DT O
small JJ O
aggregate NN O
size NN O
defect NN O
and CC O
the DT O
ability NN O
to TO O
activate VB O
guanylyl NN B-NP
cyclase NN I-NP
. . O

-DOCSTART- X X O

Five CD O
girls NNS O
with IN O
Turner NNP O
's POS O
syndrome NN O
aged VBN O
12 CD O
to TO O
17 CD O
years NNS O
showed VBN O
LH NNP B-NP
values NNS O
( -LRB- O
5.0-14.5 CD O
IU/12 NN O
h NN O
) -RRB- O
at IN O
the DT O
upper JJ O
end NN O
of IN O
or CC O
slightly RB O
above IN O
the DT O
normal JJ O
range NN O
and CC O
pathologically RB O
high JJ O
values NNS O
( -LRB- O
22.2-43.5 CD O
IU/12 NN O
h NN O
) -RRB- O
for IN O
FSH. NNP B-NP

-DOCSTART- X X O

Thirty-seven CD O
patients NNS O
with IN O
severe JJ O
temporal JJ O
lobe NN O
epilepsy NN O
were VBD O
studied VBN O
interictally RB O
with IN O
[18F]fluorodeoxyglucose-PET JJ O
in IN O
each DT O
of IN O
three CD O
conditions NNS O
: : O
resting VBG O
, , O
during IN O
emotional JJ O
speech NN O
, , O
and CC O
while IN O
performing VBG O
a DT O
visual JJ O
recognition NN O
task NN O
. . O

-DOCSTART- X X O

The DT O
sequence NN O
of IN O
Vac1p NNP B-NP
contains VBZ O
two CD O
putative JJ O
zinc-binding JJ O
RING NNP O
motifs NNS O
, , O
a DT O
zinc NN O
finger NN O
motif NN O
, , O
and CC O
a DT O
coiled-coil NN O
motif NN O
. . O

-DOCSTART- X X O

The DT O
immune JJ O
response NN O
seems VBZ O
to TO O
be VB O
partially RB O
responsible JJ O
for IN O
both DT O
protection NN O
and CC O
the DT O
destructive JJ O
consequences NNS O
of IN O
chlamydial JJ O
infection NN O
. . O

-DOCSTART- X X O

Activated NNP O
FGFR3 NNP B-NP
predominantly RB O
interacts VBZ O
with IN O
GRB2.Sos NNP B-NP
in IN O
complex JJ O
with IN O
a DT O
previously RB O
identified VBN O
90-kDa JJ O
protein NN O
and CC O
designated VBD O
protein NN B-NP
80K-H. . I-NP

-DOCSTART- X X O

It PRP O
was VBD O
predicted VBN O
that IN O
the DT O
Stroop NNP O
task NN O
would MD O
trigger VB O
greater JJR O
consumption NN O
of IN O
ice NN O
cream NN O
than IN O
a DT O
fearful JJ O
film NN O
, , O
and CC O
that IN O
this DT O
effect NN O
would MD O
be VB O
more RBR O
pronounced JJ O
for IN O
binge-eaters NNS O
than IN O
non-binge-eaters NNS O
. . O

-DOCSTART- X X O

Plasma NNP B-NP
colony-stimulating JJ I-NP
factor NN I-NP
analysis NN O
and CC O
the DT O
clinical JJ O
significance NN O

-DOCSTART- X X O

We PRP O
identified VBD O
two CD O
potential JJ O
phosphorylation NN O
sites NNS O
at IN O
serine49 CD O
and CC O
serine133 CD O
, , O
both DT O
of IN O
which WDT O
seem VBP O
to TO O
be VB O
necessary JJ O
for IN O
Myf-5 CD B-NP
activity NN O
. . O

-DOCSTART- X X O

Exposure NN O
of IN O
raft NN O
cultures NNS O
to TO O
activators NNS O
of IN O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
, , O
such JJ O
as IN O
phorbol NN O
esters NNS O
, , O
results NNS O
in IN O
the DT O
further JJ O
induction NN O
of IN O
late JJ B-NP
gene NN I-NP
expression NN O
as RB O
well RB O
as IN O
virion NN O
assembly NN O
. . O

-DOCSTART- X X O

Behavioral JJ O
effects NNS O
of IN O
benzodiazepine NN O
ligands NNS O
in IN O
non-dependent JJ O
, , O
diazepam-dependent JJ O
and CC O
diazepam-withdrawn JJ O
baboons NNS O
. . O

-DOCSTART- X X O

Gastrointestinal JJ O
accumulation NN O
of IN O
indium-111 JJ O
labelled JJ O
granulocytes NNS O
in IN O
reactive NN O
arthritis NN O
. . O

-DOCSTART- X X O

TNF-alpha NNP B-NP
stimulated VBD O
these DT O
changes NNS O
in IN O
part NN O
by IN O
increasing VBG O
transcription NN O
and CC O
stabilization NN O
of IN O
RNA NNP O
for IN O
amphiregulin NN B-NP
, , O
an DT O
EGF NN B-NP
receptor NN I-NP
ligand NN O
, , O
and CC O
amphiregulin NN B-NP
directly RB O
increased VBD O
HPV-16 CD O
E6/E7 NN B-NP
and CC O
cyclin NN B-NP
A DT I-NP
RNAs NNP I-NP
. . O

-DOCSTART- X X O

Biochemical NNP O
analyses NNS O
revealed VBD O
that IN O
the DT O
concentration NN O
of IN O
norepinephrine NN O
was VBD O
reduced VBN O
significantly RB O
in IN O
cortex-hippocampus JJ O
and CC O
olfactory JJ O
bulb NN O
but CC O
not RB O
in IN O
other JJ O
regions NNS O
, , O
while IN O
dopamine NN O
and CC O
serotonin NN O
levels NNS O
were VBD O
not RB O
altered VBN O
in IN O
any DT O
brain NN O
region NN O
examined VBN O
. . O

-DOCSTART- X X O

A DT O
mouth NN O
asymmetry NN O
study NN O
. . O

-DOCSTART- X X O

Transformation NN O
of IN O
chicken NN O
embryo NN O
fibroblasts NNS O
( -LRB- O
CEF NN O
) -RRB- O
with IN O
the DT O
Gag-Crk NNP B-NP
fusion NN O
protein NN O
results NNS O
in IN O
the DT O
elevation NN O
of IN O
tyrosine NN O
phosphorylation NN O
on IN O
specific JJ O
cellular JJ O
proteins NNS O
with IN O
molecular JJ O
weights NNS O
of IN O
130,000 CD O
, , O
110,000 CD O
, , O
and CC O
70,000 CD O
( -LRB- O
p130 NN B-NP
, , O
p110 VBD B-NP
, , O
and CC O
p70 VBD B-NP
, , O
respectively RB O
) -RRB- O
, , O
an DT O
event NN O
which WDT O
has VBZ O
been VBN O
correlated VBN O
with IN O
cell NN O
transformation NN O
. . O

-DOCSTART- X X O

Tilisolol NNP O
and CC O
carboxymethylcellulose JJ O
sodium NN O
salt NN O
( -LRB- O
CMC) NN O
were VBD O
used VBN O
as IN O
the DT O
model NN O
ophthalmic JJ O
drug NN O
and CC O
viscous JJ O
polymer NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Fetal NN O
transplants NNS O
rescue NN O
axial NN O
muscle NN O
representations NNS O
in IN O
M1 NNP O
cortex NN O
of IN O
neonatally RB O
transected VBN O
rats NNS O
that WDT O
develop VBP O
weight NN O
support NN O
. . O

-DOCSTART- X X O

However RB O
, , O
to TO O
encourage VB O
good JJ O
contact NN O
between IN O
the DT O
farmers NNS O
and CC O
the DT O
inseminating NN O
personnel NNS O
, , O
it PRP O
is VBZ O
beneficial JJ O
that IN O
herdsmen PRP O
are VBP O
present JJ O
when WRB O
cows NNS O
are VBP O
inseminated VBN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
recommended VBN O
that IN O
area NN O
correction NN O
be VB O
attempted VBN O
in IN O
bioequivalence NN O
studies NNS O
of IN O
drugs NNS O
where WRB O
high JJ O
intrasubject JJ O
variability NN O
in IN O
clearance NN O
is VBZ O
known VBN O
or CC O
suspected VBN O
. . O

-DOCSTART- X X O

A DT O
method NN O
for IN O
determining VBG O
the DT O
toxicity NN O
of IN O
neutralizers NNS O
for IN O
antimicrobial JJ O
agents NNS O
to TO O
A. NNP O
castellanii NN O
was VBD O
also RB O
evaluated VBN O
. . O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
study NN O
we PRP O
use VBP O
a DT O
tnaC-UGA-'lacZ NN B-NP
construct VB O
lacking VBG O
the DT O
tnaC-tnaA JJ B-NP
spacer NN O
region NN O
to TO O
analyze VB O
the DT O
effect NN O
of IN O
TnaC NNP B-NP
synthesis NN O
on IN O
the DT O
behavior NN O
of IN O
the DT O
ribosome JJ O
that IN O
translates NNS O
tnaC. . B-NP

-DOCSTART- X X O

Promoter NNP O
region NN O
of IN O
the DT O
human JJ B-NP
alpha NN I-NP
2A IN I-NP
adrenergic NN I-NP
receptor NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Schottky-barrier NNP O
heights NNS O
of IN O
Ti NNP O
and CC O
TiSi2 NNP O
on IN O
n-type JJ O
and CC O
p-type JJ O
Si( JJ O
100 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
majority NN O
of IN O
the DT O
human JJ B-NP
Ig NNP I-NP
heavy NN I-NP
chain NN I-NP
( -LRB- I-NP
IgH NNP I-NP
) -RRB- I-NP
constant JJ I-NP
( -LRB- I-NP
C NNP I-NP
) -RRB- I-NP
region NN I-NP
locus NN I-NP
has VBZ O
been VBN O
cloned VBN O
and CC O
mapped VBN O
. . O

-DOCSTART- X X O

On IN O
guanidine NN O
and CC O
the DT O
treatment NN O
of IN O
botulism NN O
. . O

-DOCSTART- X X O

Most JJS O
of IN O
these DT O
elements NNS O
are VBP O
adjacent JJ O
to TO O
type NN O
X NNP O
telomeric JJ O
repeats NNS O
, , O
and CC O
regions NNS O
flanking VBG O
four CD O
of IN O
five CD O
characterized VBN O
S. NNP O
paradoxus NN O
insertions NNS O
carry VBP O
autonomously RB O
replicating VBG O
sequences NNS O
. . O

-DOCSTART- X X O

Mutational JJ O
analysis NN O
of IN O
the DT O
putative JJ O
effector NN O
domain NN O
of IN O
the DT O
GTP-binding JJ B-NP
Ypt1 JJ I-NP
protein NN I-NP
in IN O
yeast NN O
suggests VBZ O
specific JJ O
regulation NN O
by IN O
a DT O
novel NN O
GAP NNP B-NP
activity NN O
. . O

-DOCSTART- X X O

From IN O
the DT O
present JJ O
results NNS O
a DT O
concept NN O
of IN O
hormone-dependent JJ O
AR NN B-NP
activation NN O
is VBZ O
proposed VBN O
, , O
which WDT O
requires VBZ O
a DT O
functional JJ O
, , O
direct JJ O
or CC O
indirect JJ O
intramolecular JJ O
interaction NN O
between IN O
the DT O
TAD NN O
and CC O
the DT O
LBD. NNP O

-DOCSTART- X X O

All DT O
patients NNS O
were VBD O
peritonitis-free JJ O
at IN O
least JJS O
6 CD O
weeks NNS O
before IN O
each DT O
PET. NN O

-DOCSTART- X X O

After IN O
control NN O
for IN O
body NN O
mass NN O
index NN O
, , O
trait NN O
anxiety NN O
and CC O
anger-in NN O
remained VBD O
independent JJ O
predictors NNS O
of IN O
diastolic JJ O
blood NN O
pressure NN O
among IN O
the DT O
women NNS O
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
vav NN B-NP
oncogene JJ I-NP
protein NN I-NP
sequence NN I-NP
exhibits VBZ O
several JJ O
motifs NNS O
reminiscent JJ O
of IN O
transcriptional JJ O
factors NNS O
. . O

-DOCSTART- X X O

The DT O
platelet NN B-NP
membrane NN I-NP
glycoprotein NN I-NP
IIb/IIIa NN I-NP
receptor NN I-NP
inhibitor IN O
abciximab NN O
is VBZ O
used VBN O
for IN O
the DT O
treatment NN O
of IN O
patients NNS O
undergoing VBG O
high-risk JJ O
percutaneous JJ O
coronary JJ O
interventions NNS O
and CC O
is VBZ O
used VBN O
in IN O
approximately RB O
one CD O
third JJ O
of IN O
coronary JJ O
interventions NNS O
in IN O
the DT O
United NNP O
States NNP O
and CC O
a DT O
growing VBG O
number NN O
of IN O
procedures NNS O
in IN O
Europe NNP O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
times NNS O
to TO O
LNR VB O
in IN O
these DT O
groups NNS O
were VBD O
42.0 CD O
months NNS O
( -LRB- O
range NN O
, , O
3.0-194.5 CD O
months NNS O
) -RRB- O
and CC O
49.0 CD O
months NNS O
( -LRB- O
range NN O
, , O
3.6-209.0 JJ O
months NNS O
) -RRB- O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
cells NNS O
were VBD O
densely RB O
ciliated VBN O
, , O
each DT O
cilium NN O
showing VBG O
a DT O
typical JJ O
9+2 CD O
fibrilar JJ O
pattern NN O
. . O

-DOCSTART- X X O

Searching VBG O
the DT O
human JJ O
DNA NN O
data NN O
base NN O
of IN O
expressed VBN O
sequence NN O
tags NNS O
( -LRB- O
EST NNP O
) -RRB- O
revealed VBD O
novel NN O
partial JJ O
sequences NNS O
similar JJ O
to TO O
, , O
but CC O
distinct JJ O
from IN O
, , O
the DT O
sequences NNS O
of IN O
the DT O
previously RB O
known VBN O
PEF NNP B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

RXRalpha/RARalpha NNP B-NP
heterodimers NNS O
and CC O
HNF-4 JJ B-NP
homodimers NNS I-NP
bind VBP O
to TO O
DR-1 NNP O
motifs NNS O
on IN O
elements NNS O
B NNP O
and CC O
I4 NNP O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Adenomas NNP O
in IN O
the DT O
upper JJ O
gastrointestinal JJ O
tract NN O
were VBD O
found VBN O
in IN O
all DT O
of IN O
the DT O
patients NNS O
: : O
Vater NNP O
's POS O
papilla--12 NN O
, , O
duodenum--nine NN O
, , O
and CC O
gastric JJ O
antrum--seven NNS O
. . O

-DOCSTART- X X O

A DT O
new JJ O
direct JJ O
hemagglutination NN O
test NN O
( -LRB- O
HI-GONAVIS PRP$ O
) -RRB- O
for IN O
urinary JJ O
LH NNP B-NP
was VBD O
compared VBN O
with IN O
the DT O
serum NN O
radioimmuno-assay NN O
of IN O
LH. NNP B-NP

-DOCSTART- X X O

They PRP O
also RB O
show VBP O
that DT O
M. NNP O
malmoense NN O
can MD O
be VB O
isolated VBN O
from IN O
the DT O
environment NN O
which WDT O
may MD O
be VB O
the DT O
source NN O
of IN O
the DT O
infection NN O
. . O

-DOCSTART- X X O

Binding NNP O
of IN O
the DT O
TorR NNP B-NP
regulator NN I-NP
to TO O
cis-acting JJ O
direct JJ O
repeats NNS O
activates VBZ O
tor NN B-NP
operon NN I-NP
expression NN O
. . O

-DOCSTART- X X O

Histological JJ O
and CC O
immunophenotypic JJ O
studies NNS O
revealed VBD O
12 CD O
large JJ O
cell NN O
lymphomas NNS O
( -LRB- O
11 CD O
B NN O
cell NN O
and CC O
one CD O
T NNP O
cell NN O
) -RRB- O
, , O
two CD O
small JJ O
noncleaved JJ O
cell NN O
lymphomas NNS O
(B-cell JJ O
phenotype NN O
) -RRB- O
, , O
and CC O
five CD O
low JJ O
grade NN O
B-cell NN O
lymphomas VBD O
( -LRB- O
two CD O
small JJ O
lymphocytic JJ O
and CC O
three CD O
follicular JJ O
mixed JJ O
lymphomas NNS O
) -RRB- O
. . O

-DOCSTART- X X O

An DT O
emended JJ O
diagnosis NN O
of IN O
Tylocephalum NNP O
is VBZ O
proposed VBN O
excluding VBG O
this DT O
feature NN O
, , O
along IN O
with IN O
distribution NN O
of IN O
the DT O
testes NNS O
in IN O
the DT O
preovarian JJ O
field NN O
and CC O
circummedullary JJ O
distribution NN O
of IN O
vitelline NN O
follicles NNS O
. . O

-DOCSTART- X X O

Role NNP O
of IN O
double-stranded JJ B-NP
RNA-dependent JJ I-NP
protein NN I-NP
kinase NN I-NP
in IN O
mediating VBG O
hypersensitivity NN O
of IN O
Fanconi NNP O
anemia NN O
complementation NN O
group NN O
C NNP O
cells NNS O
to TO O
interferon VB B-NP
gamma NN I-NP
, , O
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
, , O
and CC O
double-stranded JJ O
RNA NNP O
. . O

-DOCSTART- X X O

Different JJ O
effects NNS O
of IN O
reoxygenation NN O
on IN O
the DT O
electrical JJ O
activity NN O
of IN O
ventricular JJ O
muscle NN O
. . O

-DOCSTART- X X O

Similar JJ O
observations NNS O
were VBD O
obtained VBN O
when WRB O
these DT O
mutated JJ O
versions NNS O
of IN O
site NN O
A DT O
were VBD O
evaluated VBN O
by IN O
transient JJ O
cotransfection NN O
assays VBZ O
in IN O
CV1 NNP O
cells NNS O
. . O

-DOCSTART- X X O

YLL031c PRP B-NP
is VBZ O
an DT O
essential JJ O
gene NN O
. . O

-DOCSTART- X X O

Further RB O
, , O
cells NNS O
cotransfected VBN O
with IN O
a DT O
UF NNP B-NP
promoter-luciferase JJ I-NP
(-1935UF-Luc JJ O
) -RRB- O
reporter NN O
gene NN O
and CC O
the DT O
BTEB NNP B-NP
expression NN O
vector NN O
had VBD O
2-fold JJ O
higher JJR O
Luc JJ B-NP
activity NN O
than IN O
those DT O
cotransfected VBN O
with IN O
reporter NN O
gene NN O
and CC O
pcDNA-3 NN O
. . O

-DOCSTART- X X O

Although IN O
IRS-1 NNP B-NP
, , I-NP
-2 RB I-NP
, , I-NP
and CC I-NP
-4 NN I-NP
are VBP O
similar JJ O
in IN O
overall JJ O
structure NN O
, , O
IRS-3 NNP B-NP
is VBZ O
approximately RB O
50 CD O
% NN O
shorter JJR O
and CC O
differs NNS O
with IN O
respect NN O
to TO O
sites NNS O
of IN O
tyrosine NN O
phosphorylation NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
demonstrate VBP O
a DT O
specific JJ O
association NN O
of IN O
SIV NNP O
and CC O
HIV-2 PRP$ B-NP
nef NN I-NP
, , O
but CC O
not RB O
HIV-1 JJ B-NP
nef NN I-NP
, , O
with IN O
TCRzeta NNP B-NP
. . O

-DOCSTART- X X O

Rac2 NNP B-NP
, , O
a DT O
member NN O
of IN O
the DT O
Rho NNP B-NP
family NN I-NP
of IN O
GTPases NNP B-NP
, , O
is VBZ O
highly RB O
expressed VBN O
in IN O
myeloid JJ O
cells NNS O
and CC O
is VBZ O
a DT O
regulator NN O
of IN O
the DT O
NADPH-oxidase NNP B-NP
complex NN I-NP
. . O

-DOCSTART- X X O

The DT O
best JJS O
sequences NNS O
for IN O
pelvic JJ O
study NN O
are VBP O
, , O
in IN O
our PRP$ O
experience NN O
, , O
IR NNP O
or CC O
short JJ O
TR NN O
spin-echo NN O
for IN O
T1-weighted JJ O
images NNS O
, , O
and CC O
spin-echo JJ O
with IN O
1200 CD O
TR NN O
for IN O
T2 DT O
images NNS O
. . O

-DOCSTART- X X O

We PRP O
now RB O
report VBP O
that IN O
both DT O
HSCR NNP B-NP
mutations NNS O
impair IN O
the DT O
fixation NN O
of IN O
Shc NNP B-NP
to TO O
RET NNP B-NP
and CC O
consequently RB O
prevent VB O
its PRP$ O
phosphorylation NN O
. . O

-DOCSTART- X X O

We PRP O
now RB O
describe VBP O
a DT O
HepG2 CD B-NP
cell NN I-NP
casein NN I-NP
kinase NN I-NP
II NNP I-NP
beta JJ I-NP
subunit NN I-NP
cDNA NN I-NP
of IN O
2.57 CD O
kb NN O
containing VBG O
96 CD O
bases NNS O
of IN O
5' JJ O
untranslated JJ O
sequence NN O
, , O
645 CD O
bases NNS O
of IN O
open JJ O
reading NN O
frame NN O
, , O
and CC O
1832 CD O
bases NNS O
of IN O
3' JJ O
untranslated JJ O
sequence NN O
with IN O
two CD O
polyadenylation NN O
consensus NN O
signal NN O
sequences NNS O
and CC O
two CD O
poly( JJ O
A DT O
) -RRB- O
stretches VBZ O
. . O

-DOCSTART- X X O

Platelet NNP B-NP
factor NN I-NP
4 CD I-NP
levels NNS O
in IN O
patients NNS O
with IN O
coronary JJ O
artery NN O
disease NN O
. . O

-DOCSTART- X X O

Serum NN O
pituitary NN O
and CC O
steroid NN O
hormone NN O
levels NNS O
in IN O
the DT O
adult NN O
male NN O
: : O
one CD O
value NN O
is VBZ O
as RB O
good JJ O
as IN O
the DT O
mean NN O
of IN O
three CD O
. . O

-DOCSTART- X X O

However RB O
, , O
a DT O
lesser JJR O
extent NN O
effect NN O
was VBD O
noticed VBN O
in IN O
nonpregnant JJ O
than IN O
seen VBN O
in IN O
pregnant JJ O
rats NNS O
. . O

-DOCSTART- X X O

Despite IN O
their PRP$ O
high JJ O
degree NN O
of IN O
sequence NN O
similarity NN O
, , O
all DT O
five CD O
RFC NNP B-NP
genes NNS I-NP
are VBP O
essential JJ O
for IN O
cell NN O
proliferation NN O
in IN O
S. NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

The DT O
strongly RB O
DNA NNP O
binding NN O
p50 VBD B-NP
subunit NN I-NP
showed VBD O
only RB O
very RB O
weak JJ O
, , O
if IN O
any DT O
, , O
induction NN O
of IN O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

Stability NN O
of IN O
125 CD O
I-labeled JJ O
insulin NN B-NP
used VBN O
in IN O
radioimmunoassay NN O
of IN O
insulin NN B-NP
. . O

-DOCSTART- X X O

Influence NN O
of IN O
long-term JJ O
zimelidine NN O
treatment NN O
on IN O
LSD-induced JJ O
behavioural JJ O
effects NNS O
. . O

-DOCSTART- X X O

Using VBG O
mammalian JJ O
expression NN O
vectors NNS O
( -LRB- O
pRSV-neo NN O
and CC O
pSV2-neo JJ O
) -RRB- O
, , O
antisense JJ O
constructs NNS O
for IN O
perforin NN B-NP
and CC O
granzyme NN B-NP
B NNP I-NP
were VBD O
independently RB O
electroporated VBN O
into IN O
YT-INDY NNP O
, , O
a DT O
human JJ O
non-MHC-restricted JJ O
, , O
IL-2-independent JJ B-NP
, , O
cytotoxic JJ O
lymphocyte NN O
. . O

-DOCSTART- X X O

Like IN O
Rev-Erb NNP B-NP
, , O
BD73 CD B-NP
binds NNS O
as IN O
a DT O
monomer NN O
to TO O
a DT O
DNA NNP O
sequence NN O
which WDT O
consists VBZ O
of IN O
a DT O
specific JJ O
A/T-rich JJ O
sequence NN O
upstream RB O
of IN O
the DT O
consensus NN O
hexameric JJ O
half-site JJ O
specified VBN O
by IN O
the DT O
P NNP O
box NN O
of IN O
the DT O
DNA-binding JJ O
domain NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Allergic NNP O
rhinoconjunctivitis NNP O
is VBZ O
a DT O
common JJ O
disorder NN O
, , O
affecting VBG O
>20 CD O
% NN O
of IN O
people NNS O
of IN O
all DT O
socioeconomic JJ O
strata NNS O
. . O

-DOCSTART- X X O

The DT O
striking JJ O
similarity NN O
in IN O
preference NN O
for IN O
mismatched JJ O
and CC O
weakly JJ O
paired VBN O
nucleotides NNS O
for IN O
binding NN O
and CC O
for IN O
excision NN O
suggests VBZ O
a DT O
functional JJ O
relationship NN O
between IN O
binding JJ O
and CC O
cleavage JJ O
reactions NNS O
. . O

-DOCSTART- X X O

New NNP O
results NNS O
of IN O
importance NN O
for IN O
optimization NN O
of IN O
the DT O
postoperative JJ O
course NN O
] IN O
Complications NNS O
after IN O
major JJ O
surgery NN O
may MD O
be VB O
related VBN O
to TO O
factors NNS O
in IN O
the DT O
surgical JJ O
stress NN O
response NN O
with IN O
endocrine-metabolic JJ O
and CC O
inflammatory JJ O
changes NNS O
. . O

-DOCSTART- X X O

Immunoblotting NNP O
showed VBD O
that IN O
both PDT O
the DT O
(1-404)-peptide JJ O
and CC O
(1-506)-peptide JJ O
are VBP O
recognized VBN O
by IN O
95J10 CD B-NP
, , O
a DT O
monoclonal JJ O
antibody NN O
that WDT O
was VBD O
previously RB O
raised VBN O
against IN O
perlecan-(24-404)-peptide JJ B-NP
expressed VBN O
in IN O
Escherichia NNP O
coli NNS O
. . O

-DOCSTART- X X O

Tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
levels NNS O
were VBD O
measured VBN O
by IN O
enzyme-linked JJ O
immunoabsorbent JJ O
assay NN O
in IN O
plasma NN O
samples NNS O
obtained VBN O
from IN O
the DT O
hyperthermic JJ O
isolated JJ O
limb NN O
perfusion NN O
circuit NN O
and CC O
systemic JJ O
circulation NN O
. . O

-DOCSTART- X X O

The DT O
activity NN O
of IN O
platelet NN B-NP
factor NN I-NP
4 CD I-NP
in IN O
plasma NN O
of IN O
healthy JJ O
and CC O
high JJ O
risk NN O
newborns NNS O
. . O

-DOCSTART- X X O

Studies NNS O
of IN O
HS2-gamma NNP B-NP
gene NN I-NP
reporter NN I-NP
constructs NNS I-NP
carrying VBG O
CACCC NNP O
box NN O
deletions NNS O
revealed VBD O
that IN O
the DT O
CACCC NNP O
box NN O
sequence NN O
of IN O
the DT O
gamma NN O
gene NN O
promoter NN O
mediates NNS O
the DT O
activation NN O
of IN O
the DT O
gamma NN O
gene NN O
by IN O
FKLF. NNP B-NP

-DOCSTART- X X O

In IN O
addition NN O
, , O
mrp17-1 NN B-NP
, , O
in IN O
combination NN O
with IN O
some DT O
mutations NNS O
affecting VBG O
another DT O
mitochondrial JJ O
ribosomal JJ O
protein NN O
, , O
caused VBD O
a DT O
synthetic JJ O
defective JJ O
phenotype NN O
. . O

-DOCSTART- X X O

Characterization NN O
of IN O
human JJ B-NP
activating NN I-NP
transcription NN I-NP
factor NN I-NP
4 CD I-NP
, , O
a DT O
transcriptional JJ O
activator NN O
that IN O
interacts NNS O
with IN O
multiple JJ O
domains NNS O
of IN O
cAMP-responsive JJ B-NP
element-binding JJ I-NP
protein NN I-NP
( -LRB- O
CREB)-binding JJ B-NP
protein NN O
. . O

-DOCSTART- X X O

The DT O
Ixodes NNP O
fauna NN O
in IN O
the DT O
Michourin NNP O
region NN O
, , O
where WRB O
the DT O
pastures NNS O
in IN O
1971 CD O
were VBD O
grazed VBN O
only RB O
by IN O
sheep NN O
, , O
shows VBZ O
the DT O
following VBG O
trends NNS O
: : O
H. NNP O
punctata NNS O
and CC O
R. NNP O
turanicus VBD O
ticks NNS O
, , O
which WDT O
are VBP O
preferably RB O
parasitising NN O
in IN O
sheep NN O
, , O
increase VBP O
their PRP$ O
relative JJ O
share NN O
. . O

-DOCSTART- X X O

The DT O
contribution NN O
of IN O
residues NNS O
outside IN O
the DT O
Ras NNP B-NP
binding JJ I-NP
domain NN I-NP
of IN O
Raf NNP B-NP
( -LRB- O
RafRBD NNP B-NP
) -RRB- O
to TO O
Ras-Raf NNP B-NP
interaction NN O
and CC O
Ras-dependent NNP B-NP
Raf NNP B-NP
activation NN O
has VBZ O
remained VBN O
unresolved JJ O
. . O

-DOCSTART- X X O

We PRP O
suggest VBP O
that IN O
electrical JJ O
stimulation NN O
of IN O
the DT O
NTS NNS O
in IN O
rats NNS O
undergoing VBG O
such JJ O
surgical JJ O
preparation NN O
to TO O
observe VB O
the DT O
pressor NN O
response NN O
and/or CC O
increase NN O
in IN O
pVP NN O
, , O
represents VBZ O
a DT O
rapid JJ O
approach NN O
for IN O
screening VBG O
the DT O
neurosecretory JJ O
function NN O
of IN O
the DT O
central JJ O
neural JJ O
integration NN O
to TO O
release VB O
vasopressin NN B-NP
. . O

-DOCSTART- X X O

CONCLUSION/INTERPRETATION NN O
: : O
We PRP O
found VBD O
an DT O
increased VBN O
risk NN O
of IN O
hip NN O
fracture NN O
in IN O
women NNS O
younger JJR O
than IN O
75 CD O
years NNS O
with IN O
Type NNP O
I PRP O
diabetes NNS O
or CC O
with IN O
Type NNP O
II NNP O
diabetes NN O
of IN O
long JJ O
duration NN O
. . O

-DOCSTART- X X O

They PRP O
represent VBP O
a DT O
physiologically RB O
more RBR O
meaningful JJ O
pattern NN O
than IN O
the DT O
arithmetic JJ O
mean NN O
with IN O
standard JJ O
deviation NN O
. . O

-DOCSTART- X X O

The DT O
influence NN O
of IN O
gas NN O
composition NN O
in IN O
the DT O
air NN O
cell NN O
on IN O
pipping NN O
and CC O
liver NN O
metabolism NN O
in IN O
embryonic JJ O
chicks NNS O
. . O

-DOCSTART- X X O

In IN O
conclusion NN O
, , O
when WRB O
pulmonary JJ O
abnormalities NNS O
are VBP O
found VBN O
in IN O
HTLV-1 JJ O
carriers NNS O
, , O
we PRP O
should MD O
be VB O
careful JJ O
in IN O
determining VBG O
whether IN O
such JJ O
pulmonary JJ O
involvements NNS O
are VBP O
etiologically RB O
related VBN O
to TO O
HTLV-1 JJ O
infection NN O
. . O

-DOCSTART- X X O

Cross-species NNPS O
characterization NN O
of IN O
the DT O
promoter NN B-NP
region NN I-NP
of IN I-NP
the DT I-NP
cystic JJ I-NP
fibrosis NN I-NP
transmembrane NN I-NP
conductance NN I-NP
regulator NN I-NP
gene NN I-NP
reveals VBZ O
multiple JJ O
levels NNS O
of IN O
regulation NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
a DT O
unique JJ O
murine NN B-NP
FLT3 IN I-NP
cDNA NN I-NP
that IN O
codes NNS O
for IN O
a DT O
variant JJ O
isoform NN O
of IN O
FLT3 NNP B-NP
, , O
devoid JJ O
of IN O
the DT O
fifth JJ O
Ig-like NNP B-NP
domain NN I-NP
, , O
by IN O
comparison NN O
with IN O
the DT O
prototypic JJ O
form NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
22 CD O
% NN O
of IN O
MDS NNP O
responded VBD O
to TO O
oral JJ O
PLAC. NN O

-DOCSTART- X X O

The DT O
Synechococcus NNP B-NP
gene NN I-NP
rps1 VBD I-NP
encoding VBG O
S1 PRP B-NP
is VBZ O
located VBN O
1.1 CD O
kb NN O
downstream NN O
from IN O
psbB NN B-NP
, , O
which WDT O
encodes VBZ O
the DT O
photosystem NN B-NP
II NNP I-NP
P680 CD I-NP
chlorophyll NN I-NP
a DT I-NP
apoprotein NN I-NP
. . O

-DOCSTART- X X O

Additions NNS O
of IN O
NH4+ NNP O
up IN O
to TO O
200 CD O
micrograms NNS O
1(-1 JJ O
) -RRB- O
were VBD O
not RB O
stimulatory JJ O
, , O
whereas IN O
at IN O
1.0 CD O
mg JJ O
1(-1 JJ O
) -RRB- O
levels NNS O
, , O
Ke NNP O
was VBD O
50 CD O
% NN O
greater JJR O
than IN O
for IN O
NO3- DT O
enriched JJ O
medium NN O
. . O

-DOCSTART- X X O

Pretreatment NNP O
with IN O
lipid JJ O
X NNP O
was VBD O
not RB O
necessary JJ O
to TO O
improve VB O
survival NN O
: : O
16 CD O
of IN O
17 CD O
( -LRB- O
94 CD O
% NN O
) -RRB- O
infected VBN O
and CC O
visibly RB O
ill JJ O
animals NNS O
that IN O
received VBN O
lipid JJ O
X NNP O
and CC O
ticarcillin VBG O
6 CD O
h NN O
after IN O
thigh NN O
inoculation NN O
survived VBD O
versus JJ O
30 CD O
of IN O
44 CD O
( -LRB- O
68 CD O
% NN O
) -RRB- O
control NN O
animals NNS O
treated VBN O
with IN O
ticarcillin NN O
alone RB O
( -LRB- O
P NNP O
less RBR O
than IN O
0.0001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Between IN O
1988 CD O
and CC O
1994 CD O
, , O
data NNS O
from IN O
3 CD O
large JJ O
sites NNS O
revealed VBD O
a DT O
3-5 CD O
fold NN O
increase NN O
in IN O
the DT O
prevalence NN O
of IN O
antidepressant JJ O
( -LRB- O
ATD NNP O
) -RRB- O
treatment NN O
for IN O
U.S. NNP O
youths NNS O
aged VBN O
2-19 CD O
years NNS O
. . O

-DOCSTART- X X O

4 CD O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Analysis NNP O
by IN O
Pearson NNP O
's POS O
correlation NN O
showed VBD O
that IN O
the DT O
subjects NNS O
who WP O
had VBD O
higher JJR O
scores NNS O
of IN O
SSMS NNP O
during IN O
the DT O
drum NN O
rotation NN O
generated VBD O
the DT O
following VBG O
: : O
a DT O
) -RRB- O
a DT O
higher JJR O
rating NN O
of IN O
over-all JJ O
sickness NN O
( -LRB- O
r NN O
= SYM O
0.76 CD O
) -RRB- O
; : O
b NN O
) -RRB- O
a DT O
higher JJR O
ratio NN O
of IN O
spectral JJ O
power NN O
of IN O
EGG NNP O
at IN O
4-9 CD O
cycles NNS O
per IN O
minute NN O
( -LRB- O
cpm RP O
) -RRB- O
between IN O
drum NN O
rotation NN O
and CC O
baseline NN O
periods NNS O
( -LRB- O
r NN O
= SYM O
0.63 CD O
) -RRB- O
; : O
c NN O
) -RRB- O
a DT O
higher JJR O
net JJ O
percent NN O
increase NN O
of IN O
spectral JJ O
power NN O
in IN O
the DT O
EEG JJ O
frequency NN O
band NN O
0.5-4 CD O
Hz NNP O
between IN O
drum NN O
rotation NN O
and CC O
baseline NN O
periods NNS O
on IN O
C3 DT O
( -LRB- O
r NN O
= SYM O
0.29 CD O
) -RRB- O
and CC O
C4 NNP O
( -LRB- O
r NN O
= SYM O
0.31 CD O
) -RRB- O
; : O
d VBN O
) -RRB- O
a DT O
higher JJR O
ratio NN O
of IN O
spectral JJ O
power NN O
of IN O
EEG JJ O
frequency NN O
band NN O
0.5-4 CD O
Hz NNP O
between IN O
drum NN O
rotation NN O
and CC O
baseline NN O
periods NNS O
on IN O
C3 DT O
( -LRB- O
r NN O
= SYM O
0.31 CD O
) -RRB- O
; : O
and CC O
e NN O
) -RRB- O
a DT O
higher JJR O
level NN O
of IN O
net JJ O
increase NN O
in IN O
skin NN O
conductance NN O
from IN O
baseline NN O
to TO O
drum NN O
rotation NN O
( -LRB- O
r NN O
= SYM O
0.30 CD O
) -RRB- O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
addition NN O
of IN O
intravenous JJ O
injection NN O
of IN O
FPFD NNP O
101 CD O
resulted VBD O
in IN O
a DT O
marked JJ O
improvement NN O
in IN O
their PRP$ O
symptoms NNS O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
that IN O
Gcn5 NNP B-NP
, , O
a DT O
histone NN B-NP
H3 IN I-NP
acetylase NN I-NP
, , O
plays VBZ O
a DT O
central JJ O
role NN O
in IN O
initiation NN O
of IN O
meiosis NN O
via IN O
effects NNS O
on IN O
IME2 NNP B-NP
expression NN O
. . O

-DOCSTART- X X O

The DT O
amino IN O
acid NN O
residues NNS O
and CC O
subdomains NNS O
important JJ O
for IN O
DNA NNP O
binding NN O
, , O
hormone NN O
binding NN O
, , O
dimerization NN O
, , O
and CC O
transactivation NN O
are VBP O
mostly RB O
conserved VBN O
among IN O
all DT O
VDR JJ B-NP
species NNS O
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
describe VBP O
the DT O
nucleotide JJ O
( -LRB- O
nt NN O
) -RRB- O
sequence NN O
and CC O
genomic JJ O
organization NN O
of IN O
ipiB NN B-NP
and CC O
ipiO. NN B-NP

-DOCSTART- X X O

The DT O
phosphatidylglycerol/phosphatidylinositol NN B-NP
transfer NN I-NP
protein NN I-NP
( -LRB- O
PG/PI-TP JJ B-NP
) -RRB- O
is VBZ O
a DT O
new JJ O
and CC O
original JJ O
phospholipid JJ B-NP
transfer NN I-NP
protein NN I-NP
( -LRB- O
PLTP NNP B-NP
) -RRB- O
isolated VBN O
from IN O
the DT O
Deuteromycete NNP O
, , O
Aspergillus NNP O
oryzae NNP O
. . O

-DOCSTART- X X O

Endotoxemia NNP O
and CC O
bacteremia NNS O
in IN O
patients NNS O
with IN O
sepsis PRP$ O
syndrome NN O
in IN O
the DT O
intensive JJ O
care NN O
unit NN O
. . O

-DOCSTART- X X O

The DT O
mRNA NN O
for IN O
this DT O
protein NN O
is VBZ O
expressed VBN O
in IN O
the DT O
T-ALL JJ O
cell NN O
line NN O
Jurkat NNP O
and CC O
has VBZ O
been VBN O
designated VBN O
HUG1 NNP B-NP
, , O
for IN O
HOX11 NNP B-NP
Upstream NNP I-NP
Gene NNP I-NP
. . O

-DOCSTART- X X O

The DT O
MEF-2 JJ B-NP
proteins NNS I-NP
are VBP O
a DT O
family NN O
of IN O
transcriptional JJ O
activators NNS O
that WDT O
have VBP O
been VBN O
detected VBN O
in IN O
a DT O
wide JJ O
variety NN O
of IN O
cell NN O
types NNS O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
diabetes NNS O
and CC O
retinal JJ O
complications NNS O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
an DT O
N-terminal JJ B-NP
RNAP NNP I-NP
mutant NN I-NP
that WDT O
has VBZ O
a DT O
decreased VBN O
capacity NN O
to TO O
bind NN O
single-stranded JJ O
RNA NNP O
forms NNS O
halted VBD O
complexes NNS O
with IN O
much RB O
lower JJR O
levels NNS O
of IN O
stability NN O
than IN O
the DT O
WT NNP O
enzyme NN O
, , O
and CC O
these DT O
complexes NNS O
are VBP O
not RB O
stabilized VBN O
by IN O
the DT O
presence NN O
of IN O
the DT O
NT NNP O
strand NN O
. . O

-DOCSTART- X X O

The DT O
densities NNS O
ranged VBD O
between IN O
2 CD O
and CC O
3976 CD O
neurites/mm2 JJ O
skin NN O
surface NN O
, , O
but CC O
the DT O
overlap NN O
between IN O
subjects NNS O
and CC O
without IN O
PHN NNP O
was VBD O
small JJ O
. . O

-DOCSTART- X X O

The DT O
present JJ O
study NN O
demonstrates VBZ O
that IN O
the DT O
proto-oncogene NN B-NP
c-jun NN I-NP
represses VBZ O
transcription NN O
of IN O
the DT O
human JJ B-NP
CG NNP I-NP
alpha NN I-NP
and CC O
CG NNP B-NP
beta JJ I-NP
promoters NNS I-NP
. . O
c-Jun NN B-NP
repressed VBD O
the DT O
CG NNP B-NP
alpha NN I-NP
promoter NN I-NP
through IN O
a DT O
canonical JJ O
cAMP JJ O
response NN O
element NN O
( -LRB- O
CRE NNP O
) -RRB- O
that WDT O
is VBZ O
known VBN O
to TO O
bind NN O
c-Jun NN B-NP
and CC O
other JJ O
members NNS O
of IN O
the DT O
B-Zip JJ B-NP
transcription NN I-NP
factor NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
that IN O
the DT O
PH NNP B-NP
domain NN I-NP
of IN O
an DT O
IRS NNP B-NP
protein NN I-NP
can MD O
function VB O
in IN O
a DT O
dominant JJ O
negative JJ O
manner NN O
to TO O
inhibit VB O
insulin NN B-NP
signaling NN O
. . O

-DOCSTART- X X O

Is VBZ O
exposure NN O
to TO O
a DT O
patient NN O
with IN O
Crohn NNP O
's POS O
disease NN O
an DT O
environmental JJ O
factor NN O
for IN O
developing VBG O
the DT O
disease NN O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
low-power JJ O
laser NN O
irradiation NN O
can MD O
be VB O
used VBN O
for IN O
promotion NN O
of IN O
vascularization NN O
and CC O
take VB O
of IN O
tissue NN O
transplants NNS O
. . O

-DOCSTART- X X O

In IN O
experiment NN O
1 CD O
, , O
subjects NNS O
were VBD O
required VBN O
to TO O
discriminate VB O
male JJ O
from IN O
female JJ O
faces NNS O
and CC O
no DT O
hemispheric JJ O
asymmetries NNS O
were VBD O
found VBN O
. . O

-DOCSTART- X X O

1 CD O
. . O

-DOCSTART- X X O

For IN O
the DT O
albino NN O
, , O
both CC O
the DT O
ST1 NNP O
and CC O
ST2 NNP O
spatial JJ O
responses NNS O
peak NN O
at IN O
around RB O
0.3 CD O
cycles NNS O
deg-1 JJ O
, , O
and CC O
both DT O
curves NNS O
are VBP O
displaced VBN O
considerably RB O
to TO O
the DT O
low JJ O
spatial JJ O
frequency NN O
side NN O
of IN O
the DT O
normal JJ O
ST2 NNS O
spatial JJ O
response NN O
. . O

-DOCSTART- X X O

The DT O
scores NNS O
for IN O
these DT O
three CD O
factors NNS O
, , O
which WDT O
corresponded VBD O
to TO O
recognizable JJ O
dimensions NNS O
of IN O
depressive JJ O
illness NN O
, , O
were VBD O
then RB O
correlated VBN O
with IN O
rCBF. NNP O

-DOCSTART- X X O

The DT O
etiology NN O
was VBD O
established VBN O
in IN O
73 CD O
( -LRB- O
76.8 CD O
% NN O
) -RRB- O
out IN O
of IN O
95 CD O
cases NNS O
. . O

-DOCSTART- X X O

Depending VBG O
on IN O
the DT O
patient NN O
's POS O
body NN O
position NN O
telemetrically RB O
measured JJ O
CSF-pressures NNS O
varied VBN O
between IN O
-20 JJ O
cmH2O NN O
in IN O
erect JJ O
and CC O
15 CD O
cmH2O NN O
in IN O
supine JJ O
position NN O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
NMDA NNP B-NP
receptor NN I-NP
blockade NN O
may MD O
ameliorate VB O
the DT O
dyskinetic JJ O
complications NNS O
of IN O
long-term JJ O
levodopa NN O
therapy NN O
, , O
without IN O
diminishing VBG O
the DT O
beneficial JJ O
effects NNS O
on IN O
parkinsonian JJ O
signs NNS O
. . O

-DOCSTART- X X O

Before IN O
flecainide NN O
, , O
all DT O
patients NNS O
had VBD O
easily RB O
inducible JJ O
VT NNP O
that WDT O
was VBD O
morphologically RB O
identical JJ O
to TO O
their PRP$ O
spontaneously NN O
occurring VBG O
arrhythmia NN O
. . O

-DOCSTART- X X O

In IN O
cells NNS O
infected VBN O
with IN O
a DT O
recombinant JJ O
vaccinia NN O
virus NN O
expressing VBG O
HCV NNP O
structural JJ O
proteins NNS O
( -LRB- O
core NN B-NP
, , O
E1 NNP B-NP
, , O
and CC O
E2 NNP B-NP
) -RRB- O
, , O
DDX3 NNP B-NP
and CC O
core NN B-NP
colocalized VBN O
in IN O
distinct JJ O
spots NNS O
in IN O
the DT O
perinuclear JJ O
region NN O
of IN O
the DT O
cytoplasm NN O
. . O

-DOCSTART- X X O

However RB O
, , O
PC12 CD O
cell NN O
clones NNS O
which WDT O
expressed VBD O
p33rsu-1 NN B-NP
at IN O
an DT O
increased JJ O
level NN O
in IN O
a DT O
regulatable JJ O
fashion NN O
in IN O
response NN O
to TO O
dexamethasone NN O
were VBD O
isolated VBN O
. . O

-DOCSTART- X X O

Differential JJ O
decay NN O
of IN O
a DT O
polycistronic JJ O
Escherichia NNP O
coli NNS O
transcript NN O
is VBZ O
initiated VBN O
by IN O
RNaseE-dependent JJ B-NP
endonucleolytic JJ O
processing NN O
. . O

-DOCSTART- X X O

Monosulfates NNP O
of IN O
16-oxygenated JJ O
ketonic JJ O
C19 DT O
steroids NNS O
in IN O
adult NN O
human NN O
urine NN O
. . O

-DOCSTART- X X O

A DT O
case NN O
of IN O
2 CD O
cancers NNS O
of IN O
the DT O
colon NN O

-DOCSTART- X X O

However RB O
, , O
mutations NNS O
of IN O
the DT O
C-rich JJ O
element NN O
that IN O
disrupted VBD O
a DT O
GC JJ O
box NN O
located VBN O
on IN O
the DT O
inverse NN O
strand NN O
eliminated VBD O
PMA NNP O
responsiveness NN O
and CC O
, , O
in IN O
gel NNP O
mobility NN O
shift NN O
assays VBZ O
, , O
eliminated VBN O
binding NN O
of IN O
Sp1 NNP B-NP
. . O

-DOCSTART- X X O

Down-regulation NN O
of IN O
Id1 NNP B-NP
mRNA NNS I-NP
correlated VBD O
with IN O
mitogenesis NN O
and CC O
occurred VBD O
when WRB O
quiescent JJ O
cells NNS O
were VBD O
treated VBN O
with IN O
growth NN O
factors NNS O
that WDT O
activate VBP O
G NNP B-NP
protein-coupled JJ I-NP
receptors NNS I-NP
and CC O
receptor NN B-NP
protein NN I-NP
tyrosine NN I-NP
kinases NNS I-NP
but CC O
not RB O
with IN O
a DT O
non-mitogenic JJ O
cAMP NN O
analog NN O
. . O

-DOCSTART- X X O

Cloning NNP O
and CC O
characterization NN O
of IN O
the DT O
5' JJ O
flanking JJ O
region NN O
of IN O
human JJ B-NP
ATP-citrate NNP I-NP
lyase NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Defective JJ O
concanavalin NN B-NP
A-induced JJ I-NP
suppression NN O
in IN O
bancroftian JJ O
filariasis NN O
. . O

-DOCSTART- X X O

Demonstration NN O
of IN O
changes NNS O
in IN O
fetal NN O
liver NN O
erythropoiesis NN O
using VBG O
echo-planar JJ O
magnetic JJ O
resonance NN O
imaging NN O
. . O

-DOCSTART- X X O

Reaction NN O
of IN O
aromatic/heterocyclic JJ O
sulfonamides NNS O
possessing VBG O
free JJ O
amino NN O
, , O
imino NN O
or CC O
hydrazino NN O
moieties NNS O
with IN O
7-chloro-4-chloromethylcoumarin JJ O
afforded VBN O
a DT O
series NN O
of IN O
N-[(7-chloro-4-coumarinyl)-methyl] JJ O
- : O
derivatives NNS O
which WDT O
showed VBD O
effective JJ O
inhibition NN O
of IN O
three CD O
carbonic JJ B-NP
anhydrase NN I-NP
( -LRB- O
CA NNP B-NP
) -RRB- O
isozymes VBZ O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
the DT O
interactions NNS O
, , O
and CC O
consequently RB O
the DT O
mechanisms NNS O
, , O
governing VBG O
transcriptional JJ O
activation NN O
by IN O
CTF NNP B-NP
are VBP O
distinct JJ O
from IN O
those DT O
mediating JJ O
DNA NNP O
replication NN O
. . O

-DOCSTART- X X O

These DT O
proteins NNS O
, , O
called VBN O
variant JJ B-NP
surface NN I-NP
glycoproteins NNS I-NP
(VSGs NNS O
) -RRB- O
, , O
are VBP O
expressed VBN O
from IN O
a DT O
specific JJ O
locus NN O
, , O
the DT O
VSG NNP B-NP
gene NN I-NP
expression NN I-NP
site NN I-NP
( -LRB- I-NP
ES NNPS I-NP
) -RRB- I-NP
. . O

-DOCSTART- X X O

In IN O
situ FW O
hybridization NN O
of IN O
whole-mount JJ O
mouse NN O
embryos NNS O
with IN O
Mex5 NNP B-NP
antisense NN I-NP
RNA NNP I-NP
provide VBP O
no DT O
evidence NN O
for IN O
the DT O
exclusion NN O
of IN O
Mex5 NNP B-NP
during IN O
embryonic JJ O
development NN O
. . O

-DOCSTART- X X O

Karyo NNP O
- : O
and CC O
cytometric JJ O
investigations NNS O
of IN O
cortical JJ O
layer NN O
V NNP O
pyramidal JJ O
neurons NNS O
of IN O
albino NN O
rat NN O
after IN O
three CD O
various JJ O
fixations NNS O

-DOCSTART- X X O

The DT O
cloning NN O
of IN O
human JJ B-NP
apo NN I-NP
B-100 CC I-NP
has VBZ O
provided VBN O
new JJ O
insights NNS O
into IN O
the DT O
structure NN O
and CC O
physicochemical JJ O
properties NNS O
of IN O
apo NN B-NP
B-100 . I-NP
and CC O
will MD O
facilitate VB O
studies NNS O
on IN O
the DT O
factors NNS O
modulating VBG O
apo NN B-NP
B-100 CC I-NP
biosynthesis NN O
and CC O
the DT O
expression NN O
of IN O
the DT O
apo NN B-NP
B-100 CC I-NP
gene NN I-NP
in IN O
patients NNS O
with IN O
dyslipoproteinemias NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
green JJ O
unicellular JJ O
alga NN O
Chlamydomonas NNP O
eugametos NNS O
, , O
cellular JJ O
division NN O
is VBZ O
readily RB O
synchronized VBN O
by IN O
light/dark JJ O
cycles NNS O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
linked VBN O
Plk NNP B-NP
expression NN O
to TO O
the DT O
proliferative JJ O
activity NN O
of IN O
cells NNS O
and CC O
tissues NNS O
. . O

-DOCSTART- X X O

A DT O
1.5-month-old JJ O
boy NN O
with IN O
Sandifer NNP O
's POS O
syndrome NN O
is VBZ O
described VBN O
. . O

-DOCSTART- X X O

A DT O
40-fold JJ O
stimulation NN O
of IN O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
activity NN O
mediated VBN O
by IN O
four CD O
tandem NN O
repeats NNS O
of IN O
the DT O
SNE NNP B-NP
could MD O
be VB O
induced VBN O
within IN O
2 CD O
h NN O
( -LRB- O
and CC O
up RB O
to TO O
250-fold VB O
within IN O
6 CD O
h NN O
) -RRB- O
after IN O
addition NN O
of IN O
TPA NNP O
in IN O
DNA-transfected JJ O
U-937 JJ O
cells NNS O
, , O
indicating VBG O
that IN O
the DT O
stimulation NN O
appeared VBD O
likely JJ O
to TO O
be VB O
a DT O
true JJ O
protein NN B-NP
kinase NN I-NP
C-mediated JJ I-NP
signal NN O
transduction NN O
event NN O
rather RB O
than IN O
a DT O
differentiation NN O
response NN O
. . O

-DOCSTART- X X O

Between IN O
1988 CD O
and CC O
1995 CD O
, , O
341 CD O
children NNS O
with IN O
acute JJ O
myeloid JJ O
leukaemia NN O
( -LRB- O
AML) CC O
were VBD O
treated VBN O
on IN O
the DT O
Medical NNP O
Research NNP O
Council NNP O
Acute NNP O
Myeloid NNP O
Leukaemia NNP O
Trial NNP O
( -LRB- O
MRC JJ O
AML10 IN O
) -RRB- O
. . O

-DOCSTART- X X O

Using VBG O
the DT O
yeast NN O
two-hybrid JJ O
system NN O
, , O
we PRP O
have VBP O
isolated VBN O
an DT O
835 CD O
amino IN O
acid NN O
RING VBG O
finger NN O
( -LRB- O
C3HC4 IN O
zinc NN O
finger NN O
) -RRB- O
protein NN O
, , O
TIF1 NN B-NP
beta NN I-NP
( -LRB- O
also RB O
named VBN O
KAP-1 NN B-NP
) -RRB- O
, , O
that WDT O
specifically RB O
interacts VBZ O
with IN O
the DT O
KRAB NNP B-NP
domain NN I-NP
of IN O
the DT O
human JJ O
zinc NN O
finger NN O
factor NN O
KOX1/ZNF10 NNP B-NP
. . O

-DOCSTART- X X O

Their PRP$ O
central JJ O
projections NNS O
were VBD O
indistinguishable JJ O
from IN O
those DT O
of IN O
control NN O
axons NNS O
in IN O
all DT O
four CD O
trigeminal JJ O
subnuclei NN O
. . O

-DOCSTART- X X O

Typicality NN O
is VBZ O
probably RB O
a DT O
better JJR O
representation NN O
of IN O
Alexander NNP O
, , O
Dunbar NNP O
and CC O
others NNS O
' POS O
conclusions NNS O
than IN O
specificity NN O
, , O
which WDT O
was VBD O
always RB O
too RB O
absolute JJ O
a DT O
term NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
TAK1 NNP B-NP
, , O
TGF-beta NNP B-NP
also RB O
stimulated VBD O
JNK NNP B-NP
activity NN O
. . O

-DOCSTART- X X O

The DT O
study NN O
was VBD O
carried VBN O
out RP O
according VBG O
to TO O
the DT O
BSI NNP O
( -LRB- O
1980 CD O
) -RRB- O
recommendations NNS O
for IN O
testing VBG O
restorative JJ O
materials NNS O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

A DT O
case NN O
report NN O
. . O

-DOCSTART- X X O

Oxalates NNS O
and CC O
the DT O
digestive JJ O
tract NN O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
MCV-1 JJ B-NP
RPO1 NNS I-NP
revealed VBD O
high JJ O
amino IN O
acid NN O
homologies NNS O
to TO O
the DT O
corresponding JJ O
polypeptides NNS O
of IN O
vaccinia NN O
and CC O
variola NN O
virus NN O
. . O

-DOCSTART- X X O

This DT O
interaction NN O
is VBZ O
functional JJ O
as IN O
it PRP O
leads VBZ O
to TO O
retargeting VBG O
of IN O
NF-kappa NNP B-NP
B NNP I-NP
p50 NN B-NP
from IN O
the DT O
nucleus JJ O
to TO O
the DT O
cytoplasm NN O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
masked JJ O
toxins NNS O
in IN O
the DT O
exotoxin NN O
complex NN O
of IN O
Staphylococcus NNP O
pyogenes NNS O
und IN O
Cl NNP O
. . O
perfringens NNS O
; : O
significance NN O
of IN O
their PRP$ O
existence NN O
for IN O
clarifying VBG O
of IN O
the DT O
masking NN O
mechanism NN O

-DOCSTART- X X O

Correlation NN O
coefficients NNS O
between IN O
SF NNP O
thickness NN O
and CC O
NIR NNP O
optical JJ O
density NN O
readings NNS O
at IN O
940 CD O
nm NN O
( -LRB- O
OD1 NNP O
) -RRB- O
and CC O
950 CD O
nm NN O
( -LRB- O
OD2 IN O
) -RRB- O
wavelengths NNS O
ranged VBD O
from IN O
r NN O
= SYM O
-0.30 FW O
( -LRB- O
subscapula NN O
) -RRB- O
to TO O
r VB O
= SYM O
-0.67 FW O
( -LRB- O
biceps NNS O
) -RRB- O
for IN O
OD1 NNP O
and CC O
r NN O
= SYM O
-0.39 FW O
( -LRB- O
axilla NN O
) -RRB- O
to TO O
r VB O
= SYM O
-0.68 FW O
( -LRB- O
biceps NNS O
) -RRB- O
for IN O
OD2 NNP O
. . O

-DOCSTART- X X O

The DT O
clinical JJ O
picture NN O
, , O
the DT O
light NN O
and CC O
electron NN O
microscopic JJ O
appearance NN O
, , O
and CC O
the DT O
histochemical JJ O
findings NNS O
are VBP O
described VBN O
in IN O
six CD O
cases NNS O
of IN O
fibroma NN O
of IN O
tendon CD O
sheath NN O
. . O

-DOCSTART- X X O

We PRP O
hypothesize VBP O
that IN O
the DT O
ability NN O
of IN O
these DT O
acidic JJ O
activators NNS O
to TO O
specifically RB O
interact VB O
with IN O
multiple JJ O
components NNS O
of IN O
the DT O
transcription NN O
initiation NN O
complex NN O
likely JJ O
underlies NNS O
the DT O
dramatic JJ O
functional JJ O
synergy NN O
exhibited VBN O
by IN O
this DT O
class NN O
of IN O
activation NN O
domains NNS O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

High NNP O
and CC O
pathological JJ O
PAI-1 JJ B-NP
levels NNS O
before RB O
and CC O
after IN O
the DT O
VO NNP O
test NN O
were VBD O
consistent JJ O
with IN O
a DT O
defective JJ O
fibrinolytic JJ O
potential JJ O
due JJ O
to TO O
the DT O
inhibitory JJ O
effect NN O
of IN O
PAI-1 NN B-NP
on IN O
plasminogen NN B-NP
activation NN O
. . O

-DOCSTART- X X O

MAPKK NNP B-NP
kinase/MEKK NN I-NP
phosphorylates NNS O
and CC O
activates VBZ O
its PRP$ O
downstream JJ O
protein NN O
kinase NN O
, , O
MAPK NNP B-NP
kinase/MEK NN I-NP
, , O
which WDT O
in IN O
turn NN O
activates NNS O
MAPK. . B-NP

-DOCSTART- X X O

The DT O
author NN O
describes VBZ O
the DT O
technique NN O
in IN O
detail NN O
and CC O
presents VBZ O
the DT O
findings NNS O
for IN O
25 CD O
patients NNS O
( -LRB- O
10 CD O
men NNS O
and CC O
15 CD O
women NNS O
) -RRB- O
examined VBN O
for IN O
suspected VBN O
ileostomy NN O
dysfunction NN O
, , O
recurrent JJ O
Crohn NNP O
's POS O
disease NN O
or CC O
ileal JJ O
obstruction NN O
remote NN O
from IN O
the DT O
stoma NN O
. . O

-DOCSTART- X X O

Biochemical NNP O
studies NNS O
have VBP O
identified VBN O
a DT O
cellular JJ O
non-P JJ B-NP
element-encoded JJ I-NP
DNA NN I-NP
binding JJ I-NP
protein NN I-NP
, , O
termed VBD O
the DT O
inverted JJ B-NP
repeat NN I-NP
binding JJ I-NP
protein NN I-NP
( -LRB- O
IRBP) NN B-NP
, , O
that WDT O
specifically RB O
interacts VBZ O
with IN O
the DT O
outer JJ O
half NN O
of IN O
the DT O
31-bp JJ O
terminal NN O
inverted VBN O
repeats NNS O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
eIF5-eIF2beta JJ B-NP
interaction NN O
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
eIF5 DT B-NP
function NN O
in IN O
eukaryotic JJ O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
delayed VBN O
activation NN O
of IN O
the DT O
prostaglandin NN B-NP
G/H NNP I-NP
synthase-2 NN I-NP
promoter NN O
in IN O
bovine JJ O
granulosa NN O
cells NNS O
is VBZ O
associated VBN O
with IN O
down-regulation NN O
of IN O
truncated JJ O
upstream JJ B-NP
stimulatory NN I-NP
factor-2 NN I-NP
. . O

-DOCSTART- X X O

E1A PRP B-NP
+ VBD O
cHa-ras DT B-NP
transformed VBN O
rat NN O
embryo NN O
fibroblast NN O
cells NNS O
are VBP O
characterized VBN O
by IN O
high JJ O
and CC O
constitutive JJ O
DNA NNP O
binding NN O
activities NNS O
of IN O
AP-1 NNP B-NP
dimers NNS I-NP
with IN O
significantly RB O
altered VBN O
composition NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
study NN O
we PRP O
have VBP O
used VBN O
Southern JJ O
blot NN O
analysis NN O
to TO O
demonstrate VB O
that IN O
TSG6 NNP B-NP
is VBZ O
a DT O
single-copy JJ O
gene NN O
in IN O
the DT O
human JJ O
and CC O
murine JJ O
species NNS O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Latanoprost VB O
administered VBN O
once RB O
daily RB O
was VBD O
significantly RB O
more RBR O
effective JJ O
in IN O
reducing VBG O
IOP NNP O
compared VBN O
with IN O
unoprostone NN O
administered VBN O
twice RB O
daily RB O
in IN O
patients NNS O
with IN O
POAG NNP O
and CC O
OH. NNP O

-DOCSTART- X X O

Activation NN O
of IN O
HIV NNP O
gene NN O
expression NN O
by IN O
UV NN O
must MD O
therefore RB O
involve VB O
additional JJ O
cellular JJ O
processes NNS O
, , O
such JJ O
as IN O
those DT O
triggered VBN O
by IN O
DNA NNP O
damage NN O
, , O
for IN O
generation NN O
of IN O
a DT O
full JJ O
gene NN O
expression NN O
response NN O
. . O

-DOCSTART- X X O

Radiological NNP O
imaging VBG O
such JJ O
as IN O
UGI NNP O
series NN O
and CC O
CT NNP O
scan NN O
was VBD O
useful JJ O
to TO O
arrive VB O
at IN O
an DT O
accurate JJ O
diagnosis NN O
. . O

-DOCSTART- X X O

We PRP O
propose VBP O
that IN O
optimal JJ O
transcription NN O
of IN O
the DT O
gD NNP B-NP
gene NN I-NP
depends VBZ O
on IN O
the DT O
interaction NN O
of IN O
ICP4 NNP B-NP
with IN O
multiple JJ O
binding NN O
sites NNS O
across IN O
the DT O
gene NN O
and CC O
cellular JJ O
factors NNS O
that WDT O
recognize VBP O
specific JJ O
sequence NN O
elements NNS O
in IN O
the DT O
promoter NN O
. . O

-DOCSTART- X X O

Cetn1 NNP B-NP
possesses VBZ O
the DT O
sequence NN O
features NNS O
of IN O
an DT O
expressed VBN O
retroposon NN O
: : O
the DT O
gene NN O
lacks VBZ O
introns NNS O
, , O
the DT O
open JJ O
reading NN O
frame NN O
is VBZ O
not RB O
interrupted VBN O
by IN O
stop NN O
codons NNS O
, , O
and CC O
the DT O
coding NN O
region NN O
is VBZ O
flanked VBN O
by IN O
a DT O
pair NN O
of IN O
direct JJ O
repeats NNS O
. . O

-DOCSTART- X X O

Substitutions NNS O
of IN O
Asp11 DT O
led VBN O
to TO O
dominant JJ O
lethality NN O
. . O

-DOCSTART- X X O

We PRP O
prospectively RB O
studied VBD O
serum NN B-NP
prolactin NN I-NP
( -LRB- O
PRL NNP B-NP
) -RRB- O
elevation NN O
after IN O
different JJ O
types NNS O
of IN O
documented VBN O
seizures NNS O
in IN O
17 CD O
patients NNS O
. . O

-DOCSTART- X X O

To TO O
further RB O
identify VB O
the DT O
residues NNS O
responsible JJ O
for IN O
the DT O
activity NN O
, , O
we PRP O
isolated VBD O
the DT O
mutant JJ O
viruses NNS O
that WDT O
were VBD O
not RB O
neutralized VBN O
with IN O
the DT O
soluble JJ O
form NN O
of IN O
MHV NNP B-NP
receptor NN I-NP
proteins VBZ I-NP
, , O
since IN O
such JJ O
mutants NNS O
were VBD O
expected VBN O
to TO O
have VB O
mutations NNS O
in IN O
amino DT O
acids NNS O
responsible JJ O
for IN O
receptor-binding JJ O
activity NN O
. . O

-DOCSTART- X X O

When WRB O
lipid JJ O
X NNP O
was VBD O
combined VBN O
with IN O
ticarcillin NN O
, , O
survival NN O
differences NNS O
were VBD O
both DT O
significant JJ O
and CC O
prolonged JJ O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
secondary JJ O
stress NN O
responses NNS O
were VBD O
more RBR O
pronounced VBN O
and CC O
the DT O
ability NN O
to TO O
recover VB O
from IN O
them PRP O
seemed VBD O
to TO O
be VB O
impaired VBN O
in RP O
exposed VBN O
fish NN O
as IN O
compared VBN O
to TO O
unexposed JJ O
fish NN O
. . O

-DOCSTART- X X O

Focal NNP O
glomerulosclerosis-like JJ O
disease NN O
with IN O
nephrotic JJ O
syndrome NN O
in IN O
a DT O
horse NN O
. . O

-DOCSTART- X X O

Treatment NNP O
with IN O
polyinosinic-polycytidylic JJ O
acid NN O
to TO O
induce VB O
expression NN O
of IN O
Cre NNP B-NP
resulted VBD O
in IN O
complete JJ O
disruption NN O
of IN O
the DT O
Arnt NNP B-NP
gene NN I-NP
and CC O
loss NN O
of IN O
ARNT NNP B-NP
messenger NN I-NP
RNA NNP I-NP
( -LRB- O
mRNA NN O
) -RRB- O
expression NN O
in IN O
liver NN O
. . O

-DOCSTART- X X O

Twelve CD O
patients NNS O
of IN O
leprosy JJ O
with IN O
arthritis NN O
and CC O
161 CD O
patients NNS O
without IN O
arthritis NN O
were VBD O
studied VBN O
for IN O
immunological JJ O
parameters NNS O
like IN O
immunoglobulins NNS B-NP
( -LRB- O
IgG NNP B-NP
, , O
IgM NNP B-NP
, , O
IgA NNP B-NP
) -RRB- O
, , O
C-reactive JJ B-NP
proteins NNS I-NP
and CC O
rheumatoid NN B-NP
factor NN I-NP
. . O

-DOCSTART- X X O

All DT O
depressive JJ O
groups NNS O
showed VBD O
improved VBN O
error NN O
measures NNS O
post-treatment NN O
. . O

-DOCSTART- X X O

Plasmid NNP O
subclones NNS O
of IN O
the DT O
hr1a-containing JJ B-NP
AcMNPV NNP O
HindIII-N NNP B-NP
fragment NN O
were VBD O
examined VBN O
for IN O
their PRP$ O
ability NN O
to TO O
replicate VB O
in IN O
virus-infected JJ O
( -LRB- O
Spodoptera NN O
frugiperda NN O
) -RRB- O
Sf9 IN O
cells NNS O
, , O
and CC O
to TO O
stimulate VB O
transcription NN O
when WRB O
linked VBN O
in IN O
cis NN O
with IN O
a DT O
39K JJ B-NP
gene NN I-NP
promoter-beta-glucuronidase JJ I-NP
fusion NN I-NP
and CC O
cotransfected VBD O
into IN O
cells NNS O
along IN O
with IN O
a DT O
plasmid NN O
( -LRB- O
ple-1 NN O
) -RRB- O
containing VBG O
the DT O
gene NN O
encoding VBG O
the DT O
trans-acting JJ O
factor NN O
IE-1 NN B-NP
. . O

-DOCSTART- X X O

This DT O
new JJ O
receptor NN O
, , O
TOR NN B-NP
( -LRB- O
thymus NN B-NP
orphan JJ I-NP
receptor NN I-NP
) -RRB- O
, , O
is VBZ O
most RBS O
closely RB O
related VBN O
in IN O
both DT O
its PRP$ O
DNA-binding JJ O
domain NN O
and CC O
ligand-binding JJ O
domain NN O
, , O
90 CD O
% NN O
and CC O
53 CD O
% NN O
, , O
respectively RB O
, , O
to TO O
ROR NNP B-NP
alpha/RZR NN I-NP
alpha NN B-NP
and CC O
clusters NNS O
with IN O
these DT O
two CD O
receptors NNS O
and CC O
RZR NNP B-NP
beta NN I-NP
in IN O
a DT O
phylogenetic JJ O
tree NN O
, , O
when WRB O
both DT O
the DT O
DNA-binding JJ O
domain NN O
and CC O
the DT O
ligand-binding JJ O
domain NN O
sequences NNS O
of IN O
nuclear JJ O
receptors NNS O
are VBP O
compared VBN O
. . O

-DOCSTART- X X O

Laser NNP O
soldering NN O
with IN O
exogenous JJ O
fibrinogen NN B-NP
is VBZ O
feasible JJ O
without IN O
topical JJ O
administration NN O
of IN O
additional JJ O
clotting NN O
agents NNS O
, , O
significantly RB O
improves VBZ O
the DT O
bursting VBG O
strength NN O
of IN O
primary JJ O
laser NN O
welded VBN O
anastomoses NNS O
, , O
and CC O
appears VBZ O
to TO O
result VB O
from IN O
urokinase-resistant JJ B-NP
fibrinogen NN B-NP
cross-linking NN O
. . O

-DOCSTART- X X O

Raman NNP O
scattering NN O
from IN O
VO2 DT O
single JJ O
crystals NNS O
: : O
A DT O
study NN O
of IN O
the DT O
effects NNS O
of IN O
surface NN O
oxidation NN O
. . O

-DOCSTART- X X O

Left VBN O
ventricular JJ O
insufficiency NN O
requires VBZ O
two CD O
SP/patient JJ O
, , O
with IN O
good JJ O
results NNS O
in IN O
approximately RB O
81 CD O
p NN O
. . O
cent NN O
. . O

-DOCSTART- X X O

50-fold JJ O
increase NN O
in IN O
foreign JJ O
protein NN O
production NN O
. . O

-DOCSTART- X X O

A DT O
rare JJ O
tRNA-Arg(CCU) NN B-NP
that WDT O
regulates VBZ O
Ty1 DT B-NP
element NN I-NP
ribosomal JJ O
frameshifting NN O
is VBZ O
essential JJ O
for IN O
Ty1 NNP B-NP
retrotransposition NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
putative JJ O
binding NN O
sites NNS O
for IN O
SH3 NNP B-NP
and CC O
SH2 NNP B-NP
domains NNS I-NP
are VBP O
present JJ O
in IN O
the DT O
amino-terminal JJ O
half NN O
of IN O
the DT O
molecule NN O
. . O

-DOCSTART- X X O

The DT O
technique NN O
used VBN O
by IN O
this DT O
system NN O
involves VBZ O
a DT O
transient NN O
, , O
externally RB O
applied VBD O
increase NN O
in IN O
resistance NN O
to TO O
breathing NN O
. . O

-DOCSTART- X X O

Copyright NNP O
1999 CD O
Academic NNP O
Press NNP O
. . O

-DOCSTART- X X O

Vorozole FW O
( -LRB- O
Rivizor NN O
) -RRB- O
is VBZ O
a DT O
potent JJ O
and CC O
stereospecific JJ O
inhibitor NN O
of IN O
aromatase NN B-NP
having VBG O
shown VBN O
promising VBG O
endocrine NN O
effects NNS O
in IN O
phase NN O
I PRP O
studies NNS O
. . O

-DOCSTART- X X O

Mapping VBG O
the DT O
5' JJ O
and CC O
3' JJ O
termini NNS O
of IN O
TED NNP B-NP
RNAs NNP I-NP
indicated VBD O
that IN O
the DT O
LTRs NNS O
have VBP O
a DT O
retroviral JJ O
U3-R-U5 NNP O
structural JJ O
organization NN O
that WDT O
is VBZ O
capable JJ O
of IN O
directing VBG O
the DT O
synthesis NN O
of IN O
transcripts NNS O
that WDT O
represent VBP O
potential JJ O
substrates NNS O
for IN O
reverse NN O
transcription NN O
and CC O
intermediates NNS O
in IN O
transposition NN O
. . O

-DOCSTART- X X O

However RB O
, , O
sphincter NN O
length NN O
decreased VBN O
with IN O
age NN O
from IN O
24.3 CD O
to TO O
14.8 CD O
mm. NN O
, , O
maximal JJ O
urethral JJ O
pressure NN O
from IN O
88.7 CD O
to TO O
55 CD O
cm NN O
. . O
water NN O
and CC O
maximal JJ O
urethral JJ O
pressure NN O
during IN O
voluntary JJ O
contraction NN O
from IN O
221.4 CD O
to TO O
166.3 CD O
cm NN O
. . O
water NN O
. . O

-DOCSTART- X X O

A DT O
cephalothoracophagus JJ O
disymmetros NNS O
buffalo NN O
calf NN O
. . O

-DOCSTART- X X O

Electromobility NNP O
shift NN O
analysis NN O
using VBG O
oligonucleotides NNS O
encompassing VBG O
the DT O
proximal JJ O
, , O
distal JJ O
, , O
and CC O
BED/AP-1-binding JJ O
regions NNS O
failed VBD O
to TO O
demonstrate VB O
selective JJ O
transactivation NN O
after IN O
CD2 DT B-NP
signaling NN O
of IN O
LPMC. NNP O

-DOCSTART- X X O

Four CD O
families NNS O
of IN O
homing JJ B-NP
endonucleases NNS I-NP
have VBP O
been VBN O
identified VBN O
, , O
including VBG O
the DT O
LAGLIDADG NNP B-NP
, , O
the DT O
His-Cys NNP B-NP
box NN I-NP
, , O
the DT O
GIY-YIG NNP B-NP
and CC O
the DT O
H-N-H NNP B-NP
endonucleases NNS I-NP
. . O

-DOCSTART- X X O

Administration NNP O
of IN O
SnCl2 NNP O
and CC O
ZnSO4 NNP O
( -LRB- O
group NN O
V NNP O
) -RRB- O
resulted VBD O
in IN O
a DT O
decrease NN O
of IN O
ALA-D NNP B-NP
activity NN O
and CC O
in IN O
an DT O
increase NN O
in IN O
CP-U. NNP O

-DOCSTART- X X O

Coexistence NNP O
of IN O
Turner NNP O
's POS O
syndrome NN O
and CC O
schizophrenia NN O

-DOCSTART- X X O

A DT O
selectable JJ O
marker NN O
for IN O
transformation NN O
was VBD O
constructed VBN O
by IN O
transcriptional JJ O
fusion NN O
of IN O
a DT O
Ustilago NNP B-NP
maydis NN I-NP
heat NN I-NP
shock NN I-NP
gene NN I-NP
promoter NN I-NP
with IN O
the DT O
hygromycin NN B-NP
B NNP I-NP
phosphotransferase NN I-NP
gene NN I-NP
of IN I-NP
Escherichia NNP I-NP
coli NNS I-NP
. . O

-DOCSTART- X X O

All DT O
exon/intron NN O
splice NN O
junctions NNS O
follow VBP O
the DT O
GT/AG NNP O
rule NN O
. . O

-DOCSTART- X X O

These DT O
studies NNS O
suggest VBP O
that IN O
tandem NN O
alpha-helices NNS O
located VBN O
near IN O
the DT O
C-terminus NN O
of IN O
PC-TP NNP B-NP
facilitate VBP O
membrane NN O
binding NN O
and CC O
extraction NN O
of IN O
phosphatidylcholines NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
investigated VBD O
the DT O
mechanism NN O
by IN O
which WDT O
Tax NNP B-NP
activates VBZ O
gene NN O
expression NN O
in IN O
conjunction NN O
with IN O
members NNS O
of IN O
the DT O
ATF/CREB NNP B-NP
family NN O
. . O

-DOCSTART- X X O

We PRP O
studied VBD O
18 CD O
dogs NNS O
, , O
anaesthetised VBN O
and CC O
spontaneously RB O
breathing VBG O
both DT O
room NN O
air NN O
and CC O
after IN O
the DT O
inhalation NN O
of IN O
a DT O
gas NN O
mixture NN O
containing VBG O
10 CD O
% NN O
CO2 NN O
, , O
20.9 CD O
% NN O
O2 CD O
, , O
and CC O
69.1 CD O
% NN O
N2 NN O
, , O
to TO O
determine VB O
the DT O
role NN O
of IN O
histamine NN O
, , O
serotonin NN O
, , O
and CC O
acidaemia NN O
in IN O
pulmonary JJ O
hypertension NN O
produced VBN O
by IN O
hypercapnia NN O
. . O

-DOCSTART- X X O

In IN O
both DT O
liver NN O
and CC O
pancreatic JJ O
islet NN O
, , O
glucokinase NN B-NP
is VBZ O
subject JJ O
to TO O
inhibition NN O
by IN O
a DT O
regulatory JJ O
protein NN O
( -LRB- O
GCKR NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
this DT O
second JJ O
clinical JJ O
paper NN O
, , O
the DT O
genetic JJ O
features NNS O
of IN O
the DT O
case NN O
of IN O
microphthalmia NN O
in IN O
sheep NN O
reported VBN O
by IN O
Wagenaar NNP O
is VBZ O
discussed VBN O
in IN O
greater JJR O
detail NN O
. . O

-DOCSTART- X X O

Both DT O
the DT O
arterial NN O
and CC O
venous JJ O
thrombi NN O
were VBD O
clearly RB O
discernible JJ O
at IN O
2 CD O
to TO O
8 CD O
h NN O
after IN O
injection NN O
of IN O
99Tcm-SZ-51 CD O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
blend NN O
of IN O
Metanil NNP O
yellow JJ O
and CC O
Orange NNP O
II NNP O
( -LRB- O
1:1 CD O
) -RRB- O
resulted VBD O
in IN O
the DT O
D1 NNP O
50.value CD O
of IN O
288 CD O
min NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
show VBP O
that IN O
the DT O
activating JJ O
effect NN O
of IN O
this DT O
mutation NN O
is VBZ O
not RB O
the DT O
result NN O
of IN O
creating VBG O
an DT O
exonic JJ O
splicing NN O
enhancer NN O
( -LRB- O
ESE NNP O
) -RRB- O
or CC O
disrupting VBG O
a DT O
putative JJ O
secondary JJ O
structure NN O
. . O

-DOCSTART- X X O

The DT O
architecture NN O
of IN O
the DT O
hRap1 JJ B-NP
Myb NNP B-NP
domain NN I-NP
is VBZ O
very RB O
close JJ O
to TO O
that DT O
of IN O
each DT O
of IN O
the DT O
Myb NNP B-NP
domains VBZ I-NP
from IN O
TRF1 NNP B-NP
, , O
scRap1p JJ B-NP
and CC O
c-Myb JJ B-NP
. . O

-DOCSTART- X X O

However RB O
, , O
this DT O
posttranslational JJ O
modification NN O
of IN O
the DT O
gar2 NN B-NP
protein NN I-NP
does VBZ O
not RB O
appear VB O
to TO O
be VB O
essential JJ O
for IN O
normal JJ O
production NN O
of IN O
18S DT B-NP
rRNA NNP I-NP
. . O

-DOCSTART- X X O

The DT O
BRSV NN B-NP
L NNP I-NP
gene NN I-NP
is VBZ O
6573 CD O
nt NN O
in IN O
length NN O
and CC O
the DT O
derived VBN O
polypeptide NN O
has VBZ O
2162 CD O
aa JJ O
. . O

-DOCSTART- X X O

BRAP2 NN B-NP
also RB O
shares VBZ O
significant JJ O
homology NN O
with IN O
a DT O
hypothetical JJ O
protein NN O
from IN O
yeast NN O
Saccharomyces NNS O
cerevisiae NNS O
, , O
especially RB O
in IN O
the DT O
zinc NN O
finger NN O
region NN O
. . O

-DOCSTART- X X O

We PRP O
identified VBD O
Tyr( JJ O
112 CD O
) -RRB- O
and CC O
Leu( JJ O
175 CD O
) -RRB- O
within IN O
the DT O
RNA-binding JJ O
domain NN O
of IN O
the DT O
U1 NNP B-NP
70K NNP I-NP
protein NN I-NP
to TO O
be VB O
cross-linked JJ O
to TO O
G( JJ O
28 CD O
) -RRB- O
and CC O
U(30 NNP O
) -RRB- O
in IN O
stem-loop NN O
I PRP O
, , O
respectively RB O
. . O

-DOCSTART- X X O

In IN O
general JJ O
, , O
the DT O
scallop NN O
extract VB O
potentiated VBN O
phototactic JJ O
suppression NN O
. . O

-DOCSTART- X X O

Only RB O
Staphylococcus NNP O
xylosus NNP O
SX63 NNP O
was VBD O
detected VBN O
as IN O
a DT O
strain NN O
with IN O
high JJ O
adherence NN O
activity NN O
. . O

-DOCSTART- X X O

METHODS NNP O
: : O
The DT O
Die NNP O
Deutsche NNP O
Diabetes NNP O
Dialyse NNP O
Studie NNP O
is VBZ O
a DT O
prospective JJ O
randomized JJ O
placebo-controlled JJ O
trial NN O
that IN O
tests NNS O
the DT O
hypothesis NN O
that IN O
atorvastatin NN O
, , O
a DT O
hydroxymethyl-glutaryl JJ B-NP
coenzyme NN I-NP
A DT I-NP
reductase NN I-NP
inhibitor NN O
, , O
decreases VBZ O
the DT O
rate NN O
of IN O
cardiovascular JJ O
mortality NN O
and CC O
of IN O
nonfatal JJ O
myocardial JJ O
infarction NN O
in IN O
patients NNS O
with IN O
type NN O
2 CD O
diabetes NN O
who WP O
have VBP O
been VBN O
on IN O
hemodialysis NN O
treatment NN O
for IN O
no DT O
more JJR O
than IN O
two CD O
years NNS O
. . O

-DOCSTART- X X O

This DT O
high JJ O
dose NN O
5-FU JJ O
+ JJ O
Act-D NNP O
protocol NN O
was VBD O
effective JJ O
for IN O
drug NN O
resistant JJ O
cases NNS O
with IN O
MEA NNP O
protocol NN O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
it PRP O
appears VBZ O
that IN O
GCN2 JJ B-NP
protein NN I-NP
kinase NN I-NP
function NN O
is VBZ O
stimulated VBN O
posttranslationally RB O
in IN O
amino DT O
acid-starved JJ O
cells NNS O
. . O

-DOCSTART- X X O

HIV-2 PRP$ O
in IN O
Spain NNP O
. . O

-DOCSTART- X X O

Reversal NN O
of IN O
mefloquine JJ O
resistance NN O
in IN O
rodent NN O
Plasmodium NN O
. . O

-DOCSTART- X X O

Airborne NNP O
rabies NNS O
encephalitis NN O
: : O
demonstration NN O
of IN O
rabies NNS O
virus NN O
in IN O
the DT O
human JJ O
central JJ O
nervous JJ O
system NN O
. . O

-DOCSTART- X X O

No DT O
promoter NN O
activity NN O
could MD O
be VB O
detected VBN O
with IN O
various JJ O
mouse NN B-NP
Fli-1 NN I-NP
promoter-CAT NN I-NP
constructs NNS O
containing VBG O
600 CD O
bp JJ O
of IN O
the DT O
5' JJ O
flanking NN O
region NN O
, , O
the DT O
complete JJ O
exon NN O
1 CD O
, , O
the DT O
5' JJ O
end NN O
of IN O
intron NN O
1 CD O
and/or CC O
retroviral JJ O
LTR NNP O
sequence NN O
. . O

-DOCSTART- X X O

We PRP O
now RB O
show VBP O
that IN O
the DT O
FRAP NNP B-NP
Ser2035-->Ala NNP O
mutant JJ O
displays NNS O
similar JJ O
binding JJ O
affinity NN O
when WRB O
compared VBN O
with IN O
the DT O
wild-type JJ O
protein NN O
, , O
whereas IN O
all DT O
other JJ O
mutations NNS O
at IN O
this DT O
site NN O
, , O
including VBG O
mimics NNS O
of IN O
phosphoserine NN O
, , O
abolish VB O
binding NN O
, , O
presumably RB O
due JJ O
to TO O
either DT O
unfavorable JJ O
steric JJ O
interactions NNS O
or CC O
induced VBN O
conformational JJ O
changes NNS O
. . O

-DOCSTART- X X O

This DT O
sequence NN O
can MD O
interact VB O
with IN O
at IN O
least JJS O
two CD O
proteins NNS O
in IN O
a DT O
fibroblast JJ O
nuclear JJ O
extract VB O
that WDT O
have VBP O
binding JJ O
characteristics NNS O
of IN O
an DT O
Ets NNP B-NP
family NN I-NP
protein NN I-NP
and CC O
a DT O
serum NN B-NP
response NN I-NP
factor-like JJ I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Response NN O
properties NNS O
of IN O
single JJ O
units NNS O
in IN O
the DT O
accessory JJ O
optic JJ O
system NN O
of IN O
the DT O
dark-reared JJ O
cat NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
tetracycline NN O
on IN O
the DT O
glycogen-producing NN O
function NN O
of IN O
the DT O
liver NN O
and CC O
intestinal JJ O
microflora NN O
in IN O
white JJ O
mice NNS O

-DOCSTART- X X O

However RB O
, , O
only RB O
plasma NN B-NP
fibrinogen NN I-NP
concentrations NNS O
showed VBD O
statistically RB O
significant JJ O
positive JJ O
associations NNS O
with IN O
IMT NNP O
in IN O
both DT O
groups NNS O
. . O

-DOCSTART- X X O

METHODS. . O

-DOCSTART- X X O

Presently RB O
, , O
we PRP O
made VBD O
chain NN O
pair NN O
switch NN O
, , O
chimeric JJ O
, , O
and CC O
site NN O
mutant JJ B-NP
gamma NN I-NP
delta NN I-NP
TCRs NNS I-NP
and CC O
transfected VBD O
them PRP O
into IN O
TCR- NNP O
mutant JJ O
Jurkat NNP O
T NNP O
cells NNS O
to TO O
examine VB O
the DT O
effects NNS O
of IN O
changing VBG O
the DT O
TCR NNP B-NP
gamma NN I-NP
junctional JJ I-NP
region NN I-NP
sequences NNS I-NP
on IN O
reactivity NN O
to TO O
prenyl VB B-NP
pyrophosphate JJ I-NP
Ags NNP I-NP
. . O

-DOCSTART- X X O

The DT O
molecular JJ O
dynamics NNS O
simulations NNS O
provide VBP O
insight NN O
into IN O
the DT O
conformational JJ O
flexibility NN O
of IN O
these DT O
analogs NNS O
. . O

-DOCSTART- X X O

Modified NNP O
Grocott NNP O
's POS O
methenamine NN O
silver NN O
nitrate NN O
method NN O
for IN O
quick JJ O
staining NN O
of IN O
Pneumocystis NNP O
carinii NN O
. . O

-DOCSTART- X X O

The DT O
control NN O
of IN O
human JJ B-NP
aromatase NN I-NP
expression NN O
is VBZ O
complex JJ O
in IN O
that DT O
several JJ O
promoters NNS O
drive VBP O
aromatase JJ B-NP
expression NN O
in IN O
a DT O
tissue-specific JJ O
manner NN O
. . O

-DOCSTART- X X O

To TO O
isolate VB O
genes NNS O
that WDT O
contain VBP O
zinc NNP O
finger NN O
motifs NNS O
, , O
a DT O
human JJ O
brain NN O
cDNA NN O
library NN O
was VBD O
screened VBN O
with IN O
an DT O
oligonucleotide JJ O
complementary NN O
to TO O
the DT O
conserved JJ O
"linker NN O
" '' O
sequence NN O
between IN O
adjacent JJ O
zinc NN O
fingers NNS O
. . O

-DOCSTART- X X O

Transforming VBG B-NP
growth NN I-NP
factor NN I-NP
beta NN I-NP
activates VBZ O
the DT O
promoter NN O
of IN O
cyclin-dependent JJ B-NP
kinase NN I-NP
inhibitor NN O
p15INK4B NN B-NP
through IN O
an DT O
Sp1 NNP B-NP
consensus NN I-NP
site NN I-NP
. . O

-DOCSTART- X X O

Sociological JJ O
analysis NN O
of IN O
the DT O
family NN O
. . O

-DOCSTART- X X O

Like IN O
other JJ O
known VBN O
GCD NNP B-NP
genes NNS I-NP
, , O
GCD14 NNP B-NP
and CC O
GCD15 NNP B-NP
are VBP O
therefore RB O
probably RB O
required VBN O
for IN O
general JJ O
translation NN O
initiation NN O
in IN O
addition NN O
to TO O
their PRP$ O
roles NNS O
in IN O
GCN4-specific JJ B-NP
translational JJ O
control NN O
. . O

-DOCSTART- X X O

Sorting VBG O
information NN O
to TO O
the DT O
chloroplastic JJ O
inner JJ O
envelope NN O
is VBZ O
contained VBN O
in IN O
an DT O
NH2-proximal JJ O
part NN O
of IN O
mature JJ B-NP
IEP110 CC I-NP
( -LRB- O
110N) CD B-NP
. . O

-DOCSTART- X X O

Both DT O
algorithms NNS O
have VBP O
been VBN O
implemented VBN O
and CC O
applied VBN O
to TO O
data NNS O
simulated VBN O
for IN O
a DT O
scanner NN O
with IN O
a DT O
large JJ O
axial NN O
aperture NN O
( -LRB- O
30 CD O
degrees NNS O
) -RRB- O
, , O
and CC O
also RB O
to TO O
data NNS O
acquired VBN O
with IN O
the DT O
ECAT NNP O
HR NNP O
and CC O
the DT O
ECAT NNP O
HR+ NNP O
scanners NNS O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Murine NNP B-NP
Nramp NNP I-NP
is VBZ O
a DT O
candidate NN O
for IN O
the DT O
macrophage NN O
resistance NN O
gene NN O
Ity/Lsh/Bcg NNP B-NP
. . O

-DOCSTART- X X O

Pregnancy NNP O
was VBD O
ensued VBN O
in IN O
4 CD O
cases NNS O
in IN O
group NN O
I. NN O

-DOCSTART- X X O

Western JJ O
immunoblot NN O
analysis NN O
detected VBN O
p55gag NN B-NP
and CC O
its PRP$ O
cleavage JJ O
products NNS O
p39 VBP B-NP
and CC O
p27 VBP B-NP
in IN O
purified VBN O
particles NNS O
derived VBN O
by IN O
expression NN O
of IN O
gag NN B-NP
and CC O
gag-pol NN B-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

These DT O
three CD O
phases NNS O
of IN O
cyclin NN B-NP
E NNP I-NP
association NN O
with IN O
chromatin NN O
may MD O
facilitate VB O
the DT O
diverse JJ O
activities NNS O
of IN O
cyclin NN B-NP
E--Cdk2 NNP I-NP
in IN O
initiating VBG O
replication NN O
, , O
blocking VBG O
rereplication NN O
, , O
and CC O
allowing VBG O
resetting NN O
of IN O
origins NNS O
after IN O
mitosis NN O
. . O

-DOCSTART- X X O

It PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
renin NN B-NP
secretion NN O
is VBZ O
stimulated VBN O
by IN O
endothelin NN B-NP
, , O
a DT O
recently RB O
discovered VBN O
peptide NN O
with IN O
strong JJ O
vasoconstrictive JJ O
properties NNS O
and CC O
stimulating JJ O
effects NNS O
on IN O
renin NN B-NP
secretion NN O
. . O

-DOCSTART- X X O

A DT O
higher JJR O
percentage NN O
of IN O
children NNS O
with IN O
cerebral JJ O
malaria NN O
( -LRB- O
40 CD O
per IN O
cent NN O
) -RRB- O
than IN O
with IN O
non-cerebral JJ O
malaria NN O
( -LRB- O
29 CD O
per IN O
cent NN O
) -RRB- O
or CC O
controls NNS O
( -LRB- O
20 CD O
per IN O
cent NN O
) -RRB- O
also RB O
had VBD O
either DT O
serum NN B-NP
ferritin NN I-NP
< IN O
100 CD O
micrograms/l NN O
and CC O
inflammation NN O
or CC O
sTfR NN B-NP
> RB O
7.3 CD O
mg/l NN O
or CC O
both DT O
. . O

-DOCSTART- X X O

Patients NNS O
received VBD O
BPB NNP O
using VBG O
bupivacaine NN O
2 CD O
mg NN O
kg-1 NN O
with IN O
adrenaline NN O
1 CD O
in IN O
200,000 CD O
, , O
either CC O
with IN O
or CC O
without IN O
hyaluronidase NN B-NP
3000 CD O
iu NN O
, , O
in IN O
a DT O
volume NN O
of IN O
0.5 CD O
ml NN O
per IN O
2.54 CD O
cm NN O
of IN O
the DT O
patient NN O
's POS O
height NN O
. . O

-DOCSTART- X X O

The DT O
rifampicin JJ O
resistance NN O
of IN O
uvsW-repressed JJ B-NP
replication NN O
suggests VBZ O
that IN O
it PRP O
involves VBZ O
either RB O
tertiary JJ O
initiation NN O
or CC O
some DT O
novel JJ O
mode NN O
of IN O
initiation NN O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
proteolipids NNS O
of IN O
the DT O
vacuolar JJ B-NP
H+-ATPases NNS I-NP
were VBD O
evolved VBN O
in IN O
parallel JJ O
with IN O
the DT O
eubacterial JJ O
proteolipid NN O
, , O
from IN O
a DT O
common JJ O
ancestral JJ O
gene NN O
that WDT O
underwent VBD O
gene NN O
duplication NN O
. . O

-DOCSTART- X X O

Coexpression NNP O
of IN O
c-Rel JJ B-NP
in IN O
combination NN O
with IN O
ATF-1 NNP B-NP
, , O
CREB2 NNP B-NP
, , O
or CC O
ATF-1/CREB2 DT B-NP
leads VBZ O
to TO O
synergistic JJ O
transactivation NN O
of IN O
a DT O
CD28RE-TRE JJ B-NP
reporter NN I-NP
plasmid NN O
in IN O
quiescent JJ O
Jurkat NNP O
T-cells NNS O
. . O

-DOCSTART- X X O

Characterization NNP O
of IN O
a DT O
cDNA NN B-NP
encoding NN I-NP
CNN NNP I-NP
predicts VBZ O
a DT O
novel JJ O
structural JJ O
protein NN O
with IN O
three CD O
leucine NN O
zipper NN O
motifs NNS O
and CC O
several JJ O
coiled-coil NN O
domains NNS O
exhibiting VBG O
limited JJ O
homology NN O
to TO O
the DT O
rod NN O
portion NN O
of IN O
myosin NN B-NP
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
suggested VBN O
that IN O
the DT O
loss NN O
of IN O
weight NN O
, , O
the DT O
decrease NN O
in IN O
food NN O
intake NN O
and CC O
the DT O
increase NN O
in IN O
brain NN O
MOPEG-SO4 CC O
induced VBN O
by IN O
cyanamide NN O
reflect VBP O
possible JJ O
anorectic NN O
properties NNS O
of IN O
the DT O
drug NN O
. . O

-DOCSTART- X X O

The DT O
differential JJ O
diagnosis NN O
of IN O
mineral NN O
oil NN O
lipidosis NN O
in IN O
lymph NN O
nodes NNS O
with IN O
reaction NN O
to TO O
radiopaque NN O
oils NNS O
and CC O
Whipple NNP O
's POS O
disease NN O
is VBZ O
discussed VBN O
. . O

-DOCSTART- X X O

The DT O
serum NN O
levels NNS O
of IN O
cortisol NN O
and CC O
prolactin NN B-NP
after IN O
nasal JJ O
instillation NN O
of IN O
a DT O
suspension NN O
of IN O
vaginal JJ O
exudate NN O
showed VBD O
lower JJR O
values NNS O
than IN O
in IN O
control NN O
conditions NNS O
( -LRB- O
nasal JJ O
instillation NN O
of IN O
saline NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
data NNS O
when WRB O
used VBN O
to TO O
stimulate VB O
the DT O
collection NN O
of IN O
the DT O
information NN O
at IN O
antenatal JJ O
or CC O
postnatal JJ O
visits NNS O
, , O
nonetheless RB O
provide VBP O
an DT O
accurate JJ O
description NN O
of IN O
under-3 JJ O
mortality NN O
trends NNS O
and CC O
differences NNS O
for IN O
the DT O
two CD O
periods NNS O
examined--before DT O
1984 CD O
and CC O
before IN O
1989 CD O
. . O

-DOCSTART- X X O

The DT O
BHV-1 JJ B-NP
UL24 NNP I-NP
, , O
UL25 NNP B-NP
, , O
UL26 NNP B-NP
and CC O
UL26.5 DT B-NP
transcripts NNS I-NP
all DT O
terminated VBN O
at IN O
a DT O
common JJ O
3'-polyadenylation NN O
site NN O
and CC O
varied JJ O
significantly RB O
in IN O
their PRP$ O
relative JJ O
abundance NN O
. . O

-DOCSTART- X X O

A. NN O

-DOCSTART- X X O

Ligand NNP O
binding NN O
of IN O
multi-chain JJ O
antigen JJ O
receptors NNS O
and CC O
hematopoietin/cytokine NN B-NP
receptors NNS O
results NNS O
in IN O
rapid JJ O
activation NN O
of IN O
protein NN B-NP
tyrosine NN I-NP
kinase NN I-NP
( -LRB- O
PTK)-dependent JJ B-NP
signalling NN O
molecules NNS O
such JJ O
as IN O
phosphatidylinositol NN B-NP
3-kinase JJ I-NP
( -LRB- O
PI JJ B-NP
3-kinase NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

Post-CPB NNP O
cardiac NN O
index NN O
was VBD O
superior JJ O
in IN O
group NN O
B NNP O
( -LRB- O
3.9+/-0.3 NN O
vs. FW O

-DOCSTART- X X O

The DT O
regulatory JJ O
genes NNS O
cnrYXH WDT B-NP
have VBP O
been VBN O
cloned VBN O
, , O
overexpressed VBN O
, , O
and CC O
purified VBN O
in IN O
Escherichia NNP O
coli NNS O
. . O

-DOCSTART- X X O

The DT O
objectives NNS O
of IN O
this DT O
study NN O
were VBD O
1 CD O
) -RRB- O
to TO O
quantify VB O
the DT O
comparative JJ O
structural JJ O
static JJ O
and CC O
fatigue NN O
properties NNS O
of IN O
the DT O
pointe NN O
shoe NN O
toe NN O
box NN O
, , O
and CC O
2 CD O
) -RRB- O
to TO O
evaluate VB O
the DT O
preferred VBN O
shoe NN O
characteristics NNS O
as IN O
determined VBN O
by IN O
a DT O
survey NN O
of IN O
local JJ O
dancers NNS O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
on IN O
a DT O
case NN O
of IN O
a DT O
43-old-male JJ O
with IN O
a DT O
bronchogenic JJ O
cyst NN O
in IN O
the DT O
distal JJ O
esophagus NN O
, , O
which WDT O
was VBD O
misdiagnosed VBN O
as IN O
a DT O
malignant JJ O
esophageal JJ O
tumor NN O
based VBN O
on IN O
preoperative JJ O
imaging NN O
and CC O
high JJ O
levels NNS O
of IN O
the DT O
tumor NN O
markers NNS O
CA NNP B-NP
19-9 CD I-NP
and CC O
CA NNP B-NP
125. . I-NP

-DOCSTART- X X O

Oscillatory NNP O
flow NN O
is VBZ O
reestablished VBN O
in IN O
the DT O
model NN O
at IN O
the DT O
capillary-cerebrospinal JJ O
fluid NN O
and CC O
capillary-venous JJ O
interfaces NNS O
. . O

-DOCSTART- X X O

Human JJ B-NP
and CC I-NP
murine JJ I-NP
cytotoxic JJ I-NP
T NNP I-NP
lymphocyte NN I-NP
serine NN I-NP
proteases NNS I-NP
: : O
subsite JJ O
mapping NN O
with IN O
peptide NN O
thioester NN O
substrates NNS O
and CC O
inhibition NN O
of IN O
enzyme NN O
activity NN O
and CC O
cytolysis NN O
by IN O
isocoumarins NNS O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
the DT O
human JJ B-NP
stress NN I-NP
response NN I-NP
gene NN I-NP
GADD153 JJ I-NP
expression NN O
: : O
role NN O
of IN O
ETS1 NNP B-NP
and CC O
FLI-1 JJ B-NP
gene NN I-NP
products NNS I-NP
. . O

-DOCSTART- X X O

Each DT O
receptor NN O
must MD O
therefore RB O
engage VB O
a DT O
unique JJ O
subset NN O
of IN O
the DT O
available JJ O
signaling VBG O
elements--at JJ O
least JJS O
partly RB O
through IN O
the DT O
selection NN O
of IN O
proteins NNS O
with IN O
src-homology NN B-NP
2 CD I-NP
domains VBZ I-NP
( -LRB- O
SH2 JJ B-NP
proteins NNS I-NP
) -RRB- O
. . O

-DOCSTART- X X O

NSAIDS NNP O
and CC O
the DT O
microcirculation NN O
of IN O
the DT O
stomach NN O
. . O

-DOCSTART- X X O

Highly NNP O
significant JJ O
similarities NNS O
were VBD O
detected VBN O
between IN O
the DT O
N-terminal JJ O
region NN O
of IN O
P30 CD B-NP
and CC O
those DT O
of IN O
GENA NNP B-NP
[the NNP O
product NN O
of IN O
another DT O
unidentified JJ O
gene NN O
( -LRB- O
geneA NN B-NP
) -RRB- O
located VBN O
upstream RB O
of IN O
the DT O
aceEF-lpd JJ B-NP
operon] NN O
, , O
and CC O
GNTR NNP B-NP
( -LRB- O
a DT O
putative JJ O
transcriptional JJ O
repressor NN O
of IN O
the DT O
gluconate JJ B-NP
operon NN I-NP
of IN O
Bacillus JJ O
subtilis NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Promoting VBG O
fat JJ O
utilisation NN O
by IN O
reducing VBG O
the DT O
carbohydrate-fat JJ O
ratio NN O
of IN O
the DT O
TPN NNP O
reduces VBZ O
free JJ O
radical JJ O
activity NN O
to TO O
a DT O
similar JJ O
extent NN O
as IN O
fat JJ O
exclusion NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
postulated VBN O
that IN O
the DT O
synthesis NN O
of IN O
the DT O
peptidoglycan NN O
layer NN O
was VBD O
affected VBN O
by IN O
the DT O
antimetabolites NNS O
since IN O
the DT O
morphological JJ O
effects NNS O
were VBD O
strikingly RB O
similar JJ O
to TO O
those DT O
caused VBN O
by IN O
treatment NN O
of IN O
E. NNP O
cloacae NNS O
with IN O
disodium NN O
edetate NN O
plus CC O
lysozyme NN B-NP
. . O

-DOCSTART- X X O

The DT O
selective JJ O
5-HT2 NN B-NP
receptor NN I-NP
blocker NN O
ketanserin NN O
was VBD O
found VBN O
to TO O
reduce VB O
maximal JJ O
urethral JJ O
pressures NNS O
in IN O
healthy JJ O
females NNS O
by IN O
about IN O
40 CD O
% NN O
without IN O
reducing VBG O
blood NN O
pressure NN O
. . O

-DOCSTART- X X O

Finally RB O
, , O
the DT O
conservation NN O
of IN O
the DT O
two CD O
residues NNS O
most RBS O
sensitive JJ O
to TO O
mutations NNS O
( -LRB- O
Y949 CD O
and CC O
Y953 CD O
) -RRB- O
in IN O
TM11 NNP O
, , O
and CC O
in IN O
the DT O
homologous JJ O
TM5 CD O
, , O
of IN O
all DT O
mammalian JJ B-NP
P-gps NNS I-NP
and CC O
also RB O
in IN O
other JJ O
ABC NNP B-NP
transporters NNS I-NP
, , O
suggests VBZ O
that IN O
these DT O
residues NNS O
and CC O
domains NNS O
may MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
structural JJ O
as RB O
well RB O
as IN O
mechanistic JJ O
aspects NNS O
common JJ O
to TO O
this DT O
family NN O
of IN O
proteins NNS O
. . O

-DOCSTART- X X O

SF1/mBBP NNP B-NP
utilizes VBZ O
a DT O
"maxi-K JJ B-NP
homology NN I-NP
" '' I-NP
( -LRB- O
maxi-KH) JJ B-NP
domain NN O
for IN O
recognition NN O
of IN O
the DT O
single-stranded JJ O
BPS NNP O
and CC O
requires VBZ O
a DT O
cooperative JJ O
interaction NN O
with IN O
splicing NN O
factor NN O
U2AF65 IN B-NP
bound VBN O
to TO O
an DT O
adjacent JJ O
polypyrimidine NN O
tract NN O
( -LRB- O
PPT NNP O
) -RRB- O
for IN O
high-affinity NN O
binding NN O
. . O

-DOCSTART- X X O

The DT O
in IN O
vivo JJ O
response NN O
of IN O
the DT O
PacC-like NNP B-NP
decamers NNS I-NP
to TO O
external JJ O
pH NNS O
was VBD O
dependent JJ O
on IN O
the DT O
status NN O
of IN O
the DT O
pH-regulated JJ O
activator NN O
YlRim101p NN B-NP
, , O
which WDT O
is VBZ O
homologous JJ O
to TO O
the DT O
A. NN O
nidulans VBZ O
PacC NNP B-NP
regulator NN O
. . O

-DOCSTART- X X O

Spongiosa NNP O
regeneration NN O
in IN O
the DT O
millipore JJ O
chamber NN O

-DOCSTART- X X O

MTX NNP O
therapy NN O
decreased VBD O
Ga-67 DT O
uptake NN O
in IN O
liver NN O
, , O
tumor NN O
, , O
and CC O
muscle NN O
. . O

-DOCSTART- X X O

No DT O
transactivation NN O
of IN O
the DT O
ovalbumin NN B-NP
promoter NN I-NP
(pLovTATA NNP O
) -RRB- O
template JJ O
control NN O
was VBD O
observed VBN O
. . O

-DOCSTART- X X O

Removal NNP O
of IN O
cyclin-dependant JJ B-NP
kinases NNS I-NP
( -LRB- O
cdks NNS B-NP
) -RRB- O
or CC O
cdk2 CD B-NP
from IN O
these DT O
extracts NNS O
using VBG O
affinity NN O
matrices NNS O
severely RB O
inhibits VBZ O
initiation NN O
of IN O
S NNP O
phase NN O
. . O

-DOCSTART- X X O

Consistent NN O
with IN O
this DT O
hypothesis NN O
, , O
stimulation NN O
of IN O
A(2A)-R JJ B-NP
or CC O
PKA NNP B-NP
enhanced JJ O
nuclear JJ B-NP
aPKC NN I-NP
activity NN O
. . O

-DOCSTART- X X O

JCAHO NNP O
to TO O
use VB O
ORYX NNP O
data NNS O
to TO O
detect VB O
sentinel NN O
events NNS O
. . O

-DOCSTART- X X O

Comparisons NNS O
of IN O
the DT O
efficacy NN O
of IN O
benazepril NN O
and CC O
hydrochlorothiazide NN O
alone RB O
and CC O
in IN O
combination NN O
have VBP O
shown VBN O
that IN O
benazepril JJ O
20 CD O
mg NN O
once RB O
daily RB O
is VBZ O
as RB O
effective JJ O
as IN O
or CC O
more RBR O
effective JJ O
in IN O
lowering VBG O
diastolic JJ O
blood NN O
pressure NN O
than IN O
hydrochlorothiazide JJ O
25 CD O
mg NN O
once RB O
daily RB O
and CC O
that IN O
the DT O
combination NN O
of IN O
benazepril JJ O
20 CD O
mg NN O
and CC O
hydrochlorothiazide JJ O
25 CD O
mg NN O
has VBZ O
a DT O
possibly RB O
synergistic JJ O
effect NN O
on IN O
diastolic JJ O
blood NN O
pressure NN O
. . O

-DOCSTART- X X O

Carcinoma-related JJ B-NP
protein NN I-NP
production NN O
may MD O
have VB O
played VBN O
a DT O
role NN O
in IN O
the DT O
development NN O
of IN O
the DT O
observed JJ O
renal JJ O
lesions NNS O
. . O

-DOCSTART- X X O

Single NNP O
amino IN O
acid NN O
substitutions NNS O
were VBD O
shown VBN O
to TO O
result VB O
from IN O
the DT O
mutations NNS O
pdr1-2 NN B-NP
( -LRB- O
M308I NNP O
) -RRB- O
, , O
pdr1-3 FW B-NP
( -LRB- O
F815S) NN O
, , O
pdr1-6 NN B-NP
( -LRB- O
K302Q NN O
) -RRB- O
, , O
pdr1-7 FW B-NP
( -LRB- O
P298A NN O
) -RRB- O
and CC O
pdr1-8 DT B-NP
( -LRB- O
L1036 NNP O
W) NNP O
, , O
whereas IN O
the DT O
intragenic JJ O
suppressor NN O
mutant NN O
pdr1-100 . B-NP
is VBZ O
deleted VBN O
for IN O
the DT O
two CD O
amino IN O
acids NNS O
L537 . O
and CC O
A538. VBG O

-DOCSTART- X X O

However RB O
, , O
no DT O
statistical JJ O
difference NN O
in IN O
the DT O
Ca/P NNP O
ratio NN O
, , O
carbon NN O
concentration NN O
and CC O
surface NN O
energy NN O
were VBD O
observed VBN O
with IN O
different JJ O
heat NN O
treatments NNS O
. . O

-DOCSTART- X X O

These DT O
motions NNS O
were VBD O
found VBN O
in IN O
the DT O
N- NNP O
and CC O
C- NNP O
terminal NN O
tails NNS O
, , O
in IN O
segment NN O
33-35 CD O
which WDT O
forms VBZ O
the DT O
turn NN O
between IN O
beta-strands NNS O
S1 NNP O
and CC O
S2 NNP O
, , O
and CC O
residues NNS O
47-52 CD O
located VBN O
in IN O
a DT O
long JJ O
loop NN O
preceding VBG O
strand JJ O
S3 NNS O
. . O

-DOCSTART- X X O

Enterobius NNP O
vermicularis NN O
eggs NNS O
were VBD O
demonstrated VBN O
during IN O
microscopic JJ O
examination NN O
of IN O
a DT O
smear NN O
taken VBN O
from IN O
the DT O
posterior JJ O
fornix NN O
of IN O
the DT O
vagina NN O
. . O

-DOCSTART- X X O

Differentiation NN O
of IN O
porcine NN O
mycoplasma NN O
strains NNS O
by IN O
means NNS O
of IN O
a DT O
simple JJ O
paper NN O
chromatography NN O
test NN O
. . O

-DOCSTART- X X O

D. NNP O
, , O
Hughes NNP O
, , O
F. NNP O

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
AEBP2 NNP B-NP
cDNA NNS I-NP
revealed VBD O
that IN O
it PRP O
encodes VBZ O
a DT O
protein NN O
containing VBG O
three CD O
Gli-Kruppel JJ B-NP
( -LRB- O
Cys2-His2)-type JJ O
zinc NN O
fingers NNS O
. . O

-DOCSTART- X X O

To TO O
elucidate VB O
the DT O
mechanism NN O
of IN O
these DT O
hormonal JJ O
effects NNS O
, , O
we PRP O
have VBP O
studied VBN O
the DT O
regulatory JJ O
regions NNS O
of IN O
the DT O
PFK-2 JJ B-NP
gene NN I-NP
in IN O
transfection NN O
experiments NNS O
. . O

-DOCSTART- X X O

Tryptophan NNP O
induction NN O
prevents VBZ O
Rho-dependent JJ B-NP
transcription NN O
termination NN O
in IN O
the DT O
leader NN O
region NN O
of IN O
the DT O
operon NN O
. . O

-DOCSTART- X X O

An DT O
in IN O
vitro NN O
Raf-1 NNP B-NP
kinase NN I-NP
assay NN O
, , O
however RB O
, , O
failed VBD O
to TO O
detect VB O
LPS-induced JJ O
Raf-1 NNP B-NP
kinase NN I-NP
activity NN O
in IN O
RAW NNP O
264.7 CD O
cells NNS O
, , O
suggesting VBG O
that IN O
in IN O
RAW NNP O
264.7 CD O
cells NNS O
, , O
Raf-1 NNP B-NP
kinase NN I-NP
is VBZ O
not RB O
an DT O
activating JJ O
component NN O
of IN O
the DT O
LPS NNP O
signaling VBG O
pathway NN O
regulating VBG O
MAPK NNP B-NP
activity NN O
or CC O
sIL-1Ra JJ B-NP
promoter NN I-NP
activity NN O
. . O

-DOCSTART- X X O

Our PRP$ O
Northern NNP O
and CC O
Southern NNP O
blot NN O
analyses NNS O
of IN O
meningiomas NNS O
clearly RB O
suggest VBP O
the DT O
CLH-22 NN B-NP
gene NN I-NP
may MD O
be VB O
involved VBN O
in IN O
the DT O
tumor NN O
development NN O
and CC O
can MD O
be VB O
considered VBN O
as IN O
a DT O
candidate NN O
for IN O
a DT O
tumor NN O
suppressor NN O
. . O

-DOCSTART- X X O

The DT O
difference NN O
between IN O
the DT O
results NNS O
in IN O
the DT O
high JJ O
dose NN O
AHLG NNP B-NP
and CC O
in IN O
the DT O
control NN O
group NN O
was VBD O
significant JJ O
( -LRB- O
p NN O
less JJR O
than IN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
stress/BHV-1 NN O
model NN O
resulted VBD O
in IN O
a DT O
mild JJ O
respiratory NN O
infection NN O
in IN O
all DT O
calves NNS O
with IN O
no DT O
difference NN O
observed VBD O
between IN O
treatment NN O
groups NNS O
. . O

-DOCSTART- X X O

The DT O
pepI NN B-NP
gene NN I-NP
was VBD O
overexpressed VBN O
in IN O
Escherichia NNP O
coli NNS O
. . O

-DOCSTART- X X O

Deep NNP O
bite NN O
CL NN O
II NNP O
Div. . O

-DOCSTART- X X O

Negative JJ O
modulation NN O
of IN O
alpha1( NN B-NP
I PRP I-NP
) -RRB- I-NP
procollagen NN I-NP
gene NN I-NP
expression NN O
in IN O
human JJ O
skin NN O
fibroblasts NNS O
: : O
transcriptional JJ O
inhibition NN O
by IN O
interferon-gamma NN B-NP
. . O

-DOCSTART- X X O

In IN O
summary NN O
, , O
FGFR3 IN B-NP
signaling VBG O
pathway NN O
utilizes VBZ O
two CD O
GRB2-containing JJ B-NP
complexes NNS I-NP
; : O
Shc.GRB2.Sos NNP B-NP
and CC O
80K-H.pp66.GRB2.Sos JJ B-NP
; : O
these DT O
two CD O
complexes NNS O
may MD O
alternatively RB O
link VB O
FGFG3 PRP B-NP
to TO O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

STUDY NNP O
DESIGN NNP O
: : O
Retrospective JJ O
review NN O
. . O

-DOCSTART- X X O

One CD O
had VBD O
a DT O
48-hour JJ O
cycle NN O
and CC O
the DT O
other JJ O
a DT O
24-hour JJ O
cycle NN O
. . O

-DOCSTART- X X O

1 CD O
The DT O
effects NNS O
of IN O
high JJ O
doses NNS O
of IN O
piretanide NN O
, , O
a DT O
new JJ O
diuretic JJ O
agent NN O
chemically RB O
related VBN O
to TO O
frusemide VB O
and CC O
bumetanide VB O
were VBD O
evaluated VBN O
in IN O
twelve CD O
patients NNS O
with IN O
severe JJ O
chronic NN O
renal NN O
insufficiency NN O
( -LRB- O
creatinine CD O
clearance NN O
below IN O
25 CD O
ml/min NN O
) -RRB- O
. . O

-DOCSTART- X X O

S1 NNP B-NP
nuclease NN I-NP
protection NN O
mapping NN O
and CC O
primer JJ O
extension NN O
analysis NN O
allowed VBN O
us PRP O
to TO O
propose VB O
that IN O
the DT O
A NNP O
residue NN O
located VBN O
19 CD O
bp NN O
upstream RB O
from IN O
the DT O
translation NN O
initiation NN O
codon NN O
is VBZ O
the DT O
site NN O
of IN O
transcription NN O
initiation NN O
. . O

-DOCSTART- X X O

Various JJ O
stimuli NNS O
inactivate JJ O
IkappaB NNP B-NP
alpha NN I-NP
by IN O
triggering VBG O
phosphorylation NN O
of IN O
the DT O
N-terminal JJ O
residues NNS O
Ser32 . O
and CC O
Ser36 PRP O
. . O

-DOCSTART- X X O

A DT O
mouse NN O
brain NN O
cDNA NN O
library NN O
in IN O
lambdagt11 NN O
was VBD O
screened VBN O
for IN O
this DT O
association NN O
, , O
and CC O
two CD O
positive JJ O
clones NNS O
encoding VBG O
tyrosine FW B-NP
phosphatase NN I-NP
SH-PTP2 . B-NP
were VBD O
isolated VBN O
. . O

-DOCSTART- X X O

Intensive JJ O
therapy NN O
of IN O
viral JJ O
hepatitis NN O

-DOCSTART- X X O

Adjusting VBG O
a DT O
steady-state NN O
warfarin NN O
dose NN O
depends VBZ O
on IN O
the DT O
measured VBN O
INR NN O
values NNS O
and CC O
clinical JJ O
factors NNS O
: : O
the DT O
dose NN O
does VBZ O
not RB O
need VB O
to TO O
be VB O
adjusted VBN O
for IN O
a DT O
single JJ O
INR NN O
that WDT O
is VBZ O
slightly RB O
out IN O
of IN O
range NN O
, , O
and CC O
most RBS O
changes NNS O
should MD O
alter VB O
the DT O
total JJ O
weekly JJ O
dose NN O
by IN O
5 CD O
% NN O
to TO O
20 CD O
% NN O
. . O

-DOCSTART- X X O

Successful JJ O
resolution NN O
of IN O
progressive JJ O
multifocal JJ O
leukoencephalopathy NN O
after IN O
combination NN O
therapy NN O
with IN O
cidofovir NN O
and CC O
cytosine NN O
arabinoside NN O
. . O

-DOCSTART- X X O

FTF NNP O
( -LRB- O
Joint NNP O
Council NNP O
of IN O
Civil NNP O
Servants NNPS O
and CC O
Functionaries NNP O
) -RRB- O
: : O
clarification NN O
about IN O
membership NN O
in IN O
the DT O
main JJ O
organizations NNS O

-DOCSTART- X X O

The DT O
differences NNS O
in IN O
binding NN O
( -LRB- O
Kdapp NNP O
) -RRB- O
, , O
incorporation NN O
, , O
and CC O
extension NN O
kinetics NNS O
of IN O
8-oxo-dGTP JJ O
compared VBN O
to TO O
normal JJ O
dNTP NN O
incorporation NN O
at IN O
template JJ O
8-oxo-G JJ O
adducts NNS O
indicate VBP O
that IN O
polymerase NN O
fidelity NN O
does VBZ O
not RB O
depend VB O
solely RB O
upon IN O
the DT O
overall JJ O
geometry NN O
of IN O
Watson-Crick NNP O
base NN O
pairs NNS O
and CC O
reflects VBZ O
the DT O
asymmetry NN O
of IN O
the DT O
enzyme JJ O
active JJ O
site NN O
. . O

-DOCSTART- X X O

Retroviral NNP O
vector NN O
producer NN O
cell NN O
populations NNS O
and CC O
cell NN O
clones NNS O
were VBD O
established VBN O
for IN O
each DT O
chLTR NN B-NP
vector NN O
, , O
and CC O
all DT O
were VBD O
capable JJ O
of IN O
yielding VBG O
high JJ O
vector NN O
titers NNS O
( -LRB- O
> JJ O
10(5 CD O
) -RRB- O
G418R DT B-NP
cfu/ml NN O
on IN O
NIH-3T3 NNP O
) -RRB- O
. . O

-DOCSTART- X X O

None NN O
of IN O
these DT O
patients NNS O
developed VBD O
clinical JJ O
events NNS O
before IN O
disappearance NN O
of IN O
the DT O
phospholipid-dependent JJ O
inhibitors NNS O
of IN O
coagulation NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
not RB O
well RB O
known VBN O
that IN O
giant JJ O
cell NN O
arteritis NN O
can MD O
cause VB O
fatal JJ O
complications NNS O
due JJ O
to TO O
rupture NN O
of IN O
aortic JJ O
aneurysms NNS O
or CC O
cerebral JJ O
and CC O
myocardial JJ O
infarctions NNS O
. . O

-DOCSTART- X X O

Temporal NNP O
recruitment NN O
of IN O
the DT O
mSin3A-histone NN B-NP
deacetylase NN B-NP
corepressor NN O
complex NN O
to TO O
the DT O
ETS NNP B-NP
domain NN I-NP
transcription NN I-NP
factor NN I-NP
Elk-1 NNP B-NP
. . O

-DOCSTART- X X O

By IN O
screening VBG O
a DT O
human JJ O
testis NN O
cDNA NN O
library NN O
with IN O
a DT O
probe NN O
containing VBG O
the DT O
mouse NN B-NP
PEA3 NN I-NP
ETS NNP B-NP
domain NN O
, , O
we PRP O
isolated VBD O
a DT O
2.2 CD O
kb NN O
clone NN O
containing VBG O
a DT O
510 CD O
AA NNP O
open JJ O
reading NN O
frame NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
also RB O
affected VBN O
by IN O
the DT O
HAP2/3/4 NNP B-NP
transcription NN I-NP
factor NN I-NP
complex NN I-NP
and CC O
by IN O
SNF1 NNP B-NP
and CC O
SSN6 NNP B-NP
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
H-2RIIBP NNP B-NP
( -LRB- O
i NN O
) -RRB- O
is VBZ O
a DT O
member NN O
of IN O
the DT O
superfamily NN O
of IN O
nuclear JJ B-NP
hormone NN I-NP
receptors NNS I-NP
and CC O
( -LRB- O
ii NNS O
) -RRB- O
may MD O
regulate VB O
not RB O
only RB O
MHC JJ B-NP
class NN I-NP
I PRP I-NP
genes NNS I-NP
but CC O
also RB O
genes NNS O
containing VBG O
the DT O
ERE NNP O
and CC O
related VBN O
sequences NNS O
. . O

-DOCSTART- X X O

The DT O
occurrence NN O
of IN O
the DT O
different JJ O
types NNS O
of IN O
TCRB NNP B-NP
rearrangement NN O
patterns NNS O
has VBZ O
implications NNS O
for IN O
PCR-based JJ O
clonality NN O
assessment NN O
and CC O
for IN O
PCR-based JJ O
detection NN O
of IN O
minimal JJ O
residual JJ O
disease NN O
via IN O
TCRB NNP B-NP
gene NN I-NP
analysis NN O
. . O

-DOCSTART- X X O

Directional JJ O
growth NN O
of IN O
a DT O
smectic-A-smectic-B NN O
interface NN O
lying VBG O
along IN O
a DT O
forbidden VBN O
orientation NN O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
We PRP O
performed VBD O
nasal JJ O
mupirocin NN O
treatment NN O
on IN O
10 CD O
infants NNS O
who WP O
were VBD O
MRSA-positive JJ O
either CC O
in IN O
the DT O
nose NN O
or CC O
the DT O
pharynx NN O
and CC O
evaluated VBD O
the DT O
effect NN O
of IN O
mupirocin NN O
on IN O
the DT O
eradication NN O
of IN O
MRSA NNP O
. . O

-DOCSTART- X X O

TOM1 PRP B-NP
encodes VBZ O
a DT O
member NN O
of IN O
the DT O
hect-domain-containing JJ B-NP
E3 NNP B-NP
ubiquitin-protein NNP B-NP
ligase NN I-NP
family NN O
that WDT O
is VBZ O
required VBN O
for IN O
growth NN O
at IN O
elevated JJ O
temperatures NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
demonstrate VBP O
that IN O
m2 CD B-NP
receptors NNS I-NP
couple NN O
to TO O
both DT O
G NNP B-NP
alpha NN I-NP
i2 NN I-NP
and CC O
G NNP B-NP
alpha NN I-NP
i3 NN I-NP
in IN O
vivo JJ O
and CC O
that IN O
this DT O
interaction NN O
is VBZ O
integral JJ O
to TO O
both DT O
positive JJ O
and CC O
negative JJ O
regulatory JJ O
pathways NNS O
leading VBG O
to TO O
activation NN O
of IN O
PLC NNP B-NP
and CC O
desensitization NN O
of IN O
receptor NN O
signaling NN O
. . O

-DOCSTART- X X O

The DT O
cholesterol NN B-NP
7alpha-hydroxylase JJ I-NP
gene NN I-NP
( -LRB- O
CYP7A NNP B-NP
) -RRB- O
is VBZ O
transcriptionally RB O
regulated VBN O
by IN O
a DT O
number NN O
of IN O
factors NNS O
, , O
including VBG O
hormones NNS O
, , O
bile NN O
acids NNS O
, , O
and CC O
diurnal JJ O
rhythm NN O
. . O

-DOCSTART- X X O

Restriction NN O
mapping NN O
showed VBD O
that IN O
the DT O
two CD O
recombinant JJ O
plasmids NNS O
shared VBD O
an DT O
EcoRI JJ B-NP
fragment NN I-NP
of IN O
8.9 CD O
kb NN O
. . O

-DOCSTART- X X O

Two CD O
mutants NNS O
, , O
mapping NN O
at IN O
the DT O
HindIII NNP B-NP
site NN I-NP
( -LRB- O
between IN O
the DT O
consensus NN O
sequences NNS O
) -RRB- O
of IN O
the DT O
pSC101 JJ B-NP
tetA NN I-NP
promoter NN I-NP
, , O
were VBD O
studied VBN O
: : O
MA2 NNP O
corresponds NNS O
to TO O
a DT O
4 CD O
bp NN O
deletion NN O
between IN O
positions NNS O
-12 NN O
and CC O
-15 PRP$ O
; : O
B30 CD O
bears NNS O
a DT O
44 CD O
bp NN O
insertion NN O
C(TA)21 IN O
G NNP O
at IN O
the DT O
HindIII NNP B-NP
site NN I-NP
. . O

-DOCSTART- X X O

Meq/c-Jun NNP B-NP
heterodimers NNS O
bind VBP O
to TO O
an DT O
AP1-like JJ B-NP
sequence NN I-NP
in IN O
the DT O
meq NN B-NP
promoter NN I-NP
region NN I-NP
with IN O
an DT O
affinity NN O
much RB O
greater JJR O
than IN O
that DT O
of IN O
Meq/Meq NNP B-NP
or CC O
c-Jun/c-Jun JJ B-NP
homodimers NNS O
. . O

-DOCSTART- X X O

Infra-red JJ O
spectroscopy NN O
of IN O
tissues NNS O
in IN O
the DT O
700-400 CD O
cm-1 JJ O
region NN O
. . O

-DOCSTART- X X O

Although IN O
no DT O
detectable JJ O
phenotypes NNS O
are VBP O
associated VBN O
with IN O
a DT O
disruption NN O
allele NN O
of IN O
ABP1 NNP B-NP
, , O
mutations NNS O
that WDT O
create VBP O
a DT O
requirement NN O
for IN O
this DT O
protein NN O
have VBP O
now RB O
been VBN O
isolated VBN O
in IN O
the DT O
previously RB O
identified VBN O
gene NN B-NP
SAC6 NNP I-NP
and CC O
in IN O
two CD O
new JJ O
genes NNS O
, , O
SLA1 NNP B-NP
and CC O
SLA2 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
claustrocortical JJ O
connection NN O
was VBD O
investigated VBN O
in IN O
13 CD O
cats NNS O
with IN O
selective JJ O
injections NNS O
of IN O
30 CD O
% NN O
HRP NNP O
in IN O
the DT O
three CD O
subdivisions NNS O
of IN O
the DT O
auditory NN O
cortex NN O
.(ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
400 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

A DT O
significant JJ O
reduction NN O
in IN O
total JJ O
cellular JJ O
p27 NN B-NP
protein NN I-NP
levels NNS O
and CC O
a DT O
moderate JJ O
reduction NN O
in IN O
p27 NN B-NP
mRNA NNS I-NP
are VBP O
observed VBN O
, , O
but CC O
no DT O
changes NNS O
in IN O
Cdk NNP B-NP
regulatory JJ O
kinases NNS O
and CC O
phosphatases NNS O
occur VBP O
. . O

-DOCSTART- X X O

This DT O
result NN O
, , O
together RB O
with IN O
the DT O
fact NN O
that IN O
unrearranged JJ B-NP
V NNP I-NP
kappa NN I-NP
genes NNS I-NP
are VBP O
transcriptionally RB O
silent JJ O
, , O
suggests VBZ O
that IN O
structural JJ O
features NNS O
of IN O
both DT O
the DT O
V NNP B-NP
kappa NN I-NP
and CC O
C NNP B-NP
kappa NN I-NP
loci NNS I-NP
contribute VBP O
to TO O
the DT O
overall JJ O
transcriptional JJ O
efficiency NN O
of IN O
a DT O
rearranged JJ B-NP
V NNP I-NP
kappa-C NN I-NP
kappa NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Level NNP O
II NNP O
mosaicism NN O
occurred VBD O
in IN O
0.9 CD O
per IN O
cent NN O
of IN O
CVS NNP O
mesenchyme NN O
and CC O
1.5 CD O
per IN O
cent NN O
of IN O
amniotic JJ O
fluid NN O
cultures NNS O
and CC O
in IN O
general NN O
was VBD O
not RB O
perceived VBN O
to TO O
be VB O
of IN O
sufficient JJ O
concern NN O
to TO O
warrant VB O
cytogenetic JJ O
follow-up JJ O
studies NNS O
. . O

-DOCSTART- X X O

There EX O
are VBP O
three CD O
types NNS O
of IN O
problems NNS O
: : O
problems NNS O
arising VBG O
before IN O
the DT O
drug NN O
enters VBZ O
the DT O
body NN O
( -LRB- O
solubilization NN O
, , O
stabilization NN O
and CC O
improved JJ O
acceptability NN O
) -RRB- O
; : O
problems NNS O
associated VBN O
with IN O
the DT O
penetration NN O
and CC O
fate NN O
of IN O
the DT O
drug NN O
in IN O
the DT O
body NN O
( -LRB- O
absorption NN O
, , O
barrier NN O
crossing NN O
, , O
duration NN O
of IN O
action NN O
) -RRB- O
; : O
problems NNS O
relating VBG O
to TO O
the DT O
therapeutic JJ O
target NN O
( -LRB- O
selective JJ O
local JJ O
delivery NN O
) -RRB- O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Urbanisation NNP O
is VBZ O
associated VBN O
with IN O
an DT O
increase NN O
in IN O
the DT O
prevalence NN O
rates NNS O
of IN O
some DT O
risk NN O
behaviours VBZ O
. . O

-DOCSTART- X X O

The DT O
authors NNS O
emphasize VBP O
absence NN O
of IN O
specific JJ O
signs NNS O
of IN O
vagal JJ O
involvement NN O
, , O
importance NN O
for IN O
diagnosis NN O
of IN O
surgical JJ O
extirpation NN O
, , O
and CC O
mildness NN O
of IN O
post NN O
operative NN O
course NN O
. . O

-DOCSTART- X X O

Both DT O
in IN O
the DT O
Federal NNP O
Republic NNP O
of IN O
Germany NNP O
and CC O
in IN O
some DT O
neighbouring NN O
countries NNS O
the DT O
epizootic JJ O
situation NN O
of IN O
Aujeszky NNP O
's POS O
disease NN O
has VBZ O
been VBN O
unsatisfactory JJ O
for IN O
a DT O
long JJ O
time NN O
, , O
especially RB O
in IN O
areas NNS O
with IN O
a DT O
high JJ O
pig NN O
density NN O
. . O

-DOCSTART- X X O

The DT O
sensitivity NN O
of IN O
99mTc-IgG JJ O
scintigraphy NN O
ranged VBD O
between IN O
71 CD O
% NN O
and CC O
100 CD O
% NN O
. . O

-DOCSTART- X X O

Acad NNP O
. . O

-DOCSTART- X X O

Aggravation NNP O
of IN O
peripheral-blood JJ O
cytopenia NN O
during IN O
the DT O
first JJ O
weeks NNS O
and CC O
hypocellularity NN O
of IN O
bone-marrow JJ O
aspirates NNS O
at IN O
the DT O
end NN O
of IN O
therapy NN O
suggest VBP O
that IN O
low-dose JJ O
Ara NNP O
C NNP O
exerts VBZ O
its PRP$ O
main JJ O
activity NN O
by IN O
suppression NN O
of IN O
leukaemic JJ O
growth NN O
, , O
rather RB O
than IN O
by IN O
induction NN O
of IN O
differentiation NN O
in IN O
malignant JJ O
cells NNS O
. . O

-DOCSTART- X X O

Those DT O
participating VBG O
in IN O
this DT O
investigation NN O
( -LRB- O
65 CD O
centers NNS O
= SYM O
79 CD O
% NN O
) -RRB- O
received VBD O
a DT O
series NN O
of IN O
computer NN O
disks NNS O
containing VBG O
50 CD O
99mTc-DMSA JJ O
studies NNS O
. . O

-DOCSTART- X X O

Probiotics NNS O
, , O
prebiotics NNS O
, , O
vaccination NN O
, , O
and CC O
acidification NN O
of IN O
drinking NN O
water NN O
were VBD O
assessed VBN O
as IN O
means NN O
of IN O
reducing VBG O
Salmonella NNP O
. . O

-DOCSTART- X X O

Mutation NN O
of IN O
this DT O
threonine CD O
to TO O
isoleucine VB O
had VBD O
no DT O
observable JJ O
effect NN O
on IN O
either DT O
nuclear JJ O
localization NN O
of IN O
E1 JJ B-NP
or CC O
DNA NNP O
replication NN O
of IN O
the DT O
intact JJ O
viral JJ O
genome NN O
. . O

-DOCSTART- X X O

The DT O
recovery NN O
of IN O
xanthomegnin NNP O
added VBD O
to TO O
corn NN O
samples NNS O
at IN O
levels NNS O
of IN O
0.75--9.6 CD O
mg/kg NN O
averaged VBD O
41 CD O
% NN O
with IN O
a DT O
coefficient NN O
of IN O
variation NN O
of IN O
25 CD O
% NN O
. . O

-DOCSTART- X X O

Because IN O
of IN O
the DT O
data NNS O
, , O
we PRP O
suggest VBP O
that IN O
LAC9 JJ B-NP
contacts NNS O
positions NNS O
6 CD O
, , O
7 CD O
, , O
and CC O
8 CD O
, , O
both DT O
plus NN O
and CC O
minus NN O
, , O
of IN O
the DT O
UAS NNP O
, , O
which WDT O
are VBP O
separated VBN O
by IN O
more JJR O
than IN O
one CD O
turn NN O
of IN O
the DT O
DNA NNP O
helix NN O
, , O
and CC O
twists VBZ O
part NN O
way NN O
around IN O
the DT O
DNA NNP O
, , O
thus RB O
protecting VBG O
the DT O
broad JJ O
region NN O
of IN O
the DT O
minor JJ O
groove NN O
between IN O
the DT O
major-groove JJ O
contacts NNS O
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
amino IN O
acid JJ O
sequence NN O
of IN O
the DT O
FlaB2 NNP B-NP
polypeptide NN I-NP
was VBD O
92 CD O
% NN O
identical JJ O
to TO O
that DT O
of IN O
T. NNP B-NP
pallidum NN I-NP
FlaB2 NNP I-NP
, , O
with IN O
a DT O
76 CD O
% NN O
identity NN O
at IN O
the DT O
nucleotide JJ O
level NN O
. . O

-DOCSTART- X X O

Ion-Bernstein-wave NNP O
heating NN O
and CC O
improved VBD O
confinement NN O
in IN O
the DT O
Alcator NNP O
C NNP O
tokamak NN O
. . O

-DOCSTART- X X O

The DT O
subjects NNS O
were VBD O
started VBN O
on IN O
indomethacin IN O
25 CD O
mg JJ O
thrice NN O
daily RB O
. . O

-DOCSTART- X X O

Human JJ B-NP
parvovirus NN I-NP
B19 CC I-NP
gene NN I-NP
expression NN O
from IN O
the DT O
viral JJ B-NP
p6 NN I-NP
promoter NN I-NP
( -LRB- O
B19p6 CC B-NP
) -RRB- O
is VBZ O
restricted VBN O
to TO O
primary JJ O
human JJ O
hematopoietic NN O
cells NNS O
undergoing VBG O
erythroid JJ O
differentiation NN O
. . O

-DOCSTART- X X O

The DT O
atopic JJ O
disposition NN O
, , O
indicated VBN O
by IN O
positive JJ O
skin NN O
reactions NNS O
and CC O
IgE NNP B-NP
antibody NN O
titers NNS O
etc. FW O
, , O
and CC O
the DT O
bronchial JJ O
reactivity NN O
to TO O
inhaled JJ O
acetylcholine NN O
were VBD O
examined VBN O
on IN O
the DT O
following VBG O
three CD O
groups NNS O
: : O
( -LRB- O
1 CD O
) -RRB- O
20 CD O
young JJ O
adults NNS O
with IN O
a DT O
history NN O
of IN O
childhood NN O
asthma NN O
who WP O
have VBP O
been VBN O
symptom-free JJ O
for IN O
more JJR O
than IN O
4 CD O
yr NN O
; : O
( -LRB- O
2 CD O
) -RRB- O
20 CD O
current JJ O
asthmatics NNS O
, , O
and CC O
( -LRB- O
3 CD O
) -RRB- O
20 CD O
healthy JJ O
young JJ O
adults NNS O
. . O

-DOCSTART- X X O

Continuous JJ O
arterial JJ O
blood NN O
sampling NN O
method NN O
based VBN O
on IN O
the DT O
microsphere JJ O
model NN O
was VBD O
used VBN O
as IN O
a DT O
quantitative JJ O
rCBF NN O
measurement NN O
. . O

-DOCSTART- X X O

Members NNS O
of IN O
the DT O
steroid/hormone NN B-NP
nuclear JJ I-NP
receptor NN I-NP
superfamily NN I-NP
regulate VB O
target NN O
gene NN O
transcription NN O
via IN O
recognition NN O
and CC O
association NN O
with IN O
specific JJ O
cis-acting JJ O
sequences NNS O
of IN O
DNA NNP O
, , O
called VBD O
hormone NN O
response NN O
elements NNS O
( -LRB- O
HREs NN O
) -RRB- O
. . O

-DOCSTART- X X O

Thomas NNP O
, , O
S.S. NNP O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
these DT O
cases NNS O
, , O
patients NNS O
w VBD O
with IN O
high JJ O
Loa NN O
microfilaremia NN O
also RB O
developed VBD O
milder NN O
neurologic NN O
manifestations NNS O
causing VBG O
functional JJ O
impairment NN O
lasting VBG O
for IN O
at IN O
least JJS O
one CD O
week NN O
after IN O
treatment NN O
. . O

-DOCSTART- X X O

The DT O
patient NN O
demographics NNS O
( -LRB- O
means VBZ O
+/ VB O
- : O
standard JJ O
deviations NNS O
) -RRB- O
were VBD O
as IN O
follows VBZ O
: : O
age NN O
, , O
57 CD O
+/ NNS O
- : O
12 CD O
years NNS O
; : O
sex NN O
, , O
nine CD O
males NNS O
and CC O
three CD O
females NNS O
; : O
APACHE NNP O
II NNP O
score NN O
, , O
15 CD O
+/ NN O
- : O
3 CD O
; : O
diagnosis NN O
, , O
9 CD O
of IN O
12 CD O
patients NNS O
with IN O
pneumonia NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
corticotropin NN B-NP
releasing NN I-NP
factor NN I-NP
( -LRB- O
CRF) NNP B-NP
, , O
injected VBD O
centrally RB O
produces VBZ O
a DT O
suppression NN O
of IN O
punished VBN O
and CC O
non-punished JJ O
responding VBG O
in IN O
the DT O
conflict NN O
test NN O
consistent JJ O
with IN O
its PRP$ O
hypothesized JJ O
role NN O
in IN O
mediating VBG O
behavioral JJ O
responses NNS O
to TO O
stress VB O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
replicative JJ O
intermediates NNS O
shows VBZ O
that IN O
plasmid NN O
YRp7 NNS O
, , O
which WDT O
contains VBZ O
the DT O
chromosomal NN O
replicator NN O
ARS1 NNP O
, , O
initiates VBZ O
bidirectional JJ O
replication NN O
in IN O
a DT O
100 CD O
bp IN O
region NN O
within IN O
the DT O
sequence NN O
required VBN O
for IN O
autonomous JJ O
replication NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Concentrations NNS O
of IN O
Co NNP O
, , O
Cu NNP O
, , O
Fe NNP O
, , O
Hg NNP O
, , O
Mn NNP O
, , O
Sb NNP O
, , O
Se NNP O
and CC O
Zn NNP O
in IN O
IAEA NNP O
milk NN O
( -LRB- O
dry JJ O
) -RRB- O
standard JJ O
A-11 NN O
were VBD O
re-evaluated VBN O
with IN O
the DT O
help NN O
of IN O
instrumental JJ O
and CC O
radiochemical JJ O
neutron NN O
activation NN O
analysis NN O
( -LRB- O
NAA NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
show VBP O
that IN O
these DT O
sequences NNS O
are VBP O
essential JJ O
for IN O
processing NN O
of IN O
U18 NN B-NP
and CC O
snR38 VB B-NP
snoRNAs NNS I-NP
and CC O
that IN O
they PRP O
compensate VB O
for IN O
the DT O
lack NN O
of IN O
a DT O
canonical JJ O
terminal NN O
stem NN O
. . O

-DOCSTART- X X O

In IN O
serum-starved JJ O
NIH NNP O
3T3 CD O
cells NNS O
, , O
v-raf JJ B-NP
increased VBD O
mdr1 CD B-NP
promoter NN I-NP
activity NN O
approximately RB O
10-fold JJ O
compared VBN O
to TO O
a DT O
v-raf NN B-NP
frame-shift NN O
control NN O
. . O

-DOCSTART- X X O

A DT O
minimal JJ O
pheromone NN O
induction NN O
domain NN O
, , O
delineated VBN O
as IN O
residues NNS O
301 CD O
to TO O
335 CD O
of IN O
Ste12p NNP B-NP
, , O
is VBZ O
dependent JJ O
on IN O
the DT O
pheromone NN O
mitogen-activated JJ B-NP
protein NN I-NP
( -LRB- I-NP
MAP NNP I-NP
) -RRB- I-NP
kinase NN I-NP
pathway NN O
for IN O
induction NN O
activity NN O
. . O

-DOCSTART- X X O

To TO O
assess VB O
the DT O
effect NN O
on IN O
thrombus NN O
growth NN O
, , O
we PRP O
determined VBD O
the DT O
accretion NN O
of IN O
125I-labeled JJ O
fibrinogen NN B-NP
onto IN O
autologous JJ O
non-radioactive JJ O
thrombi NN O
preformed VBN O
in IN O
the DT O
jugular JJ O
veins NNS O
of IN O
rabbits NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
other JJ O
two CD O
cases NNS O
, , O
fluoxetine JJ O
adjunct JJ O
produced VBN O
benefits NNS O
with IN O
no DT O
additional JJ O
side NN O
effects NNS O
. . O

-DOCSTART- X X O

This DT O
radiolabeled JJ O
, , O
900-bp JJ O
amplicon NN O
was VBD O
used VBN O
as IN O
a DT O
hybridization NN O
probe NN O
to TO O
screen VB O
a DT O
cDNA NN O
library NN O
constructed VBD O
from IN O
poly( NN O
A DT O
) -RRB- O
( -LRB- O
+ NN O
) -RRB- O
RNA RB O
isolated VBN O
from IN O
induced JJ O
Taxus NNP O
cells NNS O
, , O
from IN O
which WDT O
a DT O
full-length JJ O
transacetylase NN O
sequence NN O
was VBD O
obtained VBN O
. . O

-DOCSTART- X X O

For IN O
the DT O
second JJ O
phase NN O
, , O
it PRP O
was VBD O
12.5 CD O
wk NN O
for IN O
RIR NNP O
and CC O
10 CD O
for IN O
WL NNP O
males NNS O
, , O
whereas IN O
it PRP O
was VBD O
5 CD O
wk NN O
for IN O
RIR NNP O
and CC O
6 CD O
for IN O
WL NNP O
females NNS O
. . O

-DOCSTART- X X O

TFEC NNP B-NP
RNA NNP I-NP
is VBZ O
found VBN O
in IN O
many JJ O
tissues NNS O
of IN O
adult NN O
rats NNS O
, , O
but CC O
the DT O
relative JJ O
concentrations NNS O
of IN O
TFEC NNP B-NP
and CC O
TFE3 NNP B-NP
RNAs NNP I-NP
vary VBP O
considerably RB O
in IN O
these DT O
different JJ O
tissues NNS O
. . O

-DOCSTART- X X O

VLA-4 NN B-NP
integrin NN I-NP
cross-linking NN O
on IN O
human JJ O
monocytic JJ O
THP-1 JJ O
cells NNS O
induces VBZ O
tissue NN O
factor NN O
expression NN O
by IN O
a DT O
mechanism NN O
involving VBG O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

Diethyldithiocarbamate NNP O
and CC O
amphetamine VBP O
stereotype JJ O
behavior NN O
. . O

-DOCSTART- X X O

Oct-1 NNP B-NP
is VBZ O
a DT O
ubiquitously RB O
expressed VBN O
regulatory JJ O
gene NN O
of IN O
the DT O
POU NNP B-NP
domain NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

Both DT O
RNA14 NNP B-NP
and CC O
RNA15 NNP B-NP
wild-type JJ I-NP
genes NNS I-NP
, , O
when WRB O
cloned VBN O
on IN O
a DT O
multicopy JJ O
plasmid NN O
, , O
are VBP O
able JJ O
to TO O
suppress VB O
the DT O
temperature-sensitive JJ O
phenotype NN O
of IN O
strains NNS O
bearing VBG O
either CC O
the DT O
rna14 NN B-NP
or CC O
the DT O
rna15 CD B-NP
mutation NN I-NP
, , O
suggesting VBG O
that IN O
the DT O
encoded JJ O
proteins NNS O
could MD O
interact VB O
with IN O
each DT O
other JJ O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
while IN O
GCN1 NNP B-NP
is VBZ O
required VBN O
in IN O
vivo NN O
for IN O
phosphorylation NN O
of IN O
eIF-2 JJ B-NP
alpha NN I-NP
by IN O
GCN2 NNP B-NP
, , O
cell NN O
extracts NNS O
from IN O
gcn1 JJ B-NP
delta JJ I-NP
strains NNS O
contained VBN O
wild-type JJ O
levels NNS O
of IN O
GCN2 DT B-NP
eIF-2 JJ B-NP
alpha-kinase NN I-NP
activity NN O
. . O

-DOCSTART- X X O

The DT O
phP1 JJ B-NP
mutation NN O
was VBD O
induced VBN O
by IN O
insertion NN O
of IN O
a DT O
1.2-kb JJ O
P NNP B-NP
element NN I-NP
into IN O
the DT O
5' JJ O
transcribed JJ O
nontranslated JJ O
region NN O
of IN O
the DT O
proximal JJ O
polyhomeotic JJ B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

By IN O
contrast NN O
, , O
clonidine NN O
( -LRB- O
1 CD O
micrograms/kg NN O
) -RRB- O
elicited VBN O
an DT O
immediate JJ O
and CC O
prolonged JJ O
fall NN O
in IN O
blood NN O
pressure NN O
and CC O
heart NN O
rate NN O
when WRB O
given VBN O
into IN O
the DT O
vertebral JJ O
artery NN O
, , O
but CC O
not RB O
intravenously RB O
. . O

-DOCSTART- X X O

To TO O
investigate VB O
the DT O
in IN O
vivo JJ O
role NN O
of IN O
this DT O
chimeric JJ B-NP
bZIP JJ I-NP
protein NN I-NP
in IN O
oncogenic JJ O
transformation NN O
, , O
its PRP$ O
expression NN O
was VBD O
directed VBN O
to TO O
the DT O
lymphoid JJ O
compartments NNS O
of IN O
transgenic JJ O
mice NNS O
. . O

-DOCSTART- X X O

The DT O
MALDI-TOF NNP O
experiment NN O
, , O
however RB O
, , O
proved VBD O
to TO O
be VB O
superior JJ O
to TO O
the DT O
GC NNP O
experiment NN O
, , O
particularly RB O
with IN O
regard NN O
to TO O
baseline NN O
resolution NN O
of IN O
unsaturated JJ O
acids NNS O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
serum NN O
CDT NNP O
increased VBD O
from IN O
8.5 CD O
( -LRB- O
SD NNP O
2.2 CD O
) -RRB- O
U/l . O
to TO O
16.6 CD O
( -LRB- O
SD NNP O
7.2 CD O
) -RRB- O
U/l NN O
( -LRB- O
P NNP O
< NN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
female JJ O
toads NNS O
, , O
Bufo NNP O
bufo NN O
, , O
feeding VBG O
at IN O
different JJ O
rates NNS O
, , O
the DT O
uncorrected JJ O
value NN O
of IN O
n NN O
was VBD O
0.44 CD O
, , O
when WRB O
metabolism NN O
and CC O
growth NN O
were VBD O
expressed VBN O
as IN O
kJ NN O
kJ-1 NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
vRel NN B-NP
lacks VBZ O
a DT O
strong JJ O
C-terminal JJ O
gene NN O
activation NN O
function NN O
, , O
since IN O
a DT O
LexA NNP B-NP
fusion NN I-NP
protein NN I-NP
containing VBG O
C-terminal JJ B-NP
vRel NN I-NP
sequences NNS I-NP
alone RB O
only RB O
weakly JJ O
activated JJ O
transcription NN O
. . O

-DOCSTART- X X O

Our PRP$ O
study NN O
reveals VBZ O
a DT O
consequence NN O
of IN O
adhesion NN O
receptor-mediated JJ O
signaling NN O
in IN O
T NNP O
cells NNS O
, , O
which WDT O
is VBZ O
potentially RB O
important JJ O
in IN O
the DT O
regulation NN O
of IN O
T NNP O
cell NN O
activation NN O
, , O
including VBG O
production NN O
of IN O
cytokines NNS O
and CC O
expression NN O
of IN O
proto-oncogenes NNS O
, , O
many JJ O
of IN O
which WDT O
are VBP O
controlled VBN O
through IN O
3' JJ O
AU-rich JJ O
elements NNS O
. . O

-DOCSTART- X X O

So IN O
it PRP O
is VBZ O
sometimes RB O
more RBR O
convenient JJ O
to TO O
use VB O
the DT O
back RB O
Radon NNP O
transform VB O
R-1 NN O
and CC O
then RB O
to TO O
correct VB O
the DT O
result NN O
, , O
taking VBG O
into IN O
account NN O
attenuation NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
( -LRB- O
1 LS O
) -RRB- O
RXR-TR JJ B-NP
heterodimers NNS O
play VBP O
a DT O
role NN O
in IN O
basal NN O
transactivation NN O
and CC O
T3 DT O
suppression NN O
of IN O
negatively RB O
regulated VBN O
genes NNS O
, , O
and CC O
( -LRB- O
2 CD O
) -RRB- O
RXRs NNPS B-NP
increase VB O
the DT O
dominant JJ O
negative JJ O
effect NN O
of IN O
some DT O
mutant JJ O
TRs NN B-NP
on IN O
specific JJ O
negative JJ O
TREs NN O
. . O

-DOCSTART- X X O

Injections NNS O
of IN O
PD NNP O
solutions NNS O
with IN O
13.6 CD O
, , O
22.7 CD O
, , O
and CC O
38.6 CD O
g/liter NN O
of IN O
glucose NN O
reduced VBD O
the DT O
ingestion NN O
of IN O
sucrose NN O
by IN O
12.4 CD O
% NN O
, , O
23.6 CD O
% NN O
and CC O
36.1 CD O
% NN O
, , O
respectively RB O
, , O
but CC O
did VBD O
not RB O
affect VB O
the DT O
ingestion NN O
of IN O
protein NN O
. . O

-DOCSTART- X X O

The DT O
Seldinger NNP O
technique NN O
for IN O
difficult JJ O
transurethral JJ O
catheterization NN O
: : O
a DT O
gentle JJ O
alternative NN O
to TO O
suprapubic JJ O
puncture NN O
( -LRB- O
Br NNP O
J NNP O
Surg NNP O
2000 CD O
; : O
87 CD O
: : O
1729-30 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Gingival NNP O
retraction NN O
for IN O
class NN O
V NNP O
restorations NNS O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
to TO O
p62( JJ B-NP
dok NN B-NP
) -RRB- O
, , O
DOKL VB B-NP
lacks VBZ O
YxxP NNP O
motifs NNS O
in IN O
the DT O
C NNP O
terminus NN O
and CC O
does VBZ O
not RB O
bind NN O
to TO O
Ras NNP B-NP
GTPase-activating JJ I-NP
protein NN I-NP
( -LRB- O
RasGAP NNP B-NP
) -RRB- O
upon IN O
phosphorylation NN O
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
chloroquine NN O
in IN O
saliva NN O
from IN O
seven CD O
healthy JJ O
volunteers NNS O
for IN O
21 CD O
days NNS O
after IN O
a DT O
single JJ O
600 CD O
mg JJ O
oral JJ O
dose NN O
of IN O
the DT O
drug NN O
was VBD O
established VBN O
by IN O
chromatographic JJ O
and CC O
spectroscopic JJ O
methods NNS O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
binding NN O
studies NNS O
previously RB O
showed VBD O
that IN O
NF-kappa NNP B-NP
B NNP I-NP
p50 VBD B-NP
homodimer NN O
binds NNS O
the DT O
switch NN B-NP
nuclear JJ I-NP
B-site JJ I-NP
protein NN I-NP
( -LRB- O
SNIP NN B-NP
) -RRB- O
of IN O
the DT O
S NNP B-NP
gamma NN I-NP
3 CD I-NP
tandem NN I-NP
repeat NN I-NP
. . O

-DOCSTART- X X O

Estimating VBG O
the DT O
health NN O
care NN O
costs NNS O
of IN O
smokers NNS O
. . O

-DOCSTART- X X O

Although IN O
paclitaxel NN O
alone RB O
failed VBD O
to TO O
induce VB O
p38 DT B-NP
MAPK NNP O
activation NN O
, , O
subsequent JJ O
( -LRB- O
but CC O
not RB O
prior JJ O
) -RRB- O
exposure NN O
to TO O
PD98059 VB O
induced VBN O
a DT O
dramatic JJ O
increase NN O
in IN O
p38 DT B-NP
MAPK NNP O
phosphorylation NN O
. . O

-DOCSTART- X X O

Early RB O
detection NN O
and CC O
signs NNS O
of IN O
hepatoangiosarcoma NN O
among IN O
vinyl NN O
chloride NN O
workers NNS O
. . O

-DOCSTART- X X O

Many JJ O
retroviruses NNS O
, , O
including VBG O
the DT O
human JJ O
and CC O
simian JJ O
immunodeficiency NN O
viruses NNS O
, , O
contain VBP O
a DT O
leucine NN O
zipper-like JJ O
repeat NN O
in IN O
a DT O
highly RB O
conserved VBN O
region NN O
of IN O
the DT O
external JJ O
domain NN O
of IN O
the DT O
transmembrane NN O
( -LRB- O
TM) NNP O
glycoprotein NN O
. . O

-DOCSTART- X X O

Conversion NN O
of IN O
an DT O
NF-kappaB NNP B-NP
into IN O
a DT O
GABP NNP B-NP
binding NN O
site NN O
is VBZ O
likely JJ O
to TO O
have VB O
occurred VBN O
also RB O
during IN O
the DT O
worldwide JJ O
spread NN O
of IN O
HIV-1 NN O
, , O
as IN O
we PRP O
noticed VBD O
the DT O
same JJ O
LTR NNP O
modification NN O
in IN O
subtype JJ O
E NNP O
isolates VBZ O
from IN O
Thailand NNP O
. . O

-DOCSTART- X X O

Ciprofloxacin NNP O
attained VBD O
a DT O
peak NN O
serum NN O
concentration NN O
of IN O
1.2 CD O
mg/l NN O
and CC O
a DT O
serum NN O
half-life NN O
of IN O
34 CD O
min NN O
. . O

-DOCSTART- X X O

As IN O
usual JJ O
tests NNS O
, , O
such JJ O
as IN O
"time NN O
" '' O
of IN O
cephalin NN O
are VBP O
slightly RB O
sensible JJ O
to TO O
LMW-Hep NNP O
, , O
only RB O
anti-Xa JJ O
activity NN O
can MD O
be VB O
used VBN O
. . O

-DOCSTART- X X O

Choline NNP B-NP
acetyltransferase NN I-NP
immunohistochemistry NN O
combined VBN O
with IN O
the DT O
retrograde NN O
transport NN O
of IN O
horseradish NN B-NP
peroxidase NN I-NP
showed VBD O
that IN O
the DT O
reticular JJ O
and CC O
mediodorsal JJ O
thalamic IN O
nuclei NNS O
of IN O
the DT O
cat NN O
receive VB O
an DT O
important JJ O
input NN O
from IN O
cholinergic JJ O
and CC O
non-cholinergic JJ O
neurons NNS O
of IN O
substantia NN O
innominata NN O
and CC O
adjacent JJ O
structures NNS O
in IN O
the DT O
basal NN O
forebrain NN O
. . O

-DOCSTART- X X O

The DT O
purified VBN O
RAG1 NNP B-NP
protein NN I-NP
overexpressed VBN O
in IN O
E.coli NNP O
exhibited VBD O
the DT O
expected VBN O
cleavage NN O
activity NN O
when WRB O
combined VBN O
with IN O
RAG2 NNP B-NP
purified VBN O
from IN O
transfected VBN O
293T JJ O
cells NNS O
. . O

-DOCSTART- X X O

These DT O
mutant JJ B-NP
rps7 CD I-NP
leaders NNS O
were VBD O
ligated VBN O
into IN O
an DT O
aadA JJ O
expression NN O
cassette NN O
and CC O
transformed VBD O
into IN O
the DT O
chloroplast NN O
of IN O
C. NNP O
reinhardtii NNP O
and CC O
into IN O
E. NNP O
coli NNS O
. . O

-DOCSTART- X X O

The DT O
use NN O
of IN O
medication NN O
is VBZ O
of IN O
minor JJ O
importance NN O
in IN O
the DT O
treatment NN O
of IN O
flight NN O
phobia NN O
. . O

-DOCSTART- X X O

We PRP O
previously RB O
described VBD O
the DT O
upregulation NN O
of IN O
the DT O
MT2 NNP B-NP
antigen NN I-NP
during IN O
urodele JJ O
limb NN O
regeneration NN O
and CC O
characterized VBD O
the DT O
MT2 NNP B-NP
antigen NN I-NP
as IN O
a DT O
310- CD O
to TO O
325-kDa JJ O
chondroitin-sulfated JJ O
glycoprotein NN O
with IN O
a DT O
core JJ O
protein NN O
of IN O
285-300 CD O
kDa NN O
. . O

-DOCSTART- X X O

Southern JJ O
blot NN O
analysis NN O
following VBG O
reverse NN O
transcription NN O
and CC O
PCR NN O
showed VBD O
that IN O
B2R NNP B-NP
is VBZ O
expressed VBN O
in IN O
most JJS O
mouse NN O
tissues NNS O
, , O
except IN O
the DT O
liver NN O
and CC O
spleen NN O
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
the DT O
wide JJ O
distribution NN O
of IN O
B2R NN B-NP
activity NN O
as IN O
deduced VBN O
from IN O
pharmacological JJ O
studies NNS O
. . O

-DOCSTART- X X O

Using VBG O
the DT O
interaction-trap NN O
assay NN O
to TO O
identify VB O
candidate NN O
proteins VBZ O
that DT O
bind NN O
the DT O
cytoplasmic JJ O
region NN O
of IN O
the DT O
LAR NN B-NP
transmembrane NN I-NP
protein NN I-NP
tyrosine NN I-NP
phosphatase NN I-NP
( -LRB- O
PT-Pase NN B-NP
) -RRB- O
, , O
we PRP O
isolated VBD O
a DT O
cDNA NN O
encoding VBG O
a DT O
2861-amino JJ O
acid NN O
protein NN O
termed VBD O
Trio NNP B-NP
that WDT O
contains VBZ O
three CD O
enzyme JJ O
domains NNS O
: : O
two CD O
functional JJ O
GEF NNP B-NP
domains NNS I-NP
and CC O
a DT O
protein NN B-NP
serine/threonine NN I-NP
kinase NN I-NP
( -LRB- O
PSK) NNP B-NP
domain NN O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
the DT O
putative JJ O
C2 NNP B-NP
domain NN O
of IN O
Nedd4 NNP B-NP
has VBZ O
not RB O
been VBN O
elucidated VBN O
. . O

-DOCSTART- X X O

Additionally RB O
, , O
these DT O
findings NNS O
have VBP O
important JJ O
implications NNS O
for IN O
the DT O
understanding NN O
of IN O
the DT O
mechanisms NNS O
of IN O
HIV-1 PRP$ O
latency NN O
and CC O
reactivation NN O
. . O

-DOCSTART- X X O

The DT O
average JJ O
mean JJ O
difference NN O
compared VBN O
with IN O
the DT O
low JJ O
and CC O
the DT O
intermediate JJ O
calcium NN O
group NN O
was VBD O
11 CD O
% NN O
for IN O
the DT O
femoral JJ O
neck NN O
, , O
8-11 NN O
% NN O
for IN O
the DT O
lumbar NN O
spine NN O
and CC O
5-6 CD O
% NN O
for IN O
total JJ O
body NN O
BMDs NNS O
. . O

-DOCSTART- X X O

Although IN O
the DT O
number NN O
of IN O
kits NNS O
has VBZ O
increased VBN O
, , O
the DT O
precision NN O
has VBZ O
improved VBN O
, , O
showing VBG O
that IN O
more JJR O
robust JJ O
methods NNS O
are VBP O
now RB O
employed VBN O
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
amino IN O
acid NN O
sequence NN O
contained VBD O
all DT O
consensus NN O
regions NNS O
for IN O
S-adenosyl NNP B-NP
methionine CD I-NP
methyltransferases NNS I-NP
and CC O
presented VBD O
26 CD O
% NN O
identity NN O
with IN O
Saccharomyces NNP B-NP
cerevisiae NN I-NP
DHHB-methyltransferase NN I-NP
and CC O
38 CD O
% NN O
identity NN O
with IN O
the DT O
rat NN O
protein NN O
, , O
as RB O
well RB O
as IN O
with IN O
a DT O
bacterial JJ O
( -LRB- O
Escherichia NN O
coli NNS O
and CC O
Salmonella NNP O
typhimurium NN O
) -RRB- O
methyltransferase NN B-NP
encoded VBN O
by IN O
the DT O
UBIG NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

To TO O
investigate VB O
its PRP$ O
transcription NN O
, , O
1.1 CD O
kilobases NNS O
of IN O
the DT O
5'-flanking JJ O
sequence NN O
were VBD O
fused VBN O
to TO O
a DT O
luciferase NN B-NP
reporter NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

A DT O
selective JJ O
transcriptional JJ O
induction NN O
system NN O
for IN O
mammalian JJ O
cells NNS O
based VBN O
on IN O
Gal4-estrogen NN B-NP
receptor NN B-NP
fusion NN O
proteins NNS O
. . O

-DOCSTART- X X O

The DT O
cyanobacterial JJ B-NP
phycobilisome NN I-NP
is VBZ O
a DT O
large JJ O
protein NN O
complex JJ O
located VBN O
on IN O
the DT O
photosynthetic JJ O
membrane NN O
. . O

-DOCSTART- X X O

Lamivudine NNP O
therapy NN O
for IN O
acute JJ O
hepatitis NN O
B NNP O
infection NN O
following VBG O
peripheral JJ O
blood NN O
stem VBP O
cell NN O
transplantation NN O
. . O

-DOCSTART- X X O

The DT O
collicular JJ O
labels NNS O
found VBD O
after IN O
injections NNS O
within IN O
the DT O
MST NNP O
area NN O
exhibited VBD O
their PRP$ O
distribution NN O
over IN O
the DT O
deep JJ O
SC NNP O
subdivision NN O
, , O
whereas IN O
they PRP O
spared VBD O
all PDT O
the DT O
superficial JJ O
layers NNS O
but CC O
the DT O
deep JJ O
part NN O
of IN O
the DT O
SO. NNP O

-DOCSTART- X X O

Modern JJ O
aspects NNS O
of IN O
shock-treatment NN O
in IN O
extensive JJ O
burns NNS O
( -LRB- O
author NN O
's POS O
transl NN O
) -RRB- O

-DOCSTART- X X O

Mapping NNP O
of IN O
the DT O
region NN O
in IN O
KAP-1 NN B-NP
required VBN O
for IN O
HP1 NNP B-NP
interaction NN O
showed VBD O
that IN O
amino IN O
acid NN O
substitutions NNS O
which WDT O
abolish VB O
HP1 NNP B-NP
binding NN O
in IN O
vitro NN O
reduce VB O
KAP-1 JJ B-NP
mediated JJ O
repression NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
suggest VBP O
that IN O
the DT O
Smad3/Smad4 NNP B-NP
complex NN O
has VBZ O
at IN O
least JJS O
two CD O
separable JJ O
nuclear JJ O
functions NNS O
: : O
it PRP O
forms VBZ O
a DT O
rapid JJ O
, , O
yet RB O
transient JJ O
sequence-specific JJ O
DNA NNP O
binding NN O
complex JJ O
, , O
and CC O
it PRP O
potentiates VBZ O
AP1-dependent JJ B-NP
transcriptional JJ O
activation NN O
. . O

-DOCSTART- X X O

The DT O
donors NNS O
of IN O
10 CD O
patients NNS O
were VBD O
ABO-incompatible JJ O
, , O
and CC O
for IN O
five CD O
pairs NNS O
the DT O
ABO NNP O
incompatibility NN O
was VBD O
major JJ O
. . O

-DOCSTART- X X O

The DT O
major JJ O
promoter NN O
element NN O
of IN O
the DT O
Xenopus NNP B-NP
laevis VBD I-NP
5S DT I-NP
RNA NNP I-NP
gene NN I-NP
is VBZ O
located VBN O
within IN O
the DT O
transcribed JJ O
region NN O
of IN O
the DT O
gene NN O
and CC O
forms NNS O
the DT O
binding NN O
site NN O
for IN O
the DT O
transcription NN O
initiation NN O
factor NN O
TFIIIA NNP B-NP
. . O

-DOCSTART- X X O

Small JJ O
cell NN O
tumors NNS O
in IN O
children NNS O
: : O
contribution NN O
to TO O
the DT O
solution NN O
of IN O
the DT O
problem NN O
of IN O
differential JJ O
diagnosis NN O
with IN O
immunohistochemistry NN O
and CC O
electron NN O
microscopy NN O

-DOCSTART- X X O

Four CD O
experiments NNS O
examined VBD O
the DT O
role NN O
of IN O
the DT O
cholinergic JJ O
projections NNS O
from IN O
the DT O
septum NN O
and CC O
vertical JJ O
limb NN O
nucleus NN O
of IN O
the DT O
diagonal JJ O
band NN O
of IN O
Broca NNP O
(VDB) NNP O
in IN O
acquisition NN O
and CC O
performance NN O
of IN O
a DT O
conditional JJ O
visual JJ O
discrimination NN O
. . O

-DOCSTART- X X O

Microsporum NNP O
persicolor NN O
, , O
an DT O
easily RB O
misinterpreted VBN O
dermatophyt NN O

-DOCSTART- X X O

When WRB O
they PRP O
were VBD O
exposed VBN O
to TO O
intermittent JJ O
schedules NNS O
of IN O
punishment NN O
( -LRB- O
fixed-interval JJ O
[FI] NN O
120 CD O
s PRP O
or CC O
FI NNP O
300 CD O
s VBZ O
) -RRB- O
, , O
SIB NNP O
for IN O
all DT O
but CC O
1 CD O
of IN O
the DT O
participants NNS O
increased VBD O
to TO O
levels NNS O
similar JJ O
to TO O
those DT O
observed VBN O
during IN O
baseline NN O
. . O

-DOCSTART- X X O

PKK NN B-NP
exists VBZ O
in IN O
three CD O
discernible JJ O
forms NNS O
at IN O
steady JJ O
state NN O
: : O
an DT O
underphosphorylated JJ O
form NN O
of IN O
100 CD O
kDa NN O
; : O
a DT O
soluble JJ O
, , O
cytosolic JJ O
, , O
phosphorylated JJ O
form NN O
of IN O
110 CD O
kDa NN O
; : O
and CC O
a DT O
phosphorylated JJ O
, , O
detergent-insoluble JJ O
form NN O
of IN O
112 CD O
kDa NN O
. . O

-DOCSTART- X X O

The DT O
lamina NN O
densa NN O
was VBD O
always RB O
interrupted VBN O
by IN O
numerous JJ O
small JJ O
gaps NNS O
and CC O
in IN O
some DT O
areas NNS O
the DT O
basement NN O
membrane NN O
could MD O
not RB O
be VB O
identified VBN O
over IN O
a DT O
long JJ O
distance NN O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
CA11 NNP I-NP
gene NN I-NP
appears VBZ O
to TO O
be VB O
located VBN O
between IN O
the DT O
secretor NN B-NP
type NN I-NP
alpha( NN I-NP
1,2)-fucosyltransferase JJ I-NP
gene NN I-NP
cluster NN I-NP
( -LRB- O
FUT1-FUT2-FUT2P JJ B-NP
) -RRB- O
and CC O
the DT O
D-site JJ B-NP
binding JJ I-NP
protein NN I-NP
gene NN I-NP
( -LRB- O
DBP NNP B-NP
) -RRB- O
on IN O
chromosome NN O
19q13.3 CD O
. . O

-DOCSTART- X X O

To TO O
determine VB O
the DT O
role NN O
of IN O
elevated JJ O
FAK NNP B-NP
expression NN O
in IN O
facilitating VBG O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
( -LRB- O
EGF)-stimulated JJ B-NP
human NN O
adenocarcinoma NN O
( -LRB- O
A549 DT O
) -RRB- O
cell NN O
motility NN O
, , O
antisense JJ O
oligonucleotides NNS O
were VBD O
used VBN O
to TO O
reduce VB O
FAK JJ B-NP
protein NN I-NP
expression NN O
>75 VBD O
% NN O
. . O

-DOCSTART- X X O

Evaluation NN O
of IN O
materials NNS O
and CC O
technics NNS O
in IN O
vascular JJ O
surgery NN O
using VBG O
111-Indium JJ O

-DOCSTART- X X O

In IN O
the DT O
postoperative JJ O
patient NN O
with IN O
tetralogy NN O
of IN O
Fallot NNP O
with IN O
symptomatic JJ O
ventricular JJ O
arrhythmias NNS O
, , O
it PRP O
is VBZ O
concluded VBN O
that IN O
electrophysiologic JJ O
study NN O
is VBZ O
useful JJ O
in IN O
reproducing VBG O
clinical JJ O
episodes NNS O
of IN O
VT NNP O
and CC O
in IN O
selecting VBG O
effective JJ O
antiarrhythmic JJ O
medication NN O
; : O
a DT O
small JJ O
number NN O
of IN O
patients NNS O
with IN O
ventricular JJ O
premature JJ O
complexes NNS O
alone RB O
will MD O
have VB O
inducible JJ O
sustained VBN O
VT NN O
during IN O
electrophysiologic NN O
study NN O
; : O
prognosis NN O
of IN O
these DT O
patients NNS O
may MD O
be VB O
improved VBN O
by IN O
treatment NN O
that IN O
results NNS O
in IN O
prevention NN O
of IN O
VT NNP O
induction NN O
; : O
and CC O
in IN O
patients NNS O
with IN O
right JJ O
ventricular JJ O
hypertension NN O
, , O
VT NNP O
is VBZ O
likely JJ O
to TO O
be VB O
refractory JJ O
to TO O
drug NN O
treatment NN O
. . O

-DOCSTART- X X O

In IN O
human JJ O
myxoid NN O
liposarcoma NN O
, , O
a DT O
chromosomal NN O
rearrangement NN O
leads VBZ O
to TO O
fusion NN O
of IN O
the DT O
growth-arresting NN O
and CC O
DNA-damage-inducible JJ O
transcription NN O
factor NN O
CHOP NNP B-NP
( -LRB- O
GADD153 NN B-NP
) -RRB- O
to TO O
a DT O
peptide NN O
fragment NN O
encoded VBN O
by IN O
the DT O
TLS NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Categorisation NNP O
of IN O
the DT O
different JJ O
substructures NNS O
within IN O
the DT O
sections NNS O
allows VBZ O
them PRP O
to TO O
be VB O
analysed JJ O
and CC O
displayed VBN O
separately RB O
. . O

-DOCSTART- X X O

The DT O
only JJ O
quantities NNS O
which WDT O
were VBD O
significantly RB O
different JJ O
between IN O
appendicitis NN O
and CC O
a DT O
normal JJ O
appendix NN O
were VBD O
sex NN O
, , O
duration NN O
of IN O
symptoms NNS O
, , O
anorexia NNS O
and CC O
vomiting NN O
. . O

-DOCSTART- X X O

Signaling VBG O
through IN O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
and CC O
Rac/Rho NNP B-NP
does VBZ O
not RB O
duplicate VB O
the DT O
effects NNS O
of IN O
activated JJ O
Ras NNP B-NP
on IN O
skeletal NN O
myogenesis NN O
. . O

-DOCSTART- X X O

Unlike IN O
these DT O
contaminant-responsive JJ O
T NNP O
cells NNS O
, , O
those DT O
that WDT O
are VBP O
truly RB O
specific JJ O
for IN O
natural JJ O
AChR NNP B-NP
epitopes NNS I-NP
appear VBP O
less RBR O
heterogeneous JJ O
and CC O
therefore RB O
more JJR O
suitable JJ O
targets NNS O
for IN O
selective JJ O
immunotherapy NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
This DT O
initial JJ O
experience NN O
indicates VBZ O
that IN O
there EX O
is VBZ O
short- JJR O
to TO O
middle-term JJ O
efficiency NN O
and CC O
safety NN O
when WRB O
using VBG O
GKS NNP O
to TO O
treat VB O
MTLE. . O

-DOCSTART- X X O

The DT O
aims NNS O
of IN O
this DT O
study NN O
were VBD O
to TO O
examine VB O
whether IN O
the DT O
EORTC NNP O
( -LRB- O
European JJ O
Organisation NNP O
for IN O
Research NNP O
and CC O
Treatment NNP O
of IN O
Cancer NNP O
) -RRB- O
QLQ-C30 . O
core NN O
questionnaire NN O
alone RB O
could MD O
distinguish VB O
between IN O
two CD O
clinically RB O
different JJ O
groups NNS O
of IN O
patients NNS O
and CC O
to TO O
design VB O
a DT O
module NN O
, , O
which WDT O
included VBD O
relevant JJ O
patient-defined JJ O
gastric JJ O
cancer-specific JJ O
variables NNS O
. . O

-DOCSTART- X X O

Causal VB O
modeling VBG O
combines NNS O
theory NN O
and CC O
research NN O
, , O
and CC O
because IN O
the DT O
interpretation NN O
of IN O
data NNS O
is VBZ O
possible JJ O
only RB O
within IN O
the DT O
context NN O
of IN O
the DT O
proposed VBN O
theory NN O
, , O
it PRP O
offers VBZ O
an DT O
important JJ O
method NN O
for IN O
advancing VBG O
the DT O
science NN O
while IN O
maintaining VBG O
the DT O
specificity NN O
of IN O
the DT O
practice NN O
. . O

-DOCSTART- X X O

Comparison NNP O
with IN O
alkaline NN B-NP
phosphatases NNS I-NP
and CC O
5-nucleotidase JJ B-NP

-DOCSTART- X X O

Beta JJ O
blocking VBG O
agents NNS O
. . O

-DOCSTART- X X O

When WRB O
extracorporeal JJ O
CO2 NN O
removal NN O
approximated VBD O
CO2 JJ O
production NN O
(VCO2 NN O
) -RRB- O
, , O
alveolar JJ O
ventilation NN O
almost RB O
ceased VBD O
. . O

-DOCSTART- X X O

Intravenous JJ O
administration NN O
( -LRB- O
25 CD O
mg/kg NN O
) -RRB- O
of IN O
carbonic JJ B-NP
anhydrase NN I-NP
inhibitors NNS O
( -LRB- O
acetazolamide NN O
, , O
methazolamide NN O
, , O
dichlorphenamide NN O
, , O
sulthiame NN O
) -RRB- O
induced VBN O
an DT O
early RB O
important JJ O
rise NN O
of IN O
cortical JJ O
p NN O
O2 NNP O
, , O
which WDT O
is VBZ O
not RB O
dependent JJ O
on IN O
increase NN O
of IN O
p NN O
O2 . O
and CC O
p JJ O
CO2 NN O
and CC O
decrease NN O
of IN O
pH NNS O
in IN O
arterial JJ O
blood NN O
. . O

-DOCSTART- X X O

Teratological JJ O
study NN O
of IN O
etoperidone NN O
in IN O
the DT O
rat NN O
and CC O
rabbit NN O
. . O

-DOCSTART- X X O

Colorectal JJ O
polyps NNS O
should MD O
be VB O
removed VBN O
endoscopically RB O
whenever WRB O
possible JJ O
. . O

-DOCSTART- X X O

When WRB O
the DT O
CO2 NN O
content NN O
reached VBD O
9 CD O
Vol NN O
% NN O
the DT O
animals NNS O
became VBD O
apathic JJ O
and CC O
lost VBN O
body NN O
weight NN O
. . O

-DOCSTART- X X O

Serum NN B-NP
gamma NN I-NP
glutamyltransferase NN I-NP
in IN O
the DT O
diagnosis NN O
of IN O
liver NN O
disease NN O
in IN O
cattle NNS O
. . O

-DOCSTART- X X O

By IN O
contrast NN O
, , O
secretory NN B-NP
HI PRP$ I-NP
antibodies NNS I-NP
were VBD O
not RB O
demonstrated VBN O
at IN O
the DT O
onset NN O
of IN O
illness NN O
in IN O
any DT O
of IN O
the DT O
patients NNS O
, , O
but CC O
their PRP$ O
formation NN O
started VBD O
early RB O
and CC O
the DT O
antibodies NNS O
reached VBD O
maximal JJ O
levels NNS O
about IN O
10 CD O
days NNS O
after IN O
onset NN O
of IN O
illness NN O
. . O

-DOCSTART- X X O

With IN O
the DT O
exception NN O
of IN O
virus NN O
assay NN O
and CC O
quantitation NN O
, , O
these DT O
methods NNS O
are VBP O
simple JJ O
and CC O
inexpensive JJ O
enough JJ O
to TO O
be VB O
done VBN O
in IN O
typical JJ O
shellfish NN O
microbiology NN O
laboratories NNS O
. . O

-DOCSTART- X X O

Takayasu NNP O
's POS O
disease NN O
: : O
association NN O
with IN O
HLA-B5 NNP B-NP
. . O

-DOCSTART- X X O

Patients NNS O
with IN O
Parkinson NNP O
's POS O
disease NN O
showed VBD O
a DT O
relatively RB O
high JJ O
incidence NN O
to TO O
psychoses NNS O
during IN O
drug NN O
treatment NN O
( -LRB- O
51.47 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Selective JJ O
stimulation NN O
of IN O
central JJ O
alpha-autoreceptors NNS B-NP
following VBG O
treatment NN O
with IN O
alpha-methyldopa NN O
and CC O
FLA NNP O
136 CD O
. . O

-DOCSTART- X X O

Abstracts NNS O
. . O

-DOCSTART- X X O

Removal NNP O
of IN O
thick JJ O
, , O
permanently RB O
altered VBN O
mucoas NN O
is VBZ O
recommended VBN O
even RB O
in IN O
the DT O
absence NN O
of IN O
squamous JJ O
epithelium NN O
. . O

-DOCSTART- X X O

An DT O
IgG NNP B-NP
monoclonal JJ O
gammopathy NN O
was VBD O
present JJ O
in IN O
the DT O
serum NN O
of IN O
4 CD O
patients NNS O
and CC O
Bence-Joanes NNP O
proteinuria NN O
was VBD O
found VBN O
in IN O
1 CD O
patient NN O
. . O

-DOCSTART- X X O

Studies NNS O
on IN O
immunoglobulin NN B-NP
E NNP I-NP
: : O
the DT O
impact NN O
of IN O
a DT O
sojourn NN O
with IN O
Professor NNP O
Dan NNP O
H. NNP O

-DOCSTART- X X O

Peroxydase JJ B-NP
reaction NN O
stains NNS O
were VBD O
negative JJ O
, , O
chloroacetate NN B-NP
esterase NN I-NP
were VBD O
strongly RB O
positive JJ O
. . O

-DOCSTART- X X O

Of IN O
600 CD O
mediastinoscopies NNS O
carried VBD O
out RP O
from IN O
1966 CD O
to TO O
1973 CD O
, , O
479 CD O
were VBD O
performed VBN O
to TO O
assess VB O
the DT O
operability NN O
of IN O
a DT O
pulmonary JJ O
carcinoma NN O
. . O

-DOCSTART- X X O

A DT O
mixture NN O
of IN O
human JJ B-NP
albumin NN I-NP
5 CD O
% NN O
and CC O
hydroxy-ethyl-starch NN O
was VBD O
used VBN O
as IN O
a DT O
solution NN O
for IN O
dilution NN O
. . O

-DOCSTART- X X O

Late JJ O
complications NNS O
of IN O
catheterisation NN O
for IN O
intravenous JJ O
nutrition NN O
. . O

-DOCSTART- X X O

Sings NNS O
which WDT O
are VBP O
indicative JJ O
of IN O
metaplastic JJ O
erythropoiesis NN O
are VBP O
absent JJ O
. . O

-DOCSTART- X X O

Serum-ferritin NNP O
in IN O
diagnosis NN O
of IN O
haemochromatosis NN O
. . O

-DOCSTART- X X O

Preface NN O
. . O

-DOCSTART- X X O

Thirty-five DT O
strains NNS O
of IN O
Legionnaires NNP O
' POS O
disease NN O
bacteria NNS O
were VBD O
shown VBN O
to TO O
belong VB O
in IN O
four CD O
distinct JJ O
serologic NN O
groups NNS O
on IN O
the DT O
basis NN O
of IN O
findings NNS O
obtained VBN O
with IN O
direct JJ O
fluorescent JJ O
antibody NN O
testing NN O
. . O

-DOCSTART- X X O

On IN O
the DT O
other JJ O
hand NN O
factor NN B-NP
IX NNP I-NP
activity NN O
is VBZ O
decreased VBN O
in IN O
coumarin NN O
treatment NN O
with IN O
factor NN B-NP
IX NNP I-NP
antigen IN O
remaining VBG O
normal JJ O
. . O

-DOCSTART- X X O

The DT O
concentration NN O
of IN O
alpha NN B-NP
2-macroglobulin CD I-NP
, , O
alpha NN B-NP
1-antitrypsin JJ I-NP
, , O
plasminogen NN B-NP
, , O
C3-complement NNP B-NP
, , O
fibrinogen NN B-NP
degradation NN I-NP
products NNS I-NP
( -LRB- O
FDP NNP B-NP
) -RRB- O
and CC O
fibrinolytic JJ O
activity NN O
, , O
were VBD O
studied VBN O
in IN O
the DT O
aqueous JJ O
humour NN O
and CC O
serum NN O
from IN O
nine CD O
patients NNS O
with IN O
Fuchs NNP O
' POS O
endothelial JJ O
dystrophy NN O
, , O
17 CD O
patients NNS O
with IN O
uncomplicated JJ O
senile JJ O
cataract NN O
and CC O
in IN O
the DT O
secondary JJ O
aqueous JJ O
from IN O
six CD O
cataract NN O
patients NNS O
. . O

-DOCSTART- X X O

Only RB O
17 CD O
% NN O
of IN O
all DT O
patients NNS O
admitted VBD O
it PRP O
at IN O
all DT O
times NNS O
. . O

-DOCSTART- X X O

Prazosin NNP O
alone RB O
was VBD O
effective JJ O
in IN O
volume NN O
responsive JJ O
patients NNS O
at IN O
a DT O
dose NN O
of IN O
5 CD O
+/ CD O
- : O
1.0 CD O
mg NN O
daily RB O
. . O

-DOCSTART- X X O

T4 NNP O
and CC O
FT4I NNP O
followed VBD O
parallel RB O
courses NNS O
in IN O
both DT O
groups NNS O
; : O
during IN O
the DT O
first JJ O
45 CD O
days NNS O
, , O
however RB O
, , O
the DT O
values NNS O
were VBD O
significantly RB O
lower JJR O
in IN O
premature JJ O
infants NNS O
under IN O
34 CD O
weeks NNS O
' POS O
EGA JJ O
than IN O
in IN O
term NN O
infants NNS O
( -LRB- O
P NNP O
less RBR O
than IN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Aspirin NNP O
intolerance NN O
: : O
unaltered JJ O
susceptibility NN O
of IN O
platelet NN B-NP
cyclo-oxygenase NN I-NP
to TO O
inhibition VB O
by IN O
aspirin NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

59 CD O
cases NNS O
of IN O
surgically RB O
resectable JJ O
cancers NNS O
( -LRB- O
T1 NNP O
, , O
T2 NNP O
, , O
T3 NNP O
, , O
N0 NNP O
, , O
N1 NNP O
) -RRB- O
had VBD O
a DT O
minimum JJ O
followup NN O
of IN O
two CD O
years NNS O
(average JJ O
4 CD O
years NNS O
+/ JJ O
- : O
3 CD O
months NNS O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
CBZ NNP O
and CC O
DPH NNP O
can MD O
be VB O
explained VBN O
by IN O
interference NN O
with IN O
thyroid DT O
hormone NN O
binding NN O
to TO O
TBG VB B-NP
combined VBN O
with IN O
enzyme-induced JJ O
increased VBN O
metabolic JJ O
clearance NN O
rate NN O
of IN O
thyroid JJ O
hormones NNS O
without IN O
homeostatic JJ O
maintenance NN O
of IN O
premedication NN O
levels NNS O
of IN O
FT4 NNP O
and CC O
FT3 NNP O
. . O

-DOCSTART- X X O

The DT O
present JJ O
research NN O
evaluated VBZ O
the DT O
possibility NN O
that IN O
polyethylene NN O
glycol NN O
400 CD O
( -LRB- O
PEG NN O
400 CD O
) -RRB- O
might MD O
be VB O
efficacious JJ O
, , O
toxic JJ O
, , O
or CC O
both DT O
. . O

-DOCSTART- X X O

According VBG O
to TO O
their PRP$ O
functional JJ O
properties NNS O
the DT O
latter NN O
neurons NNS O
were VBD O
subdivided VBN O
into IN O
: : O
( -LRB- O
a DT O
) -RRB- O
neurons NNS O
responding VBG O
to TO O
stimuli NNS O
near IN O
the DT O
eyes NNS O
; : O
( -LRB- O
b NN O
) -RRB- O
neurons NNS O
triggered VBN O
by IN O
complex JJ O
visual JJ O
stimuli NNS O
; : O
( -LRB- O
c NN O
) -RRB- O
neurons NNS O
inhibited VBN O
by IN O
visual JJ O
stimuli NNS O
. . O

-DOCSTART- X X O

All DT O
groups NNS O
were VBD O
tested VBN O
in IN O
a DT O
Hebb-Williams NNP O
maze NN O
at IN O
100 CD O
approximately RB O
10 CD O
days NNS O
of IN O
age NN O
. . O

-DOCSTART- X X O

Erythromycin NNP O
and CC O
clindamycin VB O
resistance NN O
in IN O
Corynebacterium NNP O
diphtheriae NN O
from IN O
skin NN O
lesions NNS O
. . O

-DOCSTART- X X O

Imposed JJ O
angular JJ O
displacements NNS O
of IN O
monkey NN O
's POS O
wrist NN O
produce VBP O
three CD O
major JJ O
peaks NNS O
of IN O
activity NN O
(terms VBZ O
M1 NNP O
, , O
M2 NNP O
, , O
and CC O
M3 JJ O
peaks NNS O
) -RRB- O
in IN O
the DT O
averaged VBN O
gross JJ O
EMG NN O
activity NN O
ot VBD O
the DT O
stretched JJ O
muscles NNS O
. . O

-DOCSTART- X X O

Hemolytic NNP O
disease NN O
of IN O
African JJ O
newborn JJ O
. . O

-DOCSTART- X X O

The DT O
majority NN O
of IN O
MRF NNP O
units NNS O
were VBD O
behaviorally RB O
incongruent JJ O
; : O
in IN O
the DT O
most RBS O
frequently RB O
observed VBN O
case NN O
, , O
their PRP$ O
activity NN O
failed VBD O
to TO O
change VB O
reliably RB O
when WRB O
behavior NN O
habituated VBD O
. . O

-DOCSTART- X X O

Variability NNP O
within IN O
Down NNP O
's POS O
syndrome NN O
( -LRB- O
trisomy-21 JJ O
) -RRB- O
: : O
empirically RB O
observed VBD O
sex NN O
differences NNS O
in IN O
IQs NNP O
. . O

-DOCSTART- X X O

Eight CD O
hours NNS O
after IN O
the DT O
administration NN O
of IN O
colchicine NN O
, , O
the DT O
serum NN B-NP
ceruloplasmin NN I-NP
level NN O
began VBD O
to TO O
rise VB O
again RB O
in IN O
female JJ O
rats NNS O
, , O
but CC O
not RB O
in IN O
male JJ O
rats NNS O
. . O

-DOCSTART- X X O

Radioimmunoassays NNP O
of IN O
pregnenolone NN O
, , O
progesterone NN O
, , O
dehydroepiandrosterone FW O
( -LRB- O
DHA NN O
) -RRB- O
16 CD O
alpha-hydroxy-DHA NNS O
, , O
estriol NN O
, , O
and CC O
cortisol NN O
were VBD O
performed VBN O
on IN O
a DT O
total NN O
of IN O
0;1 CD O
ml NN O
; : O
of IN O
fetal NN O
plasma NN O
, , O
collected VBN O
during IN O
the DT O
course NN O
of IN O
normal JJ O
vaginal JJ O
delivery NN O
. . O

-DOCSTART- X X O

In IN O
only RB O
two CD O
patients NNS O
were VBD O
we PRP O
able JJ O
to TO O
demonstrate VB O
changes NNS O
suggestive JJ O
of IN O
pulmonary JJ O
metastases NNS O
any DT O
earlier RBR O
with IN O
a DT O
99mTc-EHDP JJ O
scan NN O
than IN O
with IN O
chest NN O
radiographs NNS O
and CC O
one CD O
of IN O
these DT O
resolved VBN O
spontaneously RB O
. . O

-DOCSTART- X X O

The DT O
majority NN O
of IN O
tumors NNS O
occurred VBD O
in IN O
the DT O
nasal JJ O
cavities NNS O
, , O
although IN O
significant JJ O
incidences NNS O
were VBD O
also RB O
found VBN O
in IN O
the DT O
larynx NN O
, , O
trachea NN O
and CC O
stem NN O
bronchi NN O
. . O

-DOCSTART- X X O

Native JJ O
human JJ B-NP
fibrinogen NN I-NP
was VBD O
brought VBN O
to TO O
coagulation NN O
by IN O
adding VBG O
thrombin NN B-NP
. . O

-DOCSTART- X X O

The DT O
Southern NNP O
technique NN O
allowed VBD O
a DT O
further JJ O
localization NN O
of IN O
the DT O
region NN O
of IN O
most JJS O
extensive JJ O
transcription NN O
to TO O
a DT O
1.8 CD O
kb NN O
HindIII-EcoR NNP B-NP
I PRP B-NP
fragment NN O
. . O

-DOCSTART- X X O

SV NNP O
increased VBD O
less RBR O
in IN O
SHR NNP O
, , O
mainly RB O
reflecting VBG O
the DT O
reduced VBN O
diastolic JJ O
compliance NN O
of IN O
the DT O
hypertrophied JJ O
SHR NNP O
left VBD O
ventricle NN O
and CC O
the DT O
consequent JJ O
rightward JJ O
shift NN O
of IN O
its PRP$ O
Frank-Starling JJ O
curve NN O
. . O

-DOCSTART- X X O

The DT O
carcass NN O
of IN O
a DT O
great JJ O
horned JJ O
owl NN O
( -LRB- O
Bubo NNP O
virginianus NN O
) -RRB- O
, , O
which WDT O
had VBD O
been VBN O
found VBN O
moribund JJ O
in IN O
southern JJ O
Ontario NNP O
, , O
was VBD O
presented VBN O
for IN O
necropsy NN O
. . O

-DOCSTART- X X O

Steroid NNP O
glucuronides NNS O
in IN O
amniotic JJ O
fluid NN O
at IN O
term NN O
. . O

-DOCSTART- X X O

Polyglactin NNP O
910 CD O
suture NN O
absorption NN O
and CC O
the DT O
role NN O
of IN O
cellular JJ O
enzymes NNS O
. . O

-DOCSTART- X X O

Studies NNS O
of IN O
lipoproteins NNS O
should MD O
, , O
however RB O
, , O
be VB O
made VBN O
in IN O
children NNS O
from IN O
families NNS O
known VBN O
to TO O
have VB O
FH NNP O
or CC O
early JJ O
coronary JJ O
heart NN O
disease NN O
. . O

-DOCSTART- X X O

Sixteen CD O
other JJ O
normal JJ O
subjects NNS O
with IN O
2 CD O
g NN O
of IN O
Metyrapone NNP O
are VBP O
best JJS O
responses NNS O
. . O

-DOCSTART- X X O

EEG NNP O
theta DT O
waves NNS O
and CC O
psychological JJ O
phenomena NNS O
: : O
a DT O
review NN O
and CC O
analysis NN O
. . O

-DOCSTART- X X O

REM NNP O
dream NN O
content NN O
was VBD O
scored VBN O
for IN O
categories NNS O
suggesting VBG O
the DT O
predominant JJ O
influence NN O
of IN O
the DT O
left JJ O
hemisphere NN O
, , O
e.g. FW O
, , O
good JJ O
ego NN O
functioning NN O
, , O
verbalization RB O
, , O
or CC O
the DT O
right JJ O
hemisphere NN O
, , O
e.g. FW O
, , O
music NN O
, , O
spatial JJ O
salience NN O
, , O
bizarreness NN O
. . O

-DOCSTART- X X O

Innervation NN O
of IN O
the DT O
ventral JJ O
diaphragm NN O
of IN O
the DT O
locust NN O
( -LRB- O
Locusta JJ O
migratoria NN O
) -RRB- O
. . O

-DOCSTART- X X O

Ectopic NNP O
ACTH NNP B-NP
syndrome NN O
and CC O
medullary NN O
thyroid VBD O
carcinoma NN O
. . O

-DOCSTART- X X O

Chronic NNP O
hypophosphatemia NN O
is VBZ O
the DT O
most RBS O
common JJ O
type NN O
of IN O
"resistant JJ O
" `` O
rickets NNS O
. . O

-DOCSTART- X X O

There EX O
was VBD O
no DT O
correlation NN O
between IN O
serum NN B-NP
LH NNP I-NP
and CC O
chronological NN O
or CC O
bone NN O
age NN O
in IN O
this DT O
age NN O
group NN O
, , O
which WDT O
suggests VBZ O
that IN O
the DT O
correlation NN O
found VBN O
is VBZ O
not RB O
due JJ O
to TO O
age-related JJ O
parallel JJ O
phenomena NNS O
. . O

-DOCSTART- X X O

Molecular JJ O
neurochemistry NN O
of IN O
addictive JJ O
drugs NNS O
. . O

-DOCSTART- X X O

Efforts NNS O
were VBD O
made VBN O
to TO O
determine VB O
the DT O
amount NN O
of IN O
time NN O
required VBN O
for IN O
kidney NN O
lesions NNS O
to TO O
develop VB O
and CC O
, , O
if IN O
possible JJ O
, , O
to TO O
delineate VB O
the DT O
potential JJ O
site NN O
of IN O
action NN O
of IN O
PBB NNP O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
succimer NN O
on IN O
the DT O
intensity NN O
of IN O
tricarboxylic JJ B-NP
acid NN I-NP
dehydrogenase NN I-NP
reactions NNS O
in IN O
the DT O
brain NN O
of IN O
rats NNS O
poisoned VBN O
with IN O
mercuric NN O
chloride NN O

-DOCSTART- X X O

Technetium-99m NNP O
stannous JJ O
pyrophosphate NN O
myocardial JJ O
scintigrams NNS O
were VBD O
obtained VBN O
in IN O
138 CD O
clinically RB O
stable JJ O
patients NNS O
32.7 IN O
+/ NNP O
- : O
47.3 CD O
weeks NNS O
( -LRB- O
range NN O
6 CD O
to TO O
260 CD O
) -RRB- O
after IN O
acute JJ O
myocardial JJ O
infarction NN O
. . O

-DOCSTART- X X O

A DT O
similar JJ O
phenomenon NN O
has VBZ O
been VBN O
reported VBN O
in IN O
a DT O
few JJ O
humans NNS O
. . O

-DOCSTART- X X O

The DT O
decline NN O
in IN O
the DT O
activity NN O
of IN O
cytochrome NN B-NP
oxidase NN I-NP
, , O
peroxidase NN B-NP
and CC O
in IN O
the DT O
lipid JJ O
content NN O
of IN O
peripheral JJ O
neutrophils NNS O
was VBD O
followed VBN O
by IN O
a DT O
decrease NN O
in IN O
the DT O
phagocytic JJ O
activity NN O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
2 CD O
patients NNS O
with IN O
pseudohypoparathyroidism NN O
type NN O
I PRP O
with IN O
vitamin-D-3 JJ O
and CC O
1 CD O
alpha-Hydroxycholecalciferol NN O
consecutively RB O
resulted VBD O
in IN O
a DT O
nonuniform NN O
response NN O
with IN O
regard NN O
to TO O
the DT O
normalisation NN O
of IN O
serum-calcium NN O
. . O

-DOCSTART- X X O

Total JJ O
VO2 NN O
was VBD O
decreased VBN O
in IN O
both DT O
groups NNS O
during IN O
severe JJ O
hypoxia NN O
but CC O
limb NN O
VO2 NNP O
was VBD O
maintained VBN O
in IN O
the DT O
beta-block NN O
group NN O
. . O
beta-Block NN O
prevented VBD O
the DT O
fall NN O
in IN O
total JJ O
and CC O
limb NN O
peripheral JJ O
resistance NN O
seen VBN O
in IN O
severe JJ O
hypoxia NN O
but CC O
did VBD O
not RB O
alter VB O
the DT O
consistently RB O
more RBR O
efficient JJ O
utilization NN O
of IN O
total JJ O
O2 NNP O
delivery NN O
shown VBN O
by IN O
the DT O
limb NN O
in IN O
comparison NN O
to TO O
the DT O
whole JJ O
body NN O
by IN O
higher JJR O
O2 IN O
extraction NN O
ratios NNS O
and CC O
lower JJR O
venous JJ O
O2 NNP O
pressure NN O
. . O
beta-Vasodilator NN B-NP
receptors NNS I-NP
evidently RB O
played VBD O
an DT O
active JJ O
part NN O
in IN O
the DT O
vasodilatation NN O
seen VBN O
during IN O
severe JJ O
hypoxia NN O
. . O

-DOCSTART- X X O

Phenobarbital-induced JJ O
alterations NNS O
in IN O
the DT O
metabolism NN O
of IN O
[3H]vitamin NN O
D3 NNS O
by IN O
the DT O
perfused JJ O
rachitic JJ O
rat NN O
liver NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
corticosteroid-containing JJ O
antirheumatic JJ O
combination NN O
drugs NNS O
on IN O
endogenous JJ O
ACTH NNP B-NP
and CC O
cortisol JJ O
production NN O
. . O

-DOCSTART- X X O

Anatomy NN O
of IN O
the DT O
RNA NNP O
and CC O
gene NN O
products NNS O
of IN O
MC29 NNP O
and CC O
MH2 NNP O
, , O
two CD O
defective JJ O
avian JJ O
tumor NN O
viruses NNS O
causing VBG O
acute JJ O
leukemia NN O
and CC O
carcinoma NN O
: : O
evidence NN O
for IN O
a DT O
new JJ O
class NN O
of IN O
transforming VBG O
genes NNS O
. . O

-DOCSTART- X X O

Gamma NNP B-NP
glutamyl NN I-NP
transpeptidase NN I-NP
activity NN O
was VBD O
increased VBN O
up RB O
to TO O
15 CD O
times NNS O
above IN O
the DT O
upper JJ O
normal JJ O
limit NN O
in IN O
children NNS O
, , O
who WP O
received VBD O
aminopyrine JJ O
for IN O
two CD O
weeks NNS O
or CC O
longer RB O
. . O

-DOCSTART- X X O

XXI. . O

-DOCSTART- X X O

A DT O
gas-liquid JJ O
chromatographic JJ O
method NN O
for IN O
the DT O
determination NN O
of IN O
p-chlorophenoxyisobutyric JJ O
( -LRB- O
CPIB NN O
) -RRB- O
acid NN O
in IN O
blood NN O
plasma NN O
is VBZ O
described VBN O
. . O

-DOCSTART- X X O

Dopamine NN B-NP
receptor NN I-NP
blockade NN O
and CC O
the DT O
neuroleptics NNS O
, , O
a DT O
crystallographic JJ O
study NN O
. . O

-DOCSTART- X X O

V. NNP O

-DOCSTART- X X O

How WRB O
do VBP O
graduates NNS O
of IN O
different JJ O
types NNS O
of IN O
programs NNS O
perform VBP O
on IN O
state NN O
boards NNS O
? . O

-DOCSTART- X X O

Because IN O
of IN O
serious JJ O
infections NNS O
( -LRB- O
fever NN O
larger JJR O
than IN O
or CC O
equal JJ O
to TO O
101 CD O
degrees NNS O
F. NNP O
granulocytes VBZ O
less RBR O
than IN O
1,000/mm CD O
, , O
3 CD O
and CC O
hospitalization NN O
) -RRB- O
and CC O
1 CD O
drug NN O
death NN O
in IN O
the DT O
first JJ O
4 CD O
patients NNS O
, , O
oral JJ O
calcium NN O
leucovorin NN O
, , O
20 CD O
to TO O
30 CD O
mg/m2 CD O
orally RB O
, , O
was VBD O
given VBN O
2 CD O
days NNS O
after IN O
methotrexate NN O
in IN O
subsequent JJ O
treatment NN O
cycles NNS O
. . O

-DOCSTART- X X O

Here RB O
the DT O
conventional JJ O
tests NNS O
clearly RB O
pointed VBD O
to TO O
the DT O
presence NN O
of IN O
retrocochlear JJ O
disease NN O
. . O

-DOCSTART- X X O

The DT O
end-stage NN O
or CC O
involutional JJ O
phase NN O
of IN O
proliferative JJ O
diabetic NN O
retinopathy NN O
may MD O
result VB O
in IN O
stabilization NN O
of IN O
vision NN O
for IN O
long JJ O
periods NNS O
of IN O
time NN O
. . O

-DOCSTART- X X O

In IN O
patients NNS O
who WP O
were VBD O
not RB O
vented VBN O
, , O
there EX O
was VBD O
overall JJ O
significant JJ O
depression NN O
of IN O
function NN O
( -LRB- O
67 CD O
+/ NN O
- : O
5 CD O
% NN O
of IN O
control NN O
; : O
range NN O
, , O
91--45 CD O
% NN O
, , O
p NN O
less JJR O
than IN O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Changes NNS O
in IN O
body NN O
weight NN O
and CC O
agonistic JJ O
behavior NN O
were VBD O
also RB O
recorded VBN O
. . O

-DOCSTART- X X O

Use NN O
of IN O
radioactive JJ O
isotopes NNS O
in IN O
the DT O
chemistry NN O
of IN O
proteins NNS O

-DOCSTART- X X O

Antenatal JJ O
diagnosis NN O
of IN O
haematological JJ O
disorders--'1978' JJ O
. . O

-DOCSTART- X X O

Gonadal NNP O
dysfunction NN O
in IN O
patients NNS O
with IN O
ataxia DT O
telangiectasia NN O
. . O

-DOCSTART- X X O

Most JJS O
of IN O
the DT O
phenomena NNS O
of IN O
azotaemic JJ O
osteodystrophy NN O
are VBP O
encountered VBN O
in IN O
simple JJ O
vitamin NN O
D NN O
deficiency NN O
; : O
as IN O
in IN O
that DT O
condition NN O
, , O
deficiency NN O
of IN O
1,25-dihydroxycholecalciferol CD O
may MD O
be VB O
of IN O
primary JJ O
significance NN O
in IN O
causing VBG O
secondary JJ O
hyperparathyroidism NN O
in IN O
renal JJ O
failure NN O
. . O

-DOCSTART- X X O

Basal NNP O
FSH NNP B-NP
and CC O
LH NNP B-NP
levels NNS O
were VBD O
significantly RB O
lower JJR O
in IN O
addicts NNS O
; : O
after IN O
GnRH NNP B-NP
stimulation NN O
the DT O
addicts NNS O
' POS O
FSH NNS B-NP
and CC O
LH VB B-NP
values NNS O
increased VBN O
but CC O
not RB O
significantly RB O
compared VBN O
to TO O
controls NNS O
. . O

-DOCSTART- X X O

Adriamycin NNP O
: : O
comparison NN O
of IN O
a DT O
5-week JJ O
schedule NN O
with IN O
a DT O
3-week JJ O
schedule NN O
in IN O
the DT O
treatment NN O
of IN O
breast NN O
cancer NN O
. . O

-DOCSTART- X X O

Follow-up JJ O
controls NNS O
of IN O
luteinizing VBG B-NP
hormone NN I-NP
( -LRB- O
LH) NNP B-NP
, , O
follicle NN B-NP
stimulating NN I-NP
hormone NN I-NP
( -LRB- O
FSH) NNP B-NP
, , O
prolactin NN B-NP
( -LRB- O
HPRL) NNP B-NP
, , O
oestradiol JJ O
( -LRB- O
E2 NN O
) -RRB- O
, , O
progesterone FW O
( -LRB- O
P NNP O
) -RRB- O
and CC O
testosterone NN O
( -LRB- O
T NNP O
) -RRB- O
in IN O
the DT O
catabolic JJ O
and CC O
healing JJ O
phase NN O
of IN O
burn NN O
disease NN O
. . O

-DOCSTART- X X O

Renin NNP B-NP
studies NNS O
performed VBD O
in IN O
34 CD O
hypertensive JJ O
patients NNS O
and CC O
in IN O
a DT O
control NN O
group NN O
of IN O
11 CD O
recipients NNS O
showed VBD O
that IN O
elevation NN O
of IN O
plasma NN B-NP
renin NN I-NP
activity NN O
and CC O
of IN O
plasma NN O
aldosterone NN O
level NN O
is VBZ O
frequent JJ O
but CC O
difficult JJ O
to TO O
interpret VB O
, , O
particularly RB O
when WRB O
a DT O
renal JJ O
artery NN O
stenosis NN O
is VBZ O
observed VBN O
. . O

-DOCSTART- X X O

A DT O
randomized JJ O
clinical JJ O
trial NN O
in IN O
sixty-two CD O
adult NN O
patients NNS O
suffering VBG O
from IN O
typhoid JJ O
fever NN O
, , O
proved VBN O
by IN O
blood NN O
and CC O
marrow JJ O
culture NN O
, , O
showed VBD O
that IN O
amoxycillin NN O
in IN O
a DT O
dosage NN O
schedule NN O
of IN O
1 CD O
g NN O
8-hourly JJ O
orally RB O
for IN O
fourteen CD O
days NNS O
was VBD O
better JJR O
than IN O
chloramphenicol NN O
with IN O
regard NN O
to TO O
clinical JJ O
and CC O
temperature NN O
response NN O
and CC O
in IN O
respect NN O
of IN O
carriers NNS O
and CC O
relapse NN O
rates NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
inhibition NN O
of IN O
pepsin NN B-NP
in IN O
human JJ O
gastric JJ O
juice NN O
does VBZ O
not RB O
appear VB O
to TO O
have VB O
a DT O
major JJ O
influence NN O
on IN O
the DT O
healing NN O
of IN O
duodenal JJ O
ulcer NN O
. . O

-DOCSTART- X X O

The DT O
IDF NNP O
standard NN O
method NN O
for IN O
the DT O
detection NN O
of IN O
penicillin NN O
in IN O
milk NN O
is VBZ O
not RB O
suitable JJ O
for IN O
the DT O
detection NN O
of IN O
sulphonamide NN O
residues NNS O
in IN O
milk NN O
. . O

-DOCSTART- X X O

Capsular NNP O
antigens NNS O
of IN O
Staphylococcus NNP O
aureus NN O

-DOCSTART- X X O

The DT O
course NN O
of IN O
endotoxin NN O
fever NN O
remained VBD O
uninfluenced JJ O
by IN O
ALS. NNP O

-DOCSTART- X X O

2 CD O
new JJ O
Algerian JJ O
cases NNS O

-DOCSTART- X X O

Seventy-one CD O
percent NN O
of IN O
patients NNS O
treated VBN O
with IN O
ticarcillin NN O
alone RB O
responded VBD O
favorably RB O
. . O

-DOCSTART- X X O

Accurate NNP O
pathologic NN O
staging NN O
identifies VBZ O
patients NNS O
who WP O
are VBP O
potentially RB O
curable JJ O
with IN O
radiotherapy NN O
. . O

-DOCSTART- X X O

2. . O

-DOCSTART- X X O

Changes NNS O
in IN O
tissue NN O
PCO2 NNS O
were VBD O
less RBR O
dramatic JJ O
and CC O
did VBD O
not RB O
vary VB O
significantly RB O
from IN O
those DT O
recorded VBN O
in IN O
venous JJ O
blood NN O
. . O

-DOCSTART- X X O

Ultrasonic NNP O
evaluation NN O
of IN O
renal JJ O
calculi NNS O
. . O

-DOCSTART- X X O

Isolation NNP O
of IN O
T. NNP O
gambiense NN O
strains NNS O
in IN O
Zaire NNP O
and CC O
their PRP$ O
adaptation NN O
to TO O
laboratory NN O
animals NNS O

-DOCSTART- X X O

Intestinal JJ O
adaptation NN O
( -LRB- O
first JJ O
of IN O
two CD O
parts NNS O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
techniques NNS O
have VBP O
been VBN O
used VBN O
by IN O
many JJ O
people NNS O
for IN O
many JJ O
years NNS O
and CC O
no DT O
claim NN O
is VBZ O
being VBG O
made VBN O
for IN O
any DT O
innovation NN O
in IN O
this DT O
regard NN O
. . O

-DOCSTART- X X O

A DT O
total JJ O
of IN O
57 CD O
patients NNS O
with IN O
Hodgkin NNP O
's POS O
disease NN O
limited VBN O
to TO O
above IN O
the DT O
diaphragm FW O
( -LRB- O
Stages NNS O
I PRP O
and CC O
II NNP O
, , O
A DT O
and CC O
B) NN O
were VBD O
treated VBN O
with IN O
radiation NN O
therapy NN O
alone RB O
at IN O
the DT O
University NNP O
of IN O
Florida NNP O
between IN O
1964 CD O
and CC O
1974 CD O
. . O

-DOCSTART- X X O

Year NN O
one CD O
of IN O
the DT O
first JJ O
general JJ O
practitioner NN O
medical JJ O
unit NN O
in IN O
the DT O
greater JJR O
Glasgow NNP O
area NN O
. . O

-DOCSTART- X X O

This DT O
multiple-electrode JJ O
array NN O
for IN O
round JJ O
window NN O
cochlear NN O
implantation NN O
is VBZ O
a DT O
robust JJ O
, , O
reliable JJ O
system NN O
for IN O
inserting VBG O
20 CD O
mm CD O
along IN O
the DT O
scala NN O
tympani NNS O
with IN O
a DT O
minimum NN O
of IN O
trauma NN O
and CC O
can MD O
provide VB O
for IN O
bipolar JJ O
stimulation NN O
. . O

-DOCSTART- X X O

As IN O
authorized VBN O
by IN O
the DT O
World NNP O
Health NNP O
Organization NNP O
29th IN O
Expert NNP O
Committee NNP O
on IN O
Biological NNP O
Standardization NNP O
, , O
the DT O
preparation NN O
of IN O
human JJ B-NP
prolactin NN I-NP
in IN O
ampoules NNS O
coded VBD O
75/504 CD O
has VBZ O
been VBN O
established VBN O
as IN O
the DT O
International NNP O
Reference NNP O
Preparation NNP O
( -LRB- O
IRP NNP O
) -RRB- O
of IN O
human JJ B-NP
prolactin NN I-NP
for IN O
immunoassay NN O
. . O

-DOCSTART- X X O

i NN O
. . O

-DOCSTART- X X O

Biliary-enteric JJ O
fistulas NNS O

-DOCSTART- X X O

Such JJ O
marked JJ O
differences NNS O
are VBP O
found VBN O
occasionally RB O
in IN O
the DT O
literature NN O
: : O
heterophile NN O
antibodies NNS O
against IN O
bovine JJ B-NP
gammaglobulin NN I-NP
are VBP O
regarded VBN O
as IN O
responsible JJ O
for IN O
the DT O
interference NN O
in IN O
the DT O
Sephadex NNP O
system NN O
of IN O
RIST. NNP O

-DOCSTART- X X O

" `` O
Let VB O
the DT O
hundred CD O
flowers NNS O
bloom" NN O
. . O

-DOCSTART- X X O

Various JJ O
treatment NN O
modalities NNS O
are VBP O
reviewed VBN O
in IN O
the DT O
context NN O
of IN O
the DT O
psychology NN O
as RB O
well RB O
as IN O
the DT O
physiology NN O
of IN O
severe JJ O
intractable JJ O
pain NN O
. . O

-DOCSTART- X X O

Lethal JJ O
Tachmalcor NNP O
( -LRB- O
4-( JJ O
3'-diethylamino-2'-hydroxypropyl)-ajmaline NN O
) -RRB- O
poisoning NN O
in IN O
childhood NN O

-DOCSTART- X X O

Serum NN O
ferritin NN B-NP
concentration NN O
and CC O
bone NN O
marrow NN O
iron NN O
stores NNS O
. . O

-DOCSTART- X X O

A DT O
prospective JJ O
trail NN O
comparing VBG O
hysterectomy NN O
, , O
hysterectomy NN O
plus CC O
vaginal JJ O
radium NN O
, , O
and CC O
uterine NN O
radium NN O
plus CC O
hysterectomy NN O
in IN O
stage NN O
I PRP O
endometrial VBP O
carcinoma NN O
. . O

-DOCSTART- X X O

On IN O
the DT O
basis NN O
of IN O
a DT O
patient NN O
's POS O
report NN O
of IN O
one CD O
inaccurate JJ O
Clinitemp NNP O
, , O
we PRP O
undertook VBD O
to TO O
investigate VB O
the DT O
accuracy NN O
of IN O
this DT O
thermometer NN O
. . O

-DOCSTART- X X O

Cryoglobulinemia NNP O
in IN O
Raynaud NNP O
's POS O
syndrome NN O

-DOCSTART- X X O

Data NNP O
were VBD O
processed VBN O
with IN O
a DT O
semi-automatic JJ O
computer NN O
program NN O
which WDT O
develops VBZ O
an DT O
averaged-volume JJ O
curve NN O
from IN O
an DT O
assigned VBN O
LV NNP O
region-of-interest NN O
. . O

-DOCSTART- X X O

The DT O
preferential JJ O
serum NN B-NP
IgA IN I-NP
response NN O
observed VBN O
in IN O
the DT O
patient JJ O
population NN O
suggests VBZ O
that IN O
bronchial JJ O
associated JJ O
lymphoid JJ O
tissue NN O
in IN O
the DT O
diseased JJ O
lung NN O
is VBZ O
an DT O
important JJ O
source NN O
of IN O
circulating VBG O
IgA NNP B-NP
. . O

-DOCSTART- X X O

Ultimate NNP O
strengthes NNS O
seem VBP O
to TO O
be VB O
reached VBN O
for IN O
cast NN O
cobalt NN O
alloys NNS O
, , O
whereas IN O
titanium NN O
alloys NNS O
, , O
such JJ O
as IN O
Ta NNP O
6 CD O
V NNP O
, , O
present RB O
very RB O
high JJ O
fatigue NN O
limit NN O
under IN O
corrosion NN O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
intracisternal JJ O
injection NN O
( -LRB- O
i.c.i JJ O
. . O
) -RRB- O
of IN O
clonidine NN O
( -LRB- O
1 CD O
microgram NN O
kg-1 NN O
) -RRB- O
on IN O
blood NN O
pressure NN O
and CC O
heart NN O
rate NN O
were VBD O
studied VBN O
in IN O
conscious JJ O
rabbits NNS O
with IN O
an DT O
implanted JJ O
catheter NN O
in IN O
the DT O
cisterna NN O
magna NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
8 CD O
patients NNS O
the DT O
difference NN O
betweent IN O
he PRP O
mean VB O
diastolic JJ O
values NNS O
of IN O
delta NN O
PU NNP O
and CC O
delta JJ O
PM NNP O
was VBD O
- : O
0.54 CD O
+/ NN O
- : O
1.0 CD O
( -LRB- O
SD NNP O
) -RRB- O
mmHg NN O
. . O

-DOCSTART- X X O

A DT O
rise NN O
of IN O
hemoglobin NN B-NP
concentration NN O
accompanied VBN O
by IN O
an DT O
increase NN O
of IN O
the DT O
total JJ O
iron NN O
in IN O
the DT O
blood NN O
serum NN O
of IN O
white JJ O
mice NNS O
was VBD O
found VBN O
under IN O
oxygen NN O
pressure NN O
of IN O
4 CD O
atm NN O
for IN O
an DT O
hour NN O
( -LRB- O
preconvulsive JJ O
state NN O
) -RRB- O
and CC O
6 CD O
atm NN O
( -LRB- O
convulsive JJ O
state NN O
) -RRB- O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
methylene NN O
chloride NN O
, , O
trichloroethane NN O
, , O
trichloroethylene NN O
, , O
tetrachloroethylene NN O
and CC O
toluene NN O
on IN O
the DT O
development NN O
of IN O
chick NN O
embryos NNS O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
intraventricular JJ O
administration NN O
of IN O
streptolysin NN B-NP
O NNP I-NP
on IN O
the DT O
electroencephalogram NN O
of IN O
rabbits NNS O
. . O

-DOCSTART- X X O

The DT O
biochemistry NN O
of IN O
amniotic JJ O
fluid NN O
with IN O
poor JJ O
fetal NN O
growth NN O
. . O

-DOCSTART- X X O

Resistance NN O
to TO O
the DT O
simulated VBN O
physiologic NN O
environment NN O
was VBD O
tested VBN O
by IN O
measured VBN O
retention NN O
of IN O
mechanical JJ O
properties NNS O
after IN O
immersion NN O
times NNS O
in IN O
pseudo-extracellular JJ O
fluid NN O
( -LRB- O
PECF NN O
) -RRB- O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
as RB O
long JJ O
as IN O
three CD O
years NNS O
. . O

-DOCSTART- X X O

Isolated NNP O
calcaneal NN O
tuberculous JJ O
osteomyelitis NN O
. . O

-DOCSTART- X X O

In IN O
case NN O
of IN O
a DT O
pathologically RB O
convoluted VBN O
internal JJ O
carotid NN O
the DT O
common JJ O
carotid NN O
artery NN O
was VBD O
resected VBN O
with IN O
an DT O
end-to-end JJ O
anastomosis NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
confirm VBP O
the DT O
existence NN O
of IN O
hyperlipemic JJ O
abdominal JJ O
crisis NN O
as IN O
a DT O
distinct JJ O
entity NN O
and CC O
testify VB O
to TO O
the DT O
importance NN O
of IN O
recognizing VBG O
this DT O
syndrome NN O
in IN O
order NN O
to TO O
avoid VB O
the DT O
occurrence NN O
of IN O
acute JJ O
pancreatitis NN O
and CC O
the DT O
performance NN O
of IN O
unnecessary JJ O
and CC O
potentially RB O
harmful JJ O
surgery NN O
. . O

-DOCSTART- X X O

Their PRP$ O
conduction NN O
velocity NN O
ranged VBD O
from IN O
0.23 CD O
to TO O
0.98 CD O
m/sec NN O
( -LRB- O
group NN O
C NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
failures NNS O
frequently RB O
were VBD O
related VBN O
to TO O
patient JJ O
intolerance NN O
or CC O
poor JJ O
mechanical JJ O
fit NN O
and CC O
occurred VBD O
in IN O
the DT O
first JJ O
few JJ O
days NNS O
or CC O
first JJ O
few JJ O
months NNS O
after IN O
insertion NN O
. . O

-DOCSTART- X X O

The DT O
major JJ O
urinary JJ O
metabolites NNS O
were VBD O
3-(3-carboxyphenyl)-5-hydroxymethyl-2-oxazolidinone CD O
and CC O
a DT O
glucuronide NN O
of IN O
toloxatone NN O
. . O

-DOCSTART- X X O

Carbohydrate NNP O
metabolism NN O
and CC O
the DT O
semen NNS O
profile NN O
: : O
glucose NN O
, , O
insulin NN B-NP
, , O
and CC O
sperm JJ O
studies NNS O
. . O

-DOCSTART- X X O

The DT O
sub-acute JJ O
inhalation NN O
toxicity NN O
of IN O
furfural NN O
was VBD O
studied VBN O
in IN O
Syrian JJ O
golden JJ O
hamsters NNS O
. . O

-DOCSTART- X X O

Changes NNS O
of IN O
thirtynine DT O
serum JJ O
protein NN O
components NNS O
following VBG O
surgical JJ O
stress NN O
. . O

-DOCSTART- X X O

These DT O
differences NNS O
are VBP O
smaller JJR O
than IN O
those DT O
described VBN O
in IN O
standard JJ O
textbooks NNS O
. . O

-DOCSTART- X X O

An DT O
intravenous JJ O
preparation NN O
of IN O
doxycycline NN O
( -LRB- O
DOTC NNP O
, , O
Vibramycin NNP O
'Pfizer NNP O
') VBZ O
, , O
a DT O
long-lasting JJ O
tetracycline NN O
, , O
was VBD O
administered VBN O
mainly RB O
by IN O
drip NN O
infusion NN O
for IN O
a DT O
series NN O
of IN O
study NN O
in IN O
the DT O
pediatrics NNS O
field NN O
, , O
and CC O
the DT O
results NNS O
were VBD O
as IN O
follows VBZ O
: : O
1 CD O
) -RRB- O
DOTC VB O
( -LRB- O
100 CD O
mg NN O
) -RRB- O
was VBD O
dissolved VBN O
in IN O
a DT O
100 CD O
ml NN O
of IN O
glucose JJ O
solution NN O
and CC O
2--3 JJ O
mg/kg NN O
was VBD O
administered VBN O
intravenously RB O
. . O

-DOCSTART- X X O

5 CD O
) -RRB- O
Before IN O
and CC O
ten CD O
days NNS O
after IN O
DOTC NNP O
infusion NN O
, , O
laboratory NN O
tests NNS O
for IN O
liver NN O
and CC O
renal JJ O
functions NNS O
and CC O
blood NN O
were VBD O
performed VBN O
. . O

-DOCSTART- X X O

The DT O
enteric JJ O
route NN O
is VBZ O
the DT O
principal JJ O
mode NN O
of IN O
transmission NN O
for IN O
hepatitis NN O
A NNP O
, , O
but CC O
maximal JJ O
levels NNS O
of IN O
hepatitis NN O
A DT O
virus NN O
excretion NN O
occur VBP O
before IN O
the DT O
onset NN O
of IN O
jaundice NN O
. . O

-DOCSTART- X X O

Irradiation NN O
of IN O
human JJ O
blood NN O
platelets NNS O
with IN O
UV-A NNP O
in IN O
vitro NN O
impairs NNS O
their PRP$ O
ability NN O
to TO O
aggregate VB O
after IN O
challenge NN O
with IN O
collagen NN B-NP
. . O

-DOCSTART- X X O

With IN O
certain JJ O
exceptions NNS O
the DT O
method NN O
was VBD O
considered VBN O
suitable JJ O
in IN O
the DT O
routine JJ O
intravenous JJ O
cholangiography NN O
. . O

-DOCSTART- X X O

The DT O
six CD O
commonest JJ O
causes NNS O
of IN O
death NN O
varied VBN O
in IN O
the DT O
three CD O
ethnic JJ O
groups NNS O
. . O

-DOCSTART- X X O

Although IN O
Grice NNP O
's POS O
operation NN O
has VBZ O
been VBN O
used VBN O
all PDT O
over IN O
the DT O
world NN O
, , O
no DT O
systematic JJ O
account NN O
of IN O
it PRP O
has VBZ O
been VBN O
found VBN O
in IN O
the DT O
literature NN O
( -LRB- O
including VBG O
publications NNS O
dealing VBG O
with IN O
technique NN O
) -RRB- O
, , O
which WDT O
presents VBZ O
it PRP O
in IN O
terms NNS O
related VBN O
to TO O
the DT O
basic JJ O
" `` O
classical JJ O
" '' O
principles NNS O
on IN O
which WDT O
the DT O
operation NN O
was VBD O
conceived VBN O
. . O

-DOCSTART- X X O

( -LRB- O
5 CD O
) -RRB- O
No DT O
changes NNS O
were VBD O
observed VBN O
in IN O
the DT O
gastric JJ O
venous JJ O
blood NN O
flow NN O
by IN O
continuous JJ O
intravenous JJ O
injection NN O
of IN O
cimetidine NN O
, , O
but CC O
by IN O
rapid JJ O
injection NN O
both CC O
the DT O
flow NN O
was VBD O
augmented VBN O
and CC O
the DT O
systemic JJ O
blood NN O
pressure NN O
decreased VBN O
transiently RB O
. . O

-DOCSTART- X X O

Study VB O
on IN O
re-establishment NN O
of IN O
ovulation NN O
after IN O
termination NN O
of IN O
sex-steroidal JJ O
treatment NN O
--compared JJ O
with IN O
re-appearance NN O
of IN O
ovulation NN O
after IN O
abortion NN O
and CC O
premature JJ O
delivery NN O
. . O

-DOCSTART- X X O

Pharmacokinetics NNP O
of IN O
Carbamazepine NNP O
in IN O
man NN O
: : O
a DT O
review NN O
. . O

-DOCSTART- X X O

Of IN O
the DT O
compounds NNS O
tested VBN O
, , O
alpha-(3-methyl-2-quinoxalinyl)-N-methylnitrone JJ O
1,4-dioxide JJ O
( -LRB- O
2 CD O
) -RRB- O
was VBD O
the DT O
most RBS O
active JJ O
agent NN O
in IN O
vivo NN O
against IN O
the DT O
gram-negative JJ O
and CC O
the DT O
gram-positive JJ O
organisms NNS O
. . O

-DOCSTART- X X O

Changes NNS O
in IN O
ionic JJ O
content NN O
of IN O
the DT O
mucous JJ O
suggest VBP O
that IN O
cholinergic JJ O
mechanisms NNS O
affect VBP O
pressure NN O
in IN O
the DT O
excretory JJ O
duct NN O
of IN O
the DT O
gland NN O
. . O

-DOCSTART- X X O

Delayed JJ O
mortality NN O
of IN O
mice NNS O
following VBG O
inhalation NN O
of IN O
acute JJ O
doses NNS O
of IN O
CH2O NNP O
, , O
SO2Cl2 NNP O
, , O
and CC O
Br2 NNP O
. . O

-DOCSTART- X X O

Under IN O
halothane NN O
anesthesia NN O
, , O
the DT O
flow NN O
pneumocardiogram NN O
( -LRB- O
PnCG) NNP O
and CC O
its PRP$ O
time NN O
derivative JJ O
( -LRB- O
acceleration NN O
pneumocardiogram NN O
or CC O
dPn/dt NN O
) -RRB- O
were VBD O
transduced VBN O
during IN O
apnea NN O
by IN O
a DT O
small JJ O
high-gain JJ O
pneumotachograph NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
concluded VBN O
that IN O
stereotypy NN O
can MD O
be VB O
evoked VBN O
also RB O
in IN O
the DT O
case NN O
when WRB O
the DT O
striatal JJ O
dopaminergic JJ O
tone NN O
is VBZ O
normal JJ O
or CC O
even RB O
below IN O
normal JJ O
: : O
it PRP O
is VBZ O
the DT O
equilibrium NN O
of IN O
the DT O
striatal JJ O
cholinergic-dopaminergic JJ O
systems NNS O
which WDT O
must MD O
be VB O
shifted VBN O
towards IN O
dopamine NN O
, , O
which WDT O
is VBZ O
necessary JJ O
for IN O
the DT O
development NN O
of IN O
this DT O
behavioral JJ O
manifestation NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
duodenum NN O
a DT O
small JJ O
part NN O
of IN O
the DT O
administered VBN O
dose NN O
was VBD O
transformed VBN O
to TO O
3H-alpha-acetyldigoxin NN O
. . O

-DOCSTART- X X O

Functional JJ O
effects NNS O
following VBG O
subacute JJ O
administration NN O
. . O

-DOCSTART- X X O

Although IN O
it PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
it PRP O
is VBZ O
possible JJ O
to TO O
use VB O
orally RB O
administered VBN O
testosterone NN O
to TO O
maintain VB O
se-T JJ O
levels NNS O
in IN O
the DT O
normal JJ O
male NN O
range NN O
, , O
the DT O
convenience NN O
to TO O
the DT O
patient NN O
must MD O
be VB O
balanced VBN O
against IN O
the DT O
cost NN O
and CC O
possible JJ O
side NN O
effects NNS O
of IN O
the DT O
large JJ O
doses NNS O
required VBD O
. . O

-DOCSTART- X X O

Nursing NNP O
of IN O
patients NNS O
with IN O
gynecological JJ O
diseases NNS O

-DOCSTART- X X O

Ovarian JJ O
allotransplantation NN O
in IN O
human NN O
. . O

-DOCSTART- X X O

Allergic NNP O
reaction NN O
to TO O
Patent NNP O
Blue NNP O
Violet NNP O
during IN O
lymphography NN O
. . O

-DOCSTART- X X O

Screening NN O
of IN O
asthma NN O
patients NNS O
by IN O
determination NN O
of IN O
IgE NNP B-NP
and CC O
by IN O
comprehension NN O
of IN O
spectrum NN O
of IN O
allergospecific JJ B-NP
IgE NNP I-NP
antibodies NNS I-NP

-DOCSTART- X X O

One-third NNP O
of IN O
the DT O
men NNS O
with IN O
azoospermia NN O
and CC O
with IN O
sperm JJ O
density NN O
of IN O
less JJR O
than IN O
10 CD O
million CD O
had VBD O
marked VBN O
FSH NNP B-NP
elevation NN O
and CC O
our PRP$ O
experience NN O
confirms VBZ O
the DT O
work NN O
of IN O
others NNS O
that IN O
this DT O
indicates VBZ O
a DT O
poor JJ O
prognosis NN O
. . O

-DOCSTART- X X O

In IN O
girls NNS O
prolactin VBP B-NP
levels NNS O
rise VBP O
at IN O
stage NN O
2 CD O
, , O
and CC O
are VBP O
higher JJR O
after IN O
menarche PRP O
; : O
in IN O
boys NNS O
there EX O
is VBZ O
no DT O
change NN O
in IN O
prolactin NN B-NP
levels NNS O
. . O

-DOCSTART- X X O

In IN O
one CD O
patient NN O
with IN O
severe JJ O
diarrhea NN O
the DT O
estriol NN O
concentration NN O
in IN O
serum NN O
was VBD O
low JJ O
until IN O
the DT O
intestinal JJ O
function NN O
normalised VBD O
and CC O
the DT O
estriol NN O
concentration NN O
went VBD O
up RP O
exactly RB O
when WRB O
the DT O
diarrhea NN O
stopped VBD O
. . O

-DOCSTART- X X O

Serum NN O
levels NNS O
of IN O
IgG NNP B-NP
and CC O
IgM NNP B-NP
were VBD O
also RB O
raised VBN O
, , O
but CC O
contrary NN O
to TO O
the DT O
findings NNS O
of IN O
other JJ O
observers NNS O
IgA IN B-NP
levels NNS O
were VBD O
normal JJ O
. . O

-DOCSTART- X X O

To TO O
study VB O
the DT O
sensitivity NN O
of IN O
some DT O
central JJ O
brain NN O
structures NNS O
to TO O
the DT O
action NN O
of IN O
an DT O
electromagnetic JJ O
field NN O
of IN O
decimeter NN O
waves NNS O
( -LRB- O
EMF NN O
of IN O
DW) VBG O
a DT O
dynamic JJ O
investigation NN O
of IN O
single JJ O
unit NN O
activity NN O
was VBD O
undertaken VBN O
. . O

-DOCSTART- X X O

No DT O
systematic JJ O
L-R NN O
differences NNS O
were VBD O
observed VBN O
. . O

-DOCSTART- X X O

A DT O
decrease NN O
of IN O
the DT O
lysozyme NN B-NP
activity NN O
coincided VBD O
with IN O
the DT O
clinical JJ O
improvement NN O
of IN O
the DT O
bacterial JJ O
meningitis NN O
. . O

-DOCSTART- X X O

This DT O
implies VBZ O
that IN O
the DT O
groups NNS O
do VBP O
not RB O
just RB O
differ VB O
along IN O
one CD O
dimension NN O
, , O
but CC O
along IN O
three CD O
dimensions NNS O
. . O

-DOCSTART- X X O

Deep JJ O
tans NNS O
were VBD O
induced VBN O
over IN O
the DT O
backs NNS O
of IN O
volunteers NNS O
with IN O
repeated VBN O
exposure NN O
to TO O
longwave VB O
ultraviolet NN O
radiation NN O
( -LRB- O
UV-A NN O
) -RRB- O
. . O

-DOCSTART- X X O

1 CD O
The DT O
effects NNS O
in IN O
normal JJ O
subjects NNS O
of IN O
a DT O
single JJ O
oral JJ O
dose NN O
of IN O
Motival NN O
( -LRB- O
one CD O
tablet NN O
, , O
containing VBG O
fluphenazine NN O
0.5 CD O
mg NN O
and CC O
nortriptyline NN O
10 CD O
mg NN O
) -RRB- O
on IN O
the DT O
contingent JJ O
negative JJ O
variation NN O
( -LRB- O
CNV) NNP O
, , O
reaction NN O
time NN O
, , O
heart NN O
rate NN O
, , O
blood NN O
pressure NN O
and CC O
self-rating JJ O
scales NNS O
for IN O
alertness NN O
, , O
anxiety NN O
, , O
tension NN O
, , O
detachment NN O
and CC O
depression NN O
were VBD O
compared VBN O
with IN O
those DT O
of IN O
diazepam NN O
( -LRB- O
5 CD O
mg NN O
and CC O
7.5 CD O
mg NN O
) -RRB- O
and CC O
placebo NN O
or CC O
propranolol NN O
( -LRB- O
60 CD O
mg NN O
) -RRB- O
. . O

-DOCSTART- X X O

Smoking NNP O
was VBD O
regarded VBN O
as IN O
the DT O
major JJ O
contribution NN O
to TO O
pulmonary JJ O
dysfunction NN O
. . O

-DOCSTART- X X O

The DT O
malignity NN O
of IN O
nevoid JJ O
lentigo NN O
. . O

-DOCSTART- X X O

Elimination NNP O
of IN O
bagassosis NN O
in IN O
Louisiana NNP O
paper NN O
manufacturing NN O
plant NN O
workers NNS O
. . O

-DOCSTART- X X O

Internally RB O
oriented VBN O
patients NNS O
' POS O
scores NNS O
on IN O
Rotter NNP O
's POS O
Internal-External NNP O
Locus NNP O
of IN O
Control NNP O
Scale NNP O
remained VBD O
the DT O
same JJ O
over IN O
treatment NN O
but CC O
those DT O
of IN O
externally RB O
oriented VBN O
patients NNS O
shifted VBD O
toward IN O
greater JJR O
internal JJ O
control NN O
. . O

-DOCSTART- X X O

2 LS O
) -RRB- O
The DT O
time-sharing NN O
principle NN O
was VBD O
applied VBN O
to TO O
gain VB O
high JJ O
stability NN O
. . O

-DOCSTART- X X O

When WRB O
blood NN O
samples NNS O
of IN O
patients NNS O
with IN O
hyperbilirubinemia NN O
were VBD O
analyzed VBN O
, , O
direct JJ O
measurement NN O
of IN O
ZPP NNP O
by IN O
this DT O
fluorimeter NN O
yielded VBD O
significantly RB O
higher JJR O
levels NNS O
than IN O
did VBD O
an DT O
alternate JJ O
extraction NN O
method NN O
. . O

-DOCSTART- X X O

Delayed JJ O
hypersensitivity NN O
in IN O
man NN O
: : O
effects NNS O
of IN O
systemic JJ O
anticoagulation NN O
. . O

-DOCSTART- X X O

In IN O
three CD O
of IN O
the DT O
seven CD O
, , O
inhalation IN O
of IN O
2 CD O
ml JJ O
normal JJ O
saline NN O
produced VBD O
FEV1 JJ O
falls NNS O
of IN O
25 CD O
% NN O
to TO O
30 CD O
% NN O
, , O
but CC O
these DT O
falls NNS O
were VBD O
not RB O
as RB O
great JJ O
as IN O
each DT O
subject NN O
's POS O
reactions NNS O
to TO O
the DT O
test NN O
solutions NNS O
. . O

-DOCSTART- X X O

Experimental JJ O
studies NNS O
on IN O
virus NN O
excretion NN O
and CC O
non-arthropod JJ O
transmission NN O
. . O

-DOCSTART- X X O

At IN O
the DT O
same JJ O
time NN O
we PRP O
obtained VBD O
easily RB O
understandable JJ O
EEG-information NN O
which WDT O
has VBZ O
never RB O
previously RB O
been VBN O
available JJ O
to TO O
us PRP O
. . O

-DOCSTART- X X O

Female JJ O
mice NNS O
were VBD O
significantly RB O
more RBR O
resistant JJ O
to TO O
infection NN O
than IN O
males NNS O
. . O

-DOCSTART- X X O

Angiotensin NNP B-NP
effect NN O
in IN O
the DT O
human JJ O
kidney NN O
. . O

-DOCSTART- X X O

Procion RB O
yellow JJ O
dye NN O
was VBD O
injected VBN O
intracellularly RB O
into IN O
large JJ O
auditory NN O
fibers NNS O
of IN O
goldfish NN O
to TO O
investigate VB O
the DT O
relationship NN O
between IN O
the DT O
response NN O
type NN O
of IN O
these DT O
fibers NNS O
and CC O
their PRP$ O
site NN O
of IN O
termination NN O
in IN O
the DT O
saccular JJ O
macula NN O
. . O

-DOCSTART- X X O

Silicosis NN O
mortality NN O

-DOCSTART- X X O

These DT O
consisted VBD O
of IN O
beading VBG O
and CC O
strictures NNS O
mainly RB O
of IN O
the DT O
intrahepatic JJ O
biliary NN O
tree NN O
( -LRB- O
IHB) NNP O
. . O

-DOCSTART- X X O

Pentane NNP O
and CC O
ethane NN O
, , O
which WDT O
arise VBP O
during IN O
lipid JJ O
peroxidation NN O
in IN O
vivo NN O
, , O
were VBD O
measured VBN O
by IN O
gas NN O
chromatography NN O
in IN O
breath NN O
samples NNS O
of IN O
rats NNS O
fed VBN O
for IN O
8 CD O
weeks NNS O
a DT O
vitamin NN O
E-deficient JJ O
diet NN O
to TO O
which WDT O
had VBD O
been VBN O
added VBN O
0, IN O
11 CD O
, , O
or CC O
40 CD O
IU NNP O
vitamin NN O
E NNP O
acetate NN O
per IN O
kg NN O
. . O

-DOCSTART- X X O

The DT O
authors NNS O
report VBP O
the DT O
clinicopathologic NN O
findings NNS O
in IN O
four CD O
cases NNS O
of IN O
adult NN O
women NNS O
with IN O
rhabdomyosarcomas NNS O
that WDT O
originated VBD O
in IN O
the DT O
endometrium NN O
or CC O
cervix NN O
, , O
or CC O
both DT O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
pure JJ O
natural NN O
porcine NN B-NP
secretin NN I-NP
on IN O
endocrine NN O
and CC O
exocrine NN O
pancreatic JJ O
secretion NN O
was VBD O
studied VBN O
in IN O
the DT O
totally RB O
isolated VBN O
perfused VBN O
porcine NN O
pancreas NNS O
. . O

-DOCSTART- X X O

Urine NNP O
antibodies NNS O
could MD O
not RB O
be VB O
demonstrated VBN O
in IN O
any DT O
other JJ O
cases NNS O
. . O

-DOCSTART- X X O

99mTc JJ O
phytate NN O
, , O
198Au CD O
colloid JJ O
, , O
and CC O
99mTc JJ O
antimony NN O
sulfide NN O
have VBP O
been VBN O
used VBN O
; : O
the DT O
last JJ O
appears VBZ O
to TO O
have VB O
been VBN O
the DT O
most RBS O
satisfactory JJ O
. . O

-DOCSTART- X X O

Synovial JJ O
cysts NNS O
of IN O
the DT O
hip NN O
joint NN O

-DOCSTART- X X O

A DT O
suspected JJ O
hypothalamic JJ O
dysfunction NN O
and CC O
a DT O
slightly RB O
impaired VBN O
pituitary JJ O
function NN O
manifested VBD O
as IN O
GH NNP B-NP
deficiency NN O
were VBD O
their PRP$ O
common JJ O
endocrinological JJ O
features NNS O
. . O

-DOCSTART- X X O

A DT O
sharp JJ O
outbreak NN O
of IN O
influenza NN O
A DT O
occurred VBN O
on IN O
the DT O
base NN O
during IN O
February NNP O
that WDT O
was VBD O
due JJ O
to TO O
an DT O
A/Texas/1/77-like JJ O
virus NN O
, , O
a DT O
variant NN O
of IN O
the DT O
A/Victoria/3/75 NNP O
prototpye NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
time NN O
and CC O
dose NN O
on IN O
alterations NNS O
following VBG O
inhalation NN O
of IN O
plutonium-239 DT O
dioxide NN O
aerosol NN O
in IN O
rat NN O
. . O

-DOCSTART- X X O

Several JJ O
free JJ O
2nd-generation JJ O
schizonts NNS O
, , O
which WDT O
varied VBD O
in IN O
diameter NN O
from IN O
11 CD O
to TO O
21.6 CD O
micrometer NN O
, , O
were VBD O
found VBN O
on IN O
the DT O
epithelial JJ O
surface NN O
of IN O
the DT O
cecum NN O
. . O

-DOCSTART- X X O

Newcastle NNP O
disease NN O
virus NN O
surveillance NN O
in IN O
Hong NNP O
Kong NNP O
on IN O
local JJ O
and CC O
imported VBN O
poultry NN O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
postulated VBN O
that DT O
persistent JJ O
challenge NN O
by IN O
M. NNP O
leprae NNS O
or CC O
its PRP$ O
antigens NNS O
to TO O
the DT O
IgA NNP B-NP
immunocytes NNS O
of IN O
the DT O
intestinal JJ O
epithelium NN O
might MD O
have VB O
induced VBN O
tolerance NN O
leading VBG O
to TO O
IgA NNP B-NP
deficiency NN O
and CC O
subsequent JJ O
subtotal JJ O
atrophy NN O
of IN O
the DT O
intestinal JJ O
villi NNS O
in IN O
the DT O
patients NNS O
with IN O
lepromatous JJ O
leprosy NN O
. . O

-DOCSTART- X X O

Thyroid NNP O
disease NN O
and CC O
pregnancy NN O
. . O

-DOCSTART- X X O

Pathogens NNP O
( -LRB- O
Staphylococcus NNP O
aureus NN O
or CC O
Gram-negative JJ O
bacilli NNS O
) -RRB- O
were VBD O
isolated VBN O
from IN O
only JJ O
one CD O
member NN O
of IN O
staff NN O
in IN O
small JJ O
numbers NNS O
and CC O
irregularly RB O
and CC O
rarely RB O
in IN O
large JJ O
numbers NNS O
from IN O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
histochemistry NN O
and CC O
ultrastructure NN O
of IN O
calcified JJ O
cerebellar NN O
deposits NNS O
described VBN O
by IN O
Tonge NNP O
et NNP O
al NN O
. . O

-DOCSTART- X X O

Reaction NN O
times NNS O
to TO O
tachistoscopically VB O
presented VBN O
stimuli NNS O
in IN O
diabetics NNS O

-DOCSTART- X X O

The DT O
data NNS O
indicate VBP O
a DT O
three-phase JJ O
reaction NN O
after IN O
B1 NNP O
injection NN O
: : O
Phase NNP O
1--shortly CC O
after IN O
injection NN O
there EX O
is VBZ O
a DT O
drop NN O
of IN O
all DT O
parameters NNS O
lasting VBG O
for IN O
30 CD O
sec. NN O

-DOCSTART- X X O

A--A JJ O
natural JJ O
hydrostatic JJ O
phenomenon NN O
, , O
at IN O
the DT O
level NN O
of IN O
the DT O
ends NNS O
of IN O
the DT O
plantar NN O
arcs NNS O
, , O
diffuses VBZ O
body NN O
weight NN O
, , O
as IN O
PAIN NNP O
plays VBZ O
the DT O
role NN O
of IN O
outsentry JJ O
( -LRB- O
fig.--1 NN O
) -RRB- O
( -LRB- O
5 CD O
) -RRB- O
; : O
B--Plantar JJ O
perforating NN O
ulceration NN O
( -LRB- O
PPU) NNP O
is VBZ O
caused VBN O
by IN O
a DT O
combination NN O
of IN O
INSENSITIVITY NNP O
and CC O
TRAUMATIS VBZ O
( -LRB- O
1 CD O
) -RRB- O
; : O
C--The DT O
patient NN O
reposing NN O
, , O
as IN O
body NN O
weight NN O
( -LRB- O
traumatism NN O
) -RRB- O
effects NNS O
disappear VBP O
, , O
cicatrization NN O
process NN O
can MD O
be VB O
easily RB O
observed VBN O
; : O
D--PNEUMATIC JJ O
INSOLE NN O
, , O
being VBG O
elastic JJ O
, , O
diffuses NNS O
localized VBN O
compression NN O
at IN O
the DT O
ends NNS O
of IN O
the DT O
plantar NN O
arcs NNS O
, , O
reduces VBZ O
attrition NN O
, , O
makes VBZ O
easier JJR O
blood NN O
circulation NN O
, , O
as RB O
well RB O
as IN O
cure NN O
and CC O
prophylaxis NNS O
of IN O
PPU NNP O
( -LRB- O
fig.--6 NN O
) -RRB- O
( -LRB- O
3 CD O
) -RRB- O
. . O

-DOCSTART- X X O

As IN O
expected VBN O
, , O
the DT O
heparin NN O
did VBD O
produce VB O
increased VBN O
recalcification NN O
times NNS O
and CC O
the DT O
development NN O
of IN O
occasional JJ O
subcutaneous JJ O
hematomas NN O
. . O

-DOCSTART- X X O

Contingency NN O
contracting VBG O
between IN O
clients NNS O
and CC O
their PRP$ O
parents/caregivers NNS O
was VBD O
used VBN O
to TO O
specify VB O
consequences NNS O
for IN O
daily JJ O
self-monitoring NN O
, , O
reduced VBD O
caloric JJ O
intake NN O
, , O
weight NN O
loss NN O
, , O
and CC O
exercise NN O
. . O

-DOCSTART- X X O

Dietetics NNS O
of IN O
childhood NN O
- : O
and CC O
juvenile NN O
diabetes NNS O

-DOCSTART- X X O

The DT O
micromethod NN O
uses VBZ O
microcuvettes NNS O
and CC O
substitutes NNS O
ferrozine NN O
for IN O
the DT O
bathophenanthroline NN O
chromogen NN O
of IN O
the DT O
ICSH. NNP O

-DOCSTART- X X O

The DT O
overall JJ O
incidence NN O
of IN O
SIDS NNP O
was VBD O
1.43 CD O
per IN O
1,000 CD O
live JJ O
births NNS O
. . O

-DOCSTART- X X O

Significant JJ O
increases NNS O
in IN O
mean JJ O
serum NN O
E2 NN O
concentration NN O
( -LRB- O
100 CD O
to TO O
150 CD O
pg/ml NN O
) -RRB- O
were VBD O
noted VBN O
at IN O
6 CD O
and CC O
8 CD O
hours NNS O
after IN O
administration NN O
on IN O
day NN O
1 CD O
and CC O
at IN O
8 CD O
hours NNS O
on IN O
day NN O
4 CD O
. . O

-DOCSTART- X X O

Avian JJ O
reproductive JJ O
system NN O
: : O
daily JJ O
variations NNS O
in IN O
responses NNS O
to TO O
hormones NNS O
. . O

-DOCSTART- X X O

Biological NNP O
properties NNS O
of IN O
sumithion NN O
. . O

-DOCSTART- X X O

Serological JJ O
studies NNS O
of IN O
antibodies NNS O
to TO O
Epstein-Barr NNP O
virus NN O
in IN O
infectious JJ O
mononucleosis NN O

-DOCSTART- X X O

Carcinoembryonic NNP B-NP
antigen NN I-NP
( -LRB- O
CEA NNP B-NP
) -RRB- O
procedures NNS O
and CC O
clinical JJ O
evaluation NN O
. . O

-DOCSTART- X X O

On IN O
the DT O
basis NN O
of IN O
a DT O
global JJ O
assessment NN O
patients NNS O
showed VBD O
a DT O
highly RB O
significant JJ O
preference NN O
for IN O
imipramine NN O
compared VBN O
with IN O
placebo NN O
as IN O
adjunctive JJ O
therapy NN O
. . O

-DOCSTART- X X O

39-47 CD O
. . O

-DOCSTART- X X O

Patients NNS O
were VBD O
subclassified VBN O
into IN O
age-matched JJ O
groups NNS O
of IN O
primary JJ O
untreated JJ O
cancer NN O
( -LRB- O
21 CD O
) -RRB- O
, , O
recurrent JJ O
cancer NN O
( -LRB- O
18 CD O
) -RRB- O
, , O
and CC O
" `` O
cured VBD O
" `` O
patients NNS O
who WP O
had VBD O
been VBN O
free JJ O
of IN O
disease NN O
for IN O
at IN O
least JJS O
9 CD O
months NNS O
( -LRB- O
16 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Advances NNS O
in IN O
the DT O
management NN O
of IN O
gynecologic NN O
cancer--radiation NN O
therapy NN O
. . O

-DOCSTART- X X O

The DT O
clinico-pathological JJ O
data NNS O
from IN O
a DT O
patient NN O
with IN O
irreversible JJ O
post-partum JJ O
renal JJ O
failure NN O
( -LRB- O
IPRF NN O
) -RRB- O
are VBP O
presented VBN O
. . O

-DOCSTART- X X O

Dialyzable JJ O
transfer NN B-NP
factor NN I-NP
. . O

-DOCSTART- X X O

19-32 CD O
. . O

-DOCSTART- X X O

Rheumatoid NNP B-NP
factor NN I-NP
and CC O
antinuclear JJ O
antibody NN O
tests NNS O
were VBD O
frequently RB O
positive JJ O
, , O
and CC O
reactions NNS O
to TO O
gold JJ O
therapy NN O
were VBD O
more RBR O
frequent JJ O
than IN O
in IN O
other JJ O
rheumatoid NN O
populations NNS O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
hydrostatic JJ O
pressure NN O
on IN O
the DT O
swimming NN O
activity NN O
of IN O
three CD O
hyponeustonic JJ O
crustacea NN O
, , O
Anomalocera NNP O
patersoni NNS O
, , O
Pontella NNP O
mediterranea NN O
, , O
Labidocera NNP O
wollastoni NNS O

-DOCSTART- X X O

This DT O
report NN O
presents VBZ O
an DT O
analysis NN O
of IN O
the DT O
vocal JJ O
repertoire NN O
of IN O
howler NN O
monkeys NNS O
( -LRB- O
Alouatta NNP O
palliata NN O
) -RRB- O
observed VBN O
during IN O
a DT O
field NN O
study NN O
in IN O
southwestern JJ O
Panama NNP O
. . O

-DOCSTART- X X O

III NNP O
. . O

-DOCSTART- X X O

Pancreatic JJ O
and CC O
biliary JJ O
secretion NN O
and CC O
gastric JJ O
emptying JJ O
rates NNS O
of IN O
a DT O
liquid JJ O
test NN O
meal NN O
( -LRB- O
LTM) NNP O
were VBD O
determined VBN O
in IN O
normal JJ O
persons NNS O
, , O
in IN O
patients NNS O
with IN O
subtotal JJ O
gastrectomy NN O
with IN O
gastroduodenostomy NN O
(STG-BI NN O
) -RRB- O
or CC O
with IN O
gastrojejunostomy NN O
(STG-BII NN O
) -RRB- O
, , O
and CC O
in IN O
patients NNS O
with IN O
truncal JJ O
vagotomy NN O
and CC O
pyloroplasty NN O
( -LRB- O
V&P NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Abnormal JJ O
calcium NN O
metabolism NN O
in IN O
normocalcaemic JJ O
sarcoidosis NN O
. . O

-DOCSTART- X X O

Also RB O
, , O
except IN O
in IN O
one CD O
patient NN O
who WP O
developed VBD O
gallstones NNS O
following VBG O
institution NN O
of IN O
colestipol JJ O
, , O
saturation NN O
of IN O
gallbladder NN O
bile NN O
with IN O
cholesterol NN O
was VBD O
not RB O
markedly RB O
increased VBN O
by IN O
this DT O
drug NN O
alone RB O
. . O

-DOCSTART- X X O

The DT O
responsiveness NN O
of IN O
visual JJ O
cortex JJ O
(VC NN O
) -RRB- O
and CC O
superior JJ O
colliculus NN O
(SC NN O
) -RRB- O
was VBD O
simultaneously RB O
compared VBN O
following VBG O
conditioning NN O
" '' O
ON" NNS O
or CC O
" `` O
OFF" JJ O
stimulation NN O
, , O
in IN O
the DT O
rabbit NN O
. . O

-DOCSTART- X X O

If IN O
, , O
however RB O
, , O
the DT O
mean NN O
temperature NN O
rise NN O
was VBD O
higher JJR O
( -LRB- O
0.57 CD O
degrees NNS O
C NN O
or CC O
0.69 CD O
degrees NNS O
C) NN O
, , O
such JJ O
a DT O
selection NN O
practically RB O
resulted VBD O
in IN O
the DT O
disappearance NN O
of IN O
'passable JJ O
' '' O
qualifications NNS O
in IN O
the DT O
triplet NN O
groups NNS O
and CC O
a DT O
great JJ O
predominance NN O
of IN O
'to PRP O
be VB O
rejected VBN O
' '' O
qualifications NNS O
in IN O
the DT O
large JJ O
groups NNS O
. . O

-DOCSTART- X X O

The DT O
background NN O
processes VBZ O
depending VBG O
on IN O
the DT O
etiological JJ O
factor NN O
and CC O
the DT O
character NN O
of IN O
lesion NN O
of IN O
the DT O
epithelium NN O
are VBP O
divided VBN O
into IN O
dyshormonal JJ O
, , O
inflammatory JJ O
, , O
and CC O
posttraumatic JJ O
. . O

-DOCSTART- X X O

The DT O
sense NN O
of IN O
self NN O
. . O

-DOCSTART- X X O

Current JJ O
diagnostic JJ O
uses NNS O
of IN O
computerized JJ O
tomography NN O
in IN O
clinical JJ O
medicine NN O
. . O

-DOCSTART- X X O

A DT O
follow-up JJ O
study NN O
of IN O
22 CD O
patients NNS O
with IN O
Ebstein NNP O
's POS O
anomaly NN O
has VBZ O
been VBN O
performed VBN O
. . O

-DOCSTART- X X O

Recurrence NNP O
of IN O
bladder NN O
tumors NNS O
among IN O
the DT O
original JJ O
9 CD O
cases NNS O
has VBZ O
occurred VBN O
only RB O
among IN O
the DT O
5 CD O
whose WP$ O
properdin NN B-NP
levels NNS O
remained VBD O
below IN O
the DT O
median NN O
. . O

-DOCSTART- X X O

Treatment NNP O
with IN O
heparin NN O
, , O
plasminogen NN B-NP
activators NNS O
and CC O
fibrinogenolytic JJ O
agents NNS O
was VBD O
disappointing JJ O
although IN O
renal JJ O
function NN O
has VBZ O
stabilized VBN O
in IN O
one CD O
patient NN O
on IN O
long JJ O
term NN O
oral JJ O
anticoagulant JJ O
therapy NN O
. . O

-DOCSTART- X X O

The DT O
data NNS O
normally RB O
available JJ O
are VBP O
insufficient JJ O
and CC O
take VB O
no DT O
account NN O
of IN O
the DT O
direction NN O
of IN O
recirculation NN O
, , O
which WDT O
may MD O
be VB O
a DT O
determining VBG O
factor NN O
. . O

-DOCSTART- X X O

Estimation NN O
of IN O
L-alanine NNP O
in IN O
serum NN O
or CC O
plasma NN O
using VBG O
the DT O
LKB NNP O
reaction NN O
rate NN O
analyser NN O
. . O

-DOCSTART- X X O

The DT O
acids NNS O
were VBD O
obtained VBN O
by IN O
hydrolysis NN O
of IN O
the DT O
corresponding JJ O
esters NNS O
, , O
and CC O
their PRP$ O
anti-inflammatory JJ O
activity NN O
was VBD O
tested VBN O
. . O

-DOCSTART- X X O

Unrecognized JJ O
amnionitis NN O
and CC O
prematurity NN O
: : O
a DT O
preliminary JJ O
report NN O
. . O

-DOCSTART- X X O

Serum NN B-NP
amylase NN I-NP
became VBD O
markedly RB O
elevated JJ O
( -LRB- O
2,624 CD O
CU/100 NN O
ml NN O
) -RRB- O
, , O
as RB O
did VBD O
the DT O
serum NN O
FFA NN O
( -LRB- O
29.19 CD O
mEq/liter NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
morphological JJ O
effects NNS O
of IN O
two CD O
snake NN O
venoms NNS O
, , O
N. NNP O
naja NN O
and CC O
A. NN O
piscivorus NN O
, , O
and CC O
of IN O
the DT O
Direct NNP B-NP
Lytic NNP I-NP
Factor NNP I-NP
and CC O
Phospholipase-A NNP B-NP
, , O
compounds VBZ O
purified VBN O
from IN O
N. NNP O
naja NN O
crude NN O
venom NN O
, , O
were VBD O
investigated VBN O
on IN O
lung NN O
and CC O
cremaster NN O
vessels NNS O
of IN O
rats NNS O
. . O

-DOCSTART- X X O

The DT O
length NN O
scales NNS O
of IN O
the DT O
turbulence NN O
were VBD O
also RB O
estimated VBN O
: : O
at IN O
a DT O
Reynolds NNP O
number NN O
near IN O
4,000 CD O
the DT O
macroscale NN O
is VBZ O
about IN O
1.25 CD O
mm CD O
, , O
the DT O
Taylor NNP O
microscale NN O
is VBZ O
about IN O
0.85 CD O
mm CD O
, , O
and CC O
the DT O
Kolmogoroff NNP O
scale NN O
is VBZ O
near IN O
0.075 CD O
mm CD O
. . O

-DOCSTART- X X O

Diallylnitrosamine NNP O
( -LRB- O
DAN) NNP O
, , O
one CD O
of IN O
the DT O
few JJ O
nitrosamines NNS O
tested VBN O
thus RB O
far RB O
that WDT O
has VBZ O
not RB O
induced VBN O
neoplasms NNS O
in IN O
rats NNS O
, , O
caused VBD O
a DT O
high JJ O
incidence NN O
of IN O
respiratory JJ O
tract NN O
tumors NNS O
in IN O
Syrian JJ O
golden JJ O
hamsters NNS O
treated VBN O
sc NN O
with IN O
single JJ O
or CC O
weekly JJ O
doses NNS O
of IN O
the DT O
compound NN O
. . O

-DOCSTART- X X O

Near IN O
term NN O
, , O
under IN O
experimental JJ O
conditions NNS O
, , O
maternal JJ O
and CC O
fetal JJ O
blood NN O
gases NNS O
, , O
pH NNS O
, , O
uterine NN O
and CC O
umbilical JJ O
blood NN O
flows NNS O
were VBD O
measured VBN O
or CC O
calculated VBN O
. . O

-DOCSTART- X X O

Self-emasculation NN O
is VBZ O
the DT O
end NN O
result NN O
of IN O
an DT O
unusual JJ O
psychiatric JJ O
disorder NN O
, , O
which WDT O
initially RB O
requires VBZ O
surgical JJ O
treatment NN O
. . O

-DOCSTART- X X O

The DT O
prevalence NN O
of IN O
hepatitis NN B-NP
B NNP I-NP
surface NN I-NP
antigen NN I-NP
( -LRB- O
HBsAg NNP B-NP
) -RRB- O
and CC O
anti-HBs NNS B-NP
was VBD O
determined VBN O
by IN O
a DT O
sensitive JJ O
double-antibody NN O
radio-immunoassay NN O
technique NN O
in IN O
a DT O
series NN O
of IN O
patients NNS O
with IN O
chronic JJ O
liver NN O
diseases NNS O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
concluded VBN O
that IN O
patients NNS O
with IN O
acute JJ O
respiratory NN O
failure NN O
requiring VBG O
artificial JJ O
ventilation NN O
have VBP O
two CD O
componenents NNS O
of IN O
the DT O
pulmonary JJ O
shunt NN O
, , O
one CD O
parallel NN O
with IN O
and CC O
the DT O
other JJ O
inversely NN O
related VBN O
with IN O
the DT O
PAO2 NNP O
. . O

-DOCSTART- X X O

Levels NNS O
of IN O
both DT O
PGF NNP O
and CC O
PGFM NNP O
were VBD O
significantly RB O
higher JJR O
during IN O
early JJ O
spontaneous JJ O
labour NN O
, , O
at IN O
a DT O
cervical JJ O
dilatation NN O
of IN O
less JJR O
than IN O
4 CD O
cm NN O
, , O
than IN O
before IN O
the DT O
onset NN O
of IN O
labour NN O
. . O

-DOCSTART- X X O

The DT O
most RBS O
common JJ O
cause NN O
of IN O
renal JJ O
deterioration NN O
in IN O
the DT O
spinal JJ O
cord NN O
injured VBN O
patient NN O
is VBZ O
irreversible JJ O
vesicoureteral JJ O
reflux NN O
. . O

-DOCSTART- X X O

Propranolol NNP O
( -LRB- O
Inderal NNP O
) -RRB- O
administered VBN O
in IN O
a DT O
dose NN O
which WDT O
blocks NNS O
the DT O
beta-adrenergic JJ O
apparatus NN O
of IN O
the DT O
heart NN O
prevents VBZ O
the DT O
development NN O
of IN O
the DT O
positive JJ O
inotropic JJ O
effect NN O
of IN O
therapeutic JJ O
doses NNS O
of IN O
strophanthin JJ O
K NNP O
on IN O
a DT O
hypodynamic JJ O
left JJ O
ventricular JJ O
myocardium NN O
. . O

-DOCSTART- X X O

Recent JJ O
studies NNS O
have VBP O
shown VBN O
the DT O
rat NN O
larynx NN O
to TO O
be VB O
an DT O
important JJ O
organ NN O
in IN O
the DT O
evaluation NN O
of IN O
irritancy NN O
of IN O
inhaled JJ O
materials NNS O
. . O

-DOCSTART- X X O

Feeding VBG O
behavior NN O
, , O
circannual JJ O
body NN O
weight NN O
and CC O
hibernation NN O
rhythms NNS O
in IN O
European JJ O
hamsters NNS O
lesioned VBD O
in IN O
the DT O
noradrenergic JJ O
ascending VBG O
bundles NNS O

-DOCSTART- X X O

At IN O
a DT O
systolic JJ O
blood NN O
pressure NN O
( -LRB- O
BP NNP O
) -RRB- O
of IN O
60 CD O
mmHg NN O
, , O
C02 NNP O
responsiveness NN O
was VBD O
abolished VBN O
, , O
but CC O
was VBD O
maintained VBN O
at IN O
higher JJR O
levels NNS O
of IN O
BP. NNP O

-DOCSTART- X X O

Iodine-123 . O
was VBD O
satisfactorily RB O
imaged VBN O
only RB O
with IN O
the DT O
MEC NNP O
and CC O
pinhole JJ O
collimators NNS O
, , O
which WDT O
in IN O
turn NN O
yielded VBD O
MTF RB O
values NNS O
comparable JJ O
to TO O
those DT O
measured VBN O
for IN O
99mTc NNP O
. . O

-DOCSTART- X X O

Petrous JJ O
meningioma NN O
en IN O
plaque NN O
presenting VBG O
as IN O
a DT O
right JJ O
middle NN O
ear NN O
tumor NN O
. . O

-DOCSTART- X X O

The DT O
difficulties NNS O
to TO O
analyse JJ O
prostaglandins NNS O
( -LRB- O
PG) NN O
by IN O
gas-liquid JJ O
chromatography NN O
are VBP O
mainly RB O
due JJ O
to TO O
the DT O
lack NN O
of IN O
sensitivity NN O
of IN O
the DT O
gas-chromatograph NN O
itself PRP O
( -LRB- O
higher JJR O
than IN O
200 CD O
ng NN O
) -RRB- O
and CC O
to TO O
the DT O
poor JJ O
resolution NN O
of IN O
the DT O
packed VBN O
columns NNS O
. . O

-DOCSTART- X X O

On IN O
cessation NN O
of IN O
steroid JJ O
therapy NN O
the DT O
patient NN O
was VBD O
noted VBN O
to TO O
have VB O
radiologic NN O
manifestations NNS O
of IN O
hypertrophic JJ O
osteoarthropathy NN O
( -LRB- O
HOA NN O
) -RRB- O
as RB O
well RB O
as IN O
clinical JJ O
and CC O
laboratory NN O
features NNS O
of IN O
rheumatoid NN O
arthritis NN O
(RA NNP O
) -RRB- O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Total JJ O
IgE NN B-NP
levels NNS O
showed VBD O
a DT O
tendency NN O
to TO O
diminish VB O
. . O

-DOCSTART- X X O

Does VBZ O
afferent JJ O
loop NN O
syndrome NN O
exist VBP O
? . O
] SYM O
It PRP O
is VBZ O
the DT O
author NN O
's POS O
opinion NN O
that IN O
diagnosis NN O
of IN O
the DT O
"adducent JJ O
loop NN O
syndrome NN O
" '' O
is VBZ O
unlikely JJ O
to TO O
be VB O
correct JJ O
in IN O
patients NNS O
subjected VBN O
to TO O
Billroth-II NNP O
gastrectomy NN O
. . O

-DOCSTART- X X O

Letter NNP O
: : O
Is VBZ O
actinic JJ O
( -LRB- O
solar JJ O
) -RRB- O
damage NN O
the DT O
provoking VBG O
cause NN O
of IN O
'post-inflammatory JJ O
elastolysis NN O
and CC O
cutis NN O
laxa NN O
( -LRB- O
PECL)' NNP O
? . O

-DOCSTART- X X O

Also RB O
, , O
samples NNS O
of IN O
serum NN O
were VBD O
absorbed VBN O
with IN O
the DT O
various JJ O
solid-phase JJ O
allergens NNS O
and CC O
the DT O
reactivity NN O
of IN O
the DT O
remaining VBG O
IgE NNP B-NP
antibodies NNS I-NP
was VBD O
determined VBN O
. . O

-DOCSTART- X X O

Hematology NNP O
problem NN O
of IN O
the DT O
month NN O
: : O
band NN O
or CC O
seg NN O
? . O

-DOCSTART- X X O

Haemodilution NNP O
in IN O
cardiopulmonary JJ O
bypass NN O
using VBG O
a DT O
gelatine JJ O
derivative JJ O
for IN O
priming JJ O
. . O

-DOCSTART- X X O

The DT O
neuroleptic-induced JJ O
increase NN O
in IN O
central JJ O
DA NNP O
turnover NN O
( -LRB- O
an DT O
indicator NN O
for IN O
the DT O
degree NN O
of IN O
DA NNP B-NP
receptor NN I-NP
blocking VBG O
) -RRB- O
was VBD O
found VBN O
to TO O
be VB O
positively RB O
correlated VBN O
with IN O
the DT O
therapeutic JJ O
effect NN O
of IN O
neuroleptics NNS O
and CC O
the DT O
development NN O
of IN O
hypokinetic-rigid JJ O
symptoms NNS O
. . O

-DOCSTART- X X O

Rainbow NNP O
trout NN O
were VBD O
obtained VBN O
from IN O
a DT O
commercial JJ O
trout NN O
farm NN O
, , O
kept VBD O
in IN O
running VBG O
water NN O
and CC O
feeding VBG O
in IN O
experimental JJ O
pellets NNS O
for IN O
4 CD O
to TO O
8 CD O
weeks NNS O
. . O

-DOCSTART- X X O

Stimulation NN O
of IN O
macrophage NN O
function NN O
by IN O
killed VBN O
Bordetella NNP O
pertussis NN O
cells NNS O
did VBD O
not RB O
show VB O
any DT O
beneficial JJ O
effect NN O
as IN O
an DT O
increased VBN O
susceptibility NN O
became VBD O
apparent JJ O
. . O

-DOCSTART- X X O

Primary JJ O
amenorrhoea NN O
in IN O
a DT O
phenotypically RB O
female JJ O
individual NN O
with IN O
a DT O
karyotype NN O
46 CD O
, , O
xy JJ O
and CC O
bilateral JJ O
gonadoblastoma NN O

-DOCSTART- X X O

Application NNP O
of IN O
the DT O
2-deoxy-D-glucose JJ O
method NN O
to TO O
the DT O
coupling NN O
of IN O
cerebral JJ O
metabolism NN O
and CC O
blood NN O
flow NN O
. . O

-DOCSTART- X X O

Serum NN O
gastrin NN B-NP
levels NNS O
did VBD O
not RB O
change VB O
in IN O
either DT O
group NN O
; : O
however RB O
, , O
background NN O
serum NN O
gastrin NN B-NP
concentrations NNS O
were VBD O
significantly RB O
greater JJR O
for IN O
V&P NNP O
patients NNS O
than IN O
V&A NNP O
patients NNS O
throughout IN O
the DT O
study NN O
. . O

-DOCSTART- X X O

Mean NNP O
corpuscular JJ B-NP
hemoglobin NN I-NP
concentrations NNS O
remained VBD O
normal JJ O
for IN O
48 CD O
h NN O
and CC O
then RB O
decreased VBD O
in IN O
both DT O
groups NNS O
, , O
the DT O
CO2 NN O
group NN O
showing VBG O
the DT O
larger JJR O
decrease NN O
. . O

-DOCSTART- X X O

All DT O
Cu NNP O
values NNS O
obtained VBD O
from IN O
the DT O
organs NNS O
investigated VBN O
had VBD O
reached VBN O
a DT O
saturation NN O
level NN O
at IN O
8 CD O
mug NN O
Cu/g NN O
diet NN O
with IN O
the DT O
exception NN O
of IN O
the DT O
values NNS O
for IN O
body NN O
Cu NNP O
found VBD O
in IN O
the DT O
dams NNS O
that WDT O
were VBD O
killed VBN O
on IN O
the DT O
day NN O
of IN O
delivery NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
calcitonin NN B-NP
, , O
a DT O
large JJ O
amount NN O
of IN O
calcium NN O
given VBN O
orally RB O
, , O
pentagastrin NN O
and CC O
glucagon NN B-NP
on IN O
plasma NN O
47Ca CD O
radioactivity NN O
curves NNS O
in IN O
subjects NNS O
pretreated VBN O
with IN O
47Ca DT O
was VBD O
examined VBN O
. . O

-DOCSTART- X X O

State NN O
of IN O
the DT O
body NN O
in IN O
disorders NNS O
of IN O
diurnal JJ O
physiological JJ O
rhythms NNS O
and CC O
long-term JJ O
hypokinesia NN O

-DOCSTART- X X O

Oxygen NNP O
tension NN O
of IN O
the DT O
small JJ O
lymph NN O
vessels NNS O
( -LRB- O
PLO2 NNP O
) -RRB- O
of IN O
the DT O
rabbit NN O
hind NN O
limb NN O
was VBD O
measured VBN O
with IN O
both DT O
a DT O
flow-through JJ O
micro JJ O
chamber NN O
and CC O
a DT O
polarographic JJ O
catheter-tip NN O
oxygen NN O
electrode NN O
to TO O
obtain VB O
experimental JJ O
data NNS O
on IN O
the DT O
source NN O
of IN O
oxygen NN O
in IN O
the DT O
lymph NN O
. . O

-DOCSTART- X X O

Since IN O
myoglobin NN B-NP
is VBZ O
co-extracted VBN O
with IN O
the DT O
hemoglobin NN B-NP
, , O
the DT O
2 CD O
heme NN O
pigments NNS O
are VBP O
separated VBN O
in IN O
one CD O
portion NN O
of IN O
the DT O
extract VB O
by IN O
precipitating VBG O
the DT O
hemoglobin NN B-NP
in IN O
an DT O
85 CD O
% NN O
( -LRB- O
NH4)2SO4 NNP O
solution NN O
. . O

-DOCSTART- X X O

Considering VBG O
these DT O
sources NNS O
of IN O
error NN O
some DT O
of IN O
the DT O
variability NN O
in IN O
the DT O
present JJ O
investigation NN O
might MD O
be VB O
avoided VBN O
by IN O
systematic JJ O
instructions NNS O
. . O

-DOCSTART- X X O

Six CD O
patients NNS O
with IN O
the DT O
diagnosis NN O
of IN O
acute JJ O
mania NN O
were VBD O
treated VBN O
with IN O
high JJ O
doses NNS O
of IN O
the DT O
beta-adrenergic JJ O
blocking VBG O
agent NN O
propranolol NN O
. . O

-DOCSTART- X X O

Compared VBN O
to TO O
controls NNS O
, , O
both DT O
UB NNP O
and CC O
OCS NNP O
rats NNS O
showed VBD O
a DT O
small JJ O
but CC O
significant JJ O
post-operative JJ O
reduction NN O
in IN O
the DT O
nocturnality NN O
of IN O
drinking NN O
. . O

-DOCSTART- X X O

Dual JJ O
innervation NN O
of IN O
fast JJ O
fibers NNS O
in IN O
trunk NN O
muscles NNS O
of IN O
lamprey NN O
larvae NNS O

-DOCSTART- X X O

The DT O
feed NN O
consumed VBN O
which WDT O
was VBD O
lowered VBN O
by IN O
25 CD O
% NN O
initially RB O
, , O
did VBD O
not RB O
alter VB O
later RB O
. . O

-DOCSTART- X X O

The DT O
influence NN O
of IN O
adrenergic JJ O
nerves NNS O
of IN O
the DT O
response NN O
of IN O
blood NN O
vessels NNS O
in IN O
the DT O
rabbit NN O
ear NN O
to TO O
2--phenylalanine-8-lysine JJ B-NP
vasopressin NN I-NP
( -LRB- O
Octapressin NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

I. NN O

-DOCSTART- X X O

When WRB O
a DT O
tumour NN O
is VBZ O
present JJ O
nipple NN O
discharge NN O
is VBZ O
of IN O
little JJ O
importance NN O
for IN O
the DT O
diagnosis NN O
and CC O
treatment NN O
. . O

-DOCSTART- X X O

Who WP O
says VBZ O
'National JJ O
Health NNP O
Dis-service NNP O
' '' O
. . O

-DOCSTART- X X O

Improvement NN O
of IN O
nursing NN O
instruction NN O
to TO O
be VB O
given VBN O
at IN O
the DT O
time NN O
of IN O
discharge NN O
from IN O
the DT O
ward NN O
for IN O
premature JJ O
infants NNS O

-DOCSTART- X X O

After IN O
90 CD O
d VBD O
a DT O
subsurface NN O
, , O
radiolucent JJ O
caries-like JJ O
lesion NN O
was VBD O
observed VBN O
in IN O
two CD O
specimens NNS O
only RB O
. . O

-DOCSTART- X X O

The DT O
contraceptive JJ O
pattern NN O
of IN O
157 CD O
women NNS O
was VBD O
analysed JJ O
and CC O
13.8 CD O
percent NN O
were VBD O
using VBG O
inefficient JJ O
methods NNS O
. . O

-DOCSTART- X X O

Plethysmographic JJ O
technique NN O
and CC O
indirect JJ O
blood NN O
pressure NN O
recordings NNS O
were VBD O
used VBN O
. . O

-DOCSTART- X X O

The DT O
second JJ O
and CC O
third JJ O
responded VBD O
similarly RB O
to TO O
either DT O
a DT O
combined VBN O
cyclophosphamide NN O
+ VBZ O
antilymphocyte JJ B-NP
globulin NN I-NP
( -LRB- O
ALG NNP B-NP
) -RRB- O
treatment NN O
or CC O
to TO O
ALG NNP B-NP
administration NN O
preceded VBD O
by IN O
a DT O
small JJ O
dosage NN O
of IN O
cyclophosphamide NN O
, , O
which WDT O
had VBD O
proved VBN O
ineffective JJ O
when WRB O
administered VBN O
alone RB O
. . O

-DOCSTART- X X O

Evidence NN O
is VBZ O
presented VBN O
that IN O
Leber NNP O
's POS O
military JJ O
aneurysm NN O
retinitis NN O
is VBZ O
not RB O
a DT O
separate JJ O
entity NN O
but CC O
a DT O
special JJ O
form NN O
of IN O
Coats NNP O
' POS O
disease NN O
. . O

-DOCSTART- X X O

Fibrin NNP B-NP
cloaking VBG O
along IN O
the DT O
catheter NN O
was VBD O
found VBN O
in IN O
20 CD O
patients NNS O
studied VBN O
by IN O
pull-out NN O
arteriography NN O
and CC O
was VBD O
unassociated JJ O
with IN O
clinical JJ O
symptoms NNS O
. . O

-DOCSTART- X X O

The DT O
influence NN O
of IN O
a DT O
mobile JJ O
pupil NN O
on IN O
the DT O
response NN O
in IN O
the DT O
DC-ERG NNP O
is VBZ O
demonstrated VBN O
. . O

-DOCSTART- X X O

A DT O
newly RB O
synthesized VBN O
anti-inflammatory JJ O
agent NN O
, , O
Y-8004 NNP O
demonstrated VBD O
a DT O
greater JJR O
inhibition NN O
than IN O
did VBD O
indomethacin JJ O
( -LRB- O
IM) NN O
. . O
on IN O
inflammatory JJ O
response NN O
such JJ O
as IN O
ultraviolet NN O
erythema NN O
in IN O
guinea NN O
pigs NNS O
, , O
carrageenin NN O
edema NN O
, , O
evans NNS O
blue JJ O
and CC O
carrageenin-induced VBD O
pleuritis NN O
and CC O
acetic JJ O
acid-induced JJ O
peritonitis NN O
in IN O
rats NNS O
. . O

-DOCSTART- X X O

Lymphocyte NNP O
subpopulations NNS O
, , O
serum NN B-NP
IgE NNP I-NP
and CC O
total JJ O
eosinophil NN O
counts NNS O
in IN O
patients NNS O
with IN O
bronchial JJ O
asthma NN O
. . O

-DOCSTART- X X O

A DT O
comparison NN O
of IN O
physical JJ O
and CC O
cytogenetic JJ O
estimates NNS O
of IN O
radiation NN O
dose NN O
in IN O
patients NNS O
treated VBN O
with IN O
iodine-131 JJ O
for IN O
thyroid DT O
carcinoma NN O
. . O

-DOCSTART- X X O

Technique NN O
for IN O
obtaining VBG O
refined JJ O
ceramics NNS O
with IN O
dense JJ O
mass NN O

-DOCSTART- X X O

Mean JJ O
total JJ O
lung NN O
capacity NN O
, , O
functional JJ O
residual JJ O
capacity NN O
, , O
and CC O
residual JJ O
volume NN O
increased VBD O
significantly RB O
, , O
and CC O
the DT O
mean JJ O
closing NN O
volume NN O
, , O
the DT O
lung NN O
volume NN O
above IN O
residual JJ O
volume NN O
at IN O
which WDT O
phase NN O
IV NNP O
begins VBZ O
, , O
decreased VBN O
significantly RB O
with IN O
11 CD O
cm NN O
H20 IN O
continuous JJ O
positive JJ O
airway NN O
pressure NN O
; : O
differences NNS O
at IN O
5 CD O
cm NN O
H20 PRP O
were VBD O
not RB O
significant JJ O
. . O

-DOCSTART- X X O

Current JJ O
status NN O
of IN O
zinc NN O
deficiency NN O
in IN O
the DT O
pathogenesis NN O
of IN O
neurological JJ O
, , O
dermatological JJ O
and CC O
musculoskeletal JJ O
disorders NNS O
. . O

-DOCSTART- X X O

Calcium NNP O
and CC O
phosphorus NN O
metabolism NN O
in IN O
chronic JJ O
uremia NN O
. . O

-DOCSTART- X X O

The DT O
correcting JJ O
action NN O
of IN O
tropatepine NN O
hydrochloride NN O
upon IN O
the DT O
extrapyramidal JJ O
effects NNS O
induced VBN O
by IN O
neuroleptics NNS O
has VBZ O
been VBN O
studied VBN O
in IN O
32 CD O
acute JJ O
psychotic JJ O
states NNS O
. . O

-DOCSTART- X X O

Epididymal NNP O
growth NN O
was VBD O
retarded VBN O
in IN O
animals NNS O
maintained VBN O
solely RB O
on IN O
chickpea NN O
haulm NN O
and CC O
improved VBD O
with IN O
supplementation NN O
. . O

-DOCSTART- X X O

Residual NN O
amphotericin IN O
B NNP O
was VBD O
detected VBN O
in IN O
the DT O
feces NNS O
of IN O
the DT O
mice NNS O
only RB O
while IN O
they PRP O
were VBD O
receiving VBG O
the DT O
0.3 CD O
mg/ml JJ O
dose NN O
level NN O
. . O

-DOCSTART- X X O

Following VBG O
intravenous JJ O
administration NN O
, , O
the DT O
myocardial JJ O
concentration NN O
of IN O
tracer NN O
thallium-201 NNS O
, , O
potassium-43 JJ O
, , O
and CC O
rubidium-81 NNS O
were VBD O
determined VBN O
in IN O
mice NNS O
; : O
thallium NN O
was VBD O
present JJ O
in IN O
the DT O
greatest JJS O
concentration NN O
in IN O
the DT O
myocardium NN O
( -LRB- O
2.08 CD O
% NN O
compared VBN O
1.25 CD O
% NN O
for IN O
potassium NN O
and CC O
1.15 CD O
% NN O
for IN O
rubidium NN O
at IN O
10 CD O
minutes NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Thromboplastin NNP B-NP
time NN O
, , O
partial JJ O
thromboplastin IN B-NP
time NN O
, , O
thrombin IN B-NP
time NN O
, , O
heat-dependent NN O
fibrin NN B-NP
, , O
clot NN O
retraction NN O
, , O
and CC O
clotting JJ B-NP
factors NNS I-NP
II NNP I-NP
, , I-NP
V NNP I-NP
, , I-NP
VIII NNP I-NP
, , I-NP
IX NNP I-NP
, , I-NP
X NNP I-NP
, , O
and CC O
the DT O
platelet NN O
count NN O
were VBD O
determined VBN O
. . O

-DOCSTART- X X O

The DT O
data NNS O
support VBP O
the DT O
notion NN O
that IN O
suppression NN O
of IN O
images NNS O
during IN O
binocular JJ O
rivalry NN O
is VBZ O
independent JJ O
in IN O
both DT O
eyes NNS O
. . O

-DOCSTART- X X O

Glycogen NN O
utilization NN O
was VBD O
increased VBN O
, , O
but CC O
tissue NN O
levels NNS O
of IN O
creatine NN O
phosphate NN O
, , O
ATP NNP O
, , O
and CC O
lactate NN O
were VBD O
similar JJ O
to TO O
those DT O
in IN O
hearts NNS O
receiving VBG O
normal JJ O
flow NN O
. . O

-DOCSTART- X X O

The DT O
other JJ O
hypoglycaemic JJ O
patient NN O
showed VBD O
an DT O
exaggerated JJ O
insulin NN B-NP
release NN O
in IN O
response NN O
to TO O
tolbutamide NN O
. . O

-DOCSTART- X X O

Risk NN O
of IN O
infection NN O
in IN O
the DT O
treatment NN O
of IN O
fractures NNS O

-DOCSTART- X X O

Vitrectomy NNP O
with IN O
an DT O
alternative JJ O
instrument NN O
system NN O
. . O

-DOCSTART- X X O

The DT O
metabolic JJ O
clearance NN O
rate NN O
of IN O
progesterone NN O
was VBD O
295 CD O
+/ CD O
- : O
49 CD O
( -LRB- O
S.E. NNP O
) -RRB- O
1/day VBP O
. . O

-DOCSTART- X X O

This DT O
sequence NN O
is VBZ O
almost RB O
identical JJ O
with IN O
that DT O
of IN O
human JJ B-NP
luteinizing NN I-NP
hormone NN I-NP
( -LRB- O
Sairam NNP O
, , O
M. NNP O

-DOCSTART- X X O

Editorial NNP O
: : O
Low-dose JJ O
heparin NN O
and CC O
the DT O
prevention NN O
of IN O
venous JJ O
thromboembolic JJ O
disease NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
perceptual JJ O
salience NN O
on IN O
the DT O
matrix NN O
task NN O
performance NN O
of IN O
four- CD O
and CC O
six-year-old JJ O
children NNS O
. . O

-DOCSTART- X X O

Glucose-6-phosphate JJ B-NP
dehydrogenase JJ I-NP
(G-6-PD NN O
) -RRB- O
deficiency NN O
in IN O
the DT O
newborn JJ O
. . O

-DOCSTART- X X O

The DT O
eluting JJ O
solvent NN O
was VBD O
methanol-chloroform NN O
( -LRB- O
10+90 CD O
) -RRB- O
at IN O
a DT O
flow NN O
rate NN O
of IN O
2.0 CD O
ml/min NN O
. . O

-DOCSTART- X X O

The DT O
bronchial JJ O
epithelia NN O
of IN O
all DT O
smoke-exposed JJ O
animals NNS O
were VBD O
hyperplastic JJ O
, , O
and CC O
their PRP$ O
ultrastructure NN O
showed VBD O
invaginations NNS O
, , O
tilt NN O
of IN O
nuclear JJ O
axes NNS O
, , O
an DT O
increase NN O
in IN O
the DT O
number NN O
and CC O
size NN O
of IN O
lysosomes NNS O
and CC O
multivesiculated JJ O
bodies NNS O
, , O
and CC O
increased VBD O
numbers NNS O
of IN O
enlarged JJ O
intramitochondrial JJ O
granules NNS O
. . O

-DOCSTART- X X O

The DT O
routine JJ O
administration NN O
of IN O
fat-soluble JJ O
vitamins NNS O
appears VBZ O
unnecessary JJ O
but CC O
it PRP O
is VBZ O
prudent JJ O
to TO O
measure VB O
prothrombin JJ B-NP
time NN O
and CC O
serum NN O
vitamins NNS O
A DT O
and CC O
E NNP O
at IN O
intervals NNS O
. . O

-DOCSTART- X X O

Prostaglandins NNS O
F NNP O
( -LRB- O
PGF NN O
) -RRB- O
were VBD O
measured VBN O
in IN O
uterine NN O
vein NN O
, , O
ovarian JJ O
artery NN O
, , O
and CC O
jugular JJ O
vein NN O
plasma NN O
and CC O
in IN O
the DT O
endometrial JJ O
tissues NNS O
at IN O
various JJ O
times NNS O
during IN O
the DT O
bovine JJ O
estrous JJ O
cycle NN O
, , O
and CC O
were VBD O
compared VBN O
to TO O
peripheral JJ O
plasma NN O
progesterone NN O
levels NNS O
. . O

-DOCSTART- X X O

Groups NNS O
of IN O
ten CD O
dependent JJ O
and CC O
ten CD O
saline NN O
mice NNS O
were VBD O
singly RB O
tested VBN O
in IN O
both DT O
light JJ O
and CC O
dark JJ O
conditions NNS O
in IN O
each DT O
of IN O
five CD O
covered JJ O
cylinders NNS O
(2-23 . O
in IN O
high JJ O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
initiated VBN O
from IN O
the DT O
nucleus JJ O
accumbens NNS O
septi NNS O
were VBD O
most RBS O
marked JJ O
. . O

-DOCSTART- X X O

The DT O
appearance NN O
of IN O
dyskinetic JJ O
movement NN O
disorders NNS O
in IN O
humans NNS O
following VBG O
the DT O
chronic JJ O
use NN O
of IN O
levodopa NN O
or CC O
amphetamine NN O
may MD O
be VB O
a DT O
manifestation NN O
of IN O
similarly RB O
increased VBN O
dopamine NN B-NP
receptor NN I-NP
site NN I-NP
sensitivity NN O
within IN O
the DT O
striatum NN O
. . O

-DOCSTART- X X O

Association NNP O
with IN O
HL-A NNP B-NP
W-27 CD I-NP
. . O

-DOCSTART- X X O

Atherosclerosis . O

-DOCSTART- X X O

However RB O
, , O
a DT O
10--15 CD O
% NN O
lengthening NN O
of IN O
the DT O
partial JJ O
thromboplastin NN B-NP
time NN O
is VBZ O
evident JJ O
after IN O
24 CD O
hours NNS O
of IN O
storage NN O
. . O

-DOCSTART- X X O

This DT O
reveals VBZ O
a DT O
new JJ O
test NN O
for IN O
short JJ O
saphenous JJ O
incompetence NN O
and CC O
shows VBZ O
that IN O
14 CD O
per IN O
cent NN O
of IN O
varices NNS O
stem VBP O
from IN O
a DT O
saphenopopliteal JJ O
reflux NN O
. . O

-DOCSTART- X X O

Air NNP O
ion NN O
action NN O
on IN O
bacteria NNS O
. . O

-DOCSTART- X X O

No DT O
evidence NN O
of IN O
either DT O
positive JJ O
or CC O
negative JJ O
chemography NN O
was VBD O
found VBN O
. . O

-DOCSTART- X X O

Study NNP O
of IN O
the DT O
physico-chemical JJ O
state NN O
of IN O
plutonium-239 NN O
in IN O
a DT O
citrate NN O
solution-blood NN O
system NN O

-DOCSTART- X X O

Tobramycin NNP O
60 CD O
mg NN O
did VBD O
not RB O
show VB O
any DT O
remarkable JJ O
effect NN O
, , O
but CC O
dibecacin RB O
100 CD O
mg NN O
produced VBD O
a DT O
slight JJ O
potentiating NN O
effect NN O
on IN O
the DT O
action NN O
of IN O
d-tubocurarine NN O
. . O

-DOCSTART- X X O

The DT O
specific JJ O
electrical JJ O
resistance NN O
of IN O
the DT O
cerebrospinal JJ O
fluid NN O
was VBD O
measured VBN O
by IN O
means NNS O
of IN O
conductometry NN O
in IN O
14 CD O
cases NNS O
of IN O
meningitis NN O
purulenta NN O
, , O
17 CD O
cases NNS O
of IN O
meningitis NN O
serosa NN O
, , O
10 CD O
cases NNS O
of IN O
encephalitis NN O
and CC O
in IN O
32 CD O
control NN O
subjects NNS O
. . O

-DOCSTART- X X O

2 LS O
- : O
Chemical NN O
occlusion NN O
of IN O
vas NNS O
is VBZ O
quite RB O
effective JJ O
in IN O
producing VBG O
a DT O
block NN O
in IN O
the DT O
vas NNS O
deferens NNS O
of IN O
dogs NNS O
. . O

-DOCSTART- X X O

Besides IN O
, , O
we PRP O
found VBD O
in IN O
3 CD O
patients NNS O
increased VBN O
serum JJ B-NP
immunoglobulins NNS I-NP
, , O
chiefly RB O
IgG NNP B-NP
, , O
as IN O
first JJ O
Russe NNP O
, , O
Busey NNP O
and CC O
Barbeau NNP O
demonstrated VBD O
in IN O
a DT O
large JJ O
French-Canadian JJ O
family NN O
. . O

-DOCSTART- X X O

Generally RB O
, , O
a DT O
correlation NN O
was VBD O
observed VBN O
between IN O
highest JJS O
concentrations NNS O
of IN O
CSF NNP B-NP
immunoglobulins NNS I-NP
and CC O
degree NN O
of IN O
meningeal JJ O
inflammatory JJ O
response NN O
, , O
even RB O
if IN O
this DT O
was VBD O
a DT O
component NN O
of IN O
other JJ O
neurological JJ O
diseases NNS O
. . O

-DOCSTART- X X O

Maternal NNP O
lactation NN O

-DOCSTART- X X O

Experimental JJ O
cardiotoxicity NN O
of IN O
adriamycin NN O

-DOCSTART- X X O

Muscular NNP O
pathology NN O

-DOCSTART- X X O

Demonstration NN O
of IN O
the DT O
agent NN O
was VBD O
performed VBN O
from IN O
the DT O
6th JJ O
to TO O
the DT O
11th JJ O
day NN O
p.i RB O
. . O
by IN O
direct JJ O
microscopic JJ O
methods NNS O
( -LRB- O
Stamp NN O
and CC O
auramine NN O
staining NN O
, , O
fluorescent JJ O
antibody NN O
technique NN O
) -RRB- O
; : O
the DT O
Coxiella NNP O
content NN O
was VBD O
determined VBN O
by IN O
titration NN O
in IN O
embryonated JJ O
hen NN O
's POS O
eggs NNS O
. . O

-DOCSTART- X X O

The DT O
alterations NNS O
of IN O
5-HT JJ O
and CC O
5-HIAA JJ O
levels NNS O
in IN O
several JJ O
regions NNS O
of IN O
the DT O
brain NN O
under IN O
the DT O
conditions NNS O
examined VBN O
may MD O
indicate VB O
that IN O
IDPN NNP O
's POS O
neurotoxicity NN O
primarily RB O
affects VBZ O
5-HT-containing JJ O
neurones NNS O
. . O

-DOCSTART- X X O

( -LRB- O
5 CD O
) -RRB- O
An DT O
increase NN O
in IN O
leukocyte-counts NNS O
occurred VBD O
on IN O
the DT O
administration NN O
of IN O
serum NN O
obtained VBN O
from IN O
rabbit NN O
during IN O
phase-2 NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
obtained VBD O
tend VB O
to TO O
prove VB O
that IN O
the DT O
reticuloendothelial JJ O
system NN O
mainly RB O
participated VBD O
in IN O
beryllium NN O
retention NN O
. . O

-DOCSTART- X X O

In IN O
both DT O
cases NNS O
, , O
at IN O
the DT O
end NN O
of IN O
exposure NN O
the DT O
same JJ O
level NN O
of IN O
blood NN B-NP
carboxyhemoglobin NN I-NP
( -LRB- O
COHb NN B-NP
) -RRB- O
( -LRB- O
about IN O
50 CD O
% NN O
) -RRB- O
was VBD O
reached VBN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
indicate VBP O
that IN O
increased VBD O
pulmonary JJ O
blood NN O
flow NN O
and CC O
decreased VBD O
pulmonary RB O
vascular JJ O
resistance NN O
with IN O
advancing VBG O
gestation NN O
are VBP O
due JJ O
to TO O
an DT O
increase NN O
in IN O
the DT O
total JJ O
number NN O
of IN O
vessels NNS O
and CC O
increased VBN O
vasomotor NN O
reactivity NN O
is VBZ O
related VBN O
to TO O
an DT O
increase NN O
in IN O
the DT O
total JJ O
amount NN O
of IN O
smooth JJ O
muscle NN O
while IN O
the DT O
thickness NN O
of IN O
muscle NN O
in IN O
individual JJ O
vessels NNS O
remains VBZ O
constant JJ O
. . O

-DOCSTART- X X O

Reduction NN O
in IN O
dosage NN O
restored VBD O
normal JJ O
taste NN O
sense NN O
in IN O
all DT O
three CD O
, , O
but CC O
in IN O
two CD O
the DT O
drug NN O
had VBD O
to TO O
be VB O
discontinued VBN O
because IN O
of IN O
persisting VBG O
high JJ O
transaminase NN O
levels NNS O
. . O

-DOCSTART- X X O

A DT O
late JJ O
diagnosis NN O
of IN O
retinoblastoma NN O
is VBZ O
an DT O
unquestionable JJ O
fact NN O
that IN O
allows VBZ O
its PRP$ O
growth NN O
and CC O
leads VBZ O
to TO O
a DT O
deterioration NN O
in IN O
the DT O
outlook NN O
. . O

-DOCSTART- X X O

A DT O
note NN O
on IN O
the DT O
phase-plane NN O
technique NN O
representation NN O
of IN O
cardiac JJ O
action NN O
potentials NNS O
. . O

-DOCSTART- X X O

3 CD O
activities NNS O
of IN O
the DT O
factor NN B-NP
II NNP I-NP
molecule NN O
in IN O
the DT O
newborn JJ O
infant NN O
at IN O
term NN O

-DOCSTART- X X O

The DT O
concept NN O
of IN O
" `` O
structural JJ O
identifiability NN O
" '' O
is VBZ O
employed VBN O
in IN O
this DT O
analysis NN O
to TO O
determine VB O
which WDT O
model NN O
parameters NNS O
can MD O
be VB O
and CC O
which WDT O
cannot MD O
be VB O
determined VBN O
"uniquely RB O
" '' O
from IN O
given VBN O
input-output NN O
data NNS O
; : O
a DT O
step-by-step NN O
procedure NN O
based VBN O
on IN O
an DT O
extension NN O
of IN O
this DT O
concept NN O
is VBZ O
presented VBN O
for IN O
adapting VBG O
the DT O
overall JJ O
approach NN O
to TO O
the DT O
experimental JJ O
design NN O
problem NN O
. . O

-DOCSTART- X X O

However RB O
, , O
we PRP O
did VBD O
detect VB O
lot-to-lot NN O
variation NN O
and CC O
differences NNS O
in IN O
performance NN O
between IN O
narrow JJ O
bandpass NN O
and CC O
wide JJ O
bandpass NN O
spectrophotometers NNS O
. . O

-DOCSTART- X X O

The DT O
cochlear JJ O
compromise NN O
. . O

-DOCSTART- X X O

Biohydrogenation NNP O
of IN O
linoleic JJ O
acid NN O
into IN O
octadecenoic JJ O
acid NN O
was VBD O
observed VBN O
. . O

-DOCSTART- X X O

Chlamydial JJ O
agents NNS O
were VBD O
isolated VBN O
from IN O
the DT O
semen NNS O
near IN O
the DT O
end NN O
of IN O
the DT O
chlamydemic JJ O
phase NN O
. . O

-DOCSTART- X X O

Because IN O
of IN O
the DT O
increased VBN O
CPK NN B-NP
activity NN O
found VBD O
in IN O
normal JJ O
newborns NNS O
, , O
screening VBG O
for IN O
Duchenne-type JJ O
muscular JJ O
dystrophy NN O
should MD O
be VB O
postponed VBN O
for IN O
a DT O
few JJ O
weeks NNS O
after IN O
delivery NN O
. . O

-DOCSTART- X X O

The DT O
authors NNS O
report VBP O
the DT O
results NNS O
of IN O
a DT O
series NN O
of IN O
toxicological JJ O
tests NNS O
conducted VBN O
on IN O
plastic NN O
materials NNS O
( -LRB- O
polyethylene NN O
) -RRB- O
activated VBN O
with IN O
tetraphenylbutadiene NN O
( -LRB- O
TPB) NNP O
an DT O
additive JJ O
recently RB O
proposed VBN O
as IN O
a DT O
sensitizer NN O
capable JJ O
of IN O
photodegrading VBG O
plastic JJ O
materials NNS O
. . O

-DOCSTART- X X O

One CD O
site NN O
, , O
PAL NNP B-NP
, , O
occurs VBZ O
within IN O
the DT O
10 CD O
bp NN O
sequence NN O
GGGGAGGAGG. . O

-DOCSTART- X X O

Nuclear NNP O
extracts VBZ O
prepared VBN O
from IN O
both DT O
neural JJ O
and CC O
non-neural JJ O
cell NN O
lines NNS O
, , O
mouse NN O
brain NN O
, , O
and CC O
mouse NN O
liver NN O
contain VBP O
proteins NNS O
that WDT O
recognize VBP O
and CC O
bind VBP O
to TO O
the DT O
PROX NNP O
and CC O
PAL NNP O
sequences NNS O
indicating VBG O
that IN O
proteins NNS O
which WDT O
bind VBP O
to TO O
these DT O
target NN O
sequences NNS O
are VBP O
widespread JJ O
. . O

-DOCSTART- X X O

To TO O
determine VB O
if IN O
the DT O
NF( NNP B-NP
H) NNP I-NP
promoter NN I-NP
can MD O
be VB O
activated VBN O
in IN O
a DT O
tissue NN O
specific JJ O
manner NN O
during IN O
development NN O
transgenic NN O
mice NNS O
containing VBG O
the DT O
promoter NN O
region NN O
linked VBN O
to TO O
a DT O
beta-galactosidase JJ B-NP
reporter NN I-NP
gene NN I-NP
were VBD O
generated VBN O
. . O

-DOCSTART- X X O

A DT O
significant JJ O
direct JJ O
relationship NN O
was VBD O
observed VBN O
between IN O
the DT O
percent NN O
area NN O
density NN O
of IN O
smooth JJ O
muscle NN O
and CC O
the DT O
percent NN O
change NN O
in IN O
peak NN O
urinary JJ O
flow NN O
rate NN O
. . O

-DOCSTART- X X O

Rabbit NN B-NP
skeletal NN I-NP
muscle NN I-NP
glycogenin NN I-NP
. . O

-DOCSTART- X X O

Animals NNS O
that IN O
received VBN O
DSP-4 NN O
were VBD O
significantly RB O
retarded VBN O
in IN O
motor NN O
recovery NN O
compared VBN O
with IN O
the DT O
saline NN O
group NN O
. . O

-DOCSTART- X X O

The DT O
prophylactic JJ O
use NN O
of IN O
new JJ O
medication NN O
for IN O
patients NNS O
between IN O
the DT O
first JJ O
and CC O
second JJ O
cycle NN O
of IN O
chemotherapy NN O
, , O
in IN O
agreement NN O
with IN O
the DT O
estimates NNS O
calculated VBD O
, , O
does VBZ O
not RB O
save VB O
health NN O
care NN O
costs NNS O
but CC O
may MD O
improve VB O
the DT O
quality NN O
of IN O
life NN O
in IN O
these DT O
patients NNS O
and CC O
permit VB O
the DT O
continuation NN O
of IN O
a DT O
therapeutic JJ O
schedule NN O
without IN O
interruption NN O
which WDT O
may MD O
improve VB O
the DT O
life NN O
expectancy NN O
of IN O
the DT O
patient NN O
. . O

-DOCSTART- X X O

The DT O
isolation NN O
of IN O
this DT O
gene NN O
was VBD O
based VBN O
on IN O
the DT O
identification NN O
of IN O
the DT O
Y-231 JJ O
cosmid NN O
that WDT O
contains VBZ O
CpG JJ O
rich JJ O
sequences NNS O
( -LRB- O
HTF NN O
islands NNS O
) -RRB- O
in IN O
its PRP$ O
human JJ O
insert NN O
. . O

-DOCSTART- X X O

Tissue NNP B-NP
plasminogen NN I-NP
activator NN I-NP
, , O
its PRP$ O
inhibitor NN O
and CC O
other JJ O
parameters NNS O
of IN O
fibrinolysis NN O
in IN O
blood NN O
of IN O
patients NNS O
operated VBN O
for IN O
mild JJ O
hypertrophy NN O
of IN O
the DT O
prostate NN O

-DOCSTART- X X O

Gene NNP O
constructs NNS O
consisting VBG O
of IN O
human JJ B-NP
growth NN I-NP
hormone NN I-NP
( -LRB- O
hGH) JJ B-NP
gene NN O
driven VBN O
by IN O
promoter/regulatory JJ O
sequence NN O
of IN O
mouse NN B-NP
metallothionein NN I-NP
( -LRB- O
mMT NN B-NP
) -RRB- O
, , O
viral JJ B-NP
thymidine NN I-NP
kinase NN I-NP
(vTK) NN O
, , O
rat NN B-NP
cholecystokinin NN I-NP
(rCCK) NN O
, , O
or CC O
chicken NN B-NP
beta-actin NN I-NP
( -LRB- O
cBA NN B-NP
) -RRB- O
gene NN O
were VBD O
injected VBN O
into IN O
the DT O
cytoplasm NN O
of IN O
fertilized VBN O
medaka NN O
eggs NNS O
via IN O
the DT O
micropyle NN O
. . O

-DOCSTART- X X O

Serum NN O
gastrin NN B-NP
and CC O
AFP NNP B-NP
levels NNS O
had VBD O
the DT O
same JJ O
evolution NN O
and CC O
appear VB O
to TO O
have VB O
the DT O
same JJ O
interest NN O
to TO O
follow VB O
the DT O
course NN O
of IN O
the DT O
disease NN O
. . O

-DOCSTART- X X O

Prospects NNS O
for IN O
controlled-delivery JJ O
systems NNS O
. . O

-DOCSTART- X X O

Though IN O
hepatomegaly JJ O
and CC O
mild JJ O
elevation NN O
of IN O
enzymes NNS O
can MD O
be VB O
observed VBN O
in IN O
a DT O
significant JJ O
proportion NN O
of IN O
patients NNS O
, , O
involvement NN O
of IN O
liver NN O
leading VBG O
to TO O
acute JJ O
hepatitis NN O
or CC O
liver NN O
cell NN O
necrosis NN O
is VBZ O
a DT O
relatively RB O
uncommon JJ O
complication NN O
in IN O
P. NNP O
falciparum NN O
malaria NN O
. . O

-DOCSTART- X X O

A DT O
statistically RB O
significant JJ O
improvement NN O
due JJ O
to TO O
the DT O
administration NN O
of IN O
Bromergon NNP O
was VBD O
observed VBN O
in IN O
symptoms NNS O
associated VBN O
with IN O
overreactiveness NN O
to TO O
normal JJ O
prolactin NN B-NP
levels NNS O
, , O
i IN O
.e NN O
. . O
abdominal JJ O
tension NN O
, , O
edema NN O
, , O
weight NN O
gain NN O
and CC O
breast NN O
tenderness NN O
. . O

-DOCSTART- X X O

Most JJS O
of IN O
the DT O
patients NNS O
presented VBD O
with IN O
Transient NNP O
Ischemic NNP O
Attacks NNP O
( -LRB- O
64 CD O
% NN O
) -RRB- O
or CC O
Reversible NNP O
Ischemic NNP O
Neurologic NNP O
Deficits NNS O
( -LRB- O
19 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
cloned VBD O
the DT O
third JJ O
human JJ O
gene NN O
for IN O
the DT O
LD78 NNP B-NP
, , O
termed VBD O
LD78 DT B-NP
gamma NN I-NP
and CC O
the DT O
sequence NN O
analysis NN O
showed VBD O
that IN O
it PRP O
is VBZ O
a DT O
5'-truncated JJ O
pseudogene NN O
. . O

-DOCSTART- X X O

This DT O
analysis NN O
, , O
together RB O
with IN O
a DT O
consideration NN O
of IN O
the DT O
SCBs NNP O
found VBD O
upstream RB O
of IN O
known VBN O
SWI4,6-dependent JJ B-NP
genes NNS O
, , O
leads VBZ O
to TO O
the DT O
proposal NN O
of IN O
a DT O
revised VBN O
consensus NN O
sequence NN O
for IN O
this DT O
important JJ O
regulatory JJ O
element NN O
. . O

-DOCSTART- X X O

Mutational JJ O
analysis NN O
of IN O
a DT O
DNA NNP O
sequence NN O
involved VBN O
in IN O
linking VBG O
gene NN O
expression NN O
to TO O
the DT O
cell NN O
cycle NN O
. . O

-DOCSTART- X X O

The DT O
method NN O
was VBD O
adapted VBN O
for IN O
the DT O
determination NN O
of IN O
nadolol NN O
racemate NN O
A DT O
by IN O
a DT O
change NN O
in IN O
mobile JJ O
phase NN O
composition NN O
. . O

-DOCSTART- X X O

In IN O
7 CD O
of IN O
9 CD O
cases NNS O
, , O
the DT O
enhancer NN O
is VBZ O
fused VBN O
to TO O
the DT O
c-myc JJ B-NP
bearing NN I-NP
sequences NNS I-NP
of IN O
chromosome NN O
8. . O

-DOCSTART- X X O

These DT O
components NNS O
both DT O
had VBD O
a DT O
median JJ O
R2 NN O
of IN O
0.84 CD O
, , O
compared VBN O
to TO O
median JJ O
R2s NNS O
ranging VBG O
from IN O
0.37 CD O
to TO O
0.83 CD O
for IN O
five CD O
commonly RB O
used VBN O
ad NN O
hoc NN O
EEG NNP O
components NNS O
. . O

-DOCSTART- X X O

66 CD O
:469-479 CD O
, , O
1992 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Synergistic JJ O
transactivation NN O
of IN O
the DT O
BMRF1 NNP B-NP
promoter NN I-NP
by IN O
the DT O
Z/c-myb JJ B-NP
combination NN O
appears VBZ O
to TO O
involve VB O
direct JJ O
binding NN O
by IN O
the DT O
Z NN B-NP
protein NN I-NP
but CC O
not RB O
the DT O
c-myb JJ B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

The DT O
cellular JJ O
sequences NNS O
5' VBD O
to TO O
the DT O
viral JJ O
integration NN O
site NN O
exhibited VBN O
85 CD O
to TO O
97 CD O
% NN O
identity NN O
to TO O
several JJ O
sequences NNS O
belonging VBG O
to TO O
the DT O
mouse NN B-NP
L1 IN I-NP
family NN I-NP
of IN O
long JJ O
interspersed JJ O
repetitive JJ O
sequences NNS O
. . O

-DOCSTART- X X O

Both DT O
Rep78 NNPS B-NP
and CC O
Rep68 NNPS B-NP
cut VBD O
the DT O
terminal NN O
AAV IN O
sequence NN O
at IN O
the DT O
same JJ O
site NN O
( -LRB- O
nucleotide JJ O
124 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Nucleotide NNP O
sequence NN O
analysis NN O
revealed VBN O
that IN O
TAR-binding JJ B-NP
protein NN I-NP
is VBZ O
very RB O
similar JJ O
to TO O
the DT O
CREB2 JJ B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Drosophila NNP B-NP
UbcD1 NNP I-NP
encodes VBZ O
a DT O
highly RB O
conserved VBN O
ubiquitin-conjugating JJ B-NP
enzyme NN O
involved VBN O
in IN O
selective JJ O
protein NN O
degradation NN O
. . O

-DOCSTART- X X O

The DT O
goal NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
determine VB O
the DT O
feasibility NN O
of IN O
retrovirus NN O
mediated JJ O
expression NN O
of IN O
rp47phox NN B-NP
in IN O
the DT O
HL60 NNP O
and CC O
U937 DT O
human JJ O
hematopoietic NN O
cell NN O
lines NNS O
, , O
and CC O
in IN O
an DT O
Epstein-Barr NNP O
virus NN O
transformed VBD O
B-lymphocyte JJ O
cell NN O
line NN O
( -LRB- O
EBV-BCL NN O
) -RRB- O
derived VBN O
from IN O
a DT O
p47phox-deficient JJ B-NP
CGD NNP O
patient NN O
. . O

-DOCSTART- X X O

Comparison NN O
with IN O
the DT O
sequence NN O
databanks NNS O
show VBP O
that IN O
Tactile NNP B-NP
is VBZ O
a DT O
member NN O
of IN O
the DT O
immunoglobulin NN B-NP
gene NN I-NP
superfamily NN I-NP
, , O
with IN O
similarity NN O
to TO O
Drosophila NNP B-NP
amalgam NN I-NP
, , O
the DT O
melanoma NN B-NP
Ag NNP I-NP
MUC-18 CD I-NP
, , O
members NNS O
of IN O
the DT O
carcinoembryonic JJ B-NP
Ag NNP I-NP
family NN I-NP
, , O
the DT O
poliovirus NN B-NP
receptor NN I-NP
, , O
and CC O
the DT O
neural JJ B-NP
cell NN I-NP
adhesion NN I-NP
molecule NN I-NP
. . O

-DOCSTART- X X O

The DT O
phenotypes NNS O
of IN O
the DT O
ICP0 NNP B-NP
nonsense NN O
mutants NNS O
were VBD O
intermediate JJ O
between IN O
those DT O
of IN O
the DT O
wild-type JJ O
virus NN O
and CC O
7134 CD O
in IN O
that IN O
the DT O
more JJR O
ICP0-coding JJ B-NP
sequence NN I-NP
expressed VBN O
by IN O
a DT O
given VBN O
nonsense NN O
mutant NN O
, , O
the DT O
more JJR O
wild JJ O
type-like NN O
was VBD O
its PRP$ O
phenotype NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
nucleotide JJ O
sequence NN O
of IN O
the DT O
rightmost JJ O
43 CD O
kbp NN O
of IN O
herpesvirus NN O
saimiri NNS O
( -LRB- O
HVS NNP O
) -RRB- O
L-DNA NNP O
: : O
general JJ O
conservation NN O
of IN O
genetic JJ O
organization NN O
between IN O
HVS NNP O
and CC O
Epstein-Barr NNP O
virus NN O
. . O

-DOCSTART- X X O

Treatment NNP O
with IN O
MK-801 NNP O
induced VBD O
a DT O
burst NN O
suppression NN O
in IN O
the DT O
EEG NNP O
and CC O
a DT O
transient NN O
drop NN O
( -LRB- O
11.4 CD O
+/ RB O
- : O
6.5 CD O
mm CD O
Hg NN O
) -RRB- O
in IN O
the DT O
mean JJ O
arterial JJ O
pressure NN O
. . O

-DOCSTART- X X O

Myogenic JJ O
differentiation NN O
can MD O
be VB O
inhibited VBN O
by IN O
the DT O
adenovirus NN O
E1a NNP B-NP
protein NN I-NP
in IN O
the DT O
rat NN O
L6 IN O
muscle NN O
cell NN O
line NN O
. . O

-DOCSTART- X X O

The DT O
experiment NN O
results NNS O
showed VBD O
: : O
( -LRB- O
i FW O
) -RRB- O
not RB O
only RB O
1O2 VB O
, , O
but CC O
also RB O
free JJ O
radicals NNS O
( -LRB- O
O2-. DT O
.OH NNP O
and CC O
YHPD-. NNP O
) -RRB- O
can MD O
be VB O
formed VBN O
by IN O
the DT O
aid NN O
of IN O
YHPD NNP O
; : O
and CC O
( -LRB- O
ii NNS O
) -RRB- O
as IN O
to TO O
the DT O
ability NN O
of IN O
producing VBG O
1O2 CD O
, , O
YHPD RB O
less JJR O
than IN O
BHPD NNP O
, , O
while IN O
for IN O
generating VBG O
O2-. NNP O
and CC O
.OH NNP O
, , O
YHPD RB O
greater JJR O
than IN O
BHPD. NNP O

-DOCSTART- X X O

Acad NNP O
. . O

-DOCSTART- X X O

Both DT O
in IN O
vitro-synthesized JJ O
S2 JJ B-NP
protein NN I-NP
and CC O
synthetic JJ O
peptides NNS O
corresponding JJ O
to TO O
S2 PRP B-NP
are VBP O
shown VBN O
to TO O
react VB O
positively RB O
with IN O
sera NN O
obtained VBN O
from IN O
EIAV-infected JJ O
horses NNS O
, , O
providing VBG O
the DT O
first JJ O
direct JJ O
evidence NN O
of IN O
expression NN O
of IN O
this DT O
protein NN O
in IN O
infected JJ O
animals NNS O
. . O

-DOCSTART- X X O

Many JJ O
canonical JJ O
TATA NNP O
sequences NNS O
are VBP O
present JJ O
upstream RB O
from IN O
these DT O
VZV NNP O
transcriptional JJ O
start NN O
sites NNS O
but CC O
, , O
apparently RB O
, , O
are VBP O
not RB O
used VBN O
. . O

-DOCSTART- X X O

The DT O
ORF NNP O
4 CD O
gene NN O
was VBD O
minimally RB O
active JJ O
, , O
whereas IN O
the DT O
ORF NN O
62 CD O
gene NN O
gave VBD O
twofold JJ O
induction NN O
; : O
both DT O
genes NNS O
, , O
acting VBG O
together RB O
, , O
gave VBD O
fivefold JJ O
induction NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
the DT O
IR5 NNP B-NP
ORF NNP I-NP
of IN O
EHV-1 NNP O
possesses VBZ O
a DT O
sequence NN O
of IN O
13 CD O
amino NN O
acids NNS O
( -LRB- O
CAYWCCLGHAFAC NNP O
) -RRB- O
that WDT O
is VBZ O
a DT O
perfect JJ O
match NN O
to TO O
the DT O
consensus NN O
zinc NN O
finger NN O
motif NN O
(C-X2-4-C-X2-15-C/H-X2-4-C/H) NN O
. . O

-DOCSTART- X X O

The DT O
DNA NNP O
sequence NN O
of IN O
the DT O
sulfate NN B-NP
activation NN I-NP
locus NN I-NP
from IN O
Escherichia NNP O
coli NNS O
K-12 NN O
has VBZ O
been VBN O
determined VBN O
. . O

-DOCSTART- X X O

Plasma NNP O
membranes NNS O
of IN O
cultured JJ O
cells NNS O
contain VBP O
high JJ O
affinity NN O
receptors NNS O
for IN O
high JJ B-NP
density NN I-NP
lipoprotein NN I-NP
( -LRB- O
HDL NNP B-NP
) -RRB- O
that WDT O
appear VBP O
to TO O
mediate VB O
removal NN O
of IN O
excess NN O
intracellular JJ O
cholesterol NN O
. . O

-DOCSTART- X X O

After IN O
the DT O
first JJ O
28 CD O
patients NNS O
vincristine NN O
was VBD O
replaced VBN O
by IN O
teniposide JJ O
(VM-26 NNS O
) -RRB- O
due JJ O
to TO O
neurotoxicity NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
an DT O
internal JJ O
short JJ O
element NN O
located VBN O
at IN O
the DT O
very JJ O
5' JJ O
terminal NN O
of IN O
L1 JJ B-NP
sequence NN I-NP
and CC O
the DT O
nuclear JJ O
factor NN O
binding NN O
to TO O
the DT O
element NN O
play NN O
a DT O
crucial JJ O
role NN O
in IN O
the DT O
transcription NN O
of IN O
human JJ B-NP
L1 NNP I-NP
. . O

-DOCSTART- X X O

Tumor NN O
cells NNS O
were VBD O
focally RB O
immunoreactive JJ O
for IN O
neuron-specific JJ B-NP
enolase NN I-NP
, , O
insulin NN B-NP
, , O
glucagon NN B-NP
and CC O
VIP. NNP B-NP

-DOCSTART- X X O

A DT O
recombinant NN O
with IN O
a DT O
5' JJ O
end NN O
from IN O
src NN B-NP
and CC O
a DT O
3' JJ O
end NN O
from IN O
ros NNS B-NP
, , O
called VBD O
SRC NNP B-NP
x NNP O
ROS NNP B-NP
, , O
transformed VBN O
chicken NN O
embryo NN O
fibroblasts NNS O
( -LRB- O
CEF NN O
) -RRB- O
to TO O
a DT O
spindle JJ O
shape NN O
morphology NN O
, , O
mimicking VBG O
that IN O
of IN O
UR2 NNP B-NP
. . O

-DOCSTART- X X O

Transient NNP O
transfection NN O
assays VBZ O
showed VBN O
that IN O
site NN O
A DT O
is VBZ O
necessary JJ O
and CC O
sufficient JJ O
for IN O
RXR NNP B-NP
alpha-mediated JJ I-NP
transactivation NN O
of IN O
the DT O
apoAI JJ B-NP
gene NN I-NP
basal NN I-NP
promoter NN I-NP
in IN O
human JJ O
hepatoma NN O
HepG2 IN O
cells NNS O
in IN O
the DT O
presence NN O
of IN O
RA NNP O
and CC O
that IN O
this DT O
transactivation NN O
is VBZ O
abolished VBN O
by IN O
increasing VBG O
amounts NNS O
of IN O
cotransfected JJ O
ARP-1 NN B-NP
. . O

-DOCSTART- X X O

The DT O
enhancer NN O
region NN O
of IN O
Akv NNP O
murine NN O
leukemia NN O
virus NN O
contains VBZ O
the DT O
sequence NN O
motif NN O
ACAGATGG. . O

-DOCSTART- X X O

A DT O
third JJ O
prominent JJ O
component NN O
of IN O
apparent JJ O
molecular JJ O
mass NN O
16 CD O
kDa NN O
displayed VBD O
several JJ O
properties NNS O
, , O
including VBG O
ability NN O
to TO O
bind NN O
45Ca2+ NNS O
, , O
that WDT O
are VBP O
characteristic JJ O
of IN O
the DT O
regulatory JJ O
( -LRB- O
B NN O
) -RRB- O
subunit NN O
of IN O
mammalian JJ B-NP
calcineurin NN I-NP
and CC O
was VBD O
recognized VBN O
by IN O
an DT O
antiserum NN O
raised VBN O
against IN O
bovine JJ B-NP
calcineurin NN I-NP
. . O

-DOCSTART- X X O

As IN O
was VBD O
observed VBN O
previously RB O
for IN O
MATa NNP B-NP
cna1 CD B-NP
cna2 IN B-NP
double JJ O
mutants NNS O
, , O
MATa NNP B-NP
cnb1 VBD B-NP
mutants NNS I-NP
were VBD O
defective JJ O
in IN O
their PRP$ O
ability NN O
to TO O
recover VB O
from IN O
alpha-factor-induced DT B-NP
growth NN O
arrest NN O
. . O

-DOCSTART- X X O

Antibodies NNS O
against IN O
this DT O
purified VBN O
protein NN O
localize NN O
RIM1 NNP B-NP
to TO O
mitochondria CD O
. . O

-DOCSTART- X X O

HNF-3 JJ B-NP
beta JJ I-NP
amino-terminal JJ I-NP
sequences NNS I-NP
defined VBN O
by IN O
conserved JJ O
region NN O
IV NNP O
also RB O
contributed VBD O
to TO O
transactivation NN O
, , O
but CC O
region NN O
IV NNP O
activity NN O
required VBD O
the DT O
participation NN O
of IN O
the DT O
region NN O
II-II NNP O
I PRP O
domain NN O
. . O

-DOCSTART- X X O

The DT O
319 CD O
base NN O
pair NN O
region NN O
immediately RB O
upstream RB O
of IN O
the DT O
CAP NNP O
site NN O
is VBZ O
characterized VBN O
by IN O
the DT O
lack NN O
of IN O
a DT O
proximal JJ O
TATA NNP O
box NN O
and CC O
the DT O
presence NN O
of IN O
sequences NNS O
similar JJ O
to TO O
GC NNP O
boxes NNS O
, , O
CACCC NNP O
boxes NNS O
, , O
CCAAT NN O
boxes NNS O
, , O
activator NN B-NP
protein NN I-NP
2 CD I-NP
( -LRB- O
Ap-2 NN B-NP
) -RRB- O
sites NNS O
, , O
partial JJ O
glucocorticoid JJ O
response NN O
elements NNS O
( -LRB- O
GREs NNP O
) -RRB- O
, , O
and CC O
partial JJ O
cyclic NN O
AMP IN O
response NN O
elements NNS O
( -LRB- O
CREs NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
rats NNS O
anaesthetized VBN O
with IN O
+-chloralose JJ O
the DT O
changes NNS O
in IN O
extracellular JJ O
pH NNS O
and CC O
K+ NNP O
in IN O
spinal JJ O
cord NN O
dorsal JJ O
horn NN O
were VBD O
studied VBN O
using VBG O
pH RB O
and CC O
K+ NNP O
ion-selective JJ O
electrodes NNS O
. . O

-DOCSTART- X X O

NSCL-1 NN B-NP
is VBZ O
expressed VBN O
in IN O
a DT O
larger JJR O
number NN O
of IN O
these DT O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

Labile NNP O
LTR-binding JJ B-NP
proteins NNS I-NP
appear VBP O
to TO O
be VB O
essential JJ O
for IN O
c-myc JJ B-NP
hyperexpression NN O
, , O
since IN O
both DT O
LTR-enhanced NNP O
transcription NN O
and CC O
the DT O
activities NNS O
of IN O
LTR-binding JJ B-NP
proteins NNS I-NP
are VBP O
specifically RB O
decreased VBN O
after IN O
inhibition NN O
of IN O
protein NN O
synthesis NN O
( -LRB- O
A DT O
. . O

-DOCSTART- X X O

Ruddell NNP O
, , O
M. NNP O

-DOCSTART- X X O

Intermediate NNP O
levels NNS O
of IN O
gene NN O
activity NN O
were VBD O
observed VBN O
for IN O
TnI NN B-NP
enhancers NNS I-NP
containing VBG O
E-boxes NNP O
derived VBD O
from IN O
the DT O
MCK NNP B-NP
left VBD I-NP
E-box NNP I-NP
site NN I-NP
or CC O
from IN O
the DT O
Ig NNP B-NP
kappa NN I-NP
E2 NNP I-NP
E-box NNP I-NP
. . O

-DOCSTART- X X O

The DT O
CANNTG NNP O
motifs NNS O
were VBD O
found VBN O
to TO O
bind NN O
MyoD NNP B-NP
and CC O
myogenin PRP$ B-NP
fusion NN I-NP
proteins NNS I-NP
and CC O
to TO O
interact VB O
with IN O
proteins NNS O
in IN O
nuclear JJ O
extracts NNS O
from IN O
cultured JJ O
myotubes NNS O
. . O

-DOCSTART- X X O

Peripheral NNP O
polyneuropathy NN O
associated VBN O
with IN O
multiple JJ O
myeloma NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
cloned VBN O
and CC O
sequenced VBN O
COX12 NN B-NP
, , O
the DT O
nuclear JJ O
gene NN O
for IN O
subunit NN B-NP
VIb NNP I-NP
of IN O
Saccharomyces NNP B-NP
cerevisiae NN I-NP
cytochrome NN I-NP
c NN I-NP
oxidase NN I-NP
. . O

-DOCSTART- X X O

The DT O
basal JJ O
promoter NN O
elements NNS O
of IN O
murine NN B-NP
cytochrome NN I-NP
c NN I-NP
oxidase NN I-NP
subunit NN I-NP
IV NNP I-NP
gene NN I-NP
consist VBP O
of IN O
tandemly NN O
duplicated VBN O
ets NNS B-NP
motifs NNS O
that WDT O
bind VBP O
to TO O
GABP-related NNP B-NP
transcription NN I-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

Here RB O
we PRP O
show VBP O
that IN O
short JJ O
synthetic NN O
peptides NNS O
containing VBG O
the DT O
pRB-binding JJ B-NP
sequences NNS I-NP
of IN O
E1A NNP B-NP
are VBP O
sufficient JJ O
for IN O
interaction NN O
with IN O
p107 NNS B-NP
, , O
cyclin NN B-NP
A NNP I-NP
, , O
and CC O
p130 VBD B-NP
. . O

-DOCSTART- X X O

Mapping VBG O
the DT O
cAMP NN B-NP
receptor NN I-NP
protein NN I-NP
contact NN I-NP
site NN I-NP
on IN O
the DT O
alpha NN O
subunit NN O
of IN O
Escherichia NNP B-NP
coli NNS I-NP
RNA NNP I-NP
polymerase NN I-NP
. . O

-DOCSTART- X X O

A DT O
combination NN O
of IN O
comparative JJ O
sequence NN O
analysis NN O
and CC O
thermodynamic JJ O
methods NNS O
reveals VBZ O
the DT O
conservation NN O
of IN O
tertiary JJ O
structure NN O
elements NNS O
in IN O
the DT O
5' JJ O
untranslated JJ O
region NN O
( -LRB- O
UTR NNP O
) -RRB- O
of IN O
human JJ O
enteroviruses NNS O
and CC O
rhinoviruses NNS O
. . O

-DOCSTART- X X O

This DT O
soluble JJ O
form NN O
of IN O
the DT O
HGFr NNP B-NP
( -LRB- O
sHGFr NN B-NP
) -RRB- O
bound VBN O
HGF NN B-NP
with IN O
an DT O
affinity NN O
similar JJ O
to TO O
that DT O
of IN O
the DT O
authentic JJ O
, , O
membrane-associated JJ O
receptor NN O
. . O

-DOCSTART- X X O

Strategies NNS O
for IN O
blood NN O
screening NN O
for IN O
the DT O
hepatitis NN O
C NNP O
virus NN O
and CC O
for IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
in IN O
high JJ O
risk NN O
groups NNS O
. . O

-DOCSTART- X X O

Comparison NNP O
of IN O
data NNS O
obtained VBN O
with IN O
the DT O
results NNS O
of IN O
chronic JJ O
treatment NN O
with IN O
the DT O
opioid JJ O
antagonist NN O
permits VBZ O
to TO O
conclude VB O
that IN O
the DT O
chronic NN O
blockade NN O
increases VBZ O
the DT O
fatiguability NN O
to TO O
a DT O
great JJ O
extent NN O
than IN O
chronic JJ O
activation NN O
of IN O
opioid JJ O
system NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
cloned VBN O
and CC O
characterized VBN O
a DT O
55-kb JJ O
region NN O
of IN O
DNA NNP O
surrounding VBG O
HRAS1 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
ORF1 JJ O
protein NN O
was VBD O
found VBN O
to TO O
be VB O
highly RB O
homologous JJ O
to TO O
the DT O
putative JJ O
potexvirus NN B-NP
RNA NNP I-NP
replicases VBZ I-NP
; : O
ORF2 NNP O
, , O
-3 NN O
, , O
-5 . O
and CC O
-6 RB O
proteins VBZ O
also RB O
have VBP O
analogues NNS O
among IN O
the DT O
potex NN O
- : O
and/or CC O
carlavirus-encoded JJ O
proteins NNS O
. . O

-DOCSTART- X X O

A DT O
total NN O
of IN O
281 CD O
patients NNS O
were VBD O
divided VBN O
into IN O
groups NNS O
according VBG O
to TO O
their PRP$ O
clinical JJ O
diagnosis NN O
and CC O
were VBD O
examined VBN O
using VBG O
capnography NN O
, , O
spirometry NN O
and CC O
blood-gas NN O
analysis NN O
. . O

-DOCSTART- X X O

No DT O
significant JJ O
correlations NNS O
of IN O
peak NN O
VO2 NNS O
were VBD O
observed VBN O
between IN O
the DT O
3 CD O
tests NNS O
. . O

-DOCSTART- X X O

An DT O
RNA-binding JJ B-NP
protein NN I-NP
gene NN I-NP
( -LRB- O
rbp1 CD B-NP
) -RRB- O
from IN O
Drosophila NNP O
melanogaster NN O
, , O
encoding VBG O
an DT O
RNA NNP O
recognition NN O
motif NN O
and CC O
an DT O
Arg-Ser JJ O
rich JJ O
( -LRB- O
RS NNS O
) -RRB- O
domain NN O
, , O
has VBZ O
been VBN O
characterized VBN O
. . O

-DOCSTART- X X O

Some DT O
research NN O
studies NNS O
have VBP O
related VBN O
this DT O
kind NN O
of IN O
tumors NNS O
with IN O
prolonged VBN O
ingestion NN O
of IN O
H2 NNP O
inhibitors NNS O
and CC O
others NNS O
antacid NN O
. . O

-DOCSTART- X X O

A DT O
comparative JJ O
study NN O
of IN O
the DT O
total JJ O
protein NN O
profiles NNS O
of IN O
wild-type JJ O
S. NNP O
entomophila NN O
UC9 . O
and CC O
mutant JJ O
UC21 NNP O
revealed VBD O
that IN O
the DT O
mutant NN O
lacked VBD O
an DT O
approximately RB O
44-kDa JJ O
protein NN O
and CC O
overexpressed VBD O
an DT O
approximately RB O
20-kDa JJ O
protein NN O
. . O

-DOCSTART- X X O

Characterization NN O
of IN O
the DT O
regulon NN O
controlled VBN O
by IN O
the DT O
leucine-responsive JJ B-NP
regulatory JJ I-NP
protein NN I-NP
in IN O
Escherichia NNP O
coli NNS O
. . O

-DOCSTART- X X O

Mapping NNP O
of IN O
the DT O
mouse NN B-NP
ornithine NN I-NP
decarboxylase-related JJ I-NP
sequence NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

This DT O
mutation NN O
also RB O
results VBZ O
in IN O
markedly RB O
decreased VBN O
levels NNS O
of IN O
CAD NN B-NP
mRNA NN I-NP
and CC O
protein NN O
in IN O
the DT O
mutant NN O
. . O

-DOCSTART- X X O

The DT O
rationale NN O
for IN O
continuous JJ O
dopaminergic NN O
stimulation NN O
in IN O
patients NNS O
with IN O
Parkinson NNP O
's POS O
disease NN O
. . O

-DOCSTART- X X O

Mutational JJ O
studies NNS O
revealed VBD O
that IN O
it PRP O
was VBD O
the DT O
homeodomain NN B-NP
binding JJ I-NP
site NN I-NP
II NNP I-NP
sequence NN I-NP
that WDT O
was VBD O
required VBN O
for IN O
this DT O
regulation NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
the DT O
positions NNS O
of IN O
these DT O
introns NNS O
have VBP O
been VBN O
conserved VBN O
in IN O
comparison NN O
with IN O
the DT O
genes NNS O
of IN O
two CD O
other JJ O
transglutaminase-like JJ O
activities NNS O
described VBN O
in IN O
the DT O
literature NN O
, , O
but CC O
the DT O
TGM1 NNP B-NP
gene NN I-NP
is VBZ O
by IN O
far RB O
the DT O
smallest JJS O
characterized VBN O
to TO O
date NN O
because IN O
its PRP$ O
introns NNS O
are VBP O
relatively RB O
smaller JJR O
. . O

-DOCSTART- X X O

In IN O
a DT O
retrospective JJ O
analysis NN O
of IN O
data NNS O
from IN O
35 CD O
cases NNS O
with IN O
malignant JJ O
lymphoma NN O
from IN O
a DT O
cohort NN O
of IN O
2017 CD O
HIV-infected JJ O
patients NNS O
, , O
the DT O
stage NN O
of IN O
HIV-disease NN O
, , O
the DT O
CD4 NNP B-NP
counts VBZ O
at IN O
the DT O
time NN O
of IN O
diagnosis NN O
, , O
and CC O
the DT O
use NN O
of IN O
antineoplastic JJ O
agents NNS O
or CC O
radiotherapy NN O
were VBD O
correlated VBN O
with IN O
outcome NN O
. . O

-DOCSTART- X X O

1 CD O
. . O

-DOCSTART- X X O

The DT O
single JJ O
site NN O
of IN O
glycosylation NN O
is VBZ O
located VBN O
near IN O
the DT O
C-terminus NN O
in IN O
the DT O
N-glycosylation NN O
sequon NN O
-Asn-Cys-Ser- : O
in IN O
which WDT O
Cys NNP O
forms VBZ O
part NN O
of IN O
a DT O
disulphide NN O
bridge NN O
. . O

-DOCSTART- X X O

The DT O
pulmonary JJ O
toxic JJ O
events NNS O
induced VBN O
by IN O
acute JJ O
nitrogen NN O
dioxide NN O
( -LRB- O
NO)2 DT O
exposure NN O
were VBD O
studied VBN O
in IN O
the DT O
rat NN O
to TO O
develop VB O
an DT O
inhalation NN O
model NN O
to TO O
investigate VB O
therapeutic JJ O
measures NNS O
. . O

-DOCSTART- X X O

Interaction NNP O
of IN O
H-2Eb NNP B-NP
with IN O
an DT O
IAP NNP B-NP
retrotransposon NN I-NP
in IN O
the DT O
A20/2J NN O
B NNP O
cell NN O
lymphoma NN O
. . O

-DOCSTART- X X O

The DT O
subunit JJ O
protein NN O
of IN O
curli NNS B-NP
was VBD O
highly RB O
homologous JJ O
at IN O
its PRP$ O
amino JJ O
terminus NN O
to TO O
SEF-17 NNP B-NP
, , O
the DT O
subunit JJ O
protein NN O
of IN O
thin JJ O
, , O
aggregative JJ O
fimbriae NNS O
of IN O
Salmonella NNP O
enteritidis VBD O
27655 CD O
strain NN O
3b NN O
, , O
suggesting VBG O
that IN O
these DT O
fibres NNS O
form VBP O
a DT O
novel JJ O
class NN O
of IN O
surface NN O
organelles NNS O
on IN O
enterobacteria NN O
. . O

-DOCSTART- X X O

Substitution NNP O
of IN O
the DT O
DR1 NNP B-NP
beta NN I-NP
chain NN I-NP
with IN O
H-2E JJ B-NP
beta JJ I-NP
k NN I-NP
led VBD O
to TO O
a DT O
dramatic JJ O
loss NN O
of IN O
recognition NN O
; : O
alpha NN O
chain NN O
substitution NN O
had VBD O
a DT O
less JJR O
marked JJ O
effect NN O
. . O

-DOCSTART- X X O

The DT O
distal JJ O
portion NN O
of IN O
the DT O
rat NN B-NP
insulin NN I-NP
I PRP I-NP
gene NN I-NP
5'-flanking JJ I-NP
DNA NNP I-NP
contains VBZ O
two CD O
sequence NN O
elements NNS O
, , O
the DT O
Far NNP O
and CC O
FLAT JJ O
elements NNS O
, , O
that WDT O
can MD O
function VB O
in IN O
combination NN O
, , O
but CC O
not RB O
separately RB O
, , O
as IN O
a DT O
beta-cell-specific JJ O
transcriptional JJ O
enhancer NN O
. . O

-DOCSTART- X X O

The DT O
deduced VBD O
amino IN O
acid NN O
sequence NN O
exhibited VBD O
98 CD O
% NN O
identity NN O
to TO O
the DT O
human JJ O
cellular JJ O
transglutaminase NN O
sequence NN O
. . O

-DOCSTART- X X O

This DT O
computation NN O
is VBZ O
performed VBN O
by IN O
a DT O
parallel JJ O
network NN O
of IN O
locally RB O
connected VBN O
neuron-like JJ O
elements NNS O
. . O

-DOCSTART- X X O

Repeated VBN O
efforts NNS O
to TO O
isolate VB O
recombinant NN O
baculoviruses NNS O
containing VBG O
a DT O
wild-type JJ O
kinase NN O
failed VBD O
, , O
whereas IN O
recombinants NNS O
expressing VBG O
a DT O
nonfunctional JJ O
kinase NN O
with IN O
a DT O
catalytic JJ O
domain NN O
II NNP O
mutation NN O
were VBD O
readily RB O
isolated VBN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
a DT O
21-mer JJ O
subrepeat NN O
structure NN O
is VBZ O
also RB O
present JJ O
in IN O
each DT O
unit NN O
. . O

-DOCSTART- X X O

We PRP O
propose VBP O
that IN O
plasmids NNS O
of IN O
the DT O
pLS1 JJ O
family NN O
( -LRB- O
pE194 NN O
, , O
pADB201 JJ O
, , O
and CC O
pLB4 NNS O
) -RRB- O
share NN O
functional JJ O
and CC O
structural JJ O
characteristics NNS O
for IN O
the DT O
regulation NN O
of IN O
their PRP$ O
copy NN O
numbers NNS O
. . O

-DOCSTART- X X O

Differential JJ O
expression NN O
of IN O
the DT O
" `` O
B" JJ O
subunit NN O
of IN O
the DT O
vacuolar JJ B-NP
H( NNP I-NP
+)-ATPase NN I-NP
in IN O
bovine JJ O
tissues NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
and CC O
characterised VBN O
a DT O
differentially-regulated JJ O
gene NN O
family NN O
in IN O
the DT O
protozoan NN O
parasite NN O
Leishmania NNP O
major JJ O
. . O

-DOCSTART- X X O

At IN O
some DT O
sites NNS O
, , O
% NN O
T NNP O
is VBZ O
greatly RB O
increased VBN O
by IN O
Cl- NNP O
concentrations NNS O
up IN O
to TO O
1 CD O
M NNP O
, , O
while IN O
at IN O
other JJ O
sites NNS O
% NN O
T NNP O
is VBZ O
reduced VBN O
or CC O
unaffected VBN O
by IN O
these DT O
conditions NNS O
. . O

-DOCSTART- X X O

In IN O
summary NN O
, , O
the DT O
segments NNS O
of IN O
C3 DT B-NP
represented VBN O
by IN O
amino JJ O
acid NN O
residues NNS O
1082-1118 CD O
, , O
1117-1155 CD O
, , O
1234-1294 CD O
and CC O
1312-1404 CD O
accommodate VBP O
C3( JJ B-NP
D NN I-NP
) -RRB- I-NP
epitopes NNS I-NP
that WDT O
are VBP O
expressed VBN O
by IN O
erythrocyte-bound NN O
C3 IN B-NP
fragments NNS I-NP
, , O
but CC O
not RB O
by IN O
the DT O
corresponding JJ O
fluid-phase JJ O
fragment NN O
, , O
whereas IN O
the DT O
segments NNS O
spanning VBG O
residues NNS O
973-1026 CD O
and CC O
1477-1510 CD O
contain VBP O
C3( JJ B-NP
D NN I-NP
) -RRB- I-NP
epitopes NNS I-NP
that WDT O
are VBP O
exposed VBN O
exclusively RB O
in IN O
denatured JJ O
C3 NN B-NP
and CC O
therefore RB O
hidden VBN O
in IN O
physiological JJ O
fragments NNS O
of IN O
the DT O
protein NN O
. . O

-DOCSTART- X X O

These DT O
exons NNS O
, , O
further RB O
identified VBN O
as IN O
exons NNS O
9 CD O
, , O
10 CD O
, , O
and CC O
11 CD O
, , O
together RB O
encode VB O
the DT O
37 CD O
amino IN O
acid NN O
residues NNS O
present JJ O
in IN O
alpha NN B-NP
s1-casein NN I-NP
variant NN I-NP
A DT I-NP
but CC O
missing VBG O
in IN O
variant JJ O
F. NNP O

-DOCSTART- X X O

We PRP O
also RB O
report VBP O
here RB O
the DT O
complete JJ O
structural JJ O
organization NN O
of IN O
the DT O
goat NN B-NP
alpha NN I-NP
s1-casein JJ I-NP
transcription NN I-NP
unit NN I-NP
, , O
deduced VBN O
from IN O
polymerase NN O
chain NN O
reaction NN O
experiments NNS O
. . O

-DOCSTART- X X O

Neither DT O
gene NN O
possesses VBZ O
a DT O
distinct JJ O
transcriptional JJ O
start NN O
site NN O
as IN O
shown VBN O
by IN O
nuclease DT B-NP
S1 JJ I-NP
analysis NN O
. . O

-DOCSTART- X X O

Each DT O
group NN O
received VBD O
15 CD O
ml/kg NN O
of IN O
either DT O
6 CD O
% NN O
pentafraction NN O
, , O
6 CD O
% NN O
pentastarch NN O
, , O
or CC O
plasma NN O
followed VBD O
two CD O
hours NNS O
later RB O
by IN O
1.5 CD O
micrograms/kg/0.5 CD O
hr NN O
E. NNP O

-DOCSTART- X X O

Genetic JJ O
and CC O
biochemical JJ O
evidence NN O
suggests VBZ O
that IN O
v-Crk NN B-NP
can MD O
induce VB O
transformation NN O
of IN O
chicken NN O
embryo NN O
fibroblasts NNS O
by IN O
influencing VBG O
the DT O
activity NN O
of IN O
cellular JJ O
proteins NNS O
involved VBN O
in IN O
growth NN O
regulation NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
constructed VBN O
, , O
using VBG O
synthetic JJ O
DNA NNP O
oligonucleotides NNS O
, , O
a DT O
U14 NNP B-NP
snRNA NN I-NP
gene NN I-NP
which WDT O
has VBZ O
been VBN O
positioned VBN O
behind IN O
a DT O
T7 NNP B-NP
RNA NNP I-NP
polymerase NN I-NP
promoter NN I-NP
site NN I-NP
and CC O
then RB O
inserted VBN O
into IN O
a DT O
plasmid NN O
. . O

-DOCSTART- X X O

Gene NNP O
and CC O
pseudogene NN O
of IN O
the DT O
mouse NN O
cation-dependent NN O
mannose NN B-NP
6-phosphate NN I-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

The DT O
chick JJ O
axon-associated JJ O
surface NN O
glycoprotein NN O
neurofascin NN B-NP
is VBZ O
implicated VBN O
in IN O
axonal JJ O
growth NN O
and CC O
fasciculation NN O
as IN O
revealed VBN O
by IN O
antibody NN O
perturbation NN O
experiments NNS O
. . O

-DOCSTART- X X O

The DT O
carcinoma NN O
was VBD O
restricted VBN O
within IN O
the DT O
epithelium NN O
in IN O
one CD O
, , O
the DT O
mucosal NN O
layer NN O
in IN O
five CD O
, , O
and CC O
the DT O
submucosal NN O
layer NN O
in IN O
two CD O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
C/EBP NNP B-NP
beta NN I-NP
and CC O
C/EBP NNP B-NP
gamma NN I-NP
readily RB O
heterodimerize VB O
with IN O
each DT O
other JJ O
as RB O
well RB O
as IN O
with IN O
C/EBP NNP B-NP
alpha NN I-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
tobacco NN B-NP
GS-2 NN I-NP
is VBZ O
composed VBN O
of IN O
subunits NNS O
of IN O
identical JJ O
size NN O
in IN O
all DT O
organs NNS O
examined VBN O
. . O

-DOCSTART- X X O

Between IN O
acoR NN B-NP
and CC O
acoXABC NN B-NP
, , O
two CD O
different JJ O
types NNS O
of IN O
sequences NNS O
with IN O
dual JJ O
rotational JJ O
symmetry NN O
[CAC-(N11 . O
to TO O
N18)-GTG JJ O
and CC O
TGT-(N10 JJ O
to TO O
N14)-ACA DT O
] NN O
were VBD O
found VBN O
; : O
these DT O
sequences NNS O
are VBP O
similar JJ O
to TO O
NtrC NNP B-NP
and CC O
NifA NNP B-NP
upstream RB I-NP
activator NN I-NP
sequences NNS I-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

Although IN O
the DT O
effects NNS O
of IN O
the DT O
calcium NN O
supplement NN O
or CC O
calcium NN O
antagonist NN O
alone RB O
were VBD O
significant JJ O
, , O
such JJ O
hypotensive JJ O
responses NNS O
were VBD O
not RB O
optimal JJ O
or CC O
predictable JJ O
or CC O
clearly RB O
dose-dependent JJ O
. . O

-DOCSTART- X X O

Surprisingly RB O
, , O
the DT O
full-deletion JJ O
mutant NN O
showed VBD O
a DT O
strong JJ O
block NN O
in IN O
virus NN O
release NN O
, , O
suggesting VBG O
that IN O
NC NNP B-NP
is VBZ O
involved VBN O
in IN O
virus NN O
assembly NN O
. . O

-DOCSTART- X X O

The DT O
method NN O
requires VBZ O
a DT O
reversed-phase NN O
column NN O
and CC O
a DT O
paired-ion NN O
technique NN O
to TO O
separate JJ O
docusate NN O
sodium NN O
from IN O
other JJ O
components NNS O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
demonstrate VBP O
that IN O
the DT O
protein NN O
product NN O
of IN O
the DT O
ref-1 JJ B-NP
gene NN I-NP
stimulates VBZ O
the DT O
DNA NNP O
binding NN O
activity NN O
of IN O
Fos-Jun NNP B-NP
heterodimers NNS O
, , O
Jun-Jun NNP B-NP
homodimers NNS O
and CC O
Hela NNP O
cell NN O
AP-1 JJ B-NP
proteins VBZ I-NP
as RB O
well RB O
as IN O
that DT O
of IN O
several JJ O
other JJ O
transcription NN O
factors NNS O
including VBG O
NF-kappa NNP B-NP
B NNP I-NP
, , O
Myb NNP B-NP
and CC O
members NNS O
of IN O
the DT O
ATF/CREB NNP B-NP
family NN O
. . O

-DOCSTART- X X O

The DT O
pulpal NN O
tissues NNS O
of IN O
the DT O
permanent JJ O
mandibular JJ O
molars NNS O
were VBD O
amputated VBN O
and CC O
then RB O
dressed VBN O
with IN O
calcium NN O
hydrate NN O
. . O

-DOCSTART- X X O

The DT O
ARG NNP B-NP
SH2 NNP B-NP
domain NN I-NP
exhibited VBD O
relatively RB O
weak JJ O
affinity NN O
for IN O
BCR NNP B-NP
and CC O
was VBD O
determined VBN O
to TO O
bind NN O
about IN O
10-fold PRP$ O
less JJR O
strongly RB O
than IN O
the DT O
ABL NNP B-NP
SH2 NNP B-NP
domain NN I-NP
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
this DT O
activation NN O
occurred VBD O
only RB O
when WRB O
the DT O
regions NNS O
were VBD O
cloned VBN O
in IN O
the DT O
same JJ O
relative JJ O
orientation NN O
in IN O
which WDT O
they PRP O
exist VBP O
on IN O
wild-type JJ O
pCF10 NN O
. . O

-DOCSTART- X X O

In IN O
rats NNS O
, , O
we PRP O
examined VBD O
the DT O
effect NN O
of IN O
an DT O
omentum NN O
wrapping NN O
on IN O
the DT O
vascularization NN O
of IN O
the DT O
trachea NN O
and CC O
on IN O
regeneration NN O
of IN O
the DT O
mucosal NN O
epithelium NN O
in IN O
the DT O
very RB O
early JJ O
stage NN O
after IN O
free JJ O
tracheal NN O
grafting NN O
. . O

-DOCSTART- X X O

To TO O
study VB O
a DT O
possible JJ O
functional JJ O
role NN O
of IN O
this DT O
putative JJ O
chicken NN O
ICS NNP B-NP
, , O
an DT O
oligonucleotide JJ O
spanning NN O
the DT O
upstream JJ O
sequences NNS O
of IN O
the DT O
BF-IV NNP B-NP
gene NN I-NP
(-174/-194 NN O
) -RRB- O
was VBD O
cloned VBN O
singly RB O
or CC O
in IN O
multiple JJ O
copies NNS O
before IN O
the DT O
herpes NNS O
TK NN B-NP
promoter NN I-NP
controlling VBG O
the DT O
chloramphenicol NN B-NP
acetyl NN I-NP
transferase NN I-NP
( -LRB- O
CAT NN B-NP
) -RRB- O
gene NN O
( -LRB- O
pBLCAT2 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Through IN O
Southern JJ O
blot NN O
analyses NNS O
of IN O
DNA NNP O
from IN O
backcross JJ O
and CC O
cogenic JJ O
mice NNS O
, , O
recombinant JJ O
inbred JJ O
strains NNS O
, , O
and CC O
somatic JJ O
cell NN O
hybrids NNS O
, , O
the DT O
genetic JJ O
loci NNS O
that WDT O
produce VBP O
the DT O
cyclin NN B-NP
B1-related JJ I-NP
sequences NNS I-NP
( -LRB- O
designated VBN O
loci NNS B-NP
Cycb1-rs1 JJ I-NP
to TO O
Cycb1-rs9 DT B-NP
) -RRB- O
were VBD O
mapped VBN O
on IN O
mouse NN O
chromosomes NNS O
5 CD O
, , O
1 CD O
, , O
17 CD O
, , O
4 CD O
, , O
14 CD O
, , O
13 CD O
, , O
7 CD O
, , O
X NNP O
, , O
and CC O
8 CD O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Porcelain NNP O
to TO O
dentin RP O
bond NN O
strength NN O
with IN O
a DT O
dentin NN O
adhesive NN O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
concluded VBN O
that IN O
Scotchbond NN O
2 CD O
and CC O
Prisma NNP O
Universal NNP O
Bond NNP O
2 CD O
are VBP O
effective JJ O
and CC O
are VBP O
the DT O
dentine NN O
bonding VBG O
agents NNS O
of IN O
choice NN O
. . O

-DOCSTART- X X O

From IN O
all DT O
clinically RB O
important JJ O
yeasts NNS O
species NNS O
, , O
a DT O
total NN O
of IN O
96 CD O
% NN O
were VBD O
identified VBN O
by IN O
ATB NNP O
method NN O
according VBG O
to TO O
conventional JJ O
methods NNS O
. . O

-DOCSTART- X X O

Comments NNS O
are VBP O
given VBN O
on IN O
the DT O
present JJ O
status NN O
of IN O
regulations NNS O
concerning VBG O
water NN O
in IN O
swimming VBG O
pools NNS O
and CC O
baths--1991--( NN O
in IN O
connection NN O
with IN O
the DT O
KOK NNP O
regulations--1972--and CC O
the DT O
Federal NNP O
German NNP O
standard NN O
[DIN] NNP O
No. NN O

-DOCSTART- X X O

If IN O
no DT O
reply NN O
was VBD O
received VBN O
, , O
telephone NN O
contact NN O
or CC O
home NN O
visits NNS O
were VBD O
made VBN O
. . O

-DOCSTART- X X O

Urease NN B-NP
activity NN O
, , O
judged VBN O
as IN O
the DT O
amount NN O
of IN O
ammonia NN O
production NN O
from IN O
urea NN O
, , O
could MD O
be VB O
measured VBN O
at IN O
25 CD O
ng NN O
per IN O
tube NN O
( -LRB- O
S/N NNP O
= SYM O
1.5 CD O
) -RRB- O
with IN O
Jack NNP B-NP
bean NN I-NP
meal NN I-NP
urease NN I-NP
. . O

-DOCSTART- X X O

Consequently RB O
, , O
significant JJ O
differences NNS O
between IN O
the DT O
measured VBN O
and CC O
calculated VBN O
methods NNS O
were VBD O
noted VBN O
in IN O
oxygen NN O
uptake NN O
( -LRB- O
213 CD O
+/ NN O
- : O
41 CD O
ml/min NN O
vs IN O
193 CD O
+/ NNS O
- : O
25 CD O
ml/min NN O
, , O
p NN O
< NN O
0.001 CD O
) -RRB- O
, , O
oxygen NN O
delivery NN O
( -LRB- O
780 CD O
+/ NN O
- : O
297 CD O
ml/min NN O
vs IN O
716 CD O
+/ NNS O
- : O
296 CD O
ml/min NN O
, , O
p NN O
< NN O
0.001 CD O
) -RRB- O
, , O
and CC O
cardiac JJ O
output NN O
( -LRB- O
5.8 CD O
+/ NN O
- : O
2.2 CD O
L/min NN O
vs IN O
5.3 CD O
+/ NN O
- : O
1.8 CD O
L/min NN O
, , O
p NN O
< NN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Although IN O
a DT O
wide JJ O
range NN O
of IN O
cognitive JJ O
functions NNS O
had VBD O
been VBN O
tested VBN O
, , O
all DT O
but CC O
one CD O
seizure NN O
occurred VBD O
during IN O
assessment NN O
of IN O
memory NN O
performance NN O
. . O

-DOCSTART- X X O

The DT O
experiments NNS O
show VBP O
that IN O
it PRP O
is VBZ O
the DT O
micromilieu NN O
of IN O
the DT O
alveoli NNS O
and CC O
the DT O
condition NN O
of IN O
the DT O
AM NNP O
(certain NNP O
physiological JJ O
activation NN O
states NNS O
, , O
such JJ O
as IN O
phagocytic JJ O
activity NN O
) -RRB- O
that WDT O
essentially RB O
determine VBP O
the DT O
degree NN O
of IN O
recovery NN O
. . O

-DOCSTART- X X O

Negatively RB O
supercoiled JJ O
plasmid NN O
pUC19 . O
did VBD O
not RB O
compete VB O
, , O
whereas IN O
an DT O
otherwise RB O
identical JJ O
plasmid NN O
pUC19(CG) NN O
, , O
which WDT O
contained VBD O
a DT O
(dG-dC)7 JJ O
segment NN O
in IN O
the DT O
Z-form NN O
was VBD O
an DT O
excellent JJ O
competitor NN O
. . O

-DOCSTART- X X O

Our PRP$ O
experiments NNS O
suggest VBP O
that IN O
the DT O
SCL NNP B-NP
gene NN I-NP
can MD O
be VB O
a DT O
target NN O
for IN O
the DT O
erythroid JJ B-NP
transcription NN I-NP
factor NN I-NP
GATA-1 NN I-NP
and CC O
that IN O
the DT O
SCL NNP B-NP
gene NN I-NP
product NN I-NP
serves VBZ O
as IN O
a DT O
positive JJ O
regulator NN O
of IN O
erythroid NN O
differentiation NN O
. . O

-DOCSTART- X X O

The DT O
gene NN O
sequence NN O
also RB O
identified VBD O
a DT O
340-nucleotide JJ O
RNA NNP O
in IN O
total JJ O
yeast NN O
RNA NNP O
and CC O
in IN O
purified VBN O
RNase NNP B-NP
MRP NNP I-NP
enzyme NN I-NP
preparations NNS O
. . O

-DOCSTART- X X O

The DT O
RNase NNP B-NP
MRP NNP I-NP
RNA NNP I-NP
gene NN I-NP
was VBD O
deleted VBN O
by IN O
insertional JJ O
replacement NN O
and CC O
found VBN O
to TO O
be VB O
essential JJ O
for IN O
cellular JJ O
viability NN O
, , O
indicating VBG O
a DT O
critical JJ O
nuclear JJ O
role NN O
for IN O
RNase NNP B-NP
MRP. . I-NP

-DOCSTART- X X O

From IN O
these DT O
results NNS O
, , O
CBF-A NNP B-NP
is VBZ O
a DT O
novel NN O
CArG NNP O
box-, , O
ssDNA NN B-NP
- : I-NP
and CC I-NP
RNA-binding JJ I-NP
protein NN I-NP
, , O
as RB O
well RB O
as IN O
a DT O
repressive JJ O
transcriptional JJ O
factor NN O
. . O

-DOCSTART- X X O

Cleavage NN O
by IN O
the DT O
intron-encoded JJ O
enzyme JJ O
(I-CreI NN O
) -RRB- O
occurs VBZ O
5 CD O
bp NN O
and CC O
1 CD O
bp NN O
3' CD O
to TO O
the DT O
intron NN O
insertion NN O
site NN O
( -LRB- O
in IN O
the DT O
3'-exon JJ O
) -RRB- O
in IN O
the DT O
top NN O
( -LRB- O
/ NN O
) -RRB- O
and CC O
bottom NN O
( -LRB- O
, , O
) -RRB- O
strands NNS O
, , O
respectively RB O
, , O
resulting VBG O
in IN O
4-nt JJ O
single-stranded JJ O
overhangs NNS O
with IN O
3'-OH JJ O
termini NNS O
. . O

-DOCSTART- X X O

Western JJ O
blot NN O
analyses NNS O
detect VBP O
anti-E-specific JJ B-NP
immunoreactivity NN O
in IN O
affinity-purified JJ O
extracts NNS O
derived VBN O
from IN O
the DT O
bacterial JJ O
expression NN O
of IN O
a DT O
truncated JJ B-NP
AMPD3 JJ I-NP
cDNA NN I-NP
. . O

-DOCSTART- X X O

These DT O
results NNS O
demonstrate VBP O
that IN O
endogenous JJ O
N-methylation NN O
of IN O
salsolinol NN O
into IN O
N-methylsalsolinol NNP O
occurs VBZ O
in IN O
the DT O
brain NN O
in IN O
vivo JJ O
. . O

-DOCSTART- X X O

DR1 NNP B-NP
molecules NNS I-NP
purified VBN O
from IN O
human JJ O
lymphoblastoid NN O
cell NN O
lines NNS O
could MD O
specifically RB O
bind NN O
to TO O
these DT O
peptide NN O
sequences NNS O
expressed VBD O
on IN O
the DT O
phage NN O
surface NN O
. . O

-DOCSTART- X X O

Chronic JJ O
hepatitis NN O
B NNP O
in IN O
adopted VBN O
Romanian JJ O
children NNS O
. . O

-DOCSTART- X X O

Behind IN O
the DT O
ATPase NNP B-NP
cluster NN I-NP
, , O
two CD O
open JJ O
reading NN O
frames NNS O
were VBD O
detected VBN O
that DT O
are VBP O
not RB O
homologous JJ O
to TO O
any DT O
known VBN O
chloroplast NN O
gene NN O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
recombinant JJ O
human JJ O
Ads NNS O
that WDT O
express VBP O
noninfectious JJ O
HIV NN O
or CC O
other JJ O
microbial JJ O
proteins NNS O
are VBP O
attractive JJ O
vaccine NN O
candidates NNS O
. . O

-DOCSTART- X X O

Alignment NNP O
of IN O
the DT O
selected VBN O
sequences NNS O
allowed VBD O
us PRP O
to TO O
predict VB O
a DT O
consensus NN O
sequence NN O
for IN O
binding NN O
of IN O
the DT O
individual JJ O
homodimeric JJ O
Rel-related JJ B-NP
proteins NNS I-NP
, , O
and CC O
DNA-protein NNP O
binding JJ O
analysis NN O
of IN O
the DT O
selected VBN O
DNA NN O
sequences NNS O
revealed VBD O
sequence NN O
specificity NN O
of IN O
the DT O
proteins NNS O
. . O

-DOCSTART- X X O

Using VBG O
either CC O
a DT O
p50- NNS B-NP
or CC O
p65-selected JJ B-NP
kappa NN I-NP
B NNP I-NP
motif NN I-NP
, , O
which WDT O
displayed VBD O
differential JJ O
binding NN O
with IN O
respect NN O
to TO O
the DT O
other JJ O
protein NN O
, , O
little JJ O
to TO O
no DT O
binding NN O
was VBD O
observed VBN O
with IN O
the DT O
heterodimeric JJ B-NP
NF-kappa NNP I-NP
B NNP I-NP
complex NN I-NP
. . O

-DOCSTART- X X O

However RB O
, , O
a DT O
cosmid NN O
clone NN O
containing VBG O
the DT O
entire JJ O
mouse NN B-NP
alpha NN I-NP
1( IN I-NP
I PRP I-NP
) -RRB- I-NP
gene NN I-NP
, , O
including VBG O
3.7 CD O
kb NN O
of IN O
5' JJ O
- : O
and CC O
4 CD O
kb NN O
of IN O
3'-flanking JJ O
DNA NNP O
, , O
was VBD O
expressed VBN O
at IN O
reduced VBN O
levels NNS O
in IN O
fibroblasts NNS O
overexpressing VBG O
oncogenic JJ B-NP
ras NNS I-NP
. . O

-DOCSTART- X X O

Sequencing VBG O
analysis NN O
has VBZ O
shown VBN O
that IN O
each DT O
rap1t JJ B-NP
allele NN I-NP
contains VBZ O
a DT O
nonsense NN O
mutation NN O
within IN O
a DT O
discrete JJ O
region NN O
between IN O
amino DT O
acids NNS O
663 CD O
and CC O
684 CD O
. . O

-DOCSTART- X X O

Autopsy NNP O
demonstrated VBD O
good JJ O
survival NN O
of IN O
the DT O
transplanted JJ O
cells NNS O
with IN O
good JJ O
integration NN O
with IN O
the DT O
brain NN O
of IN O
the DT O
recipient NN O
and CC O
traces NNS O
of IN O
positive JJ O
immunocytochemical JJ O
reaction NN O
for IN O
tyrosine NN B-NP
hydroxylase NN I-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
eight CD O
patients NNS O
with IN O
persistent JJ O
generalized JJ O
lymph-adenopathy NN O
( -LRB- O
PGL NNP O
) -RRB- O
and CC O
nontender NN O
, , O
nonenlarging VBG O
nodes NNS O
, , O
pathologic NN O
analysis NN O
revealed VBN O
lymphoid JJ O
hyperplasia NN O
. . O

-DOCSTART- X X O

By IN O
using VBG O
lambda NN O
gt11 WDT O
expression NN O
cloning VBG O
with IN O
oligonucleotides NNS O
corresponding JJ O
to TO O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
1 CD O
TATA NNP O
element NN O
, , O
we PRP O
report VBP O
the DT O
identification NN O
of IN O
a DT O
cellular JJ O
protein NN O
with IN O
a DT O
calculated JJ O
molecular JJ O
mass NN O
of IN O
123 CD O
kDa NN O
that IN O
we PRP O
designate VBP O
TATA NNP B-NP
element NN I-NP
modulatory NN I-NP
factor NN I-NP
( -LRB- O
TMF) NN B-NP
. . O

-DOCSTART- X X O

Blood NN O
levels NNS O
of IN O
melatonin NN O
, , O
serotonin NN O
, , O
cortisol NN O
, , O
and CC O
prolactin VB B-NP
in IN O
relation NN O
to TO O
the DT O
circadian JJ O
rhythm NN O
of IN O
platelet NN O
serotonin NN O
uptake NN O
. . O

-DOCSTART- X X O

In IN O
8 CD O
healthy JJ O
volunteers NNS O
there EX O
were VBD O
no DT O
significant JJ O
differences NNS O
in IN O
AUC NNP O
, , O
peak NN O
plasma NN O
concentrations NNS O
or CC O
time NN O
to TO O
peak VB O
concentration NN O
when WRB O
OXC NNP O
was VBD O
administered VBN O
either CC O
with IN O
or CC O
without IN O
ERY NNP O
. . O

-DOCSTART- X X O

Using VBG O
5 CD O
ng/mL NN O
as IN O
the DT O
cutoff NN O
, , O
the DT O
sensitivity NN O
of IN O
CEA NNP B-NP
was VBD O
68 CD O
% NN O
. . O

-DOCSTART- X X O

Rolandic NNP O
spikes NNS O
and CC O
cognitive JJ O
function NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
sodium NN O
18 CD O
beta-glycyrrhetate NN O
(SGA NN O
) -RRB- O
on IN O
experimental JJ O
arrhythmia NN O
was VBD O
investigated VBN O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
diltiazem NN O
were VBD O
stereoselective JJ O
, , O
thus RB O
the DT O
potentiation NN O
induced VBN O
by IN O
d-cis PRP$ O
diltiazem NN O
was VBD O
significantly RB O
greater JJR O
in IN O
all DT O
cases NNS O
than IN O
that DT O
induced VBN O
by IN O
l-cis PRP$ O
diltiazem NN O
, , O
which WDT O
suggests VBZ O
that IN O
calcium NN O
channel NN O
blockade NN O
plays VBZ O
a DT O
role NN O
in IN O
these DT O
interactions NNS O
. . O

-DOCSTART- X X O

Substitution NNP O
of IN O
either DT O
Val33 NNP O
( -LRB- O
by IN O
Gly NNP O
) -RRB- O
or CC O
Gly28 FW O
( -LRB- O
by IN O
Ser NN O
) -RRB- O
, , O
two CD O
of IN O
the DT O
most RBS O
conserved JJ O
residues NNS O
in IN O
all DT O
protein NN O
kinases NNS O
, , O
resulted VBD O
in IN O
enzyme NN O
with IN O
marginally RB O
detectable JJ O
activity NN O
. . O

-DOCSTART- X X O

The DT O
TIMP(-59/ NNP B-NP
-53)AP1 NNP O
site NN O
is VBZ O
a DT O
promiscuous JJ O
motif NN O
that IN O
binds NNS O
c-Fos/c-Jun JJ B-NP
AP1 NNP B-NP
translated VBD O
in IN O
vitro NN O
and CC O
is VBZ O
an DT O
effective JJ O
competitor NN O
for IN O
binding NN O
of IN O
nuclear JJ B-NP
AP1 NNP I-NP
factors NNS I-NP
to TO O
the DT O
consensus NN O
TRE NN O
, , O
but CC O
in IN O
addition NN O
it PRP O
binds VBZ O
factors NNS O
that WDT O
do VBP O
not RB O
associate VB O
with IN O
the DT O
consensus NN O
TRE. . O

-DOCSTART- X X O

Involvement NN O
of IN O
AP1 NNP B-NP
and CC O
PEA3 JJ B-NP
binding NN I-NP
sites NNS I-NP
in IN O
the DT O
regulation NN O
of IN O
murine NN B-NP
tissue NN I-NP
inhibitor NN I-NP
of IN I-NP
metalloproteinases-1 NN I-NP
( -LRB- O
TIMP-1 NN B-NP
) -RRB- O
transcription NN O
. . O

-DOCSTART- X X O

A DT O
controlled JJ O
trial NN O
of IN O
recombinant JJ B-NP
human JJ I-NP
granulocyte-macrophage NN I-NP
colony-stimulating NN I-NP
factor NN I-NP
after IN O
total JJ O
body NN O
irradiation NN O
, , O
high-dose JJ O
chemotherapy NN O
, , O
and CC O
autologous JJ O
bone NN O
marrow NN O
transplantation NN O
for IN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
or CC O
malignant JJ O
lymphoma NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
demonstrate VBP O
that IN O
DMVA NNP O
does VBZ O
not RB O
cause VB O
more RBR O
myocardial JJ O
trauma NN O
than IN O
CPB NNP O
when WRB O
used VBN O
to TO O
provide VB O
resuscitative JJ O
circulatory JJ O
support NN O
. . O

-DOCSTART- X X O

Examination NNP O
of IN O
ANCA NNP B-NP
is VBZ O
not RB O
only RB O
a DT O
significant JJ O
contribution NN O
towards IN O
a DT O
more RBR O
accurate JJ O
diagnosis NN O
of IN O
renal JJ O
vasculitis NN O
, , O
but CC O
also RB O
an DT O
indicator NN O
of IN O
the DT O
activity NN O
of IN O
the DT O
disease NN O
and CC O
thus RB O
of IN O
the DT O
effectiveness NN O
of IN O
immunosuppressive JJ O
treatment NN O
. . O

-DOCSTART- X X O

Cicatricial JJ O
pemphigoid NN O
is VBZ O
an DT O
autoimmune JJ O
systemic JJ O
disease NN O
characterized VBN O
by IN O
chronic NN O
conjunctival NN O
cicatrization NN O
. . O

-DOCSTART- X X O

4 CD O
. . O

-DOCSTART- X X O

The DT O
in IN O
vivo RB O
profile NN O
of IN O
ZFH-2 NNP B-NP
in IN O
the DT O
larval JJ O
CNS NNS O
shows VBZ O
intriguing JJ O
overlap NN O
with IN O
DDC NNP B-NP
in IN O
specific JJ O
serotonin NN O
and CC O
dopamine NN O
neurons NNS O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
it PRP O
would MD O
be VB O
advantageous JJ O
to TO O
identify VB O
such JJ O
persons NNS O
and CC O
treat VB O
them PRP O
preferentially RB O
. . O

-DOCSTART- X X O

On IN O
the DT O
basis NN O
of IN O
these DT O
unique JJ O
properties NNS O
, , O
the DT O
newly RB O
characterized VBN O
hemagglutinin NN B-NP
has VBZ O
been VBN O
termed VBN O
Limulus JJ B-NP
18K JJ I-NP
agglutination-aggregation NN I-NP
factor NN I-NP
( -LRB- O
18K-LAF JJ B-NP
) -RRB- O
. . O

-DOCSTART- X X O

It PRP O
corresponds VBZ O
to TO O
the DT O
complete JJ O
mitochondrial NN O
presequence NN O
and CC O
the DT O
lipoyl-bearing NN O
domain NN O
that WDT O
are VBP O
encoded VBN O
by IN O
exons NNS O
I PRP O
through IN O
IV NNP O
of IN O
the DT O
functional JJ O
E2 NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Human JJ O
neutrophil JJ O
response NN O
to TO O
short-term JJ O
exposure NN O
to TO O
F-75 DT O
cobalt-based JJ O
alloy NN O
. . O

-DOCSTART- X X O

The DT O
second JJ O
method NN O
, , O
the DT O
"macro JJ O
" `` O
assay NN O
, , O
has VBZ O
a DT O
sensitivity NN O
range NN O
of IN O
0.03-5.0 CD O
micrograms NNS O
phosphorus NN O
with IN O
100-500 CD O
microliters NNS O
HClO4 NNP O
. . O

-DOCSTART- X X O

Nucleotide NNP O
sequence NN O
and CC O
transcriptional JJ O
analysis NN O
of IN O
the DT O
polyhedrin NN B-NP
gene NN I-NP
of IN O
Spodoptera NNP O
exigua NN O
nuclear JJ O
polyhedrosis NN O
virus NN O
. . O

-DOCSTART- X X O

As IN O
a DT O
consequence NN O
of IN O
dark JJ O
rearing NN O
, , O
the DT O
numerical JJ O
density NN O
of IN O
cortical JJ O
neurons NNS O
in IN O
area NN O
17 CD O
amounted VBD O
to TO O
about IN O
double JJ O
of IN O
the DT O
value NN O
observed VBN O
in IN O
normally RB O
reared VBN O
kittens NNS O
and CC O
was VBD O
also RB O
significantly RB O
higher JJR O
in IN O
area NN O
18 CD O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
decreased VBN O
class NN O
I PRP O
enhancer VBP O
activity NN O
in IN O
Ad12-transformed JJ O
cells NNS O
may MD O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
be VB O
due JJ O
to TO O
the DT O
higher JJR O
levels NNS O
of IN O
an DT O
enhancer-specific JJ O
factor NN O
, , O
possibly RB O
acting VBG O
as IN O
a DT O
repressor NN O
. . O

-DOCSTART- X X O

A DT O
second JJ O
domain NN O
, , O
located VBN O
in IN O
the DT O
C-terminal JJ O
437 CD O
amino IN O
acids NNS O
of IN O
IE1 NNP B-NP
, , O
is VBZ O
required VBN O
for IN O
inhibitory JJ O
and CC O
DNA-binding JJ O
activities NNS O
. . O

-DOCSTART- X X O

205 CD O
, , O
285-290 CD O
] NN O
and CC O
was VBD O
subsequently RB O
cloned VBN O
and CC O
sequenced VBN O
[J. . O

-DOCSTART- X X O

Nonreplicating VBG O
vaccinia NN O
vector NN O
efficiently RB O
expresses VBZ O
recombinant JJ O
genes NNS O
. . O

-DOCSTART- X X O

No DT O
other JJ O
changes NNS O
in IN O
hematopoietic JJ O
differentiation NN O
status NN O
were VBD O
observed VBN O
in IN O
association NN O
with IN O
Id-SCL JJ B-NP
expression NN O
. . O

-DOCSTART- X X O

Respiratory NN O
interaction NN O
after IN O
spinal JJ O
anesthesia NN O
and CC O
sedation NN O
with IN O
midazolam NN O
. . O

-DOCSTART- X X O

One CD O
air NN O
embolism NN O
occurred VBD O
; : O
this DT O
was VBD O
the DT O
only JJ O
filter- NNS O
or CC O
retrieval-related JJ O
complication NN O
. . O

-DOCSTART- X X O

The DT O
5' JJ O
region NN O
of IN O
ADH5 DT B-NP
contains VBZ O
consensus NN O
binding NN O
sites NNS O
for IN O
the DT O
transcriptional JJ O
regulatory JJ O
proteins NNS O
, , O
Sp1 NNP B-NP
, , O
AP2 NNP B-NP
, , O
LF-A1 NNP B-NP
, , O
NF-1 NNP B-NP
, , O
NF-A2 NNP B-NP
, , O
and CC O
NF-E1 NNP B-NP
. . O

-DOCSTART- X X O

Purification NN O
and CC O
cloning NN O
of IN O
a DT O
novel NN O
serine NN B-NP
protease NN I-NP
, , O
RNK-Met-1 NNP B-NP
, , O
from IN O
the DT O
granules NNS O
of IN O
a DT O
rat NN O
natural JJ O
killer NN O
cell NN O
leukemia NN O
. . O

-DOCSTART- X X O

Administration NNP O
of IN O
growth NN B-NP
hormone NN I-NP
leads VBZ O
to TO O
faster JJR O
growth NN O
, , O
but CC O
also RB O
faster JJR O
bone NN O
maturation NN O
. . O

-DOCSTART- X X O

Comparisons NNS O
with IN O
the DT O
available JJ O
amino IN O
acid NN O
residue NN O
( -LRB- O
aa JJ O
) -RRB- O
sequence NN O
information NN O
from IN O
the DT O
complete JJ O
CPMV NNP B-NP
RNA NNP I-NP
1 CD I-NP
sequence NN I-NP
and CC O
the DT O
partial JJ O
sequence NN O
of IN O
red JJ B-NP
clover NN I-NP
mottle NN I-NP
virus NN I-NP
RNA NNP I-NP
1 CD I-NP
suggest VBP O
that IN O
CPSMV NNP B-NP
RNA NNP I-NP
1 CD I-NP
specifies VBZ O
the DT O
expected VBN O
set NN O
of IN O
five CD O
mature JJ O
proteins NNS O
: : O
32K JJ B-NP
proteinase NN I-NP
cofactor NN I-NP
, , O
58K IN B-NP
presumed VBN I-NP
helicase NN I-NP
, , O
VPg NNP B-NP
5'-linked JJ I-NP
protein NN I-NP
of IN O
the DT O
genomic JJ O
RNAs NNP O
, , O
24K JJ B-NP
proteinase NN I-NP
, , O
and CC O
87K IN B-NP
presumed VBN I-NP
polymerase NN I-NP
, , O
separated VBN O
by IN O
four CD O
cleavage JJ O
sites NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
the DT O
utility NN O
of IN O
beta NN B-NP
2 CD I-NP
transferrin NN I-NP
assay NN O
in IN O
the DT O
diagnosis NN O
of IN O
cerebrospinal JJ O
fluid NN O
otorrhea NN O
is VBZ O
presented VBN O
. . O

-DOCSTART- X X O

The DT O
addition NN O
of IN O
diatrizoate NN O
to TO O
the DT O
IPRK NN O
led VBD O
to TO O
a DT O
dose-dependent NN O
biphasic JJ O
change NN O
in IN O
RPF NNP O
and CC O
GFR NNP O
characterized VBD O
by IN O
an DT O
initial JJ O
transient NN O
increase NN O
followed VBD O
by IN O
a DT O
marked JJ O
and CC O
sustained VBN O
decrease NN O
. . O

-DOCSTART- X X O

The DT O
structural JJ O
genes NNS O
encoding VBG O
glyceraldehyde-3-phosphate JJ B-NP
dehydrogenase NN I-NP
( -LRB- O
GAPDH) NNP B-NP
, , O
3-phosphoglycerate JJ B-NP
kinase NN I-NP
( -LRB- O
PGK) NNP B-NP
and CC O
the DT O
N-terminal JJ O
part NN O
of IN O
triosephosphate NN B-NP
isomerase NN I-NP
( -LRB- O
TIM NNP B-NP
) -RRB- O
from IN O
mesophilic NN O
Bacillus NN O
megaterium NN O
DSM319 . O
have VBP O
been VBN O
cloned VBN O
as IN O
a DT O
gene NN O
cluster NN O
( -LRB- O
gap NN B-NP
operon NN I-NP
) -RRB- O
by IN O
complementation NN O
of IN O
an DT O
Escherichia NNP O
coli NNS O
gap NN B-NP
amber NN I-NP
mutant NN I-NP
. . O

-DOCSTART- X X O

Laboratory NNP O
studies NNS O
showed VBD O
that IN O
the DT O
direct JJ O
fluorescent-antibody NN O
kits NNS O
were VBD O
the DT O
least JJS O
sensitive JJ O
in IN O
this DT O
case NN O
and CC O
did VBD O
not RB O
detect VB O
fewer JJR O
than IN O
10( JJ O
4 CD O
) -RRB- O
elementary JJ O
bodies NNS O
per IN O
ml NN O
, , O
while IN O
most JJS O
ELISA NNP O
kits VBD O
detected VBN O
between IN O
130 CD O
and CC O
600 CD O
elementary JJ O
bodies NNS O
per IN O
ml NN O
. . O

-DOCSTART- X X O

For IN O
this DT O
reason NN O
, , O
the DT O
particle NN O
forming VBG O
capacity NN O
of IN O
derivatives NNS O
of IN O
the DT O
HIV-1 NN B-NP
group NN I-NP
specific JJ I-NP
core NN I-NP
antigen NN I-NP
p55 VBD I-NP
gag NN I-NP
was VBD O
assayed VBN O
and CC O
compared VBN O
dependent JJ O
on IN O
various JJ O
expression NN O
systems NNS O
: : O
recombinant JJ O
bacteria NNS O
, , O
vaccinia NN O
- : O
and CC O
baculoviruses NNS O
were VBD O
established VBN O
encoding VBG O
the DT O
entire JJ O
core NN B-NP
protein NN I-NP
p55 VBD I-NP
either RB O
in IN O
its PRP$ O
authentic JJ O
sequence NN O
or CC O
lacking VBG O
the DT O
myristylation NN O
consensus NN O
signal NN O
. . O

-DOCSTART- X X O

The DT O
tramtrack JJ B-NP
(ttk NN O
) -RRB- O
gene NN O
of IN O
Drosophila NNP O
encodes VBZ O
69-kDa JJ O
and CC O
88-kDa JJ O
proteins NNS O
through IN O
alternative JJ O
splicing NN O
of IN O
the DT O
primary JJ O
ttk NN B-NP
transcript NN I-NP
. . O

-DOCSTART- X X O

Removal NNP O
of IN O
beta JJ B-NP
2-microglobulin CD I-NP
by IN O
hemodialysis NN O
and CC O
hemofiltration NN O
: : O
a DT O
four CD O
year NN O
follow VBP O
up RP O
. . O

-DOCSTART- X X O

Removal NNP O
of IN O
beta JJ B-NP
2-microglobulin CD I-NP
by IN O
hemodialysis NN O
and CC O
hemofiltration NN O
: : O
a DT O
four CD O
year NN O
follow VBP O
up RP O
. . O

-DOCSTART- X X O

Adapromine NN O
was VBD O
established VBN O
to TO O
evoke VB O
a DT O
decrease NN O
of IN O
the DT O
amplitude NN O
of IN O
the DT O
dominant JJ O
peak NN O
and CC O
dominant JJ O
theta-activity NN O
in IN O
power NN O
spectra NN O
of IN O
the DT O
EEG NNP O
in IN O
the DT O
cortex NN O
and CC O
hippocamp NN O
, , O
with IN O
an DT O
increase NN O
of IN O
rapid JJ O
wave NN O
activity NN O
in IN O
the DT O
beta JJ O
2 CD O
range NN O
in IN O
the DT O
right JJ O
cortex NN O
and CC O
hippocamp NN O
. . O

-DOCSTART- X X O

After IN O
28 CD O
days NNS O
of IN O
haloperidol JJ O
treatment NN O
, , O
similar JJ O
changes NNS O
were VBD O
observed VBN O
for IN O
delta NN O
, , O
together RB O
with IN O
an DT O
increase NN O
of IN O
alpha NN O
1 CD O
, , O
and CC O
a DT O
decrease NN O
of IN O
fast JJ O
beta NN O
. . O

-DOCSTART- X X O

Truncated NNP B-NP
ICSBP NNP I-NP
lacking VBG O
the DT O
first JJ O
33 CD O
amino-terminal JJ O
amino IN O
acids NNS O
fails VBZ O
to TO O
bind NN O
to TO O
the DT O
ICS NNP B-NP
, , O
indicating VBG O
that IN O
at IN O
least JJS O
part NN O
of IN O
the DT O
DNA NNP O
binding NN O
domain NN O
is VBZ O
located VBN O
within IN O
the DT O
well NN O
conserved VBN O
amino IN O
terminus NN O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
ICSBP NNP B-NP
may MD O
be VB O
involved VBN O
in IN O
maintaining VBG O
submaximal JJ O
transcriptional JJ O
activity NN O
of IN O
IFN-inducible JJ B-NP
genes NNS O
in IN O
hematopoietic JJ O
cells NNS O
. . O

-DOCSTART- X X O

Comparable JJ O
amounts NNS O
of IN O
alpha NN B-NP
5 CD I-NP
beta NN I-NP
1 CD I-NP
integrin NN I-NP
were VBD O
isolated VBN O
from IN O
these DT O
cells NNS O
by IN O
chromatography NN O
of IN O
detergent NN O
extracts NNS O
on IN O
a DT O
fibronectin NN B-NP
cell-binding JJ O
fragment NN O
affinity NN O
column NN O
and CC O
elution NN O
with IN O
EDTA. NNP O

-DOCSTART- X X O

Abstracts NNS O
. . O

-DOCSTART- X X O

From IN O
this DT O
library NN O
, , O
LEU2 NNP B-NP
and CC O
HIS3 PRP$ B-NP
cDNAs NNS O
were VBD O
recovered VBN O
at IN O
a DT O
frequency NN O
of IN O
about IN O
1 CD O
in IN O
10( JJ O
4 CD O
) -RRB- O
and CC O
in IN O
12 CD O
out IN O
of IN O
13 CD O
cases NNS O
these DT O
were VBD O
expressed VBN O
in IN O
a DT O
galactose-dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

However RB O
, , O
in IN O
the DT O
subgroup NN O
with IN O
normal JJ O
Ht NNP O
( -LRB- O
< NN O
0.45 CD O
l/l NN O
; : O
n RB O
= SYM O
201 CD O
) -RRB- O
there EX O
was VBD O
a DT O
significant JJ O
reduction NN O
( -LRB- O
p NN O
< JJ O
0.05 CD O
) -RRB- O
of IN O
the DT O
mortality NN O
after IN O
3 CD O
months NNS O
( -LRB- O
27 CD O
% NN O
and CC O
16 CD O
% NN O
, , O
respectively RB O
) -RRB- O
and CC O
an DT O
increase NN O
of IN O
independence NN O
at IN O
home NN O
( -LRB- O
35 CD O
% NN O
and CC O
48 CD O
% NN O
, , O
respectively RB O
) -RRB- O
due JJ O
to TO O
a DT O
reduction NN O
of IN O
the DT O
viscosity NN O
by IN O
means NNS O
of IN O
haemodilution NN O
with IN O
albumin NN B-NP
( -LRB- O
a DT O
specific JJ O
viscosity NN O
effect NN O
in IN O
the DT O
normovolaemic JJ O
group NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
appropriate JJ O
use NN O
and CC O
benefits NNS O
of IN O
bile JJ O
acid NN O
sequestrants NNS O
, , O
nicotinic JJ O
acid NN O
, , O
fibric JJ O
acids NNS O
, , O
3-hydroxy-3-methylglutaryl JJ B-NP
coenzyme NN I-NP
A DT I-NP
( -LRB- I-NP
HMG-CoA NN I-NP
) -RRB- I-NP
reductase NN I-NP
inhibitors NNS O
, , O
and CC O
probucol NN O
are VBP O
individually RB O
discussed VBN O
, , O
whereas IN O
nonpharmacologic JJ O
approaches NNS O
used VBN O
in IN O
conjunction NN O
with IN O
the DT O
drugs NNS O
are VBP O
recommended VBN O
emphatically RB O
. . O

-DOCSTART- X X O

The DT O
major JJ O
pathological JJ O
findings NNS O
of IN O
the DT O
placenta NN O
were VBD O
prematuration NN O
and CC O
hypoplasia NN O
. . O

-DOCSTART- X X O

Brucellosis--1990 . O

-DOCSTART- X X O

Assay NNP O
of IN O
urea NN O
by IN O
immobilized JJ O
urease NN B-NP
coupled VBN O
to TO O
a DT O
differential JJ O
pH-meter NN O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
the DT O
molecular JJ O
mechanisms NNS O
of IN O
the DT O
estrogen NN O
action NN O
that WDT O
govern VBP O
the DT O
lactoferrin VBG B-NP
gene NN I-NP
expression NN O
differ VBP O
between IN O
mouse NN O
and CC O
human NN O
. . O

-DOCSTART- X X O

BiP670 PRP B-NP
retains VBZ O
basal NN O
and CC O
Ca2+ JJ O
ionophore NN O
A23187-inducible JJ O
activities NNS O
. . O

-DOCSTART- X X O

Magnetic JJ O
resonance NN O
spectroscopy NN O
( -LRB- O
MRS NNP O
) -RRB- O
and CC O
imaging VBG O
( -LRB- O
MRI NNP O
) -RRB- O
are VBP O
now RB O
well RB O
established VBN O
techniques NNS O
for IN O
the DT O
study NN O
of IN O
cellular JJ O
metabolism NN O
and CC O
gross JJ O
structure NN O
of IN O
muscle NN O
. . O

-DOCSTART- X X O

Simultaneously RB O
a DT O
greater JJR O
NA NNP O
was VBD O
found VBN O
with IN O
no DT O
change NN O
in IN O
plasma NN O
epinephrine NN O
response NN O
. . O

-DOCSTART- X X O

We PRP O
investigated VBD O
the DT O
diagnostic JJ O
value NN O
of IN O
a DT O
new JJ O
in IN O
vitro NN O
test NN O
, , O
Pharmacia NNP O
CAP NNP O
System NNP O
( -LRB- O
Pharmacia NNP O
Diagnostics NNP O
AB NNP O
, , O
Uppsala NNP O
, , O
Sweden NNP O
) -RRB- O
, , O
for IN O
the DT O
quantitative JJ O
measurement NN O
of IN O
allergen-specific JJ B-NP
IgE NNP I-NP
antibodies NNS I-NP
by IN O
comparison NN O
with IN O
RAST NNP O
in IN O
2 CD O
groups NNS O
of IN O
patients NNS O
, , O
71 CD O
atopic JJ O
and CC O
48 CD O
non-atopic JJ O
. . O

-DOCSTART- X X O

As IN O
a DT O
part NN O
of IN O
a DT O
large JJ O
examination NN O
, , O
total NN O
and CC O
free JJ O
serum NN O
cholesterol NN O
, , O
total JJ O
lipid JJ O
and CC O
triglyceride JJ O
levels NNS O
were VBD O
determined VBN O
. . O

-DOCSTART- X X O

Caries NNP O
and CC O
parodontitis NN O
have VBP O
been VBN O
one CD O
of IN O
the DT O
most RBS O
spread JJ O
diseases NNS O
of IN O
mankind NN O
. . O

-DOCSTART- X X O

A DT O
second JJ O
large JJ O
group NN O
of IN O
disorders NNS O
in IN O
pregnancy NN O
is VBZ O
caused VBN O
by IN O
effects NNS O
of IN O
infections NNS O
of IN O
the DT O
mother NN O
without IN O
pathogens NNS O
being VBG O
transmitted VBN O
to TO O
the DT O
embryo NN O
or CC O
the DT O
placenta NN O
. . O

-DOCSTART- X X O

The DT O
case NN O
described VBN O
is VBZ O
that IN O
of IN O
a DT O
72-year-old JJ O
man NN O
with IN O
ochronosis NN O
who WP O
suffered VBD O
a DT O
hyperextension NN O
injury NN O
to TO O
his PRP$ O
spine NN O
in IN O
a DT O
fall NN O
, , O
resulting VBG O
in IN O
a DT O
fracture NN O
through IN O
an DT O
ankylosed JJ O
L2-L3 JJ O
disk NN O
space NN O
. . O

-DOCSTART- X X O

ME1a1 NNP B-NP
, , O
a DT O
16-base-pair JJ O
nuclear JJ O
factor NN O
binding NN O
site NN O
residing VBG O
between IN O
the DT O
c-MYC JJ B-NP
P1 NNP I-NP
and CC I-NP
P2 NNP I-NP
transcription NN I-NP
initiation NN I-NP
sites NNS I-NP
, , O
is VBZ O
required VBN O
for IN O
P2 NNP O
activity NN O
. . O

-DOCSTART- X X O

Exogenous JJ O
LHRH NNP B-NP
is VBZ O
also RB O
known VBN O
to TO O
facilitate VB O
mating VBG O
behavior NN O
in IN O
several JJ O
species NNS O
. . O

-DOCSTART- X X O

Replacing VBG O
the DT O
aspartic JJ O
acid NN O
with IN O
a DT O
lysine NN O
but CC O
not RB O
with IN O
an DT O
alanine NN O
or CC O
valine NN O
residue NN O
allowed VBD O
formation NN O
of IN O
disulfide-linked JJ O
dimers NNS O
. . O

-DOCSTART- X X O

During IN O
V-A NNP O
bypass VBD O
, , O
hemodynamics NNS O
were VBD O
stable JJ O
. . O

-DOCSTART- X X O

Greater NNP O
rupture NN O
force NN O
was VBD O
required VBN O
in IN O
the DT O
adult NN O
pigs NNS O
than IN O
in IN O
the DT O
young JJ O
pigs NNS O
. . O

-DOCSTART- X X O

Exposure JJ O
to TO O
hepatitis NN O
B NNP O
virus NN O
in IN O
the DT O
general JJ O
population NN O
of IN O
Hisayama NNP O
, , O
Japan NNP O
: : O
significance NN O
of IN O
isolated VBN O
antibody NN O
to TO O
hepatitis NN B-NP
B NNP I-NP
surface NN I-NP
antigen NN I-NP
in IN O
general JJ O
population NN O
. . O

-DOCSTART- X X O

High-resolution NNP O
computed VBD O
tomography NN O
in IN O
the DT O
diagnosis NN O
of IN O
miliary JJ O
tuberculosis NN O
. . O

-DOCSTART- X X O

Previously RB O
, , O
we PRP O
showed VBD O
that IN O
SNF2 NNP B-NP
, , O
SNF5 NNP B-NP
, , O
and CC O
SNF6 NNP B-NP
function NN O
interdependently RB O
in IN O
transcriptional JJ O
activation NN O
, , O
possibly RB O
forming VBG O
a DT O
heteromeric JJ O
complex NN O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
LexA-GAL4 NNP B-NP
and CC O
LexA-Bicoid NNP B-NP
fusion NN O
proteins NNS O
are VBP O
both DT O
dependent JJ O
on IN O
SNF2 NNP B-NP
, , O
SNF5 NNP B-NP
, , O
and CC O
SNF6 NNP B-NP
for IN O
activation NN O
of IN O
target NN O
genes NNS O
containing VBG O
one CD O
or CC O
multiple JJ O
lexA NN B-NP
operators NNS I-NP
. . O

-DOCSTART- X X O

George NNP O
T. NNP O

-DOCSTART- X X O

NE NNP B-NP
and CC O
PR3 NNP B-NP
assist VB O
in IN O
the DT O
destruction NN O
of IN O
phagocytosed JJ O
microorganisms NNS O
, , O
cleave VB O
the DT O
important JJ O
connective-tissue JJ B-NP
protein NN I-NP
elastin NN I-NP
, , O
and CC O
generate VB O
chemotactic NN O
activities NNS O
by IN O
forming VBG O
alpha NN B-NP
1-proteinase JJ I-NP
inhibitor NN I-NP
complexes NNS I-NP
and CC O
elastin JJ B-NP
peptides NNS I-NP
. . O

-DOCSTART- X X O

Factors NNS O
associated VBN O
with IN O
afterdrop NN O
included VBN O
age NN O
, , O
end-of-surgery NN O
temperature NN O
( -LRB- O
both DT O
positively RB O
) -RRB- O
and CC O
body NN O
mass NN O
( -LRB- O
negatively RB O
) -RRB- O
. . O

-DOCSTART- X X O

By IN O
contrast NN O
, , O
d( JJ B-NP
T2AG3T NN I-NP
) -RRB- I-NP
and CC O
d( JJ B-NP
T2G4T NN I-NP
) -RRB- I-NP
form NN O
only RB O
the DT O
G-quadruplex JJ O
monomer NN O
structures NNS O
independent JJ O
of IN O
K NNP O
cation NN O
concentration NN O
as IN O
reported VBN O
previously RB O
[Sen VBN O
, , O
D. NNP O
, , O
& CC O
Gilbert NNP O
, , O
W. NNP O

-DOCSTART- X X O

Differentiating VBG O
among IN O
renal JJ O
stones NNS O
. . O

-DOCSTART- X X O

IFI NNP B-NP
16 CD I-NP
mRNA NN I-NP
was VBD O
found VBN O
to TO O
be VB O
constitutively RB O
expressed VBN O
in IN O
lymphoid NN O
cells NNS O
and CC O
in IN O
cell NN O
lines NNS O
of IN O
both DT O
the DT O
T NNP O
and CC O
B NNP O
lineages NNS O
. . O

-DOCSTART- X X O

Mitochondria-lytic JJ O
action NN O
of IN O
warfarin NN O
in IN O
lymphocytes NNS O
. . O

-DOCSTART- X X O

The DT O
cDNA NN O
has VBZ O
an DT O
open JJ O
reading NN O
frame NN O
of IN O
900 CD O
amino IN O
acids NNS O
capable JJ O
of IN O
encoding VBG O
a DT O
97-kDa JJ O
protein NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
this DT O
study NN O
provides VBZ O
evidence NN O
that IN O
a DT O
novel NN O
, , O
ubiquitous JJ O
factor NN O
( -LRB- O
HF-1a NNP B-NP
) -RRB- O
and CC O
a DT O
muscle NN O
factor NN O
( -LRB- O
HF-1b/MEF-2 NN B-NP
) -RRB- O
can MD O
form VB O
a DT O
novel NN O
, , O
E-box-independent NNP O
pathway NN O
for IN O
muscle-specific JJ O
expression NN O
in IN O
ventricular JJ O
cardiac JJ O
muscle NN O
cells NNS O
. . O

-DOCSTART- X X O

Mutations NNS O
in IN O
either DT O
gene NN O
block NN O
some DT O
crucial JJ O
late JJ O
step NN O
in IN O
assembly NN O
of IN O
F1 NNP B-NP
, , O
causing VBG O
the DT O
alpha NN O
and CC O
beta JJ O
subunits NNS O
to TO O
accumulate VB O
in IN O
mitochondria NN O
as IN O
inactive JJ O
aggregates NNS O
( -LRB- O
Ackerman NNP O
, , O
S. NNP O

-DOCSTART- X X O

Estrogen NN O
replacement NN O
therapy NN O
and CC O
risk NN O
of IN O
breast NN O
cancer NN O
: : O
results NNS O
of IN O
two CD O
meta-analyses NNS O
. . O

-DOCSTART- X X O

Switching VBG O
FDC-P1/MAC JJ O
cells NNS O
from IN O
growth NN O
in IN O
M-CSF NNP B-NP
to TO O
GM-CSF NNP B-NP
caused VBD O
the DT O
selective JJ O
degradation NN O
of IN O
c-fms NNS B-NP
mRNA NNS I-NP
within IN O
6 CD O
h NN O
after IN O
factor NN O
switching NN O
. . O

-DOCSTART- X X O

There EX O
was VBD O
however RB O
, , O
no DT O
significant JJ O
difference NN O
in IN O
the DT O
prevalence NN O
of IN O
chronic JJ O
respiratory NN O
symptoms NNS O
between IN O
animal NN O
food NN O
workers NNS O
with IN O
positive JJ O
and CC O
negative JJ O
skin NN O
tests NNS O
to TO O
house VB O
dust NN O
or CC O
to TO O
fish NN O
flour NN O
or CC O
among IN O
those DT O
with IN O
increased VBN O
or CC O
normal JJ O
IgE NN B-NP
( -LRB- O
except IN O
for IN O
dyspnea NN O
) -RRB- O
. . O

-DOCSTART- X X O

Using VBG O
bovine NN B-NP
and CC I-NP
murine NN I-NP
c-myb JJ I-NP
clones NNS O
, , O
no DT O
change NN O
in IN O
the DT O
rate NN O
of IN O
c-myb JJ B-NP
gene NN I-NP
transcription NN O
or CC O
mRNA NN O
stability NN O
was VBD O
detected VBN O
during IN O
the DT O
cell NN O
cycle NN O
. . O

-DOCSTART- X X O

A DT O
13 CD O
base-pair NN O
oligonucleotide IN O
spanning VBG O
nucleotides NNS O
+80 CD O
to TO O
+92 CD O
of IN O
the DT O
5 CD B-NP
S NNP I-NP
RNA NNP I-NP
gene NN I-NP
retained VBN O
specific JJ O
and CC O
high-affinity JJ O
binding NN O
, , O
although IN O
the DT O
latter NN O
was VBD O
reduced VBN O
sixfold RB O
relative JJ O
to TO O
longer RB O
DNA NNP O
fragments NNS O
. . O

-DOCSTART- X X O

A DT O
comparison NN O
of IN O
the DT O
amino JJ O
acid NN O
sequence NN O
of IN O
the DT O
T. NNP O
thermophilus TO O
enzyme VB O
with IN O
that DT O
of IN O
the DT O
Escherichia NNP O
coli NNS O
enzyme NN O
showed VBD O
( -LRB- O
i NN O
) -RRB- O
a DT O
37 CD O
% NN O
overall JJ O
similarity NN O
; : O
( -LRB- O
ii NNS O
) -RRB- O
the DT O
conservation NN O
of IN O
the DT O
Ser NNP O
residue NN O
, , O
which WDT O
is VBZ O
known VBN O
to TO O
be VB O
phosphorylated VBN O
in IN O
the DT O
E. NNP O
coli NNS O
enzyme VBD O
, , O
and CC O
of IN O
the DT O
surrounding VBG O
sequence NN O
; : O
and CC O
( -LRB- O
iii NN O
) -RRB- O
the DT O
presence NN O
of IN O
141 CD O
extra JJ O
residues NNS O
at IN O
the DT O
C NNP O
terminus NN O
of IN O
the DT O
T. NNP O
thermophilus POS O
enzyme NN O
. . O

-DOCSTART- X X O

Radiolabelled VBN O
palmitate NN O
was VBD O
not RB O
incorporated VBN O
into IN O
the DT O
mutated JJ O
protein NN O
, , O
showing VBG O
that IN O
lipid JJ O
modification NN O
occurs VBZ O
at IN O
the DT O
Cys-22 NNP O
residue NN O
. . O

-DOCSTART- X X O

17 CD O
volunteer NN O
deaf JJ O
Ss NN O
were VBD O
compared VBN O
with IN O
18 CD O
volunteer NN O
hearing NN O
Ss NN O
on IN O
the DT O
Stanford NNP O
Hypnotic NNP O
Clinical NNP O
Scale NNP O
( -LRB- O
SHCS) NNP O
of IN O
Morgan NNP O
and CC O
J. NNP O

-DOCSTART- X X O

The DT O
gene NN O
encoding VBG O
IFN-gamma NNP B-NP
was VBD O
previously RB O
found VBN O
to TO O
contain VB O
an DT O
intronic JJ O
enhancer NN O
element NN O
that WDT O
was VBD O
not RB O
tissue-specific JJ O
in IN O
its PRP$ O
activity NN O
, , O
despite IN O
the DT O
restricted JJ O
expression NN O
of IN O
the DT O
intact JJ O
IFN-gamma-encoding JJ B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
of IN O
the DT O
polypeptide NN O
component NN O
of IN O
the DT O
Rel-related JJ B-NP
human JJ I-NP
p75 DT I-NP
nucleoprotein JJ I-NP
complex NN I-NP
has VBZ O
revealed VBN O
its PRP$ O
identity NN O
with IN O
the DT O
65-kDa JJ O
( -LRB- O
p65 NN B-NP
) -RRB- O
subunit NN O
of IN O
NF-kappa NNP B-NP
B. NNP I-NP

-DOCSTART- X X O

When WRB O
transiently RB O
transfected VBN O
into IN O
K562 NNP O
cells NNS O
, , O
this DT O
Lg JJ B-NP
genomic JJ O
clone NN O
is VBZ O
actively RB O
transcribed VBN O
, , O
suggesting VBG O
that IN O
, , O
although IN O
it PRP O
possesses VBZ O
the DT O
characteristics NNS O
of IN O
a DT O
processed VBN O
pseudogene NN O
, , O
it PRP O
is VBZ O
likely JJ O
to TO O
correspond VB O
to TO O
the DT O
gene NN O
encoding VBG O
this DT O
new JJ O
ferritin NN B-NP
subunit NN I-NP
. . O

-DOCSTART- X X O

Of IN O
the DT O
drugs NNS O
orally RB O
administered VBN O
, , O
WR-168643 NNP O
was VBD O
the DT O
best JJS O
protector NN O
with IN O
a DT O
DMF NNP O
of IN O
1.51 CD O
. . O

-DOCSTART- X X O

During IN O
the DT O
1980 CD O
's POS O
, , O
quantifications NNS O
of IN O
immunoserological JJ O
testings NNS O
, , O
especially RB O
C NNP B-NP
reactive JJ I-NP
protein NN I-NP
, , O
rheumatoid NN B-NP
factor NN I-NP
and CC O
antistreptolysin JJ B-NP
O NNP I-NP
, , O
progressed VBD O
rapidly RB O
. . O

-DOCSTART- X X O

Within IN O
the DT O
human JJ O
enhancer NN O
, , O
these DT O
two CD O
sites NNS O
are VBP O
located VBN O
within IN O
the DT O
previously RB O
defined VBN O
DNase NN B-NP
I PRP I-NP
footprints VBD I-NP
, , O
NFAT-1 NNP B-NP
and CC O
NFIL-2B NNP B-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
cardiac JJ B-NP
myosin NN I-NP
light NN I-NP
chain-2 NN I-NP
( -LRB- O
MLC-2 NN B-NP
) -RRB- O
gene NN O
promoter NN O
contains VBZ O
several JJ O
positive JJ O
and CC O
negative JJ O
cis-acting JJ O
sequences NNS O
that WDT O
are VBP O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
its PRP$ O
expression NN O
. . O

-DOCSTART- X X O

Deletion NNP O
mutagenesis NN O
demonstrated VBD O
that IN O
these DT O
two CD O
elements NNS O
are VBP O
involved VBN O
in IN O
the DT O
positive JJ O
regulation NN O
of IN O
MLC-2 NNP B-NP
gene NN I-NP
transcription NN O
. . O

-DOCSTART- X X O

Disruption NN O
mutations NNS O
have VBP O
been VBN O
constructed VBN O
in IN O
the DT O
SLK1 NNP B-NP
gene NN I-NP
. . O
slk1 CD B-NP
null JJ I-NP
mutants NNS I-NP
cannot MD O
grow VB O
at IN O
37 CD O
degrees NNS O
C NN O
, , O
but CC O
many JJ O
cells NNS O
can MD O
grow VB O
at IN O
30 CD O
, , O
24 CD O
, , O
and CC O
17 CD O
degrees NNS O
C. NNP O

-DOCSTART- X X O

Molecular JJ O
and CC O
genetic JJ O
analysis NN O
of IN O
the DT O
yeast NN B-NP
early RB I-NP
meiotic VBN I-NP
recombination NN I-NP
genes NNS I-NP
REC102 NNS I-NP
and CC O
REC107/MER2 NNS B-NP
. . O

-DOCSTART- X X O

These DT O
data NNS O
support VBP O
a DT O
possible JJ O
biological JJ O
significance NN O
of IN O
the DT O
frameshift NN O
to TO O
occur VB O
at IN O
this DT O
position NN O
of IN O
the DT O
large JJ O
overlap NN O
by IN O
including VBG O
the DT O
putative JJ O
RNA NNP O
template-binding JJ O
site NN O
of IN O
the DT O
PLRV NNP B-NP
replicase NN I-NP
in IN O
the DT O
ORF2a/ORF2b JJ B-NP
transframe NN I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Proprotein NNP O
processing NN O
occurs VBZ O
intracellularly RB O
. . O

-DOCSTART- X X O

A DT O
32P-labeled JJ O
LAP NNP B-NP
DNA-binding NN O
and CC O
dimerization NN O
domain NN O
"zipper NN O
probe NN O
" '' O
was VBD O
used VBN O
to TO O
isolate VB O
a DT O
clone NN O
that WDT O
encodes VBZ O
a DT O
new JJ O
C/EBP-homologous JJ B-NP
protein NN I-NP
: : O
CHOP-10 JJ B-NP
. . O

-DOCSTART- X X O

The DT O
level NN O
of IN O
carboxyl-terminal JJ B-NP
parathyroid NN I-NP
hormone NN I-NP
in IN O
the DT O
patients NNS O
with IN O
thyroid JJ O
carcinoma NN O
was VBD O
higher JJR O
than IN O
that IN O
in IN O
the DT O
patients NNS O
without IN O
thyroid JJ O
carcinoma NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
Caenorhabditis NNP B-NP
elegans NNS I-NP
vitellogenin IN I-NP
genes NNS I-NP
are VBP O
subject JJ O
to TO O
sex-, JJ O
stage-, JJ O
and CC O
tissue-specific JJ O
regulation NN O
: : O
they PRP O
are VBP O
expressed VBN O
solely RB O
in IN O
the DT O
adult NN O
hermaphrodite IN O
intestine NN O
. . O

-DOCSTART- X X O

The DT O
MET4 NNP B-NP
gene NN O
was VBD O
cloned VBN O
, , O
and CC O
its PRP$ O
sequence NN O
reveals VBZ O
that IN O
it PRP O
encodes VBZ O
a DT O
protein NN O
related VBN O
to TO O
the DT O
family NN O
of IN O
the DT O
bZIP NN B-NP
transcriptional JJ I-NP
activators NNS I-NP
. . O

-DOCSTART- X X O

The DT O
functions NNS O
of IN O
isolated JJ O
portions NNS O
of IN O
the DT O
insulin NN B-NP
, , O
IAPP NNP B-NP
, , O
and CC O
beta JJ B-NP
GK JJ I-NP
promoters NNS I-NP
were VBD O
studied VBN O
by IN O
using VBG O
transient JJ O
expression NN O
and CC O
DNA NNP O
binding NN O
assays VBD O
. . O

-DOCSTART- X X O

The DT O
c-Ets-1 JJ B-NP
oncoprotein NNP I-NP
is VBZ O
a DT O
transcription NN O
activator NN O
that WDT O
specifically RB O
binds VBZ O
to TO O
DNA NNP O
. . O

-DOCSTART- X X O

Previous JJ O
transactivation NN O
experiments NNS O
indicated VBD O
that IN O
three CD O
amino IN O
acids NNS O
residing VBG O
in IN O
this DT O
region NN O
, , O
Gly NNP O
, , O
Ser NNP O
and CC O
Val NNP O
, , O
appear VBP O
to TO O
be VB O
critical JJ O
for IN O
target-site JJ O
discrimination NN O
. . O

-DOCSTART- X X O

This DT O
vector NN O
transfected VBD O
into IN O
the DT O
yeast NN O
Saccharomyces NNS O
cerevisiae VBN O
directs VBZ O
expression NN O
of IN O
a DT O
secreted VBN O
mature JJ O
protein NN O
at IN O
levels NNS O
up RB O
to TO O
200 CD O
mg NN O
of IN O
LAPP/liter NN O
of IN O
culture NN O
medium NN O
. . O

-DOCSTART- X X O

This DT O
DNA NN O
motif NN O
represents VBZ O
a DT O
novel NN O
protein-binding NN O
sequence NN O
. . O

-DOCSTART- X X O

Intrapocket NNP O
chemotherapy NN O
in IN O
adult NN O
periodontitis NN O
using VBG O
a DT O
new JJ O
controlled-release NN O
insert NN O
containing VBG O
ofloxacin NNP O
( -LRB- O
PT-01 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Electromagnetic JJ O
blood NN O
flow NN O
( -LRB- O
BF NN O
) -RRB- O
probe NN O
was VBD O
applied VBN O
on IN O
the DT O
left JJ O
anterior JJ O
descending VBG O
artery NN O
( -LRB- O
LAD NN O
) -RRB- O
. . O

-DOCSTART- X X O

Hence RB O
temperature NN O
and CC O
virF NN B-NP
are VBP O
both DT O
required VBN O
for IN O
the DT O
induction NN O
of IN O
the DT O
yop NN B-NP
regulon NN I-NP
. . O

-DOCSTART- X X O

Problems NNS O
remain VBP O
to TO O
be VB O
resolved VBN O
in IN O
the DT O
area NN O
of IN O
quantitative JJ O
risk NN O
assessment NN O
. . O

-DOCSTART- X X O

The DT O
recently RB O
developed VBN O
gamma-interferon NN B-NP
( -LRB- O
IFN-gamma NN B-NP
) -RRB- O
assay NN O
system NN O
for IN O
the DT O
diagnosis NN O
of IN O
bovine JJ O
tuberculosis NN O
in IN O
cattle NNS O
has VBZ O
been VBN O
accredited VBN O
by IN O
the DT O
Standing NNP O
Committee NNP O
on IN O
Agriculture NNP O
for IN O
use NN O
in IN O
Australia NNP O
. . O

-DOCSTART- X X O

Control NNP O
Tmuscle NNP O
was VBD O
35.8 CD O
+/ CD O
- : O
0.7 CD O
degrees NNS O
C NN O
, , O
with IN O
control NN O
Wi NNP O
,max NNP O
being VBG O
51.6 CD O
( -LRB- O
SD NNP O
8.7 CD O
) -RRB- O
W.kg-1 NN O
. . O

-DOCSTART- X X O

The DT O
Klebsiella NNP B-NP
aerogenes VBZ I-NP
gene NN I-NP
maoA NNS I-NP
, , O
which WDT O
is VBZ O
involved VBN O
in IN O
the DT O
synthesis NN O
of IN O
monoamine NN B-NP
oxidase NN I-NP
, , O
was VBD O
induced VBN O
by IN O
tyramine NN O
and CC O
the DT O
related JJ O
compounds NNS O
, , O
subjected VBN O
to TO O
catabolite NN O
and CC O
ammonium NN O
ion NN O
repression NN O
, , O
and CC O
cloned VBD O
. . O

-DOCSTART- X X O

However RB O
, , O
other JJ O
regions NNS O
of IN O
the DT O
plasmid NN O
are VBP O
also RB O
efficiently RB O
repaired VBN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
human JJ B-NP
D1A NNP I-NP
gene NN I-NP
belongs VBZ O
to TO O
the DT O
category NN O
of IN O
tissue-specific JJ O
, , O
regulated JJ O
genes NNS O
that WDT O
have VBP O
housekeeping-type JJ O
promoters NNS O
. . O

-DOCSTART- X X O

Similar JJ O
observations NNS O
have VBP O
been VBN O
made VBN O
previously RB O
for IN O
other JJ O
genes NNS O
. . O

-DOCSTART- X X O

Preceptorship NNP O
of IN O
CNS NNP O
students NNS O
: : O
an DT O
exploratory JJ O
study NN O
. . O

-DOCSTART- X X O

To TO O
determine VB O
the DT O
genetic JJ O
basis NN O
for IN O
the DT O
differences NNS O
between IN O
the DT O
cardiac NN O
and CC O
brain NN B-NP
AE3 IN I-NP
variants NNS I-NP
, , O
we PRP O
isolated VBD O
and CC O
characterized VBD O
the DT O
rat NN O
gene NN O
. . O

-DOCSTART- X X O

Institution NNP O
of IN O
both DT O
intravenous JJ O
and CC O
intracisternal JJ O
administration NN O
of IN O
amphotericin JJ O
B NNP O
and CC O
possibly RB O
concomitant JJ O
intravenous JJ O
administration NN O
of IN O
dexamethasone NN O
may MD O
be VB O
warranted VBN O
in IN O
situations NNS O
in IN O
which WDT O
the DT O
association NN O
of IN O
C. NNP O
immitis NN O
with IN O
CNS NNP O
vasculitis NN O
or CC O
encephalitis NN O
appears VBZ O
likely JJ O
before IN O
serologic NN O
or CC O
cultural JJ O
confirmation NN O
of IN O
C. NNP O
immitis NN O
infection NN O
involving VBG O
the DT O
CNS NNP O
is VBZ O
available JJ O
. . O

-DOCSTART- X X O

Lac NNP B-NP
operators NNS O
were VBD O
introduced VBN O
into IN O
several JJ O
positions NNS O
within IN O
the DT O
CAB NNP B-NP
promoter NN I-NP
and CC O
operator-free JJ O
plasmid NN O
was VBD O
used VBN O
as IN O
control NN O
. . O

-DOCSTART- X X O

Overproduction NNP O
, , O
purification NN O
and CC O
characterization NN O
of IN O
M.Hinf NNP B-NP
I PRP I-NP
methyltransferase VB I-NP
and CC O
its PRP$ O
deletion NN O
mutant NN O
. . O

-DOCSTART- X X O

Various JJ O
companies NNS O
produce VBP O
this DT O
type NN O
of IN O
lens NN O
. . O

-DOCSTART- X X O

From IN O
March NNP O
5 CD O
through IN O
October NNP O
26 CD O
, , O
1991 CD O
, , O
eight CD O
persons NNS O
were VBD O
diagnosed JJ O
with IN O
elevated JJ O
blood NN O
lead NN O
levels NNS O
( -LRB- O
BLLs NN O
) -RRB- O
at IN O
a DT O
local JJ O
hospital NN O
and CC O
were VBD O
reported VBN O
to TO O
the DT O
notifiable JJ O
disease NN O
surveillance NN O
system NN O
maintained VBN O
by IN O
the DT O
Alabama NNP O
Department NNP O
of IN O
Public NNP O
Health NNP O
( -LRB- O
ADPH) NNP O
. . O

-DOCSTART- X X O

A DT O
possible JJ O
mechanism NN O
is VBZ O
that IN O
elevated JJ O
alveolar JJ O
pressure NN O
and CC O
decreased VBD O
cardiac JJ O
output NN O
eliminate VB O
blood NN O
flow NN O
from IN O
corner NN O
vessels NNS O
in IN O
nondependent JJ O
high JJ O
VA/ NN O
Q NN O
regions NNS O
. . O

-DOCSTART- X X O

Domain NNP O
II NNP O
is VBZ O
highly RB O
homologous JJ O
to TO O
the DT O
LDL NNP B-NP
receptor NN I-NP
and CC O
contains VBZ O
four CD O
repeats NNS O
with IN O
perfect JJ O
conservation NN O
of IN O
all DT O
6 CD O
consecutive JJ O
cysteines NNS O
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
present VBP O
evidence NN O
for IN O
a DT O
model NN O
in IN O
which WDT O
mRNA NN O
sequences NNS O
up IN O
to TO O
around IN O
100 CD O
nucleotides NNS O
downstream RB O
from IN O
the DT O
start NN O
codon NN O
of IN O
21K DT O
fold NN O
back RB O
and CC O
base-pair NN O
to TO O
the DT O
21K NNP O
translation NN O
initiation IN O
region NN O
, , O
thereby RB O
decreasing VBG O
the DT O
translation NN O
initiation NN O
frequency NN O
. . O

-DOCSTART- X X O

Hybridization NNP O
data NNS O
indicate VBP O
that IN O
6F6.2 CD B-NP
corresponds NNS O
to TO O
the DT O
previously RB O
characterized VBN O
m6F6 . B-NP
cDNA NN I-NP
clone NN I-NP
and CC O
that IN O
6F6.1 CD B-NP
and CC O
6F6.3 CD B-NP
, , O
but CC O
not RB O
6F6.2 JJ B-NP
, , O
are VBP O
adjacent JJ O
to TO O
alpha-type JJ B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

Protein NNP B-NP
tyrosine NN I-NP
kinases NNS I-NP
( -LRB- O
PTKs NNS B-NP
) -RRB- O
are VBP O
implicated VBN O
in IN O
the DT O
control NN O
of IN O
cell NN O
growth NN O
by IN O
virtue NN O
of IN O
their PRP$ O
frequent JJ O
appearance NN O
as IN O
products NNS O
of IN O
retroviral JJ O
oncogenes NNS O
, , O
as IN O
intracellular JJ O
signal NN O
transducers NNS O
, , O
and CC O
as IN O
growth NN B-NP
factor NN I-NP
receptors NNS I-NP
or CC O
components NNS O
thereof RB O
. . O

-DOCSTART- X X O

The DT O
IA4 NNP B-NP
mAb NN I-NP
was VBD O
identified VBN O
among IN O
a DT O
series NN O
of IN O
antibodies NNS O
raised VBN O
in IN O
BALB/c NNP O
mice NNS O
after IN O
immunization NN O
against IN O
a DT O
HLA NNP B-NP
class NN O
I-deficient JJ O
, , O
lymphokine-activated JJ O
killer NN O
( -LRB- O
LAK)-susceptible JJ O
EBV-B NN O
lymphocyte NN O
line NN O
. . O

-DOCSTART- X X O

In IN O
a DT O
randomized JJ O
double-blind JJ O
cross-over NN O
study NN O
, , O
the DT O
subjects NNS O
received VBD O
theophylline DT O
5 CD O
mg.kg-1 NN O
per IN O
day NN O
with IN O
omeprazole NN O
20 CD O
mg NN O
per IN O
day NN O
or CC O
identical JJ O
placebo NN O
during IN O
two CD O
periods NNS O
, , O
each DT O
of IN O
7 CD O
days NNS O
, , O
separated VBN O
by IN O
a DT O
washout JJ O
period NN O
of IN O
7 CD O
days NNS O
. . O

-DOCSTART- X X O

Primer NNP O
extension NN O
and CC O
mung JJ B-NP
bean NN I-NP
and CC I-NP
S1 VB I-NP
nuclease DT I-NP
mapping NN O
indicated VBD O
multiple JJ O
transcription NN O
initiation NN O
sites NNS O
and CC O
were VBD O
consistent JJ O
with IN O
Northern NNP O
analyses NNS O
. . O

-DOCSTART- X X O

Unlike IN O
the DT O
typical JJ O
enhancer NN O
element NN O
, , O
this DT O
region NN O
functions NNS O
in IN O
an DT O
orientation-dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

Allagille NNP O
's POS O
syndrome NN O
associated VBN O
with IN O
antenatal JJ O
ascites NNS O

-DOCSTART- X X O

Sensitivity NN O
and CC O
specificity NN O
was VBD O
established VBN O
for IN O
the DT O
Pharmacia NNP O
CAP NNP O
System NNP O
and CC O
the DT O
DPC NNP O
AlaSTAT NNP O
System NNP O
by IN O
comparison NN O
with IN O
results NNS O
of IN O
the DT O
skin NN O
prick NN O
test NN O
. . O

-DOCSTART- X X O

PSI-G NNP B-NP
and CC O
PSI-K NNP B-NP
probably RB O
have VBP O
evolved VBN O
from IN O
a DT O
gene NN O
duplication NN O
of IN O
an DT O
ancestral JJ O
gene NN O
. . O

-DOCSTART- X X O

Site-directed JJ O
mutagenesis NN O
revealed VBD O
that IN O
two CD O
clusters NNS O
of IN O
basic JJ O
amino IN O
acids NNS O
within IN O
a DT O
conserved JJ O
basic JJ O
region NN O
and CC O
two CD O
amphipathic JJ O
helices NNS O
within IN O
the DT O
adjacent JJ O
HLH NNP O
domain NN O
are VBP O
essential JJ O
for IN O
sequence-specific JJ O
DNA NNP O
binding NN O
and CC O
hetero-oligomerization NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Dimerization NNP O
of IN O
Myf-5 NNP B-NP
with IN O
the DT O
ubiquitously NN O
expressed VBD O
bHLH JJ O
protein NN O
E12 . B-NP
not RB O
only RB O
increases VBZ O
the DT O
affinity NN O
for IN O
DNA NN O
but CC O
also RB O
stimulates VBZ O
transactivation NN O
independently RB O
of IN O
DNA NNP O
binding NN O
. . O

-DOCSTART- X X O

The DT O
circadian JJ O
rhythmicity NN O
of IN O
sleep NN O
was VBD O
pronounced VBN O
. . O

-DOCSTART- X X O

SEA NN O
was VBD O
recorded VBN O
with IN O
bidirectional JJ O
filters NNS O
at IN O
25-250 CD O
HZ NN O
and CC O
40-250 CD O
Hz NN O
using VBG O
Simson NNP O
method NN O
. . O

-DOCSTART- X X O

Drug-drug NN O
interactions NNS O
are VBP O
most RBS O
likely JJ O
to TO O
occur VB O
in IN O
patients NNS O
receiving VBG O
multiple JJ O
medications NNS O
and CC O
with IN O
drugs NNS O
that WDT O
have VBP O
a DT O
narrow JJ O
therapeutic JJ O
window NN O
. . O

-DOCSTART- X X O

Total JJ O
body NN O
irradiation NN O
was VBD O
delivered VBN O
according VBG O
to TO O
a DT O
hyperfractionated JJ O
scheme NN O
of IN O
12 CD O
fractions NNS O
given VBN O
three CD O
per IN O
day NN O
5 CD O
hr NN O
apart RB O
for IN O
4 CD O
days NNS O
. . O

-DOCSTART- X X O

A DT O
reduction NN O
in IN O
blood NN O
pressure NN O
was VBD O
only RB O
observed VBN O
at IN O
the DT O
end NN O
of IN O
the DT O
study NN O
, , O
from IN O
142 CD O
+/ CD O
- : O
17/86.6 CD O
+/ NN O
- : O
9.1 CD O
to TO O
139 CD O
+/ CD O
- : O
13/8 CD O
2.9 CD O
+/ NN O
- : O
8.9 CD O
mmHg NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.05 CD O
for IN O
DBP) NNP O
. . O

-DOCSTART- X X O

AgMNPV NNP O
and CC O
Orgyia NNP O
pseudotsugata NN O
MNPV NNP O
( -LRB- O
OpMNPV NN O
) -RRB- O
are VBP O
similar JJ O
in IN O
terms NNS O
of IN O
promoter NN O
structure NN O
and CC O
polyhedrin NN B-NP
primary JJ I-NP
sequence NN I-NP
, , O
and CC O
the DT O
polyhedrin NN B-NP
gene NN I-NP
of IN O
both DT O
viruses NNS O
is VBZ O
transcribed VBN O
in IN O
the DT O
anti-clockwise JJ O
direction NN O
in IN O
relation NN O
to TO O
their PRP$ O
physical JJ O
maps NNS O
. . O

-DOCSTART- X X O

A DT O
gene NN O
homologous JJ O
to TO O
the DT O
Escherichia NNP B-NP
coli NNS I-NP
dnaA VBG I-NP
gene NN I-NP
was VBD O
isolated VBN O
from IN O
Pseudomonas NNP O
putida NN O
and CC O
its PRP$ O
transcription NN O
was VBD O
investigated VBN O
in IN O
E. NNP O
coli NNS O
as RB O
well RB O
as IN O
in IN O
P. NNP O
putida VBD O
. . O

-DOCSTART- X X O

STP1 NNP B-NP
is VBZ O
an DT O
unessential JJ O
yeast NN O
gene NN O
involved VBN O
in IN O
the DT O
removal NN O
of IN O
intervening VBG O
sequences NNS O
from IN O
some DT O
, , O
but CC O
not RB O
all DT O
, , O
families NNS O
of IN O
intervening NN O
sequence-containing NN O
pre-tRNAs NNS O
. . O

-DOCSTART- X X O

GCR1 NNP B-NP
gene NN I-NP
function NN O
is VBZ O
required VBN O
for IN O
high-level JJ O
glycolytic JJ O
gene NN O
expression NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

The DT O
decay NN O
curves NNS O
of IN O
chlorophyll NN O
fluorescence NN O
showed VBD O
a DT O
superposition NN O
of IN O
three CD O
exponentially RB O
decaying VBG O
components NNS O
with IN O
time NN O
constants NNS O
of IN O
T1 NNP O
= SYM O
100-200 CD O
ps NNS O
, , O
T2 DT O
= SYM O
300-500 CD O
ps NNS O
and CC O
T3 DT O
= SYM O
2.0-3.5 CD O
ns NNS O
. . O

-DOCSTART- X X O

After IN O
tilting VBG O
, , O
systolic JJ O
blood NN O
pressure NN O
fell VBD O
an DT O
average NN O
of IN O
17 CD O
% NN O
in IN O
patients NNS O
who WP O
cramped VBD O
infrequently RB O
( -LRB- O
p NN O
= SYM O
0.0031 CD O
) -RRB- O
but CC O
only RB O
10 CD O
% NN O
in IN O
frequently RB O
cramping VBG O
patients NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
are VBP O
consistent JJ O
with IN O
the DT O
roles NNS O
that IN O
CCK NNP B-NP
and CC O
trypsin IN B-NP
inhibitors NNS O
are VBP O
believed VBN O
to TO O
play VB O
in IN O
the DT O
negative JJ O
feedback NN O
control NN O
of IN O
pancreatic JJ O
exocrine JJ O
function NN O
. . O

-DOCSTART- X X O

Eight CD O
rabbits NNS O
were VBD O
exposed VBN O
to TO O
0.7 CD O
+/ NNS O
- : O
0.4 CD O
mg/m3 CD O
Co2+ NNP O
as IN O
CoCl2 NNP O
and CC O
1.2 CD O
+/ NNS O
- : O
0.7 CD O
mg/m3 CD O
Cr3+ NNP O
as IN O
Cr( NNP O
NO3)3 NNP O
( -LRB- O
group NN O
Co NNP O
+ JJ O
Cr NN O
) -RRB- O
, , O
eight CD O
to TO O
0.6 CD O
+/ NN O
- : O
0.5 CD O
mg/m3 CD O
Co2+ IN O
( -LRB- O
group NN O
Co) NNP O
, , O
and CC O
eight CD O
to TO O
filtered JJ O
air NN O
( -LRB- O
control NN O
group NN O
) -RRB- O
, , O
for IN O
4 CD O
months NNS O
, , O
5 CD O
days/week NN O
, , O
and CC O
6 CD O
hr/day NN O
. . O

-DOCSTART- X X O

16 CD O
women NNS O
were VBD O
treated VBN O
with IN O
methadone NN O
to TO O
prevent VB O
withdrawal NN O
symptoms NNS O
. . O

-DOCSTART- X X O

Disruption NNP O
demonstrates VBZ O
that IN O
CDC14 NNP B-NP
is VBZ O
an DT O
essential JJ O
gene NN O
. . O

-DOCSTART- X X O

Coronary JJ O
flow NN O
was VBD O
reduced VBN O
by IN O
10 CD O
% NN O
in IN O
the DT O
phosphocreatine NN O
and CC O
by IN O
18 CD O
% NN O
in IN O
the DT O
control NN O
group NN O
. . O

-DOCSTART- X X O

The DT O
60A JJ B-NP
transcripts NNS I-NP
and CC O
protein NN O
are VBP O
first JJ O
detected VBN O
at IN O
the DT O
onset NN O
of IN O
gastrulation NN O
, , O
primarily RB O
in IN O
the DT O
mesoderm NN O
of IN O
the DT O
extending VBG O
germ NN O
band NN O
. . O

-DOCSTART- X X O

A DT O
724-bp JJ O
segment NN O
of IN O
the DT O
5'-flanking JJ O
region NN O
consisting VBG O
of IN O
the DT O
proximal JJ O
E-box NNP O
flanked VBD O
upstream RB O
by IN O
a DT O
mammalian-specific JJ O
352-bp JJ O
region NN O
was VBD O
sufficient JJ O
for IN O
maximal JJ O
transcriptional JJ O
activation NN O
in IN O
postconfluent JJ O
BC3H1 NNP O
myoblasts NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
baculovirus-expressed JJ O
TR NN B-NP
mediates NNS O
transcriptional JJ O
activation NN O
and CC O
repression NN O
in IN O
a DT O
promoter-specific JJ O
manner NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Influence NN O
of IN O
neural JJ O
regulation NN O
on IN O
anti-arrhythmic JJ O
effects NNS O
of IN O
GABA NNP O
in IN O
rats NNS O

-DOCSTART- X X O

Recent JJ O
investigations NNS O
have VBP O
detailed VBN O
a DT O
selective JJ O
dye NN O
release NN O
technique NN O
in IN O
which WDT O
a DT O
pulse NN O
of IN O
laser NN O
light NN O
induces VBZ O
the DT O
release NN O
of IN O
a DT O
fluorescent JJ O
dye NN O
from IN O
temperature-sensitive JJ O
liposomes NNS O
circulating VBG O
in IN O
the DT O
retinal JJ O
vasculature NN O
. . O

-DOCSTART- X X O

And CC O
the DT O
natural JJ O
barriers NNS O
? . O

-DOCSTART- X X O

Three CD O
pyridoxine NN O
derivatives NNS O
have VBP O
been VBN O
isolated VBN O
from IN O
the DT O
fresh JJ O
stem NN O
bark NN O
of IN O
Albizzia NNP O
julibrissin NNP O
DURAZZ. NNP O
. . O

-DOCSTART- X X O

The DT O
serum NN O
erythropoietin NN B-NP
( -LRB- O
EPO NNP B-NP
) -RRB- O
concentrations NNS O
of IN O
15 CD O
male JJ O
triathletes NNS O
( -LRB- O
26.3 CD O
U.ml-1 NN O
) -RRB- O
were VBD O
significantly RB O
lower JJR O
than IN O
those DT O
of IN O
45 CD O
male NN O
distance NN O
runners NNS O
( -LRB- O
31.6 CD O
U.ml-1 : O
; : O
P NNP O
less RBR O
than IN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
coating NN O
materials NNS O
were VBD O
poloxamine JJ O
904 CD O
, , O
poloxamine NN O
908 CD O
, , O
poloxamine NN O
1508 CD O
, , O
poloxamer NN O
338 RB O
, , O
and CC O
Brij NNP O
35 CD O
. . O

-DOCSTART- X X O

The DT O
eating NN O
and CC O
drinking NN O
patterns NNS O
of IN O
pygmy NN O
goats NNS O
fed VBN O
ad NN O
lib NN O
and CC O
kept VBD O
on IN O
a DT O
12 CD O
h NN O
light/12 IN O
h JJ O
dark JJ O
cycle NN O
were VBD O
recorded VBN O
and CC O
analyzed VBN O
. . O

-DOCSTART- X X O

The DT O
present JJ O
study NN O
highlights IN O
the DT O
improvement NN O
in IN O
sputum NN O
amoxycillin NN O
(amoxy NN O
) -RRB- O
levels NNS O
when WRB O
a DT O
combination NN O
tablet NN O
, , O
amoxy NN O
500 CD O
mg NN O
plus CC O
bromhexeine JJ O
8 CD O
mg NN O
, , O
is VBZ O
administered VBN O
as IN O
compared VBN O
to TO O
plain JJ O
amoxy NN O
500 CD O
mg NN O
. . O

-DOCSTART- X X O

His PRP$ O
HC NNP B-NP
II NNP I-NP
activity NN O
and CC O
antigen JJ O
levels NNS O
were VBD O
49 CD O
% NN O
and CC O
50 CD O
% NN O
, , O
respectively RB O
, , O
and CC O
his PRP$ O
daughter NN O
also RB O
showed VBD O
similar JJ O
low JJ O
levels NNS O
. . O

-DOCSTART- X X O

FDA NNP O
regulations NNS O
for IN O
growth NN O
factors NNS O
and CC O
related JJ O
products NNS O
. . O

-DOCSTART- X X O

Because IN O
the DT O
adrenergic JJ O
nervous JJ O
system NN O
influences VBZ O
cardiac JJ O
arrhythmias NNS O
and CC O
myocardial JJ O
infarction NN O
can MD O
directly RB O
affect VB O
sympathetic JJ O
innervation NN O
in IN O
the DT O
heart NN O
, , O
we PRP O
investigated VBD O
the DT O
role NN O
of IN O
the DT O
sympathetic JJ O
nervous JJ O
system NN O
on IN O
reentry NN O
in IN O
the DT O
canine NN O
heart NN O
4 CD O
days NNS O
after IN O
infarction NN O
. . O

-DOCSTART- X X O

DESIGN NNP O
: : O
Serum NN O
aldosterone NN O
and CC O
plasma NN B-NP
renin NN I-NP
activity NN O
were VBD O
measured VBN O
supine NN O
prior RB O
to TO O
and CC O
60 CD O
, , O
90 CD O
, , O
120 CD O
minutes NNS O
after IN O
oral JJ O
captopril NN O
, , O
25 CD O
mg NN O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
minimum NN O
steady-state NN O
concentration NN O
after IN O
the DT O
oral JJ O
regimen NNS O
( -LRB- O
23 CD O
micrograms NNS O
.l-1 NN O
) -RRB- O
was VBD O
78 CD O
% NN O
of IN O
that IN O
after IN O
the DT O
intramuscular JJ O
regime NN O
( -LRB- O
29 CD O
micrograms NNS O
.l-1 JJ O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
mutant JJ O
proteins NNS O
retained VBN O
the DT O
ability NN O
to TO O
competitively RB O
inhibit VB O
kappa NN B-NP
B-mediated JJ I-NP
transcriptional JJ O
activation NN O
of IN O
the DT O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
long RB I-NP
terminal JJ I-NP
repeat NN I-NP
but CC O
failed VBD O
to TO O
efficiently RB O
transform VB O
chicken NN O
lymphoid NN O
cells NNS O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

In IN O
conclusion NN O
, , O
to TO O
study VB O
and CC O
overcome VB O
TI NNP O
region-based JJ O
expression NN O
problems NNS O
it PRP O
is VBZ O
worthwhile JJ O
to TO O
start VB O
out RP O
with IN O
a DT O
versatile NN O
vector NN O
containing VBG O
exhaustive JJ O
mutations NNS O
in IN O
the DT O
periShine-Dalgarno NN O
sequences NNS O
; : O
as IN O
a DT O
rule NN O
the DT O
coding NN O
MTI NNP O
subregion NN O
can MD O
be VB O
kept VBN O
unchanged JJ O
. . O

-DOCSTART- X X O

Four CD O
of IN O
these DT O
five CD O
subjects NNS O
also RB O
performed VBD O
mixed JJ O
sequences NNS O
under IN O
conditional JJ O
control NN O
of IN O
the DT O
words NNS O
( -LRB- O
e NN O
.g. NNP O
, , O
A1----B2----A3----B4----A5 . O
and CC O
its PRP$ O
reversal NN O
) -RRB- O
, , O
verifying VBG O
that IN O
the DT O
stimuli NNS O
which WDT O
occupied VBD O
the DT O
same JJ O
position NN O
in IN O
each DT O
sequence NN O
were VBD O
members NNS O
of IN O
the DT O
same JJ O
class NN O
. . O

-DOCSTART- X X O

UF-021 DT O
ophthalmic JJ O
solution NN O
( -LRB- O
0.03 CD O
to TO O
0.24 CD O
% NN O
) -RRB- O
, , O
when WRB O
topically RB O
applied VBN O
to TO O
the DT O
eyes NNS O
of IN O
rabbits NNS O
, , O
caused VBD O
dose-dependent JJ O
IOP NNP O
reduction NN O
( -LRB- O
2.8 CD O
to TO O
5.2 CD O
mmHg NN O
) -RRB- O
, , O
without IN O
transient NN O
IOP NNP O
rise NN O
. . O

-DOCSTART- X X O

Wild-type JJ O
protein NN O
bound VBN O
azido-ATP JJ O
well RB O
, , O
but CC O
mutants NNS O
with IN O
substitutions NNS O
in IN O
the DT O
consensus NN O
amino IN O
acids NNS O
were VBD O
unable JJ O
to TO O
bind NN O
azido-ATP. . O

-DOCSTART- X X O

Therefore RB O
, , O
with IN O
a DT O
biopsy NN O
from IN O
the DT O
stoma NN O
site NN O
there RB O
is VBZ O
a DT O
risk NN O
of IN O
missing VBG O
early JJ O
rejection NN O
. . O

-DOCSTART- X X O

Tissues NNPS O
and CC O
exudates NNS O
contain VBP O
sufficient JJ O
thymidine NN O
for IN O
growth NN O
of IN O
anaerobic JJ O
bacteria NNS O
in IN O
the DT O
presence NN O
of IN O
inhibitory JJ O
levels NNS O
of IN O
trimethoprim-sulfamethoxazole NN O
. . O

-DOCSTART- X X O

In IN O
a DT O
similar JJ O
experiment NN O
, , O
simultaneous JJ O
nitrofurazone NN O
administration NN O
and CC O
S. NNP O
enteritidis VBD O
challenge NN O
resulted VBD O
in IN O
no DT O
significant JJ O
differences NNS O
in IN O
S. NNP O
enteritidis VBD O
isolation NN O
frequency NN O
. . O

-DOCSTART- X X O

Incidence NN O
rate NN O
ranging VBG O
between IN O
122/100,000/year JJ O
and CC O
190/100,000/year JJ O
were VBD O
found VBN O
( -LRB- O
minimum NN O
, , O
estimated VBN O
and CC O
raw JJ O
datasets NNS O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
identified VBD O
a DT O
protein NN O
, , O
termed VBD O
NFIL-1 JJ B-NP
beta NN I-NP
A DT I-NP
( -LRB- O
NF NNP B-NP
beta NN I-NP
A) NNP I-NP
, , O
that IN O
binds NNS O
to TO O
a DT O
highly RB O
conserved VBN O
12-bp JJ O
DNA NNP O
sequence NN O
(-49 . O
to TO O
-38 DT O
) -RRB- O
located VBN O
upstream RB O
of IN O
the DT O
TATA NNP O
box NN O
motif NN O
in IN O
both DT O
the DT O
human JJ B-NP
and CC I-NP
murine JJ I-NP
IL-1 NN I-NP
beta NN I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

We PRP O
tried VBD O
amphotericin RB O
B NNP O
( -LRB- O
AmB) NNP O
, , O
and CC O
remission NN O
of IN O
the DT O
tumor NN O
was VBD O
obtained VBN O
. . O

-DOCSTART- X X O

Cutis NNP O
aplasia NN O
. . O

-DOCSTART- X X O

The DT O
DRF-2 NN B-NP
nuclear JJ I-NP
protein NN I-NP
has VBZ O
characteristics NNS O
similar JJ O
to TO O
those DT O
of IN O
the DT O
muscle-specific JJ O
regulatory JJ O
factor NN O
, , O
MEF-2 NNP B-NP
( -LRB- O
Buskin NNP O
and CC O
Hauschka NNP O
1989 CD O
; : O
Gossett NNP O
et NNP O
al NN O
. . O
, , O
1989 CD O
) -RRB- O
. . O

-DOCSTART- X X O

From IN O
the DT O
15-kb JJ O
clone NN O
a DT O
4-kb JJ B-NP
EcoRI NNP I-NP
fragment NN I-NP
containing VBG O
the DT O
first JJ O
two CD O
exons NNS O
and CC O
2.6 CD O
kb NN O
of IN O
the DT O
5' JJ O
flanking JJ O
region NN O
of IN O
the DT O
opn JJ B-NP
gene NN I-NP
was VBD O
sequenced VBN O
, , O
and CC O
the DT O
transcriptional JJ O
start NN O
site NN O
determined VBN O
by IN O
primer JJ O
extension NN O
analysis NN O
and CC O
S1 JJ B-NP
nuclease NN I-NP
mapping NN O
. . O

-DOCSTART- X X O

Production NN O
costs NNS O
included VBD O
feed NN O
, , O
non-feed JJ O
operating NN O
, , O
fixed VBN O
, , O
and CC O
replacement NN O
stock NN O
costs NNS O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
a DT O
patient JJ O
developing VBG O
factor NN B-NP
VII NNP I-NP
inhibitor VBZ I-NP
possibly RB O
as IN O
a DT O
reaction NN O
to TO O
penicillin VB O
administration NN O
; : O
it PRP O
gave VBD O
rise NN O
to TO O
fatal JJ O
haemorrhage NN O
. . O

-DOCSTART- X X O

This DT O
is VBZ O
in IN O
contrast NN O
with IN O
the DT O
classical JJ O
'oxygen JJ O
debt NN O
hypothesis' NNS O
, , O
which WDT O
states VBZ O
that IN O
the DT O
oxygen NN O
debt NN O
and CC O
lactate NN O
clearance NN O
are VBP O
linked VBN O
. . O

-DOCSTART- X X O

The DT O
clinical JJ O
application NN O
of IN O
the DT O
antibody-targeted JJ O
Phthalocyanine NNP O
was VBD O
performed VBN O
in IN O
3 CD O
patients NNS O
suffering VBG O
from IN O
an DT O
advanced JJ O
ovarian JJ O
carcinoma NN O
( -LRB- O
FIGO NNP O
III NNP O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
lung NN O
cancer NN O
tissues NNS O
of IN O
positive JJ O
67Ga CC O
scan JJ O
expressed VBN O
TFR NN B-NP
, , O
but CC O
those DT O
of IN O
a DT O
negative JJ O
scan NN O
did VBD O
not RB O
. . O

-DOCSTART- X X O

This DT O
open JJ O
reading NN O
frame NN O
was VBD O
confirmed VBN O
the DT O
correct JJ O
one CD O
by IN O
direct JJ O
amino-terminal JJ O
sequence NN O
analysis NN O
of IN O
the DT O
overproduced VBN O
msgB NN B-NP
gene NN I-NP
product NN I-NP
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
purified VBD O
and CC O
characterized VBD O
the DT O
recombinant NN B-NP
furin NN I-NP
from IN O
the DT O
conditioned JJ O
medium NN O
of IN O
these DT O
cells NNS O
. . O

-DOCSTART- X X O

Altogether IN O
these DT O
results NNS O
indicate VBP O
that IN O
the DT O
Syn NNP B-NP
5 CD I-NP
locus NN I-NP
segregates NNS O
from IN O
the DT O
gene NN O
specifying JJ O
gH NNS B-NP
, , O
to TO O
a DT O
region NN O
encompassing VBG O
portions NNS O
of IN O
the DT O
TK NNP B-NP
and CC O
UL NNP B-NP
24 CD I-NP
genes NNS I-NP
, , O
and CC O
that IN O
the DT O
syn NN B-NP
mutation NN I-NP
does VBZ O
not RB O
affect VB O
the DT O
expression NN O
or CC O
activity NN O
of IN O
TK. NNP B-NP

-DOCSTART- X X O

Nucleoprotein NNP O
( -LRB- O
N NNP O
) -RRB- O
expressed VBN O
by IN O
both DT O
recombinant JJ O
vaccinia NN O
virus NN O
and CC O
TGEV NNP O
had VBD O
a DT O
relative JJ O
molecular JJ O
mass NN O
( -LRB- O
Mr) NNP O
of IN O
47,000 CD O
and CC O
was VBD O
susceptible JJ O
to TO O
degradation NN O
at IN O
the DT O
C-terminus NN O
yielding VBG O
discrete JJ O
breakdown NN O
products NNS O
. . O

-DOCSTART- X X O

Recently RB O
, , O
the DT O
3.6-kb JJ B-NP
full-length JJ I-NP
alpha-GalNAc NN I-NP
cDNA NN I-NP
sequence NN I-NP
was VBD O
isolated VBN O
and CC O
found VBN O
to TO O
have VB O
remarkable JJ O
nucleotide NN O
and CC O
predicted VBD O
amino IN O
acid NN O
homology NN O
( -LRB- O
55.8 CD O
and CC O
46.9 CD O
% NN O
, , O
respectively RB O
) -RRB- O
with IN O
the DT O
human NN B-NP
alpha-galactosidase NN I-NP
A DT I-NP
( -LRB- O
alpha-Gal NN B-NP
A) JJ I-NP
cDNA NN O
. . O

-DOCSTART- X X O

Patients NNS O
with IN O
an DT O
enzymatic JJ O
activity NN O
below IN O
X--1 NN O
manifested VBD O
a DT O
decrease NN O
of IN O
the DT O
content NN O
of IN O
IgA NNP B-NP
, , O
IgG NNP B-NP
, , O
IgM NNP B-NP
, , O
T NNP O
and CC O
B NNP O
lymphocytes NNS O
, , O
and CC O
of IN O
phagocytic JJ O
activity NN O
of IN O
neutrophils NNS O
as IN O
compared VBN O
to TO O
patients NNS O
exhibiting VBG O
a DT O
high JJ O
enzymatic JJ O
activity NN O
. . O

-DOCSTART- X X O

The DT O
reason NN O
that IN O
nitrous JJ O
oxide NN O
does VBZ O
not RB O
produce VB O
hydroxyl JJ O
radicals NNS O
readily RB O
might MD O
be VB O
that IN O
the DT O
one-electron JJ O
reduction NN O
proceeds VBZ O
through IN O
an DT O
N2O- NNP O
intermediate JJ O
which WDT O
is VBZ O
energetically RB O
very RB O
unfavourable JJ O
: : O
EO NN O
( -LRB- O
N2O/N2O-) JJ O
= SYM O
-1.1 JJ O
V. NNP O

-DOCSTART- X X O

All DT O
mutant JJ B-NP
JCV NNP I-NP
T NNP I-NP
antigens VBZ I-NP
bound VBN O
to TO O
JCV NNP O
and CC O
SV40 DT O
origins NNS O
of IN O
DNA NNP O
replication NN O
. . O

-DOCSTART- X X O

The DT O
relation NN O
between IN O
myocardial JJ B-NP
beta-adrenergic JJ I-NP
receptor NN I-NP
and CC O
left VBD O
ventricular JJ O
( -LRB- O
LV NN O
) -RRB- O
function NN O
was VBD O
studied VBN O
in IN O
10 CD O
patients NNS O
, , O
aged VBN O
41 CD O
to TO O
61 CD O
years NNS O
(average JJ O
51 CD O
) -RRB- O
, , O
with IN O
LV NNP O
volume NN O
overload NN O
mainly RB O
due JJ O
to TO O
chronic JJ O
mitral JJ O
regurgitation NN O
. . O

-DOCSTART- X X O

Since IN O
each DT O
transcript NN O
appears VBZ O
to TO O
encode VB O
the DT O
same JJ O
protein NN O
, , O
this DT O
complexity NN O
may MD O
reflect VB O
the DT O
need NN O
for IN O
lineage-specific JJ O
or CC O
differentiation-dependent JJ O
control NN O
of IN O
expression NN O
. . O

-DOCSTART- X X O

In IN O
patients NNS O
with IN O
limited JJ O
disease NN O
, , O
the DT O
survival NN O
in IN O
the DT O
alternating NN O
arm NN O
was VBD O
significantly RB O
superior JJ O
to TO O
the DT O
survival NN O
in IN O
the DT O
CAV NN O
arm NN O
( -LRB- O
P NNP O
= SYM O
.014 CD O
) -RRB- O
or CC O
the DT O
survival NN O
in IN O
the DT O
PE NN O
arm NN O
( -LRB- O
P NNP O
= SYM O
.023 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Transfecting VBG O
the DT O
cloned JJ O
bovine NN O
PBR/IBP NNP B-NP
cDNA . O
into IN O
COS-7 JJ O
cells NNS O
resulted VBN O
in IN O
an DT O
11-fold JJ O
increase NN O
in IN O
the DT O
density NN O
of IN O
high JJ O
affinity NN O
[3H]PK IN O
11195 CD O
binding NN O
sites NNS O
which WDT O
had VBD O
only RB O
low JJ O
affinity NN O
for IN O
Ro5-4864 NNP O
. . O

-DOCSTART- X X O

The DT O
initial JJ O
phase NN O
of IN O
increased VBN O
vascular JJ O
permeability NN O
in IN O
the DT O
peritoneal NN O
cavity NN O
and CC O
LTB4 DT O
production NN O
was VBD O
dose NN O
dependently RB O
inhibited VBN O
by IN O
the DT O
5-LO JJ O
inhibitors NNS O
phenidone VBN O
, , O
BW NNP O
A4C NNP O
, , O
A63162 NNP O
, , O
and CC O
ICI NNP O
207 CD O
968 CD O
but CC O
not RB O
by IN O
dexamethasone NN O
or CC O
colchicine NN O
. . O

-DOCSTART- X X O

Discrepant JJ O
results NNS O
with IN O
a DT O
latex JJ O
agglutination NN O
test NN O
in IN O
the DT O
assessment NN O
of IN O
cytomegalovirus NN O
antibody NN O
status NN O
of IN O
cardiac NN O
transplant NN O
donors NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
identified VBN O
SWI5 PRP B-NP
's POS O
nuclear JJ O
localization NN O
signal NN O
( -LRB- O
NLS NNP O
) -RRB- O
and CC O
show VB O
that IN O
it PRP O
can MD O
confer VB O
cell NN O
cycle-dependent JJ O
nuclear JJ O
entry NN O
to TO O
a DT O
heterologous JJ O
protein NN O
. . O

-DOCSTART- X X O

We PRP O
did VBD O
not RB O
detect VB O
p50 NN B-NP
in IN O
association NN O
with IN O
native JJ B-NP
glucocorticoid NN I-NP
receptor NN I-NP
in IN O
L NNP O
cells NNS O
or CC O
with IN O
the DT O
overexpressed JJ O
glucocorticoid NN B-NP
receptor NN I-NP
in IN O
Chinese JJ O
hamster NN O
ovary NN O
cells NNS O
. . O

-DOCSTART- X X O

TPA NNP O
and CC O
TGF-beta NNP B-NP
1 CD I-NP
did VBD O
not RB O
markedly RB O
affect VB O
the DT O
activities NNS O
of IN O
the DT O
72-kDa JJ O
enzyme NN O
. . O

-DOCSTART- X X O

They PRP O
were VBD O
almost RB O
regularly RB O
excited VBN O
by IN O
pressure NN O
to TO O
the DT O
ipsilateral JJ O
cornea NN O
or CC O
to TO O
both DT O
corneas NNS O
at IN O
a DT O
strength NN O
well RB O
above IN O
the DT O
human NN O
corneal NN O
pain NN O
threshold NN O
. . O

-DOCSTART- X X O

Alignment NNP O
of IN O
the DT O
amino JJ O
acid NN O
sequences NNS O
surrounding VBG O
Tyr-766 NNP O
with IN O
corresponding JJ O
regions NNS O
of IN O
other JJ O
FGFRs NNS B-NP
revealed VBD O
conserved VBN O
tyrosine NN O
residues NNS O
in IN O
all DT O
known VBN O
members NNS O
of IN O
the DT O
FGFR NNP B-NP
family NN I-NP
. . O

-DOCSTART- X X O

The DT O
transcription NN O
initiation NN O
site NN O
was VBD O
determined VBN O
to TO O
occur VB O
66 CD O
bp NN O
upstream RB O
of IN O
the DT O
initiating NN O
Met NNP O
. . O

-DOCSTART- X X O

All DT O
anti-I JJ B-NP
and CC O
anti-i JJ B-NP
CA NNP I-NP
were VBD O
shown VBN O
to TO O
express VB O
VH4 IN B-NP
heavy JJ I-NP
chains NNS I-NP
, , O
and CC O
14 CD O
of IN O
17 CD O
CA NNP B-NP
expressed VBD O
a DT O
previously RB O
described VBN O
VH4 IN B-NP
second JJ O
hypervariable JJ O
region NN O
determinant NN O
, , O
termed VBD O
VH4-HV2a NNP B-NP
. . O

-DOCSTART- X X O

Intron NNP O
K1 NNP B-NP
cox1.2 NN I-NP
is VBZ O
not RB O
found VBN O
in IN O
S. NNP O
cerevisiae NN O
and CC O
appears VBZ O
at IN O
an DT O
unique JJ O
location NN O
in IN O
K. NNP O
lactis NN O
. . O

-DOCSTART- X X O

However RB O
, , O
alterations NNS O
in IN O
electrostatic JJ O
and CC O
hydrophobic JJ O
interactions NNS O
created VBN O
by IN O
the DT O
three CD O
amino IN O
acid NN O
substitutions NNS O
prevent VBP O
the DT O
conformational JJ O
change NN O
in IN O
the DT O
enzyme NN O
usually RB O
produced VBN O
by IN O
calmodulin NN B-NP
binding NN O
. . O

-DOCSTART- X X O

The DT O
nucleotide JJ O
sequences NNS O
at IN O
the DT O
5' JJ O
and CC O
3' JJ O
ends NNS O
of IN O
these DT O
introns NNS O
are VBP O
characteristic JJ O
of IN O
spliced JJ O
transcripts NNS O
from IN O
eukaryotic JJ O
protein-encoding JJ O
genes NNS O
, , O
with IN O
one CD O
significant JJ O
difference NN O
; : O
i IN O
.e NN O
. . O
, , O
the DT O
5' JJ O
end NN O
of IN O
the DT O
LAT JJ B-NP
intron NN I-NP
is VBZ O
GC NNP O
instead RB O
of IN O
the DT O
consensus NN O
sequence NN O
GT. . O

-DOCSTART- X X O

Two CD O
independent JJ O
promoters NNS O
as RB O
well RB O
as IN O
5' JJ O
untranslated JJ O
regions NNS O
regulate VB O
Dd JJ B-NP
ras NNS I-NP
expression NN O
in IN O
Dictyostelium NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
suggested VBD O
that IN O
, , O
depending VBG O
upon IN O
the DT O
cell NN O
type NN O
, , O
gene NN O
cotransfer NN O
using VBG O
aminoglycoside JJ O
resistance NN O
as IN O
a DT O
selectable JJ O
marker NN O
may MD O
seriously RB O
perturb VB O
important JJ O
cellular JJ O
control NN O
mechanisms NNS O
such JJ O
as IN O
the DT O
PKC NNP B-NP
pathway NN O
leading VBG O
to TO O
activation NN O
of IN O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

Transfer NNP O
RNA NNP O
genes NNS O
from IN O
Dictyostelium NNP O
discoideum NN O
are VBP O
frequently RB O
associated VBN O
with IN O
repetitive JJ O
elements NNS O
and CC O
contain VBP O
consensus NN O
boxes NNS O
in IN O
their PRP$ O
5' JJ O
and CC O
3'-flanking JJ O
regions NNS O
. . O

-DOCSTART- X X O

The DT O
factor NN O
which WDT O
binds VBZ O
to TO O
the DT O
TR NN B-NP
promoter NN I-NP
co-sedimented JJ O
with IN O
SV40 DT O
chromosomes NNS O
extracted VBN O
late RB O
in IN O
infection NN O
. . O

-DOCSTART- X X O

The DT O
patient NN O
with IN O
a DT O
prolonged JJ O
fever NN O
caused VBN O
by IN O
dissecting VBG O
aneurysm NN O
of IN O
the DT O
aorta NN O
in IN O
whom WP O
pleuropneumonia NN O
masked VBD O
the DT O
real JJ O
diseases NNS O
has VBZ O
been VBN O
presented VBN O
. . O

-DOCSTART- X X O

The DT O
resulting VBG O
clone NN O
pKB11 NN B-NP
, , O
which WDT O
has VBZ O
a DT O
1369-base JJ O
pair NN O
( -LRB- O
bp NN O
) -RRB- O
cDNA NN O
insert NN O
, , O
overlapping VBG O
pCAD142 NN B-NP
by IN O
781 CD O
bp NN O
, , O
was VBD O
identified VBN O
by IN O
hybridization NN O
methods NNS O
and CC O
sequence NN O
analysis NN O
and CC O
found VBD O
to TO O
contain VB O
the DT O
entire JJ O
cDNA NN O
sequence NN O
for IN O
the DT O
amino JJ O
end NN O
of IN O
the DT O
CAD NN B-NP
polypeptide NN I-NP
. . O

-DOCSTART- X X O

This DT O
conclusion NN O
was VBD O
confirmed VBN O
by IN O
Northern NNP O
blotting VBG O
analysis NN O
of IN O
the DT O
5'-flanking JJ O
region NN O
of IN O
CAD NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

We PRP O
report VBP O
the DT O
isolation NN O
of IN O
genomic JJ O
and CC O
cDNA JJ O
clones NNS O
of IN O
the DT O
light-independent JJ O
Sn NNP B-NP
: : I-NP
bol3 JJ I-NP
allele NN I-NP
. . O

-DOCSTART- X X O

Its PRP$ O
clearance NN O
has VBZ O
been VBN O
found VBN O
to TO O
be VB O
decreased VBN O
(typically RB O
by IN O
around RB O
25 CD O
% NN O
, , O
but CC O
often RB O
by IN O
far RB O
more RBR O
) -RRB- O
by IN O
erythromycin NN O
, , O
troleandomycin NN O
( -LRB- O
triacetyloleandomycin NN O
) -RRB- O
, , O
roxithromycin NNP O
, , O
enoxacin RB O
, , O
ciprofloxacin NN O
, , O
pefloxacin RB O
, , O
norfloxacin RB O
, , O
ofloxacin NNP O
, , O
fluoroquinolone NN O
T-3262 NNS O
, , O
pipemidic JJ O
acid NN O
, , O
cimetidine NN O
, , O
etintidine NN O
, , O
propranolol NN O
, , O
verapamil NN O
, , O
diltiazem NN O
, , O
nifedipine NN O
, , O
furosemide NN O
( -LRB- O
frusemide NN O
) -RRB- O
, , O
at IN O
least JJS O
some DT O
anovulent JJ O
agents NNS O
, , O
viloxazine NN O
, , O
allopurinol NN O
, , O
ticlopidine NN O
, , O
idrocilamide NN O
, , O
thiabendazole NN O
, , O
disulfiram NN O
, , O
influenza FW O
- : O
and CC O
BCG-vaccination NNP O
, , O
interferon NN B-NP
, , O
and CC O
caffeine NN O
( -LRB- O
half-life NN O
increase NN O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
third JJ O
is VBZ O
a DT O
partial JJ O
element NN O
terminating NN O
at IN O
a DT O
probable JJ O
internal JJ O
restriction NN O
site NN O
used VBN O
for IN O
cloning NN O
. . O

-DOCSTART- X X O

We PRP O
enrolled VBD O
253 CD O
HIV-antibody NN B-NP
positive JJ O
heroin NN O
addicts NNS O
without IN O
HIV-related JJ O
disease NN O
( -LRB- O
n NN O
= SYM O
81 CD O
) -RRB- O
or CC O
with IN O
persistent JJ O
generalized JJ O
lymphadenopathy NN O
( -LRB- O
n NN O
= SYM O
172 CD O
) -RRB- O
in IN O
a DT O
prospective JJ O
study NN O
to TO O
evaluate VB O
clinical JJ O
progression NN O
to TO O
AIDS NNP O
related VBN O
complex NN O
( -LRB- O
ARC NNP O
) -RRB- O
or CC O
AIDS NNP O
and CC O
to TO O
identify VB O
factors NNS O
of IN O
possible JJ O
prognostic JJ O
relevance NN O
. . O

-DOCSTART- X X O

No DT O
homology NN O
was VBD O
found VBN O
between IN O
RNA14 NNP B-NP
and CC O
RNA15 NNP B-NP
or CC O
between IN O
RNA14 NNP B-NP
and CC O
other JJ O
proteins NNS O
contained VBN O
in IN O
data NNS O
banks NNS O
. . O

-DOCSTART- X X O

Mutations NNS O
in IN O
the DT O
yeast NN B-NP
RNA14 NNP I-NP
and CC O
RNA15 DT B-NP
genes NNS I-NP
result VBP O
in IN O
an DT O
abnormal JJ O
mRNA NN O
decay NN O
rate NN O
; : O
sequence NN O
analysis NN O
reveals VBZ O
an DT O
RNA-binding JJ O
domain NN O
in IN O
the DT O
RNA15 NNP B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

The DT O
most RBS O
striking JJ O
difference NN O
in IN O
the DT O
birch NN B-NP
NAD( NNP I-NP
P)H-NR NNP I-NP
sequence NN I-NP
in IN O
comparison NN O
to TO O
NADH-NR NNP B-NP
sequences NNS I-NP
was VBD O
found VBN O
at IN O
the DT O
putative JJ O
pyridine NN O
nucleotide JJ O
binding JJ O
site NN O
. . O

-DOCSTART- X X O

A DT O
single JJ O
amino JJ O
acid NN O
difference NN O
in IN O
the DT O
C-terminal JJ O
region NN O
influences VBZ O
dominant JJ O
negative JJ O
activity NN O
and CC O
receptor NN O
dimer NN O
formation NN O
. . O

-DOCSTART- X X O

No DT O
such JJ O
benefits NNS O
were VBD O
seen VBN O
for IN O
children NNS O
with IN O
CD4+ PRP B-NP
counts VBZ O
below IN O
0.2 CD O
x NN O
10(9 CD O
) -RRB- O
per IN O
liter NN O
at IN O
entry NN O
. . O

-DOCSTART- X X O

Because IN O
the DT O
human JJ B-NP
Antp NNP I-NP
TATAA NNP I-NP
binding JJ I-NP
protein NN I-NP
is VBZ O
expressed VBN O
in IN O
both DT O
lymphoid JJ O
and CC O
non-lymphoid JJ O
cells NNS O
, , O
we PRP O
suggest VBP O
that IN O
this DT O
homeobox NN B-NP
gene NN I-NP
has VBZ O
evolved VBN O
a DT O
more RBR O
general JJ O
transcriptional JJ O
regulatory JJ O
function NN O
in IN O
higher JJR O
eukaryotic JJ O
cells NNS O
. . O

-DOCSTART- X X O

Among IN O
953 CD O
infants NNS O
in IN O
22 CD O
neonatal JJ O
care NN O
units NNS O
studied VBD O
, , O
23 CD O
% NN O
( -LRB- O
median JJ O
value NN O
, , O
range NN O
0-78 CD O
) -RRB- O
were VBD O
found VBN O
to TO O
be VB O
faecally RB O
colonized VBN O
with IN O
one CD O
of IN O
21 CD O
distinct JJ O
nosocomial JJ O
strains NNS O
of IN O
Escherichia NNP O
coli NNS O
, , O
Klebsiella NNP O
or CC O
Enterobacter NNP O
spp NN O
. . O

-DOCSTART- X X O

Biochemical JJ O
studies NNS O
revealed VBD O
the DT O
expected JJ O
loss NN O
of IN O
ChAT JJ B-NP
activity NN O
in IN O
the DT O
dorsal JJ O
and CC O
ventral JJ O
hippocampi NN O
of IN O
lesioned JJ O
animals NNS O
along IN O
with IN O
elevated JJ O
levels NNS O
of IN O
norepinephrine NN O
( -LRB- O
NE NNP O
) -RRB- O
in IN O
the DT O
dorsal JJ O
hippocampus NN O
of IN O
MS/HSI NNP O
animals NNS O
.(ABSTRACT . O
TRUNCATED NN O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

The DT O
localization NN O
of IN O
this DT O
proteoglycan JJ O
locus NN O
in IN O
the DT O
human JJ O
genome NN O
and CC O
the DT O
availability NN O
of IN O
new JJ O
RFLPs NNS O
provide VBP O
the DT O
tools NNS O
for IN O
future JJ O
studies NNS O
of IN O
human JJ O
diseases NNS O
where WRB O
the DT O
HSPG2 NNP B-NP
proteoglycan NN I-NP
gene NN I-NP
is VBZ O
suspected VBN O
to TO O
be VB O
involved VBN O
. . O

-DOCSTART- X X O

After IN O
2 CD O
min NN O
of IN O
dobutamine NN O
injection NN O
, , O
or CC O
after IN O
20 CD O
min NN O
of IN O
pimobendan NN O
injection NN O
, , O
the DT O
myocardium NN O
was VBD O
removed VBN O
, , O
and CC O
used VBD O
for IN O
determination NN O
of IN O
the DT O
tissue NN O
levels NNS O
of IN O
metabolites NNS O
of IN O
energy NN O
and CC O
carbohydrate NN O
metabolism NN O
. . O

-DOCSTART- X X O

In IN O
a DT O
country NN O
where WRB O
general JJ O
HIV NNP O
prevalence NN O
is VBZ O
low JJ O
, , O
the DT O
strategy NN O
is VBZ O
cost-effective JJ O
for IN O
location NN O
and CC O
counselling NN O
of IN O
unknowingly RB O
seropositive JJ O
individuals NNS O
. . O

-DOCSTART- X X O

The DT O
cis-acting JJ O
element NN O
mediating VBG O
glucocorticoid JJ O
inducibility NN O
of IN O
the DT O
chicken NN B-NP
glutamine NN I-NP
synthetase NN I-NP
gene NN I-NP
has VBZ O
been VBN O
identified VBN O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
increase NN O
in IN O
biliary JJ O
excretion NN O
did VBD O
not RB O
compensate VB O
for IN O
the DT O
reduced JJ O
elimination NN O
of IN O
bretylium NN O
and CC O
hexylsalicylic JJ O
acid NN O
via IN O
the DT O
kidney NN O
. . O

-DOCSTART- X X O

Diagnostic JJ O
value NN O
of IN O
cerebrospinal JJ B-NP
fluid NN I-NP
immunoglobulin NN I-NP
G NNP I-NP
( -LRB- O
IgG NN B-NP
) -RRB- O
in IN O
pediatric JJ O
neurological JJ O
diseases NNS O
. . O

-DOCSTART- X X O

Venkatesan NNP O
, , O
and CC O
D. NNP O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
the DT O
corresponding JJ O
mature JJ O
mRNA NN O
transcripts NNS O
( -LRB- O
3.2-3.5 CD O
kilobase NN O
pairs NNS O
(kb , O
] SYM O
in IN O
human JJ O
fibroblasts NNS O
was VBD O
shown VBN O
by IN O
Northern JJ O
blot NN O
hybridization NN O
, , O
S1 NNP B-NP
nuclease , I-NP
protection NN O
assay NN O
, , O
and CC O
the DT O
polymerase NN O
chain NN O
reaction NN O
. . O

-DOCSTART- X X O

Gap NNP B-NP
b3 CD I-NP
consists VBZ O
of IN O
two CD O
polypeptide NN O
chains NNS O
( -LRB- O
Mr NNP O
= SYM O
110,000 CD O
and CC O
30,000 CD O
) -RRB- O
, , O
which WDT O
seem VBP O
to TO O
be VB O
proteolytic JJ O
cleavage JJ O
products NNS O
connected VBN O
by IN O
disulfide JJ O
bonds NNS O
from IN O
a DT O
precursor JJ O
protein NN O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
rtFc NN B-NP
gamma NN I-NP
R NN I-NP
alpha NN I-NP
cDNA NN I-NP
clone NN O
is VBZ O
complementary JJ O
to TO O
at IN O
least JJS O
two CD O
different-sized JJ O
mRNAs NNS O
expressed VBN O
by IN O
CRNK-16 NNP O
cells NNS O
, , O
contrasting VBG O
the DT O
single JJ O
Fc JJ B-NP
gamma NN I-NP
R-related JJ I-NP
mRNA NN I-NP
species NNS O
expressed VBN O
by IN O
human NN O
and CC O
mouse NN O
natural JJ O
killer NN O
cells NNS O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
human JJ O
myeloid JJ O
cell NN O
lines NNS O
HL-60 . O
and CC O
U937 JJ O
with IN O
phorbol NN O
12-myristate JJ O
13-acetate JJ O
( -LRB- O
PMA NN O
) -RRB- O
increased VBN O
within IN O
2 CD O
h JJ O
cellular JJ O
levels NNS O
of IN O
the DT O
RNA NNP O
hybridizable JJ O
to TO O
LD78 VB B-NP
cDNA NN I-NP
. . O

-DOCSTART- X X O

Serum NNP O
IgG NNP B-NP
was VBD O
initially RB O
elevated VBN O
in IN O
6 CD O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
patient NN O
initially RB O
attained VBD O
complete JJ O
remission NN O
( -LRB- O
CR1 NNP O
) -RRB- O
with IN O
conventional JJ O
chemotherapy NN O
and CC O
then RB O
relapsed VBD O
14 CD O
months NNS O
later RB O
. . O

-DOCSTART- X X O

157 CD O
+/ NNS O
- : O
16 CD O
mg/dl NN O
; : O
NS) NNP O
, , O
glucose NN O
levels NNS O
, , O
and CC O
basal NN O
( -LRB- O
17 CD O
+/ NN O
- : O
4 CD O
vs. NN O

-DOCSTART- X X O

Platelet NNP O
aggregation NN O
and CC O
metabolic JJ O
control NN O
are VBP O
not RB O
affected VBN O
by IN O
calcium NN O
antagonist NN O
treatment NN O
in IN O
type NN O
II NNP O
diabetes NN O
mellitus NN O
. . O

-DOCSTART- X X O

Induction NN O
of IN O
Jurkat NNP O
leukemic JJ O
T NNP O
cells NNS O
with IN O
phorbol JJ O
12-myristate JJ O
13-acetate JJ O
and CC O
ionomycin JJ O
did VBD O
not RB O
affect VB O
the DT O
level NN O
of IN O
FKBP NNP B-NP
mRNA NN I-NP
. . O

-DOCSTART- X X O

GLUT5 DT B-NP
mRNA NN I-NP
is VBZ O
expressed VBN O
at IN O
highest JJS O
levels NNS O
in IN O
small JJ O
intestine NN O
and CC O
at IN O
much RB O
lower JJR O
levels NNS O
in IN O
kidney NN O
, , O
skeletal NN O
muscle NN O
, , O
and CC O
adipose VB O
tissue NN O
. . O

-DOCSTART- X X O

e NN O
. . O

-DOCSTART- X X O

Surprisingly RB O
, , O
there EX O
is VBZ O
no DT O
sequence NN O
homology NN O
between IN O
this DT O
region NN O
of IN O
Ly-6E NNP B-NP
and CC O
the DT O
established VBN O
consensus NN O
for IN O
the DT O
interferon-stimulated JJ B-NP
response NN I-NP
element NN I-NP
, , O
which WDT O
has VBZ O
been VBN O
shown VBN O
functionally RB O
important JJ O
to TO O
all DT O
previously RB O
characterized VBN O
alpha/beta NN B-NP
interferon-inducible JJ I-NP
promoters NNS O
. . O

-DOCSTART- X X O

Relatively RB O
large JJ O
DNA NN O
rearrangements NNS O
spanning VBG O
the DT O
region NN O
with IN O
tandem NN O
direct JJ O
repeats NNS O
encoding VBG O
the DT O
carboxy-terminal JJ O
histone NN B-NP
H1-like JJ I-NP
structure NN O
of IN O
AlgP NNP B-NP
were VBD O
detected VBN O
in IN O
several JJ O
strains NNS O
upon IN O
conversion NN O
from IN O
the DT O
mucoid NN O
to TO O
the DT O
nonmucoid JJ O
phenotype NN O
. . O

-DOCSTART- X X O

( -LRB- O
1988 CD O
) -RRB- O
J. NNP O

-DOCSTART- X X O

These DT O
results NNS O
strongly RB O
suggested VBD O
that IN O
similar JJ O
, , O
if IN O
not RB O
identical JJ O
, , O
the DT O
CArG NNP B-NP
box NN I-NP
binding JJ I-NP
proteins NNS I-NP
interact NN O
with IN O
the DT O
functionally RB O
different JJ O
promoter NN O
element NN O
in IN O
the DT O
VLC1 NNP B-NP
, , O
cardiac JJ B-NP
alpha-actin NN I-NP
, , O
and CC O
c-fos JJ B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

Co-existence NN O
of IN O
these DT O
regulatory JJ O
elements NNS O
with IN O
other JJ O
elements NNS O
, , O
such JJ O
as IN O
the DT O
AP-2 JJ B-NP
element NN I-NP
or CC O
CCAAT NN O
box NN O
, , O
was VBD O
also RB O
found VBN O
. . O

-DOCSTART- X X O

Recently RB O
, , O
studies NNS O
of IN O
agents NNS O
that WDT O
disrupt VB O
collagen NN B-NP
synthesis NN O
and CC O
deposition NN O
have VBP O
yielded VBN O
several JJ O
new JJ O
angiogenesis NN O
inhibitors NNS O
. . O

-DOCSTART- X X O

Since IN O
the DT O
5'-flanking JJ O
region NN O
of IN O
this DT O
gene NN O
is VBZ O
likely JJ O
involved VBN O
in IN O
hormonal JJ O
regulation NN O
of IN O
its PRP$ O
expression NN O
, , O
we PRP O
have VBP O
isolated VBN O
and CC O
partially RB O
characterized VBD O
an DT O
avian JJ O
fatty JJ B-NP
acid NN I-NP
synthase NN I-NP
gene NN O
. . O

-DOCSTART- X X O

A DT O
new JJ O
set NN O
of IN O
cDNA NN O
clones NNS O
spanning VBG O
approximately RB O
3.2 CD O
kb NN O
was VBD O
isolated VBN O
from IN O
a DT O
lambda-ZAP JJ O
goose NN O
liver NN O
cDNA NN O
library NN O
using VBG O
the DT O
5'-most JJ O
exon-containing JJ O
fragment NN O
of IN O
the DT O
5'-most JJ O
genomic JJ O
DNA NN O
clone NN O
. . O

-DOCSTART- X X O

Northern JJ O
blotting VBG O
analysis NN O
indicates VBZ O
that IN O
expression NN O
of IN O
the DT O
genes NNS O
corresponding JJ O
to TO O
these DT O
clones NNS O
is VBZ O
confined VBN O
to TO O
pollen NN O
tissue NN O
. . O

-DOCSTART- X X O

Whereas IN O
cDNA NN O
hybridization NN O
to TO O
genomic JJ O
DNA NNP O
blots NNS O
indicated VBD O
a DT O
small JJ O
subfamily NN O
of IN O
G0S19 DT B-NP
genes NNS I-NP
, , O
simple JJ O
patterns NNS O
of IN O
bands NNS O
indicated VBD O
that IN O
most JJS O
cDNAs NNS O
, , O
including VBG O
G0S30 DT B-NP
cDNA NN I-NP
, , O
corresponded VBN O
to TO O
single-copy JJ O
genes NNS O
. . O

-DOCSTART- X X O

Lymphoproliferative JJ O
disorders NNS O
arising VBG O
under IN O
immunosuppression NN O
with IN O
FK NNP O
506 CD O
: : O
initial JJ O
observations NNS O
in IN O
a DT O
large JJ O
transplant NN O
population NN O
. . O

-DOCSTART- X X O

Sequence NNP O
determination NN O
of IN O
isolated JJ O
peptides NNS O
suggested VBD O
that IN O
Asn120 NNP O
is VBZ O
glycosylated VBN O
, , O
Asn65 IN O
and CC O
Asn109 IN O
glycosylated VBN O
in IN O
some DT O
molecules NNS O
but CC O
not RB O
in IN O
others NNS O
, , O
and CC O
Asn72 IN O
not RB O
glycosylated VBN O
. . O

-DOCSTART- X X O

Isolation NNP O
and CC O
characterization NN O
of IN O
the DT O
rat NN O
chromosomal NN O
gene NN O
for IN O
a DT O
polypeptide NN O
( -LRB- O
pS1 NN B-NP
) -RRB- O
antigenically RB O
related VBN O
to TO O
statin NN B-NP
. . O

-DOCSTART- X X O

The DT O
proteins NNS O
differ VBP O
in IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
a DT O
21-amino-acid JJ O
sequence NN O
located VBN O
24 CD O
amino IN O
acids NNS O
C NNP O
terminal NN O
of IN O
the DT O
translational JJ O
initiation NN O
codon NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
also RB O
indicate VBP O
the DT O
existence NN O
of IN O
sequences NNS O
downstream IN O
of IN O
-0.11 DT O
kb NN O
which WDT O
can MD O
influence VB O
the DT O
pattern NN O
of IN O
tissue-specific JJ O
expression NN O
of IN O
the DT O
HLA-B7 JJ B-NP
gene NN I-NP
and CC O
the DT O
ability NN O
of IN O
this DT O
gene NN O
to TO O
respond VB O
to TO O
gamma NN B-NP
interferon NN I-NP
. . O

-DOCSTART- X X O

The DT O
SH2 NNP B-NP
and CC O
SH3 NNP B-NP
domains NNS I-NP
of IN O
pp60src JJ B-NP
direct JJ O
stable JJ O
association NN O
with IN O
tyrosine JJ O
phosphorylated JJ O
proteins NNS O
p130 . B-NP
and CC O
p110 PRP B-NP
. . O

-DOCSTART- X X O

Chem NNP O
. . O

-DOCSTART- X X O

These DT O
clones NNS O
overlapped VBD O
and CC O
contained VBD O
the DT O
structural JJ O
gene NN O
encoding VBG O
the DT O
complete JJ O
C5 NNP B-NP
alpha-chain NN I-NP
and CC O
90 CD O
% NN O
of IN O
the DT O
beta-chain NN O
. . O

-DOCSTART- X X O

Heterozygous NNP O
mutation NN O
in IN O
the DT O
G+5 NNP O
position NN O
of IN O
intron JJ O
33 CD O
of IN O
the DT O
pro-alpha JJ B-NP
2( JJ I-NP
I PRP I-NP
) -RRB- I-NP
gene NN I-NP
( -LRB- O
COL1A2 NN B-NP
) -RRB- O
that WDT O
causes VBZ O
aberrant JJ O
RNA NNP O
splicing NN O
and CC O
lethal JJ O
osteogenesis NN O
imperfecta NN O
. . O

-DOCSTART- X X O

The DT O
nucleotide JJ O
sequences NNS O
of IN O
these DT O
genes NNS O
differ VBP O
at IN O
only JJ O
nine CD O
positions NNS O
, , O
resulting VBG O
in IN O
three CD O
amino IN O
acid NN O
differences NNS O
. . O

-DOCSTART- X X O

The DT O
protein NN O
predicted VBN O
by IN O
the DT O
sequence NN O
of IN O
the DT O
human JJ B-NP
pim-1 NN I-NP
proto-oncogene NN I-NP
shares NNS O
extensive JJ O
homology NN O
with IN O
known VBN O
serine/threonine NN B-NP
protein NN I-NP
kinases NNS I-NP
, , O
and CC O
yet RB O
the DT O
human JJ B-NP
Pim-1 NN I-NP
enzyme NN I-NP
has VBZ O
previously RB O
been VBN O
reported VBN O
to TO O
exhibit VB O
protein NN B-NP
tyrosine NN I-NP
kinase NN I-NP
activity NN O
both CC O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

This DT O
report NN O
substantiates VBZ O
that IN O
at IN O
least JJS O
two CD O
of IN O
the DT O
18 CD O
kDa NN O
hsps NNS B-NP
in IN O
maize NN O
are VBP O
products NNS O
of IN O
different JJ O
but CC O
related VBN O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
10 CD O
kDa NN O
polypeptide NN O
was VBD O
phosphorylated VBN O
in IN O
vitro NN O
by IN O
incubating VBG O
wheat NN O
etioplast NN O
membranes NNS O
with IN O
[gamma NNP O
32P] CD O
ATP. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
targeting VBG O
partially RB O
assembled VBN O
Ti NNP B-NP
alpha-beta NN I-NP
CD3 IN B-NP
gamma NN I-NP
delta NN I-NP
epsilon NN I-NP
TCR NNP B-NP
complexes NNS I-NP
to TO O
the DT O
cell NN O
surface NN O
, , O
CD3 IN B-NP
zeta NN I-NP
appears VBZ O
to TO O
be VB O
essential JJ O
for IN O
interleukin-2 JJ B-NP
production NN O
after IN O
TCR NNP B-NP
stimulation NN O
with IN O
antigen/major JJ B-NP
histocompatibility NN I-NP
complex NN I-NP
. . O

-DOCSTART- X X O

When WRB O
desipramine NN O
was VBD O
injected VBN O
16 CD O
hrs NNS O
after IN O
fluoxetine JJ O
injection NN O
, , O
brain NN O
levels NNS O
of IN O
desipramine NN O
were VBD O
no RB O
longer RB O
elevated VBN O
. . O

-DOCSTART- X X O

Opposite IN O
effects NNS O
of IN O
CYP1 NNP B-NP
are VBP O
observed VBN O
in IN O
aerobic JJ O
, , O
heme-sufficient JJ O
cells NNS O
. . O

-DOCSTART- X X O

A DT O
segmental JJ O
analysis NN O
of IN O
the DT O
key JJ O
regions NNS O
of IN O
HLA-DR1 NNP B-NP
that IN O
control NN O
T NNP O
cell NN O
allorecognition NN O
was VBD O
performed VBN O
by IN O
using VBG O
a DT O
series NN O
of IN O
transfected JJ O
cell NN O
lines NNS O
expressing VBG O
the DT O
products NNS O
of IN O
recombinant JJ O
DRB/H-2Eb JJ B-NP
genes NNS O
, , O
paired VBN O
with IN O
either DT O
DR NN B-NP
alpha NN I-NP
or CC O
H-2E JJ B-NP
alpha NN I-NP
. . O

-DOCSTART- X X O

Finally RB O
, , O
some DT O
point NN O
mutations NNS O
in IN O
the DT O
Gag-Pol NNP B-NP
PR NNP O
domain NN O
inhibited VBD O
activation NN O
of IN O
RT NNP B-NP
in IN O
trans NNS O
by IN O
a DT O
wild-type JJ O
PR NNP B-NP
, , O
suggesting VBG O
that IN O
the DT O
correct JJ O
conformation NN O
of IN O
the DT O
PR NNP B-NP
domain NN O
in IN O
Gag-Pol NNP B-NP
is VBZ O
prerequisite JJ O
for IN O
activation NN O
of IN O
RT. NNP B-NP

-DOCSTART- X X O

The DT O
alpha NN B-NP
inhibin NN I-NP
promoter NN I-NP
containing VBG O
a DT O
mutated JJ O
CRE NNP O
was VBD O
not RB O
regulated VBN O
by IN O
forskolin NN O
in IN O
granulosa NN O
cells NNS O
and CC O
did VBD O
not RB O
bind NN O
the DT O
CREB NNP B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
the DT O
nucleotide JJ O
sequences NNS O
between IN O
the DT O
human JJ O
and CC O
bovine JJ O
DNA NN O
showed VBD O
that IN O
the DT O
sequence NN O
similarity NN O
extended VBD O
2400 CD O
bp NN O
downstream NN O
from IN O
the DT O
coding NN O
region NN O
. . O

-DOCSTART- X X O

Cloning NNP O
of IN O
a DT O
human JJ O
cDNA NN O
encoding VBG O
a DT O
CDC2-related JJ B-NP
kinase NN I-NP
by IN O
complementation NN O
of IN O
a DT O
budding VBG B-NP
yeast NN I-NP
cdc28 IN I-NP
mutation NN O
. . O

-DOCSTART- X X O

In IN O
patients NNS O
with IN O
osteomyelitis NNP O
and CC O
joint JJ O
empyema NN O
( -LRB- O
n RB O
= SYM O
48 CD O
) -RRB- O
PMN NNP B-NP
elastase NN I-NP
had VBD O
a DT O
sensitivity NN O
of IN O
77 CD O
% NN O
, , O
which WDT O
was VBD O
only RB O
exceeded VBN O
by IN O
that DT O
of IN O
the DT O
unspecific JJ O
erythrocyte NN O
sedimentation NN O
rate NN O
( -LRB- O
sensitivity NN O
89 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
above JJ O
results NNS O
mean VBP O
that IN O
the DT O
increase NN O
in IN O
alpha-adrenergic JJ B-NP
receptors NNS I-NP
makes VBZ O
the DT O
prostate NN O
, , O
which WDT O
has VBZ O
been VBN O
already RB O
hypertrophied VBN O
, , O
less RBR O
elastic JJ O
, , O
inhibiting JJ O
external JJ O
urinary JJ O
sphincter NN O
function NN O
. . O

-DOCSTART- X X O

Pharmacokinetics NNP O
of IN O
FK NNP O
506 CD O
in IN O
transplant NN O
patients NNS O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
deduced JJ O
amino JJ O
acid NN O
sequence NN O
suggests VBZ O
that IN O
CHIP28 JJ B-NP
protein NN I-NP
contains VBZ O
six CD O
bilayer-spanning JJ O
domains NNS O
, , O
two CD O
exofacial JJ O
potential JJ O
N-glycosylation NN O
sites NNS O
, , O
and CC O
intracellular JJ O
N NNP O
and CC O
C NNP O
termini NNS O
. . O

-DOCSTART- X X O

The DT O
qualitative JJ O
concentrations NNS O
of IN O
HCG NNP B-NP
had VBD O
a DT O
sensitivity NN O
of IN O
37.5 CD O
% NN O
and CC O
a DT O
specificity NN O
of IN O
100 CD O
% NN O
. . O

-DOCSTART- X X O

The DT O
reduced JJ O
rate NN O
of IN O
F NNP O
absorption NN O
and CC O
slower JJR O
rise NN O
in IN O
plasma NN O
F IN O
concentration NN O
accompanying VBG O
delayed VBN O
gastric JJ O
emptying JJ O
indicate VBP O
that IN O
passage NN O
of IN O
F NNP O
into IN O
the DT O
small JJ O
intestine NN O
is VBZ O
the DT O
major JJ O
factor NN O
in IN O
rapid JJ O
F NNP O
absorption NN O
. . O

-DOCSTART- X X O

Epidemiology NNP O
and CC O
prevention NN O
of IN O
hospital NN O
infections NNS O
in IN O
the DT O
Local JJ O
Health NNP O
Unit NN O
of IN O
Sassari NNP O
: : O
profile NN O
of IN O
bacterial JJ O
resistance NN O
and CC O
antimicrobial JJ O
agents NNS O
of IN O
large JJ O
usage NN O
. . O

-DOCSTART- X X O

Max NNP B-NP
: : O
functional JJ O
domains NNS O
and CC O
interaction NN O
with IN O
c-Myc JJ B-NP
. . O

-DOCSTART- X X O

86 CD O
: : O
3199-3203 CD O
) -RRB- O
or CC O
G1 NNP O
to TO O
S NNP O
phase NN O
( -LRB- O
Reilly NNP O
, , O
C. NNP O

-DOCSTART- X X O

Substitutions NNS O
introduced VBD O
at IN O
bases NNS O
surrounding VBG O
the DT O
ICR2 NNP B-NP
motif NN I-NP
yielded VBD O
levels NNS O
of IN O
pRNA NN O
replication NN O
that IN O
differed VBD O
, , O
depending VBG O
on IN O
the DT O
maintenance NN O
of IN O
a DT O
putative JJ O
5' JJ O
stem-loop NN O
structure NN O
in IN O
the DT O
positive JJ O
strand NN O
of IN O
the DT O
viral JJ O
genome NN O
. . O

-DOCSTART- X X O

Zn(II NNP O
) -RRB- O
coordination NN O
domain NN O
mutants NNS O
of IN O
T4 NNP B-NP
gene NN I-NP
32 CD I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

The DT O
pathophysiology NN O
and CC O
clinical JJ O
management NN O
of IN O
acute JJ O
brain NN O
injury NN O
in IN O
infancy NN O
and CC O
childhood NN O
are VBP O
presented VBN O
using VBG O
acute JJ O
traumatic JJ O
brain NN O
injury NN O
as IN O
a DT O
model NN O
. . O

-DOCSTART- X X O

Transcripts NNS O
from IN O
a DT O
second JJ O
POU-domain JJ B-NP
gene NN I-NP
, , O
Oct-25 CD B-NP
, , O
were VBD O
present JJ O
at IN O
low JJ O
levels NNS O
in IN O
oocytes NNS O
and CC O
early JJ O
embryos NNS O
and CC O
were VBD O
dramatically RB O
upregulated VBN O
during IN O
early JJ O
gastrulation NN O
. . O

-DOCSTART- X X O

In IN O
some DT O
early JJ O
B NNP O
cells NNS O
and CC O
Abelson NNP O
murine NN O
leukemia NN O
virus-transformed JJ O
pre-B-cell JJ O
lines NNS O
, , O
LT NNP B-NP
mRNA NN I-NP
is VBZ O
constitutively RB O
expressed VBN O
. . O

-DOCSTART- X X O

The DT O
genome NN O
of IN O
Thogoto NNP O
virus NN O
comprises VBZ O
six CD O
segments NNS O
of IN O
single-stranded JJ O
, , O
negative JJ O
sense NN O
RNA NNP O
. . O

-DOCSTART- X X O

These DT O
tumors NNS O
were VBD O
classified VBN O
into IN O
three CD O
broad JJ O
groups NNS O
: : O
I PRP O
, , O
cystadenoma NN O
; : O
II NNP O
, , O
cystadenocarcinoma NN O
; : O
and CC O
III NNP O
, , O
adenocarcinoma NN O
with IN O
mucin JJ B-NP
production NN O
or CC O
an DT O
associated JJ O
cyst NN O
. . O

-DOCSTART- X X O

Immunostaining NNP O
of IN O
cells NNS O
transfected VBN O
with IN O
these DT O
constructs NNS O
revealed VBD O
that IN O
both DT O
the DT O
myristoylated JJ O
and CC O
nonmyristoylated JJ O
mutants NNS O
were VBD O
localized VBN O
in IN O
nuclei NNS O
, , O
whereas IN O
wild-type JJ B-NP
PKC NN I-NP
alpha NN I-NP
was VBD O
primarily RB O
cytoplasmic JJ O
and CC O
perinuclear JJ O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
partially RB O
sequenced VBN O
the DT O
RAP74 NNP B-NP
protein NN I-NP
from IN O
purified VBN O
HeLa NNP O
cells NNS O
, , O
cloned VBD O
its PRP$ O
complementary JJ O
DNA NN O
and CC O
shown VBN O
that IN O
its PRP$ O
translation NN O
product NN O
can MD O
interact VB O
with IN O
RAP30 CD B-NP
in IN O
vitro NN O
as RB O
well RB O
as IN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
thromboxane NN B-NP
synthetase NN I-NP
inhibition NN O
on IN O
postburn NN O
mesenteric JJ O
vascular JJ O
resistance NN O
and CC O
the DT O
rate NN O
of IN O
bacterial JJ O
translocation NN O
in IN O
a DT O
chronic JJ O
porcine NN O
model NN O
. . O

-DOCSTART- X X O

The DT O
primary JJ O
pancreatic JJ O
insult NN O
seemed VBD O
to TO O
be VB O
unaffected JJ O
by IN O
the DT O
treatment NN O
, , O
because IN O
neither CC O
the DT O
rise NN O
in IN O
plasma NN B-NP
lipase NN I-NP
nor CC O
the DT O
development NN O
of IN O
ascites NNS O
or CC O
the DT O
extension NN O
of IN O
the DT O
pancreatic JJ O
necrosis NN O
were VBD O
diminished VBN O
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
amino IN O
acid NN O
sequence NN O
exhibited VBD O
70 CD O
% NN O
identity NN O
to TO O
that DT O
of IN O
Bacillus NNP B-NP
stearothermophilus NN I-NP
TyrTS NNS I-NP
and CC O
55 CD O
% NN O
identity NN O
to TO O
that DT O
of IN O
E. NNP B-NP
coli NNS I-NP
TyrTS NNS I-NP
, , O
while IN O
identity NN O
to TO O
a DT O
second JJ O
cryptic JJ O
B. NNP B-NP
subtilis NNS I-NP
TyrTS NNP I-NP
gene NN I-NP
, , O
designated VBN O
tyrZ NN B-NP
, , O
was VBD O
only RB O
27 CD O
% NN O
. . O

-DOCSTART- X X O

Heat-inducible JJ O
CAT NN B-NP
activity NN O
was VBD O
detectable JJ O
when WRB O
additional JJ O
sequences NNS O
from IN O
the DT O
native NN O
promoter NN O
containing VBG O
three CD O
CCAAT NN O
boxes NNS O
and CC O
a DT O
single JJ O
HSE NNP O
were VBD O
present JJ O
in IN O
the DT O
constructions NNS O
. . O

-DOCSTART- X X O

SETTING--Women NNP O
, , O
Infants NNP O
, , O
and CC O
Children NNP O
clinics NNS O
in IN O
Minneapolis NNP O
, , O
Minn NNP O
. . O

-DOCSTART- X X O

Testosterone JJ O
, , O
free JJ O
testosterone NN O
, , O
non-sex JJ B-NP
hormone-binding NN I-NP
globulin-bound NN I-NP
testosterone NN O
, , O
and CC O
free JJ O
androgen NN O
index NN O
: : O
which WDT O
testosterone NN O
measurement NN O
is VBZ O
most RBS O
relevant JJ O
to TO O
reproductive VB O
and CC O
sexual JJ O
function NN O
in IN O
men NNS O
with IN O
epilepsy NN O
? . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
The DT O
effectiveness NN O
of IN O
monoamine NN B-NP
oxidase NN I-NP
inhibitors NNS O
( -LRB- O
MAOIs NNS O
) -RRB- O
in IN O
tricyclic NN O
resistant JJ O
depression NN O
has VBZ O
received VBN O
surprisingly RB O
little JJ O
systematic JJ O
study NN O
. . O

-DOCSTART- X X O

The DT O
upstream JJ O
delta-alpha NN O
breakpoint NN O
is VBZ O
flanked VBN O
by IN O
the DT O
direct JJ O
repeats NNS O
of IN O
the DT O
acceptor NN O
splice NN O
site NN O
, , O
whereas IN O
the DT O
down-stream NN O
alpha-delta NN O
breakpoint NN O
is VBZ O
located VBN O
in IN O
the DT O
adjacent JJ O
intron NN O
. . O

-DOCSTART- X X O

Management NNP O
often RB O
involves VBZ O
beta JJ O
- : O
and CC O
calcium NN O
channel NN O
blocking VBG O
drugs NNS O
or CC O
type NN O
IC NN O
antiarrhythmic JJ O
drugs NNS O
. . O

-DOCSTART- X X O

Toxicity NN O
was VBD O
mild JJ O
, , O
mainly RB O
consisting VBG O
of IN O
emesis NN O
( -LRB- O
81 CD O
% NN O
of IN O
the DT O
patients NNS O
; : O
66 CD O
% NN O
of IN O
the DT O
courses NNS O
) -RRB- O
, , O
leukopenia NN O
of IN O
World NNP O
Health NNP O
Organization NNP O
( -LRB- O
WHO WP O
) -RRB- O
grade NN O
1 CD O
to TO O
2 CD O
( -LRB- O
47 CD O
% NN O
of IN O
the DT O
patients NNS O
; : O
18 CD O
% NN O
of IN O
the DT O
courses NNS O
) -RRB- O
, , O
and CC O
thrombocytopenia NN O
( -LRB- O
12 CD O
% NN O
of IN O
the DT O
patients NNS O
; : O
3 CD O
% NN O
of IN O
the DT O
courses NNS O
) -RRB- O
. . O

-DOCSTART- X X O

W.G. . O

-DOCSTART- X X O

This DT O
study NN O
confirms VBZ O
, , O
although IN O
individual JJ O
reaction NN O
is VBZ O
remarkably RB O
different JJ O
, , O
transportation NN O
as IN O
a DT O
potent JJ O
stressor NN O
for IN O
Beagle NNP O
dogs NNS O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Plasma NNP B-NP
AVP NNP I-NP
responses NNS O
to TO O
osmotic JJ O
stimulation NN O
, , O
and CC O
non-osmotic JJ O
inhibition NN O
by IN O
drinking NN O
, , O
were VBD O
normal JJ O
in IN O
patients NNS O
with IN O
compulsive JJ O
water NN O
drinking NN O
. . O

-DOCSTART- X X O

The DT O
csbA JJ B-NP
fusion NN I-NP
was VBD O
maximally RB O
expressed VBN O
during IN O
early JJ O
stationary JJ O
phase NN O
in IN O
cells NNS O
grown VBN O
in IN O
Luria NNP O
broth NN O
containing VBG O
5 CD O
% NN O
glucose NN O
and CC O
0.2 CD O
% NN O
glutamine NN O
. . O

-DOCSTART- X X O

The DT O
constraints NNS O
of IN O
primase JJ B-NP
recognition NN I-NP
sequences NNS I-NP
, , O
nucleotide JJ O
substrate JJ O
requirements NNS O
, , O
and CC O
the DT O
effects NNS O
of IN O
additional JJ O
proteins NNS O
on IN O
oligoribonucleotide JJ O
synthesis NN O
by IN O
the DT O
63-kDa JJ B-NP
gene NN I-NP
4 CD I-NP
protein NN I-NP
have VBP O
been VBN O
examined VBN O
using VBG O
templates NNS O
of IN O
defined VBN O
sequence NN O
. . O

-DOCSTART- X X O

When WRB O
both DT O
lesions NNS O
were VBD O
complete JJ O
lateral JJ O
hemisections NNS O
in IN O
weanling NN O
operates VBZ O
, , O
little JJ O
behavioral JJ O
recovery NN O
was VBD O
observed VBN O
, , O
similar JJ O
to TO O
complete JJ O
spinal JJ O
cord NN O
transection NN O
( -LRB- O
N NNP O
= SYM O
3 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Human JJ O
SRF-related JJ B-NP
proteins NNS I-NP
: : O
DNA-binding JJ O
properties NNS O
and CC O
potential JJ O
regulatory JJ O
targets NNS O
. . O

-DOCSTART- X X O

Growth NN O
factor NN O
stimulation NN O
of IN O
cells NNS O
causes VBZ O
the DT O
phosphorylation NN O
of IN O
the DT O
c-Myc JJ B-NP
transcriptional JJ I-NP
activation NN I-NP
domain NN I-NP
at IN O
Ser62 NNP O
within IN O
a DT O
proline-rich JJ O
region NN O
that WDT O
is VBZ O
highly RB O
conserved VBN O
among IN O
members NNS O
of IN O
the DT O
Myc JJ B-NP
family NN I-NP
( -LRB- O
Alvarez NNP O
, , O
E. NNP O
, , O
Northwood NNP O
, , O
I.C. NNP O
, , O
Gonzalez NNP O
, , O
F. NNP O

-DOCSTART- X X O

The DT O
authors NNS O
evaluated VBN O
the DT O
potential JJ O
for IN O
thrombotic DT O
complications NNS O
arising VBG O
from IN O
implantation NN O
of IN O
a DT O
ventricular JJ O
assist VB O
device NN O
( -LRB- O
Sarns/3M-VAD NNP O
) -RRB- O
in IN O
four CD O
calves NNS O
. . O

-DOCSTART- X X O

Cardiac NN O
output NN O
( -LRB- O
CO NNP O
) -RRB- O
was VBD O
significantly RB O
higher JJR O
( -LRB- O
p NN O
less JJR O
than IN O
0.0005 CD O
) -RRB- O
in IN O
the DT O
MBBF NNP O
group NN O
. . O

-DOCSTART- X X O

Amino NNP O
acid NN O
residues NNS O
147-167 CD O
of IN O
the DT O
previously RB O
reported VBN O
sequence NN O
are VBP O
replaced VBN O
by IN O
new JJ O
residues NNS O
147 CD O
to TO O
150 CD O
. . O

-DOCSTART- X X O

These DT O
results NNS O
strongly RB O
suggest VBP O
that IN O
locally-applied JJ O
TTC NNP O
in IN O
combination NN O
with IN O
FDBA NNP O
enhances VBZ O
new JJ O
bone NN O
formation NN O
in IN O
experimental JJ O
alveolar JJ O
bone NN O
defects NNS O
. . O

-DOCSTART- X X O

As IN O
an DT O
initial JJ O
step NN O
towards IN O
the DT O
characterization NN O
of IN O
replicative JJ O
DNA NNP B-NP
polymerases NNS I-NP
of IN I-NP
trypanosomes NNS I-NP
, , O
we PRP O
have VBP O
cloned VBN O
, , O
sequenced VBN O
and CC O
examined VBN O
the DT O
expression NN O
of IN O
the DT O
Trypanosoma NNP O
( -LRB- O
Trypanozoon NN O
) -RRB- O
brucei NN O
brucei NN O
gene NN O
that WDT O
encodes VBZ O
the DT O
DNA NNP B-NP
polymerase NN I-NP
alpha NN I-NP
catalytic JJ I-NP
core NN I-NP
( -LRB- O
pol JJ B-NP
alpha NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
there EX O
was VBD O
a DT O
significant JJ O
increase NN O
in IN O
postdexamethasone NN O
cortical JJ O
concentrations NNS O
with IN O
age NN O
( -LRB- O
p NN O
less JJR O
than IN O
0.01 CD O
; : O
r NN O
= SYM O
0.31 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Pulmonary JJ O
hypertension NN O
, , O
with IN O
or CC O
without IN O
coronary JJ O
arterial JJ O
narrowing NN O
, , O
is VBZ O
the DT O
major JJ O
condition NN O
leading VBG O
to TO O
isolated JJ O
atrial JJ O
infarction NN O
. . O

-DOCSTART- X X O

The DT O
volume NN O
fraction NN O
( -LRB- O
Vv NNP O
) -RRB- O
and CC O
number/mm2 NN O
( -LRB- O
Na NNP O
) -RRB- O
of IN O
all DT O
capillaries NNS O
( -LRB- O
perfused VBN O
and CC O
nonperfused JJ O
) -RRB- O
in IN O
a DT O
given VBN O
area NN O
of IN O
brain NN O
were VBD O
determined VBN O
after IN O
staining VBG O
for IN O
alkaline NN B-NP
phosphatase NN I-NP
. . O

-DOCSTART- X X O

Airway NNP O
pressure NN O
and CC O
air NN O
flow NN O
were VBD O
measured VBN O
at IN O
the DT O
endotracheal JJ O
tube NN O
in IN O
13 CD O
children NNS O
on IN O
a DT O
variety NN O
of IN O
ventilators NNS O
. . O

-DOCSTART- X X O

Appl NNP O
. . O

-DOCSTART- X X O

Issues NNS O
of IN O
distribution NN O
of IN O
kinetic JJ O
energy NN O
of IN O
traumatizing VBG O
object NN O
in IN O
direct JJ O
contact NN O
interaction NN O
with IN O
head NN O
during IN O
impact NN O
are VBP O
discussed VBN O
from IN O
position NN O
of IN O
biomechanics NNS O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Monitoring NNP O
SpO2 NNP O
at IN O
the DT O
nasal JJ O
septum NN O
site NN O
is VBZ O
more RBR O
reliable JJ O
than IN O
monitoring VBG O
it PRP O
at IN O
the DT O
finger NN O
site NN O
in IN O
hypothermic JJ O
patients NNS O
. . O

-DOCSTART- X X O

Diltiazem NNP O
decreased VBD O
the DT O
total JJ O
body NN O
clearance NN O
from IN O
34.0 CD O
+/ CD O
- : O
8.0 CD O
to TO O
28.6 CD O
+/ CD O
- : O
6.1 CD O
mL/min NN O
( -LRB- O
P NNP O
less RBR O
than IN O
.01 CD O
) -RRB- O
, , O
and CC O
prolonged VBN O
the DT O
elimination NN O
half-life NN O
from IN O
12.6 CD O
+/ NNS O
- : O
3.0 CD O
to TO O
14.3 CD O
+/ NN O
- : O
2.5 CD O
hours NNS O
( -LRB- O
P NNP O
less RBR O
than IN O
.01 CD O
) -RRB- O
of IN O
antipyrine NN O
without IN O
any DT O
changes NNS O
in IN O
volume NN O
of IN O
distribution NN O
. . O

-DOCSTART- X X O

Hence RB O
, , O
the DT O
uPA NNP B-NP
promoter NN I-NP
contains VBZ O
multiple JJ O
weak JJ O
cis-acting JJ O
elements NNS O
distributed VBN O
over IN O
7.0 CD O
kb NN O
5' CD O
to TO O
the DT O
translation NN O
start NN O
site NN O
. . O

-DOCSTART- X X O

P. NNP O

-DOCSTART- X X O

These DT O
introns NNS O
belong VBP O
to TO O
the DT O
class NN O
of IN O
nuclear JJ O
pre-mRNA JJ O
introns NNS O
and CC O
contain VBP O
typical JJ O
5' JJ O
- : O
and CC O
3'-consensus JJ O
sequences NNS O
, , O
as RB O
well RB O
as IN O
unique JJ O
features NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
report NN O
, , O
almost RB O
6 CD O
kb NN O
of IN O
DNA NNP O
sequence NN O
is VBZ O
presented VBN O
, , O
including VBG O
1251 CD O
bp NN O
5' CD O
to TO O
the DT O
gene NN O
, , O
over IN O
4 CD O
kb NN O
of IN O
exon NN O
and CC O
exon-intron NN O
junctions NNS O
, , O
and CC O
583 CD O
bp NN O
3' CD O
to TO O
the DT O
gene NN O
. . O

-DOCSTART- X X O

Antibodies NNS O
specific JJ O
to TO O
rE12 VB B-NP
and CC O
rNFIL-6 RB B-NP
disrupt VB O
nucleoprotein JJ O
complexes NNS O
with IN O
these DT O
DNA-binding JJ O
sites NNS O
, , O
confirming VBG O
the DT O
interaction NN O
of IN O
native JJ O
in IN O
vivo JJ O
factors NNS O
. . O

-DOCSTART- X X O

A DT O
method NN O
is VBZ O
described VBN O
for IN O
detecting VBG O
targeted VBN O
events NNS O
at IN O
the DT O
mu NN B-NP
heavy NN I-NP
chain NN I-NP
gene NN I-NP
which WDT O
relies VBZ O
on IN O
co-conversion NN O
( -LRB- O
or CC O
co-exchange NN O
) -RRB- O
of IN O
a DT O
point NN O
mutation NN O
with IN O
a DT O
selectable JJ O
marker NN O
contained VBN O
on IN O
a DT O
replacement NN O
vector NN O
. . O

-DOCSTART- X X O

Allergenic NNP O
activity NN O
of IN O
allergen NN O
extract VB O
Ambrosia NNP O
elatior JJ O
( -LRB- O
AE NNP O
) -RRB- O
was VBD O
tested VBN O
in IN O
fifteen CD O
volunteers NNS O
extremely RB O
sensitive JJ O
to TO O
the DT O
allergen NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
was VBD O
aimed VBN O
at IN O
assessing VBG O
whether IN O
c-DDP JJ O
administration NN O
immediately RB O
before IN O
radiotherapy NN O
could MD O
increase VB O
frequency NN O
and CC O
duration NN O
of IN O
objective JJ O
responses NNS O
, , O
as RB O
well RB O
as IN O
survival NN O
, , O
in IN O
patients NNS O
affected VBN O
with IN O
locally RB O
advanced JJ O
stages NNS O
of IN O
squamous JJ O
carcinomas NNS O
of IN O
the DT O
head NN O
and CC O
neck NN O
. . O

-DOCSTART- X X O

Two CD O
potential JJ O
regulatory JJ O
sequences NNS O
for IN O
DNA NNP O
binding JJ O
proteins NNS O
were VBD O
found VBN O
in IN O
the DT O
non-coding JJ O
5' JJ O
region NN O
: : O
a DT O
HAP2/HAP3 JJ B-NP
consensus NN O
recognition NN O
sequence NN O
at IN O
nucleotide-154 CD O
and CC O
a DT O
BAF1 NNP B-NP
consensus NN I-NP
recognition NN I-NP
sequence NN I-NP
at IN O
nucleotide-136 CD O
. . O

-DOCSTART- X X O

Marked NNP O
thrombocytopenia NN O
, , O
depletion NN O
of IN O
serum NN B-NP
fibrinogen NN I-NP
and CC O
prolonged JJ O
prothrombin NN B-NP
and CC O
activated VBD O
partial JJ O
thromboplastin IN B-NP
time NN O
, , O
were VBD O
recorded VBN O
at IN O
5 CD O
to TO O
10 CD O
and CC O
30 CD O
to TO O
40 CD O
minutes NNS O
after IN O
intravenous JJ O
envenomation NN O
. . O

-DOCSTART- X X O

We PRP O
exploit VBP O
the DT O
properties NNS O
of IN O
LexA NNP B-NP
fusion NN I-NP
proteins VBZ I-NP
to TO O
study VB O
the DT O
dimerization NN O
and CC O
DNA-contacting JJ O
domains NNS O
of IN O
cRel NN B-NP
. . O

-DOCSTART- X X O

The DT O
alcoholic JJ O
patient NN O
, , O
his PRP$ O
work NN O
and CC O
the DT O
subjectivity NN O
of IN O
the DT O
period NN O

-DOCSTART- X X O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
combined VBN O
treatment NN O
with IN O
a DT O
thromboxane NN B-NP
synthetase NN I-NP
inhibitor NN O
and CC O
a DT O
thromboxane NN B-NP
receptor NN I-NP
antagonist NN O
provides VBZ O
a DT O
better JJR O
protection NN O
against IN O
digoxin NN O
intoxication IN O
than IN O
with IN O
either DT O
agent NN O
alone RB O
. . O

-DOCSTART- X X O

Interspecific NNP O
backcross JJ O
analysis NN O
using VBG O
progeny NN O
derived VBN O
from IN O
matings NNS O
of IN O
( -LRB- O
C57BL/6J NN O
x NN O
Mus JJ O
spretus NN O
) -RRB- O
F1 IN O
x NN O
C57BL/6J IN O
mice NNS O
indicates VBZ O
that IN O
the DT O
thrombospondin NN B-NP
gene NN I-NP
is VBZ O
tightly RB O
linked VBN O
to TO O
the DT O
Fshb NNP B-NP
, , O
Actcl NNP B-NP
, , O
Ltk NNP B-NP
, , O
and CC O
B2M NNP B-NP
loci NNS I-NP
on IN O
murine NN O
chromosome NN O
2. . O

-DOCSTART- X X O

Adverse JJ O
foetal NN O
outcome NN O
in IN O
specific JJ O
IgM NNP B-NP
positive JJ O
Chlamydia NNP O
trachomatis NN O
infection NN O
in IN O
pregnancy NN O
. . O

-DOCSTART- X X O

Using VBG O
an DT O
image-processing JJ O
computer NN O
, , O
regional JJ O
LV NNP O
time-density NN O
curves NNS O
were VBD O
constructed VBN O
for IN O
one CD O
cardiac JJ O
cycle NN O
. . O

-DOCSTART- X X O

In IN O
a DT O
second JJ O
patient NN O
the DT O
VT NNP O
became VBD O
nonsustained JJ O
. . O

-DOCSTART- X X O

The DT O
possible JJ O
mechanisms NNS O
underlying VBG O
differences NNS O
in IN O
post-tetanic JJ O
effects NNS O
from IN O
muscle NN O
and CC O
cutaneous JJ O
afferents NNS O
in IN O
adults NNS O
and CC O
neonates NNS O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

The DT O
EPO NNP B-NP
levels NNS O
were VBD O
distinctly RB O
increased VBN O
before IN O
transfusion NN O
; : O
they PRP O
did VBD O
not RB O
significantly RB O
change VB O
just RB O
after IN O
transfusion NN O
, , O
but CC O
subsequently RB O
decreased VBD O
. . O

-DOCSTART- X X O

This DT O
differential JJ O
sensitivity NN O
to TO O
DB NNP O
, , O
as IN O
measured VBN O
by IN O
a DT O
lower JJR O
concentration NN O
of IN O
DB NNP O
which WDT O
caused VBD O
loss NN O
of IN O
righting VBG O
in IN O
LS NN O
, , O
was VBD O
accompanied VBN O
by IN O
an DT O
equal JJ O
rate NN O
of IN O
water-soluble JJ O
barbiturate JJ O
brain NN O
distribution NN O
and CC O
elimination NN O
in IN O
the DT O
two CD O
lines NNS O
. . O

-DOCSTART- X X O

Ten CD O
out IN O
of IN O
10 CD O
patients NNS O
with IN O
progressive JJ O
disease NN O
had VBD O
mast NN O
cells NNS O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
0.5 CD O
% NN O
, , O
hyaluronan NN O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
50 CD O
micrograms NNS O
.l-1 JJ O
and CC O
fibronectin RB B-NP
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
350 CD O
micrograms NNS O
.l-1 JJ O
compared VBN O
to TO O
eight CD O
out IN O
of IN O
41 CD O
patients NNS O
with IN O
stable JJ O
or CC O
regressive JJ O
disease NN O
.(ABSTRACT . O
TRUNCATED JJ O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

Our PRP$ O
mapping NN O
results NNS O
did VBD O
not RB O
suggest VB O
involvement NN O
of IN O
this DT O
gene NN O
in IN O
previously RB O
mapped JJ O
genetic JJ O
disorders NNS O
or CC O
in IN O
known VBN O
neoplasia-associated JJ O
translocation NN O
breakpoints NNS O
. . O

-DOCSTART- X X O

Arsenic JJ O
contents NNS O
in IN O
native JJ O
copper NN O

-DOCSTART- X X O

In IN O
ten CD O
other JJ O
experiments NNS O
( -LRB- O
5 CD O
experimental JJ O
and CC O
5 CD O
control NN O
rats NNS O
) -RRB- O
99mTc-sulfur JJ O
colloid NN O
was VBD O
injected VBN O
intravenously RB O
. . O

-DOCSTART- X X O

Extramedullary NNP O
relapse NN O
in IN O
childhood NN O
leukemia NN O
. . O

-DOCSTART- X X O

Mycoplasma NNP O
pneumoniae NNS O
was VBD O
isolated VBN O
from IN O
the DT O
pleural JJ O
fluid NN O
of IN O
this DT O
patient NN O
. . O

-DOCSTART- X X O

RU486 NNP O
and CC O
ONO NNP O
802 CD O
in IN O
combination NN O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
effective JJ O
in IN O
early JJ O
termination NN O
of IN O
pregnancy NN O
. . O

-DOCSTART- X X O

In IN O
line NN O
with IN O
the DT O
small JJ O
values NNS O
for IN O
QS/QC NNP O
, , O
our PRP$ O
results NNS O
further RB O
indicate VBP O
that IN O
even RB O
large JJ O
, , O
well-perfused JJ O
, , O
occluded VBD O
air NN O
spaces NNS O
in IN O
the DT O
lung NN O
will MD O
hardly RB O
affect VB O
the DT O
recovered VBN O
ventilation/perfusion NN O
distribution NN O
obtained VBN O
from IN O
inert JJ O
gas NN O
data NNS O
when WRB O
CDCSF6 PRP O
exceeds VBZ O
0.1 CD O
ml NN O
.min-1.mmHg-1 NN O
. . O

-DOCSTART- X X O

Many JJ O
cells NNS O
were VBD O
negative JJ O
for IN O
endothelial-cell NN O
markers NNS O
, , O
and CC O
they PRP O
reacted VBD O
with IN O
a DT O
monoclonal JJ O
antibody NN O
against IN O
muscle NN O
actin NN B-NP
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
contrast NN O
media NNS O
on IN O
coagulation NN B-NP
factor NN I-NP
XII NNP I-NP
. . O

-DOCSTART- X X O

Pigs NNS O
were VBD O
switched VBN O
from IN O
the DT O
growing VBG O
to TO O
the DT O
finishing VBG O
diet NN O
at IN O
57 CD O
and CC O
61 CD O
kg NN O
in IN O
Exp NNP O
. . O

-DOCSTART- X X O

In IN O
sixteen CD O
patients NNS O
with IN O
moderate JJ O
essential JJ O
hypertension NN O
the DT O
effects NNS O
of IN O
10-day JJ O
nifedipine JJ O
treatment NN O
on IN O
serum NN O
uric JJ O
acid NN O
and CC O
renal JJ O
excretion NN O
of IN O
uric JJ O
acid NN O
were VBD O
evaluated VBN O
. . O

-DOCSTART- X X O

Examples NNS O
are VBP O
using VBG O
more RBR O
subjects NNS O
or CC O
an DT O
improved VBN O
research NN O
design NN O
, , O
developing VBG O
consensus NN O
statements NNS O
or CC O
using VBG O
meta-analysis NN O
. . O

-DOCSTART- X X O

A DT O
two CD O
phase NN O
slug NN O
flow NN O
tubular JJ O
heat NN O
exchanger NN O
was VBD O
used VBN O
for IN O
the DT O
thermal JJ O
inactivation NN O
of IN O
Listeria NNP O
monocytogenes NNS O
in IN O
natural JJ O
infected JJ O
milk NN O
from IN O
seven CD O
cows NNS O
. . O

-DOCSTART- X X O

Regional NNP O
cerebral JJ O
blood NN O
flow NN O
(rCBF NN O
) -RRB- O
measurements NNS O
and CC O
psychiatric JJ O
ratings NNS O
were VBD O
performed VBN O
on IN O
seven CD O
schizophrenic JJ O
patients NNS O
( -LRB- O
mean JJ O
age NN O
= SYM O
41.4 CD O
years NNS O
) -RRB- O
who WP O
had VBD O
been VBN O
examined VBN O
18 CD O
years NNS O
previously RB O
in IN O
a DT O
study NN O
that WDT O
used VBD O
similar JJ O
psychiatric JJ O
ratings NNS O
and CC O
a DT O
comparable JJ O
rCBF NN O
technique NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
identified VBD O
a DT O
strong JJ O
positive JJ O
cis-regulatory JJ O
element NN O
at IN O
-70 DT O
bp NN O
to TO O
-75 DT O
bp NN O
in IN O
the DT O
LpS1 NNP B-NP
beta NN I-NP
promoter NN I-NP
with IN O
the DT O
sequence NN O
( -LRB- O
G)6 NNP O
and CC O
a DT O
similar JJ O
, , O
more RBR O
distal JJ O
cis-element NN O
at IN O
-721 DT O
bp NN O
to TO O
-726 DT O
bp NN O
. . O

-DOCSTART- X X O

No DT O
case NN O
of IN O
SMF NNP O
demonstrated VBD O
expansive JJ O
tumorous JJ O
growth NN O
. . O

-DOCSTART- X X O

Review NNP O
of IN O
the DT O
literature NN O
and CC O
report NN O
of IN O
a DT O
case NN O
of IN O
a DT O
dermoid JJ O
cyst NN O
. . O

-DOCSTART- X X O

In IN O
all DT O
instances NNS O
the DT O
apparent JJ O
alcohol NN O
responses NNS O
were VBD O
very RB O
small JJ O
and CC O
never RB O
exceeded VBD O
a DT O
reading NN O
of IN O
1 CD O
microgram/100ml JJ O
for IN O
breath NN O
samples NNS O
more RBR O
than IN O
10min CD O
post-exposure NN O
. . O

-DOCSTART- X X O

Maize NNP B-NP
rbcS NNP I-NP
promoter NN I-NP
activity NN O
depends VBZ O
on IN O
sequence NN O
elements NNS O
not RB O
found VBN O
in IN O
dicot NN B-NP
rbcS NNS I-NP
promoters NNS I-NP
. . O

-DOCSTART- X X O

The DT O
relatively RB O
scanty JJ O
number NN O
of IN O
examples NNS O
, , O
which WDT O
could MD O
be VB O
justified VBN O
by IN O
the DT O
variety NN O
and CC O
complexity NN O
of IN O
combined VBN O
exposure NN O
, , O
allows VBZ O
to TO O
conclude VB O
that IN O
life-style NN O
factors NNS O
have VBP O
considerable JJ O
influence NN O
on IN O
interindividual JJ O
differences NNS O
in IN O
susceptibility NN O
to TO O
xenobiotics NNS O
toxicity NN O
. . O

-DOCSTART- X X O

After IN O
treatment NN O
with IN O
tunicamycin NN O
, , O
the DT O
transfectants NNS O
secreted VBN O
unglycosylated JJ O
18-kDa JJ O
polypeptides NNS O
which WDT O
could MD O
also RB O
bind NN O
IgE. . B-NP

-DOCSTART- X X O

PAS1 NNP B-NP
, , O
a DT O
yeast NN O
gene NN O
required VBN O
for IN O
peroxisome JJ O
biogenesis NN O
, , O
encodes VBZ O
a DT O
member NN O
of IN O
a DT O
novel JJ O
family NN O
of IN O
putative JJ O
ATPases NNS B-NP
. . O

-DOCSTART- X X O

The DT O
gene NN O
is VBZ O
1,139 CD O
base NN O
pairs NNS O
( -LRB- O
bp NN O
) -RRB- O
long RB O
, , O
and CC O
, , O
like IN O
other JJ O
members NNS O
of IN O
the DT O
SIG NNP B-NP
family NN I-NP
, , O
the DT O
beta NN B-NP
TG NNP I-NP
gene NN I-NP
is VBZ O
divided VBN O
into IN O
3 CD O
exons NNS O
. . O

-DOCSTART- X X O

The DT O
pp90rsk-protein JJ B-NP
kinase NN I-NP
activity NN O
( -LRB- O
referred VBD O
to TO O
as IN O
rsk-kinase NN B-NP
) -RRB- O
is VBZ O
also RB O
not RB O
related VBN O
to TO O
cofactor-dependent JJ O
signal NN O
transducing VBG O
protein NN O
kinases NNS O
such JJ O
as IN O
the DT O
cyclic NN B-NP
AMP-dependent JJ I-NP
protein NN I-NP
kinases NNS I-NP
, , O
members NNS O
of IN O
the DT O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
family NN I-NP
, , O
or CC O
other JJ O
Ca2( JJ B-NP
+)-dependent JJ I-NP
protein NN I-NP
kinases NNS I-NP
. . O

-DOCSTART- X X O

Human JJ B-NP
GATA-3 NN I-NP
: : O
a DT O
lineage-restricted JJ O
transcription NN O
factor NN O
that WDT O
regulates VBZ O
the DT O
expression NN O
of IN O
the DT O
T NNP B-NP
cell NN I-NP
receptor NN I-NP
alpha NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Like IN O
many JJ O
eukaryotic JJ O
transcription NN O
factors NNS O
, , O
these DT O
proteins NNS O
bind VBP O
to TO O
DNA NNP O
as IN O
dimers NNS O
. . O

-DOCSTART- X X O

Southwestern NNP O
blot NN O
analysis NN O
demonstrated VBN O
that IN O
this DT O
phosphoprotein NN O
can MD O
bind VBP O
the DT O
kappa NN B-NP
B NNP I-NP
element NN I-NP
directly RB O
and CC O
specifically RB O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
positive JJ O
effect NN O
of IN O
NS1 NNP B-NP
on IN O
the DT O
steady-state NN O
levels NNS O
of IN O
P4 NNP B-NP
transcripts NNS I-NP
depends VBZ O
on IN O
the DT O
amplification NN O
of IN O
gene NN O
copy NN O
number NN O
and CC O
the DT O
integrity NN O
of IN O
the DT O
terminal NN O
repeats NNS O
. . O

-DOCSTART- X X O

The DT O
minus-end-directed JJ O
microtubule NN O
motors NNS O
, , O
the DT O
dyneins NNS B-NP
, , O
may MD O
also RB O
constitute VB O
a DT O
superfamily NN O
of IN O
force-generating JJ O
proteins NNS O
with IN O
distinct JJ O
attachment NN O
domains VBZ O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
transparent JJ O
, , O
cheap JJ O
to TO O
be VB O
made VBN O
, , O
and CC O
easy JJ O
to TO O
empty JJ O
and CC O
was VBD O
tested VBN O
in IN O
118 CD O
animals NNS O
for IN O
two CD O
and CC O
four CD O
weeks NNS O
. . O

-DOCSTART- X X O

The DT O
incompatibility NN O
group NN O
W NNP O
plasmid VBD O
pSa DT O
suppresses NNS O
Agrobacterium NNP O
tumefaciens JJ O
oncogenicity NN O
( -LRB- O
J. NNP O

-DOCSTART- X X O

Potential JJ O
translational JJ O
start NN O
signals NNS O
are VBP O
upstream RB O
of IN O
ORF1 NNP O
and CC O
ORF2 NNP O
. . O

-DOCSTART- X X O

Imaging NNP O
of IN O
D2 NNP B-NP
dopamine NN I-NP
receptor NN I-NP

-DOCSTART- X X O

The DT O
Thr161Val NNP O
mutation NN O
causes VBZ O
a DT O
lethal JJ O
phenotype NN O
in IN O
the DT O
fission NN O
yeast NN O
Schizosaccharomyces NNP O
pombe VBD O
, , O
while IN O
replacement NN O
of IN O
Thr161 NNP O
with IN O
glutamic JJ O
acid NN O
, , O
potentially RB O
mimicking JJ O
phosphorylation NN O
, , O
causes VBZ O
uncoordination NN O
of IN O
mitosis NN O
and CC O
multiple JJ O
cytokinesis NN O
. . O

-DOCSTART- X X O

Deregulation NN O
of IN O
their PRP$ O
expression NN O
may MD O
contribute VB O
to TO O
malignant JJ O
transformation NN O
associated VBN O
with IN O
HTLV-1 JJ O
infection NN O
. . O

-DOCSTART- X X O

The DT O
murine NN B-NP
Mov-34 NNP I-NP
gene NN I-NP
: : O
full-length JJ O
cDNA NN O
and CC O
genomic JJ O
organization NN O
. . O

-DOCSTART- X X O

CREB NNP B-NP
was VBD O
identified VBN O
as IN O
one CD O
of IN O
the DT O
protein NN O
components NNS O
in IN O
several JJ O
of IN O
the DT O
gel JJ O
shift NN O
complexes NNS O
formed VBD O
with IN O
the DT O
variant NN O
CRE. . O

-DOCSTART- X X O

The DT O
RNA NNP O
genome NN O
of IN O
rabbit NN O
hemorrhagic NN O
disease NN O
virus NN O
( -LRB- O
RHDV NN O
) -RRB- O
was VBD O
molecularly RB O
cloned VBN O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
we PRP O
have VBP O
developed VBN O
a DT O
system NN O
to TO O
study VB O
nuclear JJ O
targeting VBG O
in IN O
plants NNS O
and CC O
have VBP O
established VBN O
that IN O
the DT O
nuclear JJ O
transport NN O
machinery NN O
is VBZ O
similar JJ O
in IN O
monocots NNS O
and CC O
dicots NNS O
. . O

-DOCSTART- X X O

A DT O
vector NN O
containing VBG O
a DT O
transcriptionally NN O
inactive JJ O
neomycin JJ B-NP
phosphotransferase NN I-NP
II NNP I-NP
gene NN I-NP
was VBD O
used VBN O
to TO O
select VB O
promoter NN O
sequences NNS O
from IN O
a DT O
pool NN O
of IN O
random JJ O
genomic JJ O
DNA NN O
fragments NNS O
. . O

-DOCSTART- X X O

Previous JJ O
analysis NN O
of IN O
the DT O
98-bp JJ O
sequence NN O
has VBZ O
delineated VBN O
several JJ O
protein-binding JJ O
domains NNS O
that WDT O
are VBP O
recognized VBN O
by IN O
nuclear JJ O
factors NNS O
present JJ O
in IN O
human JJ O
brain NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
second JJ O
transcriptional JJ O
unit NN O
, , O
designated VBN O
UL26.5 NNP B-NP
, , O
predicted VBD O
to TO O
specify VB O
a DT O
protein NN O
of IN O
329 CD O
amino IN O
acids NNS O
, , O
encodes VBZ O
the DT O
family NN B-NP
35 CD I-NP
proteins NNS I-NP
; : O
it PRP O
is VBZ O
transcribed VBN O
by IN O
an DT O
mRNA NN O
which WDT O
initiates VBZ O
at IN O
approximately RB O
nucleotide JJ O
+1000 CD O
of IN O
the DT O
UL26 NNP B-NP
transcription NN O
initiation NN O
site NN O
and CC O
is VBZ O
translated VBN O
from IN O
the DT O
methionine CD O
initiation NN O
codon NN O
located VBN O
at IN O
position NN O
+1099 CD O
of IN O
the DT O
UL26 NNP B-NP
transcriptional JJ I-NP
unit NN I-NP
. . O

-DOCSTART- X X O

The DT O
adeno-associated JJ B-NP
virus NN I-NP
( -LRB- I-NP
AAV NN I-NP
) -RRB- I-NP
rep NN I-NP
gene NN I-NP
encodes VBZ O
four CD O
proteins NNS O
( -LRB- O
Rep78 CD B-NP
, , O
Rep68 CD B-NP
, , O
Rep52 NNP B-NP
, , O
and CC O
Rep40 NNP B-NP
) -RRB- O
required VBN O
for IN O
AAV NNP O
DNA NNP O
replication NN O
and CC O
AAV NNP O
gene NN O
regulation NN O
. . O

-DOCSTART- X X O

A DT O
larger JJR O
region NN O
upstream RB O
of IN O
human JJ B-NP
CMV NNP I-NP
dbp NN I-NP
also RB O
mediated JJ O
replication NN O
in IN O
transient JJ O
assays NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
relative JJ O
positions NNS O
of IN O
the DT O
VV NN O
genes NNS O
( -LRB- O
genus JJ O
Orthopoxvirus NN O
) -RRB- O
are VBP O
different JJ O
than IN O
those DT O
of IN O
the DT O
corresponding JJ O
ORFs NNP O
in IN O
SFV NNP O
( -LRB- O
genus NN O
Leporipoxvirus NNP O
) -RRB- O
, , O
indicating VBG O
complex JJ O
rearrangements NNS O
of IN O
DNA NNP O
in IN O
the DT O
genome NN O
of IN O
one CD O
or CC O
both DT O
of IN O
these DT O
viruses NNS O
subsequent JJ O
to TO O
their PRP$ O
divergence NN O
from IN O
a DT O
common JJ O
ancestor NN O
. . O

-DOCSTART- X X O

This DT O
result NN O
suggests VBZ O
that IN O
phosphorylation NN O
of IN O
Thr NNP O
14 CD O
and/or IN O
Tyr NNP O
15 CD O
inhibits VBZ O
p34cdc2 RBR B-NP
kinase JJ I-NP
activity NN O
, , O
in IN O
line NN O
with IN O
the DT O
location NN O
of IN O
these DT O
residues NNS O
within IN O
the DT O
putative JJ O
ATP NNP O
binding NN O
site NN O
of IN O
the DT O
kinase NN O
. . O

-DOCSTART- X X O

In IN O
short-term JJ O
cotransfections NNS O
, , O
a DT O
pFRTK-CAT NN B-NP
target NN O
containing VBG O
EBNA-1-binding JJ B-NP
sites NNS I-NP
from IN O
the DT O
EBV NNP O
origin NN O
of IN O
plasmid NN O
replication NN O
, , O
ori-P NNP B-NP
, , O
was VBD O
transactivated VBN O
by IN O
a DT O
carboxy-terminal JJ B-NP
EBNA-1 JJ I-NP
construction NN I-NP
(amino NN O
acids NNS O
450 CD O
to TO O
641 CD O
) -RRB- O
that WDT O
also RB O
carried VBD O
a DT O
c-myc JJ B-NP
nuclear JJ I-NP
localization NN I-NP
signal NN I-NP
. . O

-DOCSTART- X X O

The DT O
findings NNS O
are VBP O
compatible JJ O
with IN O
the DT O
idea NN O
that IN O
the DT O
genes NNS O
encoding VBG O
PDGF NNP B-NP
receptors NNS I-NP
in IN O
glioma NN O
cells NNS O
are VBP O
regulated VBN O
in IN O
concert NN O
with IN O
other JJ O
genes NNS O
, , O
the DT O
expression NN O
of IN O
which WDT O
may MD O
reflect VB O
the DT O
developmental JJ O
program NN O
of IN O
normal JJ O
glia NN O
cell NN O
lineages NNS O
. . O

-DOCSTART- X X O

This DT O
study NN O
tested VBD O
the DT O
hypothesis NN O
that WDT O
sodium NN O
channel NN O
blocking VBG O
drugs NNS O
selectively RB O
prolong VB O
the DT O
late JJ O
potential NN O
, , O
or CC O
terminal NN O
low JJ O
amplitude JJ O
signal NN O
, , O
portion NN O
of IN O
the DT O
signal-averaged JJ O
QRS NNP O
complex NN O
and CC O
that DT O
prolongation NN O
of IN O
the DT O
late JJ O
potential NN O
would MD O
correlate VB O
with IN O
slowing VBG O
of IN O
ventricular JJ O
tachycardia NN O
. . O

-DOCSTART- X X O

Whereas IN O
a DT O
PR55 `` B-NP
beta JJ I-NP
transcript NN I-NP
of IN O
about IN O
2.3 CD O
kb NN O
was VBD O
detected VBN O
at IN O
high JJ O
levels NNS O
in IN O
the DT O
neuroblastoma NN O
derived VBD O
cell NN O
line NN O
LA-N-1 NN O
, , O
the DT O
level NN O
of IN O
the DT O
mRNA NN O
was VBD O
very RB O
low JJ O
in IN O
the DT O
other JJ O
human JJ O
cell NN O
lines NNS O
analyzed VBD O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
c-myc NN B-NP
were VBD O
further RB O
dissected VBN O
by IN O
showing VBG O
that IN O
c-myc NN B-NP
can MD O
inhibit VB O
differentiation NN O
independently RB O
of IN O
Id NN B-NP
, , O
a DT O
negative JJ O
regulator NN O
of IN O
muscle NN O
differentiation NN O
. . O

-DOCSTART- X X O

Stable JJ O
association NN O
of IN O
U2 DT B-NP
snRNP NN I-NP
with IN O
the DT O
branchpoint NN O
sequence NN O
of IN O
mammalian JJ O
pre-mRNAs JJ O
requires VBZ O
binding NN O
of IN O
a DT O
non-snRNP JJ O
protein NN O
to TO O
the DT O
polypyrimidine NN O
tract NN O
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

Nucleotide NNP O
sequences NNS O
between IN O
the DT O
env NN B-NP
gene NN I-NP
and CC O
the DT O
LTR NNP B-NP
of IN I-NP
SFV-1 NNP I-NP
were VBD O
determined VBN O
. . O

-DOCSTART- X X O

This DT O
element NN O
was VBD O
used VBN O
to TO O
screen VB O
an DT O
EMBL3 NN O
mouse NN O
genomic JJ O
library NN O
. . O

-DOCSTART- X X O

The DT O
rad9.192 JJ B-NP
DNA NN I-NP
repair NN I-NP
mutant JJ I-NP
from IN I-NP
the DT I-NP
fission NN I-NP
yeast NN I-NP
, , I-NP
Schizosaccharomyces NNP I-NP
pombe NN I-NP
, , O
is VBZ O
sensitive JJ O
to TO O
both DT O
UV NN O
and CC O
ionising NN O
radiation NN O
. . O

-DOCSTART- X X O

The DT O
patient NN O
was VBD O
a DT O
78-year-old JJ O
male NN O
in IN O
whom WP O
skin NN O
lesions NNS O
preceded VBD O
the DT O
diagnosis NN O
of IN O
myelofibrosis NN O
. . O

-DOCSTART- X X O

After IN O
resection NN O
of IN O
the DT O
proximal JJ O
fragment NN O
, , O
all DT O
scaphoid JJ O
contact NN O
area NN O
and CC O
pressure NN O
was VBD O
born VBN O
by IN O
the DT O
distal JJ O
scaphoid JJ O
fragment NN O
. . O

-DOCSTART- X X O

Plate NNP O
luting NN O
, , O
a DT O
technique NN O
that WDT O
uses VBZ O
polymethylmethacrylate NN O
( -LRB- O
PMMA NNP O
) -RRB- O
interposed VBN O
between IN O
the DT O
plate NN O
and CC O
the DT O
bone NN O
, , O
as RB O
well RB O
as IN O
between IN O
the DT O
screw NN O
heads NNS O
and CC O
the DT O
plate NN O
, , O
to TO O
improve VB O
the DT O
stability NN O
of IN O
internal JJ O
fixation NN O
was VBD O
tested VBN O
in IN O
vitro NN O
using VBG O
20 CD O
paired JJ O
equine JJ O
third JJ O
metacarpal NN O
bones NNS O
with IN O
mid-diaphyseal JJ O
osteotomies NNS O
plated VBN O
with IN O
six-hole JJ O
broad JJ O
ASIF NN O
compression NN O
plates NNS O
. . O

-DOCSTART- X X O

Thyroid NNP O
lymphoma NN O
and CC O
its PRP$ O
management NN O
. . O

-DOCSTART- X X O

The DT O
protein NN O
encoded VBN O
by IN O
ORF113 NNP B-NP
contains VBZ O
a DT O
transmembrane NN O
domain NN O
. . O

-DOCSTART- X X O

Dd NNP B-NP
PK1 NNP I-NP
RNA NNP I-NP
decreases VBZ O
after IN O
6 CD O
h NN O
of IN O
starvation NN O
to TO O
re-accumulate VB O
once RB O
the DT O
cells NNS O
have VBP O
aggregated VBN O
. . O

-DOCSTART- X X O

The DT O
various JJ O
forms NNS O
of IN O
sickle JJ O
cell NN O
disease NN O
share NN O
the DT O
common JJ O
feature NN O
of IN O
an DT O
abnormal JJ O
globin NN B-NP
chain NN I-NP
that WDT O
, , O
under IN O
certain JJ O
conditions NNS O
such JJ O
as IN O
hypoxia NN O
, , O
results NNS O
in IN O
the DT O
sickling JJ O
of IN O
red JJ O
blood NN O
cells NNS O
and CC O
obstruction NN O
of IN O
blood NN O
vessels NNS O
. . O

-DOCSTART- X X O

The DT O
primary JJ O
structure NN O
of IN O
each DT O
of IN O
the DT O
three CD O
proteins NNS O
has VBZ O
about RB O
70 CD O
% NN O
homology NN O
with IN O
that DT O
of IN O
mouse NN B-NP
contrapsin NN I-NP
, , O
in IN O
contrast NN O
to TO O
43-46 CD O
% NN O
homology NN O
with IN O
that DT O
of IN O
rat NN B-NP
alpha NN I-NP
1-protease DT I-NP
inhibitor NN O
. . O

-DOCSTART- X X O

Linear NNP O
regression NN O
analysis NN O
was VBD O
performed VBN O
and CC O
the DT O
following VBG O
result NN O
was VBD O
obtained VBN O
: : O
clearance NN O
( -LRB- O
HMPAO NNP O
) -RRB- O
= SYM O
0.07 CD O
+ CD O
0.43 CD O
. . O
rCBF NN O
with IN O
a DT O
high JJ O
significance NN O
( -LRB- O
p NN O
less JJR O
than IN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( -LRB- I-NP
HIV-1 NN I-NP
) -RRB- I-NP
IN IN I-NP
, , O
expressed VBN O
in IN O
Escherichia NNP O
coli NNS O
, , O
was VBD O
purified VBN O
to TO O
near VB O
homogeneity NN O
. . O

-DOCSTART- X X O

Thigh JJ O
girth NN O
correlated VBD O
positively RB O
with IN O
HDL NNP B-NP
and CC O
HDL2-C NNP B-NP
and CC O
mass NN O
, , O
and CC O
with IN O
LDL NNP B-NP
particle NN O
size NN O
among IN O
women NNS O
. . O

-DOCSTART- X X O

Contributions NNS O
from IN O
pairs NNS O
of IN O
source NN O
and CC O
target NN O
volume NN O
elements NNS O
are VBP O
summed VBN O
for IN O
the DT O
S NNP O
values NNS O
between IN O
the DT O
tumor NN O
and CC O
itself PRP O
, , O
between IN O
the DT O
remaining VBG O
healthy JJ O
host NN O
organ NN O
and CC O
itself PRP O
, , O
and CC O
between IN O
the DT O
tumor NN O
and CC O
the DT O
remaining VBG O
healthy JJ O
host NN O
organ NN O
, , O
with IN O
the DT O
reciprocity NN O
theorem NN O
assumed VBD O
for IN O
the DT O
last JJ O
. . O

-DOCSTART- X X O

Paradoxically RB O
, , O
however RB O
, , O
the DT O
GH NNP B-NP
receptor NN I-NP
cloned VBD O
from IN O
liver NN O
exhibits NNS O
no DT O
sequence NN O
similarity NN O
to TO O
receptors NNS O
with IN O
known VBN O
signal NN O
transduction NN O
mechanisms NNS O
, , O
including VBG O
those DT O
exhibiting JJ O
ligand-activated JJ O
tyrosine NN B-NP
kinase NN I-NP
activity NN O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
Ets NNP B-NP
- : O
and CC O
notch-related JJ B-NP
subunits NNS O
in IN O
GA NNP B-NP
binding JJ I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
ileum NN O
, , O
enterotoxin NN O
increased VBD O
the DT O
luminal JJ O
disappearance NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.05 CD O
) -RRB- O
and CC O
peripheral JJ O
blood NN O
appearance NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.001 CD O
) -RRB- O
of IN O
chloroquine NN O
. . O

-DOCSTART- X X O

Formalin NNP O
activated VBD O
both DT O
SNO NNP O
NS NNP O
and CC O
NnS NNP O
neurones NNS O
, , O
but CC O
, , O
when WRB O
they PRP O
responded VBD O
, , O
NS NNS O
neurones NNS O
( -LRB- O
n NN O
= SYM O
5 CD O
) -RRB- O
showed VBD O
only RB O
the DT O
first JJ O
phase NN O
of IN O
activity NN O
while IN O
NnS NNP O
neurones NNS O
showed VBD O
either CC O
one CD O
( -LRB- O
n NN O
= SYM O
13 CD O
) -RRB- O
or CC O
two CD O
phases NNS O
( -LRB- O
n NN O
= SYM O
6 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Uptake NNP O
of IN O
ofloxacin NNP O
by IN O
Escherichia NNP O
coli NNS O

-DOCSTART- X X O

The DT O
effectiveness NN O
of IN O
alpha-mercapto-beta-(2-furyl JJ O
)acrylic JJ O
acid NN O
( -LRB- O
MFA NN O
) -RRB- O
and CC O
N-benzyl-N-dithiocarboxy-D-glucamine JJ O
( -LRB- O
NaB NN O
) -RRB- O
, , O
used VBN O
in IN O
combination NN O
, , O
in IN O
the DT O
mobilization NN O
and CC O
excretion NN O
of IN O
lead NN O
was VBD O
investigated VBN O
in IN O
rats NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
beta-1 NN B-NP
may MD O
act VB O
as IN O
a DT O
tissue-specific JJ O
, , O
trans-acting JJ O
regulator NN O
of IN O
the DT O
expression NN O
of IN O
the DT O
beta-zein JJ B-NP
gene NN I-NP
in IN O
developing VBG O
maize NN O
endosperm NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
examines VBZ O
the DT O
effects NNS O
of IN O
hypovolemia NN O
on IN O
the DT O
extracellular JJ O
ptO2 NN O
and CC O
ptH VB O
distributions NNS O
at IN O
multiple JJ O
tissue NN O
sites NNS O
using VBG O
a DT O
recently RB O
developed VBN O
multipoint JJ O
microelectrode NN O
, , O
that WDT O
provides VBZ O
simultaneous JJ O
measurements NNS O
of IN O
ptO2 NN O
and CC O
ptH. NN O

-DOCSTART- X X O

The DT O
domains VBZ O
involved VBN O
in IN O
superactivation NN O
appear VBP O
to TO O
be VB O
a DT O
subset NN O
of IN O
those DT O
necessary JJ O
to TO O
achieve VB O
synergistic JJ O
activation NN O
. . O

-DOCSTART- X X O

Chlamydia NNP O
trachomatis NN O
and CC O
Chlamydia NNP O
psittaci NNS O
were VBD O
not RB O
affected VBN O
by IN O
methanol NN O
fixation NN O
. . O

-DOCSTART- X X O

Although IN O
human JJ O
infections NNS O
with IN O
bacteraemia NN O
due JJ O
to TO O
Pasteurella NNP O
multocida . O
are VBP O
not RB O
uncommon JJ O
, , O
endocarditis NN O
associated VBN O
with IN O
P. NNP O
haemolytica NN O
is VBZ O
rare JJ O
. . O

-DOCSTART- X X O

For IN O
SMX NNP O
at IN O
pH DT O
7.0, CD O
a DT O
1:1 CD O
complex NN O
is VBZ O
formed VBN O
, , O
but CC O
at IN O
pH RB O
7.5 CD O
HPCD NNP O
has VBZ O
little JJ O
effect NN O
on IN O
the DT O
solubility NN O
of IN O
the DT O
highly RB O
ionized VBN O
SMX NNP O
, , O
presumably RB O
since IN O
only RB O
un-ionized JJ O
molecules NNS O
can MD O
form VB O
inclusion NN O
complexes NNS O
with IN O
the DT O
HPCD. NNP O

-DOCSTART- X X O

PO2 NN O
measurements NNS O
using VBG O
a DT O
double JJ O
barrelled VBN O
recess NN O
type NN O
microelectrodes NNS O
were VBD O
measured VBN O
in IN O
the DT O
optic JJ O
nerve NN O
head NN O
of IN O
miniature JJ O
pigs NNS O
in IN O
normoxia NNS O
and CC O
hyperoxia NN O
. . O

-DOCSTART- X X O

POU-specific JJ B-NP
and CC O
POU-homeo JJ B-NP
domains NNS O
of IN O
Oct3 NNP B-NP
were VBD O
produced VBN O
in IN O
Echerichia NNP O
coli NNS O
for IN O
characterization NN O
of IN O
DNA NNP O
binding NN O
to TO O
the DT O
octamer NN O
sequence NN O
. . O

-DOCSTART- X X O

A DT O
deletion NN O
series NN O
of IN O
the DT O
5' JJ O
flanking NN O
region NN O
was VBD O
created VBN O
from IN O
position NN O
-1329 . O
to TO O
-74 DT O
relative JJ O
to TO O
the DT O
transcriptional JJ O
initiation NN O
site NN O
and CC O
similarly RB O
examined VBN O
in IN O
transgenic JJ O
tobacco NN O
. . O

-DOCSTART- X X O

The DT O
nucleotide JJ O
( -LRB- O
nt NN O
) -RRB- O
sequences NNS O
of IN O
the DT O
exons NNS O
, , O
exon/intron NN O
boundaries NNS O
and CC O
5' JJ O
- : O
and CC O
3'-untranslated JJ O
regions NNS O
were VBD O
determined VBN O
. . O

-DOCSTART- X X O

Out IN O
of IN O
40 CD O
patients NNS O
, , O
who WP O
initially RB O
did VBD O
not RB O
show VB O
eye NN O
complications NNS O
due JJ O
to TO O
leprosy JJ O
, , O
37 CD O
patients NNS O
were VBD O
essentially RB O
the DT O
same JJ O
10 CD O
years NNS O
later RB O
. . O

-DOCSTART- X X O

Toxicity NN O
was VBD O
very RB O
mild JJ O
with IN O
both DT O
regimens NNS O
, , O
although IN O
sedation NN O
was VBD O
significantly RB O
higher JJR O
in IN O
arm NN O
B NNP O
( -LRB- O
p NN O
less JJR O
than IN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Increasing VBG O
mean JJ O
arterial JJ O
pressure NN O
by IN O
phenylephrine NN O
infusion NN O
to TO O
levels NNS O
much RB O
greater JJR O
than IN O
produced VBN O
by IN O
NMA NNP O
and CC O
NNA NNP O
caused VBD O
only RB O
small JJ O
reductions NNS O
in IN O
cardiac JJ O
output NN O
. . O

-DOCSTART- X X O

J. NNP O

-DOCSTART- X X O

With IN O
stepwise NN O
reductions NNS O
in IN O
flow NN O
, , O
the DT O
peak NN O
( -LRB- O
S NNP O
) -RRB- O
and CC O
trough NN O
( -LRB- O
D) JJ O
points NNS O
of IN O
the DT O
maximum NN O
shifted-frequency NN O
envelope NN O
fell VBD O
in IN O
parallel NN O
in IN O
a DT O
linear JJ O
fashion NN O
until IN O
D NNP O
reached VBD O
zero CD O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
promoters NNS O
containing VBG O
a DT O
TATA NNP O
box NN O
in IN O
the DT O
absence NN O
of IN O
Sp1 NNP B-NP
sites NNS I-NP
or CC O
Sp1 VB B-NP
sites NNS I-NP
in IN O
the DT O
absence NN O
of IN O
a DT O
TATA NNP O
box NN O
were VBD O
equally RB O
inducible JJ O
in IN O
vitro NN O
, , O
as RB O
was VBD O
an DT O
RNA NNP B-NP
polymerase NN I-NP
III NNP I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Evaluation NN O
of IN O
left JJ O
ventricular JJ O
function NN O
using VBG O
gated VBD O
planar JJ O
myocardial JJ O
imaging NN O
with IN O
Tc-99m-MIB NNP O
I PRP O

-DOCSTART- X X O

Ivermectin NNP O
uptake NN O
and CC O
distribution NN O
in IN O
the DT O
plasma NN O
and CC O
tissue NN O
of IN O
Sudanese JJ O
and CC O
Mexican JJ O
patients NNS O
infected VBD O
with IN O
Onchocerca NNP O
volvulus NN O
. . O

-DOCSTART- X X O

Bone NNP O
marrow NN O
abnormalities NNS O
in IN O
Hodgkin NNP O
's POS O
disease NN O
are VBP O
reviewed VBN O
and CC O
the DT O
current JJ O
understanding NN O
of IN O
the DT O
pathological JJ O
mechanisms NNS O
leading VBG O
to TO O
aplastic JJ O
anemia NN O
is VBZ O
discussed VBN O
. . O

-DOCSTART- X X O

DNA NNP O
hybridization NN O
analysis NN O
revealed VBN O
that IN O
both DT O
pigmented JJ O
and CC O
nonpigmented JJ O
cells NNS O
of IN O
Y NNP O
. . O
pestis NNS O
possess VBP O
a DT O
DNA NNP O
locus NN O
homologous JJ O
to TO O
the DT O
Escherichia NNP B-NP
coli NNS I-NP
fur NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Expression NN O
was VBD O
cell NN O
cycle NN O
controlled VBN O
, , O
with IN O
steady-state NN O
RNA NN O
levels NNS O
significantly RB O
higher JJR O
in IN O
growth-arrested JJ O
than IN O
in IN O
growth-stimulated JJ O
cells NNS O
. . O

-DOCSTART- X X O

Relationship NN O
between IN O
mitochondrial JJ B-NP
NADH-ubiquinone NN I-NP
reductase NN I-NP
and CC O
a DT O
bacterial JJ B-NP
NAD-reducing JJ I-NP
hydrogenase NN I-NP
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
mRNA JJ O
expression NN O
shows VBZ O
that IN O
AT-BP1 NNP B-NP
and CC O
AT-BP2 NNP B-NP
are VBP O
expressed VBN O
in IN O
all PDT O
the DT O
tissues NNS O
examined VBN O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
two CD O
patients NNS O
receiving VBG O
maintenance NN O
valproate NN O
, , O
one CD O
with IN O
resolving JJ O
acute JJ O
hepatitis NN O
C NNP O
and CC O
the DT O
other JJ O
with IN O
chronic JJ O
persistent JJ O
hepatitis NN O
C NNP O
, , O
with IN O
incidental JJ O
microvesicular JJ O
steatosis NN O
demonstrated VBD O
on IN O
oil-red JJ O
O NNP O
stains NNS O
. . O

-DOCSTART- X X O

If IN O
this DT O
is VBZ O
the DT O
case NN O
, , O
identification NN O
and CC O
characterization NN O
of IN O
transcripts NNS O
from IN O
the DT O
Ig NNP B-NP
loci NNS I-NP
should MD O
permit VB O
a DT O
better JJR O
understanding NN O
of IN O
the DT O
gene NN O
rearrangement NN O
process NN O
. . O

-DOCSTART- X X O

Transcription NN O
of IN O
the DT O
metH NNS B-NP
gene NN I-NP
in IN I-NP
Salmonella NNP I-NP
typhimurium NN I-NP
and CC I-NP
Escherichia NNP I-NP
coli NNS I-NP
is VBZ O
positively RB O
regulated VBN O
by IN O
the DT O
metR NN B-NP
gene NN I-NP
product NN I-NP
, , O
a DT O
DNA NNP O
binding JJ O
protein NN O
. . O

-DOCSTART- X X O

Disruption NN O
of IN O
the DT O
chromosomal NN B-NP
AAR1 NNP I-NP
gene NN I-NP
in IN O
alpha NN O
and CC O
a/alpha NN O
cells NNS O
conferred VBN O
the DT O
nonmating JJ O
phenotype NN O
, , O
and CC O
the DT O
a/alpha NN O
diploids NNS O
could MD O
not RB O
sporulate VB O
. . O

-DOCSTART- X X O

The DT O
ORF NNP O
was VBD O
analyzed VBN O
for IN O
secondary JJ O
structural JJ O
features NNS O
, , O
and CC O
the DT O
sequence NN O
data NNS O
bases NNS O
were VBD O
searched VBN O
for IN O
homologies NNS O
. . O

-DOCSTART- X X O

Mitomycin-C NNP O
can MD O
cause VB O
severe JJ O
necrosis NN O
and CC O
ulceration NN O
when WRB O
extravasated VBN O
inadvertently RB O
into IN O
skin NN O
and CC O
soft JJ O
tissues NNS O
following VBG O
IV NNP O
drug NN O
administration NN O
. . O

-DOCSTART- X X O

INTERVENTIONS NNS O
: : O
Patients NNS O
received VBD O
rt-PA NNP B-NP
, , O
heparin NN O
, , O
and CC O
aspirin NN O
. . O

-DOCSTART- X X O

Consistent NNP O
with IN O
the DT O
in IN O
vivo JJ O
result NN O
, , O
the DT O
pseudorevertant JJ O
endonucleases NNS O
in IN O
the DT O
crude NN O
cell NN O
extract VB O
display NN O
site-specific JJ O
partial JJ O
DNA NN O
cleavage NN O
activity NN O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
reveals VBZ O
that IN O
the DT O
DNA NNP O
binding NN O
domain NN O
of IN O
ILF NNP B-NP
has VBZ O
strong JJ O
homology NN O
to TO O
the DT O
recently RB O
described VBN O
fork NN B-NP
head NN I-NP
DNA NNP I-NP
binding NN I-NP
domain NN I-NP
found VBD O
in IN O
the DT O
Drosophila NNP B-NP
homeotic JJ I-NP
protein NN I-NP
fork NN I-NP
head NN I-NP
and CC O
a DT O
family NN O
of IN O
hepatocyte JJ B-NP
nuclear JJ I-NP
factors NNS I-NP
, , O
HNF-3 JJ B-NP
. . O

-DOCSTART- X X O

Lengthy NNP O
and CC O
repeated VBN O
hemodialyses NNS O
were VBD O
required VBN O
to TO O
lower VB O
lithemia NN O
to TO O
nontoxic JJ O
ranges NNS O
. . O

-DOCSTART- X X O

A DT O
single JJ O
i.p NN O
. . O
injection NN O
of IN O
d JJ O
,l-baclofen JJ O
10 CD O
mg/kg NN O
both DT O
reduced JJ O
noradrenaline NN O
( -LRB- O
NA NNP O
) -RRB- O
biosynthesis NN O
in IN O
vivo FW O
( -LRB- O
31 CD O
% NN O
) -RRB- O
and CC O
the DT O
endogenous JJ O
concentration NN O
of IN O
normetanephrine JJ O
( -LRB- O
NMN) JJ O
( -LRB- O
32 CD O
% NN O
) -RRB- O
and CC O
increased VBD O
NA NNP O
levels NNS O
( -LRB- O
28 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Fufang NNP O
wuzi VBD O
yanzong VBG O
pills NNS O
have VBP O
strong JJ O
leukogenic JJ O
effect NN O
on IN O
cyclophosphamide NN O
induced VBN O
leukopenia NN O
in IN O
mice NNS O
. . O

-DOCSTART- X X O

Mutations NNS O
in IN O
the DT O
small JJ O
subunit NN O
of IN O
ribulosebisphosphate JJ B-NP
carboxylase NN I-NP
affect VBP O
subunit NN O
binding NN O
and CC O
catalysis NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
NZ-107 NNP O
may MD O
be VB O
a DT O
useful JJ O
drug NN O
for IN O
the DT O
treatment NN O
of IN O
bronchial JJ O
asthma NN O
by IN O
reducing VBG O
late-phase JJ O
airway NN O
responses NNS O
and CC O
airway NN O
hyperreactivity NN O
. . O

-DOCSTART- X X O

In IN O
study NN O
2 CD O
, , O
the DT O
correlation NN O
coefficients NNS O
between IN O
the DT O
ISO2 NN O
measurements NNS O
obtained VBN O
at IN O
the DT O
ulcer NN O
margin NN O
and CC O
at IN O
the DT O
adjacent JJ O
normal JJ O
mucosa NN O
, , O
and CC O
delta JJ O
ISO2 NN O
obtained VBN O
by IN O
the DT O
experienced JJ O
observer NN O
and CC O
one CD O
of IN O
the DT O
three CD O
learners NNS O
were VBD O
0.94 CD O
, , O
0.97 CD O
, , O
and CC O
0.94 CD O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Anti-HBc JJ B-NP
production NN O
of IN O
PBMC NNP O
was VBD O
enhanced VBN O
remarkably RB O
in IN O
this DT O
case NN O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
the DT O
sMtCK NN B-NP
genomic JJ I-NP
upstream RB I-NP
sequences NNS I-NP
reveals VBZ O
a DT O
typical JJ O
TATAA JJ O
box NN O
within IN O
the DT O
80 CD O
base NN O
pairs NNS O
( -LRB- O
bp NN O
) -RRB- O
that IN O
, , O
by IN O
transfection NN O
experiments NNS O
, , O
are VBP O
sufficient JJ O
to TO O
promote VB O
expression NN O
of IN O
chimeric JJ O
plasmids NNS O
with IN O
the DT O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
reporter NN I-NP
. . O

-DOCSTART- X X O

The DT O
cDNA NN O
segment NN O
is VBZ O
flanked VBN O
by IN O
the DT O
immunoglobulin NN B-NP
gene NN I-NP
recombination NN I-NP
signal NN I-NP
sequences NNS I-NP
so RB O
that IN O
the DT O
cDNA NN O
segment NN O
can MD O
invert VB O
and CC O
the DT O
human JJ B-NP
IL-2R NN I-NP
L NNP I-NP
chain NN I-NP
is VBZ O
subsequently RB O
expressed VBN O
under IN O
the DT O
control NN O
of IN O
the DT O
SV40 NNP B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Deletion NNP O
of IN O
the DT O
proximal JJ O
octanucleotide NN O
motif NN O
from IN O
the DT O
plasmid NN O
containing VBG O
the DT O
-461 JJ O
fragment NN O
of IN O
the DT O
LPL NNP B-NP
promoter NN I-NP
, , O
resulted VBD O
in IN O
a DT O
79 CD O
and CC O
76 CD O
% NN O
decrease NN O
in IN O
the DT O
level NN O
of IN O
expression NN O
in IN O
transfected VBN O
3T3-L1 JJ O
adipocytes NNS O
and CC O
HepG2 CD O
hepatocytes NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Ventilatory NNP O
management NN O
casebook NN O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
revealed VBN O
that IN O
in IN O
addition NN O
to TO O
the DT O
non-spliced JJ O
variant JJ O
, , O
multiple JJ O
mRNA NN O
species NNS O
were VBD O
generated VBN O
by IN O
alternative JJ O
splicing NN O
resulting VBG O
in IN O
the DT O
exclusion NN O
of IN O
92 CD O
, , O
166 CD O
, , O
170 CD O
, , O
174 CD O
and CC O
263 CD O
nucleotides NNS O
( -LRB- O
nt NN O
) -RRB- O
, , O
respectively RB O
, , O
from IN O
exon NN O
1 CD O
. . O

-DOCSTART- X X O

Position NNP O
22 CD O
is VBZ O
an DT O
isoleucine NN O
in IN O
the DT O
complete JJ B-NP
SsoL12 NN I-NP
protein NN I-NP
sequence NN I-NP
, , O
coded VBN O
by IN O
an DT O
AUA NNP O
codon NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NNS O
, , O
copper NN O
levels NNS O
exert VBP O
some DT O
control NN O
over IN O
the DT O
level NN O
of IN O
SOD1 JJ B-NP
expression NN O
. . O

-DOCSTART- X X O

Of IN O
these DT O
179 CD O
samples NNS O
, , O
Mobiluncus NNP O
SP NNP O
was VBD O
observed VBN O
in IN O
35 CD O
( -LRB- O
19.6 CD O
% NN O
) -RRB- O
using VBG O
Gram NNP O
staining NN O
and CC O
in IN O
18 CD O
( -LRB- O
10.1 CD O
% NN O
) -RRB- O
this DT O
microorganism NN O
was VBD O
isolated VBN O
in IN O
agar JJ O
RLK NN O
and CC O
anaerobic JJ O
atmosphere NN O
. . O

-DOCSTART- X X O

Since IN O
the DT O
morphology NN O
of IN O
the DT O
lesions NNS O
can MD O
mimic VB O
that IN O
of IN O
other JJ O
cutaneous JJ O
disorders NNS O
, , O
Bowen NNP O
's POS O
disease NN O
is VBZ O
often RB O
not RB O
recognized VBN O
initially RB O
. . O

-DOCSTART- X X O

To TO O
lower VB O
the DT O
current JJ O
high JJ O
incidence NN O
of IN O
NANB-induced JJ O
PTH NNP O
, , O
in IN O
1986 CD O
, , O
the DT O
American NNP O
Association NNP O
of IN O
Blood NN O
Banks NNS O
( -LRB- O
AABB NN O
) -RRB- O
recommended VBD O
testing VBG O
for IN O
these DT O
PTH-associated JJ O
" `` O
surrogate VB O
" `` O
markers NNS O
on IN O
all DT O
donated VBN O
units NNS O
of IN O
blood NN O
. . O

-DOCSTART- X X O

Insulin-like JJ B-NP
growth NN I-NP
factor NN I-NP
1 CD I-NP
( -LRB- O
IGF-1 NN B-NP
) -RRB- O
in IN O
burn NN O
patients NNS O
. . O

-DOCSTART- X X O

Fusion NN O
of IN O
ubiquitin NNP B-NP
to TO O
pADPRP VB B-NP
increased VBN O
the DT O
yield NN O
of IN O
pADPRP JJ B-NP
approximately RB O
10-fold JJ O
compared VBN O
to TO O
that DT O
of IN O
the DT O
unfused JJ O
enzyme NN O
. . O

-DOCSTART- X X O

In IN O
group NN O
III NNP O
, , O
patients NNS O
also RB O
received VBD O
their PRP$ O
own JJ O
mediastinal JJ O
drainage NN O
blood NN O
, , O
shed VBD O
for IN O
6 CD O
hours NNS O
after IN O
operation NN O
, , O
after IN O
concentration NN O
and CC O
washing VBG O
in IN O
a DT O
MBRS. NNP O

-DOCSTART- X X O

The DT O
suppression NN O
was VBD O
also RB O
demonstrated VBN O
in IN O
a DT O
transient JJ O
expression NN O
assay NN O
in IN O
vivo JJ O
using VBG O
isolated VBN O
barley NN O
endosperms NNS O
. . O

-DOCSTART- X X O

The DT O
examinations NNS O
were VBD O
performed VBN O
on IN O
two CD O
groups NNS O
of IN O
20 CD O
(using NN O
AmF/SnF2)-, JJ O
resp. NN O

-DOCSTART- X X O

RNA NNP O
gel NNP O
retardation NN O
and CC O
competition NN O
analyses NNS O
indicate VBP O
that IN O
TRP-185 DT B-NP
binding NN O
is VBZ O
strongly RB O
dependent JJ O
on IN O
the DT O
TAR NNP O
RNA NNP O
loop NN O
sequences NNS O
. . O

-DOCSTART- X X O

The DT O
vaccine NN O
used VBD O
was VBD O
known VBN O
to TO O
be VB O
immunogenic JJ O
for IN O
older JJR O
children NNS O
and CC O
adults NNS O
. . O

-DOCSTART- X X O

Both DT O
groups NNS O
then RB O
underwent IN O
hypnotic JJ O
induction NN O
, , O
and CC O
completed VBD O
the DT O
test NN O
again RB O
( -LRB- O
R2 UH O
) -RRB- O
. . O

-DOCSTART- X X O

Applications NNS O
of IN O
three-dimensional JJ O
analysis NN O
to TO O
the DT O
auditory JJ O
P300 CD O
. . O

-DOCSTART- X X O

The DT O
construct VB O
was VBD O
introduced VBN O
into IN O
BW2001 CD O
(xth-11 NN O
, , O
nfo-2 NN O
) -RRB- O
strain NN O
cells NNS O
of IN O
Escherichia NNP O
coli NNS O
. . O

-DOCSTART- X X O

Recombinant JJ B-NP
human JJ I-NP
TFIID NN I-NP
supported VBD O
weak JJ O
basal NN O
transcription NN O
in IN O
heat-treated JJ O
nuclear JJ O
extracts NNS O
whereas IN O
a DT O
partially RB O
purified VBN O
TFIID NNP B-NP
fraction NN O
from IN O
HeLa NNP O
cells NNS O
reconstituted VBD O
a DT O
maximal JJ O
level NN O
of IN O
transcription NN O
. . O

-DOCSTART- X X O

Only RB O
after IN O
a DT O
pretreatment NN O
aimed VBN O
at IN O
increasing VBG O
its PRP$ O
oxide NN O
surface NN O
layer NN O
was VBD O
titanium NN O
powder NN O
found VBD O
to TO O
accelerate VB O
the DT O
precipitation NN O
from IN O
solutions NNS O
containing VBG O
2 CD O
mmol/L JJ O
CaCl2 NNP O
, , O
2 CD O
mmol/L JJ O
KH2PO4 NNP O
, , O
50 CD O
mmol/L JJ O
Hepes NNP O
, , O
pH RB O
7.2 CD O
, , O
and CC O
to TO O
induce VB O
precipitation NN O
from IN O
metastable JJ O
solutions NNS O
containing VBG O
1.2 CD O
mmol/L JJ O
CaCl2 NNP O
, , O
1.2 CD O
mmol/L NN O
KH2PO4 NNP O
, , O
50 CD O
mmol/L JJ O
Hepes NNP O
, , O
pH RB O
7.2 CD O
, , O
at IN O
37 CD O
degrees NNS O
C. NNP O

-DOCSTART- X X O

Neither DT O
model NN O
, , O
as IN O
applied VBD O
, , O
provided VBD O
a DT O
satisfactory JJ O
account NN O
of IN O
the DT O
effects NNS O
of IN O
the DT O
main JJ O
variables NNS O
of IN O
number NN O
of IN O
tones NNS O
and CC O
amount NN O
of IN O
perturbation NN O
.(ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
400 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

( -LRB- O
2 CD O
) -RRB- O
Diffusion NN O
limitation NN O
in IN O
the DT O
heterogeneous JJ O
model NN O
sets NNS O
in IN O
at IN O
a DT O
lower JJR O
O2 IN O
requirement NN O
value NN O
, , O
and CC O
increases NNS O
more RBR O
gradually RB O
with IN O
increasing VBG O
O2 JJ O
requirement NN O
, , O
than IN O
in IN O
the DT O
corresponding JJ O
homogeneous JJ O
models NNS O
with IN O
the DT O
same JJ O
average NN O
cylinder NN O
diameter NN O
. . O

-DOCSTART- X X O

At IN O
the DT O
time NN O
of IN O
the DT O
seizure NN O
, , O
the DT O
patient NN O
was VBD O
asked VBN O
to TO O
read VB O
a DT O
test NN O
phrase NN O
aloud RB O
until IN O
it PRP O
was VBD O
read VBN O
correctly RB O
and CC O
clearly RB O
. . O

-DOCSTART- X X O

Echinococcus NNP O
granulosus NN O
was VBD O
diagnosed VBN O
by IN O
fine-needle JJ O
aspiration NN O
cytology NN O
of IN O
a DT O
lung NN O
cyst NN O
in IN O
a DT O
6-yr-old JJ O
white JJ O
female NN O
in IN O
central JJ O
Missouri NNP O
. . O

-DOCSTART- X X O

The DT O
sequence NN O
was VBD O
determined VBN O
of IN O
6493 CD O
nucleotides NNS O
encompassing VBG O
the DT O
bet NN B-NP
genes NNS I-NP
of IN I-NP
Escherichia NNP I-NP
coli NNS I-NP
which WDT O
encode VBP O
the DT O
osmoregulatory NN O
choline-glycine NN O
betaine NN O
pathway NN O
. . O

-DOCSTART- X X O

Confocal NNP O
fluorescence NN O
microscopy NN O
in IN O
modern JJ O
cell NN O
biology NN O
. . O

-DOCSTART- X X O

Fortunately RB O
DDT-, NNP O
HCH- NNP O
and CC O
HCB-levels NNP O
decreased VBD O
in IN O
breast NN O
milk NN O
during IN O
the DT O
last JJ O
years NNS O
. . O

-DOCSTART- X X O

A DT O
herpesvirus NN O
proteinase NN O
activity NN O
has VBZ O
been VBN O
identified VBN O
and CC O
partially RB O
characterized VBN O
by IN O
using VBG O
the DT O
cloned JJ O
enzyme NN O
and CC O
substrate JJ O
genes NNS O
in IN O
transient JJ O
transfection NN O
assays VBZ O
. . O

-DOCSTART- X X O

Adult NN O
H NNP O
, , O
but CC O
not RB O
R, NNP O
manifested VBD O
the DT O
burrowing NN O
preference NN O
whenever WRB O
offered VBN O
the DT O
opportunity NN O
. . O

-DOCSTART- X X O

The DT O
rear JJ O
silver NN O
liquid JJ O
chamber NN O
was VBD O
threefold JJ O
thick JJ O
to TO O
17 CD O
MeV NNP O
protons NNS O
in IN O
water NN O
and CC O
it PRP O
efficiently RB O
produced VBD O
either DT O
13N JJ O
by IN O
the DT O
16O(p JJ O
, , O
alpha)13N JJ O
reaction NN O
or CC O
[18F]fluoride VB O
ion NN O
by IN O
the DT O
18O(p JJ O
, , O
n)18F JJ O
reaction NN O
. . O

-DOCSTART- X X O

Heterogeneous NNP O
electron NN O
transfer NN O
of IN O
cytochrome NN B-NP
c NNS I-NP
facilitated VBN O
by IN O
polypyrrole NN O
and CC O
methylene NN O
blue JJ O
polypyrrole NN O
film NN O
modified VBN O
electrodes NNS O
. . O

-DOCSTART- X X O

Selective JJ O
activation NN O
of IN O
adrenaline NN O
secretion NN O
by IN O
the DT O
rat NN O
adrenal NN O
in IN O
neuroglycopenia NN O
detected VBN O
via IN O
microdialysis NN O

-DOCSTART- X X O

Urine NN O
specimens NNS O
containing VBG O
either DT O
phencyclidine JJ O
(PCP NNS O
) -RRB- O
or CC O
11-nor-delta CD O
9-tetrahydrocannabinol-9-carboxylic JJ O
acid NN O
( -LRB- O
9-THC-COOH) CC O
were VBD O
adulterated VBN O
with IN O
sodium NN O
chloride NN O
, , O
bleach JJ O
, , O
vinegar NN O
, , O
potassium NN O
hydroxide NN O
, , O
liquid JJ O
soap NN O
, , O
2-propanol JJ O
, , O
and CC O
ammonia NN O
. . O

-DOCSTART- X X O

Four CD O
putative JJ O
positive JJ O
cDNA NN O
clones NNS O
were VBD O
isolated VBN O
, , O
and CC O
the DT O
largest JJS O
insert NN O
(pASB-1 NN O
) -RRB- O
was VBD O
sequenced VBN O
in IN O
both DT O
orientations NNS O
. . O

-DOCSTART- X X O

Sci NNS O
. . O

-DOCSTART- X X O

Dose NNP O
standardisation NN O
of IN O
botulinum NN B-NP
toxin NN I-NP
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
the DT O
beta-adrenergic JJ O
agonist NN O
, , O
isoproterenol NN O
, , O
has VBZ O
little JJ O
influence NN O
on IN O
vascular JJ O
capacitance NN O
or CC O
liver NN O
volume NN O
of IN O
dogs NNS O
, , O
unless IN O
the DT O
hepatic JJ O
outflow NN O
resistance NN O
is VBZ O
elevated VBN O
by IN O
agents NNS O
such JJ O
as IN O
histamine NN O
. . O

-DOCSTART- X X O

DNA NNP O
sequence NN O
and CC O
evolution NN O
of IN O
the DT O
CPS NNP B-NP
domain NN I-NP
of IN O
the DT O
Syrian JJ B-NP
hamster NN I-NP
multifunctional JJ I-NP
protein NN I-NP
CAD. . I-NP

-DOCSTART- X X O

A DT O
high-frequency NN O
restriction NN O
fragment NN O
length NN O
polymorphism NN O
was VBD O
evident JJ O
in IN O
the DT O
DNA NN O
from IN O
29 CD O
unrelated JJ O
individuals NNS O
using VBG O
the DT O
enzyme NN O
BglII NNP B-NP
. . O

-DOCSTART- X X O

The DT O
antilog JJ O
transformation NN O
of IN O
pH NNS O
did VBD O
not RB O
improve VB O
the DT O
results NNS O
. . O

-DOCSTART- X X O

Telomeres NNP O
prevent VBP O
end-to-end JJ O
fusions NNS O
and CC O
exonucleolytic JJ O
degradation NN O
, , O
enable VB O
the DT O
end NN O
of IN O
the DT O
linear JJ O
DNA NNP O
molecule NN O
to TO O
replicate VB O
, , O
and CC O
function NN O
in IN O
cell NN O
division NN O
. . O

-DOCSTART- X X O

One CD O
of IN O
these DT O
is VBZ O
located VBN O
in IN O
the DT O
5'-untranslated JJ O
region NN O
, , O
and CC O
may MD O
encode VB O
regulatory JJ O
sequences NNS O
. . O

-DOCSTART- X X O

The DT O
native JJ O
enzyme NN O
purified VBN O
from IN O
protease-B-deficient JJ B-NP
URA2-transformed JJ B-NP
cells NNS O
, , O
was VBD O
phosphorylated VBN O
in IN O
vitro NN O
using VBG O
catalytic JJ O
subunits NNS O
of IN O
pure JJ O
cAMP-dependent JJ B-NP
protein NN I-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

This DT O
study NN O
suggests VBZ O
that IN O
BSPMs NNP O
are VBP O
useful JJ O
in IN O
the DT O
assessment NN O
of IN O
AMI NNP O
in IN O
terms NNS O
of IN O
diagnosis NN O
, , O
location NN O
and CC O
extent NN O
of IN O
myocardial JJ O
infarct NN O
. . O

-DOCSTART- X X O

A DT O
bovine NN O
abomasum IN O
lambda NN O
gt11 IN O
cDNA DT O
library NN O
was VBD O
screened VBN O
with IN O
a DT O
monoclonal JJ O
antibody NN O
raised VBD O
against IN O
the DT O
rabbit NN B-NP
H,K-ATPase NN I-NP
beta NN I-NP
subunit NN I-NP
. . O

-DOCSTART- X X O

Characterization NN O
of IN O
the DT O
5' JJ O
end NN O
of IN O
the DT O
growth-regulated JJ O
Syrian JJ B-NP
hamster NN I-NP
CAD NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Examination NNP O
of IN O
immediate-early JJ B-NP
transcription NN I-NP
factor NN I-NP
expression NN O
during IN O
the DT O
MDI NNP O
regimen NNS O
revealed VBD O
that IN O
RA NNP O
mediated VBD O
an DT O
elevated JJ O
, , O
prolonged JJ O
expression NN O
of IN O
c-Jun JJ B-NP
mRNA NN I-NP
accompanied VBN O
by IN O
diminished JJ O
expression NN O
of IN O
c-Fos JJ B-NP
and CC O
Jun-B NNP B-NP
mRNAs NNS I-NP
. . O

-DOCSTART- X X O

Although IN O
heart NN O
rate NN O
and CC O
diastolic JJ O
pressure NN O
rose VBD O
in IN O
some DT O
degree NN O
1 CD O
min NN O
after IN O
intubation NN O
, , O
free JJ O
and CC O
total JJ O
CA NNP O
concentrations NNS O
did VBD O
not RB O
increase NN O
during IN O
study NN O
period NN O
. . O

-DOCSTART- X X O

Processing NNP O
, , O
secretion NN O
, , O
and CC O
immunoreactivity NN O
of IN O
carboxy NN B-NP
terminally RB I-NP
truncated VBD I-NP
dengue-2 NN I-NP
virus NN I-NP
envelope NN I-NP
proteins VBZ I-NP
expressed VBN O
in IN O
insect NN O
cells NNS O
by IN O
recombinant JJ O
baculoviruses NNS O
. . O

-DOCSTART- X X O

Combined VBN O
therapy NN O
with IN O
MK-801 JJ O
and CC O
nimodipine JJ O
for IN O
protection NN O
of IN O
ischemic JJ O
brain NN O
damage NN O
. . O

-DOCSTART- X X O

Initial JJ O
screening NN O
of IN O
a DT O
rat NN O
liver NN O
cDNA NN O
library NN O
with IN O
an DT O
oligonucleotide JJ O
probe NN O
derived VBN O
from IN O
the DT O
rat NN O
SCP2 JJ B-NP
protein NN O
sequence NN O
revealed VBD O
an DT O
825-base JJ O
pair NN O
cDNA NN O
clone NN O
coding NN O
for IN O
the DT O
complete JJ O
SCP2 JJ B-NP
protein NN O
sequence NN O
. . O

-DOCSTART- X X O

The DT O
addition NN O
of IN O
an DT O
equimolar JJ O
complex NN O
of IN O
the DT O
fourth JJ O
and CC O
seventh JJ O
largest JJS O
subunits NNS O
, , O
purified VBN O
from IN O
pol JJ B-NP
II NNP I-NP
holoenzyme NN I-NP
by IN O
ion-exchange JJ O
chromatography NN O
in IN O
the DT O
presence NN O
of IN O
urea NN O
, , O
restored VBN O
promoter-directed JJ O
initiation NN O
activity NN O
to TO O
pol VB B-NP
II NNP I-NP
delta JJ I-NP
4/7 CD I-NP
. . O

-DOCSTART- X X O

We PRP O
report VBP O
here RB O
the DT O
identification NN O
of IN O
HSF NNP B-NP
in IN O
the DT O
fission NN O
yeast NN O
Schizosaccharomyces NNP O
pombe VBD O
. . O

-DOCSTART- X X O

Induction NN O
requires VBZ O
the DT O
ACE1 NNP B-NP
gene NN I-NP
product NN I-NP
, , O
which WDT O
binds VBZ O
to TO O
specific JJ O
sites NNS O
in IN O
the DT O
promoter NN O
region NN O
of IN O
the DT O
CUP1 NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Gel NNP O
mobility NN O
shift NN O
assays VBZ O
using VBG O
a DT O
synthetic JJ O
E6 NNP B-NP
motif NN I-NP
detected VBD O
a DT O
B-cell-specific JJ O
complex NN O
in IN O
addition NN O
to TO O
a DT O
ubiquitous JJ O
band NN O
found VBD O
also RB O
in IN O
T NNP O
cells NNS O
and CC O
HeLa NNP O
cells NNS O
. . O

-DOCSTART- X X O

Seven CD O
clones NNS O
encoding JJ O
interferon NN B-NP
response NN I-NP
element NN I-NP
binding JJ I-NP
factors NNS I-NP
have VBP O
been VBN O
isolated VBN O
from IN O
a DT O
mouse NN O
fibroblast NN O
lambda VBD O
gt11 CD O
cDNA NN O
library NN O
by IN O
using VBG O
a DT O
32P JJ O
end-labeled JJ O
tandem NN O
trimer NN O
of IN O
the DT O
mouse NN B-NP
( -LRB- I-NP
2'-5')oligoadenylate JJ I-NP
synthetase NN I-NP
gene NN I-NP
interferon JJ O
response NN O
element NN O
as IN O
a DT O
probe NN O
. . O

-DOCSTART- X X O

Adenylosuccinate NNP B-NP
synthetase NN I-NP
( -LRB- O
IMP:L-aspartate NN O
ligase NN B-NP
( -LRB- O
GDP NNP O
) -RRB- O
, , O
EC NNP B-NP
6.3.4.4 CD I-NP
) -RRB- O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
purine NN O
biosynthesis NN O
catalyzing VBG O
the DT O
GTP-dependent JJ O
conversion NN O
of IN O
IMP NNP O
to TO O
AMP. NNP O

-DOCSTART- X X O

Immunophenotyping NNP O
in IN O
four CD O
cases NNS O
, , O
demonstrated VBD O
non-B JJ O
, , O
non-T JJ O
cell NN O
origin NN O
in IN O
three CD O
and CC O
pre-B JJ O
cell NN O
origin NN O
in IN O
one CD O
. . O

-DOCSTART- X X O

DNA-protein NNP O
UV NN O
cross-linking NN O
studies NNS O
indicated VBD O
that IN O
UHF-1 NNP B-NP
has VBZ O
an DT O
electrophoretic JJ O
mobility NN O
on IN O
sodium NN O
dodecyl NN O
sulfate-acrylamide JJ O
gels NNS O
of IN O
approximately RB O
85 CD O
kDa NN O
and CC O
suggested VBD O
that IN O
additional JJ O
proteins NNS O
, , O
specific JJ O
to TO O
each DT O
promoter NN O
, , O
bind NN O
to TO O
each DT O
site NN O
. . O

-DOCSTART- X X O

The DT O
specific JJ O
interaction NN O
between IN O
a DT O
defined VBN O
structural JJ O
element NN O
of IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
mRNA NN O
( -LRB- O
RRE NNP B-NP
, , O
the DT O
Rev NNP B-NP
response NN I-NP
element NN I-NP
) -RRB- O
and CC O
the DT O
virus-encoded JJ B-NP
protein NN I-NP
Rev NNP I-NP
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
regulation NN O
of IN O
the DT O
export NN O
of IN O
unspliced JJ O
or CC O
singly RB O
spliced VBN O
mRNA NN O
from IN O
the DT O
nucleus JJ O
to TO O
the DT O
cytoplasm NN O
. . O

-DOCSTART- X X O

Alanine NNP B-NP
aminotransferase NN I-NP
in IN O
clinical JJ O
practice NN O
. . O

-DOCSTART- X X O

DNA NN O
from IN O
PCR NNP O
was VBD O
labeled VBN O
and CC O
used VBN O
to TO O
isolate VB O
several JJ O
lambda NN O
gt11 IN O
cDNA NN O
clones NNS O
, , O
including VBG O
one CD O
full-length JJ O
one CD O
( -LRB- O
Dd JJ B-NP
kinase-2 NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

Radiation-induced JJ O
changes NNS O
in IN O
the DT O
area NN O
of IN O
alveoli NNS O
and CC O
septa NN O
as RB O
well RB O
as IN O
collagen NN B-NP
content NN O
were VBD O
seen VBN O
11 CD O
weeks NNS O
after IN O
irradiation NN O
. . O

-DOCSTART- X X O

The DT O
first JJ O
follow-up NN O
was VBD O
at IN O
a DT O
nearly RB O
constant JJ O
interval NN O
of IN O
5.1 CD O
years NNS O
in IN O
Caerphilly NNP O
and CC O
3.2 CD O
years NNS O
in IN O
Speedwell NNP O
; : O
251 CD O
major JJ O
IHD NNP O
events NNS O
had VBD O
occurred VBN O
. . O

-DOCSTART- X X O

Perilunar NNP O
luxation--an NN O
unusual JJ O
injury NN O
demanding VBG O
immediate JJ O
and CC O
correct JJ O
treatment NN O

-DOCSTART- X X O

Landsberg NNP O
( -LRB- O
La-O NNP O
) -RRB- O
and CC O
cv. VBG O

-DOCSTART- X X O

Isoform NNP B-NP
C NNP I-NP
beta NN I-NP
2 CD I-NP
, , O
an DT O
unusual JJ O
form NN O
of IN O
the DT O
bovine NN O
catalytic JJ O
subunit NN O
of IN O
cAMP-dependent JJ B-NP
protein NN I-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

Salient NNP O
applications NNS O
of IN O
PB-PK NNP O
modeling VBG O
to TO O
toxicological JJ O
problems NNS O
are VBP O
illustrated VBN O
with IN O
examples NNS O
. . O

-DOCSTART- X X O

Occupational NNP O
asthma NN O
and CC O
rhinoconjunctivitis NN O
from IN O
inhalation NN O
of IN O
crystalline NN O
bovine NN B-NP
serum NN I-NP
albumin NN I-NP
powder NN O
. . O

-DOCSTART- X X O

A DT O
further JJ O
subdivision NN O
of IN O
Category NNP O
pN1 . O
into IN O
pN1a DT O
( -LRB- O
metastasis NN O
in IN O
single JJ O
node NN O
) -RRB- O
and CC O
pN1b JJ O
( -LRB- O
two CD O
or CC O
more JJR O
nodes NNS O
) -RRB- O
is VBZ O
recommended VBN O
. . O

-DOCSTART- X X O

Amino NNP O
acid NN O
sequence NN O
comparisons NNS O
of IN O
the DT O
E74A JJ B-NP
protein NN I-NP
reveal VBP O
a DT O
highly RB O
conserved VBN O
C-terminal JJ O
region NN O
that WDT O
is VBZ O
rich JJ O
in IN O
basic JJ O
amino IN O
acid NN O
residues NNS O
and CC O
which WDT O
has VBZ O
been VBN O
proposed VBN O
to TO O
possess VB O
sequence-specific JJ O
DNA NNP O
binding NN O
activity NN O
. . O

-DOCSTART- X X O

Age NNP O
at IN O
POI NNP O
and CC O
asymptote NN O
were VBD O
achieved VBN O
later RB O
for IN O
Line NNP O
RBC2 NNP O
than IN O
for IN O
Line NNP O
F. NNP O

-DOCSTART- X X O

A DT O
dose NN O
of IN O
3 CD O
and CC O
6 CD O
micrograms/kg/day NN O
GM-CSF NNP B-NP
reduces VBZ O
the DT O
severity NN O
of IN O
neutropenia NN O
and CC O
thrombocytopenia NN O
after IN O
carboplatin-cyclophosphamide NN O
chemotherapy NN O
, , O
which WDT O
may MD O
lead VB O
to TO O
more RBR O
effective JJ O
chemotherapy NN O
for IN O
ovarian JJ O
cancer NN O
in IN O
the DT O
future NN O
. . O

-DOCSTART- X X O

I PRP O
propose VBP O
that IN O
their PRP$ O
gene NN O
products NNS O
bind VBP O
to TO O
the DT O
chromatin NN O
to TO O
establish VB O
or CC O
maintain VB O
a DT O
proper JJ O
higher JJR O
order NN O
structure NN O
as IN O
a DT O
prerequisite NN O
for IN O
a DT O
regulated JJ O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

The DT O
C4BP NNP B-NP
alpha NN I-NP
gene NN I-NP
is VBZ O
organized VBN O
as IN O
follows VBZ O
: : O
the DT O
first JJ O
exon NN O
codes NNS O
for IN O
the DT O
first JJ O
198 CD O
nucleotides NNS O
of IN O
the DT O
5' JJ O
UTR. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( -LRB- I-NP
HIV-1 NN I-NP
) -RRB- I-NP
Rev NNP I-NP
protein NN I-NP
is VBZ O
a DT O
positive JJ O
posttranscriptional JJ O
regulator NN O
of IN O
viral JJ O
structural JJ O
gene NN O
expression NN O
and CC O
essential JJ O
for IN O
virus NN O
replication NN O
. . O

-DOCSTART- X X O

Once RB O
the DT O
proliferation NN O
of IN O
fibroblasts NNS O
and CC O
collagen NN B-NP
synthesis NN O
had VBD O
led VBN O
to TO O
an DT O
increase NN O
of IN O
mechanical JJ O
strength NN O
, , O
no DT O
negative JJ O
effect NN O
on IN O
wound NN O
healing NN O
could MD O
be VB O
detected VBN O
applying VBG O
the DT O
same JJ O
chemotherapeutic NN O
agents NNS O
. . O

-DOCSTART- X X O

The DT O
CDC7 NNP B-NP
gene NN I-NP
has VBZ O
two CD O
in-frame JJ O
AUG NNP O
codons NNS O
as IN O
possible JJ O
translation NN O
start VB O
sites NNS O
, , O
which WDT O
would MD O
produce VB O
58 CD O
- : O
and CC O
56-kDa JJ O
proteins NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

During IN O
the DT O
years NNS O
1980-87 CD O
a DT O
total NN O
of IN O
287 CD O
persons NNS O
received VBD O
disability NN O
pensions NNS O
in IN O
the DT O
municipality NN O
of IN O
Nordreisa NNP O
in IN O
northern JJ O
Norway NNP O
. . O

-DOCSTART- X X O

HeLa NNP O
and CC O
Jurkat NNP O
cell NN O
lines NNS O
carrying VBG O
the DT O
nef JJ B-NP
gene NN I-NP
linked VBN O
to TO O
the DT O
CMV NNP O
promoter NN O
or CC O
the DT O
HIV-1 NN B-NP
LTR NNP I-NP
were VBD O
isolated VBN O
by IN O
coselection NN O
for IN O
neomycin JJ O
resistance NN O
. . O

-DOCSTART- X X O

MEASUREMENTS NNS O
AND CC O
MAIN NNP O
RESULTS NNS O
: : O
The DT O
two CD O
groups NNS O
were VBD O
similar JJ O
on IN O
entry NN O
into IN O
the DT O
study NN O
, , O
including VBG O
mean JJ O
FEV1 NN O
measurements NNS O
( -LRB- O
0.70 CD O
L NNP O
atropine/0.60 IN O
L NNP O
metaproterenol NN O
, , O
P NNP O
greater JJR O
than IN O
.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
view NN O
of IN O
the DT O
short JJ O
t1/2 NN O
, , O
we PRP O
used VBD O
three CD O
doses/day NN O
. . O

-DOCSTART- X X O

Temporal JJ O
control NN O
of IN O
GUS NNP B-NP
expression NN O
was VBD O
found VBN O
to TO O
involve VB O
two CD O
negative JJ O
regulatory JJ O
sequences NNS O
, , O
NRS1 NNP O
(-391 CD O
to TO O
-295 DT O
) -RRB- O
and CC O
NRS2 NNP O
(-518 CD O
to TO O
-418 CD O
) -RRB- O
, , O
as RB O
well RB O
as IN O
the DT O
positive JJ O
domain NN O
UAS1 NNP O
. . O

-DOCSTART- X X O

In IN O
most JJS O
cases NNS O
, , O
DR4-homozygous JJ B-NP
, , O
DRB1-heterozygous JJ B-NP
individuals NNS O
could MD O
be VB O
genotyped VBN O
with IN O
the DT O
panel NN O
of IN O
probes NNS O
. . O

-DOCSTART- X X O

Two CD O
patients NNS O
had VBD O
immediate JJ O
adverse JJ O
effects NNS O
from IN O
NMF NNP O
; : O
one CD O
had VBD O
a DT O
grand JJ O
mal JJ O
seizure NN O
and CC O
the DT O
other JJ O
developed JJ O
severe JJ O
abdominal JJ O
pain NN O
. . O

-DOCSTART- X X O

The DT O
muscles NNS O
from IN O
the DT O
ischemic JJ O
group NN O
had VBD O
significantly RB O
lower JJR O
( -LRB- O
P NNP O
less RBR O
than IN O
.05 CD O
) -RRB- O
values NNS O
for IN O
capillary NN O
density NN O
and CC O
capillary NN O
to TO O
fiber NN O
ratio NN O
and CC O
significantly RB O
higher JJR O
intercapillary NN O
distance NN O
than IN O
those DT O
from IN O
the DT O
normal JJ O
group NN O
. . O

-DOCSTART- X X O

Polymerase NN O
chain NN O
reaction NN O
analysis NN O
of IN O
ETS1 JJ B-NP
cDNA NN I-NP
identified VBN O
several JJ O
amplified JJ O
products NNS O
, , O
indicating VBG O
alternative JJ O
splicing NN O
. . O

-DOCSTART- X X O

Most JJS O
of IN O
the DT O
expressed VBN O
human JJ B-NP
E3 NN I-NP
polypeptides NNS I-NP
( -LRB- O
five CD O
bands NNS O
) -RRB- O
were VBD O
found VBN O
in IN O
the DT O
insoluble JJ O
pellet NN O
while IN O
primarily RB O
full-length JJ B-NP
mature JJ I-NP
E3 NNS I-NP
was VBD O
found VBN O
in IN O
the DT O
soluble JJ O
fraction NN O
. . O

-DOCSTART- X X O

Two CD O
homologues NNS O
of IN O
the DT O
rhombotin NNP B-NP
gene NN I-NP
have VBP O
now RB O
been VBN O
isolated VBN O
. . O

-DOCSTART- X X O

Angina NNP O
haemorrhagica VBD O
bullosa NN O
causing VBG O
respiratory JJ O
obstruction NN O
postoperatively RB O
. . O

-DOCSTART- X X O

Conclusion NNP O
: : O
inlet NN O
type NN O
VSD NNP O
and CC O
perimembranous JJ O
type NN O
TOF NN O
have VBP O
anatomic JJ O
features NNS O
in IN O
which WDT O
the DT O
proximal JJ O
His PRP$ O
bundle NN O
tends VBZ O
to TO O
be VB O
jeopardized VBN O
by IN O
suturing VBG O
for IN O
VSD NNP O
closure NN O
. . O

-DOCSTART- X X O

The DT O
gcd2-503 JJ B-NP
mutation NN O
also RB O
results VBZ O
in IN O
polysome DT O
runoff NN O
, , O
accumulation NN O
of IN O
inactive JJ O
80S CD B-NP
ribosomal JJ I-NP
couples NNS I-NP
, , O
and CC O
accumulation NN O
of IN O
at IN O
least JJS O
one CD O
of IN O
the DT O
subunits NNS O
of IN O
the DT O
general JJ B-NP
translation NN I-NP
initiation NN I-NP
factor NN I-NP
2 CD I-NP
(eIF-2 JJ O
alpha NN B-NP
) -RRB- O
in IN O
43S-48S DT B-NP
particles NNS O
following VBG O
a DT O
shift NN O
to TO O
the DT O
restrictive JJ O
temperature NN O
. . O

-DOCSTART- X X O

To TO O
measure VB O
the DT O
enhancer NN O
activity NN O
of IN O
DR60 NNP B-NP
, , O
a DT O
reporter NN O
plasmid NN O
was VBD O
constructed VBN O
that IN O
contained VBN O
DR60 NNP B-NP
cloned VBD O
upstream RB O
of IN O
the DT O
reporter NN O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
gene NN I-NP
under IN O
the DT O
control NN O
of IN O
the DT O
delayed-early JJ O
39K JJ O
promoter NN O
. . O

-DOCSTART- X X O

A DT O
single JJ O
case NN O
of IN O
an DT O
adenocarcinoma NN O
, , O
arising VBG O
in IN O
a DT O
retroperitoneal NN O
enterogenous JJ O
cyst NN O
and CC O
which WDT O
presented VBD O
as IN O
a DT O
left JJ O
renal JJ O
cyst NN O
, , O
is VBZ O
reported VBN O
. . O

-DOCSTART- X X O

Using VBG O
the DT O
polymerase NN O
chain NN O
reaction NN O
, , O
we PRP O
analyzed VBD O
the DT O
U6 NNP B-NP
RNA NNP I-NP
genes NNS I-NP
of IN O
52 CD O
organisms NNS O
. . O

-DOCSTART- X X O

Hydrophobicity NN O
analysis NN O
indicated VBN O
that IN O
the DT O
KlaA NNP B-NP
and CC O
KlaB NNP B-NP
polypeptides NNS I-NP
are VBP O
likely JJ O
to TO O
be VB O
soluble JJ O
, , O
whereas IN O
the DT O
KlaC NNP B-NP
polypeptide NN I-NP
was VBD O
predicted VBN O
to TO O
have VB O
four CD O
potential JJ O
membrane-spanning NN O
domains NNS O
. . O

-DOCSTART- X X O

The DT O
remainder NN O
( -LRB- O
18.4 CD O
% NN O
) -RRB- O
was VBD O
with IN O
IgA NNP B-NP
nephropathy NN O
, , O
which WDT O
was VBD O
histologically RB O
mild JJ O
. . O

-DOCSTART- X X O

3. . O

-DOCSTART- X X O

To TO O
determine VB O
whether IN O
mononuclear JJ O
cell NN O
secretory NN O
products NNS O
contribute VBP O
to TO O
the DT O
changes NNS O
in IN O
bone NN O
turnover NN O
that WDT O
characterize VBP O
the DT O
development NN O
of IN O
postmenopausal JJ O
osteoporosis NN O
, , O
we PRP O
evaluated VBD O
the DT O
effects NNS O
of IN O
oophorectomy NN O
and CC O
subsequent JJ O
estrogen NN O
replacement NN O
on IN O
the DT O
spontaneous JJ O
secretion NN O
of IN O
interleukin NN B-NP
1 CD I-NP
( -LRB- O
IL-1 NN B-NP
) -RRB- O
and CC O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
( -LRB- O
TNF-alpha NNP B-NP
) -RRB- O
and CC O
on IN O
the DT O
phytohemagglutinin NN B-NP
A-induced JJ I-NP
secretion NN O
of IN O
granulocyte-macrophage JJ B-NP
colony-stimulating JJ I-NP
factor NN I-NP
( -LRB- O
GM-CSF NNP B-NP
) -RRB- O
from IN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
standard JJ O
principles NNS O
of IN O
surgical JJ O
management NN O
must MD O
be VB O
adhered VBN O
to TO O
when WRB O
using VBG O
Sandostatin NNP O
to TO O
treat VB O
patients NNS O
with IN O
these DT O
disorders NNS O
. . O

-DOCSTART- X X O

The DT O
sequence NN O
of IN O
the DT O
pMxL1 NN O
plasmid NN O
containing VBG O
the DT O
invertible JJ O
region NN O
contains VBZ O
a DT O
perfect JJ O
tandem NN O
repeat NN O
of IN O
19 CD O
bp NN O
in IN O
the DT O
orientation NN O
1 CD O
nonexpressed VBD O
pilin VBG B-NP
gene NN I-NP
at IN O
the DT O
middle NN O
of IN O
the DT O
recombination NN O
junction NN O
site NN O
. . O

-DOCSTART- X X O

No DT O
evidence NN O
for IN O
the DT O
presence NN O
of IN O
introns NNS O
within IN O
the DT O
acvA NN B-NP
gene NN I-NP
has VBZ O
been VBN O
found VBN O
. . O

-DOCSTART- X X O

When WRB O
given VBN O
the DT O
choice NN O
between IN O
an DT O
estrous JJ O
female NN O
and CC O
a DT O
sexually RB O
active JJ O
male NN O
in IN O
the DT O
AOF NNP O
, , O
flutamide NN O
females NNS O
, , O
as RB O
well RB O
as IN O
controls NNS O
, , O
preferred VBN O
the DT O
male JJ O
partner NN O
. . O

-DOCSTART- X X O

Hypoxic NNP O
ventilatory NN O
responses NNS O
were VBD O
-1.99 DT O
+/ JJ O
- : O
0.37 CD O
L/min/ NNP O
% NN O
SaO2 NNP O
in IN O
the DT O
relatives NNS O
and CC O
-1.54 DT O
+/ NNS O
- : O
0.25 CD O
L/min/ NN O
% NN O
SaO2 NNS O
in IN O
the DT O
control NN O
subjects NNS O
.(ABSTRACT VBP O
TRUNCATED JJ O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

This DT O
computerized JJ O
list NN O
was VBD O
linked VBN O
to TO O
the DT O
central JJ O
files NNS O
of IN O
the DT O
Massachusetts NNP O
Cancer NNP O
Registry NNP O
and CC O
cases NNS O
diagnosed VBD O
between IN O
1982 CD O
and CC O
1988 CD O
were VBD O
identified VBN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
present JJ O
evidence NN O
for IN O
a DT O
negative JJ O
regulatory JJ O
element NN O
in IN O
the DT O
5' JJ O
flanking JJ O
region NN O
of IN O
the DT O
Mlu NNP B-NP
I PRP I-NP
upstream RB I-NP
activation NN I-NP
sequence NN I-NP
. . O

-DOCSTART- X X O

A DT O
method NN O
for IN O
establishing VBG O
stimulus NN O
control NN O
of IN O
ethanol NN O
responding VBG O
was VBD O
developed VBN O
. . O

-DOCSTART- X X O

Endothelial NNP O
cell NN O
seeding NN O
. . O

-DOCSTART- X X O

After IN O
hemodynamic JJ O
stabilization NN O
, , O
the DT O
goal NN O
of IN O
therapy NN O
is VBZ O
to TO O
diminish VB O
the DT O
chance NN O
that IN O
an DT O
ulcer NN O
will MD O
continue VB O
to TO O
bleed VB O
or CC O
will MD O
rebleed VB O
. . O

-DOCSTART- X X O

The DT O
stimulus NN O
threshold NN O
for IN O
EER NNP O
showed VBD O
a DT O
less JJR O
individual JJ O
variation NN O
than IN O
amplitude NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
electrically RB O
evoked VBN O
response NN O
( -LRB- O
EER NN O
) -RRB- O
in IN O
relation NN O
to TO O
the DT O
central JJ O
visual JJ O
pathway NN O
of IN O
the DT O
cat NN O
( -LRB- O
1 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
plasma NN O
fibrinogen NN B-NP
levels NNS O
increased VBN O
by IN O
a DT O
mean NN O
of IN O
17.6 CD O
% NN O
, , O
a DT O
potentially RB O
adverse JJ O
effect NN O
of IN O
gemfibrozil NN O
that WDT O
has VBZ O
not RB O
been VBN O
previously RB O
reported VBN O
. . O

-DOCSTART- X X O

Gemfibrozil NNP O
in IN O
hyperlipidaemic JJ O
patients NNS O
with IN O
peripheral JJ O
arterial JJ O
disease NN O
: : O
some DT O
undiscovered JJ O
actions NNS O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
pharmacological JJ O
profiling NN O
in IN O
safety NN O
assessment NN O
. . O

-DOCSTART- X X O

In IN O
all DT O
cases NNS O
, , O
high-level JJ O
expression NN O
of IN O
the DT O
truncated JJ B-NP
avian JJ I-NP
integrins NNS I-NP
was VBD O
obtained VBN O
. . O

-DOCSTART- X X O

The DT O
authors NNS O
evaluate VB O
the DT O
clinical JJ O
efficacy NN O
of IN O
EMB NNP O
AZS NNP O
in IN O
recurrent JJ O
ulcer NN O
after IN O
operation NN O
on IN O
the DT O
stomach NN O
caused VBN O
by IN O
a DT O
high JJ O
level NN O
of IN O
acid NN O
production NN O
and CC O
ulcerative JJ O
gastroduodenal JJ O
bleeding NN O
. . O

-DOCSTART- X X O

In IN O
adulthood NN O
these DT O
rats NNS O
were VBD O
hyperactive JJ O
and CC O
learned VBD O
the DT O
active JJ O
avoidance NN O
response NN O
later RB O
than IN O
the DT O
controls NNS O
. . O

-DOCSTART- X X O

Phosphopeptide NNP O
mapping NN O
revealed VBD O
the DT O
same JJ O
autophosphorylation NN O
sites NNS O
utilized VBN O
by IN O
EGFR-IC JJ B-NP
as IN O
those DT O
identified VBN O
in IN O
wild-type JJ B-NP
EGFR. . I-NP

-DOCSTART- X X O

The DT O
TCF-1 NNP B-NP
alpha NN I-NP
binding NN I-NP
site NN I-NP
was VBD O
also RB O
required VBN O
for IN O
TCR NNP B-NP
alpha NN I-NP
enhancer NN I-NP
activity NN O
in IN O
transcriptionally RB O
active JJ O
extracts NNS O
from IN O
Jurkat NNP O
but CC O
not RB O
HeLa NNP O
cells NNS O
, , O
confirming VBG O
that IN O
TCF-1 NNP B-NP
alpha NN I-NP
is VBZ O
a DT O
T-cell-specific JJ B-NP
transcription NN I-NP
factor NN I-NP
. . O

-DOCSTART- X X O

In IN O
this DT O
model NN O
, , O
eltoprazine NN O
has VBZ O
a DT O
very RB O
specific JJ O
anti-aggressive JJ O
( -LRB- O
serenic JJ O
) -RRB- O
profile NN O
, , O
inhibiting VBG O
aggression NN O
while IN O
social JJ O
interaction NN O
and CC O
exploration NN O
are VBP O
not RB O
decreased VBN O
but CC O
even RB O
enhanced VBN O
; : O
inactivity NN O
, , O
a DT O
measure NN O
for IN O
sedation NN O
, , O
is VBZ O
not RB O
affected VBN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
separate JJ O
and CC O
combined VBN O
effects NNS O
of IN O
plutonium-239 NN O
, , O
hexachlorobutadiene NN O
and CC O
tributyl NN O
phosphate NN O
on IN O
the DT O
thymus NN O
gland NN O
of IN O
rats NNS O

-DOCSTART- X X O

Data NNP O
collection NN O
was VBD O
made VBN O
with IN O
a DT O
query NN O
language NN O
, , O
and CC O
data NNS O
analysis NN O
performed VBN O
with IN O
an DT O
interactive JJ O
knowledge-based JJ O
statistical JJ O
tool NN O
, , O
MAXITAB NNP O
, , O
employing VBG O
a DT O
multivariate JJ O
tabular JJ O
analysis NN O
technique NN O
. . O

-DOCSTART- X X O

Diuresis NNP O
was VBD O
induced VBN O
by IN O
scheduled VBN O
drinking NN O
of IN O
tea NN O
( -LRB- O
150 CD O
ml/h NN O
) -RRB- O
. . O

-DOCSTART- X X O

Diagnostic JJ O
value NN O
of IN O
adenosine JJ B-NP
deaminase NN I-NP
activity NN O
in IN O
tuberculous JJ O
effusions NNS O
. . O

-DOCSTART- X X O

Femoral JJ O
strain NN O
adaptation NN O
after IN O
total JJ O
hip NN O
replacement NN O
: : O
a DT O
comparison NN O
of IN O
cemented JJ O
and CC O
porous JJ O
ingrowth NN O
components NNS O
in IN O
canines NNS O
. . O

-DOCSTART- X X O

Promoter NNP O
activities NNS O
were VBD O
estimated VBN O
using VBG O
beta-glucuronidase JJ B-NP
and CC O
neomycin JJ B-NP
phosphotransferase NN I-NP
II NNP I-NP
reporter NN I-NP
gene NN I-NP
systems NNS I-NP
. . O

-DOCSTART- X X O

The DT O
5' JJ O
regions NNS O
of IN O
these DT O
two CD O
soybean NN B-NP
actin NN I-NP
genes NNS I-NP
contain VBP O
many JJ O
unusual JJ O
features NNS O
including VBG O
( -LRB- O
CT) NNP O
repeats NNS O
and CC O
long JJ O
stretches NNS O
of IN O
pyrimidine-rich JJ O
DNA NN O
. . O

-DOCSTART- X X O

No DT O
patient NN O
had VBD O
a DT O
history NN O
of IN O
excess JJ O
alcohol NN O
intake NN O
, , O
or CC O
prolonged JJ O
intake NN O
of IN O
hepatotoxic JJ O
drugs NNS O
and CC O
steroids NNS O
, , O
and CC O
were VBD O
not RB O
obese JJ O
or CC O
malnourished JJ O
. . O

-DOCSTART- X X O

An DT O
evolutionary JJ O
comparison NN O
of IN O
amino JJ O
acid NN O
sequences NNS O
of IN O
34 CD O
HSP70 CD B-NP
proteins NNS I-NP
from IN O
17 CD O
species NNS O
suggests VBZ O
that IN O
BiP NNP B-NP
genes NNS I-NP
share VBP O
a DT O
common JJ O
ancestor NN O
, , O
which WDT O
diverged VBD O
from IN O
other JJ O
HSP70 CD B-NP
genes NNS I-NP
near IN O
the DT O
time NN O
when WRB O
eukaryotes NNS O
first RB O
appeared VBD O
. . O

-DOCSTART- X X O

Spore NN O
inocula NN O
( -LRB- O
approximately RB O
10(6 JJ O
)/coupon NN O
) -RRB- O
were VBD O
dried VBN O
onto IN O
0.5-in CD O
. . O

-DOCSTART- X X O

Reverse NN O
transcription-PCR NN O
was VBD O
then RB O
used VBN O
to TO O
clone VB O
from IN O
human JJ O
poly( NN O
A DT O
) -RRB- O
+ NN O
RNA IN O
the DT O
cDNA NN O
corresponding JJ O
to TO O
the DT O
expressed VBN O
homolog NN O
of IN O
psi NNS B-NP
ARF NNP I-NP
4 CD I-NP
, , O
referred VBD O
to TO O
as IN O
human JJ B-NP
ARF NN I-NP
4 CD I-NP
. . O

-DOCSTART- X X O

To TO O
evaluate VB O
the DT O
cost NN O
and CC O
benefits NNS O
of IN O
screening NN O
tests NNS O
for IN O
Chlamydia NNP O
trachomatis NN O
in IN O
adolescent JJ O
males NNS O
, , O
we PRP O
developed VBD O
a DT O
decision NN O
analysis NN O
model NN O
and CC O
compared VBN O
the DT O
leukocyte NN B-NP
esterase NN I-NP
urine NN O
dipstick NN O
test NN O
with IN O
culture NN O
, , O
with IN O
direct-smear JJ O
fluorescent JJ O
antibody NN O
( -LRB- O
DFA NNP O
) -RRB- O
, , O
and CC O
with IN O
the DT O
option NN O
of IN O
no DT O
screening NN O
( -LRB- O
no DT O
treatment NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
N-terminal JJ O
115 CD O
amino IN O
acids NNS O
correspond VBP O
to TO O
a DT O
putative JJ O
DNA-binding JJ O
domain NN O
and CC O
show VB O
significant JJ O
sequence NN O
similarity NN O
with IN O
other JJ O
cloned JJ O
IFN JJ B-NP
response NN I-NP
factors NNS I-NP
( -LRB- O
IRF-1 NN B-NP
and CC O
IRF-2 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Maternal NNP O
seizures NNS O
had VBD O
occurred VBN O
during IN O
pregnancy NN O
in IN O
52 CD O
per IN O
cent NN O
. . O

-DOCSTART- X X O

Krox-24 NNP B-NP
is VBZ O
therefore RB O
a DT O
sequence-specific JJ O
transcriptional JJ O
activator NN O
. . O

-DOCSTART- X X O

The DT O
interindividual JJ O
variability NN O
of IN O
the DT O
parameters NNS O
is VBZ O
taken VBN O
into IN O
consideration NN O
by IN O
interactively RB O
determining VBG O
the DT O
threshold NN O
levels NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
a DT O
sequence NN O
match NN O
between IN O
enhancers NNS O
and CC O
certain JJ O
promoter NN O
elements NNS O
is VBZ O
critical JJ O
. . O

-DOCSTART- X X O

This DT O
Mr NNP O
is VBZ O
similar JJ O
to TO O
those DT O
of IN O
the DT O
purified VBN B-NP
smg NN I-NP
p25A NN I-NP
GDI NNP I-NP
estimated VBN O
by IN O
sodium NN O
dodecyl NN O
sulfate-polyacrylamide NN O
gel NN O
electrophoresis NN O
and CC O
sucrose NN O
density NN O
gradient NN O
ultracentrifugation NN O
, , O
which WDT O
are VBP O
about IN O
54,000 CD O
and CC O
65,000 CD O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Critical JJ O
residues NNS O
required VBN O
for IN O
repression NN O
are VBP O
located VBN O
within IN O
the DT O
C-terminal JJ O
27 CD O
amino IN O
acids NNS O
of IN O
c-Fos JJ B-NP
, , O
since IN O
v-Fos JJ B-NP
and CC O
C-terminal JJ O
truncations NNS O
of IN O
c-Fos NNS B-NP
did VBD O
not RB O
down RB O
regulate VB O
. . O

-DOCSTART- X X O

In IN O
this DT O
paper NN O
, , O
we PRP O
have VBP O
analyzed VBN O
the DT O
structure NN O
of IN O
human JJ O
gene NN O
for IN O
Gx NNP B-NP
alpha NN I-NP
, , O
which WDT O
spans VBZ O
more RBR O
than IN O
60 CD O
kilobases NNS O
. . O

-DOCSTART- X X O

Uses NNS O
of IN O
orthoclone NN O
OKT3 NNS B-NP
for IN O
prophylaxis NNS O
of IN O
rejection NN O
and CC O
induction NN O
in IN O
initial JJ O
nonfunction NN O
in IN O
kidney NN O
transplantation NN O
. . O

-DOCSTART- X X O

Uses NNS O
of IN O
orthoclone NN O
OKT3 NNS O
for IN O
prophylaxis NNS O
of IN O
rejection NN O
and CC O
induction NN O
in IN O
initial JJ O
nonfunction NN O
in IN O
kidney NN O
transplantation NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
we PRP O
notice VBP O
two CD O
potential JJ O
consensus NN O
motifs NNS O
which WDT O
are VBP O
also RB O
found VBN O
in IN O
corresponding JJ O
positions NNS O
in IN O
the DT O
genes NNS O
for IN O
the DT O
nerve NN B-NP
growth NN I-NP
factor NN I-NP
receptor NN I-NP
and CC O
the DT O
68-kDa JJ B-NP
neurofilament NN I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
the DT O
-119 JJ O
to TO O
-81 JJ O
fragment NN O
of IN O
the DT O
CCK NNP B-NP
promoter NN I-NP
contains VBZ O
a DT O
transcriptional JJ O
enhancer NN O
that WDT O
potentiates VBZ O
the DT O
transcription NN O
from IN O
the DT O
herpes NNS O
simplex JJ O
virus NN O
thymidine DT B-NP
kinase NN I-NP
promoter NN I-NP
in IN O
a DT O
position NN O
- : O
and CC O
orientation-independent JJ O
manner NN O
. . O

-DOCSTART- X X O

Five CD O
of IN O
10 CD O
scars NNS O
studied VBD O
decreased VBN O
at IN O
least JJS O
50 CD O
% NN O
in IN O
linear JJ O
dimensions NNS O
. . O

-DOCSTART- X X O

Managing VBG O
dysphagia NN O
in IN O
a DT O
chronic JJ O
care NN O
setting NN O
: : O
an DT O
introduction NN O
. . O

-DOCSTART- X X O

Gel-mobility-shift JJ O
assays IN O
confirmed VBN O
that IN O
the DT O
Raji NNP O
nuclear JJ O
proteins NNS O
that WDT O
bound VBD O
to TO O
W NNP O
and CC O
V NNP O
elements NNS O
were VBD O
competed VBN O
with IN O
by IN O
an DT O
HLA-DRA NNP B-NP
X-box NNP I-NP
oligonucleotide NNP I-NP
. . O

-DOCSTART- X X O

The DT O
NF1 NNP B-NP
locus NN I-NP
encodes VBZ O
a DT O
protein NN O
functionally RB O
related VBN O
to TO O
mammalian JJ B-NP
GAP NNP I-NP
and CC O
yeast NN B-NP
IRA NNP I-NP
proteins VBZ I-NP
. . O

-DOCSTART- X X O

Hence RB O
, , O
the DT O
replacement NN O
of IN O
Phe-62 NNP O
with IN O
Ser NNP O
specifically RB O
affects VBZ O
a DT O
determinant NN O
on IN O
the DT O
lambda NN B-NP
I PRP I-NP
light RB I-NP
chain VBP I-NP
that DT O
is VBZ O
necessary JJ O
for IN O
the DT O
intracellular JJ O
transport NN O
of IN O
this DT O
molecule NN O
. . O

-DOCSTART- X X O

Disruption NN O
of IN O
ARF2 NN B-NP
causes VBZ O
no DT O
detectable JJ O
phenotype NN O
. . O

-DOCSTART- X X O

Human JJ O
recombinant JJ O
DNA-derived JJ O
antihemophilic JJ B-NP
factor NN I-NP
( -LRB- O
factor NN B-NP
VIII NNP I-NP
) -RRB- O
in IN O
the DT O
treatment NN O
of IN O
hemophilia NNS O
A. NN O
recombinant NN O
Factor NNP B-NP
VIII NNP I-NP
Study NNP O
Group NNP O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
expression NN O
of IN O
the DT O
promoter NN O
in IN O
embryonic JJ O
Drosophila NNP O
melanogaster NN O
cells NNS O
that WDT O
lack VBP O
MyoD1 JJ B-NP
and CC O
Sp1 NNP B-NP
is VBZ O
strictly RB O
dependent JJ O
on IN O
all DT O
three CD O
sites NNS O
remaining VBG O
intact JJ O
and CC O
on IN O
the DT O
presence NN O
of IN O
exogenously RB O
supplied VBN O
Sp1 NNP B-NP
and CC O
MyoD1 NNP B-NP
. . O

-DOCSTART- X X O

To TO O
identify VB O
structural JJ O
features NNS O
of IN O
residues NNS O
flanking VBG O
the DT O
c-region NN O
that IN O
influence NN O
the DT O
fidelity NN O
and CC O
efficiency NN O
of IN O
signal NN O
peptidase NN O
cleavage NN O
as RB O
well RB O
as IN O
co-translational JJ O
translocation NN O
, , O
we PRP O
introduced VBD O
six CD O
amino JJ O
acid NN O
substitutions NNS O
into IN O
the DT O
COOH NNP O
terminus NN O
of IN O
the DT O
hydrophobic JJ O
core NN O
and CC O
seven CD O
substitutions NNS O
at IN O
the DT O
NH2 NNP O
terminus NN O
of IN O
the DT O
mature JJ O
region NN O
( -LRB- O
the DT O
+1 JJ O
position NN O
) -RRB- O
of IN O
a DT O
model NN O
eukaryotic JJ B-NP
preprotein-human JJ I-NP
pre( JJ I-NP
delta NN I-NP
pro)apoA-II NN I-NP
. . O

-DOCSTART- X X O

Of IN O
848 CD O
patients NNS O
, , O
819 CD O
cases NNS O
with IN O
complete JJ O
description NN O
of IN O
patient NN O
's POS O
background NN O
were VBD O
evaluable JJ O
: : O
Group NNP O
A NNP O
( -LRB- O
surgery NN O
+ NN O
MMC NNP O
+ JJ O
5-FU:chemotherapy JJ O
) -RRB- O
253 CD O
cases NNS O
, , O
group NN O
B NNP O
( -LRB- O
surgery NN O
+ NN O
MMC NNP O
+ NNP O
5-FU JJ O
+ NN O
OK-432 . O
or CC O
PSK:immunochemotherapy JJ O
) -RRB- O
282 CD O
and CC O
group NN O
C NNP O
( -LRB- O
surgery NN O
alone RB O
) -RRB- O
284 CD O
. . O

-DOCSTART- X X O

This DT O
model NN O
is VBZ O
further RB O
supported VBN O
by IN O
binding NN O
of IN O
the DT O
Fos-Jun NNP B-NP
complex NN O
at IN O
an DT O
AP-1 JJ B-NP
site NN I-NP
in IN O
the DT O
type NN B-NP
alpha NN I-NP
I PRP I-NP
collagen RB I-NP
promoter NN I-NP
that WDT O
is VBZ O
contiguous JJ O
with IN O
, , O
but CC O
not RB O
overlapping VBG O
, , O
the DT O
VDRE. NNP O

-DOCSTART- X X O

In IN O
the DT O
controls NNS O
, , O
it PRP O
was VBD O
found VBN O
that IN O
all DT O
right-handed JJ O
and CC O
10 CD O
out IN O
of IN O
14 CD O
left-handed JJ O
control NN O
subjects NNS O
showed VBD O
a DT O
right NN O
VHF NN O
( -LRB- O
i FW O
.e FW O
. . O
, , O
left JJ O
hemisphere NN O
) -RRB- O
advantage NN O
. . O

-DOCSTART- X X O

The DT O
deduced VBD O
amino IN O
acid NN O
sequence NN O
has VBZ O
the DT O
greatest JJS O
homology NN O
( -LRB- O
61 CD O
% NN O
) -RRB- O
to TO O
the DT O
green JJ B-NP
alga NN I-NP
Scenedemus NN I-NP
obliquus NN I-NP
plastocyanin NN I-NP
. . O

-DOCSTART- X X O

Higher JJR O
fasting JJ O
serum NN O
gastrin NN B-NP
concentration NN O
( -LRB- O
102.0 CD O
+/ NN O
- : O
21.1 CD O
vs NN O
63.3 CD O
+/ NN O
- : O
8.3 CD O
ng NN O
.l-1 NN O
) -RRB- O
, , O
and CC O
greater JJR O
postprandial JJ O
gastrin NN B-NP
release NN O
( -LRB- O
AUC0-120 NNP O
: : O
16690 CD O
+/ CD O
- : O
2648 CD O
vs NN O
10654 CD O
+/ NNS O
- : O
1283 CD O
ng NN O
.l-1 JJ O
min NN O
) -RRB- O
were VBD O
observed VBN O
after IN O
VTP-HM JJ O
than IN O
after IN O
VTP-Cas NNP O
. . O

-DOCSTART- X X O

The DT O
experimental JJ O
group NN O
consisted VBD O
of IN O
61 CD O
examinees NNS O
class NN O
II/2 IN O
orthodontic JJ O
anomalies NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
article NN O
we PRP O
propose VBP O
to TO O
find VB O
out RP O
the DT O
percentage NN O
of IN O
normal JJ O
occlusion NN O
and CC O
the DT O
distribution NN O
of IN O
maloclusions NNS O
, , O
according VBG O
to TO O
the DT O
anteroposterior JJ O
relationship NN O
between IN O
the DT O
dental JJ O
archs NNS O
( -LRB- O
following VBG O
the DT O
ANGLE3 JJ O
classification NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
that DT O
case NN O
, , O
the DT O
ratio NN O
of IN O
brush NN O
abrasion NN O
was VBD O
0.268 CD O
, , O
compressive JJ O
and CC O
transverse JJ O
strength NN O
, , O
124.3 CD O
and CC O
86.3 CD O
MPa NNP O
respectively RB O
, , O
hardness NN O
, , O
43.2 CD O
Hk NN O
, , O
water NN O
absorption NN O
14.2 CD O
micrograms/mm3 NNS O
and CC O
thermal JJ O
expansion NN O
coefficient NN O
, , O
47.4 CD O
x NN O
10(-6 CD O
)/degrees NNS O
C. NNP O

-DOCSTART- X X O

9 CD O
, , O
1498-1506 CD O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
previously RB O
identified VBN O
, , O
by IN O
screening VBG O
a DT O
lambda NN O
gt11 WDT O
expression NN O
library NN O
, , O
murine JJ B-NP
protein NN I-NP
mXBP NNS I-NP
, , O
which WDT O
binds VBZ O
to TO O
a DT O
sequence NN O
which WDT O
overlaps VBZ O
the DT O
3' JJ O
end NN O
of IN O
the DT O
murine JJ B-NP
class NN I-NP
II NNP I-NP
major JJ I-NP
histocompatibility NN I-NP
complex NN I-NP
A DT I-NP
alpha NN I-NP
gene NN I-NP
X NNP I-NP
box NN I-NP
, , O
a DT O
conserved JJ O
transcription NN O
element NN O
found VBD O
upstream RB O
of IN O
all DT O
class NN O
II NNP O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
p36 NN B-NP
gene NN I-NP
is VBZ O
at IN O
least JJS O
22 CD O
kb NN O
in IN O
length NN O
and CC O
has VBZ O
a DT O
coding NN O
sequence NN O
of IN O
approximately RB O
1 CD O
kb NN O
, , O
representing VBG O
only RB O
4.5 CD O
% NN O
of IN O
the DT O
gene NN O
.(ABSTRACT JJ O
TRUNCATED JJ O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

This DT O
multimodality NN O
treatment NN O
for IN O
locally RB O
advanced JJ O
gynecologic NN O
tumors NNS O
appears VBZ O
feasible VBN O
with IN O
modification NN O
, , O
and CC O
continued VBD O
work NN O
exploring VBG O
this DT O
approach NN O
is VBZ O
encouraged VBN O
. . O

-DOCSTART- X X O

With IN O
the DT O
modified JJ O
fingertip-to-floor NN O
( -LRB- O
MFTF NN O
) -RRB- O
method NN O
, , O
patients NNS O
stand VBP O
on IN O
a DT O
stool NN O
and CC O
forward RB O
bend VB O
so RB O
that IN O
measurements NNS O
can MD O
be VB O
taken VBN O
on IN O
patients NNS O
who WP O
are VBP O
able JJ O
to TO O
touch VB O
the DT O
floor NN O
or CC O
reach VB O
beyond IN O
the DT O
level NN O
of IN O
the DT O
floor NN O
. . O

-DOCSTART- X X O

Luteinizing VBG B-NP
hormone-releasing NN I-NP
hormone NN I-NP
analog NN O
therapy NN O
of IN O
uterine JJ O
fibroid NN O
: : O
analysis NN O
of IN O
results NNS O
obtained VBN O
with IN O
buserelin NN O
administered VBN O
intranasally RB O
and CC O
goserelin VB O
administered VBN O
subcutaneously RB O
as IN O
a DT O
monthly JJ O
depot NN O
. . O

-DOCSTART- X X O

In IN O
Experiments NNS O
1 CD O
and CC O
2 CD O
, , O
infants NNS O
, , O
like IN O
adults NNS O
, , O
initially RB O
categorized VBN O
novel JJ O
objects NNS O
on IN O
the DT O
basis NN O
of IN O
physical JJ O
appearance NN O
, , O
but CC O
only RB O
if IN O
trained VBN O
with IN O
multiple JJ O
exemplars NNS O
, , O
after IN O
delays NNS O
of IN O
1 CD O
and CC O
7 CD O
days NNS O
. . O

-DOCSTART- X X O

The DT O
clinical JJ O
picture NN O
of IN O
the DT O
disease NN O
was VBD O
significantly RB O
different JJ O
from IN O
anthropogenic JJ O
cutaneous JJ O
leishmaniasis NN O
caused VBN O
by IN O
L. NNP O
tropica NN O
but CC O
similar JJ O
to TO O
cutaneous JJ O
patterns NNS O
caused VBN O
by IN O
L. NNP O
infantum NN O
which WDT O
was VBD O
a DT O
prevalent JJ O
pattern NN O
in IN O
the DT O
southern JJ O
France NNP O
. . O

-DOCSTART- X X O

Although IN O
there EX O
are VBP O
no DT O
octamer JJ O
elements NNS O
in IN O
the DT O
adenovirus NN O
genome NN O
that WDT O
are VBP O
known VBN O
to TO O
be VB O
important JJ O
for IN O
transcription NN O
, , O
there EX O
are VBP O
octamer JJ O
elements NNS O
in IN O
the DT O
viral NN O
terminal NN O
repeat NN O
sequences NNS O
. . O

-DOCSTART- X X O

In IN O
comparison NN O
with IN O
the DT O
16 CD O
introns NNS O
reported VBD O
in IN O
AHA3 NNP B-NP
, , O
AHA2 NNP B-NP
is VBZ O
missing VBG O
one CD O
intron NN O
in IN O
the DT O
5'-untranslated JJ O
region NN O
and CC O
a DT O
second JJ O
intron NN O
in IN O
the DT O
C-terminal JJ O
coding NN O
region NN O
. . O

-DOCSTART- X X O

Impaction NN O
of IN O
gastrostomy NN O
tube NN O
in IN O
the DT O
abdominal JJ O
wall NN O
. . O

-DOCSTART- X X O

Both DT O
antidepressants NNS O
elevated VBD O
the DT O
pain NN O
threshold NN O
acutely RB O
, , O
while IN O
pretreatment NN O
with IN O
pCPA NNS O
largely RB O
blocked VBD O
the DT O
analgesia NN O
. . O

-DOCSTART- X X O

Sci NNS O
. . O

-DOCSTART- X X O

A DT O
needs NNS O
assessment NN O
of IN O
these DT O
families NNS O
was VBD O
also RB O
done VBN O
. . O

-DOCSTART- X X O

TCR NNP B-NP
alpha NN I-NP
and CC I-NP
beta JJ I-NP
gene NN I-NP
expression NN O
may MD O
be VB O
regulated VBN O
by IN O
a DT O
common JJ O
set NN O
of IN O
T-cell JJ B-NP
nuclear JJ I-NP
proteins NNS I-NP
in IN O
that IN O
the DT O
T NNP B-NP
beta NN I-NP
2 CD I-NP
element NN I-NP
binding NN O
a DT O
set NN O
of IN O
cyclic JJ B-NP
AMP NNP I-NP
response NN I-NP
element-binding JJ I-NP
proteins NNS I-NP
that WDT O
are VBP O
also RB O
bound VBN O
by IN O
the DT O
T NNP B-NP
alpha NN I-NP
1 CD I-NP
element NN I-NP
of IN O
the DT O
human JJ O
TCR NNP B-NP
alpha NN I-NP
enhancer NN O
and CC O
the DT O
decamer NN O
element NN O
present NN O
in IN O
a DT O
large JJ O
number NN O
of IN O
human JJ O
and CC O
murine JJ O
TCR NNP B-NP
beta JJ I-NP
promoters NNS O
. . O

-DOCSTART- X X O

The DT O
3' JJ O
stem-loop NN O
is VBZ O
highly RB O
divergent JJ O
in IN O
structure NN O
among IN O
species NNS O
and CC O
lies VBZ O
immediately RB O
upstream RB O
of IN O
the DT O
binding JJ O
site NN O
for IN O
Sm NNP B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

These DT O
losses NNS O
account VBP O
for IN O
the DT O
resistance NN O
of IN O
EDS-IV NNP O
collagen NN B-NP
to TO O
cyanogen NN O
bromide NN O
and CC O
mammalian JJ B-NP
collagenase NN I-NP
digestion NN O
. . O

-DOCSTART- X X O

Two CD O
other JJ O
peptides NNS O
, , O
either CC O
partially RB O
or CC O
totally RB O
lacking VBG O
the DT O
basic JJ O
region NN O
, , O
but CC O
containing VBG O
the DT O
intact JJ O
leucine NN O
zipper NN O
domain NN O
, , O
readily RB O
form VB O
dimers NNS O
but CC O
do VBP O
not RB O
bind NN O
to TO O
the DT O
CRE. NNP O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
CRE NNP O
of IN O
the DT O
human JJ B-NP
c-fos NN I-NP
promoter NN I-NP
located VBN O
at IN O
-60 DT O
was VBD O
weakly RB O
induced VBN O
by IN O
cAMP NNS O
and CC O
E1a NNP B-NP
in IN O
both DT O
HeLa NNP O
and CC O
PC12 NNP O
cells NNS O
. . O

-DOCSTART- X X O

Although IN O
popular JJ O
this DT O
hypothesis NN O
is VBZ O
far RB O
from IN O
explaining VBG O
all PDT O
the DT O
clinical JJ O
facts NNS O
, , O
namely RB O
that DT O
rigidity NN O
is VBZ O
equal JJ O
in IN O
extensor NN O
and CC O
flexor NN O
, , O
proximal JJ O
and CC O
distal JJ O
muscles NNS O
. . O

-DOCSTART- X X O

The DT O
ratio NN O
of IN O
P-31 JJ O
NMR-S NNP O
derived VBD O
inorganic JJ O
phosphates NNS O
[Pi] . O
to TO O
phosphocreatine JJ O
[PCr] NN O
was VBD O
significantly RB O
greater JJR O
at IN O
rest NN O
in IN O
LVH NNP O
baboons NNS O
[0.53 CD O
+/ NNS O
- : O
0.06 CD O
versus NN O
controls NNS O
= SYM O
0.41 CD O
+/ CD O
- : O
0.17 CD O
; : O
P NNP O
less RBR O
than IN O
0.05] CD O
. . O

-DOCSTART- X X O

Cutaneous NNP O
necrosis NN O
associated VBN O
with IN O
protein NN B-NP
S NNP I-NP
deficiency NN O
. . O

-DOCSTART- X X O

Critical JJ O
study NN O

-DOCSTART- X X O

Regional NNP O
cerebral NN O
blood NN O
flow NN O
was VBD O
measured VBN O
using VBG O
N-isopropyl-123I-iodoamphetamine JJ O
with IN O
single-photon JJ O
emission NN O
computed VBN O
tomography NN O
( -LRB- O
CT) NN O
in IN O
16 CD O
aged JJ O
patients NNS O
with IN O
noninsulin-dependent JJ O
diabetes NN O
mellitus NN O
( -LRB- O
NIDDM NNP O
, , O
average JJ O
age NN O
72.8 CD O
years NNS O
, , O
average JJ O
fasting NN O
plasma NN O
glucose NN O
7.7 CD O
mmol/L NN O
) -RRB- O
, , O
and CC O
12 CD O
nondiabetic JJ O
subjects NNS O
( -LRB- O
71.6 CD O
years NNS O
, , O
5.3 CD O
mmol/L NN O
) -RRB- O
. . O

-DOCSTART- X X O

Mean JJ O
ROI-A/B NNP O
ratio NN O
was VBD O
49.6 CD O
+/ NN O
- : O
1.7 CD O
% NN O
in IN O
the DT O
diabetic JJ O
group NN O
, , O
significantly RB O
lower JJR O
than IN O
the DT O
57.9 CD O
+/ JJ O
- : O
1.6 CD O
% NN O
at IN O
the DT O
nondiabetic JJ O
group NN O
( -LRB- O
p NN O
less JJR O
than IN O
0.005 CD O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
data NNS O
strongly RB O
implicate VB O
the DT O
normal JJ O
product NN O
of IN O
the DT O
int-2 JJ B-NP
gene NN I-NP
, , O
which WDT O
is VBZ O
related VBN O
to TO O
the DT O
fibroblast JJ B-NP
growth NN I-NP
factor NN I-NP
family NN I-NP
, , O
as IN O
a DT O
contributory NN O
factor NN O
in IN O
virally RB O
induced VBN O
mammary JJ O
tumors NNS O
. . O

-DOCSTART- X X O

The DT O
PC2 JJ B-NP
protein NN I-NP
also RB O
shows VBZ O
great JJ O
similarity NN O
to TO O
the DT O
incomplete JJ O
NH2-terminal JJ O
sequence NN O
of IN O
the DT O
human JJ B-NP
furin NN I-NP
gene NN I-NP
product NN I-NP
, , O
a DT O
putative JJ O
membrane-inserted JJ O
receptor-like JJ O
molecule NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
used VBD O
footprinting NN O
and CC O
gel NN O
mobility NN O
retardation NN O
assays VBZ O
to TO O
reveal VB O
that IN O
bacterially RB O
synthesized VBN O
Zta NNP B-NP
fusion NN I-NP
proteins VBZ I-NP
bound VBN O
directly RB O
to TO O
six CD O
TGTGCAA-like JJ O
motifs NNS O
within IN O
DSL. NNP B-NP

-DOCSTART- X X O

The DT O
zta NN B-NP
transactivator NN I-NP
involved VBN O
in IN O
induction NN O
of IN O
lytic JJ O
cycle NN O
gene NN O
expression NN O
in IN O
Epstein-Barr NNP O
virus-infected JJ O
lymphocytes NNS O
binds NNS O
to TO O
both DT O
AP-1 NNP B-NP
and CC O
ZRE VB B-NP
sites NNS I-NP
in IN O
target NN O
promoter NN O
and CC O
enhancer NN O
regions NNS O
. . O

-DOCSTART- X X O

Fragments NNS O
containing VBG O
the DT O
21-base-pair JJ O
repeat NN O
region NN O
, , O
the DT O
enhancer NN B-NP
of IN I-NP
simian JJ I-NP
virus NN I-NP
40 CD I-NP
or CC O
both DT O
strongly RB O
stimulated VBN O
beta-galactosidase JJ B-NP
synthesis NN O
, , O
and CC O
three CD O
fragments NNS O
from IN O
the DT O
polyomavirus NN B-NP
enhancer NN I-NP
region NN I-NP
stimulated VBD O
moderate JJ O
levels NNS O
. . O

-DOCSTART- X X O

The DT O
sites NNS O
targeted VBN O
for IN O
mutagenesis NN O
, , O
residues NNS O
60 CD O
, , O
61 CD O
, , O
and CC O
66 CD O
, , O
are VBP O
located VBN O
within IN O
a DT O
putative JJ O
helical JJ O
loop NN O
structure NN O
which WDT O
may MD O
be VB O
involved VBN O
in IN O
substrate JJ O
recognition NN O
by IN O
the DT O
enzyme NN O
. . O

-DOCSTART- X X O

The DT O
possible JJ O
benefits NNS O
of IN O
LMW JJ O
heparin NN O
( -LRB- O
reduced VBN O
frequency NN O
of IN O
bleeding VBG O
, , O
alleviation NN O
of IN O
hypertriglyceridemia NN O
) -RRB- O
were VBD O
not RB O
, , O
however RB O
, , O
apparent JJ O
, , O
possibly RB O
because IN O
of IN O
the DT O
short JJ O
observation NN O
period NN O
and CC O
the DT O
low JJ O
incidence NN O
of IN O
hemorrhagic JJ O
complications NNS O
in IN O
routine JJ O
dialyses NNS O
. . O

-DOCSTART- X X O

The DT O
deduced JJ O
amino JJ O
acid NN O
sequence NN O
of IN O
destrin NN B-NP
is VBZ O
165 CD O
residues NNS O
long JJ O
and CC O
is VBZ O
very RB O
similar JJ O
( -LRB- O
71 CD O
% NN O
identical JJ O
) -RRB- O
to TO O
that DT O
of IN O
cofilin NN B-NP
, , O
a DT O
widely RB O
distributed VBN O
, , O
pH-sensitive JJ O
actin-modulating JJ B-NP
protein NN O
. . O

-DOCSTART- X X O

With IN O
only RB O
purified VBN O
T NNP B-NP
antigen NN I-NP
in IN O
the DT O
presence NN O
of IN O
topoisomerase NN B-NP
I PRP I-NP
to TO O
unwind VB O
purified VBN O
DNA NNP O
, , O
ori-auxiliary JJ O
sequences NNS O
strongly RB O
facilitated JJ O
T-antigen-dependent JJ B-NP
DNA NN O
conformational JJ O
changes NNS O
consistent JJ O
with IN O
melting VBG O
the DT O
first JJ O
50 CD O
base NN O
pairs NNS O
. . O

-DOCSTART- X X O

Conservation NNP O
of IN O
function NN O
of IN O
Drosophila NNP B-NP
melanogaster NN I-NP
abl NN I-NP
and CC O
murine NN B-NP
v-abl JJ I-NP
proteins NNS I-NP
in IN O
transformation NN O
of IN O
mammalian JJ O
cells NNS O
. . O

-DOCSTART- X X O

In IN O
transient JJ O
cotransfection NN O
assays IN O
using VBG O
Chang NNP O
liver NN O
cells NNS O
(CCL JJ O
13 CD O
) -RRB- O
, , O
pM1 JJ O
DNA NNP O
exerts NNS O
a DT O
6- CD O
to TO O
10-fold JJ O
trans-activating JJ O
effect NN O
on IN O
the DT O
expression NN O
of IN O
the DT O
pSV2CAT JJ O
reporter NN O
plasmid NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
determined VBN O
the DT O
nucleotide JJ O
( -LRB- O
nt NN O
) -RRB- O
sequence NN O
of IN O
the DT O
7.5-kb JJ B-NP
COR JJ I-NP
segment NN I-NP
that WDT O
encompasses VBZ O
a DT O
cluster NN O
of IN O
six CD O
genes NNS O
( -LRB- O
CYC1 NNP B-NP
, , O
UTR1 NNP B-NP
, , O
UTR3 NNP B-NP
, , O
OSM1 NNP B-NP
, , O
tRNA( JJ B-NP
Gly NNP I-NP
) -RRB- I-NP
and CC O
RAD7 NNPS B-NP
) -RRB- O
located VBN O
on IN O
chromosome NN O
X NNP O
of IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NNS O
. . O

-DOCSTART- X X O

The DT O
antinociceptive JJ O
properties NNS O
, , O
as IN O
measured VBN O
by IN O
the DT O
tail-flick NN O
and CC O
hot-plate JJ O
tests NNS O
, , O
and CC O
the DT O
motor NN O
effects NNS O
of IN O
an DT O
intrathecally-administered JJ O
benzodiazepine NN O
agonist NN O
midazolam NN O
, , O
alone RB O
, , O
and CC O
in IN O
combination NN O
with IN O
morphine NN O
, , O
was VBD O
examined VBN O
in IN O
rats NNS O
. . O

-DOCSTART- X X O

Constructs NNS O
were VBD O
made VBN O
in IN O
which WDT O
an DT O
AATAAA NNP O
and CC O
the DT O
GT-rich JJ O
region NN O
were VBD O
separated VBN O
by IN O
various JJ O
distances NNS O
ranging VBG O
from IN O
7 CD O
to TO O
43 CD O
bp NN O
. . O

-DOCSTART- X X O

We PRP O
cloned VBD O
and CC O
sequenced VBD O
the DT O
cDNAs NN O
against IN O
genomic JJ O
RNA NNP O
and CC O
mRNA NNS O
for IN O
phosphoprotein NN B-NP
( -LRB- I-NP
P NNP I-NP
) -RRB- I-NP
of IN O
human JJ O
parainfluenza NN O
type NN O
2 CD O
virus NN O
( -LRB- O
PIV-2 NN O
) -RRB- O
. . O
cDNA NN O
clone NN O
from IN O
genomic JJ O
RNA NNP O
was VBD O
1439 CD O
nucleotides NNS O
in IN O
length NN O
excluding VBG O
poly( NN O
A DT O
) -RRB- O
and CC O
was VBD O
found VBN O
to TO O
have VB O
two CD O
small JJ O
open JJ O
reading NN O
frames NNS O
encoding JJ O
proteins NNS O
of IN O
233 CD O
and CC O
249 CD O
amino IN O
acids NNS O
. . O

-DOCSTART- X X O

The DT O
cDNA NN O
sequence NN O
has VBZ O
an DT O
813-bp JJ O
open JJ O
reading NN O
frame NN O
( -LRB- O
ORF NN O
) -RRB- O
whose WP$ O
predicted VBD O
amino IN O
acid NN O
sequence NN O
is VBZ O
97.6 CD O
% NN O
identical JJ O
to TO O
the DT O
272 CD O
carboxy-terminal JJ O
amino IN O
acids NNS O
of IN O
the DT O
human JJ B-NP
ets-1 NN I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

The DT O
sacT JJ B-NP
gene NN I-NP
regulating VBG O
the DT O
sacPA NN B-NP
operon NN I-NP
in IN I-NP
Bacillus NNP I-NP
subtilis . I-NP
shares NNS O
strong JJ O
homology NN O
with IN O
transcriptional JJ O
antiterminators NNS O
. . O

-DOCSTART- X X O

The DT O
TraD NNP B-NP
protein NN I-NP
(83,899 VBD I-NP
Da NNP I-NP
) -RRB- I-NP
contains VBZ O
three CD O
hydrophobic JJ O
regions NNS O
, , O
of IN O
which WDT O
two CD O
are VBP O
located VBN O
near IN O
the DT O
amino-terminal JJ O
region NN O
. . O

-DOCSTART- X X O

The DT O
protein NN O
product NN O
of IN O
orfD NNP B-NP
, , O
which WDT O
is VBZ O
probably RB O
a DT O
new JJ O
tra NN B-NP
gene NN I-NP
( -LRB- O
named VBN O
traX NN B-NP
) -RRB- O
, , O
contains VBZ O
65 CD O
% NN O
hydrophobic JJ O
amino IN O
acids NNS O
, , O
especially RB O
rich JJ O
in IN O
alanine JJR O
and CC O
leucine NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
analysis NN O
of IN O
the DT O
E2 NNP B-NP
proteins VBZ I-NP
present JJ O
in IN O
various JJ O
cell NN O
lines NNS O
harboring VBG O
specific JJ O
BPV-1 JJ O
mutants NNS O
, , O
including VBG O
the DT O
2558 CD O
acceptor NN O
mutant JJ O
, , O
proves VBZ O
that IN O
alternate JJ O
modes NNS O
of IN O
E2 JJ B-NP
expression NN O
exist VBP O
. . O

-DOCSTART- X X O

Disruption NN O
of IN O
the DT O
IRA2 NNP B-NP
gene NN I-NP
resulted VBD O
in IN O
( -LRB- O
i NN O
) -RRB- O
increased VBN O
sensitivity NN O
to TO O
heat VB O
shock NN O
and CC O
nitrogen NN O
starvation NN O
, , O
( -LRB- O
ii NNS O
) -RRB- O
sporulation NN O
defects NNS O
, , O
and CC O
( -LRB- O
iii NN O
) -RRB- O
suppression NN O
of IN O
the DT O
lethality NN O
of IN O
the DT O
cdc25 CD B-NP
mutant NN I-NP
. . O

-DOCSTART- X X O

A DT O
gene NN O
in IN O
Drosophila NNP O
melanogaster NN O
that IN O
maps NNS O
cytologically RB O
to TO O
2C1-3 VB O
on IN O
the DT O
distal JJ O
portion NN O
of IN O
the DT O
X-chromosome NNP O
encodes VBZ O
a DT O
member NN O
of IN O
the DT O
steroid/thyroid NN B-NP
hormone NN I-NP
receptor NN I-NP
superfamily NN I-NP
. . O

-DOCSTART- X X O

A DT O
portion NN O
of IN O
Region NNP O
II NNP O
also RB O
resembles VBZ O
part NN O
of IN O
the DT O
human JJ O
c-jun NN B-NP
oncoprotein NNP O
's POS O
leucine NN O
zipper NN O
, , O
which WDT O
in IN O
turn NN O
, , O
has VBZ O
been VBN O
demonstrated VBN O
to TO O
be VB O
the DT O
heterodimerization NN O
site NN O
between IN O
the DT O
jun NN B-NP
and CC O
fos NNS B-NP
oncoproteins NNS I-NP
. . O

-DOCSTART- X X O

The DT O
diagnosis NN O
of IN O
miliary JJ O
tuberculosis NN O
should MD O
be VB O
systematically RB O
considered VBN O
in IN O
ARDS NNP O
of IN O
unknown JJ O
origin NN O
. . O

-DOCSTART- X X O

The DT O
26S NNP B-NP
rRNA NNP I-NP
binding NN I-NP
ribosomal JJ I-NP
protein NN I-NP
equivalent NN O
to TO O
bacterial JJ B-NP
protein NN I-NP
L11 NNP I-NP
is VBZ O
encoded VBN O
by IN O
unspliced JJ O
duplicated VBN O
genes NNS O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

Five CD O
healthy JJ O
male JJ O
subjects NNS O
inspired VBN O
air NN O
for IN O
20 CD O
min NN O
and CC O
then RB O
5 CD O
% NN O
CO2/95 IN O
% NN O
O2 IN O
for IN O
30 CD O
min NN O
, , O
of IN O
which WDT O
the DT O
first JJ O
10 CD O
min NN O
was VBD O
used VBN O
to TO O
achieve VB O
a DT O
steady-state NN O
end-tidal JJ O
CO2 NNP O
measurement NN O
. . O

-DOCSTART- X X O

Significant JJ O
correlations NNS O
were VBD O
obtained VBN O
between IN O
changes NNS O
in IN O
SSEP NNP O
in IN O
response NN O
to TO O
AS NNP O
and CC O
the DT O
presence NN O
of IN O
not RB O
deep JJ O
residual-organic JJ O
disturbances NNS O
, , O
so-called JJ O
"ground NN O
" '' O
in IN O
psychogenic JJ O
disorders NNS O
. . O

-DOCSTART- X X O

The DT O
E6/E7 NNP B-NP
promoter NN O
of IN O
all DT O
genital JJ O
human JJ O
papillomaviruses NNS O
is VBZ O
responsible JJ O
for IN O
expression NN O
of IN O
the DT O
viral NN O
transforming VBG O
genes NNS O
. . O

-DOCSTART- X X O

Immunohistochemical JJ O
analysis NN O
of IN O
several JJ O
rat NN O
organs NNS O
also RB O
showed VBD O
staining NN O
in IN O
epithelial JJ O
cells NNS O
. . O

-DOCSTART- X X O

Both DT O
strains NNS O
grew VBD O
very RB O
poorly RB O
, , O
or CC O
not RB O
at IN O
all DT O
, , O
on IN O
nonfermentable JJ O
carbon NN O
sources NNS O
and CC O
exhibited VBD O
, , O
at IN O
most RBS O
, , O
only RB O
5 CD O
% NN O
of IN O
wild-type JJ B-NP
ubiquinol-cytochrome NN I-NP
c NN I-NP
oxidoreductase NN I-NP
activity NN O
. . O

-DOCSTART- X X O

Transcription NN O
of IN O
the DT O
first JJ O
operon NN O
coding NN O
for IN O
m-xylene-degrading JJ O
enzymes NNS O
on IN O
the DT O
TOL NNP O
plasmid NN O
of IN O
Pseudomonas NNP O
putida NN O
is VBZ O
activated VBN O
by IN O
the DT O
xylR NNP B-NP
gene NN I-NP
product NN I-NP
in IN O
the DT O
presence NN O
of IN O
m-xylene NN O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
also RB O
that IN O
RA NNP O
represses VBZ O
the DT O
transcriptional JJ O
activity NN O
of IN O
a DT O
reporter NN O
gene NN O
containing VBG O
a DT O
TPA NNP O
responding VBG O
AP1 IN B-NP
binding JJ I-NP
site NN I-NP
driving VBG O
the DT O
HSV NNP B-NP
tk NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Risk NN O
factors NNS O
influencing VBG O
lymph NN O
nodes NNS O
metastasis NN O
in IN O
lung NN O
cancer NN O
with IN O
stage NN O
I PRP O
, , O
II NNP O
or CC O
IIIA NNP O

-DOCSTART- X X O

Multifunctional JJ B-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
MFPK) NNP B-NP
phosphorylates VBZ O
ATP-citrate JJ B-NP
lyase NN I-NP
on IN O
peptide NN B-NP
B NNP I-NP
on IN O
two CD O
sites NNS O
, , O
BT NNP O
and CC O
BS NNP O
, , O
on IN O
threonine CD O
and CC O
serine NN O
, , O
respectively RB O
, , O
inhibitor VBP B-NP
2 CD I-NP
on IN O
a DT O
threonyl NN O
residue NN O
, , O
and CC O
glycogen NN B-NP
synthase NN I-NP
at IN O
sites NNS O
2 CD O
and CC O
3. CD O

-DOCSTART- X X O

The DT O
characterized VBD O
Y' NNP B-NP
repeated VBD I-NP
sequence NN I-NP
families NNS I-NP
provide VBP O
an DT O
experimental JJ O
system NN O
in IN O
which WDT O
repeated VBD O
sequence NN O
interactions NNS O
and CC O
subsequent JJ O
evolution NN O
can MD O
be VB O
studied VBN O
. . O

-DOCSTART- X X O

Unlike IN O
p59v-rel NN B-NP
, , O
which WDT O
is VBZ O
a DT O
nuclear JJ O
protein NN O
in IN O
CEF NNP O
, , O
indirect JJ O
immunofluorescence NN O
showed VBD O
that IN O
p68c-rel NN B-NP
in IN O
JD214c-rel JJ O
infected JJ O
CEF NN O
is VBZ O
located VBN O
exclusively RB O
in IN O
the DT O
cytoplasm NN O
of IN O
these DT O
cells NNS O
, , O
even RB O
though IN O
the DT O
sequence NN O
of IN O
p68c-rel NN B-NP
showed VBD O
that IN O
it PRP O
contains VBZ O
a DT O
nuclear JJ O
localizing JJ O
sequence NN O
identical JJ O
to TO O
the DT O
one CD O
previously RB O
identified VBN O
in IN O
p59v-rel NN B-NP
. . O

-DOCSTART- X X O

However RB O
, , O
primary JJ O
transcripts NNS O
of IN O
a DT O
variant JJ B-NP
tRNA(Val JJ I-NP
)( JJ I-NP
UAC NNP I-NP
) -RRB- I-NP
gene NN I-NP
are VBP O
processing VBG O
deficient NN O
under IN O
standard JJ O
growth NN O
conditions NNS O
( -LRB- O
30 CD O
degrees NNS O
C) NN O
, , O
due JJ O
to TO O
a DT O
slightly RB O
altered VBN O
5' IN O
flanking VBG O
region NN O
. . O

-DOCSTART- X X O

Three CD O
of IN O
the DT O
short JJ O
ORFs NNP O
in IN O
the DT O
central JJ O
region NN O
of IN O
BIV NNP O
have VBP O
been VBN O
identified VBN O
by IN O
location NN O
and CC O
structural JJ O
similarity NN O
to TO O
the DT O
nonstructural/regulatory JJ O
genes NNS O
(vif VBN O
, , O
tat VB B-NP
, , O
and CC O
rev NN B-NP
) -RRB- O
of IN O
other JJ O
lentiviruses NNS O
; : O
we PRP O
also RB O
discovered VBD O
two CD O
unique JJ O
ORFs NNP O
, , O
termed VBD O
W NNP O
and CC O
Y NNP O
, , O
which WDT O
may MD O
serve VB O
as IN O
exons NNS O
for IN O
novel JJ O
genes NNS O
. . O

-DOCSTART- X X O

Truncations NNS O
composed VBN O
of IN O
78 CD O
and CC O
64 CD O
amino IN O
acids NNS O
were VBD O
translocated VBN O
across IN O
the DT O
endoplasmic JJ O
reticulum NN O
membrane NN O
, , O
and CC O
translocation NN O
was VBD O
found VBN O
to TO O
be VB O
strictly RB O
co-translational JJ O
and CC O
SRP-dependent JJ B-NP
. . O

-DOCSTART- X X O

Pulmonary JJ O
vascular JJ O
resistance NN O
was VBD O
not RB O
altered VBN O
, , O
ejection NN O
fraction NN O
remained VBD O
unchanged JJ O
and CC O
isovolumic JJ O
relaxation NN O
period NN O
was VBD O
lengthened VBN O
( -LRB- O
119 CD O
+/ NN O
- : O
20.1 CD O
to TO O
147.39 CD O
+/ CD O
- : O
21.15 CD O
, , O
P NNP O
less JJR O
than IN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
contribution NN O
that IN O
alternative JJ O
splicing JJ O
events NNS O
in IN O
c-myb JJ B-NP
expression NN O
may MD O
make VB O
on IN O
c-myb JJ B-NP
function NN O
remains VBZ O
to TO O
be VB O
elucidated VBN O
. . O

-DOCSTART- X X O

R. NNP O

-DOCSTART- X X O

Specific JJ O
hyperimmune JJ B-NP
globulins NNS I-NP
to TO O
pathogens NNS O
such JJ O
as IN O
Haemophilus NNP O
influenzae NN O
and CC O
Streptococcus NNP O
pneumoniae NNS O
have VBP O
also RB O
been VBN O
studied VBN O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
yeast NN B-NP
LEU2. . I-NP

-DOCSTART- X X O

Since IN O
general JJ B-NP
regulatory JJ I-NP
factor NN I-NP
I PRP I-NP
( -LRB- O
GRFI)/repressor/activator NNP B-NP
site NN B-NP
binding JJ I-NP
protein NN I-NP
1 CD I-NP
(RAP1 NN O
)/translation NN O
upstream RB B-NP
factor NN I-NP
( -LRB- O
TUF) NN B-NP
is VBZ O
believed VBN O
to TO O
be VB O
an DT O
activator NN O
of IN O
MAT NN B-NP
alpha NN I-NP
expression NN O
, , O
we PRP O
examined VBD O
whether IN O
PYK1 NNP B-NP
, , O
which WDT O
is VBZ O
known VBN O
to TO O
be VB O
regulated VBN O
by IN O
GRFI/RAP1/TUF NNP B-NP
, , O
is VBZ O
also RB O
affected VBN O
by IN O
the DT O
gal11 NN B-NP
mutation NN I-NP
. . O

-DOCSTART- X X O

Deletion NN O
from IN O
either CC O
the DT O
N- NNP O
or CC O
C-terminal JJ O
ends NNS O
of IN O
repA NNS B-NP
( -LRB- O
28 CD O
and CC O
69 CD O
codons NNS O
, , O
respectively RB O
, , O
out IN O
of IN O
the DT O
286-codon CD O
open JJ O
reading NN O
frame NN O
) -RRB- O
affected VBN O
the DT O
initiator NN O
but CC O
not RB O
the DT O
inhibitory JJ O
activity NN O
. . O

-DOCSTART- X X O

Guiding NNP O
patients NNS O
in IN O
the DT O
decision NN O
should MD O
involve VB O
a DT O
multidisciplinary JJ O
team NN O
composed VBN O
of IN O
a DT O
surgical JJ O
oncologist NN O
, , O
geneticist NN O
, , O
pathologist NN O
, , O
psychotherapist NN O
and CC O
plastic NN O
surgeon NN O
. . O

-DOCSTART- X X O

IgG NNP B-NP
and CC O
IgM NNP B-NP
antibody NN O
activity NN O
was VBD O
determined VBN O
by IN O
adding VBG O
a DT O
1:100 CD O
dilution NN O
of IN O
serum JJ O
to TO O
plates NNS O
coated VBN O
with IN O
A60 DT B-NP
antigen NN I-NP
. . O

-DOCSTART- X X O

These DT O
factors NNS O
belong VBP O
to TO O
a DT O
set NN O
of IN O
genetically RB O
distinct JJ O
molecules NNS O
, , O
including VBG O
AP-4 NNP B-NP
and CC O
MLTF NNP B-NP
, , O
that DT O
bind NN O
to TO O
the DT O
CACCTGTC NNP O
motif NN O
or CC O
related VBN O
sequences NNS O
. . O

-DOCSTART- X X O

Among IN O
known VBN O
flea NN O
larvae NNS O
, , O
the DT O
genus NN O
Anomiopsyllus DT O
( -LRB- O
Anomiopsyllinae NNP O
, , O
Anomiopsyllini NNP O
) -RRB- O
is VBZ O
as IN O
distinctive JJ O
in IN O
larval NN O
form NN O
as IN O
are VBP O
the DT O
adults NNS O
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
have VBP O
used VBN O
specific JJ O
antibody NN O
to TO O
identify VB O
and CC O
characterize VB O
the DT O
SSN6 NNP B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Clinical NNP O
nutrition NN O
of IN O
adult JJ O
horses NNS O
. . O

-DOCSTART- X X O

The DT O
computer-programmed JJ O
cytocentrifuge NN O
is VBZ O
currently RB O
most RBS O
popular JJ O
. . O

-DOCSTART- X X O

RNase NN B-NP
protection NN O
assays VBZ O
reveal VB O
that IN O
this DT O
gene NN O
, , O
unr JJ B-NP
, , O
is VBZ O
transcribed VBN O
in IN O
the DT O
same JJ O
direction NN O
as IN O
N-ras NNP B-NP
and CC O
that IN O
its PRP$ O
3' JJ O
end NN O
is VBZ O
located VBN O
just RB O
130 CD O
base NN O
pairs NNS O
away RB O
from IN O
the DT O
point NN O
at IN O
which WDT O
N-ras NNP B-NP
transcription NN O
begins VBZ O
. . O

-DOCSTART- X X O

Isolation NNP O
of IN O
a DT O
temperature-sensitive JJ O
mutant NN O
with IN O
an DT O
altered JJ O
tRNA NN B-NP
nucleotidyltransferase NN I-NP
and CC O
cloning NN O
of IN O
the DT O
gene NN B-NP
encoding VBG I-NP
tRNA DT I-NP
nucleotidyltransferase JJ I-NP
in IN I-NP
the DT I-NP
yeast NN I-NP
Saccharomyces NNP I-NP
cerevisiae NNS I-NP
. . O

-DOCSTART- X X O

The DT O
juxtamembrane JJ O
region NN O
of IN O
the DT O
insulin NN B-NP
receptor NN I-NP
( -LRB- I-NP
IR NNP I-NP
) -RRB- I-NP
beta-subunit NN I-NP
contains VBZ O
an DT O
unphosphorylated JJ O
tyrosyl NN O
residue NN O
( -LRB- O
Tyr960 NNP O
) -RRB- O
that WDT O
is VBZ O
essential JJ O
for IN O
insulin-stimulated JJ B-NP
tyrosyl NN O
phosphorylation NN O
of IN O
some DT O
endogenous JJ O
substrates NNS O
and CC O
certain JJ O
biological JJ O
responses NNS O
( -LRB- O
White NNP O
, , O
M.F. NNP O
, , O
Livingston NNP O
, , O
J.N. NNP O
, , O
Backer NNP O
, , O
J.M. NNP O
, , O
Lauris NNP O
, , O
V. NNP O
, , O
Dull NNP O
, , O
T.J. NNP O
, , O
Ullrich NNP O
, , O
A. NN O
, , O
and CC O
Kahn NNP O
, , O
C.R. NNP O

-DOCSTART- X X O

The DT O
3' JJ O
region NN O
, , O
GA2 NNP B-NP
, , O
is VBZ O
necessary JJ O
for IN O
maximal JJ O
expression NN O
. . O

-DOCSTART- X X O

Pups NNS O
placed VBD O
into IN O
the DT O
novel NN O
environment NN O
with IN O
their PRP$ O
mothers NNS O
exhibited VBD O
an DT O
intermediate JJ O
level NN O
of IN O
DA NNP O
turnover NN O
. . O

-DOCSTART- X X O

The DT O
grandfather NN O
and CC O
the DT O
granddaughter NN O
both DT O
had VBD O
microtia NN O
and CC O
meatal JJ O
atresia NN O
, , O
whereas IN O
the DT O
daughter NN O
had VBD O
a DT O
normal JJ O
outer JJ O
ear NN O
except IN O
for IN O
a DT O
narrow JJ O
meatus NN O
and CC O
auricular JJ O
appendages NNS O
. . O

-DOCSTART- X X O

The DT O
urinary JJ O
protein NN O
, , O
serum NN O
albumin NN B-NP
, , O
BUN NNP O
and CC O
SCr NNP O
all DT O
had VBD O
very RB O
significant JJ O
improvement NN O
. . O

-DOCSTART- X X O

More RBR O
generally RB O
, , O
Ets1 NNP B-NP
and CC O
Ets2 NNP B-NP
could MD O
regulate VB O
transcription NN O
of IN O
cellular JJ O
genes NNS O
. . O

-DOCSTART- X X O

Within IN O
this DT O
sequence NN O
the DT O
MSAS NNP B-NP
gene NN I-NP
was VBD O
identified VBN O
as IN O
a DT O
5322-bp-long JJ O
open JJ O
reading NN O
frame NN O
coding NN O
for IN O
a DT O
protein NN O
of IN O
1774 CD O
amino IN O
acids NNS O
and CC O
190,731 CD O
Da NNP O
molecular JJ O
mass NN O
. . O

-DOCSTART- X X O

Standardized JJ O
gastric JJ O
wall NN O
specimens NNS O
from IN O
the DT O
area NN O
of IN O
grossly RB O
healed VBN O
ulcers NNS O
were VBD O
obtained VBN O
, , O
processed VBN O
, , O
and CC O
evaluated VBN O
by IN O
light NN O
microscopy NN O
and CC O
by IN O
transmission NN O
electron NN O
microscopy NN O
. . O

-DOCSTART- X X O

2. . O

-DOCSTART- X X O

This DT O
last JJ O
includes VBZ O
tissue NN O
O2 JJ O
transfer NN O
( -LRB- O
Ft JJ O
' '' O
) -RRB- O
and CC O
mitochondrial JJ O
O2 NN O
utilization NN O
( -LRB- O
Fm JJ O
' '' O
) -RRB- O
. . O

-DOCSTART- X X O

Foveating VBG O
saccades NNS O
, , O
therefore RB O
, , O
can MD O
be VB O
distinguished VBN O
from IN O
other JJ O
FEMs NNS O
on IN O
the DT O
basis NN O
of IN O
speed NN O
. . O

-DOCSTART- X X O

Chick NNP B-NP
brain NN I-NP
actin NN I-NP
depolymerizing JJ I-NP
factor NN I-NP
( -LRB- O
ADF) NNP B-NP
is VBZ O
a DT O
19-kDa JJ O
protein NN O
that IN O
severs JJ O
actin NN B-NP
filaments NNS I-NP
and CC O
binds NNS O
actin IN B-NP
monomers NNS I-NP
. . O

-DOCSTART- X X O

Initial JJ O
experience NN O
with IN O
a DT O
serotonin NN O
agonist NN O
. . O

-DOCSTART- X X O

Primer JJ O
extension NN O
analysis NN O
and CC O
RNA NNP O
sequencing NN O
demonstrates VBZ O
that IN O
the DT O
transcription NN O
start NN O
point NN O
of IN O
rat NN B-NP
ODC NNP I-NP
mRNA NN I-NP
is VBZ O
located VBN O
303 JJ O
nt NN O
upstream RB O
from IN O
the DT O
A NNP O
residue NN O
in IN O
the DT O
start NN O
codon NN O
. . O

-DOCSTART- X X O

For IN O
85Sr JJ O
, , O
larger-than-expected JJ O
distribution NN O
coefficients NNS O
were VBD O
obtained VBN O
in IN O
the DT O
desorption NN O
experiments NNS O
, , O
an DT O
indication NN O
of IN O
the DT O
irreversible JJ O
formation NN O
of IN O
metal-oxyhydroxides NNS O
during IN O
a DT O
slow JJ O
reaction NN O
. . O

-DOCSTART- X X O

This DT O
growth NN O
arrest NN O
is VBZ O
partly RB O
suppressed VBN O
on IN O
minimal JJ O
medium NN O
or CC O
under IN O
conditions NNS O
in IN O
which WDT O
the DT O
cells NNS O
are VBP O
less RBR O
dependent JJ O
on IN O
mitochondrial JJ O
metabolism NN O
. . O

-DOCSTART- X X O

Giant NNP O
pilomatrix NN O
carcinoma NN O
: : O
report NN O
and CC O
review NN O
of IN O
the DT O
literature NN O
. . O

-DOCSTART- X X O

Further JJ O
studies NNS O
of IN O
mandibular JJ O
movement NN O
at IN O
initial JJ O
tooth NN O
contact NN O
. . O

-DOCSTART- X X O

Each DT O
parent NN O
interacted VBN O
with IN O
their PRP$ O
4- JJ O
or CC O
5-year-old JJ O
son NN O
or CC O
daughter NN O
in IN O
each DT O
of IN O
two CD O
conversations--unstructured JJ O
( -LRB- O
social JJ O
conversation NN O
) -RRB- O
and CC O
structured VBN O
( -LRB- O
task NN O
activity NN O
) -RRB- O
. . O

-DOCSTART- X X O

Droperidol-induced JJ O
extrapyramidal JJ O
symptoms NNS O
in IN O
an DT O
adolescent NN O
following VBG O
strabismus NN O
surgery NN O
. . O

-DOCSTART- X X O

The DT O
induction NN O
by IN O
pseudorabies NNS O
virus NN O
of IN O
an DT O
IL-6 NN B-NP
construct VB I-NP
containing VBG O
the DT O
IL-6 NNP B-NP
TATA NNP I-NP
box NN I-NP
and CC O
the DT O
RNA NNP O
start NN O
site NN O
( -LRB- O
"initiator NN O
" '' O
or CC O
Inr JJ O
element NN O
) -RRB- O
but CC O
not RB O
the DT O
MRE NNP O
region NN O
was VBD O
also RB O
repressed VBN O
by IN O
Dex NNP O
in IN O
the DT O
presence NN O
of IN O
wild-type JJ B-NP
GR CD I-NP
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
class NN O
I PRP O
cytologic VBD O
smears NNS O
with IN O
moderate JJ O
to TO O
severe JJ O
inflammation NN O
may MD O
be VB O
associated VBN O
with IN O
findings NNS O
of IN O
condylomata NN O
and CC O
cervical JJ O
dysplasia NN O
. . O

-DOCSTART- X X O

As IN O
in IN O
mammals NNS O
, , O
considerable JJ O
nucleotide JJ O
diversity NN O
was VBD O
observed VBN O
at IN O
the DT O
junctions NNS O
of IN O
the DT O
variable JJ O
, , O
diversity NN O
, , O
and CC O
joining VBG O
elements NNS O
in IN O
chicken NN B-NP
TCR NN I-NP
beta NN I-NP
cDNAs NNS I-NP
. . O

-DOCSTART- X X O

Rats NNS O
with IN O
one CD O
olfactory JJ O
bulb NN O
removed VBD O
and CC O
the DT O
contralateral JJ O
naris NN O
closed VBD O
can MD O
detect VB O
odors NNS O
. . O

-DOCSTART- X X O

The DT O
Ets-1 JJ B-NP
binding NN I-NP
site NN I-NP
was VBD O
localized VBN O
to TO O
a DT O
17-base JJ O
pair NN O
( -LRB- O
bp NN O
) -RRB- O
region NN O
from IN O
the DT O
3' JJ O
end NN O
of IN O
T NNP B-NP
alpha NN I-NP
2. . I-NP

-DOCSTART- X X O

We PRP O
have VBP O
now RB O
identified VBN O
, , O
after IN O
21 CD O
serial JJ O
undiluted JJ O
passages NNS O
of IN O
MHV NNP O
, , O
a DT O
small JJ B-NP
DI NNP I-NP
RNA NNP I-NP
, , O
DIssF NNP B-NP
, , O
which WDT O
is VBZ O
efficiently RB O
packaged VBN O
into IN O
virions NNS O
. . O

-DOCSTART- X X O

The DT O
Jenkins NNP O
Activity NNP O
Survey NNP O
and CC O
the DT O
CPI-revised JJ O
: : O
further JJ O
evidence NN O
of IN O
adaptive JJ O
and CC O
maladaptive JJ O
type NN O
A DT O
traits NNS O
. . O

-DOCSTART- X X O

There EX O
was VBD O
evidence NN O
of IN O
attenuated VBN O
regression NN O
slopes NNS O
relating VBG O
recalled VBN O
to TO O
observed JJ O
portion NN O
sizes VBZ O
for IN O
4 CD O
of IN O
the DT O
10 CD O
food NN O
groups NNS O
; : O
adjusted VBN O
r2 NN O
values NNS O
for IN O
the DT O
recalled VBN O
portion NN O
sizes VBZ O
ranged VBN O
from IN O
0.02 CD O
to TO O
0.94 CD O
. . O

-DOCSTART- X X O

The DT O
SUP44 NNP B-NP
suppressor NN I-NP
mutation NN I-NP
occurs VBZ O
near IN O
a DT O
region NN O
of IN O
the DT O
protein NN O
that IN O
corresponds NNS O
to TO O
the DT O
known VBN O
positions NNS O
of IN O
alterations NNS O
in IN O
E. NNP B-NP
coli NNS I-NP
S5 . I-NP
ram NN I-NP
mutations NNS I-NP
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
disruption NN O
of IN O
the DT O
VPS34 NNP B-NP
locus NN I-NP
resulted VBD O
in IN O
a DT O
temperature-sensitive JJ O
growth NN O
defect NN O
, , O
indicating VBG O
that IN O
the DT O
VPS34 NNP B-NP
gene NN I-NP
is VBZ O
essential JJ O
for IN O
vegetative NN O
growth NN O
only RB O
at IN O
elevated JJ O
growth NN O
temperatures NNS O
. . O

-DOCSTART- X X O

We PRP O
describe VBP O
a DT O
case NN O
of IN O
a DT O
perinephric JJ O
abscess NN O
treated VBN O
with IN O
amphotericin RB O
B NNP O
and CC O
nephrectomy NN O
. . O

-DOCSTART- X X O

This DT O
, , O
together RB O
with IN O
the DT O
data NNS O
obtained VBN O
with IN O
haloperidol JJ O
, , O
suggests VBZ O
that IN O
a DT O
minimal JJ O
increase NN O
in IN O
the DT O
firing NN O
rate NN O
of IN O
LC NNP O
cells NNS O
( -LRB- O
+140 CD O
% NN O
) -RRB- O
is VBZ O
required VBN O
before IN O
it PRP O
could MD O
influence VB O
the DT O
turnover NN O
of IN O
NA NNP O
, , O
as IN O
measured VBN O
by IN O
DOPAC NNP O
changes NNS O
. . O

-DOCSTART- X X O

Perceptions NNS O
of IN O
illness NN O
intrusiveness NN O
were VBD O
significantly RB O
higher JJR O
when WRB O
both DT O
muscle NN O
cramp NN O
and CC O
headache NN O
symptoms NNS O
occurred VBD O
during IN O
one CD O
or CC O
more JJR O
assessment NN O
intervals NNS O
as IN O
compared VBN O
to TO O
when WRB O
muscle NN O
cramps NNS O
or CC O
headaches NNS O
, , O
only RB O
, , O
occurred VBD O
. . O

-DOCSTART- X X O

Results NNS O
have VBP O
surprisingly RB O
revealed VBN O
the DT O
presence NN O
of IN O
three CD O
U14 IN B-NP
snRNA-homologous JJ I-NP
regions NNS I-NP
positioned VBD O
within IN O
introns NNS O
5 CD O
, , O
6 CD O
, , O
and CC O
8 CD O
of IN O
the DT O
mouse NN O
cognate NN O
hsc70 IN B-NP
heat NN O
shock NN O
gene NN O
. . O

-DOCSTART- X X O

The DT O
highly RB O
restrained JJ O
girls NNS O
had VBD O
a DT O
significantly RB O
higher JJR O
EAT NN O
score NN O
than IN O
the DT O
low-restrained JJ O
girls NNS O
, , O
and CC O
shared VBN O
with IN O
their PRP$ O
mothers NNS O
a DT O
susceptibility NN O
to TO O
the DT O
disinhibitory JJ O
effects NNS O
of IN O
negative JJ O
mood NN O
states NNS O
on IN O
their PRP$ O
eating NN O
behaviour NN O
. . O

-DOCSTART- X X O

The DT O
Mauriceville NNP O
and CC O
Varkud NNP O
mitochondrial JJ O
plasmids NNS O
are VBP O
closely RB O
related VBN O
, , O
closed-circular JJ O
DNAs NNP O
( -LRB- O
3.6 CD O
and CC O
3.7 CD O
kb NN O
, , O
respectively RB O
) -RRB- O
that WDT O
have VBP O
characteristics NNS O
of IN O
mtDNA NN O
introns NNS O
and CC O
retroid JJ O
elements NNS O
. . O

-DOCSTART- X X O

The DT O
circadian JJ O
rhythm NN O
, , O
however RB O
, , O
was VBD O
not RB O
affected VBN O
and CC O
the DT O
difference NN O
between IN O
minimum NN O
( -LRB- O
12.00 CD O
h NN O
) -RRB- O
and CC O
maximum JJ O
( -LRB- O
18.50 CD O
h NN O
) -RRB- O
serum NN O
concentrations NNS O
was VBD O
31.3 CD O
% NN O
. . O

-DOCSTART- X X O

Sequence NN O
and CC O
genetic JJ O
organization NN O
of IN O
a DT O
Zymomonas NNP O
mobilis NN O
gene NN O
cluster NN O
that WDT O
encodes VBZ O
several JJ O
enzymes NNS O
of IN O
glucose NN O
metabolism NN O
. . O

-DOCSTART- X X O

Most JJS O
strains NNS O
( -LRB- O
95 CD O
% NN O
) -RRB- O
of IN O
S. NNP O
lugdunensis NN O
produced VBD O
a DT O
delta JJ B-NP
hemolysin NN I-NP
like IN O
that DT O
seen VBN O
with IN O
nine CD O
other JJ O
species NNS O
of IN O
CNS. NNP O

-DOCSTART- X X O

For IN O
this DT O
, , O
cDNAs RB O
containing VBG O
the DT O
60K JJ O
, , O
87K JJ O
, , O
110K JJ O
and CC O
170K JJ O
protein NN O
coding NN O
sequences NNS O
were VBD O
each DT O
provided VBN O
with IN O
an DT O
ATG NNP O
start NN O
codon NN O
and CC O
the DT O
cDNA NN O
containing VBG O
the DT O
60K JJ O
coding NN O
sequence NN O
with IN O
a DT O
TAA NNP O
stop NN O
codon NN O
immediately RB O
downstream RB O
of IN O
the DT O
coding NN O
sequence NN O
. . O

-DOCSTART- X X O

Finally RB O
, , O
a DT O
complementary JJ O
footprinting NN O
analysis NN O
of IN O
the DT O
upstream JJ O
region NN O
of IN O
the DT O
constitutively NN O
expressed VBD O
HSC82 NNP B-NP
gene NN I-NP
reveals VBZ O
the DT O
presence NN O
of IN O
three CD O
discrete JJ O
protein NN O
complexes NNS O
. . O

-DOCSTART- X X O

Pathophysiology NN O
of IN O
bone NN O
loss NN O
in IN O
castrated JJ O
animals NNS O
. . O

-DOCSTART- X X O

First RB O
, , O
each DT O
lung NN O
was VBD O
cut VBN O
into IN O
slices NNS O
, , O
from IN O
which WDT O
primary JJ O
disectors NNS O
were VBD O
sampled VBN O
systematically RB O
with IN O
a DT O
known VBN O
sampling NN O
fraction NN O
. . O

-DOCSTART- X X O

Assuming VBG O
O2 NNP O
consumption NN O
of IN O
the DT O
isolated JJ O
skin NN O
to TO O
be VB O
same JJ O
as IN O
in IN O
situ FW O
, , O
calculations NNS O
showed VBD O
that IN O
when WRB O
water NN O
PO2 NN O
was VBD O
high JJ O
( -LRB- O
150 CD O
mm CD O
Hg NN O
) -RRB- O
, , O
about IN O
40 CD O
% NN O
of IN O
total JJ O
cutaneous JJ O
O2 NNP O
uptake NN O
was VBD O
consumed VBN O
by IN O
the DT O
skin NN O
. . O

-DOCSTART- X X O

Experiments NNS O
showed VBD O
that IN O
temporary JJ O
arrest NN O
of IN O
pulmonary JJ O
circulation NN O
under IN O
conditions NNS O
of IN O
extracorporeal JJ O
circulation NN O
is VBZ O
attended VBN O
by IN O
the DT O
development NN O
of IN O
ischemia NN O
of IN O
the DT O
respiratory JJ O
pulmonary JJ O
tissue NN O
. . O

-DOCSTART- X X O

Plasma NNP O
Al NNP O
was VBD O
obtained VBN O
during IN O
each DT O
baseline NN O
and CC O
drug NN O
course NN O
. . O

-DOCSTART- X X O

The DT O
survival NN O
in IN O
the DT O
case NN O
of IN O
these DT O
patients NNS O
was VBD O
studied VBN O
five CD O
years NNS O
later RB O
. . O

-DOCSTART- X X O

The DT O
occurrence NN O
, , O
maintenance NN O
and CC O
possible JJ O
involvement NN O
of IN O
these DT O
repeated VBN O
sequences NNS O
, , O
capable JJ O
of IN O
forming VBG O
stable JJ O
secondary JJ O
structures NNS O
, , O
are VBP O
discussed VBN O
in IN O
relation NN O
to TO O
their PRP$ O
location NN O
in IN O
the DT O
region NN O
of IN O
control NN O
signals NNS O
. . O

-DOCSTART- X X O

The DT O
endodontal JJ O
treatment NN O
need NN O
has VBZ O
been VBN O
forming VBG O
a DT O
clinical JJ O
order NN O
of IN O
magnitude NN O
. . O

-DOCSTART- X X O

1 CD O
( -LRB- O
"long JJ O
method NN O
" '' O
) -RRB- O
and CC O
the DT O
HML NNP O
method NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
may MD O
suggest VB O
involvement NN O
of IN O
peripheral JJ O
enkephalins NNS O
in IN O
pain NN O
modulation NN O
in IN O
patients NNS O
with IN O
episodic JJ O
cluster NN O
headache NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
cisapride NN O
on IN O
upper-gastrointestinal JJ O
motility NN O
and CC O
digestive JJ O
hormones NNS O

-DOCSTART- X X O

Common JJ O
foot NN O
pathologies NNS O
are VBP O
heel NN O
pain NN O
, , O
metatarsalgia NN O
, , O
hammertoes NNS O
and CC O
clawtoes NNS O
, , O
bunions NNS O
, , O
hallux NN O
rigidus NN O
, , O
corns NNS O
and CC O
calluses NNS O
, , O
nail NN O
pathologies NNS O
, , O
arthritis NN O
, , O
and CC O
neuropathies NNS O
. . O

-DOCSTART- X X O

Liver NN O
dysfunction NN O
in IN O
the DT O
presence NN O
of IN O
different JJ O
adverse JJ O
reactions NNS O
presented VBN O
with IN O
a DT O
higher JJR O
activity NN O
in IN O
the DT O
blood NN O
serum NN O
of IN O
indicator NN O
liver NN O
enzymes NNS O
and CC O
its PRP$ O
impaired JJ O
protein-forming JJ O
function NN O
. . O

-DOCSTART- X X O

The DT O
CT NNP O
characteristics NNS O
are VBP O
discussed VBN O
and CC O
the DT O
recent JJ O
literature NN O
is VBZ O
reviewed VBN O
. . O

-DOCSTART- X X O

Unfortunately RB O
, , O
these DT O
preservatives NNS O
may MD O
also RB O
interfere VB O
with IN O
microbiological JJ O
assays NNS O
used VBN O
to TO O
determine VB O
product NN O
sterility NN O
or CC O
bioburden JJ O
levels NNS O
. . O

-DOCSTART- X X O

In IN O
26 CD O
patients NNS O
with IN O
angina DT O
pectoris NN O
, , O
the DT O
changes NNS O
of IN O
LVEF NNP O
, , O
LVESV NNP O
and CC O
PSP/LVESV NNP O
were VBD O
more RBR O
sensitive JJ O
for IN O
the DT O
detection NN O
of IN O
exercise-induced JJ O
ischemia NN O
than IN O
the DT O
appearance NN O
of IN O
chest NN O
pain NN O
and CC O
the DT O
changes NNS O
of IN O
ECG. NNP O

-DOCSTART- X X O

In IN O
both DT O
groups NNS O
there RB O
were VBD O
5 CD O
management NN O
failure NN O
of IN O
therapy NN O
, , O
so RB O
that IN O
alternative JJ O
medication NN O
or CC O
a DT O
cesarean JJ O
section NN O
lead NN O
to TO O
delivery NN O
. . O

-DOCSTART- X X O

The DT O
uteroglobin NN B-NP
promoter NN I-NP
contains VBZ O
a DT O
noncanonical JJ O
estrogen NN O
responsive JJ O
element NN O
. . O

-DOCSTART- X X O

Significance NN O
of IN O
cytokine NN O
production NN O
and CC O
adhesion NN O
molecules NNS O
in IN O
malarial JJ O
immunopathology NN O
. . O

-DOCSTART- X X O

Further JJ O
research NN O
is VBZ O
recommended VBN O
to TO O
identify VB O
the DT O
coping NN O
styles NNS O
associated VBN O
with IN O
the DT O
high JJ O
EE/low NN O
EE NN O
research NN O
classification NN O
. . O

-DOCSTART- X X O

Ultrastructural NNP O
and CC O
morphometric JJ O
study NN O
of IN O
the DT O
myeloid JJ O
parenchyma NN O
cells NNS O
of IN O
mice NNS O
prior RB O
and CC O
after IN O
X-ray NN O
exposure NN O

-DOCSTART- X X O

Using VBG O
an DT O
audiotape NN O
cassette NN O
and CC O
headphones NNS O
the DT O
duration NN O
of IN O
the DT O
hallucinations NNS O
decreased VBD O
significantly RB O
. . O

-DOCSTART- X X O

Very RB O
good JJ O
accuracy NN O
( -LRB- O
r NN O
greater JJR O
than IN O
0.9 CD O
) -RRB- O
was VBD O
found VBN O
when WRB O
except IN O
comparing VBG O
H*2 PRP O
with IN O
the DT O
other JJ O
machine NN O
and CC O
the DT O
reference NN O
methods NNS O
, , O
except IN O
for IN O
MCHCH NNP O
and CC O
basophil JJ O
count NN O
. . O

-DOCSTART- X X O

Interlimb NN O
coordination NN O
during IN O
fictive JJ O
locomotion NN O
in IN O
the DT O
thalamic JJ O
cat NN O
. . O

-DOCSTART- X X O

Antileukoproteinase NNP B-NP
( -LRB- O
ALP NNP B-NP
) -RRB- O
is VBZ O
a DT O
low JJ O
mol NN O
wt IN O
mucosal NN O
secretory NN O
protein NN O
which WDT O
, , O
in IN O
human JJ O
tissues NNS O
, , O
inhibits VBZ O
the DT O
activities NNS O
of IN O
the DT O
neutral JJ O
serine NN B-NP
lysosomal JJ I-NP
proteinases NNS I-NP
elastase JJ B-NP
and CC O
cathepsin-G. NN B-NP

-DOCSTART- X X O

In IN O
particular JJ O
, , O
71 CD O
and CC O
69 CD O
% NN O
amino IN O
acid NN O
sequence NN O
similarities NNS O
were VBD O
identified VBN O
with IN O
hsp70 CD B-NP
of IN I-NP
Escherichia NNP I-NP
coli NNS I-NP
and CC I-NP
Bacillus NNP I-NP
megaterium NN I-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

No DT O
causal JJ O
relations NNS O
may MD O
be VB O
inferred VBN O
from IN O
the DT O
correlation NN O
between IN O
the DT O
level NN O
of IN O
trapezius NN O
activity NN O
and CC O
complaints NNS O
, , O
though IN O
it PRP O
indicates VBZ O
that IN O
individual JJ O
, , O
inexpedient JJ O
muscle NN O
activity NN O
patterns NNS O
may MD O
constitute VB O
an DT O
important JJ O
risk NN O
factor NN O
for IN O
development NN O
of IN O
musculo-skeletal JJ O
complaints NNS O
. . O

-DOCSTART- X X O

All DT O
89 CD O
participating VBG O
household NN O
members NNS O
were VBD O
anti-HIV JJ B-NP
seronegative JJ O
, , O
and CC O
78 CD O
who WP O
were VBD O
tested VBN O
were VBD O
serum VBN B-NP
p24 DT I-NP
antigen JJ I-NP
negative JJ O
. . O

-DOCSTART- X X O

To TO O
determine VB O
the DT O
effects NNS O
on IN O
the DT O
pulmonary JJ O
barrier NN O
of IN O
several JJ O
surface NN O
active JJ O
agents NNS O
, , O
a DT O
series NN O
of IN O
metered JJ O
dose NN O
inhalers NNS O
( -LRB- O
MDIs NNS O
) -RRB- O
was VBD O
prepared VBN O
and CC O
used VBN O
to TO O
dose NN O
aerosolized JJ O
surfactant NN O
to TO O
the DT O
airways NNS O
of IN O
isolated JJ O
perfused JJ O
rat NN O
lungs NNS O
. . O

-DOCSTART- X X O

The DT O
therapeutic JJ O
protocole NN O
used VBN O
at IN O
the DT O
Gustave NNP O
Roussy NNP O
Institute NNP O
for IN O
invasive JJ O
epithelioma NN O
of IN O
the DT O
uterine NN O
cervix NN O
rests VBZ O
, , O
for IN O
limited JJ O
forms NNS O
( -LRB- O
T1B-T2 JJ O
proximal NN O
) -RRB- O
, , O
on IN O
combined VBN O
radiology NN O
and CC O
surgery NN O
. . O

-DOCSTART- X X O

The DT O
introns NNS O
are VBP O
1.6-1.9 CD O
kbp JJ O
long JJ O
. . O

-DOCSTART- X X O

After IN O
an DT O
initial JJ O
titration NN O
period NN O
and CC O
adjustment NN O
of IN O
the DT O
therapeutic JJ O
dose NN O
, , O
the DT O
individual JJ O
doses NNS O
were VBD O
from IN O
21 CD O
to TO O
500 CD O
micrograms/24 CD O
hrs NNS O
( -LRB- O
mean NN O
160 CD O
micrograms/24 NN O
hrs NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Erythrocyte NNP O
protoporphyrin NN O
concentration NN O
increased VBN O
significantly RB O
( -LRB- O
P NNP O
less RBR O
than IN O
0.05 CD O
) -RRB- O
by IN O
14 CD O
days NNS O
in IN O
dogs NNS O
fed VBN O
the DT O
basal JJ O
diet NN O
, , O
and CC O
remained VBD O
significantly RB O
high JJ O
relative JJ O
to TO O
that DT O
in IN O
dogs NNS O
of IN O
the DT O
other JJ O
dietary NN O
groups NNS O
for IN O
the DT O
remainder NN O
of IN O
the DT O
study NN O
. . O

-DOCSTART- X X O

From IN O
an DT O
RNK-16 CD O
lambda-gt11 JJ O
library NN O
, , O
we PRP O
have VBP O
isolated VBN O
and CC O
sequenced VBN O
a DT O
novel NN O
cDNA NN O
rat NN B-NP
NK NNP I-NP
cell NN I-NP
protease NN I-NP
1 CD I-NP
( -LRB- O
RNKP-1 NN B-NP
) -RRB- O
that WDT O
has VBZ O
characteristics NNS O
unique JJ O
to TO O
serine NN B-NP
proteases NNS I-NP
. . O

-DOCSTART- X X O

The DT O
induction NN O
of IN O
RNKP-1 JJ B-NP
expression NN O
in IN O
the DT O
Con NNP B-NP
A-cultured NNP I-NP
spleen JJ O
cells NNS O
is VBZ O
accompanied VBN O
by IN O
increases NNS O
in IN O
both DT O
NK NNP O
and CC O
lymphokine-activated JJ O
killer NN O
lymphocyte NN O
activities NNS O
. . O

-DOCSTART- X X O

The DT O
abscess NN O
was VBD O
debrided VBN O
and CC O
the DT O
septum NN O
was VBD O
patched VBN O
with IN O
a DT O
single JJ O
layer NN O
of IN O
autologous JJ O
pericardium NN O
. . O

-DOCSTART- X X O

In IN O
18 CD O
% NN O
lymphography NN O
was VBD O
clearly RB O
positive JJ O
and CC O
CT JJ O
negative JJ O
. . O

-DOCSTART- X X O

The DT O
present JJ O
study NN O
examined VBD O
the DT O
effect NN O
of IN O
intensity NN O
, , O
rate NN O
, , O
and CC O
polarity NN O
on IN O
the DT O
spectral JJ O
content NN O
of IN O
ABRs NNS O
of IN O
15 CD O
normal-hearing JJ O
subjects NNS O
. . O

-DOCSTART- X X O

Similar JJ O
memory NN O
impairments NNS O
found VBN O
in IN O
medial JJ O
septal-vertical JJ O
diagonal JJ O
band NN O
of IN O
Broca NNP O
and CC O
nucleus JJ O
basalis NNS O
lesioned VBD O
rats NNS O
: : O
are VBP O
memory NN O
defects NNS O
induced VBN O
by IN O
nucleus JJ O
basalis NNS O
lesions NNS O
related VBN O
to TO O
the DT O
degree NN O
of IN O
non-specific JJ O
subcortical JJ O
cell NN O
loss NN O
? . O
The DT O
function NN O
of IN O
nucleus JJ O
basalis NNS O
( -LRB- O
NB) NNP O
and CC O
medial JJ O
septal-vertical JJ O
diagonal JJ O
band NN O
of IN O
Broca NNP O
( -LRB- O
MS-VDBB NN O
) -RRB- O
in IN O
a DT O
place NN O
navigation NN O
task NN O
requiring VBG O
reference NN O
memory NN O
was VBD O
investigated VBN O
. . O

-DOCSTART- X X O

The DT O
kappa NN O
coefficient NN O
of IN O
agreement NN O
between IN O
the DT O
Patho NNP O
Dx NNP O
Kit NN O
and CC O
the DT O
standard JJ O
method NN O
was VBD O
0.958 CD O
. . O

-DOCSTART- X X O

Senior JJ O
systems--45 NN O
; : O
Mental NNP O
health NN O
and CC O
illness NN O
in IN O
old JJ O
age--3 NN O
. . O

-DOCSTART- X X O

Patients NNS O
with IN O
acute JJ O
myocardial JJ O
infarction NN O
had VBD O
higher JJR O
plasma NN O
concentrations NNS O
of IN O
neutrophil JJ B-NP
elastase NN I-NP
and CC O
the DT O
non-peroxide JJ O
diene NN O
conjugated VBN O
isomer NN O
of IN O
linoleic JJ O
acid NN O
than IN O
normal JJ O
volunteers NNS O
or CC O
patients NNS O
with IN O
stable JJ O
ischaemic JJ O
heart NN O
disease NN O
. . O

-DOCSTART- X X O

Determination NNP O
of IN O
three-dimensional JJ O
imaging NN O
properties NNS O
of IN O
a DT O
light NN O
microscope NN O
system NN O
. . O

-DOCSTART- X X O

The DT O
cis-acting JJ O
element NN O
, , O
identified VBN O
as IN O
CACGTGACCCG NNP O
, , O
is VBZ O
located VBN O
34 CD O
bp NN O
upstream RB O
from IN O
the DT O
transcription NN O
initiation NN O
site NN O
, , O
and CC O
contains VBZ O
the DT O
core NN O
sequence NN O
of IN O
the DT O
upstream JJ O
promoter NN O
sequence NN O
of IN O
Ad2MLP. NNP B-NP

-DOCSTART- X X O

The DT O
clinical JJ O
relevance NN O
of IN O
these DT O
findings NNS O
is VBZ O
strengthened VBN O
by IN O
the DT O
observation NN O
that IN O
similar JJ O
results NNS O
were VBD O
obtained VBN O
when WRB O
P.HCl NNP O
was VBD O
given VBN O
by IN O
the DT O
intravenous JJ O
route NN O
. . O

-DOCSTART- X X O

The DT O
procedure NN O
has VBZ O
been VBN O
applied VBN O
to TO O
three CD O
materials NNS O
: : O
particle NN O
board NN O
with IN O
carpet NN O
; : O
gypsum NN O
board NN O
with IN O
wallpaper NN O
; : O
and CC O
plywood NN O
with IN O
polyurethane NN O
lacquer NN O
, , O
for IN O
which WDT O
the DT O
steady-state NN O
emission NN O
factors NNS O
( -LRB- O
mg NN O
m-2 JJ O
h-1 NN O
) -RRB- O
of IN O
several JJ O
compounds NNS O
are VBP O
given VBN O
. . O

-DOCSTART- X X O

Comparison NNP O
of IN O
transmembrane NN O
and CC O
cytoplasmic JJ O
domains NNS O
to TO O
a DT O
third JJ O
cell-surface NN O
proteoglycan NN O
, , O
48K5 CD B-NP
from IN O
human JJ O
lung NN O
fibroblasts NNS O
( -LRB- O
Marynen NNP O
, , O
P. NNP O
, , O
Zhang NNP O
, , O
J. NNP O
, , O
Cassiman NNP O
, , O
J. NNP O
, , O
Vanden NNP O
Berghe NNP O
, , O
H. NNP O
, , O
and CC O
David NNP O
, , O
C. NNP O

-DOCSTART- X X O

A DT O
second JJ O
, , O
novel JJ O
C NNP O
subunit NN O
( -LRB- O
CeCAT NN B-NP
alpha' NNS I-NP
, , O
374 CD O
residues NNS O
) -RRB- O
has VBZ O
a DT O
unique JJ O
56-residue JJ O
carboxyl-terminal JJ O
region NN O
that WDT O
is VBZ O
generated VBN O
by IN O
the DT O
alternative JJ O
splicing NN O
of IN O
the DT O
C NNP B-NP
pre-mRNA JJ I-NP
. . O

-DOCSTART- X X O

The DT O
alternative JJ O
exon NN O
introduces VBZ O
the DT O
novel NN O
carboxyl NN O
terminus NN O
and CC O
a DT O
new JJ O
translation NN O
stop NN O
signal NN O
, , O
while IN O
simultaneously RB O
converting VBG O
the DT O
coding NN O
sequence NN O
for IN O
40 CD O
carboxyl-terminal JJ O
residues NNS O
in IN O
CeCAT NNP B-NP
alpha NN I-NP
into IN O
3'-untranslated JJ O
nucleotides NNS O
. . O

-DOCSTART- X X O

Slowly RB O
adapting VBG O
type NN O
I PRP O
mechanoreceptor MD O
discharge VB O
as IN O
a DT O
function NN O
of IN O
dynamic JJ O
force NN O
versus JJ O
dynamic JJ O
displacement NN O
of IN O
glabrous JJ O
skin NN O
of IN O
raccoon NN O
and CC O
squirrel NN O
monkey JJ O
hand NN O
. . O

-DOCSTART- X X O

Methods NNS O
used VBN O
include VBP O
Cobb NNP O
angle NN O
and CC O
a DT O
segmental JJ O
evaluation NN O
( -LRB- O
T7-T12 NN O
) -RRB- O
of IN O
each DT O
of IN O
convex NN O
and CC O
concave NN O
rib-vertebra NN O
angles NNS O
( -LRB- O
RVAs NNS O
) -RRB- O
, , O
rib-vertebra JJ O
angle NN O
differences NNS O
( -LRB- O
RVADs NNS O
) -RRB- O
, , O
vertebral JJ O
rotation NN O
, , O
tilt VB O
and CC O
displacement VB O
. . O

-DOCSTART- X X O

Lars NNP O
has VBZ O
AIDS--a DT O
more JJR O
dignified JJ O
life NN O
with IN O
care NN O
at IN O
home NN O
. . O

-DOCSTART- X X O

The DT O
application NN O
of IN O
these DT O
microelectrodes NNS O
to TO O
the DT O
measurement NN O
of IN O
rapid JJ O
, , O
transient JJ O
changes NNS O
in IN O
retinal JJ O
[ NN O
K+]o NNP O
is VBZ O
presented VBN O
. . O

-DOCSTART- X X O

Combining VBG O
multiple JJ O
laboratory NN O
studies NNS O
may MD O
be VB O
of IN O
value NN O
in IN O
predetermining VBG O
the DT O
eventual JJ O
outcome NN O
in IN O
near-drowning JJ O
. . O

-DOCSTART- X X O

Accumulations NNS O
of IN O
Tl+1 NNP O
( -LRB- O
202Tl JJ O
label NN O
) -RRB- O
were VBD O
6 CD O
times NNS O
those DT O
for IN O
Ga NNP O
or CC O
In IN O
in IN O
the DT O
brain NN O
and CC O
muscles NNS O
, , O
and CC O
.1 CD O
times NNS O
in IN O
plasma NN O
. . O

-DOCSTART- X X O

The DT O
afferents NNS O
' POS O
phase NN O
of IN O
response NN O
was VBD O
unmodified JJ O
by IN O
electrical JJ O
EVS NNP O
stimulation NN O
. . O

-DOCSTART- X X O

Solving VBG O
an DT O
age NN O
old JJ O
problem NN O
. . O

-DOCSTART- X X O

The DT O
distribution NN O
of IN O
their PRP$ O
fibrinogen NN B-NP
levels NNS O
was VBD O
Gaussian NNP O
, , O
but CC O
more RBR O
wide-based JJ O
than IN O
the DT O
distribution NN O
of IN O
our PRP$ O
normal JJ O
controls NNS O
. . O

-DOCSTART- X X O

The DT O
examination NN O
was VBD O
focused VBN O
on IN O
assessment NN O
of IN O
different JJ O
types NNS O
of IN O
drusen NN O
, , O
on IN O
evaluation NN O
of IN O
the DT O
development NN O
and CC O
incidence NN O
of IN O
risk NN O
factors NNS O
leading VBG O
to TO O
complications NNS O
and CC O
loss NN O
of IN O
central JJ O
vision NN O
. . O

-DOCSTART- X X O

They PRP O
were VBD O
then RB O
subjected VBN O
to TO O
whole-body JJ O
heat NN O
stress NN O
( -LRB- O
water-perfused JJ O
suits NNS O
) -RRB- O
, , O
and CC O
the DT O
3 CD O
minutes NNS O
of IN O
LBNP NNP O
was VBD O
repeated VBN O
. . O

-DOCSTART- X X O

An DT O
NF1-related JJ B-NP
vitellogenin NN I-NP
activator NN I-NP
element NN I-NP
mediates NNS O
transcription NN O
from IN O
the DT O
estrogen-regulated JJ O
Xenopus NNP B-NP
laevis NN I-NP
vitellogenin NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

At IN O
the DT O
carboxyl NN O
terminus NN O
, , O
deletion NN O
as RB O
far RB O
as IN O
residue JJ O
388 CC O
did VBD O
not RB O
affect VB O
in IN O
vitro NN O
TRF.C NNP B-NP
assembly NN O
, , O
although IN O
trans-activating JJ O
activity NN O
was VBD O
abolished VBN O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
mean JJ O
luminance NN O
were VBD O
also RB O
measured VBN O
and CC O
a DT O
general JJ O
expression NN O
that WDT O
would MD O
take VB O
them PRP O
into IN O
account NN O
was VBD O
derived VBN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
hyperglycemia NN O
on IN O
pain NN O
threshold NN O
in IN O
alloxan-diabetic JJ O
rats NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
synthesized VBN O
[7,7-2H2]-19-OHA JJ O
with IN O
high JJ O
deuterium NN O
content NN O
and CC O
, , O
together RB O
with IN O
[7,7-2H2]A JJ O
and CC O
[9,11-2H2]estrone JJ O
( -LRB- O
E1 NN O
) -RRB- O
, , O
have VBP O
developed VBN O
a DT O
quantitative JJ O
assay NN O
of IN O
serum NN O
level NN O
19-OHA NNS O
, , O
A DT O
, , O
and CC O
E1 NNP O
using VBG O
the DT O
gas NN O
chromatography/mass NN O
spectrometry-mass NN O
fragmentography NN O
method NN O
to TO O
monitor VB O
individual JJ O
subjects NNS O
throughout IN O
pregnancy NN O
. . O

-DOCSTART- X X O

Since IN O
the DT O
UfAP NNP B-NP
and CC O
UTMP NNP B-NP
share NN O
many JJ O
biosynthetic JJ O
and CC O
structural JJ O
features NNS O
that WDT O
include VBP O
site NN O
of IN O
biosynthesis NN O
in IN O
the DT O
endometrium NN O
, , O
P4-responsiveness NNP O
, , O
the DT O
presence NN O
of IN O
the DT O
mannose NN O
6-phosphate JJ O
lysosomal JJ O
recognition NN O
marker NN O
, , O
and CC O
considerable JJ O
sequence NN O
similarity NN O
, , O
the DT O
UfAP NNP B-NP
and CC O
the DT O
UTMP NNP B-NP
may MD O
have VB O
homologous JJ O
function NN O
which WDT O
for IN O
both DT O
still RB O
remains VBZ O
obscure JJ O
. . O

-DOCSTART- X X O

Treating VBG O
renal JJ O
anaemia NN O
with IN O
recombinant JJ O
human JJ O
erythropoietin NN B-NP
. . O

-DOCSTART- X X O

The DT O
pseudolymphoma NN O
syndrome NN O
is VBZ O
a DT O
reversible JJ O
reactive NN O
condition NN O
consisting VBG O
of IN O
fever NN O
, , O
lymphadenopathy NN O
and CC O
generalized JJ O
rash NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
local JJ O
geomagnetic JJ O
field NN O
, , O
the DT O
animals NNS O
preferred VBD O
the DT O
SE-sector NNP O
. . O

-DOCSTART- X X O

In IN O
the DT O
artificial JJ O
lung NN O
, , O
like IN O
in IN O
the DT O
natural JJ O
lung NN O
and CC O
peripheral JJ O
tissues NNS O
, , O
gas NN O
exchanges NNS O
depend VB O
on IN O
several JJ O
parameters NNS O
: : O
blood NN O
inlet NN O
conditions NNS O
, , O
blood NN O
flow NN O
rate NN O
, , O
temperature NN O
, , O
composition NN O
of IN O
the DT O
gas NN O
mixture NN O
used VBD O
for IN O
ventilation NN O
, , O
blood NN O
tissue NN O
perfusion NN O
, , O
O2 NNP O
consumption NN O
, , O
etc FW O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
DNA NN O
ploidy NN O
is VBZ O
a DT O
major JJ O
objective JJ O
prognostic JJ O
factor NN O
and CC O
therapeutic JJ O
determinant NN O
for IN O
endometrial JJ O
carcinoma NN O
. . O

-DOCSTART- X X O

A DT O
semiautomatic JJ O
digital JJ O
system NN O
( -LRB- O
Videoplan NNP O
2 CD O
) -RRB- O
was VBD O
used VBN O
. . O

-DOCSTART- X X O

Environmental JJ O
factors NNS O
were VBD O
more RBR O
important JJ O
in IN O
the DT O
older JJR O
cohorts NNS O
( -LRB- O
perhaps RB O
because IN O
of IN O
less JJR O
reliable JJ O
recall NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
order NN O
of IN O
the DT O
helicase NN B-NP
motif NN I-NP
and CC O
the DT O
nsP3 JJ B-NP
homology NN I-NP
region NN I-NP
in IN O
the DT O
RUB NNP O
genome NN O
is VBZ O
reversed VBN O
with IN O
respect NN O
to TO O
the DT O
alphavirus NN O
genome NN O
indicating VBG O
that IN O
a DT O
genetic JJ O
rearrangement NN O
has VBZ O
occurred VBN O
during IN O
the DT O
evolution NN O
of IN O
these DT O
viruses NNS O
. . O

-DOCSTART- X X O

The DT O
results NNS O
suggest VBP O
followings--1 JJ O
) -RRB- O
both DT O
eosinophils NNS O
and CC O
neutrophils NNS O
participate VBP O
in IN O
hypersecretion NN O
of IN O
type NN O
Ib NN O
in IN O
atopic JJ O
cases NNS O
, , O
and CC O
only RB O
eosinophils NNS O
in IN O
non-atopic JJ O
cases NNS O
. . O

-DOCSTART- X X O

There EX O
were VBD O
5 CD O
treatments NNS O
: : O
control NN O
( -LRB- O
C NNP O
) -RRB- O
; : O
a DT O
wooden JJ O
surround NN O
in IN O
one CD O
rear JJ O
corner NN O
of IN O
the DT O
cage NN O
( -LRB- O
S NNP O
) -RRB- O
; : O
a DT O
fiberglass NN O
rollaway NN O
hollow NN O
in IN O
one CD O
rear JJ O
corner NN O
of IN O
the DT O
cage NN O
( -LRB- O
H) NNP O
; : O
a DT O
hollow NN O
and CC O
a DT O
surround NN O
( -LRB- O
H/S NNP O
) -RRB- O
; : O
a DT O
nest NN O
box NN O
attached VBN O
to TO O
the DT O
back NN O
of IN O
the DT O
cage NN O
, , O
containing VBG O
a DT O
hollow JJ O
( -LRB- O
N) NN O
. . O

-DOCSTART- X X O

While IN O
no DT O
significant JJ O
differences NNS O
in IN O
the DT O
tensile JJ O
responses NNS O
or CC O
failure NN O
characteristics NNS O
were VBD O
noted VBN O
for IN O
irradiated JJ O
and CC O
nonirradiated JJ O
grafts NNS O
in IN O
the DT O
drip NN O
, , O
in IN O
the DT O
bath NN O
environment NN O
the DT O
nonirradiated JJ O
tissues NNS O
had VBD O
greater JJR O
strength NN O
and CC O
modulus NN O
. . O

-DOCSTART- X X O

The DT O
patient NN O
was VBD O
treated VBN O
with IN O
benzathine NN O
penicillin NN O
, , O
2,400,000 CD O
U NNP O
weekly JJ O
for IN O
three CD O
weeks NNS O
. . O

-DOCSTART- X X O

A DT O
consensus NN O
binding NN O
site NN O
for IN O
the DT O
transcription NN O
factor NN O
SP1 NNP B-NP
was VBD O
identified VBN O
in IN O
intron NN O
As IN O
downstream NN O
of IN O
the DT O
proenkephalin NN B-NP
germ NN I-NP
cell NN I-NP
cap NN I-NP
site NN I-NP
region NN I-NP
. . O

-DOCSTART- X X O

This DT O
proposed VBN O
method NN O
is VBZ O
similar JJ O
in IN O
principle NN O
to TO O
the DT O
sets NNS O
technique NN O
but CC O
is VBZ O
shown VBN O
to TO O
have VB O
much RB O
better JJR O
expected VBN O
time NN O
to TO O
alarm VB O
properties NNS O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
on IN O
reflex NN O
latencies NNS O
but CC O
not RB O
on IN O
paCO2 NN O
or CC O
pHa NN O
were VBD O
blocked VBN O
by IN O
naloxone NN O
( -LRB- O
2 CD O
mg/kg NN O
) -RRB- O
, , O
and CC O
were VBD O
not RB O
present JJ O
in IN O
morphine-tolerant JJ O
animals NNS O
. . O

-DOCSTART- X X O

Drug NN O
and CC O
personnel NNS O
costs NNS O
were VBD O
reduced VBN O
when WRB O
batch NN O
manufacturing NN O
with IN O
40-mL JJ O
multidose JJ O
vials NNS O
was VBD O
compared VBN O
with IN O
extemporaneous JJ O
compounding NN O
with IN O
unit-dose NN O
vials NNS O
. . O

-DOCSTART- X X O

Dermal JJ O
toxicity NN O
and CC O
carcinogenicity NN O
of IN O
4-vinyl-1-cyclohexene JJ O
diepoxide NN O
in IN O
Fischer NNP O
rats NNS O
and CC O
B6C3F1 NNP O
mice NNS O
. . O

-DOCSTART- X X O

MK-927 CD O
: : O
a DT O
topically RB O
active JJ O
ocular JJ O
hypotensive JJ O
carbonic JJ B-NP
anhydrase NN I-NP
inhibitor NN O
. . O

-DOCSTART- X X O

PCR-derived JJ O
fragments NNS O
were VBD O
used VBN O
as IN O
probes NNS O
for IN O
the DT O
isolation NN O
of IN O
the DT O
U3 NNP B-NP
snRNA NN I-NP
genes NNS I-NP
from IN O
a DT O
genomic JJ O
library NN O
of IN O
Arabidopsis NNP O
. . O

-DOCSTART- X X O

Co-administration NN O
of IN O
5FU JJ O
, , O
angiotensin IN B-NP
II NNP I-NP
and CC O
microspheres NNS O
via IN O
the DT O
hepatic JJ O
artery NN O
may MD O
reduce VB O
drug NN O
exposure NN O
in IN O
the DT O
systemic JJ O
compartment NN O
and CC O
therefore RB O
may MD O
increase VB O
the DT O
therapeutic JJ O
ratio NN O
of IN O
5FU JJ O
administration NN O
via IN O
the DT O
hepatic JJ O
artery NN O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
tap NN O
( -LRB- O
TW NNP O
) -RRB- O
or CC O
carbonated VBN O
( -LRB- O
CW) JJ O
water NN O
on IN O
arterial JJ O
pH NNS O
, , O
partial JJ O
pressure NN O
of IN O
carbon NN O
dioxide NN O
(PCO2 IN O
) -RRB- O
and CC O
plasma NN O
lactate NN O
were VBD O
determined VBN O
in IN O
heat-stressed JJ O
broilers NNS O
. . O

-DOCSTART- X X O

Transient JJ O
expression NN O
of IN O
human JJ B-NP
and CC I-NP
chicken NN I-NP
progesterone NN I-NP
receptors NNS I-NP
does VBZ O
not RB O
support VB O
alternative JJ O
translational JJ O
initiation NN O
from IN O
a DT O
single JJ O
mRNA NN O
as IN O
the DT O
mechanism NN O
generating VBG O
two CD O
receptor NN O
isoforms NNS O
. . O

-DOCSTART- X X O

The DT O
Community NNP O
Adjustment NNP O
Scale NNP O
provided VBD O
outcome NN O
data NNS O
related VBN O
to TO O
the DT O
subjects NNS O
' POS O
degree NN O
of IN O
productivity NN O
, , O
ability NN O
to TO O
maintain VB O
close JJ O
relationships NNS O
, , O
and CC O
presence/absence NN O
of IN O
symptomatology NN O
an DT O
average JJ O
of IN O
32 CD O
years NNS O
after IN O
initial JJ O
admission NN O
. . O

-DOCSTART- X X O

However RB O
, , O
at IN O
18 CD O
months NNS O
of IN O
age NN O
, , O
significantly RB O
higher JJR O
levels NNS O
of IN O
IgG1 NNP B-NP
( -LRB- O
P NNP O
less RBR O
than IN O
0.05 CD O
) -RRB- O
and CC O
of IN O
IgG4 NNP B-NP
( -LRB- O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
were VBD O
found VBN O
in IN O
infants NNS O
with IN O
an DT O
elevated JJ O
IgE NN B-NP
( -LRB- O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
8.0 CD O
kU/l NN O
) -RRB- O
than IN O
in IN O
those DT O
with IN O
a DT O
lower JJR O
level NN O
. . O

-DOCSTART- X X O

The DT O
protein NN O
sequence NN O
contains VBZ O
seven CD O
potential JJ O
N-linked JJ O
glycosylation NN O
sites NNS O
and CC O
a DT O
threonine/serine-rich JJ O
region NN O
which WDT O
is VBZ O
a DT O
potential JJ O
site NN O
for IN O
attachment NN O
of IN O
O-linked JJ O
carbohydrate NN O
. . O

-DOCSTART- X X O

On IN O
histologic NN O
examination NN O
the DT O
cuboidal JJ O
epithelium NN O
of IN O
the DT O
mucous JJ O
membrane NN O
was VBD O
found VBN O
to TO O
be VB O
changed VBN O
into IN O
columnar NN O
epithelium NN O
, , O
with IN O
uneven JJ O
distribution NN O
of IN O
enlarged VBN O
nuclei NNS O
in IN O
the DT O
vacuolized JJ O
cytoplasm NN O
. . O

-DOCSTART- X X O

The DT O
same JJ O
trend NN O
was VBD O
noted VBN O
between IN O
YG NNP O
4.5 CD O
heifers NNS O
and CC O
YG NN O
5.5 CD O
steers NNS O
, , O
indicating VBG O
a DT O
sex-related JJ O
deposition NN O
of IN O
seam NN O
fat NN O
in IN O
fed NN O
cattle NNS O
. . O

-DOCSTART- X X O

Toxicities NNP O
included VBD O
: : O
nausea/vomiting NN O
( -LRB- O
69 CD O
% NN O
) -RRB- O
, , O
headache NN O
( -LRB- O
25 CD O
% NN O
) -RRB- O
, , O
chills NNS O
( -LRB- O
69 CD O
% NN O
) -RRB- O
, , O
pain NN O
at IN O
tumor NN O
sites NNS O
( -LRB- O
63 CD O
% NN O
) -RRB- O
, , O
hypotension NN O
( -LRB- O
31 CD O
% NN O
) -RRB- O
, , O
and CC O
hypertension NN O
( -LRB- O
38 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Fatal NN O
encephalitis NN O
in IN O
a DT O
patient NN O
with IN O
chronic JJ O
graft-versus-host NN O
disease NN O
. . O

-DOCSTART- X X O

Compared VBN O
to TO O
its PRP$ O
counterpart NN O
in IN O
the DT O
GPB NNP B-NP
gene NN I-NP
, , O
exon NN O
3 CD O
of IN O
the DT O
GPE NNP B-NP
gene NN I-NP
contains VBZ O
several JJ O
point NN O
mutations NNS O
, , O
an DT O
insertion NN O
of IN O
24 CD O
bp NN O
, , O
and CC O
a DT O
stop NN O
codon NN O
which WDT O
shortens VBZ O
the DT O
reading NN O
frame NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
corroborate VBP O
the DT O
idea NN O
that IN O
the DT O
structure NN O
of IN O
relaxation NN O
curves NNS O
contains VBZ O
information NN O
on IN O
the DT O
distance NN O
scale NN O
and CC O
on IN O
the DT O
architecture NN O
of IN O
the DT O
pore NN O
space NN O
, , O
even RB O
if IN O
it PRP O
is VBZ O
difficult JJ O
to TO O
extract VB O
it PRP O
without IN O
ambiguities NNS O
. . O

-DOCSTART- X X O

Serotonin NNP B-NP
5-HT2 NN I-NP
receptor NN I-NP
binding NN O
on IN O
blood NN O
platelets NNS O
as IN O
a DT O
state NN O
dependent JJ O
marker NN O
in IN O
major JJ O
affective JJ O
disorder NN O
. . O

-DOCSTART- X X O

Although IN O
%BF NNP O
was VBD O
correlated VBN O
with IN O
all PDT O
the DT O
BMIs NNS O
( -LRB- O
r NN O
= SYM O
0.60-0.82 CD O
) -RRB- O
, , O
applying VBG O
objective JJ O
definitions NNS O
of IN O
obesity NN O
based VBN O
on IN O
BMIs NNP O
or CC O
%BF NNP O
by IN O
densitometry NN O
often RB O
produced VBD O
conflicting JJ O
results NNS O
. . O

-DOCSTART- X X O

Promoter NNP O
elements NNS O
include VBP O
an DT O
atypical JJ O
TATA NNP O
box NN O
( -LRB- O
GTTA NNP O
) -RRB- O
, , O
one CD O
CCAAT NN O
box NN O
much RB O
further RB O
from IN O
the DT O
initiation NN O
site NN O
, , O
three CD O
reverse JJ O
compliments NNS O
of IN O
CCAAT NN O
( -LRB- O
ATTGG) NNP O
, , O
and CC O
two CD O
pyrimidine-rich JJ O
nucleotide JJ O
stretches NNS O
. . O

-DOCSTART- X X O

The DT O
cloned VBN O
genes NNS O
were VBD O
identified VBN O
in IN O
genetic JJ O
libraries NNS O
by IN O
hybridization NN O
screening NN O
using VBG O
four CD O
deoxyoligonucleotide NN O
probes NNS O
which WDT O
corresponded VBD O
to TO O
the DT O
partial JJ O
amino NN O
acid NN O
sequence NN O
of IN O
the DT O
purified VBN O
enzyme NN O
. . O

-DOCSTART- X X O

The DT O
pattern NN O
for IN O
catalytic JJ O
zinc NN O
sites NNS O
included VBD O
two CD O
ligands NNS O
close RB O
in IN O
sequence NN O
, , O
a DT O
sequence-distant JJ O
ligand NN O
, , O
and CC O
a DT O
main-chain JJ O
hydrogen NN O
bond NN O
joining VBG O
two CD O
ligands NNS O
. . O

-DOCSTART- X X O

Results NNS O
of IN O
the DT O
long-term JJ O
observation NN O
and CC O
treatment NN O
of IN O
patients NNS O
with IN O
arterial JJ O
hypertension NN O

-DOCSTART- X X O

Comparison NNP O
of IN O
propofol NN O
and CC O
thiopentone NN O
as IN O
anaesthetic JJ O
agents NNS O
for IN O
electroconvulsive JJ O
therapy NN O
. . O

-DOCSTART- X X O

In IN O
Experiment NNP O
II NNP O
, , O
as IN O
performing VBG O
moderate JJ O
supine NN O
cycling NN O
( -LRB- O
55 CD O
% NN O
VO2 JJ O
max NN O
) -RRB- O
for IN O
50 CD O
minutes NNS O
under IN O
several JJ O
LBNP NNP O
conditions NNS O
in IN O
5 CD O
sedentary JJ O
women NNS O
, , O
there EX O
were VBD O
correspondingly RB O
similar JJ O
changing VBG O
manners NNS O
of IN O
the DT O
cardiovascular JJ O
adjustments NNS O
to TO O
each DT O
of IN O
the DT O
phases NNS O
given VBN O
in IN O
Experiment NN O
I. NN O

-DOCSTART- X X O

Commercially NNP O
available JJ O
formulations NNS O
of IN O
2.5 CD O
% NN O
and CC O
5 CD O
% NN O
lambdacyhalothrin NN O
can MD O
be VB O
diluted VBN O
either CC O
with IN O
water NN O
for IN O
ULV NNP O
cold JJ O
aerosol NN O
space-spraying NN O
or CC O
with IN O
diesel/kerosene NN O
for IN O
thermal DT O
fogging NN O
at IN O
recommended VBN O
application NN O
rates NNS O
of IN O
0.5-1 CD O
g NN O
ai VBP O
/ha NN O
for IN O
mosquito NN O
control NN O
and CC O
2 CD O
g NN O
ai VBP O
/ha NN O
for IN O
housefly NN O
control NN O
. . O

-DOCSTART- X X O

The DT O
trk-2h JJ B-NP
oncogene NN I-NP
, , O
isolated VBN O
from IN O
the DT O
human JJ O
breast NN O
carcinoma NN O
cell NN O
line NN O
MDA-MB NNP O
231 CD O
by IN O
genomic JJ O
DNA-transfection NN O
into IN O
NIH3T3 NNP O
cells NNS O
, , O
consists VBZ O
of IN O
the DT O
trk NN B-NP
proto-oncogene NN I-NP
receptor NN I-NP
kinase NN I-NP
domain NN I-NP
fused VBN O
to TO O
a DT O
N-terminal JJ O
41 CD O
amino IN O
acid NN O
activating NN O
sequence NN O
( -LRB- O
Kozma NNP O
, , O
S.C. NNP O
, , O
Redmond NNP O
, , O
S.M.S. NNP O
, , O
Xiao-Chang NNP O
, , O
F. NNP O
, , O
Saurer NNP O
, , O
S.M. NNP O
, , O
Groner NNP O
, , O
B. NNP O
and CC O
Hynes NNP O
, , O
N.E. NNP O

-DOCSTART- X X O

Since IN O
very RB O
recent JJ O
scanning-deletion NN O
analysis NN O
indicates VBZ O
that IN O
there EX O
is VBZ O
a DT O
critical JJ O
region NN O
for IN O
activity NN O
near IN O
Cys-118 NN O
and CC O
that DT O
Cys-118 DT O
is VBZ O
necessary JJ O
for IN O
maximal JJ O
activity NN O
, , O
we PRP O
conclude VBP O
that IN O
the DT O
Cys-118 NNS O
residue VBP O
is VBZ O
necessary JJ O
for IN O
proper JJ O
glycosylation NN O
and CC O
maximal JJ O
biologic NN O
activity NN O
of IN O
GM-CSF. NNP B-NP

-DOCSTART- X X O

Molecular JJ O
and CC O
functional JJ O
characterization NN O
of IN O
the DT O
promoter NN O
of IN O
ETS2 NNP B-NP
, , O
the DT O
human JJ O
c-ets-2 NN B-NP
gene NN O
. . O

-DOCSTART- X X O

Branch NNP O
occlusion NN O
of IN O
Heubner NNP O
's POS O
artery NN O
, , O
or CC O
perforators NNS O
from IN O
the DT O
proximal JJ O
anterior JJ O
or CC O
middle JJ O
cerebral NN O
arteries NNS O
were VBD O
the DT O
posited JJ O
mechanism NN O
of IN O
infarction NN O
. . O

-DOCSTART- X X O

All DT O
ABFI-binding JJ B-NP
sites NNS I-NP
, , O
regardless RB O
of IN O
origin NN O
, , O
provided VBN O
weak JJ O
UAS NNP O
function NN O
in IN O
vivo NN O
when WRB O
examined VBN O
in IN O
test NN O
plasmids NNS O
. . O

-DOCSTART- X X O

An DT O
examination NN O
of IN O
the DT O
properties NNS O
of IN O
sequences NNS O
surrounding VBG O
ARS1 NN O
left VBD O
open RP O
the DT O
possibility NN O
that IN O
ABFI NNP B-NP
enhances VBZ O
the DT O
initiation NN O
of IN O
DNA NNP O
replication NN O
at IN O
ARS1 NNP O
by IN O
transcriptional JJ O
activation NN O
. . O

-DOCSTART- X X O

Nonvascular JJ O
ophthalmic JJ O
and CC O
neurologic JJ O
disorders NNS O
that WDT O
can MD O
be VB O
confused VBN O
with IN O
amaurosis NN O
fugax NN O
are VBP O
listed VBN O
, , O
and CC O
an DT O
algorithm NN O
for IN O
evaluation NN O
( -LRB- O
which WDT O
includes VBZ O
ophthalmic JJ O
examination NN O
, , O
laboratory NN O
studies NNS O
, , O
and CC O
noninvasive JJ O
carotid NN O
artery NN O
studies NNS O
) -RRB- O
is VBZ O
given VBN O
. . O

-DOCSTART- X X O

Likewise RB O
, , O
whether IN O
or CC O
not RB O
the DT O
hypotensive JJ O
action NN O
of IN O
converting VBG O
enzyme JJ O
inhibitors NNS O
is VBZ O
age-related JJ O
is VBZ O
as RB O
yet RB O
unknown JJ O
. . O

-DOCSTART- X X O

Polyclonal NNP O
antiserum NN O
generated VBD O
to TO O
the DT O
fusion NN O
protein NN O
was VBD O
capable JJ O
of IN O
detecting VBG O
42 CD O
- : O
and CC O
46-kilodalton JJ O
polypeptides NNS O
from IN O
virus NN O
particles NNS O
; : O
both DT O
polypeptides NNS O
were VBD O
also RB O
shown VBN O
to TO O
contain VB O
HBsAg NNP B-NP
determinants NNS I-NP
. . O

-DOCSTART- X X O

At IN O
maximum NN O
photosensitivity NN O
the DT O
inhibitory JJ O
amino IN O
acids NNS O
gamma-aminobutyric JJ O
acid NN O
and CC O
taurine NN O
were VBD O
lower JJR O
, , O
and CC O
those DT O
of IN O
asparagine NN O
( -LRB- O
metabolite NN O
of IN O
the DT O
excitatory JJ O
amino IN O
acid NN O
aspartate NN O
) -RRB- O
were VBD O
higher JJR O
, , O
than IN O
when WRB O
the DT O
animals NNS O
were VBD O
not RB O
photosensitive JJ O
. . O

-DOCSTART- X X O

We PRP O
evaluated VBD O
the DT O
likelihood NN O
of IN O
tissues NNS O
to TO O
be VB O
positive JJ O
for IN O
carcinoembryonic JJ B-NP
antigen NN I-NP
and CC O
the DT O
intensity NN O
of IN O
carcinoembryonic JJ B-NP
antigen JJ I-NP
staining NN O
in IN O
specimens NNS O
of IN O
villous JJ O
adenomas NNS O
, , O
mixed JJ O
polypoid NN O
villous JJ O
adenomas NNS O
, , O
polypoid NN O
adenomas NNS O
, , O
and CC O
diverticulitis NN O
using VBG O
the DT O
peroxidase-antiperoxidase JJ B-NP
technique NN O
. . O

-DOCSTART- X X O

The DT O
priming JJ O
activity NN O
of IN O
DNA NNP O
incised VBN O
by IN O
either DT O
of IN O
the DT O
Drosophila NNP O
enzymes NNS O
can MD O
be VB O
enhanced VBN O
, , O
however RB O
, , O
by IN O
an DT O
additional JJ O
incubation NN O
with IN O
E. NNP B-NP
coli NNS I-NP
endonuclease VBP I-NP
IV NNP I-NP
, , O
which WDT O
is VBZ O
known VBN O
to TO O
cleave VB O
depurinated JJ O
DNA NN O
on IN O
the DT O
5'-side JJ O
of IN O
an DT O
apurinic JJ O
site NN O
. . O

-DOCSTART- X X O

The DT O
cDNAs JJ O
cross-hybridize NN O
with IN O
genomic JJ O
sequences NNS O
in IN O
rat NN O
, , O
human JJ O
, , O
and CC O
chicken NN O
DNA NN O
, , O
but CC O
not RB O
with IN O
DNA NNP O
from IN O
frog NN O
, , O
Drosophila NNP O
, , O
or CC O
sea NN O
urchin NN O
. . O

-DOCSTART- X X O

Deletion NNP O
analysis NN O
was VBD O
carried VBN O
out RP O
within IN O
a DT O
part NN O
of IN O
the DT O
5'-flanking JJ O
region NN O
showing VBG O
homology NN O
to TO O
the DT O
upstream JJ O
region NN O
of IN O
the DT O
yeast NN B-NP
CYC1 NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
N1 NNP O
and CC O
P2 NNP O
were VBD O
comparable JJ O
in IN O
amplitude NN O
and CC O
both DT O
had VBD O
prolonged VBN O
refractory JJ O
periods NNS O
. . O

-DOCSTART- X X O

Tolerance NNP O
to TO O
fenfluramine VB O
anorexia DT O
: : O
fact NN O
or CC O
fiction NN O
? . O
Recent JJ O
findings NNS O
in IN O
this DT O
laboratory NN O
with IN O
regard NN O
to TO O
tolerance NN O
to TO O
fenfluramine VB O
anorexia DT O
are VBP O
reviewed VBN O
with IN O
respect NN O
to TO O
generality NN O
of IN O
the DT O
behavioural NN O
phenomenon NN O
. . O

-DOCSTART- X X O

In IN O
30 CD O
dogs NNS O
the DT O
left NN O
limb NN O
( -LRB- O
tail NN O
) -RRB- O
of IN O
the DT O
pancreas NNS O
was VBD O
removed VBN O
but CC O
left VBN O
in IN O
the DT O
abdominal NN O
cavity NN O
after IN O
cessation NN O
of IN O
blood NN O
flow NN O
to TO O
produce VB O
warm JJ O
ischemia NN O
for IN O
30 CD O
, , O
60 CD O
, , O
and CC O
120 CD O
min NN O
( -LRB- O
10 CD O
dogs NNS O
at IN O
each DT O
time NN O
point NN O
) -RRB- O
, , O
and CC O
then RB O
was VBD O
flushed VBN O
with IN O
cold JJ O
Ringers NNS O
' POS O
lactate NN O
and CC O
transplanted VBD O
to TO O
the DT O
iliac JJ O
vessels NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
beta JJ B-NP
2-adrenoceptor JJ I-NP
sensitivity NN O
appears VBZ O
to TO O
be VB O
unaltered JJ O
in IN O
BHT. NNP O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
Hansel NNP O
's POS O
stain NN O
substantially RB O
improves VBZ O
the DT O
recognition NN O
of IN O
eosinophiluria NN O
as IN O
compared VBN O
with IN O
Wright NNP O
's POS O
stain NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
negative JJ O
inotropic JJ O
action NN O
of IN O
nicorandil NN O
is VBZ O
caused VBN O
by IN O
inhibition NN O
of IN O
Ca JJ O
influx NN O
and CC O
intracellular JJ O
mobilization NN O
of IN O
Ca JJ O
. . O

-DOCSTART- X X O

The DT O
study NN O
included VBD O
139 CD O
eyes NNS O
with IN O
presumed JJ O
ocular JJ O
histoplasmosis NN O
syndrome NN O
( -LRB- O
POHS) JJ O
and CC O
age-related JJ O
macular JJ O
degeneration NN O
( -LRB- O
AMD) NNP O
. . O

-DOCSTART- X X O

Comparison NNP O
of IN O
elastase-1 JJ B-NP
with IN O
amylase NN B-NP
, , O
lipase NN B-NP
, , O
and CC O
trypsin-like JJ B-NP
immunoreactivity NN O
in IN O
the DT O
diagnosis NN O
of IN O
acute JJ O
pancreatitis NN O
. . O

-DOCSTART- X X O

Lysozyme NNP B-NP
activity NN O
was VBD O
evidently RB O
increased VBN O
as RB O
well RB O
in IN O
undiluted JJ O
as IN O
in IN O
diluted VBN O
sera NN O
in IN O
all DT O
our PRP$ O
tested VBN O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
first JJ O
involved JJ O
measurements NNS O
of IN O
the DT O
steady JJ O
state NN O
levels NNS O
of IN O
mRNAs NNS O
for IN O
subunit NN O
5 CD O
of IN O
cytochrome NN B-NP
oxidase NN I-NP
and CC O
the DT O
beta JJ O
subunit NN O
of IN O
F1 NNP B-NP
ATPase NNP I-NP
in IN O
wild JJ O
type NN O
and CC O
in IN O
a DT O
hem2 NN B-NP
mutant NN I-NP
. . O

-DOCSTART- X X O

ATP NNP O
gamma NNP O
S NNP O
inhibition NN O
can MD O
be VB O
overcome VBN O
by IN O
high JJ O
concentrations NNS O
of IN O
ATP NNP O
, , O
dATP NN O
, , O
araATP NN O
, , O
or CC O
ddATP. VBG O

-DOCSTART- X X O

ASL-8123 JJ O
demonstrated VBD O
weak JJ O
competitive JJ O
beta-adrenoreceptor NN B-NP
blocking VBG O
activity NN O
in IN O
isolated JJ O
guinea NN O
pig NN O
right NN O
atria NN O
with IN O
a DT O
pA2 NN O
of IN O
3.73 CD O
+/ NNS O
- : O
0.07 CD O
; : O
no DT O
agonist-like JJ O
activity NN O
was VBD O
observed VBN O
in IN O
this DT O
tissue NN O
at IN O
concentrations NNS O
of IN O
ASL-8123 JJ O
from IN O
3 CD O
X NNP O
10(-5 CD O
) -RRB- O
to TO O
1 CD O
X NNP O
10(-2 CD O
) -RRB- O
M. NNP O

-DOCSTART- X X O

Enhancer NN O
and CC O
promoter NN O
elements NNS O
directing VBG O
activation NN O
and CC O
glucocorticoid JJ O
repression NN O
of IN O
the DT O
alpha NN B-NP
1-fetoprotein JJ I-NP
gene NN I-NP
in IN O
hepatocytes NNS O
. . O

-DOCSTART- X X O

Hybridization NN O
of IN O
a DT O
probe NN O
from IN O
this DT O
region NN O
to TO O
electrophoretic JJ O
blots NNS O
of IN O
RNAs NNP O
from IN O
different JJ O
human NN O
tissues NNS O
showed VBD O
a DT O
predominant NN O
2.8-kilobase JJ O
(kb NN O
) -RRB- O
message NN O
accompanied VBN O
by IN O
weaker JJR O
bands NNS O
4.1 CD O
and CC O
2.1 CD O
kb NN O
in IN O
size NN O
. . O

-DOCSTART- X X O

Svensson NNP O
et NNP O
al NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
report NN O
we PRP O
describe VBP O
for IN O
the DT O
first JJ O
time NN O
the DT O
complete JJ O
primary JJ O
structure NN O
of IN O
type NN B-NP
X NNP I-NP
collagen NN I-NP
, , O
based VBN O
on IN O
cloning NN O
and CC O
sequencing NN O
of IN O
cDNA NN O
and CC O
genomic JJ O
DNA NN O
. . O

-DOCSTART- X X O

Viable JJ O
flap NN O
areas NNS O
were VBD O
established VBN O
following VBG O
vascular JJ O
pedicle NN O
ligation NN O
( -LRB- O
both DT O
vessels NNS O
or CC O
only RB O
artery NN O
or CC O
vein NN O
) -RRB- O
, , O
on IN O
the DT O
third JJ O
day NN O
after IN O
flap NN O
replantation NN O
in IN O
both DT O
island NN O
and CC O
free JJ O
flaps NNS O
. . O

-DOCSTART- X X O

A DT O
9.5-kb JJ O
KpnI-Sal NN B-NP
I PRP B-NP
fragment NN O
, , O
where WRB O
all PDT O
the DT O
DNA NN O
changes NNS O
associated VBN O
with IN O
su( JJ B-NP
Hw NN I-NP
) -RRB- I-NP
mutations NNS I-NP
were VBD O
mapped VBN O
, , O
was VBD O
able JJ O
to TO O
rescue VB O
the DT O
su( JJ B-NP
Hw NN I-NP
) -RRB- I-NP
mutant JJ I-NP
phenotype NN O
after IN O
P-element-mediated JJ O
germ-line NN O
transformation NN O
. . O

-DOCSTART- X X O

The DT O
corticosterone NN O
synthesis NN O
inhibitor NN O
metyrapone NN O
( -LRB- O
75 CD O
mg/kg NN O
i.p. NN O
) -RRB- O
was VBD O
given VBN O
to TO O
attenuate VB O
the DT O
rise NN O
of IN O
corticosterone NN O
to TO O
a DT O
level NN O
typical JJ O
of IN O
stressed VBN O
males NNS O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
L655,240 CD O
, , O
a DT O
selective JJ O
thromboxane NN O
and CC O
prostaglandin NN O
endoperoxide NN O
antagonist NN O
, , O
on IN O
ischemia NN O
- : O
and CC O
reperfusion-induced JJ O
cardiac JJ O
arrhythmias NNS O
. . O

-DOCSTART- X X O

In IN O
10 CD O
pentobarbitalized JJ O
dogs NNS O
, , O
plasma NN O
viscosity NN O
( -LRB- O
Ep NNP O
) -RRB- O
was VBD O
raised VBN O
fourfold RB O
while IN O
apparent JJ O
blood NN O
viscosity NN O
( -LRB- O
Ea NNP O
) -RRB- O
increased VBD O
about IN O
twofold JJ O
by IN O
two CD O
steps NNS O
of IN O
exchange NN O
transfusion NN O
of IN O
200 CD O
ml NN O
of IN O
plasma NN O
with IN O
plasma NN O
containing VBG O
high JJ O
molecular JJ O
weight NN O
dextran NN O
( -LRB- O
mol NN O
wt NN O
500,000 CD O
, , O
20 CD O
% NN O
wt/vol NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
small JJ B-NP
IGF-binding JJ I-NP
protein NN I-NP
is VBZ O
abundant JJ O
in IN O
human JJ O
amniotic JJ O
fluid NN O
. . O

-DOCSTART- X X O

The DT O
investigation NN O
was VBD O
thereafter RB O
continued VBN O
in IN O
an DT O
open JJ O
fashion NN O
by IN O
administering VBG O
a DT O
single JJ O
10 CD O
mg JJ O
dose NN O
of IN O
the DT O
MAO-B NNP B-NP
inhibitor NN O
deprenyl NN O
to TO O
the DT O
same JJ O
subjects NNS O
. . O

-DOCSTART- X X O

The DT O
investigation NN O
was VBD O
apt JJ O
at IN O
studying VBG O
the DT O
relationship NN O
between IN O
urinary JJ O
metabolites NNS O
of IN O
serotonin NN O
and CC O
catecholamine NN O
(5-HIAA JJ O
and CC O
VMA NNP O
) -RRB- O
, , O
T-cells NNS O
( -LRB- O
OKT3+ JJ B-NP
) -RRB- O
, , O
T-helper NNP O
( -LRB- O
OKT4+ NN B-NP
) -RRB- O
, , O
T-suppressor NNP O
( -LRB- O
OKT8+ NN B-NP
) -RRB- O
and CC O
B-cells NNP O
( -LRB- O
EAC-rosette NN O
forming VBG O
cells NNS O
) -RRB- O
in IN O
normal JJ O
( -LRB- O
10 CD O
subjects NNS O
, , O
1 CD O
female NN O
, , O
9 CD O
male NN O
, , O
age NN O
21 CD O
+/ NN O
- : O
5 CD O
years NNS O
) -RRB- O
and CC O
stress VB O
administered VBN O
subjects NNS O
( -LRB- O
20 CD O
subjects NNS O
, , O
3 CD O
female NN O
, , O
17 CD O
male NN O
, , O
age NN O
20 CD O
+/ NN O
- : O
4 CD O
years NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Their PRP$ O
hydropathic JJ O
plots NNS O
are VBP O
very RB O
similar JJ O
and CC O
both DT O
possess VBP O
three CD O
hydrophobic JJ O
segments NNS O
that WDT O
are VBP O
likely JJ O
alpha-helical JJ O
transmembrane NN O
segments NNS O
. . O

-DOCSTART- X X O

Angiotensin NNP B-NP
converting VBG I-NP
enzyme JJ I-NP
inhibitors NNS O
enhance VB O
the DT O
antihypertensive JJ O
efficacy NN O
of IN O
diuretics NNS O
and CC O
blunt JJ O
or CC O
prevent VB O
adverse JJ O
metabolic JJ O
effects NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
the DT O
significant JJ O
reduction NN O
in IN O
blood NN O
pressure NN O
, , O
the DT O
angiotensin NN B-NP
converting VBG I-NP
enzyme JJ I-NP
(ACE NN O
) -RRB- O
inhibitor VBZ O
ramipril JJ O
caused VBD O
a DT O
significant JJ O
regression NN O
of IN O
pathologic NN O
left VBD O
ventricular JJ O
hypertrophy NN O
demonstrated VBN O
by IN O
magnetic JJ O
resonance NN O
imaging NN O
and CC O
echocardiography NN O
. . O

-DOCSTART- X X O

Endocrine NNP O
cells NNS O
were VBD O
studied VBN O
by IN O
means NNS O
of IN O
Grimelius NNP O
' POS O
silver NN O
staining NN O
and CC O
immunostaining NN O
for IN O
chromogranin NN B-NP
, , O
a DT O
general JJ O
marker NN O
of IN O
endocrine NN O
cells NNS O
. . O

-DOCSTART- X X O

Tissue NNP O
necrosis NN O
was VBD O
evaluated VBN O
using VBG O
triphenyltetrazolium NN O
staining NN O
and CC O
was VBD O
related VBN O
to TO O
two CD O
major JJ O
baseline NN O
predictors NNS O
of IN O
infarct NN O
size NN O
: : O
anatomic JJ O
risk NN O
zone NN O
size NN O
and CC O
coronary JJ O
collateral NN O
flow NN O
. . O

-DOCSTART- X X O

To TO O
study VB O
the DT O
retinal JJ O
surface NN O
in IN O
the DT O
human JJ O
eye NN O
in IN O
normal JJ O
and CC O
diseased JJ O
states NNS O
we PRP O
used VBD O
laser NN O
scanning NN O
tomography NN O
. . O

-DOCSTART- X X O

Previously RB O
, , O
we PRP O
reported VBD O
the DT O
sequence NN O
of IN O
the DT O
gene NN B-NP
encoding VBG I-NP
human JJ I-NP
K14 NNP I-NP
( -LRB- O
D. NNP O

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
the DT O
5' JJ O
flanking NN O
region NN O
revealed VBD O
several JJ O
GC NNP O
boxes NNS O
but CC O
no DT O
identifiable JJ O
TATA NNP O
box NN O
. . O

-DOCSTART- X X O

The DT O
underlying JJ O
cirrhosis NN O
was VBD O
alcoholic JJ O
in IN O
11 CD O
( -LRB- O
53.3 CD O
% NN O
) -RRB- O
, , O
cryptogenic JJ O
in IN O
5 CD O
( -LRB- O
23.8 CD O
% NN O
) -RRB- O
, , O
and CC O
hepatitis NN O
B NNP O
chronic NN O
infection NN O
related VBN O
in IN O
5 CD O
( -LRB- O
23.8 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Once RB O
P-450scc JJ B-NP
mRNA NN I-NP
is VBZ O
induced VBN O
as IN O
a DT O
consequence NN O
of IN O
the DT O
LH/hCG NNP B-NP
surge NN O
it PRP O
is VBZ O
constitutively RB O
maintained VBN O
by IN O
luteinized JJ O
cells NNS O
in IN O
vivo JJ O
(0-4 JJ O
days NNS O
) -RRB- O
and CC O
in IN O
vitro NN O
(0-9 JJ O
days NNS O
) -RRB- O
in IN O
the DT O
absence NN O
of IN O
gonadotropins NNS B-NP
, , O
is VBZ O
susceptible JJ O
to TO O
modulation NN O
by IN O
prolactin NN B-NP
and CC O
is VBZ O
no RB O
longer RB O
regulated VBN O
by IN O
cAMP. VBG O

-DOCSTART- X X O

NIK-244 NNP O
suppressed VBD O
coronary JJ O
ligation NN O
- : O
and CC O
digitalis-induced JJ O
arrhythmias NNS O
, , O
and CC O
the DT O
minimum JJ O
effective JJ O
plasma NN O
concentrations NNS O
for IN O
arrhythmias NNS O
induced VBN O
by IN O
24-h JJ O
and CC O
48-h JJ O
coronary JJ O
ligation NN O
and CC O
digitalis NNS O
were VBD O
0.41 CD O
+/ NNS O
- : O
0.10 CD O
( -LRB- O
by IN O
1 CD O
mg/kg NN O
i NN O
.v. , O
) -RRB- O
, , O
0.70 CD O
+/ NNS O
- : O
0.13 CD O
( -LRB- O
by IN O
1 CD O
mg/kg NN O
i NN O
.v. , O
) -RRB- O
, , O
and CC O
0.21 CD O
+/ NNS O
- : O
0.08 CD O
( -LRB- O
by IN O
0.5 CD O
mg/kg NN O
i NN O
.v. . O
) -RRB- O
microgram/ml NN O
, , O
respectively RB O
( -LRB- O
mean VB O
+/ JJ O
- : O
SD NNP O
of IN O
the DT O
mean NN O
, , O
n RB O
= SYM O
6 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Thus RB O
, , O
phosphodiesterase NN O
inhibitors NNS O
that WDT O
produce VBP O
an DT O
opiate JJ O
quasi-withdrawal NN O
syndrome NN O
potentiate NN O
interoceptive JJ O
stimuli NNS O
and CC O
weight NN O
loss NN O
associated VBN O
with IN O
the DT O
withdrawal NN O
syndrome NN O
precipitated VBN O
by IN O
naltrexone NN O
in IN O
morphine-dependent JJ O
rats NNS O
. . O

-DOCSTART- X X O

The DT O
diagnostic JJ O
value NN O
of IN O
blood NN O
serum NN O
and CC O
urinary JJ B-NP
amylase NN I-NP
, , O
lipase NN B-NP
, , O
and CC O
trypsin VB B-NP
in IN O
exacerbations NNS O
of IN O
chronic JJ O
relapsing NN O
pancreatitis NN O
is VBZ O
discussed VBN O
. . O

-DOCSTART- X X O

Intravenous JJ O
gamma NN B-NP
globulins NNS I-NP

-DOCSTART- X X O

Myocardial JJ O
perfusion NN O
was VBD O
evaluated VBN O
using VBG O
the DT O
enhanced JJ O
gray JJ O
level NN O
after IN O
contrast NN O
injection NN O
, , O
and CC O
the DT O
level NN O
was VBD O
compared VBN O
with IN O
the DT O
morphology NN O
and CC O
degree NN O
of IN O
collateral NN O
development NN O
. . O

-DOCSTART- X X O

Once RB O
NGF NNP B-NP
administration NN O
is VBZ O
proven VBN O
effective JJ O
it PRP O
will MD O
be VB O
possible JJ O
to TO O
develop VB O
alternative JJ O
ways NNS O
of IN O
NGF NNP B-NP
administration NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
were VBD O
as IN O
follows VBZ O
: : O
1 CD O
) -RRB- O
Total JJ O
integrated JJ O
EMG NN O
activity NN O
of IN O
FB NNP O
group NN O
was VBD O
approximately RB O
equal JJ O
in IN O
any DT O
occluded JJ O
position NN O
, , O
whereas IN O
that DT O
of IN O
CG NNP O
and CC O
GF NNP O
group NN O
varied VBN O
from IN O
position NN O
to TO O
position VB O
. . O

-DOCSTART- X X O

In IN O
76 CD O
% NN O
of IN O
59 CD O
lead-toxic JJ O
children NNS O
, , O
bone NN O
lead NN O
values NNS O
measured VBN O
by IN O
LXRF NNP O
were VBD O
equal JJ O
to TO O
or CC O
greater JJR O
than IN O
those DT O
measured VBN O
in IN O
normal JJ O
and CC O
industrially RB O
exposed VBN O
adults NNS O
. . O

-DOCSTART- X X O

When WRB O
considered VBN O
with IN O
the DT O
known VBN O
neurotoxic JJ O
effects NNS O
on IN O
children NNS O
of IN O
"low JJ O
levels NNS O
" '' O
of IN O
exposure NN O
to TO O
lead VB O
, , O
these DT O
results NNS O
also RB O
suggest VBP O
that IN O
either CC O
an DT O
excessively RB O
narrow JJ O
margin NN O
of IN O
safety NN O
or CC O
insufficient JJ O
safety NN O
is VBZ O
provided VBN O
by IN O
present JJ O
U.S. NNP O
guidelines NNS O
, , O
which WDT O
classify VBP O
an DT O
elevated JJ O
blood NN O
lead NN O
concentration NN O
as IN O
25 CD O
micrograms/dl NN O
or CC O
greater JJR O
. . O

-DOCSTART- X X O

The DT O
thrombolytic JJ O
effects NNS O
of IN O
native JJ O
tissue-type NN B-NP
plasminogen NN I-NP
activator NN I-NP
( -LRB- O
AK-124 DT B-NP
) -RRB- O
on IN O
experimental JJ O
canine CD O
coronary JJ O
thrombosis NN O
. . O

-DOCSTART- X X O

Enzyme-linked JJ O
immunosorbent JJ O
assay NN O
for IN O
screening VBG O
aflatoxin NN O
B1 NNS O
in IN O
cottonseed NN O
products NNS O
and CC O
mixed JJ O
feed NN O
: : O
collaborative JJ O
study NN O
. . O

-DOCSTART- X X O

However RB O
, , O
experiments NNS O
with IN O
S1 JJ B-NP
mapping NN O
of IN O
in IN O
vivo JJ O
transcripts NNS O
, , O
gene NN O
disruptions NNS O
in IN O
the DT O
alpha NN O
region NN O
, , O
and CC O
a DT O
single-copy JJ O
transcriptional JJ O
fusion NN O
vector NN O
all DT O
suggested VBN O
that IN O
these DT O
possible JJ O
promoters NNS O
were VBD O
largely RB O
inactive JJ O
during IN O
logarithmic JJ O
growth NN O
, , O
that IN O
the DT O
major JJ O
promoter NN O
for IN O
the DT O
alpha NN O
operon NN O
lay VBD O
upstream RB O
from IN O
the DT O
region NN O
cloned VBD O
, , O
and CC O
that IN O
the DT O
genes NNS O
in IN O
the DT O
IF1 NNP B-NP
to TO O
L17 DT B-NP
interval NN O
were VBD O
cotranscribed VBN O
. . O

-DOCSTART- X X O

Functional NNP O
rearranged VBD O
antibody NN O
genes NNS O
were VBD O
detected VBN O
with IN O
JH NNP B-NP
and CC O
VH NNP B-NP
heavy JJ I-NP
chain NN I-NP
probes NNS O
and CC O
with IN O
Jk NNP B-NP
and CC O
Vk NNP B-NP
light NN I-NP
chain NN I-NP
probes NNS O
. . O

-DOCSTART- X X O

Two CD O
specific JJ O
DNA-protein NNP O
complexes NNS O
were VBD O
identified VBN O
in IN O
gel NNP O
retardation NN O
assays IN O
using VBG O
HeLa NNP O
cell NN O
nuclear JJ O
extracts NNS O
and CC O
an DT O
oligonucleotide JJ O
probe NN O
spanning VBG O
the DT O
footprinted JJ O
region NN O
. . O

-DOCSTART- X X O

After IN O
transfection NN O
, , O
specific JJ O
TSH NNS B-NP
beta JJ I-NP
promoter NN I-NP
activity NN O
was VBD O
evident JJ O
in IN O
both DT O
TRH-responsive JJ B-NP
pituitary-derived JJ O
GH3 NNS O
and CC O
primary JJ O
pituitary JJ O
cell NN O
cultures NNS O
. . O

-DOCSTART- X X O

In IN O
transformed VBN O
E. NNP O
coli NNS O
, , O
constitutive JJ B-NP
CAT NN I-NP
expression NN O
is VBZ O
maintained VBN O
when WRB O
as RB O
little JJ O
as IN O
0.3 CD O
kilobase NN O
of IN O
DNA NNP O
from IN O
the DT O
3' JJ O
end NN O
of IN O
the DT O
1.6-kilobase JJ O
segment NN O
is VBZ O
inserted VBN O
in IN O
the DT O
correct JJ O
orientation NN O
in IN O
front NN O
of IN O
the DT O
CAT NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Lowering NNP O
of IN O
the DT O
renal JJ O
blood NN O
flow NN O
alters IN O
the DT O
glomerular JJ O
and CC O
tubular JJ O
excretion NN O
processes NNS O
. . O

-DOCSTART- X X O

Tonometry NN O
of IN O
blood NN O
samples NNS O
from IN O
patients NNS O
may MD O
also RB O
be VB O
used VBN O
in IN O
the DT O
determination NN O
of IN O
acid-base NN O
quantities NNS O
and CC O
hemoglobin-oxygen NN B-NP
affinity NN O
e.g NN O
. . O
p50 '' O
. . O

-DOCSTART- X X O

The DT O
ORF1 NNP O
product NN O
was VBD O
required VBN O
for IN O
competence NN O
, , O
while IN O
ORF2 NNP O
, , O
which WDT O
was VBD O
cotranscribed VBN O
with IN O
ORF1 NNP O
and CC O
encoded VBD O
a DT O
predicted VBD O
protein NN O
of IN O
126 CD O
amino IN O
acids NNS O
, , O
was VBD O
not RB O
. . O

-DOCSTART- X X O

These DT O
case NN O
reports VBZ O
provide VB O
further JJ O
evidence NN O
that IN O
LiCO3 PRP O
can MD O
be VB O
a DT O
useful JJ O
medication NN O
in IN O
the DT O
treatment NN O
of IN O
aggressive JJ O
behavior NN O
and CC O
affective JJ O
instability NN O
after IN O
brain NN O
injury NN O
, , O
but CC O
that IN O
it PRP O
has VBZ O
significant JJ O
potential NN O
for IN O
neurotoxicity NN O
in IN O
this DT O
population NN O
, , O
particularly RB O
when WRB O
used VBN O
in IN O
conjunction NN O
with IN O
neuroleptic JJ O
agents NNS O
. . O

-DOCSTART- X X O

A DT O
215-base-pair JJ O
( -LRB- O
bp NN O
) -RRB- O
region NN O
of IN O
the DT O
mouse NN B-NP
MOPC NNP I-NP
41 CD I-NP
kappa NN I-NP
light-chain NN I-NP
immunoglobulin NN I-NP
gene NN I-NP
enhancer NN I-NP
has VBZ O
been VBN O
analyzed VBN O
for IN O
specific JJ O
binding NN O
of IN O
lymphoid NN O
and CC O
nonlymphoid JJ O
nuclear JJ O
factors NNS O
. . O

-DOCSTART- X X O

This DT O
paper NN O
presents VBZ O
the DT O
reasons NNS O
why WRB O
countries NNS O
to TO O
which WDT O
Chagas NNP O
disease NN O
is VBZ O
endemic VBN O
should MD O
carry VB O
out RP O
the DT O
relevant JJ O
research NN O
themselves PRP O
. . O

-DOCSTART- X X O

Gastric NNP O
CO2/HCO3 NNP O
was VBD O
determined VBN O
in IN O
absence NN O
of IN O
simultaneous JJ O
inhibition NN O
of IN O
acid NN O
secretion NN O
by IN O
intra JJ O
- : O
and CC O
extragastric JJ O
pCO2/pH NN O
measurements NNS O
in IN O
23 CD O
persons NNS O
and CC O
calculated VBN O
using VBG O
the DT O
equation NN O
of IN O
Henderson-Hasselbalch NNP O
. . O
pCO2 '' O
was VBD O
measured VBN O
with IN O
use NN O
of IN O
a DT O
new JJ O
electrode NN O
. . O

-DOCSTART- X X O

Forty CD O
patients NNS O
, , O
divided VBN O
according VBG O
to TO O
their PRP$ O
initial JJ O
total JJ O
gastrointestinal JJ O
transit NN O
times NNS O
and CC O
presenting VBG O
symptoms NNS O
, , O
were VBD O
treated VBN O
with IN O
cimetropium NN O
bromide NN O
50 CD O
mg NN O
t.d NN O
.s NNS O
. . O
or CC O
placebo NN O
for IN O
1 CD O
month NN O
according VBG O
to TO O
a DT O
double-blind JJ O
, , O
parallel JJ O
group NN O
design NN O
. . O

-DOCSTART- X X O

An DT O
immunologically RB O
related JJ O
protein NN O
was VBD O
detected VBN O
in IN O
ribosome JJ O
and CC O
membrane NN O
fractions NNS O
of IN O
mitochondria NN O
from IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

According VBG O
to TO O
the DT O
published VBN O
sequence NN O
of IN O
the DT O
CHS1 NNP B-NP
gene NN I-NP
, , O
this DT O
fragment NN O
contains VBZ O
four CD O
repeats NNS O
of IN O
a DT O
TGAAACA NNP O
consensus NN O
sequence NN O
previously RB O
identified VBN O
in IN O
the DT O
alpha-factor-inducible JJ B-NP
BAR1 NNP B-NP
promoter NN I-NP
[Kronstad NN O
, , O
J. NNP O

-DOCSTART- X X O

Southern JJ O
blot NN O
analyses NNS O
demonstrated VBD O
a DT O
low JJ O
, , O
if IN O
not RB O
single JJ O
, , O
copy VBP O
number NN O
for IN O
this DT O
gene NN O
and CC O
conservation NN O
of IN O
this DT O
domain NN O
in IN O
other JJ O
vertebrates NNS O
. . O

-DOCSTART- X X O

Three CD O
missense NN O
mutants NNS O
in IN O
subunit NN O
a DT O
of IN O
the DT O
Escherichia NNP B-NP
coli NNS I-NP
F1F0-ATPase JJ I-NP
were VBD O
isolated VBN O
and CC O
characterized VBN O
after IN O
hydroxylamine NN O
mutagenesis NN O
of IN O
a DT O
plasmid NN O
carrying VBG O
the DT O
uncB NN B-NP
( -LRB- I-NP
subunit NN I-NP
a DT I-NP
) -RRB- I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

In IN O
supine JJ O
position NN O
, , O
plasma NN O
ANP NN B-NP
levels NNS O
ranged VBD O
from IN O
12 CD O
pg/ml NN O
to TO O
51.5 CD O
pg/ml NN O
, , O
with IN O
an DT O
average JJ O
level NN O
of IN O
35.3 CD O
+/ NNS O
- : O
11.5 CD O
pg/ml NN O
. . O

-DOCSTART- X X O

The DT O
adenovirus NN B-NP
E1A NNP I-NP
gene NN I-NP
encodes VBZ O
a DT O
protein NN O
that WDT O
transcriptionally RB O
activates VBZ O
viral NN B-NP
early JJ I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

RNA NNP O
transcripts NNS O
that IN O
hybridize NN O
to TO O
the DT O
introduced VBN O
foreign JJ O
gene NN O
have VBP O
been VBN O
identified VBN O
. . O

-DOCSTART- X X O

At IN O
the DT O
basal JJ O
unstimulated JJ O
condition NN O
, , O
Ren1d NNP B-NP
5' VBZ I-NP
flanking VBG I-NP
sequence NN I-NP
in IN O
the DT O
sense NN O
orientation IN O
inhibited JJ O
basal NN O
CAT WDT B-NP
expression NN O
from IN O
the DT O
TK NNP B-NP
promoter NN I-NP
of IN O
pUTKAT1 NNS O
, , O
whereas IN O
the DT O
same JJ O
sequence NN O
in IN O
the DT O
antisense NN O
orientation NN O
did VBD O
not RB O
. . O

-DOCSTART- X X O

None NN O
were VBD O
restricted VBN O
from IN O
clinical JJ O
duties NNS O
, , O
were VBD O
given VBN O
varicella-zoster JJ B-NP
immune JJ I-NP
globulin NN I-NP
, , O
or CC O
developed JJ O
disease NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
formalin NN O
test NN O
, , O
however RB O
, , O
naloxone NN O
attenuated VBD O
morphine NN O
analgesia NN O
at IN O
the DT O
lower JJR O
doses NNS O
( -LRB- O
0.1 CD O
and CC O
0.3 CD O
mg/kg NN O
) -RRB- O
and CC O
potentiated VBD O
morphine NN O
analgesia NN O
at IN O
the DT O
highest JJS O
dose NN O
( -LRB- O
10 CD O
mg/kg NN O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
cDNA JJ O
clones NNS O
from IN O
rat NN O
brain NN O
and CC O
human JJ O
liver NN O
encoding VBG O
a DT O
putative JJ O
isoform NN O
of IN O
the DT O
Na,K-ATPase NNP B-NP
beta NN I-NP
subunit NN I-NP
. . O

-DOCSTART- X X O

We PRP O
have VBP O
determined VBN O
that IN O
several JJ O
E1 NNP B-NP
mutants NNS I-NP
mapping NN O
in IN O
both DT O
the DT O
M NNP O
and CC O
R NN O
regions NNS O
and CC O
a DT O
single JJ O
mutant NN O
of IN O
the DT O
upstream JJ O
regulatory JJ O
region NN O
have VBP O
a DT O
higher JJR O
transforming NN O
activity NN O
on IN O
mouse NN O
C127 NN O
cells NNS O
than IN O
the DT O
wild-type JJ O
genome NN O
does VBZ O
. . O

-DOCSTART- X X O

UbiA NNP B-NP
is VBZ O
also RB O
unique JJ O
among IN O
known VBN O
polyubiquitin NN B-NP
genes NNS I-NP
in IN O
containing VBG O
four CD O
cis-spliced JJ O
introns NNS O
within IN O
its PRP$ O
coding NN O
sequence NN O
. . O

-DOCSTART- X X O

That DT O
of IN O
the DT O
T2 NNP B-NP
gene NN I-NP
contains VBZ O
numerous JJ O
potential JJ O
sites NNS O
for IN O
binding VBG O
the DT O
mammalian JJ B-NP
transcription NN I-NP
factor NN I-NP
SP1 NNP I-NP
, , O
but CC O
no DT O
TATA NNP O
or CC O
CCAAT NNP O
sequences NNS O
are VBP O
evident JJ O
near IN O
to TO O
its PRP$ O
5' JJ O
end NN O
, , O
although IN O
these DT O
latter JJ O
features NNS O
are VBP O
associated VBN O
with IN O
the DT O
human JJ B-NP
T1 NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Radiation NNP O
therapy NN O
was VBD O
effective JJ O
in IN O
controlling VBG O
symptomatic JJ O
metastasis NN O
in IN O
all DT O
three CD O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
methylation NN O
of IN O
nuclear JJ O
and CC O
chloroplast NN O
DNAs NN O
has VBZ O
been VBN O
examined VBN O
in IN O
relation NN O
to TO O
the DT O
known VBN O
differential JJ O
expression NN O
of IN O
C4 NNP B-NP
photosynthesis NN I-NP
genes NNS I-NP
in IN O
the DT O
bundle NN O
sheath NN O
and CC O
mesophyll VB O
cells NNS O
of IN O
etiolated JJ O
, , O
greening JJ O
, , O
and CC O
fully RB O
green JJ O
maize NN O
leaves NNS O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
( -LRB- O
a DT O
) -RRB- O
the DT O
likelihood NN O
of IN O
detecting VBG O
carcinoma NN O
or CC O
atypical JJ O
hyperplasia NN O
exclusively RB O
in IN O
the DT O
adipose NN O
tissue NN O
component NN O
of IN O
grossly RB O
benign JJ O
breast NN O
biopsies NNS O
is VBZ O
extremely RB O
low JJ O
, , O
and CC O
( -LRB- O
b NN O
) -RRB- O
a DT O
possible JJ O
cost-effective JJ O
method NN O
of IN O
sampling VBG O
grossly RB O
benign JJ O
breast NN O
biopsies NNS O
consists VBZ O
of IN O
initially RB O
submitting VBG O
a DT O
maximum NN O
of IN O
10 CD O
blocks NNS O
of IN O
fibrous JJ O
parenchyma NN O
for IN O
each DT O
case NN O
, , O
then RB O
examining VBG O
the DT O
remaining VBG O
tissue NN O
histologically RB O
only RB O
if IN O
carcinoma NN O
or CC O
atypical JJ O
hyperplasia NN O
is VBZ O
found VBN O
among IN O
these DT O
blocks NNS O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
DNA NN O
from IN O
15 CD O
cases NNS O
of IN O
sporadic JJ O
and CC O
familial JJ O
Wilms NNP O
' POS O
tumor NN O
did VBD O
not RB O
reveal VB O
any DT O
changes NNS O
, , O
indicating VBG O
that IN O
the DT O
translocation NN O
breakpoint NN O
does VBZ O
not RB O
reside VB O
in IN O
this DT O
gene NN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
provide VBP O
evidence NN O
that IN O
neither CC O
the DT O
lambda NN B-NP
O NNP I-NP
and CC O
P NNP B-NP
initiators NNS I-NP
nor CC O
the DT O
E. NNP B-NP
coli NNS I-NP
DnaJ NNP I-NP
and CC O
DnaK NNP B-NP
heat NN O
shock NN O
proteins VBZ O
play VB O
a DT O
direct JJ O
role NN O
in IN O
the DT O
propagation NN O
of IN O
lambda NN O
replication NN O
forks NNS O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Synthetic JJ O
oligonucleotides NNS O
representing VBG O
the DT O
19 CD O
bp NN O
repeat NN O
unit NN O
strongly RB O
reduced VBD O
the DT O
activity NN O
of IN O
the DT O
IE1/2 NNP B-NP
enhancer/promoter NN I-NP
in IN O
cotransfection NN O
assays IN O
after IN O
transient JJ O
expression NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
nitrogen NN O
( -LRB- O
PN2 NNP O
: : O
5 CD O
and CC O
14 CD O
MPa NNP O
) -RRB- O
and CC O
helium NN O
( -LRB- O
PHe NNP O
: : O
13 CD O
and CC O
14 CD O
MPa NNP O
) -RRB- O
were VBD O
also RB O
tested VBN O
. . O

-DOCSTART- X X O

Antibodies NNS O
raised VBD O
to TO O
the DT O
expressed VBN O
NS3 NN B-NP
by IN O
immunization NN O
of IN O
mice NNS O
detected VBN O
both DT O
NS3 NNP B-NP
and CC O
NS3A NNP B-NP
in IN O
BTV-10-infected JJ O
BHK NN O
cells NNS O
but CC O
not RB O
in IN O
purified VBN O
BTV-10 NNP O
virus NN O
particles NNS O
. . O

-DOCSTART- X X O

Similarly RB O
, , O
supraventricular JJ O
tachycaydia NN O
following VBG O
resuscitative JJ O
efforts NNS O
appeared VBD O
to TO O
be VB O
associated VBN O
with IN O
a DT O
negative JJ O
outcome NN O
. . O

-DOCSTART- X X O

The DT O
negative JJ O
calcium JJ O
balance NN O
with IN O
hyperparathyroidemia NN O
occurred VBD O
after IN O
continuous JJ O
oral JJ O
administration NN O
of IN O
Cd NNP O
and CC O
developed JJ O
via IN O
increased VBN O
urinary JJ O
excretion NN O
of IN O
calcium NN O
. . O

-DOCSTART- X X O

Clone NNP O
4c FW O
( -LRB- O
2681 JJ O
bp NN O
) -RRB- O
had VBD O
a DT O
coding NN O
region NN O
identical JJ O
to TO O
that DT O
of IN O
clone NN O
22c CC O
but CC O
it PRP O
included VBD O
a DT O
putative JJ O
intron NN O
of IN O
959 CD O
bp NN O
. . O

-DOCSTART- X X O

The DT O
application NN O
of IN O
ISH NNP O
and CC O
IHC NNP O
did VBD O
not RB O
change VB O
significantly RB O
the DT O
routine JJ O
histologic NN O
classification NN O
of IN O
pneumonias NNS O
into IN O
CMV-IP NNP O
and CC O
IIP. NNP O

-DOCSTART- X X O

Validity NNP O
of IN O
immunohistology NN O
and CC O
in IN O
situ FW O
hybridization NN O
in IN O
the DT O
differential JJ O
diagnosis NN O
of IN O
cytomegalovirus NN O
pneumonia NN O
and CC O
idiopathic JJ O
interstitial JJ O
pneumonia NN O
after IN O
allogenic DT O
bone NN O
marrow NN O
transplantation NN O

-DOCSTART- X X O

Erythrocytic JJ O
stages NNS O
of IN O
mammalian JJ O
malarial JJ O
parasites NNS O
contain VBP O
acristate NN O
mitochondria NNS O
whose WP$ O
functions NNS O
are VBP O
not RB O
well RB O
understood VBN O
. . O

-DOCSTART- X X O

However RB O
, , O
bilateral JJ O
diffuse JJ O
pulmonary JJ O
infiltrations NNS O
developed VBN O
21 CD O
days NNS O
later RB O
. . O

-DOCSTART- X X O

VP5 CD B-NP
, , O
which WDT O
encodes VBZ O
the DT O
major JJ B-NP
capsid JJ I-NP
protein NN I-NP
, , O
each DT O
fused VBN O
to TO O
the DT O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Of IN O
202 CD O
initially RB O
seronegative JJ O
caretakers NNS O
( -LRB- O
observed VBN O
for IN O
an DT O
average NN O
of IN O
305 CD O
days NNS O
per IN O
woman NN O
) -RRB- O
, , O
19 CD O
seroconverted VBD O
, , O
for IN O
an DT O
annual JJ O
seroconversion NN O
rate NN O
of IN O
11 CD O
percent NN O
. . O

-DOCSTART- X X O

First RB O
, , O
a DT O
pet54 NN B-NP
::LEU2 IN O
cytoductant JJ O
bearing VBG O
the DT O
'short JJ O
' '' O
mitochondrial JJ O
genome NN O
that WDT O
lacks VBZ O
both DT O
COX1 NNP B-NP
introns NNS I-NP
aI5 IN B-NP
alpha NN I-NP
and CC O
aI5 DT B-NP
beta NN I-NP
is VBZ O
defective JJ O
only RB O
in IN O
COX3 NNP B-NP
gene NN I-NP
expression NN O
and CC O
not RB O
in IN O
COX1 NNP B-NP
mRNA NN I-NP
splicing NN O
or CC O
mRNA NN O
translation NN O
. . O

-DOCSTART- X X O

Since IN O
considerable JJ O
variations NNS O
in IN O
length NN O
and CC O
primary JJ O
sequence NN O
in IN O
the DT O
CDR3 NN B-NP
( -LRB- O
complementarity NN B-NP
determining VBG I-NP
region NN I-NP
) -RRB- O
peptides NNS O
of IN O
all PDT O
the DT O
H-chains NNS B-NP
are VBP O
evident JJ O
, , O
conservation NN O
of IN O
the DT O
D-region NN B-NP
structure NN O
does VBZ O
not RB O
appear VB O
to TO O
be VB O
necessary JJ O
for IN O
effective JJ O
hapten JJ O
binding NN O
. . O

-DOCSTART- X X O

Tyrosine NNP B-NP
kinase NN I-NP
oncogenes NNS O
abrogate RB O
interleukin-3 JJ B-NP
dependence NN O
of IN O
murine NN O
myeloid JJ O
cells NNS O
through IN O
signaling VBG O
pathways NNS O
involving VBG O
c-myc JJ B-NP
: : O
conditional JJ O
regulation NN O
of IN O
c-myc JJ B-NP
transcription NN O
by IN O
temperature-sensitive JJ O
v-abl NN B-NP
. . O

-DOCSTART- X X O

This DT O
TC-II JJ B-NP
enhanson NN I-NP
, , O
which WDT O
is VBZ O
identical JJ O
to TO O
the DT O
kappa NN B-NP
B NNP I-NP
motif NN I-NP
from IN O
the DT O
kappa NN B-NP
chain NN I-NP
enhancer NN I-NP
, , O
was VBD O
active JJ O
in IN O
both DT O
lymphoid JJ O
and CC O
non-lymphoid JJ O
cells NNS O
, , O
which WDT O
contrasts VBZ O
with IN O
the DT O
previously RB O
reported VBN O
lymphoid JJ O
cell NN O
specificity NN O
of IN O
the DT O
kappa NN B-NP
B NNP I-NP
motif NN I-NP
. . O

-DOCSTART- X X O

The DT O
DNA NNP O
helix NN O
at IN O
the DT O
tandemly NN O
repeated VBN O
, , O
13mer JJ O
sequence NN O
is VBZ O
thermodynamically RB O
unstable JJ O
, , O
as IN O
evidenced VBN O
by IN O
hypersensitivity NN O
to TO O
single-strand-specific JJ B-NP
nuclease NN I-NP
in IN O
a DT O
negatively JJ O
supercoiled JJ O
plasmid NN O
, , O
and CC O
demonstrated VBD O
by IN O
stable JJ O
DNA NN O
unwinding JJ O
seen VBN O
after IN O
two-dimensional JJ O
gel NN O
electrophoresis NN O
of IN O
topoisomers NNS O
. . O

-DOCSTART- X X O

There EX O
has VBZ O
been VBN O
similar JJ O
improvement NN O
in IN O
treating VBG O
ampullary NN O
and CC O
periampullary NN O
cancer NN O
, , O
gallbladder NN O
cancer NN O
, , O
or CC O
extrahepatic JJ O
bile NN O
duct NN O
cancer NN O
. . O

-DOCSTART- X X O

Beta-endorphin NNP B-NP
, , O
ACTH NNP B-NP
and CC O
cortisol JJ O
secretion NN O
were VBD O
measured VBN O
in IN O
twelve CD O
healthy JJ O
adult NN O
males NNS O
after IN O
nasal JJ O
spray NN O
administration NN O
200 CD O
IU NNP O
salmon NN B-NP
calcitonin NN I-NP
. . O

-DOCSTART- X X O

The DT O
data NNS O
indicate VBP O
that IN O
calcitonin NN B-NP
induced VBD O
a DT O
beta-endorphin JJ B-NP
increase NN O
independent JJ O
of IN O
enhanced JJ O
corticotrophin-cortisol JJ B-NP
release NN O
. . O

-DOCSTART- X X O

Rare NNP O
neurogenic JJ O
tumor NN O
with IN O
metastasis NN O
to TO O
mouth NN O
, , O
jaw NN O
and CC O
face NN O
regions NNS O

-DOCSTART- X X O

We PRP O
have VBP O
designated VBN O
the DT O
protein NN O
"cellular JJ B-NP
NBP" NN I-NP
( -LRB- O
CNBP) NNP B-NP
. . O

-DOCSTART- X X O

Responsiveness NN O
to TO O
beta-2 CD O
agonist JJ O
therapy NN O
was VBD O
retained VBN O
with IN O
both DT O
agents NNS O
( -LRB- O
p NN O
less JJR O
than IN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Drug NN O
use NN O
in IN O
trauma NN O
victims NNS O
. . O

-DOCSTART- X X O

A DT O
critical JJ O
heart NN O
rate NN O
and/or CC O
appropriate JJ O
sympathetic JJ O
state NN O
was VBD O
found VBN O
to TO O
provoke VB O
all DT O
instances NNS O
of IN O
reentrant NN O
or CC O
automatic JJ O
atrial JJ O
tachycardia NN O
and CC O
atypical JJ O
junctional JJ O
tachycardia NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
neu NN B-NP
proto-oncogene NN I-NP
did VBD O
not RB O
show VB O
kinase NN O
activity NN O
or CC O
transforming NN O
properties NNS O
when WRB O
expressed VBN O
at IN O
similar JJ O
levels NNS O
in IN O
NIH NNP O
3T3 CD O
cells NNS O
.(ABSTRACT JJ O
TRUNCATED JJ O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

The DT O
65-bp JJ O
sequence NN O
contains VBZ O
the DT O
octameric JJ O
cAMP-responsive JJ O
enhancer NN O
( -LRB- O
CRE NNP O
) -RRB- O
TGACGTCA NNP O
( -LRB- O
nucleotides NNS O
-48 : O
to TO O
-41 JJ O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
full JJ O
mu-opioid JJ O
agonists NNS O
fentanyl NN O
, , O
morphine NN O
, , O
I-methadone NNP O
and CC O
levorphanol NN O
produced VBD O
50 CD O
% NN O
fentanyl-appropriate JJ O
responding VBG O
at IN O
doses NNS O
only RB O
1.3 CD O
to TO O
10.9 CD O
times NNS O
smaller JJR O
than IN O
those DT O
required VBN O
to TO O
decrease VB O
response NN O
rates NNS O
by IN O
50 CD O
% NN O
. . O

-DOCSTART- X X O

Isolation NNP O
and CC O
characterization NN O
of IN O
a DT O
cDNA NN O
encoding VBG O
a DT O
putative JJ O
cytokine NN O
which WDT O
is VBZ O
induced VBN O
by IN O
stimulation NN O
via IN O
the DT O
CD2 NNP B-NP
structure NN I-NP
on IN O
human JJ O
T NNP O
lymphocytes NNS O
. . O

-DOCSTART- X X O

After IN O
termination NN O
of IN O
medication NN O
the DT O
animals NNS O
were VBD O
kindled VBN O
electrically RB O
in IN O
the DT O
nucleus JJ O
amygdala NN O
. . O

-DOCSTART- X X O

Tumour NNP B-NP
necrosis NN I-NP
factor NN I-NP
and CC O
adult NN O
respiratory NN O
distress NN O
syndrome NN O
. . O

-DOCSTART- X X O

Monitoring NN O
of IN O
rheumatoid NN O
arthritis NN O
. . O

-DOCSTART- X X O

The DT O
decrease NN O
in IN O
left JJ O
ventricular NN O
( -LRB- O
LV NN O
) -RRB- O
stroke NN O
volume NN O
during IN O
positive JJ O
end-expiratory JJ O
pressure NN O
( -LRB- O
PEEP NN O
) -RRB- O
has VBZ O
been VBN O
attributed VBN O
to TO O
reduced VBN O
LV NNP O
filling NN O
and CC O
a DT O
decreased VBD O
contractile JJ O
state NN O
. . O

-DOCSTART- X X O

An DT O
experiment NN O
on IN O
the DT O
return-of-fear NN O
( -LRB- O
ROF NNP O
) -RRB- O
was VBD O
carried VBN O
out RP O
on IN O
40 CD O
snake- NNS O
or CC O
spider-phobic JJ O
subjects NNS O
in IN O
order NN O
to TO O
determine VB O
whether IN O
an DT O
arousing VBG O
event NN O
that WDT O
occurs VBZ O
shortly RB O
before IN O
retest NN O
influences VBZ O
the DT O
magnitude NN O
of IN O
the DT O
ROF. NNP O

-DOCSTART- X X O

Evolutionary JJ O
conservation NN O
of IN O
homeodomain-binding NN B-NP
sites NNS O
and CC O
other JJ O
sequences NNS O
upstream RB O
and CC O
within IN O
the DT O
major JJ O
transcription NN O
unit NN O
of IN O
the DT O
Drosophila NNP B-NP
segmentation NN I-NP
gene NN I-NP
engrailed VBN I-NP
. . O

-DOCSTART- X X O

To TO O
assess VB O
the DT O
functional JJ O
importance NN O
of IN O
these DT O
NBS NNP O
in IN O
the DT O
overall JJ O
drug NN O
resistance NN O
phenotype NN O
conferred VBN O
by IN O
mdr1 CD B-NP
, , O
we PRP O
introduced VBD O
amino IN O
acid NN O
substitutions NNS O
in IN O
the DT O
core NN O
consensus NN O
sequence NN O
for IN O
nucleotide JJ O
binding NN O
, , O
GXGKST. . O

-DOCSTART- X X O

When WRB O
the DT O
first JJ O
twitch NN O
of IN O
TOF NNP O
spontaneously RB O
recovered VBD O
to TO O
10 CD O
% NN O
of IN O
control NN O
value NN O
, , O
neostigmine NN O
was VBD O
injected VBN O
( -LRB- O
40 CD O
micrograms/kg NN O
in IN O
adults NNS O
, , O
30 CD O
micrograms/kg NN O
in IN O
infants NNS O
and CC O
children NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Selection NNP O
of IN O
the DT O
22 CD O
items NNS O
of IN O
the DT O
Clinical NNP O
Institute NNP O
Withdrawal NN O
Assessment-Benzodiazepines NNP O
( -LRB- O
CIWA-B) NNP O
was VBD O
based VBN O
on IN O
statistically RB O
significant JJ O
differences NNS O
between IN O
baseline NN O
and CC O
critical JJ O
withdrawal NN O
periods NNS O
in IN O
high-dose JJ O
subjects NNS O
and CC O
between IN O
symptoms NNS O
associated VBN O
with IN O
placebo NN O
and CC O
diazepam NN O
in IN O
low-dose JJ O
subjects NNS O
, , O
using VBG O
contingency NN O
tables NNS O
and CC O
logistic JJ O
regression NN O
analysis NN O
. . O

-DOCSTART- X X O

Antihistamines NNS O
in IN O
asthma NN O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
revealed VBN O
multiple JJ O
oIGF-I JJ B-NP
transcripts NNS I-NP
in IN O
a DT O
broad JJ O
band NN O
at IN O
800-1,100 CD O
nucleotides NNS O
and CC O
other JJ O
transcripts NNS O
of IN O
higher JJR O
molecular JJ O
weight NN O
in IN O
liver NN O
. . O

-DOCSTART- X X O

The DT O
discussion NN O
focuses VBZ O
primarily RB O
on IN O
the DT O
newer JJR O
drugs NNS O
like IN O
angiotensin NN B-NP
converting VBG I-NP
enzyme JJ I-NP
inhibitors NNS O
, , O
alpha-adrenergic NN B-NP
receptor NN I-NP
blockers NNS O
, , O
and CC O
calcium NN O
antagonists NNS O
. . O

-DOCSTART- X X O

High NNP O
ATP/GTP NNP O
ratios NNS O
promoted VBD O
initiation NN O
of IN O
RNA NNP O
primer NN O
synthesis NN O
at IN O
3'-dCTTT JJ O
sites NNS O
, , O
whereas IN O
low JJ O
ATP/GTP JJ O
ratios NNS O
promoted VBN O
initiation NN O
at IN O
3'-dCCC JJ O
sites NNS O
. . O

-DOCSTART- X X O

After IN O
hepatitis NNP O
B NNP O
vaccine NN O
immunization NN O
, , O
serum NN O
antibody NN O
response NN O
was VBD O
of IN O
primary JJ O
type NN O
in IN O
33 CD O
cases NNS O
with IN O
anti-HBs NNS B-NP
less JJR O
than IN O
2.1 CD O
S/N NN O
( -LRB- O
S/N NN O
Ratio NN O
Unit NN O
) -RRB- O
at IN O
T0 NNP O
, , O
the DT O
anti-HBs JJ B-NP
positive JJ O
rate NN O
was VBD O
39.4 CD O
% NN O
, , O
84.8 CD O
% NN O
, , O
96.7 CD O
% NN O
and CC O
96.7 CD O
% NN O
in IN O
T1 NNP O
, , O
T2 NNP O
, , O
T0 NNP O
and CC O
T12 NNP O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
experimental JJ O
design NN O
incorporated VBN O
a DT O
multiple JJ O
regression NN O
model NN O
, , O
sequential JJ O
treatments NNS O
and CC O
a DT O
proportional JJ O
end NN O
point NN O
( -LRB- O
95 CD O
% NN O
) -RRB- O
for IN O
protection NN O
time NN O
. . O

-DOCSTART- X X O

GN101 NNP O
, , O
YC819-9 NNP O
, , O
and CC O
SB3 NNP O
. . O

-DOCSTART- X X O

5 CD O
. . O

-DOCSTART- X X O

Of IN O
165 CD O
women NNS O
with IN O
non-malignant JJ O
diagnoses NNS O
26 CD O
( -LRB- O
16 CD O
% NN O
) -RRB- O
had VBD O
CA NNP B-NP
125 CD I-NP
levels NNS O
in IN O
excess NN O
of IN O
35 CD O
U/ml NN O
and CC O
8 CD O
( -LRB- O
5 CD O
% NN O
) -RRB- O
greater JJR O
than IN O
65 CD O
U/ml JJ O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
at IN O
steady JJ O
state NN O
the DT O
timing NN O
of IN O
a DT O
light JJ O
meal NN O
is VBZ O
unlikely JJ O
to TO O
alter VB O
in IN O
any DT O
clinically RB O
important JJ O
manner NN O
the DT O
pharmacokinetics NNS O
of IN O
nifedipine JJ O
released VBN O
from IN O
'biphasic JJ O
' POS O
tablets NNS O
. . O

-DOCSTART- X X O

Recent JJ O
investigations NNS O
have VBP O
shown VBN O
that IN O
Grenz NNP O
rays NNS O
can MD O
suppress VB O
the DT O
allergic JJ O
contact NN O
dermatitis NN O
reaction NN O
completely RB O
and CC O
that DT O
Langerhans NNP O
cells NNS O
, , O
identified VBN O
by IN O
OKT6 CD B-NP
antibodies NNS I-NP
and CC O
electron NN O
microscopy NN O
, , O
disappear VBP O
from IN O
the DT O
epidermis NN O
at IN O
the DT O
same JJ O
time NN O
. . O

-DOCSTART- X X O

The DT O
elements NNS O
responsible JJ O
for IN O
glucocorticoid JJ O
stimulation NN O
of IN O
ADH NNP B-NP
gene NN I-NP
transcription NN O
appear VBP O
to TO O
reside VB O
outside IN O
of IN O
this DT O
region NN O
. . O

-DOCSTART- X X O

1 CD O
. . O

-DOCSTART- X X O

With IN O
respect NN O
to TO O
effective JJ O
diffusivity NN O
of IN O
platelets NNS O
( -LRB- O
De FW O
) -RRB- O
and CC O
the DT O
surface NN O
reactivity NN O
constant JJ O
( -LRB- O
K) NNP O
, , O
less RBR O
significant JJ O
differences NNS O
were VBD O
found VBN O
among IN O
artificial JJ O
materials NNS O
. . O

-DOCSTART- X X O

Intracellular JJ O
activity NN O
studies NNS O
indicated VBD O
that IN O
, , O
at IN O
ten CD O
times NNS O
MBC NNP O
, , O
only RB O
penicillin NN O
had VBD O
any DT O
significant JJ O
activity NN O
against IN O
intracellular JJ O
staphylococci NNS O
, , O
reducing VBG O
survival NN O
by IN O
28 CD O
% NN O
. . O

-DOCSTART- X X O

Such JJ O
transgenic JJ O
plants NNS O
should MD O
enable VB O
not RB O
only RB O
the DT O
mutational JJ O
analysis NN O
of IN O
sequence NN O
elements NNS O
within IN O
the DT O
replication NN O
origin NN O
region NN O
, , O
but CC O
also RB O
the DT O
construction NN O
of IN O
a DT O
new JJ O
generation NN O
of IN O
vectors NNS O
for IN O
gene NN O
amplification NN O
in IN O
plants NNS O
, , O
based VBN O
on IN O
a DT O
minimal JJ O
virus NN O
replicon NN O
. . O

-DOCSTART- X X O

Four CD O
full-thickness JJ O
skin NN O
incisions NNS O
were VBD O
made VBN O
in IN O
the DT O
back NN O
of IN O
10 CD O
female JJ O
pigs NNS O
that WDT O
treated VBD O
twice RB O
a DT O
day NN O
for IN O
14 CD O
days NNS O
with IN O
2 CD O
ml NN O
of IN O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
( -LRB- O
300 CD O
ng/ml NN O
) -RRB- O
or CC O
2 CD O
ml NN O
of IN O
Ringer NNP O
's POS O
lactate NN O
solution NN O
in IN O
a DT O
single-blind JJ O
, , O
randomized JJ O
fashion NN O
. . O

-DOCSTART- X X O

During IN O
challenge NN O
, , O
rebiopsy NN O
was VBD O
done VBN O
when WRB O
reticulin NN B-NP
antibodies NNS I-NP
turned VBD O
positive JJ O
( -LRB- O
mean JJ O
0.6 CD O
years NNS O
, , O
range NN O
0.2-2.0) CD O
or CC O
at IN O
the DT O
end NN O
of IN O
the DT O
two CD O
year NN O
study NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
iron NN O
intake NN O
on IN O
59Fe JJ O
absorption NN O
throughout IN O
pregnancy NN O
, , O
and CC O
on IN O
maternal JJ O
and CC O
fetal JJ O
Fe NNP O
status NN O
towards IN O
the DT O
end NN O
of IN O
pregnancy NN O
, , O
was VBD O
investigated VBN O
in IN O
rats NNS O
. . O

-DOCSTART- X X O

The DT O
deduced JJ O
protein NN O
sequence NN O
is VBZ O
characterized VBN O
by IN O
a DT O
putative JJ O
16-residue JJ O
amino-terminal JJ O
signal NN O
peptide NN O
that WDT O
is VBZ O
cleaved VBN O
, , O
resulting VBG O
in IN O
a DT O
239-residue JJ O
polypeptide NN O
. . O

-DOCSTART- X X O

Reagent JJ O
strips NNS O
are VBP O
frequently RB O
used VBN O
in IN O
the DT O
practice NN O
of IN O
laboratory NN O
medicine NN O
as RB O
well RB O
as IN O
outside IN O
the DT O
professional JJ O
laboratories NNS O
. . O

-DOCSTART- X X O

The DT O
lowest JJS O
detectable NN O
concentration NN O
was VBD O
1.0 CD O
ng/ml NN O
in IN O
the DT O
serum NN O
. . O

-DOCSTART- X X O

Precipitating NNP O
antibodies NNS O
for IN O
Thermophilic DT O
actinomycetes NNS O
and CC O
M.f NNP O
. . O
were VBD O
negative JJ O
. . O

-DOCSTART- X X O

LON-72 NN O
( -LRB- O
34 CD O
isolates NNS O
) -RRB- O
, , O
LON-73 JJ O
( -LRB- O
1 CD O
) -RRB- O
, , O
LON-71 NNP O
( -LRB- O
2 CD O
) -RRB- O
and CC O
LON-10 NNP O
( -LRB- O
2 CD O
) -RRB- O
were VBD O
found VBN O
at IN O
altitudes NNS O
around IN O
2000 CD O
m NN O
, , O
3 CD O
of IN O
them PRP O
in IN O
a DT O
single JJ O
village NN O
. . O

-DOCSTART- X X O

Significance NN O
of IN O
delta-aminolevulinic JJ O
acid NN O
analysis NN O
in IN O
clinical JJ O
tests NNS O

-DOCSTART- X X O

Although IN O
the DT O
fertility NN O
decline NN O
in IN O
the DT O
black JJ O
population NN O
in IN O
the DT O
Mississippi NNP O
Delta NNP O
between IN O
the DT O
late JJ O
1870 CD O
's POS O
and CC O
early JJ O
1930 CD O
's POS O
closely RB O
paralleled JJ O
that IN O
of IN O
the DT O
national JJ O
black JJ O
population NN O
, , O
it PRP O
rose VBD O
much RB O
more RBR O
dramatically RB O
in IN O
the DT O
1940 CD O
's POS O
and CC O
1950 CD O
's VBZ O
to TO O
almost RB O
1880 CD O
levels NNS O
. . O

-DOCSTART- X X O

According VBG O
to TO O
their PRP$ O
staining NN O
affinity NN O
for IN O
anti-T JJ B-NP
antibodies NNS I-NP
, , O
the DT O
glandular JJ O
tissue NN O
cells NNS O
were VBD O
classified VBN O
as IN O
T-, JJ B-NP
T+ NNP B-NP
, , O
T++ NNP B-NP
, , O
and CC O
T NNP B-NP
and CC O
the DT O
annual JJ O
changes NNS O
in IN O
the DT O
numbers NNS O
of IN O
these DT O
cell NN O
populations NNS O
, , O
as RB O
well RB O
as IN O
in IN O
the DT O
volume NN O
occupied VBN O
by IN O
the DT O
glandular JJ O
tissue NN O
, , O
were VBD O
calculated VBN O
. . O

-DOCSTART- X X O

Ampicillin NNP O
( -LRB- O
AMP NNP O
) -RRB- O
alone RB O
or CC O
with IN O
an DT O
aminoglycoside NN O
( -LRB- O
AMI NNP O
) -RRB- O
was VBD O
the DT O
treatment NN O
in IN O
9 CD O
and CC O
16 CD O
cases NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

We PRP O
investigated VBD O
the DT O
incidence NN O
of IN O
congenital JJ O
color NN O
deficiency NN O
among IN O
Koreans NNP O
by IN O
the DT O
use NN O
of IN O
H-R-R JJ O
pseudoisochromatic JJ O
plates NNS O
. . O

-DOCSTART- X X O

The DT O
differential JJ O
diagnosis NN O
of IN O
both DT O
affections NNS O
is VBZ O
based VBN O
on IN O
the DT O
clinical JJ O
course NN O
, , O
sialography NN O
and CC O
CT NNP O
examination NN O
which WDT O
along RP O
with IN O
modern JJ O
ATB NNP O
treatment NN O
significantly RB O
modify VB O
hitherto PRP$ O
used VBN O
surgical JJ O
therapy NN O
. . O

-DOCSTART- X X O

Retrograde NNP O
filling NN O
consists VBZ O
in IN O
sealing VBG O
endodontics NNS O
system NN O
directly RB O
at IN O
the DT O
apical JJ O
zone NN O
after IN O
surgical JJ O
approach NN O
. . O

-DOCSTART- X X O

The DT O
maximum JJ O
stress NN O
due JJ O
to TO O
the DT O
hygroscopic JJ O
examination NN O
of IN O
the DT O
composite NN O
was VBD O
0.74 CD O
kg/mm2 CD O
at IN O
equilibrium NN O
of IN O
the DT O
water NN O
absorbed VBN O
of IN O
the DT O
composite JJ O
. . O

-DOCSTART- X X O

Ischemic NNP O
heart NN O
disease NN O
evaluated VBN O
by IN O
exercise NN O
stress NN O
thallium-201 DT O
myocardial JJ O
scintigraphy NN O
: : O
a DT O
comparison NN O
of IN O
SPECT NNP O
and CC O
bull NN O
's POS O
eye NN O
display NN O

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
the DT O
47-kilodalton JJ B-NP
major JJ I-NP
integral NN I-NP
membrane NN I-NP
immunogen NN I-NP
of IN I-NP
Treponema NNP I-NP
pallidum NN I-NP
. . O

-DOCSTART- X X O

Potential JJ O
consensus NN O
sequences NNS O
for IN O
early JJ O
and CC O
late JJ O
regulatory JJ O
elements NNS O
were VBD O
identified VBN O
. . O

-DOCSTART- X X O

An DT O
FP NNP B-NP
mutant NN I-NP
, , O
AcFP875-2 NNP B-NP
, , O
had VBD O
a DT O
1.6-kbp JJ O
insertion NN O
of IN O
S. NNP O
frugiperda CC O
DNA NNP O
near IN O
the DT O
5' JJ O
end NN O
of IN O
these DT O
transcripts NNS O
which WDT O
by IN O
S1 JJ B-NP
analysis NN O
were VBD O
shown VBN O
to TO O
initiate VB O
within IN O
the DT O
host NN O
cell NN O
sequence NN O
. . O

-DOCSTART- X X O

Construction NN O
of IN O
a DT O
RIP1 NNP B-NP
deletion NN O
strain NN O
and CC O
isolation NN O
of IN O
temperature-sensitive JJ O
mutants NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
whole JJ O
group NN O
, , O
basal JJ O
GH NNP B-NP
and CC O
somatomedin-C JJ B-NP
levels NNS O
decreased VBD O
from IN O
a DT O
mean JJ O
( -LRB- O
+/ FW O
- : O
standard JJ O
error NN O
of IN O
the DT O
mean JJ O
) -RRB- O
of IN O
52.3 CD O
+/ NN O
- : O
12.7 CD O
to TO O
11.1 CD O
+/ JJ O
- : O
6.3 CD O
ng/ml NN O
and CC O
from IN O
7.6 CD O
+/ CD O
- : O
0.7 CD O
to TO O
2.5 CD O
+/ NN O
- : O
0.5 CD O
U/ml NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Application NNP O
of IN O
different JJ O
criteria NNS O
of IN O
cure NN O
revealed VBD O
that IN O
19 CD O
patients NNS O
( -LRB- O
66 CD O
% NN O
) -RRB- O
had VBD O
basal JJ O
GH IN B-NP
levels NNS O
below IN O
5 CD O
ng/ml NN O
, , O
17 CD O
patients NNS O
( -LRB- O
59 CD O
% NN O
) -RRB- O
had VBD O
normal JJ O
somatomedin-C NN B-NP
values NNS O
, , O
16 CD O
patients NNS O
( -LRB- O
55 CD O
% NN O
) -RRB- O
had VBD O
complete JJ O
GH NNP B-NP
suppression NN O
( -LRB- O
less RBR O
than IN O
1 CD O
ng/ml NN O
) -RRB- O
during IN O
OGTT NNP O
, , O
and CC O
13 CD O
patients NNS O
( -LRB- O
45 CD O
% NN O
) -RRB- O
met VBD O
the DT O
above-mentioned JJ O
criteria NNS O
with IN O
disappearance NN O
of IN O
the DT O
paradoxical JJ O
GH NNP B-NP
response NN O
to TO O
TRH/GnRH NNP B-NP
test NN O
. . O

-DOCSTART- X X O

It PRP O
suggests VBZ O
a DT O
sequence NN O
of IN O
surgical JJ O
planning NN O
that WDT O
can MD O
prevent VB O
them PRP O
and CC O
also RB O
offers VBZ O
ways NNS O
of IN O
dealing VBG O
with IN O
the DT O
problems NNS O
should MD O
they PRP O
occur VB O
. . O

-DOCSTART- X X O

Platelet NNP B-NP
activating VBG I-NP
factor NN I-NP
was VBD O
given VBN O
in IN O
six CD O
doses NNS O
at IN O
15 CD O
minute NN O
intervals NNS O
and CC O
airway NN O
response NN O
measured VBN O
as IN O
change NN O
in IN O
partial JJ O
expiratory NN O
flow NN O
at IN O
30 CD O
% NN O
of IN O
vital JJ O
capacity NN O
(Vp30 IN O
) -RRB- O
. . O

-DOCSTART- X X O

There EX O
was VBD O
no DT O
significant JJ O
correlation NN O
between IN O
baseline NN O
PC40 NN O
methacholine NN O
and CC O
the DT O
maximal JJ O
fall NN O
in IN O
Vp30 NNP O
after IN O
either CC O
the DT O
first JJ O
( -LRB- O
12 CD O
micrograms NNS O
) -RRB- O
or CC O
the DT O
second JJ O
dose NN O
( -LRB- O
24 CD O
micrograms NNS O
) -RRB- O
of IN O
platelet NN B-NP
activating VBG I-NP
factor NN I-NP
. . O

-DOCSTART- X X O

Both DT O
BG NNP O
and CC O
IRI NNP B-NP
concentrations NNS O
during IN O
the DT O
OGTT NNP O
were VBD O
the DT O
lowest JJS O
in IN O
body NN O
builders NNS O
, , O
medium NN O
in IN O
controls NNS O
, , O
and CC O
the DT O
highest JJS O
in IN O
obese JJ O
men NNS O
. . O

-DOCSTART- X X O

Postcoital NNP O
contraception NN O
: : O
a DT O
family NN O
planning NN O
study NN O
. . O

-DOCSTART- X X O

A DT O
0.5 CD O
rating NN O
was VBD O
intended VBN O
to TO O
characterize VB O
subjects NNS O
in IN O
whom WP O
mild JJ O
cognitive JJ O
impairment NN O
due JJ O
to TO O
senile JJ O
dementia NN O
of IN O
the DT O
Alzheimer NNP O
type NN O
was VBD O
suspected VBN O
but CC O
was VBD O
insufficient JJ O
in IN O
degree NN O
to TO O
warrant VB O
a DT O
diagnosis NN O
of IN O
definite JJ O
dementia NN O
. . O

-DOCSTART- X X O

An DT O
implant NN O
may MD O
release VB O
a DT O
drug NN O
either CC O
by IN O
diffusion NN O
concurrent JJ O
with IN O
dissolution NN O
of IN O
the DT O
polymeric JJ O
implant NN O
material NN O
without IN O
depolymerization NN O
( -LRB- O
Type NNP O
A) NNP O
or CC O
by IN O
bioerosion NN O
involving VBG O
depolymerization NN O
( -LRB- O
Type NNP O
B) NNP O
. . O

-DOCSTART- X X O

Although IN O
it PRP O
is VBZ O
well RB O
known VBN O
that IN O
calcium NN O
channel NN O
blockers NNS O
can MD O
influence VB O
contraction NN O
of IN O
vascular JJ O
smooth JJ O
muscle NN O
, , O
there EX O
is VBZ O
less JJR O
knowledge NN O
on IN O
its PRP$ O
effect NN O
on IN O
excitation NN O
contraction NN O
coupling NN O
in IN O
the DT O
endocrine NN O
glands NNS O
and CC O
more JJR O
specifically RB O
on IN O
insulin NN B-NP
and CC O
glucagon NN B-NP
release NN O
. . O

-DOCSTART- X X O

The DT O
site-specific JJ O
DNA NNP O
inversion NN O
system NN O
Cin NNP B-NP
encoded VBD O
by IN O
the DT O
bacteriophage NN O
P1 NNP O
consists VBZ O
of IN O
a DT O
recombinase NN B-NP
, , O
two CD O
inverted JJ O
crossing-over NN O
sites NNS O
and CC O
a DT O
recombinational JJ O
enhancer NN O
. . O

-DOCSTART- X X O

The DT O
terminator IN O
region NN O
supported VBN O
termination NN O
of IN O
transcripts NNS O
initiated VBN O
by IN O
RNA NNP B-NP
polymerase NN I-NP
I PRP I-NP
in IN O
vivo RB O
. . O

-DOCSTART- X X O

The DT O
galactose NN B-NP
transporter NN I-NP
shows VBZ O
both DT O
sequence NN O
and CC O
structural JJ O
homology NN O
with IN O
a DT O
superfamily NN O
of IN O
sugar NN B-NP
transporters NNS I-NP
which WDT O
includes VBZ O
the DT O
human JJ B-NP
HepG2-erythrocyte NNP I-NP
and CC I-NP
fetal JJ I-NP
muscle NN I-NP
glucose NN I-NP
transporters NNS I-NP
, , O
the DT O
rat NN B-NP
brain NN I-NP
and CC I-NP
liver NN I-NP
glucose NN I-NP
transporters NNS I-NP
, , O
the DT O
Escherichia NNP B-NP
coli NNS I-NP
xylose NN I-NP
and CC I-NP
arabinose NN I-NP
permeases NNS I-NP
, , O
and CC O
the DT O
S. NNP B-NP
cerevisiae NN I-NP
glucose NN I-NP
, , I-NP
maltose NN I-NP
, , I-NP
and CC I-NP
galactose NN I-NP
transporters NNS I-NP
. . O

-DOCSTART- X X O

Of IN O
110 CD O
previously RB O
untreated JJ O
patients NNS O
who WP O
had VBD O
entered VBN O
the DT O
study NN O
of IN O
protocol NN O
TCL821 NNP O
, , O
96 CD O
were VBD O
evaluable JJ O
. . O

-DOCSTART- X X O

There EX O
were VBD O
3/32 CD O
( -LRB- O
9.4 CD O
per IN O
cent NN O
) -RRB- O
adverse JJ O
reactions NNS O
( -LRB- O
ADRs NNS O
) -RRB- O
, , O
and CC O
one CD O
case NN O
each DT O
of IN O
nausea NN O
, , O
dizziness NN O
and CC O
increased VBD O
menstrual JJ O
flow NN O
. . O

-DOCSTART- X X O

The DT O
seventh JJ O
cysteine NN O
residue NN O
of IN O
CTSE NNP B-NP
is VBZ O
located VBN O
within IN O
the DT O
activation NN O
peptide IN O
region NN O
of IN O
the DT O
proenzyme NN O
. . O

-DOCSTART- X X O

The DT O
p34.8 NNS B-NP
gene NN I-NP
has VBZ O
a DT O
strong JJ O
codon NN O
usage NN O
bias NN O
which WDT O
is VBZ O
strikingly RB O
different JJ O
from IN O
that DT O
of IN O
the DT O
polyhedrin NN B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Of IN O
the DT O
single-stranded JJ O
DNA NNP O
transformants NNS O
, , O
65 CD O
% NN O
resulted VBD O
from IN O
replacement NN O
of IN O
the DT O
resident NN O
met2 VBD B-NP
mutation NN I-NP
by IN O
the DT O
exogenous JJ O
wild-type JJ O
allele NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
strongly RB O
support VBP O
the DT O
notion NN O
that IN O
the DT O
OBF1-binding JJ B-NP
sites NNS I-NP
and CC O
the DT O
OBF1 JJ B-NP
protein NN I-NP
are VBP O
important JJ O
for IN O
normal JJ O
ARS NNS O
function VBP O
as IN O
an DT O
origin NN O
of IN O
replication NN O
. . O

-DOCSTART- X X O

On IN O
the DT O
basis NN O
of IN O
S1 NNP B-NP
nuclease POS I-NP
protection NN O
analysis NN O
of IN O
RNA NNP O
preparations NNS O
from IN O
several JJ O
mouse NN O
tissues NNS O
, , O
both DT O
dhfr JJ B-NP
and CC O
divergent JJ O
genes NNS O
showed VBD O
similar JJ O
levels NNS O
of IN O
expression NN O
but CC O
did VBD O
show VB O
some DT O
specificity NN O
in IN O
start NN O
site NN O
utilization NN O
. . O

-DOCSTART- X X O

62:2491-2499 CD O
, , O
1987 CD O
) -RRB- O
. . O

-DOCSTART- X X O

With IN O
both DT O
wild-type JJ O
and CC O
the DT O
mutant JJ O
enzymes NNS O
, , O
ATP NNP O
activates VBZ O
both DT O
[14C]Asp NNP O
in IN O
equilibrium NN O
N-carbamyl-L-aspartate NN O
(C-Asp NN O
) -RRB- O
and CC O
the DT O
[32P]carbamyl NNP O
phosphate NN O
(C-P) NN O
in IN O
equilibrium NN O
Pi NNP O
exchanges NNS O
. . O

-DOCSTART- X X O

Survival JJ O
rates NNS O
for IN O
the DT O
original JJ O
treatment NN O
group NN O
were VBD O
84.5 CD O
% NN O
and CC O
57.6 CD O
% NN O
at IN O
12 CD O
and CC O
21 CD O
months NNS O
, , O
respectively RB O
; : O
for IN O
the DT O
delayed JJ O
treatment NN O
group NN O
, , O
78.8 CD O
% NN O
and CC O
64.6 CD O
% NN O
at IN O
12 CD O
and CC O
21 CD O
months NNS O
, , O
respectively RB O
, , O
and CC O
78.8 CD O
% NN O
and CC O
47.5 CD O
% NN O
at IN O
12 CD O
and CC O
21 CD O
months NNS O
, , O
respectively RB O
, , O
for IN O
77 CD O
subjects NNS O
with IN O
AIDS NNP O
and CC O
93.0 CD O
% NN O
and CC O
71.8 CD O
% NN O
, , O
respectively RB O
, , O
for IN O
50 CD O
subjects NNS O
with IN O
AIDS-related JJ O
complex NN O
in IN O
the DT O
original JJ O
treatment NN O
group NN O
. . O

-DOCSTART- X X O

Mapping JJ O
results NNS O
suggested VBD O
that IN O
the DT O
complementation NN O
group NN O
identified VBN O
by IN O
these DT O
mutants NNS O
is VBZ O
allelic JJ O
to TO O
the DT O
ag NN B-NP
alpha NN I-NP
1 CD I-NP
mutation NN O
identified VBN O
previously RB O
. . O

-DOCSTART- X X O

Agranulocytosis NNP O
treatment NN O
with IN O
rhGM-CSF NN B-NP

-DOCSTART- X X O

The DT O
R. NNP B-NP
meliloti NN I-NP
nifH NN I-NP
promoter NN I-NP
but CC O
not RB O
the DT O
K. NNP B-NP
pneumoniae NN I-NP
nifH NN I-NP
promoter NN I-NP
showed VBD O
sigma NN B-NP
54-dependent JJ I-NP
methylation NN O
protection NN O
of IN O
guanine NNP O
residues NNS O
at IN O
-14 NN O
, , O
-25 . O
and CC O
-26 JJ O
, , O
the DT O
most RBS O
conserved JJ O
nucleotides NNS O
characteristic JJ O
of IN O
sigma NN B-NP
54-dependent JJ I-NP
promoters NNS I-NP
. . O

-DOCSTART- X X O

Routine JJ O
clinical JJ O
analysis NN O
revealed VBD O
lower JJR O
hematocrit NN O
and CC O
hemoglobin NN B-NP
, , O
and CC O
elevated VBD O
BUN NNP O
and CC O
alkaline DT B-NP
phosphatase NN I-NP
in IN O
the DT O
treated VBN O
group NN O
. . O

-DOCSTART- X X O

To TO O
assess VB O
the DT O
health NN O
significance NN O
of IN O
the DT O
early JJ O
renal JJ O
changes NNS O
after IN O
chronic JJ O
exposure NN O
to TO O
cadmium NN O
, , O
23 CD O
workers NNS O
removed VBN O
from IN O
exposure NN O
because IN O
of IN O
the DT O
discovery NN O
of IN O
an DT O
increased VBN O
urinary JJ O
excretion NN O
of IN O
beta JJ B-NP
2-microglobulin CD I-NP
or CC O
retinol NN B-NP
binding JJ I-NP
protein NN I-NP
, , O
or CC O
both DT O
, , O
have VBP O
been VBN O
examined VBN O
once RB O
a DT O
year NN O
for IN O
five CD O
years NNS O
. . O

-DOCSTART- X X O

A DT O
transcription NN O
factor NN O
exclusion NN O
assay NN O
was VBD O
used VBN O
to TO O
show VB O
that IN O
the DT O
PCF1 NNP B-NP
mutation NN I-NP
affects VBZ O
two CD O
distinct JJ O
stages NNS O
in IN O
transcription NN O
: : O
one CD O
prior JJ O
to TO O
and CC O
one CD O
after IN O
stable JJ O
complex NN O
formation NN O
; : O
and CC O
that IN O
these DT O
effects NNS O
are VBP O
mediated VBN O
by IN O
a DT O
component NN O
of IN O
the DT O
stable JJ O
complex NN O
. . O

-DOCSTART- X X O

These DT O
adverse JJ O
effects NNS O
usually RB O
abate VBP O
with IN O
time NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
3'-untranslated JJ O
regions NNS O
of IN O
pmGT10 DT B-NP
display NN O
a DT O
marked JJ O
degree NN O
of IN O
homology NN O
to TO O
the DT O
3' JJ O
region NN O
of IN O
the DT O
rat NN B-NP
Yb1 NNP I-NP
gene NN I-NP
, , O
while IN O
this DT O
region NN O
of IN O
pmGT2 JJ B-NP
displays NNS O
marked VBD O
homology NN O
to TO O
the DT O
corresponding JJ O
region NN O
of IN O
the DT O
rat NN B-NP
Yb2 NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Model NNP O
IV NNP O
: : O
primary JJ O
abutments NNS O
with IN O
the DT O
lateral JJ O
incisor NN O
and CC O
the DT O
second JJ O
molar NN O
as IN O
secondary JJ O
abutments NNS O
. . O

-DOCSTART- X X O

The DT O
incidence NN O
of IN O
fetal JJ O
breathing NN O
movements NNS O
( -LRB- O
06.00-10.00 CD O
h NN O
) -RRB- O
decreased VBN O
with IN O
increasing VBG O
gestational JJ O
age NN O
while IN O
fetal NN O
arterial NN O
concentrations NNS O
of IN O
plasma NN O
PGE NNP O
increased VBD O
significantly RB O
over IN O
the DT O
same JJ O
period NN O
of IN O
gestation NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
examined VBN O
the DT O
role NN O
of IN O
two CD O
recombination NN O
- : O
and CC O
repair-defective JJ O
mutations NNS O
, , O
rad1 NNS B-NP
and CC O
rad52 NN B-NP
, , O
on IN O
direct JJ O
repeat NN O
recombination NN O
in IN O
transcriptionally RB O
active JJ O
and CC O
inactive JJ O
sequences NNS O
. . O

-DOCSTART- X X O

On IN O
the DT O
other JJ O
hand NN O
, , O
knowledge NN O
of IN O
the DT O
epidemiology NN O
of IN O
Parkinson NNP O
's POS O
disease NN O
is VBZ O
necessary JJ O
in IN O
creating VBG O
etiological JJ O
hypotheses NNS O
, , O
since IN O
only RB O
hypotheses VBZ O
consistent JJ O
with IN O
the DT O
epidemiological JJ O
profile NN O
deserve VBP O
careful JJ O
testing NN O
. . O

-DOCSTART- X X O

The DT O
stereoselectivity NN O
of IN O
drug NN O
action NN O
. . O

-DOCSTART- X X O

A DT O
combination NN O
of IN O
cisplatin NN O
and CC O
5-fluorouracil NN O
, , O
both DT O
administered VBN O
4 CD O
days NNS O
continuously RB O
as IN O
infusion NN O
, , O
was VBD O
assessed VBN O
in IN O
advanced JJ O
head NN O
and CC O
neck NN O
cancer NN O
. . O

-DOCSTART- X X O

Diagnosis NNP O
of IN O
primary JJ O
sclerosing NN O
cholangitis NN O
in IN O
a DT O
blood NN O
donor NN O
with IN O
elevated JJ O
serum NN B-NP
alanine IN I-NP
aminotransferase NN I-NP
. . O

-DOCSTART- X X O

When WRB O
statistically RB O
analyzed VBN O
in IN O
various JJ O
subgroupings NNS O
, , O
the DT O
obtained VBN O
average NN O
sedimentation NN O
coefficients NNS O
and CC O
polydispersity NN O
profiles NNS O
supported VBD O
the DT O
following JJ O
conclusions NNS O
: : O
( -LRB- O
a DT O
) -RRB- O
loss NN O
of IN O
proteoglycan JJ O
aggregation NN O
and CC O
sedimentability NN O
is VBZ O
confirmed VBN O
to TO O
be VB O
a DT O
primary JJ O
sign NN O
of IN O
cartilage NN O
matrix NN O
degradation NN O
; : O
( -LRB- O
b NN O
) -RRB- O
higher JJR O
S NNP O
values NNS O
for IN O
proteoglycans NNS O
of IN O
the DT O
high JJ O
weight NN O
( -LRB- O
HW)-bearing JJ O
areas NNS O
and CC O
lower JJR O
values NNS O
for IN O
those DT O
of IN O
the DT O
low JJ O
weight NN O
( -LRB- O
LW)-bearing JJ O
areas NNS O
were VBD O
a DT O
typical JJ O
finding NN O
in IN O
normal JJ O
cartilage NN O
samples NNS O
; : O
( -LRB- O
c NN O
) -RRB- O
inversion NN O
of IN O
this DT O
pattern NN O
was VBD O
indicative JJ O
of IN O
matrix NN O
degradation NN O
, , O
suggesting VBG O
that IN O
the DT O
HW NNP O
regions NNS O
are VBP O
more RBR O
affected JJ O
than IN O
the DT O
LW-bearing JJ O
areas NNS O
; : O
( -LRB- O
d NN O
) -RRB- O
the DT O
average NN O
S NNP O
value NN O
distribution NN O
across IN O
cartilage NN O
thickness NN O
tended VBD O
to TO O
resemble VB O
the DT O
corresponding JJ O
proteoglycan NN O
content JJ O
versus NN O
distance NN O
from IN O
articular JJ O
surface NN O
; : O
and CC O
( -LRB- O
e NN O
) -RRB- O
the DT O
deepest JJS O
cartilage NN O
layer NN O
had VBD O
, , O
in IN O
most JJS O
cases NNS O
, , O
the DT O
smallest JJS O
amount NN O
of IN O
aggregates NNS O
while IN O
the DT O
highest JJS O
average NN O
sedimentability NN O
was VBD O
observed VBN O
at IN O
the DT O
middle JJ O
zone NN O
of IN O
the DT O
normal JJ O
samples NNS O
. . O

-DOCSTART- X X O

End NN O
points NNS O
measured VBN O
were VBD O
perioperative JJ O
( -LRB- O
30-day JJ O
) -RRB- O
myocardial JJ O
infarction NN O
( -LRB- O
MI NNP O
) -RRB- O
rate NN O
and CC O
death NN O
. . O

-DOCSTART- X X O

Liquid NN O
chromatography NN O
with IN O
amperometric JJ O
detection NN O
(LC/AD NN O
) -RRB- O
is VBZ O
used VBN O
to TO O
determine VB O
fluazifop JJ O
acid NN O
produced VBD O
from IN O
the DT O
metabolism NN O
or CC O
base NN O
hydrolysis NN O
of IN O
fluazifop-butyl NN O
in IN O
soybeans NNS O
and CC O
soybean NN O
oil NN O
. . O

-DOCSTART- X X O

Validation NNP O
of IN O
the DT O
survey NN O
of IN O
work NN O
styles NNS O
: : O
a DT O
profile NN O
measure NN O
of IN O
the DT O
type NN O
A DT O
behaviour NN O
pattern NN O
. . O

-DOCSTART- X X O

Only RB O
one CD O
ADR NN O
was VBD O
related VBN O
definitely RB O
to TO O
ciprofloxacin VB O
therapy NN O
. . O

-DOCSTART- X X O

HIV NNP O
infectiousness NN O
and CC O
the DT O
AIDS NNP O
epidemic NN O
. . O

-DOCSTART- X X O

From IN O
day NN O
30 CD O
after IN O
turnout NN O
, , O
the DT O
PFB-group NN O
had VBD O
significantly RB O
lower JJR O
serum NN B-NP
pepsinogen NN I-NP
levels NNS O
, , O
which WDT O
reflects VBZ O
the DT O
low JJ O
degree NN O
of IN O
abomasal JJ O
damage NN O
in IN O
these DT O
animals NNS O
. . O

-DOCSTART- X X O

The DT O
corresponding JJ O
inhibition NN O
of IN O
acid NN B-NP
phosphatase NN I-NP
activity NN O
in IN O
control NN O
male JJ O
and CC O
female JJ O
guinea NN O
pigs NNS O
was VBD O
15.91 CD O
% NN O
and CC O
20.33 CD O
% NN O
respectively RB O
. . O

-DOCSTART- X X O

Its PRP$ O
clinical JJ O
and CC O
histopathologic NN O
characteristics NNS O
. . O

-DOCSTART- X X O

Fundus NNP O
changes NNS O
in IN O
( -LRB- O
type NN O
II NNP O
) -RRB- O
mesangiocapillary NN O
glomerulonephritis NN O
simulating VBG O
drusen NN O
: : O
a DT O
histopathological JJ O
report NN O
. . O

-DOCSTART- X X O

Chronic JJ O
dose NN O
effects NNS O
of IN O
methyl NN O
parathion NN O
on IN O
nuthatches NNS O
: : O
cholinesterase NN B-NP
and CC O
ptilochronology NN O
. . O

-DOCSTART- X X O

A DT O
method NN O
for IN O
determining VBG O
optimal JJ O
development NN O
conditions NNS O
by IN O
summary NN O
oxygen NN O
consumption NN O

-DOCSTART- X X O

Men NNS O
were VBD O
more RBR O
positive JJ O
about IN O
their PRP$ O
physical JJ O
fitness NN O
than IN O
women NNS O
. . O

-DOCSTART- X X O

Handgrip NN O
dynamometry NN O
was VBD O
also RB O
carried VBN O
out RP O
in IN O
249 CD O
of IN O
the DT O
patients NNS O
. . O

-DOCSTART- X X O

In IN O
cerebrospinal JJ O
fluid NN O
, , O
an DT O
ADA NNP B-NP
catalytic JJ O
concentration NN O
above IN O
0.15 CD O
mu NN O
kat/L NN O
strongly RB O
suggests VBZ O
tuberculous JJ O
meningitis NNS O
in IN O
patients NNS O
older JJR O
than IN O
7 CD O
years NNS O
( -LRB- O
sensitivity NN O
1.00 CD O
, , O
specificity NN O
0.99 CD O
and CC O
efficiency NN O
0.99 VBP O
) -RRB- O
. . O

-DOCSTART- X X O

NERVTRACK NNP O
contains VBZ O
4000 CD O
anatomical JJ O
data NNS O
items NNS O
arranged VBN O
in IN O
a DT O
tree-like JJ O
manner NN O
reflecting VBG O
structural JJ O
and CC O
functional JJ O
relationships NNS O
. . O

-DOCSTART- X X O

Swim-over NN O
: : O
an DT O
alternative JJ O
method NN O
for IN O
harvesting VBG O
motile JJ O
spermatozoa NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
striking VBG O
that IN O
the DT O
active JJ O
CHO NNP O
spacer NN O
promoter NN O
violated VBD O
the DT O
otherwise RB O
universal JJ O
rule NN O
that IN O
metazoan NN B-NP
RNA NNP I-NP
polymerase NN I-NP
I PRP I-NP
promoters NNS I-NP
all DT O
have VBP O
a DT O
G NNP O
residue NN O
at IN O
position NN O
-16 CD O
. . O

-DOCSTART- X X O

The DT O
author NN O
provides VBZ O
a DT O
rationale NN O
for IN O
an DT O
interactional JJ O
view NN O
and CC O
presents VBZ O
a DT O
case NN O
in IN O
which WDT O
post-surgical JJ O
hiccups NNS O
were VBD O
successfully RB O
treated VBN O
, , O
using VBG O
principles NNS O
developed VBN O
by IN O
the DT O
Mental NNP O
Research NNP O
Institute NNP O
. . O

-DOCSTART- X X O

The DT O
relative JJ O
toxicity NN O
of IN O
nickel NN O
oxide NN O
( -LRB- O
NiO NNP O
) -RRB- O
, , O
nickel NN O
sulfate NN O
hexahydrate NN O
( -LRB- O
NiSO4.6H2O NNP O
) -RRB- O
, , O
and CC O
nickel NN O
subsulfide NN O
( -LRB- O
Ni3S2 NNP O
) -RRB- O
was VBD O
studied VBN O
in IN O
F344/N NNP O
rats NNS O
and CC O
B6C3F1 NNP O
mice NNS O
after IN O
inhalation NN O
exposure NN O
for IN O
6 CD O
hr/day NN O
, , O
5 CD O
days/week NN O
, , O
for IN O
13 CD O
weeks NNS O
. . O

-DOCSTART- X X O

From IN O
the DT O
National NNP O
Institutes NNPS O
of IN O
Health NNP O
. . O

-DOCSTART- X X O

In IN O
the DT O
final JJ O
model NN O
, , O
grade NN O
( -LRB- O
p NN O
= SYM O
0.0002 CD O
) -RRB- O
, , O
peritoneal JJ O
cytologic NN O
results NNS O
( -LRB- O
p NN O
= SYM O
0.0002 CD O
) -RRB- O
, , O
progesterone NN B-NP
receptor NN I-NP
status NN O
( -LRB- O
p NN O
= SYM O
0.004 CD O
) -RRB- O
, , O
and CC O
age NN O
as IN O
a DT O
continuous JJ O
variable NN O
( -LRB- O
p NN O
= SYM O
0.008 CD O
) -RRB- O
were VBD O
most RBS O
closely RB O
associated VBN O
with IN O
disease-free JJ O
survival NN O
. . O

-DOCSTART- X X O

In IN O
Experiment NN O
2 CD O
, , O
we PRP O
again RB O
used VBD O
classification NN O
, , O
but CC O
the DT O
fixed VBN O
standard NN O
75 CD O
was VBD O
not RB O
at IN O
the DT O
center NN O
of IN O
the DT O
range NN O
of IN O
target NN O
numbers NNS O
( -LRB- O
20 CD O
, , O
21 CD O
, , O
... : O

-DOCSTART- X X O

The DT O
oxygen NN O
uptake NN O
(VO2 IN O
) -RRB- O
, , O
carbon NN O
dioxide NN O
output NN O
(VCO2 NN O
) -RRB- O
, , O
respiratory JJ O
rate NN O
(fR NN O
) -RRB- O
, , O
minute JJ O
ventilation NN O
(VE) NN O
, , O
alveolar JJ O
ventilation NN O
(VA NN O
) -RRB- O
, , O
alveolar JJ O
oxygen NN O
pressure NN O
( -LRB- O
PAO2 NN O
) -RRB- O
, , O
and CC O
VE/VO2 NNP O
ratio NN O
were VBD O
higher JJR O
in IN O
the DT O
cows NNS O
, , O
while IN O
the DT O
tidal JJ O
volume NN O
(VT NN O
) -RRB- O
and CC O
physiological JJ O
dead JJ O
space NN O
(VD NN O
) -RRB- O
were VBD O
larger JJR O
in IN O
the DT O
horses NNS O
. . O

-DOCSTART- X X O

Epithelial NNP O
damage NN O
was VBD O
not RB O
observed VBN O
in IN O
any DT O
controls NNS O
but CC O
was VBD O
in IN O
all DT O
tissues NNS O
exposed VBN O
to TO O
SO2 NNP O
. . O

-DOCSTART- X X O

Among IN O
booked VBN O
patients NNS O
the DT O
maternal JJ O
mortality NN O
rate NN O
was VBD O
0.32 CD O
and CC O
among IN O
unbooked JJ O
patients NNS O
11.13 CD O
per IN O
1000 CD O
deliveries NNS O
. . O

-DOCSTART- X X O

The DT O
present JJ O
study NN O
investigates VBZ O
whether IN O
prostaglandins NNS O
" `` O
cytoprotect VB O
" '' O
the DT O
gastric JJ O
mucosa NN O
against IN O
hemorrhage-induced JJ O
stress NN O
ulceration NN O
by IN O
assessing VBG O
the DT O
influence NN O
of IN O
16,16-dimethyl JJ O
prostaglandin NN O
E2 . O
( -LRB- O
16,16-dm JJ O
PGE2 NN O
) -RRB- O
on IN O
gross JJ O
and CC O
microscopic JJ O
lesion NN O
formation NN O
, , O
intramucosal JJ O
tissue NN O
pH NNS O
, , O
H+ NNP O
back-diffusion NN O
, , O
and CC O
mucosal NN O
blood NN O
flow NN O
in IN O
rat NN O
gastric VBN O
mucosa NN O
exposed VBN O
to TO O
luminal JJ O
acid NN O
( -LRB- O
100 CD O
mM JJ O
HCl NN O
) -RRB- O
during IN O
hemorrhagic JJ O
shock NN O
( -LRB- O
13 CD O
ml/kg NN O
for IN O
20 CD O
min NN O
) -RRB- O
. . O

-DOCSTART- X X O

Transcripts NNS O
characterized VBN O
include VBP O
( -LRB- O
i NN O
) -RRB- O
abundant JJ O
monocistronic JJ O
L11e JJ B-NP
and CC O
tricistronic JJ O
L1e-L10e-L12e JJ B-NP
transcripts NNS O
; : O
( -LRB- O
ii NNS O
) -RRB- O
less RBR O
abundant JJ O
bicistronic JJ O
NAB-L11e JJ B-NP
and CC O
monocistronic JJ O
NAB NNP B-NP
transcripts NNS I-NP
and CC O
( -LRB- O
iii NN O
) -RRB- O
a DT O
very RB O
rare JJ O
ORF IN O
monocistronic JJ O
transcript NN O
. . O

-DOCSTART- X X O

At IN O
each DT O
level NN O
of IN O
PaO2 NN O
we PRP O
obtained VBD O
simultaneous JJ O
measures NNS O
of IN O
arterial NN O
and CC O
venous JJ O
blood NN O
gases NNS O
, , O
venous JJ O
lactate NN O
concentration NN O
, , O
and CC O
changes NNS O
in IN O
the DT O
relative JJ O
concentrations NNS O
of IN O
inorganic JJ O
phosphate NN O
, , O
phosphocreatine NN O
, , O
and CC O
ATP NNP O
measured VBD O
with IN O
31P JJ O
magnetic JJ O
resonance NN O
spectroscopy NN O
. . O

-DOCSTART- X X O

The DT O
transcription NN O
initiation NN O
site NN O
was VBD O
determined VBN O
by IN O
S1 NNP B-NP
nuclease NN I-NP
mapping NN O
. . O

-DOCSTART- X X O

The DT O
mobility NN O
of IN O
the DT O
upper JJ O
and CC O
lower JJR O
premolars NNS O
under IN O
load NN O
was VBD O
investigated VBN O
in IN O
relation NN O
to TO O
the DT O
interproximal JJ O
contact NN O
and CC O
occlusal JJ O
facets NNS O
. . O

-DOCSTART- X X O

A DT O
larval JJ B-NP
albumin-like JJ I-NP
protein NN I-NP
was VBD O
not RB O
detectable JJ O
by IN O
silver JJ O
staining NN O
in IN O
serum NN O
of IN O
tadpoles NNS O
before IN O
the DT O
beginning NN O
of IN O
metamorphosis NN O
at IN O
stage NN O
48 CD O
. . O

-DOCSTART- X X O

Isolated JJ O
proteinuria NN O
( -LRB- O
i FW O
.e FW O
. . O
without IN O
hematuria NN O
and/or CC O
pyuria NN O
) -RRB- O
is VBZ O
a DT O
frequent JJ O
finding NN O
. . O

-DOCSTART- X X O

Dynamic NNP O
and CC O
static JJ O
scintigrams NNS O
, , O
using VBG O
99mtechnetium NNP O
methylene NN O
diphosphonate NN O
, , O
were VBD O
obtained VBN O
at IN O
zero CD O
, , O
six CD O
, , O
and CC O
12 CD O
weeks NNS O
after IN O
fracture NN O
. . O

-DOCSTART- X X O

On IN O
admission NN O
to TO O
our PRP$ O
department NN O
in IN O
September NNP O
, , O
1987 CD O
, , O
the DT O
patient NN O
was VBD O
alert JJ O
and CC O
had VBD O
spastic JJ O
paraparesis NN O
, , O
the DT O
impairment NN O
of IN O
all DT O
sensory JJ O
modalities NNS O
below IN O
the DT O
level NN O
of IN O
Th DT O
10 CD O
and CC O
urinary JJ O
disturbance NN O
. . O

-DOCSTART- X X O

Prostaglandins NNS O
and CC O
gallstones NNS O

-DOCSTART- X X O

The DT O
nature NN O
of IN O
the DT O
process NN O
formed VBN O
by IN O
the DT O
successive JJ O
occurrences NNS O
of IN O
this DT O
arrhythmia NN O
was VBD O
studied VBN O
in IN O
8 CD O
patients NNS O
with IN O
a DT O
history NN O
of IN O
symptomatic JJ O
paroxysmal JJ O
AF NNS O
. . O

-DOCSTART- X X O

This DT O
would MD O
have VB O
had VBD O
the DT O
effect NN O
of IN O
positioning VBG O
the DT O
genes NNS O
currently RB O
on IN O
the DT O
long JJ O
arm NN O
adjacent JJ O
to TO O
the DT O
centromeric JJ O
heterochromatin NN O
, , O
perhaps RB O
resulting VBG O
in IN O
a DT O
"position NN O
effect NN O
" '' O
on IN O
transcription NN O
of IN O
these DT O
genes NNS O
. . O

-DOCSTART- X X O

Obesity NN O
was VBD O
strongly RB O
associated VBN O
with IN O
the DT O
proportions NNS O
of IN O
nonprotein-bound JJ O
and CC O
albumin-bound JJ B-NP
estradiol NN O
, , O
and CC O
inversely RB O
associated VBN O
with IN O
sex NN B-NP
hormone NN I-NP
binding NN I-NP
globulin NN I-NP
( -LRB- O
SHBG NNP B-NP
) -RRB- O
levels NNS O
and CC O
the DT O
proportion NN O
of IN O
SHBG-bound JJ B-NP
estradiol NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
zinc NN O
deficiency NN O
on IN O
trace NN O
metals NNS O
in IN O
the DT O
liver NN O
, , O
spleen VBN O
, , O
kidney NN O
, , O
pancreas NNS O
and CC O
duodenum NN O
was VBD O
investigated VBN O
in IN O
the DT O
control NN O
and CC O
zinc-deficient JJ O
rats NNS O
at IN O
17 CD O
days NNS O
and CC O
20 CD O
days NNS O
of IN O
pregnancy NN O
. . O

-DOCSTART- X X O

Our PRP$ O
findings NNS O
support VBP O
the DT O
view NN O
of IN O
a DT O
multifactorial JJ O
genesis NN O
of IN O
the DT O
cardiac JJ O
involvement NN O
in IN O
uremic JJ O
patients NNS O
. . O

-DOCSTART- X X O

Heating VBG O
cells NNS O
to TO O
43 CD O
degrees NNS O
C NN O
decreased VBD O
the DT O
amount NN O
of IN O
newly RB O
synthesized VBN O
rRNA NNP O
to TO O
less JJR O
than IN O
5 CD O
% NN O
of IN O
the DT O
control NN O
level NN O
and CC O
led VBD O
to TO O
greater JJR O
than IN O
95 CD O
% NN O
inhibition NN O
of IN O
transcription NN O
termination NN O
at IN O
a DT O
region NN O
355 CD O
to TO O
362 CD O
nucleotides NNS O
downstream IN O
of IN O
the DT O
3' JJ O
end NN O
of IN O
28S DT B-NP
rRNA NNP I-NP
, , O
with IN O
readthrough NN O
continuing VBG O
into IN O
the DT O
next JJ O
transcription NN O
unit NN O
. . O

-DOCSTART- X X O

Deletion NNP O
analysis NN O
showed VBD O
that IN O
the DT O
NF-4FA NNP B-NP
, , O
NF-4FB NNP B-NP
, , O
and CC O
AP-1 NNP B-NP
sequences NNS O
are VBP O
each DT O
necessary JJ O
for IN O
full JJ O
enhancer NN O
activity NN O
. . O

-DOCSTART- X X O

Reye NNP O
's POS O
syndrome NN O
: : O
reports NNS O
of IN O
7 CD O
cases NNS O
in IN O
the DT O
period NN O
1982-1987 CD O

-DOCSTART- X X O

When WRB O
two-dimensional JJ O
polyacrylamide NN O
gel NN O
electrophoretic JJ O
patterns NNS O
of IN O
[35S]methionine-labeled JJ O
proteins NNS O
secreted VBN O
from IN O
cells NNS O
infected VBN O
with IN O
parental JJ O
and CC O
recombinant JJ O
viruses NNS O
were VBD O
compared VBN O
, , O
a DT O
spot NN O
missing VBG O
from IN O
the DT O
latter JJ O
corresponded VBN O
in IN O
molecular JJ O
weigh VBP O
and CC O
isoelectric JJ O
point NN O
with IN O
that DT O
predicted VBN O
from IN O
the DT O
N1L NNP B-NP
ORF. . I-NP

-DOCSTART- X X O

PULSE NN O
is VBZ O
used VBN O
to TO O
set VB O
such JJ O
NMR NN O
spectroscopic NN O
parameters NNS O
as IN O
the DT O
delay NN O
and CC O
duration NN O
of IN O
rf NN O
transmit NN O
and CC O
receive VB O
gates NNS O
, , O
rf NN O
phase NN O
, , O
sampling VBG O
times NNS O
, , O
and CC O
such JJ O
imaging NN O
parameters NNS O
as IN O
rf NN O
pulse NN O
shape NN O
and CC O
gradient NN O
waveforms NNS O
. . O

-DOCSTART- X X O

Definite JJ O
JPsA NNP O
( -LRB- O
24 CD O
patients NNS O
) -RRB- O
was VBD O
defined VBN O
as IN O
arthritis NN O
associated VBN O
, , O
but CC O
not RB O
necessarily RB O
coincident JJ O
, , O
with IN O
a DT O
typical JJ O
psoriatic JJ O
rash NN O
, , O
or CC O
arthritis NN O
plus CC O
at IN O
least JJS O
3 CD O
of IN O
4 CD O
minor JJ O
criteria NNS O
: : O
dactylitis NN O
, , O
nail NN O
pitting NN O
, , O
psoriasis-like JJ O
rash NN O
, , O
or CC O
family NN O
history NN O
of IN O
psoriasis NN O
. . O

-DOCSTART- X X O

Hence RB O
follows VBZ O
Kurti NNP O
's POS O
demand NN O
to TO O
mete VB O
out RP O
appropriate JJ O
importance NN O
to TO O
the DT O
arguments NNS O
. . O

-DOCSTART- X X O

The DT O
author NN O
gives VBZ O
an DT O
account NN O
of IN O
antipsychotic JJ O
, , O
analgetic JJ O
, , O
myorelaxing VBG O
and CC O
vasodilatating VBG O
effects NNS O
of IN O
some DT O
calcium NN O
antagonists NNS O
, , O
and CC O
their PRP$ O
clinical JJ O
application NN O
is VBZ O
discussed VBN O
. . O

-DOCSTART- X X O

A DT O
correlation NN O
coefficient NN O
was VBD O
used VBN O
for IN O
assessing VBG O
the DT O
similarity NN O
of IN O
each DT O
map NN O
pattern NN O
with IN O
the DT O
normal JJ O
mean NN O
IQRST NN O
map NN O
. . O

-DOCSTART- X X O

A DT O
hospital-based JJ O
study NN O
of IN O
the DT O
relationship NN O
between IN O
retained VBD O
placenta NN O
and CC O
mastitis NN O
in IN O
dairy NN O
cows NNS O
. . O

-DOCSTART- X X O

Asthma NNP O
was VBD O
significantly RB O
more RBR O
often RB O
associated VBN O
with IN O
ASA NNP O
group NN O
(91 NN O
% NN O
) -RRB- O
vs IN O
46 CD O
% NN O
at IN O
AT WDT O
and CC O
in IN O
only RB O
16 CD O
% NN O
at IN O
INTR NNP O
group NN O
. . O

-DOCSTART- X X O

A DT O
value NN O
of IN O
1.1 CD O
l/kg NN O
was VBD O
used VBN O
for IN O
V NNP O
in IN O
calculating VBG O
all DT O
single JJ O
sample NN O
estimates NNS O
of IN O
clearance NN O
( -LRB- O
CL) NN O
, , O
and CC O
a DT O
value NN O
of IN O
4.3 CD O
l/kg NN O
was VBD O
used VBN O
to TO O
calculate VB O
single JJ O
sample NN O
estimates NNS O
of IN O
clearance NN O
of IN O
plasma NN O
unbound JJ O
drug NN O
( -LRB- O
CLunb NN O
) -RRB- O
. . O

-DOCSTART- X X O

Halothane NNP O
is VBZ O
metabolized VBN O
by IN O
an DT O
oxidative JJ O
pathway NN O
to TO O
stable JJ O
, , O
nonvolatile JJ O
end NN O
products NNS O
, , O
trifluoroacetic JJ O
acid NN O
( -LRB- O
TFAA NNP O
) -RRB- O
and CC O
bromide NN O
( -LRB- O
Br-) NNP O
, , O
and CC O
by IN O
reductive JJ O
pathways NNS O
to TO O
Br-and NNP O
inorganic IN O
fluoride NN O
(F-) NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
HAPE-S-S NNP O
are VBP O
prone JJ O
to TO O
irregular JJ O
nocturnal JJ O
breathing NN O
patterns NNS O
at IN O
high JJ O
altitude NN O
, , O
which WDT O
is VBZ O
associated VBN O
with IN O
the DT O
development NN O
of IN O
AMS NNP O
, , O
but CC O
it PRP O
was VBD O
not RB O
possible JJ O
to TO O
determine VB O
whether IN O
these DT O
abnormal JJ O
breathing NN O
patterns NNS O
are VBP O
a DT O
cause NN O
or CC O
an DT O
effect NN O
of IN O
AMS. NNP O

-DOCSTART- X X O

Buflomedil NNP O
( -LRB- O
i NN O
.v. NN O
) -RRB- O
induced VBN O
a DT O
dose-dependent JJ O
increase NN O
of IN O
cardiac JJ O
output NN O
at IN O
0.16-0.64 CD O
mg/kg NN O
, , O
biphasic JJ O
changes NNS O
at IN O
1.28 CD O
and CC O
2.56 CD O
mg/kg NN O
and CC O
a DT O
marked JJ O
decrease NN O
and CC O
subsequent JJ O
slight JJ O
increase NN O
at IN O
a DT O
large JJ O
dose NN O
of IN O
5.12 CD O
mg/kg NN O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
possible JJ O
to TO O
classify VB O
the DT O
animals NNS O
into IN O
high JJ O
and CC O
low JJ O
responders NNS O
according VBG O
to TO O
the DT O
pattern NN O
of IN O
humoral JJ O
immune JJ O
response NN O
. . O

-DOCSTART- X X O

Heart NN O
rate NN O
( -LRB- O
HR NN O
) -RRB- O
, , O
rectal JJ O
temperature NN O
( -LRB- O
Tre NNP O
) -RRB- O
, , O
blood NN O
pressure NN O
, , O
temperature NN O
and CC O
relative JJ O
humidity NN O
changes NNS O
inside IN O
clothing NN O
were VBD O
measured VBN O
on IN O
18 CD O
professional JJ O
firemen NNS O
( -LRB- O
mean JJ O
age NN O
29.4 CD O
+/ NN O
- : O
7.4 CD O
yr NN O
, , O
VO2 NNP O
max NN O
41.4 CD O
+ NN O
8.8 CD O
ml NN O
kg-1 JJ O
min-1 NN O
) -RRB- O
wearing VBG O
fire NN O
fighter NN O
's POS O
uniforms NNS O
( -LRB- O
SU) JJ O
or CC O
aluminized JJ O
, , O
fire NN O
resistant NN O
, , O
impermeable JJ O
clothing NN O
with IN O
self NN O
contained VBN O
breathing NN O
apparatus NN O
( -LRB- O
FE) NNP O
. . O

-DOCSTART- X X O

The DT O
clinical JJ O
tolerance NN O
and CC O
pharmacokinetics NNS O
of IN O
FCE NNP O
22101 CD O
( -LRB- O
sodium NN O
(5R NN O
, , O
6S)-6-[( JJ O
1R)-hydroxyethyl]-2-carbamoyloxymethyl-2-penem-3-carboxylate JJ O
) -RRB- O
, , O
a DT O
new JJ O
penem NN O
antibiotic JJ O
, , O
have VBP O
been VBN O
studied VBN O
after IN O
giving VBG O
a DT O
single JJ O
i NN O
.v. VBD O
dose NN O
of IN O
4 CD O
mg.kg-1 CD O
to TO O
ten CD O
healthy JJ O
male JJ O
volunteers NNS O
. . O

-DOCSTART- X X O

DNA NNP O
blot NN O
hybridization NN O
suggests VBZ O
that IN O
the DT O
rat NN O
genome NN O
may MD O
contain VB O
more JJR O
than IN O
one CD O
gene NN O
encoding VBG O
PtdIns NNS B-NP
transfer VB I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Another DT O
segment NN O
of IN O
CRL3 NNP B-NP
(-296 CD O
to TO O
-184 CD O
) -RRB- O
, , O
also RB O
displaying VBG O
enhancer NN O
function NN O
, , O
contained VBD O
tandem NN O
repeated VBN O
sequences NNS O
( -LRB- O
DR-A1 NN O
and CC O
DR-A2 NN O
) -RRB- O
. . O

-DOCSTART- X X O

1-(1-Naphthyl)piperazine JJ O
(1-NP JJ O
) -RRB- O
has VBZ O
been VBN O
reported VBN O
to TO O
have VB O
serotonin NN O
antagonist NN O
properties NNS O
at IN O
the DT O
5-HT2 JJ B-NP
subtype NN I-NP
of IN O
receptor NN O
, , O
and CC O
it PRP O
has VBZ O
been VBN O
suggested VBN O
that IN O
it PRP O
may MD O
have VB O
agonist JJ O
actions NNS O
at IN O
the DT O
5-HT1 JJ B-NP
site NN I-NP
. . O

-DOCSTART- X X O

The DT O
characteristic JJ O
feature NN O
of IN O
liver NN O
and CC O
spleen JJ O
MP NNP O
function NN O
in IN O
patients NNS O
with IN O
VHA NNP O
associated VBN O
with IN O
HBsAg NNP B-NP
carriership NN O
consisted VBD O
in IN O
the DT O
lack NN O
of IN O
the DT O
compensatory JJ O
reaction NN O
on IN O
the DT O
part NN O
of IN O
spleen JJ O
MP NNP O
, , O
which WDT O
was VBD O
likely JJ O
to TO O
be VB O
connected VBN O
with IN O
overstrain NN O
of IN O
long JJ O
standing NN O
and CC O
depletion NN O
of IN O
the DT O
MP NNP O
system NN O
due JJ O
to TO O
permanent JJ O
antigenic JJ O
stimulation NN O
of IN O
HBsAg NNP B-NP
. . O

-DOCSTART- X X O

A DT O
soap NN O
and CC O
water NN O
( -LRB- O
1:1 CD O
, , O
v/v NN O
) -RRB- O
solution NN O
effectively RB O
decontaminated VBD O
powdered VBN O
stratum NN O
corneum NN O
. . O

-DOCSTART- X X O

Histiocytic JJ O
panniculitis NN O
was VBD O
observed VBN O
in IN O
biopsy JJ O
specimens NNS O
with IN O
cytophagocytosis NN O
. . O

-DOCSTART- X X O

Electrocardiographic JJ O
right JJ O
ventricular NN O
hypertrophy NN O
was VBD O
seen VBN O
in IN O
4 CD O
, , O
and CC O
biventricular JJ O
hypertrophy NN O
in IN O
5 CD O
patients NNS O
. . O

-DOCSTART- X X O

Sequencing VBG O
analysis NN O
revealed VBN O
that IN O
the DT O
0.54- CD O
and CC O
0.4-kb JJ O
fragments NNS O
are VBP O
identical JJ O
except IN O
for IN O
150 CD O
nucleotides NNS O
missing VBG O
at IN O
the DT O
5' JJ O
region NN O
of IN O
the DT O
0.4-kb JJ O
fragment NN O
. . O

-DOCSTART- X X O

The DT O
mature JJ O
protein NN O
also RB O
contains VBZ O
a DT O
cysteine-rich JJ O
, , O
highly RB O
hydrophilic JJ O
region NN O
homologous NN O
to TO O
the DT O
ovomucoid JJ B-NP
serine NN I-NP
protease NN I-NP
inhibitors NNS I-NP
( -LRB- O
residues NNS O
76-132 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Within IN O
each DT O
lobe NN O
, , O
the DT O
PA NNP O
dispersion NN O
was VBD O
up IN O
to TO O
10 CD O
cmH2O CD O
at IN O
CFV NNP O
of IN O
90 CD O
l/min NN O
; : O
when WRB O
flow NN O
decreased VBD O
, , O
PA NNP O
at IN O
all DT O
sites NNS O
decreased VBD O
, , O
as IN O
did VBD O
the DT O
intralobar NN O
dispersion NN O
. . O

-DOCSTART- X X O

The DT O
system NN O
consisted VBD O
of IN O
the DT O
intact JJ O
canine CD O
heart NN O
connected VBN O
to TO O
a DT O
microcomputer NN O
that WDT O
operated VBD O
as IN O
the DT O
modulated JJ O
parasystolic JJ O
pacemaker NN O
. . O

-DOCSTART- X X O

In IN O
order NN O
to TO O
identify VB O
and CC O
classify VB O
the DT O
basic JJ O
CT NN O
appearances NNS O
of IN O
interstitial JJ O
pneumonia NN O
, , O
radiologic NN O
-pathologic NN O
correlative JJ O
study NN O
was VBD O
performed VBN O
using VBG O
inflated JJ O
and CC O
fixed VBN O
lungs NNS O
from IN O
autopsy NN O
and CC O
surgery NN O
. . O

-DOCSTART- X X O

The DT O
disease NN O
ran VBD O
an DT O
atypical JJ O
course NN O
; : O
with IN O
early JJ O
jaundice NN O
syndrome NN O
, , O
severe JJ O
enterorrhagia NN O
and CC O
late JJ O
appearance NN O
of IN O
roseola NN O
. . O

-DOCSTART- X X O

The DT O
transcription NN O
factor NN O
Sp1 NNP B-NP
bound VBD O
to TO O
eight CD O
sites NNS O
, , O
as IN O
demonstrated VBN O
by IN O
footprinting VBG O
assays . O
and CC O
gel JJ O
shift NN O
analysis NN O
with IN O
purified VBN O
Sp1 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
combination NN O
PIP NNP O
64 CD O
micrograms NNS O
- : O
PEF NN O
4 CD O
micrograms NNS O
prevents VBZ O
the DT O
frequent JJ O
secondary JJ O
regrowth NN O
seen VBN O
after IN O
6 CD O
hours NNS O
with IN O
the DT O
antibiotics NNS O
used VBN O
alone RB O
. . O

-DOCSTART- X X O

With IN O
a DT O
sample NN O
of IN O
mothers NNS O
of IN O
healthy JJ O
infants NNS O
, , O
all DT O
three CD O
subscales NNS O
of IN O
the DT O
revised VBN O
instrument NN O
, , O
WPL-R NNP O
, , O
had VBD O
acceptable JJ O
levels NNS O
of IN O
internal JJ O
consistency NN O
at IN O
7 CD O
, , O
30 CD O
, , O
and CC O
90 CD O
days NNS O
postpartum NN O
, , O
and CC O
stability NN O
across IN O
administrations NNS O
. . O

-DOCSTART- X X O

Acute JJ O
experiments NNS O
on IN O
nembutal-anesthetized JJ O
cats NNS O
( -LRB- O
50 CD O
mg/kg NN O
) -RRB- O
were VBD O
employed VBN O
to TO O
investigate VB O
the DT O
effect NN O
of IN O
1 CD O
T NNP O
pulsating VBG O
magnetic JJ O
field NN O
( -LRB- O
PMF) NNP O
on IN O
neuromuscular JJ O
system NN O
of IN O
the DT O
leg NN O
. . O

-DOCSTART- X X O

No DT O
significant JJ O
differences NNS O
were VBD O
found VBN O
between IN O
the DT O
TS NNS O
and CC O
the DT O
PTS. NNP O

-DOCSTART- X X O

A DT O
genomic JJ O
DNA NNP O
clone NN O
encoding NN O
oryzacystatin NN B-NP
( -LRB- O
Oc NNP B-NP
) -RRB- O
, , O
a DT O
cysteine NN B-NP
proteinase NN I-NP
inhibitor NN O
( -LRB- O
cystatin NN B-NP
) -RRB- O
of IN O
rice NN O
, , O
was VBD O
isolated VBN O
from IN O
a DT O
lambda NN O
EMBL3 NN O
phage NN O
library NN O
constructed VBN O
with IN O
Sau3AI JJ B-NP
partial JJ O
digests NNS O
of IN O
rice NN O
chromosomal NN O
DNA NN O
, , O
by IN O
screening VBG O
with IN O
an DT O
oc NN B-NP
cDNA NN I-NP
as IN O
a DT O
probe NN O
. . O

-DOCSTART- X X O

The DT O
use NN O
of IN O
an DT O
appropriate JJ O
solution NN O
of IN O
methylene NN O
blue JJ O
( -LRB- O
0.2 CD O
% NN O
in IN O
0.9 CD O
M NNP O
NaCl NNP O
for IN O
15 CD O
min NN O
) -RRB- O
permits VBZ O
the DT O
staining NN O
of IN O
premalignant JJ O
areas NNS O
and CC O
CIS NNP O
, , O
and CC O
their PRP$ O
early JJ O
diagnosis NN O
. . O

-DOCSTART- X X O

Lower JJR O
limits NNS O
( -LRB- O
to TO O
10 CD O
micrograms/kg NN O
) -RRB- O
were VBD O
detectable JJ O
, , O
but CC O
with IN O
lower JJR O
reliability NN O
(60 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Instead RB O
, , O
some DT O
small JJ O
negative JJ O
effects NNS O
are VBP O
observed VBN O
, , O
particularly RB O
involving VBG O
effects NNS O
of IN O
husbands NNS O
' POS O
retirement NN O
on IN O
the DT O
marital JJ O
satisfaction NN O
of IN O
employed VBN O
wives NNS O
. . O

-DOCSTART- X X O

In IN O
one CD O
acromegalic JJ O
patient NN O
visual JJ O
improvement NN O
was VBD O
obtained VBN O
while IN O
the DT O
abnormal JJ O
GH NNP B-NP
secretion NN O
remained VBD O
unaltered JJ O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
PPSF NNP O
+ NNP O
DBP NNP O
side NN O
showed VBD O
large JJ O
amounts NNS O
of IN O
bone NN O
formation NN O
, , O
and CC O
bone NN O
almost RB O
covered VBD O
the DT O
implant NN O
. . O

-DOCSTART- X X O

Immunohistochemical NNP O
studies NNS O
revealed VBD O
positive JJ O
staining NN O
for IN O
S100 DT B-NP
protein NN I-NP
in IN O
all DT O
the DT O
granular JJ O
cell NN O
tumors NNS O
of IN O
the DT O
adult NN O
but CC O
in IN O
none NN O
of IN O
the DT O
congenital NN O
granular JJ O
cell NN O
epulides NNS O
. . O

-DOCSTART- X X O

Pacing VBG O
the DT O
Roux NNP O
limb NN O
abolished VBD O
the DT O
ectopic JJ O
pacemakers NNS O
, , O
restored VBD O
the DT O
slow JJ O
emptying NN O
of IN O
liquids NNS O
to TO O
the DT O
more RBR O
rapid JJ O
rate NN O
found VBD O
in IN O
the DT O
Billroth JJ O
dogs NNS O
( -LRB- O
t1/2 NN O
: : O
paced VBD O
Roux NNP O
, , O
72 CD O
+/ NN O
- : O
15 CD O
minutes NNS O
; : O
Billroth NNP O
, , O
43 CD O
+/ NNS O
- : O
9 CD O
minutes NNS O
; : O
p VB O
greater JJR O
than IN O
0.05 CD O
) -RRB- O
and CC O
did VBD O
not RB O
change VB O
emptying VBG O
of IN O
solids NNS O
. . O

-DOCSTART- X X O

The DT O
treatments NNS O
were VBD O
60 CD O
mg NN O
t.i.d NN O
. . O
and CC O
120 CD O
mg NN O
t.i.d NN O
. . O
during IN O
14 CD O
days NNS O
' POS O
treatment NN O
, , O
with IN O
the DT O
last JJ O
dose NN O
pulsed VBD O
with IN O
1.85 CD O
MBq NNP O
[14C]diltiazem NNP O
. . O

-DOCSTART- X X O

A DT O
great JJ O
deal NN O
of IN O
information NN O
is VBZ O
available JJ O
on IN O
the DT O
morphology NN O
of IN O
the DT O
claustrum NN O
in IN O
various JJ O
animal NN O
species NNS O
, , O
as RB O
well RB O
as IN O
on IN O
its PRP$ O
neuronal JJ O
distribution NN O
and CC O
relationships NNS O
with IN O
the DT O
cerebral JJ O
cortex NN O
and CC O
other JJ O
nuclei NNS O
. . O

-DOCSTART- X X O

Low-grade NNP O
glioma NN O
. . O

-DOCSTART- X X O

In IN O
terms NNS O
of IN O
sequence NN O
repetitions NNS O
, , O
seven CD O
tandemly , O
repeated VBN O
copies NNS O
of IN O
the DT O
hexanucleotide NN O
ATTGTT NNP O
and CC O
three CD O
flanking NN O
regions NNS O
of IN O
dyad NN O
symmetry NN O
were VBD O
detected VBN O
, , O
all DT O
in IN O
ORF NNP O
T3C. . O

-DOCSTART- X X O

7. . O

-DOCSTART- X X O

These DT O
data NNS O
suggest VBP O
that IN O
the DT O
G-protein NNP B-NP
gene NN I-NP
family NN I-NP
may MD O
be VB O
distributed VBN O
over IN O
at IN O
least JJS O
two CD O
human JJ O
chromosomes NNS O
. . O

-DOCSTART- X X O

In IN O
44 CD O
evaluable NN O
patients NNS O
the DT O
response NN O
rate NN O
was VBD O
50 CD O
% NN O
, , O
with IN O
one CD O
complete JJ O
response NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
also RB O
found VBN O
that IN O
the DT O
in IN O
vitro NN O
interaction NN O
between IN O
the DT O
SV40 NNP O
octamer NN O
motif NN O
and CC O
the DT O
lymphoid NN B-NP
cell-specific JJ I-NP
protein NN I-NP
oct-B2 NN I-NP
was VBD O
negatively RB O
modulated VBN O
by IN O
a DT O
component NN O
present NN O
in IN O
the DT O
nuclear JJ O
extracts NNS O
from IN O
several JJ O
lymphoid JJ O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

Growth NN O
, , O
4-PA JJ O
and CC O
14C JJ O
turnover NN O
data NNS O
indicated VBD O
that IN O
WB NNP O
contributed VBD O
to TO O
B-6 DT O
intake NN O
of IN O
these DT O
rats NNS O
. . O

-DOCSTART- X X O

DNA NNP O
sequence NN O
analysis NN O
revealed VBN O
that IN O
these DT O
clones NNS O
encode VBP O
two CD O
distinct JJ O
forms NNS O
of IN O
translocase NN B-NP
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
acetazolamide JJ O
(ACZ NN O
) -RRB- O
on IN O
HCO3- NNP O
and CC O
Cl- NNP O
activities NNS O
in IN O
inner JJ O
ear NN O
fluid NN O
was VBD O
investigated VBN O
by IN O
ion-selective JJ O
microelectrode NN O
methods NNS O
. . O

-DOCSTART- X X O

These DT O
offspring NN O
of IN O
the DT O
alpha-MSH NNS B-NP
treated VBN O
mothers NNS O
were VBD O
less RBR O
sensitive JJ O
to TO O
pain NN O
and CC O
as IN O
adults NNS O
showed VBD O
a DT O
reduced JJ O
analgesic JJ O
response NN O
to TO O
morphine NN O
. . O

-DOCSTART- X X O

Simian NNP O
immunodeficiency NN O
virus NN O
( -LRB- O
SIV NNP O
) -RRB- O
is VBZ O
a DT O
lentivirus NN O
with IN O
morphological JJ O
and CC O
antigenic JJ O
similarities NNS O
to TO O
human JJ O
immunodeficiency NN O
virus NN O
, , O
the DT O
causative JJ O
agent NN O
of IN O
acquired VBN O
immunodeficiency NN O
syndrome NN O
( -LRB- O
AIDS NNP O
) -RRB- O
of IN O
humans NNS O
. . O

-DOCSTART- X X O

The DT O
lack NN O
of IN O
change NN O
in IN O
the DT O
ratio NN O
of IN O
the DT O
two CD O
spliced JJ O
products NNS O
expressed VBN O
from IN O
either RB O
the DT O
normal JJ O
or CC O
the DT O
5'-rearranged JJ B-NP
myb NN I-NP
further RB O
indicates VBZ O
that IN O
the DT O
insertion NN O
of IN O
the DT O
unique JJ O
121 CD O
amino IN O
acids NNS O
in IN O
the DT O
larger JJR O
myb NN B-NP
transcripts NNS I-NP
is VBZ O
not RB O
a DT O
consequence NN O
of IN O
tumor-specific JJ O
activation NN O
of IN O
the DT O
mouse NN B-NP
myb NN I-NP
oncogene NN I-NP
. . O

-DOCSTART- X X O

The DT O
use NN O
of IN O
CRF-41 NNP B-NP
in IN O
the DT O
differential JJ O
diagnosis NN O
of IN O
Cushing NNP O
's POS O
syndrome NN O
and CC O
obesity NN O
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
L NNP B-NP
mRNA . I-NP
was VBD O
6398 CD O
nucleotides NNS O
long RB O
and CC O
contained VBD O
a DT O
single JJ O
open JJ O
reading NN O
frame NN O
corresponding JJ O
to TO O
an DT O
L NNP B-NP
protein NN I-NP
encompassing VBG I-NP
2109 CD I-NP
amino IN I-NP
acids NNS I-NP
with IN O
a DT O
MW NNP O
of IN O
241,546 CD O
. . O

-DOCSTART- X X O

The DT O
results NNS O
suggest VBP O
that IN O
the DT O
organization NN O
of IN O
functional JJ O
units NNS O
of IN O
the DT O
72-bp JJ O
repeat NN O
required VBN O
for IN O
transcriptional JJ O
enhancement NN O
of IN O
the DT O
early JJ O
promoter NN O
is VBZ O
different JJ O
from IN O
that DT O
required VBN O
for IN O
late JJ O
promoter NN O
function NN O
. . O

-DOCSTART- X X O

Variations NNS O
in IN O
the DT O
5' JJ O
half NN O
of IN O
U3 NNP O
were VBD O
primarily RB O
due JJ O
to TO O
insertions NNS O
and CC O
deletions NNS O
. . O

-DOCSTART- X X O

Either CC O
two CD O
or CC O
more JJR O
different JJ O
sequences NNS O
can MD O
promote VB O
cleavage JJ O
, , O
or CC O
a DT O
single JJ O
element NN O
exists VBZ O
which WDT O
is VBZ O
long JJ O
and CC O
diffuse JJ O
. . O

-DOCSTART- X X O

The DT O
bactericidal JJ O
activity NN O
of IN O
six CD O
new JJ O
rifamycin JJ O
derivatives--rifabutin NN O
( -LRB- O
RBU) NNP O
, , O
FCE NNP O
22250 CD O
( -LRB- O
F22 NN O
) -RRB- O
, , O
rifapentine JJ O
( -LRB- O
RPE) NN O
, , O
CGP NNP O
29861 CD O
( -LRB- O
C29 IN O
) -RRB- O
, , O
CGP NNP O
7040 CD O
( -LRB- O
C70 NN O
) -RRB- O
and CC O
CGP NNP O
27557 CD O
( -LRB- O
C27 NN O
) -RRB- O
and CC O
rifampicin JJ O
( -LRB- O
RMP)--have JJ O
been VBN O
measured VBN O
against IN O
log NN O
phase NN O
and CC O
, , O
as IN O
a DT O
better JJR O
test NN O
of IN O
sterilising NN O
activity NN O
, , O
against IN O
stationary JJ O
phase NN O
cultures NNS O
of IN O
Mycobacterium NNP O
tuberculosis NN O
, , O
H37Rv. . O

-DOCSTART- X X O

Mo NNP O
+ NNP O
SV NNP O
M-MuLV-inoculated NNP O
animals NNS O
became VBD O
moribund JJ O
at IN O
3 CD O
to TO O
13 CD O
months NNS O
postinoculation NN O
, , O
whereas IN O
delta JJ O
Mo NNP O
+ NNP O
SV NNP O
M-MuLV-inoculated NNP O
animals NNS O
became VBD O
moribund JJ O
at IN O
6 CD O
to TO O
24 CD O
months NNS O
postinoculation NN O
. . O

-DOCSTART- X X O

Amino NNP O
acid NN O
sequence NN O
of IN O
one CD O
human JJ O
liver NN O
clone NN O
( -LRB- O
HL-14 NN O
) -RRB- O
was VBD O
identical JJ O
to TO O
the DT O
rabbit NN B-NP
skeletal NN I-NP
muscle NN I-NP
phosphatase NN I-NP
2A IN I-NP
cDNA NN I-NP
( -LRB- O
with IN O
97 CD O
% NN O
nucleotide JJ O
identity NN O
) -RRB- O
. . O

-DOCSTART- X X O

Herpes NNP O
virus NN O
infection NN O
was VBD O
characterized VBN O
by IN O
inversion NN O
of IN O
the DT O
T4/T8 CD O
ratio NN O
below IN O
1.0 CD O
( -LRB- O
sensitivity NN O
90 CD O
% NN O
, , O
specificity RB O
88 CD O
% NN O
) -RRB- O
, , O
caused VBN O
by IN O
proliferation NN O
of IN O
the DT O
T8 CD O
subpopulation NN O
, , O
which--compared VBD O
with IN O
the DT O
findings NNS O
in IN O
patients NNS O
with IN O
rejection NN O
crises--was NNS O
significantly RB O
raised VBD O
( -LRB- O
P NNP O
less RBR O
than IN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
levels NNS O
of IN O
NPY-ir NN B-NP
in IN O
the DT O
rat NN O
vas NNS O
deferens NNS O
were VBD O
not RB O
affected VBN O
by IN O
either DT O
surgical JJ O
or CC O
pharmacological JJ O
treatment NN O
. . O

-DOCSTART- X X O

The DT O
mechanism NN O
by IN O
which WDT O
E2-C JJ B-NP
represses NNS O
E2-dependent JJ B-NP
enhancer NN I-NP
activity NN O
most RBS O
likely JJ O
involves VBZ O
competition NN O
with IN O
E2 NNP B-NP
for IN O
binding NN O
to TO O
a DT O
common JJ O
transcriptional JJ O
regulatory JJ O
site NN O
.(ABSTRACT . O
TRUNCATED JJ O
AT WDT O
400 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

Accurate NNP O
evaluation NN O
of IN O
the DT O
treatment NN O
results NNS O
in IN O
unresectable JJ O
lung NN O
cancer NN O
patients NNS O
must MD O
take VB O
the DT O
strong JJ O
prognostic JJ O
factors NNS O
into IN O
account NN O
. . O

-DOCSTART- X X O

( -LRB- O
anti-IIa DT B-NP
) -RRB- O
and CC O
Holmer NNP O
et NNP O
al NN O
. . O

-DOCSTART- X X O

Introduction NN O
of IN O
v-fms NNS B-NP
into IN O
a DT O
CSF-1 JJ B-NP
dependent JJ O
murine NN O
macrophage NN O
cell NN O
line NN O
induced VBN O
factor NN O
independence NN O
and CC O
tumorigenicity NN O
by IN O
a DT O
nonautocrine NN O
mechanism NN O
. . O

-DOCSTART- X X O

The DT O
primary JJ O
structure NN O
and CC O
cotranscription NN O
of IN O
the DT O
petCA NN B-NP
genes NNS I-NP
encoding VBG O
the DT O
Rieske-FeS NNP B-NP
( -LRB- O
nuclear JJ B-NP
encoded VBN I-NP
in IN I-NP
plants NNS I-NP
) -RRB- O
and CC O
apocytochrome VB B-NP
f NN I-NP
proteins NNS I-NP
has VBZ O
been VBN O
described VBN O
previously RB O
( -LRB- O
Kallas NNP O
, , O
T. NNP O
, , O
Spiller NNP O
, , O
S. NNP O
, , O
and CC O
Malkin NNP O
, , O
R. NNP O

-DOCSTART- X X O

The DT O
Nostoc NNP O
petBD NN B-NP
genes NNS I-NP
are VBP O
not RB O
closely RB O
linked VBN O
to TO O
the DT O
psbB NN B-NP
gene NN I-NP
( -LRB- O
encoding VBG O
the DT O
51-kDa JJ O
photosystem NN B-NP
II NNP I-NP
polypeptide NN I-NP
) -RRB- O
and CC O
do VB O
not RB O
contain VB O
introns NNS O
as RB O
do VBP O
the DT O
closely RB O
related VBN O
chloroplast NN O
genes NNS O
. . O

-DOCSTART- X X O

Whereas IN O
the DT O
muscle NN O
isoform NN O
consists VBZ O
of IN O
997 CD O
amino IN O
acids NNS O
and CC O
terminates NNS O
with IN O
the DT O
sequence NN O
Ala-Ile-Leu-Glu NNP O
, , O
the DT O
second JJ O
isoform NN O
is VBZ O
1043 CD O
amino IN O
acids NNS O
in IN O
length NN O
due JJ O
to TO O
the DT O
replacement NN O
of IN O
these DT O
last JJ O
4 CD O
amino IN O
acids NNS O
with IN O
a DT O
50-amino JJ O
acid NN O
sequence NN O
that WDT O
contains VBZ O
a DT O
potential JJ O
transmembrane NN O
domain NN O
followed VBN O
by IN O
a DT O
consensus NN O
sequence NN O
for IN O
an DT O
N-linked JJ O
glycosylation NN O
site NN O
. . O

-DOCSTART- X X O

Substitution NNP O
of IN O
a DT O
threonine CD O
residue NN O
by IN O
an DT O
alanine JJR O
residue NN O
at IN O
position NN O
-2 RB O
( -LRB- O
P2 NN O
) -RRB- O
of IN O
this DT O
cleavage JJ O
site NN O
abolished VBD O
cleavage JJ O
, , O
whereas IN O
substitution NN O
of IN O
a DT O
tyrosine NN O
residue NN O
by IN O
a DT O
phenylalanine NN O
residue NN O
at IN O
amino DT O
acid NN O
position NN O
-1 NN O
( -LRB- O
P1 NNP O
) -RRB- O
of IN O
the DT O
cleavage JJ O
site NN O
did VBD O
not RB O
influence NN O
processing NN O
. . O

-DOCSTART- X X O

One CD O
of IN O
these DT O
, , O
the DT O
origin NN O
core NN O
, , O
is VBZ O
required VBN O
only RB O
for IN O
DNA NNP O
replication NN O
. . O

-DOCSTART- X X O

A DT O
17-mer JJ O
oligodeoxynucleotide JJ O
, , O
corresponding JJ O
to TO O
a DT O
region NN O
of IN O
the DT O
VtHb NNP B-NP
amino IN I-NP
acid NN I-NP
sequence NN I-NP
was VBD O
used VBN O
as IN O
a DT O
hybridization NN O
probe NN O
to TO O
screen VB O
a DT O
Vitreoscilla NNP O
genomic JJ O
library NN O
constructed VBN O
in IN O
broad-host-range JJ O
cosmid JJ O
vector NN O
pVK102 NN O
. . O

-DOCSTART- X X O

( -LRB- O
total NN O
soluble JJ O
solids NNS O
) -RRB- O
and CC O
organoleptic JJ O
characteristics NNS O
under IN O
the DT O
influence NN O
of IN O
different JJ O
treatments NNS O
. . O

-DOCSTART- X X O

The DT O
progression NN O
of IN O
non-A JJ O
, , O
non-B JJ O
hepatitis NN O
to TO O
chronic JJ O
diseases NNS O
, , O
and CC O
the DT O
transformation NN O
to TO O
hepatocellular JJ O
carcinoma NN O

-DOCSTART- X X O

Elevated NNP O
IOP NNP O
developed VBD O
in IN O
35 CD O
patients NNS O
( -LRB- O
44 CD O
eyes NNS O
) -RRB- O
during IN O
the DT O
study NN O
. . O

-DOCSTART- X X O

Poor JJ O
response NN O
when WRB O
laboratory NN O
recommended VBD O
range NN O
for IN O
serum NN O
lithium NN O
is VBZ O
changed VBN O
. . O

-DOCSTART- X X O

Further JJ O
analysis NN O
of IN O
this DT O
DNA NN O
fragment NN O
showed VBD O
that IN O
four CD O
genes NNS O
are VBP O
present JJ O
encoding JJ O
proteins NNS O
of IN O
16 CD O
, , O
18.5 CD O
, , O
21 CD O
and CC O
89 CD O
kDal NN O
. . O

-DOCSTART- X X O

Hantaan NNP O
virus NN O
. . O

-DOCSTART- X X O

Replacement NNP B-NP
variant NN I-NP
histone NN I-NP
genes NNS I-NP
contain VBP O
intervening VBG O
sequences NNS O
. . O

-DOCSTART- X X O

Double-blind NNP O
randomised VBD O
trial NN O
of IN O
intravenous JJ O
tissue-type NN B-NP
plasminogen NN I-NP
activator NN I-NP
versus NN O
placebo NN O
in IN O
acute JJ O
myocardial JJ O
infarction NN O
. . O

-DOCSTART- X X O

Intravesical NNP O
chemotherapy NN O
. . O

-DOCSTART- X X O

Bisoprolol NNP O
was VBD O
found VBN O
to TO O
be VB O
an DT O
effective JJ O
beta-adrenoceptor NN B-NP
antagonist NN O
, , O
the DT O
pA2 NN O
values NNS O
determined VBN O
against IN O
isoprenaline NN O
in IN O
guinea NN O
pig NN O
atria NN O
and CC O
tracheal NN O
muscle NN O
being VBG O
7.45 CD O
and CC O
6.41 CD O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Output NN O
of IN O
99mTcO-4 JJ O
by IN O
the DT O
parotid JJ O
gland NN O
closely RB O
mimicked JJ O
fluctuations NNS O
in IN O
parotid NN O
saliva NN O
flow NN O
rate NN O
. . O

-DOCSTART- X X O

The DT O
Hagen-Poiseuille JJ O
equation NN O
is VBZ O
used VBN O
to TO O
assess VB O
the DT O
effects NNS O
of IN O
attached VBN O
parasites NNS O
in IN O
the DT O
foregut NN O
of IN O
Leishmania-infected JJ O
sandflies NNS O
on IN O
blood NN O
flow NN O
. . O

-DOCSTART- X X O

An DT O
endometrial JJ O
luteal NN O
phase NN O
deficiency NN O
was VBD O
detected VBN O
in IN O
15 CD O
( -LRB- O
30 CD O
% NN O
) -RRB- O
of IN O
aborting NN O
patients NNS O
. . O

-DOCSTART- X X O

Prenatal JJ O
exposure NN O
to TO O
the DT O
fungicide NN O
dinocap NN O
causes VBZ O
behavioral JJ O
torticollis NNS O
, , O
ballooning NN O
and CC O
cleft NN O
palate NN O
in IN O
mice NNS O
, , O
but CC O
not RB O
rats NNS O
or CC O
hamsters NNS O
. . O

-DOCSTART- X X O

The DT O
sensitivity NN O
of IN O
the DT O
vas NNS O
deferens NNS O
to TO O
adrenaline NN O
was VBD O
also RB O
reduced VBN O
in IN O
scorbutic JJ O
guinea NN O
pigs NNS O
, , O
thus RB O
decreasing VBG O
their PRP$ O
fertility NN O
rate NN O
. . O

-DOCSTART- X X O

In IN O
metabolic JJ O
acidosis NN O
there EX O
was VBD O
a DT O
marked JJ O
stimulation NN O
when WRB O
clamped VBN O
at IN O
-10 JJ O
to TO O
-100 DT O
mV NN O
. . O

-DOCSTART- X X O

Present DT O
results NNS O
reveal VBP O
a DT O
frequency-dependent JJ O
inhibition NN O
of IN O
ganglionic JJ O
transmission NN O
by IN O
diltiazem NN O
, , O
and CC O
suggest VBP O
that IN O
diltiazem NN O
may MD O
depress VB O
excessive JJ O
sympathetic JJ O
activity NN O
without IN O
affecting VBG O
normal JJ O
ganglionic JJ O
transmission NN O
. . O

-DOCSTART- X X O

Body NNP O
temperature NN O
and CC O
overall JJ O
conductance NN O
in IN O
the DT O
cold NN O
appear VBP O
to TO O
be VB O
more JJR O
variable JJ O
in IN O
P. NNP O
s VBZ O
. . O
campbelli CC O
than IN O
in IN O
nominative JJ O
sp. NN O

-DOCSTART- X X O

Two CD O
polyadenylation NN O
sites NNS O
were VBD O
used VBN O
, , O
one CD O
at IN O
the DT O
end NN O
of IN O
the DT O
early JJ B-NP
( -LRB- I-NP
E NNP I-NP
) -RRB- I-NP
region NN I-NP
of IN O
the DT O
viral JJ O
DNA NN O
, , O
the DT O
other JJ O
at IN O
the DT O
end NN O
of IN O
the DT O
late JJ B-NP
( -LRB- I-NP
L NNP I-NP
) -RRB- I-NP
region NN I-NP
. . O

-DOCSTART- X X O

A DT O
drug NN O
with IN O
ISA NNP O
"down NN O
regulates VBZ O
" `` O
beta JJ B-NP
receptors NNS I-NP
; : O
thus RB O
, , O
when WRB O
the DT O
drug NN O
is VBZ O
withdrawn VBN O
there EX O
is VBZ O
no DT O
post-beta-blocking JJ O
drug NN O
hypersensitivity NN O
in IN O
contrast NN O
to TO O
agents NNS O
without IN O
ISA NNP O
. . O

-DOCSTART- X X O

Terazosin NNP O
, , O
a DT O
structural JJ O
analog NN O
of IN O
prazosin NN O
, , O
also RB O
inhibits VBZ O
alpha NN B-NP
1 CD I-NP
adrenoceptors NNS I-NP
and CC O
is VBZ O
recommended VBN O
as IN O
once RB O
or CC O
twice-daily RB O
therapy NN O
. . O

-DOCSTART- X X O

Testing VBG O
blood NN O
donors NNS O
for IN O
non-A JJ O
, , O
non-B JJ O
hepatitis NN O
: : O
irrational JJ O
, , O
perhaps RB O
, , O
but CC O
inescapable JJ O
. . O

-DOCSTART- X X O

In IN O
a DT O
randomised JJ O
double-blind JJ O
study NN O
, , O
46 CD O
first JJ O
episode NN O
schizophrenics NNS O
were VBD O
given VBN O
pimozide NN O
or CC O
flupenthixol NN O
for IN O
up RB O
to TO O
5 CD O
weeks NNS O
; : O
the DT O
mean JJ O
daily JJ O
dose NN O
at IN O
the DT O
end NN O
was VBD O
18.8 CD O
mg NN O
pimozide NN O
and CC O
20 CD O
mg JJ O
flupenthixol NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
been VBN O
able JJ O
to TO O
map NN O
specific JJ O
DNA NN O
fragments NNS O
at IN O
the DT O
bases NNS O
of IN O
chromatin NN O
loops NNS O
with IN O
the DT O
help NN O
of IN O
a DT O
novel NN O
extraction NN O
procedure NN O
by IN O
using VBG O
lithium-3', JJ O
5'-diiodosalicylate JJ O
. . O

-DOCSTART- X X O

Finally RB O
, , O
the DT O
recovery NN O
indexes NNS O
represented VBN O
by IN O
the DT O
times NNS O
required VBN O
for IN O
T1/T0 NNP O
and CC O
T4/T1 NNP O
to TO O
rise VB O
from IN O
25 CD O
% NN O
to TO O
75 CD O
% NN O
respectively RB O
were VBD O
studied VBN O
. . O

-DOCSTART- X X O

DPA NNP O
attenuated VBD O
the DT O
increase NN O
of IN O
the DT O
intensity NN O
of IN O
the DT O
ischemic JJ O
and CC O
pressure NN O
pain NN O
components NNS O
with IN O
increasing VBG O
ischemia NN O
duration NN O
, , O
but CC O
only RB O
the DT O
effect NN O
on IN O
the DT O
pressure NN O
pain NN O
component NN O
was VBD O
significant JJ O
. . O

-DOCSTART- X X O

Topical NNP O
1 CD O
percent NN O
isoproterenol NN O
in IN O
the DT O
presence NN O
of IN O
the DT O
phosphodiesterase NN O
inhibitor IN O
theophylline NN O
was VBD O
tested VBN O
for IN O
its PRP$ O
ability NN O
to TO O
stimulate VB O
the DT O
rate NN O
of IN O
aqueous JJ O
humor NN O
flow NN O
through IN O
the DT O
anterior JJ O
chamber NN O
of IN O
the DT O
normal JJ O
and CC O
the DT O
partially RB O
adrenergically RB O
denervated VBN O
human JJ O
eye NN O
( -LRB- O
Horner NNP O
's POS O
syndrome NN O
) -RRB- O
. . O

-DOCSTART- X X O

Hyperthyroidism NNP O
is VBZ O
one CD O
of IN O
the DT O
numerous JJ O
causes NNS O
of IN O
infertility NN O
and CC O
recurrent JJ O
abortion NN O
. . O

-DOCSTART- X X O

A DT O
strong JJ O
correlation NN O
exists VBZ O
between IN O
the DT O
numbers NNS O
of IN O
CFU-GM NNP O
transfused VBD O
and CC O
the DT O
rate NN O
of IN O
granulocytes NNS O
and CC O
platelets NNS O
recovery NN O
. . O

-DOCSTART- X X O

We PRP O
propose VBP O
that IN O
the DT O
technique NN O
of IN O
low-frequency NN O
kindling NN O
is VBZ O
a DT O
useful JJ O
experimental JJ O
model NN O
in IN O
assessing VBG O
the DT O
effects NNS O
of IN O
antipsychotic JJ O
or CC O
antiepileptic JJ O
drugs NNS O
on IN O
the DT O
excitability NN O
of IN O
the DT O
limbic JJ O
regions NNS O
. . O

-DOCSTART- X X O

Three CD O
sequence NN O
elements NNS O
are VBP O
shown VBN O
to TO O
be VB O
required VBN O
for IN O
accurate JJ O
and CC O
efficient JJ O
transcription NN O
termination NN O
by IN O
RNA NNP B-NP
polymerase NN I-NP
I PRP I-NP
( -LRB- O
pol NN B-NP
I PRP I-NP
) -RRB- O
assayed VBD O
both DT O
in IN O
a DT O
cell-free JJ O
transcription NN O
system NN O
and CC O
in IN O
vivo RB O
after IN O
transfection NN O
of IN O
rDNA NNP O
minigene NN O
constructs NNS O
into IN O
3T6 CD O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
biosynthesis NN O
and CC O
stability NN O
of IN O
the DT O
three CD O
mutant JJ O
proteins NNS O
were VBD O
similar JJ O
to TO O
those DT O
of IN O
the DT O
wild-type JJ B-NP
erbB NN I-NP
protein NN I-NP
, , O
and CC O
all DT O
three CD O
retained VBD O
the DT O
ability NN O
to TO O
transform VB O
chicken NN O
embryo NN O
fibroblasts NNS O
. . O

-DOCSTART- X X O

A DT O
new JJ O
physiopathological JJ O
treatment NN O
of IN O
HBV-related JJ O
polyarteritis NN O
inspired VBN O
by IN O
advances NNS O
in IN O
the DT O
treatment NN O
of IN O
chronic JJ O
active JJ O
hepatitis NN O
B NNP O
was VBD O
tested VBN O
in IN O
7 CD O
patients NNS O
. . O

-DOCSTART- X X O

Like IN O
scrotal JJ O
testes NNS O
, , O
undescended JJ O
testes NNS O
were VBD O
hypointense JJ O
to TO O
fat JJ O
on IN O
sequences NNS O
with IN O
a DT O
short JJ O
repetition NN O
time NN O
( -LRB- O
TR NN O
) -RRB- O
and CC O
echo VB O
time NN O
( -LRB- O
TE VB O
) -RRB- O
in IN O
all DT O
cases NNS O
, , O
and CC O
hyperintense NN O
or CC O
isointense NN O
to TO O
fat JJ O
on IN O
long JJ O
TR/TE NN O
sequences NNS O
in IN O
all DT O
but CC O
two CD O
cases NNS O
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
describe VBP O
the DT O
isolation NN O
of IN O
bovine NN B-NP
and CC I-NP
rat NN I-NP
GHF-1 JJ I-NP
cDNA NN I-NP
clones NNS O
. . O

-DOCSTART- X X O

To TO O
explore VB O
the DT O
functional JJ O
properties NNS O
of IN O
the DT O
protein NN O
encoded VBN O
by IN O
neu NN B-NP
, , O
we PRP O
created VBD O
a DT O
fusion NN O
gene NN O
that WDT O
joins VBZ O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
neu NN B-NP
to TO O
the DT O
extracellular JJ O
portion NN O
of IN O
an DT O
immunoglobulin NN B-NP
heavy JJ I-NP
chain NN I-NP
. . O

-DOCSTART- X X O

By IN O
sequence NN O
comparison NN O
, , O
42 CD O
blocks NNS O
of IN O
homology NN O
are VBP O
defined VBN O
in IN O
the DT O
5'-terminal JJ O
region NN O
, , O
of IN O
which WDT O
36 CD O
appear VBP O
in IN O
the DT O
CpG NNP O
island NN O
and CC O
contain VBP O
numerous JJ O
conserved JJ O
CpG NNP O
dinucleotides NNS O
. . O

-DOCSTART- X X O

Efficacy NN O
and CC O
field NN O
evaluation NN O
of IN O
Bacillus NN O
thuringiensis NN O
(H-14 NN O
) -RRB- O
and CC O
B. NNP O
sphaericus NN O
against IN O
floodwater NN O
mosquitoes NNS O
in IN O
California NNP O
. . O

-DOCSTART- X X O

This DT O
loss NN O
was VBD O
independent JJ O
of IN O
drug NN O
concentration NN O
and CC O
a DT O
correction NN O
factor NN O
was VBD O
employed VBN O
to TO O
calculate VB O
the DT O
true JJ O
free JJ O
diazepam NN O
concentration NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
a DT O
perfluorochemical JJ O
blood NN O
substitute NN O
on IN O
diazepam NN O
binding NN O
by IN O
human JJ B-NP
albumin NN I-NP
. . O

-DOCSTART- X X O

A DT O
second JJ O
promoter NN O
activity NN O
was VBD O
identified VBN O
in IN O
the DT O
region NN O
between IN O
the DT O
two CD O
major JJ O
transcriptional JJ O
start NN O
sites NNS O
. . O

-DOCSTART- X X O

A DT O
decamer NN O
sequence NN O
, , O
5'-CGA-CCCCUCC-3' JJ O
, , O
complementary JJ O
to TO O
a DT O
conserved JJ O
sequence NN O
adjacent JJ O
to TO O
the DT O
enzymatic JJ O
cleavage JJ O
site NN O
on IN O
the DT O
mitochondrial JJ O
RNA NNP O
substrate NN O
, , O
is VBZ O
present JJ O
in IN O
the DT O
RNAase NNP B-NP
MRP NNP I-NP
RNA NNP I-NP
. . O

-DOCSTART- X X O

Computer NN O
analysis NN O
included VBN O
digital JJ O
averaging NN O
, , O
followed VBN O
by IN O
digital JJ O
filtering NN O
in IN O
different JJ O
frequency NN O
bands NNS O
in IN O
order NN O
to TO O
determine VB O
the DT O
frequency NN O
range NN O
corresponding JJ O
to TO O
notches NNS O
and CC O
slurs NNS O
. . O

-DOCSTART- X X O

On IN O
admission NN O
to TO O
the DT O
ICU NNP O
, , O
117 CD O
patients NNS O
(61 JJ O
percent NN O
) -RRB- O
had VBD O
hypomagnesemia NN O
( -LRB- O
serum NN O
Mg RB O
less JJR O
than IN O
1.5 CD O
mEq/dl JJ O
) -RRB- O
, , O
66 CD O
patients NNS O
( -LRB- O
34 CD O
percent NN O
) -RRB- O
had VBD O
normomagnesemia NN O
( -LRB- O
1.5 CD O
to TO O
2.0 CD O
mEq/dl NN O
) -RRB- O
, , O
and CC O
ten CD O
patients NNS O
( -LRB- O
5 CD O
percent NN O
) -RRB- O
had VBD O
hypermagnesemia NN O
( -LRB- O
greater JJR O
than IN O
2.0 CD O
mEq/dl NN O
) -RRB- O
. . O

-DOCSTART- X X O

Controlled VBN O
versus JJ O
uncontrolled JJ O
reperfusion NN O
of IN O
ischemic JJ O
myocardium NN O
after IN O
experimental JJ O
coronary JJ O
artery NN O
occlusion NN O
was VBD O
studied VBN O
to TO O
determine VB O
the DT O
effect NN O
on IN O
regional JJ O
ventricular JJ O
wall NN O
motion NN O
and CC O
associated VBN O
biochemical JJ O
alterations NNS O
. . O

-DOCSTART- X X O

We PRP O
also RB O
examined VBD O
the DT O
relationship NN O
between IN O
the DT O
side NN O
of IN O
sinusitis NN O
and CC O
the DT O
cleft JJ O
side NN O
in IN O
patients NNS O
with IN O
unilateral JJ O
cleft NN O
palate NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
at IN O
these DT O
low JJ O
levels NNS O
studied VBN O
, , O
aluminum NN O
accumulates NNS O
in IN O
intestinal JJ O
tissue NN O
, , O
and CC O
that IN O
this DT O
accumulation NN O
is VBZ O
enhanced VBN O
by IN O
citrate NN O
ligand NN O
. . O

-DOCSTART- X X O

Recently RB O
, , O
an DT O
electrical-mechanical JJ O
analog NN O
model NN O
of IN O
heat NN O
flow NN O
within IN O
the DT O
brain NN O
has VBZ O
been VBN O
developed VBN O
from IN O
which WDT O
an DT O
expression NN O
for IN O
CBF NNP O
has VBZ O
been VBN O
derived VBN O
: : O
CBF NNP O
= SYM O
Cb/(tau NNP O
rho NN O
c NN O
) -RRB- O
where WRB O
tau NNS O
is VBZ O
the DT O
thermal JJ O
decay NN O
constant JJ O
, , O
rho NNP O
is VBZ O
the DT O
density NN O
of IN O
blood NN O
, , O
and CC O
c NN O
is VBZ O
its PRP$ O
specific JJ O
heat NN O
. . O

-DOCSTART- X X O

All DT O
of IN O
the DT O
newly RB O
acquired VBN O
proviruses NNS O
identified VBN O
in IN O
mosaic JJ O
founder NN O
SWR/J-RF/J NN O
mice NNS O
that WDT O
could MD O
be VB O
transmitted VBN O
through IN O
the DT O
germ NN O
line NN O
were VBD O
also RB O
present JJ O
in IN O
somatic JJ O
tissues NNS O
, , O
demonstrating VBG O
that DT O
viral JJ O
integration NN O
occurred VBD O
before IN O
the DT O
germ NN O
line NN O
was VBD O
set VBN O
aside RB O
from IN O
the DT O
somatic JJ O
lineages NNS O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
of IN O
the DT O
cDNA NN O
for IN O
the DT O
human JJ B-NP
U2 NN I-NP
snRNA-specific JJ I-NP
A' JJ I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Successful JJ O
use NN O
of IN O
transureteroureterostomy NN O
to TO O
salvage VB O
ureterosigmoidostomy NN O
after IN O
anastomotic JJ O
failure NN O
. . O

-DOCSTART- X X O

Oxfendazole NNP O
, , O
which WDT O
was VBD O
active JJ O
for IN O
the DT O
shortest NN O
time NN O
( -LRB- O
about IN O
65 CD O
days NNS O
) -RRB- O
from IN O
the DT O
start NN O
of IN O
grazing VBG O
( -LRB- O
May NNP O
1 CD O
) -RRB- O
, , O
produced VBD O
a DT O
78.1 CD O
per IN O
cent NN O
reduction NN O
in IN O
Ostertagia NNP O
species NNS O
and CC O
an DT O
84.4 CD O
per IN O
cent NN O
reduction NN O
in IN O
D NNP O
viviparus NN O
. . O

-DOCSTART- X X O

Platelet NNP O
function NN O
and CC O
platelet-polymorphonuclear-neutrophil NN O
interaction NN O
in IN O
patients NNS O
with IN O
deficient JJ O
platelet NN B-NP
lipoxygenase NN I-NP
activity NN O
. . O

-DOCSTART- X X O

Spontaneous JJ O
degradation NN O
of IN O
atracurium NN O
in IN O
plasma NN O
is VBZ O
the DT O
major JJ O
route NN O
of IN O
elimination NN O
in IN O
man NN O
and CC O
contributes VBZ O
to TO O
a DT O
short JJ O
elimination NN O
half-life NN O
( -LRB- O
approximatively RB O
20 CD O
min NN O
) -RRB- O
. . O

-DOCSTART- X X O

Group NNP O
A DT O
was VBD O
treated VBN O
with IN O
three CD O
or CC O
four CD O
doses NNS O
of IN O
hepatitis NN B-NP
B NNP I-NP
immune JJ I-NP
globulin NN I-NP
( -LRB- O
HBIG NNP B-NP
) -RRB- O
in IN O
one CD O
of IN O
three CD O
different JJ O
schedules NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
former JJ O
instance NN O
, , O
in IN O
addition NN O
to TO O
serum VB O
calcium NN O
and CC O
phosphorous JJ O
ion NN O
concentrations NNS O
, , O
tissue NN O
pH NNS O
, , O
blood NN O
supply NN O
, , O
hormones NNS O
, , O
i IN O
.e NN O
. . O
, , O
vitamin NN O
D NNP O
, , O
vitamin NN O
A NNP O
, , O
and CC O
various JJ O
enzymes NNS O
( -LRB- O
e NN O
.g. NNP O
, , O
alkaline NN B-NP
phosphatase NN I-NP
and CC O
pyrophosphatase NN B-NP
) -RRB- O
may MD O
all DT O
play VB O
significant JJ O
, , O
ancillary JJ O
, , O
time-dependent NN O
, , O
but CC O
as RB O
yet RB O
undetermined JJ O
roles NNS O
. . O

-DOCSTART- X X O

Penicillinase NNP B-NP
production NN O
in IN O
Staphylococcus NNP O
aureus NN O
strains NNS O
of IN O
clinical JJ O
importance NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
quantitative JJ O
analysis NN O
of IN O
thallium-201 DT O
uptake NN O
and CC O
washout IN O
provided VBN O
objective JJ O
evidence NN O
for IN O
improved VBN O
myocardial JJ O
perfusion NN O
after IN O
coronary JJ O
angioplasty NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
reports VBZ O
the DT O
effects NNS O
of IN O
a DT O
preparation NN O
with IN O
50 CD O
micrograms NNS O
ethinyl NN O
estradiol NN O
and CC O
2 CD O
mg JJ O
cyproterone NN O
acetate NN O
on IN O
gonadotropins NNS B-NP
, , O
prolactin NN B-NP
, , O
testosterone NN O
, , O
sex NN B-NP
hormone NN I-NP
binding NN I-NP
globulin NN I-NP
( -LRB- O
SHBG) NNP B-NP
, , O
androstenedione NN O
, , O
and CC O
calculated VBD O
free JJ O
testosterone NN O
index NN O
before IN O
and CC O
after IN O
six CD O
months NNS O
of IN O
treatment NN O
. . O

-DOCSTART- X X O

Preventive JJ O
effect NN O
of IN O
ONO-3708 CD O
on IN O
thrombosis NN O
and CC O
vasospasms NNS O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Monospecific NNP O
antibodies NNS O
, , O
eluted VBD O
from IN O
the DT O
beta-galactosidase JJ B-NP
fusion NN O
protein NN O
of IN O
either DT O
clone NN O
reacted VBD O
with IN O
the DT O
U1 NNP B-NP
snRNP-specific JJ I-NP
A DT B-NP
antigen NN I-NP
. . O

-DOCSTART- X X O

Schedule NNP O
2 CD O
, , O
in IN O
which WDT O
2.4 CD O
mg/kg NN O
c-DDP NN O
was VBD O
administered VBN O
immediately RB O
before IN O
X-ray NN O
on IN O
5 CD O
consecutive JJ O
days NNS O
produced VBD O
the DT O
highest JJS O
degree NN O
of IN O
enhancement NN O
of IN O
radiation NN O
effect NN O
( -LRB- O
expressed VBD O
as IN O
dose-effect JJ O
factor NN O
) -RRB- O
; : O
and CC O
the DT O
next JJ O
greatest JJS O
enhancement NN O
was VBD O
produced VBN O
by IN O
12 CD O
mg/kg NN O
c-DDP JJ O
administered VBN O
24 CD O
h NN O
before IN O
the DT O
start NN O
of IN O
fractionated JJ O
daily JJ O
radiotherapy NN O
. . O

-DOCSTART- X X O

The DT O
cpc-1-encoded JJ B-NP
transcript NN I-NP
contains VBZ O
three CD O
open JJ O
reading NN O
frames NNS O
, , O
two CD O
of IN O
which WDT O
are VBP O
located VBN O
in IN O
the DT O
720-nucleotide JJ O
leader NN O
segment NN O
preceding VBG O
the DT O
cpc-1 NN B-NP
coding VBG I-NP
region NN I-NP
. . O

-DOCSTART- X X O

Ig NNP B-NP
D-JH NNP I-NP
recombinations NNS O
may MD O
precede VB O
TcR NNP B-NP
gene NN I-NP
recombination NN O
in IN O
these DT O
early JJ O
T NNP O
cell NN O
lines NNS O
, , O
and CC O
some DT O
but CC O
not RB O
all DT O
express NN O
sterile JJ O
Cmu NN B-NP
transcripts NNS I-NP
. . O

-DOCSTART- X X O

The DT O
RAD18 CD B-NP
gene NN I-NP
open JJ I-NP
reading NN I-NP
frame NN I-NP
encodes VBZ O
a DT O
protein NN O
of IN O
487 CD O
amino IN O
acids NNS O
, , O
with IN O
a DT O
calculated JJ O
molecular JJ O
weight NN O
of IN O
55,512 CD O
. . O

-DOCSTART- X X O

The DT O
absorbable JJ O
perisplenic JJ O
mesh NN O
is VBZ O
an DT O
important JJ O
improvement NN O
, , O
and CC O
in IN O
some DT O
cases NNS O
it PRP O
may MD O
replace VB O
other JJ O
techniques NNS O
for IN O
arresting VBG O
splenic JJ O
bleeding NN O
. . O

-DOCSTART- X X O

A DT O
rare JJ O
chronic JJ O
course NN O
of IN O
Budd-Chiari NNP O
syndrome NN O
associated VBN O
with IN O
thrombosis NN O
of IN O
the DT O
portal JJ O
vein NN O
was VBD O
observed VBN O
in IN O
a DT O
30-year-old JJ O
male JJ O
patient JJ O
suffering NN O
from IN O
postmyocarditic JJ O
cardiosclerosis NN O
. . O

-DOCSTART- X X O

After IN O
one CD O
accommodation NN O
night NN O
, , O
sleep VB O
EEG JJ O
recordings NNS O
were VBD O
performed VBN O
during IN O
three CD O
consecutive JJ O
nights NNS O
in IN O
ten CD O
drug-free JJ O
inpatients NNS O
presenting VBG O
generalized VBN O
anxiety NN O
disorder NN O
( -LRB- O
GAD NN O
) -RRB- O
with IN O
significant JJ O
depression NN O
, , O
compared VBN O
with IN O
a DT O
age NN O
- : O
and CC O
sex-matched JJ O
group NN O
of IN O
patients NNS O
with IN O
GAD NNP O
and CC O
a DT O
group NN O
of IN O
primary JJ O
major JJ O
depressive JJ O
disorder NN O
( -LRB- O
MDD NN O
) -RRB- O
patients NNS O
. . O

-DOCSTART- X X O

Oligonucleotide NNP O
mutagenesis NN O
of IN O
these DT O
binding JJ O
domains NNS O
indicated VBD O
their PRP$ O
importance NN O
in IN O
the DT O
transcriptional JJ O
regulation NN O
of IN O
the DT O
E3 JJ B-NP
promoter NN I-NP
in IN O
yeast NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
concentration NN O
of IN O
PGI2 VBG O
on IN O
the DT O
newly-formed JJ O
luminal JJ O
surface NN O
remained VBD O
low JJ O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
single JJ O
and CC O
combined VBN O
maltose NN O
tetrapalmitate NN O
immunotherapy NN O
, , O
cyclophosphamide NN O
chemotherapy NN O
and CC O
radiotherapy NN O
on IN O
ethyl NN O
carbamate NN O
accelerated VBN O
primary JJ O
lung NN O
cancer NN O
in IN O
A/J NNP O
mice NNS O
. . O

-DOCSTART- X X O

A DT O
114-base JJ O
pair NN O
sequence NN O
of IN O
predominantly RB O
repeating VBG O
purine-pyrimidine JJ O
nucleotides NNS O
separates VBZ O
these DT O
two CD O
d(AC NNS O
) -RRB- O
repeats NNS O
. . O

-DOCSTART- X X O

When WRB O
the DT O
coding NN O
segments NNS O
, , O
including VBG O
both DT O
framework NN O
and CC O
complementarity-determining JJ O
regions NNS O
, , O
of IN O
these DT O
genes NNS O
and CC O
the DT O
murine NN O
probe NN O
sequences NNS O
are VBP O
compared VBN O
by IN O
metric JJ O
analysis NN O
, , O
it PRP O
is VBZ O
apparent JJ O
that IN O
the DT O
caiman NN O
genes NNS O
are VBP O
only RB O
slightly RB O
more RBR O
related VBN O
to TO O
each DT O
other JJ O
than IN O
to TO O
the DT O
mammalian JJ O
sequence NN O
, , O
consistent JJ O
with IN O
significant JJ O
preservation NN O
of IN O
nucleotide JJ O
sequence NN O
over IN O
an DT O
extended JJ O
period NN O
of IN O
phylogenetic JJ O
time NN O
. . O

-DOCSTART- X X O

Evidence NN O
for IN O
a DT O
role NN O
of IN O
endogenous JJ B-NP
corticotropin-releasing JJ I-NP
factor NN I-NP
in IN O
cold JJ O
, , O
ether JJ O
, , O
immobilization NN O
, , O
and CC O
traumatic JJ O
stress NN O
. . O

-DOCSTART- X X O

81 CD O
milk NN O
samples NNS O
collected VBD O
from IN O
35 CD O
donors NNS O
3 CD O
days NNS O
to TO O
7 CD O
months NNS O
after IN O
delivery NN O
were VBD O
examined VBN O
for IN O
the DT O
occurrence NN O
of IN O
cytomegalovirus NN O
( -LRB- O
CMV) NNP O
. . O

-DOCSTART- X X O

Three CD O
cases NNS O
of IN O
primary JJ O
signet-ring JJ O
cell NN O
carcinoma NN O
of IN O
the DT O
rectum NN O
are VBP O
described VBN O
. . O

-DOCSTART- X X O

The DT O
data NNS O
obtained VBD O
up RP O
to TO O
now RB O
only RB O
suggest VBP O
the DT O
future JJ O
potentiality NN O
of IN O
Bestatin NNP O
treatment NN O
for IN O
these DT O
types NNS O
of IN O
malignancy NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
suggest VBP O
that IN O
dopaminergic JJ O
regulation NN O
of IN O
adrenal JJ O
zona NN O
glomerulosa NN O
corticosteroid NN O
and CC O
renal JJ B-NP
renin NN I-NP
secretion NN O
is VBZ O
absent JJ O
in IN O
patients NNS O
with IN O
high JJ O
spinal JJ O
cord NN O
transections NNS O
, , O
suggesting VBG O
that IN O
intact JJ O
neural JJ O
pathways NNS O
from IN O
the DT O
central JJ O
nervous JJ O
system NN O
are VBP O
necessary JJ O
for IN O
metoclopramide JJ O
stimulation NN O
of IN O
aldosterone NN O
and CC O
renin NN B-NP
secretion NN O
in IN O
men NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
absence NN O
of IN O
enhancer NN O
sequences NNS O
, , O
the DT O
adenovirus NN B-NP
E1A NNP I-NP
gene NN I-NP
can MD O
not RB O
stimulate VB O
CATase JJ B-NP
synthesis NN O
. . O

-DOCSTART- X X O

FK NNP O
33-824 CD O
, , O
a DT O
methionine-enkephalin NN O
analogue NN O
, , O
suppressed VBD O
plasma NN O
ACTH NNP B-NP
to TO O
85 CD O
% NN O
of IN O
basal JJ O
level NN O
, , O
while IN O
bromocriptine JJ O
( -LRB- O
CB-154 NN O
) -RRB- O
caused VBD O
no DT O
significant JJ O
change NN O
. . O

-DOCSTART- X X O

The DT O
homology NN O
to TO O
v-mil JJ B-NP
starts NNS O
within IN O
the DT O
coding NN O
sequence NN O
of IN O
exon NN O
1 CD O
and CC O
ends VBZ O
within IN O
the DT O
3' JJ O
untranslated JJ O
region NN O
of IN O
exon NN O
11 CD O
, , O
12 CD O
nucleotides NNS O
downstream RB O
from IN O
the DT O
nonsense NN O
codon NN O
terminating NN O
the DT O
large JJ O
open JJ O
reading NN O
frame NN O
shared VBD O
between IN O
c-mil JJ B-NP
and CC O
v-mil JJ B-NP
. . O

-DOCSTART- X X O

Six CD O
( -LRB- O
four CD O
FAP NNP O
; : O
two CD O
primary JJ O
amyloidosis NN O
) -RRB- O
also RB O
had VBD O
diffusely RB O
positive JJ O
myocardial JJ O
uptakes NNS O
, , O
but CC O
the DT O
intensity NN O
was VBD O
less JJR O
than IN O
that DT O
of IN O
the DT O
sternum NN O
. . O

-DOCSTART- X X O

The DT O
intensity NN O
of IN O
myocardial JJ O
uptake NN O
of IN O
Tc-99m-PYP JJ O
in IN O
patients NNS O
with IN O
echocardiographic JJ O
left JJ O
ventricular JJ O
hypertrophy NN O
and/or CC O
highly RB O
refractile JJ O
myocardial JJ O
echoes NNS O
, , O
so-called JJ O
granular JJ O
sparkling JJ O
appearance NN O
( -LRB- O
GS NNP O
) -RRB- O
was VBD O
slightly RB O
greater JJR O
than IN O
that DT O
in IN O
patients NNS O
with IN O
neither DT O
myocardial JJ O
hypertrophy NN O
nor CC O
GS. NNP O

-DOCSTART- X X O

The DT O
210 CD O
kDa NN O
precursor NN O
is VBZ O
converted VBN O
slowly RB O
( -LRB- O
t NN O
1/2 CD O
= SYM O
2 CD O
h NN O
) -RRB- O
by IN O
proteolytic JJ O
processing NN O
into IN O
a DT O
125 CD O
kDa NN O
( -LRB- O
alpha' NNS O
) -RRB- O
and CC O
83 CD O
kDa NN O
( -LRB- O
beta' IN O
) -RRB- O
species NNS O
. . O

-DOCSTART- X X O

Alveolar NNP O
lymphocytes NNS O
were VBD O
surprisingly RB O
increased VBN O
in IN O
most JJS O
patients NNS O
with IN O
AIDS NNP O
( -LRB- O
mean VBP O
26.1 CD O
+/ JJ O
- : O
21.9 CD O
% NN O
; : O
range NN O
1-76 CD O
% NN O
) -RRB- O
and CC O
CGL NNP O
( -LRB- O
mean VBP O
26.6 CD O
+/ JJ O
- : O
22.6 CD O
% NN O
; : O
range NN O
3-76 CD O
% NN O
) -RRB- O
with IN O
criteria NNS O
of IN O
activation NN O
contrasting NN O
with IN O
the DT O
blood NN O
lymphopenia NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
determined VBN O
that IN O
these DT O
nicks NNS O
occur VBP O
in IN O
both DT O
the DT O
wild-type JJ O
and CC O
the DT O
mutant JJ O
sites NNS O
. . O

-DOCSTART- X X O

Its PRP$ O
predicted VBD O
amino IN O
acid NN O
sequence NN O
shows VBZ O
extensive JJ O
homology NN O
to TO O
those DT O
of IN O
Drosophila NNP B-NP
hsp70 CD I-NP
, , O
trout NN B-NP
hsp70 NN I-NP
, , O
Xenopus NNP B-NP
hsp70 VBD I-NP
, , O
yeast NN B-NP
hsp70 NN I-NP
, , O
and CC O
some DT O
homology NN O
to TO O
the DT O
heat-inducible JJ B-NP
dnaK NN I-NP
gene NN I-NP
product NN I-NP
of IN O
Escherichia NNP O
coli NNS O
. . O

-DOCSTART- X X O

When WRB O
phosphorylation NN O
of IN O
exogenous JJ O
peptide NN O
substrates NNS O
was VBD O
measured VBN O
as IN O
a DT O
function NN O
of IN O
receptor NN O
self-phosphorylation NN O
, , O
tyrosine FW B-NP
kinase FW I-NP
activity NN O
was VBD O
found VBN O
to TO O
be VB O
enhanced VBN O
two CD O
to TO O
threefold VB O
at IN O
1-2 JJ O
mol NN O
of IN O
phosphate NN O
per IN O
mol NN O
of IN O
receptor NN O
. . O

-DOCSTART- X X O

At IN O
temperatures NNS O
permissive JJ O
for IN O
transformation NN O
, , O
6m2 CD O
cells NNS O
contain VBP O
P58gag NNP B-NP
produced VBD O
from IN O
the DT O
4.0-kilobase JJ O
(kb NN O
) -RRB- O
viral NN O
RNA NNP O
genome NN O
and CC O
P85gag-mos JJ B-NP
translated VBN O
from IN O
a DT O
3.5-kb JJ O
spliced JJ O
mRNA NN O
. . O

-DOCSTART- X X O

The DT O
pet56 NNS B-NP
and CC O
his3 PRP$ B-NP
genes NNS I-NP
are VBP O
transcribed VBN O
divergently RB O
from IN O
initiation NN O
sites NNS O
that WDT O
are VBP O
separated VBN O
by IN O
only RB O
192 CD O
bp NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
concluded VBN O
that IN O
in IN O
patients NNS O
with IN O
first-attack JJ O
genital NN O
herpes NNS O
, , O
the DT O
type NN O
of IN O
HSV NNP O
is VBZ O
the DT O
most RBS O
important JJ O
determinant NN O
of IN O
subsequent JJ O
recurrences NNS O
and CC O
that DT O
intravenous JJ O
acyclovir NN O
has VBZ O
little JJ O
effect NN O
on IN O
subsequent JJ O
recurrences NNS O
. . O

-DOCSTART- X X O

One CD O
group NN O
( -LRB- O
n NN O
= SYM O
9 CD O
) -RRB- O
was VBD O
premedicated VBN O
with IN O
midazolam NN O
, , O
0.1 CD O
mg NN O
kg-1 NN O
, , O
and CC O
atropine JJ O
0.2-0.4 CD O
mg JJ O
i.m NN O
. . O

-DOCSTART- X X O

Comparison NNP O
with IN O
a DT O
recently RB O
described VBN O
c-sis NN B-NP
cDNA NN I-NP
clone NN I-NP
( -LRB- O
Collins NNP O
et NNP O
al NN O
. . O
, , O
Nature NNP O
316 CD O
, , O
748-750 CD O
( -LRB- O
1985 CD O
) -RRB- O
) -RRB- O
revealed VBD O
that IN O
the DT O
1.9 CD O
kbp JJ O
DNA NNP O
region NN O
contained VBD O
a DT O
large JJ O
5' JJ B-NP
c-sis NN I-NP
exon NN I-NP
of IN O
at IN O
least JJS O
1050 CD O
bp NN O
. . O

-DOCSTART- X X O

The DT O
nucleotide JJ O
sequence NN O
of IN O
3874 CD O
bp NN O
of IN O
cloned VBN O
R. NNP O
sphaeroides VBZ O
chromosomal JJ O
DNA NN O
, , O
including VBG O
the DT O
three CD O
structural JJ O
genes NNS O
fbcF NN B-NP
, , O
fbcB NN B-NP
and CC O
fbcC NN B-NP
has VBZ O
been VBN O
determined VBN O
. . O

-DOCSTART- X X O

The DT O
N-terminal JJ O
sequence NN O
of IN O
one CD O
hydrophilic JJ O
peptide NN O
of IN O
the DT O
FeS NNP B-NP
protein NN I-NP
has VBZ O
been VBN O
also RB O
obtained VBN O
confirming VBG O
the DT O
fbcF NN B-NP
reading NN O
frame NN O
. . O

-DOCSTART- X X O

The DT O
5' JJ O
and CC O
3' JJ O
untranslated JJ O
sequences NNS O
contain VBP O
characteristic JJ O
sequences NNS O
that WDT O
are VBP O
involved VBN O
in IN O
the DT O
initiation NN O
and CC O
termination NN O
of IN O
transcription NN O
, , O
including VBG O
two CD O
possible JJ O
promoters NNS O
, , O
one CD O
of IN O
which WDT O
may MD O
contain VB O
two CD O
overlapping VBG O
-10 JJ O
sequences NNS O
. . O

-DOCSTART- X X O

Unlike IN O
P135gag-myb-ets NNS B-NP
and CC O
the DT O
Mr NNP O
75,000 CD O
translation NN O
product NN O
of IN O
c-myb JJ B-NP
( -LRB- O
P75c-myb JJ B-NP
) -RRB- O
, , O
which WDT O
are VBP O
nuclear JJ O
proteins NNS O
, , O
P54c-ets NNS B-NP
was VBD O
found VBN O
to TO O
be VB O
predominantly RB O
cytoplasmic JJ O
. . O

-DOCSTART- X X O

The DT O
C-terminal JJ O
end NN O
of IN O
this DT O
polypeptide NN O
harbors VBZ O
three CD O
types NNS O
of IN O
repeated VBN O
sequences NNS O
. . O

-DOCSTART- X X O

Further JJ O
outbreaks NNS O
of IN O
ocular JJ O
disease NN O
in IN O
farmed JJ O
red JJ O
deer NNS O
calves VBZ O
caused VBN O
by IN O
HVC-1 NNP O
were VBD O
investigated VBN O
. . O

-DOCSTART- X X O

From IN O
our PRP$ O
ultrastructural JJ O
and CC O
biochemical JJ O
studies NNS O
, , O
it PRP O
is VBZ O
evident JJ O
that IN O
Type JJ O
II NNP O
pneumocytes NNS O
are VBP O
an DT O
early JJ O
target NN O
of IN O
radiation NN O
and CC O
the DT O
release NN O
of IN O
surfactant NN O
into IN O
the DT O
alveolus NN O
shortly RB O
after IN O
exposure NN O
persists NNS O
for IN O
days NNS O
and CC O
weeks NNS O
. . O

-DOCSTART- X X O

Two CD O
copies NNS O
of IN O
the DT O
72-bp JJ O
repeat NN O
provided VBD O
efficient JJ O
activation NN O
of IN O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

The DT O
open JJ O
reading NN O
frames NNS O
of IN O
rbsD NNP B-NP
, , O
rbsA NNP B-NP
, , O
and CC O
rbsC JJ B-NP
encode JJ O
proteins NNS O
of IN O
139 CD O
, , O
501 CD O
, , O
and CC O
321 CD O
amino IN O
acid NN O
residues NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

In IN O
order NN O
to TO O
study VB O
the DT O
influence NN O
of IN O
iron NN O
overload NN O
on IN O
the DT O
polymorphonuclear NN O
leucocyte NN O
( -LRB- O
PMN) NNP O
metabolism NN O
of IN O
patients NNS O
on IN O
chronic JJ O
hemodialysis NN O
, , O
generation NN O
of IN O
superoxide NN O
anion NN O
( -LRB- O
O2-) JJ O
by IN O
PMN NNP O
in IN O
whole JJ O
blood NN O
was VBD O
compared VBN O
in IN O
two CD O
groups NNS O
of IN O
hemodialyzed JJ O
patients NNS O
: : O
group NN O
A DT O
consisted VBN O
of IN O
twenty-one CD O
individuals NNS O
with IN O
serum NN O
ferritin NN B-NP
levels NNS O
above IN O
1000 CD O
ng/ml NN O
and CC O
group NN O
B NNP O
of IN O
nineteen CD O
individuals NNS O
with IN O
serum NN O
ferritin NN B-NP
levels NNS O
below IN O
1000 CD O
ng/ml NN O
. . O

-DOCSTART- X X O

Osteocalcin NNP B-NP
( -LRB- O
and CC O
urinary JJ O
hydroxyproline NN O
) -RRB- O
were VBD O
not RB O
elevated VBN O
in IN O
isolated JJ O
hyperphosphatasaemia NN O
, , O
indicating VBG O
that IN O
mechanisms NNS O
other JJ O
than IN O
increased VBN O
bone NN O
turnover NN O
may MD O
account VB O
for IN O
the DT O
markedly NN O
elevated VBD O
serum NN B-NP
alkaline NN I-NP
phosphatase NN I-NP
activity NN O
in IN O
these DT O
subjects NNS O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
glucocorticoid JJ O
unresponsive JJ O
cell NN O
variants NNS O
using VBG O
a DT O
mouse NN B-NP
glucocorticoid NN I-NP
receptor NN I-NP
complementary JJ O
DNA NNP O
clone NN O
. . O

-DOCSTART- X X O

Among IN O
the DT O
v-myc JJ B-NP
codons NNS O
, , O
the DT O
first JJ O
5 CD O
are VBP O
derived VBN O
from IN O
the DT O
noncoding JJ O
5' JJ O
terminus NN O
of IN O
the DT O
second JJ O
c-myc JJ B-NP
exon NN O
, , O
and CC O
412 CD O
codons NNS O
correspond NN O
to TO O
the DT O
c-myc JJ B-NP
coding NN O
region NN O
. . O

-DOCSTART- X X O

A DT O
recombinant JJ O
vector NN O
, , O
p410+ JJ O
, , O
was VBD O
constructed VBN O
which WDT O
carried VBD O
the DT O
BamHI-K JJ B-NP
fragment NN I-NP
( -LRB- O
nucleotides NNS O
107565 CD O
to TO O
112625 CD O
of IN O
the DT O
B95-8 JJ O
strain NN O
, , O
encoding VBG O
the DT O
EBV-associated JJ O
nuclear JJ O
antigen JJ O
EBNA-1 NN B-NP
) -RRB- O
, , O
the DT O
cis-acting JJ O
sequence NN O
from IN O
the DT O
BamHI-C JJ B-NP
fragment NN I-NP
, , O
and CC O
a DT O
dominant JJ O
selectable JJ O
marker NN O
gene NN O
encoding VBG O
G-418 DT O
resistance NN O
in IN O
animal NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
hexanucleotide NN O
5'-TGTCCT-3' JJ O
, , O
thought VBD O
to TO O
be VB O
important JJ O
for IN O
GRE NNP O
activity NN O
, , O
not RB O
only RB O
was VBD O
found VBN O
in IN O
this DT O
sequence NN O
and CC O
in IN O
the DT O
5'-flanking JJ O
region NN O
, , O
but CC O
also RB O
was VBD O
present JJ O
twice RB O
in IN O
the DT O
3' JJ O
end NN O
of IN O
the DT O
gene NN O
that WDT O
did VBD O
not RB O
show VB O
specific JJ O
receptor NN O
binding NN O
. . O

-DOCSTART- X X O

Five CD O
patients NNS O
developed VBD O
metastatic JJ O
spread NN O
, , O
and CC O
all DT O
of IN O
them PRP O
died VBD O
of IN O
tumor NN O
. . O

-DOCSTART- X X O

The DT O
52-protein JJ O
subunit NN O
of IN O
T4 DT B-NP
DNA NNP I-NP
topoisomerase NN I-NP
is VBZ O
homologous JJ O
to TO O
the DT O
gyrA-protein NN B-NP
of IN O
gyrase NN B-NP
. . O

-DOCSTART- X X O

Translation NN O
of IN O
specific JJ O
cellular JJ O
genes NNS O
from IN O
the DT O
chimeric JJ O
viral-cellular JJ O
transcripts NNS O
seems VBZ O
to TO O
be VB O
unlikely JJ O
. . O

-DOCSTART- X X O

The DT O
molecular JJ O
weight NN O
of IN O
in IN O
vivo-labeled JJ O
proteins NNS O
was VBD O
increased VBN O
relative JJ O
to TO O
that DT O
of IN O
in IN O
vitro-translated JJ O
proteins NNS O
, , O
indicating VBG O
that IN O
a DT O
posttranslational JJ O
modification NN O
had VBD O
occurred VBN O
. . O

-DOCSTART- X X O

Insertion NN O
of IN O
4 CD O
bp NN O
reduced VBN O
SV40 IN B-NP
early JJ I-NP
promoter-dependent JJ I-NP
chloramphenicol NN B-NP
acetyltransferase NN I-NP
( -LRB- O
CAT NN B-NP
) -RRB- O
expression NN O
by IN O
six CD O
- : O
to TO O
eightfold RB O
. . O

-DOCSTART- X X O

Nuclease NN O
footprinting NN O
revealed VBD O
that IN O
purified VBN O
glucocorticoid NN B-NP
receptor NN I-NP
bound VBN O
at IN O
multiple JJ O
discrete NN O
sites NNS O
within IN O
and CC O
at IN O
the DT O
borders NNS O
of IN O
the DT O
tandemly NN O
repeated VBD O
sequence NN O
motif NN O
that WDT O
defines VBZ O
Sa NNP B-NP
. . O

-DOCSTART- X X O

The DT O
coding NN O
region NN O
of IN O
2385 CD O
nucleotides NNS O
corresponds NNS O
to TO O
a DT O
polypeptide NN O
chain NN O
of IN O
795 CD O
amino IN O
acids NNS O
, , O
giving VBG O
a DT O
molecular JJ O
weight NN O
of IN O
91,555 CD O
for IN O
the DT O
hsp108 CD B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Gluzman NNP O
, , O
EMBO NNP O
J. NNP O

-DOCSTART- X X O

A DT O
single JJ O
exon NN O
encodes VBZ O
the DT O
carboxyl-terminal JJ O
26 CD O
amino IN O
acids NNS O
of IN O
the DT O
ssd NN B-NP
chain NN I-NP
and CC O
the DT O
3' JJ O
untranslated JJ O
region NN O
of IN O
its PRP$ O
mRNA NN O
, , O
ending VBG O
with IN O
a DT O
poly( NN O
A)-addition NN O
site NN O
. . O

-DOCSTART- X X O

SPECT JJ O
examination NN O
of IN O
the DT O
TMJ NN O
using VBG O
99m JJ O
Tc-MDP NNP O
was VBD O
performed VBN O
in IN O
43 CD O
patients NNS O
with IN O
arthrographically RB O
proven VBN O
anterior JJ O
dislocation NN O
of IN O
the DT O
disc NN O
and CC O
in IN O
30 CD O
normals NNS O
. . O

-DOCSTART- X X O

Two CD O
mutants NNS O
, , O
each DT O
representative NN O
of IN O
a DT O
separate JJ O
pet NN B-NP
complementation NN O
group NN O
, , O
have VBP O
been VBN O
analyzed VBN O
. . O

-DOCSTART- X X O

A DT O
centromere NN O
in IN O
S. NNP O
cerevisiae NN O
consists VBZ O
of IN O
a DT O
region NN O
of IN O
DNA NNP O
, , O
approximately RB O
150 CD O
bp NN O
in IN O
length NN O
, , O
containing VBG O
three CD O
important JJ O
sequence NN O
elements NNS O
, , O
which WDT O
are VBP O
folded VBN O
with IN O
proteins NNS O
into IN O
a DT O
specific JJ O
conformation NN O
in IN O
the DT O
chromatin NN O
( -LRB- O
the DT O
yeast NN O
kinetochore NN O
) -RRB- O
. . O

-DOCSTART- X X O

Constitutive JJ O
function NN O
of IN O
a DT O
positively RB O
regulated JJ O
promoter NN O
reveals VBZ O
new JJ O
sequences NNS O
essential JJ O
for IN O
activity NN O
. . O

-DOCSTART- X X O

Two CD O
separate JJ O
NF1-binding JJ B-NP
loci NNS I-NP
were VBD O
also RB O
found VBN O
in IN O
the DT O
equivalent NN O
IE68 IN B-NP
gene NN I-NP
of IN O
HCMV( JJ O
Towne NNP O
) -RRB- O
DNA NNP O
, , O
but CC O
in IN O
this DT O
case NN O
the DT O
DNA NNP O
sequence NN O
and CC O
competition NN O
filter NN O
binding CC O
experiments NNS O
indicated VBD O
a DT O
maximum NN O
of IN O
only RB O
four CD O
to TO O
five CD O
consensus NN O
binding NN O
sites NNS O
encompassing VBG O
the DT O
promoter-enhancer JJ O
region NN O
. . O

-DOCSTART- X X O

The DT O
previously RB O
described VBN O
four CD O
sets NNS O
of IN O
13 CD O
- : O
to TO O
18-base-pair JJ O
interspersed JJ O
repeat NN O
elements NNS O
between IN O
-55 NN O
and CC O
-580 JJ O
provide VBP O
most JJS O
of IN O
the DT O
high JJ O
basal NN O
transcriptional JJ O
strength NN O
, , O
whereas IN O
the DT O
arrangement NN O
of IN O
further JJ O
upstream RB O
tandemly RB O
repeated VBN O
NF1-binding JJ B-NP
sites NNS I-NP
may MD O
contribute VB O
significantly RB O
to TO O
the DT O
expanded VBN O
biological JJ O
host NN O
range NN O
for IN O
expression NN O
of IN O
SCMV NNP B-NP
IE94 IN I-NP
compared VBN O
with IN O
HCMV NNP B-NP
IE68 NNP I-NP
. . O

-DOCSTART- X X O

We PRP O
inserted VBN O
genes NNS O
or CC O
gene NN O
segments NNS O
, , O
that DT O
code NN O
for IN O
the DT O
bacterial JJ B-NP
chloramphenicol NN I-NP
acetyltransferase NN I-NP
, , O
the DT O
bacterial JJ O
gene NN O
conferring VBG O
resistance NN O
against IN O
hygromycin NN O
, , O
and CC O
the DT O
ORF NNP O
E7 NNP B-NP
of IN O
the DT O
human JJ O
papillomavirus NN O
type NN O
18 CD O
into IN O
these DT O
vectors NNS O
. . O

-DOCSTART- X X O

By IN O
contrast NN O
, , O
their PRP$ O
basal JJ O
adrenal JJ O
androgen NN O
levels NNS O
were VBD O
significantly RB O
decreased VBN O
compared VBN O
to TO O
those DT O
in IN O
normal JJ O
subjects NNS O
on IN O
both DT O
the DT O
day NN O
on IN O
and CC O
the DT O
day NN O
off IN O
prednisone NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Active JJ O
lambda NN B-NP
and CC I-NP
kappa NN I-NP
antibody NN I-NP
gene NN I-NP
rearrangement NN O
in IN O
Abelson NNP O
murine NN O
leukemia NN O
virus-transformed JJ O
pre-B JJ O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

During IN O
pentobarbital NN O
anesthesia NN O
, , O
the DT O
basal NN O
VO2 NN O
was VBD O
5.26 CD O
ml/kg/min NN O
and CC O
was VBD O
increased VBN O
by IN O
epinephrine NN O
in IN O
a DT O
dose NN O
dependent JJ O
manner NN O
at IN O
plasma NN O
concentrations NNS O
between IN O
3.9 CD O
ng/ml NN O
(VO2 IN O
= SYM O
5.68 CD O
ml/kg/min NN O
) -RRB- O
and CC O
36.5 CD O
ng/ml JJ O
(VO2 NN O
= SYM O
6.47 CD O
ml/kg/min NN O
) -RRB- O
. . O

-DOCSTART- X X O

Oligonucleotide-directed JJ O
mutagenesis NN O
was VBD O
used VBN O
to TO O
create VB O
an DT O
NdeI JJ B-NP
restriction NN I-NP
site NN I-NP
at IN O
the DT O
natural JJ O
ATG NNP O
of IN O
the DT O
yeast NN O
R. NNP O

-DOCSTART- X X O

One CD O
group NN O
of IN O
six CD O
cDNA NNS O
clones NNS O
was VBD O
derived VBN O
from IN O
a DT O
2.9-kilobase JJ O
early JJ O
transcript NN O
encoded VBN O
by IN O
the DT O
IR2 NNP O
repeat NN O
element NN O
and CC O
showed VBD O
restriction NN O
site NN O
polymorphism NN O
for IN O
the DT O
enzyme NN B-NP
SmaI. . I-NP

-DOCSTART- X X O

Combined VBN O
immunochemotherapy NN O
with IN O
cyclophosphamide NN O
plus CC O
BCG NNP O
gave VBD O
a DT O
better JJR O
enhancement NN O
of IN O
the DT O
antitumor JJ O
effect NN O
of IN O
the DT O
cytostatic JJ O
than IN O
that DT O
of IN O
the DT O
combination NN O
of IN O
methotrexate NN O
plus CC O
BCG NNP O
and CC O
cyclophosphamide NN O
plus CC O
levamisole NN O
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
circulating VBG O
platelet NN O
aggregates NNS O
and CC O
elevated VBD O
levels NNS O
of IN O
fibrinopeptide NN B-NP
A DT I-NP
( -LRB- O
a DT O
cleavage JJ O
product NN O
of IN O
fibrin NN B-NP
) -RRB- O
suggests VBZ O
that IN O
platelet NN O
activation NN O
and CC O
fibrin NN B-NP
deposition NN O
may MD O
play VB O
a DT O
role NN O
in IN O
the DT O
pathogenesis NN O
of IN O
this DT O
disorder NN O
. . O

-DOCSTART- X X O

4 CD O
. . O

-DOCSTART- X X O

In IN O
general JJ O
, , O
the DT O
values NNS O
obtained VBN O
by IN O
the DT O
two CD O
methods NNS O
were VBD O
in IN O
agreement NN O
for IN O
each DT O
species NN O
of IN O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
and CC O
followed VBD O
the DT O
order NN O
: : O
wild JJ O
type NN O
greater JJR O
than IN O
Glu24----Gly JJ O
greater JJR O
than IN O
Asp27----Gly DT O
much JJ O
greater JJR O
than IN O
Pro7----Thr JJ O
greater JJR O
than IN O
Tyr29----Gly JJ O
greater JJR O
than IN O
Leu47----His NNP O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
a DT O
prevalence NN O
study NN O
of IN O
the DT O
best JJS O
visual JJ O
acuity NN O
in IN O
the DT O
affected JJ O
eye NN O
of IN O
100 CD O
selected VBN O
patients NNS O
with IN O
herpetic JJ O
keratitis NN O
seen VBN O
during IN O
a DT O
two-year JJ O
period NN O
. . O

-DOCSTART- X X O

Bacteriologic NNP O
culture NN O
of IN O
pancreatic JJ O
tissue NN O
was VBD O
positive JJ O
in IN O
6/8 CD O
IB NNP O
and CC O
3/17 CD O
NIB NN O
rats NNS O
( -LRB- O
p NN O
less JJR O
than IN O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

After IN O
infection NN O
of IN O
293 CD O
cells NNS O
( -LRB- O
which WDT O
provide VBP O
complementary JJ O
E1a-E1b JJ B-NP
functions NNS O
) -RRB- O
, , O
both DT O
viruses NNS O
directed VBD O
equal JJ O
amounts NNS O
of IN O
P/C-specific JJ B-NP
mRNA NN I-NP
transcription NN O
. . O

-DOCSTART- X X O

This DT O
makes VBZ O
these DT O
compounds NNS O
attractive JJ O
as IN O
vehicles NNS O
for IN O
these DT O
and CC O
other JJ O
gases NNS O
in-vivo JJ O
and CC O
in-vitro JJ O
. . O

-DOCSTART- X X O

DNA NNP O
sequencing NN O
of IN O
the DT O
DPM1 NNP B-NP
gene NN I-NP
revealed VBD O
an DT O
open JJ O
reading NN O
frame NN O
of IN O
801 CD O
bases NNS O
. . O

-DOCSTART- X X O

Administration NNP O
of IN O
anticoagulants NNS O
, , O
i IN O
.e NN O
. . O
, , O
heparin NN O
, , O
prostaglandin NN O
E1 NNS O
and CC O
ticlopidine NN O
seems VBZ O
to TO O
be VB O
effective JJ O
in IN O
alleviating VBG O
symptoms NNS O
and CC O
might MD O
prevent VB O
further JJ O
deterioration NN O
. . O

-DOCSTART- X X O

Mutational JJ O
analysis NN O
of IN O
the DT O
L1 NNP B-NP
binding NN I-NP
site NN I-NP
of IN O
23S NNP B-NP
rRNA NNP I-NP
in IN I-NP
Escherichia NNP I-NP
coli NNS I-NP
. . O

-DOCSTART- X X O

Prostacyclin NNP O
formation NN O
, , O
reflected VBN O
by IN O
the DT O
excretion NN O
rate NN O
of IN O
its PRP$ O
stable JJ O
metabolite NN O
6-keto-prostaglandin JJ O
F1 NNP O
alpha NN O
, , O
was VBD O
measured VBN O
by IN O
means NNS O
of IN O
radioimmunoassay NN O
in IN O
4-hour JJ O
urine NN O
specimens NNS O
obtained VBN O
during IN O
a DT O
smoking-free JJ O
period NN O
and CC O
after IN O
participants NNS O
had VBD O
inhaled VBN O
smoke NN O
from IN O
four CD O
high-nicotine JJ O
cigarettes NNS O
. . O

-DOCSTART- X X O

The DT O
in IN O
vitro NN O
activity NN O
of IN O
mecillinam NN O
and CC O
amoxicillin/clavulanic NN O
acid NN O
against IN O
Escherichia NNP O
coli NNS O
strains NNS O
producing VBG O
beta-lactamases NNS B-NP
of IN O
the DT O
TEM-1 NNP B-NP
, , O
Oxa-1 NNP B-NP
and CC O
chromosomal NN O
type NN O
were VBD O
studied VBN O
using VBG O
the DT O
broth NN O
and CC O
agar NN O
dilution NN O
technique NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
imply VBP O
that IN O
the DT O
GCN3 JJ B-NP
product NN I-NP
can MD O
promote VB O
either DT O
repression NN O
or CC O
activation NN O
of IN O
GCN4 DT B-NP
expression NN O
depending VBG O
on IN O
amino IN O
acid NN O
availability NN O
. . O

-DOCSTART- X X O

The DT O
efficacy NN O
of IN O
these DT O
immunosuppressive JJ O
drugs NNS O
is VBZ O
clinical JJ O
proven VBN O
. . O

-DOCSTART- X X O

The DT O
amino JJ O
acid NN O
sequence NN O
of IN O
the DT O
S. NNP O
aureus NN O
peptide NN O
carrying VBG O
the DT O
phosphoryl NN O
group NN O
was VBD O
found VBN O
to TO O
be VB O
Gln-Val-Val-Ser-Thr-Phe-Met-Gly-Asn-Gly-Leu-Ala-Ile-Pro-His-Gly-Thr-Asp- NNP O
Asp. . O

-DOCSTART- X X O

These DT O
mutations NNS O
alter VBP O
two CD O
regions NNS O
of IN O
GAL4 NNP B-NP
protein NN I-NP
: : O
the DT O
DNA NNP O
binding NN O
domain NN O
, , O
and CC O
the DT O
transcription NN O
activation NN O
domain NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
indicated VBD O
that IN O
two CD O
genes NNS O
( -LRB- O
citA NNS B-NP
and CC O
citB NN B-NP
) -RRB- O
have VBP O
separate JJ O
promoters NNS O
, , O
and CC O
the DT O
location NN O
of IN O
the DT O
promoter NN O
for IN O
the DT O
citB NN B-NP
gene NN I-NP
in IN O
the DT O
Tn3411 NNP B-NP
nucleotide JJ O
sequence NN O
was VBD O
different JJ O
from IN O
that DT O
in IN O
pMS185 NN O
. . O

-DOCSTART- X X O

The DT O
rci NNS B-NP
gene NN I-NP
was VBD O
fused VBN O
with IN O
lacZ NN B-NP
and CC O
its PRP$ O
gene NN O
product NN O
was VBD O
identified VBN O
by IN O
Western JJ O
blot NN O
analysis NN O
. . O

-DOCSTART- X X O

Structure NN O
and CC O
regulation NN O
of IN O
a DT O
nuclear JJ O
gene NN O
in IN O
Saccharomyces NNS O
cerevisiae NNS O
that WDT O
specifies VBZ O
MRP13 CD B-NP
, , O
a DT O
protein NN O
of IN O
the DT O
small JJ O
subunit NN O
of IN O
the DT O
mitochondrial JJ O
ribosome JJ O
. . O

-DOCSTART- X X O

Although IN O
large JJ O
epidemiologic NN O
studies NNS O
are VBP O
best RB O
able JJ O
to TO O
identify VB O
the DT O
relative JJ O
contributions NNS O
of IN O
specific JJ O
risk NN O
factors NNS O
while IN O
controlling VBG O
for IN O
other JJ O
risk NN O
factors NNS O
, , O
new JJ O
studies NNS O
need VBP O
to TO O
focus VB O
on IN O
important JJ O
unresolved JJ O
questions NNS O
. . O

-DOCSTART- X X O

The DT O
amino IN O
acid NN O
sequences NNS O
of IN O
the DT O
yeast NN O
and CC O
mammalian JJ O
mitochondrial NN O
targeting VBG O
sequences NNS O
are VBP O
similar JJ O
but CC O
less RBR O
related JJ O
than IN O
the DT O
mature JJ O
polypeptides NNS O
. . O

-DOCSTART- X X O

Van NNP O
der FW O
Ende NNP O
, , O
R. NNP O

-DOCSTART- X X O

Amounts NNS O
of IN O
glucose NN O
infused VBN O
during IN O
the DT O
last JJ O
20 CD O
min NN O
of IN O
each DT O
2 CD O
hour NN O
insulin NN B-NP
infusion NN O
were VBD O
( -LRB- O
at IN O
1 CD O
and CC O
10 CD O
m/kg/min NN O
respectively RB O
) -RRB- O
: : O
before IN O
treatment NN O
( -LRB- O
K+ NNP O
= SYM O
2.7 CD O
mmol/l NN O
) -RRB- O
: : O
2.4 CD O
and CC O
8.4 CD O
mg/kg/min NN O
; : O
after IN O
spironolactone NN O
( -LRB- O
K+ NNP O
= SYM O
3.9 CD O
mmol/l NN O
) -RRB- O
: : O
3.3 CD O
and CC O
15.4 CD O
mg/kg/min NN O
; : O
after IN O
indomethacine NN O
( -LRB- O
K+ NNP O
= SYM O
3.7 CD O
mmol/l NN O
) -RRB- O
: : O
5 CD O
and CC O
19 CD O
mg/kg/min NN O
after IN O
stopping VBG O
drugs NNS O
( -LRB- O
K+ IN O
= SYM O
2.9 CD O
mmol/l NN O
) -RRB- O
: : O
2.5 CD O
and CC O
5.3 CD O
mg/kg/min NN O
. . O

-DOCSTART- X X O

Mycobacterium NNP O
avium-intracellulare NN O
complex NN O
infections NNS O
in IN O
the DT O
acquired VBN O
immunodeficiency NN O
syndrome NN O
. . O

-DOCSTART- X X O

Recurrence NN O
of IN O
oxalate JJ O
deposition NN O
in IN O
a DT O
renal JJ O
transplant NN O
during IN O
ciclosporin VBG O
A DT O
therapy NN O
. . O

-DOCSTART- X X O

The DT O
bile NN O
acid NN O
sequestrants NNS O
( -LRB- O
cholestyramine NN O
and CC O
colestipol NN O
) -RRB- O
, , O
nicotinic JJ O
acid NN O
, , O
fenofibrate NN O
and CC O
inhibitors NNS O
of IN O
hydroxymethylglutaryl NN B-NP
coenzyme NN I-NP
A DT I-NP
( -LRB- I-NP
HMG JJ I-NP
CoA NN I-NP
) -RRB- I-NP
reductase NN I-NP
( -LRB- O
e NN O
.g NN O
. . O
lovastatin NN O
or CC O
simvastatin NN O
) -RRB- O
are VBP O
the DT O
most RBS O
effective JJ O
drugs NNS O
for IN O
use NN O
in IN O
patients NNS O
with IN O
primary JJ O
hypercholesterolaemia NN O
; : O
these DT O
agents NNS O
reduce VBP O
plasma NN O
concentrations NNS O
of IN O
total JJ O
and CC O
LDL-cholesterol JJ B-NP
by IN O
15 CD O
to TO O
45 CD O
% NN O
. . O

-DOCSTART- X X O

Analysis NN O
in IN O
3 CD O
groups NNS O
of IN O
patients NNS O
suffering VBG O
from IN O
simple JJ O
acute JJ O
and CC O
pernicious JJ O
malarial NN O
flare-ups NNS O

-DOCSTART- X X O

Statement NN O
on IN O
the DT O
development NN O
of IN O
guidelines NNS O
for IN O
the DT O
prevention NN O
of IN O
AIDS NNP O
transmission NN O
in IN O
the DT O
workplace NN O
. . O

-DOCSTART- X X O

Cocaine-treated NNP O
rats NNS O
acquired VBD O
a DT O
preference NN O
for IN O
cocaine-associated JJ O
contextual JJ O
stimuli NNS O
( -LRB- O
CS) NN O
relative JJ O
to TO O
saline-injected JJ O
control NN O
rats NNS O
. . O

-DOCSTART- X X O

Intravenous JJ O
glucose JJ O
tolerance NN O
tests NNS O
were VBD O
performed VBN O
before IN O
operation NN O
, , O
before IN O
starting VBG O
CyA NNP O
and CC O
after IN O
3 CD O
weeks NNS O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
glutaraldehyde NN O
on IN O
dimensions NNS O
and CC O
ultrastructure NN O
of IN O
microvascular JJ O
beds NNS O
in IN O
rat NN O
mesentery NN O
were VBD O
studied VBN O
in IN O
two CD O
kinds NNS O
of IN O
experiment NN O
, , O
administering VBG O
the DT O
fixative JJ O
by IN O
intra-arterial JJ O
perfusion NN O
at IN O
a DT O
pressure NN O
of IN O
80 CD O
mm CD O
Hg NN O
and CC O
by IN O
superfusion NN O
of IN O
the DT O
exteriorized JJ O
mesenteric JJ O
membrane NN O
. . O

-DOCSTART- X X O

This DT O
gave VBD O
rise NN O
to TO O
RNA NNP O
molecules NNS O
with IN O
3'-untranslated JJ O
regions NNS O
of IN O
roughly RB O
375 CD O
, , O
655 CD O
, , O
and CC O
945 CD O
base NN O
pairs NNS O
. . O

-DOCSTART- X X O

Clinical NNP O
findings NNS O
were VBD O
: : O
height NN O
183 CD O
cm NN O
, , O
weight NN O
62 CD O
kg NN O
, , O
increased VBD O
length NN O
of IN O
lower JJR O
limbs NNS O
, , O
P2-A2 JJ O
pilosity NN O
and CC O
micropenis NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
it PRP O
may MD O
be VB O
possible JJ O
to TO O
individualize VB O
hCG JJ B-NP
administration NN O
at IN O
midcycle NN O
by IN O
determining VBG O
the DT O
number NN O
of IN O
follicles NNS O
greater JJR O
than IN O
1 CD O
cm NN O
by IN O
ultrasound JJ O
on IN O
cycle NN O
day NN O
12 CD O
or CC O
13 CD O
and CC O
giving VBG O
hCG NN B-NP
when WRB O
serum NN O
E2 NN O
levels NNS O
reach VBP O
1100 CD O
to TO O
1200 CD O
pmol/l NN O
per IN O
follicle NN O
. . O

-DOCSTART- X X O

The DT O
8 CD O
patients NNS O
receiving VBG O
Ir192 NNP O
implant NN O
in IN O
addition NN O
to TO O
external JJ O
radiation NN O
showed VBD O
improved VBN O
( -LRB- O
p NN O
= SYM O
0.06 CD O
) -RRB- O
survival NN O
compared VBN O
to TO O
the DT O
9 CD O
receiving NN O
external JJ O
only RB O
: : O
median JJ O
15 CD O
months NNS O
( -LRB- O
range NN O
1.5-34 CD O
+ JJ O
months NNS O
) -RRB- O
versus NN O
7 CD O
months NNS O
( -LRB- O
range NN O
2.5-21 JJ O
months NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Within IN O
Stage NNP O
IA NNP O
, , O
141 CD O
patients NNS O
had VBD O
well RB O
differentiated JJ O
tumor NN O
( -LRB- O
G1 JJ O
) -RRB- O
, , O
20 CD O
had VBD O
moderately RB O
well RB O
differentiated JJ O
tumor NN O
( -LRB- O
G2 NNP O
) -RRB- O
, , O
and CC O
12 CD O
patients NNS O
had VBD O
poorly RB O
differentiated JJ O
( -LRB- O
G3 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Mechanism NN O
of IN O
the DT O
t( JJ O
14;18 CD O
) -RRB- O
chromosomal NN O
translocation NN O
: : O
structural JJ O
analysis NN O
of IN O
both DT O
derivative JJ O
14 CD O
and CC O
18 CD O
reciprocal JJ O
partners NNS O
. . O

-DOCSTART- X X O

After IN O
age NN O
30 CD O
, , O
mean JJ O
hemoglobin NN B-NP
levels NNS O
for IN O
men NNS O
gradually RB O
declined VBD O
, , O
while IN O
those DT O
in IN O
women NNS O
rose VBD O
, , O
so RB O
that IN O
the DT O
sex NN O
difference NN O
diminished VBN O
after IN O
60 CD O
years NNS O
of IN O
age NN O
. . O

-DOCSTART- X X O

Ritanserin NNP O
is VBZ O
a DT O
new JJ O
substance NN O
with IN O
highly RB O
selective JJ O
blocking VBG O
activity NN O
on IN O
S2 NNP B-NP
receptors NNS I-NP
for IN O
5-HT JJ O
in IN O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

-DOCSTART- X X O

Ethylene NNP O
glycol NN O
and CC O
diethylene NN O
glycol NN O
were VBD O
each DT O
administered VBN O
once IN O
weekly JJ O
subcutaneously NN O
to TO O
groups NNS O
of IN O
100 CD O
female JJ O
NMRI NNP O
mice NNS O
at IN O
3 CD O
dosages NNS O
( -LRB- O
30 CD O
; : O
10 CD O
und NN O
3 CD O
mg NN O
single JJ O
dose NN O
per IN O
mouse NN O
) -RRB- O
. . O

-DOCSTART- X X O

Comparison NNP O
of IN O
beta JJ B-NP
2-microglobulin JJ I-NP
removal NN O
using VBG O
the DT O
same JJ O
polysulphone NN O
membrane NN O
for IN O
haemodialysis NN O
and CC O
haemofiltration NN O
shows NNS O
that IN O
beta JJ B-NP
2-microglobulin NNP I-NP
is VBZ O
more RBR O
effectively RB O
removed VBN O
by IN O
convection NN O
than IN O
by IN O
diffusion NN O
when WRB O
both DT O
treatment NN O
modes NNS O
are VBP O
matched VBN O
for IN O
blood NN O
flow NN O
and CC O
urea NN O
clearance NN O
. . O

-DOCSTART- X X O

40.3 CD O
+/ NN O
- : O
10.1 CD O
mg/l NN O
( -LRB- O
SD NNP O
) -RRB- O
vs IN O
31.2 CD O
+/ CD O
- : O
8.0, CD O
P NNP O
less JJR O
than IN O
0.01 CD O
) -RRB- O
. . O
beta NN B-NP
2m . I-NP
was VBD O
not RB O
significantly RB O
higher JJR O
in IN O
patients NNS O
with IN O
bone NN O
cysts NNS O
( -LRB- O
37.7 CD O
+/ NN O
- : O
11.4 CD O
mg/l NN O
vs IN O
37.0 CD O
+/ CD O
- : O
10.0) CD O
, , O
but CC O
median JJ O
duration NN O
of IN O
dialysis NN O
was VBD O
significantly RB O
( -LRB- O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
longer RBR O
in IN O
patients NNS O
with IN O
bone NN O
cysts NNS O
(90 VBD O
vs IN O
57 CD O
months NNS O
) -RRB- O
. . O
beta NN B-NP
2m . I-NP
was VBD O
lower JJR O
in IN O
patients NNS O
maintained VBN O
on IN O
dialysis NN O
for IN O
less JJR O
than IN O
1 CD O
year NN O
and CC O
whose WP$ O
residual JJ O
urine NN O
volume NN O
was VBD O
greater JJR O
than IN O
0.1 CD O
litre NN O
per IN O
day NN O
. . O

-DOCSTART- X X O

In IN O
overdoses VBZ O
up RP O
to TO O
2 CD O
g NN O
fluvoxamine NN O
no DT O
lasting VBG O
toxic JJ O
effects NNS O
were VBD O
observed VBN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
concluded VBN O
that IN O
the DT O
plasma NN B-NP
prolactin NN I-NP
response NN O
to TO O
12.5 CD O
micrograms NNS O
i VBP O
.v. . O

-DOCSTART- X X O

No DT O
effect NN O
was VBD O
found VBN O
on IN O
grooming VBG O
behavior NN O
. . O

-DOCSTART- X X O

The DT O
remaining VBG O
six CD O
patients NNS O
had VBD O
slightly RB O
decreased VBN O
( -LRB- O
n NN O
= SYM O
3 CD O
) -RRB- O
or CC O
normal JJ O
( -LRB- O
n NN O
= SYM O
3 CD O
) -RRB- O
seminal JJ O
parameters NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
a DT O
wild-type JJ O
strain NN O
containing VBG O
a DT O
temperature-sensitive JJ B-NP
threonyl-tRNA JJ I-NP
synthetase NN I-NP
mutation NN I-NP
showed VBD O
increased VBN O
thr NN B-NP
operon NN I-NP
expression NN O
at IN O
the DT O
non-permissive JJ O
temperature NN O
, , O
whereas IN O
none NN O
of IN O
the DT O
mutants NNS O
showed VBD O
any DT O
change NN O
. . O

-DOCSTART- X X O

Significant JJ O
treatment-related JJ O
problems NNS O
appeared VBD O
during IN O
the DT O
second JJ O
decade NN O
in IN O
5 CD O
patients NNS O
, , O
including VBG O
one CD O
chest NN O
wall NN O
sarcoma NN O
; : O
all DT O
of IN O
these DT O
patients NNS O
had VBD O
received VBN O
at IN O
least JJS O
60 CD O
Gy NNP O
to TO O
breast NN O
and CC O
regional JJ O
nodal JJ O
areas NNS O
. . O

-DOCSTART- X X O

Clinical NNP O
and CC O
biological JJ O
correlates NNS O
of IN O
panic NN O
states NNS O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
long-term JJ O
parenteral JJ O
nutrition NN O
on IN O
gastrin NN B-NP
release NN O
in IN O
dogs NNS O
. . O

-DOCSTART- X X O

Of IN O
7 CD O
patients NNS O
treated VBN O
with IN O
cyclophosphamide NN O
, , O
hexamethylmelamine NN O
, , O
adriamycin NN O
and CC O
cisplatin NN O
( -LRB- O
CHAP-5 CC O
) -RRB- O
, , O
6 CD O
had VBD O
measurable JJ O
disease NN O
, , O
of IN O
whom WP O
5 CD O
yielded VBD O
a DT O
response NN O
( -LRB- O
2 CD O
complete JJ O
responses NNS O
for IN O
19+ JJ O
and CC O
40 CD O
months NNS O
and CC O
3 CD O
partial JJ O
responses NNS O
for IN O
4 CD O
, , O
7 CD O
and CC O
8 CD O
months NNS O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
DNA NNP O
sequence NN O
encodes VBZ O
a DT O
protein NN O
of IN O
1520 CD O
amino IN O
acids NNS O
with IN O
sequence NN O
homology NN O
to TO O
the DT O
human JJ B-NP
c-abl NN I-NP
proto-oncogene NN I-NP
product NN I-NP
, , O
beginning VBG O
at IN O
the DT O
amino NN O
terminus NN O
and CC O
extending VBG O
656 CD O
amino IN O
acids NNS O
through IN O
the DT O
region NN O
essential JJ O
for IN O
tyrosine NN B-NP
kinase NN I-NP
activity NN O
. . O

-DOCSTART- X X O

In IN O
64 CD O
% NN O
a DT O
small JJ O
cardiac NN O
vein NN O
does VBZ O
not RB O
exist VB O
, , O
but CC O
its PRP$ O
origin NN O
, , O
the DT O
right JJ O
marginal JJ O
vein NN O
, , O
joins VBZ O
the DT O
system NN O
of IN O
anterior JJ O
cardiac JJ O
veins NNS O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
neuroplasticity NN O
in IN O
the DT O
response NN O
to TO O
drugs NNS O
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

The DT O
results NNS O
of IN O
these DT O
experiments NNS O
indicate VBP O
that IN O
at IN O
least JJS O
two CD O
upstream RB O
activator NN O
sequences NNS O
( -LRB- O
UAS NNP O
) -RRB- O
mediate JJ O
maximum NN O
induction NN O
by IN O
galactose NN O
. . O

-DOCSTART- X X O

Reversal NN O
of IN O
the DT O
increase NN O
in IN O
apomorphine-induced JJ O
stereotypy NN O
and CC O
aggression NN O
in IN O
REM NNP O
sleep NN O
deprived VBD O
rats NNS O
by IN O
dopamine NN O
agonist JJ O
pretreatments NNS O
. . O

-DOCSTART- X X O

The DT O
heart NN O
rate NN O
, , O
respiratory JJ O
rate NN O
, , O
arterial JJ O
O2 NNP O
and CC O
systemic JJ O
vascular JJ O
resistance NN O
were VBD O
not RB O
significantly RB O
altered VBN O
. . O

-DOCSTART- X X O

Human JJ B-NP
rIL-3 JJ I-NP
expressed VBN O
in IN O
COS7 NNP O
cells NNS O
has VBZ O
multipotential JJ O
CSF NNP B-NP
activity NN O
in IN O
semisolid JJ O
cultures NNS O
of IN O
bone NN O
marrow NN O
cells NNS O
, , O
and CC O
selectively RB O
induced VBN O
the DT O
proliferation NN O
of IN O
My-10+ JJ O
marrow NN O
or CC O
cord NN O
blood NN O
cells NNS O
in IN O
liquid JJ O
cultures NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
findings NNS O
suggest VBP O
that IN O
the DT O
mtr NN B-NP
product NN I-NP
causes VBZ O
both DT O
transcription NN O
attenuation NN O
and CC O
inhibition NN O
of IN O
translation NN O
of IN O
trpE JJ B-NP
mRNA NN I-NP
. . O

-DOCSTART- X X O

Apropos NNP O
of IN O
a DT O
case NN O

-DOCSTART- X X O

A DT O
prostaglandin NN O
analogue NN O
given VBN O
in IN O
early JJ O
pregnancy NN O
and CC O
human JJ B-NP
chorionic JJ I-NP
gonadotropin NN I-NP
given VBN O
near IN O
the DT O
end NN O
of IN O
the DT O
ensuing VBG O
follicular JJ O
phase NN O
were VBD O
used VBN O
for IN O
controlling VBG O
the DT O
reproductive JJ O
cycle NN O
, , O
timing VBG O
oocyte NN O
collection NN O
, , O
and CC O
synchronizing VBG O
the DT O
cycles NNS O
of IN O
oocyte NN O
donors NNS O
and CC O
embryo NN O
recipients NNS O
. . O

-DOCSTART- X X O

The DT O
nucleolin NN B-NP
gene NN I-NP
extends VBZ O
over IN O
9000 CD O
base-pairs NNS O
and CC O
is VBZ O
split VBN O
into IN O
14 CD O
exons NNS O
that IN O
encode JJ O
the DT O
706 CD O
amino IN O
acid NN O
residues NNS O
of IN O
the DT O
protein NN O
. . O

-DOCSTART- X X O

Although IN O
L-threo-dihydroxyphenylserine JJ O
( -LRB- O
DOPS) VB O
, , O
an DT O
artificial JJ O
norepinephrine NN O
( -LRB- O
NE NNP O
) -RRB- O
precursor NN O
, , O
did VBD O
not RB O
change VB O
immobility NN O
in IN O
intact JJ O
mice NNS O
, , O
DOPS VB O
significantly RB O
reduced VBN O
immobility NN O
in IN O
mice NNS O
pretreated VBN O
with IN O
the DT O
selective JJ O
NE NNP O
neurotoxin NN O
DSP4 NNP O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
report VBP O
the DT O
complete JJ O
6-kilobase JJ O
cDNA NN O
sequence NN O
coding NN O
for IN O
a DT O
chain NN O
of IN O
1775 CD O
amino IN O
acids NNS O
, , O
as RB O
well RB O
as IN O
the DT O
genomic JJ O
structure NN O
. . O

-DOCSTART- X X O

The DT O
distribution NN O
of IN O
the DT O
sites NNS O
of IN O
recombinational JJ O
resolution NN O
is VBZ O
inversely RB O
correlated VBN O
with IN O
that DT O
of IN O
the DT O
gradient NN O
of IN O
sequence NN O
divergence NN O
, , O
with IN O
only RB O
approximately RB O
7 CD O
% NN O
of IN O
the DT O
X NNP O
recombinants VBZ O
resolved VBN O
within IN O
the DT O
3' JJ O
third JJ O
of IN O
the DT O
X NNP O
blocks NNS O
where WRB O
two CD O
diverged VBN O
Alu NNP B-NP
family NN O
repeats VBZ O
reside NN O
. . O

-DOCSTART- X X O

Potentiation NN O
of IN O
the DT O
thrombolytic JJ O
efficacy NN O
of IN O
single-chain JJ B-NP
urokinase NN I-NP
( -LRB- O
Pro-urokinase NN B-NP
) -RRB- O
by IN O
heparin NN O
. . O

-DOCSTART- X X O

Of IN O
49 CD O
receptors NNS O
which WDT O
fired VBD O
in IN O
phase NN O
with IN O
ventilation NN O
, , O
13 CD O
behaved VBD O
like IN O
mammalian JJ O
rapidly RB O
adapting VBG O
pulmonary JJ O
stretch NN O
receptors NNS O
, , O
19 CD O
like IN O
mammalian JJ O
slowly RB O
adapting VBG O
pulmonary JJ O
stretch NN O
receptors NNS O
( -LRB- O
PSR NN O
) -RRB- O
, , O
and CC O
17 CD O
like IN O
avian JJ O
intrapulmonary JJ O
CO2-sensitive JJ O
chemoreceptors NNS O
( -LRB- O
IPC NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
the DT O
IA NNP O
task NN O
, , O
post-training VBG O
intraperitoneal JJ O
injections NNS O
of IN O
picrotoxin NN O
and CC O
bicuculline NN O
induced VBD O
a DT O
dose-dependent JJ O
enhancement NN O
of IN O
retention NN O
measured VBN O
24 CD O
h NN O
after IN O
the DT O
training NN O
, , O
while IN O
retention NN O
was VBD O
not RB O
affected VBN O
by IN O
bicuculline NN O
methiodide NN O
( -LRB- O
a DT O
GABA NNP B-NP
receptor NN I-NP
antagonist NN O
that WDT O
does VBZ O
not RB O
readily RB O
cross VB O
the DT O
blood-brain NN O
barrier NN O
) -RRB- O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
suggested VBN O
that IN O
the DT O
use NN O
of IN O
endogenous JJ O
creatinine NN O
clearance NN O
to TO O
estimate VB O
the DT O
glomerular JJ O
filtration NN O
rate NN O
( -LRB- O
GFR NN O
) -RRB- O
requires VBZ O
caution NN O
and CC O
the DT O
recognition NN O
of IN O
the DT O
limitations NNS O
of IN O
the DT O
method NN O
, , O
and CC O
that IN O
simpler JJR O
techniques NNS O
( -LRB- O
serum NN O
creatinine VB O
or CC O
estimated VBN O
endogenous JJ O
creatinine JJ O
clearance NN O
) -RRB- O
are VBP O
preferable JJ O
in IN O
routine JJ O
practice NN O
. . O

-DOCSTART- X X O

A DT O
protein NN O
footprint NN O
also RB O
was VBD O
identified VBN O
for IN O
a DT O
GC JJ O
box NN O
element NN O
at IN O
nucleotides NNS O
-59 . O
to TO O
-45 CD O
. . O

-DOCSTART- X X O

The DT O
central JJ O
visual JJ O
fields NNS O
of IN O
2165 CD O
normal JJ O
and CC O
106 CD O
glaucoma NN O
eyes NNS O
were VBD O
measured VBN O
using VBG O
a DT O
threshold NN O
related VBN O
suprathreshold NN O
strategy NN O
. . O

-DOCSTART- X X O

The DT O
variability NN O
is VBZ O
most RBS O
likely JJ O
a DT O
result NN O
of IN O
alternative JJ O
splicing NN O
of IN O
exons NNS O
from IN O
the DT O
primary JJ O
elastin NN B-NP
transcripts NNS I-NP
. . O

-DOCSTART- X X O

The DT O
CHARGE NNP O
association NN O
is VBZ O
a DT O
collection NN O
of IN O
multisystem JJ O
congenital NN O
anomalies NNS O
including VBG O
choanal JJ O
atresia NN O
. . O

-DOCSTART- X X O

Evaluation NN O
of IN O
human JJ O
and CC O
bovine JJ O
modified-hemoglobin NN O
solution NN O
as IN O
oxygen-carrying NN O
fluid NN O
for IN O
blood NN O
volume NN O
replacement NN O
. . O

-DOCSTART- X X O

26 CD O
micrograms NNS O
PAF NNP B-NP
or CC O
placebo NN O
was VBD O
sprayed VBN O
into IN O
each DT O
nasal JJ O
cavity NN O
8 CD O
h NN O
and CC O
1 CD O
h NN O
before IN O
a DT O
nasal JJ O
allergen NN O
challenge NN O
. . O

-DOCSTART- X X O

Sci NNS O
. . O

-DOCSTART- X X O

Chem NNP O
. . O

-DOCSTART- X X O

Comparison NNP O
was VBD O
made VBN O
with IN O
other JJ O
neuroradiological JJ O
imaging NN O
modalities NNS O
including VBG O
CT NNP O
, , O
myelography NN O
, , O
CT NNP O
ventriculography NN O
, , O
and CC O
CT NNP O
myelocisternography NN O
. . O

-DOCSTART- X X O

The DT O
test NN O
for IN O
alpha-naphthyl NN B-NP
esterase NN I-NP
and CC O
quantitation NN O
of IN O
macrophages NNS O
( -LRB- O
absolute JJ O
number NN O
) -RRB- O
per IN O
infiltration NN O
area NN O
unit NN O
adjacent JJ O
to TO O
the DT O
abscess NN O
suggest VBP O
a DT O
direct JJ O
correlation NN O
between IN O
the DT O
absolute JJ O
number NN O
of IN O
macrophages NNS O
and CC O
the DT O
width NN O
of IN O
the DT O
capsule NN O
. . O

-DOCSTART- X X O

Determined VBN O
as IN O
migration NN O
differentials NNS O
, , O
chemotactic NN O
and CC O
chemokinetic JJ O
responsiveness NN O
tended VBD O
to TO O
be VB O
higher JJR O
in IN O
the DT O
neutropenic JJ O
group NN O
. . O

-DOCSTART- X X O

The DT O
deduced VBN O
96-residue JJ O
amino IN O
acid NN O
coding NN O
sequence NN O
of IN O
the DT O
murine NN O
HMG-I( JJ B-NP
Y NNP I-NP
) -RRB- I-NP
cDNA NN O
is VBZ O
very RB O
similar JJ O
to TO O
the DT O
reported VBN O
amino IN O
acid NN O
sequence NN O
of IN O
human JJ O
HMG-I NN B-NP
, , O
except IN O
that IN O
it PRP O
lacks VBZ O
11 CD O
internal JJ O
amino NN O
acids NNS O
reported VBD O
in IN O
the DT O
human JJ O
protein NN O
. . O

-DOCSTART- X X O

Interpersonal JJ O
style NN O
differences NNS O
among IN O
drug NN O
abusers NNS O
were VBD O
explored VBN O
using VBG O
Ryan NNP O
's POS O
( -LRB- O
1977 CD O
) -RRB- O
typological JJ O
system NN O
of IN O
FIRO-B NNP O
interpretation NN O
. . O

-DOCSTART- X X O

Sera NN O
from IN O
euthyroid NN O
post-menopausal JJ O
or CC O
pregnant JJ O
women NNS O
yielded VBD O
TSH NNP B-NP
levels NNS O
within IN O
the DT O
normal JJ O
range NN O
. . O

-DOCSTART- X X O

No DT O
UOxase NN B-NP
mRNA NN I-NP
was VBD O
detected VBN O
in IN O
11 CD O
nonhepatic JJ O
tissues NNS O
of IN O
rat NN O
, , O
suggesting VBG O
tissue NN O
specificity NN O
of IN O
expression NN O
of IN O
this DT O
UOxase NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
results NNS O
presented VBD O
suggest VBP O
that IN O
TIQ NNP O
reduces VBZ O
the DT O
turnover NN O
rate NN O
of IN O
the DT O
nigrostriatal JJ O
dopamine NN O
neurons NNS O
after IN O
repeated VBN O
administration NN O
for IN O
a DT O
long JJ O
period NN O
in IN O
mice NNS O
. . O

-DOCSTART- X X O

The DT O
glomerular JJ O
filtration NN O
rate NN O
did VBD O
not RB O
change NN O
but CC O
lithium NN O
clearance NN O
fell VBD O
by IN O
30 CD O
% NN O
. . O

-DOCSTART- X X O

The DT O
pathogenesis NN O
of IN O
Dupuytren NNP O
's POS O
contracture NN O

-DOCSTART- X X O

An DT O
ELISA NNP O
procedure NN O
was VBD O
developed VBN O
for IN O
monitoring VBG O
the DT O
specific JJ O
IgE NN B-NP
response NN O
in IN O
dogs NNS O
to TO O
Dirofilaria NNP O
immitis NN O
infection NN O
. . O

-DOCSTART- X X O

Fifty CD O
min NN O
after IN O
release NN O
from IN O
stress NN O
, , O
increases NNS O
in IN O
plasma NN O
corticosterone NN O
levels NNS O
induced VBN O
by IN O
stress NN O
recovered VBN O
in IN O
the DT O
biting JJ O
group NN O
but CC O
remained VBD O
high JJ O
in IN O
the DT O
non-biting JJ O
group NN O
. . O

-DOCSTART- X X O

The DT O
only JJ O
isolate NN O
of IN O
Aeromonas NNP O
hydrophila NN O
produced VBD O
cytotoxic JJ O
enterotoxin NN O
and CC O
was VBD O
invasive JJ O
. . O

-DOCSTART- X X O

Variety NNP O
of IN O
cows NNS O
and CC O
sires NNS O
according VBG O
to TO O
types NNS O
of IN O
dermatoglyphics NNS O
( -LRB- O
patterns NNS O
) -RRB- O
of IN O
the DT O
nose-labial JJ O
mirror NN O
of IN O
cattle NNS O

-DOCSTART- X X O

Although IN O
not RB O
consistently RB O
identified VBN O
in IN O
all DT O
samples NNS O
, , O
secondary JJ O
Academic NNP O
, , O
Personal NNP O
Responsibility NNP O
, , O
and CC O
Community/Vocational NNP O
dimensions NNS O
were VBD O
also RB O
identified VBN O
. . O

-DOCSTART- X X O

Not RB O
even RB O
extensive JJ O
pancreatic JJ O
resection NN O
could MD O
prevent VB O
pancreatic JJ O
remnant JJ O
infection NN O
. . O

-DOCSTART- X X O

It PRP O
has VBZ O
been VBN O
calculated VBN O
that IN O
600,000 CD O
new JJ O
cases NNS O
of IN O
lung NN O
cancer NN O
occur VBP O
worldwide RB O
every DT O
year NN O
, , O
most JJS O
of IN O
them PRP O
due JJ O
to TO O
smoking NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
the DT O
methods NNS O
of IN O
cutaneous JJ O
administration NN O
of IN O
methyl NN O
isobutyl NN O
ketone NN O
on IN O
its PRP$ O
toxicity NN O

-DOCSTART- X X O

Incorporation NN O
of IN O
0.1 CD O
or CC O
0.2 CD O
M NNP O
sodium NN O
dihydrogen NN O
phosphate NN O
in IN O
the DT O
sugar NN O
solutions NNS O
resulted VBD O
in IN O
a DT O
decrease NN O
in IN O
the DT O
shelf-life NN O
of IN O
diltiazem NN O
. . O

-DOCSTART- X X O

Increasing VBG O
the DT O
phosphorus NN O
content NN O
of IN O
the DT O
diet NN O
improved VBD O
the DT O
reabsorption NN O
of IN O
calcium NN O
and CC O
magnesium NN O
. . O

-DOCSTART- X X O

The DT O
increase NN O
in IN O
amplitudes NNS O
of IN O
the DT O
b-wave NN O
during IN O
the DT O
adaptation NN O
period NN O
was VBD O
more RBR O
prominent JJ O
in IN O
lead-exposed JJ O
subjects NNS O
than IN O
in IN O
controls NNS O
. . O

-DOCSTART- X X O

Possible JJ O
factors NNS O
for IN O
the DT O
development NN O
of IN O
psychotic JJ O
symptomatology NN O
during IN O
group NN O
activities NNS O
and CC O
the DT O
role NN O
of IN O
group NN O
dynamics NNS O
acting VBG O
as IN O
stress NN O
factors NNS O
precipitating VBG O
functional JJ O
psychoses NNS O
, , O
especially RB O
bipolar JJ O
manifestations NNS O
, , O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

Baseline NN O
measurements NNS O
of IN O
forced JJ O
expiratory NN O
volume NN O
in IN O
1 CD O
s VBZ O
( -LRB- O
FEV1 CC O
) -RRB- O
, , O
specific JJ O
airway NN O
conductance NN O
(SGaw NN O
) -RRB- O
and CC O
the DT O
provocative JJ O
dose NN O
of IN O
carbachol NN O
causing VBG O
a DT O
35 CD O
% NN O
reduction NN O
in IN O
SGaw NNP O
( -LRB- O
PD35 NN O
) -RRB- O
, , O
and CC O
a DT O
20 CD O
% NN O
reduction NN O
in IN O
FEV1 NNP O
( -LRB- O
PD20 NN O
) -RRB- O
were VBD O
established VBN O
on IN O
entry NN O
while IN O
each DT O
subject NN O
was VBD O
still RB O
smoking VBG O
. . O

-DOCSTART- X X O

The DT O
results NNS O
indicate VBP O
that IN O
the DT O
pooling NN O
requirements NNS O
are VBP O
task NN O
dependent JJ O
. . O

-DOCSTART- X X O

In IN O
the DT O
infected JJ O
neonates NNS O
serum NN O
alpha-amylase NN B-NP
value NN O
, , O
as IN O
determined VBN O
by IN O
the DT O
blue JJ O
starch NN O
method NN O
, , O
was VBD O
only RB O
40 CD O
% NN O
that IN O
of IN O
healthy JJ O
controls NNS O
; : O
the DT O
mean JJ O
value NN O
of IN O
175.1 CD O
+/ NNS O
- : O
64.9 CD O
IU/l NN O
for IN O
healthy JJ O
neonates NNS O
was VBD O
significantly RB O
higher JJR O
( -LRB- O
p NN O
less JJR O
than IN O
0.0010 CD O
) -RRB- O
than IN O
the DT O
value NN O
of IN O
82.8 CD O
+/ NNS O
- : O
44.4 CD O
IU/l NN O
for IN O
the DT O
infected JJ O
neonates NNS O
. . O

-DOCSTART- X X O

Records NNP O
of IN O
31 CD O
children NNS O
with IN O
AIDS NNP O
or CC O
AIDS-related NNP O
complex NN O
admitted VBD O
to TO O
the DT O
pediatric JJ O
intensive JJ O
care NN O
unit NN O
for IN O
acute JJ O
respiratory JJ O
failure NN O
throughout IN O
a DT O
46-month JJ O
period NN O
were VBD O
reviewed VBN O
. . O

-DOCSTART- X X O

Fourteen CD O
patients NNS O
were VBD O
in IN O
the DT O
multifocal JJ O
disease NN O
group NN O
; : O
13 CD O
were VBD O
detected VBN O
by IN O
SPECT NNP O
and CC O
10 CD O
by IN O
TCT. NNP O

-DOCSTART- X X O

SPECT NNP O
is VBZ O
an DT O
important JJ O
aid NN O
in IN O
the DT O
diagnosis NN O
of IN O
AIDS NNP O
dementia NN O
complex NN O
and CC O
contributes NNS O
to TO O
the DT O
understanding NN O
of IN O
the DT O
pathophysiological JJ O
mechanisms NNS O
of IN O
this DT O
disorder NN O
. . O

-DOCSTART- X X O

We PRP O
were VBD O
interested VBN O
in IN O
studying VBG O
the DT O
relationship NN O
between IN O
the DT O
circadian NN O
rhythm NN O
in IN O
body NN O
temperature NN O
and CC O
24-h JJ O
variations NNS O
in IN O
plasma NN O
concentrations NNS O
of IN O
iron NN O
, , O
zinc NN O
, , O
circulating VBG O
leukocyte NN O
counts NNS O
, , O
and CC O
plasma NN O
interleukin NN B-NP
1 CD I-NP
( -LRB- O
IL-1 NN B-NP
) -RRB- O
activity NN O
. . O

-DOCSTART- X X O

The DT O
murine NN B-NP
MHC NNP I-NP
class NN I-NP
I PRP I-NP
genes NNS I-NP
, , O
H-2Dq JJ B-NP
and CC O
H-2Lq JJ B-NP
, , O
are VBP O
strikingly RB O
homologous JJ O
to TO O
each DT O
other JJ O
, , O
H-2Ld JJ B-NP
, , O
and CC O
two CD O
genes NNS O
reported VBD O
to TO O
encode VB O
tumor-specific JJ O
antigens NNS O
. . O

-DOCSTART- X X O

The DT O
active JJ O
derivatives NNS O
of IN O
the DT O
present JJ O
series NN O
were VBD O
also RB O
tested VBN O
for IN O
their PRP$ O
analgesic JJ O
activity NN O
against IN O
aconitine-induced JJ O
writhing NN O
in IN O
albino DT O
mice NNS O
and CC O
ulcerogenic JJ O
activity NN O
in IN O
albino NN O
rats NNS O
. . O

-DOCSTART- X X O

In IN O
untreated JJ O
mice NNS O
, , O
bactericidal JJ O
activity NN O
of IN O
peritoneal NN O
macrophages NNS O
decreased VBD O
from IN O
one CD O
day NN O
to TO O
3 CD O
days NNS O
after IN O
ip NN O
injection NN O
of IN O
killed VBN O
L. NNP O
monocytogenes NNS O
. . O

-DOCSTART- X X O

Among IN O
a DT O
population NN O
of IN O
18,175 CD O
children NNS O
below IN O
7 CD O
years NNS O
of IN O
age NN O
in IN O
medium NN O
sized VBD O
towns NNS O
and CC O
rural JJ O
areas NNS O
in IN O
south-western JJ O
Germany NNP O
552 CD O
( -LRB- O
3.03 CD O
% NN O
) -RRB- O
cases NNS O
of IN O
croup NN O
were VBD O
registered VBN O
during IN O
a DT O
12 CD O
months NNS O
period NN O
in IN O
1984-85 CD O
by IN O
their PRP$ O
physicians NNS O
. . O

-DOCSTART- X X O

We PRP O
concluded VBD O
that IN O
Ga-fbg JJ O
scintigraphy NN O
is VBZ O
a DT O
very RB O
simple JJ O
method NN O
and CC O
sufficiently RB O
useful JJ O
for IN O
detecting VBG O
active JJ O
left VBN O
ventricular JJ O
thrombi NN O
and CC O
for IN O
monitoring VBG O
the DT O
effect NN O
of IN O
anticoagulant JJ O
therapy NN O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
assessment NN O
of IN O
the DT O
biocompatibility NN O
of IN O
dental JJ O
materials--the NN O
millipore , O
filter NN O
method NN O
. . O

-DOCSTART- X X O

Hypomagnesemia NNP O
was VBD O
due JJ O
to TO O
magnesium VB O
wasting VBG O
by IN O
the DT O
kidney NN O
. . O

-DOCSTART- X X O

Dentalplaque NNP O
was VBD O
controlled VBN O
by IN O
the DT O
oral JJ O
higienic JJ O
index NN O
of IN O
the DT O
whole JJ O
dentition NN O
daily RB O
, , O
after IN O
staining VBG O
with IN O
1 CD O
per IN O
cent NN O
alkaline NN O
fuxin NN O
. . O

-DOCSTART- X X O

GRFI NNP B-NP
bound VBD O
to TO O
sequences NNS O
at IN O
the DT O
negative JJ O
regulatory JJ O
elements NNS O
( -LRB- O
silencers NNS O
) -RRB- O
of IN O
the DT O
silent JJ B-NP
mating NN I-NP
type NN I-NP
loci NNS I-NP
HML NNP B-NP
E NNP I-NP
and CC O
HMR NNP B-NP
E NNP I-NP
and CC O
to TO O
the DT O
upstream JJ O
activating NN O
sequence NN O
( -LRB- O
UAS NNP O
) -RRB- O
required VBN O
for IN O
transcription NN O
of IN O
the DT O
MAT NN B-NP
alpha NN I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
these DT O
mutations NNS O
on IN O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
activity NN O
were VBD O
assayed VBN O
by IN O
measuring VBG O
the DT O
ability NN O
of IN O
mutant JJ O
genes NNS O
to TO O
confer VB O
alpha-amanitin JJ B-NP
resistance NN O
after IN O
transfection NN O
of IN O
susceptible JJ O
rodent NN O
cells NNS O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
the DT O
use NN O
of IN O
a DT O
new JJ O
technetium-99m-albumin NN O
colloid JJ O
white JJ O
blood NN O
cell NN O
( -LRB- O
TAC-WBC JJ O
) -RRB- O
scan NN O
in IN O
the DT O
evaluation NN O
of IN O
appendicitis NN O
. . O

-DOCSTART- X X O

The DT O
SSB-poly(dT NNP B-NP
) -RRB- O
affinity NN O
is VBZ O
too RB O
high JJ O
to TO O
measure VB O
in IN O
buffers NNS O
containing VBG O
even RB O
5 CD O
M NNP O
NaCl NNP O
; : O
however RB O
, , O
in IN O
1.8-2.5 CD O
M NNP O
NaBr NNP O
, , O
we PRP O
measure NN O
alpha NN O
log VBP O
Kobsd/alpha NNP O
log VBP O
[NaBr RB O
] SYM O
= SYM O
-5.7 : O
+/ VBP O
- : O
0.7 CD O
, , O
with IN O
a DT O
lower JJR O
value NN O
of IN O
omega JJ O
T/O NNP O
= SYM O
130 CD O
+/ CD O
- : O
70 CD O
. . O

-DOCSTART- X X O

The DT O
behavior NN O
of IN O
suf12-null/SUF12+ JJ B-NP
heterozygotes NNS I-NP
indicates VBZ O
that IN O
suf12 NN B-NP
is VBZ O
co-dominantly RB O
expressed VBN O
and CC O
suggests VBZ O
that IN O
suf12 NN B-NP
allele-specific JJ O
suppression NN O
may MD O
result VB O
from IN O
functionally RB O
distinct JJ O
mutant JJ O
proteins NNS O
rather RB O
than IN O
variation NN O
in IN O
residual JJ O
wild-type JJ B-NP
SUF12+ JJ I-NP
activity NN O
. . O

-DOCSTART- X X O

Antituberculosis VBG O
agents NNS O
. . O

-DOCSTART- X X O

The DT O
putative JJ O
immunity NN O
protein NN O
was VBD O
detected VBN O
among IN O
the DT O
[35S]methionine-labelled JJ O
proteins NNS O
produced VBN O
by IN O
minicells NNS O
carrying VBG O
cni NNS B-NP
cloned VBN O
under IN O
lac NN B-NP
promoter NN I-NP
control NN O
, , O
and CC O
when WRB O
the DT O
gene NN O
was VBD O
subcloned VBN O
into IN O
expression NN O
vectors NNS O
under IN O
the DT O
control NN O
of IN O
a DT O
bacteriophage JJ O
T7 NN O
promoter NN O
. . O

-DOCSTART- X X O

Antibodies NNS O
made VBD O
against IN O
fusion NN O
protein NN O
produced VBN O
by IN O
the DT O
DP1A NNP B-NP
clone NN O
reacted VBD O
specifically RB O
with IN O
DP-I JJ B-NP
and CC I-NP
-II JJ I-NP
on IN O
immunoblots NNS O
. . O

-DOCSTART- X X O

Stable JJ O
patients NNS O
have VBP O
mucous JJ O
hypersecretion NN O
and CC O
little JJ O
evidence NN O
of IN O
acute JJ O
inflammation NN O
. . O

-DOCSTART- X X O

Hyperprolactinaemia NNP O
, , O
moderate JJ O
hypogonadism NN O
, , O
infraclinical JJ O
neuropathies NNS O
, , O
arterial JJ O
stenoses NNS O
and CC O
moderate JJ O
venous JJ O
leakages NNS O
seem VBP O
to TO O
play VB O
a DT O
partial JJ O
role NN O
of IN O
organic JJ O
starter NN O
or CC O
cofactor NN O
, , O
the DT O
sexual JJ O
consequences NNS O
of IN O
which WDT O
are VBP O
amplified VBN O
by IN O
psychological JJ O
factors NNS O
, , O
partly RB O
secondary JJ O
to TO O
the DT O
initial JJ O
sexual JJ O
failures NNS O
. . O

-DOCSTART- X X O

Yang NNP O
and CC O
H. NNP O

-DOCSTART- X X O

Six CD O
healthy JJ O
male JJ O
subjects NNS O
received VBN O
single JJ O
oral JJ O
doses NNS O
of IN O
regular JJ O
release NN O
( -LRB- O
RR NN O
) -RRB- O
quinidine NN O
sulfate NN O
, , O
sustained VBD O
release NN O
( -LRB- O
SR NN O
) -RRB- O
quinidine NN O
bisulfate NN O
and CC O
the DT O
same JJ O
dose NN O
of IN O
the DT O
SR NNP O
product NN O
with IN O
food NN O
( -LRB- O
SR-F) NNP O
. . O

-DOCSTART- X X O

This DT O
report NN O
expands VBZ O
on IN O
previous JJ O
work NN O
with IN O
interferon NN B-NP
alfa-2b NN I-NP
( -LRB- I-NP
Intron NNP I-NP
A NNP I-NP
; : I-NP
Schering-Plough NNP I-NP
) -RRB- I-NP
in IN O
the DT O
treatment NN O
of IN O
hairy JJ O
cell NN O
leukemia NN O
( -LRB- O
HCL) NNP O
. . O

-DOCSTART- X X O

Clinical NNP O
chemistry NN O
. . O

-DOCSTART- X X O

Revascularization NN O
after IN O
anterior JJ O
maxillary NN O
and CC O
mandibular JJ O
osteotomy NN O

-DOCSTART- X X O

Static JJ O
orthoses NNS O
for IN O
the DT O
management NN O
of IN O
microstomia NN O
. . O

-DOCSTART- X X O

The DT O
intrapancreatic JJ O
spread NN O
of IN O
the DT O
carcinoma NN O
correlated VBN O
with IN O
portal JJ O
invasion NN O
of IN O
carcinoma NN O
, , O
hardness NN O
of IN O
the DT O
body NN O
and CC O
tail NN O
, , O
obstruction NN O
of IN O
main JJ O
pancreatic JJ O
duct NN O
and CC O
irregular JJ O
pancreaticogram NN O
. . O

-DOCSTART- X X O

Lysosomal JJ O
enzymes NNS O
that IN O
degrade NN O
cartilage NN O
are VBP O
released VBN O
. . O

-DOCSTART- X X O

Contrary NNP O
to TO O
the DT O
observation NN O
made VBN O
with IN O
other JJ O
S. NNP O
pombe NN O
genes NNS O
transcribed VBN O
in IN O
the DT O
budding VBG O
yeast NN O
, , O
the DT O
heterologous JJ O
actin NN B-NP
gene NN I-NP
transcript NN I-NP
is VBZ O
initiated VBN O
39 CD O
nucleotides NNS O
upstream RB O
of IN O
the DT O
initiation NN O
start NN O
site NN O
used VBN O
in IN O
the DT O
homologous JJ O
yeast NN O
. . O

-DOCSTART- X X O

A DT O
multicentre JJ O
study NN O
involving VBG O
9 CD O
Italian JJ O
institutions NNS O
was VBD O
carried VBN O
out RP O
to TO O
compare VB O
the DT O
efficacy NN O
and CC O
safety NN O
of IN O
ranitidine NN O
150 CD O
mg NN O
b.i.d NN O
. . O
and CC O
ranitidine JJ O
300 CD O
mg NN O
nocte NN O
in IN O
the DT O
treatment NN O
of IN O
reflux NN O
oesophagitis NN O
. . O

-DOCSTART- X X O

Proctoscopy NNP O
and CC O
roentgenographic JJ O
studies NNS O
may MD O
be VB O
an DT O
important JJ O
part NN O
of IN O
evaluation NN O
, , O
especially RB O
in IN O
patients NNS O
who WP O
present VBP O
with IN O
perianal JJ O
suppuration NN O
, , O
masses NNS O
, , O
or CC O
anal NN O
fissures NNS O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
to TO O
this DT O
mRNA NN O
, , O
90 CD O
% NN O
of IN O
alpha NN B-NP
and CC I-NP
beta JJ I-NP
actin NN I-NP
mRNAs NNS I-NP
were VBD O
translated VBN O
in IN O
both DT O
myoblasts NNS O
and CC O
myotubes NNS O
. . O

-DOCSTART- X X O

Plasma NNP B-NP
renin NN I-NP
activity NN O
does VBZ O
not RB O
predict VB O
the DT O
antihypertensive JJ O
efficacy NN O
of IN O
chlorthalidone NN O
. . O

-DOCSTART- X X O

Cephradine NNP O
250 CD O
mg NN O
at IN O
night NN O
for IN O
12 CD O
months NNS O
was VBD O
given VBN O
as IN O
a DT O
prophylactic JJ O
measure NN O
to TO O
33 CD O
female NN O
patients NNS O
of IN O
mean JJ O
age NN O
41.6 CD O
years NNS O
, , O
who WP O
had VBD O
a DT O
history NN O
in IN O
the DT O
preceding VBG O
12 CD O
months NNS O
of IN O
between IN O
three CD O
and CC O
24 CD O
( -LRB- O
median NN O
= SYM O
7 CD O
) -RRB- O
episodes NNS O
of IN O
frequency NN O
and/or CC O
dysuria NN O
. . O

-DOCSTART- X X O

If IN O
this DT O
is VBZ O
unavailable JJ O
, , O
then RB O
Supramid NNP O
has VBZ O
a DT O
proven VBN O
record NN O
for IN O
good JJ O
tissue NN O
compatibility NN O
and CC O
resistance NN O
to TO O
infection NN O
. . O

-DOCSTART- X X O

The DT O
activity NN O
of IN O
the DT O
EGF NN B-NP
receptor NN I-NP
promoter NN I-NP
can MD O
be VB O
modulated VBN O
by IN O
E1A JJ B-NP
protein NN I-NP
and CC O
receptor NN O
RNA NN O
levels NNS O
increased VBN O
by IN O
stimulation NN O
with IN O
phorbol NN O
ester NN O
or CC O
fetal NN O
calf NN O
serum NN O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
antimalarial JJ O
activity NN O
of IN O
neem NN O
( -LRB- O
Azadirachta NN O
indica NN O
A. NN O

-DOCSTART- X X O

" `` O
In IN O
vitro NN O
" `` O
study NN O
of IN O
dentin NN O
adhesion NN O
to TO O
adhesives NNS O
made VBN O
from IN O
urethane NN O
molecules NNS O
with IN O
free JJ O
groups NNS O
of IN O
isocyanate JJ O

-DOCSTART- X X O

Hand-held JJ O
, , O
continuous-wave JJ O
Doppler NNP O
probes NNS O
, , O
coupled VBN O
with IN O
sound JJ O
spectral JJ O
analysis NN O
, , O
can MD O
successfully RB O
predict VB O
carotid JJ O
artery NN O
stenosis NN O
. . O

-DOCSTART- X X O

The DT O
program NN O
has VBZ O
been VBN O
written VBN O
in IN O
a DT O
generic JJ O
BASIC NN O
in IN O
order NN O
to TO O
make VB O
the DT O
procedure NN O
user-friendly NN O
. . O

-DOCSTART- X X O

Fifty-four CD O
patients NNS O
were VBD O
divided VBN O
into IN O
groups NNS O
according VBG O
to TO O
their PRP$ O
clinical JJ O
presentation NN O
; : O
seven CD O
asymptomatic JJ O
volunteers NNS O
, , O
20 CD O
patients NNS O
with IN O
duodenal-gastric JJ O
reflux NN O
gastropathy NN O
( -LRB- O
DRG NN O
) -RRB- O
, , O
16 CD O
patients NNS O
with IN O
recurrent JJ O
ulcers NNS O
of IN O
the DT O
duodenal JJ O
bulb NN O
( -LRB- O
RUD) NNP O
, , O
and CC O
11 CD O
patients NNS O
with IN O
Moynihan NNP O
's POS O
disease NN O
. . O

-DOCSTART- X X O

High NNP O
concentrations NNS O
of IN O
tumor-associated JJ O
trypsin NN B-NP
inhibitor NN O
in IN O
hemodialyzed JJ O
patients NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
chicken NN O
liver NN O
, , O
levels NNS O
of IN O
chicken NN B-NP
MT NNP I-NP
mRNA . I-NP
were VBD O
rapidly RB O
induced VBN O
by IN O
metals NNS O
( -LRB- O
Cd2+ NNP O
, , O
Zn2+ NNP O
, , O
Cu2+ NNP O
) -RRB- O
, , O
glucocorticoids NNS O
and CC O
lipopolysaccharide NN O
. . O

-DOCSTART- X X O

With IN O
histology NN O
and CC O
Evans NNP O
blue JJ O
injections NNS O
, , O
blood-brain NN O
barrier NN O
alterations NNS O
were VBD O
seen VBN O
as RB O
early RB O
as IN O
4 CD O
days NNS O
after IN O
a DT O
dose NN O
of IN O
50 CD O
Gy NNP O
. . O

-DOCSTART- X X O

Dosimetric NNP O
estimates VBZ O
for IN O
these DT O
organs NNS O
were VBD O
2.3 CD O
+/ CD O
- : O
1.1 CD O
and CC O
2.3 CD O
+/ NNS O
- : O
1.4 CD O
rad NN O
( -LRB- O
.02 CD O
+/ NN O
- : O
.01 JJ O
Gy NNP O
) -RRB- O
, , O
respectively RB O
, , O
with IN O
a DT O
whole-body JJ O
estimate NN O
of IN O
0.28 CD O
rad NN O
( -LRB- O
.003 JJ O
Gy NNP O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
significant JJ O
association NN O
between IN O
a DT O
family NN O
history NN O
and CC O
a DT O
higher JJR O
urinary JJ O
pH NNS O
was VBD O
observed VBN O
among IN O
the DT O
female JJ O
calcium NN O
stone NN O
patients NNS O
. . O

-DOCSTART- X X O

New NNP O
technologies NNS O
in IN O
diagnosis NN O
and CC O
classification NN O
of IN O
malignancy NN O
. . O

-DOCSTART- X X O

Thus RB O
the DT O
present JJ O
data NNS O
also RB O
suggest VBP O
that IN O
BP NNP O
and CC O
HR NNP O
measurements NNS O
are VBP O
influenced VBN O
not RB O
only RB O
by IN O
state-dependent JJ O
factors NNS O
but CC O
also RB O
by IN O
at IN O
least JJS O
three CD O
different JJ O
factors NNS O
that WDT O
are VBP O
each DT O
independent JJ O
of IN O
the DT O
state NN O
: : O
one CD O
leads VBZ O
to TO O
BP NNP O
and CC O
HR NNP O
values NNS O
that WDT O
are VBP O
influenced VBN O
by IN O
the DT O
cycle NN O
the DT O
animal NN O
is VBZ O
in IN O
and CC O
the DT O
other JJ O
two CD O
influence NN O
, , O
respectively RB O
, , O
the DT O
ranking NN O
of IN O
the DT O
individual NN O
's POS O
BP NNP O
and CC O
HR NNP O
levels NNS O
within IN O
the DT O
population NN O
. . O

-DOCSTART- X X O

The DT O
correlation NN O
between IN O
PaCO2 NNP O
and CC O
PtcO2 NNP O
in IN O
RDS NNP O
was VBD O
insufficient JJ O
to TO O
make VB O
clinical JJ O
judgement NN O
. . O

-DOCSTART- X X O

One CD O
millimolar JJ O
ouabain NN O
completely RB O
inhibited VBD O
net JJ O
HCO3- CC O
secretion NN O
. . O

-DOCSTART- X X O

The DT O
same JJ O
rhythmic JJ O
structure NN O
enables VBZ O
a DT O
prediction NN O
to TO O
be VB O
made VBN O
concerning VBG O
when WRB O
vowels NNS O
of IN O
stressed VBN O
syllables NNS O
will MD O
be VB O
auditorily RB O
perceived VBN O
. . O

-DOCSTART- X X O

Vocal NNP O
cord NN O
abduction NN O
rehabilitation NN O
by IN O
nervous JJ O
selective JJ O
anastomosis NN O
. . O

-DOCSTART- X X O

UK NNP O
's POS O
biotechnology NN O
lacking VBG O
specialists NNS O
. . O

-DOCSTART- X X O

A DT O
case NN O
of IN O
AIDS-related JJ O
complex NN O
( -LRB- O
ARC/LAS NNP O
) -RRB- O
in IN O
a DT O
health NN O
worker NN O

-DOCSTART- X X O

Distant NNP O
spread NN O
was VBD O
found VBN O
in IN O
46 CD O
patients NNS O
( -LRB- O
34 CD O
% NN O
) -RRB- O
, , O
42 CD O
of IN O
whom WP O
had VBD O
serum NN O
Tg RB B-NP
greater JJR O
than IN O
10 CD O
micrograms/l NN O
. . O

-DOCSTART- X X O

After IN O
the DT O
meal NN O
containing VBG O
potato NN O
, , O
plasma NN O
glucose NN O
levels NNS O
rose VBD O
sharply RB O
, , O
peaked VBD O
at IN O
30-45 CD O
min NN O
and CC O
fell VBD O
below IN O
initial JJ O
levels NNS O
2 CD O
to TO O
3 CD O
h NN O
later RB O
. . O

-DOCSTART- X X O

The DT O
relations NNS O
among IN O
various JJ O
negative JJ O
emotional JJ O
and CC O
behavioral JJ O
characteristics NNS O
( -LRB- O
e NN O
.g. NNP O
, , O
aggression NN O
, , O
anxiety NN O
, , O
undercompliance NN O
, , O
depressive JJ O
mood NN O
) -RRB- O
and CC O
adjustment NN O
were VBD O
examined VBN O
through IN O
use NN O
of IN O
data NNS O
from IN O
the DT O
31-year-old JJ O
New NNP O
York NNP O
Longitudinal NNP O
Study NNP O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
improved VBN O
our PRP$ O
system NN O
for IN O
nuclear JJ O
contour NN O
digitization NN O
and CC O
determined VBD O
its PRP$ O
theoretical JJ O
limitations NNS O
by IN O
digitizing VBG O
standardized JJ O
objects NNS O
. . O

-DOCSTART- X X O

The DT O
skin NN O
site NN O
, , O
6-cm-distal JJ O
and CC O
-proximal JJ O
subcutaneous JJ O
segments NNS O
of IN O
the DT O
catheter NN O
, , O
exudates NNS O
, , O
and CC O
blood NN O
were VBD O
cultured VBN O
. . O

-DOCSTART- X X O

Because IN O
of IN O
its PRP$ O
great JJ O
reliability NN O
, , O
conventional JJ O
arteriography NN O
occupies VBZ O
a DT O
place NN O
of IN O
choice NN O
among IN O
the DT O
medical JJ O
imaging NN O
techniques NNS O
. . O

-DOCSTART- X X O

Rapid NNP O
detection NN O
of IN O
radioisotopically RB O
contaminated VBN O
test NN O
serum NN O
before IN O
radioassay NN O
of IN O
vitamin NN O
B12 NN O
. . O

-DOCSTART- X X O

The DT O
former JJ O
group NN O
did VBD O
excrete RB O
less JJR O
dry JJ O
fecal NN O
material NN O
compared VBN O
to TO O
both DT O
other JJ O
groups NNS O
. . O

-DOCSTART- X X O

The DT O
maximum JJ O
deflections NNS O
of IN O
phase NN O
IV NNP O
for IN O
Ar NNP O
and CC O
N2 NNP O
from IN O
extrapolated JJ O
phase NN O
III NNP O
slopes NNS O
were VBD O
smaller JJR O
in IN O
the DT O
prone JJ O
position NN O
, , O
suggesting VBG O
more RBR O
uniform JJ O
tracer NN O
gas NN O
concentrations NNS O
across IN O
the DT O
lungs NNS O
. . O

-DOCSTART- X X O

Recent JJ O
developments NNS O
in IN O
drugs NNS O
antagonistic JJ O
to TO O
factors NNS O
causing VBG O
peptic JJ O
ulcer--clinical JJ O
efficacy NN O
and CC O
problems NNS O
; : O
gastrin NN B-NP
receptor NN I-NP
blockaders NNS O

-DOCSTART- X X O

Static JJ O
magnetic JJ O
fields NNS O
affect VBP O
the DT O
diffusion NN O
of IN O
biological JJ O
particles NNS O
in IN O
solutions NNS O
through IN O
the DT O
Lorentz NNP O
force NN O
and CC O
Maxwell NNP O
stress NN O
. . O

-DOCSTART- X X O

SPA NNP O
from IN O
PAG NNP O
sites NNS O
was VBD O
associated VBN O
with IN O
aversion NN O
. . O

-DOCSTART- X X O

The DT O
artery NN O
cuff NN O
was VBD O
slightly RB O
superior JJ O
to TO O
the DT O
fat JJ O
wrap NN O
, , O
particularly RB O
in IN O
having VBG O
fewer JJR O
adhesions NNS O
and CC O
a DT O
better JJR O
histological JJ O
picture NN O
. . O

-DOCSTART- X X O

The DT O
development NN O
and CC O
distribution NN O
of IN O
Trypanosoma NNP O
congolense NN O
, , O
T NNP O
vivax , O
and CC O
T NNP O
brucei NN O
in IN O
the DT O
skin NN O
of IN O
goats NNS O
was VBD O
examined VBN O
after IN O
the DT O
animals NNS O
were VBD O
bitten VBN O
by IN O
infected JJ O
Glossina NNP O
morsitans NNS O
centralis NNS O
. . O

-DOCSTART- X X O

Electroglottography NNP O
is VBZ O
a DT O
useful JJ O
, , O
non-invasive JJ O
technique NN O
that WDT O
can MD O
assist VB O
in IN O
the DT O
assessment NN O
of IN O
vocal JJ O
fold NN O
dysfunction NN O
. . O

-DOCSTART- X X O

The DT O
pharmacological JJ O
effects NNS O
of IN O
the DT O
novel JJ O
compound NN O
WEB NNP O
1881 CD O
FU NNP O
( -LRB- O
4-amino-methyl-1-benzyl-pyrrolidine-2-one-fumarate JJ O
) -RRB- O
were VBD O
investigated VBN O
. . O

-DOCSTART- X X O

Histopathological JJ O
examination NN O
revealed VBD O
dose-related JJ O
proliferation NN O
of IN O
type NN O
II NNP O
pneumocytes VBZ O
in IN O
dams NNS O
and CC O
proliferation NN O
of IN O
interstitial JJ O
cells NNS O
and CC O
delayed VBN O
septal/capillary JJ O
development NN O
in IN O
neonates NNS O
.(ABSTRACT . O
TRUNCATED NN O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

So RB O
far RB O
no DT O
problems NNS O
with IN O
multiply NN O
resistant JJ O
strains NNS O
have VBP O
developed VBN O
. . O

-DOCSTART- X X O

During IN O
the DT O
observation NN O
period NN O
of IN O
0.4-30 CD O
weeks NNS O
, , O
cardiac JJ O
white JJ O
spots NNS O
on IN O
the DT O
right JJ O
ventricle NN O
of IN O
BALB/c NNP O
mice NNS O
were VBD O
first RB O
detected VBN O
at IN O
three CD O
weeks NNS O
( -LRB- O
6 CD O
of IN O
20 CD O
mice NNS O
; : O
30 CD O
% NN O
) -RRB- O
, , O
and CC O
the DT O
maximal JJ O
incidence NN O
of IN O
cardiac JJ O
white JJ O
spots NNS O
was VBD O
obtained VBN O
at IN O
nine CD O
weeks NNS O
( -LRB- O
39 CD O
of IN O
44 CD O
mice NNS O
; : O
88 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Increasing VBG O
the DT O
RH NNP O
beyond IN O
32 CD O
% NN O
resulted VBD O
in IN O
solvation NN O
of IN O
the DT O
peroxy NN O
radical JJ O
, , O
sterically RB O
hindering VBG O
the DT O
radical JJ O
from IN O
entering VBG O
the DT O
propagation NN O
transition NN O
state NN O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
produced VBN O
by IN O
oral JJ O
administration NN O
of IN O
500 CD O
mg/kg NN O
p-xylene NN O
or CC O
toluene NN O
lasted VBD O
at IN O
least JJS O
8 CD O
hr NN O
, , O
while IN O
the DT O
effect NN O
of IN O
inhaled JJ O
p-xylene NN O
dissipated VBN O
within IN O
75 CD O
min NN O
of IN O
removal NN O
from IN O
the DT O
exposure NN O
. . O

-DOCSTART- X X O

PATIENTS NNS O
and CC O
METHODS NNS O
: : O
Thallium-201 DT O
myocardial JJ O
scintigraphy NN O
was VBD O
performed VBN O
at IN O
rest NN O
and CC O
after IN O
0.56 CD O
mg/kg NN O
intravenous JJ O
dipyridamole NN O
during IN O
four CD O
minutes NNS O
in IN O
16 CD O
patients NNS O
with IN O
sarcoidosis NN O
. . O

-DOCSTART- X X O

The DT O
TA VBZ O
muscle NN O
was VBD O
fatigued VBN O
by IN O
four CD O
forms NNS O
of IN O
repeated VBN O
isometric JJ O
contractions NNS O
: : O
( -LRB- O
1 CD O
) -RRB- O
maximal NN O
voluntary JJ O
contractions NNS O
( -LRB- O
MVC) NN O
, , O
( -LRB- O
2 CD O
) -RRB- O
MVC NNP O
with IN O
circulation NN O
occluded VBD O
, , O
( -LRB- O
3 CD O
) -RRB- O
electrically RB O
evoked VBN O
contractions NNS O
with IN O
20 CD O
Hz NN O
supramaximal JJ O
voltage NN O
stimulation NN O
and CC O
( -LRB- O
4 CD O
) -RRB- O
electrically RB O
evoked VBN O
contractions NNS O
with IN O
circulation NN O
occluded VBD O
. . O

-DOCSTART- X X O

Which WDT O
cineangiographically RB O
assessed VBN O
anatomic DT O
variable JJ O
correlates NNS O
best RB O
with IN O
functional JJ O
measurements NNS O
of IN O
stenosis NN O
severity NN O
? . O
A DT O
comparison NN O
of IN O
quantitative JJ O
analysis NN O
of IN O
the DT O
coronary JJ O
cineangiogram NN O
with IN O
measured VBN O
coronary JJ O
flow NN O
reserve NN O
and CC O
exercise/redistribution NN O
thallium-201 DT O
scintigraphy NN O
. . O

-DOCSTART- X X O

Water NN O
content NN O
and CC O
equilibrium NN O
water NN O
partition NN O
in IN O
immature JJ O
cartilage NN O
. . O

-DOCSTART- X X O

Thyroid PRP$ O
function NN O
tests NNS O
were VBD O
performed VBN O
on IN O
300 CD O
admissions NNS O
, , O
leaving VBG O
707 CD O
untested JJ O
. . O

-DOCSTART- X X O

Data NNP O
on IN O
the DT O
line NN O
spread NN O
function NN O
( -LRB- O
LSF NN O
) -RRB- O
were VBD O
obtained VBN O
from IN O
the DT O
image NN O
of IN O
a DT O
0.2 CD O
mm CD O
wide JJ O
slit NN O
between IN O
tungsten NN O
blocks NNS O
that WDT O
were VBD O
positioned VBN O
at IN O
the DT O
isocentre NN O
in IN O
front NN O
of IN O
a DT O
polystyrene NN O
phantom NN O
. . O

-DOCSTART- X X O

Papers NNS O
of IN O
the DT O
Society NNP O
for IN O
Clinical NNP O
Vascular NNP O
Surgery NNP O
. . O

-DOCSTART- X X O

Liquid NN O
chromatographic JJ O
method NN O
for IN O
determination NN O
of IN O
citreoviridin NN O
in IN O
corn NN O
and CC O
rice NN O
. . O

-DOCSTART- X X O

Pregnant JJ O
rats NNS O
were VBD O
exposed VBN O
to TO O
one CD O
of IN O
the DT O
following NN O
: : O
( -LRB- O
1 CD O
) -RRB- O
10 CD O
% NN O
O2 CD O
in IN O
N2 NNP O
or CC O
100 CD O
% NN O
O2 CD O
for IN O
2 CD O
days NNS O
beginning VBG O
at IN O
day NN O
7 CD O
, , O
11 CD O
, , O
14 CD O
, , O
or CC O
18 CD O
of IN O
pregnancy NN O
; : O
( -LRB- O
2 CD O
) -RRB- O
10 CD O
% NN O
O2 CD O
in IN O
N2 NNP O
or CC O
100 CD O
% NN O
O2 IN O
for IN O
10 CD O
h/day NN O
beginning VBG O
at IN O
day NN O
7 CD O
; : O
or CC O
( -LRB- O
3 LS O
) -RRB- O
14-11 CD O
% NN O
O2 CD O
in IN O
N2 NN O
continuously RB O
beginning VBG O
at IN O
day NN O
14 CD O
till IN O
day NN O
21 CD O
when WRB O
they PRP O
were VBD O
sacrificed VBN O
. . O

-DOCSTART- X X O

Addition NN O
of IN O
sucralfate JJ O
or CC O
De-Nol JJ O
resulted VBN O
in IN O
increments NNS O
of IN O
gastric JJ O
HCO3 NNP O
secretion NN O
, , O
reaching VBG O
about IN O
45 CD O
% NN O
and CC O
59 CD O
% NN O
, , O
respectively RB O
, , O
of IN O
the DT O
maximal JJ O
HCO3 JJ O
response NN O
to TO O
16,16-dimethyl CD O
PGE2 CD O
( -LRB- O
dmPGE2 NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
Salmo NNP O
gairdneri NN O
, , O
no DT O
specialized JJ O
system NN O
of IN O
portal JJ O
vessels NNS O
appears VBZ O
to TO O
exist VB O
between IN O
the DT O
pineal JJ O
organ NN O
and CC O
other JJ O
portions NNS O
of IN O
the DT O
brain NN O
. . O

-DOCSTART- X X O

The DT O
4 CD O
degrees NNS O
stimuli NN O
were VBD O
found VBN O
to TO O
elicit JJ O
scalp NN O
distributions NNS O
for IN O
the DT O
pattern NN O
reversal NN O
P100 CD O
and CC O
the DT O
pattern NN O
onset IN O
C1 DT O
consistent JJ O
with IN O
striate JJ O
and CC O
extrastriate JJ O
visual JJ O
cortical JJ O
origins NNS O
respectively RB O
. . O

-DOCSTART- X X O

Nuclear NNP B-NP
factor NN I-NP
III NNP I-NP
( -LRB- O
NFIII NNP B-NP
) -RRB- O
is VBZ O
a DT O
protein NN O
from IN O
HeLa NNP O
cells NNS O
that WDT O
stimulates VBZ O
the DT O
initiation NN O
of IN O
adenovirus NN O
type NN O
2 CD O
( -LRB- O
Ad2 NN O
) -RRB- O
DNA NN O
replication NN O
by IN O
binding NN O
to TO O
a DT O
specific JJ O
nucleotide JJ O
sequence NN O
in IN O
the DT O
origin NN O
, , O
adjacent JJ O
to TO O
the DT O
nuclear JJ B-NP
factor NN I-NP
I PRP I-NP
recognition NN I-NP
site NN I-NP
. . O

-DOCSTART- X X O

A DT O
Golgi NNP O
study NN O
of IN O
the DT O
sixth JJ O
layer NN O
of IN O
the DT O
cerebral JJ O
cortex NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
cephalothin JJ O
clearance NN O
of IN O
S. NNP O
aureus NN O
from IN O
a DT O
site NN O
accessible JJ O
to TO O
phagocytes NNS O
was VBD O
delayed VBN O
when WRB O
compared VBN O
to TO O
a DT O
phagocyte-inaccessible JJ O
site NN O
. . O

-DOCSTART- X X O

The DT O
findings NNS O
are VBP O
discussed VBN O
in IN O
the DT O
context NN O
of IN O
known JJ O
properties NNS O
of IN O
cortical-bar NN O
detectors NNS O
. . O

-DOCSTART- X X O

Mean JJ O
rCBF NN O
increased VBN O
in IN O
some DT O
patients NNS O
4-8 JJ O
weeks NNS O
after IN O
surgery NN O
on IN O
the DT O
ipsilateral JJ O
side NN O
. . O

-DOCSTART- X X O

Quantitative NNP O
computed VBD O
tomography NN O
for IN O
measuring VBG O
vertebral JJ O
bone NN O
mineral NN O
content NN O
offers VBZ O
high JJ O
sensitivity NN O
and CC O
reproducibility NN O
. . O

-DOCSTART- X X O

Kf,c NNP O
and CC O
CT NNP O
( -LRB- O
referenced VBD O
to TO O
the DT O
initial JJ O
lung NN O
mass NN O
) -RRB- O
decreased VBN O
linearly RB O
with IN O
reductions NNS O
in IN O
lung NN O
mass NN O
% NN O
delta NN O
Kf,c NNP O
= SYM O
1.26-0.98 CD O
% NN O
mass NN O
removed VBN O
( -LRB- O
r NN O
= SYM O
0.90 CD O
, , O
P NNP O
less JJR O
than IN O
0.01 CD O
) -RRB- O
and CC O
% NN O
delta NN O
CT NNP O
= SYM O
-3.99-0.98 : O
% NN O
mass NN O
removed VBN O
( -LRB- O
r NN O
= SYM O
0.82 CD O
, , O
P NNP O
less JJR O
than IN O
0.01 CD O
) -RRB- O
relationships NNS O
that WDT O
were VBD O
not RB O
altered VBN O
by IN O
blocker NN O
pretreatment NN O
.(ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

Research NNP O
was VBD O
carried VBN O
out RP O
on IN O
the DT O
rheumatoid NN B-NP
factors NNS I-NP
in IN O
the DT O
serum NN O
of IN O
917 CD O
patients NNS O
by IN O
means NNS O
of IN O
two CD O
tests NNS O
( -LRB- O
one CD O
using VBG O
polystyrene NN O
and CC O
one CD O
with IN O
erythrocytes NNS O
) -RRB- O
and CC O
the DT O
results NNS O
obtained VBN O
were VBD O
compared VBN O
using VBG O
a DT O
method NN O
of IN O
reference NN O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
supercritical JJ O
fluid NN O
chromatography NN O
( -LRB- O
SFC) NNP O
as IN O
a DT O
viable JJ O
technique NN O
for IN O
analyzing VBG O
agricultural JJ O
products NNS O
has VBZ O
been VBN O
investigated VBN O
using VBG O
packed VBD O
and CC O
capillary NN O
column NN O
methodology NN O
. . O

-DOCSTART- X X O

Nitrofurazone NN O
significantly RB O
reduced VBD O
the DT O
rise NN O
in IN O
LH NNP B-NP
induced VBN O
by IN O
LHRH. NNP B-NP

-DOCSTART- X X O

After IN O
a DT O
baseline NN O
study NN O
, , O
WPW NNP O
syndrome NN O
was VBD O
simulated VBN O
by IN O
stimulation NN O
at IN O
seven CD O
different JJ O
sites NNS O
around IN O
the DT O
base NN O
of IN O
the DT O
ventricles NNS O
, , O
and CC O
RNV NNP O
's POS O
were VBD O
obtained VBN O
. . O

-DOCSTART- X X O

Man NN O
and CC O
insect NN O
, , O
past NN O
, , O
present NN O
, , O
future NN O

-DOCSTART- X X O

The DT O
criterion NN O
was VBD O
reached VBN O
after IN O
two CD O
sessions NNS O
and CC O
generalization NN O
to TO O
a DT O
variety NN O
of IN O
pills NNS O
and CC O
capsules NNS O
occurred VBD O
. . O

-DOCSTART- X X O

Enoxacin NNP O
appears VBZ O
to TO O
be VB O
well RB O
suited VBN O
for IN O
the DT O
treatment NN O
of IN O
complicated JJ O
UTI. . O

-DOCSTART- X X O

In IN O
14 CD O
cases NNS O
, , O
isolates NNS O
were VBD O
biotyped VBN O
yielding VBG O
eight CD O
with IN O
biotype NN O
II NNP O
, , O
four CD O
with IN O
biotype NN O
III NNP O
, , O
and CC O
one CD O
each DT O
with IN O
biotypes NNS O
IV NNP O
and CC O
V. NNP O

-DOCSTART- X X O

In IN O
a DT O
previous JJ O
interim JJ O
report NN O
we PRP O
noted VBD O
more JJR O
prompt JJ O
resolution NN O
of IN O
dermatomal JJ O
signs NNS O
and CC O
symptoms NNS O
with IN O
acyclovir NN O
treatment NN O
. . O

-DOCSTART- X X O

The DT O
detectability NN O
of IN O
the DT O
defects NNS O
in IN O
RCA NNP O
or CC O
LAD NNP O
region NN O
was VBD O
80 CD O
% NN O
in IN O
single-position NN O
scans NNS O
in IN O
stress NN O
studies NNS O
. . O

-DOCSTART- X X O

These DT O
data NNS O
should MD O
be VB O
useful JJ O
in IN O
developing VBG O
reagents NNS O
for IN O
heterozygote NN O
detection NN O
and CC O
prenatal JJ O
diagnosis NN O
of IN O
11 CD B-NP
beta-hydroxylase JJ I-NP
deficiency NN O
, , O
the DT O
second JJ O
most RBS O
frequent JJ O
cause NN O
of IN O
congenital JJ O
adrenal JJ O
hyperplasia NN O
. . O

-DOCSTART- X X O

Osteocalcin NNP B-NP
( -LRB- O
serum NN B-NP
bone-Gla JJ I-NP
protein NN I-NP
, , O
sBGP) NN B-NP
, , O
serum NN B-NP
alkaline NN I-NP
phosphatase NN I-NP
(sAP NNP O
) -RRB- O
and CC O
urinary JJ O
hydroxyproline/creatinine NN O
ratio NN O
(uOH-Prol/creatinine NNP O
) -RRB- O
have VBP O
been VBN O
measured VBN O
in IN O
21 CD O
patients NNS O
with IN O
primary JJ O
hyperparathyroidism NN O
( -LRB- O
PHPT NN O
) -RRB- O
and CC O
in IN O
nine CD O
patients NNS O
with IN O
hypercalcaemia NN O
of IN O
malignancy NN O
( -LRB- O
HM) NNP O
. . O

-DOCSTART- X X O

Multivariate VB O
logistic JJ O
regression NN O
analysis NN O
indicated VBN O
that IN O
seropositivity NN O
was VBD O
strongly RB O
associated VBN O
with IN O
the DT O
prevalence NN O
of IN O
hepatitis NN O
B NNP O
in IN O
an DT O
employee NN O
's POS O
country NN O
of IN O
birth NN O
and CC O
with IN O
age NN O
. . O

-DOCSTART- X X O

Natl NNP O
. . O

-DOCSTART- X X O

Neither DT O
ethanol NN O
nor CC O
estrogen NN O
has VBZ O
been VBN O
shown VBN O
to TO O
cause VB O
UROD-deficiency NN B-NP
in IN O
animals NNS O
. . O

-DOCSTART- X X O

Although IN O
not RB O
common JJ O
, , O
the DT O
disorder NN O
is VBZ O
the DT O
most RBS O
frequently RB O
diagnosed JJ O
disturbance NN O
of IN O
porphyrin NN O
metabolism NN O
in IN O
many JJ O
countries NNS O
, , O
and CC O
further JJ O
insight NN O
into IN O
its PRP$ O
unusual JJ O
pathogenesis NN O
may MD O
clarify VB O
the DT O
hepatotoxic JJ O
effects NNS O
of IN O
the DT O
4 CD O
etiologic NN O
agents NNS O
. . O

-DOCSTART- X X O

Five CD O
out IN O
of IN O
eight CD O
consecutive JJ O
cases NNS O
with IN O
initial JJ O
symptoms NNS O
of IN O
a DT O
'midline JJ O
granuloma' NNS O
were VBD O
identified VBN O
as IN O
malignant JJ O
histiocytosis NN O
( -LRB- O
histiocytic JJ O
sarcoma NN O
) -RRB- O
which WDT O
within IN O
5 CD O
months NNS O
to TO O
4 CD O
years NNS O
led VBN O
to TO O
generalization NN O
and CC O
death NN O
. . O

-DOCSTART- X X O

The DT O
highest JJS O
postoperative JJ O
CK-MB NN B-NP
level NN O
was VBD O
less JJR O
after IN O
BC NNP O
(BC NNP O
, , O
31 CD O
+/ NNS O
- : O
17 CD O
U/L NN O
; : O
CC NNP O
, , O
56 CD O
+/ NN O
- : O
13 CD O
U/L NN O
; : O
p NN O
less JJR O
than IN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

No DT O
relevant JJ O
changes NNS O
in IN O
heart NN O
rate NN O
, , O
body NN O
weight NN O
, , O
and CC O
plasma NN O
levels NNS O
of IN O
renin NN B-NP
activity NN O
and CC O
aldosterone NN O
concentration NN O
were VBD O
observed VBN O
. . O

-DOCSTART- X X O

State-approved JJ O
schools NNS O
of IN O
nursing NN O
R.N. . O

-DOCSTART- X X O

In IN O
a DT O
maxicell NN O
system NN O
a DT O
protein NN O
with IN O
an DT O
approximate JJ O
molecular JJ O
weight NN O
of IN O
36,000 CD O
was VBD O
synthesized VBN O
. . O

-DOCSTART- X X O

This DT O
means VBZ O
that IN O
the DT O
loss NN O
of IN O
recessives NNS O
must MD O
be VB O
calculated VBN O
by IN O
using VBG O
a DT O
hypergeometric JJ O
and CC O
not RB O
a DT O
binomial JJ O
model NN O
as IN O
Fisher NNP O
did VBD O
. . O

-DOCSTART- X X O

The DT O
small JJ O
size NN O
and CC O
placement NN O
of IN O
the DT O
mutagenesis NN O
marker NN O
( -LRB- O
the DT O
supF NN B-NP
suppressor NN I-NP
tRNA NNS I-NP
gene NN I-NP
from IN I-NP
Escherichia NNP I-NP
coli NNS I-NP
) -RRB- O
within IN O
the DT O
vector NN O
substantially RB O
reduced VBD O
the DT O
frequency NN O
of IN O
spontaneous JJ O
mutations NNS O
normally RB O
observed VBN O
after IN O
transfection NN O
of IN O
mammalian JJ O
cells NNS O
with IN O
plasmid JJ O
DNA NN O
; : O
hence RB O
, , O
UV-induced JJ O
mutations NNS O
were VBD O
easily RB O
identified VBN O
above IN O
the DT O
spontaneous JJ O
background NN O
. . O

-DOCSTART- X X O

Tetrad NNP O
analysis NN O
and CC O
mitotic JJ O
recombination NN O
experiments NNS O
localized VBN O
the DT O
PEP4 NNP B-NP
gene NN I-NP
proximal JJ O
to TO O
GAL4 VB B-NP
on IN O
chromosome NN O
XVI. . O

-DOCSTART- X X O

The DT O
poly( NN O
A DT O
) -RRB- O
segment NN O
of IN O
the DT O
RNA NNP O
was VBD O
selectively RB O
cross-linked JJ O
to TO O
the DT O
72,000-molecular-weight JJ O
protein NN O
( -LRB- O
72K JJ O
protein NN O
) -RRB- O
. . O

-DOCSTART- X X O

Ciprofloxacin NNP O
: : O
an DT O
overview NN O
of IN O
adverse JJ O
experiences NNS O
. . O

-DOCSTART- X X O

The DT O
rho NNP B-NP
genes NNS I-NP
comprise VBP O
an DT O
evolutionarily RB O
conserved VBN O
family NN O
with IN O
significant JJ O
homology NN O
to TO O
the DT O
ras NNS B-NP
oncogene IN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

Also RB O
, , O
component NN O
I PRP O
significantly RB O
correlated VBD O
with IN O
fasting JJ O
insulin NN B-NP
and CC O
VO2 NNP O
max NN O
for IN O
both DT O
sexes NNS O
and CC O
with IN O
basal JJ O
metabolism NN O
and CC O
HDL-cholesterol NN B-NP
for IN O
females NNS O
and CC O
males NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
serum JJ B-NP
insulin NN I-NP
response NN O
cannot NN O
. . O

-DOCSTART- X X O

SCL NN O
prolonged VBN O
promptly RB O
after IN O
verapamil NN O
, , O
and CC O
sinus IN O
arrest NN O
developed VBN O
in IN O
two CD O
of IN O
10 CD O
group NN O
2 CD O
and CC O
two CD O
of IN O
five CD O
group NN O
3 CD O
animals NNS O
. . O

-DOCSTART- X X O

Development NNP O
of IN O
a DT O
yeast NN O
system NN O
to TO O
assay VB O
mutational JJ O
specificity NN O
. . O

-DOCSTART- X X O

The DT O
present JJ O
investigation NN O
sought VBD O
to TO O
identify VB O
the DT O
principal JJ O
dimensions NNS O
of IN O
the DT O
Framingham NNP O
Type NNP O
A DT O
scale NN O
(FTAS NNS O
) -RRB- O
and CC O
then RB O
to TO O
examine VB O
their PRP$ O
physiological JJ O
and CC O
psychological JJ O
correlates NNS O
. . O

-DOCSTART- X X O

Legionella NNP O
, , O
microbial JJ O
ecology NN O
, , O
and CC O
inconspicuous JJ O
consumption NN O
. . O

-DOCSTART- X X O

Lymphatics NNS O
in IN O
the DT O
aorta NN O
of IN O
rats NNS O
treated VBN O
with IN O
a DT O
soy-bean NN O
oil NN O
extract VB O
( -LRB- O
lipofundin NN O
) -RRB- O
. . O

-DOCSTART- X X O

As IN O
a DT O
last JJ O
resort NN O
, , O
it PRP O
may MD O
be VB O
possible JJ O
to TO O
maintain VB O
a DT O
patient NN O
on IN O
dialysis NN O
in IN O
reasonable JJ O
health NN O
with IN O
a DT O
DiaTAP NNP O
button NN O
graft NN O
complex JJ O
infected JJ O
with IN O
Staphylococcus NNP O
epidermidis NN O
and CC O
intermittent JJ O
positive JJ O
blood NN O
cultures NNS O
using VBG O
long JJ O
term NN O
vancomycin NN O
therapy NN O
. . O

-DOCSTART- X X O

For IN O
signal NN O
durations NNS O
less JJR O
than IN O
10 CD O
ms NNS O
, , O
however RB O
, , O
the DT O
SoNo NNP O
and CC O
S NNP O
pi NN O
No DT O
threshold NN O
functions VBZ O
converged VBN O
and CC O
the DT O
masking-level JJ O
difference NN O
decreased VBD O
. . O

-DOCSTART- X X O

The DT O
spleen JJ O
rate NN O
of IN O
about RB O
600 CD O
villagers NNS O
of IN O
RK NN O
I PRP O
examined VBD O
was VBD O
54.3 CD O
% NN O
and CC O
the DT O
parasite NN O
rate NN O
13.2 CD O
% NN O
before IN O
the DT O
drug NN O
intervention NN O
. . O

-DOCSTART- X X O

Multiple NNP O
dosing NN O
four CD O
times NNS O
daily RB O
for IN O
7 CD O
days NNS O
of IN O
indoprofen JJ O
200 CD O
mg NN O
, , O
a DT O
non-steroidal JJ O
anti-inflammatory JJ O
drug NN O
with IN O
a DT O
short JJ O
half-life NN O
( -LRB- O
t1/2 NN O
) -RRB- O
, , O
revealed VBD O
drug NN O
accumulation NN O
in IN O
eight CD O
elderly JJ O
subjects NNS O
. . O

-DOCSTART- X X O

In IN O
10 CD O
patients NNS O
with IN O
subacute JJ O
cardiac JJ O
tamponade NN O
, , O
pulmonary JJ O
wedge NN O
pressure NN O
( -LRB- O
PWP) NNP O
, , O
RAP NNP O
, , O
and CC O
IPP NNP O
were VBD O
measured VBN O
along IN O
with IN O
indexes NNS O
of IN O
systolic JJ O
function NN O
. . O

-DOCSTART- X X O

Encompassing NNP O
tamponade NN O
and CC O
pericardiocentesis NN O
data NNS O
, , O
left VBD O
ventricular JJ O
stroke NN O
work NN O
index NN O
showed VBD O
positive JJ O
correlation NN O
with IN O
TMFP1 NNP O
( -LRB- O
r NN O
= SYM O
.59 CD O
) -RRB- O
and CC O
TMFP2 NNP O
( -LRB- O
r NN O
= SYM O
.52 CD O
) -RRB- O
but CC O
not RB O
with IN O
TMFP3 NNP O
. . O

-DOCSTART- X X O

Similarly RB O
, , O
actuarial JJ O
interpretations NNS O
for IN O
the DT O
second JJ O
protocols NNS O
were VBD O
not RB O
more RBR O
frequently RB O
selected VBN O
by IN O
therapists NNS O
as IN O
more RBR O
valid JJ O
, , O
regardless RB O
of IN O
treatment NN O
condition NN O
and CC O
elevation NN O
of IN O
the DT O
F NNP O
and CC O
F-K NNP O
indices NNS O
on IN O
the DT O
first JJ O
MMPI NNP O
profile NN O
. . O

-DOCSTART- X X O

The DT O
study NN O
disclosed VBD O
generalized JJ O
atrophy NN O
and CC O
diffuse JJ O
symmetric JJ O
white JJ O
matter NN O
hypodensities NNS O
. . O

-DOCSTART- X X O

The DT O
diagnosis NN O
of IN O
metachromatic JJ O
leukodystrophy NN O
( -LRB- O
MLD NNP O
) -RRB- O
was VBD O
confirmed VBN O
by IN O
the DT O
finding NN O
of IN O
low JJ O
arylsulfatase NN B-NP
A DT I-NP
( -LRB- O
ASA NNP B-NP
) -RRB- O
levels NNS O
in IN O
cultured JJ O
fibroblasts NNS O
in IN O
both DT O
sisters NNS O
. . O

-DOCSTART- X X O

Significantly RB O
lower JJR O
heart NN O
rate NN O
reactivity NN O
and CC O
significantly RB O
less RBR O
pronounced VBD O
left VBN O
temporal JJ O
artery NN O
pulse NN O
amplitude NN O
responses NNS O
were VBD O
found VBN O
in IN O
non-medicated JJ O
TH IN O
subjects NNS O
than IN O
in IN O
controls NNS O
. . O

-DOCSTART- X X O

Drugs NNS O
that WDT O
are VBP O
transformed VBN O
via IN O
phase NN O
II NNP O
reactions NNS O
usually RB O
do VBP O
not RB O
require VB O
dosage NN O
adjustment NN O
. . O

-DOCSTART- X X O

Using VBG O
the DT O
balloon-gas NN O
procedure NN O
with IN O
a DT O
single JJ O
gas NN O
injection NN O
, , O
a DT O
bubble NN O
was VBD O
obtained VBN O
that DT O
was VBD O
large JJ O
enough RB O
to TO O
tamponade VB O
a DT O
giant NN O
tear VB O
without IN O
prior JJ O
drainage NN O
of IN O
subretinal JJ O
fluid NN O
or CC O
vitrectomy NN O
. . O

-DOCSTART- X X O

Heat-labile-like JJ O
enterotoxin NN O
( -LRB- O
LT) NNP B-NP
was VBD O
produced VBN O
by IN O
26 CD O
of IN O
42 CD O
stool NN O
isolates NNS O
( -LRB- O
62 CD O
% NN O
) -RRB- O
, , O
while IN O
only RB O
1 CD O
of IN O
the DT O
42 CD O
isolates NNS O
( -LRB- O
2 CD O
% NN O
) -RRB- O
produced VBN O
enterotoxinlike JJ O
activity NN O
in IN O
suckling NN O
mice NNS O
; : O
65 CD O
% NN O
of IN O
the DT O
cytotoxin-producing NN O
strains NNS O
also RB O
produced VBD O
an DT O
LT-like JJ B-NP
material NN O
. . O

-DOCSTART- X X O

Persistent JJ O
acantholytic JJ O
dermatosis NN O
with IN O
increased JJ O
light NN O
sensitivity NN O

-DOCSTART- X X O

Thus RB O
, , O
a DT O
negative JJ O
test NN O
is VBZ O
compatible JJ O
with IN O
low JJ O
disease NN O
activity NN O
and/or CC O
efficacy NN O
of IN O
calcium NN O
antagonist NN O
treatment NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
a DT O
negative JJ O
test NN O
is VBZ O
compatible JJ O
with IN O
low JJ O
disease NN O
activity NN O
and/or CC O
efficacy NN O
of IN O
calcium NN O
antagonist NN O
treatment NN O
. . O

-DOCSTART- X X O

In IN O
subjects NNS O
( -LRB- O
n NN O
= SYM O
5 CD O
) -RRB- O
with IN O
quadriplegia NN O
and CC O
reduced VBN O
sympathetic JJ O
tone NN O
secondary JJ O
to TO O
cervical JJ O
cord NN O
trauma NN O
, , O
TcpO2 NNP O
at IN O
42 CD O
degrees NNS O
C NN O
and CC O
vasodilation NN O
index NN O
were VBD O
increased VBN O
( -LRB- O
45.0 CD O
mmHg NN O
and CC O
0.61 CD O
) -RRB- O
; : O
TcpO2 CD O
at IN O
45 CD O
degrees NNS O
C NN O
did VBD O
not RB O
change NN O
. . O

-DOCSTART- X X O

The DT O
other JJ O
model NN O
was VBD O
a DT O
continuous JJ O
exponential NN O
plus CC O
constant JJ O
of IN O
the DT O
form NN O
La NNP O
- : O
= SYM O
a DT O
+ JJ O
b[exp( NN O
cVO2 IN O
)] NN O
. . O

-DOCSTART- X X O

Cell NNP O
. . O

-DOCSTART- X X O

Timing NN O
of IN O
symptoms NNS O
and CC O
oocyst NNP O
excretion NN O
in IN O
human JJ O
cryptosporidiosis NN O
. . O

-DOCSTART- X X O

After IN O
dopamine NN O
infusion NN O
in IN O
women NNS O
with IN O
polycystic JJ O
ovary JJ O
syndrome NN O
and CC O
in IN O
matched VBN O
controls NNS O
, , O
steady JJ O
state NN O
levels NNS O
of IN O
plasma NN O
dopamine NN O
, , O
norepinephrine NN O
, , O
and CC O
the DT O
ratio NN O
of IN O
dopamine/norepinephrine NN O
were VBD O
similar JJ O
in IN O
the DT O
two CD O
groups NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
normal JJ O
, , O
basal JJ O
(unstimulated JJ O
) -RRB- O
condition NN O
there EX O
were VBD O
no DT O
significant JJ O
correlations NNS O
( -LRB- O
p NN O
greater JJR O
than IN O
0.05 CD O
) -RRB- O
between IN O
the DT O
systolic JJ O
blood NN O
pressure NN O
and CC O
dopamine NN O
( -LRB- O
r NN O
= SYM O
0.09 CD O
) -RRB- O
, , O
norepinephrine JJ O
( -LRB- O
r NN O
= SYM O
0.26 CD O
) -RRB- O
, , O
or CC O
epinephrine NN O
( -LRB- O
r NN O
= SYM O
0.27 CD O
) -RRB- O
, , O
nor CC O
were VBD O
there RB O
significant JJ O
correlations NNS O
between IN O
melatonin NN O
and CC O
dopamine NN O
( -LRB- O
r NN O
= SYM O
-0.01 FW O
) -RRB- O
, , O
norepinephrine JJ O
( -LRB- O
r NN O
= SYM O
-0.26 FW O
) -RRB- O
, , O
or CC O
growth NN B-NP
hormone NN I-NP
( -LRB- O
r NN O
= SYM O
0.17 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
4 CD O
patients NNS O
with IN O
carboxyhemoglobin NN B-NP
levels NNS O
in IN O
excess NN O
of IN O
10 CD O
% NN O
may MD O
represent VB O
occult JJ O
carbon NN O
monoxide NN O
poisoning NN O
in IN O
this DT O
population NN O
. . O

-DOCSTART- X X O

Hypoglycemic JJ O
action NN O
of IN O
"he DT O
xiang NNP O
zhuang NN O
qi CC O
gong JJ O
" '' O
and CC O
its PRP$ O
mechanism NN O
on IN O
diabetes NNS O
mellitus . O

-DOCSTART- X X O

This DT O
region NN O
of IN O
60 CD O
amino IN O
acids NNS O
may MD O
be VB O
involved VBN O
in IN O
coiled-coil NN O
interactions NNS O
similar JJ O
to TO O
those DT O
that WDT O
facilitate VBP O
the DT O
filament NN O
formation NN O
in IN O
the DT O
rod NN O
region NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
largely RB O
predicted VBN O
by IN O
lupus JJ O
anticoagulant NN O
(estimated VBN O
by IN O
activated JJ O
partial JJ O
thromboplastin NN B-NP
time NN O
) -RRB- O
and/or CC O
antibody NN O
to TO O
cardiolipin VB O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
several JJ O
opioid JJ O
agonists NNS O
and CC O
the DT O
opioid JJ O
antagonist NN O
naloxone NN O
were VBD O
examined VBN O
in IN O
rats NNS O
responding VBG O
under IN O
a DT O
fixed-consecutive-number JJ O
(FCN) NN O
schedule NN O
. . O

-DOCSTART- X X O

The DT O
rate-decreasing NN O
effects NNS O
of IN O
morphine NN O
and CC O
U50488 NNS O
were VBD O
reversed VBN O
completely RB O
by IN O
a DT O
0.01 CD O
and CC O
1.0 CD O
mg/kg JJ O
dose NN O
of IN O
naloxone NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Convulsive JJ O
status NN O
epilepticus NN O
after IN O
infusion NN O
of IN O
cisplatin NN O

-DOCSTART- X X O

The DT O
following VBG O
markers NNS O
were VBD O
looked VBN O
for IN O
in IN O
the DT O
serum NN O
, , O
skin NN O
and CC O
liver NN O
of IN O
all DT O
patients NNS O
with IN O
chronic JJ O
hepatitis NN O
: : O
HBV NNP O
( -LRB- O
HBs NNP B-NP
Ag NNP I-NP
and CC O
HBe NNP B-NP
Ag NNP I-NP
, , O
anti-HBs JJ B-NP
, , O
anti-HBe JJ B-NP
and CC O
anti-HBc JJ B-NP
in IN O
the DT O
serum NN O
, , O
HBs NNP B-NP
and CC I-NP
HBc NNP I-NP
Ag NNP I-NP
in IN O
the DT O
liver NN O
) -RRB- O
; : O
non-A JJ B-NP
non-B JJ I-NP
( -LRB- O
non-A JJ B-NP
, , I-NP
non-B JJ I-NP
Ag NNP I-NP
and CC I-NP
antibody NN I-NP
, , O
anti NNS B-NP
non-A JJ I-NP
non-Bc JJ I-NP
in IN O
the DT O
serum NN O
, , O
non-A JJ B-NP
, , I-NP
non-Bc JJ I-NP
Ag NNP I-NP
in IN O
the DT O
liver NN O
) -RRB- O
. . O

-DOCSTART- X X O

Groups NNP O
of IN O
male JJ O
and CC O
female JJ O
Fischer NNP O
344 CD O
rats NNS O
, , O
B6C3F1 NNP O
mice NNS O
, , O
and CC O
Hartley NNP O
guinea NN O
pigs NNS O
were VBD O
exposed VBN O
once RB O
for IN O
6 CD O
hr NN O
to TO O
mean VB O
concentrations NNS O
of IN O
10.5 CD O
, , O
5.4 CD O
, , O
2.4 CD O
, , O
1.0, CD O
or CC O
0 CD O
( -LRB- O
control NN O
) -RRB- O
ppm NN O
of IN O
methyl NN O
isocyanate VBP O
( -LRB- O
MIC NN O
) -RRB- O
vapor NN O
. . O

-DOCSTART- X X O

Radionuclide NNP O
study NN O
and CC O
endomyocardial JJ O
biopsy NN O
revealed VBD O
remarkable JJ O
degeneration NN O
of IN O
myocardium NN O
. . O

-DOCSTART- X X O

Typical JJ O
and CC O
atypical JJ O
clinical JJ O
features NNS O
of IN O
this DT O
lacrimal JJ O
sac NN O
cyst NN O
are VBP O
emphasized VBN O
. . O

-DOCSTART- X X O

Samples NNS O
from IN O
1415 CD O
neurological JJ O
patients NNS O
were VBD O
used VBN O
to TO O
study VB O
the DT O
diagnostic JJ O
value NN O
of IN O
acid NN B-NP
alpha NN I-NP
1-glycoprotein JJ I-NP
in IN O
the DT O
lumbar NN O
cerebrospinal JJ O
fluid NN O
. . O

-DOCSTART- X X O

For IN O
patients NNS O
with IN O
recurrent JJ O
or CC O
metastatic JJ O
disease NN O
, , O
the DT O
data NNS O
suggest VBP O
that IN O
I-131 NNP O
MIBG NNP O
scintigraphy NN O
is VBZ O
the DT O
examination NN O
of IN O
choice NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
on IN O
the DT O
Cohler NNP O
's POS O
maternal JJ O
scale NN O
, , O
Korean JJ O
mothers NNS O
were VBD O
found VBN O
to TO O
view VB O
their PRP$ O
infants NNS O
as IN O
more RBR O
passive JJ O
and CC O
dependent JJ O
than IN O
American JJ O
mothers NNS O
did VBD O
( -LRB- O
P NNP O
less RBR O
than IN O
0.00 CD O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
preoperative JJ O
teaching NN O
booklet NN O
for IN O
pediatric JJ O
patients NNS O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
for IN O
mono-intronic JJ O
precursors NNS O
in IN O
which WDT O
there EX O
is VBZ O
only RB O
one CD O
choice NN O
of IN O
splice NN O
sites NNS O
, , O
most JJS O
of IN O
the DT O
exon NN O
sequences NNS O
are VBP O
not RB O
mechanistically RB O
involved VBN O
in IN O
the DT O
splicing NN O
process NN O
. . O

-DOCSTART- X X O

A DT O
careful JJ O
, , O
radiolabelled JJ O
tissue-distribution NN O
study NN O
is VBZ O
warranted VBN O
to TO O
elucidate VB O
the DT O
complicated JJ O
metabolic JJ O
fate NN O
of IN O
perhexiline NN O
. . O

-DOCSTART- X X O

Systemic JJ O
lupus FW O
erythematosus FW O
was VBD O
diagnosed VBN O
. . O

-DOCSTART- X X O

In IN O
the DT O
evening NN O
, , O
the DT O
amplitude NN O
of IN O
the DT O
responses NNS O
to TO O
both DT O
O2 NNP O
and CC O
CO2 NNP O
increased VBD O
but CC O
the DT O
increase NN O
in IN O
CO2 NNP O
sensitivity NN O
was VBD O
proportionally RB O
more RBR O
important JJ O
. . O

-DOCSTART- X X O

The DT O
statistical JJ O
significance NN O
of IN O
the DT O
prognosis NN O
factors NNS O
was VBD O
studied VBN O
by IN O
uni- NNS O
and CC O
multivariative JJ O
methods NNS O
, , O
according VBG O
to TO O
the DT O
model NN O
of IN O
Cox NNP O
, , O
with IN O
the DT O
help NN O
of IN O
an DT O
IMB NNP O
computer NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
less JJR O
antidopaminergic JJ O
activity NN O
of IN O
RHAL NNP O
in IN O
this DT O
neuroleptic JJ O
test NN O
might MD O
be VB O
explained VBN O
by IN O
the DT O
lesser JJR O
conversion NN O
of IN O
RHAL NNP O
to TO O
HAL NNP O
. . O

-DOCSTART- X X O

The DT O
purpose NN O
of IN O
this DT O
study NN O
is VBZ O
twofold JJ O
: : O
( -LRB- O
1 CD O
) -RRB- O
to TO O
present VB O
a DT O
parallel JJ O
form NN O
of IN O
the DT O
Gudjonsson NNP O
Suggestibility NNP O
Scale NNP O
( -LRB- O
GSS NNP O
, , O
Form NN O
1 CD O
) -RRB- O
; : O
( -LRB- O
2 CD O
) -RRB- O
to TO O
study VB O
test-retest NN O
reliabilities NNS O
of IN O
interrogative JJ O
suggestibility NN O
. . O

-DOCSTART- X X O

In IN O
vivo FW O
epiluminescence NN O
microscopy NN O
of IN O
pigmented JJ O
skin NN O
lesions NNS O
. . O

-DOCSTART- X X O

Statistically RB O
significant JJ O
effects NNS O
were VBD O
noted VBN O
at IN O
doses NNS O
which WDT O
did VBD O
not RB O
appear VB O
to TO O
be VB O
maternally RB O
toxic JJ O
. . O

-DOCSTART- X X O

Low NNP O
MAO NNP B-NP
subjects NNS O
showed VBD O
a DT O
pattern NN O
of IN O
higher JJR O
scores NNS O
in IN O
KSP NNP O
Impulsiveness NNP O
, , O
EPQ NNP O
Neuroticism NNP O
, , O
and CC O
KSP NNP O
Somatic NNP O
Anxiety NNP O
and CC O
Irritability NNP O
and CC O
lower JJR O
scores NNS O
in IN O
KSP NNP O
Socialization NNP O
, , O
in IN O
line NN O
with IN O
personality NN O
profiles NNS O
found VBD O
in IN O
alcoholics NNS O
, , O
psychopaths NNS O
, , O
and CC O
suicide NN O
attempters NNS O
who WP O
also RB O
tend VBP O
to TO O
have VB O
low JJ O
platelet NN O
MAO NNP B-NP
activity NN O
. . O

-DOCSTART- X X O

In IN O
group NN O
I PRP O
, , O
Paw NNP O
, , O
delta JJ O
V NNP O
, , O
PaO2 NNP O
, , O
Vinj NNP O
and CC O
VT NNP O
significantly RB O
decreased VBD O
whereas IN O
operating VBG O
pressure NN O
and CC O
E NNP O
significantly RB O
increased VBD O
when WRB O
the DT O
internal JJ O
diameter NN O
of IN O
the DT O
injector NN O
cannula NN O
was VBD O
reduced VBN O
. . O

-DOCSTART- X X O

The DT O
number NN O
of IN O
fecal JJ O
pellets NNS O
ingested VBN O
peaked VBD O
at IN O
5 CD O
to TO O
6 CD O
weeks NNS O
old JJ O
( -LRB- O
13 CD O
pellets/day NN O
) -RRB- O
and CC O
gradually RB O
decreased VBN O
, , O
thereafter RB O
( -LRB- O
2.1 CD O
pellets NNS O
at IN O
78 CD O
weeks NNS O
old JJ O
, , O
1.5 CD O
pellets NNS O
at IN O
104 CD O
weeks NNS O
old JJ O
) -RRB- O
. . O

-DOCSTART- X X O

For IN O
colostral JJ O
milk NN O
there EX O
was VBD O
a DT O
significant JJ O
correlation NN O
of IN O
vitamin NN O
K1 IN O
to TO O
cholesterol NN O
( -LRB- O
r NN O
= SYM O
0.62 CD O
) -RRB- O
but CC O
not RB O
to TO O
total VB O
lipid JJ O
or CC O
phospholipid JJ O
suggesting VBG O
a DT O
role NN O
for IN O
cholesterol NN O
in IN O
the DT O
secretion NN O
of IN O
vitamin NN O
K1 IN O
into IN O
colostral JJ O
milk NN O
. . O

-DOCSTART- X X O

A DT O
rate-decreasing NN O
dose NN O
of IN O
physostigmine NN O
, , O
an DT O
acetylcholinesterase NN B-NP
inhibitor NN O
, , O
was VBD O
studied VBN O
in IN O
combination NN O
with IN O
the DT O
range NN O
of IN O
atropine NN O
doses NNS O
. . O

-DOCSTART- X X O

Two CD O
new JJ O
glucosidase NN B-NP
inhibitors NNS O
( -LRB- O
BAY NNP O
m NN O
1099 CD O
and CC O
BAY NNP O
o IN O
1248 CD O
) -RRB- O
were VBD O
studied VBN O
in IN O
volunteers NNS O
and CC O
type NN O
II NNP O
diabetics NNS O
under IN O
various JJ O
conditions NNS O
. . O

-DOCSTART- X X O

The DT O
models NNS O
accurately RB O
localized VBD O
the DT O
common JJ O
boundaries NNS O
between IN O
the DT O
PBB NNP O
and CC O
CN. NNP O

-DOCSTART- X X O

However RB O
, , O
conversions NNS O
of IN O
12 CD O
mm CD O
or CC O
more JJR O
from IN O
a DT O
documented VBN O
negative JJ O
result NN O
indicated VBD O
spread VBN O
of IN O
infection NN O
. . O

-DOCSTART- X X O

The DT O
maximum JJ O
amplitude NN O
of IN O
evoked JJ O
responses NNS O
in IN O
the DT O
cervical JJ O
sympathetic JJ O
trunk NN O
was VBD O
obtained VBN O
when WRB O
the DT O
T2 NNP O
white JJ O
ramus NN O
was VBD O
stimulated VBN O
and CC O
decreased VBN O
gradually RB O
when WRB O
followed VBN O
by IN O
the DT O
stimulation NN O
of IN O
T1 NNP O
, , O
T3 NNP O
, , O
T4 NNP O
and CC O
T5 DT O
white JJ O
rami NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
concluded VBN O
that IN O
contact NN O
allergy NN O
to TO O
K-CG NNP O
is VBZ O
common JJ O
. . O

-DOCSTART- X X O

The DT O
less-polar JJ O
mycolic JJ O
acid-containing NN O
Rhodococcus NNP O
species NNS O
showed VBD O
chromatographic JJ O
patterns NNS O
that WDT O
partially RB O
overlapped VBD O
( -LRB- O
in IN O
elution NN O
times NNS O
) -RRB- O
the DT O
patterns NNS O
of IN O
Nocardia NNP O
asteroides NNS O
, , O
N. NNP O
otitidiscaviarum NNP O
, , O
and CC O
N. NNP O
brasiliensis NN O
, , O
but CC O
the DT O
larger JJR O
number NN O
of IN O
peaks NNS O
in IN O
the DT O
last JJ O
species NNS O
made VBD O
separation NN O
between IN O
the DT O
genera NN O
possible JJ O
. . O

-DOCSTART- X X O

The DT O
development NN O
of IN O
a DT O
data NN O
base NN O
is VBZ O
described VBN O
which WDT O
can MD O
be VB O
used VBN O
as IN O
common JJ O
reference NN O
for IN O
ECG NNP O
computer NN O
programs NNS O
analyzing VBG O
12 CD O
or CC O
15 CD O
simultaneously RB O
recorded VBN O
leads NNS O
. . O

-DOCSTART- X X O

Blood NN B-NP
serum NN I-NP
erythropoietin NN I-NP
level NN O
and CC O
basic JJ O
hematological NN O
indices NNS O
during IN O
the DT O
adaptation NN O
of IN O
healthy JJ O
newborn JJ O
infants NNS O

-DOCSTART- X X O

49 CD O
, , O
XXXXY NNP O
chromosome NN O
anomaly CC O
: : O
an DT O
unusual JJ O
variant NN O
of IN O
Klinefelter NNP O
's POS O
syndrome NN O
. . O

-DOCSTART- X X O

Contraction NN O
of IN O
the DT O
tracheal NN O
muscle NN O
and CC O
the DT O
activity NN O
of IN O
stretch NN O
receptors NNS O
in IN O
the DT O
trachea NN O

-DOCSTART- X X O

Infants NNS O
of IN O
this DT O
sample NN O
had VBD O
monocular JJ O
PL NNP O
visual JJ O
acuities NNS O
similar JJ O
to TO O
those DT O
established VBN O
by IN O
McDonald NNP O
et NNP O
al NN O
. . O
in IN O
a DT O
laboratory NN O
setting NN O
. . O

-DOCSTART- X X O

The DT O
number NN O
of IN O
crystalline NN O
deposits NNS O
is VBZ O
less RBR O
in IN O
the DT O
advanced JJ O
atrophic JJ O
areas NNS O
of IN O
the DT O
RPE-choriocapillaris NNP O
complex NN O
. . O

-DOCSTART- X X O

The DT O
subjects NNS O
received VBD O
a DT O
single JJ O
500 CD O
mg JJ O
dose NN O
of IN O
acetaminophen NN O
i IN O
.v. NNP O
and CC O
concentrations NNS O
in IN O
plasma NN O
were VBD O
measured VBN O
for IN O
360 CD O
minutes NNS O
and CC O
in IN O
urine NN O
for IN O
24 CD O
h NN O
in IN O
order NN O
to TO O
estimate VB O
the DT O
production NN O
of IN O
metabolites NNS O
. . O

-DOCSTART- X X O

Mean IN O
weighted JJ O
skin NN O
temperature NN O
( -LRB- O
Tsk NN O
) -RRB- O
was VBD O
lower JJR O
( -LRB- O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
following VBG O
acclimation NN O
than IN O
before RB O
, , O
and CC O
acclimation NN O
resulted VBD O
in IN O
a DT O
larger JJR O
( -LRB- O
P NNP O
less RBR O
than IN O
0.02 CD O
) -RRB- O
Tre-to-Tsk NNP O
gradient NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
L-methionine NNP O
supplementation NN O
on IN O
the DT O
utilization NN O
of IN O
a DT O
soy NN O
protein NN O
isolate VBP O
( -LRB- O
SPI NN O
) -RRB- O
was VBD O
evaluated VBN O
by IN O
short-term JJ O
nitrogen JJ O
balance NN O
studies NNS O
in IN O
young JJ O
women NNS O
. . O

-DOCSTART- X X O

Primary JJ O
invasive JJ O
Haemophilus NNP O
influenzae NN O
type NN O
b NN O
disease NN O
: : O
a DT O
population-based JJ O
assessment NN O
of IN O
risk NN O
factors NNS O
. . O

-DOCSTART- X X O

Factors NNS O
that WDT O
showed VBD O
significant JJ O
correlation NN O
to TO O
elevated JJ O
CIC NN O
's VBZ O
in IN O
the DT O
highly RB O
elevated JJ O
portion NN O
of IN O
our PRP$ O
CIC JJ O
population NN O
were VBD O
poor JJ O
NIH NNP O
score NN O
, , O
increased VBN O
patient NN O
age NN O
, , O
low JJ O
peak NN O
expiratory NN O
flow NN O
rate NN O
, , O
and CC O
elevated VBD O
total JJ O
serum NN B-NP
IgG. . I-NP

-DOCSTART- X X O

New NNP O
and CC O
successful JJ O
steps NNS O
have VBP O
been VBN O
made VBN O
in IN O
immunodiagnostics NNS O
, , O
immunotherapy NN O
, , O
and CC O
immunoprophylaxis NNS O
of IN O
immunologically RB O
conditioned VBN O
infertility NN O
. . O

-DOCSTART- X X O

Amikacin NNP O
was VBD O
the DT O
most RBS O
stable JJ O
and CC O
tobramycin NN O
was VBD O
the DT O
least JJS O
stable JJ O
aminoglycoside IN O
under IN O
the DT O
conditions NNS O
tested VBN O
. . O

-DOCSTART- X X O

This DT O
may MD O
explain VB O
in IN O
part NN O
a DT O
secular JJ O
trend NN O
towards IN O
reduced VBN O
birthweight NN O
for IN O
gestation NN O
in IN O
preterm JJ O
infants NNS O
. . O

-DOCSTART- X X O

Adhesion NN O
, , O
phagocytosis NN O
, , O
chemotactic NN O
and CC O
random JJ O
migration NN O
, , O
nitroblue JJ O
tetrazolium NN O
dye VBN O
reduction NN O
of IN O
peritoneal JJ O
exudate NN O
neutrophils NNS O
and CC O
macrophages NNS O
, , O
fibrinogen NN B-NP
level NN O
, , O
gelation NN O
of IN O
soluble JJ O
fibrin NNS B-NP
and CC O
serial JJ O
dilution NN O
protamine NN O
sulfate JJ O
test NN O
were VBD O
investigated VBN O
in IN O
115 CD O
New NNP O
Zealand NNP O
white JJ O
rabbits NNS O
with IN O
experimentally RB O
induced VBN O
Shwartzman NNP O
phenomenon NN O
in IN O
the DT O
colon NN O
, , O
and CC O
in IN O
control NN O
animals NNS O
. . O

-DOCSTART- X X O

He PRP O
visited VBD O
our PRP$ O
hospital NN O
and CC O
left VBD O
solitary JJ O
renal NN O
cyst NN O
was VBD O
suspected VBN O
. . O

-DOCSTART- X X O

A DT O
significant JJ O
herd NN O
X NNP O
period NN O
interaction NN O
existed VBD O
for IN O
liver NN O
TG NN O
and CC O
serum NN O
dextran NN O
precipitable JJ O
cholesterol NN O
concentrations NNS O
. . O

-DOCSTART- X X O

The DT O
results NNS O
show VBP O
that IN O
nerve NN O
and CC O
roots NNS O
differ VBP O
considerably RB O
both DT O
in IN O
the DT O
force NN O
they PRP O
sustain VBP O
before IN O
failure NN O
and CC O
in IN O
the DT O
other JJ O
biomechanics NNS O
they PRP O
exhibit VBP O
. . O

-DOCSTART- X X O

When WRB O
the DT O
coronary JJ O
sinus IN O
pressure NN O
reached VBN O
15 CD O
torr NN O
, , O
there EX O
was VBD O
a DT O
significant JJ O
decrease NN O
in IN O
cardiac JJ O
index NN O
( -LRB- O
3.60 CD O
+/ NN O
- : O
0.5 CD O
to TO O
2.70 CD O
+/ CD O
- : O
0.6 CD O
L/min/m2 NN O
, , O
p NN O
less RBR O
than IN O
0.001 CD O
) -RRB- O
, , O
coronary JJ O
blood NN O
flow NN O
( -LRB- O
13.7 CD O
+/ NN O
- : O
3.1 CD O
to TO O
7.0 CD O
+/ NNS O
- : O
2.1 CD O
ml/min NN O
, , O
p NN O
less RBR O
than IN O
0.001 CD O
) -RRB- O
, , O
rate NN O
of IN O
rise NN O
of IN O
left JJ O
ventricular JJ O
pressure NN O
( -LRB- O
1,567 CD O
+/ NN O
- : O
275 CD O
to TO O
1,331 CD O
+/ CD O
- : O
314 CD O
, , O
p RB O
less JJR O
than IN O
0.05 CD O
) -RRB- O
, , O
and CC O
an DT O
increase NN O
in IN O
coronary JJ O
arteriovenous JJ O
difference NN O
( -LRB- O
62.8 CD O
% NN O
+/ NN O
- : O
9.3 CD O
% NN O
to TO O
70.5 CD O
% NN O
+/ NN O
- : O
5.4 CD O
% NN O
saturation NN O
, , O
p NN O
less JJR O
than IN O
0.03 CD O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
a DT O
series NN O
of IN O
402 CD O
consecutive JJ O
autopsies NNS O
, , O
parietal NN O
pleural JJ O
plaques NNS O
( -LRB- O
PP NNP O
) -RRB- O
were VBD O
found VBN O
in IN O
68 CD O
individuals NNS O
above IN O
40 CD O
years NNS O
of IN O
age NN O
. . O

-DOCSTART- X X O

On IN O
transition NN O
from IN O
high JJ O
to TO O
low JJ O
voltage NN O
there EX O
was VBD O
a DT O
significant JJ O
fall NN O
in IN O
arterial JJ O
pressure NN O
( -LRB- O
7 CD O
% NN O
) -RRB- O
and CC O
an DT O
increase NN O
in IN O
flow NN O
( -LRB- O
19-38 CD O
% NN O
) -RRB- O
to TO O
areas NNS O
of IN O
the DT O
brain NN O
corresponding JJ O
to TO O
the DT O
arborization NN O
of IN O
the DT O
reticular JJ O
formation NN O
, , O
i IN O
.e NN O
. . O
excluding VBG O
the DT O
cerebrum NN O
and CC O
cerebellum NN O
. . O

-DOCSTART- X X O

Findings NNS O
of IN O
positive JJ O
potentials NNS O
showed VBD O
that DT O
N1 NN O
originated VBD O
in IN O
the DT O
area NN O
of IN O
ventral JJ O
gray JJ O
matter NN O
through IN O
the DT O
ventro-lateral NN O
column NN O
and CC O
N2 NN O
through IN O
the DT O
dorsal NN O
column NN O
. . O

-DOCSTART- X X O

There EX O
have VBP O
been VBN O
five CD O
problems NNS O
( -LRB- O
extravasation NN O
2 CD O
, , O
suspected VBN O
sepsis NN O
1 CD O
, , O
and CC O
hematoma NN O
2 CD O
) -RRB- O
during IN O
a DT O
total NN O
of IN O
2,927 CD O
days NNS O
of IN O
exposure NN O
. . O

-DOCSTART- X X O

Two CD O
studies NNS O
assessed VBN O
two CD O
types NNS O
of IN O
reliability NN O
of IN O
the DT O
student NN O
Jenkins NNP O
Activity NNP O
Survey NNP O
( -LRB- O
JAS NNP O
; : O
a DT O
questionnaire NN O
measure NN O
of IN O
Type NNP O
A DT O
behavior NN O
) -RRB- O
. . O

-DOCSTART- X X O

Splenectomized VBN O
patients NNS O
are VBP O
predisposed VBN O
toward IN O
developing VBG O
overwhelming JJ O
bacterial JJ O
infections NNS O
. . O

-DOCSTART- X X O

Possibilities NNS O
and CC O
outlook NN O
for IN O
wrist NN O
joint NN O
endoprosthesis NN O

-DOCSTART- X X O

Study NNP O
of IN O
the DT O
energy NN O
metabolism NN O
of IN O
the DT O
sensomotor NN O
cortex NN O
and CC O
hippocampus NN O
by IN O
the DT O
( -LRB- O
14C)2-deoxyglucose JJ O
method NN O
during IN O
the DT O
development NN O
of IN O
dissociated JJ O
states NNS O

-DOCSTART- X X O

Among IN O
them PRP O
, , O
26 CD O
cases NNS O
were VBD O
benign JJ O
and CC O
34 CD O
malignant JJ O
. . O

-DOCSTART- X X O

Fast JJ O
goal-directed JJ O
voluntary JJ O
movements NNS O
of IN O
the DT O
human JJ O
upper JJ O
extremity NN O
are VBP O
known VBN O
to TO O
be VB O
associated VBN O
with IN O
three CD O
distinct JJ O
bursts NNS O
of IN O
EMG NNP O
activity NN O
in IN O
antagonistic JJ O
muscles NNS O
. . O

-DOCSTART- X X O

The DT O
combination NN O
of IN O
F1 NNP O
and CC O
F2 NNP O
which WDT O
was VBD O
the DT O
best JJS O
predictor NN O
of IN O
CHD NNP O
in IN O
this DT O
population NN O
( -LRB- O
G1 NNP O
) -RRB- O
might MD O
be VB O
interpreted VBN O
as IN O
reflecting VBG O
trunk NN O
adiposity NN O
mainly RB O
abdominal NN O
. . O

-DOCSTART- X X O

The DT O
relations NNS O
between IN O
type NN O
A DT O
behavior NN O
, , O
clinically RB O
relevant JJ O
behavior NN O
, , O
academic JJ O
achievement NN O
, , O
and CC O
IQ NNP O
in IN O
children NNS O
. . O

-DOCSTART- X X O

The DT O
rats NNS O
were VBD O
used VBN O
for IN O
the DT O
study NN O
of IN O
the DT O
effects NNS O
of IN O
sepsis NN O
on IN O
the DT O
utilization NN O
of IN O
exogenous JJ O
fat JJ O
emulsion NN O
. . O

-DOCSTART- X X O

Results NNS O
of IN O
electron NN O
therapy NN O
of IN O
tumors NNS O
in IN O
different JJ O
sites NNS O

-DOCSTART- X X O

Incidences NNS O
of IN O
nonfatal JJ O
stroke NN O
, , O
myocardial JJ O
infarction NN O
, , O
angina DT O
pectoris NN O
und NN O
left VBD O
ventricular JJ O
hypertrophy NN O
could MD O
also RB O
be VB O
lowered VBN O
. . O

-DOCSTART- X X O

High NNP O
radial JJ O
r NN O
values NNS O
with IN O
small JJ O
standard JJ O
deviations NNS O
were VBD O
observed VBN O
in IN O
normal JJ O
LV NN O
( -LRB- O
0.972 CD O
+/ NN O
- : O
0.016 CD O
) -RRB- O
and CC O
in IN O
non-MI JJ O
regions NNS O
( -LRB- O
0.964 CD O
+/ NN O
- : O
0.018 CD O
) -RRB- O
, , O
indicating VBG O
temporally RB O
homogeneous JJ O
radial JJ O
shortening NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
during IN O
pregnancy NN O
there EX O
are VBP O
increases NNS O
in IN O
bone NN O
formation NN O
rates NNS O
contributing VBG O
to TO O
the DT O
increases NNS O
in IN O
skeletal JJ O
mass NN O
. . O

-DOCSTART- X X O

Prevention NN O
by IN O
a DT O
heparin-antithrombin NN O
III NNP B-NP
combination NN O

-DOCSTART- X X O

N-Substituted JJ O
trimethylsilylcarbamates NNS O
were VBD O
tested VBN O
as IN O
derivatizing VBG O
reagents NNS O
for IN O
gas NN O
chromatographic JJ O
analysis NN O
. . O

-DOCSTART- X X O

MICs NNS O
of IN O
four CD O
antifungal JJ O
agents NNS O
(5-fluorocytosine JJ O
, , O
miconazole JJ O
, , O
ketoconazole NN O
, , O
and CC O
amphotericin IN O
B) NNP O
for IN O
84 CD O
clinical JJ O
isolates NNS O
of IN O
various JJ O
Candida NNP O
species NNS O
were VBD O
then RB O
determined VBN O
with IN O
both DT O
media NNS O
in IN O
agar NN O
dilution NN O
and CC O
microtiter NN O
broth NN O
dilution NN O
systems NNS O
. . O

-DOCSTART- X X O

Evidence NN O
that IN O
opiate JJ O
addiction NN O
is VBZ O
in IN O
part NN O
an DT O
immune JJ O
response NN O
. . O

-DOCSTART- X X O

Parasitological JJ O
post-mortem JJ O
examination NN O
of IN O
all DT O
seropositive JJ O
animals NNS O
showed VBD O
five CD O
and CC O
seven CD O
false-positive JJ O
animals NNS O
when WRB O
E/S NNP B-NP
and CC I-NP
CWE NNP I-NP
antigens NNS I-NP
were VBD O
used VBN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Examples NNS O
of IN O
its PRP$ O
use NN O
in IN O
the DT O
intensive JJ O
therapy NN O
unit NN O
are VBP O
described VBN O
. . O

-DOCSTART- X X O

The DT O
growing VBG O
drug NN O
problem NN O
is VBZ O
also RB O
reflected VBN O
in IN O
the DT O
increasing VBG O
number NN O
of IN O
cases NNS O
of IN O
hepatitis NN O
B NNP O
and CC O
of IN O
drug-related JJ O
deaths NNS O
. . O

-DOCSTART- X X O

A DT O
large JJ O
increase NN O
of IN O
serum NN O
ketones NNS O
occurred VBD O
under IN O
all DT O
conditions NNS O
, , O
and CC O
the DT O
exercise NN O
respiratory NN O
quotient NN O
suggested VBD O
some DT O
increase NN O
of IN O
fat JJ O
utilization NN O
, , O
WW NNP O
( -LRB- O
0.85 CD O
) -RRB- O
through IN O
CW NNP O
( -LRB- O
0.84 CD O
) -RRB- O
to TO O
CC NNP O
( -LRB- O
0.83 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Respiratory NN O
adaptation NN O
to TO O
chronic JJ O
hypoxia NN O
in IN O
newborn JJ O
rats NNS O
. . O

-DOCSTART- X X O

RPS14 NNP B-NP
introns NNS O
3 CD O
and CC O
4 CD O
both DT O
contain VBP O
Alu NNP B-NP
sequences NNS O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
there EX O
may MD O
be VB O
a DT O
relationship NN O
between IN O
the DT O
pathogenesis NN O
of IN O
MAL NNP O
, , O
narcolepsy NN O
, , O
and CC O
OSA NNP O
. . O

-DOCSTART- X X O

While IN O
the DT O
examiner NN O
observed VBD O
the DT O
interior NN O
of IN O
the DT O
eye NN O
with IN O
indirect JJ O
ophthalmoscopy NN O
, , O
the DT O
point NN O
source NN O
of IN O
light NN O
from IN O
the DT O
fiberoptic JJ O
light NN O
pipe NN O
was VBD O
moved VBN O
along IN O
the DT O
margins NNS O
of IN O
the DT O
episcleral JJ O
plaque NN O
. . O

-DOCSTART- X X O

From IN O
life-table JJ O
analyses NNS O
of IN O
these DT O
patients NNS O
, , O
we PRP O
estimated VBD O
that IN O
the DT O
incidence NN O
of IN O
secondary JJ O
chondrosarcoma NN O
in IN O
patients NNS O
who WP O
have VBP O
Ollier JJ O
disease NN O
is VBZ O
about IN O
25 CD O
per IN O
cent NN O
at IN O
the DT O
age NN O
of IN O
forty CD O
years NNS O
, , O
and CC O
that IN O
malignant JJ O
degeneration NN O
is VBZ O
almost RB O
a DT O
certainty NN O
in IN O
patients NNS O
who WP O
have VBP O
Maffucci NNP O
syndrome NN O
. . O

-DOCSTART- X X O

The DT O
lethal JJ O
toxicity NN O
of IN O
inorganic JJ O
( -LRB- O
HgCl2 NN O
) -RRB- O
and CC O
organic JJ O
( -LRB- O
CH3HgCl JJ O
) -RRB- O
mercury NN O
chloride NN O
was VBD O
compared VBN O
for IN O
Coturnix NNP O
( -LRB- O
Japanese JJ O
quail NN O
, , O
Coturnix NNP O
japonica NN O
) -RRB- O
of IN O
different JJ O
ages NNS O
from IN O
hatch NN O
through IN O
adulthood NN O
by IN O
single-dose JJ O
acute JJ O
oral JJ O
and CC O
intramuscular JJ O
injections NNS O
and CC O
by IN O
a DT O
5-d JJ O
dietary NN O
trial NN O
. . O

-DOCSTART- X X O

Since IN O
the DT O
integrated VBN O
13h00-16h00 CD O
plasma NN O
cortisol NN O
estimation NN O
is VBZ O
cheaper JJR O
and CC O
simpler JJR O
than IN O
the DT O
mean JJ O
13h00-16h00 CD O
plasma NN O
cortisol NN O
estimation NN O
, , O
we PRP O
recommend VBP O
it PRP O
as IN O
an DT O
adjunct NN O
in IN O
the DT O
diagnosis NN O
of IN O
Cushing NNP O
's POS O
syndrome NN O
. . O

-DOCSTART- X X O

Most JJS O
of IN O
the DT O
patients NNS O
had VBD O
locally RB O
advanced VBN O
lesions NNS O
(63 IN O
T3-4 NN O
: : O
91.5 CD O
% NN O
) -RRB- O
according VBG O
to TO O
the DT O
adopted VBN O
TNM NNP O
system NN O
( -LRB- O
Lederman-Gadeberg NNP O
, , O
Sisson-Jesse NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Selenium NNP O
( -LRB- O
.1 JJ O
ppm NN O
) -RRB- O
and CC O
E NNP O
( -LRB- O
50 CD O
IU/kg NN O
) -RRB- O
supplementation NN O
of IN O
the DT O
diet NN O
of IN O
the DT O
sow NN O
increased VBD O
plasma NN O
tocopherol NN O
and CC O
Se NNP O
concentrations NNS O
, , O
but CC O
did VBD O
not RB O
increase VB O
plasma NN B-NP
glutathione NN I-NP
peroxidase NN I-NP
( -LRB- O
GSH-Px JJ B-NP
) -RRB- O
activity NN O
. . O

-DOCSTART- X X O

The DT O
in IN O
vitro NN O
antibacterial JJ O
potency NN O
is VBZ O
greatest JJS O
when WRB O
the DT O
1-substituent JJ O
is VBZ O
2,4-difluorophenyl JJ O
and CC O
the DT O
7-substituent JJ O
is VBZ O
a DT O
3-amino-1-pyrrolidinyl JJ O
group NN O
. . O

-DOCSTART- X X O

The DT O
M NNP B-NP
reading NN I-NP
frame NN I-NP
differed VBD O
from IN O
the DT O
reported VBN O
sequence NN O
by IN O
a DT O
single JJ O
nucleotide JJ O
corresponding JJ O
to TO O
a DT O
conservative JJ O
lysine NN O
to TO O
arginine VB O
amino IN O
acid NN O
substitution NN O
near IN O
the DT O
carboxy-terminus NN O
conserved VBD O
among IN O
the DT O
M NNP B-NP
proteins NNS I-NP
of IN O
paramyxoviruses NNS O
. . O

-DOCSTART- X X O

Laryngographic JJ O
changes NNS O
following VBG O
endotracheal JJ O
intubation NN O
in IN O
adults NNS O
. . O

-DOCSTART- X X O

Intensification NN O
of IN O
human JJ O
myocardial JJ O
contractile NN O
activity NN O
as IN O
affected VBN O
by IN O
blood NN O
serum NN O

-DOCSTART- X X O

Autotransplantation NNP O
of IN O
a DT O
vein NN O
segment NN O
with IN O
valve NN O
in IN O
the DT O
treatment NN O
of IN O
deep JJ O
vein NN O
valvular JJ O
insufficiency NN O
of IN O
the DT O
lower JJR O
extremity NN O

-DOCSTART- X X O

The DT O
observation NN O
of IN O
late JJ O
effects NNS O
after IN O
irradiations NNS O
or CC O
after IN O
space NN O
flights NNS O
show VBP O
the DT O
difficulties NNS O
encountered VBN O
in IN O
assessing VBG O
radiative JJ O
risks NNS O
during IN O
long JJ O
duration NN O
space NN O
flights NNS O
. . O

-DOCSTART- X X O

Practical JJ O
use NN O
and CC O
interpretation NN O
of IN O
viral JJ O
hepatitis NN O
B NNP O
markers NNS O
and CC O
hepatic JJ O
biopsy NN O
in IN O
HBs NNP B-NP
Ag NNP I-NP
carriers NNS O
and CC O
at IN O
the DT O
chronic JJ O
hepatitis NN O
stage NN O

-DOCSTART- X X O

The DT O
1 CD O
, , O
2 CD O
, , O
3 CD O
and CC O
4 CD O
year NN O
survival NN O
rates NNS O
were VBD O
94 CD O
% NN O
, , O
84 CD O
% NN O
, , O
76 CD O
% NN O
and CC O
63 CD O
% NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Inhibition NN O
of IN O
histalog-stimulated JJ O
gastric JJ O
secretion NN O
by IN O
40 CD O
749 CD O
RP NNP O
, , O
a DT O
new JJ O
long-acting JJ O
gastric JJ O
antisecretory JJ O
agent NN O
. . O

-DOCSTART- X X O

Five-year JJ O
prospective JJ O
study NN O
of IN O
peripheral JJ O
white JJ O
blood NN O
cells NNS O
in IN O
infectious JJ O
mononucleosis NN O
. . O

-DOCSTART- X X O

Northern JJ O
blotting VBG O
with IN O
a DT O
unique JJ O
17-mer JJ O
oligonucleotide NN O
demonstrated VBD O
the DT O
absence NN O
of IN O
the DT O
mutant JJ O
sequence NN O
in IN O
the DT O
mRNA NN O
from IN O
which WDT O
the DT O
cDNA NN O
library NN O
giving VBG O
rise NN O
to TO O
the DT O
mutant JJ O
cDNA NN O
was VBD O
constructed VBN O
. . O

-DOCSTART- X X O

Chemotherapy NN O
of IN O
metastasizing JJ O
breast NN O
cancer NN O

-DOCSTART- X X O

In IN O
recent JJ O
years NNS O
, , O
successful JJ O
physiological JJ O
models NNS O
have VBP O
been VBN O
developed VBN O
for IN O
a DT O
variety NN O
of IN O
volatile JJ O
and CC O
nonvolatile JJ O
chemicals NNS O
, , O
and CC O
their PRP$ O
ability NN O
to TO O
perform VB O
the DT O
extrapolations NNS O
needed VBN O
in IN O
risk NN O
assessment NN O
has VBZ O
been VBN O
demonstrated VBN O
. . O

-DOCSTART- X X O

Linear NNP O
extrapolation NN O
is VBZ O
used VBN O
below IN O
the DT O
experimental JJ O
data NNS O
range VBP O
to TO O
establish VB O
an DT O
upper JJ O
bound JJ O
on IN O
carcinogenic JJ O
risk NN O
at IN O
low JJ O
doses NNS O
. . O

-DOCSTART- X X O

Hisako NNP O
Minowa NNP O
who WP O
has VBZ O
worked VBN O
as IN O
a DT O
psychiatric JJ O
counsellor NN O
in IN O
industry NN O
for IN O
the DT O
past JJ O
20 CD O
years NNS O

-DOCSTART- X X O

Deletion NNP O
mapping NN O
studies NNS O
revealed VBD O
that IN O
the DT O
upstream JJ O
DNA NN O
sequences NNS O
up RB O
to TO O
-86 DT O
were VBD O
sufficient JJ O
for IN O
the DT O
optimal JJ O
basal NN O
level NN O
transcription NN O
in IN O
HeLa NNP O
cells NNS O
and CC O
also RB O
for IN O
the DT O
EIA-induced JJ B-NP
transcription NN O
. . O

-DOCSTART- X X O

Incorporation NN O
of IN O
the DT O
polyene NN O
antibiotic JJ O
amphotericin NN O
B NNP O
( -LRB- O
AMB) RB O
in IN O
liposomes NNS O
results NNS O
in IN O
a DT O
marked VBN O
reduction NN O
in IN O
drug NN O
toxicity NN O
with IN O
no DT O
loss NN O
of IN O
antifungal JJ O
potency NN O
. . O

-DOCSTART- X X O

Serum NNP B-NP
IgM NNP I-NP
and CC O
IgE NNP B-NP
concentrations NNS O
, , O
allergen-specific JJ B-NP
IgE NNP I-NP
scores NNS O
, , O
and CC O
the DT O
tumor NN O
E2R NN B-NP
status NN O
were VBD O
combined VBN O
to TO O
construct VB O
a DT O
three-level JJ O
risk NN O
classification NN O
that WDT O
was VBD O
more JJR O
prognostic JJ O
than IN O
any DT O
of IN O
the DT O
individual JJ O
components NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
T.C. NNP O
, , O
LDL-C. NNP B-NP
, , O
HDL-C. NNP B-NP
, , O
HDL2-C. NNP B-NP
, , O
apo NN B-NP
B NNP I-NP
, , O
apo RB B-NP
A-I/B NNP I-NP
ratio NN O
and CC O
apo VB B-NP
A-II/B NNP I-NP
ratio NN O
are VBP O
predictive JJ O
risk NN O
factors NNS O
of IN O
the DT O
coronary JJ O
heart NN O
disease NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
concluded VBN O
that IN O
the DT O
unique JJ O
suppository NN O
formulation NN O
of IN O
CZX-S NNP O
is VBZ O
useful JJ O
in IN O
the DT O
treatment NN O
of IN O
infections NNS O
in IN O
children NNS O
with IN O
heavy JJ O
psychophysiologic NN O
disorders NNS O
and CC O
in IN O
children NNS O
who WP O
cannot MD O
take VB O
oral JJ O
drugs NNS O
because IN O
of IN O
severe JJ O
vomiting NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
marked VBD O
hypertension NN O
accompanied VBN O
this DT O
disorder NN O
and CC O
all DT O
abnormalities NNS O
, , O
including VBG O
the DT O
hypertension NN O
, , O
responded VBD O
to TO O
1-desamino-8-D-arginine DT B-NP
vasopressin JJ I-NP
therapy NN O
. . O

-DOCSTART- X X O

Single NNP O
photon NN O
emission NN O
computerized JJ O
tomography NN O
( -LRB- O
SPECT) NNP O
, , O
by IN O
providing VBG O
three-dimensional JJ O
representation NN O
of IN O
myocardial JJ O
Tl-201 NNP O
, , O
offers VBZ O
promise NN O
for IN O
improved JJ O
localization NN O
of IN O
CAD. NNP O

-DOCSTART- X X O

The DT O
results NNS O
obtained VBN O
are VBP O
similar JJ O
to TO O
those DT O
described VBN O
with IN O
the DT O
previous JJ O
Cremophor NNP O
formulation NN O
although IN O
greater JJR O
variability NN O
in IN O
induction NN O
and CC O
recovery NN O
times NNS O
was VBD O
noted VBN O
with IN O
the DT O
emulsion NN O
formulation NN O
. . O

-DOCSTART- X X O

Diagnosis NNP O
of IN O
unilateral JJ O
renal JJ O
artery NN O
lesions NNS O
after IN O
captopril DT O
administration NN O
. . O

-DOCSTART- X X O

A DT O
yeast NN O
DNA NN O
fragment NN O
carrying VBG O
the DT O
gene NN B-NP
CP CD I-NP
A1 NNS I-NP
encoding VBG O
the DT O
small JJ O
subunit NN O
of IN O
the DT O
arginine NN O
pathway NN O
carbamoyl-phosphate NN B-NP
synthetase NN I-NP
has VBZ O
been VBN O
sequenced VBN O
. . O

-DOCSTART- X X O

The DT O
H2 NN B-NP
receptor NN I-NP
antagonists NNS O
and CC O
sucralfate JJ O
cost NN O
about IN O
the DT O
same JJ O
and CC O
have VBP O
few JJ O
side JJ O
effects NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
indoramin NN O
may MD O
have VB O
Class NNP O
III NNP O
antiarrhythmic JJ O
activity NN O
. . O

-DOCSTART- X X O

A DT O
high JJ O
efficacy NN O
of IN O
the DT O
combined VBN O
use NN O
of IN O
nontoxic JJ O
doses NNS O
of IN O
two CD O
pharmaceuticals NNS O
: : O
cystamine NN O
( -LRB- O
50 CD O
mg/kg NN O
) -RRB- O
and CC O
mexamine NN O
( -LRB- O
25 CD O
mg/kg NN O
) -RRB- O
under IN O
the DT O
conditions NNS O
of IN O
short-term JJ O
exogenous JJ O
hypoxia NN O
( -LRB- O
7.5 CD O
% NN O
O2 NN O
) -RRB- O
was VBD O
found VBN O
in IN O
( -LRB- O
CBA NNP O
X NNP O
C57Bl)F1 NNP O
mice NNS O
. . O

-DOCSTART- X X O

The DT O
Mean NNP O
was VBD O
74,3 CD O
+/ CD O
- : O
53,6 CD O
micrograms NNS O
J/g JJ O
Cr NNP O
, , O
the DT O
Median NNP O
61 CD O
micrograms NNS O
J/g JJ O
Cr NNP O
. . O

-DOCSTART- X X O

In IN O
the DT O
region NN O
Walgau NNP O
with IN O
mixed JJ O
industrial-rural JJ O
population NN O
an DT O
iodine JJ O
deficiency NN O
I PRP O
was VBD O
found VBN O
in IN O
81 CD O
% NN O
and CC O
an DT O
iodine JJ O
deficiency NN O
II NNP O
in IN O
45 CD O
% NN O
. . O

-DOCSTART- X X O

The DT O
structural JJ O
gene NN O
for IN O
hydrogenase NN B-NP
encodes VBZ O
a DT O
protein NN O
product NN O
of IN O
molecular JJ O
mass NN O
45820 CD O
Da NNP O
. . O

-DOCSTART- X X O

Pancreaticoduodenal NNP O
lymph NN O
node NN O
enlargement NN O
, , O
regardless RB O
of IN O
cause NN O
, , O
has VBZ O
been VBN O
a DT O
source NN O
of IN O
imaging VBG O
confusion NN O
because IN O
of IN O
its PRP$ O
propensity NN O
to TO O
mimic VB O
pancreatic JJ O
malignancy NN O
yet CC O
not RB O
cause VB O
biliary JJ O
obstruction NN O
. . O

-DOCSTART- X X O

Interference NN O
with IN O
rheumatoid NN B-NP
factor NN I-NP
was VBD O
only RB O
observed VBN O
in IN O
the DT O
ELISA NNP O
enzygnost NN O
if IN O
sera NN O
were VBD O
not RB O
pretreated VBN O
with IN O
latex JJ O
adsorbents NNS O
. . O

-DOCSTART- X X O

Such JJ O
studied VBN O
acquired VBN O
with IN O
low JJ O
energy NN O
or CC O
medium JJ O
energy NN O
collimation NN O
and CC O
a DT O
window NN O
centered VBN O
on IN O
the DT O
159 CD O
keV NN O
123I CD O
photopeak NN O
contain VBP O
appreciable JJ O
septal JJ O
breakthrough NN O
signals NNS O
originating VBG O
from IN O
Compton NNP O
scatter NN O
of IN O
high JJ O
energy NN O
photons NNS O
primarily RB O
from IN O
124I. VBG O

-DOCSTART- X X O

Nursing VBG O
education--the DT O
computer NN O
obligation NN O
. . O

-DOCSTART- X X O

Shear NNP O
bond NN O
strength NN O
of IN O
a DT O
composite JJ O
resin NN O
to TO O
an DT O
etched JJ O
glass NN O
ionomer NN O
. . O

-DOCSTART- X X O

An DT O
additional JJ O
advantage NN O
is VBZ O
that IN O
the DT O
resin NN O
can MD O
be VB O
removed VBN O
and CC O
the DT O
immunoperoxidase JJ B-NP
technique NN O
carried VBD O
out RP O
on IN O
thin JJ O
sections NNS O
. . O

-DOCSTART- X X O

Such JJ O
a DT O
concept NN O
is VBZ O
crucial JJ O
to TO O
our PRP$ O
understanding NN O
of IN O
the DT O
pathology NN O
of IN O
ageing NN O
in IN O
general JJ O
. . O

-DOCSTART- X X O

We PRP O
consider VBP O
that DT O
DIL-CP NNP O
is VBZ O
a DT O
safe JJ O
and CC O
excellent JJ O
CP CD O
in IN O
CABG NNP O
surgery NN O
and CC O
we PRP O
are VBP O
now RB O
utilizing VBG O
this DT O
CP CD O
in IN O
all DT O
patients NNS O
requiring VBG O
CABG NNP O
surgery NN O
. . O

-DOCSTART- X X O

Oral NNP O
candidiasis NN O

-DOCSTART- X X O

In IN O
addition NN O
, , O
the DT O
gcd1-101 JJ B-NP
mutation NN I-NP
suppressed VBD O
the DT O
low JJ O
translational JJ O
efficiency NN O
of IN O
GCN4-lacZ JJ B-NP
mRNA NN O
observed VBD O
in IN O
gcn2 CD B-NP
- : I-NP
and CC O
gcn3 CD B-NP
- : I-NP
cells NNS O
. . O

-DOCSTART- X X O

This DT O
suggests VBZ O
that IN O
alaproclate NN O
acutely RB O
increases VBZ O
the DT O
responsiveness NN O
of IN O
postsynaptic JJ O
muscarinic NN B-NP
and CC I-NP
alpha NN I-NP
1 CD I-NP
adrenoceptors NNS I-NP
. . O

-DOCSTART- X X O

The DT O
concentrations NNS O
of IN O
apo NN B-NP
A-I NN I-NP
and CC O
apo VB B-NP
A-II NNP I-NP
of IN O
abstainers NNS O
decreased VBN O
significantly RB O
compared VBN O
with IN O
the DT O
corresponding JJ O
changes NNS O
in IN O
controls NNS O
. . O

-DOCSTART- X X O

The DT O
distribution NN O
of IN O
patients NNS O
was VBD O
as IN O
follows VBZ O
: : O
group NN O
1--complex JJ O
gamma-therapy NN O
( -LRB- O
55 CD O
cases NNS O
) -RRB- O
, , O
group NN O
2--complex JJ O
gamma-therapy NN O
plus CC O
iliac JJ O
lymphadenectomy NN O
( -LRB- O
50 CD O
cases NNS O
) -RRB- O
and CC O
group NN O
3--complex JJ O
radiation NN O
treatment NN O
with IN O
megavolt JJ O
bremsstrahlung NN O
beam NN O
from IN O
the DT O
luc JJ O
type NN O
installation NN O
and CC O
iliac JJ O
lymphadenectomy NN O
( -LRB- O
50 CD O
cases NNS O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
availability NN O
of IN O
cryoprecipitate NN O
and CC O
DDAVP NNP O
offers VBZ O
an DT O
alternative NN O
and CC O
effective JJ O
treatment NN O
for IN O
the DT O
temporary JJ O
reversal NN O
of IN O
uremic JJ O
bleeding VBG O
in IN O
patients NNS O
who WP O
require VBP O
urgent JJ O
invasive JJ O
procedures NNS O
. . O

-DOCSTART- X X O

Biopsies NNS O
of IN O
the DT O
jejunal NN O
mucosa NN O
have VBP O
shown VBN O
abnormal JJ O
enzyme NN O
activity NN O
or CC O
deficiencies NNS O
in IN O
transport NN O
mechanisms NNS O
. . O

-DOCSTART- X X O

A DT O
significant JJ O
degree NN O
of IN O
homology NN O
was VBD O
also RB O
found VBN O
among IN O
these DT O
genes NNS O
and CC O
the DT O
Mtase NNP B-NP
gene NN I-NP
of IN O
related VBN O
phage NN O
SPR NN O
, , O
which WDT O
codes NNS O
for IN O
an DT O
enzyme NN O
with IN O
different JJ O
modification NN O
specificity NN O
. . O

-DOCSTART- X X O

Thyrotropin-releasing PRP$ B-NP
hormone-induced JJ I-NP
contraction NN O
of IN O
urethral NN O
and CC O
vaginal JJ O
muscle NN O
. . O

-DOCSTART- X X O

In IN O
a DT O
blind JJ O
controlled JJ O
trial NN O
, , O
15 CD O
patients NNS O
with IN O
COCM NNP O
( -LRB- O
NYHA NNP O
II-III NNP O
) -RRB- O
with IN O
sinus NN O
rhythm NN O
and CC O
a DT O
left JJ O
ventricular JJ O
ejection NN O
fraction NN O
( -LRB- O
LV-EF NN O
) -RRB- O
of IN O
34.5 CD O
+/ JJ O
- : O
2.6 CD O
% NN O
received VBN O
consecutively NN O
D NN O
( -LRB- O
0.25-0.5 CD O
mg/d NN O
) -RRB- O
, , O
placebo FW O
( -LRB- O
PLAC NN O
) -RRB- O
, , O
P NNP O
( -LRB- O
slow JJ O
releases NNS O
= SYM O
SR NN O
) -RRB- O
( -LRB- O
80 CD O
mg/d JJ O
SR NN O
) -RRB- O
and CC O
both DT O
drugs NNS O
combined VBN O
in IN O
respective JJ O
doses NNS O
. . O

-DOCSTART- X X O

The DT O
sample NN O
is VBZ O
deproteinized VBN O
and CC O
after IN O
centrifugation NN O
valproic JJ O
acid NN O
in IN O
the DT O
supernatant NN O
is VBZ O
measured VBN O
in IN O
the DT O
free JJ O
form NN O
by IN O
direct JJ O
injection NN O
into IN O
the DT O
gas NN O
chromatograph NN O
. . O

-DOCSTART- X X O

Changes NNS O
in IN O
muscarinic JJ B-NP
acetylcholine NN I-NP
receptors NNS I-NP
in IN O
guinea-pig JJ O
lung NN O
: : O
effects NNS O
of IN O
aging VBG O
, , O
inhalation NN O
of IN O
an DT O
allergen NN O
, , O
administration NN O
of IN O
drugs NNS O
, , O
and CC O
vagotomy NN O
. . O

-DOCSTART- X X O

Greek NNP O
classicism NN O
in IN O
living VBG O
structure NN O
? . O
Some DT O
deductive JJ O
pathways NNS O
in IN O
animal NN O
morphology NN O
. . O

-DOCSTART- X X O

Three CD O
chromosomal NN B-NP
crsA NNS I-NP
mutations NNS I-NP
, , O
crsA1 NNS B-NP
, , O
crsA4 NNS B-NP
, , O
and CC O
crsA47 CD B-NP
, , O
were VBD O
transferred VBN O
by IN O
the DT O
"gene NN O
conversion NN O
" `` O
process NN O
to TO O
B. NNP O
subtilis NNS O
plasmid VBD O
pRPD11 NNS O
, , O
which WDT O
consists VBZ O
of IN O
the DT O
entire JJ O
wild-type JJ B-NP
rpoD NN I-NP
coding NN I-NP
sequence NN I-NP
, , O
encoding VBG O
the DT O
major JJ B-NP
sigma NN I-NP
43 CD I-NP
factor NN I-NP
of IN I-NP
B. NNP I-NP
subtilis NNS I-NP
RNA NNP I-NP
polymerase NN I-NP
, , O
and CC O
pUB110 PRP O
. . O

-DOCSTART- X X O

The DT O
data NNS O
indicate VBP O
that IN O
the DT O
five CD O
different JJ O
( -LRB- O
and CC O
partially RB O
overlapping VBG O
) -RRB- O
sry NN B-NP
messenger NN I-NP
RNAs IN I-NP
detectable NN O
in IN O
early JJ O
embryos NNS O
are VBP O
initiated VBN O
at IN O
three CD O
separate JJ O
sites NNS O
, , O
each DT O
directly RB O
upstream RB O
from IN O
one CD O
of IN O
the DT O
three CD O
protein-coding JJ O
regions NNS O
, , O
designated VBN O
( -LRB- O
in IN O
5' JJ O
to TO O
3' JJ O
order NN O
) -RRB- O
beta NN O
, , O
alpha NN O
and CC O
delta NN O
. . O

-DOCSTART- X X O

Chronic NNP O
thyroiditis NN O
as IN O
a DT O
risk NN O
factor NN O
of IN O
B-cell JJ O
lymphoma NN O
in IN O
the DT O
thyroid NN O
gland NN O
. . O

-DOCSTART- X X O

Plasma NNP B-NP
secretin NN I-NP
levels NNS O
also RB O
augmented VBN O
after IN O
the DT O
administration NN O
of IN O
ethanol JJ O
solutions NNS O
, , O
with IN O
a DT O
delay NN O
of IN O
about IN O
one CD O
hour NN O
after IN O
the DT O
onset NN O
of IN O
acid NN O
secretion NN O
. . O

-DOCSTART- X X O

Spectrophotometric JJ O
microanalysis NN O
of IN O
ethylenediaminotetracetic JJ O
acid NN O
in IN O
pharmaceutical JJ O
preparations NNS O

-DOCSTART- X X O

A DT O
comparison NN O
among IN O
the DT O
5' JJ O
flanking NN O
regions NNS O
encompassing VBG O
the DT O
presumptive JJ O
HS NNP B-NP
promoter NN I-NP
of IN O
the DT O
soybean NN B-NP
HS-protein NN I-NP
genes NNS I-NP
demonstrated VBD O
this DT O
region NN O
to TO O
be VB O
extremely RB O
homologous JJ O
. . O

-DOCSTART- X X O

Results NNS O
of IN O
this DT O
study NN O
indicate VBP O
that IN O
GLC NNP O
of IN O
short JJ O
chain NN O
fatty JJ O
acids NNS O
produced VBN O
on IN O
agar NN O
medium NN O
by IN O
anaerobes NNS O
, , O
combined VBN O
with IN O
simple JJ O
tests NNS O
such JJ O
as IN O
Gram NNP O
's POS O
stain NN O
and CC O
colonial JJ O
morphology NN O
, , O
may MD O
allow VB O
fir JJ O
direct JJ O
presumptive NN O
genus NN O
identification NN O
from IN O
an DT O
initial JJ O
pure JJ O
agar NN O
culture NN O
. . O

-DOCSTART- X X O

Using VBG O
this DT O
method NN O
, , O
we PRP O
measured VBD O
absorption IN O
of IN O
low JJ O
doses NNS O
of IN O
vitamin NN O
A DT O
, , O
which WDT O
may MD O
provide VB O
a DT O
more RBR O
physiological JJ O
approach NN O
to TO O
assessment NN O
of IN O
fat JJ O
malabsorption NN O
. . O

-DOCSTART- X X O

Tissue NNP O
pressure NN O
, , O
rCBF NN O
, , O
and CC O
water NN O
content NN O
were VBD O
measured VBN O
from IN O
gray JJ O
matter NN O
in IN O
the DT O
central JJ O
core NN O
and CC O
the DT O
peripheral JJ O
margin NN O
of IN O
the DT O
MCA NNP O
territory NN O
over IN O
6 CD O
h NN O
after IN O
MCAO. NNP O

-DOCSTART- X X O

During IN O
this DT O
time NN O
, , O
the DT O
patients NNS O
all RB O
had VBD O
the DT O
characteristic JJ O
plasma NN O
thyroid VBD O
hormone NN O
changes NNS O
associated VBN O
with IN O
amiodarone JJ O
therapy NN O
, , O
i IN O
.e NN O
. . O
increased VBD O
T4 CD O
, , O
free JJ O
T4 NNP O
, , O
and CC O
rT3 JJ O
and CC O
decreased VBD O
T3 CD O
, , O
while IN O
remaining VBG O
clinically RB O
euthyroid JJ O
. . O

-DOCSTART- X X O

Drug NN O
and CC O
nutrient JJ O
interactions NNS O
. . O

-DOCSTART- X X O

In IN O
each DT O
compartment NN O
O2 . O
is VBZ O
removed VBN O
by IN O
the DT O
tissues NNS O
as IN O
a DT O
chemical NN O
reaction NN O
takes VBZ O
place NN O
between IN O
O2 NNP O
and CC O
oxyhemoglobin NN B-NP
( -LRB- O
HbO2 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Cortisol NNP O
excretion NN O
, , O
appeared VBD O
to TO O
be VB O
markedly RB O
affected VBN O
by IN O
the DT O
season NN O
although IN O
other JJ O
factors NNS O
such JJ O
as IN O
social JJ O
and CC O
environmental JJ O
stress NN O
cannot MD O
be VB O
discounted VBN O
. . O

-DOCSTART- X X O

Two CD O
studies NNS O
on IN O
the DT O
relationship NN O
between IN O
taking VBG O
a DT O
commercial JJ O
coaching NN O
course NN O
and CC O
performance NN O
on IN O
the DT O
Medical NNP O
College NNP O
Admission NNP O
Test NNP O
(MCAT NN O
) -RRB- O
are VBP O
reported VBN O
. . O

-DOCSTART- X X O

The DT O
financial JJ O
impact NN O
of IN O
childhood NN O
asthma NN O
has VBZ O
not RB O
been VBN O
assessed VBN O
since IN O
Vance NNP O
and CC O
Taylor NNP O
reported VBD O
their PRP$ O
data NNS O
in IN O
Annals NNS O
of IN O
Allergy NNP O
13 CD O
years NNS O
ago RB O
. . O

-DOCSTART- X X O

Hypersplenism NN O

-DOCSTART- X X O

The DT O
topography NN O
and CC O
trajectories NNS O
of IN O
the DT O
commissural JJ O
fibers NNS O
of IN O
the DT O
superior JJ O
temporal JJ O
region NN O
(STR NN O
) -RRB- O
are VBP O
studied VBN O
using VBG O
the DT O
autoradiographic JJ O
technique NN O
. . O

-DOCSTART- X X O

The DT O
primary JJ O
CT NN O
findings NNS O
were VBD O
misinterpreted VBN O
as IN O
a DT O
brain NN O
infarct NN O
or CC O
possibly RB O
a DT O
tumour NN O
. . O

-DOCSTART- X X O

Shoulder NNP O
forearm JJ O
support NN O
for IN O
the DT O
subluxed JJ O
shoulder NN O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
both DT O
in IN O
the DT O
early JJ O
stages NNS O
(0T VBP O
, , O
0N NNP O
) -RRB- O
and CC O
in IN O
more RBR O
severe JJ O
stages NNS O
of IN O
VWF NNP O
( -LRB- O
stages NNS O
1-2 JJ O
) -RRB- O
cold JJ O
induced VBN O
hyperreactivity NN O
in IN O
the DT O
digital JJ O
vessels NNS O
and CC O
Raynaud NNP O
's POS O
syndrome NN O
are VBP O
vascular JJ O
disorders NNS O
of IN O
functional JJ O
origin NN O
occurring VBG O
without IN O
any DT O
prethrombotic JJ O
alterations NNS O
. . O

-DOCSTART- X X O

In IN O
MCCP NNP O
functions NNS O
of IN O
the DT O
source NN O
emission NN O
, , O
surface NN O
reflection NN O
, , O
photoacceptor NN O
sensitivity NN O
are VBP O
approximated VBN O
by IN O
the DT O
normal JJ O
distribution NN O
curves NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
kidneys NNS O
perfused VBN O
for IN O
72 CD O
hr NN O
demonstrated VBD O
more RBR O
similar JJ O
renal JJ O
functions NNS O
when WRB O
tested VBN O
by IN O
either DT O
IMPK NNP O
or CC O
IBPK. NNP O

-DOCSTART- X X O

To TO O
assess VB O
the DT O
effects NNS O
of IN O
alveolar JJ O
hypoxia NN O
and CC O
angiotensin NN B-NP
II NNP I-NP
infusion NN O
on IN O
distribution NN O
of IN O
blood NN O
flow NN O
to TO O
the DT O
lung NN O
we PRP O
performed VBD O
perfusion IN O
lung NN O
scans NNS O
on IN O
anesthetized DT O
mechanically RB O
ventilated VBN O
lambs NNS O
. . O

-DOCSTART- X X O

A DT O
flow NN O
rate NN O
of IN O
at IN O
least JJS O
5 CD O
mL/h NN O
is VBZ O
required VBN O
through IN O
the DT O
receptor NN O
(volume NN O
, , O
0.4 CD O
mL NN O
) -RRB- O
for IN O
accurate JJ O
results NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
now RB O
located VBN O
the DT O
5' JJ O
ends NNS O
of IN O
the DT O
two CD O
remaining VBG O
late JJ O
mRNAs NNS O
. . O

-DOCSTART- X X O

Recurrent JJ O
acute JJ O
rhinosinusitis NN O
was VBD O
common JJ O
in IN O
both DT O
groups NNS O
of IN O
patients NNS O
, , O
but CC O
the DT O
development NN O
of IN O
chronic NN O
rhinosinusitis NN O
was VBD O
only RB O
found VBN O
in IN O
patients NNS O
with IN O
CVID NNP O
, , O
indicating VBG O
the DT O
more RBR O
severe JJ O
nature NN O
of IN O
this DT O
condition NN O
compared VBN O
with IN O
selective JJ O
IgA NNP B-NP
deficiency NN O
. . O

-DOCSTART- X X O

The DT O
various JJ O
muscles NNS O
of IN O
the DT O
pelvic JJ O
floor NN O
region NN O
could MD O
be VB O
reflexly RB O
activated VBN O
either CC O
individually RB O
or CC O
as IN O
a DT O
mass NN O
unit NN O
depending VBG O
on IN O
the DT O
intensity NN O
of IN O
stimulation NN O
. . O

-DOCSTART- X X O

It PRP O
has VBZ O
been VBN O
reported VBN O
that IN O
rat NN O
blood NN O
chloroform NN O
levels NNS O
were VBD O
significantly RB O
decreased VBN O
after IN O
treatment NN O
with IN O
ClO2 NNP O
. . O

-DOCSTART- X X O

The DT O
frequency NN O
of IN O
lactase NN B-NP
phenotypes NNS I-NP
in IN O
Aymara NNP O
children NNS O
. . O

-DOCSTART- X X O

Activities NNS O
of IN O
hepatic JJ O
cytochrome NN B-NP
P-450-dependent JJ I-NP
metabolizing VBG O
enzymes NNS O
such JJ O
as IN O
aminopyrine JJ B-NP
- : I-NP
and CC I-NP
TMO NNP I-NP
N-demethylase NNP I-NP
and CC O
aniline NN B-NP
hydroxylase NN I-NP
activity NN O
were VBD O
decreased VBN O
by IN O
pretreatment NN O
of IN O
rats NNS O
with IN O
cimetidine NN O
, , O
whereas IN O
in IN O
the DT O
rats NNS O
pretreated VBN O
with IN O
ranitidine NN O
, , O
these DT O
enzyme JJ O
activities NNS O
were VBD O
not RB O
changed VBN O
. . O

-DOCSTART- X X O

Doxorubicin NNP O
, , O
dacarbazine NN O
, , O
vincristine NN O
, , O
and CC O
cyclophosphamide NN O
in IN O
the DT O
treatment NN O
of IN O
advanced JJ O
gastrointestinal JJ O
leiomyosarcoma NN O
. . O

-DOCSTART- X X O

Electrochemical JJ O
detection NN O
of IN O
depressed JJ O
circulating VBG O
levels NNS O
of IN O
vitamin NN O
K1 . O
in IN O
osteoporosis NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
experiments NNS O
, , O
we PRP O
investigate VB O
the DT O
role NN O
played VBD O
by IN O
the DT O
temporal JJ O
pattern NN O
of IN O
neural JJ O
activity NN O
during IN O
the DT O
ontogeny NN O
of IN O
frequency NN O
tuning NN O
in IN O
the DT O
mouse NN O
central JJ O
auditory NN O
system NN O
. . O

-DOCSTART- X X O

Ultrastructure NNP O
of IN O
the DT O
tumor NN O
in IN O
1 CD O
patient NN O
in IN O
whom WP O
transurethral NN O
resection NN O
was VBD O
performed VBN O
2 CD O
weeks NNS O
after IN O
alum NN O
irrigation NN O
revealed VBD O
well RB O
preserved VBN O
nuclear JJ O
chromatin NN O
, , O
thus RB O
, , O
suggesting VBG O
that IN O
whatever WDT O
changes NNS O
occur VBP O
after IN O
alum NN O
irrigation NN O
are VBP O
short-lived JJ O
. . O

-DOCSTART- X X O

The DT O
generally RB O
adopted VBN O
criteria NNS O
enabling VBG O
to TO O
classify VB O
the DT O
examined VBN O
persons NNS O
into IN O
the DT O
following VBG O
3 CD O
groups NNS O
have VBP O
been VBN O
used VBN O
: : O
( -LRB- O
a DT O
) -RRB- O
diseased JJ O
of IN O
BEN NNS O
; : O
( -LRB- O
b NN O
) -RRB- O
suspect VBP O
to TO O
be VB O
diseased JJ O
of IN O
BEN NNS O
, , O
and CC O
( -LRB- O
c NN O
) -RRB- O
individuals NNS O
without IN O
signs NNS O
of IN O
a DT O
renal JJ O
disease NN O
. . O

-DOCSTART- X X O

The DT O
POEMS NNP O
syndrome NN O
( -LRB- O
Polyneuropathy NNP O
, , O
Organomegaly NNP O
, , O
Endocrinopathy NNP O
, , O
Monoclonal NNP O
component NN O
, , O
Skin NNP O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
metastasis-free JJ O
patients NNS O
, , O
the DT O
best JJS O
results NNS O
were VBD O
obtained VBN O
with IN O
tumor NN O
diameters NNS O
under IN O
2 CD O
cm NN O
regardless RB O
of IN O
their PRP$ O
localization NN O
in IN O
lung NN O
tissue NN O
and CC O
with IN O
2--4.9 CD O
cm NN O
tumors NNS O
embedded VBN O
in IN O
lung NN O
parenchyma NN O
. . O

-DOCSTART- X X O

Two CD O
siblings NNS O
with IN O
hemolytic JJ O
anemia NN O
caused VBN O
by IN O
triosephosphate NN B-NP
isomerase NN I-NP
deficiency NN O
developed VBD O
a DT O
progressive JJ O
neurological JJ O
syndrome NN O
featuring VBG O
dystonic JJ O
movements NNS O
, , O
tremor NN O
, , O
pyramidal JJ O
tract NN O
signs NNS O
, , O
and CC O
evidence NN O
of IN O
spinal JJ O
motor NN O
neuron NN O
involvement NN O
. . O

-DOCSTART- X X O

One PRP O
extract VB O
with IN O
the DT O
lowest JJS O
PCA NN O
content NN O
was VBD O
non-carcinogenic JJ O
. . O

-DOCSTART- X X O

In IN O
the DT O
10 CD O
patients NNS O
with IN O
a DT O
more RBR O
severe JJ O
degree NN O
of IN O
steatorrhea NN O
the DT O
decrease NN O
in IN O
fat JJ O
loss NN O
approached VBD O
20 CD O
% NN O
and CC O
a DT O
close JJ O
relationship NN O
was VBD O
found VBN O
( -LRB- O
r NN O
= SYM O
0.84 CD O
, , O
p RB O
less JJR O
than IN O
0.01 CD O
) -RRB- O
between IN O
the DT O
extent NN O
of IN O
the DT O
fatty JJ O
acid NN O
loss NN O
on IN O
placebo NN O
and CC O
the DT O
decrease NN O
of IN O
this DT O
loss NN O
on IN O
taurine NN O
. . O

-DOCSTART- X X O

Aortic JJ O
diameters NNS O
in IN O
infants NNS O
and CC O
young JJ O
children NNS O
: : O
normative JJ O
angiographic JJ O
data NNS O
. . O

-DOCSTART- X X O

Hydrocortisone NNP O
caused VBD O
lymphopenia NN O
and CC O
inhibited VBD O
the DT O
blastogenic JJ O
response NN O
of IN O
peripheral JJ O
blood NN O
lymphocytes NNS O
to TO O
phytohemagglutinin VB B-NP
and CC O
concanavalin VB B-NP
A DT I-NP
mitogens NNS O
. . O

-DOCSTART- X X O

Chenodeoxycholic JJ O
acid NN O
( -LRB- O
cheno NN O
) -RRB- O
and CC O
ursodeoxycholic JJ O
acid NN O
(urso RB O
) -RRB- O
dissolve VB O
cholesterol NN O
gallstones NNS O
in IN O
man NN O
. . O

-DOCSTART- X X O

Sensory NNP O
evoked VBD O
field NN O
potentials NNS O
were VBD O
recorded VBN O
from IN O
the DT O
mesencephalic NN O
reticular NN O
formation NN O
( -LRB- O
MRF) NNP O
, , O
central JJ O
gray JJ O
( -LRB- O
CG) NN O
and CC O
somatosensory JJ O
cortex NN O
(SCX) NNS O
, , O
following VBG O
incremental JJ O
doses NNS O
of IN O
halothane NN O
in IN O
freely-moving JJ O
rats NNS O
. . O

-DOCSTART- X X O

OODG NNP O
is VBZ O
a DT O
diagnostic JJ O
method NN O
permitting VBG O
assessment NN O
of IN O
ocular JJ O
pulse NN O
curves NNS O
and CC O
objective JJ O
determination NN O
of IN O
blood NN O
pressures NNS O
in IN O
the DT O
ophthalmic JJ O
circulatory NN O
system NN O
( -LRB- O
retinal JJ O
and CC O
ciliary JJ O
arterial JJ O
blood NN O
pressures NNS O
) -RRB- O
simultaneously RB O
for IN O
both DT O
eyes NNS O
, , O
without IN O
dilatation NN O
of IN O
the DT O
pupils NNS O
. . O

-DOCSTART- X X O

Viral NNP O
infections NNS O
have VBP O
long RB O
been VBN O
suspected VBN O
to TO O
be VB O
causative JJ O
agents NNS O
in IN O
a DT O
number NN O
of IN O
inner JJ O
ear NN O
dysfunctions NNS O
. . O

-DOCSTART- X X O

Retrospective JJ O
analyses NNS O
of IN O
this DT O
death NN O
revealed VBD O
a DT O
significant JJ O
decrease NN O
of IN O
the DT O
left JJ O
ventricular NN O
( -LRB- O
LV NN O
) -RRB- O
end-diastolic JJ O
volume NN O
index NN O
( -LRB- O
EDVI NNP O
) -RRB- O
of IN O
21 CD O
ml/m2 CD O
( -LRB- O
36 CD O
% NN O
of IN O
normal JJ O
) -RRB- O
. . O

-DOCSTART- X X O

Polysorbate NN O
80 CD O
did VBD O
not RB O
have VB O
a DT O
direct JJ O
stimulant NN O
or CC O
relaxant JJ O
effect NN O
on IN O
either DT O
guinea NN O
pig NN O
ileum NN O
or CC O
rat NN O
uterus NN O
, , O
however RB O
, , O
it PRP O
antagonised VBD O
the DT O
contractions NNS O
induced VBN O
by IN O
acetylcholine NN O
, , O
histamine NN O
, , O
barium NN O
, , O
5-hydroxytryptamine JJ O
and CC O
carbachol NN O
in IN O
a DT O
dose-dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

Individual NNP O
alcohol NN O
reaction NN O
profiles NNS O
. . O

-DOCSTART- X X O

35 CD O
patients NNS O
with IN O
acute JJ O
arterial NN O
occlusions NNS O
[27] . O
and CC O
graft JJ O
thromboses NNS O
[8] VBD O
, , O
responsible JJ O
for IN O
severe JJ O
and CC O
recent JJ O
ischemia NN O
, , O
were VBD O
treated VBN O
by IN O
fibrinolytic JJ O
therapy NN O
( -LRB- O
Urokinase NNP B-NP
: : O
1 CD O
000 CD O
units/kg/hour NN O
, , O
and CC O
Lys NNP O
Plasminogen NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
androgenic JJ O
hormones NNS O
reduce VBP O
HDL-cholesterol NNP B-NP
concentrations NNS O
and CC O
the DT O
HDL2-cholesterol NNP B-NP
subfraction NN O
, , O
possibly RB O
by IN O
enhancing VBG O
hepatic JJ B-NP
triglyceride NN I-NP
lipase NN I-NP
activity NN O
. . O

-DOCSTART- X X O

Shape NNP O
factor NN O
correlated VBD O
well RB O
with IN O
hemodynamic JJ O
data NNS O
for IN O
RV/LV NNP O
systolic JJ O
pressure NN O
ratios NNS O
( -LRB- O
r NN O
= SYM O
0.93 CD O
, , O
p RB O
less JJR O
than IN O
0.001 CD O
) -RRB- O
for IN O
normalized JJ O
interventricular JJ O
pressure NN O
differences NNS O
( -LRB- O
r NN O
= SYM O
-0.95 FW O
, , O
p NN O
less JJR O
than IN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
initial JJ O
plasma NN O
retinol NN O
level NN O
in IN O
conjunction NN O
with IN O
RBP NNP B-NP
was VBD O
found VBN O
to TO O
be VB O
even RB O
lower JJR O
in IN O
12 CD O
patients NNS O
( -LRB- O
35.1 CD O
micrograms NNS O
dl-1 JJ O
, , O
3.7 CD O
mg JJ O
dl-1 NN O
) -RRB- O
who WP O
subsequently RB O
had VBD O
cancer NN O
recurrence NN O
than IN O
in IN O
those DT O
who WP O
remained VBD O
free JJ O
of IN O
apparent JJ O
cancer NN O
( -LRB- O
44.5 CD O
micrograms NNS O
dl-1 JJ O
, , O
4.6 CD O
mg JJ O
dl-1 NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
results NNS O
indicate VBP O
that IN O
: : O
1 LS O
) -RRB- O
the DT O
initial JJ O
response NN O
to TO O
tethering NN O
varies NNS O
according VBG O
to TO O
previous JJ O
penning NN O
and CC O
handling VBG O
experience NN O
, , O
2 CD O
) -RRB- O
although IN O
the DT O
circadian JJ O
rhythm NN O
of IN O
cortisol NN O
was VBD O
either DT O
altered VBN O
or CC O
disrupted VBN O
during IN O
estrus NN O
, , O
such JJ O
disruptions NNS O
were VBD O
not RB O
influenced VBN O
by IN O
type NN O
of IN O
penning NN O
and CC O
3 CD O
) -RRB- O
tether NN O
stalls NNS O
may MD O
chronically RB O
increase VB O
cortisol JJ O
concentrations NNS O
in IN O
gilts NNS O
. . O

-DOCSTART- X X O

Male JJ O
Japanese JJ O
quail NN O
were VBD O
chronically RB O
exposed VBN O
to TO O
5000 CD O
ppm NN O
manganese JJ O
( -LRB- O
Mn NN O
) -RRB- O
as IN O
particulate NN O
manganese JJ O
oxide NN O
( -LRB- O
Mn3O4 NNP O
) -RRB- O
in IN O
their PRP$ O
diet NN O
from IN O
hatching NN O
to TO O
75 CD O
days NNS O
of IN O
age NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
indicated VBD O
that IN O
the DT O
Japanese JJ O
quail NN O
was VBD O
less RBR O
sensitive JJ O
to TO O
particulate VB O
Mn3O4 IN O
exposure NN O
than IN O
rodents NNS O
treated VBN O
comparably RB O
. . O

-DOCSTART- X X O

Scintigraphic JJ O
visualisation NN O
of IN O
Walker NNP O
carcinoma-256 CD O
in IN O
Sprague-Dawley NNP O
rats NNS O
by IN O
means NNS O
of IN O
99mTc-labelled JJ O
monocytes NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
were VBD O
compared VBN O
with IN O
those DT O
obtained VBN O
in IN O
-D JJ O
mothers NNS O
and CC O
pups NNS O
, , O
after IN O
giving VBG O
the DT O
mothers NNS O
an DT O
oral JJ O
supplement NN O
( -LRB- O
10 CD O
i NN O
.u NN O
. . O
vitamin NN O
D3/day NN O
) -RRB- O
during IN O
the DT O
period NN O
of IN O
lactation NN O
( -LRB- O
20 CD O
days NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Before IN O
birth NN O
, , O
there EX O
were VBD O
a DT O
few JJ O
perivascular JJ O
adrenergic JJ O
nerves NNS O
and CC O
correspondingly RB O
low JJ O
ovarian JJ O
NE NNP O
levels NNS O
. . O

-DOCSTART- X X O

Monitoring NN O
changes NNS O
in IN O
the DT O
heart NN O
rate NN O
of IN O
the DT O
premature JJ O
fetus NN O
during IN O
tocolysis NN O
with IN O
the DT O
beta-adrenomimetics NNS O
partusisten RB O
and CC O
Pre-par NNP O

-DOCSTART- X X O

Treatment NNP O
with IN O
oxyphenylbutazone NN O
and CC O
hydrocortisone NN O
failed VBD O
to TO O
inhibit VB O
the DT O
raised VBN O
serum NN B-NP
CPN NNP I-NP
levels NNS O
. . O

-DOCSTART- X X O

40,000 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
Cox NNP O
proportional JJ O
hazards NNS O
model NN O
was VBD O
applied VBN O
to TO O
the DT O
data NNS O
in IN O
order NN O
to TO O
determine VB O
the DT O
prognostic JJ O
factors NNS O
for IN O
long-term JJ O
survival NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
showed VBD O
: : O
that DT O
progesterone NN O
secretion NN O
is VBZ O
pulsatile RB O
throughout IN O
the DT O
human JJ O
luteal NN O
phase NN O
, , O
with IN O
maximum JJ O
frequency NN O
in IN O
the DT O
mid-luteal JJ O
phase NN O
; : O
that IN O
during IN O
the DT O
mid-luteal JJ O
phase NN O
most RBS O
subjects NNS O
had VBD O
progesterone VBN O
levels NNS O
both DT O
above IN O
and CC O
below IN O
currently RB O
accepted VBN O
ovulatory NN O
thresholds NNS O
; : O
the DT O
use NN O
of IN O
a DT O
single JJ O
measurement NN O
of IN O
progesterone NN O
in IN O
the DT O
mid-luteal JJ O
phase NN O
is VBZ O
not RB O
always RB O
a DT O
reliable JJ O
indicator NN O
of IN O
ovulation NN O
; : O
a DT O
threshold NN O
greater JJR O
than IN O
20 CD O
nmol/l NN O
may MD O
yield VB O
an DT O
unacceptable JJ O
number NN O
of IN O
false JJ O
negative JJ O
results NNS O
. . O

-DOCSTART- X X O

The DT O
fast JJ O
real-time NN O
digital JJ O
processing NN O
of IN O
the DT O
N2 NN O
and CC O
flow NN O
signals NNS O
incorporated JJ O
filtering VBG O
, , O
delay VB O
compensation NN O
, , O
and CC O
corrections NNS O
for IN O
the DT O
effects NNS O
of IN O
changes NNS O
in IN O
gas NN O
composition NN O
and CC O
temperature NN O
. . O

-DOCSTART- X X O

Histamine NN O
reactivity NN O
was VBD O
significantly RB O
reduced VBN O
after IN O
the DT O
nifedipine NN O
aerosol NN O
, , O
the DT O
geometric JJ O
mean JJ O
provocative JJ O
concentration NN O
causing VBG O
a DT O
35 CD O
% NN O
fall NN O
in IN O
specific JJ O
airway NN O
conductance NN O
, , O
rising VBG O
from IN O
5.0 CD O
to TO O
10.9 CD O
mg/ml NN O
of IN O
histamine NN O
( -LRB- O
p NN O
less JJR O
than IN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Pharmacologic NNP O
doses NNS O
of IN O
vitamin NN O
B6 CC O
administered VBN O
to TO O
lactating VBG O
women NNS O
have VBP O
been VBN O
reported VBN O
to TO O
suppress VB O
plasma NN B-NP
prolactin NN I-NP
. . O

-DOCSTART- X X O

There EX O
was VBD O
a DT O
significant JJ O
but CC O
similar JJ O
elevation NN O
of IN O
mean JJ O
O2 NNP O
uptake NN O
during IN O
40 CD O
min NN O
postexercise NN O
by IN O
13.6 CD O
% NN O
in IN O
both DT O
the DT O
fasted JJ O
( -LRB- O
p NN O
less JJR O
than IN O
0.001 CD O
) -RRB- O
and CC O
fed VBN O
state NN O
( -LRB- O
p NN O
less JJR O
than IN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

National NNP O
Institutes NNPS O
of IN O
Health NNP O
Consensus NNP O
Development NNP O
Conference NNP O
Statement NNP O
. . O

-DOCSTART- X X O

Greater NNP O
attenuation NN O
of IN O
the DT O
N1-P2 JJ O
and CC O
baseline-P2 JJ O
amplitude NN O
of IN O
the DT O
probe NN O
EPs NNS O
was VBD O
observed VBN O
when WRB O
the DT O
probe NN O
stimulus NN O
was VBD O
presented VBN O
to TO O
the DT O
right JJ O
ear NN O
and CC O
the DT O
verbal JJ O
material NN O
presented VBN O
to TO O
the DT O
left JJ O
ear NN O
than IN O
when WRB O
the DT O
opposite JJ O
stimulation NN O
arrangement NN O
was VBD O
used VBN O
. . O

-DOCSTART- X X O

Germ-free JJ O
rabbits NNS O
given VBN O
mouse NN O
CRF-flora NNP O
showed VBD O
values NNS O
quite RB O
different JJ O
from IN O
control NN O
animals NNS O
for IN O
most JJS O
parameters NNS O
, , O
indicating VBG O
unsuitability NN O
of IN O
mouse NN O
CRF NN O
flora NNS O
to TO O
'normalize VB O
' '' O
rabbits NNS O
. . O

-DOCSTART- X X O

The DT O
weak JJ O
relationships NNS O
between IN O
F NNP O
and CC O
Zn NNP O
to TO O
Mg NNP O
clearly RB O
have VBP O
no DT O
significant JJ O
effect NN O
on IN O
the DT O
contents NNS O
of IN O
these DT O
elements NNS O
in IN O
bone NN O
. . O

-DOCSTART- X X O

L3-L4 DT O
compressive JJ O
load NN O
was VBD O
calculated VBN O
using VBG O
a DT O
model NN O
of IN O
the DT O
anatomy NN O
of IN O
the DT O
trunk NN O
musculoskeletal NN O
system NN O
. . O

-DOCSTART- X X O

Diagnosis NNP O
: : O
progressive JJ O
multifocal JJ O
leukoencephalopathy NN O
. . O

-DOCSTART- X X O

Component JJ O
P100 CD O
was VBD O
associated VBN O
with IN O
a DT O
frontal JJ O
negativity NN O
of IN O
similar JJ O
latency NN O
favoring NN O
the DT O
hypothesis NN O
of IN O
a DT O
dipolar JJ O
occipital NN O
generator NN O
. . O

-DOCSTART- X X O

Although IN O
no DT O
differences NNS O
were VBD O
noted VBN O
in IN O
the DT O
decrease NN O
in IN O
platelet NN O
counts NNS O
between IN O
the DT O
two CD O
groups NNS O
, , O
fibrinogen NN B-NP
levels NNS O
and CC O
alpha NN B-NP
2-antiplasmin JJ I-NP
levels NNS O
declined VBD O
less JJR O
drastically RB O
in IN O
the DT O
antithrombin-treated JJ B-NP
group NN O
. . O

-DOCSTART- X X O

Failure NN O
of IN O
stapedius NN O
reflexometry NN O
in IN O
the DT O
diagnosis NN O
of IN O
myasthenia NN O
gravis NN O
. . O

-DOCSTART- X X O

Factors NNS O
influencing VBG O
semen NNS O
characteristics NNS O
in IN O
young JJ O
boars NNS O
reared VBD O
in IN O
a DT O
subtropical JJ O
environment NN O
were VBD O
studied VBN O
. . O

-DOCSTART- X X O

[14C]-beta-phenethylamine JJ O
, , O
its PRP$ O
distribution NN O
after IN O
administration NN O
by IN O
various JJ O
routes NNS O
to TO O
cats NNS O
, , O
and CC O
the DT O
effects NNS O
of IN O
monoamine NN B-NP
oxidase NN I-NP
inhibitors NNS O
. . O

-DOCSTART- X X O

All DT O
runners NNS O
drank VBD O
a DT O
total NN O
of IN O
1.4 CD O
L NNP O
of IN O
water NN O
during IN O
the DT O
race NN O
. . O

-DOCSTART- X X O

The DT O
rates NNS O
of IN O
total JJ O
energy NN O
use NN O
( -LRB- O
mean VB O
+/ JJ O
- : O
SD NNP O
= SYM O
39.3 CD O
+/ CD O
- : O
1.2 CD O
vs NN O
35.7 CD O
+/ NNS O
- : O
1.3 CD O
kJ NN O
X NNP O
min-1 CD O
; : O
P NNP O
less RBR O
than IN O
0.05 CD O
) -RRB- O
were VBD O
significantly RB O
higher JJR O
at IN O
-10 JJ O
degrees NNS O
C NN O
than IN O
at IN O
22 CD O
degrees NNS O
C. NNP O

-DOCSTART- X X O

The DT O
recommendation NN O
is VBZ O
made VBN O
that IN O
specific JJ O
sub-groups NNS O
of IN O
attempters NNS O
need VBP O
to TO O
be VB O
identified VBN O
and CC O
may MD O
warrant VB O
specialized VBN O
intervention NN O
strategies NNS O
. . O

-DOCSTART- X X O

Gains NNS O
increased VBD O
3.5 CD O
% NN O
( -LRB- O
P NNP O
less RBR O
than IN O
.10 CD O
) -RRB- O
and CC O
feed NN O
conversion NN O
improved VBD O
5.9 CD O
% NN O
( -LRB- O
P NNP O
less RBR O
than IN O
.07 CD O
) -RRB- O
in IN O
steers NNS O
fed VBN O
.28 CD O
% NN O
AS-VFA NN O
compared VBN O
with IN O
gain NN O
and CC O
feed NN O
conversion NN O
of IN O
the DT O
control NN O
steers NNS O
. . O

-DOCSTART- X X O

Postnatal NNP O
volumetric JJ O
development NN O
of IN O
the DT O
prefrontal JJ O
cortex NN O
in IN O
the DT O
rat NN O
. . O

-DOCSTART- X X O

Daily NNP O
and CC O
seasonal JJ O
rhythmicity NN O
in IN O
the DT O
methylation NN O
of IN O
pineal NN O
indolic JJ O
compounds NNS O
in IN O
adult NN O
male NN O
golden JJ O
hamsters NNS O
, , O
kept VBD O
under IN O
natural JJ O
conditions NNS O
. . O

-DOCSTART- X X O

Among IN O
the DT O
patients NNS O
grades NNS O
1-2-3 NNP O
, , O
81 CD O
% NN O
had VBD O
a DT O
good JJ O
out IN O
come VBN O
without IN O
any DT O
neurological JJ O
abnormality NN O
, , O
among IN O
the DT O
patients NNS O
graded VBD O
4-5 CD O
, , O
only RB O
27 CD O
% NN O
had VBD O
a DT O
fair JJ O
out IN O
come VBN O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
Paget NNP O
's POS O
disease NN O
. . O

-DOCSTART- X X O

Improvement NN O
of IN O
the DT O
CRT NNP O
display NN O
of IN O
an DT O
averager NN O
. . O

-DOCSTART- X X O

Is VBZ O
desensitization NN O
' '' O
for IN O
ragweed NN O
hay NN O
fever NN O
immunologically RB O
specific JJ O
? . O

-DOCSTART- X X O

Evaluation NN O
of IN O
thyroid JJ O
function NN O
. . O

-DOCSTART- X X O

HL-A NNP B-NP
antibodies NNS I-NP
in IN O
polytransfused VBN O
patients NNS O

-DOCSTART- X X O

Demonstration NN O
of IN O
fine JJ O
structure NN O
of IN O
the DT O
guinea NN O
pig NN O
organ NN O
of IN O
Corti NNP O
after IN O
electron NN O
microscopic NN O
silver NN O
staining VBG O

-DOCSTART- X X O

Histamine NN O
metabolism NN O
in IN O
hemorrhagic-hypotensive JJ O
shock NN O

-DOCSTART- X X O

They PRP O
also RB O
discuss VBP O
the DT O
existing VBG O
nomenclature NN O
. . O

-DOCSTART- X X O

Studies NNS O
on IN O
alcoholic JJ O
liver NN O
injury NN O
. . O

-DOCSTART- X X O

Hypothalamic JJ O
control NN O
of IN O
coronary JJ O
circulation NN O
in IN O
the DT O
dog NN O
. . O

-DOCSTART- X X O

Poliomyelitis NNP O
from IN O
a DT O
vaccine NN O
. . O

-DOCSTART- X X O

To TO O
the DT O
problem NN O
of IN O
the DT O
stimulation NN O
of IN O
the DT O
growth NN O
of IN O
transplantable JJ O
tumors NNS O
of IN O
animals NNS O
previously RB O
treated VBN O
with IN O
antineoplastic JJ O
antibiotics NNS O

-DOCSTART- X X O

Assessment NNP O
of IN O
nutrient JJ O
media NNS O
in IN O
the DT O
diagnosis NN O
of IN O
diptheria NN O

-DOCSTART- X X O

Aluminium NNP O
resin NN O
for IN O
the DT O
treatment NN O
of IN O
the DT O
hyperkalamia NN O
of IN O
renal JJ O
failure NN O
. . O

-DOCSTART- X X O

Serotonin NN O
levels NNS O
in IN O
infant NN O
hypothyroidism NN O
. . O

-DOCSTART- X X O

Cerebrospinal JJ O
fluid NN O
transferrin VBG B-NP
II NNP I-NP
studies NNS O
in IN O
ischemic JJ O
disorders NNS O
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

-DOCSTART- X X O

High NNP O
dosages NNS O
of IN O
D-penicillamine NN O
in IN O
pulmonary NN O
fibroses NNS O

-DOCSTART- X X O

Effect NN O
of IN O
immune JJ O
lymphocytes NNS O
and CC O
of IN O
rabbit-anti-lymphocyte JJ B-NP
globulin NN I-NP
(RAMLG NN O
) -RRB- O
on IN O
infected VBN O
macrophages NNS O
exposed VBN O
to TO O
increased VBN O
incubation NN O
temperature NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Estral JJ O
cycle NN O
in IN O
white JJ O
rats NNS O
in IN O
the DT O
low JJ O
and CC O
high JJ O
mountains NNS O
of IN O
Kirghizia NNP O

-DOCSTART- X X O

Lactation NN O
of IN O
baboons NNS O
fed VBN O
a DT O
low JJ O
protein NN O
maintenance NN O
diet NN O
. . O

-DOCSTART- X X O

Studies NNS O
on IN O
the DT O
organic JJ O
matrix NN O
of IN O
human JJ O
ear NN O
ossicles NNS O

-DOCSTART- X X O

A DT O
medical-geographical JJ O
review NN O

-DOCSTART- X X O

Sensitization NN O
to TO O
hyperlactatemia NN O
induced VBN O
by IN O
phenformin NN O
after IN O
subtotal JJ O
ablation NN O
of IN O
the DT O
pancreas NNS O
. . O

-DOCSTART- X X O

Vitamin NNP O
D3 NNP O
and CC O
calcium NN O
absorption NN O
in IN O
the DT O
chick NN O
. . O

-DOCSTART- X X O

The DT O
incidence NN O
of IN O
tumours NNS O
in IN O
young JJ O
chickens NNS O
. . O

-DOCSTART- X X O

Their PRP$ O
effect NN O
on IN O
the DT O
guinea NN O
pig NN O
vas NNS O
deferens NNS O
. . O

-DOCSTART- X X O

Androgens NNP O
and CC O
growth NN O
. . O

-DOCSTART- X X O

Studies NNS O
on IN O
swine NN O
enteroviruses NNS O
. . O

-DOCSTART- X X O

Ultrasound NNP O
effect NN O
on IN O
the DT O
cytochrome NN B-NP
oxidase NN I-NP
activity NN O

-DOCSTART- X X O

Metastasis NNP O
of IN O
colon NN O
carcinoma NN O
to TO O
the DT O
lip NN O
. . O

-DOCSTART- X X O

Conditions NNS O
influencing VBG O
inhibitors NNS O
of IN O
the DT O
colony-stimulating JJ B-NP
factor NN I-NP
( -LRB- O
CSF) NNP B-NP
. . O

-DOCSTART- X X O

An DT O
automated JJ O
method NN O
for IN O
the DT O
quantitative JJ O
analysis NN O
of IN O
the DT O
polyamines NNS O
putrescine NN O
, , O
spermidine NN O
and CC O
spermine NN O
in IN O
cerebrospinal JJ O
fluid NN O
( -LRB- O
CSF NNP O
) -RRB- O
was VBD O
used VBN O
to TO O
analyze VB O
CSF NNP O
samples NNS O
from IN O
37 CD O
patients NNS O
with IN O
central JJ O
nervous JJ O
system NN O
( -LRB- O
CNS NNP O
) -RRB- O
tumors NNS O
and CC O
from IN O
13 CD O
patients NNS O
without IN O
tumors NNS O
. . O

-DOCSTART- X X O

Natural JJ O
and CC O
induced JJ O
malarias NNS O
in IN O
western JJ O
hemisphere NN O
monkeys NNS O
. . O

-DOCSTART- X X O

Copper NN O
and CC O
ceruloplasmin NN B-NP
content NN O
in IN O
pregnant JJ O
women NNS O
and CC O
in IN O
women NNS O
with IN O
certain JJ O
gynecological JJ O
diseases NNS O

-DOCSTART- X X O

Effect NN O
of IN O
noise NN O
on IN O
CO-induced JJ O
increases NNS O
of IN O
LAP NNP B-NP
and CC O
GPT NNP B-NP
activity NN O
in IN O
the DT O
plasma NN O
of IN O
rats NNS O

-DOCSTART- X X O

Kinetics NNP O
of IN O
calcium NN O
metabolism NN O
. . O

-DOCSTART- X X O

Pathology NN O
of IN O
neuritis NN O
caudae NN O
equinae NN O
in IN O
the DT O
horse NN O

-DOCSTART- X X O

Abnormal JJ O
characteristics NNS O
and CC O
verticillation NN O
in IN O
Platynothrus NNP O
peltifer NN O

-DOCSTART- X X O

Selected VBN O
topics NNS O
in IN O
laboratory NN O
animal NN O
medicine NN O
. . O

-DOCSTART- X X O

Clinical JJ O
course NN O
and CC O
nursing NN O
care NN O
of IN O
patients NNS O
with IN O
decubitus JJ O
ulcer--use NN O
of IN O
pillows NNS O
stuffed VBN O
with IN O
buckwheat NN O
chaff NN O

-DOCSTART- X X O

From IN O
the DT O
Icelandic NNP O
Red NNP O
Cross NNP O
activities NNS O

-DOCSTART- X X O

Electrocardiograms NNP O
of IN O
the DT O
month NN O
. . O

-DOCSTART- X X O

Composites NNS O
as IN O
restoration NN O
materials NNS O

-DOCSTART- X X O

Hodgkin NNP O
's POS O
disease NN O
. . O

-DOCSTART- X X O

Value NNP O
of IN O
Normotest NNP O
and CC O
antithrombin JJ B-NP
3 CD I-NP
in IN O
the DT O
assessment NN O
of IN O
liver NN O
function NN O
. . O

-DOCSTART- X X O

Glutathione NNP B-NP
peroxidase NN I-NP
in IN O
human JJ O
red JJ O
cells NNS O
in IN O
health NN O
and CC O
disease NN O
. . O

-DOCSTART- X X O

Histopathologic JJ O
response NN O
of IN O
gingival NN O
tissues NNS O
to TO O
hemodent NN O
and CC O
aluminum NN O
chloride NN O
solutions NNS O
as IN O
tissue NN O
displacement NN O
materials NNS O
. . O

-DOCSTART- X X O

Intracellular NNP O
pH NNS O
, , O
H NNP O
ion NN O
flux NN O
and CC O
H NNP O
ion NN O
permeability NN O
coefficient NN O
in IN O
bullfrog NN O
toe NN O
muscle NN O
. . O

-DOCSTART- X X O

Proceedings NNS O
: : O
Reversible JJ O
complete JJ O
heart NN O
block NN O
following VBG O
surgery NN O
of IN O
congenital NN O
heart NN O
defects NNS O

-DOCSTART- X X O

Extracellular JJ O
fibril NN O
formation NN O
by IN O
neuroglial JJ O
cells NNS O
at IN O
the DT O
vitreoretinal JJ O
junction NN O
of IN O
the DT O
human JJ O
eye NN O
. . O

-DOCSTART- X X O

Blood NN O
platelets NNS O
, , O
coagulation NN O
factors NNS O
and CC O
morphologic JJ O
organ NN O
changes NNS O
following VBG O
scalding JJ O
shock NN O
in IN O
rhesus NN O
monkeys NNS O

-DOCSTART- X X O

Cell NNP O
viability NN O
and CC O
lysosomal JJ B-NP
enzymes NNS I-NP

-DOCSTART- X X O

Further JJ O
investigation NN O
on IN O
the DT O
chemotactic NN O
influence NN O
of IN O
thymic DT B-NP
hormone NN I-NP
on IN O
lymphocytes NNS O

-DOCSTART- X X O

1,3-bis(2-chloroethyl)-1-nitrosourea CD O
( -LRB- O
bcnu NN O
) -RRB- O
and CC O
other JJ O
nitrosoureas NNS O
in IN O
cancer NN O
treatment NN O
: : O
a DT O
review NN O
. . O

-DOCSTART- X X O

Pneumothorax NN O
following VBG O
lung NN O
abscess NN O
in IN O
the DT O
renal JJ O
transplant NN O
patient NN O
. . O

-DOCSTART- X X O

Temporal NNP O
relationships NNS O
and CC O
the DT O
development NN O
phase NN O
affected VBN O
. . O

-DOCSTART- X X O

Letter NNP O
: : O
Salmonella NNP O
detection NN O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
antilymphocyte JJ O
sera NN O
on IN O
formation NN O
of IN O
transplantation NN O
and CC O
anti-infection NN O
immunity NN O
in IN O
mice NNS O

-DOCSTART- X X O

60th JJ O
birthday NN O
of IN O
colonel NN O
prof NN O
. . O
e.cerny NN O
m.d NN O
. . O

-DOCSTART- X X O

Cortical NNP O
afferents NNS O
to TO O
the DT O
entorhinal JJ O
cortex NN O
of IN O
the DT O
Rhesus NNP O
monkey NN O
. . O

-DOCSTART- X X O

Mechanism NN O
of IN O
immunogenesis NN O
in IN O
vaccination NN O
with IN O
streptomycin-dependent JJ O
mutants NNS O
of IN O
salmonellae NN O
and CC O
shigellae NN O
. . O

-DOCSTART- X X O

Resistance NN O
pattern NN O
of IN O
Mycobacterium NNP O
tuberculosis NN O
( -LRB- O
H NNP O
37 CD O
Rv NN O
) -RRB- O
to TO O
a DT O
new JJ O
antibiotic JJ O
, , O
lividomycin . O

-DOCSTART- X X O

Pulmonary JJ O
arterial JJ O
pressure NN O
and CC O
structure NN O
in IN O
the DT O
patas NNS O
monkey NN O
after IN O
prolonged JJ O
administration NN O
of IN O
aminorex JJ O
fumarate NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
triftazin JJ O
and CC O
aminazin JJ O
on IN O
hippocampal JJ O
bioelectric JJ O
activity NN O

-DOCSTART- X X O

Pathological JJ O
processes NNS O
in IN O
the DT O
cervix NN O
uteri NN O

-DOCSTART- X X O

Benign NNP O
intramural JJ O
tumors NNS O
of IN O
the DT O
esophagus NN O

-DOCSTART- X X O

General NNP O
formulae NNS O
for IN O
estimating VBG O
heritability NN O
in IN O
a DT O
population NN O
with IN O
related JJ O
parents NNS O
. . O

-DOCSTART- X X O

Antibiotic JJ O
effect NN O
of IN O
the DT O
mud NN O
from IN O
heviz NN O

-DOCSTART- X X O

Role NNP O
of IN O
histoclinical JJ O
studies NNS O
in IN O
the DT O
prophylaxis NNS O
of IN O
spontaneous JJ O
abortions NNS O

-DOCSTART- X X O

Range NNP O
behavior NN O
of IN O
Hereford NNP O
, , O
Hereford RB O
x NN O
Holstein NNP O
and CC O
Holstein NNP O
non-lactating JJ O
heifers NNS O
. . O

-DOCSTART- X X O

Chemical NNP O
constituents NNS O
of IN O
the DT O
gentianaceae JJ O
V NNP O
: : O
tetraoxygenated JJ O
xanthones NNS O
of IN O
Swertia NNP O
chirata NNS O
Buch.-Ham NNP O
. . O

-DOCSTART- X X O

Compensative JJ O
justice NN O
and CC O
moral JJ O
investment NN O
among IN O
Japanese JJ O
, , O
Chinese JJ O
, , O
and CC O
Koreans NNP O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
cortisone NN O
, , O
starvation NN O
, , O
and CC O
rickets NNS O
on IN O
oxidative JJ O
enzyme JJ O
activities NNS O
of IN O
epiphyseal NN O
cartilage NN O
from IN O
rats NNS O
. . O

-DOCSTART- X X O

Estimation NN O
of IN O
renin NN B-NP
secretion NN O
rate NN O
and CC O
renal JJ O
plasma NN O
flow NN O
from IN O
peripheral JJ O
and CC O
renal JJ B-NP
vein NN I-NP
renin NN I-NP
levels NNS O
. . O

-DOCSTART- X X O

Choice NN O
of IN O
vessel NN O
. . O

-DOCSTART- X X O

Pneumothorax NN O
complicated VBN O
by IN O
chronic JJ O
steroid NN O
treatment NN O
. . O

-DOCSTART- X X O

Polycythemia-1973 NN O
. . O

-DOCSTART- X X O

Familial NNP O
juvenile NN O
nephronophthisis NN O

-DOCSTART- X X O

Early RB O
heparin NN O
therapy NN O
in IN O
60 CD O
children NNS O
with IN O
acute JJ O
meningococcemia NN O
. . O

-DOCSTART- X X O

9,11-Seco JJ O
steroids NNS O
derived VBN O
from IN O
estradiol JJ O
3-methyl JJ O
ether NN O
. . O

-DOCSTART- X X O

Psychological NNP O
examinations NNS O
in IN O
patients NNS O
with IN O
chronic JJ O
kidney NN O
insufficiency NN O

-DOCSTART- X X O

Possibilities NNS O
of IN O
needleless JJ O
administration NN O
of IN O
various JJ O
substances NNS O
to TO O
animals NNS O

-DOCSTART- X X O

Observations NNS O
on IN O
the DT O
flight NN O
activities NNS O
of IN O
Chrysops NNP O
caecutiens NNS O
L. NNP O

-DOCSTART- X X O

Combination NNP O
of IN O
3 CD O
multiple JJ O
primary JJ O
malignant JJ O
and CC O
benign JJ O
tumors NNS O
of IN O
the DT O
breasts NNS O
and CC O
uterus NN O

-DOCSTART- X X O

Analysis NNP O
of IN O
clearance NN O
curve NN O
of IN O
rose NN O
bengal-I-131 . O

-DOCSTART- X X O

Proceedings NNS O
: : O
Barrels NNS O
and CC O
somatotopy NN O
in IN O
S NNP O
I PRP O
neocortex RB O
of IN O
the DT O
brush-tailed JJ O
possum NN O
. . O

-DOCSTART- X X O

Canine NNP O
reproduction NN O
: : O
effects NNS O
of IN O
a DT O
single JJ O
injection NN O
of IN O
medroxyprogesterone JJ O
acetate NN O
on IN O
the DT O
reproductive JJ O
organs NNS O
of IN O
the DT O
bitch NN O
. . O

-DOCSTART- X X O

3. . O

-DOCSTART- X X O

Letter NNP O
: : O
Aryl NNP B-NP
hydrocarbon NN I-NP
hydroxylase NN I-NP
and CC O
smoking NN O
. . O

-DOCSTART- X X O

Evaluation NN O
of IN O
1,10-phenanthroline CD O
as IN O
a DT O
reagent NN O
for IN O
sialic JJ O
acid NN O
determinations NNS O
. . O

-DOCSTART- X X O

Nonteratogenicity NN O
in IN O
rats NNS O
of IN O
blighted JJ O
potatoes NNS O
and CC O
compounds NNS O
contained VBN O
in IN O
them PRP O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
a DT O
high-intensity JJ O
SHF NNP O
field NN O
on IN O
the DT O
blood NN O
coagulation NN O
system NN O

-DOCSTART- X X O

Relationship NN O
between IN O
gross JJ O
lesions NNS O
and CC O
Escherichia NNP O
coli NNS O
serotypes NNS O
in IN O
chronic NN O
respiratory NN O
disease NN O
( -LRB- O
CRD NNP O
) -RRB- O
of IN O
poultry NN O
. . O

-DOCSTART- X X O

Plastic JJ O
solution NN O
of IN O
elbow NN O
joint JJ O
ankylosis NN O
with IN O
a DT O
decorticated JJ O
cylindrical JJ O
flap NN O

-DOCSTART- X X O

The DT O
Twentieth NNP O
Anniversary NN O
of IN O
the DT O
Pomeranian NNP O
Medical NNP O
Academy NNP O
. . O

-DOCSTART- X X O

Immunelectrophoretic JJ O
pattern NN O
of IN O
Wassermann NNP O
reagin NNP O
and CC O
comparison NN O
of IN O
the DT O
appearance NN O
time NN O
between IN O
RPCF NNP B-NP
and CC O
FTA NNP B-NP
antibodies NNS I-NP

-DOCSTART- X X O

Electrocardiographic NNP O
QRS NNP O
complexes NNS O
and CC O
vectorcardiographic JJ O
QRS NNP O
loop NN O

-DOCSTART- X X O

Study NNP O
of IN O
antinuclear JJ O
autoantibodies NNS O
by IN O
immunofluorescence NN O
technic NN O
in IN O
collagen NN B-NP
diseases NNS O

-DOCSTART- X X O

Cardiac NNP O
preservation NN O
. . O

-DOCSTART- X X O

Dr. NNP O

-DOCSTART- X X O

The DT O
metabolism NN O
and CC O
pharmacology NN O
of IN O
5-fluorouracil NN O
. . O

-DOCSTART- X X O

Human JJ O
synovial JJ O
fluid NN O
: : O
detection NN O
of IN O
a DT O
new JJ O
component NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
temperature NN O
and CC O
moulting VBG O
cycle NN O
on IN O
melanin NN O
synthesis NN O
in IN O
the DT O
newt NN O
, , O
Triturus NNP O
cristatus NN O
. . O

-DOCSTART- X X O

Morphological NNP O
and CC O
functional JJ O
alterations NNS O
noted VBD O
after IN O
baboon NN O
renal JJ O
allotransplantation NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
corticosteroids NNS O
. . O

-DOCSTART- X X O

Immunogenicity NN O
of IN O
various JJ O
mycobacteria NNS O
and CC O
the DT O
corresponding JJ O
levels NNS O
of IN O
cross-protection NN O
developed VBN O
between IN O
species NNS O
. . O

-DOCSTART- X X O

Ten-year JJ O
experience NN O
with IN O
one-stage NN O
proctocolectomy NN O
and CC O
anal NN O
ileostomy NN O
. . O

-DOCSTART- X X O

Nitrogen-hydrogen JJ O
tautomerism NN O
in IN O
porphyrins NNS O
and CC O
chlorins NNS O
. . O

-DOCSTART- X X O

Photopic NNP O
spectral JJ O
sensitivity NN O
determined VBN O
electroretinographically RB O
for IN O
the DT O
pigeon NN O
eye NN O
. . O

-DOCSTART- X X O

Cholinesterase NN B-NP

-DOCSTART- X X O

Sodium NNP O
restriction NN O
in IN O
cardiac JJ O
failure NN O
. . O

-DOCSTART- X X O

Clinical NNP O
and CC O
angiographic JJ O
examinations NNS O
in IN O
occlusion NN O
disease NN O
of IN O
the DT O
great JJ O
intestinal JJ O
arteries NNS O

-DOCSTART- X X O

Serum NN O
lipid JJ O
changes NNS O
during IN O
pregnancy NN O
due JJ O
to TO O
oral JJ O
calcium NN O
administration NN O

-DOCSTART- X X O

Successful JJ O
treatment NN O
of IN O
candidiasis NN O
with IN O
transfer NN B-NP
factor NN I-NP
. . O

-DOCSTART- X X O

A DT O
possible JJ O
role NN O
for IN O
the DT O
mixed JJ O
function NN O
oxidase NN B-NP
enzyme NN O
system NN O
in IN O
the DT O
requirement NN O
for IN O
selenium NN O
in IN O
the DT O
rat NN O
. . O

-DOCSTART- X X O

On IN O
the DT O
constituents NNS O
of IN O
Dryopteris NNP O
polylepis . O

-DOCSTART- X X O

Oscilloscope NNP O
triggering VBG O
circuit NN O
for IN O
recording VBG O
long JJ O
transients NNS O
at IN O
fast JJ O
sweep NN O
speeds NNS O
. . O

-DOCSTART- X X O

Derivatives NNS O
of IN O
boswellic JJ O
acids NNS O
. . O

-DOCSTART- X X O

Coronary JJ O
arteries--old NN O
and CC O
new JJ O
. . O

-DOCSTART- X X O

Antiviral JJ O
agents NNS O
. . O

-DOCSTART- X X O

Separation NNP O
of IN O
ninhydrin-positive JJ O
compounds NNS O
in IN O
urine NN O
by IN O
the DT O
combined VBN O
methods NNS O
of IN O
medium-tension NN O
intophoresis NN O
and CC O
partition NN O
chromatography NN O

-DOCSTART- X X O

Conservative JJ O
treatment NN O
of IN O
central JJ O
nervous JJ O
system NN O
injuries NNS O

-DOCSTART- X X O

Spasmus NNP O
nutans NNS O
: : O
a DT O
syndrome NN O
of IN O
auto-arousal JJ O
. . O

-DOCSTART- X X O

6 CD O
. . O

-DOCSTART- X X O

Slowed JJ O
lysosomal JJ B-NP
enzyme NN I-NP
release NN O
and CC O
its PRP$ O
normalization NN O
by IN O
drugs NNS O
in IN O
adjuvant-induced JJ O
polyarthritis NN O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
ovarian JJ O
neoplasms NNS O

-DOCSTART- X X O

Bacterial NNP O
metabolism NN O
of IN O
4-chlorophenoxyacetate JJ O
. . O

-DOCSTART- X X O

I. NN O

-DOCSTART- X X O

Surgical JJ O
treatment NN O
of IN O
pathologic NN O
scars NNS O
of IN O
myocardial JJ O
infarct NN O

-DOCSTART- X X O

The DT O
interaction NN O
of IN O
caffeine NN O
, , O
theophylline NN O
and CC O
theobromine NN O
with IN O
monoamine NN B-NP
oxidase NN I-NP
inhibitors NNS O
. . O

-DOCSTART- X X O

A DT O
case NN O
of IN O
M NNP O
hemoglobinosis NN O

-DOCSTART- X X O

Radiosensitive NNP O
nature NN O
of IN O
paravascular JJ O
infiltrate-producing JJ O
potential NN O
of IN O
parental JJ O
spleen JJ O
cells NNS O
. . O

-DOCSTART- X X O

1 CD O
. . O

-DOCSTART- X X O

Results NNS O
of IN O
the DT O
official JJ O
inspection NN O
of IN O
the DT O
commercial JJ O
anti-inflammatory JJ O
enzyme NN O
preparations NNS O
containing VBG O
chymotrypsin NN B-NP
and CC O
trypsin NN B-NP
by IN O
means NNS O
of IN O
modified VBN O
NF NNP O
13 CD O
methods NNS O

-DOCSTART- X X O

Second JJ O
report NN O
of IN O
the DT O
Norwegian JJ O
Cancer NNP O
Society NNP O
. . O

-DOCSTART- X X O

Modification NNP O
of IN O
the DT O
growth NN O
of IN O
Tetrahymena NNP O
by IN O
compounds NNS O
which WDT O
affect VBP O
the DT O
adrenergic JJ O
mechanism NN O
. . O

-DOCSTART- X X O

A DT O
brief JJ O
discussion NN O
of IN O
color NN O
deficiencies NNS O
. . O

-DOCSTART- X X O

BIM NNP O
130 CD O
. . O

-DOCSTART- X X O

Problems NNS O
in IN O
the DT O
determination NN O
of IN O
the DT O
antigenic JJ O
content NN O
of IN O
influenza NN O
vaccines NNS O
. . O

-DOCSTART- X X O

Aedes NNP O
aegypti FW O
( -LRB- O
L. NNP O
) -RRB- O
and CC O
Aedes NNP O
albopictus NN O
(Skuse NN O
) -RRB- O
in IN O
Singapore NNP O
City NNP O
. . O

-DOCSTART- X X O

Homograft NNP O
response NN O
and CC O
hemagglutinin NN B-NP
production NN O
by IN O
sensitized JJ O
thymectomized JJ O
irradiated JJ O
adult NN O
mice NNS O
. . O

-DOCSTART- X X O

Comparative JJ O
study NN O
on IN O
acute JJ O
oral JJ O
overload NN O
using VBG O
tolbutamide NN O
and CC O
tolazamide NN O
in IN O
normal JJ O
and CC O
diabetic JJ O
subjects NNS O
. . O

-DOCSTART- X X O

Mycotoxins NNP O
in IN O
feeds VBZ O
and CC O
foods NNS O
. . O

-DOCSTART- X X O

Factors NNS O
influencing NN O
in IN O
vitro NN O
skin NN B-NP
permeability NN I-NP
factor NN I-NP
production NN O
by IN O
Vibrio NNP O
cholerae NNS O
. . O

-DOCSTART- X X O

Biological NNP O
action NN O
and CC O
kinetics NNS O
of IN O
the DT O
elimination NN O
of IN O
tritium NN O
oxide NN O
in IN O
dogs NNS O

-DOCSTART- X X O

Renin NNP B-NP
secretion NN O
in IN O
essential JJ O
and CC O
accelerated VBN O
hypertension NN O
. . O

-DOCSTART- X X O

The DT O
need NN O
for IN O
including VBG O
forensic JJ O
medical JJ O
expertise NN O
in IN O
the DT O
list NN O
of IN O
urgent JJ O
criminal JJ O
investigative NN O
actions NNS O

-DOCSTART- X X O

Tolerance NNP O
test NN O
of IN O
HB NNP O
419 CD O
in IN O
animal NN O
experiments NNS O

-DOCSTART- X X O

The DT O
" `` O
28 CD O
percent NN O
" '' O
Venturi NNP O
mask VB O
in IN O
obstructive JJ O
airway NN O
disease NN O
. . O

-DOCSTART- X X O

3'-Methyl NN O
, , O
8-methyl NN O
, , O
and CC O
8-phenyl JJ O
derivatives NNS O
of IN O
5,9-dimethyl-6,7-benzomorphans NNS O
. . O

-DOCSTART- X X O

Antidromic JJ O
invasion NN O
of IN O
impulses NNS O
and CC O
recurrent JJ O
collateral NN O
inhibition NN O
in IN O
pyramidal JJ O
tract NN O
neurones NNS O
. . O

-DOCSTART- X X O

The DT O
distribution NN O
of IN O
body NN O
fluids NNS O
following VBG O
hemorrhage NN O
and CC O
resuscitation NN O
in IN O
combat NN O
casualties NNS O
. . O

-DOCSTART- X X O

Once RB O
more RBR O
Hong NNP O
Kong NNP O
influenza NN O
in IN O
the DT O
Netherlands NNPS O

-DOCSTART- X X O

Difficulties NNS O
bound VBN O
to TO O
measuring VBG O
of IN O
sputum NN O
viscosity NN O

-DOCSTART- X X O

Lipid NNP O
concentration NN O
and CC O
lipase NN B-NP
activity NN O
in IN O
the DT O
epiphysis NN O
of IN O
adrenalectomized JJ O
rats NNS O
consuming VBG O
food NN O
with IN O
different JJ O
sodium NN O
content NN O

-DOCSTART- X X O

Behavior IN O
of IN O
aspartate NN B-NP
aminotransferase NN I-NP
(EC JJ O
2.6.1.1 CD B-NP
) -RRB- O
and CC O
alanine JJR B-NP
aminotransferase JJ I-NP
(EC NN O
2.6.1.2 CD B-NP
) -RRB- O
in IN O
rat NN O
serum NN O
during IN O
the DT O
course NN O
of IN O
acute JJ O
radiation NN O
syndrome NN O
following VBG O
whole JJ O
body NN O
X-irradiation NN O

-DOCSTART- X X O

Diminished NNP O
forearm NN O
arteriolar NN O
dilator NN O
capacity NN O
produced VBN O
by IN O
mineralocorticoid-induced JJ O
salt NN O
retention NN O
in IN O
man NN O
. . O

-DOCSTART- X X O

Studies NNS O
on IN O
the DT O
pathogenicity NN O
of IN O
ECHO NNP O
9 CD O
( -LRB- O
HILL NN O
) -RRB- O
virus NN O
and CC O
its PRP$ O
mutants NNS O
for IN O
suckling VBG O
mice NNS O

-DOCSTART- X X O

Counter-current JJ O
heat NN O
exchange NN O
in IN O
the DT O
respiratory JJ O
passages NNS O
: : O
effect NN O
on IN O
water NN O
and CC O
heat VB O
balance NN O
. . O

-DOCSTART- X X O

Calibration NNP O
and CC O
a DT O
correction NN O
of IN O
blood NN O
O2 DT O
content NN O
measured VBN O
by IN O
Po2 NNP O
and CC O
CO NNP O
saturation NN O
. . O

-DOCSTART- X X O

Mae NNP O
West NNP O
and CC O
the DT O
doctor NN O
shortage NN O
. . O

-DOCSTART- X X O

Elimination NNP O
of IN O
gamma-irradiation NN O
induced VBN O
oxidation NN O
in IN O
aqueous JJ O
drug NN O
preparations NNS O

-DOCSTART- X X O

Bimodal JJ O
cochlear JJ O
response NN O
curves NNS O
in IN O
rodents NNS O
. . O

-DOCSTART- X X O

A DT O
new JJ O
hemagglutination NN O
test NN O
for IN O
the DT O
on-slide JJ O
assay NN O
of IN O
rheumatoid NN B-NP
factor NN I-NP

-DOCSTART- X X O

CO2 NN O
assimilation NN O
by IN O
chloroplasts NNS O
illuminated VBN O
on IN O
filter NN O
paper NN O
. . O

-DOCSTART- X X O

The DT O
biology NN O
of IN O
Hyostrongylus NNP O
ruidus NNP O
. . O

-DOCSTART- X X O

The DT O
association NN O
of IN O
clopamide NN O
and CC O
hydergine NN O
( -LRB- O
Brinedine NNP O
) -RRB- O
in IN O
the DT O
treatment NN O
of IN O
the DT O
vasculo-renal JJ O
syndromes NNS O
of IN O
pregnancy NN O

-DOCSTART- X X O

Leukemia NNP O
in IN O
twins NNS O
: : O
world-wide JJ O
review NN O
of IN O
clinical JJ O
cases NNS O
. . O

-DOCSTART- X X O

Quantitation NNP O
of IN O
exocrine NN B-NP
IgA NN I-NP
in IN O
human JJ O
serum NN O
in IN O
health NN O
and CC O
disease NN O
. . O

-DOCSTART- X X O

Gastrointestinal JJ O
manifestations NNS O
of IN O
systemic JJ O
sclerosis NN O

-DOCSTART- X X O

Iodine NNP O
metabolism NN O
in IN O
chronic JJ O
thyroiditis NN O
. . O

-DOCSTART- X X O

V. NNP O

-DOCSTART- X X O

Propagation NNP O
and CC O
hormone NN O
production NN O
by IN O
human JJ O
normal JJ O
and CC O
malignant JJ O
trophoblast NN O
in IN O
rats NNS O
. . O

-DOCSTART- X X O

Sensitive NNP O
fluorometric JJ O
method NN O
of IN O
determining VBG O
SH- NNP O
and CC O
S-S-groups NNP O
when WRB O
jointly RB O
present JJ O

-DOCSTART- X X O

Morphogenesis NNP O
of IN O
the DT O
trochanter NN O
produced VBN O
by IN O
femoral JJ O
regeneration NN O
in IN O
the DT O
phasmid JJ O
Carausius NNP O
morosus NN O
Br . O

-DOCSTART- X X O

Behavioral NNP O
and CC O
electrographic JJ O
expression NN O
of IN O
natural JJ O
sleep NN O
and CC O
wakefulness NN O
in IN O
reptiles NNS O

-DOCSTART- X X O

Sensitivities NNS O
of IN O
thromboplastins NNS B-NP
to TO O
factor VB B-NP
VII NNP I-NP
deficiency NN O
. . O

-DOCSTART- X X O

3. . O

-DOCSTART- X X O

Central NNP O
venous JJ O
catheter NN O
used VBN O
for IN O
recording VBG O
intracardiac JJ O
electrocardiogram NN O
. . O

-DOCSTART- X X O

Two CD O
Lab NNP O
8 CD O
computer NN O
programmes NNS O
for IN O
use NN O
in IN O
the DT O
study NN O
of IN O
the DT O
isometric JJ O
and CC O
isotonic JJ O
contractile JJ O
characteristics NNS O
of IN O
skeletal JJ O
muscle NN O
. . O

-DOCSTART- X X O

Open VB O
head-brain NN O
injuries NNS O

-DOCSTART- X X O

The DT O
modification NN O
of IN O
P32 DT O
uptake NN O
into IN O
the DT O
Jensen NNP O
sarcoma NN O
in IN O
vitro NN O
by IN O
adding VBG O
of IN O
peroxide NN O
to TO O
the DT O
nutritive JJ O
medium NN O

-DOCSTART- X X O

5-(Dimethylaminopropyl)-19,11-dihydro-5H-benzo[2,3]pyrido[6,7-b]azepine JJ O
. . O

-DOCSTART- X X O

Osteogenesis NNP O
imperfecta NN O

-DOCSTART- X X O

Investigation NNP O
on IN O
the DT O
exchange NN O
of IN O
Ca45 NNP O
in IN O
intact JJ O
and CC O
burned JJ O
rats NNS O
by IN O
the DT O
kinetic JJ O
analysis NN O
method NN O

-DOCSTART- X X O

Effect NN O
of IN O
thrombotic NN O
and CC O
antithrombotic JJ O
drugs NNS O
on IN O
the DT O
surface NN O
charge NN O
characteristics NNS O
of IN O
canine VBG O
blood NN O
vessels NNS O
: : O
in IN O
vivo NN O
and CC O
in IN O
vitro NN O
studies NNS O
. . O

-DOCSTART- X X O

Measurements NNS O
of IN O
activity NN O
with IN O
the DT O
radioprotective JJ O
chamber NN O
VA-K-254 NN O
of IN O
the DT O
osimeter NN O
VA-J18 . O

-DOCSTART- X X O

3-(N-Alkyl-N-2-chloroethylaminomethyl)-5- CD O
or CC O
7-halogenobenzo[b]thiophen CD O
hydrochlorides NNS O
. . O

-DOCSTART- X X O

Nephrectomy RB O
applied VBD O
to TO O
cattle NNS O

-DOCSTART- X X O

Evaluation NN O
of IN O
automatic JJ O
blood NN O
cell NN O
counters NNS O
. . O

-DOCSTART- X X O

Determination NNP O
of IN O
transaminases NNS O
with IN O
an DT O
autoanalyzer NN O

-DOCSTART- X X O

Sterols NNP O
in IN O
pollen NN O
. . O

-DOCSTART- X X O

Histological JJ O
observations NNS O
on IN O
the DT O
decidua NN O
in IN O
the DT O
second JJ O
half NN O
of IN O
pregnancy NN O

-DOCSTART- X X O

Studies NNS O
on IN O
the DT O
method NN O
of IN O
size NN O
reduction NN O
of IN O
medicinal JJ O
compounds NNS O
. . O

-DOCSTART- X X O

Identification NN O
and CC O
estimation NN O
of IN O
monosaccharides NNS O
and CC O
disaccharides NNS O
in IN O
urine NN O
by IN O
gas-liquid JJ O
chromatography NN O
. . O

-DOCSTART- X X O

Steroids NNP O
in IN O
germfree NN O
and CC O
conventional JJ O
rats NNS O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
loading VBG O
the DT O
respiratory NN O
pumps NNS O
on IN O
the DT O
oxygen NN O
consumption NN O
of IN O
Callionymus NNP O
lyra NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
a DT O
constant JJ O
magnetic JJ O
field NN O
on RP O
the DT O
phagocytic JJ O
activity NN O
of IN O
Paramecia NNP O

-DOCSTART- X X O

Studies NNS O
carried VBD O
out RP O
with IN O
the DT O
Glossina NNP O
morsitans NNS O
colony NN O
of IN O
Lisbon NNP O
. . O

-DOCSTART- X X O

Relations NNPS O
between IN O
adrenergic JJ O
mechanisms NNS O
and CC O
analgesic JJ O
effects NNS O

-DOCSTART- X X O

The DT O
bearing NN O
of IN O
season NN O
and CC O
sequence NN O
of IN O
calving VBG O
on IN O
frequency NN O
of IN O
male JJ O
, , O
female JJ O
and CC O
total JJ O
calvings NNS O
in IN O
Hariana NNP O
cows NNS O
. . O

-DOCSTART- X X O

Caries NNP O
prevention NN O
in IN O
the DT O
dental JJ O
office NN O
. . O

-DOCSTART- X X O

Clinical NNP O
applications NNS O
of IN O
inhibition NN O
of IN O
beta-adrenergic JJ B-NP
receptors NNS I-NP
with IN O
propranolol NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
castration NN O
on IN O
pituitary JJ B-NP
and CC I-NP
serum JJ I-NP
LH NNP I-NP
and CC O
FSH NNP B-NP
in IN O
testosterone-sterilized JJ O
rats NNS O
. . O

-DOCSTART- X X O

Evidence NN O
forthe IN O
electroosmosis NN O
theory NN O
of IN O
transport NN O
in IN O
the DT O
phloem NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
heparin NN O
on IN O
the DT O
inactivation NN O
of IN O
serum NN B-NP
lipoprotein NN I-NP
lipase NN I-NP
by IN O
the DT O
liver NN O
in IN O
unanesthetized JJ O
dogs NNS O
. . O

-DOCSTART- X X O

Specialist NNP O
in IN O
family NN O
practice--prototype NN O
of IN O
a DT O
doctor NN O
. . O

-DOCSTART- X X O

The DT O
possibility NN O
of IN O
selective JJ O
chemotherapy NN O
of IN O
progressive JJ O
recurring VBG O
ovarian NN O
carcinoma NN O
with IN O
the DT O
aid NN O
of IN O
cytodiagnosis NN O
and CC O
incorporation NN O
of IN O
tagged VBN O
idoxuridine NN O

-DOCSTART- X X O

Variation NNP O
in IN O
the DT O
temporal-spatial JJ O
distribution NN O
of IN O
228Ra CD O
and CC O
224Ra CD O
in IN O
the DT O
RES NNP O
and CC O
marrow-free JJ O
skeleton NN O
after IN O
incorporation NN O
of IN O
colloidal JJ O
ThO2 . O

-DOCSTART- X X O

Absorption NN O
of IN O
electrolytes NNS O
from IN O
the DT O
colon NN O
in IN O
cases NNS O
of IN O
ulcerative JJ O
colitis NN O
and CC O
in IN O
control NN O
subjects NNS O
. . O

-DOCSTART- X X O

Ion NNP O
injection NN O
. . O

-DOCSTART- X X O

Polyvinyl NN O
alcohol NN O
as IN O
a DT O
solution NN O
mediator NN O

-DOCSTART- X X O

Mining NN O
the DT O
diagnostic JJ O
iron NN O
ore NN O
. . O

-DOCSTART- X X O

The DT O
need NN O
in IN O
the DT O
small JJ O
hospital NN O
. . O

-DOCSTART- X X O

On IN O
the DT O
character NN O
of IN O
changes NNS O
in IN O
the DT O
enzyme NN O
activity NN O
in IN O
the DT O
brain NN O
tissue NN O
during IN O
reflex NN O
epilepsy NN O

-DOCSTART- X X O

A DT O
malignant JJ O
true JJ O
teratoma NN O
of IN O
liver NN O
in IN O
childhood NN O
. . O

-DOCSTART- X X O

Functional JJ O
disorders NNS O
of IN O
the DT O
ureter NN O
following VBG O
gynecologic NN O
surgery NN O

-DOCSTART- X X O

Study NNP O
of IN O
the DT O
alterations NNS O
of IN O
intestinal JJ O
absorption NN O
, , O
by IN O
means NNS O
of IN O
I-131-triolein NNP O
, , O
in IN O
the DT O
whole JJ O
body NN O
irradiated JJ O
rat NN O

-DOCSTART- X X O

Chemical NNP O
histologic NN O
and CC O
immunologic JJ O
responses NNS O
in IN O
rats NNS O
to TO O
CC1-4 NNP O
by IN O
different JJ O
routes NNS O
of IN O
administration NN O
. . O

-DOCSTART- X X O

Statistics NNS O
of IN O
the DT O
past JJ O
5 CD O
years NNS O

-DOCSTART- X X O

On IN O
the DT O
diagnosis NN O
of IN O
bovine JJ O
leucosis NN O
and CC O
its PRP$ O
control NN O
in IN O
southern JJ O
Lower NNP O
Saxony NNP O

-DOCSTART- X X O

Studies NNS O
on IN O
the DT O
intracutaneous JJ O
infection NN O
of IN O
rabbits NNS O
by IN O
Staphylococcus NNP O
aureus NN O
. . O

-DOCSTART- X X O

On IN O
catabolism NN O
of IN O
aminoketones NNS O
in IN O
climacteric JJ O
age NN O

-DOCSTART- X X O

Naphthalene NNP O
and CC O
paradichlorobenzene NN O
in IN O
clinical JJ O
toxicology NN O

-DOCSTART- X X O

IV. . O

-DOCSTART- X X O

Studies NNS O
on IN O
powdered JJ O
preparations NNS O
. . O

-DOCSTART- X X O

A DT O
case NN O
report NN O
with IN O
angiographic JJ O
follow-up JJ O
study NN O
. . O

-DOCSTART- X X O

Further JJ O
studies NNS O
on IN O
a DT O
"new JJ O
" `` O
human JJ O
isoprecipitin NN B-NP
system NN O
( -LRB- O
Australia NNP O
antigen NN O
) -RRB- O
. . O

-DOCSTART- X X O

When WRB O
the DT O
cervical JJ O
Pap NNP O
smear NN O
is VBZ O
positive JJ O
. . O

-DOCSTART- X X O

Persistence NNP O
of IN O
toxaphene NN O
in IN O
treated VBN O
lakes NNS O
. . O

-DOCSTART- X X O

Studies NNS O
on IN O
Coxsackie NNP O
B NNP O
Type NNP O
5 CD O
virus NN O
infections NNS O
. . O

-DOCSTART- X X O

Value NN O
of IN O
the DT O
method NN O
of IN O
passive JJ O
hemagglutination NN O
with IN O
polysaccharide NN O
C NNP O
in IN O
detecting VBG O
C-reactive JJ B-NP
protein NN I-NP
as IN O
compared VBN O
to TO O
precipitation NN O
in IN O
capillaries NNS O
and CC O
slide NN O
latex RB O
test NN O
with IN O
anti-CRP JJ B-NP
serum NN O

-DOCSTART- X X O

Concussion NN O
of IN O
the DT O
spinal JJ O
cord NN O

-DOCSTART- X X O

Antimicrobial JJ O
substance NN O
isolated VBN O
from IN O
an DT O
acorn NN O
extract VB O
. . O

-DOCSTART- X X O

The DT O
pathogenicity NN O
of IN O
Achromobacter NNP O
puntatum NN O
for IN O
cold JJ O
blooded JJ O
and CC O
warm JJ O
blooded JJ O
animals NNS O

-DOCSTART- X X O

Consanguinity NNP O
and CC O
migration NN O
in IN O
the DT O
marriages NNS O
of IN O
the DT O
region NN O
of IN O
Nunoa NNP O
, , O
Santiago NNP O
, , O
1850-1960 CD O

-DOCSTART- X X O

On IN O
the DT O
amount NN O
and CC O
significance NN O
of IN O
the DT O
effective JJ O
glucose NN O
level NN O
in IN O
tumors NNS O
. . O

-DOCSTART- X X O

Studies NNS O
of IN O
lipogenesis NN O
by IN O
labelled JJ O
precursors NNS O
in IN O
the DT O
pregnant JJ O
rat NN O
. . O

-DOCSTART- X X O

Pharmacodynamic NNP O
studies NNS O
on IN O
the DT O
cardiovascular JJ O
system NN O
of IN O
spontaneously RB O
hypertensive JJ O
rats NNS O
. . O

-DOCSTART- X X O

Nuclear NNP O
spin NN O
of IN O
249Bk JJ O
from IN O
the DT O
hyperfine NN O
structure NN O
in IN O
its PRP$ O
emission NN O
spectrum NN O
. . O

-DOCSTART- X X O

Further JJ O
observations NNS O
on IN O
resorption NN O
in IN O
guinea NN O
pigs NNS O
following VBG O
injections NNS O
of IN O
trypan DT O
blue JJ O
. . O

-DOCSTART- X X O

Derivatives NNS O
of IN O
fluorene NN O
. . O

-DOCSTART- X X O

Retention NNP O
behavior NN O
of IN O
steroids NNS O
in IN O
gas NN O
chromatography NN O
with IN O
a DT O
series NN O
of IN O
combination NN O
columns NNS O
. . O

-DOCSTART- X X O

XXI. . O

-DOCSTART- X X O

Electrophoretic JJ O
characteriaztion NN O
of IN O
virus-induced JJ O
interferon NN B-NP
of IN O
the DT O
blood NN O
and CC O
urine NN O
in IN O
rabbits NNS O

-DOCSTART- X X O

Iron NNP O
and CC O
folate JJ O
deficiency NN O
in IN O
pregnancy NN O

-DOCSTART- X X O

Symposium NN O
on IN O
presenile NN O
spongy NN O
encephalopathies NNS O
. . O

-DOCSTART- X X O

The DT O
immuno-purified JJ O
mRNA NN O
in IN O
the DT O
polysome JJ O
complex NN O
was VBD O
used VBN O
to TO O
prepare VB O
cDNA NN O
with IN O
which WDT O
to TO O
probe VB O
a DT O
D. NNP O
melanogaster NN O
genomic JJ O
library NN O
. . O

-DOCSTART- X X O

Elevated VBN O
maternal JJ B-NP
alpha NN I-NP
fetoproteins NNS I-NP
and CC O
oligoamnios NNS O
: : O
fetal NN O
prognosis NN O

-DOCSTART- X X O

Also RB O
discussed VBN O
is VBZ O
the DT O
possibility NN O
of IN O
a DT O
combined JJ O
genetic JJ O
and CC O
environmental JJ O
etiology NN O
. . O

-DOCSTART- X X O

Courses NNS O
were VBD O
repeated VBN O
monthly RB O
upon IN O
recovery NN O
of IN O
myelosuppression NN O
. . O

-DOCSTART- X X O

The DT O
PEPCK NN B-NP
promoter NN O
fragment NN O
was VBD O
introduced VBN O
either RB O
in IN O
the DT O
proper JJ O
orientation NN O
for IN O
transcription NN O
of IN O
the DT O
TK NNP B-NP
gene NN I-NP
or CC O
in IN O
the DT O
opposite JJ O
orientation NN O
. . O

-DOCSTART- X X O

Many JJ O
mammary JJ O
tumors NNS O
induced VBN O
by IN O
mouse NN O
mammary NN O
tumor NN O
virus NN O
( -LRB- O
MMTV NN O
) -RRB- O
contain VBP O
a DT O
provirus NN O
in IN O
the DT O
same JJ O
region NN O
of IN O
the DT O
host-cell NN O
genome NN O
, , O
leading VBG O
to TO O
expression NN O
of IN O
a DT O
putative JJ O
cellular JJ O
oncogene NN O
called VBD O
int-1 NN B-NP
. . O

-DOCSTART- X X O

Hepatitis NNP O
B NNP O
virus NN O
and CC O
hepatoma NN O
. . O

-DOCSTART- X X O

USA NNP O
80 CD O
, , O
3618-3622 NN O
) -RRB- O
The DT O
two CD O
proteins NNS O
show VBP O
36 CD O
% NN O
identities NNS O
in IN O
their PRP$ O
amino JJ O
acid NN O
sequence NN O
, , O
in IN O
an DT O
alignment NN O
requiring VBG O
six CD O
gaps NNS O
. . O

-DOCSTART- X X O

The DT O
envelope NN B-NP
glycoproteins NNS I-NP
of IN I-NP
Rous NNP I-NP
sarcoma NN I-NP
virus NN I-NP
( -LRB- I-NP
RSV) NNP I-NP
, , O
gp85 CD B-NP
and CC O
gp37 CD B-NP
, , O
are VBP O
anchored VBN O
in IN O
the DT O
membrane NN O
by IN O
a DT O
27-amino JJ O
acid NN O
, , O
hydrophobic JJ O
domain NN O
that WDT O
lies VBZ O
adjacent JJ O
to TO O
a DT O
22-amino JJ O
acid NN O
, , O
cytoplasmic JJ O
domain NN O
at IN O
the DT O
carboxy NN O
terminus NN O
of IN O
gp37 CD B-NP
. . O

-DOCSTART- X X O

Effect NN O
of IN O
acute JJ O
and CC O
chronic JJ O
psychogenic JJ O
stress NN O
on IN O
corticoadrenal JJ O
and CC O
pituitary-thyroid JJ B-NP
hormones NNS I-NP
in IN O
male JJ O
rats NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
concluded VBN O
that IN O
haloperidol NN O
selectively RB O
reduced VBD O
the DT O
animal NN O
's POS O
capacity NN O
to TO O
'programme POS O
non-stimulus JJ O
directed VBN O
motor NN O
behaviour NN O
'. . O

-DOCSTART- X X O

The DT O
results NNS O
presented VBD O
in IN O
this DT O
report NN O
suggest VBP O
that IN O
the DT O
SV40 NNP O
G-C-rich NNP O
sequences NNS O
can MD O
function VB O
as IN O
independent JJ O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
transcriptional-control JJ O
elements NNS O
. . O

-DOCSTART- X X O

Theories NNS O
proffered VBD O
to TO O
account VB O
for IN O
the DT O
modality NN O
shift NN O
effect NN O
are VBP O
critically RB O
evaluated VBN O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
cardioselective JJ O
beta-1 JJ O
adrenergic JJ O
agonist NN O
, , O
1-(4-hydroxyphenoxy)-isopropylamino-2-propanol JJ O
) -RRB- O
, , O
i FW O
.e FW O
. . O
, , O
prenalterol NN O
, , O
were VBD O
examined VBN O
on IN O
direct JJ O
and CC O
continuous JJ O
measurements NNS O
of IN O
left JJ O
ventricular JJ O
( -LRB- O
LV NN O
) -RRB- O
pressure NN O
, , O
diameter NN O
, , O
dP/dt RB O
, , O
velocity NN O
of IN O
shortening NN O
, , O
arterial JJ O
pressure NN O
, , O
iliac JJ O
blood NN O
flow NN O
and CC O
heart NN O
rate NN O
in IN O
10 CD O
conscious JJ O
dogs NNS O
. . O

-DOCSTART- X X O

Endorphins NNS B-NP
at IN O
the DT O
approach NN O
of IN O
death NN O
. . O

-DOCSTART- X X O

The DT O
roll-over NN O
test NN O
to TO O
predict VB O
toxemia NN O
in IN O
pregnancy NN O
. . O

-DOCSTART- X X O

Can MD O
thyroglobulin PRP B-NP
assay VB O
really RB O
supplant VB O
radioiodine JJ O
scans NNS O
in IN O
patients NNS O
with IN O
differentiated JJ O
thyroid NN O
cancer NN O
? . O

-DOCSTART- X X O

3 CD O
Significant JJ O
reductions NNS O
in IN O
lying VBG O
mean JJ O
arterial JJ O
blood NN O
pressure NN O
were VBD O
observed VBN O
with IN O
daily JJ O
doses NNS O
of IN O
200 CD O
mg NN O
( -LRB- O
- : O
9 CD O
% NN O
) -RRB- O
, , O
400 CD O
mg NN O
( -LRB- O
- : O
10 CD O
% NN O
) -RRB- O
and CC O
800 CD O
mg NN O
( -LRB- O
- : O
14 CD O
% NN O
) -RRB- O
, , O
and CC O
were VBD O
associated VBN O
with IN O
significant JJ O
decreases NNS O
in IN O
heart NN O
rate NN O
and CC O
plasma NN B-NP
renin NN I-NP
activity NN O
. . O

-DOCSTART- X X O

Isolation NNP O
of IN O
Aeromonas NNP O
from IN O
faeces NNS O
. . O

-DOCSTART- X X O

Plasma NNP O
and CC O
erthrocyte VB O
lipid JJ O
profile NN O
and CC O
lipoprotein NN B-NP
lipase NN I-NP
activity NN O
in IN O
postheparin NN O
plasma NN O
on IN O
vasectomized JJ O
rabbits NNS O
were VBD O
studied VBN O
and CC O
also RB O
the DT O
incidence NN O
of IN O
atherosclerosis NN O
in IN O
different JJ O
arterial NN O
beds NNS O
. . O

-DOCSTART- X X O

( -LRB- O
iii NN O
) -RRB- O
The DT O
mRNA NN O
is VBZ O
not RB O
efficiently RB O
polyadenylated VBN O
at IN O
sequences NNS O
in IN O
the DT O
3' JJ O
end NN O
of IN O
the DT O
DHFR NNP B-NP
cDNA NN I-NP
but CC O
rather RB O
uses VBZ O
polyadenylation NN O
signals NNS O
downstream RB O
from IN O
the DT O
DHFR NNP B-NP
cDNA NN I-NP
. . O

-DOCSTART- X X O

Propranolol NNP O
also RB O
effectively RB O
controlled VBD O
her PRP$ O
familial JJ O
tremor NN O
. . O

-DOCSTART- X X O

The DT O
distribution NN O
phase NN O
is VBZ O
followed VBN O
by IN O
an DT O
elimination NN O
phase NN O
with IN O
a DT O
much RB O
longer RBR O
half-life JJ O
( -LRB- O
mean VBP O
value NN O
375 CD O
min NN O
) -RRB- O
and CC O
a DT O
volume NN O
of IN O
distribution NN O
of IN O
approximately RB O
200-400 CD O
l NN O
. . O

-DOCSTART- X X O

Risk NN O
of IN O
HTLV NNP O
infection NN O
in IN O
patients NNS O
on IN O
haemodialysis NN O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
metabolism NN O
of IN O
progesterone NN O
by IN O
the DT O
human JJ O
undescended JJ O
testis NN O
. . O

-DOCSTART- X X O

Two CD O
patients NNS O
withdrew VBD O
from IN O
therapy NN O
, , O
one CD O
for IN O
personal JJ O
reasons NNS O
and CC O
one CD O
because IN O
a DT O
paraspinal JJ O
mass NN O
developed VBN O
. . O

-DOCSTART- X X O

All DT O
patients NNS O
received VBD O
VCR NNP O
1.0 CD O
mg/m2 CD O
weekly JJ O
for IN O
6 CD O
weeks NNS O
with IN O
dose NN O
modification NN O
for IN O
neurotoxicity NN O
. . O

-DOCSTART- X X O

Glutamic JJ O
acid NN O
in IN O
a DT O
dose NN O
of IN O
1/100 CD O
of IN O
the DT O
LD50 NNP O
was VBD O
injected VBN O
in IN O
the DT O
form NN O
of IN O
sodium NN O
salt NN O
into IN O
male JJ O
and CC O
female JJ O
Wistar NNP O
rats NNS O
for IN O
7 CD O
days NNS O
after IN O
8- CD O
and CC O
12-day JJ O
injections NNS O
of IN O
dexazone NN O
. . O

-DOCSTART- X X O

Serum NN O
ascorbic JJ O
acid NN O
had VBD O
an DT O
inverse NN O
and CC O
the DT O
strongest JJS O
association NN O
with IN O
systolic JJ O
blood NN O
pressure NN O
among IN O
the DT O
risk NN O
factors NNS O
including VBG O
blood NN O
pressure NN O
, , O
total JJ O
cholesterol NN O
, , O
triglyceride NN O
, , O
gamma-GTP JJ B-NP
and CC O
obesity NN O
. . O

-DOCSTART- X X O

Plasma NNP B-NP
secretin NN I-NP
, , O
pancreozymin NN B-NP
, , O
and CC O
somatostatin-like JJ B-NP
hormone NN I-NP
in IN O
chronic JJ O
renal JJ O
failure NN O
patients NNS O
. . O

-DOCSTART- X X O

Thalamotomy DT O
aiming VBG O
at IN O
the DT O
CM-Pf NNP O
complex NN O
and CC O
using VBG O
stereotactic JJ O
gamma NN O
irradiation NN O
has VBZ O
been VBN O
performed VBN O
in IN O
a DT O
series NN O
of IN O
52 CD O
patients NNS O
with IN O
severe JJ O
pain NN O
due JJ O
to TO O
malignancy NN O
. . O

-DOCSTART- X X O

2 CD O
Silastic NNP O
capsules NNS O
, , O
each DT O
containing VBG O
22-23 CD O
mg NN O
of IN O
ethinyl NN O
estradiol NN O
, , O
were VBD O
inserted VBN O
subcutaneously RB O
in IN O
5 CD O
men NNS O
with IN O
benign JJ O
prostatic JJ O
hypertrophy NN O
. . O

-DOCSTART- X X O

When WRB O
used VBN O
subcutaneously RB O
or CC O
intravenously RB O
in IN O
maximum NN O
tolerated VBD O
doses NNS O
the DT O
antibiotic JJ O
inhibited VBD O
the DT O
development NN O
of IN O
lymphadenosis NN O
NK/Li NNP O
by IN O
90 CD O
and CC O
70 CD O
per IN O
cent NN O
respectively RB O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
2-(p-chlorophenyl)cyclopropylamine JJ O
on IN O
5-hydroxyindole JJ O
concentration NN O
and CC O
monoamine NN B-NP
oxidase NN I-NP
activity NN O
in IN O
rat NN O
brain NN O
. . O

-DOCSTART- X X O

Then RB O
, , O
pure JJ O
pancreatic JJ O
juice NN O
was VBD O
infused VBN O
into IN O
the DT O
duodenum NN O
. . O

-DOCSTART- X X O

An DT O
experiment NN O
was VBD O
carried VBN O
on IN O
133 CD O
grown VBN O
up IN O
fowls NNS O
and CC O
broilers NNS O
from IN O
4 CD O
industrial JJ O
farms NNS O
, , O
vaccinated VBN O
with IN O
spray NN O
lento VBN O
and CC O
mesogenic JJ O
vaccines NNS O
for IN O
straining VBG O
the DT O
immunity NN O
against IN O
pseodopest NN O
through IN O
RIHA NNP O
and CC O
provoking VBG O
pseudoplague NN O
with IN O
a DT O
pathogenic JJ O
virus NN O
. . O

-DOCSTART- X X O

( -LRB- O
2 LS O
) -RRB- O
The DT O
inappropriateness NN O
of IN O
adaptive JJ O
segmentation NN O
for IN O
the DT O
isolation NN O
of IN O
spikes NNS O
and CC O
sharp JJ O
waves NNS O
, , O
which WDT O
had VBD O
been VBN O
anticipated VBN O
in IN O
view NN O
of IN O
the DT O
short JJ O
duration NN O
of IN O
such JJ O
transients NNS O
in IN O
relation NN O
to TO O
the DT O
length NN O
of IN O
the DT O
window NN O
( -LRB- O
1.2 CD O
sec) NN O
used VBN O
for IN O
the DT O
autocorrelation NN O
functions NNS O
employed VBN O
in IN O
the DT O
segmentation NN O
algorithm NN O
, , O
was VBD O
confirmed VBN O
. . O

-DOCSTART- X X O

The DT O
ability NN O
of IN O
chronic JJ O
UM-272 NN O
( -LRB- O
dimethylpropranolol NN O
) -RRB- O
treatment NN O
to TO O
prevent VB O
the DT O
induction NN O
of IN O
reentrant JJ O
ventricular JJ O
tachyarrhythmias NNS O
was VBD O
assessed VBN O
in IN O
the DT O
conscious JJ O
dog NN O
subjected VBN O
to TO O
serial JJ O
programmed JJ O
electrical JJ O
stimulation NN O
on IN O
days NNS O
3--5 CD O
after IN O
myocardial JJ O
infarction NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
latter JJ O
category NN O
particular JJ O
emphasis NN O
is VBZ O
being VBG O
placed VBN O
on IN O
new JJ O
anthracycline NN O
analogues NNS O
of IN O
doxorubicin NN O
and CC O
analogues NNS O
of IN O
cisplatinum NN O
diammine NN O
dichloride NN O
. . O

-DOCSTART- X X O

Unusual JJ O
course NN O
of IN O
plasmocytosis NN O
. . O

-DOCSTART- X X O

Late RB O
mRNA RB O
selected VBN O
by IN O
a DT O
cDNA NN O
homologous NN O
to TO O
the DT O
HindIII-P/EcoRI-B NNP B-NP
region NN O
of IN O
the DT O
AcNPV NN O
map NN O
directed VBD O
the DT O
synthesis NN O
of IN O
31K NN O
and CC O
30K JJ O
proteins NNS O
which WDT O
comigrated VBD O
with IN O
the DT O
31K NN O
and CC O
30K JJ O
proteins NNS O
translated VBN O
from IN O
RNA NNP O
selected VBN O
by IN O
the DT O
HindIII-A/EcoRI-C/SstI-G NNP B-NP
cDNA NN O
. . O

-DOCSTART- X X O

A DT O
polypeptide NN O
chain NN O
of IN O
34 CD O
residues NNS O
of IN O
the DT O
deduced JJ O
yeast NN O
amino IN O
acid JJ O
sequence NN O
closely RB O
resembles VBZ O
a DT O
peptide NN O
sequence NN O
at IN O
the DT O
ADP NNP O
binding NN O
site NN O
of IN O
bovine JJ B-NP
muscle NN I-NP
pyruvate JJ I-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

The DT O
P165 CD O
component NN O
, , O
however RB O
, , O
could MD O
be VB O
differentiated VBN O
from IN O
the DT O
two CD O
later RB O
components NNS O
since IN O
it PRP O
increased VBD O
in IN O
amplitude NN O
with IN O
increased JJ O
task NN O
demands NNS O
while IN O
the DT O
N2 NNP O
and CC O
P3 NNP O
amplitudes NNS O
remained VBD O
constant JJ O
. . O

-DOCSTART- X X O

Differential JJ O
drawing VBG O
size NN O
associated VBN O
with IN O
unilateral JJ O
brain NN O
damage NN O
. . O

-DOCSTART- X X O

Toxicity NN O
was VBD O
significant JJ O
in IN O
selected VBN O
cases NNS O
; : O
three CD O
patients NNS O
developed VBD O
WBC NNP O
counts VBZ O
less RBR O
than IN O
1,000/mm3 CD O
and CC O
one CD O
of IN O
these DT O
patients NNS O
died VBD O
with IN O
sepsis NN O
. . O

-DOCSTART- X X O

Subdural JJ O
electrodes NNS O
may MD O
yield VB O
larger JJR O
VEP NN O
amplitudes NNS O
than IN O
skull NN O
or CC O
scalp NN O
electrodes NNS O
. . O

-DOCSTART- X X O

Use NN O
of IN O
the DT O
immunofluorescence NN O
method NN O
for IN O
identification NN O
of IN O
enteroviruses NNS O
in IN O
cell NN O
cultures NNS O

-DOCSTART- X X O

This DT O
fraction NN O
is VBZ O
resistant JJ O
to TO O
digestions NNS O
by IN O
DNase NNP B-NP
I PRP I-NP
and CC O
RNase NNP B-NP
T1 NNP I-NP
and CC O
disappears VBZ O
completely RB O
upon IN O
alkali JJ O
hydrolysis NN O
. . O

-DOCSTART- X X O

The DT O
direct JJ O
effects NNS O
of IN O
transmitter NN O
release NN O
were VBD O
( -LRB- O
a DT O
) -RRB- O
an DT O
early JJ O
fall NN O
in IN O
MAP NNP O
followed VBD O
by IN O
a DT O
late JJ O
pressor NN O
effect NN O
; : O
and CC O
( -LRB- O
b NN O
) -RRB- O
an DT O
early JJ O
bradycardia NN O
followed VBN O
by IN O
a DT O
late JJ O
tachycardia NN O
. . O

-DOCSTART- X X O

The DT O
number NN O
of IN O
elements NNS O
and CC O
their PRP$ O
sizes NNS O
relative JJ O
to TO O
the DT O
configuration NN O
were VBD O
varied VBN O
in IN O
a DT O
series NN O
of IN O
five CD O
experiments NNS O
. . O

-DOCSTART- X X O

Immunochemotherapy NNP O
with IN O
schizophyllan JJ O
( -LRB- O
SPG) JJ O
combined VBN O
with IN O
chemotherapeutic JJ O
agents NNS O
was VBD O
evaluated VBN O
in IN O
two CD O
syngeneic JJ O
tumor-C3H/He JJ O
mouse NN O
systems NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
when WRB O
combined VBN O
with IN O
mitomycin JJ O
C NNP O
given VBN O
with IN O
1 CD O
to TO O
5-days DT O
interval NN O
, , O
the DT O
concurrent JJ O
administration NN O
of IN O
SPG JJ O
prolonged VBN O
significantly RB O
the DT O
life-span NN O
of IN O
the DT O
tumor-bearing JJ O
mice NNS O
. . O

-DOCSTART- X X O

Data NNP O
are VBP O
presented VBN O
hinting VBG O
that IN O
the DT O
15 CD O
beta-hydroxy-, JJ O
metabolite NN O
of IN O
CPA NNS O
may MD O
actually RB O
be VB O
the DT O
biologically RB O
active JJ O
agent NN O
. . O

-DOCSTART- X X O

The DT O
abluminal JJ O
surface NN O
is VBZ O
often RB O
almost RB O
entirely RB O
encircled VBN O
by IN O
a DT O
thick JJ O
layer NN O
of IN O
fibrillary JJ O
connective JJ O
tissue NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
in IN O
LL NNP O
patients NNS O
during IN O
ENL NNP O
the DT O
ConA-induced JJ B-NP
suppressor NN O
response NN O
was VBD O
markedly RB O
reduced VBN O
. . O

-DOCSTART- X X O

Functional JJ O
characterization NN O
of IN O
a DT O
fraction NN O
identified VBN O
by IN O
its PRP$ O
activity NN O
in IN O
a DT O
second JJ O
template JJ O
rescue NN O
assay NN O
. . O

-DOCSTART- X X O

Fibrin NNP B-NP
gels NNS O
and CC O
their PRP$ O
possible JJ O
implication NN O
for IN O
surface NN O
hemorheology NN O
in IN O
health NN O
and CC O
disease NN O
. . O

-DOCSTART- X X O

Radiogallium NN O
imaging NN O
is VBZ O
thus RB O
of IN O
limited JJ O
use NN O
in IN O
evaluation NN O
of IN O
suspected VBN O
giant JJ O
cell NN O
tumors NNS O
of IN O
bone NN O
. . O

-DOCSTART- X X O

Ventricular JJ O
volume NN O
stiffness NN O
vs. IN O
the DT O
mean JJ O
wall NN O
stress NN O
relationship NN O
of IN O
LVH NNP O
shifted VBD O
upward RB O
, , O
whereas IN O
the DT O
normalized JJ O
wall NN O
muscle NN O
stiffness NN O
vs. IN O
the DT O
mean JJ O
wall NN O
stress NN O
relationship NN O
of IN O
LVH NNP O
showed VBD O
a DT O
smaller JJR O
slope NN O
. . O

-DOCSTART- X X O

Synthesis NN O
of IN O
( -LRB- O
+)-lysergic JJ O
acid NN O
diethylamide NN O
tartrate NN O

-DOCSTART- X X O

Weight NN O
loss NN O
reduces VBZ O
arterial JJ O
pressure NN O
by IN O
a DT O
decrease NN O
in IN O
intravascular JJ O
volume NN O
and CC O
cardiac JJ O
output NN O
associated VBN O
with IN O
a DT O
fall NN O
in IN O
sympathetic JJ O
activity NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
was VBD O
undertaken VBN O
to TO O
assess VB O
the DT O
effects NNS O
of IN O
hypothermia NN O
and CC O
chemical NN O
cardioplegia NN O
on IN O
the DT O
functional JJ O
recovery NN O
of IN O
hypertrophied JJ O
non-failing JJ O
rat NN O
hearts NNS O
subjected VBN O
to TO O
an DT O
extended JJ O
period NN O
of IN O
global JJ O
ischaemia NN O
. . O

-DOCSTART- X X O

Among IN O
six CD O
different JJ O
library NN O
isolates NNS O
containing VBG O
6.5- CD B-NP
to TO I-NP
7-kb CD I-NP
IAP NNP I-NP
units NNS I-NP
, , O
some DT O
restriction NN O
sites NNS O
were VBD O
highly RB O
conserved VBN O
whereas IN O
others NNS O
varied VBD O
in IN O
both DT O
occurrence NN O
and CC O
position NN O
. . O

-DOCSTART- X X O

Catecholamines NNP O
and CC O
aversive JJ O
learning NN O
: : O
a DT O
review NN O
. . O

-DOCSTART- X X O

The DT O
antibody NN O
titer NN O
of IN O
202 CD O
chickens NNS O
to TO O
SA-11 NN O
rotavirus NN O
was VBD O
determined VBN O
by IN O
enzyme-linked JJ O
immunosorbent JJ O
blocking VBG O
assay NN O
. . O

-DOCSTART- X X O

Thus RB O
it PRP O
appears VBZ O
that IN O
insertion NN O
of IN O
a DT O
transposable JJ O
element NN O
near IN O
the DT O
5' JJ O
terminus NN O
of IN O
the DT O
structural JJ O
gene NN O
can MD O
produce VB O
constitutive JJ O
expression NN O
of IN O
a DT O
normally RB O
glucose-repressed JJ O
enzyme NN O
. . O

-DOCSTART- X X O

Five CD O
experiments NNS O
examined VBD O
the DT O
influence NN O
of IN O
opiate NN O
antagonists NNS O
on IN O
both DT O
the DT O
short-term JJ O
analgesic NN O
reaction NN O
resulting VBG O
30 CD O
min NN O
after IN O
exposure NN O
to TO O
inescapable JJ O
shock NN O
and CC O
the DT O
long-term JJ O
analgesic NN O
reaction NN O
resulting VBG O
after IN O
reexposure NN O
to TO O
shock VB O
24 CD O
hr NN O
after IN O
inescapable JJ O
shock NN O
exposure NN O
. . O

-DOCSTART- X X O

During IN O
the DT O
period NN O
from IN O
May NNP O
to TO O
August NNP O
, , O
1978 CD O
, , O
an DT O
epidemic NN O
of IN O
hand NN O
, , O
foot NN O
and CC O
mouth NN O
disease NN O
( -LRB- O
HFMD) NNP O
occurred VBD O
in IN O
Gifu NNP O
prefecture NN O
. . O

-DOCSTART- X X O

A DT O
22K JJ O
polypeptide NN O
was VBD O
detected VBN O
as IN O
a DT O
translation NN O
product NN O
of IN O
late JJ O
RNA NNP O
that WDT O
hybridized VBD O
to TO O
this DT O
DNA NN O
fragment NN O
. . O

-DOCSTART- X X O

The DT O
genome NN O
of IN O
avian JJ O
erythroblastosis NN O
virus NN O
contains VBZ O
two CD O
independently RB O
expressed VBD O
genetic JJ O
loci NNS O
(v-erbA . O
and CC O
v-erbB JJ B-NP
) -RRB- O
whose WP$ O
activities NNS O
are VBP O
probably RB O
responsible JJ O
for IN O
oncogenesis NN O
by IN O
the DT O
virus NN O
. . O

-DOCSTART- X X O

Both DT O
neural JJ O
and CC O
hormonal JJ O
pathways NNS O
and CC O
both DT O
opiate JJ O
and CC O
nonopiate JJ O
substances NNS O
play VBP O
roles NNS O
in IN O
the DT O
complex JJ O
modulation NN O
of IN O
pain NN O
transmission NN O
. . O

-DOCSTART- X X O

WR-2721 DT O
(S-2-(3 JJ O
aminopropylamino NN O
) -RRB- O
ethylphosphorothioic JJ O
acid NN O
) -RRB- O
has VBZ O
been VBN O
investigated VBN O
for IN O
its PRP$ O
ability NN O
to TO O
protect VB O
gut NN O
, , O
lung NN O
, , O
and CC O
testis NN O
, , O
as RB O
well RB O
as IN O
fibrosarcoma NN O
( -LRB- O
FSa NNP O
) -RRB- O
tumor NN O
nodules NNS O
, , O
in IN O
the DT O
lungs NNS O
of IN O
mice NNS O
from IN O
gamma-radiation NN O
injury NN O
. . O

-DOCSTART- X X O

In IN O
fact NN O
, , O
families NNS O
of IN O
polypeptides NNS O
were VBD O
produced VBN O
by IN O
initiation NN O
of IN O
translation NN O
at IN O
AUG NNP O
codons NNS O
within IN O
sequences NNS O
coding VBG O
for IN O
VP1 NNP B-NP
and CC O
T NNP B-NP
, , O
presumably RB O
as IN O
a DT O
result NN O
of IN O
transcription NN O
initiation IN O
events NNS O
that WDT O
generated VBD O
5' JJ O
ends NNS O
immediately RB O
upstream RB O
from IN O
these DT O
AUGs NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
TRP1 NNP B-NP
RI NNP O
Circle NNP O
DNA NNP O
is VBZ O
organized VBN O
into IN O
nucleosomes NNS O
whose WP$ O
size NN O
and CC O
spacing NN O
are VBP O
indistinguishable JJ O
from IN O
that DT O
of IN O
bulk NN O
yeast NN O
chromatin NN O
. . O

-DOCSTART- X X O

In IN O
49 CD O
patients NNS O
in IN O
whom WP O
gated VBD O
equilibrium NN O
ventriculography NN O
and CC O
cardiac NN O
catheterization NN O
were VBD O
performed VBN O
within IN O
a DT O
6 CD O
day NN O
interval NN O
, , O
total JJ O
and CC O
fractional JJ O
portions NNS O
of IN O
global JJ O
and CC O
regional JJ O
right JJ O
ventricular NN O
ejection NN O
fraction NN O
( -LRB- O
RVEF NN O
) -RRB- O
were VBD O
correlated VBN O
with IN O
pulmonary JJ O
arterial NN O
systolic JJ O
pressure NN O
. . O

-DOCSTART- X X O

74 CD O
, , O
193-197 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Two CD O
mutations NNS O
that WDT O
affect VBP O
larval JJ B-NP
cuticle NN I-NP
protein NN I-NP
gene NN I-NP
expression NN O
in IN O
the DT O
2/3 CD O
variant JJ O
Drosophila NNP O
melanogaster NN O
strain NN O
were VBD O
investigated VBN O
. . O

-DOCSTART- X X O

The DT O
strong JJ O
conservation NN O
of IN O
the DT O
inverted VBN O
terminal NN O
repeat NN O
sequence NN O
may MD O
reflect VB O
a DT O
common JJ O
integration NN O
mechanism NN O
for IN O
VL30 DT B-NP
elements NNS I-NP
and CC O
MuLV NNP O
proviruses NNS O
. . O

-DOCSTART- X X O

A DT O
cDNA NN O
cloning NN O
vector NN O
that WDT O
permits VBZ O
expression NN O
of IN O
cDNA NN O
inserts NNS O
in IN O
mammalian JJ O
cells NNS O
. . O

-DOCSTART- X X O

Hybridization NN O
of IN O
plasmid-transformed JJ O
Escherichia NNP O
coli NNS O
RR1 IN O
colonies NNS O
with IN O
32P-labeled JJ O
viral JJ O
genome NN O
RNAs NNS O
demonstrated VBD O
the DT O
presence NN O
of IN O
DNA NNP O
clones NNS O
representative NN O
of IN O
each DT O
of IN O
the DT O
10 CD O
reovirus NN O
RNAs NNS O
and CC O
10 CD O
of IN O
the DT O
11 CD O
constituent JJ O
segments NNS O
of IN O
the DT O
rotavirus NN O
genome NN O
. . O

-DOCSTART- X X O

In IN O
conclusion NN O
, , O
these DT O
studies NNS O
indicate VBP O
that IN O
LiCl NNP O
( -LRB- O
1 CD O
) -RRB- O
decreases VBZ O
histamine-stimulated JJ O
gastric JJ O
acid NN O
secretion NN O
, , O
and CC O
( -LRB- O
2 CD O
) -RRB- O
diminishes VBZ O
bile-induced JJ O
disruption NN O
of IN O
the DT O
gastric JJ O
mucosal NN O
barrier NN O
in IN O
the DT O
canine CD O
Heidenhain NNP O
pouch NN O
. . O

-DOCSTART- X X O

The DT O
junctions NNS O
between IN O
viral JJ O
and CC O
cellular JJ O
sequences NNS O
were VBD O
determined VBN O
by IN O
DNA NNP O
sequence NN O
analysis NN O
to TO O
be VB O
517 CD O
nucleotides NNS O
into IN O
the DT O
p30 NN B-NP
sequence NN I-NP
and CC O
1,920 CD O
nucleotides NNS O
into IN O
the DT O
polymerase NN O
sequence NN O
. . O

-DOCSTART- X X O

Gel NNP O
route NN O
preparation NN O
of IN O
low JJ O
fusing NN O
dental JJ O
porcelain NN O
frit NN O
. . O

-DOCSTART- X X O

Viral NNP O
RNA NNP O
, , O
molecularly RB O
cloned VBD O
proviral JJ O
DNA NN O
, , O
and CC O
virus-specific JJ O
protein NN O
of IN O
avian JJ O
retrovirus NN O
MH2 . O
were VBD O
analyzed VBN O
. . O

-DOCSTART- X X O

Intracellular JJ O
recordings NNS O
were VBD O
performed VBN O
on IN O
the DT O
optic JJ O
tectum NN O
of IN O
the DT O
carp NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Plasmids NNS O
for IN O
the DT O
cloning NN O
and CC O
expression NN O
of IN O
full-length JJ O
double-stranded JJ O
cDNAs NNS O
under IN O
control NN O
of IN O
the DT O
SV40 JJ B-NP
early JJ I-NP
or CC O
late JJ B-NP
gene NN I-NP
promoter NN O
. . O

-DOCSTART- X X O

Supplementing VBG O
a DT O
soybean NN O
protein NN O
and CC O
sucrose-based JJ O
diet NN O
with IN O
levels NNS O
of IN O
2.2 CD O
, , O
11 CD O
, , O
and CC O
55 CD O
ppm NN O
of IN O
the DT O
antibiotic JJ O
, , O
from IN O
the DT O
two CD O
sources NNS O
each DT O
with IN O
two CD O
different JJ O
purities NNS O
, , O
improved VBD O
weight NN O
gain NN O
of IN O
chicks NNS O
an DT O
average NN O
of IN O
23 CD O
% NN O
and CC O
improved VBN O
feed NN O
efficiency NN O
an DT O
average NN O
of IN O
13 CD O
% NN O
at IN O
the DT O
higher JJR O
levels NNS O
( -LRB- O
all DT O
P NNP O
less JJR O
than IN O
.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
splice NN O
acceptor NN O
site NN O
is VBZ O
ca MD O
. . O

-DOCSTART- X X O

This DT O
is VBZ O
consistent JJ O
with IN O
a DT O
model NN O
proposing VBG O
that IN O
SSV NNP O
was VBD O
generated VBN O
by IN O
recombination NN O
between IN O
proviral JJ O
DNA NN O
of IN O
a DT O
simian JJ O
sarcoma NN O
associated VBN O
virus NN O
and CC O
proto-sis NN B-NP
and CC O
that DT O
introns NNS O
were VBD O
spliced VBN O
out IN O
subsequently RB O
from IN O
a DT O
fused VBN O
viral-sis NN B-NP
messenger NN I-NP
RNA NNP I-NP
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
, , O
with IN O
autonomic JJ O
nervous JJ O
system NN O
activity NN O
intact JJ O
, , O
carotid JJ O
chemoreceptor NN O
reflex NN O
activation NN O
can MD O
elicit VB O
an DT O
absolute JJ O
reflexly NN O
mediated VBN O
reduction NN O
in IN O
coronary JJ O
blood NN O
flow NN O
in IN O
the DT O
normal JJ O
, , O
conscious JJ O
dog NN O
, , O
despite IN O
an DT O
increase NN O
in IN O
arterial JJ O
pressure NN O
. . O

-DOCSTART- X X O

Female JJ O
subjects NNS O
, , O
including VBG O
both DT O
normal JJ O
subjects NNS O
and CC O
idiopathic JJ O
calcium NN O
stone-formers NNS O
, , O
have VBP O
higher JJR O
urinary JJ O
cyclic NN O
AMP NNP O
levels NNS O
than IN O
their PRP$ O
male NN O
counterparts NNS O
, , O
and CC O
this DT O
difference NN O
is VBZ O
significant JJ O
when WRB O
urinary JJ O
cyclic JJ O
AMP NNP O
is VBZ O
expressed VBN O
in IN O
the DT O
units NNS O
mumol/g NN O
of IN O
creatinine CD O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
desipramine NN O
probably RB O
represents VBZ O
inhibition NN O
of IN O
neuronal JJ O
uptake NN O
and CC O
that DT O
of IN O
amitriptyline JJ O
and CC O
mianserin JJ O
blockade NN O
of IN O
neuronal JJ O
uptake NN O
and CC O
prejunctional JJ O
alpha NN B-NP
2-adrenoreceptors NNS I-NP
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
the DT O
gp54 CD B-NP
structural JJ I-NP
gene NN I-NP
is VBZ O
required VBN O
for IN O
initiation NN O
or CC O
amplification NN O
of IN O
the DT O
splenic JJ O
erythroblast NN O
hyperplasia NN O
which WDT O
characterizes VBZ O
the DT O
preleukemic JJ O
phase NN O
of IN O
Rauscher NNP O
disease NN O
. . O

-DOCSTART- X X O

Surgical JJ O
treatment NN O
of IN O
pulmonary JJ O
metastases NNS O
. . O

-DOCSTART- X X O

Each DT O
of IN O
these DT O
spliced VBN O
mRNAs NNS O
has VBZ O
an DT O
untranslated JJ O
leader NN O
sequence NN O
of IN O
249 CD O
bases NNS O
and CC O
a DT O
single JJ O
intron NN O
of IN O
approximately RB O
540 CD O
bases NNS O
which WDT O
are VBP O
contained VBN O
entirely RB O
within IN O
TRs/IRs NNP O
sequences NNS O
. . O

-DOCSTART- X X O

The DT O
expression NN O
of IN O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
was VBD O
detected VBN O
within IN O
1 CD O
h NN O
after IN O
infection NN O
of IN O
cells NNS O
with IN O
recombinant JJ O
virus NN O
, , O
reflecting VBG O
the DT O
early JJ O
nature NN O
of IN O
the DT O
promoters NNS O
used VBN O
. . O

-DOCSTART- X X O

NPT NNP B-NP
II NNP I-NP
synthesis NN O
, , O
measured VBN O
by IN O
agar NN O
plate NN O
assays IN O
of IN O
kanamycin NN O
resistance NN O
and CC O
by IN O
immunoprecipitation NN O
of IN O
the DT O
NPT NNP B-NP
II NNP I-NP
protein NN I-NP
, , O
was VBD O
repressed VBN O
in IN O
the DT O
presence NN O
of IN O
cysteine NN O
and CC O
derepressed VBN O
in IN O
its PRP$ O
absence NN O
. . O

-DOCSTART- X X O

A DT O
computed JJ O
tomographic JJ O
scan NN O
obtained VBN O
after IN O
EOE-13 JJ O
infusion NN O
accurately RB O
showed VBD O
the DT O
perfusion NN O
pattern NN O
of IN O
the DT O
implanted JJ O
catheter NN O
. . O

-DOCSTART- X X O

No DT O
significant JJ O
correlation NN O
was VBD O
found VBN O
between IN O
LVM NNP O
or CC O
wall NN O
thickness NN O
and CC O
body NN O
surface NN O
area NN O
, , O
age NN O
, , O
blood NN O
pressure NN O
, , O
heart NN O
rate NN O
, , O
cardiac JJ O
output NN O
, , O
total JJ O
peripheral JJ O
resistance NN O
and CC O
left VBD O
ventricular JJ O
systolic JJ O
wall NN O
stress NN O
, , O
whereas IN O
CD25 NNP O
was VBD O
correlated VBN O
with IN O
urinary JJ O
catecholamines NNS O
only RB O
in IN O
hypertensive JJ O
patients NNS O
( -LRB- O
r NNP O
= SYM O
0.606 CD O
, , O
p RB O
less JJR O
than IN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
gene NN B-NP
cat-86 NN I-NP
, , O
specifying VBG O
chloramphenicol-inducible JJ B-NP
chloramphenicol NN I-NP
acetyltransferase NN I-NP
, , O
is VBZ O
located VBN O
on IN O
the DT O
1.1-kilobase JJ O
cloned JJ O
DNA NN O
. . O

-DOCSTART- X X O

The DT O
myeloproliferative JJ O
sarcoma NN O
virus NN O
( -LRB- O
MPSV NNP O
) -RRB- O
was VBD O
derived VBN O
by IN O
passage NN O
of IN O
Moloney NNP O
sarcoma NN O
virus NN O
( -LRB- O
Mo-MuSV NNP O
) -RRB- O
in IN O
adult NN O
mice NNS O
. . O

-DOCSTART- X X O

The DT O
same-sized JJ O
EBNA NNP B-NP
protein NN I-NP
( -LRB- I-NP
approximately RB I-NP
78,000 CD I-NP
) -RRB- I-NP
was VBD O
made VBN O
after IN O
transfection NN O
with IN O
BamHI-K NNP B-NP
( -LRB- I-NP
5.2 CD I-NP
kilobase NN I-NP
pairs NNS I-NP
[kbp] RB I-NP
) -RRB- I-NP
or CC O
the DT O
I1f JJ O
subfragment NN O
( -LRB- O
2.9 CD O
kbp NN O
) -RRB- O
. . O

-DOCSTART- X X O

They PRP O
generated VBD O
ca MD O
. . O

-DOCSTART- X X O

An DT O
immunologic JJ O
test NN O
using VBG O
stomach NN O
and CC O
tumor NN O
antigens NNS O
for IN O
screening NN O
of IN O
those DT O
at IN O
high JJ O
risk NN O
for IN O
stomach NN O
cancer NN O
is VBZ O
suggested VBN O
. . O

-DOCSTART- X X O

Thirty CD O
isolates NNS O
of IN O
Haemophilus NNP O
influenzae NN O
type NN O
b NN O
were VBD O
obtained VBN O
during IN O
an DT O
outbreak NN O
of IN O
invasive JJ O
H. NNP O
influenzae NN O
type NN O
b NN O
disease NN O
and CC O
were VBD O
classified VBN O
by IN O
the DT O
electrophoretic JJ O
profile NN O
of IN O
their PRP$ O
lipopolysaccharide NN O
( -LRB- O
LPS) NNP O
. . O

-DOCSTART- X X O

Tiaprofenic NNP O
acid NN O
overdose NN O
. . O

-DOCSTART- X X O

Frog NNP O
type NN O
I PRP O
( -LRB- O
Ft NN O
I PRP O
) -RRB- O
and CC O
frog JJ O
type NN O
II NNP O
( -LRB- O
Ft NN O
II NNP O
) -RRB- O
slowly RB O
adapting VBG O
( -LRB- O
SA NNP O
) -RRB- O
units NNS O
produced VBD O
spikes NNS O
only RB O
at IN O
the DT O
indentation NN O
phase NN O
, , O
and CC O
the DT O
threshold NN O
response NN O
phase NN O
( -LRB- O
TRP NNP O
) -RRB- O
, , O
i FW O
.e FW O
. . O
. . O
the DT O
phase NN O
of IN O
the DT O
first JJ O
spike NN O
was VBD O
for IN O
ca MD O
. . O

-DOCSTART- X X O

DMCM NNP O
also RB O
permits VBZ O
extension NN O
of IN O
the DT O
possibilities NNS O
of IN O
obtaining VBG O
and CC O
transplanting VBG O
donor JJ O
organs NNS O
. . O

-DOCSTART- X X O

In IN O
patients NNS O
in IN O
group NN O
A DT O
( -LRB- O
"normal JJ O
" `` O
CI) NNP O
, , O
the DT O
CI NNP O
, , O
heart NN O
rate NN O
and CC O
the DT O
mean JJ O
circumferential JJ O
fiber NN O
shortening NN O
velocity NN O
( -LRB- O
mVCF NN O
) -RRB- O
were VBD O
normal JJ O
, , O
but CC O
the DT O
TPR NNP O
was VBD O
increased VBN O
significantly RB O
. . O

-DOCSTART- X X O

Immunologically RB O
reactive JJ O
insulin NN B-NP
levels NNS O
were VBD O
determined VBN O
in IN O
freely-moving JJ O
normal JJ O
rats NNS O
offered VBD O
three CD O
different JJ O
test-meals NNS O
. . O

-DOCSTART- X X O

The DT O
genes NNS O
at IN O
each DT O
locus NN O
are VBP O
divergently RB O
transcribed VBN O
and CC O
the DT O
coding NN O
sequences NNS O
are VBP O
separated VBN O
by IN O
646 CD O
base-pairs NNS O
at IN O
one CD O
locus NN O
and CC O
676 CD O
base-pairs NNS O
at IN O
the DT O
other JJ O
. . O

-DOCSTART- X X O

The DT O
enzymic JJ O
hydrolysis NN O
of IN O
urea NN O
produces VBZ O
ammonia NN O
which WDT O
causes VBZ O
a DT O
vivid JJ O
yellow NN O
to TO O
purple JJ O
colour NN O
change NN O
in IN O
the DT O
pH JJ O
indicator NN O
. . O

-DOCSTART- X X O

Plasma NNP O
renin NN B-NP
activity NN O
did VBD O
not RB O
change VB O
in IN O
response NN O
to TO O
head-up JJ O
tilt NN O
or CC O
isoprenaline NN O
infusion NN O
in IN O
the DT O
patients NNS O
. . O

-DOCSTART- X X O

Induced NNP O
gamma-ray NN O
spectroscopy NN O

-DOCSTART- X X O

Bepridil NNP O
, , O
a DT O
calcium NN O
antagonist NN O
with IN O
a DT O
half-life NN O
of IN O
approximately RB O
42 CD O
hours NNS O
, , O
was VBD O
compared VBN O
with IN O
placebo NN O
in IN O
a DT O
double-blind JJ O
, , O
randomized JJ O
, , O
crossover JJ O
trial NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
negative JJ O
pleural JJ O
pressure NN O
on IN O
left VBN O
ventricular JJ O
hemodynamics NNS O
. . O

-DOCSTART- X X O

Lauciello NNP O
describes VBZ O
a DT O
technique NN O
for IN O
the DT O
placement NN O
of IN O
functionally RB O
generated VBN O
amalgam NN O
stops VBZ O
as IN O
restorations NNS O
within IN O
mandibular JJ O
acrylic JJ O
teeth NNS O
. . O

-DOCSTART- X X O

These DT O
data NNS O
suggest VBP O
that IN O
a DT O
major JJ O
part NN O
of IN O
the DT O
reduction NN O
in IN O
food NN O
intake NN O
in IN O
hyperphagic NN O
rats NNS O
eating VBG O
a DT O
quinine-adulterated JJ O
diet NN O
is VBZ O
due JJ O
to TO O
postingestional JJ O
events NNS O
. . O

-DOCSTART- X X O

The DT O
aspirate NN O
from IN O
a DT O
parathyroid NN O
cyst NN O
was VBD O
watery NN O
clear JJ O
and CC O
contained VBD O
high JJ O
amount NN O
of IN O
parathyroid NN B-NP
hormone NN I-NP
. . O

-DOCSTART- X X O

The DT O
numerous JJ O
tests NNS O
demonstrate VBP O
that IN O
the DT O
HDL-2M NNP O
can MD O
be VB O
extensively RB O
and CC O
successfully RB O
used VBD O
for IN O
therapy NN O
of IN O
insulin-dependent JJ B-NP
diabetes NNS O
mellitus NN O
in IN O
clinical JJ O
practice NN O
. . O

-DOCSTART- X X O

Transplantation NN O
of IN O
kidneys NNS O
of IN O
juvenile JJ O
donors NNS O
in IN O
adult NN O
recipients NNS O
. . O

-DOCSTART- X X O

Results NNS O
of IN O
a DT O
controlled JJ O
study NN O

-DOCSTART- X X O

Hydrallazine NNP O
also RB O
caused VBD O
a DT O
slight JJ O
increase NN O
in IN O
plasma NN B-NP
renin NN I-NP
activity NN O
and CC O
urinary JJ O
excretion NN O
of IN O
noradrenaline NN O
. . O

-DOCSTART- X X O

After IN O
description NN O
of IN O
his PRP$ O
short JJ O
life NN O
and CC O
an DT O
explanation NN O
of IN O
the DT O
light JJ O
conductor NN O
Bozzini NNP O
's POS O
merit NN O
is VBZ O
emphasized VBN O
, , O
by IN O
his PRP$ O
invention NN O
as IN O
first JJ O
physician NN O
to TO O
have VB O
made VBN O
accessible JJ O
to TO O
medicine NN O
endoscopic NN O
diagnostic JJ O
possibilities NNS O
. . O

-DOCSTART- X X O

The DT O
susceptibility NN O
of IN O
the DT O
PPNG NNP O
strains NNS O
to TO O
clinically VB O
relevant JJ O
antibiotics NNS O
varied VBN O
with IN O
the DT O
plasmid NN O
pattern NN O
; : O
this DT O
stresses VBZ O
the DT O
necessity NN O
of IN O
permanent JJ O
surveillance NN O
of IN O
gonococcal JJ O
infections NNS O
and CC O
of IN O
regular JJ O
evaluation NN O
of IN O
the DT O
recommendations NNS O
for IN O
antimicrobial JJ O
treatment NN O
. . O

-DOCSTART- X X O

195mPt-labeled JJ O
cisplatin NN O
was VBD O
administered VBN O
iv NN O
and CC O
ip NN O
to TO O
control VB O
mice NNS O
and CC O
to TO O
mice NNS O
bearing VBG O
Sarcoma NNP O
180 CD O
. . O

-DOCSTART- X X O

New NNP O
beta-blocking JJ O
drugs NNS O
have VBP O
been VBN O
introduced VBN O
which WDT O
may MD O
prove VB O
beneficial JJ O
in IN O
certain JJ O
clinical JJ O
situations NNS O
since IN O
they PRP O
exert VBP O
more RBR O
selective JJ O
blockade NN O
of IN O
the DT O
cardiac NN B-NP
receptors NNS I-NP
( -LRB- O
beta1 NN B-NP
) -RRB- O
as IN O
opposed VBN O
to TO O
smooth JJ B-NP
muscle NN I-NP
receptors NNS I-NP
( -LRB- O
beta2 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

If IN O
facilities NNS O
for IN O
measurements NNS O
of IN O
O2 JJ O
consumption NN O
and CC O
hence RB O
metabolic JJ O
rate NN O
are VBP O
available JJ O
, , O
these DT O
should MD O
be VB O
utilized VBN O
. . O

-DOCSTART- X X O

This DT O
generally RB O
means VBZ O
an DT O
energy NN O
intake NN O
of IN O
1.4 CD O
to TO O
1.6 CD O
times NNS O
the DT O
energy NN O
expenditure NN O
, , O
with IN O
a DT O
N NNP O
intake NN O
of IN O
250 CD O
to TO O
400 CD O
mg/kg/day NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
37 CD O
patients NNS O
without IN O
lung NN O
disease NN O
respiratory NN O
muscle NN O
weakness NN O
was VBD O
accompanied VBN O
by IN O
significant JJ O
decreases NNS O
in IN O
vital JJ O
capacity NN O
, , O
total JJ O
lung NN O
capacity NN O
, , O
and CC O
maximum NN O
voluntary JJ O
ventilation NN O
; : O
by IN O
significant JJ O
increases NNS O
in IN O
residual JJ O
volume NN O
and CC O
arterial JJ O
carbon NN O
dioxide NN O
tension NN O
( -LRB- O
PaCO2 NN O
) -RRB- O
; : O
and CC O
greater JJR O
likelihood NN O
of IN O
dependence NN O
on IN O
ventilators NNS O
, , O
atelectasis NN O
, , O
and CC O
pneumonia NN O
. . O

-DOCSTART- X X O

Commun NNP O
. . O

-DOCSTART- X X O

The DT O
statistical JJ O
analysis NN O
of IN O
data NNS O
of IN O
TRH NNP B-NP
test NN O
on IN O
a DT O
sample NN O
of IN O
57 CD O
healthy JJ O
volunteers NNS O
has VBZ O
permitted VBN O
an DT O
evaluation NN O
of IN O
the DT O
upper JJ O
limits NNS O
of IN O
the DT O
normal JJ O
thyrotropin NN B-NP
response NN O
; : O
the DT O
secretory NN O
area NN O
( -LRB- O
As IN O
) -RRB- O
was VBD O
shown VBN O
to TO O
be VB O
more JJR O
discriminating NN O
. . O

-DOCSTART- X X O

Total NNP O
cumulative JJ O
doses NNS O
of IN O
doxorubicin NN O
ranged VBD O
from IN O
145 CD O
to TO O
625 CD O
mg NN O
./m.2 CD O
. . O

-DOCSTART- X X O

Movement NNP O
programming NN O
depends VBZ O
on IN O
understanding NN O
of IN O
behavioral JJ O
requirements NNS O
. . O

-DOCSTART- X X O

Transitory NNP O
subclinical JJ O
and CC O
permanent JJ O
hypothyroidism NN O
in IN O
the DT O
course NN O
of IN O
subacute JJ O
thyroiditis NN O
( -LRB- O
de FW O
Quervain NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Gonadotropin VBG B-NP
levels NNS O
in IN O
mothers NNS O
who WP O
have VBP O
had VBN O
two CD O
sets NNS O
of IN O
DZ NNP O
twins NNS O
. . O

-DOCSTART- X X O

Freezing NNP O
of IN O
plasma NN O
to TO O
obtain VB O
better JJR O
yield NN O
of IN O
factor NN B-NP
VIII:C. . I-NP

-DOCSTART- X X O

These DT O
children NNS O
were VBD O
grouped VBN O
into IN O
four CD O
diagnostic JJ O
categories NNS O
: : O
1 CD O
) -RRB- O
idiopathic JJ O
GH NNP B-NP
deficiency NN O
( -LRB- O
n NN O
= SYM O
10 CD O
) -RRB- O
; : O
2 CD O
) -RRB- O
organic JJ O
hypopituitarism NN O
( -LRB- O
n NN O
= SYM O
7 CD O
) -RRB- O
; : O
3 CD O
) -RRB- O
intrauterine NN O
growth NN O
retardation NN O
( -LRB- O
n RB O
= SYM O
5 CD O
) -RRB- O
; : O
and CC O
4 CD O
) -RRB- O
constitutional JJ O
delay NN O
of IN O
growth NN O
and/or CC O
familial JJ O
short JJ O
stature NN O
( -LRB- O
n NN O
= SYM O
18 CD O
) -RRB- O
, , O
by IN O
standard JJ O
clinical JJ O
criteria NNS O
and CC O
physiological JJ O
and CC O
pharmacological JJ O
tests NNS O
of IN O
GH NNP B-NP
reserve NN O
. . O

-DOCSTART- X X O

Each DT O
patient NN O
had VBD O
measurable JJ O
LH NNP B-NP
and CC O
FSH NNP B-NP
levels NNS O
, , O
with IN O
pulsed VBN O
nocturnal JJ O
secretion NN O
, , O
and CC O
pubertal JJ O
LH NNP B-NP
and CC O
FSH NNP B-NP
responses NNS O
to TO O
LRH. NNP B-NP

-DOCSTART- X X O

Cimetidine NNP O
800 CD O
mg NN O
given VBN O
at IN O
night NN O
is VBZ O
as RB O
effective JJ O
as IN O
400 CD O
mg NN O
twice RB O
daily RB O
; : O
the DT O
single JJ O
dose NN O
regimen NNS O
may MD O
improve VB O
patient NN O
compliance NN O
, , O
thus RB O
facilitating VBG O
treatment NN O
. . O

-DOCSTART- X X O

Ceftazidime NN O
shows VBZ O
promise NN O
as IN O
single-agent JJ O
therapy NN O
for IN O
serious JJ O
gram-negative JJ O
bacillary NN O
infections NNS O
. . O

-DOCSTART- X X O

The DT O
management NN O
of IN O
the DT O
" `` O
chronic JJ O
" '' O
patient NN O
. . O

-DOCSTART- X X O

Study NNP O
of IN O
bacterial JJ O
motility NN O
and CC O
rate NN O
of IN O
movement NN O
using VBG O
a DT O
closed JJ O
circuit NN O
television NN O

-DOCSTART- X X O

Each DT O
causative NN O
organism NN O
has VBZ O
a DT O
species-specific JJ O
preference NN O
and CC O
requirement NN O
for IN O
temperature NN O
, , O
salinity NN O
, , O
pH RB O
, , O
the DT O
basic JJ O
nutrients NNS O
, , O
and CC O
growth NN O
factors NNS O
, , O
and CC O
the DT O
toxin NN O
formation NN O
is VBZ O
affected VBN O
by IN O
these DT O
environmental JJ O
factors NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
concluded VBN O
that IN O
axillo-axillary NN O
by-pass NN O
is VBZ O
a DT O
simple JJ O
solution NN O
for IN O
a DT O
complex JJ O
haemodynamic JJ O
, , O
clinical JJ O
and CC O
therapeutic JJ O
problem NN O
. . O

-DOCSTART- X X O

Deformities NNS O
of IN O
the DT O
tip NN O
of IN O
the DT O
olecranon JJ O
and CC O
of IN O
the DT O
coronoid JJ O
process NN O
are VBP O
also RB O
described VBN O
( -LRB- O
De FW O
Palma NNP O
1956 CD O
, , O
Jordan NNP O
1958 CD O
, , O
Ahlberg NNP O
1965 CD O
, , O
Weseloh JJ O
1973 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Statokinesimetric NNP O
recording NN O
in IN O
Huntington NNP O
choreas NNS O

-DOCSTART- X X O

In IN O
doses NNS O
of IN O
0.03-0.3 CD O
mg/kg NN O
i IN O
.v. NNP O
, , O
SG-75 . O
did VBD O
not RB O
significantly RB O
affect VB O
pulse NN O
pressure NN O
, , O
heart NN O
rate NN O
, , O
aortic JJ O
blood NN O
flow NN O
, , O
left VBD O
ventricular JJ O
pressure NN O
( -LRB- O
LVP NNP O
) -RRB- O
and CC O
LVdP/dt NNP O
max NN O
. . O

-DOCSTART- X X O

Resting VBG O
VE CD O
in IN O
the DT O
luteal JJ O
phase NN O
was VBD O
7.8 CD O
% NN O
greater JJR O
than IN O
that DT O
in IN O
the DT O
follicular JJ O
phase NN O
. . O

-DOCSTART- X X O

Endothelium NN O
of IN O
the DT O
central JJ O
ear NN O
artery NN O
of IN O
an DT O
anesthetized JJ O
rabbit NN O
is VBZ O
damaged VBN O
by IN O
placing VBG O
artery NN O
forceps NNS O
on IN O
the DT O
ear NN O
directly RB O
over IN O
the DT O
vessel NN O
. . O

-DOCSTART- X X O

Despite IN O
supraphysiologic NN O
E2 NN O
concentrations NNS O
, , O
however RB O
, , O
cervical JJ O
mucus NN O
scores NNS O
were VBD O
significantly RB O
reduced VBN O
in IN O
the DT O
CC-treated JJ O
group NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Significant JJ O
clinical JJ O
differences NNS O
between IN O
the DT O
patients NNS O
treated VBD O
with IN O
and CC O
without IN O
AMB NNP O
were VBD O
longer RB O
survival NN O
time NN O
following VBG O
diagnosis NN O
of IN O
illness NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.05 CD O
) -RRB- O
and CC O
more RBR O
frequent JJ O
cranial JJ O
nerve NN O
signs NNS O
in IN O
the DT O
treated VBN O
patients NNS O
( -LRB- O
P NNP O
= SYM O
0.089 CD O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
pharmacokinetic JJ O
study NN O
of IN O
apalcillin NN O
was VBD O
performed VBN O
in IN O
12 CD O
patients NNS O
in IN O
an DT O
intensive-care JJ O
unit NN O
. . O

-DOCSTART- X X O

Catch-up JJ O
growth NN O
was VBD O
observed VBN O
only RB O
for IN O
a DT O
12-month JJ O
period NN O
in IN O
4 CD O
children NNS O
with IN O
a DT O
bone NN O
age NN O
of IN O
7 CD O
to TO O
8 CD O
years NNS O
. . O

-DOCSTART- X X O

Thrombocyte NNP O
function NN O
was VBD O
impaired VBN O
in IN O
all DT O
patients NNS O
, , O
characterized VBN O
by IN O
a DT O
diminished JJ O
platelet NN O
shape NN O
change NN O
. . O

-DOCSTART- X X O

The DT O
findings NNS O
demonstrate VBP O
that IN O
AMPH NNP O
administration NN O
induces VBZ O
a DT O
significant JJ O
increase NN O
in IN O
the DT O
height NN O
of IN O
a DT O
major JJ O
electroactive JJ O
peak NN O
in IN O
the DT O
caudate NN O
nucleus NN O
of IN O
pigtail NN O
monkeys NNS O
, , O
and CC O
further JJ O
that IN O
such JJ O
amphetamine-induced JJ O
increases NNS O
can MD O
be VB O
manipulated VBN O
by IN O
altering VBG O
the DT O
affective JJ O
and/or CC O
emotional JJ O
state NN O
of IN O
the DT O
animal NN O
. . O

-DOCSTART- X X O

In IN O
two CD O
experiments NNS O
, , O
neonatal JJ O
female NN O
BALB/cCrgl NNP O
or CC O
BALB/cfC3HCrgl NNP O
mice NNS O
were VBD O
given VBN O
subcutaneous JJ O
injections NNS O
of IN O
5 CD O
micrograms NNS O
17 CD O
beta-estradiol JJ O
or CC O
sesame JJ O
oil NN O
for IN O
the DT O
first JJ O
3 CD O
days NNS O
of IN O
life NN O
and CC O
were VBD O
ovariectomized VBN O
at IN O
60 CD O
days NNS O
of IN O
age NN O
, , O
at IN O
which WDT O
time NN O
vaginal JJ O
concretions NNS O
( -LRB- O
Experiments NNS O
I PRP O
and CC O
II NNP O
) -RRB- O
or CC O
silica NN O
( -LRB- O
Experiment NN O
II NNP O
) -RRB- O
were VBD O
implanted VBN O
intravaginally RB O
. . O

-DOCSTART- X X O

For IN O
228 CD O
of IN O
425 CD O
deaths NNS O
( -LRB- O
54 CD O
% NN O
) -RRB- O
occurring VBG O
among IN O
26 CD O
100 CD O
people NNS O
of IN O
known VBN O
age NN O
in IN O
the DT O
Malumfashi NNP O
area NN O
of IN O
northern JJ O
Nigeria NNP O
, , O
data NNS O
were VBD O
collected VBN O
on IN O
symptoms NNS O
present JJ O
prior RB O
to TO O
death NN O
. . O

-DOCSTART- X X O

Other JJ O
than IN O
d JJ O
7 CD O
, , O
there EX O
was VBD O
no DT O
significant JJ O
effect NN O
on IN O
the DT O
number NN O
of IN O
implants NNS O
. . O

-DOCSTART- X X O

The DT O
results NNS O
imply VBP O
that IN O
kindling NN O
does VBZ O
not RB O
produce VB O
its PRP$ O
facilitating JJ O
effect NN O
on IN O
acquisition NN O
of IN O
HPC NNP O
SS NNP O
by IN O
removing VBG O
a DT O
disruptive JJ O
effect NN O
of IN O
the DT O
stimulation NN O
. . O

-DOCSTART- X X O

The DT O
persistent JJ O
fetal NN O
dispersion NN O
of IN O
nodal JJ O
and CC O
Hiss JJ O
bundle NN O
fragments NNS O
within IN O
the DT O
ventricular JJ O
septum NN O
is VBZ O
proposed VBN O
as IN O
a DT O
possible JJ O
explanation NN O
. . O

-DOCSTART- X X O

SFP NNP O
was VBD O
significantly RB O
elevated VBN O
in IN O
Hn NN O
( -LRB- O
s PRP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
average NN O
birth NN O
mass NN O
of IN O
these DT O
newborns NNS O
was VBD O
3491.9 CD O
+/ CD O
- : O
2 CD O
SD NNP O
780.5 CD O
g NN O
and CC O
that IN O
in IN O
the DT O
control NN O
group NN O
3,767.5 CD O
+/ NNS O
- : O
2 CD O
SD NNP O
824.2 CD O
g NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

By IN O
contrast NN O
, , O
kidneys NNS O
from IN O
rats NNS O
with IN O
chronic JJ O
metabolic JJ O
acidosis NN O
produced VBN O
significantly RB O
more RBR O
NH3 JJ O
than IN O
both DT O
these DT O
groups NNS O
( -LRB- O
2.73 CD O
+/ NN O
- : O
0.29 CD O
mumol NN O
X NNP O
min-1 CD O
X NNP O
g-1 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Serodiagnosis NN O
of IN O
trypanosomiasis NN O
in IN O
dromedary JJ O
camels NNS O
using VBG O
a DT O
card NN O
agglutination NN O
test NN O
set VBN O
( -LRB- O
Testryp JJ O
CATT NN O
) -RRB- O
. . O

-DOCSTART- X X O

Proteinuria--selected JJ O
physiopathological JJ O
and CC O
clinical JJ O
problems NNS O

-DOCSTART- X X O

However RB O
, , O
subcutaneously RB O
administered VBN O
pneumococci NNS O
gave VBD O
a DT O
lower JJR O
mortality NN O
than IN O
pneumococci NNS O
given VBN O
intravenously RB O
or CC O
intraperitoneally RB O
. . O

-DOCSTART- X X O

Scientific NNP O
cooperation NN O
of IN O
CMEA NNP O
member NN O
countries NNS O
has VBZ O
been VBN O
carried VBN O
out RP O
since IN O
1974 CD O
under IN O
the DT O
sponsorship NN O
of IN O
the DT O
Cancer NNP O
Research NNP O
Institute NNP O
, , O
Slovak NNP O
Academy NNP O
of IN O
Sciences NNPS O
( -LRB- O
Czechoslovakia NNP O
) -RRB- O
within IN O
the DT O
framework NN O
of IN O
CMEA. NNP O

-DOCSTART- X X O

A DT O
new JJ O
variant NN O
of IN O
the DT O
EMG-BFB NN O
method NN O
( -LRB- O
multichannel NN O
) -RRB- O
is VBZ O
offered VBN O
which WDT O
has VBZ O
made VBN O
it PRP O
possible JJ O
to TO O
use VB O
the DT O
method NN O
not RB O
only RB O
for IN O
training NN O
weakened JJ O
muscles NNS O
and CC O
reducing VBG O
spasticity NN O
in IN O
their PRP$ O
antagonists NNS O
but CC O
also RB O
for IN O
improving VBG O
motor NN O
coordination NN O
. . O

-DOCSTART- X X O

Lymphocytes NNS O
from IN O
all DT O
3 CD O
species NNS O
yielded VBN O
maximum JJ O
responses NNS O
with IN O
a DT O
48-hour JJ O
prelabel NN O
and CC O
12- RB O
to TO O
- : O
16 CD O
hour NN O
postlabel NN O
incubation NN O
period NN O
at IN O
41 CD O
C NNP O
and CC O
1:20 CD O
blood NN O
dilution NN O
. . O

-DOCSTART- X X O

Removal NNP O
of IN O
lipid JJ O
fractions NNS O
of IN O
plant NN O
extractions NNS O
with IN O
hexane NN O
is VBZ O
recommended VBN O
to TO O
avoid VB O
damage NN O
to TO O
the DT O
HPLC NNP O
column NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
Arithmetic JJ O
subtest NN O
one CD O
of IN O
the DT O
items NNS O
would MD O
not RB O
meet VB O
the DT O
difficulty NN O
grading VBG O
shown VBN O
while IN O
the DT O
last JJ O
two CD O
items NNS O
offer VBP O
very RB O
little JJ O
possibility NN O
of IN O
success NN O
for IN O
all DT O
subjects NNS O
.(ABSTRACT VBP O
TRUNCATED JJ O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

The DT O
toxicological JJ O
evaluation NN O
of IN O
chlorofluorocarbon NN O
22 CD O
( -LRB- O
CFC NNP O
22 CD O
) -RRB- O
. . O

-DOCSTART- X X O

All DT O
patients NNS O
were VBD O
evaluable JJ O
for IN O
toxicity NN O
and CC O
9 CD O
for IN O
response NN O
. . O

-DOCSTART- X X O

Methods NNS O
of IN O
clinical JJ O
and CC O
experimental JJ O
algesimetry NN O
are VBP O
described VBN O
that DT O
have VBP O
been VBN O
used VBN O
to TO O
evaluate VB O
effects NNS O
of IN O
peripherally RB O
and CC O
centrally RB O
acting VBG O
analgesics NNS O
. . O

-DOCSTART- X X O

The DT O
present JJ O
paper NN O
elucidates VBZ O
the DT O
existing VBG O
discrepancies NNS O
, , O
and CC O
offers VBZ O
a DT O
consistent JJ O
terminology NN O
incorporating NN O
also RB O
such JJ O
terms NNS O
as IN O
"additivity" NNP O
, , O
"potentiation" NNP O
, , O
and CC O
" `` O
simple JJ O
similarity" JJ O
. . O

-DOCSTART- X X O

We PRP O
propose VBP O
that IN O
the DT O
ambiguous JJ O
discrimination NN O
required VBD O
a DT O
greater JJR O
time NN O
for IN O
simulus JJ O
evaluation NN O
and CC O
that IN O
this DT O
was VBD O
reflected VBN O
in IN O
the DT O
delayed VBN O
P3 JJ O
latencies NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
respect NN O
C NNP B-NP
reactive JJ I-NP
protein NN I-NP
concentrations NNS O
are VBP O
superior JJ O
to TO O
white JJ O
cell NN O
count NN O
, , O
erythrocyte JJ O
sedimentation NN O
rate NN O
, , O
and CC O
temperature NN O
and CC O
the DT O
concentrations NNS O
of IN O
antiproteases NNS O
. . O

-DOCSTART- X X O

Human JJ B-NP
thyroid NN I-NP
stimulator NN I-NP
( -LRB- O
HTS NNS B-NP
) -RRB- O
in IN O
thyroid NN O
diseases NNS O

-DOCSTART- X X O

Brainstem NN O
auditory NN O
evoked JJ O
responses NNS O
( -LRB- O
BAERs NNS O
) -RRB- O
and CC O
quantitative JJ O
saccadic JJ O
eye NN O
movement NN O
studies NNS O
provide VBP O
information NN O
on IN O
the DT O
integrity NN O
of IN O
pathways NNS O
traversing VBG O
the DT O
brainstem NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
ketamine NN O
on IN O
the DT O
circulatory JJ O
functions NNS O
and CC O
body NN O
tissue NN O
oxygenation NN O
in IN O
dogs NNS O
under IN O
normal JJ O
and CC O
hypovolemic JJ O
conditions NNS O
. . O

-DOCSTART- X X O

The DT O
salient JJ O
clinical JJ O
features NNS O
, , O
the DT O
problems NNS O
of IN O
management NN O
and CC O
the DT O
modern JJ O
approaches NNS O
to TO O
the DT O
reconstruction NN O
of IN O
facial JJ O
deformities NNS O
seen VBN O
in IN O
this DT O
disease NN O
are VBP O
described VBN O
. . O

-DOCSTART- X X O

Besides IN O
, , O
it PRP O
was VBD O
considered VBN O
that IN O
the DT O
NPF NNP O
was VBD O
a DT O
useful JJ O
tool NN O
for IN O
activation NN O
of IN O
velopharyngeal NN O
activity NN O
by IN O
way NN O
of IN O
visual JJ O
feed-back NN O
control NN O
. . O

-DOCSTART- X X O

In IN O
a DT O
man NN O
with IN O
myelomonocytic JJ O
leukemia NN O
, , O
the DT O
association NN O
of IN O
increased VBN O
prostatic JJ B-NP
acid NN I-NP
phosphatase NN I-NP
activity NN O
in IN O
serum NN O
and CC O
the DT O
presence NN O
of IN O
typical JJ O
bone NN O
lesions NNS O
on IN O
roentgenography NN O
suggested VBD O
the DT O
existence NN O
of IN O
disseminated VBN O
prostatic JJ O
carcinoma NN O
. . O

-DOCSTART- X X O

No DT O
anisotropism NN O
was VBD O
recorded VBN O
in IN O
a DT O
tetrahydrofuran JJ O
solution NN O
. . O

-DOCSTART- X X O

As IN O
pleural JJ O
thickening NN O
is VBZ O
seen VBN O
commonly RB O
in IN O
asbestosis NN O
and CC O
may MD O
influence VB O
lung NN O
volumes NNS O
and CC O
the DT O
ratio NN O
of IN O
transfer NN B-NP
factor NN I-NP
to TO O
effective JJ O
alveolar JJ O
volume NN O
, , O
the DT O
results NNS O
of IN O
these DT O
measurements NNS O
were VBD O
compared VBN O
only RB O
in IN O
the DT O
cases NNS O
showing VBG O
absent JJ O
or CC O
minimal JJ O
pleural JJ O
thickening NN O
. . O

-DOCSTART- X X O

The DT O
invasive JJ O
pattern NN O
of IN O
squamous JJ O
cell NN O
carcinoma NN O
in IN O
the DT O
mandibular JJ O
gingiva NN O

-DOCSTART- X X O

Azygos NNS O
vein NN O
abutting VBG O
the DT O
posterior JJ O
wall NN O
of IN O
the DT O
right JJ O
main JJ O
and CC O
upper JJ O
lobe NN O
bronchi NN O
: : O
a DT O
normal JJ O
CT NN O
variant NN O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
history NN O
of IN O
acute JJ O
severe JJ O
complications NNS O
from IN O
otitis NN O
media NNS O
revealed VBD O
a DT O
higher JJR O
frequency NN O
in IN O
those DT O
individuals NNS O
with IN O
alpha NN B-NP
1-antitrypsin JJ I-NP
deficiency NN O
as IN O
compared VBN O
to TO O
normals NNS O
. . O

-DOCSTART- X X O

The DT O
Sarns NNP O
51F IN O
cavoatrial JJ O
cannula NNS O
decompressed VBD O
the DT O
venous JJ O
system NN O
as IN O
efficiently RB O
as IN O
the DT O
double JJ O
caval NN O
cannulas NNS O
. . O

-DOCSTART- X X O

All DT O
other JJ O
changes NNS O
at IN O
the DT O
3-, JJ O
5-, JJ O
and CC O
6-positions NNS O
, , O
as RB O
well RB O
as IN O
the DT O
replacement NN O
of IN O
the DT O
phenyl NN O
group NN O
at IN O
position NN O
2 CD O
, , O
caused VBD O
a DT O
marked JJ O
decrease NN O
of IN O
activity NN O
. . O

-DOCSTART- X X O

Three CD O
experiments NNS O
contrasted VBD O
the DT O
effects NNS O
of IN O
6-hydroxydopamine-induced JJ O
lesions NNS O
of IN O
the DT O
ventral JJ O
noradrenergic JJ O
and CC O
dorsal JJ O
noradrenergic JJ O
projections NNS O
, , O
predominantly RB O
to TO O
hypothalamus NN O
and CC O
cortex NN O
, , O
respectively RB O
, , O
upon IN O
body NN O
weight NN O
changes NNS O
and CC O
food-related JJ O
behaviour NN O
in IN O
the DT O
rat NN O
. . O

-DOCSTART- X X O

Limb NNP O
allografts NNS O
in IN O
rats NNS O
immunosuppressed VBN O
with IN O
cyclosporin NN O
A. NN O

-DOCSTART- X X O

The DT O
method NN O
involved VBN O
deproteinizing VBG O
samples NNS O
with IN O
two CD O
volumes NNS O
of IN O
acetonitrile JJ O
followed VBN O
by IN O
injection NN O
of IN O
5 CD O
microliters NNS O
of IN O
deproteinized JJ O
supernatant NN O
onto IN O
a DT O
C18 NN O
reversed-phase NN O
column NN O
. . O

-DOCSTART- X X O

This DT O
paper NN O
brings VBZ O
together RB O
data NNS O
, , O
obtained VBN O
from IN O
a DT O
variety NN O
of IN O
sources NNS O
, , O
on IN O
the DT O
extent NN O
of IN O
prescription NN O
and CC O
use NN O
of IN O
psychotropic JJ O
drugs NNS O
in IN O
the DT O
late JJ O
1960s NNS O
and CC O
early RB O
1970s CD O
. . O

-DOCSTART- X X O

Female JJ O
Wistar NNP O
rats NNS O
were VBD O
fed VBN O
a DT O
liquid JJ O
diet NN O
, , O
Sustacal NNP O
, , O
which WDT O
contained VBD O
ethanol NN O
( -LRB- O
40 CD O
% NN O
of IN O
calories NNS O
) -RRB- O
or CC O
isocaloric JJ O
sucrose NN O
. . O

-DOCSTART- X X O

Four CD O
patients NNS O
( -LRB- O
group NN O
1 CD O
) -RRB- O
had VBD O
type NN O
I PRP O
basement NN O
membrane NN O
nephropathy NN O
, , O
characterized VBN O
by IN O
marked JJ O
thickening NN O
and CC O
lamellation NN O
of IN O
the DT O
basement NN O
membrane NN O
in IN O
a DT O
pattern NN O
resembling NN O
that IN O
of IN O
Alport NNP O
's POS O
syndrome NN O
. . O

-DOCSTART- X X O

Thin-layer NNP O
chromatographic JJ O
methods NNS O
were VBD O
up-dated JJ O
for IN O
pharmacokinetic JJ O
studies NNS O
of IN O
imipramine NN O
in IN O
plasma NN O
and CC O
urine NN O
. . O

-DOCSTART- X X O

Increasing VBG O
the DT O
cut-off JJ O
point NN O
to TO O
3 CD O
positive JJ O
responses NNS O
decreased VBD O
the DT O
sensitivity NN O
to TO O
81 CD O
% NN O
and CC O
increased VBD O
the DT O
specificity NN O
to TO O
94 CD O
% NN O
. . O

-DOCSTART- X X O

This DT O
phenomenon NN O
may MD O
be VB O
regarded VBN O
as IN O
a DT O
variant NN O
of IN O
selective JJ O
individual JJ O
cell NN O
death NN O
, , O
currently RB O
referred VBN O
to TO O
as IN O
apoptosis NN O
, , O
which WDT O
has VBZ O
not RB O
been VBN O
previously RB O
reported VBN O
in IN O
a DT O
case NN O
of IN O
embryonal JJ O
rhabdomyosarcoma NN O
. . O

-DOCSTART- X X O

Combination NNP O
of IN O
a DT O
Shwachman NNP O
syndrome NN O
and CC O
a DT O
complex JJ O
granulocyte NN O
function NN O
disorder NN O
in IN O
a DT O
girl NN O

-DOCSTART- X X O

A DT O
combined VBN O
series NN O
of IN O
patients NNS O
experienced VBD O
a DT O
TOL NN O
after IN O
two CD O
or CC O
more JJR O
previous JJ O
cesarean NN O
deliveries NNS O
; : O
the DT O
rate NN O
of IN O
vaginal JJ O
delivery NN O
was VBD O
66 CD O
% NN O
, , O
and CC O
there EX O
was VBD O
virtually RB O
no DT O
morbidity NN O
. . O

-DOCSTART- X X O

Trial NN O
3 CD O
broiler NN O
chickens NNS O
were VBD O
maintained VBN O
on IN O
control NN O
feed NN O
until IN O
they PRP O
reached VBD O
3 CD O
weeks NNS O
of IN O
age NN O
at IN O
which WDT O
time NN O
they PRP O
were VBD O
taken VBN O
off IN O
of IN O
feed NN O
for IN O
2.5 CD O
hr NN O
and CC O
then RB O
placed VBD O
on IN O
either DT O
control NN O
feed NN O
or CC O
feed NN O
containing VBG O
4.0 CD O
ppm NN O
ochratoxin NN O
A DT O
, , O
and CC O
heart NN O
rate NN O
and CC O
blood NN O
pressure NN O
were VBD O
measured VBN O
every DT O
half NN O
hour NN O
through IN O
7 CD O
hr NN O
. . O

-DOCSTART- X X O

The DT O
carcinogen NN O
bioassay NN O
therefore RB O
is VBZ O
a DT O
very RB O
important JJ O
component NN O
of IN O
the DT O
battery NN O
of IN O
toxicological JJ O
tests NNS O
used VBN O
in IN O
hazard NN O
evaluation NN O
. . O

-DOCSTART- X X O

Harmful JJ O
effects NNS O
in IN O
animals NNS O
and CC O
man NN O
may MD O
result VB O
from IN O
both DT O
deficient NN O
or CC O
excessive JJ O
amounts NNS O
of IN O
intake NN O
. . O

-DOCSTART- X X O

The DT O
analysis NN O
of IN O
the DT O
structure NN O
of IN O
the DT O
sleep NN O
period NN O
as IN O
a DT O
whole NN O
reveals VBZ O
that IN O
with IN O
increasing VBG O
of IN O
the DT O
age NN O
the DT O
delta-wave NN O
stage NN O
( -LRB- O
DS NNPS O
) -RRB- O
of IN O
the DT O
QS NNS O
( -LRB- O
determined VBN O
by IN O
defined VBN O
polygraphic JJ O
parameters NNS O
) -RRB- O
increases NNS O
, , O
while IN O
the DT O
paradoxical JJ O
phase NN O
of IN O
sleep NN O
( -LRB- O
PS) NNP O
decreases VBZ O
, , O
this DT O
change NN O
being VBG O
more RBR O
pronounced VBN O
during IN O
the DT O
first JJ O
six CD O
months NNS O
than IN O
during IN O
the DT O
second JJ O
ones NNS O
of IN O
the DT O
first JJ O
year NN O
of IN O
the DT O
life NN O
. . O

-DOCSTART- X X O

While IN O
these DT O
findings NNS O
may MD O
reflect VB O
the DT O
sensitivity NN O
of IN O
a DT O
thick JJ O
myocardial JJ O
wall NN O
to TO O
ischaemia NN O
during IN O
surgery NN O
, , O
the DT O
postoperative JJ O
recovery NN O
was VBD O
not RB O
related VBN O
to TO O
the DT O
serum NN B-NP
CK-MB NN I-NP
level NN O
. . O

-DOCSTART- X X O

Morphofunctional JJ O
status NN O
of IN O
the DT O
formed JJ O
elements NNS O
of IN O
the DT O
blood NN O
in IN O
rats NNS O
subjected VBN O
to TO O
different JJ O
variants NNS O
of IN O
combined VBN O
and CC O
isolated VBN O
exposure NN O
to TO O
BR-1 NN O
benzene NN O

-DOCSTART- X X O

Using VBG O
a DT O
MOS-Hypersil NNP O
reversed-phase NN O
column NN O
with IN O
a DT O
phosphate JJ O
buffer--acetonitrile JJ O
mobile JJ O
phase NN O
, , O
baseline JJ O
separation NN O
of IN O
antipyrine NN O
, , O
its PRP$ O
metabolites NNS O
3-hydroxymethylantipyrine JJ O
, , O
norantipyrine JJ O
and CC O
4-hydroxyantipyrine JJ O
, , O
and CC O
the DT O
internal JJ O
standard NN O
, , O
phenacetin NN O
, , O
was VBD O
achieved VBN O
within IN O
6 CD O
min NN O
. . O

-DOCSTART- X X O

The DT O
liver NN O
in IN O
the DT O
severely RB O
ill JJ O

-DOCSTART- X X O

In IN O
a DT O
randomized JJ O
study NN O
on IN O
150 CD O
patients NNS O
( -LRB- O
ASA NNP O
1 CD O
) -RRB- O
undergoing VBG O
induction NN O
of IN O
anaesthesia NN O
, , O
the DT O
effects NNS O
of IN O
Fentanyl NNP O
( -LRB- O
0.1 CD O
mg NN O
) -RRB- O
, , O
the DT O
combination NN O
of IN O
Fentanyl NNP O
( -LRB- O
0.1 CD O
mg NN O
) -RRB- O
and CC O
Droperidol NNP O
( -LRB- O
5 CD O
mg NN O
) -RRB- O
( -LRB- O
Innovar NNP O
, , O
Thalamonal NNP O
) -RRB- O
and CC O
Atropine NNP O
( -LRB- O
0.01 CD O
mg/kg NN O
b.w NN O
. . O
) -RRB- O
alone RB O
on IN O
cardiocirculatory JJ O
parameters NNS O
were VBD O
studied VBN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
confirming VBG O
the DT O
high JJ O
validity NN O
of IN O
NOM NNP O
inhibiting VBG O
test NN O
in IN O
the DT O
diagnosis NN O
of IN O
tumoural JJ O
hyperprolactinemic JJ O
states NNS O
, , O
reveal VBP O
contradictory JJ O
responses NNS O
to TO O
CD/LD NNP O
, , O
LD NNP O
and CC O
DOM NNP O
, , O
with IN O
sustain VB O
the DT O
existence NN O
of IN O
2 CD O
sub-group NN O
of IN O
Prolactinomas NNP O
: : O
with IN O
or CC O
without IN O
a DT O
maintained VBN O
DA NNP O
central JJ O
tonus NN O
supporting VBG O
the DT O
possibility NN O
of IN O
different JJ O
etiopathogenetical JJ O
factors NNS O
in IN O
inducing VBG O
a DT O
tumoural JJ O
hyperprolactinemic JJ O
states NNS O
. . O

-DOCSTART- X X O

Amikacin NNP O
concentrations NNS O
in IN O
serum NN O
and CC O
blister NN O
fluid NN O
in IN O
healthy JJ O
volunteers NNS O
and CC O
in IN O
patients NNS O
with IN O
renal JJ O
impairment NN O
. . O

-DOCSTART- X X O

The DT O
subgroup NN O
innervating VBG O
the DT O
medial JJ O
rectus NN O
lies VBZ O
exclusively RB O
along IN O
the DT O
medial JJ O
face NN O
of IN O
the DT O
oculomotor NN O
nucleus NN O
, , O
with IN O
no DT O
aberrant JJ O
neurons NNS O
in IN O
the DT O
medial JJ O
longitudinal JJ O
fasciculus NN O
, , O
as RB O
have VBP O
been VBN O
found VBN O
in IN O
other JJ O
mammals NNS O
. . O

-DOCSTART- X X O

Hepatitis NNP O
B NNP O
vaccination NN O
strategy NN O
for IN O
health-care NN O
workers NNS O
in IN O
a DT O
country NN O
of IN O
intermediate JJ O
hepatitis NN O
B NNP O
endemicity NN O
. . O

-DOCSTART- X X O

An DT O
intravenous JJ O
drip NN O
infusion NN O
of IN O
AMK NNP O
in IN O
adequate JJ O
dosage NN O
would MD O
be VB O
beneficial JJ O
to TO O
use VB O
against IN O
some DT O
infectious JJ O
diseases NNS O
of IN O
otorhinolaryngologic NNP O
field NN O
. . O

-DOCSTART- X X O

The DT O
authors NNS O
have VBP O
tested VBN O
the DT O
interference NN O
of IN O
the DT O
hemoglobin NN B-NP
by IN O
two CD O
routine JJ O
methods NNS O
( -LRB- O
Berthelot NNP O
classic NN O
and CC O
Berthelot NNP O
modified VBN O
) -RRB- O
for IN O
the DT O
determination NN O
of IN O
plasmatic JJ O
urea NN O
. . O

-DOCSTART- X X O

Parkinsonian JJ O
patients NNS O
had VBD O
a DT O
significantly RB O
lower JJR O
prevalence NN O
of IN O
alcohol NN O
use NN O
. . O

-DOCSTART- X X O

These DT O
cells NNS O
averaged VBD O
17 CD O
microns NNS O
in IN O
diameter NN O
and CC O
reproduced VBN O
by IN O
fission NN O
, , O
forming VBG O
clusters NNS O
of IN O
two CD O
or CC O
four CD O
daughter NN O
cells NNS O
. . O

-DOCSTART- X X O

Female JJ O
but CC O
not RB O
male JJ O
mortalities NNS O
were VBD O
significantly RB O
higher JJR O
for IN O
cake-fed JJ O
rats NNS O
than IN O
for IN O
those DT O
fed VBN O
diet NN O
41B. . O

-DOCSTART- X X O

The DT O
associations NNS O
between IN O
sex-hormone-binding JJ B-NP
globulin NN I-NP
capacity NN O
( -LRB- O
SHBG) NNP B-NP
, , O
age NN O
, , O
body NN O
mass NN O
index NN O
( -LRB- O
BMI NNP O
) -RRB- O
, , O
and CC O
physical JJ O
fitness NN O
have VBP O
been VBN O
studied VBN O
in IN O
34 CD O
men NNS O
and CC O
36 CD O
women NNS O
. . O

-DOCSTART- X X O

After IN O
1.5 CD O
years NNS O
of IN O
such JJ O
photoperiodic JJ O
control NN O
, , O
all DT O
ewes NNS O
were VBD O
blinded VBN O
by IN O
bilateral JJ O
orbital NN O
enucleation NN O
. . O

-DOCSTART- X X O

The DT O
concentrations NNS O
of IN O
C4 NNP B-NP
and CC O
C1-INH NNP B-NP
increased VBD O
with IN O
advancing VBG O
stage NN O
of IN O
disease NN O
and CC O
were VBD O
above RB O
normal JJ O
mean NN O
values NNS O
in IN O
all DT O
stages NNS O
. . O

-DOCSTART- X X O

Less RBR O
antibacterial JJ O
activity NN O
was VBD O
shown VBN O
toward IN O
the DT O
Gram-negative NNP O
bacilli NNS O
, , O
i IN O
.e NN O
. . O
, , O
Pseudomonas NNP O
, , O
Klebsiella-Enterobacter NNP O
, , O
Shigella NNP O
, , O
Escherichia NNP O
coli NNS O
, , O
Serratia NNP O
marcescens NNS O
and CC O
Proteus NNP O
. . O

-DOCSTART- X X O

The DT O
mucosal NN O
defence NN O
capacity NN O
against IN O
proteolytic JJ O
leukocyte NN O
enzymes NNS O
. . O

-DOCSTART- X X O

The DT O
apparatus NN O
consists VBZ O
of IN O
an DT O
Am-241 JJ O
exciting JJ O
source( NNS O
300 CD O
mCi NN O
) -RRB- O
and CC O
pure JJ O
Ge NNP O
detector(50 NN O
mm2 VBD O
X NNP O
5 CD O
mm CD O
) -RRB- O
for IN O
measuring VBG O
K NNP O
alpha NN O
fluorescent VBD O
x-rays( JJ O
28.3 CD O
and CC O
28.6 CD O
KeV NNP O
) -RRB- O
emitted VBN O
from IN O
exited JJ O
iodine NN O
. . O

-DOCSTART- X X O

Ultrastructural JJ O
studies NNS O
of IN O
retinopathy NN O
of IN O
premature JJ O
infants NNS O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
antithrombotic JJ O
drugs NNS O
in IN O
patients NNS O
with IN O
left JJ O
ventricular JJ O
thrombi NN O
: : O
assessment NN O
with IN O
indium-111 JJ O
platelet NN O
imaging NN O
and CC O
two-dimensional JJ O
echocardiography NN O
. . O

-DOCSTART- X X O

The DT O
Prolactin NNP B-NP
levels NNS O
were VBD O
within IN O
the DT O
physiological JJ O
norms NNS O
; : O
the DT O
responses NNS O
to TO O
TRH NNP B-NP
were VBD O
normal JJ O
, , O
and CC O
elevated VBD O
only RB O
in IN O
a DT O
few JJ O
cases NNS O
. . O

-DOCSTART- X X O

Private JJ O
hospital NN O
accreditation NN O
. . O

-DOCSTART- X X O

Antithrombin NNP B-NP
III NNP I-NP
in IN O
hip NN O
surgery NN O

-DOCSTART- X X O

In IN O
14 CD O
of IN O
21 CD O
infant NN O
hearts NNS O
( -LRB- O
66 CD O
% NN O
) -RRB- O
with IN O
aortic JJ O
arch NN O
interruption NN O
between IN O
the DT O
left JJ O
common JJ O
carotid NN O
and CC O
left VBD O
subclavian NN O
arteries NNS O
( -LRB- O
type NN O
B NNP O
of IN O
Celoria NNP O
and CC O
Patton NNP O
) -RRB- O
, , O
the DT O
right JJ O
subclavian NN O
artery NN O
( -LRB- O
SA NNP O
) -RRB- O
arose VBD O
anomalously RB O
. . O

-DOCSTART- X X O

Absorption NN O
was VBD O
rapid JJ O
, , O
with IN O
a DT O
mean JJ O
time NN O
to TO O
peak VB O
of IN O
39 CD O
min NN O
. . O

-DOCSTART- X X O

Within IN O
the DT O
compartment NN O
or CC O
dimension NN O
of IN O
severity NN O
of IN O
depression NN O
a DT O
subscale NN O
of IN O
the DT O
Hamilton NNP O
Depression NNP O
Scale NNP O
( -LRB- O
or CC O
the DT O
Melancholia NNP O
Scale NNP O
) -RRB- O
was VBD O
shown VBN O
to TO O
have VB O
reached VBN O
an DT O
instrumental JJ O
perfection NN O
, , O
e.g RB O
. . O
as IN O
an DT O
outcome NN O
measure NN O
of IN O
antidepressant JJ O
treatment NN O
. . O

-DOCSTART- X X O

Significant NNP O
immunoglobulinuria NNS O
developed VBD O
prior RB O
to TO O
the DT O
development NN O
of IN O
azotemia NN O
, , O
significantly RB O
decreased VBD O
creatinine CD O
clearance NN O
, , O
significant JJ O
proteinuria NN O
( -LRB- O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
3+ VB O
dipstick NN O
or CC O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
5 CD O
gm NN O
per IN O
24-hour JJ O
urine NN O
collection NN O
) -RRB- O
, , O
or CC O
oliguria NNP O
. . O

-DOCSTART- X X O

A DT O
total JJ O
number NN O
of IN O
1628 CD O
cases NNS O
were VBD O
collected VBN O
from IN O
135 CD O
medical JJ O
institutions NNS O
. . O

-DOCSTART- X X O

The DT O
AD NNPS O
components NNS O
were VBD O
markedly RB O
more RBR O
dependent JJ O
on IN O
the DT O
affective JJ O
state NN O
of IN O
the DT O
rat NN O
then RB O
was VBD O
the DT O
V1 NNP O
component NN O
. . O

-DOCSTART- X X O

Monkeys NNS O
were VBD O
evaluated VBN O
before IN O
and CC O
after IN O
unilateral JJ O
and CC O
serial JJ O
bilateral JJ O
removal NN O
of IN O
superior JJ O
temporal JJ O
cortex NN O
. . O

-DOCSTART- X X O

All DT O
samples NNS O
exhibited VBD O
a DT O
decline NN O
in IN O
ethanol NN O
concentration NN O
, , O
with IN O
most JJS O
losses NNS O
falling VBG O
within IN O
the DT O
expected VBN O
20 CD O
to TO O
40 CD O
mg CD O
% NN O
range NN O
. . O

-DOCSTART- X X O

Plasma NNP B-NP
lactoferrin NN I-NP
and CC O
the DT O
blood NN O
count NN O
of IN O
polynuclear NN O
neutrophils NNS O

-DOCSTART- X X O

Pilot NN O
study NN O
of IN O
blood NN O
coagulation NN O
in IN O
gout NN O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
statistical JJ O
analysis NN O
consist VBP O
of IN O
the DT O
F NN O
test NN O
followed VBN O
by IN O
Snedecor NNP O
's POS O
contrast NN O
test NN O
. . O

-DOCSTART- X X O

In IN O
a DT O
recent JJ O
measles NNS O
epidemic JJ O
in IN O
El NNP O
Paso NNP O
, , O
TX NNP O
, , O
120,000 CD O
records NNS O
were VBD O
screened VBN O
using VBG O
these DT O
criteria NNS O
, , O
and CC O
as IN O
a DT O
result NN O
13,000 CD O
students NNS O
were VBD O
vaccinated VBN O
. . O

-DOCSTART- X X O

No DT O
patient NN O
with IN O
bradyarrhythmia NN O
-related JJ O
SCD NNP O
had VBD O
manifest JJ O
atrioventricular JJ O
block NN O
or CC O
bundle NN O
branch NN O
block NN O
. . O

-DOCSTART- X X O

The DT O
measurement NN O
of IN O
the DT O
areas NNS O
of IN O
fibrin NN B-NP
, , O
of IN O
tissue NN O
and CC O
fibrinolysis NN O
, , O
at IN O
the DT O
above JJ O
mentioned VBN O
times NNS O
, , O
has VBZ O
been VBN O
effected VBN O
at IN O
standard JJ O
magnification NN O
( -LRB- O
15 CD O
X NNP O
) -RRB- O
by IN O
an DT O
image NN O
analyser NN O
( -LRB- O
Videoplan NNP O
) -RRB- O
scale NN O
1:8. . O

-DOCSTART- X X O

Diclofenac NNP O
sodium-chlormezanone NN O
poisoning NN O
. . O

-DOCSTART- X X O

Postprandial NNP O
plasma NN B-NP
enteroglucagon NN I-NP
concentration NN O
after IN O
90 CD O
minutes NNS O
in IN O
untreated JJ O
patients NNS O
correlated VBD O
positively RB O
to TO O
the DT O
faecal JJ O
fat JJ O
excretion NN O
( -LRB- O
r NN O
= SYM O
0.58 CD O
, , O
p RB O
less JJR O
than IN O
0.02 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Blood NN O
pressure NN O
in IN O
children NNS O
. . O

-DOCSTART- X X O

The DT O
results NNS O
showed VBD O
that IN O
the DT O
sensitivity NN O
of IN O
the DT O
3 CD O
given VBN O
guinea NN O
pig NN O
strains NNS O
was VBD O
comparable JJ O
. . O

-DOCSTART- X X O

Twenty-one CD O
percent NN O
of IN O
these DT O
patients NNS O
had VBD O
neurologic JJ O
disease NN O
that WDT O
appeared VBD O
to TO O
be VB O
responsible JJ O
for IN O
the DT O
tinnitus NN O
. . O

-DOCSTART- X X O

The DT O
maps NNS O
of IN O
Case NN O
2 CD O
showed VBD O
that IN O
a DT O
maximum NN O
first JJ O
appeared VBD O
on IN O
the DT O
upper JJ O
right NN O
back RB O
and CC O
then RB O
moved VBD O
down IN O
the DT O
right JJ O
side NN O
of IN O
the DT O
posterior JJ O
thorax NN O
. . O

-DOCSTART- X X O

Twenty-eight NNP O
were VBD O
excluded VBN O
as IN O
gallstones NNS O
were VBD O
not RB O
proved VBN O
: : O
of IN O
the DT O
remainder NN O
, , O
21 CD O
patients NNS O
received VBD O
glucagon NNP B-NP
and CC O
22 CD O
placebo NN O
. . O

-DOCSTART- X X O

Regions NNS O
of IN O
the DT O
translated VBN O
open JJ O
reading NN O
frames NNS O
of IN O
cobA NN B-NP
and CC O
the DT O
third JJ O
intron NN O
of IN O
the DT O
cob NN B-NP
gene NN I-NP
in IN I-NP
yeast NN I-NP
show VBP O
high JJ O
amino IN O
acid NN O
homology NN O
. . O

-DOCSTART- X X O

The DT O
13,14-dihydro-15-keto-metabolites NNS O
of IN O
PGE2 NNP O
and CC O
PGF2 NNP O
alpha NN O
had VBD O
no DT O
statistically RB O
significant JJ O
antiarrhythmic JJ O
effect NN O
. . O

-DOCSTART- X X O

Nucleotide NNP O
sequence NN O
of IN O
DNA NNP O
controlling VBG O
expression NN O
of IN O
genes NNS O
for IN O
maltosaccharide NN O
utilization NN O
in IN O
Streptococcus NNP O
pneumoniae NNS O
. . O

-DOCSTART- X X O

The DT O
hypertension NN O
with IN O
elevated JJ O
PRA NNP O
, , O
however RB O
, , O
was VBD O
resistant JJ O
to TO O
the DT O
angiotensin NN B-NP
II NNP I-NP
( -LRB- O
AII NN B-NP
) -RRB- O
analog NN O
[Sar1 NNP O
, , O
Ile8 DT O
] NN O
ALL. . O

-DOCSTART- X X O

Effects NNS O
of IN O
dopamine NN O
and CC O
of IN O
a DT O
dopaminergic JJ O
blocker NN O
, , O
haloperidol NN O
, , O
on IN O
the DT O
responses NNS O
of IN O
carotid JJ O
body NN O
chemoreceptors NNS O
to TO O
hypoxia NN O
and CC O
hypercapnia NN O
were VBD O
investigated VBN O
in IN O
16 CD O
anesthetized JJ O
cats NNS O
. . O

-DOCSTART- X X O

HLA-A NNP B-NP
and CC I-NP
B NNP I-NP
phenotypes NNS O
of IN O
105 CD O
patients NNS O
suffering VBG O
from IN O
malignant JJ O
melanomas NNS O
were VBD O
determined VBN O
, , O
with IN O
special JJ O
regard NN O
for IN O
metastatic JJ O
form NN O
or CC O
relapse NN O
. . O

-DOCSTART- X X O

Trypanosoma NNP O
cruzi NN O
. . O

-DOCSTART- X X O

The DT O
subjects NNS O
of IN O
the DT O
study NN O
were VBD O
10 CD O
normal JJ O
subjects NNS O
and CC O
64 CD O
patients NNS O
with IN O
gastroduodenal JJ O
disease NN O
. . O

-DOCSTART- X X O

1 CD O
. . O

-DOCSTART- X X O

A DT O
convenient JJ O
measure NN O
of IN O
this DT O
impairment NN O
may MD O
be VB O
obtained VBN O
using VBG O
the DT O
ratio NN O
of IN O
urine NN O
volume NN O
( -LRB- O
V NNP O
) -RRB- O
divided VBN O
by IN O
lithium NN O
clearance NN O
( -LRB- O
CLi) NN O
. . O

-DOCSTART- X X O

Nitrogen JJ O
balance NN O
was VBD O
compared VBN O
, , O
and CC O
metabolic JJ O
complications NNS O
were VBD O
monitored VBN O
by IN O
evaluating VBG O
BUN NNP O
, , O
serum NN O
creatinine VB O
, , O
creatinine VB O
clearance NN O
, , O
serum NN O
CO2 NN O
, , O
SGOT NNP B-NP
, , O
SGPT NNP B-NP
, , O
serum NN B-NP
LDH NNP I-NP
, , O
and CC O
serum NN B-NP
alkaline NN I-NP
phosphatase NN I-NP
. . O

-DOCSTART- X X O

Production NN O
of IN O
C NNP B-NP
mu NN I-NP
RNAs NNS I-NP
, , O
unlike IN O
mu NN B-NP
mRNAs NNS I-NP
, , O
does VBZ O
not RB O
require VB O
recombination NN O
with IN O
the DT O
joining VBG B-NP
region NN I-NP
( -LRB- O
JH) NNP B-NP
locus NN O
. . O

-DOCSTART- X X O

The DT O
1.9-kb JJ O
C NNP B-NP
mu NN I-NP
RNA NNP O
contains VBZ O
the DT O
3' JJ O
sequence NN O
characteristic NN O
of IN O
secreted JJ O
mu NN B-NP
chain NN I-NP
, , O
whereas IN O
the DT O
longer JJR O
species NNS O
bear VBP O
that IN O
of IN O
membrane-bound NN O
mu NN B-NP
chin NN O
. . O

-DOCSTART- X X O

Transcripts NNS O
of IN O
the DT O
immunoglobulin NN B-NP
C NNP I-NP
mu NN I-NP
gene NN I-NP
vary VBP O
in IN O
structure NN O
and CC O
splicing NN O
during IN O
lymphoid JJ O
development NN O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
DNA NNP O
rearrangement NN O
and CC O
alternative JJ O
RNA NNP O
processing NN O
in IN O
the DT O
expression NN O
of IN O
immunoglobulin NN B-NP
delta NN I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

Although IN O
the DT O
mechanism NN O
of IN O
action NN O
of IN O
ICRF-159 NNP O
and CC O
187 CD O
has VBZ O
not RB O
been VBN O
clearly RB O
defined VBN O
, , O
it PRP O
is VBZ O
evident JJ O
from IN O
both DT O
preclinical JJ O
and CC O
early JJ O
clinical JJ O
studies NNS O
that IN O
these DT O
compounds NNS O
are VBP O
of IN O
interest NN O
. . O

-DOCSTART- X X O

All DT O
62 CD O
isolates NNS O
were VBD O
resistant JJ O
to TO O
lincomycin NN O
, , O
colistin NN O
, , O
nystatin NN O
, , O
amphotericin IN O
B NNP O
, , O
trimethoprim NN O
lactate NN O
, , O
polymyxin NN O
B NNP O
, , O
and CC O
anisomycin RB O
. . O

-DOCSTART- X X O

The DT O
evaluation NN O
of IN O
amniotic JJ O
fluid JJ O
delta NN O
OD450 . O
is VBZ O
considered VBN O
to TO O
be VB O
the DT O
cornerstone NN O
of IN O
clinical JJ O
management NN O
. . O

-DOCSTART- X X O

Host JJ O
lipids NNS O
in IN O
tuberculous JJ O
infection NN O
. . O

-DOCSTART- X X O

Fenfluramine NN O
( -LRB- O
in IN O
doses NNS O
ranging VBG O
from IN O
0.0625-4.0 JJ O
mg/kg/infusion NN O
) -RRB- O
did VBD O
not RB O
maintain VB O
self-administration NN O
behavior NN O
at IN O
or CC O
above IN O
the DT O
minimum NN O
requirement NN O
( -LRB- O
FR JJ O
30 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
the DT O
fatty JJ B-NP
acid NN I-NP
cyclo-oxygenase NN I-NP
inhibitor NN O
indomethacin NN O
on IN O
cerebral JJ O
blood NN O
flow NN O
( -LRB- O
CBF NN O
) -RRB- O
and CC O
the DT O
metabolic JJ O
rate NN O
for IN O
oxygen NN O
( -LRB- O
CMRO2 NN O
) -RRB- O
was VBD O
studied VBN O
in IN O
paralyzed JJ O
and CC O
artificially RB O
ventilated VBD O
rats NNS O
. . O

-DOCSTART- X X O

The DT O
rat NN O
incisor NN O
is VBZ O
an DT O
excellent JJ O
model NN O
system NN O
in IN O
which WDT O
to TO O
study VB O
amelgenesis NN O
. . O

-DOCSTART- X X O

The DT O
already RB O
elevated VBN O
prolactin NN B-NP
levels NNS O
in IN O
nursing NN O
women NNS O
were VBD O
not RB O
influenced VBN O
by IN O
chronic JJ O
oestradiol JJ O
administration NN O
. . O

-DOCSTART- X X O

Factor NNP B-NP
VIII NNP I-NP
procoagulant NN O
activity NN O
, , O
antigen JJ O
concentration NN O
and CC O
von NNP B-NP
Willebrand NNP I-NP
activity NN O
as IN O
ristocetin NN B-NP
cofactor NN I-NP
were VBD O
determined VBN O
several JJ O
times NNS O
in IN O
10 CD O
patients NNS O
with IN O
DIC. NNP O

-DOCSTART- X X O

Morphine-dependent NNP O
and CC O
control NN O
rats NNS O
in IN O
an DT O
oral JJ O
free-choice NN O
protocol NN O
were VBD O
treated VBN O
with IN O
gamma-vinyl NN O
GABA NNP O
( -LRB- O
GVG) NNP O
, , O
60 CD O
, , O
120 CD O
and CC O
240 CD O
mg/kg NN O
IP NN O
, , O
for IN O
3 CD O
days NNS O
over IN O
three CD O
successive JJ O
periods NNS O
. . O

-DOCSTART- X X O

Significance NN O
of IN O
the DT O
pulmonary JJ O
gas NN O
exchange NN O
reaction NN O
to TO O
physical JJ O
loading NN O
in IN O
evaluating VBG O
the DT O
effectiveness NN O
of IN O
mitral JJ O
commissurotomy NN O

-DOCSTART- X X O

Thyreoliberin NNP B-NP
VUFB NNP O
in IN O
thyroid DT O
gammagraphy NN O

-DOCSTART- X X O

For IN O
steers NNS O
the DT O
urinary JJ O
N NNP O
values NNS O
were VBD O
403 CD O
and CC O
295 CD O
mg/kg NN O
W0.75 CD O
at IN O
200 CD O
and CC O
350 CD O
kg JJ O
live JJ O
weight NN O
respectively RB O
and CC O
total JJ O
N NNP O
excretion NN O
including VBG O
faecal JJ O
N NNP O
was VBD O
408 CD O
and CC O
320 CD O
mg/kg JJ O
W0.75 CD O
. . O

-DOCSTART- X X O

Advances NNS O
in IN O
hemophilia NNS O
treatment NN O
: : O
a DT O
hepatitis-safe JJ O
factor NN B-NP
VIII NNP I-NP
concentrate NN O

-DOCSTART- X X O

Comparison NNP O
of IN O
three CD O
different JJ O
preparations NNS O
of IN O
disodium NN O
cromoglycate NN O
in IN O
the DT O
prevention NN O
of IN O
exercise-induced JJ O
bronchospasm NN O
: : O
a DT O
double-blind JJ O
study NN O
. . O

-DOCSTART- X X O

LCBF NN O
in IN O
normal JJ O
and CC O
hypoxic JJ O
puppies NNS O
was VBD O
correlated VBN O
with IN O
local JJ O
cerebral NN O
glucose NN O
utilization NN O
(LCGU) IN O
obtained VBN O
under IN O
the DT O
same JJ O
experimental JJ O
conditions NNS O
( -LRB- O
Duffy NNP O
et NNP O
al NN O
, , O
1982 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Detection NNP O
of IN O
hemophilia NNS O
A DT O
carriers NNS O
. . O

-DOCSTART- X X O

Bile NNP O
bilirubin NN O
did VBD O
not RB O
rise VB O
within IN O
12 CD O
h NN O
after IN O
haem NN O
infusion IN O
a DT O
finding NN O
which WDT O
warrants VBZ O
further JJ O
investigation NN O
. . O

-DOCSTART- X X O

Autoimmune NNP O
manipulation NN O
aids NNS O
juvenile JJ O
diabetes NN O
management NN O
. . O

-DOCSTART- X X O

The DT O
decrease NN O
in IN O
HDL-cholesterol NNP B-NP
with IN O
increasing VBG O
VLDL-triglycerides NNS B-NP
was VBD O
relatively RB O
much RB O
larger JJR O
than IN O
the DT O
concomitant JJ O
decrease NN O
in IN O
apo NN B-NP
A-I. . I-NP

-DOCSTART- X X O

Apo NNP B-NP
A-I NNP I-NP
level NN O
was VBD O
unrelated JJ O
to TO O
age NN O
, , O
but CC O
increased VBD O
with IN O
ethanol NN O
consumption NN O
and CC O
decreased VBD O
with IN O
adiposity NN O
. . O

-DOCSTART- X X O

TEMTU NNP O
and CC O
DPTU NNP O
were VBD O
the DT O
most RBS O
potent JJ O
teratogens NNS O
. . O

-DOCSTART- X X O

Selenium NNP O
, , O
as IN O
a DT O
constituent NN O
of IN O
glutathione NN B-NP
peroxidase NN I-NP
, , O
plays VBZ O
a DT O
role NN O
in IN O
the DT O
antioxidant JJ O
defense NN O
systems NNS O
of IN O
the DT O
body NN O
, , O
but CC O
other JJ O
metabolic JJ O
roles NNS O
for IN O
selenium NN O
may MD O
yet RB O
be VB O
discovered VBN O
. . O

-DOCSTART- X X O

Diagnostic JJ O
value NN O
of IN O
serum NN B-NP
myoglobin NN I-NP
in IN O
cases NNS O
of IN O
neuromuscular JJ O
disease NN O

-DOCSTART- X X O

During IN O
the DT O
last JJ O
6 CD O
months NNS O
of IN O
the DT O
study NN O
a DT O
striking JJ O
change NN O
in IN O
epidemiology NN O
concerning VBG O
hepatitis NN O
A DT O
was VBD O
seen VBN O
, , O
apparently RB O
caused VBN O
by IN O
a DT O
steep JJ O
increase NN O
in IN O
the DT O
incidence NN O
of IN O
this DT O
type NN O
of IN O
hepatitis NN O
among IN O
drug NN O
addicts NNS O
. . O

-DOCSTART- X X O

Asthmatic JJ O
patients NNS O
showed VBD O
greater JJR O
responses NNS O
of IN O
both DT O
parameters NNS O
to TO O
adrenaline VB O
than IN O
controls NNS O
indicating VBG O
that IN O
long-term JJ O
corticosteroid NN O
treatment NN O
enhances VBZ O
the DT O
acute JJ O
responses NNS O
of IN O
plasminogen NN B-NP
activator NN I-NP
and CC O
clotting VBG B-NP
factor NN I-NP
VIII NNP I-NP
to TO O
adrenaline VB O
infusion NN O
. . O

-DOCSTART- X X O

Sulphur NNP O
amino IN O
acids NNS O
( -LRB- O
g/16 CD O
g NN O
N NNP O
) -RRB- O
were VBD O
higher JJR O
in IN O
the DT O
isolates NNS O
than IN O
in IN O
the DT O
flours NNS O
. . O

-DOCSTART- X X O

Time NNP O
shifts VBZ O
increase NN O
growth NN B-NP
hormone NN I-NP
release NN O
. . O

-DOCSTART- X X O

Vesicles NNS O
could MD O
be VB O
induced VBN O
only RB O
with IN O
multiple JJ O
exposures NNS O
to TO O
UVA NNP O
. . O

-DOCSTART- X X O

Self-heating JJ O
after IN O
deep JJ O
hypothermia NN O
( -LRB- O
20 CD O
degrees NNS O
C NN O
) -RRB- O
causes VBZ O
a DT O
considerable JJ O
increase NN O
in IN O
the DT O
brain NN O
tissues NNS O
glutaminase JJ B-NP
activity NN O
at IN O
all DT O
studied VBN O
incubation NN O
temperatures NNS O
( -LRB- O
37 CD O
, , O
30 CD O
, , O
20 CD O
and CC O
10 CD O
degrees NNS O
C NN O
) -RRB- O
as IN O
compared VBN O
to TO O
control VB O
rats NNS O
and CC O
rats NNS O
under IN O
hypothermia NN O
. . O

-DOCSTART- X X O

According VBG O
to TO O
Sugiura NNP O
's POS O
classification NN O
, , O
they PRP O
consisted VBD O
of IN O
Type NNP O
Ia NNP O
in IN O
63 CD O
% NN O
, , O
Type NNP O
Ib NNP O
in IN O
11 CD O
% NN O
, , O
Type NNP O
II NNP O
in IN O
11 CD O
% NN O
, , O
and CC O
Type NNP O
III NNP O
in IN O
16 CD O
% NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
was VBD O
undertaken VBN O
to TO O
define VB O
the DT O
mechanism NN O
for IN O
the DT O
respiratory NN O
inhibition NN O
observed VBD O
during IN O
high-frequency NN O
oscillatory NN O
ventilation NN O
( -LRB- O
HFOV NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Determination NNP O
of IN O
20 CD O
alpha-hydroxy-9 DT O
beta,10 CD O
alpha-pregna-4,6-dien-3-one NN O
in IN O
plasma NN O
by IN O
selected VBN O
ion NN O
monitoring NN O
. . O

-DOCSTART- X X O

Because IN O
of IN O
a DT O
rapid JJ O
development NN O
of IN O
the DT O
connective JJ O
tissue NN O
scars NNS O
, , O
however RB O
, , O
at IN O
the DT O
place NN O
of IN O
the DT O
destroyed VBN O
glandular JJ O
parenchyma NN O
areas NNS O
, , O
there EX O
is VBZ O
no DT O
normalization NN O
of IN O
the DT O
organ NN O
's POS O
structure NN O
and CC O
function NN O
by IN O
the DT O
42d JJ O
day NN O
. . O

-DOCSTART- X X O

Histological JJ O
signs NNS O
of IN O
the DT O
flare-up JJ O
reaction NN O
were VBD O
already RB O
present JJ O
at IN O
6 CD O
hr NN O
after IN O
i DT O
.v. NNP O
challenge NN O
and CC O
lasted VBD O
for IN O
at IN O
least JJS O
4 CD O
days NNS O
. . O

-DOCSTART- X X O

Plasma NNP O
fibrinogen NN B-NP
was VBD O
measured VBN O
by IN O
the DT O
turbidimetric JJ O
method NN O
in IN O
timol NN O
turbidimetric JJ O
units NNS O
. . O

-DOCSTART- X X O

Five CD O
patients NNS O
with IN O
type NN O
III NNP O
musculoskeletal NN O
infection NN O
from IN O
nongonococcal JJ O
Neisseria NNP O
species NNS O
were VBD O
examined VBN O
during IN O
a DT O
13-month JJ O
period NN O
. . O

-DOCSTART- X X O

Distal NNP O
tubular JJ O
acidification NN O
and CC O
the DT O
threshold NN O
for IN O
proximal JJ O
tubular JJ O
bicarbonate NN O
reabsorption NN O
were VBD O
normal JJ O
, , O
as RB O
was VBD O
urine JJ O
concentrating VBG O
capacity NN O
. . O

-DOCSTART- X X O

Detection NNP O
of IN O
exercise-induced JJ O
asynergy NN O
by IN O
M-mode NNP O
echocardiography NN O
. . O

-DOCSTART- X X O

The DT O
Tullio NNP O
phenomenon NN O
, , O
fistula NN O
test NN O
, , O
and CC O
Hennebert NNP O
's POS O
sign NN O
: : O
clinical JJ O
significance NN O
. . O

-DOCSTART- X X O

Both DT O
groups NNS O
were VBD O
subjected VBN O
to TO O
tests NNS O
of IN O
delayed VBN O
hypersensitivity NN O
with IN O
Candidin NNP B-NP
, , O
Trycophytin NNP B-NP
and CC O
Tuberculin NNP B-NP
. . O

-DOCSTART- X X O

Serum NN O
lactate NN B-NP
dehydrogenase NN I-NP
and CC O
haptoglobin NN B-NP
levels NNS O
were VBD O
normal JJ O
, , O
and CC O
total JJ O
bilirubin NN O
was VBD O
only RB O
slightly RB O
elevated VBN O
. . O

-DOCSTART- X X O

Low-dose NN O
D NNP O
( -LRB- O
0.4-0.8 CD O
mg NN O
) -RRB- O
and CC O
DB NNP O
( -LRB- O
1.0-5.0 CD O
mg NN O
) -RRB- O
did VBD O
not RB O
significantly RB O
alter VB O
any DT O
parameter NN O
from IN O
control NN O
. . O

-DOCSTART- X X O

Leads VBZ O
from IN O
the DT O
MMWR NNP O
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
visna-maedi NN O
in IN O
Italy NNP O
is VBZ O
reported VBN O
for IN O
the DT O
first JJ O
time NN O
. . O

-DOCSTART- X X O

High JJ O
levels NNS O
of IN O
IC NN O
coincided VBN O
with IN O
relative JJ O
hypocomplementemia NN O
. . O

-DOCSTART- X X O

Circulating VBG O
platelets NNS O
may MD O
be VB O
activated VBN O
by IN O
exposed JJ O
triple-helical JJ O
collagen NN B-NP
in IN O
atherosclerotic JJ O
lesions NNS O
in IN O
Mg-deficient JJ O
ruminants NNS O
. . O

-DOCSTART- X X O

Pathogenetic JJ O
relationships NNS O
between IN O
renal JJ O
tubular JJ O
acidosis NN O
and CC O
sodium NN O
metabolism NN O
alterations NNS O
in IN O
liver NN O
cirrhosis NN O
. . O

-DOCSTART- X X O

5 CD O
microU/l JJ O
thyrotropin NN B-NP
: : O
75 CD O
% NN O
( -LRB- O
1974) CD O
, , O
45 CD O
% NN O
( -LRB- O
1977 CD O
) -RRB- O
and CC O
20 CD O
% NN O
( -LRB- O
1980 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
prevalence NN O
of IN O
CPAF NNP O
was VBD O
similar JJ O
in IN O
type NN O
1 CD O
and CC O
type NN O
2 CD O
diabetes NN O
, , O
was VBD O
greater JJR O
in IN O
women NNS O
than IN O
in IN O
men NNS O
, , O
and CC O
was VBD O
significantly RB O
greater JJR O
after IN O
repeated VBN O
administrations NNS O
than IN O
after IN O
one CD O
single JJ O
administration NN O
of IN O
chlorpropamide NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
confirm VBP O
and CC O
extend VBP O
previous JJ O
work NN O
by IN O
other JJ O
researchers NNS O
. . O

-DOCSTART- X X O

In IN O
patients NNS O
with IN O
complete JJ O
or CC O
partial JJ O
remission NN O
of IN O
the DT O
tumor NN O
, , O
the DT O
neopterine NN O
excretion NN O
dropped VBD O
to TO O
normal JJ O
values NNS O
. . O

-DOCSTART- X X O

Total JJ O
PGE NNP O
levels NNS O
in IN O
synovial JJ O
fluid NN O
remained VBD O
significantly RB O
depressed VBN O
in IN O
the DT O
patient NN O
group NN O
for IN O
24 CD O
hours NNS O
after IN O
the DT O
400-mg JJ O
test NN O
dose NN O
of IN O
tolmetin NN O
on IN O
day NN O
8. . O

-DOCSTART- X X O

Normal JJ O
rates NNS O
of IN O
weight NN O
gain NN O
were VBD O
seen VBN O
once RB O
absorbed VBN O
energy NN O
intakes NNS O
reached VBD O
100-110 CD O
% NN O
of IN O
requirements NNS O
. . O

-DOCSTART- X X O

Its PRP$ O
vasodilatory JJ O
, , O
anti-vasopressor JJ O
, , O
and CC O
platelet VB O
stabilizing VBG O
effects NNS O
could MD O
be VB O
expected VBN O
to TO O
counteract VB O
the DT O
placental JJ O
ischemia NN O
, , O
hypertension NN O
and CC O
excessive JJ O
coagulation NN O
that WDT O
are VBP O
seen VBN O
in IN O
pre-eclampsia NNP O
. . O

-DOCSTART- X X O

Behcet NNP O
's POS O
syndrome NN O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
emotional-painful JJ O
stress NN O
( -LRB- O
EPS) NNP O
on IN O
myocardial JJ O
extensibility NN O
and CC O
contractility NN O
was VBD O
studied VBN O
on IN O
an DT O
isolated JJ O
rat NN O
atrium NN O
. . O

-DOCSTART- X X O

The DT O
hyperacute JJ O
phase NN O
of IN O
posterolateral JJ O
myocardial JJ O
infarction NN O
. . O

-DOCSTART- X X O

Statistics NNS O
for IN O
nurse NN O
managers--3 NN O
. . O

-DOCSTART- X X O

The DT O
infection NN O
rate NN O
was VBD O
five CD O
times NNS O
greater JJR O
in IN O
patients NNS O
with IN O
Hickman NNP O
catheters NNS O
than IN O
in IN O
those DT O
with IN O
Broviac NNP O
catheters NNS O
( -LRB- O
p NN O
= SYM O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

After IN O
a DT O
year NN O
of IN O
planning NN O
in IN O
the DT O
Laboratory NNP O
Assistants NNPS O
' POS O
School NNP O
in IN O
Stockholm NNP O
: : O
new JJ O
education NN O
for IN O
laboratory NN O
assistants NNS O
is VBZ O
now RB O
arranged VBN O

-DOCSTART- X X O

The DT O
electrocardiogram NN O
. . O

-DOCSTART- X X O

Use NN O
of IN O
prostaglandin NN O
F2 NN O
alpha NN O
( -LRB- O
PGF2 JJ O
alpha NN O
) -RRB- O
in IN O
cattle NNS O
breeding VBG O
. . O

-DOCSTART- X X O

Thus RB O
it PRP O
appears VBZ O
that IN O
the DT O
management NN O
of IN O
blood NN O
, , O
including VBG O
washing NN O
is VBZ O
of IN O
great JJ O
importance NN O
. . O

-DOCSTART- X X O

Range NNP O
, , O
variations NNS O
and CC O
neoplastic JJ O
potential NN O
. . O

-DOCSTART- X X O

The DT O
scores NNS O
are VBP O
dependent JJ O
in IN O
part NN O
on IN O
the DT O
reliability NN O
of IN O
faculty NN O
evaluations NNS O
. . O

-DOCSTART- X X O

Utero-placental JJ O
blood NN O
flow NN O
and CC O
the DT O
effect NN O
of IN O
beta JJ B-NP
2-adrenoceptor JJ I-NP
stimulating NN O
drugs NNS O
. . O

-DOCSTART- X X O

The DT O
arginyl NN O
peptide NN O
bonds NNS O
that WDT O
are VBP O
cleaved VBN O
in IN O
the DT O
conversion NN O
of IN O
human JJ B-NP
factor NN I-NP
IX NNP I-NP
to TO O
factor VB B-NP
IXa NNP I-NP
by IN O
factor NN B-NP
XIa NNP I-NP
were VBD O
identified VBN O
as IN O
Arg145-Ala146 NNP O
and CC O
Arg180-Val181 NNP O
. . O

-DOCSTART- X X O

Fluorometric JJ O
methods NNS O
can MD O
also RB O
provide VB O
information NN O
about IN O
porphyrin NN O
binding NN O
sites NNS O
that WDT O
is VBZ O
useful JJ O
in IN O
understanding VBG O
porphyrin NN O
transport NN O
and CC O
clearance NN O
. . O

-DOCSTART- X X O

Renal NNP O
and CC O
extrarenal JJ O
arterial JJ O
fibromuscular JJ O
hyperplasia NN O
with IN O
hypertension NN O
. . O

-DOCSTART- X X O

The DT O
monoexponential JJ O
rate NN O
of IN O
clearance NN O
of IN O
tracer--obtained NN O
from IN O
the DT O
portion NN O
of IN O
the DT O
residue-detection NN O
curve NN O
reflecting VBG O
metabolism NN O
of IN O
fatty JJ O
acid NN O
incorporated VBN O
into IN O
neutral JJ O
lipids--correlated JJ O
directly RB O
with IN O
induced JJ O
changes NNS O
in IN O
tension-time JJ O
index NN O
after IN O
injections NNS O
into IN O
the DT O
left JJ O
atrium NN O
( -LRB- O
r NN O
= SYM O
0.96 CD O
, , O
n RB O
= SYM O
12 CD O
) -RRB- O
, , O
right JJ O
atrium NN O
( -LRB- O
r NN O
= SYM O
0.86 CD O
, , O
n RB O
= SYM O
14) CD O
, , O
and CC O
ear NN O
vein NN O
( -LRB- O
r NN O
= SYM O
0.93 CD O
, , O
n RB O
= SYM O
14 CD O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
case NN O
of IN O
anterior JJ O
cleavage JJ O
syndrome NN O
in IN O
a DT O
27-year-old JJ O
female JJ O
patient NN O
is VBZ O
described VBN O
. . O

-DOCSTART- X X O

The DT O
daily JJ O
administration NN O
of IN O
betamethasone NN O
for IN O
three CD O
weeks NNS O
markedly RB O
reduced VBD O
the DT O
absorption NN O
of IN O
calcium NN O
and CC O
phosphate NN O
as RB O
well RB O
as IN O
the DT O
growth NN O
rate NN O
. . O

-DOCSTART- X X O

REV NN O
I PRP O
: : O
All DT O
vessels NNS O
up IN O
to TO O
50 CD O
% NN O
stenosed VBN O
have VBP O
a DT O
patent NN O
graft NN O
. . O

-DOCSTART- X X O

The DT O
extraction NN O
measurements NNS O
were VBD O
used VBN O
to TO O
test VB O
for IN O
extracerebral JJ O
contamination NN O
of IN O
venous JJ O
outflow NN O
. . O

-DOCSTART- X X O

On IN O
line NN O
calculation NN O
of IN O
steroid NN O
concentrations NNS O
by IN O
radioimmunoassay NN O

-DOCSTART- X X O

Detection NNP O
of IN O
congenital JJ O
hypothyroidism NN O
in IN O
26,282 CD O
newborn JJ O
infants NNS O

-DOCSTART- X X O

The DT O
results NNS O
indicate VBP O
that IN O
folate JJ O
compounds NNS O
decrease NN O
formate JJ O
accumulation NN O
after IN O
methanol NN O
by IN O
stimulating VBG O
formate JJ O
oxidation NN O
or CC O
utilization NN O
and CC O
suggest VBP O
a DT O
possible JJ O
use NN O
for IN O
folates NNS O
in IN O
the DT O
treatment NN O
of IN O
certain JJ O
cases NNS O
of IN O
human JJ O
methanol NN O
poisoning NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
sodium NN O
saccharin NN O
in IN O
the DT O
diet NN O
on IN O
caecal JJ O
microflora NN O
. . O

-DOCSTART- X X O

The DT O
residue JJ O
functions NNS O
, , O
R(t NN O
) -RRB- O
, , O
for IN O
C-11 NN O
CPZ NN O
and CC O
In-113m JJ O
transferrin NN B-NP
were VBD O
plotted VBN O
against IN O
time NN O
for IN O
selected VBN O
areas NNS O
of IN O
interest NN O
, , O
and CC O
the DT O
CPZ NNP O
area-weighted CC O
extraction NN O
, , O
E(t NNP O
) -RRB- O
, , O
was VBD O
computed VBN O
for IN O
the DT O
same JJ O
areas NNS O
every DT O
250 CD O
msec NN O
using VBG O
the DT O
formula NN O
: : O
E(t NN O
) -RRB- O
= SYM O
[RT(t NN O
) -RRB- O
- : O
RR(t NN O
) -RRB- O
] SYM O
/[ VB O
1 LS O
- : O
RR(t JJ O
)] NN O
, , O
where WRB O
RT NNP O
and CC O
RR NNP O
are VBP O
the DT O
normalized JJ O
residue JJ O
functions NNS O
for IN O
CPZ NN O
and CC O
transferrin NN B-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

Synchronous JJ O
extracts NNS O
showed VBD O
no DT O
significant JJ O
migration NN O
inhibition NN O
in IN O
allogeneic DT O
assays NNS O
. . O

-DOCSTART- X X O

Ten CD O
days NNS O
of IN O
cefadroxil JJ O
therapy NN O
was VBD O
used VBN O
to TO O
treat VB O
44 CD O
children NNS O
with IN O
urinary JJ O
tract NN O
infection NN O
and CC O
CRP NNP B-NP
values NNS O
greater JJR O
than IN O
or CC O
equal JJ O
to TO O
28 CD O
microgram/ml NN O
( -LRB- O
CRP-positive JJ B-NP
group NN O
) -RRB- O
. . O

-DOCSTART- X X O

After IN O
acclimation NN O
, , O
resting VBG O
supine NN O
and CC O
sitting VBG O
DPB NNP O
decreased VBD O
( -LRB- O
P NNP O
less RBR O
than IN O
0.05 CD O
) -RRB- O
by IN O
6 CD O
and CC O
9 CD O
mmHg NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
peptide NN O
map NN O
similarities NNS O
, , O
partial JJ O
amino-terminal JJ O
sequence NN O
data NNS O
, , O
and CC O
common JJ O
genetic JJ O
origin NN O
, , O
it PRP O
is VBZ O
suggested VBN O
that IN O
p60 NN B-NP
and CC O
p62 NN B-NP
have VBP O
identical JJ O
amino IN O
acid NN O
sequences NNS O
carboxy-terminal JJ O
to TO O
the DT O
p60 NN B-NP
initiator NN O
methionine NN O
( -LRB- O
residue JJ O
21 CD O
of IN O
p62 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

All DT O
patients NNS O
in IN O
the DT O
control NN O
group NN O
showed VBD O
a DT O
significant JJ O
improvement NN O
in IN O
their PRP$ O
PEFR NN O
while IN O
only RB O
3 CD O
patients NNS O
in IN O
the DT O
treated VBN O
group NN O
showed VBD O
an DT O
improvement NN O
. . O

-DOCSTART- X X O

Facts NNS O
on IN O
the DT O
Economic NNP O
Recovery NNP O
Tax NNP O
Act NNP O
of IN O
1981 CD O
for IN O
speech-language NN O
pathologists NNS O
and CC O
audiologists NNS O
. . O

-DOCSTART- X X O

From IN O
Pap NNP O
to TO O
ApUp NNP O
. . O

-DOCSTART- X X O

The DT O
relationship NN O
between IN O
the DT O
rare JJ O
complications NNS O
mentioned VBN O
above IN O
and CC O
the DT O
pathophysiology NN O
of IN O
Bartter NNP O
's POS O
syndrome NN O
is VBZ O
still RB O
obscure JJ O
. . O

-DOCSTART- X X O

Using VBG O
an DT O
opsonophagocytic JJ O
bacterial JJ O
assay NN O
and CC O
a DT O
suckling JJ O
rat NN O
model NN O
of IN O
GBS NNP O
sepsis NN O
, , O
we PRP O
analyzed VBD O
a DT O
modified VBN O
human JJ B-NP
immunoglobulin NN I-NP
for IN O
opsonic JJ O
and CC O
protective JJ O
antibody NN O
. . O

-DOCSTART- X X O

Glomerular JJ O
lesions NNS O
in IN O
renal JJ O
allografts NNS O
. . O

-DOCSTART- X X O

Commonly JJ O
observed JJ O
systemic JJ O
toxic JJ O
effects NNS O
( -LRB- O
bone NN O
marrow NN O
, , O
gastrointestinal JJ O
tract NN O
, , O
and CC O
heart NN O
) -RRB- O
were VBD O
not RB O
seen VBN O
in IN O
this DT O
study NN O
. . O

-DOCSTART- X X O

2. . O

-DOCSTART- X X O

When WRB O
vascular JJ O
pressure NN O
( -LRB- O
Pvas NNP O
) -RRB- O
was VBD O
raised VBN O
abruptly RB O
from IN O
-5 PRP$ O
to TO O
+25 CD O
cmH2O NNS O
by IN O
air NN O
inflation NN O
for IN O
60 CD O
min NN O
, , O
Px NNP O
( -LRB- O
f NN O
) -RRB- O
became VBD O
abruptly RB O
less JJR O
negative JJ O
, , O
then RB O
remained VBD O
stable JJ O
. . O

-DOCSTART- X X O

( -LRB- O
1980 CD O
) -RRB- O
: : O
Science NN O
210 CD O
, , O
77-72 CD O
) -RRB- O
that IN O
stimulating VBG O
the DT O
crossed VBN O
olivocochlear JJ O
bundle NN O
( -LRB- O
COCB) NN O
can MD O
change VB O
the DT O
magnitude NN O
of IN O
the DT O
distortion NN O
product NN O
( -LRB- O
f2-f1 JJ O
) -RRB- O
in IN O
the DT O
ear-canal JJ O
sound NN O
pressure NN O
. . O

-DOCSTART- X X O

When WRB O
the DT O
l-methadone-sensitive JJ O
, , O
opioid JJ B-NP
receptor NN I-NP
is VBZ O
blocked VBN O
by IN O
naloxone NN O
or CC O
tolerance NN O
has VBZ O
developed VBN O
, , O
than IN O
l-methadone NN O
can MD O
produce VB O
behavioral JJ O
effects NNS O
by IN O
a DT O
nonopioid JJ O
mechanism NN O
. . O

-DOCSTART- X X O

Microwave NNP O
hyperthermia-induced VBD O
blood-brain NN O
barrier NN O
alterations NNS O
. . O

-DOCSTART- X X O

Diagnosis NNP O
of IN O
phenylalanine NN B-NP
hydroxylase NN I-NP
deficiency NN O
( -LRB- O
phenylketonuria NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
10 CD O
control NN O
sheep NN O
mean VBP O
plasma NN O
TXB2 NN O
concentration NN O
increased VBN O
from IN O
0.39 CD O
ng/ml JJ O
prebypass NN O
to TO O
about IN O
1.1 CD O
ng/ml NN O
at IN O
8 CD O
and CC O
16 CD O
min NN O
of IN O
bypass NN O
. . O

-DOCSTART- X X O

The DT O
respiratory NN O
rate NN O
was VBD O
13 CD O
+/ JJ O
- : O
1 CD O
breaths/min NN O
with IN O
52 CD O
+/ NNS O
- : O
4 CD O
% NN O
of IN O
the DT O
respiratory JJ O
cycle NN O
spent VBD O
in IN O
inspiration NN O
; : O
end-tidal JJ O
CO2 JJ O
pressure NN O
increased VBN O
by IN O
3.3 CD O
+/ CD O
- : O
1.0 CD O
Torr NNP O
during IN O
runs NNS O
at IN O
SIP. NNP O

-DOCSTART- X X O

There EX O
was VBD O
no DT O
further JJ O
increase NN O
in IN O
oxygen NN O
consumption NN O
when WRB O
these DT O
subjects NNS O
breathed VBD O
with IN O
inspiratory JJ O
pressures NNS O
above IN O
SIP. NNP O

-DOCSTART- X X O

We PRP O
compared VBD O
the DT O
volume NN O
of IN O
the DT O
pulmonary JJ O
extravascular JJ O
, , O
extracellular JJ O
water NN O
space NN O
using VBG O
sodium NN O
and CC O
sucrose JJ O
indicators NNS O
in IN O
8 CD O
normal JJ O
and CC O
11 CD O
edematous JJ O
rabbit NN O
lungs NNS O
by IN O
steady-state NN O
techniques NNS O
. . O

-DOCSTART- X X O

Investigated NNP O
the DT O
reliability NN O
, , O
validity NN O
and CC O
dimensionality NN O
of IN O
scores NNS O
obtained VBN O
by IN O
acute JJ O
psychiatric JJ O
inpatients NNS O
( -LRB- O
N NNP O
= SYM O
120 CD O
) -RRB- O
on IN O
the DT O
Michigan NNP O
Alcoholism NNP O
Screening NNP O
Test NNP O
adapted VBD O
to TO O
assess VB O
lifetime NN O
and CC O
current JJ O
symptomatology NN O
. . O

-DOCSTART- X X O

A DT O
simple JJ O
method NN O
for IN O
measuring VBG O
urinary JJ O
iron NN O
following VBG O
the DT O
administration NN O
of IN O
desferrioxamine NN O
( -LRB- O
DF) NNP O
is VBZ O
described VBN O
. . O

-DOCSTART- X X O

Recommendations NNS O
to TO O
deal VB O
with IN O
these DT O
and CC O
related JJ O
issues NNS O
are VBP O
presented VBN O
. . O

-DOCSTART- X X O

Use NN O
of IN O
subcutaneous JJ O
deferoxamine NN O
in IN O
a DT O
child NN O
with IN O
hemochromatosis NN O
associated VBN O
with IN O
congenital JJ O
dyserythropoietic JJ O
anemia NN O
, , O
type NN O
I. NN O

-DOCSTART- X X O

The DT O
differential JJ O
investigation NN O
of IN O
lipoproteins NNS O
, , O
however RB O
, , O
showed VBD O
that IN O
the DT O
high-density NN B-NP
lipoprotein NN I-NP
( -LRB- O
HDL NNP B-NP
) -RRB- O
fractions NNS O
are VBP O
absolutely RB O
or CC O
relatively RB O
decreased VBN O
with IN O
respect NN O
to TO O
low-density JJ B-NP
lipoproteins NNS I-NP
( -LRB- O
LDL NNP B-NP
) -RRB- O
in IN O
cerebral NN O
infarcts NNS O
and CC O
in IN O
transient NN O
ischaemic JJ O
attacks NNS O
. . O

-DOCSTART- X X O

Preparation NN O
of IN O
a DT O
stable JJ O
phospholipid JJ O
reagent NN O
for IN O
coagulation NN O
assays VBZ O
. . O

-DOCSTART- X X O

A DT O
note NN O
on IN O
some DT O
consequences NNS O
of IN O
UV JJ O
vision NN O
in IN O
birds NNS O
. . O

-DOCSTART- X X O

Before IN O
turnout NN O
, , O
a DT O
morantel NN O
sustained VBD O
release NN O
bolus NN O
( -LRB- O
MSRB NNP O
) -RRB- O
was VBD O
administered VBN O
to TO O
each DT O
animal NN O
in IN O
the DT O
" `` O
treated VBN O
" '' O
category NN O
. . O

-DOCSTART- X X O

In IN O
a DT O
longitudinal JJ O
study NN O
, , O
14 CD O
low-risk JJ O
fetuses NNS O
were VBD O
studied VBN O
at IN O
2-week JJ O
intervals NNS O
from IN O
32 CD O
weeks NNS O
of IN O
gestation NN O
onward RB O
. . O

-DOCSTART- X X O

Further RB O
, , O
intracerebroventricular JJ O
injections NNS O
of IN O
KA NNP O
resulted VBD O
in IN O
the DT O
substantial JJ O
loss NN O
of IN O
pyramidal JJ O
cells NNS O
in IN O
the DT O
whole JJ O
CA3 JJ O
field NN O
of IN O
the DT O
hippocampus NN O
. . O

-DOCSTART- X X O

Seventeen CD O
of IN O
the DT O
35 CD O
patients NNS O
were VBD O
randomly RB O
chosen VBN O
to TO O
receive VB O
a DT O
training NN O
program NN O
( -LRB- O
lasting VBG O
approximately RB O
1 CD O
month NN O
) -RRB- O
designed VBN O
to TO O
establish VB O
a DT O
systematic JJ O
strategy NN O
of IN O
organizing VBG O
complex JJ O
visual JJ O
material NN O
. . O

-DOCSTART- X X O

The DT O
duration NN O
and CC O
the DT O
amplitude NN O
of IN O
the DT O
negative JJ O
potential NN O
were VBD O
greatest JJS O
for IN O
completely RB O
regenerating VBG O
ears NNS O
with IN O
overgrowth NN O
, , O
smaller JJR O
for IN O
partially RB O
regenerating JJ O
ears NNS O
, , O
and CC O
smallest JJS O
for IN O
the DT O
nonregenerating JJ O
ears NNS O
. . O

-DOCSTART- X X O

The DT O
steepness NN O
of IN O
the DT O
standard JJ O
O2 NNP O
dissociation NN O
curve NN O
becomes VBZ O
greater JJR O
during IN O
the DT O
training NN O
period NN O
( -LRB- O
increase NN O
in IN O
Hill NNP O
's POS O
n NN O
from IN O
2.68 CD O
+/ CD O
- : O
0.10 CD O
to TO O
2.96 CD O
+/ CD O
- : O
0.15 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Conjugated NNP O
and CC O
unconjugated JJ O
phenylacetic JJ O
acid NN O
and CC O
m NN O
- : O
and CC O
p-hydroxyphenylacetic JJ O
acid NN O
have VBP O
been VBN O
determined VBN O
in IN O
the DT O
plasma NN O
of IN O
normal JJ O
, , O
healthy JJ O
subjects NNS O
after IN O
fasting VBG O
, , O
consumption NN O
of IN O
a DT O
meal NN O
and CC O
ingestion NN O
of IN O
deuterium NN O
labelled VBN O
amine IN O
precursors NNS O
, , O
by IN O
high-resolution JJ O
gas NN O
chromatography--high NN O
resolution NN O
mass NN O
spectrometry NN O
with IN O
selected VBN O
ion NN O
monitoring NN O
of IN O
their PRP$ O
trifluoroethyl-pentafluoropropionyl JJ O
derivatives NNS O
. . O

-DOCSTART- X X O

They PRP O
consisted VBD O
of IN O
behavioural NN O
disorders NNS O
, , O
tetraparesis NN O
, , O
incontinence NN O
and CC O
oculomotor NN O
paralysis NN O
. . O

-DOCSTART- X X O

CSF NNP O
adenosine FW B-NP
deaminase NN I-NP
activity NN O
( -LRB- O
ADA NNP O
) -RRB- O
was VBD O
measured VBN O
at IN O
the DT O
same JJ O
time NN O
. . O

-DOCSTART- X X O

Histamine NN O
reactivity NN O
had VBD O
returned VBN O
to TO O
normal JJ O
in IN O
half PDT O
the DT O
workers NNS O
who WP O
had VBD O
left VBN O
their PRP$ O
original JJ O
factories NNS O
, , O
but CC O
in IN O
only RB O
one CD O
worker NN O
who WP O
had VBD O
moved VBN O
within IN O
her PRP$ O
original JJ O
factory NN O
. . O

-DOCSTART- X X O

There EX O
were VBD O
no DT O
significant JJ O
differences NNS O
in IN O
EF NN O
between IN O
the DT O
two CD O
studies NNS O
, , O
both DT O
at IN O
rest NN O
( -LRB- O
56.0 CD O
+/ NN O
- : O
13.8 CD O
% NN O
vs NN O
58.2 CD O
+/ NNS O
- : O
11.7 CD O
% NN O
, , O
p NN O
= SYM O
NS NNS O
) -RRB- O
and CC O
with IN O
exercise NN O
( -LRB- O
51.1 CD O
+/ NN O
- : O
17.6 CD O
% NN O
vs IN O
54.3 CD O
+/ CD O
- : O
17.6 CD O
% NN O
, , O
p NN O
= SYM O
NS NNS O
) -RRB- O
and CC O
a DT O
highly RB O
significant JJ O
correlation NN O
was VBD O
shown VBN O
between IN O
the DT O
two CD O
groups NNS O
of IN O
values NNS O
( -LRB- O
rest NN O
r NN O
= SYM O
0.90 CD O
, , O
exercise NN O
r NN O
= SYM O
0.93 CD O
, , O
p RB O
less JJR O
than IN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Re NNP O
: : O
A DT O
modified JJ O
method NN O
for IN O
the DT O
in IN O
vivo JJ O
labeling NN O
of IN O
red JJ O
blood NN O
cells NNS O
with IN O
Tc-99m JJ O
. . O

-DOCSTART- X X O

Parasitological NNP O
and CC O
pathological JJ O
findings NNS O
in IN O
capuchin NN O
monkeys NNS O
infected VBD O
with IN O
Schistosoma NNP O
japonicum NN O
or CC O
Schistosoma NNP O
mansoni NNS O
. . O

-DOCSTART- X X O

The DT O
pia NN O
mater NN O
at IN O
the DT O
site NN O
of IN O
the DT O
entry NN O
of IN O
blood NN O
vessels NNS O
into IN O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

-DOCSTART- X X O

Experimental JJ O
reproduction NN O
of IN O
malignant JJ O
catarrhal JJ O
fever NN O
in IN O
Bali NNP O
cattle NNS O

-DOCSTART- X X O

1 CD O
A DT O
colonic JJ O
delivery NN O
system NN O
is VBZ O
described VBN O
to TO O
deliver VB O
orally RB O
ingested VBN O
drugs NNS O
to TO O
the DT O
colon NN O
and CC O
release NN O
them PRP O
at IN O
that DT O
site NN O
by IN O
coating NN O
with IN O
an DT O
acrylic NN O
based VBN O
resin NN O
( -LRB- O
Eudragit JJ O
S NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Administration NNP O
of IN O
the DT O
dopamine NN O
agonist NN O
bromocriptine NN O
( -LRB- O
2.5 CD O
mg NN O
three CD O
times NNS O
a DT O
day NN O
for IN O
4 CD O
days NNS O
) -RRB- O
suppressed VBN O
( -LRB- O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
mean VBP O
24-h JJ O
plasma NN O
18-OHB JJ O
levels NNS O
from IN O
21.9 CD O
+/ CD O
- : O
2.0 CD O
to TO O
14.8 CD O
+/ NNS O
- : O
1.4 CD O
ng/dl NN O
. . O

-DOCSTART- X X O

Restarting VBG O
time NN O
was VBD O
not RB O
affected VBN O
by IN O
magnesium NN O
cardioplegia NN O
. . O

-DOCSTART- X X O

The DT O
most RBS O
common JJ O
types NNS O
of IN O
malformations NNS O
were VBD O
eye NN O
defects NNS O
and CC O
open JJ O
coeloms NNS O
. . O

-DOCSTART- X X O

Repair NNP O
of IN O
a DT O
cosmetic JJ O
defect NN O
of IN O
the DT O
lower JJR O
leg NN O
with IN O
a DT O
myocutaneous JJ O
free JJ O
flap NN O
. . O

-DOCSTART- X X O

In IN O
Malmo NNP O
, , O
Sweden NNP O
, , O
17,181 CD O
school NN O
children NNS O
born VBN O
in IN O
the DT O
years NNS O
1961-1965 CD O
were VBD O
screened VBN O
for IN O
scoliosis NN O
once RB O
a DT O
year NN O
between IN O
the DT O
ages NNS O
of IN O
7 CD O
and CC O
16 CD O
years NNS O
, , O
during IN O
1971-1980 CD O
. . O

-DOCSTART- X X O

In IN O
the DT O
past NN O
, , O
immunology NN O
in IN O
Singapore NNP O
was VBD O
mainly RB O
confined VBN O
to TO O
serology VB O
for IN O
the DT O
diagnosis NN O
of IN O
certain JJ O
infectious JJ O
diseases NNS O
. . O

-DOCSTART- X X O

Intra-articular JJ O
dislocation NN O
of IN O
the DT O
patella NN O
. . O

-DOCSTART- X X O

Histological JJ O
evaluation NN O
revealed VBD O
a DT O
more JJR O
than IN O
twofold JJ O
increase NN O
in IN O
the DT O
number NN O
of IN O
interepithelial JJ O
mononuclear NN O
cells NNS O
( -LRB- O
p NN O
less JJR O
than IN O
0.005 CD O
) -RRB- O
, , O
while IN O
the DT O
number NN O
of IN O
epithelial JJ O
cells/100 CD O
microns NNS O
of IN O
villous JJ O
mucosa NN O
and CC O
the DT O
mean JJ O
height NN O
of IN O
the DT O
epithelial NN O
cells NNS O
were VBD O
comparable JJ O
in IN O
both DT O
groups NNS O
. . O

-DOCSTART- X X O

A DT O
suspected JJ O
new JJ O
storage NN O
disease NN O
in IN O
cattle NNS O
. . O

-DOCSTART- X X O

For IN O
various JJ O
dog NN O
vessels NNS O
in IN O
vivo NN O
, , O
Q/Dk NNP O
ranged VBD O
from IN O
0.15 CD O
to TO O
47 CD O
X NNP O
10(5 CD O
) -RRB- O
Torr/cm2 NNP O
. . O

-DOCSTART- X X O

Modification NNP O
of IN O
enteral JJ O
resorption NN O
by IN O
cytostatic JJ O
therapy NN O

-DOCSTART- X X O

Asymptomatic JJ O
bacteriospermia NN O
and CC O
fertility NN O

-DOCSTART- X X O

Triumph NN O
of IN O
Leninist JJ O
national JJ O
policy NN O

-DOCSTART- X X O

The DT O
application NN O
of IN O
ultrafiltration NN O
to TO O
sample NN O
preparation NN O
in IN O
the DT O
detection NN O
and CC O
quantification NN O
of IN O
ethylene NN O
glycol NN O
in IN O
plasma NN O
by IN O
gas NN O
chromatography NN O
is VBZ O
described VBN O
. . O

-DOCSTART- X X O

A DT O
new JJ O
Onchocerca NNP O
species NNS O
, , O
a DT O
parasite NN O
of IN O
domestic JJ O
cattle NNS O
, , O
in IN O
Senegal NNP O

-DOCSTART- X X O

It PRP O
was VBD O
suggested VBN O
that IN O
the DT O
absence NN O
of IN O
pronounced JJ O
differences NNS O
between IN O
conditions NNS O
may MD O
have VB O
been VBN O
due JJ O
to TO O
the DT O
complexity NN O
of IN O
the DT O
task NN O
or CC O
the DT O
type NN O
of IN O
prompts NNS O
employed VBN O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
penetration NN O
tests NNS O
of IN O
human JJ O
sperm NN O
into IN O
cervical JJ O
mucus NN O
were VBD O
introduced VBN O
in IN O
order NN O
to TO O
study VB O
the DT O
interaction NN O
between IN O
sperm NN O
and CC O
cervical JJ O
mucus NN O
. . O

-DOCSTART- X X O

Vibrio NNP O
fluvialis NNS O
( -LRB- O
group NN O
F NN O
vibrio NN O
) -RRB- O
in IN O
Maharashtra NNP O
. . O

-DOCSTART- X X O

Serum NN B-NP
creatine NN I-NP
kinase NN I-NP
(SCK) NN O
was VBD O
measured VBN O
in IN O
ten CD O
subjects NNS O
in IN O
the DT O
laboratory NN O
before IN O
and CC O
after IN O
the DT O
performance NN O
of IN O
bicycle NN O
ergometry NN O
and CC O
a DT O
lifting NN O
task NN O
. . O

-DOCSTART- X X O

Organisms NNPS O
were VBD O
not RB O
observed VBN O
in IN O
the DT O
5 CD O
bobcats NNS O
trapped VBN O
in IN O
2 CD O
other JJ O
counties NNS O
. . O

-DOCSTART- X X O

The DT O
cause NN O
of IN O
death NN O
is VBZ O
often RB O
quite RB O
apparent JJ O
from IN O
the DT O
pathological JJ O
and CC O
toxicological JJ O
findings NNS O
; : O
however RB O
, , O
the DT O
manner NN O
of IN O
death NN O
often RB O
gives VBZ O
the DT O
examining NN O
official NN O
some DT O
difficulty NN O
. . O

-DOCSTART- X X O

The DT O
average JJ O
annual JJ O
cost NN O
per IN O
head NN O
of IN O
population NN O
was VBD O
US+0 NNP O
X NNP O
46 CD O
. . O

-DOCSTART- X X O

Both DT O
groups NNS O
rejected VBD O
pops NNS O
with IN O
added JJ O
SOA NN O
, , O
decreasing VBG O
mouthing NN O
times NNS O
as IN O
SOA NNP O
concentration NN O
increased VBD O
. . O

-DOCSTART- X X O

The DT O
mean NN O
extracted VBD O
concentration NN O
of IN O
flucloxacillin VBG O
obtained VBN O
at IN O
operation NN O
was VBD O
12.9 CD O
micrograms/ml JJ O
( -LRB- O
SD JJ O
5.25 CD O
) -RRB- O
in IN O
synovial JJ O
fluid NN O
; : O
2.9 CD O
micrograms/g NN O
( -LRB- O
SD NNP O
3.59 CD O
) -RRB- O
in IN O
synovium NN O
; : O
2.0 CD O
micrograms/g NN O
( -LRB- O
SD NNP O
1.48 CD O
) -RRB- O
in IN O
cancellous JJ O
bone NN O
and CC O
1.3 CD O
micrograms/g NN O
( -LRB- O
SD NNP O
1.25 CD O
) -RRB- O
in IN O
cortical JJ O
bone NN O
. . O

-DOCSTART- X X O

A DT O
preliminary JJ O
study NN O
of IN O
vincristine NN O
, , O
methotrexate NN O
, , O
and CC O
prednisolone NN O
(VM*P) NN O
combination NN O
chemotherapy NN O
for IN O
advanced JJ O
adult NN O
non-Hodgkin NN O
's POS O
lymphoma NN O

-DOCSTART- X X O

Lacrimal NNP O
secretion NN O
in IN O
hyperthyroidism NN O

-DOCSTART- X X O

A DT O
further JJ O
study NN O
on IN O
plasminogen NN B-NP
activator NN I-NP
release NN O
by IN O
vasoactive JJ O
agents NNS O
in IN O
the DT O
isolated JJ O
perfused JJ O
dog NN O
leg NN O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
meat NN O
muscle NN O
800 CD O
V NNP O
for IN O
45 CD O
s VBZ O
reduced VBN O
weeping NN O
but CC O
increased VBD O
slightly RB O
the DT O
rate NN O
of IN O
autoxidation NN O
of IN O
lipids NNS O
. . O

-DOCSTART- X X O

A DT O
method NN O
for IN O
determining VBG O
cumulative JJ O
behavioral NN O
toxicity NN O
after IN O
chronic JJ O
oral JJ O
administration NN O
of IN O
l-alpha-acetylmethadol JJ O
to TO O
female JJ O
rats NNS O
. . O

-DOCSTART- X X O

The DT O
number NN O
of IN O
muricidal JJ O
rats NNS O
increased VBN O
with IN O
increase NN O
in IN O
the DT O
duration NN O
of IN O
Cd JJ O
administration NN O
in IN O
association NN O
with IN O
greater JJR O
accumulation NN O
of IN O
Cd NNP O
in IN O
the DT O
olfactory JJ O
bulb NN O
than IN O
in IN O
any DT O
other JJ O
region NN O
of IN O
the DT O
brain NN O
. . O

-DOCSTART- X X O

This DT O
test NN O
should MD O
provide VB O
another DT O
practical JJ O
means NNS O
to TO O
study VB O
leprosy JJ O
. . O

-DOCSTART- X X O

The DT O
preferences NNS O
were VBD O
for IN O
intact JJ O
vis-a-vis NN O
castrated VBD O
males NNS O
, , O
though IN O
injections NNS O
of IN O
TP NNP O
restored VBD O
the DT O
castrates NNS O
' POS O
attractiveness NN O
to TO O
the DT O
females NNS O
. . O

-DOCSTART- X X O

Inhibition NN O
of IN O
Fusarium NNP O
moniliforme NN O
var NN O
. . O
subglutinans NNS O
, , O
the DT O
causal JJ O
agent NN O
of IN O
pine NN O
pitch NN O
canker NN O
, , O
by IN O
the DT O
soil NN O
bacterium NN O
Arthrobacter NNP O
sp. . O

-DOCSTART- X X O

The DT O
five-drug JJ O
combination NN O
of IN O
fluorouracil NN O
imidazole NN O
carboxamide NN O
dimethyl NN O
triazeno NN O
, , O
vincristine NN O
, , O
bis-chloroethyl NN O
nitrosourea NN O
, , O
and CC O
prednisone NN O
( -LRB- O
FIVB NNP O
+ NN O
P NNP O
) -RRB- O
was VBD O
given VBN O
to TO O
120 CD O
women NNS O
with IN O
metastatic JJ O
breast NN O
cancer NN O
. . O

-DOCSTART- X X O

Visual JJ O
response NN O
properties NNS O
of IN O
neurons NNS O
in IN O
four CD O
extrastriate JJ O
visual JJ O
areas NNS O
of IN O
the DT O
owl NN O
monkey NN O
( -LRB- O
Aotus NNP O
trivirgatus NN O
) -RRB- O
: : O
a DT O
quantitative JJ O
comparison NN O
of IN O
medial JJ O
, , O
dorsomedial JJ O
, , O
dorsolateral JJ O
, , O
and CC O
middle JJ O
temporal JJ O
areas NNS O
. . O

-DOCSTART- X X O

A DT O
unified JJ O
approach NN O
to TO O
the DT O
standardization NN O
of IN O
allergens NNS O
. . O

-DOCSTART- X X O

Clinical NNP O
and CC O
anatomical JJ O
considerations NNS O

-DOCSTART- X X O

Several JJ O
authors NNS O
have VBP O
recently RB O
reported VBN O
interference NN O
in IN O
theophylline DT O
analysis NN O
by IN O
paraxanthine NN O
( -LRB- O
1,7-dimethylxanthine CD O
) -RRB- O
, , O
an DT O
important JJ O
metabolite NN O
of IN O
caffeine NN O
. . O

-DOCSTART- X X O

Multi NNP O
drug NN O
regimens NNS O
like IN O
C-MOPP NNP O
, , O
CHOP NNP O
and CC O
BACOP NNP O
led VBD O
to TO O
high JJ O
remission NN O
rates NNS O
and CC O
in IN O
some DT O
cases NNS O
probably RB O
also RB O
to TO O
a DT O
cure NN O
of IN O
the DT O
disease NN O
. . O

-DOCSTART- X X O

For IN O
monocytes NNS O
, , O
as IN O
measured VBN O
on IN O
the DT O
Hematrak NNP O
, , O
it PRP O
was VBD O
13.4 CD O
% NN O
. . O

-DOCSTART- X X O

Morphological NNP O
features NNS O
of IN O
Jat NNP O
dentition NN O
. . O

-DOCSTART- X X O

Clinical NNP O
accuracy NN O
of IN O
updated VBN O
version NN O
of IN O
the DT O
Phadebas NNP O
RAST NNP O
test NN O
. . O

-DOCSTART- X X O

Cross NNP O
reactivity NN O
in IN O
theophylline DT O
RIA NNP O
kit NN O
decreased VBD O
. . O

-DOCSTART- X X O

Strontium-90 NNP O
was VBD O
inject JJ O
i FW O
.v. FW O
into IN O
pregnant JJ O
rats NNS O
on IN O
day NN O
18 CD O
post NN O
conception NN O
( -LRB- O
p.c. NN O
) -RRB- O
. . O

-DOCSTART- X X O

Recording VBG O
of IN O
the DT O
digital JJ O
sphygmic JJ O
activity NN O
in IN O
the DT O
lower JJR O
extremities NNS O
with IN O
the DT O
photoplethysmographic JJ O
and CC O
strain-gauge JJ O
methods NNS O
. . O

-DOCSTART- X X O

Eight CD O
hr NN O
of IN O
acidosis NN O
caused VBD O
a DT O
significant JJ O
( -LRB- O
P NNP O
less RBR O
than IN O
0.01 CD O
) -RRB- O
decrease NN O
in IN O
P50 NNP O
in IN O
vitro NN O
which WDT O
fell VBD O
from IN O
29.0 CD O
to TO O
24.4 CD O
torr NN O
. . O

-DOCSTART- X X O

Catheter NNP O
transit NN O
slows VBZ O
the DT O
response NN O
to TO O
a DT O
step NN O
increase NN O
in IN O
concentration NN O
by IN O
about IN O
0.13 CD O
s VBZ O
( -LRB- O
from IN O
10 CD O
per IN O
cent-90 CD O
per IN O
cent NN O
) -RRB- O
and CC O
prolongs VBZ O
the DT O
transit NN O
time NN O
through IN O
the DT O
catheter NN O
for IN O
a DT O
volatile JJ O
anesthetic NN O
by IN O
about IN O
0.04 CD O
s VBZ O
more RBR O
than IN O
N2 NNP O
. . O

-DOCSTART- X X O

These DT O
women NNS O
should MD O
not RB O
be VB O
given VBN O
the DT O
current JJ O
estrogen NN O
PPI NNP O
, , O
which WDT O
was VBD O
designed VBN O
to TO O
warn VB O
women NNS O
of IN O
the DT O
risks NNS O
of IN O
long-term JJ O
estrogen NN O
use NN O
; : O
a DT O
PPI NNP O
should MD O
be VB O
written VBN O
specifically RB O
for IN O
patients NNS O
receiving VBG O
short JJ O
courses NNS O
. . O

-DOCSTART- X X O

The DT O
oral JJ O
temperature NN O
rose VBD O
and CC O
the DT O
serum NN B-NP
creatine NN I-NP
kinase NN I-NP
levels NNS O
fell VBD O
only RB O
in IN O
those DT O
patients NNS O
who WP O
were VBD O
actively RB O
warmed VBN O
. . O

-DOCSTART- X X O

Determination NNP O
of IN O
aortic JJ O
distensibility NN O
and CC O
its PRP$ O
variations NNS O
in IN O
arterial JJ O
hypertension NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
prostaglandin NN O
inhibitors NNS O
on IN O
the DT O
onset NN O
of IN O
proteinuria NN O
and CC O
stroke NN O
in IN O
stroke-prone JJ O
spontaneously RB O
hypertensive JJ O
rats NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
the DT O
general JJ O
clinical JJ O
criteria NNS O
for IN O
inhalation NN O
injury--presence NN O
of IN O
facial JJ O
or CC O
oropharyngeal JJ O
burns NNS O
, , O
carboxyhemoglobin NN B-NP
levels NNS O
, , O
carbonaceous JJ O
sputum NN O
, , O
or CC O
closed JJ O
space NN O
injury--did NN O
not RB O
differentiate JJ O
patients NNS O
with IN O
airway NN O
injury NN O
only RB O
from IN O
those DT O
with IN O
parenchymal JJ O
injury NN O
. . O

-DOCSTART- X X O

Survival NNP O
was VBD O
calculated VBN O
both DT O
from IN O
the DT O
date NN O
of IN O
onset NN O
and CC O
from IN O
the DT O
date NN O
of IN O
diagnosis NN O
. . O

-DOCSTART- X X O

Methisergide NNP O
( -LRB- O
0.5 CD O
mg/kg NN O
, , O
i.p. NN O
) -RRB- O
, , O
a DT O
blocker NN O
of IN O
serotonin NN B-NP
receptors NNS I-NP
, , O
prevented VBD O
the DT O
development NN O
of IN O
the DT O
antinociceptive JJ O
effect NN O
of IN O
serotonin NN O
. . O

-DOCSTART- X X O

The DT O
plasma NN O
half-life NN O
of IN O
slow JJ O
disposition NN O
phase NN O
t1/2 IN O
beta JJ O
, , O
increases NNS O
from IN O
0.26 CD O
hour NN O
in IN O
rabbits NNS O
with IN O
normal JJ O
renal JJ O
function NN O
to TO O
5.41 CD O
hours NNS O
in IN O
rabbits NNS O
with IN O
severe JJ O
renal JJ O
impairment NN O
. . O

-DOCSTART- X X O

Corticosteroid NNP O
therapy NN O
is VBZ O
known VBN O
to TO O
be VB O
hazardous JJ O
in IN O
patients NNS O
with IN O
occult JJ O
infection NN O
but CC O
the DT O
mechanism NN O
by IN O
which WDT O
the DT O
host NN O
parasite NN O
relationship NN O
is VBZ O
altered VBN O
by IN O
steroids NNS O
is VBZ O
not RB O
known VBN O
. . O
We PRP O
have VBP O
used VBN O
an DT O
intestinal JJ O
protozoal NN O
parasite NN O
, , O
Giardia NNP O
muris VBD O
, , O
to TO O
examine VB O
the DT O
effects NNS O
of IN O
corticosteroids NNS O
on IN O
the DT O
number NN O
of IN O
parasites NNS O
in IN O
the DT O
intestine NN O
in IN O
the DT O
course NN O
of IN O
a DT O
primary JJ O
infection NN O
. . O

-DOCSTART- X X O

With IN O
Sair NNP O
and CC O
So2 NNP O
, , O
mean VBP O
vital JJ O
capacity NN O
was VBD O
reduced VBN O
by IN O
44 CD O
% NN O
from IN O
control NN O
. . O

-DOCSTART- X X O

The DT O
relationship NN O
between IN O
estrogenic JJ O
properties NNS O
of IN O
Tamoxifen NNP O
and CC O
breast NN O
cancer NN O
management NN O
is VBZ O
discussed VBN O
. . O

-DOCSTART- X X O

The DT O
new JJ O
semi-synthetic JJ O
oral JJ O
cephalosporin NN O
, , O
CGP NNP O
9,000 CD O
, , O
has VBZ O
been VBN O
evaluated VBN O
in IN O
a DT O
large JJ O
number NN O
of IN O
hospitalized VBN O
patients NNS O
with IN O
urinary JJ O
infections NNS O
. . O

-DOCSTART- X X O

A DT O
fluoroimmunoassay NN O
for IN O
the DT O
determination NN O
of IN O
serum NN O
of IN O
plasma NN O
levels NNS O
of IN O
propranolol NN O
was VBD O
developed VBN O
using VBG O
antibodies NNS O
to TO O
propranolol VB O
coupled VBN O
to TO O
magnetizable JJ O
solid-phase JJ O
particles NNS O
and CC O
fluorescein-labeled JJ O
propranolol NN O
as IN O
tracer NN O
. . O

-DOCSTART- X X O

The DT O
syncytial JJ O
microvillous JJ O
projections NNS O
seemed VBD O
to TO O
be VB O
more RBR O
numerous JJ O
and CC O
longer RB O
in IN O
CNF NNP O
, , O
otherwise RB O
the DT O
structure NN O
of IN O
the DT O
trophoblastic JJ O
layer NN O
of IN O
the DT O
villi NNS O
and CC O
the DT O
lining NN O
of IN O
the DT O
subtrophoblastic JJ O
vessels NNS O
were VBD O
identical JJ O
in IN O
CNF NNP O
and CC O
controls NNS O
. . O

-DOCSTART- X X O

It PRP O
has VBZ O
been VBN O
shown VBN O
in IN O
experiments NNS O
in IN O
vitro NN O
that IN O
the DT O
hepatotrophic JJ O
organic JJ O
anions NNS O
, , O
the DT O
radiographic JJ O
contrast NN O
agent NN O
(RCA NNP O
) -RRB- O
bilignost NN O
used VBN O
in IN O
cholecystography NN O
and CC O
Bengal NNP O
pink JJ O
, , O
have VBP O
an DT O
affinity NN O
, , O
unlike IN O
the DT O
urographic JJ O
RCA NNP O
triombrin NN O
and CC O
renotrophic JJ O
dye JJ O
indigo-carmine NN O
, , O
for IN O
the DT O
plasmatic JJ O
membranes NNS O
( -LRB- O
PM) NN O
of IN O
liver NN O
cells NNS O
. . O

-DOCSTART- X X O

33 CD O
out IN O
of IN O
90 CD O
neurons NNS O
of IN O
the DT O
cat NN O
medial JJ O
geniculate JJ O
body NN O
revealed VBD O
the DT O
selectivity NN O
of IN O
their PRP$ O
afterdischarges NNS O
to TO O
movement NN O
of IN O
sound NN O
when WRB O
velocity NN O
of IN O
the DT O
movement NN O
changed VBD O
from IN O
30 CD O
to TO O
180 CD O
deg/s NNS O
. . O

-DOCSTART- X X O

In IN O
controls NNS O
, , O
only RB O
modest JJ O
differences NNS O
were VBD O
observed VBN O
. . O

-DOCSTART- X X O

Assay NNP O
of IN O
serum NN B-NP
immunoreactive JJ I-NP
trypsin NN I-NP
in IN O
dried JJ O
blood NN O
spots NNS O
and CC O
the DT O
early JJ O
detection NN O
of IN O
cystic JJ O
fibrosis NN O
. . O

-DOCSTART- X X O

Leukocyte NNP O
enzyme NN O
activity NN O
and CC O
blood NN O
lymphocyte NN O
blast NN O
transformation NN O
in IN O
chronic NN O
bronchitis NN O

-DOCSTART- X X O

Based VBN O
on IN O
AUC NNP O
infinity NN O
analyses NNS O
, , O
the DT O
pharmacokinetics NNS O
of IN O
buflomedil NN O
were VBD O
found VBN O
to TO O
be VB O
linear NN O
within IN O
the DT O
dose NN O
ranges VBZ O
studied VBN O
( -LRB- O
50 CD O
to TO O
200 CD O
mg NN O
for IN O
i NN O
. . O
v. CC O
injection NN O
and CC O
150 CD O
to TO O
450 CD O
mg JJ O
for IN O
oral JJ O
administration NN O
) -RRB- O
. . O

-DOCSTART- X X O

Gastrin NNP B-NP
secretion NN O
during IN O
food NN O
stimulation NN O
in IN O
digestive JJ O
system NN O
diseases NNS O

-DOCSTART- X X O

Delayed JJ O
or CC O
paradoxically RB O
emptying JJ O
regions NNS O
of IN O
the DT O
left JJ O
ventricle NN O
were VBD O
detected VBN O
by IN O
a DT O
relatively RB O
new JJ O
nuclear JJ O
technique--phase NN O
imaging NN O
. . O

-DOCSTART- X X O

Nineteen CD O
patients NNS O
with IN O
non-visualized JJ O
gallbladder NN O
with IN O
OCG NNP O
subsequently RB O
had VBD O
Tc-99m-PyG JJ O
cholescintigraphy NN O
performed VBN O
. . O

-DOCSTART- X X O

Anamnestic JJ O
data NNS O
were VBD O
obtained VBN O
from IN O
case NN O
history NN O
, , O
smoking NN O
habits NNS O
were VBD O
not RB O
known VBN O
in IN O
collective JJ O
A NNP O
and CC O
C. NNP O

-DOCSTART- X X O

The DT O
determination NN O
of IN O
physical JJ O
performance NN O
capacity NN O
was VBD O
based VBN O
on IN O
W170 CD O
, , O
W85 CD O
% NN O
and CC O
on IN O
predicted VBN O
VO2 NN O
max NN O
measured VBN O
with IN O
continuously RB O
increasing VBG O
work NN O
load NN O
on IN O
a DT O
bicycle NN O
ergometer NN O
. . O

-DOCSTART- X X O

LD50 DT O
values NNS O
of IN O
terms NNS O
of IN O
KP NNP O
were VBD O
84 CD O
mg/kg NN O
in IN O
male JJ O
rats NNS O
and CC O
122 CD O
mg/kg NN O
in IN O
female JJ O
rats NNS O
when WRB O
KP-CMC NNP O
was VBD O
administered VBN O
intrarectally RB O
, , O
and CC O
117 CD O
mg/kg NN O
in IN O
male NN O
and CC O
92 CD O
mg/kg NN O
in IN O
female NN O
when WRB O
KP-T10 NNP O
was VBD O
administered VBN O
intrarectally RB O
. . O
, , O
while IN O
peroral JJ O
administration NN O
of IN O
KP-CMC NNP O
showed VBD O
LD50 DT O
values NNS O
of IN O
68 CD O
mg/kg NN O
in IN O
males NNS O
and CC O
78 CD O
mg/kg NN O
in IN O
females NNS O
in IN O
terms NNS O
of IN O
KP. NNP O

-DOCSTART- X X O

Autotransfusion NNP O
was VBD O
performed VBN O
as IN O
follows VBZ O
: : O
Heparin-ACD-B- NNP O
Heparin-DPD- NNP O
Heparin-ACD-B NNP O
etc FW O
. . O

-DOCSTART- X X O

Generally RB O
the DT O
differences NNS O
between IN O
short JJ O
gut NN O
and CC O
sham NN O
operation NN O
animals NNS O
disappeared VBD O
when WRB O
the DT O
data NNS O
were VBD O
normalised JJ O
for IN O
mucosal NN O
weight NN O
. . O

-DOCSTART- X X O

The DT O
architecture NN O
of IN O
microvasculature NN O
in IN O
these DT O
two CD O
regions NNS O
was VBD O
also RB O
examined VBN O
by IN O
scanning VBG O
electron NN O
microscopy NN O
, , O
using VBG O
the DT O
resin NN O
casting NN O
method NN O
. . O

-DOCSTART- X X O

Chordoma NNP O
of IN O
the DT O
spinal JJ O
cord NN O
in IN O
a DT O
F344 NNP O
rat NN O
. . O

-DOCSTART- X X O

Micro NNP O
high-performance NN O
liquid JJ O
chromatographic NN O
system NN O
with IN O
micro JJ O
precolumn NN O
and CC O
dual JJ O
electrochemical JJ O
detector NN O
for IN O
direct JJ O
injection NN O
analysis NN O
of IN O
catecholamines NNS O
in IN O
body NN O
fluids NNS O
. . O

-DOCSTART- X X O

A DT O
narrow JJ O
zone NN O
of IN O
myelin-axonal JJ O
dissociation NN O
was VBD O
also RB O
observed VBN O
. . O

-DOCSTART- X X O

The DT O
IgA NNP B-NP
deficiency NN O
is VBZ O
combined VBN O
with IN O
the DT O
IgE NNP B-NP
one CD O
. . O

-DOCSTART- X X O

Prevention NNP O
of IN O
transfusion NN O
reactions NNS O
by IN O
the DT O
use NN O
of IN O
saline NN O
washed VBN O
red JJ O
blood NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
geometric JJ O
mean JJ O
hemagglutination-inhibition NN O
antibody NN O
titers NNS O
( -LRB- O
GMT NNP O
) -RRB- O
of IN O
non-immunized JJ O
, , O
once-immunized JJ O
, , O
and CC O
twice-immunized JJ O
chickens NNS O
were VBD O
compared VBN O
at IN O
2-week JJ O
intervals NNS O
following VBG O
primary JJ O
immunization NN O
, , O
secondary JJ O
immunization NN O
, , O
and CC O
challenge NN O
. . O

-DOCSTART- X X O

The DT O
quantitative JJ O
determination NN O
of IN O
HBSAG--a NNP B-NP
valuable JJ O
aid NN O
in IN O
evaluating VBG O
the DT O
infectiousness NN O
of IN O
hepatitis NN O
B NNP O
virus NN O
carriers NNS O

-DOCSTART- X X O

2. JJ O
numerous JJ O
narrow JJ O
shunt NN O
vessels NNS O
departing VBG O
continuously RB O
from IN O
the DT O
primary JJ O
arteries NNS O
to TO O
feed VB O
a DT O
secondary JJ O
arterial NN O
system NN O
which WDT O
parallels VBZ O
the DT O
primary JJ O
one CD O
. . O

-DOCSTART- X X O

Urological JJ O
complications NNS O
are VBP O
frequent JJ O
during IN O
and CC O
after IN O
the DT O
treatment NN O
of IN O
gynecological JJ O
malignancy NN O
. . O

-DOCSTART- X X O

Arachnoid NNP O
cyst NN O
. . O

-DOCSTART- X X O

100 CD O
more JJR O
than IN O
in IN O
the DT O
summer NN O
coat NN O
) -RRB- O
. . O

-DOCSTART- X X O

Hypotension NNP O
was VBD O
produced VBN O
by IN O
head NN O
up IN O
tilt NN O
. . O

-DOCSTART- X X O

Therefore RB O
the DT O
procedure NN O
of IN O
Lich-Gregoir NNP O
is VBZ O
not RB O
to TO O
be VB O
recommended VBN O
in IN O
adults NNS O
. . O

-DOCSTART- X X O

Mucoepidermoid JJ O
and CC O
acinous JJ O
cell NN O
carcinomas NNS O
of IN O
salivary JJ O
tissues NNS O
. . O

-DOCSTART- X X O

Two CD O
new JJ O
artifacts NNS O
in IN O
automated VBN O
coagulation NN O
testing NN O
. . O

-DOCSTART- X X O

Longitudinal JJ O
force-length NN O
relationships NNS O
of IN O
guinea NN O
pig NN O
ureter NN O
were VBD O
studied VBN O
in IN O
vitro NN O
in IN O
animals NNS O
3 CD O
weeks NNS O
, , O
3 CD O
months NNS O
, , O
and CC O
3 CD O
years NNS O
of IN O
age NN O
. . O

-DOCSTART- X X O

Angiographic JJ O
work-up NN O
in IN O
a DT O
patient NN O
with IN O
late JJ O
vaginal JJ O
metastasis NN O
from IN O
a DT O
renal JJ O
carcinoma NN O
. . O

-DOCSTART- X X O

The DT O
following VBG O
aspects NNS O
were VBD O
assessed VBN O
: : O
( -LRB- O
1 LS O
) -RRB- O
The DT O
effect NN O
on IN O
the DT O
cardiovascular JJ O
system NN O
in IN O
terms NNS O
of IN O
brachial JJ O
arterial JJ O
pressure NN O
, , O
pulse NN O
rate NN O
, , O
and CC O
oxygen NN O
consumption NN O
(VO2 NN O
) -RRB- O
during IN O
exercise NN O
in IN O
5 CD O
health NN O
volunteers NNS O
; : O
( -LRB- O
2 CD O
) -RRB- O
emg NN O
activity NN O
of IN O
the DT O
tibialis NN O
anterior NN O
and CC O
gastrocnemius NN O
muscles NNS O
during IN O
exercise NN O
in IN O
the DT O
same JJ O
5 CD O
volunteers NNS O
; : O
and CC O
( -LRB- O
3 CD O
) -RRB- O
postexercise NN O
ankle NN O
pressure NN O
changes NNS O
in IN O
10 CD O
subjects NNS O
with IN O
angiographically RB O
proven VBN O
occlusive JJ O
arterial JJ O
diseases NNS O
of IN O
the DT O
lower JJR O
extremities NNS O
. . O

-DOCSTART- X X O

Changes NNS O
in IN O
immunologic JJ O
reactivity NN O
in IN O
subjects NNS O
receiving VBG O
transfer NN B-NP
factor NN I-NP
could MD O
not RB O
be VB O
distinguished VBN O
from IN O
those DT O
in IN O
subjects NNS O
receiving VBG O
placebo NN O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
argued VBN O
that IN O
this DT O
arose VBD O
from IN O
the DT O
possibility NN O
that IN O
the DT O
nature NN O
of IN O
blue JJ O
collar NN O
jobs NNS O
was VBD O
physical JJ O
, , O
and CC O
that DT O
loss NN O
of IN O
myocardial JJ O
tissue NN O
might MD O
be VB O
expected VBN O
to TO O
more RBR O
markedly RB O
interfere VB O
with IN O
their PRP$ O
work NN O
efficiency NN O
( -LRB- O
on IN O
returning VBG O
to TO O
work VB O
) -RRB- O
than IN O
it PRP O
would MD O
the DT O
efficiency NN O
of IN O
the DT O
more JJR O
sedentary JJ O
jobs NNS O
of IN O
white JJ O
collar NN O
workers NNS O
. . O

-DOCSTART- X X O

Specific JJ O
clotting NN O
factor NN O
assays WDT O
showed VBD O
an DT O
isolated JJ O
deficiency NN O
of IN O
factor NN B-NP
X NNP I-NP
ranging VBG O
from IN O
7 CD O
to TO O
12 CD O
per IN O
cent NN O
on IN O
three CD O
determinations NNS O
. . O

-DOCSTART- X X O

Charcoal-facilitated JJ O
dialysis NN O
. . O

-DOCSTART- X X O

Blood NN O
variables NNS O
measured VBN O
at IN O
eight CD O
intervals NNS O
before RB O
, , O
during IN O
, , O
and CC O
after IN O
operation NN O
were VBD O
as RB O
follows VBZ O
: : O
seven CD O
plasma NN O
proteins NNS O
, , O
free JJ O
hemoglobin NN B-NP
, , O
formed VBN O
elements NNS O
, , O
and CC O
clotting VBG O
functions NNS O
. . O

-DOCSTART- X X O

Retinal JJ O
changes NNS O
in IN O
pigmentary NN O
retinopathy NN O
in IN O
children NNS O

-DOCSTART- X X O

As IN O
a DT O
result NN O
, , O
beta-apo-8'-carotenoic JJ O
acid NN O
ethyl NN O
ester NN O
( -LRB- O
apo-EE NN O
) -RRB- O
was VBD O
used VBN O
as IN O
a DT O
reference NN O
standard NN O
in IN O
Experiments NNS O
4 CD O
to TO O
6 CD O
. . O

-DOCSTART- X X O

It PRP O
appears VBZ O
that IN O
the DT O
pulmonary JJ O
gas NN O
exchange NN O
parenchyma NN O
of IN O
these DT O
smallest JJS O
mammals NNS O
is VBZ O
well RB O
suited VBN O
to TO O
supply VB O
the DT O
organism NN O
with IN O
the DT O
comparatively RB O
high JJ O
levels NNS O
of IN O
O2 NN O
required VBN O
by IN O
the DT O
high JJ O
metabolic JJ O
rates NNS O
, , O
exhibiting VBG O
a DT O
structural JJ O
adaptation NN O
of IN O
the DT O
lung NN O
to TO O
higher JJR O
VO2 NN O
. . O

-DOCSTART- X X O

However RB O
, , O
at IN O
lower JJR O
temperature NN O
the DT O
positive JJ O
staircase NN O
was VBD O
not RB O
clear JJ O
and CC O
rather RB O
negative JJ O
staircase NN O
appeared VBD O
(1--3 JJ O
Hz NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Visual JJ O
averaged VBD O
evoked VBN O
responses NNS O
and CC O
platelet NN B-NP
monoamine NN I-NP
oxidase NN I-NP
in IN O
patients NNS O
suffering VBG O
from IN O
alcoholism NN O
. . O

-DOCSTART- X X O

Six CD O
hours NNS O
after IN O
the DT O
last JJ O
administration NN O
, , O
uterus NNP O
of IN O
Gf NNP O
and CC O
Cv NNP O
mice NNS O
were VBD O
weight NN O
337.6 CD O
mg NN O
% NN O
and CC O
423.5 CD O
mg NN O
% NN O
respectively RB O
, , O
the DT O
difference NN O
was VBD O
statistically RB O
significant JJ O
( -LRB- O
p NN O
less JJR O
than IN O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Autoradiographic NNP O
localisation NN O
of IN O
its PRP$ O
cellular JJ O
distribution NN O
in IN O
the DT O
kidney NN O
. . O

-DOCSTART- X X O

Hippocampal JJ O
stimulation NN O
overlapping IN O
conditioned JJ O
stimulus NN O
preexposure NN O
produced VBD O
attenuation NN O
of IN O
latent JJ O
inhibition NN O
, , O
as IN O
did VBD O
stimulation NN O
presented VBN O
during IN O
conditioning NN O
after IN O
preexposure NN O
. . O

-DOCSTART- X X O

Cataract NN O
extraction NN O
in IN O
primary JJ O
glaucoma NN O

-DOCSTART- X X O

In IN O
the DT O
intact JJ O
animal NN O
, , O
postextrasystolic JJ O
potentiation NN O
depended VBD O
on IN O
the DT O
basic JJ O
pacing NN O
interval NN O
, , O
t0 NN O
, , O
and CC O
the DT O
timing NN O
of IN O
the DT O
extrasystole NN O
, , O
t1 VBD O
: : O
when WRB O
t0 PRP O
was VBD O
held VBN O
constant JJ O
and CC O
t1 JJ O
was VBD O
increased VBN O
, , O
potentiation NN O
decreased VBD O
; : O
when WRB O
t1 PRP O
was VBD O
held VBN O
constant JJ O
and CC O
t0 DT O
was VBD O
increased VBN O
, , O
potentiation NN O
increased VBD O
. . O

-DOCSTART- X X O

Implications NNS O
of IN O
this DT O
observation NN O
for IN O
pediatrics NNS O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
suppurative NN O
peritonitis NN O

-DOCSTART- X X O

We PRP O
report VBP O
a DT O
case NN O
of IN O
pheochromocytoma NN O
manifesting NN O
during IN O
the DT O
third JJ O
trimester NN O
of IN O
pregnancy NN O
. . O

-DOCSTART- X X O

Fasting VBG O
plasma NN O
and CC O
lipoprotein NN O
lipid JJ O
concentrations NNS O
, , O
adipose DT B-NP
tissue NN I-NP
lipoprotein NN I-NP
lipase NN I-NP
activity NN O
, , O
anthropometric JJ O
data NNS O
, , O
alcohol NN O
consumption NN O
, , O
smoking VBG O
habits NNS O
, , O
weekly JJ O
mileage NN O
run VBN O
and CC O
performance NN O
on IN O
a DT O
bicycle NN O
ergometer NN O
were VBD O
recorded VBN O
before IN O
and CC O
after IN O
the DT O
training NN O
period NN O
. . O

-DOCSTART- X X O

The DT O
C18:1 NNP O
: : O
C10 DT O
value NN O
is VBZ O
a DT O
convenient JJ O
measure NN O
of IN O
these DT O
changes NNS O
and CC O
can MD O
be VB O
determined VBN O
more RBR O
rapidly RB O
than IN O
determining VBG O
all PDT O
the DT O
lower JJR O
fatty NN O
acids NNS O
. . O

-DOCSTART- X X O

A DT O
progressive JJ O
growth NN O
of IN O
blood NN O
erythrocyte NN O
membrane NN O
injury NN O
has VBZ O
been VBN O
demonstrated VBN O
after IN O
rats NNS O
were VBD O
exposed VBN O
to TO O
gamma-irradiaton NN O
at IN O
a DT O
dose NN O
of IN O
100 CD O
to TO O
500 CD O
Gy NNP O
. . O

-DOCSTART- X X O

One CD O
hundred CD O
twenty CD O
units NNS O
of IN O
deglycerolized JJ O
red JJ O
blood NN O
cells NNS O
, , O
some DT O
with IN O
glycerol NN O
added VBN O
so RB O
as IN O
to TO O
exceed VB O
an DT O
acceptable JJ O
1 CD O
% NN O
glycerol NN O
content NN O
, , O
had VBD O
measurements NNS O
made VBN O
of IN O
the DT O
post-wash NN O
supernatant JJ O
fluid NN O
by IN O
refractive JJ O
index NN O
and CC O
osmometry NN O
. . O

-DOCSTART- X X O

The DT O
symptoms NNS O
and CC O
objective JJ O
findings NNS O
were VBD O
caused VBN O
by IN O
a DT O
malignant JJ O
lymphoma NN O
, , O
and CC O
the DT O
diagnosis NN O
was VBD O
established VBN O
from IN O
a DT O
drill NN O
biopsy NN O
. . O

-DOCSTART- X X O

Our PRP$ O
study NN O
differs NNS O
from IN O
previous JJ O
studies NNS O
in IN O
that IN O
it PRP O
is VBZ O
limited VBN O
to TO O
one CD O
diagnostic JJ O
entity NN O
, , O
yet RB O
at IN O
the DT O
same JJ O
time NN O
evaluates VBZ O
a DT O
broad JJ O
range NN O
of IN O
social JJ O
and CC O
work-related JJ O
factors NNS O
in IN O
disability NN O
. . O

-DOCSTART- X X O

All DT O
control NN O
persons NNS O
had VBD O
a DT O
normal JJ O
reaction NN O
to TO O
DNFB. NNP O

-DOCSTART- X X O

In IN O
a DT O
control NN O
group NN O
both DT O
common JJ O
carotid NN O
arteries NNS O
(CCA IN O
) -RRB- O
were VBD O
ligated VBN O
. . O

-DOCSTART- X X O

At IN O
pH DT O
6.9 CD O
, , O
the DT O
same JJ O
lidocaine NN O
concentrations NNS O
significantly RB O
reduced VBD O
resting VBG O
potential JJ O
(3-10 NN O
% NN O
) -RRB- O
, , O
action NN O
potential JJ O
amplitude IN O
(3-8 CD O
% NN O
) -RRB- O
and CC O
Vmax NNP O
( -LRB- O
14-22 JJ O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Simultaneous JJ O
right NN O
and CC O
left VBD O
adrenal JJ O
and CC O
peripheral JJ O
blood NN O
samples NNS O
were VBD O
collected VBN O
for IN O
determination NN O
of IN O
oestrone JJ O
( -LRB- O
E1 NN O
) -RRB- O
and CC O
oestradiol JJ O
( -LRB- O
E2 NN O
) -RRB- O
. . O

-DOCSTART- X X O

All DT O
lambs NNS O
with IN O
B NNP O
breeding NN O
had VBD O
significantly RB O
higher JJR O
Hb NN B-NP
levels NNS O
at IN O
the DT O
end NN O
of IN O
the DT O
experiment NN O
than IN O
did VBD O
NB NNP O
lambs NNS O
. . O
b NN O
and CC O
S NNP O
x NNP O
B NNP O
lambs NNS O
had VBD O
higher JJR O
( -LRB- O
P NNP O
< , O
.05 CD O
) -RRB- O
Hb NN B-NP
levels NNS O
than IN O
the DT O
D NNP O
x NN O
B NNP O
lambs NNS O
, , O
and CC O
B NNP O
lambs NNS O
had VBD O
the DT O
highest JJS O
( -LRB- O
P NNP O
< NN O
.05 CD O
) -RRB- O
mean VBP O
corpuscular JJ O
hemoglobin NN B-NP
concentrations NNS O
. . O

-DOCSTART- X X O

The DT O
same JJ O
response NN O
occurs VBZ O
whether IN O
acrylamide NN O
is VBZ O
given VBN O
immediately RB O
after IN O
nerve NN O
ligation NN O
or CC O
1 CD O
week NN O
later RB O
. . O

-DOCSTART- X X O

The DT O
operation NN O
recommended VBN O
is VBZ O
excision NN O
of IN O
3 CD O
mm CD O
of IN O
central JJ O
slip NN O
followed VBN O
by IN O
end-to-end JJ O
repair NN O
of IN O
the DT O
tendon NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
unclipped JJ O
group NN O
arterial NN O
pressure NN O
decreased VBN O
50 CD O
mmHg NN O
to TO O
normal JJ O
by IN O
24 CD O
h NN O
and CC O
was VBD O
associated VBN O
with IN O
increased VBN O
diuresis NN O
and CC O
a DT O
small JJ O
decrease NN O
in IN O
blood NN O
volume NN O
( -LRB- O
9.8 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
ESEG NNP O
's POS O
are VBP O
a DT O
direct JJ O
result NN O
of IN O
the DT O
NEXT NNP O
study NN O
. . O

-DOCSTART- X X O

A DT O
third JJ O
series NN O
of IN O
mice NNS O
were VBD O
given VBN O
a DT O
single JJ O
injection NN O
of IN O
5-OH-DA JJ O
, , O
sacrificed JJ O
, , O
and CC O
prepared VBD O
for IN O
ultrastructural JJ O
study NN O
. . O

-DOCSTART- X X O

Fourteen CD O
different JJ O
species NNS O
( -LRB- O
eight CD O
Platyhelmintha NN O
, , O
one CD O
Nematoda NNP O
and CC O
five CD O
Crustacea NNP O
) -RRB- O
have VBP O
been VBN O
inventorized VBN O
. . O

-DOCSTART- X X O

No DT O
symptoms NNS O
other JJ O
than IN O
hot JJ O
flush NN O
showed VBD O
such JJ O
significant JJ O
correlation NN O
with IN O
plasma NN O
epinephrine NN O
or CC O
norepinephrine JJ O
levels NNS O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
values NNS O
of IN O
the DT O
concentrations NNS O
of IN O
the DT O
components NNS O
due JJ O
to TO O
tobacco NN O
smoke NN O
are VBP O
: : O
CO NNP O
= SYM O
1.1 CD O
ppm NN O
, , O
NO DT O
= SYM O
32 CD O
ppb NN O
, , O
NO2 DT O
= SYM O
24 CD O
ppb NN O
, , O
nicotine JJ O
= SYM O
0.9 CD O
micrograms/m3 CD O
, , O
particulate JJ O
matter NN O
= SYM O
133 CD O
micrograms/m3 CD O
. . O

-DOCSTART- X X O

The DT O
average JJ O
backscatter NN O
coefficient NN O
was VBD O
six CD O
time NN O
larger JJR O
in IN O
regions NNS O
of IN O
infarct NN O
studied VBN O
8--10 CD O
weeks NNS O
after IN O
occlusion NN O
than IN O
that IN O
in IN O
regions NNS O
of IN O
infarct NN O
studied VBN O
5--6 CD O
weeks NNS O
after IN O
occlusion NN O
. . O

-DOCSTART- X X O

Early RB O
infection NN O
was VBD O
detected VBN O
in IN O
one CD O
of IN O
50 CD O
control NN O
women NNS O
who WP O
gave VBD O
birth NN O
to TO O
a DT O
healthy JJ O
infant NN O
. . O

-DOCSTART- X X O

Family NNP O
planning NN O
continues VBZ O
to TO O
play VB O
a DT O
minor JJ O
role NN O
, , O
and CC O
only RB O
25.3 CD O
per IN O
cent NN O
of IN O
all DT O
patients NNS O
reviewed VBN O
took VBD O
to TO O
oral JJ O
contraceptives NNS O
for IN O
shorter JJR O
or CC O
longer JJR O
periods NNS O
of IN O
time NN O
. . O
- : O
The DT O
percentages NNS O
of IN O
primiparae NNS O
and CC O
secundiparae NNS O
in IN O
all DT O
births NNS O
as RB O
well RB O
as IN O
the DT O
high JJ O
percentage NN O
of IN O
multigravidity NN O
are VBP O
parameters NNS O
by IN O
which WDT O
the DT O
approach NN O
to TO O
reproduction NN O
differs NNS O
substantively RB O
from IN O
behaviour NN O
patterns NNS O
in IN O
Europe NNP O
. . O

-DOCSTART- X X O

The DT O
identification NN O
of IN O
viable JJ O
myocardium NN O
with IN O
both DT O
99mTc-tetrofosmin NNP O
and CC O
201Tl NNP O
can MD O
be VB O
greatly RB O
enhanced VBN O
to TO O
a DT O
similar JJ O
degree NN O
if IN O
the DT O
severity NN O
of IN O
reduction NN O
in IN O
activity NN O
within IN O
nonreversible JJ O
defects NNS O
is VBZ O
considered VBN O
. . O

-DOCSTART- X X O

The DT O
temporal JJ O
component NN O
lacked VBD O
a DT O
mandibular JJ O
fossa NN O
as RB O
well RB O
as IN O
articular JJ O
eminence NN O
. . O

-DOCSTART- X X O

The DT O
protein NN B-NP
ELT-1 NN I-NP
, , O
encoded VBN O
by IN O
a DT O
single-copy JJ O
gene NN O
homologous JJ O
to TO O
the DT O
GATA NNP B-NP
family NN I-NP
of IN I-NP
vertebrate JJ I-NP
transcription NN I-NP
factors NNS I-NP
, , O
is VBZ O
potentially RB O
capable JJ O
of IN O
interacting VBG O
with IN O
this DT O
element NN O
. . O

-DOCSTART- X X O

However RB O
, , O
in IN O
contrast NN O
with IN O
previous JJ O
in IN O
vitro NN O
cell-free JJ O
integration NN O
studies NNS O
, , O
alteration NN O
of IN O
the DT O
highly RB O
conserved VBN O
CA NNP O
dinucleotide NN O
resulted VBD O
in IN O
a DT O
mutant NN O
which WDT O
still RB O
retained VBD O
40 CD O
% NN O
of IN O
wild-type JJ O
integration NN O
activity NN O
. . O

-DOCSTART- X X O

The DT O
resulting VBG O
R NN B-NP
protein NN I-NP
terminates VBZ O
five CD O
codons NNS O
downstream RB O
of IN O
the DT O
frameshift NN O
site NN O
at IN O
the DT O
V NNP B-NP
protein NN I-NP
stop NN O
codon NN O
. . O

-DOCSTART- X X O

By IN O
site-specific JJ O
mutagenesis NN O
, , O
we PRP O
also RB O
show VBP O
that IN O
individual JJ O
ICP27 NN B-NP
C-terminal JJ I-NP
amino IN I-NP
acid NN I-NP
residues NNS I-NP
that WDT O
are VBP O
positionally RB O
conserved VBN O
in IN O
ICP27 DT B-NP
homologs NNS I-NP
in IN O
other JJ O
herpesviruses NNS O
(D-357 CC O
, , O
E-358 UH O
, , O
H-479 UH O
, , O
C-400 NN O
, , O
C-483 NN O
, , O
and CC O
C-488 NN O
) -RRB- O
are VBP O
critical JJ O
for IN O
trans-regulatory JJ O
activity NN O
. . O

-DOCSTART- X X O

Magnetic JJ O
resonance NN O
imaging NN O
( -LRB- O
MRI NNP O
) -RRB- O
has VBZ O
enabled VBN O
us PRP O
to TO O
see VB O
the DT O
spinal JJ O
intramedullary NN O
pathology NN O
as IN O
differences NNS O
in IN O
signal NN O
intensity NN O
. . O

-DOCSTART- X X O

Malaria NNP O
, , O
anaemia NN O
, , O
and CC O
HIV-1 PRP$ O
transmission NN O
in IN O
central JJ O
Africa NNP O
. . O

-DOCSTART- X X O

Peroxisome DT B-NP
proliferator-activated JJ I-NP
receptors NNS I-NP
( -LRB- O
PPARs NNS B-NP
) -RRB- O
and CC O
retinoid JJ B-NP
X NNP I-NP
receptors NNS I-NP
( -LRB- O
RXRs NNS B-NP
) -RRB- O
are VBP O
nuclear JJ B-NP
hormone NN I-NP
receptors NNS I-NP
that WDT O
are VBP O
activated VBN O
by IN O
fatty JJ O
acids NNS O
and CC O
9-cis-retinoic JJ O
acid NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Some DT O
strains NNS O
of IN O
A. NN O
parasiticus NN O
produced VBD O
all DT O
four CD O
aflatoxins NNS O
B1 IN O
B2 JJ O
G1 NNP O
G2 NNP O
, , O
while IN O
the DT O
other JJ O
ones NNS O
produced VBN O
AF NNS O
B1 CC O
+ NNS O
G1 IN O
only RB O
, , O
with IN O
concentrations NNS O
of IN O
aflatoxins NNS O
from IN O
0.1 CD O
to TO O
450 CD O
mg/kg NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
a DT O
new JJ O
, , O
larger JJR O
rat NN B-NP
B-myc JJ I-NP
genomic JJ I-NP
clone NN I-NP
. . O

-DOCSTART- X X O

Both DT O
classes NNS O
of IN O
MHBst NNP B-NP
proteins NNS I-NP
were VBD O
found VBN O
to TO O
form VB O
dimers NNS O
; : O
an DT O
which WDT O
is VBZ O
involved VBN O
in IN O
mediating VBG O
the DT O
dimerization NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
sequence NN O
identified VBD O
four CD O
open JJ O
reading NN O
frames NNS O
( -LRB- O
ORFs NNS O
) -RRB- O
which WDT O
are VBP O
designated VBN O
UL1 NNP B-NP
, , O
UL2 NNP B-NP
, , O
UL3 NNP B-NP
, , O
and CC O
UL3.5 IN B-NP
based VBN O
on IN O
their PRP$ O
homology NN O
with IN O
proteins NNS O
of IN O
herpes PRP$ O
simplex JJ O
virus-1 NN O
( -LRB- O
HSV-1 NN O
) -RRB- O
, , O
pseudorabies VBZ O
virus NN O
( -LRB- O
PRV NN O
) -RRB- O
, , O
equine JJ O
herpesvirus-1 NN O
, , O
and CC O
varicella-zoster JJ O
virus NN O
. . O

-DOCSTART- X X O

The DT O
serum NN O
levels NNS O
of IN O
IgE NNP B-NP
, , O
and CC O
asIgE NN B-NP
and CC O
IgG-4 NN B-NP
against IN O
14 CD O
common JJ O
food NN O
allergens NNS O
were VBD O
determined VBN O
. . O

-DOCSTART- X X O

Two CD O
experiments NNS O
investigating VBG O
the DT O
effects NNS O
of IN O
short-term JJ O
spaceflight NN O
on IN O
cancellous JJ O
bone NN O
turnover NN O
were VBD O
carried VBN O
out RP O
: : O
Physiological NNP O
Systems NNPS O
Experiment-1 FW O
( -LRB- O
PSE-1 NN O
) -RRB- O
( -LRB- O
a DT O
4-d JJ O
orbital NN O
spaceflight NN O
) -RRB- O
and CC O
PSE-2 NNP O
( -LRB- O
a DT O
10-d JJ O
flight NN O
) -RRB- O
. . O

-DOCSTART- X X O

That DT O
sequence NN O
strongly RB O
promoted VBD O
the DT O
transcription NN O
of IN O
the DT O
promotorless JJ O
chloramphenicol NN B-NP
acetyltranferase NN I-NP
( -LRB- O
CAT NN B-NP
) -RRB- O
gene NN O
in IN O
cells NNS O
of IN O
pancreatic JJ O
origin NN O
( -LRB- O
AR-42J) NN O
but CC O
not RB O
in IN O
cells NNS O
of IN O
non-pancreatic JJ O
origin NN O
( -LRB- O
Rat NNP O
2 CD O
and CC O
IEC NNP O
6 CD O
) -RRB- O
. . O

-DOCSTART- X X O

An DT O
approach NN O
to TO O
a DT O
biomathematical JJ O
model NN O
of IN O
lymphocytopoiesis NN O
. . O

-DOCSTART- X X O

These DT O
are VBP O
two CD O
regions NNS O
of IN O
known VBN O
conserved VBN O
synteny NN O
, , O
providing VBG O
further JJ O
evidence NN O
that IN O
the DT O
human JJ B-NP
STEP NNP I-NP
is VBZ O
a DT O
true JJ O
homolog NN O
of IN O
the DT O
murine NN B-NP
STEP NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Carbonic NNP B-NP
anhydrase NN I-NP
V NNP I-NP
( -LRB- O
CA NNP B-NP
V NNP I-NP
) -RRB- O
is VBZ O
expressed VBN O
in IN O
mitochondrial NN O
matrix NN O
in IN O
liver NN O
and CC O
several JJ O
other JJ O
tissues NNS O
. . O

-DOCSTART- X X O

Vitamin NNP O
D3 NNP O
plus CC O
nicotine JJ O
treatment NN O
produced VBD O
parallel JJ O
increases NNS O
in IN O
cardiac JJ O
mass NN O
and CC O
elastic JJ O
modulus NN O
, , O
with IN O
a DT O
significant JJ O
correlation NN O
between IN O
the DT O
two CD O
. . O

-DOCSTART- X X O

This DT O
finding NN O
is VBZ O
consistent JJ O
with IN O
the DT O
notion NN O
that IN O
the DT O
dsRNA NN O
binding NN O
domains NNS O
may MD O
be VB O
composed VBN O
of IN O
two CD O
separate JJ O
functional JJ O
subdomains NNS O
. . O

-DOCSTART- X X O

We PRP O
studied VBD O
the DT O
GR CD B-NP
in IN O
DMS-79 CD O
cells NNS O
derived VBN O
from IN O
a DT O
human JJ O
ACTH-secreting NNP B-NP
small JJ O
cell NN O
lung NN O
cancer NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
as IN O
expected VBN O
, , O
trans-splicing NN O
depends VBZ O
on IN O
the DT O
integrity NN O
of IN O
U2 NNP B-NP
, , O
U4 NNP B-NP
, , O
and CC O
U6 NNP B-NP
snRNAs NNS I-NP
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
PCC4.aza1R NNP O
cells NNS O
with IN O
an DT O
RAR-selective JJ B-NP
agonist NN O
also RB O
repressed VBD O
the DT O
expression NN O
of IN O
EC-1 JJ B-NP
mRNA NN I-NP
while IN O
treatment NN O
with IN O
an DT O
RXR-selective JJ B-NP
agonist NN O
reduced VBD O
EC-1 JJ B-NP
expression NN O
slightly RB O
. . O

-DOCSTART- X X O

In IN O
the DT O
absence NN O
of IN O
E1A243 NNP B-NP
, , O
YY1 NNP B-NP
represses VBZ O
CRE-dependent JJ O
transcription NN O
of IN O
c-fos NNS B-NP
by IN O
physically RB O
interacting VBG O
with IN O
ATF/CREB NNP B-NP
proteins VBZ O
bound VBN O
to TO O
the DT O
-67 NN O
CRE. . O

-DOCSTART- X X O

Shift-down JJ O
experiments NNS O
indicated VBD O
that IN O
the DT O
10( JJ O
4) CD O
- : O
to TO O
10(5)-fold JJ O
reduction NN O
in IN O
virus NN O
yield NN O
at IN O
the DT O
nonpermissive JJ O
temperature NN O
was VBD O
due JJ O
to TO O
the DT O
disfunction NN O
of IN O
alpha NN B-NP
TIF NN I-NP
late RB O
in IN O
infection NN O
, , O
presumably RB O
in IN O
virion NN O
maturation NN O
. . O

-DOCSTART- X X O

Human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
Vpr NN I-NP
is VBZ O
a DT O
virion-associated JJ O
, , O
regulatory JJ O
protein NN O
that WDT O
is VBZ O
required VBN O
for IN O
efficient JJ O
viral JJ O
replication NN O
in IN O
monocytes/macrophages NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
transcriptional JJ O
regulation NN O
, , O
splicing NN O
, , O
kinase NN O
interaction NN O
sites NNS O
, , O
and CC O
tyrosine NN O
phosphorylation NN O
of IN O
the DT O
LMP2A NNP B-NP
homologs NNS I-NP
have VBP O
been VBN O
conserved VBN O
despite IN O
significant JJ O
sequences NNS O
heterogeneity NN O
in IN O
the DT O
preterminal JJ O
repeat NN O
regions NNS O
of IN O
these DT O
human JJ O
and CC O
nonhuman JJ O
primate JJ O
EBVs NNS O
. . O

-DOCSTART- X X O

Results NNS O
of IN O
the DT O
ECAT NNP O
Angina NNP O
Pectoris NNP O
Study NNP O
Group NNP O
. . O

-DOCSTART- X X O

These DT O
motifs NNS O
include VBP O
a DT O
Chi NNP O
motif NN O
and CC O
a DT O
Chi-like JJ O
element NN O
previously RB O
found VBN O
in IN O
the DT O
recombination NN O
hotspot IN O
region NN O
of IN O
the DT O
Bcl-2 JJ B-NP
proto-oncogene NN I-NP
and CC O
close JJ O
to TO O
chromosomal NN O
breakpoints NNS O
in IN O
T-ALL JJ O
lines NNS O
. . O

-DOCSTART- X X O

Common JJ O
history NN O
and CC O
prospects NNS O
in IN O
surgical JJ O
gynecology NN O
of IN O
the DT O
Charite NNP O
and CC O
the DT O
Vienna NNP O
University NNP O
Clinic NNP O

-DOCSTART- X X O

In IN O
contrast NN O
with IN O
the DT O
previously RB O
reported VBN O
HMGR1 JJ B-NP
mRNA NN I-NP
( -LRB- O
HMGR1S JJ B-NP
mRNA NN I-NP
) -RRB- O
, , O
which WDT O
is VBZ O
detected VBN O
at IN O
high JJ O
levels NNS O
in IN O
all DT O
tissues NNS O
of IN O
the DT O
plant NN O
, , O
HMGR1L NNP B-NP
mRNA NN I-NP
is VBZ O
present JJ O
at IN O
relatively RB O
low JJ O
levels NNS O
and CC O
its PRP$ O
expression NN O
is VBZ O
restricted VBN O
mostly RB O
to TO O
seedlings NNS O
, , O
roots NNS O
and CC O
inflorescences NNS O
. . O

-DOCSTART- X X O

In IN O
adult NN O
tissues NNS O
, , O
it PRP O
was VBD O
less RBR O
restricted VBN O
, , O
indicating VBG O
that IN O
RAFTK NNP B-NP
expression NN O
is VBZ O
developmentally RB O
up-regulated JJ O
. . O

-DOCSTART- X X O

J. NNP O

-DOCSTART- X X O

TPBF NNP B-NP
has VBZ O
two CD O
potential JJ O
coiled-coil NN O
regions NNS O
, , O
a DT O
basic JJ O
region NN O
, , O
a DT O
proline-rich JJ O
region NN O
, , O
a DT O
histidine-rich JJ O
N NNP O
terminus NN O
, , O
and CC O
a DT O
nuclear JJ O
targeting VBG O
sequence NN O
. . O

-DOCSTART- X X O

A DT O
tobacco NN O
homologue NN O
( -LRB- O
trolC NN B-NP
) -RRB- O
of IN O
the DT O
rolC NNP B-NP
gene NN I-NP
of IN I-NP
the DT I-NP
Agrobacterium NNP I-NP
rhizogenes NNS I-NP
Ri-plasmid NNP I-NP
was VBD O
cloned VBN O
and CC O
sequenced VBN O
from IN O
Nicotiana NNP O
tabacum NN O
L. NNP O
cv. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
a DT O
1- JJ O
or CC O
24-hour JJ O
pretreatment NN O
regimen NNS O
with IN O
monophosphoryl NN O
lipid NN O
A DT O
( -LRB- O
MLA NNP O
, , O
35 CD O
micrograms/kg NN O
i NN O
.v. NN O
) -RRB- O
on IN O
myocardial JJ O
stunning JJ O
produced VBN O
by IN O
repetitive JJ O
coronary JJ O
occlusions NNS O
were VBD O
studied VBN O
in IN O
barbital-anesthetized JJ O
dogs NNS O
. . O

-DOCSTART- X X O

These DT O
incisors NNS O
were VBD O
studied VBN O
by IN O
scanning VBG O
electron NN O
microscopy-energy NN O
dispersive JJ O
spectroscopy NN O
analysis NN O
( -LRB- O
SEM-EDS NNP O
) -RRB- O
and CC O
light JJ O
microscopy NN O
to TO O
examine VB O
the DT O
calciotraumatic JJ O
lines NNS O
of IN O
strontium NN O
in IN O
the DT O
rat NN O
incisor NN O
labial NN O
dentin NN O
. . O

-DOCSTART- X X O

A DT O
platelet-derived JJ B-NP
growth NN I-NP
factor NN I-NP
receptor NN I-NP
( -LRB- O
PDGF-R NN B-NP
) -RRB- O
phosphopeptide NN O
containing VBG O
Tyr-857 NNP O
does VBZ O
not RB O
bind NN O
appreciably RB O
to TO O
the DT O
Src NNP B-NP
SH2 NNP I-NP
domain NN I-NP
, , O
suggesting VBG O
it PRP O
is VBZ O
not RB O
the DT O
PDGF-R NNP B-NP
binding NN O
site NN O
for IN O
Src NNP B-NP
as IN O
previously RB O
reported VBN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
also RB O
tested VBN O
Src NNP B-NP
SH2 NNP B-NP
mutants NNS O
for IN O
their PRP$ O
binding JJ O
properties NNS O
and CC O
have VBP O
interpreted VBN O
our PRP$ O
results NNS O
in IN O
light NN O
of IN O
the DT O
recent JJ O
crystal NN O
structure NN O
solution NN O
for IN O
the DT O
Src NNP B-NP
SH2 NNP B-NP
domain NN O
. . O

-DOCSTART- X X O

These DT O
observations NNS O
link VBP O
actin IN B-NP
plaque NN O
assembly NN O
to TO O
increased VBN O
cell NN O
substrate NN O
adhesion NN O
. . O

-DOCSTART- X X O

There EX O
are VBP O
two CD O
immunogenic JJ O
sites NNS O
on IN O
the DT O
type NN O
A DT O
influenza NN O
A/Japan/57 IN O
( -LRB- O
H2N2 NN O
) -RRB- O
hemagglutinin FW B-NP
( -LRB- O
HA NNP B-NP
) -RRB- O
that WDT O
can MD O
be VB O
recognized VBN O
by IN O
class NN B-NP
I PRP I-NP
major VBP I-NP
histocompatibility NN I-NP
complex NN I-NP
( -LRB- O
MHC) NNP B-NP
, , O
H-2Kd-restricted JJ B-NP
cytolytic JJ O
T NNP O
lymphocytes NNS O
( -LRB- O
CTLs NNS O
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
enhancer NN O
activates VBZ O
both DT O
the DT O
K19 NNP B-NP
and CC O
TK NNP B-NP
basal JJ I-NP
promoters NNS I-NP
in IN O
HeLa NNP O
cells NNS O
. . O

-DOCSTART- X X O

Mechanism NN O
of IN O
enhancement NN O
of IN O
DNA NNP O
expression NN O
consequent JJ O
to TO O
cointernalization NN O
of IN O
a DT O
replication-deficient JJ O
adenovirus NN O
and CC O
unmodified JJ O
plasmid JJ O
DNA NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
one CD O
IRF NNP B-NP
binding NN I-NP
site NN I-NP
was VBD O
found VBN O
within IN O
the DT O
IRF-2 NN B-NP
promoter NN I-NP
, , O
and CC O
expression NN O
of IN O
the DT O
IRF-2 NNP B-NP
gene NN I-NP
was VBD O
affected VBN O
by IN O
both DT O
transient JJ O
and CC O
stable JJ O
IRF-1 JJ B-NP
expression NN O
. . O

-DOCSTART- X X O

The DT O
highest JJS O
decrease NN O
in IN O
mutagenic JJ O
activity NN O
was VBD O
observed VBN O
when WRB O
enzymatic JJ O
bleaching NN O
was VBD O
used VBN O
together RB O
with IN O
chlorine NN O
. . O

-DOCSTART- X X O

There EX O
was VBD O
also RB O
a DT O
highly RB O
significant JJ O
correlation NN O
between IN O
total JJ O
selenium NN O
intake NN O
and CC O
liver NN O
selenium NN O
concentration NN O
( -LRB- O
r NN O
= SYM O
0.99 CD O
, , O
p NN O
< NN O
0.01 CD O
) -RRB- O
after IN O
1 CD O
mo NN O
of IN O
treatment NN O
, , O
but CC O
this DT O
time NN O
liver NN O
selenium NN O
did VBD O
not RB O
change VB O
with IN O
time NN O
, , O
and CC O
the DT O
correlation NN O
remained VBD O
highly RB O
significant JJ O
throughout IN O
the DT O
investigation NN O
. . O

-DOCSTART- X X O

Antibodies NNPS O
affinity-purified JJ O
using VBG O
the DT O
bacterially RB O
expressed VBN O
recombinant JJ O
protein NN O
recognized VBD O
the DT O
56K JJ B-NP
autoantigen NN I-NP
in IN O
a DT O
HeLa NNP O
cell NN O
extract VB O
. . O
cDNA NN O
sequencing NN O
revealed VBD O
that IN O
the DT O
56K JJ B-NP
cDNA NN I-NP
shares NNS O
a DT O
high JJ O
degree NN O
of IN O
homology NN O
in IN O
both DT O
nucleotide JJ O
(87 NN O
% NN O
) -RRB- O
and CC O
amino JJ O
acid NN O
sequence NN O
(92.5 CC O
% NN O
) -RRB- O
with IN O
bovine NN B-NP
annexin IN I-NP
XI NNP I-NP
, , O
indicating VBG O
that IN O
the DT O
56K JJ B-NP
cDNA NN I-NP
encodes VBZ O
the DT O
human JJ B-NP
homologue NN I-NP
of IN I-NP
annexin DT I-NP
XI NNP I-NP
, , O
a DT O
member NN O
of IN O
the DT O
Ca( NNP B-NP
2+)-dependent JJ I-NP
phospholipid JJ I-NP
binding JJ I-NP
protein NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

The DT O
avidin-biotin NN B-NP
complex NN I-NP
peroxidase NN I-NP
( -LRB- O
ABC-P) JJ B-NP
method NN O
was VBD O
used VBN O
to TO O
detect VB O
Mycobacterium NNP O
bovis NNS O
, , O
and CC O
the DT O
results NNS O
were VBD O
compared VBN O
with IN O
those DT O
obtained VBN O
by IN O
the DT O
Ziehl-Neelsen NNP O
( -LRB- O
ZN NN O
) -RRB- O
technique NN O
. . O

-DOCSTART- X X O

Its PRP$ O
role NN O
in IN O
these DT O
processes NNS O
suggests VBZ O
that IN O
the DT O
function NN O
of IN O
c-Myb NN B-NP
may MD O
be VB O
important JJ O
early RB O
in IN O
the DT O
establishment NN O
of IN O
the DT O
hematopoietic JJ O
lineage NN O
. . O

-DOCSTART- X X O

The DT O
transforming VBG O
gene NN O
of IN O
the DT O
avian JJ B-NP
sarcoma NN I-NP
virus NN I-NP
CT10 CC I-NP
encodes VBZ O
a DT O
fusion NN O
protein NN O
( -LRB- O
p47gag-crk JJ B-NP
or CC O
v-Crk NN B-NP
) -RRB- O
containing VBG O
viral JJ B-NP
Gag NNP I-NP
sequences NNS I-NP
fused VBN O
to TO O
cellular JJ O
sequences NNS O
consisting VBG O
primarily RB O
of IN O
Src NNP B-NP
homology NN I-NP
regions NNS I-NP
2 CD I-NP
and CC I-NP
3 CD I-NP
( -LRB- O
SH2 NN B-NP
and CC O
SH3 JJ B-NP
sequences NNS I-NP
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
specific JJ O
methylation NN O
pattern NN O
caused VBN O
inactivation NN O
of IN O
the DT O
HSV NNP B-NP
tk NN I-NP
gene NN I-NP
, , O
while IN O
methylation NN O
of IN O
the DT O
cytosine NN O
residues NNS O
within IN O
the DT O
nucleotide JJ O
sequence NN O
from IN O
+811 CD O
to TO O
+1309 VB O
had VBD O
no DT O
effect NN O
on IN O
HSV NNP B-NP
tk JJ I-NP
gene NN I-NP
activity NN O
. . O

-DOCSTART- X X O

GTRE NNP O
, , O
TRE NNP O
, , O
and CC O
CRE NNP O
oligonucleotides NNS O
all DT O
compete VBP O
more RBR O
efficiently RB O
for IN O
protein NN O
binding NN O
to TO O
their PRP$ O
labeled VBN O
congeners NNS O
than IN O
for IN O
protein NN O
binding NN O
to TO O
either DT O
of IN O
the DT O
other JJ O
labeled VBN O
oligonucleotides NNS O
, , O
suggesting VBG O
that IN O
the DT O
GTRE NNP O
, , O
TRE NNP O
, , O
and CC O
CRE NNP O
oligonucleotides NNS O
, , O
suggesting VBG O
that IN O
the DT O
GTRE NNP O
, , O
TRE NNP O
, , O
and CC O
CRE NNP O
oligonucleotides NNS O
each DT O
bind NN O
unique JJ O
as RB O
well RB O
as IN O
common JJ O
proteins NNS O
, , O
likely JJ O
to TO O
be VB O
members NNS O
of IN O
the DT O
Jun/Fos NNP B-NP
and CC O
cAMP-responsive JJ B-NP
element-binding JJ I-NP
protein/activating NN I-NP
transcription NN B-NP
factors NNS I-NP
( -LRB- O
CREB/ATF NN B-NP
) -RRB- O
families NNS O
of IN O
transcription NN O
factors NNS O
, , O
in IN O
chromaffin NN O
cells NNS O
. . O

-DOCSTART- X X O

One CD O
patient NN O
only RB O
had VBD O
any DT O
test NN O
abnormalities NNS O
. . O

-DOCSTART- X X O

One CD O
antibody NN O
, , O
mAb1C2 NN B-NP
, , O
and CC O
a DT O
synthetic JJ O
peptide NN O
comprising VBG O
its PRP$ O
epitope NN O
selectively RB O
inhibited VBD O
in IN O
vitro NN O
transcription NN O
from IN O
TATA-containing JJ O
, , O
but CC O
not RB O
from IN O
TATA-less JJ O
promoters NNS O
, , O
irrespective NN O
of IN O
whether IN O
they PRP O
were VBD O
transcribed VBN O
by IN O
Pol NNP B-NP
II NNP I-NP
or CC O
Pol NNP B-NP
III NNP I-NP
. . O

-DOCSTART- X X O

The DT O
lymph NN O
nodes VBZ O
from IN O
two CD O
of IN O
the DT O
patients NNS O
with IN O
rheumatoid NNP O
arthritis NN O
contained VBD O
numerous JJ O
sarcoid JJ O
like IN O
granulomata NN O
, , O
further RB O
indicating VBG O
a DT O
possible JJ O
association NN O
between IN O
sarcoidosis NN O
and CC O
rheumatoid NN O
arthritis NN O
. . O

-DOCSTART- X X O

HCV NN O
infection NN O
acquired VBN O
during IN O
or CC O
after IN O
BMT NNP O
caused VBD O
only RB O
mild JJ O
acute JJ O
hepatitis NN O
C NNP O
, , O
which WDT O
progressed VBD O
to TO O
chronic JJ O
hepatitis NN O
C NNP O
in IN O
one CD O
patient NN O
surviving VBG O
10 CD O
years NNS O
after IN O
BMT. NNP O

-DOCSTART- X X O

Hepatitis NNP O
C NNP O
virus NN O
infection NN O
is VBZ O
a DT O
risk NN O
factor NN O
for IN O
liver NN O
failure NN O
from IN O
veno-occlusive JJ O
disease NN O
after IN O
bone NN O
marrow NN O
transplantation NN O
. . O

-DOCSTART- X X O

These DT O
human JJ O
IFN-beta-transformed NNP B-NP
cell NN O
populations NNS O
have VBP O
acquired VBN O
a DT O
low JJ O
, , O
constitutive JJ O
production NN O
of IN O
human JJ B-NP
IFN NNP I-NP
, , O
while IN O
replicating VBG O
at IN O
a DT O
rate NN O
similar JJ O
to TO O
that DT O
of IN O
untransformed JJ O
cells NNS O
and CC O
of IN O
cells NNS O
transformed VBN O
with IN O
the DT O
control NN O
vector NN O
carrying VBG O
a DT O
human JJ B-NP
IFN-beta NN I-NP
sequence NN I-NP
encoding VBG O
an DT O
inactive JJ O
, , O
mutated JJ O
protein NN O
. . O

-DOCSTART- X X O

Improvement NN O
of IN O
the DT O
polypyrimidine NN O
tract NN O
also RB O
increased VBD O
the DT O
splicing NN O
efficiency NN O
, , O
but CC O
to TO O
a DT O
degree NN O
slightly RB O
less JJR O
than IN O
that IN O
obtained VBN O
with IN O
the DT O
branchpoint NN O
mutation NN O
. . O

-DOCSTART- X X O

Joys NNP O
and CC O
F. NNP O

-DOCSTART- X X O

A DT O
full-length JJ B-NP
PRL NN I-NP
receptor NN I-NP
( -LRB- O
PRLR NN B-NP
) -RRB- O
complementary JJ O
DNA NN O
from IN O
pigeons NNS O
was VBD O
obtained VBN O
by IN O
screening VBG O
pigeon NN O
crop NN O
sac NN O
libraries NNS O
and CC O
by IN O
reverse NN O
transcription NN O
coupled VBN O
with IN O
polymerase NN O
chain NN O
reaction NN O
. . O

-DOCSTART- X X O

After IN O
7 CD O
days NNS O
, , O
a DT O
spontaneous JJ O
regression NN O
of IN O
the DT O
morphologic NN O
alterations NNS O
caused VBN O
by IN O
caerulein-induced JJ O
acute JJ O
pancreatitis NN O
occurs VBZ O
; : O
however RB O
, , O
recovery NN O
of IN O
the DT O
secretory JJ O
function NN O
of IN O
the DT O
pancreas NNS O
was VBD O
only RB O
reached VBN O
after IN O
this DT O
period NN O
of IN O
time NN O
when WRB O
L-364,718 DT O
was VBD O
administered VBN O
therapeutically RB O
( -LRB- O
0.1 CD O
mg/kg/day NN O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
observed VBD O
that IN O
dephosphorylation NN O
severely RB O
inhibits VBZ O
the DT O
DNA-binding JJ O
ability NN O
of IN O
C/EBP-delta NNP B-NP
and CC O
its PRP$ O
transactivating VBG O
potential JJ O
increases NNS O
in IN O
the DT O
presence NN O
of IN O
cellular JJ O
phosphatase NN O
inhibitors NNS O
, , O
such JJ O
as IN O
okadaic JJ O
acid NN O
and CC O
sodium NN O
orthovanadate NN O
. . O

-DOCSTART- X X O

Two CD O
promoters NNS O
were VBD O
identified VBN O
by IN O
S1 NNP B-NP
nuclease NN I-NP
mapping NN O
: : O
P1 NNP O
, , O
which WDT O
lies VBZ O
about RB O
72 CD O
bp NN O
upstream RB O
from IN O
the DT O
structural JJ O
gene NN O
; : O
and CC O
P2 NNP O
, , O
which WDT O
lies VBZ O
about IN O
35 CD O
bp NN O
upstream RB O
. . O

-DOCSTART- X X O

Interleukin-8 NNS B-NP
( -LRB- O
IL-8 DT B-NP
) -RRB- O
is VBZ O
a DT O
potent JJ O
inflammatory NN O
mediator NN O
that WDT O
belongs VBZ O
to TO O
the DT O
family NN O
of IN O
C-X-C NNP B-NP
chemokines NNS I-NP
. . O

-DOCSTART- X X O

On IN O
the DT O
other JJ O
hand NN O
, , O
cells NNS O
containing VBG O
a DT O
PTP1C NNP B-NP
in IN O
which WDT O
the DT O
catalytic JJ O
site NN O
had VBD O
been VBN O
inactivated VBN O
through IN O
mutagenesis NN O
, , O
stably RB O
phosphorylated VBD O
the DT O
phosphatase NN O
. . O

-DOCSTART- X X O

We PRP O
recently RB O
found VBD O
that IN O
the DT O
p72syk JJ B-NP
protein NN I-NP
tyrosine NN I-NP
kinase NN I-NP
is VBZ O
physically RB O
associated VBN O
with IN O
the DT O
TCR/CD3 NNP B-NP
complex NN O
and CC O
is VBZ O
rapidly RB O
tyrosine JJ O
phosphorylated JJ O
and CC O
activated VBN O
by IN O
receptor NN O
triggering VBG O
also RB O
in IN O
T NNP O
cells NNS O
lacking VBG O
p56lck NN B-NP
. . O

-DOCSTART- X X O

The DT O
transforming JJ O
protein NN O
of IN O
Rous JJ O
sarcoma NN O
virus NN O
, , O
pp60v-src JJ B-NP
, , O
and CC O
its PRP$ O
normal JJ O
cellular JJ O
homolog NN O
, , O
pp60c-src JJ B-NP
, , O
differ VBP O
not RB O
only RB O
in IN O
oncogenic JJ O
potential JJ O
but CC O
also RB O
in IN O
their PRP$ O
subcellular JJ O
localization NN O
and CC O
cytoskeletal NN O
binding JJ O
ability NN O
. . O
pp60v-src WDT B-NP
has VBZ O
been VBN O
shown VBN O
to TO O
stably VB O
associate NN O
with IN O
a DT O
detergent-insoluble JJ O
cytoskeletal NN O
matrix NN O
, , O
whereas IN O
pp60c-src JJ B-NP
does VBZ O
not RB O
. . O

-DOCSTART- X X O

We PRP O
determined VBD O
whether IN O
regional JJ O
myocardial JJ O
work NN O
efficiency NN O
( -LRB- O
segment NN O
work/regional JJ O
O2 JJ O
consumption NN O
) -RRB- O
would MD O
be VB O
elevated VBN O
by IN O
surgically-augmented JJ O
inflow NN O
. . O

-DOCSTART- X X O

Anti-NPROSP-C NNP B-NP
also RB O
exclusively RB O
detected VBN O
time-dependent NN O
appearances NNS O
of IN O
5-10-kDa JJ B-NP
proSP-C JJ I-NP
forms NNS O
in IN O
lamellar JJ O
bodies NNS O
and CC O
homogenates NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
B6-derived JJ O
Db NNP B-NP
mutant NN I-NP
B6.CH-2bm13 CC I-NP
( -LRB- I-NP
bm13 NN I-NP
) -RRB- I-NP
strain NN O
, , O
part NN O
of IN O
the DT O
class NN B-NP
I PRP I-NP
Db VBP I-NP
antigen-presenting JJ I-NP
groove NN I-NP
is VBZ O
shaped VBN O
by IN O
a DT O
class NN B-NP
I PRP I-NP
Kb-encoded VBD I-NP
sequence NN I-NP
. . O

-DOCSTART- X X O

Our PRP$ O
findings NNS O
confirm VBP O
the DT O
high JJ O
frequency NN O
of IN O
proximal JJ O
nerve NN O
lesions NNS O
in IN O
early JJ O
GBS NNP O
and CC O
CIDP NNP O
, , O
not RB O
all DT O
of IN O
which WDT O
are VBP O
associated VBN O
with IN O
distal JJ O
motor NN O
conduction NN O
abnormalities NNS O
, , O
and CC O
suggest VBP O
that IN O
assessment NN O
of IN O
multiple JJ O
F NNP O
wave NN O
parameters NNS O
, , O
in IN O
particular JJ O
chronodispersion NN O
, , O
mean VBP O
latency RB O
and CC O
mean VB O
amplitude NN O
( -LRB- O
in IN O
addition NN O
to TO O
absence NN O
and CC O
minimum JJ O
latency NN O
) -RRB- O
, , O
increases VBZ O
the DT O
yield NN O
of IN O
F NNP O
wave NN O
studies NNS O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
alterations NNS O
of IN O
primer-binding JJ O
site NN O
sequences NNS O
on IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
replication NN O
. . O

-DOCSTART- X X O

Presentation NNP O
of IN O
a DT O
horse NN B-NP
cytochrome NN I-NP
c NN I-NP
peptide NN I-NP
by IN O
multiple JJ O
H-2b JJ B-NP
class NN I-NP
I PRP I-NP
major VBP I-NP
histocompatibility NN I-NP
complex NN I-NP
( -LRB- O
MHC NN B-NP
) -RRB- O
molecules NNS O
to TO O
C57BL/6 VB O
- : O
and CC O
bm1-derived JJ O
cytotoxic JJ O
T NNP O
lymphocytes NNS O
: : O
presence NN O
of IN O
a DT O
single JJ O
MHC NNP B-NP
anchor NN I-NP
residue NN I-NP
may MD O
confer VB O
efficient JJ O
peptide-specific JJ O
CTL JJ O
recognition NN O
. . O

-DOCSTART- X X O

A DT O
particularly RB O
striking JJ O
HpaII RB B-NP
tiny JJ O
fragment NN O
island NN O
, , O
extending VBG O
over IN O
nearly RB O
2,000 CD O
base NN O
pairs NNS O
, , O
surrounds NNS O
the DT O
USF2 NNP B-NP
translation NN I-NP
initiation NN I-NP
site NN I-NP
. . O

-DOCSTART- X X O

Diagnosis NNP O
of IN O
prostatic JJ O
carcinoma NN O
: : O
the DT O
yield NN O
of IN O
serum NN B-NP
prostate NN I-NP
specific JJ I-NP
antigen NN I-NP
, , O
digital JJ O
rectal JJ O
examination NN O
and CC O
transrectal NN O
ultrasonography NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
revealed VBD O
a DT O
hierarchy NN O
of IN O
ligand NN O
affinities NNS O
that WDT O
mirrored VBD O
their PRP$ O
adhesive JJ O
activity NN O
( -LRB- O
rsVCAM-1 JJ B-NP
> NN O
fibronectin NN B-NP
variants NNS I-NP
containing VBG O
CS1 NNP B-NP
> NNP O
> IN O
other JJ O
fibronectin JJ B-NP
variants NNS I-NP
) -RRB- O
. . O

-DOCSTART- X X O

When WRB O
expressed VBN O
in IN O
and CC O
purified VBN O
from IN O
Escherichia NNP O
coli NNS O
, , O
both DT O
full-length JJ B-NP
Fpr3 NNS I-NP
and CC O
its PRP$ O
isolated VBN O
COOH-terminal JJ O
domain NN O
exhibit NN O
readily RB O
detectable JJ O
PPIase NNP B-NP
activity NN O
. . O

-DOCSTART- X X O

Recent JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
the DT O
activated JJ O
GH NN B-NP
receptor NN I-NP
can MD O
stimulate VB O
Stat1 NNP B-NP
, , O
a DT O
cytoplasmic JJ O
transcription NN O
factor NN O
that WDT O
becomes VBZ O
tyrosine NN O
phosphorylated VBN O
and CC O
translocates NNS O
to TO O
the DT O
nucleus JJ O
, , O
where WRB O
it PRP O
can MD O
interact VB O
with IN O
specific JJ O
DNA NN O
sequences NNS O
to TO O
modulate VB O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

In IN O
viral JJ O
infections NNS O
, , O
G-CSF NNP B-NP
was VBD O
correlated VBN O
with IN O
mononuclear JJ O
cells NNS O
( -LRB- O
rs NNS O
= SYM O
0.41 CD O
, , O
P NNP O
< JJ O
0.05 CD O
) -RRB- O
, , O
white JJ O
blood NN O
cell NN O
counts NNS O
( -LRB- O
rs NNS O
= SYM O
0.56 CD O
, , O
P NNP O
< JJ O
0.01 CD O
) -RRB- O
, , O
neutrophils NNS O
( -LRB- O
rs NNS O
= SYM O
0.41 CD O
, , O
P NNP O
< JJ O
0.05 CD O
) -RRB- O
and CC O
CRP NNP B-NP
( -LRB- O
rs NNS O
= SYM O
0.47 CD O
, , O
P NNP O
< JJ O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Phosphoamino NNP O
acid NN O
analysis NN O
of IN O
radiolabeled JJ O
ASGPR NNP B-NP
subunits NNS I-NP
identified VBD O
Ser( JJ O
P NNP O
) -RRB- O
as IN O
the DT O
predominant NN O
( -LRB- O
approximately RB O
95 CD O
% NN O
) -RRB- O
and CC O
Thr( JJ O
P NNP O
) -RRB- O
as IN O
a DT O
minor JJ O
( -LRB- O
approximately RB O
5 CD O
% NN O
) -RRB- O
phosphoamino NN O
acid NN O
in IN O
each DT O
polypeptide NN O
and CC O
confirmed VBD O
the DT O
presence NN O
of IN O
Tyr( JJ O
P NNP O
) -RRB- O
( -LRB- O
approximately RB O
1 CD O
% NN O
) -RRB- O
in IN O
RHL1 NNP B-NP
. . O

-DOCSTART- X X O

To TO O
further RBR O
define VB O
the DT O
structural JJ O
requirements NNS O
for IN O
ZAP-70 DT B-NP
interaction NN O
with IN O
the DT O
TCR NNP B-NP
, , O
we PRP O
developed VBD O
a DT O
binding JJ O
assay NN O
using VBG O
immobilized JJ O
glutathione NN B-NP
S-transferase JJ I-NP
fusion NN I-NP
proteins NNS I-NP
containing VBG O
the DT O
NH2- NNP O
and/or CC O
COOH-terminal JJ B-NP
SH2 NNP I-NP
domains NNS I-NP
of IN O
ZAP-70 NNP B-NP
, , O
and CC O
soluble JJ O
synthetic JJ O
peptides NNS O
with IN O
the DT O
sequence NN O
of IN O
the DT O
cytoplasmic JJ O
region NN O
of IN O
the DT O
TCR NNP B-NP
zeta NN I-NP
chain NN I-NP
(TCR NN O
zeta NN B-NP
cyt NN I-NP
) -RRB- O
or CC O
individual JJ O
TCR NN B-NP
zeta NN I-NP
and CC O
CD3 DT B-NP
epsilon NN I-NP
TAM NNP I-NP
motifs NNS I-NP
. . O

-DOCSTART- X X O

The DT O
three-dimensional JJ O
structure NN O
of IN O
RT NNP B-NP
shows VBZ O
that IN O
it PRP O
is VBZ O
a DT O
strikingly RB O
asymmetric JJ O
heterodimer NN O
consisting VBG O
of IN O
two CD O
differently RB O
folded JJ O
subunits NNS O
( -LRB- O
molecular JJ O
weights NNS O
66 CD O
kDa NN O
and CC O
51 CD O
kDa NN O
) -RRB- O
with IN O
identical JJ O
amino-terminal JJ O
amino IN O
acid NN O
sequences NNS O
( -LRB- O
residues NNS O
1-428 CD O
) -RRB- O
. . O

-DOCSTART- X X O

All DT O
subsequent JJ O
patients NNS O
were VBD O
treated VBN O
at IN O
the DT O
maximal JJ O
tolerated JJ O
dose NN O
of IN O
EDXR NNP O
( -LRB- O
35 CD O
mg/m2/day NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
median JJ O
post-treatment NN O
, , O
pre-operative JJ O
serum NN B-NP
PSA NNP I-NP
was VBD O
0.4 CD O
ng/ml NN O
. . O

-DOCSTART- X X O

Membrane-bound NNP O
Steel NNP B-NP
factor NN I-NP
induces VBZ O
more RBR O
persistent JJ O
tyrosine NN B-NP
kinase NN I-NP
activation NN O
and CC O
longer JJR O
life NN O
span NN O
of IN O
c-kit NN B-NP
gene-encoded JJ O
protein NN O
than IN O
its PRP$ O
soluble JJ O
form NN O
. . O

-DOCSTART- X X O

Patients NNS O
with IN O
more JJR O
than IN O
250 CD O
PVC/24 CD O
hours NNS O
were VBD O
selected VBN O
for IN O
distribution NN O
of IN O
PVC NNP O
and CC O
CI NNP O
evaluation NN O
. . O

-DOCSTART- X X O

Horvath NNP O
, , O
I. NN O

-DOCSTART- X X O

Cell NN O
lines NNS O
derived VBN O
from IN O
the DT O
tumors NNS O
were VBD O
examined VBN O
by IN O
fluorescent JJ O
in IN O
situ FW O
hybridization NN O
for IN O
the DT O
status NN O
of IN O
the DT O
transferred VBN O
human JJ O
chromosome NN O
and CC O
by IN O
PCR NNP O
for IN O
marker NN O
loss NN O
. . O

-DOCSTART- X X O

The DT O
amino IN O
acid NN O
sequences NNS O
of IN O
the DT O
predicted VBN O
RfbA NNP B-NP
and CC O
RfbB NNP B-NP
homologs NNS I-NP
showed VBD O
identities NNS O
of IN O
75.7 CD O
% NN O
(87.9 CD O
% NN O
total JJ O
similarity NN O
) -RRB- O
and CC O
78.0 CD O
% NN O
(86.5 CD O
% NN O
total JJ O
similarity NN O
) -RRB- O
, , O
respectively RB O
. . O

-DOCSTART- X X O

However RB O
, , O
multiple JJ O
alanine IN O
substitutions NNS O
or CC O
proline NN O
( -LRB- O
helix-destabilizing NN O
) -RRB- O
substitutions NNS O
disrupted VBD O
both DT O
oligomerization NNP O
and CC O
transport NN O
of IN O
GP64 NNP B-NP
EFP. . I-NP

-DOCSTART- X X O

The DT O
FinO NNP B-NP
protein NN I-NP
of IN O
IncF NNP O
plasmids NNS O
binds NNS O
FinP NNP B-NP
antisense NN I-NP
RNA NNP I-NP
and CC O
its PRP$ O
target NN O
, , O
traJ NN B-NP
mRNA NN I-NP
, , O
and CC O
promotes NNS O
duplex NN O
formation NN O
. . O

-DOCSTART- X X O

A DT O
chicken NN B-NP
paxillin NN I-NP
cDNA NN I-NP
was VBD O
also RB O
cloned VBN O
and CC O
is VBZ O
predicted VBN O
to TO O
encode VB O
a DT O
protein NN O
approximately RB O
90 CD O
% NN O
identical JJ O
to TO O
human JJ B-NP
paxil-lin NN I-NP
. . O

-DOCSTART- X X O

We PRP O
linked VBD O
a DT O
4.1-kilobase JJ O
pair NN O
HindIII NNP B-NP
DNA NNP I-NP
fragment NN I-NP
from IN O
the DT O
region NN O
upstream RB O
of IN O
the DT O
human JJ B-NP
AP NNP I-NP
endonuclease NN I-NP
gene NN I-NP
( -LRB- O
APE NNP B-NP
) -RRB- O
to TO O
the DT O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
( -LRB- O
CAT NN B-NP
) -RRB- O
gene NN O
. . O

-DOCSTART- X X O

CD7+/CD3- DT B-NP
T-cell JJ O
precursors NNS O
exhibit VBP O
V NNP B-NP
delta NN I-NP
2D JJ I-NP
delta NN I-NP
3 CD I-NP
rearrangements NNS I-NP
. . O

-DOCSTART- X X O

Transcription NN O
of IN O
the DT O
vascular JJ B-NP
cell NN I-NP
adhesion NN I-NP
molecule NN I-NP
1 CD I-NP
(VCAM-1 NN O
) -RRB- O
gene NN O
in IN O
endothelial JJ O
cells NNS O
is VBZ O
induced VBN O
by IN O
lipopolysaccharide NN O
and CC O
the DT O
inflammatory NN O
cytokines NNS B-NP
interleukin-1 JJ I-NP
beta NN I-NP
and CC O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
( -LRB- O
TNF-alpha NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Experiments NNS O
with IN O
recombinant JJ O
proteins NNS O
showed VBD O
that DT O
p50/p65 NN B-NP
and CC O
high-mobility-group NN B-NP
I( JJ I-NP
Y NNP I-NP
) -RRB- I-NP
protein NN I-NP
cooperatively RB O
facilitated VBD O
the DT O
binding NN O
of IN O
IRF-1 NN B-NP
to TO O
the DT O
VCAM1 NNP B-NP
IRF NNP B-NP
binding NN I-NP
site NN I-NP
and CC O
that DT O
IRF-1 JJ B-NP
physically RB O
interacted VBN O
with IN O
p50 NN B-NP
and CC O
with IN O
high-mobility-group JJ B-NP
I( JJ I-NP
Y PRP I-NP
) -RRB- I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Based VBN O
on IN O
these DT O
results NNS O
the DT O
minimal JJ O
control NN O
element NN O
( -LRB- O
AX JJ O
470 CD O
) -RRB- O
specifying VBG O
the DT O
anterior JJ O
boundary NN O
of IN O
Hox NNP B-NP
expression NN O
was VBD O
designated VBN O
as IN O
Hoxa-7 NNP B-NP
enhancer NN I-NP
. . O

-DOCSTART- X X O

In IN O
this DT O
report NN O
we PRP O
describe VBP O
the DT O
isolation NN O
of IN O
a DT O
Fab NNP B-NP
fragment NN I-NP
( -LRB- O
Fab NNP B-NP
A8 . I-NP
) -RRB- O
showing VBG O
a DT O
high JJ O
relative JJ O
affinity NN O
for IN O
the DT O
receptor NN O
( -LRB- O
0.5 CD O
nM NN O
) -RRB- O
. . O

-DOCSTART- X X O

When WRB O
combined VBN O
with IN O
independent JJ O
activating NN O
mutations NNS O
in IN O
the DT O
c-abl JJ B-NP
kinase NN I-NP
domain NN I-NP
or CC O
NH2-terminus NNP O
, , O
the DT O
G128R NNP B-NP
mutation NN O
blocked VBN O
transformation NN O
by IN O
the DT O
double JJ O
mutant NN O
, , O
suggesting VBG O
that IN O
the DT O
G128R NNP B-NP
mutant NN I-NP
was VBD O
unable JJ O
to TO O
transform VB O
cells NNS O
for IN O
trivial JJ O
reasons NNS O
. . O

-DOCSTART- X X O

Changes NNS O
induced VBN O
in IN O
the DT O
gills NNS O
of IN O
milkfish NN O
( -LRB- O
Chanos NNP O
chanos NNS O
Forsskal NNP O
) -RRB- O
fingerlings NNS O
after IN O
acute JJ O
exposure NN O
to TO O
nifurpirinol NN O
( -LRB- O
Furanace NNP O
; : O
P-7138 CD O
) -RRB- O
. . O

-DOCSTART- X X O

As IN O
expected VBN O
, , O
the DT O
insulin NN B-NP
effect NN O
to TO O
increase VB O
ras NNS B-NP
GTP NNP I-NP
formation NN O
and CC O
MAP NNP B-NP
kinase NN I-NP
activity NN O
was VBD O
negligible JJ O
in IN O
A/K1018 DT O
cells NNS O
but CC O
normal JJ O
, , O
or CC O
supernormal JJ O
, , O
in IN O
Y/F2 NNP O
cells NNS O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
these DT O
regions NNS O
showed VBD O
a DT O
CAAT NN O
box NN O
upstream RB O
of IN O
exon NN O
1a CD O
and CC O
high JJ O
G-C JJ O
content NN O
regions NNS O
within IN O
both DT O
P1 NNP O
and CC O
P2 NNP O
. . O

-DOCSTART- X X O

GCD10 PRP B-NP
was VBD O
first RB O
identified VBN O
genetically RB O
as IN O
a DT O
translational JJ O
repressor NN O
of IN O
GCN4 NNP B-NP
. . O

-DOCSTART- X X O

GCD10 DT B-NP
binds NNS O
RNA NNP O
in IN O
vitro NN O
and CC O
we PRP O
present VBP O
strong JJ O
biochemical JJ O
evidence NN O
that IN O
it PRP O
is VBZ O
identical JJ O
to TO O
the DT O
RNA-binding JJ O
subunit NN O
of IN O
yeast NN B-NP
initiation NN I-NP
factor-3 JJ I-NP
(eIF-3 NN O
) -RRB- O
. . O
eIF-3 NN B-NP
is VBZ O
a DT O
multisubunit NN O
complex NN O
that IN O
stimulates NNS O
translation NN O
initiation NN O
in IN O
vitro NN O
at IN O
several JJ O
different JJ O
steps NNS O
. . O

-DOCSTART- X X O

A DT O
transformation-competent JJ O
mutant JJ O
, , O
like IN O
the DT O
wild-type JJ B-NP
E5 NNP I-NP
protein NN I-NP
, , O
bound VBD O
the DT O
receptor NN O
and CC O
induced NN O
receptor NN O
tyrosine NN O
phosphorylation NN O
and CC O
down-regulation NN O
. . O

-DOCSTART- X X O

Appropriate JJ O
restriction NN O
sites NNS O
allow VBP O
one CD O
to TO O
insert VB O
virtually RB O
any DT O
desired VBN O
cDNA NN O
fragment NN O
directly RB O
behind IN O
the DT O
epitope-specific JJ O
sequence NN O
and CC O
before IN O
a DT O
long JJ O
poly( NN O
A DT O
) -RRB- O
tail NN O
. . O

-DOCSTART- X X O

Both DT O
PPC-1 NNP O
and CC O
ALVA-31 NNP O
cells NNS O
display VBP O
tumorigenesis NN O
and CC O
invasiveness NN O
in IN O
nude JJ O
mice NNS O
, , O
whereas IN O
LNCap NNP O
cells NNS O
exhibit VBP O
a DT O
less JJR O
malignant JJ O
phenotype NN O
, , O
suggesting VBG O
a DT O
correlation NN O
between IN O
CD44 NNP B-NP
variant NN I-NP
( -LRB- O
CD44v NN B-NP
) -RRB- O
expression NN O
and CC O
aggressive JJ O
prostate NN O
tumor NN O
behavior NN O
. . O

-DOCSTART- X X O

Two CD O
such JJ O
genes NNS O
, , O
designated VBN O
hsiggll150 NN B-NP
and CC O
hsiggll295 VBD B-NP
, , O
were VBD O
cloned VBN O
and CC O
sequenced VBN O
from IN O
genomic JJ O
DNA NN O
. . O

-DOCSTART- X X O

A DT O
retrospective JJ O
epidemiological JJ O
study NN O
is VBZ O
reported VBN O
concerning VBG O
burn NN O
injuries NNS O
in IN O
775 CD O
children NNS O
hospitalized VBN O
at IN O
the DT O
unit NN O
of IN O
burn NN O
care NN O
of IN O
Casablanca NNP O
between IN O
1985 CD O
and CC O
1993 CD O
. . O

-DOCSTART- X X O

The DT O
RAD6/UBC2 NNP B-NP
gene NN O
from IN O
Saccharomyces NNS O
cerevisiae NNS O
encodes VBZ O
a DT O
ubiquitin-conjugating JJ B-NP
enzyme NN I-NP
involved VBN O
in IN O
DNA NNP O
repair NN O
, , O
induced VBN O
mutagenesis NN O
, , O
and CC O
sporulation NN O
. . O

-DOCSTART- X X O

Echocardiography NNP O
revealed VBD O
right JJ O
ventricular RB O
diastolic JJ O
collapse NN O
( -LRB- O
RVDC NNP O
) -RRB- O
without IN O
physical JJ O
signs NNS O
of IN O
cardiac JJ O
tamponade NN O
. . O

-DOCSTART- X X O

In IN O
on-going JJ O
screening NN O
programmes NNS O
, , O
the DT O
Haemoccult JJ O
test NN O
consists VBZ O
of IN O
six CD O
slides NNS O
and CC O
a DT O
test NN O
is VBZ O
considered VBN O
positive JJ O
if IN O
at IN O
least JJS O
one CD O
slide NN O
is VBZ O
coloured VBN O
. . O

-DOCSTART- X X O

We PRP O
showed VBD O
previously RB O
that IN O
a DT O
fusion NN O
protein NN O
( -LRB- O
GAL4-p40 NN B-NP
) -RRB- O
containing VBG O
the DT O
DNA-binding JJ O
domain NN O
of IN O
GAL4 NNP B-NP
and CC O
sequences NNS O
of IN O
chicken NN B-NP
l RB I-NP
kappa FW I-NP
B-alpha FW I-NP
( -LRB- O
p40 NN B-NP
) -RRB- O
inhibits VBZ O
growth NN O
in IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
demonstrated VBN O
previously RB O
that IN O
two CD O
binding JJ O
sites NNS O
in IN O
the DT O
-184 JJ B-NP
HNF-3 JJ I-NP
beta NN I-NP
promoter NN I-NP
are VBP O
recognized VBN O
by IN O
widely RB O
distributed VBN O
factors NNS O
and CC O
that IN O
there EX O
is VBZ O
also RB O
a DT O
critical JJ O
autoregulatory NN O
site NN O
, , O
we PRP O
identified VBD O
a DT O
binding JJ O
site NN O
for IN O
a DT O
cell-specific JJ O
factor NN O
, , O
LF-H3 JJ B-NP
beta NN I-NP
, , O
that WDT O
may MD O
function VB O
in IN O
restricting VBG O
HNF-3 JJ B-NP
beta NN I-NP
gene NN I-NP
expression NN O
to TO O
hepatocytes NNS O
. . O

-DOCSTART- X X O

The DT O
flow NN O
rate NN O
of IN O
phosphate NN O
buffered VBN O
saline NN O
through IN O
dermis NN O
was VBD O
measured VBN O
as IN O
a DT O
function NN O
of IN O
applied JJ O
pressure NN O
. . O

-DOCSTART- X X O

However RB O
, , O
parallax NN O
measurements NNS O
showed VBD O
that IN O
at IN O
150K CD O
, , O
collapse NN O
of IN O
Epon NNP O
sections NNS O
does VBZ O
not RB O
take VB O
place NN O
. . O

-DOCSTART- X X O

Although IN O
within IN O
normal JJ O
limits NNS O
, , O
latency RB O
was VBD O
high JJ O
. . O

-DOCSTART- X X O

The DT O
outcome NN O
of IN O
the DT O
optimization NN O
of IN O
the DT O
seven-field JJ O
plan NN O
prompted VBD O
an DT O
investigation NN O
into IN O
the DT O
best JJS O
results NNS O
that WDT O
could MD O
be VB O
achieved VBN O
by IN O
an DT O
"ideal JJ O
" `` O
conformal JJ O
radiotherapy NN O
technique NN O
. . O

-DOCSTART- X X O

The DT O
pea NN B-NP
rps10 VBD I-NP
intron NN I-NP
is VBZ O
homologous JJ O
to TO O
introns NNS O
in IN O
rrn26 CD B-NP
and CC O
cox3 CD B-NP
in IN O
the DT O
Marchantia NNP O
mitochondrial NN O
genome NN O
, , O
while IN O
the DT O
Marchantia NNP B-NP
rps10 CD I-NP
gene NN I-NP
lacks VBZ O
an DT O
intron NN O
. . O

-DOCSTART- X X O

Serum NN O
magnesium NN O
in IN O
79 CD O
patients NNS O
of IN O
gynecologic NNP O
neoplasms NNS O
treated VBN O
with IN O
cisplatin NN O
and CC O
their PRP$ O
controls NNS O
was VBD O
measured VBN O
. . O

-DOCSTART- X X O

Alanine NNP B-NP
aminotransferase FW I-NP
( -LRB- O
ALT) NN B-NP
levels NNS O
had VBD O
been VBN O
elevated VBN O
for IN O
six CD O
months NNS O
in IN O
all DT O
patients NNS O
and CC O
hepatitis NNP O
B NNP O
viral NN O
infection NN O
was VBD O
replicative JJ O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
we PRP O
have VBP O
investigated VBN O
the DT O
role NN O
of IN O
C/EBP NNP B-NP
beta NN I-NP
in IN O
initiating VBG O
the DT O
adipogenic JJ O
program NN O
by IN O
overexpressing VBG O
C/EBP NNP B-NP
beta NN I-NP
in IN O
multipotential JJ O
NIH-3T3 JJ O
fibroblasts NNS O
. . O

-DOCSTART- X X O

XYL1 PRP B-NP
was VBD O
isolated VBN O
as IN O
a DT O
highly RB O
expressed VBN O
fusion NN O
clone NN O
from IN O
a DT O
'lacZ JJ B-NP
translational JJ O
fusion NN O
library NN O
. . O

-DOCSTART- X X O

However RB O
, , O
division NN O
of IN O
the DT O
chest NN O
wall NN O
muscles NNS O
, , O
usually RB O
with IN O
diathermy NN O
, , O
contributes VBZ O
to TO O
prolonged JJ O
pain NN O
and CC O
morbidity NN O
. . O

-DOCSTART- X X O

Closure NN O
of IN O
an DT O
open JJ O
high JJ O
below-knee NN O
guillotine NN O
amputation NN O
wound NN O
using VBG O
a DT O
skin-stretching NN O
device NN O
. . O

-DOCSTART- X X O

Our PRP$ O
study NN O
was VBD O
addressed VBN O
to TO O
the DT O
synthesis NN O
of IN O
some DT O
derivatives NNS O
of IN O
this DT O
sequence NN O
in IN O
order NN O
to TO O
obtain VB O
both DT O
peptide NN O
substrates NNS O
suitable JJ O
for IN O
the DT O
detection NN O
of IN O
the DT O
Src-like JJ B-NP
tyrosine NN B-NP
kinase NN I-NP
activity NN O
and CC O
active JJ O
site-directed NN O
inhibitors NNS O
specific JJ O
for IN O
this DT O
class NN O
of IN O
enzymes NNS O
. . O

-DOCSTART- X X O

Citrate NNP B-NP
synthase NN I-NP
activity NN O
was VBD O
increased VBN O
in IN O
the DT O
medial JJ O
head NN O
( -LRB- O
81 CD O
% NN O
, , O
P NNP O
< JJ O
0.001 CD O
) -RRB- O
and CC O
the DT O
red JJ O
long JJ O
head NN O
(88 IN O
% NN O
, , O
P NNP O
< JJ O
0.001 CD O
) -RRB- O
of IN O
the DT O
triceps NNS O
brachii NNS O
muscle NN O
in IN O
R NN O
rats NNS O
but CC O
not RB O
in IN O
the DT O
white JJ O
long JJ O
head NN O
( -LRB- O
25 CD O
% NN O
, , O
P NNP O
= SYM O
0.06 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
expression NN O
of IN O
the DT O
putative JJ O
operon NN O
bglPH NNS B-NP
of IN O
Bacillus NNP O
subtilis NNS O
was VBD O
studied VBN O
by IN O
using VBG O
bglP'-lacZ JJ B-NP
transcriptional JJ O
fusions NNS O
. . O

-DOCSTART- X X O

Although IN O
eight CD O
contiguous JJ O
genes NNS O
necessary JJ O
for IN O
urease NN B-NP
activity NN O
have VBP O
been VBN O
cloned VBN O
and CC O
sequenced VBN O
, , O
the DT O
transcriptional JJ O
organization NN O
and CC O
regulation NN O
of IN O
specific JJ O
genes NNS O
within IN O
the DT O
Proteus NNP B-NP
gene NN I-NP
cluster NN I-NP
has VBZ O
not RB O
been VBN O
investigated VBN O
in IN O
detail NN O
. . O

-DOCSTART- X X O

The DT O
hypBFCDE NN B-NP
operon NN I-NP
from IN O
Rhizobium NNP O
leguminosarum NN O
biovar NN O
viciae NN O
is VBZ O
expressed VBN O
from IN O
an DT O
Fnr-type JJ B-NP
promoter NN I-NP
that WDT O
escapes VBZ O
mutagenesis NN O
of IN O
the DT O
fnrN JJ B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

We PRP O
demonstrate VBP O
that IN O
a DT O
VT+ NNP O
peptide NN O
was VBD O
specifically RB O
phosphorylated VBN O
by IN O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
( -LRB- O
PKC NNP B-NP
) -RRB- O
in IN O
vitro NN O
, , O
but CC O
not RB O
by IN O
protein NN B-NP
kinase NN I-NP
A DT I-NP
( -LRB- O
PKA NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Indeed RB O
, , O
ERM NNP B-NP
and CC O
c-Jun JJ B-NP
synergistically RB O
activated VBN O
the DT O
EBS-CRE NNP O
without IN O
making VBG O
an DT O
apparent JJ O
ternary NN O
complex NN O
. . O

-DOCSTART- X X O

A DT O
mutant JJ O
( -LRB- O
residues NNS O
1-332 CD O
) -RRB- O
showed VBD O
complete JJ O
Ca2+/CaM-dependent JJ O
activity NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
the DT O
R206S NNP B-NP
HSF NNP I-NP
substitution NN O
exhibits NNS O
constitutive JJ O
transcriptional JJ O
activation NN O
from IN O
a DT O
consensus NN O
HSE NN O
( -LRB- O
HSE2 NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
two CD O
bases NNS O
immediately RB O
flanking VBG O
the DT O
5' JJ O
end NN O
of IN O
the DT O
element NN O
proved VBD O
to TO O
be VB O
very RB O
important JJ O
to TO O
its PRP$ O
function NN O
as IN O
a DT O
UAS NNP O
element NN O
as IN O
did VBD O
the DT O
two CD O
bases NNS O
immediately RB O
3' CD O
of IN O
the DT O
bHLH JJ O
core NN O
motif NN O
. . O

-DOCSTART- X X O

These DT O
intron NN O
chimeras NNS O
show VBP O
that IN O
peripheral JJ O
sequences NNS O
and CC O
the DT O
elements NNS O
that WDT O
define VB O
the DT O
splice NN O
sites NNS O
are VBP O
adequate JJ O
for IN O
self-splicing NN O
activity NN O
but CC O
that IN O
the DT O
central JJ O
portions NNS O
containing VBG O
the DT O
catalytic JJ O
cores NNS O
of IN O
ai4 NNS B-NP
and CC O
bi4 NNS B-NP
are VBP O
deficient JJ O
; : O
these DT O
cores NNS O
are VBP O
the DT O
likely JJ O
targets NNS O
of IN O
the DT O
splicing JJ O
proteins NNS O
. . O

-DOCSTART- X X O

Twenty CD O
food NN O
products NNS O
were VBD O
contaminated VBN O
with IN O
V. NNP O
cholerae NNS O
O1 NNP O
, , O
Ogawa NNP O
, , O
toxigenic JJ O
and CC O
not RB O
toxigenic JJ O
strains NNS O
: : O
yoghurt NN O
, , O
cream NN O
cheese NN O
, , O
apricot JJ O
marmelade NN O
, , O
hip NN O
rose VBD O
marmelade NN O
, , O
mayonnaise NN O
, , O
italian IN O
pasta NN O
for IN O
"empanadas" NN O
, , O
"dulce NNP O
de NNP O
leche" VBD O
, , O
meat NN O
sausage NN O
, , O
meat NN O
and CC O
spinach NN O
ravioli NNS O
, , O
margarine NN O
, , O
milk NN O
dessert NN O
( -LRB- O
made VBN O
with IN O
cocoa NN O
, , O
milk NN O
confiture NN O
, , O
starch NN O
and CC O
additives NNS O
) -RRB- O
, , O
lettuce NN O
, , O
tuna DT O
fish NN O
, , O
ricotta NN O
and CC O
sterilized VBN O
milk NN O
. . O

-DOCSTART- X X O

The DT O
expression NN O
of IN O
the DT O
pilin NN B-NP
gene NN I-NP
, , O
tcpA NNS B-NP
, , O
is VBZ O
dependent JJ O
upon IN O
ToxR NNP B-NP
and CC O
upon IN O
ToxT. NNP B-NP

-DOCSTART- X X O

Ras NNP B-NP
p21Val JJ I-NP
inhibits VBZ O
myogenesis NN O
without IN O
altering VBG O
the DT O
DNA NNP O
binding NN O
or CC O
transcriptional JJ O
activities NNS O
of IN O
the DT O
myogenic JJ B-NP
basic JJ I-NP
helix-loop-helix NN I-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

In IN O
cells NNS O
limited VBN O
for IN O
His PRP$ O
, , O
increased VBD O
expression NN O
of IN O
arg-2 NN B-NP
and CC O
cpc-1 NN B-NP
, , O
and CC O
decreased VBD O
expression NN O
of IN O
cox-5 CD B-NP
, , O
also RB O
had VBD O
translational JJ O
and CC O
transcriptional JJ O
components NNS O
. . O

-DOCSTART- X X O

The DT O
peptide NN O
sequences NNS O
reveal VBP O
that IN O
the DT O
factor NN O
consists VBZ O
of IN O
GABP NNP B-NP
alpha NN I-NP
and CC O
GABP NNP B-NP
beta NN I-NP
1 CD I-NP
with IN O
Ets NNP B-NP
and CC O
Notch NNP B-NP
motifs NNS I-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

Immunofluorescence NNP O
microscopy NN O
and CC O
cell NN O
fractionation NN O
analyses NNS O
showed VBD O
that IN O
the DT O
110-kDa JJ O
protein NN O
was VBD O
exclusively RB O
nuclear JJ O
, , O
whereas IN O
the DT O
150-kDa JJ O
protein NN O
was VBD O
present JJ O
in IN O
both DT O
the DT O
cytoplasm NN O
and CC O
nucleus NN O
of IN O
human JJ O
cells NNS O
. . O

-DOCSTART- X X O

T-cell NN O
hybridomas NNS O
, , O
thymocytes NNS O
, , O
and CC O
T NNP O
cells NNS O
can MD O
be VB O
induced VBN O
to TO O
undergo VB O
apoptotic JJ O
cell NN O
death NN O
by IN O
activation NN O
through IN O
the DT O
T-cell NN B-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

The DT O
kinase NN O
is VBZ O
essential JJ O
in IN O
vivo NN O
for IN O
normal JJ O
phosphorylation NN O
of IN O
the DT O
CTD NNP O
and CC O
for IN O
normal JJ O
growth NN O
and CC O
differentiation NN O
. . O

-DOCSTART- X X O

A DT O
general JJ O
model NN O
for IN O
ARE-mediated JJ O
mRNA NN O
degradation NN O
involving VBG O
a DT O
potential JJ O
role NN O
for IN O
certain JJ O
heterogeneous JJ O
nuclear JJ O
ribonucleoproteins NNS O
and CC O
ARE-binding JJ B-NP
proteins NNS I-NP
is VBZ O
proposed VBN O
. . O

-DOCSTART- X X O

Finally RB O
, , O
we PRP O
demonstrate VBP O
that IN O
C/EBP NNP B-NP
alpha NN I-NP
can MD O
also RB O
active JJ O
the DT O
GM-CSF NNP B-NP
receptor NN I-NP
alpha NN I-NP
promoter NN O
in IN O
nonmyeloid JJ O
cells NNS O
. . O

-DOCSTART- X X O

Endocytosis NNP O
and CC O
vacuolar JJ O
degradation NN O
of IN O
the DT O
plasma NN O
membrane-localized JJ O
Pdr5 . B-NP
ATP-binding JJ I-NP
cassette NN I-NP
multidrug NN I-NP
transporter NN I-NP
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

Mutational JJ O
analysis NN O
of IN O
mRNA NN B-NP
capping VBG I-NP
enzyme NN I-NP
identifies VBZ O
amino IN O
acids NNS O
involved VBN O
in IN O
GTP NNP O
binding NN O
, , O
enzyme-guanylate JJ O
formation NN O
, , O
and CC O
GMP NNP O
transfer NN O
to TO O
RNA NNP O
. . O

-DOCSTART- X X O

Disruption NN O
of IN O
the DT O
HOG1 NNP B-NP
and CC O
PBS2 NNP B-NP
genes NNS I-NP
leads VBZ O
to TO O
a DT O
dramatic JJ O
decrease NN O
of IN O
the DT O
HSP12 NNP B-NP
inducibility NN O
in IN O
osmostressed JJ O
cells NNS O
, , O
whereas IN O
overproduction IN O
of IN O
Hog1 NNP B-NP
produces VBZ O
a DT O
fivefold JJ O
increase NN O
in IN O
wild-type JJ O
induced JJ O
levels NNS O
upon IN O
a DT O
shift NN O
to TO O
a DT O
high JJ O
salt NN O
concentration NN O
. . O

-DOCSTART- X X O

( -LRB- O
1986 CD O
) -RRB- O
method NN O
of IN O
separation NN O
of IN O
Cryptosporidium NNP O
spp NN O
. . O
oocysts NNS O
from IN O
feces NNS O
by IN O
using VBG O
a DT O
percoll NN O
discontinuous JJ O
density NN O
gradient NN O
appeared VBD O
a DT O
method NN O
of IN O
choice NN O
for IN O
obtaining VBG O
large JJ O
numbers NNS O
of IN O
oocysts NNS O
of IN O
C. NNP O
parvum , O
free JJ O
of IN O
fecal JJ O
contamination NN O
. . O

-DOCSTART- X X O

Staphylococcal NNP B-NP
enterotoxin NN I-NP
A DT I-NP
involvement NN O
in IN O
the DT O
illness NN O
of IN O
a DT O
20-month-old JJ O
burn NN O
patient NN O
. . O

-DOCSTART- X X O

Four CD O
p53 NN B-NP
DNA-binding NN I-NP
domain NN I-NP
peptides NNS I-NP
bind VBP O
natural JJ O
p53-response NN B-NP
elements NNS I-NP
and CC O
bend VB O
the DT O
DNA NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
G NNP B-NP
beta JJ I-NP
gamma-stimulated JJ I-NP
Shc NNP B-NP
phosphorylation NN O
represents VBZ O
an DT O
early JJ O
step NN O
in IN O
the DT O
pathway NN O
leading VBG O
to TO O
p21ras VB B-NP
activation NN O
, , O
similar JJ O
to TO O
the DT O
mechanism NN O
utilized VBN O
by IN O
growth NN B-NP
factor NN I-NP
tyrosine NN I-NP
kinase NN I-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

This DT O
report NN O
focused VBD O
on IN O
the DT O
relationship NN O
between IN O
Type JJ O
A DT O
behavior NN O
and CC O
eight CD O
basic JJ O
emotion NN O
dimensions NNS O
. . O

-DOCSTART- X X O

As IN O
for IN O
31 CD O
stage NN O
I-II JJ O
lung NN O
cancer NN O
patients NNS O
, , O
CR NNP O
has VBZ O
been VBN O
observed VBN O
in IN O
82.8 CD O
% NN O
of IN O
them PRP O
and CC O
PR NNP O
in IN O
13.8 CD O
% NN O
; : O
the DT O
response NN O
was VBD O
always RB O
assessed VBN O
with IN O
chest NN O
radiography NN O
, , O
CT NNP O
, , O
FBS NNP O
, , O
cytology NN O
and/or CC O
histology NN O
. . O

-DOCSTART- X X O

Pediatric NNP O
medical JJ O
emergencies NNS O
in IN O
a DT O
regional JJ O
hospital NN O
: : O
appropriate JJ O
locale NN O
? . O

-DOCSTART- X X O

METHODS NNS O
: : O
All DT O
these DT O
30 CD O
non-responders NNS O
received VBD O
an DT O
extra JJ O
dose NN O
of IN O
the DT O
same JJ O
vaccine NN O
2 CD O
months NNS O
after IN O
primary JJ O
immunization NN O
and CC O
a DT O
booster NN O
dose NN O
with IN O
a DT O
yeast-derived JJ O
vaccine NN O
6 CD O
years NNS O
later RB O
. . O

-DOCSTART- X X O

An DT O
abnormally RB O
high JJ O
percentage NN O
of IN O
hypertensive JJ O
patients NNS O
( -LRB- O
approximately RB O
30 CD O
% NN O
) -RRB- O
undergoing VBG O
cardiac NN O
catheterization NN O
because IN O
of IN O
anginal JJ O
pain NN O
and/or CC O
exercise-induced JJ O
ST-segment NN O
depressions NNS O
has VBZ O
angiographically RB O
normal JJ O
coronary JJ O
arteries NNS O
. . O

-DOCSTART- X X O

Mibefradil NNP O
( -LRB- O
Ro NNP O
40-5967 CD O
) -RRB- O
is VBZ O
a DT O
novel NN O
calcium NN O
antagonist NN O
from IN O
a DT O
new JJ O
chemical NN O
class NN O
and CC O
is VBZ O
the DT O
first JJ O
that IN O
selectively RB O
blocks NNS O
the DT O
T-type NN O
calcium NN O
channel NN O
. . O

-DOCSTART- X X O

However RB O
, , O
2 CD O
minimum NN O
alveolar NN O
concentration NN O
anesthesia CC O
did VBD O
significantly RB O
decrease VB O
the DT O
calculated VBN O
VE CD O
at IN O
a DT O
PCO2 NN O
of IN O
60 CD O
mmHg NN O
( -LRB- O
from IN O
7.4 CD O
+/ NN O
- : O
1.2 CD O
to TO O
4.0 CD O
+/ CD O
- : O
0.6 CD O
l.min-1 NN O
) -RRB- O
, , O
indicating VBG O
a DT O
rightward JJ O
shift NN O
in IN O
the DT O
response NN O
relationship NN O
. . O

-DOCSTART- X X O

cDNA NN O
encoding VBG O
a DT O
functional JJ O
feline NN B-NP
liver/bone/kidney-type JJ I-NP
alkaline NN I-NP
phosphatase NN I-NP
. . O

-DOCSTART- X X O

Protein NNP B-NP
kinase NN I-NP
C NNP I-NP
( -LRB- O
PKC) NNP B-NP
, , O
a DT O
widely-distributed JJ O
enzyme NN O
implicated VBN O
in IN O
the DT O
regulation NN O
of IN O
many JJ O
physiological JJ O
processes NNS O
, , O
consists VBZ O
of IN O
a DT O
family NN O
of IN O
at IN O
least JJS O
twelve CD O
isoenzymes NNS O
which WDT O
differ VBP O
in IN O
tissue NN O
distribution NN O
, , O
subcellular JJ O
localization NN O
, , O
regulatory JJ O
properties NNS O
, , O
etc FW O
. . O

-DOCSTART- X X O

This DT O
work NN O
, , O
therefore RB O
, , O
also RB O
emphasizes VBZ O
the DT O
importance NN O
of IN O
careful JJ O
choice NN O
of IN O
oligonucleotide JJ O
and CC O
cDNA JJ O
probes NNS O
to TO O
study VB O
PKC NNP B-NP
zeta NNP I-NP
mRNA NN I-NP
. . O

-DOCSTART- X X O

However RB O
, , O
a DT O
strongly RB O
increased JJ O
frequency NN O
of IN O
CpG NNP O
dinucleotides NNS O
was VBD O
found VBN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
focused VBD O
on IN O
the DT O
role NN O
of IN O
the DT O
5' JJ O
proximal JJ O
regulatory JJ O
cassette NN O
(-190 : O
; : O
+53 JJ O
bp NN O
) -RRB- O
of IN O
the DT O
rat NN B-NP
enkephalin NN I-NP
(rENK) NNP O
gene NN O
in IN O
the DT O
developmental JJ O
regulation NN O
of IN O
the DT O
enkephalin NN B-NP
phenotype NN O
. . O

-DOCSTART- X X O

Unexpectedly RB O
, , O
all DT O
ENK-specific JJ B-NP
motifs NNS I-NP
formed VBN O
specific JJ O
and CC O
highly RB O
abundant JJ O
protein-DNA NN O
complexes NNS O
when WRB O
nuclear JJ O
extracts NNS O
from IN O
the DT O
human JJ O
tumor NN O
cell NN O
line NN O
( -LRB- O
HeLa NNP O
) -RRB- O
, , O
which WDT O
does VBZ O
not RB O
express VB O
ENK JJ B-NP
, , O
were VBD O
used VBN O
. . O

-DOCSTART- X X O

Infant NN O
aged VBN O
3.5 CD O
years NNS O
presents VBZ O
persistence NN O
of IN O
primordial JJ O
vitreous JJ O
body NN O
with IN O
crystalline NN O
dislocation NN O
in IN O
the DT O
camera NN O
aquosa NN O
and CC O
secondary JJ O
buphthalmos NN O
of IN O
the DT O
left JJ O
eye NN O
and CC O
microphthalmos NN O
with IN O
dislocation NN O
of IN O
the DT O
crystalline NN O
in IN O
the DT O
vitreous JJ O
body NN O
of IN O
the DT O
right JJ O
eye NN O
. . O

-DOCSTART- X X O

MZF-1 JJ B-NP
represses NNS O
CAT WDT B-NP
reporter NN I-NP
gene NN I-NP
expression NN O
via IN O
GAL4 NNP B-NP
binding NN I-NP
sites NNS I-NP
in IN O
the DT O
nonhematopoietic JJ O
cell NN O
lines NNS O
NIH NNP O
3T3 CD O
and CC O
293 CD O
. . O

-DOCSTART- X X O

As IN O
with IN O
the DT O
heterologous JJ O
DNA NNP O
binding NN O
domain NN O
, , O
MZF-1 NNP B-NP
represses VBZ O
reporter NN O
gene NN O
expression NN O
in IN O
nonhematopoietic JJ O
cell NN O
lines NNS O
and CC O
activates NNS O
expression NN O
in IN O
hematopoietic JJ O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

Analyses NNS O
of IN O
hGMR NN B-NP
beta NN I-NP
subunit NN I-NP
mutants NNS I-NP
revealed VBD O
two CD O
cytoplasmic JJ O
regions NNS O
involved VBN O
in IN O
activation NN O
of IN O
the DT O
c-myc JJ B-NP
promoter NN I-NP
, , O
one CD O
is VBZ O
essential JJ O
and CC O
the DT O
other JJ O
is VBZ O
dispensable JJ O
but CC O
enhances VBZ O
the DT O
activity NN O
. . O

-DOCSTART- X X O

Similarly RB O
, , O
we PRP O
observed VBD O
synthetic JJ O
phenotypes NNS O
between IN O
mutations NNS O
in IN O
MIF2 NNP B-NP
and CC O
trans-acting JJ O
mutations NNS O
in IN O
three CD O
known JJ O
yeast NN O
centromere JJ O
protein NN O
genes-CEP1/CBF1/CPF1 JJ O
, , O
NDC10/CBF2 NNP B-NP
, , O
and CC O
CEP3/CBF3B. NNP B-NP

-DOCSTART- X X O

Estimated VBN O
daily JJ O
intakes NNS O
( -LRB- O
EDIs NNS O
) -RRB- O
per IN O
person NN O
were VBD O
0.56 CD O
microgram NN O
for IN O
total JJ O
HCH NNP O
, , O
0.20 CD O
microgram NN O
for IN O
gamma-HCH NNP O
, , O
0.09 CD O
microgram NN O
for IN O
dieldrin NN O
, , O
1.42 CD O
micrograms NNS O
for IN O
total JJ O
DDT NNP O
, , O
and CC O
0.15 CD O
microgram NN O
for IN O
HCB. NNP O

-DOCSTART- X X O

In IN O
two CD O
further JJ O
cases NNS O
( -LRB- O
one CD O
type NN O
I PRP O
and CC O
one CD O
type NN O
III NNP O
SMA NNP O
) -RRB- O
, , O
de FW O
novo FW O
deletions NNS O
of IN O
only RB O
one CD O
copy NN O
of IN O
Ag1-CA NNP B-NP
and CC O
C212 NNP B-NP
were VBD O
found VBN O
. . O

-DOCSTART- X X O

With IN O
each DT O
of IN O
the DT O
three CD O
pairs NNS O
of IN O
isolates NNS O
( -LRB- O
case NN O
and CC O
suspicious JJ O
case NN O
) -RRB- O
, , O
identical JJ O
IS6110 IN O
banding VBG O
patterns NNS O
were VBD O
found VBN O
suggesting VBG O
identical JJ O
MTB NNP O
strains NNS O
. . O

-DOCSTART- X X O

These DT O
early JJ O
structural JJ O
processes NNS O
are VBP O
assumed VBN O
to TO O
be VB O
subserved VBN O
by IN O
the DT O
anterior JJ O
parts NNS O
of IN O
the DT O
left JJ O
hemisphere NN O
, , O
as IN O
event-related JJ O
brain NN O
potentials NNS O
show VBP O
this DT O
area NN O
to TO O
be VB O
maximally RB O
activated VBN O
when WRB O
phrase NN O
structure NN O
violations NNS O
are VBP O
processed VBN O
and CC O
as IN O
circumscribed JJ O
lesions NNS O
in IN O
this DT O
area NN O
lead NN O
to TO O
an DT O
impairment NN O
of IN O
the DT O
on-line JJ O
structural JJ O
assignment NN O
. . O

-DOCSTART- X X O

In IN O
men NNS O
with IN O
BMI NNP O
< NNP O
30 CD O
, , O
the DT O
OR NN O
was VBD O
1.83 CD O
for IN O
postprandial JJ O
TG NNP O
( -LRB- O
P NNP O
= SYM O
.041 CD O
) -RRB- O
and CC O
2.77 CD O
for IN O
postprandial JJ O
RP NNP O
( -LRB- O
P NNP O
= SYM O
.032 CD O
) -RRB- O
in IN O
models NNS O
that WDT O
included VBD O
fasting JJ O
TG NNP O
, , O
LDL-C NNP B-NP
, , O
and CC O
hypertension NN O
. . O

-DOCSTART- X X O

SL1 JJ B-NP
trans-splicing NN O
specified VBN O
by IN O
AU-rich JJ O
synthetic JJ O
RNA NNP O
inserted VBD O
at IN O
the DT O
5' JJ O
end NN O
of IN O
Caenorhabditis NNP O
elegans NNS O
pre-mRNA JJ O
. . O

-DOCSTART- X X O

A DT O
pyrazolo-quinoline JJ O
compound NN O
, , O
6-methoxy-4-[2-[(2-hydroxyethoxyl)-ethyl]amino]-3-methyl-1M-pyrazo JJ O
lo NN O
[3,4-b]quinoline NN O
(SCH JJ O
51344 CD O
) -RRB- O
, , O
was VBD O
identified VBN O
based VBN O
on IN O
its PRP$ O
ability NN O
to TO O
derepress VB O
human JJ O
smooth JJ O
muscle NN O
alpha-actin NN B-NP
promoter NN I-NP
activity NN O
in IN O
ras-transformed JJ B-NP
cells NNS O
. . O

-DOCSTART- X X O

On IN O
the DT O
basis NN O
of IN O
these DT O
relations NNS O
, , O
a DT O
risk NN O
factor-selection NN O
scale NN O
( -LRB- O
RFSS) FW O
( -LRB- O
range NN O
, , O
0 CD O
to TO O
10 CD O
) -RRB- O
was VBD O
developed VBN O
by IN O
computing VBG O
appropriate JJ O
weights NNS O
for IN O
each DT O
risk NN O
factor NN O
. . O

-DOCSTART- X X O

Repression NN O
of IN O
glucocorticoid JJ B-NP
receptor-mediated JJ I-NP
transcriptional JJ O
activation NN O
by IN O
unliganded JJ O
thyroid NN B-NP
hormone NN I-NP
receptor NN I-NP
( -LRB- O
TR NN B-NP
) -RRB- O
is VBZ O
TR NNP B-NP
isoform-specific JJ O
. . O

-DOCSTART- X X O

Overexpression IN O
of IN O
wild-type JJ B-NP
p53 NN I-NP
also RB O
induces VBZ O
apoptosis NN O
in IN O
an DT O
LCL. . O

-DOCSTART- X X O

Cloning NNP O
, , O
sequencing NN O
and CC O
expression NN O
of IN O
the DT O
3-phosphoglycerate JJ B-NP
kinase NN I-NP
gene NN I-NP
of IN O
Pyrococcus NNP O
woesei NNS O
in IN O
Escherichia NNP O
coli NNS O
and CC O
characterization NN O
of IN O
the DT O
protein NN O
. . O

-DOCSTART- X X O

We PRP O
sought VBD O
to TO O
determine VB O
whether IN O
such JJ O
differences NNS O
in IN O
polyadenylation NN O
affect VBP O
the DT O
steady-state NN O
levels NNS O
of IN O
DHFR NNP B-NP
and CC O
mRNAs NNS O
expressed VBN O
from IN O
either DT O
allele JJ O
and CC O
, , O
in IN O
a DT O
more RBR O
general JJ O
sense NN O
, , O
to TO O
ask VB O
whether IN O
differences NNS O
in IN O
3' JJ O
end NN O
RNA NNP O
processing NN O
in IN O
a DT O
gene NN O
containing VBG O
multiple JJ O
poly( NN O
A DT O
) -RRB- O
sites NNS O
affects VBZ O
the DT O
final JJ O
level NN O
of IN O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
a DT O
Drosophila NNP O
melanogaster NN O
( -LRB- O
Dm NN O
) -RRB- O
cDNA NN O
encoding VBG O
a DT O
polypeptide NN O
that WDT O
has VBZ O
extensive JJ O
sequence NN O
similarity NN O
to TO O
the DT O
mammalian JJ B-NP
MAPKAPK-2 NN I-NP
. . O

-DOCSTART- X X O

The DT O
finding NN O
that IN O
the DT O
chimeric JJ B-NP
TdT NNP I-NP
::Pol NNP O
beta NN B-NP
protein NN I-NP
possessed VBD O
significant JJ O
template-dependent JJ O
polymerase NN O
activity NN O
suggests VBZ O
that IN O
aa JJ O
1-60 CD O
of IN O
Pol NNP B-NP
beta NN I-NP
are VBP O
involved VBN O
in IN O
template JJ O
utilization NN O
during IN O
the DT O
polymerization NN O
reaction NN O
, , O
as IN O
suggested VBN O
by IN O
the DT O
previous JJ O
finding NN O
that IN O
the DT O
8-kDa JJ O
N-terminal JJ O
domain NN O
of IN O
Pol NNP B-NP
beta NN I-NP
possesses VBZ O
ssDNA-binding JJ O
activity NN O
[Kumar NNP O
et NNP O
al NN O
. . O
, , O
J. NNP O

-DOCSTART- X X O

The DT O
integrity NN O
of IN O
the DT O
cDNA NN O
sequence NN O
was VBD O
confirmed VBN O
by IN O
analysis NN O
of IN O
several JJ O
overlapping VBG O
genomic JJ O
clones NNS O
that WDT O
span VBP O
the DT O
GAR1 NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

In IN O
Trial NNP O
1 CD O
, , O
eight CD O
sows NNS O
were VBD O
allowed VBN O
to TO O
farrow VB O
naturally RB O
( -LRB- O
d VBN O
114 CD O
, , O
NF NNP O
sows NNS O
) -RRB- O
and CC O
eight CD O
sows NNS O
were VBD O
induced VBN O
to TO O
farrow VB O
( -LRB- O
IF IN O
sows NNS O
) -RRB- O
prematurely RB O
by IN O
injection NN O
of IN O
prostaglandin NN O
F2 IN O
alpha NN O
on IN O
d JJ O
112 CD O
of IN O
gestation NN O
. . O

-DOCSTART- X X O

End-tidal JJ O
PO2 NNP O
and CC O
the DT O
ratio NN O
of IN O
minute NN O
ventilation NN O
to TO O
oxygen NN O
consumption NN O
(VE/VO2 IN O
) -RRB- O
were VBD O
lower JJR O
while IN O
PETCO2 NN O
was VBD O
higher JJR O
for IN O
Hyp NNP O
( -LRB- O
P NNP O
< , O
or CC O
= SYM O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggested VBD O
that IN O
NfxB NNP B-NP
negatively RB O
autoregulates VBZ O
the DT O
expression NN O
of IN O
nfxB NN B-NP
itself PRP O
. . O

-DOCSTART- X X O

If IN O
NCR-sensitive JJ O
gene NN O
expression NN O
occurs VBZ O
exclusively RB O
by IN O
this DT O
pathway NN O
, , O
as RB O
has VBZ O
been VBN O
thought VBN O
to TO O
be VB O
the DT O
case NN O
, , O
then RB O
the DT O
NCR NNP O
sensitivity NN O
of IN O
a DT O
gene NN O
's POS O
expression NN O
should MD O
be VB O
abolished VBN O
by IN O
a DT O
ure2 JJ B-NP
delta NN I-NP
mutation NN I-NP
. . O

-DOCSTART- X X O

The DT O
single-stranded JJ O
DNA NNP O
Pur NNP B-NP
alpha NN I-NP
recognition NN I-NP
element NN I-NP
disrupts VBD O
these DT O
complexes NNS O
. . O

-DOCSTART- X X O

Association NNP O
of IN O
human JJ B-NP
Pur NNP I-NP
alpha NN I-NP
with IN O
the DT O
retinoblastoma NN B-NP
protein NN I-NP
, , O
Rb NNP B-NP
, , O
regulates VBZ O
binding NN O
to TO O
the DT O
single-stranded JJ O
DNA NNP O
Pur NNP B-NP
alpha NN I-NP
recognition NN I-NP
element NN I-NP
. . O

-DOCSTART- X X O

The DT O
insulin-induced JJ B-NP
DNA-binding NN O
complex NN O
was VBD O
identified VBN O
as IN O
the DT O
p50/p65 NN B-NP
heterodimer NN O
. . O

-DOCSTART- X X O

Using VBG O
varying VBG O
conditions NNS O
, , O
three CD O
distinct JJ O
complexes NNS O
were VBD O
shown VBN O
to TO O
interact VB O
specifically RB O
with IN O
the DT O
NIP NNP B-NP
region NN I-NP
, , O
although IN O
only RB O
one CD O
correlates NNS O
with IN O
repressor NN O
activity NN O
. . O

-DOCSTART- X X O

Exchange NNP O
of IN O
the DT O
LPL NNP B-NP
and CC O
HL NNP B-NP
lids NNS O
resulted VBD O
in IN O
a DT O
reversal NN O
of IN O
the DT O
phospholipase/neutral JJ B-NP
lipase NN B-NP
ratio NN O
, , O
establishing VBG O
the DT O
important JJ O
role NN O
of IN O
this DT O
region NN O
in IN O
mediating VBG O
substrate JJ O
specificity NN O
. . O

-DOCSTART- X X O

The DT O
interferon-inducible JJ B-NP
protein NN B-NP
kinase NN I-NP
PKR NN I-NP
modulates VBZ O
the DT O
transcriptional JJ O
activation NN O
of IN O
immunoglobulin NN B-NP
kappa NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Truncated NNP O
forms NNS O
of IN O
a DT O
novel NN O
yeast NN O
protein NN O
suppress VBD O
the DT O
lethality NN O
of IN O
a DT O
G NNP B-NP
protein NN I-NP
alpha NN I-NP
subunit NN I-NP
deficiency NN O
by IN O
interacting VBG O
with IN O
the DT O
beta JJ O
subunit NN O
. . O

-DOCSTART- X X O

Levels NNP O
of IN O
TSG-14 CD B-NP
protein NN I-NP
( -LRB- O
also RB O
termed VBN O
PTX-3 NN B-NP
) -RRB- O
become VBP O
elevated VBN O
in IN O
the DT O
serum NN O
of IN O
mice NNS O
and CC O
humans NNS O
after IN O
injection NN O
with IN O
bacterial JJ O
lipopolysaccharide NN O
, , O
but CC O
in IN O
contrast NN O
to TO O
conventional JJ O
acute JJ O
phase NN O
proteins NNS O
, , O
the DT O
bulk NN O
of IN O
TSG-14 DT B-NP
synthesis NN O
in IN O
the DT O
intact JJ O
organism NN O
occurs VBZ O
outside IN O
the DT O
liver NN O
. . O

-DOCSTART- X X O

The DT O
mouse NN B-NP
beta NN I-NP
2-syntrophin JJ I-NP
gene NN I-NP
( -LRB- O
> CD O
33 CD O
kilobases NNS O
) -RRB- O
contains VBZ O
seven CD O
exons NNS O
, , O
all DT O
of IN O
which WDT O
have VBP O
homologues NNS O
at IN O
the DT O
corresponding JJ O
position NN O
in IN O
the DT O
alpha NN B-NP
1-syntrophin JJ I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

We PRP O
report VBP O
here RB O
the DT O
cloning NN O
of IN O
the DT O
murine NN O
p44 VBD B-NP
MAP NNP B-NP
kinase NN I-NP
( -LRB- O
extracellular JJ B-NP
signal-regulated JJ I-NP
kinase NN I-NP
1 CD I-NP
) -RRB- O
gene NN O
, , O
the DT O
determination NN O
of IN O
its PRP$ O
intron/exon JJ O
boundaries NNS O
, , O
and CC O
the DT O
characterization NN O
of IN O
its PRP$ O
promoter NN O
. . O

-DOCSTART- X X O

One CD O
of IN O
these DT O
is VBZ O
surrounded VBN O
by IN O
an DT O
adenine-uridine JJ O
rich JJ O
region NN O
that WDT O
can MD O
form VB O
an DT O
11-base JJ O
pair NN O
stem NN O
structure NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
verapamil NN O
and CC O
propranolol NN O
on IN O
early JJ O
afterdepolarizations NNS O
and CC O
ventricular JJ O
arrhythmias NNS O
induced VBN O
by IN O
epinephrine NN O
in IN O
congenital JJ O
long JJ O
QT NNP O
syndrome NN O
. . O

-DOCSTART- X X O

Deletion NNP O
of IN O
the DT O
NF-IL6 NNP B-NP
beta NN I-NP
leucine NN I-NP
zipper NN I-NP
domain NN I-NP
also RB O
greatly RB O
diminished VBN O
the DT O
interaction NN O
between IN O
these DT O
two CD O
proteins NNS O
. . O

-DOCSTART- X X O

Two CD O
domains NNS O
of IN O
EBNA2 NNP B-NP
defined VBN O
by IN O
deletion NN O
of IN O
amino DT O
acids NNS O
247-337 CD O
and CC O
437-476 CD O
were VBD O
found VBN O
to TO O
be VB O
important JJ O
for IN O
the DT O
activation NN O
of IN O
both DT O
promoters NNS O
, , O
while IN O
two CD O
different JJ O
domains NNS O
corresponding JJ O
to TO O
residues NNS O
4-18 . O
and CC O
118-198 CD O
were VBD O
required VBN O
solely RB O
for IN O
the DT O
LMP1 NNP B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Additionally RB O
, , O
the DT O
enzyme NN O
shows VBZ O
activity NN O
towards IN O
triglycerides NNS O
such JJ O
as IN O
olive JJ O
oil NN O
and CC O
tributyrin NN O
and CC O
towards IN O
egg-yolk NN O
emulsions NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
low JJ O
concentrations NNS O
of IN O
IL-1 DT B-NP
beta NN I-NP
may MD O
be VB O
useful JJ O
for IN O
nonsurgical JJ O
treatment NN O
of IN O
human JJ O
vitreous JJ O
hemorrhage NN O
. . O

-DOCSTART- X X O

Two CD O
transcripts NNS O
of IN O
1.6 CD O
kb NN O
and CC O
5.8 CD O
kb NN O
are VBP O
5' JJ O
coterminal JJ O
and CC O
may MD O
both DT O
encode VB O
the DT O
novel NN O
glycoprotein NNP B-NP
gene NN I-NP
EUS4 NNS I-NP
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
few JJ O
studies NNS O
that WDT O
address VBP O
antimicrobial JJ O
prophylaxis NNS O
in IN O
bone NN O
marrow NN O
transplantation NN O
have VBP O
not RB O
always RB O
shown VBN O
a DT O
survival NN O
benefit NN O
. . O

-DOCSTART- X X O

The DT O
fracture NN O
groups NNS O
were VBD O
significantly RB O
older JJR O
and CC O
had VBD O
more JJR O
years NNS O
since IN O
menopause NN O
than IN O
the DT O
control NN O
groups NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
we PRP O
found VBD O
differences NNS O
in IN O
the DT O
binding NN O
of IN O
nuclear JJ O
factors NNS O
from IN O
shoots NNS O
versus RB O
from IN O
roots NNS O
, , O
in IN O
agreement NN O
with IN O
the DT O
different JJ O
activities NNS O
of IN O
the DT O
promoter NN O
in IN O
these DT O
two CD O
organs NNS O
. . O

-DOCSTART- X X O

The DT O
prevalence NN O
and CC O
incidence NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
types NNS O
1 CD O
and CC O
2 CD O
( -LRB- O
HIV-1 NN O
, , O
HIV-2 NN O
) -RRB- O
, , O
human JJ O
T-lymphotropic NNP O
virus NN O
types NNS O
I PRP O
and CC O
II NNP O
( -LRB- O
HTLV-I/II NN O
) -RRB- O
, , O
and CC O
syphilitic JJ O
infections NNS O
and CC O
the DT O
association NN O
between IN O
these DT O
infections NNS O
were VBD O
determined VBN O
in IN O
a DT O
cohort NN O
of IN O
police NN O
officers NNS O
in IN O
Guinea-Bissau NNP O
. . O

-DOCSTART- X X O

By IN O
in IN O
vitro NN O
immunoprecipitations NNS O
and CC O
gel JJ O
shift NN O
assays VBZ O
, , O
we PRP O
identified VBD O
two CD O
classes NNS O
of IN O
high JJ O
affinity NN O
Engrailed-binding JJ B-NP
sites NNS I-NP
upstream RB O
of IN O
each DT O
of IN O
the DT O
two CD O
polyhomeotic JJ O
transcription NN O
units NNS O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
this DT O
sequence NN O
combined VBN O
with IN O
that DT O
previously RB O
reported VBN O
for IN O
the DT O
5'-flanking JJ O
region NN O
directly RB O
proximal JJ O
to TO O
the DT O
start NN O
of IN O
transcription NN O
revealed VBD O
several JJ O
putative JJ O
regulatory JJ O
sequences NNS O
. . O

-DOCSTART- X X O

By IN O
using VBG O
lacZ NN B-NP
fusions NNS I-NP
, , O
it PRP O
was VBD O
possible JJ O
to TO O
localize VB O
the DT O
DNA NNP O
sequences NNS O
required VBD O
to TO O
mediate VB O
nitrate JJ O
repression NN O
to TO O
the DT O
pfl NN B-NP
promoter-regulatory JJ I-NP
region NN I-NP
. . O

-DOCSTART- X X O

Vestibular JJ O
adaptation NN O
exercises NNS O
and CC O
recovery NN O
: : O
acute JJ O
stage NN O
after IN O
acoustic JJ O
neuroma NN O
resection NN O
. . O

-DOCSTART- X X O

The DT O
experimental JJ O
design NN O
represents VBZ O
a DT O
2 CD O
x NN O
3 CD O
factorial JJ O
arrangement NN O
of IN O
treatments NNS O
with IN O
three CD O
dietary JJ O
levels NNS O
of IN O
incorporation NN O
of IN O
RSB NNP O
( -LRB- O
0 CD O
, , O
50 CD O
, , O
and CC O
100 CD O
% NN O
) -RRB- O
, , O
and CC O
chickens NNS O
either CC O
infected VBN O
or CC O
uninfected JJ O
. . O

-DOCSTART- X X O

There EX O
were VBD O
no DT O
significant JJ O
changes NNS O
in IN O
either CC O
the DT O
fatty JJ O
acid NN O
composition NN O
of IN O
biliary JJ O
lecithin JJ O
or CC O
in IN O
the DT O
bile NN O
acid NN O
composition NN O
of IN O
bile NN O
. . O

-DOCSTART- X X O

Total JJ O
cholesterol NN O
was VBD O
also RB O
reduced VBN O
at IN O
week NN O
12 CD O
by IN O
17.0 CD O
% NN O
( -LRB- O
20 CD O
mg/day NN O
) -RRB- O
and CC O
15.7 CD O
% NN O
( -LRB- O
20-30 JJ O
mg/day NN O
) -RRB- O
, , O
and CC O
at IN O
week NN O
52 CD O
by IN O
20.4 CD O
% NN O
( -LRB- O
< NN O
or CC O
= SYM O
20 CD O
mg/day NN O
) -RRB- O
and CC O
19.2 CD O
% NN O
( -LRB- O
> NN O
or CC O
= SYM O
30 CD O
mg/day NN O
) -RRB- O
. . O

-DOCSTART- X X O

Although IN O
further JJ O
studies NNS O
are VBP O
required VBN O
to TO O
determine VB O
the DT O
precise JJ O
role NN O
of IN O
PEBP2 NN B-NP
in IN O
the DT O
GM-CSF NNP B-NP
promoter NN I-NP
activity NN O
, , O
the DT O
present JJ O
findings NNS O
suggested VBD O
the DT O
importance NN O
of IN O
the DT O
relative JJ O
ratio NN O
of IN O
different JJ O
PEBP2 NN B-NP
isoforms NNS I-NP
in IN O
regulating VBG O
the DT O
levels NNS O
of IN O
the DT O
promoter NN O
activity NN O
. . O

-DOCSTART- X X O

Piperacillin-tazobactam NNP O
can MD O
be VB O
used VBN O
for IN O
the DT O
treatment NN O
of IN O
infections NNS O
caused VBN O
by IN O
gram-negative JJ O
, , O
gram-positive JJ O
, , O
aerobic JJ O
, , O
and CC O
anaerobic JJ O
bacteria NNS O
. . O

-DOCSTART- X X O

The DT O
spectrum NN O
of IN O
phenotypes NNS O
caused VBN O
by IN O
these DT O
mutations NNS O
was VBD O
strikingly RB O
different JJ O
than IN O
mutations NNS O
in IN O
the DT O
adaptor NN O
for IN O
the DT O
VP16 NNP B-NP
activation NN I-NP
domain NN I-NP
. . O

-DOCSTART- X X O

Increase VB O
in IN O
urinary JJ O
calcium NN O
and CC O
oxalate NN O
after IN O
fructose JJ O
infusion NN O
. . O

-DOCSTART- X X O

The DT O
5'flanking JJ O
region NN O
is VBZ O
highly RB O
GC JJ O
rich JJ O
, , O
with IN O
multiple JJ O
CpG NNP O
doublets NNS O
, , O
and CC O
contains VBZ O
multiple JJ O
binding NN O
sites NNS O
for IN O
Sp1 NNP B-NP
. . O

-DOCSTART- X X O

Increased VBN O
blood NN O
pressure NN O
during IN O
CyA NNP O
treatment NN O
was VBD O
independent JJ O
of IN O
circulating VBG O
ET-1 JJ B-NP
levels NNS O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
several JJ O
Tat NNPS B-NP
mutants NNS I-NP
indicated VBD O
that IN O
both DT O
the DT O
cysteine-rich JJ O
and CC O
the DT O
core NN O
domains NNS O
of IN O
this DT O
transactivator NN O
are VBP O
necessary JJ O
and CC O
sufficient JJ O
to TO O
activate VB O
transcription NN O
when WRB O
TBP NNP B-NP
is VBZ O
overexpressed VBN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
depletion NN O
of IN O
Oct-1 NNP B-NP
from IN O
the DT O
nuclear JJ O
extract VB O
by IN O
using VBG O
Oct-1-specific NNP B-NP
antiserum NN O
or CC O
a DT O
sequence-specific JJ O
DNA NN O
affinity NN O
resin NN O
decreased VBD O
in IN O
vitro NN O
transcription NN O
from IN O
the DT O
wild-type JJ O
MMTV NNP O
promoter NN O
to TO O
a DT O
level NN O
identical JJ O
to TO O
that DT O
obtained VBN O
from IN O
a DT O
promoter NN O
in IN O
which WDT O
all DT O
three CD O
octamer-related JJ O
sequences NNS O
were VBD O
mutated VBN O
. . O

-DOCSTART- X X O

Transactivation NN O
of IN O
the DT O
HIV-1 NN B-NP
LTR NNP I-NP
by IN O
T3R NNP B-NP
alpha NN I-NP
and CC O
several JJ O
receptor NN O
mutants NNS O
revealed VBD O
that IN O
the DT O
50-amino-acid JJ O
N-terminal JJ O
A/B NNP O
region NN O
of IN O
T3R NNP B-NP
alpha NN I-NP
, , O
known VBN O
to TO O
interact VB O
with IN O
the DT O
basal JJ B-NP
transcription NN I-NP
factor NN I-NP
TFIIB NNP I-NP
, , O
is VBZ O
critical JJ O
for IN O
activation NN O
of IN O
both DT O
Tat-dependent NNP B-NP
and CC O
Tat-independent NNP B-NP
responsive JJ O
sequences NNS O
of IN O
the DT O
LTR. NNP O

-DOCSTART- X X O

Finally RB O
, , O
we PRP O
show VBP O
that IN O
complexes NNS O
similar JJ O
to TO O
the DT O
C25 NNP B-NP
, , O
C30 NNP B-NP
and CC O
C35 DT B-NP
complexes NNS I-NP
are VBP O
formed VBN O
by IN O
rat NN O
cortex NN O
nuclear JJ O
extracts NNS O
and CC O
the DT O
SAA NNP O
element NN O
in IN O
EMSA NNP O
experiments NNS O
, , O
suggesting VBG O
the DT O
relevance NN O
of IN O
our PRP$ O
in IN O
vitro NN O
observations NNS O
to TO O
the DT O
in IN O
vivo JJ O
functioning NN O
of IN O
the DT O
rat NN B-NP
APP NNP I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

The DT O
analysis NN O
of IN O
the DT O
prevalence NN O
values NNS O
shows VBZ O
clearly RB O
that IN O
the DT O
global JJ O
MS-frequency NN O
is VBZ O
closer RBR O
related VBN O
to TO O
the DT O
geomagnetic JJ O
than IN O
to TO O
the DT O
geographic JJ O
latitude NN O
. . O

-DOCSTART- X X O

Subhuman JJ O
primates NNS O
appear VBP O
to TO O
be VB O
more RBR O
sensitive JJ O
to TO O
reproductive VB O
and CC O
other JJ O
adverse JJ O
effects NNS O
of IN O
PCBs NNS O
than IN O
humans NNS O
. . O

-DOCSTART- X X O

The DT O
cryptococcal JJ B-NP
antigen JJ I-NP
test NN O
was VBD O
positive JJ O
at IN O
1:125 CD O
by IN O
latex JJ O
agglutination NN O
. . O

-DOCSTART- X X O

Both DT O
mu NNS B-NP
and CC I-NP
gamma NN I-NP
2b IN I-NP
heavy JJ I-NP
chain NN I-NP
genes NNS I-NP
cause VBP O
this DT O
feedback NN O
inhibition NN O
of IN O
heavy JJ O
chain NN O
gene NN O
rearrangement NN O
. . O

-DOCSTART- X X O

Purified VBN O
CarP NNP B-NP
binds NNS O
in IN O
vitro NN O
to TO O
the DT O
carAB NN B-NP
control NN I-NP
region NN I-NP
and CC O
protects VBZ O
against IN O
DNase NN B-NP
I PRP I-NP
two CD O
approximately RB O
25 CD O
bp NN O
long JJ O
stretches NNS O
, , O
one CD O
of IN O
which WDT O
is VBZ O
located VBN O
just RB O
downstream RB O
of IN O
the DT O
GATC NNP O
sequence NN O
. . O

-DOCSTART- X X O

They PRP O
include VBP O
genes NNS O
encoding VBG O
three CD O
subunits NNS O
of IN O
the DT O
cytochrome NN B-NP
oxidase NN I-NP
( -LRB- O
cox1 NN B-NP
to TO I-NP
3 CD I-NP
) -RRB- O
, , O
apocytochrome NN B-NP
b NN I-NP
( -LRB- O
cob NN B-NP
) -RRB- O
, , O
seven CD O
subunits NNS O
of IN O
the DT O
NADH NNP B-NP
dehydrogenase NN I-NP
complex NN I-NP
( -LRB- O
nad1 JJ B-NP
to TO I-NP
6 CD I-NP
, , O
nad4L) NN B-NP
, , O
two CD O
ATPase NNP B-NP
subunits NNS O
(atp6 . O
and CC O
atp9 PRP B-NP
) -RRB- O
, , O
three CD O
ribosomal JJ O
RNAs NNS O
( -LRB- O
rrn5 CD B-NP
, , O
srn NN B-NP
and CC O
lrn NN B-NP
) -RRB- O
, , O
23 CD O
tRNAs NNS O
and CC O
four CD O
ribosomal JJ O
proteins NNS O
( -LRB- O
rps3 CD B-NP
, , O
rps11 CD B-NP
, , O
rps12 CD B-NP
and CC O
rpl16 CD B-NP
) -RRB- O
. . O

-DOCSTART- X X O

From IN O
day NN O
10 CD O
, , O
a DT O
significant JJ O
increase NN O
in IN O
platelet NN O
count NN O
was VBD O
observed VBN O
in IN O
eight CD O
of IN O
the DT O
ten CD O
patients NNS O
treated VBN O
with IN O
heparin NN O
( -LRB- O
p NN O
< JJ O
0.05 CD O
) -RRB- O
, , O
with IN O
return NN O
to TO O
the DT O
initial JJ O
value NN O
after IN O
heparin NN O
cessation NN O
in IN O
six CD O
of IN O
the DT O
responders NNS O
. . O

-DOCSTART- X X O

The DT O
Babcock NNP O
Surgical NNP O
Clinic NNP O
. . O

-DOCSTART- X X O

Resources NNP O
for IN O
helping VBG O
patients NNS O
to TO O
quit VB O
smoking NN O
. . O

-DOCSTART- X X O

The DT O
PEBP2 NN B-NP
alpha NN I-NP
proteins NNS I-NP
contain VBP O
a DT O
128-amino-acid JJ O
( -LRB- O
aa JJ O
) -RRB- O
region NN O
highly RB O
homologous JJ O
to TO O
the DT O
Drosophila NNP B-NP
melanogaster NN I-NP
segmentation NN I-NP
gene NN I-NP
runt NN I-NP
. . O

-DOCSTART- X X O

Histopathological JJ O
features NNS O
of IN O
relapsed JJ O
leprosy NN O
. . O

-DOCSTART- X X O

One CD O
of IN O
these DT O
factors NNS O
, , O
HRF-1 NNP B-NP
, , O
recognizes VBZ O
a DT O
cis NN O
element NN O
consisting VBG O
of IN O
an DT O
inverted JJ O
palindromic JJ O
motif NN O
. . O

-DOCSTART- X X O

D. NNP O

-DOCSTART- X X O

It PRP O
was VBD O
proposed VBN O
that IN O
the DT O
synthetase-related JJ O
sequences NNS O
of IN O
GCN2 NNP B-NP
stimulate VB O
the DT O
activity NN O
of IN O
the DT O
kinase NN O
by IN O
interacting VBG O
directly RB O
with IN O
uncharged JJ O
tRNA NN O
that IN O
accumulates NNS O
during IN O
amino JJ O
acid NN O
limitation NN O
. . O

-DOCSTART- X X O

To TO O
compare VB O
the DT O
PAX3 NNP B-NP
and CC O
putative JJ O
PAX3-FKHR JJ B-NP
transactivation NN O
domains VBZ O
, , O
we PRP O
fused VBD O
C-terminal JJ O
test NN O
fragments NNS O
to TO O
the DT O
heterologous JJ O
GAL4 NNP B-NP
DNA-binding NNP I-NP
domain NN I-NP
and CC O
tested VBN O
activation NN O
of IN O
a DT O
reporter NN O
gene NN O
co-transfected VBD O
into IN O
four CD O
cell NN O
types NNS O
. . O

-DOCSTART- X X O

All DT O
subjects NNS O
were VBD O
submitted VBN O
to TO O
ECG NNP O
and CC O
arterial JJ O
blood NN O
pressure NN O
determination NN O
and CC O
were VBD O
assayed VBN O
for IN O
TSH NNP B-NP
, , O
thyroid DT O
hormone NN O
, , O
PRL NNP B-NP
, , O
glucose NN O
, , O
creatinine CD O
, , O
nitrogen NN O
, , O
glutamine NN B-NP
transaminase NN I-NP
, , O
cholesterol NN O
and CC O
triglycerides VBZ O
plasma NN O
levels NNS O
before IN O
therapy NN O
( -LRB- O
T0 NN O
) -RRB- O
, , O
after IN O
30 CD O
treatment NN O
days NNS O
( -LRB- O
T30 CD O
) -RRB- O
and CC O
after IN O
a DT O
15 CD O
days NNS O
washout IN O
( -LRB- O
T45 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Acute JJ O
decrease NN O
in IN O
body NN O
temperature NN O
( -LRB- O
TB NNP O
) -RRB- O
lowered VBD O
PaCO2 NNP O
( -LRB- O
32.5 CD O
to TO O
14.5 CD O
mmHg NN O
) -RRB- O
and CC O
[HCO3-]a( JJ O
24.20 CD O
mEq/L NN O
to TO O
17.56 CD O
mEq/L NN O
) -RRB- O
, , O
increased VBD O
pHa NN O
( -LRB- O
7.481 CD O
to TO O
7.608 CD O
) -RRB- O
and CC O
diminished VBD O
the DT O
[OH-]/[ JJ O
H+ NNP O
] NNP O
ratio NN O
, , O
but CC O
had VBD O
no DT O
significant JJ O
effect NN O
on IN O
[SID] NNP O
or CC O
[Atot] NNP O
, , O
although IN O
both DT O
total JJ O
phosphorus NN O
[PT NNP O
] SYM O
and CC O
inorganic JJ O
phosphate NN O
[Pi] NN O
increased VBD O
. . O

-DOCSTART- X X O

Hepatitis NNP O
B NNP O
vaccine NN O
: : O
still RB O
has VBZ O
its PRP$ O
problems NNS O
. . O

-DOCSTART- X X O

The DT O
RAT3 NNP B-NP
gene NN I-NP
encodes VBZ O
an DT O
1157-amino JJ O
acid NN O
protein NN O
without IN O
similarity NN O
to TO O
other JJ O
known VBN O
proteins NNS O
. . O

-DOCSTART- X X O

Tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
( -LRB- O
TNF NN B-NP
alpha NN I-NP
) -RRB- O
, , O
a DT O
proinflammatory NN O
cytokine NN O
, , O
inhibits VBZ O
cAMP-stimulated JJ O
testosterone NN O
production NN O
in IN O
mouse NN O
Leydig NNP O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
Drosophila NNP B-NP
insulin NN I-NP
receptor NN I-NP
homolog NN I-NP
: : O
a DT O
gene NN O
essential JJ O
for IN O
embryonic JJ O
development NN O
encodes VBZ O
two CD O
receptor NN O
isoforms VBZ O
with IN O
different JJ O
signaling NN O
potential NN O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
here RB O
that IN O
RA NNP O
and CC O
E1A NNP B-NP
induce VB O
phosphorylation NN O
of IN O
the DT O
E1A-associated JJ B-NP
300 CD I-NP
kDa JJ I-NP
protein NN I-NP
( -LRB- O
p300 NN B-NP
) -RRB- O
during IN O
the DT O
differentiation NN O
of IN O
F9 CD O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
double-stranded JJ O
RNA NNP O
binding NN O
domain NN O
( -LRB- O
dsRBD NN O
) -RRB- O
is VBZ O
an DT O
approximately RB O
65 CD O
amino IN O
acid NN O
motif NN O
that WDT O
is VBZ O
found VBN O
in IN O
a DT O
variety NN O
of IN O
proteins NNS O
that WDT O
interact NN O
with IN O
double-stranded JJ O
( -LRB- O
ds NNS O
) -RRB- O
RNA NNP O
, , O
such JJ O
as IN O
Escherichia NNP O
coli NNS O
RNase NNP B-NP
III NNP I-NP
and CC O
the DT O
dsRNA-dependent JJ B-NP
kinase NN I-NP
, , O
PKR NNP B-NP
. . O

-DOCSTART- X X O

SCA NNP B-NP
was VBD O
resistant JJ O
to TO O
inhibitors NNS O
of IN O
serine NN O
, , O
aspartyl NN O
, , O
and CC O
metalloproteases NNS B-NP
, , O
but CC O
it PRP O
was VBD O
sensitive JJ O
to TO O
N-ethylmaleimide NNP O
. . O

-DOCSTART- X X O

Mutational JJ O
analysis NN O
of IN O
potential JJ O
activating NN O
phosphorylation NN O
sites NNS O
found VBD O
in IN O
NIMA NNP B-NP
, , O
NIM-1 NNP B-NP
, , O
and CC O
related JJ O
protein NN O
kinases NNS O
was VBD O
performed VBN O
on IN O
NIMA. NNP B-NP

-DOCSTART- X X O

NH2- NNP O
and CC O
COOH-terminal JJ O
deletion NN O
analysis NN O
revealed VBN O
that IN O
both DT O
the DT O
PH NNP B-NP
and CC O
putative JJ O
guanine NNP B-NP
nucleotide JJ I-NP
exchange NN I-NP
factor NN I-NP
domains NNS I-NP
are VBP O
required VBN O
, , O
but CC O
the DT O
zinc NN O
butterfly NN O
is VBZ O
dispensable JJ O
, , O
for IN O
transformation NN O
. . O

-DOCSTART- X X O

The DT O
objective NN O
of IN O
our PRP$ O
study NN O
was VBD O
to TO O
evaluate VB O
the DT O
age NN O
, , O
sex NN O
, , O
clinical JJ O
conditions NNS O
, , O
family NN O
history NN O
, , O
site NN O
, , O
catheter NN O
association NN O
, , O
means VBZ O
of IN O
radiologic NN O
evaluation NN O
, , O
development NN O
of IN O
pulmonary JJ O
involvement NN O
, , O
prevalence NN O
of IN O
antithrombin JJ B-NP
III NNP I-NP
, , O
protein NN B-NP
C NNP I-NP
and CC O
protein NN B-NP
S NNP I-NP
deficiencies NNS O
, , O
and CC O
lupus JJ O
anticoagulants NNS O
in IN O
children NNS O
who WP O
suffered VBD O
a DT O
thrombotic JJ O
event NN O
. . O

-DOCSTART- X X O

Radiotherapy NN O
and CC O
early JJ O
orchiectomy NN O
in IN O
stage NN O
D1 IN O
prostatic JJ O
carcinoma NN O

-DOCSTART- X X O

The DT O
ARX2 NN O
procedure NN O
models NNS O
the DT O
recorded JJ O
signal NN O
as IN O
the DT O
sum NN O
of IN O
three CD O
signals NNS O
: : O
( -LRB- O
a DT O
) -RRB- O
the DT O
background NN O
EEG NNP O
activity NN O
, , O
modelled JJ O
as IN O
an DT O
autoregressive JJ O
process NN O
driven VBN O
by IN O
a DT O
white JJ O
noise NN O
; : O
( -LRB- O
b NN O
) -RRB- O
a DT O
filtered VBN O
version NN O
of IN O
a DT O
reference NN O
signal NN O
carrying VBG O
the DT O
average JJ O
information NN O
contained VBN O
in IN O
each DT O
sweep NN O
; : O
( -LRB- O
c NN O
) -RRB- O
a DT O
signal NN O
due JJ O
to TO O
the DT O
ocular JJ O
artefact NN O
propagation NN O
. . O

-DOCSTART- X X O

The DT O
expression NN O
of IN O
the DT O
gene NN O
encoding VBG O
the DT O
enzyme NN O
( -LRB- O
CYP19 IN B-NP
) -RRB- O
is VBZ O
regulated VBN O
, , O
in IN O
part NN O
, , O
by IN O
tissue-specific JJ O
promoters NNS O
through IN O
the DT O
use NN O
of IN O
alternative-splicing NN O
mechanisms NNS O
. . O

-DOCSTART- X X O

Using VBG O
mutagenesis NN O
, , O
we PRP O
have VBP O
identified VBN O
two CD O
mutations NNS O
of IN O
the DT O
second JJ O
actin-binding JJ B-NP
domain NN I-NP
that WDT O
can MD O
also RB O
suppress VB O
the DT O
act1 JJ B-NP
mutations NNS O
of IN O
interest NN O
. . O

-DOCSTART- X X O

CIITA NNP B-NP
mRNA NN I-NP
is VBZ O
normally RB O
inducible JJ O
by IN O
IFN-gamma NNP B-NP
in IN O
class NN O
II NNP O
non-inducible JJ O
, , O
RB-defective JJ O
lines NNS O
, , O
and CC O
in IN O
one CD O
line NN O
, , O
re-expression NN O
of IN O
RB NNP B-NP
has VBZ O
no DT O
effect NN O
on IN O
CIITA NNP B-NP
mRNA NN I-NP
induction NN O
levels NNS O
. . O

-DOCSTART- X X O

The DT O
normal JJ O
cell NN O
cycle NN O
is VBZ O
regulated VBN O
by IN O
several JJ O
molecules NNS O
, , O
such JJ O
as IN O
the DT O
tumor-suppressor JJ B-NP
protein NN I-NP
pRb NN I-NP
, , O
the DT O
G1 NNP B-NP
cyclins NNS I-NP
, , O
the DT O
cyclin-dependent JJ B-NP
kinases NNS I-NP
, , O
and CC O
their PRP$ O
inhibitors NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
are VBP O
very RB O
useful JJ O
for IN O
deciding VBG O
on IN O
the DT O
doses NNS O
of IN O
hormones NNS O
and CC O
the DT O
expected VBN O
serum NN O
estradiol NN O
level NN O
in IN O
HRT NNP O
for IN O
Japanese JJ O
women NNS O
. . O

-DOCSTART- X X O

One CD O
month NN O
after IN O
the DT O
DTaP NNP O
booster NN O
vaccination NN O
, , O
both DT O
groups NNS O
had VBD O
6- CD O
to TO O
40-fold JJ O
increases NNS O
in IN O
serum NN O
antibody NN O
concentrations NNS O
to TO O
all DT O
antigens NNS O
tested VBN O
; : O
the DT O
concentrations NNS O
against IN O
the DT O
three CD O
pertussis NN B-NP
antigens NNS I-NP
were VBD O
higher JJR O
in IN O
the DT O
DTaP-primed JJ O
children NNS O
( -LRB- O
p NN O
< JJ O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
this DT O
amino-terminal JJ O
determinant NN O
appears VBZ O
not RB O
to TO O
reside VB O
in IN O
the DT O
HSV-alpha NNP O
TIF NNP B-NP
, , O
which WDT O
displays VBZ O
no DT O
independent JJ O
amino-terminal JJ O
activity NN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
show VBP O
that IN O
in IN O
fusions NNS O
with IN O
the DT O
DNA NNP O
binding NN O
domain NN O
of IN O
GAL4 NNP B-NP
, , O
full JJ O
activity NN O
requires VBZ O
the DT O
entire JJ O
BHV-alpha NN B-NP
TIF NN I-NP
, , O
although IN O
both DT O
amino NN O
and CC O
carboxyl NN O
termini NNS O
display VBP O
some DT O
activity NN O
on IN O
their PRP$ O
own JJ O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
show VBP O
that DT O
messenger NN O
RNAs IN O
encoding NN O
trans-sialidases NNS O
containing VBG O
the DT O
repeats NNS O
are VBP O
not RB O
present JJ O
in IN O
epimastigotes NNS O
but CC O
are VBP O
abundant JJ O
in IN O
trypomastigotes NNS O
. . O

-DOCSTART- X X O

From IN O
May NNP O
1985 CD O
to TO O
May MD O
1989 CD O
, , O
126 CD O
necropsies NNS O
were VBD O
performed VBN O
at IN O
the DT O
Sao NNP O
Paulo NNP O
City NNP O
Morgue NNP O
on IN O
cadavers NNS O
of IN O
individuals NNS O
AIDS NNP O
victims NNS O
whose WP$ O
unnatural JJ O
deaths NNS O
had VBD O
prompted VBN O
police NN O
investigations NNS O
. . O

-DOCSTART- X X O

A DT O
model NN O
with IN O
age NN O
and CC O
weight NN O
described VBD O
the DT O
best JJS O
fit NN O
for IN O
TBBMD NNP O
, , O
whereas IN O
age NN O
, , O
weight NN O
, , O
and CC O
height NN O
described VBD O
the DT O
best JJS O
fit NN O
for IN O
total JJ O
body NN O
TBBMC. . O

-DOCSTART- X X O

The DT O
C-terminal JJ O
peptide NN O
sequences NNS O
of IN O
the DT O
human JJ B-NP
lymphocyte-specific JJ I-NP
high JJ I-NP
mobility NN I-NP
group NN I-NP
( -LRB- I-NP
HMG)-box NNP I-NP
transcription NN I-NP
factor NN I-NP
TCF-1 NN I-NP
are VBP O
determined VBN O
by IN O
alternative JJ O
splice NN O
mechanisms NNS O
affecting VBG O
the DT O
exons NNS O
VIII NNP O
to TO O
X NNP O
. . O

-DOCSTART- X X O

A DT O
new JJ O
vector NN O
, , O
pHBK280 NN O
, , O
was VBD O
designed VBN O
to TO O
facilitate VB O
this DT O
analysis NN O
. . O

-DOCSTART- X X O

A DT O
TATA-less JJ O
promoter NN O
containing VBG O
binding JJ O
sites NNS O
for IN O
ubiquitous JJ O
transcription NN O
factors NNS O
mediates NNS O
cell NN O
type-specific JJ O
regulation NN O
of IN O
the DT O
gene NN O
for IN O
transcription NN B-NP
enhancer NN I-NP
factor-1 NN I-NP
( -LRB- O
TEF-1 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
describe VBP O
an DT O
in IN O
vitro NN O
assay NN O
where WRB O
the DT O
NS3-4A NNP B-NP
polyprotein NN I-NP
, , O
NS3 NNP B-NP
, , O
the DT O
serine NN B-NP
proteinase NN I-NP
domain NN I-NP
( -LRB- I-NP
the DT I-NP
N-terminal JJ I-NP
181 CD I-NP
residues NNS I-NP
of IN I-NP
NS3 NNP I-NP
) -RRB- I-NP
, , O
and CC O
the DT O
NS4A NNP B-NP
cofactor NN I-NP
were VBD O
produced VBN O
by IN O
cell-free JJ O
translation NN O
and CC O
tested VBD O
for IN O
trans-processing NN O
of IN O
radiolabeled JJ O
substrates NNS O
. . O

-DOCSTART- X X O

We PRP O
purified VBD O
both DT O
proteins NNS O
from IN O
human JJ O
platelet NN O
membranes NNS O
using VBG O
DEAE-Sepharose DT O
chromatography NN O
followed VBN O
by IN O
mAb JJ B-NP
F11 NNP I-NP
affinity NN O
chromatography NN O
. . O

-DOCSTART- X X O

Our PRP$ O
evidence NN O
derives VBZ O
from IN O
three CD O
principal JJ O
observations NNS O
: : O
1 CD O
) -RRB- O
a DT O
transfection NN O
construct VB O
containing VBG O
only RB O
122 CD O
nucleotides NNS O
( -LRB- O
nt NN O
) -RRB- O
of IN O
promoter NN O
1 CD O
and CC O
328 CD O
nt NN O
of IN O
the DT O
5'-UTR JJ O
retained VBN O
full JJ O
PGE2-stimulated JJ O
reporter NN O
expression NN O
; : O
2 CD O
) -RRB- O
maximal NN O
PGE2-driven JJ O
reporter NN O
expression NN O
required VBD O
the DT O
presence NN O
of IN O
nt JJ O
196 CD O
to TO O
328 CD O
of IN O
exon NN O
1 CD O
when WRB O
tested VBN O
within IN O
the DT O
context NN O
of IN O
IGF-I JJ B-NP
promoter NN I-NP
1 CD I-NP
; : O
3 CD O
) -RRB- O
cotransfection NN O
of IN O
IGF-I NNP B-NP
promoter-luciferase-reporter NN I-NP
constructs NNS O
with IN O
a DT O
plasmid NN O
encoding VBG O
the DT O
alpha-isoform NN O
of IN O
the DT O
catalytic JJ O
subunit NN O
of IN O
murine NN B-NP
cAMP-dependent JJ I-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
PKA NN B-NP
) -RRB- O
produced VBN O
results NNS O
comparable JJ O
to TO O
those DT O
seen VBN O
with IN O
PGE2 NNP O
treatment NN O
, , O
whereas IN O
cotransfection NN O
with IN O
a DT O
plasmid NN O
encoding VBG O
a DT O
mutant JJ O
regulatory JJ O
subunit NN O
of IN O
PKA NNP B-NP
that IN O
cannot DT O
bind NN O
cAMP NNS O
blocked VBD O
PGE2-induced JJ O
reporter NN O
expression NN O
. . O

-DOCSTART- X X O

Retransformation NNP O
of IN O
uvsH77 CD B-NP
mutants NNS I-NP
with IN O
the DT O
rescued VBN O
cosmids NNS O
from IN O
the DT O
MMS-resistant JJ O
transformants NNS O
resulted VBD O
in IN O
restoration NN O
of IN O
both DT O
UV NN O
and CC O
MMS NNP O
resistance NN O
to TO O
wild-type JJ O
levels NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
this DT O
element NN O
confers VBZ O
p53 NN B-NP
induction NN O
to TO O
the DT O
otherwise RB O
nonresponsive JJ O
adenovirus JJ O
major JJ O
late JJ O
promoter NN O
. . O

-DOCSTART- X X O

In IN O
flies NNS O
, , O
the DT O
dShc JJ B-NP
protein NN I-NP
physically RB O
associates NNS O
with IN O
the DT O
activated JJ O
Drosophila NNP B-NP
epidermal JJ I-NP
growth NN I-NP
factor NN I-NP
receptor NN I-NP
homolog NN I-NP
( -LRB- O
DER NN B-NP
) -RRB- O
and CC O
is VBZ O
inducibly RB O
phosphorylated VBN O
on IN O
tyrosine NN O
by IN O
DER NNP B-NP
. . O

-DOCSTART- X X O

A DT O
Drosophila NNP B-NP
shc NN I-NP
gene NN I-NP
product NN I-NP
is VBZ O
implicated VBN O
in IN O
signaling VBG O
by IN O
the DT O
DER NN B-NP
receptor NN I-NP
tyrosine NN I-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

This DT O
inhibition NN O
can MD O
be VB O
overcome VBN O
by IN O
mutating VBG O
either CC O
the DT O
exon NN O
's POS O
5' JJ O
or CC O
3' JJ O
splice NN O
site NN O
to TO O
make VB O
it PRP O
correspond VB O
more RBR O
closely RB O
to TO O
the DT O
relevant JJ O
consensus NN O
sequence NN O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
revealed VBD O
the DT O
expression NN O
of IN O
LIMK-1 JJ B-NP
mRNA NN I-NP
predominantly RB O
in IN O
the DT O
brain NN O
and CC O
the DT O
expression NN O
of IN O
LIMK-2 JJ B-NP
mRNA NN I-NP
in IN O
various JJ O
tissues NNS O
in IN O
the DT O
rat NN O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
relative JJ O
binding NN O
affinity NN O
for IN O
the DT O
motifs NNS O
is VBZ O
different JJ O
. . O

-DOCSTART- X X O

On IN O
the DT O
basis NN O
of IN O
this DT O
anatomic JJ O
concept NN O
, , O
the DT O
brachioplasty JJ O
procedure NN O
was VBD O
modified VBN O
to TO O
provide VB O
secure JJ O
anchoring NN O
of IN O
the DT O
arm NN O
flap NN O
to TO O
the DT O
axillary NN O
fascia VBD O
along IN O
with IN O
strong JJ O
superficial JJ O
fascial JJ O
system NN O
repair NN O
of IN O
incisions NNS O
, , O
reducing VBG O
the DT O
risk NN O
of IN O
widening VBG O
or CC O
migration NN O
of IN O
scars NNS O
and CC O
unnatural JJ O
contours NNS O
. . O

-DOCSTART- X X O

INF-alpha NNP B-NP
therapy NN O
has VBZ O
been VBN O
a DT O
major JJ O
development NN O
in IN O
the DT O
treatment NN O
of IN O
CML. NNP O

-DOCSTART- X X O

Max NNP B-NP
was VBD O
constantly RB O
transcribed VBN O
at IN O
a DT O
relatively RB O
low JJ O
level NN O
during IN O
cell NN O
cycle NN O
progression NN O
. . O

-DOCSTART- X X O

Key JJ O
areas NNS O
of IN O
the DT O
selection NN O
process NN O
including VBG O
medical JJ O
and CC O
surgical JJ O
alternatives NNS O
to TO O
transplantation NN O
, , O
the DT O
composition NN O
of IN O
the DT O
transplant NN O
work-up NN O
, , O
specific JJ O
inclusion NN O
criteria NNS O
as RB O
well RB O
as IN O
specific JJ O
psychosocial JJ O
factors NNS O
and CC O
specific JJ O
disease NN O
etiologies NNS O
and CC O
co-morbidities NNS O
that WDT O
might MD O
represent VB O
contraindications NNS O
were VBD O
extensively RB O
reviewed VBN O
. . O

-DOCSTART- X X O

The DT O
transport NN O
of IN O
a DT O
genetically RB O
engineered VBN O
chimeric JJ O
transmembrane NN O
protein NN O
connected VBN O
to TO O
this DT O
ER NNP O
leader NN O
sequence NN O
was VBD O
as RB O
efficient JJ O
as IN O
that DT O
of IN O
the DT O
original JJ O
protein NN O
from IN O
which WDT O
the DT O
ER NNP O
sequence NN O
has VBZ O
been VBN O
derived VBN O
. . O

-DOCSTART- X X O

A DT O
polymorphic JJ O
bipartite JJ O
motif NN O
signals NNS O
nuclear JJ O
targeting VBG O
of IN O
early JJ O
auxin-inducible JJ O
proteins NNS O
related VBN O
to TO O
PS-IAA4 NNP B-NP
from IN I-NP
pea NN I-NP
( -LRB- I-NP
Pisum IN I-NP
sativum NN I-NP
) -RRB- I-NP
. . O

-DOCSTART- X X O

Comparative JJ O
DNA NNP O
sequence NN O
analysis NN O
showed VBD O
the DT O
Genethon NNP O
microsatellite NN B-NP
D19S596 IN I-NP
lies VBZ O
2.2 CD O
kb JJ O
downstream NN O
of IN O
the DT O
coding VBG O
region NN O
of IN O
FUT1 NNP B-NP
, , O
indicating VBG O
that IN O
the DT O
cluster NN O
comprising VBG O
the DT O
closely RB O
linked VBN O
FUT1 NNP B-NP
and CC O
FUT2 NNP B-NP
genes NNS I-NP
is VBZ O
located VBN O
4 CD O
cM NNS O
distal JJ O
to TO O
D19S412 CD B-NP
( -LRB- O
lod NN O
score NN O
13.7 CD O
) -RRB- O
and CC O
9 CD O
cM NNS O
proximal JJ O
to TO O
D19S571 VB B-NP
( -LRB- O
lod NN O
score NN O
11.7 CD O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
transcription NN O
activation NN O
by IN O
LEF-1 JJ B-NP
in IN O
vitro NN O
is VBZ O
a DT O
chromatin-dependent NN O
process NN O
that WDT O
requires VBZ O
a DT O
functional JJ O
trans-activation NN O
domain NN O
in IN O
addition NN O
to TO O
the DT O
HMG NNP B-NP
domain NN I-NP
. . O

-DOCSTART- X X O

TH-SH3 DT B-NP
binding NN O
in IN O
vitro NN O
is VBZ O
abolished VBN O
by IN O
specific JJ O
, , O
single JJ O
amino IN O
acid NN O
substitutions NNS O
within IN O
the DT O
Btk NNP B-NP
TH IN B-NP
domain NN I-NP
or CC O
the DT O
Fyn NNP B-NP
SH3 NNP B-NP
domain NN I-NP
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
K-glypican NNP B-NP
is VBZ O
a DT O
novel NN O
GPI-anchored NNP B-NP
HSPG NNP I-NP
involved VBD O
in IN O
embryonic JJ O
development NN O
. . O

-DOCSTART- X X O

The DT O
plant NN O
hormone NN O
auxin NN O
transcriptionally RB O
activates VBZ O
early JJ B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

The DT O
ubiquitous JJ O
transcription NN O
factor NN O
Oct-1 . B-NP
forms NNS O
complexes NNS O
with IN O
an DT O
octamer NN O
motif NN O
present NN O
within IN O
FPIV NNP O
by IN O
gel NNP O
shift NN O
analysis NN O
with IN O
liver NN O
and CC O
kidney NN O
extracts NNS O
, , O
making VBG O
Oct-1 NNP B-NP
an DT O
intriguing JJ O
candidate NN O
for IN O
partnership NN O
in IN O
androgen NN O
regulation NN O
. . O

-DOCSTART- X X O

We PRP O
used VBD O
deletion NN O
analysis NN O
and CC O
transfection NN O
assays RB O
with IN O
reporter NN O
gene NN O
constructs NNS O
to TO O
examine VB O
the DT O
transcription NN O
control NN O
elements NNS O
in IN O
the DT O
5' JJ O
flanking JJ O
region NN O
of IN O
the DT O
human JJ B-NP
EpoR NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Adrenergic NNP O
system NN O
activation NN O
, , O
indicated VBN O
by IN O
metanephrine/epinephrine NN O
ratio NN O
, , O
increased VBD O
with IN O
time NN O
in IN O
losing VBG O
males NNS O
, , O
except IN O
that IN O
after IN O
one CD O
month NN O
of IN O
cohabitation NN O
, , O
turnover NN O
returned VBD O
to TO O
levels NNS O
that IN O
equaled VBN O
those DT O
of IN O
control NN O
animals NNS O
. . O

-DOCSTART- X X O

A. NN O

-DOCSTART- X X O

Transcription NN O
factors NNS O
containing VBG O
a DT O
basic JJ O
helix-loop-helix NN O
( -LRB- O
bHLH) NN O
motif NN O
regulate VB O
the DT O
expression NN O
of IN O
tissue-specific JJ O
genes NNS O
in IN O
a DT O
number NN O
of IN O
mammalian JJ O
and CC O
insect JJ O
systems NNS O
. . O

-DOCSTART- X X O

Primer NNP O
extension NN O
and CC O
S1 JJ B-NP
nuclease NN I-NP
mapping NN O
experiments NNS O
were VBD O
used VBN O
to TO O
locate VB O
the DT O
transcription NN O
initiation NN O
site NN O
of IN O
Nramp1 NNP B-NP
and CC O
revealed VBD O
the DT O
presence NN O
of IN O
one CD O
major JJ O
and CC O
several JJ O
minor JJ O
initiation NN O
sites NNS O
. . O

-DOCSTART- X X O

EsaR NNP B-NP
can MD O
repress VB O
its PRP$ O
own JJ O
expression NN O
but CC O
seems VBZ O
not RB O
to TO O
regulate VB O
the DT O
expression NN O
of IN O
esaI. NN B-NP

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
the DT O
5'-flanking JJ O
region NN O
of IN O
the DT O
CD69 NNP B-NP
gene NN I-NP
revealed VBD O
the DT O
presence NN O
of IN O
a DT O
potential JJ O
TATA NNP O
element NN O
30 CD O
base NN O
pairs NNS O
upstream RB O
of IN O
the DT O
major JJ O
transcription NN O
initiation NN O
site NN O
and CC O
several JJ O
putative JJ O
binding NN O
sequences NNS O
for IN O
inducible JJ O
transcription NN O
factors NNS O
( -LRB- O
NF-kappa NNP B-NP
B NNP I-NP
, , O
Egr-1 NNP B-NP
, , O
AP-1 NN B-NP
) -RRB- O
, , O
which WDT O
might MD O
mediate VB O
the DT O
inducible JJ O
expression NN O
of IN O
this DT O
gene NN O
. . O

-DOCSTART- X X O

The DT O
plasmin-derived JJ B-NP
D NNP I-NP
( -LRB- I-NP
approximately RB I-NP
105-kDa JJ I-NP
) -RRB- I-NP
product NN I-NP
, , O
however RB O
, , O
could MD O
be VB O
cross-linked VBN O
into IN O
DD NNP O
dimers NNS O
. . O

-DOCSTART- X X O

All DT O
clinical JJ O
isolates NNS O
were VBD O
concomitantly RB O
tested VBN O
by IN O
disk NN O
diffusion NN O
and CC O
agar NN O
dilution NN O
procedures NNS O
as IN O
outlined VBN O
by IN O
the DT O
National NNP O
Committee NNP O
for IN O
Clinical NNP O
Laboratory NNP O
Standards NNPS O
. . O

-DOCSTART- X X O

The DT O
nucleotide JJ O
sequence NN O
of IN O
the DT O
chloroplast NN O
( -LRB- O
cp NN O
) -RRB- O
DNA NN O
from IN O
maize NN O
( -LRB- O
Zea NNP O
mays VBZ O
) -RRB- O
has VBZ O
been VBN O
completed VBN O
. . O

-DOCSTART- X X O

Investigation NNP O
of IN O
the DT O
control NN O
of IN O
coronavirus NN O
subgenomic JJ O
mRNA NN O
transcription NN O
by IN O
using VBG O
T7-generated JJ O
negative-sense JJ O
RNA NNP O
transcripts NNS O
. . O

-DOCSTART- X X O

Mean JJ O
longitudinal JJ O
extension NN O
of IN O
the DT O
epidural JJ O
lesion NN O
was VBD O
2.6 CD O
vertebral JJ O
segments NNS O
. . O

-DOCSTART- X X O

The DT O
association NN O
of IN O
p255 VBG B-NP
with IN O
splicing NN O
complexes NNS O
is VBZ O
suggested VBN O
by IN O
the DT O
finding NN O
that IN O
mAb JJ B-NP
CC3 NNS I-NP
can MD O
inhibit VB O
in IN O
vitro NN O
splicing NN O
and CC O
immunoprecipitate NN O
pre-messenger JJ O
RNA NNP O
and CC O
splicing NN O
products NNS O
. . O

-DOCSTART- X X O

L-735,524 DT O
free JJ O
base NN O
or CC O
sulfate NN O
salt NN O
was VBD O
administered VBN O
orally RB O
as IN O
suspension NN O
, , O
solution NN O
or CC O
in IN O
solid JJ O
dosage NN O
forms NNS O
to TO O
fasted JJ O
or CC O
fed VBN O
Beagle NNP O
dogs VBZ O
. . O

-DOCSTART- X X O

Doppler NNP O
ultrasound JJ O
studies NNS O
of IN O
long-term JJ O
follow-up NN O
of IN O
children NNS O
with IN O
hemolytic-uremic JJ O
syndrome NN O

-DOCSTART- X X O

Thus RB O
, , O
endemic JJ O
cumlations NNS O
of IN O
hepatitis NN O
A DT O
diseases NNS O
are VBP O
possible JJ O
. . O

-DOCSTART- X X O

The DT O
properties NNS O
of IN O
the DT O
phi NN O
29 CD O
SSB-ssDNA NNP B-NP
complex JJ O
are VBP O
described VBN O
. . O

-DOCSTART- X X O

This DT O
shows VBZ O
that IN O
the DT O
characteristically NN O
diffuse JJ O
banding NN O
pattern NN O
of IN O
plant NN O
nuclear JJ O
proteins NNS O
interacting VBG O
with IN O
the DT O
G-box NN O
is VBZ O
also RB O
observed VBN O
in IN O
a DT O
binding JJ O
assay NN O
using VBG O
only RB O
one CD O
recombinant NN B-NP
GBF. . I-NP

-DOCSTART- X X O

The DT O
physical JJ O
linkage NN O
of IN O
the DT O
FHR2 NNP B-NP
and CC O
the DT O
factor NN B-NP
H NNP I-NP
genes NNS I-NP
provides VBZ O
additional JJ O
evidence NN O
for IN O
a DT O
close JJ O
relatedness NN O
of IN O
complement NN B-NP
factor NN I-NP
H NNP I-NP
and CC O
the DT O
factor NN B-NP
H-related JJ I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

The DT O
third JJ O
domain NN O
had VBD O
the DT O
motif NN O
of IN O
a DT O
cAMP JJ O
response NN O
element NN O
( -LRB- O
CRE NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
tyrosine-phosphorylated JJ O
state NN O
of IN O
CAK NNP B-NP
beta NN I-NP
was VBD O
not RB O
reduced VBN O
on IN O
trypsinization NN O
, , O
nor CC O
enhanced JJ O
in IN O
response NN O
to TO O
plating VBG O
3Y1 CD O
cells NNS O
onto IN O
fibronectin NNS B-NP
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
while IN O
many JJ O
muscle NN O
gene NN O
E-boxes NNS O
are VBP O
capable JJ O
of IN O
binding VBG O
the DT O
previously RB O
characterized VBN O
spectrum NN O
of IN O
MDF/bH-L-H JJ B-NP
heterodimers NNS I-NP
in IN O
vitro NN O
, , O
MCK-L NNP B-NP
type NN O
E-boxes NNP O
probably RB O
bind VBP O
qualitatively RB O
different JJ O
factors NNS O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
, , O
in IN O
comparison NN O
to TO O
reports NNS O
from IN O
other JJ O
regions NNS O
, , O
Scandinavian JJ O
renal JJ O
transplant NN O
recipients NNS O
are VBP O
at IN O
high JJ O
risk NN O
of IN O
dying VBG O
of IN O
IHD. NNP O

-DOCSTART- X X O

The DT O
serum NN O
concentration NN O
of IN O
iP JJ O
before IN O
dialysis NN O
( -LRB- O
HD NNP O
) -RRB- O
was VBD O
on IN O
average JJ O
3.06 CD O
( -LRB- O
+/ FW O
- : O
0.81 CD O
) -RRB- O
mmol/l NN O
and CC O
D NNP O
was VBD O
on IN O
average JJ O
55.6 CD O
( -LRB- O
+/ FW O
- : O
10.0) CD O
mmol NN O
. . O

-DOCSTART- X X O

A DT O
significant JJ O
correlation NN O
between IN O
a DT O
number NN O
of IN O
functional JJ O
parameters NNS O
of IN O
gastric JJ O
secretion NN O
, , O
incretion NN O
and CC O
histological JJ O
changes NNS O
of IN O
gastric JJ O
mucosa NN O
was VBD O
found VBN O
in IN O
patients NNS O
with IN O
chronic JJ O
gastritis NN O
. . O

-DOCSTART- X X O

Little NNP O
or CC O
no DT O
protection NN O
was VBD O
detected VBN O
using VBG O
adrenal JJ O
cortex NN O
, , O
adrenal JJ O
medulla NN O
, , O
liver NN O
, , O
kidney NN O
cortex NN O
, , O
spleen JJ O
, , O
or CC O
T-lymphocyte JJ O
total JJ O
RNA NNP O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
a DT O
direct JJ O
correlation NN O
between IN O
the DT O
levels NNS O
of IN O
transcription NN O
of IN O
the DT O
acc NN B-NP
genes NNS I-NP
and CC O
the DT O
rate NN O
of IN O
cellular JJ O
growth NN O
. . O

-DOCSTART- X X O

The DT O
hybridizing JJ O
clone NN O
of IN O
V. NNP O
vulnificus JJ O
chromosomal NN O
DNA NN O
complemented VBN O
a DT O
V. NNP B-NP
cholerae NN I-NP
fur NN I-NP
mutant NN I-NP
. . O

-DOCSTART- X X O

We PRP O
generated VBD O
transformed VBN O
B NNP O
lymphoblast NN O
cell NN O
lines NNS O
from IN O
controls NNS O
, , O
from IN O
four CD O
patients NNS O
with IN O
p47-phox-deficient JJ B-NP
chronic NN O
granulomatous JJ O
disease NN O
, , O
and CC O
from IN O
three CD O
parents NNS O
. . O

-DOCSTART- X X O

RNase NN B-NP
protection NN O
and CC O
primer JJ O
extension NN O
assays VBZ O
confirmed VBN O
that IN O
the DT O
5' JJ O
non-coding JJ O
exon NN O
is VBZ O
included VBN O
in IN O
the DT O
DDT1 NNP O
aFGF NN B-NP
mRNA NN I-NP
and CC O
that IN O
a DT O
major JJ O
transcription NN O
start NN O
site NN O
is VBZ O
approximately RB O
136 CD O
bp NN O
upstream RB O
of IN O
the DT O
5' JJ O
non-coding JJ O
splice NN O
junction NN O
of IN O
this DT O
exon NN O
. . O

-DOCSTART- X X O

The DT O
roles NNS O
of IN O
phorbol NN O
esters NNS O
and CC O
cyclic JJ O
AMP NNP O
in IN O
mediating VBG O
the DT O
GnRH JJ B-NP
response NN O
were VBD O
also RB O
investigated VBN O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
and CC O
characterization NN O
of IN O
two CD O
genes NNS B-NP
encoding VBG I-NP
gp138 CD I-NP
, , O
a DT O
cell NN O
surface NN O
glycoprotein NN O
involved VBN O
in IN O
the DT O
sexual JJ O
cell NN O
fusion NN O
of IN O
Dictyostelium NN O
discoideum NN O
. . O

-DOCSTART- X X O

Piroximone NN O
is VBZ O
a DT O
new JJ O
phosphodiesterase NN B-NP
III NNP I-NP
inhibitor CC O
that WDT O
combines VBZ O
inotropic NN O
and CC O
vasodilator NN O
properties NNS O
. . O

-DOCSTART- X X O

Since IN O
we PRP O
have VBP O
observed VBN O
effects NNS O
of IN O
growth NN O
factors NNS O
and CC O
cAMP NNS O
as RB O
well RB O
as IN O
estradiol NN O
( -LRB- O
E2 NN O
) -RRB- O
on IN O
regulation NN O
of IN O
expression NN O
of IN O
some DT O
genes NNS O
stimulated VBN O
by IN O
the DT O
estrogen NN B-NP
receptor NN I-NP
( -LRB- O
ER NNP B-NP
) -RRB- O
, , O
we PRP O
have VBP O
undertaken VBN O
studies NNS O
to TO O
examine VB O
directly RB O
whether IN O
activators NNS O
of IN O
protein NN O
kinases NNS O
can MD O
modulate VB O
transcriptional JJ O
activity NN O
of IN O
the DT O
ER NNP B-NP
. . O

-DOCSTART- X X O

RNA RB B-NP
polymerase NN I-NP
bound VBD O
to TO O
the DT O
+10A NN O
promoter NN O
partially RB O
protects VBZ O
a DT O
20 CD O
base-pair NN O
sequence NN O
from IN O
DNase NN B-NP
I PRP I-NP
digestion VBD O
upstream RB O
of IN O
the DT O
start NN O
site NN O
. . O

-DOCSTART- X X O

Salivary NNP O
sodium NN O
, , O
calcium NN O
, , O
and CC O
magnesium NN O
concentrations NNS O
were VBD O
significantly RB O
higher JJR O
in IN O
the DT O
SLE JJ O
patients NNS O
with IN O
systemic JJ O
lupus NN O
erythematosus NN O
, , O
whereas IN O
potassium NN O
and CC O
total JJ O
protein NN O
concentrations NNS O
and CC O
amylase NN B-NP
activity NN O
did VBD O
not RB O
differ VB O
significantly RB O
from IN O
the DT O
controls NNS O
. . O

-DOCSTART- X X O

Chem NNP O
. . O

-DOCSTART- X X O

Recombinant NNP O
plasmid VBD O
pFV100 PRP O
was VBD O
subsequently RB O
isolated VBN O
by IN O
its PRP$ O
ability NN O
to TO O
complement VB O
B-band NNP O
expression NN O
in IN O
ge6 CD B-NP
. . O

-DOCSTART- X X O

We PRP O
here RB O
demonstrate VBP O
that IN O
a DT O
temperature-sensitive JJ O
fission NN O
yeast NN O
mutant NN O
which WDT O
has VBZ O
a DT O
mutation NN O
in IN O
a DT O
homologous JJ O
gene NN O
, , O
and CC O
two CD O
of IN O
three CD O
additional JJ O
( -LRB- O
mtr1/prp20/srm1 NN B-NP
) -RRB- O
mutants NNS O
accumulate VBP O
nuclear JJ O
poly( NN O
A DT O
) -RRB- O
+ NN O
RNA NNP O
at IN O
37 CD O
degrees NNS O
C. NNP O

-DOCSTART- X X O

Since IN O
RCC1p NNP B-NP
acts VBZ O
as IN O
GNRP NNP B-NP
for IN O
Ran NNP B-NP
, , O
a DT O
small JJ B-NP
nuclear JJ I-NP
GTPase NN I-NP
of IN O
the DT O
ras NNS B-NP
superfamily NN I-NP
, , O
we PRP O
have VBP O
identified VBN O
two CD O
homologs NNS O
of IN O
Ran NNP B-NP
in IN O
S.cerevisiae NNP O
( -LRB- O
CNR1 NNP B-NP
and CC O
CNR2 NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Prostate NNP B-NP
specific JJ I-NP
antigen NN I-NP
shows VBZ O
the DT O
metastatic JJ O
cases NNS O
better JJR O
[correction NN O
of IN O
worse JJR O
] NN O
than IN O
prostatic JJ B-NP
acid NN I-NP
phosphatase NN I-NP
. . O

-DOCSTART- X X O

Protein NNP O
phosphorylation NN O
appears VBZ O
to TO O
play VB O
a DT O
critical JJ O
role NN O
in IN O
uPA NNP B-NP
gene NN I-NP
expression NN O
in IN O
these DT O
cells NNS O
; : O
protein NN B-NP
kinase NN I-NP
C-activating NN I-NP
phorbol NN O
esters NNS O
cooperate VBP O
with IN O
pp60v-src JJ B-NP
to TO O
synergistically RB O
increase VB O
uPA NNP B-NP
mRNA NNS I-NP
, , O
whereas IN O
cyclic JJ B-NP
AMP NNP I-NP
(cAMP)-dependent JJ I-NP
protein NN I-NP
kinase-activating NN I-NP
agents NNS O
( -LRB- O
e NN O
.g. NNP O
, , O
8-bromo JJ O
cAMP NN O
) -RRB- O
repress NN O
uPA IN B-NP
mRNA NN I-NP
levels NNS O
. . O

-DOCSTART- X X O

Of IN O
these DT O
carriers NNS O
149 CD O
were VBD O
diagnosed VBN O
to TO O
be VB O
asymptomatic JJ O
clinically RB O
, , O
biochemically RB O
and CC O
echographically RB O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
mutations NNS O
in IN O
the DT O
coding NN O
sequence NN O
of IN O
the DT O
proto-oncogene NN B-NP
c-kit NN I-NP
in IN O
a DT O
human JJ O
mast NN O
cell NN O
leukemia NN O
cell NN O
line NN O
causing VBG O
ligand-independent JJ O
activation NN O
of IN O
c-kit JJ B-NP
product NN I-NP
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Delineation NN O
of IN O
the DT O
morphologic NN O
aspects NNS O
of IN O
age-related JJ O
macular JJ O
degeneration NN O
( -LRB- O
ARMD) NN O
is VBZ O
helpful JJ O
in IN O
correlation NN O
with IN O
the DT O
clinical JJ O
features NNS O
and CC O
may MD O
contribute VB O
to TO O
understanding VBG O
the DT O
pathogenesis NN O
. . O

-DOCSTART- X X O

Risk NNP O
factors NNS O
associated VBN O
with IN O
a DT O
high JJ O
seroprevalence NN O
of IN O
hepatitis NN O
C NNP O
virus NN O
infection NN O
in IN O
Egyptian JJ O
blood NN O
donors NNS O
. . O

-DOCSTART- X X O

This DT O
agent NN O
, , O
isolated VBN O
from IN O
the DT O
fungus NN O
Streptomyces NNP O
tsukubaensis NN O
, , O
has VBZ O
a DT O
mechanism NN O
of IN O
action NN O
similar JJ O
to TO O
that DT O
of IN O
cyclosporine NN O
. . O

-DOCSTART- X X O

Finally RB O
, , O
the DT O
stability NN O
of IN O
the DT O
nucleotide JJ O
binding JJ O
function NN O
of IN O
the DT O
two CD O
proteins NNS O
is VBZ O
similar JJ O
as IN O
assessed VBN O
by IN O
sensitivity NN O
to TO O
urea NN O
. . O

-DOCSTART- X X O

By IN O
contrast NN O
, , O
all DT O
proteins NNS O
initiated VBN O
with IN O
a DT O
methionine NN O
placed VBD O
one CD O
residue NN O
upstream RB O
of IN O
the DT O
natural JJ O
N NNP O
terminus NN O
of IN O
PR NNP B-NP
failed VBD O
to TO O
show VB O
specific JJ O
proteolysis NN O
. . O

-DOCSTART- X X O

However RB O
, , O
there EX O
were VBD O
some DT O
properties NNS O
of IN O
Rak NN B-NP
that WDT O
are VBP O
distinct JJ O
from IN O
Src-like JJ B-NP
kinases NNS I-NP
: : O
( -LRB- O
a DT O
) -RRB- O
expression NN O
of IN O
Rak NN B-NP
was VBD O
predominantly RB O
in IN O
epithelial-derived JJ O
cell NN O
lines NNS O
and CC O
tissues NNS O
, , O
especially RB O
normal JJ O
liver NN O
and CC O
kidney NN O
, , O
and CC O
cell NN O
lines NNS O
of IN O
breast NN O
and CC O
colon NN O
origin NN O
; : O
( -LRB- O
b NN O
) -RRB- O
Rak NN B-NP
does VBZ O
not RB O
harbor NN O
the DT O
NH2-terminal JJ O
glycine NN O
essential JJ O
for IN O
myristylation NN O
and CC O
membrane NN O
localization NN O
; : O
and CC O
( -LRB- O
c NN O
) -RRB- O
Rak NN B-NP
possesses VBZ O
a DT O
putative JJ O
bipartite JJ O
nuclear JJ O
localization NN O
signal NN O
in IN O
the DT O
SH2 NNP B-NP
domain NN I-NP
, , O
and CC O
subcellular JJ O
fractionation NN O
studies NNS O
revealed VBD O
that IN O
p54rak JJ B-NP
resides NNS O
predominantly RB O
in IN O
the DT O
nucleus NN O
. . O

-DOCSTART- X X O

PATIENTS NNS O
AND CC O
METHODS NNS O
: : O
We PRP O
report VBP O
our PRP$ O
experience NN O
with IN O
seven CD O
children NNS O
with IN O
active JJ O
small JJ O
bowel NN O
Crohn NNP O
's POS O
disease NN O
given VBN O
a DT O
casein-based JJ B-NP
, , O
polymeric JJ O
feed NN O
rich JJ O
in IN O
TGF-beta JJ B-NP
2 CD I-NP
( -LRB- O
Specific NNP O
Polymeric NNP O
Diet NNP O
; : O
Nestle-Clintec NNP O
; : O
Vevey NNP O
, , O
Switzerland NNP O
) -RRB- O
as IN O
complete JJ O
nutrition NN O
for IN O
8 CD O
weeks NNS O
. . O

-DOCSTART- X X O

The DT O
leader NN O
sequence NN O
of IN O
the DT O
isolated VBN O
cDNA NN O
clone NN O
contains VBZ O
several JJ O
small JJ O
open JJ O
reading NN O
frames NNS O
upstream RB O
of IN O
the DT O
initiation NN O
codon NN O
of IN O
the DT O
largest JJS O
open JJ O
reading NN O
frame NN O
coding NN O
for IN O
the DT O
homeodomain JJ B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

A DT O
small JJ O
amount NN O
of IN O
HSP81-1 JJ B-NP
mRNA NN I-NP
was VBD O
detected VBN O
only RB O
in IN O
roots NNS O
. . O

-DOCSTART- X X O

Cell NNP O
adhesion NN O
and CC O
migration NN O
assays RB O
demonstrate VBP O
that IN O
alpha NN B-NP
6 CD I-NP
beta NN I-NP
1 CD I-NP
is VBZ O
the DT O
major JJ O
laminin NN B-NP
receptor NN I-NP
in IN O
undifferentiated JJ O
F9 CD O
cells NNS O
as RB O
well RB O
as IN O
F9-derived JJ O
PE NN O
cells NNS O
. . O

-DOCSTART- X X O

Among IN O
the DT O
mixed JJ O
race NN O
persons NNS O
one CD O
Chukcha-Eskimo NNP O
had VBD O
AS NNP O
, , O
one CD O
Eskimo-Russian NNP O
had VBD O
psoriatic JJ O
arthritis NN O
( -LRB- O
PsA NN O
) -RRB- O
. . O

-DOCSTART- X X O

Although IN O
most JJS O
SH2-pTyr JJ B-NP
interactions NNS O
occur VBP O
between IN O
two CD O
different JJ O
types NNS O
of IN O
molecules NNS O
, , O
some DT O
appear VBP O
to TO O
involve VB O
only RB O
a DT O
single JJ O
molecular JJ O
type NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Closure JJ O
time NN O
of IN O
fistulas NNS O
in IN O
patients NNS O
receiving VBG O
TPN NNP O
+ NNP O
somatostatin NN B-NP
was VBD O
significantly RB O
shorter JJR O
( -LRB- O
13.86 CD O
+/ NN O
- : O
1.84 CD O
versus NN O
20.4 CD O
+/ NNS O
- : O
2.89 CD O
days NNS O
) -RRB- O
than IN O
in IN O
those DT O
receiving VBG O
TPN NNP O
alone RB O
. . O

-DOCSTART- X X O

Experimental JJ O
adhesion NN O
prophylaxis NNS O
with IN O
recombinant JJ B-NP
tissue NN I-NP
plasminogen NN I-NP
activator NN I-NP
. . O

-DOCSTART- X X O

To TO O
determine VB O
which WDT O
sequences NNS O
in IN O
the DT O
rat NN B-NP
P450c17 NN I-NP
promoter NN I-NP
may MD O
be VB O
responsible JJ O
for IN O
basal JJ O
and CC O
cAMP-stimulated JJ O
gene NN O
transcription NN O
, , O
deletion NN O
constructs NNS O
containing VBG O
between IN O
-1,560 JJ O
and CC O
-53 JJ O
base NN O
pairs NNS O
of IN O
5'-flanking JJ O
DNA NN O
from IN O
the DT O
rat NN B-NP
P450c17 NN I-NP
gene NN I-NP
were VBD O
ligated VBN O
to TO O
plasmids NNS O
expressing VBG O
the DT O
reporter NN O
gene NN O
luciferase NN B-NP
and CC O
transfected VBD O
into IN O
two CD O
mouse NN O
cell NN O
lines NNS O
, , O
adrenal JJ O
Y-1 JJ O
cells NNS O
, , O
and CC O
testicular JJ O
Leydig NNP O
MA-10 NNP O
cells NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
cloned VBN O
and CC O
sequenced VBN O
the DT O
mouse NN B-NP
NMO1 NN I-NP
cDNA NN I-NP
, , O
which WDT O
encodes VBZ O
the DT O
NAD( NNP B-NP
P)H NNP I-NP
:menadione NN I-NP
oxidoreductase NN I-NP
[also RB O
called VBD O
NAD( NNP B-NP
P)H NNP I-NP
:(quinone NN I-NP
acceptor NN I-NP
) -RRB- I-NP
oxidoreductase NN I-NP
; : O
quinone NN B-NP
reductase NN I-NP
; : O
azo JJ B-NP
dye JJ I-NP
reductase NN I-NP
; : O
DT NNP B-NP
diaphorase NN I-NP
; : O
EC NNP B-NP
1.6.99.2] CD I-NP
. . O

-DOCSTART- X X O

Escherichia NNP O
coli NNS O
JRG582 . O
is VBZ O
an DT O
ampD JJ B-NP
ampE NN B-NP
deletion NN O
derivative NN O
of IN O
strain NN O
HfrH NNP O
and CC O
accordingly RB O
it PRP O
is VBZ O
derepressed VBN O
for IN O
expression NN O
of IN O
the DT O
cloned JJ O
inducible JJ O
beta-lactamase JJ B-NP
gene NN I-NP
of IN O
Citrobacter NNP O
freundii NNS O
, , O
carried VBD O
on IN O
plasmid NN O
pNU305 NN O
. . O

-DOCSTART- X X O

Male JJ O
contraception NN O
: : O
ideas NNS O
for IN O
the DT O
future NN O
. . O

-DOCSTART- X X O

While IN O
daily JJ O
food NN O
intake NN O
was VBD O
almost RB O
constant JJ O
regardless RB O
of IN O
the DT O
dietary JJ O
protein NN O
level NN O
, , O
water NN O
intake NN O
and CC O
urine NN O
volume NN O
increased VBD O
with IN O
increasing VBG O
the DT O
dietary JJ O
protein NN O
. . O

-DOCSTART- X X O

Transcriptional NNP O
regulation NN O
of IN O
the DT O
vacuolar JJ B-NP
H( NNP I-NP
+)-ATPase NNP I-NP
B2 NN I-NP
subunit NN I-NP
gene NN I-NP
in IN O
differentiating VBG O
THP-1 JJ O
cells NNS O
. . O

-DOCSTART- X X O

An DT O
E NNP O
box NN O
element NN O
is VBZ O
required VBN O
for IN O
the DT O
expression NN O
of IN O
the DT O
ad4bp JJ B-NP
gene NN I-NP
, , O
a DT O
mammalian JJ B-NP
homologue NN I-NP
of IN I-NP
ftz-f1 JJ I-NP
gene NN I-NP
, , O
which WDT O
is VBZ O
essential JJ O
for IN O
adrenal JJ O
and CC O
gonadal JJ O
development NN O
. . O

-DOCSTART- X X O

Mutations NNS O
in IN O
the DT O
VPS45 NNP B-NP
gene NN I-NP
, , O
a DT O
SEC1 NNP B-NP
homologue NN O
, , O
result NN O
in IN O
vacuolar JJ O
protein NN O
sorting VBG O
defects NNS O
and CC O
accumulation NN O
of IN O
membrane NN O
vesicles NNS O
. . O

-DOCSTART- X X O

In IN O
293 CD O
cells NNS O
, , O
expression NN O
of IN O
the DT O
NF-kappa NNP B-NP
B NNP I-NP
inhibitor NN O
, , O
I PRP B-NP
kappa VBD I-NP
B-alpha NNP I-NP
, , O
reduced VBD O
the DT O
stimulatory JJ O
activity NN O
of IN O
LMP. NNP B-NP

-DOCSTART- X X O

This DT O
experimental JJ O
design NN O
was VBD O
used VBN O
to TO O
determine VB O
the DT O
effect NN O
of IN O
displacement NN O
of IN O
the DT O
alpha NN B-NP
4-2 JJ I-NP
binding JJ I-NP
site NN I-NP
on IN O
the DT O
repression NN O
of IN O
alpha NN B-NP
4 CD I-NP
gene NN I-NP
transcription NN O
by IN O
ICP4 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
GRE NNP O
at IN O
nucleotide JJ O
7640 CD O
is VBZ O
a DT O
composite JJ O
GRE JJ O
(cGRE NN O
) -RRB- O
containing VBG O
an DT O
overlapping JJ O
activator NN B-NP
protein-1 NN I-NP
( -LRB- O
AP-1 NN B-NP
) -RRB- O
motif NN O
for IN O
the DT O
c-jun JJ B-NP
homodimer NN I-NP
and CC O
c-jun/c-fos JJ B-NP
heterodimer NN O
. . O

-DOCSTART- X X O

Transcriptional NNP O
activation NN O
by IN O
thyroid NN O
hormone NN O
( -LRB- O
T3 NN O
) -RRB- O
requires VBZ O
interactions NNS O
between IN O
the DT O
T3 NN B-NP
receptor NN I-NP
( -LRB- O
TR NN B-NP
) -RRB- O
and CC O
T3 JJ O
response NN O
elements NNS O
( -LRB- O
TREs NN O
) -RRB- O
composed VBN O
of IN O
two CD O
copies NNS O
of IN O
sequences NNS O
related VBN O
to TO O
AGGTCA NNP O
. . O

-DOCSTART- X X O

A DT O
multivariate JJ O
analysis NN O
of IN O
risk NN O
factors NNS O
for IN O
relapse NN O
examined VBN O
age NN O
, , O
WBC NNP O
at IN O
diagnosis NN O
, , O
blast NN O
count NN O
at IN O
diagnosis NN O
, , O
percentage NN O
of IN O
marrow NN O
blasts NNS O
, , O
FAB NNP B-NP
subtype NN O
, , O
the DT O
number NN O
of IN O
remission NN O
induction NN O
courses NNS O
to TO O
achieve VB O
a DT O
remission NN O
, , O
maintenance NN O
therapy NN O
, , O
consolidation NN O
therapy NN O
, , O
marrow NN O
cell NN O
dose NN O
, , O
donor-recipient JJ O
sex NN O
, , O
GVHD NNP O
prophylaxis VBD O
regimen NNS O
and CC O
isolation NN O
and CC O
decontamination NN O
in IN O
laminar NN O
airflow NN O
rooms NNS O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
these DT O
three CD O
gain-of-function NN O
mutants NNS O
differ VBP O
considerably RB O
in IN O
their PRP$ O
ability NN O
to TO O
bypass VB O
the DT O
sex NN O
determination NN O
signal NN O
, , O
with IN O
SxlM4 NNP B-NP
being VBG O
the DT O
strongest JJS O
and CC O
SxlM1 VB B-NP
the DT O
weakest JJS O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
these DT O
three CD O
gain-of-function NN O
mutants NNS O
differ VBP O
considerably RB O
in IN O
their PRP$ O
ability NN O
to TO O
bypass VB O
the DT O
sex NN O
determination NN O
signal NN O
, , O
with IN O
SxlM4 NNP B-NP
being VBG O
the DT O
strongest JJS O
and CC O
SxlM1 VB B-NP
the DT O
weakest JJS O
. . O

-DOCSTART- X X O

No DT O
significant JJ O
differences NNS O
were VBD O
identified VBN O
between IN O
groups NNS O
for IN O
pH NNS O
, , O
PaCO2 NNP O
, , O
intracranial JJ O
pressure NN O
, , O
heart NN O
rate NN O
, , O
brain NN O
temperature NN O
, , O
or CC O
glucose NN O
levels NNS O
. . O

-DOCSTART- X X O

Anesthesiologists NNS O
often RB O
use VBP O
more JJR O
than IN O
one CD O
drug NN O
in IN O
a DT O
patient NN O
to TO O
achieve VB O
a DT O
target NN O
response NN O
, , O
such JJ O
as IN O
a DT O
desired VBN O
blood NN O
pressure NN O
. . O

-DOCSTART- X X O

We PRP O
suggest VBP O
that IN O
this DT O
gene NN O
cluster NN O
codes NNS O
for IN O
( -LRB- O
parts NNS O
of IN O
) -RRB- O
a DT O
multisubunit NN B-NP
cytochrome NN I-NP
c NNS I-NP
haem VBP I-NP
lyase NN I-NP
. . O

-DOCSTART- X X O

Standard JJ O
reference NN O
sources NNS O
indicate VBP O
that IN O
an DT O
able-bodied JJ O
11-year-old JJ O
child NN O
of IN O
comparable JJ O
height NN O
requires VBZ O
1,493 CD O
kcal/d NN O
for IN O
support NN O
of IN O
basal JJ O
metabolic JJ O
functions NNS O
. . O

-DOCSTART- X X O

Weak NNP O
allergenicity NN O
of IN O
recombinant JJ B-NP
hirudin NN I-NP
CGP NN I-NP
39393 CD I-NP
( -LRB- O
REVASC NN O
) -RRB- O
in IN O
immunocompetent JJ O
volunteers NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
a DT O
clear JJ O
difference NN O
exists VBZ O
between IN O
myoblasts NNS O
and CC O
10T1/2 CD O
cells NNS O
( -LRB- O
and CC O
other JJ O
non-muscle JJ O
cell NN O
types NNS O
) -RRB- O
in IN O
the DT O
chromatin NN O
structure NN O
of IN O
the DT O
chromosomal NN O
myoD NN B-NP
core NN I-NP
enhancer NN I-NP
, , O
suggesting VBG O
that IN O
the DT O
myoD NN B-NP
enhancer NN I-NP
is VBZ O
repressed VBN O
by IN O
epigenetic JJ O
mechanisms NNS O
in IN O
10T1/2 CD O
cells NNS O
. . O

-DOCSTART- X X O

Using VBG O
Ki-ras-transformed NNP B-NP
3T3 NNP O
cells NNS O
as IN O
a DT O
model NN O
system NN O
, , O
we PRP O
show VBP O
that IN O
both DT O
RA NNP O
and CC O
the DT O
'dissociating JJ O
' '' O
retinoids NNS O
inhibit VBP O
anchorage-independent JJ O
cell NN O
proliferation NN O
, , O
suggesting VBG O
that IN O
retinoid-induced JJ O
growth NN O
inhibition NN O
may MD O
be VB O
related VBN O
to TO O
AP1 NNP B-NP
transrepression NN O
. . O

-DOCSTART- X X O

The DT O
Oct NNP B-NP
and CC O
HMG2 NNP B-NP
proteins VBZ I-NP
also RB O
interact VB O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Atopic NNP O
dermatitis NN O
is VBZ O
an DT O
"itch NN O
which WDT O
rashes VBZ O
and CC O
not RB O
a DT O
rash NN O
which WDT O
itches VBZ O
" `` O
and CC O
therefore RB O
, , O
any DT O
patient JJ O
treatment NN O
program NN O
should MD O
address VB O
the DT O
multiplicity NN O
of IN O
potential JJ O
trigger NN O
factors NNS O
that WDT O
provoke VBP O
this DT O
itching NN O
. . O

-DOCSTART- X X O

The DT O
beta JJ O
subunit NN O
of IN O
the DT O
Fc NNP B-NP
epsilon NN I-NP
R1 NNP I-NP
is VBZ O
a DT O
33-kDa JJ O
tyrosine NN O
phosphoprotein NN O
, , O
but CC O
the DT O
p33 NN B-NP
Grb2-binding JJ B-NP
protein NN I-NP
described VBN O
in IN O
the DT O
present JJ O
report NN O
is VBZ O
not RB O
the DT O
Fc JJ B-NP
epsilon NN I-NP
R1 IN I-NP
beta JJ I-NP
chain NN I-NP
and CC O
its PRP$ O
identity NN O
is VBZ O
unknown JJ O
. . O

-DOCSTART- X X O

To TO O
study VB O
the DT O
mechanisms NNS O
as RB O
well RB O
as IN O
magnitude NN O
of IN O
the DT O
transmembrane NN O
transfer NN O
of IN O
bacterial JJ O
products NNS O
from IN O
the DT O
dialysate NN O
, , O
we PRP O
developed VBD O
a DT O
computerized JJ O
in IN O
vitro NN O
dialysis NN O
model NN O
which WDT O
provides VBZ O
continuous JJ O
pressure NN O
recording VBG O
from IN O
the DT O
arterial NN O
, , O
venous JJ O
, , O
dialysate NN O
inflow NN O
and CC O
outflow NN O
ports NNS O
. . O

-DOCSTART- X X O

After IN O
24 CD O
hour NN O
incubation NN O
, , O
total JJ O
cell-associated JJ O
IL-1Ra NNP B-NP
and CC O
IL-1 DT B-NP
beta NN I-NP
were VBD O
measured VBN O
by IN O
specific JJ O
radioimmunoassay NN O
. . O

-DOCSTART- X X O

Each DT O
dietary NN O
treatment NN O
was VBD O
fed VBN O
to TO O
six CD O
pen NN O
replicates NNS O
of IN O
five CD O
chicks NNS O
per IN O
pen NN O
for IN O
21 CD O
d NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
recent JJ O
evidence NN O
suggests VBZ O
that IN O
children NNS O
with IN O
sickle-hemoglobin JJ B-NP
C NNP I-NP
disease NN O
do VBP O
not RB O
develop VB O
functional JJ O
asplenia NN O
before IN O
3 CD O
to TO O
4 CD O
years NNS O
of IN O
age NN O
and CC O
thus RB O
may MD O
not RB O
benefit VB O
from IN O
penicillin VBG O
prophylaxis NNS O
. . O

-DOCSTART- X X O

Deletion NNP O
analysis NN O
indicates VBZ O
that IN O
TBP NNP B-NP
and CC O
hTAFII18 VB B-NP
bind NN O
to TO O
distinct JJ O
domains NNS O
of IN O
hTAFII28 NNS B-NP
. . O
hTAFII18 NN B-NP
also RB O
interacts VBZ O
with IN O
TBP NNP B-NP
, , O
but CC O
it PRP O
interacts VBZ O
more RBR O
strongly RB O
with IN O
hTAFII28 PRP B-NP
and CC O
hTAFII30 PRP B-NP
. . O

-DOCSTART- X X O

The DT O
NarX NNP B-NP
and CC O
NarQ NNP B-NP
proteins VBZ I-NP
with IN O
amino DT O
acid NN O
substitutions NNS O
at IN O
the DT O
first JJ O
conserved JJ O
histidine NN O
position NN O
were VBD O
also RB O
unable JJ O
to TO O
dephosphorylate VB O
NarL-phosphate JJ B-NP
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Because IN O
ATF-1 NNP B-NP
and CC O
CREM NNP B-NP
are VBP O
known VBN O
to TO O
bind NN O
to TO O
cAMP VB O
response NN O
elements NNS O
( -LRB- O
CRE) NN O
, , O
this DT O
functional JJ O
sequence NN O
was VBD O
named VBN O
the DT O
kappa NN B-NP
E3'-CRE. . I-NP

-DOCSTART- X X O

The DT O
TTG-2 NNP B-NP
gene NN I-NP
has VBZ O
been VBN O
identified VBN O
at IN O
the DT O
site NN O
of IN O
chromosomal NN O
translocations NNS O
in IN O
acute JJ O
T-cell NN O
leukemia NN O
's POS O
(T-ALL) NN O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
studies NNS O
with IN O
blood NN O
cells NNS O
incubated VBN O
with IN O
acetate NN O
or CC O
bicarbonate NN O
ions NNS O
in IN O
concentrations NNS O
, , O
which WDT O
are VBP O
observed VBN O
in IN O
vivo JJ O
during IN O
hemodialysis NN O
, , O
suggest VBP O
that IN O
probably RB O
these DT O
ions NNS O
do VBP O
not RB O
directly RB O
affect VB O
superoxide NN O
anions NNS O
generation NN O
, , O
erythrocyte JJ O
SOD-1 JJ B-NP
and CC O
catalase JJ B-NP
activities NNS O
and CC O
erythrocyte NN O
membrane NN O
lipid VBD O
peroxidation NN O
. . O

-DOCSTART- X X O

Short JJ O
therapy NN O
with IN O
omeprazole NN O
20 CD O
mg/b.i.d. NN O
, , O
clarithromycin NN O
500 CD O
mg/b.i.d. NN O
, , O
and CC O
CBS NNP O
120 CD O
mg/q.i.d NN O
. . O
is VBZ O
a DT O
safe JJ O
, , O
well RB O
tolerated VBN O
combination NN O
that IN O
achieves VBZ O
a DT O
80.6 CD O
% NN O
eradication NN O
rate NN O
of IN O
H. NNP O
pylori NN O
and CC O
duodenal JJ O
ulcer NN O
healing NN O
rates NNS O
as RB O
good JJ O
as IN O
those DT O
achieved VBN O
by IN O
omeprazole NN O
20 CD O
mg/d NN O
when WRB O
given VBN O
for IN O
4 CD O
wk NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
A DT O
comparison NN O
of IN O
the DT O
LysU NNP B-NP
crystal NN O
structure NN O
with IN O
the DT O
structures NNS O
of IN O
seryl- NNS B-NP
and CC I-NP
aspartyl-tRNA DT I-NP
synthetases NNS I-NP
enables VBZ O
a DT O
conserved JJ O
core NN O
to TO O
be VB O
identified VBN O
. . O

-DOCSTART- X X O

Whole JJ O
bowel NN O
irrigation NN O
is VBZ O
a DT O
recently RB O
described VBN O
technique NN O
to TO O
enhance VB O
the DT O
passage NN O
of IN O
drugs NNS O
already RB O
beyond IN O
the DT O
pylorus NN O
. . O

-DOCSTART- X X O

As IN O
in IN O
Tb NNP O
, , O
U6 NNP B-NP
is VBZ O
a DT O
single-copy JJ O
gene NN O
and CC O
two CD O
tRNA JJ O
genes NNS O
, , O
tRNAGln NN B-NP
and CC O
tRNAIle NN B-NP
, , O
are VBP O
found VBN O
upstream RB O
to TO O
the DT O
gene NN O
. . O

-DOCSTART- X X O

Hematopoietic JJ B-NP
growth NN I-NP
factors NNS I-NP
have VBP O
already RB O
had VBN O
an DT O
enormous JJ O
impact NN O
on IN O
transfusion NN O
practice NN O
by IN O
eliminating VBG O
or CC O
reducing VBG O
the DT O
need NN O
for IN O
red JJ O
blood NN O
cell NN O
transfusions NNS O
in IN O
a DT O
variety NN O
of IN O
anemic JJ O
states NNS O
characterized VBN O
by IN O
an DT O
absolute JJ O
or CC O
relative JJ O
decrease NN O
in IN O
erythropoietin NN B-NP
. . O

-DOCSTART- X X O

During IN O
IC NN O
breaths NNS O
and CC O
following VBG O
EC NNP O
and CC O
VC NNP O
breaths NNS O
at IN O
rest NN O
, , O
end-tidal JJ O
CO2 NN O
pressure NN O
( -LRB- O
PET,CO2 NN O
) -RRB- O
fell VBD O
by IN O
7.5 CD O
, , O
8.5 CD O
and CC O
9.5 CD O
mmHg NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

2. . O

-DOCSTART- X X O

The DT O
predicted VBD O
amino IN O
acid JJ O
sequence NN O
of IN O
the DT O
SGC1 NNP B-NP
gene NN I-NP
product NN I-NP
includes VBZ O
a DT O
region NN O
with IN O
substantial JJ O
similarity NN O
to TO O
the DT O
basic-helix-loop-helix NN O
domain NN O
of IN O
the DT O
Myc NNP B-NP
family NN I-NP
of IN O
DNA-binding JJ O
proteins NNS O
. . O

-DOCSTART- X X O

By IN O
creating VBG O
Pax-6-BSAP JJ B-NP
fusion NN O
proteins NNS O
, , O
we PRP O
were VBD O
able JJ O
to TO O
identify VB O
a DT O
short JJ O
amino IN O
acid NN O
stretch NN O
in IN O
the DT O
N-terminal JJ O
part NN O
of IN O
the DT O
paired JJ B-NP
domain NN O
which WDT O
is VBZ O
responsible JJ O
for IN O
these DT O
differences NNS O
in IN O
DNA-binding JJ O
specificity NN O
. . O

-DOCSTART- X X O

To TO O
establish VB O
a DT O
possible JJ O
association NN O
between IN O
familial JJ O
dysfibrinogenemia NN O
and CC O
thrombophilia NNS O
, , O
data NNS O
on IN O
cases NNS O
with IN O
both DT O
affections NNS O
were VBD O
collected VBN O
in IN O
a DT O
study NN O
within IN O
the DT O
framework NN O
of IN O
the DT O
SSC NNP O
Subcommittee NNP O
on IN O
Fibrinogen NNP B-NP
of IN O
the DT O
International NNP O
Society NNP O
on IN O
Thrombosis NNP O
and CC O
Haemostasis NNP O
. . O

-DOCSTART- X X O

Conjugated NNP O
estrogens NNS O
shorten NN O
bleeding NN O
time NN O
in IN O
uraemia NN O
: : O
a DT O
possible JJ O
role NN O
of IN O
serotonin NN O
? . O

-DOCSTART- X X O

Two CD O
mammalian JJ O
enzymes NNS O
, , O
the DT O
haem-controlled JJ B-NP
repressor NN I-NP
( -LRB- O
HCR NN B-NP
) -RRB- O
and CC O
the DT O
double-stranded JJ B-NP
RNA-activated JJ I-NP
inhibitor NN I-NP
( -LRB- O
dsI NN B-NP
) -RRB- O
, , O
phosphorylate JJ O
Ser-51 NNP O
of IN O
the DT O
alpha NN O
subunit NN O
, , O
thereby RB O
inhibiting VBG O
the DT O
exchange NN O
of IN O
bound VBN O
nucleotides NNS O
on IN O
, , O
and CC O
thus RB O
the DT O
recycling NN O
of IN O
, , O
eIF-2 NN B-NP
. . O

-DOCSTART- X X O

A DT O
triple JJ O
Ser-->Ala NN O
mutant JJ O
form NN O
of IN O
yeast NN O
eIF-2 JJ B-NP
alpha NN I-NP
was VBD O
found VBN O
to TO O
be VB O
no RB O
longer RB O
phosphorylated VBN O
by IN O
either DT O
of IN O
the DT O
yeast NN O
( -LRB- O
or CC O
mammalian JJ O
) -RRB- O
casein NN B-NP
kinase NN I-NP
activities NNS O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

The DT O
cases NNS O
included VBD O
35 CD O
de IN O
novo RB O
diffuse JJ O
aggressive JJ O
lymphomas NNS O
( -LRB- O
DAL NNP O
; : O
19 CD O
large-cell JJ O
, , O
4 CD O
mixed-cell NN O
, , O
and CC O
12 CD O
large-cell JJ O
immunoblastic JJ O
) -RRB- O
, , O
52 CD O
transformed VBD O
aggressive JJ O
lymphomas NNS O
derived VBN O
from IN O
follicular JJ O
lymphomas NNS O
( -LRB- O
TFL NN O
) -RRB- O
, , O
42 CD O
indolent JJ O
follicular JJ O
lymphomas NNS O
( -LRB- O
FL NNP O
) -RRB- O
, , O
14 CD O
mantle JJ O
cell NN O
lymphomas NNS O
(MCL) RB O
, , O
and CC O
27 CD O
small JJ O
noncleaved JJ O
cell NN O
lymphomas NNS O
( -LRB- O
SNCL) NN O
. . O

-DOCSTART- X X O

Female JJ O
patients NNS O
with IN O
breast NN O
cancer NN O
diagnosed VBD O
between IN O
1982 CD O
and CC O
1991 CD O
at IN O
Roswell NNP O
Park NNP O
Cancer NNP O
Institute NNP O
( -LRB- O
RPCI) NNP O
in IN O
Buffalo NNP O
, , O
New NNP O
York NNP O
, , O
who WP O
provided VBD O
information NN O
on IN O
their PRP$ O
cigarette NN O
smoking NN O
history NN O
at IN O
the DT O
time NN O
of IN O
their PRP$ O
diagnosis NN O
were VBD O
included VBN O
. . O

-DOCSTART- X X O

Data NNP O
from IN O
the DT O
V-HeFT NNP O
II NNP O
show NN O
that IN O
at IN O
2-year JJ O
follow-up NN O
, , O
a DT O
progressive JJ O
rise NN O
of IN O
plasma NN O
norepinephrine NN O
was VBD O
observed VBN O
in IN O
both DT O
treatment NN O
arms NNS O
, , O
suggesting VBG O
that IN O
disease NN O
progresses VBZ O
despite IN O
treatment NN O
with IN O
either CC O
an DT O
angiotensin-converting JJ B-NP
enzyme NN I-NP
inhibitor NN O
, , O
enalapril NN O
, , O
or CC O
vasodilator NN O
therapy NN O
with IN O
hydralazine/isosorbide JJ O
dinitrate NN O
. . O

-DOCSTART- X X O

Transcript NN O
analysis NN O
reveals VBZ O
that IN O
lethal JJ O
B NNP B-NP
block NN I-NP
substitutions NNS O
reduce VBP O
U6 DT B-NP
RNA NNP I-NP
synthesis NN O
at IN O
least JJS O
10-fold JJ O
in IN O
vivo JJ O
and CC O
20-fold JJ O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
Bcl-2/Bcl-2 JJ B-NP
homodimerization NN O
using VBG O
both DT O
in IN O
vitro NN O
binding NN O
assays VBZ O
as RB O
well RB O
as IN O
a DT O
yeast NN O
two-hybrid JJ O
method NN O
provided VBD O
evidence NN O
in IN O
support NN O
of IN O
a DT O
head-to-tail JJ O
model NN O
for IN O
Bcl-2/Bcl-2 JJ B-NP
homodimerization NN O
and CC O
revealed VBD O
that IN O
sequences NNS O
within IN O
the DT O
NH2-terminal JJ O
A DT O
domain NN O
interact NN O
with IN O
a DT O
structure NN O
that WDT O
requires VBZ O
the DT O
presence NN O
of IN O
both DT O
the DT O
carboxyl NN O
B NNP O
and CC O
C NNP O
domains NNS O
in IN O
combination NN O
. . O

-DOCSTART- X X O

The DT O
protein NN O
is VBZ O
composed VBN O
of IN O
a DT O
central JJ O
alpha-helical JJ O
portion NN O
with IN O
globular JJ O
domains NNS O
at IN O
both DT O
NH2 NNP O
and CC O
COOH NNP O
termini NNS O
, , O
and CC O
the DT O
epitope NN O
to TO O
the DT O
monoclonal JJ O
antibody NN O
resides NNS O
in IN O
the DT O
central JJ O
alpha-helical JJ O
stalk NN O
. . O

-DOCSTART- X X O

Radioligand NNP O
binding NN O
was VBD O
indistinguishable JJ O
for IN O
both DT O
transiently RB O
expressed VBN O
constructs NNS O
. . O

-DOCSTART- X X O

Diagnosis NNP O
of IN O
FHCS NNP O
has VBZ O
been VBN O
weighed VBN O
upon IN O
laparoscopic JJ O
findings NNS O
. . O

-DOCSTART- X X O

Human NNP B-NP
papillomavirus NN I-NP
type NN I-NP
31b IN I-NP
late JJ I-NP
gene NN I-NP
expression NN O
is VBZ O
regulated VBN O
through IN O
protein NN B-NP
kinase NN I-NP
C-mediated JJ I-NP
changes NNS O
in IN O
RNA NNP O
processing NN O
. . O

-DOCSTART- X X O

Studies NNS O
using VBG O
an DT O
inhibitor NN O
or CC O
a DT O
mutant JJ B-NP
Lb NNP I-NP
proteinase NN I-NP
indicated VBD O
that IN O
stimulation NN O
of IN O
IRES-driven NNP O
translation NN O
is VBZ O
mediated JJ O
via IN O
proteolysis NN O
of IN O
some DT O
cellular JJ O
component( NN O
s VBZ O
) -RRB- O
. . O

-DOCSTART- X X O

As IN O
it PRP O
had VBD O
been VBN O
previously RB O
reported VBN O
that IN O
the DT O
18-bp JJ O
palindrome NN O
contains VBZ O
sufficient JJ O
nucleotide JJ O
sequence NN O
information NN O
for IN O
E1 NNP B-NP
binding NN O
, , O
we PRP O
speculate VBP O
that IN O
a DT O
minimal JJ O
E1 JJ B-NP
recognition NN O
motif NN O
is VBZ O
presented VBN O
in IN O
each DT O
half NN O
site NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
commercially RB O
available JJ O
intravenous JJ O
formulation NN O
of IN O
Cyclosporin NNP O
A DT O
( -LRB- O
Sandimmun NNP O
) -RRB- O
, , O
polyoxyethylated VBN O
castor NN O
oil NN O
( -LRB- O
Cremophor NN O
EL NNP O
) -RRB- O
is VBZ O
used VBN O
as IN O
a DT O
solubilizing JJ O
agent NN O
. . O

-DOCSTART- X X O

Lung NNP O
function NN O
tests NNS O
( -LRB- O
EFR NN O
) -RRB- O
were VBD O
performed VBN O
on IN O
these DT O
patients NNS O
for IN O
a DT O
period NN O
of IN O
19.2 CD O
+/ NNS O
- : O
3.4 CD O
months NNS O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
marginal JJ O
discrepancy NN O
of IN O
provisional JJ O
restorations NNS O
was VBD O
compared VBN O
for IN O
restorations NNS O
fabricated VBN O
from IN O
stone NN O
, , O
low-viscosity JJ O
poly(vinyl NN O
siloxane NN O
) -RRB- O
, , O
and CC O
medium-viscosity NN O
poly(vinyl NN O
siloxane NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
two CD O
internal JJ O
promoters NNS O
, , O
PmiaA NNP B-NP
and CC O
P1hfq NNP B-NP
were VBD O
identified VBN O
and CC O
mapped VBN O
to TO O
201 CD O
and CC O
837 CD O
nucleotides NNS O
upstream RB O
from IN O
the DT O
respective JJ O
translation NN O
start VB O
sites NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
mutL NNS B-NP
, , O
miaA NNS B-NP
, , O
and CC O
hfq JJ B-NP
expression NN O
could MD O
be VB O
regulated VBN O
by IN O
multiple JJ O
mechanisms NNS O
, , O
including VBG O
degree NN O
of IN O
cotranscription NN O
from IN O
upstream JJ O
genes NNS O
, , O
modulation NN O
of IN O
internal JJ O
promoter NN O
strength NN O
, , O
and CC O
by IN O
RNase NNP B-NP
E NNP I-NP
activity NN O
. . O

-DOCSTART- X X O

Coronary JJ O
T1 NNP O
and CC O
T2 DT O
weighted JJ O
images NNS O
were VBD O
obtained VBN O
. . O

-DOCSTART- X X O

Functional JJ O
analysis NN O
of IN O
the DT O
sGTH NN B-NP
alpha NN I-NP
subunit NN I-NP
promoter NN I-NP
by IN O
the DT O
transient JJ O
transfection NN O
of IN O
several JJ O
sGTH NN B-NP
alpha/CAT NN I-NP
chimeric JJ O
plasmids NNS O
into IN O
rainbow NN O
trout NN O
pituitary JJ O
cells NNS O
suggests VBZ O
that IN O
its PRP$ O
pituitary-specific JJ O
expression NN O
is VBZ O
GSE-dependent JJ B-NP
. . O

-DOCSTART- X X O

Indium-111 NNP O
OncoScint NNP O
CR/OV NNP O
and CC O
F-18 NN O
FDG NNP O
in IN O
colorectal NN O
and CC O
ovarian JJ O
carcinoma NN O
recurrences NNS O
. . O

-DOCSTART- X X O

The DT O
Myc NNP B-NP
LZ NNP I-NP
was VBD O
found VBN O
to TO O
prevent VB O
homodimeric JJ O
interactions NNS O
, , O
thus RB O
explaining VBG O
Myc NNP B-NP
inability NN O
to TO O
homodimerize VB O
efficiently RB O
. . O

-DOCSTART- X X O

Staphylococcus NNP O
aureus NN O
and CC O
CNS NNS O
showed VBD O
high JJ O
or CC O
moderate JJ O
resistance NN O
rates NNS O
to TO O
methicillin VB O
( -LRB- O
DMPPC NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
gene NN O
pairs NNS O
psbB-psbT JJ B-NP
and CC O
psbH-psbN JJ B-NP
are VBP O
cotranscribed VBN O
from IN O
opposite JJ O
strands NNS O
. . O

-DOCSTART- X X O

Hybridization NN O
signals NNS O
were VBD O
also RB O
detected VBN O
with IN O
total JJ O
DNAs NNP O
of IN O
Rhizobium NNP O
leguminosarum NN O
bv. , O
phaseoli NNS O
, , O
Rhodobacter NNP O
capsulatus NN O
and CC O
Escherichia NNP O
coli NNS O
, , O
but CC O
not RB O
those DT O
of IN O
Xanthomonas NNP O
campestris NN O
pv. VBD O
campestris NN O
and CC O
Pseudomonas NNP O
putida VBD O
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
amino IN O
acid JJ O
sequence NN O
contains VBZ O
regions NNS O
identical JJ O
to TO O
the DT O
sequences NNS O
of IN O
peptides NNS O
derived VBN O
from IN O
bovine JJ B-NP
liver NN I-NP
eIF-2B NN I-NP
alpha NN I-NP
subunit NN I-NP
. . O

-DOCSTART- X X O

When WRB O
RNA NNP O
encoding VBZ O
the DT O
tail NN O
domain NN O
of IN O
desmoglein NN B-NP
was VBD O
coinjected VBN O
with IN O
plakoglobin NN B-NP
RNA NNP I-NP
, , O
both CC O
the DT O
dorsalizing JJ O
effect NN O
and CC O
nuclear JJ O
accumulation NN O
of IN O
plakoglobin NN B-NP
were VBD O
suppressed VBN O
. . O

-DOCSTART- X X O

Six CD O
of IN O
them PRP O
, , O
NUC1 NNP B-NP
, , O
PRP21 NNP B-NP
( -LRB- O
also RB O
called VBN O
SPP91 NNP B-NP
) -RRB- O
, , O
CDC6 NNP B-NP
, , O
CRY2 NNP B-NP
, , O
the DT O
gene NN O
encoding VBG O
the DT O
ribosomal JJ B-NP
protein NN I-NP
S24 NNP I-NP
and CC O
the DT O
gene NN O
coding NN O
for IN O
a DT O
hypothetical JJ O
protein NN O
of IN O
599 CD O
amino IN O
acids NNS O
, , O
have VBP O
been VBN O
sequenced VBN O
previously RB O
. . O

-DOCSTART- X X O

Intrastriatal NNP O
grafts NNS O
of IN O
nigral NN O
and CC O
adrenal JJ O
tissues NNS O
have VBP O
been VBN O
found VBN O
to TO O
be VB O
effective JJ O
in IN O
alleviating VBG O
many JJ O
of IN O
the DT O
simple JJ O
motor NN O
and CC O
sensorimotor NN O
deficits NNS O
associated VBN O
with IN O
lesions NNS O
of IN O
the DT O
nigrostriatal JJ O
dopamine NN O
system NN O
. . O

-DOCSTART- X X O

Thereafter RB O
, , O
the DT O
aggregation NN O
rose VBD O
to TO O
the DT O
initial JJ O
100 CD O
% NN O
value NN O
4 CD O
h NN O
after IN O
drug NN O
application NN O
and CC O
remained VBD O
at IN O
this DT O
level NN O
during IN O
the DT O
observation NN O
period NN O
.(ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

The DT O
emerging VBG O
complexity NN O
of IN O
the DT O
5' JJ O
regulatory JJ O
region NN O
of IN O
the DT O
GH NNP B-NP
receptor NN I-NP
gene NN I-NP
was VBD O
emphasised VBN O
by IN O
the DT O
observation NN O
that IN O
probes NNS O
derived VBN O
from IN O
exon JJ O
1B NNS O
and CC O
the DT O
distal JJ O
3' JJ O
intron NN O
boundary NN O
do VBP O
not RB O
hybridise NN O
with IN O
previously RB O
cloned VBN O
genomic JJ O
sequences NNS O
that WDT O
span VBP O
the DT O
liver-specific JJ O
P1 NNP O
promoter NN O
and CC O
exon NN O
2. . O

-DOCSTART- X X O

A DT O
polymorphic JJ O
dinucleotide NN O
( -LRB- O
GT/CA NNP O
)n IN O
repeat NN O
contained VBN O
in IN O
the DT O
NHE5 NNP O
cosmid NN O
was VBD O
identified VBN O
and CC O
developed VBN O
into IN O
a DT O
microsatellite NN O
PCR NN O
marker NN O
. . O

-DOCSTART- X X O

The DT O
proteins NNS O
are VBP O
more RBR O
than IN O
90 CD O
% NN O
identical JJ O
to TO O
each DT O
other JJ O
within IN O
the DT O
protein NN O
kinase NN O
domain NN O
but CC O
only RB O
51-59 CD O
% NN O
identical JJ O
to TO O
other JJ O
casein NN B-NP
kinase NN I-NP
I PRP I-NP
isoforms VBZ I-NP
within IN O
this DT O
region NN O
. . O

-DOCSTART- X X O

UAS1 NNP O
is VBZ O
the DT O
binding JJ O
site NN O
for IN O
the DT O
transcriptional JJ O
regulator NN O
Adr1p NNP B-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
context NN O
of IN O
the DT O
ADH2 NNPS B-NP
upstream RB I-NP
regulatory JJ I-NP
region NN I-NP
, , O
including VBG O
UAS1 NNP O
, , O
working VBG O
in IN O
concert NN O
with IN O
the DT O
ADH2 NNP B-NP
basal NN I-NP
promoter NN I-NP
elements NNS I-NP
, , O
UAS2-dependent JJ O
gene NN O
activation NN O
was VBD O
dependent JJ O
on IN O
orientation NN O
, , O
copy VBP O
number NN O
, , O
and CC O
helix NN O
phase NN O
. . O

-DOCSTART- X X O

Induction NN O
in IN O
AP-1 JJ B-NP
DNA NNP O
binding NN O
correlates VBZ O
with IN O
a DT O
concomitant JJ O
GH NNP B-NP
trans-activation NN O
of IN O
c-jun JJ B-NP
and CC O
c-fos JJ B-NP
genes NNS I-NP
described VBN O
previously RB O
. . O

-DOCSTART- X X O

Short-course NN O
amphotericin RB O
B NNP O
therapy NN O
for IN O
candidemia NN O
in IN O
pediatric JJ O
patients NNS O
. . O

-DOCSTART- X X O

Since IN O
AP-1 NNP B-NP
is VBZ O
an DT O
important JJ O
mediator NN O
of IN O
tumor NN O
promoter NN O
action NN O
, , O
these DT O
findings NNS O
may MD O
explain VB O
the DT O
anti-tumor-promoting JJ O
activity NN O
of IN O
phenolic JJ O
antioxidants NNS O
. . O

-DOCSTART- X X O

The DT O
second JJ O
complex NN O
, , O
when WRB O
purified VBN O
, , O
contained VBD O
four CD O
protein NN O
components NNS O
including VBG O
the DT O
36-kDa JJ O
protein NN O
. . O

-DOCSTART- X X O

The DT O
protein NN O
expressed VBD O
from IN O
the DT O
cloned JJ O
cDNA NN O
is VBZ O
secreted VBN O
into IN O
the DT O
culture NN O
medium NN O
and CC O
yields NNS O
of IN O
up RP O
to TO O
40 CD O
mg NN O
per IN O
litre NN O
have VBP O
been VBN O
obtained VBN O
. . O

-DOCSTART- X X O

The DT O
study NN O
was VBD O
repeated VBN O
after IN O
administration NN O
of IN O
oral JJ O
amiodarone NN O
, , O
50 CD O
mg/kg/day NN O
for IN O
2 CD O
days NNS O
in IN O
8 CD O
divided VBN O
doses NNS O
( -LRB- O
mean JJ O
dose NN O
6.9 CD O
+/ NN O
- : O
0.4 CD O
g NN O
) -RRB- O
. . O

-DOCSTART- X X O

Plasmids NNS O
pAMS12 NN O
, , O
pAMS13 . O
and CC O
pAMS14 PRP O
were VBD O
transformed VBN O
into IN O
a DT O
laboratory NN O
strain NN O
of IN O
Saccharomyces NNP O
cerevisiae NNS O
, , O
whereas IN O
pAMS15 PRP O
was VBD O
stably RB O
introduced VBN O
into IN O
two CD O
commercial JJ O
wine NN O
yeast NN O
strains NNS O
. . O

-DOCSTART- X X O

Repair NN O
of IN O
this DT O
insertion NN O
by IN O
homologous JJ O
recombination NN O
restores VBZ O
the DT O
activity NN O
of IN O
the DT O
hprt NN B-NP
locus NN I-NP
, , O
thus RB O
confirming VBG O
the DT O
site NN O
of IN O
mutation NN O
. . O

-DOCSTART- X X O

The DT O
timing NN O
of IN O
fla JJ B-NP
gene NN I-NP
expression NN O
in IN O
the DT O
cell NN O
cycle NN O
is VBZ O
determined VBN O
by IN O
specialized JJ O
forms NNS O
of IN O
RNA NNP B-NP
polymerase NN I-NP
and CC O
the DT O
appearance NN O
and/or IN O
activation NN O
of IN O
regulatory JJ O
proteins NNS O
. . O

-DOCSTART- X X O

Polypeptides NNS O
of IN O
the DT O
same JJ O
apparent JJ O
sizes NNS O
are VBP O
detected VBN O
in IN O
spores NNS O
of IN O
a DT O
cotE NN B-NP
null NN O
mutant JJ O
, , O
on IN O
which WDT O
basis NN O
we PRP O
infer VBP O
that IN O
the DT O
products NNS O
of IN O
the DT O
cotJ NN B-NP
operon NN I-NP
are VBP O
required VBN O
for IN O
the DT O
normal JJ O
formation NN O
of IN O
the DT O
inner JJ O
layers NNS O
of IN O
the DT O
coat NN O
or CC O
are VBP O
themselves PRP O
structural JJ O
components NNS O
of IN O
the DT O
coat NN O
. . O

-DOCSTART- X X O

EEA1 NNP B-NP
is VBZ O
a DT O
conserved JJ O
alpha-helical JJ O
peripheral JJ O
membrane NN O
protein NN O
flanked VBN O
by IN O
cysteine NN O
"fingers NNS O
" '' O
and CC O
contains VBZ O
a DT O
calmodulin-binding JJ B-NP
IQ NNP I-NP
motif NN I-NP
. . O

-DOCSTART- X X O

Sensing VBG O
with IN O
chemically RB O
and CC O
biologically RB O
modified VBN O
carbon NN O
electrodes NNS O
. . O

-DOCSTART- X X O

Elevation NNP O
of IN O
the DT O
tissues NNS O
of IN O
the DT O
face NN O
is VBZ O
essentially RB O
vertical JJ O
and CC O
acts VBZ O
on IN O
the DT O
forehead NN O
, , O
temporal JJ O
region NN O
, , O
gaze NN O
and CC O
cheekbones NNS O
. . O

-DOCSTART- X X O

This DT O
region NN O
binds VBZ O
two CD O
ubiquitous JJ O
nuclear JJ O
factors NNS O
, , O
USF/MLTF NNP B-NP
and CC O
the DT O
CAAT-binding JJ B-NP
transcription NN I-NP
factor/nuclear NN I-NP
factor NN B-NP
1 CD I-NP
( -LRB- O
CTF/NF1 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
potential JJ O
impact NN O
of IN O
using VBG O
a DT O
rapid JJ O
diagnostic JJ O
test NN O
( -LRB- O
Strep NN O
A DT O
OIA NNP O
) -RRB- O
on IN O
detection NN O
and CC O
treatment NN O
of IN O
group NN O
A DT O
beta-hemolytic JJ O
streptococcal NN O
( -LRB- O
GABHS) NNP O
pharyngitis NN O
in IN O
a DT O
large-volume JJ O
pediatric JJ O
and CC O
adolescent JJ O
clinic NN O
was VBD O
examined VBN O
. . O

-DOCSTART- X X O

YAC NNP O
and CC O
cosmid JJ O
contigs NNS O
spanning VBG O
the DT O
BRCA1 JJ B-NP
region NN I-NP
were VBD O
used VBN O
to TO O
select VB O
cDNA DT O
clones NNS O
from IN O
pools NNS O
of IN O
cDNAs NNS O
derived VBN O
from IN O
human JJ O
placenta NN O
, , O
HeLa NNP O
cells NNS O
, , O
activated VBN O
T NNP O
cells NNS O
, , O
and CC O
fetal JJ O
head NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
assesses VBZ O
the DT O
feasibility NN O
and CC O
toxicity NN O
of IN O
adoptive JJ O
immunotherapy NN O
with IN O
tumor NN O
infiltrating NN O
lymphocytes NNS O
and CC O
recombinant JJ B-NP
interleukin-2 NN I-NP
in IN O
29 CD O
patients NNS O
who WP O
underwent VBD O
resection NN O
for IN O
stage NN O
III NNP O
non-small-cell JJ O
lung NN O
cancer NN O
. . O

-DOCSTART- X X O

MATERIAL NNP O
AND CC O
METHODS NNP O
: : O
Of IN O
the DT O
17 CD O
men NNS O
and CC O
17 CD O
women NNS O
, , O
who WP O
were VBD O
21 CD O
to TO O
80 CD O
years NNS O
of IN O
age NN O
, , O
27 CD O
had VBD O
hereditary JJ O
motor NN O
and CC O
sensory JJ O
neuropathy NN O
type NN O
I PRP O
and CC O
7 CD O
had VBD O
acquired VBN O
demyelinating VBG O
polyneuropathy NN O
. . O

-DOCSTART- X X O

DNA NNP O
sequencing NN O
and CC O
Southern JJ O
blot NN O
analyses NNS O
established VBN O
that IN O
the DT O
cDNA NN O
clones NNS O
are VBP O
derived VBN O
from IN O
two CD O
different JJ O
genes NNS O
. . O

-DOCSTART- X X O

Muscle NNP B-NP
GSH-Px NNP I-NP
activity NN O
after IN O
prolonged JJ O
exercise NN O
, , O
training NN O
, , O
and CC O
selenium NN O
supplementation NN O
. . O

-DOCSTART- X X O

Mutation NN O
of IN O
the DT O
Sp1 NNP B-NP
element NN I-NP
, , O
which WDT O
abolishes VBZ O
Sp1 NNP B-NP
binding NN O
, , O
results NNS O
in IN O
a DT O
6-10-fold JJ O
reduction NN O
in IN O
reporter NN O
activity NN O
. . O

-DOCSTART- X X O

Schooling NNP O
is VBZ O
found VBN O
to TO O
be VB O
related VBN O
to TO O
good JJ O
health NN O
even RB O
after IN O
controlling VBG O
for IN O
differences NNS O
in IN O
observable JJ O
health NN O
inputs NNS O
. . O

-DOCSTART- X X O

With IN O
this DT O
bisected JJ O
diastolic JJ O
driving NN O
, , O
the DT O
abnormal JJ O
echo NN O
disappeared VBD O
completely RB O
. . O

-DOCSTART- X X O

It PRP O
acts VBZ O
on IN O
Cdks NNS B-NP
in IN O
the DT O
G1 NNP O
and CC O
S NNP O
phases NNS O
of IN O
the DT O
cell NN O
cycle NN O
, , O
and CC O
also RB O
binds VBZ O
to TO O
proliferating VBG B-NP
cell NN I-NP
nuclear JJ I-NP
antigen NN I-NP
(PCNA NN O
) -RRB- O
, , O
blocking VBG O
DNA NNP O
replication NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Two CD O
major JJ O
and CC O
one CD O
minor JJ O
transcription NN O
initiation NN O
sites NNS O
were VBD O
assigned VBN O
to TO O
positions NNS O
+1 JJ O
and CC O
+24 RBR O
and CC O
position NN O
+14 VBD O
, , O
respectively RB O
, , O
by IN O
a DT O
combination NN O
of IN O
ribonuclease NN O
protection NN O
, , O
primer JJ O
extension NN O
, , O
and CC O
5' JJ O
RACE NNP O
analyses NNS O
. . O

-DOCSTART- X X O

The DT O
roxithromycin JJ O
doses NNS O
that WDT O
were VBD O
chosen VBN O
for IN O
these DT O
studies NNS O
were VBD O
less JJR O
than IN O
achievable JJ O
blood NN O
levels NNS O
. . O

-DOCSTART- X X O

Further RB O
, , O
the DT O
ORFs NNP O
of IN O
components NNS O
3 CD O
and CC O
5 CD O
potentially RB O
encoded VBN O
proteins NNS O
of IN O
about IN O
20 CD O
kDa NN O
, , O
the DT O
size NN O
of IN O
the DT O
BBTV NNP B-NP
coat NN I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Serial JJ O
followup JJ O
strength NN O
data NNS O
for IN O
2 CD O
patients NNS O
were VBD O
compared VBN O
to TO O
change VB O
in IN O
creatinine CD B-NP
kinase NN I-NP
( -LRB- O
CK) JJ B-NP
levels NNS O
. . O

-DOCSTART- X X O

An DT O
explanation NN O
explored VBD O
for IN O
this DT O
lack NN O
of IN O
gene NN O
expression NN O
was VBD O
that IN O
increased VBN O
levels NNS O
of IN O
RAR NN B-NP
alpha NN I-NP
or CC O
PML NNP B-NP
might MD O
suppress VB O
APL NNP O
cell NN O
growth NN O
. . O

-DOCSTART- X X O

Transfection NN O
of IN O
non-deleted JJ O
expression NN O
vector NN O
into IN O
NIH3T3 NNP O
cells NNS O
results NNS O
in IN O
acquisition NN O
of IN O
focus-forming NN O
activity NN O
while IN O
a DT O
deleted VBN O
form NN O
of IN O
expression NN O
vector NN O
fails VBZ O
to TO O
show VB O
this DT O
activity NN O
even RB O
in IN O
the DT O
presence NN O
of IN O
basic JJ B-NP
FGF. . I-NP

-DOCSTART- X X O

Cytosolic JJ O
extracts NNS O
from IN O
a DT O
variety NN O
of IN O
mammalian JJ O
cell NN O
lines NNS O
( -LRB- O
monkey NN O
Cos7 NNS O
, , O
several JJ O
mouse NN O
fibrosarcomas NNS O
and CC O
human JJ O
HeLa NNP O
S3 NN O
) -RRB- O
demonstrated VBD O
similar JJ O
TGF-beta NNP B-NP
1 CD I-NP
dependent JJ O
RNA-protein JJ O
band NN O
shifts VBZ O
as IN O
cell NN O
extract VB O
from IN O
BALB/c NNP O
3T3 CD O
mouse NN O
fibroblasts NNS O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
The DT O
MTD NNP O
for IN O
CPT-11 NN O
administered VBN O
in IN O
a DT O
3 CD O
consecutive-days-every-3 JJ O
weeks NNS O
schedule NN O
in IN O
this DT O
patient JJ O
population NN O
is VBZ O
115 CD O
mg/m2/day NN O
. . O

-DOCSTART- X X O

A DT O
73 CD O
bp JJ O
fragment NN O
( -LRB- O
X1 JJ O
region NN O
) -RRB- O
of IN O
the DT O
PRB-1b JJ B-NP
promoter NN I-NP
, , O
located VBN O
between IN O
positions NNS O
-213 JJ O
and CC O
-141 JJ O
, , O
was VBD O
sufficient JJ O
to TO O
confer VB O
ethylene NN O
responsiveness NN O
to TO O
the DT O
reporter NN O
gene NN O
. . O

-DOCSTART- X X O

Although IN O
the DT O
extracellular JJ O
domain NN O
of IN O
the DT O
TSH-R NNP B-NP
is VBZ O
sufficient JJ O
for IN O
high JJ O
affinity NN O
binding NN O
of IN O
TSH NNP B-NP
, , O
we PRP O
conclude VBP O
that IN O
the DT O
hyt NN O
mutation NN O
in IN O
the DT O
fourth JJ O
transmembrane NN O
domain NN O
eliminates VBZ O
TSH NNP B-NP
binding NN O
. . O

-DOCSTART- X X O

The DT O
absence NN O
of IN O
other JJ O
regions NNS O
of IN O
hybridization NN O
suggests VBZ O
that IN O
there EX O
are VBP O
no DT O
closely RB O
related JJ O
sequences NNS O
( -LRB- O
e NN O
.g. NN O
, , O
reverse VB O
transcribed JJ O
pseudogenes NNS O
) -RRB- O
scattered VBN O
throughout IN O
the DT O
genome NN O
and CC O
that IN O
if IN O
there EX O
are VBP O
closely RB O
related VBN O
genes NNS O
, , O
they PRP O
must MD O
be VB O
clustered VBN O
near IN O
GSTT2 NNP B-NP
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
lens NN O
dose NN O
( -LRB- O
3.6 CD O
Gy/25 : O
fractions NNS O
) -RRB- O
was VBD O
higher JJR O
compared VBN O
to TO O
the DT O
other JJ O
techniques NNS O
. . O

-DOCSTART- X X O

Antibodies NNS O
to TO O
the DT O
human NN B-NP
PTS1R NN I-NP
recognize VBP O
this DT O
protein NN O
in IN O
human NN O
, , O
monkey NN O
, , O
rat NN O
, , O
and CC O
hamster NN O
cells NNS O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
here RB O
that IN O
in IN O
cultured JJ O
Jurkat NNP O
T NNP O
cells NNS O
, , O
Cbl NNP B-NP
is VBZ O
coprecipitated VBN O
with IN O
antibody NN O
against IN O
the DT O
adapter NN B-NP
protein NN I-NP
Grb2 NNP I-NP
. . O

-DOCSTART- X X O

Otte NNP O
, , O
Mol NNP O
. . O

-DOCSTART- X X O

Scalp NN O
flaps NNS O
can MD O
be VB O
expanded VBN O
just RB O
to TO O
the DT O
point NN O
of IN O
becoming VBG O
noticeable JJ O
over IN O
4 CD O
to TO O
6 CD O
weeks NNS O
followed VBD O
by IN O
scalp NN O
flap NN O
transposition NN O
and CC O
easy JJ O
closure NN O
of IN O
the DT O
donor NN O
site NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
Center NNP O
for IN O
Human NNP O
Genetics NNP O
in IN O
Leuven NNP O
, , O
predictive JJ O
DNA-testing NN O
for IN O
Huntington NNP O
's POS O
disease NN O
is VBZ O
available JJ O
as IN O
a DT O
clinical JJ O
service NN O
since IN O
November NNP O
1987 CD O
, , O
initially RB O
by IN O
DNA-linkage NNP O
and CC O
since IN O
mid JJ O
1993 CD O
by IN O
direct JJ O
mutation NN O
analysis NN O
. . O

-DOCSTART- X X O

Risks NNS O
of IN O
chronicity NN O
following VBG O
acute JJ O
hepatitis NN O
B NNP O
virus NN O
infection NN O
: : O
a DT O
review NN O
. . O

-DOCSTART- X X O

Examination NNP O
of IN O
neurohumoral JJ O
factors NNS O
revealed VBD O
a DT O
hyperactive JJ O
sympathetic JJ O
nervous JJ O
system NN O
and CC O
an DT O
increase NN O
in IN O
plasma NN O
renin NN B-NP
activity NN O
. . O

-DOCSTART- X X O

The DT O
amino-terminal JJ O
DNA-binding JJ O
domain NN O
of IN O
Pip NN B-NP
exhibits NNS O
a DT O
high JJ O
degree NN O
of IN O
homology NN O
to TO O
the DT O
DNA-binding JJ O
domains NNS O
of IN O
members NNS O
of IN O
the DT O
interferon NN B-NP
regulatory JJ I-NP
factor NN I-NP
( -LRB- O
IRF NN B-NP
) -RRB- O
family NN O
, , O
which WDT O
includes VBZ O
IRF-1 NNP B-NP
, , O
IRF-2 NNP B-NP
, , O
ICSBP NNP B-NP
, , O
and CC O
ISGF3 NNP B-NP
gamma NN I-NP
. . O

-DOCSTART- X X O

The DT O
RAP74 NNP B-NP
subunit NN I-NP
of IN O
TFIIF NNP B-NP
alone RB O
contained VBD O
the DT O
stimulatory JJ O
activity NN O
and CC O
the DT O
minimal JJ O
region NN O
sufficient JJ O
for IN O
stimulation NN O
corresponds NNS O
to TO O
COOH-terminal JJ O
residues NNS O
358-517 CD O
. . O

-DOCSTART- X X O

The DT O
hsp70 NN B-NP
gene NN I-NP
family NN I-NP
of IN O
Neurospora NNP O
crassa VBD O
: : O
cloning NN O
, , O
sequence NN O
analysis NN O
, , O
expression NN O
, , O
and CC O
genetic JJ O
mapping NN O
of IN O
the DT O
major JJ O
stress-inducible JJ O
member NN O
. . O

-DOCSTART- X X O

The DT O
deduced VBD O
amino IN O
acid NN O
sequences NNS O
of IN O
each DT O
of IN O
the DT O
W3A1 NNP B-NP
ETF NNP I-NP
subunits NNS I-NP
exhibit VBP O
only RB O
approximately RB O
30 CD O
% NN O
identity NN O
with IN O
the DT O
corresponding JJ O
subunits NNS O
of IN O
the DT O
ETF NNP B-NP
from IN O
human JJ O
, , O
rat NN O
, , O
and CC O
Paracoccus NNP O
denitrificans NNPS O
, , O
which WDT O
as IN O
a DT O
group NN O
are VBP O
greater JJR O
than IN O
50 CD O
% NN O
identical JJ O
. . O

-DOCSTART- X X O

Other JJ O
assays DT O
also RB O
distinguished VBN O
the DT O
processive JJ O
replication NN O
of IN O
pNeo.Myc-2.4 NN O
from IN O
the DT O
dispersive JJ O
labeling NN O
of IN O
control NN O
plasmids NNS O
. . O

-DOCSTART- X X O

Reconstitution NNP O
of IN O
complexes NNS O
containing VBG O
p62 NN B-NP
and CC O
the DT O
src JJ B-NP
family NN I-NP
kinase NN I-NP
p59fyn NN B-NP
in IN O
HeLa NNP O
cells NNS O
demonstrated VBD O
that IN O
complex JJ O
formation NN O
resulted VBD O
in IN O
tyrosine NN O
phosphorylation NN O
of IN O
p62 NN B-NP
and CC O
was VBD O
mediated VBN O
by IN O
both DT O
the DT O
SH3 NNP B-NP
and CC O
SH2 NNP B-NP
domains NNS I-NP
of IN O
p59fyn NN B-NP
. . O

-DOCSTART- X X O

Therefore RB O
, , O
it PRP O
is VBZ O
hoped VBN O
that IN O
by IN O
defining VBG O
the DT O
transcriptional JJ O
control NN O
of IN O
the DT O
L7 NNP B-NP
gene NN I-NP
insights NNS O
into IN O
the DT O
mechanisms NNS O
that IN O
control NN O
functional JJ O
fate NN O
and CC O
organization NN O
in IN O
the DT O
nervous JJ O
system NN O
can MD O
be VB O
gained VBN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
a DT O
Maf-related JJ B-NP
protein NN I-NP
, , O
Nrl NN B-NP
, , O
completely RB O
mimicked VBN O
c-Maf JJ B-NP
actions NNS O
. . O

-DOCSTART- X X O

In IN O
studies NNS O
of IN O
many JJ O
different JJ O
phenotypically RB O
distinct JJ O
cells NNS O
, , O
the DT O
CRE NNP O
of IN O
the DT O
somatostatin NN B-NP
gene NN I-NP
promoter NN I-NP
is VBZ O
a DT O
prototype NN O
of IN O
a DT O
highly RB O
cAMP-responsive JJ O
element NN O
regulated VBN O
by IN O
CREB. NNP B-NP

-DOCSTART- X X O

The DT O
first JJ O
gene NN O
, , O
NSR1 NNP B-NP
, , O
a DT O
previously RB O
identified VBN O
gene NN O
, , O
encodes VBZ O
a DT O
protein NN O
involved VBN O
in IN O
ribosomal JJ O
RNA NNP O
maturation NN O
and CC O
possibly RB O
in IN O
transport NN O
of IN O
proteins NNS O
into IN O
the DT O
nucleus NN O
. . O

-DOCSTART- X X O

Comparative JJ O
study NN O
of IN O
the DT O
differential JJ O
white JJ O
blood NN O
cell NN O
count NN O
using VBG O
three CD O
automated JJ O
analyzers NNS O
: : O
Coulter NNP O
STKS NNP O
, , O
Sysmex NNP O
NE NNP O
8000 CD O
and CC O
Technicon NNP O
H-1 NNP O
. . O

-DOCSTART- X X O

Further JJ O
studies NNS O
established VBN O
that IN O
the DT O
Ep-induced JJ B-NP
increase NN O
in IN O
beta-globin JJ B-NP
mRNA NN I-NP
could MD O
be VB O
inhibited VBN O
by IN O
the DT O
tyrosine NN B-NP
kinase NN I-NP
inhibitor IN O
genistein NN O
and CC O
the DT O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
inhibitor IN O
Compound NNP O
3.(ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

This DT O
study NN O
investigated VBD O
the DT O
degree NN O
to TO O
which WDT O
racial JJ O
identity NN O
influences VBZ O
Mexican-Americans NNP O
' POS O
performance NN O
on IN O
the DT O
L, NNP O
K NNP O
, , O
and CC O
MF NNP O
scales NNS O
of IN O
the DT O
MMPI-2 NNP O
. . O

-DOCSTART- X X O

To TO O
do VB O
this DT O
, , O
segments NNS O
of IN O
DNA NN O
from IN O
the DT O
5' JJ O
flank NN O
of IN O
the DT O
initiation NN O
sites NNS O
for IN O
germline NN O
epsilon NN O
RNA NNP O
were VBD O
ligated VBN O
to TO O
a DT O
luciferase NN B-NP
reporter NN I-NP
gene NN I-NP
and CC O
transfected VBN O
into IN O
two CD O
mouse NN O
B NN O
cell NN O
lines NNS O
, , O
one CD O
of IN O
which WDT O
can MD O
be VB O
induced VBN O
to TO O
switch VB O
to TO O
IgE. NNP B-NP

-DOCSTART- X X O

Oncogenic JJ O
capacity NN O
of IN O
the DT O
E2F1 NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

In IN O
some DT O
of IN O
the DT O
cases NNS O
of IN O
solitary JJ O
lesion NN O
, , O
serum NN B-NP
TSH NNS I-NP
levels NNS O
, , O
serum NN B-NP
thyroglobulin NN I-NP
values NNS O
, , O
and CC O
131I JJ O
protein NN O
bounded VBD O
iodine NN O
( -LRB- O
131I-PBI JJ O
) -RRB- O
were VBD O
measured VBN O
, , O
but CC O
there EX O
were VBD O
no DT O
significant JJ O
differences NNS O
between IN O
successful JJ O
and CC O
unsuccessful JJ O
therapy NN O
. . O

-DOCSTART- X X O

Endo16 NNP B-NP
transcripts NNS I-NP
are VBP O
confined VBN O
to TO O
the DT O
definitive JJ O
vegetal NN O
plate NN O
in IN O
blastula NN O
stage NN O
embryos NNS O
; : O
at IN O
gastrula NN O
stage NN O
this DT O
gene NN O
is VBZ O
expressed VBN O
throughout IN O
the DT O
archenteron NN O
, , O
but CC O
later RB O
only RB O
in IN O
the DT O
midgut NN O
. . O

-DOCSTART- X X O

Another DT O
full JJ O
ORF NN O
was VBD O
found VBN O
on IN O
the DT O
opposite JJ O
strand NN O
downstream NN O
from IN O
the DT O
nspC JJ B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
U14 NNP B-NP
genes NNS I-NP
of IN O
mouse NN O
as RB O
well RB O
as IN O
rat NN O
, , O
hamster NN O
, , O
human JJ O
, , O
Xenopus NNP O
and CC O
trout NN O
are VBP O
encoded VBN O
within IN O
introns NNS O
of IN O
the DT O
constitutively NN O
expressed VBD O
70-kDa-cognate-heat-shock JJ B-NP
protein NN I-NP
gene NN I-NP
( -LRB- O
hsc70 CD B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Inclusion NN O
in IN O
this DT O
family NN O
of IN O
proteins NNS O
suggests VBZ O
that IN O
FliQ NNP B-NP
and CC O
FliR NNP B-NP
may MD O
participate VB O
in IN O
an DT O
export NN O
pathway NN O
required VBN O
for IN O
flagellum NN O
assembly NN O
. . O

-DOCSTART- X X O

Chem NNP O
. . O

-DOCSTART- X X O

Increase NN O
in IN O
blood NN O
NEFA NNP O
was VBD O
further RB O
augmented VBN O
by IN O
fat JJ O
plus CC O
AA NNP O
supplementation NN O
, , O
but CC O
no DT O
changes NNS O
in IN O
concentrations NNS O
of IN O
Lys NNP O
or CC O
Met NNP O
in IN O
blood NN O
were VBD O
found VBN O
. . O

-DOCSTART- X X O

Virol NNP O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
the DT O
deduced JJ O
amino JJ B-NP
acid NN I-NP
sequence NN I-NP
of IN I-NP
gamma-kafirin NN I-NP
with IN O
the DT O
published VBN O
sequences NNS B-NP
of IN I-NP
gamma-prolamins NNS I-NP
of IN I-NP
maize NN I-NP
, , I-NP
and CC I-NP
Coix NNP I-NP
revealed VBD O
highly RB O
conserved VBN O
domains NNS O
. . O

-DOCSTART- X X O

Atcys1 NNP B-NP
, , O
Athyp1 NNP B-NP
, , O
AKin10 NNP B-NP
and CC O
the DT O
ORF NNP O
are VBP O
very RB O
close RB O
to TO O
each DT O
other JJ O
and CC O
organized VBN O
in IN O
the DT O
same JJ O
polarity NN O
; : O
hence RB O
, , O
the DT O
intergenic JJ O
regions NNS O
probably RB O
contain VBP O
, , O
within IN O
less JJR O
than IN O
0.5 CD O
kb NN O
, , O
all DT O
the DT O
regulatory JJ O
elements NNS O
necessary JJ O
to TO O
govern VB O
initiation NN O
and CC O
termination NN O
of IN O
transcription NN O
. . O

-DOCSTART- X X O

Southern JJ O
blot NN O
hybridization NN O
experiments NNS O
suggest VBP O
the DT O
presence NN O
of IN O
one CD O
copy NN O
of IN O
Atcys1 NNP B-NP
, , O
Athyp1 NNP B-NP
and CC O
AKin10 DT B-NP
per IN O
haploid JJ O
genome NN O
, , O
and CC O
Northern JJ O
blot NN O
analysis NN O
demonstrates VBZ O
that IN O
the DT O
three CD O
genes NNS O
are VBP O
differentially RB O
expressed VBN O
in IN O
roots NNS O
, , O
shoots NNS O
and CC O
leaves NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
HAC1 NNP B-NP
may MD O
also RB O
be VB O
one CD O
of IN O
the DT O
meiotic JJ O
genes NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
identification NN O
of IN O
a DT O
Dr1-like JJ B-NP
protein NN I-NP
in IN O
A.thaliana NNP O
strongly RB O
argues VBZ O
for IN O
the DT O
ubiquity NN O
of IN O
this DT O
protein NN O
among IN O
eukaryotic JJ O
genera NN O
and CC O
for IN O
a DT O
conserved JJ O
mechanism NN O
to TO O
regulate VB O
transcription NN O
initiation NN O
that WDT O
involves VBZ O
Dr1 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
pre NN O
- : O
and CC O
postoperative JJ O
haemoglobin NN B-NP
concentrations NNS O
in IN O
the DT O
autologous JJ O
group NN O
were VBD O
lower JJR O
by IN O
15 CD O
and CC O
10 CD O
g/L NN O
, , O
respectively RB O
, , O
after IN O
primary JJ O
THR NN O
and CC O
by IN O
10 CD O
g/L NN O
in IN O
both DT O
instances NNS O
after IN O
revision NN O
THR. . O

-DOCSTART- X X O

( -LRB- O
iv) NN O
Although IN O
UCRBP NNP B-NP
has VBZ O
been VBN O
previously RB O
shown VBN O
to TO O
act VB O
as IN O
a DT O
transcriptional JJ O
repressor NN O
, , O
we PRP O
show VBP O
here RB O
that IN O
UCRBP NNP B-NP
can MD O
also RB O
act VB O
as IN O
a DT O
positive JJ O
transactivator NN O
of IN O
a DT O
reporter NN O
driven VBN O
by IN O
UCR NNP O
elements NNS O
when WRB O
used VBN O
in IN O
co-transfection NN O
assays VBZ O
. . O

-DOCSTART- X X O

Chem NNP O
. . O

-DOCSTART- X X O

These DT O
results NNS O
demonstrate VBP O
that IN O
EKLF NNP B-NP
provides VBZ O
a DT O
crucial JJ O
transactivation NN O
function NN O
for IN O
globin NN B-NP
expression NN O
and CC O
further JJ O
reinforce VBP O
the DT O
idea NN O
that IN O
EKLF NNP B-NP
is VBZ O
an DT O
important JJ O
regulator NN O
of IN O
CACCC NNP O
element-directed JJ O
transcription NN O
in IN O
erythroid JJ O
cells NNS O
. . O

-DOCSTART- X X O

Using VBG O
a DT O
battery NN O
of IN O
I PRP B-NP
kappa VBD I-NP
B NNP I-NP
alpha NN I-NP
mutants NNS I-NP
, , O
we PRP O
show VBP O
that IN O
( -LRB- O
i NN O
) -RRB- O
a DT O
dimer NN O
binds VBZ O
a DT O
single JJ O
I PRP B-NP
kappa VBD I-NP
B NNP I-NP
alpha NN I-NP
molecule NN I-NP
, , O
( -LRB- O
ii NNS O
) -RRB- O
the DT O
acidic NN O
C-terminal JJ O
region NN O
of IN O
I PRP B-NP
kappa VBD I-NP
B NNP I-NP
alpha NN I-NP
is VBZ O
not RB O
required VBN O
for IN O
protein-protein NN O
binding NN O
and CC O
does VBZ O
not RB O
mask VB O
the DT O
nuclear JJ O
localization NN O
signal NN O
of IN O
the DT O
dimer NN O
, , O
( -LRB- O
iii NNS O
) -RRB- O
the DT O
same JJ O
C-terminal JJ O
region NN O
is VBZ O
required VBN O
for IN O
inhibition NN O
of IN O
DNA NNP O
binding NN O
, , O
and CC O
( -LRB- O
iv) NN O
this DT O
inhibition NN O
may MD O
be VB O
accomplished VBN O
by IN O
direct JJ O
interaction NN O
between IN O
the DT O
PEST-like JJ O
region NN O
and CC O
the DT O
DNA-binding JJ O
region NN O
of IN O
one CD O
of IN O
the DT O
subunits NNS O
of IN O
the DT O
dimer NN O
. . O

-DOCSTART- X X O

The DT O
negative JJ O
regulatory JJ O
activity NN O
of IN O
the DT O
N-terminal JJ O
domain NN O
was VBD O
antagonized VBN O
by IN O
a DT O
C-terminal JJ O
segment NN O
of IN O
Pho81p NNP B-NP
supplied VBD O
in IN O
trans NNS O
. . O

-DOCSTART- X X O

At IN O
different JJ O
times NNS O
of IN O
the DT O
surgical JJ O
procedures NNS O
( -LRB- O
thorax NN O
opening NN O
and CC O
closure NN O
, , O
period NN O
of IN O
cardiopulmonary JJ O
bypass NN O
) -RRB- O
67 CD O
to TO O
100 CD O
% NN O
of IN O
the DT O
patients NNS O
in IN O
group NN O
1 CD O
had VBD O
vancomycin RB O
concentrations NNS O
in IN O
the DT O
studied VBN O
tissues NNS O
above IN O
the DT O
MIC NNP O
90 CD O
for IN O
Staphylococcus NNP O
aureus NN O
( -LRB- O
1 CD O
microgram/g NN O
) -RRB- O
and CC O
Staphylococcus NNP O
epidermidis NN O
( -LRB- O
2 CD O
micrograms/g NN O
) -RRB- O
. . O

-DOCSTART- X X O

On-line NNP O
angioscopic JJ O
images NNS O
of IN O
tissue NN O
flaps NNS O
floating VBG O
in IN O
the DT O
lumen NNS O
, , O
recent JJ O
or CC O
structured JJ O
thrombi NN O
, , O
artery NN O
wall NN O
dissections NNS O
, , O
plaque NN O
ruptures NNS O
, , O
deep JJ O
fissurations NNS O
and CC O
sub-intimal JJ O
haemorrhages NNS O
demonstrate VBP O
, , O
in IN O
live JJ O
colour NN O
, , O
the DT O
pathophysiological JJ O
mechanisms NNS O
of IN O
coronary JJ O
artery NN O
stenosis NN O
. . O

-DOCSTART- X X O

Basal NNP O
components NNS O
of IN O
the DT O
transcription NN O
apparatus NN O
( -LRB- O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
, , O
TATA-binding JJ B-NP
protein NN I-NP
) -RRB- O
contain VBP O
activation NN O
domains NNS O
: : O
is VBZ O
the DT O
repetitive JJ O
C-terminal JJ O
domain NN O
( -LRB- O
CTD NNP O
) -RRB- O
of IN O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
a DT O
"portable JJ O
enhancer NN O
domain NN O
" '' O
? . O
Regions NNPS O
rich JJ O
in IN O
serine NN O
, , O
threonine CD O
, , O
and CC O
proline NN O
residues NNS O
can MD O
be VB O
found VBN O
in IN O
transcriptional JJ O
activation NN O
domains NNS O
, , O
as RB O
well RB O
as IN O
in IN O
the DT O
N-terminal JJ O
parts NNS O
of IN O
mammalian JJ B-NP
TATA-binding JJ I-NP
proteins NNS I-NP
, , O
where WRB O
they PRP O
are VBP O
interrupted VBN O
by IN O
polyglutamine NN O
stretches NNS O
. . O

-DOCSTART- X X O

Mutagenesis NNP O
of IN O
IM1 NNP B-NP
enhances VBZ O
the DT O
ability NN O
of IN O
c-Fos NNS B-NP
to TO O
activate VB O
an DT O
AP1 JJ B-NP
bearing NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

This DT O
failure NN O
to TO O
execute VB O
regulated VBN O
G1/S NNP O
arrest NN O
is VBZ O
correlated VBN O
with IN O
enhanced JJ O
thermosensitivity NN O
of IN O
colony-forming JJ O
ability NN O
. . O

-DOCSTART- X X O

The DT O
marker NN O
orders NNS O
from IN O
the DT O
genetic JJ O
and CC O
RH JJ O
maps NNS O
were VBD O
consistent JJ O
. . O

-DOCSTART- X X O

Haplotype NNP O
mapping NN O
and CC O
sequence NN O
analysis NN O
of IN O
the DT O
mouse NN O
Nramp NN B-NP
gene NN I-NP
predict VBP O
susceptibility NN O
to TO O
infection NN O
with IN O
intracellular JJ O
parasites NNS O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
peak NN O
filling NN O
rate NN O
( -LRB- O
PFR NN O
) -RRB- O
, , O
normalized JJ O
to TO O
end VB O
diastolic JJ O
volume NN O
( -LRB- O
EDV) NNP O
, , O
or CC O
stroke NN O
volume NN O
( -LRB- O
SV) NNP O
, , O
or CC O
expressed VBN O
as IN O
the DT O
ratio NN O
of IN O
PFR-to-PER NNP O
was VBD O
reduced VBN O
( -LRB- O
p NN O
< JJ O
0.01 CD O
) -RRB- O
, , O
time NN O
to TO O
PFR NNP O
( -LRB- O
TPFR NN O
) -RRB- O
was VBD O
prolonged VBN O
( -LRB- O
p NN O
< JJ O
0.01 CD O
) -RRB- O
, , O
and CC O
echocardiographic JJ O
left JJ O
ventricular JJ O
mass NN O
index NN O
was VBD O
higher JJR O
( -LRB- O
p NN O
< JJ O
0.001 CD O
) -RRB- O
in IN O
patients NNS O
with IN O
acromegaly JJ O
compared VBN O
to TO O
normals NNS O
. . O

-DOCSTART- X X O

A DT O
genetic JJ O
complementation NN O
system NN O
was VBD O
developed VBN O
in IN O
which WDT O
tobacco NN B-NP
etch NN I-NP
virus NN I-NP
( -LRB- I-NP
TEV NNP I-NP
) -RRB- I-NP
polymerase NN I-NP
( -LRB- O
NIb)-expressing JJ B-NP
transgenic NN O
plants NNS O
or CC O
protoplasts NNS O
were VBD O
inoculated VBN O
with IN O
NIb-defective JJ B-NP
TEV NNP B-NP
mutants NNS I-NP
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
the DT O
genomes NNS O
of IN O
PMTV NNP O
, , O
BNYVV NNP O
, , O
and CC O
SBWMV NNP O
shows VBZ O
that IN O
furoviruses NNS O
exhibit VBP O
considerable JJ O
heterogeneity NN O
in IN O
genome JJ O
organization NN O
. . O

-DOCSTART- X X O

The DT O
drug NN O
sensitivity NN O
was VBD O
100 CD O
% NN O
for IN O
vancomycin NN O
(VCM) NN O
, , O
30 CD O
% NN O
for IN O
imipenam NN O
( -LRB- O
IMP) NNP O
, , O
31 CD O
% NN O
for IN O
minomycin NN O
( -LRB- O
MINO NN O
) -RRB- O
, , O
31 CD O
% NN O
for IN O
amikacin FW O
( -LRB- O
AMK) NN O
, , O
and CC O
7 CD O
% NN O
for IN O
fosfomycin NNS O
( -LRB- O
FOM) NN O
. . O

-DOCSTART- X X O

Deglycosylation NN O
with IN O
endoglycosidase NN B-NP
H NNP I-NP
showed VBD O
that IN O
the DT O
mutant JJ O
receptors NNS O
had VBD O
mainly RB O
high-mannose JJ O
oligosaccharide JJ O
chains NNS O
. . O

-DOCSTART- X X O

Dietary NNP O
supplement NN O
with IN O
fish NN O
oil NN O
and CC O
related JJ O
n-3 NN O
EFAs NN O
has VBZ O
been VBN O
used VBN O
to TO O
study VB O
their PRP$ O
antihypertensive JJ O
property NN O
in IN O
animals NNS O
and CC O
humans NNS O
with IN O
borderline NN O
and CC O
essential JJ O
hypertension NN O
. . O

-DOCSTART- X X O

The DT O
HSD3B1 NNP B-NP
and CC O
HSD3B2 NNP B-NP
genes NNS I-NP
encoding VBG O
the DT O
types NNS B-NP
I PRP I-NP
and CC I-NP
II NNP I-NP
3 CD I-NP
beta-HSD JJ I-NP
isoenzymes NNS I-NP
, , O
respectively RB O
, , O
have VBP O
been VBN O
previously RB O
assigned VBN O
by IN O
in IN O
situ FW O
hybridization NN O
to TO O
the DT O
chromosome NN O
1p13.1 IN O
region NN O
. . O

-DOCSTART- X X O

Insulin-stimulated NNP B-NP
glucose NN O
transport NN O
in IN O
adipocytes NNS O
is VBZ O
mediated VBN O
by IN O
the DT O
insulin NN B-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

Intron-exon NNP O
structure NN O
of IN O
the DT O
porcine NN B-NP
I PRP I-NP
kappa VBD I-NP
B NNP I-NP
alpha-encoding NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
kallistatin NN B-NP
gene NN I-NP
was VBD O
localized VBN O
by IN O
in IN O
situ FW O
hybridization NN O
to TO O
human JJ O
chromosome NN O
14q31-q32.1 CD O
, , O
close RB O
to TO O
the DT O
serpin NN B-NP
genes NNS I-NP
encoding VBG O
alpha NN B-NP
1-antichymotrypsin JJ I-NP
, , O
protein NN B-NP
C NNP I-NP
inhibitor NN I-NP
, , O
alpha NN B-NP
1-antitrypsin JJ I-NP
, , O
and CC O
corticosteroid-binding JJ B-NP
globulin NN I-NP
. . O

-DOCSTART- X X O

The DT O
locus NN O
encoding VBG O
the DT O
XD NNP B-NP
gene NN I-NP
( -LRB- O
designated VBN O
Xd NN B-NP
) -RRB- O
was VBD O
mapped VBN O
to TO O
the DT O
distal JJ O
part NN O
of IN O
mouse NN O
chromosome NN O
17 CD O
by IN O
haplotype JJ O
analysis NN O
of IN O
114 CD O
interspecific JJ O
backcross JJ O
mice NNS O
. . O

-DOCSTART- X X O

An DT O
interatrial JJ O
communication NN O
mitigates VBZ O
the DT O
impairment NN O
of IN O
LV NNP O
function NN O
after IN O
an DT O
acute JJ O
and CC O
sustained VBN O
drop NN O
of IN O
intrathoracic JJ O
pressure NN O
. . O

-DOCSTART- X X O

Self NNP O
or CC O
foreign JJ O
cellular JJ O
proteins NNS O
provide VBP O
peptides NNS O
for IN O
presentation NN O
by IN O
major JJ B-NP
histocompatibility NN I-NP
complex NN I-NP
( -LRB- I-NP
MHC NNP I-NP
) -RRB- I-NP
class NN I-NP
I PRP I-NP
molecules NNS I-NP
on IN O
the DT O
surface NN O
of IN O
antigen JJ O
presenting VBG O
cells NNS O
( -LRB- O
APC NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
characteristics NNS O
of IN O
the DT O
VirD1/VirD2-mediated NNP B-NP
cleavage NN O
reaction NN O
strongly RB O
resemble VB O
those DT O
observed VBN O
with IN O
relaxosomes NNS O
of IN O
IncP NNP O
plasmids NNS O
involved VBN O
in IN O
initiation NN O
of IN O
transfer NN O
DNA NN O
replication NN O
during IN O
bacterial JJ O
conjugation NN O
. . O

-DOCSTART- X X O

Isoelectric NNP O
focusing VBG O
of IN O
tryptic JJ O
peptides NNS O
generated VBD O
from IN O
MHC-B NNP B-NP
phosphorylated VBD O
with IN O
cdc2 CD B-NP
kinase NN I-NP
revealed VBD O
one CD O
major JJ O
phosphopeptide NN O
that WDT O
was VBD O
purified VBN O
by IN O
reverse-phase JJ O
high JJ O
performance NN O
liquid NN O
chromatography NN O
and CC O
sequenced VBD O
. . O

-DOCSTART- X X O

The DT O
deduced JJ O
protein NN O
sequence NN O
was VBD O
88 CD O
% NN O
homologous JJ O
to TO O
that DT O
of IN O
hNUC NN B-NP
I PRP I-NP
, , O
isolated VBN O
from IN O
human JJ O
osteosarcoma NN O
cells NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
cotransfection NN O
studies NNS O
indicate VBP O
that IN O
RVR NN B-NP
does VBZ O
not RB O
activate VB O
transcription NN O
when WRB O
this DT O
hormone NN O
response NN O
element NN O
is VBZ O
linked VBN O
to TO O
a DT O
reporter NN O
gene NN O
but CC O
rather RB O
acts VBZ O
as IN O
a DT O
potent JJ O
competitive JJ O
repressor NN O
of IN O
ROR NNP B-NP
alpha NN I-NP
function NN O
. . O

-DOCSTART- X X O

These DT O
studies NNS O
indicate VBP O
that IN O
in IN O
vitro NN O
and CC O
in IN O
vivo JJ O
electrical JJ O
stimulation NN O
generate VBP O
reactive JJ O
oxygen NN O
species NNS O
and CC O
affect VB O
SOD JJ B-NP
activity NN O
, , O
which WDT O
in IN O
part NN O
are VBP O
responsible JJ O
for IN O
decreased VBN O
sperm JJ O
motion NN O
and CC O
viability NN O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
human JJ B-NP
and CC I-NP
murine JJ I-NP
blk NN I-NP
sequences NNS I-NP
indicated VBD O
that IN O
they PRP O
share VBP O
86 CD O
% NN O
amino IN O
acid NN O
identity NN O
, , O
the DT O
most RBS O
conserved JJ O
region NN O
being VBG O
the DT O
catalytic JJ O
domain NN O
(93 VBD O
% NN O
identity NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
mRNAs NNS O
of IN O
the DT O
GRF NNP B-NP
genes NNS I-NP
are VBP O
encoded VBN O
by IN O
six CD O
exons NNS O
interrupted VBN O
by IN O
five CD O
introns NNS O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
ethanol NN O
on IN O
human JJ O
sensorimotor NN O
reactivity NN O
was VBD O
assessed VBN O
by IN O
examining VBG O
the DT O
acoustic JJ O
startle JJ O
response NN O
. . O

-DOCSTART- X X O

Digitalis NNP O
glycosides NNS O
or CC O
beta-receptor NN B-NP
antagonists NNS O
are VBP O
not RB O
helpful JJ O
in IN O
the DT O
therapy NN O
of IN O
this DT O
form NN O
of IN O
atrial JJ O
fibrillation NN O
whereas IN O
class NN O
I PRP O
antiarrhythmic JJ O
drugs NNS O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
more RBR O
effective JJ O
. . O

-DOCSTART- X X O

Atrial JJ O
fibrillation NN O
and CC O
the DT O
autonomic JJ O
nervous JJ O
system NN O

-DOCSTART- X X O

VIII NNP O
in IN O
doses NNS O
2-3 CD O
times NNS O
higher JJR O
than IN O
usually RB O
used VBN O
in IN O
haemophiliacs NNS O
without IN O
inhibitor NN O
were VBD O
successful JJ O
. . O

-DOCSTART- X X O

Removal NNP O
of IN O
PDMP NNP O
from IN O
the DT O
cell NN O
medium NN O
resulted VBD O
in IN O
reversal NN O
of IN O
the DT O
cell NN O
cycle NN O
changes NNS O
, , O
with IN O
cells NNS O
re-entering VBG O
the DT O
S NNP O
phase NN O
. . O

-DOCSTART- X X O

A DT O
major JJ O
task NN O
for IN O
sports NNS O
scientists NNS O
may MD O
be VB O
to TO O
verify VB O
empirically RB O
the DT O
nature NN O
of IN O
an DT O
integrated JJ O
model NN O
of IN O
the DT O
sport NN O
performer NN O
. . O

-DOCSTART- X X O

The DT O
requirement NN O
of IN O
PilE NNP B-NP
in IN O
pilus NN O
biogenesis NN O
was VBD O
confirmed VBN O
by IN O
demonstrating VBG O
that DT O
chromosomal NN B-NP
pilE NN I-NP
insertion NN I-NP
mutants NNS I-NP
were VBD O
pilus JJ O
- : O
and CC O
twitching-motility NN O
deficient NN O
. . O

-DOCSTART- X X O

The DT O
pilE JJ B-NP
gene NN I-NP
product NN I-NP
of IN I-NP
Pseudomonas NNP I-NP
aeruginosa NN I-NP
, , O
required VBN O
for IN O
pilus NN O
biogenesis NN O
, , O
shares NNS O
amino IN O
acid NN O
sequence NN O
identity NN O
with IN O
the DT O
N-termini NNP O
of IN O
type NN B-NP
4 CD I-NP
prepilin JJ I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Because IN O
of IN O
the DT O
functional JJ O
conservation NN O
of IN O
cell NN O
cycle NN O
control NN O
elements NNS O
, , O
the DT O
expression NN O
of IN O
a DT O
vertebrate JJ B-NP
wee1 CD I-NP
or CC O
mik1 CD B-NP
homolog NN I-NP
would MD O
be VB O
expected VBN O
to TO O
rescue VB O
such JJ O
lethal JJ O
mutations NNS O
in IN O
yeast NN O
. . O

-DOCSTART- X X O

Near IN O
a DT O
third JJ O
( -LRB- O
31.6 CD O
% NN O
) -RRB- O
of IN O
Insulin NNP B-NP
Dependent NNP O
and CC O
a DT O
third JJ O
( -LRB- O
33.41 CD O
% NN O
) -RRB- O
for IN O
Non FW O
Insulin NNP B-NP
Dependent NNP O
were VBD O
of IN O
D NNP O
, , O
F NNP O
, , O
H NNP O
White NNP O
's POS O
Class NN O
. . O

-DOCSTART- X X O

As IN O
the DT O
half-life NN O
of IN O
the DT O
compound NN O
did VBD O
never RB O
exceed VB O
8-9 CD O
h NN O
, , O
the DT O
data NNS O
do VBP O
not RB O
support VB O
any DT O
change NN O
of IN O
pidotimod JJ O
administration NN O
schedule NN O
( -LRB- O
every DT O
24-12 JJ O
h NN O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
comparative JJ O
study NN O
by IN O
holographic JJ O
interferometry NN O
of IN O
ten CD O
porcine NN O
bioprosthetic JJ O
valves NNS O
( -LRB- O
seven CD O
Carpentier-Edwards NNS O
SAV NNP O
, , O
two CD O
BioImplant NNP O
and CC O
one CD O
Valcor NNP O
) -RRB- O
with IN O
five CD O
human JJ O
aortic NN O
valves NNS O
before IN O
and CC O
after IN O
glutaraldehyde NN O
treatment NN O
is VBZ O
presented VBN O
. . O

-DOCSTART- X X O

No DT O
serious JJ O
side NN O
effects NNS O
were VBD O
observed VBN O
. . O

-DOCSTART- X X O

Specific NNP O
binding NN O
was VBD O
not RB O
observed VBN O
with IN O
either CC O
the DT O
orthologous JJ O
rat NN O
or CC O
mouse NN O
fragments NNS O
using VBG O
human JJ O
or CC O
rodent JJ O
extracts NNS O
. . O

-DOCSTART- X X O

Lack NN O
of IN O
cyclin NN B-NP
D-Cdk JJ I-NP
complexes NNS O
in IN O
Rb-negative JJ B-NP
cells NNS O
correlates VBZ O
with IN O
high JJ O
levels NNS O
of IN O
p16INK4/MTS1 DT B-NP
tumour NN O
suppressor NN O
gene NN O
product NN O
. . O

-DOCSTART- X X O

Recombinant JJ B-NP
human JJ I-NP
serum NN I-NP
albumin NN I-NP
( -LRB- O
rHSA NN B-NP
) -RRB- O
produced VBN O
by IN O
cultured JJ O
fermentation NN O
has VBZ O
been VBN O
prepared VBN O
in IN O
the DT O
form NN O
of IN O
microcapsules NNS O
nominally RB O
3-5 CD O
microns NNS O
in IN O
diameter NN O
and CC O
radiolabelled VBD O
with IN O
technetium-99m JJ O
following JJ O
reduction NN O
with IN O
stannous JJ O
chloride NN O
. . O

-DOCSTART- X X O

Such JJ O
an DT O
intervention NN O
may MD O
be VB O
of IN O
considerable JJ O
use NN O
for IN O
the DT O
treatment NN O
of IN O
angiogenesis-dependent JJ O
diseases NNS O
involving VBG O
FGF-2 NN B-NP
. . O

-DOCSTART- X X O

We PRP O
have VBP O
attempted VBN O
to TO O
clone VB O
two CD O
recessive JJ O
extragenic JJ O
suppressors NNS O
of IN O
such JJ O
ts NNS O
mutants NNS O
( -LRB- O
sdp1 NN B-NP
for IN O
mutation NN B-NP
pol3-14 NN I-NP
and CC O
sdp5-1 NN B-NP
for IN O
mutation NN B-NP
pol3-11 NN I-NP
) -RRB- O
by IN O
transforming VBG O
thermoresistant DT O
haploid JJ O
strains NNS O
pol3-14 NN B-NP
sdp1 NN I-NP
and CC O
pol3-11 NN B-NP
sdp5-1 NN I-NP
with IN O
wild-type JJ O
genomic JJ O
libraries NNS O
in IN O
singlecopy JJ O
or CC O
multicopy JJ O
vectors NNS O
. . O

-DOCSTART- X X O

UV NN O
cross-linking JJ O
experiments NNS O
show VBP O
that IN O
TEP NNP B-NP
has VBZ O
an DT O
apparent JJ O
molecular JJ O
mass NN O
of IN O
approximately RB O
65 CD O
kDa NN O
. . O

-DOCSTART- X X O

In IN O
acute-phase JJ O
livers NNS O
, , O
we PRP O
observed VBD O
a DT O
dramatic JJ O
reduction NN O
in IN O
HNF-3 JJ B-NP
alpha NN I-NP
expression NN O
which WDT O
correlates VBZ O
with IN O
a DT O
decrease NN O
in IN O
the DT O
expression NN O
of IN O
its PRP$ O
target NN O
gene NN O
, , O
the DT O
TTR NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

This DT O
mutant JJ O
was VBD O
identified VBN O
by IN O
screening VBG O
with IN O
a DT O
TGF-beta-inducible JJ B-NP
vector NN O
a DT O
series NN O
of IN O
mink NN O
lung NN O
epithelial NN O
cell NN O
clones NNS O
that WDT O
have VBP O
normal JJ O
TGF-beta JJ B-NP
binding NN O
activity NN O
but CC O
have VBP O
lost VBN O
antiproliferative JJ O
and CC O
transcriptional JJ O
responses NNS O
to TO O
TGF-beta NNP B-NP
. . O

-DOCSTART- X X O

By IN O
treating VBG O
monkey JJ O
COS NNS O
cells NNS O
with IN O
oligonucleotides NNS O
linked VBN O
to TO O
psoralen VB O
, , O
we PRP O
have VBP O
generated VBN O
targeted VBN O
mutations NNS O
in IN O
a DT O
simian JJ O
virus NN O
40 CD O
( -LRB- O
SV40 NN O
) -RRB- O
vector NN O
contained VBD O
within IN O
the DT O
cells NNS O
via IN O
intracellular JJ O
triple JJ O
helix NN O
formation NN O
. . O

-DOCSTART- X X O

The DT O
interleukin NN B-NP
2 CD I-NP
receptor NN I-NP
alpha-chain NN I-NP
( -LRB- O
IL-2R JJ B-NP
alpha NN I-NP
) -RRB- O
gene NN O
is VBZ O
rapidly RB O
and CC O
potently RB O
induced VBN O
in IN O
T NNP O
cells NNS O
in IN O
response NN O
to TO O
mitogenic JJ O
stimuli NNS O
. . O

-DOCSTART- X X O

OBJECTIVES NNS O
: : O
1 CD O
) -RRB- O
to TO O
determine VB O
serum JJ B-NP
ACE NNP I-NP
activity NN O
in IN O
patients NNS O
with IN O
COPD NNP O
treated VBD O
with IN O
and CC O
without IN O
continuous JJ O
ambulatory NN O
oxygen NN O
therapy NN O
( -LRB- O
CAOT NNP O
) -RRB- O
; : O
2 CD O
) -RRB- O
to TO O
verify VB O
whether IN O
there EX O
is VBZ O
a DT O
correlation NN O
between IN O
ACE NNP B-NP
and CC O
any DT O
hematological JJ O
, , O
spirometric JJ O
or CC O
gasometric JJ O
parameter NN O
. . O

-DOCSTART- X X O

In IN O
order NN O
to TO O
infer VB O
shape NN O
from IN O
contour NN O
, , O
the DT O
human JJ O
visual JJ O
system NN O
must MD O
selectively RB O
integrate VB O
fragments NNS O
projecting VBG O
from IN O
a DT O
common JJ O
object NN O
while IN O
keeping VBG O
fragments NNS O
from IN O
different JJ O
objects NNS O
separate VBP O
. . O

-DOCSTART- X X O

Constructs NNS O
designed VBN O
and CC O
expressed VBN O
were VBD O
E2L1(1-98 NNS B-NP
) -RRB- I-NP
, , O
E2L1.H1(1-128 DT B-NP
) -RRB- I-NP
, , O
E2L2( JJ B-NP
120-233 JJ I-NP
) -RRB- I-NP
, , O
E2H1.L2(98-233 JJ B-NP
) -RRB- I-NP
, , O
and CC O
E2L1.H1.L2(1-233 JJ B-NP
) -RRB- I-NP
, , O
where WRB O
numbers NNS O
in IN O
parentheses NNS O
give VBP O
the DT O
amino NN O
acid NN O
sequence NN O
for IN O
the DT O
portions NNS O
of IN O
the DT O
E2 NNP B-NP
component NN O
incorporated VBN O
into IN O
a DT O
construct VB O
. . O

-DOCSTART- X X O

Thus RB O
, , O
we PRP O
have VBP O
produced VBN O
lipoyl JJ O
domain NN O
constructs NNS O
that WDT O
can MD O
be VB O
employed VBN O
in IN O
sorting VBG O
the DT O
specific JJ O
roles NNS O
of IN O
E2L1 NNP B-NP
and CC O
E2L2 NNP B-NP
in IN O
facilitating VBG O
catalytic JJ O
and CC O
regulatory JJ O
processes NNS O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
Ten CD O
influenza NN O
A DT O
( -LRB- O
H3N2 NN O
) -RRB- O
viruses VBZ O
isolated VBN O
during IN O
the DT O
outbreaks NNS O
were VBD O
examined VBN O
for IN O
resistance NN O
to TO O
amantadine VB O
and CC O
rimantadine VB O
by IN O
means NNS O
of IN O
an DT O
enzyme NN O
immunoassay NN O
and CC O
by IN O
sequencing NN O
of IN O
the DT O
viral JJ O
nucleic JJ O
acid NN O
that IN O
encodes VBZ O
the DT O
transmembrane NN O
domain NN O
of IN O
the DT O
M2 JJ B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

The DT O
first JJ O
contains VBZ O
ATF/CRE NNP B-NP
and CC O
TBP/TATA NNP B-NP
sequence NN O
motifs NNS O
within IN O
an DT O
87-bp JJ O
region NN O
. . O

-DOCSTART- X X O

Gene NNP O
expression NN O
occurs VBZ O
in IN O
a DT O
circadian JJ O
rhythm NN O
and CC O
induced VBN O
by IN O
light NN O
in IN O
leaves NNS O
of IN O
dark-adapted JJ O
plants NNS O
. . O

-DOCSTART- X X O

The DT O
tissue-specific JJ O
expression NN O
of IN O
DP NNP B-NP
family NN I-NP
members NNS I-NP
suggests VBZ O
that IN O
the DT O
combination NN O
of IN O
DP/E2F NNP B-NP
heterodimers NNS O
that WDT O
constitute VBP O
DRTF1/E2F NN B-NP
is VBZ O
influenced VBN O
by IN O
the DT O
phenotype NN O
of IN O
the DT O
cell NN O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
recurrent JJ O
FSGS NNS O
has VBZ O
included VBN O
high-dose JJ O
steroids NNS O
, , O
high-dose JJ O
cyclosporine NN O
( -LRB- O
CSA NNP O
) -RRB- O
, , O
plasmapheresis NN O
, , O
and CC O
ACE NNP B-NP
inhibitors NNS O
with IN O
mixed JJ O
results NNS O
. . O

-DOCSTART- X X O

Promoter NNP O
region NN O
of IN O
the DT O
transcriptional JJ O
unit NN O
for IN O
human JJ B-NP
alpha NN I-NP
1-chimaerin JJ I-NP
, , O
a DT O
neuron-specific JJ B-NP
GTPase-activating JJ I-NP
protein NN I-NP
for IN O
p21rac. DT B-NP
alpha NN B-NP
1-chimaerin NNP I-NP
is VBZ O
a DT O
neuron-specific JJ B-NP
GTPase-activating JJ I-NP
protein NN I-NP
for IN O
p21rac NN B-NP
, , O
a DT O
protein NN O
involved VBN O
in IN O
morphological JJ O
events NNS O
. . O

-DOCSTART- X X O

Upstream NN O
from IN O
the DT O
transcription NN O
start NN O
point NN O
(tsp) NN O
, , O
a DT O
nucleotide JJ O
sequence NN O
highly RB O
homologous JJ O
to TO O
the DT O
consensus NN B-NP
sequence NN I-NP
motif NN I-NP
for IN I-NP
the DT I-NP
sigma NN I-NP
35-recognized JJ I-NP
promoters NNS I-NP
was VBD O
found VBN O
. . O

-DOCSTART- X X O

In IN O
this DT O
paper NN O
, , O
an DT O
analysis NN O
of IN O
the DT O
dynamics NNS O
in IN O
the DT O
closing NN O
phase NN O
of IN O
the DT O
occluder NN O
of IN O
a DT O
mechanical JJ O
monoleaflet NN O
heart NN O
valve NN O
prosthesis NN O
is VBZ O
presented VBN O
. . O

-DOCSTART- X X O

When WRB O
expressed VBN O
per IN O
kilogram NN O
body NN O
weight NN O
, , O
mean JJ O
GIT NNP O
increased VBD O
in IN O
the DT O
dF NN O
group NN O
from IN O
0.14 CD O
% NN O
to TO O
0.16 CD O
% NN O
above IN O
RMR NNP O
, , O
with IN O
a DT O
significant JJ O
decrease NN O
from IN O
0.15 CD O
% NN O
to TO O
0.13 CD O
% NN O
in IN O
the DT O
P NNP O
group NN O
. . O

-DOCSTART- X X O

However RB O
, , O
inclusion NN O
of IN O
the DT O
neighboring VBG O
CGGAAR NN O
motifs NNS O
from IN O
the DT O
ICP4 NNP B-NP
promoter NN I-NP
, , O
which WDT O
bind VBP O
factors NNS O
GABP JJ B-NP
alpha NN I-NP
and CC I-NP
beta NN I-NP
, , O
results NNS O
in IN O
a DT O
strong JJ O
synergistic JJ O
activation NN O
. . O

-DOCSTART- X X O

This DT O
finding NN O
represents VBZ O
both DT O
a DT O
potentially RB O
important JJ O
mechanism NN O
by IN O
which WDT O
HPV NNP O
gene NN O
expression NN O
can MD O
be VB O
regulated VBN O
and CC O
an DT O
interesting JJ O
model NN O
for IN O
the DT O
study NN O
of IN O
transcriptional JJ O
cooperativity NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
sequence NN O
upstream RB O
of IN O
this DT O
initiation NN O
codon NN O
reveals VBZ O
the DT O
presence NN O
of IN O
a DT O
promotor NN O
sequence NN O
. . O

-DOCSTART- X X O

SUP46 NNP B-NP
is VBZ O
implicated VBN O
in IN O
translation NN O
fidelity NN O
and CC O
encodes VBZ O
the DT O
ribosomal JJ B-NP
protein NN I-NP
S13 NN I-NP
. . O

-DOCSTART- X X O

To TO O
explore VB O
the DT O
functional JJ O
relationship NN O
between IN O
c-fos JJ B-NP
and CC O
Rb NNP B-NP
, , O
a DT O
eukaryotic JJ O
expression NN O
plasmid NN O
was VBD O
constructed VBN O
containing VBG O
the DT O
c-fos JJ B-NP
gene NN I-NP
under IN O
control NN O
of IN O
the DT O
SV40 JJ B-NP
promoter NN I-NP
complex NN O
. . O

-DOCSTART- X X O

The DT O
high JJ O
degree NN O
of IN O
sequence NN O
identity NN O
(96 NN O
% NN O
) -RRB- O
between IN O
hydrolase NN B-NP
B NNP I-NP
and CC I-NP
C NNP I-NP
, , O
particularly RB O
in IN O
the DT O
3' JJ O
untranslated JJ O
region NN O
, , O
suggests VBZ O
that IN O
the DT O
genes NNS O
encoding VBG O
these DT O
two CD O
carboxylesterases NNS B-NP
evolved VBN O
by IN O
duplication NN O
and CC O
divergence NN O
of IN O
a DT O
common JJ O
ancestral JJ O
gene NN O
. . O

-DOCSTART- X X O

Secondary JJ O
pancreatic JJ O
involvement NN O
of IN O
mycosis NN O
fungoides NNS O
detected VBN O
by IN O
a DT O
clinically RB O
palpable JJ O
mass NN O
. . O

-DOCSTART- X X O

The DT O
NR2 NNP O
hybrid NN O
is VBZ O
a DT O
powerful JJ O
tool NN O
for IN O
the DT O
mapping NN O
of IN O
new JJ O
probes NNS O
of IN O
this DT O
region NN O
, , O
as RB O
well RB O
as IN O
for IN O
obtaining VBG O
new JJ O
informative NN O
probes NNS O
specific JJ O
for IN O
the DT O
deletion NN O
by IN O
subtractive JJ O
cloning NN O
of IN O
the DT O
region NN O
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
report VBP O
the DT O
characterization NN O
of IN O
an DT O
alternatively RB O
processed VBN O
form NN O
of IN O
AFAP-110 JJ B-NP
that IN O
encodes VBZ O
an DT O
additional JJ O
258 CD O
base NN O
pair NN O
( -LRB- O
bp NN O
) -RRB- O
of IN O
open JJ O
reading NN O
frame NN O
. . O

-DOCSTART- X X O

In IN O
ICE NNP B-NP
gamma NN I-NP
, , O
most JJS O
of IN O
the DT O
propeptide NN O
(amino NN O
acids NNS O
20-112 JJ O
) -RRB- O
is VBZ O
deleted VBN O
, , O
which WDT O
suggests VBZ O
that IN O
it PRP O
may MD O
function VB O
as IN O
a DT O
catalyst NN O
for IN O
ICE NNP B-NP
autoprocessing NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

The DT O
p97-depleted JJ B-NP
nuclei NNS O
remained VBD O
largely RB O
competent JJ O
for IN O
nuclear JJ O
protein NN O
import NN O
. . O

-DOCSTART- X X O

A DT O
potential JJ O
outcome NN O
of IN O
these DT O
biochemical JJ O
effects NNS O
may MD O
include VB O
the DT O
limited JJ O
responsiveness NN O
of IN O
infected JJ O
T NNP O
cells NNS O
to TO O
antigenic JJ O
stimulation NN O
observed VBD O
during IN O
HIV-1 JJ O
infection NN O
. . O

-DOCSTART- X X O

The DT O
full JJ O
protocol NN O
was VBD O
completed VBN O
by IN O
33 CD O
patients NNS O
( -LRB- O
45 CD O
% NN O
of IN O
original JJ O
cohort NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
we PRP O
found VBD O
that IN O
cell-specific JJ O
suppression NN O
of IN O
RA-stimulated NNP O
zif268 CD B-NP
gene NN I-NP
expression NN O
can MD O
be VB O
attributed VBN O
to TO O
a DT O
29 CD O
base NN O
pair NN O
nucleotide JJ O
sequence NN O
, , O
located VBN O
downstream NN O
of IN O
the DT O
RA-responsive JJ O
region NN O
in IN O
the DT O
zif268 CD B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
major JJ O
PKC NNP B-NP
beta NN I-NP
transcription NN O
initiation NN O
site NN O
was VBD O
identified VBN O
by IN O
primer JJ O
extension NN O
and CC O
S1 NNP B-NP
nuclease VBP I-NP
protection NN O
. . O

-DOCSTART- X X O

Supplementary NNP O
Phase NNP O
Contraste NNP O
RSE NNP O
( -LRB- O
" `` O
Rapid NNP O
Sequential NNP O
Excitation NNP O
" '' O
) -RRB- O
sequences NNS O
were VBD O
carried VBN O
out RP O
in IN O
29 CD O
patients NNS O
. . O

-DOCSTART- X X O

In IN O
yeast NN O
, , O
the DT O
products NNS O
of IN O
the DT O
UPF1 NNP B-NP
and CC O
UPF3 NNP B-NP
genes NNS I-NP
are VBP O
required VBN O
for IN O
this DT O
decay NN O
pathway NN O
, , O
and CC O
in IN O
this DT O
report NN O
we PRP O
focus VBP O
on IN O
the DT O
identification NN O
and CC O
characterization NN O
of IN O
additional JJ O
factors NNS O
required VBD O
for IN O
rapid JJ O
decay NN O
of IN O
nonsense-containing JJ O
mRNAs NNS O
. . O

-DOCSTART- X X O

Mutations NNS O
in IN O
UPF1 DT B-NP
lead NN O
to TO O
the DT O
selective JJ O
stabilization NN O
of IN O
mRNAs NNS O
containing VBG O
early JJ O
nonsense NN O
mutations NNS O
without IN O
affecting VBG O
the DT O
decay NN O
rates NNS O
of IN O
most JJS O
other JJ O
mRNAs NNS O
. . O

-DOCSTART- X X O

A DT O
DNA NNP O
fragment NN O
encoding VBG O
the DT O
DNA-binding JJ O
domain NN O
(amino NN O
acids NNS O
1-60 JJ O
) -RRB- O
of IN O
the DT O
Escherichia NNP B-NP
coli NNS I-NP
fru NN I-NP
transcriptional JJ I-NP
regulator NN I-NP
was VBD O
cloned VBN O
into IN O
the DT O
pGEX-KT JJ O
vector NN O
and CC O
expressed VBD O
in IN O
frame NN O
with IN O
the DT O
fused VBN O
gene NN O
encoding VBG O
glutathione NN B-NP
S-transferase NN I-NP
. . O

-DOCSTART- X X O

Using VBG O
gel NNP O
retardation NN O
assays VBZ O
with IN O
HepG2 PRP O
nuclear JJ O
extract VB O
, , O
we PRP O
demonstrated VBD O
the DT O
presence NN O
of IN O
a DT O
specific JJ O
protein NN O
which WDT O
bound VBD O
to TO O
the DT O
NRE NNP O
fragment NN O
. . O

-DOCSTART- X X O

0.61 CD O
+/ NNS O
- : O
0.04 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Several JJ O
nuclear JJ O
factors NNS O
that WDT O
interact NN O
with IN O
sequences NNS O
in IN O
the DT O
5' JJ O
flanking JJ O
region NN O
of IN O
the DT O
mouse NN B-NP
tyrosinase NN I-NP
gene NN I-NP
were VBD O
identified VBN O
using VBG O
band NN O
shift NN O
and CC O
methylation NN O
interference NN O
assays VBZ O
. . O

-DOCSTART- X X O

Twenty-two CD O
consecutive JJ O
patients NNS O
with IN O
ischaemic JJ O
ulcers NNS O
had VBD O
tcPO2 DT O
measured VBN O
and CC O
the DT O
ankle/brachial JJ O
( -LRB- O
ABI NN O
) -RRB- O
and CC O
toe/brachial JJ O
( -LRB- O
TBI NN O
) -RRB- O
indices NNS O
calculated VBN O
. . O

-DOCSTART- X X O

Current JJ O
status NN O
of IN O
telepathology NN O
. . O

-DOCSTART- X X O

PMEK1 JJ B-NP
displays NNS O
96 CD O
and CC O
80 CD O
% NN O
identity NN O
respectively RB O
with IN O
the DT O
tobacco NN B-NP
NTF3 NN I-NP
and CC O
Arabidopsis NNP B-NP
ATMPK1 NNP I-NP
kinases NNS I-NP
, , O
and CC O
only RB O
50 CD O
% NN O
to TO O
the DT O
more JJR O
distantly RB O
related VBN O
plant NN O
MAP NNP O
kinase NN O
MsERK1 NNP B-NP
from IN O
alfalfa NN O
. . O

-DOCSTART- X X O

Translation NN O
of IN O
the DT O
coding NN O
segment NN O
, , O
which WDT O
was VBD O
designated VBN O
MsPRP2 NNP B-NP
, , O
suggested VBD O
it PRP O
encodes VBZ O
a DT O
chimeric JJ O
40,569 CD O
Da NNP O
cell NN O
wall NN O
protein NN O
with IN O
an DT O
amino-terminal JJ O
signal NN O
sequence NN O
, , O
a DT O
repetitive JJ O
proline-rich JJ O
sequence NN O
, , O
and CC O
a DT O
cysteine-rich JJ O
carboxyl-terminal JJ O
sequence NN O
homologous JJ O
to TO O
nonspecific JJ O
lipid JJ O
transfer NN O
proteins NNS O
. . O

-DOCSTART- X X O

This DT O
concept NN O
is VBZ O
supported VBN O
by IN O
the DT O
identification NN O
of IN O
RH-like JJ B-NP
genes NNS I-NP
in IN O
non JJ O
human JJ O
primates NNS O
. . O

-DOCSTART- X X O

With IN O
steady JJ O
illumination NN O
, , O
outer JJ O
retinal JJ O
( -LRB- O
photoreceptor NN O
) -RRB- O
QO2 CD O
decreased VBD O
to TO O
1.4 CD O
+/ CD O
- : O
0.9 CD O
ml NN O
O2/( IN O
100 CD O
g.min NN O
) -RRB- O
, , O
but CC O
inner JJ O
retinal JJ O
QO2 NN O
remained VBD O
unchanged JJ O
at IN O
3.7 CD O
+/ CD O
- : O
1.5 CD O
ml NN O
O2/( IN O
100 CD O
g.min NN O
) -RRB- O
( -LRB- O
5 CD O
cats NNS O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
catenins NNS B-NP
bind VBP O
to TO O
APC NNP B-NP
and CC O
E-cadherin NNP B-NP
in IN O
a DT O
similar JJ O
fashion NN O
, , O
but CC O
APC NNP B-NP
and CC O
E-cadherin NNP B-NP
do VBP O
not RB O
associate VB O
with IN O
each DT O
other JJ O
either CC O
in IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
catenins NNS B-NP
. . O

-DOCSTART- X X O

However RB O
, , O
addition NN O
of IN O
core NN B-NP
DNA NN I-NP
polymerase NN I-NP
III NNP I-NP
to TO O
preinitiation NN O
complex NN O
, , O
fully RB O
reconstituting VBG O
holoenzyme NN O
resulted VBD O
in IN O
replacement NN O
of IN O
gamma NN O
by IN O
alpha NN O
at IN O
the DT O
primer NN O
terminus NN O
. . O

-DOCSTART- X X O

The DT O
PSD2 NNP B-NP
gene NN I-NP
was VBD O
heterologously RB O
expressed VBN O
by IN O
infection NN O
of IN O
Sf-9 DT O
insect NN O
cells NNS O
with IN O
recombinant JJ O
baculovirus NN O
, , O
resulting VBG O
in IN O
a DT O
10-fold JJ O
increase NN O
in IN O
PSD NNP B-NP
activity NN O
. . O

-DOCSTART- X X O

Computerized VBN O
detection NN O
of IN O
abnormal JJ O
asymmetry NN O
in IN O
digital JJ O
chest NN O
radiographs NNS O
. . O

-DOCSTART- X X O

Like IN O
Epo NNP B-NP
, , O
HNF-4 NNP B-NP
is VBZ O
expressed VBN O
in IN O
kidney NN O
, , O
liver NN O
, , O
and CC O
Hep3B NNP O
cells NNS O
but CC O
not RB O
in IN O
HeLa NNP O
cells NNS O
. . O

-DOCSTART- X X O

These DT O
observations NNS O
indicate VBP O
that IN O
there EX O
are VBP O
multiple JJ O
mechanisms NNS O
by IN O
which WDT O
an DT O
individual JJ O
transcript NN O
can MD O
be VB O
degraded VBN O
following VBG O
deadenylation NN O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
here RB O
that IN O
the DT O
binding NN O
of IN O
C1F NNP B-NP
in IN O
vitro NN O
is VBZ O
sensitive JJ O
to TO O
the DT O
concentration NN O
of IN O
calcium NN O
ions NNS O
. . O

-DOCSTART- X X O

Survival NNP O
after IN O
development NN O
of IN O
symptomatic JJ O
infection NN O
(P-2 NN O
) -RRB- O
did VBD O
not RB O
differ VB O
by IN O
transmission NN O
mode NN O
. . O

-DOCSTART- X X O

The DT O
aim NN O
of IN O
this DT O
retrospective JJ O
study NN O
was VBD O
to TO O
demonstrate VB O
that IN O
in IN O
certain JJ O
cases NNS O
of IN O
expulsive JJ O
choroidal JJ O
hemorrhage NN O
(ECH) IN O
anatomical JJ O
success NN O
and CC O
useful JJ O
vision NN O
can MD O
be VB O
obtained VBN O
with IN O
repeated VBN O
vitreoretinal JJ O
surgery NN O
. . O

-DOCSTART- X X O

The DT O
function NN O
of IN O
the DT O
C-terminal JJ O
tail NN O
in IN O
telomere JJ O
maintenance NN O
is VBZ O
not RB O
mediated VBN O
through IN O
the DT O
RAP1 NNP B-NP
interacting NN I-NP
factor NN I-NP
RIF1 NNP B-NP
: : O
rap1 CD B-NP
alleles NNS I-NP
defective JJ O
in IN O
both DT O
the DT O
C-terminal JJ O
tail NN O
and CC O
RIF1 VB B-NP
interaction NN I-NP
domains NNS I-NP
have VBP O
additive JJ O
effects NNS O
on IN O
telomere JJ O
length NN O
. . O

-DOCSTART- X X O

The DT O
resulting JJ O
integrated JJ O
physical NN O
, , O
genetic JJ O
, , O
and CC O
cytogenetic JJ O
map NN O
constitutes VBZ O
a DT O
resource NN O
for IN O
the DT O
characterization NN O
of IN O
genes NNS O
that WDT O
may MD O
be VB O
involved VBN O
in IN O
the DT O
WAGR NNP O
syndrome NN O
. . O

-DOCSTART- X X O

The DT O
contribution NN O
of IN O
skin NN O
flow NN O
to TO O
the DT O
changes NNS O
in IN O
760-800 CD O
nm NN O
absorption NN O
was VBD O
investigated VBN O
by IN O
simultaneous JJ O
measurement NN O
of IN O
skin NN O
flow NN O
by IN O
laser NN O
flow NN O
Doppler NNP O
and CC O
NIR NNP O
recordings NNS O
during IN O
hot JJ O
water NN O
immersion NN O
. . O

-DOCSTART- X X O

Proteins NNS O
immunoprecipitated VBD O
from IN O
lysates NNS O
of IN O
control NN O
- : O
and CC O
VEGF-stimulated JJ B-NP
BAEC NNP O
with IN O
antisera NN O
to TO O
phospholipase NN B-NP
C-gamma NN I-NP
( -LRB- O
PLC-gamma NNP B-NP
) -RRB- O
were VBD O
fractionated VBN O
by IN O
SDS-polyacrylamide NNP O
gel NNP O
electrophoresis NN O
and CC O
transferred VBD O
to TO O
Immobilon-P. NNP O

-DOCSTART- X X O

Involvement NN O
of IN O
early JJ B-NP
growth NN I-NP
response NN I-NP
factor NN I-NP
Egr-1 NN I-NP
in IN O
apolipoprotein NN B-NP
AI NNP I-NP
gene NN I-NP
transcription NN O
. . O

-DOCSTART- X X O

Three CD O
classes NNS O
of IN O
test NN O
objects NNS O
were VBD O
considered VBN O
: : O
( -LRB- O
1 CD O
) -RRB- O
a DT O
multicompartment NN O
test NN O
object NN O
for IN O
31P DT O
MRS NNP O
measurements NNS O
performed VBN O
with IN O
slice-selective JJ O
sequences NNS O
; : O
( -LRB- O
2 CD O
) -RRB- O
a DT O
two-compartment JJ O
test NN O
object NN O
for IN O
volume-selection NN O
1H IN O
MRS NNP O
; : O
and CC O
( -LRB- O
3 LS O
) -RRB- O
two-compartment JJ O
test NN O
objects VBZ O
for IN O
assessing VBG O
the DT O
performance NN O
of IN O
experimental JJ O
systems NNS O
using VBG O
ISIS NNP O
as IN O
volume NN O
localization NN O
sequence NN O
in IN O
31P NNP O
MRS. . O

-DOCSTART- X X O

Pregnancy NNP O
screening NN O
by IN O
uterine JJ O
artery NN O
Doppler NNP O
velocimetry--which , O
criterion NN O
performs NNS O
best RB O
? . O
OBJECTIVE JJ O
: : O
To TO O
test VB O
whether IN O
repeating VBG O
Doppler NNP O
studies NNS O
of IN O
the DT O
uteroplacental JJ O
circulation NN O
late RB O
in IN O
gestation NN O
will MD O
improve VB O
the DT O
test NN O
's POS O
power NN O
for IN O
predicting VBG O
pregnancy-induced JJ O
hypertension NN O
and CC O
fetal NN O
growth NN O
restriction NN O
( -LRB- O
FGR NN O
) -RRB- O
, , O
and CC O
whether IN O
analysis NN O
based VBN O
on IN O
a DT O
combination NN O
of IN O
quantitative JJ O
and CC O
qualitative JJ O
assessments NNS O
of IN O
the DT O
uterine NN O
arterial NN O
waveforms NNS O
will MD O
yield VB O
better JJR O
results NNS O
than IN O
analysis NN O
based VBN O
on IN O
either DT O
alone RB O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
the DT O
Ca JJ O
entry NN O
blocker NN O
nitrendipine NN O
, , O
the DT O
antioxidant JJ O
superoxide NN B-NP
dismutase NN I-NP
( -LRB- O
SOD NNP B-NP
) -RRB- O
, , O
and CC O
a DT O
combination NN O
of IN O
nitrendipine NN O
and CC O
superoxide NN B-NP
dismutase NN I-NP
on IN O
postischemic JJ O
renal JJ O
function NN O
was VBD O
studied VBN O
in IN O
four CD O
groups NNS O
( -LRB- O
n RB O
= SYM O
24 CD O
) -RRB- O
of IN O
rats NNS O
. . O

-DOCSTART- X X O

PURPOSE NNP O
: : O
The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
evaluate VB O
the DT O
bony JJ O
anchorage NN O
of IN O
a DT O
new JJ O
implant NN O
(orderly RB O
wired VBN O
surface NN O
effect NN O
with IN O
alloy DT O
Ti NNP O
Al NNP O
Va NNP O
and CC O
ordered VBD O
pores NNS O
of IN O
488 CD O
mu NN O
) -RRB- O
. . O

-DOCSTART- X X O

To TO O
determine VB O
whether IN O
food NN O
and/or CC O
water NN O
in IN O
the DT O
gastrointestinal JJ O
tract NN O
affects VBZ O
restitution NN O
of IN O
blood NN O
volume NN O
and CC O
plasma NN O
protein NN O
after IN O
hemorrhage NN O
, , O
fed VBN O
and CC O
24-h-fasted JJ O
awake JJ O
rats NNS O
received VBD O
a DT O
20 CD O
ml.kg-1 NN O
x NN O
3 CD O
min-1 NN O
hemorrhage NN O
, , O
and CC O
restitution NN O
of IN O
blood NN O
volume NN O
was VBD O
measured VBN O
by IN O
Evans NNP O
blue JJ O
dye NN O
and CC O
dilution NN O
of IN O
hematocrit NN O
. . O

-DOCSTART- X X O

We PRP O
took VBD O
advantage NN O
of IN O
the DT O
high JJ O
degree NN O
of IN O
aa JJ O
sequence NN O
homology NN O
between IN O
DAHPSs NNP B-NP
from IN O
several JJ O
species NNS O
to TO O
isolate VB O
ARO3 DT B-NP
homologues NNS I-NP
from IN O
the DT O
pathogenic JJ O
yeast NN O
Candida NNP O
albicans NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
demonstrate VBP O
that IN O
BOX NNP O
DNA NNP O
enhances VBZ O
transcription NN O
from IN O
the DT O
thymidine NN B-NP
kinase NN I-NP
( -LRB- O
TK) NNP B-NP
promoter NN O
in IN O
various JJ O
EC NNP O
cells NNS O
. . O

-DOCSTART- X X O

Deletion NNP O
analyses NNS O
of IN O
the DT O
construct VB O
revealed VBD O
that IN O
the DT O
transcription NN O
of IN O
BOXF1 NNP B-NP
gene NN I-NP
is VBZ O
regulated VBN O
by IN O
BOX NNP O
DNA NNP O
, , O
preferentially RB O
in IN O
undifferentiated JJ O
EC NNP O
cells NNS O
versus IN O
differentiated JJ O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
an DT O
unusual JJ O
transcript NN O
possessing JJ O
IVS2C NNP B-NP
beta NN I-NP
1 CD I-NP
at IN O
the DT O
5' JJ O
terminus NN O
suggests VBZ O
that IN O
cleavage NN O
of IN O
its PRP$ O
splice NN O
acceptor NN O
is VBZ O
inefficient JJ O
or CC O
negatively RB O
regulated VBN O
. . O

-DOCSTART- X X O

During IN O
chronic NN O
treatment NN O
, , O
when WRB O
plasma NN O
concentrations NNS O
fluctuated VBD O
between IN O
23.5 CD O
ng NN O
.ml-1 NN O
at IN O
8 CD O
h NN O
and CC O
14 CD O
ng JJ O
.ml-1 NN O
at IN O
24 CD O
h NN O
post-dosing NN O
, , O
ST NNP O
segment NN O
depression NN O
at IN O
an DT O
individually RB O
comparable JJ O
workload NN O
was VBD O
significantly RB O
decreased VBN O
by IN O
28 CD O
% NN O
compared VBN O
with IN O
placebo NN O
( -LRB- O
P NNP O
< NN O
0.005 CD O
) -RRB- O
at IN O
both DT O
points NNS O
in IN O
time NN O
. . O

-DOCSTART- X X O

Evoked DT O
electromyographic JJ O
response NN O
to TO O
indirect JJ O
supramaximal JJ O
stimulation NN O
at IN O
1 CD O
Hz NN O
was VBD O
monitored VBN O
in IN O
ten CD O
adult NN O
goats NNS O
under IN O
thiopentone-halothane NN O
anaesthesia NN O
. . O

-DOCSTART- X X O

313 CD O
, , O
98-102 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Group NNP O
6 CD O
was VBD O
given VBN O
physostigmine NN O
, , O
0.1 CD O
mg/kg NN O
i IN O
.v. NNP O
, , O
known VBN O
to TO O
inhibit VB O
cholinesterase NN B-NP
degradation NN O
, , O
5 CD O
min NN O
before IN O
bupivacaine JJ O
administration NN O
, , O
and CC O
Group NNP O
7 CD O
received VBD O
a DT O
combination NN O
of IN O
physostigmine NN O
pretreatment NN O
and CC O
electrical JJ O
vagal NN O
stimulation NN O
. . O

-DOCSTART- X X O

To TO O
examine VB O
the DT O
possibility NN O
that IN O
LNNB NNP O
performance NN O
of IN O
the DT O
schizophrenic JJ O
groups NNS O
may MD O
have VB O
been VBN O
related VBN O
to TO O
neuroleptic JJ O
medication NN O
, , O
analyses NNS O
were VBD O
completed VBN O
on IN O
the DT O
relationship NN O
between IN O
medication NN O
levels NNS O
and CC O
LNNB NNP O
scores NNS O
. . O

-DOCSTART- X X O

ISIS NNP O
5 CD O
possibilities NNS O
. . O

-DOCSTART- X X O

At IN O
the DT O
MTD NNP O
( -LRB- O
8 CD O
mg/m2/day NN O
) -RRB- O
, , O
the DT O
dose-limiting JJ O
toxicity NN O
of IN O
this DT O
agent NN O
is VBZ O
myelosuppression NN O
. . O

-DOCSTART- X X O

Mitogen-induced JJ O
lymphocyte NN O
proliferation NN O
was VBD O
diminished VBN O
. . O

-DOCSTART- X X O

Some DT O
of IN O
these DT O
targets NNS O
were VBD O
reported VBN O
to TO O
code NN O
for IN O
molecules NNS O
involved VBN O
in IN O
cell-cell NN O
interactions NNS O
, , O
whereas IN O
no DT O
relationship NN O
has VBZ O
yet RB O
been VBN O
demonstrated VBN O
between IN O
Hox NNP B-NP
genes NNS I-NP
and CC O
other JJ O
transcription NN O
factors NNS O
involved VBN O
in IN O
determining VBG O
and/or IN O
maintaining VBG O
tissue NN O
specificity NN O
. . O

-DOCSTART- X X O

HER2 PRP B-NP
overexpressing VBG O
cells NNS O
showed VBD O
a DT O
single JJ O
prominent JJ O
DNase NN B-NP
I PRP I-NP
hypersensitive VBD O
site NN O
near IN O
a DT O
conserved VBN O
and CC O
hitherto VBN O
unrecognized JJ O
ets NNS B-NP
response NN O
element NN O
( -LRB- O
GAGGAA NNP O
) -RRB- O
, , O
located VBN O
38 CD O
bases NNS O
down-stream RB O
from IN O
the DT O
CAAT NN O
box NN O
and CC O
directly RB O
5' CD O
of IN O
the DT O
TATA NNP O
box NN O
in IN O
the DT O
human JJ B-NP
HER2 NNP I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Gel-shift JJ O
assays IN O
with IN O
nuclear JJ O
extracts NNS O
and CC O
oligonucleotide JJ O
sequences NNS O
spanning VBG O
the DT O
0.125-kb JJ O
promoter NN O
region NN O
detected VBD O
an DT O
ETS-immunoreactive JJ B-NP
complex NN O
, , O
present JJ O
most JJS O
abundantly RB O
in IN O
cells NNS O
overexpressing VBG O
HER2 NNP B-NP
, , O
whose WP$ O
high-affinity JJ O
binding NN O
depended VBD O
on IN O
the DT O
GAGGAA NNP O
response NN O
element NN O
. . O

-DOCSTART- X X O

The DT O
gene NN O
for IN O
the DT O
RNA-dependent JJ B-NP
eIF-2 NN I-NP
alpha NN I-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
PKR NN B-NP
) -RRB- O
was VBD O
isolated VBN O
from IN O
mouse NN O
genomic JJ O
DNA NN O
and CC O
characterized VBD O
. . O

-DOCSTART- X X O

Similar JJ O
to TO O
the DT O
mouse NN O
gene NN O
, , O
the DT O
5' JJ O
flanking JJ O
region NN O
of IN O
human JJ B-NP
CD79 NNP I-NP
alpha NN I-NP
lacks VBZ O
a DT O
TATA NNP O
box NN O
; : O
however RB O
, , O
unlike IN O
mouse NN B-NP
CD79 IN I-NP
alpha NN I-NP
, , O
a DT O
classical JJ O
octamer NN O
motif NN O
could MD O
not RB O
be VB O
identified VBN O
in IN O
the DT O
human JJ O
gene NN O
. . O

-DOCSTART- X X O

Detailed VBN O
molecular JJ O
organization NN O
of IN O
the DT O
coding NN O
and CC O
upstream RB O
regulatory JJ O
regions NNS O
of IN O
the DT O
murine NN O
homeodomain-containing NN B-NP
gene NN I-NP
, , O
Msx-1 NNP B-NP
, , O
is VBZ O
reported VBN O
. . O

-DOCSTART- X X O

In IN O
order NN O
to TO O
define VB O
potential JJ O
candidate NN O
genes NNS O
for IN O
inherited VBN O
disorders NNS O
characterized VBN O
by IN O
aberrant JJ O
gene NN O
expression NN O
, , O
we PRP O
utilized VBD O
Kruppel-related JJ B-NP
sequences NNS I-NP
to TO O
isolate VB O
zinc NN O
finger-containing NN O
cDNAs NNS O
. . O

-DOCSTART- X X O

The DT O
ratio NN O
of IN O
the DT O
activity NN O
of IN O
arogenate JJ B-NP
dehydrogenase NN I-NP
to TO O
that DT O
of IN O
prephenate JJ B-NP
dehydrogenase NN I-NP
( -LRB- O
approximately RB O
3:1 JJ O
) -RRB- O
remained VBD O
constant JJ O
throughout IN O
purification NN O
, , O
and CC O
the DT O
two CD O
activities NNS O
were VBD O
therefore RB O
inseparable JJ O
. . O

-DOCSTART- X X O

The DT O
Y NNP O
. . O
lipolytica NNS O
genomic JJ O
POT1 NNP B-NP
gene NN O
was VBD O
disrupted VBN O
by IN O
replacing VBG O
120 CD O
bp NN O
of IN O
its PRP$ O
coding NN O
sequence NN O
with IN O
2.7 CD O
kbp NN O
of IN O
DNA NNP O
including VBG O
the DT O
Y NNP O
. . O
lipolytica VBD O
LEU2 NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
concluded VBN O
that IN O
CT NNP O
should MD O
be VB O
routinely RB O
employed VBN O
in IN O
patients NNS O
with IN O
N1-N3 JJ O
neck NN O
disease NN O
to TO O
determine VB O
the DT O
proper JJ O
electron-energy NN O
prescription NN O
. . O

-DOCSTART- X X O

The DT O
novel NN O
Notch NNP B-NP
homologue NN I-NP
mouse NN B-NP
Notch NN I-NP
3 CD I-NP
lacks VBZ O
specific JJ O
epidermal JJ B-NP
growth NN I-NP
factor-repeats NNS I-NP
and CC O
is VBZ O
expressed VBN O
in IN O
proliferating VBG O
neuroepithelium NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
presence NN O
of IN O
the DT O
in IN O
vivo JJ O
reducing VBG O
system NN O
( -LRB- O
thioredoxin NN B-NP
, , O
thioredoxin NN B-NP
reductase NN I-NP
, , O
and CC O
NADPH) NNP O
, , O
however RB O
, , O
each DT O
of IN O
these DT O
mutants NNS O
catalyzed VBD O
the DT O
formation NN O
of IN O
only RB O
0.6-0.8 CD O
dCTPs NNS O
per IN O
mole NN O
of IN O
enzyme NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
both CC O
the DT O
exon NN O
1- . O
and CC O
exon JJ O
2-initiated JJ O
forms NNS O
of IN O
the DT O
c-Myc JJ B-NP
protein NN I-NP
stimulated VBD O
transcription NN O
of IN O
a DT O
Myc/Max-responsive JJ B-NP
reporter NN O
construct VB O
to TO O
a DT O
similar JJ O
level NN O
. . O

-DOCSTART- X X O

Expression NNP O
is VBZ O
exclusively RB O
limited VBN O
to TO O
the DT O
CNS NNS O
at IN O
this DT O
and CC O
later JJ O
stages NNS O
. . O

-DOCSTART- X X O

Disruption NN O
of IN O
any DT O
one CD O
of IN O
the DT O
four CD O
genes NNS O
encoding VBG O
the DT O
newly RB O
identified VBN O
SRP NNP B-NP
proteins VBZ I-NP
results NNS O
in IN O
slow JJ O
cell NN O
growth NN O
and CC O
inefficient JJ O
protein NN O
translocation NN O
across IN O
the DT O
ER NNP O
membrane NN O
. . O

-DOCSTART- X X O

Genetic JJ O
alterations NNS O
in IN O
elements NNS O
of IN O
normal JJ O
signal NN O
transduction NN O
mechanisms NNS O
are VBP O
known VBN O
to TO O
be VB O
oncogenic JJ O
events NNS O
often RB O
resulting VBG O
in IN O
aberrant JJ O
activation NN O
of IN O
programs NNS O
of IN O
gene NN O
transcription NN O
. . O

-DOCSTART- X X O

The DT O
expression NN O
pattern NN O
of IN O
GL2 NNP B-NP
, , O
as IN O
demonstrated VBN O
by IN O
in IN O
situ FW O
hybridization NN O
, , O
indicated VBD O
that IN O
the DT O
gene NN O
is VBZ O
expressed VBN O
in IN O
trichome NN O
progenitor NN O
cells NNS O
and CC O
at IN O
stages NNS O
associated VBN O
with IN O
trichome NN O
development NN O
. . O

-DOCSTART- X X O

Binding JJ O
site NN O
selection NN O
using VBG O
in IN O
vitro-synthesized JJ O
proteins NNS O
reveals VBZ O
that IN O
the DT O
ROR NNP B-NP
alpha NN I-NP
1 CD I-NP
and CC O
ROR NNP B-NP
alpha NN I-NP
2 CD I-NP
isoforms VBZ I-NP
bind NN O
DNA NN O
as IN O
monomers NNS O
to TO O
hormone NN O
response NN O
elements NNS O
composed VBN O
of IN O
a DT O
6-bp JJ O
AT-rich JJ O
sequence NN O
preceding VBG O
a DT O
half-site JJ O
core NN O
motif NN O
PuGGTCA NNP O
( -LRB- O
RORE NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
p73pct1/p85cdc10 VBZ B-NP
complex JJ O
binds NNS O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo JJ O
to TO O
MCB NNP B-NP
but CC O
not RB O
SCB NNP B-NP
or CC O
E2F NNP B-NP
sites NNS I-NP
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
the DT O
en FW B-NP
stripes NNS O
expand VBP O
anteriorly RB O
in IN O
slp NN B-NP
mutant JJ O
embryos NNS O
and CC O
that DT O
slp NN B-NP
activity NN O
is VBZ O
an DT O
absolute JJ O
requirement NN O
for IN O
maintenance NN O
of IN O
wg JJ B-NP
expression NN O
at IN O
the DT O
same JJ O
time NN O
that IN O
wg JJ B-NP
transcription NN O
is VBZ O
dependent JJ O
on IN O
hh NN B-NP
. . O

-DOCSTART- X X O

CMV NNP O
hyperimmunoglobulin NN B-NP
treatment NN O
( -LRB- O
Cytotect NNP O
, , O
Biotest NN O
) -RRB- O
was VBD O
started VBN O
( -LRB- O
2 CD O
ml/kg NN O
bw NN O
on IN O
day NN O
1 CD O
and CC O
3 CD O
, , O
and CC O
1 CD O
ml/kg NN O
on IN O
days NNS O
5 CD O
, , O
7 CD O
and CC O
9 CD O
) -RRB- O
, , O
which WDT O
led VBD O
to TO O
the DT O
eradication NN O
of IN O
the DT O
residual JJ O
infiltrate NN O
and CC O
CMV-DNA NNP O
in IN O
the DT O
myocardium NN O
. . O

-DOCSTART- X X O

ORF NN O
2 CD O
potentially RB O
encoded VBN O
a DT O
hydrophobic JJ O
protein NN O
of IN O
29 CD O
,705 CD O
Da NNP O
with IN O
six CD O
potential JJ O
membrane-spanning NN O
regions NNS O
. . O

-DOCSTART- X X O

DNA NNP O
sequence NN O
analysis NN O
showed VBD O
that IN O
the DT O
gene NN O
was VBD O
525 CD O
bp NN O
long RB O
and CC O
encoded VBD O
a DT O
175-amino-acid JJ O
protein NN O
with IN O
a DT O
molecular JJ O
weight NN O
of IN O
19,094 CD O
containing VBG O
a DT O
21-residue JJ O
typical JJ O
lipoprotein NN O
signal NN O
peptide NN O
and CC O
consensus NN O
prolipoprotein NN O
processing VBG O
site NN O
. . O

-DOCSTART- X X O

DNA NNP O
sequence NN O
and CC O
functions NNS O
of IN O
the DT O
actVI JJ B-NP
region NN I-NP
of IN O
the DT O
actinorhodin NN B-NP
biosynthetic JJ I-NP
gene NN I-NP
cluster NN I-NP
of IN I-NP
Streptomyces NNP I-NP
coelicolor NN I-NP
A3( JJ I-NP
2 CD I-NP
) -RRB- I-NP
. . O

-DOCSTART- X X O

( -LRB- O
1992 CD O
) -RRB- O
Genomics NNPS O
12 CD O
, , O
58-62 CD O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
comparison NN O
of IN O
the DT O
predicted VBN O
polypeptide NN O
sequence NN O
of IN O
the DT O
Drosophila NNP O
protein NN O
with IN O
the DT O
equivalent JJ O
subunits NNS O
from IN O
mouse NN O
and CC O
yeast NN O
suggests VBZ O
that IN O
they PRP O
are VBP O
closely RB O
related VBN O
and CC O
defines VBZ O
three CD O
conserved JJ O
regions NNS O
which WDT O
are VBP O
likely JJ O
to TO O
be VB O
important JJ O
for IN O
enzyme JJ O
activity NN O
. . O

-DOCSTART- X X O

Plasmids NNS O
were VBD O
constructed VBN O
with IN O
the DT O
mouse NN O
promoter NN O
region NN O
linked VBN O
to TO O
the DT O
reporter NN B-NP
gene NN I-NP
chloramphenicol NN I-NP
acetyltransferase NN I-NP
( -LRB- O
CAT NN B-NP
) -RRB- O
, , O
and CC O
transiently RB O
and CC O
stably RB O
transfected VBN O
in IN O
the DT O
INS-1 JJ O
cells NNS O
. . O

-DOCSTART- X X O

Cytoplasmic JJ B-NP
dynein NN I-NP
is VBZ O
a DT O
multisubunit NN O
, , O
microtubule-dependent JJ O
mechanochemical JJ O
enzyme NN O
that WDT O
has VBZ O
been VBN O
proposed VBN O
to TO O
function NN O
in IN O
a DT O
variety NN O
of IN O
intracellular JJ O
movements NNS O
, , O
including VBG O
minus-end-directed JJ O
transport NN O
of IN O
organelles NNS O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
the DT O
plakoglobin-binding JJ B-NP
domain NN O
in IN O
desmoglein NN B-NP
and CC O
its PRP$ O
role NN O
in IN O
plaque NN O
assembly NN O
and CC O
intermediate JJ O
filament NN O
anchorage NN O
. . O

-DOCSTART- X X O

Specifically RB O
, , O
this DT O
study NN O
determined VBD O
the DT O
influence NN O
of IN O
: : O
( -LRB- O
1 CD O
) -RRB- O
an DT O
awareness NN O
strategy NN O
, , O
( -LRB- O
2 CD O
) -RRB- O
a DT O
non-awareness NN O
strategy NN O
, , O
( -LRB- O
3 CD O
) -RRB- O
a DT O
Five-Step NNP O
Approach NNP O
strategy NN O
and CC O
( -LRB- O
4 CD O
) -RRB- O
a DT O
control NN O
condition NN O
. . O

-DOCSTART- X X O

As IN O
shown VBN O
previously RB O
, , O
EBNA2 NNP B-NP
transactivates VBZ O
the DT O
promoters NNS O
of IN O
the DT O
viral JJ B-NP
latent JJ I-NP
membrane NN I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

A DT O
simple JJ O
registration NN O
as IN O
an DT O
incentive NN O
for IN O
improvement NN O

-DOCSTART- X X O

The DT O
transverse NN O
magnetization NN O
decays NNS O
mentioned VBN O
above IN O
exhibited JJ O
two CD O
components NNS O
, , O
a DT O
T2 NN O
fast RB O
( -LRB- O
T2f NN O
) -RRB- O
and CC O
a DT O
T2 NN O
slow JJ O
( -LRB- O
T2s NN O
) -RRB- O
component NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
The DT O
diagnostic JJ O
quality NN O
of IN O
FDG NNP O
images NNS O
was VBD O
at IN O
least JJS O
as RB O
good JJ O
as IN O
that DT O
of IN O
their PRP$ O
Tl-201 JJ O
counterparts NNS O
, , O
with IN O
less JJR O
liver NN O
background NN O
in IN O
all DT O
but CC O
one CD O
FDG JJ O
study NN O
. . O

-DOCSTART- X X O

The DT O
coordinated JJ O
expression NN O
of IN O
CD4 NNP B-NP
and CC O
CD8 VB B-NP
during IN O
T-cell DT O
development NN O
is VBZ O
tightly RB O
coupled VBN O
with IN O
the DT O
maturation NN O
state NN O
of IN O
the DT O
T NNP O
cell NN O
. . O

-DOCSTART- X X O

The DT O
dying VBG O
tTG-transfected JJ B-NP
cells NNS O
exhibit VBP O
both DT O
cytoplasmic JJ O
and CC O
nuclear JJ O
changes NNS O
characteristic JJ O
of IN O
cells NNS O
undergoing VBG O
apoptosis NN O
. . O

-DOCSTART- X X O

The DT O
protein NN O
encoded VBN O
is VBZ O
114 CD O
kDa NN O
and CC O
contains VBZ O
eight CD O
zinc NN O
finger NN O
motifs NNS O
, , O
seven CD O
of IN O
which WDT O
are VBP O
present JJ O
in IN O
two CD O
clusters NNS O
at IN O
opposite JJ O
ends NNS O
of IN O
the DT O
molecule NN O
. . O

-DOCSTART- X X O

Tissue-specific JJ O
expression NN O
of IN O
the DT O
diazepam-binding JJ B-NP
inhibitor NN I-NP
in IN O
Drosophila NNP O
melanogaster NN O
: : O
cloning NN O
, , O
structure NN O
, , O
and CC O
localization NN O
of IN O
the DT O
gene NN O
. . O

-DOCSTART- X X O

Using VBG O
a DT O
v-erbA NN B-NP
probe NN O
, , O
we PRP O
obtained VBD O
a DT O
cDNA NN O
which WDT O
encodes VBZ O
a DT O
novel NN O
445-amino-acid JJ O
protein NN O
, , O
RLD-1 NN B-NP
, , O
that WDT O
contains VBZ O
the DT O
characteristic JJ O
domains NNS O
of IN O
nuclear JJ O
receptors NNS O
. . O

-DOCSTART- X X O

Only RB O
two CD O
of IN O
the DT O
isoforms NNS O
possess VBP O
the DT O
N-terminal JJ O
zinc NN O
finger NN O
domain NN O
that WDT O
is VBZ O
necessary JJ O
and CC O
sufficient JJ O
for IN O
TdT NNP B-NP
promoter NN I-NP
binding NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
provides VBZ O
direct JJ O
evidence NN O
that IN O
USF NNP B-NP
, , O
a DT O
member NN O
of IN O
the DT O
basic JJ B-NP
helix-loop-helix NN I-NP
leucine NN I-NP
zipper NN I-NP
family NN I-NP
, , O
binds NNS O
to TO O
MLE1 NNP B-NP
, , O
HF-1a NNP B-NP
, , O
and CC O
PRE JJ B-NP
B NNP I-NP
sites NNS I-NP
and CC O
suggests VBZ O
that IN O
it PRP O
is VBZ O
a DT O
component NN O
of IN O
protein NN O
complexes NNS O
that WDT O
may MD O
coordinately RB O
control VB O
the DT O
expression NN O
of IN O
MLC-2v NNP B-NP
and CC O
alpha-myosin DT B-NP
heavy-chain JJ I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

Human JJ O
T-cell NN O
leukemia NN O
virus NN O
type NN O
I PRP O
Tax NNP B-NP
activation NN O
of IN O
NF-kappa NNP B-NP
B/Rel NNP I-NP
involves VBZ O
phosphorylation NN O
and CC O
degradation NN O
of IN O
I PRP B-NP
kappa VBD I-NP
B NNP I-NP
alpha NN I-NP
and CC O
RelA NNP B-NP
( -LRB- I-NP
p65)-mediated JJ I-NP
induction NN O
of IN O
the DT O
c-rel JJ B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Because IN O
endogenous JJ O
HSF NNP B-NP
DNA-binding NN O
activity NN O
is VBZ O
low JJ O
and CC O
anti-hHSF1 JJ B-NP
antibody NN I-NP
does VBZ O
not RB O
recognize VB O
Xenopus NNP B-NP
HSF NNP I-NP
, , O
we PRP O
employed VBD O
this DT O
system NN O
for IN O
mapping NN O
regions NNS O
in IN O
hHSF1 NN B-NP
that WDT O
are VBP O
required VBN O
for IN O
the DT O
maintenance NN O
of IN O
the DT O
monomeric JJ O
state NN O
. . O

-DOCSTART- X X O

Enhancers NNS O
containing VBG O
disrupted VBN O
Ets-1 JJ B-NP
binding NN I-NP
sites NNS I-NP
were VBD O
tested VBN O
in IN O
transient JJ O
expression NN O
assays VBZ O
in IN O
the DT O
murine NN O
T-cell NN O
line NN O
EL4.E1 NNP O
; : O
alterations NNS O
in IN O
the DT O
LVb JJ O
element NN O
affected VBD O
constitutive JJ O
enhancer NN O
activity NN O
, , O
while IN O
mutation NN O
of IN O
either CC O
the DT O
LVb NNP O
or CC O
LVc NNP O
element NN O
disrupted VBD O
phorbol NN O
ester-induced JJ O
enhancer NN O
activity NN O
. . O

-DOCSTART- X X O

These DT O
RZR NNP B-NP
subtypes NNS O
represent VBP O
members NNS O
of IN O
a DT O
new JJ O
family NN O
of IN O
orphan JJ B-NP
nuclear JJ I-NP
receptors NNS I-NP
that WDT O
most RBS O
likely JJ O
regulate VB O
specific JJ O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
these DT O
response NN O
elements NNS O
display VBP O
dramatically RB O
reduced VBN O
affinity NN O
for IN O
retinoic JJ B-NP
acid NN I-NP
receptor-retinoid-X NN I-NP
receptor NN B-NP
heterodimers NNS O
. . O

-DOCSTART- X X O

The DT O
unexpected JJ O
presence NN O
of IN O
the DT O
tRNA(trp)(CCA)-gene NN B-NP
transcript NN I-NP
in IN I-NP
mitochondria NN I-NP
is VBZ O
also RB O
reported VBN O
. . O

-DOCSTART- X X O

The DT O
parameters NNS O
of IN O
nonspecific JJ O
humoral JJ O
immunity--serum JJ O
immunoglobulins NNS B-NP
and CC O
immune JJ O
complexes--were JJ O
evaluated VBN O
in IN O
irradiated JJ O
group NN O
of IN O
patients NNS O
with IN O
uterine JJ O
cervix NN O
carcinoma NN O
( -LRB- O
Stages NNP O
IIB NNP O
and CC O
IIIB NNP O
) -RRB- O
, , O
during IN O
one CD O
year NN O
follow VBP O
up RP O
. . O

-DOCSTART- X X O

Mutation NN O
of IN O
KRKR NNP O
to TO O
NGER NNP O
retains VBZ O
MO15 CD B-NP
in IN O
the DT O
cytoplasmic JJ O
compartment NN O
, , O
whilst IN O
the DT O
wild-type JJ O
protein NN O
is VBZ O
detected VBN O
exclusively RB O
in IN O
the DT O
nucleus NN O
. . O

-DOCSTART- X X O

Strikingly RB O
, , O
this DT O
subdomain NN O
is VBZ O
also RB O
present JJ O
in IN O
the DT O
otherwise RB O
unrelated JJ O
N-terminal JJ O
activating JJ O
region NN O
of IN O
p58c-ets-2 NN B-NP
and CC O
was VBD O
thus RB O
named VBN O
BEC NNP B-NP
for IN O
Ets-1-beta/Ets-2-Conserved JJ B-NP
sequence NN B-NP
. . O

-DOCSTART- X X O

This DT O
work NN O
unravels VBZ O
a DT O
new JJ O
model NN O
for IN O
the DT O
ets-1/ets-2 JJ B-NP
gene NN B-NP
's POS O
evolution NN O
, , O
based VBN O
for IN O
the DT O
first JJ O
time NN O
on IN O
both DT O
structural JJ O
and CC O
functional JJ O
evidences NNS O
. . O

-DOCSTART- X X O

The DT O
v-ets NNS B-NP
oncogene NN I-NP
of IN O
the DT O
avian JJ O
retrovirus NN O
E26 NNS O
differs NNS O
from IN O
its PRP$ O
cellular JJ O
progenitor NN O
p68c-ets-1 NN B-NP
by IN O
two CD O
amino IN O
acid NN O
substitutions NNS O
( -LRB- O
alanine DT O
285 CD O
and CC O
isoleucine NN O
445 . O
in IN O
c-ets-1 JJ B-NP
both DT O
substituted VBN O
by IN O
valine NN O
in IN O
v-ets NNS B-NP
, , O
mutations NNS O
A DT O
and CC O
B NNP O
respectively RB O
) -RRB- O
and CC O
its PRP$ O
carboxy-terminal JJ O
end NN O
( -LRB- O
mutation NN O
C NNP O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
genetic JJ O
system NN O
was VBD O
devised VBN O
to TO O
select VB O
for IN O
pi NN B-NP
protein NN I-NP
mutants NNS I-NP
which WDT O
discriminate VBP O
between IN O
IR NNP O
and CC O
DR NN O
( -LRB- O
York NNP O
et NNP O
al NN O
. . O
, , O
Gene NNP O
( -LRB- O
Amst NN O
. . O
) -RRB- O
116 CD O
, , O
7-12 CD O
, , O
1992 CD O
; : O
York NNP O
and CC O
Filutowicz NNP O
, , O
J. NNP O

-DOCSTART- X X O

These DT O
results NNS O
provide VBP O
evidence NN O
of IN O
a DT O
bypass NN O
of IN O
p53-induced JJ B-NP
Waf1/Cip1-mediated JJ B-NP
cell NN O
cycle NN O
regulatory JJ O
pathways NNS O
by IN O
a DT O
member NN O
of IN O
the DT O
myb NN B-NP
oncogene IN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

HBx NNP B-NP
strongly RB O
elevates VBZ O
levels NNS O
of IN O
GTP-bound JJ O
Ras NNP B-NP
, , O
activated VBN O
and CC O
phosphorylated VBN O
Raf NNP B-NP
, , O
and CC O
tyrosine-phosphorylated JJ O
and CC O
activated JJ O
MAP NNP B-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

Role NNP O
of IN O
c-myc JJ B-NP
in IN O
simian JJ B-NP
virus NN I-NP
40 CD I-NP
large JJ I-NP
tumor NN I-NP
antigen-induced JJ I-NP
DNA NNP O
synthesis NN O
in IN O
quiescent JJ O
3T3-L1 JJ O
mouse NN O
fibroblasts NNS O
. . O

-DOCSTART- X X O

All DT O
groups NNS O
were VBD O
challenged VBN O
subsequently RB O
with IN O
naloxone NN O
( -LRB- O
0.4 CD O
mg/kg NN O
) -RRB- O
in IN O
the DT O
distinctive JJ O
environment NN O
and CC O
then RB O
observed VBD O
for IN O
signs NNS O
of IN O
opiate JJ O
withdrawal NN O
. . O

-DOCSTART- X X O

Laser NNP O
therapy NN O
of IN O
penile NN O
carcinoma NN O

-DOCSTART- X X O

It PRP O
was VBD O
shown VBN O
that IN O
estradiol NN O
concentrations NNS O
obtained VBN O
after IN O
estradiol NN O
valerate NN O
and CC O
micronized JJ O
estradiol NN O
ingestion NN O
were VBD O
dependent JJ O
on IN O
the DT O
patient NN O
's POS O
age NN O
as RB O
well RB O
as IN O
on IN O
the DT O
constitutional JJ O
type NN O
. . O

-DOCSTART- X X O

There EX O
were VBD O
9 CD O
patients NNS O
in IN O
NYHA NNP O
class NN O
III NNP O
and CC O
8 CD O
in IN O
class NN O
IV.(ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

Constipation NNP O
is VBZ O
not RB O
a DT O
risk NN O
factor NN O
for IN O
hemorrhoids NNS O
: : O
a DT O
case-control NN O
study NN O
of IN O
potential JJ O
etiological JJ O
agents NNS O
. . O

-DOCSTART- X X O

TG-day JJ O
and CC O
TG-night JJ O
were VBD O
19.4 CD O
+/ NNS O
- : O
6.1 CD O
% NN O
, , O
26.6 CD O
+/ NNS O
- : O
5.3 CD O
% NN O
, , O
( -LRB- O
750 CD O
mm3 CD O
< NN O
T. NNP O

-DOCSTART- X X O

The DT O
fibrinogen NN B-NP
, , O
serum JJ O
proteins NNS O
, , O
sodium NN O
heparin NN O
and CC O
membrane NN O
contributed VBD O
to TO O
Cm NNP O
by IN O
20 CD O
% NN O
, , O
14 CD O
% NN O
, , O
2 CD O
% NN O
and CC O
64 CD O
% NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Optima NNP O
) -RRB- O
genomic JJ O
library NN O
by IN O
hybridizing VBG O
with IN O
elicitor-induced JJ O
stilbene NN B-NP
synthase NN I-NP
cDNA NN I-NP
as IN O
a DT O
probe NN O
. . O

-DOCSTART- X X O

The DT O
site-directed JJ O
mutation NN O
of IN O
the DT O
kappa NN B-NP
B NNP I-NP
motif NN I-NP
in IN O
IL-6/CAT JJ B-NP
plasmid NN O
resulted VBD O
in IN O
the DT O
complete JJ O
abrogation NN O
of IN O
IL-6 DT B-NP
promoter NN I-NP
activity NN O
in IN O
these DT O
cells NNS O
. . O

-DOCSTART- X X O

Use NN O
of IN O
the DT O
vena NN O
cava NN O
to TO O
extend VB O
the DT O
right NN O
renal NN O
vein NN O
for IN O
cadaver NN O
transplantation NN O
is VBZ O
controversial JJ O
. . O

-DOCSTART- X X O

Enhanced VBN O
hepatic JJ O
portal JJ O
blood NN O
flow NN O
induced VBN O
by IN O
prostaglandin NN O
E1 NN O
following VBG O
liver NN O
transplantation NN O
in IN O
pigs NNS O
. . O

-DOCSTART- X X O

One CD O
gene NN O
appears VBZ O
ubiquitously RB O
expressed VBN O
while IN O
the DT O
other JJ O
is VBZ O
prominently RB O
expressed VBN O
in IN O
muscle NN O
. . O

-DOCSTART- X X O

For IN O
HeLa NNP O
, , O
293 CD O
, , O
U937 NNP O
, , O
and CC O
A549 IN O
cells NNS O
, , O
participation NN O
of IN O
E2F-1 NN B-NP
, , O
DP-1 NNP B-NP
, , O
cyclin NN B-NP
A NNP I-NP
, , O
and CC O
RB NNP B-NP
was VBD O
involved VBN O
in IN O
formation NN O
of IN O
some DT O
complexes NNS O
only RB O
, , O
assuming VBG O
participation NN O
of IN O
factors NNS O
different JJ O
from IN O
E2F-1 NN B-NP
or CC O
DP-1 NN B-NP
in IN O
others NNS O
. . O

-DOCSTART- X X O

E1A DT B-NP
autoactivation NN O
mediated VBN O
by IN O
these DT O
sites NNS O
was VBD O
about IN O
twofold JJ O
compared VBN O
with IN O
a DT O
ninefold JJ O
activation NN O
described VBN O
for IN O
the DT O
complete JJ O
E1A NNP B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

During IN O
heat NN O
exposure NN O
, , O
chicks NNS O
that WDT O
had VBD O
been VBN O
subjected VBN O
to TO O
early JJ O
60 CD O
% NN O
restriction NN O
with IN O
non-metyrapone-treated JJ O
food NN O
had VBD O
lower JJR O
H/L JJ O
ratios NNS O
and CC O
improved VBD O
resistance NN O
to TO O
marble NN O
spleen JJ O
disease NN O
infection NN O
. . O

-DOCSTART- X X O

Analyses NNS O
of IN O
additional JJ O
tumors NNS O
induced VBN O
in IN O
mice NNS O
from IN O
two CD O
reciprocal JJ O
crosses NNS O
, , O
A/J NNP O
x NNP O
C3H/HeJ NNP O
F1 NNP O
( -LRB- O
hereafter RB O
called VBN O
AC3F1 NNP O
) -RRB- O
and CC O
C3H/HeJ NNP O
x NNP O
A/J NNP O
F1 NNP O
( -LRB- O
hereafter RB O
called VBN O
C3AF1 NNP O
) -RRB- O
, , O
provided VBD O
evidence NN O
for IN O
the DT O
inactivation NN O
of IN O
one CD O
allele NN O
of IN O
the DT O
putative JJ O
chromosome NN O
4 CD O
tumor NN O
suppressor NN O
gene NN O
by IN O
parental JJ O
imprinting NN O
. . O

-DOCSTART- X X O

Lesion NNP O
diameters NNS O
of IN O
greater JJR O
than IN O
20 CD O
mm CD O
and CC O
the DT O
large JJ O
sessile-type NN O
configurations NNS O
were VBD O
factors NNS O
that WDT O
were VBD O
associated VBN O
with IN O
incomplete JJ O
removal NN O
. . O

-DOCSTART- X X O

Routinely NNP O
collected VBD O
, , O
processed VBN O
and CC O
stored VBN O
breast NN O
cancer NN O
tissue NN O
blocks NNS O
recovered VBD O
from IN O
the DT O
archives NNS O
of IN O
the DT O
Pathology NNP O
laboratory NN O
in IN O
Dar NNP O
es NNS O
Salaam NNP O
after IN O
storage NN O
of IN O
up RB O
to TO O
3 CD O
years NNS O
were VBD O
analysed VBN O
by IN O
a DT O
flow NN O
cytometry NN O
for IN O
DNA NNP O
ploidy NN O
and CC O
S-phase JJ O
fraction NN O
. . O

-DOCSTART- X X O

Cbf3 PRP B-NP
contains VBZ O
three CD O
proteins NNS O
, , O
Cbf3a NNP B-NP
, , O
Cbf3b NNP B-NP
and CC O
Cbf3c NNP B-NP
. . O

-DOCSTART- X X O

Such JJ O
an DT O
interaction NN O
could MD O
be VB O
detected VBN O
using VBG O
a DT O
GST-POU JJ B-NP
fusion NN O
protein NN O
bound VBD O
to TO O
glutathione-agarose VB O
beads NNS O
. . O

-DOCSTART- X X O

These DT O
mutations NNS O
are VBP O
localized VBN O
in IN O
the DT O
same JJ O
region NN O
where WRB O
the DT O
HSV NNP B-NP
transactivator NN I-NP
VP16 IN I-NP
binds NNS O
, , O
but CC O
did VBD O
not RB O
coincide VB O
with IN O
the DT O
VP16 NNP B-NP
contacts NNS O
. . O

-DOCSTART- X X O

In IN O
general JJ O
, , O
the DT O
filtration NN O
rate NN O
in IN O
relevant JJ O
areas NNS O
appears VBZ O
to TO O
be VB O
an DT O
integrative JJ O
and CC O
easily RB O
determined VBN O
parameter NN O
, , O
reflecting VBG O
hormonal JJ O
and CC O
neurogenic JJ O
vascular JJ O
as RB O
well RB O
as IN O
local JJ O
interstitial JJ O
control NN O
of IN O
the DT O
Starling VBG O
forces NNS O
. . O

-DOCSTART- X X O

Notably RB O
, , O
these DT O
residues NNS O
are VBP O
located VBN O
in IN O
different JJ O
domains NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
rapamycin RB O
inhibited JJ O
proliferation NN O
of IN O
Ba/F3-EpoRgp55 DT O
but CC O
not RB O
of IN O
MEL NNP O
cells NNS O
despite IN O
inhibition NN O
of IN O
p70 DT B-NP
S6 NNP I-NP
kinase NN I-NP
activity NN O
in IN O
both DT O
cells NNS O
. . O

-DOCSTART- X X O

Intraventricular NNP O
injection NN O
of IN O
( -LRB- O
2S,1'R JJ O
,2'R NN O
,3'R)-2-(2,3-dicarboxycyclopropyl)glycine JJ O
(DCG-IV NN O
) -RRB- O
, , O
a DT O
potent JJ O
agonist NN O
for IN O
metabotropic NN O
glutamate NN B-NP
receptors NNS I-NP
, , O
to TO O
rats NNS O
retarded VBN O
dose-dependently RB O
the DT O
recovery NN O
from IN O
halothane NN O
anesthesia NN O
at IN O
a DT O
dose NN O
range NN O
from IN O
30 CD O
to TO O
300 CD O
pmol/rat NN O
. . O

-DOCSTART- X X O

The DT O
hepatocyte NN B-NP
nuclear JJ I-NP
factor-3 NN I-NP
( -LRB- O
HNF-3 JJ B-NP
)/forkhead NN O
(fkh NN O
) -RRB- O
proteins VBZ O
consist VB O
of IN O
an DT O
extensive JJ O
family NN O
of IN O
tissue-specific JJ O
and CC O
developmental JJ O
gene NN O
regulators NNS O
which WDT O
share NN O
homology NN O
within IN O
the DT O
winged JJ O
helix NN O
DNA NN O
binding NN O
motif NN O
. . O

-DOCSTART- X X O

Homozygous NNP O
null JJ O
embryos NNS O
also RB O
displayed VBD O
abnormalities NNS O
in IN O
heart NN O
development NN O
, , O
consistent JJ O
with IN O
the DT O
conclusion NN O
that IN O
Tek NNP B-NP
is VBZ O
necessary JJ O
for IN O
endocardial/myocardial JJ O
interactions NNS O
during IN O
development NN O
. . O

-DOCSTART- X X O

A DT O
strong JJ O
trithorax NN B-NP
binding NN I-NP
site NN I-NP
was VBD O
found VBN O
at IN O
the DT O
cytological JJ O
location NN O
of IN O
the DT O
fork NN B-NP
head NN I-NP
gene NN I-NP
, , O
a DT O
region-specific JJ O
homeotic JJ B-NP
gene NN I-NP
not RB O
located VBN O
within IN O
a DT O
homeotic JJ B-NP
complex NN I-NP
. . O

-DOCSTART- X X O

In IN O
particular JJ O
, , O
changes NNS O
in IN O
intracellular JJ O
Ca2+ NNP O
have VBP O
the DT O
potential JJ O
to TO O
either DT O
inhibit VB O
or CC O
augment VB O
the DT O
ability NN O
of IN O
cAMP JJ O
to TO O
stimulate VB O
transcription NN O
, , O
depending VBG O
on IN O
the DT O
presence NN O
of IN O
specific JJ O
forms NNS O
of IN O
Ca2+/calmodulin-dependent JJ B-NP
protein NN I-NP
kinases NNS I-NP
. . O

-DOCSTART- X X O

Antibodies NNS O
directed VBD O
against IN O
the DT O
SNM1 JJ B-NP
protein NN I-NP
immunoprecipitated VBD O
RNase NNP B-NP
MRP NNP I-NP
RNA NNP I-NP
from IN O
whole-cell JJ O
extracts NNS O
without IN O
precipitating VBG O
the DT O
structurally NN O
and CC O
functionally RB O
related VBN O
RNase NNP B-NP
P NNP I-NP
RNA NNP I-NP
. . O

-DOCSTART- X X O

C/EBP NNP B-NP
alpha NN I-NP
also RB O
activates VBZ O
the DT O
promoter NN O
of IN O
the DT O
rat NN B-NP
class-I NN I-NP
ADH NNP I-NP
gene NN I-NP
in IN O
a DT O
sequence-specific JJ O
manner NN O
[ IN O
Potter NNP O
et NNP O
al NN O
. . O
, , O
Arch NNP O
. . O

-DOCSTART- X X O

C/EBP NNP B-NP
alpha NN I-NP
also RB O
activates VBZ O
the DT O
promoter NN O
of IN O
the DT O
rat NN B-NP
class-I NN I-NP
ADH NNP I-NP
gene NN I-NP
in IN O
a DT O
sequence-specific JJ O
manner NN O
[ IN O
Potter NNP O
et NNP O
al NN O
. . O
, , O
Arch NNP O
. . O

-DOCSTART- X X O

In IN O
human JJ O
brain NN O
, , O
contactin NN B-NP
was VBD O
first RB O
identified VBN O
by IN O
amino DT O
terminal NN O
and CC O
peptide NN O
sequencing NN O
of IN O
the DT O
lentil-lectin-binding JJ B-NP
glycoprotein NN I-NP
Gp135 NN I-NP
. . O

-DOCSTART- X X O

A DT O
cDNA NN O
for IN O
a DT O
newly RB O
discovered VBN O
pseudogene NN O
, , O
closely RB O
related VBN O
to TO O
the DT O
mouse NN B-NP
mast NN I-NP
cell NN I-NP
chymases NNS I-NP
was VBD O
isolated VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
amplification NN O
from IN O
a DT O
mouse NN O
connective NN O
tissue-like JJ O
mast NN O
cell NN O
line NN O
. . O

-DOCSTART- X X O

Other JJ O
adverse JJ O
events NNS O
with IN O
incidences NNS O
significantly RB O
higher JJR O
than IN O
with IN O
placebo NN O
were VBD O
dizziness NN O
, , O
constipation NN O
, , O
sweating VBG O
, , O
nervousness NN O
, , O
and CC O
abnormal JJ O
ejaculation NN O
. . O

-DOCSTART- X X O

Homology NNP O
was VBD O
also RB O
detected VBN O
between IN O
the DT O
putative JJ O
transit NN O
peptide NN O
sequence NN O
of IN O
cysteine JJ B-NP
synthase NN I-NP
C NNP I-NP
and CC O
other JJ O
mitochondrion-targeting JJ O
leader NN O
sequences NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
our PRP$ O
data NNS O
also RB O
show VBP O
that IN O
, , O
in IN O
addition NN O
to TO O
TEF-1 NNP B-NP
, , O
another DT O
HF-1a-related JJ B-NP
factor NN I-NP
may MD O
be VB O
recognized VBN O
by IN O
the DT O
alpha-MHC JJ B-NP
gene NN I-NP
EM NNP O
element NN O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
mechanisms NNS O
that IN O
control NN O
activation NN O
of IN O
the DT O
MAP NNP B-NP
kinase NN I-NP
cascade NN O
temporally RB O
and CC O
spatially RB O
may MD O
be VB O
important JJ O
for IN O
specification NN O
of IN O
cellular JJ O
responses NNS O
. . O

-DOCSTART- X X O

This DT O
motif NN O
is VBZ O
similar JJ O
to TO O
but CC O
distinct JJ O
from IN O
the DT O
LIM NNP B-NP
domain NN I-NP
and CC O
the DT O
RING NNP B-NP
finger NN I-NP
family NN I-NP
, , O
and CC O
is VBZ O
reminiscent JJ O
of IN O
known VBN O
metal-binding NN O
regions NNS O
. . O

-DOCSTART- X X O

The DT O
P131 NNP O
ORF NNP O
is VBZ O
followed VBN O
in-frame JJ O
by IN O
a DT O
second JJ O
ORF NN O
which WDT O
is VBZ O
probably RB O
expressed VBN O
by IN O
partial JJ O
readthrough NN O
of IN O
the DT O
UGA NNP O
termination NN O
codon NN O
of IN O
the DT O
P131 NNP O
ORF NNP O
to TO O
produce VB O
a DT O
polypeptide NN O
of IN O
M(r NNP O
) -RRB- O
191044 CD O
( -LRB- O
P191 NN O
) -RRB- O
. . O

-DOCSTART- X X O

One CD O
hundred CD O
fifty CD O
patients NNS O
were VBD O
reviewed VBN O
at IN O
1 CD O
year NN O
after IN O
arthroplasty NN O
. . O

-DOCSTART- X X O

Segments NNS O
with IN O
more JJR O
reduced JJ O
BMIPP NNP O
uptake NN O
than IN O
MIBI JJ O
uptake NN O
( -LRB- O
mismatching NN O
) -RRB- O
showed VBD O
either DT O
normal JJ O
wall NN O
motion NN O
or CC O
demonstrated VBD O
inotropic JJ O
reserve NN O
during IN O
dobutamine NN O
stimulation NN O
. . O

-DOCSTART- X X O

The DT O
defined VBN O
length NN O
of IN O
the DT O
mRNA NN O
, , O
1,838 CD O
nucleotides NNS O
, , O
was VBD O
in IN O
agreement NN O
with IN O
that DT O
of IN O
a DT O
1.9-kb JJ O
RNA NNP O
expressed VBD O
throughout IN O
the DT O
replication NN O
cycle NN O
, , O
starting VBG O
at IN O
the DT O
early JJ O
stages NNS O
of IN O
infection NN O
. . O

-DOCSTART- X X O

Transient NNP O
transfections NNS O
of IN O
a DT O
construct VB O
expressing VBG O
the DT O
RNA NNP O
transcript NN O
defined VBN O
by IN O
clone JJ O
B1.1 NNP O
into IN O
D17 CD O
cells NNS O
led VBN O
to TO O
the DT O
expression NN O
of IN O
an DT O
Env/Mlvi-4 JJ B-NP
fusion NN O
protein NN O
with IN O
an DT O
apparent JJ O
molecular JJ O
mass NN O
of IN O
33 CD O
kDa NN O
. . O

-DOCSTART- X X O

Articles NNS O
addressing VBG O
valvular JJ O
heart NN O
disease NN O
or CC O
heart NN O
failure NN O
secondary JJ O
to TO O
acute JJ O
myocardial JJ O
infarction NN O
or CC O
Chagas NNP O
' POS O
disease NN O
were VBD O
excluded VBN O
. . O

-DOCSTART- X X O

All DT O
nuclear JJ O
receptors NNS O
have VBP O
several JJ O
well-characterized JJ O
structural JJ O
domains NNS O
, , O
including VBG O
a DT O
conserved JJ O
DNA-binding JJ O
domain NN O
, , O
and CC O
a DT O
ligand NN O
binding NN O
domain NN O
at IN O
the DT O
carboxyl NN O
terminus NN O
of IN O
the DT O
receptor NN O
. . O

-DOCSTART- X X O

The DT O
sample NN O
includes VBZ O
all PDT O
the DT O
HIV-infected-patients NNS O
continuously RB O
referred VBD O
to TO O
the DT O
Outpatient NNP O
Service NNP O
of IN O
the DT O
Infectious NNP O
Diseases NNP O
dept VBD O
. . O
of IN O
Bologna NNP O
's POS O
" `` O
Ospedale NNP O
Maggiore NNP O
" '' O
General NNP O
Hospital NNP O
during IN O
some DT O
five CD O
days NNS O
( -LRB- O
19-23rd JJ O
, , O
July NNP O
1993 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
presence NN O
of IN O
the DT O
Cln2 NNP B-NP
PEST NNP I-NP
domain NN I-NP
was VBD O
sufficient JJ O
to TO O
destabilize VB O
a DT O
heterologous JJ O
protein NN O
. . O

-DOCSTART- X X O

Electrophoretic NNP O
mobility NN O
shift NN O
assays VBZ O
with IN O
each DT O
of IN O
these DT O
sequences NNS O
demonstrated VBD O
complexes NNS O
with IN O
mobilities NNS O
identical JJ O
to TO O
those DT O
of IN O
the DT O
NF-kappa NNP B-NP
B NNP I-NP
site NN I-NP
from IN O
the DT O
kappa NN B-NP
light-chain JJ I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Although IN O
a DT O
carboxyl-terminal JJ O
HSF NNP B-NP
transcriptional JJ O
activation NN O
domain NN O
is VBZ O
critical JJ O
for IN O
the DT O
activation NN O
of IN O
CUP1 NNP B-NP
transcription NN O
in IN O
response NN O
to TO O
both DT O
heat NN O
shock NN O
stress NN O
and CC O
glucose NN O
starvation NN O
, , O
this DT O
region NN O
is VBZ O
dispensable JJ O
for IN O
transient JJ O
heat NN O
shock NN O
activation NN O
of IN O
at IN O
least JJS O
two CD O
genes NNS O
encoding VBG O
members NNS O
of IN O
the DT O
S. NNP O
cerevisiae NN O
hsp70 IN B-NP
family NN I-NP
. . O

-DOCSTART- X X O

We PRP O
have VBP O
recently RB O
detected VBN O
high JJ O
levels NNS O
of IN O
CKB NNP B-NP
mRNA NN I-NP
in IN O
HeLa NNP O
cells NNS O
and CC O
, , O
in IN O
this DT O
study NN O
, , O
have VBP O
tested VBN O
whether IN O
this DT O
may MD O
be VB O
due JJ O
to TO O
the DT O
extremely RB O
low JJ O
amounts NNS O
of IN O
p53 NN B-NP
protein NN I-NP
present NN O
in IN O
HeLa NNP O
cells NNS O
. . O

-DOCSTART- X X O

A DT O
normal JJ O
systemic JJ O
response NN O
was VBD O
obtained VBN O
after IN O
IF NNP O
, , O
indicating VBG O
that IN O
rhG-CSF NNP B-NP
retains VBZ O
activity NN O
in IN O
the DT O
solid JJ O
state NN O
. . O

-DOCSTART- X X O

PAI-1 JJ B-NP
levels NNS O
increased VBN O
significantly RB O
in IN O
patients NNS O
who WP O
received VBD O
iohexol NN O
but CC O
not RB O
in IN O
those DT O
who WP O
received VBD O
ioxaglate NN O
. . O

-DOCSTART- X X O

The DT O
recovery NN O
value NN O
of IN O
systolic JJ O
pressure NN O
was VBD O
higher JJR O
than IN O
diastolic JJ O
pressure NN O
and CC O
pulse NN O
pressure NN O
increased VBN O
. . O

-DOCSTART- X X O

The DT O
importance NN O
of IN O
hepatitis NN O
C NNP O
virus NN O
( -LRB- O
HCV NNP O
) -RRB- O
infection NN O
as IN O
a DT O
cause NN O
of IN O
chronic NN O
liver NN O
disease NN O
has VBZ O
become VBN O
clear JJ O
with IN O
the DT O
introduction NN O
of IN O
serologic NN O
detection NN O
methods NNS O
. . O

-DOCSTART- X X O

Human NNP O
adenovirus NN O
type NN O
41 CD O
contains VBZ O
two CD O
fibers NNS O
. . O

-DOCSTART- X X O

Outflow NNP O
obstruction NN O
of IN O
pancreatic JJ O
juice NN O
, , O
i IN O
.e NN O
. . O
, , O
"relative JJ O
stenosis NN O
of IN O
the DT O
minor JJ O
papilla NN O
, , O
" '' O
was VBD O
considered VBN O
to TO O
be VB O
present JJ O
in IN O
the DT O
patients NNS O
with IN O
type NN O
II NNP O
papilla NN O
, , O
and CC O
, , O
therefore RB O
, , O
the DT O
patients NNS O
with IN O
type NN O
II NNP O
papilla NN O
might MD O
suffer VB O
from IN O
acute JJ O
pancreatitis NN O
resulting VBG O
from IN O
poor JJ O
drainage NN O
of IN O
pancreatic JJ O
juice NN O
and CC O
excessive JJ O
pressure NN O
in IN O
the DT O
dorsal JJ O
duct NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
ISO NNP O
group NN O
, , O
at IN O
pre-DEX JJ O
, , O
CBF NNP O
increased VBD O
from IN O
86 CD O
+/ CD O
- : O
8 CD O
to TO O
166 CD O
+/ NNS O
- : O
19 CD O
mL.min-1.100 CD O
g-1 NN O
in IN O
response NN O
to TO O
hypercapnia NN O
(PCO2 IN O
approximately RB O
90 CD O
mmHg NN O
) -RRB- O
.(ABSTRACT . O
TRUNCATED NNP O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

In IN O
H4IIE JJ O
rat NN O
hepatoma NN O
cells NNS O
, , O
glucocorticoids NNS O
, , O
retinoic JJ O
acid NN O
and CC O
cyclic NN O
AMP JJ O
(cAMP NN O
) -RRB- O
increase NN O
PEPCK NN B-NP
gene NN I-NP
transcription NN O
whereas IN O
insulin NN B-NP
and CC O
phorbol NN O
esters NNS O
have VBP O
the DT O
opposite JJ O
effect NN O
. . O

-DOCSTART- X X O

Acta NNP O
572 CD O
, , O
113-120] CD O
. . O

-DOCSTART- X X O

A DT O
stretch NN O
of IN O
16 CD O
nucleotides NNS O
just RB O
upstream RB O
of IN O
the DT O
IL-4RE NNP B-NP
contributed VBD O
to TO O
IL-4 DT B-NP
inducibility NN O
and CC O
formed VBD O
nucleoprotein JJ O
complexes NNS O
with IN O
constitutive JJ O
factors NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
previous JJ O
study NN O
suggested VBD O
that IN O
pertussis NN B-NP
toxin NN I-NP
( -LRB- O
IAP)-sensitive JJ B-NP
GTP-binding NN B-NP
protein( NN I-NP
s VBZ I-NP
) -RRB- I-NP
(G-protein NN O
) -RRB- O
is VBZ O
involved VBN O
in IN O
the DT O
process NN O
of IN O
differentiation NN O
by IN O
hormones/IBMX NNS O
, , O
accompanied VBN O
by IN O
c-fos JJ B-NP
induction NN O
. . O

-DOCSTART- X X O

ATX NNP B-NP
, , O
like IN O
PC-1 NN B-NP
, , O
was VBD O
found VBN O
to TO O
hydrolyze VB O
the DT O
type NN B-NP
I PRP I-NP
phosphodiesterase VBP I-NP
substrate JJ O
p-nitrophenyl JJ O
thymidine-5'-monophosphate NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
site-specific JJ O
mutations NNS O
in IN O
the DT O
mouse NN B-NP
platelet-derived VBN I-NP
growth NN I-NP
factor NN I-NP
( -LRB- I-NP
PDGF NN I-NP
) -RRB- I-NP
beta-receptor NN I-NP
on IN O
activation NN O
of IN O
the DT O
Na+/H+ NNP B-NP
exchanger NN I-NP
was VBD O
examined VBN O
in IN O
normal JJ O
murine NN O
mammary NN O
gland NN O
epithelial NN O
( -LRB- O
NMuMG) NNP O
and CC O
Chinese JJ O
hamster NN O
ovary NN O
( -LRB- O
CHO NNP O
) -RRB- O
cells NNS O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
revealed VBN O
: : O
1 CD O
) -RRB- O
a DT O
kinase NN O
catalytic JJ O
domain NN O
most RBS O
characteristic JJ O
of IN O
serine/threonine NN B-NP
kinases NNS I-NP
but CC O
hybrid NN O
between IN O
members NNS O
of IN O
the DT O
family NN O
of IN O
microtubule-associated JJ B-NP
protein NN I-NP
kinase NN I-NP
kinase NN I-NP
kinases NNS I-NP
and CC O
the DT O
fibroblast JJ B-NP
growth NN I-NP
factor NN I-NP
receptor NN I-NP
family NN I-NP
; : O
2 CD O
) -RRB- O
two CD O
putative JJ O
alpha-helical JJ O
leucine NN O
zipper NN O
motifs NNS O
separated VBN O
by IN O
a DT O
25-amino JJ O
acid NN O
charged VBD O
intermediate JJ O
segment NN O
but CC O
lacking VBG O
an DT O
NH2-terminal JJ O
basic JJ O
domain NN O
; : O
and CC O
3 CD O
) -RRB- O
COOH-terminal JJ O
and CC O
NH2-terminal JJ O
proline-rich JJ O
domains NNS O
suggestive VBP O
of IN O
src NN B-NP
homology NN I-NP
3 CD I-NP
( -LRB- O
SH3 NN B-NP
) -RRB- O
domain NN O
binding JJ O
regions NNS O
. . O

-DOCSTART- X X O

Type JJ O
2 CD O
genomes NNS O
containing VBG O
this DT O
sequence NN O
presumably RB O
more RBR O
closely RB O
reflect VB O
the DT O
structure NN O
of IN O
the DT O
infectious JJ O
, , O
replication-competent JJ O
retrovirus NN O
ancestors NNS O
of IN O
the DT O
HERV-K NNP O
family NN O
than IN O
do VBP O
type NN O
1 CD O
genomes VBZ O
that IN O
lack NN O
the DT O
sequence NN O
. . O

-DOCSTART- X X O

However RB O
, , O
when WRB O
domain NN O
I PRP O
and CC O
domain NN O
II NNP O
were VBD O
linked VBN O
on IN O
the DT O
same JJ O
plasmid NN O
, , O
high JJ O
levels NNS O
of IN O
replication NN O
were VBD O
observed VBN O
. . O

-DOCSTART- X X O

Point NNP O
mutations NNS O
that IN O
suppressed VBN O
the DT O
in IN O
vitro NN O
binding NN O
of IN O
NF-Y NNP B-NP
to TO O
the DT O
internal JJ O
palindromic JJ O
arm NN O
reduced VBD O
the DT O
activity NN O
of IN O
the DT O
resident NN O
P4 NNP O
promoter NN O
, , O
while IN O
those DT O
preventing VBG O
complex JJ O
formation NN O
with IN O
USF NNP B-NP
did VBD O
not RB O
, , O
as IN O
determined VBN O
by IN O
transient JJ O
expression NN O
assays IN O
using VBG O
the DT O
luciferase NN B-NP
reporter NN O
gene NN O
. . O

-DOCSTART- X X O

Surprisingly RB O
, , O
Northern NNP O
( -LRB- O
RNA NN O
) -RRB- O
blot NN O
analysis NN O
and CC O
reverse VB B-NP
transcriptase-PCRs NNS I-NP
performed VBN O
after IN O
transfection NN O
of IN O
COS-7 NNP O
or CC O
HeLa NNP O
cells NNS O
with IN O
these DT O
viral JJ O
RNAs NNS O
revealed VBD O
that IN O
Y88S NNP B-NP
and CC O
Y88L NNP B-NP
RNAs NNP I-NP
replicated VBD O
at IN O
only RB O
very RB O
low JJ O
levels NNS O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
by IN O
complementation NN O
of IN O
the DT O
WA NNP B-NP
fyuA NN I-NP
mutant NN I-NP
by IN O
the DT O
cloned VBN O
fyuA NN B-NP
gene NN I-NP
, , O
yersiniabactin NNP O
uptake NNP O
and CC O
mouse NN O
virulence NN O
were VBD O
restored VBN O
. . O

-DOCSTART- X X O

The DT O
other JJ O
element NN O
bound VBN O
RBP-J NN B-NP
kappa NN I-NP
with IN O
low JJ O
affinity NN O
. . O

-DOCSTART- X X O

The DT O
basal NN O
promoter NN O
strength NN O
of IN O
constructs NNS O
that WDT O
contained VBD O
deletions NNS O
in IN O
the DT O
U5 NNP B-NP
region NN I-NP
of IN O
the DT O
LTR NNP O
was VBD O
analyzed VBN O
by IN O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
( -LRB- O
CAT NN B-NP
) -RRB- O
assays VBZ O
following VBG O
transfection NN O
of IN O
HeLa NNP O
cells NNS O
or CC O
Jurkat NNP O
T-cells NNS O
in IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
viral JJ O
transactivator NN O
tax NN B-NP
protein NN O
. . O

-DOCSTART- X X O

Recently RB O
, , O
a DT O
protein NN O
designated VBN O
GF14 NNP B-NP
has VBZ O
been VBN O
isolated VBN O
that DT O
is VBZ O
associated VBN O
with IN O
the DT O
GBF JJ B-NP
protein NN I-NP
complex NN I-NP
. . O

-DOCSTART- X X O

Propafenone NN O
is VBZ O
well RB O
tolerated VBN O
in IN O
the DT O
majority NN O
of IN O
young JJ O
patients NNS O
. . O

-DOCSTART- X X O

2 CD O
patients NNS O
( -LRB- O
11 CD O
% NN O
) -RRB- O
had VBD O
significant JJ O
morbidity NN O
502 CD O
and CC O
529 CD O
days NNS O
respectively RB O
after IN O
transplantation NN O
. . O

-DOCSTART- X X O

A DT O
recent JJ O
index NN O
( -LRB- O
Fluorosis NNP O
Risk NNP O
Index NNP O
) -RRB- O
developed VBN O
by IN O
Pendrys NNS O
( -LRB- O
1990 CD O
) -RRB- O
is VBZ O
also RB O
included VBN O
in IN O
this DT O
review NN O
. . O

-DOCSTART- X X O

Alternative JJ O
splicing NN O
of IN O
the DT O
cytoplasmic JJ O
tail NN O
appears VBZ O
to TO O
generate VB O
multiple JJ O
PECAM-1 JJ B-NP
isoforms NNS I-NP
that WDT O
may MD O
regulate VB O
phosphorylation NN O
, , O
cytoskeletal JJ O
association NN O
, , O
and CC O
affinity NN O
modulation NN O
of IN O
the DT O
mature JJ O
protein NN O
. . O

-DOCSTART- X X O

Transfer NNP O
also RB O
correlated VBD O
inversely RB O
with IN O
gastric JJ O
juice NN O
pH NNS O
( -LRB- O
r NN O
= SYM O
-0.619 FW O
, , O
P NNP O
< JJ O
0.02 CD O
) -RRB- O
. . O

-DOCSTART- X X O

If IN O
this DT O
is VBZ O
present JJ O
, , O
such JJ O
patients NNS O
should MD O
be VB O
closely RB O
monitored VBN O
, , O
and CC O
any DT O
atypical JJ O
lesions NNS O
biopsied VBD O
. . O

-DOCSTART- X X O

Cumulated VBN O
maximum JJ O
lod NN O
scores NNS O
between IN O
FRDA NNP B-NP
and CC O
D9S5 NNP B-NP
and CC O
between IN O
FRDA NNP B-NP
and CC O
D9S15 NNP B-NP
are VBP O
above IN O
36 CD O
and CC O
61 CD O
, , O
respectively RB O
, , O
at IN O
a DT O
recombination NN O
fraction NN O
of IN O
0, JJ O
indicating VBG O
that IN O
recombination NN O
events NNS O
needed VBD O
to TO O
orient VB O
the DT O
search NN O
of IN O
the DT O
gene NN O
are VBP O
very RB O
difficult JJ O
to TO O
identify VB O
and CC O
ascertain VB O
. . O

-DOCSTART- X X O

A DT O
receptor-like JJ B-NP
protein NN I-NP
kinase NN I-NP
, , O
OsPK10 NNP B-NP
, , O
has VBZ O
been VBN O
cloned VBN O
from IN O
rice NN O
( -LRB- O
Oryza NNP O
sativa NN O
) -RRB- O
. . O

-DOCSTART- X X O

Goodpasture NNP O
's-like JJ O
syndrome NN O
and CC O
effect NN O
of IN O
extracorporeal JJ O
membrane NN O
oxygenator NN O
support NN O
. . O

-DOCSTART- X X O

A DT O
cDNA NN O
clone NN O
pCZ1 NNS O
, , O
with IN O
a DT O
1.1 CD O
kb NN O
insert NN O
, , O
was VBD O
isolated VBN O
from IN O
a DT O
NaCl-adapted JJ O
tobacco NN O
cell NN O
cDNA NN O
library NN O
that WDT O
encodes VBZ O
an DT O
apparently RB O
full-length JJ O
29 CD O
kDa JJ O
protein NN O
( -LRB- O
251 CD O
amino NN O
acids NNS O
) -RRB- O
with IN O
a DT O
calculated JJ O
pI NN O
of IN O
5.7 CD O
. . O

-DOCSTART- X X O

The DT O
git1 NN B-NP
, , O
git3 CD B-NP
, , O
git5 CD B-NP
, , O
git7 CD B-NP
, , O
git8 CD B-NP
and CC O
git10 CD B-NP
genes NNS I-NP
act VBP O
upstream RB O
of IN O
adenylate JJ B-NP
cyclase NN I-NP
, , O
presumably RB O
encoding VBG O
an DT O
adenylate JJ B-NP
cyclase NN I-NP
activation NN O
pathway NN O
. . O

-DOCSTART- X X O

These DT O
same JJ O
regions NNS O
showed VBD O
remarkable JJ O
homology NN O
to TO O
two CD O
invertebrate JJ O
proteins NNS O
, , O
CNC NNP B-NP
and CC O
skin-1 NN B-NP
, , O
postulated VBD O
to TO O
regulate VB O
embryonic JJ O
development NN O
in IN O
Drosophila NNP O
melanogaster NN O
and CC O
Caenorhabditis NNP O
elegans NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

DNA NNP O
sequence NN O
analysis NN O
has VBZ O
confirmed VBN O
that IN O
this DT O
mutation NN O
affects VBZ O
the DT O
C-terminal JJ O
region NN O
of IN O
the DT O
alpha NN O
subunit NN O
, , O
changing VBG O
a DT O
leucine NN O
residue NN O
at IN O
position NN O
290 CD O
to TO O
a DT O
histidine NN O
( -LRB- O
rpoAL290H) NN B-NP
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
These DT O
findings NNS O
indicate VBP O
a DT O
physical JJ O
barrier NN O
of IN O
oesophageal JJ O
surfactant NN O
which WDT O
could MD O
offer VB O
some DT O
degree NN O
of IN O
protection NN O
against IN O
gastro-oesophageal JJ O
reflux NN O
but CC O
one CD O
which WDT O
is VBZ O
particularly RB O
prone JJ O
to TO O
attack VB O
by IN O
bile NN O
. . O

-DOCSTART- X X O

Differential JJ O
screening NN O
of IN O
mitochondrial JJ O
cDNA NN O
libraries NNS O
from IN O
male-fertile JJ O
and CC O
cytoplasmic JJ O
male-sterile JJ O
sugar-beet NN O
reveals VBZ O
genome JJ O
rearrangements NNS O
at IN O
atp6 NNS B-NP
and CC O
atpA DT B-NP
loci NNS I-NP
. . O

-DOCSTART- X X O

I PRP O
hypothesize VBP O
that IN O
white JJ B-NP
gene NN I-NP
expression NN O
from IN O
P[en NNP B-NP
] SYM I-NP
is VBZ O
repressed VBN O
by IN O
the DT O
formation NN O
of IN O
a DT O
protein NN O
complex NN O
which WDT O
is VBZ O
initiated VBN O
at IN O
the DT O
engrailed JJ B-NP
PS NNP I-NP
sites NNS I-NP
and CC O
also RB O
requires VBZ O
interactions NNS O
with IN O
flanking VBG O
genomic JJ O
DNA NN O
. . O

-DOCSTART- X X O

SPP41 NNP B-NP
was VBD O
cloned VBN O
and CC O
sequenced VBN O
and CC O
found VBN O
to TO O
be VB O
essential JJ O
. . O
spp43 '' B-NP
is VBZ O
allelic JJ O
to TO O
the DT O
previously RB O
identified VBN O
suppressor NN B-NP
srn1 NNS I-NP
, , O
which WDT O
encodes VBZ O
a DT O
negative JJ O
regulator NN O
of IN O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

To TO O
see VB O
if IN O
a DT O
pulse NN O
oximeter NN O
can MD O
monitor VB O
the DT O
fetus NN O
during IN O
labour NN O
we PRP O
recruited VBD O
100 CD O
Caucasian JJ O
women NNS O
in IN O
normal JJ O
uncomplicated JJ O
labour NN O
. . O

-DOCSTART- X X O

A DT O
causal JJ O
analysis NN O
of IN O
secondary JJ O
variables NNS O
showed VBD O
that IN O
the DT O
formation NN O
of IN O
FB NNP O
memories NNS O
was VBD O
primarily RB O
associated VBN O
with IN O
the DT O
level NN O
of IN O
importance NN O
attached VBN O
to TO O
the DT O
event NN O
and CC O
level NN O
of IN O
affective JJ O
response NN O
to TO O
the DT O
news NN O
. . O

-DOCSTART- X X O

The DT O
IPL1 NNP B-NP
gene NN I-NP
is VBZ O
required VBN O
for IN O
high-fidelity JJ O
chromosome NN O
segregation NN O
in IN O
the DT O
budding VBG O
yeast NN O
Saccharomyces NNS O
cerevisiae VBN O
. . O

-DOCSTART- X X O

2. . O

-DOCSTART- X X O

No DT O
drop NN O
in IN O
oxygen NN O
saturation NN O
( -LRB- O
SaO2 NNP O
) -RRB- O
or CC O
visual JJ O
evidence NN O
of IN O
transient NN O
electroencephalographic JJ O
( -LRB- O
EEG NN O
) -RRB- O
arousals NNS O
can MD O
be VB O
found VBN O
at IN O
repeat NN O
polysomnography NN O
. . O

-DOCSTART- X X O

The DT O
complete JJ O
gene NN O
organization NN O
was VBD O
obtained VBN O
by IN O
combining VBG O
the DT O
results NNS O
of IN O
the DT O
sequence NN O
of IN O
these DT O
clones NNS O
and CC O
those DT O
of IN O
the DT O
characterization NN O
of IN O
polymerase NN O
chain NN O
reaction-amplified VBD O
genomic JJ O
segments NNS O
. . O

-DOCSTART- X X O

Mammalian NNP B-NP
ABPs NNPS I-NP
and CC O
SHBGs NNP B-NP
bind VBP O
sex NN O
steroids NNS O
with IN O
high JJ O
affinity NN O
, , O
but CC O
some DT O
binding NN O
properties NNS O
differ VBP O
among IN O
species NNS O
. . O

-DOCSTART- X X O

Sample NNP O
treatment NN O
was VBD O
optimized JJ O
in IN O
order NN O
to TO O
achieve VB O
a DT O
complete JJ O
extraction NN O
of IN O
labetalol NN O
diastereoisomers NNS O
and CC O
to TO O
avoid VB O
racemization NN O
during IN O
extraction NN O
. . O

-DOCSTART- X X O

A DT O
more RBR O
complete JJ O
analysis NN O
of IN O
dose NN O
response NN O
, , O
time NN O
and CC O
mode NN O
of IN O
Ga NNP O
administration NN O
( -LRB- O
preinjury NN O
or CC O
postinjury NN O
) -RRB- O
, , O
and CC O
availability NN O
of IN O
Ga NNP O
across IN O
the DT O
blood-brain NN O
barrier NN O
is VBZ O
needed VBN O
to TO O
further VB O
evaluate VB O
the DT O
efficacy NN O
of IN O
this DT O
compound NN O
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
regulatory JJ O
sequences NNS O
for IN O
the DT O
binding NN O
of IN O
transcription NN O
factors NNS O
such JJ O
as IN O
NF-kappa NNP B-NP
B NNP I-NP
and CC O
AP-2 NNP B-NP
, , O
whose WP$ O
activation NN O
is VBZ O
associated VBN O
with IN O
the DT O
immediate JJ O
response NN O
of IN O
the DT O
cell NN O
to TO O
an DT O
injury NN O
, , O
may MD O
be VB O
an DT O
indication NN O
of IN O
the DT O
important JJ O
role NN O
which WDT O
HO-1 NNP B-NP
may MD O
play VB O
in IN O
defense NN O
mechanisms NNS O
against IN O
tissue NN O
injury NN O
. . O

-DOCSTART- X X O

The DT O
femoroarterial JJ O
coronary JJ O
sinus NN O
difference NN O
in IN O
lactate NN O
turned VBD O
negative JJ O
, , O
and CC O
pH RB O
, , O
PCO2 NNP O
and CC O
potassium NN O
differences NNS O
increased VBN O
in IN O
group NN O
2 CD O
during IN O
pacing NN O
. . O

-DOCSTART- X X O

A DT O
randomised JJ O
, , O
controlled JJ O
trial NN O
was VBD O
undertaken VBN O
in IN O
40 CD O
patients NNS O
with IN O
active JJ O
Crohn NNP O
's POS O
disease NN O
to TO O
evaluate VB O
clinical JJ O
and CC O
nutritional JJ O
outcomes NNS O
after IN O
an DT O
amino JJ O
acid NN O
based VBN O
diet NN O
containing VBG O
3 CD O
% NN O
fat NN O
was VBD O
given VBN O
by IN O
a DT O
feeding VBG O
tube NN O
compared VBN O
with IN O
a DT O
peptide NN O
based VBN O
diet NN O
containing VBG O
33 CD O
% NN O
fat JJ O
. . O

-DOCSTART- X X O

The DT O
fepA-entD JJ B-NP
and CC O
fes-entF JJ B-NP
operons NNS O
in IN O
the DT O
enterobactin NN O
synthesis NN O
and CC O
transport NN O
system NN O
are VBP O
divergently RB O
transcribed VBN O
from IN O
overlapping JJ O
promoters NNS O
, , O
and CC O
both DT O
are VBP O
inhibited VBN O
by IN O
the DT O
Fur NNP B-NP
repressor NN I-NP
protein NN I-NP
under IN O
iron-replete JJ O
conditions NNS O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
a DT O
6.3-kbp JJ O
genomic JJ O
EcoRI-fragment NN B-NP
of IN O
Alcaligenes NNP O
eutrophus NN O
, , O
which WDT O
was VBD O
recently RB O
identified VBN O
by IN O
using VBG O
a DT O
dihydrolipoamide JJ B-NP
dehydrogenase-specific JJ I-NP
DNA NN O
probe NN O
( -LRB- O
A DT O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
we PRP O
sought VBD O
to TO O
test VB O
the DT O
hypothesis NN O
that IN O
, , O
when WRB O
equal JJ O
volumes NNS O
are VBP O
administered VBN O
intrathecally RB O
, , O
significant JJ O
differences NNS O
exist VBP O
in IN O
the DT O
potential JJ O
to TO O
three CD O
commonly RB O
used VBN O
anesthetic JJ O
solutions NNS O
to TO O
induce VB O
sensory JJ O
impairment NN O
. . O

-DOCSTART- X X O

The DT O
proteins VBZ O
encoded VBN O
downstream NN O
of IN O
rpoN NNP B-NP
are VBP O
known VBN O
to TO O
negatively RB O
regulate VB O
sigma NN B-NP
54 CD I-NP
activity NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
demonstrate VBP O
that IN O
a DT O
class NN O
of IN O
proline-rich JJ O
activator NN O
proteins NNS O
and CC O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
possess VBP O
a DT O
common JJ O
structural JJ O
and CC O
functional JJ O
component NN O
which WDT O
can MD O
interact VB O
with IN O
the DT O
same JJ O
target NN O
in IN O
the DT O
general JJ O
transcription NN O
machinery NN O
. . O

-DOCSTART- X X O

Cloning NN O
of IN O
higher JJR B-NP
plant NN I-NP
omega-3 NN I-NP
fatty JJ I-NP
acid NN I-NP
desaturases NNS I-NP
. . O

-DOCSTART- X X O

65 CD O
, , O
3829-3838 CD O
, , O
1991 CD O
) -RRB- O
, , O
a DT O
truncated JJ O
form NN O
of IN O
the DT O
IE NN B-NP
polypeptide NN I-NP
lacking VBG O
IE NNP B-NP
amino IN I-NP
acid NN I-NP
residues NNS I-NP
1-322 JJ I-NP
( -LRB- O
and CC O
, , O
therefore RB O
lacks VBZ O
the DT O
deduced JJ O
transcriptional JJ O
activation NN O
domain NN O
) -RRB- O
, , O
fails VBZ O
to TO O
transactivate VB O
the DT O
EHV-1 JJ B-NP
tk NN I-NP
promoter NN I-NP
, , O
but CC O
retains VBZ O
the DT O
ability NN O
to TO O
down-regulate JJ O
the DT O
EHV-1 JJ B-NP
IE NNP I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Human NNP O
preterm NN O
birth NN O
is VBZ O
associated VBN O
with IN O
significantly RB O
lower JJR O
progesterone/17 NN O
beta-estradiol JJ O
ratios NNS O
than IN O
those DT O
of IN O
women NNS O
with IN O
preterm JJ O
labor NN O
delivered VBN O
at IN O
term NN O
. . O

-DOCSTART- X X O

The DT O
availability NN O
of IN O
sequence NN O
from IN O
multiple JJ O
species NNS O
has VBZ O
permitted VBN O
us PRP O
to TO O
determine VB O
that IN O
the DT O
UBE NNP O
site NN O
has VBZ O
close JJ O
similarity NN O
to TO O
motifs NNS O
that IN O
bind NN O
members NNS O
of IN O
the DT O
NF-1 JJ B-NP
family NN I-NP
of IN I-NP
transcription NN I-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

The DT O
mechanism NN O
whereby WRB O
zeta NNP B-NP
PKC NNP I-NP
regulates VBZ O
NF-kappa NNP B-NP
B NNP I-NP
most JJS O
probably RB O
involves VBZ O
the DT O
activation NN O
of IN O
a DT O
putative NN O
I PRP B-NP
kappa VBD I-NP
B NNP I-NP
kinase NN I-NP
of IN O
molecular JJ O
mass NN O
approximately RB O
50 CD O
kDa NN O
, , O
which WDT O
phosphorylates VBZ O
and CC O
inactivates VBZ O
I PRP B-NP
kappa VB I-NP
B. NNP I-NP

-DOCSTART- X X O

Stable JJ O
expression NN O
of IN O
truncated JJ B-NP
inositol NN I-NP
1,4,5-trisphosphate JJ I-NP
receptor NN I-NP
subunits NNS I-NP
in IN O
3T3 JJ O
fibroblasts NNS O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
the DT O
identification NN O
and CC O
characterization NN O
of IN O
myr NN B-NP
4 CD I-NP
( -LRB- O
myosin NN B-NP
from IN I-NP
rat NN I-NP
) -RRB- O
, , O
the DT O
first JJ O
mammalian JJ B-NP
myosin NN I-NP
I PRP I-NP
that WDT O
is VBZ O
not RB O
closely RB O
related VBN O
to TO O
brush VB O
border NN O
myosin NN B-NP
I. NN I-NP

-DOCSTART- X X O

In IN O
addition NN O
, , O
computer NN O
analysis NN O
suggests VBZ O
that IN O
sequences NNS O
similar JJ O
to TO O
the DT O
A NNP O
stem NN O
element NN O
are VBP O
present JJ O
within IN O
the DT O
three CD O
AAV NNP B-NP
promoter NN I-NP
regions NNS O
. . O

-DOCSTART- X X O

32Pi JJ O
labeling NN O
or CC O
isoelectric JJ O
focusing VBG O
analysis NN O
of IN O
eIF-2 JJ B-NP
alpha NN I-NP
from IN O
conditional JJ O
casein NN B-NP
kinase NN I-NP
II NNP I-NP
mutants NNS I-NP
indicated VBD O
that IN O
phosphorylation NN O
of IN O
eIF-2 JJ B-NP
alpha NN I-NP
is VBZ O
abolished VBN O
or CC O
dephosphorylated VBN O
forms NNS O
of IN O
eIF-2 JJ B-NP
alpha NN I-NP
are VBP O
detected VBN O
when WRB O
these DT O
strains NNS O
are VBP O
grown VBN O
at IN O
the DT O
restrictive JJ O
growth NN O
conditions NNS O
. . O

-DOCSTART- X X O

The DT O
R2 IN O
region NN O
within IN O
the DT O
class NN O
I PRP O
enhancer RB O
acts VBZ O
as IN O
a DT O
negative JJ O
element NN O
in IN O
Ad12-transformed JJ O
cells NNS O
and CC O
exhibits NNS O
a DT O
stronger JJR O
binding NN O
activity NN O
than IN O
is VBZ O
observed VBN O
in IN O
nontumorigenic JJ O
Ad5-transformed JJ O
cells NNS O
, , O
which WDT O
are VBP O
not RB O
reduced VBN O
in IN O
class NN O
I PRP O
expression NN O
. . O

-DOCSTART- X X O

PURPOSE NNP O
: : O
To TO O
evaluate VB O
the DT O
kinetics NNS O
of IN O
erythropoietin NN B-NP
( -LRB- O
EPO NNP B-NP
) -RRB- O
production NN O
and CC O
address NN O
the DT O
pathogenesis NN O
of IN O
anemia NN O
of IN O
prematurity NN O
, , O
we PRP O
measured VBD O
EPO NNP B-NP
levels NNS O
in IN O
infants NNS O
during IN O
the DT O
first JJ O
year NN O
of IN O
life NN O
. . O

-DOCSTART- X X O

We PRP O
speculate VBP O
that IN O
mast NN O
cell NN O
degranulation NN O
may MD O
be VB O
involved VBN O
in IN O
the DT O
pathogenesis NN O
of IN O
necrobiosis NN O
by IN O
altering VBG O
fibroblast JJ O
enzyme NN O
activity NN O
and/or CC O
producing VBG O
prolonged VBN O
inflammatory JJ O
reactions NNS O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
of IN O
a DT O
cysteine NN B-NP
synthase NN I-NP
cDNA NN I-NP
from IN O
Citrullus NN O
vulgaris NN O
( -LRB- O
watermelon NN O
) -RRB- O
by IN O
genetic JJ O
complementation NN O
in IN O
an DT O
Escherichia NNP O
coli NNS O
Cys NNS O
- : O
auxotroph NN O
. . O

-DOCSTART- X X O

In IN O
earlier JJR O
studies NNS O
we PRP O
identified VBD O
several JJ O
regulatory JJ O
elements NNS O
that WDT O
control NN O
transcriptional JJ O
activation NN O
and CC O
aerobic JJ O
repression NN O
of IN O
one CD O
of IN O
these DT O
genes NNS O
, , O
COX5b NNP B-NP
. . O

-DOCSTART- X X O

However RB O
, , O
Southern JJ O
blot NN O
and CC O
karyotype NN O
analyses NNS O
did VBD O
not RB O
reveal VB O
any DT O
significant JJ O
changes NNS O
in IN O
copy NN O
number NN O
or CC O
gross JJ O
rearrangements NNS O
of IN O
the DT O
p53 NN B-NP
gene NN I-NP
in IN O
any DT O
of IN O
the DT O
p53- NNS B-NP
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

HupI PRP B-NP
showed VBD O
strong JJ O
identity NN O
to TO O
rubredoxin NN B-NP
and CC O
rubredoxin-like JJ B-NP
proteins NNS I-NP
from IN O
many JJ O
other JJ O
bacteria NNS O
. . O

-DOCSTART- X X O

An DT O
examination NN O
was VBD O
performed VBN O
in IN O
15 CD O
patients NNS O
who WP O
had VBD O
developed VBN O
pronounced VBN O
osteomalacia NNP O
following VBG O
gastric JJ O
resection NN O
. . O

-DOCSTART- X X O

However RB O
, , O
regional JJ O
MVO2 NNP O
increased VBD O
to TO O
about IN O
the DT O
same JJ O
extent NN O
in IN O
the DT O
CFX NNP O
( -LRB- O
from IN O
6.0 CD O
+/ NNS O
- : O
0.7 CD O
to TO O
12.4 CD O
+/ NN O
- : O
0.9 CD O
ml NN O
O2.min-1 JJ O
times NNS O
100 CD O
g-1 NN O
) -RRB- O
and CC O
the DT O
LAD NN O
region NN O
( -LRB- O
from IN O
7.0 CD O
+/ CD O
- : O
0.6 CD O
to TO O
14.5 CD O
+/ NNS O
- : O
1.3 CD O
ml NN O
O2.min-1 JJ O
times NNS O
100 CD O
g-1 NN O
) -RRB- O
. . O

-DOCSTART- X X O

IGF NN B-NP
I PRP I-NP
and CC O
insulin NN B-NP
receptors NNS I-NP
are VBP O
homologous JJ O
proteins NNS O
that WDT O
function VBP O
in IN O
distinct JJ O
physiological JJ O
pathways NNS O
. . O

-DOCSTART- X X O

Tryptic JJ O
cleavage NN O
and CC O
peptide NN O
sequence NN O
analysis NN O
demonstrated VBN O
that IN O
the DT O
98-kD JJ O
protein NN O
is VBZ O
identical JJ O
to TO O
a DT O
recently RB O
cloned VBN O
protein NN O
, , O
special JJ B-NP
A-T-rich JJ I-NP
binding JJ I-NP
protein NN I-NP
1 CD I-NP
( -LRB- O
SATB1 NN B-NP
) -RRB- O
, , O
that WDT O
binds VBZ O
selectively RB O
to TO O
nuclear JJ O
matrix/scaffold-associated JJ O
regions NNS O
of IN O
DNA NNP O
( -LRB- O
MARs/SARs NN O
) -RRB- O
. . O

-DOCSTART- X X O

Acute NNP O
pancreatitis NN O
: : O
a DT O
multisystem JJ O
disease NN O
. . O

-DOCSTART- X X O

Alginate NNP O
biosynthesis NN O
is VBZ O
controlled VBN O
by IN O
a DT O
complex JJ O
regulatory JJ O
mechanism NN O
. . O

-DOCSTART- X X O

The DT O
sequence NN O
upstream RB O
of IN O
the DT O
rhlA NN B-NP
promoter NN I-NP
contains VBZ O
two CD O
inverted JJ O
repeats NNS O
which WDT O
define VB O
putative JJ O
binding NN O
sites NNS O
for IN O
the DT O
RhlR NNP B-NP
regulator NN I-NP
. . O

-DOCSTART- X X O

Heparin NNP O
had VBD O
no DT O
effect NN O
on IN O
rAC-st JJ B-NP
myosin JJ I-NP
light NN I-NP
chain NN I-NP
phosphatase NN I-NP
activity NN O
, , O
while IN O
the DT O
B NNP O
subunit-containing JJ O
forms NNS O
were VBD O
stimulated VBN O
2-3-fold JJ O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
AND CC O
DESIGN NNP O
: : O
Fifty-nine CD O
melanocytic JJ O
nevi NN O
with IN O
eccentric JJ O
foci NNS O
of IN O
hyperpigmentation NN O
( -LRB- O
"small JJ O
dark NN O
dots NNS O
" `` O
) -RRB- O
that WDT O
measured VBD O
primarily RB O
1 CD O
to TO O
2 CD O
mm CD O
in IN O
diameter NN O
were VBD O
prospectively RB O
examined VBN O
to TO O
determine VB O
the DT O
histologic NN O
correlates NNS O
of IN O
the DT O
dark JJ O
dots NNS O
. . O

-DOCSTART- X X O

The DT O
central JJ O
globular JJ O
domain NN O
is VBZ O
highly RB O
similar JJ O
to TO O
those DT O
regions NNS O
from IN O
other JJ O
H1 NNP B-NP
molecules NNS I-NP
, , O
and CC O
the DT O
carboxyl-terminal JJ O
domain NN O
contains VBZ O
a DT O
repeating VBG O
hexapeptide NN O
motif NN O
, , O
variants NNS O
of IN O
which WDT O
are VBP O
conserved VBN O
among IN O
H1 NNP B-NP
molecules NNS I-NP
. . O

-DOCSTART- X X O

A DT O
single JJ O
NMSC NNP O
was VBD O
present JJ O
in IN O
69.4 CD O
% NN O
, , O
two CD O
in IN O
16 CD O
% NN O
, , O
three CD O
in IN O
6.4 CD O
% NN O
, , O
four CD O
in IN O
3.5 CD O
% NN O
, , O
five CD O
to TO O
nine CD O
in IN O
4.2 CD O
% NN O
, , O
and CC O
0.5 CD O
% NN O
had VBD O
ten CD O
or CC O
more JJR O
. . O

-DOCSTART- X X O

A DT O
constitutive JJ O
mutant JJ O
form NN O
with IN O
a DT O
single JJ O
substitution NN O
(V88A NN O
) -RRB- O
in IN O
the DT O
amino-terminal JJ O
( -LRB- O
response NN O
regulator NN O
) -RRB- O
region NN O
was VBD O
used VBN O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Sonographic JJ O
angiography NN O
has VBZ O
a DT O
possible JJ O
role NN O
in IN O
the DT O
detection NN O
of IN O
small JJ O
nodules NNS O
in IN O
patients NNS O
with IN O
CRF. NNP O

-DOCSTART- X X O

The DT O
first JJ O
85 CD O
nt NN O
upstream RB O
of IN O
the DT O
transcription NN O
initiation NN O
site NN O
of IN O
the DT O
mouse NN B-NP
desmin NN I-NP
gene NN I-NP
, , O
which WDT O
contain VBP O
an DT O
E NN O
box NN O
( -LRB- O
E1 NNP O
) -RRB- O
, , O
the DT O
binding JJ O
site NN O
of IN O
the DT O
helix-loop-helix NN B-NP
myogenic JJ I-NP
regulators NNS I-NP
, , O
are VBP O
sufficient JJ O
to TO O
confer VB O
low JJ O
level NN O
muscle-specific JJ O
expression NN O
. . O

-DOCSTART- X X O

We PRP O
find VBP O
that DT O
beta JJ B-NP
II NNP I-NP
PKC NNP I-NP
phosphorylates NNS O
nuclear JJ B-NP
envelope NN I-NP
lamin NN I-NP
B NNP I-NP
at IN O
10-20 CD O
times NNS O
the DT O
rate NN O
of IN O
alpha NN B-NP
PKC NNP I-NP
, , O
whereas IN O
both DT O
kinases NNS O
phosphorylate VBP O
soluble JJ B-NP
lamin NN I-NP
B NNP I-NP
at IN O
similar JJ O
rates NNS O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
parathyroid NN B-NP
hormone-related JJ I-NP
protein NN I-NP
( -LRB- O
PTHrP NN B-NP
) -RRB- O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
demonstrate VBP O
that IN O
a DT O
diverse JJ O
set NN O
of IN O
carboxyl-terminal JJ O
sequence NN O
motifs NNS O
and CC O
posttranslational JJ O
modifications NNS O
lead NN O
to TO O
functional JJ O
Ras NNP B-NP
proteins VBZ I-NP
in IN O
yeast NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
c-Abl JJ B-NP
activates NNS O
c-myc JJ B-NP
transcription NN O
indirectly RB O
with IN O
no DT O
requirement NN O
for IN O
DNA NNP O
binding NN O
by IN O
c-Abl JJ B-NP
. . O

-DOCSTART- X X O

Extensive JJ O
DNA NNP O
rearrangement NN O
occurs VBZ O
during IN O
the DT O
development NN O
of IN O
the DT O
somatic JJ O
macronucleus NN O
from IN O
the DT O
germ NN O
line NN O
micronucleus NN O
in IN O
ciliated JJ O
protozoans NNS O
. . O

-DOCSTART- X X O

An DT O
in IN O
vitro NN O
binding JJ O
site NN O
selection NN O
procedure NN O
was VBD O
used VBN O
to TO O
determine VB O
DNA NNP O
sequences NNS O
preferentially RB O
bound VBN O
by IN O
wild-type JJ B-NP
HLF NNP I-NP
and CC O
chimeric JJ O
E2A-HLF JJ B-NP
proteins NNS O
isolated VBN O
from IN O
various JJ O
t( NNS O
17;19)-bearing JJ O
leukemias NNS O
. . O

-DOCSTART- X X O

The DT O
Oct-2 NNP B-NP
glutamine-rich JJ O
and CC O
proline-rich JJ O
activation NN O
domains VBZ O
can MD O
synergize VB O
with IN O
each DT O
other JJ O
or CC O
duplicates NNS O
of IN O
themselves PRP O
to TO O
activate VB O
transcription NN O
. . O

-DOCSTART- X X O

Binding NNP O
of IN O
U2 DT B-NP
small JJ I-NP
nuclear JJ I-NP
ribonucleoprotein NN I-NP
( -LRB- O
snRNP NN O
) -RRB- O
to TO O
the DT O
pre-mRNA NNP O
is VBZ O
an DT O
early JJ O
and CC O
important JJ O
step NN O
in IN O
spliceosome JJ O
assembly NN O
. . O

-DOCSTART- X X O

Marine NNP O
oils NNS O
and CC O
cardiovascular JJ O
reactivity NN O
. . O

-DOCSTART- X X O

The DT O
diagnostic JJ O
significance NN O
of IN O
creatine JJ B-NP
phosphokinase NN I-NP
antibodies NNS O
in IN O
the DT O
cardiac JJ O
muscle NN O
in IN O
non-coronarogenic JJ O
myocardial JJ O
diseases NNS O

-DOCSTART- X X O

According VBG O
to TO O
the DT O
results NNS O
of IN O
assays VBG O
obtained VBN O
with IN O
the DT O
use NN O
of IN O
assay NN O
systems NNS O
ORTHO IN O
ELISA NNP O
and CC O
ABBOTT NNP O
HCV NNP O
EIA NNP O
( -LRB- O
USA NNP O
) -RRB- O
, , O
the DT O
detection NN O
rate NN O
of IN O
anti-HCV-C100-3 JJ B-NP
among IN O
primary JJ O
blood NN O
donors NNS O
in IN O
Moscow NNP O
was VBD O
1.37 CD O
% NN O
and CC O
was VBD O
not RB O
different JJ O
from IN O
that DT O
among IN O
HBsAg NN B-NP
carriers NNS O
( -LRB- O
1.8 CD O
% NN O
) -RRB- O
and CC O
among IN O
donors NNS O
with IN O
anti-HCV-C100-3 JJ B-NP
in IN O
the DT O
blood NN O
( -LRB- O
1.6 CD O
% NN O
) -RRB- O
( -LRB- O
p NN O
< JJ O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
examined VBD O
the DT O
hypothesis NN O
that IN O
the DT O
coronary JJ O
vasomotor NN O
responses NNS O
to TO O
etomidate VB O
( -LRB- O
ETO NNP O
) -RRB- O
, , O
propofol FW O
( -LRB- O
PRO NN O
) -RRB- O
, , O
and CC O
sodium NN O
thiopental JJ O
(STP NNS O
) -RRB- O
are VBP O
mediated VBN O
through IN O
contrasting VBG O
effects NNS O
on IN O
the DT O
resting VBG O
nitric JJ O
oxide NN O
( -LRB- O
NO)-dependent JJ O
vasodilator NN O
tone NN O
that WDT O
opposes VBZ O
adrenergic JJ O
vasoconstrictor NN O
activity NN O
in IN O
the DT O
intact JJ O
dog NN O
. . O

-DOCSTART- X X O

Significant NNP O
alterations NNS O
in IN O
CBC NNP O
results NNS O
and CC O
serum NN B-NP
CRP NNP I-NP
concentration NN O
, , O
compared VBN O
with IN O
baseline NN O
values NNS O
, , O
were VBD O
lacking VBG O
in IN O
dogs NNS O
of IN O
the DT O
control NN O
group NN O
. . O

-DOCSTART- X X O

These DT O
alternative JJ O
splice NN O
variants NNS O
were VBD O
detected VBN O
in IN O
RNA NNP O
isolated VBD O
from IN O
several JJ O
sources NNS O
, , O
including VBG O
primary JJ O
leptomeningeal JJ O
tissue NN O
and CC O
an DT O
established JJ O
line NN O
of IN O
leptomeningeal JJ O
cells NNS O
( -LRB- O
LMC) NNP O
. . O

-DOCSTART- X X O

Surface-coil JJ O
experiments NNS O
on IN O
phantoms NNS O
and CC O
on IN O
human JJ O
calf NN O
muscles NNS O
in IN O
vivo NN O
are VBP O
presented VBN O
. . O

-DOCSTART- X X O

Large JJ O
interpatient JJ O
variation NN O
in IN O
peak NN O
PCZ NN O
plasma NN O
levels NNS O
(91-3215 CC O
ng/ml NN O
) -RRB- O
was VBD O
seen VBN O
, , O
with IN O
the DT O
plasma NN O
half-life NN O
( -LRB- O
t1/2 JJ O
alpha NN O
) -RRB- O
being VBG O
approximately RB O
57 CD O
min NN O
in IN O
patients NNS O
given VBN O
135-180 CD O
mg/m2 CD O
PCZ. . O

-DOCSTART- X X O

The DT O
maximal JJ O
effect NN O
was VBD O
seen VBN O
at IN O
100 CD O
ng/ml JJ O
EGF NN B-NP
, , O
with IN O
a DT O
time NN O
lag NN O
of IN O
about IN O
5 CD O
h NN O
. . O

-DOCSTART- X X O

KAR1 NNP B-NP
encodes VBZ O
an DT O
essential JJ O
component NN O
of IN O
the DT O
yeast NN O
spindle NN O
pole NN O
body NN O
( -LRB- O
SPB) NNP O
that WDT O
is VBZ O
required VBN O
for IN O
karyogamy NN O
and CC O
SPB NNP O
duplication NN O
. . O

-DOCSTART- X X O

During IN O
transcript NN O
elongation NN O
, , O
the DT O
sizes NNS O
of IN O
the DT O
DNA NNP O
footprint NN O
and CC O
the DT O
single-stranded JJ O
transcription NN O
bubble NN O
vary VBP O
markedly RB O
among IN O
transcription NN O
complexes NNS O
halted VBD O
at IN O
different JJ O
template JJ O
positions NNS O
. . O

-DOCSTART- X X O

All DT O
our PRP$ O
patients NNS O
had VBD O
polyps NNS O
, , O
23 CD O
( -LRB- O
54 CD O
% NN O
) -RRB- O
had VBD O
asthma NN O
, , O
12 CD O
( -LRB- O
27 CD O
% NN O
) -RRB- O
had VBD O
aspirin JJ O
sensitivity NN O
, , O
20 CD O
( -LRB- O
65 CD O
% NN O
) -RRB- O
had VBD O
eosinophilia NNS O
, , O
and CC O
9 CD O
( -LRB- O
69 CD O
% NN O
) -RRB- O
had VBD O
increased VBN O
total JJ O
IgE NN B-NP
levels NNS O
. . O

-DOCSTART- X X O

A DT O
short JJ O
sequence NN O
surrounding VBG O
the DT O
major JJ O
JNK NNP B-NP
phosphorylation NN O
site NN O
of IN O
c-Jun NN B-NP
is VBZ O
conserved VBN O
in IN O
c-Fos JJ B-NP
and CC O
is VBZ O
part NN O
of IN O
its PRP$ O
activation NN O
domain NN O
, , O
suggesting VBG O
that IN O
c-Fos NNS B-NP
may MD O
be VB O
similarly RB O
regulated VBN O
. . O

-DOCSTART- X X O

c-Fos JJ B-NP
transcriptional JJ O
activity NN O
stimulated VBN O
by IN O
H-Ras-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
distinct JJ O
from IN O
JNK NNP B-NP
and CC O
ERK. NNP B-NP

-DOCSTART- X X O

A DT O
new JJ O
generation NN O
of IN O
information NN O
retrieval NN O
tools NNS O
for IN O
biologists NNS O
: : O
the DT O
example NN O
of IN O
the DT O
ExPASy NNP O
WWW NNP O
server NN O
. . O

-DOCSTART- X X O

The DT O
partial JJ O
ORF NN O
was VBD O
found VBN O
to TO O
be VB O
identical JJ O
to TO O
the DT O
C NNP O
terminus NN O
of IN O
HrpJ2 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
binding NN O
of IN O
transcription NN O
factor NN O
AP-1 NN B-NP
and CC O
vitamin NN B-NP
D NN I-NP
receptor NN I-NP
(VDR) NN O
to TO O
the DT O
composite JJ O
AP-1 NN B-NP
plus CC I-NP
vitamin-D-responsive JJ I-NP
promoter NN I-NP
region NN O
( -LRB- O
AP-1 NN B-NP
+ JJ I-NP
VDRE NNP I-NP
) -RRB- O
of IN O
the DT O
human JJ B-NP
osteocalcin NN I-NP
gene NN I-NP
was VBD O
characterized VBN O
in IN O
osteocalcin-producing NN B-NP
( -LRB- O
MG-63 JJ O
) -RRB- O
and CC O
non-producing JJ O
( -LRB- O
U2-Os JJ O
, , O
SaOs-2 JJ O
) -RRB- O
human JJ O
osteosarcoma NN O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

Rapid NNP O
detection NN O
of IN O
this DT O
mutation NN O
is VBZ O
achieved VBN O
by IN O
restriction NN O
digestion NN O
of IN O
PCR-amplified JJ O
genomic JJ O
DNA NN O
; : O
a DT O
mismatch NN O
primer NN O
combined VBN O
with IN O
the DT O
point NN O
mutation NN O
creates VBZ O
a DT O
Tru9I JJ B-NP
restriction NN I-NP
site NN I-NP
. . O

-DOCSTART- X X O

Wild JJ B-NP
type NN I-NP
and CC I-NP
mutant JJ I-NP
Epo NNP I-NP
cDNAs NNS I-NP
were VBD O
transiently RB O
expressed VBN O
at IN O
high JJ O
levels NNS O
in IN O
COS1 NNP O
and CC O
COS7 NNP O
cells NNS O
. . O

-DOCSTART- X X O

OBJECTIVE--To NNP O
assess VBP O
the DT O
risk NN O
of IN O
hepatitis NN O
A NNP O
in IN O
international JJ O
travelers NNS O
and CC O
to TO O
recommend VB O
preventive JJ O
measures NNS O
. . O

-DOCSTART- X X O

2. . O

-DOCSTART- X X O

Acupuncture NNP O
effect NN O
on IN O
deep JJ O
receptors NNS O
was VBD O
not RB O
limited VBN O
to TO O
one CD O
point NN O
but CC O
within IN O
a DT O
certain JJ O
area NN O
, , O
namely RB O
distant JJ O
effect NN O
existed VBD O
. . O

-DOCSTART- X X O

Smoking VBG O
history NN O
and CC O
awake JJ O
oxygen NN O
saturation NN O
( -LRB- O
SaO2 NNP O
) -RRB- O
was VBD O
recorded VBN O
in IN O
all DT O
of IN O
them PRP O
. . O

-DOCSTART- X X O

This DT O
mode NN O
of IN O
ternary JJ O
complex JJ O
formation NN O
is VBZ O
in IN O
contrast NN O
to TO O
the DT O
one CD O
seen VBN O
in IN O
the DT O
promoter NN O
of IN O
the DT O
c-fos JJ B-NP
protooncogene NN I-NP
, , O
where WRB O
formation NN O
of IN O
the DT O
ternary JJ O
complex NN O
is VBZ O
dependent JJ O
on IN O
the DT O
prior JJ O
assembly NN O
of IN O
the DT O
serum NN B-NP
response NN I-NP
factor-DNA NNS I-NP
binary JJ I-NP
complex NN I-NP
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
leader-mRNA JJ O
fusion NN O
in IN O
coronavirus NN O
transcription NN O
does VBZ O
not RB O
require VB O
direct JJ O
RNA-RNA JJ O
interaction NN O
between IN O
complementary JJ O
sequences NNS O
. . O

-DOCSTART- X X O

Vaccinia NNP O
virus-expressed JJ O
, , O
purified VBN O
full-length JJ B-NP
HPV-16 . I-NP
and CC I-NP
BPV-1 JJ I-NP
E2 JJ I-NP
proteins NNS I-NP
bound VBN O
a DT O
consensus NN O
E2 NN B-NP
site NN I-NP
with IN O
high JJ O
specific JJ O
affinities NNS O
( -LRB- O
Kd NNP O
= SYM O
approximately RB O
10(-9 CD O
) -RRB- O
M NNP O
) -RRB- O
and CC O
stimulated VBD O
in IN O
vitro NN O
transcription NN O
up IN O
to TO O
six CD O
- : O
to TO O
eightfold RB O
. . O

-DOCSTART- X X O

This DT O
alternatively RB O
spliced VBN O
transcript NN O
contained VBD O
an DT O
open JJ O
reading NN O
frame NN O
extending VBG O
from IN O
the DT O
upstream JJ O
J NNP O
alpha NN O
11-2 CD O
region NN O
to TO O
82 CD O
nucleotides NNS O
downstream NN O
of IN O
the DT O
beginning NN O
of IN O
the DT O
TCR NNP B-NP
C NNP I-NP
alpha NN I-NP
region NN I-NP
, , O
and CC O
potentially RB O
encoded VBD O
a DT O
36 CD O
amino IN O
acid NN O
polypeptide NN O
. . O

-DOCSTART- X X O

Demographic JJ O
characteristics NNS O
and CC O
risk VB O
factor NN O
data NNS O
for IN O
76,672 CD O
clients NNS O
were VBD O
studied VBN O
to TO O
characterize VB O
the DT O
distribution NN O
of IN O
infection NN O
with IN O
human JJ O
immunodeficiency NN O
virus NN O
( -LRB- O
HIV NNP O
) -RRB- O
and CC O
the DT O
use NN O
of IN O
counseling NN O
and CC O
testing VBG O
facilities NNS O
in IN O
Houston NNP O
, , O
Tex NNP O
. . O

-DOCSTART- X X O

Results NNS O
indicate VBP O
that IN O
KNM-LU NNP O
335 CD O
differs NNS O
from IN O
both DT O
human JJ O
and CC O
chimpanzee JJ O
M1s NNS O
in IN O
relative JJ O
distances NNS O
( -LRB- O
measured VBN O
in IN O
three CD O
dimensions NNS O
) -RRB- O
between IN O
crown NN O
fissure NN O
termini NN O
. . O

-DOCSTART- X X O

We PRP O
describe VBP O
49 CD O
cases NNS O
with IN O
papillary NN O
tumor NN O
< VBD O
1 CD O
cm NN O
. . O

-DOCSTART- X X O

Structure NNP O
, , O
promoter NN O
analysis NN O
and CC O
chromosomal JJ O
assignment NN O
of IN O
the DT O
human JJ B-NP
APEX NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
polyubiquitin NN B-NP
gene NN I-NP
was VBD O
transcribed VBN O
throughout IN O
the DT O
Volvox NNP O
life NN O
cycle NN O
with IN O
peaks NNS O
in IN O
the DT O
1.6-kb JJ O
mRNA NN O
levels NNS O
during IN O
pre-cleavage JJ O
, , O
cleavage JJ O
, , O
and CC O
post-inversion NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
in IN O
stress-induced JJ O
arrhythmic JJ O
disease NN O
as RB O
well RB O
as IN O
in IN O
ischemic JJ O
heart NN O
disease NN O
, , O
the DT O
main JJ O
pathogenetic NN O
links NNS O
are VBP O
outside IN O
the DT O
heart NN O
, , O
but CC O
they PRP O
differ VBP O
from IN O
those DT O
observed VBN O
in IN O
ischemia NN O
. . O

-DOCSTART- X X O

The DT O
consensus NN O
gene NN O
order NN O
deduced VBN O
by IN O
combining VBG O
data NNS O
from IN O
both DT O
crosses NNS O
is VBZ O
D2Mit1-(Dbh, JJ B-NP
Notch1)-( JJ B-NP
Col5a1,Rxra)-Spna2-Ab JJ B-NP
l-(Ak1,Fpgs) JJ B-NP
- : O
( -LRB- O
Grp78,Pbx3)-(Epb7.2,Hc,Gsn)-Acra NNP B-NP
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
the DT O
megabase NN O
region NN O
surrounding VBG O
the DT O
dagA NN B-NP
locus NN I-NP
was VBD O
mapped VBN O
. . O

-DOCSTART- X X O

SECONDARY NNP O
OUTCOME NNP O
MEASURE--Double-blind NNP O
caffeine-withdrawal NN O
evaluation NN O
. . O

-DOCSTART- X X O

Elimination NNP O
of IN O
natural JJ O
antibodies NNS O
in IN O
discordant NN O
xenografts NNS O

-DOCSTART- X X O

An DT O
8-bp JJ O
sequence NN O
( -LRB- O
ATTTCAAA NNP O
) -RRB- O
within IN O
the DT O
protected JJ O
region NN O
shares NNS O
significant JJ O
homology NN O
with IN O
promoter NN O
sequences NNS O
required VBN O
for IN O
ethylene NN O
responsiveness NN O
from IN O
the DT O
tomato NN O
fruit-ripening NN O
E4 NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Cowpox NNP O
virus NN O
contains VBZ O
two CD O
copies NNS O
of IN O
an DT O
early JJ B-NP
gene NN I-NP
encoding VBG O
a DT O
soluble JJ O
secreted JJ O
form NN O
of IN O
the DT O
type NN B-NP
II NNP I-NP
TNF NNP I-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

DNase NN B-NP
I PRP I-NP
footprinting VBG O
analysis NN O
indicated VBN O
that IN O
DREF NNP B-NP
binds NNS O
to TO O
the DT O
24-bp JJ O
DRE NNP O
region NN O
of IN O
the DT O
DNA NNP B-NP
polymerase NN I-NP
alpha NN I-NP
gene NN I-NP
in IN O
which WDT O
8-bp JJ O
palindromic JJ O
sequences NNS O
are VBP O
centered VBN O
. . O

-DOCSTART- X X O

However RB O
, , O
tyrA NN B-NP
can MD O
be VB O
expressed VBN O
efficiently RB O
from IN O
an DT O
internal JJ O
promoter NN O
which WDT O
appears VBZ O
to TO O
lie VB O
within IN O
the DT O
3' JJ O
portion NN O
of IN O
aroF NNS B-NP
. . O

-DOCSTART- X X O

Within IN O
the DT O
span NN O
of IN O
attenuator NN O
region NN O
encoding VBG O
the DT O
three CD O
stem-loop JJ O
structures NNS O
of IN O
mRNA NN O
secondary JJ O
configuration NN O
, , O
hot JJ O
spots NNS O
of IN O
base-residue JJ O
divergence NN O
were VBD O
localized VBN O
to TO O
looped-out JJ O
regions NNS O
. . O

-DOCSTART- X X O

Most JJS O
, , O
however RB O
, , O
would MD O
tell VB O
the DT O
spouse NN O
the DT O
full JJ O
truth NN O
about IN O
both DT O
diagnosis NN O
and CC O
prognosis NN O
. . O

-DOCSTART- X X O

Previous JJ O
studies NNS O
showed VBD O
that IN O
mutations NNS O
in IN O
the DT O
6K JJ O
protein NN O
led VBD O
to TO O
the DT O
slow JJ O
release NN O
of IN O
aberrant JJ O
, , O
multi-cored JJ O
infectious JJ O
virions NNS O
. . O

-DOCSTART- X X O

Metabolism NN O
of IN O
calcium NN O
and CC O
vitamin NN O
D3 NNS O
in IN O
patients NNS O
with IN O
acute JJ O
tubulointerstitial JJ O
nephritis NN O
: : O
a DT O
study NN O
of IN O
41 CD O
patients NNS O
with IN O
nephropathia NN O
epidemica NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
this DT O
study NN O
demonstrates VBZ O
that IN O
reduced VBN O
inotropy NN O
with IN O
timolol NN O
helped VBD O
uniform JJ O
local JJ O
contraction NN O
as IN O
estimated VBN O
by IN O
the DT O
increased VBN O
LONG/CIRC NNP O
ratio NN O
, , O
a DT O
transition NN O
that WDT O
could MD O
improve VB O
contraction NN O
efficacy NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
moderate JJ O
hypercapnia NN O
on IN O
hypothermia NN O
induced VBN O
by IN O
cold JJ O
He-O2 NNP O
in IN O
rats NNS O
. . O

-DOCSTART- X X O

The DT O
RFLP NNP O
patterns NNS O
of IN O
the DT O
isolates NNS O
from IN O
six CD O
of IN O
these DT O
patients NNS O
remained VBD O
essentially RB O
unchanged JJ O
( -LRB- O
two CD O
strains NNS O
showed VBD O
one CD O
additional JJ O
band NN O
) -RRB- O
despite IN O
the DT O
development NN O
of IN O
drug NN O
resistance NN O
. . O

-DOCSTART- X X O

We PRP O
recommend VBP O
that IN O
ovarian JJ O
stimulation NN O
is VBZ O
done VBN O
only RB O
if IN O
there EX O
is VBZ O
a DT O
valid JJ O
indication NN O
after IN O
proper JJ O
assessment NN O
of IN O
the DT O
ovaries NNS O
, , O
and CC O
that DT O
women NNS O
who WP O
have VBP O
had VBN O
ovarian JJ O
stimulation NN O
are VBP O
followed VBN O
for IN O
longer JJR O
than IN O
at IN O
present NN O
. . O

-DOCSTART- X X O

Activation NN O
of IN O
the DT O
aboral JJ O
ectoderm-specific JJ B-NP
Spec2a NNP I-NP
gene NN I-NP
in IN O
blastula-stage NN O
sea NN O
urchin IN O
embryos NNS O
requires VBZ O
an DT O
upstream JJ O
regulatory JJ O
region NN O
that WDT O
is VBZ O
part NN O
of IN O
a DT O
repetitive JJ O
sequence NN O
element NN O
( -LRB- O
RSR NNP O
) -RRB- O
associated VBN O
with IN O
all DT O
Spec1/Spec2 JJ B-NP
genes NNS O
. . O

-DOCSTART- X X O

A DT O
transcript NN O
of IN O
about IN O
2 CD O
kb NN O
is VBZ O
expected VBN O
for IN O
each DT O
PPO NNP B-NP
. . O

-DOCSTART- X X O

Mutations NNS O
in IN O
a DT O
region NN O
located VBN O
15 CD O
to TO O
30 CD O
bp NN O
downstream NN O
from IN O
the DT O
major JJ O
transcription NN O
start NN O
site NN O
that WDT O
shows VBZ O
good JJ O
homology NN O
to TO O
a DT O
sequence NN O
in IN O
the DT O
first JJ O
exon NN O
of IN O
c-fos JJ B-NP
implicated VBN O
as IN O
a DT O
negative JJ O
regulatory JJ O
element NN O
resulted VBD O
in IN O
a DT O
significant JJ O
increase NN O
in IN O
basal JJ O
gene NN O
expression NN O
but CC O
did VBD O
not RB O
affect VB O
regulation NN O
. . O

-DOCSTART- X X O

Salazopyrine NNP O
desensitization NN O

-DOCSTART- X X O

During IN O
exercise NN O
, , O
the DT O
Pes-Ves NNP O
relation NN O
was VBD O
shifted VBN O
toward IN O
the DT O
left NN O
and CC O
the DT O
slope NN O
[end-systolic JJ O
elastance NN O
( -LRB- O
Ees NNS O
) -RRB- O
] SYM O
increased VBN O
from IN O
7.7 CD O
+/ CD O
- : O
2.8 CD O
to TO O
12.7 CD O
+/ CD O
- : O
4.2 CD O
( -LRB- O
SD NNP O
) -RRB- O
mmHg/ml NN O
( -LRB- O
P NNP O
< NN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
HRI NNP B-NP
and CC O
dsRNA-PK JJ B-NP
phosphorylate NN O
yeast NN B-NP
eIF-2 JJ I-NP
alpha NN I-NP
in IN O
vitro NN O
and CC O
in IN O
vivo JJ O
and CC O
functionally RB O
substitute VB O
for IN O
GCN2 NNP B-NP
protein NN I-NP
to TO O
stimulate VB O
GCN4 NNP B-NP
translation NN O
in IN O
yeast NN O
. . O

-DOCSTART- X X O

Double-staining NNP O
confirmed VBD O
that IN O
there EX O
were VBD O
separate JJ O
populations NNS O
of IN O
CD68-positive JJ B-NP
macrophages NNS O
and CC O
XIIIa-positive JJ B-NP
dendrocytes NNS O
. . O

-DOCSTART- X X O

Southern JJ O
analysis NN O
on IN O
genomic JJ O
DNA NNP O
isolated VBN O
from IN O
tissues NNS O
and CC O
cell NN O
lines NNS O
from IN O
several JJ O
mouse NN O
strains NNS O
using VBG O
mCD22 NN B-NP
cDNA NN I-NP
demonstrated VBD O
that IN O
the DT O
Cd22 NN B-NP
locus NN I-NP
encoding VBG O
mCD22 NN B-NP
is VBZ O
a DT O
single JJ O
copy NN O
gene NN O
of IN O
< CD O
or CC O
= SYM O
30 CD O
kb NN O
. . O

-DOCSTART- X X O

The DT O
concentrations NNS O
of IN O
plasma NN O
ACTH NNP B-NP
and CC O
cortisol NN O
increased VBN O
by IN O
40 CD O
% NN O
and CC O
60 CD O
% NN O
after IN O
MPTP NNP O
treatment NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Instead RB O
, , O
the DT O
results NNS O
support VBP O
the DT O
idea NN O
that IN O
Pc JJ B-NP
group NN I-NP
products NNS I-NP
provide VBP O
stable JJ O
memory NN O
or CC O
imprinting VBG O
of IN O
boundaries NNS O
which WDT O
are VBP O
initially RB O
specified VBN O
by IN O
gap NN O
and CC O
pair-rule NN O
regulators NNS O
. . O

-DOCSTART- X X O

To TO O
investigate VB O
the DT O
regulation NN O
of IN O
expression NN O
of IN O
the DT O
human JJ B-NP
mdr1 CD I-NP
gene NN I-NP
, , O
the DT O
response NN O
of IN O
the DT O
mdr1 NN B-NP
promoter NN I-NP
to TO O
signals NNS O
involved VBN O
in IN O
cell NN O
proliferation NN O
was VBD O
examined VBN O
. . O

-DOCSTART- X X O

Fenoldopam NNP O
, , O
a DT O
dopamine NN B-NP
receptor NN I-NP
agonist NN O
, , O
has VBZ O
been VBN O
shown VBN O
, , O
in IN O
animal NN O
experiments NNS O
, , O
to TO O
improve VB O
renal JJ O
perfusion NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
3' JJ O
flanking JJ O
region NN O
of IN O
the DT O
27 CD B-NP
kDa NN I-NP
zein JJ I-NP
gene NN I-NP
, , O
several JJ O
AATAAA-like JJ O
sequences NNS O
and CC O
a DT O
sequence NN O
resembling VBG O
the DT O
mammalian JJ O
GT-rich JJ O
sequence NN O
are VBP O
present RB O
around IN O
the DT O
polyadenylation NN O
sites NNS O
. . O

-DOCSTART- X X O

When WRB O
the DT O
promoter NN O
region NN O
was VBD O
linked VBN O
with IN O
a DT O
heterologous JJ O
reporter NN O
gene NN O
, , O
we PRP O
found VBD O
that IN O
the DT O
promoter NN O
region NN O
is VBZ O
inducible JJ O
by IN O
both DT O
interferons NNS B-NP
( -LRB- O
interferon-alpha NN B-NP
and CC I-NP
-gamma NN I-NP
) -RRB- O
and CC O
interferon JJ B-NP
regulatory JJ I-NP
factor NN I-NP
1 CD I-NP
. . O

-DOCSTART- X X O

The DT O
approach NN O
derives VBZ O
from IN O
a DT O
recently RB O
described VBN O
strategy NN O
for IN O
making VBG O
recombinants NNS O
from IN O
five CD O
overlapping JJ O
EBV NNP O
cosmid-cloned JJ O
DNAs NN O
( -LRB- O
B. NNP O

-DOCSTART- X X O

Comparative JJ O
analysis NN O
with IN O
an DT O
antiandrogen NN O
niftolid JJ O
and CC O
synthetic JJ B-NP
GnRH NNP I-NP
was VBD O
carried VBN O
out RP O
in IN O
22 CD O
normal JJ O
subjects NNS O
, , O
14 CD O
patients NNS O
with IN O
primary JJ O
and CC O
20 CD O
ones NNS O
with IN O
secondary JJ O
hypogonadism NN O
, , O
and CC O
in IN O
5 CD O
patients NNS O
with IN O
clinical JJ O
signs NNS O
of IN O
gonadal JJ O
insufficiency NN O
and CC O
obscure JJ O
diagnosis NN O
in IN O
order NN O
to TO O
elucidate VB O
the DT O
pituitary JJ B-NP
gonadotropin NN I-NP
reserves NNS O
. . O

-DOCSTART- X X O

All DT O
other JJ O
normal JJ O
and CC O
transformed VBD O
lymphoid JJ O
and CC O
nonlymphoid JJ O
cell NN O
lines NNS O
and CC O
normal JJ O
tissues NNS O
were VBD O
negative JJ O
for IN O
PANG NN B-NP
expression NN O
except IN O
for IN O
the DT O
brain NN O
, , O
wherein WRB O
unique JJ O
4.0- CD O
and CC O
6.1-kb JJ O
transcripts NNS O
were VBD O
detected VBN O
. . O

-DOCSTART- X X O

The DT O
cis-acting JJ O
regulatory JJ O
properties NNS O
of IN O
an DT O
872 CD O
bp NN O
promoter NN O
fragment NN O
of IN O
a DT O
B. NNP O
napus FW O
oleosin NNP B-NP
gene NN I-NP
were VBD O
examined VBN O
by IN O
analysis NN O
of IN O
beta-glucuronidase JJ B-NP
( -LRB- O
GUS) JJ B-NP
expression NN O
in IN O
transgenic JJ O
tobacco NN O
plants NNS O
containing VBG O
an DT O
oleosin JJ B-NP
promoter-GUS JJ I-NP
transcriptional JJ O
fusion NN O
. . O

-DOCSTART- X X O

This DT O
indicates VBZ O
that IN O
the DT O
mechanism NN O
by IN O
which WDT O
CX NNP O
blocks NNS O
rapid JJ O
degradation NN O
of IN O
tubulin NN B-NP
mRNA NNS I-NP
in IN O
vivo NN O
is VBZ O
not RB O
simply RB O
by IN O
preventing VBG O
its PRP$ O
translation NN O
and CC O
suggests VBZ O
the DT O
involvement NN O
of IN O
an DT O
altered JJ O
trans-factor NN O
. . O

-DOCSTART- X X O

L. NNP O
, , O
Greer NNP O
, , O
J. NNP O
& CC O
Carter NNP O
, , O
G. NNP O

-DOCSTART- X X O

Increasing VBG O
the DT O
extracellular JJ O
calcium NN O
concentration NN O
enhanced VBN O
detrusor NN O
contractility NN O
in IN O
a DT O
dose-dependent JJ O
manner NN O
in IN O
both DT O
control NN O
and CC O
obstructed VBD O
bladders NNS O
. . O

-DOCSTART- X X O

Structural JJ O
organization NN O
of IN O
the DT O
gene NN O
encoding VBG O
the DT O
human JJ B-NP
lipocalin NN I-NP
tear VB I-NP
prealbumin NN I-NP
and CC O
synthesis NN O
of IN O
the DT O
recombinant JJ O
protein NN O
in IN O
Escherichia NNP O
coli NNS O
. . O

-DOCSTART- X X O

The DT O
sequence NN O
has VBZ O
a DT O
1092-bp JJ O
open JJ O
reading NN O
frame NN O
encoding VBG O
a DT O
protein NN O
of IN O
364 CD O
amino IN O
acids NNS O
. . O

-DOCSTART- X X O

The DT O
gene NN O
organization NN O
of IN O
CRSV NNP B-NP
RNA-1 NN I-NP
is VBZ O
similar JJ O
to TO O
those DT O
of IN O
red JJ O
clover NN O
necrotic JJ O
mosaic NN O
(RCNMV) NNS O
and CC O
sweet JJ O
clover NN O
necrotic JJ O
mosaic NN O
(SCNMV) IN O
dianthoviruses NNS O
with IN O
the DT O
exception NN O
that IN O
CRSV NNP B-NP
RNA-1 NNP I-NP
contains VBZ O
the DT O
additional JJ O
3'-terminal JJ O
ORF. . O

-DOCSTART- X X O

Members NNS O
of IN O
the DT O
myocyte-specific JJ B-NP
enhancer-binding JJ I-NP
factor NN I-NP
2 CD I-NP
( -LRB- O
MEF2 NN B-NP
) -RRB- O
family NN O
of IN O
transcription NN O
factors NNS O
bind VBP O
a DT O
conserved JJ O
A/T-rich JJ O
sequence NN O
in IN O
the DT O
control NN O
regions NNS O
of IN O
numerous JJ O
muscle-specific JJ O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
films NNS O
were VBD O
analyzed VBN O
using VBG O
a DT O
scanning NN O
helium-neon NN O
laser NN O
densitometer NN O
with IN O
a DT O
small JJ O
aperture NN O
of IN O
5-10 JJ O
microns NNS O
. . O

-DOCSTART- X X O

Viral NNP O
genomic JJ O
RNA NN O
for IN O
these DT O
reactions NNS O
was VBD O
obtained VBN O
directly RB O
from IN O
fecal JJ O
specimens NNS O
of IN O
infected JJ O
infant NN O
rats NNS O
. . O

-DOCSTART- X X O

GATA-1 JJ B-NP
mRNA NN I-NP
was VBD O
present JJ O
in IN O
equivalent JJ O
levels NNS O
in IN O
both DT O
erythroid JJ O
cell NN O
lines NNS O
, , O
but CC O
at IN O
a DT O
low JJ O
level NN O
in IN O
FDC-P1 JJ O
cells NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
investigated VBN O
the DT O
role NN O
of IN O
cellular JJ B-NP
p21ras JJ I-NP
protein NN I-NP
in IN O
insulin NN B-NP
and CC O
insulin-like JJ B-NP
growth NN I-NP
factor-I NN I-NP
( -LRB- O
IGF-I) NNP B-NP
signaling VBG O
pathways NNS O
. . O

-DOCSTART- X X O

The DT O
lack NN O
of IN O
the DT O
C2 NNP B-NP
domain NN O
of IN O
the DT O
Ca( NNP B-NP
2+)-dependent JJ I-NP
PKCs NNS I-NP
and CC O
the DT O
presence NN O
of IN O
a DT O
unique JJ O
NH2-terminal JJ O
sequence NN O
with IN O
a DT O
potential JJ O
signal NN O
peptide NN O
and CC O
a DT O
transmembrane NN O
domain NN O
suggest VBP O
that IN O
PKC NNP B-NP
mu NN I-NP
is VBZ O
a DT O
novel JJ O
member NN O
of IN O
the DT O
subgroup NN O
of IN O
atypical JJ O
PKCs NNS B-NP
. . O

-DOCSTART- X X O

However RB O
, , O
three CD O
Hm1 IN B-NP
mutants NNS I-NP
that WDT O
were VBD O
moderately RB O
deficient JJ O
in IN O
stimulating JJ O
PI NNP O
turnover NN O
displayed VBD O
normal JJ O
sequestration NN O
, , O
suggesting VBG O
distinct JJ O
mechanisms NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
in IN O
vitro NN O
decay NN O
reaction NN O
mixtures VBZ O
supplemented VBN O
with IN O
the DT O
20-nt JJ O
sense NN O
RNA NNP O
transcript NN O
resulted VBD O
in IN O
stabilization NN O
of IN O
R2 NNP B-NP
message NN I-NP
. . O

-DOCSTART- X X O

Deletion NNP O
analyses NNS O
of IN O
the DT O
pCD41 JJ B-NP
ORF-A NNP I-NP
and CC O
the DT O
use NN O
of IN O
promoter NN O
constructs NNS O
further RB O
mapped VBD O
an DT O
internal JJ O
functional JJ O
promoter NN O
within IN O
the DT O
pCD41 JJ B-NP
sequence NN I-NP
that WDT O
can MD O
direct VB O
the DT O
synthesis NN O
of IN O
the DT O
trans-activating JJ O
protein NN O
. . O

-DOCSTART- X X O

Seven CD O
of IN O
these DT O
had VBD O
counterparts NNS O
in IN O
the DT O
US NNP O
of IN O
herpes PRP$ O
simplex JJ O
type NN O
1 CD O
( -LRB- O
HSV-1 NN O
) -RRB- O
, , O
pseudorabies VBZ O
virus NN O
( -LRB- O
PRV NN O
) -RRB- O
, , O
and CC O
equine JJ O
herpesvirus NN O
type NN O
1 CD O
( -LRB- O
EHV-1 NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
inferred JJ O
amino JJ O
acid NN O
sequence NN O
of IN O
the DT O
cyanobacterial JJ B-NP
HemB NNP I-NP
protein NN I-NP
indicates VBZ O
a DT O
significant JJ O
difference NN O
in IN O
the DT O
metal NN O
cofactor NN O
requirement NN O
from IN O
the DT O
higher-plant JJ O
enzymes NNS O
, , O
which WDT O
was VBD O
confirmed VBN O
by IN O
overexpression NN O
and CC O
biochemical JJ O
analysis NN O
. . O

-DOCSTART- X X O

METHODS NNS O
AND CC O
RESULTS NNS O
: : O
In IN O
25 CD O
open-chest NN O
, , O
anesthetized JJ O
dogs NNS O
, , O
progressive JJ O
circumflex NN O
artery NN O
stenosis NN O
led VBD O
to TO O
a DT O
concordant NN O
decrease NN O
of IN O
circumflex JJ O
artery NN O
resting VBG O
and CC O
hyperemic JJ O
flow NN O
, , O
coronary JJ O
flow NN O
reserve NN O
, , O
and CC O
inverse JJ O
angiographic JJ O
mean JJ O
transit NN O
time NN O
Tmicro-1 JJ O
( -LRB- O
P NNP O
< NN O
.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

However RB O
, , O
a DT O
correlation NN O
was VBD O
observed VBN O
between IN O
SF NNP O
levels NNS O
of IN O
IL-8 DT B-NP
with IN O
those DT O
of IN O
lactate NN O
, , O
LDH NNP B-NP
, , O
beta JJ B-NP
2-microglobulin JJ I-NP
and CC O
glucose NN O
. . O

-DOCSTART- X X O

Although IN O
inactive JJ O
in IN O
cells NNS O
under IN O
normal JJ O
conditions NNS O
, , O
the DT O
CHOP NNP B-NP
gene NN I-NP
is VBZ O
markedly RB O
induced VBN O
by IN O
a DT O
variety NN O
of IN O
cellular JJ O
stresses VBZ O
, , O
including VBG O
nutrient JJ O
deprivation NN O
and CC O
metabolic JJ O
perturbations NNS O
. . O

-DOCSTART- X X O

The DT O
previously RB O
described VBN O
enhanced JJ O
translation NN O
of IN O
spinach JJ O
L12 NNP B-NP
mRNA NN I-NP
from IN O
its PRP$ O
two CD O
tandem NN O
AUG NNP O
codons NNS O
and CC O
the DT O
two CD O
functional JJ O
rpl12 CD B-NP
genes NNS I-NP
in IN O
Arabidopsis NNP O
probably RB O
provide VBP O
two CD O
mechanisms NNS O
for IN O
generating VBG O
the DT O
four CD O
copies NNS O
of IN O
L12/chloroplast JJ B-NP
ribosome JJ I-NP
, , O
qualitatively RB O
different JJ O
from IN O
those DT O
attempted VBN O
in IN O
eubacteria NN O
. . O

-DOCSTART- X X O

The DT O
alpha NN O
7A IN O
form NN O
RNA NNP O
contains VBZ O
an DT O
additional JJ O
113 CD O
nucleotides NNS O
compared VBN O
to TO O
the DT O
B NNP O
form NN O
, , O
and CC O
a DT O
common JJ O
coding NN O
region NN O
in IN O
the DT O
A NNP O
and CC O
B NNP O
form NN O
RNAs NN O
is VBZ O
used VBN O
in IN O
alternate JJ O
reading NN O
frames NNS O
. . O

-DOCSTART- X X O

CRS NNP B-NP
function NN O
in IN O
a DT O
5' JJ O
LTR-linked JJ O
gene NN O
expression NN O
assay NN O
correlates VBZ O
with IN O
the DT O
ability NN O
of IN O
both DT O
p60CRS NNS B-NP
and CC O
p40CRS NNS B-NP
to TO O
interact VB O
with IN O
5' JJ O
LTR NNP O
RNA NNP O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Regionalization NNP O
of IN O
drug NN O
delivery NN O
is VBZ O
a DT O
potential JJ O
method NN O
to TO O
avoid VB O
this DT O
problem NN O
. . O

-DOCSTART- X X O

MEK NNP B-NP
itself PRP O
is VBZ O
activated VBN O
via IN O
serine NN O
phosphorylation NN O
by IN O
upstream RB B-NP
activator NN I-NP
kinases NNS I-NP
, , O
including VBG O
c-raf JJ B-NP
, , O
mos NNPS B-NP
and CC O
MEK NNP B-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

The DT O
c-myc JJ B-NP
and CC O
skeletal JJ B-NP
alpha-actin NN I-NP
gene NN I-NP
promoters NNS I-NP
contain VBP O
YY1 JJ B-NP
binding NN I-NP
sites NNS I-NP
thought VBD O
to TO O
act VB O
either RB O
as IN O
positive JJ O
or CC O
negative JJ O
cis-acting JJ O
elements NNS O
. . O

-DOCSTART- X X O

MSSP-1 JJ B-NP
produced VBN O
in IN O
E. NNP O
coli NNS O
as IN O
a DT O
fusion NN O
protein NN O
with IN O
GST NNP B-NP
specifically RB O
interacted VBD O
with IN O
single-stranded JJ O
TCTTAT NN O
( -LRB- O
plus CC O
myc(H-P)21 JJ B-NP
) -RRB- O
and CC O
ACT-ATT NNP O
( -LRB- O
in IN O
minus NN O
myc(H-P)21 NN B-NP
) -RRB- O
, , O
the DT O
consensus NN O
of IN O
which WDT O
can MD O
be VB O
referred VBN O
to TO O
as IN O
A/TCTA/TA/TT. . O

-DOCSTART- X X O

Within IN O
12 CD O
hours NNS O
after IN O
MR NNP O
tomography NN O
the DT O
patients NNS O
were VBD O
surgically RB O
explored VBN O
, , O
biopsied JJ O
and CC O
if IN O
necessary JJ O
orchiectomised NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
show VBP O
that IN O
both DT O
the DT O
amino NN O
and CC O
carboxy NN O
termini NNS O
of IN O
the DT O
NS1 JJ B-NP
protein NN I-NP
molecule NN I-NP
and CC O
the DT O
cysteines NNS O
at IN O
residues NNS O
337 CD O
and CC O
340 CD O
are VBP O
essential JJ O
for IN O
tubule NN O
formation NN O
. . O

-DOCSTART- X X O

The DT O
3' JJ O
UTR NN O
has VBZ O
several JJ O
stable JJ O
hairpins NNS O
that WDT O
are VBP O
flanked VBN O
by IN O
single-stranded JJ O
( -LRB- O
A/U)UGC NNP O
sequences NNS O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
the DT O
major JJ O
site NN O
of IN O
transcriptional JJ O
initiation NN O
, , O
which WDT O
was VBD O
localized VBN O
by IN O
primer JJ O
extension NN O
250 CD O
bp NN O
upstream RB O
of IN O
the DT O
5' JJ O
end NN O
of IN O
the DT O
Ets-1 JJ B-NP
cDNA NN I-NP
clone NN I-NP
, , O
was VBD O
shown VBN O
to TO O
be VB O
identical JJ O
in IN O
normal JJ O
cells NNS O
and CC O
tumors NNS O
carrying VBG O
a DT O
provirus NN O
in IN O
the DT O
Tpl-1 JJ B-NP
locus NN I-NP
. . O

-DOCSTART- X X O

In IN O
this DT O
report NN O
, , O
we PRP O
present VBP O
two CD O
lines NNS O
of IN O
evidence NN O
that IN O
all DT O
ribosomes NNS O
which WDT O
synthesize VBP O
GCN4 NNS B-NP
have VBP O
previously RB O
translated VBN O
uORF1 NNP O
, , O
resumed VBD O
scanning NN O
, , O
and CC O
reinitiated VBD O
at IN O
the DT O
GCN4 NNP B-NP
start NN O
site NN O
. . O

-DOCSTART- X X O

Concordantly RB O
, , O
it PRP O
was VBD O
shown VBN O
that IN O
the DT O
dnHLH JJ B-NP
protein NN I-NP
Id1 NN B-NP
inhibits VBZ O
differentiation NN O
of IN O
muscle NN O
and CC O
myeloid JJ O
cells NNS O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

RNP1 NNP B-NP
, , O
a DT O
new JJ O
ribonucleoprotein NN O
gene NN O
of IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NNS O
. . O

-DOCSTART- X X O

To TO O
achieve VB O
complete JJ O
dissection NN O
of IN O
the DT O
anterior JJ O
vitreous JJ O
, , O
we PRP O
remove VBP O
even RB O
a DT O
clear JJ O
lens NN O
during IN O
the DT O
first JJ O
surgical JJ O
intervention NN O
in IN O
selected JJ O
cases NNS O
. . O

-DOCSTART- X X O

Restoration NNP O
of IN O
opponens NNS O
function VBP O
with IN O
transplantation NN O
of IN O
free JJ O
composites NNS O
dorsal JJ O
pedal JJ O
skin NN O
flap NN O
containing VBG O
m NN O
. . O
extensor NN O
hallucis NN O
brevis . O

-DOCSTART- X X O

Neither DT O
ethanol NN O
regimen VBZ O
impaired VBN O
spontaneous JJ O
alternation NN O
, , O
but CC O
the DT O
4 CD O
g NN O
ethanol.kg-1 NN O
x NN O
day-1 JJ O
regimen NNS O
increased VBD O
the DT O
percent NN O
completed VBD O
trials NNS O
. . O

-DOCSTART- X X O

The DT O
mean NN O
( -LRB- O
+/ FW O
- : O
sd NN O
) -RRB- O
intra-vesicular JJ O
pressure NN O
( -LRB- O
IVP NNP O
) -RRB- O
and CC O
maximal JJ O
urethral JJ O
closure NN O
pressures NNS O
( -LRB- O
MUCP NNS O
) -RRB- O
were VBD O
10.3 CD O
( -LRB- O
+/ NN O
- : O
1.7 CD O
) -RRB- O
and CC O
129.8 CD O
( -LRB- O
+/ FW O
- : O
19.6 CD O
) -RRB- O
cmH2O NN O
, , O
respectively RB O
, , O
and CC O
the DT O
ratio NN O
between IN O
MUCP NNP O
and CC O
IVP NNP O
was VBD O
13.2 CD O
( -LRB- O
+/ NN O
- : O
2.5 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Several JJ O
highly RB O
conserved VBN O
regions NNS O
were VBD O
identified VBN O
at IN O
the DT O
near JJ O
N NNP O
terminus NN O
, , O
middle JJ O
and CC O
C NNP O
terminus NN O
. . O

-DOCSTART- X X O

Thioredoxin NNP B-NP
( -LRB- O
TR NN B-NP
) -RRB- O
is VBZ O
a DT O
small JJ O
ubiquitous JJ O
dithiol-reductase NN B-NP
enzyme NN I-NP
first RB O
identified VBN O
in IN O
bacteria NNS O
and CC O
plants NNS O
. . O

-DOCSTART- X X O

The DT O
cysteine-rich JJ O
region NN O
of IN O
raf-1 JJ B-NP
kinase NN I-NP
contains VBZ O
zinc NN O
, , O
translocates VBZ O
to TO O
liposomes NNS O
, , O
and CC O
is VBZ O
adjacent JJ O
to TO O
a DT O
segment NN O
that WDT O
binds VBZ O
GTP-ras NNP B-NP
. . O

-DOCSTART- X X O

Kinetic NNP O
coupling NN O
and CC O
requirement NN O
for IN O
ATP NNP O
hydrolysis NN O
. . O

-DOCSTART- X X O

ATP NNP O
by IN O
itself PRP O
also RB O
reduced VBD O
polypeptide NN O
binding NN O
to TO O
Ssb1/2p VB B-NP
to TO O
a DT O
level NN O
that WDT O
was VBD O
intermediate JJ O
between IN O
that DT O
observed VBN O
for IN O
the DT O
Ssa NNP B-NP
Hsp70 NNP B-NP
proteins VBZ I-NP
tested VBN O
and CC O
BiP NNP B-NP
and CC O
DnaK. NNP B-NP

-DOCSTART- X X O

Digestion NN O
of IN O
NF-IL6 NNP B-NP
with IN O
endoprotease NN B-NP
Asp-N NNP I-NP
produced VBD O
a DT O
domain NN O
smaller JJR O
than IN O
the DT O
TCD NNP B-NP
( -LRB- O
NF-IL6 NNP B-NP
bZIP NN I-NP
domains VBZ I-NP
( -LRB- O
NFBD NN B-NP
) -RRB- O
( -LRB- O
272-345 CD O
) -RRB- O
) -RRB- O
, , O
a DT O
domain NN O
identified VBN O
either CC O
in IN O
the DT O
absence NN O
or CC O
the DT O
presence NN O
of IN O
DNA NNP O
. . O

-DOCSTART- X X O

Signaling VBG O
by IN O
tyrosine NN B-NP
kinases NNS I-NP
involves VBZ O
direct JJ O
associations NNS O
between IN O
proteins NNS O
with IN O
Src NNP B-NP
homology NN I-NP
2 CD I-NP
( -LRB- O
SH2 NN B-NP
) -RRB- O
domains NNS O
and CC O
sites NNS O
of IN O
tyrosine NN O
phosphorylation NN O
. . O

-DOCSTART- X X O

Structure NN O
and CC O
expression NN O
of IN O
the DT O
alternative JJ O
sigma NN B-NP
factor NN I-NP
, , O
RpoN NNP B-NP
, , O
in IN O
Rhodobacter NNP O
capsulatus NN O
; : O
physiological JJ O
relevance NN O
of IN O
an DT O
autoactivated JJ O
nifU2-rpoN JJ B-NP
superoperon NN O
. . O

-DOCSTART- X X O

Thus RB O
our PRP$ O
observations NNS O
establish VB O
a DT O
functional JJ O
link NN O
between IN O
the DT O
PKC NNP B-NP
and CC O
retinoid JJ O
pathways NNS O
, , O
which WDT O
are VBP O
generally RB O
considered VBN O
to TO O
have VB O
antagonistic JJ O
activities NNS O
on IN O
differentiation NN O
processes NNS O
. . O

-DOCSTART- X X O

Expression NNP O
plasmids NNS O
harboring VBG O
full-length JJ O
or CC O
kinase JJ O
domain NN O
of IN O
PKC NNP B-NP
alpha NN I-NP
and CC O
PKC JJ B-NP
delta NN I-NP
( -LRB- O
PKC NNP B-NP
alpha NN I-NP
K NNP I-NP
and CC O
PKC NNP B-NP
delta JJ I-NP
K NNP I-NP
) -RRB- O
were VBD O
constructed VBN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
both DT O
PKC NNP B-NP
alpha NN I-NP
( -LRB- O
calcium NN O
dependent JJ O
) -RRB- O
and CC O
PKC JJ B-NP
delta NN I-NP
( -LRB- O
calcium NN O
independent JJ O
) -RRB- O
may MD O
mediate VB O
the DT O
transcription NN O
of IN O
TPA-inducible JJ O
genes NNS O
through IN O
both DT O
AP-1 NNP B-NP
and CC O
non-AP-1 JJ O
sequences NNS O
. . O

-DOCSTART- X X O

With IN O
a DT O
cutoff NN O
level NN O
for IN O
TSST-1 NN B-NP
of IN O
less JJR O
than IN O
100 CD O
pg/ml NN O
, , O
28 CD O
samples NNS O
obtained VBD O
from IN O
12 CD O
patients NNS O
were VBD O
positive JJ O
for IN O
TSST-1 NN B-NP
. . O

-DOCSTART- X X O

Mapping NNP O
of IN O
intracellular JJ O
localization NN O
domains NNS O
and CC O
evidence NN O
for IN O
colocalization NN O
interactions NNS O
between IN O
the DT O
IE110 NNP B-NP
and CC O
IE175 DT B-NP
nuclear JJ O
transactivator NN O
proteins NNS O
of IN O
herpes PRP$ O
simplex JJ O
virus NN O
. . O

-DOCSTART- X X O

The DT O
revertant NN O
TATA NNP O
boxes NNS O
accelerated VBD O
the DT O
kinetics NNS O
of IN O
HIV NNP O
replication NN O
when WRB O
present JJ O
in IN O
the DT O
context NN O
of IN O
an DT O
LTR NN O
containing VBG O
a DT O
Sp1 JJ B-NP
mutation NN O
( -LRB- O
deletion NN O
or CC O
site NN O
specific JJ O
) -RRB- O
; : O
no DT O
effect NN O
was VBD O
observed VBN O
on IN O
the DT O
infectivity NN O
of IN O
wild-type JJ O
HIV. . O

-DOCSTART- X X O

Panlobular NNP O
emphysema NN O

-DOCSTART- X X O

Since IN O
the DT O
ETS NNP B-NP
domain NN I-NP
, , O
which WDT O
is VBZ O
localized VBN O
in IN O
the DT O
carboxy NN O
terminal JJ O
region NN O
of IN O
the DT O
encoded JJ O
protein NN O
, , O
is VBZ O
95 CD O
% NN O
and CC O
96 CD O
% NN O
identical JJ O
to TO O
that DT O
of IN O
PEA3 NNP B-NP
and CC O
ER81 NNP B-NP
, , O
respectively RB O
, , O
we PRP O
named VBD O
this DT O
new JJ O
member NN O
'Ets VBZ B-NP
Related VBN I-NP
Molecule NNP I-NP
PEA3-like JJ I-NP
' '' I-NP
( -LRB- O
ERM NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Gel NNP O
shift NN O
analysis NN O
indicates VBZ O
that IN O
the DT O
full-length JJ B-NP
ERM JJ I-NP
protein NN I-NP
is VBZ O
able JJ O
to TO O
bind NN O
specifically RB O
to TO O
an DT O
oligonucleotide NN O
containing VBG O
the DT O
consensus NN O
nucleotide JJ O
core NN O
sequence NN O
GGAA IN O
recognized VBN O
by IN O
the DT O
Ets NNP B-NP
proteins VBZ O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
estradiol NN O
on IN O
worm NN O
burden NN O
and CC O
peripheral JJ O
leukocytes NNS O
in IN O
Parastrongylus NNP O
malaysiensis-infected JJ O
rats NNS O
. . O

-DOCSTART- X X O

Sequence NN O
comparisons NNS O
have VBP O
shown VBN O
that IN O
Aps1p NNP B-NP
is VBZ O
more RBR O
similar JJ O
to TO O
the DT O
sigma NN O
subunit NN O
of IN O
the DT O
Golgi-localized JJ O
mammalian JJ O
AP-1 NN B-NP
complex NN I-NP
than IN O
Aps2p NNP B-NP
, , O
which WDT O
is VBZ O
more RBR O
related VBN O
to TO O
the DT O
plasma NN O
membrane NN O
AP-2 NN B-NP
sigma NN I-NP
subunit NN O
. . O

-DOCSTART- X X O

The DT O
Saccharomyces NNP B-NP
cerevisiae NN I-NP
APS1 NNP I-NP
gene NN I-NP
encodes VBZ O
a DT O
homolog NN O
of IN O
the DT O
small JJ O
subunit NN O
of IN O
the DT O
mammalian JJ B-NP
clathrin JJ I-NP
AP-1 NN B-NP
complex NN I-NP
: : O
evidence NN O
for IN O
functional JJ O
interaction NN O
with IN O
clathrin NN B-NP
at IN O
the DT O
Golgi NNP O
complex NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
are VBP O
the DT O
first JJ O
to TO O
demonstrate VB O
the DT O
structural JJ O
organization NN O
of IN O
a DT O
vertebrate JJ O
gene NN O
encoding VBG O
an DT O
integral NN O
membrane NN O
protein NN O
of IN O
the DT O
nuclear JJ O
envelope NN O
that WDT O
may MD O
be VB O
a DT O
member NN O
of IN O
a DT O
family NN O
of IN O
polypeptides NNS O
conserved VBN O
in IN O
evolution NN O
. . O

-DOCSTART- X X O

Biochemical NNP O
characterization NN O
of IN O
valosin-containing JJ B-NP
protein NN I-NP
, , O
a DT O
protein NN B-NP
tyrosine NN I-NP
kinase NN I-NP
substrate NN O
in IN O
hematopoietic JJ O
cells NNS O
. . O

-DOCSTART- X X O

All DT O
patients NNS O
with IN O
deterioriation NN O
in IN O
mental JJ O
status NN O
showed VBD O
a DT O
marked JJ O
increase NN O
in IN O
liver NN O
enzymes NNS O
( -LRB- O
aspartate NN B-NP
and CC I-NP
alanine JJ I-NP
aminotransaminases NNS I-NP
) -RRB- O
and CC O
severe JJ O
coagulopathy NN O
. . O

-DOCSTART- X X O

Eleven NNP O
patients NNS O
tested VBD O
positive JJ O
for IN O
the DT O
hepatitis NN B-NP
B NNP I-NP
surface NN I-NP
antigen NN I-NP
( -LRB- O
HBsAg NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
xylose NN B-NP
isomerase-encoding JJ I-NP
gene NN I-NP
(xylA NNS O
) -RRB- O
of IN O
Clostridium NNP O
thermosaccharolyticum , O
: : O
cloning NN O
, , O
sequencing NN O
and CC O
phylogeny NN O
of IN O
XylA NNP B-NP
enzymes NNS I-NP
. . O

-DOCSTART- X X O

Surprisingly RB O
, , O
TFIIIC NNP B-NP
alpha NN I-NP
has VBZ O
no DT O
homology NN O
to TO O
any DT O
of IN O
the DT O
yeast NN B-NP
TFIIIC NN I-NP
subunits NNS I-NP
already RB O
cloned VBN O
, , O
suggesting VBG O
a DT O
significant JJ O
degree NN O
of IN O
evolutionary JJ O
divergence NN O
for IN O
RNA NNP B-NP
polymerase NN I-NP
III NNP I-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

Transactivation NNP O
domain NN O
is VBZ O
located VBN O
downstream NN O
of IN O
the DT O
128-amino-acid JJ B-NP
runt NN I-NP
homology NN I-NP
region NN I-NP
, , O
referred VBD O
to TO O
as IN O
the DT O
Runt NNP B-NP
domain NN I-NP
. . O

-DOCSTART- X X O

We PRP O
estimate VBP O
that IN O
the DT O
protease NN O
activity NN O
is VBZ O
at IN O
least JJS O
35-fold JJ O
greater JJR O
in IN O
mature JJ O
B NNP O
cells NNS O
than IN O
in IN O
pre-B JJ O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
ligand NN O
for IN O
RXR NNP B-NP
, , O
9-cis DT O
retinoic JJ O
acid NN O
, , O
has VBZ O
the DT O
opposite JJ O
effect NN O
of IN O
destabilizing VBG O
the DT O
heterodimeric-DNA NN O
complex NN O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
the DT O
amino-terminal JJ O
sequence NN O
of IN O
the DT O
purified VBN O
carA NN B-NP
product NN I-NP
is VBZ O
identical JJ O
to TO O
that DT O
derived VBN O
from IN O
the DT O
nucleotide JJ O
sequence NN O
in IN O
both DT O
organisms NNS O
, , O
P. NNP O
stutzeri NN O
having VBG O
four CD O
additional JJ O
amino NN O
acids NNS O
. . O

-DOCSTART- X X O

Aneurysmal JJ O
bone NN O
cyst NN O
of IN O
the DT O
jaws NNS O
: : O
analysis NN O
of IN O
11 CD O
cases NNS O
. . O

-DOCSTART- X X O

Location NN O
and CC O
orientation NN O
of IN O
an DT O
activating JJ O
region NN O
in IN O
the DT O
Escherichia NNP O
coli NNS O
transcription NN O
factor NN O
, , O
FNR. . B-NP

-DOCSTART- X X O

Moxidectin NNP O
( -LRB- O
at IN O
3 CD O
times NNS O
the DT O
therapeutic JJ O
dose NN O
) -RRB- O
did VBD O
not RB O
have VB O
deleterious JJ O
effects NNS O
on IN O
cow NN O
reproductive NN O
performance NN O
as IN O
examined VBN O
(eg NN O
, , O
at IN O
folliculogenesis NN O
, , O
ovulation NN O
, , O
and CC O
the DT O
early JJ O
embryonic JJ O
phase NN O
of IN O
development NN O
) -RRB- O
. . O

-DOCSTART- X X O

Northern-blot JJ O
analysis NN O
of IN O
mRNA NN O
from IN O
Avicel-grown JJ O
N. NNP O
patriciarum NN O
showed VBD O
that IN O
xynB NNP B-NP
hybridized VBD O
to TO O
a DT O
3.4 CD O
kb NN O
mRNA NN O
species NNS O
. . O

-DOCSTART- X X O

The DT O
class NN B-NP
II NNP I-NP
Escherichia NNP I-NP
coli NNS I-NP
alanine JJR I-NP
tRNA NN I-NP
synthetase NN I-NP
aminoacylates VBZ I-NP
RNA NNP I-NP
miniduplexes NNS I-NP
, , O
which WDT O
reconstruct VBP O
the DT O
acceptor NN O
end NN O
of IN O
alanine DT B-NP
tRNA NN I-NP
with IN O
the DT O
critical JJ O
G3:U70 NN O
base NN O
pair NN O
. . O

-DOCSTART- X X O

Simple NN O
reaction NN O
time NN O
(RT NNP O
) -RRB- O
to TO O
a DT O
peripheral JJ O
visual JJ O
target NN O
( -LRB- O
S2 NN O
) -RRB- O
is VBZ O
shortened VBN O
when WRB O
a DT O
non-informative JJ O
cue NN O
( -LRB- O
S1 NNP O
) -RRB- O
is VBZ O
flashed VBN O
at IN O
the DT O
S2 NNP O
location NN O
100-150 CD O
ms NNS O
before IN O
target NN O
onset NN O
( -LRB- O
early JJ O
facilitation NN O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
second JJ O
study NN O
group NN O
, , O
with IN O
intact JJ O
cardiac JJ O
innervation NN O
, , O
consisted VBD O
of IN O
19 CD O
patients NNS O
with IN O
stable JJ O
angina NN O
pectoris NN O
class NN O
I PRP O
to TO O
III NNP O
. . O

-DOCSTART- X X O

Treatment NNP O
was VBD O
well-tolerated JJ O
. . O

-DOCSTART- X X O

A DT O
concentration NN O
of IN O
12.5 CD O
ppm NN O
SO2 NNP O
induced VBD O
a DT O
decrease NN O
from IN O
baseline NN O
values NNS O
of IN O
approximately RB O
80 CD O
% NN O
in IN O
mean JJ O
MCA NNP O
and CC O
of IN O
roughly RB O
70 CD O
% NN O
in IN O
mean JJ O
CBF. . O

-DOCSTART- X X O

We PRP O
have VBP O
used VBN O
these DT O
modified VBN O
assay NN O
conditions NNS O
to TO O
extend VB O
studies NNS O
on IN O
the DT O
transposition NN O
pathway NN O
. . O

-DOCSTART- X X O

Renal NNP O
cell NN O
carcinoma NN O
in IN O
children NNS O
: : O
a DT O
single JJ O
institution NN O
's POS O
experience NN O
. . O

-DOCSTART- X X O

Factors NNS O
associated VBN O
with IN O
intrafamilial JJ O
transmission NN O
of IN O
hepatitis NN O
B NNP O
virus NN O
infection NN O
in IN O
Korea NNP O
. . O

-DOCSTART- X X O

Northern JJ O
analysis NN O
, , O
to TO O
search VB O
for IN O
a DT O
pcbAB NN B-NP
transcript NN I-NP
, , O
showed VBD O
no DT O
distinct JJ O
transcript NN O
and CC O
indicated VBD O
severely RB O
degraded JJ O
mRNA NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
minimal JJ O
requirements NNS O
for IN O
induction NN O
of IN O
PEPCK NN B-NP
by IN O
PKA NNP B-NP
and CC O
inhibition NN O
by IN O
insulin NN B-NP
include VBP O
: : O
1 CD O
) -RRB- O
the DT O
CREB NNP B-NP
activation NN I-NP
domain NN I-NP
, , O
2 CD O
) -RRB- O
the DT O
PEPCK NN B-NP
TATA NNP I-NP
sequence NN I-NP
, , O
and CC O
3 CD O
) -RRB- O
insulin-responsive JJ B-NP
hepatoma NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
high JJ O
degree NN O
of IN O
conservation NN O
between IN O
NQO2 NNP B-NP
and CC O
NQO1 NNP B-NP
gene NN I-NP
organization NN O
and CC O
sequence NN O
confirmed VBD O
that IN O
NQO2 NNP B-NP
gene NN I-NP
encodes VBZ O
for IN O
a DT O
second JJ O
member NN O
of IN O
the DT O
NQO NNP B-NP
gene NN I-NP
family NN I-NP
in IN O
human NN O
. . O

-DOCSTART- X X O

The DT O
efficacy NN O
of IN O
a DT O
Propionibacterium NNP O
acnes NNS O
product NN O
for IN O
treatment NN O
of IN O
coliform NN O
mastitis NN O
was VBD O
evaluated VBN O
following VBG O
intramammary JJ O
infusion NN O
of IN O
Escherichia NNP O
coli NNS O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
eps15 CD I-NP
gene NN I-NP
, , O
encoding VBG O
a DT O
tyrosine NN B-NP
kinase NN I-NP
substrate NN O
, , O
is VBZ O
conserved VBN O
in IN O
evolution NN O
and CC O
maps NNS O
to TO O
1p31-p32 CD O
. . O

-DOCSTART- X X O

The DT O
gene NN O
encoding VBG O
the DT O
105-kDa JJ B-NP
protein NN I-NP
( -LRB- I-NP
p105 NN I-NP
) -RRB- I-NP
precursor NN I-NP
of IN O
the DT O
p50 NN B-NP
subunit NN I-NP
of IN O
transcription NN O
factor NN O
NF-kappa NNP B-NP
B NNP I-NP
also RB O
encodes VBZ O
a DT O
p70 NN B-NP
I PRP I-NP
kappa VBD I-NP
B NNP I-NP
protein NN I-NP
, , O
I PRP B-NP
kappa VBD I-NP
B NNP I-NP
gamma NN I-NP
, , O
which WDT O
is VBZ O
identical JJ O
to TO O
the DT O
C-terminal JJ O
607 CD O
amino IN O
acids NNS O
of IN O
p105 NN B-NP
. . O

-DOCSTART- X X O

Alternative JJ O
splicing NN O
of IN O
RNA NNP O
transcripts NNS O
encoded VBN O
by IN O
the DT O
murine NN O
p105 VBD B-NP
NF-kappa NNP B-NP
B NNP I-NP
gene NN O
generates VBZ O
I PRP B-NP
kappa VB I-NP
B NNP I-NP
gamma NN I-NP
isoforms VBZ I-NP
with IN O
different JJ O
inhibitory JJ O
activities NNS O
. . O

-DOCSTART- X X O

Topical NNP O
L-NNA NNP O
attenuated VBD O
the DT O
hypercapnic JJ O
increase NN O
of IN O
CoBF NNP O
by IN O
52 CD O
+/ NNS O
- : O
6 CD O
% NN O
and CC O
CeBF NN O
by IN O
29 CD O
+/ NNS O
- : O
5 CD O
% NN O
after IN O
45-min JJ O
exposure NN O
. . O

-DOCSTART- X X O

Glutamyl-tRNA NNP B-NP
synthetase NN I-NP
and CC O
prolyl-tRNA NN B-NP
synthetase NN I-NP
belong VBP O
to TO O
different JJ O
classes NNS O
of IN O
aminoacyl-tRNA DT B-NP
synthetases NNS I-NP
that WDT O
are VBP O
thought VBN O
to TO O
have VB O
evolved VBN O
along IN O
independent JJ O
evolutionary JJ O
pathways NNS O
. . O

-DOCSTART- X X O

DESIGN--A NNP O
randomised VBD O
study NN O
was VBD O
conducted VBN O
in IN O
all DT O
women NNS O
aged VBN O
50-70 CD O
years NNS O
who WP O
were VBD O
eligible JJ O
for IN O
breast NN O
cancer NN O
screening NN O
and CC O
living VBG O
in IN O
the DT O
city NN O
of IN O
Utrecht NNP O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
an DT O
immediate-early JJ B-NP
gene NN I-NP
in IN O
the DT O
Marek NNP O
's POS O
disease NN O
virus NN O
long JJ O
internal JJ O
repeat NN O
region NN O
which WDT O
encodes VBZ O
a DT O
unique JJ O
14-kilodalton JJ O
polypeptide NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
used VBN O
a DT O
full-length JJ O
cDNA NN O
clone NN O
of IN O
a DT O
mouse NN O
hepatitis NN O
virus NN O
strain NN O
A59 IN O
defective JJ O
interfering NN O
( -LRB- O
DI) NNP O
RNA NNP O
, , O
pMIDI-C JJ B-NP
, , O
and CC O
cassette NN O
mutagenesis NN O
to TO O
study VB O
the DT O
mechanism NN O
of IN O
coronavirus JJ O
subgenomic JJ O
mRNA NN O
synthesis NN O
. . O

-DOCSTART- X X O

To TO O
study VB O
the DT O
structure-function NN O
of IN O
the DT O
gene NN B-NP
5 CD I-NP
product NN I-NP
, , O
wild-type JJ O
and CC O
mutant JJ O
forms NNS O
of IN O
NS53 NNP B-NP
were VBD O
produced VBN O
by IN O
using VBG O
a DT O
recombinant JJ O
baculovirus NN O
expression NN O
system NN O
and CC O
a DT O
recombinant JJ O
vaccinia NN O
virus/T7 NN O
(vTF7-3 NN O
) -RRB- O
expression NN O
system NN O
. . O

-DOCSTART- X X O

Gel NNP O
electrophoresis NN O
and CC O
Western JJ O
immunoblot NN O
analyses NNS O
of IN O
intracellular JJ O
fractions NNS O
derived VBN O
from IN O
infected JJ O
cells NNS O
revealed VBD O
that IN O
large JJ O
amounts NNS O
of IN O
NS53 NNP B-NP
were VBD O
present JJ O
in IN O
the DT O
cytosol NN O
and CC O
in IN O
association NN O
with IN O
the DT O
cytoskeletal NN O
matrix NN O
. . O

-DOCSTART- X X O

The DT O
transcription NN B-NP
factor NN I-NP
AP-2 NN I-NP
is VBZ O
encoded VBN O
by IN O
a DT O
gene NN O
located VBN O
on IN O
chromosome NN O
6 CD O
near IN O
the DT O
HLA NNP B-NP
locus NN I-NP
. . O

-DOCSTART- X X O

San NNP O
Martin NNP O
's POS O
psychological JJ O
traits NNS O
coupled VBN O
to TO O
his PRP$ O
work NN O
with IN O
masonic JJ O
lodges NNS O
that WDT O
allowed VBD O
him PRP O
to TO O
display VB O
his PRP$ O
abilities NNS O
as IN O
strategist NN O
and CC O
political JJ O
ruler NN O
. . O

-DOCSTART- X X O

The DT O
participants NNS O
were VBD O
homosexual JJ O
men NNS O
in IN O
hepatitis NNP O
B NNP O
vaccine NN O
trials NNS O
in IN O
Amsterdam NNP O
( -LRB- O
n NN O
= SYM O
74) CD O
, , O
New NNP O
York NNP O
City NNP O
( -LRB- O
n NN O
= SYM O
120 CD O
) -RRB- O
, , O
and CC O
San NNP O
Francisco NNP O
( -LRB- O
n NN O
= SYM O
168 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Thrombotic JJ O
thrombocytopenic IN O
purpura NN O
in IN O
systemic JJ O
lupus NN O
erythematosus NN O
. . O

-DOCSTART- X X O

Comparison NN O
with IN O
the DT O
crystal NN O
structure NN O
of IN O
Desulfovibrio NNP O
gigas NNP O
, , O
Dg NNP O
, , O
Fd NNP B-NP
( -LRB- O
Kissinger NNP O
et NNP O
al NN O
. . O
, , O
1991 CD O
) -RRB- O
reveals VBZ O
a DT O
very RB O
similar JJ O
folding JJ O
topology NN O
, , O
although IN O
several JJ O
secondary JJ O
structural JJ O
elements NNS O
are VBP O
extended VBN O
in IN O
Pf NNP O
relative JJ O
to TO O
Dg NNP O
Fd NNP B-NP
. . O

-DOCSTART- X X O

Eight CD O
highly RB O
trained VBN O
male NN O
kayakers NNS O
were VBD O
studied VBN O
to TO O
determine VB O
the DT O
relationship NN O
between IN O
critical JJ O
power NN O
( -LRB- O
CP CD O
) -RRB- O
and CC O
the DT O
onset NN O
of IN O
blood NN O
lactate NN O
accumulation NN O
( -LRB- O
OBLA NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Women NNP O
's POS O
opportunities NNS O
for IN O
paid VBN O
work NN O
outside IN O
the DT O
home NN O
are VBP O
constrained VBN O
by IN O
their PRP$ O
role NN O
as IN O
primary JJ O
carer NN O
within IN O
the DT O
family NN O
, , O
writes VBZ O
Trudy NNP O
Wynne NNP O
. . O

-DOCSTART- X X O

Bacterially RB O
expressed VBD O
protein NN O
, , O
as RB O
well RB O
as IN O
the DT O
in IN O
vitro NN O
reticulocyte NN O
lysate NN O
translation NN O
product NN O
, , O
comigrated VBN O
with IN O
the DT O
purified VBN O
37-kDa JJ O
protein NN O
on IN O
sodium NN O
dodecyl NN O
sulfate-polyacrylamide JJ O
gels NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
this DT O
kinase NN O
is VBZ O
well RB O
conserved VBN O
evolutionarily RB O
, , O
ubiquitously RB O
expressed VBN O
, , O
and CC O
its PRP$ O
genes NNS O
map VBP O
to TO O
a DT O
position NN O
on IN O
human JJ O
chromosome NN O
1 CD O
frequently RB O
deleted VBN O
in IN O
the DT O
late JJ O
stages NNS O
of IN O
tumorigenesis NN O
. . O

-DOCSTART- X X O

Deletion NNP O
analysis NN O
of IN O
the DT O
ICL1 NNP B-NP
promoter NN I-NP
led VBD O
to TO O
the DT O
identification NN O
of IN O
an DT O
upstream JJ O
activating NN O
sequence NN O
element NN O
, , O
UASICL1 NNP O
( -LRB- O
5' VBD O
CATTCATCCG JJ O
3' JJ O
) -RRB- O
, , O
necessary JJ O
and CC O
sufficient JJ O
for IN O
conferring VBG O
carbon NN O
source-dependent JJ O
regulation NN O
on IN O
a DT O
heterologous JJ O
reporter NN O
gene NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
the DT O
interaction NN O
of IN O
ZAP-70 NNP B-NP
with IN O
the DT O
motif NN O
was VBD O
dependent JJ O
on IN O
the DT O
presence NN O
of IN O
both DT O
ZAP-70 NNP B-NP
SH2 NNP B-NP
domains NNS I-NP
and CC O
both DT O
of IN O
the DT O
tyrosine NN O
residues NNS O
in IN O
the DT O
motif NN O
, , O
suggesting VBG O
that IN O
ZAP-70 DT B-NP
interacts NNS O
with IN O
two CD O
phosphotyrosine NN O
residues NNS O
and CC O
that IN O
the DT O
binding NN O
of IN O
the DT O
two CD O
SH2 NNP B-NP
domains NNS I-NP
is VBZ O
cooperative JJ O
. . O

-DOCSTART- X X O

In IN O
Mv1Lu NNP O
lung NN O
epithelial NN O
cells NNS O
, , O
ActR-IB NNP B-NP
and CC O
T NNP B-NP
beta NN I-NP
R-I NNP I-NP
signal NN O
a DT O
common JJ O
set NN O
of IN O
growth-inhibitory JJ O
and CC O
transcriptional JJ O
responses NNS O
in IN O
association NN O
with IN O
their PRP$ O
corresponding JJ O
ligands NNS O
and CC O
type NN B-NP
II NNP I-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

50 CD O
kDa NN O
and CC O
130-170 CD O
kDa NNS O
were VBD O
detected VBN O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
systemic JJ O
glucose NN O
concentration NN O
on IN O
brain NN O
metabolism NN O
following VBG O
repeated VBN O
brain NN O
ischemia NN O
. . O

-DOCSTART- X X O

On IN O
physical JJ O
examination NN O
a DT O
mild JJ O
symmetrical JJ O
polyarthritis NN O
of IN O
small JJ O
and CC O
large JJ O
joints NNS O
was VBD O
seen VBN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
we PRP O
observe VBP O
that IN O
the DT O
hUBF-promoter NN B-NP
interaction NN O
is VBZ O
highly RB O
sensitive JJ O
to TO O
the DT O
antagonistic JJ O
effects NNS O
of IN O
cisplatin-DNA NN O
adducts NNS O
. . O

-DOCSTART- X X O

A DT O
total NN O
of IN O
7 CD O
( -LRB- O
4 CD O
males NNS O
and CC O
3 CD O
females NNS O
) -RRB- O
patients NNS O
were VBD O
included VBN O
in IN O
this DT O
retrospective JJ O
study NN O
to TO O
determine VB O
the DT O
sensitivity NN O
of IN O
radioimmunoscintigraphy NN O
with IN O
I-131 DT O
labeled VBN O
anti NNS B-NP
CEA/CA IN I-NP
19-9 CD B-NP
monoclonal JJ O
antibodies NNS O
. . O

-DOCSTART- X X O

A DT O
genomic JJ O
clone NN O
for IN O
the DT O
cyc07 CD B-NP
gene NN I-NP
, , O
which WDT O
is VBZ O
expressed VBN O
specifically RB O
at IN O
the DT O
S NNP O
phase NN O
during IN O
the DT O
cell NN O
cycle NN O
in IN O
synchronous JJ O
cultures NNS O
of IN O
periwinkle NN O
( -LRB- O
Catharanthus JJ O
roseus NN O
) -RRB- O
cells NNS O
, , O
was VBD O
isolated VBN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Translocation NN O
of IN O
bacteria NNS O
or CC O
endotoxin NN O
from IN O
the DT O
gastrointestinal JJ O
tract NN O
into IN O
the DT O
bloodstream NN O
has VBZ O
been VBN O
noted VBN O
in IN O
animal NN O
experiments NNS O
; : O
however RB O
, , O
translocation NN O
was VBD O
not RB O
detected VBN O
in IN O
our PRP$ O
patients NNS O
with IN O
hemorrhagic JJ O
shock NN O
. . O

-DOCSTART- X X O

Southern JJ O
blotting JJ O
analysis NN O
implied VBN O
the DT O
occurrence NN O
of IN O
multiple JJ O
COXVb JJ B-NP
genes NNS I-NP
in IN O
the DT O
rat NN O
genome NN O
. . O

-DOCSTART- X X O

Subunit JJ O
composition NN O
and CC O
domain NN O
structure NN O
of IN O
the DT O
Spo0A NNP B-NP
sporulation NN I-NP
transcription NN I-NP
factor NN I-NP
of IN I-NP
Bacillus NNP I-NP
subtilis NNS I-NP
. . O

-DOCSTART- X X O

Electrophoretic NNP O
mobility NN O
shift NN O
analysis NN O
indicates VBZ O
that IN O
NF-IL-6 NNP B-NP
, , O
as RB O
well RB O
as IN O
other JJ O
related JJ O
members NNS O
of IN O
this DT O
family NN O
, , O
bind NN O
specifically RB O
to TO O
the DT O
NF-IL-6 NNP B-NP
site NN O
in IN O
the DT O
IL-8 NN B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

BYV NNP O
, , O
citrus VBD O
tristeza NN O
virus NN O
( -LRB- O
CTV NN O
) -RRB- O
, , O
beet RB O
yellow JJ O
stunt NN O
virus NN O
( -LRB- O
BYSV NN O
) -RRB- O
and CC O
carnation NN O
necrotic JJ O
fleck NN O
virus NN O
templates VBZ O
produced VBN O
1 CD O
kb JJ O
amplification NN O
products NNS O
, , O
which WDT O
were VBD O
shown VBN O
by IN O
sequencing VBG O
to TO O
represent VB O
fragments NNS O
of IN O
the DT O
respective JJ O
HSP70 CD B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

The DT O
p53 NN B-NP
tumor NN I-NP
suppressor NN I-NP
gene NN I-NP
product NN I-NP
, , O
a DT O
sequence-specific JJ O
DNA-binding JJ O
protein NN O
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
act VB O
as IN O
a DT O
transcriptional JJ O
activator NN O
and CC O
repressor NN O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Mutational JJ O
analysis NN O
of IN O
chromosomal NN O
segment NN O
64AB NN O
, , O
a DT O
region NN O
containing VBG O
the DT O
glutamic JJ B-NP
acid NN I-NP
decarboxylase NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Cloning NNP O
and CC O
sequencing NN O
of IN O
the DT O
corresponding JJ O
cDNAs NN O
indicates VBZ O
that IN O
, , O
via IN O
alternative JJ O
splicing NN O
, , O
the DT O
rearranged JJ O
gene NN O
codes NNS O
for IN O
two CD O
proteins NNS O
of IN O
84 CD O
and CC O
85 CD O
kD NN O
( -LRB- O
p84/8 NN B-NP
5 CD I-NP
) -RRB- O
which WDT O
retain VBP O
the DT O
DNA-binding NNP O
rel NN B-NP
domain NN I-NP
and CC O
the DT O
first JJ O
five CD O
ankyrin IN B-NP
repeats NNS O
, , O
but CC O
have VBP O
lost VBN O
their PRP$ O
carboxy-terminus NN O
including VBG O
the DT O
seventh JJ O
ankyrin NN B-NP
repeat NN O
. . O

-DOCSTART- X X O

Transient NNP O
co-transfection NN O
assays VBZ O
involving VBG O
NFKB2 NNP B-NP
expression NN O
vectors NNS O
and CC O
kappa VB B-NP
B-driven JJ I-NP
reporter NN O
plasmids NNS O
indicate VBP O
that IN O
NFKB2 NNP B-NP
p85 . B-NP
has VBZ O
lost VBN O
the DT O
transcriptional JJ O
repressor NN O
functions VBZ O
typical JJ O
of IN O
normal JJ O
NFKB2 NN B-NP
p52 NN B-NP
. . O

-DOCSTART- X X O

Also RB O
, , O
HR21ap NNP B-NP
as RB O
well RB O
as IN O
HR21Xap NN B-NP
are VBP O
specific JJ O
in IN O
their PRP$ O
inhibition NN O
of IN O
Sp1 NNP B-NP
binding NN O
. . O

-DOCSTART- X X O

Intravenous JJ O
antibiotic JJ O
therapy NN O
in IN O
cystic JJ O
fibrosis NN O
: : O
in IN O
hospital NN O
or CC O
at IN O
home NN O
? . O

-DOCSTART- X X O

The DT O
ns2 JJ B-NP
gene NN I-NP
comprises VBZ O
an DT O
open JJ O
reading NN O
frame NN O
( -LRB- O
ORF NN O
) -RRB- O
encoding VBG O
a DT O
putative JJ O
nonstructural JJ O
( -LRB- O
ns NNS O
) -RRB- O
protein NN O
of IN O
279 CD O
amino IN O
acids NNS O
with IN O
a DT O
predicted VBN O
molecular JJ O
mass NN O
of IN O
32-kDa JJ O
. . O

-DOCSTART- X X O

Co-transfection NN O
of IN O
a DT O
tat NN B-NP
expressing VBG O
plasmid NN O
with IN O
these DT O
viruses NNS O
containing VBG O
the DT O
tat JJ B-NP
ORF NNP I-NP
mutations NNS O
resulted VBD O
in IN O
higher JJR O
levels NNS O
of IN O
virus NN O
production NN O
demonstrating VBG O
that IN O
the DT O
effects NNS O
of IN O
both DT O
mutants NNS O
are VBP O
tat JJ B-NP
specific JJ O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
gag NN B-NP
and CC O
rev JJ B-NP
proteins NNS I-NP
in IN O
the DT O
transfected JJ O
cells NNS O
demonstrated VBN O
that IN O
these DT O
proteins NNS O
were VBD O
not RB O
detectable JJ O
in IN O
cells NNS O
transfected VBN O
with IN O
the DT O
tat NN B-NP
mutants NNS I-NP
but CC O
could MD O
be VB O
readily RB O
detected VBN O
when WRB O
the DT O
mutations NNS O
were VBD O
complemented VBN O
in IN O
trans NNS O
with IN O
a DT O
tat JJ B-NP
expression NN O
vector NN O
. . O

-DOCSTART- X X O

The DT O
hydrophobicity NN O
profile NN O
of IN O
the DT O
methyltransferase NN O
reveals VBZ O
the DT O
presence NN O
of IN O
at IN O
least JJS O
five CD O
potential JJ O
transmembrane NN O
domains NNS O
. . O

-DOCSTART- X X O

The DT O
patients NNS O
in IN O
one CD O
group NN O
had VBD O
intrauterine JJ O
catheters NNS O
inserted VBN O
and CC O
oxytocin NN B-NP
was VBD O
titrated VBN O
to TO O
achieve VB O
the DT O
75th JJ O
percentile NN O
of IN O
uterine NN O
activity NN O
observed VBD O
in IN O
spontaneous JJ O
normal JJ O
labour NN O
according VBG O
to TO O
parity NN O
. . O

-DOCSTART- X X O

The DT O
ultrastructure NN O
of IN O
retinal JJ O
vessels NNS O
was VBD O
examined VBN O
in IN O
three CD O
eyes NNS O
from IN O
diabetic JJ O
patients NNS O
and CC O
two CD O
eyes NNS O
from IN O
control NN O
subjects NNS O
. . O

-DOCSTART- X X O

The DT O
regulatory JJ O
region NN O
also RB O
has VBZ O
a DT O
sequence NN O
similar JJ O
to TO O
the DT O
binding JJ O
site NN O
for IN O
a DT O
liver-specific JJ O
transcription NN O
factor NN O
, , O
hepatocyte JJ B-NP
nuclear JJ I-NP
factor NN I-NP
1 CD I-NP
( -LRB- O
HNF-1 NN B-NP
) -RRB- O
, , O
at IN O
positions NNS O
-120 JJ O
to TO O
-132 JJ O
. . O

-DOCSTART- X X O

Thus RB O
, , O
we PRP O
have VBP O
identified VBN O
a DT O
GRE NNP O
sufficient JJ O
to TO O
account VB O
for IN O
full JJ O
glucocorticoid NN O
inducibility NN O
and CC O
an DT O
HNF-1 JJ B-NP
site NN I-NP
close JJ O
to TO O
the DT O
promoter NN O
that WDT O
are VBP O
major JJ O
determinants NNS O
of IN O
transcriptional JJ O
control NN O
of IN O
the DT O
Xenopus NNP B-NP
fibrinogen NN I-NP
B NNP I-NP
beta NN I-NP
subunit NN I-NP
gene NN I-NP
in IN O
cells NNS O
from IN O
normal JJ O
liver NN O
tissue NN O
. . O

-DOCSTART- X X O

Acad NNP O
. . O

-DOCSTART- X X O

The DT O
PRB-1b JJ B-NP
gene NN I-NP
encodes VBZ O
for IN O
a DT O
basic-type JJ O
component NN O
of IN O
the DT O
pathogenesis-related JJ O
PR-1 JJ B-NP
protein NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

Reviewing VBG O
manuscripts NNS O
: : O
developing VBG O
an DT O
efficient JJ O
system NN O
. . O

-DOCSTART- X X O

We PRP O
suggest VBP O
that IN O
CT NNP O
scan MD O
be VB O
preferable JJ O
in IN O
diagnosis NN O
of IN O
tumors NNS O
in IN O
that DT O
area NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
aging VBG O
on IN O
respiratory NN O
skeletal NN O
muscles NNS O
. . O

-DOCSTART- X X O

The DT O
lengths NNS O
of IN O
the DT O
complete JJ O
polypeptide NN O
chain NN O
of IN O
the DT O
recombinant JJ O
enzyme NN O
and CC O
its PRP$ O
transit NN O
peptide NN O
are VBP O
388 CD O
and CC O
53 CD O
residues NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

We PRP O
also RB O
compared VBD O
the DT O
sequence NN O
with IN O
the DT O
partly RB O
homologous JJ O
products NNS O
of IN O
the DT O
S. NNP O
cerevisiae NN O
genes NNS O
TPS2 . B-NP
and CC O
TSL1 JJ B-NP
which WDT O
code NN O
for IN O
the DT O
larger JJR O
subunits NNS O
of IN O
the DT O
trehalose JJ B-NP
synthase NN I-NP
complex NN I-NP
and CC O
with IN O
a DT O
TSL1 NNP B-NP
homologue NN I-NP
, , O
TPS3 NNP B-NP
, , O
of IN O
unknown JJ O
function NN O
. . O

-DOCSTART- X X O

The DT O
nit-3 JJ B-NP
gene NN I-NP
of IN I-NP
the DT I-NP
filamentous JJ I-NP
fungus NN I-NP
Neurospora NNP I-NP
crassa NN I-NP
encodes VBZ O
nitrate JJ B-NP
reductase NN I-NP
, , O
the DT O
enzyme NN O
which WDT O
catalyzes VBZ O
the DT O
first JJ O
step NN O
in IN O
nitrate JJ O
assimilation NN O
. . O

-DOCSTART- X X O

A DT O
Dictyostelium NN O
transformant NN O
overexpressing IN O
DdPTPa NNP B-NP
does VBZ O
not RB O
develop VB O
normally RB O
. . O

-DOCSTART- X X O

This DT O
motif NN O
has VBZ O
been VBN O
shown VBN O
to TO O
mediate JJ O
protein NN O
interactions NNS O
in IN O
the DT O
case NN O
of IN O
ankyrin NN B-NP
as RB O
well RB O
as IN O
several JJ O
other JJ O
repeat-bearing JJ O
proteins NNS O
. . O

-DOCSTART- X X O

[Ala85]Dk(69-85 NN B-NP
) -RRB- I-NP
retains VBZ O
full JJ O
biological JJ O
activity NN O
. . O

-DOCSTART- X X O

We PRP O
postulate VBP O
that DT O
CaM NNP B-NP
binding NN O
by IN O
HIV NNP B-NP
envelope NN I-NP
proteins VBZ I-NP
is VBZ O
likely JJ O
to TO O
exert VB O
diverse JJ O
modulatory JJ O
effects NNS O
, , O
and CC O
the DT O
mechanism NN O
for IN O
HIV-induced PRP$ O
cytotoxicity NN O
may MD O
involve VB O
, , O
in IN O
part NN O
, , O
inhibition IN O
of IN O
CaM-regulated JJ B-NP
cellular JJ O
functions NNS O
. . O

-DOCSTART- X X O

The DT O
major JJ O
myosin-binding JJ B-NP
domain NN I-NP
of IN O
skeletal JJ B-NP
muscle NN I-NP
MyBP-C NNP I-NP
( -LRB- O
C NNP B-NP
protein NN I-NP
) -RRB- O
resides VBZ O
in IN O
the DT O
COOH-terminal JJ O
, , O
immunoglobulin IN B-NP
C2 NNP B-NP
motif NN I-NP
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
periseizure NN O
lipid JJ O
accumulation NN O
is VBZ O
related VBN O
to TO O
cortical JJ O
oxygenation NN O
. . O

-DOCSTART- X X O

Most JJS O
smokers NNS O
would MD O
prefer VB O
to TO O
quit VB O
smoking NN O
on IN O
their PRP$ O
own JJ O
. . O

-DOCSTART- X X O

The DT O
inhibitory JJ O
response NN O
to TO O
taps NNS O
is VBZ O
essentially RB O
a DT O
protective JJ O
reflex NN O
which WDT O
probably RB O
serves VBZ O
to TO O
reduce VB O
the DT O
activity NN O
of IN O
the DT O
jaw-closing NN O
muscles NNS O
when WRB O
one NN O
bites VBZ O
unexpectedly RB O
on IN O
hard JJ O
objects NNS O
. . O

-DOCSTART- X X O

The DT O
product NN O
of IN O
the DT O
vpr NN B-NP
open JJ I-NP
reading NN I-NP
frame NN I-NP
of IN I-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( -LRB- I-NP
HIV-1 NN I-NP
) -RRB- I-NP
is VBZ O
a DT O
15-kDa JJ O
, , O
arginine-rich JJ O
protein NN O
that WDT O
is VBZ O
present JJ O
in IN O
virions NNS O
in IN O
molar JJ O
quantities NNS O
equivalent JJ O
to TO O
that DT O
of IN O
Gag NNP B-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
capsid JJ B-NP
proteins NNS I-NP
derived VBN O
from IN O
the DT O
P1 NNP B-NP
precursor NN I-NP
with IN O
a DT O
valine NN O
substitution NN O
at IN O
the DT O
amino JJ O
terminus NN O
of IN O
VP1 JJ B-NP
(VP1-G001V NN O
) -RRB- O
assembled VBN O
empty JJ O
capsid NN O
particles NNS O
but CC O
were VBD O
deficient JJ O
in IN O
assembling VBG O
RNA-containing JJ O
virions NNS O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
In IN O
an DT O
18 CD O
moth NN O
period NN O
and CC O
out IN O
of IN O
a DT O
total NN O
of IN O
284 CD O
positive JJ O
blood NN O
cultures NNS O
( -LRB- O
154 CD O
significant JJ O
isolations NNS O
) -RRB- O
14 CD O
episodes NNS O
of IN O
bacteremia NN O
by IN O
M. NNP O
tuberculosis NN O
were VBD O
studied VBN O
in IN O
12 CD O
prison NN O
patients NNS O
coinfected VBN O
by IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
with IN O
associated VBN O
severe JJ O
immunosuppression NN O
( -LRB- O
mean NN O
of IN O
CD4 NNP B-NP
= SYM O
0.068 CD O
x NN O
10(9 CD O
)/l NN O
) -RRB- O
. . O

-DOCSTART- X X O

Acid NNP O
instilled VBD O
on IN O
the DT O
larynx NN O
of IN O
maturing VBG O
rabbits NNS O
resulted VBD O
in IN O
significant JJ O
obstructive JJ O
, , O
central JJ O
, , O
and CC O
mixed JJ O
apnea NN O
. . O

-DOCSTART- X X O

By IN O
using VBG O
total-protein JJ O
extracts NNS O
from IN O
mycelia NNS O
grown VBN O
under IN O
penicillin VBG O
producing VBG O
conditions NNS O
we PRP O
have VBP O
detected VBN O
a DT O
DNA-binding NN O
activity NN O
that IN O
specifically RB O
shifts VBZ O
a DT O
promoter NN O
fragment NN O
located VBN O
between IN O
-654 NNP O
and CC O
-455 DT O
( -LRB- O
relative JJ O
to TO O
IPNS NNS B-NP
tsp NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

Similar JJ O
synergistic JJ O
activation NN O
was VBD O
observed VBN O
in IN O
the DT O
IL-8 NN B-NP
promoter NN I-NP
, , O
which WDT O
also RB O
contains VBZ O
both DT O
NF-IL6 NNP B-NP
and CC O
NF-kappa NNP B-NP
B NNP I-NP
binding NN I-NP
sites NNS I-NP
. . O

-DOCSTART- X X O

Notice NN O
of IN O
retraction NN O
. . O

-DOCSTART- X X O

As IN O
regards NNS O
lipid VBD O
metabolism NN O
, , O
the DT O
mean JJ O
values NNS O
for IN O
total NN O
triglycerides NNS O
, , O
cholesterol NN O
, , O
LDL-cholesterol NNP B-NP
and CC O
HDL-cholesterol NNP B-NP
seen VBN O
at IN O
the DT O
end NN O
of IN O
five CD O
years NNS O
of IN O
Norplant-2 NNP O
rod NN O
use NN O
and CC O
six CD O
months NNS O
postremoval , O
were VBD O
similar JJ O
to TO O
the DT O
preinsertion NN O
mean NN O
. . O

-DOCSTART- X X O

At IN O
a DT O
PaCO2 NNP O
of IN O
40 CD O
mmHg NN O
, , O
baseline NN O
brain NN O
pHi NN O
measured VBD O
7.03 CD O
+/ NNS O
- : O
0.04 CD O
, , O
while IN O
regional JJ O
cortical JJ O
blood NN O
flow NN O
was VBD O
47.0 CD O
+/ NNP O
- : O
4.3 CD O
ml NN O
.100 CD O
g-1.min-1 NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
diltiazem NN O
on IN O
netilmicin-induced JJ O
nephrotoxicity NN O
in IN O
rabbits NNS O
. . O

-DOCSTART- X X O

About IN O
20 CD O
% NN O
of IN O
single-stranded JJ O
DNA NNP O
binding NN O
was VBD O
observed VBN O
in IN O
the DT O
presence NN O
of IN O
MgdTDP NNP O
, , O
but CC O
none NN O
was VBD O
detectable VBN O
in IN O
the DT O
absence NN O
of IN O
nucleotides NNS O
. . O

-DOCSTART- X X O

To TO O
our PRP$ O
knowledge NN O
this DT O
is VBZ O
the DT O
first JJ O
case NN O
in IN O
which WDT O
a DT O
probable JJ O
association NN O
between IN O
cholelithiasis NN O
and CC O
Wildervanck NNP O
's POS O
syndrome NN O
has VBZ O
been VBN O
recorded VBN O
. . O

-DOCSTART- X X O

Both DT O
4,8-DiMeIQx JJ O
and CC O
A DT O
alpha NN O
C NNP O
were VBD O
found VBN O
at IN O
< NNP O
1 CD O
p.p.b NN O
. . O

-DOCSTART- X X O

Three CD O
cysteine NN O
and CC O
four CD O
tryptophan IN O
residues NNS O
, , O
previously RB O
identified VBN O
as IN O
conserved VBN O
amongst IN O
nitrous-oxide JJ B-NP
reductases NNS I-NP
, , O
are VBP O
found VBN O
in IN O
the DT O
Paracoccus NNP O
enzyme NN O
. . O

-DOCSTART- X X O

Delineating VBG O
the DT O
molecular JJ O
basis NN O
for IN O
agonist-induced JJ O
destabilization NN O
of IN O
mRNA NN O
of IN O
G-protein-linked JJ B-NP
receptors NNS I-NP
that IN O
contributes NNS O
to TO O
receptor NN O
down-regulation NN O
is VBZ O
fundamental JJ O
to TO O
our PRP$ O
understanding NN O
of IN O
long-term JJ O
regulation NN O
of IN O
receptors NNS O
by IN O
agonist NN O
. . O

-DOCSTART- X X O

Addition NN O
of IN O
phalloidin-stabilized JJ O
F-actin NNP B-NP
nuclei NNS O
and CC O
phalloidin NN O
restored VBN O
L266D NNP O
actin NN B-NP
's POS O
ability NN O
to TO O
polymerize VB O
at IN O
4 CD O
degrees NNS O
C. NNP O

-DOCSTART- X X O

These DT O
cells NNS O
produce VBP O
a DT O
low JJ O
level NN O
of IN O
IL-5 NNP B-NP
when WRB O
stimulated VBN O
with IN O
PMA NNP O
alone RB O
; : O
however RB O
, , O
N6 NNP O
, , O
O2-dibutyryl JJ O
cAMP NN O
( -LRB- O
Bt2cAMP) NNP O
, , O
in IN O
combination NN O
with IN O
PMA NNP O
, , O
augmented VBN O
by IN O
more JJR O
than IN O
tenfold RB O
the DT O
IL-5 NN B-NP
production NN O
at IN O
the DT O
mRNA NN O
and CC O
the DT O
protein NN O
levels NNS O
. . O

-DOCSTART- X X O

Hu-Met-1 JJ B-NP
mRNA JJ I-NP
expression NN O
in IN O
a DT O
small JJ O
number NN O
of IN O
human JJ O
T NNP O
cell NN O
tumor NN O
lines NNS O
did VBD O
not RB O
correlate VB O
with IN O
any DT O
particular JJ O
phenotype NN O
or CC O
stage NN O
of IN O
development NN O
. . O

-DOCSTART- X X O

Partial JJ O
engorgement NN O
was VBD O
higher JJR O
in IN O
the DT O
treatments NNS O
. . O

-DOCSTART- X X O

Strains NNS O
bearing VBG O
the DT O
drs2 NN B-NP
mutation NN I-NP
process NN O
the DT O
20S CD B-NP
precursor NN I-NP
of IN O
the DT O
mature JJ B-NP
18S NNP I-NP
rRNA NNP I-NP
slowly RB O
and CC O
are VBP O
deficient JJ O
in IN O
40S DT B-NP
ribosomal JJ I-NP
subunits NNS I-NP
. . O

-DOCSTART- X X O

Hepatitis NNP O
B NNP O
and CC O
liver NN O
transplantation NN O
. . O

-DOCSTART- X X O

One CD O
complex NN O
most RBS O
likely JJ O
contained VBN O
Sp1 NNP B-NP
, , O
and CC O
another DT O
complex NN O
showed VBD O
S-phase-specific JJ O
binding NN O
, , O
suggesting VBG O
a DT O
direct JJ O
role NN O
in IN O
the DT O
cell-cycle-dependent NN O
R1 NNP B-NP
gene NN I-NP
expression NN O
. . O

-DOCSTART- X X O

These DT O
combined VBN O
observations NNS O
define VB O
a DT O
promoter NN O
and CC O
an DT O
enhancer NN O
for IN O
the DT O
chicken NN B-NP
L-CAM NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
rate NN O
of IN O
enzymic JJ O
stimulation NN O
induced VBN O
by IN O
a DT O
given VBN O
nitrate NN O
correlates VBZ O
closely RB O
with IN O
the DT O
rate NN O
of IN O
measured JJ O
NO DT O
production NN O
from IN O
the DT O
nitrate JJ O
molecule NN O
. . O

-DOCSTART- X X O

Clipping VBG O
resulted VBD O
in IN O
a DT O
serious JJ O
mislocalization NN O
of IN O
the DT O
position NN O
of IN O
the DT O
peak NN O
of IN O
the DT O
epicortical JJ O
potential JJ O
field NN O
. . O

-DOCSTART- X X O

The DT O
247-kDa JJ O
complex NN O
appears VBZ O
to TO O
contain VB O
two CD O
distinct JJ O
protein-DNA NN O
complexes NNS O
of IN O
approximately RB O
232 CD O
and CC O
256 CD O
kDa NN O
and CC O
represents VBZ O
two CD O
proteins NNS O
covalently RB O
cross-linked VBN O
to TO O
a DT O
single JJ O
DRE NNP O
oligonucleotide NNP O
, , O
while IN O
the DT O
97 CD O
, , O
105 CD O
, , O
and CC O
115-kDa DT O
complexes NNS O
represent VBP O
single JJ O
protein-DRE JJ O
cross-links NNS O
. . O

-DOCSTART- X X O

The DT O
promoter NN O
and CC O
upstream JJ O
region NN O
of IN O
the DT O
Brassica NNP B-NP
napus NN I-NP
2S . I-NP
storage NN I-NP
protein NN I-NP
napA NN I-NP
gene NN I-NP
were VBD O
studied VBN O
to TO O
identify VB O
cis-acting JJ O
sequences NNS O
involved VBN O
in IN O
developmental JJ O
seed-specific JJ O
expression NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
sequences NNS O
outside IN O
of IN O
the DT O
hLEF NN B-NP
HMG NNP I-NP
box NN I-NP
mediate JJ O
cell NN O
- : O
and CC O
context-specific JJ O
activation NN O
of IN O
the DT O
TCR NNP B-NP
alpha NN I-NP
enhancer NN I-NP
and CC O
may MD O
facilitate VB O
interactions NNS O
between IN O
hLEF NN B-NP
and CC O
other JJ O
T-cell-specific JJ O
factors NNS O
recruited VBD O
to TO O
the DT O
enhancer NN O
. . O

-DOCSTART- X X O

A DT O
cAMP JJ O
response NN O
element NN O
( -LRB- O
CRE NNP O
) -RRB- O
consensus NN O
signal NN O
was VBD O
identified VBN O
in IN O
the DT O
5'-noncoding JJ O
region NN O
. . O
cAMP '' O
regulates VBZ O
the DT O
expression NN O
of IN O
Kv1.5 NNP B-NP
gene NN I-NP
in IN O
a DT O
cell-specific JJ O
manner NN O
. . O

-DOCSTART- X X O

A DT O
number NN O
of IN O
serological JJ O
tests NNS O
measuring VBG O
the DT O
presence NN O
of IN O
Helicobacter NNP O
pylori-specific JJ O
serum NN O
immunoglobulin NN B-NP
G NNP I-NP
( -LRB- O
IgG NN B-NP
) -RRB- O
are VBP O
now RB O
commercially RB O
available JJ O
. . O

-DOCSTART- X X O

The DT O
degree NN O
of IN O
hypoperfusion NN O
was VBD O
slightly RB O
related VBN O
to TO O
decrease VB O
in IN O
FEV1.0 CD O
% NN O
, , O
V25 NNP O
and CC O
PaO2 NNP O
and CC O
increase NN O
in IN O
circulating VBG O
blood NN O
volume NN O
and CC O
peripheral JJ O
red JJ O
blood NN O
cell NN O
counts NNS O
. . O

-DOCSTART- X X O

Two CD O
patients NNS O
were VBD O
treated VBN O
successfully RB O
with IN O
a DT O
combination NN O
of IN O
metronidazole NN O
( -LRB- O
a DT O
tissue NN O
amoebicide NN O
) -RRB- O
and CC O
diloxanide NN O
( -LRB- O
a DT O
lumenal JJ O
amoebicide NN O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
identified VBN O
in IN O
the DT O
5' JJ O
untranslated JJ O
region NN O
of IN O
the DT O
Drosophila NNP B-NP
copia NN I-NP
retrotransposon NN I-NP
, , O
3' VBD O
to TO O
the DT O
left JJ O
LTR NNP O
, , O
a DT O
sequence NN O
for IN O
transcriptional JJ O
regulation NN O
by IN O
homeoproteins NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
study NN O
, , O
lesions NNS O
of IN O
the DT O
OPT NNP O
complex NN O
( -LRB- O
the DT O
thalamic , O
source NN O
of IN O
afferents NNS O
to TO O
IHA NNP O
and CC O
HD NNP O
) -RRB- O
were VBD O
found VBN O
to TO O
have VB O
no DT O
effect NN O
on IN O
color-reversal JJ O
learning NN O
performance NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
In IN O
our PRP$ O
patients NNS O
and CC O
within IN O
the DT O
range NN O
of IN O
treatment NN O
variables NNS O
studied VBN O
, , O
age NN O
, , O
Karnofsky NNP O
index NN O
, , O
and CC O
graft-versus-host JJ O
disease NN O
are VBP O
the DT O
most RBS O
important JJ O
factors NNS O
related VBN O
with IN O
early JJ O
mortality NN O
. . O

-DOCSTART- X X O

Nucleotide NNP O
sequence NN O
analysis NN O
of IN O
the DT O
HA NNP B-NP
gene NN I-NP
in IN O
these DT O
two CD O
mutants NNS O
confirmed VBD O
the DT O
HA NNP B-NP
- : I-NP
phenotype NN O
. . O

-DOCSTART- X X O

The DT O
drug-resistant JJ O
cell NN O
lines NNS O
P388/ADR/3 . O
and CC O
P388/ADR/7 PRP O
express VBP O
a DT O
shortened JJ O
topo NN B-NP
II NNP I-NP
alpha NN I-NP
mRNA NN I-NP
transcript NN I-NP
in IN O
addition NN O
to TO O
the DT O
native JJ O
transcript NN O
present NN O
in IN O
the DT O
drug-sensitive JJ O
P388/4 NNP O
cell NN O
line NN O
. . O

-DOCSTART- X X O

The DT O
phi NN B-NP
AP3 IN I-NP
factor NN I-NP
is VBZ O
a DT O
nuclear JJ O
phosphoprotein NN O
; : O
the DT O
extent NN O
of IN O
its PRP$ O
phosphorylation NN O
is VBZ O
regulated VBN O
during IN O
the DT O
cell NN O
cycle NN O
. . O

-DOCSTART- X X O

The DT O
functional JJ O
homology NN O
of IN O
Cwg2 NNP B-NP
with IN O
Cdc43 NNP B-NP
, , O
which WDT O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
control NN O
of IN O
cell NN O
polarity NN O
, , O
suggests VBZ O
a DT O
link NN O
between IN O
two CD O
morphogenetic JJ O
events NNS O
such JJ O
as IN O
establishment NN O
of IN O
cell NN O
polarity NN O
and CC O
cell NN O
wall NN O
biosynthesis NN O
. . O

-DOCSTART- X X O

By IN O
using VBG O
the DT O
full-length JJ O
cytoplasmic JJ O
domain NN O
and CC O
mutants NNS O
with IN O
progressive JJ O
carboxy-terminal JJ O
deletions NNS O
, , O
internal JJ O
deletions NNS O
, , O
or CC O
point NN O
mutations NNS O
, , O
we PRP O
identified VBD O
the DT O
first JJ O
150 CD O
amino IN O
acid NN O
residues NNS O
of IN O
LIFR NNP B-NP
as IN O
the DT O
minimal JJ O
region NN O
necessary JJ O
for IN O
signaling VBG O
. . O

-DOCSTART- X X O

To TO O
examine VB O
the DT O
biochemical JJ O
basis NN O
of IN O
the DT O
end NN O
joining VBG O
, , O
nuclear JJ O
extracts NNS O
were VBD O
prepared VBN O
from IN O
a DT O
wide JJ O
variety NN O
of IN O
mammalian JJ O
cell NN O
lines NNS O
and CC O
tested VBN O
for IN O
their PRP$ O
ability NN O
to TO O
join VB O
test NN O
plasmid NN O
substrates NNS O
. . O

-DOCSTART- X X O

Recombinant JJ O
expression NN O
of IN O
a DT O
chimeric JJ O
EGFR/ErbB-3 NN B-NP
receptor NN B-NP
in IN O
NIH NNP O
3T3 CD O
fibroblasts NNS O
allowed VBD O
us PRP O
to TO O
investigate VB O
cytoplasmic JJ O
events NNS O
associated VBN O
with IN O
ErbB-3 JJ B-NP
signal NN O
transduction NN O
upon IN O
ligand NN O
activation NN O
. . O

-DOCSTART- X X O

Oligonucleotide NNP O
competitors NNS O
were VBD O
used VBN O
to TO O
evaluate VB O
the DT O
accessibility NN O
of IN O
the DT O
TATA-binding JJ O
site NN O
in IN O
TIF-IB NNP B-NP
, , O
TFIID NNP B-NP
, , O
and CC O
TFIIIB NNP B-NP
. . O

-DOCSTART- X X O

The DT O
227-to-239 CD O
region NN O
blocked VBD O
ADR1 JJR B-NP
activity NN O
independently RB O
of IN O
the DT O
TAD NNP B-NP
present NN O
on IN O
ADR1 NNP B-NP
, , O
ADR1 NNP B-NP
DNA NNP O
binding NN O
, , O
and CC O
specific JJ O
ADH2 VBG B-NP
promoter NN I-NP
sequences NNS I-NP
. . O

-DOCSTART- X X O

Repeated VBN O
administration NN O
of IN O
GRg2 NNP O
20 CD O
mg/kg NN O
i.p NN O
. . O
significantly RB O
improved VBD O
the DT O
CYP-induced JJ O
recognitional JJ O
deficits NNS O
by IN O
increasing VBG O
the DT O
CYP-decreased JJ O
rate NN O
from IN O
55.8 CD O
+/ CD O
- : O
9.6 CD O
to TO O
80.8 CD O
+/ CD O
- : O
4.2 CD O
in IN O
d NN O
3 CD O
learning NN O
acquisition NN O
( -LRB- O
F(1,14 NNP O
) -RRB- O
= SYM O
5.6 CD O
, , O
p NN O
< NN O
0.05 CD O
) -RRB- O
, , O
from IN O
53.4 CD O
+/ NNS O
- : O
8.4 CD O
to TO O
60.0 CD O
+/ CD O
- : O
8.2 CD O
in IN O
48 CD O
h JJ O
memory NN O
acquisition NN O
( -LRB- O
F(1,14 NNP O
) -RRB- O
= SYM O
7.5 CD O
, , O
p NN O
< NN O
0.05 CD O
) -RRB- O
and CC O
from IN O
55.0 CD O
+/ NN O
- : O
5.5 CD O
to TO O
88.3 CD O
+/ NNS O
- : O
2.5 CD O
in IN O
24 CD O
h NN O
memory NN O
retention NN O
( -LRB- O
F(1,12 NN O
) -RRB- O
27.5 CD O
, , O
p NN O
< NN O
0.01 CD O
) -RRB- O
as RB O
well RB O
as IN O
from IN O
60.0 CD O
+/ NN O
- : O
6.8 CD O
to TO O
85.6 CD O
+/ NNS O
- : O
6.9 CD O
in IN O
48 CD O
h JJ O
memory NN O
retrieval NN O
( -LRB- O
F(1,12 NN O
) -RRB- O
= SYM O
5.2 CD O
, , O
p NN O
< NN O
0.05 CD O
) -RRB- O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Human JJ B-NP
bcl3 JJ I-NP
protein NN I-NP
specifically RB O
displaces VBZ O
( -LRB- B-NP
p50)2-DNA NN I-NP
complexes NNS I-NP
. . O

-DOCSTART- X X O

The DT O
therapeutic JJ O
action NN O
of IN O
cyclosporin NN O
A DT O
( -LRB- O
Sandimmun NNP O
) -RRB- O
: : O
its PRP$ O
application NN O
in IN O
rheumatoid NN O
arthritis NN O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
translation NN O
experiments NNS O
show VBP O
that IN O
human JJ O
cDNA NN O
derived VBD O
RNA NNP O
translates VBZ O
into IN O
a DT O
protein NN O
with IN O
a DT O
mobility NN O
of IN O
44-46 CD O
kD NN O
on IN O
SDS NNP O
polyacrylamide NN O
gels NNS O
. . O

-DOCSTART- X X O

Pentazocine NNP O
analgesia NN O
: : O
is VBZ O
there RB O
a DT O
niche NN O
for IN O
Talwin NNP O
Nx NNP O
? . O
Pentazocine NNP O
can MD O
be VB O
a DT O
useful JJ O
analgesic NN O
agent NN O
for IN O
the DT O
management NN O
of IN O
acute JJ O
dental JJ O
pain NN O
. . O

-DOCSTART- X X O

A DT O
sequence NN O
homology NN O
analysis NN O
between IN O
human JJ B-NP
nm23-H1 NN I-NP
and CC O
the DT O
homolog NN O
gene NN O
of IN O
the DT O
rat NN O
( -LRB- O
NDP-K JJ B-NP
beta NN I-NP
) -RRB- O
shows VBZ O
that IN O
exon-intron NN O
boundaries NNS O
are VBP O
well RB O
conserved VBN O
between IN O
these DT O
two CD O
species NNS O
. . O

-DOCSTART- X X O

Response NN O
durations NNS O
were VBD O
short JJ O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
REP21 NNP O
plants NNS O
were VBD O
resistant JJ O
to TO O
an DT O
unusually RB O
broad JJ O
range NN O
of IN O
tobamoviruses NNS O
including VBG O
tomato NN O
mosaic NN O
virus NN O
, , O
tobacco NN O
mild JJ O
green JJ O
mosaic NN O
virus NN O
, , O
TMV-U5 NNP O
, , O
green JJ O
tomato NN O
atypical JJ O
mosaic NN O
virus NN O
, , O
and CC O
ribgrass NN O
mosaic NN O
virus NN O
. . O

-DOCSTART- X X O

Drug NNP O
effect NN O
, , O
measured VBD O
as IN O
postural JJ O
sway NN O
, , O
was VBD O
also RB O
similar JJ O
in IN O
the DT O
patients NNS O
with IN O
cirrhosis NN O
and CC O
control NN O
subjects NNS O
; : O
therefore RB O
the DT O
ratio NN O
of IN O
effect NN O
area NN O
under IN O
the DT O
curve NN O
to TO O
concentration NN O
area NN O
under IN O
the DT O
curve NN O
, , O
a DT O
measure NN O
of IN O
sensitivity NN O
, , O
did VBD O
not RB O
differ VB O
significantly RB O
between IN O
the DT O
patients NNS O
with IN O
cirrhosis NN O
and CC O
the DT O
control NN O
subjects NNS O
. . O

-DOCSTART- X X O

We PRP O
present JJ O
evidence NN O
that IN O
YY1 NNP B-NP
, , O
a DT O
ubiquitously RB O
expressed VBN O
DNA-binding JJ O
protein NN O
, , O
regulates VBZ O
the DT O
activity NN O
of IN O
the DT O
c-fos JJ B-NP
promoter NN I-NP
primarily RB O
through IN O
an DT O
effect NN O
on IN O
DNA NNP O
structure NN O
. . O

-DOCSTART- X X O

In IN O
a DT O
retrospective JJ O
analysis NN O
of IN O
first-time JJ O
total JJ O
colonoscopies NNS O
in IN O
685 CD O
patients NNS O
, , O
we PRP O
investigated VBD O
the DT O
relationship NN O
between IN O
hyperplastic JJ O
and CC O
adenomatous JJ O
polyps NNS O
. . O

-DOCSTART- X X O

The DT O
rate NN O
of IN O
decrement NN O
in IN O
DPOAE NNP O
amplitude NN O
over IN O
a DT O
prescribed JJ O
time NN O
period NN O
was VBD O
utilized VBN O
as IN O
a DT O
measure NN O
of IN O
susceptibility NN O
to TO O
the DT O
acoustic JJ O
trauma NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
single JJ O
base NN O
substitutions NNS O
at IN O
glycine-870 NN O
codon NN O
of IN O
gramicidin NN B-NP
S NNP I-NP
synthetase NN I-NP
2 CD I-NP
gene NN I-NP
on IN O
proline NN O
activation NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
show VBP O
that IN O
the DT O
structure NN O
of IN O
the DT O
decorin VBG B-NP
gene NN I-NP
promoter NN I-NP
is VBZ O
different JJ O
from IN O
that DT O
of IN O
any DT O
other JJ O
proteoglycan NN O
promoter NN O
characterized VBD O
so RB O
far RB O
and CC O
indicate VBP O
that IN O
the DT O
pur/pyr NN O
segment NN O
plays VBZ O
a DT O
role NN O
in IN O
the DT O
regulation NN O
of IN O
gene NN O
transcription NN O
. . O

-DOCSTART- X X O

267 CD O
, , O
4870-4877 JJ O
) -RRB- O
) -RRB- O
indicates VBZ O
an DT O
overall JJ O
identity NN O
of IN O
58 CD O
and CC O
56 CD O
% NN O
, , O
respectively RB O
, , O
with IN O
a DT O
91 CD O
and CC O
92 CD O
% NN O
identity NN O
in IN O
the DT O
highly RB O
conserved VBN O
transmembrane NN O
and CC O
cytoplasmic JJ O
domains NNS O
. . O

-DOCSTART- X X O

S. NNP O
, , O
K. NNP O

-DOCSTART- X X O

The DT O
survival NN O
rate NN O
at IN O
forty CD O
months NNS O
in IN O
15 CD O
patients NNS O
with IN O
N2 NNP O
disease NN O
who WP O
underwent VBD O
R2b NNP O
operation NN O
was VBD O
51 CD O
% NN O
. . O

-DOCSTART- X X O

Mothers NNS O
with IN O
severe JJ O
anatomical NN O
abnormalities NNS O
, , O
who WP O
are VBP O
HIV NNP O
positive JJ O
, , O
have VB O
active JJ O
TB NN O
or CC O
whose WP$ O
children NNS O
have VBP O
inherited VBN O
mono NN O
- : O
or CC O
disaccharide NN O
intolerances NNS O
should MD O
not RB O
breastfeed VB O
. . O

-DOCSTART- X X O

G. NNP O

-DOCSTART- X X O

The DT O
psaD NN B-NP
, , O
psaF NN B-NP
, , O
psaH NNS B-NP
, , O
and CC O
psaL JJ B-NP
products NNS I-NP
have VBP O
two CD O
isoforms NNS O
each DT O
that DT O
are VBP O
distinguished VBN O
by IN O
different JJ O
mobilities NNS O
in IN O
polyacrylamide NN O
gel NN O
electrophoresis NN O
, , O
and CC O
the DT O
psaE JJ B-NP
product NN I-NP
has VBZ O
four CD O
isoforms NNS O
. . O

-DOCSTART- X X O

When WRB O
Hy-Vac NNP O
SPF NNP O
type NN O
V NNP O
embryos NNS O
were VBD O
exposed VBN O
to TO O
either DT O
0.20 CD O
ml JJ O
50 CD O
% NN O
ethanol NN O
in IN O
CRS NNP O
or CC O
to TO O
0.20 CD O
ml NN O
CRS NNP O
( -LRB- O
controls NNS O
) -RRB- O
, , O
ethanol-treated JJ O
embryos NNS O
showed VBD O
a DT O
VSD NNP O
incidence NN O
of IN O
34.1 CD O
% NN O
compared VBN O
with IN O
a DT O
3.6 CD O
% NN O
incidence NN O
in IN O
the DT O
controls NNS O
( -LRB- O
P NNP O
= SYM O
0.0017 CD O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
our PRP$ O
studies NNS O
, , O
we PRP O
utilized VBD O
HIV-1 PRP$ O
HXB2 NN B-NP
and CC O
HIV-1 NN O
Z2Z6 IN B-NP
core NN I-NP
enhancers NNS I-NP
because IN O
the DT O
Z2Z6 NNP B-NP
strain NN O
has VBZ O
a DT O
single JJ O
point NN O
mutation NN O
flanking VBG O
the DT O
right JJ O
ETS-binding NNP B-NP
site NN I-NP
. . O

-DOCSTART- X X O

The DT O
secondary JJ O
, , O
but CC O
not RB O
the DT O
primary JJ O
, , O
antibody NN O
responses NNS O
of IN O
male JJ O
C57Bl/6 NNS O
mice NNS O
were VBD O
higher JJR O
among IN O
mice NNS O
housed VBN O
alone RB O
compared VBN O
to TO O
mice NNS O
housed VBN O
in IN O
groups NNS O
; : O
differences NNS O
were VBD O
observed VBN O
for IN O
both DT O
IgM NNP B-NP
and CC O
IgG NNP B-NP
anti-KLH JJ I-NP
antibodies NNS I-NP
. . O

-DOCSTART- X X O

Interleukin-6 NN B-NP
may MD O
possibly RB O
potentiate VB O
metastasis NN O
of IN O
cardiac JJ O
myxoma NN O
. . O

-DOCSTART- X X O

Responses NNS O
to TO O
the DT O
Plowright NNP O
Rinderpest NNP O
vaccine NN O
by IN O
43 CD O
calves NNS O
and CC O
70 CD O
adult NN O
cattle NNS O
in IN O
Uganda NNP O
in IN O
1990 CD O
, , O
through IN O
the DT O
production NN O
of IN O
IgG NNP B-NP
antibodies NNS I-NP
, , O
were VBD O
monitored VBN O
for IN O
4 CD O
weeks NNS O
using VBG O
the DT O
ELISA NNP O
assay NN O
. . O

-DOCSTART- X X O

Because IN O
of IN O
the DT O
small JJ O
number NN O
of IN O
visceral JJ O
angiography NN O
procedures NNS O
performed VBN O
( -LRB- O
38 CD O
) -RRB- O
, , O
no DT O
definitive JJ O
conclusions NNS O
could MD O
be VB O
drawn VBN O
as IN O
to TO O
the DT O
differences NNS O
between IN O
ionic JJ O
and CC O
nonionic JJ O
agents NNS O
regarding VBG O
grade-2 JJ O
and CC O
grade-3 JJ O
adverse JJ O
events NNS O
. . O

-DOCSTART- X X O

Tumours NNS O
of IN O
the DT O
cavum NN O
oris NN O
and CC O
oropharynx NN O
of IN O
T1-stage NN O
are VBP O
possible JJ O
only RB O
in IN O
1 CD O
of IN O
3 CD O
cases NNS O
. . O

-DOCSTART- X X O

Plasma NNP O
, , O
LDL NNP B-NP
and CC O
liver NN O
cholesterol NN O
concentrations NNS O
were VBD O
higher JJR O
in IN O
the DT O
hyperlipidemic JJ O
control NN O
than IN O
the DT O
nonhyperlipidemic JJ O
control NN O
and CC O
lower JJR O
in IN O
the DT O
groups NNS O
fed VBN O
diets NNS O
containing VBG O
pectin NN B-NP
or CC O
prune NN O
fiber NN O
than IN O
in IN O
the DT O
hyperlipidemic JJ O
control NN O
group NN O
. . O

-DOCSTART- X X O

Glomerular JJ O
mesangial NN O
cells NNS O
expressed VBN O
an DT O
abundant JJ O
1.1 CD O
kb NN O
mRNA NN O
transcript NN O
for IN O
Id1 NNP B-NP
, , O
but CC O
in IN O
contrast NN O
to TO O
other JJ O
cell NN O
types NNS O
Id1 IN B-NP
mRNA NN I-NP
was VBD O
expressed VBN O
in IN O
both DT O
randomly RB O
cycling JJ O
cells NNS O
and CC O
in IN O
serum-deprived JJ O
, , O
quiescent JJ O
cultures NNS O
. . O

-DOCSTART- X X O

Routine NNP O
psychometric JJ O
screening NN O
of IN O
IHD NNP O
patients NNS O
may MD O
provide VB O
a DT O
cost-effective JJ O
means NN O
of IN O
alerting VBG O
cardiologists NNS O
and CC O
internists NNS O
to TO O
the DT O
relatively RB O
high JJ O
levels NNS O
of IN O
distress NN O
among IN O
their PRP$ O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
sequence NN O
similarity NN O
has VBZ O
suggested VBN O
that IN O
SCG10 NNP B-NP
and CC O
stathmin NN B-NP
have VBP O
been VBN O
derived VBN O
from IN O
structurally RB O
and CC O
evolutionarily RB O
related VBN O
genes NNS O
. . O

-DOCSTART- X X O

These DT O
data NNS O
are VBP O
consistent JJ O
with IN O
the DT O
idea NN O
that IN O
the DT O
neuron-specific JJ B-NP
SCG10 NNP I-NP
gene NN I-NP
evolved VBN O
by IN O
duplication NN O
and CC O
modification NN O
of IN O
the DT O
more RBR O
broadly RB O
expressed VBN O
stathmin/Lap18 NN B-NP
gene NN O
. . O

-DOCSTART- X X O

The DT O
deduced JJ O
amino JJ O
acid NN O
sequence NN O
of IN O
the DT O
mouse NN B-NP
HO-1 NN I-NP
gene NN I-NP
is VBZ O
identical JJ O
to TO O
that DT O
of IN O
p32 NN B-NP
, , O
initially RB O
identified VBN O
as IN O
a DT O
stress-induced JJ O
protein NN O
in IN O
mouse NN O
BALBc/3T3 IN O
cells NNS O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
T3 DT O
( -LRB- O
10(-8 CD O
) -RRB- O
M NNP O
) -RRB- O
selectively RB O
stimulates VBZ O
transcription NN O
from IN O
rGH-TRE- NNP B-NP
and CC O
TREpal-, NNP O
but CC O
not RB O
ME-TRE- NNP O
and CC O
F2-TRE-, JJ O
containing VBG O
templates NNS O
in IN O
which WDT O
these DT O
TREs NNS O
are VBP O
linked VBN O
in IN O
front NN O
of IN O
the DT O
rGH NNP B-NP
minimal JJ I-NP
promoter NN I-NP
containing VBG O
only RB O
the DT O
TATA NNP B-NP
box NN I-NP
binding JJ I-NP
protein NN I-NP
, , O
but CC O
not RB O
any DT O
other JJ O
proximal JJ O
binding JJ O
protein NN O
, , O
sequence NN O
. . O

-DOCSTART- X X O

The DT O
structural JJ O
analysis NN O
also RB O
demonstrated VBD O
that IN O
the DT O
heterogeneity NN O
of IN O
the DT O
HDC NNP B-NP
mRNA NN I-NP
is VBZ O
caused VBN O
by IN O
an DT O
insertion NN O
of IN O
the DT O
seventh JJ O
intron NN O
sequence NN O
and CC O
alternative JJ O
use NN O
of IN O
the DT O
splicing NN O
acceptor NN O
site NN O
at IN O
the DT O
12th JJ O
exon NN O
. . O

-DOCSTART- X X O

A DT O
complementary JJ O
DNA NN O
was VBD O
isolated VBN O
from IN O
Caenorhabditis NNP O
elegans NNS O
that WDT O
encoded VBD O
a DT O
polypeptide NN O
of IN O
1438 CD O
amino IN O
acid NN O
residues NNS O
, , O
CeGAP NNP B-NP
, , O
which WDT O
contains VBZ O
a DT O
domain NN O
with IN O
sequence NN O
similarity NN O
to TO O
the DT O
COOH-terminal JJ B-NP
segment NN I-NP
( -LRB- I-NP
GTPase-activating JJ I-NP
protein NN I-NP
region NN I-NP
) -RRB- I-NP
of IN O
Bcr NNP B-NP
and CC O
other JJ O
known VBN O
GTPase-activating JJ B-NP
proteins NNS I-NP
of IN O
the DT O
Rho NNP B-NP
subfamily NN I-NP
. . O

-DOCSTART- X X O

Repression NN O
is VBZ O
alleviated VBN O
when WRB O
the DT O
two CD O
( -LRB- O
for IN O
E2 NN B-NP
) -RRB- O
or CC O
three CD O
( -LRB- O
for IN O
E2-C) JJ B-NP
promoter-proximal JJ O
copies NNS O
of IN O
E2-RS NNP B-NP
are VBP O
mutated VBN O
. . O

-DOCSTART- X X O

A DT O
mutant JJ O
in IN O
the DT O
AAV NNP O
terminal NN O
resolution NN O
site NN O
( -LRB- O
trs NNS O
) -RRB- O
was VBD O
defective JJ O
for IN O
DNA NNP O
replication NN O
in IN O
the DT O
in IN O
vitro NN O
assay NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
indicate VBP O
that IN O
rep NN B-NP
strongly RB O
enhances VBZ O
the DT O
function NN O
of IN O
negative JJ O
regulatory JJ O
elements NNS O
of IN O
the DT O
LTR. NNP O

-DOCSTART- X X O

However RB O
, , O
artificially RB O
ventilated VBN O
rats NNS O
, , O
pretreated VBN O
with IN O
MK-801 JJ O
, , O
were VBD O
more RBR O
sensitive JJ O
( -LRB- O
lethal JJ O
cocaine NN O
dose NN O
, , O
76.6 CD O
+/ NNS O
- : O
8.0 CD O
mg/kg NN O
, , O
n RB O
= SYM O
5 CD O
) -RRB- O
than IN O
vehicle NN O
pretreated VBN O
rats NNS O
( -LRB- O
129.4 CD O
+/ NN O
- : O
15.8 CD O
mg/kg NN O
, , O
n RB O
= SYM O
6) CD O
, , O
indicating VBG O
that IN O
MK-801 NNP O
may MD O
increase VB O
both DT O
the DT O
respiratory NN O
and CC O
the DT O
cardiac JJ O
toxicity NN O
of IN O
cocaine NN O
in IN O
urethane NN O
anesthetized CC O
rats NNS O
. . O

-DOCSTART- X X O

The DT O
Oct-3/4 NNP B-NP
gene NN I-NP
product NN I-NP
, , O
which WDT O
belongs VBZ O
to TO O
the DT O
POU NNP B-NP
family NN I-NP
of IN I-NP
transcription NN I-NP
factors NNS I-NP
, , O
is VBZ O
a DT O
good JJ O
candidate NN O
for IN O
regulating JJ O
initial JJ O
differentiation NN O
decisions NNS O
. . O

-DOCSTART- X X O

Using VBG O
site-directed JJ O
mutagenesis NN O
, , O
we PRP O
show VBP O
that IN O
the DT O
RAREoct NNP B-NP
contributes VBZ O
to TO O
the DT O
transcriptional JJ O
activation NN O
of IN O
Oct-3/4 NNP B-NP
promoter NN I-NP
in IN O
P19 CD O
cells NNS O
and CC O
, , O
most RBS O
interestingly RB O
, , O
mediates VBZ O
the DT O
RA-induced JJ O
repression NN O
in IN O
RA-differentiated JJ O
EC NNP O
cells NNS O
. . O

-DOCSTART- X X O

176:787-792 CD O
, , O
1992 CD O
; : O
M. NNP O

-DOCSTART- X X O

When WRB O
expressed VBN O
alone RB O
in IN O
test NN O
cells NNS O
, , O
Atr-I NNP B-NP
is VBZ O
unable JJ O
to TO O
bind NN O
TGF-beta NNP B-NP
, , O
activin NN B-NP
, , O
or CC O
bone NN B-NP
morphogenetic JJ I-NP
protein NN I-NP
2. . I-NP

-DOCSTART- X X O

Therefore RB O
, , O
Mxi1 NNP B-NP
and CC O
Mad NNP B-NP
might MD O
antagonize VB O
Myc NNP B-NP
function NN O
and CC O
are VBP O
candidate NN O
tumor NN O
suppressor NN O
genes NNS O
. . O

-DOCSTART- X X O

To TO O
our PRP$ O
knowledge NN O
, , O
type NN O
IV NNP O
renal NNP O
tubular JJ O
acidosis NN O
has VBZ O
not RB O
been VBN O
reported VBN O
previously RB O
in IN O
association NN O
with IN O
Alport NNP O
's POS O
syndrome NN O
in IN O
an DT O
adult NN O
patient NN O
. . O

-DOCSTART- X X O

Fast NN O
continuous JJ O
expansion NN O
. . O

-DOCSTART- X X O

Each DT O
repeat NN O
consists VBZ O
of IN O
12 CD O
nt NN O
, , O
coding VBG O
for IN O
the DT O
reiterated VBD O
sequence NN O
, , O
K/NPAG. . O

-DOCSTART- X X O

ENV NNP B-NP
also RB O
was VBD O
secreted VBN O
from IN O
P. NNP O
pastoris NN O
using VBG O
the DT O
S. NNP B-NP
cerevisiae NN I-NP
alpha-factor NN I-NP
prepro JJ I-NP
secretion NN I-NP
leader NN I-NP
and CC O
the DT O
S. NNP B-NP
cerevisiae NN I-NP
invertase NN I-NP
signal NN I-NP
sequence NN I-NP
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
To TO O
determine VB O
the DT O
predictors NNS O
of IN O
desipramine-refractory JJ O
depression NN O
, , O
the DT O
authors NNS O
examined VBD O
the DT O
outcome NN O
in IN O
patients NNS O
with IN O
major JJ O
depression NN O
who WP O
were VBD O
admitted VBN O
to TO O
a DT O
general JJ O
hospital NN O
and CC O
treated VBD O
with IN O
desipramine NN O
adjusted VBN O
to TO O
an DT O
adequate JJ O
blood NN O
level NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
intact JJ O
hGH JJ B-NP
gene NN I-NP
or CC O
hGH VB B-NP
5'-flanking JJ I-NP
DNA NN I-NP
( -LRB- I-NP
5'-FR JJ I-NP
) -RRB- I-NP
coupled VBN O
to TO O
the DT O
hGh NN B-NP
cDNA NN I-NP
or CC O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
or CC O
luciferase NN B-NP
genes NNS I-NP
, , O
indicated VBD O
that IN O
cAMP IN O
primarily RB O
stimulated VBN O
hGH IN B-NP
promoter NN I-NP
activity NN O
. . O

-DOCSTART- X X O

The DT O
Harleco NNP O
apparatus NN O
is VBZ O
a DT O
simple NN O
, , O
useful JJ O
, , O
cost-effective JJ O
adjunct NN O
to TO O
the DT O
diagnosis NN O
and CC O
treatment NN O
of IN O
this DT O
life-threatening JJ O
condition NN O
. . O

-DOCSTART- X X O

Co-transfection NN O
of IN O
expression NN O
vectors NNS O
for IN O
CCAAT/enhancer NNP B-NP
binding JJ I-NP
protein NN I-NP
( -LRB- I-NP
C/EBP NN I-NP
) -RRB- I-NP
alpha NN I-NP
and CC O
C/EBP NNP B-NP
beta NN I-NP
trans-activated VBD O
the DT O
rat NN B-NP
uncoupling VBG I-NP
protein NN I-NP
gene NN I-NP
promoter NN I-NP
due JJ O
to TO O
sequences NNS O
in IN O
the DT O
5' JJ O
proximal JJ O
region NN O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
not RB O
possible JJ O
to TO O
study VB O
the DT O
basis NN O
for IN O
tissue-specific JJ O
expression NN O
of IN O
this DT O
gene NN O
, , O
because IN O
the DT O
beta NN B-NP
3 CD I-NP
gene NN I-NP
promoter NN I-NP
had VBD O
not RB O
been VBN O
isolated VBN O
previously RB O
. . O

-DOCSTART- X X O

Isolation NNP O
and CC O
characterization NN O
of IN O
a DT O
TATA-less JJ O
promoter NN O
for IN O
the DT O
human JJ B-NP
beta NN I-NP
3 CD I-NP
integrin NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Subretinal JJ O
fluid NN O
was VBD O
punctured VBN O
on IN O
the DT O
poorer JJR O
eye NN O
in IN O
19 CD O
eyes NNS O
( -LRB- O
52.7 CD O
% NN O
) -RRB- O
and CC O
on IN O
the DT O
better JJR O
eye NN O
in IN O
7 CD O
eyes NNS O
( -LRB- O
19.4 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
data NNS O
indicate VBP O
that IN O
activation NN O
of IN O
these DT O
enzymes NNS O
is VBZ O
not RB O
sufficient JJ O
for IN O
the DT O
acute JJ O
stimulation NN O
of IN O
glucose NN O
transport NN O
. . O

-DOCSTART- X X O

Transcriptional JJ O
analysis NN O
of IN O
a DT O
series NN O
of IN O
deletion NN O
mutants NNS O
of IN O
the DT O
gene NN O
in IN O
the DT O
nuclear JJ O
extracts NNS O
prepared VBN O
from IN O
the DT O
middle JJ O
silk NN O
gland NN O
of IN O
2-day-old JJ O
fifth JJ O
instar NN O
larvae NNS O
revealed VBD O
the DT O
presence NN O
of IN O
multiple JJ O
cis-regulatory JJ O
elements NNS O
located VBN O
both DT O
upstream RB O
and CC O
downstream RB O
of IN O
the DT O
initiation NN O
site NN O
. . O

-DOCSTART- X X O

Concerted JJ O
action NN O
of IN O
three CD O
distinct JJ O
domains NNS O
in IN O
the DT O
DNA NNP O
cleaving-joining JJ O
reaction NN O
catalyzed JJ O
by IN O
relaxase NN B-NP
( -LRB- O
TraI NNP B-NP
) -RRB- O
of IN O
conjugative JJ O
plasmid NN O
RP4 NNP O
. . O

-DOCSTART- X X O

The DT O
HGF-induced JJ B-NP
cell NN O
motility NN O
was VBD O
mimicked VBN O
by IN O
12-0-tetradecanoyl-phorbol-13-acetate CD O
, , O
a DT O
protein NN B-NP
kinase NN I-NP
C-activating NN I-NP
phorbol NN O
ester NN O
, , O
but CC O
not RB O
by IN O
Ca2+ JJ O
ionophore NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
report NN O
, , O
66 CD O
hemochromatosis NN O
families NNS O
yielding VBG O
151 CD O
hemochromatosis NN O
chromosomes NNS O
and CC O
182 CD O
normal JJ O
chromosomes NNS O
were VBD O
RFLP-typed JJ O
with IN O
a DT O
battery NN O
of IN O
probes NNS O
, , O
including VBG O
two CD O
newly RB O
derived VBN O
polymorphic JJ O
markers NNS O
from IN O
the DT O
6.7 CD O
and CC O
HLA-F JJ B-NP
loci NNS I-NP
located VBN O
150 CD O
and CC O
250 CD O
kb JJ O
telomeric JJ O
to TO O
HLA-A NNP B-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

Pneumothorax NN O
during IN O
laparoscopic JJ O
dissection NN O
of IN O
the DT O
diaphragmatic JJ O
hiatus NN O
. . O

-DOCSTART- X X O

Mutations NNS O
in IN O
the DT O
nuclear JJ B-NP
gene NN I-NP
CBP1 . I-NP
of IN I-NP
Saccharomyces NNS I-NP
cerevisiae NNS I-NP
result VBP O
in IN O
degradation NN O
of IN O
mitochondrially RB B-NP
encoded VBN I-NP
cytochrome NN I-NP
b NN I-NP
( -LRB- O
cob NN B-NP
) -RRB- O
RNA NN O
; : O
thus RB O
, , O
the DT O
cells NNS O
are VBP O
unable JJ O
to TO O
respire VB O
. . O

-DOCSTART- X X O

To TO O
gain VB O
further JJ O
insight NN O
into IN O
the DT O
pathogenesis NN O
of IN O
the DT O
adult NN O
respiratory NN O
distress NN O
syndrome NN O
( -LRB- O
ARDS NNP O
) -RRB- O
, , O
the DT O
authors NNS O
studied VBN O
possible JJ O
relationships NNS O
among IN O
the DT O
activation NN O
status NN O
of IN O
circulating VBG O
polymorphonuclear NN O
neutrophils NNS O
( -LRB- O
PMN) NNP O
, , O
cytokine NN O
levels NNS O
, , O
and CC O
the DT O
severity NN O
of IN O
lung NN O
injury NN O
in IN O
31 CD O
patients NNS O
: : O
15 CD O
with IN O
ARDS NNP O
, , O
9 CD O
with IN O
severe JJ O
pneumonia NN O
uncomplicated VBN O
by IN O
ARDS NNP O
, , O
and CC O
7 CD O
mechanically RB O
ventilated VBN O
patients NNS O
with IN O
neither DT O
ARDS NNP O
nor CC O
pneumonia NN O
. . O

-DOCSTART- X X O

Amiodarone JJ O
, , O
seldom RB O
used VBN O
as IN O
first-line JJ O
treatment NN O
, , O
appears VBZ O
to TO O
be VB O
the DT O
most RBS O
effective JJ O
drug NN O
. . O

-DOCSTART- X X O

Two CD O
experiments NNS O
were VBD O
conducted VBN O
to TO O
study VB O
the DT O
vacuous JJ O
jaw NN O
movements NNS O
induced VBN O
in IN O
rats NNS O
by IN O
acute JJ O
administration NN O
of IN O
the DT O
monoamine-depleting JJ O
agent NN O
reserpine NNP O
. . O

-DOCSTART- X X O

Depletion NNP O
of IN O
dopamine NN O
in IN O
the DT O
nucleus JJ O
accumbens NNS O
led VBD O
to TO O
a DT O
dramatic JJ O
shift NN O
in IN O
behavior NN O
in IN O
which WDT O
there EX O
was VBD O
a DT O
significant JJ O
decrease NN O
in IN O
lever JJ O
pressing VBG O
but CC O
a DT O
significant JJ O
increase NN O
in IN O
consumption NN O
of IN O
lab NN O
chow NN O
. . O

-DOCSTART- X X O

Recovery NNP O
of IN O
carbimazole-induced JJ O
agranulocytosis NN O
following VBG O
recombinant JJ B-NP
granulocyte-macrophage JJ I-NP
colony NN I-NP
stimulating NN I-NP
factor NN I-NP
( -LRB- O
rhGM-CSF NN B-NP
) -RRB- O
administration NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
system NN O
can MD O
be VB O
used VBN O
to TO O
detect VB O
and CC O
study VB O
dynamic JJ O
perfusion NN O
changes NNS O
from IN O
the DT O
brain NN O
surface NN O
with IN O
minimal JJ O
tissue NN O
damage NN O
. . O

-DOCSTART- X X O

The DT O
neglect NN O
of IN O
Richards NNP O
's POS O
theory NN O
demonstrates VBZ O
the DT O
range NN O
of IN O
factors NNS O
, , O
other JJ O
than IN O
the DT O
strictly RB O
scientific JJ O
, , O
which WDT O
can MD O
be VB O
important JJ O
in IN O
determining VBG O
the DT O
influence NN O
or CC O
otherwise RB O
of IN O
a DT O
psychological JJ O
theory NN O
. . O

-DOCSTART- X X O

The DT O
positive-acting JJ O
global JJ O
sulfur NN O
regulatory JJ O
protein NN O
, , O
CYS3 NNP B-NP
, , O
of IN O
Neurospora NNP O
crassa VBD O
turns NNS O
on IN O
the DT O
expression NN O
of IN O
a DT O
family NN O
of IN O
unlinked JJ O
structural JJ O
genes NNS O
that WDT O
encode VBP O
enzymes NNS O
of IN O
sulfur NN O
catabolism NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
upstream JJ O
untranslated JJ O
region NN O
of IN O
CHL15 NNP B-NP
revealed VBD O
the DT O
presence NN O
of IN O
the DT O
hexamer NN O
element NN O
, , O
ACGCGT NNP O
( -LRB- O
an DT O
MluI NNP B-NP
restriction NN I-NP
site NN I-NP
) -RRB- O
controlling VBG O
both DT O
the DT O
periodic JJ O
expression NN O
and CC O
coordinate VB O
regulation NN O
of IN O
the DT O
DNA NNP O
synthesis NN O
genes NNS O
in IN O
budding VBG O
yeast NN O
. . O

-DOCSTART- X X O

The DT O
C-terminal JJ O
region NN O
of IN O
the DT O
150-kDa JJ O
protein NN O
contains VBZ O
an DT O
NTP-binding JJ O
helicase NN B-NP
motif NN I-NP
and CC O
the DT O
readthrough JJ O
region NN O
, , O
an DT O
RNA NNP B-NP
polymerase NN I-NP
motif NN I-NP
, , O
indicating VBG O
that IN O
these DT O
two CD O
overlapping JJ O
proteins NNS O
may MD O
form VB O
an DT O
RNA NNP O
replication NN O
complex NN O
similar JJ O
to TO O
those DT O
of IN O
tobamo- NNS O
and CC O
tobraviruses NNS O
. . O

-DOCSTART- X X O

The DT O
5' JJ O
ends NNS O
of IN O
F3R NNP B-NP
late JJ O
transcripts NNS O
were VBD O
located VBN O
to TO O
an DT O
A NNP O
within IN O
the DT O
sequence NN O
5'-TAAAG JJ O
, , O
41 CD O
nt NN O
downstream NN O
from IN O
the DT O
early JJ O
promoter NN O
and CC O
17 CD O
nt NN O
upstream RB O
from IN O
the DT O
initiation NN O
codon NN O
. . O

-DOCSTART- X X O

On IN O
T2 DT O
weighted JJ O
images NNS O
, , O
low JJ O
intensity NN O
areas NNS O
in IN O
the DT O
thalamus NN O
, , O
the DT O
striatum NN O
, , O
the DT O
anterior JJ O
limb NN O
of IN O
the DT O
internal JJ O
capsule NN O
, , O
the DT O
tegmentum NN O
of IN O
midbrain NN O
, , O
high JJ O
intensity NN O
areas NNS O
in IN O
middle JJ O
cerebellar NN O
peduncle NN O
, , O
the DT O
posterior JJ O
limb NN O
of IN O
the DT O
internal JJ O
capsule NN O
, , O
the DT O
lateral JJ O
part NN O
of IN O
the DT O
cerebral JJ O
peduncle NN O
, , O
and CC O
the DT O
cerebral JJ O
white JJ O
matter NN O
were VBD O
noted VBN O
. . O

-DOCSTART- X X O

Using VBG O
the DT O
rap1t NN B-NP
alleles NNS I-NP
to TO O
generate VB O
wild-type JJ O
cells NNS O
differing VBG O
only RB O
in IN O
telomere JJ O
tract NN O
lengths NNS O
, , O
we PRP O
also RB O
show VBP O
that DT O
telomere JJ O
position NN O
effects NNS O
are VBP O
highly RB O
sensitive JJ O
to TO O
changes NNS O
in IN O
the DT O
size NN O
( -LRB- O
or CC O
structure NN O
) -RRB- O
of IN O
the DT O
telomeric JJ O
tract NN O
. . O

-DOCSTART- X X O

Pronounced JJ O
microangiopathy NN O
characterized VBN O
by IN O
avascular JJ O
fields NNS O
, , O
enlarged VBN O
and CC O
tortuous JJ O
capillaries NNS O
and CC O
increased VBD O
transcapillary NN O
diffusion NN O
of IN O
sodium NN O
fluorescein NN O
, , O
was VBD O
clearly RB O
demonstrable JJ O
in IN O
the DT O
area NN O
of IN O
the DT O
nodules NNS O
. . O

-DOCSTART- X X O

Epigenetic JJ O
switching NN O
of IN O
transcriptional JJ O
states NNS O
: : O
cis NNS O
- : O
and CC O
trans-acting JJ O
factors NNS O
affecting VBG O
establishment NN O
of IN O
silencing NN O
at IN O
the DT O
HMR NNP B-NP
locus NN I-NP
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

NF-kappa NNP B-NP
B NNP I-NP
p65 VBD B-NP
, , O
p50 VBD B-NP
, , O
and CC O
Rel NNP B-NP
functionally RB O
synergize NN O
with IN O
C/EBP NNP B-NP
alpha NN I-NP
, , O
C/EBP NNP B-NP
beta NN I-NP
, , O
and CC O
C/EBP NNP B-NP
delta NN I-NP
. . O

-DOCSTART- X X O

There EX O
was VBD O
no DT O
clear JJ O
correlation NN O
between IN O
the DT O
MFA NNP O
and CC O
the DT O
severity NN O
of IN O
the DT O
UTS NNP O
phenotype NN O
. . O

-DOCSTART- X X O

The DT O
plasmatic JJ B-NP
albumin NN I-NP
concentration NN O
( -LRB- O
3.5-4.5 CD O
g/dl NN O
) -RRB- O
represents VBZ O
about IN O
60 CD O
% NN O
of IN O
the DT O
total JJ O
plasma NN O
protein NN O
. . O

-DOCSTART- X X O

These DT O
lesions NNS O
were VBD O
asymptomatic JJ O
, , O
but CC O
both DT O
were VBD O
characterized VBN O
clinically RB O
by IN O
central JJ O
ulceration NN O
. . O

-DOCSTART- X X O

Neither DT O
RD19 NNP B-NP
nor CC O
RD21 NNP B-NP
mRNA NN I-NP
synthesis NN O
was VBD O
responsive JJ O
to TO O
cold JJ O
or CC O
to TO O
heat VB O
stress NN O
. . O

-DOCSTART- X X O

One CD O
defective JJ O
RNA NNP O
with IN O
a DT O
large JJ O
deletion NN O
in IN O
the DT O
p70 NN B-NP
coding VBG I-NP
region NN I-NP
was VBD O
able JJ O
to TO O
replicate VB O
efficiently RB O
, , O
both CC O
when WRB O
inoculated VBN O
with IN O
the DT O
helper NN O
genome NN O
and CC O
when WRB O
inoculated VBN O
with IN O
a DT O
second JJ O
complementing NN O
defective JJ O
RNA NNP O
that IN O
supplied VBD O
a DT O
wild-type JJ B-NP
p70 NN I-NP
. . O

-DOCSTART- X X O

Morphometrical NNP O
quantification NN O
of IN O
brain NN O
edema NN O
related VBN O
to TO O
experimental JJ O
multiple JJ O
micro-infarcts NNS O
in IN O
mice NNS O
: : O
assessment NN O
of IN O
neurotropin JJ B-NP
effect NN O
. . O

-DOCSTART- X X O

One CD O
member NN O
of IN O
this DT O
multigene NN O
family NN O
, , O
GATA-3 JJ B-NP
, , O
is VBZ O
most RBS O
abundantly RB O
expressed VBN O
in IN O
T NNP O
lymphocytes NNS O
, , O
a DT O
cellular JJ O
target NN O
for IN O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( -LRB- O
HIV-1 NN O
) -RRB- O
infection NN O
and CC O
replication NN O
. . O

-DOCSTART- X X O

Pneumoscrotum NN O
is VBZ O
a DT O
rare JJ O
condition NN O
that WDT O
receives VBZ O
little JJ O
discussion NN O
in IN O
standard JJ O
texts NNS O
of IN O
urology NN O
. . O

-DOCSTART- X X O

The DT O
first JJ O
gene NN O
codes NNS O
for IN O
a DT O
protein NN O
containing VBG O
11 CD O
cystein NN O
residues NNS O
in IN O
an DT O
arrangement NN O
typical JJ O
for IN O
Fe/S NNP B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Triton-disrupted JJ O
cells NNS O
retained VBN O
capacity NN O
for IN O
activation NN O
of IN O
the DT O
pathway NN O
by IN O
both DT O
peptide NN O
growth NN O
factors NNS O
and CC O
by IN O
addition NN O
of IN O
GTP-loaded JJ O
p21 NN B-NP
rasVal12 NN B-NP
. . O

-DOCSTART- X X O

To TO O
begin VB O
to TO O
examine VB O
the DT O
mechanism NN O
controlling VBG O
expression NN O
of IN O
this DT O
gene NN O
during IN O
the DT O
cell-cycle NN O
, , O
a DT O
mouse NN B-NP
B-myb NN I-NP
5' VBZ I-NP
flanking VBG I-NP
sequence NN I-NP
was VBD O
isolated VBN O
from IN O
a DT O
cosmid JJ O
library NN O
and CC O
shown VBN O
to TO O
promote VB O
efficiently RB O
the DT O
transcription NN O
of IN O
a DT O
luciferase NN B-NP
reporter NN I-NP
gene NN I-NP
when WRB O
transfected VBN O
into IN O
NIH3T3 NNP O
fibroblasts NNS O
. . O

-DOCSTART- X X O

The DT O
influence NN O
of IN O
a DT O
high JJ O
ionic JJ O
strength NN O
on IN O
the DT O
resolution NN O
was VBD O
clearly RB O
shown VBN O
. . O

-DOCSTART- X X O

The DT O
number NN O
of IN O
bacteria NNS O
in IN O
the DT O
lung NN O
, , O
peripheral JJ O
white JJ O
blood NN O
cell NN O
and CC O
BAL NNP O
fluid NN O
cell NN O
also RB O
decreased VBN O
by IN O
the DT O
administration NN O
of IN O
FN. NNP B-NP

-DOCSTART- X X O

In IN O
mice NNS O
, , O
three CD O
major JJ O
families NNS O
of IN O
L1 NNP O
elements NNS O
, , O
termed VBN O
" `` O
A NNP O
, , O
" '' O
" `` O
F NNP O
, , O
" '' O
and CC O
"V NNP O
, , O
" `` O
have VBP O
been VBN O
defined VBN O
on IN O
the DT O
basis NN O
of IN O
the DT O
sequence NN O
found VBD O
at IN O
the DT O
5' JJ O
terminus NN O
. . O

-DOCSTART- X X O

TFEC NNP B-NP
, , O
a DT O
basic JJ B-NP
helix-loop-helix NN I-NP
protein NN I-NP
, , O
forms NNS O
heterodimers NNS O
with IN O
TFE3 NNP B-NP
and CC O
inhibits VBZ O
TFE3-dependent JJ B-NP
transcription NN O
activation NN O
. . O

-DOCSTART- X X O

The DT O
equivalent NN O
of IN O
the DT O
third JJ O
ligand NN O
, , O
H-87 NNP O
, , O
is VBZ O
T-47 CD O
in IN O
the DT O
PSTAIRE NNP O
sequence NN O
motif NN O
. . O

-DOCSTART- X X O

Similar JJ O
results NNS O
were VBD O
seen VBN O
on IN O
Western JJ O
blots NNS O
of IN O
Autographa NNP O
californica NN O
MNPV NNP O
( -LRB- O
AcMNPV)-infected JJ O
Spodoptera NNP O
frugiperda NN O
cells NNS O
. . O

-DOCSTART- X X O

In IN O
infected JJ O
mammalian JJ O
cells NNS O
, , O
the DT O
ARV NN B-NP
G NNP I-NP
and CC O
GNS NNP B-NP
genes NNS I-NP
are VBP O
transcribed VBN O
primarily RB O
as IN O
a DT O
polycistronic JJ O
mRNA NN O
which WDT O
appears VBZ O
to TO O
extend VB O
from IN O
the DT O
consensus NN O
sequence NN O
( -LRB- O
AACAG NNP O
) -RRB- O
at IN O
the DT O
start NN O
of IN O
the DT O
G NNP B-NP
gene NN I-NP
to TO O
the DT O
next JJ O
recognized VBN O
polyadenylation NN O
signal NN O
( -LRB- O
CATG[A]7 JJ O
) -RRB- O
located VBN O
697 CD O
nucleotides NNS O
downstream NN O
of IN O
the DT O
GNS NNP B-NP
protein NN I-NP
termination NN O
codon NN O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
and CC O
expression NN O
of IN O
RPE65 CD B-NP
, , O
a DT O
novel NN O
retinal JJ O
pigment NN O
epithelium-specific JJ O
microsomal JJ O
protein NN O
that WDT O
is VBZ O
post-transcriptionally RB O
regulated VBN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
power NN O
( -LRB- O
in IN O
mu NN O
W) NN O
required VBN O
to TO O
produce VB O
the DT O
observed JJ O
flow NN O
rate NN O
was VBD O
estimated VBN O
at IN O
each DT O
outflow NN O
pressure NN O
as IN O
the DT O
product NN O
of IN O
the DT O
flow NN O
rate NN O
and CC O
the DT O
pressure NN O
across IN O
the DT O
lymphatic JJ O
vessel NN O
. . O

-DOCSTART- X X O

Although IN O
antisperm JJ O
antibodies NNS O
are VBP O
associated VBN O
with IN O
infertility NN O
, , O
many JJ O
hospital NN O
laboratories NNS O
do VBP O
not RB O
test VB O
for IN O
these DT O
antibodies NNS O
. . O

-DOCSTART- X X O

PPD-specific JJ B-NP
IgG NNP B-NP
subclass NN O
responses NNS O
were VBD O
evident JJ O
to TO O
all DT O
four CD O
IgG NNP B-NP
subclasses NNS O
. . O

-DOCSTART- X X O

Anterior JJ O
body NN O
pattern NN O
in IN O
Drosophila NNP O
is VBZ O
specified VBN O
by IN O
the DT O
graded JJ O
distribution NN O
of IN O
the DT O
bicoid JJ B-NP
protein NN I-NP
( -LRB- O
bcd NN B-NP
) -RRB- O
, , O
which WDT O
activates VBZ O
subordinate JJ O
genes NNS O
in IN O
distinct JJ O
anterior JJ O
domains NNS O
. . O

-DOCSTART- X X O

GAP-N NNP B-NP
bound VBD O
constitutively RB O
to TO O
p190 VB B-NP
in IN O
both DT O
serum-deprived JJ O
and CC O
growth NN O
factor-stimulated JJ O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
peptide NN O
sequence NN O
contains VBZ O
a DT O
region NN O
of IN O
80 CD O
amino JJ O
acids NNS O
that WDT O
shows VBZ O
similarity NN O
to TO O
bcl-2 CD B-NP
and CC O
to TO O
the DT O
recently RB O
described VBN O
bcl-2-related JJ B-NP
gene NN I-NP
, , O
MCL1 NNP B-NP
. . O

-DOCSTART- X X O

Botulinum NN B-NP
toxin NN I-NP
: : O
preferred VBN O
treatment NN O
for IN O
hemifacial JJ O
spasm NN O
. . O

-DOCSTART- X X O

The DT O
Saccharomyces NNP B-NP
cerevisiae NN I-NP
GAL1 NNP I-NP
and CC O
GAL10 NNP B-NP
genes NNS I-NP
are VBP O
controlled VBN O
in IN O
response NN O
to TO O
the DT O
availability NN O
of IN O
galactose NN O
and CC O
glucose NN O
by IN O
multiple JJ O
activating NN O
and CC O
repressing VBG O
proteins NNS O
bound VBN O
at IN O
adjacent JJ O
or CC O
overlapping VBG O
sites NNS O
in IN O
UASG. NNP O

-DOCSTART- X X O

Surprisingly RB O
, , O
the DT O
results NNS O
of IN O
several JJ O
experiments NNS O
suggest VBP O
that IN O
the DT O
TSF NNP B-NP
genes NNS I-NP
encode JJ O
global JJ O
regulatory JJ O
factors NNS O
. . O
tsf1 NN B-NP
to TO O
tsf6 VB B-NP
mutations NNS O
derepressed VBN O
expression NN O
from IN O
yeast NN O
CYC-GAL JJ B-NP
hybrid JJ O
promoters NNS O
( -LRB- O
fused VBN O
to TO O
lacZ NN B-NP
) -RRB- O
that WDT O
harbor VBP O
a DT O
variety NN O
of IN O
operator NN O
sequences NNS O
, , O
and CC O
caused VBD O
pleiotropic JJ O
defects NNS O
in IN O
cell NN O
growth NN O
, , O
mating NN O
, , O
and CC O
sporulation NN O
. . O

-DOCSTART- X X O

Sex NN O
of IN O
calf NN O
(variate JJ O
2 CD O
) -RRB- O
was VBD O
associated VBN O
most RBS O
closely RB O
with IN O
width NN O
of IN O
muzzle NN O
and CC O
head NN O
. . O

-DOCSTART- X X O

Sequence NN O
comparison NN O
indicates VBZ O
that IN O
exons NNS O
5'/L JJ O
and CC O
L/N NNP O
in IN O
PSG12 NNP B-NP
and CC O
PSG12 NNP B-NP
psi NNS I-NP
are VBP O
99 CD O
% NN O
identical JJ O
, , O
except IN O
that IN O
the DT O
L/N NNP O
exon NN O
in IN O
the DT O
PSG12 NNP B-NP
psi NNS I-NP
gene NN I-NP
contains VBZ O
a DT O
stop NN O
codon NN O
. . O

-DOCSTART- X X O

We PRP O
suggest VBP O
that IN O
the DT O
ER NNP O
lumenal JJ O
variable JJ O
domain NN O
of IN O
gp19K NNP B-NP
has VBZ O
a DT O
specific JJ O
tertiary NN O
structure NN O
that WDT O
is VBZ O
important JJ O
for IN O
binding NN O
to TO O
the DT O
polymorphic JJ O
alpha NN O
1 CD O
and CC O
alpha NN O
2 CD O
domains VBZ O
of IN O
class NN B-NP
I PRP I-NP
heavy JJ I-NP
( -LRB- I-NP
alpha NN I-NP
) -RRB- I-NP
chains NNS I-NP
. . O

-DOCSTART- X X O

We PRP O
recently RB O
found VBD O
that IN O
17 CD O
beta-estradiol JJ O
( -LRB- O
E2 NN O
) -RRB- O
not RB O
only RB O
suppresses VBZ O
bone NN O
resorption NN O
but CC O
also RB O
stimulates VBZ O
bone NN O
formation NN O
in IN O
the DT O
cancellous JJ O
bone NN O
of IN O
female JJ O
rats NNS O
. . O

-DOCSTART- X X O

Single-photon NNP O
emission NN O
computed VBD O
tomography NN O
( -LRB- O
SPECT) JJ O
with IN O
99mTc-hexamethylpropyleneamine JJ O
oxime NN O
( -LRB- O
HMPAO NNP O
) -RRB- O
was VBD O
used VBN O
to TO O
investigate VB O
changes NNS O
in IN O
cerebral JJ O
blood NN O
flow NN O
in IN O
seven CD O
patients NNS O
with IN O
cortical JJ O
visual JJ O
impairment NN O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
Twenty-two CD O
patients NNS O
were VBD O
grouped VBN O
according VBG O
to TO O
their PRP$ O
etiology NN O
based VBN O
on IN O
the DT O
study NN O
of IN O
antiadrenal JJ O
antibodies NNS O
at IN O
diagnosis NN O
of IN O
the DT O
disease NN O
: : O
7 CD O
were VBD O
positive JJ O
( -LRB- O
autoimmune NN O
etiology NN O
or CC O
EAA NNP O
) -RRB- O
, , O
11 CD O
were VBD O
negative JJ O
( -LRB- O
tuberculous JJ O
etiology NN O
or CC O
EAT NN O
) -RRB- O
and CC O
in IN O
four CD O
serologic NN O
study NN O
was VBD O
not RB O
available JJ O
(undetermined VBD O
etiology NN O
or CC O
EAI NNS O
) -RRB- O
. . O

-DOCSTART- X X O

2-AP JJ O
induced VBD O
marked VBN O
, , O
steady JJ O
rises NNS O
in IN O
mRNA NN O
accumulation NN O
from IN O
both DT O
transfected VBN O
and CC O
chromosomally RB O
integrated VBN O
HIV-1 NN O
constructs NNS O
but CC O
no DT O
increases NNS O
from IN O
an DT O
endogenous JJ O
gene NN O
encoding VBG O
gamma-actin NN B-NP
or CC O
glucose NN B-NP
6-phosphate JJ I-NP
dehydrogenase NN I-NP
. . O

-DOCSTART- X X O

Protein NNP B-NP
tyrosine NN I-NP
phosphatases NNS I-NP
( -LRB- O
PTPs NNS B-NP
) -RRB- O
, , O
together RB O
with IN O
protein NN B-NP
tyrosine NN I-NP
kinases NNS I-NP
( -LRB- O
PTKs NNS B-NP
) -RRB- O
, , O
are VBP O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
cell NN O
activation NN O
, , O
growth NN O
, , O
and CC O
differentiation NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
a DT O
p21X JJ B-NP
protein NN I-NP
lacking VBG O
the DT O
N-terminus NNP O
of IN O
Rex1 NNP B-NP
was VBD O
expressed VBN O
at IN O
high JJ O
levels NNS O
; : O
our PRP$ O
data NNS O
indicate VBP O
that IN O
p21X PRP B-NP
is VBZ O
translated VBN O
from IN O
the DT O
1.6-kb JJ O
mRNA NN O
which WDT O
is VBZ O
derived VBN O
primarily RB O
from IN O
deleted VBN O
proviruses NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
it PRP O
was VBD O
confirmed VBN O
that IN O
the DT O
sodium NN O
lauryl NN O
sulfate NN O
method NN O
of IN O
estimating VBG O
hemoglobin NN B-NP
concentration NN O
is VBZ O
an DT O
appropriate JJ O
alternative NN O
to TO O
the DT O
cyanmethemoglobin NN B-NP
method NN O
and CC O
avoids VBZ O
the DT O
generation NN O
of IN O
toxic JJ O
wastes NNS O
. . O

-DOCSTART- X X O

XII NNP O
. . O

-DOCSTART- X X O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
structures NNS O
of IN O
the DT O
b-Zip JJ O
domain NN O
are VBP O
well RB O
conserved VBN O
among IN O
these DT O
Maf-related JJ B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Under IN O
these DT O
conditions NNS O
, , O
transfections NNS O
with IN O
cDNAs NNS O
of IN O
the DT O
NF-kappa NNP B-NP
B NNP I-NP
p50 NN B-NP
and CC O
serum NN B-NP
response NN I-NP
factor NN I-NP
( -LRB- O
SRF NN B-NP
) -RRB- O
produced VBD O
a DT O
factor( JJ O
s VBZ O
) -RRB- O
that DT O
mediated JJ O
Tax NNP B-NP
binding NN O
to TO O
the DT O
NF-kappa NNP B-NP
B NNP I-NP
site NN I-NP
and CC O
the DT O
CArG NNP O
box NN O
respectively RB O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
here RB O
that IN O
v-Rel NN B-NP
specifically RB O
increased VBD O
expression NN O
from IN O
a DT O
reporter NN O
plasmid NN O
containing VBG O
multiple JJ O
Sp1 JJ B-NP
binding NN I-NP
sites NNS I-NP
approximately RB O
sixfold JJ O
in IN O
chicken NN O
embryo NN O
fibroblasts NNS O
( -LRB- O
CEFs NNS O
) -RRB- O
, , O
even RB O
though IN O
v-Rel JJ B-NP
did VBD O
not RB O
bind NN O
directly RB O
to TO O
these DT O
sites NNS O
. . O
v-Rel NN B-NP
also RB O
increased VBD O
expression NN O
from IN O
a DT O
reporter NN O
plasmid NN O
containing VBG O
a DT O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( -LRB- I-NP
HIV-1 NN I-NP
) -RRB- I-NP
long RB I-NP
terminal JJ I-NP
repeat NN I-NP
( -LRB- O
LTR NNP O
) -RRB- O
in IN O
which WDT O
the DT O
kappa NN B-NP
B NNP I-NP
binding NN I-NP
sites NNS I-NP
were VBD O
mutated JJ O
but CC O
which WDT O
still RB O
contained VBD O
intact JJ O
Sp1 JJ B-NP
binding NN I-NP
sites NNS I-NP
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
This DT O
retrospective JJ O
analysis NN O
does VBZ O
not RB O
confirm VB O
the DT O
efficacy NN O
of IN O
one CD O
course NN O
of IN O
simultaneous JJ O
Mitomycin-C NNP O
and CC O
5-fluorouracil CD O
, , O
at IN O
least JJS O
in IN O
association NN O
with IN O
full-dose JJ O
radiotherapy NN O
incorporating NN O
Iridium-192 NNP O
boost NN O
. . O

-DOCSTART- X X O

Despite IN O
the DT O
existence NN O
of IN O
30 CD O
cysteine NN O
residues NNS O
, , O
carboxymethylation NN O
prevented VBD O
the DT O
formation NN O
of IN O
most JJS O
if IN O
not RB O
all DT O
disulfide JJ O
bonds NNS O
that WDT O
otherwise RB O
occurred VBD O
when WRB O
the DT O
cells NNS O
were VBD O
sonicated VBN O
. . O

-DOCSTART- X X O

Cerebro-oculo-facioskeletal NN O
syndrome NN O
( -LRB- O
Pena-Shokeir JJ O
syndrome NN O
II NNP O
) -RRB- O

-DOCSTART- X X O

Deletion NNP O
of IN O
a DT O
53-bp JJ O
early JJ O
promoter NN O
region NN O
containing VBG O
the DT O
transcription NN O
start NN O
site NN O
and CC O
a DT O
putative JJ O
TATA NNP O
box NN O
completely RB O
abolishes VBZ O
the DT O
ability NN O
of IN O
upstream RB O
elements NNS O
to TO O
drive VB O
transcription NN O
of IN O
the DT O
luciferase NN B-NP
cDNA NN I-NP
. . O

-DOCSTART- X X O

Dissipation NN O
of IN O
claudication NN O
pain NN O
after IN O
walking VBG O
: : O
implications NNS O
for IN O
endurance NN O
training NN O
. . O

-DOCSTART- X X O

Alternative JJ O
transcript NN O
of IN O
the DT O
nonselective-type JJ O
endothelin NN B-NP
receptor NN I-NP
from IN O
rat NN O
brain NN O
. . O

-DOCSTART- X X O

The DT O
Functional NNP O
Independence NNP O
Measure NN O
: : O
a DT O
comparative JJ O
study NN O
of IN O
clinician NN O
and CC O
self NN O
ratings NNS O
. . O

-DOCSTART- X X O

Polymyxin NNP O
B NNP O
was VBD O
given VBN O
intravenously RB O
for IN O
1 CD O
week NN O
postburn NN O
in IN O
doses NNS O
designed VBN O
to TO O
neutralize VB O
circulating VBG O
endotoxemia NN O
. . O

-DOCSTART- X X O

SvO2 PRP O
can MD O
be VB O
determined VBN O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

The DT O
transverse NN O
relaxation NN O
time NN O
( -LRB- O
T2 NN O
) -RRB- O
and CC O
apparent JJ O
diffusion NN O
coefficient NN O
of IN O
water NN O
were VBD O
determined VBN O
. . O

-DOCSTART- X X O

The DT O
Drosophila NNP O
clathrin VBD B-NP
heavy JJ I-NP
chain NN I-NP
gene NN O
: : O
clathrin JJ B-NP
function NN O
is VBZ O
essential JJ O
in IN O
a DT O
multicellular JJ O
organism NN O
. . O

-DOCSTART- X X O

The DT O
binding JJ O
specificity NN O
of IN O
this DT O
protein NN O
was VBD O
compared VBN O
to TO O
that DT O
of IN O
human JJ B-NP
E2F NN I-NP
using VBG O
a DT O
number NN O
of IN O
mutant JJ B-NP
E2F NN I-NP
sites NNS I-NP
as IN O
competitors NNS O
. . O

-DOCSTART- X X O

To TO O
analyze VB O
the DT O
VH NNP O
regions NNS O
of IN O
polyreactive JJ O
antibodies NNS O
, , O
with IN O
particular JJ O
attention NN O
at IN O
their PRP$ O
somatically RB O
mutated JJ O
status NN O
, , O
we PRP O
generated VBD O
five CD O
IgG NNP B-NP
( -LRB- O
three CD O
IgG1 NNP B-NP
and CC O
two CD O
IgG3 NNS B-NP
) -RRB- O
mAb NN O
(using VBG O
B NNP O
cells NNS O
from IN O
a DT O
healthy JJ O
subject NN O
, , O
a DT O
patient NN O
with IN O
insulin-dependent JJ B-NP
diabetes NNS O
mellitus NN O
and CC O
a DT O
patient NN O
with IN O
SLE) NNP O
, , O
which WDT O
bound VBD O
with IN O
various JJ O
efficiencies NNS O
a DT O
number NN O
of IN O
different JJ O
self NN O
and CC O
foreign JJ O
Ag NNP O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
a DT O
functional JJ O
cross-talk NN O
between IN O
RB NNP B-NP
protein NN I-NP
and CC O
p21ras NNS B-NP
, , O
which WDT O
balances VBZ O
the DT O
cell NN O
phenotype NN O
between IN O
normal JJ O
and CC O
transformed VBD O
states NNS O
. . O

-DOCSTART- X X O

Kinetics NNP O
of IN O
the DT O
inhibition NN O
indicated VBD O
that IN O
this DT O
polymerase NN O
domain NN O
can MD O
inhibit VB O
viral JJ O
replication NN O
only RB O
during IN O
the DT O
preinitiation NN O
stage NN O
. . O

-DOCSTART- X X O

3. . O

-DOCSTART- X X O

McCann NNP O
III NNP O
, , O
F. NNP O

-DOCSTART- X X O

These DT O
cell NN O
lines NNS O
, , O
selected VBN O
for IN O
the DT O
ability NN O
to TO O
support VB O
the DT O
replication NN O
of IN O
a DT O
temperature-sensitive JJ O
VP5 CD B-NP
mutant JJ I-NP
, , O
were VBD O
used VBN O
to TO O
isolate VB O
VP5 CD B-NP
and CC O
VP23 CD B-NP
null JJ O
mutants NNS O
. . O

-DOCSTART- X X O

The DT O
E1 NNP B-NP
nuclear JJ I-NP
transport NN I-NP
motif NN I-NP
is VBZ O
highly RB O
conserved VBN O
in IN O
the DT O
animal NN O
and CC O
human JJ O
papillomaviruses NNS O
and CC O
is VBZ O
encoded VBN O
in IN O
a DT O
similar JJ O
region NN O
in IN O
the DT O
related VBN O
E1 NNP B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

The DT O
E1 NNP B-NP
replication NN I-NP
protein NN I-NP
of IN O
bovine NN O
papillomavirus NN O
type NN O
1 CD O
contains VBZ O
an DT O
extended JJ O
nuclear JJ O
localization NN O
signal NN O
that WDT O
includes VBZ O
a DT O
p34cdc2 NN B-NP
phosphorylation NN O
site NN O
. . O

-DOCSTART- X X O

In IN O
order NN O
to TO O
investigate VB O
to TO O
what WDT O
extent NN O
this DT O
interaction NN O
might MD O
contribute VB O
to TO O
tumor NN O
induction NN O
by IN O
the DT O
virus NN O
, , O
we PRP O
have VBP O
introduced VBN O
two CD O
different JJ O
point NN O
mutations NNS O
within IN O
the DT O
putative JJ O
pRb-binding JJ B-NP
sequence NN I-NP
of IN O
large JJ B-NP
T NNP I-NP
antigen NN I-NP
, , O
and CC O
as IN O
a DT O
preliminary JJ O
to TO O
in IN O
vivo JJ O
experiments NNS O
we PRP O
have VBP O
studied VBN O
their PRP$ O
effects NNS O
in IN O
vitro NN O
on IN O
some DT O
biological JJ O
activities NNS O
relevant JJ O
to TO O
tumor NN O
induction NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
the DT O
conservation NN O
of IN O
nucleotides NNS O
154 CD O
to TO O
156 CD O
is VBZ O
likely JJ O
to TO O
be VB O
a DT O
consequence NN O
of IN O
their PRP$ O
role NN O
as IN O
a DT O
sequence-specific JJ O
recognition NN O
element NN O
for IN O
the DT O
SRP54 NNP B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

A DT O
region NN O
of IN O
the DT O
deduced JJ O
protein NN O
shares NNS O
extensive JJ O
homology NN O
with IN O
a DT O
catalytic JJ O
region NN O
of IN O
Raf NNP B-NP
kinases NNS I-NP
, , O
a DT O
feature NN O
shared VBN O
only RB O
with IN O
TFIIE NNP B-NP
among IN O
transcription NN O
factors NNS O
. . O

-DOCSTART- X X O

The DT O
low JJ O
molecular JJ O
mass NN O
polypeptide NN O
complex NN O
is VBZ O
assumed VBN O
to TO O
be VB O
involved VBN O
in IN O
antigen JJ O
presentation NN O
, , O
generating VBG O
peptides NNS O
from IN O
cytosolic JJ O
protein NN O
antigens NNS O
, , O
which WDT O
are VBP O
subsequently RB O
presented VBN O
to TO O
cytotoxic JJ O
T-lymphocytes NNS O
on IN O
the DT O
cell NN O
surface NN O
. . O

-DOCSTART- X X O

The DT O
C-terminal JJ O
approximately RB O
50 CD O
amino IN O
acids NNS O
of IN O
Bel-1 NNP B-NP
are VBP O
shown VBN O
to TO O
be VB O
essential JJ O
for IN O
Bel-1 NNP B-NP
activity NN O
but CC O
can MD O
be VB O
effectively RB O
substituted VBN O
by IN O
the DT O
C-terminal JJ O
activation NN O
domain NN O
of IN O
VP16 NNP B-NP
. . O

-DOCSTART- X X O

Optimal NNP O
activation NN O
of IN O
T NNP O
cells NNS O
requires VBZ O
at IN O
least JJS O
two CD O
signals NNS O
. . O

-DOCSTART- X X O

All DT O
four CD O
of IN O
the DT O
genes NNS O
have VBP O
a DT O
similar JJ O
structure NN O
, , O
with IN O
the DT O
receptor NN O
protein NN O
encoded VBN O
in IN O
a DT O
single JJ O
exon NN O
. . O

-DOCSTART- X X O

Identity NN O
of IN O
GABP NNP B-NP
with IN O
NRF-2 NNP B-NP
, , O
a DT O
multisubunit JJ O
activator NN O
of IN O
cytochrome NN B-NP
oxidase NN I-NP
expression NN O
, , O
reveals VBZ O
a DT O
cellular JJ O
role NN O
for IN O
an DT O
ETS NNP B-NP
domain NN I-NP
activator NN O
of IN O
viral JJ O
promoters NNS O
. . O

-DOCSTART- X X O

The DT O
intracellular JJ O
basic JJ B-NP
region/helix-loop-helix NN I-NP
( -LRB- I-NP
bHLH) NN I-NP
dioxin NN I-NP
receptor NN I-NP
mediates NNS O
signal VBP O
transduction NN O
by IN O
dioxin NN O
( -LRB- O
2,3,7,8-tetrachlorodibenzo-p-dioxin CD O
) -RRB- O
and CC O
functions VBZ O
as IN O
a DT O
ligand-activated JJ O
DNA NN O
binding JJ O
protein NN O
directly RB O
interacting JJ O
with IN O
target NN O
genes NNS O
by IN O
binding JJ O
to TO O
dioxin VB O
response NN O
elements NNS O
. . O

-DOCSTART- X X O

The DT O
alpha NN B-NP
2A-adrenergic JJ I-NP
receptor NN I-NP
( -LRB- O
alpha NN B-NP
2AAR JJ I-NP
) -RRB- O
is VBZ O
coupled VBN O
to TO O
a DT O
variety NN O
of IN O
effectors NNS O
via IN O
pertussis NN B-NP
toxin-sensitive JJ I-NP
GTP-binding JJ B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

A DT O
sequence NN O
comparison NN O
reveals VBZ O
two CD O
CCAAT/enhancer NN B-NP
binding JJ I-NP
protein NN I-NP
( -LRB- O
C/EBP NN B-NP
) -RRB- O
consensus NN O
sequences NNS O
, , O
basic JJ O
DNA NNP O
binding JJ O
region NN O
and CC O
leucine NN O
zippers NNS O
1 CD O
and CC O
2 CD O
( -LRB- O
bZIP1 NN O
and CC O
bZIP2 NN O
) -RRB- O
, , O
within IN O
this DT O
region NN O
. . O

-DOCSTART- X X O

One CD O
of IN O
these DT O
genes NNS O
, , O
REC114 NNP B-NP
, , O
is VBZ O
described VBN O
here RB O
, , O
and CC O
the DT O
data NNS O
confirm VBP O
that IN O
REC114 NNP B-NP
is VBZ O
a DT O
meiosis-specific JJ O
recombination NN O
gene NN O
with IN O
no DT O
detectable JJ O
function NN O
in IN O
mitosis NN O
. . O

-DOCSTART- X X O

The DT O
transactivation NN O
function NN O
of IN O
EBNA2 NNP B-NP
was VBD O
also RB O
observed VBN O
in IN O
the DT O
HeLa NNP O
epithelial NN O
cell NN O
line NN O
, , O
which WDT O
suggests VBZ O
that IN O
EBV NNP O
and CC O
HIV-1 PRP$ O
infection NN O
of IN O
non-B JJ O
cells NNS O
may MD O
result VB O
in IN O
HIV-1 PRP$ B-NP
promoter NN I-NP
activation NN O
. . O

-DOCSTART- X X O

Nuclear JJ B-NP
protein NN I-NP
phosphatase NN I-NP
2A IN I-NP
dephosphorylates NNS O
protein NN B-NP
kinase NN I-NP
A-phosphorylated JJ I-NP
CREB NNP B-NP
and CC O
regulates VBZ O
CREB NNP B-NP
transcriptional JJ O
stimulation NN O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
IL-6 DT B-NP
activates NNS O
JRE-IL6 . B-NP
through IN O
an DT O
H7-sensitive JJ O
pathway NN O
that WDT O
does VBZ O
not RB O
involve VB O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
, , O
cyclic JJ B-NP
AMP-dependent JJ I-NP
kinase NN I-NP
, , O
Ca( NNP B-NP
2+) CD I-NP
- : I-NP
or CC I-NP
calmodulin-dependent JJ I-NP
kinases NNS I-NP
, , O
Ras NNP B-NP
, , O
Raf-1 NNP B-NP
, , O
or CC O
NF-IL6 NNP B-NP
( -LRB- O
C/EBP JJ B-NP
beta NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

Growth NN O
factor NN O
stimulation NN O
rapidly RB O
induces VBZ O
a DT O
reversible JJ O
change NN O
in IN O
the DT O
electrophoretic JJ O
mobility NN O
of IN O
the DT O
ternary JJ O
complex NN O
, , O
accompanied VBN O
by IN O
increased JJ O
phosphorylation NN O
of IN O
the DT O
Elk-1 NNP B-NP
C-terminal JJ I-NP
region NN I-NP
and CC O
by IN O
the DT O
activation NN O
of IN O
a DT O
42 CD B-NP
kd NN I-NP
cellular JJ I-NP
Elk-1 NNP I-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

This DT O
stimulatory JJ O
effect NN O
could MD O
also RB O
be VB O
elicited VBN O
by IN O
c-Jun NN B-NP
, , O
which WDT O
interacts VBZ O
with IN O
topo NN B-NP
II NNP I-NP
, , O
but CC O
not RB O
by IN O
c-Fos NNS B-NP
, , O
which WDT O
does VBZ O
not RB O
bind NN O
topo NN B-NP
II NNP I-NP
in IN O
our PRP$ O
in IN O
vitro NN O
assay NN O
. . O

-DOCSTART- X X O

After IN O
surgery NN O
, , O
patients NNS O
self NN O
administered VBN O
one CD O
of IN O
three CD O
possible JJ O
postsurgical JJ O
medications NNS O
, , O
which WDT O
included VBD O
placebo NN O
, , O
codeine NN O
60 CD O
mg NN O
, , O
and CC O
ibuprofen RB O
400 CD O
mg NN O
, , O
when WRB O
their PRP$ O
pain NN O
reached VBD O
a DT O
moderate JJ O
or CC O
severe JJ O
intensity NN O
. . O

-DOCSTART- X X O

Replacement NN O
of IN O
the DT O
wild-type JJ O
5'-regulatory JJ O
region NN O
with IN O
either DT O
of IN O
the DT O
mutants NNS O
' POS O
cis-acting JJ O
regulatory JJ O
element NN O
resulted VBD O
in IN O
the DT O
anaerobic JJ O
expression NN O
of IN O
active JJ B-NP
Mn-superoxide JJ I-NP
dismutase NN I-NP
. . O

-DOCSTART- X X O

The DT O
orf61 JJ B-NP
gene NN I-NP
product NN I-NP
, , O
when WRB O
expressed VBN O
from IN O
an DT O
exogenous JJ O
promoter NN O
, , O
inhibited VBD O
int-mediated JJ B-NP
integration NN O
at IN O
the DT O
chromosomal NN B-NP
attB NN I-NP
site NN I-NP
. . O

-DOCSTART- X X O

Analysis NN O
by IN O
cell NN O
surface NN O
immunofluorescence NN O
showed VBD O
that IN O
the DT O
UL28 NNP B-NP
gene NN I-NP
is VBZ O
not RB O
required VBN O
for IN O
expression NN O
of IN O
viral JJ O
glycoproteins NNS O
on IN O
the DT O
surface NN O
of IN O
infected JJ O
cells NNS O
. . O

-DOCSTART- X X O

Estrogen NN O
treatment NN O
in IN O
high JJ O
doses NNS O
is VBZ O
effective JJ O
in IN O
reducing VBG O
adult JJ O
stature NN O
in IN O
constitutionally RB O
tall JJ O
girls NNS O
. . O

-DOCSTART- X X O

Mutations NNS O
at IN O
the DT O
extreme JJ O
C-terminus NN O
of IN O
EIAV NNP B-NP
Tat NNPS I-NP
impaired VBN O
both DT O
RNA NNP O
binding NN O
and CC O
activation NN O
domain NN O
functions NNS O
, , O
suggesting VBG O
effects NNS O
on IN O
secondary JJ O
or CC O
tertiary JJ O
structure NN O
. . O

-DOCSTART- X X O

This DT O
observation NN O
suggests VBZ O
that IN O
the DT O
methyl-directed JJ O
repair NN O
system NN O
utilizes VBZ O
the DT O
proximal JJ O
d(GATC NNS O
) -RRB- O
sequence NN O
to TO O
direct JJ O
correction NN O
. . O

-DOCSTART- X X O

Uracil NNP B-NP
DNA NNP I-NP
glycosylase NN I-NP
catalyzes NNS O
the DT O
initial JJ O
step NN O
in IN O
the DT O
repair NN O
pathway NN O
that WDT O
removes VBZ O
potentially RB O
mutagenic JJ O
uracil NN O
from IN O
duplex JJ O
DNA NN O
. . O

-DOCSTART- X X O

Current JJ O
clinical JJ O
trials NNS O
should MD O
answer VB O
the DT O
question NN O
of IN O
which WDT O
of IN O
the DT O
therapeutic JJ O
options NNS O
impairs NNS O
quality NN O
of IN O
life NN O
less RBR O
. . O

-DOCSTART- X X O

Lithium NNP O
phthalocyanine , O
( -LRB- O
LiPc NNP O
) -RRB- O
is VBZ O
a DT O
prototype NN O
of IN O
another DT O
generation NN O
of IN O
synthetic JJ O
, , O
metallic-organic JJ O
, , O
paramagnetic JJ O
crystallites NNS O
that WDT O
appear VBP O
very RB O
useful JJ O
for IN O
in IN O
vitro NN O
and CC O
in IN O
vivo JJ O
electron NN O
paramagnetic JJ O
resonance NN O
oximetry NN O
. . O

-DOCSTART- X X O

Recipients NNS O
with IN O
acute JJ O
leukaemia NN O
in IN O
first JJ O
remission NN O
or CC O
chronic NN O
myeloid JJ O
leukaemia NN O
in IN O
first JJ O
chronic JJ O
phase NN O
were VBD O
analysed JJ O
as IN O
good JJ O
risk NN O
, , O
and CC O
those DT O
beyond IN O
these DT O
stages NNS O
, , O
as RB O
poor JJ O
risk NN O
patients NNS O
. . O

-DOCSTART- X X O

Losses NNS O
during IN O
the DT O
complete JJ O
procedure NN O
are VBP O
corrected VBN O
for IN O
using VBG O
radioactive JJ O
estrogen NN O
conjugates VBZ O
during IN O
the DT O
first JJ O
steps NNS O
and CC O
later RB O
by IN O
adding VBG O
deuterated JJ O
internal JJ O
standards NNS O
of IN O
all DT O
compounds NNS O
measured VBN O
( -LRB- O
matairesinol NN O
, , O
enterodiol NN O
, , O
enterolactone NN O
, , O
daidzein NN O
, , O
O-desmethylangolensin NNP O
, , O
equol NN O
, , O
and CC O
genistein NN O
) -RRB- O
. . O

-DOCSTART- X X O

IE2-IE2 DT B-NP
interactions NNS O
were VBD O
mapped VBN O
to TO O
a DT O
domain NN O
containing VBG O
a DT O
putative JJ O
helix-turn-helix NN O
motif NN O
located VBN O
near IN O
the DT O
C NNP O
terminus NN O
of IN O
IE2 NNP B-NP
, , O
between IN O
amino IN O
acids NNS O
456 CD O
and CC O
539 CD O
. . O

-DOCSTART- X X O

A DT O
sheep NN O
testicular NN O
cDNA IN O
library NN O
constructed VBN O
in IN O
pcDNA1 JJ O
vector NN O
was VBD O
screened VBN O
with IN O
a DT O
probe NN O
generated VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
(PCR NN O
) -RRB- O
and CC O
corresponding JJ O
to TO O
a DT O
1.6 CD O
kb JJ O
fragment NN O
of IN O
the DT O
rat NN B-NP
luteinizing VBG I-NP
hormone NN I-NP
receptor NN I-NP
cDNA NN I-NP
. . O

-DOCSTART- X X O

The DT O
ability NN O
of IN O
spt2 NNS B-NP
mutations NNS I-NP
to TO O
suppress VB O
the DT O
transcriptional JJ O
interference NN O
caused VBN O
by IN O
the DT O
delta NN B-NP
promoter NN I-NP
insertion NN I-NP
his-4-912 JJ I-NP
delta NN I-NP
correlates VBZ O
with IN O
an DT O
increase NN O
in IN O
wild-type JJ B-NP
HIS4 NNP I-NP
mRNA NN I-NP
levels NNS O
. . O

-DOCSTART- X X O

The DT O
conserved VBD O
ninth JJ O
C-terminal JJ O
heptad NN O
in IN O
thyroid NN O
hormone NN O
and CC O
retinoic JJ B-NP
acid NN I-NP
receptors NNS I-NP
mediates VBZ O
diverse JJ O
responses NNS O
by IN O
affecting VBG O
heterodimer NN O
but CC O
not RB O
homodimer NN O
formation NN O
. . O

-DOCSTART- X X O

Steroidogenic JJ B-NP
factor NN I-NP
1 CD I-NP
, , O
an DT O
orphan JJ B-NP
nuclear JJ I-NP
receptor NN I-NP
, , O
regulates VBZ O
the DT O
expression NN O
of IN O
the DT O
rat NN B-NP
aromatase JJ I-NP
gene NN I-NP
in IN O
gonadal VBG O
tissues NNS O
. . O

-DOCSTART- X X O

To TO O
study VB O
the DT O
functional JJ O
differences NNS O
between IN O
cutaneous JJ O
HPV5 CD O
and CC O
HPV8 CD O
E7s JJ B-NP
and CC O
genital JJ B-NP
HPV16 IN I-NP
E7 PRP I-NP
, , O
we PRP O
cloned VBD O
each DT O
of IN O
the DT O
E7 NNS B-NP
open JJ O
reading NN O
frames NNS O
and CC O
tested VBD O
their PRP$ O
immortalizing JJ O
and CC O
transforming JJ O
activities NNS O
, , O
the DT O
binding JJ O
ability NN O
of IN O
their PRP$ O
products NNS O
with IN O
retinoblastoma NN B-NP
protein NN I-NP
( -LRB- O
RB NN B-NP
) -RRB- O
and CC O
their PRP$ O
complementation NN O
activity NN O
of IN O
a DT O
RB-nonbinding JJ B-NP
adenovirus NN I-NP
E1A NNP I-NP
mutant NN I-NP
. . O

-DOCSTART- X X O

The DT O
rhaB NN B-NP
transcription NN I-NP
start NN I-NP
site NN I-NP
was VBD O
mapped VBN O
to TO O
-24 DT O
relative JJ O
to TO O
the DT O
start NN O
of IN O
translation NN O
. . O

-DOCSTART- X X O

Several JJ O
lines NNS O
of IN O
evidence NN O
demonstrate VBP O
that IN O
this DT O
growth NN O
inhibition NN O
requires VBZ O
active JJ O
PKA NNP B-NP
subunits NNS I-NP
and CC O
cAMP NN O
: : O
( -LRB- O
i NN O
) -RRB- O
this DT O
phenotype NN O
is VBZ O
dependent JJ O
on IN O
cAMP JJ O
since IN O
it PRP O
is VBZ O
not RB O
seen VBN O
in IN O
a DT O
strain NN O
lacking VBG O
adenylyl JJ B-NP
cyclase NN I-NP
activity NN O
, , O
but CC O
the DT O
growth NN O
rate NN O
of IN O
these DT O
transformants NNS O
is VBZ O
slower JJR O
when WRB O
exogenous JJ O
cAMP NN O
is VBZ O
added VBN O
; : O
( -LRB- O
ii NNS O
) -RRB- O
normal JJ O
growth NN O
occurs VBZ O
when WRB O
wild-type JJ O
RI NNP B-NP
cDNA NN O
is VBZ O
replaced VBN O
by IN O
a DT O
mutant JJ B-NP
RI NNP I-NP
cDNA NN I-NP
encoding VBG O
a DT O
RI NNP B-NP
protein NN I-NP
with IN O
reduced JJ O
cAMP NN O
binding NN O
; : O
and CC O
( -LRB- O
iii NN O
) -RRB- O
the DT O
growth-inhibited JJ O
phenotype NN O
of IN O
the DT O
transformed VBN O
BL21(DE3 NN O
) -RRB- O
cells NNS O
requires VBZ O
soluble JJ O
, , O
active JJ O
C NNP B-NP
alpha NN I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

BCR-ABL JJ B-NP
and CC O
v-abl JJ B-NP
oncogenes NNS I-NP
induce VB O
distinct JJ O
patterns NNS O
of IN O
thymic JJ O
lymphoma NN O
involving VBG O
different JJ O
lymphocyte NN O
subsets NNS O
. . O

-DOCSTART- X X O

LDL NNP B-NP
cholesterol NN I-NP
decreased VBD O
from IN O
4.74 CD O
+/ CD O
- : O
0.87 CD O
to TO O
3.78 CD O
+/ CD O
- : O
0.78 CD O
mmol/l NN O
after IN O
8 CD O
weeks NNS O
on IN O
simvastatin NN O
( -LRB- O
P NNP O
< NN O
0.001 CD O
) -RRB- O
, , O
and CC O
apo NN B-NP
B NNP I-NP
fell VBD O
from IN O
142 CD O
+/ CD O
- : O
31 CD O
to TO O
112 CD O
+/ CD O
- : O
22 CD O
mg/dl NN O
( -LRB- O
P NNP O
< NN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
negative JJ O
element NN O
may MD O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
be VB O
responsible JJ O
for IN O
the DT O
cell NN O
type-specific JJ O
expression NN O
of IN O
the DT O
DGK NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

A DT O
new JJ O
bioencapsulation NN O
technology NN O
for IN O
microbial JJ O
inoculants NNS O
. . O

-DOCSTART- X X O

It PRP O
contains VBZ O
three CD O
putative JJ O
binding NN O
sites NNS O
for IN O
transcription NN B-NP
factor NN I-NP
Sp1 NNP I-NP
as RB O
well RB O
as IN O
several JJ O
short JJ O
sequences NNS O
that WDT O
are VBP O
similar JJ O
to TO O
known JJ O
cis-acting NN O
enhancers NNS O
or CC O
binding NN O
sites NNS O
for IN O
transcription NN O
factors NNS O
. . O

-DOCSTART- X X O

French JJ O
bean NN O
contains VBZ O
a DT O
small JJ O
family NN O
of IN O
genes NNS B-NP
encoding VBG I-NP
PAL NNP I-NP
and CC O
two CD O
of IN O
these DT O
genes NNS O
, , O
PAL2 NNP B-NP
and CC O
PAL3 NNP B-NP
, , O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
differentially RB O
expressed VBN O
at IN O
the DT O
mRNA NN O
level NN O
in IN O
bean NN O
tissues NNS O
. . O

-DOCSTART- X X O

By IN O
stepwise RB O
linear JJ O
multiple JJ O
regression NN O
analysis NN O
, , O
ionized VBD O
magnesium NN O
was VBD O
significantly RB O
related VBN O
to TO O
cyclosporin NN O
trough NN O
level NN O
and CC O
total JJ O
cholesterol NN O
but CC O
not RB O
to TO O
serum VB O
creatinine VBN O
, , O
time NN O
after IN O
transplant NN O
or CC O
the DT O
dose NN O
of IN O
cyclosporin NN O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
insulin-like JJ I-NP
growth NN I-NP
factor NN I-NP
II NNP I-NP
( -LRB- O
IGF-II NN B-NP
) -RRB- O
gene NN O
contains VBZ O
four CD O
promoters NNS O
( -LRB- O
P1 '' O
, , O
P2 NNP O
, , O
P3 NNP O
and CC O
P4 NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
in IN O
transient NN O
transfection NN O
assays VBZ O
, , O
PU.1 UH B-NP
alone RB O
activated VBN O
reporter NN O
constructs NNS O
containing VBG O
the DT O
JB NNP O
cis-element NN O
, , O
and CC O
the DT O
activation NN O
was VBD O
shown VBN O
to TO O
be VB O
dependent JJ O
on IN O
a DT O
glutamine-rich JJ O
sequence NN O
in IN O
the DT O
amino-terminal JJ O
portion NN O
of IN O
PU.1 NNP B-NP
. . O

-DOCSTART- X X O

Army NNP O
veterans NNS O
given VBN O
yellow JJ O
fever NN O
vaccine NN O
contaminated VBN O
with IN O
hepatitis NN O
B NNP O
virus NN O
in IN O
1942 CD O
and CC O
controls NNS O
and CC O
( -LRB- O
b NN O
) -RRB- O
a DT O
case-control NN O
study NN O
comparing NN O
veterans NNS O
with IN O
hepatocellular JJ O
carcinoma NN O
in IN O
Veterans NNP O
Affairs NNP O
hospitals NNS O
with IN O
matched VBN O
controls NNS O
with IN O
respect NN O
to TO O
receipt VB O
of IN O
contaminated JJ O
vaccine NN O
in IN O
1942 CD O
. . O

-DOCSTART- X X O

Defects NNS O
of IN O
fibrillin NNS B-NP
( -LRB- O
FBN1 NNP B-NP
) -RRB- O
, , O
a DT O
glycoprotein NN O
component NN O
of IN O
the DT O
extracellular JJ O
microfibril NN O
, , O
cause NN O
Marfan NNP O
syndrome NN O
. . O

-DOCSTART- X X O

Distinguishing VBG O
roles NNS O
of IN O
the DT O
membrane-cytoskeleton NN O
and CC O
cadherin NN B-NP
mediated JJ O
cell-cell NN O
adhesion NN O
in IN O
generating VBG O
different JJ O
Na+, NNP B-NP
K( NNP I-NP
+)-ATPase NNP I-NP
distributions NNS O
in IN O
polarized JJ O
epithelia NN O
. . O

-DOCSTART- X X O

Neonatal JJ O
lupus NN O
erythematosus NN O
is VBZ O
most RBS O
often RB O
associated VBN O
with IN O
autoantibodies NNS O
against IN O
Ro NNP B-NP
and CC O
La NNP B-NP
antigens NNS O
. . O

-DOCSTART- X X O

Genetic JJ O
abnormalities NNS O
that WDT O
could MD O
lead VB O
to TO O
mutagenesis NN O
include VBP O
chromosomal NN O
abnormalities NNS O
and CC O
single-gene JJ O
mutations NNS O
. . O

-DOCSTART- X X O

Hops NNP O
, , O
and CC O
L. NNP O

-DOCSTART- X X O

Continued NNP O
absorption NN O
of IN O
amino DT O
acids NNS O
by IN O
the DT O
NBB NN O
carrier NN O
( -LRB- O
for IN O
neutral JJ O
amino JJ O
acids NNS O
) -RRB- O
, , O
the DT O
Y+ NN O
system NN O
( -LRB- O
for IN O
dibasic JJ O
amino JJ O
acids NNS O
) -RRB- O
, , O
and CC O
the DT O
PHE JJ O
carrier NN O
were VBD O
operative JJ O
even RB O
during IN O
the DT O
actively RB O
purging VBG O
stage NN O
of IN O
watery NN O
diarrhoea NN O
due JJ O
to TO O
cholera NN O
. . O

-DOCSTART- X X O

1 CD O
) -RRB- O
CFDN NNP O
, , O
AMPC NNP O
and CC O
MNZ NNP O
showed VBD O
a DT O
potent JJ O
antimicrobial JJ O
activity NN O
against IN O
H. NNP O
pylori NN O
, , O
and CC O
especially RB O
, , O
AMPC NNP O
showed VBD O
a DT O
marked JJ O
bactericidal JJ O
activity NN O
in IN O
a DT O
short JJ O
time NN O
. . O

-DOCSTART- X X O

A DT O
high JJ O
mean JJ O
intensity NN O
of IN O
CLTPA NNP O
( -LRB- O
standardized VBD O
multivariate JJ O
regression NN O
coefficient NN O
beta NN O
-0.059 -LRB- O
, , O
p NN O
= SYM O
0.020 CD O
) -RRB- O
and CC O
a DT O
high JJ O
maximal NN O
oxygen NN O
uptake NN O
( -LRB- O
beta JJ O
-0.163 NN O
, , O
p NN O
< NN O
0.001 CD O
) -RRB- O
were VBD O
associated VBN O
with IN O
reduced JJ O
plasma NN B-NP
fibrinogen NN I-NP
when WRB O
adjusting VBG O
for IN O
the DT O
strongest JJS O
covariates NNS O
. . O

-DOCSTART- X X O

What WP O
young JJ O
people NNS O
think VBP O
and CC O
do VBP O
when WRB O
the DT O
option NN O
for IN O
cystic JJ O
fibrosis NN O
carrier NN O
testing NN O
is VBZ O
available JJ O
. . O

-DOCSTART- X X O

A DT O
patient NN O
matches VBZ O
a DT O
PIC NN O
patient NN O
if IN O
both DT O
have VBP O
the DT O
same JJ O
mechanism NN O
of IN O
injury NN O
, , O
the DT O
same JJ O
coding NN O
of IN O
Revised VBN O
Trauma NNP O
Score NN O
variables NNS O
( -LRB- O
Glascow NNP O
Coma NNP O
Scale NNP O
score NN O
, , O
systolic JJ O
blood NN O
pressure NN O
, , O
respiratory JJ O
rate NN O
) -RRB- O
, , O
the DT O
same JJ O
coded JJ O
age NN O
per IN O
A DT O
Severity NNP O
Characterization NNP O
of IN O
Trauma NNP O
) -RRB- O
( -LRB- O
ASCOT NNP O
) -RRB- O
, , O
and CC O
if IN O
they PRP O
differ VBP O
by IN O
no DT O
more JJR O
than IN O
0.5 CD O
for IN O
A DT O
, , O
B NNP O
, , O
and CC O
C NNP O
( -LRB- O
the DT O
ASCOT NNP O
components NNS O
for IN O
serious JJ O
injuries NNS O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
a DT O
cosmid JJ O
containing VBG O
DNA NN O
that WDT O
corresponds VBZ O
to TO O
the DT O
site NN O
of IN O
transposon NN O
insertion NN O
in IN O
257DH4 CD O
and CC O
have VB O
localized VBN O
Tn5 . B-NP
on IN O
an DT O
8.0 CD B-NP
kb NN I-NP
EcoRI NNP I-NP
fragment NN I-NP
. . O

-DOCSTART- X X O

Transient NNP O
transfection NN O
experiments NNS O
revealed VBD O
that IN O
Pax-8 DT B-NP
isoforms VBZ I-NP
a DT I-NP
and CC I-NP
b NN I-NP
, , O
but CC O
not RB O
c SYM O
and CC O
d VBN O
, , O
strongly RB O
stimulate VB O
transcription NN O
from IN O
a DT O
promoter NN O
containing VBG O
six CD O
copies NNS O
of IN O
a DT O
paired-domain JJ B-NP
recognition NN I-NP
sequence NN I-NP
. . O

-DOCSTART- X X O

The DT O
amino-terminal JJ O
third JJ O
of IN O
the DT O
protein NN O
contains VBZ O
a DT O
high-mobility-group JJ B-NP
motif NN I-NP
characteristic NN O
of IN O
DNA-binding JJ O
proteins NNS O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
the DT O
3'-end-adjacent JJ O
sequence NN O
CA NNP O
( -LRB- O
N)3-10AGTNNAA NNP O
, , O
conserved VBD O
in IN O
plant NN O
Pol NNP B-NP
II-specific NNP I-NP
U NNP B-NP
snRNA NN I-NP
genes NNS I-NP
, , O
is VBZ O
essential JJ O
for IN O
the DT O
3'-end JJ O
formation NN O
of IN O
U2 NNP B-NP
transcripts NNS I-NP
and CC O
, , O
similar JJ O
to TO O
the DT O
vertebrate JJ O
3' JJ O
box NN O
, , O
is VBZ O
highly RB O
tolerant JJ O
to TO O
mutation NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
Rb JJ B-NP
protein NN I-NP
is VBZ O
interacting VBG O
with IN O
some DT O
component( JJ O
s VBZ O
) -RRB- O
of IN O
the DT O
cell NN O
cycle-regulatory JJ O
machinery NN O
during IN O
G2 NNP O
phase NN O
. . O

-DOCSTART- X X O

MDBP NNP B-NP
from IN O
HeLa NNP O
and CC O
Raji NNP O
cells NNS O
formed VBN O
DNA-protein NNP O
complexes NNS O
with IN O
X-box NN O
oligonucleotides NNS O
that IN O
coelectrophoresed VBN O
with IN O
those DT O
containing VBG O
standard JJ O
MDBP NNP B-NP
sites NNS I-NP
. . O

-DOCSTART- X X O

Consistent NNP O
with IN O
the DT O
hypothesis NN O
that IN O
it PRP O
acts VBZ O
as IN O
transcriptional JJ O
regulator NN O
, , O
wild-type JJ B-NP
p53 NN I-NP
protein NN I-NP
binds NNS O
DNA NN O
and CC O
activates NNS O
transcription NN O
of IN O
several JJ O
promoters NNS O
. . O

-DOCSTART- X X O

The DT O
E1 NNP B-NP
gene NN I-NP
is VBZ O
located VBN O
within IN O
the DT O
first JJ O
intron NN O
of IN O
the DT O
gene NN O
for IN O
RCC1 NNP B-NP
, , O
a DT O
protein NN O
that WDT O
regulates VBZ O
onset NN O
of IN O
mitosis NN O
. . O

-DOCSTART- X X O

Genomic JJ O
Southern JJ O
blot NN O
analysis NN O
and CC O
chromosome NN O
mapping NN O
showed VBD O
that IN O
GPRK6 NNP B-NP
hybridizes VBZ O
to TO O
two CD O
closely RB O
related JJ O
genes NNS O
located VBN O
on IN O
chromosomes NNS O
5 CD O
and CC O
13 CD O
and CC O
are VBP O
, , O
therefore RB O
, , O
distinct JJ O
from IN O
the DT O
GPRK NNP B-NP
located VBD O
near IN O
the DT O
Huntington NNP B-NP
disease NN I-NP
locus NN I-NP
on IN O
chromosome NN O
4 CD O
. . O

-DOCSTART- X X O

These DT O
CTD NNP B-NP
kinases NNS I-NP
, , O
designated VBN O
CTDK1 NNP B-NP
and CC O
CTDK2 NNP B-NP
, , O
are VBP O
fractionated VBN O
by IN O
chromatography NN O
on IN O
Mono NNP O
Q NNP O
. . O

-DOCSTART- X X O

The DT O
sequence NN O
of IN O
the DT O
HIR1 NNP B-NP
gene NN I-NP
predicts VBZ O
an DT O
88-kDa JJ O
protein NN O
with IN O
three CD O
repeats NNS O
of IN O
a DT O
motif NN O
found VBN O
in IN O
the DT O
G NNP B-NP
beta NN I-NP
subunit NN I-NP
of IN O
retinal JJ B-NP
transducin NN I-NP
and CC O
in IN O
a DT O
yeast NN O
transcriptional JJ O
repressor NN O
, , O
Tup1 NNP B-NP
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

L. NNP O
, , O
Stange NNP O
, , O
G. NNP O
, , O
Markovich NNP O
, , O
D. NNP O
, , O
Biber NNP O
, , O
J. NNP O
, , O
Testar NNP O
, , O
X. NNP O
, , O
Zorzano NNP O
, , O
A. NN O
, , O
Palacin NNP O
, , O
M. NNP O
, , O
and CC O
Murer NNP O
, , O
H. NNP O

-DOCSTART- X X O

They PRP O
were VBD O
called VBN O
PACE4 NNP B-NP
and CC O
PC4 NNP B-NP
. . O

-DOCSTART- X X O

265 CD O
, , O
1102-1110 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Both DT O
fusion NN O
proteins VBZ O
form NN O
stable JJ O
specific JJ O
complexes NNS O
with IN O
a DT O
short JJ O
DNA NN O
duplex NN O
harboring VBG O
the DT O
CTGT(at)4ACAG JJ O
consensus NN O
sequence NN O
of IN O
the DT O
LexA NNP B-NP
repressor NN I-NP
. . O

-DOCSTART- X X O

As IN O
the DT O
components NNS O
of IN O
these DT O
complexes NNS O
, , O
at IN O
least JJS O
five CD O
TRBPs NNS B-NP
( -LRB- O
p30 NN B-NP
, , O
p37 NNS B-NP
, , O
p46 NNS B-NP
, , O
p50 NN B-NP
, , O
and CC O
p56 NNS B-NP
) -RRB- O
showing VBG O
specific JJ O
binding NN O
to TO O
the DT O
TAR NN O
RNA NNP O
were VBD O
detected VBN O
in IN O
the DT O
uv NN O
cross-linking NN O
assay NN O
. . O

-DOCSTART- X X O

The DT O
use NN O
of IN O
this DT O
model NN O
for IN O
investigating VBG O
pathophysiologically RB O
significant JJ O
issues NNS O
in IN O
denervating VBG O
diseases NNS O
is VBZ O
illustrated VBN O
with IN O
five CD O
different JJ O
sets NNS O
of IN O
parameters NNS O
. . O

-DOCSTART- X X O

We PRP O
describe VBP O
a DT O
novel NN O
cytoplasmic JJ B-NP
tyrosine NN I-NP
kinase NN I-NP
, , O
termed VBD O
BPK NNP B-NP
( -LRB- O
B NNP B-NP
cell NN I-NP
progenitor NN I-NP
kinase NN I-NP
) -RRB- O
, , O
which WDT O
is VBZ O
expressed VBN O
in IN O
all DT O
stages NNS O
of IN O
the DT O
B NNP O
lineage NN O
and CC O
in IN O
myeloid JJ O
cells NNS O
. . O

-DOCSTART- X X O

Large JJ O
differences NNS O
between IN O
the DT O
groups NNS O
were VBD O
not RB O
observed VBN O
in IN O
HA-synthesizing JJ B-NP
enzyme NN I-NP
activity NN O
, , O
but CC O
degradative JJ O
enzyme NN O
activity NN O
was VBD O
much RB O
higher JJR O
in IN O
aspirin-induced JJ O
asthma-related JJ O
polyps NNS O
than IN O
in IN O
other JJ O
types NNS O
of IN O
nasal JJ O
polyps NNS O
tested VBN O
. . O

-DOCSTART- X X O

In IN O
the DT O
multivariate JJ O
analysis NN O
, , O
six CD O
variables NNS O
were VBD O
independently RB O
correlated VBN O
with IN O
survival NN O
: : O
blood NN O
urea NN O
nitrogen NN O
level NN O
, , O
serum NN B-NP
aspartate NN I-NP
aminotransferase JJ I-NP
level NN O
, , O
community-acquired JJ O
vs. CC O
hospital-acquired JJ O
peritonitis NN O
, , O
age NN O
, , O
Child-Pugh JJ O
score NN O
and CC O
ileus NN O
. . O

-DOCSTART- X X O

One CD O
such JJ O
mutant NN O
also RB O
affects VBZ O
the DT O
overlapping JJ O
-10 JJ O
hexamer NN O
of IN O
PR NNP O
and CC O
results NNS O
in IN O
reduced JJ O
occupancy NN O
by IN O
both DT O
MerR NNP B-NP
and CC O
RNA NNP B-NP
polymerase NN I-NP
, , O
likely JJ O
as IN O
a DT O
result NN O
of IN O
inefficient JJ O
transcriptional JJ O
initiation NN O
of IN O
merR NN B-NP
mRNA NN I-NP
. . O

-DOCSTART- X X O

Finally RB O
, , O
we PRP O
present VBP O
evidence NN O
that IN O
fimbrin NN B-NP
is VBZ O
a DT O
third JJ O
distinct JJ O
plastin NN B-NP
isoform NN I-NP
which WDT O
is VBZ O
specifically RB O
expressed VBN O
at IN O
high JJ O
levels NNS O
in IN O
the DT O
small JJ O
intestine NN O
. . O

-DOCSTART- X X O

This DT O
promoter NN O
could MD O
direct VB O
the DT O
constitutive JJ O
expression NN O
of IN O
the DT O
reporter NN O
beta-galactosidase NN B-NP
at IN O
high JJ O
frequency NN O
in IN O
transfected JJ O
colonies NNS O
of IN O
transformed VBN O
cells NNS O
that WDT O
express VBP O
L-plastin NNP B-NP
constitutively RB O
; : O
by IN O
contrast NN O
, , O
this DT O
promoter NN O
was VBD O
virtually RB O
inactive JJ O
in IN O
transfected JJ O
colonies NNS O
of IN O
normal JJ O
fibroblasts NNS O
and CC O
it PRP O
exhibited VBD O
a DT O
low JJ O
frequency NN O
of IN O
constitutive JJ O
activation NN O
in IN O
transfected JJ O
colonies NNS O
of IN O
in IN O
vitro NN O
SV40-transformed JJ O
fibroblasts NNS O
which WDT O
did VBD O
not RB O
exhibit NN O
L-plastin JJ B-NP
expression NN O
. . O

-DOCSTART- X X O

The DT O
half-life NN O
of IN O
the DT O
serum-induced JJ O
CBP/tk NNP B-NP
binding NN O
activity NN O
was VBD O
estimated VBN O
to TO O
be VB O
less JJR O
than IN O
1 CD O
h NN O
.(ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
400 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

The DT O
gene NN O
includes VBZ O
three CD O
exons NNS O
and CC O
two CD O
introns NNS O
within IN O
1.6 CD O
kilobases NNS O
of IN O
DNA NNP O
, , O
and CC O
the DT O
entire JJ O
open JJ O
reading NN O
frame NN O
for IN O
glycoprotein NN B-NP
IX NNP I-NP
is VBZ O
included VBN O
within IN O
the DT O
third JJ O
exon NN O
. . O

-DOCSTART- X X O

Rhizobium NN O
meliloti NNS O
large JJ O
plasmid NN O
pRmeGR4b NN O
carries VBZ O
the DT O
nodulation NN O
competitiveness NN O
locus NN O
nfe NN B-NP
responsible JJ O
for IN O
the DT O
nodulation NN O
efficiency NN O
and CC O
competitive JJ O
ability NN O
of IN O
strain NN O
GR4 NNP O
on IN O
alfalfa DT O
roots NNS O
. . O

-DOCSTART- X X O

Further RB O
, , O
the DT O
ability NN O
of IN O
recombinant JJ O
beta NN O
and/or CC O
gamma NN O
chains NNS O
to TO O
function NN O
in IN O
defined VBN O
biochemical JJ O
assays IN O
of IN O
beta JJ O
gamma NN O
activity NN O
was VBD O
assessed VBN O
for IN O
membrane NN O
extracts NNS O
and CC O
supernatant JJ O
fractions NNS O
from IN O
infected JJ O
Sf9 NNP O
cells NNS O
. . O

-DOCSTART- X X O

These DT O
data NNS O
establish VBP O
Smd1p JJ B-NP
as IN O
a DT O
required JJ O
component NN O
of IN O
the DT O
cellular JJ O
splicing NN O
apparatus NN O
and CC O
a DT O
factor NN O
in IN O
snRNA NN O
maturation NN O
and CC O
stability NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
compared VBD O
the DT O
gross JJ O
and CC O
fine JJ O
motor NN O
performance NN O
of IN O
14 CD O
traumatically RB O
brain-injured JJ O
children NNS O
( -LRB- O
five CD O
to TO O
15 CD O
years NNS O
old JJ O
, , O
with IN O
loss NN O
of IN O
consciousness NN O
for IN O
at IN O
least JJS O
24 CD O
hours NNS O
) -RRB- O
to TO O
14 CD O
normal JJ O
children NNS O
group NN O
matched VBN O
for IN O
age NN O
and CC O
sex NN O
. . O

-DOCSTART- X X O

These DT O
exons NNS O
were VBD O
identified VBN O
by IN O
cloning VBG O
and CC O
sequencing VBG O
cDNAs NNS O
obtained VBN O
by IN O
polymerase NN O
chain NN O
reaction NN O
amplification NN O
of IN O
a DT O
fibroblast JJ O
cDNA NN O
library NN O
. . O

-DOCSTART- X X O

Deletion NNP O
of IN O
the DT O
apeA NN B-NP
gene NN I-NP
, , O
either CC O
with IN O
or CC O
without IN O
deletion NN O
of IN O
other JJ O
proteinases NNS O
( -LRB- O
protease NN B-NP
IV NNP I-NP
and CC O
aminopeptidase DT B-NP
N) NNP I-NP
, , O
did VBD O
not RB O
have VB O
any DT O
effect NN O
on IN O
cell NN O
growth NN O
in IN O
the DT O
various JJ O
media NNS O
tested VBN O
. . O

-DOCSTART- X X O

In IN O
Experiment NN O
2 CD O
scopolamine NN O
hydrobromide NN O
, , O
0.5 CD O
and CC O
1.0 CD O
mg/kg JJ O
i.p. NN O
, , O
was VBD O
administered VBN O
1 CD O
h NN O
before IN O
each DT O
electrical JJ O
stimulation NN O
until IN O
each DT O
rat NN O
showed VBD O
the DT O
stage-3 NN O
seizure NN O
. . O

-DOCSTART- X X O

PNT NNP O
, , O
ADD NNP O
and CC O
BSS NNP O
in IN O
the DT O
initial JJ O
stage NN O
of IN O
kindling NN O
, , O
kindling VBG O
rate NN O
for IN O
the DT O
stage-3 NN O
and CC O
-5 DT O
seizures NNS O
, , O
seizure NN O
parameters NNS O
at IN O
the DT O
first JJ O
stage-3 NN O
and CC O
-5 NN O
were VBD O
recorded VBN O
and CC O
compared VBN O
to TO O
the DT O
values NNS O
of IN O
saline-treated JJ O
, , O
control NN O
group NN O
. . O

-DOCSTART- X X O

CONCLUSIONS. NN O

-DOCSTART- X X O

Naval JJ O
personnel NNS O
who WP O
exceed VBP O
standards NNS O
for IN O
%BF NN O
can MD O
be VB O
separated VBN O
from IN O
active JJ O
duty NN O
. . O

-DOCSTART- X X O

Weak VB O
promoter NN O
activity NN O
was VBD O
observed VBN O
for IN O
the DT O
promoter NN O
of IN O
the DT O
C1 NNP B-NP
and CC O
C2 NNP B-NP
ORFs NNP O
( -LRB- O
C1-C2 JJ B-NP
gene NN O
) -RRB- O
and CC O
for IN O
the DT O
promoter NN O
of IN O
the DT O
V1 NNP B-NP
ORF. . I-NP

-DOCSTART- X X O

The DT O
amino JJ O
acid NN O
sequence NN O
alignment NN O
of IN O
TC NNP B-NP
II NNP I-NP
with IN O
that DT O
of IN O
other JJ O
Cbl JJ B-NP
binding JJ I-NP
proteins NNS I-NP
( -LRB- O
rat NN B-NP
intrinsic JJ I-NP
factor NN I-NP
, , O
human JJ B-NP
transcobalamin NN I-NP
I PRP I-NP
and CC O
porcine JJ B-NP
haptocorrin NN I-NP
) -RRB- O
revealed VBN O
only RB O
33 CD O
% NN O
overall JJ O
homology NN O
. . O

-DOCSTART- X X O

The DT O
evaluation NN O
was VBD O
performed VBN O
using VBG O
a DT O
retrospective JJ O
study NN O
design NN O
with IN O
newborn JJ O
blood NN O
samples NNS O
from IN O
three CD O
screening NN O
centres NNS O
. . O

-DOCSTART- X X O

A DT O
region NN O
in IN O
the DT O
C-terminus NN O
of IN O
adenovirus JJ B-NP
2/5 CD I-NP
E1a JJ I-NP
protein NN I-NP
is VBZ O
required VBN O
for IN O
association NN O
with IN O
a DT O
cellular JJ O
phosphoprotein NN O
and CC O
important JJ O
for IN O
the DT O
negative JJ O
modulation NN O
of IN O
T24-ras DT O
mediated VBN O
transformation NN O
, , O
tumorigenesis NN O
and CC O
metastasis NN O
. . O

-DOCSTART- X X O

These DT O
studies NNS O
demonstrate VBP O
that IN O
both DT O
G NNP B-NP
alpha NN I-NP
i IN I-NP
genes NNS I-NP
are VBP O
dynamically RB O
regulated VBN O
in IN O
LLC-PK1 JJ O
cells NNS O
by IN O
both DT O
growth NN O
, , O
differentiation NN O
, , O
and CC O
hormone NN O
signals NNS O
. . O

-DOCSTART- X X O

When WRB O
ligated VBN O
to TO O
the DT O
proIL-1 NN B-NP
beta NN I-NP
cap NN I-NP
site-proximal JJ I-NP
region NN I-NP
( -LRB- O
located VBN O
between IN O
-131 JJ O
to TO O
+12 VB O
) -RRB- O
, , O
both CC O
the DT O
proIL-1 NN B-NP
beta NN I-NP
and CC O
the DT O
simian JJ B-NP
virus NN I-NP
40 CD I-NP
enhancer NN I-NP
elements NNS I-NP
functioned VBD O
more RBR O
efficiently RB O
in IN O
monocytes NNS O
than IN O
in IN O
HeLa NNP O
cells NNS O
, , O
which WDT O
are VBP O
not RB O
normally RB O
competent JJ O
for IN O
IL-1 DT B-NP
beta JJ I-NP
expression NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
and CC O
characterized VBN O
the DT O
GCD6 NNP B-NP
and CC O
GCD7 DT B-NP
genes NNS I-NP
and CC O
shown VBN O
that IN O
their PRP$ O
products NNS O
are VBP O
required VBN O
to TO O
repress VB O
GCN4 NNP B-NP
translation NN O
under IN O
nonstarvation NN O
conditions NNS O
. . O

-DOCSTART- X X O

While IN O
the DT O
latter JJ O
corresponded JJ O
to TO O
a DT O
protein NN O
of IN O
824 CD O
amino IN O
acids NNS O
, , O
an DT O
upstream RB O
open JJ O
reading NN O
frame NN O
(uORF NN O
) -RRB- O
within IN O
the DT O
5' JJ O
leader NN O
could MD O
potentially RB O
encode VB O
a DT O
54 CD O
amino IN O
acid NN O
peptide NN O
. . O

-DOCSTART- X X O

The DT O
SCH9 NNP B-NP
protein NN I-NP
kinase NN I-NP
mRNA NN I-NP
contains VBZ O
a DT O
long JJ O
5' JJ O
leader NN O
with IN O
a DT O
small JJ O
open JJ O
reading NN O
frame NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
to TO O
T NNP O
cells NNS O
, , O
in IN O
fibroblasts NNS O
PILOT NNP B-NP
gene NN I-NP
expression NN O
requires VBZ O
only RB O
one CD O
signal NN O
( -LRB- O
PMA NNP O
) -RRB- O
and CC O
is VBZ O
not RB O
affected VBN O
by IN O
CyA NNP O
. . O

-DOCSTART- X X O

In IN O
order NN O
to TO O
investigate VB O
how WRB O
these DT O
expression NN O
patterns NNS O
are VBP O
established VBN O
, , O
we PRP O
fused VBD O
promoter NN O
regions NNS O
of IN O
an DT O
acidic NN O
and CC O
a DT O
basic JJ O
glucanase NN B-NP
gene NN I-NP
to TO O
the DT O
beta-glucuronidase NN B-NP
( -LRB- O
GUS) NNP B-NP
reporter NN O
gene NN O
and CC O
examined VBN O
expression NN O
of IN O
these DT O
constructs NNS O
in IN O
transgenic JJ O
tobacco NN O
plants NNS O
. . O

-DOCSTART- X X O

Southern JJ O
blot NN O
analysis NN O
using VBG O
probes NNS O
from IN O
the DT O
3' JJ O
portions NNS O
of IN O
the DT O
genomic JJ O
and CC O
B. NNP B-NP
napus NN I-NP
MA NNP I-NP
and CC O
MB NNP B-NP
cDNA NN I-NP
clones NNS O
showed VBD O
that IN O
MA NNP B-NP
type NN I-NP
myrosinases NNS B-NP
are VBP O
encoded VBN O
by IN O
approximately RB O
4 CD O
genes NNS O
, , O
while IN O
MB NNP B-NP
type NN I-NP
myrosinases NNS B-NP
are VBP O
encoded VBN O
by IN O
more JJR O
than IN O
10 CD O
genes NNS O
in IN O
B. NNP O
napus NN O
. . O

-DOCSTART- X X O

Sudomoina NNP O
, , O
A. NN O

-DOCSTART- X X O

Zinc NNP O
fingers NNS O
( -LRB- O
Zf NN O
) -RRB- O
are VBP O
a DT O
common JJ O
structural JJ O
motif NN O
found VBD O
in IN O
many JJ O
nucleic JJ O
acid-binding JJ O
proteins NNS O
. . O

-DOCSTART- X X O

The DT O
deduced JJ O
bovine NN O
EFIA# NNP B-NP
1 CD I-NP
amino IN O
acid NN O
( -LRB- O
aa JJ O
) -RRB- O
sequence NN O
is VBZ O
98 CD O
% NN O
identical JJ O
to TO O
rat VB O
EFIA NNP B-NP
and CC O
100 CD O
% NN O
identical JJ O
to TO O
human JJ O
EFIA/DbpB/YB-1 JJ B-NP
family NN O
member NN O
DNA-binding JJ B-NP
protein NN I-NP
B NNP I-NP
( -LRB- O
DbpB NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
tracheal NN O
insufflation NN O
of IN O
deferoxamine NN O
on IN O
acute JJ O
ozone NN O
toxicity NN O
in IN O
rats NNS O
. . O

-DOCSTART- X X O

Localization NN O
of IN O
the DT O
insertion NN O
locus NN O
in IN O
the DT O
yeast NN O
genome NN O
and CC O
complementation NN O
studies NNS O
with IN O
the DT O
temperature-sensitive JJ O
mutant JJ O
indicate VBP O
that IN O
the DT O
two CD O
mutations NNS O
are VBP O
allelic JJ O
. . O

-DOCSTART- X X O

Replacement NN O
of IN O
the DT O
spacer NN O
sequence NN O
between IN O
the DT O
two CD O
ARMs NNS O
with IN O
a DT O
shorter JJR O
stretch NN O
of IN O
sequence NN O
also RB O
reduced VBD O
RNA NNP O
binding NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Second JJ O
, , O
the DT O
transcription NN B-NP
factor NN I-NP
Gal-ER NNP I-NP
was VBD O
rendered VBN O
more RBR O
potent JJ O
and CC O
less RBR O
susceptible JJ O
to TO O
cell NN O
type-specific JJ O
variation NN O
by IN O
fusing VBG O
the DT O
strong JJ O
activating JJ O
domain NN O
of IN O
the DT O
herpesvirus NN B-NP
protein NN I-NP
VP16 IN I-NP
onto IN O
its PRP$ O
C NNP O
terminus NN O
. . O

-DOCSTART- X X O

The DT O
exogenous JJ O
fos JJ B-NP
gene NN I-NP
was VBD O
rapidly RB O
induced VBN O
to TO O
maximal JJ O
levels NNS O
within IN O
1-2 JJ O
hr NN O
of IN O
estrogen NN O
addition NN O
. . O

-DOCSTART- X X O

Elimination NNP O
of IN O
Haemophilus NNP O
influenzae NN O
type NN O
b NN O
meningitis NN O
after IN O
introduction NN O
of IN O
vaccination NN O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
study NN O
we PRP O
demonstrated VBD O
a DT O
unique JJ O
mechanism NN O
of IN O
action NN O
of IN O
8-Cl-cAMP JJ O
in IN O
the DT O
regulation NN O
of IN O
these DT O
kinase JJ O
isozymes NNS O
in IN O
HL-60 CD O
human JJ O
promyelocytic JJ O
leukemia NN O
cells NNS O
. . O

-DOCSTART- X X O

Overlapping VBG O
clones NNS O
representing VBG O
full-length JJ O
cDNAs NNS O
for IN O
MMI NNP B-NP
alpha NN I-NP
were VBD O
obtained VBN O
from IN O
mouse NN O
brain NN O
. . O

-DOCSTART- X X O

Pathways NNP O
linking VBG O
the DT O
olfactory JJ O
bulbs NNS O
with IN O
the DT O
medial JJ O
preoptic JJ O
anterior JJ O
hypothalamus NN O
are VBP O
important JJ O
for IN O
intermale JJ O
aggression NN O
in IN O
mice NNS O
. . O

-DOCSTART- X X O

Pokeweed NNP B-NP
mitogen NN I-NP
( -LRB- O
PWM NNP B-NP
) -RRB- O
or CC O
anti-CD3 JJ B-NP
significantly RB O
increases VBZ O
c-jun NN B-NP
messenger NN I-NP
RNA NNP I-NP
( -LRB- I-NP
mRNA NN I-NP
) -RRB- I-NP
levels NNS O
in IN O
T NNP O
cells NNS O
. . O

-DOCSTART- X X O

Following VBG O
seizure NN O
induction NN O
, , O
MABP NNP O
increased VBD O
to TO O
105 CD O
mm CD O
Hg NNP O
and CC O
brain NN O
pHi NN O
fell VBD O
to TO O
6.79 CD O
+/ CD O
- : O
0.03 CD O
within IN O
15 CD O
min NN O
and CC O
remained VBD O
at IN O
this DT O
level NN O
for IN O
1 CD O
h NN O
( -LRB- O
P NNP O
< NN O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
rats NNS O
receiving VBG O
U74500A FW O
( -LRB- O
2 CD O
mg/kg NN O
i IN O
.v. NNP O
infusion IN O
commencing VBG O
30 CD O
min NN O
prior JJ O
to TO O
revascularisation NN O
) -RRB- O
exhibited VBN O
enhanced VBN O
GMBF NNP O
throughout IN O
reperfusion NN O
[P IN O
I PRP O
10 CD O
min NN O
: : O
3.26 CD O
( -LRB- O
2.56-3.63 CD O
) -RRB- O
; : O
120 CD O
min NN O
: : O
2.03 CD O
( -LRB- O
1.73-2.25 CD O
) -RRB- O
; : O
240 CD O
min NN O
: : O
2.13 CD O
( -LRB- O
1.75-2.44 CD O
) -RRB- O
, , O
p NN O
< IN O
0.01 CD O
vs. NN O
controls NNS O
and CC O
normals NNS O
] SYM O
with IN O
complete JJ O
muscle NN O
salvage NN O
[GMV IN O
100 CD O
% NN O
in IN O
all DT O
reperfused JJ O
muscles NNS O
, , O
p NN O
< NN O
0.01 CD O
vs. NN O
controls NNS O
, , O
not RB O
significant JJ O
( -LRB- O
NS NNS O
) -RRB- O
vs. FW O
normals NNS O
and CC O
6 CD O
h NN O
ischaemia] IN O
.(ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

Sterile JJ O
mutants NNS O
of IN O
Saccharomyces NNS O
cerevisiae NNS O
were VBD O
isolated VBN O
from IN O
alpha NN O
* IN O
cells NNS O
having VBG O
the DT O
a/alpha NN B-NP
aar1-6 NN I-NP
genotype NN O
( -LRB- O
exhibiting NN O
alpha NN O
mating VBG O
ability NN O
and CC O
weak JJ O
a DT O
mating NN O
ability NN O
as IN O
a DT O
result NN O
of IN O
a DT O
defect NN O
in IN O
a1-alpha NN B-NP
2 CD I-NP
repression NN O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
studied VBD O
the DT O
functional JJ O
interaction NN O
between IN O
human JJ O
embryonic NN O
zeta NN B-NP
2 CD I-NP
globin NN I-NP
promoter NN O
and CC O
the DT O
alpha NN B-NP
globin NN I-NP
regulatory JJ I-NP
element NN I-NP
( -LRB- O
HS-40 JJ B-NP
) -RRB- O
located VBN O
40 CD O
kb VBG O
upstream RB O
of IN O
the DT O
zeta NN B-NP
2 CD I-NP
globin NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

It PRP O
was VBD O
shown VBN O
by IN O
transient JJ O
expression NN O
assay NN O
that WDT O
HS-40 UH B-NP
behaved VBD O
as IN O
an DT O
authentic JJ O
enhancer NN O
for IN O
high-level JJ O
zeta NN B-NP
2 CD I-NP
globin NN I-NP
promoter NN I-NP
activity NN O
in IN O
K562 NNP O
cells NNS O
, , O
an DT O
erythroid JJ O
cell NN O
line NN O
of IN O
embryonic JJ O
and/or CC O
fetal JJ O
origin NN O
. . O

-DOCSTART- X X O

Breitbart NNP O
, , O
L. NNP O

-DOCSTART- X X O

This DT O
study NN O
evaluates VBZ O
the DT O
feasibility NN O
of IN O
indirect JJ O
mesenteric JJ O
lymphangiography NN O
as IN O
a DT O
colonoscopic JJ O
technique NN O
in IN O
a DT O
canine NN O
model NN O
. . O

-DOCSTART- X X O

5 CD O
micrograms/l NN O
was VBD O
detected VBN O
in IN O
urine NN O
from IN O
some DT O
non-occupationally RB O
exposed VBN O
persons NNS O
. . O

-DOCSTART- X X O

This DT O
prospective JJ O
study NN O
compared VBN O
the DT O
measured JJ O
energy NN O
expenditures NNS O
of IN O
30 CD O
patients NNS O
using VBG O
indirect JJ O
calorimetry NN O
with IN O
their PRP$ O
predicted VBN O
basal NN O
energy NN O
expenditure NN O
according VBG O
to TO O
the DT O
Harris-Benedict JJ O
equation NN O
, , O
or CC O
their PRP$ O
calculated JJ O
energy NN O
expenditure NN O
derived VBD O
from IN O
basal JJ O
energy NN O
expenditure NN O
times NNS O
, , O
an DT O
activity NN O
factor NN O
, , O
and CC O
a DT O
stress NN O
factor NN O
. . O

-DOCSTART- X X O

However RB O
, , O
after IN O
repeated VBN O
infections NNS O
, , O
hypobiotic JJ O
larvae NNS O
were VBD O
numerous JJ O
. . O

-DOCSTART- X X O

This DT O
was VBD O
performed VBN O
in IN O
a DT O
double JJ O
blinded VBN O
, , O
randomized VBD O
, , O
placebo-controlled JJ O
study NN O
. . O

-DOCSTART- X X O

There EX O
was VBD O
either RB O
no DT O
change NN O
or CC O
an DT O
improvement NN O
in IN O
renographic JJ O
findings NNS O
( -LRB- O
t1/2 CD O
time NN O
and/or IN O
split JJ O
function NN O
) -RRB- O
in IN O
40 CD O
patients NNS O
(93 VBD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
discuss VBP O
the DT O
need NN O
to TO O
use VB O
animals NNS O
older JJR O
than IN O
3 CD O
months NNS O
for IN O
the DT O
study NN O
of IN O
'adult JJ O
' '' O
regeneration NN O
phenomena NNS O
since IN O
3-month-old JJ O
rats NNS O
may MD O
be VB O
somewhat RB O
immature JJ O
. . O

-DOCSTART- X X O

Nuclear NNP B-NP
beta JJ I-NP
II NNP I-NP
PKC NNP I-NP
, , O
like IN O
p34cdc2 DT B-NP
kinase NN I-NP
, , O
may MD O
function VB O
to TO O
regulate VB O
nuclear JJ O
lamina NN O
structural JJ O
stability NN O
during IN O
cell NN O
cycle NN O
. . O

-DOCSTART- X X O

In IN O
situ FW O
copper-phenanthroline NN O
footprinting NN O
of IN O
individual JJ O
gel JJ O
shift NN O
assembly NN O
intermediates NNS O
shows VBZ O
that IN O
on IN O
the DT O
302-nucleotide JJ O
G4oric JJ O
, , O
the DT O
first JJ O
two CD O
SSB NNP B-NP
tetramers NNS I-NP
assemble NN O
at IN O
random JJ O
, , O
but CC O
the DT O
addition NN O
of IN O
more JJR O
SSB NNP B-NP
tetramers NNS I-NP
results NNS O
in IN O
formation NN O
of IN O
a DT O
unique JJ O
structure NN O
. . O

-DOCSTART- X X O

Finger NNP B-NP
associated JJ I-NP
box-zinc NN I-NP
finger NN I-NP
proteins NNS I-NP
( -LRB- O
FAX-ZFPs NNS B-NP
) -RRB- O
constitute VBP O
a DT O
subfamily NN O
of IN O
the DT O
many JJ O
C2H2 JJ B-NP
type NN I-NP
ZFPs NNS I-NP
in IN O
Xenopus NNP O
laevis NN O
. . O

-DOCSTART- X X O

Further JJ O
evidence NN O
for IN O
a DT O
clustered JJ O
organization NN O
of IN O
FAX-ZFP NNP B-NP
transcription NN O
units NNS O
is VBZ O
provided VBN O
by IN O
Southern JJ O
blot NN O
analysis NN O
of IN O
large JJ O
genomic JJ O
restriction NN O
fragments NNS O
separated VBN O
by IN O
transverse JJ O
field NN O
gel NN O
electrophoresis NN O
, , O
and CC O
by IN O
in IN O
situ NN O
hybridization NN O
on IN O
intact JJ O
chromosomes NNS O
. . O

-DOCSTART- X X O

A DT O
rat NN O
cDNA NN O
that WDT O
encodes VBZ O
eIF-5 DT B-NP
has VBZ O
been VBN O
isolated VBN O
and CC O
expressed VBN O
in IN O
Escherichia NNP O
coli NNS O
to TO O
yield VB O
a DT O
catalytically RB O
active JJ O
eIF-5 DT B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

In IN O
F42A-stimulated JJ O
internalization NN O
assays VBZ O
on IN O
forskolin-induced JJ O
YT-1 JJ O
cells NNS O
, , O
the DT O
IL-2R JJ B-NP
alpha NN I-NP
chain NN I-NP
is VBZ O
consistently RB O
endocytosed VBN O
together RB O
with IN O
the DT O
IL-2R JJ B-NP
beta NN I-NP
subunit NN I-NP
indicating VBG O
that IN O
IL-2R NNP B-NP
alpha NN I-NP
is VBZ O
stably RB O
associated VBN O
with IN O
the DT O
F42A-IL-2R JJ B-NP
beta NN I-NP
complex NN I-NP
even RB O
though IN O
the DT O
alpha-subunit NN O
contributes VBZ O
little RB O
if IN O
any DT O
affinity NN O
to TO O
the DT O
F42A NNP O
binding NN O
reaction NN O
. . O

-DOCSTART- X X O

We PRP O
obtained VBD O
the DT O
prevalence NN O
of IN O
IgG NNP B-NP
antibodies NNS I-NP
against IN O
Trypanosoma NNP O
cruzi , O
among IN O
1076 CD O
blood NN O
donors NNS O
at IN O
the DT O
Instituto NNP O
Nacional NNP O
de FW O
Cardiologia NNP O
" `` O
Ignacio VB O
Chavez NNP O
" '' O
in IN O
Mexico NNP O
City NNP O
. . O

-DOCSTART- X X O

Examination NN O
of IN O
the DT O
immediate JJ O
sequence NN O
5' VBD O
to TO O
the DT O
mRNA NNS O
start VBP O
site NN O
reveals VBZ O
no DT O
TATA NNP O
box NN O
and CC O
multiple JJ O
known VBN O
enhancer NN O
sequences NNS O
. . O

-DOCSTART- X X O

The DT O
short-term JJ O
synthesis NN O
and CC O
infant-regulated JJ O
removal NN O
of IN O
milk NN O
in IN O
lactating VBG O
women NNS O
. . O

-DOCSTART- X X O

Pseudosubstrate( NNP O
19-36) CD O
, , O
derived VBN O
from IN O
the DT O
C-terminus NN O
of IN O
Ca-dependent JJ B-NP
PKC NNP I-NP
isotypes NNS I-NP
, , O
inhibited VBD O
beta-PKC JJ B-NP
but CC O
not RB O
nPKC JJ B-NP
activity NN O
using VBG O
either DT O
Histone NN B-NP
IIIS NNP I-NP
or CC O
peptide( JJ O
19-31 NNS O
) -RRB- O
as IN O
substrate NN O
. . O

-DOCSTART- X X O

B NNP O
cell-specific JJ O
mb-1 NN B-NP
and CC O
B29 CD B-NP
genes NNS I-NP
encode VBP O
the DT O
alpha/beta JJ O
components NNS O
of IN O
the DT O
BCR-associated JJ B-NP
complex JJ I-NP
in IN O
mature JJ O
sIgM+ NN B-NP
B NNP O
cells NNS O
. . O

-DOCSTART- X X O

Mutations NNS O
at IN O
three CD O
sites NNS O
have VBP O
larger JJR O
effects NNS O
in IN O
muscle NN O
than IN O
nonmuscle NN O
cells NNS O
; : O
an DT O
A/T-rich JJ O
site NN O
mutation NN O
has VBZ O
a DT O
pronounced JJ O
effect NN O
in IN O
both DT O
striated JJ O
muscle NN O
types NNS O
, , O
mutations NNS O
at IN O
the DT O
MEF1 NNP B-NP
( -LRB- I-NP
Right RB I-NP
E-box NNP I-NP
) -RRB- I-NP
site NN I-NP
are VBP O
relatively RB O
specific JJ O
to TO O
expression NN O
in IN O
skeletal JJ O
muscle NN O
, , O
and CC O
mutations NNS O
at IN O
the DT O
CArG NNP O
site NN O
are VBP O
relatively RB O
specific JJ O
to TO O
expression NN O
in IN O
cardiac JJ O
muscle NN O
. . O

-DOCSTART- X X O

Transient NNP O
transfection NN O
analysis NN O
with IN O
these DT O
mutations NNS O
revealed VBD O
that IN O
only RB O
a DT O
10-bp JJ O
region NN O
, , O
containing VBG O
precisely RB O
the DT O
Ets NNS B-NP
and CC O
proximal JJ O
LyF-1 JJ B-NP
binding NN I-NP
sites NNS I-NP
, , O
was VBD O
needed VBN O
for IN O
D' NNP O
activity NN O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
here RB O
that IN O
a DT O
25-bp JJ O
promoter NN O
element NN O
previously RB O
shown VBN O
to TO O
be VB O
important JJ O
for IN O
the DT O
G1-S NNP O
activation NN O
of IN O
the DT O
human JJ B-NP
thymidine NN I-NP
kinase NN I-NP
( -LRB- O
htk NN B-NP
) -RRB- O
promoter NN O
in IN O
growth-stimulated JJ O
cells NNS O
is VBZ O
a DT O
cellular JJ O
target NN O
of IN O
cyclin NN B-NP
A DT I-NP
and CC O
the DT O
p33cdk2 NN B-NP
complexes NNS I-NP
. . O

-DOCSTART- X X O

These DT O
protective JJ O
influences NNS O
were VBD O
observed VBN O
throughout IN O
the DT O
range NN O
of IN O
filling VBG O
pressures NNS O
measured VBN O
, , O
from IN O
0 CD O
to TO O
30 CD O
mmHg NN O
. . O

-DOCSTART- X X O

DNase NN B-NP
I PRP I-NP
footprinting VBG O
with IN O
rat NN O
liver NN O
nuclear JJ O
extracts NNS O
identified VBN O
7 CD O
major JJ O
protein-binding NN O
domains VBZ O
termed VBN O
P1 NNS O
through IN O
P7 NNS O
in IN O
a DT O
796 CD O
base NN O
pair NN O
DNA NN O
fragment NN O
( -LRB- O
base NN O
pairs NNS O
-763 . O
to TO O
+33 CD O
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
may MD O
account VB O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
for IN O
the DT O
ability NN O
of IN O
excess JJ O
wt JJ B-NP
p53 NN I-NP
to TO O
inhibit VB O
cell NN O
proliferation NN O
and CC O
to TO O
interfere VB O
with IN O
neoplastic JJ O
processes NNS O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
of IN O
total JJ O
cellular JJ O
RNA NNP O
indicated VBD O
that IN O
xylP NNP B-NP
encodes VBZ O
a DT O
1.3-kb JJ O
transcript NN O
which WDT O
is VBZ O
induced VBN O
by IN O
xylan NN O
. . O

-DOCSTART- X X O

The DT O
nifJ NN B-NP
and CC O
nifH JJ B-NP
promoters NNS I-NP
of IN I-NP
Klebsiella NNP I-NP
pneumoniae NNS I-NP
are VBP O
divergently RB O
transcribed VBN O
sigma NN B-NP
54-dependent JJ I-NP
promoters NNS I-NP
that WDT O
are VBP O
positively RB O
activated VBN O
by IN O
the DT O
NifA NNP B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

These DT O
data NNS O
show VBP O
that IN O
PTH NNP B-NP
and CC O
cAMP NNS O
can MD O
repress VB O
collagen NN B-NP
promoter NN I-NP
activity NN O
in IN O
calvariae NN O
from IN O
transgenic JJ O
mice NNS O
, , O
suggesting VBG O
that IN O
the DT O
alpha NN B-NP
1( IN I-NP
I PRP I-NP
) -RRB- I-NP
collagen NN I-NP
promoter NN I-NP
may MD O
contain VB O
cis NNPS O
elements NNS O
down-stream NN O
of IN O
-2.3 JJ O
kilobases NNS O
that IN O
mediate JJ O
PTH NNP B-NP
and CC O
cAMP JJ O
repression NN O
of IN O
collagen NN B-NP
gene NN I-NP
expression NN O
in IN O
bone NN O
. . O

-DOCSTART- X X O

Both DT O
inhaled VBN O
and CC O
superfused VBN O
isoflurane NN O
dilated VBD O
the DT O
baseline NN O
vein NN O
diameter NN O
before IN O
stimulation NN O
. . O

-DOCSTART- X X O

Prevalence NN O
of IN O
rheumatoid NN O
arthritis NN O
and CC O
rheumatoid NN B-NP
factor NN I-NP
in IN O
women NNS O
: : O
evidence NN O
for IN O
a DT O
secular JJ O
decline NN O
. . O

-DOCSTART- X X O

Sequence NN O
comparison NN O
between IN O
the DT O
translated VBN O
ORF NNP O
and CC O
a DT O
protein NN O
database NN O
reveal VBP O
between IN O
26.5 CD O
and CC O
23.4 CD O
% NN O
aa JJ O
sequence NN O
homology NN O
to TO O
bacterial JJ B-NP
transmembrane NN I-NP
( -LRB- I-NP
TM) NNP I-NP
proteins VBZ I-NP
including VBG O
those DT O
mediating JJ O
chloramphenicol NN O
( -LRB- O
Cm NN O
) -RRB- O
and CC O
tetracycline NN O
( -LRB- O
Tc NNP O
) -RRB- O
resistance NN O
and CC O
an DT O
arabinose-proton NN O
symport NN O
protein NN O
. . O

-DOCSTART- X X O

The DT O
yeast NN O
gene NN O
that WDT O
encodes VBZ O
eIF-5 CD B-NP
, , O
designated VBN O
TIF5 NNP B-NP
, , O
has VBZ O
been VBN O
isolated VBN O
and CC O
expressed VBN O
in IN O
Escherichia NNP O
coli NNS O
to TO O
yield VB O
a DT O
catalytically RB O
active JJ O
eIF-5 DT B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Xylose VB O
- : O
and CC O
arabinose-containing NN O
polymers NNS O
were VBD O
better JJR O
digested JJ O
than IN O
was VBD O
cellulose JJ O
for IN O
both DT O
breads NNS O
. . O

-DOCSTART- X X O

The DT O
technical JJ O
construction NN O
of IN O
the DT O
mouth NN O
protectors NNS O
is VBZ O
illustrated VBN O
, , O
as RB O
is VBZ O
the DT O
need NN O
for IN O
instrumentation NN O
and CC O
its PRP$ O
costs NNS O
and CC O
the DT O
materials NNS O
required VBN O
to TO O
manufacture VB O
these DT O
mouth NN O
protectors NNS O
. . O

-DOCSTART- X X O

The DT O
alpha-subunit NN O
by IN O
itself PRP O
binds NNS O
to TO O
telomeric JJ O
DNA NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
the DT O
alpha-subunit NN O
of IN O
the DT O
telomere-binding JJ B-NP
protein NN I-NP
, , O
like IN O
many JJ O
transcription NN O
factors NNS O
, , O
has VBZ O
separable JJ O
DNA-binding NN O
and CC O
protein-protein NN O
interaction NN O
domains VBZ O
. . O

-DOCSTART- X X O

Three CD O
patients NNS O
had VBD O
well-, JJ O
6 CD O
patients NNS O
had VBD O
moderately-, JJ O
and CC O
5 CD O
patients NNS O
had VBD O
poorly-differentiated JJ O
adenocarcinoma NN O
of IN O
the DT O
prostate NN O
. . O

-DOCSTART- X X O

Spontaneous JJ O
burst NN O
firing VBG O
in IN O
cat NN O
primary JJ O
auditory NN O
cortex NN O
: : O
age NN O
and CC O
depth NN O
dependence NN O
and CC O
its PRP$ O
effect NN O
on IN O
neural JJ O
interaction NN O
measures NNS O
. . O

-DOCSTART- X X O

By IN O
applying VBG O
the DT O
potentiometric JJ O
method NN O
, , O
in IN O
aqueous JJ O
medium NN O
of IN O
ionic JJ O
strength NN O
mu NN O
= SYM O
0.2 CD O
, , O
the DT O
stability NN O
constants NNS O
, , O
log VBP O
beta NN O
1 CD O
= SYM O
4.42 CD O
and CC O
log VBP O
beta NN O
2 CD O
= SYM O
8.57 CD O
were VBD O
obtained VBN O
. . O

-DOCSTART- X X O

The DT O
bcl-2 JJ B-NP
gene NN I-NP
can MD O
potentially RB O
encode VB O
26 CD O
- : O
and CC O
22-kDa JJ O
proteins NNS O
that WDT O
differ VBP O
only RB O
in IN O
their PRP$ O
carboxyl NN O
tails NNS O
because IN O
of IN O
an DT O
alternative NN O
splicing NN O
mechanism NN O
. . O

-DOCSTART- X X O

The DT O
active JJ O
open JJ O
reading NN O
frame NN O
in IN O
the DT O
clone JJ O
maps NNS O
at IN O
27 CD O
min NN O
on IN O
the DT O
E. NNP O
coli NNS O
chromosome NN O
and CC O
is VBZ O
identical JJ O
in IN O
sequence NN O
to TO O
a DT O
wild JJ O
type NN O
counterpart NN O
. . O

-DOCSTART- X X O

As IN O
a DT O
result NN O
of IN O
alternative JJ O
splicing NN O
, , O
the DT O
BGP NNP B-NP
gene NN I-NP
is VBZ O
transcribed VBN O
into IN O
at IN O
least JJS O
seven CD O
distinct JJ O
mRNA NNS O
species NNS O
. . O

-DOCSTART- X X O

A DT O
comparison NN O
of IN O
the DT O
promoters NNS O
for IN O
muMIP-1 JJ B-NP
beta JJ I-NP
and CC O
muMIP-1 JJ B-NP
alpha NN I-NP
reveals VBZ O
a DT O
conserved JJ O
CK-1 JJ O
element NN O
, , O
but CC O
transient JJ O
expression NN O
studies NNS O
in IN O
RAW NNP O
264.7 CD O
macrophages NNS O
with IN O
proximal JJ O
fragments NNS O
of IN O
either CC O
the DT O
muMIP-1 NN B-NP
beta NN I-NP
or CC O
the DT O
muMIP-1 JJ B-NP
alpha NN I-NP
5' IN I-NP
promoter NN I-NP
fused VBN O
to TO O
a DT O
human JJ B-NP
growth NN I-NP
hormone NN I-NP
reporter NN I-NP
gene NN I-NP
link NN O
LPS-inducibility NN O
in IN O
both DT O
to TO O
promoter NN O
segments NNS O
near IN O
to TO O
, , O
but CC O
not RB O
identical JJ O
with IN O
, , O
the DT O
consensus NN O
CK-1 NN O
sequence NN O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
and CC O
identification NN O
of IN O
two CD O
hyp JJ B-NP
regulatory JJ I-NP
mutants NNS I-NP
. . O

-DOCSTART- X X O

The DT O
level NN O
of IN O
the DT O
SUP4A53T61 NNP B-NP
transcript NN I-NP
was VBD O
threefold RB O
higher JJR O
in IN O
the DT O
tap1-1 NN B-NP
mutant JJ I-NP
than IN O
in IN O
the DT O
wild JJ O
type NN O
. . O

-DOCSTART- X X O

NF-HB NNP B-NP
( -LRB- O
BSAP NNP B-NP
) -RRB- O
is VBZ O
a DT O
repressor NN O
of IN O
the DT O
murine NN B-NP
immunoglobulin IN I-NP
heavy-chain JJ I-NP
3' JJ I-NP
alpha NN I-NP
enhancer NN I-NP
at IN O
early JJ O
stages NNS O
of IN O
B-cell JJ O
differentiation NN O
. . O

-DOCSTART- X X O

Since IN O
the DT O
regulation NN O
of IN O
SWI4 NNP B-NP
is VBZ O
required VBN O
for IN O
normal JJ O
cell NN O
cycle NN O
progression NN O
, , O
we PRP O
have VBP O
characterized VBN O
cis NNPS O
- : O
and CC O
trans-acting JJ O
regulators NNS O
of IN O
SWI4 NNP B-NP
transcription NN O
. . O

-DOCSTART- X X O

In IN O
17 CD O
patients NNS O
with IN O
deletions NNS O
, , O
the DT O
parental JJ O
origin NN O
of IN O
deletion NN O
was VBD O
determined VBN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
grade NN O
III NNP O
BGCT NNP O
can MD O
be VB O
treated VBN O
by IN O
modified VBN O
intralesional JJ O
excision NN O
provided VBD O
the DT O
articular JJ O
surfaces NNS O
and CC O
part NN O
of IN O
the DT O
metaphysis NN O
are VBP O
intact JJ O
. . O

-DOCSTART- X X O

Second JJ O
, , O
nitrate JJ O
induction NN O
of IN O
aeg-46.5 DT B-NP
operon NN I-NP
expression NN O
is VBZ O
substantially RB O
enhanced VBN O
in IN O
narL DT B-NP
null JJ O
strains NNS O
( -LRB- O
M.H. . O

-DOCSTART- X X O

This DT O
new JJ O
knowledge NN O
has VBZ O
contributed VBN O
to TO O
the DT O
development NN O
of IN O
a DT O
successful JJ O
immunoprophylactic JJ O
strategy NN O
for IN O
eliminating VBG O
Hib NNP O
disease NN O
. . O

-DOCSTART- X X O

The DT O
HMG NNP B-NP
CoA NNP I-NP
reductase NN I-NP
inhibitors NNS O
are VBP O
the DT O
most RBS O
effective JJ O
cholesterol-lowering JJ O
agents NNS O
currently RB O
available JJ O
. . O

-DOCSTART- X X O

The DT O
etiology NN O
, , O
pathology NN O
, , O
brain NN O
CT NN O
scan JJ O
features NNS O
, , O
clinical JJ O
manifestations NNS O
and CC O
treatment NN O
of IN O
these DT O
accidents NNS O
were VBD O
discussed VBN O
. . O

-DOCSTART- X X O

One CD O
enigmatic JJ O
aspect NN O
of IN O
GATA NNP B-NP
factor NN I-NP
expression NN O
is VBZ O
that IN O
several JJ O
GATA NNP B-NP
proteins NNS I-NP
, , O
which WDT O
ostensibly RB O
share VBP O
the DT O
same JJ O
DNA-binding NN O
site NN O
specificity NN O
, , O
are VBP O
coexpressed VBN O
in IN O
erythroid JJ O
cells NNS O
. . O

-DOCSTART- X X O

Pit-1 NNP B-NP
is VBZ O
a DT O
tissue-specific JJ O
POU NNP B-NP
domain NN I-NP
factor NN I-NP
obligatory NN O
for IN O
the DT O
appearance NN O
of IN O
three CD O
cell NN O
phenotypes NNS O
in IN O
the DT O
anterior JJ O
pituitary JJ O
gland NN O
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

Characterization NNP O
and CC O
hormonal JJ O
regulation NN O
of IN O
the DT O
promoter NN O
of IN O
the DT O
rat NN B-NP
prostaglandin NN I-NP
endoperoxide NN I-NP
synthase NN I-NP
2 CD I-NP
gene NN I-NP
in IN O
granulosa CD O
cells NNS O
. . O

-DOCSTART- X X O

In IN O
mammalian JJ O
cells NNS O
, , O
phosphorylation NN O
of IN O
eIF-2 JJ B-NP
alpha NN I-NP
inhibits VBZ O
the DT O
activity NN O
of IN O
eIF-2B NN B-NP
, , O
the DT O
GDP-GTP NNP B-NP
exchange NN I-NP
factor NN I-NP
for IN O
eIF-2 NN B-NP
. . O

-DOCSTART- X X O

In IN O
conclusion NN O
, , O
these DT O
observations NNS O
demonstrated VBD O
that IN O
stratification NN O
of IN O
acute JJ O
MI NNP O
patients NNS O
by IN O
plasma NN O
ANF NN B-NP
level NN O
is VBZ O
a DT O
useful JJ O
non-invasive JJ O
method NN O
for IN O
predicting VBG O
prognosis NN O
and CC O
for IN O
identifying VBG O
individuals NNS O
at IN O
high JJ O
risk NN O
of IN O
cardiac JJ O
death NN O
. . O

-DOCSTART- X X O

Seven CD O
out IN O
of IN O
34 CD O
patients NNS O
died VBD O
, , O
giving VBG O
a DT O
mortality NN O
rate NN O
of IN O
21 CD O
% NN O
. . O

-DOCSTART- X X O

SSG1 NNP B-NP
, , O
a DT O
gene NN O
encoding VBG O
a DT O
sporulation-specific JJ B-NP
1,3-beta-glucanase JJ I-NP
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
this DT O
protein NN O
in IN O
E. NNP O
coli NNS O
demonstrated VBD O
that IN O
tyrosine NN O
was VBD O
incorporated VBN O
during IN O
suppression NN O
and CC O
that DT O
yeast NN B-NP
cytoplasmic JJ I-NP
TyrRS NNP I-NP
activity NN O
was VBD O
produced VBN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
reported VBN O
that IN O
, , O
at IN O
present JJ O
, , O
most JJS O
of IN O
the DT O
MRSAs NNP O
spreading VBG O
in IN O
Japan NNP O
are VBP O
acceleratedly RB O
acquiring VBG O
resistance NN O
to TO O
many JJ O
drugs NNS O
, , O
and CC O
especially RB O
, , O
they PRP O
are VBP O
developing VBG O
high JJ O
resistance NN O
against IN O
beta-lactams NNS O
. . O

-DOCSTART- X X O

Beg2 NNP B-NP
and CC O
Beg1 NNP B-NP
are VBP O
regulated VBN O
differently RB O
which WDT O
may MD O
indicate VB O
variation NN O
in IN O
storage NN O
or CC O
utilization NN O
properties NNS O
among IN O
the DT O
barley NN B-NP
globulins NNS I-NP
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Statistically RB O
significant JJ O
differences NNS O
were VBD O
obtained VBN O
between IN O
group NN O
I PRP O
and CC O
II NNP O
concerning VBG O
the DT O
number NN O
of IN O
patients NNS O
in IN O
whom WP O
induced VBD O
atrial JJ O
fibrillation NN O
with IN O
conduction NN O
by IN O
the DT O
accessory JJ O
pathway NN O
and CC O
RR NN O
< NN O
or CC O
= SYM O
250 CD O
msec NN O
was VBD O
found VBN O
( -LRB- O
0 CD O
vs IN O
6 CD O
, , O
p NN O
= SYM O
0.0045 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Both DT O
immunophilins NNS B-NP
may MD O
have VB O
important JJ O
roles NNS O
in IN O
receptor NN O
assembly NN O
and CC O
may MD O
represent VB O
a DT O
new JJ O
category NN O
of IN O
ligand NN O
- : O
and CC O
calcium-dependent JJ O
modulators NNS O
of IN O
protein NN O
function NN O
. . O

-DOCSTART- X X O

The DT O
GTPase NNP B-NP
activity NN O
of IN O
CDC42Ce NNP B-NP
is VBZ O
moderately RB O
stimulated VBN O
by IN O
human JJ B-NP
n-chimaerin NN I-NP
, , O
a DT O
GTPase-activating JJ B-NP
protein NN I-NP
for IN O
the DT O
related JJ O
p21 NN B-NP
rac1 NN B-NP
. . O

-DOCSTART- X X O

Tl-201 DT O
uptake NN O
ratio NN O
of IN O
the DT O
right JJ O
ventricle NN O
, , O
which WDT O
represents VBZ O
the DT O
ratio NN O
of IN O
total JJ O
counts NNS O
of IN O
the DT O
right JJ O
ventricle NN O
to TO O
counts NNS O
of IN O
the DT O
administered VBN O
dose NN O
of IN O
Tl-201 JJ O
, , O
was VBD O
higher JJR O
in IN O
COPD NNP O
, , O
especially RB O
in IN O
pulmonary JJ O
emphysema NN O
and CC O
B NNP O
type NN O
COPD NN O
by IN O
Burrows NNP O
classification NN O
than IN O
in IN O
controls NNS O
. . O

-DOCSTART- X X O

A DT O
second JJ O
hydrophobic JJ O
domain NN O
, , O
bordered VBN O
by IN O
two CD O
hydrophilic JJ O
regions NNS O
strongly RB O
suggests VBZ O
a DT O
transmembrane NN O
region NN O
. . O

-DOCSTART- X X O

This DT O
gene NN O
spans VBZ O
23 CD O
kb NN O
and CC O
is VBZ O
composed VBN O
of IN O
five CD O
exons NNS O
and CC O
four CD O
introns NNS O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
a DT O
range NN O
of IN O
microenvironmental JJ O
conditions NNS O
exist VBP O
within IN O
purified JJ O
water NN O
systems NNS O
, , O
leading VBG O
to TO O
variable JJ O
populations NNS O
of IN O
bacteria NNS O
. . O

-DOCSTART- X X O

This DT O
conclusion NN O
is VBZ O
based VBN O
on IN O
the DT O
observations NNS O
of IN O
the DT O
immunologic JJ O
changes NNS O
that WDT O
characterize VBP O
the DT O
acute JJ O
stages NNS O
of IN O
illness NN O
as RB O
well RB O
as IN O
on IN O
the DT O
demonstrated VBN O
association NN O
with IN O
toxin-producing JJ O
bacteria NNS O
in IN O
the DT O
pharynx NN O
and CC O
gastrointestinal JJ O
tract NN O
. . O

-DOCSTART- X X O

These DT O
cell NN O
lines NNS O
displayed VBD O
methylation NN O
of IN O
the DT O
CpG NNP O
island NN O
surrounding VBG O
the DT O
first JJ O
exon NN O
of IN O
p16INK4A NN B-NP
and CC O
expressed VBD O
abundant JJ O
levels NNS O
of IN O
a DT O
nontranslated JJ O
mRNA NN O
containing VBG O
an DT O
alternative JJ O
first JJ O
exon NN O
( -LRB- O
E1 JJ O
beta NN O
) -RRB- O
, , O
as RB O
did VBD O
all DT O
other JJ O
cell NN O
lines NNS O
in IN O
which WDT O
the DT O
p16INK4A NN B-NP
locus NN I-NP
was VBD O
not RB O
deleted VBN O
. . O

-DOCSTART- X X O

Umweltchem NNP O
. . O

-DOCSTART- X X O

Egd1p NNP B-NP
is VBZ O
homologous JJ O
to TO O
human JJ B-NP
BTF3b NNP I-NP
, , O
recently RB O
identified VBN O
as IN O
the DT O
beta JJ O
subunit NN O
of IN O
the DT O
heterodimeric JJ B-NP
nascent-polypeptide-associated JJ I-NP
complex NN I-NP
( -LRB- O
NAC NNP B-NP
) -RRB- O
involved VBN O
in IN O
ensuring VBG O
signal-sequence-specific JJ O
protein NN O
sorting NN O
and CC O
translocation NN O
[ IN O
Wiedmann NNP O
et NNP O
al NN O
. . O
, , O
Nature NN O
370 CD O
( -LRB- O
1994 CD O
) -RRB- O
434-440] CD O
. . O

-DOCSTART- X X O

The DT O
5' JJ O
flanking NN O
regions NNS O
of IN O
both DT O
pelA NNS B-NP
and CC O
pelB NNS B-NP
were VBD O
translationally RB O
fused VBN O
to TO O
the DT O
beta-glucuronidase JJ B-NP
gene NN I-NP
and CC O
introduced VBN O
into IN O
F. NNP O
solani JJ O
f NN O
. . O
sp. NN O
pisi NN O
, , O
and CC O
beta-glucuronidase JJ B-NP
activities NNS O
of IN O
the DT O
transformants NNS O
were VBD O
measured VBN O
. . O

-DOCSTART- X X O

We PRP O
failed VBD O
to TO O
find VB O
these DT O
data NNS O
to TO O
be VB O
useful JJ O
in IN O
predicting VBG O
the DT O
time NN O
of IN O
onset NN O
of IN O
initial JJ O
seizures NNS O
after IN O
acute JJ O
ischemic JJ O
stroke NN O
and CC O
recurrence NN O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
papillomavirus NN I-NP
type NN I-NP
16 CD I-NP
E7 JJ I-NP
protein NN I-NP
complements NNS O
adenovirus NN B-NP
type NN I-NP
5 CD I-NP
E1A NNP I-NP
amino-terminus-dependent JJ O
transactivation NN O
of IN O
adenovirus NN B-NP
type NN I-NP
5 CD I-NP
early JJ I-NP
genes NNS I-NP
and CC O
increases NNS O
ATF NNP B-NP
and CC O
Oct-1 NNP B-NP
DNA NNP O
binding NN O
activity NN O
. . O

-DOCSTART- X X O

A DT O
chaotropic NN O
detergent NN O
, , O
0.1 CD O
% NN O
Nonidet NN O
P-40 NN O
, , O
also RB O
abolished VBD O
the DT O
interaction NN O
, , O
further RB O
supporting VBG O
the DT O
hydrophobic JJ O
nature NN O
of IN O
the DT O
interaction NN O
. . O

-DOCSTART- X X O

Degradation NN O
of IN O
the DT O
soybean NN B-NP
ribulose-1,5-bisphosphate NN I-NP
carboxylase NN I-NP
small-subunit JJ I-NP
mRNA NN I-NP
, , O
SRS4 NNP B-NP
, , O
initiates VBZ O
with IN O
endonucleolytic JJ O
cleavage NN O
. . O

-DOCSTART- X X O

Cloning NNP O
and CC O
sequencing NN O
revealed VBD O
that IN O
dMax NN B-NP
contains VBZ O
a DT O
deletion NN O
spanning VBG O
the DT O
basic JJ O
region NN O
and CC O
helix NN O
1 CD O
and CC O
the DT O
loop NN O
of IN O
the DT O
helix-loop-helix NN O
region NN O
, , O
presumably RB O
as IN O
a DT O
result NN O
of IN O
alternative JJ O
splicing NN O
of IN O
max NN B-NP
RNA NNP I-NP
. . O

-DOCSTART- X X O

The DT O
domain NN O
structure NN O
of IN O
bovine JJ B-NP
LTBP-2 NN I-NP
is VBZ O
very RB O
similar JJ O
to TO O
that DT O
of IN O
the DT O
human JJ B-NP
LTBP-2 NN I-NP
, , O
containing VBG O
20 CD O
examples NNS O
of IN O
6-cysteine JJ O
epidermal JJ B-NP
growth NN I-NP
factor-like JJ I-NP
repeats NNS I-NP
, , O
16 CD O
of IN O
which WDT O
have VBP O
the DT O
consensus NN O
sequence NN O
for IN O
calcium NN O
binding NN O
, , O
together RB O
with IN O
4 CD O
examples NNS O
of IN O
8-cysteine JJ O
motifs NNS O
characteristic JJ O
of IN O
fibrillins NNS B-NP
and CC O
LTBP-1 NN B-NP
. . O

-DOCSTART- X X O

We PRP O
now RB O
report VBP O
the DT O
isolation NN O
and CC O
expression NN O
of IN O
cDNAs NNS O
encoding VBG O
PTF NNP B-NP
gamma NN I-NP
and CC O
PTF JJ B-NP
delta NN I-NP
, , O
as RB O
well RB O
as IN O
functional JJ O
studies NNS O
with IN O
cognate JJ O
antibodies NNS O
that WDT O
recognize VBP O
the DT O
native JJ O
PTF NNP B-NP
complex NN I-NP
in IN O
HeLa NNP O
extracts NNS O
. . O

-DOCSTART- X X O

The DT O
TEA1 NNP B-NP
( -LRB- O
Ty NN B-NP
enhancer NN I-NP
activator NN I-NP
) -RRB- O
gene NN O
sequence NN O
predicts VBZ O
a DT O
protein NN O
of IN O
86.9 CD O
kDa NN O
whose WP$ O
N NNP O
terminus NN O
contains VBZ O
a DT O
zinc NN O
cluster NN O
and CC O
dimerization NN O
motif NN O
typical JJ O
of IN O
the DT O
Gal4-type JJ B-NP
family NN I-NP
of IN O
DNA-binding JJ O
proteins NNS O
. . O

-DOCSTART- X X O

This DT O
study NN O
underlines VBZ O
the DT O
importance NN O
of IN O
terminal NN O
SC5b-9 . B-NP
complement NN I-NP
complex NN I-NP
as IN O
a DT O
suitable JJ O
marker NN O
in IN O
the DT O
evaluation NN O
of IN O
complement NN O
activation NN O
during IN O
cardiopulmonary JJ O
bypass NN O
. . O

-DOCSTART- X X O

Striking VBG O
sequence NN O
similarities NNS O
( -LRB- O
57 CD O
and CC O
53 CD O
% NN O
) -RRB- O
were VBD O
observed VBN O
with IN O
yeast NN O
mitochondrial JJ O
proteins NNS O
, , O
SMF1 NNP B-NP
and CC O
SMF2 NNP B-NP
, , O
especially RB O
within IN O
putative JJ O
functional JJ O
domains NNS O
: : O
exon NN O
6 CD O
encoding VBG O
the DT O
second JJ O
transmembrane NN O
spanning NN O
domain NN O
, , O
site NN O
of IN O
the DT O
murine NN B-NP
susceptibility NN I-NP
mutation NN O
; : O
and CC O
exon JJ O
11 CD O
encoding VBG O
a DT O
conserved JJ O
transport NN O
motif NN O
. . O

-DOCSTART- X X O

Stems NNS O
contain VBP O
distinctly RB O
less JJR O
P NNP B-NP
protein NN I-NP
mRNA NN I-NP
and CC O
the DT O
relative JJ O
level NN O
in IN O
roots NNS O
is VBZ O
very RB O
low JJ O
but CC O
still RB O
clearly RB O
detectable JJ O
. . O

-DOCSTART- X X O

The DT O
B. NNP B-NP
germanica NN I-NP
cyclophilin NN I-NP
amino IN I-NP
acid NN I-NP
sequence NN I-NP
shares NNS O
83 CD O
% NN O
identity NN O
with IN O
the DT O
cytosolic JJ B-NP
cyclophilin NN I-NP
isoform NN I-NP
from IN I-NP
Drosophila NNP I-NP
melanogaster NN I-NP
( -LRB- O
Cyp-1 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
we PRP O
have VBP O
identified VBN O
a DT O
soluble JJ O
form NN O
of IN O
ERp57/GRP58 NNS B-NP
by IN O
Western JJ O
blotting NN O
and CC O
biosynthetic JJ O
labeling NN O
. . O

-DOCSTART- X X O

Comparison NNP O
of IN O
promoters NNS O
repressed VBN O
by IN O
c-myc NN B-NP
reveals VBZ O
a DT O
weak JJ O
consensus NN O
sequence NN O
of IN O
the DT O
initiator NN O
( -LRB- O
Inr NN O
) -RRB- O
element NN O
: : O
TCA( NNP O
+1)YYYNY NNP O
. . O

-DOCSTART- X X O

Transfection NN O
analyses NNS O
indicate VBP O
that IN O
mutation NN O
of IN O
any DT O
one CD O
of IN O
these DT O
TGACCT NNP O
motifs NNS O
or CC O
truncation NN O
of IN O
the DT O
entire JJ O
HD NNP B-NP
PPRE NNP O
into IN O
a DT O
separate JJ O
DR1 NN O
and CC O
DR2 CD O
element NN O
significantly RB O
reduced VBD O
the DT O
transcriptional JJ O
response NN O
of IN O
HD NNP B-NP
PPRE NNP O
to TO O
peroxisome VB O
proliferators NNS O
. . O

-DOCSTART- X X O

The DT O
site NN O
of IN O
autophosphorylation NN O
is VBZ O
Tyr397 IN O
which WDT O
corresponds NNS O
to TO O
the DT O
consensus NN O
autophosphorylation NN O
site NN O
of IN O
other JJ O
Src NNP B-NP
family NN I-NP
tyrosine NN B-NP
kinases NNS I-NP
. . O

-DOCSTART- X X O

This DT O
protein-protein NN O
interaction NN O
does VBZ O
not RB O
require VB O
the DT O
simultaneous JJ O
binding NN O
of IN O
Oct NNP B-NP
proteins VBZ I-NP
to TO O
DNA NNP O
, , O
and CC O
high JJ O
resolution NN O
footprinting NN O
of IN O
the DT O
Oct-DNA NNP B-NP
interaction NN O
reveals VBZ O
that IN O
binding NN O
of IN O
BOB.1/OBF.1 NNP B-NP
to TO O
Oct1 NNP B-NP
or CC O
Oct2 NNP B-NP
does VBZ O
not RB O
alter VB O
the DT O
interaction NN O
with IN O
DNA NNP O
. . O

-DOCSTART- X X O

Unlike IN O
ARF NN B-NP
, , O
the DT O
ARP NNP B-NP
immunoreactivity NN O
was VBD O
detected VBN O
in IN O
plasma NN O
membranes NNS O
but CC O
not RB O
in IN O
cytosol NN O
of IN O
fractionated JJ O
3T3-L1 JJ O
cells NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
considered VBN O
that IN O
the DT O
recurrent JJ O
annular JJ O
erythema NN O
is VBZ O
a DT O
specific JJ O
skin NN O
manifestation NN O
of IN O
SjS NNP O
with IN O
anti DT B-NP
SS-A/SS-B NNP I-NP
antibodies NNS B-NP
. . O

-DOCSTART- X X O

Competition NN O
needs VBZ O
to TO O
be VB O
better JJR O
studied VBN O
, , O
since IN O
in IN O
Central NNP O
America NNP O
and CC O
Caribean NNP O
islands NNS O
this DT O
kind NN O
of IN O
study NN O
has VBZ O
favored VBN O
the DT O
biological JJ O
control NN O
of IN O
planorbid NN O
species NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
paper NN O
we PRP O
describe VBP O
properties NNS O
of IN O
the DT O
cdc10-C4 JJ B-NP
mutant NN O
of IN O
the DT O
fission NN O
yeast NN O
Schizosaccharomyces NNP O
pombe VBD O
. . O

-DOCSTART- X X O

TIEG NNP B-NP
expression NN O
in IN O
hFOB NN O
cells NNS O
was VBD O
highly RB O
induced VBN O
by IN O
TGF-beta NNP B-NP
and CC O
bone NN B-NP
morphogenetic JJ I-NP
protein-2 NN I-NP
( -LRB- O
BMP-2 NNP B-NP
) -RRB- O
, , O
with IN O
a DT O
moderate JJ O
induction NN O
by IN O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
( -LRB- O
EGF) NNP B-NP
, , O
but CC O
no DT O
induction NN O
by IN O
other JJ O
growth NN O
factors/cytokines NNS O
was VBD O
observed VBN O
. . O

-DOCSTART- X X O

An DT O
infectious JJ O
origin NN O
should MD O
always RB O
be VB O
excluded VBN O
since IN O
specific JJ O
etiologic NN O
therapy NN O
may MD O
be VB O
implemented VBN O
. . O

-DOCSTART- X X O

In IN O
particular JJ O
, , O
the DT O
highly RB O
expressed VBN O
ADH1 NNP B-NP
gene NN I-NP
is VBZ O
represented VBN O
in IN O
this DT O
database NN O
by IN O
no DT O
less JJR O
than IN O
20 CD O
EST NNP O
sequences NNS O
. . O

-DOCSTART- X X O

Five CD O
families NNS O
of IN O
Ashkenazi NNP O
Jewish NNP O
descent NN O
carried VBD O
the DT O
185delAG CD O
mutation NN O
and CC O
shared VBD O
the DT O
same JJ O
haplotype NN O
at IN O
eight CD O
polymorphic JJ O
markers NNS O
spanning VBG O
approximately RB O
850 CD O
kb NN O
at IN O
BRCA1 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
subjects NNS O
from IN O
the DT O
two CD O
regions NNS O
with IN O
a DT O
higher JJR O
pollution NN O
level NN O
had VBD O
lower JJR O
FVC NNP O
and CC O
FEV1 NNP O
values NNS O
than IN O
those DT O
from IN O
the DT O
Viskovo NNP O
region NN O
. . O

-DOCSTART- X X O

PTP-S3 JJ B-NP
differs NNS O
from IN O
PTP-S4 NNP B-NP
in IN O
having VBG O
a DT O
deletion NN O
of IN O
19 CD O
amino IN O
acids NNS O
corresponding JJ O
to TO O
exon VB O
E1 NNP O
. . O

-DOCSTART- X X O

All DT O
three CD O
NR NNP B-NP
isoforms NNS I-NP
are VBP O
expressed VBN O
in IN O
cv. NN O

-DOCSTART- X X O

The DT O
Arabidopsis NNP B-NP
FAD7 NNP I-NP
gene NN I-NP
encodes VBZ O
a DT O
chloroplast NN B-NP
omega-3 NN I-NP
fatty JJ I-NP
acid NN I-NP
desaturase NN I-NP
that WDT O
catalyzes VBZ O
the DT O
desaturation NN O
of IN O
lipid-linked JJ O
dienoic JJ O
fatty NN O
acids NNS O
( -LRB- O
18:2 CD O
and CC O
16 CD O
:2 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Protein NNP O
kinases NNS O
play VBP O
pivotal JJ O
roles NNS O
in IN O
the DT O
control NN O
of IN O
many JJ O
cellular JJ O
processes NNS O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
internal JJ O
and CC O
5' JJ O
deletions NNS O
revealed VBD O
tha IN O
the DT O
distal JJ O
promoter NN O
was VBD O
not RB O
required VBN O
for IN O
full JJ O
transcriptional JJ O
activity NN O
and CC O
that IN O
the DT O
first JJ O
631 CD O
base NN O
pairs NNS O
of IN O
WNT-5A DT B-NP
harbored VBN O
the DT O
strongest JJS O
promoter NN O
activity NN O
. . O

-DOCSTART- X X O

The DT O
protein NN O
kinase NN O
domains NNS O
of IN O
LIMK1 NNP B-NP
and CC O
LIMK2 NNP B-NP
are VBP O
unique JJ O
in IN O
that IN O
they PRP O
contain VBP O
an DT O
unusual JJ O
sequence NN O
motif NN O
Asp-Leu-Asn-Ser-His-Asn . O
in IN O
subdomain JJ O
VIB NNP O
and CC O
a DT O
highly RB O
basic JJ O
insert NN O
between IN O
subdomains NNS O
VII NNP O
and CC O
VIII NNP O
. . O

-DOCSTART- X X O

A DT O
human JJ O
recombinant NN O
cDNA NN O
clone NN O
that WDT O
encoded VBD O
253 CD O
amino IN O
acids NNS O
residues NNS O
of IN O
a DT O
zinc-finger JJ B-NP
protein NN I-NP
( -LRB- O
THZif-1 NN B-NP
) -RRB- O
was VBD O
cloned VBN O
by IN O
screening VBG O
a DT O
cDNA JJ O
library NN O
prepared VBD O
from IN O
human JJ O
promyelocytic JJ O
leukemia NN O
HL60 IN O
cells NNS O
with IN O
synthetic JJ O
oligodeoxynucleotide JJ O
probes NNS O
that IN O
corresponded VBN O
to TO O
the DT O
amino JJ O
acid NN O
sequences NNS O
of IN O
tryptic JJ O
peptides NNS O
derived VBN O
from IN O
the DT O
DNA-binding NN O
protein NN O
specific NN O
for IN O
the DT O
nuclease-hypersensitive JJ B-NP
element NN I-NP
( -LRB- O
NHE NNP B-NP
) -RRB- O
of IN O
the DT O
human JJ B-NP
c-myc NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Taking VBG O
into IN O
consideration NN O
weight NN O
and CC O
seasonal JJ O
changes NNS O
in IN O
bone NN O
mass NN O
, , O
total NN O
( -LRB- O
TBBMC) NNP O
and CC O
regional JJ O
body NN O
bone NN O
mineral NN O
content NN O
were VBD O
measured VBN O
in IN O
38 CD O
women NNS O
treated VBN O
with IN O
GnRH NNP B-NP
agonists NNS O
for IN O
6 CD O
months NNS O
for IN O
endometriosis NN O
or CC O
leiomyomata NN O
. . O

-DOCSTART- X X O

The DT O
encoded JJ O
polypeptide NN O
is VBZ O
similar JJ O
in IN O
sequence NN O
to TO O
the DT O
ABA-1 JJ B-NP
allergen NN I-NP
of IN I-NP
Ascaris NNP I-NP
, , O
the DT O
gp15/400 NN B-NP
'ladder , I-NP
' '' I-NP
protein NN I-NP
of IN I-NP
Brugia NNP I-NP
malayi NN I-NP
, , I-NP
Brugia NNP I-NP
pahangi , I-NP
and CC I-NP
Wuchereria NNP I-NP
bancrofti NNS I-NP
, , O
and CC O
a DT O
15-kDa JJ B-NP
antigen NN I-NP
of IN I-NP
Dirofilaria NNP I-NP
immitis NN I-NP
. . O

-DOCSTART- X X O

Certain JJ O
transcript NN O
patterns NNS O
in IN O
Epifagus NNP O
plastids NNS O
are VBP O
highly RB O
complex JJ O
and CC O
similar JJ O
to TO O
those DT O
of IN O
tobacco NN O
operons NNS O
. . O

-DOCSTART- X X O

Spontaneous JJ O
recovery NN O
occurs VBZ O
within IN O
30 CD O
min NN O
to TO O
2 CD O
hrs NNS O
. . O

-DOCSTART- X X O

Diabetes NNP O
care NN O
: : O
a DT O
guideline NN O
to TO O
the DT O
facilities NNS O
needed VBN O
to TO O
support VB O
internationally RB O
endorsed VBN O
standards NNS O
. . O

-DOCSTART- X X O

To TO O
identify VB O
some DT O
of IN O
the DT O
genes NNS O
expressed VBN O
in IN O
LPS-activated NNP O
coelomocytes NNS O
, , O
we PRP O
sequenced VBD O
randomly RB O
chosen VBN O
clones NNS O
from IN O
a DT O
directionally RB O
constructed VBN O
cDNA DT O
library NN O
to TO O
produce VB O
a DT O
set NN O
of IN O
expressed VBN O
sequence NN O
tags NNS O
( -LRB- O
ESTs NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Characterization NNP O
of IN O
an DT O
EcR/USP NNP B-NP
heterodimer NN O
target NN O
site NN O
that IN O
mediates NNS O
ecdysone NN O
responsiveness NN O
of IN O
the DT O
Drosophila NNP B-NP
Lsp-2 NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

In IN O
vivo RB O
, , O
selective JJ O
activation NN O
of IN O
SAPKs NNP B-NP
stimulates NNS O
formation NN O
of IN O
the DT O
ternary NN O
complex NN O
containing VBG O
Elk-1 NNP B-NP
, , O
serum JJ B-NP
response NN I-NP
factor NN I-NP
and CC O
the DT O
serum JJ O
response NN O
element NN O
, , O
and CC O
enhances NNS O
Elk-1-dependent JJ B-NP
transcription NN O
. . O

-DOCSTART- X X O

An DT O
epidemic JJ O
of IN O
hepatitis NN O
B NNP O
virus NN O
infection NN O
among IN O
intravenous JJ O
drug NN O
users NNS O
in IN O
Iceland NNP O
. . O

-DOCSTART- X X O

The DT O
transposon-inactivated JJ O
gene NN O
, , O
designated VBN O
pilP NN B-NP
, , O
is VBZ O
525 CD O
bp JJ O
long JJ O
, , O
potentially RB O
encoding VBG O
a DT O
19.1-kDa JJ O
protein NN O
precursor NN O
that WDT O
contains VBZ O
a DT O
typical JJ O
membrane NN O
lipoprotein NN O
leader NN O
sequence NN O
. . O

-DOCSTART- X X O

Upstream NN O
of IN O
the DT O
dra NN B-NP
gene NN I-NP
an DT O
open JJ O
reading NN O
frame NN O
of IN O
313 CD O
amino IN O
acids NNS O
was VBD O
identified VBN O
. . O

-DOCSTART- X X O

Sucrose-specific JJ O
regulation NN O
of IN O
scrB NN B-NP
was VBD O
also RB O
lost VBN O
upon IN O
deletion NN O
of IN O
4 CD O
bp NN O
of IN O
a DT O
palindromic JJ O
sequence NN O
( -LRB- O
OB NN O
) -RRB- O
covering VBG O
positions NNS O
+6 VBP O
to TO O
+21 VB O
downstream NN O
of IN O
the DT O
scrB NN B-NP
transcriptional JJ O
start NN O
site NN O
. . O

-DOCSTART- X X O

CXC NNP O
chemokines NNS O
bind VBP O
to TO O
unique JJ O
sets NNS O
of IN O
selectivity NN O
determinants NNS O
that WDT O
can MD O
function VB O
independently RB O
and CC O
are VBP O
broadly RB O
distributed VBN O
on IN O
multiple JJ O
domains NNS O
of IN O
human JJ O
interleukin-8 NN B-NP
receptor NN I-NP
B. NNP I-NP

-DOCSTART- X X O

Oligodeoxynucleotides NNP O
antisense NN O
to TO O
the DT O
predicted VBN O
translation NN O
initiation NN O
regions NNS O
of IN O
ICP4 NNP B-NP
and CC O
pp38 VBD B-NP
mRNAs RB I-NP
inhibited JJ O
proliferation NN O
of IN O
MSB1 JJ O
cells NNS O
but CC O
not RB O
MDCC-CU91 JJ O
( -LRB- O
CU91 NN O
) -RRB- O
reticuloendotheliosis VBZ O
virus-transformed JJ O
cells NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
case NN O
the DT O
degree NN O
of IN O
promoter NN O
methylation NN O
, , O
which WDT O
could MD O
extend VB O
beyond IN O
the DT O
T-DNA NNP O
borders NNS O
, , O
was VBD O
not RB O
correlated VBN O
with IN O
the DT O
reduction NN O
in IN O
steady-state NN O
poly( NN O
A DT O
) -RRB- O
+ IN O
mRNA NN O
levels NNS O
, , O
the DT O
silenced JJ O
state NN O
was VBD O
transmitted VBN O
through IN O
meiosis NN O
and CC O
reactivation NN O
lasted VBD O
several JJ O
generations NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
consensus NN O
sequences NNS O
for IN O
phosphatase NN O
regulation NN O
are VBP O
5'-GCACGTGGG-3' JJ O
and CC O
5'-GCACGTTTT-3' JJ O
which WDT O
differ VBP O
from IN O
the DT O
binding NN O
sequences NNS O
for IN O
the DT O
Cpflp NN B-NP
protein NN O
required VBN O
for IN O
transcription NN O
of IN O
the DT O
genes NNS O
in IN O
methionine CD O
biosynthesis NN O
and CC O
for IN O
centromere JJ O
function NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
report VBP O
that IN O
the DT O
proline-rich JJ O
region NN O
of IN O
CAP NNP B-NP
is VBZ O
recognized VBN O
by IN O
the DT O
SH3 JJ B-NP
domains NNS I-NP
of IN O
several JJ O
proteins NNS O
, , O
including VBG O
the DT O
yeast NN B-NP
actin-associated JJ I-NP
protein NN I-NP
Abp1p NNP I-NP
. . O

-DOCSTART- X X O

We PRP O
have VBP O
identified VBN O
and CC O
characterized VBN O
a DT O
vitamin NN O
D NNP O
response NN O
element NN O
(VDRE RB O
) -RRB- O
in IN O
the DT O
promoter NN O
of IN O
c-fos NNS B-NP
. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
protein NN O
binding NN O
at IN O
sequences NNS O
known VBN O
to TO O
be VB O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
transcription NN O
, , O
genomic JJ O
footprinting NN O
of IN O
the DT O
entire JJ O
promoter NN O
region NN O
also RB O
showed VBD O
that IN O
a DT O
protein NN O
factor NN O
is VBZ O
constitutively RB O
bound VBN O
to TO O
the DT O
first JJ O
intron NN O
of IN O
the DT O
rep3 JJ B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Differentiation NN O
was VBD O
not RB O
observed VBN O
after IN O
cellular JJ O
expression NN O
of IN O
GTPase-deficient JJ B-NP
forms NNS O
of IN O
alpha NN B-NP
i2 NN I-NP
or CC O
alpha NN B-NP
0, IN I-NP
indicating VBG O
selectivity NN O
for IN O
the DT O
Gq NNP B-NP
family NN I-NP
of IN O
G NNP B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Paf1p NNP B-NP
may MD O
therefore RB O
be VB O
required VBN O
for IN O
both DT O
positive JJ O
and CC O
negative JJ O
regulation NN O
of IN O
subsets NNS O
of IN O
yeast NN O
genes NNS O
. . O

-DOCSTART- X X O

Molecular JJ O
characterization NN O
of IN O
malignant JJ O
melanoma NN O
of IN O
soft JJ O
parts NNS O
or CC O
soft JJ O
tissue NN O
clear JJ O
cell NN O
sarcoma NN O
which WDT O
shares VBZ O
t( JJ O
12;22 CD O
) -RRB- O
chromosome NN O
translocation NN O
revealed VBD O
fusion NN O
of IN O
EWS NNP B-NP
with IN O
a DT O
transcriptional JJ O
factor NN O
gene NN B-NP
ATF-1 JJ I-NP
. . O

-DOCSTART- X X O

A DT O
short JJ O
open JJ O
reading NN O
frame NN O
( -LRB- O
ORF2 NN O
) -RRB- O
, , O
of IN O
unknown JJ O
function NN O
, , O
is VBZ O
present JJ O
in IN O
all DT O
FIV NNP O
isolates NNS O
. . O

-DOCSTART- X X O

The DT O
patient NN O
was VBD O
homozygous JJ O
for IN O
the DT O
underlying JJ O
mutation NN O
, , O
which WDT O
was VBD O
found VBN O
to TO O
be VB O
a DT O
G-->T JJ O
transversion NN O
within IN O
the DT O
acceptor NN O
splice NN O
site NN O
between IN O
intron NN O
e NN O
and CC O
exon NN O
6 CD O
, , O
abolishing NN O
normal JJ O
RNA NNP O
splicing NN O
. . O

-DOCSTART- X X O

These DT O
regions NNS O
overlap VBP O
with IN O
the DT O
HIT NNP B-NP
protein NN I-NP
similarity NN I-NP
regions NNS I-NP
. . O

-DOCSTART- X X O

We PRP O
tested VBD O
10 CD O
rats NNS O
with IN O
electrophysiologically RB O
guided VBN O
, , O
ibotenic JJ O
acid NN O
lesions NNS O
of IN O
the DT O
PBN NNP O
( -LRB- O
PBNx NN O
) -RRB- O
to TO O
determine VB O
whether IN O
they PRP O
could MD O
acquire VB O
a DT O
LiCl-induced JJ O
CTA NNP O
to TO O
l-alanine VB O
( -LRB- O
0.3 CD O
M NNP O
) -RRB- O
or CC O
demonstrate VB O
a DT O
sodium NN O
appetite NN O
following VBG O
furosemide JJ O
treatment NN O
and CC O
overnight JJ O
access NN O
to TO O
sodium NN O
deficient NN O
chow NN O
. . O

-DOCSTART- X X O

Liposomal NNP O
Amphotericin-B NNP O
failed VBD O
in IN O
6/7 CD O
patients NNS O
with IN O
culture-proven JJ O
mycosis NN O
who WP O
died VBD O
from IN O
infection NN O
with IN O
Aspergillus DT O
( -LRB- O
n NN O
= SYM O
2 CD O
) -RRB- O
and CC O
Candida NNP O
( -LRB- O
n NN O
= SYM O
4) CD O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Mg2+ NNP O
and CC O
Mn2+ NNP O
compete VBP O
for IN O
binding JJ O
sites NNS O
, , O
with IN O
the DT O
former JJ O
having VBG O
lower JJR O
affinity NN O
. . O

-DOCSTART- X X O

Magnetic JJ O
storm NN O
indicators NNS O
could MD O
be VB O
used VBN O
in IN O
medicine NN O
, , O
in IN O
geophysics NNS O
and CC O
for IN O
special JJ O
purposes NNS O
. . O

-DOCSTART- X X O

Transgenic JJ O
tobacco NN O
plants NNS O
( -LRB- O
ppa-1 NN B-NP
) -RRB- O
constitutively RB O
expressing VBG O
Escherichia NNP B-NP
coli NNS I-NP
pyrophosphatase NN I-NP
behind IN O
the DT O
35S NNP B-NP
CaMV NNP I-NP
promoter NN I-NP
accumulate VBP O
high JJ O
levels NNS O
of IN O
soluble JJ O
sugars NNS O
in IN O
their PRP$ O
leaves NNS O
[27] VBD O
. . O

-DOCSTART- X X O

Human JJ B-NP
LAF-4 NN I-NP
readily RB O
hybridized VBN O
with IN O
genes NNS O
in IN O
mouse NN O
and CC O
chicken NN O
, , O
thus RB O
showing VBG O
that IN O
this DT O
gene NN O
family NN O
has VBZ O
been VBN O
highly RB O
conserved VBN O
during IN O
vertebrate JJ O
evolution NN O
. . O

-DOCSTART- X X O

CBT NNP O
is VBZ O
discussed VBN O
in IN O
comparison NN O
with IN O
the DT O
Wisconsin NNP O
Card NNP O
Sorting NNP O
Test NNP O
as IN O
a DT O
potential JJ O
cognitive NN O
activation NN O
task NN O
for IN O
functional JJ O
neuroimaging NN O
of IN O
the DT O
frontal JJ O
lobes NNS O
. . O

-DOCSTART- X X O

These DT O
data NNS O
indicate VBP O
that IN O
although IN O
218leu PRP O
retains VBZ O
normal JJ O
transactivation NN O
activity NN O
on IN O
a DT O
p53 NN B-NP
promoter NN I-NP
in IN O
yeast NN O
at IN O
physiological JJ O
temperatures NNS O
, , O
it PRP O
is VBZ O
not RB O
capable JJ O
of IN O
normal JJ O
p53 NN B-NP
function NN O
in IN O
the DT O
presence NN O
of IN O
a DT O
248trp JJ B-NP
allele NN I-NP
in IN O
SNU-C5 DT O
cells NNS O
. . O

-DOCSTART- X X O

Cycles NNS O
were VBD O
repeated VBN O
every DT O
3 CD O
weeks NNS O
. . O

-DOCSTART- X X O

Neither DT O
class NN O
II NNP O
nor CC O
IV NNP O
infections NNS O
precluded VBD O
transplantation NN O
. . O

-DOCSTART- X X O

Although IN O
a DT O
great JJ O
deal NN O
is VBZ O
understood VBN O
about IN O
how WRB O
bHLH JJ B-NP
factors NNS I-NP
activate JJ O
gene NN O
transcription NN O
via IN O
E-box NNP O
DNA NNP O
consensus NN O
sequences NNS O
, , O
studies NNS O
of IN O
bHLH DT B-NP
factor NN I-NP
function NN O
in IN O
higher JJR O
eukaryotes NNS O
often RB O
have VBP O
been VBN O
hindered VBN O
by IN O
the DT O
presence NN O
of IN O
multiple JJ O
family NN O
members NNS O
. . O

-DOCSTART- X X O

Mobility NN O
and CC O
supershift NN O
assays VBZ O
demonstrated VBN O
that IN O
upstream RB B-NP
stimulatory JJ I-NP
factor NN I-NP
( -LRB- O
USF NNP B-NP
) -RRB- O
and CC O
Sp1 NNP B-NP
bind NN O
to TO O
the DT O
former JJ O
elements NNS O
and CC O
competition NN O
experiments NNS O
confirmed VBD O
that IN O
CREB/ATF NNP B-NP
and CC O
AP-1 NNP B-NP
bind NN O
to TO O
the DT O
CRE/TRE NNP O
element NN O
. . O

-DOCSTART- X X O

Upstream NNP O
of IN O
-37 CD O
, , O
the DT O
5' JJ O
untranslated JJ O
sequences NNS O
of IN O
the DT O
isolates NNS O
differ VBP O
in IN O
both DT O
length NN O
and CC O
sequence NN O
. . O

-DOCSTART- X X O

In IN O
these DT O
cases NNS O
, , O
greatly RB O
increased VBN O
human JJ B-NP
chorionic NN I-NP
gonadotropin IN I-NP
(hCG) JJ O
levels NNS O
and CC O
suppressed VBN O
TSH NNS B-NP
levels NNS O
suggest VBP O
that IN O
hCG NN B-NP
has VBZ O
thyrotropic JJ O
activity NN O
. . O

-DOCSTART- X X O

High NNP O
fibrinogen NN B-NP
levels NNS O
could MD O
thus RB O
be VB O
a DT O
risk NN O
for IN O
perioperative JJ O
thrombosis NN O
. . O

-DOCSTART- X X O

Strontium NN O
chloride NN O
Sr NN O
89 CD O
is VBZ O
costly JJ O
, , O
but CC O
preliminary JJ O
analysis NN O
indicates VBZ O
that IN O
it PRP O
may MD O
reduce VB O
management NN O
expenditures NNS O
overall JJ O
.(ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
250 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

This DT O
study NN O
determined VBD O
the DT O
arthritogenic JJ O
potential NN O
of IN O
silicone NN O
gel NN O
by IN O
either DT O
mixing VBG O
it PRP O
with IN O
bovine JJ B-NP
collagen NN I-NP
II NNP I-NP
( -LRB- O
BII NNP B-NP
) -RRB- O
or CC O
by IN O
injecting VBG O
silicone NN O
gel NN O
alone RB O
in IN O
DA NNP O
rats NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
it PRP O
remains VBZ O
an DT O
open JJ O
question NN O
whether IN O
vertebrate JJ B-NP
Hox NNP I-NP
genes NNS I-NP
expressed VBN O
under IN O
the DT O
control NN O
of IN O
Drosophila NNP O
regulatory JJ O
sequences NNS O
can MD O
substitute VB O
the DT O
function NN O
of IN O
Drosophila NNP B-NP
Hox NNP I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

We PRP O
propose VBP O
that IN O
CTS1 NNP B-NP
and CC I-NP
CTS2 NNP I-NP
of IN I-NP
Ci NNP I-NP
are VBP O
members NNS O
of IN O
two CD O
distinct JJ O
classes NNS O
of IN O
fungal JJ B-NP
chitinases NNS I-NP
, , O
an DT O
observation NN O
not RB O
previously RB O
reported VBN O
for IN O
a DT O
single JJ O
fungus NN O
. . O

-DOCSTART- X X O

Although IN O
the DT O
consumption NN O
of IN O
myoglobin-bound JJ B-NP
O2 NNP O
( -LRB- O
MbO2 NNP O
) -RRB- O
stores NNS O
in IN O
seal NN O
muscles NNS O
has VBZ O
been VBN O
demonstrated VBN O
in IN O
seal NN O
muscles NNS O
during IN O
laboratory NN O
simulations NNS O
of IN O
diving NN O
, , O
this DT O
may MD O
not RB O
be VB O
a DT O
feature NN O
of IN O
normal JJ O
field NN O
diving NN O
in IN O
which WDT O
measurements NNS O
of IN O
heart NN O
rate NN O
and CC O
lactate NN O
production NN O
show NN O
marked VBD O
differences NNS O
from IN O
the DT O
profound JJ O
diving JJ O
response NN O
induced VBN O
by IN O
forced JJ O
immersion NN O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
purH NN I-NP
cDNA NN I-NP
is VBZ O
1776 CD O
base NN O
pairs NNS O
in IN O
length NN O
encoding VBZ O
for IN O
a DT O
591-amino JJ O
acid NN O
polypeptic NN O
( -LRB- O
Mr NNP O
= SYM O
64,425 CD O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
our PRP$ O
opinion NN O
, , O
the DT O
SM-CMA NNP O
system NN O
is VBZ O
, , O
despite IN O
some DT O
shortcomings NNS O
in IN O
its PRP$ O
user-interface NN O
, , O
a DT O
useful JJ O
and CC O
versatile JJ O
instrument NN O
for IN O
examination NN O
of IN O
human JJ O
semen NNS O
samples NNS O
, , O
with IN O
desirable JJ O
features NNS O
. . O

-DOCSTART- X X O

The DT O
purpose NN O
of IN O
the DT O
study NN O
reported VBD O
here RB O
was VBD O
to TO O
investigate VB O
whether IN O
differences NNS O
in IN O
T1 NNP O
and CC O
T2 NNP O
between IN O
tumors NNS O
are VBP O
mainly RB O
a DT O
consequence NN O
of IN O
differences NNS O
in IN O
the DT O
fractional JJ O
volume NN O
of IN O
the DT O
extracellular JJ O
compartment NN O
. . O

-DOCSTART- X X O

Oligonucleotides NNS O
, , O
designed VBN O
on IN O
the DT O
basis NN O
of IN O
conserved JJ O
flanking NN O
amino IN O
acid JJ O
sequence NN O
segments NNS O
within IN O
the DT O
catalytic JJ O
domain NN O
of IN O
eukaryotic JJ B-NP
protein NN I-NP
kinase NN I-NP
C NNP I-NP
( -LRB- O
PKC NNP B-NP
) -RRB- O
proteins VBZ O
, , O
were VBD O
used VBN O
as IN O
primers NNS O
for IN O
polymerase NN O
chain NN O
reactions NNS O
to TO O
amplify VB O
a DT O
427-bp JJ O
chromosomal NN O
DNA NN O
fragment NN O
from IN O
the DT O
filamentous JJ O
fungus NN O
Trichoderma NNP O
reesei NNP O
. . O

-DOCSTART- X X O

This DT O
region NN O
contains VBZ O
a DT O
motif NN O
with IN O
partial JJ O
identity NN O
with IN O
the DT O
binding JJ O
site NN O
for IN O
the DT O
ubiquitous JJ O
transcription NN O
factor NN O
upstream RB B-NP
stimulatory JJ I-NP
factor NN I-NP
( -LRB- O
USF) NNP B-NP
, , O
which WDT O
binds VBZ O
to TO O
the DT O
human JJ B-NP
insulin NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

The DT O
method NN O
has VBZ O
been VBN O
satisfactorily RB O
applied VBN O
to TO O
the DT O
determination NN O
of IN O
paracetamol NN O
in IN O
pharmaceutical JJ O
formulations NNS O
and CC O
biological JJ O
fluids NNS O
. . O

-DOCSTART- X X O

The DT O
Clb5 NNP B-NP
kinase NN I-NP
, , O
which WDT O
promotes VBZ O
S NNP O
phase NN O
, , O
remains VBZ O
active JJ O
during IN O
the DT O
G2-phase JJ O
arrest NN O
of IN O
cells NNS O
of IN O
the DT O
parental JJ O
strain NN O
, , O
but CC O
its PRP$ O
activity NN O
declines VBZ O
rapidly RB O
in IN O
sim JJ B-NP
mutants NNS I-NP
. . O

-DOCSTART- X X O

Rad6 NNP B-NP
mutants NNS I-NP
display VBP O
a DT O
remarkably RB O
pleiotropic JJ O
phenotype NN O
, , O
implicating VBG O
the DT O
protein NN O
in IN O
DNA NN O
damage-induced VBN O
mutagenesis NN O
, , O
postreplication NN O
repair NN O
, , O
repression NN O
of IN O
retrotransposition NN O
, , O
and CC O
sporulation NN O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
the DT O
molecular JJ O
cloning NN O
and CC O
functional JJ O
characterization NN O
of IN O
USF2 NNP B-NP
isoforms VBZ I-NP
, , O
corresponding JJ O
to TO O
a DT O
44-kDa JJ O
subunit NN O
, , O
USF2a NNP B-NP
, , O
and CC O
a DT O
new JJ O
38-kDa JJ O
subunit NN O
, , O
USF2b NNP B-NP
, , O
generated VBN O
by IN O
differential JJ O
splicing NN O
. . O

-DOCSTART- X X O

The DT O
preferential JJ O
heterodimerization NN O
of IN O
USF NNP B-NP
subunits NNS I-NP
was VBD O
reproduced VBN O
ex NN O
vivo RB O
, , O
while IN O
the DT O
in IN O
vitro NN O
association NN O
of IN O
cotranslated JJ O
subunits NNS O
, , O
or CC O
recombinant JJ B-NP
USF NNP I-NP
proteins VBZ I-NP
, , O
appeared VBD O
to TO O
be VB O
random JJ O
. . O

-DOCSTART- X X O

GRP78 CD B-NP
, , O
a DT O
molecular JJ O
chaperone NN O
expressed VBN O
in IN O
the DT O
endoplasmic JJ O
reticulum NN O
, , O
is VBZ O
a DT O
"glucose-regulated JJ O
protein NN O
" '' O
induced VBN O
by IN O
stress NN O
responses NNS O
that IN O
deplete JJ O
glucose NN O
or CC O
intracisternal JJ O
calcium NN O
or CC O
otherwise RB O
disrupt VB O
glycoprotein NN O
trafficking NN O
. . O

-DOCSTART- X X O

To TO O
elucidate VB O
the DT O
functional JJ O
significance NN O
of IN O
Fyn NNP B-NP
in IN O
the DT O
expression NN O
of IN O
viral JJ O
promoters NNS O
, , O
we PRP O
transfected VBD O
a DT O
Fyn-expression NN B-NP
vector NN O
together RB O
with IN O
a DT O
reporter NN O
plasmid NN O
containing VBG O
the DT O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
gene NN I-NP
driven VBN O
by IN O
HIV NNP B-NP
LTR NNP I-NP
into IN O
a DT O
human JJ O
T NNP O
cell NN O
line NN O
, , O
Jurkat NNP O
. . O

-DOCSTART- X X O

We PRP O
conducted VBD O
a DT O
prospective JJ O
, , O
randomized VBN O
controlled VBN O
trial NN O
of IN O
metoprolol NN O
, , O
a DT O
selective JJ O
beta-blocker NN O
for IN O
prevention NN O
of IN O
gastrointestinal JJ O
bleeding NN O
from IN O
portal JJ O
hypertension NN O
in IN O
29 CD O
non-selected JJ O
patients NNS O
with IN O
liver NN O
disease NN O
and CC O
previous JJ O
gastrointestinal JJ O
bleeding NN O
. . O

-DOCSTART- X X O

A DT O
genetic JJ O
and CC O
molecular JJ O
analysis NN O
of IN O
non-inducible JJ O
qutA NN B-NP
mutants NNS I-NP
showed VBD O
that IN O
all DT O
23 CD O
mutations NNS O
analysed CC O
map NN O
within IN O
the DT O
N-terminal JJ O
half NN O
of IN O
the DT O
encoded VBN O
QUTA NNP B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

These DT O
studies NNS O
indicate VBP O
that IN O
the DT O
acidimetric JJ O
test NN O
was VBD O
less RBR O
sensitive JJ O
than IN O
the DT O
chromogenic NN O
cephalosporin NN O
substrates NNS O
and CC O
that DT O
nitrocefin NN O
and CC O
S1 NNP O
could MD O
be VB O
used VBN O
to TO O
screen VB O
for IN O
beta-lactamase JJ B-NP
production NN O
in IN O
these DT O
tested JJ O
species NNS O
. . O

-DOCSTART- X X O

Suppressors NNS O
of IN O
defective JJ O
silencing NN O
in IN O
yeast NN O
: : O
effects NNS O
on IN O
transcriptional JJ O
repression NN O
at IN O
the DT O
HMR NNP B-NP
locus NN I-NP
, , O
cell NN O
growth NN O
and CC O
telomere JJ O
structure NN O
. . O

-DOCSTART- X X O

Although IN O
ANP NNP B-NP
induced VBD O
systemic JJ O
capillary NN O
filtration NN O
, , O
in IN O
the DT O
calf NN O
, , O
filtration NN O
was VBD O
reduced VBN O
with IN O
ANP. NNP B-NP

-DOCSTART- X X O

With IN O
current JJ O
methodology NN O
beta-2 NN B-NP
transferrin NN I-NP
does VBZ O
not RB O
appear VB O
to TO O
be VB O
a DT O
reliable JJ O
clinical JJ O
marker NN O
for IN O
perilymph NN O
in IN O
the DT O
operative JJ O
setting NN O
. . O

-DOCSTART- X X O

The DT O
hIGF-I JJ B-NP
gene NN I-NP
has VBZ O
two CD O
promoters NNS O
, , O
P1 NNP O
and CC O
P2 NNP O
. . O

-DOCSTART- X X O

Gel NNP O
mobility NN O
shift NN O
assays VBZ O
indicated VBN O
that IN O
at IN O
least JJS O
four CD O
nuclear JJ O
proteins NNS O
with IN O
distinct JJ O
biochemical JJ O
and CC O
binding JJ O
properties NNS O
possess VBP O
the DT O
ability NN O
to TO O
bind NN O
the DT O
3 CD O
beta JJ O
I-A NNP O
element NN O
to TO O
produce VB O
four CD O
DNA-protein JJ O
complexes NNS O
( -LRB- O
R1 CD O
to TO O
R4 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Sixty-five CD O
patients NNS O
( -LRB- O
aged VBN O
between IN O
3 CD O
years NNS O
5 CD O
months NNS O
and CC O
60 CD O
years NNS O
) -RRB- O
suffering VBG O
from IN O
medically RB O
resistant JJ O
temporal JJ O
lobe NN O
epilepsy NN O
( -LRB- O
TLE NN O
) -RRB- O
were VBD O
operated VBN O
on IN O
over IN O
a DT O
period NN O
of IN O
33 CD O
months NNS O
in IN O
Bethel NNP O
Epilepsy NNP O
Center NNP O
. . O

-DOCSTART- X X O

Significant NNP O
correlations NNS O
existed VBD O
between IN O
FEV1 NNP O
and CC O
the DT O
corresponding JJ O
values NNS O
of IN O
Raw NNP O
, , O
MEF50 NNP O
and CC O
MEF25 NNP O
, , O
although IN O
there EX O
were VBD O
considerable JJ O
individual JJ O
differences NNS O
between IN O
test NN O
results NNS O
. . O

-DOCSTART- X X O

This DT O
region NN O
also RB O
contains VBZ O
a DT O
gene NN O
specifying VBG O
a DT O
Leu-tRNA NNP B-NP
precursor NN I-NP
and CC O
a DT O
remnant NN O
of IN O
a DT O
tau JJ O
element NN O
. . O

-DOCSTART- X X O

Occupational JJ O
exposure NN O
to TO O
hepatitis NN O
B NNP O
virus NN O
and CC O
human JJ O
immunodeficiency NN O
virus NN O
: : O
a DT O
comparative JJ O
risk NN O
analysis NN O
. . O

-DOCSTART- X X O

Hybrid NNP O
female NN O
mice NNS O
( -LRB- O
C57BL NN O
x NN O
CBA NNP O
) -RRB- O
were VBD O
paired VBN O
with IN O
breeder NN O
males NNS O
( -LRB- O
CD-1 NN O
) -RRB- O
and CC O
LNG NNP O
pellets NNS O
were VBD O
implanted VBN O
on IN O
day NN O
0, IN O
the DT O
day NN O
on IN O
which WDT O
copulation NN O
plugs NNS O
were VBD O
found VBN O
, , O
or CC O
on IN O
day NN O
2 CD O
or CC O
day NN O
3 CD O
in IN O
the DT O
postcoital JJ O
period NN O
. . O

-DOCSTART- X X O

Studies NNS O
on IN O
the DT O
life NN O
cycle NN O
of IN O
Haplorchis NNP O
pumilio NN O
( -LRB- O
Looss NNP O
, , O
1896 CD O
) -RRB- O
Looss NNP O
, , O
1899 CD O
with IN O
morphological JJ O
redescription NN O
of IN O
larval JJ O
and CC O
adult JJ O
stages NNS O
. . O

-DOCSTART- X X O

Regressing VBG O
microaneurysms NNS O
in IN O
5 CD O
cases NNS O
of IN O
hepatitis NN O
B NNP O
virus NN O
related VBD O
polyarteritis NN O
nodosa NN O
. . O

-DOCSTART- X X O

A DT O
3-week JJ O
regimen NNS O
of IN O
erythropoietin NN B-NP
may MD O
help VB O
prevent VB O
the DT O
donor NN O
's POS O
need NN O
to TO O
receive VB O
allogeneic DT O
blood NN O
transfusion NN O
, , O
when WRB O
the DT O
initial JJ O
Hb NN B-NP
levels NNS O
were VBD O
below RB O
130 CD O
milligrams NNS O
. . O

-DOCSTART- X X O

Its PRP$ O
organization NN O
and CC O
regulation NN O
indicate VBP O
that IN O
the DT O
S. NNP B-NP
pombe NN I-NP
URA1 NNP I-NP
gene NN I-NP
product NN I-NP
appears VBZ O
very RB O
similar JJ O
to TO O
the DT O
S. NNP B-NP
cerevisiae NN I-NP
URA2 NNP I-NP
gene NN I-NP
product NN I-NP
. . O

-DOCSTART- X X O

These DT O
findings NNS O
demonstrate VBP O
that IN O
haemodialysis NN O
patients NNS O
with IN O
chronic JJ O
hepatitis NN O
C NNP O
respond NN O
well RB O
to TO O
interferon NN B-NP
treatment NN O
and CC O
that IN O
a DT O
long-term JJ O
response NN O
is VBZ O
achieved VBN O
in IN O
a DT O
high JJ O
proportion NN O
of IN O
patients NNS O
. . O

-DOCSTART- X X O

Synthetic JJ O
enantiomers NNS O
of IN O
drugs NNS O

-DOCSTART- X X O

Polysome JJ O
analysis NN O
further RB O
indicated VBD O
that IN O
these DT O
germ NN B-NP
cell-specific JJ I-NP
Sp1 NNP I-NP
mRNAs NNS I-NP
are VBP O
translated VBN O
, , O
albeit IN O
with IN O
a DT O
lower JJR O
efficiency NN O
than IN O
the DT O
somatic JJ O
transcript NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
proposes VBZ O
an DT O
estimator NN O
for IN O
such JJ O
global JJ O
synchronizing JJ O
effects NNS O
upon IN O
unit-pair NN O
correlations NNS O
based VBN O
on IN O
local JJ O
field NN O
potentials NNS O
( -LRB- O
LFPs NNS O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
DNA NNP O
sequences NNS O
upstream RB O
of IN O
these DT O
termini NNS O
exhibit VBP O
homology NN O
to TO O
plant NN O
mitochondrial-processing NN O
sites NNS O
, , O
therefore RB O
the DT O
proximal JJ O
5' JJ O
ends NNS O
are VBP O
most RBS O
probably RB O
generated VBN O
by IN O
RNA NNP O
processing NN O
. . O

-DOCSTART- X X O

Curing VBG O
shrinkage NN O
and CC O
volumetric JJ O
changes NNS O
of IN O
resin-modified JJ O
glass NN O
ionomer NN O
restorative NN O
materials NNS O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
repeated VBN O
exposures NNS O
of IN O
hydrogen NN O
sulphide NN O
on IN O
rat NN O
hippocampal NN O
EEG. . O

-DOCSTART- X X O

The DT O
gene NN O
encodes VBZ O
an DT O
ATP-binding JJ B-NP
cassette NN I-NP
, , O
ABC NNP B-NP
transporter NN I-NP
. . O

-DOCSTART- X X O

The DT O
T-box NNP O
motif NN O
is VBZ O
present JJ O
in IN O
a DT O
family NN O
of IN O
genes NNS O
whose WP$ O
structural JJ O
features NNS O
and CC O
expression NN O
patterns NNS O
support VBP O
their PRP$ O
involvement NN O
in IN O
developmental JJ O
gene NN O
regulation NN O
. . O

-DOCSTART- X X O

Do VB O
overall JJ O
treatment NN O
time NN O
, , O
field NN O
size NN O
, , O
and CC O
treatment NN O
energy NN O
influence NN O
local JJ O
control NN O
of IN O
T1-T2 DT O
squamous JJ O
cell NN O
carcinomas NNS O
of IN O
the DT O
glottic JJ O
larynx NN O
? . O
PURPOSE . O
: : O
To TO O
evaluate VB O
treatment NN O
and CC O
patient NN O
related VBN O
prognostic JJ O
factors NNS O
that WDT O
may MD O
influence VB O
local JJ O
control NN O
in IN O
the DT O
treatment NN O
of IN O
T1-T2 DT O
squamous JJ O
cell NN O
carcinoma NN O
of IN O
the DT O
glottic JJ O
larynx NN O
. . O

-DOCSTART- X X O

Mutations NNS O
in IN O
the DT O
alpha-amanitin NN B-NP
conserved VBD O
domain NN O
of IN O
the DT O
largest JJS O
subunit NN O
of IN O
yeast NN B-NP
RNA NNP I-NP
polymerase NN I-NP
III NNP I-NP
affect VBP O
pausing VBG O
, , O
RNA NNP O
cleavage NN O
and CC O
transcriptional JJ O
transitions NNS O
. . O

-DOCSTART- X X O

The DT O
evidence NN O
presented VBD O
here RB O
suggests VBZ O
that IN O
the DT O
p40 NN B-NP
complex NN I-NP
is VBZ O
a DT O
ribonucleoprotein NN O
complex NN O
containing VBG O
L1Hs JJ B-NP
RNA( JJ I-NP
s PRP I-NP
) -RRB- I-NP
and CC O
that DT O
protein-protein NN O
interactions NNS O
in IN O
which WDT O
alpha-helix NN O
structures NNS O
participate VBP O
, , O
for IN O
example NN O
coiled-coils NNS O
, , O
may MD O
occur VB O
in IN O
the DT O
complex NN O
. . O

-DOCSTART- X X O

The DT O
5' JJ O
external JJ O
transcribed NN O
spacer NN O
( -LRB- O
ETS NNP O
) -RRB- O
region NN O
of IN O
the DT O
pre-rRNA JJ O
in IN O
Saccharomyces NNP O
cerevisiae NN O
contains VBZ O
a DT O
sequence NN O
with IN O
10 CD O
bp NN O
of IN O
perfect JJ O
complementarity NN O
to TO O
the DT O
U3 JJ B-NP
snoRNA NN I-NP
. . O

-DOCSTART- X X O

These DT O
animals NNS O
were VBD O
viable JJ O
and CC O
fertile JJ O
. . O

-DOCSTART- X X O

This DT O
spindle NN O
defect NN O
of IN O
pds1 DT B-NP
mutants NNS I-NP
results NNS O
from IN O
a DT O
temperature-sensitive JJ O
step NN O
that WDT O
occurs VBZ O
around IN O
the DT O
G1/S NNP O
boundary NN O
about IN O
the DT O
time NN O
of IN O
spindle NN O
assembly NN O
. . O

-DOCSTART- X X O

However RB O
, , O
for IN O
the DT O
evaluable JJ O
cases NNS O
, , O
the DT O
performances NNS O
of IN O
the DT O
CD3500 NN O
and CC O
the DT O
STKS NNS O
were VBD O
broadly RB O
similar JJ O
and CC O
generally RB O
correlated VBN O
well RB O
with IN O
the DT O
manual JJ O
reference NN O
procedure NN O
. . O

-DOCSTART- X X O

Both DT O
EWS-FLI-1 NNP B-NP
and CC O
FLI-1 JJ B-NP
proteins NNS I-NP
function VBP O
as IN O
transcription NN O
factors NNS O
that WDT O
bind VBP O
specifically RB O
to TO O
ets NNS B-NP
sequences NNS O
( -LRB- O
the DT O
ets NNS B-NP
boxes NNS O
) -RRB- O
present JJ O
in IN O
promoter NN O
elements NNS O
. . O

-DOCSTART- X X O

Additional JJ O
studies NNS O
with IN O
new JJ O
and CC O
reprocessed JJ O
regenerated JJ O
cellulose NN O
dialyzers NNS O
comparing VBG O
450 CD O
and CC O
220 CD O
mL/min NN O
blood NN O
flow NN O
rates NNS O
at IN O
10 CD O
minutes NNS O
showed VBD O
no DT O
change NN O
in IN O
BTG. NNP O

-DOCSTART- X X O

DNA NNP O
methylation NN O
, , O
especially RB O
of IN O
either DT O
one CD O
or CC O
both DT O
of IN O
the DT O
deoxyadenosines NNS O
at IN O
the DT O
two CD O
GATC NNP O
motifs FW O
( -LRB- O
one NN O
in IN O
the DT O
first JJ O
exon NN O
and CC O
the DT O
other JJ O
in IN O
the DT O
first JJ O
intron NN O
of IN O
the DT O
rice NN O
CatA NNP B-NP
gene NN I-NP
) -RRB- O
, , O
appeared VBD O
to TO O
be VB O
responsible JJ O
for IN O
the DT O
CatA NNP B-NP
promoter NN I-NP
activity NN O
identified VBD O
in IN O
the DT O
transient NN O
assay NN O
. . O

-DOCSTART- X X O

Overlapping VBG O
cDNA NN O
clones NNS O
were VBD O
isolated VBN O
and CC O
sequenced VBN O
. . O

-DOCSTART- X X O

Epitope NNP O
mapping NN O
revealed VBD O
that IN O
these DT O
three CD O
clones NNS O
appear VBP O
to TO O
recognize VB O
an DT O
identical JJ O
epitope NN O
domain NN O
present NN O
on IN O
the DT O
C-terminal JJ O
RNP NNP O
motif NN O
of IN O
the DT O
U1A JJ B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Variables NNS O
evaluated VBN O
were VBD O
number NN O
of IN O
weekly JJ O
anginal JJ O
events NNS O
, , O
data NNS O
from IN O
ergometric JJ O
exercise NN O
testing NN O
with IN O
simultaneous JJ O
electrocardiographic JJ O
registration NN O
, , O
semiquantitative JJ O
evaluation NN O
of IN O
Tc-99m JJ O
2-methoxy JJ O
isobutyl NN O
isonitrile VBP O
( -LRB- O
MIBI NN O
) -RRB- O
scans NNS O
and CC O
rheologic NN O
variables NNS O
. . O

-DOCSTART- X X O

As IN O
the DT O
length NN O
of IN O
the DT O
fatty JJ O
acid NN O
decreased VBD O
, , O
the DT O
binding NN O
affinity NN O
was VBD O
reduced VBN O
; : O
myristic JJ O
acid NN O
( -LRB- O
14:0 CD O
) -RRB- O
bound VBN O
with IN O
a DT O
K(d NNP O
) -RRB- O
of IN O
1409 CD O
+/ NNS O
- : O
423 CD O
nM NN O
, , O
but CC O
medium-chain JJ O
( -LRB- O
decanoic JJ O
acid NN O
, , O
10:0 CD O
) -RRB- O
and CC O
short-chain JJ O
(octanoic JJ O
acid NN O
, , O
8:0 CD O
) -RRB- O
lipids NNS O
were VBD O
not RB O
bound VBN O
at IN O
all DT O
. . O

-DOCSTART- X X O

The DT O
membrane-distal JJ O
cytoplasmic JJ O
region NN O
of IN O
human JJ B-NP
granulocyte NN I-NP
colony-stimulating NN I-NP
factor NN I-NP
receptor NN I-NP
is VBZ O
required VBN O
for IN O
STAT3 NNS B-NP
but CC O
not RB O
STAT1 NNP B-NP
homodimer NN I-NP
formation NN O
. . O

-DOCSTART- X X O

Although IN O
some DT O
residues NNS O
are VBP O
found VBN O
reactive NN O
toward IN O
dimethylsulphate NN O
and CC O
kethoxal NN O
in IN O
regions NNS O
predicted VBD O
to TO O
be VB O
unpaired JJ O
by IN O
the DT O
phylogenetic JJ O
secondary JJ O
structure NN O
model NN O
of IN O
4.5S CD B-NP
RNA NN I-NP
, , O
generally RB O
the DT O
reactivity NN O
is VBZ O
low JJ O
, , O
and CC O
some DT O
residues NNS O
in IN O
internal JJ O
loops NNS O
are VBP O
not RB O
reactive VB O
at IN O
all DT O
. . O

-DOCSTART- X X O

The DT O
alpha NN O
T3-1 JJ O
cell NN O
line NN O
, , O
a DT O
GnRH-responsive JJ B-NP
gonadotroph NN O
cell NN O
line NN O
developed VBN O
by IN O
targeted JJ O
oncogenesis NN O
in IN O
transgenic JJ O
mice NNS O
, , O
was VBD O
used VBN O
to TO O
study VB O
regulation NN O
of IN O
the DT O
glycoprotein NN B-NP
hormone NN I-NP
alpha-subunit NN I-NP
by IN O
activin NN B-NP
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
posteroventral JJ O
pallidotomy NN O
on IN O
Parkinson NNP O
's POS O
disease NN O
. . O

-DOCSTART- X X O

However RB O
, , O
only RB O
complete JJ B-NP
DnaJ NN I-NP
can MD O
cooperate VB O
with IN O
DnaK NNP B-NP
and CC O
a DT O
third JJ O
protein NN O
, , O
GrpE NNP B-NP
, , O
in IN O
refolding VBG O
denatured VBN B-NP
firefly RB I-NP
luciferase NN I-NP
. . O

-DOCSTART- X X O

TNF NNP B-NP
Treatment NNP O
of IN O
cell NN O
activated VBN O
the DT O
p38 NNS B-NP
MAP NNP I-NP
kinase NN I-NP
pathway NN O
, , O
as IN O
revealed VBN O
by IN O
increased VBN O
phosphorylation NN O
of IN O
p38 DT B-NP
MAP NNP I-NP
kinase NN I-NP
itself PRP O
, , O
activation NN O
of IN O
the DT O
substrate JJ O
protein NN O
MAPKAP NNP B-NP
kinase-2 NN I-NP
, , O
and CC O
culminating VBG O
in IN O
the DT O
phosphorylation NN O
of IN O
the DT O
heat NN B-NP
shock NN I-NP
protein NN I-NP
27 CD I-NP
( -LRB- O
hsp27 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
a DT O
novel JJ O
protein NN O
from IN O
Drosophila NNP O
nuclear JJ O
extracts NNS O
which WDT O
binds VBZ O
specifically RB O
to TO O
a DT O
site NN O
in IN O
this DT O
second JJ O
region NN O
. . O

-DOCSTART- X X O

DNase NN B-NP
I PRP I-NP
footprinting CD O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
assays VBZ O
indicate VB O
that IN O
PBP NNP B-NP
binds NNS O
to TO O
the DT O
half-site NN O
of IN O
each DT O
palindrome NN O
with IN O
the DT O
core NN O
recognition NN O
sequence NN O
TGGGAG. . O

-DOCSTART- X X O

These DT O
results NNS O
demonstrate VBP O
that IN O
sequences NNS O
in IN O
the DT O
SH2/SH3/SH2 NNP B-NP
region NN O
of IN O
p120 DT B-NP
GAP NNP B-NP
are VBP O
required VBN O
for IN O
full JJ O
catalytic JJ O
activity NN O
toward IN O
Ras NNP B-NP
. . O

-DOCSTART- X X O

The DT O
novel NN O
hematopoietic NN B-NP
growth NN I-NP
factor NN I-NP
FLT3 IN I-NP
ligand NN I-NP
( -LRB- O
FL NNP B-NP
) -RRB- O
is VBZ O
the DT O
cognate JJ O
ligand NN O
for IN O
the DT O
FLT3 NNP B-NP
, , O
tyrosine NN B-NP
kinase NN I-NP
receptor NN I-NP
( -LRB- O
R NN B-NP
) -RRB- O
, , O
also RB O
referred VBD O
to TO O
as IN O
FLK-2 JJ B-NP
and CC O
STK-1 JJ B-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
to TO O
the DT O
selective JJ O
expression NN O
of IN O
the DT O
receptor NN O
, , O
FL NNP B-NP
expression NN O
was VBD O
detected VBN O
in IN O
90-100 CD O
% NN O
of IN O
the DT O
various JJ O
cell NN O
types NNS O
of IN O
leukemia NN O
cell NN O
lines NNS O
from IN O
all DT O
hematopoietic JJ O
cell NN O
lineages NNS O
. . O

-DOCSTART- X X O

Further JJ O
analysis NN O
of IN O
this DT O
domain NN O
by IN O
in IN O
vitro NN O
mutagenesis NN O
pointed VBD O
to TO O
a DT O
core NN O
of IN O
hydrophobic JJ O
and CC O
acidic JJ O
residues NNS O
as IN O
critical JJ O
for IN O
the DT O
activity NN O
. . O

-DOCSTART- X X O

The DT O
neural JJ O
mechanism NN O
of IN O
parkinsonian JJ O
motor NN O
symptoms NNS O
, , O
i VBP O
.e NN O
. . O
, , O
rigidity NN O
, , O
tremor NN O
and CC O
akinesia NN O
, , O
which WDT O
are VBP O
the DT O
result NN O
of IN O
nigrostriatal NN O
dopamine NN O
deficiency NN O
, , O
is VBZ O
interpreted VBN O
from IN O
long-term JJ O
observations NNS O
on IN O
the DT O
effect NN O
of IN O
surgical JJ O
and CC O
pharmacological JJ O
treatment NN O
of IN O
the DT O
disease NN O
in IN O
relation NN O
to TO O
the DT O
neuropathological JJ O
findings NNS O
within IN O
the DT O
substantia NN O
nigra NN O
zona NN O
compacta NN O
( -LRB- O
SNc NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Protein NNP O
splicing NN O
: : O
evidence NN O
for IN O
an DT O
N-O NNP O
acyl NN O
rearrangement NN O
as IN O
the DT O
initial JJ O
step NN O
in IN O
the DT O
splicing NN O
process NN O
. . O

-DOCSTART- X X O

LY290181 NNP O
appears VBZ O
to TO O
inhibit VB O
uPA NNP B-NP
promoter NN I-NP
activation NN O
by IN O
blocking VBG O
phorbol NN O
ester-stimulated JJ O
binding NN O
of IN O
nuclear JJ O
proteins NNS O
to TO O
the DT O
uPA NNP B-NP
PEA3/12-0-tetradecanoylphorbol JJ B-NP
13-acetate JJ O
responsive JJ O
element NN O
( -LRB- O
TRE NN O
) -RRB- O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
keratinocytes NNS O
expressing VBG O
a DT O
normal JJ O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
receptor NN I-NP
( -LRB- O
EGFR NN B-NP
) -RRB- O
with IN O
TGFalpha NNP B-NP
or CC O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
for IN O
5 CD O
min NN O
induced VBN O
PKCdelta NNP B-NP
tyrosine FW O
phosphorylation NN O
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

Thus RB O
, , O
hGRbeta JJ B-NP
potentially RB O
functions NNS O
as IN O
a DT O
dominant JJ O
negative JJ O
inhibitor NN O
of IN O
hGRalpha NN B-NP
activity NN O
. . O

-DOCSTART- X X O

Gas6 NNP B-NP
contains VBZ O
an DT O
NH2-terminal JJ O
Gla NNP O
domain NN O
followed VBN O
by IN O
four CD O
epidermal JJ B-NP
growth NN I-NP
factor-like JJ I-NP
repeats NNS I-NP
and CC O
tandem NN O
globular JJ O
( -LRB- O
G NNP O
) -RRB- O
domains VBZ O
. . O

-DOCSTART- X X O

Both DT O
P5CDh NNP B-NP
cDNA NN I-NP
clones NNS O
detect VBP O
a DT O
single JJ O
3.2-kb JJ O
transcript NN O
on IN O
Northern JJ O
blots NNS O
of IN O
multiple JJ O
human JJ O
tissues NNS O
, , O
indicating VBG O
the DT O
long JJ O
cDNA NN O
containing VBG O
the DT O
3'-untranslated JJ O
intron NN O
represents VBZ O
the DT O
predominant JJ O
transcript NN O
. . O

-DOCSTART- X X O

Polymerization NN O
of IN O
neurofilament NN B-NP
L NNP I-NP
protein NN I-NP
in IN O
vitro NN O
was VBD O
inhibited VBN O
by IN O
phosphorylation NN O
of IN O
neurofilament NN B-NP
L NNP I-NP
protein NN I-NP
by IN O
PKN. NNP B-NP

-DOCSTART- X X O

The DT O
protein NN O
folds VBZ O
correctly RB O
with IN O
two CD O
disulfide JJ O
bonds NNS O
and CC O
a DT O
free JJ O
thiol NN O
group NN O
at IN O
Cys25 NNP O
. . O

-DOCSTART- X X O

We PRP O
and CC O
others NNS O
have VBP O
demonstrated VBN O
that IN O
the DT O
c-cbl JJ B-NP
proto-oncogene NN I-NP
product NN I-NP
is VBZ O
one CD O
of IN O
the DT O
earliest JJS O
targets NNS O
of IN O
tyrosine NN O
phosphorylation NN O
upon IN O
T NNP B-NP
cell NN I-NP
receptor NN I-NP
stimulation NN O
. . O

-DOCSTART- X X O

A DT O
substantial JJ O
fraction NN O
of IN O
Cbl NNP B-NP
was VBD O
constitutively RB O
associated VBN O
with IN O
Grb2 NNP B-NP
and CC O
this DT O
interaction NN O
was VBD O
mediated VBN O
by IN O
Grb2 NNP B-NP
SH3 NNP B-NP
domains VBZ O
. . O

-DOCSTART- X X O

An DT O
AP-1 NN B-NP
binding NN I-NP
sequence NN I-NP
is VBZ O
essential JJ O
for IN O
regulation NN O
of IN O
the DT O
human JJ B-NP
alpha2( NN I-NP
I PRP I-NP
) -RRB- I-NP
collagen NN I-NP
( -LRB- O
COL1A2 NN B-NP
) -RRB- O
promoter NN O
activity NN O
by IN O
transforming VBG B-NP
growth NN I-NP
factor-beta NN I-NP
. . O

-DOCSTART- X X O

The DT O
men NNS O
self-selected VBD O
a DT O
prescribed JJ O
diet NN O
at IN O
home NN O
emphasizing VBG O
saturated VBN O
fat JJ O
as IN O
the DT O
visible JJ O
fat JJ O
for IN O
1 CD O
week NN O
. . O

-DOCSTART- X X O

Conversely RB O
, , O
when WRB O
VDR NNP B-NP
is VBZ O
overexpressed VBN O
, , O
vitamin NN O
D3 IN O
attenuates NNS O
9-cis . O
RA NNP O
induction NN O
from IN O
an DT O
RXR-responsive JJ B-NP
element NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
illuminate VBP O
a DT O
hitherto VBD O
unanticipated JJ O
function NN O
of IN O
U6 NNP B-NP
RNA NNP I-NP
: : O
the DT O
modulation NN O
of IN O
a DT O
phosphorylation-dephosphorylation NN O
cycle NN O
of IN O
C1 NNP B-NP
hnRNP JJ I-NP
protein NN I-NP
that IN O
influences VBZ O
the DT O
binding JJ O
affinity NN O
of IN O
this DT O
protein NN O
for IN O
pre-mRNA JJ O
. . O

-DOCSTART- X X O

Electrophoretic NNP O
mobility NN O
shift NN O
assays IN O
( -LRB- O
EMSAs NN O
) -RRB- O
using VBG O
purified VBN O
glucocorticoid JJ B-NP
receptor NN I-NP
DNA NNP I-NP
binding NN I-NP
domain NN I-NP
( -LRB- O
DBD NNP O
) -RRB- O
demonstrated VBD O
that IN O
both DT O
GRE-2 JJ B-NP
and CC I-NP
-3 JJ I-NP
motifs NNS I-NP
interact NN O
with IN O
DBD NNP O
and CC O
oligonucleotide JJ O
competition NN O
experiments NNS O
established VBN O
that IN O
these DT O
have VBP O
different JJ O
affinities NNS O
for IN O
DBD. NNP O

-DOCSTART- X X O

The DT O
large JJ O
subfamily NN O
of IN O
receptor NN B-NP
tyrosine NN I-NP
kinases NNS I-NP
(RTKs NNS O
) -RRB- O
for IN O
which WDT O
EPH NNP B-NP
is VBZ O
the DT O
prototype NN O
have VBP O
likely JJ O
roles NNS O
in IN O
intercellular JJ O
communication NN O
during IN O
normal JJ O
mammalian JJ O
development NN O
, , O
but CC O
the DT O
biochemical JJ O
signalling NN O
pathways NNS O
utilised VBN O
by IN O
this DT O
family NN O
are VBP O
poorly RB O
characterised VBN O
. . O

-DOCSTART- X X O

The DT O
17-kDa JJ O
protein NN O
is VBZ O
required VBN O
for IN O
the DT O
systemic JJ O
infection NN O
of IN O
plants NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
cloned VBN O
and CC O
sequenced VBN O
a DT O
3574-bp JJ O
Bacillus NN O
subtilis NNS O
( -LRB- O
Bs NN O
) -RRB- O
DNA NN O
fragment NN O
located VBN O
between IN O
the DT O
nrdA NN B-NP
and CC O
citB NN B-NP
genes NNS I-NP
at IN O
about IN O
169 CD O
degrees NNS O
on IN O
the DT O
chromosome NN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
Msp NNP B-NP
was VBD O
toxic JJ O
to TO O
E. NNP O
coli NNS O
when WRB O
the DT O
entire JJ O
msp NN B-NP
gene NN I-NP
was VBD O
present JJ O
. . O

-DOCSTART- X X O

Lyn NNP B-NP
kinase NN I-NP
immunoprecipitated VBD O
from IN O
lysates NNS O
of IN O
irradiated JJ O
BCP NNP O
as RB O
well RB O
as IN O
a DT O
full-length JJ O
glutathione NN B-NP
S-transferase NN I-NP
( -LRB- O
GST)-Lyn JJ B-NP
fusion NN O
protein-phosphorylated JJ O
recombinant JJ B-NP
human JJ I-NP
p34cdc2 NN I-NP
on IN O
tyrosine NN O
15 CD O
. . O

-DOCSTART- X X O

Mutations NNS O
within IN O
conserved VBN O
region NN O
2 CD O
( -LRB- O
CR2 NN O
) -RRB- O
of IN O
E1A NNP B-NP
that IN O
inhibit VBP O
the DT O
binding NN O
of IN O
E1A NNP B-NP
to TO O
the DT O
retinoblastoma NN B-NP
gene NN I-NP
product NN I-NP
( -LRB- O
pRb NN B-NP
) -RRB- O
further RBR O
enhanced VBN O
the DT O
stimulation NN O
of IN O
transcription NN O
from IN O
the DT O
PEPCK NN B-NP
promoter NN I-NP
by IN O
2 CD O
3-fold JJ O
compared VBN O
with IN O
wild JJ B-NP
type NN I-NP
E1A. . I-NP

-DOCSTART- X X O

Using VBG O
autoantibodies NNS O
from IN O
a DT O
Sjogren NNP O
's POS O
syndrome NN O
patient NN O
, , O
we PRP O
have VBP O
previously RB O
identified VBN O
a DT O
230-kDa JJ O
peripheral JJ O
membrane NN O
protein NN O
associated VBN O
with IN O
the DT O
cytosolic JJ O
face NN O
of IN O
the DT O
trans-Golgi NN O
( -LRB- O
Kooy NNP O
, , O
J. NNP O
, , O
Toh NNP O
, , O
B. NNP O

-DOCSTART- X X O

Apart RB O
from IN O
two CD O
proline-rich JJ O
regions NNS O
(amino RB O
acids NNS O
1-117 CD O
and CC O
239-270 CD O
) -RRB- O
, , O
p230 PRP B-NP
contains VBZ O
a DT O
very RB O
high JJ O
frequency NN O
of IN O
heptad NN O
repeats NNS O
, , O
characteristic JJ O
of IN O
alpha-helices NNS O
that IN O
form NN O
dimeric JJ O
coiled-coil NN O
structures NNS O
. . O
p230 NN B-NP
also RB O
includes VBZ O
the DT O
sequence NN O
ESLALEELEL NNP O
(amino NNP O
acids NNS O
538-546 CD O
) -RRB- O
, , O
a DT O
motif NN O
found VBN O
in IN O
the DT O
granin NN B-NP
family NN I-NP
of IN O
acidic JJ O
proteins NNS O
present JJ O
in IN O
secretory JJ O
granules NNS O
of IN O
neuroendocrine JJ O
cells NNS O
. . O

-DOCSTART- X X O

Binding NNP O
specificity NN O
and CC O
modulation NN O
of IN O
the DT O
ApoA-I NNP B-NP
promoter NN I-NP
activity NN O
by IN O
homo- NNS O
and CC O
heterodimers NNS O
of IN O
nuclear JJ O
receptors NNS O
. . O

-DOCSTART- X X O

They PRP O
were VBD O
found VBN O
to TO O
stimulate VB O
at IN O
nanomolar JJ O
concentrations NNS O
the DT O
turnover NN O
of IN O
biosynthetically RB O
labeled VBN O
ceramide NN O
, , O
glucosylceramide NN O
, , O
and CC O
lactosylceramide NN O
. . O

-DOCSTART- X X O

There EX O
is VBZ O
growing VBG O
evidence NN O
that IN O
mammalian JJ B-NP
AMP-activated JJ I-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
AMPK) NNP B-NP
plays VBZ O
a DT O
role NN O
in IN O
protecting VBG O
cells NNS O
from IN O
stresses VBZ O
that DT O
cause NN O
ATP NNP O
depletion NN O
by IN O
switching VBG O
off RP O
ATP-consuming JJ O
biosynthetic JJ O
pathways NNS O
. . O

-DOCSTART- X X O

Sterol-mediated JJ O
suppression NN O
of IN O
cleavage NN O
of IN O
SREBP-1 NN B-NP
was VBD O
found VBN O
to TO O
be VB O
dependent JJ O
on IN O
the DT O
extreme JJ O
COOH-terminal JJ O
region NN O
( -LRB- O
residue NN O
1034 CD O
to TO O
the DT O
COOH JJ O
terminus NN O
) -RRB- O
, , O
which WDT O
exists VBZ O
in IN O
two CD O
forms NNS O
as IN O
a DT O
result NN O
of IN O
alternative JJ O
splicing NN O
. . O

-DOCSTART- X X O

Am NNP O
. . O

-DOCSTART- X X O

However RB O
, , O
a DT O
> NN O
10-fold JJ O
increase NN O
in IN O
ERK3 JJ B-NP
activity NN O
in IN O
each DT O
PKC NNP B-NP
beta NN I-NP
transfectant NN O
was VBD O
shown VBN O
by IN O
immunoprecipitation NN O
with IN O
anti-ERK3 JJ B-NP
monoclonal JJ I-NP
antibody NN I-NP
followed VBN O
by IN O
either DT O
immune JJ O
complex JJ O
kinase NN O
assay NN O
or CC O
by IN O
in IN O
gel NNP O
kinase NN O
assay NN O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
this DT O
100-bp JJ O
Col2a1 NNP B-NP
enhancer NN I-NP
revealed VBD O
several JJ O
sequence NN O
motifs NNS O
similar JJ O
to TO O
motifs NNS O
present VB O
within IN O
the DT O
regulatory JJ O
region NN O
of IN O
the DT O
link NN B-NP
protein NN I-NP
gene NN I-NP
, , O
another DT O
cartilage NN O
gene NN O
. . O

-DOCSTART- X X O

Significantly RB O
, , O
pPKR NN B-NP
is VBZ O
capable JJ O
of IN O
specifically RB O
phosphorylating VBG O
Ser51 NNP O
in IN O
a DT O
synthetic JJ B-NP
eIF-2alpha NN I-NP
peptide NN I-NP
, , O
a DT O
key JJ O
characteristic NN O
of IN O
the DT O
eIF-2alpha NN B-NP
kinase NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

Vertebrate NNP B-NP
synapsins NNS I-NP
constitute VBP O
a DT O
family NN O
of IN O
synaptic JJ O
proteins NNS O
that WDT O
participate VBP O
in IN O
the DT O
regulation NN O
of IN O
neurotransmitter NN O
release NN O
. . O

-DOCSTART- X X O

ZEBRA NNP B-NP
and CC O
cellular JJ O
AP-1 JJ B-NP
bZip NN I-NP
activators NNS I-NP
, , O
such JJ O
as IN O
c-Fos NNS B-NP
, , O
have VBP O
homologous JJ O
DNA-binding JJ O
domains NNS O
, , O
and CC O
their PRP$ O
DNA-binding JJ O
specificities NNS O
overlap VBP O
. . O

-DOCSTART- X X O

This DT O
result NN O
suggested VBD O
that IN O
mutant JJ O
I299 NNP O
has VBZ O
diminished VBN O
cap-binding JJ O
activity NN O
. . O

-DOCSTART- X X O

UV NN O
cross-linking JJ O
experiments NNS O
demonstrated VBD O
that IN O
HSV NNP O
infection NN O
caused VBD O
enhanced JJ O
binding NN O
of IN O
protein NN O
factors NNS O
, , O
including VBG O
the DT O
64-kDa JJ B-NP
component NN I-NP
of IN I-NP
cleavage JJ I-NP
stimulation NN I-NP
factor NN I-NP
( -LRB- O
CstF NN B-NP
) -RRB- O
, , O
to TO O
poly( VB O
A DT O
) -RRB- O
site NN O
RNAs NNS O
from IN O
virus NN O
genes NNS O
of IN O
all DT O
temporal JJ O
classes NNS O
and CC O
that IN O
this DT O
enhanced JJ O
binding NN O
required VBN O
expression NN O
of IN O
IE63 NNP B-NP
. . O

-DOCSTART- X X O

We PRP O
show VBP O
here RB O
that IN O
these DT O
Jun/eb1 NNP B-NP
chimeras NNS O
are VBP O
potent JJ O
transactivators NNS O
of IN O
AP1 NNP B-NP
sites NNS I-NP
and CC O
that IN O
they PRP O
can MD O
cooperate VB O
with IN O
c-Ha-Ras JJ B-NP
to TO O
induce VB O
foci NNS O
. . O

-DOCSTART- X X O

In IN O
synchronized JJ O
HeLa NNP O
cells NNS O
, , O
expression NN O
of IN O
luciferase NN B-NP
activity NN O
was VBD O
induced VBN O
at IN O
the DT O
beginning NN O
of IN O
DNA NNP O
synthesis NN O
and CC O
was VBD O
dependent JJ O
on IN O
the DT O
presence NN O
of IN O
an DT O
E2F-binding JJ B-NP
site NN I-NP
in IN O
the DT O
H2A.1 NNP B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

We PRP O
constructed VBD O
a DT O
yeast NN O
reporter NN O
strain VBP O
containing VBG O
the DT O
lacZ JJ B-NP
gene NN I-NP
under IN O
the DT O
control NN O
of IN O
the DT O
CYC1 NNP B-NP
promoter NN I-NP
associated VBN O
with IN O
three CD O
copies NNS O
of IN O
TRE-1 NN B-NP
. . O

-DOCSTART- X X O

If IN O
hnRNP JJ B-NP
K NNP I-NP
is VBZ O
a DT O
transcription NN O
factor NN O
, , O
then RB O
interactions NNS O
with IN O
the DT O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
transcription NN O
apparatus NN O
are VBP O
predicted VBN O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
increase NN O
in IN O
V NNP O
O2 NNP O
may MD O
have VB O
been VBN O
a DT O
consequence NN O
of IN O
the DT O
increase NN O
in IN O
Q NNP O
O2 NNP O
rather RB O
than IN O
a DT O
response NN O
to TO O
the DT O
procedure NN O
itself PRP O
. . O

-DOCSTART- X X O

Several JJ O
cytokines NNS O
exhibit VBP O
a DT O
high JJ O
degree NN O
of IN O
temporal JJ O
regulation NN O
as RB O
well RB O
as IN O
somnogenic JJ O
potency NN O
( -LRB- O
e NN O
.g. NNP O
, , O
interleukin-1 JJ B-NP
[IL-1] JJ O
, , O
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
[TNF-alpha] NN O
) -RRB- O
. . O

-DOCSTART- X X O

No DT O
difference NN O
in IN O
elastin NN B-NP
peptide NN I-NP
concentration NN O
was VBD O
observed VBN O
between IN O
emphysematous JJ O
patients NNS O
and CC O
control NN O
subjects NNS O
( -LRB- O
mean VB O
+/ JJ O
- : O
SD NNP O
= SYM O
2.39 CD O
+/ CD O
- : O
1.18 CD O
micrograms/ml NN O
in IN O
patients NNS O
versus IN O
2.55 CD O
+/ CD O
- : O
1.34 CD O
micrograms/ml NN O
in IN O
policemen NNS O
and CC O
2.59 CD O
+/ NNS O
- : O
1.20 CD O
micrograms/ml NN O
in IN O
coal NN O
miners NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
this DT O
region NN O
as IN O
the DT O
E. NNP B-NP
coli NNS I-NP
tmk VBD I-NP
gene NN I-NP
was VBD O
confirmed VBN O
by IN O
functional JJ O
complementation NN O
of IN O
a DT O
yeast NN B-NP
dTMP IN I-NP
kinase NN I-NP
temperature-sensitive JJ O
mutant JJ O
and CC O
by IN O
in IN O
vitro NN O
enzyme NN O
assay NN O
of IN O
the DT O
thymidylate JJ B-NP
kinase NN I-NP
activity NN O
in IN O
cell NN O
extracts NNS O
of IN O
E. NNP O
coli NNS O
by IN O
use NN O
of IN O
tmk-overproducing NN B-NP
plasmids NNS O
. . O

-DOCSTART- X X O

Consistent NNP O
with IN O
ErbB-2 NNP B-NP
being VBG O
a DT O
shared VBN O
receptor NN O
subunit NN O
, , O
its PRP$ O
tyrosine NN O
phosphorylation NN O
was VBD O
increased VBN O
by IN O
both DT O
heterologous JJ O
ligands NNS O
and CC O
it PRP O
mediated VBD O
a DT O
trans-inhibitory JJ O
effect NN O
of IN O
NDF NNP B-NP
on IN O
EGF NNP B-NP
binding NN O
. . O

-DOCSTART- X X O

The DT O
cDNA NN O
corresponding JJ O
to TO O
the DT O
FPS1 NNP B-NP
gene NN I-NP
was VBD O
isolated VBN O
by IN O
functional JJ O
complementation NN O
of IN O
a DT O
mutant JJ O
yeast NN O
strain VBP O
defective JJ O
in IN O
FPS NNP B-NP
activity NN O
( -LRB- O
Delourme NNP O
, , O
D. NNP O
, , O
Lacroute NNP O
, , O
F. NNP O
, , O
and CC O
Karst NNP O
, , O
F. NNP O

-DOCSTART- X X O

The DT O
isolated VBN O
plasmin NN B-NP
fragments NNS O
of IN O
VEGF NNP B-NP
were VBD O
compared VBN O
with IN O
respect NN O
to TO O
heparin VB O
binding NN O
, , O
interaction NN O
with IN O
soluble JJ O
VEGF NNP B-NP
receptors NNS I-NP
, , O
and CC O
ability NN O
to TO O
promote VB O
endothelial JJ O
cell NN O
mitogenesis NN O
. . O

-DOCSTART- X X O

VDR/RXR NN B-NP
bound VBD O
well RB O
to TO O
the DT O
VDREs NNP O
and CC O
to TO O
DR4 NNP O
and CC O
DR5 NNP O
using VBG O
the DT O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
when WRB O
the DT O
isoform NN O
containing VBG O
the DT O
C NNP O
epsilon4 NN O
domain NN O
joined VBD O
directly RB O
to TO O
the DT O
M2 NN O
exon NN O
( -LRB- O
IgE JJ B-NP
grande NN I-NP
) -RRB- O
is VBZ O
expressed VBN O
in IN O
the DT O
J558L JJ O
cell NN O
line NN O
, , O
it PRP O
is VBZ O
degraded VBN O
intracellularly RB O
, , O
suggesting VBG O
a DT O
cell NN O
line-dependent NN O
regulation NN O
of IN O
secretion NN O
. . O

-DOCSTART- X X O

Human JJ B-NP
cytomegalovirus NN I-NP
immediate-early JJ I-NP
protein NN I-NP
IE2 IN I-NP
tethers NNS O
a DT O
transcriptional JJ O
repression NN O
domain NN O
to TO O
p53 NN B-NP
. . O

-DOCSTART- X X O

The DT O
antibodies NNS O
inhibited VBD O
specifically RB O
the DT O
transcription NN O
of IN O
DNA NNP B-NP
polymerase NN I-NP
alpha NN I-NP
promoter NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Immunocytochemical JJ O
analysis NN O
demonstrated VBN O
the DT O
presence NN O
of IN O
DREF NNP B-NP
polypeptide NN I-NP
in IN O
nuclei NNS O
after IN O
the DT O
eighth JJ O
nuclear JJ O
division NN O
cycle NN O
, , O
suggesting VBG O
that IN O
nuclear JJ O
accumulation NN O
of IN O
DREF NN B-NP
is VBZ O
important JJ O
for IN O
the DT O
coordinate VBP O
zygotic JJ O
expression NN O
of IN O
DNA NNP O
replication-related VBD O
genes NNS O
carrying VBG O
DRE NNP O
sequences NNS O
. . O

-DOCSTART- X X O

A DT O
DNA NN O
fragment NN O
carrying VBG O
1,100 CD O
nucleotides NNS O
derived VBN O
from IN O
the DT O
5'-flanking JJ O
region NN O
of IN O
the DT O
UGT1A1 NNP B-NP
gene NN I-NP
was VBD O
enough RB O
for IN O
MC NNP O
induction NN O
. . O

-DOCSTART- X X O

This DT O
result NN O
supports VBZ O
the DT O
argument NN O
that IN O
the DT O
beta NN O
' POS O
subunit NN O
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
determining VBG O
the DT O
progress NN O
of IN O
transcription NN O
elongation NN O
. . O

-DOCSTART- X X O

The DT O
extraction NN O
recovery NN O
of IN O
Amphotericin NNP O
B NNP O
from IN O
the DT O
cerebrospinal JJ O
fluid NN O
is VBZ O
higher JJR O
than IN O
90 CD O
% NN O
over IN O
the DT O
entire JJ O
linear JJ O
range NN O
. . O

-DOCSTART- X X O

HuEpo-R NNP B-NP
Ab CD I-NP
inhibited VBD O
Epo-induced JJ B-NP
parental JJ O
UT-7 JJ O
cell NN O
growth NN O
, , O
but CC O
not RB O
that IN O
of IN O
cells NNS O
of IN O
clone JJ O
12 CD O
, , O
suggesting VBG O
that IN O
the DT O
muEpo-R NN B-NP
is VBZ O
able JJ O
to TO O
induce VB O
human JJ O
UT-7 NN O
cell NN O
proliferation NN O
. . O

-DOCSTART- X X O

The DT O
sequence NN O
and CC O
isolated VBN O
cDNAs NNS O
will MD O
provide VB O
useful JJ O
reagents NNS O
for IN O
studying VBG O
the DT O
expression NN O
of IN O
Brca1 NNP B-NP
in IN O
the DT O
mouse NN O
, , O
and CC O
for IN O
testing VBG O
the DT O
importance NN O
of IN O
the DT O
evolutionarily NN O
conserved VBD O
domains NNS O
. . O

-DOCSTART- X X O

A DT O
study NN O
was VBD O
performed VBN O
to TO O
compare VB O
the DT O
ONLINE NNP O
and CC O
EMIT NNP O
II NNP O
immunoassays VBZ O
with IN O
gas NN O
chromatographic/mass NN O
spectrometric JJ O
( -LRB- O
GC/MS NNP O
) -RRB- O
analysis NN O
of IN O
methaqualone NN O
metabolites NNS O
on IN O
urine JJ O
using VBG O
samples NNS O
obtained VBN O
from IN O
a DT O
clinical JJ O
study NN O
. . O

-DOCSTART- X X O

This DT O
protein NN O
encoded VBN O
by IN O
this DT O
cDNA NN O
, , O
which WDT O
we PRP O
have VBP O
termed VBN O
p150TSP JJ B-NP
( -LRB- O
for IN O
TPR-containing NN O
, , O
SH2-binding JJ B-NP
phosphoprotein NN I-NP
) -RRB- O
, , O
is VBZ O
located VBN O
predominantly RB O
in IN O
the DT O
nucleus JJ O
and CC O
is VBZ O
highly RB O
conserved VBN O
in IN O
evolution NN O
. . O

-DOCSTART- X X O

Both DT O
mutant JJ O
receptors NNS O
were VBD O
expressed VBN O
on IN O
the DT O
cell NN O
surface NN O
and CC O
bound JJ O
insulin NN B-NP
normally RB O
, , O
but CC O
showed VBD O
markedly RB O
impaired VBN O
autophosphorylation NN O
in IN O
response NN O
to TO O
insulin NN B-NP
. . O

-DOCSTART- X X O

Transcription NN O
from IN O
adenovirus JJ B-NP
E2-early JJ I-NP
promoter NN I-NP
is VBZ O
controlled VBN O
by IN O
a DT O
unique JJ O
array NN O
of IN O
four CD O
cis-acting JJ O
elements NNS O
which WDT O
include VBP O
an DT O
atypical JJ O
TBP NNP B-NP
site NN I-NP
, , O
two CD O
E2F NNP B-NP
sites NNS I-NP
present JJ O
in IN O
an DT O
inverted JJ O
orientation NN O
relative JJ O
to TO O
each DT O
other JJ O
, , O
and CC O
an DT O
ATF NNP B-NP
site NN I-NP
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
we PRP O
showed VBD O
that IN O
the DT O
IL-6/interferon NN B-NP
gamma NN B-NP
( -LRB- O
IFN JJ B-NP
gamma NN I-NP
) -RRB- O
response NN O
element NN O
in IN O
the DT O
IRF-1 NN B-NP
promoter NN I-NP
( -LRB- O
IR/IRF-1 NN B-NP
) -RRB- O
, , O
which WDT O
contains VBZ O
a DT O
Stat-binding JJ B-NP
site NN I-NP
and CC O
an DT O
adjacent JJ O
CRE-like JJ O
site NN O
, , O
also RB O
makes VBZ O
IL-6-induced JJ B-NP
binding NN O
complexes NNS O
similar JJ O
to TO O
JRE-IL6-BCs JJ O
. . O

-DOCSTART- X X O

A DT O
second JJ O
peptide NN O
(amino NN O
acids NNS O
58-77 . O
) -RRB- O
also RB O
antagonized VBD O
p21-activity NN B-NP
, , O
but CC O
this DT O
peptide NN O
did VBD O
not RB O
affect VB O
the DT O
ability NN O
of IN O
p21 NNS B-NP
to TO O
interact VB O
with IN O
cyclin NN B-NP
E/Cdk2 NN I-NP
. . O

-DOCSTART- X X O

A DT O
p21 NN B-NP
peptide NN I-NP
spanning VBG O
amino IN O
acids NNS O
139-164 CD O
was VBD O
found VBN O
to TO O
bind NN O
PCNA NNS B-NP
in IN O
a DT O
filter NN O
binding NN O
assay NN O
and CC O
this DT O
peptide NN O
suppressed VBD O
recombinant JJ O
p21-PCNA JJ B-NP
interaction NN O
. . O

-DOCSTART- X X O

OND NNP O
8 CD O
mg NN O
tid JJ O
days NNS O
2-3 CD O
, , O
and CC O
8 CD O
mg NN O
tid JJ O
prn NN O
days NNS O
4-5 . O
and CC O
prednisolone JJ O
75-100 CD O
mg NN O
qds NNS O
days NNS O
2-5 CD O
and CC O
2 CD O
) -RRB- O
MCP NNP O
30 CD O
mg/metylprednisolone NN O
80 CD O
mg JJ O
i FW O
.v. FW O
before IN O
CT NNP O
and CC O
MCP NNP O
20 CD O
mg NN O
p.r NN O
. . O
after IN O
4 CD O
and CC O
8 CD O
h NN O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
dynamic JJ O
properties NNS O
of IN O
this DT O
protein NN O
fragment NN O
were VBD O
measured VBN O
and CC O
analyzed VBN O
using VBG O
both DT O
isotropic JJ O
and CC O
anisotropic JJ O
models NNS O
of IN O
molecular JJ O
motion NN O
. . O

-DOCSTART- X X O

Isolation NNP O
by IN O
PCR NNP O
of IN O
a DT O
cDNA NN O
clone NN O
from IN O
pea NN O
petals NNS O
with IN O
similarity NN O
to TO O
petunia NN O
and CC O
wheat NN B-NP
zinc NN I-NP
finger NN I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

This DT O
fragment NN O
can MD O
bind NN O
several JJ O
trans-acting JJ O
factors NNS O
in IN O
vitro NN O
, , O
including VBG O
GATA-1 JJ B-NP
and CC O
members NNS O
of IN O
the DT O
Ets NNP B-NP
family NN I-NP
. . O

-DOCSTART- X X O

Exposure NN O
of IN O
peripheral JJ O
blood NN O
T NNP O
cells NNS O
from IN O
young JJ O
subjects NNS O
to TO O
PHA NNP B-NP
or CC O
cross-linked JJ O
anti-CD3 JJ B-NP
monoclonal JJ I-NP
antibodies NNS I-NP
stimulated VBD O
rapid JJ O
increases NNS O
in IN O
MAPK NNP B-NP
and CC O
MEK NNP B-NP
enzymatic JJ O
activity NN O
. . O

-DOCSTART- X X O

These DT O
different JJ O
observations NNS O
exclude VBP O
a DT O
heterozygosity NN O
of IN O
the DT O
A NNP O
--> NNP O
G NNP O
mutation NN O
at IN O
codon NN O
beta NN O
77 CD O
, , O
as RB O
well RB O
as IN O
a DT O
deletion NN O
comparable JJ O
to TO O
that DT O
of IN O
Hbs NNP B-NP
Lepore NNP I-NP
or CC I-NP
Kenya NNP I-NP
, , O
or CC O
a DT O
beta-globin JJ B-NP
gene NN I-NP
duplication NN O
, , O
and CC O
point NN O
to TO O
a DT O
nontraditional JJ O
inheritance NN O
of IN O
Hb NNP B-NP
Costa NNP I-NP
Rica NNP I-NP
. . O

-DOCSTART- X X O

This DT O
is VBZ O
the DT O
first JJ O
description NN O
, , O
to TO O
our PRP$ O
knowledge NN O
, , O
of IN O
regulatory JJ O
elements NNS O
that WDT O
control VBP O
expression NN O
of IN O
a DT O
gene NN O
encoding VBG O
a DT O
B7 CD B-NP
costimulatory NN I-NP
molecule NN I-NP
. . O

-DOCSTART- X X O

T NNP O
cell NN O
leukemia-associated JJ O
human NN O
Notch/translocation-associated NNP B-NP
Notch NNP B-NP
homologue NN O
has VBZ O
I PRP B-NP
kappa VB I-NP
B-like JJ I-NP
activity NN O
and CC O
physically RB O
interacts NNS O
with IN O
nuclear JJ B-NP
factor-kappa NN I-NP
B NNP I-NP
proteins VBZ O
in IN O
T NNP O
cells NNS O
. . O

-DOCSTART- X X O

Polyprotein NN O
processing NN O
in IN O
Southampton NNP O
virus NN O
: : O
identification NN O
of IN O
3C-like JJ B-NP
protease NN I-NP
cleavage NN O
sites NNS O
by IN O
in IN O
vitro NN O
mutagenesis NN O
. . O

-DOCSTART- X X O

The DT O
humanized JJ B-NP
LL2 NNP I-NP
( -LRB- O
hLL2 NN B-NP
) -RRB- O
, , O
lacking VBG O
light NN B-NP
chain NN I-NP
variable JJ I-NP
region NN I-NP
glycosylation NN O
, , O
exhibited VBD O
immunoreactivities NNS O
that WDT O
were VBD O
comparable JJ O
to TO O
that DT O
of IN O
chimeric JJ B-NP
LL2 NNP I-NP
( -LRB- O
cLL2 NN B-NP
) -RRB- O
, , O
which WDT O
was VBD O
shown VBN O
previously RB O
to TO O
have VB O
antigen-binding JJ O
properties NNS O
similar JJ O
to TO O
its PRP$ O
murine NN O
counterpart NN O
, , O
suggesting VBG O
that IN O
the DT O
VK-appended JJ O
oligosaccharides NNS O
found VBD O
in IN O
mLL2 NN B-NP
are VBP O
not RB O
necessary JJ O
for IN O
antigen JJ O
binding NN O
. . O

-DOCSTART- X X O

An DT O
apparent JJ O
N-terminal JJ O
transit NN O
peptide NN O
in IN O
the DT O
coding NN O
region NN O
and CC O
a DT O
3' JJ O
poly( NN O
A DT O
) -RRB- O
tail NN O
exist VBP O
in IN O
the DT O
cDNA NN O
clone NN O
indicated VBD O
that IN O
this DT O
chloroplast JJ O
protein NN O
as IN O
nuclear JJ O
encoded VBN O
. . O

-DOCSTART- X X O

Deletion NNP O
analysis NN O
of IN O
rOC NNP B-NP
promoter-chloramphenicol NN I-NP
acetyltransferase NN B-NP
constructs NNS O
demonstrates VBZ O
that IN O
an DT O
AML-1-binding JJ B-NP
sequence NN I-NP
within IN O
the DT O
proximal JJ O
promoter NN O
(-138 . O
to TO O
-130 JJ O
nt NN O
) -RRB- O
contributes VBZ O
to TO O
75 CD O
% NN O
of IN O
the DT O
level NN O
of IN O
osteocalcin NN B-NP
gene NN I-NP
expression NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
a DT O
critical JJ O
question NN O
is VBZ O
how WRB O
HOX JJ B-NP
proteins NNS I-NP
select VBP O
the DT O
correct JJ O
sets NNS O
of IN O
target NN O
genes NNS O
in IN O
vivo RB O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
the DT O
Rho NNP B-NP
family NN I-NP
protein NN I-NP
Cdc42 NNP B-NP
, , O
a DT O
conserved JJ O
morphogenetic JJ B-NP
G NNP I-NP
protein NN I-NP
, , O
is VBZ O
also RB O
a DT O
potent JJ O
regulator NN O
of IN O
filamentous JJ O
growth NN O
and CC O
FG(TyA NN B-NP
) -RRB- O
: : O
:lacZ JJ O
expression NN O
in IN O
S. NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

This DT O
region NN O
includes VBZ O
verA RB B-NP
, , O
a DT O
structural JJ O
gene NN O
previously RB O
shown VBN O
to TO O
be VB O
required VBN O
for IN O
ST NNP O
biosynthesis NN O
, , O
and CC O
24 CD O
additional JJ O
closely RB O
spaced VBN O
transcripts NNS O
ranging VBG O
in IN O
size NN O
from IN O
0.6 CD O
to TO O
7.2 CD O
kb NN O
that WDT O
are VBP O
coordinately RB O
induced VBN O
only RB O
under IN O
ST-producing JJ O
conditions NNS O
. . O

-DOCSTART- X X O

Subcellular JJ O
localizations NNS O
of IN O
the DT O
wild-type JJ B-NP
CBFbeta NNP I-NP
and CC O
the DT O
CBFbeta-SMMHC JJ B-NP
fusion NN O
protein NN O
were VBD O
determined VBN O
by IN O
immunofluorescence NN O
of IN O
NIH NNP O
3T3 CD O
cells NNS O
that WDT O
overexpress VBP O
wild-type JJ O
or CC O
fusion NN O
protein NN O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
the DT O
isolation NN O
of IN O
human JJ O
cDNAs NNS O
homologous JJ O
to TO O
the DT O
Drosophila NNP B-NP
dishevelled VBD I-NP
( -LRB- O
dsh NN B-NP
) -RRB- O
segment-polarity NN O
gene NN O
. . O

-DOCSTART- X X O

Escherichia NNP O
coli NNS O
BL21 CC O
( -LRB- O
DE3)plysS NNP O
, , O
harbouring VBG O
a DT O
recombinant NN O
plasmid NN O
containing VBG O
the DT O
catalase-peroxidase JJ B-NP
gene NN O
, , O
produced VBD O
a DT O
large JJ O
amount NN O
of IN O
proteins NNS O
that WDT O
co-migrated VBD O
on IN O
SDS/PAGE NNP O
with IN O
the DT O
native JJ O
enzyme NN O
. . O

-DOCSTART- X X O

Cdk2 NNP B-NP
formed VBD O
a DT O
complex JJ O
with IN O
cyclin NN B-NP
D1 NNS I-NP
in IN O
this DT O
system NN O
. . O

-DOCSTART- X X O

Large JJ B-NP
T NNP I-NP
antigen NN I-NP
was VBD O
coimmunoprecipitated VBN O
by IN O
antibodies NNS O
to TO O
epitope-tagged JJ O
TBP NNP B-NP
, , O
endogenous JJ O
TBP NNP B-NP
, , O
hTAF(II)100 CD B-NP
, , O
hTAF(II)130 CD B-NP
, , O
and CC O
hTAF(II)250 PRP B-NP
, , O
under IN O
conditions NNS O
where WRB O
holo-TFIID NN B-NP
would MD O
be VB O
precipitated VBN O
. . O

-DOCSTART- X X O

A DT O
human JJ O
cytoplasmic NN O
signaling VBG O
protein NN O
has VBZ O
been VBN O
cloned VBN O
that IN O
possesses NNS O
the DT O
same JJ O
structural JJ O
arrangement NN O
of IN O
SH3-SH2-SH3 JJ B-NP
domains NNS O
as IN O
Grb2 NNP B-NP
. . O

-DOCSTART- X X O

E3/19K JJ B-NP
resides NNS O
in IN O
the DT O
endoplasmic JJ O
reticulum NN O
where WRB O
it PRP O
binds VBZ O
to TO O
MHC NNP B-NP
class NN I-NP
I PRP I-NP
molecules NNS I-NP
, , O
thereby RB O
preventing VBG O
their PRP$ O
transport NN O
to TO O
the DT O
cell NN O
surface NN O
. . O

-DOCSTART- X X O

Cloning NN O
of IN O
individual JJ O
ZI NNP O
domains VBZ O
upstream RB O
of IN O
a DT O
minimal JJ O
promoter NN O
demonstrated VBD O
that IN O
the DT O
ZIA NNP O
, , O
ZIC NNP O
, , O
and CC O
ZID NNP O
domains VBZ O
, , O
but CC O
not RB O
the DT O
ZIB NNP O
domain NN O
, , O
are VBP O
TPA NNP O
responsive JJ O
. . O

-DOCSTART- X X O

Clb2/Cdc28 DT B-NP
kinase NN O
is VBZ O
not RB O
required VBN O
for IN O
the DT O
repression NN O
of IN O
MCB-binding JJ B-NP
factor NN I-NP
transcriptional JJ O
activity NN O
in IN O
G2 NNP O
and CC O
M NNP O
phase NN O
. . O

-DOCSTART- X X O

The DT O
carboxy NN O
terminus NN O
of IN O
Mbp1 NNP B-NP
is VBZ O
sufficient JJ O
for IN O
interaction NN O
with IN O
Swi6 NNP B-NP
, , O
and CC O
the DT O
carboxy NN O
terminus NN O
of IN O
Swi6 NNP B-NP
is VBZ O
required VBN O
for IN O
interaction NN O
with IN O
Mbp1 NNP B-NP
. . O

-DOCSTART- X X O

A DT O
new JJ O
UASH NNP O
consensus NN O
sequence NN O
derived VBN O
from IN O
this DT O
mutational JJ O
analysis NN O
closely RB O
matches VBZ O
a DT O
consensus NN O
Abf1 IN B-NP
binding JJ I-NP
site NN I-NP
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
and CC O
analyzed VBN O
human JJ B-NP
CTCF NN I-NP
cDNA NN I-NP
clones NNS O
and CC O
show NN O
here RB O
that IN O
the DT O
ubiquitously NN O
expressed VBD O
11-zinc-finger CD B-NP
factor NN I-NP
CTCF NN I-NP
is VBZ O
an DT O
exceptionally RB O
highly RB O
conserved VBN O
protein NN O
displaying VBG O
93 CD O
% NN O
identity NN O
between IN O
avian NN O
and CC O
human JJ O
amino IN O
acid NN O
sequences NNS O
. . O

-DOCSTART- X X O

Mutational JJ O
analysis NN O
of IN O
the DT O
P2-proximal JJ B-NP
CTCF NNP I-NP
binding NN I-NP
site NN I-NP
and CC O
transient-cotransfection NN O
experiments NNS O
demonstrate VBP O
that IN O
CTCF NNP B-NP
is VBZ O
a DT O
transcriptional JJ O
repressor NN O
of IN O
the DT O
human JJ B-NP
c-myc NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

A DT O
chromosome NN B-NP
transmission NN I-NP
fidelity NN I-NP
( -LRB- O
ctf NN B-NP
) -RRB- O
mutant NN O
, , O
s138 CD O
, , O
of IN O
Saccharomyces NNP O
cerevisiae NN O
was VBD O
identified VBN O
by IN O
its PRP$ O
centromere JJ O
( -LRB- O
CEN NNS O
) -RRB- O
transcriptional JJ O
readthrough JJ O
phenotype NN O
, , O
suggesting VBG O
perturbed JJ O
kinetochore NN O
integrity NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

The DT O
growth NN O
defect NN O
of IN O
a DT O
reg1 JJ B-NP
reg2 NN B-NP
double JJ I-NP
mutant NN I-NP
is VBZ O
alleviated VBN O
by IN O
a DT O
loss-of-function NN O
mutation NN O
in IN O
the DT O
SNF1-encoded JJ B-NP
protein NN I-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

Sp1 NNP B-NP
binds NNS O
two CD O
sites NNS O
in IN O
the DT O
CD11c NNP B-NP
promoter NN I-NP
in IN O
vivo JJ O
specifically RB O
in IN O
myeloid JJ O
cells NNS O
and CC O
cooperates NNS O
with IN O
AP1 NNP B-NP
to TO O
activate VB O
transcription NN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
the DT O
phenylalanine NN B-NP
hydroxylase NN I-NP
gene NN I-NP
in IN O
livers NNS O
and CC O
kidneys NNS O
of IN O
rodents NNS O
is VBZ O
activated VBN O
at IN O
birth NN O
and CC O
is VBZ O
induced VBN O
by IN O
glucocorticoids NNS O
and CC O
cyclic JJ O
AMP NNP O
in IN O
the DT O
liver NN O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
here RB O
the DT O
identification NN O
of IN O
a DT O
cDNA NN O
that WDT O
encodes VBZ O
a DT O
new JJ O
member NN O
of IN O
the DT O
GTPase-activating JJ B-NP
protein NN I-NP
( -LRB- O
GAP NNP B-NP
) -RRB- O
family NN O
of IN O
GTPase NNP B-NP
regulators NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
further RB O
investigated VBD O
the DT O
regulation NN O
of IN O
the DT O
synthesis NN O
of IN O
the DT O
c-mos JJ B-NP
oncogene NNP I-NP
product NN I-NP
, , O
which WDT O
is VBZ O
necessary JJ O
for IN O
the DT O
activation NN O
of IN O
Cdc2 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
heterogeneity NN O
of IN O
bovine JJ B-NP
IgG2--VIII NNP I-NP
. . O

-DOCSTART- X X O

Positioning NNP O
this DT O
uORF NN O
, , O
together RB O
with IN O
its PRP$ O
accompanying VBG O
Kozak NNP O
sequences NNS O
, , O
between IN O
a DT O
heterologous JJ O
promoter NN O
from IN O
SV40 NNP O
and CC O
a DT O
CAT NN B-NP
reporter NN I-NP
gene NN I-NP
resulted VBD O
in IN O
marked JJ O
inhibition NN O
of IN O
CAT JJ B-NP
protein NN I-NP
production NN O
without IN O
a DT O
decrease NN O
in IN O
CAT NNP B-NP
mRNA NN I-NP
. . O

-DOCSTART- X X O

Mesial NNP O
temporal JJ O
sclerosis NN O
was VBD O
characterized VBN O
by IN O
severe JJ O
neuronal JJ O
loss NN O
accompanied VBN O
by IN O
gliosis NN O
occurring VBG O
in IN O
the DT O
CA1/prosubiculum NNP O
( -LRB- O
27 CD O
patients NNS O
, , O
100 CD O
% NN O
) -RRB- O
, , O
focally RB O
in IN O
the DT O
dentate NN O
gyrus NN O
( -LRB- O
12 CD O
patients NNS O
, , O
44 CD O
% NN O
) -RRB- O
, , O
and CC O
in IN O
the DT O
CA4 NNP O
region NN O
( -LRB- O
11 CD O
patients NNS O
, , O
41 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Mesial NNP O
temporal JJ O
sclerosis NN O
. . O

-DOCSTART- X X O

More RBR O
specific JJ O
adverse JJ O
events NNS O
, , O
also RB O
frequently RB O
considered VBN O
as IN O
dose-limiting JJ O
toxicities NNS O
, , O
include VBP O
hypotension NN O
with IN O
IL-1 NNP B-NP
, , O
severe JJ O
headache NN O
or CC O
skin NN O
rash NN O
with IN O
IL-3 JJ B-NP
, , O
and CC O
nasal JJ O
congestion NN O
and CC O
gastroduodenal JJ O
lesions NNS O
with IN O
IL-4. PRP$ B-NP

-DOCSTART- X X O

Therefore RB O
, , O
magnetic JJ O
resonance NN O
imaging NN O
was VBD O
used VBN O
to TO O
determine VB O
liver NN O
volume NN O
in IN O
pediatric JJ O
and CC O
adolescent JJ O
patients NNS O
, , O
in IN O
whom WP O
systemic JJ O
clearance NN O
of IN O
three CD O
model NN O
substrates NNS O
[lorazepam VBP O
( -LRB- O
0.03 CD O
mg/kg NN O
) -RRB- O
, , O
antipyrine JJ O
( -LRB- O
10 CD O
mg/kg NN O
) -RRB- O
, , O
and CC O
indocyanine JJ O
green JJ O
( -LRB- O
ICG NN O
; : O
0.5 CD O
mg/kg NN O
) -RRB- O
] SYM O
was VBD O
also RB O
determined VBN O
. . O

-DOCSTART- X X O

A DT O
mutational JJ O
analysis NN O
has VBZ O
resolved VBN O
a DT O
region NN O
of IN O
seven CD O
amino IN O
acids NNS O
(amino VBP O
acids NNS O
26-32 CD O
) -RRB- O
in IN O
the DT O
N-terminus NNP O
of IN O
Bob1 NNP B-NP
that WDT O
are VBP O
important JJ O
for IN O
contacting VBG O
the DT O
DNA NNP B-NP
binding NN I-NP
POU NNP I-NP
domain NN I-NP
of IN O
Oct-1 NNP B-NP
or CC O
Oct-2 NNP B-NP
. . O

-DOCSTART- X X O

Heme NNP B-NP
oxygenase NN I-NP
1 CD I-NP
is VBZ O
an DT O
essential JJ O
enzyme NN O
in IN O
heme NN O
catabolism NN O
that WDT O
cleaves VBZ O
heme NN O
to TO O
form VB O
biliverdin NN O
, , O
iron NN O
, , O
and CC O
carbon NN O
monoxide NN O
. . O

-DOCSTART- X X O

155 CD O
aa JJ O
, , O
shares NNS O
78 CD O
% NN O
identity NN O
with IN O
the DT O
analogous JJ O
region NN O
of IN O
Xenopus NNP O
laevis VBD O
FGF3 CD B-NP
and CC O
72 CD O
% NN O
identity NN O
with IN O
the DT O
product NN O
of IN O
the DT O
more JJR O
distantly RB O
related VBN O
human JJ O
gene NN O
. . O

-DOCSTART- X X O

Defects NNS O
in IN O
the DT O
Schizosaccharomyces NNP O
pombe NN O
( -LRB- O
Sp NNP O
) -RRB- O
cell NN O
cycle-controlling NN O
genes NNS O
prevent VBP O
the DT O
cell NN O
cycle NN O
progression NN O
. . O

-DOCSTART- X X O

The DT O
DNA NNP O
sequence NN O
immediately RB O
upstream RB O
from IN O
the DT O
- : O
10 CD O
hexamer NN O
contained VBD O
the DT O
TGn JJ O
motif NN O
described VBN O
as IN O
an DT O
extended JJ O
-10 JJ O
region NN O
in IN O
prokaryotic JJ O
promoters NNS O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
from IN O
these DT O
studies NNS O
that IN O
CKII NNP B-NP
may MD O
act VB O
as IN O
a DT O
positive JJ O
regulator NN O
of IN O
myogenesis NN O
by IN O
preventing VBG O
E NNP B-NP
protein NN I-NP
homodimers NNS I-NP
from IN O
binding NN O
to TO O
muscle NN O
gene NN O
regulatory JJ O
elements NNS O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
negative JJ O
regulators NNS O
such JJ O
as IN O
NCE3 NNP B-NP
, , O
as RB O
well RB O
as IN O
the DT O
previously RB O
described VBN O
SIN5 NNP B-NP
gene NN I-NP
, , O
in IN O
determining VBG O
the DT O
promoter NN O
specificity NN O
of IN O
homologous JJ O
activators NNS O
is VBZ O
discussed VBN O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
strand JJ O
selective JJ O
repair NN O
in IN O
DNA NN O
fragments NNS O
within IN O
two CD O
active JJ O
genes NNS O
, , O
DHFR NNP B-NP
and CC O
an DT O
unknown JJ O
gene NN O
adjacent JJ O
to TO O
DHFR. NNP B-NP

-DOCSTART- X X O

MATERIALS NNS O
AND CC O
METHODS NNS O
: : O
Coronal NNP O
3D NNP O
GRE NNP O
imaging NN O
was VBD O
used VBN O
to TO O
study VB O
the DT O
volar JJ O
, , O
middle JJ O
, , O
and CC O
dorsal JJ O
portions NNS O
of IN O
the DT O
SLL NNP O
in IN O
14 CD O
patients NNS O
with IN O
an DT O
arthroscopically RB O
normal JJ O
SLL NNP O
and CC O
in IN O
five CD O
cadaveric JJ O
wrists NNS O
that WDT O
had VBD O
a DT O
normal JJ O
SLL NNP O
proved VBD O
with IN O
dissection NN O
. . O

-DOCSTART- X X O

In IN O
an DT O
effort NN O
to TO O
contribute VB O
to TO O
the DT O
transcript NN O
map NN O
of IN O
human NN O
chromosome NN O
21 CD O
and CC O
the DT O
understanding NN O
of IN O
the DT O
pathophysiology NN O
of IN O
trisomy NN O
21 CD O
, , O
we PRP O
have VBP O
used VBN O
exon NN O
trapping VBG O
to TO O
identify VB O
fragments NNS O
of IN O
chromosome NN O
21 CD O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
model NN O
captures VBZ O
the DT O
essence NN O
of IN O
predator-prey NN O
dynamics NNS O
to TO O
provide VB O
reasonable JJ O
predictions NNS O
of IN O
population NN O
patterns NNS O
. . O

-DOCSTART- X X O

The DT O
exon-intron NN O
distribution NN O
of IN O
Cdebp NNP B-NP
appears VBZ O
strikingly RB O
similar JJ O
to TO O
that DT O
of IN O
the DT O
App NNP B-NP
gene NN I-NP
in IN O
the DT O
regions NNS O
encoding VBG O
the DT O
conserved JJ O
domains NNS O
, , O
with IN O
a DT O
divergent JJ O
structure NN O
in IN O
the DT O
other JJ O
parts NNS O
. . O

-DOCSTART- X X O

DNA NNP O
sequence NN O
analysis NN O
reveals VBZ O
that IN O
the DT O
gene NN O
encodes VBZ O
a DT O
protein NN O
highly RB O
homologous JJ O
to TO O
rat VB B-NP
CRP1 NNP I-NP
. . O

-DOCSTART- X X O

Both DT O
of IN O
these DT O
domains NNS O
have VBP O
striking JJ O
sequence NN O
homology NN O
with IN O
human JJ O
SIM NNP B-NP
and CC O
Drosophila NNP O
SIM NNP B-NP
proteins VBZ O
. . O

-DOCSTART- X X O

Promoter NNP O
activity NN O
was VBD O
high JJ O
in IN O
cell NN O
lines NNS O
that IN O
expressed VBN O
high JJ O
levels NNS O
of IN O
endogenous JJ O
D3 JJ B-NP
mRNA NN I-NP
, , O
as IN O
indicated VBN O
by IN O
Northern JJ O
blot NN O
analyses NNS O
, , O
and CC O
was VBD O
significantly RB O
reduced VBN O
when WRB O
the DT O
promoter NN O
was VBD O
truncated VBN O
to TO O
-122 DT O
bp NN O
. . O

-DOCSTART- X X O

Some DT O
users NNS O
will MD O
willingly RB O
comply VB O
with IN O
management NN O
measures NNS O
, , O
other JJ O
users NNS O
will MD O
comply VB O
in IN O
response NN O
to TO O
education NN O
, , O
but CC O
there EX O
will MD O
be VB O
another DT O
group NN O
who WP O
will MD O
only RB O
respond VB O
to TO O
enforcement NN O
activities NNS O
. . O

-DOCSTART- X X O

Collectively RB O
, , O
these DT O
data NNS O
indicate VBP O
that IN O
HIP NNP B-NP
is VBZ O
a DT O
membrane-associated JJ O
HP-binding JJ B-NP
protein NN I-NP
expressed VBN O
on IN O
the DT O
surface NN O
of IN O
normal JJ O
human JJ O
uterine NN O
epithelia NN O
and CC O
uterine NN O
epithelial NN O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

The DT O
corresponding JJ O
gene NN O
was VBD O
identified VBN O
in IN O
the DT O
GenBankTM NNP O
data NN O
base NN O
by IN O
sequence NN O
alignment NN O
and CC O
termed VBD O
RPS30A. . B-NP

-DOCSTART- X X O

The DT O
location NN O
of IN O
multiple JJ O
GRK2 NNP B-NP
and CC O
GRK5 CD B-NP
phosphoacceptor NN I-NP
sites NNS I-NP
at IN O
the DT O
extreme JJ O
carboxyl NN O
terminus NN O
of IN O
the DT O
beta2AR NN B-NP
is VBZ O
highly RB O
reminiscent JJ O
of IN O
GRK1-mediated JJ B-NP
phosphorylation NN O
of IN O
rhodopsin NN B-NP
. . O

-DOCSTART- X X O

This DT O
regulation NN O
could MD O
not RB O
be VB O
appreciably RB O
modified VBN O
by IN O
enhanced JJ O
expression NN O
of IN O
STAT JJ B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Receptors NNS O
for IN O
interleukin NN B-NP
( -LRB- I-NP
IL)-10 JJ I-NP
and CC O
IL-6-type JJ B-NP
cytokines NNS I-NP
use VBP O
similar JJ O
signaling NN O
mechanisms NNS O
for IN O
inducing NN O
transcription NN O
through IN O
IL-6 DT B-NP
response NN O
elements NNS O
. . O

-DOCSTART- X X O

This DT O
phenomenon NN O
did VBD O
not RB O
require VB O
DNA NNP O
binding NN O
by IN O
the DT O
"interfering NN O
" '' O
receptor NN O
but CC O
required VBD O
it PRP O
to TO O
be VB O
hormone-bound JJ O
, , O
indicating VBG O
that IN O
a DT O
transcriptionally RB O
active JJ O
form NN O
of IN O
the DT O
interfering NN O
receptor NN O
is VBZ O
essential JJ O
for IN O
the DT O
interfering JJ O
effect NN O
. . O

-DOCSTART- X X O

The DT O
receptor NN B-NP
for IN I-NP
hyaluronan NN I-NP
mediated JJ I-NP
motility NN I-NP
( -LRB- B-NP
RHAMM) NNP I-NP
gene NN I-NP
expression NN O
is VBZ O
markedly RB O
elevated VBN O
in IN O
fibrosarcomas NNS O
exposed VBN O
to TO O
transforming VBG B-NP
growth NN I-NP
factor-beta1 FW I-NP
( -LRB- O
TGF-beta1 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
promoter NN O
of IN O
the DT O
rat NN B-NP
PGS-2 JJ I-NP
gene NN I-NP
contains VBZ O
a DT O
CAAT NN B-NP
enhancer-binding JJ I-NP
protein NN I-NP
consensus NN I-NP
site NN I-NP
( -LRB- I-NP
CAAT JJ I-NP
box NN I-NP
) -RRB- I-NP
which WDT O
can MD O
confer VB O
hormone NN O
inducibility NN O
to TO O
a DT O
PGS-2.CAT JJ B-NP
reporter NN O
gene NN O
, , O
as RB O
well RB O
as IN O
a DT O
putative JJ O
E-box NNP O
region NN O
. . O

-DOCSTART- X X O

Notably RB O
, , O
SRF NNP B-NP
has VBZ O
been VBN O
found VBN O
to TO O
be VB O
a DT O
key JJ O
regulator NN O
of IN O
members NNS O
of IN O
a DT O
class NN O
of IN O
cellular JJ O
response NN O
genes NNS O
termed VBN O
immediate-early JJ B-NP
genes NNS I-NP
( -LRB- O
IEGs NNS B-NP
) -RRB- O
, , O
many JJ O
of IN O
which WDT O
are VBP O
believed VBN O
to TO O
be VB O
involved VBN O
in IN O
regulating VBG O
cell NN O
growth NN O
and CC O
differentiation NN O
. . O

-DOCSTART- X X O

Clinical NNP O
evaluation NN O
of IN O
the DT O
Allergan NNP O
Humphrey NNP O
500 CD O
autorefractor NN O
and CC O
the DT O
Nidek NNP O
AR-1000 CC O
autorefractor NN O
. . O

-DOCSTART- X X O

None NN O
of IN O
the DT O
five CD O
proprotein NN O
processing NN O
proteases NNS O
tested VBN O
were VBD O
capable JJ O
of IN O
cleaving VBG O
human JJ B-NP
pro-LPH NNS I-NP
, , O
strongly RB O
suggesting VBG O
that IN O
they PRP O
are VBP O
not RB O
involved VBN O
in IN O
the DT O
maturation NN O
of IN O
this DT O
enzyme NN O
. . O

-DOCSTART- X X O

Selective NNP O
translation NN O
initiation NN O
by IN O
ribosome JJ O
jumping NN O
in IN O
adenovirus-infected JJ O
and CC O
heat-shocked JJ O
cells NNS O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
direct JJ O
cDNA NN O
mapping NN O
using VBG O
fluorescence NN O
in IN O
situ FW O
hybridization NN O
provides VBZ O
an DT O
accurate JJ O
and CC O
rapid JJ O
approach NN O
to TO O
the DT O
definition NN O
of IN O
a DT O
transcribed NN O
map NN O
of IN O
the DT O
human JJ O
genome NN O
. . O

-DOCSTART- X X O

YAC NNP O
and CC O
cosmid JJ O
contigs NNS O
spanning VBG O
the DT O
Batten NNP B-NP
disease NN I-NP
( -LRB- O
CLN3 NN B-NP
) -RRB- O
region NN O
at IN O
16p12.1-p11.2 CD O
. . O

-DOCSTART- X X O

Isolation NNP O
of IN O
a DT O
near JJ O
full-length JJ O
cDNA NN O
from IN O
a DT O
human NN O
fetal NN O
brain NN O
cDNA NN O
library NN O
revealed VBD O
a DT O
protein NN B-NP
serine-threonine NN I-NP
phosphatase NN I-NP
with IN O
a DT O
tetratricopeptide NN O
motif NN O
, , O
almost RB O
identical JJ O
to TO O
human JJ B-NP
PPP5C NNP I-NP
( -LRB- O
PP5 NNP B-NP
) -RRB- O
and CC O
highly RB O
homologous JJ O
to TO O
rat VB B-NP
PPT. . I-NP

-DOCSTART- X X O

Ly-49 NNP B-NP
is VBZ O
a DT O
family NN B-NP
type NN I-NP
II NNP I-NP
transmembrane JJ I-NP
proteins NNS I-NP
encoded VBN O
by IN O
a DT O
gene NN O
cluster NN O
on IN O
murine NN O
chromosome NN O
6 CD O
. . O

-DOCSTART- X X O

The DT O
Dox-A2 NNP B-NP
ORF NNP I-NP
driven VBN O
by IN O
the DT O
TDH3 NNP B-NP
promoter NN I-NP
complemented VBD O
the DT O
phenotype NN O
of IN O
a DT O
strain NN O
deleted VBN O
for IN O
sun2 NN B-NP
. . O

-DOCSTART- X X O

The DT O
introduction NN O
of IN O
hARF4 NN B-NP
to TO O
the DT O
cells NNS O
maintained VBD O
the DT O
balance NN O
between IN O
cytosolic JJ O
and CC O
membrane-associated JJ O
Sec7p JJ B-NP
pools NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
data NNS O
demonstrate VBP O
directly RB O
that IN O
Rpm1r NNP B-NP
is VBZ O
transcribed VBN O
with IN O
its PRP$ O
substrates NNS O
, , O
tRNA NNS B-NP
met VBD I-NP
f NN I-NP
and CC O
tRNAPro NN B-NP
, , O
from IN O
a DT O
promoter NN O
located VBN O
upstream RB O
of IN O
the DT O
tRNA NN B-NP
met VBD I-NP
f NN I-NP
gene NN I-NP
and CC O
suggest VB O
that IN O
a DT O
portion NN O
also RB O
originates VBZ O
from IN O
a DT O
second JJ O
promoter NN O
, , O
located VBN O
between IN O
the DT O
tRNA NN B-NP
met VBD I-NP
f NN I-NP
gene NN I-NP
and CC O
RPM1. VBG B-NP

-DOCSTART- X X O

Furthermore RB O
, , O
strains NNS O
with IN O
mutant JJ B-NP
RPM1 NNP I-NP
genes NNS I-NP
also RB O
accumulate VBP O
precursor NN B-NP
Rpm1r NN I-NP
, , O
suggesting VBG O
that IN O
mutations NNS O
in IN O
either DT O
gene NN O
can MD O
lead VB O
to TO O
similar JJ O
biogenesis NN O
defects NNS O
. . O

-DOCSTART- X X O

FTF NN B-NP
is VBZ O
also RB O
abundantly RB O
expressed VBN O
in IN O
the DT O
pancreas NNS O
and CC O
may MD O
exert VB O
differentiation NN O
functions NNS O
in IN O
endodermal JJ O
sublineages NNS O
, , O
similar JJ O
to TO O
SF-1 JJ B-NP
in IN O
steroidogenic JJ O
tissues NNS O
. . O

-DOCSTART- X X O

Stylohyoid NNP O
chain NN O
ossification NN O
: : O
choice NN O
of IN O
the DT O
surgical JJ O
approach NN O
. . O

-DOCSTART- X X O

Cluster NNP O
formation NN O
of IN O
E-cadherin NNP B-NP
on IN O
the DT O
cell NN O
surface NN O
is VBZ O
believed VBN O
to TO O
be VB O
of IN O
major JJ O
importance NN O
for IN O
cell-cell NN O
adhesion NN O
. . O

-DOCSTART- X X O

DNA NNP B-NP
polymerase NN I-NP
E NNP I-NP
, , O
DNA NNP B-NP
ligase NN I-NP
III NNP I-NP
and CC O
a DT O
DNA NNP O
structure-specific JJ O
endonuclease NN O
co-purify , O
with IN O
the DT O
five CD O
polypeptide NN O
complex NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
however RB O
, , O
it PRP O
is VBZ O
homologous JJ O
to TO O
several JJ O
expressed VBN O
sequence NN O
tags NNS O
( -LRB- O
EST NNP O
) -RRB- O
of IN O
unknown JJ O
function NN O
from IN O
Caenorhabditis NNP O
elegans NNS O
, , O
Oryza NNP O
sativa NN O
and CC O
Homo NN O
sapiens NNS O
. . O

-DOCSTART- X X O

Mean JJ O
increase NN O
of IN O
milk NN O
protein NN O
yield NN O
was VBD O
46 CD O
g/d NN O
with IN O
Met NNP O
plus CC O
Lys NNP O
, , O
and CC O
mean JJ O
increase NN O
of IN O
true JJ O
protein NN O
content NN O
was VBD O
1.1 CD O
g/kg NN O
of IN O
milk NN O
. . O

-DOCSTART- X X O

Each DT O
half NN O
molecule NN O
contains VBZ O
four CD O
disulfide NN O
linkages NNS O
and CC O
four CD O
cis NNS O
peptides NNS O
. . O

-DOCSTART- X X O

Only RB O
fully RB O
processed VBN O
Pra NNP B-NP
( -LRB- O
N0 NN O
and CC O
Nb NN O
) -RRB- O
and CC O
ICP35 PRP B-NP
( -LRB- O
ICP35 IN B-NP
e,f NN I-NP
) -RRB- O
are VBP O
present JJ O
in IN O
B NNP O
capsids NNS O
, , O
which WDT O
are VBP O
believed VBN O
to TO O
be VB O
precursors NNS O
of IN O
mature JJ O
virions NNS O
. . O

-DOCSTART- X X O

A DT O
chimeric JJ O
VP16-Tat NN B-NP
construct VB O
containing VBG O
the DT O
leucine NN O
mutations NNS O
showed VBD O
no DT O
increased VBN O
AP-1 NN B-NP
responsiveness NN O
in IN O
comparison NN O
with IN O
that DT O
of IN O
the DT O
VP16 NNP B-NP
activation NN I-NP
domain NN I-NP
alone RB O
. . O

-DOCSTART- X X O

Here RB O
, , O
the DT O
cloning NN O
and CC O
characterization NN O
of IN O
S-RNase JJ B-NP
genes NNS I-NP
from IN O
two CD O
species NNS O
of IN O
Rosaceae NNP O
, , O
apple NN O
( -LRB- O
Malus NNP O
x NN O
domestica NN O
) -RRB- O
and CC O
Japanese JJ O
pear NN O
( -LRB- O
Pyrus JJ O
serotina NN O
) -RRB- O
is VBZ O
described VBN O
and CC O
these DT O
sequences NNS O
are VBP O
compared VBN O
with IN O
those DT O
of IN O
other JJ O
T2-type JJ B-NP
RNases NNS I-NP
. . O

-DOCSTART- X X O

A DT O
phylogenetic JJ O
tree NN O
of IN O
members NNS O
of IN O
the DT O
T2/S-RNase JJ B-NP
superfamily NN I-NP
in IN O
plants NNS O
was VBD O
obtained VBN O
. . O

-DOCSTART- X X O

In IN O
a DT O
Hoosier NNP O
Oncology NNP O
Group NNP O
randomized VBD O
study NN O
involving VBG O
extensive-disease NN O
SCLC NNP O
patients NNS O
, , O
VIP NNP O
was VBD O
superior JJ O
to TO O
etoposide/cisplatin VB O
with IN O
regard NN O
to TO O
median NN O
time NN O
to TO O
progression NN O
( -LRB- O
6.6 CD O
v NN O
5.8 CD O
months NNS O
) -RRB- O
, , O
median JJ O
survival NN O
times NNS O
( -LRB- O
9.1 CD O
v NN O
7.3 CD O
months NNS O
) -RRB- O
, , O
and CC O
2- CD O
and CC O
3-year JJ O
survival NN O
rates NNS O
( -LRB- O
13 CD O
% NN O
v NN O
5 CD O
% NN O
and CC O
5 CD O
% NN O
v NN O
0 CD O
% NN O
, , O
respectively RB O
) -RRB- O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
shown VBN O
that IN O
administration NN O
of IN O
immunomodulator NN O
neurotropin NN B-NP
( -LRB- O
NSP) JJ B-NP
results NNS O
in IN O
more JJR O
steady JJ O
consolidation NN O
and CC O
retention NN O
of IN O
feeding VBG O
and CC O
avoidance NN O
behavior NN O
, , O
and CC O
some DT O
neurophysiological JJ O
mechanisms NNS O
of IN O
that DT O
phenomena NNS O
were VBD O
revealed VBN O
. . O

-DOCSTART- X X O

Atopic NNP O
allergy NN O
and CC O
other JJ O
hypersensitivities NNS O
. . O

-DOCSTART- X X O

Despite IN O
significant JJ O
lethality NN O
and CC O
cardiovascular JJ O
dysfunction NN O
, , O
in IN O
the DT O
septic JJ O
group NN O
on IN O
Days NNS O
1 CD O
and CC O
2 CD O
, , O
septic JJ O
versus NN O
control NN O
animals NNS O
had VBD O
no DT O
significant JJ O
differences NNS O
in IN O
mean JJ O
metabolic JJ O
cart NN O
measured VBN O
( -LRB- O
Vo2DIR NN O
, , O
ml/kg/min NN O
; : O
Day NNP O
1 CD O
: : O
11.9 CD O
versus NN O
12.4 CD O
, , O
p NN O
= SYM O
0.81 CD O
; : O
Day NNP O
2 CD O
: : O
14.2 CD O
versus NN O
13.5 CD O
, , O
p NN O
= SYM O
0.72 CD O
, , O
respectively RB O
) -RRB- O
and CC O
intravascular JJ O
catheter NN O
calculated VBN O
( -LRB- O
Vo2INDIR NNP O
, , O
ml/kg/min NN O
; : O
Day NNP O
1 CD O
: : O
11.2 CD O
versus NN O
11.2 CD O
, , O
p NN O
= SYM O
0.99 CD O
; : O
Day NNP O
2 CD O
: : O
12.8 CD O
versus NN O
15.4 CD O
, , O
p NN O
= SYM O
0.49 CD O
, , O
respectively RB O
) -RRB- O
. . O

-DOCSTART- X X O

After IN O
6 CD O
h NN O
of IN O
reperfusion NN O
, , O
PO2/FlO2 NNP O
ratio NN O
was VBD O
significantly RB O
better JJR O
after IN O
Combined JJ O
Therapy NNP O
( -LRB- O
372 NN O
+/ NN O
- : O
52 CD O
mm CD O
Hg NN O
) -RRB- O
than IN O
in IN O
the DT O
Recipient JJ O
Instilled NNP O
( -LRB- O
117 CD O
+/ NNS O
- : O
47 CD O
mm CD O
Hg NN O
) -RRB- O
and CC O
Control NNP O
groups NNS O
(87 VBP O
+/ VBN O
- : O
26 CD O
mm CD O
Hg NN O
) -RRB- O
, , O
with IN O
intermediate JJ O
values NNS O
in IN O
Donor NNP O
Aerosol NNP O
dogs VBZ O
( -LRB- O
232 CD O
+/ NN O
- : O
64 CD O
mm CD O
Hg NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
euglobulin NN B-NP
clot NN O
lysis NN O
time NN O
was VBD O
slightly RB O
longer RB O
in IN O
the DT O
smokers NNS O
than IN O
in IN O
the DT O
non-smokers NNS O
in IN O
all DT O
three CD O
experimental JJ O
situations NNS O
, , O
but CC O
the DT O
differences NNS O
were VBD O
not RB O
significant JJ O
. . O

-DOCSTART- X X O

Although IN O
the DT O
DSK2-1 JJ B-NP
mutation NN I-NP
alters NNS O
a DT O
conserved JJ O
residue NN O
in IN O
the DT O
Dsk2p NNP B-NP
ubiquitin-like JJ B-NP
domain NN I-NP
, , O
we PRP O
detect VBP O
no DT O
differences NNS O
in IN O
Dsk2p JJ B-NP
or CC O
Cdc31p JJ B-NP
stability NN O
. . O

-DOCSTART- X X O

Although IN O
IL-2 NNP B-NP
and CC O
IFN-alpha NNP B-NP
activated VBD O
STAT1 NNP B-NP
alpha NN I-NP
and CC O
STAT5 NNPS B-NP
, , O
IL-2 DT B-NP
predominantly RB O
activated VBN O
STAT5 NNP B-NP
, , O
while IN O
IFN-alpha NNP B-NP
predominantly RB O
activated VBD O
STAT1 NNP B-NP
alpha NN I-NP
. . O

-DOCSTART- X X O

Consistent NN O
with IN O
this DT O
interpretation NN O
, , O
recombinant JJ B-NP
CREB NNP I-NP
and CC O
activating VBG B-NP
transcription NN I-NP
factor NN I-NP
proteins VBZ I-NP
bound VBN O
the DT O
junB NN B-NP
CRE-like JJ O
site NN O
, , O
but CC O
did VBD O
not RB O
interact NN O
with IN O
a DT O
mutant JJ O
CRE-like JJ O
site NN O
. . O

-DOCSTART- X X O

One CD O
complex NN O
containing VBG O
a DT O
70 CD O
D NNP O
protein NN O
was VBD O
found VBN O
to TO O
be VB O
associated VBN O
specifically RB O
with IN O
transcriptionally RB O
active JJ O
leukemia NN O
cells NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
confirm VBP O
the DT O
participation NN O
of IN O
intron NN O
1 CD O
in IN O
transcriptional JJ O
regulation NN O
of IN O
the DT O
c-myb JJ B-NP
gene NN I-NP
( -LRB- O
in IN O
mouse NN O
and CC O
human NN O
) -RRB- O
and CC O
implicate VB O
multiple JJ O
and CC O
complex JJ O
regulatory JJ O
mechanisms NNS O
of IN O
activation NN O
during IN O
myelomonocytic JJ O
differentiation NN O
and CC O
leukemic JJ O
cell NN O
growth NN O
control NN O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
To TO O
compare VB O
pregnancy NN O
complications NNS O
in IN O
women NNS O
having VBG O
genetic JJ O
amniocentesis NN O
at IN O
11-14 CD O
weeks NNS O
versus IN O
those DT O
undergoing VBG O
amniocentesis NN O
at IN O
16-19 CD O
weeks NNS O
' POS O
gestation NN O
. . O

-DOCSTART- X X O

Two CD O
new JJ O
flavone NN O
glucosides NNS O
, , O
nevadensin RB O
5-O-beta-D-glucoside JJ O
and CC O
nevadensin RB O
5-O-beta-D-glucosyl(1-->6)beta-D-glucoside JJ O
, , O
have VBP O
been VBN O
isolated VBN O
from IN O
the DT O
aerial JJ O
parts NNS O
of IN O
Lysionotus NNP O
pauciflorus NN O
. . O

-DOCSTART- X X O

Reproductive NNP O
period NN O
affects VBZ O
water NN O
intake NN O
in IN O
heat-stressed JJ O
dehydrated JJ O
goats NNS O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
Rats NNP O
received VBD O
continuous JJ O
intragastric JJ O
infusion NN O
of IN O
elemental JJ O
diet NN O
or CC O
with IN O
supplementation NN O
of IN O
oatbase NN O
, , O
Lactobacillus NNP O
reuteri NN O
R2LC NNP O
, , O
and CC O
Lactobacillus NNP O
plantarum NN O
DSM NNP O
9843 CD O
, , O
with IN O
and CC O
without IN O
fermentation NN O
, , O
from IN O
the DT O
beginning NN O
of IN O
the DT O
study NN O
. . O

-DOCSTART- X X O

By IN O
using VBG O
a DT O
DNA NN O
sequence NN O
selected VBN O
for IN O
its PRP$ O
ability NN O
to TO O
bind NN O
recombinant NN B-NP
BCL-6 . I-NP
in IN O
vitro NN O
, , O
we PRP O
show VBP O
here RB O
that IN O
BCL-6 NNP B-NP
is VBZ O
present JJ O
in IN O
DNA-binding JJ O
complexes NNS O
in IN O
nuclear JJ O
extracts NNS O
from IN O
various JJ O
B-cell JJ O
lines NNS O
. . O

-DOCSTART- X X O

The DT O
predictive JJ O
value NN O
of IN O
a DT O
positive JJ O
flag NN O
was VBD O
77.7 CD O
% NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Our PRP$ O
findings NNS O
suggest VBP O
that IN O
pre-treatment JJ O
with IN O
coenzyme NN O
Q10 . O
may MD O
play VB O
a DT O
protective JJ O
role NN O
during IN O
routine JJ O
vascular JJ O
procedures NNS O
requiring VBG O
abdominal JJ O
aortic JJ O
cross NN O
clamping NN O
by IN O
attenuating VBG O
the DT O
degree NN O
of IN O
peroxidative JJ O
damage NN O
. . O

-DOCSTART- X X O

Gap1(IP4BP) NNP B-NP
, , O
one CD O
of IN O
a DT O
member NN O
of IN O
Ras NNP B-NP
GTPase-activating NNP I-NP
proteins VBZ I-NP
, , O
has VBZ O
been VBN O
identified VBN O
as IN O
a DT O
specific JJ O
inositol NN B-NP
1,3,4,5-tetrakisphosphate JJ I-NP
( -LRB- I-NP
IP4)-binding JJ I-NP
protein NN I-NP
( -LRB- O
Cullen NNP O
, , O
P. NNP O

-DOCSTART- X X O

We PRP O
previously RB O
described VBD O
the DT O
purification NN O
of IN O
an DT O
83-kDa JJ B-NP
phosphatidic JJ I-NP
acid NN I-NP
phosphatase NN I-NP
( -LRB- O
PAP NNP B-NP
) -RRB- O
from IN O
the DT O
porcine NN O
thymus NN O
membranes NNS O
( -LRB- O
Kanoh NNP O
, , O
H. NNP O
, , O
Imai NNP O
, , O
S.-i. NNP O
, , O
Yamada NNP O
, , O
K. NNP O
and CC O
Sakane NNP O
, , O
F.(1992 NN O
) -RRB- O
J. NNP O

-DOCSTART- X X O

The DT O
mechanism NN O
involves VBZ O
Gbetagamma NNP B-NP
subunit-mediated JJ O
increases NNS O
in IN O
tyrosine NN O
phosphorylation NN O
of IN O
the DT O
Shc NNP B-NP
adapter NN I-NP
protein NN I-NP
, , O
Shc*Grb2 NNP B-NP
complex NN O
formation NN O
, , O
and CC O
recruitment NN O
of IN O
Ras NNP B-NP
guanine NNP I-NP
nucleotide JJ I-NP
exchange NN I-NP
factor NN I-NP
activity NN O
. . O

-DOCSTART- X X O

Next JJ O
, , O
we PRP O
stably RB O
overexpressed VBD O
wild-type JJ B-NP
Shc NNP I-NP
or CC O
Y317F NNP B-NP
mutant JJ I-NP
Shc NNP I-NP
into IN O
HIRc NNP O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
small JJ B-NP
GTPase NNP I-NP
Rho NNP B-NP
is VBZ O
implicated VBN O
in IN O
physiological JJ O
functions NNS O
associated VBN O
with IN O
actin-myosin JJ B-NP
filaments NNS O
such JJ O
as IN O
cytokinesis NN O
, , O
cell NN O
motility NN O
, , O
and CC O
smooth JJ O
muscle NN O
contraction NN O
. . O

-DOCSTART- X X O

Conversely RB O
, , O
activation NN O
of IN O
this DT O
signaling NN O
pathway NN O
by IN O
expression NN O
of IN O
a DT O
constitutively RB O
active JJ O
MKK1 IN B-NP
mutant JJ I-NP
dramatically RB O
increased VBN O
cyclin NN B-NP
D1 IN I-NP
promoter NN O
activity NN O
and CC O
cyclin NN B-NP
D1 IN I-NP
protein NN I-NP
expression NN O
, , O
in IN O
a DT O
growth NN O
factor-independent NN O
manner NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
upstream RB O
insertion NN O
of IN O
the DT O
GSTP1 NNP B-NP
silencer NN I-NP
element NN I-NP
failed VBD O
to TO O
inhibit VB O
activity NN O
of IN O
a DT O
heterologous JJ O
promoter NN O
in IN O
MCF7 CD O
cells NNS O
. . O

-DOCSTART- X X O

An DT O
expression NN O
library NN O
was VBD O
constructed VBN O
by IN O
inserting VBG O
5' JJ O
portion-enriched JJ O
cDNAs NNS O
from IN O
phytohemagglutinin-stimulated JJ B-NP
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
into IN O
upstream RB O
of IN O
signal NN B-NP
sequence-deleted JJ I-NP
CD4 NNP I-NP
cDNA NN I-NP
in IN O
an DT O
Epstein-Barr NNP O
virus NN O
shuttle NN O
vector NN O
. . O

-DOCSTART- X X O

The DT O
cis-acting JJ O
elements NNS O
that WDT O
control NN O
promoter NN O
activity NN O
include VBP O
binding JJ O
sites NNS O
for IN O
transcription NN O
factors NNS O
Sp1 . B-NP
and CC O
alphaCbf NN B-NP
, , O
a DT O
60-kDa JJ B-NP
CCAAT NN I-NP
box-binding JJ I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Collectively RB O
, , O
our PRP$ O
findings NNS O
demonstrate VBP O
that IN O
SF-1 NNP B-NP
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
controlling VBG O
the DT O
basal NN O
and CC O
cAMP-stimulated JJ O
expression NN O
of IN O
the DT O
StAR NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Using VBG O
one CD O
of IN O
the DT O
six CD O
fragments NNS O
( -LRB- O
CPK3-8 CC B-NP
) -RRB- O
, , O
we PRP O
isolated VBD O
a DT O
2022 CD B-NP
bp NN I-NP
cDNA NN I-NP
( -LRB- I-NP
VrCDPK-1 NN I-NP
) -RRB- I-NP
from IN O
a DT O
Vigna NNP O
radiata NNP O
lambda VBD O
gt11 CD O
library NN O
. . O

-DOCSTART- X X O

Workplace NNP O
violence--nurses NNS O
at IN O
risk NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
The DT O
LV NNP O
maximum NN O
brightness NN O
and CC O
area NN O
under IN O
the DT O
curve NN O
showed VBD O
significant JJ O
negative JJ O
correlations NNS O
( -LRB- O
p NN O
= SYM O
< JJ O
0.004 CD O
) -RRB- O
with IN O
the DT O
FIO2 NNP O
, , O
while IN O
the DT O
minimum NN O
brightness NN O
showed VBD O
a DT O
significant JJ O
positive JJ O
correlation NN O
( -LRB- O
p NN O
= SYM O
< JJ O
0.002 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
results NNS O
also RB O
imply VBP O
that IN O
the DT O
absence NN O
of IN O
perforin JJ B-NP
expression NN O
in IN O
non-cytotoxic JJ O
cells NNS O
may MD O
be VB O
due JJ O
to TO O
the DT O
suppression NN O
of IN O
the DT O
induction NN O
of IN O
the DT O
killer-cell-specific JJ O
trans-acting NN O
factor NN O
NF-P2 NNP B-NP
. . O

-DOCSTART- X X O

We PRP O
identify VBP O
considerable JJ O
spatio-temporal JJ O
similarities NNS O
between IN O
reported JJ O
expression NN O
patterns NNS O
of IN O
Ypr10 CD B-NP
genes NNS I-NP
and CC O
ribonuclease VB O
genes NNS O
, , O
which WDT O
, , O
together RB O
with IN O
the DT O
significant JJ O
sequence NN O
similarity NN O
to TO O
the DT O
ginseng NN B-NP
ribonuclease NN I-NP
, , O
support VB O
the DT O
hypothesis NN O
of IN O
a DT O
ribonuclease NN O
function NN O
for IN O
PR-10 JJ B-NP
proteins NNS I-NP
and CC O
allow VB O
the DT O
prediction NN O
of IN O
possible JJ O
biological JJ O
roles NNS O
. . O

-DOCSTART- X X O

The DT O
expression NN O
of IN O
ERV3 JJ B-NP
env NN I-NP
mRNA NN I-NP
was VBD O
found VBN O
to TO O
be VB O
differentiation-associated JJ O
, , O
with IN O
high JJ O
expression NN O
detected VBN O
in IN O
the DT O
late JJ O
stages NNS O
of IN O
monocytic JJ O
development NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
exclusively RB O
observed VBN O
in IN O
smooth JJ O
muscle NN O
cells NNS O
by IN O
Northern JJ O
blotting NN O
and CC O
immunohistochemical JJ O
analysis NN O
and CC O
therefore RB O
designated VBN O
" `` B-NP
smoothelin JJR I-NP
. . I-NP
" '' I-NP
A DT O
human JJ O
smooth JJ O
muscle NN O
cDNA NNS O
library NN O
was VBD O
screened VBN O
with IN O
the DT O
monoclonal JJ B-NP
antibody NN I-NP
R4A NNP I-NP
, , O
and CC O
a DT O
full-size JJ O
cDNA NN O
of IN O
the DT O
protein NN O
was VBD O
selected VBN O
. . O

-DOCSTART- X X O

Using VBG O
immunogold JJ O
electron NN O
microscopy NN O
, , O
we PRP O
found VBD O
that IN O
p58/p45 NN B-NP
and CC O
p54 NN B-NP
are VBP O
localized VBN O
on IN O
both DT O
sides NNS O
of IN O
the DT O
nuclear JJ O
pore NN O
complex NN O
, , O
like IN O
p62 NN B-NP
. . O

-DOCSTART- X X O

Transcription NNP O
initiation NN O
sites NNS O
of IN O
the DT O
rat NN O
II NNP B-NP
beta-, JJ I-NP
III NNP I-NP
beta NN I-NP
, , I-NP
and CC I-NP
O NNP I-NP
beta-globin NN I-NP
genes NNS O
were VBD O
determined VBN O
to TO O
be VB O
52 CD O
base NN O
pairs NNS O
( -LRB- O
bp NN O
) -RRB- O
5'-upstream NN O
of IN O
the DT O
translation NN O
initiation NN O
codon NN O
( -LRB- O
ATG) NNP O
, , O
in IN O
each DT O
gene NN O
by IN O
primer JJ O
extension NN O
analysis NN O
. . O

-DOCSTART- X X O

Aggravating VBG O
process NN O
induced VBN O
by IN O
indomethacin NNS O
on IN O
chronic JJ O
gastric JJ O
lesion NN O
in IN O
rat NN O
. . O

-DOCSTART- X X O

Epstein-Barr NNP B-NP
virus NN I-NP
nuclear JJ I-NP
protein NN I-NP
2 CD I-NP
( -LRB- O
EBNA2 NN B-NP
) -RRB- O
binds NNS O
to TO O
a DT O
component NN O
of IN O
the DT O
human JJ O
SNF-SWI NNP B-NP
complex NN O
, , O
hSNF5/Ini1 NN B-NP
. . O

-DOCSTART- X X O

Our PRP$ O
studies NNS O
also RB O
excluded VBN O
the DT O
possibility NN O
that IN O
the DT O
phosphorylation NN O
of IN O
Ser-2 NNP O
, , O
Ser-123 NNP O
, , O
or CC O
Ser-210 NNP O
, , O
had VBD O
roles NNS O
in IN O
the DT O
trans-suppression NN O
activity NN O
of IN O
the DT O
large JJ B-NP
HDAg NNP I-NP
, , O
in IN O
the DT O
assembly NN O
of IN O
empty JJ O
virus-like JJ B-NP
HDAg NNP I-NP
particle NN I-NP
, , O
and CC O
in IN O
the DT O
nuclear JJ O
transport NN O
of IN O
HDAgs NNP B-NP
. . O

-DOCSTART- X X O

Homologous NNP O
recombination NN O
between IN O
the DT O
Autographa NNP O
californica NN O
nuclear JJ O
polyhedrosis NN O
virus NN O
( -LRB- O
AcNPV NNP O
) -RRB- O
genome NN O
and CC O
a DT O
0.6-kbp-long JJ O
DNA NN O
fragment NN O
derived VBD O
from IN O
the DT O
putative JJ O
DNA NNP B-NP
helicase NN I-NP
gene NN I-NP
of IN I-NP
Bombyx NNP I-NP
mori NN I-NP
nuclear JJ I-NP
polyhedrosis NN I-NP
virus NN I-NP
generates VBZ O
eh2-AcNPV JJ O
, , O
an DT O
expanded-host-range JJ O
AcNPV NN O
mutant NN O
( -LRB- O
S. NNP O

-DOCSTART- X X O

The DT O
data NNS O
further RB O
indicate VBP O
that IN O
the DT O
IL-7R JJ B-NP
alpha NN I-NP
chains NNS I-NP
are VBP O
directly RB O
involved VBN O
in IN O
the DT O
activation NN O
of IN O
JAKs NNP B-NP
and CC O
STATs NNP B-NP
and CC O
have VBP O
a DT O
major JJ O
role NN O
in IN O
proliferative JJ O
signaling NN O
in IN O
precursor NN O
B NNP O
cells NNS O
. . O

-DOCSTART- X X O

5 CD O
) -RRB- O
We PRP O
've VBP O
noticed VBN O
that IN O
the DT O
mean JJ O
value NN O
of IN O
the DT O
cost NN O
for IN O
episode NN O
of IN O
pnx NN O
s VBZ O
. . O
in IN O
class NN O
A DT O
was VBD O
more JJR O
than IN O
15 CD O
% NN O
compared VBN O
to TO O
class NN O
B NNP O
and CC O
the DT O
cost NN O
for IN O
patient NN O
in IN O
class NN O
A DT O
was VBD O
nearly RB O
double JJ O
than IN O
in IN O
class NN O
B. NNP O

-DOCSTART- X X O

We PRP O
have VBP O
been VBN O
studying VBG O
the DT O
interaction NN O
of IN O
the DT O
oncogenic JJ O
human JJ O
polyomavirus NN O
BK NNP O
( -LRB- O
BKV NN O
) -RRB- O
with IN O
the DT O
tumor-suppressor JJ B-NP
protein NN I-NP
p53 NN I-NP
to TO O
understand VB O
the DT O
biology NN O
of IN O
this DT O
virus NN O
as RB O
well RB O
as IN O
to TO O
understand VB O
the DT O
basic JJ O
mechanisms NNS O
of IN O
p53 NN B-NP
transactivation NN O
. . O

-DOCSTART- X X O

Site NNP O
S-II NNP O
also RB O
spans VBZ O
a DT O
23 CD O
bp NN O
sequence NN O
containing VBG O
two CD O
tandem JJ O
consensus NN O
binding NN O
sites NNS O
with IN O
three CD O
base NN O
pair NN O
mismatches NNS O
in IN O
each DT O
and CC O
a DT O
one NN O
base NN O
pair NN O
deletion NN O
. . O

-DOCSTART- X X O

Treatment NNP O
is VBZ O
instituted VBN O
with IN O
prednisone NN O
and CC O
cyclophosphamide NN O
. . O

-DOCSTART- X X O

Microcomputer NNP O
management NN O
of IN O
chronic NN O
hepatitis NN O
B NNP O
virus NN O
asymptomatic JJ O
patients NNS O

-DOCSTART- X X O

The DT O
standard JJ O
dosage NN O
of IN O
anti-D JJ B-NP
currently RB O
given VBN O
at IN O
all DT O
gestational JJ O
ages NNS O
is VBZ O
1 CD O
ampoule NN O
containing VBG O
125 CD O
micrograms NNS O
of IN O
anti-D. PRP$ B-NP

-DOCSTART- X X O

We PRP O
report VBP O
here RB O
the DT O
molecular JJ O
cloning NN O
of IN O
a DT O
putative JJ O
adhesive NN O
molecule NN O
from IN O
P. NNP O
falciparum NN O
that WDT O
shares VBZ O
both DT O
sequence NN O
and CC O
structural JJ O
similarities NNS O
with IN O
a DT O
sporozoite JJ O
surface NN O
molecule NN O
from IN O
Plasmodium NNP O
termed VBD O
the DT O
thrombospondin-related JJ B-NP
anonymous JJ I-NP
protein NN I-NP
( -LRB- O
TRAP NN B-NP
) -RRB- O
and CC O
, , O
to TO O
a DT O
lesser JJR O
extent NN O
, , O
with IN O
the DT O
circumsporozoite NN B-NP
( -LRB- I-NP
CS) JJ I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

There EX O
are VBP O
no DT O
introns NNS O
within IN O
the DT O
gene NN O
, , O
which WDT O
contains VBZ O
a DT O
9360-bp JJ O
open JJ O
reading NN O
frame NN O
and CC O
encodes VBZ O
a DT O
377-kDa JJ O
protein NN O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
The DT O
results NNS O
demonstrate VBP O
that IN O
at IN O
the DT O
site NN O
of IN O
lumbar JJ O
disc NN O
herniation NN O
, , O
inflammatory NN O
cytokines NNS O
such JJ O
as IN O
interleukin-1 JJ B-NP
alpha NN I-NP
are VBP O
produced VBN O
, , O
which WDT O
increases VBZ O
prostaglandin NN O
E2 CC O
production NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
distinct JJ O
cytoplasmic JJ O
domains NNS O
of IN O
these DT O
cytokine JJ O
receptors NNS O
elicit NN O
convergent NN O
signaling VBG O
pathways NNS O
and CC O
provide VB O
evidence NN O
that IN O
beta JJ B-NP
c NN I-NP
and CC O
IL-2R DT B-NP
beta JJ I-NP
function NN O
as IN O
a DT O
complete JJ O
signal NN O
transducer NN O
. . O

-DOCSTART- X X O

U24 NNP B-NP
has VBZ O
two CD O
separate JJ O
12 CD O
nt JJ O
long JJ O
complementarities NNS O
to TO O
a DT O
highly RB O
conserved VBN O
tract NN O
of IN O
28S DT B-NP
rRNA NNP I-NP
. . O

-DOCSTART- X X O

Possible JJ O
relationship NN O
between IN O
hyperinsulinemia NN O
and CC O
glomerular JJ O
hypertrophy NN O
in IN O
nephrosclerosis NN O
. . O

-DOCSTART- X X O

Blood NN O
GSH-Px JJ B-NP
activity NN O
was VBD O
measured VBN O
with IN O
a DT O
spectrophotometer NN O
, , O
using VBG O
a DT O
modification NN O
of IN O
a DT O
previously RB O
described VBN O
assay NN O
. . O

-DOCSTART- X X O

The DT O
concentrations NNS O
of IN O
vitamin NN O
A DT O
precursors NNS O
and CC O
vitamin NN O
E NNP O
in IN O
the DT O
hay NN O
were VBD O
below IN O
currently RB O
recommended VBN O
dietary NN O
levels NNS O
for IN O
llamas NNS O
, , O
and CC O
alfalfa DT O
hay NN O
appears VBZ O
to TO O
provide VB O
an DT O
unreliable JJ O
source NN O
of IN O
vitamins NNS O
A DT O
and CC O
E NNP O
in IN O
this DT O
species NN O
. . O

-DOCSTART- X X O

Eight CD O
cats NNS O
infected VBD O
with IN O
H. NNP O
pylori NN O
were VBD O
used VBN O
in IN O
the DT O
study NN O
. . O

-DOCSTART- X X O

However RB O
, , O
as IN O
determined VBN O
by IN O
PCR NNP O
with IN O
primers NNS O
specific JJ O
for IN O
the DT O
26-kDa JJ O
product NN O
, , O
the DT O
majority NN O
of IN O
cats NNS O
at IN O
2 CD O
and CC O
4 CD O
weeks NNS O
p.t JJ O
. . O
had VBD O
gastric JJ O
fluid NN O
samples NNS O
which WDT O
were VBD O
positive JJ O
for IN O
H. NNP O
pylori NN O
and CC O
three CD O
of IN O
three CD O
cats NNS O
at IN O
2 CD O
weeks NNS O
p.t RB O
. . O
had VBD O
dental JJ O
plaque NN O
which WDT O
was VBD O
positive JJ O
for IN O
H. NNP O
pylori NN O
. . O

-DOCSTART- X X O

STUDY NNP O
DESIGN. NNP O

-DOCSTART- X X O

Differential JJ O
activation NN O
of IN O
the DT O
extracellular JJ B-NP
signal-regulated JJ I-NP
kinase NN I-NP
, , O
Jun NNP B-NP
kinase NN I-NP
and CC O
Janus NNP B-NP
kinase-Stat NN I-NP
pathways NNS O
by IN O
oncostatin NNP B-NP
M NNP I-NP
and CC O
basic JJ B-NP
fibroblast JJ I-NP
growth NN I-NP
factor NN I-NP
in IN O
AIDS-derived JJ O
Kaposi NNP O
's POS O
sarcoma NN O
cells NNS O
. . O

-DOCSTART- X X O

Ten CD O
weeks NNS O
after IN O
reconstruction NN O
, , O
the DT O
regenerating JJ O
nerves NNS O
already RB O
resembled VBD O
normal JJ O
nerves NNS O
. . O

-DOCSTART- X X O

The DT O
distribution NN O
and CC O
organization NN O
of IN O
projections NNS O
from IN O
the DT O
spinal JJ O
cervical JJ O
enlargement NN O
to TO O
subnucleus NN O
reticularis NN O
dorsalis NNS O
( -LRB- O
SRD NNP O
) -RRB- O
and CC O
the DT O
neighbouring NN O
Cuneate NN O
nucleus NN O
( -LRB- O
Cu NNP O
) -RRB- O
area NN O
was VBD O
studied VBN O
in IN O
the DT O
rat NN O
by IN O
using VBG O
microinjections NNS O
of IN O
Phaseolus NNP B-NP
vulgaris NN I-NP
leucoagglutinin FW I-NP
( -LRB- O
PHA-L) NN B-NP
into IN O
different JJ O
laminae NNS O
around IN O
the DT O
C7 NNP O
level NN O
. . O

-DOCSTART- X X O

The DT O
levels NNS O
of IN O
fibrinogen NN B-NP
as RB O
well RB O
as IN O
antithrombin JJ B-NP
III NNP I-NP
( -LRB- O
ATIII NNP B-NP
) -RRB- O
and CC O
heparin JJ B-NP
cofactor NN I-NP
II NNP I-NP
( -LRB- O
HCII NN B-NP
) -RRB- O
activities NNS O
were VBD O
steadily RB O
increased VBN O
in IN O
loop-bearing VBG O
animals NNS O
. . O

-DOCSTART- X X O

Facioscapulohumeral NNP O
muscular JJ O
dystrophy NN O
( -LRB- O
FSHD NN O
) -RRB- O
is VBZ O
an DT O
autosomal JJ O
dominant JJ O
, , O
neuromuscular JJ O
disorder NN O
characterized VBN O
by IN O
progressive JJ O
weakness NN O
of IN O
muscles NNS O
in IN O
the DT O
face NN O
, , O
shoulder NN O
and CC O
upper JJ O
arm NN O
. . O

-DOCSTART- X X O

Patients NNS O
who WP O
have VBP O
undergone VBN O
thyroidectomy NN O
for IN O
thyroid DT O
carcinoma NN O
are VBP O
frequently RB O
subjected VBN O
to TO O
periods NNS O
of IN O
induced JJ O
severe JJ O
hypothyroidism NN O
in IN O
preparation NN O
for IN O
131I JJ O
whole JJ O
body NN O
scanning NN O
and CC O
measurement NN O
of IN O
serum NN O
TG. . B-NP

-DOCSTART- X X O

Full NNP O
thyroid VBD O
function NN O
testing NN O
was VBD O
performed VBN O
on IN O
600 CD O
randomly JJ O
selected VBN O
samples NNS O
with IN O
normal JJ O
TSH NNS B-NP
values NNS O
and CC O
also RB O
on IN O
subjects NNS O
with IN O
abnormal JJ O
TSH NNP B-NP
levels NNS O
. . O

-DOCSTART- X X O

In IN O
a DT O
third JJ O
experiment NN O
, , O
crossover VB O
AM VBP O
between IN O
dissimilar JJ O
textures NNS O
was VBD O
investigated VBN O
, , O
and CC O
it PRP O
was VBD O
found VBN O
that IN O
the DT O
more JJR O
salient NN O
textures NNS O
carried VBD O
the DT O
AM. NNP O

-DOCSTART- X X O

Catha NNP O
edulis NN O
, , O
a DT O
plant NN O
that WDT O
has VBZ O
amphetamine JJ O
effects NNS O
. . O

-DOCSTART- X X O

The DT O
predicted VBD O
protein NN O
, , O
Seb1p NNP B-NP
, , O
consists VBZ O
of IN O
82 CD O
amino IN O
acids NNS O
and CC O
contains VBZ O
one CD O
potential JJ O
membrane-spanning NN O
region NN O
at IN O
the DT O
C-terminus NN O
but CC O
no DT O
N-terminal JJ O
signal NN O
sequence NN O
. . O

-DOCSTART- X X O

Nonetheless RB O
, , O
that IN O
ventricular JJ O
afferents NNS O
, , O
in IN O
certain JJ O
special JJ O
settings NNS O
, , O
are VBP O
able JJ O
to TO O
induce VB O
e.g NN O
. . O
generalised VBD O
vasodilation NN O
and CC O
hypotension NN O
cannot MD O
be VB O
excluded VBN O
. . O

-DOCSTART- X X O

Fragments NNS O
and CC O
analogs NNS O
of IN O
the DT O
hormone NN O
ACTH NNP B-NP
were VBD O
previously RB O
shown VBN O
to TO O
have VB O
beneficial JJ O
effect NN O
on IN O
the DT O
outcome NN O
of IN O
head NN O
injury NN O
, , O
while IN O
elevated JJ O
levels NNS O
of IN O
corticosterone NN O
( -LRB- O
CS) NNP O
exacerbate NN O
it PRP O
. . O

-DOCSTART- X X O

Study NN O
groups NNS O
were VBD O
control NN O
, , O
and CC O
those DT O
treated VBN O
with IN O
the DT O
alpha1-adrenoceptor-subtype JJ B-NP
blockers NNS O
WB4101 IN O
( -LRB- O
0.5 CD O
mg/kg NN O
i NN O
.v. , O
) -RRB- O
or CC O
chloroethylclonidine NN O
( -LRB- O
1.9 CD O
mg/kg NN O
i NN O
.v. NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
occurrence NN O
of IN O
multiple JJ O
malignancy NN O
was VBD O
studied VBN O
in IN O
674 CD O
patients NNS O
with IN O
hematologic NN O
malignancies NNS O
who WP O
were VBD O
admitted VBN O
to TO O
this DT O
department NN O
during IN O
the DT O
past JJ O
10 CD O
years NNS O
. . O

-DOCSTART- X X O

Transcriptional JJ O
control NN O
of IN O
a DT O
nuclear JJ O
gene NN O
encoding VBG O
a DT O
mitochondrial JJ O
fatty JJ O
acid NN O
oxidation NN O
enzyme NN O
in IN O
transgenic JJ O
mice NNS O
: : O
role NN O
for IN O
nuclear JJ O
receptors NNS O
in IN O
cardiac JJ O
and CC O
brown JJ O
adipose NN O
expression NN O
. . O

-DOCSTART- X X O

Hoeben NNP O
, , O
F.J. NNP O

-DOCSTART- X X O

Twelve CD O
genomic JJ O
fragments NNS O
containing VBG O
novel JJ O
response NN O
elements NNS O
are VBP O
described VBN O
, , O
and CC O
the DT O
transcription NN O
unit NN O
associated VBN O
with IN O
one CD O
of IN O
them PRP O
, , O
NN-84AG NNP B-NP
, , O
was VBD O
characterized VBN O
in IN O
detail NN O
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

Alterations NNP O
of IN O
the DT O
5q23-q31 JJ O
interval NN O
are VBP O
frequently RB O
observed VBN O
in IN O
myelodysplasia NN O
and CC O
myeloid JJ O
leukemia NN O
. . O

-DOCSTART- X X O

Previous JJ O
studies NNS O
have VBP O
suggested VBN O
that IN O
the DT O
616 CD O
amino IN O
acid NN O
, , O
70-kDa JJ B-NP
subunit NN I-NP
of IN I-NP
RPA NNP I-NP
( -LRB- O
RPA NN B-NP
70 CD I-NP
) -RRB- O
is VBZ O
composed VBN O
of IN O
multiple JJ O
structural/functional JJ O
domains NNS O
. . O

-DOCSTART- X X O

Neurons NNS O
were VBD O
held VBN O
at IN O
-67 DT O
mV NN O
to TO O
equate VB O
voltage-dependent JJ O
effects NNS O
. . O

-DOCSTART- X X O

This DT O
site NN O
acts VBZ O
as IN O
a DT O
negative JJ O
element NN O
when WRB O
transferred VBN O
to TO O
the DT O
thymidine NN B-NP
kinase NN I-NP
promoter NN I-NP
, , O
but CC O
does VBZ O
not RB O
confer VB O
inducibility NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
support VBP O
a DT O
model NN O
where WRB O
both DT O
E2F- NNP B-NP
and CC O
CDE-mediated JJ O
repression NN O
, , O
acting VBG O
at IN O
different JJ O
stages NNS O
in IN O
the DT O
cell NN O
cycle NN O
, , O
are VBP O
dependent JJ O
on IN O
promoter-specific JJ O
CHR NNP O
elements NNS O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
the DT O
deduced JJ O
amino IN O
acid NN O
sequences NNS O
with IN O
protein NN O
sequences NNS O
of IN O
T. NNP O
pyriformis VBG O
H2As NNP B-NP
showed VBD O
only RB O
two CD O
and CC O
three CD O
differences NNS O
respectively RB O
, , O
in IN O
a DT O
total NN O
of IN O
137 CD O
amino IN O
acids NNS O
for IN O
H2A1 NNP B-NP
, , O
and CC O
132 CD O
amino IN O
acids NNS O
for IN O
H2A2 NNP B-NP
, , O
indicating VBG O
the DT O
two CD O
genes NNS O
arose VBD O
before IN O
the DT O
divergence NN O
of IN O
these DT O
two CD O
species NNS O
. . O

-DOCSTART- X X O

Cognitive JJ O
visual JJ O
dysfunction NN O
in IN O
a DT O
child NN O
with IN O
cerebral JJ O
damage NN O
. . O

-DOCSTART- X X O

Interaction NNP O
was VBD O
apparently RB O
determined VBN O
by IN O
the DT O
N-terminal JJ O
splice NN O
region NN O
of IN O
RPDE-6 NN B-NP
, , O
as IN O
the DT O
PDE4A NNP B-NP
splice NN O
variant NN O
RPDE-39 NNP B-NP
, , O
which WDT O
differs VBZ O
from IN O
RPDE-6 NN B-NP
at IN O
the DT O
extreme JJ O
N-terminus NNP O
, , O
failed VBD O
to TO O
associate VB O
with IN O
v-Src-SH3 JJ B-NP
; : O
met26RD1 NNS B-NP
( -LRB- O
where WRB O
RD1 NNP B-NP
is VBZ O
rat NN B-NP
'dunc-like JJ I-NP
' '' I-NP
PDE NN I-NP
) -RRB- O
, , O
which WDT O
has VBZ O
the DT O
N-terminal JJ O
splice NN O
region NN O
deleted VBN O
, , O
failed VBD O
to TO O
associate VB O
with IN O
v-Src-SH3 JJ B-NP
, , O
and CC O
the DT O
association NN O
of IN O
RPDE-6 NNP B-NP
and CC O
v-Src-SH3 DT B-NP
was VBD O
blocked VBN O
by IN O
a DT O
fusion NN O
protein NN O
formed VBD O
from IN O
the DT O
N-terminal JJ O
splice NN O
region NN O
. . O

-DOCSTART- X X O

Large JJ O
strain NN O
differences NNS O
were VBD O
found VBN O
for IN O
all DT O
variables NNS O
recorded VBN O
, , O
i IN O
.e NN O
. . O
, , O
the DT O
proportion NN O
of IN O
attacking VBG O
males NNS O
, , O
the DT O
time NN O
spent VBN O
in IN O
the DT O
brightly JJ O
lit NN O
box NN O
, , O
and CC O
the DT O
number NN O
of IN O
transitions NNS O
between IN O
the DT O
lit NN O
and CC O
the DT O
dark JJ O
boxes NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
the DT O
oxidation NN O
peak NN O
of IN O
this DT O
product NN O
, , O
arising VBG O
in IN O
acidic JJ O
media NNS O
at IN O
0.42 CD O
V NNP O
, , O
which WDT O
was VBD O
analysed VBN O
using VBG O
DPV NNP O
, , O
again RB O
following VBG O
the DT O
accumulation NN O
of IN O
clenbuterol NN O
at IN O
the DT O
Nafion-modified JJ O
CPE. NNP O

-DOCSTART- X X O

Phenylephrine NNP O
is VBZ O
a DT O
pure JJ O
alpha-1 NN B-NP
adrenoreceptor NN I-NP
agonist NN O
known VBN O
to TO O
produce VB O
marked VBN O
systemic JJ O
vasoconstriction NN O
and CC O
associated VBN O
hypertension NN O
with IN O
occasional JJ O
profound JJ O
reflex NN O
bradycardia NN O
. . O

-DOCSTART- X X O

The DT O
expression NN O
of IN O
the DT O
first JJ O
two CD O
genes NNS O
located VBN O
in IN O
this DT O
unit NN O
(c-gvpD JJ O
and CC O
c-gvpE JJ B-NP
) -RRB- O
was VBD O
also RB O
monitored VBN O
by IN O
Western JJ O
blot NN O
( -LRB- O
immunoblot NN O
) -RRB- O
analyses NNS O
using VBG O
antisera NN O
raised VBN O
against IN O
these DT O
proteins NNS O
synthesized VBN O
in IN O
Escherichia NNP O
coli NNS O
. . O

-DOCSTART- X X O

CASE NNP O
REPORT NNP O
: : O
Referred NNP O
because IN O
of IN O
a DT O
right JJ O
corneal NN O
perforation NN O
with IN O
cellular JJ O
reaction NN O
in IN O
anterior JJ O
chamber NN O
, , O
a DT O
patient NN O
was VBD O
sutured VBN O
and CC O
treated VBN O
with IN O
a DT O
single JJ O
intravitreal JJ O
injection NN O
of IN O
0.2 CD O
ml NN O
( -LRB- O
1 CD O
mg NN O
) -RRB- O
Amikacin NNP O
and CC O
0.2 CD O
ml NN O
( -LRB- O
1 CD O
mg NN O
) -RRB- O
Vancomycin NNP O
. . O

-DOCSTART- X X O

The DT O
P-wr JJ B-NP
and CC O
P-rr JJ B-NP
cDNA NN I-NP
sequences NNS I-NP
are VBP O
very RB O
similar JJ O
in IN O
their PRP$ O
5' JJ O
regions NNS O
. . O

-DOCSTART- X X O

The DT O
structure NN O
of IN O
these DT O
genes NNS O
suggests VBZ O
a DT O
common JJ O
ancestor NN O
for IN O
all DT O
viperid JJ B-NP
PLA2 NNP I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

Increased VBN O
PTHRP NNP B-NP
production NN O
by IN O
a DT O
tyrosine NN B-NP
kinase NN I-NP
oncogene NN I-NP
, , O
Tpr-Met NNP B-NP
: : O
role NN O
of IN O
the DT O
Ras NNP B-NP
signaling VBG O
pathway NN O
. . O

-DOCSTART- X X O

All DT O
patients NNS O
had VBD O
abnormal JJ O
von NNP B-NP
Willebrand NNP I-NP
factor NN I-NP
(vWF NN O
) -RRB- O
fragmentation NN O
as IN O
reflected VBN O
by IN O
decreased VBN O
high JJ O
molecular JJ O
weight NN O
and CC O
increased VBD O
low JJ O
molecular JJ O
weight NN O
vWF IN B-NP
multimers NNS I-NP
in IN O
the DT O
circulation NN O
. . O

-DOCSTART- X X O

In IN O
an DT O
attempt NN O
to TO O
investigate VB O
whether IN O
the DT O
intergenic JJ O
region NN O
between IN O
the DT O
oleosin NN B-NP
and CC O
a DT O
second JJ O
open JJ O
reading NN O
frame NN O
( -LRB- O
ORFII NNP O
) -RRB- O
in IN O
Brassica NNP O
napus FW O
( -LRB- O
L. NNP O
) -RRB- O
is VBZ O
a DT O
divergent JJ O
promoter NN O
, , O
and CC O
also RB O
to TO O
characterize VB O
the DT O
ORFII NNP B-NP
, , O
cDNA NN B-NP
clones NNS I-NP
homologous JJ I-NP
to TO I-NP
ORFII NNP I-NP
were VBD O
isolated VBN O
from IN O
a DT O
leaf NN O
cDNA VBG O
library NN O
. . O

-DOCSTART- X X O

The DT O
ORFII NNP B-NP
gene NN I-NP
product NN I-NP
is VBZ O
targeted VBN O
to TO O
the DT O
chloroplast NN O
, , O
which WDT O
is VBZ O
consistent JJ O
with IN O
previous JJ O
data NNS O
indicating VBG O
the DT O
presence NN O
of IN O
PMSR NNP B-NP
activity NN O
in IN O
the DT O
chloroplast NN O
. . O

-DOCSTART- X X O

The DT O
patients NNS O
are VBP O
two CD O
healthy JJ O
adult NN O
males NNS O
. . O

-DOCSTART- X X O

Indoor NNP O
concentrations NNS O
were VBD O
only RB O
weakly RB O
correlated VBN O
with IN O
outdoor JJ O
concentrations NNS O
, , O
however RB O
, , O
and CC O
personal JJ O
exposures NNS O
were VBD O
even RB O
more RBR O
poorly RB O
correlated VBN O
with IN O
outdoor JJ O
concentrations NNS O
. . O

-DOCSTART- X X O

The DT O
5' JJ O
flanking JJ O
region NN O
of IN O
the DT O
mouse NN B-NP
Met-ase-1 NNP I-NP
gene NN I-NP
also RB O
shares VBZ O
considerable JJ O
regions NNS O
of IN O
identity NN O
with IN O
the DT O
5' JJ O
flanking JJ O
region NN O
of IN O
the DT O
rat NN B-NP
Met-ase-1 NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
[18F]FMISO NNP O
TMRR NNP O
is VBZ O
a DT O
simple JJ O
and CC O
clinically RB O
useful JJ O
index NN O
for IN O
detecting VBG O
tumour NN O
hypoxia NN O
in IN O
NPC. NNP O

-DOCSTART- X X O

Improved VBN O
methods NNS O
have VBP O
been VBN O
developed VBN O
for IN O
maintaining VBG O
and CC O
breeding VBG O
the DT O
neotropical JJ O
short-tailed JJ O
fruit NN O
bat NN O
, , O
Carollia NNP O
perspicillata NNS O
, , O
in IN O
an DT O
easily-reproduced JJ O
, , O
laboratory NN O
setting NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
the DT O
time NN O
to TO O
engraftment NN O
was VBD O
significantly RB O
shorter JJR O
in IN O
the DT O
amifostine JJ O
arm NN O
in IN O
both DT O
cohorts NNS O
. . O

-DOCSTART- X X O

Also RB O
like IN O
the DT O
thrombin NN B-NP
receptor NN I-NP
, , O
PAR2 NNP B-NP
can MD O
be VB O
activated VBN O
by IN O
the DT O
hexapeptide NN O
corresponding JJ O
to TO O
its PRP$ O
tethered JJ O
ligand NN O
sequence NN O
independent JJ O
of IN O
receptor NN O
cleavage NN O
. . O

-DOCSTART- X X O

Using VBG O
fluorescence NN O
in IN O
situ FW O
hybridization NN O
, , O
we PRP O
mapped VBD O
the DT O
chromosome-17 NN O
breakpoint NN O
in IN O
a DT O
patient NN O
with IN O
acampomelic JJ O
CMPD NNP O
and CC O
sex NN O
reversal NN O
, , O
who WP O
carries VBZ O
a DT O
de FW O
novo FW O
constitutional JJ O
t( JJ O
12;17 CD O
) -RRB- O
translocation NN O
, , O
between IN O
two CD O
known VBN O
cosmid NN O
markers NNS O
in IN O
the DT O
17q24-q25 CD O
region NN O
. . O

-DOCSTART- X X O

This DT O
is VBZ O
concluded VBN O
from IN O
the DT O
isolation NN O
of IN O
cDNAs NNS O
from IN O
spinach NN O
( -LRB- O
Spinacia NNP O
oleracea NN O
) -RRB- O
and CC O
barley NN O
( -LRB- O
Hordeum NNP O
vulgare NN O
cv. . O

-DOCSTART- X X O

The DT O
data NNS O
presented VBN O
in IN O
this DT O
work NN O
indicate VBP O
that IN O
thi1 DT B-NP
may MD O
also RB O
be VB O
involved VBN O
in IN O
DNA NNP O
damage NN O
tolerance NN O
in IN O
plant NN O
cells NNS O
. . O

-DOCSTART- X X O

DESIGN NNP O
: : O
A DT O
cross-sectional JJ O
study NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
SPK NNP O
and CC O
PTA NNP O
category NN O
, , O
anti-T-cell JJ O
therapy NN O
significantly RB O
lowered VBD O
the DT O
risk NN O
of IN O
graft NN O
loss NN O
. . O

-DOCSTART- X X O

A DT O
transgenic JJ O
complementation NN O
assay NN O
was VBD O
used VBN O
to TO O
test VB O
whether IN O
NIa NNP B-NP
supplied VBD O
in IN O
trans NNS O
could MD O
rescue VB O
amplification-defective JJ O
viral JJ O
genomes NNS O
encoding VBG O
altered VBN O
NIa NNP B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

The DT O
rCBF NN O
and CC O
vasomotion NN O
were VBD O
recorded VBN O
by IN O
laser-doppler NN O
fluxmetry NN O
. . O

-DOCSTART- X X O

The DT O
triple JJ O
combination NN O
of IN O
nizatidine NN O
, , O
clarithromycin NN O
, , O
and CC O
bismuth NN O
subcitrate NN O
resulted VBD O
in IN O
an DT O
ulcer NN O
healing NN O
rate NN O
of IN O
98 CD O
% NN O
and CC O
an DT O
H. NNP O
pylori NN O
eradication NN O
rate NN O
of IN O
90 CD O
% NN O
. . O

-DOCSTART- X X O

Serine NN O
528 CD O
is VBZ O
phosphorylated VBN O
in IN O
vivo NN O
in IN O
several JJ O
cell NN O
lines NNS O
, , O
and CC O
substitution NN O
of IN O
serine NN O
528 CD O
to TO O
alanine VB O
( -LRB- O
S528A NN O
) -RRB- O
resulted VBD O
in IN O
an DT O
increased VBN O
ability NN O
of IN O
Myb NNP B-NP
to TO O
transactivate VB O
a DT O
synthetic NN O
promoter NN O
containing VBG O
five CD O
copies NNS O
of IN O
the DT O
mim-1A JJ B-NP
Myb-responsive JJ B-NP
element NN O
and CC O
a DT O
minimal JJ O
herpes NNS B-NP
tk VBP I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

The DT O
DNA NNP O
binding NN O
and CC O
multimerization NN O
activities NNS O
of IN O
c-Myb JJ B-NP
appear VBP O
to TO O
be VB O
unaffected JJ O
by IN O
the DT O
S528A NNP O
substitution NN O
, , O
suggesting VBG O
that IN O
phosphorylation NN O
of IN O
serine NN O
528 CD O
may MD O
mediate VB O
its PRP$ O
effect NN O
on IN O
the DT O
transcription NN O
transactivating NN O
activity NN O
of IN O
c-Myb JJ B-NP
by IN O
regulating VBG O
interactions NNS O
with IN O
other JJ O
proteins NNS O
. . O

-DOCSTART- X X O

The DT O
amount NN O
of IN O
these DT O
factors NNS O
was VBD O
reduced VBN O
in IN O
GEO NN O
cells NNS O
in IN O
which WDT O
the DT O
u-PAR NN B-NP
gene NN I-NP
is VBZ O
only RB O
weakly RB O
transcriptionally RB O
activated VBN O
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

Cys-757 NNS O
within IN O
the DT O
( -LRB- O
Fe4S4)-siroheme-binding JJ O
domain NN O
was VBD O
essential JJ O
for IN O
native JJ O
enzyme NN O
activity NN O
. . O

-DOCSTART- X X O

Altogether RB O
, , O
our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
transcriptional JJ O
activity NN O
of IN O
Cut NNP B-NP
proteins NNS I-NP
is VBZ O
modulated VBN O
by IN O
PKC. NNP B-NP

-DOCSTART- X X O

Furthermore RB O
, , O
freezing VBG O
in IN O
the DT O
presence NN O
of IN O
bovine JJ B-NP
lactalbumin NN I-NP
resulted VBD O
in IN O
a DT O
good JJ O
maintenance NN O
of IN O
the DT O
cellular JJ O
viability NN O
and CC O
of IN O
the DT O
CCCD NNP O
heterogeneity NN O
in IN O
respect NN O
to TO O
fresh JJ O
cells NNS O
. . O

-DOCSTART- X X O

Five-year JJ O
survivals NNS O
amounted VBD O
to TO O
100 CD O
% NN O
, , O
86.2 CD O
% NN O
, , O
59.4 CD O
% NN O
, , O
29.8 CD O
% NN O
, , O
and CC O
20 CD O
% NN O
for IN O
stages NNS O
I PRP O
, , O
II NNP O
, , O
III NNP O
, , O
IVA NNP O
and CC O
IVB NNP O
respectively RB O
. . O

-DOCSTART- X X O

Targeted NNP O
disruption NN O
of IN O
the DT O
OGG1 NNP B-NP
gene NN I-NP
in IN O
yeast NN O
revealed VBD O
a DT O
second JJ O
OG NNP B-NP
glycosylase/lyase NN I-NP
protein NN I-NP
, , O
tentatively RB O
named VBN O
Ogg2 NNP B-NP
, , O
which WDT O
differs VBZ O
from IN O
Ogg1 NNP B-NP
in IN O
that IN O
it PRP O
preferentially RB O
acts VBZ O
on IN O
OG:G. NNP O

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
the DT O
isolated VBN O
genomic JJ O
clone NN O
revealed VBD O
that IN O
the DT O
DNA NNP O
binding NN O
domain NN O
of IN O
this DT O
orphan JJ O
receptor NN O
is VBZ O
most RBS O
homologous JJ O
to TO O
the DT O
human JJ B-NP
TR2 NN I-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

Genomic JJ O
DNA NNP O
hybridization NN O
suggests VBZ O
that IN O
SpSHR2 NNP B-NP
is VBZ O
a DT O
single-copy JJ O
gene NN O
in IN O
the DT O
S. NNP O
purpuratus NN O
genome NN O
. . O

-DOCSTART- X X O

A DT O
3-yr JJ O
retrospective JJ O
review NN O
is VBZ O
effective JJ O
and CC O
detects VBZ O
94 CD O
% NN O
of IN O
the DT O
undercalls NNS O
. . O

-DOCSTART- X X O

Isolation NN O
and CC O
identification NN O
of IN O
genes NNS O
activating VBG O
UAS2-dependent JJ B-NP
ADH2 NNPS I-NP
expression NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

Patients NNS O
with IN O
low JJ O
probability NN O
of IN O
having VBG O
aluminum NN O
overload NN O
( -LRB- O
serum VBN O
iron NN O
levels NNS O
< RB O
40 CD O
micrograms/L NN O
and CC O
DAI NNP O
< NNP O
150 CD O
micrograms/L NNS O
) -RRB- O
had VBD O
significantly RB O
higher JJR O
values NNS O
of IN O
serum NN O
iron NN O
, , O
iron NN O
transferrin NN B-NP
saturation NN O
, , O
and CC O
serum NN B-NP
ferritin NN I-NP
levels NNS O
compared VBN O
with IN O
those DT O
patients NNS O
with IN O
a DT O
high JJ O
probability NN O
of IN O
having VBG O
aluminum NN O
overload NN O
( -LRB- O
serum NN O
aluminum NN O
levels NNS O
> RB O
40 CD O
micrograms/L NN O
and CC O
DAI NNP O
> NNP O
150 CD O
micrograms/L NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Ha-RasV12 . B-NP
and CC O
activated JJ O
proteins NNS O
in IN O
both DT O
the DT O
extra-cellular JJ B-NP
regulated JJ I-NP
kinase NN I-NP
( -LRB- O
ERK) NNP B-NP
and CC O
the DT O
stress-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
SAPK) NNP B-NP
or CC O
Jun NNP B-NP
N-terminal JJ I-NP
kinase NN I-NP
( -LRB- O
JNK) NNP B-NP
cascades NNS O
independently RB O
stimulated VBD O
PEA3-mediated JJ B-NP
gene NN O
expression NN O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
reverse NN O
transcribed VBN O
, , O
amplified VBN O
cDNA NN O
generated VBD O
from IN O
total JJ O
RNA NNP O
isolated VBD O
from IN O
transfected JJ O
cells NNS O
demonstrated VBN O
the DT O
presence NN O
of IN O
abnormally RB O
spliced VBN O
products NNS O
containing VBG O
13 CD O
and CC O
78 CD O
additional JJ O
bases NNS O
as RB O
well RB O
as IN O
the DT O
accumulation NN O
of IN O
unspliced JJ O
mRNA NN O
. . O

-DOCSTART- X X O

A DT O
1.5-kb JJ O
HindIII NNP B-NP
genomic JJ O
fragment NN O
carrying VBG O
the DT O
vspA JJ B-NP
gene NN O
from IN O
M. NNP O
bovis POS O
PG45 NNP O
was VBD O
cloned VBN O
and CC O
sequenced VBN O
. . O

-DOCSTART- X X O

A DT O
subsequent JJ O
screen NN O
for IN O
the DT O
loss NN O
of IN O
the DT O
positively RB O
selectable JJ O
target NN O
locus NN O
marker NN O
detects VBZ O
the DT O
desired VBN O
replacement NN O
at IN O
modest JJ O
frequency NN O
( -LRB- O
> IN O
2 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
procedural JJ O
variations NNS O
on IN O
lateralized JJ O
Stroop NNP O
effects NNS O
. . O

-DOCSTART- X X O

In IN O
a DT O
third JJ O
experiment NN O
, , O
a DT O
Chessmaster NNP O
gradually RB O
increases VBZ O
the DT O
number NN O
of IN O
boards NNS O
he PRP O
can MD O
reproduce VB O
with IN O
higher JJR O
than IN O
70 CD O
% NN O
average JJ O
accuracy NN O
to TO O
nine CD O
, , O
replacing VBG O
as RB O
many JJ O
as IN O
160 CD O
pieces NNS O
correctly RB O
. . O

-DOCSTART- X X O

PCNA NNP B-NP
mRNA NN I-NP
has VBZ O
a DT O
3'UTR JJ O
antisense NN O
to TO O
yellow JJ O
crescent JJ O
RNA NN O
and CC O
is VBZ O
localized VBN O
in IN O
ascidian JJ O
eggs NNS O
and CC O
embryos NNS O
. . O

-DOCSTART- X X O

A DT O
1.8-kb JJ O
cDNA NN O
clone NN O
( -LRB- O
designed VBN O
hKID RB B-NP
, , O
gene NN B-NP
symbol NN I-NP
AQP2L NNP I-NP
) -RRB- O
with IN O
homology NN O
to TO O
the DT O
aquaporins NNS B-NP
was VBD O
isolated VBN O
from IN O
a DT O
human JJ O
kidney NN O
cDNA NN O
library NN O
. . O

-DOCSTART- X X O

PCR/Southern JJ O
blot NN O
analysis NN O
of IN O
human JJ O
kidney NN O
cDNA NN O
using VBG O
primers NNS O
flanking VBG O
the DT O
hKID NN B-NP
coding NN I-NP
sequence NN I-NP
revealed VBD O
expression NN O
of IN O
a DT O
full-length JJ O
mRNA NN O
and CC O
short JJ O
transcripts NNS O
with IN O
partial JJ O
exon NN O
1 CD O
and CC O
partial JJ O
exon NN O
4 CD O
deletions NNS O
. . O

-DOCSTART- X X O

The DT O
high JJ O
sequence NN O
homology NN O
, , O
similar JJ O
genomic JJ O
structure NN O
, , O
and CC O
identical JJ O
chromosomal NN O
loci NNS O
of IN O
hKID NN B-NP
, , O
MIP NNP B-NP
, , O
and CC O
AQP-2 NNP B-NP
suggest VBP O
a DT O
MIP NNP B-NP
family NN I-NP
gene NN I-NP
cluster NN I-NP
at IN O
chromosome NN O
locus NN O
12q13 CD O
. . O

-DOCSTART- X X O

The DT O
importance NN O
of IN O
temporal JJ O
factors NNS O
on IN O
the DT O
presence NN O
and CC O
severity NN O
of IN O
ethanol NN O
withdrawal NN O
signs NNS O
in IN O
the DT O
rat NN O
was VBD O
quantified VBN O
using VBG O
rating NN O
scale NN O
, , O
tremor NN O
, , O
and CC O
acoustic JJ O
startle NN O
paradigms NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
multidomained JJ O
ROK NNP B-NP
alpha NN I-NP
appears VBZ O
to TO O
be VB O
involved VBN O
in IN O
reorganization NN O
of IN O
the DT O
cytoskeleton NN O
, , O
with IN O
the DT O
N NNP O
and CC O
C NNP O
termini NNS O
acting VBG O
as IN O
positive JJ O
and CC O
negative JJ O
regulators NNS O
, , O
respectively RB O
, , O
of IN O
the DT O
kinase NN O
domain NN O
whose WP$ O
activity NN O
is VBZ O
crucial JJ O
for IN O
formation NN O
of IN O
stress NN O
fibers NNS O
and CC O
focal JJ O
adhesion NN O
complexes NNS O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
and CC O
the DT O
differential JJ O
tissue NN O
distribution NN O
of IN O
p54 NN B-NP
suggest VBP O
that IN O
this DT O
novel NN O
SR NNP B-NP
protein NN I-NP
may MD O
participate VB O
in IN O
regulation NN O
of IN O
alternative NN O
splicing NN O
in IN O
a DT O
tissue NN O
- : O
and CC O
substrate-dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

An DT O
interaction NN O
screen NN O
with IN O
the DT O
repression NN O
domain NN O
of IN O
the DT O
orphan JJ B-NP
receptor NN I-NP
RevErb NNP I-NP
identified VBD O
N-CoR NNP B-NP
, , O
the DT O
corepressor NN O
for IN O
thyroid DT B-NP
hormone NN I-NP
receptor NN I-NP
( -LRB- O
TR NN B-NP
) -RRB- O
and CC O
retinoic JJ B-NP
acid NN I-NP
receptor NN I-NP
(RAR NN O
) -RRB- O
. . O

-DOCSTART- X X O

Our PRP$ O
analysis NN O
suggests VBZ O
that IN O
Upf1p NNP B-NP
is VBZ O
a DT O
multifunctional JJ O
protein NN O
with IN O
separable JJ O
activities NNS O
that WDT O
can MD O
affect VB O
mRNA JJ O
turnover NN O
and CC O
nonsense NN O
suppression NN O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
Ste4 NNP B-NP
as IN O
a DT O
potential JJ O
regulator NN O
of IN O
Byr2 NNP B-NP
in IN O
the DT O
sexual JJ O
response NN O
pathway NN O
of IN O
Schizosaccharomyces NNP O
pombe NN O
. . O

-DOCSTART- X X O

Platelet-derived NNP B-NP
growth NN I-NP
factor-dependent NN I-NP
activation NN O
of IN O
phosphatidylinositol NN B-NP
3-kinase JJ I-NP
is VBZ O
regulated VBN O
by IN O
receptor NN O
binding NN O
of IN O
SH2-domain-containing JJ B-NP
proteins NNS I-NP
which WDT O
influence VBP O
Ras NNP B-NP
activity NN O
. . O

-DOCSTART- X X O

In IN O
transient JJ O
cotransfections NNS O
E1A PRP B-NP
could MD O
induce VB O
the DT O
activity NN O
of IN O
the DT O
p53 NN B-NP
promoter NN I-NP
to TO O
a DT O
high JJ O
level NN O
; : O
12S DT B-NP
E1A NNP I-NP
was VBD O
threefold JJ O
as RB O
efficient JJ O
as IN O
13S DT B-NP
E1A NNP I-NP
in IN O
this DT O
activity NN O
, , O
and CC O
YY1 NNP B-NP
bound VBD O
to TO O
the DT O
composite JJ O
element NN O
was VBD O
shown VBN O
to TO O
mediate JJ O
55 CD O
% NN O
of IN O
this DT O
induction NN O
. . O

-DOCSTART- X X O

DNA-dependent JJ B-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
DNA-PK) NNP B-NP
consists VBZ O
of IN O
a DT O
heterodimeric JJ O
protein NN O
( -LRB- O
Ku NNP B-NP
) -RRB- O
and CC O
a DT O
large JJ O
catalytic JJ O
subunit NN O
( -LRB- O
DNA-PKcs NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

However RB O
, , O
in IN O
a DT O
multivariate JJ O
analysis NN O
considering VBG O
age NN O
, , O
gender NN O
, , O
and CC O
a DT O
previous JJ O
history NN O
of IN O
cardiovascular JJ O
diseases NNS O
, , O
female JJ O
gender NN O
was VBD O
not RB O
independently RB O
associated VBN O
with IN O
death NN O
. . O

-DOCSTART- X X O

Despite IN O
the DT O
presence NN O
of IN O
one CD O
additional JJ O
ribonucleotide NN B-NP
reductase NN I-NP
, , O
the DT O
nrdAB-encoded JJ B-NP
enzyme NN I-NP
is VBZ O
essential JJ O
to TO O
the DT O
aerobic JJ O
growth NN O
of IN O
the DT O
cell NN O
because IN O
nrdAB-defective JJ B-NP
mutants NNS I-NP
of IN O
both DT O
species NNS O
are VBP O
not RB O
viable JJ O
in IN O
the DT O
presence NN O
of IN O
oxygen NN O
. . O

-DOCSTART- X X O

Motivational NNP O
factors NNS O
focusing VBG O
on IN O
attitudes NNS O
, , O
perceived VBN O
susceptibility NN O
to TO O
pregnancy NN O
, , O
and CC O
normative JJ O
factors NNS O
were VBD O
also RB O
relevant JJ O
. . O

-DOCSTART- X X O

High-resolution NNP O
structure NN O
of IN O
the DT O
diphtheria NN B-NP
toxin NN I-NP
repressor NN I-NP
complexed VBN O
with IN O
cobalt NN O
and CC O
manganese NN O
reveals VBZ O
an DT O
SH3-like JJ B-NP
third JJ O
domain NN O
and CC O
suggests VBZ O
a DT O
possible JJ O
role NN O
of IN O
phosphate NN O
as IN O
co-corepressor NN O
. . O

-DOCSTART- X X O

FEV1 NNP O
did VBD O
not RB O
fall VB O
significantly RB O
in IN O
patients NNS O
without IN O
acute JJ O
or CC O
chronic JJ O
GVHD NNP O
and CC O
recovered VBD O
earlier JJR O
than IN O
in IN O
patients NNS O
without IN O
posttransplant JJ O
pulmonary JJ O
infection NN O
. . O

-DOCSTART- X X O

Therapy NNP O
with IN O
dietary NN O
modification NN O
and CC O
triglyceride NN O
lowering VBG O
drugs NNS O
resulted VBD O
in IN O
resolution NN O
of IN O
symptoms NNS O
and CC O
parotid VBD O
swelling VBG O
in IN O
one CD O
patient NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
cloned VBN O
a DT O
novel JJ O
protein NN O
kinase NN O
, , O
termed VBD O
hematopoietic JJ B-NP
progenitor NN I-NP
kinase NN I-NP
1 CD I-NP
( -LRB- O
HPK1 NN B-NP
) -RRB- O
, , O
that WDT O
is VBZ O
expressed VBN O
predominantly RB O
in IN O
hematopoietic JJ O
cells NNS O
, , O
including VBG O
early JJ O
progenitor NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
fragments NNS O
are VBP O
separated VBN O
and CC O
directly RB O
sized VBN O
by IN O
agarose DT O
gel NNP O
electrophoresis NN O
. . O

-DOCSTART- X X O

Linkage NN O
studies NNS O
have VBP O
shown VBN O
locus JJ O
heterogeneity NN O
with IN O
one CD O
TSC NNP B-NP
gene NN I-NP
mapped VBD O
to TO O
chromosome NN O
9q34 CD O
and CC O
a DT O
second JJ O
to TO O
16p13.3 CD O
. . O

-DOCSTART- X X O

The DT O
cytogenetic JJ O
expression NN O
of IN O
the DT O
folate JJ O
sensitive JJ O
fragile JJ O
site NN O
, , O
FRAXE NNP B-NP
, , O
is VBZ O
due JJ O
to TO O
the DT O
expansion NN O
of IN O
a DT O
GCC NNP O
repeat NN O
in IN O
proximal JJ O
Xq28 NNS O
of IN O
the DT O
human JJ O
X NNP O
chromosome NN O
and CC O
is VBZ O
associated VBN O
with IN O
a DT O
mild JJ O
form NN O
of IN O
mental JJ O
handicap NN O
. . O

-DOCSTART- X X O

DNA NNP O
sequence NN O
analysis NN O
of IN O
a DT O
3213 CD O
bp NN O
BamHI-Cla CC B-NP
I PRP B-NP
fragment NN O
revealed VBD O
that IN O
three CD O
open JJ O
reading NN O
frames NNS O
( -LRB- O
ORFs NNS O
) -RRB- O
were VBD O
encoded VBN O
in IN O
the DT O
same JJ O
orientation NN O
. . O

-DOCSTART- X X O

The DT O
initial JJ O
inpatient JJ O
experience NN O
for IN O
individuals NNS O
with IN O
HIV-related PRP$ O
TB NN O
may MD O
be VB O
pivotal JJ O
to TO O
the DT O
acceptance NN O
of IN O
and CC O
participation NN O
in IN O
ongoing JJ O
TB NN O
care NN O
. . O

-DOCSTART- X X O

Tristetraprolin NNP B-NP
( -LRB- O
TTP NN B-NP
) -RRB- O
is VBZ O
the DT O
prototype NN O
of IN O
a DT O
group NN O
of IN O
potential JJ O
transcription NN O
factors NNS O
that WDT O
contain VBP O
two CD O
or CC O
more JJR O
unusual JJ O
CCCH NNP O
zinc NN O
fingers NNS O
. . O

-DOCSTART- X X O

This DT O
element NN O
, , O
termed VBD O
CREsp-a NNP O
( -LRB- O
TGACCTCA NN O
) -RRB- O
, , O
differs VBZ O
by IN O
one CD O
nucleotide NN O
from IN O
a DT O
palindromic JJ O
CRE NNP O
( -LRB- O
CREpal NNP O
, , O
TGACGTCA NNP O
) -RRB- O
, , O
which WDT O
is VBZ O
known VBN O
to TO O
bind NN O
CREB NNP B-NP
as IN O
a DT O
homodimer NN O
. . O

-DOCSTART- X X O

An DT O
inverted VBN O
Alu NNP B-NP
repeat VBP O
element NN O
, , O
flanked VBN O
by IN O
nonamer JJ O
direct JJ O
repeats NNS O
, , O
was VBD O
identified VBN O
within IN O
the DT O
region NN O
-913/-620 NN O
, , O
relative JJ O
to TO O
the DT O
cap NN O
site NN O
. . O

-DOCSTART- X X O

The DT O
ewes NNS O
were VBD O
returned VBN O
to TO O
normoxia DT O
, , O
and CC O
monitoring NN O
was VBD O
continued VBN O
for IN O
1 CD O
h NN O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
the DT O
amino JJ O
acid NN O
sequences NNS O
of IN O
the DT O
RPO1 NNP B-NP
polypeptides NNS I-NP
of IN I-NP
IIV6 NNP I-NP
, , I-NP
LCDV NNP I-NP
, , I-NP
and CC I-NP
MCV-1 NNP I-NP
with IN O
the DT O
corresponding JJ O
prokaryotic JJ O
, , O
eukaryotic JJ O
, , O
and CC O
viral JJ O
proteins NNS O
revealed VBD O
differences NNS O
in IN O
amino JJ O
acid NN O
similarity NN O
and CC O
phylogenetic JJ O
relationships NNS O
. . O

-DOCSTART- X X O

The DT O
use NN O
of IN O
primary JJ O
GE NNP O
cells NNS O
thus RB O
provides VBZ O
a DT O
convenient JJ O
in IN O
vitro NN O
system NN O
for IN O
further JJ O
study NN O
of IN O
the DT O
endocrine NN O
, , O
paracrine NN O
, , O
and CC O
autocrine JJ O
factors NNS O
regulating VBG O
endometrial JJ O
gene NN O
expression NN O
during IN O
pregnancy NN O
. . O

-DOCSTART- X X O

We PRP O
performed VBD O
dipole JJ O
estimation NN O
of IN O
spikes NNS O
and CC O
SEP NNP O
components NNS O
in IN O
identical JJ O
patients NNS O
. . O

-DOCSTART- X X O

Proximal NNP O
CBD NNP O
was VBD O
inversely RB O
correlated VBN O
with IN O
bone NN B-NP
alkaline NN I-NP
phosphatase NN I-NP
( -LRB- O
r NN O
= SYM O
-0.71 FW O
, , O
p NN O
< NN O
0.01 CD O
) -RRB- O
and CC O
intact JJ O
PTH NNP B-NP
( -LRB- O
r NN O
= SYM O
-0.59 FW O
, , O
p JJ O
< JJ O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
a DT O
comparison NN O
of IN O
the DT O
hCHLR NN B-NP
gene NN I-NP
sequences NNS I-NP
with IN O
available JJ O
databases NNS O
indicates VBZ O
that IN O
a DT O
large JJ O
portion NN O
of IN O
these DT O
genes NNS O
, , O
including VBG O
exons NNS O
encoding VBG O
two CD O
functional JJ O
domains NNS O
of IN O
the DT O
carboxyl-terminal JJ O
region NN O
of IN O
these DT O
proteins NNS O
, , O
has VBZ O
been VBN O
duplicated VBN O
as IN O
part NN O
of IN O
a DT O
larger JJR O
human NN O
telomeric NN O
repeat NN O
sequence NN O
found VBD O
on IN O
many JJ O
human JJ O
chromosomes NNS O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
here RB O
that IN O
the DT O
LIM NNP B-NP
domain NN I-NP
homeobox NN B-NP
protein NN I-NP
isl-1 NN B-NP
activates VBZ O
the DT O
rat NN B-NP
amylin IN I-NP
promoter NN I-NP
in IN O
both DT O
fibroblast JJ O
and CC O
islet JJ O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
likely JJ O
that IN O
other JJ O
pathways NNS O
involve VBP O
alternate JJ O
signal NN O
transduction NN O
events NNS O
( -LRB- O
e NN O
.g. NNP O
, , O
calcium NN O
mobilization NN O
) -RRB- O
and CC O
promoter NN O
response NN O
elements NNS O
( -LRB- O
e NN O
.g. NNP O
, , O
SRE NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
CD4 NNP B-NP
count NN O
at IN O
which WDT O
remission NN O
occurs VBZ O
may MD O
reflect VB O
severe JJ O
immunodeficiency NN O
such JJ O
that IN O
risk NN O
for IN O
AIDS-related JJ O
infection NN O
is VBZ O
high JJ O
. . O

-DOCSTART- X X O

Although IN O
diagnostic JJ O
laparoscopy NN O
is VBZ O
still RB O
considered VBN O
the DT O
standard JJ O
reference NN O
in IN O
the DT O
diagnosis NN O
of IN O
ectopic JJ O
pregnancy NN O
( -LRB- O
EP) NNP O
, , O
use NN O
of IN O
high-resolution NN O
endovaginal JJ O
sonography NN O
, , O
in IN O
conjunction NN O
with IN O
qualitative JJ O
serum NN O
assays IN O
of IN O
the DT O
beta JJ O
subunit NN O
of IN O
human JJ B-NP
chorionic NN I-NP
gonadotropin NN I-NP
( -LRB- O
beta-hCG) NN B-NP
, , O
allows VBZ O
detection NN O
of IN O
earlier JJR O
and CC O
smaller JJR O
EPs NNS O
. . O

-DOCSTART- X X O

Bifunctionality NN O
of IN O
the DT O
AcMNPV NNP B-NP
homologous JJ I-NP
region NN I-NP
sequence NN I-NP
( -LRB- O
hr1 NN B-NP
) -RRB- O
: : O
enhancer NN O
and CC O
ori NNP O
functions NNS O
have VBP O
different JJ O
sequence NN O
requirements NNS O
. . O

-DOCSTART- X X O

RVR NN B-NP
'loss TO O
of IN O
function NN O
' '' O
studies NNS O
by IN O
constitutive JJ O
over-expression NN O
of IN O
a DT O
dominant JJ O
negative JJ O
RVR NN B-NP
delta NN I-NP
E NNP I-NP
resulted VBD O
in IN O
increased JJ O
levels NNS O
of IN O
p21Cip1/Waf1 NN B-NP
and CC O
myogenin NN B-NP
mRNAs NNS I-NP
after IN O
serum NN O
withdrawal NN O
. . O

-DOCSTART- X X O

These DT O
two CD O
repeat NN O
motifs NNS O
are VBP O
organized VBN O
in IN O
an DT O
extremely RB O
well-ordered JJ O
pattern NN O
in IN O
each DT O
domain NN O
, , O
which WDT O
suggests VBZ O
that IN O
SbHRGP3 PRP B-NP
belongs VBZ O
to TO O
a DT O
new JJ O
group NN O
of IN O
proteins NNS O
having VBG O
the DT O
repeat NN O
motifs NNS O
of IN O
two CD O
distinct JJ O
groups NNS O
of IN O
dicot NN B-NP
extensins NNS I-NP
. . O

-DOCSTART- X X O

Their PRP$ O
use NN O
established VBD O
that IN O
the DT O
BrAAP NNP O
activity NN O
catalyzed VBD O
both DT O
a DT O
postproline NN O
and CC O
a DT O
postglutamate JJ O
cleavage NN O
and CC O
therefore RB O
has VBZ O
a DT O
broader JJR O
specificity NN O
than IN O
previously RB O
recognized VBN O
. . O

-DOCSTART- X X O

A DT O
stable JJ O
heterologous JJ O
cell NN O
line NN O
containing VBG O
the DT O
mouse NN B-NP
TRH NN I-NP
receptor NN I-NP
was VBD O
constructed VBN O
by IN O
transfection NN O
of IN O
nonexcitable JJ O
293 CD O
cells NNS O
, , O
which WDT O
lack VBP O
L NNP O
channel NN O
activity NN O
. . O

-DOCSTART- X X O

To TO O
understand VB O
further RB O
the DT O
expression NN O
and CC O
regulation NN O
of IN O
the DT O
V1aR NN B-NP
, , O
we PRP O
now RB O
describe VBP O
the DT O
genomic JJ O
characteristics NNS O
, , O
tissue NN O
expression NN O
, , O
chromosomal NN O
localization NN O
, , O
and CC O
regional JJ O
mapping NN O
of IN O
the DT O
human JJ B-NP
V1aR NNP I-NP
gene NN I-NP
, , O
AVPR1A. . B-NP

-DOCSTART- X X O

The DT O
final JJ O
predicted VBD O
structure NN O
has VBZ O
an DT O
overall JJ O
backbone NN O
deviation NN O
of IN O
0.7 CD O
A DT O
from IN O
that IN O
of IN O
ras-p21 NN B-NP
. . O

-DOCSTART- X X O

Genomic JJ O
organization NN O
of IN O
the DT O
human JJ B-NP
beta-catenin NN I-NP
gene NN I-NP
( -LRB- O
CTNNB1 NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
although IN O
the DT O
regional JJ O
distribution NN O
of IN O
lean JJ O
tissue NN O
mass NN O
in IN O
the DT O
trunk NN O
and CC O
legs NNS O
remained VBD O
fairly RB O
constant JJ O
at IN O
different JJ O
pubertal JJ O
stages NNS O
, , O
the DT O
regional JJ O
distribution NN O
of IN O
fat NN O
was VBD O
altered VBN O
significantly RB O
, , O
becoming VBG O
more RBR O
central JJ O
and CC O
less RBR O
peripheral JJ O
. . O

-DOCSTART- X X O

17.5 CD O
% NN O
of IN O
cycles NNS O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
here RB O
the DT O
discovery NN O
of IN O
a DT O
new JJ O
actin-related JJ B-NP
gene NN I-NP
in IN O
this DT O
organism NN O
, , O
which WDT O
we PRP O
have VBP O
named VBN O
ACT4 NNP B-NP
. . O

-DOCSTART- X X O

Two CD O
of IN O
the DT O
ORFs NNS O
are VBP O
completely RB O
internal JJ O
to TO O
longer JJR O
ones NNS O
and CC O
a DT O
third JJ O
is VBZ O
partially RB O
embedded VBN O
in IN O
G2850 NNP B-NP
. . O

-DOCSTART- X X O

MVR NNP O
typing NN O
of IN O
rare-length JJ O
alleles NNS O
indicates VBZ O
that IN O
they PRP O
are VBP O
comprised VBN O
of IN O
disorganized JJ O
sequences NNS O
, , O
although IN O
they PRP O
usually RB O
bear VBP O
a DT O
resemblance NN O
to TO O
one CD O
of IN O
the DT O
common JJ O
alleles NNS O
at IN O
the DT O
5'-most JJ O
end NN O
. . O

-DOCSTART- X X O

Two CD O
classes NNS O
of IN O
inactive JJ O
receptors NNS O
were VBD O
identified VBN O
: : O
one CD O
in IN O
which WDT O
both DT O
transcriptional JJ O
activation NN O
and CC O
dimerization NN O
were VBD O
compromised VBN O
and CC O
a DT O
second JJ O
in IN O
which WDT O
only JJ O
transcriptional JJ O
activation NN O
was VBD O
abolished VBN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
localize VBP O
a DT O
transferable JJ O
40-amino JJ O
acid NN O
region NN O
within IN O
the DT O
LBDs NNS B-NP
of IN O
RXR NNP B-NP
, , O
RAR NNP B-NP
, , O
TR NNP B-NP
, , O
and CC O
chicken NN B-NP
ovalbumin NN I-NP
upstream RB I-NP
promoter NN I-NP
transcription NN I-NP
factor NN I-NP
that WDT O
is VBZ O
critical JJ O
for IN O
determining VBG O
identity NN O
in IN O
the DT O
heterodimeric JJ O
interaction NN O
and CC O
for IN O
high-affinity JJ O
DNA NNP O
binding NN O
. . O

-DOCSTART- X X O

Restriction NNP O
enzyme NN O
mapping NN O
and CC O
Southern JJ O
analysis NN O
indicated VBN O
further RB O
that IN O
the DT O
human JJ B-NP
MZF-1 NNP I-NP
gene NN I-NP
is VBZ O
a DT O
single-copy JJ O
gene NN O
. . O

-DOCSTART- X X O

The DT O
detection NN O
ratio NN O
peaked VBD O
at IN O
ages NNS O
30 CD O
to TO O
34 CD O
and CC O
decreased VBD O
heavily RB O
during IN O
the DT O
next JJ O
15 CD O
years NNS O
of IN O
age NN O
. . O

-DOCSTART- X X O

The DT O
nonconsensus JJ O
TATA NNP O
box NN O
in IN O
promoter NN O
B NN O
plays VBZ O
a DT O
more RBR O
important JJ O
role NN O
in IN O
promoter NN O
activity NN O
than IN O
the DT O
TATA NNP O
box NN O
in IN O
promoter NN O
A. NN O

-DOCSTART- X X O

Demispan NNP O
is VBZ O
a DT O
reliable JJ O
and CC O
reproducible JJ O
measure NN O
of IN O
stature NN O
in IN O
the DT O
elderly JJ O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
performed VBN O
toeprinting VBG O
analyses NNS O
on IN O
repA DT B-NP
mRNA NN I-NP
of IN O
plasmid NN O
R1 NNS O
, , O
both DT O
free JJ O
and CC O
in IN O
duplex NN O
with IN O
the DT O
antisense NN O
RNA NNP O
, , O
CopA. . B-NP

-DOCSTART- X X O

Previous JJ O
work NN O
showed VBD O
that IN O
repA NN B-NP
( -LRB- O
initiator NN O
protein NN O
) -RRB- O
expression NN O
requires VBZ O
tap NN B-NP
( -LRB- O
leader NN O
peptide NN O
) -RRB- O
translation NN O
. . O

-DOCSTART- X X O

Tonsillectomy NN O
is VBZ O
an DT O
effective JJ O
means NN O
of IN O
prophylaxis NNS O
for IN O
upper JJ O
respiratory NN O
infection NN O
in IN O
habitual JJ O
angina NN O
patients NNS O
. . O

-DOCSTART- X X O

Pharmacokinetic JJ O
parameters NNS O
were VBD O
similar JJ O
to TO O
values NNS O
given VBN O
in IN O
the DT O
literature NN O
for IN O
intravenous JJ O
( -LRB- O
IV NNP O
) -RRB- O
or CC O
intraarterial JJ O
( -LRB- O
IA NNP O
) -RRB- O
bolus NN O
MMC NNP O
injections NNS O
( -LRB- O
Tmax NNP O
= SYM O
7.0 CD O
min NN O
following VBG O
the DT O
beginning NN O
of IN O
MMC NNP O
infusion NN O
, , O
Vss NNP O
= SYM O
0.57 CD O
1/kg CD O
, , O
C1 NNP O
= SYM O
8.9 CD O
ml/min.kg NN O
, , O
T1/2 NNP O
alpha NN O
= SYM O
8.3 CD O
min NN O
, , O
T1/2 DT O
beta JJ O
= SYM O
58.6 CD O
min NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
identified VBD O
four CD O
distinct JJ O
E2F NNP B-NP
complexes NNS I-NP
present JJ O
in IN O
aged JJ O
and CC O
senescent JJ O
normal JJ O
, , O
human JJ O
diploid NN O
fibroblasts NNS O
. . O

-DOCSTART- X X O

If IN O
we PRP O
apply VBP O
the DT O
finding NN O
of IN O
non-visualization NN O
of IN O
the DT O
GB NNP O
at IN O
4 CD O
h NN O
post NN O
injection NN O
as IN O
the DT O
criterion NN O
for IN O
the DT O
diagnosis NN O
of IN O
AC NNP O
, , O
the DT O
diagnostic JJ O
accuracy NN O
was VBD O
only RB O
40.7 CD O
% NN O
( -LRB- O
11/27 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Evidence NN O
for IN O
the DT O
promoting VBG O
role NN O
of IN O
the DT O
intra-uterine JJ B-NP
kinin NN I-NP
release NN O
in IN O
the DT O
development NN O
of IN O
late JJ O
hypertonic NN O
saline-induced JJ O
abortion NN O
. . O

-DOCSTART- X X O

This DT O
GAP NNP B-NP
activity NN O
was VBD O
observed VBN O
in IN O
3T3-L1 JJ O
adipocyte NN O
lysates NNS O
, , O
and CC O
was VBD O
able JJ O
to TO O
accelerate VB O
the DT O
hydrolysis NN O
of IN O
the DT O
[alpha-32P]GTP JJ O
bound JJ O
to TO O
GST-Rab4 VB B-NP
into IN O
[alpha-32P]GDP. PRP$ O

-DOCSTART- X X O

CONCLUSION NN O
: : O
During IN O
chronic NN O
treatment NN O
, , O
the DT O
haemodynamic JJ O
response NN O
to TO O
oral JJ O
cilazapril NN O
was VBD O
attenuated VBN O
, , O
indicating VBG O
that IN O
continued JJ O
clinical JJ O
improvement NN O
in IN O
patients NNS O
with IN O
CHF NNP O
on IN O
CLZ NN O
is VBZ O
independent JJ O
of IN O
to TO O
its PRP$ O
acute JJ O
haemodynamic JJ O
effects NNS O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
, , O
in IN O
AIDS NNP O
patients NNS O
with IN O
cryptococcosis NN O
, , O
tolerance NN O
to TO O
ILd-AmB NNP O
was VBD O
acceptable JJ O
when WRB O
the DT O
daily JJ O
dosage NN O
did VBD O
not RB O
exceed VB O
1 CD O
mg/kg JJ O
, , O
but CC O
the DT O
higher JJR O
1.5 CD O
mg/kg JJ O
daily JJ O
dosage NN O
was VBD O
associated VBN O
with IN O
an DT O
unacceptable JJ O
rate NN O
of IN O
nephrotoxicity NN O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
the DT O
second JJ O
RCC1-like JJ B-NP
motif NN I-NP
located VBN O
at IN O
the DT O
amino-terminus NN O
of IN O
p619 DT B-NP
stimulates NNS O
guanine VBP O
nucleotide JJ O
exchange NN O
on IN O
ARF1 NNP B-NP
and CC O
on IN O
members NNS O
of IN O
the DT O
related JJ O
Rab NNP B-NP
proteins VBZ I-NP
, , O
but CC O
not RB O
on IN O
other JJ O
small JJ B-NP
GTP NNP I-NP
binding JJ I-NP
proteins NNS I-NP
such JJ O
as IN O
Ran NNP B-NP
or CC O
R-Ras2/TC21 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
reconstituted VBD O
RNA NNP B-NP
polymerases NNS I-NP
containing VBG O
the DT O
mutant JJ O
alpha NN O
subunits NNS O
were VBD O
examined VBN O
for IN O
their PRP$ O
response NN O
to TO O
transcription NN O
activation NN O
by IN O
cAMP-CRP JJ B-NP
and CC O
the DT O
rrnBP1 JJ B-NP
UP NNP I-NP
element NN I-NP
. . O

-DOCSTART- X X O

A DT O
decrease NN O
of IN O
erythrocyte JJ O
Mn NNP O
with IN O
age NN O
, , O
expressed VBN O
in IN O
nmol/L NN O
, , O
was VBD O
noted VBN O
( -LRB- O
p NN O
< JJ O
0.02 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
thymidine DT B-NP
kinase NN I-NP
gene NN I-NP
in IN O
normal JJ O
human JJ O
diploid NN O
cells NNS O
is VBZ O
both DT O
cell NN O
cycle NN O
- : O
and CC O
age-dependent NN O
and CC O
appears VBZ O
to TO O
be VB O
transcriptionally RB O
regulated VBN O
. . O

-DOCSTART- X X O

These DT O
bacteria NNS O
produce VBP O
and CC O
export VBP O
proteins NNS O
capable JJ O
of IN O
specific JJ O
interactions NNS O
with IN O
key JJ O
mammalian JJ O
cell NN O
regulatory JJ O
molecules NNS O
in IN O
order NN O
to TO O
derail VB O
the DT O
normal JJ O
functions NNS O
of IN O
the DT O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
elevations NNS O
achieved VBN O
by IN O
LDEE NN O
given VBN O
s.c. NN O
were VBD O
higher JJR O
than IN O
those DT O
achieved VBN O
after IN O
i.p NN O
. . O
administration NN O
and CC O
lasted VBD O
for IN O
longer JJR O
periods NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
although IN O
p28 NNS B-NP
may MD O
play VB O
only RB O
a DT O
limited JJ O
role NN O
during IN O
the DT O
early JJ O
embryonic JJ O
cleavages NNS O
, , O
it PRP O
may MD O
function VB O
later RB O
in IN O
development NN O
to TO O
establish VB O
a DT O
somatic JJ O
type NN O
of IN O
cell NN O
cycle NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
suggested VBN O
that IN O
the DT O
observed JJ O
clinical JJ O
phenomena NNS O
in IN O
response NN O
to TO O
morphine NN O
can MD O
be VB O
explained VBN O
by IN O
differences NNS O
in IN O
expression NN O
and CC O
sensitivity NN O
of IN O
some DT O
opioid NN B-NP
receptor NN I-NP
subtypes NNS O
in IN O
migraine NN O
. . O

-DOCSTART- X X O

Previous JJ O
studies NNS O
demonstrated VBD O
that IN O
the DT O
flavin-containing NN B-NP
monooxygenases NNS I-NP
( -LRB- O
FMO NN B-NP
) -RRB- O
are VBP O
expressed VBN O
in IN O
a DT O
tissue-specific JJ O
manner NN O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
these DT O
observations NNS O
indicate VBP O
that IN O
the DT O
C-terminal JJ O
24 CD O
amino IN O
acids NNS O
are VBP O
sufficient JJ O
for IN O
NodO NNP B-NP
secretion NN O
although IN O
the DT O
region NN O
adjacent JJ O
to TO O
this DT O
domain NN O
appears VBZ O
to TO O
affect VB O
secretion NN O
efficiency NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
despite IN O
the DT O
potential JJ O
for IN O
common JJ O
regulatory JJ O
mechanisms NNS O
, , O
the DT O
available JJ O
evidence NN O
indicates VBZ O
that IN O
the DT O
Mtx NNP B-NP
minimal JJ I-NP
promoter NN I-NP
does VBZ O
not RB O
significantly RB O
affect VB O
Thbs3 DT B-NP
gene NN I-NP
expression NN O
. . O

-DOCSTART- X X O

MSSP NNP B-NP
proteins NNS I-NP
have VBP O
been VBN O
identified VBN O
by IN O
their PRP$ O
binding NN O
to TO O
an DT O
upstream JJ O
element NN O
of IN O
c-myc JJ B-NP
. . O

-DOCSTART- X X O

Gene NNP B-NP
1 CD I-NP
has VBZ O
been VBN O
completely RB O
sequenced VBN O
. . O

-DOCSTART- X X O

Both DT O
alleles NNS O
are VBP O
functionally RB O
expressed VBN O
and CC O
are VBP O
distributed VBN O
within IN O
CD4+/CD8+ NNP B-NP
T NNP O
cell NN O
subsets NNS O
. . O

-DOCSTART- X X O

The DT O
deduced JJ O
amino JJ O
acid NN O
sequence NN O
of IN O
LvUSF2 NNP B-NP
is VBZ O
nearly RB O
identical JJ O
to TO O
LvUSF1 VB B-NP
except IN O
at IN O
the DT O
amino JJ O
end NN O
, , O
where WRB O
they PRP O
are VBP O
sharply RB O
divergent JJ O
. . O

-DOCSTART- X X O

ECM NNP O
disruption NN O
in IN O
Lytechinus NNP O
embryos NNS O
caused VBD O
a DT O
relative JJ O
drop NN O
in IN O
USF NNP B-NP
RNA NNP I-NP
accumulation NN O
levels NNS O
to TO O
approximately RB O
60 CD O
% NN O
of IN O
control NN O
embryos NNS O
, , O
while IN O
LpS1 NNP B-NP
RNA NNP I-NP
accumulation NN O
levels NNS O
dropped VBD O
to TO O
less JJR O
than IN O
5 CD O
% NN O
. . O

-DOCSTART- X X O

Sixty CD O
days NNS O
after IN O
the DT O
intervention NN O
, , O
twitch VB O
and CC O
tetanic JJ O
tensions NNS O
remained VBD O
dependent JJ O
upon IN O
the DT O
extracellular JJ O
Ca2+ JJ O
concentration NN O
([Ca]o NN O
) -RRB- O
both CC O
in IN O
groups NNS O
A DT O
and CC O
B. NNP O

-DOCSTART- X X O

Discrimination NNP O
between IN O
HIV-1 NN O
and CC O
HIV-2 NN O
showed VBD O
evidence NN O
for IN O
the DT O
presence NN O
of IN O
HIV-1 PRP$ O
only RB O
. . O

-DOCSTART- X X O

The DT O
HiNF-D NNP B-NP
( -LRB- O
CDP/cut NN B-NP
) -RRB- O
complex NN O
with IN O
the DT O
H4 NNP B-NP
promoter NN I-NP
is VBZ O
immunoreactive JJ O
with IN O
antibodies NNS O
against IN O
CDP/cut NNP B-NP
and CC O
pRB NN B-NP
but CC O
not RB O
p107 VB B-NP
, , O
whereas IN O
the DT O
CDP/cut NN B-NP
complex NN O
with IN O
a DT O
nonhistone NN O
promoter NN O
( -LRB- O
gp91-phox NN B-NP
) -RRB- O
reacts VBZ O
only RB O
with IN O
CDP NNP B-NP
and CC O
p107 VBD B-NP
antibodies NNS O
. . O

-DOCSTART- X X O

The DT O
amplification NN O
was VBD O
achieved VBN O
using VBG O
two CD O
primers NNS O
which WDT O
correspond VBP O
to TO O
TRH NNP B-NP
progenitor NN I-NP
sequence NN I-NP
( -LRB- O
Lys/Arg-Arg-Gln-His-Pro-Gly-Lys/Arg-Arg JJ O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
intranodal JJ O
mesothelial NN O
cells NNS O
occupied VBN O
the DT O
sinusoids NNS O
of IN O
the DT O
lymph NN O
nodes NNS O
and CC O
were VBD O
initially RB O
suspected VBN O
of IN O
being VBG O
metastatic VBN O
from IN O
the DT O
ovarian JJ O
tumor NN O
in IN O
each DT O
case NN O
. . O

-DOCSTART- X X O

Administration NNP O
of IN O
RIFA NNP O
at IN O
200 CD O
mg/kg/day NN O
in IN O
combination NN O
with IN O
ATO NNP O
at IN O
100 CD O
mg/kg/day NN O
resulted VBD O
in IN O
a DT O
marked JJ O
prolongation NN O
of IN O
survival NN O
compared VBN O
with IN O
that DT O
for IN O
mice NNS O
that IN O
received VBN O
ATO NNP O
or CC O
RIFA NNP O
alone RB O
. . O

-DOCSTART- X X O

Eight-four CD O
ACOAs NNP O
were VBD O
tested VBN O
in IN O
order NN O
to TO O
examine VB O
the DT O
fit NN O
of IN O
the DT O
model NN O
to TO O
the DT O
data NNS O
by IN O
path NN O
analysis NN O
with IN O
LISREL NNP O
VII NNP O
. . O

-DOCSTART- X X O

Two CD O
of IN O
seven CD O
initiation NN O
sites NNS O
were VBD O
flanked VBN O
by IN O
a DT O
sequence NN O
homologous NN O
to TO O
the DT O
consensus NN O
promoter NN O
motif NN O
that WDT O
includes VBZ O
the DT O
CRTA NNP O
motif FW O
( -LRB- O
where WRB O
R NN O
is VBZ O
A DT O
or CC O
G NNP O
) -RRB- O
of IN O
the DT O
rice NN O
mitochondrion NN O
. . O

-DOCSTART- X X O

Selection NNP O
using VBG O
SC NNP O
EPD NNP O
was VBD O
more RBR O
effective JJ O
than IN O
phenotypic NN O
selection NN O
in IN O
reducing VBG O
age NN O
at IN O
puberty NN O
in IN O
daughters NNS O
. . O

-DOCSTART- X X O

The DT O
mammalian JJ B-NP
homeodomain JJ I-NP
proteins NNS I-NP
encoded VBN O
by IN O
Hox NNP B-NP
genes NNS I-NP
play VBP O
an DT O
important JJ O
role NN O
in IN O
embryonic JJ O
development NN O
by IN O
providing VBG O
positional JJ O
queues NNS O
which WDT O
define VB O
developmental JJ O
identities NNS O
along IN O
the DT O
anteroposterior JJ O
axis NN O
of IN O
developing VBG O
organisms NNS O
. . O

-DOCSTART- X X O

Interferon NNP B-NP
stimulated VBD I-NP
gene NN I-NP
factor NN I-NP
3 CD I-NP
( -LRB- O
ISGF3 NN B-NP
) -RRB- O
is VBZ O
a DT O
trimeric JJ O
transcription NN O
factor NN O
activated VBN O
on IN O
treatment NN O
of IN O
cells NNS O
with IN O
interferon-alpha JJ B-NP
and CC I-NP
beta JJ I-NP
( -LRB- O
type NN B-NP
I PRP I-NP
IFNs RB I-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
TYAC/P1 NNP O
resource NN O
, , O
derivative JJ O
STSs NNS O
, , O
and CC O
polymorphisms NNS O
constitute VBP O
an DT O
enabling VBG O
resource NN O
to TO O
further JJ O
studies NNS O
of IN O
telomere JJ O
structure NN O
and CC O
function NN O
and CC O
a DT O
means VBZ O
for IN O
physical JJ O
and CC O
genetic JJ O
map NN O
integration NN O
and CC O
closure NN O
. . O

-DOCSTART- X X O

Three CD O
mutants NNS O
were VBD O
isolated VBN O
from IN O
the DT O
widely RB O
used VBN O
strain NN O
, , O
PAO1 NNP O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
common JJ O
upstream RB O
signals NNS O
cause VB O
activation NN O
of IN O
Ras NNP B-NP
and CC O
TC21 NNP B-NP
, , O
but CC O
activated VBD O
TC21 NNP B-NP
controls VBZ O
cell NN O
growth NN O
via IN O
distinct JJ O
Raf-independent NNP B-NP
downstream NN O
signaling VBG O
pathways NNS O
. . O

-DOCSTART- X X O

Fission NNP B-NP
yeast NN I-NP
mal2+ NN I-NP
is VBZ O
required VBN O
for IN O
chromosome NN O
segregation NN O
. . O

-DOCSTART- X X O

The DT O
requirement NN O
of IN O
Tyr-19 JJ O
dephosphorylation NN O
for IN O
spindle NN O
assembly NN O
is VBZ O
also RB O
observed VBN O
under IN O
conditions NNS O
in IN O
which WDT O
spindle NN O
formation NN O
is VBZ O
independent JJ O
of IN O
mitosis NN O
, , O
suggesting VBG O
that IN O
the DT O
involvement NN O
of IN O
Cdc28/Clb JJ B-NP
kinase NN O
in IN O
SPB NNP O
separation NN O
is VBZ O
direct JJ O
. . O

-DOCSTART- X X O

A DT O
subset NN O
of IN O
these DT O
DMP1 JJ B-NP
recognition NN I-NP
sequences NNS I-NP
containing VBG O
a DT O
GGA JJ O
trinucleotide NN O
core NN O
can MD O
also RB O
function VB O
as IN O
Ets-responsive JJ B-NP
elements NNS I-NP
. . O

-DOCSTART- X X O

This DT O
technique NN O
was VBD O
employed VBN O
in IN O
12 CD O
patients NNS O
with IN O
a DT O
unicameral JJ O
bone NN O
cyst NN O
. . O

-DOCSTART- X X O

Enterococcus NNP O
faecium NN O
strains NNS O
with IN O
vanA-mediated JJ O
glycopeptide NN O
resistance NN O
were VBD O
isolated VBN O
by IN O
enrichment NN O
culture NN O
from IN O
the DT O
intestines NNS O
and CC O
feces NNS O
of IN O
several JJ O
animal NN O
species NNS O
, , O
mainly RB O
horses NNS O
and CC O
dogs NNS O
( -LRB- O
8 CD O
% NN O
positive JJ O
) -RRB- O
, , O
chickens NNS O
( -LRB- O
7 CD O
% NN O
positive JJ O
) -RRB- O
, , O
and CC O
pigs NNS O
( -LRB- O
6 CD O
% NN O
positive JJ O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
amino-terminal JJ O
region NN O
of IN O
E1A DT B-NP
binds NNS O
several JJ O
high JJ O
molecular JJ O
weight NN O
proteins NNS O
and CC O
inhibits VBZ O
the DT O
transcriptional JJ O
coactivator NN O
function NN O
of IN O
p300 NN B-NP
and CC O
the DT O
homologous JJ O
cAMP JJ B-NP
response NN I-NP
element NN I-NP
( -LRB- I-NP
CRE)-binding JJ I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Transient NNP O
transfection NN O
assays VBZ O
using VBG O
reporter NN O
gene NN O
constructs NNS O
containing VBG O
various JJ O
lengths NNS O
of IN O
the DT O
5' JJ B-NP
mdr1b NN I-NP
sequences NNS I-NP
revealed VBD O
that IN O
the DT O
sequence NN O
located VBN O
between-247 CD O
to TO O
-126 DT O
bp NN O
was VBD O
important JJ O
for IN O
the DT O
expression NN O
of IN O
the DT O
reporter NN O
gene NN O
in IN O
many JJ O
different JJ O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
the DT O
5'UTR JJ O
characteristic NN O
of IN O
testis-specific JJ B-NP
c-mos NNS I-NP
mRNA RB I-NP
strongly RB O
represses VBZ O
translation NN O
relative JJ O
to TO O
the DT O
translation NN O
of IN O
transcripts NNS O
that WDT O
contain VBP O
a DT O
5'UTR JJ O
derived VBN O
from IN O
beta-globin JJ B-NP
mRNA NN I-NP
, , O
and CC O
this DT O
is VBZ O
mainly RB O
due JJ O
to TO O
the DT O
four CD O
uORFs NNS O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
F-wave NN O
may MD O
be VB O
elicited VBN O
in IN O
motoneuron NN O
of IN O
different JJ O
depolarization NN O
threshold NN O
but CC O
primarily RB O
in IN O
larger JJR O
and CC O
faster JJR O
nerve NN O
fibers NNS O
, , O
with IN O
a DT O
lower JJR O
threshold NN O
of IN O
depolarization NN O
. . O

-DOCSTART- X X O

Northern JJ O
analysis NN O
of IN O
the DT O
3.1-kb JJ B-NP
PWP2H NNP I-NP
cDNA NNS I-NP
revealed VBD O
that IN O
a DT O
3.3-kb JJ O
major JJ O
transcript NN O
is VBZ O
ubiquitously RB O
expressed VBN O
in IN O
human JJ O
adult NN O
tissues NNS O
. . O

-DOCSTART- X X O

Forty-eight NNP O
10-12-week-old JJ O
male NN O
Sprague-Dawley NNP O
rats NNS O
were VBD O
randomized VBN O
to TO O
receive VB O
, , O
daily RB O
for IN O
28 CD O
days NNS O
: : O
( -LRB- O
1 CD O
) -RRB- O
CsA DT O
vehicle NN O
p.o RB O
. . O
plus CC O
FB NNP O
vehicle NN O
sc NN O
; : O
( -LRB- O
2 CD O
) -RRB- O
CsA NN O
( -LRB- O
15 CD O
mg/kg NN O
) -RRB- O
p.o NN O
. . O
plus CC O
FB NNP O
vehicle NN O
sc NN O
, , O
( -LRB- O
3 CD O
) -RRB- O
CsA DT O
vehicle NN O
p.o RB O
. . O
plus CC O
FB NNP O
( -LRB- O
1.5 CD O
mg/kg NN O
) -RRB- O
sc NN O
; : O
and CC O
( -LRB- O
4 CD O
) -RRB- O
CsA NN O
( -LRB- O
15 CD O
mg/kg NN O
) -RRB- O
p.o NN O
. . O
plus CC O
FB NNP O
( -LRB- O
1.5 CD O
mg/kg NN O
) -RRB- O
sc NN O
. . O

-DOCSTART- X X O

Oncogenic NNP O
activation NN O
of IN O
the DT O
tyrosine NN B-NP
kinase NN I-NP
domain NN I-NP
of IN O
the DT O
human JJ B-NP
trk NN I-NP
proto-oncogene NN I-NP
by IN O
fusion NN O
to TO O
a DT O
cell NN O
adhesion NN O
molecule NN O
. . O

-DOCSTART- X X O

Physiol NNP O
. . O

-DOCSTART- X X O

The DT O
nucleotide JJ O
sequence NN O
of IN O
22,846 CD O
bp NN O
of IN O
the DT O
left JJ O
arm NN O
of IN O
chromosome NN O
IV NNP O
is VBZ O
described VBN O
. . O

-DOCSTART- X X O

Natural JJ O
FL NNP B-NP
protein NN I-NP
has VBZ O
been VBN O
purified VBN O
from IN O
a DT O
stromal JJ O
cell NN O
line NN O
and CC O
shown VBN O
to TO O
be VB O
a DT O
65 CD O
kD NN O
nondisulfide-linked JJ O
homodimeric JJ O
glycoprotein NN O
comprised VBN O
of IN O
30 CD O
kD NN O
subunits NNS O
, , O
each DT O
containing VBG O
12 CD O
kD NN O
of IN O
N- NNP O
and CC O
O-linked JJ O
sugars NNS O
. . O

-DOCSTART- X X O

The DT O
objective NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
examine VB O
the DT O
influence NN O
of IN O
HHCA NNP O
and CC O
other JJ O
serological JJ O
factors NNS O
upon IN O
the DT O
development NN O
of IN O
VGS. NNP O

-DOCSTART- X X O

Spliced JJ O
exons NNS O
of IN O
adenovirus NN O
late JJ O
RNAs NNP O
colocalize NN O
with IN O
snRNP NN O
in IN O
a DT O
specific JJ O
nuclear JJ O
domain NN O
. . O

-DOCSTART- X X O

Using VBG O
Spurr NNP O
's POS O
resin NN O
as IN O
a DT O
mounting VBG O
medium NN O
, , O
we PRP O
could MD O
observe VB O
thick JJ O
specimens NNS O
with IN O
oil NN O
immersion RB O
objective JJ O
lens NN O
without IN O
the DT O
use NN O
of IN O
coverslips NNS O
, , O
then RB O
avoid VB O
air NN O
bubbles NNS O
near IN O
the DT O
specimen NNS O
. . O

-DOCSTART- X X O

Beyond IN O
the DT O
Tower NNP O
of IN O
Babel NNP O
: : O
a DT O
nomenclature NN O
for IN O
suicidology NN O
. . O

-DOCSTART- X X O

Infection NN O
with IN O
Neisseria NNP O
meningitidis NNS O
group NN O
B NNP O
has VBZ O
been VBN O
difficult JJ O
to TO O
detect VB O
, , O
partly RB O
because IN O
this DT O
bacterial JJ O
group NN O
's POS O
polysaccharide NN O
is VBZ O
a DT O
weak JJ O
immunogen NN O
. . O

-DOCSTART- X X O

RNase NN B-NP
protection NN O
analysis NN O
of IN O
two CD O
rRNA NN O
fragments NNS O
whose WP$ O
genes NNS O
are VBP O
adjacent JJ O
provided VBN O
evidence NN O
for IN O
a DT O
polycistronic NN O
transcript NN O
containing VBG O
sequences NNS O
from IN O
both DT O
, , O
as RB O
well RB O
as IN O
separate JJ O
small JJ O
RNAs NNS O
. . O

-DOCSTART- X X O

The DT O
PAI-2 NNP B-NP
gene NN I-NP
is VBZ O
one CD O
of IN O
the DT O
most RBS O
TNF-responsive JJ B-NP
genes NNS I-NP
known VBN O
and CC O
is VBZ O
also RB O
highly RB O
induced VBN O
by IN O
the DT O
phorbol NN O
ester NN O
phorbol NN O
12-myristate JJ O
13-acetate JJ O
( -LRB- O
PMA NN O
) -RRB- O
and CC O
the DT O
phosphatase NN O
inhibitor NN O
, , O
okadaic JJ O
acid NN O
, , O
in IN O
both DT O
HT-1080 JJ O
fibrosarcoma NN O
and CC O
U-937 JJ O
histiocytic JJ O
cells NNS O
. . O

-DOCSTART- X X O

220 CD O
, , O
263-273 CD O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
two CD O
contigs NNS O
contain VBP O
a DT O
total NN O
of IN O
163 CD O
open JJ O
reading NN O
frames NNS O
( -LRB- O
ORFs NNS O
) -RRB- O
in IN O
26-29 CD O
putative JJ O
operons NNS O
; : O
56 CD O
ORFs NNS O
could MD O
be VB O
identified VBN O
with IN O
reasonable JJ O
certainty NN O
. . O

-DOCSTART- X X O

Growth NN O
factors NNS O
induce VB O
the DT O
expression NN O
of IN O
the DT O
immediate JJ B-NP
early JJ I-NP
gene NN I-NP
products NNS I-NP
MAP NNP B-NP
kinase NN I-NP
phosphatase-1 NN I-NP
( -LRB- O
MKP-1 NN B-NP
) -RRB- O
, , O
c-Fos JJ B-NP
and CC O
c-Jun JJ B-NP
. . O

-DOCSTART- X X O

Vascular JJ O
responses NNS O
to TO O
reactive VB O
hyperemia NN O
( -LRB- O
with IN O
flow NN O
increase NN O
leading VBG O
to TO O
endothelium-dependent JJ O
dilation NN O
) -RRB- O
and CC O
to TO O
sublingual JJ O
glyceryl NN O
trinitrate NN O
( -LRB- O
GTN NNP O
; : O
endothelium-independent JJ O
dilation NN O
) -RRB- O
were VBD O
recorded VBN O
. . O

-DOCSTART- X X O

During IN O
this DT O
period NN O
, , O
administration NN O
of IN O
additional JJ O
exogenous JJ B-NP
PRL NN I-NP
did VBD O
not RB O
stimulate VB O
further JJ O
activation NN O
( -LRB- O
binding NN O
) -RRB- O
of IN O
the DT O
Stat NNP B-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

Intraperitoneal NNP O
administration NN O
of IN O
L-5-hydroxytryptophan JJ O
(L-5-HTP JJ O
) -RRB- O
at IN O
doses NNS O
of IN O
25 CD O
to TO O
100 CD O
mg/kg NN O
dramatically RB O
increase VB O
defecation NN O
in IN O
mice NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
VA-SMV JJ O
mode NN O
, , O
the DT O
connection NN O
was VBD O
made VBN O
with IN O
valved JJ O
conduits NNS O
from IN O
the DT O
LV NN O
apex NN O
( -LRB- O
inflow NN O
) -RRB- O
to TO O
the DT O
ascending VBG O
aorta NN O
(outflow NN O
) -RRB- O
( -LRB- O
n RB O
= SYM O
11 CD O
) -RRB- O
or CC O
to TO O
the DT O
DAo NNP O
( -LRB- O
n NN O
= SYM O
12 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
evidence NN O
in IN O
support NN O
of IN O
this DT O
was VBD O
derived VBN O
from IN O
the DT O
fact NN O
that IN O
the DT O
affinity NN O
or CC O
interaction NN O
between IN O
the DT O
two CD O
subunits NNS O
was VBD O
impaired VBN O
as IN O
indicated VBN O
by IN O
the DT O
first JJ O
order NN O
rate NN O
constant JJ O
of IN O
hCG JJ B-NP
alpha NN I-NP
1 CD I-NP
beta NN I-NP
(km IN O
= SYM O
4.1 CD O
x NN O
10(-2 CD O
) -RRB- O
min-1 NN O
) -RRB- O
at IN O
pH DT O
3.0 CD O
at IN O
23 CD O
degrees NNS O
C NN O
which WDT O
is VBZ O
one CD O
order NN O
of IN O
magnitude NN O
greater JJR O
relative JJ O
to TO O
rehCG NNP B-NP
(kw NNP O
= SYM O
4.6 CD O
x NN O
10(-3 JJ O
) -RRB- O
min-1 NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
majority NN O
of IN O
the DT O
cases NNS O
with IN O
0-I JJ O
or CC O
0-II JJ O
I PRP O
components NNS O
were VBD O
sm NN O
. . O
cancer NN O
. . O

-DOCSTART- X X O

These DT O
patients NNS O
appear VBP O
to TO O
have VB O
slightly RB O
better JJR O
pulmonary JJ O
function NN O
and CC O
nutritional JJ O
status NN O
; : O
yet RB O
, , O
they PRP O
seem VBP O
to TO O
have VB O
a DT O
higher JJR O
degree NN O
of IN O
health NN O
care NN O
utilization NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
found VBN O
that IN O
PEA2 NN B-NP
is VBZ O
also RB O
required VBN O
for IN O
the DT O
bipolar JJ O
budding JJ O
pattern NN O
and CC O
that IN O
it PRP O
encodes VBZ O
a DT O
novel JJ O
protein NN O
with IN O
a DT O
predicted VBN O
coiled-coil NN O
domain NN O
. . O

-DOCSTART- X X O

Signaling VBG O
from IN O
the DT O
small JJ B-NP
GTP-binding JJ I-NP
proteins NNS I-NP
Rac1 NNP I-NP
and CC O
Cdc42 NNP B-NP
to TO O
the DT O
c-Jun JJ B-NP
N-terminal JJ I-NP
kinase/stress-activated JJ I-NP
protein NN B-NP
kinase NN I-NP
pathway NN O
. . O

-DOCSTART- X X O

Correlating VBG O
with IN O
the DT O
previous JJ O
observation NN O
that IN O
CBF NNP B-NP
binding NN O
to TO O
the DT O
78C1 JJ O
site NN O
is VBZ O
enhanced VBN O
by IN O
EGTA NNP O
and CC O
EDTA NNP O
, , O
these DT O
divalent JJ O
cation NN O
chelators NNS O
specifically RB O
stimulate VB O
78C1-directed JJ O
transcription NN O
. . O

-DOCSTART- X X O

The DT O
human JJ O
gene NN O
fragment NN O
ligated VBN O
to TO O
the DT O
minimal JJ O
rat NN O
liver NN O
glucokinase NN B-NP
promoter NN O
was VBD O
shown VBN O
to TO O
work VB O
as IN O
an DT O
enhancer NN O
in IN O
the DT O
hepatocyte NN O
transfection NN O
system NN O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
truncated JJ O
deer NN B-NP
receptor NN I-NP
lacks VBZ O
the DT O
most RBS O
C-terminal JJ O
tyrosine NN O
residue NN O
in IN O
the DT O
intracellular JJ O
domain NN O
which WDT O
is VBZ O
believed VBN O
to TO O
be VB O
essential JJ O
for IN O
activation NN O
of IN O
the DT O
beta-casein JJ B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

This DT O
report NN O
provides VBZ O
further JJ O
evidence NN O
for IN O
the DT O
riMLF NN O
in IN O
the DT O
control NN O
of IN O
downgaze NN O
, , O
and CC O
a DT O
synkinesis NN O
is VBZ O
postulated VBN O
for IN O
the DT O
development NN O
of IN O
the DT O
convergence NN O
retraction NN O
nystagmus NN O
. . O

-DOCSTART- X X O

Rifabutin NNP O
has VBZ O
substantial JJ O
efficacy NN O
when WRB O
combined VBN O
with IN O
other JJ O
agents NNS O
. . O

-DOCSTART- X X O

The DT O
STE20 NNP B-NP
gene NN I-NP
, , O
encoding VBG O
a DT O
protein NN O
kinase NN O
required VBD O
for IN O
pheromone NN O
signal NN O
transduction NN O
, , O
has VBZ O
recently RB O
been VBN O
identified VBN O
in IN O
a DT O
genetic JJ O
screen NN O
for IN O
high-gene-dosage NN O
suppressors NNS O
of IN O
a DT O
partly RB O
defective JJ O
G NNP B-NP
beta NN I-NP
mutation NN O
. . O

-DOCSTART- X X O

This DT O
enzyme NN O
is VBZ O
designated VBN O
(1-->4)-beta-xylan JJ B-NP
endohydrolase NN I-NP
isoenzyme NN I-NP
X-I. . I-NP

-DOCSTART- X X O

Magnetic JJ O
resonance NN O
imaging NN O
in IN O
coccidioidal JJ O
arthritis NN O
. . O

-DOCSTART- X X O

REM JJ O
sleep NN O
deprivation NN O
was VBD O
performed VBN O
using VBG O
the DT O
platform NN O
technique NN O
. . O

-DOCSTART- X X O

The DT O
same JJ O
ligands NNS O
also RB O
exhibit VBP O
a DT O
similar JJ O
inhibitory JJ O
effect NN O
on IN O
PDGF-BB-dependent JJ B-NP
[3H]thymidine JJ O
incorporation NN O
in IN O
PAE NNP O
cells NNS O
expressing VBG O
the DT O
PDGF NNP B-NP
beta-receptors NNS I-NP
. . O

-DOCSTART- X X O

We PRP O
analyzed VBD O
serial JJ O
biopsy NN O
specimens NNS O
from IN O
eight CD O
patients NNS O
with IN O
FL NNP O
for IN O
secondary JJ O
alterations NNS O
of IN O
the DT O
rearranged JJ B-NP
bcl-2 JJ I-NP
gene NN I-NP
in IN O
the DT O
breakpoint NN O
and CC O
open JJ O
reading NN O
frame NN O
( -LRB- O
ORF NN O
) -RRB- O
regions NNS O
. . O

-DOCSTART- X X O

In IN O
all DT O
eight CD O
cases NNS O
, , O
neither CC O
FL NNP O
nor CC O
DLL NNP O
cells NNS O
showed VBD O
alterations NNS O
of IN O
bcl-2 JJ B-NP
gene NN I-NP
sequences NNS I-NP
in IN O
the DT O
breakpoint NN O
region NN O
, , O
suggesting VBG O
high JJ O
conservation NN O
of IN O
the DT O
bcl-2 JJ B-NP
gene NN I-NP
during IN O
both DT O
t( JJ O
14 CD O
; : O
18 CD O
) -RRB- O
translocation NN O
and CC O
morphologic NN O
transformation NN O
of IN O
the DT O
FL NNP O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
optimal JJ O
sequence NN O
for IN O
interaction NN O
with IN O
mu NN B-NP
2 CD I-NP
and CC O
with IN O
AP-2 NNP B-NP
has VBZ O
tyrosine NN O
as IN O
an DT O
anchor NN O
and CC O
prefers VBZ O
arginine VBN O
at IN O
position NN O
Y NNP O
+ NNP O
2 CD O
and CC O
leucine VB O
at IN O
position NN O
Y PRP O
+ . O
3. . O

-DOCSTART- X X O

STK/RON-expressing JJ B-NP
Ba/F3 IN O
pro-B JJ O
cells NNS O
( -LRB- O
BaF/STK) NNP O
exhibited VBD O
MSP-dependent JJ B-NP
growth NN O
, , O
whereas IN O
STK/ NNP B-NP
RON-expressing NNP B-NP
mouse NN O
erythroleukaemia NN O
cells NNS O
( -LRB- O
MEL/ NNP O
STK) NNP B-NP
displayed VBD O
MSP-induced JJ B-NP
apoptosis NN O
. . O

-DOCSTART- X X O

Kss1 DT B-NP
binds NNS O
specifically RB O
to TO O
a DT O
GST-Dig1 JJ B-NP
fusion NN O
in IN O
the DT O
absence NN O
of IN O
any DT O
other JJ O
yeast NN O
protein NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
dig1 JJ B-NP
dig2 NN B-NP
cells NNS O
constitutively RB O
invade VBP O
agar JJ O
medium NN O
, , O
whereas IN O
a DT O
dig1 JJ B-NP
dig2 NN B-NP
ste12 NN B-NP
triple JJ O
mutant NN O
does VBZ O
not RB O
, , O
indicating VBG O
that IN O
Dig1 NNP B-NP
and CC O
Dig2 NNP B-NP
share NN O
a DT O
role NN O
in IN O
negatively RB O
regulating VBG O
the DT O
invasive JJ O
growth NN O
pathway NN O
. . O

-DOCSTART- X X O

Transient JJ O
expression NN O
of IN O
VSF-1 NN B-NP
in IN O
protoplasts NNS O
stimulated VBN O
vs-1 JJ B-NP
dependent JJ O
activation NN O
of IN O
the DT O
-76/grp1.8 NNS B-NP
minimal JJ I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Keeping VBG O
in IN O
mind NN O
the DT O
limited JJ O
range NN O
of IN O
age NN O
and CC O
dosages NNS O
, , O
advantages NNS O
and CC O
disadvantages NNS O
of IN O
the DT O
drug NN O
are VBP O
discussed VBN O
, , O
comparing VBG O
the DT O
experimental JJ O
results NNS O
with IN O
those DT O
derived VBN O
from IN O
the DT O
literature NN O
. . O

-DOCSTART- X X O

Blood NN O
sampling NN O
procedures NNS O
were VBD O
videotaped VBN O
. . O

-DOCSTART- X X O

The DT O
current JJ O
study NN O
defines VBZ O
the DT O
vinculin- NNS B-NP
and CC O
FAK-interaction NNP B-NP
domains VBZ I-NP
on IN O
paxillin NN B-NP
and CC O
identifies VBZ O
the DT O
principal NN O
paxillin NN B-NP
focal JJ O
adhesion NN O
targeting VBG O
motif NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
demonstrate VBP O
the DT O
presence NN O
of IN O
a DT O
single JJ O
binding JJ O
site NN O
for IN O
vinculin NN B-NP
, , O
and CC O
at IN O
least JJS O
two CD O
binding JJ O
sites NNS O
for IN O
FAK NNP B-NP
that WDT O
are VBP O
separated VBN O
by IN O
an DT O
intervening JJ O
stretch NN O
of IN O
100 CD O
amino IN O
acids NNS O
. . O

-DOCSTART- X X O

These DT O
data NNS O
demonstrate VBP O
that IN O
paxillin VBG B-NP
localizes NNS O
to TO O
focal JJ O
adhesions NNS O
independent JJ O
of IN O
interactions NNS O
with IN O
vinculin NN B-NP
and/or CC O
FAK NNP B-NP
, , O
and CC O
represents VBZ O
the DT O
first JJ O
definitive JJ O
demonstration NN O
of IN O
LIM NNP B-NP
domains VBZ I-NP
functioning VBG O
as IN O
a DT O
primary JJ O
determinant NN O
of IN O
protein NN O
subcellular NN O
localization NN O
to TO O
focal JJ O
adhesions NNS O
. . O

-DOCSTART- X X O

Several JJ O
agents NNS O
have VBP O
been VBN O
tried VBN O
for IN O
treatment NN O
, , O
often RB O
limited JJ O
by IN O
toxic JJ O
side NN O
effects NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
are VBP O
consistent JJ O
with IN O
the DT O
well RB O
established VBN O
polarity NN O
of IN O
RXR NNP B-NP
heterodimer NN O
binding NN O
to TO O
bipartite JJ O
hormone NN O
response NN O
elements NNS O
, , O
with IN O
the DT O
VDR NNP B-NP
recognizing VBG O
the DT O
3'-half-element NN O
. . O

-DOCSTART- X X O

PPAR NN B-NP
gamma NN I-NP
mRNA NN I-NP
levels NNS O
were VBD O
reduced VBN O
by IN O
95 CD O
% NN O
with IN O
3 CD O
nM JJ O
TNF NNP B-NP
alpha NN I-NP
treatment NN O
for IN O
24 CD O
h NN O
. . O

-DOCSTART- X X O

Exons NNS O
III NNP O
to TO O
VIII NNP O
, , O
which WDT O
cover VBP O
the DT O
coding VBG O
region NN O
and CC O
the DT O
3' JJ O
untranslated JJ O
region NN O
, , O
are VBP O
almost RB O
identical JJ O
in IN O
all DT O
types NNS O
of IN O
PST NNP B-NP
or CC O
AST NNP B-NP
cDNAs NNS I-NP
. . O

-DOCSTART- X X O

Growth NN O
factor NN O
allows VBZ O
effective JJ O
dose-intensive JJ O
regimen NNS O
in IN O
advanced JJ O
breast NN O
cancer NN O
patients NNS O
. . O

-DOCSTART- X X O

Recombinant NNP B-NP
erythropoietin NN I-NP
(r-HuEPO NN O
) -RRB- O
in IN O
the DT O
treatment NN O
of IN O
anemia NN O
in IN O
multiple JJ O
myeloma NN O

-DOCSTART- X X O

Ki-ras NNP B-NP
and CC O
p53 NN B-NP
mutations NNS I-NP
in IN O
pancreatic JJ O
ductal JJ O
adenocarcinoma NN O
. . O

-DOCSTART- X X O

Epidemiological NNP O
data NNS O
are VBP O
quite RB O
controversial JJ O
but CC O
sudden JJ O
death NN O
occurring VBG O
during IN O
sporting NN O
activity NN O
is VBZ O
probably RB O
not RB O
a DT O
rare JJ O
occurrence NN O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
ratio NN O
M/Pc NNP O
provides VBZ O
a DT O
useful JJ O
index NN O
that IN O
seems VBZ O
to TO O
be VB O
independent JJ O
of IN O
the DT O
metabolic JJ O
demand NN O
. . O

-DOCSTART- X X O

The DT O
mobility NN O
shift NN O
assay NN O
of IN O
the DT O
65 CD O
bp JJ O
(-318/ JJ O
-254 NN O
) -RRB- O
fragment NN O
with IN O
nuclear JJ O
extract VB O
from IN O
the DT O
dark-adapted JJ O
sample NN O
showed VBD O
an DT O
additional JJ O
band NN O
, , O
not RB O
seen VBN O
with IN O
the DT O
light-grown JJ O
sample NN O
. . O

-DOCSTART- X X O

When WRB O
the DT O
E1A NNP B-NP
N-terminus NNP I-NP
is VBZ O
used VBN O
as IN O
a DT O
competitor NN O
in IN O
squelshing VBG O
experiments NNS O
it PRP O
abolishes VBZ O
CBP-induced JJ B-NP
activation NN O
of IN O
E2F1/DP1 NNP B-NP
, , O
whereas IN O
an DT O
E1A NN B-NP
mutant NN I-NP
lacking VBG O
CBP NNP B-NP
binding JJ O
ability NN O
fails VBZ O
to TO O
do VB O
so RB O
. . O

-DOCSTART- X X O

On IN O
the DT O
third JJ O
occasion NN O
water NN O
( -LRB- O
W NNP O
) -RRB- O
was VBD O
ingested VBN O
throughout IN O
the DT O
run NN O
. . O

-DOCSTART- X X O

The DT O
nm23-H1/nm23-H2 JJ B-NP
gene NN O
transcriptional JJ O
activity NN O
ratio NN O
varied VBN O
depending VBG O
on IN O
the DT O
cell NN O
line NN O
. . O

-DOCSTART- X X O

Discordance NNP O
on IN O
the DT O
cost NN O
dimension NN O
correlated VBD O
negatively RB O
with IN O
G NNP B-NP
Hb NNP I-NP
, , O
suggesting VBG O
better JJR O
glycemic JJ O
control NN O
with IN O
greater JJR O
disagreement NN O
. . O

-DOCSTART- X X O

DATA NNP O
SOURCES NNP O
: : O
Epidemiologic NNP O
studies NNS O
, , O
research NN O
studies NNS O
, , O
review NN O
articles NNS O
, , O
and CC O
government NN O
reports NNS O
pertaining VBG O
to TO O
epidemiology NN O
of IN O
lung NN O
cancer NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
The DT O
age NN O
distribution NN O
was VBD O
28 CD O
to TO O
83 CD O
years NNS O
old JJ O
( -LRB- O
mean NN O
was VBD O
54.1 CD O
years NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Histological JJ O
changes NNS O
, , O
including VBG O
cortical JJ O
cell NN O
involution NN O
and CC O
hemorrhage NN O
occurring VBG O
during IN O
the DT O
neonatal JJ O
period NN O
, , O
would MD O
seem VB O
to TO O
have VB O
crucial JJ O
relevance NN O
to TO O
the DT O
remodeling NN O
of IN O
the DT O
adrenal JJ O
vasculature NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
co-expression NN O
of IN O
both DT O
p46 NNS B-NP
and CC O
p54 NN B-NP
subunits NNS I-NP
markedly RB O
altered VBD O
the DT O
subcellular JJ O
distribution NN O
of IN O
p46 NNS B-NP
; : O
co-expressed JJ O
p46 NN B-NP
was VBD O
transported VBN O
into IN O
the DT O
nucleus JJ O
as IN O
efficiently RB O
as IN O
p54 NN B-NP
. . O

-DOCSTART- X X O

The DT O
results NNS O
suggest VBP O
that IN O
, , O
although IN O
both DT O
the DT O
N- NNP O
and CC O
C-terminal JJ O
regions NNS O
of IN O
talin NN B-NP
bind NN O
actin NN B-NP
, , O
the DT O
properties NNS O
of IN O
these DT O
two CD O
regions NNS O
of IN O
the DT O
protein NN O
are VBP O
distinct JJ O
. . O

-DOCSTART- X X O

Merr NNP O
. . O
) -RRB- O
embryo NN O
library NN O
. . O

-DOCSTART- X X O

In IN O
3Y1 JJ O
and CC O
3Y1 JJ O
v-crk-transformed JJ B-NP
fibroblasts NNS O
, , O
almost RB O
all DT O
of IN O
the DT O
total JJ O
PTP1B NNP B-NP
and CC O
about IN O
40 CD O
% NN O
of IN O
total JJ O
p130( JJ B-NP
Cas NNS B-NP
) -RRB- O
co-sediment NN O
with IN O
membranes NNS O
composed VBN O
primarily RB O
of IN O
endoplasmic JJ O
reticulum NN O
. . O

-DOCSTART- X X O

Replacing VBG O
residues NNS O
405-419 CD O
on IN O
delta419 JJ O
with IN O
the DT O
conserved JJ O
AF-2 JJ O
domain NN O
from IN O
the DT O
vitamin NN B-NP
D3 NN I-NP
receptor NN I-NP
or CC O
the DT O
estrogen NN B-NP
receptor NN I-NP
results NNS O
in IN O
a DT O
receptor NN O
with IN O
wild-type JJ O
or CC O
low JJ O
transcriptional JJ O
activity NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Administration NNP O
of IN O
a DT O
second JJ O
dose NN O
of IN O
vaccine NN O
during IN O
the DT O
outbreak NN O
was VBD O
not RB O
protective JJ O
. . O

-DOCSTART- X X O

But CC O
, , O
as IN O
Theriault NNP O
explains VBZ O
, , O
improvements NNS O
in IN O
assessing VBG O
exposure NN O
have VBP O
not RB O
yet RB O
translated VBN O
into IN O
clear JJ O
and CC O
consistent JJ O
findings NNS O
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

Evolutive JJ O
morphology NN O
of IN O
the DT O
olfactory JJ O
bulb NN O
in IN O
man NN O
and CC O
certain JJ O
non-human JJ O
mammals NNS O

-DOCSTART- X X O

From IN O
these DT O
results NNS O
, , O
we PRP O
concluded VBD O
that IN O
this DT O
ORF NN O
is VBZ O
the DT O
FRDS NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
Rho1p NNP B-NP
regulates VBZ O
cytoskeletal NN O
reorganization NN O
at IN O
least JJS O
through IN O
Bni1p NNP B-NP
and CC O
Pkc1p NNP B-NP
. . O

-DOCSTART- X X O

The DT O
ERH NNP B-NP
expression NN O
profile NN O
is VBZ O
similar JJ O
, , O
to TO O
that DT O
of IN O
An3 NNP B-NP
, , O
which WDT O
localizes VBZ O
to TO O
the DT O
animal NN O
hemisphere NN O
of IN O
oocytes NNS O
and CC O
is VBZ O
abundantly RB O
expressed VBN O
in IN O
the DT O
embryo NN O
. . O

-DOCSTART- X X O

Waves NNP O
N1 NNP O
, , O
P3 NNP O
and CC O
CNV NNP O
were VBD O
recorded VBN O
during IN O
a DT O
CNV NNP O
paradigm NN O
in IN O
a DT O
simple JJ O
reaction NN O
time NN O
task NN O
with IN O
a DT O
constant JJ O
interstimulus NN O
interval NN O
( -LRB- O
ISI) NNP O
of IN O
1 CD O
sec. NN O

-DOCSTART- X X O

Therefore RB O
, , O
both CC O
the DT O
Chilean NNP O
and CC O
the DT O
Japanese JJ O
samples NNS O
collected VBD O
in IN O
high-risk JJ O
areas NNS O
showed VBD O
higher JJR O
mutagenic JJ O
rates NNS O
than IN O
the DT O
Japanese JJ O
ones NNS O
in IN O
a DT O
low-risk JJ O
area NN O
, , O
with IN O
a DT O
statistical JJ O
significance NN O
( -LRB- O
p NN O
< JJ O
0.001 CD O
) -RRB- O
, , O
chi-square JJ O
test NN O
) -RRB- O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
ASN1 NNP B-NP
and CC O
ASN2 NNP B-NP
expression NN O
was VBD O
studied VBN O
using VBG O
lacZ NN B-NP
fusions NNS I-NP
and CC O
both DT O
genes NNS O
were VBD O
found VBN O
to TO O
be VB O
several JJ O
times NNS O
less RBR O
expressed VBD O
in IN O
the DT O
absence NN O
of IN O
the DT O
transcription NN O
activator NN O
Gcn4p NNP B-NP
. . O

-DOCSTART- X X O

Several JJ O
particular JJ O
features NNS O
of IN O
this DT O
polypeptide NN O
fragment NN O
from IN O
the DT O
hamster NN B-NP
lysyl-tRNA NN I-NP
synthetase NN I-NP
suggest VBP O
that IN O
it PRP O
is VBZ O
implicated VBN O
in IN O
the DT O
assembly NN O
of IN O
that DT O
enzyme NN O
within IN O
the DT O
multisynthetase JJ O
complex NN O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
oral JJ O
vanadyl NN O
sulfate NN O
(VOSO4 NN O
) -RRB- O
( -LRB- O
0.5 CD O
mg/kg/day NN O
) -RRB- O
on IN O
anthropometry NN O
, , O
body NN O
composition NN O
, , O
and CC O
performance NN O
were VBD O
investigated VBN O
in IN O
a DT O
12-week JJ O
, , O
double-blind JJ O
, , O
placebo-controlled JJ O
trial NN O
involving VBG O
weight-training NN O
volunteers NNS O
. . O

-DOCSTART- X X O

Later RB O
in IN O
development NN O
, , O
Tbx6 DT B-NP
expression NN O
is VBZ O
restricted VBN O
to TO O
presomitic NN O
, , O
paraxial JJ O
mesoderm NN O
and CC O
to TO O
the DT O
tail NN O
bud NN O
, , O
which WDT O
replaces VBZ O
the DT O
streak NN O
as IN O
the DT O
source NN O
of IN O
mesoderm NN O
. . O

-DOCSTART- X X O

Disruption NN O
of IN O
re-replication NN O
control NN O
by IN O
overexpression NN O
of IN O
human JJ B-NP
ORC1 NNS I-NP
in IN O
fission NN O
yeast NN O
. . O

-DOCSTART- X X O

Human JJ B-NP
acid NN I-NP
ceramidase NN I-NP
( -LRB- O
(AC NNP B-NP
) -RRB- I-NP
N-acylsphingosine NNP I-NP
amidohydrolase VBP I-NP
, , O
EC NNP B-NP
3.5 CD I-NP
. . O

-DOCSTART- X X O

The DT O
0.22-kb JJ O
NheI/BglI NN B-NP
I PRP B-NP
promoter NN O
exhibited VBN O
PMA NNP O
inducibility NN O
in IN O
myeloid JJ O
cells NNS O
and CC O
contained VBD O
a DT O
PMA-responsive JJ O
element NN O
recognized VBN O
by IN O
Sp1 NNP B-NP
and CC O
EGR-1 JJ B-NP
transcription NN I-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

When WRB O
the DT O
degree NN O
of IN O
exercise NN O
was VBD O
maximal JJ O
, , O
mPAP PRP O
was VBD O
maintained VBN O
, , O
SVI NNP O
decreased VBD O
, , O
HR NNP O
was VBD O
unchanged JJ O
, , O
and CC O
CO NNP O
and CC O
VO2 NNP O
decreased VBD O
. . O

-DOCSTART- X X O

To TO O
elucidate VB O
whether IN O
potential JJ O
endocrine NN O
changes NNS O
resulted VBD O
from IN O
acute JJ O
hypoxaemia NN O
alone RB O
, , O
the DT O
underlying JJ O
disease NN O
, , O
or CC O
unspecific JJ O
influences NNS O
connected VBN O
with IN O
the DT O
ICU NNP O
setting NN O
, , O
all DT O
measurements NNS O
were VBD O
compared VBN O
to TO O
those DT O
of IN O
a DT O
completely RB O
healthy JJ O
reference NN O
group NN O
( -LRB- O
REF NN O
) -RRB- O
with IN O
comparable JJ O
acute JJ O
experimental JJ O
hypoxaemia NN O
. . O

-DOCSTART- X X O

There EX O
were VBD O
no DT O
significant JJ O
differences NNS O
in IN O
graft NN O
survival NN O
between IN O
groups NNS O
with IN O
early JJ O
graft NN O
function NN O
( -LRB- O
EGF NN O
) -RRB- O
and CC O
DGF NNP O
, , O
either CC O
in IN O
first JJ O
transplantations NNS O
or CC O
retransplantations NNS O
. . O

-DOCSTART- X X O

Thrombosis NNP O
of IN O
the DT O
renal JJ O
vein NN O
may MD O
be VB O
dramatic JJ O
and CC O
include VBP O
renal JJ O
failure NN O
. . O

-DOCSTART- X X O

327 CD O
and CC O
736 CD O
protocols NNS O
of IN O
postmortem NN O
examinations NNS O
from IN O
Moscow NNP O
hospitals NNS O
N NNP O
31 CD O
and CC O
57 CD O
, , O
respectively RB O
, , O
were VBD O
evaluated VBN O
statistically RB O
. . O

-DOCSTART- X X O

The DT O
sequencing NN O
of IN O
the DT O
conditional JJ O
lethal JJ O
mutation NN O
ts-A13 NN O
, , O
localized VBN O
in IN O
the DT O
nrdE NN B-NP
cistron NN I-NP
, , O
and CC O
the DT O
lethality NN O
of IN O
insertional JJ O
mutations NNS O
targeted VBN O
in IN O
the DT O
internal JJ O
region NN O
of IN O
nrdE NN B-NP
and CC O
nrdF NN B-NP
, , O
demonstrated VBD O
the DT O
essential JJ O
role NN O
of IN O
this DT O
locus NN O
. . O

-DOCSTART- X X O

The DT O
microdensitometric JJ O
scores NNS O
and CC O
their PRP$ O
side-to-side JJ O
differences NNS O
in IN O
patients NNS O
correlated VBD O
negatively RB O
with IN O
the DT O
serum NN O
25-OHD JJ O
concentration NN O
and CC O
positively RB O
with IN O
the DT O
degree NN O
of IN O
paralysis NN O
. . O

-DOCSTART- X X O

This DT O
correlated JJ O
with IN O
reduced JJ O
levels NNS O
of IN O
secreted JJ O
hepatitis NN B-NP
B NNP I-NP
e NN I-NP
antigen NN I-NP
and CC O
increased VBD O
intracellular JJ O
levels NNS O
of IN O
core NN B-NP
and CC O
Pol JJ B-NP
proteins NNS I-NP
and CC O
replicative JJ O
HBV NNP O
DNA NNP O
intermediates NNS O
. . O

-DOCSTART- X X O

The DT O
SCMV NNP B-NP
SNE NNP I-NP
sites NNS I-NP
contain VBP O
potential JJ O
overlapping JJ O
core NN O
recognition NN O
binding NN O
motifs NNS O
for IN O
SRF NNP B-NP
, , O
Rel/NFkappaB NNP B-NP
, , O
ETS NNP B-NP
, , O
and CC O
YY1 NNP B-NP
class NN I-NP
transcription NN I-NP
factors NNS I-NP
but CC O
fail VB O
to TO O
respond VB O
to TO O
either DT O
serum NN O
or CC O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
. . O

-DOCSTART- X X O

Upon IN O
serum NN O
withdrawal NN O
at IN O
the DT O
permissive JJ O
temperature NN O
, , O
p53-mediated JJ B-NP
apoptosis NN O
was VBD O
induced VBN O
in IN O
50 CD O
to TO O
60 CD O
% NN O
of IN O
the DT O
cells NNS O
. . O

-DOCSTART- X X O

To TO O
circumvent VB O
this DT O
problem NN O
, , O
a DT O
simple JJ O
two-step JJ O
strategy NN O
was VBD O
devised VBN O
by IN O
which WDT O
essential JJ O
cis-acting NN O
sites NNS O
like IN O
the DT O
a DT O
sequence NN O
can MD O
be VB O
readily RB O
deleted VBN O
from IN O
their PRP$ O
natural JJ O
loci NNS O
in IN O
large JJ O
viral JJ O
DNA NN O
genomes NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
report NN O
, , O
we PRP O
demonstrate VBP O
that IN O
hGCN5 PRP B-NP
is VBZ O
also RB O
an DT O
HAT NN B-NP
and CC O
has VBZ O
the DT O
same JJ O
substrate NN O
specificity NN O
as IN O
yGCN5 PRP B-NP
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
six CD O
arginine IN O
mutations NNS O
of IN O
oxidative JJ O
phosphorylation NN O
and CC O
AAC NNP B-NP
expression NN O
. . O

-DOCSTART- X X O

The DT O
implications NNS O
for IN O
estimates NNS O
of IN O
cortical JJ O
magnification NN O
and CC O
possible JJ O
differences NNS O
in IN O
the DT O
specializations NNS O
of IN O
foveal NN O
and CC O
peripheral JJ O
vision NN O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

G-CSF NNP B-NP
activates NNS O
multiple JJ O
signaling VBG O
molecules NNS O
, , O
including VBG O
the DT O
JAK1 NNP B-NP
and CC O
JAK2 NNP B-NP
kinases NNS I-NP
and CC O
the DT O
STAT NNP B-NP
transcription NN O
factors NNS O
. . O

-DOCSTART- X X O

The DT O
RI NNP B-NP
alpha NN I-NP
gene NN I-NP
is VBZ O
composed VBN O
of IN O
nine CD O
coding VBG O
exons NNS O
of IN O
varying VBG O
lengths NNS O
, , O
separated VBN O
by IN O
introns NNS O
, , O
giving VBG O
the DT O
gene NN O
a DT O
total JJ O
length NN O
of IN O
at IN O
least JJS O
21 CD O
kb NN O
. . O
our PRP$ O
recent JJ O
cloning NN O
of IN O
a DT O
processed VBN O
RI NNP B-NP
alpha NN I-NP
pseudogene NN I-NP
with IN O
a DT O
5'-noncoding JJ O
region NN O
different JJ O
from IN O
the DT O
previously RB O
reported VBN O
RI NNP B-NP
alpha NN I-NP
complementary NN I-NP
RNA NNP I-NP
indicated VBD O
that IN O
the DT O
RI NNP B-NP
alpha NN I-NP
gene NN I-NP
may MD O
have VB O
multiple JJ O
leader NN O
exons VBD O
giving VBG O
rise NN O
to TO O
alternately RB O
spliced VBN O
messenger NN O
RNAs NNS O
( -LRB- O
mRNAs NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
double JJ O
mutants NNS O
with IN O
either DT O
dim1-delta JJ B-NP
or CC O
dim2-1 JJ B-NP
and CC O
the DT O
endocytosis NN O
mutants NNS B-NP
end4-1 NN I-NP
or CC O
act1-1 NN B-NP
displayed VBD O
synthetic JJ O
growth NN O
defects NNS O
, , O
indicating VBG O
that IN O
the DT O
DIM NNP B-NP
gene NN I-NP
products NNS I-NP
function VBP O
in IN O
a DT O
common JJ O
or CC O
parallel JJ O
endocytic JJ O
pathway NN O
. . O

-DOCSTART- X X O

Stable JJ O
transfection NN O
of IN O
the DT O
BL NNPS O
cell NN O
line NN O
Raji NNP O
with IN O
constructs NNS O
containing VBG O
core NN O
promoter NN O
mutations NNS O
confirmed VBD O
that IN O
the DT O
proximal JJ O
Sp1 NNP B-NP
site NN I-NP
and CC O
the DT O
TATA NNP O
box NN O
are VBP O
essential JJ O
for IN O
the DT O
activation NN O
of IN O
promoter NN O
P1 NN O
by IN O
the DT O
Ig NNP B-NP
kappa NN I-NP
enhancers NNS I-NP
. . O

-DOCSTART- X X O

Finally RB O
, , O
the DT O
C-terminal JJ O
region NN O
of IN O
ENBP1 NNP B-NP
shows VBZ O
strong JJ O
homology NN O
to TO O
a DT O
protein NN O
from IN O
rat NN O
that WDT O
is VBZ O
specifically RB O
expressed VBN O
in IN O
testis NN O
tissue NN O
. . O

-DOCSTART- X X O

The DT O
conservation NN O
of IN O
both DT O
the DT O
G-box NNP O
and CC O
H-box NNP O
in IN O
different JJ O
CHS NNP B-NP
promoters NNS I-NP
emphasizes VBZ O
their PRP$ O
importance NN O
as IN O
regulatory JJ O
motifs NNS O
. . O

-DOCSTART- X X O

Mortality NN O
on IN O
the DT O
last JJ O
ranch NN O
was VBD O
particularly RB O
severe JJ O
among IN O
certain JJ O
segregated VBN O
groups NNS O
of IN O
turkeys NNS O
that WDT O
included VBD O
toms NNS O
, , O
heavier JJR O
birds NNS O
, , O
and CC O
birds NNS O
undergoing VBG O
a DT O
stressful JJ O
event NN O
such JJ O
as IN O
artificial JJ O
insemination NN O
. . O

-DOCSTART- X X O

Further RB O
, , O
the DT O
PIP2 JJ O
content NN O
of IN O
the DT O
85-90 CD O
kDa JJ O
protein NN O
appeared VBD O
to TO O
decrease VB O
with IN O
CSF-1 NNP B-NP
treatment NN O
. . O

-DOCSTART- X X O

Further RB O
, , O
the DT O
PIP2 JJ O
content NN O
of IN O
the DT O
85-90 CD O
kDa JJ O
protein NN O
appeared VBD O
to TO O
decrease VB O
with IN O
CSF-1 NNP B-NP
treatment NN O
. . O

-DOCSTART- X X O

Just RB O
before IN O
inserting VBG O
on IN O
the DT O
anterior JJ O
margin NN O
and CC O
apex NN O
of IN O
the DT O
iliac JJ O
crest NN O
it PRP O
widens VBZ O
, , O
assuming VBG O
the DT O
aspect NN O
of IN O
a DT O
small JJ O
cone NN O
. . O

-DOCSTART- X X O

The DT O
first JJ O
identification NN O
of IN O
the DT O
active JJ O
37LRP/p40 CD B-NP
gene NN O
presented VBN O
in IN O
this DT O
study NN O
is VBZ O
a DT O
critical JJ O
step NN O
toward IN O
the DT O
isolation NN O
of IN O
the DT O
corresponding JJ O
human JJ O
gene NN O
and CC O
the DT O
understanding NN O
of IN O
the DT O
molecular JJ O
mechanisms NNS O
involved VBN O
in IN O
the DT O
up-regulation NN O
of IN O
its PRP$ O
expression NN O
during IN O
tumor NN O
invasion NN O
and CC O
metastasis NN O
. . O

-DOCSTART- X X O

The DT O
STAT-1 NNP B-NP
signaling NN O
pathway NN O
provides VBZ O
at IN O
least JJS O
one CD O
mechanism NN O
for IN O
activation NN O
of IN O
the DT O
CAEV NNP B-NP
LTR NNP I-NP
by IN O
IFN-gamma NNP B-NP
in IN O
monocytes NNS O
. . O

-DOCSTART- X X O

Reperfusion NN O
caused VBD O
a DT O
transient JJ O
reduction NN O
in IN O
lactate NN O
production NN O
and CC O
a DT O
significant JJ O
increase NN O
in IN O
LDH NNP B-NP
release NN O
. . O

-DOCSTART- X X O

INTERVENTION( NN O
S) NNP O
: : O
Twenty-six CD O
hemostasis NN O
parameters NNS O
evaluated VBN O
repeatedly RB O
in IN O
patients NNS O
undergoing VBG O
IVF-ET. NNP O

-DOCSTART- X X O

Unlike IN O
wild-type JJ B-NP
p53 NN I-NP
, , O
the DT O
delta NN B-NP
proAE NN I-NP
mutant JJ I-NP
cDNA NN I-NP
can MD O
be VB O
stably RB O
expressed VBN O
in IN O
tumor NN O
derived VBD O
cell NN O
lines NNS O
with IN O
few JJ O
immediate JJ O
detrimental JJ O
effects NNS O
. . O

-DOCSTART- X X O

The DT O
patient NN O
's POS O
role NN O
, , O
organized VBN O
by IN O
the DT O
prerequisites NNS O
of IN O
expressive JJ O
freedom NN O
, , O
is VBZ O
counter RB O
posed VBN O
with IN O
the DT O
psychoanalyst NN O
's POS O
, , O
which WDT O
is VBZ O
structured VBN O
to TO O
empower VB O
listening VBG O
and CC O
understanding VBG O
. . O

-DOCSTART- X X O

The DT O
most RBS O
common JJ O
risk NN O
factor NN O
reported VBD O
for IN O
both DT O
recent JJ O
and CC O
all DT O
other JJ O
hepatitis NN O
C NNP O
cases NNS O
was VBD O
a DT O
history NN O
of IN O
injecting VBG O
drug NN O
use NN O
, , O
although IN O
the DT O
proportion NN O
of IN O
cases NNS O
with IN O
that DT O
history NN O
was VBD O
different JJ O
in IN O
NT NNP O
from IN O
ACT NNP O
and CC O
Queensland NNP O
. . O

-DOCSTART- X X O

Silencing NN O
can MD O
be VB O
restored VBN O
by IN O
creation NN O
of IN O
a DT O
telomere NN O
at IN O
13 CD O
kb NN O
from IN O
the DT O
reporter NN O
construct VB O
, , O
or CC O
by IN O
insertion NN O
of IN O
340 CD O
bp NN O
of IN O
yeast NN O
telomeric JJ O
repeat NN O
sequence NN O
at IN O
this DT O
site NN O
without IN O
chromosomal NN O
truncation NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
with IN O
previous JJ O
two-pool JJ O
models NNS O
, , O
provisions NNS O
were VBD O
made VBN O
for IN O
folate JJ O
turnover NN O
by IN O
urinary JJ O
folate JJ O
excretion NN O
( -LRB- O
as IN O
measured VBN O
here RB O
) -RRB- O
and CC O
by IN O
fecal JJ O
excretion NN O
and CC O
catabolic JJ O
processes NNS O
. . O

-DOCSTART- X X O

Several JJ O
artifacts NNS O
occurred VBD O
that IN O
interfered JJ O
with IN O
visualization NN O
of IN O
the DT O
diaphragm NN O
. . O

-DOCSTART- X X O

The DT O
syndrome NN O
of IN O
resistance NN O
to TO O
thyroid DT O
hormone NN O
is VBZ O
characterized VBN O
by IN O
elevated JJ O
serum NN O
free JJ O
thyroid NN O
hormones NNS O
, , O
failure NN O
to TO O
suppress VB O
pituitary JJ B-NP
thyrotropin IN I-NP
secretion NN O
, , O
and CC O
variable JJ O
peripheral JJ O
refractoriness NN O
to TO O
hormone NN O
action NN O
. . O

-DOCSTART- X X O

Finally RB O
, , O
nonphotosynthetic JJ O
mutants NNS O
, , O
including VBG O
the DT O
tscA-lacking JJ B-NP
photosystem NN I-NP
I PRP I-NP
mutant VBP I-NP
, , O
H13 NNP O
, , O
did VBD O
not RB O
show VB O
evidence NN O
of IN O
light-stimulated JJ O
RNA NNP O
processing NN O
. . O

-DOCSTART- X X O

The DT O
progression NN O
of IN O
acute JJ O
bronchitis NN O
is VBZ O
associated VBN O
with IN O
elevated JJ O
blood NN O
concentrations NNS O
of IN O
acute-phase JJ O
proteins NNS O
, , O
KKS NNP B-NP
activation NN O
in IN O
the DT O
blood NN O
and CC O
high JJ O
serotonin NN O
and CC O
lactic JJ O
acid NN O
content NN O
in IN O
the DT O
humor NN O
condensated VBN O
from IN O
the DT O
exhaled JJ O
air NN O
. . O

-DOCSTART- X X O

During IN O
skeletal NN O
muscle NN O
development NN O
, , O
different JJ O
types NNS O
of IN O
muscle NN O
fibers NNS O
are VBP O
generated VBN O
, , O
which WDT O
express VBP O
different JJ O
combinations NNS O
of IN O
muscle-specific JJ O
gene NN O
products NNS O
. . O

-DOCSTART- X X O

We PRP O
discuss VBP O
these DT O
results NNS O
with IN O
respect NN O
to TO O
the DT O
transcriptional JJ O
induction NN O
of IN O
the DT O
HNF-3 JJ B-NP
alpha NN I-NP
gene NN I-NP
in IN O
respiratory JJ O
epithelium NN O
during IN O
embryogenesis NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Mitosis NNP O
is VBZ O
regulated VBN O
by IN O
MPF NNP B-NP
( -LRB- O
maturation NN B-NP
promoting VBG I-NP
factor NN I-NP
) -RRB- O
, , O
the DT O
active JJ O
form NN O
of IN O
Cdc2/28-cyclin NNP B-NP
B NNP B-NP
complexes NNS O
. . O

-DOCSTART- X X O

Ectopic JJ O
expression NN O
of IN O
Apo-3 JJ B-NP
in IN O
HEK293 CD O
or CC O
HeLa NNP O
cells NNS O
induced VBN O
marked JJ O
apoptosis NN O
. . O

-DOCSTART- X X O

An DT O
N-terminal JJ O
arm NN O
from IN O
each DT O
subunit NN O
wraps VBZ O
around IN O
the DT O
dinucleotide-binding JJ O
domain NN O
of IN O
an DT O
adjacent JJ O
subunit NN O
, , O
covering VBG O
the DT O
adenine JJ O
ring NN O
of IN O
NADP. NNP O

-DOCSTART- X X O

Similarity NNP O
is VBZ O
most RBS O
striking JJ O
in IN O
the DT O
zinc NN O
knuckle NN O
region NN O
, , O
a DT O
region NN O
characteristic NN O
of IN O
gag NN B-NP
genes NNS I-NP
of IN O
most JJS O
replication-competent JJ O
retroelements NNS O
. . O

-DOCSTART- X X O

D. NNP O
melanogaster NN O
HeT-A NNP B-NP
coding NN O
sequences NNS O
have VBP O
a DT O
polymorphic JJ O
region NN O
with IN O
insertions/deletions NNS O
of IN O
1-31 JJ O
codons NNS O
and CC O
many JJ O
nucleotide JJ O
changes NNS O
. . O

-DOCSTART- X X O

Eukaryotic JJ B-NP
initiation NN I-NP
factor NN I-NP
3 CD I-NP
(eIF3 NN O
) -RRB- O
is VBZ O
a DT O
large JJ O
multisubunit NN O
complex NN O
that IN O
stabilizes VBZ O
the DT O
ternary JJ O
complex JJ O
, , O
eIF2 JJ B-NP
x NN O
GTP NNP O
x NN O
tRNA( NN B-NP
Met NNP I-NP
)i NNP I-NP
and CC O
promotes VBZ O
mRNA RB O
binding JJ O
to TO O
the DT O
40 CD B-NP
S NNP I-NP
ribosomal NNP I-NP
subunit NN I-NP
. . O
eIF3 '' B-NP
also RB O
functions VBZ O
as IN O
a DT O
ribosome JJ O
subunit NN O
anti-association NN O
factor NN O
. . O

-DOCSTART- X X O

Our PRP$ O
data NNS O
, , O
combined VBN O
with IN O
those DT O
of IN O
Hershey NNP O
and CC O
co-workers NNS O
, , O
suggest VBP O
that IN O
mammalian JJ B-NP
eIF3 NN I-NP
is VBZ O
composed VBN O
of IN O
at IN O
least JJS O
10 CD O
subunits NNS O
: : O
p170 VB B-NP
, , O
p116 FW B-NP
( -LRB- O
hPrt1 NN B-NP
) -RRB- O
, , O
p110 VBD B-NP
, , O
p66 NNS B-NP
, , O
p48 NNS B-NP
, , O
p47 NNS B-NP
, , O
p44 NNS B-NP
, , O
p40 VBD B-NP
, , O
p36 VBD B-NP
, , O
and CC O
p35 VBD B-NP
. . O

-DOCSTART- X X O

Identification NN O
of IN O
a DT O
cis-acting JJ O
element NN O
in IN O
the DT O
class NN B-NP
I PRP I-NP
major VBP I-NP
histocompatibility NN I-NP
complex JJ I-NP
gene NN I-NP
promoter NN I-NP
responsive JJ O
to TO O
activation NN O
by IN O
retroviral JJ O
sequences NNS O
. . O

-DOCSTART- X X O

Lack JJ O
of IN O
sufficient JJ O
data NNS O
on IN O
vibration NN O
measurements NNS O
and CC O
employment NN O
durations NNS O
add VBP O
to TO O
the DT O
uncertainty NN O
, , O
as RB O
do VBP O
variations NNS O
in IN O
tool NN O
conditions NNS O
( -LRB- O
grinder NN O
wheels NNS O
, , O
etc NN O
) -RRB- O
and CC O
inherent JJ O
difficulties NNS O
in IN O
measurement NN O
. . O

-DOCSTART- X X O

C/EBP NNP B-NP
beta NN I-NP
V NNP I-NP
> IN O
A DT O
selectively JJ O
binds NNS O
only RB O
the DT O
subset NN O
of IN O
C/EBP NNP B-NP
sites NNS I-NP
that WDT O
are VBP O
also RB O
DBP VB B-NP
sites NNS I-NP
, , O
both DT O
as IN O
oligonucleotides NNS O
and CC O
within IN O
the DT O
natural JJ O
contexts NNS O
of IN O
the DT O
albumin NN B-NP
and CC O
cholesterol NN B-NP
hydroxylase JJ I-NP
promoters NNS I-NP
. . O

-DOCSTART- X X O

Specific NNP O
IgG NNP B-NP
, , O
specific JJ O
IgE NNP B-NP
and CC O
total JJ O
IgE NNP B-NP
immunoglobulins NNS I-NP
against IN O
Toxocara NNP B-NP
canis NN I-NP
excretory/secretory NN I-NP
antigens NNS I-NP
( -LRB- O
TES NNS B-NP
) -RRB- O
were VBD O
detected VBN O
by IN O
using VBG O
ELISA NNP O
technique NN O
. . O

-DOCSTART- X X O

Mutating VBG O
the DT O
E-box NN O
in IN O
the DT O
context NN O
of IN O
the DT O
3'-flanking JJ O
region NN O
confirmed VBD O
that IN O
it PRP O
contributes VBZ O
to TO O
the DT O
enhancement NN O
of IN O
transcriptional JJ O
activity NN O
of IN O
the DT O
alpha1( NN B-NP
I PRP I-NP
) -RRB- I-NP
collagen NN I-NP
gene NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Expression NN O
of IN O
neuronal JJ O
traits NNS O
in IN O
pancreatic JJ O
beta JJ O
cells NNS O
. . O

-DOCSTART- X X O

We PRP O
propose VBP O
that IN O
Mnt NNP B-NP
:Max NNP O
:Sin3 IN O
complexes NNS O
normally RB O
function VBP O
to TO O
restrict VB O
Myc:Max NNP B-NP
activities NNS O
associated VBN O
with IN O
cell NN O
proliferation NN O
. . O

-DOCSTART- X X O

Phenotypic JJ O
changes NNS O
induced VBN O
by IN O
wild JJ B-NP
type NN I-NP
and CC I-NP
variant JJ I-NP
c-src JJ I-NP
genes NNS I-NP
carrying VBG O
C-terminal JJ O
sequence NN O
alterations NNS O
. . O

-DOCSTART- X X O

The DT O
resurgence NN O
of IN O
drug-resistant JJ O
malaria NN O
makes VBZ O
urgent JJ O
the DT O
evaluation NN O
of IN O
new JJ O
antimalarial JJ O
agents NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
p51 NN B-NP
subunit NN I-NP
, , O
the DT O
Cys181 NNP O
side-chain NN O
is VBZ O
oriented VBN O
in IN O
a DT O
similar JJ O
direction NN O
to TO O
the DT O
Tyr181 NNP O
side-chain NN O
in IN O
the DT O
wild-type JJ O
complex NN O
. . O

-DOCSTART- X X O

The DT O
relatively RB O
high JJ O
level NN O
transcription NN O
from IN O
this DT O
gene NN O
shows VBZ O
that IN O
the DT O
polymorphic JJ O
chromosome NN O
ends NNS O
of IN O
P. NNP O
falciparum NN O
, , O
which WDT O
have VBP O
been VBN O
proposed VBN O
to TO O
be VB O
transcriptionally RB O
silent JJ O
, , O
can MD O
be VB O
active JJ O
expression NN O
sites NNS O
for IN O
var JJ B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

NUP145 NNP B-NP
was VBD O
previously RB O
identified VBN O
by IN O
using VBG O
a DT O
genetic JJ O
synthetic JJ O
lethal JJ O
screen NN O
( -LRB- O
E. NNP O

-DOCSTART- X X O

Prevalence NNP O
of IN O
sleep-disordered JJ O
breathing NN O
( -LRB- O
SDB) NNP O
is VBZ O
reported VBN O
to TO O
increase VB O
in IN O
menopausal JJ O
women NNS O
. . O

-DOCSTART- X X O

A DT O
total NN O
of IN O
1459 CD O
men NNS O
aged VBN O
48 CD O
to TO O
84 CD O
years NNS O
, , O
who WP O
were VBD O
diagnosed VBN O
for IN O
the DT O
first JJ O
time NN O
by IN O
physicians NNS O
as IN O
having VBG O
BPH NNP O
in IN O
1994 CD O
and CC O
who WP O
had VBD O
not RB O
received VBN O
treatment NN O
, , O
participated VBD O
in IN O
the DT O
study NN O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
translation NN O
of IN O
the DT O
mTRF1 JJ B-NP
cDNA NN I-NP
resulted VBD O
in IN O
a DT O
56 CD O
kDa JJ O
protein NN O
that IN O
binds NNS O
to TO O
TTAGGG NNP O
repeat NN O
arrays NNS O
. . O
mTRF1 NN B-NP
displayed VBD O
the DT O
same JJ O
sequence NN O
specificity NN O
as IN O
hTRF1 NNS B-NP
, , O
preferring VBG O
arrays NNS O
of IN O
TTAGGG NNP O
repeats NNS O
as IN O
a DT O
binding NN O
substrate NN O
over IN O
TTAGGC NNP O
and CC O
TTGGGG NNP O
repeats NNS O
. . O

-DOCSTART- X X O

The DT O
ubiquitously RB O
expressed VBN O
E12 NN B-NP
bHLH IN I-NP
protein NN I-NP
dimerizes VBZ O
with IN O
numerous JJ O
cell-specific JJ O
bHLH NNS B-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

The DT O
E-box NNP O
sequence NN O
in IN O
the DT O
SE2 JJ B-NP
fragment NN I-NP
of IN O
the DT O
transferrin NN B-NP
promoter NN I-NP
was VBD O
CATCTG NNP O
and CC O
was VBD O
similar JJ O
in IN O
gel JJ O
shifts NNS O
to TO O
the DT O
consensus NN O
E-box NN O
elements NNS O
( -LRB- O
CANNTG NN O
) -RRB- O
previously RB O
characterized VBD O
. . O

-DOCSTART- X X O

A DT O
5.3-kb JJ O
DNA NN O
fragment NN O
, , O
which WDT O
included VBD O
the DT O
entire JJ O
structural JJ O
porin NN B-NP
gene NN I-NP
( -LRB- O
named VBN O
porCa NN B-NP
) -RRB- O
and CC O
its PRP$ O
flanking NN O
regions NNS O
, , O
was VBD O
identified VBN O
. . O

-DOCSTART- X X O

Full-length NNP B-NP
AT-PHH1 NNP I-NP
, , O
and CC O
both DT O
AT-PHH1 NNP B-NP
and CC O
AT-PHH1 JJ B-NP
delta NN I-NP
C-513 NN I-NP
( -LRB- O
truncated VBN O
to TO O
be VB O
approximately RB O
the DT O
size NN O
of IN O
microbial JJ B-NP
photolyase JJ I-NP
genes NNS I-NP
) -RRB- O
cDNAs NNS O
, , O
were VBD O
overexpressed VBN O
, , O
respectively RB O
, , O
in IN O
yeast NN O
and CC O
Escherichia NNP O
coli NNS O
mutants NNS O
hypersensitive JJ O
to TO O
ultraviolet VB O
light NN O
. . O

-DOCSTART- X X O

This DT O
report NN O
presents VBZ O
the DT O
isolation NN O
and CC O
characterization NN O
of IN O
the DT O
5'-flanking JJ O
region NN O
( -LRB- O
1.2 CD O
kb NN O
) -RRB- O
and CC O
exon VBD O
1 CD O
of IN O
the DT O
human JJ B-NP
RII NNP I-NP
alpha NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

A DT O
cohort NN O
of IN O
Swedish JJ O
children NNS O
was VBD O
monitored VBN O
from IN O
6 CD O
months NNS O
to TO O
11 CD O
years NNS O
of IN O
age NN O
. . O

-DOCSTART- X X O

The DT O
primary JJ O
structure NN O
of IN O
a DT O
2671 CD O
bp JJ O
DNA NN O
fragment NN O
between IN O
the DT O
pla NN B-NP
gene NN I-NP
( -LRB- O
encoding VBG O
plasminogen NN B-NP
activator NN I-NP
) -RRB- O
and CC O
the DT O
origin NN O
of IN O
replication NN O
of IN O
the DT O
wild-type JJ O
Yersinia NNP O
pestis NN O
plasmid NN O
pYP358 NNS O
was VBD O
determined VBN O
. . O

-DOCSTART- X X O

MAIN NNP O
OUTCOME NNP O
MEASURES NNP O
: : O
Associations NNP O
of IN O
factor NN O
analysis-derived CC O
syndromes NNS O
with IN O
risk NN O
factors NNS O
for IN O
chemical NN O
interactions NNS O
that WDT O
inhibit VBP O
butyrylcholinesterase NN B-NP
and CC O
neuropathy NN O
target NN O
esterase NN B-NP
. . O

-DOCSTART- X X O

Control NNP O
examination NN O
was VBD O
performed VBN O
at IN O
the DT O
end NN O
of IN O
each DT O
period NN O
. . O

-DOCSTART- X X O

The DT O
GHR NNP B-NP
mRNA:GHBP CD I-NP
mRNA NN B-NP
ratio NN O
was VBD O
1.1 CD O
+/ CD O
- : O
0.12 CD O
and CC O
remained VBD O
unchanged JJ O
during IN O
differentiation NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
demonstrate VBP O
( -LRB- O
i NN O
) -RRB- O
that IN O
the DT O
selenocysteine-specific JJ O
UGA NNP O
codon NN O
is VBZ O
readily RB O
suppressed VBN O
under IN O
conditions NNS O
where WRB O
the DT O
homologous JJ B-NP
SelB NNP I-NP
protein NN I-NP
is VBZ O
absent JJ O
and CC O
( -LRB- O
ii NNS O
) -RRB- O
that IN O
apart RB O
from IN O
the DT O
specificity NN O
of IN O
the DT O
SelB-mRNA NNP B-NP
interaction NN O
, , O
a DT O
structural JJ O
compatibility NN O
of IN O
the DT O
quaternary JJ O
complex NN O
with IN O
the DT O
ribosome JJ O
is VBZ O
required VBN O
. . O

-DOCSTART- X X O

One CD O
linker-peptide NN O
insertion NN O
in IN O
the DT O
RsaA NNP B-NP
C NNP I-NP
terminus IN I-NP
(amino NNP I-NP
acid NN I-NP
784 CD I-NP
) -RRB- I-NP
had VBD O
no DT O
effect NN O
on IN O
S-layer NNP O
biogenesis NN O
, , O
while IN O
another DT O
(amino NN O
acid NN O
907 VBD O
) -RRB- O
disrupted VBD O
secretion NN O
of IN O
the DT O
protein NN O
, , O
suggesting VBG O
that IN O
RsaA NNP B-NP
possesses VBZ O
a DT O
secretion NN O
signal NN O
lying VBG O
C NNP O
terminal NN O
to TO O
amino VB O
acid NN O
784 CD O
, , O
near IN O
or CC O
including VBG O
amino JJ O
acid NN O
907 VBD O
. . O

-DOCSTART- X X O

To TO O
characterize VB O
the DT O
gene NN O
products NNS O
, , O
the DT O
cvaA NN B-NP
gene NN I-NP
was VBD O
subcloned VBN O
and CC O
expressed VBN O
under IN O
the DT O
control NN O
of IN O
T7 DT B-NP
RNA NNP I-NP
polymerase NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

PrpB NNP B-NP
showed VBD O
homology NN O
to TO O
carboxyphosphonoenolpyruvate VB B-NP
phosphonomutase NN I-NP
of IN I-NP
Streptomyces NNP I-NP
hygroscopicus NN I-NP
and CC O
to TO O
its PRP$ O
homolog NN O
in IN O
the DT O
carnation NN O
Dianthus NNP O
caryophyllus NN O
; : O
PrpC NNP B-NP
was VBD O
homologous JJ O
to TO O
both DT O
archaeal NN B-NP
and CC I-NP
bacterial JJ I-NP
citrate NN I-NP
synthases NNS I-NP
; : O
PrpD NNP B-NP
showed VBD O
homology NN O
to TO O
yeast NN O
and CC O
Bacillus NNP O
subtilis VBD O
proteins NNS O
of IN O
unknown JJ O
function NN O
; : O
PrpE NNP B-NP
showed VBD O
homology NN O
to TO O
acetyl VB B-NP
coenzyme NN I-NP
A DT I-NP
synthetases NNS I-NP
. . O

-DOCSTART- X X O

JNK NNP B-NP
and CC O
p38 NNS B-NP
are VBP O
constitutively RB O
present JJ O
in IN O
the DT O
nucleus JJ O
, , O
and CC O
DNA-bound JJ O
c-JUN NN B-NP
and CC O
ATF-2 NNP B-NP
are VBP O
stably RB O
contacted VBN O
by IN O
JNK NNP B-NP
and CC O
p38 VBD B-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
dominant JJ O
interfering JJ O
forms NNS O
of IN O
the DT O
JNK/p38 CD B-NP
signaling NN O
pathway NN O
demonstrate VBP O
that IN O
activation NN O
of IN O
these DT O
kinases NNS O
is VBZ O
critical JJ O
for IN O
cytokine-induced JJ O
E-selectin NNP B-NP
gene NN I-NP
expression NN O
. . O

-DOCSTART- X X O

Sp1 NNP B-NP
binds VBZ O
the DT O
CTC NNP O
repeat NN O
with IN O
an DT O
affinity NN O
, , O
KD NNP O
= SYM O
0.37 CD O
nM NNS O
, , O
at IN O
least JJS O
as RB O
high JJ O
as IN O
the DT O
consensus NN O
GC NNP O
box NN O
. . O

-DOCSTART- X X O

Mutant JJ O
enzyme JJ O
forms NNS O
were VBD O
prepared VBN O
to TO O
eliminate VB O
the DT O
initial JJ O
autoprocessing NN O
site NN O
and CC O
thus RB O
form VB O
an DT O
active JJ O
single-chain JJ O
protein NN O
for IN O
structure-function NN O
studies NNS O
. . O

-DOCSTART- X X O

The DT O
primer NN O
is VBZ O
generated VBN O
by IN O
a DT O
cleavage NN O
that WDT O
occurs VBZ O
between IN O
bases NNS O
11 CD O
and CC O
12 CD O
of IN O
the DT O
Tf1 NNP B-NP
mRNA NN I-NP
. . O

-DOCSTART- X X O

Similarly RB O
, , O
we PRP O
examined VBD O
whether IN O
the DT O
ELK1 NNP B-NP
, , O
SAP1a NNP B-NP
, , O
FLI1 NNP B-NP
, , O
EWS-FLI1 NNP B-NP
, , O
ETS1 NNP B-NP
, , O
ETS2 NNP B-NP
, , O
PEA3 NN B-NP
and CC O
PU.1 JJ B-NP
proteins NNS I-NP
can MD O
form VB O
ternary JJ O
complexes NNS O
with IN O
SRF NNP B-NP
on IN O
the DT O
Egr1 NNP B-NP
SREI NNP B-NP
and CC I-NP
II NNP I-NP
. . O

-DOCSTART- X X O

This DT O
R-domain NN O
may MD O
modulate VB O
the DT O
interaction NN O
with IN O
SRF NN B-NP
, , O
providing VBG O
a DT O
mechanism NN O
that WDT O
would MD O
be VB O
unique JJ O
to TO O
FLI1 NNP B-NP
and CC O
EWS-FLI1 NNP B-NP
, , O
thus RB O
implicating VBG O
a DT O
novel JJ O
function NN O
for IN O
these DT O
ETS NNS B-NP
transcription NN I-NP
factors NNS I-NP
in IN O
the DT O
regulation NN O
of IN O
the DT O
Egr1 NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
total JJ O
number NN O
of IN O
specimens NNS O
was VBD O
131 CD O
with IN O
78 CD O
nonsmokers NNS O
and CC O
53 CD O
smokers NNS O
. . O

-DOCSTART- X X O

CDNA NNP O
cloning NN O
of IN O
chick NN B-NP
brain NN I-NP
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic JJ I-NP
acid NN I-NP
receptors NNS I-NP
reveals VBZ O
conservation NN O
of IN O
structure NN O
, , O
function NN O
and CC O
post-transcriptional JJ O
processes NNS O
with IN O
mammalian JJ O
receptors NNS O
. . O

-DOCSTART- X X O

Remarkably RB O
, , O
both DT O
TTD-A NNP O
and CC O
XP-D NNP O
defects NNS O
are VBP O
associated VBN O
with IN O
subunits NNS O
of IN O
TFIIH NNP B-NP
, , O
a DT O
basal JJ O
transcription NN O
factor NN O
with IN O
a DT O
second JJ O
function NN O
in IN O
DNA NNP O
repair NN O
. . O

-DOCSTART- X X O

In IN O
Experiment NNP O
1 CD O
, , O
pups NNS O
that WDT O
had VBD O
received VBN O
an DT O
injection NN O
of IN O
the DT O
noncompetitive JJ O
N-methyl-D-aspartate NN B-NP
receptor NN I-NP
antagonist NN O
MK-801 . O
( -LRB- O
0.1 CD O
mg/kg NN O
, , O
i.p. NN O
) -RRB- O
either CC O
30 CD O
min NN O
before IN O
or CC O
immediately RB O
after IN O
conditioning NN O
spent VBD O
less JJR O
time NN O
over IN O
the DT O
conditioned JJ O
odor NN O
than IN O
saline-treated JJ O
controls NNS O
. . O

-DOCSTART- X X O

Cholesterol NNP B-NP
side-chain NN I-NP
cleavage NN I-NP
cytochrome NN I-NP
P450 . I-NP
( -LRB- O
CYP11A NNPS B-NP
; : O
P450scc NN B-NP
) -RRB- O
gene NN O
expression NN O
is VBZ O
regulated VBN O
by IN O
gonadotropins NNS B-NP
via IN O
cAMP NN O
in IN O
the DT O
ovary JJ O
and CC O
by IN O
ACTH NNP B-NP
via IN O
cAMP NN O
in IN O
adrenal JJ O
cortical JJ O
cells NNS O
. . O

-DOCSTART- X X O

One CD O
possible JJ O
solution NN O
is VBZ O
a DT O
thin JJ O
radial JJ O
forearm JJ O
free JJ O
flap NN O
. . O

-DOCSTART- X X O

Phylogenetic JJ O
analysis NN O
gave VBD O
evidence NN O
for IN O
a DT O
close JJ O
evolutionary JJ O
relationship NN O
between IN O
PhHV-1 JJ O
and CC O
members NNS O
of IN O
the DT O
Varicellovirus NNP O
genus NN O
of IN O
the DT O
alpha-Herpesvirinae NNS O
and CC O
canid NN O
herpesvirus NN O
in IN O
particular JJ O
. . O

-DOCSTART- X X O

In IN O
this DT O
method NN O
, , O
PLP NNP O
in IN O
plasma NN O
can MD O
be VB O
determined VBN O
with IN O
high JJ O
sensitivity NN O
using VBG O
derivatization NN O
with IN O
sodium NN O
bisulfite NN O
in IN O
the DT O
mobile JJ O
phase NN O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
the DT O
effect NN O
exerted VBN O
by IN O
TIS1 NNP B-NP
appeared VBD O
to TO O
be VB O
selective JJ O
for IN O
the DT O
MCK NNP B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Experimental JJ O
data NNS O
showed VBD O
that IN O
these DT O
abnormal JJ O
proteins NNS O
are VBP O
constitutively RB O
localized VBN O
in IN O
the DT O
nucleus JJ O
, , O
have VBP O
lost VBN O
the DT O
transcriptional JJ O
repressor NN O
functions VBZ O
typical JJ O
of IN O
normal JJ O
NF-kappa NNP B-NP
B2p52 NNP I-NP
and CC O
may MD O
be VB O
capable JJ O
of IN O
transactivation NN O
activity NN O
. . O

-DOCSTART- X X O

Because IN O
L-plastin NNP B-NP
expression NN O
in IN O
tissue-specifically NN O
regulated VBN O
in IN O
both DT O
humans NNS O
and CC O
rodents NNS O
, , O
it PRP O
is VBZ O
likely JJ O
that IN O
similar JJ O
mechanisms NNS O
regulate VB O
L-plastin NNP B-NP
gene NN I-NP
expression NN O
in IN O
human JJ O
and CC O
rodent JJ O
cells NNS O
and CC O
that IN O
they PRP O
could MD O
be VB O
identified VBN O
by IN O
comparing VBG O
the DT O
function NN O
and CC O
nucleotide JJ O
sequences NNS O
of IN O
the DT O
human JJ O
and CC O
murine JJ O
L-plastin NNP B-NP
gene NN O
promoters NNS O
. . O

-DOCSTART- X X O

What WP O
's POS O
new JJ O
in IN O
gynecologic NN O
and CC O
obstetrical JJ O
surgery NN O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
expression NN O
of IN O
CBF1 NNP B-NP
in IN O
yeast NN O
was VBD O
found VBN O
to TO O
activate JJ O
transcription NN O
of IN O
reporter NN O
genes NNS O
containing VBG O
the DT O
C-repeat/DRE NN O
as IN O
an DT O
upstream JJ O
activator NN O
sequence NN O
but CC O
not RB O
mutant JJ O
versions NNS O
of IN O
the DT O
DNA NNP O
element NN O
. . O

-DOCSTART- X X O

Forty-one CD O
ASA NNP O
physical JJ O
status NN O
I PRP O
or CC O
II NNP O
adult NN O
patients NNS O
undergoing VBG O
a DT O
variety NN O
of IN O
1-1.5 CD O
h NN O
surgical JJ O
procedures NNS O
were VBD O
randomly RB O
allocated VBN O
to TO O
receive VB O
CCA NNP O
with IN O
desflurane NN O
or CC O
isoflurane NN O
with IN O
ventilation NN O
being VBG O
either DT O
spontaneous JJ O
or CC O
controlled JJ O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
Our PRP$ O
goal NN O
was VBD O
to TO O
determine VB O
whether IN O
chlamydia-infected JJ O
women NNS O
have VBP O
a DT O
higher JJR O
rate NN O
of IN O
febrile JJ O
complications NNS O
after IN O
postpartum NN O
tubal JJ O
ligation NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
electrophoresis NN O
mobility NN O
shift NN O
assay NN O
using VBG O
nuclear JJ O
extracts NNS O
of IN O
the DT O
myogenic JJ O
cells NNS O
, , O
MyoD NNP B-NP
and CC O
myogenin VBD B-NP
bound VBN O
to TO O
the DT O
right JJ O
E-box NN O
in IN O
the DT O
enhancer NN O
region NN O
of IN O
the DT O
MCK NNP B-NP
gene NN I-NP
even RB O
in IN O
the DT O
presence NN O
of IN O
BMP-2 NNP B-NP
. . O

-DOCSTART- X X O

Finally RB O
, , O
antibody NN O
binding NN O
to TO O
site NN O
IIIa NNP O
on IN O
the DT O
hCG-ectodomain JJ B-NP
complex NN I-NP
was VBD O
also RB O
hindered VBN O
by IN O
an DT O
anti-peptide JJ O
mAb NN O
directed VBN O
against IN O
a DT O
peptide NN O
encoded VBN O
by IN O
the DT O
eighth JJ O
exon NN O
( -LRB- O
pE NN O
x JJ O
8 CD O
) -RRB- O
of IN O
the DT O
LHR. NNP B-NP

-DOCSTART- X X O

cDNA NN O
cloning NN O
, , O
expression NN O
analysis NN O
, , O
and CC O
chromosomal NN O
localization NN O
of IN O
a DT O
gene NN O
with IN O
high JJ O
homology NN O
to TO O
wheat NN B-NP
eIF-(iso)4 NNS I-NP
F NNP I-NP
and CC O
mammalian JJ B-NP
eIF-4G. . I-NP

-DOCSTART- X X O

Human NNP B-NP
granulocyte-macrophage NN I-NP
colony-stimulating NN I-NP
factor NN I-NP
( -LRB- O
hGM-CSF NN B-NP
) -RRB- O
activates VBZ O
a DT O
set NN O
of IN O
genes NNS O
such JJ O
as IN O
c-fos NNS B-NP
, , O
jun NN B-NP
, , O
myc JJ B-NP
, , O
and CC O
early JJ B-NP
growth NN I-NP
response NN I-NP
gene NN I-NP
1 CD I-NP
(egr-1 CD O
) -RRB- O
. . O

-DOCSTART- X X O

When WRB O
expressed VBN O
in IN O
COS-7 NNP O
cells NNS O
, , O
MKP-4 JJ B-NP
blocks NNS O
activation NN O
of IN O
MAP NNP B-NP
kinases NNS I-NP
with IN O
the DT O
selectivity NN O
ERK NNP B-NP
> NNP O
p38 VBD B-NP
= SYM O
JNK/SAPK. . B-NP

-DOCSTART- X X O

Most JJS O
kinases NNS O
are VBP O
not RB O
significantly RB O
inhibited VBN O
by IN O
roscovitine NN O
. . O
cdc2/cyclin CD B-NP
B NNP B-NP
, , O
cdk2/cyclin IN B-NP
A DT B-NP
, , O
cdk2/cyclin IN B-NP
E NNP B-NP
and CC O
cdk5/p35 CD B-NP
only RB O
are VBP O
substantially RB O
inhibited VBN O
( -LRB- O
IC50 IN O
values NNS O
of IN O
0.65 CD O
, , O
0.7 CD O
, , O
0.7 CD O
and CC O
0.2 CD O
microM NN O
, , O
respectively RB O
) -RRB- O
. . O
cdk4/cyclin CD B-NP
D1 NNP B-NP
and CC O
cdk6/cyclin IN B-NP
D2 NNP B-NP
are VBP O
very RB O
poorly RB O
inhibited VBN O
by IN O
roscovitine NN O
( -LRB- O
IC50 PRP O
> VBD O
100 CD O
microM NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Although IN O
Pho85 NNP B-NP
is VBZ O
not RB O
essential JJ O
for IN O
viability NN O
, , O
Pcl1,2-Pho85 DT B-NP
kinase NN O
complexes NNS O
become VBP O
essential JJ O
for IN O
Start NNP O
in IN O
the DT O
absence NN O
of IN O
Cln1,2-Cdc28 DT B-NP
kinases NNS O
. . O

-DOCSTART- X X O

Using VBG O
the DT O
yeast NN O
two-hybrid JJ O
system NN O
to TO O
screen VB O
for IN O
proteins NNS O
which WDT O
interact NN O
with IN O
Tax1 NNP B-NP
, , O
we PRP O
isolated VBD O
the DT O
B NNP O
subunit NN O
of IN O
the DT O
CCAAT NN O
binding JJ O
protein NN O
NF-Y NNP B-NP
from IN O
a DT O
HeLa NNP O
cDNA NN O
library NN O
. . O

-DOCSTART- X X O

Enhancer NNP O
activity NN O
requires VBZ O
both DT O
the DT O
AP-1 NNP B-NP
site NN I-NP
and CC O
these DT O
adjacent JJ O
sequences NNS O
. . O

-DOCSTART- X X O

Constitutive JJ O
activation NN O
of IN O
Rac1 NNP B-NP
and CC O
RhoA NNP B-NP
causes VBZ O
tumorigenic JJ O
transformation NN O
of IN O
NIH NNP O
3T3 CD O
cells NNS O
, , O
and CC O
their PRP$ O
functions NNS O
may MD O
be VB O
required VBN O
for IN O
full JJ O
Ras NNP B-NP
transformation NN O
. . O

-DOCSTART- X X O

DNA NNP O
sequencing NN O
of IN O
a DT O
17-kb JJ O
segment NN O
encompassing VBG O
a DT O
gammaherpesvirus NN O
divergent NN O
locus NN O
( -LRB- O
DL-B) NNP O
between IN O
ORF11 CD O
and CC O
ORF17 CD O
revealed VBD O
the DT O
presence NN O
of IN O
nine CD O
viral JJ O
ORFs NNS O
with IN O
predicted VBN O
gene NN O
products NNS O
related VBN O
to TO O
cellular JJ O
proteins NNS O
. . O

-DOCSTART- X X O

Studies NNS O
in IN O
mammalian JJ O
cells NNS O
have VBP O
correlated VBN O
induction NN O
of IN O
inhibitory JJ O
tyrosine NN O
15 CD O
( -LRB- O
Y15 IN O
) -RRB- O
phosphorylation NN O
on IN O
p34cdc2 NN B-NP
with IN O
the DT O
response NN O
to TO O
DNA NNP O
damage NN O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
herein IN O
the DT O
case NN O
of IN O
a DT O
30-year-old JJ O
man NN O
in IN O
whom WP O
ectopic JJ O
mediastinal JJ O
parathyroid NN O
adenoma NN O
was VBD O
detected VBN O
by IN O
99mTc-methoxyisobutylisonitrile JJ O
scintigraphy JJ O
(99mTc-MIBI JJ O
) -RRB- O
. . O

-DOCSTART- X X O

Cardiac NNP B-NP
endothelin NN I-NP
release NN O
and CC O
infarct NN O
size NN O
, , O
myocardial JJ O
blood NN O
flow NN O
, , O
and CC O
ventricular JJ O
function NN O
in IN O
canine CD O
infarction NN O
and CC O
reperfusion NN O
. . O

-DOCSTART- X X O

Recent JJ O
application NN O
of IN O
recombinant JJ O
canarypox NN O
ALVAC/HIV-1 NN O
vectors NNS O
as IN O
vaccine NN O
immunogens NNS O
in IN O
HIV-1,-noninfected PRP$ O
volunteers NNS O
has VBZ O
produced VBN O
CTL JJ O
responses NNS O
in IN O
a DT O
significant JJ O
number NN O
of IN O
vaccinees NNS O
. . O

-DOCSTART- X X O

The DT O
relevance NN O
of IN O
these DT O
elements NNS O
in IN O
conferring VBG O
anaerobic JJ O
induction NN O
of IN O
gpc4 DT B-NP
gene NN I-NP
expression NN O
is VBZ O
discussed VBN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
support VBP O
the DT O
idea NN O
that IN O
the DT O
repression NN O
activity NN O
of IN O
NRS NNP B-NP
F/REST NNP I-NP
depends VBZ O
upon IN O
the DT O
species NNS O
of IN O
promoter NN O
to TO O
which WDT O
it PRP O
is VBZ O
linked VBN O
and CC O
upon IN O
the DT O
proteins NNS O
that WDT O
bind VBP O
to TO O
those DT O
promoters NNS O
. . O

-DOCSTART- X X O

In IN O
summary NN O
, , O
p56(lck NN B-NP
) -RRB- O
activity NN O
stimulates NNS O
G1/S VBP O
transition NN O
in IN O
immature JJ O
thymoblasts NNS O
and CC O
maintains VBZ O
cell NN O
viability NN O
via IN O
transduction NN O
of IN O
constitutive JJ O
activation NN O
signals NNS O
downstream RB O
to TO O
components NNS O
of IN O
the DT O
Ras/Raf/MAPK NNP B-NP
pathway NN O
. . O

-DOCSTART- X X O

The DT O
FBF NNP O
questionnaire NN O
did VBD O
not RB O
highlight VB O
a DT O
characteristic JJ O
basic NN O
symptoms NNS O
profile NN O
of IN O
schizoaffective JJ O
disorder NN O
, , O
when WRB O
compared VBN O
with IN O
bipolar JJ O
affective JJ O
disorder NN O
and CC O
schizophrenia NN O
. . O

-DOCSTART- X X O

Cognate NNP O
promoter NN O
elements NNS O
implicated VBN O
in IN O
glucocorticoid JJ O
- : O
and CC O
cAMP-mediated JJ O
regulation NN O
as RB O
well RB O
as IN O
in IN O
liver-, JJ O
myeloid-, JJ O
and CC O
lymphocyte-specific JJ O
expression NN O
are VBP O
located VBN O
within IN O
the DT O
5' JJ O
flanking NN O
sequence NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
studied VBN O
the DT O
biokinetics NNS O
of IN O
BLM NNP O
labeled VBD O
with IN O
indium-111 JJ O
( -LRB- O
In-111 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Acetoin-dependent JJ O
expression NN O
of IN O
the DT O
acoABCD NN B-NP
operon NN I-NP
could MD O
be VB O
restored VBN O
in IN O
the DT O
E. NNP B-NP
coli NNS I-NP
acoK VBP I-NP
mutants NNS I-NP
by IN O
supplying VBG O
a DT O
plasmid NN O
carrying VBG O
an DT O
intact JJ O
acoK NN B-NP
, , O
suggesting VBG O
a DT O
transactivating JJ O
function NN O
of IN O
the DT O
gene NN O
product NN O
. . O

-DOCSTART- X X O

Mutations NNS O
in IN O
the DT O
alpha NN B-NP
and CC I-NP
sigma-70 JJ I-NP
subunits NNS I-NP
of IN I-NP
RNA NNP I-NP
polymerase NN I-NP
affect VBP O
expression NN O
of IN O
the DT O
mer NN B-NP
operon NN I-NP
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
we PRP O
provide VBP O
evidence NN O
for IN O
the DT O
existence NN O
of IN O
an DT O
activator NN O
, , O
NFE NNP B-NP
, , O
which WDT O
in IN O
combination NN O
with IN O
the DT O
p50 NN B-NP
and CC O
c-Rel JJ B-NP
proteins NNS I-NP
, , O
are VBP O
part NN O
of IN O
the DT O
transcription NN O
factor NN O
machinery NN O
that WDT O
regulates VBZ O
3' JJ O
enhancer NN O
activity NN O
, , O
and CC O
thus RB O
the DT O
control NN O
of IN O
the DT O
IgH NNP B-NP
locus NN I-NP
in IN O
late JJ O
B NNP O
lymphocyte NN O
development NN O
. . O

-DOCSTART- X X O

The DT O
genes NNS O
encoding VBG O
the DT O
transcription NN B-NP
factor NN I-NP
yTAFII60 NN I-NP
, , O
the DT O
G4p1 JJ B-NP
protein NN I-NP
and CC O
a DT O
putative JJ O
glucose NN O
transporter NN O
are VBP O
contained VBN O
in IN O
a DT O
12.3 CD O
kb NN O
DNA NN O
fragment NN O
on IN O
the DT O
left JJ O
arm NN O
of IN O
Saccharomyces NNP O
cerevisiae NN O
chromosome NN O
VII NNP O
. . O

-DOCSTART- X X O

The DT O
protector NN O
doubled VBD O
the DT O
estimated VBN O
fall NN O
distance NN O
for IN O
fracture NN O
of IN O
the DT O
trochanter NN O
. . O

-DOCSTART- X X O

Marinol/marijuana NNP O
usage NN O
was VBD O
associated VBN O
with IN O
depressed JJ O
CD4+ NNP B-NP
counts NNS O
and CC O
elevated VBD O
amylase NN B-NP
levels NNS O
within IN O
the DT O
DDI NNP O
subgroup NN O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
Fifty-eight JJ O
patients NNS O
who WP O
underwent VBD O
a DT O
curative JJ O
hepatic JJ O
resection NN O
for IN O
HCC NNP O
and CC O
whose WP$ O
preoperative JJ O
AFP JJ B-NP
levels NNS O
were VBD O
>100 CD O
ng/ml NN O
, , O
were VBD O
selected VBN O
for IN O
this DT O
study NN O
. . O

-DOCSTART- X X O

Calmodulin-binding JJ B-NP
peptide NN I-NP
( -LRB- O
CBP) NNP B-NP
, , O
a DT O
peptide NN O
of IN O
26 CD O
amino IN O
acids NNS O
derived VBN O
from IN O
muscle NN B-NP
myosin NN I-NP
light NN I-NP
chain NN I-NP
kinase NN I-NP
( -LRB- O
MLC NNP B-NP
K) NNP I-NP
, , O
binds NNS O
to TO O
calmodulin VB B-NP
with IN O
nanomolar JJ O
affinity NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
show VBP O
that IN O
the DT O
type NN O
of IN O
tyrosine NN B-NP
kinase NN I-NP
receptor NN I-NP
stimulated VBD O
also RB O
participates NNS O
in IN O
the DT O
nature NN O
of IN O
the DT O
cAMP JJ O
effect NN O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
of IN O
LeMT( JJ B-NP
A DT I-NP
) -RRB- I-NP
and CC O
LeMT( NNP B-NP
B NNP I-NP
) -RRB- I-NP
showed VBD O
that IN O
transcripts NNS O
of IN O
both DT O
MT-like JJ B-NP
genes NNS I-NP
were VBD O
more RBR O
abundant JJ O
in IN O
leaves NNS O
than IN O
roots NNS O
in IN O
tomato NN O
plants NNS O
grown VBN O
without IN O
addition NN O
of IN O
extra JJ O
metal NN O
ions NNS O
, , O
a DT O
characteristic NN O
of IN O
type NN B-NP
II NNP I-NP
MTs NNP I-NP
. . O

-DOCSTART- X X O

In IN O
some DT O
instances NNS O
, , O
this DT O
is VBZ O
partly RB O
mediated VBN O
by IN O
the DT O
expression NN O
of IN O
virally RB O
encoded VBN O
proteases NNS O
which WDT O
lead VBP O
to TO O
the DT O
cleavage NN O
of IN O
initiation NN B-NP
factor NN I-NP
eIF4G. . I-NP

-DOCSTART- X X O

Unlike IN O
class NN O
II NNP O
- : O
and CC O
III-specific NNP O
TBP-TAF NNP B-NP
complexes NNS O
, , O
the DT O
corresponding JJ O
murine NN O
and CC O
human JJ O
class NN O
I-specific JJ O
transcription NN O
initiation NN O
factor NN O
TIF-IB/SL1 NNP B-NP
exhibits VBZ O
a DT O
pronounced JJ O
selectivity NN O
for IN O
its PRP$ O
homologous JJ O
promoter NN O
. . O

-DOCSTART- X X O

We PRP O
now RB O
describe VBP O
the DT O
identification NN O
of IN O
DEK NNP B-NP
as IN O
this DT O
43-kDa JJ B-NP
pets NNS I-NP
factor NN I-NP
. . O

-DOCSTART- X X O

These DT O
elements NNS O
comprise VBP O
a DT O
binding JJ O
site NN O
for IN O
Krox NNP B-NP
proteins NNS I-NP
, , O
one CD O
for IN O
nuclear JJ B-NP
factor NN I-NP
1 CD I-NP
, , O
an DT O
octamer NN O
motif NN O
that WDT O
binds VBZ O
POU-homeodomain JJ B-NP
proteins NNS I-NP
, , O
and CC O
a DT O
novel NN O
TN NNP B-NP
control NN I-NP
element NN I-NP
. . O

-DOCSTART- X X O

Therefore RB O
, , O
the DT O
impaired JJ O
floor NN O
plate NN O
development NN O
in IN O
oep JJ B-NP
mutants NNS I-NP
is VBZ O
not RB O
caused VBN O
by IN O
the DT O
absence NN O
of IN O
the DT O
floor NN B-NP
plate NN I-NP
inducer NN I-NP
shh NN I-NP
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
The DT O
medians NNS O
of IN O
average JJ O
daily JJ O
CD34+ NN B-NP
cell NN O
yields NNS O
for IN O
patients NNS O
who WP O
received VBD O
paclitaxel NN O
plus CC O
CY NNP O
, , O
CE NNP O
, , O
and CC O
CEP NNP O
with IN O
G-CSF NNP B-NP
were VBD O
12.9 CD O
, , O
11.03 CD O
, , O
and CC O
5.37 CD O
x NN O
10(6 CD O
)/kg NN O
, , O
respectively RB O
, , O
compared VBN O
with IN O
2.02 CD O
x NN O
10(6 CD O
)/kg NN O
in IN O
the DT O
reference NN O
group NN O
that IN O
received VBD O
CY NNP O
with IN O
G-CSF NNP B-NP
( -LRB- O
P NNP O
= SYM O
< JJ O
.0001 CD O
, , O
.002 CD O
, , O
and CC O
.09 CD O
, , O
respectively RB O
) -RRB- O
. . O

-DOCSTART- X X O

Increased VBN O
p53 NN B-NP
activity NN O
induced VBN O
by IN O
OP NNP O
is VBZ O
not RB O
due JJ O
to TO O
elevated VBN O
p53 NN B-NP
mRNA NNS I-NP
nor CC O
to TO O
protein NN O
levels NNS O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Chronic NNP O
administration NN O
of IN O
misoprostol NN O
may MD O
have VB O
caused VBN O
a DT O
negative JJ O
natriuretic JJ O
effect NN O
in IN O
cirrhotic JJ O
patients NNS O
with IN O
ascites NNS O
. . O

-DOCSTART- X X O

The DT O
region NN O
of IN O
plasmid NN O
pCM2 NN O
encoding VBG O
the DT O
pathogenicity NN B-NP
locus NN I-NP
pat-1 NN I-NP
was VBD O
mapped VBN O
by IN O
deletion NN O
analysis NN O
and CC O
complementation NN O
studies NNS O
to TO O
a DT O
1.5-kb CD O
Bg/II/Sma NNP B-NP
I PRP B-NP
DNA NNP O
fragment NN O
. . O

-DOCSTART- X X O

Transient NNP O
cotransfection NN O
of IN O
tat JJ B-NP
cDNA NNS I-NP
in IN O
sense NN O
orientation NN O
( -LRB- O
tat/S NNS B-NP
) -RRB- O
, , O
together RB O
with IN O
a DT O
plasmid NN O
containing VBG O
the DT O
c-fos JJ B-NP
promoter NN I-NP
(FC3 NN O
, , O
from IN O
-711 JJ O
to TO O
+42 VB O
) -RRB- O
in IN O
front NN O
of IN O
the DT O
bacterial JJ B-NP
chloramphenicol NN I-NP
acetyltransferase NN I-NP
( -LRB- O
CAT NN B-NP
) -RRB- O
gene NN O
significantly RB O
enhanced VBN O
CAT NN B-NP
activity NN O
in IN O
Jurkat NNP O
cells NNS O
activated VBN O
by IN O
the DT O
addition NN O
of IN O
15 CD O
% NN O
fetal NN O
calf NN O
serum NN O
(FCS) RB O
or CC O
5 CD O
micrograms/mL NN O
phytohemagglutinin NN B-NP
plus CC O
10(-7 CD O
) -RRB- O
mol/L NN O
phorbol NN O
myristate NN O
acetate NN O
( -LRB- O
PMA NNP O
) -RRB- O
and CC O
U937 IN O
cells NNS O
activated VBN O
by IN O
15 CD O
% NN O
FCS NNS O
or CC O
10(-7 CD O
) -RRB- O
mol/L NN O
PMA. . O

-DOCSTART- X X O

Snail NN O
mortality NN O
did VBD O
not RB O
differ VB O
among IN O
the DT O
various JJ O
treatment NN O
conditions NNS O
. . O

-DOCSTART- X X O

Derepression NNP O
of IN O
gene NN O
expression NN O
mediated VBN O
by IN O
the DT O
5' JJ O
upstream JJ O
region NN O
of IN O
the DT O
isocitrate NN B-NP
lyase NN I-NP
gene NN I-NP
of IN I-NP
Candida NNP I-NP
tropicalis NNPS I-NP
is VBZ O
controlled VBN O
by IN O
two CD O
distinct JJ O
regulatory JJ O
pathways NNS O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

To TO O
avoid VB O
complications NNS O
, , O
accurate JJ O
quantitative JJ O
analysis NN O
of IN O
NO RB O
and CC O
NO2 DT O
is VBZ O
necessary JJ O
during IN O
this DT O
therapy NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
cis NNPS O
elements NNS O
positioned VBN O
between IN O
the DT O
alpha NN B-NP
3 CD I-NP
and CC O
beta JJ B-NP
4 CD I-NP
coding NN O
regions NNS O
are VBP O
important JJ O
for IN O
establishing VBG O
part NN O
of IN O
the DT O
restricted JJ O
CNS NNP O
patterns NNS O
of IN O
beta JJ B-NP
4 CD I-NP
, , O
alpha NN B-NP
3 CD I-NP
, , O
and CC O
alpha NN B-NP
5 CD I-NP
gene NN I-NP
transcription NN O
. . O

-DOCSTART- X X O

RNase NN B-NP
protection NN O
experiments NNS O
confirmed VBD O
the DT O
presence NN O
of IN O
the DT O
GHR1-279 NNP B-NP
variant NN I-NP
in IN O
IM-9 NNP O
cells NNS O
and CC O
human JJ O
liver NN O
. . O

-DOCSTART- X X O

Functional JJ O
tests NNS O
using VBG O
a DT O
reporter NN O
gene NN O
, , O
containing VBG O
Stat5-binding JJ B-NP
elements NNS I-NP
, , O
confirmed VBN O
that IN O
while IN O
the DT O
variant JJ O
form NN O
was VBD O
inactive JJ O
by IN O
itself PRP O
, , O
it PRP O
could MD O
inhibit VB O
the DT O
function NN O
of IN O
the DT O
full-length JJ O
receptor NN O
. . O

-DOCSTART- X X O

Conversely RB O
, , O
activated VBN O
glucocorticoid JJ B-NP
receptors NNS I-NP
suppressed VBD O
the DT O
transactivation NN O
function NN O
of IN O
p53 NN B-NP
, , O
while IN O
transrepression NN O
by IN O
p53 NN B-NP
was VBD O
largely RB O
unaffected JJ O
. . O

-DOCSTART- X X O

This DT O
brief JJ O
review NN O
analyses NNS O
these DT O
interactions NNS O
and CC O
defines NNS O
clinical JJ O
settings NNS O
where WRB O
antibiotic-induced JJ O
endotoxin NN O
release NN O
may MD O
prove VB O
to TO O
be VB O
clinically RB O
relevant JJ O
. . O

-DOCSTART- X X O

This DT O
promoter NN O
segment NN O
could MD O
drive VB O
expression NN O
of IN O
a DT O
luciferase NN B-NP
reporter NN I-NP
gene NN I-NP
, , O
could MD O
confer VB O
correct JJ O
transcriptional JJ O
initiation NN O
to TO O
the DT O
reporter NN O
and CC O
could MD O
confer VB O
the DT O
EGF-responsiveness NNP B-NP
previously RB O
observed VBD O
in IN O
the DT O
native JJ O
gene NN O
. . O

-DOCSTART- X X O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
that IN O
an DT O
in IN O
vitro-synthesized JJ O
alphavirus NN O
RNA NNP O
lacking VBG O
a DT O
poly( NN O
A DT O
) -RRB- O
tail NN O
can MD O
initiate VB O
infection NN O
and CC O
produce VB O
3' JJ O
polyadenylated JJ O
viral JJ O
genome NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

The DT O
human JJ O
coreceptor NN O
was VBD O
as RB O
active JJ O
as IN O
the DT O
simian NN O
for IN O
SIV NNP O
entry NN O
. . O

-DOCSTART- X X O

These DT O
changes NNS O
in IN O
virus NN O
entry NN O
features NNS O
may MD O
result VB O
in IN O
coronaviruses NNS O
with IN O
novel JJ O
pathogenic JJ O
properties NNS O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Among IN O
women NNS O
, , O
the DT O
age-related JJ O
decline NN O
in IN O
BMD NNP O
at IN O
all DT O
non-spine JJ O
skeletal NN O
sites NNS O
was VBD O
significantly RB O
different JJ O
from IN O
zero CD O
, , O
with IN O
the DT O
largest JJS O
decline NN O
seen VBN O
at IN O
the DT O
femoral JJ O
neck NN O
(-.0038 CC O
g/cm2/y NN O
, , O
p NN O
< JJ O
.001 CD O
) -RRB- O
and CC O
the DT O
smallest JJS O
at IN O
the DT O
trochanter NN O
of IN O
the DT O
hip NN O
(-.0023 CC O
g/cm2/y NN O
, , O
p NN O
= SYM O
.03 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Sixty-nine FW O
( -LRB- O
44 CD O
% NN O
) -RRB- O
patients NNS O
were VBD O
administered VBN O
250 CD O
MBq NNP O
( -LRB- O
7 CD O
mCi NN O
) -RRB- O
99Tcm-tetrofosmin . O
at IN O
rest NN O
followed VBD O
4 CD O
h NN O
later RB O
by IN O
750 CD O
MBq NNP O
( -LRB- O
21 CD O
mCi NN O
) -RRB- O
during IN O
stress NN O
( -LRB- O
the DT O
1 CD O
day NN O
protocol NN O
) -RRB- O
, , O
whereas IN O
88 CD O
( -LRB- O
56 CD O
% NN O
) -RRB- O
patients NNS O
had VBD O
rest NN O
and CC O
stress NN O
imaging VBG O
studies NNS O
on IN O
two CD O
separate JJ O
days NNS O
, , O
receiving VBG O
a DT O
500 CD O
MBq NNP O
( -LRB- O
14 CD O
mCi NN O
) -RRB- O
dose NN O
of IN O
99Tcm-tetrofosmin JJ O
on IN O
each DT O
occasion NN O
( -LRB- O
the DT O
2 CD O
day NN O
protocol NN O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
thus RB O
identified VBN O
the DT O
first JJ O
mammalian JJ B-NP
homolog NN I-NP
of IN I-NP
yeast NN I-NP
UPF1 NNP I-NP
, , O
a DT O
protein NN O
that WDT O
regulates VBZ O
levels NNS O
of IN O
nonsense NN O
mRNA NN O
, , O
and CC O
we PRP O
tentatively RB O
name VB O
this DT O
protein NN O
human NN B-NP
HUPF1 NN I-NP
( -LRB- O
for IN O
human JJ B-NP
homolog NN I-NP
of IN I-NP
UPF1 NNP I-NP
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
cell NN O
lines NNS O
transformed VBN O
by IN O
BCR/ABL NNP B-NP
, , O
CRKL NNP B-NP
was VBD O
tyrosine FW O
phosphorylated VBD O
, , O
while IN O
CRK NNP B-NP
was VBD O
not RB O
. . O

-DOCSTART- X X O

In IN O
untransformed JJ O
cells NNS O
, , O
three CD O
major JJ O
proteins NNS O
coprecipitated VBN O
with IN O
CRKL NNP B-NP
, , O
identified VBN O
as IN O
C3G NNP B-NP
, , O
SOS NNP B-NP
and CC O
c-ABL. PRP$ B-NP

-DOCSTART- X X O

Circulating VBG O
oxytocin NN B-NP
in IN O
male JJ O
guinea NN O
pigs NNS O
affected VBN O
by IN O
the DT O
female JJ O
cohabitation NN O
and CC O
reproductive JJ O
condition NN O
. . O

-DOCSTART- X X O

In IN O
cellular JJ O
supernatant JJ O
fraction NN O
, , O
SHRSP NNP O
showed VBD O
a DT O
decrease NN O
of IN O
magnesium NN O
in IN O
many JJ O
tissues NNS O
and CC O
an DT O
elevation NN O
of IN O
the DT O
calcium NN O
to TO O
magnesium NN O
ratio NN O
when WRB O
compared VBN O
to TO O
age-matched DT O
WKY NNP O
and CC O
SHRSR. NNP O

-DOCSTART- X X O

Antisense NNP O
transcription NN O
of IN O
a DT O
murine NN B-NP
FGFR-3 JJ I-NP
psuedogene NN I-NP
during IN O
fetal NN O
developement NN O
. . O

-DOCSTART- X X O

GH NNP B-NP
deficiency NN O
may MD O
be VB O
absolute JJ O
, , O
but CC O
often RB O
is VBZ O
not RB O
and CC O
the DT O
diagnosis NN O
may MD O
be VB O
complicated VBN O
by IN O
a DT O
constellation NN O
of IN O
physical JJ O
and CC O
hormonal JJ O
findings NNS O
that WDT O
are VBP O
along IN O
a DT O
spectrum NN O
from IN O
low JJ O
normal JJ O
GH NN B-NP
sufficiency NN O
to TO O
absent VB O
GH NNP B-NP
secretion NN O
. . O

-DOCSTART- X X O

Positive JJ O
CRP NNP B-NP
test NN O
were VBD O
seen VBN O
. . O

-DOCSTART- X X O

During IN O
the DT O
febrile JJ O
period NN O
, , O
pleocytosis NN O
was VBD O
associated VBN O
with IN O
high JJ O
levels NNS O
of IN O
IgG NNP B-NP
, , O
IL-6 NNP B-NP
, , O
TNF-alpha NNP B-NP
, , O
and CC O
PGE2 NNP O
in IN O
the DT O
cerebrospinal JJ O
fluid NN O
. . O

-DOCSTART- X X O

Recognition NNP O
mechanisms NNS O
of IN O
the DT O
minus-strand JJ O
origin NN O
of IN O
phage NN O
f1 NNS O
by IN O
Escherichia NNP B-NP
coli NNS I-NP
RNA NNP I-NP
polymerase NN I-NP
. . O

-DOCSTART- X X O

The DT O
minimum NN O
and CC O
essential JJ O
subunits NNS O
for IN O
RNA NNP O
synthesis NN O
have VBP O
not RB O
yet RB O
been VBN O
identified VBN O
. . O

-DOCSTART- X X O

Syndecan-4 NNP B-NP
is VBZ O
a DT O
focal JJ O
adhesion NN O
component NN O
, , O
and CC O
this DT O
interaction NN O
may MD O
both DT O
localize VB O
PKC NNP B-NP
and CC O
amplify VB O
its PRP$ O
activity NN O
at IN O
sites NNS O
of IN O
forming VBG O
adhesions NNS O
. . O

-DOCSTART- X X O

Members NNS O
of IN O
the DT O
MAPK NNP B-NP
family NN I-NP
include VBP O
the DT O
extracellular JJ B-NP
response NN I-NP
kinases NNS I-NP
( -LRB- O
ERKs NNS B-NP
or CC O
p42/44(MAPK) JJ B-NP
) -RRB- O
, , O
the DT O
c-Jun JJ B-NP
amino-terminal JJ I-NP
kinases NNS I-NP
( -LRB- O
JNKs NN B-NP
) -RRB- O
, , O
and CC O
the DT O
p38/Hog NN B-NP
1 CD B-NP
protein NN O
kinases NNS O
. . O

-DOCSTART- X X O

MOP5 IN B-NP
contained VBD O
the DT O
characteristic JJ O
PAS NNP B-NP
domain NN O
and CC O
a DT O
variable JJ O
C NNP O
terminus NN O
; : O
it PRP O
is VBZ O
possible JJ O
that IN O
the DT O
cDNA NN O
contains VBZ O
a DT O
bHLH JJ O
domain NN O
, , O
but CC O
the DT O
entire JJ O
open JJ O
reading NN O
frame NN O
has VBZ O
yet RB O
to TO O
be VB O
completed VBN O
. . O

-DOCSTART- X X O

Some DT O
8.8 CD O
kb NN O
of IN O
the DT O
Lactobacillus JJ O
sake NN O
plasmid VBD O
pCIM1 PRP O
was VBD O
sequenced VBN O
, , O
revealing VBG O
eight CD O
tightly RB O
clustered VBN O
open JJ O
reading NN O
frames NNS O
( -LRB- O
ORFs NNS O
) -RRB- O
downstream RB O
from IN O
lasA NN B-NP
, , O
which WDT O
encodes VBZ O
pre-lactocin JJ B-NP
S. NNP I-NP

-DOCSTART- X X O

Purified NNP B-NP
Pra NNP I-NP
was VBD O
also RB O
shown VBN O
to TO O
physically RB O
interact VB O
with IN O
pyruvate JJ B-NP
kinase NN I-NP
( -LRB- O
Pk NN B-NP
) -RRB- O
; : O
Pk JJ B-NP
and CC O
Pra NNP B-NP
can MD O
form VB O
a DT O
complex JJ O
, , O
but CC O
when WRB O
the DT O
12-kDa JJ B-NP
Ndk NNP I-NP
, , O
Pk NNP B-NP
, , O
and CC O
Pra NNP B-NP
are VBP O
all DT O
present JJ O
, , O
Pk NNP B-NP
has VBZ O
a DT O
higher JJR O
affinity NN O
than IN O
Pra NNP B-NP
for IN O
forming VBG O
a DT O
complex NN O
with IN O
the DT O
12-kDa JJ B-NP
Ndk NN I-NP
. . O

-DOCSTART- X X O

Apart RB O
from IN O
iron NN O
regulation NN O
, , O
sodA JJ B-NP
expression NN O
was VBD O
affected VBN O
by IN O
changes NNS O
in IN O
DNA NNP O
topology NN O
induced VBN O
by IN O
coumermycin NN O
A DT O
but CC O
not RB O
by IN O
the DT O
global JJ O
virulence NN O
regulatory JJ O
Bvg NN B-NP
system NN I-NP
. . O

-DOCSTART- X X O

M. NNP B-NP
leprae NNS I-NP
OxyR NNP I-NP
was VBD O
overproduced VBN O
and CC O
purified VBN O
, , O
and CC O
its PRP$ O
binding NN O
to TO O
the DT O
oxyR-ahpC JJ B-NP
intergenic JJ O
region NN O
of IN O
M. NNP O
leprae NNS O
was VBD O
demonstrated VBN O
. . O

-DOCSTART- X X O

The DT O
binding JJ O
site NN O
for IN O
OxyR NNP B-NP
overlapped VBD O
P1oxyR NNP B-NP
, , O
reminiscent NN O
of IN O
the DT O
autoregulatory NN O
loops VBZ O
controlling VBG O
expression NN O
of IN O
oxyR NN B-NP
in IN O
enteric JJ O
bacteria NNS O
and CC O
characteristic JJ O
of IN O
the DT O
LysR NNP B-NP
superfamily NN I-NP
in IN O
general JJ O
. . O

-DOCSTART- X X O

Thirty-five CD O
patients NNS O
were VBD O
included VBN O
. . O

-DOCSTART- X X O

Therefore RB O
more RBR O
active JJ O
and CC O
tolerable JJ O
salvage NN O
regimens NNS O
are VBP O
needed VBN O
. . O

-DOCSTART- X X O

While IN O
TGF-beta1 NNP B-NP
does VBZ O
not RB O
alter VB O
the DT O
mitogen-induced JJ O
expression NN O
and CC O
abundance NN O
of IN O
G1 DT O
phase NN O
cyclin NN B-NP
D1 NNP I-NP
and CC O
cdks VBD B-NP
4 CD I-NP
and CC I-NP
2 CD I-NP
in IN O
MCs NNP O
, , O
it PRP O
inhibits VBZ O
cyclin NN B-NP
E-cdk NNP I-NP
2 CD B-NP
activity NN O
, , O
thus RB O
preventing VBG O
mitogen-elicited JJ O
phosphorylation NN O
and CC O
inactivation NN O
of IN O
pRb NN B-NP
in IN O
G1 DT O
phase NN O
and CC O
transition NN O
to TO O
S NNP O
phase NN O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
range NN O
of IN O
values NNS O
observed VBN O
is VBZ O
suggestive JJ O
of IN O
the DT O
need NN O
to TO O
investigate VB O
districts NNS O
with IN O
contrasting VBG O
values NNS O
of IN O
SYPLR NNP O
with IN O
respect NN O
to TO O
the DT O
inter-relationships NNS O
between IN O
sociodemographic JJ O
characteristics NNS O
, , O
duration NN O
of IN O
symptoms NNS O
, , O
clinical JJ O
presentation NN O
and CC O
treatment NN O
efficacy NN O
. . O

-DOCSTART- X X O

The DT O
prominent JJ O
lesions NNS O
were VBD O
confined VBN O
to TO O
the DT O
cerebral JJ O
surface NN O
layer NN O
and CC O
leptomeningeal JJ O
tissue NN O
including VBG O
the DT O
arachnoid NN O
vessels NNS O
, , O
which WDT O
were VBD O
all DT O
bathed VBN O
in IN O
the DT O
cerebrospinal JJ O
fluid NN O
, , O
suggesting VBG O
that IN O
some DT O
necrotizing JJ O
toxins NNS O
had VBD O
been VBN O
secreted VBN O
into IN O
the DT O
fluid NN O
by IN O
the DT O
B. NNP O
cereus NN O
. . O

-DOCSTART- X X O

Movement VB O
time NN O
and CC O
kinematic JJ O
characteristics NNS O
were VBD O
analyzed VBN O
together RB O
with IN O
the DT O
magnitude NN O
of IN O
cerebral JJ O
blood NN O
flow NN O
to TO O
identify VB O
areas NNS O
of IN O
brain NN O
activity NN O
proportionate JJ O
to TO O
task NN O
and CC O
movement NN O
variables NNS O
. . O

-DOCSTART- X X O

Areas NNS O
with IN O
significantly RB O
greater JJR O
rCBF NN O
for IN O
targeting VBG O
were VBD O
the DT O
left JJ O
motor NN O
cortex NN O
, , O
left VBD O
intraparietal JJ O
sulcus NN O
, , O
and CC O
left VBD O
caudate NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
tri-snRNP-specific JJ O
27K JJ O
protein NN O
could MD O
potentially RB O
be VB O
involved VBN O
in IN O
SR NNP B-NP
protein-mediated JJ O
protein/protein NN O
interactions NNS O
and CC O
, , O
additionally RB O
, , O
its PRP$ O
phosphorylation NN O
state NN O
could MD O
modulate VB O
pre-mRNA JJ O
splicing NN O
. . O

-DOCSTART- X X O

Purified VBN B-NP
P7 PRP I-NP
could MD O
be VB O
assembled VBN O
onto IN O
particles NNS O
lacking VBG O
P7 NNS B-NP
and CC O
particles NNS O
lacking VBG O
both DT O
P2 NNP B-NP
( -LRB- O
RNA NN B-NP
polymerase NN I-NP
) -RRB- O
and CC O
P7 NNP B-NP
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
same JJ O
U1A NNP B-NP
peptide NN I-NP
, , O
when WRB O
conjugated VBN O
to TO O
BSA NNP B-NP
, , O
inhibits VBZ O
vertebrate JJ B-NP
PAP. . I-NP

-DOCSTART- X X O

Plasma NN O
levels NNS O
of IN O
protein NN B-NP
C NNP I-NP
, , O
protein NN B-NP
S NNP I-NP
, , O
and CC O
antithrombin JJ B-NP
III NNP I-NP
in IN O
patients NNS O
with IN O
subarachnoid JJ O
haemorrhage NN O
. . O

-DOCSTART- X X O

Recombinant NNP O
plasmids NNS O
containing VBG O
the DT O
entire JJ O
322 CD O
nt NN O
5' IN O
UTR NNP O
of IN O
exon NN O
1 CD O
and CC O
a DT O
1630 CD O
nt JJ O
segment NN O
of IN O
5' DT O
flanking VBG O
sequence NN O
stimulated VBD O
luciferase NN B-NP
activity NN O
nearly RB O
70 CD O
times NNS O
higher JJR O
than IN O
a DT O
promoterless JJ O
control NN O
plasmid NN O
. . O

-DOCSTART- X X O

Analysis NN O
for IN O
DNA-protein NNP O
interactions NNS O
by IN O
in IN O
vitro NN O
DNase-I JJ B-NP
footprinting NN O
identified VBD O
a DT O
broad JJ O
region NN O
of IN O
protection NN O
extending VBG O
from IN O
nt NN O
-12 NN O
to TO O
+38. MD O

-DOCSTART- X X O

It PRP O
is VBZ O
also RB O
homologous JJ O
to TO O
other JJ O
sugar NN O
carriers NNS O
from IN O
human NN O
, , O
mouse NN O
and CC O
Escherichia NNP O
coli NNS O
. . O

-DOCSTART- X X O

Although IN O
methods NNS O
to TO O
align JJ O
the DT O
control NN O
and CC O
activation NN O
fMR IN O
images NNS O
may MD O
correct VB O
for IN O
some DT O
of IN O
this DT O
motional JJ O
error NN O
, , O
they PRP O
will MD O
be VB O
incomplete JJ O
in IN O
correcting VBG O
for IN O
those DT O
that IN O
depend VBP O
on IN O
spatial JJ O
orientation NN O
. . O

-DOCSTART- X X O

Three CD O
women NNS O
have VBP O
had VBN O
abnormal JJ O
endocervical JJ O
follow VBP O
up RP O
cytology NN O
suggestive NN O
of IN O
residual JJ O
disease NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
homologous JJ O
DNA NN O
sequences NNS O
within IN O
the DT O
first JJ O
intron NN O
of IN O
the DT O
mouse NN B-NP
and CC I-NP
human JJ I-NP
mts1 NN I-NP
genes NNS I-NP
: : O
kB-like JJ B-NP
site NN I-NP
and CC O
microsatellite JJ O
DNA NN O

-DOCSTART- X X O

The DT O
integration NN O
at IN O
the DT O
VIP NNP B-NP
CyRE NNP B-NP
of IN O
the DT O
Jak-Stat NNP B-NP
and CC O
AP-1 NNP B-NP
signaling VBG O
pathways NNS O
with IN O
other JJ O
pre-existing JJ O
proteins NNS O
provides VBZ O
a DT O
cellular JJ O
mechanism NN O
for IN O
cell NN O
- : O
and CC O
cytokine-specific JJ O
signaling NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
show VBP O
that IN O
the DT O
temperature-sensitive JJ B-NP
rad54-3 JJ I-NP
allele NN I-NP
blocks NNS O
mitotic JJ O
recombination NN O
between IN O
tandemly NN O
repeated VBN O
DYZ3 IN B-NP
satellite NN I-NP
sequences NNS I-NP
and CC O
significantly RB O
stabilizes VBZ O
a DT O
human JJ B-NP
DYZ5 CC I-NP
satellite-containing JJ O
YAC NNP O
clone NN O
. . O

-DOCSTART- X X O

Circularized NNP O
Ac/Ds NNP B-NP
transposons NNS O
: : O
formation NN O
, , O
structure NN O
and CC O
fate NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
have VBP O
examined VBN O
the DT O
regulation NN O
of IN O
B-Myb JJ B-NP
activity NN O
by IN O
cyclin-Cdks NNS B-NP
. . O

-DOCSTART- X X O

This DT O
locus JJ O
maps NNS O
approximately RB O
160 CD O
kbp NN O
from IN O
the DT O
genes NNS O
encoding VBG O
cytadherence-associated JJ O
proteins NNS O
HMW1 . B-NP
and CC O
HMW3 JJ B-NP
, , O
and CC O
yet RB O
insertions NNS O
therein RB O
result VBP O
in IN O
loss NN O
of IN O
these DT O
proteins NNS O
and CC O
a DT O
hemadsorption-negative JJ O
( -LRB- O
HA-) JJ O
phenotype NN O
, , O
prompting VBG O
the DT O
designation NN O
cytadherence-regulatory NN B-NP
locus NN I-NP
( -LRB- O
crl NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Coliphage NNP B-NP
186 CD I-NP
B NNP I-NP
is VBZ O
a DT O
72-amino JJ O
acid JJ O
protein NN O
belonging VBG O
to TO O
the DT O
Ogr NNP B-NP
family NN O
of IN O
analogous JJ O
transcription NN O
factors NNS O
present JJ O
in IN O
P2-like JJ O
phage NN O
, , O
which WDT O
contain VBP O
a DT O
Cys-X2-Cys-X22-Cys-X4-Cys NNP O
presumptive NN O
zinc-finger NN O
motif NN O
. . O

-DOCSTART- X X O

Diacylglycerol NNP B-NP
kinase FW I-NP
( -LRB- O
DGK) NN B-NP
attenuates NNS O
levels NNS O
of IN O
second JJ O
messenger NN O
diacylglycerol NN O
in IN O
cells NNS O
and CC O
produces VBZ O
another DT O
( -LRB- O
putative NN O
) -RRB- O
messenger NN O
, , O
phosphatidic JJ O
acid NN O
. . O

-DOCSTART- X X O

Active JJ O
complexes NNS O
eluted VBD O
at IN O
a DT O
higher JJR O
molecular JJ O
weight NN O
than IN O
inactive JJ O
complexes NNS O
, , O
were VBD O
relatively RB O
deficient JJ O
in IN O
both DT O
p21 NNS B-NP
and CC O
p27 NN B-NP
, , O
and CC O
contained VBD O
Cdk2 NNP B-NP
with IN O
increased VBN O
threonine CD O
160 CD O
phosphorylation NN O
, , O
consistent JJ O
with IN O
a DT O
mechanism NN O
of IN O
activation NN O
of IN O
cyclin NN B-NP
E-Cdk2 NN I-NP
involving VBG O
both DT O
reduced VBN O
CDK NN B-NP
inhibitor NN O
association NN O
and CC O
CDK-activating JJ B-NP
kinase-mediated JJ I-NP
phosphorylation NN O
of IN O
Cdk2 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
derivatives NNS O
of IN O
the DT O
latter JJ O
two CD O
cell NN O
lines NNS O
showed VBD O
increased VBN O
expression NN O
of IN O
the DT O
p27Kip1 JJ B-NP
protein NN I-NP
and CC O
inhibition NN O
of IN O
cell NN O
growth NN O
. . O

-DOCSTART- X X O

Chronic NNP O
renal JJ O
failure NN O
patients NNS O
essentially RB O
die VBP O
from IN O
cardiovascular JJ O
causes NNS O
, , O
and CC O
the DT O
frequency NN O
of IN O
malignant JJ O
disease NN O
responsible JJ O
for IN O
death NN O
is VBZ O
estimated VBN O
to TO O
be VB O
10 CD O
% NN O
. . O

-DOCSTART- X X O

The DT O
new JJ O
FIGO NNP O
definition NN O
of IN O
cervical JJ O
cancer NN O
stage NN O
IA NNP O
: : O
a DT O
critique NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
Vpu NNP B-NP
on IN O
class NN O
I PRP O
biogenesis NN O
was VBD O
analyzed VBN O
in IN O
more JJR O
detail NN O
using VBG O
a DT O
Vpu-expressing JJ B-NP
recombinant NN O
vaccinia NN O
virus NN O
( -LRB- O
VV NN O
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
study NN O
indicates VBZ O
that IN O
the DT O
phenotype NN O
of IN O
myofibrillar JJ O
disarray NN O
seen VBN O
in IN O
HCM NNP O
patients NNS O
which WDT O
harbor VBP O
either DT O
of IN O
these DT O
two CD O
mutations NNS O
may MD O
not RB O
be VB O
directly RB O
due JJ O
to TO O
the DT O
failure NN O
of IN O
the DT O
mutant JJ B-NP
myosin JJ I-NP
heavy JJ I-NP
chain NN I-NP
protein NN I-NP
to TO O
assemble VB O
and CC O
form VB O
normal JJ O
sarcomeres NNS O
, , O
but CC O
may MD O
rather RB O
be VB O
a DT O
secondary JJ O
effect NN O
possibly RB O
resulting VBG O
from IN O
the DT O
chronic JJ O
stress NN O
of IN O
decreased VBN O
beta NN B-NP
MHC IN I-NP
function NN O
. . O

-DOCSTART- X X O

Inductively RB O
coupled VBN O
plasma NN O
atomic JJ O
emission NN O
spectroscopy NN O
was VBD O
employed VBN O
to TO O
obtain VB O
the DT O
tissue NN O
silicon NN O
measurements NNS O
. . O

-DOCSTART- X X O

A DT O
method NN O
for IN O
the DT O
simultaneous JJ O
determination NN O
of IN O
de(N-methyl)-N-ethyl-8,9 JJ O
-anhydroerythromycin JJ O
A DT O
6,9-hemiacetal JJ O
( -LRB- O
EM523 NN O
, , O
I PRP O
) -RRB- O
and CC O
its PRP$ O
three CD O
metabolites NNS O
in IN O
human JJ O
plasma NN O
and CC O
urine NN O
has VBZ O
been VBN O
developed VBN O
using VBG O
high-performance JJ O
liquid JJ O
chromatography NN O
( -LRB- O
HPLC NNP O
) -RRB- O
with IN O
chemiluminescence NN O
( -LRB- O
CL NN O
) -RRB- O
detection NN O
. . O

-DOCSTART- X X O

Similarly RB O
, , O
the DT O
DNA-binding JJ O
activity NN O
of IN O
activator NN B-NP
protein NN I-NP
1 CD I-NP
( -LRB- O
AP-1 NN B-NP
) -RRB- O
is VBZ O
modified VBN O
by IN O
a DT O
DNA NN B-NP
repair NN I-NP
enzyme NN I-NP
, , O
redox NN B-NP
factor NN I-NP
1 CD I-NP
( -LRB- O
Ref-1 NN B-NP
) -RRB- O
, , O
which WDT O
is VBZ O
identical JJ O
to TO O
a DT O
DNA NN B-NP
repair NN I-NP
enzyme JJ I-NP
, , O
AP NNP B-NP
endonuclease NN I-NP
. . O

-DOCSTART- X X O

Results NNS O
from IN O
our PRP$ O
and CC O
other JJ O
laboratories NNS O
have VBP O
suggested VBN O
that IN O
UCN-01 NNP O
induces VBZ O
preferential JJ O
G1-phase JJ O
accumulation NN O
in IN O
several JJ O
human JJ O
tumor NN O
cell NN O
lines NNS O
tested VBN O
. . O

-DOCSTART- X X O

Northern JJ O
and CC O
RT-PCR JJ O
analysis NN O
of IN O
Ube3a NNP B-NP
expression NN O
in IN O
mouse NN O
tissues NNS O
from IN O
animals NNS O
with IN O
segmental JJ O
, , O
paternal JJ O
uniparental JJ O
disomy NN O
failed VBD O
to TO O
detect VB O
substantially RB O
reduced VBN O
or CC O
absent JJ O
expression NN O
compared VBN O
to TO O
control VB O
animals NNS O
, , O
failing VBG O
to TO O
provide VB O
any DT O
evidence NN O
for IN O
maternal-specific JJ O
expression NN O
from IN O
this DT O
locus NN O
. . O

-DOCSTART- X X O

A DT O
novel NN O
, , O
testis-specific JJ B-NP
mRNA NN I-NP
transcript NN I-NP
encoding VBG O
an DT O
NH2-terminal JJ B-NP
truncated JJ I-NP
nitric-oxide NN I-NP
synthase NN I-NP
. . O
mRNA '' O
diversity NN O
represents VBZ O
a DT O
major JJ O
theme NN O
of IN O
neuronal JJ B-NP
nitric-oxide NN I-NP
synthase NN I-NP
( -LRB- O
nNOS NNS B-NP
) -RRB- O
gene NN O
expression NN O
in IN O
somatic JJ O
cells/tissues NNS O
. . O

-DOCSTART- X X O

Unlike IN O
the DT O
MAR-binding NN O
domain NN O
, , O
the DT O
homeodomain NN B-NP
when WRB O
isolated VBN O
binds NNS O
poorly RB O
and CC O
with IN O
low JJ O
specificity NN O
to TO O
DNA NNP O
. . O

-DOCSTART- X X O

Cyclin NNP B-NP
D1 NNP I-NP
could MD O
not RB O
be VB O
displaced VBN O
from IN O
cdk4 CD B-NP
in IN O
the DT O
resistant JJ O
184A1L5R CD O
cell NN O
lysates NNS O
. . O

-DOCSTART- X X O

The DT O
importance NN O
of IN O
posttranslational JJ O
regulation NN O
of IN O
p15INK4B NN B-NP
by IN O
TGF-beta NNP B-NP
is VBZ O
underlined VBN O
by IN O
the DT O
observation NN O
that IN O
in IN O
TGF-beta-resistant JJ B-NP
184A1L5R CD O
, , O
although IN O
the DT O
p15 NN B-NP
transcript NN I-NP
increased VBD O
, , O
p15INK4B JJ B-NP
protein NN I-NP
was VBD O
not RB O
stabilized VBN O
and CC O
did VBD O
not RB O
accumulate VB O
, , O
and CC O
cyclin NN B-NP
D1-cdk JJ I-NP
association NN O
and CC O
kinase NN O
activation NN O
were VBD O
not RB O
inhibited VBN O
. . O

-DOCSTART- X X O

The DT O
Rlm1 JJ B-NP
protein NN I-NP
, , O
a DT O
member NN O
of IN O
the DT O
MADS NNP B-NP
box NN I-NP
family NN I-NP
of IN O
transcription NN O
factors NNS O
, , O
functions NNS O
downstream NN O
of IN O
Mpk1 NNP B-NP
in IN O
the DT O
pathway NN O
. . O

-DOCSTART- X X O

DNA-binding JJ O
activity NN O
was VBD O
not RB O
increased VBN O
by IN O
the DT O
addition NN O
of IN O
forskolin NN O
to TO O
thecal JJ O
or CC O
luteal JJ O
cells NNS O
. . O

-DOCSTART- X X O

Upon IN O
induction NN O
of IN O
SOS NNP O
, , O
viability NN O
increased VBD O
2-6-fold JJ O
. . O

-DOCSTART- X X O

In IN O
particular JJ O
, , O
Western JJ O
, , O
supershift JJ O
, , O
and CC O
promoter NN O
deletion NN O
analyses NNS O
suggested VBD O
a DT O
role NN O
for IN O
CCAAT/enhancer-binding JJ B-NP
protein-beta NN I-NP
( -LRB- O
C/EBP-beta JJ B-NP
) -RRB- O
binding JJ O
site NN O
between IN O
-2010 CD O
and CC O
-1954 CD O
in IN O
regulating JJ O
transcription NN O
of IN O
collagenase-1 NN B-NP
in IN O
monocytic JJ O
cells NNS O
. . O

-DOCSTART- X X O

Cdc2 DT B-NP
co-precipitates NNS O
with IN O
Pch1 NNP B-NP
in IN O
S. NNP O
pombe , O
cell NN O
lysates NNS O
, , O
although IN O
Cdc2 NNP B-NP
may MD O
not RB O
be VB O
the DT O
major JJ O
catalytic JJ O
partner NN O
of IN O
a DT O
Pch1 NNP B-NP
kinase NN I-NP
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Little NNP O
is VBZ O
known VBN O
about IN O
the DT O
mechanism NN O
, , O
but CC O
the DT O
availability NN O
of IN O
rapid JJ O
facile JJ O
assays NNS O
for IN O
monitoring NN O
immunoglobulin NN B-NP
hypermutation NN O
would MD O
greatly RB O
aid VB O
the DT O
development NN O
of IN O
culture NN O
systems NNS O
for IN O
hypermutating NN O
B NNP O
cells NNS O
as RB O
well RB O
as IN O
the DT O
screening NN O
for IN O
individuals NNS O
deficient JJ O
in IN O
the DT O
process NN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
the DT O
human JJ B-NP
heat NN I-NP
shock NN I-NP
protein NN I-NP
70 CD I-NP
gene NN I-NP
( -LRB- O
hsp70 CD B-NP
) -RRB- O
is VBZ O
induced VBN O
by IN O
various JJ O
kinds NNS O
of IN O
stress NN O
and CC O
by IN O
oncogenes NNS O
. . O

-DOCSTART- X X O

Of IN O
these DT O
proteins NNS O
, , O
five CD O
have VBP O
previously RB O
been VBN O
shown VBN O
to TO O
be VB O
phosphorylated VBN O
during IN O
mitosis NN O
(epithelial-microtubule NN O
associated VBN B-NP
protein-115 NN I-NP
, , O
Oct91 NNP B-NP
, , O
Elongation NNP B-NP
factor NN I-NP
1gamma VBD I-NP
, , O
BRG1 NNP B-NP
and CC O
Ribosomal JJ B-NP
protein NN I-NP
L18A DT I-NP
) -RRB- O
, , O
five CD O
are VBP O
related VBN O
to TO O
proteins NNS O
postulated VBN O
to TO O
have VB O
roles NNS O
in IN O
mitosis NN O
(epithelial-microtubule NN O
associated VBN B-NP
protein-115 NN I-NP
, , O
Schizosaccharomyces NNP B-NP
pombe VBD I-NP
Cdc5 PRP I-NP
, , O
innercentrosome JJ B-NP
protein NN I-NP
, , O
BRG1 NN B-NP
and CC O
the DT O
RNA NNP B-NP
helicase NN I-NP
WM6) NNP I-NP
, , O
and CC O
nine CD O
are VBP O
related VBN O
to TO O
transcription NN O
factors NNS O
( -LRB- O
BRG1 NN B-NP
, , O
negative JJ B-NP
co-factor NN I-NP
2alpha CD I-NP
, , O
Oct91 NNP B-NP
, , O
S. NNP O
pombe , O
Cdc5 NNP B-NP
, , O
HoxD1 NNP B-NP
, , O
Sox3 NNP B-NP
, , O
Vent2 NNP B-NP
, , O
and CC O
two CD O
isoforms NNS O
of IN O
Xbr1b NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Thus RB O
, , O
depending VBG O
on IN O
their PRP$ O
location NN O
, , O
psoralen JJ O
cross-links NNS O
affected VBD O
different JJ O
steps NNS O
in IN O
the DT O
initiation NN O
process NN O
. . O

-DOCSTART- X X O

L-canavanine NNP O
, , O
a DT O
selective JJ O
inhibitor NN O
of IN O
the DT O
inducible JJ O
nitric JJ B-NP
oxide NN I-NP
synthase NN I-NP
, , O
increases VBZ O
the DT O
mean JJ O
systemic JJ O
filling NN O
pressure NN O
, , O
thereby RB O
improving VBG O
venous JJ O
return NN O
, , O
under IN O
these DT O
conditions NNS O
. . O

-DOCSTART- X X O

The DT O
different JJ O
holoenzyme NN B-NP
RNA NNP I-NP
polymerases NNS I-NP
generated VBD O
upon IN O
reconstituting VBG O
these DT O
mutants NNS O
independently RB O
with IN O
core NN B-NP
RNA NN I-NP
polymerase NN I-NP
( -LRB- O
alpha2beta JJ B-NP
beta' NNS I-NP
) -RRB- O
have VBP O
shown VBN O
reduced VBN O
transcriptional JJ O
activity NN O
in IN O
comparison NN O
to TO O
the DT O
enzyme NN O
containing VBG O
wild-type JJ B-NP
sigma NN I-NP
factor NN I-NP
. . O

-DOCSTART- X X O

These DT O
data NNS O
are VBP O
consistent JJ O
with IN O
a DT O
model NN O
in IN O
which WDT O
GATA-5 NNP B-NP
performs VBZ O
a DT O
unique JJ O
temporally RB O
and CC O
spatially RB O
restricted VBN O
function NN O
in IN O
the DT O
embryonic JJ O
heart NN O
and CC O
lung NN O
. . O

-DOCSTART- X X O

The DT O
exonic JJ O
sequence NN O
encodes VBZ O
a DT O
protein NN O
of IN O
495 CD O
amino IN O
acids NNS O
that WDT O
is VBZ O
nearly RB O
identical JJ O
to TO O
the DT O
previously RB O
reported VBN O
protein NN O
sequence NN O
of IN O
human JJ B-NP
GPT-1 NN I-NP
. . O

-DOCSTART- X X O

Here RB O
we PRP O
characterize VBP O
an DT O
S. NNP B-NP
cerevisiae NN I-NP
Swi3 NN I-NP
homolog NN I-NP
( -LRB- O
Swh3 NN B-NP
) -RRB- O
and CC O
present JJ O
evidence NN O
that IN O
it PRP O
associates NNS O
in IN O
a DT O
complex NN O
with IN O
a DT O
Snf2 NNP B-NP
homolog NN I-NP
, , O
Sthl NNP B-NP
. . O

-DOCSTART- X X O

Shc NNP B-NP
stimulates NNS O
Ras/mitogen-activated JJ B-NP
protein NN B-NP
kinase NN I-NP
( -LRB- O
MAPK) NNP B-NP
through IN O
forming VBG O
a DT O
complex JJ O
with IN O
Grb2 NNP B-NP
at IN O
the DT O
phosphorylated JJ O
tyrosine FW O
( -LRB- O
Y FW O
) -RRB- O
residue JJ O
317 CD O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
Y239/240F NNP B-NP
Shc NNP I-NP
, , O
but CC O
not RB O
Y317F NNP B-NP
Shc NNP I-NP
, , O
reduced VBD O
the DT O
EGF-induced JJ B-NP
c-myc JJ B-NP
message NN O
. . O

-DOCSTART- X X O

The DT O
Ras NNP B-NP
guanine NNP I-NP
nucleotide-binding JJ I-NP
protein NN I-NP
functions NNS O
as IN O
a DT O
molecular JJ O
switch NN O
in IN O
signalling VBG O
downstream NN O
of IN O
protein-tyrosine NN B-NP
kinases NNS I-NP
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
Rlm1 NNP B-NP
and CC O
Smp1 NNP B-NP
have VBP O
MEF2-related JJ B-NP
DNA-binding JJ O
specificities NNS O
: : O
Rlm1 CD B-NP
binds NNS O
with IN O
the DT O
same JJ O
specificity NN O
as IN O
MEF2 NNP B-NP
, , O
CTA( NNP B-NP
T/A)4TAG NNP I-NP
, , O
while IN O
SMP1 NNP B-NP
binds VBZ O
a DT O
more RBR O
extended JJ O
consensus NN O
sequence NN O
, , O
ACTACTA( NNP O
T/A)4TAG. . O

-DOCSTART- X X O

Domains NNS O
I PRP O
and CC O
II NNP O
of IN O
B" NNP B-NP
are VBP O
buried VBN O
upon IN O
assembly NN O
of IN O
the DT O
TFIIIB-DNA NNP B-NP
complex NN I-NP
, , O
as IN O
determined VBN O
by IN O
protein NN O
footprinting NN O
. . O

-DOCSTART- X X O

Domain NNP O
switch VBP O
experiments NNS O
reveal VBP O
that IN O
C/EBP DT B-NP
beta JJ I-NP
proteins NNS I-NP
containing VBG O
either CC O
the DT O
leucine NN O
zipper NN O
or CC O
the DT O
activation NN O
domain NN O
of IN O
C/EBP NNP B-NP
alpha NN I-NP
are VBP O
unable JJ O
to TO O
stimulate VB O
the DT O
2D5 CD B-NP
promoter NN I-NP
yet RB O
are VBP O
fully RB O
capable JJ O
of IN O
transactivating VBG O
an DT O
artificial JJ O
promoter NN O
bearing VBG O
a DT O
high-affinity NN O
C/EBP NNP B-NP
site NN I-NP
. . O

-DOCSTART- X X O

The DT O
similar JJ O
phenotypes NNS O
of IN O
bur6 NNS B-NP
and CC O
bur3 NNS B-NP
( -LRB- O
mot1 NN B-NP
) -RRB- O
mutations NNS O
suggest VBP O
that IN O
Bur6p NNP B-NP
and CC O
Mot1p NNP B-NP
have VBP O
related VBN O
, , O
but CC O
not RB O
identical JJ O
, , O
functions NNS O
in IN O
modulating VBG O
the DT O
activity NN O
of IN O
the DT O
general JJ O
transcription NN O
machinery NN O
in IN O
vivo JJ O
. . O

-DOCSTART- X X O

Time-activity NNP O
curves NNS O
from IN O
the DT O
gastric JJ O
region NN O
of IN O
interest NN O
were VBD O
used VBN O
, , O
after IN O
subjection NN O
to TO O
appropriate JJ O
corrective JJ O
procedures NNS O
, , O
to TO O
calculate VB O
the DT O
mean JJ O
gastric JJ O
transit NN O
time NN O
( -LRB- O
MTT NNP O
90 CD O
) -RRB- O
and CC O
the DT O
fraction NN O
of IN O
the DT O
test NN O
meal NN O
retained VBN O
in IN O
the DT O
stomach NN O
after IN O
90 CD O
min NN O
( -LRB- O
F90 CD O
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
study NN O
provides VBZ O
a DT O
direct JJ O
demonstration NN O
of IN O
a DT O
role NN O
for IN O
G NNP B-NP
betagamma NN I-NP
in IN O
mediating VBG O
the DT O
agonist-stimulated JJ O
translocation NN O
of IN O
GRK2 NNP B-NP
and CC O
GRK3 NNP B-NP
in IN O
an DT O
intact JJ O
cellular JJ O
system NN O
and CC O
demonstrates VBZ O
isoform NN O
specificity NN O
in IN O
the DT O
interaction NN O
of IN O
these DT O
components NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
RA-mediated JJ O
repression NN O
of IN O
the DT O
hMGP JJ B-NP
gene NN I-NP
is VBZ O
due JJ O
to TO O
binding NN O
of IN O
liganded JJ O
RAR/RXR NN B-NP
to TO O
a DT O
novel NN O
negative JJ O
RA NNP O
response NN O
element NN O
. . O

-DOCSTART- X X O

Point NNP O
mutations NNS O
of IN O
the DT O
five CD O
tyrosine NN O
residues NNS O
in IN O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
the DT O
receptor NN O
were VBD O
subsequently RB O
used VBN O
to TO O
confirm VB O
our PRP$ O
conclusions NNS O
. . O

-DOCSTART- X X O

We PRP O
describe VBP O
a DT O
novel NN O
method NN O
using VBG O
Saccharomyces NNP O
cerevisiae NNS O
for IN O
detecting VBG O
protein-truncating JJ O
mutations NNS O
in IN O
any DT O
gene NN O
of IN O
interest NN O
. . O

-DOCSTART- X X O

The DT O
electromyographically RB O
recorded JJ O
responses NNS O
consisted VBD O
of IN O
an DT O
early JJ O
R1 JJ O
response NN O
in IN O
the DT O
orbicularis NN O
oculi IN O
muscle NN O
ipsilateral NN O
to TO O
the DT O
side NN O
of IN O
stimulation NN O
, , O
a DT O
bilateral NN O
late JJ O
response NN O
( -LRB- O
ipsilateral JJ O
R2 NN O
and CC O
contralateral JJ O
Rc NN O
) -RRB- O
and CC O
a DT O
third JJ O
, , O
R3 JJ O
response NN O
, , O
in IN O
the DT O
ipsilateral JJ O
orbicularis NN O
oculi IN O
muscle NN O
. . O

-DOCSTART- X X O

The DT O
prognosis NN O
of IN O
seven CD O
patients NNS O
who WP O
received VBD O
ABSCT NNP O
was VBD O
significantly RB O
better JJR O
than IN O
that DT O
of IN O
13 CD O
patients NNS O
who WP O
received VBD O
conventional JJ O
therapy NN O
alone RB O
. . O

-DOCSTART- X X O

The DT O
Jem NNP B-NP
peptide NN O
sequence NN O
shows VBZ O
a DT O
'leucine-zipper JJ O
' '' O
dimerisation NN O
motif NN O
with IN O
limited JJ O
homology NN O
to TO O
Fos/Jun NNP B-NP
and CC O
ATF/CREB NNP B-NP
proteins NNS O
and CC O
several JJ O
putative JJ O
phosphorylation NN O
sites NNS O
. . O

-DOCSTART- X X O

A DT O
genetic JJ O
screen NN O
applied VBN O
to TO O
mutants NNS O
in IN O
the DT O
branch NN O
site NN O
region NN O
shows VBZ O
that IN O
all DT O
positions NNS O
in IN O
the DT O
conserved JJ O
TACTAAC JJ O
sequence NN O
are VBP O
important JJ O
for IN O
intron NN O
recognition NN O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
the DT O
p50 NN B-NP
sequence NN I-NP
to TO O
other JJ O
cloned JJ O
proteins NNS O
revealed VBD O
89 CD O
% NN O
homology NN O
with IN O
a DT O
glycosaminoglycan-binding JJ O
protein NN O
and CC O
54 CD O
% NN O
homology NN O
with IN O
Drosophila NNP B-NP
cell NN I-NP
cycle NN I-NP
control NN I-NP
protein NN I-NP
( -LRB- I-NP
cdc NN I-NP
) -RRB- I-NP
37 CD O
. . O

-DOCSTART- X X O

The DT O
atp NN B-NP
1 CD I-NP
and CC O
atp IN B-NP
2 CD I-NP
types NNS O
of IN O
cDNA NN O
sequences NNS O
were VBD O
the DT O
most RBS O
redundant JJ O
among IN O
the DT O
28 CD O
different JJ O
isoperoxidases NNS B-NP
identified VBN O
among IN O
about IN O
200 CD O
peroxidase NN B-NP
encoding NN I-NP
ESTs NNP I-NP
. . O

-DOCSTART- X X O

Additional JJ O
information NN O
including VBG O
echocardiographic JJ O
sequences NNS O
, , O
perioperative JJ O
video NN O
sequences NNS O
, , O
x-ray JJ O
analysis NN O
, , O
angiograms NNS O
, , O
etc FW O
. . O
is VBZ O
represented VBN O
in IN O
the DT O
program NN O
. . O

-DOCSTART- X X O

In IN O
Schizosaccharomyces NNP O
pombe NN O
, , O
the DT O
activity NN O
of IN O
the DT O
M-phase-inducing NN O
Cdc2/Cdc13 IN B-NP
cyclin-dependent JJ O
kinase NN O
is VBZ O
inhibited VBN O
by IN O
Wee1 NNP B-NP
and CC O
Mik1 NNP B-NP
tyrosine NN B-NP
kinases NNS I-NP
, , O
and CC O
activated VBN O
by IN O
Cdc25 NNP B-NP
and CC O
Pyp3 NNP B-NP
tyrosine NN B-NP
phosphatases NNS I-NP
. . O

-DOCSTART- X X O

4.26 CD O
+/ NNS O
- : O
1.54 CD O
mmol/l NN O
, , O
P NNP O
< JJ O
0.01 CD O
) -RRB- O
, , O
and CC O
systolic JJ O
BP NNP O
responses NNS O
to TO O
intravenous JJ O
norepinephrine NN O
and CC O
angiotensin NN B-NP
II NNP I-NP
were VBD O
significantly RB O
higher JJR O
on IN O
glibenclamide NN O
than IN O
on IN O
metformin NN O
( -LRB- O
P NNP O
< , O
0.02 CD O
and CC O
P NNP O
< NNP O
0.05 CD O
, , O
respectively RB O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
sequencing NN O
of IN O
Stellate NN B-NP
copies NNS O
located VBN O
along IN O
the DT O
discontinuous JJ O
cluster NN O
revealed VBD O
a DT O
complex JJ O
pattern NN O
of IN O
diversification NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
indicate VBP O
that IN O
DNA NNP O
methylation NN O
, , O
chromatin NN O
structure NN O
, , O
and CC O
transactivation NN O
at IN O
an DT O
Sp1 NNP B-NP
site NN I-NP
contribute VBP O
to TO O
the DT O
highly RB O
restricted VBN O
expression NN O
of IN O
this DT O
myelomonocytic JJ O
lineage NN O
specific JJ O
gene NN O
. . O

-DOCSTART- X X O

Finally RB O
, , O
we PRP O
show VBP O
that IN O
PhLP NNP B-NP
complexes NNS O
, , O
at IN O
least JJS O
partially RB O
, , O
with IN O
Gbetagamma NNP B-NP
in IN O
vivo RB O
. . O

-DOCSTART- X X O

CTF1alpha NNP B-NP
, , O
expressed VBD O
in IN O
Escherichia NNP O
coli NNS O
, , O
showed VBD O
specific JJ O
binding NN O
to TO O
the DT O
palindrome NN O
2 CD O
DNA NN O
fragment NN O
but CC O
not RB O
to TO O
palindrome VB O
1 CD O
or CC O
mutant JJ O
palindrome NN O
2 CD O
DNA NN O
fragments NNS O
, , O
suggesting VBG O
specific JJ O
binding NN O
of IN O
CTF1alpha NNP B-NP
to TO O
palindrome VB O
2. . O

-DOCSTART- X X O

Cyclin NNP B-NP
G2 NNP I-NP
is VBZ O
highly RB O
expressed VBN O
in IN O
the DT O
immune JJ O
system NN O
where WRB O
immunologic JJ O
tolerance NN O
subjects NNS O
self-reactive JJ O
lymphocytes NNS O
to TO O
negative JJ O
selection NN O
and CC O
clonal JJ O
deletion NN O
via IN O
apoptosis NN O
. . O

-DOCSTART- X X O

A DT O
sterol-regulated JJ O
protease NN O
initiates VBZ O
release NN O
of IN O
the DT O
NH2-terminal JJ O
segments NNS O
of IN O
sterol NN B-NP
regulatory JJ I-NP
element-binding JJ I-NP
proteins NNS I-NP
( -LRB- O
SREBPs NNS B-NP
) -RRB- O
from IN O
cell NN O
membranes NNS O
, , O
thereby RB O
allowing VBG O
them PRP O
to TO O
enter VB O
the DT O
nucleus JJ O
and CC O
to TO O
stimulate VB O
transcription NN O
of IN O
genes NNS O
involved VBN O
in IN O
the DT O
uptake NN O
and CC O
synthesis NN O
of IN O
cholesterol NN O
and CC O
fatty JJ O
acids NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
P. NNP O
aeruginosa NN O
orfX NNP O
and CC O
vfr JJ B-NP
promoters NNS I-NP
are VBP O
arranged VBN O
in IN O
a DT O
back-to-back JJ O
orientation NN O
rather RB O
than IN O
the DT O
face-to-face JJ O
orientation NN O
of IN O
the DT O
dorf NN O
and CC O
crp JJ B-NP
promoters NNS I-NP
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
cloned JJ O
PCR NN O
products NNS O
confirmed VBD O
the DT O
presence NN O
of IN O
two CD O
different JJ O
nifV-like JJ B-NP
DNA NN I-NP
fragments NNS I-NP
, , O
which WDT O
were VBD O
subsequently RB O
used VBN O
as IN O
nifV JJ B-NP
- : O
and CC O
leuA-specific JJ B-NP
probes NNS I-NP
, , O
respectively RB O
, , O
to TO O
clone VB O
XbaI NNP B-NP
fragments NNS I-NP
of IN O
2.1 CD O
kbp NN O
( -LRB- O
pOST4 NN O
) -RRB- O
and CC O
2.6 CD O
kbp NN O
( -LRB- O
pOST2 NN O
) -RRB- O
. . O

-DOCSTART- X X O

( -LRB- O
3 CD O
) -RRB- O
This DT O
effect NN O
occurs VBZ O
without IN O
removing VBG O
TRs NNS B-NP
from IN O
the DT O
TRE. NNP O

-DOCSTART- X X O

In IN O
a DT O
model NN O
of IN O
the DT O
ternary JJ O
complex NN O
, , O
the DT O
segment NN O
of IN O
NFAT NNP B-NP
nearest JJS O
AP-1 NN B-NP
is VBZ O
the DT O
Rel NNP B-NP
insert NN O
region NN O
( -LRB- O
RIR NNP O
) -RRB- O
, , O
a DT O
feature NN O
that WDT O
is VBZ O
notable JJ O
for IN O
its PRP$ O
hypervariability NN O
in IN O
size NN O
and CC O
in IN O
sequence NN O
amongst IN O
members NNS O
of IN O
the DT O
Rel NNP B-NP
transcription NN I-NP
factor NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

This DT O
protein NN O
can MD O
bind NN O
to TO O
a DT O
region NN O
of IN O
the DT O
promoter NN O
of IN O
an DT O
Arabidopsis NNP B-NP
light-harvesting NN I-NP
chlorophyll NN I-NP
a/b IN I-NP
protein NN I-NP
gene NN I-NP
, , O
Lhcb1*3 CD B-NP
, , O
which WDT O
is VBZ O
necessary JJ O
for IN O
its PRP$ O
regulation NN O
by IN O
phytochrome NN B-NP
. . O

-DOCSTART- X X O

It PRP O
has VBZ O
repeatedly RB O
been VBN O
shown VBN O
that IN O
HCMV NNP O
IE1/IE2 NNP B-NP
can MD O
independently RB O
transactivate VB O
HIV-1 NN B-NP
LTR. . I-NP

-DOCSTART- X X O

Respiratory NN O
chain NN O
enzyme NN O
activity NN O
was VBD O
normal JJ O
. . O

-DOCSTART- X X O

Children NNS O
's POS O
temperament NN O
and CC O
maternal JJ O
socialization NN O
at IN O
Time NN O
1 CD O
( -LRB- O
n NN O
= SYM O
103 CD O
, , O
aged VBN O
2-3 JJ O
years NNS O
) -RRB- O
were VBD O
considered VBN O
predictors NNS O
of IN O
future JJ O
conscience NN O
, , O
assessed VBN O
using VBG O
new JJ O
observational JJ O
and CC O
narrative JJ O
measures NNS O
. . O

-DOCSTART- X X O

FN-stimulated JJ B-NP
c-Src JJ B-NP
PTK NN B-NP
activity NN O
was VBD O
enhanced VBN O
by IN O
wild JJ O
type NN O
FAK NNP B-NP
expression NN O
, , O
whereas IN O
FN-stimulated JJ B-NP
activation NN O
of IN O
ERK2 NNP B-NP
was VBD O
blocked VBN O
by IN O
expression NN O
of IN O
the DT O
c-Src JJ B-NP
binding NN I-NP
site NN I-NP
Phe-397 JJ I-NP
mutant JJ I-NP
of IN O
FAK. NNP B-NP

-DOCSTART- X X O

Each DT O
sample NN O
was VBD O
analysed JJ O
as RB O
soon RB O
as IN O
possible JJ O
, , O
and CC O
repeated VBD O
15 CD O
, , O
30 CD O
, , O
60 CD O
and CC O
120 CD O
min NN O
after IN O
sampling NN O
. . O

-DOCSTART- X X O

Anesthesia NNP O
was VBD O
maintained VBN O
with IN O
isoflurane NN O
( -LRB- O
ISO)/N2O/ NNP O
O2 NNP O
inhalation NN O
. . O

-DOCSTART- X X O

The DT O
altered VBD O
amino IN O
acid NN O
residues NNS O
of IN O
the DT O
seven CD O
mutant JJ B-NP
9ORF1 CD I-NP
polypeptides NNS I-NP
clustered VBN O
within IN O
three CD O
separate JJ O
regions NNS O
referred VBD O
to TO O
as IN O
region NN O
I PRP O
( -LRB- O
residues NNS O
34 CD O
to TO O
41 CD O
) -RRB- O
, , O
region NN O
II NNP O
( -LRB- O
residues NNS O
89 CD O
to TO O
91 CD O
) -RRB- O
, , O
and CC O
C-terminal JJ O
region NN O
III NNP O
( -LRB- O
residues NNS O
122 CD O
to TO O
125 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
C-LIP NN O
also RB O
was VBD O
compared VBN O
with IN O
transcather NN O
arterial NN O
embolization NN O
( -LRB- O
TAE NNP O
; : O
C-LIP NN O
followed VBN O
by IN O
gelatin JJ O
sponge NN O
) -RRB- O
and CC O
percutaneous JJ O
ethanol NN O
injection NN O
therapy NN O
( -LRB- O
PEIT NN O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
also RB O
demonstrate VBP O
that IN O
preformed JJ O
triplexes NNS O
are VBP O
quite RB O
stable JJ O
when WRB O
precipitated VBN O
with IN O
ethanol NN O
and CC O
resuspended VBD O
in IN O
water NN O
. . O

-DOCSTART- X X O

Transfection NN O
experiments NNS O
using VBG O
preformed JJ O
triplexes NNS O
with IN O
a DT O
reporter NN O
plasmid NN O
containing VBG O
the DT O
collagen NN B-NP
promoter NN I-NP
sequence NN I-NP
showed VBD O
significant JJ O
inhibition NN O
of IN O
transcription NN O
when WRB O
compared VBN O
with IN O
a DT O
control NN O
phosphorothioate NN O
ODN. . O

-DOCSTART- X X O

In IN O
several JJ O
studies NNS O
the DT O
RDFS NNP O
has VBZ O
shown VBN O
evidence NN O
of IN O
reliability NN O
and CC O
validity NN O
. . O

-DOCSTART- X X O

Latanoprost NNP O
produces VBZ O
an DT O
additional JJ O
reduction NN O
of IN O
intraocular JJ O
pressure NN O
( -LRB- O
IOP) NN O
when WRB O
used VBN O
in IN O
combination NN O
with IN O
timolol NN O
, , O
pilocarpine NN O
, , O
acetazolamide NN O
and CC O
dipivefrin NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
dietary NN O
safflower NN O
phospholipids NNS O
may MD O
be VB O
a DT O
valuable JJ O
ingredient NN O
to TO O
layers NNS O
for IN O
reducing VBG O
liver NN O
triglycerides NNS O
and CC O
serum NN O
cholesterol NN O
without IN O
any DT O
adverse JJ O
effects NNS O
. . O

-DOCSTART- X X O

Transient NNP O
overexpression IN O
of IN O
c-Jun JJ B-NP
induced JJ O
tenascin-C JJ B-NP
expression NN O
in IN O
primary JJ O
REF NN O
and CC O
in IN O
FR3T3 NNP O
, , O
an DT O
established VBN O
fibroblast JJ O
cell NN O
line NN O
. . O

-DOCSTART- X X O

Inhibition NN O
of IN O
the DT O
Raf-1 NNP B-NP
kinase NN I-NP
by IN O
cyclic JJ O
AMP NNP O
agonists NNS O
causes VBZ O
apoptosis NN O
of IN O
v-abl-transformed JJ B-NP
cells NNS O
. . O

-DOCSTART- X X O

Selected JJ O
parameters NNS O
: : O
heart NN O
rate NN O
( -LRB- O
HR NN O
) -RRB- O
, , O
arterial JJ O
blood NN O
pressure NN O
( -LRB- O
ABP NNP O
) -RRB- O
and CC O
arterial JJ O
O2 NN O
saturation NN O
( -LRB- O
SaO2 JJ O
) -RRB- O
monitored VBN O
by IN O
pulsoximetry NN O
were VBD O
measured VBN O
during IN O
the DT O
procedure NN O
. . O

-DOCSTART- X X O

Both DT O
quantitative JJ O
and CC O
qualitative JJ O
analysis NN O
of IN O
individual JJ O
cytoarchitectonic JJ O
peculiarities NNS O
of IN O
Meynart NNP O
's POS O
nucleus JJ O
as RB O
well RB O
as IN O
of IN O
external JJ O
part NN O
of IN O
dorsomedial JJ O
nucleus NN O
of IN O
thalamus NN O
was VBD O
performed VBN O
in IN O
mentally RB O
normal JJ O
individuals NNS O
. . O

-DOCSTART- X X O

Positional NNP O
cloning NN O
has VBZ O
already RB O
produced VBN O
the DT O
sequences NNS O
of IN O
more JJR O
than IN O
70 CD O
human JJ O
genes NNS O
associated VBN O
with IN O
specific JJ O
diseases NNS O
. . O

-DOCSTART- X X O

Genes NNP O
for IN O
ocs NNP B-NP
element NN I-NP
binding NN I-NP
factors NNS I-NP
( -LRB- O
OBFs NNS B-NP
) -RRB- O
, , O
belonging VBG O
to TO O
a DT O
specific JJ O
class NN O
of IN O
basic-region NN B-NP
leucine NN I-NP
zipper NN I-NP
( -LRB- I-NP
bZIP NN I-NP
) -RRB- I-NP
transcription NN I-NP
factors NNS I-NP
, , O
have VBP O
been VBN O
isolated VBN O
in IN O
a DT O
number NN O
of IN O
plants NNS O
. . O

-DOCSTART- X X O

The DT O
30-day JJ O
mortality NN O
in IN O
the DT O
CPB NNP O
group NN O
and CC O
the DT O
non-CPB JJ O
group NN O
were VBD O
20 CD O
% NN O
and CC O
4.6 CD O
% NN O
, , O
respectively RB O
which WDT O
was VBD O
not RB O
statistically RB O
significant JJ O
( -LRB- O
p NN O
= SYM O
0.06 CD O
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
association NN O
appears VBZ O
to TO O
be VB O
mediated VBN O
by IN O
Src-SH2 NNP B-NP
domain NN O
, , O
because IN O
PECAM-1 NN B-NP
can MD O
be VB O
precipitated VBN O
by IN O
a DT O
GST-Src-SH2 JJ B-NP
affinity NN O
matrix NN O
. . O

-DOCSTART- X X O

An DT O
alternatively NN O
spliced VBD O
MAdCAM-1 JJ B-NP
variant NN O
was VBD O
identified VBN O
that IN O
lacks VBZ O
exon JJ O
4 CD O
encoding VBG O
the DT O
mucin JJ B-NP
domain NN O
, , O
and CC O
may MD O
mediate VB O
leukocyte JJ O
adhesion NN O
to TO O
LPAM-1 NNP B-NP
without IN O
adhesion NN O
to TO O
the DT O
alternate JJ O
receptor NN O
, , O
L-selectin NNP B-NP
. . O

-DOCSTART- X X O

In IN O
summary NN O
, , O
the DT O
data NNS O
establish VBP O
that IN O
the DT O
previously RB O
reported VBN O
human JJ B-NP
MAdCAM-1 NN I-NP
cDNA NN I-NP
does VBZ O
indeed RB O
encode VB O
the DT O
human JJ O
homologue NN O
of IN O
mouse NN B-NP
MAdCAM-1 NN I-NP
, , O
despite IN O
gross JJ O
dissimilarities NNS O
in IN O
the DT O
MAdCAM-1 NN B-NP
C-terminal JJ O
structures NNS O
. . O

-DOCSTART- X X O

MATERIAL NNP O
AND CC O
METHODS NNP O
: : O
The DT O
authors NNS O
analyzed VBD O
41 CD O
persons NNS O
formerly RB O
submitted VBD O
to TO O
surgery NN O
( -LRB- O
after IN O
8 CD O
years NNS O
and CC O
4 CD O
months NNS O
, , O
as IN O
a DT O
mean NN O
) -RRB- O
, , O
31 CD O
to TO O
highly RB O
selective JJ O
vagotomy NN O
, , O
and CC O
10 CD O
to TO O
truncal JJ O
or CC O
selective JJ O
vagotomy NN O
plus CC O
gastroduodenal JJ O
drainage NN O
. . O

-DOCSTART- X X O

The DT O
monkey NN B-NP
LHR NN I-NP
cDNA NN I-NP
displayed VBD O
83-94 CD O
% NN O
overall JJ O
sequence NN O
homology NN O
with IN O
the DT O
other JJ O
mammalian JJ B-NP
LHR NNP I-NP
cDNAs NNS I-NP
. . O

-DOCSTART- X X O

In IN O
unc-4 JJ B-NP
mutants NNS I-NP
, , O
VA NNP O
motor NN O
neurons NNS O
assume VBP O
the DT O
pattern NN O
of IN O
synaptic NN O
input NN O
normally RB O
reserved VBN O
for IN O
their PRP$ O
lineal JJ O
sister NN O
cells NNS O
, , O
the DT O
VB NNP O
motor NN O
neurons NNS O
; : O
the DT O
loss NN O
of IN O
normal JJ O
input NN O
to TO O
the DT O
VAs NNP O
produces VBZ O
a DT O
distinctive JJ O
backward JJ O
movement NN O
defect NN O
. . O

-DOCSTART- X X O

No DT O
patient NN O
in IN O
group NN O
2 CD O
developed VBN O
HAT NN O
( -LRB- O
P NNP O
= SYM O
0.006 CD O
versus JJ O
group NN O
1 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Sequence NNP O
comparison NN O
of IN O
the DT O
0.38 CD O
kb NN O
promoter NN O
sequence NN O
with IN O
the DT O
promoters NNS O
of IN O
the DT O
Sm-E NNP B-NP
gene NN O
and CC O
U1 DT B-NP
snRNA NN I-NP
genes NNS I-NP
revealed VBD O
several JJ O
homologous JJ O
motifs NNS O
, , O
suggesting VBG O
that IN O
genes NNS O
encoding VBG O
the DT O
snRNP JJ O
components NNS O
may MD O
be VB O
coordinately RB O
regulated VBN O
. . O

-DOCSTART- X X O

A DT O
xylE JJ B-NP
transcriptional JJ I-NP
fusion NN I-NP
to TO O
the DT O
putative JJ O
mxbD NN B-NP
promoter NN I-NP
showed VBD O
low-level JJ O
expression NN O
in IN O
wild-type JJ O
cells NNS O
grown VBN O
on IN O
one-carbon NN O
( -LRB- O
C1 NN O
) -RRB- O
compounds NNS O
and CC O
no DT O
detectable JJ O
expression NN O
in IN O
cells NNS O
grown VBN O
on IN O
succinate JJ O
. . O

-DOCSTART- X X O

In IN O
the DT O
studies NNS O
reported VBD O
here RB O
, , O
the DT O
5'-flanking JJ O
region NN O
of IN O
the DT O
human JJ B-NP
gp130 CD I-NP
gene NN I-NP
was VBD O
isolated VBN O
and CC O
the DT O
transcription NN O
initiation NN O
sites NNS O
were VBD O
mapped VBN O
. . O

-DOCSTART- X X O

Insulin NNP B-NP
regulation NN O
of IN O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
kinase NN I-NP
( -LRB- O
MEK) NNP B-NP
, , O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
and CC O
casein NN B-NP
kinase NN I-NP
in IN O
the DT O
cell NN O
nucleus NN O
: : O
a DT O
possible JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

Sequencing NN O
of IN O
the DT O
three CD O
pag-3 NN B-NP
alleles NNS I-NP
showed VBD O
that IN O
two CD O
apparent JJ O
null JJ O
alleles NNS O
encode VBP O
a DT O
nonsense NN O
mutation NN O
before IN O
the DT O
zinc NN O
fingers NNS O
and CC O
a DT O
missense NN O
mutation NN O
in IN O
the DT O
fourth JJ O
zinc NN O
finger NN O
that IN O
changes NNS O
a DT O
coordinating NN O
histidine NN O
to TO O
a DT O
tyrosine NN O
. . O

-DOCSTART- X X O

Pax-3 NN B-NP
is VBZ O
a DT O
paired-type NN B-NP
homeobox NN I-NP
gene NN I-NP
that WDT O
is VBZ O
specifically RB O
expressed VBN O
in IN O
the DT O
dorsal JJ O
and CC O
posterior JJ O
neural JJ O
tube NN O
. . O

-DOCSTART- X X O

Instead RB O
, , O
they PRP O
contained VBD O
dendritic JJ O
cells NNS O
that WDT O
express VBP O
melanogenic JJ O
marker NN O
proteins VBZ O
such JJ O
as IN O
tyrosinase NN B-NP
and CC O
tyrosinase-related JJ B-NP
protein NN I-NP
1 CD I-NP
. . O

-DOCSTART- X X O

Cloning NNP O
and CC O
characterization NN O
of IN O
a DT O
cDNA NN O
encoding VBG O
a DT O
bacteriophage-type JJ B-NP
RNA NNP I-NP
polymerase NN I-NP
from IN O
the DT O
higher JJR O
plant NN O
Chenopodium NN O
album NN O
. . O

-DOCSTART- X X O

These DT O
six CD O
amino IN O
acids NNS O
are VBP O
part NN O
of IN O
an DT O
amphipathic JJ O
helix NN O
that WDT O
is VBZ O
highly RB O
conserved VBN O
among IN O
nuclear JJ B-NP
hormone NN I-NP
receptors NNS I-NP
and CC O
contains VBZ O
the DT O
core NN O
domain NN O
of IN O
the DT O
ligand-dependent JJ O
transactivation NN O
function NN O
, , O
AF-2 JJ O
. . O

-DOCSTART- X X O

Surprisingly RB O
, , O
the DT O
RXR-specific JJ B-NP
ligand NN O
9-cis-retinoic JJ O
acid NN O
induced VBD O
binding NN O
of IN O
SRC-1 NN B-NP
to TO O
the DT O
RXR NNP B-NP
component NN I-NP
of IN O
the DT O
TRE-bound NN O
heterodimer NN O
. . O

-DOCSTART- X X O

Diver VB O
respiratory JJ O
responses NNS O
to TO O
a DT O
tunable JJ O
closed-circuit NN O
breathing NN O
apparatus NN O
. . O

-DOCSTART- X X O

Measurement NN O
of IN O
the DT O
time NN O
constant JJ O
of IN O
VO2 NN O
and CC O
oxygen NN O
pulse NN O
during IN O
constant JJ O
work NN O
rate NN O
exercise NN O
are VBP O
useful JJ O
for IN O
the DT O
objective JJ O
evaluation NN O
of IN O
the DT O
training NN O
effect NN O
of IN O
patients NNS O
with IN O
COPD. NNP O

-DOCSTART- X X O

Characterization NNP O
of IN O
CR1 NNP B-NP
repeat VBP O
random JJ O
PCR NN O
markers NNS O
for IN O
mapping VBG O
the DT O
chicken NN O
genome NN O
. . O

-DOCSTART- X X O

A DT O
reversed-phase NN O
high-performance NN O
liquid JJ O
chromatographic NN O
( -LRB- O
HPLC NNP O
) -RRB- O
method NN O
for IN O
the DT O
determination NN O
of IN O
cocaine NN O
metabolites NNS O
produced VBD O
in IN O
vitro NN O
by IN O
serum NN B-NP
and CC I-NP
liver NN I-NP
esterases NNS I-NP
is VBZ O
described VBN O
. . O

-DOCSTART- X X O

Mutational JJ O
studies NNS O
provide VBP O
evidence NN O
to TO O
this DT O
end NN O
and CC O
indicate VBP O
that IN O
the DT O
side NN O
chains NNS O
of IN O
subdomain JJ O
4.2 CD O
make VBP O
specific JJ O
contacts NNS O
with IN O
the DT O
nucleotides NNS O
at IN O
-35 CD O
. . O

-DOCSTART- X X O

Concomitantly RB O
, , O
p34CDC2 DT B-NP
histone NN B-NP
H1 IN I-NP
kinase NN O
activity NN O
increases NNS O
in IN O
the DT O
former JJ O
, , O
but CC O
not RB O
in IN O
the DT O
latter JJ O
cell NN O
lines NNS O
, , O
hence RB O
suggesting VBG O
a DT O
role NN O
for IN O
this DT O
protein NN O
in IN O
radiation-induced JJ O
cell NN O
death NN O
. . O

-DOCSTART- X X O

Using VBG O
PRL-R NNP B-NP
tagged VBD O
both DT O
in IN O
the DT O
N-terminal JJ O
or CC O
C-terminal JJ O
regions NNS O
of IN O
the DT O
mature JJ O
receptor NN O
excludes VBZ O
the DT O
possibility NN O
of IN O
a DT O
cleaved JJ O
fragment NN O
which WDT O
could MD O
have VB O
been VBN O
subsequently RB O
imported VBN O
into IN O
the DT O
nucleus NN O
. . O

-DOCSTART- X X O

A DT O
similar JJ O
chimera NN O
was VBD O
assembled VBN O
from IN O
the DT O
two CD O
halves NNS O
of IN O
the DT O
molecule NN O
expressed VBD O
separately RB O
in IN O
different JJ O
bacteria NNS O
and CC O
refolded VBN O
together RB O
. . O

-DOCSTART- X X O

All DT O
six CD O
genes NNS O
were VBD O
cloned VBN O
and CC O
characterised VBN O
. . O

-DOCSTART- X X O

We PRP O
analysed VBD O
two CD O
regions NNS O
involved VBN O
in IN O
preS2/S VBG B-NP
gene NN B-NP
transcription NN O
of IN O
the DT O
HBV NNP O
adw NN O
subtype NN O
: : O
the DT O
diverged JJ O
TATA NNP O
box NN O
and CC O
a DT O
putative JJ O
initiator NN O
element NN O
. . O

-DOCSTART- X X O

Indeed RB O
the DT O
predicted VBN O
folding NN O
of IN O
the DT O
5' JJ O
and CC O
3'-untranslated JJ O
regions NNS O
revealed VBD O
patterns NNS O
of IN O
stem NN O
and CC O
loop NN O
structures NNS O
conserved VBD O
for IN O
all DT O
tick-borne JJ O
flaviviruses NNS O
suggesting VBG O
a DT O
purifying NN O
selection NN O
for IN O
preservation NN O
of IN O
essential JJ O
RNA NN O
secondary JJ O
structures NNS O
which WDT O
could MD O
be VB O
involved VBN O
in IN O
translational JJ O
control NN O
and CC O
replication NN O
. . O

-DOCSTART- X X O

Recently RB O
we PRP O
have VBP O
performed VBN O
a DT O
detailed JJ O
analysis NN O
of IN O
specific JJ O
neuronal JJ O
populations NNS O
affected VBN O
by IN O
the DT O
mutation NN O
which WDT O
shed VBD O
new JJ O
light NN O
on IN O
the DT O
role NN O
of IN O
Krox-20 NNP B-NP
in IN O
the DT O
segmentation NN O
and CC O
on IN O
the DT O
physiological JJ O
consequences NNS O
of IN O
its PRP$ O
inactivation NN O
. . O

-DOCSTART- X X O

The DT O
most RBS O
important JJ O
one NN O
among IN O
them PRP O
is VBZ O
Cyclosporin NNP O
A NNP O
, , O
which WDT O
is VBZ O
a DT O
selective JJ O
immunosuppressive JJ O
drug NN O
. . O

-DOCSTART- X X O

Consistent NNP O
with IN O
its PRP$ O
role NN O
in IN O
p53 NN B-NP
ubiquitination NN O
, , O
mE6-AP . B-NP
was VBD O
found VBN O
both DT O
in IN O
the DT O
nucleus JJ O
and CC O
cytosol JJ O
, , O
while IN O
Nedd-4 NNP B-NP
was VBD O
found VBN O
only RB O
in IN O
the DT O
cytosol NN O
. . O

-DOCSTART- X X O

SPP NNP B-NP
also RB O
induced VBD O
transient JJ O
tyrosine NN O
phosphorylation NN O
of IN O
focal JJ B-NP
adhesion NN I-NP
kinase NN I-NP
( -LRB- O
p125(FAK) NN B-NP
) -RRB- O
, , O
a DT O
cytosolic JJ B-NP
tyrosine NN I-NP
kinase NN I-NP
that IN O
localizes NNS O
in IN O
focal JJ O
adhesions NNS O
, , O
and CC O
of IN O
the DT O
cytoskeleton-associated JJ B-NP
protein NN I-NP
paxillin NN I-NP
. . O

-DOCSTART- X X O

Using VBG O
a DT O
conditional-lethal JJ O
mutant JJ O
allele NN O
of IN O
SUP45 NNP B-NP
( -LRB- O
sup45-2 NN B-NP
) -RRB- O
and CC O
a DT O
combination NN O
of IN O
in IN O
vivo JJ O
and CC O
in IN O
vitro NN O
approaches NNS O
, , O
we PRP O
demonstrate VBP O
that IN O
the DT O
product NN O
of IN O
the DT O
SUP45 NNP B-NP
gene NN I-NP
( -LRB- O
Sup45p NNP B-NP
or CC O
eRF1 DT B-NP
) -RRB- O
is VBZ O
a DT O
factor NN O
required VBN O
for IN O
translation NN O
termination NN O
in IN O
yeast NN O
. . O

-DOCSTART- X X O

A DT O
neonatal JJ O
alloimmune NN O
thrombocytopenia NN O
with IN O
an DT O
HPA-3a NNP B-NP
( -LRB- O
Baka NNP O
) -RRB- O
incompatibility NN O
was VBD O
confirmed VBN O
. . O

-DOCSTART- X X O

Most JJS O
eukaryotic JJ O
mRNAs NNS O
are VBP O
translated VBN O
by IN O
a DT O
"scanning NN O
ribosome DT O
" `` O
mechanism NN O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
Tc-99m JJ O
sestamibi NN O
perfusion NN O
imaging NN O
and CC O
echocardiography NN O
using VBG O
an DT O
arbutamine NN O
infusion NN O
for IN O
the DT O
detection NN O
of IN O
coronary JJ O
artery NN O
disease NN O
. . O

-DOCSTART- X X O

Also RB O
, , O
transient JJ O
overexpression NN O
of IN O
this DT O
protein NN O
in IN O
C2C12 NN O
cells NNS O
reduced VBN O
the DT O
transcription NN O
of IN O
a DT O
CAT-reporter NN B-NP
regulated VBN O
by IN O
an DT O
E12/MyoD NNP B-NP
driven JJ O
enhancer NN O
. . O

-DOCSTART- X X O

Five CD O
of IN O
these DT O
have VBP O
ocular JJ O
or CC O
oculocutaneous JJ O
albinism NN O
. . O

-DOCSTART- X X O

Comprising VBG O
a DT O
126-nucleotide JJ O
5' JJ O
untranscribed JJ O
genomic JJ O
sequence NN O
and CC O
a DT O
466-nucleotide JJ O
5' JJ O
noncoding JJ O
cDNA NN O
sequence NN O
, , O
the DT O
592-nucleotide JJ O
5' JJ O
CpG NNP O
island NN O
lacked VBD O
TATA NNP O
and CC O
CAAT NNP O
boxes NNS O
but CC O
displayed VBD O
a DT O
high JJ O
G+C JJ O
content NN O
, , O
was VBD O
enriched VBN O
for IN O
CpG NNP O
dinucleotides NNS O
, , O
and CC O
contained VBD O
a DT O
potential JJ O
Sp1-binding JJ B-NP
site NN I-NP
, , O
i IN O
.e NN O
. . O
, , O
features NNS O
compatible JJ O
with IN O
a DT O
housekeeping NN O
gene NN O
. . O

-DOCSTART- X X O

SSeCKS NNP B-NP
( -LRB- O
pronounced JJ O
essex NN O
) -RRB- O
encodes VBZ O
a DT O
major JJ O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
substrate NN O
, , O
the DT O
expression NN O
of IN O
which WDT O
is VBZ O
down-regulated JJ O
in IN O
src JJ B-NP
- : O
and CC O
ras-transformed JJ B-NP
rodent NN O
fibroblasts NNS O
but CC O
not RB O
in IN O
raf-transformed JJ O
rodent NN O
fibroblasts NNS O
( -LRB- O
X NNP O
. . O

-DOCSTART- X X O

Type NN O
I PRP O
position-vestibular-pause RB O
( -LRB- O
PVP JJ O
I PRP O
) -RRB- O
and CC O
vestibular-only JJ O
( -LRB- O
V NN O
I PRP O
) -RRB- O
neurons NNS O
, , O
as RB O
well RB O
as IN O
a DT O
smaller JJR O
number NN O
of IN O
other JJ O
type NN O
I PRP O
and CC O
type NN O
II NNP O
eye-plus-vestibular JJ O
neurons NNS O
were VBD O
studied VBN O
. . O

-DOCSTART- X X O

Taurine NN O
deficiency NN O
significantly RB O
depressed VBD O
the DT O
amplitude NN O
of IN O
OP1 NNP O
and CC O
OP4 NNP O
. . O

-DOCSTART- X X O

Alternative JJ O
splicing NN O
of IN O
CDC25B NNP B-NP
may MD O
therefore RB O
contribute VB O
to TO O
the DT O
control NN O
of IN O
cell NN O
proliferation NN O
. . O

-DOCSTART- X X O

The DT O
findings NNS O
suggest VBP O
that IN O
ERP NNP O
effects NNS O
of IN O
distinct JJ O
memory NN O
processes NNS O
are VBP O
differentially RB O
influenced VBN O
by IN O
the DT O
encoding JJ O
instructions NNS O
. . O

-DOCSTART- X X O

The DT O
second JJ O
primary JJ O
mutant NN O
contained VBD O
a DT O
proline-to-leucine NN O
change NN O
at IN O
position NN O
243 CD O
( -LRB- O
P243L NN O
) -RRB- O
. . O

-DOCSTART- X X O

Induction NN O
of IN O
correctly RB O
spliced VBN O
germline NN O
transcripts NNS O
is VBZ O
necessary JJ O
to TO O
target VB O
a DT O
switch NN O
region NN O
for IN O
recombination NN O
and CC O
switching NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
PCE NNP B-NP
binds NNS O
a DT O
Pbx NNP B-NP
dimer NN I-NP
partner NN I-NP
that WDT O
behaves VBZ O
unlike IN O
Class NN B-NP
I PRP I-NP
Hox RB I-NP
proteins VBZ I-NP
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
NH2-terminal JJ O
portion NN O
of IN O
the DT O
homologue NN O
was VBD O
not RB O
translocated VBN O
into IN O
the DT O
outer JJ O
membrane NN O
without IN O
its PRP$ O
COOH-terminal JJ O
part NN O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
and CC O
characterization NN O
of IN O
a DT O
cDNA NN O
, , O
CHEMR1 NNP B-NP
, , O
encoding VBG O
a DT O
chemokine NN O
receptor NN O
with IN O
a DT O
homology NN O
to TO O
the DT O
human JJ B-NP
C-C NN I-NP
chemokine NN I-NP
receptor NN I-NP
, , O
CCR-4. . B-NP

-DOCSTART- X X O

Organization NNP O
of IN O
the DT O
human JJ B-NP
LU NNP I-NP
gene NN I-NP
and CC O
molecular JJ O
basis NN O
of IN O
the DT O
Lu( NNP B-NP
a DT I-NP
)/Lu( JJ I-NP
b NN B-NP
) -RRB- I-NP
blood NN O
group NN O
polymorphism NN O
. . O

-DOCSTART- X X O

The DT O
active JJ O
state NN O
is VBZ O
terminated VBN O
by IN O
hydrolysis NN O
of IN O
bound JJ O
GTP NNP O
, , O
producing VBG O
inactive JJ O
ARF-GDP. . B-NP

-DOCSTART- X X O

We PRP O
suggest VBP O
that IN O
apart RB O
from IN O
the DT O
World NNP O
Summit NNP O
for IN O
Children NNP O
's POS O
under-five JJ O
mortality NN O
target NN O
for IN O
the DT O
year NN O
2000 CD O
, , O
intraregional JJ O
targets NNS O
to TO O
reduce VB O
geographical JJ O
inequalities NNS O
in IN O
under-five JJ O
mortality NN O
should MD O
be VB O
specified VBN O
. . O

-DOCSTART- X X O

The DT O
immunophilin NN B-NP
, , O
which WDT O
can MD O
be VB O
of IN O
the DT O
FK506 NNP O
- : O
or CC O
cyclosporin NN O
A-binding JJ O
class NN O
, , O
binds NNS O
to TO O
hsp90 VB B-NP
via IN O
its PRP$ O
tetratricopeptide NN O
repeat NN O
( -LRB- O
TPR NNP O
) -RRB- O
domain NN O
, , O
and CC O
different JJ O
receptor NN O
heterocomplexes NNS O
exist VBP O
depending VBG O
upon IN O
which WDT O
immunophilin NN B-NP
occupies VBZ O
the DT O
TPR-binding JJ O
region NN O
of IN O
hsp90 NN B-NP
. . O

-DOCSTART- X X O

Secretion NN O
in IN O
milk NN O
and CC O
transplacental JJ O
transfer NN O
of IN O
two CD O
iodized JJ O
oils NNS O
, , O
Lipiodol NNP O
UF NNP O
and CC O
Oriodol NNP O
, , O
in IN O
rabbits NNS O
. . O

-DOCSTART- X X O

Sequencing NN O
of IN O
the DT O
facB NN B-NP
gene NN I-NP
revealed VBD O
that IN O
it PRP O
encodes VBZ O
a DT O
protein NN O
that WDT O
contains VBZ O
an DT O
N-terminal JJ O
GAL4-like JJ B-NP
Zn(II)2Cys6 NNS O
( -LRB- O
or CC O
C6 JJ O
zinc NN O
) -RRB- O
binuclear NN O
cluster NN O
for IN O
DNA NNP O
binding NN O
, , O
leucine NN O
zipper-like NN O
heptad NN O
repeat NN O
motifs NNS O
and CC O
central JJ O
and CC O
C-terminal JJ O
acidic NN O
alpha-helical JJ O
regions NNS O
, , O
consistent JJ O
with IN O
a DT O
function NN O
as IN O
a DT O
DNA-binding NN O
transcriptional JJ O
activator NN O
. . O

-DOCSTART- X X O

Overexpression IN O
of IN O
Sed5p JJ B-NP
allowed VBN O
growth NN O
in IN O
the DT O
absence NN O
of IN O
Vti1p NNP B-NP
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
p150 DT B-NP
suppresses NNS O
actin IN B-NP
gelation NN O
, , O
which WDT O
is VBZ O
induced VBN O
by IN O
smooth JJ B-NP
muscle NN I-NP
alpha-actinin NN I-NP
. . O

-DOCSTART- X X O

Denaturation NN O
of IN O
the DT O
simian JJ O
virus NN O
40 CD O
origin NN O
of IN O
replication NN O
mediated VBN O
by IN O
human JJ B-NP
replication NN I-NP
protein NN I-NP
A. NN I-NP

-DOCSTART- X X O

This DT O
effect NN O
was VBD O
abolished VBN O
once RB O
the DT O
EM NNP O
motif NN O
in IN O
the DT O
promoter-reporter NN O
construct VB O
was VBD O
mutated VBN O
, , O
thus RB O
suggesting VBG O
that IN O
the DT O
synergistic JJ O
transactivation NN O
function NN O
of IN O
the DT O
TEF-1-Max NNP B-NP
heterotypic NN O
complex NN O
is VBZ O
mediated VBN O
through IN O
binding NN O
of IN O
the DT O
complex NN O
to TO O
the DT O
EM NNP O
motif NN O
. . O

-DOCSTART- X X O

Interdigitated NNP O
residues NNS O
within IN O
a DT O
small JJ O
region NN O
of IN O
VP16 DT B-NP
interact NN O
with IN O
Oct-1 NNP B-NP
, , O
HCF NNP B-NP
, , O
and CC O
DNA NNP O
. . O

-DOCSTART- X X O

With IN O
a DT O
view NN O
to TO O
identifying VBG O
other JJ O
important JJ O
U14 NNP B-NP
interactions NNS O
, , O
a DT O
stem-loop JJ O
domain NN O
required VBN O
for IN O
activity NN O
of IN O
Saccharomyces NNP B-NP
cerevisiae NNS I-NP
U14 IN I-NP
RNAs NNP I-NP
( -LRB- O
the DT O
Y NNP O
domain NN O
) -RRB- O
was VBD O
first RB O
subjected VBN O
to TO O
detailed JJ O
mutational JJ O
analysis NN O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
these DT O
results NNS O
and CC O
because IN O
Cdc68 PRP B-NP
has VBZ O
been VBN O
implicated VBN O
as IN O
a DT O
regulator NN O
of IN O
chromatin NN O
structure NN O
, , O
we PRP O
postulate VBP O
that IN O
polymerase NN B-NP
alpha NN I-NP
may MD O
interact VB O
with IN O
these DT O
proteins NNS O
to TO O
gain VB O
access NN O
to TO O
its PRP$ O
template JJ O
or CC O
to TO O
origins NNS O
of IN O
replication NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

In IN O
12 CD O
cases NNS O
( -LRB- O
3.1 CD O
% NN O
) -RRB- O
, , O
a DT O
change NN O
in IN O
stage NN O
resulted VBD O
. . O

-DOCSTART- X X O

Promoter NNP O
recognition NN O
algorithms NNS O
identified VBD O
divergent JJ O
promoter NN O
elements NNS O
within IN O
the DT O
CpG NNP O
island NN O
, , O
which WDT O
lies VBZ O
between IN O
the DT O
ATM NNP B-NP
and CC O
E14/NPAT JJ B-NP
genes NNS O
, , O
and CC O
provide VB O
evidence NN O
for IN O
a DT O
putative JJ O
second JJ O
ATM NNP B-NP
promoter NN I-NP
located VBN O
within IN O
intron NN O
3 CD O
, , O
immediately RB O
upstream RB O
of IN O
the DT O
first JJ O
coding NN O
exon NN O
. . O

-DOCSTART- X X O

Recombinant NNP B-NP
soluble JJ I-NP
pMCP NNS I-NP
that WDT O
lacked VBD O
transmembrane NN O
and CC O
cytoplasmic JJ O
domains NNS O
had VBD O
factor NN B-NP
I PRP I-NP
cofactor VBD I-NP
activity NN O
in IN O
C3b NNP B-NP
cleavage NN O
, , O
indicating VBG O
that IN O
it PRP O
is VBZ O
functionally RB O
, , O
as RB O
well RB O
as IN O
structurally RB O
homologous JJ O
to TO O
MCP. NNP B-NP

-DOCSTART- X X O

Liquid NN O
chromatographic JJ O
separation NN O
was VBD O
achieved VBN O
on IN O
a DT O
Zorbax NNP O
RX NNP O
C8 IN O
analytical JJ O
column NN O
using VBG O
gradient JJ O
elution NN O
. . O

-DOCSTART- X X O

The DT O
linear JJ O
plasmid NN O
pDHL1 NNS O
from IN O
Debaryomyces NNS O
hansenii NNS O
encodes VBZ O
a DT O
protein NN O
highly RB O
homologous JJ O
to TO O
the DT O
pGKL1-plasmid JJ B-NP
DNA NNP I-NP
polymerase NN I-NP
. . O

-DOCSTART- X X O

The DT O
RNA-binding JJ O
and CC O
RNA-DNA JJ B-NP
helicase NN I-NP
activities NNS O
of IN O
the DT O
Escherichia NNP B-NP
coli NNS I-NP
transcription NN I-NP
termination NN I-NP
factor NN I-NP
rho WDT I-NP
have VBP O
been VBN O
investigated VBN O
using VBG O
natural JJ O
RNA NNP O
molecules NNS O
that WDT O
are VBP O
255 CD O
and CC O
391 CD O
nucleotide JJ O
residues NNS O
in IN O
length NN O
and CC O
that IN O
contain VBP O
the DT O
trp NN B-NP
t NN I-NP
' POS I-NP
rho-dependent JJ I-NP
termination NN I-NP
sequence NN I-NP
of IN O
E. NNP O
coli NNS O
. . O

-DOCSTART- X X O

The DT O
p20-CGGBP JJ B-NP
gene NN I-NP
is VBZ O
conserved VBN O
among IN O
mammals NNS O
but CC O
shows VBZ O
no DT O
homology NN O
to TO O
non-vertebrate JJ O
species NNS O
. . O

-DOCSTART- X X O

The DT O
pWP-19 NN B-NP
also RB O
encodes VBZ O
the DT O
AAV NNP O
inverted VBD O
terminal JJ O
repeats NNS O
for IN O
integration NN O
and CC O
replication NN O
and CC O
the DT O
herpes NNS O
virus NN O
thymidine DT B-NP
kinase NN I-NP
promoter-driven JJ O
gene NN O
for IN O
neomycin JJ O
resistance NN O
( -LRB- O
neoR NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
developed VBN O
a DT O
rAAV-mediated JJ O
gene NN O
transfer NN O
system NN O
for IN O
the DT O
rat NN B-NP
preproinsulin NN I-NP
II NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
serum NN O
levels NNS O
of IN O
beta-human JJ B-NP
chorionic JJ I-NP
gonadotropin NN I-NP
( -LRB- O
HCG) NNP B-NP
and CC O
placental JJ B-NP
alkaline NN I-NP
phosphatase NN I-NP
( -LRB- O
PLAP NNP B-NP
) -RRB- O
were VBD O
not RB O
elevated VBN O
. . O

-DOCSTART- X X O

This DT O
indicates VBZ O
that IN O
recruitment NN O
of IN O
large JJ B-NP
T NNP I-NP
antigen NN I-NP
to TO O
the DT O
rRNA NNP O
promoter NN O
by IN O
SL1 NNP B-NP
constitutes VBZ O
a DT O
crucial JJ O
step NN O
in IN O
the DT O
activation NN O
process NN O
. . O

-DOCSTART- X X O

In IN O
1990 CD O
, , O
an DT O
International NNP O
Commission NNP O
for IN O
the DT O
Certification NN O
of IN O
Eradication NNP O
of IN O
Poliomyelitis NNP O
Eradication NNP O
( -LRB- O
ICCPE NN O
) -RRB- O
was VBD O
established VBN O
by IN O
the DT O
Pan NNP O
American NNP O
Health NNP O
Organization NNP O
to TO O
eventually RB O
determine VB O
if IN O
transmission NN O
was VBD O
interrupted VBN O
. . O

-DOCSTART- X X O

Functional JJ O
and CC O
regulatory JJ O
analysis NN O
of IN O
the DT O
two CD O
copies NNS O
of IN O
the DT O
fixNOQP JJ B-NP
operon NN I-NP
of IN O
Rhizobium NNP O
leguminosarum NN O
strain NN O
VF39 NNP O
. . O

-DOCSTART- X X O

Thus RB O
E14.1TG3B1 NNP O
is VBZ O
a DT O
useful JJ O
ES NNPS O
cell NN O
line NN O
for IN O
modifying VBG O
the DT O
mouse NN O
genome NN O
using VBG O
the DT O
HPRT NNP B-NP
gene NN I-NP
as IN O
a DT O
selection NN O
marker NN O
and CC O
for IN O
transmission NN O
at IN O
a DT O
high JJ O
frequency NN O
into IN O
the DT O
mouse NN O
germ NN O
line NN O
. . O

-DOCSTART- X X O

Lung NNP O
and CC O
multi-system JJ O
damage NN O
were VBD O
early JJ O
indicators NNS O
of IN O
poor JJ O
outcome NN O
in IN O
severe JJ O
non-fatal JJ O
disease NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
suggest VBP O
that IN O
the DT O
bulbospinal JJ O
micturition NN O
reflex NN O
evoked VBN O
by IN O
bladder NN O
filling VBG O
and CC O
L-dopa NNP O
involves VBZ O
a DT O
descending VBG O
pathway NN O
where WRB O
transmission NN O
is VBZ O
partly RB O
mediated VBN O
by IN O
spinal JJ B-NP
alpha NN I-NP
1-adrenoceptors NNS I-NP
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
This DT O
study NN O
was VBD O
designed VBN O
to TO O
analyze VB O
the DT O
common JJ O
cause NN O
of IN O
asthenopia NN O
, , O
mixed JJ O
astigmatism NN O
. . O

-DOCSTART- X X O

Disturbance NN O
of IN O
regeneration NN O
in IN O
the DT O
above JJ O
pathological JJ O
condition NN O
results NNS O
from IN O
the DT O
damage NN O
to TO O
tunica NN O
propria NNS O
and CC O
loss NN O
of IN O
its PRP$ O
function NN O
for IN O
the DT O
support NN O
of IN O
structural JJ O
homeostasis NN O
. . O

-DOCSTART- X X O

The DT O
C-terminal JJ O
mature JJ O
region NN O
is VBZ O
highly RB O
conserved VBN O
in IN O
other JJ O
serine NN B-NP
carboxypeptidases NNS I-NP
. . O

-DOCSTART- X X O

Here RB O
we PRP O
demonstrate VBP O
that IN O
AML1a NNP B-NP
, , O
which WDT O
solely RB O
has VBZ O
no DT O
effects NNS O
as IN O
a DT O
transcriptional JJ O
regulator NN O
, , O
dominantly RB O
suppresses VBZ O
transcriptional JJ O
activation NN O
by IN O
AML1b NNP B-NP
, , O
and CC O
that DT O
AML1a NNP B-NP
exhibits VBZ O
the DT O
higher JJR O
affinity NN O
for IN O
DNA-binding NN O
than IN O
AML1b NNP B-NP
. . O

-DOCSTART- X X O

However RB O
, , O
using VBG O
ATL-16T NNP O
nuclear JJ O
extract VB O
, , O
we PRP O
demonstrated VBD O
that IN O
GATA-4 NNP B-NP
is VBZ O
the DT O
only JJ O
GATA-binding JJ B-NP
protein NN I-NP
that WDT O
forms VBZ O
specific JJ O
DNA-protein NN O
complex NN O
with IN O
the DT O
-70 JJ O
GATA NNP O
site NN O
. . O

-DOCSTART- X X O

The DT O
impact NN O
of IN O
social JJ O
support NN O
on IN O
the DT O
relationships NNS O
of IN O
gay JJ O
male NN O
couples NNS O
is VBZ O
examined VBN O
. . O

-DOCSTART- X X O

The DT O
ubiquitously NN O
expressed VBD O
hypoxia-inducible JJ B-NP
factor-1 NN I-NP
( -LRB- O
HIF-1 NN B-NP
) -RRB- O
is VBZ O
involved VBN O
in IN O
expression NN O
of IN O
a DT O
large JJ O
number NN O
of IN O
oxygen-regulated JJ O
genes NNS O
. . O

-DOCSTART- X X O

Stromelysin-1 JJ B-NP
, , O
matrix NN B-NP
metalloproteinase-3 NN I-NP
( -LRB- O
MMP-3 NN B-NP
) -RRB- O
, , O
is VBZ O
an DT O
important JJ O
endopeptidase NN O
selectively RB O
expressed VBN O
by IN O
somatic JJ O
cells NNS O
in IN O
organ NN O
tissues NNS O
. . O

-DOCSTART- X X O

Tendon NNP O
also RB O
shows VBZ O
a DT O
degree NN O
of IN O
extensibility NN O
. . O

-DOCSTART- X X O

Surveillance NNP O
for IN O
preeclampsia NN O
was VBD O
conducted VBN O
by IN O
personnel NNS O
unaware JJ O
of IN O
treatment-group NN O
assignments NNS O
, , O
using VBG O
standardized JJ O
measurements NNS O
of IN O
blood NN O
pressure NN O
and CC O
urinary JJ O
protein NN O
excretion NN O
at IN O
uniformly RB O
scheduled VBN O
prenatal JJ O
visits NNS O
, , O
protocols NNS O
for IN O
monitoring VBG O
these DT O
measurements NNS O
during IN O
the DT O
hospitalization NN O
for IN O
delivery NN O
, , O
and CC O
reviews NNS O
of IN O
medical JJ O
records NNS O
of IN O
unscheduled JJ O
outpatient NN O
visits NNS O
and CC O
all DT O
hospitalizations NNS O
. . O

-DOCSTART- X X O

We PRP O
also RB O
provide VBP O
evidence NN O
that IN O
gar2 NN B-NP
is VBZ O
phosphorylated VBN O
in IN O
vitro NN O
by IN O
a DT O
p13(suc1)-Sepharose-bound JJ B-NP
kinase NN O
from IN O
Schizosaccharomyces NNP O
pombe NN O
extracts VBZ O
that DT O
displays NNS O
cell NN O
cycle-regulated JJ O
activity NN O
similar JJ O
to TO O
that DT O
of IN O
the DT O
p34(cdc2(kinase NN B-NP
. . O

-DOCSTART- X X O

However RB O
, , O
by IN O
immobilized JJ O
metal NN O
affinity NN O
chromatography NN O
assay NN O
, , O
self-association NN O
of IN O
PR-A NNP B-NP
was VBD O
3.5-fold JJ O
more RBR O
efficient JJ O
than IN O
that DT O
of IN O
either CC O
the DT O
DhLBD NN O
or CC O
hLBD NN O
constructs NNS O
. . O

-DOCSTART- X X O

The DT O
overall JJ O
results NNS O
of IN O
this DT O
paper NN O
are VBP O
consistent JJ O
with IN O
the DT O
conclusion NN O
that IN O
the DT O
carboxyl-terminal JJ O
LBD NNP O
is VBZ O
not RB O
sufficient JJ O
for IN O
mediating VBG O
PR NNP B-NP
dimerization NN O
and CC O
that IN O
multiple JJ O
regions NNS O
, , O
including VBG O
the DT O
hinge NN O
and CC O
amino-terminal JJ O
sequences NNS O
, , O
contribute VBP O
either RB O
directly RB O
or CC O
indirectly RB O
to TO O
homodimerization NN O
of IN O
PR NNP B-NP
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
correlate VBP O
Dox NNP O
effects NNS O
on IN O
cell NN O
cycle NN O
with IN O
changes NNS O
of IN O
E2F/DP NNP B-NP
complexes NNS O
and CC O
activity NN O
in IN O
differentiating JJ O
C2C12 NN O
myocytes NNS O
. . O

-DOCSTART- X X O

Vitrectomy NNP O
was VBD O
still RB O
a DT O
significant JJ O
risk NN O
factor NN O
when WRB O
macular JJ O
holes NNS O
were VBD O
excluded VBN O
. . O

-DOCSTART- X X O

Invited JJ O
editorial NN O
on IN O
" `` O
Acute NNP O
and CC O
chronic JJ O
effects NNS O
of IN O
exercise NN O
on IN O
leptin NN B-NP
levels NNS O
in IN O
humans NNS O
" '' O
. . O

-DOCSTART- X X O

Both DT O
promoters NNS O
lack VBP O
a DT O
TATA NNP O
box NN O
, , O
and CC O
Pint NNP B-NP
belongs VBZ O
to TO O
the DT O
MED-1 JJ B-NP
class NN O
of IN O
promoters NNS O
, , O
which WDT O
initiate VBP O
transcription NN O
at IN O
multiple JJ O
sites NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
initiated VBN O
studies NNS O
to TO O
identify VB O
candidate NN O
signal NN O
transducers NNS O
that IN O
associate NN O
with IN O
the DT O
cytosolic JJ O
domain NN O
( -LRB- O
cd NN O
) -RRB- O
of IN O
the DT O
IL-1R NNP B-NP
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
sought VBD O
to TO O
identify VB O
mechanisms NNS O
that WDT O
could MD O
account VB O
for IN O
the DT O
antimitogenic JJ O
effects NNS O
of IN O
IL-4. PRP$ B-NP

-DOCSTART- X X O

A DT O
soluble JJ O
62-kDa JJ O
protein NN O
was VBD O
produced VBN O
without IN O
the DT O
proteolytic JJ O
processing NN O
by IN O
inserting VBG O
the DT O
coding NN O
sequence NN O
of IN O
amino DT O
acids NNS O
112 CD O
to TO O
660 CD O
of IN O
ORF-2 CD O
in IN O
a DT O
baculovirus NN O
expression NN O
vector NN O
and CC O
using VBG O
the DT O
corresponding JJ O
virus NN O
to TO O
infect VB O
Sf9 IN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
CPK-MB NNP B-NP
isoenzyme NN O
showed VBD O
no DT O
percentage NN O
increase NN O
of IN O
total JJ O
CPK NNP B-NP
higher JJR O
than IN O
5 CD O
% NN O
, , O
measured VBN O
at IN O
6 CD O
, , O
12 CD O
, , O
and CC O
24 CD O
h NN O
after IN O
the DT O
shock NN O
, , O
independent JJ O
of IN O
the DT O
number NN O
of IN O
attempts NNS O
of IN O
cardioversion NN O
. . O

-DOCSTART- X X O

Results NNS O
support VBP O
the DT O
hypothesis NN O
that IN O
endogenous JJ B-NP
corticotropin-releasing JJ I-NP
factor NN I-NP
, , O
perhaps RB O
acting VBG O
at IN O
a DT O
peripheral JJ O
binding NN O
site NN O
, , O
suppresses VBZ O
the DT O
active JJ O
behavioral JJ O
response NN O
characteristic NN O
of IN O
pups NNS O
during IN O
the DT O
early JJ O
phase NN O
of IN O
isolation NN O
in IN O
novel NN O
surroundings NNS O
. . O

-DOCSTART- X X O

The DT O
gray JJ O
matter NN O
NAA/m IN O
I PRP O
ratio NN O
clearly RB O
separated VBD O
the DT O
two CD O
groups NNS O
. . O

-DOCSTART- X X O

As IN O
with IN O
the DT O
murine NN B-NP
and CC I-NP
human NN I-NP
mb-1 NN I-NP
genes NNS I-NP
, , O
the DT O
5' JJ O
region NN O
of IN O
the DT O
bovine NN B-NP
mb-1 NN I-NP
gene NN I-NP
lacked VBD O
a DT O
TATA NNP O
box NN O
. . O

-DOCSTART- X X O

Chloramphenicol NNP B-NP
acetyltransferase NN I-NP
assays VBZ O
examining VBG O
the DT O
ability NN O
of IN O
IE86 NNP B-NP
to TO O
repress VB O
activity NN O
from IN O
the DT O
HCMV NNP O
major JJ O
IE NN B-NP
promoter NN I-NP
or CC O
activate VB O
the DT O
HCMV NN B-NP
early RB I-NP
promoter NN I-NP
for IN O
the DT O
2.2-kb JJ O
class NN O
of IN O
RNAs NNP O
demonstrated VBD O
the DT O
functional JJ O
integrity NN O
of IN O
the DT O
IE86 NNP B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Transcription NNP O
factor NN O
binding VBG O
sites NNS O
downstream IN O
of IN O
the DT O
human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
transcription NN O
start NN O
site NN O
are VBP O
important JJ O
for IN O
virus NN O
infectivity NN O
. . O

-DOCSTART- X X O

Crystal JJ O
structure NN O
of IN O
an DT O
oligomer NN O
of IN O
proteolytic JJ O
zymogens NNS O
: : O
detailed JJ O
conformational JJ O
analysis NN O
of IN O
the DT O
bovine JJ O
ternary JJ O
complex NN O
and CC O
implications NNS O
for IN O
their PRP$ O
activation NN O
. . O

-DOCSTART- X X O

We PRP O
suppose VBP O
that IN O
this DT O
injection NN O
speed NN O
( -LRB- O
0.1-0.2 CD O
ml JJ O
.s-1 NN O
) -RRB- O
is VBZ O
suitable JJ O
for IN O
spinal JJ O
anesthesia NN O
. . O

-DOCSTART- X X O

Alternative JJ O
splicing NN O
of IN O
ClC-6 NN B-NP
( -LRB- O
a DT O
member NN O
of IN O
the DT O
CIC NNP B-NP
chloride-channel NN I-NP
family NN I-NP
) -RRB- O
transcripts NNS O
generates VBZ O
three CD O
truncated JJ O
isoforms NNS O
one CD O
of IN O
which WDT O
, , O
ClC-6c NNP B-NP
, , O
is VBZ O
kidney-specific JJ O
. . O

-DOCSTART- X X O

The DT O
behavior NN O
of IN O
different JJ O
types NNS O
of IN O
polytetrafluoroethylene NN O
( -LRB- O
PTFE NNP O
) -RRB- O
prostheses VBZ O
in IN O
the DT O
reparative JJ O
scarring JJ O
process NN O
of IN O
abdominal JJ O
wall NN O
defects NNS O
. . O

-DOCSTART- X X O

The DT O
control NN O
group NN O
revealed VBD O
significantly RB O
higher JJR O
levels NNS O
of IN O
coagulation NN B-NP
factors NNS I-NP
II NNP I-NP
, , I-NP
V NNP I-NP
and CC I-NP
VIII NNP I-NP
, , O
compared VBN O
to TO O
the DT O
index NN O
group NN O
. . O

-DOCSTART- X X O

The DT O
frequency NN O
of IN O
positive JJ O
anti-GM1 JJ B-NP
antibody NN I-NP
titers NNS O
in IN O
the DT O
Guillain-Barre NNP O
syndrome NN O
patients NNS O
with IN O
PEN NNP O
19 CD O
isolates NNS O
was VBD O
higher JJR O
than IN O
that IN O
in IN O
the DT O
Guillain-Barre NNP O
syndrome NN O
and CC O
Fisher NNP O
's POS O
syndrome NN O
patients NNS O
without IN O
PEN NNP O
19 CD O
isolates NNS O
. . O

-DOCSTART- X X O

NF-kappa NNP B-NP
B/Rel NNP I-NP
transcription NN O
factors NNS O
participate VBP O
in IN O
the DT O
activation NN O
of IN O
numerous JJ O
genes NNS O
involved VBN O
in IN O
immune JJ O
regulation/inflammation NN O
including VBG O
cytokines NNS O
, , O
cell NN O
surface NN O
receptors NNS O
, , O
adhesion NN O
molecules NNS O
, , O
and CC O
acute JJ O
phase NN O
proteins NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
separated VBN O
a DT O
dermatan NN O
sulfate NN O
proteoglycan NN O
, , O
epiphycan NN O
, , O
from IN O
decorin NN B-NP
and CC O
biglycan JJ O
by IN O
using VBG O
dissociative JJ O
extraction NN O
of IN O
bovine JJ O
fetal NN O
epiphyseal NN O
cartilage NN O
, , O
followed VBN O
by IN O
sequential JJ O
ion-exchange NN O
, , O
gel NNP O
permeation NN O
, , O
hydrophobic JJ O
, , O
and CC O
Zn2+ NNP O
chelate VBP O
chromatographic JJ O
steps NNS O
. . O

-DOCSTART- X X O

These DT O
analyses NNS O
demonstrate VBP O
that IN O
the DT O
dUTPase NN B-NP
isoforms NNS O
are VBP O
encoded VBN O
by IN O
the DT O
same JJ O
gene NN O
with IN O
isoform-specific JJ O
transcripts NNS O
arising VBG O
through IN O
the DT O
use NN O
of IN O
alternative JJ O
5' JJ O
exons NNS O
. . O

-DOCSTART- X X O

3600-fold JJ O
to TO O
apparent JJ O
homogeneity NN O
with IN O
a DT O
41 CD O
% NN O
yield NN O
by IN O
affinity NN O
chromatography NN O
utilizing VBG O
DNA-cellulose NN O
; : O
the DT O
purity NN O
of IN O
the DT O
final JJ O
preparation NN O
was VBD O
assessed VBN O
by IN O
SDS/PAGE NN O
, , O
lack NN O
of IN O
contamination NN O
by IN O
other JJ O
nucleases NNS O
and CC O
production NN O
of IN O
a DT O
monospecific JJ O
antibody NN O
against IN O
the DT O
enzyme NN O
. . O

-DOCSTART- X X O

We PRP O
further RB O
found VBD O
that IN O
KmMig1p NNP B-NP
is VBZ O
fully RB O
functional JJ O
when WRB O
expressed VBN O
in IN O
S. NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

A DT O
pre-boutonniere JJ O
deformity NN O
was VBD O
simulated VBN O
by IN O
dividing VBG O
the DT O
central JJ O
slip NN O
. . O

-DOCSTART- X X O

Future JJ O
analysis NN O
of IN O
long-term JJ O
outcome NN O
measures NNS O
of IN O
performance NN O
with IN O
the DT O
implant NN O
will MD O
confirm VB O
or CC O
dispute VB O
the DT O
benefit NN O
of IN O
ear NN O
selection NN O
using VBG O
the DT O
Prom-EABR. NNP O

-DOCSTART- X X O

This DT O
protein NN O
, , O
designated VBN O
p532 NN B-NP
based VBN O
on IN O
its PRP$ O
predicted VBN O
molecular JJ O
weight NN O
( -LRB- O
EMBO NN O
J NNP O
15 CD O
: : O
5738 CD O
, , O
1996 CD O
) -RRB- O
, , O
contains VBZ O
multiple JJ O
structural JJ O
domains NNS O
including VBG O
two CD O
regions NNS O
of IN O
seven CD O
internal JJ O
repeats NNS O
highly RB O
related VBN O
to TO O
the DT O
cell NN O
cycle NN O
regulator NN O
RCC1 NNP B-NP
, , O
a DT O
guanine NNP B-NP
nucleotide JJ I-NP
exchange NN I-NP
factor NN I-NP
for IN O
the DT O
small JJ B-NP
GTP-binding JJ I-NP
protein NN I-NP
Ran VBD B-NP
, , O
seven CD O
beta-repeat JJ O
domains NNS O
characteristic NN O
of IN O
the DT O
beta JJ O
subunit NN O
of IN O
heterotrimeric JJ B-NP
G NNP I-NP
proteins NNS I-NP
, , O
three CD O
putative JJ O
SH3 JJ B-NP
binding NN I-NP
sites NNS I-NP
, , O
a DT O
putative JJ O
leucine-zipper NN O
and CC O
a DT O
carboxy-terminal JJ B-NP
HECT NNP I-NP
domain NN I-NP
characteristic NN O
of IN O
E3 JJ B-NP
ubiquitin-protein JJ I-NP
ligases NNS I-NP
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
L45 NNP O
sequence NN O
between IN O
kinase NN O
subdomains NNS O
IV NNP O
and CC O
V NNP O
specifies VBZ O
TGF-beta JJ B-NP
responsiveness NN O
of IN O
the DT O
type NN B-NP
I PRP I-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

The DT O
two CD O
mouse NN O
lines NNS O
carrying VBG O
the DT O
unfragmented JJ O
Hnf3g-lacZ JJ B-NP
YAC NNP O
showed VBD O
tissue-specific JJ O
, , O
copy NN O
number-dependent NN O
and CC O
position-independent JJ O
expression NN O
, , O
proving VBG O
that IN O
170 CD O
kb NN O
of IN O
the DT O
Hnf3g JJ B-NP
locus NN O
contain VBP O
all DT O
elements NNS O
important JJ O
in IN O
the DT O
regulation NN O
of IN O
Hnf3g NNP B-NP
. . O

-DOCSTART- X X O

Upstream NNP O
activating NN O
sequences NNS O
( -LRB- O
UASs NN O
) -RRB- O
derived VBN O
from IN O
known VBN O
Ste12p-dependent NNP B-NP
genes NNS O
have VBP O
previously RB O
been VBN O
characterized VBN O
to TO O
require VB O
either DT O
multiple JJ O
PREs JJ O
or CC O
a DT O
single JJ O
PRE JJ O
coupled VBN O
to TO O
a DT O
binding JJ O
site NN O
for IN O
a DT O
second JJ O
protein NN O
. . O

-DOCSTART- X X O

Prominent JJ O
protein NN O
kinase NN O
cascades NNS O
are VBP O
those DT O
that IN O
activate JJ O
mitogen-activated JJ B-NP
protein NN I-NP
( -LRB- I-NP
MAP NNP I-NP
) -RRB- I-NP
kinases NNS I-NP
. . O

-DOCSTART- X X O

JNK NNP B-NP
is VBZ O
additionally RB O
regulated VBN O
by IN O
the DT O
Ras-related NNP B-NP
G NNP B-NP
proteins VBZ I-NP
Rac NNP B-NP
and CC O
Cdc42 NNP B-NP
. . O

-DOCSTART- X X O

While IN O
important JJ O
for IN O
ligand-dependent JJ O
transactivation NN O
, , O
this DT O
interaction NN O
surface NN O
is VBZ O
not RB O
directly RB O
involved VBN O
in IN O
transrepression NN O
of IN O
AP-1 JJ B-NP
activity NN O
. . O

-DOCSTART- X X O

Gal4-Eed JJ B-NP
fusion NN O
protein NN O
represses VBZ O
transcription NN O
of IN O
a DT O
reporter NN O
gene NN O
driven VBN O
by IN O
a DT O
promoter NN O
that WDT O
contains VBZ O
Gal4-binding JJ B-NP
DNA NNP I-NP
elements NNS I-NP
. . O

-DOCSTART- X X O

In IN O
situ FW O
hybridization NN O
analysis NN O
in IN O
adult JJ O
rat NN O
tissue NN O
reveals VBZ O
good JJ O
correlation NN O
with IN O
this DT O
pattern NN O
and CC O
indicates VBZ O
that IN O
drm NN B-NP
mRNA NN I-NP
is VBZ O
most RBS O
highly RB O
expressed VBN O
in IN O
nondividing NN O
and CC O
terminally RB O
differentiated JJ O
cells NNS O
, , O
such JJ O
as IN O
neurons NNS O
, , O
type NN O
1 CD O
lung NN O
cells NNS O
, , O
and CC O
goblet NN O
cells NNS O
. . O

-DOCSTART- X X O

Neither DT O
of IN O
these DT O
proteins NNS O
, , O
individually RB O
or CC O
as IN O
a DT O
pair NN O
, , O
can MD O
bind NN O
the DT O
alpha-globin NN B-NP
3'UTR NN I-NP
unless IN O
they PRP O
are VBP O
complexed VBN O
with IN O
the DT O
remaining VBG O
non-poly( JJ O
C NNP O
) -RRB- O
binding JJ O
proteins NNS O
of IN O
the DT O
alpha-complex NN B-NP
. . O

-DOCSTART- X X O

A DT O
2 CD O
years NNS O
and CC O
9 CD O
months NNS O
old JJ O
female JJ O
patient NN O
, , O
with IN O
the DT O
diagnosis NN O
of IN O
Weaver NNP O
syndrome NN O
is VBZ O
reported VBN O
. . O

-DOCSTART- X X O

Confirming VBG O
measures NNS O
made VBN O
by IN O
nurses NNS O
and CC O
additionally RB O
, , O
ABPM NNP O
for IN O
women NNS O
, , O
seem VBP O
to TO O
lessen VB O
this DT O
effect NN O
. . O

-DOCSTART- X X O

( -LRB- O
1996a CD O
) -RRB- O
Biochemistry NNP O
35 CD O
, , O
1589-1598] CD O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
Lrp NNP B-NP
binds NNS O
a DT O
central JJ O
palindromic JJ O
site NN O
, , O
interacting VBG O
predominantly RB O
with IN O
the DT O
major JJ O
groove NN O
of IN O
its PRP$ O
DNA NNP O
target NN O
, , O
and CC O
that DT O
additional JJ O
dimers NNS O
bind VBP O
to TO O
flanking VBG O
sites NNS O
to TO O
form VB O
a DT O
nucleoprotein JJ O
activation NN O
complex NN O
. . O

-DOCSTART- X X O

Sustained JJ O
activation NN O
of IN O
p21 JJ B-NP
expression NN O
is VBZ O
proposed VBN O
to TO O
be VB O
a DT O
distinguishing NN O
feature NN O
of IN O
the DT O
activity NN O
of IN O
NGF NNP B-NP
that IN O
contributes VBZ O
to TO O
PC12 VB O
growth NN O
arrest NN O
during IN O
differentiation NN O

-DOCSTART- X X O

The DT O
remaining VBG O
80 CD O
patients NNS O
underwent IN O
recordings NNS O
of IN O
ECG NNP O
, , O
beat-to-beat NN O
arterial NN O
oxygen NN O
saturation NN O
( -LRB- O
SaO2 NNP O
) -RRB- O
, , O
and CC O
respiration NN O
during IN O
both DT O
spontaneous JJ O
and CC O
controlled JJ O
breathing NN O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
total JJ O
white JJ O
cell NN O
count NN O
increased VBN O
from IN O
a DT O
baseline NN O
of IN O
11.3 CD O
x NN O
10(9 CD O
)/L NN O
( -LRB- O
SD NNP O
2.3 CD O
) -RRB- O
to TO O
16.2 CD O
x NN O
10(9 CD O
)/L NNP O
( -LRB- O
SD NN O
4.6 CD O
) -RRB- O
on IN O
day NN O
1 CD O
, , O
normalising VBG O
thereafter RB O
. . O

-DOCSTART- X X O

These DT O
lesions NNS O
may MD O
be VB O
treated VBN O
by IN O
propranolol NN O
or CC O
phentolamine NN O
. . O

-DOCSTART- X X O

Both DT O
of IN O
these DT O
dogs NNS O
had VBD O
low JJ O
serum NN O
IgG NN B-NP
( -LRB- O
3.5 CD O
to TO O
7.2 CD O
mg/ml NN O
) -RRB- O
and CC O
the DT O
second JJ O
littermate JJ O
also RB O
had VBD O
reduced VBN O
serum NN O
IgA IN B-NP
( -LRB- O
< NN O
0.1 CD O
to TO O
0.15 CD O
mg/ml NN O
) -RRB- O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Valproate NNP O
appears VBZ O
to TO O
inhibit VB O
the DT O
glucuronidation NN O
of IN O
carbamazepine-10,11-trans-diol NN O
, , O
and CC O
probably RB O
also RB O
inhibits VBZ O
the DT O
conversion NN O
of IN O
carbamazepine-10,11-epoxide NN O
to TO O
this DT O
trans-diol JJ O
derivative JJ O
, , O
rather RB O
than IN O
simply RB O
inhibiting VBG O
the DT O
latter JJ O
reaction NN O
only RB O
. . O

-DOCSTART- X X O

The DT O
Ogg1 JJ B-NP
protein NN I-NP
efficiently RB O
cleaves VBZ O
a DT O
DNA NNP O
duplex NN O
where WRB O
a DT O
preformed JJ O
AP NNP B-NP
site NN I-NP
is VBZ O
placed VBN O
opposite IN O
a DT O
cytosine FW O
( -LRB- O
AP/C NN O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
consensus NN O
sequence NN O
indicates VBZ O
a DT O
highly RB O
conserved VBN O
lysine NN O
residue NN O
, , O
K120 NNP O
of IN O
endonuclease NN B-NP
III NNP I-NP
or CC O
K241 NNP O
of IN O
Ogg1 NNP B-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

Overall RB O
, , O
these DT O
findings NNS O
demonstrate VBP O
that IN O
mutations NNS O
E768D NNP O
and CC O
V804L NNP O
are VBP O
gain-of-function NN O
mutations NNS O
that WDT O
confer VBP O
to TO O
the DT O
long JJ B-NP
RET NN I-NP
isoform VBP I-NP
the DT O
capacity NN O
to TO O
exert VB O
a DT O
biological JJ O
effect NN O
, , O
although IN O
these DT O
mutations NNS O
are VBP O
more RBR O
weakly JJ O
activating NN O
than IN O
the DT O
MEN2A NNP B-NP
and CC O
MEN2B NNP B-NP
mutations NNS O
. . O

-DOCSTART- X X O

E2F PRP B-NP
is VBZ O
a DT O
heterodimeric JJ O
complex JJ O
consisting VBG O
of IN O
E2F NNP B-NP
family NN I-NP
members NNS I-NP
(1-5 CC I-NP
) -RRB- I-NP
and CC O
DP NNP B-NP
proteins VBZ I-NP
(1-3 JJ I-NP
) -RRB- I-NP
. . O

-DOCSTART- X X O

EBER1 NNP B-NP
mRNA NN I-NP
, , O
a DT O
consistent JJ O
marker NN O
of IN O
viral JJ O
latency NN O
, , O
was VBD O
positive JJ O
in IN O
all DT O
PEL NNP O
cases NNS O
, , O
although IN O
at IN O
lower JJR O
levels NNS O
than IN O
in IN O
the DT O
non-PEL JJ O
controls NNS O
due JJ O
to TO O
EBER1 NNP B-NP
expression NN O
by IN O
only RB O
a DT O
variable JJ O
subset NN O
of IN O
lymphoma NN O
cells NNS O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
Four CD O
hundred CD O
fifty CD O
patients NNS O
with IN O
the DT O
diagnosis NN O
of IN O
squamous JJ O
cell NN O
carcinoma NN O
of IN O
the DT O
oral JJ O
cavity NN O
received VBD O
their PRP$ O
primary JJ O
treatment NN O
at IN O
Roswell NNP O
Park NNP O
Cancer NNP O
Center NNP O
( -LRB- O
RPCI) NN O
from IN O
1971 CD O
to TO O
1991 CD O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
use NN O
of IN O
presaturation NN O
is VBZ O
recommended VBN O
for IN O
myocardial JJ O
motion NN O
studies NNS O
using VBG O
cine NN O
PC NN O
velocity NN O
data NNS O
. . O

-DOCSTART- X X O

PURPOSE/OBJECTIVES NNP O
: : O
To TO O
examine VB O
the DT O
question NN O
of IN O
whether IN O
an DT O
early JJ O
first JJ O
full-term JJ O
pregnancy NN O
( -LRB- O
FFTP NNP O
) -RRB- O
protects VBZ O
against IN O
breast NN O
cancer NN O
and CC O
whether IN O
interruption NN O
of IN O
the DT O
pregnancy NN O
with IN O
an DT O
induced JJ O
abortion NN O
increases NNS O
breast NN O
cancer NN O
risk NN O
. . O

-DOCSTART- X X O

Two CD O
related JJ O
studies NNS O
conducted VBN O
over IN O
a DT O
five CD O
week NN O
period NN O
measured VBN O
and CC O
typed VBN O
HLA-DQA1 JJ B-NP
from IN O
accumulated VBN O
DNA NN O
on IN O
autopsy JJ O
room NN O
and CC O
Forensic NNP O
DNA NNP O
Laboratory NNP O
structures NNS O
. . O

-DOCSTART- X X O

BRCA1 NN B-NP
, , O
a DT O
familial JJ O
breast NN O
and CC O
ovarian JJ O
cancer NN O
susceptibility NN O
gene NN O
encodes VBZ O
nuclear JJ O
phosphoproteins NNS O
that WDT O
function VBP O
as IN O
tumor NN O
suppressors NNS O
in IN O
human JJ O
breast NN O
cancer NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
alternative JJ O
splice NN O
sites NNS O
for IN O
the DT O
smallest JJS O
adducin JJ B-NP
isoform NN O
, , O
beta-3 JJ B-NP
, , O
are VBP O
alternative JJ O
donor NN O
and CC O
acceptor NN O
sites NNS O
within IN O
exons NNS O
7 CD O
and CC O
12 CD O
. . O

-DOCSTART- X X O

Neural JJ O
blockade NN O
in IN O
chronic NN O
and CC O
cancer NN O
pain NN O
. . O

-DOCSTART- X X O

Two CD O
new JJ O
temperature-sensitive JJ O
alleles NNS O
of IN O
SEC3 NNP B-NP
, , O
1 CD O
of IN O
10 CD O
late-acting JJ O
SEC NNP B-NP
genes NNS I-NP
required VBN O
for IN O
targeting VBG O
or CC O
fusion NN O
of IN O
post-Golgi JJ O
secretory NN O
vesicles NNS O
to TO O
the DT O
plasma NN O
membrane NN O
in IN O
Saccharomyces NNP O
cerevisiae NNS O
, , O
were VBD O
isolated VBN O
in IN O
a DT O
screen NN O
for IN O
temperature-sensitive JJ O
secretory NN O
mutants NNS O
that WDT O
are VBP O
synthetically RB O
lethal JJ O
with IN O
sec4-8. PRP$ B-NP

-DOCSTART- X X O

Five CD O
cell NN O
strains NNS O
of IN O
human JJ O
dermal NN O
fibroblasts NNS O
were VBD O
each DT O
treated VBN O
with IN O
three CD O
samples NNS O
of IN O
burn NN O
blister NN O
fluid NN O
and CC O
the DT O
effect NN O
compared VBN O
with IN O
the DT O
rate NN O
of IN O
contraction NN O
of IN O
free JJ O
floating VBG O
fibroblast RB O
populated JJ O
collagen NN B-NP
lattices NNS O
( -LRB- O
FPCL) NN O
. . O

-DOCSTART- X X O

Cell NNP O
49 CD O
, , O
753-761] CD O
. . O

-DOCSTART- X X O

Twenty-one CD O
ELISA-positive JJ O
sera NN O
were VBD O
tested VBN O
and CC O
confirmed VBN O
positive JJ O
by IN O
plaque NN O
reduction NN O
neutralization NN O
testing NN O
. . O

-DOCSTART- X X O

Tyrosine NNP O
1356 CD O
forms NNS O
a DT O
multisubstrate JJ O
binding NN O
site NN O
for IN O
the DT O
Grb2 NNP B-NP
and CC O
Shc NNP B-NP
adaptor VBD I-NP
proteins NNS I-NP
, , O
the DT O
p85 NN B-NP
subunit NN I-NP
of IN O
phosphatidylinositol NN B-NP
3'-kinase JJ I-NP
, , O
phospholipase JJ B-NP
Cgamma NNP I-NP
, , O
and CC O
a DT O
phosphatase NN O
, , O
SHP2 NNP B-NP
. . O

-DOCSTART- X X O

Gtx NNP B-NP
mRNA NN I-NP
accumulates NNS O
in IN O
parallel NN O
with IN O
the DT O
RNAs NNP O
encoding VBG O
the DT O
major JJ O
structural JJ O
proteins NNS O
of IN O
myelin NN O
, , O
myelin VBP B-NP
basic JJ I-NP
protein NN I-NP
( -LRB- O
MBP) NNP B-NP
, , O
and CC O
proteolipid JJ B-NP
protein NN I-NP
( -LRB- O
PLP NNP B-NP
) -RRB- O
during IN O
postnatal JJ O
brain NN O
development NN O
; : O
Gtx NNP B-NP
mRNA CD I-NP
decreases NNS O
in IN O
parallel JJ O
with IN O
MBP NNP B-NP
and CC O
PLP NNP B-NP
mRNAs NNS I-NP
in IN O
the DT O
brains NNS O
of IN O
myelin-deficient JJ O
rats NNS O
, , O
which WDT O
have VBP O
a DT O
point NN O
mutation NN O
in IN O
the DT O
PLP NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Contacts NNS O
between IN O
Bacillus NNP O
subtilis NNS O
catabolite VBP O
regulatory JJ O
protein NN O
CcpA NN B-NP
and CC O
amyO NN B-NP
target NN O
site NN O
. . O

-DOCSTART- X X O

They PRP O
also RB O
interact VB O
with IN O
GTPase NNP B-NP
activating VBG I-NP
proteins NNS I-NP
encoded VBN O
by IN O
IRA1 NNP B-NP
and CC O
IRA2 NNP B-NP
. . O

-DOCSTART- X X O

For IN O
E2 NNP O
, , O
each DT O
cat NN O
was VBD O
given VBN O
either DT O
5 CD O
( -LRB- O
group NN O
[G] NN O
1 CD O
) -RRB- O
or CC O
10 CD O
( -LRB- O
G2 NN O
) -RRB- O
mg NN O
of IN O
itraconazole/kg DT O
( -LRB- O
capsules NNS O
) -RRB- O
twice RB O
daily RB O
for IN O
6 CD O
weeks NNS O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
For IN O
E1 NNP O
, , O
itraconazole DT O
plasma NN O
drug NN O
concentration NN O
extrapolated VBN O
to TO O
time NN O
zero CD O
( -LRB- O
IV NNP O
dose NN O
) -RRB- O
was VBD O
5.2 CD O
+/ CD O
- : O
1.4 CD O
micrograms/ml NN O
, , O
and CC O
mean JJ O
residence NN O
time NN O
( -LRB- O
MRT NNP O
) -RRB- O
was VBD O
37 CD O
+/ NN O
- : O
16 CD O
hours NNS O
. . O

-DOCSTART- X X O

G-CSF NNP B-NP
was VBD O
started VBN O
on IN O
day NN O
3 CD O
of IN O
each DT O
cycle NN O
( -LRB- O
5 CD O
microg/kg/day NN O
) -RRB- O
and CC O
was VBD O
stopped VBN O
the DT O
day NN O
before IN O
the DT O
last JJ O
apheresis NN O
or CC O
when WRB O
absolute JJ O
neutrophil NN O
count NN O
was VBD O
above IN O
0.5 CD O
x NN O
10(9 CD O
)/l NN O
. . O

-DOCSTART- X X O

Crosstalk NNP O
among IN O
the DT O
pathways NNS O
may MD O
explain VB O
how WRB O
some DT O
forms NNS O
of IN O
stress NN O
can MD O
contribute VB O
to TO O
the DT O
development NN O
of IN O
a DT O
malignancy NN O
. . O

-DOCSTART- X X O

The DT O
majority NN O
of IN O
PI NNP B-NP
kinase NN I-NP
activity NN O
appeared VBD O
to TO O
be VB O
cbl-associated JJ B-NP
after IN O
PRL NNP B-NP
stimulation NN O
. . O

-DOCSTART- X X O

Mutation NN O
of IN O
Enh4 NNP B-NP
, , O
an DT O
essential JJ O
GT-IIC-like JJ B-NP
enhanson NN I-NP
in IN O
the DT O
context NN O
of IN O
the DT O
intact JJ O
enhancer NN O
, , O
abolishes NNS O
silencer NN O
activity NN O
, , O
and CC O
multimerized VBD O
GT-IIC NNP B-NP
enhansons NNS I-NP
mimic VBP O
the DT O
intact JJ O
CSEn NNP B-NP
enhancer/silencer NN I-NP
activities NNS O
in IN O
BeWo NNP O
and CC O
GC NNP O
cells NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Using VBG O
lectin-affinity NN B-NP
chromatography NN O
, , O
discordance NN O
between IN O
the DT O
pattern NN O
of IN O
O-glycosylation NN O
of IN O
SSBP NNP B-NP
and CC O
DSBP NNP B-NP
was VBD O
demonstrated VBN O
. . O

-DOCSTART- X X O

Deletion NNP O
mapping NN O
experiments NNS O
determined VBN O
that IN O
the DT O
sequences NNS O
required VBN O
for IN O
full JJ O
activity NN O
in IN O
MSC-1 JJ O
cells NNS O
were VBD O
included VBN O
within IN O
619 CD O
bp NN O
of IN O
the DT O
start NN O
site NN O
and CC O
identified VBD O
several JJ O
regions NNS O
that IN O
demonstrated VBD O
increased VBN O
luciferase NN B-NP
activity NN O
: : O
the DT O
-583 JJ O
bp NN O
to TO O
-564 DT O
bp NN O
, , O
-503 JJ O
bp NN O
to TO O
-484 DT O
bp NN O
, , O
and CC O
-114 DT O
bp NN O
to TO O
-65 DT O
regions NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
PH NNP B-NP
and CC O
PTB NNP O
domains NNS O
are VBP O
highly RB O
homologous JJ O
( -LRB- O
at IN O
least JJS O
40 CD O
% NN O
identical JJ O
) -RRB- O
to TO O
those DT O
found VBN O
in IN O
insulin NN B-NP
receptor NN I-NP
substrates NNS I-NP
1 CD I-NP
, , I-NP
2 CD I-NP
, , I-NP
and CC I-NP
3 CD I-NP
( -LRB- O
IRS-1 NN B-NP
, , O
IRS-2 NNP B-NP
, , O
and CC O
IRS-3 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

As IN O
demonstrated VBN O
by IN O
gel NNP O
mobility POS O
shift NN O
analysis NN O
and CC O
supershift JJ O
experiments NNS O
, , O
FIRE1 NNP B-NP
, , O
located VBN O
between IN O
-516 NNS O
and CC O
-498 NNS O
, , O
is VBZ O
responsible JJ O
for IN O
binding JJ O
NF-Y NNP B-NP
. . O

-DOCSTART- X X O

MR NNP O
imaging NN O
of IN O
traumatic JJ O
head NN O
injuries NNS O
using VBG O
FLAIR NNP O
technique NN O

-DOCSTART- X X O

Gag NNP B-NP
protein NN O
sequence NN O
motifs NNS O
of IN O
the DT O
NC NNP B-NP
domain NN I-NP
of IN O
primate JJ O
foamy JJ O
viruses NNS O
assumed VBD O
to TO O
be VB O
involved VBN O
in IN O
genome NN O
encapsidation NN O
are VBP O
not RB O
conserved VBN O
in IN O
FeFV. NNP O

-DOCSTART- X X O

MEASUREMENTS NNS O
AND CC O
MAIN NNP O
RESULTS NNS O
: : O
Lung NNP O
elastance NN O
( -LRB- O
EL NNP O
) -RRB- O
and CC O
resistance NN O
( -LRB- O
RL NN O
) -RRB- O
were VBD O
calculated VBN O
from IN O
measurements NNS O
of IN O
airway NN O
pressure NN O
, , O
esophageal JJ O
pressure NN O
, , O
and CC O
airway NN O
flow NN O
in IN O
five CD O
anesthetized JJ O
, , O
paralyzed JJ O
dogs NNS O
during IN O
sinusoidal JJ O
forcing VBG O
at IN O
a DT O
constant JJ O
mean JJ O
airway NN O
pressure NN O
of IN O
10 CD O
cmH2O NN O
in IN O
a DT O
wide JJ O
range NN O
of IN O
breathing NN O
frequencies NNS O
( -LRB- O
0.2 CD O
to TO O
1.0 CD O
Hz NN O
in IN O
intervals NNS O
of IN O
0.2 CD O
) -RRB- O
and CC O
tidal JJ O
volumes NNS O
( -LRB- O
50 CD O
, , O
100 CD O
, , O
200 CD O
, , O
and CC O
to TO O
300 CD O
mL NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
Cut9 NNP B-NP
subunit NN I-NP
is VBZ O
likely JJ O
to TO O
be VB O
a DT O
target NN O
for IN O
regulating JJ O
APC/ NNP B-NP
cyclosome JJ I-NP
function NN O
through IN O
protein-protein NN O
interactions NNS O
and CC O
phosphorylation NN O
. . O

-DOCSTART- X X O

The DT O
dose NN O
was VBD O
50 CD O
Gy/20 IN O
fractions/5 CD O
weeks NNS O
. . O

-DOCSTART- X X O

All PDT O
the DT O
women NNS O
received VBD O
13.5 CD O
mg JJ O
plain JJ O
bupivacaine NN O
via IN O
subarachnoid JJ O
injection NN O
at IN O
the DT O
L2-3 JJ O
interspace NN O
. . O

-DOCSTART- X X O

Naltrexone NN O
has VBZ O
been VBN O
recently RB O
approved VBN O
by IN O
the DT O
Food NNP O
and CC O
Drug NNP O
Administration NNP O
for IN O
the DT O
treatment NN O
of IN O
alcohol NN O
dependence NN O
. . O

-DOCSTART- X X O

Ent-kaurene JJ B-NP
synthase NN I-NP
from IN I-NP
the DT I-NP
fungus NN I-NP
Phaeosphaeria NNP I-NP
sp. . O

-DOCSTART- X X O

We PRP O
describe VBP O
a DT O
novel NN O
zinc NNP B-NP
finger NN I-NP
protein NN I-NP
, , O
dsRBP-ZFa JJ B-NP
, , O
isolated VBN O
by IN O
screening VBG O
an DT O
expression NN O
library NN O
with IN O
dsRNA NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
retroplasmid JJ O
reverse NN B-NP
transcriptase NN I-NP
is VBZ O
uniquely RB O
adapted VBN O
to TO O
initiate VB O
cDNA DT O
synthesis NN O
by IN O
recognizing VBG O
a DT O
3' JJ O
CCA NNP O
sequence NN O
. . O

-DOCSTART- X X O

Together RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
EGF/Ras/Raf NNP B-NP
induces VBZ O
transcription NN O
via IN O
combined VBN O
activation NN O
of IN O
ATF3/c-Jun NNP B-NP
and CC O
a DT O
52-kDa JJ O
nuclear JJ O
factor NN O
, , O
whereas IN O
JunD NNP B-NP
acts VBZ O
as IN O
a DT O
repressor NN O
of IN O
this DT O
response NN O
. . O

-DOCSTART- X X O

Together RB O
, , O
these DT O
data NNS O
support VBP O
a DT O
model NN O
in IN O
which WDT O
Tax NNP B-NP
anchors NNS O
CBP NNP B-NP
to TO O
the DT O
HTLV-1 NN B-NP
promoter NN I-NP
, , O
with IN O
strong JJ O
transcriptional JJ O
activation NN O
resulting VBG O
from IN O
the DT O
CBP-associated JJ B-NP
activities NNS O
of IN O
nucleosome JJ O
remodeling NN O
and CC O
recruitment NN O
of IN O
the DT O
general JJ O
transcription NN O
machinery NN O
. . O

-DOCSTART- X X O

Consistent NN O
with IN O
this DT O
model NN O
, , O
a DT O
synthetic NN O
construct VB O
containing VBG O
three CD O
tandem NN O
copies NNS O
of IN O
the DT O
native JJ O
LDL NNP B-NP
receptor NN I-NP
SREBP NNP B-NP
site NN O
linked VBN O
to TO O
a DT O
single JJ O
Sp1 NNP B-NP
site NN I-NP
was VBD O
also RB O
significantly RB O
activated VBN O
in IN O
a DT O
buttonhead-independent NN B-NP
fashion NN O
. . O

-DOCSTART- X X O

Various JJ O
assays RB O
demonstrate VBP O
promoter NN O
activity NN O
in IN O
this DT O
sequence NN O
that IN O
reproduces VBZ O
the DT O
normal JJ O
control NN O
of IN O
E2F2 NNP B-NP
expression NN O
during IN O
a DT O
growth NN O
stimulation NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
adult NN O
mouse NN O
, , O
ERR NNP B-NP
alpha NN I-NP
is VBZ O
most RBS O
highly RB O
expressed VBN O
in IN O
kidney NN O
, , O
heart NN O
, , O
and CC O
brown JJ O
adipocytes NNS O
, , O
tissues NNS O
which WDT O
preferentially RB O
metabolize VBP O
fatty JJ O
acids NNS O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
5' JJ O
flanking JJ O
region NN O
of IN O
the DT O
gene NN O
also RB O
revealed VBD O
the DT O
presence NN O
of IN O
multiple JJ O
TATA NNP O
and CC O
CAAT NNP O
sequences NNS O
. . O

-DOCSTART- X X O

The DT O
complete JJ O
response NN O
( -LRB- O
CR VBD O
) -RRB- O
rate NN O
was VBD O
34 CD O
% NN O
in IN O
the DT O
CODE NNP O
with IN O
rhG-CSF NNP B-NP
group NN O
and CC O
23 CD O
% NN O
in IN O
the DT O
CODE NNP O
alone RB O
group NN O
; : O
the DT O
median NN O
survival NN O
was VBD O
59 CD O
and CC O
32 CD O
weeks NNS O
, , O
respectively RB O
, , O
in IN O
these DT O
groups NNS O
( -LRB- O
P NNP O
= SYM O
0.004 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Heterogeneous JJ B-NP
nuclear JJ I-NP
ribonucleoprotein NN I-NP
A1 IN I-NP
binds NNS O
to TO O
the DT O
transcription-regulatory JJ O
region NN O
of IN O
mouse NN O
hepatitis NN O
virus NN O
RNA NNP O
. . O

-DOCSTART- X X O

In IN O
the DT O
first JJ O
part NN O
of IN O
our PRP$ O
study NN O
, , O
the DT O
highest JJS O
mutagenicity NN O
was VBD O
revealed VBN O
by IN O
TA98 DT O
strain NN O
without IN O
enzymatic JJ O
activation NN O
, , O
suggesting VBG O
a DT O
direct-acting JJ O
mutagenicity NN O
prevalence NN O
in IN O
diesel NN O
particulate NN O
. . O

-DOCSTART- X X O

The DT O
addition NN O
of IN O
culture NN O
to TO O
the DT O
CC NNP O
and CC O
CC:SW NNP O
by-products NNS O
resulted VBD O
in IN O
pH NN O
values NNS O
lower JJR O
( -LRB- O
P NNP O
< NN O
0.05 CD O
) -RRB- O
than IN O
those DT O
without IN O
culture NN O
on IN O
Day NNP O
21 CD O
, , O
and CC O
the DT O
15 CD O
% NN O
carbohydrate NN O
treatment NN O
significantly RB O
reduced VBD O
pH RB O
beyond IN O
the DT O
5 CD O
% NN O
carbohydrate NN O
. . O

-DOCSTART- X X O

Myocardial JJ O
interstitial JJ O
edema NN O
is VBZ O
more RBR O
likely JJ O
a DT O
potential JJ O
mechanism NN O
of IN O
diastolic JJ O
dysfunction NN O
after IN O
DC NNP O
shocks NNS O
. . O

-DOCSTART- X X O

Two CD O
experiments NNS O
( -LRB- O
N NNP O
= SYM O
20 CD O
each DT O
) -RRB- O
were VBD O
carried VBN O
out RP O
to TO O
explore VB O
the DT O
nature NN O
of IN O
ERP NNP O
negativities NNS O
in IN O
a DT O
visuospatial JJ O
memory NN O
task NN O
and CC O
in IN O
an DT O
auditory JJ O
spatial JJ O
memory NN O
task NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

The DT O
pattern NN O
and CC O
timing NN O
of IN O
CARP NNP B-NP
mRNA NN I-NP
expression NN O
, , O
including VBG O
transient JJ O
expression NN O
in IN O
the DT O
tongue NN O
at IN O
14.5 CD O
days NNS O
p.c. RB O
, , O
coincides VBZ O
with IN O
that DT O
of IN O
Nkx2.5/Csx NNP B-NP
( -LRB- O
a DT O
putative JJ O
homolog NN O
of IN O
tinman NN B-NP
, , O
the DT O
Drosophila NNP O
melanogaster NN O
gene NN O
responsible JJ O
for IN O
cardiac JJ O
development NN O
) -RRB- O
. . O

-DOCSTART- X X O

Overexpression IN O
of IN O
CARP NNP B-NP
in IN O
cardiomyocytes NNS O
suppresses NNS O
cardiac JJ B-NP
troponin FW I-NP
C NNP I-NP
and CC O
atrial JJ B-NP
natriuretic JJ I-NP
factor NN I-NP
transcription NN O
. . O

-DOCSTART- X X O

Hence RB O
, , O
scs32 VBG B-NP
only RB O
partially RB O
suppressed VBN O
the DT O
ts NNS O
phenotype NN O
and CC O
was VBD O
unable JJ O
to TO O
suppress VB O
the DT O
Ino-phenotype NNP O
of IN O
rpo26-31 CD B-NP
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Patients NNS O
wit NN O
clinically RB O
palpable JJ O
neck NN O
disease NN O
( -LRB- O
N1-3 JJ O
) -RRB- O
, , O
histological JJ O
evidence NN O
of IN O
metastatic JJ O
nodal JJ O
disease NN O
, , O
extracapsular JJ O
spread NN O
, , O
and CC O
three CD O
or CC O
more RBR O
positive JJ O
lymph NN O
nodes NNS O
are VBP O
at IN O
greater JJR O
risk NN O
of IN O
developing VBG O
failure NN O
at IN O
distant JJ O
sites NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
subcloned VBN O
into IN O
pBR322 DT O
deoxyribonucleic JJ O
acid NN O
( -LRB- O
DNA NN O
) -RRB- O
sequences NNS O
mapping NN O
either CC O
in IN O
the DT O
coding NN O
region NN O
, , O
the DT O
5' JJ O
spacer NN O
, , O
or CC O
the DT O
3' JJ O
spacer NN O
of IN O
the DT O
H2B NNP B-NP
histone NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

4 CD O
. . O

-DOCSTART- X X O

The DT O
combination NN O
of IN O
hydralazine NN O
hydrochloride NN O
and CC O
isosorbide NN O
dinitrate NN O
also RB O
improves VBZ O
survival NN O
, , O
but CC O
direct JJ O
comparison NN O
of IN O
both DT O
regimens NNS O
provided VBD O
evidence NN O
for IN O
a DT O
less JJR O
favourable JJ O
effect NN O
than IN O
that DT O
of IN O
the DT O
ACE NNP B-NP
inhibitors NNS O
. . O

-DOCSTART- X X O

To TO O
address VB O
mechanisms NNS O
that WDT O
define VB O
interactions NNS O
of IN O
Site NNP B-NP
II NNP I-NP
regulatory JJ I-NP
factors NNS I-NP
with IN O
this DT O
cell NN O
cycle NN O
control NN O
element NN O
, , O
we PRP O
have VBP O
investigated VBN O
these DT O
determinants NNS O
of IN O
transcriptional JJ O
regulation NN O
at IN O
the DT O
G1/S NNP O
phase NN O
transition NN O
in IN O
FDC-P1 JJ O
hematopoietic JJ O
progenitor NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
goal NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
identify VB O
neuronal JJ O
cell NN O
cultures NNS O
that IN O
express JJ O
RC3/neurogranin NN B-NP
, , O
to TO O
check VB O
whether IN O
they PRP O
are VBP O
sensitive JJ O
to TO O
T3 VB O
, , O
and CC O
to TO O
examine VB O
the DT O
mechanism NN O
of IN O
regulation NN O
. . O

-DOCSTART- X X O

Their PRP$ O
circadian JJ O
responses NNS O
to TO O
both DT O
photic JJ O
and CC O
non-photic JJ O
cues NNS O
were VBD O
then RB O
tested VBN O
. . O

-DOCSTART- X X O

Although IN O
previous JJ O
data NNS O
have VBP O
suggested VBN O
that IN O
Rev NNP B-NP
uses VBZ O
the DT O
same JJ O
export NN O
pathway NN O
as IN O
uracil-rich JJ O
small JJ O
nuclear JJ O
RNAs NNS O
and CC O
5S NNS B-NP
ribosomal JJ I-NP
RNA NNP I-NP
, , O
the DT O
CTE NNP O
seems VBZ O
to TO O
interact VB O
with IN O
evolutionarily RB O
conserved VBN O
factors NNS O
that WDT O
are VBP O
essential JJ O
for IN O
cellular JJ O
mRNA JJ O
export NN O
. . O

-DOCSTART- X X O

ArgR NNP B-NP
was VBD O
shown VBN O
to TO O
be VB O
a DT O
dimer NN O
of IN O
two CD O
equal JJ O
subunits NNS O
, , O
each DT O
with IN O
a DT O
molecular JJ O
mass NN O
of IN O
37,000 CD O
Da NNP O
. . O

-DOCSTART- X X O

Plasma NNP B-NP
leptin NN I-NP
concentrations NNS O
were VBD O
higher JJR O
in IN O
women NNS O
than IN O
men NNS O
, , O
even RB O
after IN O
the DT O
adjustment NN O
for IN O
differences NNS O
in IN O
fat JJ O
mass NN O
( -LRB- O
28 CD O
+/ NN O
- : O
3 CD O
ng/ml NN O
for IN O
women NNS O
vs. CC O

-DOCSTART- X X O

This DT O
interaction NN O
involved VBN O
the DT O
SH3 JJ B-NP
region NN I-NP
of IN O
p50( NN B-NP
cs NNS B-NP
k NN I-NP
) -RRB- O
and CC O
a DT O
proline-rich JJ O
region NN O
( -LRB- O
PPPLPERTPESFVLADM) NNP O
outside IN O
the DT O
catalytic JJ O
region NN O
of IN O
PTP-PEST. NNP B-NP

-DOCSTART- X X O

Following VBG O
2.5 CD O
Gy NNP O
, , O
HbO2 IN B-NP
changes NNS O
were VBD O
minimal JJ O
. . O

-DOCSTART- X X O

Polarised JJ O
expression NN O
of IN O
human JJ O
intestinal JJ O
N-benzoyl-L-tyrosyl-p-aminobenzoic JJ B-NP
acid NN I-NP
hydrolase NN I-NP
( -LRB- O
human JJ B-NP
meprin NN I-NP
) -RRB- O
alpha NN O
and CC O
beta JJ O
subunits NNS O
in IN O
Madin-Darby JJ O
canine CD O
kidney NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
cycle NN O
length NN O
of IN O
induced JJ O
VT NN O
( -LRB- O
n NN O
= SYM O
10 CD O
VTs NNS O
) -RRB- O
was VBD O
380 CD O
+/ CD O
- : O
41 CD O
msec. NN O

-DOCSTART- X X O

Transient NNP O
hyperammonaemia NN O
in IN O
an DT O
adult JJ O
German JJ O
shepherd NN O
dog NN O
. . O

-DOCSTART- X X O

We PRP O
established VBD O
that IN O
the DT O
2.6 CD O
kb NN O
mRNA NN O
V-1 NN O
and CC O
the DT O
2.3 CD O
kb NN O
GGT NNP B-NP
mRNA . O
V-2 NNP O
derive NN O
, , O
by IN O
alternate JJ O
splicing NN O
, , O
from IN O
a DT O
primary JJ O
transcript NN O
initiated VBN O
on IN O
a DT O
distal JJ O
promoter NN O
on IN O
the DT O
rat NN B-NP
GGT NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

These DT O
repressor NN O
sites NNS O
are VBP O
pyrimidine JJ O
rich JJ O
and CC O
bind NN O
avidly RB O
to TO O
the DT O
polypyrimidine NN B-NP
tract NN I-NP
binding JJ I-NP
protein NN I-NP
( -LRB- O
PTB NN B-NP
) -RRB- O
in IN O
HeLa NNP O
nuclear JJ O
extracts NNS O
as IN O
determined VBN O
by IN O
UV NN O
crosslinking/competition NN O
assays VBZ O
. . O

-DOCSTART- X X O

For IN O
higher JJR O
expression NN O
of IN O
lipA NN B-NP
in IN O
S. NNP O
lividans NNS O
, , O
the DT O
gene NN O
was VBD O
cloned VBN O
next JJ O
to TO O
the DT O
strong JJ O
aphII NN B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
to TO O
the DT O
wild-type JJ O
protein NN O
, , O
expression NN O
of IN O
p45 DT B-NP
NF-E2 NNP B-NP
lacking VBG O
this DT O
activation NN O
domain NN O
in IN O
an DT O
NF-E2 JJ B-NP
null JJ O
cell NN O
line NN O
fails VBZ O
to TO O
support VB O
enhancer-dependent JJ O
transcription NN O
in IN O
transient JJ O
assays NNS O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
one CD O
potential JJ O
mechanism NN O
for IN O
direct JJ O
recruitment NN O
of IN O
distal JJ O
regulatory JJ O
regions NNS O
of IN O
the DT O
globin NN B-NP
loci NNS I-NP
to TO O
the DT O
individual JJ O
promoters NNS O
. . O

-DOCSTART- X X O

The DT O
promoter NN O
region NN O
showed VBD O
no DT O
consensus NN O
TATA NNP O
box NN O
but CC O
it PRP O
contains VBZ O
CCAAT JJ O
and CC O
CreA NNP B-NP
boxes NNS O
known VBN O
to TO O
be VB O
involved VBN O
in IN O
both DT O
stress NN O
and CC O
carbon-catabolite JJ O
regulation NN O
of IN O
fungal JJ O
promoters NNS O
. . O

-DOCSTART- X X O

The DT O
ORF3 JJ O
mutant JJ O
produced VBN O
reduced VBN O
levels NNS O
of IN O
tabtoxin NN B-NP
, , O
indicating VBG O
that IN O
ORF3 NNP O
may MD O
have VB O
a DT O
role NN O
in IN O
T NNP B-NP
beta NN I-NP
L NNP I-NP
biosynthesis NN O
. . O

-DOCSTART- X X O

These DT O
transcripts NNS O
contain VBP O
the DT O
5' JJ O
ends NNS O
of IN O
mature JJ O
UbCRBP NNP B-NP
mRNAs NNS I-NP
; : O
extend VB O
through IN O
UbCRBP NNP B-NP
, , O
across IN O
the DT O
intergenic JJ O
region NN O
, , O
and CC O
a DT O
significant JJ O
distance NN O
3' IN O
into IN O
the DT O
enolase JJ B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

As IN O
a DT O
result NN O
, , O
the DT O
subendocardial/subepicardial JJ O
blood NN O
flow NN O
ratio NN O
( -LRB- O
ENDO/EPI NNP O
) -RRB- O
increased VBN O
from IN O
0.44 CD O
+/ CD O
- : O
0.09 CD O
during IN O
control NN O
stenosis NN O
to TO O
0.85 CD O
+/ CD O
- : O
0.13 CD O
after IN O
ITF NNP O
1129 CD O
( -LRB- O
10 CD O
micrograms/kg/min NN O
i NN O
.v. , O
) -RRB- O
and CC O
to TO O
0.81 CD O
+/ CD O
- : O
0.12 CD O
after IN O
NTG. NNP O

-DOCSTART- X X O

In IN O
support NN O
of IN O
this DT O
interpretation NN O
we PRP O
demonstrate VBP O
that IN O
MQ9b NNP B-NP
binds NNS O
strongly RB O
5 CD O
of IN O
17 CD O
motif-positive JJ O
, , O
pathogen-derived JJ O
synthetic JJ O
peptides NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
although IN O
deletion NN O
of IN O
Fp1 NNP B-NP
in IN O
the DT O
hCRBP1 JJ B-NP
gene NN I-NP
yielded VBD O
increased VBN O
CAT JJ B-NP
activity NN O
, , O
pointing VBG O
toward IN O
a DT O
negative JJ O
regulatory JJ O
function NN O
exerted VBN O
by IN O
this DT O
element NN O
, , O
its PRP$ O
insertion NN O
upstream RB O
of IN O
the DT O
p12 NN B-NP
basal NN I-NP
promoter NN I-NP
results NNS O
in IN O
an DT O
impressive JJ O
positive JJ O
stimulation NN O
of IN O
CAT NNP B-NP
gene NN I-NP
expression NN O
. . O

-DOCSTART- X X O

Gaucher NNP O
's POS O
disease NN O
is VBZ O
a DT O
rare JJ O
metabolic JJ O
disorder NN O
characterized VBN O
by IN O
the DT O
lack NN O
of IN O
beta-glucocerebrosidase JJ B-NP
enzyme NN I-NP
. . O

-DOCSTART- X X O

Overexpression NNP O
of IN O
BAG-1 NNP B-NP
also RB O
protected VBD O
certain JJ O
cell NN O
lines NNS O
from IN O
heat NN O
shock-induced JJ O
cell NN O
death NN O
. . O

-DOCSTART- X X O

The DT O
5' JJ O
flanking JJ O
region NN O
contains VBZ O
potential JJ O
binding NN O
sites NNS O
for IN O
TATA-binding JJ B-NP
protein NN I-NP
, , O
Sp1 NNP B-NP
, , O
nuclear JJ B-NP
factor NN I-NP
1 CD I-NP
( -LRB- O
NF1 NN B-NP
) -RRB- O
, , O
CAAT-box NNP B-NP
binding JJ I-NP
protein NN I-NP
( -LRB- O
C/EBP) NN B-NP
, , O
hepatocyte JJ B-NP
nuclear JJ I-NP
factors NNS I-NP
1 CD I-NP
and CC I-NP
5 CD I-NP
( -LRB- O
HNF1 NNP B-NP
, , O
HNF5 IN B-NP
) -RRB- O
and CC O
activator JJ B-NP
proteins NNS I-NP
1 CD I-NP
and CC I-NP
2 CD I-NP
( -LRB- O
AP1 NN B-NP
, , O
AP2 NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
recognition NN O
specificity NN O
of IN O
the DT O
p55 NN B-NP
PDZ NN B-NP
domain NN I-NP
appears VBZ O
to TO O
be VB O
unique JJ O
, , O
since IN O
the DT O
three CD O
PDZ NNP B-NP
domains NNS I-NP
of IN O
hDlg NN B-NP
( -LRB- O
human JJ O
lymphocyte NN O
homologue NN O
of IN O
the DT O
Drosophila NNP B-NP
discs NNS I-NP
large JJ I-NP
tumor NN I-NP
suppressor NN I-NP
) -RRB- O
do VBP O
not RB O
bind NN O
the DT O
cytoplasmic JJ O
domain NN O
of IN O
glycophorin NN B-NP
C. NNP I-NP

-DOCSTART- X X O

By IN O
analyzing VBG O
the DT O
RanGAP NNP B-NP
activity NN O
of IN O
a DT O
series NN O
of IN O
recombinantly VBG O
expressed VBN O
rna1p JJ B-NP
mutant NN I-NP
derivatives NNS O
, , O
we PRP O
show VBP O
that IN O
the DT O
highly RB O
acidic JJ O
sequence NN O
in IN O
the DT O
C-terminal JJ O
domain NN O
of IN O
both DT O
yeast NN O
proteins NNS O
is VBZ O
indispensable JJ O
for IN O
activating VBG O
Ran-mediated NNP B-NP
GTP NNP O
hydrolysis NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
absence NN O
of IN O
MHC JJ B-NP
class NN I-NP
II NNP I-NP
, , O
purified VBN B-NP
soluble JJ I-NP
D10 IN I-NP
TCR NNP I-NP
bound VBD O
to TO O
Staphylococcus NNP B-NP
aureus NN I-NP
enterotoxin NN I-NP
C2 . I-NP
with IN O
an DT O
association NN O
rate NN O
of IN O
1.69+/-0.12 CD O
x NN O
10( JJ O
4)M(-1 JJ O
) -RRB- O
sec(-1 NN O
) -RRB- O
and CC O
a DT O
dissociation NN O
rate NN O
of IN O
1.9+/-0.47 CD O
x NN O
10(-2 CD O
) -RRB- O
sec(-1 NN O
) -RRB- O
, , O
giving VBG O
a DT O
dissociation NN O
constant JJ O
of IN O
1.1 CD O
microM. . O

-DOCSTART- X X O

Evidence NN O
for IN O
such JJ O
peak JJ O
shifts NNS O
has VBZ O
been VBN O
found VBN O
in IN O
the DT O
responses NNS O
of IN O
auditory JJ O
nerve NN O
fibers NNS O
, , O
cochlear NN O
microphonics NNS O
, , O
and CC O
the DT O
responses NNS O
of IN O
outer JJ O
hair NN O
cells NNS O
and CC O
supporting VBG O
cells NNS O
in IN O
the DT O
cochlea NN O
, , O
as RB O
well RB O
as IN O
in IN O
basilar NN O
membrane NN O
vibration NN O
measurements NNS O
, , O
and CC O
indirectly RB O
, , O
in IN O
psychophysical JJ O
data NNS O
. . O

-DOCSTART- X X O

Mnt NNP B-NP
:Max NNP O
complexes NNS O
also RB O
efficiently RB O
suppress VB O
Myc-dependent JJ B-NP
activation NN O
from IN O
the DT O
same JJ O
promoter NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
United NNP O
States NNPS O
high-MW JJ O
HES NNP O
480 CD O
which WDT O
is VBZ O
difficult JJ O
to TO O
degrade VB O
is VBZ O
most RBS O
frequently RB O
used VBN O
and CC O
results NNS O
in IN O
a DT O
larger JJR O
in IN O
vivo JJ O
MW NNP O
and CC O
subsequent JJ O
decrease NN O
in IN O
factor NN B-NP
VIII/von NNP I-NP
Willebrand NNP B-NP
factor NN I-NP
levels NNS O
. . O

-DOCSTART- X X O

Assays NNP O
of IN O
total JJ O
cholesterol NN O
as RB O
well RB O
as IN O
the DT O
HDL NNP B-NP
, , O
HDL2 NNP B-NP
, , O
LDL NNP B-NP
, , O
triglycerides VBZ O
, , O
endothelin-1 NN B-NP
, , O
lipoprotein NN B-NP
( -LRB- I-NP
a DT I-NP
) -RRB- I-NP
, , O
estradiol NN O
and CC O
FSH NNS B-NP
were VBD O
also RB O
obtained VBN O
at IN O
baseline NN O
before IN O
receiving VBG O
ERT NNP O
and CC O
after IN O
3 CD O
months NNS O
of IN O
ERT. NNP O

-DOCSTART- X X O

The DT O
distributed VBN O
current JJ O
density NN O
J NN O
is VBZ O
calculated VBN O
within IN O
the DT O
volume NN O
defined VBN O
by IN O
the DT O
motor NN O
unit NN O
. . O

-DOCSTART- X X O

The DT O
cleavage JJ O
dipeptides NNS O
of IN O
C1YVV NNP B-NP
NIa NNP I-NP
protease NN I-NP
are VBP O
Q( NNP O
E)/S(A,G) NNP O
. . O

-DOCSTART- X X O

However RB O
, , O
we PRP O
were VBD O
unable JJ O
to TO O
identify VB O
a DT O
p4 NN B-NP
molecule NN O
. . O

-DOCSTART- X X O

( -LRB- O
iv) NN O
The DT O
accumulation NN O
of IN O
cyclin NN B-NP
D3 JJ I-NP
protein NN I-NP
in IN O
Vero NN O
cells NNS O
infected VBN O
with IN O
an DT O
alpha0 NN B-NP
deletion NN I-NP
mutant NN I-NP
was VBD O
reduced VBN O
relative JJ O
to TO O
that DT O
of IN O
cells NNS O
infected VBN O
with IN O
wild-type JJ O
virus NN O
or CC O
a DT O
recombinant JJ O
virus NN O
in IN O
which WDT O
the DT O
deleted VBN O
alpha0 NN B-NP
sequences NNS I-NP
were VBD O
restored VBN O
. . O

-DOCSTART- X X O

These DT O
effects NNS O
were VBD O
abrogated VBN O
by IN O
co-expression NN O
of IN O
kinase-deficient JJ B-NP
PKC NNP I-NP
zeta NN I-NP
and CC O
inhibition NN O
of IN O
phosphatidylinositol NN B-NP
3-kinase JJ I-NP
p85alpha-p110 . B-NP
by IN O
wortmannin NN O
, , O
LY294002 NNP O
and CC O
a DT O
dominant-negative JJ O
mutant NN O
of IN O
p85alpha NN B-NP
. . O

-DOCSTART- X X O

Protein NNP B-NP
phosphatase NN I-NP
2A CC I-NP
is VBZ O
a DT O
critical JJ O
regulator NN O
of IN O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
zeta NN I-NP
signaling VBG O
targeted VBN O
by IN O
SV40 DT B-NP
small JJ I-NP
t NN I-NP
to TO O
promote VB O
cell NN O
growth NN O
and CC O
NF-kappaB NNP B-NP
activation NN O
. . O

-DOCSTART- X X O

Underlying VBG O
the DT O
clustering NN O
of IN O
these DT O
risk NN O
variables NNS O
were VBD O
three CD O
factors NNS O
. . O

-DOCSTART- X X O

Supplementation NN O
was VBD O
stopped VBN O
when WRB O
pl-ALB NN B-NP
reached VBD O
2.0 CD O
g/dL NN O
. . O

-DOCSTART- X X O

Detection NNP O
of IN O
airborne JJ O
Mycobacterium NNP O
tuberculosis NN O
by IN O
air NN O
filtration NN O
and CC O
polymerase NN O
chain NN O
reaction NN O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
show VBP O
that DT O
EBP50 NNP B-NP
is VBZ O
a DT O
physiologically RB O
relevant JJ O
ezrin NN B-NP
binding JJ I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Deletion NNP O
of IN O
the DT O
POR2 NNP B-NP
gene NN I-NP
alone RB O
had VBD O
no DT O
detectable JJ O
phenotype NN O
, , O
while IN O
yeasts NNS O
with IN O
deletions NNS O
of IN O
both DT O
the DT O
POR1 NNP B-NP
and CC O
POR2 NNP B-NP
genes NNS I-NP
were VBD O
viable JJ O
and CC O
able JJ O
to TO O
grow VB O
on IN O
glycerol NN O
at IN O
30 CD O
degrees NNS O
C NN O
, , O
albeit IN O
more RBR O
slowly RB O
than IN O
delta JJ B-NP
por1 NN I-NP
single JJ I-NP
mutants NNS I-NP
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
our PRP$ O
novel NN O
observation NN O
that WDT O
expression NN O
of IN O
a DT O
highly RB O
activated VBN O
FGFR3 DT B-NP
kinase NN I-NP
domain NN I-NP
is VBZ O
able JJ O
to TO O
morphologically RB O
transform VB O
fibroblasts NNS O
suggests VBZ O
that IN O
dysregulation NN O
of IN O
FGFR3 NNP B-NP
has VBZ O
the DT O
potential JJ O
to TO O
play VB O
a DT O
role NN O
in IN O
human JJ O
neoplasia NN O
. . O

-DOCSTART- X X O

However RB O
, , O
Cbf5p NNP B-NP
was VBD O
found VBN O
to TO O
be VB O
nucleolar JJ O
and CC O
is VBZ O
highly RB O
homologous JJ O
to TO O
the DT O
rat NN B-NP
nucleolar JJ I-NP
protein NN I-NP
NAP57 NNP I-NP
, , O
which WDT O
coimmunoprecipitates VBZ O
with IN O
Nopp140 NNP B-NP
and CC O
which WDT O
is VBZ O
postulated VBN O
to TO O
be VB O
involved VBN O
in IN O
nucleolar-cytoplasmic JJ O
shuttling NN O
( -LRB- O
U. . O

-DOCSTART- X X O

Ig VB B-NP
heavy JJ I-NP
chain NN I-NP
class NN O
switching NN O
is VBZ O
directed VBN O
by IN O
cytokines NNS O
inducing VBG O
transcription NN O
from IN O
unrearranged JJ O
CH NNP B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

The DT O
available JJ O
data NNS O
suggest VBP O
that IN O
the DT O
NF NNP B-NP
kappa NN I-NP
B2 NN I-NP
nucleoprotein IN I-NP
complex NN I-NP
may MD O
cooperate VB O
with IN O
DNA-bound JJ O
STAT6 NNS B-NP
to TO O
achieve VB O
IL-4-dependent JJ B-NP
activation NN O
of IN O
the DT O
human JJ B-NP
IgE NNP I-NP
germline NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

EXERCISE NNP O
IN IN O
THE DT O
TERRESTRIAL NNP O
CHRISTMAS NNP O
ISLAND NNP O
RED VBD O
CRAB NNP O
GECARCOIDEA NNP O
NATALIS NNP O
- : O
ENERGETICS NNP O
OF IN O
LOCOMOTION NN O

-DOCSTART- X X O

THE DT O
SCALING NN O
OF IN O
SONG NNP O
FREQUENCY NNP O
IN IN O
CICADAS NNP O

-DOCSTART- X X O

In IN O
this DT O
study NN O
we PRP O
have VBP O
introduced VBN O
mutations NNS O
into IN O
the DT O
corresponding JJ O
elements NNS O
of IN O
two CD O
cox3 JJ B-NP
promoters NNS I-NP
and CC O
show NN O
that IN O
while IN O
the DT O
core NN O
element NN O
is VBZ O
essential JJ O
for IN O
cox3 VBG B-NP
promoter NN I-NP
activity NN O
, , O
upstream RB O
element NN O
mutations NNS O
have VBP O
little RB O
or CC O
no DT O
effect NN O
. . O

-DOCSTART- X X O

The DT O
histidine-tagged JJ O
gene NN O
, , O
rpoCHIS NNP B-NP
, , O
was VBD O
used VBN O
to TO O
replace VB O
the DT O
wild-type JJ O
allele NN O
in IN O
the DT O
chromosome NN O
of IN O
S. NNP O
coelicolor NN O
and CC O
S. NNP O
lividans NNS O
. . O

-DOCSTART- X X O

The DT O
malate NN B-NP
synthase NN I-NP
gene NN I-NP
, , O
MLS1 NNP B-NP
, , O
of IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NN O
is VBZ O
transcriptionally RB O
regulated VBN O
by IN O
the DT O
carbon NN O
source NN O
in IN O
the DT O
growth NN O
medium NN O
. . O

-DOCSTART- X X O

Lack NN O
of IN O
controlled JJ O
prospective JJ O
studies NNS O
of IN O
sleep NN O
electroencephalograms NNS O
( -LRB- O
EEG) NN O
, , O
and CC O
the DT O
use NN O
of IN O
medication NN O
, , O
in IN O
children NNS O
with IN O
developmental JJ O
dysphasia NN O
, , O
may MD O
deny VB O
appropriate JJ O
treatment NN O
strategies NNS O
to TO O
children NNS O
with IN O
severe JJ O
developmental JJ O
speech NN O
and CC O
language NN O
disorders NNS O
. . O

-DOCSTART- X X O

Prior RB O
to TO O
meals NNS O
2 CD O
to TO O
3 CD O
times NNS O
daily RB O
, , O
1-2 JJ O
tablespoons NNS O
of IN O
Alzoon NNP O
are VBP O
recommended VBN O
. . O

-DOCSTART- X X O

Widening NN O
of IN O
the DT O
abdominal JJ O
aortic JJ O
wall NN O
on IN O
an DT O
ultrasound JJ O
examination NN O
was VBD O
the DT O
key NN O
to TO O
the DT O
incidental JJ O
diagnosis NN O
of IN O
a DT O
clinically RB O
unsuspected JJ O
type NN O
B NNP O
dissection NN O
. . O

-DOCSTART- X X O

Ovaries NNS O
of IN O
10 CD O
animals NNS O
per IN O
group NN O
from IN O
16 CD O
studies NNS O
in IN O
CD-1 NN O
mice NNS O
and CC O
1 CD O
study NN O
each DT O
in IN O
C3H NNP O
and CC O
C57BL/6 NNP O
mice NNS O
were VBD O
sectioned VBN O
serially RB O
at IN O
6 CD O
microm NN O
. . O

-DOCSTART- X X O

The DT O
sequenced NN O
cDNA NN O
predicts VBZ O
a DT O
704-amino JJ O
acid NN O
protein NN O
80 CD O
% NN O
identical JJ O
to TO O
human JJ B-NP
progelatinase NN I-NP
B. NNP I-NP

-DOCSTART- X X O

The DT O
inhibition NN O
by IN O
cytosolic JJ O
Ca2+ NNP O
was VBD O
caused VBN O
by IN O
a DT O
decrease NN O
in IN O
cooperativity NN O
and CC O
by IN O
a DT O
shift NN O
in IN O
EC50 NNP O
toward IN O
higher JJR O
InsP3 IN O
concentrations NNS O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
The DT O
standardised JJ O
mortality NN O
ratio NN O
( -LRB- O
SMR NNP O
) -RRB- O
for IN O
all DT O
malignant JJ O
neoplasms NNS O
was VBD O
94 CD O
(95 CD O
% NN O
CI NNP O
74 CD O
to TO O
118 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
of IN O
this DT O
region NN O
revealed VBD O
three CD O
eight-bp CD O
repetitive JJ O
elements NNS O
, , O
the DT O
deletion NN O
of IN O
which WDT O
restored VBD O
wild-type JJ O
levels NNS O
of IN O
luciferase NN B-NP
activity NN O
to TO O
the DT O
-916-bp JJ O
reporter NN O
plasmid NN O
. . O

-DOCSTART- X X O

Using VBG O
5'RACE NNP O
and CC O
reverse VB O
transcription-PCR JJ O
(RT-PCR NN O
) -RRB- O
methodologies NNS O
, , O
we PRP O
cloned VBD O
these DT O
sequences NNS O
from IN O
brain NN O
and CC O
placenta NN O
and CC O
found VBD O
this DT O
material NN O
to TO O
be VB O
composed VBN O
of IN O
alternatively RB O
spliced VBN O
exons NNS O
using VBG O
a DT O
previously RB O
reported VBN O
noncoding JJ O
exon NN O
( -LRB- O
1A DT O
) -RRB- O
and CC O
a DT O
novel NN O
97-bp NNP O
noncoding JJ O
exon NN O
( -LRB- O
1B IN O
) -RRB- O
. . O

-DOCSTART- X X O

This DT O
is VBZ O
the DT O
first JJ O
study NN O
in IN O
which WDT O
mutation NN O
screening NN O
has VBZ O
been VBN O
performed VBN O
for IN O
both DT O
the DT O
EXT1 NNPS B-NP
and CC O
EXT2 NNPS B-NP
genes NNS I-NP
prior RB O
to TO O
any DT O
linkage NN O
analysis NN O
. . O

-DOCSTART- X X O

The DT O
regurgitation NN O
of IN O
large JJ O
vitreous JJ O
injections NNS O
. . O

-DOCSTART- X X O

Positron NNP O
emission NN O
tomography NN O
radioligands NNS O
for IN O
dopamine NN B-NP
transporters NNS I-NP
and CC O
studies NNS O
in IN O
human JJ O
and CC O
nonhuman JJ O
primates NNS O
. . O

-DOCSTART- X X O

Attenuation VB O
from IN O
the DT O
vit NN B-NP
A2 IN I-NP
consensus NN O
ERE RB O
is VBZ O
not RB O
necessarily RB O
dependent JJ O
on IN O
DNA NNP O
binding NN O
as IN O
the DT O
TR NN B-NP
alpha NN I-NP
DNA NNP O
binding NN O
mutant NN O
was VBD O
still RB O
able JJ O
to TO O
inhibit VB O
E-dependent NNP O
transactivation NN O
. . O

-DOCSTART- X X O

Expression NN O
from IN O
this DT O
element NN O
is VBZ O
regulated VBN O
by IN O
a DT O
heteromeric JJ O
protein NN O
complex NN O
containing VBG O
ubiquitous JJ O
( -LRB- O
i FW O
.e NN O
. . O
the DT O
E2A NNP B-NP
- : O
and CC O
HEB-encoded JJ B-NP
proteins NNS I-NP
) -RRB- O
and CC O
islet-enriched JJ O
members NNS O
of IN O
the DT O
bHLH JJ B-NP
family NN I-NP
. . O

-DOCSTART- X X O

The DT O
most RBS O
common JJ O
grade NN O
3 CD O
toxicity NN O
was VBD O
neutropenia NN O
, , O
thrombocytopenia NN O
, , O
and CC O
parasthesias NNS O
( -LRB- O
observed VBN O
in IN O
<10 CD O
% NN O
of IN O
cycles NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Serum NNP O
concentrations NNS O
of IN O
E2 NNP O
and CC O
TBOH NNP O
were VBD O
measured VBN O
on IN O
d VBN O
0, IN O
1 CD O
, , O
3 CD O
, , O
5 CD O
, , O
7 CD O
, , O
13 CD O
, , O
21 CD O
, , O
28 CD O
, , O
42 CD O
, , O
56 CD O
, , O
84 CD O
, , O
112 CD O
, , O
and CC O
140 CD O
in IN O
finishing VBG O
heifers NNS O
administered VBN O
the DT O
following JJ O
treatments NNS O
: : O
1 CD O
) -RRB- O
control NN O
; : O
2 CD O
) -RRB- O
MGA NNP O
, , O
.5 CD O
mg NN O
per IN O
heifer NN O
daily RB O
; : O
3 CD O
) -RRB- O
Revalor-H NNP O
( -LRB- O
140 CD O
mg JJ O
TBA NNP O
+ NNP O
14 CD O
mg JJ O
E2 NN O
) -RRB- O
; : O
4 CD O
) -RRB- O
Revalor-H NNP O
+ NNS O
MGA NNP O
; : O
5 CD O
) -RRB- O
Finaplix-H NNP O
( -LRB- O
200 CD O
mg JJ O
TBA NNP O
) -RRB- O
; : O
and CC O
6 CD O
) -RRB- O
Finaplix-H NNP O
+ NNS O
MGA. . O

-DOCSTART- X X O

Serum NNP O
E2 NNP O
concentrations NNS O
increased VBD O
numerically RB O
two CD O
- : O
to TO O
threefold VB O
from IN O
d JJ O
56 CD O
to TO O
140 CD O
in IN O
controls NNS O
fed VBN O
MGA NNP O
, , O
compared VBN O
with IN O
controls NNS O
not RB O
fed VBN O
MGA. . O

-DOCSTART- X X O

Interferon NNP B-NP
Regulatory NNP I-NP
Factor NNP I-NP
( -LRB- I-NP
IRF)-1 NN I-NP
has VBZ O
been VBN O
characterized VBN O
as IN O
an DT O
important JJ O
growth NN O
regulatory JJ O
and CC O
immunomodulatory JJ O
transcription NN O
factor NN O
. . O

-DOCSTART- X X O

The DT O
genomic JJ O
structure NN O
of IN O
brk NN B-NP
consists VBZ O
of IN O
8 CD O
exons NNS O
, , O
whose WP$ O
boundaries NNS O
are VBP O
distinct JJ O
from IN O
other JJ O
non-receptor JJ O
PTK NNP B-NP
family NN I-NP
members NNS O
, , O
again RB O
indicating VBG O
a DT O
structural JJ O
and CC O
functional JJ O
divergence NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
previously RB O
reported VBN O
that IN O
expression NN O
of IN O
a DT O
tumour NN O
derived VBN O
brk JJ B-NP
cDNA NN I-NP
in IN O
mouse NN O
embryonic NN O
fibroblasts NNS O
and CC O
human JJ O
mammary NN O
epithelial NN O
cells NNS O
supports VBZ O
anchorage NN O
independent JJ O
growth NN O
, , O
and CC O
in IN O
the DT O
latter NN O
potentiates VBZ O
the DT O
mitogenic JJ O
response NN O
to TO O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
. . O

-DOCSTART- X X O

Anti-hepatitis NNP B-NP
A DT I-NP
virus NN O
( -LRB- O
HAV NNP O
) -RRB- O
titer NN O
after IN O
vaccination NN O
was VBD O
measured VBN O
in IN O
83 CD O
HIV-positive JJ O
and CC O
39 CD O
HIV-negative JJ O
men NNS O
. . O

-DOCSTART- X X O

One CD O
skull NN O
does VBZ O
not RB O
a DT O
species NNS O
make VBP O
. . O

-DOCSTART- X X O

Surprisingly RB O
, , O
calf NN B-NP
thymus NN I-NP
CstF NN I-NP
contained VBD O
an DT O
additional JJ O
, , O
novel JJ O
form NN O
of IN O
the DT O
64-kDa JJ O
subunit NN O
with IN O
a DT O
molecular JJ O
mass NN O
of IN O
70 CD O
kDa NN O
. . O

-DOCSTART- X X O

Null NNP O
mutations NNS O
in IN O
daf-3 JJ B-NP
suppress NN O
mutations NNS O
in IN O
genes NNS O
encoding VBG O
this DT O
TGF-beta JJ B-NP
signal NN O
, , O
its PRP$ O
receptors NNS O
, , O
and CC O
associated JJ O
Smad JJ B-NP
signal NN I-NP
transduction IN I-NP
proteins NNS I-NP
. . O
daf-3 NN B-NP
encodes VBZ O
a DT O
Smad JJ B-NP
protein NN I-NP
that WDT O
is VBZ O
most RBS O
closely RB O
related VBN O
to TO O
mammalian JJ B-NP
DPC4 NNP I-NP
, , O
and CC O
is VBZ O
expressed VBN O
throughout IN O
development NN O
in IN O
many JJ O
of IN O
the DT O
tissues NNS O
that WDT O
are VBP O
remodeled VBN O
during IN O
dauer NN O
development NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
favor VBP O
the DT O
possibility NN O
that IN O
the DT O
Drosophila NNP B-NP
EGF NNP I-NP
receptor NN I-NP
DER/Egfr IN B-NP
expressed VBN O
by IN O
the DT O
EMA NNP O
cells NNS O
functions NNS O
as IN O
a DT O
receptor NN O
for IN O
Vein NNP B-NP
. . O

-DOCSTART- X X O

PATIENTS NNS O
AND CC O
METHODS NNS O
: : O
In IN O
807 CD O
consecutive JJ O
patients NNS O
from IN O
the DT O
Chilean NNP O
National NNP O
Registry NNP O
of IN O
Acute NNP O
Myocardial NNP O
Infarction IN O
we PRP O
analyzed VBD O
the DT O
resolution NN O
of IN O
chest NN O
pain NN O
and CC O
ST NNP O
segment NN O
elevation NN O
over IN O
50 CD O
% NN O
within IN O
the DT O
first JJ O
90 CD O
min NN O
, , O
abrupt JJ O
CK NN B-NP
rise NN O
within IN O
8 CD O
h NN O
and CC O
T NNP O
wave NN O
inversion NN O
in IN O
infarct NN O
related VBN O
EKG NNP O
leads VBZ O
within IN O
the DT O
first JJ O
24 CD O
h NN O
after IN O
thrombolysis NN O
. . O

-DOCSTART- X X O

Because IN O
of IN O
the DT O
operon NN O
structure NN O
of IN O
this DT O
organism NN O
, , O
traditional JJ O
methods NNS O
such JJ O
as IN O
insertional JJ O
mutagenesis NN O
run VBP O
the DT O
risk NN O
of IN O
introducing VBG O
polar JJ O
effects NNS O
on IN O
downstream NN O
genes NNS O
or CC O
creating VBG O
secondary JJ O
mutations NNS O
elsewhere RB O
in IN O
the DT O
genome NN O
. . O

-DOCSTART- X X O

Nucleotide NNP O
sequence NN O
analysis NN O
of IN O
R NN O
has VBZ O
revealed VBN O
similarities NNS O
to TO O
the DT O
R1 NNP O
plasmid NN O
found VBD O
in IN O
some DT O
South NNP O
American NNP O
maize NN O
races NNS O
with IN O
RU NNP O
cytoplasm NN O
, , O
to TO O
the DT O
M1 NNP O
plasmid NN O
found VBD O
in IN O
one CD O
source NN O
of IN O
Zea NNP O
luxurians NNS O
teosinte NN O
, , O
to TO O
the DT O
atp9 JJS B-NP
mitochondrial JJ I-NP
gene NN I-NP
and CC O
its PRP$ O
3' JJ O
flanking NN O
sequence NN O
, , O
and CC O
also RB O
to TO O
a DT O
region NN O
3' IN O
to TO O
the DT O
orf221 CD B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Cloning NNP O
of IN O
a DT O
human JJ B-NP
phosphoinositide NN I-NP
3-kinase NN I-NP
with IN O
a DT O
C2 NNP B-NP
domain NN O
that WDT O
displays VBZ O
reduced VBN O
sensitivity NN O
to TO O
the DT O
inhibitor NN O
wortmannin NN O
. . O

-DOCSTART- X X O

Functional JJ O
analysis NN O
of IN O
promoter NN O
activity NN O
of IN O
the DT O
5'-flanking JJ O
region NN O
of IN O
cyclin NN B-NP
D2 NNP I-NP
suggested VBD O
that IN O
the DT O
region NN O
- : O
1,100 CD O
to TO O
- : O
805 CD O
including VBG O
C/EBP NNP B-NP
, , O
PEA3 NNP B-NP
, , O
AP2 NNP B-NP
, , O
NF-Y NNP B-NP
, , O
c-Myc JJ B-NP
, , O
and CC O
Sp1 NNP B-NP
may MD O
have VB O
a DT O
major JJ O
positive JJ O
regulatory JJ O
activity NN O
for IN O
expression NN O
of IN O
cyclin NN B-NP
D2 NN I-NP
. . O

-DOCSTART- X X O

Effect NN O
of IN O
alcohol NN O
on IN O
minimal JJ O
effective JJ O
nCPAP JJ O
pressure NN O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
resensitization NN O
of IN O
a DT O
sequestration-impaired JJ O
beta2AR NN B-NP
mutant JJ O
( -LRB- O
Y326A NN O
) -RRB- O
was VBD O
reestablished VBN O
following VBG O
the DT O
overexpression NN O
of IN O
either DT O
GRK2 NNP B-NP
or CC O
beta-arrestin CD B-NP
1 CD I-NP
. . O

-DOCSTART- X X O

We PRP O
have VBP O
overexpressed VBN O
, , O
purified VBN O
, , O
characterized VBN O
, , O
and CC O
crystallized VBD O
the DT O
BTB/POZ NNP B-NP
domain NN O
from IN O
PLZF NNP B-NP
( -LRB- O
PLZF-BTB/POZ NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
also RB O
identified VBD O
Sp1 NNP B-NP
, , O
Sp3 NNP B-NP
, , O
and CC O
NGFI-A/Egr-1 JJ B-NP
as IN O
the DT O
primary JJ O
nuclear JJ O
transcription NN O
factors NNS O
binding JJ O
to TO O
TRE1 NNP B-NP
which WDT O
mediate JJ O
Tax NNP B-NP
responsiveness NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
segment NN O
nesting NN O
differentially RB O
increases VBZ O
the DT O
copy NN O
number NN O
of IN O
genes NNS O
encoded VBN O
by IN O
segment NN O
W, IN O
suggesting VBG O
that IN O
the DT O
unusual JJ O
genomic JJ O
organization NN O
of IN O
PDVs NNS O
may MD O
be VB O
directly RB O
linked VBN O
to TO O
the DT O
unique JJ O
functions NNS O
of IN O
this DT O
virus NN O
in IN O
its PRP$ O
obligate NN O
mutualistic JJ O
association NN O
with IN O
parasitic JJ O
wasps NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
deletion NN O
and CC O
mutation NN O
analyses NNS O
of IN O
the DT O
VCAM-1 NN B-NP
promoter NN I-NP
performed VBN O
with IN O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
constructs NNS I-NP
revealed VBD O
that IN O
Tax NNP B-NP
was VBD O
trans NNS O
activating VBG O
the DT O
VCAM-1 NN B-NP
promoter NN I-NP
via IN O
two CD O
NF-kappaB NNP B-NP
sites NNS I-NP
present JJ O
at IN O
bp JJ O
-72 NN O
and CC O
-57 NN O
in IN O
the DT O
VCAM-1 JJ B-NP
gene NN I-NP
promoter NN I-NP
, , O
with IN O
both DT O
of IN O
them PRP O
being VBG O
required VBN O
for IN O
the DT O
Tax-induced JJ B-NP
expression NN O
of IN O
this DT O
adhesion NN O
molecule NN O
. . O

-DOCSTART- X X O

Processivity NNP O
of IN O
DNA NNP O
synthesis NN O
by IN O
the DT O
mutant NN O
holoenzyme NN O
containing VBG O
pcna-79 NN B-NP
was VBD O
unaffected JJ O
on IN O
poly(dA NN O
) -RRB- O
x NN O
oligo(dT JJ O
) -RRB- O
but CC O
was VBD O
dramatically RB O
reduced VBN O
on IN O
a DT O
natural JJ O
template NN O
with IN O
secondary JJ O
structure NN O
. . O

-DOCSTART- X X O

The DT O
Scm NNP B-NP
and CC O
ph JJ B-NP
proteins NNS O
share VBP O
a DT O
homology NN O
domain NN O
with IN O
38 CD O
% NN O
identity NN O
over IN O
a DT O
length NN O
of IN O
65 CD O
amino IN O
acids NNS O
, , O
termed VBD O
the DT O
SPM NNP O
domain NN O
, , O
that WDT O
is VBZ O
located VBN O
at IN O
their PRP$ O
respective JJ O
C NNP O
termini NNS O
. . O

-DOCSTART- X X O

It PRP O
has VBZ O
been VBN O
previously RB O
shown VBN O
that IN O
genes NNS O
transcribed VBN O
by IN O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
( -LRB- O
RNAP NNP B-NP
II NNP I-NP
) -RRB- O
are VBP O
subject JJ O
to TO O
position VB O
effect NN O
variegation NN O
when WRB O
located VBN O
near IN O
yeast NN O
telomeres NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
predicted VBN O
transmembrane NN O
domain NN O
, , O
Casr-rs2 NNP B-NP
and CC O
Casr-rs3 NNP B-NP
are VBP O
95 CD O
% NN O
identical JJ O
to TO O
Casr-rs1 NNP B-NP
. . O

-DOCSTART- X X O

Recently RB O
, , O
roles NNS O
also RB O
have VBP O
been VBN O
suggested VBN O
for IN O
the DT O
nuclear JJ O
trans-factor NN O
GATA-1 NN B-NP
in IN O
regulating VBG O
progenitor NN O
cell NN O
proliferation NN O
. . O

-DOCSTART- X X O

PET NN O
activation NN O
studies NNS O
are VBP O
performed VBN O
widely RB O
to TO O
study VB O
human JJ O
brain NN O
function NN O
. . O

-DOCSTART- X X O

F-box JJ B-NP
proteins NNS I-NP
are VBP O
receptors NNS O
that IN O
recruit NN O
phosphorylated VBD O
substrates NNS O
to TO O
the DT O
SCF NNP B-NP
ubiquitin-ligase NN B-NP
complex NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
context NN O
of IN O
liver NN O
allograft NN O
shortage NN O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
an DT O
ELT NNP O
should MD O
not RB O
be VB O
performed VBN O
in IN O
patients NNS O
with IN O
cardiac JJ O
failure NN O
, , O
more JJR O
than IN O
two CD O
OSF NNP O
, , O
or CC O
an DT O
APACHE NN O
II NNP O
score NN O
higher JJR O
than IN O
30 CD O
. . O

-DOCSTART- X X O

The DT O
SH3 JJ B-NP
domains NNS I-NP
of IN O
Grb2 NNP B-NP
bound VBD O
in IN O
vitro NN O
to TO O
specific JJ O
proline-rich JJ O
motifs NNS O
in IN O
the DT O
HPK1 NNP B-NP
tail NN O
and CC O
functioned VBD O
synergistically RB O
to TO O
direct VB O
the DT O
stable JJ O
binding NN O
of IN O
Grb2 NNP B-NP
to TO O
HPK1 VB B-NP
in IN O
transfected JJ O
Cos1 NNP O
cells NNS O
. . O

-DOCSTART- X X O

By IN O
far-Western JJ O
analysis NN O
and CC O
coimmunoprecipitation NN O
studies NNS O
, , O
we PRP O
demonstrate VBP O
that IN O
ZNF74 NNP B-NP
interacts NNS O
, , O
via IN O
its PRP$ O
zinc NNP O
finger NN O
domain NN O
, , O
with IN O
the DT O
hyperphosphorylated JJ O
largest JJS O
subunit NN O
of IN O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
( -LRB- O
pol NN B-NP
IIo NNP I-NP
) -RRB- O
but CC O
not RB O
with IN O
the DT O
hypophosphorylated VBN O
form NN O
. . O

-DOCSTART- X X O

The DT O
cellular JJ O
rate NN O
of IN O
anticoagulant JJ B-NP
heparan NN I-NP
sulfate NN I-NP
proteoglycan NN I-NP
( -LRB- O
HSPGact NN B-NP
) -RRB- O
generation NN O
is VBZ O
determined VBN O
by IN O
the DT O
level NN O
of IN O
a DT O
kinetically RB O
limiting VBG O
microsomal JJ O
activity NN O
, , O
HSact NNP O
conversion NN O
activity NN O
, , O
which WDT O
is VBZ O
predominantly RB O
composed VBN O
of IN O
the DT O
long JJ O
sought VBN O
heparan NN B-NP
sulfate NN I-NP
D-glucosaminyl NNP I-NP
3-O-sulfotransferase JJ I-NP
(3-OST NN O
) -RRB- O
( -LRB- O
Shworak NNP O
, , O
N. NNP O

-DOCSTART- X X O

An DT O
end NN O
to TO O
the DT O
lottery NN O
. . O

-DOCSTART- X X O

We PRP O
previously RB O
showed VBD O
that IN O
the DT O
N-terminal JJ O
portion NN O
common JJ O
to TO O
various JJ O
chimeric JJ B-NP
MLL NNP I-NP
products NNS I-NP
, , O
as RB O
well RB O
as IN O
to TO O
MLL-LTG9 NNP B-NP
and CC O
MLL-LTG19 NNP B-NP
, , O
localizes VBZ O
in IN O
the DT O
nuclei JJ O
, , O
and CC O
therefore RB O
suggested VBD O
that IN O
it PRP O
might MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
leukemogenesis NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
pattern NN O
of IN O
blood NN O
supply NN O
is VBZ O
relevant JJ O
to TO O
the DT O
structural JJ O
organisation NN O
of IN O
mature JJ O
lamellar JJ O
bone NN O
around IN O
the DT O
implant NN O
. . O

-DOCSTART- X X O

Induction NN O
of IN O
AtP5CS1 DT B-NP
mRNA JJ I-NP
accumulation NN O
in IN O
salt-treated JJ O
seedlings NNS O
involves VBZ O
an DT O
immediate JJ O
early JJ O
transcriptional JJ O
response NN O
regulated VBN O
by IN O
ABA NNP O
signalling NN O
that WDT O
is VBZ O
not RB O
inhibited VBN O
by IN O
cycloheximide NN O
, , O
but CC O
abolished VBD O
by IN O
the DT O
deficiency NN O
of IN O
ABA NNP O
biosynthesis NN O
in IN O
the DT O
aba1 JJ B-NP
Arabidopsis NNP I-NP
mutant NN I-NP
. . O

-DOCSTART- X X O

( -LRB- O
ii NNS O
) -RRB- O
An DT O
AF NNS O
G-CSF NNP B-NP
level NN O
> IN O
2000 CD O
pg/ JJ O
ml NN O
is VBZ O
a DT O
strong JJ O
positive JJ O
predictor NN O
of IN O
CAM. NNP O

-DOCSTART- X X O

A DT O
positive JJ O
correlation NN O
between IN O
serum NN B-NP
myoglobin NN I-NP
and CC O
CA NNP B-NP
III NNP I-NP
concentrations NNS O
( -LRB- O
rs NNS O
= SYM O
0.933 CD O
, , O
P NNP O
< JJ O
0.001 CD O
) -RRB- O
was VBD O
observed VBN O
in IN O
hemodialyzed JJ O
patients NNS O
with IN O
chronic JJ O
renal JJ O
failure NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
over-replication NN O
phenotype NN O
produced VBN O
by IN O
this DT O
mutant JJ B-NP
p65cdc18 NN I-NP
is VBZ O
resistant JJ O
to TO O
increased VBN O
mitotic JJ O
cyclin/CDK NN B-NP
activity NN O
, , O
a DT O
known VBN O
inhibitor NN O
of IN O
over-replication NN O
. . O

-DOCSTART- X X O

Rip1p NNP B-NP
is VBZ O
inessential JJ O
, , O
associated VBN O
with IN O
nuclear JJ O
pore NN O
complexes NNS O
, , O
and CC O
structurally RB O
related VBN O
to TO O
the DT O
FG-nucleoporin NNP B-NP
family NN I-NP
of IN O
pore JJ O
proteins NNS O
. . O

-DOCSTART- X X O

The DT O
CNXA NNP O
domain NN O
is VBZ O
similar JJ O
at IN O
the DT O
amino JJ O
acid NN O
level NN O
to TO O
the DT O
Escherichia NNP B-NP
coli NNS I-NP
moaA VBG I-NP
gene NN I-NP
product NN I-NP
, , O
while IN O
CNXC NNP O
is VBZ O
similar JJ O
to TO O
the DT O
E. NNP B-NP
coli NNS I-NP
moaC JJ I-NP
product NN I-NP
, , O
with IN O
both DT O
E. NNP O
coli NNS O
products NNS O
encoded VBN O
by IN O
different JJ O
cistrons NNS O
. . O

-DOCSTART- X X O

Deletions NNS O
in IN O
each DT O
of IN O
these DT O
regions NNS O
abolish VB O
membrane NN O
localization NN O
of IN O
Tiam1 NNP B-NP
and CC O
membrane NN O
ruffling NN O
, , O
suggesting VBG O
that IN O
they PRP O
function VBP O
cooperatively RB O
. . O

-DOCSTART- X X O

Histological JJ O
slides NNS O
of IN O
one CD O
biopsy NN O
of IN O
each DT O
patient NN O
( -LRB- O
formalin-fixed JJ O
and CC O
paraffin-embedded JJ O
) -RRB- O
were VBD O
stained VBN O
with IN O
a DT O
Modified JJ O
Giemsa NNP O
( -LRB- O
MG) NNP O
, , O
the DT O
Warthin-Starry NNP O
( -LRB- O
WS) NNP O
, , O
and CC O
an DT O
immunohistochemical JJ O
method NN O
( -LRB- O
IMM) NNP O
using VBG O
purified VBN O
polyclonal JJ O
H. NNP O
pylori NN O
antiserum NN O
( -LRB- O
DAKO NNP O
B471 NNP O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
indicate VBP O
that IN O
the DT O
t( NN O
4 CD O
; : O
14)( CD O
p16.3 NNS O
; : O
q32 CD O
) -RRB- O
represents VBZ O
a DT O
novel NN O
, , O
recurrent VBD O
chromosomal NN O
translocation NN O
in IN O
MM NNP O
, , O
and CC O
suggest VBP O
that IN O
the DT O
FGFR3 NNP B-NP
gene NN I-NP
may MD O
be VB O
the DT O
target NN O
of IN O
this DT O
abnormality NN O
and CC O
thus RB O
contribute VB O
to TO O
tumorigenesis NN O
in IN O
MM. NNP O

-DOCSTART- X X O

The DT O
full JJ O
length NN O
cDNA RB O
sequence NN O
of IN O
a DT O
Type NN B-NP
I PRP I-NP
transforming VBG I-NP
growth NN I-NP
factor-beta NN I-NP
( -LRB- I-NP
TGF-beta NN I-NP
) -RRB- I-NP
receptor NN I-NP
has VBZ O
been VBN O
isolated VBN O
from IN O
the DT O
filarial NN O
parasitic NN O
nematode NN O
Brugia NNP O
pahangi NN O
. . O

-DOCSTART- X X O

This DT O
sequence NN O
possessed VBD O
homology NN O
with IN O
a DT O
methylation-sensitive JJ O
promoter NN O
element NN O
, , O
Enh2 NNP O
, , O
present NN O
in IN O
the DT O
LTR NNP O
of IN O
mouse NN O
intractisternal JJ O
A-particles NNS O
. . O

-DOCSTART- X X O

Codon NNP O
optimization NN O
for IN O
high-level JJ O
expression NN O
of IN O
human JJ B-NP
erythropoietin NN I-NP
( -LRB- O
EPO NNP B-NP
) -RRB- O
in IN O
mammalian JJ O
cells NNS O
. . O

-DOCSTART- X X O

Parodoxical JJ O
rise NN O
in IN O
urinary JJ B-NP
albumin NN I-NP
levels NNS O
after IN O
treatment NN O
of IN O
essential JJ O
hypertension NN O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
Rat7p/Nup159p NNP B-NP
is VBZ O
anchored VBN O
within IN O
the DT O
NPC NNP O
through IN O
its PRP$ O
coiled-coil JJ O
region NN O
and CC O
adjacent JJ O
sequences NNS O
. . O

-DOCSTART- X X O

In IN O
a DT O
group NN O
of IN O
13 CD O
patients NNS O
with IN O
obliterative JJ O
arteriopathies NNS O
of IN O
the DT O
lower JJR O
limbs NNS O
the DT O
plasma NN O
levels NNS O
of IN O
thrombomodulin NN B-NP
( -LRB- O
TM) NNP B-NP
, , O
betathromboglobulin IN B-NP
( -LRB- O
beta-TG) NN B-NP
, , O
D-dimer NNP O
( -LRB- O
DD NNP O
) -RRB- O
and CC O
plasminogen NN B-NP
activator-inhibitor NN I-NP
(pAI-1 NN O
) -RRB- O
were VBD O
measured VBN O
, , O
and CC O
compared VBN O
to TO O
the DT O
values NNS O
obtained VBN O
from IN O
10 CD O
healthy JJ O
volunteers NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
now RB O
shown VBN O
that IN O
in IN O
vivo JJ O
phosphorylation NN O
of IN O
14-3-3 JJ B-NP
zeta NN I-NP
at IN O
the DT O
CKIalpha NN B-NP
site NN I-NP
( -LRB- I-NP
Thr-233 DT I-NP
) -RRB- I-NP
negatively RB O
regulates VBZ O
its PRP$ O
binding NN O
to TO O
c-Raf JJ B-NP
, , O
and CC O
may MD O
be VB O
important JJ O
in IN O
Raf-mediated NNP B-NP
signal NN O
transduction NN O
. . O

-DOCSTART- X X O

Mouse NN B-NP
mast NN I-NP
cell NN I-NP
protease NN I-NP
9 CD I-NP
, , O
a DT O
novel NN O
member NN O
of IN O
the DT O
chromosome NN O
14 CD O
family NN O
of IN O
serine NN B-NP
proteases NNS I-NP
that WDT O
is VBZ O
selectively RB O
expressed VBN O
in IN O
uterine JJ O
mast NN O
cells NNS O
. . O

-DOCSTART- X X O

A DT O
DNase NNP B-NP
I-hypersensitive NNP I-NP
site NN I-NP
has VBZ O
also RB O
been VBN O
mapped VBN O
in IN O
the DT O
258-base JJ O
pair NN O
enhancer NN O
region NN O
. . O

-DOCSTART- X X O

[Pulmonary JJ O
vascular JJ O
resistance NN O
( -LRB- O
PVR NN O
) -RRB- O
during IN O
10 CD O
% NN O
O2-PVR NN O
during IN O
21 CD O
% NN O
O2/PVR NN O
during IN O
21 CD O
% NN O
O2] IN O
x NN O
100 CD O
was VBD O
termed VBN O
as IN O
hypoxic JJ O
pulmonary NN O
vasoconstriction NN O
( -LRB- O
HPV NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Protein NNP O
phosphatases NNS O
play VBP O
a DT O
critical JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
the DT O
eukaryotic JJ O
cell NN O
cycle NN O
and CC O
signal NN O
transduction NN O
. . O

-DOCSTART- X X O

The DT O
cell NN O
cycle-regulated JJ O
transcription NN O
factor NN O
E2F NN B-NP
is VBZ O
also RB O
known VBN O
to TO O
bend VB O
DNA NNP O
upon IN O
binding JJ O
. . O

-DOCSTART- X X O

Transcriptional NNP O
regulation NN O
of IN O
SUP35 NNP B-NP
and CC O
SUP45 NNP B-NP
in IN I-NP
Saccharomyces NNP I-NP
cerevisiae NN I-NP
. . O

-DOCSTART- X X O

Xenopus NNP B-NP
Ran-binding NNP I-NP
protein NN I-NP
1 CD I-NP
: : O
molecular JJ O
interactions NNS O
and CC O
effects NNS O
on IN O
nuclear JJ O
assembly NN O
in IN O
Xenopus NNP O
egg NN O
extracts NNS O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
Total JJ O
muscle NN O
paralysis NN O
was VBD O
induced VBN O
under IN O
general JJ O
anesthesia NN O
in IN O
a DT O
group NN O
of IN O
obese JJ O
persons NNS O
( -LRB- O
n NN O
= SYM O
9 CD O
; : O
body NN O
mass NN O
index NN O
, , O
32 CD O
+/ CD O
- : O
3 CD O
kg[-2] NN O
) -RRB- O
and CC O
in IN O
a DT O
group NN O
of IN O
nonobese JJ O
persons NNS O
( -LRB- O
n NN O
= SYM O
9 CD O
; : O
body NN O
mas NNS O
index NN O
, , O
21 CD O
+/ NNP O
- : O
2 CD O
kg[-2] NN O
) -RRB- O
. . O

-DOCSTART- X X O

Our PRP$ O
findings NNS O
provide VBP O
the DT O
first JJ O
evidence NN O
that IN O
the DT O
function NN O
of IN O
WT1 NNP B-NP
can MD O
be VB O
modulated VBN O
by IN O
its PRP$ O
phosphorylation NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
an DT O
additional JJ O
sequence NN O
of IN O
nucleotides NNS O
145-165 CD O
from IN O
the DT O
3' JJ O
end NN O
of IN O
RNA3 DT B-NP
enhanced JJ O
template JJ O
recognition NN O
by IN O
RdRp NNP B-NP
in IN O
vitro NN O
and CC O
accumulation NN O
of IN O
RNA3 CD B-NP
in IN O
vivo JJ O
to TO O
wild-type JJ O
levels NNS O
. . O

-DOCSTART- X X O

Restriction NNP O
enzyme NN O
mapping NN O
, , O
subcloning NN O
, , O
and CC O
DNA NNP O
sequencing NN O
analysis NN O
of IN O
recombinant JJ O
phage NN O
lambda NN O
and CC O
P1 JJ O
clones NNS O
revealed VBD O
that IN O
exons NNS O
encoding VBG O
the DT O
1.9-kb JJ O
mouse NN B-NP
TS NNS I-NP
mRNA . I-NP
are VBP O
dispersed VBN O
over IN O
>150 CD O
kb JJ O
genomic JJ O
DNA NN O
. . O

-DOCSTART- X X O

Transfection NNP O
analyses NNS O
indicated VBD O
that IN O
the DT O
expression NN O
of IN O
Tbxas1 NNP B-NP
is VBZ O
controlled VBN O
by IN O
a DT O
short JJ O
( -LRB- O
70-bp JJ O
) -RRB- O
positive JJ O
regulatory JJ O
sequence NN O
and CC O
several JJ O
upstream RB O
repressive JJ O
elements NNS O
. . O

-DOCSTART- X X O

The DT O
results NNS O
of IN O
this DT O
study NN O
suggest VBP O
that IN O
NF-kappaB NNP B-NP
activity NN O
may MD O
be VB O
regulated VBN O
by IN O
its PRP$ O
interaction NN O
with IN O
the DT O
cell NN O
cycle NN O
regulatory JJ O
protein NN O
, , O
E2F-1 NN B-NP
. . O

-DOCSTART- X X O

However RB O
, , O
one CD O
CAK-phosphorylated JJ B-NP
phosphopeptide NN O
comigrates VBZ O
with IN O
a DT O
Cdc2-phosphorylated JJ B-NP
phosphopeptide NN O
previously RB O
shown VBN O
to TO O
be VB O
mitosis-specific JJ O
, , O
suggesting VBG O
that IN O
, , O
in IN O
vitro NN O
, , O
CAK NNP B-NP
is VBZ O
able JJ O
to TO O
phosphorylate VB O
at IN O
least JJS O
one CD O
site NN O
that WDT O
is VBZ O
also RB O
phosphorylated VBN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

The DT O
mHIF-1 JJ B-NP
alpha NN I-NP
structural JJ I-NP
gene NN I-NP
is VBZ O
composed VBN O
of IN O
15 CD O
exons NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
when WRB O
a DT O
second JJ O
, , O
upstream RB B-NP
IRE-like JJ I-NP
sequence NN I-NP
was VBD O
evaluated VBN O
by IN O
EMSA NNP O
, , O
a DT O
DNA NNP O
binding NN O
pattern NN O
distinct JJ O
from IN O
that DT O
seen VBN O
following JJ O
exposure NN O
to TO O
IFN-gamma NNP B-NP
alone RB O
was VBD O
observed VBN O
after IN O
prolonged JJ O
stimulation NN O
with IN O
both DT O
IFN-alpha NNP B-NP
and CC O
IFN-gamma NNP B-NP
. . O

-DOCSTART- X X O

In IN O
Arabidopsis NNP O
, , O
the DT O
induction NN O
of IN O
a DT O
dehydration-responsive JJ O
gene NN O
, , O
rd22 CD B-NP
, , O
is VBZ O
mediated VBN O
by IN O
abscisic JJ O
acid NN O
( -LRB- O
ABA NNP O
) -RRB- O
and CC O
requires VBZ O
protein NN O
biosynthesis NN O
for IN O
ABA-dependent JJ O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

A DT O
cDNA NN O
encoding VBG O
a DT O
MYC-related JJ B-NP
DNA NN I-NP
binding JJ I-NP
protein NN I-NP
was VBD O
isolated VBN O
by IN O
DNA-ligand NNP O
binding JJ O
screening NN O
, , O
using VBG O
the DT O
67-bp JJ O
region NN O
as IN O
a DT O
probe NN O
, , O
and CC O
designated VBD O
rd22BP1 NNS B-NP
. . O

-DOCSTART- X X O

Human NNP B-NP
PDK1 NNP I-NP
is VBZ O
homologous JJ O
to TO O
the DT O
Drosophila NNP B-NP
protein NN I-NP
kinase NN I-NP
DSTPK61 NN I-NP
, , O
which WDT O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
regulation NN O
of IN O
sex NN O
differentiation NN O
, , O
oogenesis NN O
and CC O
spermatogenesis NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
synergistic JJ O
effects NNS O
of IN O
HNF-1beta JJ B-NP
and CC O
the DT O
GR CD B-NP
on IN O
dexamethasone-stimulated JJ O
promoter NN O
activity NN O
require VBP O
that IN O
they PRP O
are VBP O
bound VBN O
to TO O
the DT O
HNF-1 JJ B-NP
site NN I-NP
and CC O
the DT O
GRE NNP O
, , O
respectively RB O
, , O
and CC O
may MD O
involve VB O
protein-protein NN O
interactions NNS O
between IN O
the DT O
transcription NN O
factors NNS O
, , O
or CC O
between IN O
them PRP O
and CC O
the DT O
basal NN O
transcription NN O
machinery NN O
or CC O
a DT O
steroid NN B-NP
receptor NN I-NP
coactivator NN I-NP
. . O

-DOCSTART- X X O

An DT O
open JJ O
reading NN O
frame NN O
of IN O
2862 CD O
bp NN O
encoding VBG O
a DT O
954 CD O
amino IN O
acid JJ O
protein NN O
was VBD O
identified VBN O
. . O

-DOCSTART- X X O

One CD O
of IN O
these DT O
, , O
an DT O
AACA NNP O
motif NN O
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
a DT O
negative JJ O
regulator NN O
in IN O
non-seed JJ O
tissues NNS O
and CC O
has VBZ O
a DT O
similarity NN O
to TO O
the DT O
barley NN O
gibberellin VBG O
responsive JJ O
element NN O
recognized VBN O
by IN O
MYB-like JJ B-NP
DNA NNP I-NP
binding JJ I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Strain NNP O
CFN037 NNP O
is VBZ O
an DT O
R. NNP O
etli FW O
mutant JJ O
induced VBN O
by IN O
a DT O
single JJ O
Tn5mob NN B-NP
insertion NN O
in IN O
the DT O
promoter NN O
region NN O
of IN O
the DT O
thiCOGE NN B-NP
gene NN I-NP
cluster NN I-NP
. . O

-DOCSTART- X X O

We PRP O
have VBP O
cloned VBN O
and CC O
sequenced VBN O
a DT O
region NN O
encoding VBG O
a DT O
lipase NN B-NP
operon NN I-NP
and CC O
a DT O
putative JJ O
, , O
previously RB O
uncharacterized JJ O
metalloprotease NN B-NP
of IN I-NP
Vibrio NNP I-NP
cholerae NNS I-NP
O1 NNP I-NP
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
amount NN O
of IN O
tRNA(3Lys NNS B-NP
) -RRB- I-NP
that WDT O
was VBD O
placed VBN O
onto IN O
viral JJ O
RNA NNP O
in IN O
mutated JJ O
viruses NNS O
was VBD O
significantly RB O
less JJR O
than IN O
that DT O
placed VBN O
in IN O
the DT O
wild-type JJ O
virus NN O
. . O

-DOCSTART- X X O

This DT O
protein NN O
is VBZ O
present JJ O
in IN O
both DT O
HeLa NNP O
nuclear JJ O
extracts NNS O
and CC O
S100 CD B-NP
extracts NNS O
but CC O
absent JJ O
from IN O
SR NNP B-NP
protein NN I-NP
preparations NNS O
, , O
suggesting VBG O
that IN O
it PRP O
is VBZ O
not RB O
a DT O
classical JJ O
SR NNP B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Differential JJ O
regulation NN O
of IN O
the DT O
pre-C JJ B-NP
and CC O
pregenomic JJ O
promoters NNS O
of IN O
human JJ O
hepatitis NN O
B NNP O
virus NN O
by IN O
members NNS O
of IN O
the DT O
nuclear JJ B-NP
receptor NN I-NP
superfamily NN I-NP
. . O

-DOCSTART- X X O

Acad NNP O
. . O

-DOCSTART- X X O

We PRP O
previously RB O
described VBD O
two CD O
alanine JJR O
cluster NN O
mutations NNS O
, , O
R77 CD O
to TO O
A DT O
( -LRB- O
R77A)-K79A NN O
and CC O
E192A-E194A NNP O
, , O
which WDT O
selectively RB O
inactivated VBD O
the DT O
triphosphatase NN O
component NN O
. . O

-DOCSTART- X X O

Both DT O
inserts NNS O
are VBP O
larger JJR O
than IN O
their PRP$ O
homologues NNS O
in IN O
eIF-2alpha DT B-NP
kinases NNS I-NP
. . O

-DOCSTART- X X O

Three CD O
monopolar JJ O
electrodes NNS O
were VBD O
inserted VBN O
into IN O
the DT O
left JJ O
and CC O
right JJ O
lateral JJ O
vestibulospinal JJ O
tract NN O
( -LRB- O
LVST NN O
) -RRB- O
and CC O
medial JJ O
vestibulospinal JJ O
tract NN O
( -LRB- O
MVST NNP O
) -RRB- O
of IN O
the DT O
C1 NNP O
segment NN O
, , O
to TO O
determine VB O
the DT O
pathway NN O
of IN O
axons NNS O
. . O

-DOCSTART- X X O

Polyhomeotic NNP B-NP
and CC I-NP
Posterior NNP I-NP
Sex NN I-NP
Combs NNS I-NP
may MD O
participate VB O
in IN O
a DT O
more RBR O
general JJ O
transcriptional JJ O
mechanism NN O
that WDT O
causes VBZ O
modulated JJ O
gene NN O
repression NN O
, , O
whereas IN O
the DT O
inclusion NN O
of IN O
Polycomb JJ B-NP
protein NN I-NP
in IN O
the DT O
complex NN O
at IN O
PREs JJ B-NP
leads NNS O
to TO O
stable JJ O
silencing NN O
. . O

-DOCSTART- X X O

The DT O
yeast NN O
silent JJ B-NP
information NN I-NP
regulator NN I-NP
Sir4p NNP I-NP
anchors NNS O
and CC O
partitions NNS O
plasmids NNS O
. . O

-DOCSTART- X X O

Polysome NNP O
analyses NNS O
in IN O
a DT O
temperature-sensitive JJ O
fal1-1 NN B-NP
mutant NN I-NP
and CC O
a DT O
Fal1p-depleted JJ B-NP
strain NN O
reveal VB O
a DT O
decrease NN O
in IN O
the DT O
number NN O
of IN O
40S NNS B-NP
ribosomal JJ I-NP
subunits NNS I-NP
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
identified VBN O
some DT O
of IN O
these DT O
cDNA NNS O
clones NNS O
as IN O
Dlc-1 NNP B-NP
, , O
a DT O
sequence NN O
encoding VBG O
a DT O
small JJ O
, , O
9-kDa JJ B-NP
human JJ I-NP
homolog NN I-NP
of IN I-NP
the DT I-NP
outer-arm JJ I-NP
dynein NN I-NP
light-chain JJ I-NP
protein NN O
. . O

-DOCSTART- X X O

Importantly RB O
, , O
in IN O
HeLa NNP O
and CC O
293 CD O
cells NNS O
, , O
endogenous JJ O
and CC O
transfected VBD O
I PRP B-NP
kappaB VB I-NP
alpha NN I-NP
coimmunoprecipitated VBN O
with IN O
Myc-tagged JJ B-NP
or CC O
endogenous JJ O
Dlc-1 NN B-NP
. . O

-DOCSTART- X X O

Identification NN O
of IN O
dynein NN B-NP
heavy NN I-NP
chain NN I-NP
genes NNS I-NP
expressed VBN O
in IN O
human NN O
and CC O
mouse NN O
testis NN O
: : O
chromosomal NN O
localization NN O
of IN O
an DT O
axonemal NN B-NP
dynein NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
proposed VBN O
mechanism NN O
of IN O
effect NN O
states NNS O
that WDT O
mono(2-ethylhexyl NN O
) -RRB- O
phthalate NN O
( -LRB- O
MEHP) NNP O
, , O
the DT O
primary JJ O
hydrolysis NN O
product NN O
of IN O
DEHP NNP O
, , O
mimics VBZ O
the DT O
inducing NN O
prostaglandins NNS O
( -LRB- O
PG) NN O
PGD( JJ O
2 CD O
) -RRB- O
, , O
9alpha,11betaPGF2 NNP O
, , O
and CC O
PGF2alpha NNP O
, , O
and CC O
thromboxanes NNS O
in IN O
the DT O
lungs NNS O
, , O
thereby RB O
increasing VBG O
the DT O
risk NN O
of IN O
inducing VBG O
inflammation NN O
in IN O
the DT O
airways NNS O
, , O
which WDT O
is VBZ O
a DT O
characteristic NN O
of IN O
asthma NN O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
14 CD O
protein NN O
binding NN O
sites NNS O
that WDT O
were VBD O
occupied VBN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Constitutive JJ O
protection NN O
of IN O
E2F NNP B-NP
recognition NN I-NP
sequences NNS I-NP
in IN O
the DT O
human JJ B-NP
thymidine NN I-NP
kinase NN I-NP
promoter NN I-NP
during IN O
cell NN O
cycle NN O
progression NN O
. . O

-DOCSTART- X X O

Comparison NNP O
of IN O
genomic JJ O
sequence NN O
shows VBZ O
that IN O
the DT O
ph NN B-NP
locus NN I-NP
has VBZ O
been VBN O
duplicated VBN O
, , O
and CC O
that IN O
it PRP O
contains VBZ O
proximal JJ O
and CC O
distal JJ O
transcription NN O
units NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
reviewed VBN O
the DT O
experience NN O
of IN O
a DT O
major JJ O
MMT NNP O
general JJ O
practice NN O
with IN O
hepatitis NN O
C NNP O
virus NN O
( -LRB- O
HCV NNP O
) -RRB- O
infection NN O
from IN O
1991 CD O
to TO O
1995 CD O
. . O

-DOCSTART- X X O

The DT O
author NN O
analyzes NNS O
extensive JJ O
own JJ O
data NNS O
based VBN O
on IN O
study NN O
into IN O
particular JJ O
features NNS O
of IN O
cardiovascular JJ O
disorders NNS O
in IN O
chronic NN O
renal JJ O
impairement NN O
with IN O
making VBG O
use NN O
of IN O
modern JJ O
diagnostic JJ O
tools NNS O
. . O

-DOCSTART- X X O

The DT O
ZnF20 NNP B-NP
cDNA NN I-NP
hybridized VBD O
to TO O
multiple JJ O
transcripts NNS O
in IN O
a DT O
thyroid NN O
cancer NN O
cell NN O
line NN O
( -LRB- O
8.0, CD O
4.5 CD O
and CC O
2 CD O
kb NN O
) -RRB- O
that WDT O
increased VBD O
after IN O
cycloheximide NN O
treatment NN O
and CC O
decayed VBD O
<2 CD O
h NN O
after IN O
addition NN O
of IN O
actinomycin NN O
D. NNP O

-DOCSTART- X X O

Glutathione NN B-NP
S-transferase NN I-NP
( -LRB- O
GST)-E2F JJ B-NP
and CC O
GST-DP JJ B-NP
fusion NN O
proteins NNS O
were VBD O
found VBN O
to TO O
cooperate VB O
in IN O
binding NN O
to TO O
the DT O
three CD O
E2F NNP B-NP
sites NNS I-NP
in IN O
the DT O
DNA NNP B-NP
polymerase NN I-NP
alpha NN I-NP
gene NN I-NP
promoter NN I-NP
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Two CD O
sterol JJ O
regulatory JJ O
element-like JJ O
sequences NNS O
mediate JJ O
up-regulation NN O
of IN O
caveolin NN B-NP
gene NN I-NP
transcription NN O
in IN O
response NN O
to TO O
low JJ B-NP
density NN I-NP
lipoprotein IN I-NP
free JJ O
cholesterol NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
We PRP O
obtained VBD O
normal JJ O
EPO NNP B-NP
levels NNS O
for IN O
mothers NNS O
and CC O
newborns NNS O
for IN O
our PRP$ O
area NN O
, , O
similarly RB O
to TO O
the DT O
previously RB O
described VBN O
ones NNS O
. . O

-DOCSTART- X X O

Ischaemia NNP O
was VBD O
induced VBN O
by IN O
a DT O
low JJ O
flow NN O
rate NN O
of IN O
0.8 CD O
mL JJ O
min-1 NN O
for IN O
30 CD O
min NN O
, , O
and CC O
was VBD O
followed VBN O
by IN O
a DT O
40-minute JJ O
reperfusion NN O
. . O

-DOCSTART- X X O

First RB O
, , O
two CD O
MCTs NNS O
using VBG O
a DT O
long JJ O
electrode NN O
, , O
3 CD O
cm NN O
in IN O
size NN O
, , O
were VBD O
performed VBN O
in IN O
the DT O
central JJ O
area NN O
of IN O
the DT O
tumor NN O
, , O
and CC O
eight CD O
MCTs NNP O
by IN O
a DT O
short JJ O
electrode NN O
, , O
2 CD O
cm NN O
in IN O
size NN O
, , O
were VBD O
done VBN O
in IN O
the DT O
peripheral JJ O
and CC O
surrounding VBG O
area NN O
of IN O
the DT O
tumor NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Checkpoint VB O
pathways NNS O
prevent VB O
cell-cycle NN O
progression NN O
in IN O
the DT O
event NN O
of IN O
DNA NNP O
lesions NNS O
. . O

-DOCSTART- X X O

Direct JJ O
proof NN O
that IN O
the DT O
heightened VBN O
renal JJ O
cellular JJ O
apoptosis NN O
in IN O
PKD NNP O
is VBZ O
not RB O
occurring VBG O
through IN O
p53 NN B-NP
was VBD O
obtained VBN O
by IN O
successive JJ O
matings NNS O
between IN O
SBM NNP O
and CC O
p53(-/-) JJ B-NP
mice NNS O
. . O

-DOCSTART- X X O

Accumulated NNP O
evidence NN O
indicates VBZ O
that IN O
, , O
upon IN O
stimulation NN O
with IN O
interferon-gamma NN B-NP
( -LRB- O
IFN-gamma NNP B-NP
) -RRB- O
, , O
three CD O
beta-type JJ O
subunits NNS O
, , O
designated VBN O
LMP2 NNP B-NP
, , O
LMP7 NNP B-NP
, , O
and CC O
PSMB10 NNP B-NP
, , O
are VBP O
incorporated VBN O
into IN O
the DT O
20S JJ B-NP
proteasome JJ I-NP
by IN O
displacing VBG O
the DT O
housekeeping NN O
beta-type NN O
subunits NNS O
designated VBN O
PSMB6 NNP B-NP
, , O
PSMB5 NNP B-NP
, , O
and CC O
PSMB7 NNP B-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

This DT O
difference NN O
may MD O
result VB O
from IN O
the DT O
lower JJR O
match NN O
to TO O
the DT O
ARG NN O
box NN O
consensus NN O
of IN O
the DT O
O(rocD NNP B-NP
) -RRB- I-NP
site NN I-NP
. . O

-DOCSTART- X X O

Ask VB O
AONE NNP O
's POS O
experts NNS O
... : O
about IN O
productivity NN O
indicators NNS O
. . O

-DOCSTART- X X O

The DT O
progress NN O
of IN O
morphological JJ O
research NN O
on IN O
the DT O
parabrachial JJ O
nucleus NN O

-DOCSTART- X X O

In IN O
an DT O
effort NN O
to TO O
separate VB O
domains NNS O
of IN O
FadR NNP B-NP
required VBD O
for IN O
DNA NNP O
binding NN O
, , O
dimerization NN O
, , O
and CC O
ligand NN O
binding NN O
, , O
chimeric JJ O
protein NN O
fusions NNS O
between IN O
the DT O
DNA NNP O
binding NN O
domain NN O
of IN O
LexA NNP B-NP
and CC O
different JJ O
regions NNS O
of IN O
FadR NNP B-NP
were VBD O
constructed VBN O
. . O

-DOCSTART- X X O

Inhibition NN O
appears VBZ O
to TO O
result VB O
from IN O
titration NN O
of IN O
general JJ O
transcription NN O
factors NNS O
because IN O
MDM2 NNP B-NP
overexpression IN O
inhibits VBZ O
c-fos JJ B-NP
as RB O
well RB O
as IN O
other JJ O
promoters NNS O
in IN O
vivo JJ O
and CC O
basal JJ O
transcription NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
show VBP O
by IN O
immunogold JJ O
electron NN O
microscopy NN O
immunocytochemistry NN O
that IN O
amphiphysin NN B-NP
I PRP I-NP
is VBZ O
localized VBN O
in IN O
the DT O
nerve NN O
terminal NN O
cytomatrix NN O
and CC O
is VBZ O
partially RB O
associated VBN O
with IN O
endocytic JJ O
intermediates NNS O
. . O

-DOCSTART- X X O

During IN O
the DT O
aftermath NN O
of IN O
excitation NN O
of IN O
the DT O
skin NN O
sympathetic JJ O
nerve NN O
by IN O
mental JJ O
arithmetics NNS O
, , O
3/12 CD O
A DT O
delta NN O
units NNS O
were VBD O
turned VBN O
to TO O
the DT O
active JJ O
state NN O
with IN O
decreased VBN O
mechanical JJ O
threshold NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
Hex NNP B-NP
expression NN O
marks VBZ O
the DT O
earliest JJS O
unequivocal JJ O
molecular JJ O
anteroposterior JJ O
asymmetry NN O
in IN O
the DT O
mouse NN O
embryo NN O
and CC O
indicates VBZ O
that IN O
the DT O
anteroposterior JJ O
axis NN O
of IN O
the DT O
embryo NN O
develops VBZ O
from IN O
conversion NN O
of IN O
a DT O
proximodistal JJ O
asymmetry NN O
established VBN O
in IN O
the DT O
primitive JJ O
endoderm NN O
lineage NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
While IN O
INR NNP O
correction NN O
may MD O
be VB O
achieved VBN O
by IN O
all DT O
the DT O
above JJ O
methods NNS O
, , O
that IN O
relating VBG O
log NN O
reference NN O
INR NN O
to TO O
log VB O
local JJ O
prothrombin NN B-NP
time NN O
by IN O
linear JJ O
regression NN O
analysis NN O
is VBZ O
the DT O
simplest JJS O
to TO O
perform VB O
. . O

-DOCSTART- X X O

Western JJ O
blot NN O
analysis NN O
of IN O
various JJ O
bovine NN O
tissues NNS O
with IN O
human JJ O
NMT NNP B-NP
peptide NN I-NP
antibody NN I-NP
indicated VBD O
a DT O
common JJ O
prominent JJ O
immunoreactive JJ O
band NN O
with IN O
an DT O
apparent JJ O
molecular JJ O
mass NN O
of IN O
48.5-50 CD O
kDa NN O
in IN O
all DT O
tissues NNS O
. . O

-DOCSTART- X X O

Transcription NNP O
start VB O
sites NNS O
of IN O
the DT O
plastid NN O
ACCase NN B-NP
genes NNS I-NP
were VBD O
estimated VBN O
from IN O
the DT O
longest JJS O
cDNA NN O
clones NNS O
obtained VBN O
by IN O
5'-RACE JJ O
( -LRB- O
rapid JJ O
amplification NN O
of IN O
cDNA JJ O
ends NNS O
) -RRB- O
. . O

-DOCSTART- X X O

AIDS-related JJ O
disseminated JJ O
histoplasmosis NN O
in IN O
San NNP O
Francisco NNP O
, , O
California NNP O
. . O

-DOCSTART- X X O

Thus RB O
, , O
Fis NNP B-NP
acts VBZ O
as IN O
an DT O
accessory JJ O
transcriptional JJ O
activator NN O
at IN O
the DT O
mar NN B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

TNF-alpha NN B-NP
exposure NN O
markedly NN O
increased VBN O
activity NN O
of IN O
several JJ O
RNA-binding JJ O
proteins NNS O
, , O
especially RB O
a DT O
novel NN O
Mr NNP O
50,000-55,000 CD O
RNA-binding JJ O
protein NN O
. . O

-DOCSTART- X X O

Southern JJ O
blot NN O
analysis NN O
of IN O
endonuclease-digested JJ O
genomic JJ O
DNA NN O
from IN O
primary JJ O
chick NN O
embryo NN O
fibroblasts NNS O
( -LRB- O
CEF NN O
) -RRB- O
suggested VBD O
that IN O
MEK2 NNP B-NP
is VBZ O
a DT O
single-copy JJ O
gene NN O
in IN O
this DT O
vertebrate JJ O
species NNS O
. . O

-DOCSTART- X X O

SCID NNP O
V( NNP B-NP
D)J NNP B-NP
recombination NN O
can MD O
be VB O
partly RB O
rescued VBN O
in IN O
T-lymphocytes NNS O
by IN O
either DT O
DNA-damaging JJ O
agents NNS O
( -LRB- O
gamma-irradiation NN O
and CC O
bieomycin NN O
) -RRB- O
or CC O
a DT O
null JJ O
mutation NN O
of IN O
the DT O
p53 NN B-NP
gene NN I-NP
, , O
possibly RB O
because IN O
of IN O
transiently RB O
elevated JJ O
DNA NN O
repair NN O
activity NN O
in IN O
response NN O
to TO O
DNA NNP O
damage NN O
or CC O
to TO O
delayed VBN O
apoptosis NN O
in IN O
the DT O
absence NN O
of IN O
p53 NN B-NP
. . O

-DOCSTART- X X O

Coexpression NNP O
of IN O
mouse NN O
PKR(1-515)WT NN B-NP
as IN O
a DT O
Gal4 NNP B-NP
DNA-binding NNP O
domain NN O
fusion NN O
with IN O
either CC O
the DT O
catalytic-deficient JJ O
human JJ O
PKR(1-551 NNS B-NP
) -RRB- I-NP
K296R NNP O
mutant NN O
, , O
the DT O
RNA-binding-deficient JJ O
human JJ O
PKR(1-551)K64E/K296R NN B-NP
double JJ O
mutant NN O
, , O
or CC O
wild-type JJ O
mouse NN O
PKR(1-515)WT . B-NP
as IN O
full-length JJ O
PKR-Gal4 NNP B-NP
activation NN O
domain NN O
fusions NNS O
resulted VBD O
in IN O
activation NN O
of IN O
the DT O
HIS3 NNP B-NP
and CC O
lacZ JJ B-NP
reporters NNS O
. . O

-DOCSTART- X X O

An DT O
even RB O
greater JJR O
inflammatory NN O
response NN O
was VBD O
observed VBN O
after IN O
intratracheal JJ O
instillation NN O
of IN O
ufCB NNP O
, , O
but CC O
not RB O
after IN O
CB NNP O
instillation NN O
. . O

-DOCSTART- X X O

These DT O
defects NNS O
no DT O
doubt NN O
impair VB O
the DT O
folding NN O
and CC O
configuration NN O
necessary JJ O
for IN O
normal JJ O
processing NN O
of IN O
the DT O
AVP NNP B-NP
gene NN I-NP
precursor NN I-NP
. . O

-DOCSTART- X X O

Similarities NNS O
between IN O
the DT O
hIGFBP-1 NN B-NP
and CC O
phosphoenolpyruvate JJ B-NP
kinase NN I-NP
( -LRB- O
PEPCK) JJ B-NP
promoters NNS O
, , O
including VBG O
regions NNS O
conferring VBG O
insulin NN B-NP
, , O
glucocorticoid JJ O
, , O
and CC O
cyclic JJ O
adenosine-monophosphate JJ O
responses NNS O
, , O
are VBP O
consistent JJ O
with IN O
our PRP$ O
previous JJ O
hypothesis NN O
that IN O
IGFBP-1 NNP B-NP
is VBZ O
involved VBN O
in IN O
regulation NN O
of IN O
glucose NN O
metabolism NN O
. . O

-DOCSTART- X X O

This DT O
binary JJ O
repeat NN O
contains VBZ O
repetitive JJ O
DNA NN O
elements NNS O
that WDT O
include VBP O
LINES NNP O
, , O
SINES NNP O
, , O
medium NN O
reiteration NN O
frequency NN O
repeats NNS O
, , O
and CC O
a DT O
transposon-like JJ O
element NN O
. . O

-DOCSTART- X X O

At IN O
60 CD O
days NNS O
the DT O
amount NN O
of IN O
gangliosides NNS O
was VBD O
on IN O
average NN O
lower JJR O
in IN O
females NNS O
than IN O
in IN O
males NNS O
, , O
even RB O
if IN O
with IN O
some DT O
exception NN O
. . O

-DOCSTART- X X O

The DT O
existence NN O
of IN O
these DT O
two CD O
categories NNS O
of IN O
strains NNS O
offers VBZ O
a DT O
new JJ O
genetic JJ O
system NN O
in IN O
which WDT O
the DT O
properties NNS O
of IN O
a DT O
potential JJ O
invertebrate NN O
retrovirus NN O
can MD O
be VB O
tested VBN O
. . O

-DOCSTART- X X O

As IN O
a DT O
sequence-specific JJ O
DNA NN O
binding NN O
transcription NN O
factor NN O
, , O
p53 NN B-NP
specifically RB O
binds VBZ O
to TO O
a DT O
20-bp JJ O
consensus NN O
motif NN O
5'-PuPuPuC( JJ O
A/T NN O
) -RRB- O
( -LRB- O
T/A)GPyPyPyPuPuPuC( NNP O
A/T NNP O
)( NNP O
T/A)GPyPyPy-3' NNP O
. . O

-DOCSTART- X X O

TSA NNP O
treatment NN O
, , O
however RB O
, , O
did VBD O
not RB O
detectably RB O
alter VB O
enhancer NN O
factor NN O
binding NN O
or CC O
the DT O
positioning NN O
of IN O
nuc-1 JJ B-NP
on IN O
the DT O
majority NN O
of IN O
the DT O
chromatin NN O
templates NNS O
indicating VBG O
that IN O
protein NN O
acetylation NN O
and CC O
chromatin NN O
remodeling NN O
may MD O
be VB O
limiting VBG O
steps NNS O
that WDT O
occur VBP O
only RB O
on IN O
transcriptionally RB O
competent JJ O
templates NNS O
, , O
or CC O
that IN O
remodeling VBG O
of IN O
nuc-1 NN B-NP
requires VBZ O
additional JJ O
factors NNS O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
moderate JJ O
overexpression NN O
of IN O
Chk1 NNP B-NP
suppresses VBZ O
the DT O
phenotypes NNS O
of IN O
cut5 CD B-NP
and CC O
crb2 CD B-NP
mutants NNS I-NP
. . O

-DOCSTART- X X O

Tcn1p/Crz1p NNP B-NP
, , O
a DT O
calcineurin-dependent JJ O
transcription NN O
factor NN O
that WDT O
differentially RB O
regulates VBZ O
gene NN O
expression NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

We PRP O
introduced VBD O
the DT O
gel NN O
technique NN O
as IN O
a DT O
routine JJ O
assay NN O
for IN O
antibody NN O
detection NN O
and CC O
identification NN O
in IN O
1993 CD O
. . O

-DOCSTART- X X O

Stability NN O
of IN O
pyrimethamine NN O
in IN O
a DT O
liquid JJ O
dosage NN O
formulation NN O
stored VBN O
for IN O
three CD O
months NNS O
. . O

-DOCSTART- X X O

Bilateral NNP O
basal NN O
arteries NNS O
were VBD O
measured VBN O
by IN O
the DT O
transtemporal JJ O
approach NN O
with IN O
a DT O
2 CD O
MHz NNP O
pulsed VBD O
Doppler NNP O
instrument NN O
(TC-2 NN O
64B IN O
EME) NNP O
. . O

-DOCSTART- X X O

The DT O
Saccharomyces NNP B-NP
cerevisiae NN I-NP
RAD30 NNP I-NP
gene NN I-NP
, , O
a DT O
homologue NN B-NP
of IN I-NP
Escherichia NNP I-NP
coli NNS I-NP
dinB NN I-NP
and CC O
umuC NNP B-NP
, , O
is VBZ O
DNA NNP O
damage NN O
inducible JJ O
and CC O
functions NNS O
in IN O
a DT O
novel NN O
error-free JJ O
postreplication NN O
repair NN O
mechanism NN O
. . O

-DOCSTART- X X O

However RB O
, , O
in IN O
a DT O
new JJ O
experiment NN O
in IN O
which WDT O
the DT O
deletion NN O
task NN O
was VBD O
presented VBN O
as IN O
a DT O
puppet NN O
game NN O
, , O
and CC O
with IN O
pretraining JJ O
and CC O
selection NN O
on IN O
vowel NN O
deletion NN O
, , O
a DT O
significantly RB O
higher JJR O
level NN O
of IN O
success NN O
was VBD O
achieved VBN O
by IN O
the DT O
children NNS O
working VBG O
with IN O
the DT O
CVCC NNP O
material NN O
. . O

-DOCSTART- X X O

Gel-shift JJ O
assays IN O
identified VBN O
two CD O
Sp1 NNP B-NP
binding NN I-NP
sites NNS I-NP
within IN O
this DT O
element NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
, , O
in IN O
this DT O
experimental JJ O
model NN O
, , O
ACE NNP B-NP
inhibitors NNS O
limit VBP O
the DT O
arrhythmias NNS O
following VBG O
ischemia-reperfusion NN O
and CC O
free JJ O
radical JJ O
scavenging JJ O
action NN O
of IN O
these DT O
drugs NNS O
does VBZ O
not RB O
have VB O
a DT O
major JJ O
contributory JJ O
role NN O
in IN O
their PRP$ O
protective JJ O
effect NN O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
values NNS O
of IN O
the DT O
first JJ O
three CD O
components NNS O
were VBD O
not RB O
significantly RB O
different JJ O
in IN O
ARVD NN O
patients NNS O
and CC O
control NN O
subjects NNS O
. . O

-DOCSTART- X X O

Two CD O
disulphide JJ O
bridges NNS O
, , O
which WDT O
are VBP O
conserved VBN O
in IN O
all DT O
spermadhesin NN O
molecules NNS O
and CC O
many JJ O
CUB NNP O
domains NNS O
, , O
crosslink VB O
loop NN O
LA NNP O
and CC O
strand VB O
beta JJ O
4 CD O
and CC O
loops VBZ O
LE JJ O
and CC O
LG NNP O
, , O
respectively RB O
, , O
at IN O
opposite JJ O
edges NNS O
of IN O
the DT O
same JJ O
face NN O
of IN O
the DT O
domain NN O
. . O

-DOCSTART- X X O

Mg-chelatase NN B-NP
of IN O
tobacco NN O
: : O
identification NN O
of IN O
a DT O
Chl NNP B-NP
D NNP I-NP
cDNA . I-NP
sequence NN I-NP
encoding VBG O
a DT O
third JJ O
subunit NN O
, , O
analysis NN O
of IN O
the DT O
interaction NN O
of IN O
the DT O
three CD O
subunits NNS O
with IN O
the DT O
yeast NN O
two-hybrid JJ O
system NN O
, , O
and CC O
reconstitution NN O
of IN O
the DT O
enzyme NN O
activity NN O
by IN O
co-expression NN O
of IN O
recombinant NN B-NP
CHL NNP I-NP
D NNP I-NP
, , O
CHL NNP B-NP
H NNP I-NP
and CC O
CHL NNP B-NP
I. NN I-NP

-DOCSTART- X X O

One CD O
R-EST NN O
and CC O
one CD O
Pto-like JJ B-NP
sequence NN I-NP
each DT O
mapped VBN O
to TO O
two CD O
locations NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
in IN O
addition NN O
to TO O
Grb2-mediated JJ B-NP
activation NN O
of IN O
Ras NNP B-NP
, , O
PLC-gamma1-mediated JJ B-NP
DAG NNP O
production NN O
is VBZ O
required VBN O
for IN O
EGF- NNP B-NP
and CC O
PDGF-induced NNP B-NP
S-phase NNP O
entry NN O
and CC O
gene NN O
expression NN O
, , O
possibly RB O
through IN O
activation NN O
of IN O
PKC. NNP B-NP

-DOCSTART- X X O

In IN O
serum-stimulated JJ O
cells NNS O
, , O
the DT O
binding NN O
of IN O
NF-Y/CBF NNP B-NP
to TO O
TKC1 NNP B-NP
increased VBD O
gradually RB O
, , O
reaching VBG O
a DT O
plateau NN O
at IN O
the DT O
S NNP O
phase NN O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
In IN O
our PRP$ O
animal NN O
model NN O
, , O
blood-brain NN O
barrier NN O
disruption NN O
was VBD O
a DT O
reproducible JJ O
, , O
integral JJ O
finding NN O
of IN O
single-fraction NN O
, , O
high-dose JJ O
irradiation NN O
injury NN O
. . O

-DOCSTART- X X O

Cell NNP O
factor-mediated JJ O
regulatory JJ O
interactions NNS O
are VBP O
involved VBN O
in IN O
regulating VBG O
the DT O
restricted JJ O
expression NN O
of IN O
the DT O
HCMV NNP B-NP
major JJ I-NP
immediate-early JJ I-NP
( -LRB- I-NP
IE NN I-NP
) -RRB- I-NP
gene NN I-NP
( -LRB- O
J. NNP O

-DOCSTART- X X O

C. NNP O

-DOCSTART- X X O

The DT O
5' JJ O
end NN O
of IN O
the DT O
genomic JJ O
RNA NNP O
of IN O
rubella NN O
virus NN O
( -LRB- O
RUB) NNP O
contains VBZ O
a DT O
14-nucleotide JJ O
( -LRB- O
nt NN O
) -RRB- O
single-stranded JJ O
leader NN O
( -LRB- O
ss-leader NN O
) -RRB- O
followed VBN O
by IN O
a DT O
stem-and-loop JJ O
structure NN O
[ IN O
5'( JJ O
+)SL] NNS O
( -LRB- O
nt NN O
15 CD O
to TO O
65 CD O
) -RRB- O
, , O
the DT O
complement NN O
of IN O
which WDT O
at IN O
the DT O
3' JJ O
end NN O
of IN O
the DT O
minus-strand JJ O
RNA NNP O
[ NNP O
3'(-)SL] NNP O
has VBZ O
been VBN O
proposed VBN O
to TO O
function NN O
as IN O
a DT O
promoter NN O
for IN O
synthesis NN O
of IN O
genomic JJ O
plus CC O
strands NNS O
. . O

-DOCSTART- X X O

To TO O
investigate VB O
the DT O
requirements NNS O
for IN O
CBF2 NNP B-NP
binding NN O
, , O
we PRP O
synthesized VBD O
a DT O
series NN O
of IN O
oligonucleotides NNS O
carrying VBG O
double JJ O
transversion NN O
mutations NNS O
spanning VBG O
both DT O
the DT O
conserved JJ O
core NN O
sequence NN O
and CC O
outside JJ O
flanking NN O
sequences NNS O
. . O

-DOCSTART- X X O

To TO O
investigate VB O
the DT O
activity NN O
of IN O
TCF11 NNP B-NP
through IN O
this DT O
selected VBN O
site NN O
, , O
both DT O
alone RB O
and CC O
in IN O
the DT O
presence NN O
of IN O
MafG NNP B-NP
, , O
we PRP O
have VBP O
used VBN O
a DT O
transient NN O
transfection NN O
assay NN O
. . O

-DOCSTART- X X O

Ca2+/calmodulin-dependent JJ B-NP
protein NN I-NP
kinase NN I-NP
II NNP I-NP
( -LRB- O
CaMK NN B-NP
II NNP I-NP
) -RRB- O
is VBZ O
a DT O
multifunctional JJ O
serine/threonine NN B-NP
protein NN I-NP
kinase NN I-NP
that WDT O
regulates VBZ O
ion NN O
channels NNS O
, , O
metabolic JJ O
enzymes NNS O
, , O
cytoskeletal JJ O
proteins NNS O
, , O
and CC O
possibly RB O
transcription NN O
factors NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
a DT O
catalytically RB O
inactive JJ O
version NN O
of IN O
the DT O
Src NNP B-NP
family NN I-NP
member NN O
, , O
Lck NNP B-NP
( -LRB- O
lymphoid NN B-NP
cell NN I-NP
kinase NN I-NP
) -RRB- O
, , O
was VBD O
expressed VBN O
, , O
purified VBN O
, , O
and CC O
evaluated VBN O
as IN O
a DT O
Csk NNP B-NP
substrate NN O
. . O

-DOCSTART- X X O

A. NN O
, , O
Swift NNP O
, , O
A. NN O

-DOCSTART- X X O

Neuronal JJ O
mechanisms NNS O
underlying VBG O
stimulus-response NN O
(S-R NN O
) -RRB- O
associations NNS O
in IN O
S-R NNP O
compatibility NN O
tasks NNS O
were VBD O
identified VBN O
in IN O
2 CD O
experiments NNS O
with IN O
monkeys NNS O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
the DT O
antagonistic JJ O
effects NNS O
of IN O
CRP NNP B-NP
and CC O
KdgR NNP B-NP
on IN O
the DT O
expression NN O
of IN O
the DT O
pectinolysis NN B-NP
genes NNS I-NP
occur VBP O
by IN O
different JJ O
mechanisms NNS O
, , O
including VBG O
direct JJ O
competition NN O
between IN O
the DT O
two CD O
regulators NNS O
or CC O
between IN O
the DT O
repressor NN O
and CC O
RNA NNP B-NP
polymerase NN I-NP
for IN O
the DT O
occupation NN O
of IN O
a DT O
common JJ O
DNA NNP O
region NN O
on IN O
the DT O
target NN O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
well-known JJ O
Rel/NF-kappaB JJ B-NP
family NN O
of IN O
vertebrate JJ O
transcription NN O
factors NNS O
comprises VBZ O
a DT O
number NN O
of IN O
structurally RB O
related VBN O
, , O
interacting JJ O
proteins NNS O
that WDT O
bind VBP O
DNA NNP O
as IN O
dimers NNS O
and CC O
whose WP$ O
activity NN O
is VBZ O
regulated VBN O
by IN O
subcellular JJ O
location NN O
. . O

-DOCSTART- X X O

Lysine-ketoglutarate JJ B-NP
reductase NN I-NP
and CC O
saccharopine NN B-NP
dehydrogenase NN I-NP
from IN O
Arabidopsis NNP O
thaliana . O
: : O
nucleotide JJ O
sequence NN O
and CC O
characterization NN O
. . O

-DOCSTART- X X O

The DT O
purpose NN O
of IN O
this DT O
investigation NN O
was VBD O
to TO O
describe VB O
a DT O
new JJ O
formulation NN O
of IN O
silver NN O
sulfadiazine NN O
in IN O
a DT O
water NN O
soluble JJ O
gel NN O
, , O
poloxamer NN O
188 CD O
. . O

-DOCSTART- X X O

The DT O
study NN O
goals NNS O
were VBD O
to TO O
isolate VB O
a DT O
full-length JJ O
clone NN O
encoding VBG O
CO-Ag NNP B-NP
from IN O
a DT O
bovine NN O
corneal NN O
cDNA NN O
library NN O
and CC O
to TO O
express VB O
this DT O
clone NN O
in IN O
Escherichia NNP O
coli NNS O
( -LRB- O
E. NNP O
coli) NN O
. . O

-DOCSTART- X X O

The DT O
gene NN O
contains VBZ O
six CD O
exons NNS O
separated VBN O
by IN O
1.1-5.8 CD O
kb NN O
introns NNS O
and CC O
has VBZ O
been VBN O
localized VBN O
to TO O
the DT O
murine NN O
chromosome NN O
2 CD O
by IN O
linkage NN O
analysis NN O
. . O

-DOCSTART- X X O

A DT O
cytosolic JJ O
variant NN O
of IN O
the DT O
protein NN O
underwent IN O
efficient JJ O
transphosphorylation NN O
, , O
yet RB O
failed VBD O
to TO O
activate VB O
appreciably RB O
either CC O
p70(S6k VB B-NP
) -RRB- O
or CC O
MAP NNP B-NP
kinase NN I-NP
following VBG O
treatment NN O
with IN O
FK1012 NNP O
. . O

-DOCSTART- X X O

Conversely RB O
, , O
the DT O
inactive JJ O
dAK NN B-NP
subunit NN I-NP
is VBZ O
progressively RB O
activated VBN O
by IN O
1 CD O
) -RRB- O
association NN O
with IN O
a DT O
dGK NN B-NP
or CC O
dCK NN B-NP
subunit NN I-NP
and CC O
2 CD O
) -RRB- O
the DT O
conformationally NN O
driven VBN O
heterotropic JJ O
affect VB O
of IN O
dGuo NN B-NP
or CC O
dCyd NN B-NP
bound VBN O
to TO O
the DT O
opposing VBG O
subunit NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
A DT O
50-mg JJ O
daily JJ O
dose NN O
of IN O
bicalutamide NN O
is VBZ O
sufficient JJ O
when WRB O
given VBN O
in IN O
combination NN O
with IN O
an DT O
agent NN O
, , O
such JJ O
as IN O
a DT O
LHRH-A NNP B-NP
, , O
that WDT O
lowers VBZ O
serum NN O
testosterone NN O
, , O
but CC O
higher JJR O
doses NNS O
of IN O
bicalutamide NN O
may MD O
be VB O
needed VBN O
when WRB O
the DT O
drug NN O
is VBZ O
given VBN O
as IN O
monotherapy NN O
. . O

-DOCSTART- X X O

Although IN O
the DT O
gene NN O
is VBZ O
substantially RB O
smaller JJR O
than IN O
the DT O
human JJ O
genes NNS O
for IN O
other JJ O
mitochondrial JJ O
enzymes NNS O
, , O
its PRP$ O
intron/exon JJ O
organization NN O
is VBZ O
very RB O
similar JJ O
, , O
especially RB O
to TO O
that DT O
of IN O
P450scc NNP B-NP
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Looking VBG O
at IN O
the DT O
question NN O
of IN O
its PRP$ O
benefits NNS O
, , O
we PRP O
were VBD O
unable JJ O
to TO O
find VB O
any DT O
methodologically RB O
sound JJ O
studies NNS O
that WDT O
have VBP O
shown VBN O
efficacy NN O
for IN O
EMDR NN O
in IN O
eating VBG O
disorders NNS O
, , O
or CC O
, , O
indeed RB O
, , O
any DT O
psychiatric JJ O
disorder NN O
. . O

-DOCSTART- X X O

Transient NNP O
overexpression IN O
of IN O
mutant JJ B-NP
EphB1 NNP I-NP
receptors NNS I-NP
( -LRB- O
Y594F NN O
) -RRB- O
blocked VBN O
Nck NN B-NP
recruitment NN O
to TO O
EphB1 NNP B-NP
, , O
attenuated VBD O
downstream RB O
JNK NNP B-NP
activation NN O
, , O
and CC O
blocked VBD O
cell NN O
attachment NN O
responses NNS O
. . O

-DOCSTART- X X O

S. NNP O
, , O
and CC O
Walter NNP O
, , O
P. NNP O

-DOCSTART- X X O

Here RB O
we PRP O
demonstrate VBP O
that IN O
Hh NNP B-NP
and CC O
Patched NNP B-NP
( -LRB- O
Ptc NN B-NP
) -RRB- O
act NN O
through IN O
those DT O
Ci NNP B-NP
binding NN O
sites NNS O
to TO O
modulate VB O
the DT O
level NN O
of IN O
Ci-dependent JJ B-NP
transcriptional JJ O
activation NN O
in IN O
S2 NNP O
cells NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
the DT O
median JJ O
increase NN O
in IN O
cyclosporine NN O
DR/C(SS NNP O
trough NN O
) -RRB- O
was VBD O
18 CD O
l JJ O
h-1 JJ O
(-3.1 JJ O
to TO O
42.1 CD O
l NN O
h-1 NN O
, , O
interquartile JJ O
range NN O
) -RRB- O
. . O

-DOCSTART- X X O

Patients NNS O
and CC O
their PRP$ O
relatives NNS O
must MD O
be VB O
informed VBN O
about IN O
the DT O
available JJ O
effective JJ O
treatment NN O
possibilities NNS O
and CC O
about IN O
the DT O
right JJ O
moment NN O
for IN O
their PRP$ O
application NN O
in IN O
an DT O
individual JJ O
patient NN O
. . O

-DOCSTART- X X O

Several JJ O
PTPases NNS B-NP
were VBD O
expressed VBN O
abundantly RB O
in IN O
the DT O
5-FU-treated JJ O
bone NN O
marrow NN O
stem NN O
cells NNS O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
PTPRO NNP B-NP
was VBD O
also RB O
observed VBN O
in IN O
human JJ B-NP
CD34+ NNP I-NP
bone NN O
marrow NN O
cells NNS O
and CC O
5-FU-treated JJ O
murine NN O
primitive JJ O
stem NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
organization NN O
of IN O
SPP1 NNP B-NP
genes NNS I-NP
involved VBN O
in IN O
the DT O
replication NN O
, , O
DNA NNP O
packaging NN O
and CC O
phage JJ O
assembly NN O
proteins NNS O
resembles VBZ O
the DT O
organization NN O
of IN O
genes NNS O
of IN O
equivalent JJ O
regions NNS O
of IN O
different JJ O
E. NNP O
coli NNS O
double-stranded JJ O
DNA NNP O
phages NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
showed VBD O
that IN O
compared VBN O
to TO O
the DT O
primary JJ O
photon NN O
fluence NN O
, , O
the DT O
extra-focal JJ O
photon NN O
fluence NN O
from IN O
the DT O
primary JJ O
collimator NN O
and CC O
the DT O
flattening NN O
filter NN O
was VBD O
11%-16 CD O
% NN O
at IN O
the DT O
isocenter NN O
, , O
among IN O
which WDT O
70 CD O
% NN O
was VBD O
contributed VBN O
by IN O
the DT O
flattening NN O
filter NN O
. . O

-DOCSTART- X X O

The DT O
functional JJ O
mature JJ O
domain NN O
of IN O
pediocin NN B-NP
AcH NNP I-NP
( -LRB- I-NP
Lys+1 NNP I-NP
to TO I-NP
Cys+44 NNP I-NP
) -RRB- I-NP
is VBZ O
targeted VBN O
into IN O
the DT O
E. NNP O
coli NNS O
sec JJ O
machinery NN O
and CC O
secreted VBN O
to TO O
the DT O
periplasm NN O
in IN O
active JJ O
form NN O
when WRB O
fused VBN O
in IN O
frame NN O
to TO O
the DT O
COOH NNP O
terminus NN O
of IN O
the DT O
secretory JJ B-NP
protein NN I-NP
maltose-binding JJ I-NP
protein NN I-NP
( -LRB- O
MBP) NN B-NP
. . O

-DOCSTART- X X O

Isomers NNS O
were VBD O
differentiated JJ O
based VBN O
on IN O
the DT O
MS-MS NNP O
data NNS O
of IN O
the DT O
trofluoroacetyl-biphenylol JJ O
derivatives NNS O
. . O

-DOCSTART- X X O

Although IN O
RAD17 NNP B-NP
, , O
RAD24 NNP B-NP
and CC O
MEC3 NNP B-NP
are VBP O
not RB O
required VBN O
for IN O
cell NN O
cycle NN O
arrest NN O
when WRB O
S NNP O
phase NN O
is VBZ O
inhibited VBN O
by IN O
hydroxyurea NN O
( -LRB- O
HU) NNP O
, , O
they PRP O
do VBP O
contribute VB O
to TO O
the DT O
viability NN O
of IN O
yeast NN O
cells NNS O
grown VBN O
in IN O
the DT O
presence NN O
of IN O
HU NNP O
, , O
possibly RB O
because IN O
they PRP O
are VBP O
required VBN O
for IN O
the DT O
repair NN O
of IN O
HU-induced JJ O
DNA NNP O
damage NN O
. . O

-DOCSTART- X X O

Clinical NNP O
value NN O
of IN O
the DT O
estimation NN O
of IN O
growth NN O
kinetics NNS O
of IN O
primary JJ O
ovarian JJ O
cancer NN O
recurrences NNS O
by IN O
CA125 DT B-NP
doubling NN O
time NN O

-DOCSTART- X X O

The DT O
patient NN O
underwent IN O
two CD O
intracytoplasmic JJ O
sperm NN O
injection NN O
cycles NNS O
with IN O
thawed DT O
epididymal JJ O
spermatozoa NNS O
, , O
in IN O
which WDT O
, , O
due JJ O
to TO O
a DT O
pharmacist NN O
's POS O
mistake NN O
, , O
ovarian JJ O
stimulation NN O
was VBD O
carried VBN O
out RP O
by IN O
a DT O
combination NN O
of IN O
long-acting JJ O
gonadotrophin-releasing NN B-NP
hormone NN I-NP
agonist NN O
( -LRB- O
leuprolide NN O
depot NN O
) -RRB- O
and CC O
gonadotrophins NNS B-NP
. . O

-DOCSTART- X X O

Protein NNP B-NP
C NNP I-NP
deficiency NN O
or CC O
protein NN B-NP
S NNP I-NP
deficiency NN O
was VBD O
the DT O
only RB O
identified VBN O
risk NN O
factor NN O
for IN O
5.4 CD O
% NN O
( -LRB- O
2 CD O
patients NNS O
) -RRB- O
and CC O
13.5 CD O
% NN O
( -LRB- O
5 CD O
patients NNS O
) -RRB- O
, , O
respectively RB O
, , O
of IN O
these DT O
37 CD O
children NNS O
. . O

-DOCSTART- X X O

Perhaps RB O
in IN O
addition NN O
to TO O
, , O
or CC O
as IN O
part NN O
of IN O
, , O
its PRP$ O
essential JJ O
function NN O
in IN O
late JJ O
mitosis NN O
, , O
MOB1 NNP B-NP
is VBZ O
required VBN O
for IN O
a DT O
cell NN O
cycle NN O
reset NN O
function NN O
necessary JJ O
for IN O
the DT O
initiation NN O
of IN O
the DT O
spindle NN O
pole NN O
body NN O
duplication NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
overproduction IN O
of IN O
Der3p NNP B-NP
is VBZ O
lethal JJ O
in IN O
a DT O
sec61-2 JJ B-NP
strain NN O
at IN O
the DT O
permissive JJ O
temperature NN O
of IN O
25 CD O
degrees NNS O
C. NNP O

-DOCSTART- X X O

Normal JJ O
baseline NN O
( -LRB- O
day-8 JJ O
) -RRB- O
PC NN O
levels NNS O
(86 CD O
and CC O
89 CD O
% NN O
) -RRB- O
were VBD O
markedly RB O
reduced VBN O
in IN O
both DT O
patients NNS O
at IN O
the DT O
time NN O
of IN O
VOD NNP O
manifestation NN O
on IN O
day NN O
20 CD O
and CC O
40 CD O
, , O
respectively RB O
( -LRB- O
26 CD O
and CC O
31 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

To TO O
examine VB O
the DT O
role NN O
of IN O
this DT O
CE2 JJ O
element NN O
in IN O
regulating VBG O
Hoxa1 NNP B-NP
expression NN O
in IN O
vivo JJ O
, , O
transgenic JJ O
mice NNS O
were VBD O
generated VBN O
which WDT O
express VBP O
a DT O
Hoxa1 NNP B-NP
beta-galactosidase NN B-NP
reporter NN O
gene NN O
that WDT O
contains VBZ O
a DT O
mutation NN O
in IN O
the DT O
CE2 NNP O
element NN O
. . O

-DOCSTART- X X O

An DT O
evolutionary JJ O
conserved JJ O
element NN O
is VBZ O
essential JJ O
for IN O
somite NN O
and CC O
adjacent JJ O
mesenchymal JJ O
expression NN O
of IN O
the DT O
Hoxa1 NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Altogether RB O
46 CD O
phase NN O
III NNP O
activities NNS O
were VBD O
recorded VBN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
previously RB O
identified VBN O
a DT O
liver-enriched JJ O
transcription NN O
factor NN O
, , O
HNF-6 NNP B-NP
, , O
which WDT O
is VBZ O
required VBN O
for IN O
HNF-3 JJ B-NP
beta JJ I-NP
promoter NN I-NP
activity NN O
and CC O
also RB O
recognizes VBZ O
the DT O
regulatory JJ O
region NN O
of IN O
numerous JJ O
hepatocyte-specific JJ O
genes NNS O
. . O

-DOCSTART- X X O

A DT O
cDNA NN O
clone NN O
was VBD O
identified VBN O
encoding VBG O
a DT O
second JJ O
GHS-R-related JJ B-NP
gene NN I-NP
( -LRB- O
GPR39 NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

( -LRB- O
1997 CD O
) -RRB- O
Science NNP O
275 CD O
, , O
1927-1930 CD O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
hybridoma NN O
clone NN O
( -LRB- O
7H1 CD O
) -RRB- O
resulting VBG O
from IN O
the DT O
fusion NN O
between IN O
CEMLAI/NP NNP O
and CC O
human JJ O
embryonic NN O
fibroblasts VBZ O
MRC5 IN O
cells NNS O
produced VBN O
very RB O
large JJ O
amounts NNS O
of IN O
P47 NNS B-NP
that WDT O
was VBD O
purified VBN O
using VBG O
Jacalin NNP B-NP
lectin NN I-NP
( -LRB- O
specific JJ O
for IN O
O-glycans NNS O
) -RRB- O
and CC O
microsequenced JJ O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
DNase NN B-NP
I PRP I-NP
footprinting CD O
of IN O
the DT O
200-bp JJ O
proximal JJ O
region NN O
of IN O
the DT O
promoter NN O
with IN O
a DT O
murine NN O
Hepa NNP O
1-6 CD O
cell NN O
nuclear JJ O
extract VB O
revealed VBN O
a DT O
clear JJ O
footprint NN O
of IN O
a DT O
region NN O
corresponding JJ O
to TO O
-80 VB O
to TO O
-28 DT O
bp NN O
of IN O
the DT O
murine NN B-NP
fVII JJ I-NP
gene NN I-NP
, , O
suggesting VBG O
that IN O
liver NN O
factors NNS O
interact NN O
with IN O
this DT O
region NN O
of IN O
the DT O
DNA NNP O
. . O

-DOCSTART- X X O

A DT O
comparative JJ O
study NN O
was VBD O
undertaken VBN O
between IN O
an DT O
enzymatic JJ O
immunohistochemical JJ O
technique NN O
( -LRB- O
EIT NN O
) -RRB- O
developed VBN O
for IN O
the DT O
diagnosis NN O
of IN O
human JJ O
trichinellosis NN O
and CC O
the DT O
indirect JJ O
immunofluorescence NN O
test NN O
( -LRB- O
IIF) NNP O
, , O
analysing VBG O
sera NN O
from IN O
outbreaks NNS O
of IN O
human JJ O
trichinellosis NN O
in IN O
Argentina NNP O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
establish VB O
GKLF NN B-NP
as IN O
a DT O
sequence-specific JJ O
transcription NN O
factor NN O
likely JJ O
involved VBN O
in IN O
regulation NN O
of IN O
expression NN O
of IN O
endogenous JJ O
genes NNS O
. . O

-DOCSTART- X X O

CES4 NNP B-NP
on IN O
a DT O
multicopy JJ O
plasmid NN O
was VBD O
unable JJ O
to TO O
suppress VB O
tif1-A79V NN B-NP
. . O

-DOCSTART- X X O

We PRP O
have VBP O
used VBN O
mutation-directed JJ O
chemical NN O
cross-linking NN O
with IN O
bis( NN O
sulfosuccinimidyl NN O
)suberate NN O
( -LRB- O
BS3 NNP O
) -RRB- O
to TO O
investigate VB O
the DT O
architecture NN O
of IN O
the DT O
gp41 CD B-NP
oligomer NN I-NP
. . O

-DOCSTART- X X O

In IN O
an DT O
effort NN O
to TO O
identify VB O
the DT O
USH1C NNP B-NP
disease NN I-NP
gene NN I-NP
we PRP O
have VBP O
isolated VBN O
the DT O
region NN O
between IN O
these DT O
markers NNS O
in IN O
yeast NN O
artificial JJ O
chromosomes NNS O
(YACs NNS O
) -RRB- O
using VBG O
a DT O
combination NN O
of IN O
STS NNS O
content JJ O
mapping NN O
and CC O
Alu-PCR NNP B-NP
hybridization NN O
. . O

-DOCSTART- X X O

PowerBLAST NN O
analysis NN O
identified VBN O
six CD O
clusters NNS O
of IN O
expressed VBN O
sequence NN O
tags NNS O
( -LRB- O
ESTs NNP O
) -RRB- O
, , O
two CD O
known VBN O
genes NNS O
( -LRB- O
BIR NNP B-NP
, , O
SUR1 NNP B-NP
) -RRB- O
mapped VBD O
previously RB O
to TO O
this DT O
region NN O
, , O
and CC O
a DT O
previously RB O
characterized VBN O
but CC O
unmapped VBN O
gene NN B-NP
NEFA JJ I-NP
( -LRB- O
DNA NN B-NP
binding/EF NN I-NP
hand/acidic JJ I-NP
amino-acid-rich JJ I-NP
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
negatively RB O
regulatory JJ O
region NN O
may MD O
exist VB O
from IN O
-1782 JJ O
to TO O
-1295 DT O
bp NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
cloned VBN O
a DT O
kinase NN O
, , O
Nlk NNP B-NP
, , O
that WDT O
is VBZ O
a DT O
murine NN B-NP
homolog NN I-NP
of IN I-NP
the DT I-NP
Drosophila NNP I-NP
nemo NN I-NP
( -LRB- O
nmo NN B-NP
) -RRB- O
gene NN O
. . O

-DOCSTART- X X O

Genetic JJ O
analysis NN O
has VBZ O
subsequently RB O
identified VBN O
subpathways NNS O
of IN O
the DT O
DNA NNP O
structure NN O
checkpoints NNS O
, , O
including VBG O
the DT O
reversible JJ O
arrest NN O
of IN O
DNA NNP O
synthesis NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
Esigma54 NNP B-NP
promoters NNS I-NP
are VBP O
responsive JJ O
to TO O
CRP NNP B-NP
, , O
a DT O
protein NN O
unrelated JJ O
to TO O
sigma54 VB B-NP
activators NNS I-NP
, , O
and CC O
the DT O
repression NN O
exerted VBN O
is VBZ O
the DT O
direct JJ O
result NN O
of IN O
an DT O
interaction NN O
between IN O
Esigma54 NNP B-NP
and CC O
the DT O
CRP-cAMP NNP B-NP
complex NN I-NP
. . O

-DOCSTART- X X O

GlcNAc JJ O
- : O
and CC O
GlcNAc2-PP-Dolichol JJ O
biosynthesis NN O
could MD O
be VB O
shown VBN O
with IN O
isolated JJ O
S.cerevisiae NNS O
membranes NNS O
from IN O
cells NNS O
harboring VBG O
the DT O
recombinant JJ O
plasmid NN O
and CC O
grown VBN O
on IN O
glucose NN O
thus RB O
suppressing VBG O
transcription NN O
of IN O
the DT O
endogenous JJ O
gene NN O
. . O

-DOCSTART- X X O

Demonstration NNP O
of IN O
tissue NN O
lesions NNS O
after IN O
intramuscular JJ O
injection NN O
by IN O
determination NN O
of IN O
creatine JJ B-NP
kinase NN I-NP
in IN O
blood NN O

-DOCSTART- X X O

Antibodies NNS O
raised VBD O
against IN O
GST JJ B-NP
mSH2-B NN I-NP
identified VBN O
a DT O
cellular JJ O
protein NN O
of IN O
92 CD O
kDa NN O
that WDT O
was VBD O
not RB O
found VBN O
to TO O
be VB O
phosphorylated VBN O
on IN O
Tyr NNP O
. . O

-DOCSTART- X X O

Interleukin-6 NNP B-NP
( -LRB- O
IL-6 NN B-NP
) -RRB- O
is VBZ O
a DT O
pleiotropic JJ O
cytokine NN O
, , O
which WDT O
is VBZ O
involved VBN O
in IN O
inflammatory NN O
and CC O
immune JJ O
responses NNS O
, , O
acute JJ O
phase NN O
reactions NNS O
, , O
and CC O
hematopoiesis NN O
. . O

-DOCSTART- X X O

Levels NNP O
of IN O
the DT O
MEK NNP B-NP
inhibitor NN O
PD98059 . O
that WDT O
block NN O
EGF-induced JJ B-NP
mitogenesis NN O
and CC O
MAP NNP B-NP
kinase NN I-NP
phosphorylation NN O
also RB O
abrogate RB O
EGF-induced JJ B-NP
focal JJ O
adhesion NN O
disassembly NN O
and CC O
cell NN O
motility NN O
. . O

-DOCSTART- X X O

51.9 CD O
% NN O
( -LRB- O
P=0.0006 CD O
) -RRB- O
in IN O
the DT O
MMF NNP O
versus IN O
the DT O
AZA NN O
groups NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Pao2 NNP O
increased VBD O
from IN O
15.5 CD O
+/ NNS O
- : O
5.6 CD O
kPa NN O
( -LRB- O
116 CD O
+/ RB O
- : O
42 CD O
mm CD O
Hg NN O
) -RRB- O
to TO O
17.3 CD O
+/ JJ O
- : O
6.3 CD O
kPa NN O
( -LRB- O
130 CD O
+/ NNS O
- : O
47 CD O
mm CD O
Hg NN O
) -RRB- O
( -LRB- O
P NNP O
< NN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Nine NNP O
cats NNS O
received VBD O
PMEA NNP O
at IN O
a DT O
dosage NN O
of IN O
10 CD O
mg/kg JJ O
body NN O
weight NN O
, , O
nine CD O
cats NNS O
received VBD O
FPMPA NNP O
at IN O
a DT O
dosage NN O
of IN O
25 CD O
mg/kg JJ O
body NN O
weight NN O
. . O

-DOCSTART- X X O

We PRP O
present VBP O
the DT O
preliminary JJ O
results NNS O
obtained VBD O
on IN O
36 CD O
patients NNS O
which WDT O
were VBD O
followed VBN O
for IN O
a DT O
mean JJ O
period NN O
of IN O
12 CD O
months NNS O
. . O

-DOCSTART- X X O

PATIENTS NNS O
AND CC O
METHOD NNS O
: : O
Since IN O
1986 CD O
, , O
62 CD O
patients NNS O
were VBD O
irradiated JJ O
stereotactically RB O
. . O

-DOCSTART- X X O

Training VBG O
for IN O
audit NN O
. . O

-DOCSTART- X X O

A DT O
putative JJ O
inhibitor( NN O
s VBZ O
) -RRB- O
appears VBZ O
to TO O
co-elute VB O
in IN O
the DT O
inactive JJ O
fraction NN O
that WDT O
blocked VBD O
the DT O
L(alpha NN B-NP
) -RRB- I-NP
activity NN O
. . O

-DOCSTART- X X O

Using VBG O
himA PRP B-NP
mutants NNS I-NP
, , O
we PRP O
confirmed VBD O
that IN O
IHF NNP B-NP
plays VBZ O
a DT O
role NN O
in IN O
the DT O
molybdate-dependent JJ O
regulation NN O
of IN O
dmsA-lacZ JJ B-NP
expression NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Cross-talking NNP O
among IN O
Drosophila NNP O
nuclear JJ O
receptors NNS O
at IN O
the DT O
promiscuous JJ O
response NN O
element NN O
of IN O
the DT O
ng-1 NN B-NP
and CC O
ng-2 NN B-NP
intermolt NN I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

The DT O
ipsilateral JJ O
breast NN O
tumor NN O
relapse NN O
rate NN O
was VBD O
similar JJ O
between IN O
the DT O
PALP NNP O
and CC O
MGDET NNP O
groups NNS O
. . O

-DOCSTART- X X O

The DT O
CAPLC1 JJ B-NP
protein NN I-NP
also RB O
exhibited VBD O
several JJ O
unique JJ O
features NNS O
, , O
including VBG O
a DT O
novel JJ O
stretch NN O
of IN O
18-19 CD O
amino IN O
acid NN O
residues NNS O
within IN O
the DT O
X NNP O
domain NN O
and CC O
an DT O
unusually RB O
long JJ O
N-terminus NN O
which WDT O
did VBD O
not RB O
contain VB O
a DT O
recognizable JJ O
EF-hand NNP O
Ca( NNP O
2+)-binding JJ O
domain NN O
. . O

-DOCSTART- X X O

This DT O
hypothesis NN O
is VBZ O
consistent JJ O
with IN O
the DT O
occurrence NN O
of IN O
PEA3 JJ B-NP
binding NN I-NP
sites NNS I-NP
in IN O
the DT O
PEA3 NN B-NP
promoter NN I-NP
and CC O
with IN O
the DT O
ability NN O
of IN O
PEA3 NN B-NP
to TO O
transactivate VB O
this DT O
promoter NN O
. . O

-DOCSTART- X X O

Pet-1 NNP B-NP
can MD O
bind NN O
specifically RB O
to TO O
a DT O
PEA3 NN B-NP
ETS NNS B-NP
DNA-binding JJ O
motif NN O
and CC O
can MD O
modulate VB O
transcription NN O
of IN O
synthetic JJ O
promoter NN O
constructs NNS O
in IN O
a DT O
sequence-specific JJ O
manner NN O
. . O

-DOCSTART- X X O

The DT O
protein NN O
expressed VBN O
by IN O
F2771 NNP B-NP
cDNA NN I-NP
in IN O
transfected JJ O
COS NNP O
cells NNS O
is VBZ O
localized VBN O
in IN O
the DT O
cytoplasm NN O
. . O

-DOCSTART- X X O

Northern JJ O
analysis NN O
indicated VBN O
differential JJ O
expression NN O
by IN O
tissue NN O
with IN O
highest JJS O
expression NN O
in IN O
the DT O
heart NN O
. . O

-DOCSTART- X X O

The DT O
mRNAs NNS O
of IN O
these DT O
genes NNS O
contain VBP O
respectively RB O
one CD O
(YAP1 JJ O
uORF NN B-NP
) -RRB- O
and CC O
two CD O
(YAP2 JJ O
uORF1 NNS B-NP
and CC O
uORF2 NN O
) -RRB- O
upstream RB O
open JJ O
reading NN O
frames NNS O
. . O
uORF-mediated JJ O
modulation NN O
of IN O
post-termination JJ O
events NNS O
on IN O
the DT O
5'-untranslated JJ O
region NN O
( -LRB- O
5'-UTR JJ O
) -RRB- O
directs VBZ O
differential JJ O
control NN O
not RB O
only RB O
of IN O
translation NN O
but CC O
also RB O
of IN O
mRNA NN O
decay NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
tissues NNS O
tested VBN O
, , O
except IN O
brain NN O
, , O
the DT O
message NN O
for IN O
CLIP-170 NN B-NP
was VBD O
more RBR O
abundant JJ O
than IN O
that IN O
for IN O
Restin NNP B-NP
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Chemicals NNS O
vary VBP O
considerably RB O
in IN O
their PRP$ O
intrinsic JJ O
ability NN O
to TO O
cause VB O
allergic JJ O
contact NN O
dermatitis NN O
. . O

-DOCSTART- X X O

Cytoskeletal NNP O
polarization NN O
of IN O
T NNP O
cells NNS O
is VBZ O
regulated VBN O
by IN O
an DT O
immunoreceptor NN O
tyrosine-based JJ O
activation NN O
motif-dependent NN O
mechanism NN O
. . O

-DOCSTART- X X O

Also RB O
, , O
the DT O
deduced VBN O
amino IN O
acids NNS O
of IN O
the DT O
antigenic JJ B-NP
regions NNS I-NP
A DT I-NP
, , I-NP
B NNP I-NP
and CC I-NP
C NNP I-NP
of IN I-NP
VP7 NNPS I-NP
were VBD O
nearly RB O
conserved VBN O
within IN O
the DT O
phylogenetic JJ O
lineages NNS O
. . O

-DOCSTART- X X O

The DT O
cloned VBD O
alcR NN B-NP
gene NN I-NP
provided VBN O
in IN O
trans NNS O
restored VBN O
these DT O
siderophore NN O
system NN O
activities NNS O
to TO O
the DT O
mutants NNS O
. . O

-DOCSTART- X X O

Copyright NNP O
1998 CD O
Academic NNP O
Press NNP O
. . O

-DOCSTART- X X O

It PRP O
may MD O
also RB O
be VB O
suggested VBN O
that IN O
particular JJ O
care NN O
should MD O
be VB O
taken VBN O
when WRB O
such JJ O
a DT O
trans-dominant JJ O
Rev NNP B-NP
mutant NN I-NP
is VBZ O
considered VBN O
to TO O
be VB O
used VBN O
as IN O
a DT O
genetic JJ O
therapy NN O
against IN O
HIV-I PRP$ O
infection NN O
, , O
in IN O
individuals NNS O
infected VBN O
with IN O
both DT O
HIV-I NNP O
and CC O
HTLV-1 NNP O
. . O

-DOCSTART- X X O

We PRP O
analyzed VBD O
the DT O
P-SAECG NN O
in IN O
the DT O
time NN O
and CC O
frequency NN O
domain NN O
in IN O
23 CD O
patients NNS O
with IN O
Paf NNP O
and CC O
19 CD O
controls NNS O
. . O

-DOCSTART- X X O

Competitive JJ O
reverse NN O
transcription-polymerase NN O
chain NN O
reaction NN O
and CC O
HPLC NNP O
analysis NN O
showed VBD O
that IN O
RUSH-1alpha NNP B-NP
is VBZ O
the DT O
progesterone-dependent NN O
splice NN O
variant NN O
. . O

-DOCSTART- X X O

Transcervical NNP O
amnioinfusion NN O
. . O

-DOCSTART- X X O

SETTING NN O
: : O
A DT O
division NN O
of IN O
a DT O
large JJ O
tea NN O
plantation NN O
in IN O
Kandy NNP O
. . O

-DOCSTART- X X O

In IN O
order NN O
to TO O
decipher VB O
the DT O
pathway NN O
that WDT O
leads VBZ O
to TO O
Hox NNP B-NP
gene NN I-NP
induction NN O
, , O
we PRP O
have VBP O
investigated VBN O
whether IN O
a DT O
Hox NNP B-NP
gene NN I-NP
regulator NN O
, , O
the DT O
leucine NN O
zipper NN O
transcription NN O
factor NN O
MafB/Kr NNP B-NP
, , O
is VBZ O
itself PRP O
transcriptionally RB O
regulated VBN O
by IN O
the DT O
environmental JJ O
signals NNS O
. . O

-DOCSTART- X X O

Reporter NNP O
constructs NNS O
function NN O
in IN O
a DT O
parallel JJ O
manner NN O
, , O
demonstrating VBG O
the DT O
key JJ O
role NN O
of IN O
the DT O
AhR NNP B-NP
in IN O
constitutive JJ O
as RB O
well RB O
as IN O
TCDD-induced JJ O
expression NN O
of IN O
Cyp1B1 NNP B-NP
in IN O
mouse NN O
embryo NN O
fibroblasts NNS O
. . O

-DOCSTART- X X O

Transfection NN O
studies NNS O
also RB O
showed VBD O
that IN O
3'-deletion NN O
of IN O
sequences NNS O
downstream NN O
of IN O
the DT O
transcriptional JJ O
start NN O
site NN O
( -LRB- O
+1/+47 CD O
) -RRB- O
markedly RB O
reduced VBD O
OSM NNP B-NP
-fold JJ O
induction NN O
. . O

-DOCSTART- X X O

The DT O
COOH-terminal JJ O
region NN O
of IN O
the DT O
transcripts NNS O
contained VBD O
fifteen CD O
triplet NN O
repeats NNS O
( -LRB- O
GCT NNP O
; : O
alanine JJR O
) -RRB- O
at IN O
nucleotide JJ O
465 CD O
to TO O
509 CD O
, , O
which WDT O
is VBZ O
significantly RB O
expanded VBN O
compared VBN O
to TO O
the DT O
rat NN B-NP
RL14 NN I-NP
. . O

-DOCSTART- X X O

Control NNP O
of IN O
fatty JJ O
liver NN O
syndrome NN O
in IN O
a DT O
Jersey NNP O
herd NN O
by IN O
a DT O
change NN O
of IN O
diet NN O
and CC O
the DT O
use NN O
of IN O
recombinant JJ O
bovine NN O
somatotrophin NN B-NP
. . O

-DOCSTART- X X O

C.D2-Chr JJ O
4 CD O
congenic JJ O
strains NNS O
harboring VBG O
DBA/2 NNP O
alleles NNS O
associated VBN O
with IN O
the DT O
Pctr1 NNP B-NP
locus NN I-NP
contained VBD O
DBA/2 CD O
"resistant JJ O
" '' O
alleles NNS O
of IN O
the DT O
CDK4/CDK6 NNP B-NP
inhibitors NNS O
p16 VBD B-NP
and CC O
p15 VBD B-NP
. . O

-DOCSTART- X X O

Alison NNP O
Bell NNP O
Memorial NNP O
Award NNP O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
A DT O
population NN O
survey NN O
was VBD O
undertaken VBN O
in IN O
10,148 CD O
individuals NNS O
to TO O
measure VB O
the DT O
prevalence NN O
and CC O
identify VB O
the DT O
causes NNS O
of IN O
blindness NN O
in IN O
Lebanon NNP O
. . O

-DOCSTART- X X O

During IN O
organogenesis NN O
, , O
HFH-8 CC B-NP
expression NN O
is VBZ O
found VBN O
in IN O
the DT O
splanchnic JJ O
mesoderm NN O
in IN O
close JJ O
apposition NN O
of IN O
the DT O
gut NN O
endoderm NN O
, , O
suggesting VBG O
a DT O
role NN O
in IN O
mesenchymal-epithelial JJ O
induction NN O
of IN O
lung NN O
and CC O
gut NN O
morphogenesis NN O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
duration NN O
of IN O
pain NN O
relief NN O
was VBD O
4-6 JJ O
weeks NNS O
. . O

-DOCSTART- X X O

The DT O
ESEM NNP O
differs NNS O
from IN O
conventional JJ O
SEM NNP O
in IN O
that IN O
no DT O
sample NN O
preparation NN O
is VBZ O
needed VBN O
, , O
eliminating VBG O
artifactual JJ O
changes NNS O
. . O

-DOCSTART- X X O

Sp1 NNP B-NP
can MD O
activate VB O
transcription NN O
through IN O
immunoglobulin NN B-NP
kappa-chain NN I-NP
enhancer NN I-NP
or CC O
P-selectin NNP B-NP
promoter NN I-NP
NF-kappaB NN B-NP
sites NNS I-NP
. . O
p50 NN B-NP
homodimers NNS I-NP
replace VBP O
Sp1 NNP B-NP
from IN O
the DT O
P-selectin NNP B-NP
promoter NN I-NP
by IN O
binding JJ O
site NN O
competition NN O
and CC O
thereby RB O
either RB O
inhibit VBP O
basal NN O
Sp1-driven JJ B-NP
expression NN O
or CC O
, , O
in IN O
concert NN O
with IN O
Bcl-3 NN B-NP
, , O
stimulate VB O
expression NN O
. . O

-DOCSTART- X X O

The DT O
TATA NNP B-NP
box-binding JJ I-NP
protein NN I-NP
( -LRB- O
TBP NN B-NP
) -RRB- O
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
transcription NN O
by IN O
all DT O
three CD O
eukaryotic JJ O
nuclear JJ B-NP
RNA NNP I-NP
polymerases NNS I-NP
, , O
polymerases NNS B-NP
( -LRB- I-NP
Pol NNP I-NP
) -RRB- I-NP
I PRP I-NP
, , I-NP
II NNP I-NP
, , I-NP
and CC I-NP
III NNP I-NP
. . O

-DOCSTART- X X O

A DT O
triple-mutant JJ B-NP
TBP NNP I-NP
( -LRB- O
R231E NNP O
+ NNP O
R235E NNP O
+ JJ O
R239S NNS O
) -RRB- O
had VBD O
greatly RB O
reduced VBN O
activity NN O
for IN O
yeast NN B-NP
U6 IN I-NP
snRNA VBN I-NP
gene NN I-NP
transcription NN O
while IN O
remaining VBG O
active JJ O
for IN O
Pol NNP B-NP
II NNP I-NP
basal NN O
transcription NN O
. . O

-DOCSTART- X X O

To TO O
determine VB O
the DT O
true JJ O
molecular JJ O
identity NN O
of IN O
SFD NNP B-NP
, , O
both CC O
the DT O
50- CD O
and CC O
57-kDa JJ O
polypeptides NNS O
were VBD O
directly RB O
sequenced VBN O
. . O

-DOCSTART- X X O

This DT O
structure NN O
interconnects VBZ O
specific JJ O
triplets NNS O
of IN O
the DT O
basal JJ O
bodies NNS O
with IN O
the DT O
microtubular JJ O
bundles NNS O
that WDT O
emerge VBP O
from IN O
the DT O
basal JJ O
apparatus NN O
. . O

-DOCSTART- X X O

To TO O
understand VB O
the DT O
regulatory JJ O
mechanism NN O
controlling VBG O
its PRP$ O
expression NN O
at IN O
low JJ O
temperature NN O
, , O
the DT O
promoter NN O
region NN O
has VBZ O
been VBN O
characterized VBN O
. . O

-DOCSTART- X X O

For IN O
the DT O
5HT5A JJ B-NP
receptor NN I-NP
the DT O
addition NN O
of IN O
yohimbine NN O
resulted VBD O
in IN O
a DT O
similar JJ O
but CC O
smaller JJR O
effect NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
examined VBN O
reporter NN O
gene NN O
( -LRB- O
beta-gal JJ B-NP
) -RRB- O
expression NN O
directed VBN O
by IN O
human JJ B-NP
heat NN I-NP
shock NN I-NP
transcription NN I-NP
factors NNS I-NP
1 CD I-NP
and CC I-NP
2 CD I-NP
( -LRB- O
HSF1 NNP B-NP
and CC O
HSF2 NNP B-NP
) -RRB- O
in IN O
HeLa NNP O
cells NNS O
and CC O
in IN O
yeast NN O
( -LRB- O
Saccharomyces NNP O
cerevisiae NN O
) -RRB- O
. . O

-DOCSTART- X X O

Its PRP$ O
expression NN O
pattern NN O
is VBZ O
representative JJ O
of IN O
many JJ O
B NNP O
cell-specific JJ O
proteins NNS O
, , O
which WDT O
are VBP O
essential JJ O
for IN O
B NNP O
cell NN O
development NN O
and CC O
activation NN O
but CC O
are VBP O
down-regulated JJ O
after IN O
B NNP O
cells NNS O
become VBP O
terminally RB O
differentiated JJ O
plasma NN O
cells NNS O
. . O

-DOCSTART- X X O

Infectious JJ O
mutant JJ O
virus NN O
progeny NN O
was VBD O
obtained VBN O
only RB O
on IN O
complementing VBG O
gK-expressing JJ B-NP
cells NNS O
, , O
suggesting VBG O
that IN O
gK NN B-NP
has VBZ O
an DT O
important JJ O
function NN O
in IN O
the DT O
replication NN O
cycle NN O
. . O

-DOCSTART- X X O

Cleavage NNP O
and CC O
DNA NNP O
joining VBG O
reactions NNS O
, , O
carried VBD O
out RP O
by IN O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( -LRB- I-NP
HIV-1 NN I-NP
) -RRB- I-NP
integrase NN I-NP
, , O
are VBP O
necessary JJ O
to TO O
effect VB O
the DT O
covalent JJ O
insertion NN O
of IN O
HIV-1 PRP$ O
DNA NN O
into IN O
the DT O
host NN O
genome NN O
. . O

-DOCSTART- X X O

Activation NN O
of IN O
the DT O
mitogen NN B-NP
activated JJ I-NP
protein NN I-NP
( -LRB- I-NP
MAP NNP I-NP
) -RRB- I-NP
kinase NN I-NP
is VBZ O
a DT O
primary JJ O
consequence NN O
of IN O
Ras NNP B-NP
activation NN O
and CC O
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
mediating VBG O
Ras NNP B-NP
signal NN O
transduction NN O
. . O

-DOCSTART- X X O

Histone NN B-NP
acetylation NN O
levels NNS O
in IN O
cells NNS O
result VBP O
from IN O
a DT O
dynamic JJ O
equilibrium NN O
between IN O
competing VBG O
histone NN B-NP
acetylases NNS I-NP
and CC I-NP
deacetylases NNS I-NP
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
XCoe2 NNP B-NP
may MD O
play VB O
a DT O
pivotal JJ O
role NN O
in IN O
the DT O
transcriptional JJ O
cascade NN O
that WDT O
specifies VBZ O
primary JJ O
neurons NNS O
in IN O
Xenopus NNP O
embryos NNS O
: : O
by IN O
maintaining VBG O
Delta-Notch NNP B-NP
signalling NN O
, , O
XCoe2 NNP B-NP
stabilises VBZ O
the DT O
higher JJR O
neural JJ O
potential NN O
of IN O
selected VBN O
progenitor NN O
cells NNS O
that WDT O
express VBP O
X-ngnr-1 NN B-NP
, , O
ensuring VBG O
the DT O
transition NN O
between IN O
neural JJ O
competence NN O
and CC O
irreversible JJ O
commitment NN O
to TO O
a DT O
neural JJ O
fate NN O
; : O
and CC O
it PRP O
promotes VBZ O
neuronal JJ O
differentiation NN O
by IN O
activating VBG O
XNeuroD NNP B-NP
expression NN O
, , O
directly RB O
or CC O
indirectly RB O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Patients NNS O
in IN O
Group NNP O
A NNP O
had VBD O
a DT O
higher JJR O
incidence NN O
of IN O
posterolateral JJ O
wall NN O
motion NN O
abnormalities NNS O
( -LRB- O
p NN O
< JJ O
0.001 CD O
) -RRB- O
on IN O
radionuclide NN O
ventriculography NN O
, , O
a DT O
larger JJR O
infarct NN O
area NN O
( -LRB- O
as IN O
evidenced VBN O
by IN O
higher JJR O
peak NN O
creatine NN B-NP
kinase NN I-NP
levels NNS O
) -RRB- O
( -LRB- O
p NN O
< JJ O
0.02 CD O
) -RRB- O
and CC O
a DT O
lower JJR O
left VBN O
ventricular JJ O
ejection NN O
fraction NN O
( -LRB- O
LVEF NN O
) -RRB- O
at IN O
hospital NN O
discharge NN O
( -LRB- O
p NN O
< JJ O
0.008 CD O
) -RRB- O
than IN O
those DT O
in IN O
Group NNP O
B. NNP O

-DOCSTART- X X O

CyIIa NNP B-NP
transcription NN O
follows VBZ O
, , O
and CC O
is VBZ O
therefore RB O
downstream RB O
of IN O
, , O
the DT O
initial JJ O
specification NN O
of IN O
these DT O
embryonic JJ O
domains NNS O
. . O

-DOCSTART- X X O

We PRP O
also RB O
present JJ O
evidence NN O
that IN O
human JJ B-NP
HYAL1 NNP I-NP
is VBZ O
identical JJ O
to TO O
an DT O
uncharacterized JJ O
gene NN O
positionally RB O
cloned VBN O
by IN O
others NNS O
from IN O
chromosome NN O
3p21.3 CD O
that WDT O
is VBZ O
homozygously RB O
deleted VBN O
in IN O
several JJ O
small-cell JJ O
lung NN O
carcinoma NN O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

In IN O
patients NNS O
with IN O
myalgia NNP O
, , O
Raynaud NNP O
's POS O
syndrome NN O
, , O
skin NN O
vasculitis NN O
and CC O
vascular JJ O
diseases NNS O
WFAg IN B-NP
concentrations NNS O
were VBD O
higher JJR O
than IN O
in IN O
patients NNS O
without IN O
them PRP O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
intragenic JJ O
revertants NNS O
shows VBZ O
that IN O
this DT O
function NN O
depends VBZ O
on IN O
the DT O
amino JJ O
acid NN O
preceding VBG O
the DT O
first JJ O
cysteine NN O
residue NN O
of IN O
the DT O
DNA-binding JJ O
domain NN O
of IN O
Hap1p NNP B-NP
. . O

-DOCSTART- X X O

A DT O
review NN O
of IN O
studies NNS O
published VBN O
between IN O
1983 CD O
and CC O
1995 CD O
shows NNS O
that IN O
there EX O
are VBP O
some DT O
common JJ O
factors NNS O
as IN O
regards NNS O
the DT O
psychological JJ O
distress NN O
and CC O
social JJ O
and CC O
functional JJ O
limitations NNS O
this DT O
group NN O
of IN O
patients NNS O
has VBZ O
to TO O
deal VB O
with IN O
. . O

-DOCSTART- X X O

We PRP O
further JJ O
show NN O
that IN O
proteolytic JJ O
targeting VBG O
by IN O
calpain NN B-NP
II NNP I-NP
and CC O
the DT O
proteasome NN O
involves VBZ O
different JJ O
structural JJ O
elements NNS O
of IN O
YY1 NNP B-NP
. . O

-DOCSTART- X X O

Primers NNS O
for IN O
subsequent JJ O
rounds NNS O
of IN O
RACE NNP O
were VBD O
designed VBN O
from IN O
the DT O
5'-ends NNS O
of IN O
amplified JJ O
RACE NNP O
products NNS O
. . O

-DOCSTART- X X O

Surprisingly RB O
, , O
the DT O
CSF1R/IRDelta960 NNP B-NP
was VBD O
as RB O
effective JJ O
as IN O
the DT O
CSF1R/IR NNP B-NP
in IN O
mediating VBG O
CSF-1 JJ B-NP
protection NN O
of IN O
cells NNS O
from IN O
staurosporine-induced JJ O
apoptosis NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
The DT O
special JJ O
clinical JJ O
presentation NN O
of IN O
our PRP$ O
case NN O
of IN O
possible JJ O
Gardner NNP O
's POS O
syndrome NN O
is VBZ O
discussed VBN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
would MD O
suggest VB O
that IN O
a DT O
high JJ O
UV NN O
sensitivity NN O
is VBZ O
associated VBN O
with IN O
high JJ O
phaeomelanin NN O
and CC O
low JJ O
eumelanin NN O
levels NNS O
, , O
and CC O
point NN O
to TO O
the DT O
eumelanin/phaeomelanin NN O
ratio NN O
as IN O
a DT O
novel JJ O
chemical NN O
parameter NN O
that WDT O
could MD O
be VB O
used VBN O
for IN O
predicting VBG O
individuals NNS O
at IN O
high JJ O
risk NN O
for IN O
skin NN O
cancer NN O
and CC O
melanoma NN O
. . O

-DOCSTART- X X O

The DT O
cAMP-dependent JJ O
mitogenic JJ O
pathway NN O
is VBZ O
unique JJ O
as IN O
it PRP O
is VBZ O
independent JJ O
of IN O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
activation NN O
and CC O
differs NNS O
from IN O
growth NN O
factor-dependent NN O
pathways NNS O
at IN O
the DT O
level NN O
of IN O
the DT O
expression NN O
of IN O
several JJ O
protooncogenes/transcription NN O
factors NNS O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Use NN O
of IN O
the DT O
first JJ O
method NN O
was VBD O
associated VBN O
with IN O
a DT O
reduction NN O
in IN O
the DT O
time NN O
patients NNS O
remained VBD O
in IN O
the DT O
ICU NNP O
before IN O
transfer NN O
to TO O
another DT O
unit NN O
and CC O
savings NNS O
in IN O
nursing NN O
time NN O
, , O
but CC O
the DT O
two CD O
methods NNS O
did VBD O
not RB O
differ VB O
according VBG O
to TO O
clinical JJ O
outcomes NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
elucidated VBN O
the DT O
exon-intron NN O
organization NN O
of IN O
the DT O
entire JJ O
human JJ O
CD58 NN B-NP
gene NN I-NP
, , O
including VBG O
approximately RB O
2.5 CD O
kilobases NNS O
(kb JJ O
) -RRB- O
of IN O
5'-flanking JJ O
DNA NN O
. . O

-DOCSTART- X X O

Two CD O
hundred CD O
sixty-four CD O
patients NNS O
scheduled VBN O
for IN O
DCBM NNP O
were VBD O
randomized VBN O
to TO O
receive VB O
intravenously RB O
geG JJ O
0.25 CD O
mg NN O
( -LRB- O
geG-25 CD O
) -RRB- O
, , O
or CC O
geG JJ O
0.5 CD O
mg NN O
( -LRB- O
geG-50 NN O
) -RRB- O
, , O
or CC O
HBB NNP O
20 CD O
mg NN O
as IN O
hypotonic JJ O
agent NN O
. . O

-DOCSTART- X X O

If IN O
the DT O
haemoglobin NN B-NP
concentration NN O
( -LRB- O
Hb NN B-NP
) -RRB- O
was VBD O
less JJR O
than IN O
12 CD O
g NN O
dL-1 NN O
they PRP O
were VBD O
given VBN O
a DT O
four CD O
week NN O
course NN O
of IN O
ferrous JJ O
sulphate NN O
. . O

-DOCSTART- X X O

In IN O
all DT O
cells NNS O
, , O
the DT O
accumulation NN O
of IN O
high JJ O
Dsg JJ B-NP
protein NN I-NP
levels NNS O
required VBD O
calcium NN O
and CC O
was VBD O
not RB O
observed VBN O
in IN O
low JJ O
calcium NN O
( -LRB- O
0.05-0.07 CD O
mM NN O
) -RRB- O
media NNS O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
restriction NN O
enzyme NN O
analysis NN O
, , O
Southern JJ O
blots NNS O
, , O
polymerase NN O
chain NN O
reaction NN O
analysis NN O
and CC O
DNA NNP O
sequencing NN O
, , O
it PRP O
was VBD O
confirmed VBN O
that IN O
the DT O
three CD O
overlapping JJ O
clones NNS O
isolated VBD O
cover VB O
the DT O
entire JJ O
cHO-1 JJ B-NP
gene NN I-NP
, , O
as RB O
well RB O
as IN O
approximately RB O
10 CD O
kb NN O
of IN O
the DT O
flanking NN O
regions NNS O
on IN O
both DT O
ends NNS O
. . O

-DOCSTART- X X O

E1A PRP B-NP
represses VBZ O
apolipoprotein RB B-NP
AI JJ I-NP
enhancer NN I-NP
activity NN O
in IN O
liver NN O
cells NNS O
through IN O
a DT O
pRb JJ B-NP
- : O
and CC O
CBP-independent JJ B-NP
pathway NN O
. . O

-DOCSTART- X X O

Position-independent JJ O
expression NN O
of IN O
a DT O
human JJ O
nerve NN B-NP
growth NN I-NP
factor-luciferase NN I-NP
reporter NN O
gene NN O
cloned VBD O
on IN O
a DT O
yeast NN O
artificial JJ O
chromosome NN O
vector NN O
. . O

-DOCSTART- X X O

Calcitriol NNP O
therapy NN O
was VBD O
associated VBN O
with IN O
a DT O
decrease NN O
in IN O
serum NN O
iPTH NN B-NP
levels NNS O
( -LRB- O
701 CD O
+/ NN O
- : O
103.9 CD O
vs. NN O

-DOCSTART- X X O

Alterations NNP O
in IN O
DNase NNP B-NP
I PRP I-NP
reactivity NN O
of IN O
the DT O
GC-response NNP O
element NN O
region NN O
suggest VBP O
that IN O
GC NNP B-NP
receptor-GC NNP I-NP
complexes NNS I-NP
may MD O
associate VB O
, , O
in IN O
a DT O
transient JJ O
manner NN O
, , O
with IN O
the DT O
promoter NN O
in IN O
the DT O
actively RB O
transcribing VBG O
control NN O
state NN O
. . O

-DOCSTART- X X O

Most RBS O
pituitary JJ O
hormone-coding JJ O
gene NN O
promoters NNS O
are VBP O
activated VBN O
by IN O
Ptx1 NNP B-NP
. . O

-DOCSTART- X X O

One CD O
of IN O
these DT O
small JJ B-NP
inteins NNS I-NP
might MD O
be VB O
inactive JJ O
or CC O
a DT O
"pseudo NNP B-NP
intein NN I-NP
. . I-NP
" '' I-NP
The DT O
results NNS O
suggest VBP O
a DT O
modular JJ O
architecture NN O
for IN O
inteins NNS B-NP
, , O
clarify VB O
their PRP$ O
origin NN O
and CC O
relationship NN O
to TO O
other JJ O
protein NN O
families NNS O
, , O
and CC O
extend VB O
recent JJ O
experimental JJ O
findings NNS O
on IN O
the DT O
functional JJ O
roles NNS O
of IN O
intein NN B-NP
N NNP I-NP
, , I-NP
C NNP I-NP
, , I-NP
and CC I-NP
EN NNS I-NP
motifs NNS I-NP
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
TGF-betaf NNP B-NP
potentiates VBZ O
the DT O
c-fos JJ B-NP
SRE NNP O
activated VBN O
by IN O
PKC NNP B-NP
through IN O
the DT O
SRF NNP B-NP
binding NN I-NP
site NN I-NP
. . O

-DOCSTART- X X O

RT-PCR NNP O
indicated VBD O
that IN O
p21 DT B-NP
mRNA NN I-NP
was VBD O
induced VBN O
1.4-, JJ O
2.0-, JJ O
and CC O
3.1-fold JJ O
in IN O
the DT O
2-day JJ O
neonatal NN O
, , O
7-day JJ O
neonatal JJ O
, , O
and CC O
adult JJ O
stages NNS O
, , O
respectively RB O
, , O
compared VBN O
to TO O
the DT O
17-day JJ O
fetal NN O
stage NN O
. . O

-DOCSTART- X X O

Ganciclovir NNP O
and CC O
foscarnet JJ O
efficacy NN O
in IN O
AIDS-related JJ O
CMV NNP O
polyradiculopathy NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
identified VBN O
two CD O
functional JJ O
elements NNS O
, , O
both DT O
located VBN O
downstream NN O
from IN O
the DT O
TATA NNP O
motif NN O
, , O
that IN O
control NN O
Id4 IN B-NP
promoter NN I-NP
activity NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
AND CC O
OBJECTIVES NNP O
: : O
The DT O
sexually RB O
transmitted JJ O
diseases NNS O
(STD IN O
) -RRB- O
control NN O
program NN O
for IN O
female JJ O
sex NN O
workers NNS O
( -LRB- O
FSW) NN O
in IN O
Lima NNP O
, , O
Peru NNP O
, , O
provided VBD O
periodic JJ O
serological JJ O
tests NNS O
for IN O
syphilis NNS O
and CC O
cervical JJ O
smears NNS O
for IN O
gonococci NNS O
, , O
but CC O
not RB O
medication NN O
for IN O
STD NNP O
or CC O
condoms NNS O
. . O

-DOCSTART- X X O

Two CD O
rare JJ O
novel NN O
mutations NNS O
, , O
D811N NNP O
in IN O
exon JJ O
20 CD O
and CC O
R835C NNP O
in IN O
exon NN O
21 CD O
, , O
were VBD O
identified VBN O
in IN O
the DT O
first JJ O
nucleotide-binding JJ O
fold NN O
( -LRB- O
NBF) NNP O
, , O
a DT O
functionally RB O
important JJ O
region NN O
of IN O
SUR1 NNP B-NP
, , O
in IN O
one CD O
patient NN O
each DT O
, , O
both DT O
heterozygotes NNS O
. . O

-DOCSTART- X X O

Chimaeric JJ O
VP16-E2 JJ B-NP
molecules NNS O
suggest VBP O
that IN O
the DT O
epithelial NN O
specific JJ O
transcriptional JJ O
activation NN O
of IN O
the DT O
BPV-4 NNP B-NP
LCR NNP I-NP
promoter NN I-NP
is VBZ O
mediated VBN O
by IN O
the DT O
E2 NNP B-NP
transactivation NN I-NP
domain NN I-NP
. . O

-DOCSTART- X X O

These DT O
changes NNS O
correlate VBP O
directly RB O
with IN O
an DT O
increase NN O
in IN O
the DT O
acetylation NN O
levels NNS O
of IN O
all DT O
four CD O
core NN B-NP
histones NNS I-NP
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Drosophila NNP B-NP
orthodenticle NN I-NP
(otd NN O
) -RRB- O
and CC O
murine NN B-NP
Otx JJ I-NP
genes NNS I-NP
exemplify VBP O
this DT O
, , O
both DT O
in IN O
terms NNS O
of IN O
expression NN O
patterns NNS O
and CC O
mutant JJ O
phenotypes NNS O
. . O

-DOCSTART- X X O

APETALA3 DT B-NP
transcripts NNS I-NP
are VBP O
first JJ O
detected VBN O
in IN O
a DT O
meristematic JJ O
region NN O
that WDT O
will MD O
give VB O
rise NN O
to TO O
the DT O
petal NN O
and CC O
stamen VB O
primordia NN O
, , O
and CC O
expression NN O
is VBZ O
maintained VBN O
in IN O
this DT O
region NN O
during IN O
subsequent JJ O
development NN O
of IN O
these DT O
organs NNS O
. . O

-DOCSTART- X X O

We PRP O
also RB O
recovered VBD O
mutations NNS O
in IN O
the DT O
60A JJ B-NP
gene NN I-NP
which WDT O
encodes VBZ O
another DT O
TGF-beta-related JJ B-NP
factor NN I-NP
in IN O
Drosophila NNP O
. . O

-DOCSTART- X X O

Cell NN O
lines NNS O
are VBP O
checked VBN O
to TO O
find VB O
out RP O
whether IN O
they PRP O
develop VBP O
tumors NNS O
in IN O
nude JJ O
mice NNS O
followed VBN O
by IN O
an DT O
analysis NN O
of IN O
the DT O
karyotype NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
IgM NNP B-NP
can MD O
be VB O
absent JJ O
in IN O
children NNS O
with IN O
congenital JJ O
toxoplasmosis NN O
or CC O
subjects NNS O
with IN O
secondary JJ O
reactivation NN O
. . O

-DOCSTART- X X O

Both DT O
variants NNS O
display VBP O
the DT O
seven-transmembrane JJ O
topology NN O
that WDT O
is VBZ O
typical JJ O
for IN O
G NNP B-NP
protein-coupled JJ I-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

A DT O
constitutive JJ O
allele NN O
of IN O
GPA2 NNP B-NP
could MD O
stimulate VB O
growth NN O
of IN O
a DT O
strain NN O
lacking VBG O
both DT O
RAS NNP B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

The DT O
COOH-terminus NNP O
of IN O
this DT O
new JJ O
isoform NN O
, , O
which WDT O
we PRP O
designate VBP O
beta JJ B-NP
4 CD I-NP
, , O
lacks VBZ O
a DT O
22 CD O
amino IN O
acid NN O
lysine-rich JJ O
sequence NN O
common JJ O
to TO O
both DT O
the DT O
human JJ B-NP
red JJ I-NP
cell NN I-NP
alpha NN I-NP
- : I-NP
and CC I-NP
beta-adducin JJ I-NP
subunits NNS I-NP
and CC O
homologous JJ O
to TO O
a DT O
highly RB O
conserved VBN O
region NN O
in IN O
MARCKS NNP B-NP
, , O
a DT O
filamentous JJ O
actin-cross NN B-NP
linking VBG O
protein NN O
regulated VBN O
by IN O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
and CC O
calcium/calmodulin NN O
. . O
beta NN B-NP
4-adducin JJ I-NP
preserves NNS O
a DT O
previously RB O
identified VBN O
calmodulin NN B-NP
binding JJ I-NP
domain NN I-NP
. . O

-DOCSTART- X X O

The DT O
plant NN O
protein NN O
maintains VBZ O
all PDT O
the DT O
functional JJ O
domains NNS O
found VBD O
in IN O
the DT O
other JJ O
proteins NNS O
, , O
including VBG O
nuclear JJ O
localization NN O
signal NN O
, , O
DNA-binding NNP O
domain NN O
and CC O
helicase NN B-NP
motifs NNS I-NP
, , O
suggesting VBG O
that IN O
it PRP O
might MD O
also RB O
act VB O
as IN O
part NN O
of IN O
the DT O
RNA NNP O
transcription NN O
apparatus NN O
, , O
as RB O
well RB O
as IN O
nucleotide JJ O
excision NN O
repair NN O
in IN O
plant NN O
cells NNS O
. . O

-DOCSTART- X X O

This DT O
paper NN O
describes VBZ O
the DT O
genomic JJ O
organization NN O
of IN O
mouse NN O
gC1qBP NN B-NP
and CC O
the DT O
characterization NN O
of IN O
its PRP$ O
5' JJ O
flanking JJ O
region NN O
. . O

-DOCSTART- X X O

LysR JJ B-NP
proteins NNS I-NP
have VBP O
been VBN O
shown VBN O
to TO O
regulate VB O
urease NN B-NP
in IN I-NP
Klebsiella NNP I-NP
aerogenes NNS I-NP
( -LRB- O
NAC NNP B-NP
) -RRB- O
, , O
and CC O
catalase NN B-NP
in IN I-NP
Escherichia NNP I-NP
coli NNS I-NP
( -LRB- O
OxyR NN B-NP
) -RRB- O
, , O
which WDT O
offers VBZ O
the DT O
intracellular JJ O
bacterium NN O
protection NN O
from IN O
phagolysosome JJ O
damage NN O
. . O

-DOCSTART- X X O

Full-length NNP B-NP
FLAP NNP I-NP
clones NNS O
were VBD O
isolated VBN O
from IN O
a DT O
mouse NN O
skeletal NN O
muscle NN O
cDNA IN O
library NN O
. . O

-DOCSTART- X X O

Members NNS O
of IN O
the DT O
meis1 NN B-NP
and CC O
pbx NN B-NP
homeodomain NN I-NP
protein NN I-NP
families NNS I-NP
cooperatively RB O
bind VBP O
a DT O
cAMP-responsive JJ O
sequence NN O
( -LRB- O
CRS1 NNP O
) -RRB- O
from IN O
bovine NN B-NP
CYP17 NN I-NP
. . O

-DOCSTART- X X O

We PRP O
have VBP O
visualized VBN O
DNA-protein NNP O
complexes NNS O
by IN O
electron NN O
microscopy NN O
and CC O
a DT O
high-affinity NN O
binding NN O
site NN O
of IN O
WDV NNP B-NP
Rep NNP I-NP
protein NN I-NP
within IN O
the DT O
core NN O
element NN O
has VBZ O
been VBN O
mapped VBN O
to TO O
approximately RB O
144 CD O
+/ NNS O
- : O
18 CD O
bp NN O
upstream RB O
from IN O
the DT O
initiation NN O
site NN O
, , O
between IN O
the DT O
start NN O
site NN O
for IN O
complementary-sense JJ O
transcription NN O
and CC O
the DT O
TATA NNP O
box NN O
. . O

-DOCSTART- X X O

Alternative JJ O
splicing NN O
of IN O
fibroblast JJ B-NP
growth NN I-NP
factor NN I-NP
receptor NN I-NP
2 CD I-NP
( -LRB- O
FGF-R2 NN B-NP
) -RRB- O
is VBZ O
an DT O
example NN O
of IN O
highly RB O
regulated VBN O
alternative JJ O
splicing NN O
in IN O
which WDT O
exons VBD O
IIIb NNP O
and CC O
IIIc NNP O
are VBP O
utilized VBN O
in IN O
a DT O
mutually RB O
exclusive JJ O
manner NN O
in IN O
different JJ O
cell NN O
types NNS O
. . O

-DOCSTART- X X O

The DT O
genomic JJ O
fragments NNS O
were VBD O
fused VBN O
upstream RB O
of IN O
the DT O
luciferase NN B-NP
reporter NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Deletion NNP O
of IN O
the DT O
last JJ O
two CD O
Ser NN O
residues NNS O
, , O
including VBG O
one CD O
PKC NNP B-NP
consensus NN O
site NN O
in IN O
the DT O
receptor NN O
tail NN O
, , O
prevented VBD O
only RB O
phorbol JJ O
12-myristate JJ O
13-acetate-induced JJ O
desensitization NN O
by IN O
30 CD O
% NN O
. . O

-DOCSTART- X X O

Despite IN O
its PRP$ O
requirement NN O
for IN O
enhancer-dependent JJ O
splicing NN O
activity NN O
in IN O
vitro NN O
, , O
the DT O
dU2AF38 NNS B-NP
RS NNP I-NP
domain NN I-NP
was VBD O
also RB O
inessential JJ O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

The DT O
addition NN O
of IN O
a DT O
Paf-containing NN B-NP
extract VB O
does VBZ O
not RB O
lead VB O
to TO O
significant JJ O
protein NN O
binding NN O
to TO O
these DT O
two CD O
hly RB B-NP
target NN I-NP
sequences NNS I-NP
in IN O
the DT O
absence NN O
of IN O
PrfA NNP B-NP
but CC O
converts VBZ O
the DT O
complex JJ O
( -LRB- O
CIII NN O
) -RRB- O
consisting VBG O
of IN O
PrfA NNP B-NP
and CC O
the DT O
109 CD B-NP
bp NN I-NP
hly RB I-NP
DNA NNP I-NP
fragment NN I-NP
to TO O
a DT O
slower JJR O
migrating JJ O
PrfA-Paf-DNA NN B-NP
complex NN O
( -LRB- O
CI) NN O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
it PRP O
is VBZ O
the DT O
assumptions NNS O
behind IN O
steady-state JJ O
O2 NNP O
uptake NN O
that WDT O
do VBP O
not RB O
permit VB O
proper JJ O
interpretation NN O
of IN O
energy NN O
expenditure NN O
during IN O
EPOC NNP O
; : O
1 CD O
l NN O
O2 IN O
not RB O
= SYM O
20.9 CD O
kJ. . O

-DOCSTART- X X O

The DT O
predicted VBD O
amino IN O
acid JJ O
sequence NN O
of IN O
m-Staf NN B-NP
is VBZ O
highly RB O
homologous JJ O
to TO O
that DT O
of IN O
Staf NNP B-NP
, , O
another DT O
selenocysteine NN B-NP
tRNA NN I-NP
gene NN I-NP
transcription NN I-NP
activating VBG I-NP
factor NN I-NP
of IN O
Xenopus NNP O
laevis NNS O
. . O

-DOCSTART- X X O

Among IN O
three CD O
isoforms NNS O
, , O
the DT O
beta JJ O
isoform NN O
has VBZ O
the DT O
greatest JJS O
Vmax NN O
value NN O
for IN O
the DT O
PtdIns( NNP B-NP
4)P IN I-NP
kinase NN I-NP
activity NN O
and CC O
the DT O
gamma NN O
isoform NN O
is VBZ O
most RBS O
markedly RB O
stimulated VBN O
by IN O
phosphatidic JJ O
acid NN O
. . O

-DOCSTART- X X O

Two CD O
differentially RB O
expressed VBD O
LNX JJ B-NP
messages NNS I-NP
encode JJ O
overlapping JJ O
proteins NNS O
with IN O
predicted VBN O
molecular JJ O
masses NNS O
of IN O
80 CD B-NP
kDa NN I-NP
( -LRB- I-NP
LNX NNP I-NP
) -RRB- I-NP
and CC O
70 CD B-NP
kDa NN I-NP
( -LRB- I-NP
LNX-b) NNP I-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
contractile JJ O
action NN O
of IN O
arachidonic JJ O
acid NN O
, , O
via IN O
a DT O
presumed VBN O
cyclooxygenase NN B-NP
product NN O
that WDT O
mediated VBD O
the DT O
contractions NNS O
caused VBN O
by IN O
both DT O
TF NNP B-NP
and CC O
EGF NNP B-NP
, , O
was VBD O
not RB O
blocked VBN O
by IN O
any DT O
of IN O
the DT O
signal NN O
pathway NN O
probe NN O
inhibitors NNS O
. . O

-DOCSTART- X X O

Recent JJ O
studies NNS O
have VBP O
revealed VBN O
unconventional JJ O
myosin NN B-NP
V NNP I-NP
to TO O
be VB O
an DT O
important JJ O
actin-based JJ B-NP
molecular JJ O
motor NN O
involved VBN O
in IN O
vesicular JJ O
movement NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
a DT O
minor JJ O
start NN O
site NN O
was VBD O
localized VBN O
179 CD O
bp NN O
upstream RB O
of IN O
the DT O
major JJ O
site NN O
using VBG O
reverse JJ B-NP
transcriptase-polymerase NN I-NP
chain NN O
reaction NN O
with IN O
various JJ O
P1 JJ O
primers NNS O
( -LRB- O
primer JJ O
walking NN O
) -RRB- O
, , O
primer JJ O
extension NN O
, , O
and CC O
cDNA NN O
cloning NN O
. . O

-DOCSTART- X X O

The DT O
iron NN O
dependence NN O
of IN O
transcription NN O
and CC O
expression NN O
of IN O
cvaA NN B-NP
, , O
which WDT O
encodes VBZ O
a DT O
transporter NN O
accessory JJ O
protein NN O
, , O
and CC O
cvi NN B-NP
, , O
encoding VBG O
the DT O
colicin NN B-NP
V NNP I-NP
immunity NN I-NP
protein NN I-NP
, , O
was VBD O
assessed VBN O
under IN O
conditions NNS O
of IN O
iron NN O
excess NN O
or CC O
depletion NN O
. . O

-DOCSTART- X X O

In IN O
a DT O
gntR NN B-NP
deletion NN I-NP
mutant NN I-NP
, , O
the DT O
expression NN O
of IN O
a DT O
chromosomal NN O
gntT NN B-NP
: : O
:lacZ JJ O
fusion NN O
is VBZ O
both DT O
high JJ O
and CC O
constitutive JJ O
, , O
confirming VBG O
that DT O
GntR NNP B-NP
is VBZ O
the DT O
negative JJ O
regulator NN O
of IN O
gntT. NN B-NP

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
deletion NN O
of IN O
bcp NN B-NP
from IN O
the DT O
chromosome NN O
had VBD O
no DT O
effect NN O
on IN O
gcv-lacZ JJ B-NP
expression NN O
. . O

-DOCSTART- X X O

The DT O
mitochondrial JJ B-NP
regulatory JJ I-NP
region NN I-NP
( -LRB- O
mrr NN B-NP
) -RRB- O
located VBN O
between IN O
the DT O
tRNAPhe NN B-NP
and CC O
tRNAPro NN B-NP
genes NNS I-NP
of IN O
mitochondrial JJ O
DNA NN O
( -LRB- O
mtDNA NN O
) -RRB- O
is VBZ O
essential JJ O
for IN O
regulation NN O
of IN O
replication NN O
and CC O
transcription NN O
of IN O
the DT O
mitochondrial JJ O
genome NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
report NN O
, , O
we PRP O
investigate VB O
the DT O
mechanism NN O
underlying VBG O
Ras NNP B-NP
activation NN O
upon IN O
stimulation NN O
of IN O
these DT O
two CD O
types NNS O
of IN O
receptors NNS O
in IN O
hematopoietic JJ O
cells NNS O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
we PRP O
conclude VBP O
that IN O
DnaA NNP B-NP
may MD O
contact VB O
the DT O
beta JJ O
subunit NN O
of IN O
RNA NNP B-NP
polymerase NN I-NP
during IN O
activation NN O
of IN O
the DT O
pR NN B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Expression NNP O
of IN O
Bcl-XL NNP B-NP
inhibited VBD O
the DT O
association NN O
of IN O
Apaf-1 JJ B-NP
with IN O
caspase-9 CD B-NP
in IN O
mammalian JJ O
cells NNS O
. . O

-DOCSTART- X X O

Whole-mount JJ O
in IN O
situ FW O
hybridization NN O
to TO O
early JJ O
mouse NN O
embryos NNS O
of IN O
9.5-10.5 CD O
days NNS O
indicated VBD O
a DT O
complex JJ O
pattern NN O
of IN O
Arp1 NNP B-NP
expression NN O
spatially RB O
overlapping VBG O
with IN O
the DT O
expression NN O
of IN O
All1 NNP B-NP
. . O

-DOCSTART- X X O

These DT O
mutants NNS O
were VBD O
tested VBN O
for IN O
ability NN O
to TO O
bind NN O
each DT O
of IN O
the DT O
Site NNP B-NP
II NNP I-NP
cognate JJ I-NP
proteins NNS I-NP
, , O
and CC O
subsequently RB O
evaluated VBN O
for IN O
ability NN O
to TO O
confer VB O
H4 IN B-NP
transcriptional JJ O
activity NN O
using VBG O
chimeric JJ O
H4 IN B-NP
promoter/CAT JJ O
fusion NN O
constructs NNS O
in IN O
different JJ O
cell NN O
types NNS O
. . O

-DOCSTART- X X O

Increased VBN O
plasma NN O
IgE NN B-NP
was VBD O
also RB O
confirmed VBN O
in IN O
the DT O
NC NNP O
mice NNS O
, , O
and CC O
treatment NN O
with IN O
FK506 NNP O
ointment NN O
reduced VBD O
the DT O
plasma NN O
IgE NNP B-NP
level NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
in IN O
the DT O
ischemia/angiotension NN O
II-induced NNP B-NP
AHF NNP O
model NN O
, , O
NIC NNP O
decreased VBD O
left VBN O
ventricular JJ O
end-diastolic JJ O
pressure NN O
( -LRB- O
LVEDP NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Group NNP O
A DT O
( -LRB- O
68.7+/-2.7 JJ O
years NNS O
) -RRB- O
consisted VBD O
of IN O
patients NNS O
with IN O
0 CD O
or CC O
1 CD O
risk NN O
factors NNS O
; : O
B NNP O
( -LRB- O
68.3+/-4.2 JJ O
years NNS O
) -RRB- O
those DT O
with IN O
2 CD O
risk NN O
factors NNS O
; : O
and CC O
C NNP O
( -LRB- O
69.2+/-3.6 CD O
years NNS O
) -RRB- O
those DT O
with IN O
3 CD O
or CC O
more JJR O
risk NN O
factors NNS O
. . O

-DOCSTART- X X O

We PRP O
further RB O
demonstrate VBP O
that IN O
RU486-PR-B NNP O
interacts VBZ O
physically RB O
with IN O
NCoR NNP B-NP
in IN O
vitro NN O
. . O

-DOCSTART- X X O

PRL NN B-NP
receptor NN I-NP
also RB O
activates VBZ O
SHP-2 NNP B-NP
, , O
a DT O
cytosolic JJ B-NP
tyrosine NN I-NP
phosphatase NN I-NP
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
These DT O
routinely RB O
collected VBD O
data NNS O
provided VBN O
quantitative JJ O
estimates NNS O
of IN O
changes NNS O
in IN O
CBZ NNP O
Cl/F NNP O
due JJ O
to TO O
comedication NN O
and CC O
an DT O
age-related JJ O
decrease NN O
in IN O
Cl/F NNP O
The DT O
derived VBN O
regression NN O
equations NNS O
reasonably RB O
predicted VBD O
concentrations NNS O
in IN O
a DT O
separate JJ O
validation NN O
set VBN O
. . O

-DOCSTART- X X O

ATP-dependent JJ O
assembly NN O
of IN O
a DT O
ternary JJ O
complex NN O
consisting VBG O
of IN O
a DT O
DNA NNP O
mismatch NN O
and CC O
the DT O
yeast NN O
MSH2-MSH6 . B-NP
and CC O
MLH1-PMS1 JJ B-NP
protein NN O
complexes NNS O
. . O

-DOCSTART- X X O

Instead RB O
, , O
it PRP O
contained VBD O
two CD O
tandem NN O
kappaB NN B-NP
elements NNS I-NP
and CC O
a DT O
variant JJ O
activating NN B-NP
transcription NN I-NP
factor/cAMP IN I-NP
response NN I-NP
element NN I-NP
site NN O
, , O
which WDT O
closely RB O
resembled VBD O
sites NNS O
in IN O
the DT O
E-selectin NNP B-NP
gene NN I-NP
that WDT O
are VBP O
required VBN O
for IN O
TNF-alpha NNP B-NP
- : O
or CC O
LPS-inducible JJ O
expression NN O
. . O

-DOCSTART- X X O

We PRP O
recently RB O
characterized VBD O
a DT O
single JJ O
yeast NN B-NP
hnRNP NN I-NP
methyltransferase NN I-NP
( -LRB- O
HMT1 NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Identification NN O
and CC O
characterization NN O
of IN O
two CD O
putative JJ O
human JJ B-NP
arginine NN I-NP
methyltransferases NNS I-NP
( -LRB- O
HRMT1L1 NNP B-NP
and CC O
HRMT1L2 NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
the DT O
activated JJ O
PDGF NN B-NP
beta-receptor NN I-NP
was VBD O
found VBN O
not RB O
to TO O
bind NN O
Crk NNP B-NP
proteins VBZ I-NP
. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
a DT O
previously RB O
characterized VBN O
promoter NN O
( -LRB- O
P1 NNP O
) -RRB- O
, , O
we PRP O
now RB O
show VBP O
the DT O
existence NN O
of IN O
a DT O
second JJ O
promoter NN O
for IN O
the DT O
human JJ B-NP
IL-5Ralpha NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Overall JJ O
agreement NN O
between IN O
rest/postnitroglycerin NN O
technetium-99m NN O
tetrofosmin NN O
SPET NNP O
studies NNS O
and CC O
rest/redistribution NN O
or CC O
rest/reinjection NN O
thallium-201 DT O
SPET NNP O
studies NNS O
, , O
regarding VBG O
the DT O
presence NN O
of IN O
myocardial JJ O
viability NN O
, , O
was VBD O
87 CD O
% NN O
and CC O
90 CD O
% NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Their PRP$ O
use NN O
resulted VBD O
in IN O
a DT O
sensitivity NN O
of IN O
73 CD O
% NN O
and CC O
a DT O
specificity NN O
of IN O
74 CD O
% NN O
with IN O
regard NN O
to TO O
predictability NN O
of IN O
ALT NNP B-NP
levels NNS O
increasing VBG O
during IN O
the DT O
trial NN O
. . O

-DOCSTART- X X O

One CD O
hundred CD O
replicate NN O
data NNS O
sets NNS O
of IN O
100 CD O
subjects NNS O
each DT O
were VBD O
simulated VBN O
for IN O
each DT O
missing VBG O
data NNS O
scenario NN O
. . O

-DOCSTART- X X O

Spatial JJ O
accuracy NN O
of IN O
primary JJ O
and CC O
secondary JJ O
memory-guided JJ O
saccades NNS O
in IN O
schizophrenic JJ O
patients NNS O
. . O

-DOCSTART- X X O

Successful JJ O
treatment NN O
with IN O
nasal JJ O
continuous JJ O
positive JJ O
airway NN O
pressure NN O
( -LRB- O
8.3 CD O
+/ NN O
- : O
1.5 CD O
cmH2O NN O
) -RRB- O
for IN O
3 CD O
days NNS O
caused VBD O
a DT O
significant JJ O
decrease NN O
in IN O
mean JJ O
blood NN O
pressure NN O
in IN O
OSAS. NNP O

-DOCSTART- X X O

When WRB O
data NNS O
were VBD O
expressed VBN O
in IN O
a DT O
cumulative JJ O
manner NN O
, , O
the DT O
response NN O
to TO O
intravenous JJ O
adenosine NN O
3 CD O
mg NN O
, , O
6 CD O
mg NN O
, , O
9 CD O
mg NN O
and CC O
12 CD O
mg NN O
in IN O
the DT O
24 CD O
episodes NNS O
of IN O
PSVT NNP O
were VBD O
5 CD O
episodes NNS O
( -LRB- O
21 CD O
% NN O
) -RRB- O
, , O
16 CD O
episodes NNS O
( -LRB- O
67 CD O
% NN O
) -RRB- O
, , O
20 CD O
episodes NNS O
(83 IN O
% NN O
) -RRB- O
and CC O
20 CD O
episodes NNS O
(83 IN O
% NN O
) -RRB- O
respectively RB O
. . O

-DOCSTART- X X O

To TO O
study VB O
retinoid JJ O
signalling NN O
in IN O
zebrafish NN O
embryos NNS O
, , O
we PRP O
developed VBD O
a DT O
novel NN O
method NN O
to TO O
detect VB O
endogenous JJ O
retinoids NNS O
in IN O
situ NN O
in IN O
embryos NNS O
, , O
using VBG O
a DT O
fusion NN O
protein NN O
of IN O
the DT O
ligand NN O
inducible JJ O
transactivation NN O
domain NN O
of IN O
a DT O
retinoic JJ B-NP
acid NN I-NP
receptor NN I-NP
and CC O
a DT O
heterologous JJ O
DNA NNP O
binding NN O
domain NN O
. . O

-DOCSTART- X X O

Fluorescence NNP O
in IN O
situ FW O
hybridization NN O
of IN O
metaphase NN O
spreads NNS O
of IN O
chromosome NN O
8 CD O
, , O
containing VBG O
hybrid JJ O
cell NN O
line NN O
706-B6 . O
clone NN O
17 CD O
( -LRB- O
CL-17 NN O
) -RRB- O
with IN O
cosmid JJ O
c101F1 NN O
, , O
placed VBD O
the DT O
9804 CD B-NP
gene NN I-NP
close JJ O
to TO O
the DT O
telomere NN O
at IN O
8q24.3 CD O
. . O

-DOCSTART- X X O

The DT O
interaction NN O
between IN O
piroxicam NN O
and CC O
poloxamer NN O
was VBD O
studied VBN O
by IN O
x-ray NN O
diffractometry NN O
(XRD) NNP O
, , O
infrared VBD O
( -LRB- O
IR NN O
) -RRB- O
spectroscopy NN O
and CC O
differential JJ O
thermal JJ O
analysis NN O
(DTA NN O
) -RRB- O
with IN O
a DT O
solid JJ O
dispersion NN O
, , O
coprecipitate NN O
, , O
or CC O
physical JJ O
mixture NN O
. . O

-DOCSTART- X X O

The DT O
N-syndecan-dependent JJ O
neurite JJ O
outgrowth NN O
is VBZ O
inhibited VBN O
by IN O
the DT O
tyrosine NN B-NP
kinase NN I-NP
inhibitors NNS O
herbimycin IN O
A NNP O
and CC O
PP1 NNP B-NP
. . O

-DOCSTART- X X O

An DT O
in IN O
vivo JJ O
ZAP-70 NNP B-NP
substrate NN O
, , O
SLP-76 NNP B-NP
, , O
implicated VBN O
in IN O
Erk NNP B-NP
activation NN O
, , O
also RB O
became VBD O
rapidly RB O
tyrosine-phosphorylated JJ O
in IN O
Jurkat NNP O
cells NNS O
, , O
but CC O
not RB O
in IN O
P116 CD O
cells NNS O
, , O
upon IN O
treatment NN O
with IN O
H2O2 NNP O
. . O

-DOCSTART- X X O

The DT O
results NNS O
confirm VBP O
that IN O
a DT O
single JJ O
base NN O
change NN O
in IN O
the DT O
branchpoint NN O
consensus NN O
sequence NN O
of IN O
an DT O
intron NN O
can MD O
cause VB O
human JJ O
disease NN O
although IN O
this DT O
sequence NN O
is VBZ O
poorly RB O
conserved VBN O
in IN O
mammals NNS O
. . O

-DOCSTART- X X O

Conversely RB O
, , O
the DT O
central JJ O
regions NNS O
are VBP O
highly RB O
variable JJ O
. . O

-DOCSTART- X X O

Among IN O
the DT O
H/ACA NNP B-NP
snoRNAs NN I-NP
associated VBN O
with IN O
Gar1p NNP B-NP
, , O
one NN O
can MD O
distinguish VB O
a DT O
large JJ O
group NN O
of IN O
snoRNAs NNS O
that WDT O
are VBP O
not RB O
essential JJ O
in IN O
yeast NN O
and CC O
serve VB O
as IN O
guides NNS O
for IN O
pseudouridine NN O
synthesis NN O
onto IN O
the DT O
pre-rRNA JJ O
molecule NN O
. . O

-DOCSTART- X X O

It PRP O
bound VBD O
to TO O
vitamin NN B-NP
D NN I-NP
receptor NN I-NP
(VDR) NN O
but CC O
not RB O
retinoic JJ B-NP
acid NN I-NP
Xalpha NN I-NP
receptor NN I-NP
( -LRB- O
RXRalpha NN B-NP
) -RRB- O
in IN O
the DT O
human JJ O
T NNP O
cell NN O
line NN O
MT2 IN O
cells NNS O
. . O

-DOCSTART- X X O

We PRP O
previously RB O
demonstrated VBD O
that IN O
acute JJ O
expression NN O
of IN O
the DT O
bovine NN O
papillomavirus NN O
type NN O
1 CD O
( -LRB- O
BPV1 CC O
) -RRB- O
E2 JJ B-NP
protein NN I-NP
in IN O
HeLa NNP O
and CC O
HT-3 JJ O
cervical JJ O
carcinoma NN O
cell NN O
lines NNS O
greatly RB O
reduced VBN O
cellular JJ O
proliferation NN O
by IN O
imposing VBG O
a DT O
specific JJ O
G1/S JJ O
phase NN O
growth NN O
arrest NN O
. . O

-DOCSTART- X X O

Specialized NNP O
actin NN B-NP
tails NNS O
that WDT O
propel VBP O
IEV NNP O
particles NNS O
to TO O
the DT O
periphery NN O
and CC O
virus-tipped JJ O
microvilli NNS O
( -LRB- O
both DT O
common JJ O
in IN O
wild-type-infected JJ O
cells NNS O
) -RRB- O
were VBD O
absent JJ O
in IN O
cells NNS O
infected VBN O
with IN O
vA33delta NN O
. . O

-DOCSTART- X X O

Their PRP$ O
mean JJ O
IOP NNP O
was VBD O
15.3 CD O
( -LRB- O
SD NNP O
3.7 CD O
) -RRB- O
mmHg NN O
prior RB O
to TO O
induction NN O
of IN O
anesthesia NN O
, , O
13.5 CD O
( -LRB- O
SD NNP O
3.5 CD O
) -RRB- O
mmHg NN O
after IN O
loss NN O
of IN O
eyelash NN O
reflex NN O
following VBG O
injection NN O
of IN O
methohexitone NN O
, , O
16.1 CD O
( -LRB- O
SD NN O
2.4 CD O
) -RRB- O
mmHg NN O
after IN O
cessation NN O
of IN O
muscle NN O
fasciculations NNS O
induced VBN O
by IN O
suxamethonium NN O
, , O
19.2 CD O
( -LRB- O
SD NNP O
5.6 CD O
) -RRB- O
mmHg NN O
after IN O
cessation NN O
of IN O
convulsion NN O
and CC O
15.5 CD O
( -LRB- O
SD NNP O
4.4 CD O
) -RRB- O
mmHg . O
following VBG O
resumption NN O
of IN O
regular JJ O
spontaneous JJ O
respiration NN O
. . O

-DOCSTART- X X O

Post-translational NNP O
modifications NNS O
such JJ O
as IN O
glycosylation NN O
and CC O
phosphorylation NN O
could MD O
be VB O
excluded VBN O
as IN O
potential JJ O
explanations NNS O
for IN O
the DT O
protein NN O
heterogeneity NN O
. . O

-DOCSTART- X X O

Rhesus NNP O
macaques NNS O
and CC O
BALB/c NNP O
mice NNS O
inoculated VBN O
with IN O
the DT O
Mengo NNP O
virus NN O
SIV NNP O
recombinants VBZ O
failed VBN O
to TO O
develop VB O
CTL JJ O
responses NNS O
against IN O
the DT O
SIV NNP O
gene NN O
products NNS O
, , O
while IN O
one CD O
of IN O
the DT O
HIV-Nef NNP B-NP
recombinants NNS I-NP
induced VBD O
a DT O
weak JJ O
CTL JJ O
response NN O
in IN O
mice NNS O
directed VBN O
to TO O
an DT O
HIV1 NNP B-NP
Nef NNP I-NP
peptide NN I-NP
spanning VBG O
positions NNS O
182-198. . O

-DOCSTART- X X O

Trichloroethylene NNP O
, , O
in IN O
turn NN O
, , O
increased VBD O
the DT O
AUC JJ O
5.0 CD O
( -LRB- O
1.9-13.4) CD O
, , O
25.8 CD O
( -LRB- O
8.2-80.8 CD O
) -RRB- O
and CC O
2.9 CD O
( -LRB- O
1.6-5.4) CD O
, , O
respectively RB O
, , O
whereas IN O
the DT O
corresponding JJ O
values NNS O
for IN O
n-hexane NN O
were VBD O
1.9 CD O
( -LRB- O
0.7-5.1 CD O
) -RRB- O
, , O
1.5 CD O
( -LRB- O
0.5-4.6) JJ O
, , O
and CC O
3.2 CD O
( -LRB- O
1.8-5.9 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Solution NNP O
structure NN O
of IN O
the DT O
IRF-2 NNP B-NP
DNA-binding NNP I-NP
domain NN I-NP
: : O
a DT O
novel NN O
subgroup NN O
of IN O
the DT O
winged JJ B-NP
helix-turn-helix NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
receptor/G JJ B-NP
protein NN I-NP
coupling NN O
appeared VBD O
unaffected JJ O
by IN O
expression NN O
of IN O
loop NN O
3i NN O
domains VBZ O
derived VBN O
from IN O
two CD O
receptors NNS O
coupled VBN O
to TO O
G( JJ B-NP
i/o NN I-NP
) -RRB- I-NP
proteins VBZ I-NP
( -LRB- O
M2Ach-muscarinic JJ B-NP
and CC I-NP
alpha2A-adrenergic JJ I-NP
receptors NNS I-NP
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
catalytic JJ O
domain NN O
of IN O
eukaryotic JJ B-NP
DNA NNP I-NP
topoisomerase NN I-NP
I. NN I-NP

-DOCSTART- X X O

Another DT O
stem-loop NN O
called VBD O
structure NN O
III NNP O
near IN O
the DT O
3'-end NN O
of IN O
repY NN B-NP
sequesters NNS O
both CC O
the DT O
5'-rCGCC-3' JJ O
sequence NN O
and CC O
the DT O
repZ NN B-NP
ribosome-binding NN I-NP
site NN I-NP
. . O

-DOCSTART- X X O

All DT O
three CD O
genes NNS O
have VBP O
been VBN O
mapped VBN O
precisely RB O
to TO O
a DT O
small JJ O
region NN O
on IN O
human JJ O
chromosome NN O
16p12.1-p11.2 CD O
( -LRB- O
homologous NN O
to TO O
mouse NN O
chromosome NN O
7 CD O
) -RRB- O
, , O
using VBG O
somatic JJ O
cell NN O
hybrids NNS O
and CC O
cosmid JJ O
clones NNS O
. . O

-DOCSTART- X X O

In IN O
fus3 CD B-NP
mutants NNS I-NP
, , O
the DT O
levels NNS O
of IN O
Ty1 NNP B-NP
RNA NNP I-NP
, , O
protein NN O
synthesis NN O
, , O
and CC O
proteolytic JJ O
processing NN O
were VBD O
not RB O
altered VBN O
relative JJ O
to TO O
those DT O
in IN O
FUS3 JJ B-NP
strains NNS O
but CC O
steady-state NN O
levels NNS O
of IN O
TyA NNP B-NP
, , O
integrase NN B-NP
, , O
and CC O
reverse VB B-NP
transcriptase JJ I-NP
proteins NNS O
and CC O
Ty1 DT B-NP
cDNA NN I-NP
were VBD O
all DT O
increased VBN O
. . O

-DOCSTART- X X O

Posttranslational NNP O
regulation NN O
of IN O
Ty1 NNP B-NP
retrotransposition NN O
by IN O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
Fus3 NN I-NP
. . O

-DOCSTART- X X O

The DT O
general JJ O
transcription NN B-NP
factor NN I-NP
IIA NNP I-NP
( -LRB- O
TFIIA NN B-NP
) -RRB- O
interacts VBZ O
with IN O
the DT O
TATA NNP B-NP
binding JJ I-NP
protein NN I-NP
( -LRB- O
TBP NN B-NP
) -RRB- O
and CC O
promoter NN O
DNA NN O
to TO O
mediate JJ O
transcription NN O
activation NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Their PRP$ O
function NN O
is VBZ O
not RB O
only RB O
to TO O
recruit VB O
Pho2 NNP B-NP
to TO O
the DT O
promoter NN O
but CC O
to TO O
allow VB O
cooperative JJ O
binding NN O
of IN O
Pho4 NNP B-NP
together RB O
with IN O
Pho2 NNP B-NP
. . O

-DOCSTART- X X O

Substitution NNP O
of IN O
the DT O
Ser-Thr NNP O
sites NNS O
with IN O
the DT O
phosphomimetic JJ O
Asp NNP O
generated VBD O
a DT O
constitutively RB O
active JJ O
form NN O
of IN O
IRF-3 NN B-NP
that WDT O
functioned VBD O
as IN O
a DT O
very RB O
strong JJ O
activator NN O
of IN O
promoters NNS O
containing VBG O
PRDI-PRDII NNP B-NP
I PRP B-NP
or CC O
ISRE NNP B-NP
regulatory JJ I-NP
elements NNS I-NP
. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
DNA-protein NNP O
interactions NNS O
, , O
protein-protein NN O
interactions NNS O
with IN O
partner NN O
proteins NNS O
often RB O
play VBP O
major JJ O
roles NNS O
in IN O
targeting VBG O
ETS-domain JJ B-NP
proteins NNS I-NP
to TO O
specific JJ O
promoters NNS O
. . O

-DOCSTART- X X O

Localization NN O
of IN O
67 CD O
exons NNS O
on IN O
a DT O
YAC NNP O
contig NN O
spanning NN O
1.5 CD O
Mb NNS O
around IN O
the DT O
multidrug NN B-NP
resistance NN I-NP
gene NN I-NP
region NN I-NP
of IN O
human JJ O
chromosome NN O
7q21.1 CD O
. . O

-DOCSTART- X X O

The DT O
complete JJ O
exon-intron NN O
organization NN O
of IN O
the DT O
murine NN O
gene NN O
encoding VBG O
M-protein NNP B-NP
, , O
a DT O
structural JJ O
protein NN O
of IN O
sarcomeric JJ O
myofibrils NNS O
, , O
was VBD O
determined VBN O
. . O

-DOCSTART- X X O

Mean+/-SD NNP O
serum NN B-NP
VEGF NN I-NP
concentrations NNS O
were VBD O
significantly RB O
higher JJR O
( -LRB- O
P NNP O
< NN O
0.001 CD O
) -RRB- O
in IN O
women NNS O
with IN O
PCO NNP O
and CC O
PCOS NNP O
( -LRB- O
3.4+/-0.7 CD O
and CC O
3.2+/-0.66 CD O
ng/ml JJ O
respectively RB O
) -RRB- O
compared VBN O
with IN O
women NNS O
with IN O
normal JJ O
ovaries NNS O
( -LRB- O
2.3+/-0.5 CD O
ng/ml NN O
) -RRB- O
. . O

-DOCSTART- X X O

Strikingly RB O
, , O
these DT O
cells NNS O
contain VBP O
a DT O
missense NN O
mutation NN O
of IN O
the DT O
p53 NN B-NP
gene NN I-NP
at IN O
codon CD O
242 CD O
( -LRB- O
p53( NN B-NP
242 CD O
) -RRB- O
) -RRB- O
, , O
which WDT O
substitutes NNS O
alanine JJR O
for IN O
glycine NN O
. . O

-DOCSTART- X X O

The DT O
new JJ O
algorithm NN O
, , O
called VBN O
RBI-MAP NNP O
, , O
is VBZ O
based VBN O
on IN O
the DT O
rescaled VBN O
block NN O
iterative NN O
EM NN O
( -LRB- O
RBI-EM) JJ O
algorithm NN O
. . O

-DOCSTART- X X O

A DT O
third JJ O
ORF NN O
, , O
ORF5 CD O
, , O
shows VBZ O
homology NN O
with IN O
gene NN B-NP
agrB NN I-NP
from IN O
Staphylococcus NNP O
aureus NN O
, , O
which WDT O
is VBZ O
involved VBN O
in IN O
the DT O
mechanism NN O
of IN O
regulation NN O
of IN O
the DT O
virulence NN O
phenotype NN O
in IN O
this DT O
species NN O
. . O

-DOCSTART- X X O

An DT O
association NN O
between IN O
hSIE JJ B-NP
and CC O
Stat-3 JJ B-NP
after IN O
MHC-I JJ B-NP
ligation NN O
was VBD O
directly RB O
demonstrated VBN O
by IN O
precipitating VBG O
Stat-3 NN B-NP
from IN O
nuclear JJ O
extracts NNS O
with IN O
biotinylated JJ O
hSIE NN B-NP
probe NN O
and CC O
avidin-coupled JJ B-NP
agarose NN O
. . O

-DOCSTART- X X O

The DT O
localization NN O
of IN O
ZAP-70 CD B-NP
to TO O
the DT O
cell NN O
cortex NN O
is VBZ O
, , O
therefore RB O
, , O
regulated VBN O
by IN O
the DT O
activity NN O
of IN O
SRC-family NNP B-NP
kinases NNS I-NP
, , O
independently RB O
of IN O
their PRP$ O
ability NN O
to TO O
phosphorylate VB O
immunoreceptor NN O
tyrosine-based JJ O
activation NN O
motifs NNS O
of IN O
the DT O
TCR. NNP B-NP

-DOCSTART- X X O

A DT O
site-directed JJ O
R618K NN O
mutation NN O
in IN O
the DT O
Stat5 NNP B-NP
SH2 NNP B-NP
domain NN I-NP
abolished VBD O
the DT O
phosphorylation NN O
by IN O
Jak2 NNP B-NP
, , O
while IN O
deletion NN O
of IN O
the DT O
C NNP O
terminus NN O
led VBD O
to TO O
Stat5 NNP B-NP
hyperphosphorylation NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
nitric JJ B-NP
oxide NN I-NP
synthase NN I-NP
inhibitor NN O
on IN O
reperfusion NN O
injury NN O
of IN O
the DT O
brain NN O
under IN O
hypothermic JJ O
circulatory NN O
arrest NN O
. . O

-DOCSTART- X X O

We PRP O
studied VBD O
the DT O
human JJ O
vestibulo-ocular JJ O
reflex JJ O
(VOR NN O
) -RRB- O
in IN O
response NN O
to TO O
head NN O
'impulses NNS O
' '' O
: : O
brief NN O
, , O
unpredictable JJ O
, , O
passive JJ O
, , O
high-acceleration JJ O
(up NN O
to TO O
4000 CD O
degrees/s2 NN O
) -RRB- O
, , O
low-amplitude JJ O
( -LRB- O
20-30 CD O
degrees NNS O
) -RRB- O
head NN O
rotations NNS O
. . O

-DOCSTART- X X O

These DT O
patients NNS O
failed VBD O
to TO O
respond VB O
to TO O
intravenous JJ O
cyclophosphamide NN O
and CC O
steroids NNS O
and CC O
were VBD O
then RB O
changed VBN O
to TO O
receive VB O
oral JJ O
cyclosporine NN O
A DT O
, , O
at IN O
a DT O
dose NN O
of IN O
5 CD O
mg/kg/day NN O
. . O

-DOCSTART- X X O

The DT O
DNA NNP O
binding NN O
activities NNS O
of IN O
the DT O
three CD O
repressor NN O
preparations NNS O
were VBD O
studied VBN O
using VBG O
fragments NNS O
containing VBG O
CIRs NNP O
( -LRB- O
CIR3-CIR6 NN O
) -RRB- O
from IN O
the DT O
essential JJ O
early JJ O
region NN O
as IN O
templates NNS O
for IN O
DNase NN B-NP
I PRP I-NP
footprinting CD O
. . O

-DOCSTART- X X O

Molecular JJ O
modelling NN O
suggested VBD O
that IN O
the DT O
tetramerization NN O
domain NN O
was VBD O
a DT O
four-helix CD O
bundle NN O
, , O
stabilized VBN O
by IN O
interactions NNS O
of IN O
seven CD O
conserved VBD O
aromatic JJ O
amino IN O
acids NNS O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
silymarin NN O
may MD O
exert VB O
a DT O
strong JJ O
anticarcinogenic JJ O
effect NN O
against IN O
PCA NNP O
and CC O
that IN O
this DT O
effect NN O
is VBZ O
likely JJ O
to TO O
involve VB O
impairment NN O
of IN O
erbB1-SHC-mediated JJ B-NP
signaling NN O
pathway NN O
, , O
induction NN O
of IN O
CDKIs NNP B-NP
, , O
and CC O
a DT O
resultant NN O
G1 IN O
arrest NN O
. . O

-DOCSTART- X X O

Indeed RB O
, , O
it PRP O
is VBZ O
shown VBN O
that IN O
it PRP O
mediates VBZ O
the DT O
formation NN O
of IN O
disulfide-linked JJ O
homodimers NNS O
and CC O
that IN O
the DT O
formation NN O
of IN O
homo- NNS O
and CC O
heterodimers NNS O
are VBP O
mutually RB O
excluded VBN O
. . O

-DOCSTART- X X O

N. NNP O
, , O
and CC O
Fanning NNP O
, , O
E. NNP O

-DOCSTART- X X O

We PRP O
have VBP O
shown VBN O
previously RB O
that IN O
GH3 NNP O
cells NNS O
transfected VBN O
with IN O
the DT O
rat NN B-NP
GnRH NNP I-NP
receptor NN I-NP
cDNA NN I-NP
( -LRB- O
GGH3-1' JJ O
cells NNS O
) -RRB- O
support VBP O
the DT O
expression NN O
of IN O
a DT O
cotransfected JJ O
fusion NN O
gene NN O
composed VBN O
of IN O
797 CD O
base NN O
pairs NNS O
of IN O
rat NN B-NP
LHbeta NNP I-NP
gene NN I-NP
5'-flanking JJ I-NP
sequence NN I-NP
and CC O
the DT O
first JJ O
5 CD O
base NN O
pairs NNS O
of IN O
the DT O
5'-untranslated JJ O
region NN O
fused VBN O
to TO O
a DT O
luciferase NN B-NP
reporter NN I-NP
(-797/+5LHbetaLUC) JJ I-NP
and CC O
respond VB O
to TO O
a DT O
GnRH NNP B-NP
agonist NN O
with IN O
a DT O
10-fold JJ O
stimulation NN O
of IN O
activity NN O
. . O

-DOCSTART- X X O

In IN O
patients NNS O
with IN O
type NN O
IA NNP O
maple NN O
syrup NN O
urine NN O
disease NN O
, , O
the DT O
E1alpha NNP B-NP
subunit NN I-NP
is VBZ O
affected VBN O
, , O
resulting VBG O
in IN O
the DT O
loss NN O
of IN O
E1 NNP B-NP
and CC O
branched-chain JJ B-NP
ketoacid NN I-NP
dehydrogenase NN I-NP
catalytic JJ O
activities NNS O
. . O

-DOCSTART- X X O

OBJECTIVES NNP O
: : O
To TO O
measure VB O
coagulation NN B-NP
factor NN I-NP
VIII NN I-NP
:coagulant NN I-NP
( -LRB- O
F.VIII:C) NNP B-NP
and CC O
C1-esterase JJ B-NP
inhibitor NN I-NP
( -LRB- O
C1-INH) JJ B-NP
, , O
hemostasis-associated JJ O
acute-phase JJ O
reactant JJ O
proteins NNS O
and CC O
coagulation NN B-NP
factors NNS I-NP
VII NNP I-NP
( -LRB- O
F.VII NNP B-NP
) -RRB- O
, , O
IX NNP O
( -LRB- O
F.IX NNP B-NP
) -RRB- O
, , O
and CC O
X NNP O
( -LRB- O
F.X) NNP B-NP
, , O
hemostasis NN O
proteins VBZ O
not RB O
associated VBN O
with IN O
an DT O
acute-phase JJ O
response NN O
, , O
in IN O
a DT O
select JJ O
population NN O
of IN O
horses NNS O
with IN O
colic JJ O
and CC O
hemostasis NN O
abnormalities NNS O
, , O
and CC O
presumed VBN O
to TO O
have VB O
acute-phase JJ O
changes NNS O
. . O

-DOCSTART- X X O

The DT O
data NNS O
suggest VBP O
that IN O
plasminogen NN B-NP
, , O
alpha NN B-NP
2AP NNP I-NP
, , O
and CC O
C1-INH NNP B-NP
, , O
should MD O
be VB O
considered VBN O
equine JJ O
acute-phase JJ O
proteins NNS O
. . O

-DOCSTART- X X O

None NN O
of IN O
the DT O
patients NNS O
was VBD O
obese NNP O
. . O

-DOCSTART- X X O

RACK1 NNP B-NP
, , O
a DT O
receptor NN O
for IN O
activated JJ B-NP
C NNP I-NP
kinase NN I-NP
and CC O
a DT O
homolog NN O
of IN O
the DT O
beta JJ O
subunit NN O
of IN O
G NNP B-NP
proteins VBZ I-NP
, , O
inhibits VBZ O
activity NN O
of IN O
src JJ B-NP
tyrosine NN I-NP
kinases NNS I-NP
and CC O
growth NN O
of IN O
NIH NNP O
3T3 CD O
cells NNS O
. . O

-DOCSTART- X X O

Peptide NNP O
sequences NNS O
of IN O
the DT O
zinc NN B-NP
finger NN I-NP
protein NN I-NP
Ttk NNP I-NP
and CC O
the DT O
transcription NN B-NP
factor NN I-NP
Adf-1 NN I-NP
were VBD O
obtained VBN O
. . O

-DOCSTART- X X O

HEF1 NNP B-NP
, , O
p130( JJ B-NP
Cas NNP B-NP
) -RRB- O
, , O
and CC O
Efs/Sin NNP B-NP
constitute VBP O
a DT O
family NN O
of IN O
multidomain JJ O
docking JJ O
proteins NNS O
that WDT O
have VBP O
been VBN O
implicated VBN O
in IN O
coordinating VBG O
the DT O
regulation NN O
of IN O
cell NN O
adhesion NN O
. . O

-DOCSTART- X X O

In IN O
support NN O
of IN O
a DT O
role NN O
at IN O
the DT O
spindle NN O
, , O
two-hybrid JJ O
library NN O
screening NN O
with IN O
HEF1 NNP B-NP
identifies VBZ O
the DT O
human JJ O
homolog NN O
of IN O
the DT O
G2/M NNP B-NP
spindle-regulatory JJ I-NP
protein NN I-NP
Dim1p NNP I-NP
as IN O
a DT O
specific JJ O
interactor NN O
with IN O
a DT O
region NN O
of IN O
HEF1 NNP B-NP
encompassed VBD O
in IN O
p55(HEF1 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

However RB O
, , O
a DT O
zinc-depleted JJ O
enzyme NN O
was VBD O
obtained VBN O
after IN O
prolonged JJ O
dialysis NN O
against IN O
the DT O
specific JJ O
chelating VBG O
agent NN O
1,10-phenanthroline NNP O
. . O

-DOCSTART- X X O

All DT O
patients NNS O
diagnosed VBD O
of IN O
H. NNP O
influenza NN O
type NN O
b NN O
meningitis NN O
were VBD O
less JJR O
than IN O
3 CD O
years NNS O
old JJ O
. . O

-DOCSTART- X X O

The DT O
lines NNS O
also RB O
differed VBD O
in IN O
postsynaptic JJ O
, , O
but CC O
not RB O
presynaptic JJ O
, , O
5-HT1A JJ B-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

The DT O
bZP2 NN B-NP
cDNA NN I-NP
( -LRB- I-NP
115-1914 CD I-NP
nt NN I-NP
, , I-NP
1.8 CD I-NP
kb NN I-NP
) -RRB- I-NP
, , O
excluding VBG O
sequences NNS O
coding VBG O
for IN O
N-terminal JJ O
signal NN O
sequence NN O
and CC O
C-terminal JJ O
transmembranelike JJ O
domain NN O
, , O
was VBD O
PCR NNP O
amplified JJ O
and CC O
Sac1-Sal1 JJ B-NP
restricted JJ O
fragment NN O
cloned VBD O
in IN O
frame NN O
downstream NN O
of IN O
the DT O
T5 NNP O
promoter NN O
under IN O
the DT O
lac NN B-NP
operator NN I-NP
control NN O
in IN O
a DT O
pQE-30 JJ O
vector NN O
. . O

-DOCSTART- X X O

Control NNP O
subjects NNS O
' POS O
evoked JJ O
potentials NNS O
( -LRB- O
EPs NNS O
) -RRB- O
were VBD O
characterized VBN O
by IN O
an DT O
initial JJ O
positivity NN O
in IN O
the DT O
90-140 CD O
ms NNS O
range VBP O
( -LRB- O
P1 NN O
) -RRB- O
at IN O
the DT O
temporo-occipital JJ O
site NN O
. . O

-DOCSTART- X X O

Class NN B-NP
I PRP I-NP
alpha1,2-mannosidases NNS I-NP
play VBP O
an DT O
essential JJ O
role NN O
in IN O
the DT O
elaboration NN O
of IN O
complex JJ O
and CC O
hybrid JJ O
N NNP O
-glycans NNS O
in IN O
mammalian JJ O
cells NNS O
. . O

-DOCSTART- X X O

Structural JJ O
features NNS O
of IN O
the DT O
minimal JJ O
DNA NNP O
binding NN O
domain NN O
( -LRB- O
M98-F219 CD O
) -RRB- O
of IN O
human JJ B-NP
nucleotide JJ I-NP
excision NN I-NP
repair NN I-NP
protein NN I-NP
XPA. . I-NP

-DOCSTART- X X O

Amongst IN O
other JJ O
qualities NNS O
, , O
the DT O
book NN O
's POS O
importance NN O
lies VBZ O
in IN O
the DT O
fact NN O
that IN O
it PRP O
associates NNS O
an DT O
elaborate JJ O
theoretical JJ O
construction NN O
with IN O
the DT O
empirical JJ O
data NNS O
, , O
working VBG O
within IN O
the DT O
possibilities NNS O
provided VBN O
by IN O
late JJ O
19th-century JJ O
moral JJ O
statistics NNS O
. . O

-DOCSTART- X X O

Recently RB O
, , O
extremely RB O
high JJ O
levels NNS O
of IN O
endothelin-1 NN B-NP
( -LRB- O
ET-1 NN B-NP
) -RRB- O
were VBD O
detected VBN O
in IN O
the DT O
pericardial JJ O
fluid NN O
of IN O
patients NNS O
undergoing VBG O
cardiac JJ O
surgery NN O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
the DT O
surfaces NNS O
of IN O
tracheal NN O
cartilage NN O
matrix NN O
are VBP O
collagen-rich JJ B-NP
and CC O
surround JJ O
a DT O
proteoglycan-rich JJ O
core NN O
. . O

-DOCSTART- X X O

Roles NNP O
of IN O
the DT O
Candida NNP B-NP
albicans NNS I-NP
mitogen-activated JJ I-NP
protein NN I-NP
kinase NN I-NP
homolog NN I-NP
, , O
Cek1p NNP B-NP
, , O
in IN O
hyphal JJ O
development NN O
and CC O
systemic JJ O
candidiasis NN O
. . O

-DOCSTART- X X O

Neither CC O
the DT O
reaction NN O
of IN O
monosaccharides NNS O
nor CC O
the DT O
disaccharides NNS O
with IN O
beta-alanine CD O
resulted VBD O
in IN O
the DT O
formation NN O
of IN O
maltol NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
a DT O
Mac1p NNP B-NP
mutant NN I-NP
, , O
refractile JJ O
for IN O
copper-dependent JJ O
repression NN O
of IN O
the DT O
Cu( NN B-NP
I PRP I-NP
) -RRB- I-NP
transport NN I-NP
genes NNS I-NP
, , O
showed VBD O
an DT O
aberrant JJ O
pattern NN O
of IN O
CUP1 JJ B-NP
expression NN O
and CC O
copper NN O
sensitivity NN O
. . O

-DOCSTART- X X O

The DT O
clinical JJ O
and CC O
laboratory NN O
features NNS O
of IN O
72 CD O
children NNS O
with IN O
Henoch-Schonlein NNP O
purpura NN O
( -LRB- O
HSP) PRP O
were VBD O
examined VBN O
to TO O
determine VB O
if IN O
there EX O
were VBD O
associations NNS O
between IN O
the DT O
laboratory NN O
indices--including JJ O
white JJ O
blood NN O
cell NN O
( -LRB- O
WBC NNP O
) -RRB- O
counts VBZ O
, , O
serum NN B-NP
C-reactive JJ I-NP
protein NN I-NP
( -LRB- O
CRP NNP B-NP
) -RRB- O
levels NNS O
, , O
platelet NN O
( -LRB- O
PLT) NNP O
counts--and CC O
the DT O
clinical JJ O
manifestations NNS O
of IN O
acute JJ O
HSP. . O

-DOCSTART- X X O

In IN O
contrast NN O
to TO O
other JJ O
known VBN O
retroviruses NNS O
, , O
the DT O
FV NNP B-NP
pol NN I-NP
genes NNS I-NP
are VBP O
expressed VBN O
via IN O
spliced VBN O
transcripts NNS O
. . O

-DOCSTART- X X O

The DT O
5' JJ O
flanking JJ O
region NN O
of IN O
the DT O
CD1 NNP B-NP
gene NN I-NP
contained VBD O
the DT O
binding NN O
motifs NNS O
for IN O
two CD O
cytokine-inducible JJ O
transcription NN O
factors NNS O
, , O
NF-IL2-A NNP B-NP
and CC O
NF-IL6 NNP B-NP
. . O

-DOCSTART- X X O

Fregnac NNP O
, , O
M. NNP O

-DOCSTART- X X O

GLRaV-2 NN O
is VBZ O
the DT O
only JJ O
closterovirus NN O
, , O
so RB O
far RB O
, , O
that IN O
matches VBZ O
the DT O
genome JJ O
organization NN O
of IN O
the DT O
type NN O
member NN O
of IN O
the DT O
group NN O
, , O
BYV NNP O
, , O
and CC O
thus RB O
can MD O
be VB O
unambiguously RB O
classified VBN O
as IN O
a DT O
definitive JJ O
member NN O
of IN O
the DT O
genus JJ O
Closterovirus NNP O
. . O

-DOCSTART- X X O

Demographic JJ O
and CC O
clinical JJ O
data NNS O
were VBD O
compared VBN O
with IN O
a DT O
control NN O
group NN O
of IN O
339 CD O
healthy JJ O
age-matched JJ O
women NNS O
and CC O
with IN O
a DT O
sample NN O
of IN O
224 CD O
women NNS O
with IN O
wrist NN O
fracture NN O
. . O

-DOCSTART- X X O

Identical JJ O
results NNS O
were VBD O
obtained VBN O
when WRB O
transfections NNS O
and CC O
mobility NN O
shift NN O
assays . O
were VBD O
performed VBN O
in IN O
primary JJ O
rat NN O
hepatocytes NNS O
in IN O
which WDT O
the DT O
endogenous JJ O
ALS NNS B-NP
gene NN I-NP
is VBZ O
expressed VBN O
. . O

-DOCSTART- X X O

This DT O
E NNP O
box NN O
sequence NN O
( -LRB- O
CACGTG NNP O
) -RRB- O
is VBZ O
identical JJ O
to TO O
the DT O
binding JJ O
element NN O
for IN O
USF NNP B-NP
(upstream NNP O
stimulatory JJ B-NP
factor NN I-NP
) -RRB- O
, , O
a DT O
member NN O
of IN O
the DT O
helix-loop-helix NN B-NP
family NN I-NP
of IN I-NP
transcription NN I-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

Interferon NNP B-NP
beta JJ I-NP
therapy NN O
was VBD O
discontinued VBN O
for IN O
4 CD O
weeks NNS O
. . O

-DOCSTART- X X O

Examination NN O
of IN O
the DT O
mitochondrial JJ B-NP
bc1 JJ I-NP
complex JJ I-NP
crystal NN I-NP
structure NN I-NP
[ IN O
Zhang NNP O
, , O
Z. NNP O
, , O
Huang NNP O
, , O
L. NNP O
, , O
Shulmeister NNP O
, , O
V. NNP O

-DOCSTART- X X O

Two CD O
protease-resistant JJ O
fragments NNS O
spanning VBG O
the DT O
N- NNP O
and CC O
C-terminal JJ O
halves NNS O
of IN O
the DT O
nuclease NN O
were VBD O
identified VBN O
using VBG O
different JJ O
proteases NNS O
which WDT O
cleave VBP O
the DT O
protein NN O
in IN O
the DT O
same JJ O
region NN O
. . O

-DOCSTART- X X O

The DT O
side-to-side NN O
difference NN O
was VBD O
statistically RB O
significant JJ O
at IN O
EXT NNP O
30 CD O
degrees/s NN O
and CC O
60 CD O
degrees/s NNS O
( -LRB- O
p NN O
< JJ O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
ability NN O
to TO O
maintain VB O
expression NN O
of IN O
FAS1 NNP B-NP
in IN O
nmt1-451Dino2 DT B-NP
Delta NNP O
cells NNS O
suggests VBZ O
the DT O
existence NN O
of IN O
another DT O
transcription NN O
factor NN O
, , O
or CC O
factors NNS O
, , O
whose WP$ O
expression/activity NN O
is VBZ O
inversely RB O
related VBN O
to TO O
overall JJ O
levels NNS O
of IN O
cellular JJ O
protein NN O
N-myristoy-lation NN O
. . O

-DOCSTART- X X O

Rev-erbAalpha/beta NN B-NP
) -RRB- O
, , O
Mxi-1 JJ B-NP
and CC O
Mad JJ B-NP
bHLH-zip JJ O
proteins NNS O
and CC O
the DT O
oncoproteins NNS O
PLZF NNP B-NP
and CC O
LAZ3/BCL6 NNP B-NP
is VBZ O
mediated VBN O
by IN O
the DT O
corepressors NNS O
N-CoR NNP B-NP
and CC O
SMRT. NNP B-NP

-DOCSTART- X X O

There EX O
was VBD O
no DT O
evidence NN O
of IN O
any DT O
persistent JJ O
oscillation NN O
within IN O
the DT O
ULF NNP O
band NN O
. . O

-DOCSTART- X X O

The DT O
purified VBN O
recombinant JJ O
protein NN O
was VBD O
assayed VBN O
for IN O
its PRP$ O
enzyme NN O
activity NN O
by IN O
monitoring NN O
transfer NN O
of IN O
[3H]methyl NN O
groups NNS O
from IN O
the DT O
substrate JJ O
DNA NN O
to TO O
the DT O
MGMT NNP B-NP
protein NN I-NP
; : O
the DT O
activity NN O
was VBD O
found VBN O
to TO O
be VB O
stable JJ O
at IN O
90 CD O
degrees NNS O
C NN O
for IN O
at IN O
least JJS O
30 CD O
min NN O
. . O

-DOCSTART- X X O

Elimination NNP O
of IN O
the DT O
inducible JJ O
response NN O
requires VBZ O
simultaneous JJ O
mutation NN O
of IN O
both DT O
sequences NNS O
, , O
however RB O
, , O
in IN O
the DT O
presence NN O
of IN O
an DT O
intact JJ O
EpRE NNP O
the DT O
upstream JJ O
AP-1 NN B-NP
site NN I-NP
is VBZ O
irrelevant JJ O
to TO O
induction NN O
. . O

-DOCSTART- X X O

Three CD O
high JJ B-NP
mobility NN I-NP
group-like JJ I-NP
sequences NNS I-NP
within IN O
a DT O
48-base JJ O
pair NN O
enhancer NN O
of IN O
the DT O
Col2a1 NNP B-NP
gene NN I-NP
are VBP O
required VBN O
for IN O
cartilage-specific JJ O
expression NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

The DT O
sequence NN O
contains VBZ O
an DT O
open JJ O
reading NN O
frame NN O
of IN O
1744 CD O
nt NN O
in IN O
the DT O
virus-sense NN O
strand NN O
, , O
a DT O
3' JJ O
untranslated JJ O
region NN O
of IN O
1360 CD O
nt NN O
and CC O
a DT O
3' JJ O
poly( NN O
A DT O
) -RRB- O
tail NN O
. . O

-DOCSTART- X X O

A DT O
phylogenetic JJ O
analysis NN O
of IN O
the DT O
reverse NN B-NP
transcriptase NN I-NP
domain NN I-NP
confirms VBZ O
our PRP$ O
differential JJ O
genetic JJ O
assessment NN O
that WDT O
Cyclops VBZ B-NP
from IN O
pea NN O
is VBZ O
a DT O
novel JJ O
element NN O
with IN O
no DT O
specific JJ O
relationship NN O
to TO O
the DT O
previously RB O
described VBN O
Gypsy-like JJ B-NP
elements NNS I-NP
from IN O
plants NNS O
. . O

-DOCSTART- X X O

At IN O
physiological JJ O
doses NNS O
, , O
either CC O
insulin-like JJ B-NP
growth NN I-NP
factor NN I-NP
I PRP I-NP
( -LRB- O
IGF-I) NNP B-NP
or CC O
insulin NN B-NP
turned VBD O
out RP O
to TO O
be VB O
as RB O
potent JJ O
as IN O
dibutyryl NN O
cAMP NNS O
( -LRB- O
dbcAMP NN O
) -RRB- O
in IN O
increasing VBG O
UCP1 JJ B-NP
gene NN I-NP
transcription NN O
rate NN O
( -LRB- O
1 CD O
h NN O
) -RRB- O
and CC O
also RB O
UCP1 IN B-NP
mRNA NN I-NP
accumulation NN O
( -LRB- O
3 CD O
h NN O
) -RRB- O
, , O
their PRP$ O
maximal JJ O
effect NN O
( -LRB- O
15-fold JJ O
increase NN O
) -RRB- O
reached VBN O
upon IN O
treatment NN O
for IN O
24 CD O
h NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
insulin NN B-NP
induced VBN O
AP-1 JJ B-NP
DNA NNP O
binding NN O
activity NN O
, , O
this DT O
effect NN O
being VBG O
totally RB O
prevented VBN O
in IN O
the DT O
presence NN O
of IN O
MEK-1 JJ B-NP
inhibitor NN O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
the DT O
human JJ O
p21/WAF1/Cip1 NN B-NP
promoter NN O
in IN O
hepatic JJ O
cells NNS O
by IN O
functional JJ O
interactions NNS O
between IN O
Sp1 NNP B-NP
and CC O
Smad NNP B-NP
family NN I-NP
members NNS I-NP
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
We PRP O
isolated VBD O
a DT O
C. NNP O
elegans NNS O
cDNA NN O
that WDT O
encoded VBD O
a DT O
protein NN O
which WDT O
was VBD O
similar JJ O
to TO O
, , O
but CC O
not RB O
exactly RB O
homologous JJ O
with IN O
mammalian JJ O
p120 NN B-NP
Ras-GAP. . B-NP

-DOCSTART- X X O

The DT O
weak JJ O
base NN O
ketoconazole NN O
showed VBD O
complete JJ O
dissolution NN O
from IN O
a DT O
tablet NN O
formulation NN O
in IN O
Simulated NNP O
Gastric NNP O
Fluid NNP O
without IN O
pepsin NN B-NP
(SGFsp NN O
) -RRB- O
within IN O
30 CD O
minutes NNS O
, , O
70 CD O
% NN O
dissolution NN O
in IN O
2 CD O
hours NNS O
under IN O
fed VBN O
state NN O
simulated VBN O
upper JJ O
jejunal NN O
conditions NNS O
but CC O
only RB O
6 CD O
% NN O
dissolution NN O
in IN O
2 CD O
hours NNS O
under IN O
fasted JJ O
state NN O
conditions NNS O
. . O

-DOCSTART- X X O

In IN O
mammals NNS O
, , O
the DT O
Rb JJ B-NP
protein NN I-NP
interacts NNS O
specifically RB O
with IN O
D-type JJ B-NP
cyclins NNS I-NP
and CC O
regulates VBZ O
cell NN O
proliferation NN O
by IN O
binding JJ O
and CC O
inhibiting JJ O
E2F JJ B-NP
transcription NN I-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
the DT O
signals NNS O
obtained VBN O
by IN O
ligation NN O
of IN O
the DT O
TCR NNP B-NP
, , O
T NNP O
cells NNS O
need VBP O
additional JJ O
, , O
co-stimulatory JJ O
signals NNS O
to TO O
be VB O
activated VBN O
. . O

-DOCSTART- X X O

We PRP O
characterized VBD O
the DT O
structure NN O
of IN O
this DT O
leader NN O
mRNA NN O
by IN O
using VBG O
the DT O
program NN O
Mfold RB O
and CC O
a DT O
combination NN O
of IN O
nested JJ O
and CC O
internal JJ O
deletions NNS O
transcriptionally RB O
fused VBN O
to TO O
a DT O
promoterless JJ O
lac NN B-NP
operon NN I-NP
. . O

-DOCSTART- X X O

The DT O
importance NN O
of IN O
these DT O
sites NNS O
for IN O
transcriptional JJ O
activation NN O
was VBD O
studied VBN O
by IN O
site-directed DT O
mutagenesis NN O
followed VBN O
by IN O
promoter NN O
function NN O
analysis NN O
of IN O
the DT O
mutants NNS O
with IN O
a DT O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
reporter NN I-NP
system NN O
. . O

-DOCSTART- X X O

Routine JJ O
blood NN O
examination NN O
showed VBD O
leukocytosis NN O
, , O
thrombocytopenia NN O
, , O
positive JJ O
CRP NNP B-NP
, , O
and CC O
elevated VBD O
myocardial JJ O
enzymes NNS O
. . O

-DOCSTART- X X O

Previous JJ O
studies NNS O
have VBP O
suggested VBN O
that IN O
moderate JJ O
cooling NN O
increases VBZ O
the DT O
responsiveness NN O
of IN O
vascular JJ B-NP
alpha2-adrenoceptors NNS I-NP
. . O

-DOCSTART- X X O

The DT O
use NN O
of IN O
antibodies NNS O
to TO O
the DT O
polypyrimidine NN B-NP
tract NN I-NP
binding JJ I-NP
protein NN I-NP
( -LRB- O
PTB NN B-NP
) -RRB- O
to TO O
analyze VB O
the DT O
protein NN O
components NNS O
that WDT O
assemble VBP O
on IN O
alternatively RB O
spliced VBN O
pre-mRNAs JJ O
that IN O
use NN O
distant JJ O
branch NN O
points NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
applied VBN O
the DT O
mRNA NN O
differential JJ O
display NN O
method NN O
to TO O
compare VB O
and CC O
analyze VB O
mRNAs NNS O
prepared VBN O
from IN O
five CD O
normal JJ O
nasopharyngeal JJ O
epithelial NN O
cell NN O
cultures NNS O
and CC O
five CD O
nasopharyngeal JJ O
carcinoma NN O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

SETTING NNP O
: : O
University NNP O
hospital-based VBD O
, , O
tertiary JJ O
care NN O
infertility NN O
center NN O
. . O

-DOCSTART- X X O

RESULT( JJ O
S) NN O
: : O
In IN O
patients NNS O
with IN O
elevated JJ O
FSH NNS B-NP
levels NNS O
on IN O
cycle NN O
day NN O
3 CD O
, , O
a DT O
low JJ O
oocyte NN O
yield NN O
was VBD O
achieved VBN O
( -LRB- O
7 CD O
versus JJ O
11 CD O
) -RRB- O
and CC O
a DT O
high JJ O
number NN O
of IN O
ampules NNS O
of IN O
hMG NN B-NP
was VBD O
necessary JJ O
( -LRB- O
56 CD O
versus JJ O
33 CD O
) -RRB- O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Of IN O
the DT O
patients NNS O
with IN O
IS NNP O
, , O
67 CD O
% NN O
had VBD O
significantly RB O
greater JJR O
values NNS O
of IN O
directional JJ O
preponderance NN O
on IN O
the DT O
OVAR NN O
test NN O
( -LRB- O
a DT O
measure NN O
of IN O
otolith NNP O
system NN O
imbalance NN O
) -RRB- O
compared VBN O
with IN O
control NN O
subjects NNS O
. . O

-DOCSTART- X X O

As IN O
predicted VBN O
by IN O
the DT O
Wing NNP O
and CC O
Kristofferson NNP O
model NN O
, , O
the DT O
durations NNS O
of IN O
successive JJ O
ISIs NNP O
tended VBD O
to TO O
be VB O
negatively RB O
correlated VBN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
included VBD O
in IN O
the DT O
KG1a NNP O
EST NNP O
dataset NN O
are VBP O
candidates NNS O
for IN O
new JJ O
human JJ O
genes NNS O
that WDT O
may MD O
play VB O
roles NNS O
in IN O
hematopoietic JJ O
differentiative JJ O
progression NN O
and CC O
lineage NN O
commitment NN O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
the DT O
following VBG O
: : O
Specific JJ O
mutations NNS O
affected VBD O
the DT O
precise JJ O
carbohydrate NN O
structure NN O
and CC O
folding NN O
of IN O
the DT O
HA NNP B-NP
trimer NN I-NP
. . O

-DOCSTART- X X O

The DT O
results NNS O
show VBP O
that IN O
ROS NNP O
production NN O
by IN O
viable JJ O
spermatozoa NNS O
is VBZ O
highly RB O
correlated VBN O
with IN O
the DT O
concentration NN O
of IN O
PMN NNP B-NP
elastase NN I-NP
and CC O
the DT O
number NN O
of IN O
both DT O
peroxidase-positive JJ B-NP
and CC O
round JJ O
cells NNS O
. . O

-DOCSTART- X X O

Yeast NNP B-NP
U1 NNP I-NP
snRNP NN I-NP
is VBZ O
considerably RB O
more RBR O
complex JJ O
than IN O
its PRP$ O
metazoan NN O
counterpart NN O
, , O
which WDT O
suggests VBZ O
possible JJ O
differences NNS O
between IN O
yeast NN O
and CC O
metazoa NNS O
in IN O
early JJ O
splicing NN O
events NNS O
. . O

-DOCSTART- X X O

The DT O
opioid JJ O
antagonist NN O
naltrexone NN O
( -LRB- O
0.01-1.0 CD O
mg/kg NN O
) -RRB- O
antagonized VBN O
the DT O
discriminative JJ O
stimulus NN O
effects NNS O
of IN O
heroin NN O
, , O
but CC O
naltrexone NN O
at IN O
doses NNS O
up IN O
to TO O
10 CD O
mg/kg NN O
had VBD O
no DT O
effect NN O
on IN O
the DT O
discriminative JJ O
stimulus NN O
effects NNS O
of IN O
cocaine NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
we PRP O
examined VBD O
hepatic JJ O
stellate NN O
cell NN O
regulation NN O
of IN O
M6P/IGFIIR NNP B-NP
expression NN O
and CC O
found VBD O
that IN O
M6P/IGFIIR NNP B-NP
mRNA NN O
transcript NN O
levels NNS O
increased VBN O
in IN O
stellate JJ O
cells NNS O
from IN O
rats NNS O
exposed VBN O
to TO O
carbon NN O
tetrachloride NN O
(CCl4 IN O
) -RRB- O
, , O
a DT O
potent JJ O
fibrogenic JJ O
stimulant NN O
. . O

-DOCSTART- X X O

One CD O
cDNA NN O
clone NN O
designated VBN O
NCoA-62 NNP O
, , O
encoded VBD O
a DT O
62 CD O
, , O
000-Da JJ O
protein NN O
that WDT O
is VBZ O
highly RB O
related VBN O
to TO O
BX42 NNP B-NP
, , O
a DT O
Drosophila NNP O
melanogaster NN O
nuclear JJ O
protein NN O
involved VBN O
in IN O
ecdysone-stimulated JJ O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

These DT O
widely RB O
expressed VBN O
proteins NNS O
share VBP O
a DT O
C-terminal JJ O
region NN O
that WDT O
bears VBZ O
significant JJ O
sequence NN O
homology NN O
to TO O
a DT O
group NN O
of IN O
GDP/GTP NNP B-NP
exchange NN I-NP
proteins VBZ I-NP
for IN O
the DT O
Rab3 NNP B-NP
family NN I-NP
of IN O
small JJ B-NP
GTP NNP I-NP
binding JJ I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Whereas IN O
p82 JJ B-NP
expression NN O
had VBD O
no DT O
effect NN O
on IN O
ERK2 NNP B-NP
activation NN O
by IN O
p126 NNS B-NP
, , O
p70 VBD B-NP
completely RB O
abrogated VBN O
this DT O
activity NN O
. . O

-DOCSTART- X X O

The DT O
brackets NNS O
were VBD O
bonded VBN O
to TO O
100 CD O
freshly RB O
extracted VBN O
bovine NN O
incisors NNS O
, , O
and CC O
, , O
after IN O
storage NN O
in IN O
tap NN O
water NN O
at IN O
room NN O
temperature NN O
for IN O
24 CD O
hours NNS O
, , O
they PRP O
were VBD O
subsequently RB O
tested VBN O
in IN O
a DT O
shear JJ O
mode NN O
using VBG O
a DT O
universal JJ O
testing NN O
machine NN O
. . O

-DOCSTART- X X O

The DT O
growth NN O
of IN O
Aer NNP O
. . O
hydrophila NN O
in IN O
filter-sterilized JJ O
lettuce NN O
extract VB O
was VBD O
completely RB O
inhibited VBN O
by IN O
0.1 CD O
% NN O
( -LRB- O
v/v NN O
) -RRB- O
BMC NNP O
whereas IN O
that DT O
of IN O
Ps NNS O
. . O
fluorescens NNS O
was VBD O
not RB O
significantly RB O
affected VBN O
by IN O
1 CD O
% NN O
( -LRB- O
v/v NN O
) -RRB- O
BMC. . O

-DOCSTART- X X O

Despite IN O
continuous JJ O
compliance NN O
, , O
unexplained JJ O
resurgence NN O
of IN O
serum NN O
ferritin NN B-NP
levels NNS O
occurred VBD O
in IN O
4/7 CD O
patients NNS O
of IN O
the DT O
'veteran' JJ O
group NN O
after IN O
4-5 CD O
years NNS O
on IN O
L1 NNP O
. . O

-DOCSTART- X X O

Hematocrit NNP O
and CC O
PaO2 NNP O
did VBD O
not RB O
change NN O
. . O

-DOCSTART- X X O

Commutative JJ O
saccadic JJ O
generator NN O
is VBZ O
sufficient JJ O
to TO O
control VB O
a DT O
3-D JJ O
ocular JJ O
plant NN O
with IN O
pulleys NNS O
. . O

-DOCSTART- X X O

The DT O
virus-associated JJ O
VAI NNP B-NP
RNA NNP O
of IN O
adenovirus NN O
is VBZ O
a DT O
small JJ O
highly RB O
structured VBN O
RNA NNP O
that WDT O
is VBZ O
required VBN O
for IN O
the DT O
efficient JJ O
translation NN O
of IN O
cellular JJ O
and CC O
viral JJ O
mRNAs NNS O
at IN O
late JJ O
times NNS O
after IN O
infection NN O
. . O

-DOCSTART- X X O

Structure NN O
of IN O
the DT O
gene NN O
encoding VBG O
the DT O
human JJ O
cyclin-dependent NN B-NP
kinase NN I-NP
inhibitor IN O
p18 NNS B-NP
and CC O
mutational JJ O
analysis NN O
in IN O
breast NN O
cancer NN O
. . O

-DOCSTART- X X O

The DT O
YccA NNP B-NP
protein NN I-NP
was VBD O
found VBN O
to TO O
be VB O
degraded VBN O
in IN O
an DT O
FtsH-dependent JJ B-NP
manner NN O
in IN O
vivo JJ O
and CC O
in IN O
vitro NN O
, , O
whereas IN O
the DT O
YccA11 NN B-NP
mutant JJ I-NP
protein NN I-NP
, , O
lacking VBG O
eight CD O
amino IN O
acid NN O
residues NNS O
within IN O
the DT O
amino-terminal JJ O
cytoplasmic JJ O
domain NN O
, , O
was VBD O
refractory JJ O
to TO O
the DT O
degradation NN O
. . O

-DOCSTART- X X O

The DT O
major JJ O
type NN O
involves VBZ O
activator NN O
proteins NNS O
that WDT O
bind VBP O
to TO O
DNA NNP O
adjacent JJ O
to TO O
where WRB O
the DT O
RNA NNP B-NP
polymerase NN I-NP
( -LRB- O
RNAP NNP B-NP
) -RRB- O
holoenzyme VBP O
binds NNS O
, , O
usually RB O
assisting VBG O
in IN O
recruitment NN O
of IN O
the DT O
RNAP NNP B-NP
to TO O
the DT O
promoter NN O
. . O

-DOCSTART- X X O

It PRP O
contains VBZ O
a DT O
5'-noncoding JJ O
region NN O
(NCR NN O
) -RRB- O
of IN O
73 CD O
nucleotides NNS O
, , O
five CD O
open JJ O
reading NN O
frames NNS O
( -LRB- O
ORFs NNS O
1 CD O
to TO O
5 CD O
) -RRB- O
which WDT O
encode VBP O
proteins VBZ O
with IN O
M(r NN O
) -RRB- O
160 CD B-NP
kDa NN I-NP
RNA-dependent JJ I-NP
RNA NN I-NP
polymerase NN I-NP
( -LRB- I-NP
ORF1 NNP I-NP
) -RRB- I-NP
, , O
26 CD B-NP
kDa NN I-NP
movement NN I-NP
protein NN I-NP
1 CD I-NP
( -LRB- I-NP
ORF2 NN I-NP
) -RRB- I-NP
, , O
13 CD B-NP
kDa NN I-NP
movement NN I-NP
protein NN I-NP
2 CD I-NP
( -LRB- I-NP
ORF3 NN I-NP
) -RRB- I-NP
, , O
10 CD B-NP
kDa NN I-NP
movement NN I-NP
protein NN I-NP
3 CD I-NP
( -LRB- I-NP
ORF4 IN I-NP
) -RRB- I-NP
, , O
24 CD B-NP
kDa NN I-NP
coat NN I-NP
protein NN I-NP
( -LRB- I-NP
OFR5 IN I-NP
) -RRB- I-NP
, , O
and CC O
a DT O
3' JJ O
NCR NN O
of IN O
76 CD O
nucleotides NNS O
. . O

-DOCSTART- X X O

After IN O
profound JJ O
normovolemic JJ O
hemodilution NN O
( -LRB- O
Hct NNP O
9 CD O
% NN O
) -RRB- O
superiority NN O
of IN O
LV NNP O
MC NNP O
and CC O
LV NNP O
diastolic JJ O
properties NNS O
was VBD O
found VBN O
, , O
when WRB O
myocardial JJ O
oxygenation NN O
was VBD O
supported VBN O
by IN O
i DT O
.v. NNP O
perflubron NN O
emulsion NN O
, , O
a DT O
temporary JJ O
O2 JJ O
carrier NN O
. . O

-DOCSTART- X X O

Sp1 NNP B-NP
and CC O
two CD O
Sp3 JJ B-NP
isoforms NNS I-NP
were VBD O
detected VBN O
as IN O
the DT O
primary JJ O
cellular JJ O
constituents NNS O
of IN O
DNA-protein NNP O
complexes NNS O
formed VBD O
with IN O
the DT O
NF-kappaB-proximal JJ B-NP
site NN I-NP
. . O

-DOCSTART- X X O

These DT O
genes NNS O
may MD O
represent VB O
interesting JJ O
targets NNS O
for IN O
new JJ O
therapeutic JJ O
strategies NNS O
. . O

-DOCSTART- X X O

It PRP O
could MD O
also RB O
inhibit VB O
C1q-dependent JJ B-NP
haemolysis NN O
of IN O
both DT O
IgG- NNP B-NP
and CC O
IgM-sensitized NNP B-NP
erythrocytes NNS O
. . O

-DOCSTART- X X O

3 CD O
) -RRB- O
and CC O
one CD O
distal JJ O
(-11.8/-10.9 CD O
) -RRB- O
, , O
presented VBD O
an DT O
enhancer NN O
activity NN O
in IN O
pituitary JJ O
cells NNS O
when WRB O
placed VBN O
upstream RB O
of IN O
the DT O
SV40 NNP B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

3--It JJ O
is VBZ O
necessary JJ O
to TO O
think VB O
about IN O
cosmetic JJ O
consequences NNS O
of IN O
the DT O
chinese JJ O
flap NN O
and CC O
consider VB O
other JJ O
possibilities NNS O
of IN O
the DT O
flap NN O
choice NN O
. . O

-DOCSTART- X X O

However RB O
, , O
it PRP O
is VBZ O
only RB O
one-half JJ O
and CC O
one-third JJ O
the DT O
size NN O
of IN O
the DT O
proteolipids NNS O
from IN O
M. NNP O
thermoautotrophicum , O
and CC O
M. NNP O
jannaschii NNP O
, , O
respectively RB O
. . O
ahaK NN B-NP
is VBZ O
expressed VBN O
in IN O
Escherichia NNP O
coli NNS O
, , O
and CC O
it PRP O
is VBZ O
incorporated VBN O
into IN O
the DT O
cytoplasmic JJ O
membrane NN O
despite IN O
the DT O
different JJ O
chemical NN O
natures NNS O
of IN O
lipids NNS O
from IN O
archaea NN O
and CC O
bacteria NNS O
. . O

-DOCSTART- X X O

The DT O
cleavage NN O
of IN O
Fak NNP B-NP
by IN O
caspases NNS B-NP
may MD O
thus RB O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
execution NN O
of IN O
the DT O
suicide NN O
program NN O
by IN O
disabling VBG O
the DT O
anti-apoptotic JJ O
function NN O
of IN O
Fak NNP B-NP
. . O

-DOCSTART- X X O

Transcription NN O
initiation NN O
occurred VBD O
predominantly RB O
at IN O
the DT O
putative JJ O
sigmaA-dependent JJ B-NP
promoter NN I-NP
in IN O
exponentially RB O
growing VBG O
cells NNS O
and CC O
was VBD O
induced VBN O
under IN O
stress NN O
conditions NNS O
. . O

-DOCSTART- X X O

The DT O
genes NNS O
encoding VBG O
( -LRB- B-NP
2Fe-2S FW I-NP
) -RRB- I-NP
plant-like JJ I-NP
ferredoxins NNS I-NP
were VBD O
studied VBN O
in IN O
the DT O
widely RB O
used VBN O
cyanobacterium NN O
Synechocystis NNP O
PCC6803 CD O
. . O

-DOCSTART- X X O

A DT O
major JJ O
pool NN O
of IN O
Dsg-plakoglobin NNP B-NP
complexes NNS O
sedimented VBD O
at IN O
8S CD O
and CC O
exhibited VBD O
a DT O
1:1 CD O
stoichiometry NN O
. . O

-DOCSTART- X X O

In IN O
macrophages NNS O
, , O
LPS-inducible JJ O
HIV-1 NN O
gene NN O
expression NN O
is VBZ O
mediated VBN O
in IN O
part NN O
by IN O
binding NN O
of IN O
NF-kappa NNP B-NP
B NNP I-NP
to TO O
identical JJ O
tandem NN O
binding NN O
sites NNS O
located VBN O
within IN O
the DT O
long JJ O
terminal NN O
repeat NN O
( -LRB- O
LTR NNP O
) -RRB- O
. . O

-DOCSTART- X X O

It PRP O
can MD O
also RB O
be VB O
used VBN O
to TO O
examine VB O
various JJ O
laryngeal JJ O
parameters NNS O
obtained VBN O
from IN O
videotaped JJ O
endoscopic NN O
and CC O
stroboscopic JJ O
examinations NNS O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Two CD O
consecutive JJ O
sets NNS O
of IN O
transrectal NN O
ultrasound NN O
guided VBN O
sextant JJ O
biopsies NNS O
of IN O
the DT O
prostate NN O
performed VBN O
in IN O
a DT O
single JJ O
office NN O
visit NN O
represent VBP O
a DT O
cost-effective JJ O
biopsy NN O
strategy NN O
for IN O
men NNS O
presenting VBG O
with IN O
an DT O
abnormal JJ O
digital JJ O
rectal JJ O
examination NN O
and/or CC O
elevated VBD O
serum NN B-NP
PSA NNP I-NP
. . O

-DOCSTART- X X O

Examination NN O
of IN O
nuclear JJ O
magnetic JJ O
resonance NN O
( -LRB- O
NMR NN O
) -RRB- O
spectra NN O
of IN O
a DT O
series NN O
of IN O
N-terminally NNP B-NP
truncated VBD I-NP
MIP-1 JJ I-NP
beta NN I-NP
variants VBZ I-NP
reveals VBZ O
that IN O
these DT O
proteins NNS O
possess VBP O
a DT O
range NN O
of IN O
ability NN O
to TO O
dimerize VB O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
PKA NNP B-NP
activity NN O
is VBZ O
dispensable JJ O
in IN O
a DT O
strain NN O
lacking VBG O
Msn2p JJ B-NP
and CC O
Msn4p JJ B-NP
activity NN O
. . O

-DOCSTART- X X O

They PRP O
also RB O
indicate VBP O
that IN O
direct JJ O
interactions NNS O
between IN O
C/EBPs NNS B-NP
and CC O
specific JJ O
Ets NNS B-NP
family NN O
members NNS O
, , O
together RB O
with IN O
GATA-1 NNP B-NP
, , O
are VBP O
important JJ O
for IN O
eosinophil JJ O
lineage NN O
determination NN O
. . O

-DOCSTART- X X O

Recently RB O
, , O
a DT O
human JJ B-NP
transcription NN I-NP
elongation NN I-NP
factor NN I-NP
P-TEFb NNP I-NP
, , O
consisting VBG O
of IN O
CDK9 DT B-NP
kinase NN I-NP
, , O
cyclin NN B-NP
T NNP I-NP
and CC O
other JJ O
associated JJ O
factors NNS O
, , O
has VBZ O
been VBN O
shown VBN O
to TO O
interact VB O
with IN O
Tat NNP B-NP
to TO O
restore VB O
Tat NNP B-NP
activation NN O
in IN O
HeLa NNP O
nuclear JJ O
extract VB O
depleted VBN O
of IN O
P-TEFb NNP B-NP
. . O

-DOCSTART- X X O

The DT O
general JJ O
recombination NN O
at IN O
a DT O
polarizing JJ O
voltage NN O
of IN O
300 CD O
V NNP O
is VBZ O
less JJR O
than IN O
2 CD O
% NN O
for IN O
dose-rates NNS O
up IN O
to TO O
about IN O
100 CD O
mGy JJ O
min-1 NN O
. . O

-DOCSTART- X X O

The DT O
low JJ O
number NN O
of IN O
false JJ O
positives NNS O
indicates VBZ O
that IN O
our PRP$ O
scheme NN O
would MD O
not RB O
confuse VB O
the DT O
radiologist NN O
by IN O
suggesting VBG O
normal JJ O
regions NNS O
as IN O
suspicious JJ O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
these DT O
data NNS O
indicate VBP O
that IN O
the DT O
VirD2 NNP B-NP
omega NNP I-NP
domain NN I-NP
is VBZ O
important JJ O
for IN O
efficient JJ O
T-DNA NNP O
integration NN O
. . O

-DOCSTART- X X O

The DT O
DHEAS NNP O
levels NNS O
in IN O
all DT O
stages NNS O
of IN O
decreased VBN O
BMD NNP O
were VBD O
significantly RB O
lower JJR O
than IN O
those DT O
in IN O
the DT O
group NN O
with IN O
normal JJ O
BMD. . O

-DOCSTART- X X O

Orientation NNP O
of IN O
the DT O
nuclear JJ O
spin NN O
system NN O
by IN O
optical JJ O
pumping VBG O
causes VBZ O
an DT O
Overhauser NNP O
shift NN O
of IN O
the DT O
excitonic JJ O
energy NN O
levels NNS O
proportional JJ O
to TO O
the DT O
degree NN O
of IN O
nuclear JJ O
orientation NN O
. . O

-DOCSTART- X X O

GTPase NNP B-NP
activating VBG O
specificity NN O
of IN O
RGS12 NNP B-NP
and CC O
binding JJ O
specificity NN O
of IN O
an DT O
alternatively RB O
spliced JJ O
PDZ NN B-NP
( -LRB- O
PSD-95/Dlg/ZO-1 NN B-NP
) -RRB- O
domain NN O
. . O

-DOCSTART- X X O

However RB O
, , O
mutations NNS O
in IN O
the DT O
HNF-4 NNP B-NP
binding NN I-NP
site NN I-NP
on IN O
element NN B-NP
CIIB NN I-NP
and CC O
inhibition NN O
of IN O
HNF-4 NNP B-NP
synthesis NN O
in IN O
HepG2 CD O
cells NNS O
by IN O
antisense JJ O
HNF-4 NN B-NP
constructs NNS I-NP
decreased VBD O
the DT O
apoCII JJ B-NP
promoter NN I-NP
activity NN O
to TO O
25-40 CD O
% NN O
of IN O
the DT O
control NN O
, , O
indicating VBG O
that IN O
HNF-4 NNP B-NP
is VBZ O
a DT O
positive JJ O
regulator NN O
of IN O
the DT O
apoCII JJ B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
we PRP O
find VBP O
that DT O
E2F-1 NN B-NP
can MD O
cause VB O
apoptosis NN O
in IN O
p53-/- DT B-NP
tumour NN O
cells NNS O
and CC O
further JJ O
p300 NN B-NP
, , O
which WDT O
also RB O
functions VBZ O
as IN O
a DT O
co-activator NN O
for IN O
the DT O
E2F/DP NNP B-NP
heterodimer NN O
, , O
enhances VBZ O
the DT O
apoptotic JJ O
activity NN O
of IN O
E2F-1 NN B-NP
. . O

-DOCSTART- X X O

Blocked VBN O
shift/supershift NN O
analysis NN O
indicates VBZ O
that IN O
Fos NNP B-NP
family NN I-NP
member NN O
proteins VBZ O
especially RB O
Fra-1 JJ B-NP
and CC O
Fra-2 JJ B-NP
are VBP O
related VBN O
to TO O
progression NN O
and CC O
no DT O
changes NNS O
found VBD O
in IN O
the DT O
Jun NNP B-NP
family NN I-NP
member NN O
proteins VBZ O
although IN O
they PRP O
are VBP O
present JJ O
in IN O
the DT O
AP-1/DNA NNP B-NP
binding NN I-NP
complex NN I-NP
. . O

-DOCSTART- X X O

Comparison NNP O
of IN O
cDNA NN O
and CC O
genomic JJ O
sequences NNS O
shows VBZ O
that IN O
the DT O
ZNF189 NNP B-NP
gene NN I-NP
spans VBZ O
approximately RB O
11 CD O
kb NN O
and CC O
is VBZ O
organized VBN O
into IN O
at IN O
least JJS O
four CD O
exons NNS O
, , O
the DT O
large JJ O
3'-end JJ O
exon NN O
coding NN O
for IN O
the DT O
complete JJ O
zinc NN O
finger NN O
domain NN O
and CC O
the DT O
3' JJ O
untranslated JJ O
region NN O
. . O

-DOCSTART- X X O

Five CD O
additional JJ O
copies NNS O
of IN O
Lian NNP B-NP
elements NNS I-NP
were VBD O
isolated VBN O
, , O
mapped VBN O
by IN O
restriction NN O
digestion NN O
, , O
and CC O
partially RB O
sequenced VBD O
. . O

-DOCSTART- X X O

Role NNP O
of IN O
the DT O
transcription NN O
start NN O
site NN O
core JJ O
region NN O
and CC O
transcription NN B-NP
factor NN I-NP
YY1 . I-NP
in IN O
Rous JJ B-NP
sarcoma NN I-NP
virus NN I-NP
long RB I-NP
terminal JJ I-NP
repeat NN I-NP
promoter NN I-NP
activity NN O
. . O

-DOCSTART- X X O

Fowlpox NNP O
virus NN O
encodes VBZ O
nonessential JJ O
homologs NNS O
of IN O
cellular JJ B-NP
alpha-SNAP NNS I-NP
, , O
PC-1 NN B-NP
, , O
and CC O
an DT O
orphan JJ O
human JJ O
homolog NN O
of IN O
a DT O
secreted JJ O
nematode JJ O
protein NN O
. . O

-DOCSTART- X X O

Addition NN O
of IN O
Rap NNP O
or CC O
KN62 NNP O
after IN O
exposure NN O
of IN O
cells NNS O
to TO O
progesterone VB O
agonist JJ O
Org NNP O
2058 CD O
had VBD O
no DT O
effect NN O
on IN O
induction NN O
of IN O
CAT NN B-NP
activity NN O
. . O

-DOCSTART- X X O

The DT O
Dax-1 NNP B-NP
gene NN I-NP
encodes VBZ O
a DT O
protein NN O
that WDT O
is VBZ O
structurally RB O
related VBN O
to TO O
members NNS O
of IN O
the DT O
orphan JJ B-NP
nuclear JJ I-NP
receptor NN I-NP
superfamily NN I-NP
. . O

-DOCSTART- X X O

Further RB O
, , O
Ser/Thr NNP O
phosphorylation NN O
of IN O
downstream NN O
molecules NNS O
Akt . B-NP
and CC O
p70 PRP B-NP
S6 DT I-NP
kinase NN I-NP
was VBD O
inhibited VBN O
. . O

-DOCSTART- X X O

Quantitative JJ O
evaluation NN O
of IN O
the DT O
steady JJ O
state NN O
kinetics NNS O
of IN O
MEK NNP B-NP
inhibition NN O
by IN O
these DT O
compounds NNS O
reveals VBZ O
that IN O
U0126 NNP O
has VBZ O
approximately RB O
100-fold JJ O
higher JJR O
affinity NN O
for IN O
deltaN3-S218E/S222D JJ B-NP
MEK NNP I-NP
than IN O
does VBZ O
PD098059 NNP O
. . O

-DOCSTART- X X O

Regulation NN O
at IN O
37 CD O
degrees NNS O
C NN O
, , O
therefore RB O
, , O
involves VBZ O
the DT O
action NN O
of IN O
three CD O
protein NN O
kinase NN O
cascades NNS O
that IN O
repress NN O
HSF1 IN B-NP
through IN O
phosphorylation NN O
of IN O
serine NN O
residues NNS O
303 JJ O
, , O
307 CD O
, , O
and CC O
363 CD O
and CC O
may MD O
promote VB O
growth NN O
by IN O
suppressing VBG O
the DT O
heat NN O
shock NN O
response NN O
. . O

-DOCSTART- X X O

Clinical NNP O
implication NN O
of IN O
protein NN O
levels NNS O
of IN O
IL-5 DT B-NP
in IN O
induced JJ O
sputum NN O
in IN O
asthmatic JJ O
patients NNS O
. . O

-DOCSTART- X X O

In IN O
these DT O
cells NNS O
, , O
ras-induced JJ B-NP
transition NN O
is VBZ O
accompanied VBN O
by IN O
a DT O
strong JJ O
induction NN O
of IN O
AP-1-binding JJ B-NP
activity NN O
along IN O
with IN O
increased JJ O
expression NN O
of IN O
CD44 NNP B-NP
mRNA NN I-NP
and CC O
protein NN O
. . O

-DOCSTART- X X O

However RB O
, , O
little JJ O
is VBZ O
known VBN O
regarding VBG O
the DT O
genomic JJ O
organization NN O
and CC O
developmental JJ O
expression NN O
of IN O
the DT O
caveolin NN B-NP
gene NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

Suppressive VB O
therapy NN O
for IN O
thyroid NN O
nodules NNS O
. . O

-DOCSTART- X X O

Structural JJ O
analysis NN O
of IN O
the DT O
5'-regulatory JJ O
region NN O
reveals VBZ O
that IN O
the DT O
c-met NN B-NP
promoter NN I-NP
lacks VBZ O
TATA NNP O
or CC O
CAAT NNP O
elements NNS O
but CC O
has VBZ O
an DT O
extremely RB O
high JJ O
G-C JJ O
content NN O
and CC O
multiple JJ O
Sp1 JJ B-NP
binding NN I-NP
sites NNS I-NP
. . O

-DOCSTART- X X O

Each DT O
binding NN O
site NN O
, , O
however RB O
, , O
was VBD O
different JJ O
in IN O
its PRP$ O
preference NN O
for IN O
binding JJ O
partners NNS O
. . O

-DOCSTART- X X O

We PRP O
isolated VBD O
the DT O
human JJ B-NP
FGF-BP NNP I-NP
promoter NN I-NP
and CC O
determined VBN O
by IN O
deletion NN O
analysis NN O
that IN O
TPA NNP O
regulatory JJ O
elements NNS O
were VBD O
all DT O
contained VBN O
in IN O
the DT O
first JJ O
118 CD O
base NN O
pairs NNS O
upstream RB O
of IN O
the DT O
transcription NN O
start NN O
site NN O
. . O

-DOCSTART- X X O

Manipulation NNP O
of IN O
the DT O
checkpoint NN O
regulators NNS O
involved VBN O
in IN O
cell NN O
cycle NN O
arrest NN O
and CC O
apoptosis NN O
may MD O
thus RB O
provide VB O
a DT O
novel NN O
strategy NN O
to TO O
cancer NN O
therapy NN O
. . O

-DOCSTART- X X O

Electrophoretic NNP O
mobility NN O
shift NN O
assays VBZ O
demonstrated VBN O
specific JJ O
nuclear JJ O
protein NN O
binding NN O
to TO O
-85/-64 NNP O
, , O
and CC O
single JJ O
point NN O
mutations NNS O
suggested VBD O
important JJ O
binding NN O
nucleotides NNS O
between IN O
-79/-68 NNS O
with IN O
five CD O
critical JJ O
bases NNS O
between IN O
-74/-70 DT O
( -LRB- O
5'-CTCCT-3' JJ O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
diagnostic JJ O
accuracy NN O
of IN O
serum NN O
PE-1 NN B-NP
was VBD O
0.80 CD O
, , O
and CC O
that IN O
of IN O
amylase NN B-NP
0.97 CD O
. . O

-DOCSTART- X X O

We PRP O
demonstrate VBP O
that IN O
Ddc1p NNP B-NP
interacts VBZ O
physically RB O
in IN O
vivo RB O
with IN O
Mec3p NNP B-NP
, , O
and CC O
this DT O
interaction NN O
requires VBZ O
Rad17p NNP B-NP
. . O

-DOCSTART- X X O

" `` O
Complex JJ O
partial JJ O
" `` O
seizures NNS O
. . O

-DOCSTART- X X O

B NNP B-NP
cell NN I-NP
antigen NN I-NP
receptor NN I-NP
(BCR)-mediated JJ O
formation NN O
of IN O
a DT O
SHP-2-pp120 NNP B-NP
complex NN O
and CC O
its PRP$ O
inhibition NN O
by IN O
Fc NNP B-NP
gamma NNP I-NP
RIIB1-BCR NNP I-NP
coligation NN O
. . O

-DOCSTART- X X O

Deleting VBG O
SNF1 NNP B-NP
repressed VBD O
meiosis NN O
at IN O
the DT O
same JJ O
three CD O
steps NNS O
that WDT O
were VBD O
inhibited VBN O
by IN O
glucose NN O
, , O
suggesting VBG O
that IN O
glucose NN O
blocks NNS O
meiosis NN O
by IN O
inhibiting VBG O
Snf1 NNP B-NP
. . O

-DOCSTART- X X O

Here RB O
we PRP O
investigate VB O
the DT O
role NN O
of IN O
c-Cbl JJ B-NP
in IN O
development NN O
and CC O
homeostasis NN O
in IN O
mice NNS O
by IN O
targeted JJ O
disruption NN O
of IN O
the DT O
c-Cbl JJ B-NP
locus NN I-NP
. . O
c-Cbl-deficient JJ B-NP
mice NNS O
were VBD O
viable JJ O
, , O
fertile JJ O
, , O
and CC O
outwardly RB O
normal JJ O
in IN O
appearance NN O
. . O

-DOCSTART- X X O

One CD O
is VBZ O
to TO O
act VB O
within IN O
the DT O
visceral JJ O
endoderm NN O
to TO O
promote VB O
proper JJ O
streak NN O
morphogenesis NN O
. . O

-DOCSTART- X X O

We PRP O
propose VBP O
that IN O
noi/pax2.1 JJ B-NP
participates NNS O
in IN O
sequential JJ O
signaling VBG O
processes NNS O
as IN O
a DT O
key JJ O
integrator NN O
of IN O
midbrain-hindbrain NN O
boundary NN O
development NN O
. . O

-DOCSTART- X X O

Ligand-independent JJ O
activation NN O
of IN O
platelet-derived JJ B-NP
growth NN I-NP
factor NN I-NP
receptor NN I-NP
is VBZ O
a DT O
necessary JJ O
intermediate JJ O
in IN O
lysophosphatidic JJ O
, , O
acid-stimulated JJ O
mitogenic JJ O
activity NN O
in IN O
L NNP O
cells NNS O
. . O

-DOCSTART- X X O

In IN O
canrenoate-treated JJ O
rats NNS O
, , O
ANP NNP B-NP
infusion NN O
caused VBD O
greater JJR O
increases NNS O
in IN O
sodium NN O
excretion NN O
( -LRB- O
FENA NNP O
from IN O
3.05 CD O
+/ CD O
- : O
0.71 CD O
to TO O
7.21 CD O
+/ CD O
- : O
0.45 CD O
% NN O
; : O
P NNP O
< VBD O
0.05 CD O
; : O
n RB O
= SYM O
8 CD O
) -RRB- O
than IN O
saline NN O
infusion NN O
( -LRB- O
FENA NNP O
from IN O
4.16 CD O
+/ CD O
- : O
1.11 CD O
to TO O
5.47 CD O
+/ CD O
- : O
0.66 CD O
% NN O
; : O
n RB O
= SYM O
6) CD O
, , O
despite IN O
the DT O
hypocapnia NN O
. . O

-DOCSTART- X X O

Removal NN O
of IN O
the DT O
carboxyl NN O
region NN O
severely RB O
reduced VBN O
transcriptional JJ O
activation NN O
. . O

-DOCSTART- X X O

A DT O
" `` O
Level NNP O
A" NNP O
in IN O
vitro/in JJ O
vivo JJ O
correlation NN O
was VBD O
established VBN O
for IN O
a DT O
sustained VBN O
release NN O
theophylline NN O
( -LRB- O
CAS NNP O
58-55-9 CD O
) -RRB- O
preparation NN O
( -LRB- O
Bronchoretard NNP O
) -RRB- O
under IN O
investigation NN O
. . O

-DOCSTART- X X O

METHOD NNP O
: : O
50 CD O
consecutive JJ O
children NNS O
aged VBN O
from IN O
6 CD O
months NNS O
to TO O
17 CD O
years NNS O
were VBD O
included VBN O
into IN O
the DT O
study NN O
which WDT O
comprised VBD O
questionnaires NNS O
of IN O
patient NN O
and CC O
family NN O
histories NNS O
, , O
serological JJ O
screening NN O
tests NNS O
for IN O
common JJ O
inhalational JJ O
allergens NNS O
( -LRB- O
CAP JJ O
SX1 NN O
) -RRB- O
, , O
and CC O
determination NN O
of IN O
total JJ O
serum NN B-NP
immunoglobulin NN I-NP
E NNP I-NP
( -LRB- O
IgE NN B-NP
) -RRB- O
and CC O
of IN O
latex-specific JJ O
serum NN B-NP
IgE NNP I-NP
by IN O
solid-phase JJ O
immunoassays NNS O
. . O

-DOCSTART- X X O

The DT O
PDE4A-subfamily-specific JJ B-NP
linker NN I-NP
region NN I-NP
LR1 NNP O
, , O
which WDT O
joins VBZ O
UCR1 NNP O
and CC O
UCR2 NNP O
, , O
is VBZ O
encoded VBN O
by IN O
two CD O
exons NNS O
, , O
whereas IN O
LR2 NNP O
, , O
which WDT O
joins VBZ O
UCR2 NNP O
to TO O
the DT O
catalytic JJ O
unit NN O
, , O
is VBZ O
encoded VBN O
by IN O
a DT O
single JJ O
exon NN O
. . O

-DOCSTART- X X O

Pol32Delta JJ B-NP
strains NNS O
are VBP O
weak JJ O
antimutators NNS O
and CC O
are VBP O
defective JJ O
for IN O
damage-induced JJ O
mutagenesis NN O
. . O

-DOCSTART- X X O

At IN O
the DT O
same JJ O
time NN O
, , O
the DT O
results NNS O
indicate VBP O
that IN O
p53 NN B-NP
plays VBZ O
a DT O
defensive JJ O
role NN O
against IN O
HBV NNP O
by IN O
transcriptionally RB O
repressing VBG O
the DT O
HBV NNP B-NP
core NN I-NP
promoter NN I-NP
through IN O
liver-specific JJ B-NP
enhancer NN I-NP
II NNP I-NP
and CC O
HBx NNP B-NP
is VBZ O
required VBN O
to TO O
counteract VB O
this DT O
inhibitory JJ O
function NN O
of IN O
p53 NN B-NP
. . O

-DOCSTART- X X O

To TO O
gain VB O
insight NN O
into IN O
the DT O
expression NN O
of IN O
the DT O
AtCP1 NNP B-NP
gene NN I-NP
, , O
northern JJ O
blot NN O
analysis NN O
was VBD O
carried VBN O
out RP O
. . O

-DOCSTART- X X O

The DT O
aim NN O
of IN O
the DT O
study NN O
was VBD O
to TO O
correlate VB O
the DT O
responsiveness NN O
to TO O
bronchoprovocation NN O
with IN O
methacholine NN O
in IN O
subjects NNS O
a DT O
with IN O
allergic JJ O
rhinitis NN O
during IN O
and CC O
out IN O
of IN O
the DT O
pollen NN O
season NN O
with IN O
total JJ O
serum NN O
IgE NNP B-NP
and CC O
blood NN O
eosinophils NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
provide VBP O
the DT O
first JJ O
demonstration NN O
that IN O
an DT O
SR JJ B-NP
protein NN I-NP
can MD O
influence VB O
splicing NN O
of IN O
specific JJ O
pre-mRNAs JJ O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

In IN O
particular JJ O
, , O
the DT O
potential JJ O
for IN O
prostate NN O
cancer NN O
chemoprevention NN O
using VBG O
nonsteroidal JJ O
anti-inflammatory JJ O
drugs NNS O
( -LRB- O
cyclo-oxygenase NN B-NP
inhibitors NNS O
; : O
NSAIDs NNP O
) -RRB- O
has VBZ O
received VBN O
little JJ O
attention NN O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
calcitonin NN B-NP
, , O
and CC O
other JJ O
agonists NNS O
which WDT O
activate VBP O
the DT O
cAMP JJ O
pathway NN O
, , O
in IN O
regulating JJ O
transcription NN O
of IN O
the DT O
human JJ B-NP
parathyroid NN I-NP
hormone-related JJ I-NP
protein NN I-NP
( -LRB- O
PTHrP NN B-NP
) -RRB- O
gene NN O
was VBD O
investigated VBN O
in IN O
a DT O
human JJ O
lung NN O
cancer NN O
cell NN O
line NN O
( -LRB- O
BEN) NN O
. . O

-DOCSTART- X X O

To TO O
further RB O
understand VB O
the DT O
role NN O
of IN O
cis-acting JJ O
elements NNS O
in IN O
these DT O
regulatory JJ O
mechanisms NNS O
, , O
we PRP O
have VBP O
characterized VBN O
a DT O
transcriptional JJ O
promoter NN O
that WDT O
drives VBZ O
germline NN O
expression NN O
of IN O
TCR NNP B-NP
beta JJ I-NP
gene NN I-NP
segments NNS I-NP
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
crucial JJ O
role NN O
of IN O
the DT O
mutations NNS O
activating VBG O
v-erbA NN B-NP
as IN O
an DT O
oncogene NN O
is VBZ O
to TO O
'freeze VB O
' '' O
c-ErbA/ JJ B-NP
TRalpha NN B-NP
in IN O
its PRP$ O
non-liganded JJ O
, , O
repressive JJ O
conformation NN O
and CC O
to TO O
facilitate VB O
its PRP$ O
overexpression NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
describe VBP O
a DT O
mammalian JJ O
cell-free JJ O
transcription NN O
system NN O
reconstituted VBD O
with IN O
only RB O
recombinant JJ O
proteins NNS O
and CC O
epitope-tagged JJ O
multiprotein JJ O
complexes NNS O
. . O

-DOCSTART- X X O

This DT O
repressor NN O
is VBZ O
however RB O
unlikely JJ O
to TO O
mediate VB O
spi NN B-NP
2.3 CD I-NP
3' CD I-NP
UTR NN I-NP
silencer NN I-NP
action NN O
since IN O
it PRP O
was VBD O
not RB O
detected VBN O
in IN O
rat NN O
hepatocytes NNS O
. . O

-DOCSTART- X X O

A DT O
prerequisite NN O
for IN O
the DT O
synthesis NN O
of IN O
sialylated JJ O
glycoconjugates NNS O
is VBZ O
the DT O
activated JJ O
sugar-nucleotide NN O
cytidine NN O
5'-monophosphate JJ O
N-acetylneuraminic JJ O
acid NN O
( -LRB- O
CMP-Neu5Ac JJ O
) -RRB- O
, , O
which WDT O
provides VBZ O
a DT O
substrate NN O
for IN O
Golgi NNP B-NP
sialyltransferases NNS I-NP
. . O

-DOCSTART- X X O

We PRP O
propose VBP O
a DT O
model NN O
in IN O
which WDT O
Sro7 DT B-NP
function NN O
is VBZ O
involved VBN O
in IN O
the DT O
targeting VBG O
of IN O
the DT O
myosin JJ B-NP
proteins NNS I-NP
to TO O
their PRP$ O
intrinsic JJ O
pathways NNS O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
sequences NNS O
related VBN O
to TO O
this DT O
insertion NN O
in IN O
wild-type JJ O
strains NNS O
of IN O
N. NNP O
crassa NN O
and CC O
other JJ O
Neurospora NNP O
species NNS O
. . O

-DOCSTART- X X O

Human NNP B-NP
ULK1 NNP I-NP
, , O
a DT O
novel NN O
serine/threonine NN B-NP
kinase NN I-NP
related VBN O
to TO O
UNC-51 JJ B-NP
kinase NN I-NP
of IN O
Caenorhabditis NNP O
elegans NNS O
: : O
cDNA NN O
cloning NN O
, , O
expression NN O
, , O
and CC O
chromosomal JJ O
assignment NN O
. . O

-DOCSTART- X X O

Cochlear JJ O
microphonic JJ O
potentials NNS O
in IN O
patients NNS O
with IN O
vestibular JJ O
schwannomas NNS O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Significant NNP O
elevations NNS O
of IN O
IL-1alpha NNP B-NP
and CC O
IL-1beta NNP B-NP
occur VBP O
in IN O
patients NNS O
with IN O
bacterial JJ O
cystitis NN O
and CC O
microscopic JJ O
hematuria NN O
. . O

-DOCSTART- X X O

Band-shift NNP O
assays NNPS O
were VBD O
performed VBN O
using VBG O
the DT O
LPS-and NNP B-NP
IL-1-responsive JJ I-NP
element NN I-NP
( -LRB- O
LILRE NNP B-NP
) -RRB- O
oligonucleotide NNP O
, , O
a DT O
gamma NN B-NP
interferon NN I-NP
activation NN I-NP
site-like NN I-NP
site NN I-NP
that WDT O
is VBZ O
present JJ O
in IN O
the DT O
human JJ B-NP
IL-1beta NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

The DT O
C-terminal JJ O
region NN O
contains VBZ O
the DT O
PTP-like JJ B-NP
domain NN I-NP
, , O
whereas IN O
the DT O
N-terminal JJ O
region NN O
shows VBZ O
no DT O
homology NN O
to TO O
any DT O
known VBN O
mammalian JJ O
protein NN O
. . O

-DOCSTART- X X O

A DT O
safe JJ O
and CC O
simple JJ O
system NN O
for IN O
the DT O
detection NN O
of IN O
sudden JJ O
infant NN O
death NN O
syndrome NN O
( -LRB- O
SIDS NNP O
) -RRB- O
is VBZ O
proposed VBN O
. . O

-DOCSTART- X X O

The DT O
mutant JJ O
protein NN O
is VBZ O
present JJ O
at IN O
levels NNS O
slightly RB O
greater JJR O
than IN O
wild-type JJ O
, , O
but CC O
exhibits VBZ O
the DT O
same JJ O
tissue NN O
distribution NN O
as IN O
wild-type JJ O
protein NN O
, , O
and CC O
has VBZ O
approximately RB O
normal JJ O
affinity NN O
for IN O
known VBN O
target NN O
sequences NNS O
( -LRB- O
though IN O
no DT O
DNA NN O
targets VBZ O
identified VBN O
to TO O
date VB O
require VB O
the DT O
first JJ O
cut NN O
repeat NN O
for IN O
binding NN O
) -RRB- O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
We PRP O
retrospectively RB O
reviewed VBN O
242 CD O
adult NN O
cadaveric NN O
renal JJ O
transplant NN O
recipients NNS O
treated VBN O
between IN O
11/91 CD O
and CC O
5/97 CD O
. . O

-DOCSTART- X X O

The DT O
spectrum NN O
of IN O
age-associated JJ O
brain NN O
abnormalities NNS O
: : O
their PRP$ O
measurement NN O
and CC O
histopathological JJ O
correlates NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
laboratory NN O
has VBZ O
recently RB O
identified VBN O
two CD O
phosducin-like JJ B-NP
orphan JJ I-NP
proteins NNS I-NP
( -LRB- O
PhLOP1 NNP B-NP
and CC O
PhLOP2 NNP B-NP
) -RRB- O
that WDT O
lack VBP O
the DT O
ability NN O
to TO O
interact VB O
with IN O
Gbetagamma NNP B-NP
. . O

-DOCSTART- X X O

Reverse NN B-NP
transcriptase-polymerase NN I-NP
chain NN O
reaction NN O
(RT-PCR JJ O
) -RRB- O
was VBD O
performed VBN O
using VBG O
eyestalk NN O
complementary JJ O
DNA NN O
of IN O
the DT O
sand NN O
shrimp NN O
Metapenaeus NNP O
ensis VBZ O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
transcription NN O
initiating NN O
from IN O
opuE NN B-NP
P-1 NN I-NP
( -LRB- O
sigma NN B-NP
A) NN I-NP
rose VBD O
in IN O
proportion NN O
to TO O
the DT O
external JJ O
osmolarity NN O
and CC O
was VBD O
maintained VBN O
at IN O
high JJ O
levels NNS O
. . O

-DOCSTART- X X O

In IN O
insects NNS O
, , O
arylalkylamine NN B-NP
N-acetyltransferases NNS I-NP
( -LRB- O
AANATs NNS B-NP
) -RRB- O
have VBP O
been VBN O
implicated VBN O
in IN O
several JJ O
physiological JJ O
processes NNS O
, , O
including VBG O
sclerotization NN O
, , O
inactivation NN O
of IN O
certain JJ O
neurotransmitters NNS O
, , O
and CC O
, , O
similar JJ O
to TO O
the DT O
function NN O
in IN O
vertebrates NNS O
, , O
catalysis NN O
of IN O
the DT O
rate-limiting NN O
step NN O
in IN O
melatonin NN O
biosynthesis NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
establish VBP O
that DT O
hydroquinones JJ O
lead NN O
to TO O
mutagenicity NN O
and CC O
carcinogenicity NN O
. . O

-DOCSTART- X X O

IA-CT NNP O
with IN O
cisplatin NN O
50 CD O
mg NN O
and CC O
doxorubicin JJ O
30 CD O
mg NN O
was VBD O
administered VBN O
by IN O
one CD O
shot NN O
method NN O
in IN O
bilateral JJ O
internal JJ O
iliac JJ O
arteries NNS O
. . O

-DOCSTART- X X O

The DT O
genomic JJ O
structure NN O
and CC O
chromosomal NN O
location NN O
of IN O
the DT O
human JJ B-NP
TR2 NN I-NP
orphan IN I-NP
receptor NN I-NP
, , O
a DT O
member NN O
of IN O
the DT O
steroid NN B-NP
receptor NN I-NP
superfamily NN I-NP
. . O

-DOCSTART- X X O

The DT O
IE13.1 NNP O
cell NN O
line NN O
was VBD O
able JJ O
to TO O
complement VB O
a DT O
recombinant NN O
virus NN O
in IN O
which WDT O
both DT O
copies NNS O
of IN O
the DT O
IE NNP B-NP
gene NN I-NP
were VBD O
replaced VBN O
by IN O
insertion NN O
of IN O
the DT O
Escherichia NNP B-NP
coli NNS I-NP
lacZ JJ I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

DNase NN B-NP
I PRP I-NP
footprinting CD O
and CC O
electrophoretic JJ O
mobility NN O
shift NN O
analyses NNS O
revealed VBD O
two CD O
hepatocyte JJ B-NP
nuclear JJ I-NP
factor-1 NN I-NP
( -LRB- O
HNF1 NNP B-NP
) -RRB- O
, , O
three CD O
CCAAT/enhancer-binding JJ B-NP
protein NN I-NP
( -LRB- O
C/EBP) NN B-NP
, , O
and CC O
one CD O
consensus NN O
palindromic JJ O
thyroid NN O
hormone NN O
response NN O
elements NNS O
within IN O
the DT O
first JJ O
215 CD O
base NN O
pairs NNS O
( -LRB- O
bp NN O
) -RRB- O
of IN O
the DT O
promoter NN O
sequence NN O
of IN O
rat NN B-NP
Std NNP I-NP
. . O

-DOCSTART- X X O

Thus RB O
, , O
these DT O
studies NNS O
on IN O
rat NN B-NP
Std NNP I-NP
promoter NN I-NP
function NN O
indicate VBP O
that IN O
( -LRB- O
i NN O
) -RRB- O
HNF1 . B-NP
and CC O
C/EBP NNP B-NP
are VBP O
responsible JJ O
for IN O
liver NN O
specificity NN O
of IN O
the DT O
rat NN B-NP
Std NNP I-NP
gene NN I-NP
; : O
( -LRB- O
ii NNS O
) -RRB- O
androgenic JJ O
repression NN O
of IN O
the DT O
gene NN O
requires VBZ O
the DT O
presence NN O
of IN O
all DT O
of IN O
the DT O
OCT-1 JJ B-NP
and CC O
C/EBP JJ B-NP
elements NNS I-NP
between IN O
positions NNS O
-231 JJ O
and CC O
-292 JJ O
; : O
and CC O
( -LRB- O
iii NN O
) -RRB- O
AR NN B-NP
may MD O
exert VB O
its PRP$ O
negative JJ O
regulatory JJ O
effect NN O
indirectly RB O
through IN O
transcriptional JJ O
interference NN O
of IN O
OCT-1 NNP B-NP
and CC O
C/EBP NNP B-NP
rather RB O
than IN O
through IN O
a DT O
direct JJ O
DNA-AR NN B-NP
interaction NN O
. . O

-DOCSTART- X X O

The DT O
yeast NN B-NP
MMS2 NNP I-NP
gene NN I-NP
was VBD O
cloned VBN O
by IN O
its PRP$ O
ability NN O
to TO O
complement VB O
the DT O
methyl NN O
methanesulfonate JJ O
sensitivity NN O
of IN O
the DT O
mms2-1 JJ B-NP
mutant JJ I-NP
and CC O
was VBD O
later RB O
shown VBN O
to TO O
be VB O
involved VBN O
in IN O
DNA NNP O
post-replication NN O
repair NN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
the DT O
human JJ B-NP
papillomavirus NN I-NP
type NN I-NP
11 CD I-NP
E5A JJ I-NP
protein NN I-NP
from IN O
the DT O
E1E4,E5 NNP B-NP
transcript NN I-NP
. . O

-DOCSTART- X X O

Toxicity NN O
during IN O
the DT O
therapeutic JJ O
period NN O
was VBD O
not RB O
significant JJ O
in IN O
the DT O
study NN O
group NN O
compared VBN O
with IN O
the DT O
historical JJ O
control NN O
, , O
treated VBN O
with IN O
the DT O
same JJ O
regimen NNS O
without IN O
G-CSF. NNP B-NP

-DOCSTART- X X O

The DT O
purpose NN O
of IN O
this DT O
article NN O
is VBZ O
to TO O
discuss VB O
the DT O
factors NNS O
involved VBN O
in IN O
the DT O
selection NN O
of IN O
antibodies NNS O
, , O
radionuclides NNS O
and CC O
labeling VBG O
methods NNS O
in IN O
the DT O
development NN O
of IN O
radioimmunotherapy NN O
( -LRB- O
RIT NNP O
) -RRB- O
for IN O
non-Hodgkin NN O
's POS O
lymphoma NN O
( -LRB- O
NHL NNP O
) -RRB- O
from IN O
a DT O
single JJ O
clinical JJ O
study NN O
site NN O
through IN O
multicenter JJ O
trials NNS O
and CC O
commercialization NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
Rho NNP B-NP
on IN O
AP-1 NNP B-NP
is VBZ O
independent JJ O
of IN O
the DT O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
pathway NN O
, , O
as IN O
a DT O
dominant-negative JJ B-NP
MEK NNP I-NP
and CC O
a DT O
MEK NN B-NP
inhibitor NN O
( -LRB- O
PD98059 CD O
) -RRB- O
did VBD O
not RB O
affect VB O
Rho-induced JJ B-NP
AP-1 NN B-NP
activity NN O
. . O

-DOCSTART- X X O

Mutations NNS O
within IN O
the DT O
C NNP O
terminus NN O
of IN O
c-fos NNS B-NP
at IN O
serine NN O
residues NNS O
that WDT O
are VBP O
phosphorylation NN O
targets NNS O
for IN O
growth NN O
factors NNS O
and CC O
MAP NNP B-NP
kinase NN I-NP
completely RB O
abrogate JJ O
transactivation NN O
and CC O
block NN O
potentiation NN O
by IN O
MAP NNP B-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
former JJ O
cells NNS O
, , O
ets-2 NN B-NP
was VBD O
a DT O
CSF-1 JJ B-NP
immediate-early JJ O
response NN O
gene NN O
, , O
and CC O
phosphorylated JJ O
ets-2 NN B-NP
was VBD O
detected VBN O
after IN O
2 CD O
to TO O
4 CD O
h NN O
, , O
coincident NN O
with IN O
expression NN O
of IN O
ets-2 JJ B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Persistent JJ O
activation NN O
of IN O
mitogen-activated JJ B-NP
protein NN I-NP
kinases NNS I-NP
p42 VBD I-NP
and CC O
p44 NNS B-NP
and CC O
ets-2 JJ B-NP
phosphorylation NN O
in IN O
response NN O
to TO O
colony-stimulating JJ B-NP
factor NN I-NP
1/c-fms NNS I-NP
signaling VBG O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
a DT O
proline-rich JJ O
sequence NN O
in IN O
the DT O
CD2 NNP B-NP
cytoplasmic JJ I-NP
domain NN I-NP
critical JJ O
for IN O
regulation NN O
of IN O
integrin-mediated JJ B-NP
adhesion NN O
and CC O
activation NN O
of IN O
phosphoinositide NN B-NP
3-kinase CD I-NP
. . O

-DOCSTART- X X O

Vam7p NNP B-NP
, , O
a DT O
SNAP-25-like JJ B-NP
molecule NN I-NP
, , O
and CC O
Vam3p NNP B-NP
, , O
a DT O
syntaxin NN B-NP
homolog NN I-NP
, , O
function NN O
together RB O
in IN O
yeast NN O
vacuolar JJ O
protein NN O
trafficking NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
tested VBN O
this DT O
possibility NN O
by IN O
constructing VBG O
a DT O
consecutive JJ O
series NN O
of IN O
cysteine JJ O
substitutions NNS O
in IN O
the DT O
Neu NNP B-NP
juxtamembrane NNP I-NP
domain NN I-NP
in IN O
order NN O
to TO O
force VB O
dimerization NN O
along IN O
a DT O
series NN O
of IN O
interreceptor NN O
faces NNS O
. . O

-DOCSTART- X X O

It PRP O
has VBZ O
been VBN O
demonstrated VBN O
previously RB O
that IN O
Pax-6 NNP B-NP
, , O
a DT O
paired JJ B-NP
domain NN I-NP
( -LRB- O
PD)/homeodomain FW B-NP
( -LRB- O
HD NN B-NP
) -RRB- O
transcription NN O
factor NN O
critical JJ O
for IN O
eye NN O
development NN O
, , O
contributes VBZ O
to TO O
the DT O
activation NN O
of IN O
the DT O
alphaB-, NN B-NP
alphaA-, NN I-NP
delta1-, JJ I-NP
and CC I-NP
zeta-crystallin JJ I-NP
genes NNS O
in IN O
the DT O
lens NN O
. . O

-DOCSTART- X X O

Tctex-1 NN B-NP
binding NN O
required VBD O
the DT O
first JJ O
19 CD O
amino IN O
acids NNS O
of IN O
Fyn NNP B-NP
and CC O
integrity NN O
of IN O
two CD O
lysine NN O
residues NNS O
within IN O
this DT O
sequence NN O
that WDT O
were VBD O
previously RB O
shown VBN O
to TO O
be VB O
important JJ O
for IN O
Fyn NNP B-NP
interactions NNS O
with IN O
the DT O
immunoreceptor NN O
tyrosine-based JJ O
activation NN O
motifs NNS O
( -LRB- O
ITAMs) NN O
of IN O
lymphocyte NN B-NP
Ag NNP I-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

The DT O
prothrombin NN B-NP
gene NN I-NP
G20210A JJ I-NP
mutation NN I-NP
is VBZ O
not RB O
found VBN O
among IN O
Japanese JJ O
patients NNS O
with IN O
deep JJ O
vein NN O
thrombosis NN O
and CC O
healthy JJ O
individuals NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
TRAF2 NNP B-NP
initiates VBZ O
SAPK NNP B-NP
and CC O
p38 VBD B-NP
activation NN O
by IN O
binding JJ O
two CD O
proximal JJ O
protein NN O
kinases NNS O
: : O
GCK NNP B-NP
and CC O
RIP. NNP B-NP

-DOCSTART- X X O

The DT O
activity NN O
of IN O
the DT O
minimal JJ O
promoter NN O
was VBD O
found VBN O
to TO O
be VB O
controlled VBN O
by IN O
a DT O
combination NN O
of IN O
the DT O
activities NNS O
of IN O
the DT O
transcription NN O
factors NNS O
Sp1 NNP B-NP
, , O
Sp3 NNP B-NP
, , O
and CC O
NF-Y NNP B-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
studies NNS O
described VBN O
in IN O
this DT O
report NN O
, , O
we PRP O
have VBP O
investigated VBN O
the DT O
signaling NN O
pathway( NN O
s VBZ O
) -RRB- O
that WDT O
are VBP O
responsible JJ O
for IN O
CREB NNP B-NP
activation NN O
in IN O
normal JJ O
T NNP O
cells NNS O
. . O

-DOCSTART- X X O

Isolation NNP O
of IN O
a DT O
novel NN O
TP53 NNP B-NP
target NN I-NP
gene NN I-NP
from IN O
a DT O
colon NN O
cancer NN O
cell NN O
line NN O
carrying VBG O
a DT O
highly RB O
regulated VBN O
wild-type JJ B-NP
TP53 NNP I-NP
expression NN O
system NN O
. . O

-DOCSTART- X X O

Overexpression IN O
of IN O
MDR1 NNP B-NP
has VBZ O
been VBN O
demonstrated VBN O
in IN O
many JJ O
cancers NNS O
, , O
both DT O
in IN O
patient NN O
tumors NNS O
and CC O
in IN O
cell NN O
lines NNS O
selected VBN O
with IN O
a DT O
variety NN O
of IN O
chemotherapeutic JJ O
agents NNS O
. . O

-DOCSTART- X X O

Cytogenetic JJ O
and CC O
molecular JJ O
characterization NN O
of IN O
random JJ O
chromosomal NN O
rearrangements NNS O
activating VBG O
the DT O
drug NN O
resistance NN O
gene NN O
, , O
MDR1/P-glycoprotein NNP B-NP
, , O
in IN O
drug-selected JJ O
cell NN O
lines NNS O
and CC O
patients NNS O
with IN O
drug NN O
refractory NN O
ALL. . O

-DOCSTART- X X O

When WRB O
the DT O
blood NN O
pressure NN O
increase NN O
in IN O
response NN O
to TO O
smoking NN O
was VBD O
blunted VBN O
by IN O
nitroprusside JJ O
infusion NN O
, , O
there EX O
was VBD O
a DT O
striking JJ O
increase NN O
in IN O
muscle NN O
SNA NNP O
. . O

-DOCSTART- X X O

After IN O
that DT O
report NN O
, , O
carboxypeptidase NN B-NP
D NNP I-NP
( -LRB- O
CPD NNP B-NP
) -RRB- O
was VBD O
subsequently RB O
purified VBN O
from IN O
bovine NN O
pituitary NN O
and CC O
characterized VBD O
as IN O
a DT O
novel NN O
carboxypeptidase NN B-NP
E NNP I-NP
( -LRB- O
CPE)-like JJ B-NP
enzyme NN O
, , O
with IN O
many JJ O
characteristics NNS O
in IN O
common JJ O
with IN O
duck NN O
gp180 CD B-NP
( -LRB- O
Song NNP O
, , O
L. NNP O
, , O
Fricker NNP O
, , O
L.D. NNP O
, , O
1995 CD O
. . O

-DOCSTART- X X O

RA-treatment NN O
of IN O
these DT O
transfectants NNS O
induced VBD O
morphologic NN O
and CC O
immunophenotypic JJ O
maturation NN O
, , O
changes NNS O
in IN O
RA-regulated JJ O
genes NNS O
, , O
and CC O
a DT O
G1 JJ O
cell NN O
cycle NN O
arrest NN O
in IN O
a DT O
manner NN O
similar JJ O
to TO O
parental JJ O
NT2/D1 NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
histopathology NN O
and CC O
neovascularization NN O
did VBD O
not RB O
appreciably RB O
differ VB O
between IN O
xenograft NN O
tumors NNS O
derived VBN O
from IN O
FGF4 DT B-NP
over-expressing JJ O
versus NN O
control NN O
transfectants NNS O
. . O

-DOCSTART- X X O

RXR-gamma NNP B-NP
expression NN O
produced VBD O
significant JJ O
reduction NN O
in IN O
levels NNS O
of IN O
RA-responsive JJ O
genes NNS O
including VBG O
the DT O
cyclin-dependent JJ B-NP
kinase NN I-NP
inhibitors NNS O
p21Cip1/WAF1 . B-NP
and CC O
p27Kip1 JJ B-NP
, , O
resulting VBG O
in IN O
increased VBN O
cdc2 NN B-NP
and CC O
cdk2 NN B-NP
kinase NN I-NP
activity NN O
and CC O
RB NNP B-NP
phosphorylation NN O
. . O

-DOCSTART- X X O

During IN O
the DT O
CR/PP NNP O
diet NN O
only RB O
the DT O
HS NNP O
subjects NNS O
did VBD O
not RB O
show VB O
the DT O
stress-induced JJ O
rise NN O
in IN O
depression NN O
, , O
decline NN O
in IN O
vigour NN O
and CC O
cortisol NN O
elevation NN O
that IN O
they PRP O
showed VBD O
after IN O
the DT O
PR/CP NNP O
diet NN O
. . O

-DOCSTART- X X O

Generally RB O
ILC NNP O
and CC O
ILVF NNP O
values NNS O
decreased VBD O
with IN O
increasing VBG O
exposure NN O
time NN O
with IN O
rate NN O
constants NNS O
ranging VBG O
from IN O
0.03 CD O
to TO O
0.33 CD O
day-1 NNS O
( -LRB- O
wet JJ O
and CC O
lipid JJ O
weight NN O
) -RRB- O
for IN O
ILC NNP O
and CC O
0.03 CD O
to TO O
0.31 CD O
day-1 NN O
for IN O
ILVF. NNP O

-DOCSTART- X X O

The DT O
present JJ O
study NN O
sought VBD O
to TO O
develop VB O
an DT O
equation NN O
to TO O
estimate VB O
VO2peak NNP O
in IN O
peripheral JJ O
arterial NN O
occlusive JJ O
disease NN O
( -LRB- O
PAOD NNP O
) -RRB- O
patients NNS O
with IN O
intermittent JJ O
claudication NN O
and CC O
to TO O
determine VB O
independent JJ O
predictors NNS O
of IN O
VO2peak NNP O
in IN O
this DT O
population NN O
. . O

-DOCSTART- X X O

Evidence NN O
for IN O
a DT O
novel NN O
MAPKKK-independent NNP B-NP
pathway NN O
controlling VBG O
the DT O
stress NN O
activated VBN O
Sty1/Spc1 NNP B-NP
MAP NNP O
kinase NN O
in IN O
fission NN O
yeast NN O
. . O

-DOCSTART- X X O

The DT O
Abbreviated NNP O
Injury NN O
Scale NNP O
( -LRB- O
AIS) NNP O
, , O
Injury NNP O
Severity NNP O
Scale NNP O
and CC O
TRISS NNP O
methodology NN O
comprise NN O
a DT O
mathematically RB O
sound JJ O
system NN O
for IN O
the DT O
analysis NN O
of IN O
injuries NNS O
and CC O
injured VBN O
patients NNS O
. . O

-DOCSTART- X X O

This DT O
hypothesis NN O
was VBD O
tested VBN O
by IN O
introducing VBG O
mutations NNS O
at IN O
each DT O
of IN O
the DT O
three CD O
histidine NN O
pairs NNS O
, , O
the DT O
H382-X2-H385 NNP O
pair NN O
, , O
the DT O
H411-X2-H414 NNP O
pair NN O
and CC O
the DT O
H430-X5-H436 NNP O
pair NN O
, , O
which WDT O
constitute VBP O
the DT O
histidine-rich JJ O
region NN O
near IN O
the DT O
C NNP O
terminus NN O
of IN O
gp17 CD B-NP
. . O

-DOCSTART- X X O

Using VBG O
backcross JJ O
analysis NN O
, , O
both DT O
exons NNS O
1 CD O
and CC O
4 CD O
mapped VBD O
to TO O
a DT O
proximal JJ O
region NN O
of IN O
murine NN O
Chromosome NNP O
4 CD O
indistinguishable NN O
from IN O
the DT O
vacillans NNS B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Seventy-five CD O
percent NN O
of IN O
children NNS O
who WP O
received VBD O
a DT O
second JJ O
transplant NN O
for IN O
HCV NNP O
hepatitis NN O
had VBD O
early RB O
histologic NN O
recurrence NN O
that WDT O
led VBD O
to TO O
liver NN O
failure NN O
and CC O
death NN O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
embryonic JJ O
growth NN O
and CC O
lysosomal JJ O
targeting VBG O
by IN O
the DT O
imprinted VBN O
Igf2/Mpr NNP B-NP
gene NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
we PRP O
demonstrated VBD O
that IN O
Galpha11 NNP B-NP
Q209L NNP I-NP
stimulated VBD O
Src NNP B-NP
family NN I-NP
kinase NN O
activity NN O
and CC O
induced VBD O
tyrosine NN O
phosphorylation NN O
of IN O
several JJ O
proteins NNS O
in IN O
HEK-293 JJ O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
micturition NN O
pressure NN O
was VBD O
significantly RB O
decreased VBN O
only RB O
after IN O
injection NN O
with IN O
BUP-4 JJ O
in IN O
both DT O
normal JJ O
and CC O
obstructed JJ O
rats NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
in IN O
the DT O
presence NN O
of IN O
active JJ B-NP
S-CDKs NNP I-NP
and CC O
Dbf4/Cdc7 NNP B-NP
, , O
Mcms NNP B-NP
may MD O
open VB O
origins NNS O
and CC O
thereby RB O
facilitate VB O
the DT O
loading NN O
of IN O
RPA. NNP B-NP

-DOCSTART- X X O

Tyrosine NNP O
phosphorylated VBD O
STATs NNP B-NP
dimerize VB O
and CC O
translocate VB O
into IN O
the DT O
nucleus JJ O
to TO O
activate VB O
specific JJ O
genes NNS O
. . O

-DOCSTART- X X O

Nonsynonymous JJ O
substitution NN O
in IN O
abalone NN O
sperm NN O
fertilization NN O
genes NNS O
exceeds VBZ O
substitution NN O
in IN O
introns NNS O
and CC O
mitochondrial JJ O
DNA NN O
. . O

-DOCSTART- X X O

Gel NNP O
retardation NN O
assays VBZ O
detected VBN O
ZiaR-dependent NNP B-NP
complexes NNS O
forming VBG O
with IN O
the DT O
zia NN B-NP
operator-promoter NN I-NP
and CC O
ZiaR-DNA NNP B-NP
binding NN O
was VBD O
enhanced VBN O
by IN O
treatment NN O
with IN O
a DT O
metal-chelator NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Alternatively RB O
, , O
the DT O
similarity NN O
in IN O
apparent JJ O
regulatory JJ O
action NN O
of IN O
the DT O
genes NNS O
may MD O
indicate VB O
allelic JJ O
differences NNS O
wherein WRB O
the DT O
IS1112C NNP B-NP
Rf3 NNP B-NP
allele NN I-NP
may MD O
differ VB O
from IN O
alleles NNS O
of IN O
maintainer NN O
lines NNS O
by IN O
the DT O
capability NN O
to TO O
regulate VB O
both DT O
orf107 CD B-NP
and CC O
urf209 CD B-NP
processing NN O
activities NNS O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
and CC O
functional JJ O
characterization NN O
of IN O
murine NN B-NP
sphingosine NN I-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

A DT O
human JJ O
SPT3-TAFII31-GCN5-L JJ B-NP
acetylase NN B-NP
complex JJ O
distinct JJ O
from IN O
transcription NN B-NP
factor NN I-NP
IID. . I-NP

-DOCSTART- X X O

Mapping NNP O
of IN O
the DT O
DNA NNP O
binding NN O
domain NN O
of IN O
the DT O
copper-responsive JJ O
transcription NN O
factor NN O
Mac1 NNP B-NP
from IN I-NP
Saccharomyces NNP I-NP
cerevisiae NN I-NP
. . O

-DOCSTART- X X O

A DT O
further JJ O
mechanism NN O
increasing VBG O
specific JJ O
activation NN O
was VBD O
cooperation NN O
of IN O
receptors NNS O
at IN O
multiple JJ O
and CC O
weak JJ O
HREs NNP O
, , O
which WDT O
was VBD O
accentuated VBN O
in IN O
the DT O
presence NN O
of IN O
both DT O
the DT O
AR NN B-NP
N NNP O
terminus NN O
and CC O
ligand NN O
binding JJ O
domain NN O
. . O

-DOCSTART- X X O

The DT O
CBF1 NNP B-NP
site NN I-NP
within IN O
HS2 NNP O
resides NNS O
near IN O
sites NNS O
for IN O
hematopoietic JJ O
regulators NNS O
such JJ O
as IN O
GATA-1 NNP B-NP
, , O
NF-E2 NNP B-NP
, , O
and CC O
TAL1 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
rat NN B-NP
branched-chain-2-oxo-acid JJ I-NP
dehydrogenase NN I-NP
(BCOD NN I-NP
) -RRB- I-NP
kinase NN I-NP
mRNA NN I-NP
is VBZ O
transcribed VBN O
from IN O
a DT O
TATA-less JJ O
promoter NN O
that WDT O
has VBZ O
GC-rich JJ O
sequences NNS O
and CC O
two CD O
putative JJ O
Sp1 JJ B-NP
binding NN I-NP
sites NNS I-NP
near IN O
the DT O
transcription NN O
start NN O
site NN O
. . O

-DOCSTART- X X O

Until IN O
such JJ O
investigations NNS O
are VBP O
performed VBN O
, , O
we PRP O
conclude VBP O
that IN O
the DT O
role NN O
for IN O
adjuvant JJ O
treatment NN O
is VBZ O
questionable JJ O
and CC O
that IN O
TME NNP O
surgery NN O
is VBZ O
preferred VBN O
as IN O
the DT O
treatment NN O
option NN O
for IN O
Stage NNP O
T1-T3 . O
rectal NN O
cancers NNS O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
the DT O
cooperation NN O
of IN O
transcription NN B-NP
factors NNS I-NP
NF-kappaB NNP I-NP
and CC O
AP-1 NNP B-NP
is VBZ O
essential JJ O
for IN O
transactivation NN O
of IN O
IL-8 DT B-NP
gene NN I-NP
by IN O
HTLV-I JJ B-NP
Tax NNP I-NP
. . O

-DOCSTART- X X O

This DT O
study NN O
examines VBZ O
the DT O
cooperative JJ O
effects NNS O
of IN O
a DT O
human JJ O
estrogen NN B-NP
receptor-alpha NN I-NP
( -LRB- O
ERalpha NNP B-NP
) -RRB- O
isoform VBP O
on RP O
estrogen FW O
( -LRB- O
E2)-mediated JJ O
gene NN O
activation NN O
in IN O
U2-OS DT O
osteosarcoma NN O
cells NNS O
. . O

-DOCSTART- X X O

Transfection NN O
of IN O
increasing VBG O
amounts NNS O
of IN O
delta5ERalpha NN B-NP
expression NN O
vector NN O
into IN O
[ERalpha+]OS NNP O
cells NNS O
resulted VBD O
in IN O
potentiation NN O
of IN O
E2-stimulated JJ O
ERELuc NNP B-NP
activity NN O
in IN O
a DT O
synergistic JJ O
, , O
dose-dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

This DT O
sequence NN O
, , O
Thr-Gly-X-X-Gly-Asp-Gly-Lys-Ile-Phe NNP O
, , O
forms VBZ O
part NN O
of IN O
the DT O
B-loop NNP O
and CC O
is VBZ O
conserved VBN O
in IN O
a DT O
wide JJ O
variety NN O
of IN O
organisms NNS O
that WDT O
include VBP O
bacteria NNS O
, , O
algae JJ O
and CC O
archeabacteria NNS O
. . O

-DOCSTART- X X O

We PRP O
did VBD O
not RB O
observe VB O
any DT O
changes NNS O
in IN O
Bcl-2 JJ B-NP
or CC O
Bcl-2-related JJ B-NP
proteins NNS I-NP
( -LRB- O
Bcl-x NNP B-NP
, , O
Bax NNP B-NP
, , O
and CC O
Bad NNP B-NP
) -RRB- O
in IN O
control NN O
or CC O
KCREB-transfected JJ B-NP
cells NNS O
before IN O
or CC O
after IN O
treatment NN O
with IN O
Tg NNP O
. . O

-DOCSTART- X X O

The DT O
only JJ O
abundant JJ O
viral JJ O
transcript NN O
expressed VBN O
during IN O
latency RB O
is VBZ O
the DT O
latency-related JJ B-NP
( -LRB- O
LR NN B-NP
) -RRB- O
RNA NNP O
. . O

-DOCSTART- X X O

To TO O
improve VB O
test NN O
efficiency NN O
, , O
we PRP O
modified VBN O
our PRP$ O
previously RB O
introduced VBN O
contrast/color NN O
card NN O
test NN O
by IN O
including VBG O
a DT O
patterned JJ O
test NN O
stimulus NN O
and CC O
reducing VBG O
the DT O
number NN O
of IN O
stimuli NNS O
in IN O
both DT O
experimental JJ O
phases NNS O
. . O

-DOCSTART- X X O

Second JJ O
, , O
the DT O
wild-type JJ B-NP
m8 CD I-NP
3' CD I-NP
UTR NN I-NP
strongly RB O
reduces VBZ O
accumulation NN O
of IN O
heterologous JJ O
transcripts NNS O
in IN O
vivo NN O
, , O
an DT O
activity NN O
that WDT O
requires VBZ O
its PRP$ O
K NNP O
box NN O
sequences NNS O
. . O

-DOCSTART- X X O

In IN O
particular JJ O
, , O
unc-86 JJ B-NP
encodes NNS O
a DT O
POU-type JJ B-NP
homeodomain NN I-NP
protein NN I-NP
needed VBN O
for IN O
the DT O
production NN O
of IN O
the DT O
touch NN O
cells NNS O
, , O
while IN O
mec-3 NN B-NP
encodes VBZ O
a DT O
LIM-type JJ B-NP
homeodomain NN I-NP
protein NN I-NP
needed VBN O
for IN O
the DT O
differentiation NN O
of IN O
the DT O
touch NN O
cells NNS O
. . O

-DOCSTART- X X O

During IN O
the DT O
2h JJ O
resuscitation NN O
period NN O
, , O
extracellular JJ O
aspartate NN O
and CC O
glutamate NN O
concentrations NNS O
in IN O
the DT O
cerebral NN O
striatum NN O
were VBD O
higher JJR O
during IN O
hypoxaemic JJ O
resuscitation NN O
( -LRB- O
p NN O
= SYM O
0.044 CD O
and CC O
p VB O
= SYM O
0.055 CD O
, , O
respectively RB O
) -RRB- O
than IN O
during IN O
resuscitation NN O
with IN O
21 CD O
% NN O
O2 CD O
or CC O
100 CD O
% NN O
O2 CD O
, , O
suggesting VBG O
an DT O
unfavourable JJ O
accumulation NN O
of IN O
potent JJ O
excitotoxins NNS O
during IN O
hypoxaemic JJ O
resuscitation NN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
constitutively RB O
active JJ O
MEK1 NNP B-NP
, , O
the DT O
kinase NN O
that IN O
activates NNS O
ERKs NNS B-NP
, , O
or CC O
overexpression IN O
of IN O
ERK2 NNP B-NP
, , O
but CC O
not RB O
JNK1 NNP B-NP
, , O
inhibited VBD O
Stat3 NNP B-NP
activation NN O
. . O

-DOCSTART- X X O

MEKs NNP B-NP
and CC O
ERKs NNP B-NP
inhibited VBD O
IL-6 DT B-NP
activation NN O
of IN O
Stat3 NNP B-NP
harboring VBG O
a DT O
mutation NN O
at IN O
serine-727 NN O
, , O
the DT O
major JJ O
site NN O
for IN O
serine NN O
phosphorylation NN O
, , O
similar JJ O
to TO O
inhibition NN O
of IN O
wild-type JJ B-NP
Stat3 NNP I-NP
, , O
and CC O
inhibited VBD O
Janus NNP B-NP
kinases NNS I-NP
Jak1 NNP B-NP
and CC O
Jak2 NNP B-NP
upstream RB O
of IN O
Stat3 NNP B-NP
in IN O
the DT O
Jak-STAT-signaling JJ B-NP
pathway NN O
. . O

-DOCSTART- X X O

Transfection NNP O
and CC O
in IN O
vitro NN O
binding JJ O
studies NNS O
identified VBN O
within IN O
HEFT1 CD B-NP
a DT I-NP
promoter NN I-NP
whose WP$ O
basal JJ O
activity NN O
required VBD O
a DT O
GC JJ O
box NN O
activated VBN O
by IN O
Sp1 NNP B-NP
or CC O
Sp3 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
FAS NNP B-NP
promoter NN I-NP
was VBD O
up-regulated JJ O
by IN O
insulin NN B-NP
through IN O
the DT O
proximal JJ O
insulin NN B-NP
response NN I-NP
sequence NN I-NP
containing VBG O
an DT O
E-box NN O
motif NN O
at IN O
the DT O
-65-base JJ O
pair NN O
position NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
rhG-CSF NNP B-NP
on IN O
neutrophil JJ O
functions NNS O
and CC O
survival NN O
in IN O
sepsis NN O
induced VBN O
diabetic JJ O
rats NNS O
. . O

-DOCSTART- X X O

Anastrozole NNP O
is VBZ O
the DT O
first JJ O
aromatase NN B-NP
inhibitor NN O
to TO O
show VB O
a DT O
significant JJ O
survival NN O
advantage NN O
over IN O
megestrol NN O
acetate NN O
in IN O
post-menopausal JJ O
women NNS O
with IN O
advanced JJ O
breast NN O
cancer NN O
. . O

-DOCSTART- X X O

W. NNP O

-DOCSTART- X X O

Moritta NNP O
) -RRB- O
and CC O
contains VBZ O
Bis-GMA. . O

-DOCSTART- X X O

ANIMALS NNS O
: : O
Fifty CD O
dogs NNS O
with IN O
naturally RB O
developing VBG O
DM. . O

-DOCSTART- X X O

This DT O
suggests VBZ O
that IN O
while IN O
underpredictions NNS O
of IN O
pain NN O
do VBP O
not RB O
hurt VB O
more RBR O
, , O
disruption NN O
on IN O
primary JJ O
tasks NNS O
and CC O
physiological JJ O
impact NN O
are VBP O
higher JJR O
. . O

-DOCSTART- X X O

Laser NNP O
ablation NN O
has VBZ O
been VBN O
employed VBN O
as IN O
a DT O
therapeutic JJ O
measure NN O
for IN O
chronic JJ O
pulmonary NN O
emphysema NN O
. . O

-DOCSTART- X X O

The DT O
SH2-containing JJ O
adapter NN O
protein NN O
GRB10 IN B-NP
interacts NNS O
with IN O
BCR-ABL. NNP B-NP

-DOCSTART- X X O

Saccharomyces NNP O
cerevisiae NN O
contains VBZ O
four CD O
known VBN O
acyl-CoA NN B-NP
synthetases NNS I-NP
( -LRB- O
fatty JJ B-NP
acid NN I-NP
activation IN I-NP
proteins NNS I-NP
, , O
Faaps NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
recently RB O
reported VBD O
a DT O
placenta-specific JJ O
enhancer NN O
in IN O
the DT O
human JJ B-NP
leukemia NN I-NP
inhibitory JJ I-NP
factor NN I-NP
receptor NN I-NP
( -LRB- O
LIFR NNP B-NP
) -RRB- O
gene NN O
and CC O
now RB O
show VBP O
detailed JJ O
characterization NN O
of IN O
the DT O
226-base JJ O
pair NN O
enhancer NN O
(-4625/-4400 NN O
nucleotides NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Copyright NNP O
1998 CD O
Elsevier NNP O
Science NNP O
B.V. NNP O

-DOCSTART- X X O

It PRP O
may MD O
be VB O
time NN O
to TO O
reevaluate VB O
the DT O
dichotomy NN O
between IN O
AD NN O
and CC O
VaD. NNP O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
high JJ O
intensity NN O
light NN O
emissions NNS O
, , O
produced VBN O
by IN O
a DT O
novel NN O
pulsed VBD O
power NN O
energization NN O
technique NN O
( -LRB- O
PPET NNP O
) -RRB- O
, , O
on IN O
the DT O
survival NN O
of IN O
bacterial JJ O
populations NNS O
of IN O
verocytotoxigenic JJ O
Escherichia NN O
coli NNS O
( -LRB- O
serotype NN O
0157:H7 NN O
) -RRB- O
and CC O
Listeria NNP O
monocytogenes NNS O
( -LRB- O
serotype NN O
4b JJ O
) -RRB- O
were VBD O
investigated VBN O
. . O

-DOCSTART- X X O

POU-domain JJ B-NP
proteins NNS I-NP
, , O
such JJ O
as IN O
the DT O
pituitary-specific JJ B-NP
factor NN I-NP
Pit-1 NNP I-NP
, , O
are VBP O
members NNS O
of IN O
the DT O
homeodomain JJ B-NP
family NN I-NP
of IN O
proteins NNS O
which WDT O
are VBP O
important JJ O
in IN O
development NN O
and CC O
homeostasis NN O
, , O
acting VBG O
constitutively RB O
or CC O
in IN O
response NN O
to TO O
signal-transduction NN O
pathways NNS O
to TO O
either DT O
repress NN O
or CC O
activate VB O
the DT O
expression NN O
of IN O
specific JJ O
genes NNS O
. . O

-DOCSTART- X X O

This DT O
and CC O
previous JJ O
results NNS O
suggest VBP O
that IN O
the DT O
CRE NNP O
and CC O
Sp1 NNP B-NP
site NN I-NP
may MD O
synergistically RB O
activate VB O
TH IN B-NP
transcription NN O
in IN O
a DT O
promoter NN O
context-dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

T7 DT O
transcription NN O
could MD O
be VB O
manipulated VBN O
to TO O
achieve VB O
different JJ O
levels NNS O
of IN O
constitutive JJ O
expression NN O
, , O
through IN O
the DT O
use NN O
of IN O
promoter NN O
mutations NNS O
. . O

-DOCSTART- X X O

Plants NNS O
transformed VBN O
with IN O
the DT O
35S-1-sst JJ B-NP
construct VB O
accumulated VBN O
the DT O
oligofructans NNS O
1-kestose JJ O
( -LRB- O
GF2 NN O
) -RRB- O
, , O
1,1-nystose FW O
( -LRB- O
GF3 NN O
) -RRB- O
and CC O
1,1,1-fructosylnystose JJ O
( -LRB- O
GF4 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
the DT O
comparison NN O
of IN O
the DT O
predicted VBN O
amino IN O
acid NN O
sequences NNS O
of IN O
1-sst JJ B-NP
and CC O
1-fft JJ B-NP
with IN O
those DT O
of IN O
other JJ O
plant NN O
fructosyl NN B-NP
transferase NN I-NP
genes NNS I-NP
, , O
we PRP O
postulate VBP O
that IN O
both DT O
plant NN O
fructan NN B-NP
genes NNS I-NP
have VBP O
evolved VBN O
from IN O
plant NN O
invertase NN B-NP
genes NNS O
. . O

-DOCSTART- X X O

A DT O
5.0-kb JJ O
transcript NN O
detected VBN O
by IN O
the DT O
differential JJ O
display NN O
amplicon NN O
3G1 NN O
was VBD O
found VBN O
to TO O
correlate VB O
strongly RB O
with IN O
RAG1 NNP B-NP
mRNA NN I-NP
expression NN O
in IN O
various JJ O
human JJ O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
report VBP O
that IN O
swa5-1 NN B-NP
is VBZ O
a DT O
new JJ O
temperature-sensitive JJ O
allele NN O
of IN O
the DT O
clathrin JJ B-NP
heavy JJ I-NP
chain NN I-NP
gene NN I-NP
( -LRB- O
chc1-5 CD B-NP
) -RRB- O
, , O
which WDT O
carries VBZ O
a DT O
frameshift NN O
mutation NN O
near IN O
the DT O
3' JJ O
end NN O
of IN O
the DT O
CHC1 NN B-NP
open JJ O
reading NN O
frame NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
determined VBN O
the DT O
molecular JJ O
lesions NNS O
of IN O
nine CD O
Scm NNP B-NP
mutant JJ I-NP
alleles NNS I-NP
, , O
which WDT O
identify VBP O
functional JJ O
requirements NNS O
for IN O
specific JJ O
domains NNS O
. . O

-DOCSTART- X X O

Northern JJ O
analysis NN O
revealed VBN O
no DT O
detectable JJ O
expression NN O
of IN O
the DT O
transcript NN O
in IN O
diapause NN O
- : O
or CC O
nondiapause-programmed JJ O
wandering VBG O
larvae RB O
, , O
and CC O
only RB O
trace NN O
expression NN O
in IN O
nondiapausing JJ O
pupae NN O
. . O

-DOCSTART- X X O

Besides IN O
the DT O
characterization NN O
and CC O
discussion NN O
of IN O
the DT O
experimental JJ O
setup NN O
used VBN O
, , O
the DT O
rate NN O
constants NNS O
obtained VBN O
are VBP O
discussed VBN O
and CC O
compared VBN O
with IN O
estimated JJ O
values NNS O
. . O

-DOCSTART- X X O

Genomic JJ O
locus NN O
of IN O
chCTCF NN B-NP
contains VBZ O
a DT O
GC-rich JJ O
untranslated JJ O
exon NN O
separated VBN O
from IN O
seven CD O
coding NN O
exons NNS O
by IN O
a DT O
long JJ O
intron NN O
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
PDZ NNP B-NP
and CC O
SAM NNP O
domains VBZ O
in IN O
the DT O
KS5 NNP B-NP
protein NN I-NP
suggests VBZ O
that IN O
it PRP O
may MD O
act VB O
as IN O
a DT O
molecular JJ O
adaptor NN O
, , O
promoting VBG O
and CC O
relaying VBG O
information NN O
in IN O
a DT O
signal NN O
transduction NN O
pathway NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Fluoroquinolones NNP O
( -LRB- O
FQ NN O
) -RRB- O
are VBP O
contraindicated VBN O
in IN O
children NNS O
because IN O
of IN O
the DT O
risk NN O
of IN O
cartilage NN O
damage NN O
. . O

-DOCSTART- X X O

In IN O
analyses NNS O
with IN O
control NN O
for IN O
multiple JJ O
variables NNS O
, , O
relative JJ O
risk NN O
for IN O
microalbuminuria NNS O
(urinary JJ O
albumin IN B-NP
excretion NN O
, , O
20-199 JJ O
microg/min NN O
) -RRB- O
in IN O
men NNS O
and CC O
women NNS O
was VBD O
2.51 CD O
and CC O
1.62 CD O
, , O
respectively RB O
, , O
with IN O
18 CD O
mm CD O
Hg NN O
higher JJR O
( -LRB- O
1 CD O
SD NNP O
) -RRB- O
systolic JJ O
blood NN O
pressure NN O
; : O
2.25 CD O
and CC O
2.10 CD O
, , O
respectively RB O
, , O
with IN O
1.0-mmol/L JJ O
( -LRB- O
40 CD O
mg/dL NN O
) -RRB- O
higher JJR O
plasma NN O
cholesterol NN O
level NN O
; : O
1.99 CD O
and CC O
1.91 CD O
, , O
respectively RB O
, , O
for IN O
smokers NNS O
vs IN O
nonsmokers NNS O
; : O
and CC O
1.83 CD O
and CC O
1.33 CD O
, , O
respectively RB O
, , O
with IN O
4 CD O
kg/m2 CD O
higher JJR O
body NN O
mass NN O
index NN O
. . O

-DOCSTART- X X O

However RB O
, , O
while IN O
IL-1beta JJ B-NP
and CC O
TNF-alpha NNP B-NP
both DT O
induced JJ O
nuclear JJ O
binding NN O
of IN O
the DT O
Rel JJ B-NP
proteins NNS I-NP
p50 WDT B-NP
and CC O
p65 VB B-NP
to TO O
an DT O
NF-kappaB NNP B-NP
consensus NN I-NP
oligonucleotide NN I-NP
in IN O
gel NNP O
shift NN O
assays IN O
and CC O
caused VBD O
transient JJ O
degradation NN O
of IN O
inhibitor NN B-NP
of IN I-NP
NF-kappaB-alpha NNP I-NP
( -LRB- O
IkappaB-alpha NN B-NP
) -RRB- O
in IN O
the DT O
cytoplasm NN O
of IN O
myofibroblasts NNS O
, , O
only RB O
IL-1beta JJ B-NP
upregulated JJ O
PDGF-Ralpha NN B-NP
. . O

-DOCSTART- X X O

Phosphocreatine NNP O
hydrolysis NN O
during IN O
submaximal JJ O
exercise NN O
: : O
the DT O
effect NN O
of IN O
FIO2 NNP O
. . O

-DOCSTART- X X O

GETS-1 NN B-NP
is VBZ O
expressed VBN O
in IN O
many JJ O
tissues NNS O
, , O
but CC O
is VBZ O
enriched VBN O
in IN O
retina NN O
and CC O
brain NN O
. . O

-DOCSTART- X X O

The DT O
interaction NN O
of IN O
U1-70K JJ B-NP
with IN O
the DT O
SRZ JJ B-NP
proteins NNS I-NP
is VBZ O
confirmed VBN O
further RBR O
in IN O
vitro NN O
using VBG O
a DT O
blot NN O
overlay IN O
assay NN O
. . O

-DOCSTART- X X O

The DT O
major JJ O
phenotypes NNS O
resulting VBG O
from IN O
Fab1p DT B-NP
kinase NN I-NP
inactivation NN O
include VBP O
temperature-sensitive JJ O
growth NN O
, , O
vacuolar JJ O
acidification NN O
defects NNS O
, , O
and CC O
dramatic JJ O
increases NNS O
in IN O
vacuolar NN O
size NN O
. . O

-DOCSTART- X X O

The DT O
GEF NNP B-NP
and CC O
GAP NNP B-NP
activities NNS O
for IN O
Ypt1p JJ B-NP
localize NN O
to TO O
particulate VB O
cellular JJ O
fractions NNS O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
an DT O
antibody NN O
against IN O
N-SMase NNP B-NP
can MD O
abrogate VB O
Ox-LDL- NNP B-NP
and CC O
TNF-alpha-induced NNP B-NP
apoptosis NN O
and CC O
therefore RB O
may MD O
be VB O
useful JJ O
for IN O
in IN O
vivo JJ O
studies NNS O
of IN O
apoptosis NN O
in IN O
experimental JJ O
animals NNS O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
virulent JJ O
Ngo NNP O
strains NNS O
induce VB O
phosphorylation NN O
and CC O
activation NN O
of IN O
JNK NNP B-NP
but CC O
not RB O
of IN O
p38 DT B-NP
kinase NN O
. . O

-DOCSTART- X X O

Focused VBN O
beams NNS O
of IN O
classical JJ O
light NN O
ablate JJ O
elements NNS O
of IN O
the DT O
cell NN O
division NN O
machinery NN O
and CC O
switch VB O
the DT O
beating NN O
of IN O
hearts NNS O
on IN O
a DT O
cellular JJ O
basis NN O
. . O

-DOCSTART- X X O

This DT O
sequence NN O
is VBZ O
very RB O
similar JJ O
to TO O
the DT O
insulin NN B-NP
response NN I-NP
sequence NN I-NP
found VBD O
in IN O
the DT O
regulatory JJ O
region NN O
of IN O
other JJ O
genes NNS O
negatively RB O
regulated VBN O
by IN O
insulin NN B-NP
such JJ O
as IN O
those DT O
encoding VBG O
phosphoenolpyruvate JJ B-NP
carboxykinase NN I-NP
, , O
tyrosine NN B-NP
aminotransferase NN I-NP
, , O
and CC O
insulin-like JJ B-NP
growth NN I-NP
factor-binding JJ I-NP
protein NN I-NP
1 CD I-NP
. . O

-DOCSTART- X X O

The DT O
levels NNS O
of IN O
transactivation NN O
are VBP O
correlated VBN O
with IN O
the DT O
respective JJ O
binding JJ O
affinities NNS O
of IN O
the DT O
response NN O
elements NNS O
( -LRB- O
IRper-1 NN O
> NN O
DR-4 NN O
> JJ O
IRhsp-1 NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
high JJ O
density NN O
of IN O
tegumental JJ O
spines NNS O
on IN O
posterior JJ O
half NN O
of IN O
the DT O
body NN O
and CC O
the DT O
distribution NN O
of IN O
type NN O
II NNP O
papillae NN O
on IN O
dorsal JJ O
surface NN O
are VBP O
considered VBN O
to TO O
be VB O
characteristic JJ O
of IN O
C. NNP O
armatus NN O
. . O

-DOCSTART- X X O

Inactivation NN O
of IN O
p53 NN B-NP
but CC O
not RB O
p73 VB B-NP
by IN O
adenovirus NN B-NP
type NN I-NP
5 CD I-NP
E1B NNP I-NP
55-kilodalton CD I-NP
and CC I-NP
E4 NNP I-NP
34-kilodalton NNP I-NP
oncoproteins NNS I-NP
. . O

-DOCSTART- X X O

The DT O
Epstein-Barr NNP B-NP
virus NN I-NP
transactivator NN I-NP
Zta NNP I-NP
triggers VBZ O
lytic JJ O
gene NN O
expression NN O
and CC O
is VBZ O
essential JJ O
for IN O
replication NN O
of IN O
the DT O
lytic JJ O
origin NN O
, , O
oriLyt NNP O
. . O

-DOCSTART- X X O

There EX O
was VBD O
a DT O
trend NN O
in IN O
all DT O
studies NNS O
favouring VBG O
PVI. . O

-DOCSTART- X X O

A DT O
single JJ O
rectal JJ O
dose NN O
of IN O
25 CD O
mg/kg NN O
will MD O
obtain VB O
this DT O
lower JJR O
concentration NN O
within IN O
1 CD O
h NN O
of IN O
administration NN O
and CC O
maintain VB O
it PRP O
for IN O
up RB O
to TO O
6 CD O
h NN O
. . O

-DOCSTART- X X O

This DT O
domain NN O
, , O
although IN O
adjacent JJ O
to TO O
the DT O
5' JJ O
edge NN O
of IN O
the DT O
SD NNP O
sequence NN O
, , O
does VBZ O
not RB O
inhibit VB O
ribosome JJ O
binding NN O
as RB O
long RB O
as IN O
the DT O
single-stranded JJ O
region NN O
of IN O
domain NN O
3 CD O
is VBZ O
present JJ O
. . O

-DOCSTART- X X O

Previous JJ O
genetic JJ O
studies NNS O
led VBN O
to TO O
the DT O
conclusion NN O
that IN O
nitrate JJ O
and CC O
nitrite JJ O
induction NN O
of IN O
nasF NN B-NP
operon NN I-NP
expression NN O
is VBZ O
determined VBN O
by IN O
a DT O
transcriptional JJ O
antitermination NN O
mechanism NN O
. . O

-DOCSTART- X X O

The DT O
activation NN O
and CC O
injury NN O
of IN O
endothelial JJ O
cells NNS O
induced VBN O
by IN O
TNF NNP B-NP
and CC O
other JJ O
proinflammatory NN O
cytokines NNS O
may MD O
underlie VB O
the DT O
local JJ O
effects NNS O
of IN O
these DT O
mediators NNS O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
demonstrate VBP O
that IN O
THOV NNP B-NP
NP NNP I-NP
contains VBZ O
a DT O
motif NN O
(KRxxxxxxxxxKTKK) NN O
at IN O
amino JJ O
acid NN O
positions NNS O
179-193 JJ O
that IN O
represents VBZ O
a DT O
classical JJ O
bipartite JJ O
nuclear JJ O
localization NN O
signal NN O
( -LRB- O
NLS NNP O
) -RRB- O
. . O

-DOCSTART- X X O

As IN O
PP2A NNP B-NP
exerts VBZ O
a DT O
range NN O
of IN O
cellular JJ O
functions NNS O
including VBG O
cell NN O
cycle NN O
regulation NN O
and CC O
cell NN O
fate NN O
determination NN O
, , O
we PRP O
were VBD O
surprised VBN O
to TO O
find VB O
that IN O
these DT O
embryos NNS O
develop VBP O
normally RB O
until IN O
postimplantation NN O
, , O
around IN O
embryonic JJ O
day NN O
5.5/6.0. . O

-DOCSTART- X X O

Furthermore RB O
, , O
LB1 NNP B-NP
gene NN I-NP
mapped VBD O
to TO O
chromosome NN O
13q14 CD O
, , O
a DT O
region NN O
that WDT O
has VBZ O
been VBN O
involved VBN O
as IN O
a DT O
chromosomal NN O
breakpoint NN O
in IN O
DLBL. NNP O

-DOCSTART- X X O

16 CD O
subjects NNS O
were VBD O
repatch RB O
tested VBN O
to TO O
ethylmercury NN O
chloride NN O
( -LRB- O
EtHgCl NNP O
) -RRB- O
and CC O
to TO O
solutions NNS O
containing VBG O
EtHgCl NNP O
mixed JJ O
with IN O
L-cysteine JJ O
and CC O
glutathione NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Wild-type JJ B-NP
AT1A NNP I-NP
receptors NNS I-NP
, , O
expressed VBN O
in IN O
Chinese NNP O
hamster NN O
ovary NN O
cells NNS O
, , O
rapidly RB O
internalized VBN O
after IN O
Ang NNP B-NP
II NNP I-NP
stimulation NN O
[t1/2 IN O
2.3 CD O
min NN O
; : O
maximal JJ O
level NN O
of IN O
internalization NN O
( -LRB- O
Ymax NN O
) -RRB- O
78.2 CD O
% NN O
] NN O
, , O
as IN O
did VBD O
mutant JJ O
receptors NNS O
carrying VBG O
single JJ O
acidic NN O
substitutions NNS O
( -LRB- O
T332E NNP O
, , O
t1/2 VBD O
2.7 CD O
min NN O
, , O
Ymax NNP O
76.3 CD O
% NN O
; : O
S335D NNP O
, , O
t1/2 VBD O
2.4 CD O
min NN O
, , O
Ymax NNP O
76.7 CD O
% NN O
; : O
T336E NNP O
, , O
t1/2 VBD O
2.5 CD O
min NN O
, , O
Ymax NNP O
78.2 CD O
% NN O
; : O
S338D NNP O
, , O
t1/2 VBD O
2.6 CD O
min NN O
, , O
Ymax NNP O
78.4 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Forskolin NNP O
significantly RB O
enhanced VBD O
heregulin-stimulated PRP$ B-NP
expression NN O
of IN O
cyclin NN B-NP
D NNP I-NP
and CC O
phosphorylation NN O
of IN O
the DT O
retinoblastoma NN B-NP
gene NN I-NP
product NN I-NP
. . O

-DOCSTART- X X O

The DT O
ARF NN B-NP
promoter NN I-NP
was VBD O
also RB O
found VBN O
to TO O
be VB O
highly RB O
responsive JJ O
to TO O
E2F1 NNP B-NP
expression NN O
, , O
in IN O
keeping VBG O
with IN O
previous JJ O
results NNS O
at IN O
the DT O
RNA NNP O
level NN O
. . O

-DOCSTART- X X O

CM NNP O
reduced VBD O
the DT O
nuclear JJ O
binding NN O
activity NN O
of IN O
transcription NN B-NP
factor NN I-NP
AP-1 NN I-NP
. . O

-DOCSTART- X X O

Observers NNS O
with IN O
brain NN O
injury NN O
and CC O
control NN O
participants NNS O
performed VBD O
a DT O
vigilance NN O
task NN O
during IN O
which WDT O
they PRP O
received VBD O
periodic JJ O
whiffs NNS O
of IN O
unscented JJ O
air NN O
or CC O
air NN O
scented VBN O
with IN O
peppermint NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
The DT O
cardiac JJ O
index NN O
significantly RB O
changed VBD O
with IN O
varying VBG O
PaCO2 JJ O
levels NNS O
( -LRB- O
hypocapnia NN O
, , O
- : O
9 CD O
% NN O
; : O
hypercapnia NN O
, , O
13 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

After IN O
measuring VBG O
baseline NN O
Vmca NNP O
at IN O
a DT O
partial JJ O
pressure NN O
of IN O
carbon NN O
dioxide NN O
in IN O
arterial JJ O
blood NN O
( -LRB- O
PaCO2 NNP O
) -RRB- O
of IN O
37.7 CD O
+/ NNS O
- : O
4.5 CD O
mmHg NN O
( -LRB- O
mean VB O
+/ JJ O
- : O
SD NNP O
) -RRB- O
, , O
measurements NNS O
were VBD O
repeated VBN O
at IN O
a DT O
PaCO NNP O
of IN O
44.2 CD O
+/ NNS O
- : O
3.8 CD O
mmHg NN O
, , O
and CC O
the DT O
carbon NN O
dioxide NN O
reactivity NN O
( -LRB- O
absolute JJ O
value NN O
: : O
cm NN O
x NN O
s(-1 NN O
) -RRB- O
x NN O
mmHg(-1 NN O
) -RRB- O
; : O
relative JJ O
value NN O
: : O
percentage NN O
of IN O
baseline JJ O
Vmca/mmHg NN O
) -RRB- O
was VBD O
calculated VBN O
. . O

-DOCSTART- X X O

Multivariate NNP O
Cox NNP O
survival NN O
analysis NN O
identified VBN O
baseline NN O
EF NNP O
< , O
or CC O
= SYM O
30 CD O
% NN O
, , O
presence NN O
of IN O
significant JJ O
mitral JJ O
regurgitation NN O
( -LRB- O
>2+ NN O
) -RRB- O
before IN O
ablation NN O
, , O
and CC O
failure NN O
to TO O
exhibit VB O
improved VBN O
cardiac JJ O
performance NN O
by IN O
1 CD O
month NN O
after IN O
ablation NN O
as IN O
the DT O
only JJ O
independent JJ O
predictors NNS O
of IN O
death NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
developed VBN O
a DT O
new JJ O
method NN O
for IN O
estimation NN O
of IN O
regional JJ O
CBF JJ O
(rCBF NN O
) -RRB- O
and CC O
cerebrovascular JJ O
reserve NN O
capacity NN O
on IN O
a DT O
pixel-by-pixel JJ O
basis NN O
by IN O
means NNS O
of IN O
dynamic JJ O
magnetic JJ O
resonance NN O
imaging NN O
( -LRB- O
MRI NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Cost-effectiveness NN O
analysis NN O
provides VBZ O
a DT O
rational JJ O
means NN O
of IN O
allocating VBG O
limited JJ O
health NN O
care NN O
resources NNS O
by IN O
allowing VBG O
the DT O
comparison NN O
of IN O
the DT O
costs NNS O
of IN O
lipid-lowering JJ O
therapy NN O
, , O
in IN O
particular JJ O
, , O
therapy NN O
with IN O
beta-hydroxy-beta-methylglutaryl-CoA NNS B-NP
( -LRB- I-NP
coenzyme NN I-NP
A) NNP I-NP
reductase NN I-NP
inhibitors NNS O
( -LRB- O
statins NNS O
) -RRB- O
, , O
with IN O
the DT O
costs NNS O
of IN O
atherosclerosis NN O
that WDT O
could MD O
be VB O
prevented VBN O
by IN O
lowering VBG O
cholesterol NN O
. . O

-DOCSTART- X X O

Sequencing NN O
of IN O
a DT O
40-kb JJ O
DNA NN O
segment NN O
of IN O
the DT O
FK506 NNP O
gene NN O
cluster NN O
from IN O
Streptomyces NNP O
sp. . O

-DOCSTART- X X O

The DT O
predicted VBD O
domain NN O
structures NNS O
of IN O
FkbB NNP B-NP
and CC O
FkbC NNP B-NP
are VBP O
analogous JJ O
to TO O
that DT O
of IN O
FkbA NNP B-NP
and CC O
comprise VB O
30 CD O
fatty-acid-synthase(FAS)-like JJ B-NP
domains NNS O
arranged VBN O
in IN O
6 CD O
modules NNS O
. . O

-DOCSTART- X X O

1 CD O
in IN O
Ho NNP O
Chi NNP O
Minh NNP O
City NNP O
was VBD O
studied VBN O
by IN O
culture NN O
and CC O
latex JJ O
agglutination NN O
of IN O
blood NN O
, , O
cerebrospinal JJ O
fluid NN O
, , O
urine NN O
and CC O
pleural JJ O
fluid NN O
. . O

-DOCSTART- X X O

Glycogen NN O
synthesis NN O
and CC O
catabolism NN O
, , O
gluconeogenesis NN O
, , O
glycolysis NN O
, , O
motility NN O
, , O
cell NN O
surface NN O
properties NNS O
and CC O
adherence NN O
are VBP O
modulated VBN O
by IN O
csrA NNS B-NP
in IN I-NP
Escherichia NNP I-NP
coli NNS I-NP
, , O
while IN O
the DT O
production NN O
of IN O
several JJ O
secreted JJ O
virulence NN O
factors NNS O
, , O
the DT O
plant NN O
hypersensitive JJ O
response NN O
elicitor NN O
HrpN(Ecc NNP B-NP
) -RRB- O
and CC O
, , O
potentially RB O
, , O
other JJ O
secondary JJ O
metabolites NNS O
are VBP O
regulated VBN O
by IN O
rsmA NNP B-NP
in IN I-NP
Erwinia NNP I-NP
carotovora NN I-NP
. . O

-DOCSTART- X X O

Deletion NN O
analysis NN O
revealed VBN O
that IN O
the DT O
essential JJ O
domain NN O
of IN O
this DT O
promoter NN O
, , O
termed VBD O
the DT O
ORF5/deltaX JJ B-NP
transcript NN I-NP
promoter NN I-NP
, , O
mapped VBD O
to TO O
nucleotides NNS O
1525-1625 CD O
. . O

-DOCSTART- X X O

Handling VBG O
on IN O
PND NNP O
9 CD O
did VBD O
not RB O
result VB O
in IN O
elevated JJ O
CORT JJ O
levels NNS O
in IN O
any DT O
of IN O
the DT O
groups NNS O
. . O

-DOCSTART- X X O

633+/-258 CD O
aggregates/ml RB O
at IN O
0 CD O
rpm NN O
; : O
P NNP O
< NNP O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Thus RB O
, , O
IRF-7 DT B-NP
exhibits NNS O
functional JJ O
similarity NN O
to TO O
IRF-3 EX B-NP
; : O
however RB O
, , O
the DT O
preferential JJ O
expression NN O
of IN O
IRF-7 NNP B-NP
in IN O
lymphoid JJ O
cells NNS O
( -LRB- O
the DT O
cell NN O
type NN O
that IN O
expresses NNS O
IFNA NNP B-NP
) -RRB- O
suggests VBZ O
that IN O
IRF-7 NNP B-NP
may MD O
play VB O
a DT O
critical JJ O
role NN O
in IN O
regulating VBG O
the DT O
IFNA NNP B-NP
gene NN I-NP
expression NN O
. . O

-DOCSTART- X X O

PURPOSE NNP O
: : O
The DT O
role NN O
interleukin-6 NN B-NP
( -LRB- O
IL-6 NN B-NP
) -RRB- O
in IN O
the DT O
treatment NN O
of IN O
congenital JJ O
thrombocytopenias NNS O
is VBZ O
unknown JJ O
. . O

-DOCSTART- X X O

Additionally RB O
in IN O
seven CD O
subjects NNS O
adrenaline NN O
( -LRB- O
A DT O
) -RRB- O
and CC O
noradrenaline NN O
( -LRB- O
NA NNP O
) -RRB- O
concentrations NNS O
were VBD O
determined VBN O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analyses NNS O
show VBP O
that IN O
the DT O
hBub1 JJ B-NP
mRNA NN I-NP
level NN O
is VBZ O
abundantly RB O
expressed VBN O
in IN O
tissues NNS O
or CC O
cells NNS O
with IN O
a DT O
high JJ O
mitotic JJ O
index NN O
. . O

-DOCSTART- X X O

We PRP O
mapped VBD O
two CD O
overlapping JJ O
expressed VBD O
sequence NN O
tag NN O
clones NNS O
within IN O
a DT O
genomic JJ O
contig NN O
on IN O
human JJ O
chromosome NN O
5 CD O
, , O
band NN O
q31 VBD O
. . O

-DOCSTART- X X O

We PRP O
also RB O
raised VBD O
a DT O
polyclonal JJ O
antibody NN O
against IN O
the DT O
glutathione NN B-NP
S-transferase JJ I-NP
fusion NN I-NP
protein NN I-NP
containing VBG O
the DT O
NH2-terminal JJ O
86 CD O
amino IN O
acids NNS O
of IN O
human JJ B-NP
NRAMP2 NN I-NP
. . O

-DOCSTART- X X O

Inhibition NN O
of IN O
the DT O
apolipoprotein NN B-NP
B NNP I-NP
mRNA NN I-NP
editing NN O
enzyme-complex JJ O
by IN O
hnRNP JJ B-NP
C1 JJ I-NP
protein NN I-NP
and CC O
40S DT B-NP
hnRNP JJ I-NP
complexes NNS I-NP
. . O

-DOCSTART- X X O

SRC-1 NN B-NP
can MD O
relieve VB O
the DT O
NF-kappaB-mediated JJ B-NP
repression NN O
of IN O
GR CD B-NP
activity NN O
. . O

-DOCSTART- X X O

However RB O
the DT O
sequence NN O
surrounding VBG O
the DT O
transcription NN O
start NN O
site NN O
CTCA( NNP O
+1)TTCC NNP O
was VBD O
similar JJ O
to TO O
the DT O
consensus NN O
CTCA( NN O
+1)NTCT NN O
( -LRB- O
N NNP O
is VBZ O
any DT O
nucleoside JJ O
) -RRB- O
for IN O
an DT O
initiator NN O
element NN O
found VBD O
in IN O
terminal NN B-NP
deoxynucleotidyltransferase NN I-NP
and CC O
a DT O
number NN O
of IN O
other JJ O
highly RB O
regulated VBN O
genes NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
total JJ O
number NN O
of IN O
subunit NN O
c NNS O
in IN O
F0 DT B-NP
should MD O
be VB O
a DT O
multiple NN O
of IN O
2 CD O
and CC O
3. CD O

-DOCSTART- X X O

Expression NN O
of IN O
a DT O
dominant-negative JJ O
mutant NN O
of IN O
JNK1 NNP B-NP
also RB O
suppressed VBD O
glucose NN O
deprivation-induced JJ O
JNK1 NNP B-NP
activation NN O
as RB O
well RB O
as IN O
HSP70 NNP B-NP
gene NN I-NP
expression NN O
. . O

-DOCSTART- X X O

The DT O
interaction NN O
of IN O
AF-1 JJ O
with IN O
proteins NNS O
that WDT O
regulate VB O
distinct JJ O
steps NNS O
of IN O
transcription NN O
may MD O
provide VB O
a DT O
mechanism NN O
for IN O
synergistic JJ O
activation NN O
of IN O
gene NN O
expression NN O
by IN O
AF-1 JJ O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
signaling VBG O
in IN O
activated JJ O
DRA NNP B-NP
transcription NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
an DT O
increase NN O
of IN O
distance NN O
per IN O
se NN O
did VBD O
not RB O
have VB O
a DT O
deleterious JJ O
effect NN O
on IN O
translation NN O
efficiency NN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
mapped VBD O
a DT O
3'-polyadenylation NN O
site NN O
504bp JJ O
downstream NN O
of IN O
the DT O
TGA NNP O
stop NN O
codon NN O
, , O
consistent JJ O
with IN O
the DT O
2.5kb JJ O
transcript NN O
size NN O
. . O

-DOCSTART- X X O

RBP56 IN B-NP
protein NN I-NP
turned VBD O
out RP O
to TO O
be VB O
hTAFII68 IN B-NP
which WDT O
was VBD O
isolated VBN O
as IN O
a DT O
TATA-binding JJ B-NP
protein NN I-NP
associated VBN I-NP
factor NN I-NP
( -LRB- O
TAF NN B-NP
) -RRB- O
from IN O
a DT O
sub-population NN O
of IN O
TFIID NN B-NP
complexes NNS I-NP
( -LRB- O
Bertolotti NNP O
A. NN O
, , O
Lutz NNP O
, , O
Y. NNP O
, , O
Heard VBN O
, , O
D.J. NNP O
, , O
Chambon NNP O
, , O
P. NNP O
, , O
Tora NNP O
, , O
L. NNP O
, , O
1996 CD O
. . O
hTAFII68 '' B-NP
, , O
a DT O
novel NN O
RNA/ssDNA-binding NNP O
protein NN O
with IN O
homology NN O
to TO O
the DT O
proto-oncoproteins NNS O
TLS/FUS NNP B-NP
and CC O
EWS NNP B-NP
is VBZ O
associated VBN O
with IN O
both DT O
TFIID NNP B-NP
and CC O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
. . O

-DOCSTART- X X O

AMY-1 NNP B-NP
was VBD O
localized VBN O
in IN O
the DT O
cytoplasm NN O
in IN O
cells NNS O
expressing VBG O
c-myc JJ B-NP
at IN O
low JJ O
levels NNS O
, , O
but CC O
in IN O
the DT O
nucleus NN O
in IN O
the DT O
cells NNS O
of IN O
a DT O
high JJ O
c-myc JJ B-NP
expression NN O
in IN O
transiently DT O
transfected JJ O
cells NNS O
. . O

-DOCSTART- X X O

Antidepressant-like JJ O
properties NNS O
of IN O
some DT O
serotonin NN B-NP
receptor NN I-NP
ligands NNS O
and CC O
calcium NN O
channel NN O
antagonists NNS O
measured VBN O
with IN O
the DT O
forced VBN O
swimming NN O
test NN O
in IN O
mice NNS O
. . O

-DOCSTART- X X O

These DT O
characteristic JJ O
structural JJ O
features NNS O
were VBD O
used VBN O
to TO O
create VB O
the DT O
abbreviation NN O
AZF1 NNP B-NP
( -LRB- O
Asparagine-rich NNP B-NP
Zinc NNP I-NP
Finger NNP I-NP
protein NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
generated VBN O
a DT O
computer NN O
model NN O
of IN O
the DT O
C-terminal JJ O
domain NN O
of IN O
the DT O
434 CD O
repressor NN O
based VBN O
on IN O
the DT O
crystal NN O
structure NN O
of IN O
the DT O
homologous JJ B-NP
UmuD' JJ I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Large-scale JJ O
sequencing NN O
of IN O
two CD O
regions NNS O
in IN O
human JJ O
chromosome NN O
7q22 CD O
: : O
analysis NN O
of IN O
650 CD O
kb NN O
of IN O
genomic JJ O
sequence NN O
around IN O
the DT O
EPO NNP B-NP
and CC O
CUTL1 NNP B-NP
loci NNS I-NP
reveals VBZ O
17 CD O
genes NNS O
. . O

-DOCSTART- X X O

Because IN O
Trp53 CD B-NP
( -LRB- O
the DT O
mouse NN B-NP
homolog NN I-NP
of IN I-NP
human JJ I-NP
TP53 NN I-NP
) -RRB- O
is VBZ O
located VBN O
with IN O
Tk1 NNP B-NP
on IN O
chromosome NN O
11 CD O
and CC O
is VBZ O
critical JJ O
in IN O
regulating VBG O
cellular JJ O
responses NNS O
following VBG O
exposure NN O
to TO O
DNA NNP O
damaging VBG O
agents NNS O
, , O
we PRP O
wanted VBD O
to TO O
determine VB O
if IN O
these DT O
mouse NN O
lymphoma NN O
cells NNS O
harbor VBP O
mutations NNS O
in IN O
Trp53 CD B-NP
. . O

-DOCSTART- X X O

The DT O
full-length JJ O
N NNP B-NP
gene NN I-NP
, , O
encoded VBN O
by IN O
open JJ O
reading NN O
frame NN O
7 CD O
, , O
was VBD O
cloned VBN O
from IN O
the DT O
Canadian JJ O
PRRS NNP O
virus NN O
, , O
PA-8. . O

-DOCSTART- X X O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
ARNO NN B-NP
localizes NNS O
to TO O
the DT O
plasma NN O
membrane NN O
in IN O
vivo NN O
and CC O
efficiently RB O
catalyzes NNS O
ARF6 IN B-NP
nucleotide JJ O
exchange NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Renal NNP O
pathology NN O
and CC O
long-term JJ O
outcome NN O
in IN O
childhood NN O
SLE. . O

-DOCSTART- X X O

We PRP O
propose VBP O
that IN O
two CD O
pathways NNS O
regulate VB O
Stat5 DT B-NP
serine NN O
phosphorylation NN O
, , O
one CD O
that WDT O
is VBZ O
prolactin-activated JJ B-NP
and CC O
PD98059-resistant JJ O
and CC O
one CD O
that WDT O
is VBZ O
constitutively RB O
active JJ O
and CC O
PD98059-sensitive JJ O
and CC O
preferentially RB O
targets VBZ O
Stat5a NNP B-NP
. . O

-DOCSTART- X X O

An DT O
approximately RB O
37-kDa JJ O
cytoplasmic JJ O
protein NN O
is VBZ O
rapidly RB O
tyrosine-phosphorylated JJ O
in IN O
the DT O
response NN O
of IN O
mouse NN O
BAC1.2F5 CC O
macrophages NNS O
to TO O
colony NN B-NP
stimulating NN I-NP
factor-1 NN I-NP
( -LRB- O
CSF-1 NN B-NP
) -RRB- O
. . O
pp37 '' B-NP
was VBD O
purified VBN O
from IN O
the DT O
cytosolic JJ O
fraction NN O
by IN O
anti-Tyr( JJ B-NP
P NNP I-NP
) -RRB- I-NP
affinity NN O
chromatography NN O
, , O
size NN O
exclusion NN O
chromatography NN O
, , O
and CC O
C4 NNP O
reverse NN O
phase NN O
high JJ O
pressure NN O
liquid NN O
chromatography NN O
. . O

-DOCSTART- X X O

Dose NNP O
of IN O
20 CD O
ig NN O
were VBD O
administered VBN O
within IN O
a DT O
scheme NN O
from IN O
0.1 CD O
to TO O
6 CD O
months NNS O
in IN O
order NN O
to TO O
study VB O
its PRP$ O
immunogenicity NN O
, , O
which WDT O
was VBD O
evaluated VBN O
at IN O
2 CD O
, , O
7 CD O
, , O
and CC O
12 CD O
months NNS O
after IN O
the DT O
first JJ O
dose NN O
. . O

-DOCSTART- X X O

The DT O
various JJ O
available JJ O
data NNS O
strongly RB O
suggesting VBG O
an DT O
environmental JJ O
toxic JJ O
origin NN O
for IN O
the DT O
" `` O
sperm JJ O
fall NN O
" `` O
will MD O
be VB O
presented VBN O
as RB O
well RB O
as IN O
the DT O
most RBS O
frequently RB O
suspected VBN O
class NN O
of IN O
substances NNS O
, , O
the DT O
xenoestrogens NNS O
. . O

-DOCSTART- X X O

This DT O
association NN O
was VBD O
independently RB O
significant JJ O
for IN O
patients NNS O
treated VBN O
primarily RB O
( -LRB- O
not RB O
for IN O
recurrence NN O
) -RRB- O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Local JJ O
control NN O
was VBD O
highest JJS O
with IN O
Preop NNP O
in IN O
patients NNS O
presenting VBG O
primarily RB O
with IN O
gross JJ O
disease NN O
, , O
and CC O
with IN O
Postop NNP O
in IN O
patients NNS O
presenting VBG O
primarily RB O
following VBG O
gross JJ O
total JJ O
excision NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
previously RB O
mapped VBN O
the DT O
defect NN O
in IN O
RIIIS/J NNP O
to TO O
distal JJ O
mouse NN O
Chr NNP O
11 CD O
, , O
distinct JJ O
from IN O
the DT O
Vwf NNP B-NP
locus NN I-NP
on IN O
Chr NNP O
6 CD O
. . O

-DOCSTART- X X O

These DT O
data NNS O
may MD O
also RB O
aid VB O
in IN O
the DT O
localization NN O
of IN O
other JJ O
disease NN O
loci NNS O
mapped VBD O
to TO O
this DT O
region NN O
, , O
including VBG O
the DT O
gene NN O
for IN O
tricho-dento-osseous JJ O
syndrome NN O
and CC O
a DT O
murine NN O
locus NN O
for IN O
susceptibility NN O
to TO O
ozone-induced JJ O
acute JJ O
lung NN O
injury NN O
. . O

-DOCSTART- X X O

Copyright NNP O
1998 CD O
Academic NNP O
Press NNP O
. . O

-DOCSTART- X X O

Rather RB O
, , O
usp NN B-NP
is VBZ O
required VBN O
in IN O
late JJ O
third JJ O
instar NN O
larvae NNS O
for IN O
appropriate JJ O
developmental JJ O
and CC O
transcriptional JJ O
responses NNS O
to TO O
the DT O
ecdysone NN O
pulse NN O
that IN O
triggers NNS O
puparium NN O
formation NN O
. . O

-DOCSTART- X X O

An DT O
intact JJ O
neurovascular JJ O
supply NN O
is VBZ O
essential JJ O
for IN O
the DT O
viability NN O
of IN O
a DT O
muscle NN O
flap NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
An DT O
herpetic JJ O
seroconversion NN O
is VBZ O
observed VBN O
with IN O
presence NN O
of IN O
type NN O
I PRP O
herpes PRP$ O
simplex JJ O
virus NN O
( -LRB- O
HSV NN O
I PRP O
) -RRB- O
nucleic JJ O
acids NNS O
in IN O
the DT O
recipient NN O
's POS O
aqueous JJ O
humor NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
HIV-1 PRP$ O
Gag NNP B-NP
sequences NNS I-NP
can MD O
influence VB O
the DT O
viral NN B-NP
PR-mediated JJ I-NP
processing NN O
of IN O
the DT O
MuLV NNP O
TM NNP B-NP
Env NNP I-NP
protein NN I-NP
p15( JJ B-NP
E NN I-NP
) -RRB- I-NP
. . O

-DOCSTART- X X O

Mechanism NN O
of IN O
interferon NN B-NP
action NN O
: : O
identification NN O
of IN O
essential JJ O
positions NNS O
within IN O
the DT O
novel NN O
15-base-pair NNP B-NP
KCS NNP I-NP
element NN I-NP
required VBN O
for IN O
transcriptional JJ O
activation NN O
of IN O
the DT O
RNA-dependent JJ B-NP
protein NN I-NP
kinase NN I-NP
pkr NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Expression NN O
of IN O
a DT O
novel NN O
murine NN B-NP
phospholipase NN I-NP
D NNP I-NP
homolog NN I-NP
coincides VBZ O
with IN O
late JJ O
neuronal JJ O
development NN O
in IN O
the DT O
forebrain NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
low-profile JJ O
serine NN O
substitutions NNS O
in IN O
the DT O
V3 JJ B-NP
loop NN O
of IN O
HIV-1 PRP$ O
gp120 CD B-NP
IIIB/LA NNP I-NP
I PRP B-NP
on IN O
the DT O
immunogenicity NN O
of IN O
the DT O
envelope NN B-NP
protein NN O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
2' CD I-NP
, , I-NP
5'-oligoadenylate JJ I-NP
(2-5A NN I-NP
) -RRB- I-NP
synthetases NNS I-NP
are VBP O
members NNS O
of IN O
a DT O
family NN O
interferon NN B-NP
( -LRB- O
IFN)-inducible JJ B-NP
anti-viral JJ B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Low NNP O
PbrO2 NNP O
readings NNS O
, , O
however RB O
, , O
could MD O
be VB O
caused VBN O
by IN O
local JJ O
microhemorrhages NNS O
, , O
undetectable JJ O
on IN O
CT NNP O
or CC O
MRI. NNP O

-DOCSTART- X X O

The DT O
consequences NNS O
of IN O
intensive JJ O
swine NN O
production NN O
on IN O
the DT O
environment NN O
and CC O
possible JJ O
solutions NNS O
by IN O
means NNS O
of IN O
nutrition NN O
are VBP O
outlined VBN O
. . O

-DOCSTART- X X O

This DT O
study NN O
demonstrates VBZ O
that IN O
alteration NN O
of IN O
CDKN2 NNP B-NP
is VBZ O
one CD O
of IN O
the DT O
most RBS O
frequent JJ O
genetic JJ O
abnormalities NNS O
in IN O
prostate NN O
cancer NN O
and CC O
may MD O
contribute VB O
to TO O
prostate VB O
carcinogenesis NN O
. . O

-DOCSTART- X X O

PURPOSE NNP O
: : O
To TO O
determine VB O
the DT O
effects NNS O
of IN O
hypercholesterolemia NN O
and CC O
atherosclerosis-induced JJ O
chronic NN O
cavernosal NN O
arterial NN O
insufficiency NN O
on IN O
cavernosal NN O
smooth JJ O
muscle NN O
tone NN O
, , O
nitric JJ B-NP
oxide NN I-NP
synthase NN I-NP
( -LRB- O
NOS NNP B-NP
) -RRB- O
activity NN O
and CC O
cavernosal NN O
tissue NN O
synthesis NN O
of IN O
constrictor NN O
eicosanoids NNS O
. . O

-DOCSTART- X X O

( -LRB- O
1992 CD O
) -RRB- O
Biochemistry NNP O
31 CD O
, , O
3351-3358] CD O
. . O

-DOCSTART- X X O

Levels NNP O
of IN O
serum NN O
IgE NNP B-NP
were VBD O
measured VBN O
monthly JJ O
, , O
and CC O
nasal JJ O
IgE NNP B-NP
was VBD O
measured VBN O
at IN O
the DT O
height NN O
and CC O
end NN O
of IN O
the DT O
season NN O
. . O

-DOCSTART- X X O

By IN O
directly RB O
interacting JJ O
with IN O
both DT O
Arfs NNS B-NP
and CC O
tyrosine NN B-NP
kinases NNS I-NP
involved VBN O
in IN O
regulating VBG O
cell NN O
growth NN O
and CC O
cytoskeletal NN O
organization NN O
, , O
ASAP1 NNP B-NP
could MD O
coordinate VB O
membrane NN O
remodeling VBG O
events NNS O
with IN O
these DT O
processes NNS O
. . O

-DOCSTART- X X O

By IN O
DNase NN B-NP
I PRP I-NP
footprint VBD O
analysis NN O
of IN O
the DT O
PNR NNP O
element NN O
, , O
a DT O
palindrome NN O
of IN O
two CD O
high-affinity JJ O
Ets-binding JJ B-NP
sites NNS I-NP
( -LRB- O
CTTCCCTGGAAG NNP O
) -RRB- O
was VBD O
identified VBN O
. . O

-DOCSTART- X X O

These DT O
sorting VBG B-NP
nexins NNS I-NP
also RB O
associated VBN O
with IN O
the DT O
long JJ O
isoform NN O
of IN O
the DT O
leptin NN B-NP
receptor NN I-NP
but CC O
not RB O
with IN O
the DT O
short JJ O
and CC O
medium JJ O
isoforms NNS O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
protein NN O
retention NN O
experiments NNS O
in IN O
which WDT O
Hsp90 CD B-NP
heterocomplexes NNS I-NP
were VBD O
precipitated VBN O
resulted VBN O
in IN O
coprecipitation NN O
of IN O
Cns1 NNP B-NP
. . O

-DOCSTART- X X O

To TO O
modulate VB O
transcription NN O
, , O
regulatory JJ O
factors NNS O
communicate VB O
with IN O
basal JJ O
transcription NN O
factors NNS O
and/or CC O
RNA NNP B-NP
polymerases NNS I-NP
in IN O
a DT O
variety NN O
of IN O
ways NNS O
. . O

-DOCSTART- X X O

The DT O
mapping NN O
was VBD O
completed VBN O
with IN O
Southern JJ O
blotting NN O
and CC O
restriction NN O
analysis NN O
. . O

-DOCSTART- X X O

The DT O
zona NN O
pellucida NN O
( -LRB- O
ZP) NNP O
, , O
the DT O
extracellular JJ O
glycocalyx NN O
that WDT O
surrounds VBZ O
the DT O
oocyte NN O
, , O
is VBZ O
well RB O
known VBN O
to TO O
mediate VB O
homologous JJ O
gamete NN O
interaction NN O
. . O

-DOCSTART- X X O

Although IN O
pathological JJ O
thyroid JJ O
function NN O
is VBZ O
related VBN O
to TO O
changes NNS O
in IN O
energy NN O
expenditure NN O
and CC O
body NN O
composition NN O
, , O
its PRP$ O
possible JJ O
influence NN O
on IN O
leptin NN B-NP
levels NNS O
remains VBZ O
to TO O
be VB O
determined VBN O
. . O

-DOCSTART- X X O

These DT O
cognitive JJ O
deficits NNS O
were VBD O
prevented VBN O
in IN O
animals NNS O
treated VBN O
with IN O
MK-801 NNP O
during IN O
SE. NNP O

-DOCSTART- X X O

Thus RB O
, , O
hypoxia-inducible JJ O
nuclear JJ O
import NN O
and CC O
transactivation NN O
by IN O
recruitment NN O
of IN O
CBP NNP B-NP
can MD O
be VB O
functionally RB O
separated VBN O
from IN O
one CD O
another DT O
and CC O
play VBP O
critical JJ O
roles NNS O
in IN O
signal NN O
transduction NN O
by IN O
HIF-1alpha NNP B-NP
. . O

-DOCSTART- X X O

The DT O
rat NN B-NP
aldolase NN I-NP
C NNP I-NP
gene NN I-NP
encodes VBZ O
a DT O
glycolytic JJ O
enzyme NN O
strongly RB O
expressed VBD O
in IN O
adult NN O
brain NN O
. . O

-DOCSTART- X X O

A DT O
synergistic JJ O
effect NN O
on IN O
HCK NNP B-NP
promoter NN I-NP
activity NN O
was VBD O
observed VBN O
at IN O
high JJ O
concentrations NNS O
of IN O
Sp1 NNP B-NP
. . O

-DOCSTART- X X O

Western JJ O
analyses NNS O
with IN O
antisera NN O
raised VBN O
against IN O
Lu-ECAM-1 JJ B-NP
peptides NNS I-NP
show VBP O
that IN O
the DT O
N-terminal JJ O
region NN O
of IN O
the DT O
predicted VBN O
open JJ O
reading NN O
frame NN O
is VBZ O
present JJ O
only RB O
in IN O
the DT O
larger JJR O
size NN O
proteins NNS O
( -LRB- O
i IN O
.e NN O
. . O

-DOCSTART- X X O

Mammalian NNP O
sperm NN O
motility NN O
is VBZ O
regulated VBN O
by IN O
a DT O
cascade NN O
of IN O
cAMP-dependent JJ O
protein NN O
phosphorylation NN O
events NNS O
mediated VBN O
by IN O
protein NN B-NP
kinase NN I-NP
A. NN I-NP

-DOCSTART- X X O

In IN O
this DT O
paper NN O
, , O
we PRP O
show VBP O
that IN O
, , O
like IN O
BAP2 NNP B-NP
, , O
the DT O
expression NN O
of IN O
the DT O
BAP3 NNP B-NP
gene NN I-NP
in IN O
S. NNP O
cerevisiae NN O
is VBZ O
induced VBN O
by IN O
the DT O
addition NN O
of IN O
branched-chain NN O
amino IN O
acids NNS O
to TO O
the DT O
medium NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
enteral JJ O
nutritional JJ O
products NNS O
differing VBG O
in IN O
carbohydrate NN O
and CC O
fat JJ O
on IN O
indices NNS O
of IN O
carbohydrate NN O
and CC O
lipid JJ O
metabolism NN O
in IN O
patients NNS O
with IN O
NIDDM. NNP O

-DOCSTART- X X O

These DT O
studies NNS O
support VBP O
the DT O
view NN O
that IN O
HMG NNP B-NP
I( NNP I-NP
Y NNP I-NP
) -RRB- I-NP
is VBZ O
an DT O
important JJ O
cofactor NN O
for IN O
HLA-DRA NNP B-NP
gene NN I-NP
activation NN O
by IN O
Oct-2A NNP B-NP
and CC O
provide VB O
insights NNS O
into IN O
its PRP$ O
mechanism NN O
of IN O
action NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
to TO O
hemodynamic JJ O
and CC O
histopathological JJ O
predictors NNS O
of IN O
survival NN O
, , O
vWF:Ag NN B-NP
does VBZ O
not RB O
require VB O
invasive JJ O
techniques NNS O
to TO O
be VB O
determined VBN O
. . O

-DOCSTART- X X O

We PRP O
find VBP O
that DT O
BCL-6 NNP B-NP
POZ NNP O
domain NN O
mutations NNS O
that WDT O
disrupt VB O
the DT O
interaction NN O
with IN O
N-CoR NNP B-NP
and CC O
SMRT NNP B-NP
no RB O
longer RB O
repress VB O
transcription NN O
. . O

-DOCSTART- X X O

Partial JJ O
characterization NN O
of IN O
the DT O
active JJ O
site NN O
human JJ B-NP
platelet NN I-NP
cAMP IN I-NP
phosphodiesterase NN I-NP
, , O
PDE3A NNP B-NP
, , O
by IN O
site-directed JJ O
mutagenesis NN O
. . O

-DOCSTART- X X O

This DT O
core NN O
sequence NN O
, , O
along RB O
with IN O
additional JJ O
nonspecific JJ O
downstream NN O
nucleotides NNS O
, , O
is VBZ O
sufficient JJ O
for IN O
partial JJ O
suppression NN O
of IN O
spliceosome JJ O
assembly NN O
and CC O
splicing NN O
of IN O
BPV-1 JJ O
pre-mRNAs JJ O
. . O

-DOCSTART- X X O

Over-expression NN O
of IN O
the DT O
cofactor NN O
p300 NN B-NP
, , O
which WDT O
functions VBZ O
as IN O
a DT O
coactivator NN O
of IN O
myoD-mediated JJ B-NP
transcription NN O
, , O
alleviated VBN O
repression NN O
by IN O
COUP-TF NNP B-NP
II NNP I-NP
. . O

-DOCSTART- X X O

Familial JJ O
autoimmune JJ O
hepatitis NN O
and CC O
C4 NNP B-NP
deficiency NN O

-DOCSTART- X X O

The DT O
Schizosaccharomyces NNPS B-NP
pombe VBD I-NP
rad1+ JJ I-NP
cell NN I-NP
cycle NN I-NP
checkpoint NN I-NP
control NN I-NP
gene NN I-NP
is VBZ O
required VBN O
for IN O
S-phase JJ O
and CC O
G2/M JJ O
arrest NN O
in IN O
response NN O
to TO O
both DT O
DNA NNP O
damage NN O
and CC O
incomplete JJ O
DNA NN O
replication NN O
. . O

-DOCSTART- X X O

Positive JJ O
genetic JJ O
selections NNS O
for IN O
inhibition NN O
of IN O
cyclin/CDK NN B-NP
function NN O
were VBD O
characterized VBN O
using VBG O
the DT O
E. NNP B-NP
coli NNS I-NP
neo NN I-NP
and CC O
yeast NN B-NP
LEU2 JJ I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

All DT O
injections NNS O
of IN O
CSF NNP B-NP
were VBD O
given VBN O
after IN O
the DT O
initiation NN O
of IN O
neutropenia NN O
and CC O
continued VBD O
until IN O
the DT O
occurrence NN O
of IN O
an DT O
absolute JJ O
neutrophil JJ O
recovery NN O
. . O
rHu '' B-NP
GM-CSF NNP I-NP
and CC O
rHu NNP B-NP
G-CSF NNP I-NP
, , O
administered VBN O
once RB O
daily RB O
at IN O
the DT O
250 CD O
microg JJ O
m(-2 NN O
) -RRB- O
day(-1 NN O
) -RRB- O
and CC O
5 CD O
microg NN O
kg(-1 NN O
) -RRB- O
day(-1 NN O
) -RRB- O
level NN O
, , O
were VBD O
effective JJ O
in IN O
increasing VBG O
the DT O
absolute NN O
neutrophil NN O
count NN O
and CC O
neutrophil JJ O
function NN O
, , O
as IN O
measured VBN O
by IN O
an DT O
automated VBN O
chemiluminescence NN O
system NN O
. . O

-DOCSTART- X X O

We PRP O
evaluated VBD O
regional JJ O
right JJ O
ventricular JJ O
wall NN O
motion NN O
during IN O
systole NN O
in IN O
patients NNS O
with IN O
surgically RB O
repaired VBN O
tetralogy NN O
of IN O
Fallot NNP O
( -LRB- O
TOF NN O
) -RRB- O
using VBG O
color NN O
kinesis NN O
imaging NN O
. . O

-DOCSTART- X X O

RT-PCR JJ O
analysis NN O
showed VBD O
that DT O
PLP-H NNP B-NP
as RB O
well RB O
as IN O
PLP-C NNP B-NP
and CC O
PLP-D NNP B-NP
are VBP O
expressed VBN O
in IN O
all DT O
rat NN O
strains NNS O
examined VBN O
, , O
confirming VBG O
that DT O
PLP NNP B-NP
diversity NN O
is VBZ O
not RB O
due JJ O
to TO O
strain VB O
differences NNS O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
we PRP O
find VBP O
that IN O
the DT O
interaction NN O
between IN O
Tat NNPS B-NP
and CC O
hCycT1 PRP B-NP
requires VBZ O
zinc NN O
as RB O
well RB O
as IN O
essential JJ O
cysteine NN O
residues NNS O
in IN O
both DT O
proteins NNS O
. . O

-DOCSTART- X X O

During IN O
early RB O
neurogenesis NN O
, , O
Vnd NNP B-NP
protein NN I-NP
is VBZ O
restricted VBN O
to TO O
ventral NN O
column NN O
neuroectoderm NN O
and CC O
neuroblasts NNS O
; : O
later RB O
it PRP O
is VBZ O
detected VBN O
in IN O
a DT O
complex JJ O
pattern NN O
of IN O
neurons NNS O
. . O

-DOCSTART- X X O

The DT O
exodomain NN O
alone RB O
has VBZ O
the DT O
high JJ O
affinity NN O
hormone NN O
binding NN O
site NN O
but CC O
is VBZ O
not RB O
capable JJ O
of IN O
generating VBG O
hormonal JJ O
signal NN O
. . O

-DOCSTART- X X O

Pyrrolidine NNP O
dithiocarbamate NN O
, , O
a DT O
potent JJ O
transcriptional JJ O
inhibitor NN O
of IN O
the DT O
viral JJ B-NP
LTR NNP I-NP
, , O
abrogated VBD O
the DT O
cytokine NN O
responses NNS O
in IN O
both DT O
U1 NNP O
and CC O
ACH-2 NNP O
cells NNS O
, , O
suggesting VBG O
a DT O
common JJ O
TNF-alpha-mediated JJ B-NP
transcriptional JJ O
mechanism NN O
in IN O
these DT O
cell NN O
types NNS O
despite IN O
their PRP$ O
different JJ O
modes NNS O
of IN O
provirus NN O
latency RB O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
synergistic JJ O
activation NN O
of IN O
ERK2 NNP B-NP
occurred VBD O
in IN O
the DT O
absence NN O
of IN O
changes NNS O
in IN O
intracellular JJ O
Ca2+ NNP O
, , O
and CC O
was VBD O
not RB O
blocked VBN O
by IN O
inhibition NN O
of IN O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
activity NN O
and CC O
represents VBZ O
a DT O
separate JJ O
pathway NN O
by IN O
which WDT O
CD19 NNP B-NP
regulates VBZ O
B NNP O
cell NN O
function NN O
. . O

-DOCSTART- X X O

Biochemical JJ O
analysis NN O
reveals VBZ O
that IN O
KS1 NNP B-NP
is VBZ O
a DT O
nuclear JJ O
protein NN O
containing VBG O
two CD O
transcriptional JJ O
repressor NN O
domains VBZ O
, , O
R1 NNP O
and CC O
R2 NNP O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
BCH NNP O
group NN O
showed VBD O
inferior JJ O
gross JJ O
motor NN O
performance NN O
on IN O
the DT O
Bruininks-Oseretsky JJ O
Test NNP O
of IN O
Motor NNP O
Proficiency NNP O
( -LRB- O
Bruininks NNP O
1978 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
results NNS O
raise VBP O
the DT O
possibility NN O
that IN O
pH NNS O
induced VBN O
post-translational JJ O
modifications NNS O
of IN O
DdRPA NNP B-NP
are VBP O
involved VBN O
in IN O
events NNS O
that IN O
halt NN O
cell NN O
proliferation NN O
and CC O
induce VB O
differentiation NN O
in IN O
Dictyostelium NN O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
here RB O
that IN O
, , O
for IN O
a DT O
constant JJ O
amount NN O
of IN O
transfected JJ O
DNA NN O
, , O
the DT O
level NN O
of IN O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
( -LRB- O
CAT NN B-NP
) -RRB- O
mRNA NN O
is VBZ O
increased VBN O
in IN O
Vpr-expressing JJ B-NP
cells NNS O
using VBG O
either DT O
HIV-1 NN O
or CC O
a DT O
murine NN O
leukemia NN B-NP
virus NN I-NP
( -LRB- I-NP
MLV NNP I-NP
) -RRB- I-NP
SL3-3 : I-NP
LTR-CAT JJ I-NP
reporter NN O
construct VB O
. . O

-DOCSTART- X X O

We PRP O
identified VBD O
telSMN NN B-NP
mutations NNS O
in IN O
11 CD O
of IN O
these DT O
unrelated JJ O
SMA-like JJ O
individuals NNS O
who WP O
carry VBP O
a DT O
single JJ O
copy NN O
of IN O
telSMN NN B-NP
: : O
these DT O
include VBP O
two CD O
frameshift NN O
mutations NNS O
( -LRB- O
800ins11 CD O
and CC O
542delGT CD O
) -RRB- O
and CC O
three CD O
missense NN O
mutations NNS O
( -LRB- O
A2G NNP O
, , O
S262I NNP O
, , O
and CC O
T274I NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
decrease NN O
of IN O
TNF NNP B-NP
receptors NNS I-NP
by IN O
IL-4 NN B-NP
was VBD O
accompanied VBN O
by IN O
down-regulation NN O
of IN O
TNF-induced JJ B-NP
activities NNS O
, , O
including VBG O
cytotoxicity NN O
, , O
caspase-3 JJ B-NP
activation NN O
, , O
NF-kappaB NNP B-NP
and CC O
AP-1 NNP B-NP
activation NN O
, , O
and CC O
c-Jun JJ B-NP
N-terminal JJ I-NP
kinase NN I-NP
induction NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
identified VBN O
two CD O
overlapping VBG O
expressed VBN O
sequence NN O
tag NN O
clones NNS O
, , O
which WDT O
contain VBP O
the DT O
missing VBG O
4.4-kb JJ O
3'-UTR NN O
of IN O
the DT O
human JJ B-NP
D2 NN I-NP
( -LRB- O
hD2 NN B-NP
) -RRB- O
cDNA NN O
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
have VBP O
investigated VBN O
the DT O
structural JJ O
requirements NNS O
and CC O
consequences NNS O
of IN O
regulatory JJ O
phosphorylation NN O
for IN O
the DT O
interaction NN O
between IN O
c-Jun JJ B-NP
and CC O
JNK JJ B-NP
in IN O
vivo NN O
. . O

-DOCSTART- X X O

P-CIP1 NNP B-NP
, , O
a DT O
novel JJ O
protein NN O
that IN O
interacts NNS O
with IN O
the DT O
cytosolic JJ O
domain NN O
of IN O
peptidylglycine NN B-NP
alpha-amidating NN I-NP
monooxygenase NN I-NP
, , O
is VBZ O
associated VBN O
with IN O
endosomes NNS O
. . O

-DOCSTART- X X O

Immunolocalization NNP O
of IN O
Sop1p NNP B-NP
revealed VBD O
a DT O
cytoplasmic JJ O
distribution NN O
and CC O
cell NN O
fractionation NN O
studies NNS O
showed VBD O
that IN O
a DT O
significant JJ O
fraction NN O
of IN O
Sop1p NNP B-NP
was VBD O
recovered VBN O
in IN O
a DT O
sedimentable JJ O
fraction NN O
of IN O
the DT O
cytosolic JJ O
material NN O
. . O

-DOCSTART- X X O

Resultant NN O
activation NN O
of IN O
c-Jun JJ B-NP
N-terminal JJ I-NP
kinase/stress-activated JJ I-NP
protein NN B-NP
kinase NN I-NP
( -LRB- O
JNK/SAPK) NNP B-NP
. . O

-DOCSTART- X X O

Consistent NN O
with IN O
this DT O
, , O
purified VBN O
Dlk NNP B-NP
phosphorylated VBD O
core NN O
histones NNS B-NP
H3 CC I-NP
, , O
H2A NNP B-NP
and CC O
H4 NNP B-NP
as IN O
exogenous JJ O
substrates NNS O
and CC O
endogenous JJ O
histone NN B-NP
H3 . I-NP
in IN O
kinase NN O
assays IN O
with IN O
nuclear JJ O
extracts NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
we PRP O
provide VBP O
evidence NN O
that IN O
B-Myb NNP B-NP
is VBZ O
a DT O
direct JJ O
physiological JJ O
target NN O
for IN O
cyclin NN B-NP
A/Cdk2 NN I-NP
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
a DT O
novel JJ O
human NN B-NP
cyclin NN I-NP
, , O
cyclin NN B-NP
E2 NN I-NP
, , O
that WDT O
contains VBZ O
significant JJ O
homology NN O
to TO O
cyclin VB B-NP
E. NNP I-NP

-DOCSTART- X X O

Initial JJ O
experience NN O
with IN O
the DT O
new JJ O
technology NN O
indicates VBZ O
that IN O
SieScape NNP O
is VBZ O
an DT O
alternative NN O
to TO O
other JJ O
methods NNS O
such JJ O
as IN O
CT NNP O
and CC O
MRI. NNP O

-DOCSTART- X X O

The DT O
dopamine NN B-NP
D4 NN I-NP
receptor NN I-NP
as RB O
well RB O
as IN O
many JJ O
other JJ O
catecholaminergic NN B-NP
receptors NNS I-NP
contain VBP O
several JJ O
putative JJ O
SH3 NNS B-NP
binding JJ I-NP
domains NNS I-NP
. . O

-DOCSTART- X X O

The DT O
highly RB O
amyloidogenic JJ O
42-residue JJ O
form NN O
of IN O
Abeta NNP B-NP
( -LRB- O
Abeta42 NNP B-NP
) -RRB- O
is VBZ O
the DT O
first JJ O
species NNS O
to TO O
be VB O
deposited VBN O
in IN O
both DT O
sporadic JJ O
and CC O
familial JJ O
AD. . O

-DOCSTART- X X O

A-tracts NNS O
functioned VBD O
best JJS O
when WRB O
positioned VBN O
close RB O
to TO O
the DT O
-35 NN O
hexamer NN O
rather RB O
than IN O
one CD O
helical JJ O
turn NN O
farther RBR O
upstream RB O
, , O
similar JJ O
to TO O
the DT O
positioning NN O
optimal NN O
for IN O
UP NNP O
element NN O
function NN O
. . O

-DOCSTART- X X O

Raf NNP B-NP
is VBZ O
a DT O
key JJ O
serine-threonine JJ B-NP
protein NN I-NP
kinase NN I-NP
which WDT O
participates VBZ O
in IN O
the DT O
transmission NN O
of IN O
growth NN O
, , O
anti-apoptotic JJ O
and CC O
differentiation JJ O
messages NNS O
. . O

-DOCSTART- X X O

Collagen NNP B-NP
was VBD O
extracted VBN O
from IN O
the DT O
skin NN O
, , O
and CC O
the DT O
lack NN O
of IN O
type NN B-NP
III NNP I-NP
collagen NN I-NP
was VBD O
determined VBN O
by IN O
means NNS O
of IN O
sodium NN O
dodecyl NN O
sulfate-polyacrylamide NN O
gel NN O
electrophoresis NN O
( -LRB- O
SDS-PAGE NN O
) -RRB- O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
During IN O
the DT O
7-year JJ O
period NN O
, , O
10,331 CD O
symptomatic JJ O
duodenal JJ O
ulcer NN O
diseases NNS O
were VBD O
diagnosed VBN O
. . O

-DOCSTART- X X O

In IN O
turn NN O
, , O
assembly NN O
of IN O
this DT O
complex JJ O
mediates NNS O
the DT O
enzymatic JJ O
activation NN O
of IN O
the DT O
p21-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
1 CD I-NP
and CC O
facilitates NNS O
actin IN B-NP
polymerization NN O
. . O

-DOCSTART- X X O

The DT O
tip NN O
of IN O
the DT O
button NN O
caused VBD O
a DT O
perforation NN O
of IN O
the DT O
posterior JJ O
stomach NN O
wall NN O
, , O
leading VBG O
to TO O
death NN O
. . O

-DOCSTART- X X O

Jembrana NNP O
disease NN O
virus NN O
( -LRB- O
JDV NN O
) -RRB- O
is VBZ O
a DT O
newly RB O
identified VBN O
bovine JJ O
lentivirus NN O
that WDT O
is VBZ O
closely RB O
related VBN O
to TO O
the DT O
bovine NN O
immunodeficiency NN O
virus NN O
( -LRB- O
BIV NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Approximately RB O
50 CD O
% NN O
of IN O
the DT O
residues NNS O
are VBP O
conserved VBN O
among IN O
all DT O
three CD O
sequences NNS O
, , O
yet RB O
all DT O
three CD O
viruses NNS O
have VBP O
retained VBN O
response NN O
elements NNS O
for IN O
glucocorticoids NNS O
, , O
two CD O
positionally RB O
conserved VBN O
CCAAT NN O
boxes NNS O
, , O
and CC O
positionally RB O
conserved VBN O
TATA NNP O
boxes NNS O
. . O

-DOCSTART- X X O

Nhp2p NN B-NP
is VBZ O
a DT O
highly RB O
basic JJ O
protein NN O
that WDT O
belongs VBZ O
to TO O
a DT O
family NN O
of IN O
putative JJ O
RNA-binding JJ O
proteins NNS O
. . O

-DOCSTART- X X O

This DT O
study NN O
utilizes VBZ O
the DT O
mammalian JJ O
two-hybrid JJ O
system NN O
to TO O
examine VB O
the DT O
role NN O
of IN O
ligand NN O
in IN O
the DT O
dimerization NN O
of IN O
human JJ B-NP
progesterone NN I-NP
receptor NN I-NP
( -LRB- O
hPR NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

One CD O
of IN O
its PRP$ O
unique JJ O
features NNS O
appears VBZ O
to TO O
be VB O
the DT O
unusually RB O
short JJ O
5'-untranslated JJ O
regions NNS O
( -LRB- O
UTR NN O
) -RRB- O
(1-6 NN O
nucleotides NNS O
( -LRB- O
nts NNS O
) -RRB- O
) -RRB- O
and CC O
the DT O
apparent JJ O
absence NN O
of IN O
5'-cap JJ O
structures NNS O
from IN O
its PRP$ O
mRNAs NNS O
. . O

-DOCSTART- X X O

The DT O
gene NN B-NP
encoding JJ I-NP
human JJ I-NP
tissue-type NN I-NP
plasminogen NN I-NP
activator NN I-NP
(t-PA NN O
) -RRB- O
is VBZ O
regulated VBN O
in IN O
a DT O
cell-type-specific JJ O
manner NN O
. . O

-DOCSTART- X X O

Both DT O
the DT O
presence NN O
of IN O
arginine NN O
and CC O
anaerobiosis NN O
are VBP O
needed VBN O
to TO O
trigger VB O
induction NN O
of IN O
the DT O
pathway NN O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
SHBG NNP I-NP
proximal NN I-NP
promoter NN I-NP
was VBD O
analyzed VBN O
by IN O
DNase NNP B-NP
I PRP I-NP
footprinting VBG O
, , O
and CC O
the DT O
functional JJ O
significance NN O
of IN O
6 CD O
footprinted JJ O
regions NNS O
( -LRB- O
FP1-FP6 NN O
) -RRB- O
within IN O
the DT O
proximal JJ O
promoter NN O
was VBD O
studied VBN O
in IN O
human JJ O
HepG2 IN O
hepatoblastoma NN O
cells NNS O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
translation NN O
and CC O
in IN O
vivo JJ O
polysome JJ O
profile NN O
analysis NN O
indicated VBN O
that IN O
transcripts NNS B-NP
C NNP I-NP
and CC I-NP
E NNP I-NP
were VBD O
translated VBN O
with IN O
similar JJ O
translational JJ O
efficiencies NNS O
that WDT O
are VBP O
substantially RB O
greater JJR O
than IN O
that DT O
of IN O
transcript NN B-NP
D NNP I-NP
, , O
suggesting VBG O
that IN O
5'-untranslated JJ O
regions NNS O
play VBP O
a DT O
role NN O
in IN O
translational JJ O
control NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
introduced VBN O
a DT O
mutation NN O
( -LRB- O
Ser36 NNP O
--> : O
Asn NNP O
) -RRB- O
into IN O
this DT O
domain NN O
of IN O
p190 PRP$ B-NP
that WDT O
decreased VBD O
its PRP$ O
ability NN O
to TO O
bind NN O
guanine IN O
nucleotide JJ O
when WRB O
expressed VBN O
as IN O
a DT O
hemagglutinin FW B-NP
( -LRB- O
HA)-tagged JJ B-NP
protein NN O
in IN O
COS NNP O
cells NNS O
. . O

-DOCSTART- X X O

Wild NNP O
type NN O
HA-p190 NNP B-NP
induced VBD O
a DT O
phenotype NN O
of IN O
rounded JJ O
cells NNS O
with IN O
long JJ O
, , O
beaded VBN O
extensions NNS O
similar JJ O
to TO O
that DT O
seen VBN O
when WRB O
Rho NNP B-NP
function NN O
is VBZ O
disrupted VBN O
by IN O
ADP-ribosylation NNP O
. . O

-DOCSTART- X X O

We PRP O
emphasize VBP O
that DT O
ANCA-associated JJ B-NP
vasculitis NN O
is VBZ O
another DT O
important JJ O
complication NN O
of IN O
RA. NNP O

-DOCSTART- X X O

The DT O
downstream NN O
, , O
TATA-less JJ O
promoter NN O
has VBZ O
high JJ O
G+C JJ O
content NN O
, , O
and CC O
exon JJ O
1b JJ O
predominates NNS O
among IN O
abundantly RB O
expressed VBN O
mRNA JJ O
species NNS O
. . O

-DOCSTART- X X O

Although IN O
we PRP O
predicted VBD O
that IN O
overexpression NN O
of IN O
the DT O
COOH-terminal JJ O
domains NNS O
, , O
which WDT O
were VBD O
thought VBN O
to TO O
be VB O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
SREBP NNP B-NP
processing NN O
, , O
would MD O
result VB O
in IN O
disruption NN O
of IN O
the DT O
SREBP-dependent JJ B-NP
transcriptional JJ O
regulation NN O
of IN O
several JJ O
genes NNS O
, , O
the DT O
mRNA NN O
levels NNS O
for IN O
3-hydroxy-3-methylglutaryl JJ B-NP
coenzyme NN I-NP
A DT I-NP
( -LRB- I-NP
HMG JJ I-NP
CoA NN I-NP
) -RRB- I-NP
synthase NN I-NP
in IN O
these DT O
two CD O
cell NN O
lines NNS O
were VBD O
regulated VBN O
in IN O
a DT O
sterol-dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

Dry NNP O
matter NN O
intake NN O
, , O
apparent JJ O
nutrient JJ O
digestibilities NNS O
, , O
serum NN O
chemistry NN O
profiles NNS O
, , O
sphingolipid JJ O
concentrations NNS O
, , O
and CC O
persistency NN O
of IN O
FB1 NNP O
in IN O
tissues NNS O
were VBD O
evaluated VBN O
. . O

-DOCSTART- X X O

However RB O
, , O
no DT O
studies NNS O
have VBP O
been VBN O
conducted VBN O
to TO O
further RB O
investigate VB O
this DT O
potentially RB O
hazardous JJ O
effect NN O
of IN O
lidocaine NN O
. . O

-DOCSTART- X X O

E. NNP O
, , O
Scott NNP O
, , O
J. NNP O

-DOCSTART- X X O

Yap1p NNP B-NP
is VBZ O
constitutively RB O
nuclear JJ O
in IN O
a DT O
crm1 JJ B-NP
mutant JJ I-NP
, , O
and CC O
Crm1p NNP B-NP
binds NNS O
to TO O
a DT O
nuclear JJ O
export NN O
sequence NN O
( -LRB- O
NES)-like JJ O
sequence NN O
in IN O
Yap1p NNP B-NP
in IN O
the DT O
presence NN O
of IN O
RanGTP. NNP B-NP

-DOCSTART- X X O

Also RB O
, , O
the DT O
amplitude NN O
of IN O
the DT O
oscillatory NN O
potentials NNS O
( -LRB- O
O1+O2+O3+O4 CD O
) -RRB- O
was VBD O
significantly RB O
reduced VBN O
in IN O
the DT O
early JJ O
postoperative JJ O
period NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
RING1 NNP B-NP
overexpression IN O
results NNS O
in IN O
enhanced JJ O
expression NN O
of IN O
the DT O
proto-oncogenes NNS O
c-jun NN B-NP
and CC O
c-fos NNS B-NP
. . O

-DOCSTART- X X O

The DT O
yeast NN O
retrotransposon NN B-NP
Ty5 . I-NP
preferentially RB O
integrates VBZ O
into IN O
regions NNS O
of IN O
silent JJ O
chromatin NN O
. . O

-DOCSTART- X X O

The DT O
loss NN O
of IN O
SKO1 JJ B-NP
completely RB O
restored VBN O
ENA1 NNP B-NP
expression NN O
in IN O
a DT O
hog1 NN B-NP
mutant NN I-NP
and CC O
partially RB O
suppressed VBD O
the DT O
osmotic JJ O
stress NN O
sensitivity NN O
, , O
qualifying VBG O
Sko1p NNP B-NP
as IN O
a DT O
downstream NN O
effector NN O
of IN O
the DT O
HOG NNP B-NP
pathway NN O
. . O

-DOCSTART- X X O

Elevated JJ O
expression NN O
of IN O
a DT O
previously RB O
uncharacterized JJ O
gene NN O
, , O
SPP381 NNP B-NP
, , O
efficiently RB O
suppresses VBZ O
the DT O
growth NN O
and CC O
splicing NN O
defects NNS O
of IN O
a DT O
temperature-sensitive JJ O
( -LRB- O
Ts NN O
) -RRB- O
mutant JJ B-NP
prp38-1 NN I-NP
. . O

-DOCSTART- X X O

The DT O
slower-electrophoretic-mobility JJ O
form NN O
of IN O
p68 NNS B-NP
was VBD O
absent JJ O
in IN O
human JJ O
cells NNS O
in IN O
G1/S NNP O
and CC O
appeared VBD O
as IN O
the DT O
cells NNS O
entered VBN O
G2/M. . O

-DOCSTART- X X O

We PRP O
have VBP O
identified VBN O
amino IN O
acid NN O
sequences NNS O
in IN O
mammalian JJ O
and CC O
Xenopus NNP O
NeuroD1/BETA2 NNP B-NP
that WDT O
are VBP O
necessary JJ O
for IN O
insulin NN B-NP
gene NN I-NP
expression NN O
and CC O
ectopic JJ O
neurogenesis NN O
. . O

-DOCSTART- X X O

Recent JJ O
studies NNS O
have VBP O
suggested VBN O
that IN O
Y319 PRP O
also RB O
positively RB O
regulate VB O
ZAP-70 DT B-NP
function NN O
. . O

-DOCSTART- X X O

Genetic JJ O
and CC O
molecular JJ O
data NNS O
indicate VBP O
that IN O
wild-type JJ B-NP
Pan NNP I-NP
and CC O
CiD NNP B-NP
compete VBP O
for IN O
binding JJ O
to TO O
Arm NNP B-NP
, , O
leading VBG O
to TO O
a DT O
compromised JJ O
transduction NN O
of IN O
the DT O
Wg NNP B-NP
signal NN O
in IN O
heterozygous JJ O
ciD/+ JJ B-NP
animals NNS O
and CC O
to TO O
a DT O
dramatic JJ O
enhancement NN O
of IN O
the DT O
gain-of-function NN O
activity NN O
of IN O
CiD NNP B-NP
in IN O
homozygous JJ O
mutants NNS O
. . O

-DOCSTART- X X O

The DT O
location NN O
of IN O
the DT O
IBS NNP O
within IN O
the DT O
catB NN B-NP
structural JJ I-NP
gene NN I-NP
, , O
the DT O
cooperativity NN O
observed VBD O
in IN O
footprinting JJ O
studies NNS O
and CC O
phasing NN O
studies NNS O
suggest VBP O
that IN O
the DT O
IBS NNP O
participates NNS O
in IN O
the DT O
interaction NN O
of IN O
CatR NNP B-NP
with IN O
the DT O
upstream JJ O
binding NN O
sites NNS O
by IN O
looping VBG O
out RP O
the DT O
intervening NN O
DNA NN O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
transcription NN O
assays RB O
demonstrate VBP O
that IN O
the DT O
TCA-cycle NNP O
intermediate JJ O
, , O
fumarate JJ O
, , O
directly RB O
and CC O
specifically RB O
inhibits VBZ O
the DT O
formation NN O
of IN O
the DT O
clcA NN B-NP
transcript NN I-NP
. . O

-DOCSTART- X X O

Expression NN O
of IN O
p130( JJ B-NP
Cas NNS B-NP
) -RRB- O
( -LRB- O
Cas NNP B-NP
) -RRB- O
, , O
a DT O
major JJ O
binding JJ O
protein NN O
for IN O
the DT O
Crk NNP B-NP
SH2-domain NNP B-NP
, , O
also RB O
induced VBN O
JNK NNP B-NP
activation NN O
, , O
which WDT O
was VBD O
blocked VBN O
by IN O
the DT O
SH2-mutant JJ B-NP
of IN O
Crk NNP B-NP
. . O

-DOCSTART- X X O

The DT O
Og4C3 NNP B-NP
enzyme-linked VBD O
immunosorbent JJ O
assay NN O
( -LRB- O
ELISA NNP O
) -RRB- O
to TO O
detect VB O
circulating VBG O
Wuchereria NNP B-NP
bancrofti NNS I-NP
antigen RB I-NP
uses VBZ O
50 CD O
microL NN O
of IN O
serum NN O
. . O

-DOCSTART- X X O

We PRP O
now RB O
show VBP O
that IN O
gp200-MR6 DT B-NP
ligation NN O
can MD O
also RB O
mimic VB O
IL-4 NN B-NP
and CC O
have VBP O
an DT O
anti-proliferative JJ O
pro-maturational JJ O
influence NN O
within IN O
the DT O
immune JJ O
system NN O
, , O
causing VBG O
up-regulation NN O
of IN O
co-stimulatory JJ O
molecules NNS O
on IN O
B NNP O
lymphocytes NNS O
. . O

-DOCSTART- X X O

Ethylene NNP O
is VBZ O
involved VBN O
in IN O
endosperm NN O
rupture NN O
and CC O
high-level JJ O
betaGLU NN B-NP
I PRP I-NP
expression NN O
; : O
but CC O
, , O
it PRP O
does VBZ O
not RB O
affect VB O
the DT O
spatial JJ O
and CC O
temporal JJ O
pattern NN O
of IN O
betaGLU NN B-NP
I PRP I-NP
expression NN O
. . O

-DOCSTART- X X O

The DT O
divergence NN O
in IN O
primary JJ O
structure NN O
between IN O
the DT O
sheep NN O
CRF1 NNP B-NP
and CC O
the DT O
other JJ O
mammalian JJ B-NP
CRF1s NNP I-NP
is VBZ O
primarily RB O
localized VBN O
to TO O
the DT O
extracellular JJ O
amino IN O
terminal JJ O
domain NN O
of IN O
the DT O
receptor NN O
( -LRB- O
18 CD O
of IN O
22 CD O
divergent NN O
residues NNS O
, , O
ovine JJ O
vs IN O
human JJ B-NP
CRF1 NNP I-NP
) -RRB- O
. . O

-DOCSTART- X X O

Recurrent JJ O
arterial NN O
thrombotic IN O
disease NN O
on IN O
young JJ O
onset NN O
and CC O
protein NN B-NP
S NNP I-NP
deficiency NN O
. . O

-DOCSTART- X X O

We PRP O
showed VBD O
that IN O
Stat3 NNP B-NP
and CC O
Stat3beta NNP B-NP
were VBD O
affinity NN O
purified VBN O
using VBG O
phosphopeptides NNS O
containing VBG O
Y704 NNP O
and CC O
Y744 NNP O
but CC O
not RB O
by IN O
nonphosphorylated JJ O
peptide NN O
analogues NNS O
or CC O
by IN O
phosphopeptides NNS O
containing VBG O
Y729 NNP O
and CC O
Y764 NNP O
. . O

-DOCSTART- X X O

This DT O
c-Jun JJ B-NP
activity NN O
is VBZ O
inhibited VBN O
by IN O
c-Fos NNS B-NP
, , O
another DT O
protooncoprotein NN O
that WDT O
can MD O
dimerize VB O
with IN O
c-Jun JJ B-NP
to TO O
form VB O
the DT O
transcription NN O
factor NN O
AP-1 NN B-NP
. . O

-DOCSTART- X X O

Dorsal NNP O
root NN O
ganglia NN O
neuron-specific JJ O
promoter NN O
activity NN O
of IN O
the DT O
rabbit NN B-NP
beta-galactoside NN I-NP
alpha1,2-fucosyltransferase NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

This DT O
suggests VBZ O
roles NNS O
for IN O
both DT O
the DT O
CE1 NNP O
and CC O
CE2 NNP O
elements NNS O
in IN O
regulating VBG O
Hoxb1 NNP B-NP
gene NN I-NP
expression NN O
during IN O
development NN O
. . O

-DOCSTART- X X O

CAL NNP O
gain NN O
amounted VBD O
to TO O
4.2+/-1.3 CD O
mm CD O
, , O
60 CD O
% NN O
of IN O
the DT O
defects NNS O
showing VBG O
CAL NNP O
gain NN O
> NN O
or CC O
=4 CD O
mm CD O
. . O

-DOCSTART- X X O

However RB O
, , O
there EX O
has VBZ O
not RB O
been VBN O
any DT O
evidence NN O
of IN O
A. NN O
salmonicida NN O
infections NNS O
, , O
specifically RB O
furunculosis NN O
, , O
associated VBN O
with IN O
the DT O
fish NN O
in IN O
this DT O
loch NN O
. . O

-DOCSTART- X X O

Further RB O
, , O
we PRP O
show VBP O
that IN O
this DT O
EIA-inducible JJ B-NP
CBF/cdc2 NN O
is VBZ O
related VBN O
to TO O
the DT O
CBF NN B-NP
which WDT O
was VBD O
shown VBN O
to TO O
activate VB O
the DT O
heat NN B-NP
shock NN I-NP
protein NN I-NP
70 CD I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

The DT O
BAL NNP O
concentrations NNS O
of IN O
the DT O
nine CD O
cytokines NNS O
evaluated VBN O
for IN O
the DT O
more RBR O
and CC O
less RBR O
affected JJ O
lungs NNS O
were VBD O
compared VBN O
: : O
interleukin-6 NN B-NP
( -LRB- O
IL-6 NN B-NP
) -RRB- O
, , O
IL-8 '' B-NP
, , O
IL-12 NN B-NP
, , O
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
( -LRB- O
TNF-alpha NNP B-NP
) -RRB- O
, , O
and CC O
interferon NN B-NP
gamma NN I-NP
( -LRB- O
IFN-gamma NN B-NP
) -RRB- O
showed VBD O
significant JJ O
differences NNS O
( -LRB- O
p NN O
ranged VBD O
between IN O
0. CD O

-DOCSTART- X X O

Phosphorylation NNP O
analyses NNS O
indicated VBD O
that IN O
inhibition NN O
of IN O
ERK-1/2 NNP B-NP
decreased VBD O
okadaic JJ O
acid-elevated JJ O
phosphorylation NN O
of IN O
JunD NNP B-NP
and CC O
FosB. NNP B-NP

-DOCSTART- X X O

The DT O
human NN O
pathogenic NN O
bacterium NN O
group NN O
A DT O
Streptococcus NNP O
produces VBZ O
an DT O
extracellular JJ O
cysteine NN B-NP
protease NN I-NP
[streptococcal JJ O
pyrogenic JJ B-NP
exotoxin NN I-NP
B NNP I-NP
( -LRB- O
SpeB) NNP B-NP
] SYM O
that WDT O
is VBZ O
a DT O
critical JJ O
virulence NN O
factor NN O
for IN O
invasive JJ O
disease NN O
episodes NNS O
. . O

-DOCSTART- X X O

Consistent JJ O
with IN O
these DT O
findings NNS O
, , O
relatively RB O
weak JJ O
transcriptional JJ O
silencing NN O
by IN O
the DT O
native JJ O
VDR NNP B-NP
was VBD O
observed VBN O
using VBG O
the DT O
osteopontin NN B-NP
VDRE. . O

-DOCSTART- X X O

In IN O
PAV-3 NN O
, , O
the DT O
E1A NNP B-NP
region NN I-NP
is VBZ O
located VBN O
between IN O
1.5 CD O
and CC O
3.8 CD O
map NN O
units NNS O
. . O

-DOCSTART- X X O

Six CD O
putative JJ O
MDV NNP O
genome NN O
products NNS O
, , O
including VBG O
one CD O
Rep NNP B-NP
and CC O
five CD O
non-Rep JJ O
proteins NNS O
, , O
show VBP O
high JJ O
( -LRB- O
70.4-90.9 CD O
% NN O
) -RRB- O
amino IN O
acid NN O
identity NN O
to TO O
the DT O
corresponding JJ O
six CD O
FBNYV JJ B-NP
proteins NNS I-NP
, , O
whereas IN O
two CD O
other JJ O
Rep NNP B-NP
proteins NNS I-NP
encoded VBN O
by IN O
MDV-C2 NNP B-NP
and CC O
C3 NNP B-NP
are VBP O
82.3 CD O
% NN O
and CC O
73.0 CD O
% NN O
identical JJ O
to TO O
those DT O
encoded VBN O
by IN O
SCSV-C2 NNP B-NP
and CC O
C6 NNP B-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

MPO NNP B-NP
was VBD O
labeled VBN O
with IN O
1 CD O
mCi NN O
125I CD O
by IN O
a DT O
technique NN O
of IN O
self-labeling NN O
in IN O
the DT O
presence NN O
of IN O
10(-4 CD O
) -RRB- O
M NNP O
hydrogen NN O
peroxide NN O
. . O

-DOCSTART- X X O

The DT O
data NNS O
indicate VBP O
that IN O
Bmp2 PRP B-NP
is VBZ O
directly RB O
regulated VBN O
by IN O
retinoic JJ O
acid-bound NN O
receptors NNS O
and CC O
Sp1 NNP B-NP
. . O

-DOCSTART- X X O

Both DT O
proteins NNS O
were VBD O
shown VBN O
to TO O
be VB O
constitutively RB O
associated VBN O
with IN O
tubulin NN B-NP
. . O

-DOCSTART- X X O

HEED NNP B-NP
was VBD O
found VBN O
to TO O
bind NN O
to TO O
MA NNP B-NP
protein NN I-NP
in IN O
vitro NN O
, , O
as RB O
efficiently RB O
as IN O
in IN O
vivo NN O
in IN O
yeast NN O
cells NNS O
. . O

-DOCSTART- X X O

Fas-resistant JJ B-NP
DT-40 JJ O
lymphoma NN O
B-cells NNS O
rendered VBD O
BTK-deficient JJ B-NP
through IN O
targeted JJ O
disruption NN O
of IN O
the DT O
btk NN B-NP
gene NN I-NP
by IN O
homologous JJ O
recombination NN O
knockout NN O
underwent IN O
apoptosis NN O
after IN O
Fas NNP B-NP
ligation NN O
, , O
but CC O
wild-type JJ O
DT-40 JJ O
cells NNS O
or CC O
BTK-deficient JJ B-NP
DT-40 JJ O
cells NNS O
reconstituted VBN O
with IN O
wild-type JJ B-NP
human JJ I-NP
btk NN I-NP
gene NN I-NP
did VBD O
not RB O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
in IN O
order NN O
to TO O
search VB O
for IN O
the DT O
latent JJ O
genes NNS O
, , O
we PRP O
used VBD O
allotype-specific JJ O
oligonucleotides NNS O
for IN O
b5 CD O
, , O
b6 CD O
and CC O
b9 CD O
to TO O
probe VB O
DNAs NNP O
from IN O
both DT O
normal JJ O
and CC O
T. NNP O
brucei-infected VBD O
rabbits NNS O
by IN O
Southern JJ O
blotting NN O
. . O

-DOCSTART- X X O

TRAF2 NN B-NP
is VBZ O
known VBN O
to TO O
associate VB O
with IN O
TRADD NNP B-NP
, , O
and CC O
expression NN O
of IN O
a DT O
dominant-negative JJ O
N-terminal JJ O
deletion NN O
TRAF2 NN B-NP
mutant NN I-NP
was VBD O
found VBN O
to TO O
partially RB O
inhibit VB O
LMP1-induced JJ B-NP
JNK NNP B-NP
activation NN O
in IN O
293 CD O
cells NNS O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
transiently VBZ O
transfected VBN O
cells NNS O
expressing VBG O
EBNA-3 JJ B-NP
revealed VBD O
a DT O
sixfold JJ O
increase NN O
in IN O
EBNA-3 JJ B-NP
protein NN I-NP
expression NN O
from IN O
the DT O
genomic JJ O
EBNA-3 JJ B-NP
gene NN I-NP
compared VBN O
to TO O
EBNA-3 JJ B-NP
cDNA NN I-NP
. . O

-DOCSTART- X X O

However RB O
, , O
serial JJ O
passages NNS O
of IN O
fetal NN O
lamb NN O
kidney NN O
( -LRB- O
FLK) NN O
cells NNS O
, , O
which WDT O
are VBP O
sensitive JJ O
to TO O
infection NN O
with IN O
BLV NNP O
, , O
after IN O
transient JJ O
transfection NN O
revealed VBD O
that IN O
mutation NN O
of IN O
a DT O
second JJ O
tyrosine NN O
residue NN O
in IN O
the DT O
N-terminal JJ O
motif NN O
completely RB O
prevented VBD O
the DT O
propagation NN O
of IN O
the DT O
virus NN O
. . O

-DOCSTART- X X O

Varicella-zoster JJ B-NP
virus NN I-NP
( -LRB- I-NP
VZV NN I-NP
) -RRB- I-NP
glycoprotein NN I-NP
gI NN I-NP
is VBZ O
a DT O
type NN B-NP
1 CD I-NP
transmembrane NN I-NP
glycoprotein NN I-NP
which WDT O
is VBZ O
one CD O
component NN O
of IN O
the DT O
heterodimeric JJ O
gE:gI NN B-NP
Fc NN B-NP
receptor NN I-NP
complex NN O
. . O

-DOCSTART- X X O

These DT O
genes NNS O
were VBD O
expressed VBN O
in IN O
a DT O
Saccharomyces NNP O
cerevisiae NN O
mutant NN O
in IN O
which WDT O
the DT O
endogenous JJ B-NP
ferrochelatase NN I-NP
gene NN I-NP
( -LRB- O
HEM15 CD B-NP
) -RRB- O
had VBD O
been VBN O
deleted VBN O
, , O
and CC O
the DT O
phenotypes NNS O
of IN O
the DT O
transformants NNS O
were VBD O
characterized VBN O
. . O

-DOCSTART- X X O

In IN O
the DT O
second JJ O
experiment NN O
, , O
a DT O
stable JJ O
nickel NN O
isotope NN O
, , O
61Ni CD O
, , O
was VBD O
given VBN O
in RP O
drinking NN O
water NN O
to TO O
20 CD O
nickel-sensitized JJ O
women NNS O
and CC O
20 CD O
age-matched JJ O
controls NNS O
, , O
both DT O
groups NNS O
having VBG O
vesicular JJ O
hand NN O
eczema NN O
of IN O
the DT O
pompholyx NN O
type NN O
. . O

-DOCSTART- X X O

Folded VBN O
tissue NN O
and CC O
crimped VBD O
collagen NN B-NP
fibers NNS O
in IN O
the DT O
tunica NN O
albuginea NN O
permit VBP O
its PRP$ O
expansion NN O
during IN O
erection NN O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
the DT O
sequences NNS O
of IN O
attP NN B-NP
, , O
attB NN B-NP
and CC O
bacteria-prophage JJ O
junctions NNS O
attL . B-NP
and CC O
attR PRP B-NP
showed VBD O
a DT O
26 CD O
bp NN O
common JJ O
core NN O
sequence NN O
, , O
where WRB O
recombination NN O
takes VBZ O
place NN O
, , O
near IN O
the DT O
5' JJ O
end NN O
of IN O
the DT O
integrase NN B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Immunological NNP O
testing NN O
was VBD O
performed VBN O
on IN O
all DT O
brewery NN O
workers NNS O
and CC O
some DT O
control NN O
volunteers NNS O
using VBG O
skin NN O
prick NN O
testing NN O
with IN O
hops NN O
, , O
barley NN O
, , O
and CC O
yeast NN O
antigens NNS O
as RB O
well RB O
as IN O
other JJ O
nonoccupational JJ O
allergens NNS O
, , O
and CC O
by IN O
determining VBG O
total JJ O
serum NN B-NP
IgE NN I-NP
levels NNS O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
To TO O
evaluate VB O
the DT O
accuracy NN O
of IN O
working VBG O
casts NNS O
for IN O
crown NN O
and CC O
bridge NN O
restorations NNS O
made VBD O
from IN O
twin JJ O
mix NN O
putty/wash NN O
silicone NN O
elastomeric JJ O
impression NN O
materials NNS O
using VBG O
different JJ O
types NNS O
of IN O
stock NN O
tray NN O
. . O

-DOCSTART- X X O

OBJECTIVES NNP O
: : O
To TO O
assess VB O
the DT O
ability NN O
of IN O
pretreatment NN O
and CC O
post-treatment NN O
prostate-specific JJ B-NP
antigen NN I-NP
( -LRB- O
PSA NNP B-NP
) -RRB- O
measurements NNS O
, , O
clinical JJ O
tumor NN O
stage NN O
, , O
tumor NN O
grade NN O
, , O
Gleason NNP O
sum NN O
, , O
race NN O
, , O
age NN O
, , O
and CC O
radiation NN O
dose NN O
to TO O
predict VB O
the DT O
recurrence NN O
of IN O
prostate NN O
cancer NN O
following JJ O
external JJ O
beam NN O
radiation NN O
therapy NN O
(XRT NN O
) -RRB- O
since IN O
the DT O
introduction NN O
of IN O
PSA NNP B-NP
as IN O
a DT O
tumor NN O
marker NN O
at IN O
one CD O
tertiary NN O
care NN O
center NN O
. . O

-DOCSTART- X X O

To TO O
evaluate VB O
whether IN O
the DT O
human JJ O
gene NN O
is VBZ O
also RB O
a DT O
target NN O
of IN O
thyroid NN O
hormone NN O
we PRP O
have VBP O
searched VBN O
for IN O
T3-responsive JJ O
elements NNS O
in IN O
NRGN NNP B-NP
cloned VBD O
genomic JJ O
fragments NNS O
spanning VBG O
the DT O
whole JJ O
gene NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Diazepam NNP O
, , O
one CD O
of IN O
the DT O
benzodiazepine JJ O
group NN O
of IN O
tranquilizers NNS O
, , O
is VBZ O
used VBN O
as IN O
an DT O
adjunctive JJ O
drug NN O
for IN O
sedation NN O
and CC O
for IN O
relief NN O
of IN O
anxiety NN O
in IN O
the DT O
treatment NN O
of IN O
epilepsy NN O
. . O

-DOCSTART- X X O

Bioplastique NNP O
granuloma NN O
presents NNS O
with IN O
irregularly RB O
shaped VBN O
cystic JJ O
spaces NNS O
of IN O
varying VBG O
size NN O
containing VBG O
jagged JJ O
, , O
translucent JJ O
, , O
nonbirefringent JJ O
foreign JJ O
bodies NNS O
whereas IN O
Artecoll NNP O
granuloma NN O
shows VBZ O
numerous JJ O
round JJ O
vacuoles NNS O
nearly RB O
identical JJ O
in IN O
size NN O
and CC O
shape NN O
enclosing NN O
round NN O
and CC O
sharply RB O
circumscribed VBD O
, , O
translucent JJ O
, , O
nonbirefringent JJ O
foreign JJ O
bodies NNS O
. . O

-DOCSTART- X X O

This DT O
Tbx6-subfamily NNP B-NP
gene NN I-NP
is VBZ O
likely JJ O
to TO O
participate VB O
in IN O
paraxial JJ O
mesoderm NN O
formation NN O
and CC O
somitogenesis NN O
in IN O
human JJ O
embryo NN O
. . O

-DOCSTART- X X O

Structure-function JJ O
analysis NN O
of IN O
the DT O
Z-DNA-binding JJ O
domain NN O
Zalpha NNP O
of IN O
dsRNA NN B-NP
adenosine NN I-NP
deaminase NN I-NP
type NN I-NP
I PRP I-NP
reveals VBZ O
similarity NN O
to TO O
the DT O
( -LRB- B-NP
alpha NN I-NP
+ JJ I-NP
beta NN I-NP
) -RRB- I-NP
family NN I-NP
of IN O
helix-turn-helix NN B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Carbohydrates NNP O
and CC O
glycoconjugates NNS O
biophysical JJ O
methods NNS O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
of IN O
mouse NN B-NP
glycolate NN I-NP
oxidase NN I-NP
. . O

-DOCSTART- X X O

In IN O
such JJ O
a DT O
manner NN O
, , O
activated VBN O
PKR NNP B-NP
inhibits VBZ O
cell NN O
growth NN O
and CC O
induces VBZ O
apoptosis NN O
, , O
whereas IN O
disruption NN O
of IN O
normal JJ O
PKR NN B-NP
signaling VBG O
results NNS O
in IN O
unregulated JJ O
cell NN O
growth NN O
. . O

-DOCSTART- X X O

We PRP O
isolated VBD O
a DT O
ribosomal JJ B-NP
protein NN I-NP
L18 . I-NP
by IN O
interaction NN O
with IN O
PKR NNP B-NP
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
rhoA-mediated JJ B-NP
SRE NNP O
activation NN O
was VBD O
blocked VBN O
by IN O
dominant JJ O
negative JJ O
mutants NNS O
of IN O
PKC-alpha NNP B-NP
or CC O
PKC-epsilon NNP B-NP
. . O

-DOCSTART- X X O

Overexpression IN O
of IN O
PTTG NNP B-NP
in IN O
transfected JJ O
NIH NNP O
3T3 CD O
cells NNS O
also RB O
stimulated VBD O
expression NN O
and CC O
secretion NN O
of IN O
basic JJ B-NP
fibroblast JJ I-NP
growth NN I-NP
factor NN I-NP
, , O
a DT O
human JJ B-NP
pituitary NN I-NP
tumor NN I-NP
growth-regulating JJ I-NP
factor NN I-NP
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
demonstrated VBD O
the DT O
ubiquitous JJ O
expression NN O
of IN O
2.9 CD O
kb NN O
and CC O
3. CD O

-DOCSTART- X X O

Induction NN O
of IN O
anaesthesia NN O
was VBD O
standardised VBN O
: : O
fentanyl NN O
( -LRB- O
3 CD O
micrograms/kg NN O
) -RRB- O
, , O
thiopentone NN O
( -LRB- O
5 CD O
mg/kg NN O
) -RRB- O
, , O
atracurium FW O
( -LRB- O
0.4 CD O
mg/kg NN O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
comparison NN O
of IN O
the DT O
clinical JJ O
profile NN O
of IN O
cavernous JJ O
malformations NNS O
with IN O
and CC O
without IN O
associated VBN O
venous JJ O
malformations NNS O
. . O

-DOCSTART- X X O

Magnetically RB O
induced JJ O
optical JJ O
self-pulsing NN O
in IN O
a DT O
nonlinear JJ O
resonator NN O
. . O

-DOCSTART- X X O

Wave NNP O
cybernetics NNS O
: : O
A DT O
simple JJ O
model NN O
of IN O
wave-controlled JJ O
nonlinear JJ O
and CC O
nonlocal JJ O
cooperative JJ O
phenomena NNS O
. . O

-DOCSTART- X X O

Autoionization NN O
rates NNS O
and CC O
energy NN O
levels NNS O
of IN O
triplet NN O
nf NN O
, , O
v=1 VBD O
Rydberg NNP O
states NNS O
of IN O
H2 NNP O
. . O

-DOCSTART- X X O

Next JJ O
, , O
to TO O
identify VB O
regions NNS O
of IN O
the DT O
promoter NN O
involved VBN O
, , O
we PRP O
examined VBD O
a DT O
series NN O
of IN O
tenascin-C JJ B-NP
promoter NN I-NP
constructs NNS I-NP
with IN O
5' JJ O
deletions NNS O
and CC O
showed VBD O
that IN O
denatured VBD O
collagen-dependent JJ B-NP
promoter NN I-NP
activity NN O
was VBD O
retained VBN O
by IN O
a DT O
122-base JJ O
pair NN O
element NN O
, , O
located VBN O
-43 JJ O
to TO O
-165 DT O
bp NN O
upstream RB O
of IN O
the DT O
RNA NNP O
start NN O
site NN O
. . O

-DOCSTART- X X O

Nuclear NNP B-NP
factor NN I-NP
kappa NN I-NP
B NNP I-NP
( -LRB- O
NF-kappaB NN B-NP
) -RRB- O
is VBZ O
an DT O
important JJ O
transcription NN O
factor NN O
for IN O
the DT O
genes NNS O
of IN O
many JJ O
pro-inflammatory JJ O
proteins NNS O
and CC O
is VBZ O
strongly RB O
activated VBN O
by IN O
the DT O
cytokines NNS O
interleukin-1 NN B-NP
and CC O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
( -LRB- I-NP
TNF)alpha NNP I-NP
under IN O
various JJ O
pathological JJ O
conditions NNS O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
this DT O
enhancement NN O
of IN O
transcriptional JJ O
activation NN O
by IN O
COUP-TFI NNP B-NP
requires VBZ O
specifically RB O
the DT O
AF-1 JJ O
transactivation NN O
function NN O
of IN O
ER NNP B-NP
and CC O
can MD O
be VB O
observed VBN O
in IN O
the DT O
presence NN O
of IN O
E2 NNP O
or CC O
4-hydroxytamoxifen JJ O
but CC O
not RB O
ICI NNP O
164384 CD O
. . O

-DOCSTART- X X O

Recombinant NNP B-NP
Ffh NNP I-NP
has VBZ O
a DT O
melting VBG O
point NN O
of IN O
tm NN O
= SYM O
89 CD O
degreesC. . O

-DOCSTART- X X O

Unilateral NNP O
naris NN O
occlusion NN O
and CC O
the DT O
rat NN O
accessory JJ O
olfactory JJ O
bulb NN O
. . O

-DOCSTART- X X O

This DT O
region NN O
of IN O
hsp90 PRP$ B-NP
mediates NNS O
ATP-independent JJ O
chaperone NN O
activity NN O
, , O
overlaps VBZ O
the DT O
hsp90 NN B-NP
dimerization NN I-NP
domain NN I-NP
, , O
and CC O
includes VBZ O
structural JJ O
elements NNS O
important JJ O
for IN O
steroid NN B-NP
receptor NN I-NP
interaction NN O
. . O

-DOCSTART- X X O

The DT O
promoter NN O
of IN O
the DT O
rat NN O
pgp2/mdr1b NN B-NP
gene NN O
has VBZ O
a DT O
GC-rich JJ O
region NN O
( -LRB- O
pgp2GC NN B-NP
) -RRB- O
that WDT O
is VBZ O
highly RB O
conserved VBN O
in IN O
mdr JJ B-NP
genes NNS I-NP
and CC O
contains VBZ O
an DT O
consensus NN O
Sp1 IN B-NP
site NN I-NP
. . O

-DOCSTART- X X O

Sp1 NNP B-NP
's POS O
role NN O
in IN O
transactivation NN O
of IN O
the DT O
pgp2/mdr1b NN B-NP
promoter NN O
was VBD O
tested VBN O
in IN O
Drosophila NNP O
Schneider NNP O
cells NNS O
. . O

-DOCSTART- X X O

Measurements NNS O
included VBD O
bone NN O
mineral NN O
density NN O
of IN O
the DT O
lumbar NN O
spine NN O
and CC O
proximal JJ O
femur NN O
( -LRB- O
by IN O
dual-energy JJ O
X-ray NN O
absorptiometry NN O
) -RRB- O
and CC O
biochemical JJ O
markers NNS O
of IN O
bone NN O
remodeling VBG O
( -LRB- O
serum NN O
bone-specific JJ O
alkaline NN B-NP
phosphatase NN I-NP
by IN O
immunoassay NN O
and CC O
urine NN O
deoxypyridinoline NN O
by IN O
high-pressure JJ O
liquid JJ O
chromatography NN O
) -RRB- O
. . O

-DOCSTART- X X O

Human JJ B-NP
MGP NNP I-NP
is VBZ O
a DT O
10-kD JJ B-NP
skeletal NN I-NP
extracellular JJ I-NP
matrix NN I-NP
(ECM) JJ I-NP
protein NN I-NP
that WDT O
consists VBZ O
of IN O
an DT O
84-aa JJ O
mature JJ O
protein NN O
and CC O
a DT O
19-aa JJ O
transmembrane NN O
signal NN O
peptide NN O
. . O

-DOCSTART- X X O

Dual JJ O
roles NNS O
of IN O
p82 NN B-NP
, , O
the DT O
clam NN O
CPEB NNP B-NP
homolog NN I-NP
, , O
in IN O
cytoplasmic JJ O
polyadenylation NN O
and CC O
translational JJ O
masking NN O
. . O

-DOCSTART- X X O

The DT O
RNA NNP B-NP
polymerase NN I-NP
III-recruiting NNP I-NP
factor NN I-NP
TFIIIB NNP I-NP
induces VBZ O
a DT O
DNA NN O
bend NN O
between IN O
the DT O
TATA NNP O
box NN O
and CC O
the DT O
transcriptional JJ O
start NN O
site NN O
. . O

-DOCSTART- X X O

The DT O
pattern NN O
of IN O
RNase NNP B-NP
E NNP I-NP
digestion NN O
of IN O
finP305 CD B-NP
RNA NNP I-NP
differed VBD O
from IN O
FinP NNP B-NP
, , O
and CC O
GST-FinO NNP B-NP
did VBD O
not RB O
protect VB O
finP305 DT B-NP
RNA NNP I-NP
from IN O
cleavage NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
hematopoietic JJ B-NP
growth NN I-NP
factor NN I-NP
prescriptions NNS O
in IN O
19 CD O
french NN O
cancer NN O
centers NNS O

-DOCSTART- X X O

In IN O
the DT O
second JJ O
case NN O
, , O
an DT O
epidermal JJ O
cyst NN O
was VBD O
diagnosed VBN O
. . O

-DOCSTART- X X O

MotA NNP B-NP
also RB O
binds VBZ O
a DT O
DNA NN O
sequence NN O
( -LRB- O
a DT O
MotA NN B-NP
box NN I-NP
) -RRB- O
, , O
centered VBN O
at IN O
position NN O
-30 '' O
. . O

-DOCSTART- X X O

The DT O
S229A JJ O
variant NN O
can MD O
better RB O
flip VB O
modified VBN O
bases NNS O
but CC O
does VBZ O
not RB O
tightly RB O
lock VB O
the DT O
flipped JJ O
base NN O
into IN O
the DT O
adenine-binding JJ O
pocket NN O
, , O
suggesting VBG O
that IN O
Ser229 PRP O
could MD O
form VB O
a DT O
contact NN O
to TO O
the DT O
flipped JJ O
adenine NN O
. . O

-DOCSTART- X X O

The DT O
high JJ O
conservation NN O
of IN O
the DT O
3' JJ O
terminus NN O
suggests VBZ O
that IN O
this DT O
region NN O
directs VBZ O
the DT O
assembly NN O
of IN O
proteins NNS O
required VBN O
for IN O
the DT O
initiation NN O
of IN O
RNA NNP O
replication NN O
. . O

-DOCSTART- X X O

All DT O
stimulations NNS O
were VBD O
down-regulated JJ O
with IN O
GnRH-a NNP B-NP
commenced VBD O
on IN O
day NN O
21 CD O
in IN O
a DT O
long JJ O
protocol NN O
before IN O
gonadotropin NNP B-NP
stimulation NN O
. . O

-DOCSTART- X X O

Chem NNP O
. . O

-DOCSTART- X X O

No DT O
significant JJ O
differences NNS O
between IN O
the DT O
substituted VBN O
and CC O
wild JJ O
type NN O
peptides NNS O
were VBD O
observed VBN O
, , O
suggesting VBG O
that IN O
this DT O
substitution NN O
in IN O
the DT O
intact JJ O
protein NN O
may MD O
cause VB O
disruption NN O
of IN O
global JJ O
rather RB O
than IN O
local JJ O
structures NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
C3 DT B-NP
toxin NN I-NP
alone RB O
or CC O
in IN O
combination NN O
with IN O
growth NN O
factors NNS O
did VBD O
not RB O
stimulate VB O
AP-1:Luc JJ B-NP
activity NN O
and CC O
actually RB O
antagonized VBD O
the DT O
synergistic JJ O
activation NN O
of IN O
AP-1:Luc NNP B-NP
observed VBD O
in IN O
response NN O
to TO O
co-stimulation NN O
with IN O
growth NN O
factors NNS O
and CC O
Ro-31-8220 NNP O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
intraoperative JJ O
echocardiography NN O
in IN O
surgery NN O
of IN O
the DT O
heart NN O
and CC O
large JJ O
vessels NNS O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
our PRP$ O
results NNS O
demonstrate VBP O
that IN O
CAP1 NNP B-NP
is VBZ O
involved VBN O
in IN O
multidrug JJ O
resistance NN O
and CC O
oxidative VBP O
stress NN O
response NN O
in IN O
C. NNP O
albicans NNS O
. . O

-DOCSTART- X X O

The DT O
RMRI NNP O
was VBD O
tested VBN O
for IN O
interrater NN O
reliability NN O
using VBG O
three CD O
simulated JJ O
and CC O
10 CD O
actual JJ O
patients NNS O
. . O

-DOCSTART- X X O

Pokeweed NNP B-NP
antiviral JJ I-NP
protein NN I-NP
( -LRB- O
PAP NN B-NP
) -RRB- O
from IN O
Phytolacca NNP O
americana NNS O
is VBZ O
a DT O
highly RB O
specific JJ O
N-glycosidase NN B-NP
removing VBG O
adenine JJ O
residues NNS O
( -LRB- O
A4324 NNP O
in IN O
28S NNP B-NP
rRNA NNP I-NP
and CC O
A2660 NNP O
in IN O
23S JJ B-NP
rRNA NN I-NP
) -RRB- O
from IN O
intact JJ O
ribosomes NNS O
of IN O
both DT O
eukaryotes NNS O
and CC O
prokaryotes NNS O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
This DT O
meta-analysis NN O
of IN O
67 CD O
controlled JJ O
trials NNS O
was VBD O
performed VBN O
to TO O
quantify VB O
the DT O
cholesterol-lowering JJ O
effect NN O
of IN O
major JJ O
dietary NN O
fibers NNS O
. . O

-DOCSTART- X X O

The DT O
3.3-fold NN O
higher JJR O
expression NN O
in IN O
the DT O
fetal NN O
heart NN O
than IN O
in IN O
the DT O
adult NN O
heart NN O
suggests VBZ O
that IN O
HFHZ NNP B-NP
mRNA NN I-NP
is VBZ O
downregulated JJ O
in IN O
the DT O
process NN O
of IN O
development NN O
. . O

-DOCSTART- X X O

When WRB O
the DT O
high JJ O
affinity NN O
hnRNP NNS B-NP
A1 IN I-NP
binding JJ I-NP
site NN I-NP
was VBD O
inserted VBN O
into IN O
the DT O
beta-globin JJ B-NP
reporter NN I-NP
, , O
Rev NNP B-NP
was VBD O
able JJ O
to TO O
increase VB O
the DT O
cytoplasmic JJ O
levels NNS O
of IN O
unspliced JJ O
mRNAs NNS O
to TO O
14 CD O
% NN O
. . O

-DOCSTART- X X O

To TO O
date NN O
, , O
two CD O
such JJ O
proteins NNS O
, , O
PLZF NNP B-NP
and CC O
LAZ-3/BCL-6 NNP B-NP
, , O
have VBP O
been VBN O
implicated VBN O
in IN O
oncogenesis NN O
. . O

-DOCSTART- X X O

Overexpression NNP O
of IN O
POG1 NNP B-NP
inhibits VBZ O
alpha-factor-induced DT B-NP
G1 NNP O
arrest NN O
and CC O
transcriptional JJ O
repression NN O
of IN O
the DT O
CLN1 NN B-NP
and CC O
CLN2 NN B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

We PRP O
now RB O
show VBP O
that IN O
RNU2 DT B-NP
fragility NN O
can MD O
be VB O
induced VBN O
by IN O
transfection NN O
with IN O
an DT O
expression NN O
vector NN O
encoding VBG O
Ad12 NNP B-NP
E1B NNP I-NP
55 CD O
kDa NN O
alone RB O
but CC O
not RB O
by IN O
an DT O
E1 NNP B-NP
vector NN O
encoding VBG O
all DT O
E1 JJ B-NP
products NNS I-NP
( -LRB- O
3 CD O
E1A JJ B-NP
proteins NNS I-NP
, , O
as RB O
well RB O
as IN O
the DT O
E1B NNP B-NP
19 CD O
kDa NN O
and CC O
55 CD O
kDa JJ O
proteins NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Competitionsupershift NNP O
EMSA NNP O
assays VBZ O
revealed VBN O
that IN O
multiple JJ O
proteins NNS O
were VBD O
involved VBN O
in IN O
bandshift NN O
complex NN O
formation NN O
with IN O
KCS NNP B-NP
, , O
one CD O
of IN O
which WDT O
was VBD O
identified VBN O
as IN O
factor NN O
Sp1 NNP O
. . O

-DOCSTART- X X O

Experiments NNS O
on IN O
narcotized JJ O
cats NNS O
demonstrated VBD O
that IN O
the DT O
derivatives NNS O
of IN O
2-mercaptobenzimidazole JJ O
possessing VBG O
the DT O
properties NNS O
of IN O
specific JJ O
bradycardic JJ O
agents NNS O
and CC O
coded VBD O
as IN O
CM-251 NNP O
, , O
CM-266 NNP O
, , O
and CC O
CM-345 NNP O
, , O
reduce VB O
the DT O
mean JJ O
rise NN O
of IN O
segment NN O
ST NNS O
on IN O
numerous JJ O
leads NNS O
of IN O
the DT O
epicardial JJ O
electrogram NN O
during IN O
5-min JJ O
occlusion NN O
of IN O
the DT O
anterior JJ O
descending VBG O
branch NN O
of IN O
the DT O
left JJ O
coronary JJ O
artery NN O
. . O

-DOCSTART- X X O

Neither CC O
the DT O
p42/44 NN B-NP
nor CC O
the DT O
JNK NNP B-NP
pathway NN O
was VBD O
involved VBN O
in IN O
the DT O
action NN O
of IN O
IL-1beta NNP B-NP
. . O

-DOCSTART- X X O

In IN O
protocol NN O
2 CD O
, , O
eight CD O
different JJ O
subjects NNS O
performed VBN O
Con NNP O
and CC O
Ecc NNP O
arm NN O
curls NNS O
to TO O
fatigue NN O
, , O
followed VBN O
by IN O
postexercise JJ O
muscle NN O
ischemia NN O
, , O
by IN O
using VBG O
the DT O
same JJ O
resistance NN O
as IN O
in IN O
protocol NN O
1 CD O
. . O

-DOCSTART- X X O

Airflow NN O
was VBD O
measured VBN O
with IN O
a DT O
custom-designed JJ O
turbine NN O
and CC O
a DT O
45-ft.-long JJ O
cable NN O
to TO O
reach VB O
the DT O
volume-measuring NN O
module NN O
. . O

-DOCSTART- X X O

Both DT O
mutations NNS O
confer VBP O
amino IN O
acid NN O
substitutions NNS O
in IN O
the DT O
viral JJ B-NP
coat NN I-NP
protein NN I-NP
but CC O
differ VBP O
in IN O
their PRP$ O
relative JJ O
abilities NNS O
to TO O
utilize VB O
the DT O
foreign JJ O
scaffolding JJ B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Although IN O
both DT O
transcripts NNS O
share VBP O
the DT O
first JJ O
nine CD O
exons NNS O
, , O
exon JJ O
10 CD O
of IN O
ZIS-2 NN B-NP
is VBZ O
lacking VBG O
in IN O
ZIS-1 NNP B-NP
, , O
and CC O
instead RB O
, , O
exon NN O
11 CD O
( -LRB- O
10th JJ O
exon NN O
) -RRB- O
of IN O
ZIS-1 NN B-NP
is VBZ O
larger JJR O
in IN O
size NN O
, , O
leading VBG O
to TO O
the DT O
longer RBR O
3'-UTR. . O

-DOCSTART- X X O

Expression NN O
of IN O
the DT O
second JJ O
gene NN O
(XT3 NN O
) -RRB- O
was VBD O
found VBN O
to TO O
be VB O
conserved VBN O
in IN O
human JJ O
kidney NN O
, , O
and CC O
partial JJ O
sequence NN O
was VBD O
obtained VBN O
from IN O
a DT O
human JJ O
cDNA NN O
library NN O
. . O

-DOCSTART- X X O

IFN-gamma NNP B-NP
was VBD O
elevated VBN O
during IN O
active JJ O
TB NN O
when WRB O
compared VBN O
with IN O
healthy JJ O
controls NNS O
, , O
declining VBG O
during IN O
and CC O
after IN O
treatment NN O
. . O

-DOCSTART- X X O

The DT O
missing VBG O
5' JJ O
sequences NNS O
were VBD O
obtained VBN O
by IN O
5'-rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends NNS O
and CC O
by IN O
analysis NN O
of IN O
an DT O
NHE5 NNP B-NP
genomic JJ I-NP
clone NN I-NP
, , O
and CC O
the DT O
missing VBG O
3' JJ O
sequences NNS O
were VBD O
obtained VBN O
by IN O
3'-rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends NNS O
. . O

-DOCSTART- X X O

This DT O
dependence NN O
, , O
however RB O
, , O
can MD O
be VB O
overcome VBN O
to TO O
a DT O
large JJ O
extent NN O
by IN O
dividing VBG O
min NN O
LVdP/dt NN O
by IN O
mean JJ O
aortic JJ O
pressure NN O
. . O

-DOCSTART- X X O

Genoa NNP O
, , O
Italy NNP O
, , O
24-28 CD O
August NNP O
1997 CD O
. . O

-DOCSTART- X X O

Electronic JJ O
structure NN O
of IN O
delta JJ O
-plutonium NN O
and CC O
of IN O
single JJ O
Al NNP O
, , O
Ga NNP O
, , O
and CC O
Sc NNP O
impurities NNS O
in IN O
delta JJ O
-plutonium NN O
. . O

-DOCSTART- X X O

Bound-exciton NNP O
transfer NN O
and CC O
photoluminescence NN O
undulation NN O
spectra NN O
for IN O
acceptors NNS O
in IN O
ZnTe NNP O
. . O

-DOCSTART- X X O

Internal NNP O
modes NNS O
of IN O
a DT O
soliton NN O
. . O

-DOCSTART- X X O

( -LRB- O
2 CD O
) -RRB- O
Erythroid NNP O
32D NNP O
Epo1 NNP B-NP
cells NNS O
showed VBD O
a DT O
lower JJR O
level NN O
of IN O
bulk NN O
PKC NNP B-NP
catalytic JJ O
activity NN O
, , O
lacked VBD O
the DT O
expression NN O
of IN O
epsilon NN B-NP
and CC I-NP
eta NN I-NP
PKC NNP I-NP
isoforms VBZ I-NP
, , O
and CC O
showed VBD O
a DT O
weak JJ O
or CC O
absent JJ O
upregulation NN O
of IN O
the DT O
remaining VBG O
isoforms NNS O
, , O
except IN O
betaI RB B-NP
, , O
upon IN O
readdition NN O
of IN O
Epo NNP B-NP
to TO O
growth VB O
factor-starved JJ O
cells NNS O
. . O

-DOCSTART- X X O

We PRP O
used VBD O
expression NN O
cloning VBG O
to TO O
identify VB O
interleukin-6 NN B-NP
( -LRB- O
IL-6 NN B-NP
) -RRB- O
as IN O
one CD O
factor NN O
that WDT O
suppressed VBD O
growth NN O
of IN O
a DT O
pre-B-cell JJ O
variant JJ O
line NN O
, , O
1A9-M. . O

-DOCSTART- X X O

Airflow NN O
through IN O
the DT O
dust NN O
trap NN O
was VBD O
controlled VBN O
with IN O
a DT O
vacuum NN O
pump NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
in IN O
normal JJ O
intestinal JJ O
epithelial JJ O
goblet NN O
cells NNS O
, , O
TbetaRI NNP B-NP
and CC O
TbetaRII NNP B-NP
can MD O
respond VB O
to TO O
autocrine NN O
but CC O
not RB O
exogenous JJ O
TGF-beta NN B-NP
without IN O
the DT O
participation NN O
of IN O
TbetaRIII NN B-NP
. . O

-DOCSTART- X X O

The DT O
odds NNS O
ratio NN O
for IN O
CHD NNP O
was VBD O
1.21 CD O
(95 CD O
% NN O
confidence NN O
interval NN O
, , O
0.84-1.75 CD O
) -RRB- O
given VBN O
a DT O
positive JJ O
serostatus NN O
of IN O
specific JJ O
IgG NNP B-NP
antibodies NNS O
after IN O
adjustment NN O
for IN O
covariates NNS O
. . O

-DOCSTART- X X O

Another DT O
group NN O
of IN O
HIPP- NNP O
and CC O
HCX-lesioned JJ O
animals NNS O
trained VBN O
on IN O
the DT O
tasks NNS O
after IN O
the DT O
lesion NN O
showed VBD O
reduced VBN O
impairments NNS O
of IN O
the DT O
type NN O
described VBN O
above RB O
, , O
suggesting VBG O
that IN O
extrahippocampal JJ O
structures NNS O
trained VBN O
after IN O
the DT O
lesion NN O
can MD O
assume VB O
the DT O
role NN O
of IN O
the DT O
hippocampus NN O
to TO O
some DT O
degree NN O
. . O

-DOCSTART- X X O

The DT O
case NN O
for IN O
neutrinos NNS O
from IN O
SN NNP O
1987A. . O

-DOCSTART- X X O

Scaling NNP O
of IN O
fluctuations NNS O
in IN O
one-dimensional JJ O
interface NN O
and CC O
hopping VBG O
models NNS O
. . O

-DOCSTART- X X O

Mutations NNS O
affecting VBG O
only RB O
CD4 IN B-NP
regulation NN O
mapped VBD O
to TO O
residues NNS O
previously RB O
shown VBN O
to TO O
mediate VB O
the DT O
binding NN O
of IN O
Nef NNP B-NP
to TO O
this DT O
receptor NN O
, , O
such JJ O
as IN O
W57 NNP O
and CC O
L58 CD O
, , O
as RB O
well RB O
as IN O
to TO O
an DT O
AP-recruiting JJ B-NP
dileucine NN I-NP
motif NN I-NP
and CC O
to TO O
an DT O
acidic NN O
dipeptide NN O
in IN O
the DT O
C-terminal JJ O
region NN O
of IN O
the DT O
protein NN O
. . O

-DOCSTART- X X O

Several JJ O
mutations NNS O
disrupted VBD O
the DT O
endonuclease NN O
and CC O
helicase NN B-NP
activities NNS O
; : O
however RB O
, , O
only RB O
one CD O
amino-terminal-charge JJ B-NP
cluster NN I-NP
mutant JJ I-NP
protein NN I-NP
( -LRB- O
D40A-D42A-D44A JJ O
) -RRB- O
completely RB O
lost VBD O
AAV NNP O
hairpin IN O
DNA NNP O
binding NN O
activity NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
( -LRB- O
i NN O
) -RRB- O
we PRP O
have VBP O
identified VBN O
several JJ O
candidate NN O
latency RB O
genes NNS O
of IN O
murine NN O
gammaHV68 NN O
, , O
( -LRB- O
ii NNS O
) -RRB- O
expression NN O
of IN O
genes NNS O
during IN O
latency RB O
may MD O
be VB O
different JJ O
in IN O
different JJ O
organs NNS O
, , O
consistent JJ O
with IN O
multiple JJ O
latency NN O
programs NNS O
and/or CC O
multiple JJ O
cellular JJ O
sites NNS O
of IN O
latency RB O
, , O
and CC O
( -LRB- O
iii NN O
) -RRB- O
regions NNS O
of IN O
the DT O
viral JJ O
genome NN O
(v-bcl-2 JJ O
gene NN B-NP
, , O
v-GCR JJ B-NP
gene NN I-NP
, , O
and CC O
gene NN B-NP
73 CD I-NP
) -RRB- O
are VBP O
transcribed VBN O
during IN O
latency RB O
with IN O
both DT O
gammaHV68 NNS O
and CC O
primate JJ O
gammaherpesviruses NNS O
. . O

-DOCSTART- X X O

These DT O
data NNS O
indicate VBP O
a DT O
functional JJ O
role NN O
for IN O
U1 NNP B-NP
in IN O
NRS-mediated NNP B-NP
splicing NN O
inhibition NN O
. . O

-DOCSTART- X X O

This DT O
suggests VBZ O
that IN O
the DT O
DcuS-DcuR JJ B-NP
system NN O
responds NNS O
to TO O
external JJ O
substrates NNS O
. . O

-DOCSTART- X X O

Crossover NNP O
in IN O
the DT O
specific JJ O
heat NN O
of IN O
dilute JJ O
magnets NNS O
induced VBN O
by IN O
critical JJ O
spin-wave NN O
dynamics NNS O
. . O

-DOCSTART- X X O

Interplane NNP O
coupling NN O
in IN O
the DT O
superconductor NN O
Y2Ba4Cu7O15 . O
as IN O
revealed VBN O
by IN O
NQR NNP O
spin-echo JJ O
double JJ O
resonance NN O
. . O

-DOCSTART- X X O

Electronic JJ O
structure NN O
of IN O
a DT O
buried VBN O
NiSi2 NNP O
or CC O
CoSi2 NNP O
layer NN O
in IN O
bulk JJ O
Si NNP O
. . O

-DOCSTART- X X O

Raman NNP O
investigation NN O
of IN O
YBa2-xLaxCu3O7 JJ O
ceramics NNS O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
point NN O
defects NNS O
on IN O
lattice NN O
parameters NNS O
of IN O
semiconductors NNS O
. . O

-DOCSTART- X X O

The DT O
Scales NNP O
of IN O
Cognitive NNP O
Impairment NNP O
Rated NNP O
From IN O
Institutional NNP O
Records NNPS O
(SCIRFIR NNP O
) -RRB- O
, , O
a DT O
battery NN O
based VBN O
on IN O
commonly RB O
used VBN O
dementia NN O
rating NN O
instruments NNS O
, , O
was VBD O
tested VBN O
on IN O
the DT O
records NNS O
of IN O
26 CD O
chronically RB O
institutionalized VBN O
, , O
elderly JJ O
schizophrenia NN O
patients NNS O
, , O
for IN O
the DT O
purpose NN O
of IN O
retrospectively RB O
evaluating VBG O
the DT O
long-term JJ O
course NN O
of IN O
cognitive JJ O
change NN O
in IN O
schizophrenia NN O
and CC O
relating VBG O
it PRP O
to TO O
available JJ O
autopsy NN O
materials NNS O
. . O

-DOCSTART- X X O

Most RBS O
recently RB O
, , O
the DT O
use NN O
of IN O
the DT O
product NN O
of IN O
brain NN O
weight NN O
and CC O
clearance NN O
has VBZ O
been VBN O
proposed VBN O
. . O

-DOCSTART- X X O

Recombination NNP O
and CC O
transcription NN O
of IN O
the DT O
endogenous JJ B-NP
Ig NNP I-NP
heavy NN I-NP
chain NN I-NP
locus NN I-NP
is VBZ O
effected VBN O
by IN O
the DT O
Ig NNP B-NP
heavy NN I-NP
chain NN I-NP
intronic JJ I-NP
enhancer NN I-NP
core NN I-NP
region NN I-NP
in IN O
the DT O
absence NN O
of IN O
the DT O
matrix NN O
attachment NN O
regions NNS O
. . O

-DOCSTART- X X O

Two CD O
of IN O
these DT O
motifs NNS O
are VBP O
part NN O
of IN O
a DT O
highly RB O
conserved VBN O
and CC O
inducible JJ O
dyad NN O
symmetry NN O
element NN O
shown VBN O
previously RB O
to TO O
control VB O
a DT O
remote JJ O
IL-2 NN B-NP
enhancer NN I-NP
and CC O
the DT O
CD18 NN B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

In IN O
concert NN O
with IN O
the DT O
coactivator NN O
CREB NNP B-NP
binding NN I-NP
protein/p300 NN I-NP
, , O
which WDT O
interacts VBZ O
with IN O
GABPalpha NNP B-NP
, , O
the DT O
binding NN O
of IN O
GABPalpha NNP B-NP
and CC I-NP
-beta JJ I-NP
to TO O
the DT O
dyad NN O
symmetry NN O
element NN O
controls VBZ O
the DT O
induction NN O
of IN O
IL-16 DT B-NP
promoter NN I-NP
in IN O
T NNP O
cells NNS O
. . O

-DOCSTART- X X O

TPO NNP B-NP
by IN O
itself PRP O
did VBD O
not RB O
activate JJ O
ERK1 NNP B-NP
, , O
ERK2 NNP B-NP
and CC O
protein NN B-NP
kinase NN I-NP
C NNP I-NP
( -LRB- O
PKC) NNP B-NP
, , O
whereas IN O
TPO NNP B-NP
directly RB O
enhanced VBD O
the DT O
PKC-dependent JJ B-NP
activation NN O
of IN O
ERKs NNP B-NP
induced VBN O
by IN O
other JJ O
agonists NNS O
including VBG O
thrombin NN B-NP
and CC O
phorbol NN O
esters NNS O
, , O
without IN O
affecting VBG O
the DT O
PKC NNP B-NP
activation NN O
by IN O
those DT O
agonists NNS O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Fission NNP B-NP
yeast NN I-NP
SCF NNP I-NP
is VBZ O
composed VBN O
of IN O
Pop1 NNP B-NP
and CC O
Pop2 NNP B-NP
, , O
two CD O
structurally RB O
related VBN O
but CC O
functionally RB O
independent JJ O
F-box/WD-repeat JJ B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

19F IN O
NMR NNP O
studies NNS O
in IN O
ABF4-type JJ O
layered JJ O
antiferromagnets NNS O
. . O

-DOCSTART- X X O

Chirality-glass NNP O
and CC O
spin-glass JJ O
correlations NNS O
in IN O
the DT O
two-dimensional JJ O
random-bond JJ O
XY NNP O
model NN O
. . O

-DOCSTART- X X O

Echo NNP O
modulation NN O
in IN O
Pr3+ NNP O
:YAlO3 NNP O
. . O

-DOCSTART- X X O

Surface NNP O
spin NN O
waves NNS O
in IN O
a DT O
Heisenberg NNP O
ferrimagnet NN O
with IN O
a DT O
single-ion JJ O
anisotropy NN O
(uniaxial NN O
and CC O
nonuniaxial JJ O
) -RRB- O
. . O

-DOCSTART- X X O

Optically RB O
detected VBD O
librons NNS O
and CC O
phonons NNS O
in IN O
crystalline NN O
C60 NN O
. . O

-DOCSTART- X X O

Multilayer-relaxation NNP O
geometry NN O
and CC O
electronic JJ O
structure NN O
of IN O
a DT O
W( JJ O
111 CD O
) -RRB- O
surface NN O
. . O

-DOCSTART- X X O

GW NNP O
Gamma NNP O
approximation NN O
for IN O
electron NN O
self-energies NNS O
in IN O
semiconductors NNS O
and CC O
insulators NNS O
. . O

-DOCSTART- X X O

Precision NNP O
measurement NN O
of IN O
the DT O
pion NN O
mass NN O
difference NN O
m NN O
pi NN O
--m : O
pi NN O
0. . O

-DOCSTART- X X O

Testing VBG O
gravity NN O
to TO O
second JJ O
post-Newtonian JJ O
order NN O
: : O
A DT O
field-theory NN O
approach NN O
. . O

-DOCSTART- X X O

Genetic JJ O
experiments NNS O
using VBG O
mutants NNS O
defective JJ O
in IN O
apontic JJ B-NP
and CC O
bruno RB B-NP
reveal VB O
a DT O
functional JJ O
interaction NN O
between IN O
these DT O
genes NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
current JJ O
model NN O
, , O
Wingless/Wnt NNP B-NP
signal NN O
stabilizes VBZ O
Armadillo/beta-catenin NNP B-NP
, , O
which WDT O
then RB O
accumulates VBZ O
in IN O
nuclei NNS O
and CC O
binds NNS O
TCF/LEF NNP B-NP
family NN O
proteins VBZ O
, , O
forming VBG O
bipartite JJ O
transcription NN O
factors NNS O
which WDT O
activate VBP O
transcription NN O
of IN O
Wingless/Wnt NNP B-NP
responsive JJ O
genes NNS O
. . O

-DOCSTART- X X O

In IN O
support NN O
of IN O
clinical JJ O
antianginal JJ O
studies NNS O
, , O
the DT O
vasodilator NN O
nicorandil NN O
( -LRB- O
NIC NN O
) -RRB- O
was VBD O
combined VBN O
with IN O
the DT O
beta-adrenergic JJ B-NP
receptor NN I-NP
antagonists NNS O
propranolol NN O
( -LRB- O
PRO FW O
) -RRB- O
and CC O
atenolol NN O
( -LRB- O
ATN) NNP O
and CC O
with IN O
the DT O
calcium NN O
channel NN O
blocker NN O
diltiazem NN O
(DTZ NN O
) -RRB- O
to TO O
determine VB O
their PRP$ O
cardiovascular JJ O
and CC O
pharmacokinetic JJ O
interactions NNS O
. . O

-DOCSTART- X X O

Factors NNS O
influencing NN O
direct-immersion NN O
( -LRB- O
DI)-SPME JJ O
process NN O
were VBD O
also RB O
checked VBN O
and CC O
chosen VBN O
experimentally RB O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
an DT O
amino-terminal JJ O
fragment NN O
containing VBG O
the DT O
C/H1 NNP O
domain NN O
was VBD O
sufficient JJ O
for IN O
coactivation NN O
of IN O
Zta NNP B-NP
transcription NN O
and CC O
viral JJ O
reactivation NN O
function NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
a DT O
potent JJ O
splicing NN O
enhancer NN O
sequence NN O
isolated VBN O
in IN O
the DT O
selection NN O
specifically RB O
binds VBZ O
a DT O
20-kDa JJ B-NP
SR JJ I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Elimination NNP O
of IN O
ETH1 NNP B-NP
in IN O
apn1 DT B-NP
strains NNS O
also RB O
increased VBD O
spontaneous JJ O
mutation NN O
rates NNS O
9- CD O
or CC O
31-fold JJ O
compared VBN O
to TO O
the DT O
wild JJ O
type NN O
as IN O
determined VBN O
by IN O
reversion NN O
to TO O
adenine VB O
or CC O
lysine VB O
prototrophy NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Elimination NNP O
of IN O
ETH1 NNP B-NP
in IN O
apn1 DT B-NP
strains NNS O
also RB O
increased VBD O
spontaneous JJ O
mutation NN O
rates NNS O
9- CD O
or CC O
31-fold JJ O
compared VBN O
to TO O
the DT O
wild JJ O
type NN O
as IN O
determined VBN O
by IN O
reversion NN O
to TO O
adenine VB O
or CC O
lysine VB O
prototrophy NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

These DT O
data NNS O
suggest VBP O
that IN O
other JJ O
Ras NNP B-NP
effectors NNS I-NP
can MD O
collaborate VB O
with IN O
PI NNP B-NP
3-kinase CD I-NP
and CC O
with IN O
each DT O
other JJ O
to TO O
activate VB O
Pak NNP B-NP
. . O

-DOCSTART- X X O

Mammalian NNP O
Ras NNP B-NP
GTPase-activating JJ B-NP
protein NN I-NP
( -LRB- O
GAP NNP B-NP
) -RRB- O
, , O
p120 VBD B-NP
Ras-GAP NNP B-NP
, , O
has VBZ O
been VBN O
implicated VBN O
as IN O
both DT O
a DT O
downregulator NN O
and CC O
effector NN O
of IN O
Ras NNP B-NP
proteins NNS I-NP
, , O
but CC O
its PRP$ O
precise JJ O
role NN O
in IN O
Ras-mediated NNP B-NP
signal NN O
transduction NN O
pathways NNS O
is VBZ O
unclear JJ O
. . O

-DOCSTART- X X O

Three CD O
mog-1 NN B-NP
alleles NNS I-NP
possess VBP O
premature JJ O
stop NN O
codons NNS O
and CC O
are VBP O
likely JJ O
to TO O
be VB O
null JJ O
alleles NNS O
, , O
and CC O
one CD O
is VBZ O
a DT O
missense NN O
mutation NN O
and CC O
is VBZ O
likely JJ O
to TO O
retain VB O
residual JJ O
activity NN O
. . O
mog-1 NN B-NP
mRNA NN I-NP
is VBZ O
expressed VBN O
in IN O
both DT O
germ NN O
line NN O
and CC O
somatic JJ O
tissues NNS O
and CC O
appears VBZ O
to TO O
be VB O
ubiquitous JJ O
. . O

-DOCSTART- X X O

However RB O
, , O
unlike IN O
the DT O
SIN3 NNP B-NP
gene NN I-NP
of IN O
Saccharomyces NNS O
cerevisiae NNS O
, , O
pst1( JJ B-NP
+ NN I-NP
) -RRB- I-NP
is VBZ O
essential JJ O
for IN O
cell NN O
viability NN O
. . O

-DOCSTART- X X O

The DT O
Nmd3 JJ B-NP
protein NN I-NP
sequence NN I-NP
does VBZ O
not RB O
contain VB O
readily RB O
recognizable JJ O
motifs NNS O
of IN O
known VBN O
function NN O
. . O

-DOCSTART- X X O

The DT O
distribution NN O
of IN O
the DT O
various JJ O
repeats NNS O
suggests VBZ O
its PRP$ O
organization NN O
is VBZ O
similar JJ O
to TO O
the DT O
beta-heterochromatic JJ O
regions NNS O
near IN O
the DT O
base NN O
of IN O
the DT O
major JJ O
chromosome NN O
arms NNS O
. . O

-DOCSTART- X X O

Calcitonin NNP B-NP
simultaneously RB O
regulates VBZ O
both DT O
periosteal JJ O
hyperostosis NN O
and CC O
trabecular JJ O
osteopenia NN O
in IN O
the DT O
spinal JJ O
hyperostotic JJ O
mouse NN O
( -LRB- O
twy/twy JJ B-NP
) -RRB- O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Electrophoretic NNP O
mobility-shift JJ O
assays IN O
performed VBN O
with IN O
the DT O
HNF-3 JJ B-NP
X NNP O
and CC O
Y NNP O
sites NNS O
demonstrated VBD O
that IN O
both DT O
sites NNS O
are VBP O
capable JJ O
of IN O
binding JJ O
HNF-3alpha NNP B-NP
and CC O
HNF-3beta NNP B-NP
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
we PRP O
also RB O
show VBP O
that IN O
cdk7 PRP B-NP
may MD O
phosphorylate VB O
the DT O
carboxy-terminal JJ O
domain NN O
( -LRB- O
CTD NNP O
) -RRB- O
of IN O
RNA NNP B-NP
pol NN I-NP
II NNP I-NP
in IN O
the DT O
absence NN O
of IN O
promoter NN O
opening NN O
. . O

-DOCSTART- X X O

The DT O
therapy NN O
with IN O
a DT O
H2-receptor JJ B-NP
antagonist NN O
is VBZ O
less RBR O
effective JJ O
than IN O
the DT O
triple JJ O
therapies NNS O
with IN O
omeprazole NN O
or CC O
lansoprazole NN O
. . O

-DOCSTART- X X O

In IN O
humans NNS O
, , O
three CD O
tissue-specific JJ B-NP
plastin NN I-NP
isoforms NNS I-NP
have VBP O
been VBN O
identified VBN O
. . O

-DOCSTART- X X O

No DT O
TATA NNP O
or CC O
Inr NNP O
sequence NN O
was VBD O
found VBN O
. . O

-DOCSTART- X X O

The DT O
inhibition NN O
by IN O
the DT O
RIalpha NNP B-NP
subunit NN I-NP
is VBZ O
reversed VBN O
by IN O
addition NN O
of IN O
nanomolar JJ O
concentrations NNS O
of IN O
cAMP NNS O
( -LRB- O
Ka NNP O
= SYM O
40 CD O
nM) NN O
, , O
thus RB O
demonstrating VBG O
that DT O
PrKX NNP B-NP
is VBZ O
a DT O
novel NN O
, , O
type NN B-NP
I PRP I-NP
cAMP-dependent JJ I-NP
protein NN I-NP
kinase NN I-NP
that WDT O
is VBZ O
activated VBN O
at IN O
lower JJR O
cAMP NN O
concentrations NNS O
than IN O
the DT O
holoenzyme NN O
with IN O
the DT O
Calpha NNP B-NP
subunit NN I-NP
of IN O
cAMP-dependent JJ B-NP
protein NN I-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

Proteins NNS O
known VBN O
to TO O
bind NN O
the DT O
PEPCK NN B-NP
CRE NNP O
include VBP O
the DT O
CRE-binding JJ B-NP
protein NN I-NP
( -LRB- O
CREB NN B-NP
) -RRB- O
and CC O
members NNS O
of IN O
the DT O
CCAAT/enhancer-binding JJ B-NP
protein NN I-NP
( -LRB- O
C/EBP NNP B-NP
) -RRB- O
family NN O
. . O

-DOCSTART- X X O

This DT O
construct VB O
, , O
termed VBD O
pDeltaCREC/EBP RB B-NP
, , O
binds NNS O
C/EBPalpha NNP B-NP
and CC I-NP
beta JJ I-NP
but CC O
not RB O
CREB NNP B-NP
, , O
yet RB O
it PRP O
confers VBZ O
a DT O
nearly RB O
complete JJ O
glucocorticoid JJ O
response NN O
when WRB O
transiently VBG O
transfected VBN O
into IN O
H4IIE JJ O
rat NN O
hepatoma NN O
cells NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
in IN O
vitro NN O
mutagenesis NN O
of IN O
both DT O
Engrailed JJ B-NP
and CC O
Pbx1 VB B-NP
sites NNS I-NP
indicated VBN O
that IN O
other JJ O
unidentified JJ O
sites NNS O
are VBP O
responsible JJ O
for IN O
the DT O
transcriptional JJ O
enhancement NN O
observed VBD O
with IN O
the DT O
intronic JJ O
fragment NN O
. . O

-DOCSTART- X X O

Several JJ O
secondary JJ O
structure NN O
elements NNS O
were VBD O
identified VBN O
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
evidence VBP O
that IN O
the DT O
developmental JJ O
functions NNS O
of IN O
the DT O
family NN O
of IN O
transcription NN O
factors NNS O
characterized VBN O
by IN O
the DT O
POU NNP B-NP
DNA NNP I-NP
binding NN I-NP
motif NN I-NP
exerts NNS O
roles NNS O
in IN O
mammalian JJ O
development NN O
. . O

-DOCSTART- X X O

High-affinity JJ O
site-specific JJ O
DNA NN O
binding NN O
by IN O
POU NNP B-NP
domain NN I-NP
transcription NN I-NP
factors NNS I-NP
requires VBZ O
both DT O
the DT O
POU-specific JJ B-NP
and CC O
the DT O
POU-homeodomain JJ B-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
Oct-1 NNP B-NP
crystal NN O
, , O
the DT O
POU-specific JJ B-NP
domain NN I-NP
recognizes VBZ O
a DT O
GCAT NN O
half-site JJ O
, , O
while IN O
the DT O
corresponding JJ O
sequence NN O
recognized VBN O
by IN O
the DT O
Pit-1 NNP B-NP
POU-specific NNP B-NP
domain NN O
, , O
GTAT NNP O
, , O
is VBZ O
on IN O
the DT O
opposing VBG O
strand NN O
. . O

-DOCSTART- X X O

Systematic JJ O
functional JJ O
analysis NN O
of IN O
V1a/V2 NNP B-NP
hybrid NN I-NP
receptors NNS I-NP
showed VBD O
that IN O
the DT O
second JJ O
intracellular JJ O
loop NN O
of IN O
the DT O
V1a NNP B-NP
receptor NN I-NP
is VBZ O
required VBN O
and CC O
sufficient JJ O
for IN O
efficient JJ O
coupling NN O
to TO O
Gq/11 VB B-NP
, , O
whereas IN O
the DT O
third JJ O
intracellular JJ O
loop NN O
of IN O
the DT O
V2 NN B-NP
receptor NN I-NP
is VBZ O
required VBN O
and CC O
sufficient JJ O
for IN O
coupling VBG O
to TO O
Gs NNP B-NP
. . O

-DOCSTART- X X O

Most JJS O
other JJ O
end NN O
points NNS O
were VBD O
highly RB O
significant JJ O
, , O
and CC O
death NN O
, , O
which WDT O
was VBD O
monitored VBN O
across IN O
the DT O
U.S. NNP O
program NN O
, , O
was VBD O
different JJ O
with IN O
p NN O
< NN O
0.0001 CD O
. . O

-DOCSTART- X X O

The DT O
other JJ O
is VBZ O
located VBN O
at IN O
-1335 CD O
, , O
outside IN O
this DT O
highly RB O
conserved JJ O
region NN O
. . O

-DOCSTART- X X O

The DT O
fatigue NN O
exercise NN O
showed VBD O
relatively RB O
high JJ O
blood NN O
lactate NN O
concentration NN O
[12.5 CD O
( -LRB- O
SD NNP O
2.6 CD O
) -RRB- O
mmol NN O
x NN O
l(-1 NN O
) -RRB- O
] SYM O
and CC O
an DT O
increase NN O
of IN O
serum NN B-NP
creatine NN I-NP
kinase NN I-NP
( -LRB- O
CK) NNP B-NP
activity NN O
delayed VBN O
by IN O
2 CD O
days NNS O
[540 IN O
( -LRB- O
SD NN O
407 CD O
) -RRB- O
U NNP O
x NN O
l(-1 NN O
)] NN O
. . O

-DOCSTART- X X O

Those DT O
radiological JJ O
aspects NNS O
were VBD O
distributed VBN O
in IN O
two CD O
categories NNS O
: : O
1 CD O
) -RRB- O
type NN O
I-presenting NN O
variable JJ O
sinusoidal JJ O
filling NN O
. . O

-DOCSTART- X X O

Results NNS O
demonstrated VBD O
that IN O
the DT O
presence NN O
of IN O
myofibroblasts NNS O
varied VBN O
considerably RB O
from IN O
case NN O
to TO O
case NN O
and CC O
was VBD O
always RB O
related VBN O
to TO O
smooth JJ O
muscle NN O
cell NN O
dispersion NN O
, , O
which WDT O
occurred VBD O
around IN O
medium-sized JJ O
damaged VBN O
portal JJ O
vein NN O
branches NNS O
. . O

-DOCSTART- X X O

Radiative NNP O
corrections NNS O
to TO O
beta JJ O
decay NN O
and CC O
the DT O
possibility NN O
of IN O
a DT O
fourth JJ O
generation NN O
. . O

-DOCSTART- X X O

Magnetic JJ O
trapping NN O
of IN O
spin-polarized JJ O
atomic JJ O
hydrogen NN O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
and CC O
in IN O
situ FW O
hybridization NN O
analyses NNS O
revealed VBD O
GPR34 NNP B-NP
mRNA RB I-NP
transcripts VBZ I-NP
in IN O
several JJ O
human JJ O
and CC O
rat NN O
brain NN O
regions NNS O
. . O

-DOCSTART- X X O

The DT O
microphthalmia-TFE NN B-NP
( -LRB- O
MiT NNP B-NP
) -RRB- O
subfamily RB O
of IN O
basic JJ B-NP
helix-loop-helix NN I-NP
leucine NN I-NP
zipper NN I-NP
( -LRB- I-NP
bHLH-ZIP NN I-NP
) -RRB- I-NP
transcription NN I-NP
factors NNS I-NP
, , O
including VBG O
TFE3 NNP B-NP
, , O
TFEB NNP B-NP
, , O
TFEC NNP B-NP
, , O
and CC O
Mitf NNP B-NP
, , O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
regulation NN O
of IN O
tissue-specific JJ O
gene NN O
expression NN O
in IN O
several JJ O
cell NN O
lineages NNS O
. . O

-DOCSTART- X X O

Fifty-seven CD O
patients NNS O
aged VBN O
< NNP O
55 CD O
years NNS O
with IN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
( -LRB- O
ALL NNP O
) -RRB- O
in IN O
second JJ O
or CC O
third JJ O
bone NN O
marrow NN O
( -LRB- O
BM NNP O
) -RRB- O
relapse NN O
or CC O
refractory JJ O
to TO O
first-line JJ O
therapy NN O
were VBD O
enrolled VBN O
in IN O
an DT O
Italian JJ O
cooperative JJ O
study NN O
. . O

-DOCSTART- X X O

The DT O
dorsal JJ O
nerves NNS O
of IN O
the DT O
penis NNS O
were VBD O
anesthetized VBN O
bilaterally RB O
with IN O
lidocaine NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
brain NN O
, , O
muscarinic JJ B-NP
receptors NNS I-NP
mediate JJ O
motor NN O
and CC O
memory NN O
function NN O
by IN O
interaction NN O
with IN O
their PRP$ O
ligand NN O
acetylcholine NN O
. . O

-DOCSTART- X X O

Early-onset NNP O
scleral JJ O
necrosis NN O
after IN O
iodine NN O
I PRP O
125 CD O
plaque JJ O
radiotherapy NN O
for IN O
ciliochoroidal JJ O
melanoma NN O
. . O

-DOCSTART- X X O

Successful JJ O
interaction NN O
of IN O
ARF NNP B-NP
and CC O
PKC-alpha NNP B-NP
with IN O
PLD1 NNP B-NP
was VBD O
not RB O
achieved VBN O
, , O
but CC O
a DT O
C-terminal JJ O
fragment NN O
of IN O
human JJ B-NP
PLD1 NNP I-NP
( -LRB- O
denoted VBN O
" `` O
D4" NNS O
) -RRB- O
interacted VBN O
with IN O
the DT O
active JJ O
mutant NN O
of IN O
RhoA NNP B-NP
, , O
RhoAVal-14 NNP B-NP
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
investigated VBD O
the DT O
signal NN O
transduction NN O
pathways NNS O
that WDT O
are VBP O
involved VBN O
in IN O
OM-induced JJ B-NP
LDLR NNP B-NP
transcription NN O
. . O

-DOCSTART- X X O

High-pressure JJ O
effects NNS O
on IN O
ultrafast-relaxation NN O
kinetics NNS O
of IN O
excitons NNS O
in IN O
polydiacetylene NN O
4BCMU. . O

-DOCSTART- X X O

Drag NNP O
reduction NN O
in IN O
turbulent JJ O
flows NNS O
by IN O
polymers NNS O
. . O

-DOCSTART- X X O

Current JJ O
world NN O
literature NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
show VBP O
that IN O
Ski NNP B-NP
is VBZ O
a DT O
component NN O
of IN O
the DT O
HDAC NNP B-NP
complex NN I-NP
and CC O
that DT O
Ski NN B-NP
is VBZ O
required VBN O
for IN O
the DT O
transcriptional JJ O
repression NN O
mediated VBN O
by IN O
this DT O
complex NN O
. . O

-DOCSTART- X X O

Recombinant JJ O
unr JJ B-NP
acts NNS O
synergistically RB O
with IN O
recombinant JJ O
PTB NNP B-NP
to TO O
stimulate VB O
translation NN O
dependent JJ O
on IN O
the DT O
rhinovirus NN O
IRES. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
consensus NN O
binding NN O
sequence NN O
and CC O
the DT O
DNA-binding JJ O
domain NN O
of IN O
ZF5 NNP B-NP
. . O

-DOCSTART- X X O

Mapping NNP O
of IN O
the DT O
human JJ B-NP
Voltage-Dependent NNP I-NP
Anion NNP I-NP
Channel NNP I-NP
isoforms VBZ I-NP
1 CD I-NP
and CC I-NP
2 CD I-NP
reconsidered VBN O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
RNase NNP B-NP
T NNP I-NP
as IN O
a DT O
high-copy JJ O
suppressor NN O
of IN O
the DT O
UV NN O
sensitivity NN O
associated VBN O
with IN O
single-strand JJ B-NP
DNA NN I-NP
exonuclease NN I-NP
deficiency NN O
in IN O
Escherichia NNP O
coli NNS O
. . O

-DOCSTART- X X O

Inhibition NN O
of IN O
phosphatidylinositol-3 JJ B-NP
kinase NN I-NP
did VBD O
not RB O
have VB O
a DT O
significant JJ O
effect NN O
on IN O
p53 NN B-NP
conformation NN O
but CC O
did VBD O
have VB O
a DT O
weak JJ O
but CC O
significant JJ O
effect NN O
on IN O
Tpo-enhanced JJ B-NP
viability NN O
. . O

-DOCSTART- X X O

No DT O
difference NN O
in IN O
percentage NN O
of IN O
males NNS O
in IN O
semen NNS O
production NN O
was VBD O
noted VBN O
between IN O
strains NNS O
, , O
CP CD O
levels NNS O
, , O
or CC O
feeding VBG O
regimens NNS O
. . O

-DOCSTART- X X O

The DT O
Lp NNP B-NP
mouse NN I-NP
mutant NN I-NP
provides VBZ O
a DT O
model NN O
for IN O
the DT O
severe JJ O
human JJ O
neural JJ O
tube NN O
defect NN O
(NTD) NN O
, , O
cranio-rachischisis NN O
. . O

-DOCSTART- X X O

Further JJ O
analysis NN O
of IN O
AP-1 JJ B-NP
DNA NNP O
binding NN O
activities NNS O
in IN O
7- CD O
to TO O
14-day JJ O
culture NN O
activated VBN O
HSCs NNP O
led VBD O
to TO O
the DT O
discovery NN O
of IN O
high JJ B-NP
mobility NN I-NP
AP-1 NN I-NP
complexes NNS I-NP
( -LRB- O
HMAP-1 NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Mutations NNS O
of IN O
the DT O
AP-1 JJ B-NP
site NN I-NP
of IN O
the DT O
TIMP-1 NN B-NP
promoter NN I-NP
that WDT O
prevented VBD O
formation NN O
of IN O
HMAP-1 NNP B-NP
caused VBD O
a DT O
70 CD O
% NN O
loss NN O
of IN O
activity NN O
in IN O
transfected JJ O
activated JJ O
HSCs NNS O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
high JJ O
set-up NN O
accuracy NN O
and CC O
reproducibility NN O
are VBP O
mandatory JJ O
. . O

-DOCSTART- X X O

Role NNP O
of IN O
g2 CD O
in IN O
relating VBG O
the DT O
Schwinger NNP O
and CC O
Gerasimov-Drell-Hearn NNP O
sum NN O
rules NNS O
. . O

-DOCSTART- X X O

Acoustic JJ O
transmission NN O
spectra NN O
in IN O
the DT O
Penrose NNP O
lattice NN O
. . O

-DOCSTART- X X O

Two-Channel NNP O
Kondo NNP O
Lattice NNP O
: : O
An DT O
Incoherent JJ O
Metal NN O
. . O

-DOCSTART- X X O

Basal NNP O
midexpiratory NN O
lower JJR O
esophageal NN O
sphincter NN O
pressure NN O
was VBD O
similar JJ O
in IN O
the DT O
study NN O
group NN O
( -LRB- O
mean VB O
[SD] JJ O
20.1 CD O
[9.1] JJ O
mmHg NN O
) -RRB- O
and CC O
controls VBZ O
( -LRB- O
17.6 CD O
[6.0] JJ O
mmHg NN O
) -RRB- O
; : O
the DT O
pressure NN O
did VBD O
not RB O
change NN O
following VBG O
EVS NNP O
or CC O
EVL. NNP O

-DOCSTART- X X O

CPDs NNS O
at IN O
these DT O
three CD O
sites NNS O
may MD O
partially RB O
displace VB O
TFIIIA NNP B-NP
, , O
thereby RB O
enabling VBG O
rapid JJ O
repair NN O
. . O

-DOCSTART- X X O

There EX O
was VBD O
no DT O
difference NN O
in IN O
the DT O
hormone NN O
receptor NN O
status NN O
between IN O
the DT O
cases NNS O
without IN O
lymph NN O
node NN O
metastases NNS O
and CC O
with IN O
lymph NN O
node NN O
metastases NNS O
, , O
'clandestine JJ O
' '' O
or CC O
macrometastases NNS O
. . O

-DOCSTART- X X O

On IN O
the DT O
other JJ O
hand NN O
, , O
subjects NNS O
with IN O
air NN O
trapping NN O
( -LRB- O
residual JJ O
volume NN O
( -LRB- O
RV)/total JJ O
lung NN O
capacity NN O
( -LRB- O
TLC NNP O
) -RRB- O
>37 CD O
% NN O
) -RRB- O
disclosed VBN O
not RB O
only RB O
a DT O
higher JJR O
n( JJ O
mit NN O
) -RRB- O
( -LRB- O
0.63+/-0.17 CD O
versus NN O
0.43+/-0.07 CD O
mt NN O
x NN O
microm(-2 NN O
) -RRB- O
, , O
p<0.05 VBD O
) -RRB- O
but CC O
shorter JJR O
sarcomeres FW O
( -LRB- O
L(sar NN O
) -RRB- O
) -RRB- O
than IN O
subjects NNS O
without IN O
this DT O
functional JJ O
abnormality NN O
( -LRB- O
2.08+/-0.16 CD O
to TO O
2.27+/-0.15 CD O
microm NN O
, , O
p<0.05 VBD O
) -RRB- O
. . O

-DOCSTART- X X O

Gel NNP O
filtration NN O
, , O
sedimentation NN O
velocity NN O
, , O
and CC O
immunoprecipitation NN O
experiments NNS O
revealed VBD O
that IN O
beta4 PRP O
is VBZ O
a DT O
component NN O
of IN O
a DT O
multisubunit NN O
complex NN O
( -LRB- O
AP-4 NN B-NP
) -RRB- O
that WDT O
also RB O
contains VBZ O
the DT O
sigma4 NN O
polypeptide NN O
and CC O
two CD O
additional JJ O
adaptor NN O
subunit NN O
homologs VBZ O
named VBN O
mu4 CD O
( -LRB- O
mu-ARP2 NN O
) -RRB- O
and CC O
epsilon NN O
. . O

-DOCSTART- X X O

Cyclin NNP B-NP
D1-associated JJ I-NP
kinase NN I-NP
activity NN O
and CC O
protein NN O
levels NNS O
were VBD O
increased VBN O
in IN O
mammary NN O
tumors NNS O
from IN O
murine NN O
mammary NN O
tumor NN O
virus-pp60(c-src527F NN O
) -RRB- O
transgenic JJ O
mice NNS O
. . O

-DOCSTART- X X O

The DT O
SH2 NNP B-NP
domain-containing NN I-NP
inositol NN I-NP
5'-phosphatase JJ I-NP
( -LRB- O
SHIP NN B-NP
) -RRB- O
recruits VBZ O
the DT O
p85 NN B-NP
subunit NN I-NP
of IN O
phosphoinositide NN B-NP
3-kinase JJ I-NP
during IN O
FcgammaRIIb1-mediated JJ B-NP
inhibition NN O
of IN O
B NNP B-NP
cell NN I-NP
receptor NN I-NP
signaling VBG O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
the DT O
mouse NN O
genome NN O
contains VBZ O
four CD O
copies NNS O
of IN O
the DT O
ubc-9 JJ B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

An DT O
increase NN O
in IN O
bone NN O
mineral NN O
density NN O
at IN O
the DT O
spine NN O
, , O
total JJ O
hip NN O
, , O
and CC O
total JJ O
body NN O
has VBZ O
been VBN O
reported VBN O
with IN O
raloxifene NN O
but CC O
seems VBZ O
to TO O
be VB O
less JJR O
than IN O
that DT O
seen VBN O
with IN O
estrogen NN O
or CC O
alendronate JJ O
therapy NN O
. . O

-DOCSTART- X X O

However RB O
, , O
in IN O
those DT O
studies NNS O
due JJ O
to TO O
the DT O
presence NN O
of IN O
thiol JJ O
agents NNS O
in IN O
the DT O
PKC NNP B-NP
preparations NNS O
, , O
the DT O
sensitive JJ O
reaction NN O
of IN O
BPO NNP O
with IN O
redox-active JJ O
cysteine NN O
residues NNS O
in IN O
PKC NNP B-NP
was VBD O
not RB O
observed VBN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
Csx/Nkx2 NNP B-NP
. . O

-DOCSTART- X X O

We PRP O
also RB O
identified VBD O
an DT O
alternative JJ O
spliced JJ O
form NN O
of IN O
Lyp NNP B-NP
RNA NNP I-NP
, , O
Lyp2 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
costs NNS O
were VBD O
DM NNP O
11,562 CD O
for IN O
a DT O
PE NN O
, , O
DM NNP O
12,477 CD O
for IN O
a DT O
VR NNP O
and CC O
DM NNP O
7,532 CD O
for IN O
a DT O
MR. NNP O

-DOCSTART- X X O

We PRP O
now RB O
provide VBP O
evidence NN O
for IN O
physical JJ O
and CC O
functional JJ O
interaction NN O
between IN O
Doa4 NNP B-NP
and CC O
the DT O
proteasome JJ O
. . O

-DOCSTART- X X O

Independent JJ O
splicing NN O
events NNS O
involve VBP O
three CD O
previously RB O
described VBN O
cassette NN O
exons NNS O
, , O
which WDT O
are VBP O
predicted VBN O
to TO O
encode VB O
most JJS O
of IN O
the DT O
second JJ O
transmembrane NN O
domain NN O
. . O

-DOCSTART- X X O

Each DT O
of IN O
these DT O
genes NNS O
contains VBZ O
a DT O
putative JJ O
upstream JJ O
ORF NN O
, , O
while IN O
STA2 NNP B-NP
has VBZ O
two CD O
additional JJ O
in-frame JJ O
AUG NNP O
codons NNS O
5' VBD O
to TO O
the DT O
major JJ O
cistron NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
mapping NN O
of IN O
the DT O
promoter NN O
region NN O
and CC O
the DT O
identification NN O
of IN O
putative JJ O
promoter NN O
regulatory JJ O
sequences NNS O
should MD O
give VB O
insight NN O
into IN O
the DT O
transcriptional JJ O
regulation NN O
of IN O
UCP2 DT B-NP
expression--in JJ O
particular JJ O
by IN O
anyone NN O
of IN O
the DT O
above JJ O
mentioned VBN O
factors--in NN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

The DT O
rate NN O
of IN O
resectability NN O
is VBZ O
low JJ O
and CC O
5-year JJ O
survival NN O
is VBZ O
very RB O
poor JJ O
. . O

-DOCSTART- X X O

In IN O
order NN O
to TO O
better JJR O
characterize VB O
the DT O
distribution NN O
of IN O
ML NNP O
and CC O
MAP NNP O
estimates VBZ O
under IN O
these DT O
conditions NNS O
, , O
we PRP O
derive VBP O
a DT O
point NN O
approximation NN O
to TO O
density NN O
values NNS O
of IN O
the DT O
conditional JJ O
distribution NN O
of IN O
such JJ O
estimates NNS O
. . O

-DOCSTART- X X O

RT-PCR NNP O
was VBD O
performed VBN O
using VBG O
previously RB O
reported VBN O
degenerate NN O
oligonucleotide JJ O
primers NNS O
to TO O
the DT O
ligand NN O
binding NN O
domain NN O
( -LRB- O
LBD NNP O
) -RRB- O
of IN O
known VBN O
beta NN B-NP
integrin NN I-NP
subunits NNS I-NP
and CC O
Bge JJ B-NP
cDNA NN I-NP
. . O

-DOCSTART- X X O

The DT O
lowest JJS O
culture NN O
failure NN O
rate NN O
of IN O
0.2 CD O
per IN O
cent NN O
was VBD O
found VBN O
after IN O
EAF NNS O
compared VBN O
with IN O
0.9 CD O
per IN O
cent NN O
among IN O
CVS. NNP O

-DOCSTART- X X O

Ectopic JJ O
expression NN O
of IN O
d-axin JJ B-NP
inhibited JJ O
Wingless NNP B-NP
signaling NN O
. . O

-DOCSTART- X X O

The DT O
corresponding JJ O
differences NNS O
in IN O
FVIIa NNP B-NP
and CC O
PAI-1 NNP B-NP
were VBD O
not RB O
statistically RB O
significant JJ O
. . O

-DOCSTART- X X O

Primary JJ O
and CC O
secondary JJ O
structural JJ O
elements NNS O
required VBN O
for IN O
synthesis NN O
of IN O
barley NN O
yellow JJ O
dwarf NN O
virus NN O
subgenomic JJ O
RNA1 NNP O
. . O

-DOCSTART- X X O

On IN O
the DT O
other JJ O
side NN O
, , O
when WRB O
the DT O
aortic JJ O
ring NN O
was VBD O
perfused VBN O
with IN O
L-NNA NNP O
( -LRB- O
NO-synthesis NN O
inhibitor NN O
) -RRB- O
or CC O
methylene NN O
blue JJ O
( -LRB- O
soluble NN O
cGMPase JJ B-NP
inhibitor NN O
) -RRB- O
, , O
the DT O
changes NNS O
could MD O
be VB O
attenuated VBN O
. . O

-DOCSTART- X X O

Nevertheless RB O
, , O
inactivation NN O
of IN O
the DT O
cyclin NN B-NP
E-Cdk2 NNP I-NP
complex NN O
in IN O
response NN O
to TO O
mitogen NN O
starvation NN O
occurs VBZ O
normally RB O
in IN O
MEFs NNS O
that WDT O
have VBP O
a DT O
homozygous JJ O
deletion NN O
of IN O
the DT O
p27 NN B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Identification NN O
and CC O
characterization NN O
of IN O
IS2404 NNP B-NP
and CC O
IS2606 NNP B-NP
: : O
two CD O
distinct JJ O
repeated VBD O
sequences NNS O
for IN O
detection NN O
of IN O
Mycobacterium NNP O
ulcerans NNS O
by IN O
PCR. NNP O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
are VBP O
consistent JJ O
with IN O
the DT O
possibility NN O
that IN O
p202 JJ B-NP
protein NN I-NP
contributes VBZ O
to TO O
the DT O
cell NN O
growth NN O
retardation NN O
activity NN O
of IN O
the DT O
IFNs NNP B-NP
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
by IN O
modulating VBG O
p21 JJ B-NP
protein NN I-NP
levels NNS O
. . O

-DOCSTART- X X O

Similar JJ O
results NNS O
were VBD O
also RB O
obtained VBN O
with IN O
a DT O
HepG2 NNP O
hepatoblastoma NN O
cell NN O
line NN O
carrying VBG O
wt NN B-NP
p53 NN I-NP
. . O

-DOCSTART- X X O

Partial JJ O
sequencing NN O
of IN O
the DT O
region NN O
downstream NN O
of IN O
ORF-Pto NNP B-NP
revealed VBD O
homology NN O
to TO O
the DT O
ru/AB NN B-NP
genes NNS I-NP
, , O
involved VBN O
in IN O
UV NN O
resistance NN O
, , O
from IN O
plasmid NN O
pPSR1 NNS O
. . O

-DOCSTART- X X O

The DT O
MSY2 NN B-NP
associated VBN O
kinase NN O
is VBZ O
not RB O
casein VB B-NP
kinase NN I-NP
2 CD I-NP
, , O
the DT O
kinase NN O
believed VBD O
to TO O
phosphorylate VB O
mRNP3+4 NNS B-NP
in IN O
oocytes NNS O
, , O
but CC O
a DT O
yet RB O
unidentified JJ O
kinase NN O
. . O

-DOCSTART- X X O

This DT O
suggests VBZ O
that IN O
helicase-like JJ B-NP
genes NNS I-NP
may MD O
be VB O
involved VBN O
in IN O
the DT O
biosynthesis NN O
of IN O
nucleic JJ O
acids NNS O
and CC O
proteins NNS O
, , O
and CC O
that IN O
the DT O
genes NNS O
can MD O
be VB O
transcriptionally RB O
activated VBN O
by IN O
heat NN O
shock NN O
to TO O
compensate VB O
for IN O
the DT O
repressed JJ O
synthesis NN O
of IN O
mRNA NN O
and CC O
protein NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
provide VBP O
the DT O
molecular JJ O
tools NNS O
for IN O
the DT O
final JJ O
identification NN O
of IN O
the DT O
MKS NNP B-NP
and CC O
the DT O
MUL NNP B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

The DT O
H-reflex JJ O
recovery NN O
curve NN O
was VBD O
obtained VBN O
after IN O
stimulation NN O
of IN O
the DT O
median JJ O
nerve NN O
at IN O
the DT O
elbow NN O
and CC O
recording NN O
from IN O
the DT O
flexor NN O
carpi NN O
radialis NNS O
. . O

-DOCSTART- X X O

The DT O
origins NNS O
of IN O
reflected VBN O
light NN O
changes NNS O
associated VBN O
with IN O
neuronal JJ O
activity NN O
( -LRB- O
optical JJ O
signals NNS O
) -RRB- O
were VBD O
investigated VBN O
in IN O
rat NN O
somatosensory NN O
cortex NN O
with IN O
optical JJ O
imaging NN O
, , O
microspectrophotometry NN O
, , O
and CC O
laser-Doppler NN O
flowmetry NN O
, , O
and CC O
dynamic JJ O
changes NNS O
in IN O
local JJ O
hemoglobin NN B-NP
concentration NN O
and CC O
oxygenation NN O
were VBD O
focused VBN O
on IN O
. . O

-DOCSTART- X X O

Human JJ B-NP
neuronal JJ I-NP
Elav-like JJ I-NP
proteins NNS I-NP
contain VBP O
three CD O
RNP-type JJ O
RNA NNP O
recognition NN O
motifs FW O
( -LRB- O
RRMs) NN O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
frequencies NNS O
of IN O
atrial JJ O
fibrillation NN O
after IN O
coronary JJ O
artery NN O
bypass IN O
grafting VBG O
with IN O
and CC O
without IN O
the DT O
use NN O
of IN O
cardiopulmonary JJ O
bypass NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
of IN O
supershift JJ O
analysis NN O
using VBG O
specific JJ O
antibodies NNS O
against IN O
transcription NN O
factors NNS O
suggested VBD O
that IN O
both DT O
binding JJ O
complexes NNS O
contained VBD O
the DT O
NF-kappaB NNP B-NP
components NNS O
p50 NN B-NP
and CC O
p65 VBD B-NP
, , O
and CC O
did VBD O
not RB O
contain VB O
other JJ O
NF-kappaB JJ B-NP
proteins NNS I-NP
( -LRB- O
p52 NN B-NP
, , O
c-Rel NN B-NP
, , O
Rel NNP B-NP
B) NNP I-NP
, , O
AP-1 JJ B-NP
proteins NNS I-NP
(c-Fos NNS O
, , O
C-Jun NN B-NP
) -RRB- O
, , O
CREB NNP B-NP
or CC O
C/EBPbeta NNP B-NP
( -LRB- O
NF-IL6 NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
set NN O
of IN O
peptides NNS O
corresponding JJ O
to TO O
the DT O
individual JJ O
elements NNS O
of IN O
secondary JJ O
structure NN O
derived VBD O
from IN O
the DT O
N-terminal JJ O
domain NN O
of IN O
the DT O
ribosomal JJ B-NP
protein NN I-NP
L9 PRP I-NP
have VBP O
been VBN O
synthesized VBN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
showed VBD O
that IN O
IFN-gamma NNP B-NP
stimulated VBD O
the DT O
rapid JJ O
accumulation NN O
of IN O
interferon NN B-NP
regulated JJ I-NP
factor NN I-NP
( -LRB- I-NP
IRF)-1 NN I-NP
mRNA NN I-NP
, , O
followed VBN O
by IN O
a DT O
delayed VBN O
and CC O
dose-dependent JJ O
inhibition NN O
of IN O
alpha1( NN B-NP
I PRP I-NP
) -RRB- I-NP
procollagen NN I-NP
mRNA JJ I-NP
expression NN O
in IN O
skin NN O
fibroblasts NNS O
from IN O
several JJ O
different JJ O
donors NNS O
. . O

-DOCSTART- X X O

Functional JJ O
domains NNS O
of IN O
c-myc JJ B-NP
promoter NN I-NP
binding JJ I-NP
protein NN I-NP
1 CD I-NP
involved VBN O
in IN O
transcriptional JJ O
repression NN O
and CC O
cell NN O
growth NN O
regulation NN O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
we PRP O
have VBP O
named VBN O
this DT O
gene NN O
UBP43 NNP B-NP
. . O

-DOCSTART- X X O

These DT O
results NNS O
continue VBP O
to TO O
support VB O
the DT O
hypothesis NN O
that IN O
HS2 NNP O
, , O
HS3 NNP O
, , O
and CC O
HS4 NNP O
act NN O
as IN O
a DT O
single JJ O
, , O
integral JJ O
unit NN O
to TO O
regulate VB O
human JJ B-NP
globin NN I-NP
gene NN I-NP
transcription NN O
as IN O
a DT O
holocomplex NN O
, , O
but CC O
they PRP O
can MD O
also RB O
be VB O
interpreted VBN O
to TO O
say VB O
that IN O
formation NN O
of IN O
a DT O
DNase NN B-NP
I PRP I-NP
hypersensitive VBD O
holocomplex NN O
alone RB O
is VBZ O
not RB O
sufficient JJ O
for IN O
mediating VBG O
high-level JJ O
globin NN B-NP
gene NN I-NP
transcription NN O
. . O

-DOCSTART- X X O

To TO O
identify VB O
additional JJ O
non-Sir JJ O
factors NNS B-NP
that WDT O
affect VBP O
rDNA NNP O
silencing NN O
, , O
we PRP O
performed VBD O
a DT O
genetic JJ O
screen NN O
designed VBN O
to TO O
isolate VB O
mutations NNS O
which WDT O
alter VBP O
the DT O
expression NN O
of IN O
reporter NN O
genes NNS O
integrated VBN O
within IN O
the DT O
rDNA NN O
. . O

-DOCSTART- X X O

Because IN O
there EX O
is VBZ O
great JJ O
need NN O
for IN O
iron NN O
in IN O
the DT O
EPO-stimulated JJ B-NP
erythroid NN O
progenitors NNS O
, , O
it PRP O
is VBZ O
essential JJ O
that IN O
serum NN B-NP
ferritin NN I-NP
and CC O
transferrin VBG B-NP
saturation NN O
levels NNS O
should MD O
be VB O
maintained VBN O
over IN O
300 CD O
microg/liter NN O
and CC O
30 CD O
% NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
p33 JJ B-NP
subunit NN I-NP
of IN O
eIF3 NN B-NP
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
the DT O
initiation NN O
phase NN O
of IN O
protein NN O
synthesis NN O
and CC O
that IN O
its PRP$ O
RNA-binding JJ O
domain NN O
is VBZ O
required VBN O
for IN O
optimal JJ O
activity NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
elucidate VBD O
signaling VBG O
pathways NNS O
induced VBN O
by IN O
photodynamic JJ O
therapy NN O
( -LRB- O
PDT NN O
) -RRB- O
with IN O
hypericin NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
ATF-2 NNP B-NP
plays VBZ O
a DT O
central JJ O
role NN O
in IN O
TGF-beta JJ B-NP
signaling NN O
by IN O
acting VBG O
as IN O
a DT O
common JJ O
nuclear JJ O
target NN O
of IN O
both DT O
Smad NNP B-NP
and CC O
TAK1 NNP B-NP
pathways NNS O
. . O

-DOCSTART- X X O

The DT O
systolic JJ O
peak NN O
of IN O
pulmonary JJ O
vein NN O
was VBD O
higher JJR O
than IN O
the DT O
diastolic JJ O
peak NN O
in IN O
45 CD O
out IN O
of IN O
56 CD O
cases NNS O
. . O

-DOCSTART- X X O

Specimens NNS O
were VBD O
assayed VBN O
for IN O
alpha-fetoprotein NN B-NP
, , O
unconjugated JJ O
estriol NN O
, , O
free JJ O
alpha NN B-NP
hCG RB I-NP
, , O
and CC O
total JJ O
hCG. . B-NP

-DOCSTART- X X O

The DT O
following VBG O
data NNS O
were VBD O
recorded VBN O
at IN O
arrival NN O
in IN O
the DT O
intensive JJ O
care NN O
unit NN O
6 CD O
, , O
12 CD O
, , O
24 CD O
, , O
and CC O
48 CD O
hours NNS O
after IN O
termination NN O
of IN O
CPB NNP O
: : O
heart NN O
rate NN O
, , O
blood NN O
pressure NN O
, , O
left VBD O
atrial JJ O
pressure NN O
, , O
central-peripheral JJ O
temperature NN O
difference NN O
, , O
arterial-central JJ O
venous JJ O
oxygen NN O
saturation NN O
difference NN O
, , O
urine JJ O
output NN O
, , O
serum NN O
creatinine NN O
, , O
lactate NN O
and CC O
neutrophil JJ B-NP
elastase JJ I-NP
levels NNS O
, , O
the DT O
Doppler NNP O
echocardiographic JJ O
factors NNS O
shortening VBG O
fraction NN O
and CC O
preejection NN O
period/left-ventricular JJ O
ejection NN O
time NN O
, , O
and CC O
cumulative JJ O
doses NNS O
of IN O
catecholamines NNS O
(epinephrine NN O
) -RRB- O
, , O
enoximone NN O
, , O
and CC O
furosemide NN O
. . O

-DOCSTART- X X O

MDS1/EVI1 JJ B-NP
, , O
located VBN O
on IN O
chromosome NN O
3 CD O
band NN O
q26 CD O
, , O
encodes VBZ O
a DT O
zinc-finger NN B-NP
DNA-binding NN I-NP
transcription NN I-NP
activator NN I-NP
not RB O
detected VBN O
in IN O
normal JJ O
hematopoietic NN O
cells NNS O
but CC O
expressed VBN O
in IN O
several JJ O
normal JJ O
tissues NNS O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
protein NN O
sequences NNS O
of IN O
these DT O
two CD O
replicases NNS B-NP
, , O
together RB O
with IN O
previously RB O
characterized VBN O
H. NNP B-NP
pylori NN I-NP
plasmid NN I-NP
replication NN I-NP
proteins VBZ I-NP
, , O
supports VBZ O
the DT O
formation NN O
of IN O
a DT O
distinct JJ O
class NN O
of IN O
H. NNP B-NP
pylori NN I-NP
plasmid VBD I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

The DT O
JTc JJ O
delta NN O
among IN O
the DT O
three CD O
groups NNS O
did VBD O
not RB O
differ VB O
as RB O
well RB O
: : O
JTc JJ O
delta NN O
of IN O
the DT O
VT NNP O
group NN O
was VBD O
70 CD O
ms NNS O
+/ VBP O
- : O
30 CD O
ms NNS O
, , O
the DT O
JTc JJ O
delta NN O
of IN O
the DT O
PVC NNP O
group NN O
was VBD O
60 CD O
msec NN O
+/ NN O
- : O
25 CD O
msec NN O
, , O
and CC O
the DT O
JTc JJ O
delta NN O
of IN O
the DT O
control NN O
group NN O
was VBD O
70 CD O
ms NNS O
+/ VBP O
- : O
30 CD O
ms NNS O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
deletion NN O
of IN O
the DT O
upstream JJ O
portion NN O
of IN O
the DT O
delta NN O
promoter NN O
led VBD O
to TO O
a DT O
10 CD O
fold NN O
decrease NN O
in IN O
expression NN O
. . O

-DOCSTART- X X O

Site-directed JJ O
mutagenesis NN O
of IN O
binding NN O
sites NNS O
for IN O
the DT O
repressor NN B-NP
proteins VBZ I-NP
BP1 NNP I-NP
and CC O
BP2 NNP B-NP
in IN O
the DT O
upstream JJ O
portion NN O
of IN O
the DT O
beta NN B-NP
globin NN I-NP
gene NN I-NP
flanking VBG I-NP
region NN I-NP
led VBD O
to TO O
a DT O
4-6 JJ O
fold NN O
increase NN O
in IN O
promoter NN O
activity NN O
. . O

-DOCSTART- X X O

However RB O
, , O
with IN O
the DT O
alpha1 NN O
antagonist NN O
prazosin NN O
( -LRB- O
5 CD O
x NN O
10(-8)-5 CD O
x NN O
10(-7 CD O
) -RRB- O
M) NNP O
, , O
no DT O
relaxation NN O
occurred VBD O
. . O

-DOCSTART- X X O

Differential JJ O
expression NN O
of IN O
AP-2alpha NNP B-NP
and CC O
AP-2beta NNP B-NP
in IN O
the DT O
developing VBG O
chick NN O
retina NN O
: : O
repression NN O
of IN O
R-FABP JJ B-NP
promoter NN I-NP
activity NN O
by IN O
AP-2 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
algorithm NN O
also RB O
limited JJ O
TG NN O
to TO O
20 CD O
and CC O
64 CD O
% NN O
, , O
apoB NN B-NP
to TO O
6 CD O
and CC O
20 CD O
% NN O
, , O
and CC O
Lp( JJ B-NP
a DT I-NP
) -RRB- I-NP
to TO O
15 CD O
and CC O
56 CD O
% NN O
, , O
of IN O
low JJ O
- : O
and CC O
high-risk JJ O
groups NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
value NN O
of IN O
the DT O
CD79b NNP B-NP
to TO O
the DT O
CD79b NNP B-NP
internally RB O
deleted VBD O
ratio NN O
was VBD O
0.64 CD O
+/ CD O
- : O
0.20 CD O
SD NNP O
in IN O
normal JJ O
donors NNS O
and CC O
0.44 CD O
+/ NNS O
- : O
0.27 CD O
SD NNP O
in IN O
B-CLL NNP O
( -LRB- O
P NNP O
=.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

As IN O
normal JJ O
B NNP O
cells NNS O
also RB O
present VBP O
this DT O
variant JJ O
, , O
the DT O
mechanism NN O
of IN O
CD79b NNP B-NP
posttranscriptional JJ O
regulation NN O
might MD O
reflect VB O
the DT O
activation NN O
stage NN O
of IN O
the DT O
normal JJ O
B NNP O
cell NN O
from IN O
which WDT O
B-CLL NNP O
derives VBZ O
. . O

-DOCSTART- X X O

Conformational JJ O
studies NNS O
combining VBG O
secondary JJ O
structure NN O
predictions NNS O
, , O
CD NNP O
and CC O
NMR NNP O
spectroscopy VBP O
together RB O
with IN O
ELISA NNP O
assays VBZ O
, , O
showed VBD O
that IN O
the DT O
greater JJR O
is VBZ O
the DT O
propensity NN O
of IN O
the DT O
epitope NN O
for IN O
helix NN O
formation NN O
the DT O
higher JJR O
is VBZ O
the DT O
recognition NN O
by IN O
anti-K159 DT B-NP
. . O

-DOCSTART- X X O

Schwab NNP O
and CC O
England NNP O
ADL NNP O
scores NNS O
in IN O
the DT O
"off NN O
" `` O
state NN O
were VBD O
improved VBN O
by IN O
18 CD O
% NN O
and CC O
in IN O
the DT O
"on NN O
" `` O
state NN O
the DT O
scores NNS O
declined VBN O
by IN O
2 CD O
% NN O
. . O

-DOCSTART- X X O

High-level JJ O
gains NNS O
( -LRB- O
HLGs NNS O
) -RRB- O
indicative NN O
of IN O
gene NN O
amplifications NNS O
were VBD O
identified VBN O
at IN O
11q13 CD O
in IN O
two CD O
cases NNS O
, , O
and CC O
in IN O
one CD O
case NN O
each DT O
at IN O
2q33-34 CD O
, , O
3q25-29 CD O
, , O
5p15.1-15.2 CD O
, , O
7q21-22 CD O
, , O
11p11.2 CD O
, , O
12p11.2-12 CD O
, , O
and CC O
13q34 CD O
. . O

-DOCSTART- X X O

With IN O
respect NN O
to TO O
the DT O
distribution NN O
of IN O
active JJ O
MREs NNS O
over IN O
the DT O
promoter NN O
region NN O
, , O
the DT O
hMT-IIA JJ B-NP
gene NN I-NP
is VBZ O
largely RB O
different JJ O
from IN O
the DT O
mouse NN O
metallothionein-I JJ B-NP
gene NN I-NP
, , O
suggesting VBG O
that IN O
MRE NNP O
arrangement NN O
is VBZ O
not RB O
an DT O
important JJ O
factor NN O
for IN O
metal NN O
regulation NN O
. . O

-DOCSTART- X X O

The DT O
cDNA NN O
was VBD O
expressed VBN O
in IN O
Saccharomyces NNP O
cerevisiae NNS O
under IN O
the DT O
control NN O
of IN O
the DT O
yeast NN B-NP
triose JJ I-NP
phosphate NN I-NP
isomerase NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
the DT O
RNA NNP O
sequences NNS O
selected VBN O
by IN O
the DT O
mutated JJ O
zinc NN B-NP
knuckle NN I-NP
9G8 IN I-NP
variant NN I-NP
are VBP O
efficiently RB O
recognized VBN O
by IN O
SRp20 NNP B-NP
, , O
in IN O
agreement NN O
with IN O
the DT O
fact NN O
that IN O
the DT O
RBD NNP O
of IN O
9G8 CD B-NP
and CC O
SRp20 NNP B-NP
are VBP O
similar JJ O
. . O

-DOCSTART- X X O

Topoisomerase NNP B-NP
II NNP I-NP
is VBZ O
a DT O
major JJ O
target NN O
of IN O
the DT O
protein NN B-NP
kinase NN I-NP
casein NN I-NP
kinase NN I-NP
2 CD I-NP
( -LRB- O
PK NN B-NP
CK2 NN I-NP
) -RRB- O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Recent JJ O
work NN O
in IN O
this DT O
laboratory NN O
has VBZ O
shown VBN O
that IN O
the DT O
gene NN O
coding NN O
for IN O
acetate NN B-NP
kinase NN I-NP
( -LRB- O
ackA NN B-NP
) -RRB- O
in IN O
Sinorhizobium NN O
meliloti NN O
is VBZ O
up-regulated JJ O
in IN O
response NN O
to TO O
phosphate JJ O
limitation NN O
. . O

-DOCSTART- X X O

All DT O
numbers NNS O
refer VBP O
to TO O
nucleotide VB O
positions NNS O
on IN O
the DT O
wild-type JJ O
HIV-1 NN O
transcript NN O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
revealed VBN O
that IN O
the DT O
MEMA NNP B-NP
protein NN I-NP
is VBZ O
identical JJ O
with IN O
a DT O
160 CD B-NP
kDa NN I-NP
nuclear JJ I-NP
'domain JJ I-NP
rich JJ I-NP
in IN I-NP
serines NNS I-NP
' POS I-NP
( -LRB- I-NP
DRS NNS I-NP
) -RRB- I-NP
protein NN I-NP
occurring VBG O
free JJ O
in IN O
the DT O
nucleoplasm NN O
and CC O
in IN O
U2-ribonucleoprotein JJ B-NP
structures NNS I-NP
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
report VBP O
the DT O
complete JJ O
structure NN O
of IN O
the DT O
human JJ B-NP
topoisomerase NN I-NP
IIalpha NNP I-NP
gene NN I-NP
, , O
which WDT O
consists VBZ O
of IN O
35 CD O
exons NNS O
spanning VBG O
27.5 CD O
kb NN O
. . O

-DOCSTART- X X O

Dopaminergic NNP O
modulation NN O
of IN O
transcallosal NN O
activity NN O
of IN O
cat NN O
motor NN O
cortical JJ O
neurons NNS O
. . O

-DOCSTART- X X O

Previous JJ O
studies NNS O
characterized VBD O
a DT O
cytokine-inducible JJ O
, , O
functional JJ O
nuclear JJ B-NP
factor NN I-NP
( -LRB- I-NP
NF)-kappaB NNP I-NP
consensus NN I-NP
element NN I-NP
in IN O
the DT O
immediate JJ O
5' JJ O
regulatory JJ O
region NN O
of IN O
the DT O
MGSA/GRO-alpha NNP B-NP
gene NN O
at IN O
-78 CD O
bp NN O
. . O

-DOCSTART- X X O

An DT O
exon NN O
that WDT O
prevents VBZ O
transport NN O
of IN O
a DT O
mature JJ O
mRNA NN O
. . O

-DOCSTART- X X O

Four CD O
CsA-treated JJ O
patients NNS O
developed VBD O
persistently RB O
elevated VBN O
UAER NNP O
> IN O
30 CD O
mg/24 CD O
h NN O
( -LRB- O
n NN O
= SYM O
3 CD O
with IN O
microalbuminuria NN O
) -RRB- O
, , O
whereas IN O
all PDT O
the DT O
17 CD O
placebo-treated JJ O
patients NNS O
had VBD O
normal JJ O
UAER NN O
( -LRB- O
< JJ O
30 CD O
mg/24 CD O
h NN O
) -RRB- O
after IN O
7 CD O
years NNS O
of IN O
follow-up NN O
. . O

-DOCSTART- X X O

Mutational JJ O
analysis NN O
of IN O
the DT O
-84/-55 NN O
DNA NN O
showed VBD O
that IN O
JEG-3 JJ O
nuclear JJ O
proteins NNS O
bound VBN O
to TO O
a DT O
site NN O
containing VBG O
, , O
but CC O
not RB O
identical JJ O
to TO O
, , O
the DT O
SF-1 JJ B-NP
sequence NN I-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
no DT O
change NN O
was VBD O
detected VBN O
in IN O
the DT O
phenotype NN O
of IN O
'unstressed JJ O
' '' O
clones NNS O
, , O
with IN O
respect NN O
to TO O
any DT O
of IN O
the DT O
following VBG O
parameters NNS O
: : O
proliferation NN O
rate NN O
in IN O
monolayer NN O
, , O
serum-dependence NN O
for IN O
proliferation NN O
or CC O
survival NN O
, , O
tumorigenicity NN O
, , O
cellular JJ O
morphology NN O
, , O
or CC O
tissue-specific JJ O
differentiation NN O
markers NNS O
. . O

-DOCSTART- X X O

A DT O
high JJ O
reactor NN O
pH NNS O
( -LRB- O
+/-8 CD O
) -RRB- O
, , O
a DT O
short JJ O
solid JJ O
retention NN O
time NN O
( -LRB- O
<150 CD O
days NNS O
) -RRB- O
, , O
and CC O
the DT O
presence NN O
of IN O
a DT O
substantial JJ O
SRB NN O
population NN O
in IN O
the DT O
inoculum NN O
may MD O
considerably RB O
reduce VB O
the DT O
time NN O
required VBN O
for IN O
acetate-utilising JJ O
SRB NNP O
to TO O
outcompete VB O
MB. . O

-DOCSTART- X X O

In IN O
throttling VBG O
valves NNS O
, , O
the DT O
aim NN O
is VBZ O
to TO O
correlate VB O
the DT O
effect NN O
of IN O
shear NN O
to TO O
a DT O
parameter NN O
related VBN O
to TO O
the DT O
inner JJ O
geometry NN O
of IN O
the DT O
valve NN O
and CC O
to TO O
operating VBG O
conditions NNS O
. . O

-DOCSTART- X X O

The DT O
induced JJ O
respiratory NN O
burst NN O
was VBD O
investigated VBN O
by IN O
the DT O
intracellular JJ O
oxidative JJ O
transformation NN O
of IN O
dihydrorhodamine NN O
123 CD O
to TO O
the DT O
fluorescent JJ O
dye NN O
rhodamine NN O
123 CD O
via IN O
flow NN O
cytometry NN O
. . O

-DOCSTART- X X O

A DT O
mutation NN O
linked VBN O
to TO O
the DT O
SOC1 NNP B-NP
gene NN I-NP
, , O
previously RB O
defined VBN O
by IN O
recessive JJ O
mutations NNS O
that IN O
suppress NN O
cbp1 VBD B-NP
ts NNS I-NP
alleles NNS I-NP
and CC O
stabilize VB O
many JJ O
mitochondrial JJ O
mRNAs NNS O
, , O
was VBD O
also RB O
isolated VBN O
. . O

-DOCSTART- X X O

A DT O
deletion NN O
mutation NN O
analysis NN O
of IN O
the DT O
recombinant JJ O
protein NN O
has VBZ O
shown VBN O
that IN O
the DT O
N-terminal JJ O
region NN O
and CC O
the DT O
two CD O
leucine NN O
zippers NNS O
are VBP O
necessary JJ O
for IN O
the DT O
binding NN O
. . O

-DOCSTART- X X O

A DT O
database NN O
search NN O
has VBZ O
revealed VBN O
as IN O
the DT O
most RBS O
significative JJ O
homology NN O
a DT O
match NN O
with IN O
the DT O
human JJ B-NP
mitochondrial NN I-NP
transcription NN I-NP
termination NN I-NP
factor NN I-NP
(mTERF) NN O
, , O
a DT O
protein NN O
that WDT O
also RB O
binds VBZ O
DNA NNP O
as IN O
a DT O
monomer NN O
and CC O
contains VBZ O
three CD O
leucine NN O
zippers NNS O
forming VBG O
intramolecular JJ O
interactions NNS O
. . O

-DOCSTART- X X O

In IN O
all DT O
trials NNS O
, , O
antigen JJ O
challenge NN O
followed VBD O
1 CD O
h NN O
after IN O
the DT O
last JJ O
treatment NN O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
total JJ O
PSA NNP B-NP
can MD O
be VB O
detected VBN O
in IN O
all DT O
cyst NN O
fluids NNS O
and CC O
in IN O
about IN O
75 CD O
% NN O
of IN O
female JJ O
sera NN O
. . O

-DOCSTART- X X O

Type NN O
I PRP O
cysts VBD O
( -LRB- O
with IN O
a DT O
high JJ O
K+/ JJ O
Na+ JJ O
ratio NN O
) -RRB- O
tend VBP O
to TO O
have VB O
higher JJR O
total JJ O
PSA NNP B-NP
than IN O
Type NNP O
II NNP O
cysts NNS O
. . O

-DOCSTART- X X O

Despite IN O
this DT O
DNA NN O
binding NN O
activity NN O
, , O
AP-1 JJ B-NP
reporter NN I-NP
activity NN O
was VBD O
suppressed VBN O
in IN O
these DT O
cells NNS O
. . O

-DOCSTART- X X O

A DT O
single JJ O
N-glycosylation NN O
site NN O
present JJ O
in IN O
chicken NN B-NP
gp42 NN I-NP
is VBZ O
conserved VBN O
among IN O
all DT O
five CD O
of IN O
these DT O
proteins NNS O
: : O
carbohydrate JJ O
analysis NN O
of IN O
gp42 NN B-NP
revealed VBD O
the DT O
presence NN O
of IN O
a DT O
complex JJ O
type NN O
glycan NN O
chain NN O
at IN O
this DT O
site NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
describe VBP O
the DT O
optimization NN O
and CC O
characterization NN O
of IN O
a DT O
140-residue JJ O
fragment NN O
, , O
containing VBG O
the DT O
Runt JJ B-NP
domain NN I-NP
of IN O
AML1 NNP B-NP
, , O
which WDT O
is VBZ O
suitable JJ O
for IN O
structural JJ O
studies NNS O
. . O

-DOCSTART- X X O

Groups NNP O
dicker NN O
for IN O
price NN O
breaks NNS O
as IN O
anesthetic JJ O
gas NN O
goes VBZ O
multi-source JJ O
. . O

-DOCSTART- X X O

Ultrasonography NN O
provides VBZ O
excellent JJ O
intraoperative JJ O
evaluation NN O
of IN O
spinal NN O
cord NN O
injury NN O
. . O

-DOCSTART- X X O

UPMC NNP O
is VBZ O
not RB O
the DT O
only JJ O
organization NN O
pursuing VBG O
controlled VBN O
NHBC NNP O
organ NN O
procurement NN O
, , O
however RB O
. . O

-DOCSTART- X X O

Because IN O
of IN O
concerns NNS O
regarding VBG O
blood NN O
transfusion-related JJ O
communicable JJ O
disease NN O
(eg NN O
, , O
acquired VBN O
immune JJ O
deficiency NN O
syndrome NN O
and CC O
non-A JJ O
, , O
non-B JJ O
hepatitis NN O
) -RRB- O
, , O
there EX O
has VBZ O
been VBN O
increasing VBG O
research NN O
effort NN O
into IN O
postoperative JJ O
hemorrhage NN O
related VBN O
to TO O
cardiopulmonary JJ O
bypass NN O
with IN O
extracorporeal JJ O
circulation NN O
. . O

-DOCSTART- X X O

They PRP O
contrast NN O
trends NNS O
in IN O
fertility NN O
, , O
life NN O
expectancy NN O
ratios NNS O
, , O
and CC O
gender VB O
differences NNS O
in IN O
these DT O
countries NNS O
with IN O
the DT O
Hispanic JJ O
population NN O
of IN O
the DT O
United NNP O
States NNP O
. . O

-DOCSTART- X X O

Hospital NNP O
hit VBD O
for IN O
hiring VBG O
AHERF NNP O
physicians NNS O
. . O

-DOCSTART- X X O

Overexpression IN O
of IN O
either DT O
DAP-1 JJ B-NP
or CC O
sentrin NN B-NP
causes VBZ O
apoptosis NN O
of IN O
TNF-sensitive JJ B-NP
L929 CD O
fibroblast JJ O
cell NN O
line NN O
, , O
as RB O
well RB O
as IN O
TNF-resistant JJ B-NP
osteosarcoma NN O
cell NN O
line NN O
, , O
U2OS. . O

-DOCSTART- X X O

This DT O
is VBZ O
in IN O
contrast NN O
to TO O
PPARgamma2 NNP B-NP
, , O
which WDT O
was VBD O
previously RB O
shown VBN O
to TO O
be VB O
phosphorylated VBN O
at IN O
a DT O
single JJ O
site NN O
in IN O
a DT O
motif NN O
that WDT O
is VBZ O
not RB O
homologous JJ O
to TO O
the DT O
sites NNS O
now RB O
described VBN O
in IN O
PPARalpha NNP B-NP
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
KCC3 NNP B-NP
is VBZ O
a DT O
new JJ O
member NN O
of IN O
the DT O
KCC NNP B-NP
family NN I-NP
that WDT O
is VBZ O
under IN O
distinct JJ O
regulation NN O
from IN O
KCC1 NNP B-NP
. . O

-DOCSTART- X X O

We PRP O
have VBP O
screened VBN O
the DT O
elastin JJ B-NP
gene NN I-NP
for IN O
mutations NNS O
responsible JJ O
for IN O
supravalvular JJ O
aortic JJ O
stenosis NN O
( -LRB- O
SVAS NNP O
) -RRB- O
in IN O
two CD O
large JJ O
, , O
independently RB O
collected VBN O
families NNS O
with IN O
isolated VBN O
( -LRB- O
nonsyndromic JJ O
) -RRB- O
SVAS. . O

-DOCSTART- X X O

Spatiotemporal JJ O
expression NN O
of IN O
the DT O
PAX3 NNP B-NP
gene NN I-NP
is VBZ O
tightly RB O
regulated VBN O
during IN O
development NN O
. . O

-DOCSTART- X X O

25-OH-D3 JJ O
did VBD O
not RB O
adversely RB O
affect VB O
animal JJ O
health NN O
at IN O
the DT O
proposed VBN O
use NN O
level NN O
of IN O
99 CD O
micrograms/kg NN O
feed NN O
when WRB O
replacing VBG O
vitamin NN O
D3 NNS O
in IN O
turkey NN O
rations NNS O
. . O

-DOCSTART- X X O

A DT O
list NN O
of IN O
12 CD O
names NNS O
for IN O
the DT O
disease NN O
and CC O
37 CD O
diagnostic JJ O
criteria NNS O
were VBD O
proposed VBN O
to TO O
a DT O
Consensus NNP O
Panel NNP O
of IN O
12 CD O
Italian JJ O
experts NNS O
who WP O
ranked VBD O
them PRP O
in IN O
order NN O
so RB O
as IN O
to TO O
identify VB O
a DT O
core NN O
set NN O
of IN O
criteria NNS O
. . O

-DOCSTART- X X O

Methanesulfonyl NNP O
fluoride NN O
( -LRB- O
MSF) NNP O
: : O
a DT O
double-blind JJ O
, , O
placebo-controlled JJ O
study NN O
of IN O
safety NN O
and CC O
efficacy NN O
in IN O
the DT O
treatment NN O
of IN O
senile JJ O
dementia NN O
of IN O
the DT O
Alzheimer NNP O
type NN O
. . O

-DOCSTART- X X O

Voluntary NN O
wheel NN O
running VBG O
did VBD O
not RB O
significantly RB O
increase VB O
estimated VBN O
alanine RB O
or CC O
pyruvate VB O
Gneo NNP O
or CC O
absolute JJ O
glycerol NN O
Ra NNP O
. . O

-DOCSTART- X X O

Immediately RB O
after IN O
surgery NN O
, , O
dialysate NN O
PGE2 NN O
and CC O
adenosine NN O
concentrations NNS O
were VBD O
3.7 CD O
+/ NNS O
- : O
0.7 CD O
and CC O
296 CD O
+/ NNS O
- : O
127 CD O
nM NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Because IN O
of IN O
the DT O
probable JJ O
causal JJ O
relationship NN O
between IN O
constitutive JJ O
p210(bcr/abl NN B-NP
) -RRB- O
protein NN B-NP
tyrosine NN I-NP
kinase NN I-NP
activity NN O
and CC O
manifestations NNS O
of IN O
chronic-phase NN O
chronic NN O
myelogenous JJ O
leukemia NN O
( -LRB- O
CML NNP O
; : O
myeloid JJ O
expansion NN O
) -RRB- O
, , O
a DT O
key JJ O
goal NN O
is VBZ O
to TO O
identify VB O
relevant JJ O
p210 IN B-NP
substrates NNS O
in IN O
primary JJ O
chronic-phase NN O
CML NNP O
hematopoietic JJ O
progenitor NN O
cells NNS O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
precipitation NN O
with IN O
a DT O
glutathione-S-transferase-fusion NN B-NP
protein NN I-NP
containing VBG O
the DT O
C-terminal JJ O
transactivation NN O
domain NN O
of IN O
STAT5a NNP B-NP
showed VBD O
GH-regulated JJ B-NP
association NN O
of IN O
ERK1/2 NNP B-NP
with IN O
the DT O
fusion NN O
protein NN O
, , O
while IN O
this DT O
was VBD O
not RB O
seen VBN O
when WRB O
serine NN O
780 CD O
in IN O
STAT5a NNP B-NP
was VBD O
changed VBN O
to TO O
alanine VB O
. . O

-DOCSTART- X X O

One CD O
such JJ O
element NN O
, , O
1P NNP O
, , O
was VBD O
employed VBN O
to TO O
clone NN O
from IN O
a DT O
rat NN O
pituitary NN O
cDNA NN O
expression NN O
library NN O
a DT O
novel NN O
417-amino NNP B-NP
acid NN I-NP
WD VBD I-NP
protein NN I-NP
, , O
designated VBN O
PREB NN B-NP
( -LRB- I-NP
PRL JJ I-NP
regulatory JJ I-NP
element NN I-NP
binding NN I-NP
) -RRB- I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Characterization NN O
of IN O
the DT O
transcription NN B-NP
factor NN I-NP
MTF-1 NN I-NP
from IN O
the DT O
Japanese JJ O
pufferfish NN O
( -LRB- O
Fugu NN O
rubripes NNS O
) -RRB- O
reveals VBZ O
evolutionary JJ O
conservation NN O
of IN O
heavy JJ O
metal NN O
stress NN O
response NN O
. . O

-DOCSTART- X X O

The DT O
peroxisome JJ B-NP
proliferator-activated JJ I-NP
receptors NNS I-NP
( -LRB- O
PPARs NNS B-NP
) -RRB- O
are VBP O
members NNS O
of IN O
the DT O
nuclear JJ B-NP
hormone NN I-NP
receptor NN I-NP
superfamily NN I-NP
. . O

-DOCSTART- X X O

However RB O
, , O
F-SRC-1 NN B-NP
mutant NN I-NP
lacking VBG O
CBP-interacting JJ B-NP
domain NN I-NP
still RB O
preserved VBN O
enhancing VBG O
activity NN O
. . O

-DOCSTART- X X O

The DT O
catalytic JJ O
site NN O
has VBZ O
an DT O
S1 NN O
pocket NN O
lined VBD O
with IN O
conserved JJ O
hydrophobic JJ O
residues NNS O
to TO O
accommodate VB O
the DT O
pyroglutamyl NN O
residue NN O
. . O

-DOCSTART- X X O

The DT O
complete JJ O
circular JJ O
TTV NNP O
genome NN O
contained VBD O
a DT O
novel JJ O
sequence NN O
of IN O
113 CD O
nt NN O
( -LRB- O
nt NN O
3740 CD O
to TO O
3852 CD O
[=0] CD O
) -RRB- O
in IN O
between IN O
the DT O
known VBN O
3' CD O
- : O
and CC O
5'-end JJ O
arms NNS O
, , O
forming VBG O
a DT O
117-nt JJ O
GC-rich JJ O
stretch NN O
( -LRB- O
GC NNP O
content NN O
, , O
90.6 CD O
% NN O
at IN O
nt JJ O
3736 CD O
to TO O
3852 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
Asian JJ O
mouse NN O
Mus NNP O
castaneus NN O
is VBZ O
resistant JJ O
to TO O
infection NN O
by IN O
the DT O
polytropic NN O
mink NN O
cell NN O
focus-inducing NN O
(MCF NN O
) -RRB- O
subgroup NN O
of IN O
murine NN O
leukemia NN O
viruses NNS O
( -LRB- O
MuLVs NNS O
) -RRB- O
. . O

-DOCSTART- X X O

To TO O
determine VB O
the DT O
function NN O
of IN O
VZV NNP B-NP
gK NNP I-NP
in IN O
virus NN O
growth NN O
, , O
a DT O
series NN O
of IN O
gK NNP B-NP
deletion NN I-NP
mutants NNS I-NP
were VBD O
constructed VBN O
with IN O
VZV JJ O
cosmid JJ O
DNA NN O
derived VBN O
from IN O
the DT O
Oka NNP O
strain NN O
. . O

-DOCSTART- X X O

CCAAT NN B-NP
displacement NN I-NP
protein NN I-NP
binds NNS O
to TO O
and CC O
negatively RB O
regulates VBZ O
human JJ O
papillomavirus NN O
type NN O
6 CD O
E6 NNP B-NP
, , O
E7 NNP B-NP
, , O
and CC O
E1 JJ B-NP
promoters NNS O
. . O

-DOCSTART- X X O

As IN O
such JJ O
the DT O
findings NNS O
support VBP O
existing VBG O
studies NNS O
that WDT O
have VBP O
identified VBN O
given VBN O
social JJ O
characteristics NNS O
of IN O
drink NN O
drivers NNS O
. . O

-DOCSTART- X X O

Three CD O
different JJ O
site-directed JJ O
mutations NNS O
of IN O
the DT O
cyclic JJ O
AMP JJ O
response NN O
element NN O
each DT O
reduced VBD O
the DT O
nerve NN B-NP
growth NN I-NP
factor NN I-NP
effect NN O
by IN O
>90 CD O
% NN O
. . O

-DOCSTART- X X O

Using VBG O
an DT O
RNase NNP B-NP
H NNP I-NP
protection NN O
assay NN O
and CC O
specific JJ O
blocking VBG O
oligonucleotides NNS O
, , O
we PRP O
find VBP O
that DT O
recognition NN O
of IN O
the DT O
5' JJ O
splice-site JJ O
( -LRB- O
5 CD O
'ss VBZ O
) -RRB- O
and CC O
branchpoint NN O
sequence NN O
( -LRB- O
BPS) NNP O
elements NNS O
by IN O
U11 NNP B-NP
and CC O
U12 NNP B-NP
snRNPs NNPS I-NP
, , O
respectively RB O
, , O
displays VBZ O
strong JJ O
cooperativity NN O
, , O
requiring VBG O
both DT O
sites NNS O
in IN O
the DT O
pre-mRNA JJ O
substrate JJ O
for IN O
efficient JJ O
complex JJ O
formation NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
lacZ NN B-NP
transcriptional JJ I-NP
fusions NNS I-NP
shows VBZ O
that IN O
the DT O
KdgR-binding JJ B-NP
sites NNS I-NP
negatively RB O
affect VBP O
the DT O
expression NN O
of IN O
rsmB. NNP B-NP

-DOCSTART- X X O

Many JJ O
eukaryotic JJ O
cell NN O
surface NN O
proteins NNS O
are VBP O
anchored VBN O
in IN O
the DT O
lipid JJ O
bilayer NN O
through IN O
glycosylphosphatidylinositol NN O
( -LRB- O
GPI) NNP O
. . O

-DOCSTART- X X O

In IN O
the DT O
cell-free JJ O
import NN O
assay NN O
, , O
beta-catenin JJ B-NP
rapidly RB O
migrates NNS O
into IN O
the DT O
nucleus NN O
without IN O
the DT O
exogenous JJ O
addition NN O
of IN O
cytosol NN O
, , O
Ran VBD B-NP
, , O
or CC O
ATP/GTP. NNP O

-DOCSTART- X X O

In IN O
ischemic JJ O
and CC O
hypoxic JJ O
hypoxia NN O
, , O
a DT O
strong JJ O
correlation NN O
was VBD O
found VBN O
between IN O
cyt NN O
a DT O
,a3 CD O
oxidation NN O
level NN O
and CC O
VO2 NN O
in IN O
both DT O
ischemic JJ O
and CC O
hypoxic JJ O
hypoxia NN O
( -LRB- O
r2 CD O
=.90 CD O
and CC O
.87 CD O
, , O
respectively RB O
) -RRB- O
. . O

-DOCSTART- X X O

An DT O
endogenous JJ O
mammalian JJ O
regulator NN O
of IN O
this DT O
process NN O
, , O
named VBN O
Usurpin NNP B-NP
, , O
has VBZ O
been VBN O
identified VBN O
( -LRB- O
aliases NNS O
for IN O
Usurpin NNP B-NP
include VBP O
CASH NNP B-NP
, , O
Casper NNP B-NP
, , O
CLARP NNP B-NP
, , O
FLAME-1 NNP B-NP
, , O
FLIP NNP B-NP
, , O
I-FLICE NNP B-NP
and CC O
MRIT NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Plasma NNP O
glucose NN O
, , O
immunoreactive JJ B-NP
insulin NN I-NP
( -LRB- O
IRI) NNP B-NP
, , O
C-peptide NNP B-NP
, , O
glucagon NN B-NP
, , O
and CC O
GLP-1 JJ B-NP
levels NNS O
at IN O
each DT O
time NN O
point NN O
during IN O
OGTT NNP O
were VBD O
measured VBN O
. . O

-DOCSTART- X X O

Each DT O
recombinant JJ O
product NN O
was VBD O
a DT O
fusion NN O
protein NN O
with IN O
a DT O
B NNP O
domain NN O
of IN O
Staphylococcal NNP B-NP
protein NN I-NP
A DT I-NP
( -LRB- O
SPA NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Polypyrimidine NNP O
and CC O
ssDNA NN O
binding NN O
by IN O
the DT O
isolated VBN O
VH NNP B-NP
domain NN I-NP
of IN O
immunization-induced JJ O
anti-Z-DNA JJ O
Ab CD O
resembles VBZ O
the DT O
activity NN O
of IN O
natural JJ O
autoantibodies NNS O
and CC O
suggests VBZ O
that IN O
VH-dependent JJ B-NP
binding NN O
to TO O
a DT O
ligand NN O
mimicked VBN O
by IN O
polypyrimidines NNS O
may MD O
play VB O
a DT O
role NN O
in IN O
B NNP O
cell NN O
selection NN O
before IN O
immunization NN O
with IN O
Z-DNA NNP O
. . O

-DOCSTART- X X O

Technetium-99m NNP O
methylene NN O
diphosphonate NN O
scintimammography NN O
for IN O
evaluation NN O
of IN O
palpable JJ O
breast NN O
masses NNS O
. . O

-DOCSTART- X X O

Nuclear JJ O
receptors NNS O
( -LRB- O
NRs NNS O
) -RRB- O
can MD O
function VB O
as IN O
ligandinducible JJ O
transregulators NNS O
in IN O
both DT O
mammalian JJ O
and CC O
yeast NN O
cells NNS O
, , O
indicating VBG O
that DT O
important JJ O
features NNS O
of IN O
transcriptional JJ O
control NN O
have VBP O
been VBN O
conserved VBN O
throughout IN O
evolution NN O
. . O

-DOCSTART- X X O

When WRB O
tethered VBN O
to TO O
a DT O
heterologous JJ O
DNA-binding JJ O
domain NN O
, , O
PSU1 NNP B-NP
can MD O
activate VB O
transcription NN O
on IN O
its PRP$ O
own JJ O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
To TO O
follow-up JJ O
prospectively NN O
patients NNS O
with IN O
arthritis NN O
after IN O
infection NN O
with IN O
beta-haemolytic JJ O
streptococci NNS O
of IN O
Lancefield NNP O
group NN O
A DT O
( -LRB- O
beta JJ O
HSA NN O
) -RRB- O
, , O
with IN O
emphasis NN O
on IN O
clinical JJ O
characteristics NNS O
and CC O
serological JJ O
features NNS O
. . O

-DOCSTART- X X O

Bacteria NNP O
can MD O
also RB O
cause VB O
a DT O
labyrinthitis NN O
acting VBG O
directly RB O
on IN O
the DT O
inner JJ O
ear NN O
: : O
among IN O
these DT O
, , O
Treponemas NNP O
Pallidum NNP O
, , O
a DT O
spirochaete NN O
which WDT O
causes VBZ O
syphilis NNS O
and CC O
Borrelia NNP O
Burgdorferi NNP O
, , O
a DT O
spirochaete NN O
that WDT O
causes VBZ O
Lyme NNP O
Disease NNP O
, , O
must MD O
be VB O
mentioned VBN O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
the DT O
expression NN O
of IN O
the DT O
protein NN O
was VBD O
maximum JJ O
in IN O
mitosis NN O
and CC O
minimum NN O
in IN O
G1 NNP O
, , O
which WDT O
correlated VBD O
with IN O
the DT O
expression NN O
of IN O
its PRP$ O
messenger NN O
RNA NNP O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
demonstrate VBP O
that IN O
signature-tagged JJ O
mutagenesis NN O
is VBZ O
a DT O
viable JJ O
approach NN O
to TO O
identify VB O
bacterial JJ O
genes NNS O
associated VBN O
with IN O
the DT O
ability NN O
to TO O
infect VB O
the DT O
urinary JJ O
tract NN O
. . O

-DOCSTART- X X O

Pathol NN O
. . O

-DOCSTART- X X O

The DT O
eukaryotic JJ O
cell NN O
cycle NN O
is VBZ O
governed VBN O
in IN O
part NN O
by IN O
the DT O
periodic JJ O
transcription NN O
of IN O
cyclin NN B-NP
genes NNS I-NP
, , O
whose WP$ O
protein NN O
products NNS O
associate JJ O
with IN O
and CC O
positively RB O
regulate VB O
the DT O
cyclin-dependent NN B-NP
kinases NNS I-NP
. . O

-DOCSTART- X X O

The DT O
GAC1 NNP B-NP
gene NN I-NP
encodes VBZ O
the DT O
regulatory JJ O
subunit NN O
for IN O
a DT O
type NN B-NP
1 CD I-NP
serine/threonine NN I-NP
phosphoprotein NN I-NP
phosphatase NN I-NP
, , O
Glc7 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
results NNS O
demonstrate VBP O
that IN O
the DT O
Glc7 NNP B-NP
phosphatase NN I-NP
and CC O
its PRP$ O
Gac1 NNP B-NP
regulatory JJ O
subunit NN O
play NN O
positive JJ O
roles NNS O
in IN O
HSF NNP B-NP
activation NN O
of IN O
CUP1 NNP B-NP
transcription NN O
. . O

-DOCSTART- X X O

MEF NNP B-NP
and CC O
AML1B NNP B-NP
synergistically RB O
transactivated VBD O
an DT O
interleukin NN B-NP
3 CD I-NP
promoter NN I-NP
reporter NN I-NP
gene NN I-NP
construct VB I-NP
, , O
yet RB O
the DT O
activating NN O
activity NN O
of IN O
MEF NNP B-NP
was VBD O
abolished VBN O
when WRB O
MEF NNP B-NP
was VBD O
coexpressed VBN O
with IN O
AML1/ETO NNP B-NP
. . O

-DOCSTART- X X O

Mechanistically RB O
, , O
the DT O
presence NN O
of IN O
the DT O
GRR NNP O
appears VBZ O
to TO O
stop VB O
further JJ O
degradation NN O
of IN O
p50 NN B-NP
and CC O
to TO O
stabilize VB O
the DT O
molecule NN O
. . O

-DOCSTART- X X O

This DT O
phosphorylation NN O
can MD O
be VB O
catalyzed VBN O
by IN O
a DT O
break-ended JJ O
double-stranded JJ O
DNA-activated JJ O
protein NN O
kinase NN O
activity NN O
from IN O
the DT O
sea NN O
urchin IN O
nucleus JJ O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Concomitantly RB O
, , O
the DT O
total JJ O
cellular JJ O
level NN O
of IN O
p21 DT B-NP
increased VBN O
severalfold JJ O
via IN O
a DT O
posttranscriptional JJ O
mechanism NN O
. . O

-DOCSTART- X X O

Overall RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
resistant JJ O
genotypes NNS O
exist VBP O
among IN O
the DT O
WAD NNP O
goat NN O
population NN O
. . O

-DOCSTART- X X O

The DT O
molecular JJ O
mechanism NN O
by IN O
which WDT O
Gle2p NNP B-NP
and CC O
the DT O
Gle2p-Nup116p JJ B-NP
interaction NN O
function NN O
in IN O
mRNA JJ O
export NN O
is VBZ O
unknown JJ O
. . O

-DOCSTART- X X O

The DT O
Fyn NNP B-NP
NH2 NNP I-NP
terminus NN I-NP
was VBD O
necessary JJ O
but CC O
not RB O
sufficient JJ O
for IN O
interaction NN O
with IN O
zeta NN O
and CC O
both DT O
Fyn NNP B-NP
kinase NN I-NP
and CC O
SH2 NNP B-NP
domains NNS I-NP
were VBD O
required VBN O
, , O
directing VBG O
phosphorylation NN O
of IN O
zeta NN B-NP
ITAM NNP I-NP
tyrosines NNS O
and CC O
binding JJ O
to TO O
zeta DT B-NP
ITAM NNP I-NP
phosphotyrosines NNS O
. . O

-DOCSTART- X X O

In IN O
budding VBG O
yeast NN O
, , O
the DT O
protein NN O
Skp1p NNP B-NP
, , O
the DT O
cullin-family NN B-NP
member NN I-NP
Cdc53p NNP B-NP
, , O
and CC O
the DT O
F-box/WD-repeat JJ O
protein NN O
Cdc4p IN B-NP
form NN O
the DT O
SCFCdc4p NNP B-NP
ubiquitin NNP B-NP
ligase NN I-NP
complex NN O
, , O
which WDT O
targets VBZ O
the DT O
cyclin-dependent NN B-NP
kinase NN I-NP
( -LRB- O
Cdk NN B-NP
) -RRB- O
inhibitor VBZ O
Sic1p JJ B-NP
for IN O
proteolysis NN O
[3 IN O
] NNP O
[4 CD O
] SYM O
[5 CD O
] SYM O
[6 CD O
] SYM O
[7 CD O
] CD O
[8] NN O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
here RB O
that IN O
, , O
despite IN O
their PRP$ O
structural JJ O
and CC O
functional JJ O
similarities NNS O
, , O
the DT O
pop1 NN B-NP
and CC O
pop2 NN B-NP
genes NNS I-NP
fail VBP O
to TO O
complement VB O
each DT O
other JJ O
's POS O
deletion NN O
phenotypes NNS O
, , O
indicating VBG O
that IN O
they PRP O
perform VBP O
non-redundant JJ O
, , O
but CC O
potentially RB O
interdependent JJ O
, , O
functions NNS O
in IN O
proteolysis NN O
. . O

-DOCSTART- X X O

Antithrombin NNP B-NP
III NNP I-NP
prevents VBZ O
60 CD O
min NN O
warm JJ O
intestinal JJ O
ischemia NN O
reperfusion NN O
injury NN O
in IN O
rats NNS O
. . O

-DOCSTART- X X O

In IN O
retrospect NN O
, , O
the DT O
diagnoses NNS O
were VBD O
reconsidered VBN O
applying VBG O
strict JJ O
criteria NNS O
. . O

-DOCSTART- X X O

Acute NNP O
pancreatitis NN O
as IN O
a DT O
complication NN O
of IN O
polyarteritis NN O
nodosa NN O
. . O

-DOCSTART- X X O

Significantly RB O
greater JJR O
improvement NN O
( -LRB- O
p NN O
< JJ O
0.05 CD O
) -RRB- O
in IN O
the DT O
sertraline NN O
group NN O
first RB O
became VBD O
apparent JJ O
by IN O
the DT O
end NN O
of IN O
week NN O
3 CD O
on IN O
the DT O
Y-BOCS NNP O
and CC O
the DT O
CGI NNP O
Improvement NNP O
scale NN O
, , O
and CC O
by IN O
the DT O
end NN O
of IN O
weeks NNS O
6 CD O
and CC O
8 CD O
, , O
respectively RB O
, , O
on IN O
the DT O
NIMH NNP O
and CC O
CGI NNP O
Severity NNP O
scale NN O
. . O

-DOCSTART- X X O

Stress-inducible JJ B-NP
protein NN I-NP
kinases NNS I-NP
capable JJ O
of IN O
activating VBG O
c-jun JJ B-NP
expression NN O
include VBP O
stress-activated JJ B-NP
protein NN I-NP
kinase/c-Jun NN I-NP
N-terminal JJ B-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
SAPK/JNK) NNP B-NP
and CC O
p38 VBD B-NP
members NNS O
of IN O
the DT O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
MAPK) NNP B-NP
superfamily NN O
of IN O
signaling VBG O
molecules NNS O
. . O

-DOCSTART- X X O

Transforming VBG B-NP
growth NN I-NP
factor NN I-NP
( -LRB- I-NP
TGF)-beta1 DT I-NP
induces VBZ O
extracellular JJ O
matrix NN O
deposition NN O
and CC O
proliferation NN O
of IN O
mesenchymal JJ O
cells NNS O
. . O

-DOCSTART- X X O

Chronotherapeutics NNS O
in IN O
cardiovascular JJ O
disease NN O
. . O

-DOCSTART- X X O

Group NNP O
psychometric JJ O
functions NNS O
for IN O
listeners NNS O
with IN O
hearing VBG O
loss NN O
do VBP O
not RB O
show VB O
a DT O
decrease NN O
in IN O
performance NN O
at IN O
the DT O
largest JJS O
values NNS O
of IN O
delta NN O
f NN O
included VBD O
in IN O
this DT O
study NN O
. . O

-DOCSTART- X X O

Uroflowmetry NN O
can MD O
detect VB O
dysuria NN O
, , O
which WDT O
may MD O
be VB O
poorly RB O
perceived VBN O
or CC O
even RB O
unknown JJ O
to TO O
the DT O
subjects NNS O
themselves PRP O
. . O

-DOCSTART- X X O

Marked NNP O
racial JJ O
variation NN O
in IN O
birthweight NN O
percentiles NNS O
by IN O
gestational JJ O
age NN O
was VBD O
evident JJ O
. . O

-DOCSTART- X X O

Significant JJ O
correlations NNS O
between IN O
mental JJ O
status NN O
as IN O
measured VBN O
by IN O
the DT O
Mini-Mental JJ O
State NNP O
Examination NNP O
and CC O
NA/mI NNP O
, , O
mI/Cr NN O
and CC O
NA NNP O
were VBD O
found VBN O
. . O

-DOCSTART- X X O

Glucagon NNP B-NP
also RB O
induced VBD O
LUC NNP B-NP
activity NN O
very RB O
strongly RB O
when WRB O
the DT O
CRE1 NNP O
and CC O
CRE2 NNP O
sites NNS O
were VBD O
combined VBN O
; : O
induction NN O
of IN O
the DT O
( -LRB- O
CRE1)3(CRE2 NN O
)2SV40-LUC JJ O
constructs NNS O
was VBD O
positively RB O
modulated VBN O
by IN O
the DT O
pO2 NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
report VBP O
the DT O
isolation NN O
and CC O
characterization NN O
of IN O
the DT O
entire JJ O
rat NN B-NP
GSTA3 IN I-NP
(rGST JJ O
Yc1 NN B-NP
) -RRB- O
subunit NN O
gene NN O
. . O

-DOCSTART- X X O

Initial JJ O
control NN O
of IN O
bleeding NN O
is VBZ O
similar JJ O
, , O
but CC O
eradication NN O
is VBZ O
achieved VBN O
in IN O
fewer JJR O
sessions NNS O
with IN O
EVL. NNP O

-DOCSTART- X X O

Finally RB O
, , O
we PRP O
determined VBD O
the DT O
genomic JJ O
organization NN O
of IN O
the DT O
human JJ B-NP
TrxR2 NNP I-NP
gene NN I-NP
, , O
which WDT O
consists VBZ O
of IN O
18 CD O
exons NNS O
spanning VBG O
about IN O
67 CD O
kb NN O
, , O
and CC O
its PRP$ O
chromosomal NN O
localization NN O
at IN O
position NN O
22q11.2 CD O
. . O

-DOCSTART- X X O

The DT O
aims NNS O
of IN O
this DT O
study NN O
were VBD O
to TO O
determine VB O
and CC O
rank VB O
the DT O
frequency NN O
of IN O
self NN O
reported VBD O
visual JJ O
disability NN O
in IN O
daily JJ O
tasks NNS O
performed VBN O
by IN O
glaucoma NN O
patients NNS O
; : O
to TO O
examine VB O
the DT O
interrelation NN O
between IN O
disabilities NNS O
using VBG O
factor NN O
analysis NN O
; : O
to TO O
study VB O
the DT O
relation NN O
between IN O
perceived VBN O
visual JJ O
difficulty NN O
and CC O
a DT O
measure NN O
of IN O
the DT O
severity NN O
of IN O
visual JJ O
field NN O
loss NN O
; : O
to TO O
develop VB O
a DT O
glaucoma NN O
specific JJ O
subgroup NN O
of IN O
questions NNS O
; : O
and CC O
examine VBP O
the DT O
validity NN O
and CC O
reliability NN O
of IN O
this DT O
subgroup NN O
of IN O
questions NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
validity NN O
of IN O
this DT O
new JJ O
subset NN O
of IN O
questions NNS O
was VBD O
shown VBN O
to TO O
be VB O
significant JJ O
( -LRB- O
r=0.037 CD O
, , O
p<0.05 VBD O
) -RRB- O
for IN O
the DT O
correlation NN O
between IN O
a DT O
measure NN O
of IN O
the DT O
severity NN O
of IN O
binocular JJ O
visual JJ O
field NN O
loss NN O
and CC O
the DT O
mean JJ O
score NN O
of IN O
the DT O
variables NNS O
used VBN O
in IN O
the DT O
glaucoma NN O
specific JJ O
subgroup NN O
of IN O
questions NNS O
. . O

-DOCSTART- X X O

Sequence NNP O
comparison NN O
of IN O
cytochromes NNS B-NP
bd VBN I-NP
and CC O
their PRP$ O
homologs NNS O
from IN O
various JJ O
organisms NNS O
demonstrates VBZ O
that IN O
the DT O
proteins NNS O
can MD O
be VB O
classified VBN O
into IN O
two CD O
subfamilies NNS O
, , O
a DT O
proteobacterial JJ O
type NN O
including VBG O
E. NNP B-NP
coli NNS I-NP
bd VBD I-NP
and CC O
a DT O
more RBR O
widely RB O
distributed VBN O
type NN O
including VBG O
the DT O
B. NNP O
stearothermophilus NN O
enzyme NN O
, , O
suggesting VBG O
that IN O
the DT O
latter JJ O
type NN O
is VBZ O
evolutionarily RB O
older JJR O
. . O

-DOCSTART- X X O

Canalith NNP O
repositioning NN O
is VBZ O
the DT O
mainstay NN O
of IN O
treatment NN O
. . O

-DOCSTART- X X O

Solution NNP O
structure NN O
and CC O
mechanism NN O
of IN O
the DT O
MutT NNP B-NP
pyrophosphohydrolase NN I-NP
. . O

-DOCSTART- X X O

In IN O
11 CD O
eyes NNS O
that WDT O
had VBD O
been VBN O
selected VBN O
at IN O
random JJ O
10 CD O
micrograms NNS O
of IN O
recombinant JJ B-NP
tissue NN I-NP
plasminogen NN I-NP
activator NN I-NP
were VBD O
injected VBN O
midvitreally RB O
24 CD O
hrs NNS O
later RB O
. . O

-DOCSTART- X X O

Accordingly RB O
, , O
we PRP O
designated VBD O
this DT O
gene NN B-NP
CTL1 . I-NP
( -LRB- O
capping VBG B-NP
enzyme NN I-NP
RNAtriphosphatase-like JJ I-NP
1 CD I-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
binding NN O
of IN O
PH NNP B-NP
domains VBZ I-NP
to TO O
Gbetagamma NNP B-NP
was VBD O
inhibited VBN O
by IN O
preincubation NN O
of IN O
Gbetagamma NNP B-NP
with IN O
the DT O
GDP-bound JJ O
but CC O
not RB O
the DT O
GTP-bound JJ O
form NN O
of IN O
Gialpha NNP B-NP
. . O

-DOCSTART- X X O

Their PRP$ O
afterglows NNS O
are VBP O
brighter JJR O
than IN O
supernovae NN O
and CC O
therefore RB O
are VBP O
called VBN O
hypernovae NNS O
. . O

-DOCSTART- X X O

Constrictive JJ O
pericarditis NN O
and CC O
pleuropulmonary JJ O
disease NN O
linked VBN O
to TO O
ergot VB O
dopamine NN O
agonist JJ O
therapy NN O
( -LRB- O
cabergoline NN O
) -RRB- O
for IN O
Parkinson NNP O
's POS O
disease NN O
. . O

-DOCSTART- X X O

An DT O
undilated JJ O
type NN O
of IN O
APBD NNP O
is VBZ O
frequently RB O
associated VBN O
with IN O
AMT NNP O
and CC O
we PRP O
believe VBP O
, , O
therefore RB O
, , O
that IN O
clinicians NNS O
should MD O
be VB O
aware JJ O
of IN O
a DT O
possible JJ O
coexistence NN O
of IN O
APBD NNP O
and CC O
AMT. NNP O

-DOCSTART- X X O

In IN O
addition NN O
, , O
we PRP O
also RB O
constructed VBD O
and CC O
expressed VBD O
chimeric JJ O
fusion NN O
protein NN O
that WDT O
contains VBZ O
HIV-2 JJ B-NP
gag NN I-NP
with IN O
V3 DT B-NP
domains NNS O
of IN O
HIV-1IIIB NNP O
, , O
HIV-1MN NNP O
, , O
HIV-1SF2 NNP O
and CC O
HIV-1RF. PRP$ O

-DOCSTART- X X O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
V3 DT B-NP
peptides NNS O
from IN O
all DT O
major JJ O
clades NNS O
of IN O
HIV-1 NN O
carried VBN O
by IN O
HIV-2 PRP$ B-NP
gag NN I-NP
can MD O
be VB O
used VBN O
as IN O
a DT O
potential JJ O
HIV/AIDS NNP O
vaccine NN O
. . O

-DOCSTART- X X O

Efficacy NN O
was VBD O
determined VBN O
by IN O
responses NNS O
to TO O
question NN O
3 CD O
( -LRB- O
ability NN O
to TO O
achieve VB O
an DT O
erection NN O
) -RRB- O
and CC O
question NN O
4 CD O
( -LRB- O
ability NN O
to TO O
maintain VB O
an DT O
erection NN O
) -RRB- O
of IN O
the DT O
15-item JJ O
International NNP O
Index NNP O
of IN O
Erectile NNP O
Function NNP O
( -LRB- O
IIEF NN O
) -RRB- O
. . O

-DOCSTART- X X O

Evidence NN O
for IN O
the DT O
involvement NN O
of IN O
the DT O
Glc7-Reg1 JJ B-NP
phosphatase NN O
and CC O
the DT O
Snf1-Snf4 NNP B-NP
kinase NN O
in IN O
the DT O
regulation NN O
of IN O
INO1 NNP B-NP
transcription NN O
in IN O
Saccharomyces NNP O
cerevisiae NN O
. . O

-DOCSTART- X X O

In IN O
XO NNP O
males NNS O
, , O
two CD O
her-1 JJ B-NP
mRNAs NNS I-NP
, , O
her-1a . B-NP
and CC O
her-1b JJ B-NP
, , O
are VBP O
transcribed VBN O
from IN O
two CD O
separate JJ O
promoters NNS O
: : O
P1 JJ O
, , O
located VBN O
in IN O
the DT O
5'-flanking JJ O
region NN O
, , O
and CC O
P2 JJ O
, , O
located VBN O
in IN O
the DT O
large JJ O
second JJ O
intron NN O
. . O

-DOCSTART- X X O

Induction NN O
of IN O
Fas NNP B-NP
ligand NN I-NP
expression NN O
by IN O
HIV NNP O
involves VBZ O
the DT O
interaction NN O
of IN O
Nef NNP B-NP
with IN O
the DT O
T NNP B-NP
cell NN I-NP
receptor NN I-NP
zeta NN I-NP
chain NN I-NP
. . O

-DOCSTART- X X O

Receptor JJ B-NP
protein NN I-NP
tyrosine NN I-NP
phosphatases NNS I-NP
( -LRB- O
RPTPs NNS B-NP
) -RRB- O
comprise VBP O
a DT O
family NN O
of IN O
proteins NNS O
that WDT O
feature VBP O
intracellular JJ O
phosphatase JJ O
domains NNS O
and CC O
an DT O
ectodomain NN O
with IN O
putative JJ O
ligand-binding JJ O
motifs NNS O
. . O

-DOCSTART- X X O

These DT O
well-characterized JJ O
brain NN O
regions NNS O
may MD O
provide VB O
a DT O
basis NN O
for IN O
future JJ O
studies NNS O
of IN O
RPTP-kappa NNP B-NP
function NN O
. . O

-DOCSTART- X X O

Commonly RB O
used VBN O
stressors NNS O
are VBP O
mental JJ O
arithmetics NNS O
, , O
speech NN O
tasks NNS O
, , O
the DT O
Stroop NNP O
test NN O
, , O
videogame NN O
playing NN O
, , O
films NNS O
or CC O
videotapes NNS O
and CC O
interviews NNS O
. . O

-DOCSTART- X X O

The DT O
control NN O
group NN O
included VBD O
8 CD O
afterbirth NN O
samples NNS O
from IN O
physiological JJ O
full-term JJ O
pregnancies NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
we PRP O
identified VBD O
a DT O
gene NN O
between IN O
the DT O
MDV2 NNP B-NP
UL54 NNP I-NP
and CC O
UL55 DT B-NP
genes NNS I-NP
with IN O
homology NN O
to TO O
the DT O
first JJ B-NP
ORF NN I-NP
( -LRB- I-NP
ORF-1 JJ I-NP
) -RRB- I-NP
of IN I-NP
equine JJ I-NP
herpesvirus NN I-NP
type NN I-NP
1 CD I-NP
and CC O
corresponding JJ O
gene NN O
identified VBN O
in IN O
pseudorabies NNS O
virus NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
loss NN O
of IN O
MAD2 NNP B-NP
staining VBG O
in IN O
meiosis NN O
was VBD O
not RB O
correlated VBN O
with IN O
initial JJ O
microtubule NN O
attachment NN O
but CC O
was VBD O
correlated VBN O
with IN O
a DT O
measure NN O
of IN O
tension NN O
: : O
the DT O
distance NN O
between IN O
homologous JJ O
or CC O
sister NN O
kinetochores NNS O
( -LRB- O
in IN O
meiosis NN O
I PRP O
and CC O
II NNP O
, , O
respectively RB O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
epithelial JJ O
cells NNS O
, , O
the DT O
PH NNP B-NP
domain NN I-NP
of IN O
Akt/PKB NNP B-NP
localised VBD O
to TO O
sites NNS O
of IN O
cell-cell NN O
and CC O
cell-matrix NN O
contact NN O
, , O
distinct JJ O
from IN O
focal JJ O
contacts NNS O
, , O
even RB O
in IN O
the DT O
absence NN O
of IN O
serum NN O
. . O

-DOCSTART- X X O

The DT O
5' JJ O
untranslated JJ O
and CC O
coding NN O
regions NNS O
are VBP O
contained VBN O
within IN O
12 CD O
exons NNS O
, , O
with IN O
the DT O
translation NN O
start NN O
site NN O
located VBN O
within IN O
the DT O
first JJ O
exon NN O
. . O

-DOCSTART- X X O

The DT O
motility NN O
of IN O
sperm NN O
, , O
except IN O
for IN O
those DT O
adjacent JJ O
to TO O
both DT O
electrodes NNS O
, , O
did VBD O
not RB O
change VB O
after IN O
stimulation NN O
for IN O
60s NNS O
, , O
despite IN O
a DT O
high JJ O
electrical JJ O
energy NN O
. . O

-DOCSTART- X X O

Induction NN O
of IN O
the DT O
CINC NNP B-NP
promoter NN I-NP
by IN O
IL-17 NN B-NP
in IN O
IEC-6 NN O
cells NNS O
was VBD O
TNF NNP B-NP
receptor-associated JJ I-NP
factor-6 NN I-NP
( -LRB- O
TRAF6 NN B-NP
) -RRB- O
, , O
but CC O
not RB O
TRAF2 NNP B-NP
, , O
dependent JJ O
. . O

-DOCSTART- X X O

SCFFWD1 NNP B-NP
may MD O
be VB O
critical JJ O
for IN O
tumor NN O
development NN O
and CC O
suppression NN O
through IN O
regulation NN O
of IN O
beta-catenin JJ B-NP
protein NN I-NP
stability NN O
. . O

-DOCSTART- X X O

A DT O
Bub2p-dependent NNP B-NP
spindle NN O
checkpoint NN O
pathway NN O
regulates VBZ O
the DT O
Dbf2p JJ B-NP
kinase NN I-NP
in IN I-NP
budding VBG I-NP
yeast NN I-NP
. . O

-DOCSTART- X X O

We PRP O
analyzed VBD O
the DT O
modular JJ O
organization NN O
of IN O
DNA NNP B-NP
polymerase NN I-NP
beta NN I-NP
and CC O
found VBD O
that IN O
residues NNS O
making VBG O
contact NN O
with IN O
DNA NNP O
phosphates NNS O
were VBD O
localized VBN O
to TO O
five CD O
modules NNS O
. . O

-DOCSTART- X X O

Two-dimensional JJ O
gel NNP O
electrophoresis NN O
of IN O
anti-p59fyn JJ B-NP
immunoprecipitates NNS O
obtained VBN O
from IN O
non-transformed JJ O
resting VBG O
human JJ O
T NNP O
lymphocytes NNS O
resulted VBD O
in IN O
the DT O
identification NN O
of IN O
an DT O
oligomeric JJ O
protein NN O
complex NN O
which WDT O
is VBZ O
constitutively RB O
formed VBN O
between IN O
Fyn NNP B-NP
and CC O
several JJ O
additional JJ O
phosphoproteins NNS O
( -LRB- O
pp43 NN B-NP
, , O
pp72 NN B-NP
, , O
pp85 VBD B-NP
, , O
the DT O
protein NN B-NP
tyrosine NN I-NP
kinase NN I-NP
Pyk2 NNP B-NP
, , O
as RB O
well RB O
as IN O
the DT O
two CD O
recently RB O
cloned VBD O
adaptor JJ O
proteins NNS O
, , O
SKAP55 NNP B-NP
and CC O
SLAP-130 NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
other JJ O
cdc33 NNS B-NP
mutants NNS I-NP
also RB O
arrest VB O
in IN O
G1 NNP O
. . O

-DOCSTART- X X O

A DT O
cdc33-1 JJ B-NP
strain NN O
expressing VBG O
either DT O
stable JJ O
Cln3p NN B-NP
( -LRB- O
Cln3-1p JJ B-NP
) -RRB- O
or CC O
a DT O
hybrid JJ O
UBI4 NNP B-NP
5'-CLN3 CD I-NP
mRNA NN O
, , O
whose WP$ O
translation NN O
displays VBZ O
decreased VBN O
dependence NN O
on IN O
eIF4E JJ B-NP
, , O
arrested VBN O
randomly RB O
in IN O
the DT O
cell NN O
cycle NN O
. . O

-DOCSTART- X X O

Regulatory NNP O
motifs NNS O
for IN O
gene NN O
expression NN O
such JJ O
as IN O
nuclear-factor-kappaB-binding-site-like JJ B-NP
sequence NN I-NP
(kappaB NN O
site NN B-NP
) -RRB- O
and CC O
nuclear-factor-interleukin-6-binding-site-like JJ B-NP
sequence NN I-NP
( -LRB- O
NF-IL-6 UH B-NP
site NN I-NP
) -RRB- O
were VBD O
found VBN O
in IN O
the DT O
5'-upstream JJ O
regulatory JJ O
region NN O
. . O

-DOCSTART- X X O

The DT O
gene NN O
structure NN O
of IN O
Elk1 NNP B-NP
spans VBZ O
15.2 CD O
kb NN O
and CC O
consists VBZ O
of IN O
seven CD O
exons NNS O
and CC O
six CD O
introns NNS O
. . O

-DOCSTART- X X O

Total JJ O
serum NN O
calcium NN O
was VBD O
7.8 CD O
+/ CD O
- : O
0.8 CD O
mg/dl NN O
, , O
whereas IN O
ionized VBN O
calcium NN O
was VBD O
5.7 CD O
+/ CD O
- : O
0.7 CD O
mg/dl NN O
, , O
phosphorus NN O
3.2 CD O
+/ RB O
- : O
1.2 CD O
mg/dl NN O
, , O
and CC O
alkaline NN B-NP
phosphatase NN I-NP
149 CD O
+/ NNS O
- : O
48.6 CD O
U/liter NN O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
suggests VBZ O
that IN O
TtrA NNP B-NP
contains VBZ O
a DT O
molybdopterin NN O
guanine NN O
dinucleotide NN O
cofactor NN O
and CC O
a DT O
[4Fe-4S] JJ O
cluster NN O
, , O
that IN O
TtrB NNP B-NP
binds VBZ O
four CD O
[4Fe-4S] JJ O
clusters NNS O
, , O
and CC O
that DT O
TtrC NNP B-NP
is VBZ O
an DT O
integral NN O
membrane NN O
protein NN O
containing VBG O
a DT O
quinol JJ O
oxidation NN O
site NN O
. . O

-DOCSTART- X X O

Cranio-caudal JJ O
differences NNS O
in IN O
granulation NN O
tissue NN O
formation NN O
: : O
an DT O
experimental JJ O
study NN O
in IN O
the DT O
rat NN O
. . O

-DOCSTART- X X O

Site-directed JJ O
mutagenesis NN O
showed VBD O
that IN O
two CD O
adjacent JJ O
SP1 NNP B-NP
sites NNS I-NP
proximal JJ O
to TO O
exon VB O
1 CD O
were VBD O
equally RB O
important JJ O
in IN O
sustaining VBG O
basal JJ O
promoter NN O
activity NN O
. . O

-DOCSTART- X X O

Breast-fed JJ O
newborn JJ O
infants NNS O
synthesize VBP O
n-6 DT O
long-chain JJ O
polyunsaturated JJ O
fatty NN O
acids NNS O
already RB O
during IN O
the DT O
first JJ O
week NN O
of IN O
life NN O
, , O
but CC O
the DT O
contribution NN O
of IN O
endogenous JJ O
synthesis NN O
to TO O
the DT O
total JJ O
plasma NN O
long-chain RB O
polyunsaturated VBN O
pool NN O
is VBZ O
small JJ O
. . O

-DOCSTART- X X O

Ischemia NNP O
and CC O
reperfusion NN O
markedly NN O
increased VBD O
the DT O
release NN O
of IN O
6-keto-PGF1 JJ O
alpha NN O
and CC O
TXB2 NN O
. . O

-DOCSTART- X X O

Prostate-specific JJ B-NP
antigen NN I-NP
( -LRB- O
PSA NNP B-NP
) -RRB- O
promoter-driven JJ O
androgen-inducible JJ O
expression NN O
of IN O
sodium NN B-NP
iodide NN I-NP
symporter NN I-NP
in IN O
prostate NN O
cancer NN O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
clear JJ O
that IN O
subclinical JJ O
and CC O
silent JJ O
CD NNP O
exist VBP O
in IN O
a DT O
large JJ O
subgroup NN O
of IN O
the DT O
celiac JJ O
population NN O
. . O

-DOCSTART- X X O

Ras2p NNP B-NP
activates VBZ O
invasive JJ O
growth NN O
using VBG O
either DT O
of IN O
two CD O
downstream NN O
signaling VBG O
pathways NNS O
, , O
the DT O
filamentation NN O
MAPK NN B-NP
( -LRB- O
Cdc42p/Ste20p/MAPK) JJ B-NP
cascade NN O
or CC O
the DT O
cAMP-dependent JJ B-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
Cyr1p/cAMP/PKA NNP B-NP
) -RRB- O
pathway NN O
. . O

-DOCSTART- X X O

Consistent NN O
with IN O
this DT O
prediction NN O
, , O
transfections NNS O
into IN O
the DT O
hematopoietic JJ O
cell NN O
line NN O
Jurkat NNP O
showed VBD O
a DT O
9.0- CD O
and CC O
2.5-fold JJ O
activation NN O
of IN O
the DT O
mim-1 NN B-NP
promoter NN I-NP
by IN O
the DT O
p32 NN B-NP
and CC O
p30 VBD B-NP
isoforms NNS I-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

Previous JJ O
work NN O
has VBZ O
shown VBN O
that IN O
spleen JJ B-NP
necrosis NN I-NP
virus NN I-NP
( -LRB- I-NP
SNV NNP I-NP
) -RRB- I-NP
long RB I-NP
terminal JJ I-NP
repeats NNS I-NP
( -LRB- O
LTRs NNS O
) -RRB- O
are VBP O
associated VBN O
with IN O
Rex/Rex-responsive JJ B-NP
element-independent JJ O
expression NN O
of IN O
bovine JJ O
leukemia NN O
virus NN O
RNA NNP O
and CC O
supports VBZ O
the DT O
hypothesis NN O
that IN O
SNV NNP O
RNA NNP O
contains VBZ O
a DT O
cis-acting JJ O
element NN O
that IN O
interacts NNS O
with IN O
cellular JJ B-NP
Rex-like JJ I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Despite IN O
the DT O
reported VBN O
detrimental JJ O
effects NNS O
on IN O
CNS NNP O
development NN O
, , O
a DT O
number NN O
of IN O
animal NN O
studies NNS O
have VBP O
shown VBN O
that IN O
pretreatment NN O
with IN O
corticosteroids NNS O
nevertheless RB O
protect VBP O
the DT O
brain NN O
from IN O
hypoxia-ischemic JJ O
injury NN O
; : O
however RB O
, , O
clinically RB O
such JJ O
treatment NN O
is VBZ O
no RB O
longer RB O
favored VBN O
. . O

-DOCSTART- X X O

In IN O
one CD O
mechanism NN O
, , O
a DT O
specialized JJ O
ubiquitin-dependent JJ B-NP
proteolytic JJ O
system NN O
( -LRB- O
called VBD O
the DT O
APC-dependent NN O
proteolysis NN O
machinery NN O
) -RRB- O
degrades VBZ O
the DT O
mitotic JJ O
( -LRB- O
Clb NN B-NP
) -RRB- O
cyclin NN B-NP
subunit NN I-NP
. . O

-DOCSTART- X X O

Predictors NNS O
of IN O
success NN O
in IN O
pharmacy NN O
school NN O
: : O
PCAT NN O
vs. IN O
other JJ O
admission NN O
criteria NNS O
. . O

-DOCSTART- X X O

Canadian JJ O
survey NN O
reveals VBZ O
widespread JJ O
dissatisfaction NN O
among IN O
physicians NNS O
. . O

-DOCSTART- X X O

In IN O
a DT O
series NN O
of IN O
16 CD O
full-scale JJ O
fire NN O
tests NNS O
, , O
investigators NNS O
at IN O
the DT O
IIT NNP O
Research NNP O
Institute NNP O
have VBP O
concluded VBN O
that IN O
automatic JJ O
door NN O
control NN O
in IN O
the DT O
room NN O
of IN O
fire NN O
origin NN O
can MD O
significantly RB O
reduce VB O
the DT O
spread NN O
of IN O
toxic JJ O
smoke NN O
and CC O
gases NNS O
. . O

-DOCSTART- X X O

Online NNP O
LATCH NNP O
demonstrates VBZ O
a DT O
shift NN O
in IN O
identification NN O
of IN O
the DT O
library NN O
as IN O
an DT O
isolated JJ O
unit NN O
to TO O
an DT O
interactive JJ O
resource NN O
center NN O
. . O

-DOCSTART- X X O

Reporting NNP O
of IN O
adverse JJ O
events NNS O
occurring VBG O
during IN O
clinical JJ O
trials NNS O
of IN O
investigational JJ O
drugs NNS O
is VBZ O
a DT O
complex JJ O
and CC O
controversial JJ O
issue NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
paper NN O
, , O
the DT O
current JJ O
status NN O
of IN O
the DT O
understanding NN O
of IN O
the DT O
interaction NN O
mechanisms NNS O
of IN O
ultrasound NN O
with IN O
biological JJ O
media NNS O
and CC O
the DT O
factors NNS O
that WDT O
govern VBP O
different JJ O
biological JJ O
effects NNS O
are VBP O
surveyed VBN O
. . O

-DOCSTART- X X O

Members NNS O
of IN O
the DT O
mitogen NN B-NP
activated JJ I-NP
protein NN I-NP
( -LRB- I-NP
MAP NNP I-NP
) -RRB- I-NP
kinase NN I-NP
family NN I-NP
, , O
extracellular JJ B-NP
signal-regulated JJ I-NP
kinase NN I-NP
, , O
stress-activated JJ B-NP
protein NN I-NP
kinase-1/c-Jun NN I-NP
NH2-terminal JJ B-NP
kinase NN I-NP
, , O
and CC O
p38 NNS B-NP
, , O
are VBP O
central JJ O
elements NNS O
that WDT O
transduce VBP O
the DT O
signal NN O
generated VBN O
by IN O
growth NN O
factors NNS O
, , O
cytokines NNS O
, , O
and CC O
stressing VBG O
agents NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
have VBP O
investigated VBN O
the DT O
functional JJ O
role NN O
of IN O
the DT O
other JJ O
MAP NNP B-NP
kinases NNS I-NP
in IN O
PDGF-mediated JJ B-NP
cellular JJ O
responses NNS O
. . O

-DOCSTART- X X O

Analyses NNS O
of IN O
tyrosine NN O
residue-mutated JJ O
PDGF NN B-NP
receptors NNS I-NP
show VBP O
that IN O
Src NNP B-NP
homology NN I-NP
2 CD I-NP
domain-containing JJ I-NP
proteins NNS I-NP
including VBG O
Src NNP B-NP
family NN I-NP
kinases NNS I-NP
, , O
phosphatidylinositol NN B-NP
3-kinase NN I-NP
, , O
the DT O
GTPase-activating JJ B-NP
protein NN I-NP
of IN O
Ras NNP B-NP
, , O
the DT O
Src NNP B-NP
homology NN I-NP
2 CD I-NP
domain-containing NN I-NP
phosphatase NN I-NP
SHP-2 NNP B-NP
, , O
phospholipase NN B-NP
C-gamma NN I-NP
, , O
and CC O
Crk NNP B-NP
do VBP O
not RB O
play VB O
a DT O
major JJ O
role NN O
in IN O
mediating VBG O
the DT O
PDGF-induced JJ B-NP
activation NN O
of IN O
p38. VBG B-NP

-DOCSTART- X X O

Here RB O
we PRP O
show VBP O
that DT O
calpeptin NN B-NP
inhibits VBZ O
tyrosine NN B-NP
phosphatases NNS I-NP
, , O
enhancing VBG O
tyrosine FW O
phosphorylation NN O
particularly RB O
of IN O
paxillin NN B-NP
. . O

-DOCSTART- X X O

Three-dimensional JJ O
structural JJ O
studies NNS O
using VBG O
electron NN O
cryomicroscopy NN O
showed VBD O
that IN O
the DT O
binding NN O
of IN O
one CD O
Fab NNP B-NP
( -LRB- O
8H2/G5 NN O
) -RRB- O
does VBZ O
not RB O
affect VB O
the DT O
conformation NN O
of IN O
the DT O
capsid NN O
, , O
and CC O
the DT O
efficiency NN O
of IN O
mRNA JJ O
production NN O
is VBZ O
similar JJ O
to TO O
that DT O
of IN O
the DT O
native JJ O
subviral JJ O
particle NN O
. . O

-DOCSTART- X X O

Further RB O
, , O
mutational JJ O
analysis NN O
of IN O
NS5A PRP B-NP
assigned VBN O
the DT O
SH3-binding JJ B-NP
region NN I-NP
to TO O
a DT O
proline-rich JJ O
motif NN O
that WDT O
is VBZ O
highly RB O
conserved VBN O
among IN O
HCV NNP O
genotypes NNS O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
these DT O
findings NNS O
show VBP O
that DT O
16K JJ B-NP
hPRL NN I-NP
inhibits VBZ O
the DT O
VEGF-induced JJ B-NP
Ras NNP B-NP
activation NN O
; : O
this DT O
antagonism NN O
represents VBZ O
a DT O
novel NN O
and CC O
potentially RB O
important JJ O
mechanism NN O
for IN O
the DT O
control NN O
of IN O
angiogenesis NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
SRE NNP O
oligonucleotide NNP O
gel NNP O
mobility NN O
shift NN O
assays VBZ O
with IN O
nuclear JJ O
extracts NNS O
from IN O
Sertoli NNP O
cells NNS O
demonstrated VBD O
the DT O
presence NN O
of IN O
both DT O
the DT O
SRF NNP B-NP
and CC O
the DT O
ubiquitously RB O
expressed VBN O
bHLH JJ O
protein NN O
E12/E47 NNS B-NP
. . O

-DOCSTART- X X O

We PRP O
calculated VBD O
differences NNS O
in IN O
late JJ O
occlusion NN O
rates NNS O
by IN O
the DT O
chi2 NN O
( -LRB- O
chi-square NN O
) -RRB- O
test NN O
, , O
and CC O
found VBD O
these DT O
differences NNS O
were VBD O
significant JJ O
( -LRB- O
P=.04 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Baseline NNP O
electrocorticography NN O
over IN O
the DT O
surface NN O
of IN O
the DT O
temporal JJ O
lobe NN O
and CC O
depth NN O
electrode NN O
recordings NNS O
in IN O
the DT O
amygdala NN O
and CC O
hippocampus NN O
were VBD O
obtained VBN O
, , O
followed VBN O
by IN O
10 CD O
min NN O
of IN O
recording NN O
before IN O
and CC O
after IN O
the DT O
i FW O
.v. NNP O
administration NN O
of IN O
both DT O
alfentanil NN O
50 CD O
microg/kg NN O
and CC O
fentanyl NN O
10 CD O
microg/kg NN O
. . O

-DOCSTART- X X O

We PRP O
describe VBP O
a DT O
genetic JJ O
system NN O
for IN O
further JJ O
characterizing VBG O
the DT O
role NN O
of IN O
the DT O
extreme JJ O
C-terminus NN O
of IN O
the DT O
beta JJ O
subunit NN O
of IN O
E. NNP B-NP
coli NNS I-NP
RNA NNP I-NP
polymerase NN I-NP
. . O

-DOCSTART- X X O

We PRP O
suggest VBP O
that IN O
FlgN NNP B-NP
and CC O
FliT NNP B-NP
are VBP O
substrate-specific JJ O
flagellar NN O
chaperones NNS O
that WDT O
prevent VBP O
oligomerization NN O
of IN O
the DT O
HAPs NNS B-NP
by IN O
binding NN O
to TO O
their PRP$ O
helical JJ O
domains NNS O
before IN O
export NN O
. . O

-DOCSTART- X X O

Post NNP O
and CC O
core NN O
fabrication NN O
for IN O
divergent JJ O
canals NNS O
with IN O
a DT O
cast NN O
post NN O
and CC O
core NN O
and CC O
a DT O
prefabricated JJ O
dowel NN O
. . O

-DOCSTART- X X O

Rep63A NNP B-NP
( -LRB- I-NP
513 CD I-NP
amino IN I-NP
acids NNS I-NP
[aa] IN I-NP
) -RRB- I-NP
, , O
encoded VBN O
by IN O
the DT O
largest JJS O
ORF NN O
, , O
displayed VBD O
strong JJ O
similarity NN O
( -LRB- O
40 CD O
% NN O
identity NN O
) -RRB- O
to TO O
the DT O
replication NN O
proteins VBZ O
from IN O
plasmids NNS O
pAMbeta1 NNS O
, , O
pIP501 NNS O
, , O
and CC O
pSM19035 PRP O
, , O
indicating VBG O
that IN O
the DT O
pAW63 JJ O
replicon NN O
belongs VBZ O
to TO O
the DT O
pAMbeta1 JJ O
family NN O
of IN O
gram-positive JJ O
theta-replicating JJ O
plasmids NNS O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
report VBP O
the DT O
cloning NN O
and CC O
characterization NN O
of IN O
Xenopus NNP B-NP
Pax-5 NNP I-NP
and CC O
Pax-8 NNP B-NP
, , O
two CD O
orthologues NNS O
of IN O
the DT O
Pax-2/5/8 NNP B-NP
gene NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

Km NNP O
values NNS O
for IN O
ammonium NN O
, , O
2-oxoglutarate JJ O
, , O
NADH NNP O
, , O
glutamate NN O
and CC O
NAD+ NNP O
were VBD O
6.5 CD O
, , O
3.5 CD O
, , O
0.06 CD O
, , O
37.1 CD O
and CC O
0.046 CD O
mM NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Interferon-alpha NNP B-NP
may MD O
exacerbate VB O
cryoblobulinemia-related JJ O
ischemic JJ O
manifestations NNS O
: : O
an DT O
adverse JJ O
effect NN O
potentially RB O
related JJ O
to TO O
its PRP$ O
anti-angiogenic JJ O
activity NN O
. . O

-DOCSTART- X X O

Interferon-alpha NNP B-NP
may MD O
exacerbate VB O
cryoblobulinemia-related JJ O
ischemic JJ O
manifestations NNS O
: : O
an DT O
adverse JJ O
effect NN O
potentially RB O
related JJ O
to TO O
its PRP$ O
anti-angiogenic JJ O
activity NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
we PRP O
demonstrate VBP O
that IN O
the DT O
production NN O
of IN O
active JJ B-NP
recombinant NN I-NP
telomerase NN I-NP
requires VBZ O
a DT O
factor NN O
in IN O
rabbit NN O
reticulocyte NN O
lysate NN O
that WDT O
promotes VBZ O
ribonucleoprotein NN O
assembly NN O
. . O

-DOCSTART- X X O

The DT O
enhanced JJ O
binding NN O
of IN O
c-Abl JJ B-NP
to TO O
DNA NNP O
containing VBG O
5-methylcytosine JJ O
residues NNS O
may MD O
result VB O
from IN O
an DT O
increased VBN O
propensity NN O
of IN O
the DT O
double JJ O
helix NN O
to TO O
denature NN O
locally RB O
coupled VBN O
with IN O
a DT O
protein-induced JJ O
reduction NN O
in IN O
the DT O
base NN O
stacking NN O
interaction NN O
. . O

-DOCSTART- X X O

Homozygous NNP O
mutation NN O
in IN O
two CD O
children NNS O
led VBD O
to TO O
amputation NN O
of IN O
legs NNS O
due JJ O
to TO O
purpura NN O
fulminans NNS O
. . O

-DOCSTART- X X O

According VBG O
to TO O
pilot NN O
experiments NNS O
which WDT O
considered VBD O
various JJ O
durations NNS O
of IN O
global JJ O
no-flow JJ O
ischemia NN O
ranging VBG O
from IN O
10 CD O
to TO O
20 CD O
minutes NNS O
, , O
two CD O
durations NNS O
were VBD O
chosen VBN O
for IN O
the DT O
present JJ O
study NN O
: : O
20 CD O
minutes NNS O
( -LRB- O
group NN O
20 CD O
) -RRB- O
in IN O
which WDT O
ventricular JJ O
fibrillation NN O
(VF NN O
) -RRB- O
was VBD O
the DT O
predominant JJ O
form NN O
of IN O
arrhythmias NNS O
, , O
and CC O
18 CD O
minutes NNS O
( -LRB- O
group NN O
18 CD O
) -RRB- O
in IN O
which WDT O
the DT O
prevalence NN O
of IN O
VF NNP O
was VBD O
markedly RB O
lower JJR O
despite IN O
the DT O
small JJ O
difference NN O
in IN O
the DT O
duration NN O
of IN O
ischemia NN O
. . O

-DOCSTART- X X O

An DT O
end-to-end JJ O
pancreaticojejunostomy NN O
using VBG O
a DT O
mechanical JJ O
purse-string NN O
device NN O
. . O

-DOCSTART- X X O

We PRP O
further RB O
demonstrate VBP O
that IN O
the DT O
Stress-Activated-Protein-Kinase NNP B-NP
( -LRB- O
SAPK) NNP B-NP
target VB O
sites NNS O
of IN O
ATF2 NNP B-NP
, , O
Thr69 NNP O
and CC O
Thr71 NNP O
are VBP O
not RB O
required VBN O
for IN O
the DT O
formation NN O
of IN O
the DT O
p300/CBP-ATF2 JJ B-NP
multiprotein NN O
complex NN O
. . O

-DOCSTART- X X O

Blood NN O
samples NNS O
were VBD O
obtained VBN O
daily RB O
during IN O
this DT O
supplementation NN O
period NN O
and CC O
5 CD O
d NN O
thereafter RB O
( -LRB- O
d JJ O
11 CD O
to TO O
15 CD O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
mitochondrial JJ O
presequences NNS O
interact NN O
with IN O
the DT O
mt-hsp70 NN B-NP
during IN O
or CC O
after IN O
mitochondrial JJ O
protein NN O
import NN O
. . O

-DOCSTART- X X O

The DT O
3' JJ O
terminus NN O
of IN O
the DT O
genome NN O
can MD O
be VB O
folded VBN O
into IN O
a DT O
tRNA-like JJ O
secondary JJ O
structure NN O
that WDT O
has VBZ O
a DT O
valine NN O
anticodon NN O
; : O
the DT O
tRNA-like JJ O
structure NN O
lacks VBZ O
a DT O
pseudoknot NN O
in IN O
the DT O
aminoacyl JJ O
stem NN O
, , O
a DT O
feature NN O
common JJ O
to TO O
both DT O
genera NN O
of IN O
tetraviruses NNS O
. . O

-DOCSTART- X X O

O. NNP B-NP
novo-ulmi NN I-NP
RNA-7 NN I-NP
, , O
previously RB O
believed VBN O
to TO O
be VB O
a DT O
satellite-like JJ O
RNA NNP O
, , O
is VBZ O
shown VBN O
to TO O
be VB O
a DT O
defective JJ O
RNA NN O
, , O
derived VBN O
from IN O
OnuMV4-Ld DT B-NP
RNA NNP I-NP
by IN O
multiple JJ O
internal JJ O
deletions NNS O
. . O

-DOCSTART- X X O

Only RB O
one CD O
gene NN O
, , O
fibronectin NNS B-NP
( -LRB- O
FN) NNP B-NP
, , O
was VBD O
highly RB O
overexpressed VBN O
( -LRB- O
>60-fold JJ O
) -RRB- O
in IN O
LNCaP-r JJ O
cells NNS O
, , O
consistent JJ O
with IN O
previously RB O
reported VBN O
overexpression IN O
of IN O
FN NNP B-NP
in IN O
prostate NN O
cancer NN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
observed VBD O
that IN O
cell NN O
surface NN O
CD4(-)CD8(-)CD3(-) JJ B-NP
cells NNS O
with IN O
rearranged JJ B-NP
TCR NNP I-NP
genes NNS I-NP
developed VBN O
from IN O
Id3-transduced JJ B-NP
but CC O
not RB O
from IN O
control-transduced JJ O
pre-T JJ O
cells NNS O
in IN O
an DT O
FTOC. . O

-DOCSTART- X X O

As IN O
determined VBN O
in IN O
a DT O
modified VBN O
yeast NN O
two-hybrid JJ O
system NN O
, , O
mIRS3 NNS B-NP
bound VBN O
strongly RB O
to TO O
the DT O
p85 NN B-NP
subunit NN I-NP
of IN O
phosphatidylinositol NN B-NP
3-kinase CD I-NP
. . O

-DOCSTART- X X O

Insulin NNP B-NP
stimulation NN O
promoted VBN O
the DT O
association NN O
of IN O
mIRS3 JJ B-NP
with IN O
p85 PRP B-NP
, , O
SHP2 NNP B-NP
, , O
Nck NNP B-NP
, , O
and CC O
Shc NNP B-NP
. . O

-DOCSTART- X X O

The DT O
mRNA JJ O
expression NN O
of IN O
RFX1 NNP B-NP
, , O
RFX2 NNP B-NP
, , O
and CC O
RFX3 PRP B-NP
was VBD O
detected VBN O
ubiquitously RB O
, , O
but CC O
in IN O
transient-transfection NN O
assays VBZ O
, , O
multimerized JJ B-NP
RFX NNP I-NP
binding NN I-NP
sites NNS I-NP
in IN O
front NN O
of IN O
a DT O
basal NN O
promoter NN O
efficiently RB O
functioned VBD O
in IN O
a DT O
tissue NN O
- : O
and CC O
lineage-specific JJ O
manner NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
case NN O
of IN O
the DT O
unspliceable JJ O
intron NN O
, , O
repression NN O
of IN O
luciferase NN B-NP
expression NN O
likely RB O
involved VBN O
two CD O
AUF1-binding JJ B-NP
sequences NNS I-NP
, , O
since IN O
luciferase NN B-NP
expression NN O
was VBD O
increased VBN O
by IN O
deletion NN O
of IN O
these DT O
sites NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
VDR NNP B-NP
acts VBZ O
selectively RB O
on IN O
the DT O
two CD O
components NNS O
required VBN O
for IN O
activation NN O
of IN O
this DT O
promoter/enhancer NN O
: : O
it PRP O
competes VBZ O
with IN O
NFAT1 NNP B-NP
for IN O
binding NN O
to TO O
the DT O
composite JJ O
site NN O
, , O
positioning VBG O
itself PRP O
adjacent JJ O
to TO O
Jun-Fos NNP B-NP
on IN O
the DT O
DNA NN O
. . O

-DOCSTART- X X O

Two CD O
evolutionarily RB O
conserved VBN O
kinases NNS O
, , O
the DT O
cyclin NN B-NP
B NNP I-NP
( -LRB- O
Clb NN B-NP
)/cyclin-dependent JJ O
kinase NN B-NP
( -LRB- O
Cdk/Cdc28p NN B-NP
) -RRB- O
and CC O
Cdc7p NNP B-NP
along IN O
with IN O
its PRP$ O
interacting JJ O
factor NN O
Dbf4p NN B-NP
, , O
are VBP O
required VBN O
late RB O
in IN O
G1 NNP O
to TO O
initiate VB O
DNA NNP O
replication NN O
. . O

-DOCSTART- X X O

The DT O
RanQ69L NNP B-NP
preincubation NN O
leads VBZ O
to TO O
accumulation NN O
of IN O
CRM1 NNP B-NP
at IN O
the DT O
cytoplasmic JJ O
periphery NN O
of IN O
the DT O
nuclear JJ O
pore NN O
complex NN O
( -LRB- O
NPC NN O
) -RRB- O
in IN O
association NN O
with IN O
the DT O
p62 NN B-NP
complex NN I-NP
and CC O
Can/Nup214 NNP B-NP
. . O

-DOCSTART- X X O

All DT O
of IN O
the DT O
elements NNS O
exhibited VBD O
a DT O
uniform JJ O
structure NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
deduced JJ O
amino JJ O
acid NN O
sequence NN O
of IN O
a DT O
second JJ O
family NN O
( -LRB- O
ART5 IN B-NP
) -RRB- O
of IN O
transferases NNS O
, , O
cloned VBD O
from IN O
murine NN O
lymphoma NN O
cells NNS O
and CC O
expressed VBN O
in IN O
high JJ O
abundance NN O
in IN O
testis NN O
, , O
displays VBZ O
a DT O
hydrophobic JJ O
amino IN O
terminus NN O
, , O
consistent JJ O
with IN O
a DT O
signal NN O
sequence NN O
, , O
but CC O
lacks VBZ O
a DT O
hydrophobic JJ O
signal NN O
sequence NN O
at IN O
its PRP$ O
carboxyl NN O
terminus NN O
, , O
suggesting VBG O
that IN O
the DT O
protein NN O
is VBZ O
destined VBN O
for IN O
export NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Each DT O
year NN O
, , O
on IN O
average JJ O
39 CD O
% NN O
of IN O
cases NNS O
seen VBN O
in IN O
Sardinia NNP O
are VBP O
notified VBN O
; : O
646 CD O
( -LRB- O
40 CD O
% NN O
) -RRB- O
of IN O
the DT O
1591 CD O
patients NNS O
notified VBD O
during IN O
the DT O
study NN O
period NN O
were VBD O
never RB O
seen VBN O
by IN O
regional JJ O
medical JJ O
centres NNS O
. . O

-DOCSTART- X X O

This DT O
dimer NN O
interface NN O
is VBZ O
likely JJ O
important JJ O
for IN O
increasing VBG O
the DT O
DNA-binding NN O
specificity NN O
and CC O
affinity NN O
of IN O
the DT O
trimeric JJ O
form NN O
of IN O
HSF NNP B-NP
, , O
as RB O
well RB O
as IN O
for IN O
increasing VBG O
cooperativity NN O
between IN O
adjacent JJ O
trimers NNS O
. . O

-DOCSTART- X X O

The DT O
paramyxovirus NN B-NP
fusion NN I-NP
( -LRB- I-NP
F NN I-NP
) -RRB- I-NP
protein NN I-NP
mediates NNS O
membrane NN O
fusion NN O
. . O

-DOCSTART- X X O

Additionally RB O
, , O
deletion NN O
analysis NN O
of IN O
the DT O
UCP2 NNP B-NP
promoter-PLAP JJ O
constructs NNS O
indicated VBD O
that IN O
the DT O
minimal JJ O
region NN O
exhibiting VBG O
the DT O
promoter NN O
activity NN O
was VBD O
located VBN O
between IN O
nt JJ O
-33 JJ O
and CC O
+100 CD O
, , O
and CC O
that IN O
a DT O
strong JJ O
enhancer NN O
was VBD O
present JJ O
within IN O
601 CD O
bp NN O
of IN O
the DT O
5'-promoter JJ O
region NN O
. . O

-DOCSTART- X X O

The DT O
hTERT JJ B-NP
gene NN I-NP
encompasses VBZ O
more JJR O
than IN O
37kb CD O
and CC O
consists VBZ O
of IN O
16 CD O
exons NNS O
. . O

-DOCSTART- X X O

Both DT O
betaAPP IN B-NP
mRNA NN I-NP
and CC O
Abeta NNP B-NP
levels NNS O
are VBP O
increased VBN O
in IN O
trisomy NN O
21 CD O
. . O

-DOCSTART- X X O

In IN O
reperfusion NN O
B NNP O
, , O
only RB O
the DT O
diabetic NN O
group NN O
demonstrated VBD O
a DT O
significant JJ O
increase NN O
in IN O
IL-8 DT B-NP
concentrations NNS O
at IN O
1 CD O
and CC O
15 CD O
min NN O
compared VBN O
to TO O
nondiabetics NNS O
. . O

-DOCSTART- X X O

This DT O
repression NN O
was VBD O
reversed VBN O
agonists NNS O
of IN O
either DT O
receptor NN O
demonstrating VBG O
a DT O
functional JJ O
interaction NN O
between IN O
NCoR NNP B-NP
and CC O
PPARalpha.RXRalpha NNP B-NP
heterodimeric JJ O
complexes NNS O
in IN O
mammalian JJ O
cells NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
show VBP O
that IN O
SRm160/300 PRP B-NP
is VBZ O
required VBN O
for IN O
a DT O
purine-rich JJ O
ESE NNP B-NP
to TO O
promote VB O
the DT O
splicing NN O
of IN O
a DT O
pre-mRNA JJ O
derived VBN O
from IN O
the DT O
Drosophila NNP B-NP
doublesex NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Spc42p NNP B-NP
also RB O
was VBD O
identified VBN O
as IN O
a DT O
component NN O
of IN O
a DT O
cytoplasmic JJ O
SPB NN O
subcomplex NN O
containing VBG O
Spc94p/Nud1p NNP B-NP
, , O
Cnm67p NNP B-NP
, , O
and CC O
Spc42p NNP B-NP
. . O

-DOCSTART- X X O

The DT O
average JJ O
coefficients NNS O
of IN O
correlation NN O
were VBD O
0.9998 CD O
and CC O
0.9993 CD O
for IN O
the DT O
QMF NNP O
and CC O
the DT O
QIT NNP O
system NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
5-year JJ O
OS NNP O
for IN O
stage NN O
IIIB NNP O
was VBD O
30.9 CD O
% NN O
, , O
compared VBN O
to TO O
7.8 CD O
% NN O
for IN O
stage NN O
IV. . O

-DOCSTART- X X O

Furthermore RB O
, , O
heparin IN B-NP
lyase NN I-NP
treatment NN O
of IN O
extracts NNS O
of IN O
cells NNS O
expressing VBG O
recombinant JJ B-NP
YD-repeat JJ I-NP
protein NN I-NP
releases NNS O
this DT O
protein NN O
from IN O
high JJ O
molecular JJ O
mass NN O
aggregates NNS O
. . O

-DOCSTART- X X O

The DT O
coefficient NN O
of IN O
determination NN O
, , O
r2 CD O
, , O
of IN O
the DT O
other JJ O
scores NNS O
ranged VBN O
from IN O
0.56 CD O
to TO O
0.61 CD O
. . O

-DOCSTART- X X O

While IN O
determination NN O
of IN O
the DT O
protein NN O
content NN O
of IN O
the DT O
formulae NNS O
gave VBD O
no DT O
valid JJ O
information NN O
, , O
RAST/EAST NNP O
inhibition NN O
was VBD O
highest JJS O
for IN O
cow NN O
's POS O
milk NN O
, , O
followed VBN O
by IN O
the DT O
partially RB O
hydrolysed JJ O
whey IN O
formula NN O
, , O
partially RB O
hydrolysed JJ O
whey/casein IN O
formula NN O
, , O
soy/pork NN B-NP
collagen NN I-NP
formula NN O
, , O
and CC O
the DT O
amino JJ O
acid NN O
formula NN O
. . O

-DOCSTART- X X O

In IN O
light NN O
of IN O
the DT O
importance NN O
of IN O
GnRHR NNP B-NP
, , O
the DT O
molecular JJ O
mechanisms NNS O
underlying VBG O
the DT O
transcriptional JJ O
regulation NN O
of IN O
the DT O
human JJ B-NP
GnRHR NN I-NP
( -LRB- O
hGnRHR NN B-NP
) -RRB- O
gene NN O
become VBN O
a DT O
key JJ O
issue NN O
in IN O
understanding VBG O
human JJ O
reproduction NN O
. . O

-DOCSTART- X X O

Competitive JJ O
mobility NN O
shift NN O
assays VBZ O
using VBG O
either DT O
alphaT3-1 NN O
nuclear JJ O
extract VB O
or CC O
recombinant VB B-NP
SF-1 JJ I-NP
protein NN I-NP
clearly RB O
indicated VBD O
that IN O
SF-1 NNP B-NP
is VBZ O
able JJ O
to TO O
interact VB O
specifically RB O
with IN O
this DT O
GSE NNP B-NP
element NN I-NP
positioned VBD O
at IN O
-134 NNP O
. . O

-DOCSTART- X X O

Grade NNP O
3 CD O
mucositis NN O
was VBD O
reported VBN O
in IN O
1 CD O
patient NN O
. . O

-DOCSTART- X X O

CDK4 NNP B-NP
kinase NN I-NP
activities NNS O
were VBD O
unaffected JJ O
, , O
as RB O
were VBD O
the DT O
levels NNS O
of IN O
the DT O
CDK NNP B-NP
inhibitor IN O
p21Cip1 DT B-NP
present JJ O
in IN O
cyclin NN B-NP
E NNP I-NP
immunocomplexes NNS I-NP
. . O

-DOCSTART- X X O

The DT O
recombinant NN O
purified VBN O
protein NN O
expressed VBN O
in IN O
the DT O
baculovirus NN O
system NN O
had VBD O
an DT O
approximate JJ O
molecular JJ O
size NN O
20 CD O
kDa NN O
with IN O
amino-terminal JJ O
sequence NN O
of IN O
AVQGP. NNP O

-DOCSTART- X X O

Induction NN O
of IN O
the DT O
urokinase NN B-NP
promoter NN I-NP
by IN O
HGF/SF NNP B-NP
via IN O
the DT O
Met NNP B-NP
receptor NN I-NP
was VBD O
blocked VBN O
by IN O
co-expression NN O
of IN O
a DT O
dominant-negative JJ O
Grb2 NNP B-NP
and CC O
Sos1 NNP B-NP
expression NN O
construct VB O
. . O

-DOCSTART- X X O

Serine NN O
phosphorylation NN O
of IN O
STAT3 NNP B-NP
was VBD O
only RB O
apparent JJ O
after IN O
somatostatin NN B-NP
treatment NN O
and CC O
was VBD O
abolished VBN O
by IN O
pertussis NN B-NP
toxin NN I-NP
or CC O
PD NNP O
98059 CD O
, , O
together RB O
with IN O
the DT O
associated JJ O
increases NNS O
in IN O
proliferation NN O
. . O

-DOCSTART- X X O

Nevertheless RB O
, , O
we PRP O
demonstrate VBP O
that IN O
the DT O
entire JJ O
three-component JJ O
yeast NN O
capping VBG O
apparatus NN O
, , O
consisting VBG O
of IN O
RNA NNP B-NP
5'-triphosphatase JJ I-NP
( -LRB- O
Cet1p NNP B-NP
) -RRB- O
, , O
RNA NNP B-NP
guanylyltransferase NN I-NP
( -LRB- O
Ceg1p NNP B-NP
) -RRB- O
, , O
and CC O
Abd1p NNP B-NP
could MD O
be VB O
replaced VBN O
in IN O
vivo JJ O
by IN O
the DT O
two-component JJ O
mammalian JJ O
apparatus NN O
consisting VBG O
of IN O
a DT O
bifunctional JJ O
triphosphatase-guanylyltransferase NN B-NP
Mce1p NNP I-NP
and CC O
the DT O
methyltransferase NN B-NP
Hcm1( IN I-NP
121-476)p CD I-NP
. . O

-DOCSTART- X X O

The DT O
IC50 NN O
values NNS O
for IN O
rat NN O
and CC O
dog NN O
urinary JJ O
bladder NN O
were VBD O
3.9 CD O
x NN O
10(-6 CD O
) -RRB- O
M NNP O
and CC O
3.8 CD O
x NN O
10(-6 CD O
) -RRB- O
M NNP O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Although IN O
it PRP O
has VBZ O
two CD O
potential JJ O
binding NN O
sites NNS O
, , O
the DT O
purified VBN O
MerR NNP B-NP
homodimer NN I-NP
binds NNS O
only RB O
one CD O
Hg(II NN O
) -RRB- O
ion NN O
, , O
employing VBG O
Cys82 NNS O
from IN O
one CD O
monomer NN O
and CC O
Cys117 NNS O
and CC O
Cys126 NNS O
from IN O
the DT O
other JJ O
. . O

-DOCSTART- X X O

The DT O
results NNS O
of IN O
the DT O
lab NN O
and CC O
field NN O
tests NNS O
yielded VBD O
high JJ O
levels NNS O
of IN O
infestation NN O
in IN O
larvae JJ O
with IN O
values NNS O
ranging VBG O
from IN O
90 CD O
to TO O
100 CD O
% NN O
and CC O
from IN O
85 CD O
to TO O
95 CD O
% NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Amisulpride NNP O
400 CD O
mg NN O
had VBD O
several JJ O
adverse JJ O
effects NNS O
on IN O
psychomotor NN O
and CC O
, , O
although IN O
less RBR O
severe JJ O
, , O
on IN O
cognitive JJ O
performance NN O
on IN O
the DT O
fifth JJ O
day NN O
only RB O
. . O

-DOCSTART- X X O

MutY NNP B-NP
is VBZ O
an DT O
adenine-DNA JJ B-NP
glycosylase NN I-NP
with IN O
specificity NN O
for IN O
mismatches NNS O
involving VBG O
8-oxoguanine CD O
(oG.A NN O
) -RRB- O
or CC O
guanine VB O
( -LRB- O
G.A NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
kinetics NNS O
of IN O
kinase NN O
activity NN O
within IN O
these DT O
complexes NNS O
compared VBN O
to TO O
CheA NNP B-NP
alone RB O
indicate VBP O
approximately RB O
a DT O
50 CD O
% NN O
decrease NN O
in IN O
the DT O
KM NNP O
for IN O
ATP NNP O
and CC O
a DT O
100-fold JJ O
increase NN O
in IN O
the DT O
Vmax NNP O
. . O

-DOCSTART- X X O

Latexin RB B-NP
, , O
a DT O
carboxypeptidase NN B-NP
A DT I-NP
inhibitor NN O
, , O
is VBZ O
expressed VBN O
in IN O
a DT O
cell NN O
type-specific JJ O
manner NN O
in IN O
both DT O
central JJ O
and CC O
peripheral JJ O
nervous JJ O
systems NNS O
in IN O
the DT O
rat NN O
. . O

-DOCSTART- X X O

Regression NNP O
analyses NNS O
identified VBD O
7 CD O
risk NN O
and CC O
7 CD O
protective JJ O
factors NNS O
with IN O
minimal JJ O
overlap NN O
. . O

-DOCSTART- X X O

During IN O
1985 CD O
, , O
1990 CD O
, , O
and CC O
1995 CD O
, , O
respectively RB O
, , O
11.7 CD O
, , O
11.3 CD O
, , O
and CC O
11.4 CD O
infants NNS O
per IN O
100,000 CD O
live JJ O
births NNS O
had VBD O
a DT O
diagnosis NN O
of IN O
HSV NNP O
( -LRB- O
P=.98 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Subsets NNS O
of IN O
patients NNS O
were VBD O
performed VBN O
according VBG O
to TO O
the DT O
severity NN O
of IN O
trauma NN O
( -LRB- O
ISS NNP O
< NNP O
9 CD O
; : O
9-17 CD O
; : O
18-31 CD O
; : O
> JJ O
32 CD O
) -RRB- O
, , O
based VBN O
on IN O
the DT O
different JJ O
injury NN O
pattern NN O
, , O
and CC O
survivors NNS O
versus RB O
nonsurvivors NNS O
as RB O
well RB O
. . O

-DOCSTART- X X O

The DT O
median JJ O
age NN O
was VBD O
33 CD O
years NNS O
( -LRB- O
range NN O
17-56 JJ O
years NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Developmental NNP O
follow-up NN O
at IN O
age NN O
2 CD O
years NNS O
was VBD O
performed VBN O
. . O

-DOCSTART- X X O

In IN O
the DT O
whole JJ O
group NN O
of IN O
infected JJ O
children NNS O
, , O
an DT O
age-specific JJ O
z NN O
score NN O
< RB O
-2 RB O
for IN O
weight NN O
and CC O
for IN O
FFM NNP O
was VBD O
significantly RB O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
of IN O
death NN O
[relative JJ O
risk NN O
(95 IN O
% NN O
CI) IN O
= SYM O
11.4 CD O
( -LRB- O
3.1 CD O
, , O
41.0) CD O
and CC O
5.1 CD O
( -LRB- O
1.5 CD O
, , O
18.2 CD O
) -RRB- O
, , O
respectively RB O
] SYM O
; : O
when WRB O
only JJ O
children NNS O
with IN O
more RBR O
severe JJ O
disease NN O
were VBD O
considered VBN O
, , O
only RB O
z NN O
score NN O
for IN O
weight NN O
was VBD O
significantly RB O
associated VBN O
with IN O
an DT O
increased VBN O
risk NN O
[4.6 IN O
( -LRB- O
1.4 CD O
, , O
14.9)] CD O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
these DT O
cells NNS O
contained VBD O
one CD O
, , O
two CD O
, , O
or CC O
multiple JJ O
nuclei JJ O
indicative NN O
of IN O
a DT O
G2/M JJ O
delay NN O
in IN O
nuclear JJ O
division NN O
and CC O
also RB O
a DT O
defect NN O
in IN O
cytokinesis NN O
and/or CC O
cell NN O
separation NN O
. . O

-DOCSTART- X X O

DAF16 NNP B-NP
is VBZ O
known VBN O
to TO O
be VB O
a DT O
component NN O
of IN O
a DT O
signaling VBG O
pathway NN O
that WDT O
has VBZ O
been VBN O
partially RB O
dissected VBN O
genetically RB O
and CC O
includes VBZ O
homologues NNS O
of IN O
the DT O
insulin/IGF-1 NN B-NP
receptor NN B-NP
, , O
PtdIns NNP B-NP
3-kinase CD I-NP
and CC O
PKB. NNP B-NP

-DOCSTART- X X O

However RB O
, , O
neu NN B-NP
differentiation NN O
factor-induced JJ O
heterodimers NNS O
of IN O
ErbB2 NNP B-NP
and CC O
ErbB4 NNP B-NP
activated VBD O
Stat5 NNP B-NP
. . O

-DOCSTART- X X O

Although IN O
linker NN O
regions NNS O
in IN O
transcription NN O
factors NNS O
are VBP O
known VBN O
to TO O
modulate VB O
DNA NNP O
binding NN O
specificity NN O
, , O
our PRP$ O
studies NNS O
suggest VBP O
that IN O
the DT O
human JJ B-NP
HSF1 NNP I-NP
linker NN O
plays VBZ O
no DT O
role NN O
in IN O
determining VBG O
HSF1 IN B-NP
binding JJ O
preferences NNS O
in IN O
vivo JJ O
but CC O
is VBZ O
a DT O
critical JJ O
determinant NN O
in IN O
regulating VBG O
the DT O
HSF1 NNP B-NP
monomer-trimer NN I-NP
equilibrium NN O
. . O

-DOCSTART- X X O

Modulation NNP O
of IN O
human JJ B-NP
heat NN I-NP
shock NN I-NP
factor NN I-NP
trimerization NN O
by IN O
the DT O
linker NN O
domain NN O
. . O

-DOCSTART- X X O

Both DT O
functional JJ O
analyses NNS O
in IN O
undifferentiated JJ O
and CC O
differentiated JJ O
F9 IN O
cells NNS O
and CC O
characterization NN O
of IN O
DNA-protein NNP O
complexes NNS O
in IN O
vitro NN O
have VBP O
identified VBN O
the DT O
sequence NN O
motifs NNS O
GTGACT( NNP O
C) NNP O
, , O
ATTGT NNP O
, , O
and CC O
GATA NNP O
as IN O
the DT O
key JJ O
transcription NN O
factor NN O
binding VBG O
sites NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
phenotype NN O
of IN O
XLP NNP O
may MD O
result VB O
from IN O
perturbed JJ O
signaling NN O
not RB O
only RB O
through IN O
SLAM NNP B-NP
, , O
but CC O
also RB O
other JJ O
cell NN O
surface NN O
molecules NNS O
that WDT O
utilize VBP O
SAP NNP B-NP
as IN O
a DT O
signaling VBG O
adaptor JJ O
protein NN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
localized VBD O
the DT O
Fra-2 JJ B-NP
phosphorylation NN I-NP
sites NNS I-NP
by IN O
MAPK NNP B-NP
to TO O
three CD O
threonine CD O
and CC O
three CD O
serine NN O
residues NNS O
in IN O
the DT O
COOH-terminal JJ O
region NN O
by IN O
means NNS O
of IN O
site-directed JJ O
mutagenesis NN O
and CC O
showed VBD O
that IN O
the DT O
threonine CD O
residues NNS O
were VBD O
more RBR O
susceptible JJ O
to TO O
MAPK. NNP B-NP

-DOCSTART- X X O

Nevertheless RB O
, , O
they PRP O
are VBP O
functionally RB O
distinct JJ O
in IN O
that DT O
FcalphaRI NNP B-NP
binds NNS O
human JJ B-NP
IgA NNP I-NP
( -LRB- O
hIgA NN B-NP
) -RRB- O
but CC O
not RB O
bovine JJ B-NP
IgG2 NNP I-NP
( -LRB- O
bIgG2 NN B-NP
) -RRB- O
, , O
whereas IN O
bFcgamma2R JJ B-NP
binds NNS O
bIgG2 CC B-NP
but CC O
not RB O
hIgA RB B-NP
. . O

-DOCSTART- X X O

Vac1p NNP B-NP
was VBD O
found VBN O
to TO O
bind NN O
the DT O
Sec1p NNP B-NP
homologue NN I-NP
Vps45p NNP B-NP
. . O

-DOCSTART- X X O

In IN O
a DT O
heterologous JJ O
transcriptional JJ O
system NN O
in IN O
which WDT O
the DT O
upstream JJ O
regions NNS O
of IN O
oIFNtau NNP B-NP
were VBD O
inserted VBN O
in IN O
front NN O
of IN O
simian JJ B-NP
virus NN I-NP
40 CD I-NP
( -LRB- I-NP
SV40 NN I-NP
) -RRB- I-NP
promoter NN I-NP
, , O
the DT O
regions NNS O
between IN O
bases NNS O
-654 : O
and CC O
-555 DT O
were VBD O
determined VBN O
as IN O
being VBG O
the DT O
enhancer NN O
region NN O
required VBN O
for IN O
oIFNtau-SV40-CAT JJ B-NP
transactivation NN O
. . O

-DOCSTART- X X O

In IN O
co-transfection NN O
studies NNS O
, , O
the DT O
expression NN O
of IN O
c-Jun JJ B-NP
plus CC O
c-Fos JJ B-NP
enhanced JJ O
the DT O
transactivation NN O
of IN O
oIFNtau-CAT NN B-NP
but CC O
the DT O
expression NN O
of IN O
GATA-1 JJ B-NP
, , O
GATA-2 JJ B-NP
or CC O
GATA-3 JJ B-NP
did VBD O
not RB O
. . O

-DOCSTART- X X O

To TO O
identify VB O
these DT O
sites NNS O
, , O
Cdk2-phosphorylated JJ B-NP
MARCKS NNP B-NP
was VBD O
digested VBN O
with IN O
lysyl NN B-NP
endoprotease NN I-NP
and CC O
analysed JJ O
by IN O
electrospray NN O
MS. . O

-DOCSTART- X X O

The DT O
yeast NN B-NP
LPD1 NNP I-NP
gene NN I-NP
encoding VBG O
lipoamide NN B-NP
dehydrogenase NN I-NP
is VBZ O
subject JJ O
to TO O
the DT O
general JJ O
control NN O
of IN O
amino DT O
acid NN O
biosynthesis NN O
mediated VBN O
by IN O
the DT O
GCN4 NNP B-NP
transcription NN I-NP
factor NN I-NP
. . O

-DOCSTART- X X O

The DT O
relatively RB O
mild JJ O
defects NNS O
observed VBD O
in IN O
Rpd3 JJ B-NP
mutants NNS I-NP
suggest VBP O
that IN O
the DT O
recently RB O
identified VBN O
Groucho NNP B-NP
and CC O
dCtBP JJ B-NP
corepressor JJ I-NP
proteins NNS I-NP
do VBP O
not RB O
function VB O
solely RB O
through IN O
the DT O
recruitment NN O
of IN O
histone NN B-NP
deacetylases NNS I-NP
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
serum NN B-NP
TNF-a NNP I-NP
concentration NN O
decreased VBD O
significantly RB O
in IN O
patients NNS O
receiving VBG O
pentoxifylline JJ O
( -LRB- O
basal NN O
623+/-366 CD O
pg/ml NN O
; : O
6th JJ O
month NN O
562+/-358 CD O
pg/ml NN O
, , O
p NN O
< NN O
0.01 CD O
) -RRB- O
, , O
but CC O
not RB O
in IN O
the DT O
control NN O
group NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
we PRP O
show VBP O
that IN O
the DT O
expression NN O
of IN O
individual JJ O
members NNS O
of IN O
one CD O
subfamily NN O
of IN O
KRAB NNP B-NP
zinc NNP I-NP
finger NN I-NP
genes NNS I-NP
is VBZ O
restricted VBN O
to TO O
specific JJ O
hematopoietic JJ O
cell NN O
lineages NNS O
. . O

-DOCSTART- X X O

Employing VBG O
fluorescence NN O
spectroscopy NN O
and CC O
circular JJ O
dichroism NN O
, , O
we PRP O
showed VBD O
that IN O
the DT O
binding NN O
of IN O
Ca2+ NNP O
to TO O
ALG-2 NNP B-NP
induced VBD O
significant JJ O
conformational JJ O
changes NNS O
in IN O
both DT O
the DT O
N-terminal JJ O
and CC O
C-terminal JJ O
domains NNS O
of IN O
the DT O
protein NN O
. . O

-DOCSTART- X X O

They PRP O
also RB O
occur VBP O
in IN O
similar JJ O
locations NNS O
in IN O
the DT O
promoters NNS O
of IN O
several JJ O
other JJ O
ribosomal JJ B-NP
protein NN I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

Both DT O
carbachol NN O
( -LRB- O
100 CD O
microM NN O
) -RRB- O
and CC O
EGF NNP B-NP
( -LRB- O
10 CD O
nM NN O
) -RRB- O
induced VBN O
Ras NNP B-NP
activation NN O
. . O

-DOCSTART- X X O

Dominant NNP O
negative JJ O
Sos NNP B-NP
did VBD O
not RB O
affect VB O
carbachol NN O
stimulation NN O
of IN O
HA-ERK2 NNP B-NP
but CC O
inhibited VBD O
the DT O
stimulatory JJ O
effect NN O
of IN O
EGF NNP B-NP
by IN O
60 CD O
% NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Transpulmonary JJ O
passage NN O
of IN O
contrast NN O
occurred VBD O
in IN O
sufficient JJ O
amounts NNS O
to TO O
enhance VB O
the DT O
intensity NN O
of IN O
the DT O
Doppler NNP O
signal NN O
significantly RB O
, , O
but CC O
the DT O
duration NN O
of IN O
this DT O
effect NN O
was VBD O
short JJ O
. . O

-DOCSTART- X X O

In IN O
this DT O
paper NN O
, , O
such JJ O
lesions NNS O
in IN O
two CD O
cases NNS O
were VBD O
evaluated VBN O
by IN O
ultrasonography NN O
. . O

-DOCSTART- X X O

These DT O
regions NNS O
contain VBP O
inverted VBN O
E-box NNP O
palindromic JJ O
or CC O
direct JJ O
repeat NN O
motifs NNS O
and CC O
bind NN O
SREBP-1 NN B-NP
with IN O
different JJ O
affinities NNS O
. . O

-DOCSTART- X X O

To TO O
address VB O
these DT O
questions NNS O
, , O
a DT O
recombinant JJ O
FRAP/mTOR JJ B-NP
protein NN O
and CC O
a DT O
FRAP/mTOR NN B-NP
immunoprecipitate NN O
were VBD O
utilized VBN O
in IN O
in IN O
vitro NN O
kinase NN O
assays VBZ O
to TO O
phosphorylate VB O
4E-BP1 JJ B-NP
. . O

-DOCSTART- X X O

Hrs NNP B-NP
has VBZ O
a DT O
FYVE JJ O
double JJ O
zinc NN O
finger NN O
domain NN O
, , O
which WDT O
specifically RB O
binds VBZ O
phosphatidylinositol( JJ O
3)-phosphate JJ O
and CC O
is VBZ O
conserved VBN O
in IN O
several JJ O
proteins NNS O
involved VBN O
in IN O
vesicular JJ O
traffic NN O
. . O

-DOCSTART- X X O

The DT O
coexpression NN O
of IN O
full-length JJ O
expression NN O
constructs NNS O
for IN O
both DT O
DBP NNP B-NP
and CC O
hepatic JJ B-NP
leukemia NN I-NP
factor NN I-NP
resulted VBD O
in IN O
a DT O
dramatic JJ O
increase NN O
in IN O
activation NN O
mediated VBN O
by IN O
the DT O
GAL4-DBP JJ B-NP
fusion NN O
proteins NNS O
, , O
suggesting VBG O
the DT O
involvement NN O
of IN O
a DT O
regulated JJ O
coactivator NN O
in IN O
this DT O
process NN O
. . O

-DOCSTART- X X O

Three CD O
subgenomes NNS O
also RB O
comprised VBN O
15 CD O
to TO O
75 CD O
nucleotides NNS O
derived VBN O
from IN O
the DT O
5' JJ O
part NN O
of IN O
the DT O
NS2 NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Cp NN B-NP
is VBZ O
normally RB O
the DT O
main JJ O
promoter NN O
for IN O
EBNA NNP B-NP
mRNA NN I-NP
initiation NN O
, , O
so RB O
it PRP O
appears VBZ O
that IN O
EBNA3C JJ B-NP
contributes NNS O
to TO O
a DT O
negative JJ O
autoregulatory NN O
control NN O
loop NN O
. . O

-DOCSTART- X X O

These DT O
indications NNS O
of IN O
deregulated JJ O
signalling NN O
in IN O
the DT O
absence NN O
of IN O
tyrosine NN O
118 CD O
were VBD O
substantiated VBN O
by IN O
sustained JJ O
activation NN O
of IN O
STAT3 NNP B-NP
. . O

-DOCSTART- X X O

With IN O
exon NN O
trapping NN O
, , O
we PRP O
could MD O
isolate VB O
five CD O
potential JJ O
exons NNS O
from IN O
the DT O
YAC NNP O
946E12 NNP O
that IN O
spans VBZ O
the DT O
region NN O
, , O
four CD O
of IN O
which WDT O
could MD O
be VB O
placed VBN O
in IN O
the DT O
contig NN O
in IN O
the DT O
vicinity NN O
of IN O
the DT O
breakpoints NNS O
. . O

-DOCSTART- X X O

Campomelic NNP O
dysplasia NN O
translocation NN O
breakpoints NNS O
are VBP O
scattered VBN O
over IN O
1 CD O
Mb JJ O
proximal JJ O
to TO O
SOX9 VB B-NP
: : O
evidence NN O
for IN O
an DT O
extended JJ O
control NN O
region NN O
. . O

-DOCSTART- X X O

The DT O
most RBS O
common JJ O
characteristics NNS O
of IN O
VRE NNP O
patients NNS O
were VBD O
recent JJ O
prior JJ O
vancomycin NN O
use NN O
, , O
recent JJ O
prior JJ O
susceptible JJ O
enterococcal JJ O
infection NN O
, , O
coinfection NN O
with IN O
other JJ O
microbial JJ O
pathogens NNS O
, , O
and CC O
concurrent JJ O
fungal JJ O
infection NN O
. . O

-DOCSTART- X X O

A DT O
coiled-coil NN O
domain NN O
, , O
conserved VBN O
within IN O
each DT O
encoded JJ O
protein NN O
, , O
serves VBZ O
as IN O
a DT O
potential JJ O
interaction NN O
motif NN O
for IN O
FLI NNP B-NP
LRR NNP I-NP
. . O

-DOCSTART- X X O

Binding NNP O
affinities NNS O
of IN O
these DT O
recombinant JJ O
phages NNS O
as IN O
determined VBN O
by IN O
the DT O
retention NN O
of IN O
these DT O
phages NNS O
by IN O
a DT O
His-tag JJ O
immobilized JJ O
gp17 NN B-NP
column NN O
, , O
and CC O
by IN O
co-immunoprecipitation NN O
with IN O
purified VBN O
terminase NN B-NP
supported VBN O
the DT O
specific JJ O
nature NN O
of IN O
the DT O
portal JJ B-NP
protein NN I-NP
and CC O
terminase NN B-NP
interaction NN I-NP
sites NNS I-NP
. . O

-DOCSTART- X X O

Although IN O
the DT O
terminase NN B-NP
apparently RB O
interacts VBZ O
with IN O
this DT O
gp20 CD B-NP
portal JJ I-NP
peptide NN I-NP
, , O
polyclonal JJ O
antibody NN O
against IN O
the DT O
portal JJ O
peptide NN O
appears VBZ O
unable JJ O
to TO O
access VB O
it PRP O
in IN O
the DT O
native JJ O
structure NN O
, , O
suggesting VBG O
intimate JJ O
association NN O
of IN O
gp20 CD B-NP
and CC O
gp17 CD B-NP
possibly RB O
internalizes VBZ O
terminase NN B-NP
regions NNS I-NP
within IN O
the DT O
portal NN O
in IN O
the DT O
packasome JJ O
complex NN O
. . O

-DOCSTART- X X O

The DT O
hybrid JJ O
viruses NNS O
were VBD O
found VBN O
to TO O
accumulate VB O
to TO O
high JJ O
levels NNS O
in IN O
infected JJ O
plants NNS O
, , O
to TO O
form VB O
stable JJ O
virions NNS O
, , O
and CC O
to TO O
be VB O
mechanically RB O
transmissible JJ O
. . O

-DOCSTART- X X O

cDNA NN O
and CC O
structural JJ O
organization NN O
of IN O
the DT O
gene NN B-NP
Pole1 NNP I-NP
for IN O
the DT O
mouse NN B-NP
DNA NN I-NP
polymerase NN I-NP
epsilon NN I-NP
catalytic JJ I-NP
subunit NN I-NP
. . O

-DOCSTART- X X O

Nevertheless RB O
cryopreservation NN O
of IN O
spermatozoa NNS O
in IN O
a DT O
medium NN O
containing VBG O
neither DT O
SP NNP O
nor CC O
biological JJ O
substances NNS O
could MD O
offer VB O
an DT O
acceptable JJ O
cryoprotection NN O
of IN O
spermatozoa NNS O
to TO O
be VB O
used VBN O
in IN O
assisted JJ O
fertilization NN O
procedures NNS O
, , O
especially RB O
for IN O
intracytoplasmic JJ O
sperm NN O
injection NN O
. . O

-DOCSTART- X X O

A DT O
liquid NN O
chromatographic NN O
method NN O
is VBZ O
described VBN O
for IN O
analysis NN O
of IN O
beta-carotene NN O
in IN O
medical JJ O
food NN O
. . O

-DOCSTART- X X O

The DT O
FCMS NNP O
conditions NNS O
were VBD O
as IN O
follows VBZ O
: : O
2 CD O
kW NN O
maximum NN O
electrical JJ O
power NN O
consumption NN O
, , O
800 CD O
V NNP O
maximum NN O
capacitor NN O
voltage NN O
, , O
720 CD O
microseconds NNS O
pulsewidth NN O
( -LRB- O
180 CD O
microseconds NNS O
rise NN O
time NN O
) -RRB- O
, , O
and CC O
5-30 CD O
Hz NNP O
frequency NN O
. . O

-DOCSTART- X X O

Severe JJ O
hemolysis NN O
resulted VBD O
in IN O
statistically RB O
significant JJ O
changes NNS O
in IN O
the DT O
mean JJ O
values NNS O
of IN O
the DT O
above JJ O
analytes NNS O
in IN O
addition NN O
to TO O
the DT O
following JJ O
increases NNS O
: : O
alanine DT B-NP
aminotransferase NN I-NP
, , O
calcium NN O
, , O
and CC O
serum NN B-NP
globulins NNS I-NP
( -LRB- O
P NNP O
< NN O
0.001 CD O
) -RRB- O
and CC O
albumin NN B-NP
and CC O
total JJ O
protein NN O
( -LRB- O
P NNP O
< NN O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

EMSA NNP O
with IN O
crude JJ O
nuclear JJ O
extracts NNS O
demonstrated VBD O
that IN O
stimulation NN O
with IN O
CD40L JJ B-NP
results NNS O
in IN O
the DT O
induction NN O
of IN O
NF-kappaB NNP B-NP
complexes NNS I-NP
that WDT O
bind VBP O
to TO O
each DT O
of IN O
the DT O
three CD O
NF-kappaB NNP B-NP
sites NNS I-NP
and CC O
are VBP O
composed VBN O
mainly RB O
of IN O
p50 NN B-NP
and CC O
RelB NNP B-NP
, , O
but CC O
also RB O
include VBP O
c-Rel JJ B-NP
and CC O
p65 VBD B-NP
. . O

-DOCSTART- X X O

Optimal NNP O
monitoring NN O
of IN O
ODA NNP O
remains VBZ O
undefined JJ O
. . O

-DOCSTART- X X O

The DT O
major JJ O
transcription NN O
factors NNS O
controlling VBG O
arginine DT O
metabolism NN O
in IN O
Escherichia NNP O
coli NNS O
and CC O
Bacillus NNP O
subtilis NNS O
, , O
ArgR NNP B-NP
and CC O
AhrC NNP B-NP
, , O
respectively RB O
, , O
are VBP O
homologous JJ O
multimeric JJ O
proteins NNS O
that WDT O
form VBP O
l JJ O
-arginine-dependent JJ O
DNA-binding NN O
complexes NNS O
capable JJ O
of IN O
repressing VBG O
transcription NN O
of IN O
the DT O
biosynthetic JJ O
genes NNS O
( -LRB- O
both DT O
) -RRB- O
, , O
activating VBG O
transcription NN O
of IN O
catabolic JJ O
genes NNS O
( -LRB- O
AhrC JJ B-NP
only RB O
) -RRB- O
or CC O
facilitating VBG O
plasmid NN O
dimer NN O
resolution NN O
( -LRB- O
both DT O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
studied VBD O
protein NN O
fragments NNS O
consist VBP O
of IN O
residues NNS O
Arg183-His267 DT O
of IN O
the DT O
human JJ B-NP
ER NNP I-NP
and CC O
residues NNS O
Lys438-Gln520 CD O
of IN O
the DT O
rat NN O
GR CD B-NP
. . O

-DOCSTART- X X O

The DT O
exon JJ O
:intron NN O
structure NN O
of IN O
chicken NN B-NP
IL8 IN I-NP
corresponds NNS O
almost RB O
exactly RB O
to TO O
that DT O
of IN O
human JJ B-NP
IL8 NNS I-NP
and CC O
differs NNS O
from IN O
those DT O
of IN O
other JJ O
known VBN O
mammalian JJ B-NP
CXC NNP I-NP
chemokine NN I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

The DT O
Aa-Pri2 JJ B-NP
gene NN I-NP
, , O
specifically RB O
expressed VBN O
during IN O
basidiocarp JJ O
differentiation NN O
of IN O
the DT O
mushroom NN O
Agrocybe NNP O
aegerita NN O
, , O
was VBD O
cloned VBN O
. . O

-DOCSTART- X X O

The DT O
main JJ O
causes NNS O
of IN O
liver NN O
disease NN O
in IN O
the DT O
patients NNS O
with IN O
HCC NNP O
were VBD O
hepatitis NNP O
C NNP O
virus NN O
( -LRB- O
HCV NN O
) -RRB- O
( -LRB- O
77 CD O
% NN O
) -RRB- O
, , O
alcohol NN O
abuse NN O
( -LRB- O
73 CD O
% NN O
) -RRB- O
, , O
and CC O
the DT O
combination NN O
of IN O
HCV NNP O
and CC O
alcohol NN O
abuse NN O
( -LRB- O
50 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Three CD O
new JJ O
aromatase NN B-NP
inhibitors NNS O
have VBP O
recently RB O
completed VBN O
phase NN O
III NNP O
evaluation NN O
as IN O
treatment NN O
of IN O
metastatic JJ O
breast NN O
cancer NN O
in IN O
post-menopausal JJ O
women NNS O
whose WP$ O
disease NN O
has VBZ O
progressed VBN O
despite IN O
tamoxifen JJ O
therapy NN O
: : O
anastrozole NN O
( -LRB- O
ARIMIDEX NNP O
, , O
Zeneca NNP O
) -RRB- O
, , O
letrozole FW O
( -LRB- O
FEMARA NNP O
, , O
Novartis NNP O
) -RRB- O
and CC O
vorozole NN O
( -LRB- O
RIVIZOR NNP O
, , O
Janssen NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Of IN O
those DT O
injuries NNS O
, , O
143 CD O
cases NNS O
were VBD O
snowboard NN O
related VBN O
and CC O
158 CD O
cases NNS O
were VBD O
ski JJ O
related VBN O
. . O

-DOCSTART- X X O

The DT O
femoral JJ O
artery/vein NN O
and CC O
the DT O
soleus NN O
and CC O
gastrocnemius NN O
muscles NNS O
were VBD O
examined VBN O
in IN O
healthy JJ O
human JJ O
male NN O
volunteers NNS O
. . O

-DOCSTART- X X O

SRFDelta5 PRP B-NP
acts VBZ O
as IN O
a DT O
naturally RB O
occurring VBG O
dominant JJ O
negative JJ O
regulatory JJ O
mutant NN O
that IN O
blocks NNS O
SRF-dependent JJ B-NP
skeletal NN B-NP
alpha-actin NN I-NP
, , O
cardiac JJ B-NP
alpha-actin NN I-NP
, , O
smooth JJ B-NP
alpha-actin NN I-NP
, , O
SM22alpha NNP B-NP
, , O
and CC O
SRF RB B-NP
promoter-luciferase JJ O
reporter NN O
activities NNS O
. . O

-DOCSTART- X X O

In IN O
serum-free JJ O
media NNS O
, , O
p50E4F NN B-NP
accelerated VBD O
E1A-induced JJ B-NP
apoptosis NN O
. . O

-DOCSTART- X X O

The DT O
potency NN O
of IN O
the DT O
effect NN O
of IN O
Nim NNP O
( -LRB- O
0.5 CD O
mg.kg-1 JJ O
i.p. NN O
) -RRB- O
was VBD O
similar JJ O
to TO O
that DT O
of IN O
NBP NNP O
( -LRB- O
10 CD O
mg.kg-1 JJ O
i.p. NN O
) -RRB- O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
NBP NNP O
pre-treatment , O
or CC O
post-treatment NN O
markedly RB O
enhanced VBD O
the DT O
rCBF NN O
to TO O
striatum NN O
in IN O
RMCAO NNP O
rats NNS O
. . O

-DOCSTART- X X O

Progression NN O
after IN O
first-line JJ O
chemotherapy NN O
was VBD O
associated VBN O
with IN O
significantly RB O
worse JJR O
survival NN O
for IN O
patients NNS O
with IN O
metastasis NN O
. . O

-DOCSTART- X X O

Mutations NNS O
within IN O
human JJ O
UTR1 CC O
modulate JJ O
NRF-1 JJ B-NP
expression NN O
by IN O
interfering VBG O
with IN O
mRNA NN O
translational JJ O
efficiency NN O
in IN O
transfected JJ O
cells NNS O
and CC O
in IN O
an DT O
in IN O
vitro NN O
translation NN O
system NN O
. . O

-DOCSTART- X X O

As IN O
is VBZ O
deduced VBN O
from IN O
the DT O
nucleotide JJ O
sequence NN O
of IN O
the DT O
cDNA NN O
, , O
CBS-1 NNP B-NP
contains VBZ O
an DT O
open JJ O
reading NN O
frame NN O
consisting VBG O
of IN O
182 CD O
amino IN O
acids NNS O
, , O
with IN O
a DT O
molecular JJ O
weight NN O
of IN O
19.5kDa CD O
. . O

-DOCSTART- X X O

Corticostriatal NNP O
and CC O
corticosubthalamic JJ O
input NN O
zones NNS O
from IN O
the DT O
presupplementary JJ O
motor NN O
area NN O
in IN O
the DT O
macaque NN O
monkey NN O
: : O
comparison NN O
with IN O
the DT O
input NN O
zones NNS O
from IN O
the DT O
supplementary JJ O
motor NN O
area NN O
. . O

-DOCSTART- X X O

Basic NNP B-NP
fibroblast JJ I-NP
growth NN I-NP
factor NN I-NP
( -LRB- O
bFGF NN B-NP
) -RRB- O
has VBZ O
been VBN O
shown VBN O
to TO O
induce VB O
angiogenesis NN O
in IN O
various JJ O
animal NN O
models NNS O
, , O
but CC O
the DT O
methods NNS O
of IN O
administration NN O
used VBN O
experimentally RB O
are VBP O
not RB O
clinically RB O
feasible JJ O
. . O

-DOCSTART- X X O

Both DT O
filters NNS O
equally RB O
contributed VBD O
to TO O
elevation CD O
of IN O
iliac JJ O
venous JJ O
pressure NN O
( -LRB- O
median NN O
, , O
9.3 CD O
and CC O
7.2 CD O
mm CD O
Hg NNP O
[n NN O
= SYM O
9] FW O
with IN O
the DT O
spring NN O
filter NN O
and CC O
RF02 CD O
filter NN O
, , O
respectively RB O
) -RRB- O
. . O

-DOCSTART- X X O

12 CD O
healthy JJ O
women NNS O
( -LRB- O
age NN O
18-38 JJ O
years NNS O
) -RRB- O
were VBD O
examined VBN O
using VBG O
the DT O
2-hour JJ O
's POS O
method NN O
of IN O
passive JJ O
leg NN O
rising VBG O
( -LRB- O
PLR NN O
) -RRB- O
in IN O
follicular JJ O
( -LRB- O
FP NNP O
) -RRB- O
and CC O
luteal JJ O
( -LRB- O
LP NN O
) -RRB- O
phases NNS O
of IN O
normal JJ O
ovulatory JJ O
cycle NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
sgRNA2 PRP B-NP
has VBZ O
the DT O
3'TE NN O
in IN O
its PRP$ O
5' JJ O
UTR. . O

-DOCSTART- X X O

These DT O
single JJ O
mutational JJ O
defects NNS O
in IN O
the DT O
eRF1-eRF3 JJ B-NP
interaction NN O
became VBD O
evident JJ O
when WRB O
either DT O
truncated JJ O
protein NN O
eRF3C . B-NP
or CC O
C-terminally RB O
altered VBN O
eRF1 JJ B-NP
proteins NNS O
were VBD O
used VBN O
for IN O
the DT O
authentic JJ O
protein NN O
, , O
providing VBG O
further JJ O
support NN O
for IN O
the DT O
presence NN O
of IN O
a DT O
C-terminal JJ O
interaction NN O
. . O

-DOCSTART- X X O

Removal NN O
of IN O
each DT O
of IN O
three CD O
contiguous JJ O
segments NNS O
from IN O
the DT O
N-terminal JJ O
half NN O
specifically RB O
inhibits VBZ O
the DT O
formation NN O
of IN O
5.8Ss JJ B-NP
rRNA NNP I-NP
, , O
whereas IN O
deleting VBG O
part NN O
of IN O
the DT O
C-terminal JJ O
region NN O
of IN O
the DT O
protein NN O
only RB O
blocks NNS O
the DT O
production NN O
of IN O
18S DT B-NP
rRNA NNP I-NP
. . O

-DOCSTART- X X O

Ras NNP B-NP
is VBZ O
not RB O
associated VBN O
with IN O
the DT O
tegument NN O
. . O

-DOCSTART- X X O

Green NNP O
fluorescent VBD O
protein-tagged JJ O
UNC-49B NNP B-NP
and CC O
UNC-49C JJ B-NP
subunits NNS I-NP
are VBP O
coexpressed VBN O
in IN O
muscle NN O
cells NNS O
and CC O
are VBP O
colocalized VBN O
to TO O
synaptic JJ O
regions NNS O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
a DT O
protein NN O
, , O
UBC9 NNP B-NP
, , O
interacts VBZ O
specifically RB O
with IN O
TEL NNP B-NP
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
spontaneous JJ O
reports NNS O
of IN O
suspected JJ O
adverse JJ O
drug NN O
reactions NNS O
, , O
observed VBD O
in IN O
elderly JJ O
patients NNS O
( -LRB- O
over IN O
65 CD O
years NNS O
of IN O
age NN O
) -RRB- O
in IN O
Sicily NNP O
( -LRB- O
Italy NNP O
) -RRB- O
during IN O
the DT O
period NN O
from IN O
1 CD O
January NNP O
1995 CD O
to TO O
31 CD O
December NNP O
1997 CD O
. . O

-DOCSTART- X X O

Molecules NNP O
of IN O
NH3 NNP O
are VBP O
capable JJ O
of IN O
emitting VBG O
stimulated VBN O
radiation NN O
( -LRB- O
MASER NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
major JJ O
findings NNS O
of IN O
our PRP$ O
studies NNS O
are VBP O
as IN O
follows VBZ O
: : O
1 CD O
) -RRB- O
There EX O
are VBP O
no DT O
detectable JJ O
signals NNS O
around IN O
GDF-9-deficient JJ B-NP
follicles NNS O
for IN O
several JJ O
theca JJ O
cell NN O
layer NN O
markers NNS O
[i JJ O
.e NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
highly RB O
charged VBN O
residues NNS O
were VBD O
abundantly RB O
possessed VBN O
in IN O
the DT O
carboxy-terminal JJ O
part NN O
of IN O
the DT O
MDV2 NNP B-NP
UL10 NNP I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Identification NN O
and CC O
structure NN O
of IN O
the DT O
Marek NNP B-NP
's POS I-NP
disease NN I-NP
virus NN I-NP
serotype NN I-NP
2 CD I-NP
glycoprotein NN I-NP
M NNP I-NP
gene NN I-NP
: : O
comparison NN O
with IN O
glycoprotein NN B-NP
M NNP I-NP
genes NNS I-NP
of IN O
Herpesviridae NNP O
family NN O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
To TO O
perform VB O
a DT O
cost-effectiveness NN O
analysis NN O
( -LRB- O
CEA NN O
) -RRB- O
between IN O
a DT O
standard JJ O
antiemetic JJ O
regimen-chlorpromazine NN O
+ NN O
dexamethasone NN O
( -LRB- O
CPM-DEX) JJ O
- : O
and CC O
a DT O
5-HT3 JJ B-NP
receptor NN I-NP
antagonist-tropisetron NN O
( -LRB- O
TROP)--in NNP O
the DT O
control NN O
of IN O
acute JJ O
emesis NN O
induced VBN O
by IN O
highly RB O
emetogenic JJ O
chemotherapy NN O
in IN O
children NNS O
, , O
considering VBG O
two CD O
analytic JJ O
perspectives NNS O
: : O
hospital NN O
and CC O
patients NNS O
. . O

-DOCSTART- X X O

Baseline NNP O
data NNS O
were VBD O
obtained VBN O
from IN O
10 CD O
adults NNS O
. . O

-DOCSTART- X X O

A DT O
comparison NN O
of IN O
the DT O
nucleotide JJ O
and CC O
deduced JJ O
amino IN O
acid NN O
sequences NNS O
of IN O
the DT O
core NN O
regions NNS O
of IN O
the DT O
RNA-dependent JJ B-NP
RNA NNP I-NP
polymerase NN I-NP
domains VBZ I-NP
found VBN O
in IN O
these DT O
three CD O
dsRNAs NNS O
suggested VBD O
that IN O
these DT O
dsRNAs NNS O
probably RB O
evolved VBN O
independently RB O
within IN O
each DT O
host NN O
plant NN O
from IN O
a DT O
common JJ O
ancestor NN O
. . O

-DOCSTART- X X O

Consistent NN O
with IN O
this DT O
possibility NN O
, , O
a DT O
non-MBD JJ O
region NN O
of IN O
Bin1 NNP B-NP
was VBD O
sufficient JJ O
to TO O
recruit VB O
a DT O
repression NN O
function NN O
to TO O
DNA NNP O
that WDT O
was VBD O
unrelated JJ O
to TO O
histone NN B-NP
deacetylase NN I-NP
. . O

-DOCSTART- X X O

Forty-eight NNP O
sequences NNS O
, , O
30 CD O
not RB O
previously RB O
identified VBN O
as IN O
IR-responsive JJ O
, , O
were VBD O
significantly RB O
regulated VBN O
by IN O
IR NNP O
. . O

-DOCSTART- X X O

A DT O
recently RB O
described VBN O
protein NN O
, , O
metaxin NN B-NP
1 CD I-NP
, , O
serves VBZ O
as IN O
a DT O
component NN O
of IN O
a DT O
preprotein JJ O
import NN O
complex NN O
in IN O
the DT O
outer JJ O
membrane NN O
of IN O
the DT O
mammalian JJ O
mitochondrion NN O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
of IN O
rat NN B-NP
SH2-containing JJ I-NP
inositol NN I-NP
phosphatase NN I-NP
2 CD I-NP
( -LRB- O
SHIP2 NN B-NP
) -RRB- O
and CC O
its PRP$ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
insulin NN B-NP
signaling NN O
. . O

-DOCSTART- X X O

Slp1 JJ B-NP
represses NNS O
transcription NN O
via IN O
this DT O
binding JJ O
site NN O
in IN O
yeast NN O
cells NNS O
, , O
consistent JJ O
with IN O
its PRP$ O
role NN O
as IN O
a DT O
direct JJ O
repressor NN O
of IN O
ftz JJ B-NP
stripes NNS O
in IN O
interstripe JJ O
regions NNS O
during IN O
late JJ O
stages NNS O
of IN O
embryogenesis NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
of IN O
these DT O
studies NNS O
support VBP O
a DT O
model NN O
in IN O
which WDT O
VirB4 NNP B-NP
dimers NNS I-NP
or CC O
homomultimers NNS O
contribute VB O
structural JJ O
information NN O
for IN O
the DT O
assembly NN O
of IN O
a DT O
transenvelope NN O
channel NN O
competent JJ O
for IN O
bidirectional JJ O
DNA NNP O
transfer NN O
, , O
whereas IN O
an DT O
ATP-dependent JJ O
activity NN O
is VBZ O
required VBN O
for IN O
configuring VBG O
this DT O
channel NN O
as IN O
a DT O
dedicated VBN O
export NN O
machine NN O
. . O

-DOCSTART- X X O

The DT O
penicillin NN B-NP
binding JJ I-NP
proteins NNS I-NP
( -LRB- O
PBPs NNS B-NP
) -RRB- O
synthesize NN O
and CC O
remodel NN O
peptidoglycan NN O
, , O
the DT O
structural JJ O
component NN O
of IN O
the DT O
bacterial JJ O
cell NN O
wall NN O
. . O

-DOCSTART- X X O

TCR NNP B-NP
alpha NN I-NP
(TCRA NNP O
) -RRB- O
expression NN O
was VBD O
examined VBN O
in IN O
RNA NNP O
samples NNS O
from IN O
PBMC NNP O
and CC O
isolated VBD O
populations NNS O
of IN O
CD4+ NNP B-NP
, , O
CD8+ NNP B-NP
, , O
and CC O
DN NNP O
T NNP O
cells NNS O
from IN O
15 CD O
healthy JJ O
individuals NNS O
. . O

-DOCSTART- X X O

Similar JJ O
results NNS O
were VBD O
obtained VBN O
with IN O
xylitol NNP O
, , O
an DT O
activator NN O
of IN O
the DT O
pentose JJ O
phosphate NN O
pathway NN O
. . O

-DOCSTART- X X O

The DT O
high JJ B-NP
density NN I-NP
lipoprotein NN I-NP
( -LRB- I-NP
HDL NNP I-NP
) -RRB- I-NP
receptor NN I-NP
mediates VBZ O
the DT O
uptake NN O
of IN O
cholesterol NN O
and CC O
cholesteryl NN O
esters NNS O
, , O
substrates NNS O
for IN O
steroidogenesis NN O
, , O
from IN O
an DT O
HDL NNP B-NP
particle NN O
in IN O
the DT O
adrenal JJ O
gland NN O
and CC O
gonads NNS O
. . O

-DOCSTART- X X O

D3S1261 NNP B-NP
is VBZ O
physically RB O
located VBN O
at IN O
or CC O
near IN O
the DT O
MITF NNP B-NP
locus NN I-NP
, , O
while IN O
D3S2465 CD B-NP
and CC O
D3S1766 CD B-NP
are VBP O
flanking VBG O
the DT O
locus NN O
at IN O
about IN O
17.5 CD O
cM JJ O
genetic JJ O
distance NN O
each DT O
side NN O
. . O

-DOCSTART- X X O

The DT O
percentages NNS O
of IN O
recovery NN O
decreased VBN O
with IN O
storage NN O
time NN O
, , O
although IN O
the DT O
addition NN O
of IN O
dispersant NN O
( -LRB- O
Tris-Tween NNP O
80 CD O
) -RRB- O
before IN O
storage NN O
appeared VBD O
to TO O
partially RB O
prevent VB O
adhesion NN O
. . O

-DOCSTART- X X O

Point NNP O
mutations NNS O
of IN O
the DT O
site NN O
that IN O
suppressed VBN O
Pit-1 NNP B-NP
binding NN O
in IN O
vitro NN O
restored VBN O
full JJ O
tiGH NN B-NP
promoter NN I-NP
activity NN O
. . O

-DOCSTART- X X O

A DT O
human JJ B-NP
Raf-responsive NNP I-NP
zinc-finger NN I-NP
protein NN I-NP
that IN O
binds NNS O
to TO O
divergent JJ O
sequences NNS O
. . O

-DOCSTART- X X O

We PRP O
are VBP O
reporting VBG O
an DT O
autopsy NN O
case NN O
of IN O
so-called JJ O
"acute JJ O
multiple JJ O
sclerosis NN O
" '' O
that WDT O
was VBD O
difficult JJ O
to TO O
differentiate VB O
from IN O
a DT O
brain NN O
tumor NN O
on IN O
MRI NNP O
findings NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
MOM-4 NNP B-NP
and CC O
TAK1 JJ B-NP
bind NN O
related VBN O
proteins NNS O
that WDT O
promote VBP O
their PRP$ O
kinase NN O
activities NNS O
. . O

-DOCSTART- X X O

Gab2 NNP B-NP
, , O
a DT O
new JJ O
pleckstrin NN B-NP
homology NN O
domain-containing NN O
adapter NN O
protein NN O
, , O
acts VBZ O
to TO O
uncouple JJ O
signaling NN O
from IN O
ERK NNP B-NP
kinase NN I-NP
to TO O
Elk-1 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
cutaneous JJ O
xanthomas NNS O
with IN O
normal JJ O
serum NN O
lipid VBD O
levels NNS O
is VBZ O
due JJ O
to TO O
the DT O
antibetalipoproteic JJ O
activity NN O
of IN O
the DT O
monoclonal JJ B-NP
immunoglobulin NN I-NP
. . O

-DOCSTART- X X O

In IN O
an DT O
attempt NN O
to TO O
reduce VB O
the DT O
incidence NN O
of IN O
NSAID-induced JJ O
gastrointestinal JJ O
lesions NNS O
, , O
the DT O
following VBG O
approaches NNS O
have VBP O
been VBN O
proposed VBN O
: : O
( -LRB- O
i NN O
) -RRB- O
use NN O
of IN O
the DT O
prostaglandin NN O
analogue NN O
misoprostol NN O
, , O
which WDT O
is VBZ O
an DT O
antiulcer NN O
drug NN O
which WDT O
has VBZ O
been VBN O
proven VBN O
to TO O
be VB O
as IN O
effective JJ O
in IN O
the DT O
prevention NN O
of IN O
NSAID-induced JJ O
gastric JJ O
and CC O
duodenal JJ O
ulcers NNS O
as IN O
in IN O
the DT O
reduction NN O
of IN O
serious JJ O
upper JJ O
gastrointestinal JJ O
complications NNS O
; : O
( -LRB- O
ii NNS O
) -RRB- O
histamine NN B-NP
H2 NN I-NP
receptor NN I-NP
antagonists NNS O
( -LRB- O
H2 JJ O
antagonists NNS O
) -RRB- O
, , O
e.g FW O
. . O
ranitidine NNP O
, , O
cimetidine NN O
and CC O
famotidine NN O
, , O
which WDT O
are VBP O
useful JJ O
in IN O
the DT O
prevention NN O
of IN O
NSAID-induced JJ O
duodenal JJ O
ulcers NNS O
during IN O
long JJ O
term NN O
treatment NN O
, , O
but CC O
not RB O
in IN O
the DT O
prevention NN O
of IN O
NSAID-induced JJ O
gastric JJ O
ulcers NNS O
; : O
( -LRB- O
iii NN O
) -RRB- O
proton NN O
pump NN O
inhibitors VBZ O
, , O
e.g JJ O
omeprazole NN O
, , O
and CC O
pantoprazole NN O
, , O
whose WP$ O
efficacy NN O
in IN O
preventing VBG O
NSAID-associated JJ O
ulcers NNS O
has VBZ O
been VBN O
recently RB O
demonstrated VBN O
; : O
and CC O
( -LRB- O
iv) NN O
barrier NN O
agents NNS O
, , O
e.g JJ O
. . O
sucralfate NN O
, , O
which WDT O
cannot MD O
be VB O
recommended VBN O
as IN O
prophylactic JJ O
agents NNS O
to TO O
prevent VB O
NSAID-induced JJ O
gastropathy NN O
. . O

-DOCSTART- X X O

Lung NNP O
mesenchyme NN O
serves VBZ O
as IN O
a DT O
'compleat JJ O
' '' O
inducer NN O
of IN O
lung NN O
morphogenesis NN O
by IN O
secreting VBG O
soluble JJ O
peptide NN O
growth NN O
factors NNS O
. . O

-DOCSTART- X X O

The DT O
activation NN O
of IN O
the DT O
HIV NNP O
promoter NN O
required VBD O
the DT O
nuclear JJ O
localization NN O
of IN O
c-Abl JJ B-NP
and CC O
could MD O
be VB O
correlated VBN O
with IN O
increased VBN O
tyrosine NN O
phosphorylation NN O
of IN O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
. . O

-DOCSTART- X X O

The DT O
bovine NN B-NP
papillomavirus NN I-NP
E2 JJ I-NP
protein NN I-NP
can MD O
inhibit VB O
the DT O
proliferation NN O
of IN O
HT-3 JJ O
cells NNS O
, , O
a DT O
p53-negative JJ B-NP
cervical JJ O
carcinoma NN O
cell NN O
line NN O
containing VBG O
integrated VBN O
human JJ O
papillomavirus NN O
type NN O
30 CD O
DNA NN O
. . O

-DOCSTART- X X O

E2 JJ B-NP
point NN O
mutants NNS O
unable JJ O
to TO O
inhibit VB O
cell NN O
growth NN O
did VBD O
not RB O
repress VB O
cdc25A JJ B-NP
and CC O
cdc25B JJ B-NP
expression NN O
, , O
nor CC O
did VBD O
the DT O
cell NN O
cycle NN O
inhibitors VBZ O
hydroxyurea NN O
and CC O
mimosine NN O
. . O

-DOCSTART- X X O

Neurospora NNP O
crassa VBD O
CYT-18 NN B-NP
, , O
can MD O
rescue VB O
the DT O
exonic JJ O
trap NN O
and CC O
intron NN O
mutants NNS O
which WDT O
cause VBP O
a DT O
structural JJ O
defect NN O
. . O

-DOCSTART- X X O

DDP1 NNP B-NP
also RB O
localizes VBZ O
to TO O
heterochromatin VB O
in IN O
interphase JJ O
nuclei NNS O
of IN O
larval JJ O
neuroblasts NNS O
. . O

-DOCSTART- X X O

In IN O
a DT O
reconstituted JJ O
human JJ O
DNA NN O
repair NN O
system NN O
containing VBG O
DNA NNP B-NP
polymerase NN I-NP
beta JJ I-NP
and CC O
DNA NNP B-NP
ligase NN I-NP
III-XRCC1 NNP I-NP
, , O
accurate JJ O
rejoining NN O
of IN O
a DT O
3' JJ O
mismatched JJ O
base NN O
residue NN O
at IN O
a DT O
single-strand JJ O
break NN O
is VBZ O
dependent JJ O
on IN O
addition NN O
of IN O
the DT O
exonuclease NN O
. . O

-DOCSTART- X X O

The DT O
PAC NNP O
clone NN O
with IN O
an DT O
insert NN O
size NN O
of IN O
120kb CD O
was VBD O
isolated VBN O
and CC O
mapped VBN O
by IN O
restriction NN O
analysis NN O
. . O

-DOCSTART- X X O

Sequence NN O
of IN O
10q24 CD B-NP
locus NN I-NP
surrounding VBG O
the DT O
HOX11 NNP B-NP
oncogene NNP I-NP
reveals VBZ O
a DT O
new JJ O
gene NN O
HUG1 NNP B-NP
expressed VBD O
in IN O
a DT O
T-ALL JJ O
cell NN O
line NN O
. . O

-DOCSTART- X X O

About IN O
20 CD O
kb NNS O
upstream RB O
of IN O
LAMB2 NN B-NP
we PRP O
found VBD O
a DT O
gene NN O
encoding VBG O
a DT O
transcribed VBN O
, , O
non-processed JJ O
LAMB2-like JJ B-NP
pseudogene NN I-NP
( -LRB- O
LAMB2L JJ B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Site-directed JJ O
mutagenesis NN O
of IN O
the DT O
R2 JJ B-NP
protein NN I-NP
was VBD O
used VBN O
to TO O
provide VB O
evidence NN O
that IN O
this DT O
motif NN O
is VBZ O
also RB O
part NN O
of IN O
the DT O
active JJ O
site NN O
of IN O
the DT O
endonuclease NN O
encoded VBN O
by IN O
this DT O
element NN O
. . O

-DOCSTART- X X O

The DT O
infected JJ B-NP
cell NN I-NP
protein NN I-NP
no DT I-NP
. . I-NP
0 CD I-NP
( -LRB- O
ICP0 NN B-NP
) -RRB- O
of IN O
herpes PRP$ O
simplex JJ O
virus NN O
1 CD O
is VBZ O
a DT O
promiscuous JJ O
transactivator NN O
shown VBN O
to TO O
enhance VB O
the DT O
expression NN O
of IN O
genes NNS O
introducted VBN O
into IN O
cells NNS O
by IN O
infection NN O
or CC O
transfection NN O
. . O

-DOCSTART- X X O

Wrist NNP O
measurement NN O
of IN O
blood NN O
pressure NN O
: : O
some DT O
critical JJ O
remarks NNS O
to TO O
oscillometry VB O
. . O

-DOCSTART- X X O

G-box-directed JJ O
expression NN O
in IN O
leaves NNS O
required VBN O
the DT O
presence NN O
of IN O
an DT O
enhancer NN O
region NN O
from IN O
the DT O
cauliflower NN O
mosaic NN O
virus NN O
( -LRB- O
CaMV) NNP O
35S NNP B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Another DT O
element NN O
necessary JJ O
for IN O
augmenting VBG O
the DT O
amplitude NN O
of IN O
the DT O
oscillation NN O
lies VBZ O
between IN O
-178 JJ O
and CC O
-264 NN O
. . O

-DOCSTART- X X O

There EX O
was VBD O
no DT O
competition NN O
between IN O
activin NN B-NP
A NNP I-NP
and CC O
OP-1 NNP B-NP
for IN O
availability NN O
of IN O
Smad4 NNP B-NP
, , O
indicating VBG O
that IN O
the DT O
concentration NN O
of IN O
this DT O
common JJ O
signal NN O
transducer NN O
is VBZ O
not RB O
limiting VBG O
for IN O
generating VBG O
the DT O
observed JJ O
biological JJ O
responses NNS O
. . O

-DOCSTART- X X O

Our PRP$ O
data NNS O
therefore RB O
indicate VBP O
that IN O
it PRP O
is VBZ O
possible JJ O
to TO O
engineer VB O
the DT O
HA NNP B-NP
envelope NN I-NP
glycoprotein NN I-NP
by IN O
fusing VBG O
ligands NNS O
to TO O
its PRP$ O
amino-terminal JJ O
end NN O
without IN O
affecting VBG O
its PRP$ O
fusion NN O
activity NN O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
favored JJ O
, , O
parallel JJ O
beta JJ O
helix NN O
model NN O
is VBZ O
a DT O
compact JJ O
coil NN O
of IN O
ten CD O
helically RB O
arranged VBN O
beta NN O
strands NNS O
forming VBG O
two CD O
parallel JJ O
beta JJ O
sheet NN O
faces NNS O
. . O

-DOCSTART- X X O

This DT O
is VBZ O
predicted VBN O
to TO O
encode VB O
a DT O
315-residue JJ O
protein NN O
containing VBG O
seven CD O
hydrophobic JJ O
helical JJ O
regions NNS O
and CC O
a DT O
17 CD O
amino IN O
acid NN O
motif NN O
characteristic NN O
of IN O
the DT O
R7G NNP B-NP
family NN I-NP
of IN O
G-protein NNP B-NP
coupled VBN I-NP
membrane-bound NN I-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
members NNS O
of IN O
the DT O
ATF NNP B-NP
family NN I-NP
are VBP O
involved VBN O
in IN O
mediating VBG O
the DT O
transcriptional JJ O
regulation NN O
of IN O
the DT O
KGF NNP B-NP
gene NN I-NP
in IN O
response NN O
to TO O
extracellular JJ O
stimuli NNS O
via IN O
a DT O
novel NN O
CRE NNP O
regulatory JJ O
element NN O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
a DT O
high JJ O
proportion NN O
of IN O
blood NN O
samples NNS O
from IN O
a DT O
random JJ O
sample NN O
of IN O
the DT O
rest NN O
of IN O
the DT O
suspects NNS O
tested VBN O
positive JJ O
for IN O
trypanosome-specific JJ O
DNA NN O
by IN O
PCR NNP O
(79.9 CD O
% NN O
for IN O
T. NNP O
b NN O
. . O
gambiense NN O
and CC O
13.9 CD O
% NN O
for IN O
T. NNP O
b NN O
. . O
rhodesiense NN O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
multi-centre JJ O
evaluation NN O
of IN O
the DT O
card NN O
indirect JJ O
agglutination NN O
test NN O
for IN O
trypanosomiasis NN O
( -LRB- O
TrypTect JJ O
CIATT NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Results NNS O
for IN O
men NNS O
who WP O
drank VBD O
up RP O
to TO O
two CD O
drinks NNS O
per IN O
day NN O
suggest VB O
that IN O
if IN O
the DT O
dependence NN O
criteria NNS O
were VBD O
invalid JJ O
, , O
reductions NNS O
in IN O
the DT O
prevalence NN O
of IN O
specific JJ O
indicators NNS O
of IN O
alcohol NN O
dependence NN O
would MD O
range VB O
from IN O
0.3 CD O
% NN O
to TO O
5.2 CD O
% NN O
. . O

-DOCSTART- X X O

Mutagenesis NN O
of IN O
the DT O
CDE/CHR NNP O
elements NNS O
and CC O
Sp1 VB B-NP
sites NNS I-NP
in IN O
this DT O
region NN O
, , O
alone RB O
or CC O
in IN O
combination NN O
, , O
reduced VBD O
transcriptional JJ O
activity NN O
by IN O
40-60 CD O
% NN O
in IN O
asynchronously RB O
growing VBG O
cells NNS O
and CC O
abolished VBD O
cell NN O
cycle NN O
periodicity NN O
in IN O
G2-M-synchronized JJ O
cells NNS O
. . O

-DOCSTART- X X O

Using VBG O
Scheffe NNP O
's POS O
procedure NN O
as IN O
an DT O
illustration NN O
, , O
comparisons NNS O
are VBP O
made VBN O
to TO O
usual JJ O
sample NN O
size NN O
methods NNS O
that WDT O
incorrectly RB O
ignore VBP O
the DT O
stochastic JJ O
nature NN O
of IN O
S2p NNP O
. . O

-DOCSTART- X X O

The DT O
crystal NN O
structure NN O
of IN O
the DT O
VP16 NNP B-NP
core NN I-NP
has VBZ O
been VBN O
determined VBN O
at IN O
2.1 CD O
A DT O
resolution NN O
. . O

-DOCSTART- X X O

Ozagrel NNP O
, , O
ifenprodil NN O
, , O
cinnarizine NN O
and CC O
dilazep NN O
were VBD O
more RBR O
effective JJ O
than IN O
pentoxifylline NN O
in IN O
increasing VBG O
rCBF NN O
at IN O
the DT O
HPC. NNP O

-DOCSTART- X X O

The DT O
latter JJ O
method NN O
adds VBZ O
clamping VBG O
of IN O
the DT O
inferior JJ O
vena NN O
cava NN O
, , O
which WDT O
results VBZ O
in IN O
hypotension NN O
, , O
requiring VBG O
invasive JJ O
anesthetic JJ O
management NN O
. . O

-DOCSTART- X X O

By IN O
contrast NN O
, , O
PvirE NNP B-NP
or CC O
Plac NNP B-NP
promoter NN I-NP
constructs NNS I-NP
yielded VBD O
functional JJ O
VirE2 NNP B-NP
only RB O
if IN O
virE1 PRP B-NP
was VBD O
coexpressed VBN O
with IN O
virE2 NN B-NP
. . O

-DOCSTART- X X O

Simian NNP O
parainfluenza NN O
virus NN O
5 CD O
( -LRB- O
SV5 NN O
) -RRB- O
is VBZ O
a DT O
prototype NN O
of IN O
the DT O
Paramyxoviridae NNP O
family NN O
of IN O
nonsegmented JJ O
negative-sense JJ O
RNA NNP O
viruses NNS O
. . O

-DOCSTART- X X O

To TO O
investigate VB O
the DT O
functions NNS O
of IN O
GE NNP O
, , O
IG NNP O
, , O
and CC O
GS NNP O
sequences NNS O
in IN O
transcription NN O
, , O
we PRP O
constructed VBD O
plasmids NNS O
containing VBG O
cDNAs NN O
of IN O
the DT O
full-length JJ O
SV5 NNP O
genome NN O
in IN O
which WDT O
the DT O
gene NN O
junction NN O
sequences NNS O
( -LRB- O
GE NNP O
, , O
IG NNP O
, , O
and CC O
GS NNP O
sequences NNS O
) -RRB- O
located VBN O
between IN O
the DT O
hemagglutinin-neuraminidase NN B-NP
( -LRB- O
HN) NNP B-NP
and CC O
the DT O
polymerase NN B-NP
( -LRB- I-NP
L NNP I-NP
) -RRB- I-NP
genes NNS I-NP
were VBD O
replaced VBN O
with IN O
the DT O
counterpart NN O
sequences NNS O
from IN O
other JJ O
gene NN O
junctions NNS O
. . O

-DOCSTART- X X O

CXCR4 NNP B-NP
is VBZ O
a DT O
chemokine NN O
receptor NN O
and CC O
a DT O
coreceptor NN O
for IN O
T-cell-line-tropic NNP O
( -LRB- O
X4 NN O
) -RRB- O
and CC O
dual-tropic JJ O
( -LRB- O
R5X4 NN O
) -RRB- O
human NN O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
( -LRB- O
HIV-1 NN O
) -RRB- O
isolates VBZ O
. . O

-DOCSTART- X X O

These DT O
data NNS O
will MD O
help VB O
us PRP O
to TO O
better JJR O
detail NN O
the DT O
CXCR4 NNP B-NP
structural JJ O
requirements NNS O
exhibited VBN O
by IN O
different JJ O
HIV-1 NN O
strains NNS O
and CC O
will MD O
direct VB O
further JJ O
mutagenesis NN O
efforts NNS O
aimed VBN O
at IN O
better JJR O
defining NN O
the DT O
domains NNS O
in IN O
CXCR4 NNP B-NP
involved VBD O
in IN O
the DT O
HIV-1 NN O
Env-mediated JJ B-NP
fusion NN O
process NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
of IN O
these DT O
analyses NNS O
indicate VBP O
that IN O
the DT O
proteinase NN O
cleaves NNS O
at IN O
amino IN O
acid NN O
residues NNS O
E960-A961 JJ O
, , O
E1071-S1072 JJ O
, , O
E1345-T1346 NNP O
, , O
and CC O
E1419-G1420 NNP O
; : O
however RB O
, , O
the DT O
cleavage JJ O
efficiency NN O
is VBZ O
varied VBN O
. . O

-DOCSTART- X X O

y NN O
. . O

-DOCSTART- X X O

SM NNP B-NP
is VBZ O
also RB O
shown VBN O
to TO O
be VB O
associated VBN O
in IN O
vivo NN O
with IN O
other JJ O
components NNS O
of IN O
the DT O
CRM NNP B-NP
1 CD I-NP
export NN O
pathway NN O
, , O
including VBG O
the DT O
small JJ B-NP
GTPase NNP I-NP
Ran NNP I-NP
and CC O
the DT O
nucleoporin JJ O
CAN/Nup214 NNP B-NP
. . O

-DOCSTART- X X O

Identification NN O
of IN O
a DT O
spliced JJ O
gene NN O
from IN O
Kaposi NNP O
's POS O
sarcoma-associated JJ O
herpesvirus NN O
encoding VBG O
a DT O
protein NN O
with IN O
similarities NNS O
to TO O
latent JJ B-NP
membrane NN I-NP
proteins VBZ I-NP
1 CD I-NP
and CC I-NP
2A CD I-NP
of IN I-NP
Epstein-Barr NNP I-NP
virus NN I-NP
. . O

-DOCSTART- X X O

Auditory NNP O
clicks NNS O
were VBD O
given VBN O
at IN O
a DT O
rate NN O
of IN O
20 CD O
s(-1 NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
inhibition NN O
of IN O
StAR NNP B-NP
gene NN I-NP
transcription NN O
by IN O
DAX-1 NNP B-NP
was VBD O
dose-dependent JJ O
reducing VBG O
transcription NN O
to TO O
6 CD O
% NN O
of IN O
control NN O
levels NNS O
. . O

-DOCSTART- X X O

In IN O
a DT O
prospective JJ O
randomized JJ O
study NN O
, , O
287 CD O
patients NNS O
with IN O
advanced JJ O
non-small JJ O
cell NN O
lung NN O
cancer NN O
( -LRB- O
NSCLC NNP O
) -RRB- O
stage NN O
IIIb NNP O
or CC O
IV NNP O
with IN O
ECOG NNP O
performance NN O
status NN O
( -LRB- O
PS) NNP O
0-1 CD O
or CC O
2 CD O
were VBD O
randomly RB O
assigned VBN O
to TO O
receive VB O
either DT O
best JJS O
supportive JJ O
care NN O
( -LRB- O
BSC NNP O
) -RRB- O
or CC O
supportive JJ O
care NN O
plus CC O
combination NN O
chemotherapy NN O
( -LRB- O
IEP NNP O
regimen NNP O
: : O
ifosfamide NN O
3 CD O
gm/m2 CD O
IV NNP O
with IN O
mesna NN O
uroprotection NN O
, , O
epirubicin NN O
60 CD O
mg/m2 CD O
IV NNP O
on IN O
day NN O
1 CD O
and CC O
cisplatin JJ O
60 CD O
mg/m2 CD O
IV NNP O
on IN O
day NN O
2 CD O
; : O
or CC O
MVP NNP O
regimen NNS O
: : O
mitomycin-C JJ O
8 CD O
mg/m2 CD O
, , O
cisplatin VBG O
100 CD O
mg/m2 CD O
IV NNP O
on IN O
day NN O
1 CD O
, , O
vinblastine JJ O
4 CD O
mg/m2 CD O
IV NNP O
on IN O
days NNS O
1 CD O
and CC O
15 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Using VBG O
sequence NN O
information NN O
from IN O
human JJ B-NP
BMAL1 NNP I-NP
( -LRB- O
hBMAL1 NN B-NP
) -RRB- O
cDNAs NNS O
previously RB O
reported VBN O
by IN O
our PRP$ O
laboratory NN O
, , O
we PRP O
have VBP O
isolated VBN O
and CC O
characterized VBN O
cDNAs IN O
encoding VBG O
three CD O
splice NN O
variants NNS O
of IN O
the DT O
mouse NN B-NP
BMAL1 NNP I-NP
( -LRB- O
mBMAL1 NN B-NP
) -RRB- O
gene NN O
. . O

-DOCSTART- X X O

Comparison NN O
with IN O
the DT O
bHLH/PAS NNS B-NP
family NN O
genes NNS O
revealed VBD O
that IN O
the DT O
intron/exon JJ O
splice NN O
pattern NN O
of IN O
mBMAL1 JJ B-NP
most RBS O
closely RB O
matches VBZ O
that IN O
of IN O
the DT O
mAhr NN B-NP
, , O
which WDT O
suggests VBZ O
that IN O
BMAL1 NNP B-NP
and CC O
Ahr NNP B-NP
belong VBP O
to TO O
the DT O
same JJ O
subclass NN O
and CC O
may MD O
be VB O
derived VBN O
from IN O
a DT O
common JJ O
primordial JJ O
gene NN O
. . O

-DOCSTART- X X O

The DT O
transcriptional JJ O
activities NNS O
of IN O
the DT O
full-length JJ O
promoter NN O
(-295 . O
to TO O
+85 CD O
) -RRB- O
and CC O
of IN O
three CD O
deletion NN O
constructs NNS O
(-197 CC O
, , O
-154 . O
and CC O
-74 JJ O
to TO O
+85 CD O
) -RRB- O
were VBD O
significantly RB O
down-regulated JJ O
in IN O
resistant JJ O
cells NNS O
. . O

-DOCSTART- X X O

We PRP O
were VBD O
able JJ O
to TO O
detect VB O
significant JJ O
differences NNS O
in IN O
functional JJ O
residual JJ O
capacity NN O
adjusted VBN O
for IN O
weight NN O
or CC O
height NN O
, , O
and CC O
compliance NN O
of IN O
the DT O
respiratory NN O
system NN O
adjusted VBN O
for IN O
weight NN O
or CC O
lung NN O
volume NN O
in IN O
the DT O
ILD NNP O
infants NNS O
compared VBN O
to TO O
the DT O
healthy JJ O
controls NNS O
or CC O
infants NNS O
who WP O
had VBD O
PPHN NNP O
, , O
indicating VBG O
that IN O
these DT O
PFTs NNS O
were VBD O
sensitive JJ O
enough RB O
to TO O
determine VB O
abnormal JJ O
lung NN O
function NN O
in IN O
this DT O
age NN O
group NN O
. . O

-DOCSTART- X X O

A DT O
13-bp JJ O
cis-regulatory JJ O
element NN O
in IN O
the DT O
LTR NNP O
promoter NN O
of IN O
the DT O
tobacco NN B-NP
retrotransposon NN I-NP
Tto1 . I-NP
is VBZ O
involved VBN O
in IN O
responsiveness NN O
to TO O
tissue NN O
culture NN O
, , O
wounding VBG O
, , O
methyl NN O
jasmonate NN O
and CC O
fungal JJ O
elicitors NNS O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
we PRP O
describe VBP O
that IN O
platelet-derived JJ B-NP
growth NN I-NP
factor NN I-NP
( -LRB- O
PDGF) NNP B-NP
, , O
12-O-tetradecanoyl-phorbol-acetate JJ O
( -LRB- O
TPA NNP O
) -RRB- O
, , O
and CC O
forskolin IN O
induced VBN O
CREB NNP B-NP
(cAMP-responsive JJ O
element-binding JJ B-NP
protein NN I-NP
) -RRB- O
Ser-133 NN O
phosphorylation NN O
with IN O
comparable JJ O
magnitude NN O
and CC O
kinetics NNS O
in IN O
NIH NNP O
3T3 CD O
cells NNS O
. . O

-DOCSTART- X X O

This DT O
constitutes VBZ O
evidence NN O
for IN O
an DT O
in IN O
vivo JJ O
role NN O
of IN O
SRC-1 NN B-NP
in IN O
dimerization-induced JJ O
activation NN O
by IN O
OR1/RXRalpha NNP B-NP
. . O

-DOCSTART- X X O

By IN O
contrast NN O
, , O
mTRAP100 CD B-NP
coprecipitates NNS O
in IN O
vivo NN O
with IN O
another DT O
component NN O
of IN O
the DT O
TRAP NN B-NP
complex NN I-NP
( -LRB- O
TRAP220 NN B-NP
) -RRB- O
, , O
which WDT O
directly RB O
contacts VBZ O
TR NN B-NP
and CC O
the DT O
vitamin NN B-NP
D NN I-NP
receptor NN I-NP
in IN O
a DT O
ligand-dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

This DT O
sequence NN O
also RB O
confers VBZ O
VDR NNP B-NP
and CC O
vitamin NN O
D NNP O
responsiveness NN O
to TO O
a DT O
heterologous JJ O
promoter NN O
. . O

-DOCSTART- X X O

Classical NNP O
ligand-activated JJ O
nuclear JJ O
receptors NNS O
( -LRB- O
e NN O
.g NN O
. . O
thyroid DT B-NP
hormone NN I-NP
receptor NN I-NP
, , O
retinoic JJ B-NP
acid NN I-NP
receptor NN I-NP
) -RRB- O
, , O
orphan JJ B-NP
nuclear JJ I-NP
receptors NNS I-NP
( -LRB- O
e NN O
.g NN O
. . O

-DOCSTART- X X O

Expression NNP O
of IN O
GlcNAc-TI NNP B-NP
mRNA NN I-NP
in IN O
tobacco NN O
leaves NNS O
was VBD O
detected VBN O
using VBG O
RT-PCR. NNP O

-DOCSTART- X X O

Chemical NNP O
stability NN O
tests NNS O
and CC O
site-specific JJ O
mutagenesis NN O
identified VBN O
amino IN O
acids NNS O
H219 . O
and CC O
D63 JJ O
of IN O
RegS NNP B-NP
and CC O
RegR NNP B-NP
, , O
respectively RB O
, , O
as IN O
the DT O
phosphorylated JJ O
residues NNS O
. . O

-DOCSTART- X X O

An DT O
overexpression NN O
of IN O
the DT O
betaAPP JJ B-NP
gene NN I-NP
in IN O
certain JJ O
areas NNS O
of IN O
the DT O
AD NN O
brain NN O
has VBZ O
been VBN O
suggested VBN O
to TO O
be VB O
an DT O
important JJ O
factor NN O
in IN O
the DT O
neuropathology NN O
of IN O
AD. NNP O

-DOCSTART- X X O

For IN O
functional JJ O
studies NNS O
, , O
two CD O
promoter NN O
regions NNS O
were VBD O
cloned VBN O
upstream RB O
of IN O
the DT O
reporter NN O
gene NN O
, , O
chloramphenicol NN B-NP
acetyl NN I-NP
transferase NN I-NP
( -LRB- O
CAT NN B-NP
) -RRB- O
: : O
( -LRB- O
i NN O
) -RRB- O
phbetaE-B NN O
- : O
the DT O
plasmid NN O
that WDT O
contains VBZ O
the DT O
human NN O
( -LRB- O
h NN O
) -RRB- O
promoter NN O
region NN O
(-2832 . O
to TO O
+101 CD O
) -RRB- O
including VBG O
URE NNP O
, , O
and CC O
( -LRB- O
ii NNS O
) -RRB- O
prhbetaE-B NN O
- : O
the DT O
plasmid NN O
that WDT O
contains VBZ O
the DT O
rhesus NN O
( -LRB- O
rh NN O
) -RRB- O
promoter NN O
region NN O
excluding VBG O
URE NNP O
as IN O
it PRP O
lacks VBZ O
a DT O
270 CD O
bp IN O
region NN O
of IN O
the DT O
hbetaAPP NN B-NP
promoter NN I-NP
(-2435 CD O
to TO O
-2165 CD O
) -RRB- O
. . O

-DOCSTART- X X O

67 CD O
393 CD O
bp NN O
of IN O
contiguous JJ O
DNA NN O
located VBN O
between IN O
markers NNS O
cdc18 CD B-NP
and CC O
cdc14 CD B-NP
on IN O
the DT O
right JJ O
arm NN O
of IN O
fission NN O
yeast NN O
chromosome NN O
II NNP O
has VBZ O
been VBN O
sequenced VBN O
as IN O
part NN O
of IN O
the DT O
European NNP O
Union NNP O
Schizosaccharomyces NNP O
pombe VBD O
genome JJ O
sequencing NN O
project NN O
. . O

-DOCSTART- X X O

67 CD O
393 CD O
bp NN O
of IN O
contiguous JJ O
DNA NN O
located VBN O
between IN O
markers NNS O
cdc18 CD B-NP
and CC O
cdc14 CD B-NP
on IN O
the DT O
right JJ O
arm NN O
of IN O
fission NN O
yeast NN O
chromosome NN O
II NNP O
has VBZ O
been VBN O
sequenced VBN O
as IN O
part NN O
of IN O
the DT O
European NNP O
Union NNP O
Schizosaccharomyces NNP O
pombe VBD O
genome JJ O
sequencing NN O
project NN O
. . O

-DOCSTART- X X O

G-CSF NNP B-NP
( -LRB- O
480 CD O
micrograms NNS O
subcutaneously RB O
( -LRB- O
s.c. NN O
) -RRB- O
) -RRB- O
were VBD O
used VBN O
in IN O
55 CD O
and CC O
GM-CSF NNP B-NP
( -LRB- O
400 CD O
micrograms NNS O
s.c. DT O
) -RRB- O
in IN O
28 CD O
chemotherapeutic NN O
cycles NNS O
. . O

-DOCSTART- X X O

Overexpression IN O
of IN O
H411 CD B-NP
cDNA NN I-NP
in IN O
the DT O
RAW NNP O
264.7 CD O
macrophage NN O
cell NN O
line NN O
promoted VBN O
an DT O
increased JJ O
growth NN O
rate NN O
, , O
suggesting VBG O
that IN O
expression NN O
of IN O
H411 NNP B-NP
is VBZ O
part NN O
of IN O
the DT O
proliferative JJ O
cell NN O
response NN O
to TO O
LPS. NNP O

-DOCSTART- X X O

Human NNP O
expressed VBD O
sequence NN O
tag NN O
clones NNS O
were VBD O
identified VBN O
by IN O
sequence NN O
similarity NN O
to TO O
mammalian JJ B-NP
and CC I-NP
yeast NN I-NP
oligosaccharide-processing JJ I-NP
mannosidases NNS I-NP
, , O
and CC O
the DT O
full-length JJ O
coding NN O
region NN O
of IN O
the DT O
putative JJ O
mannosidase NN B-NP
homolog NN I-NP
was VBD O
isolated VBN O
by IN O
a DT O
combination NN O
of IN O
5'-rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends NNS O
and CC O
direct JJ O
polymerase NN O
chain NN O
reaction NN O
from IN O
human JJ O
placental NN O
cDNA NN O
. . O

-DOCSTART- X X O

Activation NN O
of IN O
ERK1/2 NNP B-NP
is VBZ O
correlated VBN O
with IN O
induction NN O
of IN O
the DT O
immediate-early JJ B-NP
response NN I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

The DT O
transcription NN O
of IN O
most JJS O
RP NNP B-NP
genes NNS I-NP
is VBZ O
activated VBN O
by IN O
two CD O
Rap1p NNP B-NP
binding NN I-NP
sites NNS I-NP
, , O
250 CD O
to TO O
400 CD O
bp NN O
upstream RB O
from IN O
the DT O
initiation NN O
of IN O
transcription NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
three CD O
mutant JJ O
alleles NNS O
of IN O
CDC4 NNP B-NP
( -LRB- O
cdc4-10 NN B-NP
, , O
cdc4-11 NN B-NP
, , O
and CC O
cdc4-16 CD B-NP
) -RRB- O
which WDT O
suppress VBP O
the DT O
nuclear JJ O
division NN O
defect NN O
of IN O
cdc20-1 JJ B-NP
cells NNS O
. . O

-DOCSTART- X X O

Role NNP O
of IN O
secondary JJ O
structure NN O
in IN O
discrimination NN O
between IN O
constitutive JJ O
and CC O
inducible JJ O
activators NNS O
. . O

-DOCSTART- X X O

In IN O
summary NN O
, , O
Ca( NNP O
2+)-dependent JJ O
activation NN O
of IN O
NO DT O
production NN O
mediates NNS O
apoptosis NN O
after IN O
TG JJ B-NP
exposure NN O
in IN O
JT/Neo NNP O
cells NNS O
. . O

-DOCSTART- X X O

Accumulation NNP O
of IN O
the DT O
U4/U6 NNP B-NP
duplex NN O
was VBD O
relieved VBN O
by IN O
overexpression NNP O
of IN O
wild-type JJ B-NP
Prp44p NNP I-NP
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
, , O
when WRB O
combined VBN O
with IN O
previously RB O
published VBN O
in IN O
vitro NN O
results NNS O
, , O
support VBP O
a DT O
direct JJ O
role NN O
for IN O
Prp44p NNP B-NP
in IN O
unwinding NN O
of IN O
the DT O
U4/U6 NNP B-NP
helix NN O
. . O

-DOCSTART- X X O

This DT O
approximately RB O
125-nt JJ O
RNA NNP O
proved VBD O
to TO O
arise VB O
via IN O
RNase NNP B-NP
E NNP I-NP
cleavage NN O
from IN O
the DT O
3'-terminal JJ O
region NN O
of IN O
the DT O
mRNAs NNS O
bearing VBG O
the DT O
terminator NN O
. . O

-DOCSTART- X X O

The DT O
mysteries NNS O
of IN O
geographic JJ O
variability NN O
in IN O
nonmelanoma NN O
skin NN O
cancer NN O
incidence NN O
. . O

-DOCSTART- X X O

In IN O
Saccharomyces NNP O
cerevisiae , O
the DT O
cAMP-dependent JJ B-NP
kinases NNS I-NP
( -LRB- O
PKAs NNS B-NP
) -RRB- O
promote VBP O
cytoplasmic JJ O
growth NN O
and CC O
modulate VB O
the DT O
growth-regulated JJ O
mechanism NN O
triggering VBG O
the DT O
begin VB O
of IN O
DNA NNP O
synthesis NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
shown VBN O
previously RB O
that IN O
in IN O
contrast NN O
to TO O
other JJ O
extracellular JJ O
matrix NN O
molecules NNS O
pepsin-solubilized JJ B-NP
collagen NN B-NP
VI NNP I-NP
( -LRB- O
CVI NN B-NP
) -RRB- O
can MD O
stimulate VB O
DNA NNP O
synthesis NN O
of IN O
various JJ O
mesenchymal JJ O
cell NN O
types NNS O
, , O
apparently RB O
independent JJ O
of IN O
integrin-mediated JJ B-NP
signal NN O
transduction NN O
. . O

-DOCSTART- X X O

A DT O
recombinant JJ O
derivative NN O
harboring VBG O
the DT O
pMJ101 JJ O
replication NN O
region NN O
proved VBD O
to TO O
be VB O
compatible JJ O
with IN O
pJM1 NNS O
, , O
a DT O
plasmid NN O
containing VBG O
the DT O
iron NN O
acquisition NN O
system NN O
required VBN O
for IN O
the DT O
virulence NN O
of IN O
V. NNP O
anguillarum NN O
775 CD O
, , O
another DT O
important JJ O
pathogen NN O
that WDT O
causes VBZ O
vibriosis NN O
. . O

-DOCSTART- X X O

FAK NNP B-NP
localizes VBZ O
to TO O
sites NNS O
of IN O
transmembrane NN B-NP
integrin NN I-NP
receptor NN I-NP
clustering NN O
and CC O
facilitates NNS O
intracellular JJ O
signaling VBG O
events NNS O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
various JJ O
FAK NNP B-NP
mutants NNS I-NP
in IN O
the DT O
FAK- NNP B-NP
cells NNS O
showed VBD O
that IN O
FAK NNP B-NP
kinase NN I-NP
activity NN O
, , O
the DT O
Tyr-397/SH2 JJ B-NP
domain NN I-NP
binding NN I-NP
site NN I-NP
, , O
and CC O
the DT O
first JJ O
proline-rich JJ O
SH3 NNS B-NP
binding JJ I-NP
region NN I-NP
in IN O
the DT O
FAK NNP B-NP
C-terminal JJ I-NP
domain NN I-NP
were VBD O
individually RB O
needed VBN O
to TO O
promote VB O
full JJ O
FAK-mediated JJ B-NP
FAK- NNP B-NP
cell NN O
migration NN O
to TO O
FN NNP B-NP
whereas IN O
direct JJ O
paxillin NN B-NP
binding NN O
to TO O
FAK NNP B-NP
was VBD O
not RB O
required VBN O
. . O

-DOCSTART- X X O

This DT O
dominant-negative JJ O
effect NN O
of IN O
FRNK NNP B-NP
was VBD O
reversed VBN O
by IN O
a DT O
point NN O
mutation NN O
( -LRB- O
Leu-1034 NNP O
to TO O
Ser NNP O
) -RRB- O
which WDT O
prevented VBD O
FRNK NNP B-NP
localization NN O
to TO O
focal JJ O
contact NN O
sites NNS O
. . O

-DOCSTART- X X O

Fifty CD O
six CD O
young JJ O
patients NNS O
( -LRB- O
age NN O
<45 CD O
yr NN O
) -RRB- O
with IN O
doppler-proven JJ O
DVT NNP O
were VBD O
investigated VBN O
for IN O
the DT O
presence NN O
of IN O
resistance NN O
to TO O
activated JJ B-NP
protein NN I-NP
C NNP I-NP
( -LRB- O
APC-R) NNP B-NP
, , O
lupus NN O
anticoagulant NN O
( -LRB- O
LA NNP O
) -RRB- O
, , O
anticardiolipin JJ B-NP
antibodies NNS I-NP
and CC O
deficiencies NNS O
of IN O
protein NN B-NP
C NNP I-NP
, , O
protein NN B-NP
S NNP I-NP
, , O
ATIII NNP B-NP
activities NNS O
. . O

-DOCSTART- X X O

DESIGN NNP O
: : O
Comparison NNP O
of IN O
number NN O
of IN O
women NNS O
with IN O
PKU NNS O
aged VBN O
15-44 CD O
years NNS O
on IN O
the DT O
NSW NNP O
PKU NNP O
database NN O
( -LRB- O
observed JJ O
number NN O
) -RRB- O
with IN O
expected VBN O
number NN O
derived VBN O
from IN O
population NN O
data NNS O
. . O

-DOCSTART- X X O

PURPOSE NNP O
: : O
The DT O
purposes NNS O
of IN O
the DT O
present JJ O
study NN O
were VBD O
to TO O
assess VB O
the DT O
effects NNS O
of IN O
a DT O
12-wk JJ O
laboratory NN O
based VBN O
aerobic JJ O
exercise NN O
program NN O
on IN O
cardiopulmonary JJ O
function NN O
, , O
CD4 IN B-NP
cell NN O
count NN O
, , O
and CC O
physician-assessed JJ O
health NN O
status NN O
among IN O
symptomatic JJ O
pre-AIDS NNS O
HIV-infected JJ O
individuals NNS O
( -LRB- O
N NNP O
= SYM O
28 CD O
) -RRB- O
and CC O
to TO O
assess VB O
the DT O
degree NN O
to TO O
which WDT O
ill JJ O
health NN O
was VBD O
associated VBN O
with IN O
exercise NN O
relapse NN O
. . O

-DOCSTART- X X O

The DT O
enzyme JJ O
displays NNS O
optimal JJ O
activity NN O
at IN O
about RB O
0.5 CD O
mM NN O
pantoate NN O
(k( JJ O
cat NN O
) -RRB- O
0.63 CD O
s(-1 NN O
) -RRB- O
) -RRB- O
and CC O
at IN O
pH NNS O
7.8. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
demonstrate VBP O
that IN O
the DT O
RP NNP B-NP
, , O
like IN O
the DT O
20S JJ B-NP
proteasome JJ I-NP
, , O
is VBZ O
functionally RB O
and CC O
structurally RB O
conserved VBN O
among IN O
eukaryotes NNS O
and CC O
indicate VBP O
that IN O
the DT O
plant NN B-NP
RPT NN I-NP
subunits NNS I-NP
, , O
like IN O
their PRP$ O
yeast NN O
counterparts NNS O
, , O
have VBP O
non-redundant JJ O
functions NNS O
. . O

-DOCSTART- X X O

Epidemiologic NNP O
evidence NN O
indicates VBZ O
that IN O
estrogen NN O
replacement NN O
therapy NN O
after IN O
menopause NN O
increases NNS O
breast NN O
cancer NN O
risk NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
its PRP$ O
elongation NN O
activity NN O
, , O
ELL NNP B-NP
contains VBZ O
a DT O
novel NN O
type NN O
of IN O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
interaction NN I-NP
domain NN I-NP
that WDT O
is VBZ O
capable JJ O
of IN O
repressing VBG O
polymerase NN O
activity NN O
in IN O
promoter-specific JJ O
transcription NN O
. . O

-DOCSTART- X X O

A DT O
diagnosis NN O
of IN O
IgA NNP B-NP
lambda VBD I-NP
multiple JJ O
myeloma NN O
with IN O
peritoneal JJ O
involvement NN O
was VBD O
made VBN O
. . O

-DOCSTART- X X O

The DT O
radiation NN O
burden NN O
associated VBN O
with IN O
the DT O
majority NN O
of IN O
examinations NNS O
in IN O
nuclear JJ O
medicine NN O
expressed VBN O
as IN O
the DT O
effective JJ O
dose NN O
is VBZ O
comparable JJ O
with IN O
the DT O
radiation NN O
burden NN O
of IN O
radiodiagnostic JJ O
examinations NNS O
, , O
only RB O
after IN O
administration NN O
of IN O
preparations NNS O
with IN O
131I CD O
, , O
201Tl CD O
, , O
67Ga CD O
and CC O
111In IN O
it PRP O
is VBZ O
markedly RB O
higher JJR O
. . O

-DOCSTART- X X O

Although IN O
the DT O
risk NN O
of IN O
malformation NN O
in IN O
children NNS O
born VBN O
after IN O
ICSI NNP O
is VBZ O
not RB O
increased VBN O
there EX O
is VBZ O
an DT O
increased VBN O
risk NN O
to TO O
transmit VB O
genetic JJ O
abnormalities NNS O
in IN O
case NN O
of IN O
NOA NNP O
( -LRB- O
such JJ O
as IN O
the DT O
rate NN O
of IN O
sex NN O
chromosome NN O
, , O
or CC O
microdeletions NNS O
of IN O
the DT O
Y NNP O
chromosome NN O
) -RRB- O
and CC O
in IN O
case NN O
of IN O
congenital NN O
OA NN O
( -LRB- O
mutations NNS O
of IN O
the DT O
cystic JJ B-NP
fibrosis NN I-NP
gene NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

TaV NNP O
particles NNS O
have VBP O
a DT O
buoyant JJ O
density NN O
of IN O
1.296 CD O
g/cm3 CD O
in IN O
CsCl NNP O
and CC O
consist VB O
of IN O
two CD O
capsid JJ B-NP
proteins NNS I-NP
of IN O
56 CD O
and CC O
6 CD O
kDa NN O
. . O

-DOCSTART- X X O

In IN O
about RB O
770 CD O
bp NN O
upstream JJ O
region NN O
of IN O
Spam1 NNP B-NP
that WDT O
has VBZ O
been VBN O
cloned VBN O
and CC O
sequenced VBN O
, , O
multiple JJ O
transcription NN O
factor NN O
binding VBG O
sites NNS O
including VBG O
a DT O
CRE NNP O
(cAMP-responsive JJ O
element NN O
) -RRB- O
were VBD O
found VBN O
. . O

-DOCSTART- X X O

The DT O
in IN O
vitro NN O
relaxivity NN O
of IN O
the DT O
complex NN O
is VBZ O
16.24 CD O
s(-1 NN O
) -RRB- O
mM(-1 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Structure NN O
and CC O
expression NN O
of IN O
the DT O
mouse NN B-NP
growth NN I-NP
hormone NN I-NP
receptor/growth NN I-NP
hormone NN B-NP
binding JJ I-NP
protein NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Bacterial NNP O
recovery NN O
of IN O
SA NNP O
from IN O
the DT O
liver/spleen NN O
and CC O
the DT O
cecal JJ O
tonsil NN O
in IN O
contact NN O
poults NNS O
and CC O
SG NNP O
from IN O
contact NN O
chicks NNS O
treated VBN O
with IN O
ILK NN B-NP
was VBD O
dramatically RB O
reduced VBN O
when WRB O
compared VBN O
to TO O
non-treated JJ O
contact NN O
poults NNS O
and CC O
chicks NNS O
. . O

-DOCSTART- X X O

The DT O
results NNS O
of IN O
the DT O
ISIS-2 NNP O
trial NN O
and CC O
the DT O
data NNS O
from IN O
the DT O
Antiplatelet NNP O
Trialists NNPS O
' POS O
Collaboration NNP O
indicated VBD O
that IN O
aspirin NN O
is VBZ O
mandatory JJ O
in IN O
patients NNS O
with IN O
acute JJ O
myocardial JJ O
infarction NN O
and CC O
for IN O
secondary JJ O
prevention NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
was VBD O
performed VBN O
to TO O
assess VB O
the DT O
role NN O
of IN O
additional JJ O
diagnostic JJ O
laparoscopy NN O
in IN O
the DT O
preoperative JJ O
staging NN O
of IN O
patients NNS O
with IN O
adenocarcinoma NN O
of IN O
the DT O
esophagus NN O
, , O
gastric JJ O
cancer NN O
and CC O
pancreatic JJ O
cancer NN O
prior RB O
to TO O
intended VBN O
curative JJ O
surgery NN O
. . O

-DOCSTART- X X O

This DT O
report NN O
presents VBZ O
state-specific JJ O
MMRs NNS O
for IN O
1987-1996 CD O
, , O
focusing VBG O
on IN O
persistent JJ O
disparities NNS O
in IN O
maternal JJ O
mortality NN O
between IN O
black JJ O
and CC O
white JJ O
women NNS O
. . O

-DOCSTART- X X O

Preheparin NNP O
LPL NNP B-NP
mass NN O
level NN O
did VBD O
not RB O
significantly RB O
differ VB O
in IN O
individuals NNS O
from IN O
19 CD O
to TO O
70 CD O
years NNS O
old JJ O
, , O
for IN O
both DT O
men NNS O
and CC O
women NNS O
. . O

-DOCSTART- X X O

A DT O
decrease NN O
in IN O
insulin-induced JJ B-NP
receptor NN O
kinase NN O
activity NN O
was VBD O
observed VBN O
for IN O
solubilized JJ O
chimeric JJ O
receptors NNS O
. . O

-DOCSTART- X X O

Cat-1 NNP B-NP
is VBZ O
identical JJ O
to TO O
the DT O
recently RB O
identified VBN O
binding JJ O
partner NN O
for IN O
the DT O
beta-adrenergic JJ B-NP
receptor NN I-NP
kinase NN I-NP
( -LRB- O
betaARK NN B-NP
or CC O
GRK-2 JJ B-NP
) -RRB- O
, , O
which WDT O
was VBD O
shown VBN O
to TO O
have VB O
Arf-GAP NNP B-NP
activity NN O
. . O

-DOCSTART- X X O

Cat NNP B-NP
proteins NNS I-NP
are VBP O
tyrosine-phosphorylated JJ O
when WRB O
co-expressed JJ O
in IN O
cells NNS O
with IN O
the DT O
focal JJ B-NP
adhesion NN I-NP
kinase NN I-NP
Fak NNP B-NP
and CC O
Src NNP B-NP
. . O

-DOCSTART- X X O

Immunoprecipitation NN O
experiments NNS O
using VBG O
DokR-specific JJ B-NP
antibodies NNS I-NP
revealed VBD O
an DT O
interaction NN O
between IN O
endogenous JJ B-NP
DokR NNP I-NP
and CC O
a DT O
150-kDa JJ O
protein NN O
that WDT O
is VBZ O
tyrosine-phosphorylated JJ O
in IN O
EGF-stimulated JJ B-NP
BaF/3 NNP O
cells NNS O
. . O

-DOCSTART- X X O

Expansins NNS B-NP
are VBP O
a DT O
family NN O
of IN O
proteins NNS O
that WDT O
catalyse VBP O
long-term JJ O
extension NN O
of IN O
isolated JJ O
plant NN O
cell NN O
walls NNS O
due JJ O
to TO O
an DT O
as RB O
yet RB O
unknown JJ O
biochemical JJ O
mechanism NN O
. . O

-DOCSTART- X X O

This DT O
review NN O
summarizes VBZ O
the DT O
clinical JJ O
evidence NN O
to TO O
support VB O
current JJ O
therapies NNS O
in IN O
irritable JJ O
bowel NN O
syndrome NN O
( -LRB- O
IBS NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
addition NN O
of IN O
B-Myb-glutathionine NNP B-NP
S-transferase NNP B-NP
fusion NN O
protein NN O
inhibited VBD O
complex JJ O
formation NN O
. . O

-DOCSTART- X X O

APOE-epsilon4 DT B-NP
count NN O
predicts VBZ O
age NN O
when WRB O
prevalence NN O
of IN O
AD NN O
increases NNS O
, , O
then RB O
declines VBZ O
: : O
the DT O
Cache NNP O
County NNP O
Study NNP O
. . O

-DOCSTART- X X O

Repair NNP O
of IN O
double-strand JJ O
breaks NNS O
( -LRB- O
DSBs NNS O
) -RRB- O
in IN O
chromosomal NN O
DNA NN O
by IN O
nonhomologous JJ O
end-joining NN O
( -LRB- O
NHEJ) NNP O
is VBZ O
not RB O
well RB O
characterized VBN O
in IN O
the DT O
yeast NN O
Saccharomyces NNP O
cerevisiae NNS O
. . O

-DOCSTART- X X O

A DT O
new JJ O
DNA NN B-NP
repair NN I-NP
gene NN I-NP
from IN O
Schizosaccharomyces NNP O
pombe NN O
with IN O
homology NN O
to TO O
RecA NNP B-NP
was VBD O
identified VBN O
and CC O
characterized VBN O
. . O

-DOCSTART- X X O

Among IN O
mucus-secreting JJ O
cells NNS O
, , O
the DT O
gastric JJ O
gland NN O
mucous JJ O
cells NNS O
, , O
Brunner NNP O
's POS O
glands NNS O
, , O
accessory JJ O
glands NNS O
of IN O
pancreaticobiliary NN O
tract NN O
, , O
and CC O
pancreatic JJ O
ducts NNS O
exhibiting VBG O
gastric JJ O
metaplasia NN O
are VBP O
unique JJ O
in IN O
that IN O
they PRP O
express VBP O
class NN B-NP
III NNP I-NP
mucin NN I-NP
identified VBN O
by IN O
paradoxical JJ O
Con NNP B-NP
A DT I-NP
staining VBG O
composed VBN O
of IN O
periodate NN O
oxidation NN O
, , O
sodium NN O
borohydride NN O
reduction NN O
, , O
Con NNP B-NP
A NNP I-NP
, , O
and CC O
horseradish NN B-NP
peroxidase NN I-NP
reaction NN O
. . O

-DOCSTART- X X O

The DT O
C-terminal JJ O
mutants NNS O
were VBD O
strongly RB O
dominant JJ O
over IN O
TraR NNP B-NP
, , O
suggesting VBG O
that IN O
they PRP O
can MD O
form VB O
heteromultimers NNS O
with IN O
the DT O
wild-type JJ O
activator NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
elongin JJ B-NP
C NNP I-NP
is VBZ O
found VBN O
to TO O
oligomerize VB O
in IN O
solution NN O
and CC O
to TO O
undergo VB O
significant JJ O
structural JJ O
rearrangements NNS O
upon IN O
binding NN O
of IN O
two CD O
different JJ O
partner NN O
proteins NNS O
. . O

-DOCSTART- X X O

The DT O
data NNS O
imply VBP O
that IN O
JAK/STAT JJ B-NP
signaling NN O
has VBZ O
a DT O
role NN O
in IN O
EBV-associated JJ O
malignancies NNS O
. . O

-DOCSTART- X X O

There EX O
were VBD O
27 CD O
men NNS O
and CC O
156 CD O
women NNS O
. . O

-DOCSTART- X X O

A. NN O
, , O
Bowers NNP O
, , O
K.E NNP O
, , O
and CC O
Matthews NNP O
, , O
C. NNP O

-DOCSTART- X X O

Spfkh1 NNP B-NP
is VBZ O
transcribed VBN O
in IN O
one CD O
open JJ O
reading NN O
frame NN O
that WDT O
contains VBZ O
the DT O
DNA NNP O
binding NN O
domain NN O
, , O
nuclear JJ O
localization NN O
signal NN O
and CC O
transactivation NN O
domain NN O
. . O

-DOCSTART- X X O

The DT O
molecular JJ O
mechanism NN O
of IN O
Tax-mediated NNP B-NP
trans-activation NN O
has VBZ O
been VBN O
well RB O
investigated VBN O
. . O

-DOCSTART- X X O

Gel NNP O
filtration NN O
and CC O
co-immunoprecipitation NN O
analyses NNS O
reveal VBP O
that IN O
Mad2p NNP B-NP
tightly RB O
associates NNS O
with IN O
another DT O
spindle NN O
checkpoint NN O
component NN O
, , O
Mad1p NNP B-NP
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
109 CD O
suspected VBD O
cases NNS O
with IN O
SS NNP O
underwent IN O
the DT O
biopsies NNS O
. . O

-DOCSTART- X X O

We PRP O
also RB O
identify VBP O
several JJ O
regulatory JJ O
domain NN O
mutants NNS O
in IN O
which WDT O
Cd( JJ O
2+ CD O
) -RRB- O
tolerance NN O
of IN O
the DT O
mutant JJ O
strain NN O
and CC O
transport NN O
activity NN O
of IN O
the DT O
protein NN O
are VBP O
dissociated VBN O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type-1 NN I-NP
( -LRB- I-NP
HIV-1 NN I-NP
) -RRB- I-NP
Tat NNPS I-NP
protein NN I-NP
regulates VBZ O
transcription NN O
by IN O
stimulating VBG O
RNA NNP B-NP
polymerase NN I-NP
processivity NN O
. . O

-DOCSTART- X X O

One CD O
of IN O
these DT O
SEBPs NNS B-NP
, , O
SEBP2 NNP B-NP
, , O
was VBD O
shown VBN O
to TO O
be VB O
the DT O
product NN O
of IN O
the DT O
homeotic JJ B-NP
gene NN I-NP
fork NN B-NP
head NN I-NP
. . O

-DOCSTART- X X O

Identity NN O
elements NNS O
in IN O
tRNA NN O
for IN O
mono NN O
- : O
and CC O
dimethylation NN O
reactions NNS O
by IN O
the DT O
recombinant JJ B-NP
pfTrm1p NN I-NP
were VBD O
identified VBN O
using VBG O
in IN O
vitro NN O
T7 DT O
transcripts NNS O
of IN O
33 CD O
variants NNS O
of IN O
tRNA( DT B-NP
Asp)and NNP I-NP
tRNA( NN B-NP
Phe)from NNP I-NP
yeast NN O
. . O

-DOCSTART- X X O

In IN O
insulin-responsive JJ B-NP
cells NNS O
, , O
Akt NNP B-NP
phosphorylates NNS O
and CC O
inactivates VBZ O
the DT O
serine/threonine NN B-NP
kinase NN I-NP
glycogen NN B-NP
synthase NN I-NP
kinase-3 NN I-NP
( -LRB- O
GSK-3 JJ B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
B NNP B-NP
cell NN I-NP
antigen NN I-NP
receptor NN I-NP
activates VBZ O
the DT O
Akt NNP B-NP
( -LRB- O
protein NN B-NP
kinase NN I-NP
B)/glycogen NN I-NP
synthase NN B-NP
kinase-3 NN I-NP
signaling VBG O
pathway NN O
via IN O
phosphatidylinositol NN B-NP
3-kinase CD I-NP
. . O

-DOCSTART- X X O

Fewer JJR O
recombination NN O
events NNS O
are VBP O
detected VBN O
in IN O
four CD O
different JJ O
B NNP O
and CC O
T NNP O
cell NN O
lines NNS O
that WDT O
do VBP O
not RB O
undergo VB O
switch NN O
recombination NN O
of IN O
their PRP$ O
endogenous JJ O
genes NNS O
. . O

-DOCSTART- X X O

IL-1 NN B-NP
and CC O
TNF NN B-NP
increase NN O
AND-34 CC B-NP
transcript NN I-NP
levels NNS O
in IN O
thymic JJ O
cortical JJ O
reticular JJ O
, , O
thymic JJ O
nurse NN O
, , O
and CC O
fibroblast JJ O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

To TO O
determine VB O
what WP O
role NN O
eIF4E NN B-NP
might MD O
play VB O
in IN O
c-myc JJ B-NP
expression NN O
, , O
the DT O
c-myc JJ B-NP
5' JJ I-NP
untranslated JJ I-NP
region NN I-NP
( -LRB- I-NP
UTR NN I-NP
) -RRB- I-NP
was VBD O
fused VBN O
in-frame JJ O
to TO O
CAT NNP B-NP
reporters NNS I-NP
, , O
and CC O
several JJ O
more JJR O
derivative JJ O
constructs NNS O
were VBD O
made VBN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
cell NN O
cycle NN O
proteins VBZ O
showed VBN O
that IN O
24 CD O
h NN O
of IN O
lovastatin NN O
treatment NN O
in IN O
the DT O
control NN O
cells NNS O
caused VBN O
an DT O
elevation NN O
in IN O
the DT O
levels NNS O
of IN O
the DT O
cyclin-dependent JJ B-NP
kinase NN I-NP
inhibitor NN O
p27(kip1 NN B-NP
) -RRB- O
, , O
inhibition NN O
of IN O
both DT O
cyclin NN B-NP
E- NNP I-NP
and CC I-NP
cyclin NN I-NP
A-dependent JJ I-NP
kinase NN I-NP
activity NN O
, , O
and CC O
decreased VBD O
levels NNS O
of IN O
hyperphosphorylated VBN O
retinoblastoma NN B-NP
protein NN I-NP
( -LRB- O
pRb NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Circulating VBG O
leptin NN B-NP
concentrations NNS O
in IN O
AN DT O
were VBD O
3.5+/-0.5 CD O
versus NN O
7.6+/-1.2 CD O
ng/ml NN O
in IN O
control NN O
subjects NNS O
. . O

-DOCSTART- X X O

Copyright NNP O
1999 CD O
Academic NNP O
Press NNP O
. . O

-DOCSTART- X X O

Oligonucleotide NNP O
probes NNS O
corresponding JJ O
to TO O
wild-type JJ O
and CC O
mutant JJ O
EpRE NNP O
sequences NNS O
were VBD O
used VBN O
in IN O
gel-shift JJ O
and CC O
super-shift JJ O
analyses NNS O
to TO O
identify VB O
proteins NNS O
binding NN O
. . O

-DOCSTART- X X O

PKNbeta NNP B-NP
had VBD O
high JJ O
sequence NN O
homology NN O
with IN O
PKNalpha NNP B-NP
, , O
originally RB O
isolated VBN O
PKN NNP B-NP
, , O
especially RB O
in IN O
the DT O
repeats NNS O
of IN O
charged VBN O
amino IN O
acid-rich JJ O
region NN O
with IN O
leucine-zipper NN O
like IN O
sequences NNS O
( -LRB- O
CZ NN O
region/HR1 NN O
) -RRB- O
, , O
in IN O
the DT O
carboxyl-terminal JJ O
catalytic JJ O
domain NN O
, , O
and CC O
in IN O
approximately RB O
130 CD O
amino IN O
acid NN O
stretch NN O
( -LRB- O
D NN O
region/HR2 NN O
) -RRB- O
, , O
located VBN O
between IN O
CZ NNP O
region/HR1 NNP O
and CC O
the DT O
catalytic JJ O
domain NN O
. . O

-DOCSTART- X X O

At IN O
baseline NN O
, , O
serum NN O
levels NNS O
of IN O
lycopene NN O
and CC O
FLOP NNP O
were VBD O
abnormally RB O
high JJ O
and CC O
serum JJ O
FLOP NNP O
was VBD O
correlated VBN O
significantly RB O
with IN O
plasma NN O
cyclosporine NN O
levels NNS O
( -LRB- O
r NN O
= SYM O
0.646 CD O
, , O
p NN O
= SYM O
0.016 CD O
) -RRB- O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Chronic JJ O
alcohol NN O
consumption NN O
has VBZ O
been VBN O
demonstrated VBN O
to TO O
be VB O
deleterious JJ O
to TO O
bone NN O
health NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
following VBG O
induction NN O
of IN O
stress NN O
by IN O
heat NN O
shock NN O
, , O
high JJ O
salt NN O
, , O
or CC O
ethanol NN O
, , O
conditions NNS O
under IN O
which WDT O
most RBS O
mRNA JJ O
export NN O
is VBZ O
blocked VBN O
, , O
Npl3p NNP B-NP
is VBZ O
still RB O
exported VBN O
from IN O
the DT O
nucleus NN O
. . O

-DOCSTART- X X O

For IN O
symptomatic JJ O
relief NN O
and CC O
inhibition NN O
of IN O
the DT O
growth NN O
of IN O
the DT O
metastases NNS O
interferon-a NN B-NP
and CC O
somatostatin NN B-NP
analogues NNS O
can MD O
be VB O
employed VBN O
. . O

-DOCSTART- X X O

In IN O
summary NN O
, , O
the DT O
no-adverse-effect-level JJ O
for IN O
this DT O
study NN O
was VBD O
determined VBN O
to TO O
be VB O
1000 CD O
ppm NN O
, , O
based VBN O
on IN O
decreased VBN O
weight NN O
gain NN O
in IN O
female JJ O
rats NNS O
, , O
and CC O
on IN O
slight JJ O
organ NN O
weight NN O
changes NNS O
in IN O
both DT O
sexes NNS O
at IN O
3000 CD O
ppm NN O
. . O

-DOCSTART- X X O

Some DT O
of IN O
them PRP O
produce VBP O
gigantic JJ O
sperm JJ O
several JJ O
times NNS O
the DT O
total JJ O
male JJ O
body NN O
length NN O
. . O

-DOCSTART- X X O

John NNP O
leonard VBD O
dawson NN O

-DOCSTART- X X O

PDGF NN B-NP
A-chain NN I-NP
levels NNS O
increase NN O
in IN O
cultured JJ O
vascular JJ O
smooth JJ O
muscle NN O
cells NNS O
( -LRB- O
SMCs NNS O
) -RRB- O
exposed VBN O
to TO O
ATII NNP B-NP
. . O

-DOCSTART- X X O

M-Ras JJ B-NP
interacted JJ O
poorly RB O
in IN O
a DT O
yeast NN O
two-hybrid JJ O
assay NN O
with IN O
multiple JJ O
Ras NNP B-NP
effectors NNS O
, , O
including VBG O
c-Raf-1 NN B-NP
, , O
A-Raf NNP B-NP
, , O
B-Raf NNP B-NP
, , O
phosphoinositol-3 JJ B-NP
kinase JJ I-NP
delta NN I-NP
, , O
RalGDS NNP B-NP
, , O
and CC O
Rin1 NNP B-NP
. . O

-DOCSTART- X X O

Deletion NNP O
mapping NN O
of IN O
the DT O
human JJ B-NP
presenilin-1 NN I-NP
( -LRB- O
PS1 NNP B-NP
) -RRB- O
promoter NN O
delineated VBD O
the DT O
most RBS O
active JJ O
fragment NN O
from IN O
-118 CD O
to TO O
+178 CD O
in IN O
relation NN O
to TO O
the DT O
transcription NN O
start NN O
site NN O
mapped VBN O
in IN O
this DT O
study NN O
, , O
in IN O
both DT O
human JJ O
neuroblastoma NN O
SK-N-SH NNS O
and CC O
hepatoma NN O
HepG2 IN O
cells NNS O
. . O

-DOCSTART- X X O

Microcirculatory NNP O
oxygenation NN O
and CC O
shunting VBG O
in IN O
sepsis NN O
and CC O
shock NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
E2F1 NNP B-NP
gene NN I-NP
promoter NN I-NP
showed VBD O
that IN O
the DT O
-146 NN O
to TO O
-54 DT O
region NN O
was VBD O
required VBN O
for IN O
E2-responsiveness NN B-NP
in IN O
transient NN O
transfection NN O
assays VBZ O
, , O
and CC O
subsequent JJ O
deletion/mutation NN O
analysis NN O
showed VBD O
that IN O
a DT O
single JJ O
upstream JJ O
GC-rich JJ O
and CC O
two CD O
downstream NN O
CCAAT-binding JJ O
sites NNS O
were VBD O
required VBN O
for IN O
transactivation NN O
by IN O
E2 NNP B-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
course NN O
of IN O
investigating VBG O
the DT O
mechanisms NNS O
by IN O
which WDT O
OF5 CD B-NP
and CC O
OF3 CD B-NP
regulated JJ O
CYP11A1 NNP B-NP
transcription NN O
, , O
we PRP O
found VBD O
that IN O
OF5 CD B-NP
and CC O
OF3 CD B-NP
bound JJ O
Sp1 NNP B-NP
and CC O
Sp3 NNP B-NP
in IN O
JEG-3 JJ O
cells NNS O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
differentiation NN O
of IN O
neoplastically RB O
transformed VBN O
cells NNS O
does VBZ O
not RB O
repress VB O
mitogenic JJ O
responsiveness NN O
or CC O
junB NN B-NP
or CC O
c-fos JJ B-NP
inducibility NN O
. . O

-DOCSTART- X X O

Adipocyte NNP O
differentiation NN O
of IN O
nontransformed JJ O
cells NNS O
also RB O
markedly RB O
represses VBZ O
the DT O
ability NN O
of IN O
SRF NNP B-NP
to TO O
bind NN O
to TO O
the DT O
junB NN B-NP
SRE RB O
, , O
the DT O
c-fos JJ B-NP
SRE NNP O
, , O
and CC O
other JJ O
SREs NNS O
, , O
as IN O
determined VBN O
by IN O
mobility NN O
shift NN O
and CC O
gel NN O
supershift NN O
assays VBZ O
, , O
without IN O
affecting VBG O
the DT O
DNA NNP O
binding NN O
characteristics NNS O
of IN O
the DT O
nuclear JJ O
protein NN O
SP-1 NN O
. . O

-DOCSTART- X X O

Transformation NN O
blocks NNS O
differentiation-induced JJ O
inhibition NN O
of IN O
serum JJ B-NP
response NN I-NP
factor NN I-NP
interactions NNS O
with IN O
serum JJ O
response NN O
elements NNS O
. . O

-DOCSTART- X X O

The DT O
core NN B-NP
enzyme NN I-NP
is VBZ O
homologous JJ O
to TO O
those DT O
of IN O
bacteriophages NNS O
T3 NNP O
, , O
T7 NNP O
and CC O
SP6 NNP O
whereas IN O
the DT O
specificity NN O
factor NN O
shows VBZ O
similarities NNS O
with IN O
bacterial JJ B-NP
sigma NN I-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

The DT O
Cr.psbA-4 NNP B-NP
ORF NNP I-NP
contains VBZ O
an DT O
H-N-H NNP O
motif NN O
, , O
and CC O
possibly RB O
a DT O
GIY-YIG JJ O
motif NN O
. . O

-DOCSTART- X X O

The DT O
interaction NN O
of IN O
zf4-6 NN B-NP
with IN O
full-length JJ B-NP
5 CD I-NP
S NNP I-NP
RNA NNP I-NP
was VBD O
far RB O
more RBR O
sensitive JJ O
to TO O
non-specific JJ O
competitor NN O
concentration NN O
than IN O
was VBD O
the DT O
zf4-7:5 CD B-NP
S NNP B-NP
RNA NNP I-NP
interaction NN O
, , O
suggesting VBG O
that IN O
finger NN O
seven CD O
contributes NNS O
to TO O
both DT O
affinity NN O
and CC O
specificity NN O
in IN O
this DT O
protein NN O
:RNA NNP O
interaction NN O
. . O

-DOCSTART- X X O

The DT O
STAT NNP B-NP
protein NN I-NP
accumulation NN O
resulting VBG O
from IN O
C/EBP NNP B-NP
expression NN O
was VBD O
tightly RB O
coupled VBN O
to TO O
the DT O
morphological JJ O
conversion NN O
of IN O
fibroblasts NNS O
to TO O
adipocytes NNS O
and CC O
represents VBZ O
an DT O
expression NN O
profile NN O
identical JJ O
to TO O
that DT O
reported VBN O
for IN O
mature JJ O
adipocytes NNS O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

The DT O
median JJ O
durations NNS O
for IN O
response NN O
and CC O
survival NN O
time NN O
in IN O
the DT O
late JJ O
phase NN O
II NNP O
trial NN O
were VBD O
2.3 CD O
months NNS O
and CC O
5.8 CD O
months NNS O
, , O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
'scientific JJ O
psychiatry NN O
' '' O
in IN O
understanding NN O
patients NNS O
with IN O
chronic JJ O
schizophrenia NN O
or CC O
severe JJ O
personality NN O
disorder NN O
. . O

-DOCSTART- X X O

Myocardial JJ O
antioxidant JJ O
enzymes NNS O
, , O
catalase NN B-NP
, , O
glutathione NN B-NP
peroxidase NN I-NP
and CC O
superoxide NN B-NP
dismutase NN I-NP
, , O
in IN O
the DT O
MCT-treated JJ O
rats NNS O
were VBD O
not RB O
different JJ O
compared VBN O
to TO O
control VB O
rats NNS O
. . O

-DOCSTART- X X O

The DT O
second JJ O
goal NN O
was VBD O
to TO O
ascertain VB O
the DT O
somatotopic JJ O
arrangement NN O
of IN O
the DT O
GPi NNP O
in IN O
PD. NNP O

-DOCSTART- X X O

These DT O
overall JJ O
results NNS O
indicate VBP O
that IN O
there EX O
is VBZ O
generally RB O
one CD O
PERV NN O
copy NN O
per IN O
integration NN O
site NN O
. . O

-DOCSTART- X X O

The DT O
present JJ O
investigation NN O
conducted VBN O
in IN O
a DT O
population NN O
of IN O
258 CD O
dentally RB O
aware JJ O
individuals NNS O
in IN O
the DT O
age NN O
range NN O
20-69 CD O
years NNS O
, , O
was VBD O
initiated VBN O
to TO O
elucidate VB O
the DT O
relationship NN O
between IN O
tobacco NN O
smoking NN O
and CC O
supragingival NN O
calculus NN O
, , O
taking VBG O
into IN O
account NN O
possible JJ O
confounding NN O
factors NNS O
such JJ O
as IN O
age NN O
, , O
gender NN O
, , O
oral JJ O
hygiene NN O
and CC O
gingival NN O
inflammation NN O
. . O

-DOCSTART- X X O

Patients NNS O
were VBD O
assessed VBN O
for IN O
cardiac NN O
MIBG NNP O
uptake NN O
, , O
circulating VBG O
norepinephrine JJ O
concentration NN O
, , O
LVEF NNP O
, , O
peak NN O
Vo2 NN O
, , O
x-ray JJ O
cardiothoracic JJ O
ratio NN O
, , O
M-mode NNP O
echographic JJ O
end-diastolic JJ O
diameter NN O
and CC O
right-sided JJ O
heart NN O
catheterization NN O
parameters NNS O
. . O

-DOCSTART- X X O

Nuclear NNP O
hormone NN O
receptors NNS O
( -LRB- O
NRs NNS O
) -RRB- O
are VBP O
ligand-inducible JJ O
transcription NN O
factors NNS O
that WDT O
mediate VBP O
critical JJ O
functions NNS O
in IN O
many JJ O
species NNS O
. . O

-DOCSTART- X X O

These DT O
cells NNS O
were VBD O
able JJ O
to TO O
present VB O
influenza NN O
virus NN O
particles NNS O
to TO O
HLA-DR1-restricted JJ B-NP
T NNP O
cell NN O
clones NNS O
. . O

-DOCSTART- X X O

Sequencing NN O
of IN O
zebrafish NN O
( -LRB- O
Danio NNP O
rerio NN O
) -RRB- O
bacterial JJ O
artificial JJ O
chromosome NN O
and CC O
P1 CD O
artificial JJ O
chromosome NN O
genomic JJ O
clone NN O
fragments NNS O
and CC O
of IN O
cDNA NN O
clones NNS O
has VBZ O
led VBN O
to TO O
the DT O
identification NN O
of IN O
five CD O
new JJ O
loci NNS O
coding VBG O
for IN O
beta JJ O
subunits NNS O
of IN O
proteasomes NNS O
( -LRB- O
PSMB) NNP B-NP
. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
homologues NNS O
of IN O
the DT O
human JJ B-NP
genes NNS I-NP
PSMB5 . I-NP
through IN O
PSMB9 NNP B-NP
, , O
two CD O
new JJ O
genes NNS O
, , O
PSMB11 NNP B-NP
and CC O
PSMB12 NNP B-NP
, , O
have VBP O
been VBN O
found VBN O
for IN O
which WDT O
there EX O
are VBP O
no DT O
known VBN O
corresponding JJ O
genes NNS O
in IN O
humans NNS O
. . O

-DOCSTART- X X O

It PRP O
applies VBZ O
Udry NNP O
's POS O
biosocial JJ O
perspective NN O
, , O
which WDT O
attempts VBZ O
to TO O
reconcile VB O
the DT O
biological JJ O
and CC O
sociological JJ O
models NNS O
of IN O
premarital NN O
sexual JJ O
and CC O
reproductive JJ O
behaviour NN O
. . O

-DOCSTART- X X O

Weight NNP O
and CC O
height NN O
z-scores NNS O
were VBD O
significantly RB O
associated VBN O
with IN O
BMD NNP O
z-scores NNS O
. . O

-DOCSTART- X X O

A DT O
limited JJ O
sampling NN O
strategy NN O
was VBD O
used VBN O
based VBN O
on IN O
a DT O
bayesian JJ O
parameter NN O
estimation NN O
algorithm NN O
that WDT O
is VBZ O
part NN O
of IN O
the DT O
ADAPT NNP O
II NNP O
software NN O
package NN O
. . O

-DOCSTART- X X O

Interaction NN O
of IN O
HRI NNP B-NP
with IN O
Hsc70 NNP B-NP
was VBD O
required VBN O
for IN O
the DT O
transformation NN O
of IN O
HRI NNP B-NP
, , O
as IN O
the DT O
Hsc70 CD B-NP
antagonist NN O
clofibric JJ O
acid NN O
inhibited VBD O
the DT O
folding NN O
of IN O
HRI NNP B-NP
into IN O
a DT O
mature-competent JJ O
conformation NN O
. . O

-DOCSTART- X X O

The DT O
amino IN O
acid NN O
changes NNS O
D206A . O
and CC O
D208A JJ O
abolish VB O
singly RB O
or CC O
in IN O
combination NN O
the DT O
exonuclease NN O
activity NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Previous JJ O
experimental JJ O
evidence NN O
had VBD O
indicated VBN O
that IN O
Reg1 NNP B-NP
might MD O
target VB O
Glc7 NNP B-NP
to TO O
nuclear JJ O
substrates NNS O
such JJ O
as IN O
the DT O
Snf1 NNP B-NP
kinase NN I-NP
complex NN I-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
budding JJ O
yeast NN O
, , O
Saccharomyces NNP O
cerevisiae NNS O
, , O
replicators NNS O
can MD O
function VB O
outside IN O
the DT O
chromosome NN O
as IN O
autonomously RB O
replicating VBG O
sequence NN O
( -LRB- O
ARS NNS O
) -RRB- O
elements NNS O
; : O
however RB O
, , O
within IN O
chromosome NN O
III NNP O
, , O
certain JJ O
ARSs NN O
near IN O
the DT O
transcriptionally NN O
silent JJ O
HML IN B-NP
locus JJ I-NP
show NN O
no DT O
replication NN O
origin NN O
activity NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
, , O
for IN O
the DT O
HML NNP B-NP
ARS NNP O
cluster NN O
( -LRB- O
ARS303 NN B-NP
, , O
ARS320 NNP B-NP
, , O
and CC O
ARS302 NN B-NP
) -RRB- O
, , O
inactivity NN O
of IN O
origins NNS O
is VBZ O
independent JJ O
of IN O
local JJ O
transcriptional JJ O
silencing NN O
, , O
even RB O
though IN O
origins NNS O
and CC O
silencers NNS O
share VBP O
key JJ O
cis NNPS O
- : O
and CC O
trans-acting JJ O
components NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
demonstrate VBP O
that IN O
expression NN O
of IN O
TD-IkappaBalpha NNP B-NP
blocked VBD O
phorbol NN O
myristate NN O
acetate-phytohemagglutinin NN B-NP
or CC O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha-induced CC I-NP
IkappaBalpha NNP B-NP
gene NN I-NP
transcription NN O
and CC O
abolished VBD O
NF-kappaB NNP B-NP
DNA NNP O
binding NN O
activity NN O
, , O
due JJ O
to TO O
the DT O
continued JJ O
cytoplasmic JJ O
sequestration NN O
of IN O
RelA(p65 NNP B-NP
) -RRB- O
by IN O
TD-IkappaBalpha NNP B-NP
. . O

-DOCSTART- X X O

The DT O
analysis NN O
of IN O
two CD O
distinct JJ O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
pathways NNS O
shows VBZ O
that IN O
stress-activated JJ B-NP
protein NN I-NP
kinase-Jun NN I-NP
N-terminal JJ B-NP
kinase NN I-NP
activation NN O
, , O
resulting VBG O
in IN O
the DT O
phosphorylation NN O
of IN O
ATF-2 NNP B-NP
, , O
c-Jun JJ B-NP
, , O
and CC O
JunD NNP B-NP
, , O
is VBZ O
required VBN O
not RB O
only RB O
for IN O
the DT O
IL-1- NNP B-NP
but CC O
also RB O
for IN O
the DT O
TPA-dependent NNP O
induction NN O
, , O
while IN O
the DT O
extracellular JJ B-NP
signal-related JJ I-NP
kinase NN I-NP
1 CD I-NP
( -LRB- O
ERK-1 NN B-NP
) -RRB- O
and CC O
ERK-2 JJ B-NP
activation NN O
is VBZ O
involved VBN O
in IN O
the DT O
TPA NNP O
- : O
but CC O
not RB O
in IN O
the DT O
IL-1-dependent JJ B-NP
stimulation NN O
of IN O
the DT O
uPA NNP B-NP
enhancer NN I-NP
. . O

-DOCSTART- X X O

Interdomain NNP O
signaling VBG O
in IN O
a DT O
two-domain JJ O
fragment NN O
of IN O
the DT O
human JJ B-NP
glucocorticoid NN I-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
xtRNA( NNP B-NP
Sec) NNP B-NP
gene NN O
needs VBZ O
the DT O
binding NN O
of IN O
the DT O
seven CD O
Staf NNP B-NP
zinc NNP I-NP
fingers NNS I-NP
, , O
but CC O
not RB O
Oct-1 NNP B-NP
, , O
for IN O
optimal JJ O
transcriptional JJ O
capacity NN O
. . O

-DOCSTART- X X O

Collectively RB O
, , O
these DT O
results NNS O
show VBP O
that IN O
the DT O
differential JJ O
utilization NN O
of IN O
Staf NNP B-NP
zinc NNP I-NP
finger NN I-NP
1 CD I-NP
represents VBZ O
a DT O
new JJ O
, , O
critical JJ O
determinant NN O
of IN O
the DT O
transcriptional JJ O
activation NN O
mechanism NN O
for IN O
the DT O
Xenopus NNP B-NP
tRNA( IN I-NP
Sec) NNP B-NP
and CC O
human JJ B-NP
U6 IN I-NP
snRNA JJ I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

In IN O
B NNP O
cells NNS O
, , O
HEF1 NNP B-NP
is VBZ O
phosphorylated VBN O
by IN O
a DT O
cytoskeleton-dependent JJ O
mechanism NN O
that WDT O
is VBZ O
triggered VBN O
by IN O
integrin NN B-NP
ligation NN O
. . O

-DOCSTART- X X O

The DT O
calcitonin-induced JJ B-NP
tyrosine NN O
phosphorylation NN O
of IN O
HEF1 NNP B-NP
increased VBD O
in IN O
a DT O
time NN O
- : O
and CC O
dose-dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

Independent NNP O
protrudor NN O
muscle NN O
stimulation NN O
increased VBD O
VI NN O
,max NN O
( -LRB- O
peak NN O
increase NN O
61 CD O
% NN O
, , O
P NNP O
< JJ O
0.05 CD O
) -RRB- O
, , O
did VBD O
not RB O
change VB O
Pcrit NNP O
, , O
and CC O
decreased VBD O
Rn NNP O
( -LRB- O
peak NN O
decrease NN O
of IN O
41 CD O
% NN O
, , O
P NNP O
< JJ O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
the DT O
construction NN O
of IN O
an DT O
approximately RB O
1.7-Mb JJ O
sequence-ready JJ O
YAC/BAC NNP O
clone NN O
contig NN O
of IN O
8p22-p23 CD O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
RAD30B NN I-NP
and CC O
mouse NN B-NP
Rad30b NN I-NP
mRNA NN I-NP
transcripts NNS I-NP
, , O
like IN O
many JJ O
repair NN O
proteins NNS O
, , O
are VBP O
highly RB O
expressed VBN O
in IN O
the DT O
testis NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
mouse NN B-NP
STAP NNP I-NP
gene NN I-NP
isolated VBN O
from IN O
the DT O
genomic JJ O
library NN O
revealed VBD O
that IN O
the DT O
STAP NNP B-NP
gene NN I-NP
spans VBZ O
a DT O
region NN O
of IN O
over RB O
11 CD O
kb NN O
and CC O
comprises VBZ O
eight CD O
exons NNS O
. . O

-DOCSTART- X X O

A DT O
reduced VBN O
matrix NN O
distribution NN O
and CC O
enhanced JJ O
cell NN O
density NN O
were VBD O
observed VBN O
as IN O
the DT O
biofilm NN O
aged VBN O
. . O

-DOCSTART- X X O

After IN O
10 CD O
months NNS O
of IN O
treatment NN O
with IN O
the DT O
conjugated VBN O
estrogen NN O
, , O
both DT O
his PRP$ O
height NN O
and CC O
weight NN O
showed VBD O
improvement NN O
, , O
while IN O
his PRP$ O
bone NN O
mineral NN O
density NN O
and CC O
bone NN O
age NN O
were VBD O
increased VBN O
. . O

-DOCSTART- X X O

Viscosity NN O
experiments NNS O
on IN O
the DT O
catalytic JJ O
fragment NN O
kinase NN O
reaction NN O
demonstrated VBD O
that IN O
the DT O
chemical NN O
( -LRB- O
phosphoryl JJ O
transfer NN O
) -RRB- O
step NN O
had VBD O
a DT O
reduced JJ O
rate NN O
. . O

-DOCSTART- X X O

Velocity NNP O
sedimentation NN O
, , O
cross-linking JJ O
, , O
and CC O
immunoprecipitation NN O
analyses NNS O
of IN O
detergent-solubilized JJ O
rat NN O
brain NN O
revealed VBD O
that IN O
the DT O
32 CD O
and CC O
34 CD O
kDa JJ O
polypeptides NNS O
reside NN O
within IN O
heterotetramers NNS O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
expression NN O
levels NNS O
of IN O
the DT O
different JJ O
plasmids NNS O
differed VBD O
by IN O
as RB O
much JJ O
as IN O
tenfold RB O
. . O

-DOCSTART- X X O

In IN O
EEG NNP O
only RB O
single JJ O
slow JJ O
waves NNS O
above IN O
left JJ O
temporal JJ O
region NN O
were VBD O
revealed VBN O
. . O

-DOCSTART- X X O

Molecular JJ O
characterization NN O
of IN O
type-specific JJ O
capsular JJ O
polysaccharide NN O
biosynthesis NN O
genes NNS O
of IN O
Streptococcus NNP O
agalactiae IN O
type NN O
Ia NNP O
. . O

-DOCSTART- X X O

( -LRB- O
1998 CD O
) -RRB- O
FASEB NNP O
J. NNP O

-DOCSTART- X X O

IL-1beta JJ B-NP
( -LRB- O
10 CD O
ng/ml NN O
) -RRB- O
drastically RB O
increased VBD O
both DT O
PDGFalphaR NNP B-NP
and CC O
CCAAT/enhancer-binding JJ B-NP
protein NN I-NP
delta NN I-NP
( -LRB- O
C/EBPdelta NN B-NP
) -RRB- O
mRNA NN O
levels NNS O
in IN O
a DT O
time NN O
dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

The DT O
recruitment NN O
of IN O
constitutively RB O
phosphorylated JJ O
p185(neu NN B-NP
) -RRB- O
and CC O
the DT O
activated JJ O
mitogenic JJ O
pathway NN O
proteins VBZ O
to TO O
this DT O
membrane-microfilament NN O
interaction NN O
site NN O
provides VBZ O
a DT O
physical JJ O
model NN O
for IN O
integrating VBG O
the DT O
assembly NN O
of IN O
the DT O
mitogenic JJ O
pathway NN O
with IN O
the DT O
transmission NN O
of IN O
growth NN O
factor NN O
signal NN O
to TO O
the DT O
cytoskeleton NN O
. . O

-DOCSTART- X X O

Transient NNP O
tyrosine FW O
phosphorylation NN O
of IN O
Crk NNP B-NP
in IN O
fibroblast JJ B-NP
growth NN I-NP
factor-2-stimulated JJ I-NP
endothelial JJ O
cells NNS O
was VBD O
dependent JJ O
on IN O
the DT O
juxtamembrane NN O
tyrosine NN O
residue JJ O
463 CD O
in IN O
FGFR-1 JJ B-NP
, , O
and CC O
a DT O
Crk NNP B-NP
SH2 NNP B-NP
domain NN I-NP
precipitated VBD O
FGFR-1 JJ B-NP
via IN O
phosphorylated JJ O
Tyr-463 JJ O
, , O
indicating VBG O
direct JJ O
complex JJ O
formation NN O
between IN O
Crk NNP B-NP
and CC O
FGFR-1 NNP B-NP
. . O

-DOCSTART- X X O

ECG-gated JJ O
myocardial JJ O
Technetium-99m NNP O
sestamibi NN O
SPECT NNP O
is VBZ O
a DT O
useful JJ O
technique NN O
to TO O
measure VB O
myocardial JJ O
perfusion NN O
and CC O
function NN O
simultaneously RB O
. . O

-DOCSTART- X X O

Role NNP O
of IN O
the DT O
3' JJ O
untranslated JJ O
region NN O
of IN O
baculovirus NN B-NP
p10 IN I-NP
mRNA NN I-NP
in IN O
high-level JJ O
expression NN O
of IN O
foreign JJ O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
intron NN O
is VBZ O
capable JJ O
of IN O
splicing NN O
despite IN O
the DT O
fact NN O
that IN O
both DT O
the DT O
EBS1/IBS1 NNP B-NP
and CC O
the DT O
EBS2/IBS2 NNP B-NP
sequence NN O
motifs NNS O
, , O
thought VBD O
to TO O
be VB O
necessary JJ O
for IN O
correct JJ O
splicing NN O
, , O
extend VB O
over IN O
5 CD O
instead RB O
of IN O
6 CD O
bp NN O
. . O

-DOCSTART- X X O

The DT O
Trk/Nerve NNP B-NP
Growth NN I-NP
Factor NN I-NP
receptor NN I-NP
mediates VBZ O
the DT O
rapid JJ O
activation NN O
of IN O
a DT O
number NN O
of IN O
intracellular JJ O
signaling VBG O
proteins NNS O
, , O
including VBG O
phosphatidylinositol NN B-NP
3-kinase JJ I-NP
( -LRB- O
PI JJ B-NP
3-kinase NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
controversy NN O
of IN O
significance NN O
testing NN O
: : O
misconceptions NNS O
and CC O
alternatives NNS O
. . O

-DOCSTART- X X O

Chemical NNP O
uptake NN O
into IN O
human JJ O
stratum NN O
corneum NN O
in IN O
vivo RB O
from IN O
volatile JJ O
and CC O
non-volatile JJ O
solvents NNS O
. . O

-DOCSTART- X X O

Like IN O
DNA NNP O
binding NN O
, , O
transcriptional JJ O
enhancement NN O
required VBN O
amino-terminally RB O
located VBN O
basic JJ O
amino IN O
acid NN O
residues NNS O
but CC O
not RB O
the DT O
carboxyl-terminal JJ O
portion NN O
of IN O
Hap46 NNP B-NP
known VBN O
to TO O
participate VB O
in IN O
hsp70 CD B-NP
interaction NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
tested VBN O
the DT O
function NN O
of IN O
two CD O
potential JJ O
NF-kappaB-like NNP B-NP
sites NNS I-NP
present JJ O
in IN O
the DT O
PAI-2 JJ B-NP
proximal JJ I-NP
promoter NN I-NP
for IN O
responsiveness NN O
to TO O
TNFalpha NNP B-NP
using VBG O
chloramphenicol NN B-NP
acetyl RB I-NP
transferase VB I-NP
reporter NN I-NP
gene NN I-NP
deletion NN O
and CC O
mutation NN O
analyses NNS O
. . O

-DOCSTART- X X O

N-terminal JJ O
sequence NN O
analysis NN O
and CC O
NMR NN O
measurements NNS O
revealed VBN O
that IN O
this DT O
fragment NN O
originates VBZ O
from IN O
the DT O
C-terminal JJ O
80 CD O
residues NNS O
of IN O
MBF1 CD B-NP
and CC O
form VB O
a DT O
well RB O
structured VBN O
C-terminal JJ O
domain NN O
of IN O
MBF1 NNP B-NP
, , O
MBF1CTD. . B-NP

-DOCSTART- X X O

The DT O
nucleosomal JJ O
response NN O
associated VBN O
with IN O
immediate-early JJ B-NP
gene NN I-NP
induction NN O
is VBZ O
mediated JJ O
via IN O
alternative JJ O
MAP NNP B-NP
kinase NN I-NP
cascades NNS I-NP
: : O
MSK1 NNP B-NP
as IN O
a DT O
potential JJ O
histone NN B-NP
H3/HMG-14 CC I-NP
kinase NN O
. . O

-DOCSTART- X X O

The DT O
arrangement NN O
of IN O
these DT O
cutoff-levels NNS O
leads VBZ O
to TO O
a DT O
sensitivity NN O
of IN O
85 CD O
% NN O
at IN O
a DT O
specificity NN O
of IN O
55 CD O
% NN O
for IN O
Protein NNP B-NP
S100 . I-NP
when WRB O
measured VBN O
by IN O
RIA NNP O
, , O
and CC O
to TO O
a DT O
sensitivity NN O
of IN O
77 CD O
% NN O
at IN O
a DT O
specificity NN O
of IN O
61 CD O
% NN O
when WRB O
measured VBN O
by IN O
LIA NNP O
. . O

-DOCSTART- X X O

Using VBG O
16 CD O
strains NNS O
of IN O
C. NNP O
trachomatis NN O
in IN O
triplicate NN O
assays VBZ O
, , O
we PRP O
found VBD O
the DT O
RT-PCR JJ O
method NN O
consistently RB O
more RBR O
sensitive JJ O
than IN O
the DT O
conventional JJ O
technique NN O
for IN O
all DT O
eight CD O
antimicrobials NNS O
tested VBN O
, , O
with IN O
resultant NN O
MICs NNS O
determined VBN O
by IN O
RT-PCR NNP O
ranging VBG O
from IN O
1.6-fold JJ O
higher JJR O
( -LRB- O
erythromycin NN O
) -RRB- O
to TO O
>/=195-fold $ O
higher JJR O
(amoxicillin NN O
) -RRB- O
. . O

-DOCSTART- X X O

Null NNP O
alleles NNS O
of IN O
SAS4 NNP B-NP
and CC O
SAS5 NNP B-NP
bypassed VBD O
the DT O
role NN O
of IN O
the DT O
Abf1p NNP B-NP
binding NN I-NP
site NN I-NP
of IN O
the DT O
HMR-E NNP B-NP
silencer NN I-NP
but CC O
not RB O
the DT O
role NN O
of IN O
the DT O
ACS NNP B-NP
or CC O
Rap1p NNP B-NP
binding NN I-NP
site NN I-NP
. . O

-DOCSTART- X X O

Recent JJ O
molecular JJ O
analysis NN O
has VBZ O
revealed VBN O
that IN O
the DT O
S NNP B-NP
locus NN I-NP
is VBZ O
highly RB O
polymorphic JJ O
and CC O
contains VBZ O
several JJ O
genes NNS O
, , O
i IN O
.e NN O
. . O
, , O
SLG NNP B-NP
, , O
SRK NNP B-NP
, , O
the DT O
as-yet-unidentified JJ O
pollen NN B-NP
S NNP I-NP
gene( NN I-NP
s VBZ I-NP
) -RRB- I-NP
, , O
and CC O
other JJ O
linked VBN O
genes NNS O
. . O

-DOCSTART- X X O

A DT O
cDNA NN O
encoding VBG O
a DT O
putative JJ O
RNA NNP B-NP
and/or CC I-NP
DNA NNP I-NP
helicase NN I-NP
has VBZ O
been VBN O
isolated VBN O
from IN O
Arabidopsis NNP O
thaliana POS O
cDNA NN O
libraries NNS O
. . O

-DOCSTART- X X O

In IN O
vivo RB O
, , O
MyoD NNP B-NP
requires VBZ O
this DT O
tryptophan JJ O
motif NN O
to TO O
evoke VB O
chromatin NN O
remodeling VBG O
in IN O
the DT O
Myogenin NNP B-NP
promoter NN I-NP
and CC O
to TO O
activate VB O
Myogenin NNP B-NP
transcription NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
256 CD O
Periods NNS O
of IN O
TTP NNP O
or CC O
PUNP NNP O
were VBD O
reported VBN O
by IN O
men NNS O
and CC O
174 CD O
by IN O
women NNS O
. . O

-DOCSTART- X X O

Feed DT O
intake JJ O
and CC O
BW JJ O
gains NNS O
were VBD O
decreased VBN O
( -LRB- O
P NNP O
< NN O
0.05 CD O
) -RRB- O
by IN O
dietary NN O
treatments NNS O
containing VBG O
M. NNP O

-DOCSTART- X X O

The DT O
N NNP O
terminus NN O
of IN O
beta JJ O
( -LRB- O
95 CD O
kDa NN O
) -RRB- O
corresponds NNS O
to TO O
alpha NN O
with IN O
the DT O
integrase JJ B-NP
domain NN I-NP
attached VBN O
to TO O
the DT O
C NNP O
terminus NN O
(32 NN O
kDa NN O
) -RRB- O
. . O

-DOCSTART- X X O

Skn-1a NNP B-NP
lacking VBG O
the DT O
C-terminal JJ O
region NN O
completely RB O
lost VBN O
transactivation NN O
ability NN O
, , O
irrespective JJ O
of IN O
the DT O
promoter NN O
tested VBN O
, , O
and CC O
was VBD O
able JJ O
to TO O
block VB O
transactivation NN O
by IN O
normal JJ O
Skn-1a NNP B-NP
in IN O
competition NN O
assays VBZ O
. . O

-DOCSTART- X X O

In IN O
early JJ O
Xenopus NNP O
embryos NNS O
, , O
the DT O
transforming VBG B-NP
growth NN I-NP
factor-beta NN I-NP
member NN O
activin NN B-NP
induces VBZ O
the DT O
gene NN B-NP
Mix.2 . I-NP
by IN O
stimulating VBG O
the DT O
formation NN O
of IN O
a DT O
multiprotein NN O
complex NN O
, , O
activin-responsive JJ B-NP
factor NN I-NP
( -LRB- O
ARF NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

To TO O
further RBR O
characterize VB O
the DT O
structure NN O
and CC O
evolutionary JJ O
synthesis NN O
of IN O
the DT O
CMT1A-REP JJ O
repeat NN O
, , O
fluorescent JJ O
in IN O
situ FW O
hybridization NN O
( -LRB- O
FISH) NNP O
analysis NN O
and CC O
heterologous JJ O
PCR-based JJ O
assays DT O
were VBD O
carried VBN O
out RP O
for IN O
a DT O
series NN O
of IN O
primates NNS O
. . O

-DOCSTART- X X O

Natl NNP O
. . O

-DOCSTART- X X O

In IN O
the DT O
face NN O
of IN O
the DT O
outbreak NN O
, , O
there EX O
was VBD O
a DT O
delay NN O
before IN O
vaccination NN O
was VBD O
able JJ O
to TO O
stop VB O
deaths NNS O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
show VBP O
that IN O
a DT O
novel NN O
isoform NN O
of IN O
Rapl NNP B-NP
GTPase-activating NNP I-NP
protein NN I-NP
, , O
called VBD O
rap1GAPII JJ B-NP
, , O
binds NNS O
specifically RB O
to TO O
the DT O
alpha-subunits NNS O
of IN O
the DT O
G( JJ B-NP
i NN I-NP
) -RRB- I-NP
family NN I-NP
of IN O
heterotrimeric JJ B-NP
G-proteins NNS I-NP
. . O

-DOCSTART- X X O

The DT O
B-oligomer NN O
of IN O
pertussis NN B-NP
toxin NN I-NP
deactivates VBZ O
CC NNP B-NP
chemokine NN I-NP
receptor NN I-NP
5 CD I-NP
and CC O
blocks NNS O
entry NN O
of IN O
M-tropic NNP O
HIV-1 NNP O
strains NNS O
. . O

-DOCSTART- X X O

Cross-linking VBG O
the DT O
B NNP B-NP
cell NN I-NP
Ag NNP I-NP
receptor NN I-NP
(BCR NN O
) -RRB- O
to TO O
surface VB B-NP
Fc JJ I-NP
receptors NNS I-NP
for IN O
IgG NNP B-NP
( -LRB- O
Fc NN B-NP
gamma NN I-NP
R) NNP I-NP
inhibits VBZ O
G1-to-S NNP O
progression NN O
; : O
the DT O
mechanism NN O
by IN O
which WDT O
this DT O
occurs VBZ O
is VBZ O
not RB O
completely RB O
known VBN O
. . O

-DOCSTART- X X O

Cross-linking VBG O
the DT O
B NNP B-NP
cell NN I-NP
Ag NNP I-NP
receptor NN I-NP
(BCR NN O
) -RRB- O
to TO O
surface VB B-NP
Fc JJ I-NP
receptors NNS I-NP
for IN O
IgG NNP B-NP
( -LRB- O
Fc NN B-NP
gamma NN I-NP
R) NNP I-NP
inhibits VBZ O
G1-to-S NNP O
progression NN O
; : O
the DT O
mechanism NN O
by IN O
which WDT O
this DT O
occurs VBZ O
is VBZ O
not RB O
completely RB O
known VBN O
. . O

-DOCSTART- X X O

TRAF2 NN B-NP
is VBZ O
a DT O
potent JJ O
activator NN O
of IN O
a DT O
95-kDa JJ B-NP
serine/threonine NN I-NP
kinase NN I-NP
termed VBD O
germinal JJ B-NP
center NN I-NP
kinase NN I-NP
related VBN I-NP
( -LRB- O
GCKR NN B-NP
, , O
also RB O
referred VBD O
to TO O
as IN O
KHS1 NNP B-NP
) -RRB- O
, , O
which WDT O
signals VBZ O
activation NN O
of IN O
the DT O
SAPK NNP B-NP
pathway NN O
. . O

-DOCSTART- X X O

An DT O
activation-responsive JJ O
element NN O
in IN O
single JJ B-NP
C NNP I-NP
motif-1/lymphotactin NN I-NP
promoter NN O
is VBZ O
a DT O
site NN O
of IN O
constitutive JJ O
and CC O
inducible JJ O
DNA-protein NN O
interactions NNS O
involving VBG O
nuclear JJ O
factor NN O
of IN O
activated JJ O
T NNP O
cell NN O
. . O

-DOCSTART- X X O

Cytokine-induced JJ O
NF-kappa NNP B-NP
B NNP I-NP
DNA NNP O
binding NN O
activity NN O
, , O
RelA NNP B-NP
nuclear JJ O
translocation NN O
, , O
I PRP B-NP
kappa VBD I-NP
B NNP I-NP
alpha NN I-NP
degradation NN O
, , O
I PRP B-NP
kappa VBD I-NP
B NNP I-NP
serine NN O
32 CD O
phosphorylation NN O
, , O
and CC O
I PRP B-NP
kappa VBD I-NP
B NNP I-NP
kinase FW I-NP
( -LRB- O
IKK) NN B-NP
activity NN O
were VBD O
blocked VBN O
by IN O
curcumin NN O
treatment NN O
. . O

-DOCSTART- X X O

A DT O
portion NN O
of IN O
p193 DT B-NP
is VBZ O
nuclear JJ O
and CC O
localizes NNS O
to TO O
the DT O
mitotic JJ O
spindle NN O
. . O

-DOCSTART- X X O

The DT O
main JJ O
issues NNS O
are VBP O
the DT O
need NN O
to TO O
explain VB O
a DT O
number NN O
of IN O
still RB O
unknown JJ O
mechanisms NNS O
, , O
to TO O
determine VB O
which WDT O
"natural JJ O
diet NN O
" '' O
carries VBZ O
the DT O
minimum NN O
coronary JJ O
risk NN O
and CC O
whether IN O
"new JJ O
" `` O
foods NNS O
produced VBN O
by IN O
modern JJ O
technology NN O
are VBP O
really RB O
needed VBN O
to TO O
contrast VB O
this DT O
epidemic NN O
. . O

-DOCSTART- X X O

Cotransfection NN O
of IN O
the DT O
coactivator NN O
CREB-binding JJ B-NP
protein NN I-NP
relieved VBN O
the DT O
transcriptional JJ O
repression NN O
of IN O
PPARalphawt NNP B-NP
by IN O
PPARalphatr NNP B-NP
, , O
suggesting VBG O
that IN O
the DT O
dominant JJ O
negative JJ O
effect NN O
of IN O
PPARalphatr NNP B-NP
might MD O
occur VB O
through IN O
competition NN O
for IN O
essential JJ O
coactivators NNS O
. . O

-DOCSTART- X X O

SF-1 NN B-NP
does VBZ O
not RB O
have VB O
an DT O
N-terminal JJ O
AF1 JJ O
domain NN O
. . O

-DOCSTART- X X O

To TO O
estimate VB O
the DT O
locations NNS O
of IN O
sources NNS O
with IN O
the DT O
TF-MUSIC NNP O
algorithm NN O
, , O
we PRP O
first RB O
set VBD O
the DT O
target NN O
region NN O
on IN O
the DT O
spectrogram NN O
of IN O
the DT O
somatosensory JJ O
responses NNS O
. . O

-DOCSTART- X X O

We PRP O
discuss VBP O
these DT O
results NNS O
in IN O
terms NNS O
of IN O
the DT O
influence NN O
that IN O
time NN O
and CC O
nutritional JJ O
constraints NNS O
have VBP O
on IN O
odonate JJ O
development NN O
patterns NNS O
and CC O
fitness NN O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
transcription NN O
results NNS O
indicate VBP O
that IN O
this DT O
5' JJ O
structure NN O
functions NNS O
in IN O
the DT O
attenuation NN O
mechanism NN O
, , O
since IN O
deletion NN O
of IN O
the DT O
stem-loop NN O
caused VBD O
an DT O
increase NN O
in IN O
transcription NN O
readthrough NN O
. . O

-DOCSTART- X X O

A DT O
5' JJ O
RNA NNP O
stem-loop NN O
participates NNS O
in IN O
the DT O
transcription NN O
attenuation NN O
mechanism NN O
that WDT O
controls VBZ O
expression NN O
of IN O
the DT O
Bacillus NNP B-NP
subtilis NNS I-NP
trpEDCFBA IN I-NP
operon NN I-NP
. . O

-DOCSTART- X X O

Single-alanine-substitution NNP O
mutations NNS O
had VBD O
minimal JJ O
, , O
if IN O
any DT O
, , O
effects NNS O
on IN O
S-induced JJ O
cell-to-cell JJ O
fusion NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
we PRP O
demonstrate VBP O
that IN O
transcription NN O
from IN O
the DT O
MMTV NNP B-NP
5' IN I-NP
LTR NNP I-NP
is VBZ O
highly RB O
active JJ O
in IN O
the DT O
absence NN O
of IN O
Stat5a NNP B-NP
, , O
a DT O
transcription NN O
factor NN O
that WDT O
had VBD O
been VBN O
shown VBN O
previously RB O
to TO O
be VB O
required VBN O
for IN O
transcription NN O
from IN O
the DT O
MMTV NNP B-NP
LTR. NNP I-NP

-DOCSTART- X X O

Regional NNP O
insertional JJ O
mutagenesis NN O
of IN O
specific JJ O
genes NNS O
on IN O
the DT O
CIC5F11/CIC2B9 NNP B-NP
locus NN O
of IN O
Arabidopsis NNP O
thaliana IN O
chromosome NN O
5 CD O
using VBG O
the DT O
Ac/Ds NNP B-NP
transposon NN O
in IN O
combination NN O
with IN O
the DT O
cDNA NN O
scanning NN O
method NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
NART-R NNP O
performance NN O
may MD O
not RB O
be VB O
a DT O
valid JJ O
estimate NN O
of IN O
baseline NN O
IQ NNP O
for IN O
patients NNS O
with IN O
neurologic JJ O
disorders NNS O
with IN O
suspected VBN O
language NN O
impairment NN O
. . O

-DOCSTART- X X O

Activated NNP O
areas NNS O
have VBP O
been VBN O
identified VBN O
by IN O
means NNS O
of IN O
cross-correlation NN O
analysis NN O
. . O

-DOCSTART- X X O

Natural JJ O
Haemophilus NNP O
influenzae NN O
type NN O
b NN O
capsular JJ O
polysaccharide NN O
antibodies NNS O
in IN O
412 CD O
infants NNS O
and CC O
children NNS O
from IN O
West NNP O
Africa NNP O
( -LRB- O
Burkina-Faso NNP O
) -RRB- O
and CC O
France NNP O
: : O
a DT O
cross-sectional JJ O
serosurvey NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
identified VBD O
Sp1 NNP B-NP
and CC O
Sp3 NNP B-NP
as IN O
major JJ O
factors NNS O
binding NN O
to TO O
the DT O
Sp1 NNP B-NP
sites NNS I-NP
of IN O
the DT O
p21/WAF1/Cip1 JJ B-NP
promoter NN O
in IN O
MG63 CD O
cells NNS O
through IN O
electrophoretic JJ O
mobility NN O
shift NN O
assays VBZ O
and CC O
showed VBD O
that IN O
TSA NNP O
treatment NN O
did VBD O
not RB O
change VB O
their PRP$ O
binding JJ O
activities NNS O
. . O

-DOCSTART- X X O

Galoyan NNP O
has VBZ O
summarized VBN O
the DT O
results NNS O
of IN O
his PRP$ O
discovery NN O
of IN O
cardioactive JJ O
neurohormones NNS O
. . O

-DOCSTART- X X O

To TO O
study VB O
the DT O
regulation NN O
of IN O
its PRP$ O
expression NN O
, , O
the DT O
human JJ B-NP
aldehyde NN I-NP
reductase NN I-NP
gene NN I-NP
and CC O
promoter NN O
were VBD O
cloned VBN O
and CC O
characterized VBN O
. . O

-DOCSTART- X X O

Immunohistochemical NNP O
staining VBG O
with IN O
MIB-1 JJ B-NP
and CC O
p53 NN B-NP
antibodies NNS I-NP
showed VBD O
low JJ O
( -LRB- O
< RB O
1 CD O
% NN O
) -RRB- O
and CC O
negative JJ O
reaction NN O
. . O

-DOCSTART- X X O

The DT O
C2C-Prx NNP B-NP
is VBZ O
encoded VBN O
as IN O
a DT O
preprotein NN O
of IN O
273 CD O
amino IN O
acids NNS O
containing VBG O
a DT O
putative JJ O
chloroplast-targeting NN O
signal NN O
of IN O
65 CD O
amino IN O
acids NNS O
at IN O
its PRP$ O
N-terminus NNP O
. . O

-DOCSTART- X X O

Immediately RB O
before IN O
surgery NN O
patients NNS O
received VBD O
either DT O
intravenous JJ O
hydrocortisone NN O
100 CD O
mg NN O
or CC O
placebo NN O
in IN O
random JJ O
, , O
double-blind JJ O
order NN O
. . O

-DOCSTART- X X O

A DT O
tyrosine-based JJ O
sorting NN O
signal NN O
in IN O
the DT O
beta2 NN B-NP
integrin NN I-NP
cytoplasmic JJ I-NP
domain NN I-NP
mediates VBZ O
its PRP$ O
recycling NN O
to TO O
the DT O
plasma NN O
membrane NN O
and CC O
is VBZ O
required VBN O
for IN O
ligand-supported JJ O
migration NN O
. . O

-DOCSTART- X X O

The DT O
injection NN O
of IN O
XDRP1 NNP B-NP
protein NN I-NP
into IN O
fertilized JJ O
Xenopus NNP O
eggs NNS O
blocked VBD O
embryonic JJ O
cell NN O
division NN O
. . O

-DOCSTART- X X O

Using VBG O
transgenic JJ O
Xenopus NNP O
embryos NNS O
, , O
we PRP O
demonstrate VBP O
that IN O
the DT O
integrity NN O
of IN O
these DT O
two CD O
sequences NNS O
is VBZ O
necessary JJ O
for IN O
correct JJ O
spatial JJ O
expression NN O
of IN O
a DT O
Xbra2 NNP B-NP
promoter-driven JJ I-NP
reporter NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

In IN O
order NN O
to TO O
screen VB O
for IN O
such JJ O
cofactors NNS O
, , O
we PRP O
have VBP O
used VBN O
a DT O
transcriptionally NN O
inactive JJ O
mutant NN O
of IN O
Xenopus NNP B-NP
MEF2D NNP I-NP
in IN O
a DT O
yeast NN O
two-hybrid JJ O
screen NN O
. . O

-DOCSTART- X X O

NuA4 NNP B-NP
has VBZ O
an DT O
apparent JJ O
molecular JJ O
mass NN O
of IN O
1.3 CD O
MDa NNP O
. . O

-DOCSTART- X X O

ATF1 NNP B-NP
transcription NN O
is VBZ O
negatively RB O
regulated VBN O
by IN O
unsaturated JJ O
fatty JJ O
acids NNS O
and CC O
oxygen NN O
. . O

-DOCSTART- X X O

Two CD O
patients NNS O
with IN O
recurrent JJ O
tumors NNS O
had VBD O
high JJ O
S-phase JJ O
fractions NNS O
both DT O
on IN O
the DT O
first JJ O
resected JJ O
specimens NNS O
and CC O
at IN O
the DT O
time NN O
of IN O
the DT O
second JJ O
operation NN O
. . O

-DOCSTART- X X O

Mutation NN O
of IN O
TTF-1-binding JJ B-NP
sites NNS I-NP
( -LRB- I-NP
TBE NN I-NP
) -RRB- I-NP
1 CD I-NP
, , I-NP
3 CD I-NP
, , I-NP
and CC I-NP
4 CD I-NP
in IN O
combination NN O
markedly RB O
decreased VBD O
transcriptional JJ O
activity NN O
of IN O
SP-A NNP B-NP
promoter-chloramphenicol NN O
acetyltransferase NN B-NP
constructs NNS O
containing VBG O
SP-A NNP B-NP
gene NN I-NP
sequences NNS O
from IN O
-256 PRP$ O
to TO O
+45 CD O
. . O

-DOCSTART- X X O

Insulin-like JJ B-NP
growth NN I-NP
factor-I NN I-NP
induces VBZ O
bcl-2 JJ B-NP
promoter NN I-NP
through IN O
the DT O
transcription NN O
factor NN O
cAMP-response NN B-NP
element-binding JJ I-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Synthesis NNP O
of IN O
antisense DT O
RNA NNP O
and CC O
S NNP O
phase-dependent JJ O
binding NN O
of IN O
E2F NNP B-NP
complexes NNS I-NP
in IN O
intron NN O
1 CD O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
eotaxin-3 NN B-NP
will MD O
further RB O
promote VB O
our PRP$ O
understanding NN O
of IN O
the DT O
control NN O
of IN O
eosinophil NN O
trafficking NN O
and CC O
other JJ O
CCR3-mediated JJ B-NP
biological JJ O
phenomena NNS O
. . O

-DOCSTART- X X O

NF-kappaB NNP B-NP
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
activation NN O
of IN O
HIV-1 PRP$ O
gene NN O
expression NN O
by IN O
cytokines NNS O
and CC O
other JJ O
stimuli NNS O
, , O
but CC O
the DT O
signal NN O
transduction NN O
pathways NNS O
that WDT O
regulate VB O
the DT O
switch NN O
from IN O
latent JJ O
to TO O
productive JJ O
infection NN O
have VBP O
not RB O
been VBN O
defined VBN O
. . O

-DOCSTART- X X O

These DT O
studies NNS O
suggest VBP O
that IN O
MAPK NNP B-NP
acts VBZ O
by IN O
stimulating NN O
AP-1 NN B-NP
and CC O
a DT O
subsequent JJ O
physical JJ O
and CC O
functional JJ O
interaction NN O
of IN O
AP-1 NN B-NP
with IN O
NF-kappaB NNP B-NP
, , O
resulting VBG O
in IN O
a DT O
complex JJ O
that IN O
synergistically RB O
transactivates VBZ O
the DT O
HIV-1 NN B-NP
LTR. . I-NP

-DOCSTART- X X O

ERK NNP B-NP
MAP NNP B-NP
kinase NN I-NP
links VBZ O
cytokine JJ O
signals NNS O
to TO O
activation NN O
of IN O
latent JJ O
HIV-1 NN O
infection NN O
by IN O
stimulating VBG O
a DT O
cooperative JJ O
interaction NN O
of IN O
AP-1 NNP B-NP
and CC O
NF-kappaB. NNP B-NP

-DOCSTART- X X O

A DT O
human JJ O
nuclear-localized JJ O
chaperone NN O
that WDT O
regulates VBZ O
dimerization NN O
, , O
DNA NNP O
binding NN O
, , O
and CC O
transcriptional JJ O
activity NN O
of IN O
bZIP JJ B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Clinical NNP O
differentiation NN O
of IN O
patients NNS O
with IN O
mild JJ O
diplegic JJ O
cerebral NN O
palsy NN O
( -LRB- O
CP CD O
) -RRB- O
and CC O
idiopathic JJ O
toe NN O
walking VBG O
( -LRB- O
ITW NNP O
) -RRB- O
can MD O
be VB O
difficult JJ O
. . O

-DOCSTART- X X O

Sputum NNP B-NP
IL-8 : I-NP
and CC O
MPO NNP B-NP
were VBD O
significantly RB O
increased VBN O
after IN O
BPT NNP O
in IN O
both DT O
TDI- NNP O
and CC O
grain NN O
dust-asthma NN O
( -LRB- O
P NNP O
< NN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Montelukast NNP O
reduces VBZ O
airway NN O
eosinophilic JJ O
inflammation NN O
in IN O
asthma NN O
: : O
a DT O
randomized VBN O
, , O
controlled VBN O
trial NN O
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
demonstrate VBP O
that IN O
kinase-dead JJ O
but CC O
not RB O
wild-type JJ O
forms NNS O
of IN O
Fyn NNP B-NP
, , O
Lck NNP B-NP
, , O
and CC O
ZAP-70 DT B-NP
block NN O
70Z IN O
Cbl-mediated NNP B-NP
NFAT NNP B-NP
activation NN O
. . O

-DOCSTART- X X O

Substitutions NNS O
of IN O
region NN O
I PRP O
with IN O
synthetic JJ O
sequences NNS O
showed VBD O
that IN O
no DT O
specific JJ O
sequence NN O
but CC O
rather RB O
repeats NNS O
of IN O
three CD O
or CC O
more JJR O
consecutive JJ O
adenines NNS O
or CC O
thymines NNS O
, , O
without IN O
interruption NN O
by IN O
guanine CD O
or CC O
cytosine NN O
, , O
are VBP O
required VBN O
for IN O
the DT O
ARS NNP O
activity NN O
. . O

-DOCSTART- X X O

In IN O
Saccharomyces NNP O
cerevisiae NN O
, , O
PHO85 PRP B-NP
encodes VBZ O
a DT O
cyclin-dependent JJ B-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
Cdk NN B-NP
) -RRB- O
catalytic JJ O
subunit NN O
with IN O
multiple JJ O
regulatory JJ O
roles NNS O
thought VBD O
to TO O
be VB O
specified VBN O
by IN O
association NN O
with IN O
different JJ O
cyclin NN B-NP
partners NNS O
( -LRB- O
Pcls NNS B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Mutants NNS O
with IN O
mild JJ O
lace NN B-NP
alleles NNS I-NP
grow VBP O
to TO O
become VB O
adults NNS O
with IN O
multiple JJ O
aberrant JJ O
morphologies NNS O
in IN O
the DT O
appendages NNS O
, , O
compound JJ O
eye NN O
, , O
and CC O
bristles NNS O
. . O

-DOCSTART- X X O

In IN O
fact NN O
, , O
SPT NNP B-NP
activity NN O
in IN O
the DT O
fly NN O
expressing VBG O
epitope-tagged JJ O
Lace NNP B-NP
was VBD O
absorbed VBN O
by IN O
epitope-specific JJ O
antibody NN O
. . O

-DOCSTART- X X O

Mutations NNS O
of IN O
the DT O
RET NNP B-NP
gene NN I-NP
, , O
encoding VBG O
a DT O
receptor NN B-NP
tyrosine NN I-NP
kinase NN I-NP
, , O
have VBP O
been VBN O
associated VBN O
with IN O
the DT O
inherited VBN O
cancer NN O
syndromes NNS O
MEN NNP O
2A NNP O
and CC O
MEN NNP O
2B. . O

-DOCSTART- X X O

These DT O
results NNS O
show VBP O
that IN O
targeting VBG O
of IN O
Ras-GAP NNP B-NP
could MD O
represent VB O
a DT O
novel NN O
anticancer NN O
approach NN O
. . O

-DOCSTART- X X O

EB-1 NN B-NP
, , O
a DT O
tyrosine NN B-NP
kinase NN I-NP
signal NN I-NP
transduction NN I-NP
gene NN I-NP
, , O
is VBZ O
transcriptionally RB O
activated VBN O
in IN O
the DT O
t( JJ O
1;19 CD O
) -RRB- O
subset NN O
of IN O
pre-B JJ O
ALL NNP O
, , O
which WDT O
express VBP O
oncoprotein IN O
E2a-Pbx1 NNP B-NP
. . O

-DOCSTART- X X O

Protein NNP B-NP
kinase NN I-NP
A-Ialpha NN I-NP
subunit-directed JJ O
antisense JJ O
inhibition NN O
of IN O
ovarian JJ O
cancer NN O
cell NN O
growth NN O
: : O
crosstalk NN O
with IN O
tyrosine NN B-NP
kinase NN I-NP
signaling VBG O
pathway NN O
. . O

-DOCSTART- X X O

BCL6 PRP B-NP
encodes VBZ O
a DT O
POZ/Zn NNP B-NP
finger NN I-NP
protein NN I-NP
, , O
a DT O
structure NN O
similar JJ O
to TO O
that DT O
of IN O
many JJ O
Drosophila NNP O
developmental JJ O
regulators NNS O
and CC O
to TO O
another DT O
protein NN O
involved VBN O
in IN O
a DT O
human JJ O
hematopoietic NN O
malignancy NN O
, , O
PLZF. . B-NP

-DOCSTART- X X O

Beta NN B-NP
1 CD I-NP
integrin- , I-NP
and CC O
proteoglycan-mediated JJ O
stimulation NN O
of IN O
T NNP O
lymphoma NN O
cell NN O
adhesion NN O
and CC O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
signaling NN O
by IN O
thrombospondin-1 NN B-NP
and CC O
thrombospondin-1 NN B-NP
peptides NNS I-NP
. . O

-DOCSTART- X X O

Optical JJ O
CD NNP O
, , O
and CC O
spectral JJ O
and CC O
activity NN O
analyses NNS O
were VBD O
used VBN O
to TO O
examine VB O
reactivity NN O
of IN O
HO NNP B-NP
isozymes VBZ I-NP
with IN O
NO DT O
species NNS O
produced VBN O
by IN O
NO DT O
donors NNS O
. . O

-DOCSTART- X X O

The DT O
phosphotransferase NN O
system NN O
( -LRB- O
PTS NNS O
) -RRB- O
of IN O
Streptomyces NNP O
coelicolor NN O
identification NN O
and CC O
biochemical JJ O
analysis NN O
of IN O
a DT O
histidine NN B-NP
phosphocarrier NN I-NP
protein NN I-NP
HPr RB B-NP
encoded VBN O
by IN O
the DT O
gene NN O
ptsH. . B-NP

-DOCSTART- X X O

Serum NNP O
concentrations NNS O
of IN O
bone NN B-NP
specific JJ I-NP
alkaline NN I-NP
phosphatase NN I-NP
( -LRB- O
BALP NNP B-NP
) -RRB- O
and CC O
osteocalcin RB B-NP
( -LRB- O
bone NN B-NP
Gla NNP I-NP
protein NN I-NP
, , O
BGP) NNP B-NP
, , O
urinary JJ O
levels NNS O
of IN O
pyridinoline NN O
( -LRB- O
Pyr NNP O
) -RRB- O
and CC O
deoxypyridinoline NN O
( -LRB- O
Dpyr NN O
) -RRB- O
and CC O
computed JJ O
tomography NN O
( -LRB- O
CT) NN O
measurements NNS O
of IN O
the DT O
cross-sectional JJ O
areas NNS O
of IN O
the DT O
vertebrae NNS O
and CC O
the DT O
femurs NNS O
, , O
the DT O
apparent JJ O
density NN O
of IN O
cancellous JJ O
bone NN O
in IN O
the DT O
vertebrae NNS O
, , O
and CC O
the DT O
volume NN O
and CC O
the DT O
material NN O
density NN O
of IN O
cortical JJ O
bone NN O
in IN O
the DT O
femurs NNS O
were VBD O
determined VBN O
in IN O
126 CD O
boys NNS O
and CC O
143 CD O
girls NNS O
, , O
ages NNS O
7-18 CD O
years NNS O
. . O

-DOCSTART- X X O

In IN O
another DT O
study NN O
, , O
intravenous JJ O
administration NN O
of IN O
devazepide NN O
, , O
a DT O
specific JJ O
cholecystokinin-A NN B-NP
receptor NN I-NP
antagonist NN O
, , O
at IN O
a DT O
dose NN O
of IN O
0.1 CD O
mg/kg/hr NN O
was VBD O
begun VBN O
15 CD O
min NN O
before IN O
postprandial JJ O
saline NN O
intake NN O
and CC O
continued VBD O
for IN O
1 CD O
hr NN O
. . O

-DOCSTART- X X O

This DT O
cluster NN O
consisted VBD O
of IN O
four CD O
apparently RB O
unrelated JJ O
ESTs NNP O
and CC O
two CD O
genes NNS O
, , O
pregnancy-associated JJ B-NP
plasma NN I-NP
protein-A NN I-NP
( -LRB- O
PAPP-A NNP B-NP
) -RRB- O
and CC O
a DT O
novel NN O
gene NN O
(tentatively RB O
named VBN O
EST-YD1 NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Prognostic JJ O
value NN O
of IN O
a DT O
treadmill NN O
exercise NN O
score NN O
in IN O
symptomatic JJ O
patients NNS O
with IN O
nonspecific JJ O
ST-T NNP O
abnormalities NNS O
on IN O
resting VBG O
ECG. . O

-DOCSTART- X X O

Structural JJ O
changes NNS O
in IN O
the DT O
C-terminus NN O
of IN O
Ca2+-bound JJ O
rat NN B-NP
S100B NN I-NP
( -LRB- O
beta JJ B-NP
beta NN I-NP
) -RRB- O
upon IN O
binding NN O
to TO O
a DT O
peptide NN O
derived VBN O
from IN O
the DT O
C-terminal JJ O
regulatory JJ O
domain NN O
of IN O
p53 NN B-NP
. . O

-DOCSTART- X X O

We PRP O
propose VBP O
that IN O
Gly84 NNP O
is VBZ O
part NN O
of IN O
a DT O
putative JJ O
"oxyanion NN O
hole NN O
" '' O
involved VBN O
in IN O
the DT O
stabilization NN O
of IN O
the DT O
transition NN O
state NN O
similar JJ O
to TO O
the DT O
C NNP B-NP
group NN I-NP
of IN O
the DT O
esterase/lipase NN B-NP
family NN O
. . O

-DOCSTART- X X O

The DT O
solution NN O
structure NN O
of IN O
the DT O
adduct NN O
derived VBN O
from IN O
the DT O
covalent JJ O
bonding NN O
of IN O
the DT O
fjord JJ O
region NN O
( -LRB- O
+)-(11S NNP O
, , O
12R CD O
, , O
13R CD O
, , O
14S CD O
) -RRB- O
stereoisomer NN O
of IN O
anti NNS O
-11,12-dihydroxy-13,14-epoxy-11,12,13 JJ O
, , O
14-tetrahydrobenzo[g]chrysene JJ O
, , O
( -LRB- O
+) FW O
- : O
anti NNS O
-B[g]CDE NNP O
, , O
to TO O
the DT O
exocyclic JJ O
N(6)amino NNP O
group NN O
of IN O
the DT O
adenine NN O
residue NN O
dA6 NN O
, , O
( -LRB- O
designated VBN O
( -LRB- O
+) JJS O
- : O
trans-anti NNS O
-( JJ O
B[g]C)dA6 NNP O
) -RRB- O
, , O
positioned VBD O
opposite IN O
a DT O
thymine NN O
residue NN O
dT17 NN O
in IN O
the DT O
DNA NNP O
sequence NN O
context NN O
d( VBN O
C1-T2-C3-T4-C5-( JJ O
B[g]C)A6-C7-T8-T9-C10-C11 JJ O
) -RRB- O
. . O
d( '' O
G12-G13-A14-A15-G16-T17-G18-A19-G20++ JJ O
+-A21-G22 NN O
) -RRB- O
( -LRB- O
designated VBN O
( -LRB- O
B[g]C)dA NNP O
. . O
dT '' O
11-mer JJ O
duplex NN O
) -RRB- O
, , O
has VBZ O
been VBN O
studied VBN O
using VBG O
structural JJ O
information NN O
derived VBN O
from IN O
NMR NNP O
data NNS O
in IN O
combination NN O
with IN O
molecular JJ O
dynamics NNS O
( -LRB- O
MD) NNP O
calculations NNS O
. . O

-DOCSTART- X X O

Since IN O
sildenafil NN O
came VBD O
on IN O
the DT O
market NN O
, , O
it PRP O
seems VBZ O
that IN O
the DT O
place NN O
of IN O
MUSE NNP O
is VBZ O
reduced VBN O
because IN O
comparative JJ O
studies NNS O
give VBP O
better JJR O
results NNS O
for IN O
sildenafil JJ O
than IN O
MUSE NNP O
( -LRB- O
70 CD O
% NN O
vs IN O
40 CD O
% NN O
) -RRB- O
and CC O
of IN O
course NN O
with IN O
a DT O
better JJR O
acceptance NN O
. . O

-DOCSTART- X X O

Serum NN O
antibodies NNS O
were VBD O
detected VBN O
in IN O
at IN O
least JJS O
95 CD O
% NN O
of IN O
the DT O
infected JJ O
guinea NN O
pigs NNS O
between IN O
4-30 CD O
WPI NNP O
and CC O
rats NNS O
between IN O
3-16 CD O
WPI. . O

-DOCSTART- X X O

During IN O
both DT O
encephalopathy NN O
episodes NNS O
, , O
CSF NNP O
protein NN O
and CC O
immunoglobulin NN B-NP
G NNP I-NP
( -LRB- O
IgG NN B-NP
) -RRB- O
levels NNS O
were VBD O
elevated VBN O
without IN O
an DT O
increased JJ O
IgG NN B-NP
index NN O
or CC O
IgG NNP B-NP
synthesis NN O
rate NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
These DT O
results NNS O
show VBP O
that IN O
once RB O
daily JJ O
oral JJ O
valganciclovir NN O
can MD O
produce VB O
exposures NNS O
of IN O
ganciclovir NN O
( -LRB- O
AUC24 IN O
) -RRB- O
exceeding VBG O
those DT O
attained VBN O
using VBG O
intravenous JJ O
ganciclovir NN O
10 CD O
mg/kg NN O
. . O

-DOCSTART- X X O

Except IN O
for IN O
nonperfusion NN O
of IN O
neurosensory JJ O
retinal JJ O
vessels NNS O
at IN O
a DT O
light JJ O
dose NN O
of IN O
150 CD O
J/cm2 NNP O
, , O
no DT O
other JJ O
adverse JJ O
events NNS O
were VBD O
of IN O
concern NN O
. . O

-DOCSTART- X X O

Except IN O
for IN O
nonperfusion NN O
of IN O
neurosensory JJ O
retinal JJ O
vessels NNS O
at IN O
a DT O
light JJ O
dose NN O
of IN O
150 CD O
J/cm2 NNP O
, , O
no DT O
other JJ O
adverse JJ O
events NNS O
were VBD O
of IN O
concern NN O
. . O

-DOCSTART- X X O

The DT O
healing NN O
rate NN O
in IN O
HIV-positive JJ O
patients NNS O
was VBD O
66 CD O
percent NN O
after IN O
14 CD O
weeks NNS O
and CC O
100 CD O
percent NN O
after IN O
32 CD O
weeks NNS O
; : O
the DT O
corresponding JJ O
figures NNS O
for IN O
patients NNS O
with IN O
acquired JJ O
immunodeficiency NN O
syndrome NN O
were VBD O
0 CD O
and CC O
50 CD O
percent NN O
. . O

-DOCSTART- X X O

The DT O
P NNP B-NP
mRNA NN I-NP
also RB O
contains VBZ O
a DT O
third JJ O
ORF NN O
for IN O
the DT O
V NNP B-NP
protein NN I-NP
, , O
although IN O
it PRP O
is VBZ O
unclear JJ O
how WRB O
or CC O
whether IN O
this DT O
ORF NN O
is VBZ O
accessed VBN O
. . O

-DOCSTART- X X O

A DT O
genetic JJ O
screen NN O
in IN O
yeast NN O
has VBZ O
allowed VBN O
us PRP O
to TO O
identify VB O
a DT O
novel NN O
transcriptional JJ O
factor NN O
binding NN O
to TO O
the DT O
GlRE NNP O
, , O
i IN O
.e NN O
. . O
the DT O
chicken NN B-NP
ovalbumin NN I-NP
upstream RB I-NP
promoter-transcription JJ I-NP
factor NN I-NP
II NNP I-NP
( -LRB- O
COUP-TFII NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
cloned VBN O
the DT O
single-copy JJ O
gene NN O
for IN O
the DT O
trans NNS B-NP
-spliceosomal JJ I-NP
U5 IN I-NP
snRNA NN I-NP
from IN O
the DT O
trypanosomatid JJ O
species NNS O
Leptomonas NNP O
seymouri NN O
, , O
using VBG O
U5 DT B-NP
RNA NNP I-NP
affinity NN O
selection NN O
and CC O
cDNA NN O
cloning NN O
. . O

-DOCSTART- X X O

The DT O
MMPI-A NNP O
( -LRB- O
Butcher NNP O
et NNP O
al NN O
. . O
, , O
1992 CD O
) -RRB- O
, , O
like IN O
the DT O
older JJR O
MMPI NNP O
( -LRB- O
Hathaway NNP O
& CC O
McKinley NNP O
, , O
1983 CD O
) -RRB- O
, , O
distinguishes VBZ O
between IN O
anorexia DT O
and CC O
bulimia NN O
. . O

-DOCSTART- X X O

On IN O
the DT O
other JJ O
hand NN O
, , O
phosphatidyl NN O
inositol NN O
4,5 CD O
bisphosphate NN O
( -LRB- O
PIP2 NN O
) -RRB- O
hydrolysis NN O
requires VBZ O
direct JJ O
phosphorylation NN O
at IN O
tyrosine NN O
residue NN O
of IN O
the DT O
PLC-gamma1 NNP B-NP
isozyme NN I-NP
. . O

-DOCSTART- X X O

A DT O
G22V NNP B-NP
mutant NN I-NP
of IN O
M-Ras NNP B-NP
was VBD O
constitutively RB O
active JJ O
and CC O
its PRP$ O
expression NN O
in IN O
an DT O
interleukin-3 NN B-NP
( -LRB- O
IL-3)-dependent JJ B-NP
mast NN O
cell/megakaryocyte NN O
cell NN O
line NN O
resulted VBD O
in IN O
increased JJ O
survival NN O
in IN O
the DT O
absence NN O
of IN O
IL-3 JJ B-NP
, , O
increased VBN O
growth NN O
in IN O
IL-4 NN B-NP
, , O
and CC O
, , O
at IN O
high JJ O
expression NN O
levels NNS O
, , O
in IN O
factor-independent JJ O
growth NN O
. . O

-DOCSTART- X X O

Mammalian NNP B-NP
M-Ras NNP I-NP
and CC O
a DT O
Caenorhabditis NNP O
elegans NNS O
orthologue JJ O
exhibit NN O
conserved VBN O
structural JJ O
features NNS O
, , O
and CC O
these DT O
are VBP O
likely JJ O
to TO O
mediate VB O
activation NN O
of IN O
distinctive JJ O
signaling NN O
paths NNS O
that WDT O
function NN O
in IN O
parallel JJ O
to TO O
those DT O
downstream NN O
of IN O
p21 DT B-NP
Ras NNP I-NP
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
PecS NNP B-NP
attenuates VBZ O
pelD VBN B-NP
and CC O
pelE JJ B-NP
expression NN O
rather RB O
than IN O
acting VBG O
as IN O
a DT O
true JJ O
repressor NN O
like IN O
KdgR NNP B-NP
. . O

-DOCSTART- X X O

These DT O
observations NNS O
establish VBP O
that IN O
RsmC NNP B-NP
negatively RB O
regulates VBZ O
rsmB NN B-NP
transcription NN O
but CC O
positively RB O
affects VBZ O
RsmA NN B-NP
production NN O
. . O

-DOCSTART- X X O

All DT O
were VBD O
experienced VBN O
hearing VBG O
aid NN O
users NNS O
who WP O
wore VBD O
linear NN O
Class NN O
D NNP O
instruments NNS O
with IN O
input NN O
compression NN O
limiting VBG O
at IN O
the DT O
time NN O
of IN O
their PRP$ O
enrollment NN O
in IN O
this DT O
study NN O
. . O

-DOCSTART- X X O

SCOB NNP O
testing NN O
of IN O
food-restricted JJ O
animals NNS O
, , O
using VBG O
a DT O
multiple JJ O
fixed JJ O
ratio NN O
( -LRB- O
FR NNP O
)/fixed VBD O
interval NN O
( -LRB- O
FI CD O
) -RRB- O
schedule NN O
( -LRB- O
FR20:FI120 NN O
) -RRB- O
, , O
was VBD O
conducted VBN O
prior RB O
to TO O
each DT O
exposure NN O
to TO O
maintain VB O
the DT O
operant NN O
behavior NN O
; : O
the DT O
data NNS O
from IN O
Weeks NNP O
-1 NN O
, , O
4 CD O
, , O
8 CD O
, , O
and CC O
13 CD O
were VBD O
evaluated VBN O
for IN O
evidence NN O
of IN O
neurotoxicity NN O
. . O

-DOCSTART- X X O

Ribonuclease NN O
protection NN O
assays VBZ O
revealed VBN O
that IN O
hmg1 NNS B-NP
and CC O
hmg2 NNS B-NP
are VBP O
differentially RB O
expressed VBN O
in IN O
a DT O
developmentally- NNS O
and CC O
spatially-modulated JJ O
manner NN O
during IN O
morphogenesis NN O
of IN O
specialized JJ O
terpenoid-containing NN O
pigment NN O
glands NNS O
in IN O
embryos NNS O
. . O

-DOCSTART- X X O

Differential JJ O
expression NN O
was VBD O
confirmed VBN O
by IN O
Northern NNP O
blot NN O
analysis NN O
employing VBG O
multiple JJ O
normal JJ O
and CC O
tumor NN O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

Inactivation NN O
of IN O
the DT O
Neurospora NNP B-NP
crassa VBD I-NP
mitochondrial JJ I-NP
outer JJ I-NP
membrane NN I-NP
protein NN I-NP
TOM70 . I-NP
by IN O
repeat-induced JJ O
point NN O
mutation NN O
( -LRB- O
RIP NNP O
) -RRB- O
causes VBZ O
defects NNS O
in IN O
mitochondrial JJ O
protein NN O
import NN O
and CC O
morphology NN O
. . O

-DOCSTART- X X O

Several JJ O
genes NNS O
or CC O
transcriptional JJ O
units NNS O
were VBD O
identified VBN O
, , O
including VBG O
the DT O
3' JJ O
end NN O
of IN O
ribosomal JJ B-NP
s6 NN I-NP
kinase NN I-NP
( -LRB- O
Rsk3 NN B-NP
) -RRB- O
; : O
two CD O
apparently RB O
intronless JJ O
and CC O
ORF-less JJ O
genes NNS O
; : O
and CC O
Gpr31 NNP B-NP
, , O
an DT O
intronless JJ O
, , O
putative JJ O
G-protein NNP B-NP
coupled VBN I-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

The DT O
results NNS O
suggest VBP O
that IN O
GATA-5 NNP B-NP
may MD O
have VB O
specific JJ O
downstream NN O
targets NNS O
and CC O
that DT O
GATA-4 NNP B-NP
, , I-NP
-5 -RRB- I-NP
, , I-NP
and CC I-NP
-6 RB I-NP
can MD O
only RB O
partially RB O
substitute JJ O
for IN O
each DT O
other JJ O
in IN O
cardiogenesis NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
was VBD O
designed VBN O
to TO O
compare VB O
the DT O
efficacy NN O
of IN O
efegatran NN O
plus CC O
streptokinase NN B-NP
versus NN O
heparin NN O
plus CC O
accelerated VBN O
tissue NN B-NP
plasminogen NN I-NP
activator NN I-NP
( -LRB- O
TPA NNP B-NP
) -RRB- O
in IN O
coronary JJ O
reperfusion NN O
in IN O
acute JJ O
MI NNP O
. . O

-DOCSTART- X X O

Recently RB O
, , O
cell-surface NN O
TRAIL NN B-NP
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
expressed VBN O
by IN O
activated VBN O
human JJ O
and CC O
mouse NN O
T NNP O
lymphocytes VBZ O
, , O
raising VBG O
the DT O
possibility NN O
that IN O
TRAIL NN B-NP
might MD O
be VB O
involved VBN O
in IN O
T NNP O
cell-mediated JJ O
cytotoxicity NN O
and/or CC O
immune JJ O
regulation NN O
. . O

-DOCSTART- X X O

A DT O
panel NN O
of IN O
pharmacologic NN O
inhibitors NNS O
was VBD O
used VBN O
to TO O
investigate VB O
the DT O
signal NN O
transduction NN O
pathways NNS O
involved VBN O
in IN O
TRAIL NNP B-NP
gene NN I-NP
induction NN O
following VBG O
T NNP O
lymphocyte NN O
activation NN O
. . O

-DOCSTART- X X O

From IN O
February NNP O
1991 CD O
to TO O
August NNP O
1997 CD O
, , O
124 CD O
patients NNS O
with IN O
endometrial JJ O
carcinoma NN O
were VBD O
treated VBN O
postoperatively RB O
with IN O
high-dose-rate JJ O
vaginal JJ O
vault NN O
brachytherapy NN O
as IN O
the DT O
only JJ O
adjuvant NN O
treatment NN O
. . O

-DOCSTART- X X O

Twelve CD O
patients NNS O
had VBD O
stage NN O
IBG3 JJ O
, , O
14 CD O
had VBD O
ICG1 NNP O
, , O
9 CD O
had VBD O
ICG2 NNP O
, , O
and CC O
3 CD O
had VBD O
ICG3 DT O
disease NN O
. . O

-DOCSTART- X X O

Defective JJ O
provirus NN O
genomes NNS O
of IN O
human JJ O
T-cell NN O
leukemia NN O
virus NN O
type NN O
I PRP O
are VBP O
frequently RB O
detected VBN O
in IN O
lymphocytes NNS O
from IN O
infected JJ O
individuals NNS O
and CC O
in IN O
infected JJ O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

A DT O
total NN O
of IN O
174 CD O
primer NN O
pairs NNS O
gave VBD O
interpretable JJ O
banding NN O
patterns NNS O
, , O
137 CD O
(79 CD O
% NN O
) -RRB- O
of IN O
which WDT O
revealed VBD O
at IN O
least JJS O
two CD O
alleles NNS O
on IN O
native JJ O
polyacrylamide NN O
gels NNS O
. . O

-DOCSTART- X X O

A DT O
population NN O
pharmacokinetic JJ O
study NN O
of IN O
cyclosporin NN O
in IN O
organ NN O
transplant NN O
patients NNS O
, , O
including VBG O
elderly JJ O
allograft NN O
recipients NNS O
up IN O
to TO O
75 CD O
years NNS O
of IN O
age NN O
, , O
did VBD O
not RB O
identify VB O
age NN O
as IN O
a DT O
covariable JJ O
influencing NN O
cyclosporin NN O
pharmacokinetics NNS O
. . O

-DOCSTART- X X O

Immunofluoresence NNP O
data NNS O
indicated VBD O
that IN O
once RB O
bound VBN O
to TO O
the DT O
mutant NN O
receptor NN O
, , O
fluorescent-labeled JJ O
RAP NNP B-NP
co-localized VBD O
with IN O
markers NNS O
of IN O
the DT O
endosomal JJ O
pathway NN O
, , O
whereas IN O
, , O
in IN O
cells NNS O
expressing VBG O
the DT O
wild-type JJ O
receptor NN O
, , O
RAP NNP B-NP
fluorescence NN O
co-localized VBD O
with IN O
lysosomal JJ O
markers NNS O
. . O

-DOCSTART- X X O

Interleukin-12 NN B-NP
( -LRB- O
IL-12 NN B-NP
) -RRB- O
is VBZ O
a DT O
cytokine NN O
produced VBN O
by IN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
( -LRB- O
PBMC) NN O
that WDT O
causes VBZ O
interferon-gamma NN B-NP
( -LRB- O
IFN-gamma NN B-NP
) -RRB- O
production NN O
and CC O
enhancement NN O
of IN O
cell-mediated JJ O
cytotoxicity NN O
. . O

-DOCSTART- X X O

IL-12 NN B-NP
production NN O
was VBD O
correlated VBN O
with IN O
C3a DT O
concentration NN O
measured VBN O
at IN O
the DT O
outlet NN O
of IN O
hemodialyzer NN O
after IN O
15 CD O
min NN O
of IN O
dialysis NN O
( -LRB- O
r NN O
= SYM O
0.69 CD O
, , O
P NNP O
< JJ O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
HeLa NNP O
cells NNS O
, , O
the DT O
JNKK2-JNK1 JJ B-NP
fusion NN O
protein NN O
showed VBD O
significant JJ O
JNK NNP B-NP
activity NN O
, , O
which WDT O
was VBD O
comparable JJ O
with IN O
that DT O
of IN O
JNK1 DT B-NP
activated VBN O
by IN O
many JJ O
stimuli NNS O
and CC O
activators NNS O
, , O
including VBG O
EGF NNP B-NP
, , O
TNF-alpha NNP B-NP
, , O
anisomycin NN O
, , O
UV NN O
irradiation NN O
, , O
MEKK1 NNP B-NP
, , O
and CC O
small JJ B-NP
GTP NNP I-NP
binding JJ I-NP
proteins NNS I-NP
Rac1 NNP I-NP
and CC O
Cdc42Hs NNP B-NP
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
implicate VBP O
TGF-beta JJ B-NP
RII NNP I-NP
as IN O
a DT O
direct JJ O
target NN O
of IN O
EWS-FLI1 JJ B-NP
. . O

-DOCSTART- X X O

The DT O
reduction NN O
in IN O
saturated JJ O
fatty NN O
acids NNS O
intake VBP O
led VBN O
to TO O
modest JJ O
( -LRB- O
but CC O
in IN O
group NN O
1 CD O
significant JJ O
) -RRB- O
0.15 CD O
mmol/l NN O
( -LRB- O
2.5 CD O
% NN O
) -RRB- O
reduction NN O
in IN O
total NN O
serum NN O
cholesterol NN O
level NN O
. . O

-DOCSTART- X X O

Secondly RB O
, , O
an DT O
ethanol NN O
repression NN O
autoregulation NN O
( -LRB- O
ERA NNP O
)/twelve-fold NNP O
TA VBZ O
repeat NN O
( -LRB- O
TAB) JJ O
repressor NN O
element NN O
was VBD O
identified VBN O
within IN O
the DT O
promoter NN O
region NN O
of IN O
the DT O
GLK1 NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

A DT O
crucial JJ O
transcription NN O
factor NN O
in IN O
this DT O
process NN O
is VBZ O
STAT6 NNP B-NP
, , O
which WDT O
binds VBZ O
to TO O
a DT O
specific JJ O
DNA NN O
element NN O
upon IN O
cytokine NN O
activation NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Congenital NNP O
horizontal , O
tarsal JJ O
kink NN O
is VBZ O
rare JJ O
and CC O
its PRP$ O
cause NN O
is VBZ O
unknown JJ O
. . O

-DOCSTART- X X O

A DT O
local JJ O
, , O
high-density JJ O
, , O
single-nucleotide JJ O
polymorphism NN O
map NN O
used VBN O
to TO O
clone VB O
Caenorhabditis NNP B-NP
elegans NNS I-NP
cdf-1 NN I-NP
. . O

-DOCSTART- X X O

This DT O
machinery NN O
involves VBZ O
a DT O
secondary JJ O
structure NN O
, , O
SECIS NNP O
element NN O
, , O
in IN O
the DT O
selenoprotein-encoding JJ B-NP
mRNA NNS O
, , O
directing VBG O
selenocysteine NN O
insertion NN O
at IN O
the DT O
position NN O
of IN O
an DT O
opal NN O
( -LRB- O
UGA NNP O
) -RRB- O
codon NN O
, , O
normally RB O
conferring VBG O
termination NN O
of IN O
translation NN O
. . O

-DOCSTART- X X O

High-level JJ O
expression NN O
in IN O
Escherichia NNP O
coli NNS O
of IN O
selenocysteine-containing JJ O
rat NN B-NP
thioredoxin NN I-NP
reductase NN I-NP
utilizing VBG O
gene NN O
fusions NNS O
with IN O
engineered VBN O
bacterial-type JJ O
SECIS NNP O
elements NNS O
and CC O
co-expression NN O
with IN O
the DT O
selA NN B-NP
, , O
selB NN B-NP
and CC O
selC JJ B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

In IN O
Wnt NNP B-NP
signaling NN O
, , O
beta-catenin NN B-NP
and CC O
plakoglobin NN B-NP
transduce NN O
signals NNS O
to TO O
the DT O
nucleus NN O
through IN O
interactions NNS O
with IN O
TCF-type JJ B-NP
transcription NN I-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

Assembly NN O
of IN O
a DT O
complex NN O
between IN O
FAK NNP B-NP
and CC O
Src NNP B-NP
kinases NNS I-NP
may MD O
serve VB O
to TO O
regulate VB O
the DT O
subcellular JJ O
localization NN O
and CC O
the DT O
enzymatic JJ O
activity NN O
of IN O
members NNS O
of IN O
the DT O
Src NNP B-NP
family NN I-NP
of IN O
kinases NNS O
. . O

-DOCSTART- X X O

For IN O
EPV NNP O
3 CD O
, , O
10 CD O
, , O
or CC O
40 CD O
, , O
the DT O
bias NN O
exceeded VBD O
25 CD O
% NN O
for IN O
7 CD O
, , O
3 CD O
, , O
and CC O
1 CD O
in IN O
the DT O
8-predictor NN O
model NN O
respectively RB O
, , O
when WRB O
a DT O
conventional JJ O
selection NN O
criterion NN O
was VBD O
used VBN O
( -LRB- O
alpha NN O
= SYM O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Our PRP$ O
study NN O
also RB O
demonstrated VBD O
significant JJ O
increases NNS O
in IN O
the DT O
number NN O
of IN O
larger JJR O
myelinated VBD O
fibers NNS O
crossing VBG O
the DT O
repair NN O
site NN O
in IN O
comparison NN O
with IN O
the DT O
neonatal JJ O
and CC O
adult JJ O
groups NNS O
( -LRB- O
p NN O
< JJ O
0.04 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Me( NNP O
2)SO-induced JJ O
neuronal JJ O
differentiation NN O
of IN O
N1E-115 DT O
neuroblastoma NN O
cells NNS O
increased VBN O
both DT O
the DT O
expression NN O
of IN O
the DT O
endogenous JJ B-NP
Ntr-1 JJ I-NP
gene NN I-NP
and CC O
reporter NN O
genes NNS O
driven VBN O
by IN O
NTR-1 JJ B-NP
promoter NN I-NP
sequences NNS I-NP
by IN O
3-4-fold JJ O
. . O

-DOCSTART- X X O

Cortical NNP O
dysplasias NNS O
, , O
genetics NNS O
, , O
and CC O
epileptogenesis NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
work NN O
reported VBD O
here RB O
, , O
we PRP O
used VBD O
peptide NN O
mapping NN O
, , O
mass NN O
spectrometry NN O
, , O
and CC O
site-directed VBD O
mutagenesis NN O
to TO O
identify VB O
two CD O
sets NNS O
of IN O
pAP JJ B-NP
phosphorylation NN O
sites NNS O
. . O

-DOCSTART- X X O

Both DT O
HERV-K NNP O
type NN O
1 CD O
and CC O
2 CD O
clones NNS O
were VBD O
isolated VBN O
. . O

-DOCSTART- X X O

At IN O
all DT O
time-points NNS O
, , O
most JJS O
patients NNS O
( -LRB- O
>/=87 CD O
% NN O
) -RRB- O
were VBD O
receiving VBG O
irbesartan/HCTZ JJ O
alone RB O
. . O

-DOCSTART- X X O

Modification NNP O
of IN O
dopamine NN B-NP
D2 NN I-NP
receptor NN I-NP
activity NN O
by IN O
pergolide NN O
in IN O
Parkinson NNP O
's POS O
disease NN O
: : O
an DT O
in IN O
vivo JJ O
study NN O
by IN O
PET. NNP O

-DOCSTART- X X O

High-affinity NNP O
binding NN O
sites NNS O
for IN O
both DT O
GR CD B-NP
and CC O
AP-1 NNP B-NP
nucleoproteins NNS I-NP
were VBD O
identified VBN O
at IN O
adjacent JJ O
elements NNS O
within IN O
the DT O
nGRE. NN O

-DOCSTART- X X O

When WRB O
the DT O
73-bp JJ O
fragment NN O
was VBD O
fused VBN O
to TO O
an DT O
alpha1-globin NN B-NP
promoter-CAT NN O
construct VB O
and CC O
cotransfected VBN O
with IN O
CCAAT JJ B-NP
transcription NN I-NP
factor NN I-NP
1 CD I-NP
( -LRB- O
CTF1 CC B-NP
)/NF1 VB O
into IN O
Drosophila NNP O
Schneider NNP O
SL2 NNP O
insect NN O
cells NNS O
( -LRB- O
which WDT O
lack NN O
NF1-like JJ B-NP
proteins NNS I-NP
) -RRB- O
trans-activation NN O
of IN O
CAT NN B-NP
activity NN O
was VBD O
observed VBN O
. . O

-DOCSTART- X X O

Western JJ O
blot NN O
analysis NN O
showed VBD O
a DT O
rapid JJ O
corresponding JJ O
increase NN O
in IN O
p21WAF1/CIP1 JJ B-NP
protein NN O
, , O
whereas IN O
protein NN O
levels NNS O
of IN O
another DT O
member NN O
of IN O
the DT O
cyclin-dependent JJ B-NP
kinase NN I-NP
inhibitor IN I-NP
family NN I-NP
, , O
p27kip1 NNS B-NP
, , O
were VBD O
unchanged JJ O
. . O

-DOCSTART- X X O

Aggregation NNP O
of IN O
vHnf1-deficient JJ B-NP
embryonic JJ O
stem NN O
cells NNS O
with IN O
wild-type JJ O
tetraploid JJ O
embryos NNS O
, , O
which WDT O
contribute VBP O
exclusively RB O
to TO O
extraembryonic JJ O
tissues NNS O
, , O
rescues NNS O
periimplantation NN O
lethality NN O
and CC O
allows VBZ O
development NN O
to TO O
progress VB O
to TO O
early JJ O
organogenesis NN O
. . O

-DOCSTART- X X O

nos-1 NN B-NP
and CC O
nos-2 NN B-NP
, , O
two CD O
genes NNS O
related VBN O
to TO O
Drosophila NNP B-NP
nanos NNS I-NP
, , O
regulate VB O
primordial JJ O
germ NN O
cell NN O
development NN O
and CC O
survival NN O
in IN O
Caenorhabditis NNP O
elegans NNS O
. . O

-DOCSTART- X X O

Although IN O
upstream JJ O
regulators NNS O
of IN O
Tec NNP B-NP
family NN I-NP
kinases NNS I-NP
are VBP O
relatively RB O
well RB O
characterized VBN O
, , O
little RB O
is VBZ O
known VBN O
of IN O
the DT O
downstream NN O
effectors NNS O
of IN O
these DT O
enzymes NNS O
. . O

-DOCSTART- X X O

Efficient NN O
phosphorylation NN O
of IN O
BRDG1 NNP B-NP
by IN O
Tec NNP B-NP
required VBD O
the DT O
PH NNP B-NP
and CC O
SH2 NNP B-NP
domains VBZ I-NP
as RB O
well RB O
as IN O
the DT O
kinase NN O
domain NN O
of IN O
the DT O
latter NN O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
These DT O
findings NNS O
imply VBP O
that IN O
eotaxin NN O
either CC O
is VBZ O
mechanistically RB O
involved VBN O
in IN O
acute JJ O
asthma NN O
or CC O
serves VBZ O
as IN O
a DT O
biomarker NN O
for IN O
activity NN O
of IN O
the DT O
CCR3 NN B-NP
receptor NN I-NP
ligand NN I-NP
system NN O
, , O
which WDT O
is VBZ O
functionally RB O
linked VBN O
to TO O
asthma NN O
. . O

-DOCSTART- X X O

The DT O
expression NN O
analysis NN O
of IN O
the DT O
KlHIS4 NNP B-NP
gene NN I-NP
under IN O
phosphate NN O
starvation NN O
or CC O
high JJ O
adenine NN O
supply NN O
shows VBZ O
that IN O
factors NNS O
, , O
such JJ O
as IN O
Bas1 NNP B-NP
or CC O
Bas2 NNP B-NP
, , O
involved VBN O
in IN O
the DT O
basal NN O
control NN O
may MD O
also RB O
operate VB O
in IN O
a DT O
different JJ O
way NN O
in IN O
K. NNP O
lactis NN O
. . O

-DOCSTART- X X O

These DT O
thyroid NN O
hormone NN O
changes NNS O
may MD O
be VB O
mediated VBN O
in IN O
part NN O
by IN O
cytokines NNS O
or CC O
other JJ O
inflammatory NN O
mediators NNS O
, , O
acting VBG O
at IN O
the DT O
level NN O
of IN O
the DT O
hypothalamus NN O
and CC O
pituitary JJ O
gland NN O
, , O
the DT O
thyroid NN O
gland NN O
, , O
and CC O
the DT O
hepatic JJ B-NP
deiodinase NN I-NP
system NN O
. . O

-DOCSTART- X X O

ESS NNP O
type NN O
1 CD O
, , O
with IN O
FT3 DT O
low JJ O
and CC O
FT4 NNP O
and CC O
TSH NNP B-NP
normal JJ O
, , O
is VBZ O
the DT O
most RBS O
frequent JJ O
form NN O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
We PRP O
studied VBD O
20 CD O
symptomatic JJ O
patients NNS O
with IN O
HOCM NNP O
( -LRB- O
12 CD O
men NNS O
) -RRB- O
, , O
mean VBP O
age NN O
52 CD O
+/ NN O
- : O
17 CD O
years NNS O
, , O
before IN O
and CC O
after IN O
septal JJ O
reduction NN O
using VBG O
echocardiography NN O
and CC O
electrocardiogram NN O
(ECG) NN O
. . O

-DOCSTART- X X O

Paleoceanographic NNP O
data NNS O
from IN O
the DT O
Laurentian NNP O
Fan NNP O
, , O
used VBN O
as IN O
a DT O
proxy NN O
for IN O
sea NN O
surface NN O
temperature NN O
, , O
reveal VBP O
that IN O
surface NN O
slope NN O
waters NNS O
north NN O
of IN O
the DT O
Gulf NNP O
Stream NNP O
experienced VBD O
warming VBG O
during IN O
the DT O
Little NNP O
Ice NNP O
Age NNP O
of IN O
the DT O
16th JJ O
to TO O
19th JJ O
centuries NNS O
and CC O
support VB O
the DT O
notion NN O
of IN O
an DT O
NAO-driven JJ O
coupled VBN O
system NN O
. . O

-DOCSTART- X X O

This DT O
effect NN O
required VBN O
( -LRB- O
i FW O
) -RRB- O
IR NNP B-NP
activation NN O
since IN O
it PRP O
was VBD O
abrogated VBN O
by IN O
IR NNP B-NP
mutation NN O
at IN O
tyrosines NNS O
1162 CD O
and CC O
1163 CD O
and CC O
( -LRB- O
ii NNS O
) -RRB- O
NF-kappaB NNP B-NP
activation NN O
since IN O
it PRP O
was VBD O
abolished VBN O
by IN O
overexpression NN O
of IN O
dominant-negative JJ B-NP
IkappaB-alpha( JJ I-NP
A32/36 NNS I-NP
) -RRB- I-NP
and CC O
mimicked VBN O
by IN O
overexpression NN O
of IN O
the DT O
NF-kappaB NNP B-NP
c-Rel NN B-NP
subunit NN I-NP
. . O

-DOCSTART- X X O

The DT O
factor NN O
designated VBD O
B NNP O
formed VBD O
a DT O
complex JJ O
centered VBN O
on IN O
the DT O
sequence NN O
TGTGGT NNP O
, , O
a DT O
core NN O
motif NN O
recognized VBN O
by IN O
members NNS O
of IN O
the DT O
AML/CBFalpha NNP B-NP
transcription NN I-NP
factor NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
overexpression IN O
of IN O
AML3/CBFalpha1 NNP B-NP
could MD O
rescue VB O
the DT O
AML1-ETO NNP B-NP
repression NN O
. . O

-DOCSTART- X X O

We PRP O
examined VBD O
Akt NNP B-NP
activation NN O
in IN O
Lyn-, NNP B-NP
Syk NNP B-NP
- : O
and CC O
Btk-deficient JJ B-NP
DT40 IN O
cells NNS O
and CC O
B NNP O
cells NNS O
from IN O
Lyn(-/-) JJ B-NP
mice NNS O
. . O

-DOCSTART- X X O

Regulators NNS O
of IN O
G NNP B-NP
protein NN I-NP
signaling NN I-NP
(RGS NNS I-NP
) -RRB- I-NP
proteins VBZ I-NP
that WDT O
contain VBP O
DEP NNP B-NP
( -LRB- O
disheveled VBN B-NP
, , O
EGL-10 NNP B-NP
, , O
pleckstrin NN B-NP
) -RRB- O
and CC O
GGL NNP B-NP
( -LRB- O
G NNP B-NP
protein NN I-NP
gamma NN I-NP
subunit-like JJ I-NP
) -RRB- O
domains VBZ O
form VB O
a DT O
subfamily NN O
that WDT O
includes VBZ O
the DT O
mammalian JJ B-NP
RGS NNP I-NP
proteins VBZ I-NP
RGS6 NNP B-NP
, , O
RGS7 NNP B-NP
, , O
RGS9 NNP B-NP
, , O
and CC O
RGS11 NNP B-NP
. . O

-DOCSTART- X X O

Cloning NN O
and CC O
expression NN O
of IN O
a DT O
specific JJ O
human JJ B-NP
alpha NN I-NP
1,2-mannosidase . I-NP
that WDT O
trims VBZ O
Man9GlcNAc2 NNP O
to TO O
Man8GlcNAc2 NNP O
isomer NN O
B NNP O
during IN O
N-glycan NNP O
biosynthesis NN O
. . O

-DOCSTART- X X O

The DT O
ORs NNS O
of IN O
GC NNP O
, , O
adjusted VBN O
for IN O
age NN O
and CC O
sex NN O
, , O
varied VBN O
from IN O
17.1 CD O
, , O
for IN O
those DT O
with IN O
baseline JJ O
diagnoses NNS O
of IN O
superficial JJ O
intestinal JJ O
metaplasia NN O
( -LRB- O
IM) NNP O
, , O
to TO O
29.3 CD O
, , O
for IN O
those DT O
with IN O
deep JJ O
IM NNP O
or CC O
mild JJ O
dysplasia NN O
( -LRB- O
DYS) NNP O
or CC O
IM NNP O
with IN O
glandular JJ O
atrophy NN O
and CC O
neck NN O
hyperplasia NN O
, , O
to TO O
104.2 CD O
, , O
for IN O
those DT O
with IN O
moderate JJ O
or CC O
severe JJ O
DYS NNS O
, , O
as IN O
compared VBN O
with IN O
subjects NNS O
with IN O
superficial JJ O
gastritis NN O
(SG) NNS O
or CC O
chronic JJ O
atrophic JJ O
gastritis NN O
( -LRB- O
CAG NNP O
) -RRB- O
at IN O
baseline NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
report VBP O
that IN O
Dbp5p NNP B-NP
and CC O
Rat7p NNP B-NP
interact NN O
through IN O
their PRP$ O
Nterminal JJ O
domains NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
nematode NN O
genes NNS O
could MD O
be VB O
the DT O
homologs NNS B-NP
of IN I-NP
Hh NNP I-NP
molecules NNS I-NP
in IN O
other JJ O
phyla NN O
. . O

-DOCSTART- X X O

A DT O
subset NN O
of IN O
mutations NNS O
in IN O
the DT O
Psi NNP B-NP
synthase NN I-NP
domain NN I-NP
impairs NNS O
association NN O
of IN O
the DT O
altered JJ O
Cbf5p JJ B-NP
proteins NNS I-NP
with IN O
selected VBN O
box NN O
H/ACA IN B-NP
snoRNAs NN I-NP
, , O
suggesting VBG O
that IN O
the DT O
functional JJ O
catalytic JJ O
domain NN O
is VBZ O
essential JJ O
for IN O
that DT O
interaction NN O
. . O

-DOCSTART- X X O

Although IN O
the DT O
Src NNP B-NP
tyrosine NN I-NP
kinase NN I-NP
induces VBZ O
constitutive JJ O
Stat3 NNP B-NP
phosphorylation NN O
on IN O
tyrosine NN O
, , O
activation NN O
of IN O
Stat3-mediated JJ B-NP
gene NN O
regulation NN O
requires VBZ O
both DT O
tyrosine NN O
and CC O
serine NN O
phosphorylation NN O
of IN O
Stat3 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
transcription NN B-NP
factor NN I-NP
CHOP NNP I-NP
( -LRB- O
C/EBP NNP B-NP
homologous JJ I-NP
protein NN I-NP
10 CD I-NP
) -RRB- O
is VBZ O
a DT O
bZIP JJ B-NP
protein NN I-NP
induced VBN O
by IN O
a DT O
variety NN O
of IN O
stimuli NNS O
that WDT O
evoke VBP O
cellular JJ O
stress NN O
responses NNS O
and CC O
has VBZ O
been VBN O
shown VBN O
to TO O
arrest VB O
cell NN O
growth NN O
and CC O
to TO O
promote VB O
programmed VBN O
cell NN O
death NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
CHOP NNP B-NP
not RB O
only RB O
is VBZ O
a DT O
negative JJ O
or CC O
a DT O
positive JJ O
regulator NN O
of IN O
C/EBP NNP B-NP
target NN O
genes NNS O
but CC O
also RB O
, , O
when WRB O
tethered JJ O
to TO O
AP-1 NNP B-NP
factors NNS I-NP
, , O
can MD O
activate VB O
AP-1 DT B-NP
target NN O
genes NNS O
. . O

-DOCSTART- X X O

This DT O
motif NN O
, , O
first RB O
described VBN O
for IN O
the DT O
Drosophila NNP B-NP
homeobox NN I-NP
activator NN I-NP
DEAF-1 NNP I-NP
, , O
identifies VBZ O
an DT O
emerging VBG O
group NN O
of IN O
metazoan NN O
transcriptional JJ O
modulators NNS O
. . O

-DOCSTART- X X O

RNase NN B-NP
MRP NNP I-NP
is VBZ O
a DT O
ribonucleoprotein NN O
endoribonuclease NN O
that WDT O
has VBZ O
been VBN O
shown VBN O
to TO O
have VB O
roles NNS O
in IN O
both DT O
mitochondrial JJ O
DNA NNP O
replication NN O
and CC O
nuclear JJ B-NP
5.8S NNS I-NP
rRNA NN I-NP
processing NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
examined VBN O
the DT O
regulation NN O
of IN O
the DT O
FGFR-1 JJ B-NP
gene NN I-NP
(cek-1 NN O
) -RRB- O
in IN O
avian NN O
myogenic JJ O
cultures NNS O
by IN O
immunocytochemistry NN O
and CC O
Northern JJ O
blot NN O
analysis NN O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
avian JJ B-NP
fibroblast JJ I-NP
growth NN I-NP
factor NN I-NP
receptor NN I-NP
1 CD I-NP
( -LRB- O
FGFR-1 NN B-NP
) -RRB- O
gene NN O
expression NN O
during IN O
skeletal JJ O
muscle NN O
differentiation NN O
. . O

-DOCSTART- X X O

The DT O
backbone NN O
dynamics NNS O
of IN O
residues NNS O
located VBN O
in IN O
the DT O
folded JJ O
part NN O
of IN O
CRP2( NNP B-NP
LIM2)R122A NNP B-NP
have VBP O
been VBN O
characterized VBN O
by IN O
proton-detected( JJ O
15)N JJ O
NMR NNP O
spectroscopy NN O
. . O

-DOCSTART- X X O

Rac NNP B-NP
causes VBZ O
uncapping JJ O
of IN O
actin NN B-NP
filaments NNS I-NP
(F-actin NN O
) -RRB- O
at IN O
the DT O
plus-ends NNS O
, , O
through IN O
phosphatidylinositol NN O
4,5 CD O
bisphosphate NN O
( -LRB- O
PIP2 NN O
) -RRB- O
, , O
and CC O
eventually RB O
induces VBZ O
membrane NN O
ruffling NN O
. . O

-DOCSTART- X X O

However RB O
, , O
a DT O
specific JJ O
ICE/caspase-1 NN B-NP
inhibitor NN O
called VBD O
N1445 NNP O
completely RB O
abolished VBD O
the DT O
CK-induced JJ B-NP
apoptosis NN O
by IN O
reactivating VBG O
PKB NNP B-NP
, , O
but CC O
without IN O
affecting VBG O
the DT O
CK-induced JJ B-NP
suppression NN O
of IN O
Ras NNP B-NP
transformation NN O
. . O

-DOCSTART- X X O

The DT O
AL-R8 NNP O
SI NNP O
: : O
the DT O
next JJ O
generation NN O
staging NN O
container NN O
for IN O
plutonium NN O
pits NNS O
at IN O
the DT O
USDOE NNP O
Pantex NNP O
Plant NNP O
. . O

-DOCSTART- X X O

One CD O
form NN O
of IN O
the DT O
SBEI NNP B-NP
gene NN I-NP
transcript NN I-NP
in IN O
12-day JJ O
old JJ O
kernels NNS O
contained VBD O
the DT O
exon NN O
I+II+II IN O
I PRP O
combination NN O
at IN O
the DT O
5' JJ O
end NN O
, , O
whereas IN O
other JJ O
forms NNS O
differed VBD O
by IN O
inclusion NN O
of IN O
intron NN O
1 CD O
or CC O
exclusion NN O
of IN O
exon JJ O
II NNP O
sequences NNS O
. . O

-DOCSTART- X X O

In IN O
PC NN O
, , O
rare JJ O
MNGCs NNS O
had VBD O
intranuclear JJ O
inclusions NNS O
and CC O
grooves NNS O
. . O

-DOCSTART- X X O

16 CD O
percent NN O
, , O
P<0.001 NNP O
) -RRB- O
, , O
and CC O
sustained VBD O
normalization NN O
of IN O
serum NN B-NP
alanine IN I-NP
aminotransferase JJ I-NP
levels NNS O
( -LRB- O
41 CD O
percent NN O
vs. NN O

-DOCSTART- X X O

Its PRP$ O
C-terminal JJ O
catalytic JJ O
domain NN O
was VBD O
found VBN O
to TO O
be VB O
highly RB O
conserved VBN O
in IN O
the DT O
homologues NNS O
p140(ras-GRF NN B-NP
) -RRB- O
and CC O
Sos NNP B-NP
. . O

-DOCSTART- X X O

356 CD O
, , O
93-98] CD O
. . O

-DOCSTART- X X O

The DT O
proteasome JJ O
is VBZ O
a DT O
large JJ O
complex JJ O
consisting VBG O
of IN O
two CD O
multisubunit JJ O
structures NNS O
, , O
the DT O
20S CD B-NP
and CC O
19S(PA700 CD B-NP
) -RRB- O
or CC O
P28 CD B-NP
complexes NNS I-NP
, , O
that IN O
combine NN O
to TO O
form VB O
the DT O
26S JJ B-NP
particles NNS I-NP
. . O

-DOCSTART- X X O

In IN O
assays VBG O
with IN O
purified VBN O
enzymes NNS O
, , O
wild-type JJ O
but CC O
not RB O
PTPS-S19A NNP B-NP
was VBD O
a DT O
specific JJ O
substrate NN O
for IN O
the DT O
cGMP-dependent JJ B-NP
protein NN I-NP
kinase NN I-NP
(cGK) NN I-NP
type NN I-NP
I PRP I-NP
and CC I-NP
II NNP I-NP
. . O

-DOCSTART- X X O

R. NNP O
, , O
Fleischmann NNP O
, , O
R. NNP O
, , O
Venter NNP O
, , O
J. NNP O

-DOCSTART- X X O

The DT O
N-terminal JJ O
domain NN O
of IN O
approximately RB O
70 CD O
kDa NN O
exhibits NNS O
11 CD O
imperfect JJ O
amino JJ O
acid NN O
repeats NNS O
that WDT O
show VBP O
some DT O
homology NN O
to TO O
promastigote VB O
surface NN O
glycoproteins NNS O
of IN O
the DT O
psa2/gp46 NN B-NP
complex NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
to TO O
previously RB O
characterized VBN O
proteophosphoglycans NNS O
, , O
the DT O
ppg1 JJ B-NP
gene NN O
product NN O
is VBZ O
predominantly RB O
membrane-associated JJ O
and CC O
it PRP O
is VBZ O
expressed VBN O
on IN O
the DT O
promastigote JJ O
cell NN O
surface NN O
. . O

-DOCSTART- X X O

Most RBS O
important JJ O
, , O
infection NN O
of IN O
the DT O
cells NNS O
with IN O
an DT O
adenoviral NN O
construct VB O
expressing VBG O
this DT O
mutant JJ O
inhibited VBD O
the DT O
induction NN O
of IN O
VEGF NNP B-NP
mRNA . I-NP
under IN O
conditions NNS O
that WDT O
mimic VBP O
hypoxia NN O
. . O

-DOCSTART- X X O

Neuregulin NNP B-NP
stimulates NNS O
ErbB2 NNP B-NP
, , O
ErbB3 NNP B-NP
, , O
and CC O
ErbB4 NNP B-NP
, , O
members NNS O
of IN O
the DT O
ErbB NNP B-NP
family NN I-NP
of IN O
receptor NN B-NP
tyrosine NN I-NP
kinases NNS I-NP
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
Anu2p NNP B-NP
is VBZ O
the DT O
yeast NN B-NP
homologue NN I-NP
of IN I-NP
mammalian JJ I-NP
epsilon-COP NN I-NP
and CC O
the DT O
abrupt JJ O
accumulation NN O
of IN O
the DT O
ER NNP O
membrane NN O
caused VBN O
by IN O
a DT O
blockage NN O
of IN O
the DT O
early JJ O
protein NN O
transport NN O
pathway NN O
leads VBZ O
to TO O
alteration NN O
of IN O
nuclear JJ O
morphology NN O
of IN O
the DT O
budding VBG O
yeast NN O
cells NNS O
. . O

-DOCSTART- X X O

In IN O
PC12 CD O
cells NNS O
, , O
nerve NN B-NP
growth NN I-NP
factor NN I-NP
induces VBZ O
neuronal JJ O
differentiation NN O
and CC O
repressed VBD O
expression NN O
of IN O
nrg-1 NN B-NP
. . O

-DOCSTART- X X O

In IN O
a DT O
PC12 NN O
cell NN O
mutant NN O
that WDT O
is VBZ O
deficient JJ O
in IN O
protein NN B-NP
kinase NN I-NP
A DT I-NP
activity NN O
( -LRB- O
AB.11 NNP O
) -RRB- O
, , O
all DT O
three CD O
differentiating JJ O
agents NNS O
were VBD O
unable JJ O
to TO O
down-regulate JJ O
nrg-1 JJ B-NP
mRNA NN I-NP
. . O

-DOCSTART- X X O

TSC1 DT B-NP
mutations NNS I-NP
include VBP O
two CD O
nonsense JJ O
mutations NNS O
, , O
four CD O
insertions NNS O
, , O
and CC O
three CD O
splice NN O
mutations NNS O
. . O

-DOCSTART- X X O

Twelve CD O
patients NNS O
without IN O
abnormalities NNS O
in IN O
the DT O
PTT NNP O
are VBP O
assumed VBN O
to TO O
harbor NN O
missense NN O
mutations NNS O
, , O
probably RB O
in IN O
TSC2 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
first JJ O
algorithm NN O
, , O
FOREPROJ NN O
, , O
is VBZ O
a DT O
fast-forward JJ O
projection NN O
algorithm NN O
that WDT O
allows VBZ O
calculation NN O
of IN O
the DT O
3-D JJ O
attenuation NN O
correction NN O
factors NNS O
(ACF NN O
's POS O
) -RRB- O
directly RB O
from IN O
a DT O
two-dimensional JJ O
(2-D NN O
) -RRB- O
transmission NN O
scan NN O
, , O
without IN O
first JJ O
reconstructing NN O
the DT O
attenuation NN O
map NN O
and CC O
then RB O
performing VBG O
a DT O
3-D JJ O
forward JJ O
projection NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
cloned VBN O
cDNA NN O
and CC O
genomic JJ O
DNA NN O
for IN O
a DT O
mouse NN O
gene NN O
encoding VBG O
a DT O
protein NN O
with IN O
significant JJ O
sequence NN O
similarity NN O
to TO O
conserved VB O
domains NNS O
found VBN O
in IN O
proteins NNS O
of IN O
the DT O
Spo11p NNP B-NP
family NN I-NP
. . O

-DOCSTART- X X O

RT-PCR NNP O
and CC O
in IN O
situ FW O
hybridization NN O
analyses NNS O
of IN O
a DT O
time NN O
course NN O
of IN O
juvenile JJ O
testis NN O
development NN O
indicate VBP O
that IN O
Spo11 NNP B-NP
expression NN O
begins VBZ O
in IN O
early JJ O
meiotic JJ O
Prophase NN O
I PRP O
, , O
prior RB O
to TO O
the DT O
pachytene NN O
stage NN O
, , O
with IN O
increasing VBG O
accumulation NN O
of IN O
mRNA NN O
through IN O
the DT O
pachytene NN O
stage NN O
. . O

-DOCSTART- X X O

Animals NNS O
were VBD O
put VBN O
to TO O
death NN O
8 CD O
weeks NNS O
later RB O
and CC O
the DT O
grafts NNS O
were VBD O
sterilely RB O
explanted VBN O
and CC O
analyzed VBN O
via IN O
microbiologic JJ O
culture NN O
and CC O
standard JJ O
histologic NN O
procedures NNS O
for IN O
evidence NN O
of IN O
infection NN O
. . O

-DOCSTART- X X O

The DT O
RMR NNP O
was VBD O
measured VBN O
twice RB O
in IN O
each DT O
phase NN O
and CC O
found VBD O
to TO O
be VB O
similar JJ O
( -LRB- O
F(1,18 NN O
) -RRB- O
= SYM O
0.863 CD O
) -RRB- O
across IN O
the DT O
follicular JJ O
( -LRB- O
5018 CD O
kJ/24 NN O
h NN O
) -RRB- O
and CC O
the DT O
luteal NN O
( -LRB- O
5098 CD O
kJ/24 NN O
h NN O
) -RRB- O
phases NNS O
. . O

-DOCSTART- X X O

Oseltamivir NNP O
( -LRB- O
GS4104 NN O
) -RRB- O
, , O
which WDT O
can MD O
be VB O
administered VBN O
orally RB O
, , O
is VBZ O
the DT O
prodrug NN O
of IN O
GS4071 NNP O
, , O
a DT O
potent JJ O
and CC O
selective JJ O
inhibitor NN O
of IN O
influenzavirus NN B-NP
neuraminidases NNS I-NP
. . O

-DOCSTART- X X O

In IN O
gel NNP O
mobility NN O
shift NN O
assays VBZ O
, , O
we PRP O
found VBD O
no DT O
evidence NN O
for IN O
VDR-TR NNP B-NP
heterodimer NN O
interaction NN O
with IN O
any DT O
tested VBN O
element NN O
. . O

-DOCSTART- X X O

The DT O
relative JJ O
importance NN O
of IN O
these DT O
two CD O
mechanisms NNS O
differed VBD O
in IN O
a DT O
response NN O
element-specific JJ O
manner NN O
. . O

-DOCSTART- X X O

After IN O
14 CD O
d NN O
of IN O
overfeeding JJ O
, , O
hepatic JJ O
PL NNP O
profiles NNS O
were VBD O
identical JJ O
in IN O
the DT O
two CD O
breeds NNS O
and CC O
similar JJ O
to TO O
that DT O
in IN O
control NN O
livers NNS O
; : O
choline-containing JJ O
PL NNP O
accounted VBD O
for IN O
95 CD O
% NN O
of IN O
total JJ O
PL. NNP O

-DOCSTART- X X O

C-SP NN O
duration NN O
was VBD O
significantly RB O
reduced VBN O
in IN O
ALS NNS O
patients NNS O
compared VBD O
to TO O
controls NNS O
at IN O
low JJ O
stimulation NN O
intensity NN O
corresponding JJ O
to TO O
an DT O
MEP NNP O
threshold NN O
increased VBN O
by IN O
15 CD O
% NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
show VBP O
that IN O
the DT O
spv NN B-NP
virulence NN I-NP
genes NNS I-NP
belong VBP O
simultaneously RB O
to TO O
several JJ O
regulons NNS O
in IN O
the DT O
cell NN O
, , O
raising VBG O
the DT O
possibility NN O
that IN O
spv NN B-NP
expression NN O
can MD O
be VB O
fine-tuned JJ O
in IN O
response NN O
to TO O
multiple JJ O
environmental JJ O
inputs NNS O
. . O

-DOCSTART- X X O

Intensive NNP O
synthesis NN O
of IN O
PNA NNP B-NP
in IN O
the DT O
cells NNS O
of IN O
microvascular JJ O
wall NN O
evidenced VBN O
of IN O
their PRP$ O
high JJ O
functional JJ O
activity NN O
, , O
and CC O
the DT O
synthesis NN O
of IN O
DNA NNP O
in IN O
them PRP O
showed VBD O
their PRP$ O
ability NN O
for IN O
proliferation NN O
, , O
i.g.--for JJ O
growth NN O
. . O

-DOCSTART- X X O

Tracheal NNP O
transsection NN O
combined VBN O
with IN O
hilar JJ O
ligation NN O
( -LRB- O
TL&PL) NNP O
effected VBD O
a DT O
reduction NN O
of IN O
19.9 CD O
% NN O
( -LRB- O
n RB O
.s JJ O
. . O
) -RRB- O
. . O

-DOCSTART- X X O

Kinase-deficient JJ O
erbB NNS B-NP
proteins VBZ I-NP
reduced VBN O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
( -LRB- O
EGF)-induced JJ B-NP
tyrosine NN O
phosphorylation NN O
of IN O
endogenous JJ O
Shc JJ B-NP
proteins NNS I-NP
and CC O
also RB O
reduced VBD O
immediate JJ O
and CC O
sustained VBD O
EGF-induced JJ B-NP
ERK NNP I-NP
MAPK NNP I-NP
activities NNS O
in IN O
human JJ O
glioblastoma NN O
cells NNS O
, , O
although IN O
basal JJ O
ERK NNP B-NP
MAPK NNP I-NP
activities NNS O
were VBD O
unaffected JJ O
. . O

-DOCSTART- X X O

Using VBG O
immunolocalization NN O
, , O
we PRP O
observe VBP O
that IN O
ACE3 NNP B-NP
, , O
a DT O
440-bp JJ O
chorion NN O
element NN O
that WDT O
contains VBZ O
information NN O
sufficient JJ O
to TO O
drive VB O
amplification NN O
, , O
directs VBZ O
DmORC NNP B-NP
localization NN O
in IN O
follicle NN O
cells NNS O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
homozygous JJ O
co-deletions NNS O
of IN O
CDKN2A NNP B-NP
and CC O
CDKN2B NNP B-NP
rather RB O
than IN O
mutations NNS O
targeting VBG O
individual JJ O
transcripts NNS O
are VBP O
frequently RB O
selected VBN O
for IN O
in IN O
these DT O
tumors NNS O
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
show VBP O
that IN O
aortic JJ O
explants NNS O
isolated VBN O
from IN O
PPARalpha-null JJ B-NP
mice NNS O
display VBP O
an DT O
exacerbated JJ O
response NN O
to TO O
inflammatory JJ O
stimuli NNS O
, , O
such JJ O
as IN O
lipopolysaccharide NN O
( -LRB- O
LPS) NNP O
, , O
as IN O
demonstrated VBN O
by IN O
increased JJ O
IL-6 NN B-NP
secretion NN O
. . O

-DOCSTART- X X O

Albumin NNP O
expression NN O
is VBZ O
maintained VBN O
in IN O
the DT O
liver NN O
by IN O
a DT O
combination NN O
of IN O
liver-enriched JJ O
transcription NN O
factors NNS O
such JJ O
as IN O
CAAT NNP B-NP
enhancer-binding JJ I-NP
protein NN I-NP
( -LRB- I-NP
C/EBP)alpha NNP I-NP
and CC O
C/EBPbeta NNP B-NP
. . O

-DOCSTART- X X O

The DT O
requirement NN O
for IN O
proteolytic JJ O
activity NN O
of IN O
both DT O
FVIIa NNP B-NP
and CC O
FXa NNP B-NP
suggests VBZ O
that IN O
protease-activated JJ O
receptors NNS O
may MD O
be VB O
involved VBN O
. . O

-DOCSTART- X X O

Amyloid JJ B-NP
beta-protein NN I-NP
( -LRB- O
Abeta NNP B-NP
) -RRB- O
is VBZ O
the DT O
main JJ O
constituent NN O
of IN O
amyloid JJ O
fibrils NNS O
found VBD O
in IN O
senile JJ O
plaques NNS O
and CC O
cerebral NN O
vessels NNS O
in IN O
Alzheimer NNP O
's POS O
disease NN O
( -LRB- O
AD NN O
) -RRB- O
and CC O
is VBZ O
derived VBN O
by IN O
proteolysis NN O
from IN O
the DT O
beta-amyloid JJ B-NP
precursor NN I-NP
protein NN I-NP
( -LRB- O
APP NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
also RB O
show VBP O
that IN O
activation NN O
of IN O
protein NN B-NP
kinase NN I-NP
A DT I-NP
( -LRB- O
PKA NN B-NP
) -RRB- O
signaling VBG O
is VBZ O
sufficient JJ O
to TO O
down-regulate JJ O
caveolin-1 JJ B-NP
protein NN I-NP
expression NN O
and CC O
promoter NN O
activity NN O
. . O

-DOCSTART- X X O

The DT O
importin VBG B-NP
alpha.beta NN I-NP
heterodimer NN I-NP
mediates NNS O
nuclear JJ O
import NN O
of IN O
proteins NNS O
containing VBG O
classical JJ O
nuclear JJ O
localization NN O
signals NNS O
. . O

-DOCSTART- X X O

The DT O
expressed VBN O
G1-G2 NN B-NP
bound VBN O
to TO O
both DT O
hyaluronan NN O
and CC O
link NN B-NP
protein NN I-NP
indicating VBG O
that IN O
the DT O
immunoglobulin-fold JJ B-NP
motif NN I-NP
and CC O
proteoglycan NN O
tandem NN O
repeat NN O
loops NNS O
of IN O
the DT O
G1 NNP B-NP
domain NN I-NP
were VBD O
correctly RB O
folded VBN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
suggest VBP O
that IN O
the DT O
presence NN O
or CC O
absence NN O
per IN O
se NN O
of IN O
keratan NN O
sulfate NN O
on IN O
native JJ O
G1-G2 NNP O
does VBZ O
not RB O
affect VB O
the DT O
activity NN O
of IN O
atrolysin NN O
C NNP O
toward IN O
the DT O
two CD O
sites NNS O
. . O

-DOCSTART- X X O

Despite IN O
i PRP O
.v. VBD O
steroid JJ O
therapy NN O
, , O
[NOexh NNP O
] , O
remained VBD O
elevated JJ O
throughout IN O
recovery NN O
( -LRB- O
37.9+/-4.8 CD O
ppb NN O
, , O
p<0.001 NN O
) -RRB- O
until IN O
discharge NN O
( -LRB- O
40.9+/-4.3 CD O
ppb NN O
, , O
p<0.001 NN O
) -RRB- O
. . O

-DOCSTART- X X O

It PRP O
contains VBZ O
binding JJ O
sites NNS O
for IN O
several JJ O
transcription NN O
factors NNS O
, , O
for IN O
example NN O
: : O
( -LRB- O
i NN O
) -RRB- O
a DT O
well-characterized JJ O
binding NN O
site NN O
for IN O
rel/NF-kappaB JJ B-NP
transcription NN O
factors NNS O
in IN O
its PRP$ O
3'-end JJ O
( -LRB- O
the DT O
H2TF1 NNP B-NP
or CC O
kappaB1 JJ B-NP
element NN I-NP
) -RRB- O
, , O
( -LRB- O
ii NNS O
) -RRB- O
a DT O
second JJ O
kappaB NN B-NP
site NN I-NP
( -LRB- O
the DT O
kappaB2 NN B-NP
element NN I-NP
) -RRB- O
, , O
which WDT O
is VBZ O
located VBN O
immediately RB O
adjacent JJ O
5' NNS O
to TO O
the DT O
H2TF1 NNP B-NP
element NN I-NP
and CC O
which WDT O
is VBZ O
recognized VBN O
by IN O
p65/relA NN B-NP
in IN O
the DT O
human JJ B-NP
HLA NNP I-NP
system NN O
, , O
and CC O
( -LRB- O
iii NN O
) -RRB- O
an DT O
AP-1/ATF JJ B-NP
recognition NN O
sequence NN O
in IN O
the DT O
5' JJ O
end NN O
( -LRB- O
EnA-TRE NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
tumorigenic JJ O
E1A NNP B-NP
+ , O
cHa-ras JJ B-NP
cells NNS O
are VBP O
characterized VBN O
by IN O
high JJ O
and CC O
constitutive JJ O
DNA NNP O
binding NN O
activities NNS O
of IN O
AP-1 NNP B-NP
, , O
in IN O
contrast NN O
to TO O
nontransformed JJ O
cells NNS O
and CC O
the DT O
E1A NNP B-NP
cells NNS O
. . O

-DOCSTART- X X O

The DT O
yeast NN O
C-type NN B-NP
cyclin IN I-NP
Ume3p/Srb11p NNP B-NP
and CC O
its PRP$ O
cyclin-dependent JJ B-NP
kinase NN I-NP
( -LRB- O
Cdk NN B-NP
) -RRB- O
Ume5p . B-NP
are VBP O
required VBN O
for IN O
the DT O
full JJ O
repression NN O
of IN O
genes NNS O
involved VBN O
in IN O
the DT O
stress NN O
response NN O
or CC O
meiosis NN O
. . O

-DOCSTART- X X O

In IN O
particular JJ O
, , O
the DT O
S1' NNP B-NP
specificity NN I-NP
site NN I-NP
is VBZ O
a DT O
deep JJ O
and CC O
highly RB O
hydrophobic JJ O
cavity NN O
. . O

-DOCSTART- X X O

FZD4 PRP B-NP
is VBZ O
homologous JJ O
to TO O
FZD9 VB B-NP
and CC O
FZD10 VB B-NP
, , O
and CC O
overall JJ O
amino JJ O
acid NN O
identity NN O
is VBZ O
as IN O
follows VBZ O
: : O
FZD4 IN B-NP
vs JJ O
FZD9 NNP B-NP
, , O
51.6 CD O
% NN O
; : O
FZD4 NNP B-NP
vs IN O
FZD10 CD B-NP
, , O
51.2 CD O
% NN O
; : O
FZD9 CD B-NP
vs JJ O
FZD10 CD B-NP
, , O
65.7 CD O
% NN O
. . O

-DOCSTART- X X O

The DT O
NF-kappaB NNP B-NP
responsive JJ O
reporter NN O
construct VB O
, , O
( -LRB- B-NP
PRDII NNP I-NP
)( NNP I-NP
4)-CAT JJ I-NP
, , O
was VBD O
used VBN O
to TO O
explore VB O
transcription NN O
resulting VBG O
from IN O
NF-kappaB NN B-NP
activated VBN O
by IN O
Tat NNPS B-NP
. . O

-DOCSTART- X X O

The DT O
RNA NNP O
transcripts NNS O
structurally RB O
equivalent JJ O
to TO O
I( JJ B-NP
2 CD I-NP
) -RRB- I-NP
sgRNAs NN I-NP
of IN O
TMV NNP B-NP
U1 NNP I-NP
and CC O
crTMV NN O
, , O
but CC O
containing VBG O
a DT O
hairpin NN O
structure NN O
( -LRB- O
H) NNP O
immediately RB O
upstream RB O
of IN O
IRES(MP,75 NN B-NP
) -RRB- I-NP
( -LRB- I-NP
HIRES(MP) NN I-NP
, , I-NP
( -LRB- I-NP
75 CD I-NP
)( NN I-NP
CR)-MP-CP-3'UTR JJ I-NP
; : O
HIRES(MP,75 PRP$ B-NP
)( JJ I-NP
U1)-MP-CP-3'UTR JJ I-NP
) -RRB- O
, , O
were VBD O
able JJ O
to TO O
express VB O
the DT O
MP NNP B-NP
gene NN I-NP
in IN O
vitro NN O
. . O

-DOCSTART- X X O

EIAV NNP B-NP
LTR NNP I-NP
sequence NN I-NP
variability NN O
is VBZ O
confined VBN O
mostly RB O
to TO O
a DT O
small JJ O
portion NN O
of IN O
the DT O
enhancer NN O
within IN O
the DT O
U3 JJ O
segment NN O
of IN O
the DT O
LTR. NNP O

-DOCSTART- X X O

Phosphatidylinositol NNP B-NP
3-kinase JJ I-NP
requirement NN O
in IN O
activation NN O
of IN O
the DT O
ras/C-raf-1/MEK/ERK JJ B-NP
and CC O
p70(s6k JJ B-NP
) -RRB- O
signaling VBG O
cascade NN O
by IN O
the DT O
insulinomimetic JJ O
agent NN O
vanadyl NNP O
sulfate NN O
. . O

-DOCSTART- X X O

The DT O
core NN O
of IN O
this DT O
enhancer NN O
contains VBZ O
two CD O
evolutionarily RB O
conserved JJ O
binding NN O
sites NNS O
for IN O
the DT O
homeodomain JJ B-NP
protein NN I-NP
Tinman NNP B-NP
( -LRB- O
Tin NNP B-NP
) -RRB- O
, , O
expressed VBN O
in IN O
developing VBG O
cardiac JJ O
, , O
somatic JJ O
, , O
and CC O
visceral JJ O
muscle NN O
lineages NNS O
. . O

-DOCSTART- X X O

For IN O
example NN O
, , O
introduction NN O
of IN O
immunogenic JJ O
and CC O
purification NN O
tag NN O
sequences NNS O
into IN O
the DT O
C-terminal JJ O
coding NN O
region NN O
significantly RB O
decreased VBD O
bop JJ B-NP
gene NN I-NP
mRNA NN I-NP
and CC O
protein NN O
accumulation NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
striking JJ O
ability NN O
of IN O
polyoma NN B-NP
middle NN I-NP
T NNP I-NP
antigens VBZ I-NP
to TO O
promote VB O
retinoic JJ O
acid-induced JJ O
differentiation NN O
appears VBZ O
to TO O
utilize VB O
ERK NNP B-NP
, , O
but CC O
not RB O
JNK/SPK NNP B-NP
or CC O
p38 DT B-NP
signaling NN O
. . O

-DOCSTART- X X O

We PRP O
recommend VBP O
that IN O
paracervical JJ O
block NN O
with IN O
lignocaine NN O
should MD O
be VB O
used VBN O
in IN O
conjunction NN O
with IN O
i DT O
.v. NNP O
sedation/analgesia NN O
during IN O
egg NN O
collection NN O
performed VBN O
through IN O
the DT O
transvaginal JJ O
route NN O
under IN O
ultrasound JJ O
guidance NN O
( -LRB- O
TUGOR NN O
) -RRB- O
to TO O
reduce VB O
the DT O
pain NN O
of IN O
the DT O
procedure NN O
. . O

-DOCSTART- X X O

All DT O
loci NNS O
have VBP O
a DT O
similar JJ O
organization NN O
, , O
except IN O
for IN O
H1.8 CD B-NP
that IN O
harbors VBZ O
two CD O
TcP2beta JJ B-NP
genes NNS I-NP
arranged VBN O
in IN O
tandem NN O
and CC O
separated VBN O
by IN O
a DT O
short JJ O
repetitive JJ O
sequence NN O
, , O
named VBN O
SIRE NNP O
( -LRB- O
short JJ O
interspersed VBN O
repetitive JJ O
element NN O
) -RRB- O
, , O
which WDT O
is VBZ O
also RB O
found VBN O
upstream RB O
of IN O
the DT O
first JJ O
gene NN O
of IN O
the DT O
tandem NN O
and CC O
downstream NN O
of IN O
the DT O
second JJ O
. . O

-DOCSTART- X X O

A DT O
proportion NN O
of IN O
APC NNP B-NP
wild-type JJ O
colon NN O
carcinomas NNS O
and CC O
melanomas NNS O
also RB O
contains VBZ O
constitutive JJ O
nuclear JJ O
Tcf-4/beta-catenin NN B-NP
complexes NNS O
as IN O
a DT O
result NN O
of IN O
dominant JJ O
mutations NNS O
in IN O
the DT O
N NNP O
terminus NN O
of IN O
beta-catenin NN B-NP
that IN O
render NN O
it PRP O
insensitive JJ O
to TO O
downregulation RP O
by IN O
APC NNP B-NP
, , O
GSK3 DT B-NP
beta NN I-NP
, , O
and CC O
Axin/Conductin NNP B-NP
. . O

-DOCSTART- X X O

Similar JJ O
mechanisms NNS O
leading VBG O
to TO O
deregulation NN O
of IN O
Tcf JJ B-NP
target NN I-NP
gene NN I-NP
activity NN O
are VBP O
likely JJ O
to TO O
be VB O
involved VBN O
in IN O
melanoma NN O
and CC O
other JJ O
forms NNS O
of IN O
cancer NN O
. . O

-DOCSTART- X X O

This DT O
report NN O
describes VBZ O
a DT O
patient NN O
with IN O
a DT O
previous JJ O
inferior JJ O
acute JJ O
myocardial JJ O
infarction NN O
who WP O
developed VBD O
right JJ O
ventricular JJ O
infarction NN O
with IN O
significant JJ O
anterior JJ O
lead NN O
ST NNS O
segment NN O
elevation NN O
( -LRB- O
V1-V4 NN O
) -RRB- O
caused VBN O
by IN O
the DT O
loss NN O
of IN O
two CD O
large JJ O
right JJ O
ventricular NN O
branches NNS O
during IN O
a DT O
coronary JJ O
angioplasty NN O
of IN O
the DT O
right JJ O
coronary JJ O
artery NN O
. . O

-DOCSTART- X X O

PATIENTS NNS O
AND CC O
METHODS NNS O
: : O
Immediately RB O
before IN O
radical JJ O
prostatectomy NN O
, , O
bone NN O
marrow NN O
aspirates NNS O
from IN O
both DT O
sides NNS O
of IN O
the DT O
iliac JJ O
crest NN O
were VBD O
taken VBN O
from IN O
287 CD O
patients NNS O
. . O

-DOCSTART- X X O

With IN O
regard NN O
to TO O
nonhematologic NN O
toxicities NNS O
, , O
diarrhea NN O
, , O
infection NN O
and CC O
elevated VBD O
serum NN B-NP
alkaline NN I-NP
phosphatase NN I-NP
of IN O
grade NN O
3 CD O
or CC O
over RB O
were VBD O
observed VBN O
in IN O
2 CD O
% NN O
of IN O
cycles NNS O
, , O
but CC O
were VBD O
tolerable JJ O
and CC O
reversible JJ O
. . O

-DOCSTART- X X O

LHbeta NNP B-NP
is VBZ O
expressed VBN O
in IN O
pituitary JJ O
gonadotrope NN O
cells NNS O
and CC O
CGbeta NNP B-NP
is VBZ O
expressed VBN O
in IN O
placental JJ O
trophoblast NN O
cells NNS O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
HIV-1 PRP$ O
transcription NN O
. . O

-DOCSTART- X X O

Human NNP B-NP
LTBP-1 NNP I-NP
is VBZ O
known VBN O
to TO O
exist VB O
in IN O
different JJ O
forms NNS O
. . O

-DOCSTART- X X O

It PRP O
consists VBZ O
of IN O
2185 CD O
amino IN O
acid NN O
residues NNS O
encoded VBN O
by IN O
a DT O
9-kilobase JJ O
pair NN O
mRNA NNS O
; : O
several JJ O
splice NN O
variants NNS O
have VBP O
been VBN O
detected VBN O
in IN O
human JJ O
and CC O
rat NN O
cDNA NN O
libraries NNS O
. . O

-DOCSTART- X X O

Cyclic NNP B-NP
AMP-dependent JJ I-NP
protein NN I-NP
kinase NN I-NP
binding NN O
to TO O
A-kinase DT B-NP
anchoring VBG O
proteins NNS O
in IN O
living VBG O
cells NNS O
by IN O
fluorescence NN O
resonance NN O
energy NN O
transfer NN O
of IN O
green JJ B-NP
fluorescent JJ I-NP
protein NN I-NP
fusion NN O
proteins NNS O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
In IN O
addition NN O
to TO O
the DT O
superiority NN O
of IN O
octafluoropropane-filled JJ O
microspheres NNS O
to TO O
air-filled JJ O
microspheres NNS O
for IN O
LV NNP O
opacification NN O
, , O
the DT O
efficacy NN O
of IN O
OCTA NNP O
is VBZ O
relatively RB O
unaffected JJ O
by IN O
impaired JJ O
LV NNP O
function NN O
and CC O
is VBZ O
less RBR O
susceptible JJ O
to TO O
the DT O
effects NNS O
of IN O
poor JJ O
echogenicity NN O
than IN O
AIR NNP O
. . O

-DOCSTART- X X O

Factor NNP B-NP
XI NNP I-NP
deficiency NN O
is VBZ O
a DT O
rare JJ O
hereditary JJ O
bleeding NN O
disorder NN O
affecting VBG O
the DT O
intrinsic JJ O
pathway NN O
. . O

-DOCSTART- X X O

The DT O
Ishasha NNP O
samples NNS O
show VBP O
a DT O
range NN O
encompassing VBG O
three CD O
trophic JJ O
levels NNS O
. . O

-DOCSTART- X X O

The DT O
more RBR O
traditional JJ O
SERMS NNP O
, , O
clomiphene NN O
citrate NN O
and CC O
tamoxifen JJ O
, , O
will MD O
be VB O
reviewed VBN O
along IN O
with IN O
such JJ O
modern JJ O
drugs NNS O
as IN O
raloxifene NN O
and CC O
faslodex NN O
, , O
with IN O
emphasis NN O
upon IN O
their PRP$ O
actions NNS O
on IN O
breast NN O
, , O
uterus NN O
, , O
bone NN O
and CC O
lipids NNS O
. . O

-DOCSTART- X X O

Ti NNP O
exhibited VBD O
a DT O
feather-like JJ O
morphology NN O
. . O

-DOCSTART- X X O

This DT O
organization NN O
suggests VBZ O
that IN O
duplication NN O
events NNS O
that WDT O
have VBP O
generated VBN O
the DT O
primate JJ O
FUT3-FUT5-FUT6 NNP B-NP
cluster NN O
might MD O
have VB O
occurred VBN O
through IN O
a DT O
long-interspersed-nuclear-element-based JJ O
mechanism NN O
of IN O
unequal JJ O
crossing NN O
over RB O
, , O
as IN O
described VBN O
for IN O
the DT O
globin NN B-NP
cluster NN I-NP
. . O

-DOCSTART- X X O

S. NNP O
, , O
Kim NNP O
, , O
S. NNP O

-DOCSTART- X X O

The DT O
cop NN B-NP
region NN I-NP
also RB O
harbors VBZ O
a DT O
region NN O
of IN O
plasmid NN O
incompatibility NN O
, , O
inc NN B-NP
, , O
encompassing VBG O
a DT O
stem-loop JJ O
structure NN O
, , O
the DT O
repA NN B-NP
promoter NN I-NP
, , O
Prep NNP B-NP
, , O
as RB O
well RB O
as IN O
two CD O
distinct JJ O
RepA NNP B-NP
binding NN I-NP
sites NNS I-NP
, , O
BD-1 JJ O
and CC O
BD-2 JJ O
. . O

-DOCSTART- X X O

WA VBD O
constructs NNS O
afforded VBN O
relaxed VBD O
and CC O
positive JJ O
topoisomers NNS O
, , O
and CC O
cyclization NN O
kinetics NNS O
indicated VBD O
slow JJ O
interconversion NN O
of IN O
precursors NNS O
to TO O
the DT O
two CD O
topoisomers NNS O
. . O

-DOCSTART- X X O

The DT O
RFX NNP B-NP
protein NN I-NP
family NN I-NP
includes VBZ O
members NNS O
from IN O
yeast NN O
to TO O
humans NNS O
, , O
which WDT O
function VBP O
in IN O
various JJ O
biological JJ O
systems NNS O
, , O
and CC O
share NN O
a DT O
DNA-binding JJ O
domain NN O
and CC O
a DT O
conserved JJ O
C-terminal JJ O
region NN O
. . O

-DOCSTART- X X O

Binding NNP O
to TO O
sulphatides NNS O
and CC O
the DT O
alpha-dystroglycan NN B-NP
receptor NN I-NP
was VBD O
much RB O
stronger JJR O
and CC O
required VBN O
at IN O
least JJS O
two CD O
LG NNP B-NP
modules NNS I-NP
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
propose VBP O
that IN O
an DT O
antagonistic JJ O
, , O
BMP/ALK2/Smad-mediated JJ B-NP
signaling NN O
pathway NN O
is VBZ O
active JJ O
on IN O
the DT O
right JJ O
side NN O
of IN O
the DT O
Xenopus NNP O
embryo NN O
. . O

-DOCSTART- X X O

These DT O
kinases NNS O
belong VBP O
to TO O
a DT O
new JJ O
subfamily NN O
related VBN O
to TO O
the DT O
Trk NNP B-NP
subfamily NN I-NP
. . O

-DOCSTART- X X O

The DT O
data NNS O
indicate VBP O
that IN O
etr-1 NN B-NP
is VBZ O
essential JJ O
for IN O
muscle NN O
development NN O
in IN O
C. NNP O
elegans NNS O
, , O
perhaps RB O
by IN O
playing VBG O
a DT O
role NN O
in IN O
post-transcriptional JJ O
processing NN O
of IN O
some DT O
muscle NN O
component NN O
, , O
and CC O
thus RB O
suggesting VBG O
a DT O
possible JJ O
conservation NN O
of IN O
gene NN O
function NN O
with IN O
human JJ B-NP
CUG-bp NN I-NP
. . O

-DOCSTART- X X O

Gentamicin NNP O
given VBN O
by IN O
DPI NNP O
and CC O
SVN NNP O
significantly RB O
decreased VBD O
the DT O
sputum NN O
Psa NN O
density NN O
( -LRB- O
p NN O
< JJ O
0.05 CD O
) -RRB- O
, , O
by IN O
almost RB O
one CD O
order NN O
of IN O
magnitude NN O
. . O

-DOCSTART- X X O

An DT O
analysis NN O
of IN O
sequence NN O
of IN O
the DT O
mutant JJ B-NP
recN NN I-NP
gene NN I-NP
revealed VBD O
a DT O
G:C NNP O
to TO O
T:A NNP O
transversion NN O
near IN O
the DT O
3' JJ O
end NN O
of IN O
the DT O
coding NN O
region NN O
. . O

-DOCSTART- X X O

Nevertheless RB O
, , O
in IN O
view NN O
of IN O
the DT O
potential JJ O
transmission NN O
rates NNS O
of IN O
HGV NNP O
and CC O
the DT O
lack NN O
of IN O
effective JJ O
immunization NN O
, , O
HGV NNP O
should MD O
be VB O
regarded VBN O
as IN O
a DT O
potential JJ O
occupational JJ O
hazard NN O
for IN O
medical JJ O
and CC O
dental JJ O
staff NN O
. . O

-DOCSTART- X X O

Detection NNP O
of IN O
poisoning VBG O
by IN O
Impila NNP O
( -LRB- O
Callilepis NN O
laureola NN O
) -RRB- O
in IN O
a DT O
mother NN O
and CC O
child NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
previously RB O
identified VBN O
mouse NN B-NP
and CC I-NP
human JJ I-NP
cDNAs NNS I-NP
encoding VBG I-NP
UNC-51-like JJ I-NP
kinase NN I-NP
( -LRB- O
ULK1 NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

ULKs NNP B-NP
and CC O
UNC-51 JJ B-NP
share NN O
a DT O
typical JJ O
domain NN O
structure NN O
of IN O
an DT O
amino-terminal JJ O
kinase NN O
domain NN O
, , O
a DT O
central JJ O
proline/serine NN O
rich JJ O
( -LRB- O
PS) NNP O
domain NN O
, , O
and CC O
a DT O
carboxy-terminal JJ O
( -LRB- O
C NNP O
) -RRB- O
domain NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
ULK2 NNP B-NP
is VBZ O
involved VBN O
in IN O
a DT O
previously RB O
uncharacterized JJ O
signaling NN O
pathway NN O
in IN O
mammalian JJ O
cells NNS O
. . O

-DOCSTART- X X O

Connector NNP B-NP
enhancer NN I-NP
of IN I-NP
KSR NNP I-NP
( -LRB- O
CNK) NNP B-NP
is VBZ O
a DT O
multidomain JJ O
protein NN O
required VBN O
for IN O
RAS NNP B-NP
signaling NN O
. . O

-DOCSTART- X X O

In IN O
simpler JJR O
organisms NNS O
, , O
the DT O
ATP NNP B-NP
sulfurylase NN I-NP
and CC O
APS NNP B-NP
kinase NN I-NP
reactions NNS O
are VBP O
catalyzed VBN O
by IN O
separate JJ O
enzymes NNS O
encoded VBN O
by IN O
two CD O
or CC O
three CD O
genes NNS O
, , O
suggesting VBG O
that IN O
a DT O
fusion NN O
of IN O
separate JJ O
genes NNS O
during IN O
the DT O
course NN O
of IN O
evolution NN O
generated VBD O
the DT O
bifunctional JJ O
enzyme NN O
. . O

-DOCSTART- X X O

Epstein-Barr NNP B-NP
virus NN I-NP
( -LRB- I-NP
EBV NN I-NP
) -RRB- I-NP
latent JJ I-NP
membrane NN I-NP
protein NN I-NP
1 CD I-NP
( -LRB- O
LMP1 NN B-NP
) -RRB- O
is VBZ O
essential JJ O
for IN O
EBV-mediated JJ O
transformation NN O
of IN O
primary JJ O
B NNP O
lymphocytes NNS O
. . O

-DOCSTART- X X O

The DT O
amino-terminal JJ O
half NN O
of IN O
1a CD B-NP
is VBZ O
a DT O
distant JJ O
homolog NN B-NP
of IN I-NP
alphavirus NN I-NP
nonstructural JJ I-NP
protein NN I-NP
nsP1 NN I-NP
, , O
which WDT O
has VBZ O
been VBN O
implicated VBN O
in IN O
capping VBG O
viral JJ O
RNAs NNS O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
a DT O
recombinant JJ O
Ad NN O
expressing VBG O
Ad5 DT B-NP
E4orf6/7 JJ I-NP
induced JJ O
apoptosis NN O
in IN O
rat NN O
cells NNS O
when WRB O
coinfected VBN O
with IN O
wild-type JJ O
p53-expressing JJ B-NP
Ad NN O
. . O

-DOCSTART- X X O

In IN O
HCMV( NNP O
Towne)-infected NNP O
HF NNP O
cells NNS O
at IN O
24 CD O
to TO O
48 CD O
h NN O
, , O
IE2 CC B-NP
also RB O
accumulated VBN O
in IN O
newly RB O
formed VBN O
viral JJ O
DNA NNP O
replication NN O
compartments NNS O
containing VBG O
the DT O
polymerase NN B-NP
processivity NN I-NP
factor NN I-NP
( -LRB- O
UL44 IN B-NP
) -RRB- O
, , O
the DT O
single-stranded JJ B-NP
DNA NN I-NP
binding JJ I-NP
protein NN I-NP
( -LRB- O
SSB NNP B-NP
; : O
UL57 DT B-NP
) -RRB- O
, , O
the DT O
UL112-113 JJ B-NP
accessory JJ I-NP
protein NN I-NP
, , O
and CC O
newly RB O
incorporated JJ O
bromodeoxyuridine NN O
( -LRB- O
BrdU) NNP O
. . O

-DOCSTART- X X O

Macroscopic NNP O
researches VBZ O
on IN O
heart NN O
vascularization NN O
have VBP O
indicated VBN O
that IN O
the DT O
angioarchitecture NN O
of IN O
the DT O
conducting VBG O
system NN O
differs NNS O
from IN O
that DT O
of IN O
the DT O
normal JJ O
myocardium NN O
. . O

-DOCSTART- X X O

CONCLUSION( NNP O
S) NNP O
: : O
Measuring NN O
urinary JJ O
LH NNP B-NP
levels NNS O
is VBZ O
an DT O
excellent JJ O
method NN O
for IN O
determining VBG O
ovulation NN O
. . O

-DOCSTART- X X O

However RB O
, , O
reoperation NN O
for IN O
bulky JJ O
cervical JJ O
disease NN O
( -LRB- O
group NN O
3 CD O
) -RRB- O
rarely RB O
results VBZ O
in IN O
normal JJ O
calcitonin NN B-NP
levels NNS O
and CC O
is VBZ O
associated VBN O
with IN O
a DT O
high JJ O
incidence NN O
of IN O
permanent JJ O
hypoparathyroidism NN O
. . O

-DOCSTART- X X O

We PRP O
present VBP O
a DT O
case NN O
of IN O
carcinoma NN O
of IN O
the DT O
breast NN O
presenting VBG O
concurrently RB O
with IN O
SSc NNP O
that IN O
subsequently RB O
progressed VBD O
to TO O
dialysis-dependent NN O
renal JJ O
failure NN O
in IN O
just RB O
1 CD O
month NN O
. . O

-DOCSTART- X X O

The DT O
GPI NNP O
anchor NN O
moiety NN O
is VBZ O
either DT O
absent JJ O
or CC O
present JJ O
at IN O
a DT O
very RB O
low JJ O
level NN O
in IN O
the DT O
polypeptide NN O
expressed VBD O
from IN O
the DT O
cDNA NN O
that WDT O
contained VBD O
both DT O
the DT O
signal NN O
peptide NN O
and CC O
GPI NNP O
signal NN O
sequences NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
cloned VBN O
a DT O
novel NN O
100-kDa NNP O
mammalian JJ O
protein NN O
, , O
which WDT O
was VBD O
recognized VBN O
by IN O
an DT O
anti-peptide JJ O
antibody NN O
against IN O
an DT O
epitope-containing NN O
nuclear JJ O
localization NN O
signal NN O
of IN O
NF-kappaB NNP B-NP
p65 VBD B-NP
subunit NN I-NP
. . O

-DOCSTART- X X O

Insulin-regulated JJ B-NP
events NNS O
, , O
however RB O
, , O
occur VBP O
in IN O
all DT O
cells NNS O
. . O

-DOCSTART- X X O

Regulatory NNP O
regions NNS O
in IN O
the DT O
promoter NN O
and CC O
third JJ O
intron NN O
of IN O
the DT O
growth NN B-NP
hormone NN I-NP
gene NN I-NP
in IN I-NP
rainbow NN I-NP
trout NN I-NP
, , O
Oncorhynchus RB O
mykiss JJ O
walbaum NN O
. . O

-DOCSTART- X X O

They PRP O
self-completed VBD O
the DT O
SF-36 NNP O
questionnaire NN O
and CC O
their PRP$ O
QoL NNP O
was VBD O
described VBN O
and CC O
retrospectively RB O
compared VBN O
to TO O
that DT O
of IN O
historical JJ O
controls NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
media NNS O
containing VBG O
F NNP B-NP
beta JJ I-NP
alpha/CG NN I-NP
beta NN B-NP
displayed VBD O
high-affinity JJ O
binding NN O
to TO O
both DT O
CG NNP B-NP
and CC I-NP
FSH NNP I-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
describe VBP O
a DT O
tyrosine-phosphorylated JJ O
nuclear JJ O
protein NN O
, , O
YT521-B NNP B-NP
, , O
and CC O
show VB O
that IN O
it PRP O
interacts VBZ O
with IN O
the DT O
nuclear JJ B-NP
transcriptosomal JJ I-NP
component NN I-NP
scaffold VBD I-NP
attachment NN I-NP
factor NN I-NP
B NNP I-NP
, , O
and CC O
the DT O
68-kDa JJ B-NP
Src NNP I-NP
substrate NN O
associated VBN O
during IN O
mitosis NN O
, , O
Sam68 NNS B-NP
. . O

-DOCSTART- X X O

These DT O
mutants NNS O
all DT O
failed VBD O
to TO O
interact VB O
with IN O
the DT O
TraR NNP B-NP
fusion NN I-NP
in IN O
the DT O
two-hybrid JJ O
system NN O
. . O

-DOCSTART- X X O

With IN O
constructs NNS O
containing VBG O
the DT O
binding JJ O
site NN O
of IN O
one CD O
gene NN O
fused VBN O
to TO O
the DT O
promoter NN O
of IN O
the DT O
other JJ O
, , O
we PRP O
demonstrated VBD O
that IN O
the DT O
positional JJ O
requirements NNS O
are VBP O
a DT O
function NN O
of IN O
the DT O
specific JJ O
binding NN O
site NN O
, , O
not RB O
the DT O
promoter NN O
. . O

-DOCSTART- X X O

The DT O
MXR NNP B-NP
gene NN I-NP
encodes VBZ O
a DT O
half-transporter NN O
and CC O
the DT O
absence NN O
of IN O
cytogenetic JJ O
evidence NN O
of IN O
coamplification NN O
of IN O
other JJ O
regions NNS O
suggests VBZ O
that IN O
a DT O
partner NN O
may MD O
not RB O
be VB O
overexpressed VBN O
, , O
and CC O
instead RB O
the DT O
MXR NNP B-NP
half-transporter NN I-NP
homodimerizes VBZ O
to TO O
mediate VB O
drug NN O
transport NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
smoking NN O
was VBD O
not RB O
examined VBN O
in IN O
this DT O
study NN O
, , O
as IN O
such JJ O
data NNS O
were VBD O
not RB O
available JJ O
. . O

-DOCSTART- X X O

Additional JJ O
studies NNS O
revealed VBD O
that IN O
bovine JJ B-NP
brain NN I-NP
Galpha( NNP I-NP
q/11 CD I-NP
) -RRB- I-NP
could MD O
also RB O
bind VBP O
to TO O
an DT O
N-terminal JJ O
construct VB O
of IN O
GRK2 NNP B-NP
, , O
while IN O
no DT O
binding NN O
of IN O
Galpha( JJ B-NP
q/11 NN I-NP
) -RRB- I-NP
, , O
Galpha( NNP B-NP
s VBZ I-NP
) -RRB- I-NP
, , O
Galpha( NNP B-NP
i) NN I-NP
, , O
or CC O
Galpha( JJ B-NP
12/13 CD I-NP
) -RRB- I-NP
to TO O
comparable JJ O
constructs NNS O
of IN O
GRK5 CD B-NP
or CC O
GRK6 NNP B-NP
was VBD O
observed VBN O
. . O

-DOCSTART- X X O

The DT O
elm1 JJ B-NP
kinase NN I-NP
functions NNS O
in IN O
a DT O
mitotic JJ O
signaling NN O
network NN O
in IN O
budding VBG O
yeast NN O
. . O

-DOCSTART- X X O

We PRP O
determined VBD O
whether IN O
a DT O
single JJ O
injection NN O
of IN O
slow-release NN O
estradiol-17beta NN O
( -LRB- O
SRE2 NN O
) -RRB- O
would MD O
induce VB O
pseudopregnancy NN O
in IN O
gilts NNS O
and CC O
whether IN O
PGF2alpha NNP O
would MD O
regress VB O
the DT O
corpora JJ O
lutea NN O
( -LRB- O
CL NN O
) -RRB- O
of IN O
pseudopregnancy NN O
. . O

-DOCSTART- X X O

Activation NN O
of IN O
T NNP O
cells NNS O
via IN O
the DT O
TCR NNP B-NP
and CC O
other JJ O
costimulatory NN O
receptors NNS O
triggers VBZ O
a DT O
number NN O
of IN O
signaling VBG O
cascades NNS O
. . O

-DOCSTART- X X O

A DT O
phylogenetic JJ O
analysis NN O
with IN O
the DT O
TK NNP B-NP
domains VBZ I-NP
from IN O
these DT O
sequences NNS O
and CC O
a DT O
fourth JJ O
, , O
from IN O
a DT O
novel NN O
scavenger NN B-NP
RTK NNP I-NP
( -LRB- O
all DT O
domains NNS O
comprise VBP O
the DT O
signature NN O
for IN O
the DT O
TK NNP B-NP
class NN I-NP
II NNP I-NP
receptors NNS I-NP
) -RRB- O
, , O
showed VBD O
that IN O
they PRP O
are VBP O
distantly RB O
related VBN O
to TO O
the DT O
insulin NN B-NP
and CC O
insulin-like JJ B-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

Several JJ O
7SL JJ B-NP
RNA-encoding JJ I-NP
sequences NNS I-NP
and CC O
various JJ O
intergenic JJ O
spacers NNS O
were VBD O
amplified VBN O
from IN O
the DT O
individual JJ O
HindIII NNP B-NP
fragments NNS I-NP
of IN O
about IN O
1.3 CD O
and CC O
2.8 CD O
kb NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
a DT O
binding JJ O
partner NN O
for IN O
the DT O
Fanconi NNP B-NP
anemia NN I-NP
group NN I-NP
C NNP I-NP
protein NN I-NP
( -LRB- O
FANCC NNP B-NP
) -RRB- O
by IN O
yeast NN O
two-hybrid JJ O
screening NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
both DT O
transcription NN O
activators NNS O
depend VBP O
on IN O
or CC O
interact NN O
with IN O
different JJ O
subunits NNS O
of IN O
RNA NNP B-NP
polymerase NN I-NP
, , O
although IN O
their PRP$ O
role NN O
in IN O
formation NN O
of IN O
proper JJ O
DNA NN O
geometry NN O
may MD O
also RB O
be VB O
crucial JJ O
. . O

-DOCSTART- X X O

Klebsiella NNP O
oxytoca NNP O
can MD O
assimilate VB O
nitrate JJ O
and CC O
nitrite JJ O
by IN O
using VBG O
enzymes NNS O
encoded VBN O
by IN O
the DT O
nasFEDCBA JJ B-NP
operon NN I-NP
. . O

-DOCSTART- X X O

By IN O
negatively RB O
regulating JJ O
GRK-mediated JJ B-NP
receptor NN O
phosphorylation NN O
, , O
beta-arrestin-mediated JJ B-NP
processes NNS O
such JJ O
as IN O
Src NNP B-NP
recruitment NN O
and CC O
clathrin-mediated JJ B-NP
internalization NN O
, , O
which WDT O
are VBP O
required VBN O
for IN O
GPCR-mediated NNP B-NP
ERK NNP B-NP
activation NN O
, , O
are VBP O
inhibited VBN O
, , O
thus RB O
dampening VBG O
further JJ O
ERK NN B-NP
activation NN O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
subcellular JJ O
fractionation NN O
, , O
the DT O
47-kDa JJ B-NP
P-CIP2 JJ I-NP
protein NN I-NP
is VBZ O
mostly RB O
cytosolic JJ O
. . O

-DOCSTART- X X O

Supershift NNP O
EMSAs NNP O
identified VBD O
that IN O
upstream RB B-NP
stimulatory JJ I-NP
factor-1 NN I-NP
and CC I-NP
-2 NN I-NP
( -LRB- O
USF-1 JJ B-NP
and CC I-NP
-2 RB I-NP
) -RRB- O
were VBD O
part NN O
of IN O
these DT O
complexes NNS O
. . O

-DOCSTART- X X O

These DT O
include VBP O
the DT O
CACCC NNP O
and CC O
CAAT NNP O
motifs NNS O
. . O

-DOCSTART- X X O

Skin NNP O
pH NN O
changes NNS O
associated VBN O
with IN O
iontophoresis NN O
. . O

-DOCSTART- X X O

Phosphorylation NNP O
of IN O
myosin-binding JJ B-NP
subunit NN I-NP
( -LRB- O
MBS NNP B-NP
) -RRB- O
of IN O
myosin NN B-NP
phosphatase NN I-NP
by IN O
Rho-kinase NNP B-NP
in IN O
vivo RB O
. . O

-DOCSTART- X X O

Immunohistochemical NNP O
staining NN O
was VBD O
positive JJ O
for IN O
S-100 NN B-NP
in IN O
all DT O
9 CD O
cases NNS O
stained VBD O
, , O
positive JJ O
for IN O
HMB-45 NNP B-NP
in IN O
9 CD O
(90 CD O
% NN O
) -RRB- O
of IN O
10 CD O
, , O
and CC O
negative JJ O
for IN O
cytokeratin NN B-NP
in IN O
all DT O
9 CD O
cases NNS O
in IN O
which WDT O
myxoid JJ O
melanoma NN O
remained VBD O
in IN O
the DT O
block NN O
after IN O
previous JJ O
sections NNS O
. . O

-DOCSTART- X X O

Residual NN O
urinary JJ O
abnormalities NNS O
were VBD O
significantly RB O
more RBR O
frequent JJ O
in IN O
patients NNS O
with IN O
type NN O
III NNP O
than IN O
type NN O
I PRP O
MPGN. . O

-DOCSTART- X X O

We PRP O
describe VBP O
here RB O
a DT O
Drosophila NNP B-NP
melanogaster NN I-NP
FAK NNP I-NP
homologue NN I-NP
, , O
DFak56 NNP B-NP
, , O
which WDT O
maps NNS O
to TO O
band VB O
56D CD O
on IN O
the DT O
right JJ O
arm NN O
of IN O
the DT O
second JJ O
chromosome NN O
. . O

-DOCSTART- X X O

Because IN O
the DT O
Pit-1 NNP B-NP
sites NNS I-NP
in IN O
the DT O
hGH-N JJ B-NP
gene NN I-NP
promoter NN I-NP
are VBP O
insufficient JJ O
for IN O
such JJ O
gene NN O
activation NN O
in IN O
vivo NN O
, , O
these DT O
data NNS O
suggested VBD O
a DT O
unique JJ O
chromatin-mediated JJ O
developmental JJ O
role NN O
for IN O
Pit-1 NNP B-NP
in IN O
the DT O
hGH NN B-NP
LCR. . I-NP

-DOCSTART- X X O

Recombinant NNP B-NP
prenylcysteine NN I-NP
lyase NN I-NP
was VBD O
produced VBN O
in IN O
a DT O
baculovirus-Sf9 JJ O
expression NN O
system NN O
. . O

-DOCSTART- X X O

In IN O
gel NNP O
mobility NN O
shift NN O
assays VBZ O
, , O
low JJ O
binding JJ O
activity NN O
of IN O
CBF NNP B-NP
to TO O
the DT O
wild-type JJ B-NP
AtpC NNP I-NP
promoter NN I-NP
sequence NN I-NP
was VBD O
observed VBN O
with IN O
nuclear JJ O
extracts NNS O
from IN O
tissue NN O
with IN O
low JJ O
AtpC NNP B-NP
expression NN O
levels NNS O
, , O
i IN O
.e NN O
. . O
extracts NNS O
from IN O
etiolated JJ O
and CC O
photobleached JJ O
seedlings NNS O
, , O
whereas IN O
high JJ O
binding NN O
activity NN O
was VBD O
detectable JJ O
with IN O
extracts NNS O
from IN O
tissues NNS O
with IN O
high JJ O
AtpC JJ B-NP
expression NN O
levels NNS O
, , O
i IN O
.e NN O
. . O
extracts NNS O
from IN O
light-grown JJ O
seedlings NNS O
and CC O
etiolated VBD O
seedlings NNS O
treated VBN O
with IN O
cytokinin NN B-NP
. . O

-DOCSTART- X X O

For IN O
this DT O
purpose NN O
, , O
we PRP O
used VBD O
a DT O
series NN O
of IN O
plasmid JJ O
constructs NNS O
encoding VBG O
different JJ O
forms NNS O
of IN O
the DT O
envelope NN B-NP
glycoprotein NN I-NP
E NNP I-NP
of IN I-NP
the DT I-NP
flavivirus NN I-NP
tick-borne JJ I-NP
encephalitis NN I-NP
virus NN I-NP
. . O

-DOCSTART- X X O

We PRP O
report VBP O
here RB O
that IN O
out IN O
of IN O
the DT O
major JJ O
pro-inflammatory JJ O
cytokines NNS O
examined VBN O
, , O
IL-1alpha NNP B-NP
, , O
IL-1beta NNP B-NP
, , O
TNF-alpha NNP B-NP
and CC O
IL-6 NNP B-NP
, , O
only RB O
IL-6 NNP B-NP
was VBD O
generated VBN O
and CC O
secreted VBN O
in IN O
PKCeta NNP B-NP
-expressing , O
cells NNS O
without IN O
any DT O
additional JJ O
inducer NN O
in IN O
serum-supplemented JJ O
cultures NNS O
( -LRB- O
10 CD O
% NN O
FCS) NNP O
. . O

-DOCSTART- X X O

By IN O
an DT O
induced-fit NN O
mechanism NN O
, , O
contacts NNS O
with IN O
the DT O
anticodon NN O
can MD O
activate VB O
formation NN O
of IN O
a DT O
robust JJ O
transition NN O
state NN O
at IN O
a DT O
site NN O
over IN O
70 CD O
A DT O
away RB O
. . O

-DOCSTART- X X O

These DT O
REPs NNS O
, , O
or CC O
clusters NNS O
of IN O
paralogous JJ O
loci NNS O
, , O
are VBP O
15-100 CD O
kb NN O
and CC O
harbor NN O
at IN O
least JJS O
four CD O
ESTs NNP O
and CC O
an DT O
expressed VBN O
SH3GL NNP B-NP
pseudogene NN I-NP
. . O

-DOCSTART- X X O

This DT O
revealed VBD O
a DT O
minimum NN O
of IN O
six CD O
novel JJ O
OSBP-related NNP B-NP
proteins NNS I-NP
, , O
designated VBN O
ORP-1 NN B-NP
to TO O
ORP-6 CD B-NP
. . O

-DOCSTART- X X O

However RB O
, , O
mechanisms NNS O
underlying VBG O
HIV-1 PRP$ O
gene NN O
expression NN O
in IN O
the DT O
CNS NNP O
are VBP O
poorly RB O
understood VBN O
. . O

-DOCSTART- X X O

A DT O
key JJ O
event NN O
in IN O
this DT O
process NN O
is VBZ O
the DT O
selective JJ O
recognition NN O
of IN O
the DT O
target NN O
membrane NN O
by IN O
the DT O
vesicle NN O
and CC O
the DT O
current JJ O
view NN O
is VBZ O
that IN O
SNARE NNP B-NP
protein NN I-NP
interactions NNS O
likely JJ O
play NN O
a DT O
central JJ O
role NN O
in IN O
vesicle-target NN O
recognition NN O
and CC O
or CC O
membrane NN O
fusion NN O
. . O

-DOCSTART- X X O

Scapulae NNP O
with IN O
a DT O
Type NN O
I PRP O
configuration MD O
were VBD O
found VBN O
to TO O
have VB O
low JJ O
values NNS O
for IN O
the DT O
coraco-glenoid JJ O
angle NN O
and CC O
coracoid JJ O
overlap NN O
, , O
which WDT O
are VBP O
known VBN O
to TO O
be VB O
associated VBN O
with IN O
a DT O
short JJ O
coraco-humeral JJ O
distance NN O
. . O

-DOCSTART- X X O

In IN O
conclusion NN O
: : O
( -LRB- O
i FW O
) -RRB- O
TECRA NNP O
kit NN O
is VBZ O
suggested VBN O
to TO O
be VB O
used VBN O
for IN O
screening VBG O
SE NNP O
producing VBG O
strains NNS O
; : O
( -LRB- O
ii NNS O
) -RRB- O
SET-RPLA NNP O
and CC O
RIDASCREEN NNP O
kits NNS O
are VBP O
suitable JJ O
for IN O
epidemiological JJ O
investigation NN O
of IN O
SE NNP O
types NNS O
, , O
but CC O
the DT O
lack NN O
of IN O
ability NN O
for IN O
detecting VBG O
SEE NNP O
, , O
long JJ O
time NN O
required VBN O
for IN O
testing NN O
with IN O
SET-RPLA NNP O
kit NN O
and CC O
high JJ O
background NN O
when WRB O
using VBG O
RIDASCREEN NNP O
kit NN O
must MD O
be VB O
overcome VBN O
; : O
and CC O
( -LRB- O
iii NN O
) -RRB- O
because IN O
of IN O
the DT O
complicated JJ O
test NN O
procedures NNS O
and CC O
the DT O
lack NN O
of IN O
ability NN O
for IN O
detecting VBG O
SEE NN O
, , O
the DT O
practicality NN O
of IN O
SET-EIA NNP O
kit NN O
in IN O
screening NN O
and CC O
epidemiological JJ O
research NN O
purposes NNS O
is VBZ O
low JJ O
. . O

-DOCSTART- X X O

Comparison NNP O
of IN O
immunoassay JJ O
kits NNS O
for IN O
detection NN O
of IN O
staphylococcal JJ B-NP
enterotoxins NNS I-NP
produced VBN O
by IN O
Staphylococcus NNP O
aureus NN O

-DOCSTART- X X O

Despite IN O
the DT O
high JJ O
frequency NN O
of IN O
natural JJ O
infection NN O
, , O
the DT O
seropositive JJ O
rates NNS O
of IN O
JEV NNP O
antibody NN O
still RB O
correlated VBD O
well RB O
with IN O
the DT O
dose NN O
of IN O
vaccine NN O
received VBD O
, , O
i IN O
.e NN O
. . O
, , O
67 CD O
% NN O
( -LRB- O
1122/1664 CD O
) -RRB- O
, , O
66 CD O
% NN O
( -LRB- O
65/97 CD O
) -RRB- O
, , O
33 CD O
% NN O
( -LRB- O
4/12 CD O
) -RRB- O
and CC O
40 CD O
% NN O
( -LRB- O
19/47 CD O
) -RRB- O
for IN O
children NNS O
receiving VBG O
3 CD O
, , O
2 CD O
, , O
1 CD O
, , O
and CC O
0 CD O
dose NN O
of IN O
JE NNP O
vaccines NNS O
, , O
respectively RB O
( -LRB- O
P NNP O
< NNP O
0.0001 CD O
Chi-square NNP O
for IN O
trend NN O
test NN O
) -RRB- O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
in IN O
vivo JJ O
and CC O
in IN O
vitro NN O
protein-protein NN O
interaction NN O
experiments NNS O
have VBP O
shown VBN O
that IN O
SR33 JJ B-NP
protein NN I-NP
interacts VBZ O
with IN O
itself PRP O
and CC O
with IN O
SR45 NNP B-NP
protein NN I-NP
but CC O
not RB O
with IN O
two CD O
other JJ O
members NNS O
( -LRB- O
SRZ21 NNP B-NP
and CC O
SRZ22 NNP B-NP
) -RRB- O
of IN O
the DT O
SR NNP B-NP
family NN I-NP
that WDT O
are VBP O
known VBN O
to TO O
interact VB O
with IN O
the DT O
Arabidopsis NNP O
full-length , O
U-70K NNP B-NP
only RB O
. . O

-DOCSTART- X X O

Tih1 NNP B-NP
maps NNS O
to TO O
distal JJ O
mouse NN O
Chr NNP O
1 CD O
and CC O
human JJ O
Chr NNP O
1q31 CD O
, , O
chromosomal NN O
regions NNS O
that WDT O
have VBP O
not RB O
shown VBN O
evidence NN O
for IN O
imprinting VBG O
and CC O
, , O
in IN O
contrast NN O
to TO O
Ipl NNP B-NP
, , O
Tih1 NNP B-NP
is VBZ O
expressed VBN O
equally RB O
from IN O
both DT O
parental JJ O
alleles NNS O
. . O

-DOCSTART- X X O

A DT O
novel NN O
pleckstrin VBG B-NP
homology-related JJ I-NP
gene NN I-NP
family NN I-NP
defined VBN O
by IN O
Ipl/Tssc3 NNP B-NP
, , O
TDAG51 NNP B-NP
, , O
and CC O
Tih1 NNP B-NP
: : O
tissue-specific JJ O
expression NN O
, , O
chromosomal NN O
location NN O
, , O
and CC O
parental JJ O
imprinting NN O
. . O

-DOCSTART- X X O

The DT O
potential JJ O
for IN O
highly RB O
reactive JJ O
nanoparticles NNS O
( -LRB- O
RNP NN O
) -RRB- O
to TO O
absorb VB O
destructively RB O
, , O
i IN O
.e NN O
. . O
to TO O
neutralize JJ O
highly RB O
toxic JJ O
substances NNS O
such JJ O
as IN O
the DT O
warfare NN O
agents NNS O
GA NNP O
, , O
GB NNP O
, , O
HD NNP O
and CC O
VX NNP O
, , O
has VBZ O
been VBN O
demonstrated VBN O
in IN O
the DT O
laboratory NN O
. . O

-DOCSTART- X X O

There EX O
were VBD O
minimal JJ O
negative JJ O
effects NNS O
on IN O
hematological JJ O
parameters NNS O
, , O
acid-base NN O
status NN O
, , O
and CC O
blood NN O
gases NNS O
. . O

-DOCSTART- X X O

Twelve CD O
out IN O
of IN O
43 CD O
renal JJ O
failure NN O
patients NNS O
had VBD O
troponin FW B-NP
I PRP I-NP
0.13-0.9 CD O
microg/l JJ O
using VBG O
Axsym NNP O
method NN O
and CC O
4 CD O
had VBD O
levels NNS O
of IN O
0.07-0.13 CD O
microg/l NN O
using VBG O
Immuno NNP O
1 CD O
. . O

-DOCSTART- X X O

Transient NNP O
, , O
high-level JJ O
Ras-expression NNP B-NP
induces VBZ O
transcriptional JJ O
activation NN O
of IN O
p21 NNS B-NP
mediated VBN O
by IN O
a DT O
GC-rich JJ O
region NN O
in IN O
p21 DT B-NP
promoter NN I-NP
-83-54 CC O
bp NN O
relative JJ O
to TO O
the DT O
transcription NN O
initiation NN O
site NN O
containing VBG O
binding JJ O
sites NNS O
for IN O
Sp1-family NNP B-NP
transcription NN I-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

The DT O
RET/PTC3 JJ B-NP
rearrangement NN O
is VBZ O
formed VBN O
by IN O
fusion NN O
of IN O
the DT O
ELE1 NNP B-NP
and CC O
RET NNP B-NP
genes NNS I-NP
, , O
and CC O
is VBZ O
highly RB O
prevalent JJ O
in IN O
radiation-induced JJ O
post-Chernobyl JJ O
papillary NN O
thyroid VBD O
carcinomas NNS O
. . O

-DOCSTART- X X O

Apoptosis NNP O
of IN O
small JJ O
cells NNS O
is VBZ O
still RB O
observed VBN O
after IN O
co-transfection NN O
of IN O
JBD NNP B-NP
and CC O
LMP1 NNP B-NP
but CC O
in IN O
addition NN O
a DT O
few JJ O
apoptotic JJ O
HD-MyZ JJ O
cells NNS O
with IN O
large JJ O
fused VBN O
nuclear JJ O
masses NNS O
are VBP O
identified VBN O
suggesting VBG O
that IN O
specific JJ O
inhibition NN O
of IN O
JNK NNP B-NP
leads VBZ O
also RB O
to TO O
apoptosis NN O
of IN O
LMP1 NNP B-NP
induced VBD O
RS NNP O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
mEmBP-1 JJ B-NP
protein NN I-NP
can MD O
activate VB O
transcription NN O
from IN O
a DT O
truncated JJ O
promoter NN O
containing VBG O
a DT O
pentamer NN O
of IN O
the DT O
O2 NNP B-NP
site NN I-NP
in IN O
yeast NN O
cells NNS O
; : O
however RB O
, , O
it PRP O
inhibited VBD O
regulated VBN O
transcription NN O
of IN O
a DT O
22 CD B-NP
kDa NN I-NP
zein NN I-NP
promoter NN I-NP
in IN O
a DT O
transient JJ O
expression NN O
assay NN O
using VBG O
cultured JJ O
maize NN O
endosperm NN O
cells NNS O
. . O

-DOCSTART- X X O

There EX O
were VBD O
15 CD O
deaths NNS O
, , O
seven CD O
of IN O
which WDT O
were VBD O
felt VBN O
to TO O
be VB O
avoidable JJ O
. . O

-DOCSTART- X X O

With IN O
this DT O
GH NNP B-NP
and CC O
estrogen NN O
treatment NN O
regimen VBN O
, , O
most RBS O
girls NNS O
with IN O
TS NNS O
can MD O
grow VB O
and CC O
develop VB O
much RB O
more RBR O
in IN O
conformity NN O
with IN O
their PRP$ O
healthy JJ O
peers NNS O
. . O

-DOCSTART- X X O

Higher JJR O
CYP3A23 IN B-NP
basal NN O
activity NN O
appears VBZ O
to TO O
be VB O
due JJ O
to TO O
an DT O
E-box NN O
in IN O
3A23SiteA NN B-NP
that IN O
interacts NNS O
with IN O
USF1 NNP B-NP
, , O
a DT O
ubiquitous JJ O
bHLH/leucine NN B-NP
zipper NN I-NP
transcription NN I-NP
factor NN I-NP
. . O

-DOCSTART- X X O

To TO O
understand VB O
the DT O
basis NN O
for IN O
the DT O
increased JJ O
cell NN O
surface NN O
stability NN O
compared VBN O
with IN O
wild-type JJ O
peptide NN O
and CC O
to TO O
understand VB O
the DT O
differences NNS O
in IN O
T NNP O
cell NN O
recognition NN O
between IN O
I1Y NNP B-NP
and CC O
I1F NNP B-NP
, , O
we PRP O
determined VBD O
the DT O
x-ray NN O
crystal NN O
structures NNS O
of IN O
the DT O
two CD O
class NN B-NP
I PRP I-NP
MHC-peptide NNP I-NP
complexes NNS I-NP
. . O

-DOCSTART- X X O

Redistribution NN O
of IN O
mannosidase NN B-NP
I PRP I-NP
was VBD O
also RB O
observed VBN O
in IN O
cells NNS O
incubated VBN O
at IN O
15 CD O
degrees NNS O
C. NNP O

-DOCSTART- X X O

In IN O
conclusion NN O
, , O
our PRP$ O
data NNS O
do VBP O
not RB O
support VB O
a DT O
role NN O
for IN O
IVIg NNP B-NP
in IN O
the DT O
remyelination NN O
of IN O
stable JJ O
multiple JJ O
sclerosis NN O
lesions NNS O
as IN O
measured VBN O
by IN O
central JJ O
conduction NN O
time NN O
. . O

-DOCSTART- X X O

Relative JJ O
to TO O
coherent JJ O
control NN O
words NNS O
( -LRB- O
e NN O
.g. NNP O
, , O
quick JJ O
) -RRB- O
, , O
these DT O
discourse-dependent JJ O
semantic JJ O
anomalies NNS O
elicited VBD O
a DT O
large JJ O
N400 NN O
effect NN O
that WDT O
began VBD O
at IN O
about IN O
200 CD O
to TO O
250 CD O
msec NN O
after IN O
word NN O
onset NN O
. . O

-DOCSTART- X X O

Like IN O
the DT O
Tob NNP B-NP
protein NN I-NP
, , O
Tob2 NNP B-NP
inhibited VBD O
cell NN O
cycle NN O
progression NN O
from IN O
the DT O
G0/G1 NNP O
to TO O
S NNP O
phases NNS O
. . O

-DOCSTART- X X O

The DT O
coordinate VBP O
increase NN O
in IN O
cyclin NN B-NP
D1 . I-NP
and CC O
p21 PRP B-NP
had VBD O
the DT O
effect NN O
of IN O
decreasing VBG O
the DT O
specific JJ O
but CC O
not RB O
absolute JJ O
activity NN O
of IN O
cyclin NN B-NP
D1/cdk4 NNS I-NP
. . O
p53 NN B-NP
was VBD O
not RB O
involved VBN O
since IN O
CSF-1 JJ B-NP
induction NN O
of IN O
p21 NN B-NP
was VBD O
unaffected JJ O
by IN O
dominant-negative JJ B-NP
p53 NN I-NP
expression NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
SLK NNP B-NP
displays VBZ O
high JJ O
homology NN O
to TO O
microtubule NN B-NP
and CC I-NP
nuclear JJ I-NP
associated JJ I-NP
protein NN I-NP
(M-NAP NNP O
) -RRB- O
and CC O
AT1-46 NNP B-NP
, , O
both DT O
of IN O
unknown JJ O
function NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
26 CD O
patients NNS O
( -LRB- O
20 CD O
females NNS O
and CC O
6 CD O
males NNS O
) -RRB- O
were VBD O
evaluated VBN O
. . O

-DOCSTART- X X O

Albumin NNP B-NP
dialysis NN O
: : O
effective JJ O
removal NN O
of IN O
copper NN O
in IN O
a DT O
patient NN O
with IN O
fulminant JJ O
Wilson NNP O
disease NN O
and CC O
successful JJ O
bridging NN O
to TO O
liver NN O
transplantation NN O
: : O
a DT O
new JJ O
possibility NN O
for IN O
the DT O
elimination NN O
of IN O
protein-bound NN O
toxins NNS O
. . O

-DOCSTART- X X O

Both DT O
domains NNS O
were VBD O
required VBN O
for IN O
specific JJ O
DNA NN O
binding NN O
to TO O
the DT O
beta-retinoic JJ B-NP
acid NN I-NP
receptor NN I-NP
element NN I-NP
, , O
producing VBG O
a DT O
DNase NN B-NP
I PRP I-NP
footprint VBD O
covering VBG O
predominantly RB O
one CD O
strand NN O
. . O

-DOCSTART- X X O

Snail NN B-NP
family NN I-NP
proteins NNS I-NP
are VBP O
zinc JJ O
finger NN O
transcriptional JJ O
regulators NNS O
first RB O
identified VBN O
in IN O
Drosophila NNP O
which WDT O
play VBP O
critical JJ O
roles NNS O
in IN O
cell NN O
fate NN O
determination NN O
. . O

-DOCSTART- X X O

Thrombolysis NNP O
was VBD O
followed VBN O
by IN O
a DT O
similar JJ O
increase NN O
of IN O
platelet NN O
activity NN O
with IN O
maximal JJ O
values NNS O
reached VBD O
at IN O
the DT O
3rd JJ O
hour NN O
in IN O
both DT O
groups NNS O
( -LRB- O
196 CD O
+/ NN O
- : O
43 CD O
IU/ml NNP O
in IN O
Group NNP O
1 CD O
and CC O
192 CD O
+/ NNS O
- : O
39 CD O
in IN O
Group NNP O
2 CD O
: : O
p NN O
&lt NN O
; : O
001versus IN O
baseline NN O
and CC O
p NN O
NS NNS O
between IN O
the DT O
groups NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Similar JJ O
to TO O
Hp140 VB B-NP
, , O
isolated VBN O
Hp55 IN B-NP
binds NNS O
DNA NN O
with IN O
moderate JJ O
strength NN O
and CC O
was VBD O
a DT O
specificity NN O
for IN O
double-stranded JJ O
primer-template JJ O
DNA NN O
. . O

-DOCSTART- X X O

12:2684-2697 CD O
, , O
1998 CD O
) -RRB- O
: : O
a DT O
key JJ O
step NN O
of IN O
this DT O
model NN O
is VBZ O
the DT O
activation NN O
of IN O
the DT O
MAPK NNP B-NP
Fus3p NNP I-NP
through IN O
the DT O
G(betagamma)-dependent JJ B-NP
relocalization NN O
of IN O
the DT O
Ste5p-MAPK NNP B-NP
cascade NN O
to TO O
the DT O
plasma NN O
membrane NN O
. . O

-DOCSTART- X X O

Consistent NN O
with IN O
this DT O
finding NN O
, , O
wild-type JJ B-NP
SAGA NNP I-NP
inhibits VBZ O
TBP NNP B-NP
binding NN O
to TO O
the DT O
HIS3 NN B-NP
promoter NN I-NP
in IN O
vitro NN O
, , O
while IN O
SAGA NNP B-NP
lacking VBG O
Spt3 JJ B-NP
or CC O
Spt8 NNPS B-NP
is VBZ O
not RB O
inhibitory JJ O
. . O

-DOCSTART- X X O

Particularly RB O
striking VBG O
was VBD O
the DT O
conservation NN O
of IN O
an DT O
AP-4 NNP B-NP
binding NN I-NP
site NN I-NP
within IN O
100 CD O
nucleotides NNS O
upstream RB O
of IN O
the DT O
transcription NN O
initiation NN O
site NN O
in IN O
both DT O
Aal-rpL34 NNP B-NP
and CC O
Aal-rpL8 DT B-NP
genes NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
no DT O
genetic JJ O
alteration NN O
was VBD O
detected VBN O
in IN O
any DT O
of IN O
the DT O
cancers NNS O
examined VBN O
. . O

-DOCSTART- X X O

All DT O
problems NNS O
were VBD O
associated VBN O
with IN O
fractured JJ O
or CC O
lost VBN O
screws NNS O
. . O

-DOCSTART- X X O

Statins NNS B-NP
: : O
lower JJR O
lipids NNS O
and CC O
better JJR O
bones NNS O
? . O
Although IN O
statins NNS O
are VBP O
widely RB O
used VBN O
as IN O
cholesterol-lowering JJ O
drugs NNS O
, , O
a DT O
recent JJ O
study NN O
suggests VBZ O
that IN O
these DT O
compounds NNS O
have VBP O
anabolic JJ O
effects NNS O
on IN O
bone NN O
and CC O
could MD O
be VB O
developed VBN O
into IN O
new JJ O
treatments NNS O
for IN O
common JJ O
metabolic JJ O
bone NN O
diseases NNS O
such JJ O
as IN O
osteoporosis NN O

-DOCSTART- X X O

The DT O
accumulated VBN O
products NNS O
of IN O
ancient JJ O
duplication NN O
events NNS O
can MD O
be VB O
readily RB O
observed VBN O
among IN O
the DT O
genes NNS O
encoding VBG O
voltage-dependent JJ O
Ca( JJ O
2+ JJ O
) -RRB- O
ion NN O
channels NNS O
. . O

-DOCSTART- X X O

The DT O
VirR NNP B-NP
response NN I-NP
regulator NN I-NP
from IN O
Clostridium NNP O
perfringens NNS O
binds NNS O
independently RB O
to TO O
two CD O
imperfect JJ O
direct JJ O
repeats NNS O
located VBN O
upstream RB O
of IN O
the DT O
pfoA NN B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Cloning NNP O
and CC O
sequencing NN O
of IN O
the DT O
upstream JJ O
region NN O
of IN O
pepX NNS B-NP
revealed VBD O
the DT O
presence NN O
of IN O
two CD O
ORFs NNS O
of IN O
360 CD O
and CC O
1,338 CD O
bp NN O
that WDT O
were VBD O
shown VBN O
to TO O
be VB O
able JJ O
to TO O
encode VB O
proteins NNS O
with IN O
high JJ O
homology NN O
to TO O
GlnR NNP B-NP
and CC O
GlnA NNP B-NP
proteins VBZ I-NP
, , O
respectively RB O
. . O

-DOCSTART- X X O

Objective JJ O
: : O
To TO O
evaluate VB O
endometrial JJ O
thickness NN O
and CC O
the DT O
incidence NN O
of IN O
uterine JJ O
bleeding NN O
in IN O
postmenopausal JJ O
women NNS O
using VBG O
either DT O
tibolone NN O
2.5 CD O
mg NN O
or CC O
continuous JJ O
combined VBN O
2 CD O
mg JJ O
estradiol NN O
and CC O
1 CD O
mg JJ O
norethisterone JJ O
acetate NN O
( -LRB- O
E+NETA NNP O
) -RRB- O
daily RB O
as IN O
hormone NN O
replacement NN O
therapy NN O
. . O

-DOCSTART- X X O

Histological JJ O
analysis NN O
showed VBD O
that IN O
the DT O
neuronal JJ O
loss NN O
in IN O
the DT O
DHED-treated JJ O
group NN O
was VBD O
notably RB O
reduced VBN O
in IN O
the DT O
hippocampal JJ O
area NN O
( -LRB- O
CA1 NNP O
) -RRB- O
of IN O
ischemic JJ O
rats NNS O
and CC O
in IN O
the DT O
dentate NN O
gyrus NN O
and CC O
hippocampal JJ O
area NN O
( -LRB- O
CA1 NNP O
and CC O
CA3 NNP O
) -RRB- O
of IN O
EC-lesioned JJ O
rats NNS O
compared VBN O
with IN O
the DT O
nontreated JJ O
group NN O
. . O

-DOCSTART- X X O

The DT O
extents NNS O
of IN O
phosphorylation NN O
of IN O
Ser44 NNP O
and CC O
Ser64 NNP O
were VBD O
1:1 CD O
, , O
whereas IN O
those DT O
of IN O
the DT O
four CD O
minor JJ O
sites NNS O
all DT O
together RB O
were VBD O
<30 CD O
% NN O
of IN O
the DT O
major JJ O
one CD O
. . O

-DOCSTART- X X O

Serum NNP O
HBV-DNA NNP O
, , O
viral JJ O
serology NN O
, , O
and CC O
liver NN O
enzymes NNS O
were VBD O
measured VBN O
sequentially RB O
; : O
liver NN O
histology NN O
was VBD O
taken VBN O
before IN O
and CC O
during IN O
treatment NN O
in IN O
12 CD O
patients NNS O
. . O

-DOCSTART- X X O

Chem NNP O
. . O

-DOCSTART- X X O

Animal JJ O
studies NNS O
showed VBD O
that IN O
beam NN O
equalization NN O
significantly RB O
improved VBD O
fluoroscopic JJ O
and CC O
angiographic JJ O
image NN O
quality NN O
. . O

-DOCSTART- X X O

AB004534 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
prevalence NN O
of IN O
hepatitis NN O
C NNP O
virus NN O
( -LRB- O
HCV NNP O
) -RRB- O
infection NN O
is VBZ O
relatively RB O
low JJ O
in IN O
childhood NN O
, , O
with IN O
anti-HCV JJ B-NP
prevalence NN O
rates NNS O
of IN O
0.1-0.4 CD O
% NN O
in IN O
the DT O
Western JJ O
world NN O
. . O

-DOCSTART- X X O

During IN O
latency RB O
, , O
more RBR O
than IN O
1 CD O
% NN O
of IN O
neurons NNS O
in IN O
ganglia NNS O
that WDT O
innervate VBP O
the DT O
footpad NN O
expressed VBD O
beta-galactosidase JJ B-NP
, , O
with IN O
the DT O
number NN O
of IN O
positive JJ O
cells NNS O
remaining VBG O
constant JJ O
for IN O
at IN O
least JJS O
5 CD O
months NNS O
. . O

-DOCSTART- X X O

Compared VBN O
to TO O
those DT O
with IN O
normal JJ O
renal JJ O
functions NNS O
, , O
these DT O
patients NNS O
were VBD O
older JJR O
( -LRB- O
P NNP O
< , O
or CC O
= SYM O
0.01 CD O
) -RRB- O
, , O
had VBD O
significantly RB O
elevated VBN O
blood NN O
pressures NNS O
( -LRB- O
P NNP O
< , O
0.01 CD O
or CC O
P NNP O
= SYM O
0.0001 CD O
) -RRB- O
, , O
and CC O
in IN O
the DT O
case NN O
of IN O
Type NNP O
1 CD O
DM NNP O
, , O
with IN O
a DT O
higher JJR O
body NN O
mass NN O
index NN O
( -LRB- O
P NNP O
= SYM O
0.0001 CD O
) -RRB- O
and CC O
waist-hip NN O
ratio NN O
( -LRB- O
P NNP O
< NN O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
results NNS O
show VBP O
that IN O
the DT O
CAAT-region NN O
is VBZ O
involved VBN O
in IN O
upregulating VBG O
the DT O
MDR1 NNP B-NP
promoter NN I-NP
in IN O
HL60/VCR NNP O
cells NNS O
. . O

-DOCSTART- X X O

Both DT O
receptors NNS O
utilize VBP O
protein NN B-NP
tyrosine NN I-NP
kinases NNS I-NP
( -LRB- O
PTKs NNS B-NP
) -RRB- O
for IN O
the DT O
phosphorylation NN O
of IN O
various JJ O
signaling VBG O
molecules NNS O
, , O
a DT O
process NN O
that WDT O
is VBZ O
critical JJ O
for IN O
the DT O
function NN O
of IN O
both DT O
receptors NNS O
. . O

-DOCSTART- X X O

Hypothermia NNP O
After IN O
Cardiac NNP O
Arrest NNP O
( -LRB- O
HACA NNP O
) -RRB- O
Study NNP O
Group NNP O
. . O

-DOCSTART- X X O

We PRP O
demonstrate VBP O
that IN O
both DT O
R NN B-NP
and CC O
Z NN B-NP
activate VBP O
the DT O
cellular JJ O
stress NN O
mitogen-activated JJ B-NP
protein NN I-NP
( -LRB- I-NP
MAP NNP I-NP
) -RRB- I-NP
kinases NNS I-NP
, , O
p38 NNS B-NP
and CC O
JNK NNP B-NP
, , O
resulting VBG O
in IN O
phosphorylation NN O
( -LRB- O
and CC O
activation NN O
) -RRB- O
of IN O
the DT O
cellular JJ B-NP
transcription NN I-NP
factor NN I-NP
ATF2 NNP I-NP
. . O

-DOCSTART- X X O

Two CD O
US PRP O
commercial JJ O
cultivars NNS O
( -LRB- O
Tehama NNP O
and CC O
Vina NNP O
) -RRB- O
, , O
three CD O
European JJ O
commercial JJ O
cultivars NNS O
( -LRB- O
Esterhazy NNP O
, , O
139 CD O
, , O
G120 NNP O
) -RRB- O
and CC O
five CD O
New NNP O
Zealand NNP O
selections NNS O
( -LRB- O
Rex NNP O
, , O
Dublin NNP O
's POS O
Glory NN O
, , O
Meyric NNP O
, , O
McKinster NNP O
, , O
Stanley NNP O
) -RRB- O
were VBD O
evaluated VBN O
. . O

-DOCSTART- X X O

Anatomy NN O
of IN O
the DT O
uterine NN O
artery NN O
. . O

-DOCSTART- X X O

However RB O
, , O
activation NN O
of IN O
the DT O
cAMP JJ O
pathway NN O
, , O
which WDT O
is VBZ O
known VBN O
to TO O
regulate VB O
inhibin IN B-NP
alpha NN I-NP
expression NN O
, , O
greatly RB O
enhanced VBN O
the DT O
actions NNS O
of IN O
SF-1 NNP B-NP
. . O

-DOCSTART- X X O

Previously RB O
, , O
we PRP O
showed VBD O
that IN O
the DT O
APRE NNP O
is VBZ O
a DT O
cytokine NN O
[tumor NN O
necrosis NN B-NP
factor-alpha NN I-NP
( -LRB- O
TNFalpha NNP B-NP
)] NNP O
- : O
inducible JJ O
enhancer NN O
by IN O
binding VBG O
the DT O
heterodimeric JJ B-NP
nuclear JJ I-NP
factor-kappaB NN I-NP
( -LRB- O
NF-kappaB NNP B-NP
) -RRB- O
complex NN O
Rel JJ B-NP
A DT I-NP
x NN O
NF-kappaB1 NNP B-NP
. . O

-DOCSTART- X X O

Angiotensin NNP B-NP
II NNP I-NP
induces VBZ O
nuclear JJ B-NP
factor NN I-NP
( -LRB- I-NP
NF)-kappaB1 JJ I-NP
isoforms NNS I-NP
to TO O
bind NN O
the DT O
angiotensinogen NN B-NP
gene NN I-NP
acute-phase JJ O
response NN O
element NN O
: : O
a DT O
stimulus-specific JJ O
pathway NN O
for IN O
NF-kappaB NNP B-NP
activation NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
CaMig1 NNP B-NP
formed VBD O
specific JJ O
complexes NNS O
with IN O
the DT O
URS1 JJ O
region NN O
of IN O
the DT O
S. NNP B-NP
cerevisiae NN I-NP
FBP1 NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

We PRP O
describe VBP O
a DT O
case NN O
of IN O
acetaminophen NNS O
overdose IN O
that WDT O
was VBD O
treated VBN O
with IN O
both DT O
hemodialysis NN O
( -LRB- O
HD NNP O
) -RRB- O
and CC O
NAC NNP O
due JJ O
to TO O
severe JJ O
intoxication NN O
and CC O
slow JJ O
drug NN O
clearance NN O
. . O

-DOCSTART- X X O

Following VBG O
conditioning NN O
, , O
a DT O
single JJ O
coat NN O
of IN O
adhesive NN O
was VBD O
applied VBN O
and CC O
light-cured JJ O
. . O

-DOCSTART- X X O

Eastern NNP O
Cooperative NNP O
Oncology NNP O
Group NNP O
trial NN O
E3186 NNP O
was VBD O
initiated VBN O
to TO O
explore VB O
this DT O
question NN O
. . O

-DOCSTART- X X O

We PRP O
determined VBD O
how WRB O
DNA NNP O
repair NN O
is VBZ O
affected VBN O
by IN O
TFA1 DT B-NP
conditional JJ O
mutations NNS O
. . O

-DOCSTART- X X O

These DT O
articles NNS O
both DT O
report NN O
the DT O
results NNS O
of IN O
multi-institutional JJ O
, , O
randomized JJ O
, , O
phase NN O
3 CD O
trials NNS O
for IN O
the DT O
treatment NN O
of IN O
patients NNS O
with IN O
localized JJ O
( -LRB- O
T1-3 NN O
N0-1 JJ O
M0 . O
) -RRB- O
esophageal NN O
squamous JJ O
cell NN O
carcinoma NN O
(SCC NN O
) -RRB- O
or CC O
esophageal JJ O
adenocarcinoma NN O
. . O

-DOCSTART- X X O

Studies NNS O
of IN O
MPO NNP B-NP
gene NN I-NP
regulation NN O
can MD O
help VB O
to TO O
elucidate VB O
the DT O
mechanism NN O
of IN O
normal JJ O
and CC O
abnormal JJ O
myeloid JJ O
differentiation NN O
. . O

-DOCSTART- X X O

NDRF/NeuroD2 PRP B-NP
was VBD O
co-precipitated JJ O
with IN O
PKN NNP B-NP
from IN O
the DT O
lysate NN O
of IN O
COS-7 JJ O
cells NNS O
transfected VBN O
with IN O
both DT O
expression NN O
constructs NNS O
for IN O
NDRF/NeuroD2 NNP B-NP
and CC O
PKN. NNP B-NP

-DOCSTART- X X O

Transient NNP O
transfection NN O
assays VBZ O
using VBG O
P19 CD O
cells NNS O
revealed VBD O
that IN O
expression NN O
of IN O
NDRF/NeuroD2 NNP B-NP
increased VBD O
the DT O
transactivation NN O
of IN O
the DT O
rat NN B-NP
insulin NN I-NP
promoter NN I-NP
element NN I-NP
3 CD I-NP
( -LRB- O
RIPE3 VB B-NP
) -RRB- O
enhancer VB O
up RP O
to TO O
approximately RB O
12-fold JJ O
and CC O
that DT O
co-expression NN O
of IN O
catalytically RB O
active JJ O
form NN O
of IN O
PKN NNP B-NP
, , O
but CC O
not RB O
kinase-deficient JJ O
derivative JJ O
, , O
resulted VBD O
in IN O
a DT O
further JJ O
threefold JJ O
increase NN O
of IN O
NDRF/NeuroD2-mediated JJ B-NP
transcription NN O
. . O

-DOCSTART- X X O

Upon IN O
tyrosine NN O
phosphorylation NN O
at IN O
the DT O
ITIMs, NNP O
these DT O
molecules NNS O
recruit VBP O
SH2 NNP B-NP
domain-containing NN O
phosphatases NNS O
such JJ O
as IN O
SH2-containing JJ B-NP
tyrosine NN B-NP
phosphatase-1 NN I-NP
and CC O
negatively RB O
regulate VB O
cell NN O
activity NN O
. . O

-DOCSTART- X X O

AF154055 NNS B-NP
. . O

-DOCSTART- X X O

Competition NN O
experiments NNS O
demonstrate VBP O
a DT O
negative JJ O
allosteric JJ O
relationship NN O
between IN O
these DT O
RGD JJ O
recognition NN O
sites NNS O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
showed VBD O
that IN O
the DT O
5'-flanking JJ O
region NN O
upstream RB O
to TO O
the DT O
ATG NNP O
codon NN O
did VBD O
not RB O
contain VB O
a DT O
conventional JJ O
TATA NNP O
box NN O
. . O

-DOCSTART- X X O

After IN O
i DT O
.v. NNP O
administration NN O
of IN O
500 CD O
mg NN O
acetazolamide NN O
and CC O
disinfection NN O
of IN O
the DT O
conjunctiva NN O
, , O
50 CD O
micrograms NNS O
rt-PA JJ B-NP
in IN O
0.1 CD O
ml NN O
( -LRB- O
BSS) NNP O
and CC O
0.5 CD O
ml JJ O
SF6 NNS O
were VBD O
injected VBN O
intravitreally RB O
. . O

-DOCSTART- X X O

Differential JJ O
expression NN O
and CC O
regulation NN O
by IN O
20-hydroxyecdysone CD O
of IN O
mosquito NN O
ultraspiracle NN O
isoforms VBZ O
. . O

-DOCSTART- X X O

The DT O
differentiation NN O
and CC O
maintenance NN O
of IN O
a DT O
neurotransmitter NN O
phenotype NN O
is VBZ O
guided VBN O
by IN O
the DT O
interaction NN O
of IN O
exogenous JJ O
cues NNS O
with IN O
intrinsic JJ O
genetic JJ O
machinery NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
functional JJ O
domains NNS O
of IN O
Arix NNP B-NP
reveals VBZ O
an DT O
N-terminal JJ O
activation NN O
domain NN O
and CC O
a DT O
C-terminal JJ O
repression NN O
domain NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Left VBN O
ventricular JJ O
hypertrophy NN O
is VBZ O
a DT O
heterogeneous JJ O
disorder NN O
with IN O
distinct JJ O
morphologies NNS O
. . O

-DOCSTART- X X O

Overexpression NNP O
of IN O
ICBP90 NNP B-NP
in IN O
COS-1-transfected JJ O
cells NNS O
induced VBN O
an DT O
enhanced JJ O
expression NN O
of IN O
endogenous JJ B-NP
topoisomerase NN I-NP
IIalpha NNP I-NP
. . O

-DOCSTART- X X O

To TO O
quantify VB O
any DT O
mechanical JJ O
inhibitory JJ O
effect NN O
of IN O
nasal JJ O
intermittent NN O
positive JJ O
pressure NN O
ventilation NN O
( -LRB- O
IPPV NN O
) -RRB- O
on IN O
inspiratory JJ O
activity NN O
of IN O
the DT O
diaphragm NN O
we PRP O
ventilated VBD O
five CD O
conscious JJ O
relaxed JJ O
subjects NNS O
on IN O
two CD O
occasions NNS O
at IN O
respiratory NN O
rates NNS O
similar JJ O
to TO O
quiet JJ O
breathing NN O
( -LRB- O
QB NNP O
) -RRB- O
and CC O
at IN O
three CD O
levels NNS O
of IN O
applied JJ O
pressure NN O
( -LRB- O
Pappl)--6 UH O
, , O
9 CD O
and CC O
12 CD O
cmH2O NNS O
, , O
each DT O
during IN O
hypocapnia NN O
( -LRB- O
P(CO2 NN O
) -RRB- O
allowed VBN O
to TO O
decrease VB O
) -RRB- O
and CC O
eucapnia NN O
( -LRB- O
CO2 NNP O
added VBD O
to TO O
inspired JJ O
gas NN O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
investigated VBN O
the DT O
contribution NN O
of IN O
specific JJ O
TATA-binding JJ B-NP
protein NN I-NP
( -LRB- O
TBP)-TATA NNP B-NP
interactions NNS O
to TO O
the DT O
promoter NN O
activity NN O
of IN O
a DT O
constitutively RB O
expressed VBN O
silkworm NN B-NP
tRNA( IN I-NP
C)( JJ I-NP
Ala NNP I-NP
) -RRB- I-NP
gene NN I-NP
and CC O
have VBP O
also RB O
asked VBN O
whether IN O
the DT O
lack NN O
of IN O
similar JJ O
interactions NNS O
accounts NNS O
for IN O
the DT O
low JJ O
promoter NN O
activity NN O
of IN O
a DT O
silk NN B-NP
gland-specific JJ I-NP
tRNA(SG)( JJ I-NP
Ala NNP I-NP
) -RRB- I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
sequences NNS O
showed VBD O
extensive JJ O
homologies NNS O
with IN O
squalene NN B-NP
synthase NN I-NP
genes NNS I-NP
and CC O
enzymes NNS O
from IN O
a DT O
number NN O
of IN O
other JJ O
organisms NNS O
and CC O
extreme JJ O
amino IN O
acid NN O
conservation NN O
within IN O
the DT O
binding NN O
and CC O
catalytic JJ O
domains NNS O
. . O

-DOCSTART- X X O

All DT O
clones NNS O
and CC O
strains NNS O
produced VBN O
have VBP O
been VBN O
deposited VBN O
in IN O
the DT O
EUROFAN NNP O
genetic JJ O
stock NN O
centre NN O
( -LRB- O
EUROSCARF NNP O
, , O
Frankfurt NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Two CD O
episodes NNS O
of IN O
peritonitis NN O
occurred VBD O
while IN O
the DT O
patient NN O
received VBD O
CAPD NNP O
( -LRB- O
1 CD O
episode/3.5 NN O
patient-months NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Two CD O
estrogen NN B-NP
receptor NN I-NP
( -LRB- O
ER NNP B-NP
) -RRB- O
isoforms VBZ O
with IN O
different JJ O
estrogen NN O
dependencies NNS O
are VBP O
generated VBN O
from IN O
the DT O
trout NN B-NP
ER NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

In IN O
myometrial JJ O
SMC NNP O
, , O
both DT O
isoforms NNS O
of IN O
the DT O
progesterone NN B-NP
receptor NN I-NP
, , O
PR-B NNP B-NP
and CC O
PR-A NNP B-NP
, , O
caused VBD O
a DT O
ligand-dependent JJ O
activation NN O
of IN O
PGDH-2368/luc3 JJ B-NP
. . O

-DOCSTART- X X O

Element NNP O
B NNP O
(-249/-229 CD O
) -RRB- O
shows VBZ O
more JJR O
than IN O
80 CD O
% NN O
homology NN O
to TO O
a DT O
consensus NN B-NP
c-myb JJ I-NP
element NN I-NP
, , O
but CC O
formed VBD O
two CD O
specific JJ O
complexes NNS O
that WDT O
differed VBD O
from IN O
that DT O
of IN O
c-myb NN B-NP
in IN O
the DT O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
. . O

-DOCSTART- X X O

High JJ O
resolution NN O
computed VBN O
tomography NN O
of IN O
the DT O
lungs NNS O
in IN O
patients NNS O
with IN O
rheumatoid NNP O
arthritis NN O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
increasing VBG O
the DT O
dosage NN O
of IN O
wild-type JJ B-NP
Fus3 NNP I-NP
intensifies VBZ O
the DT O
inhibition NN O
of IN O
both DT O
Ty1 NNP B-NP
transposition NN O
and CC O
invasive JJ O
growth NN O
. . O

-DOCSTART- X X O

Consistently RB O
, , O
activation NN O
of IN O
c-Jun JJ B-NP
N-terminal JJ I-NP
kinase NN I-NP
downstream NN O
of IN O
Rho NNP B-NP
family NN I-NP
GTP-binding JJ I-NP
proteins NNS I-NP
was VBD O
also RB O
enhanced VBN O
when WRB O
Dbl NNP B-NP
was VBD O
tyrosine-phosphorylated JJ O
. . O

-DOCSTART- X X O

However RB O
, , O
its PRP$ O
participation NN O
in IN O
collagen NN B-NP
binding NN O
has VBZ O
not RB O
been VBN O
shown VBN O
. . O

-DOCSTART- X X O

Together RB O
, , O
these DT O
data NNS O
suggest VBP O
that IN O
the DT O
carboxyl NN O
terminus NN O
of IN O
CFTR NNP B-NP
contains VBZ O
a DT O
tyrosine-based JJ O
internalization NN O
signal NN O
that WDT O
interacts VBZ O
with IN O
the DT O
endocytic JJ O
adaptor NN O
complex JJ O
AP-2 NN B-NP
to TO O
facilitate VB O
efficient JJ O
entry NN O
of IN O
CFTR NNP B-NP
into IN O
clathrin-coated JJ B-NP
vesicles NNS O
. . O

-DOCSTART- X X O

The DT O
insulin NN B-NP
therapy NN O
regimen NNS O
did VBD O
not RB O
affect VB O
the DT O
evolution NN O
of IN O
the DT O
patients NNS O
and CC O
no DT O
significant JJ O
relationship NN O
existed VBD O
between IN O
the DT O
age NN O
at IN O
diagnosis NN O
, , O
duration NN O
of IN O
diabetes NNS O
, , O
daily JJ O
insulin NN B-NP
dosage NN O
or CC O
metabolic JJ O
control NN O
and CC O
height NN O
or CC O
BMI NNP O
. . O

-DOCSTART- X X O

The DT O
applicability NN O
of IN O
laparoscopic JJ O
donor NN O
nephrectomy NN O
( -LRB- O
LDN) NNP O
has VBZ O
not RB O
been VBN O
assessed VBN O
in IN O
the DT O
obese NN O
donor NN O
. . O

-DOCSTART- X X O

The DT O
RING NNP O
finger NN O
, , O
B2 JJ O
box NN O
, , O
and CC O
coiled-coil JJ O
region NN O
are VBP O
required VBN O
for IN O
oligomerization NN O
of IN O
KAP-1-RBCC NNP B-NP
and CC O
KRAB NNP B-NP
binding NN O
, , O
as IN O
mutations NNS O
in IN O
these DT O
domains NNS O
concomitantly RB O
abolished VBD O
these DT O
functions NNS O
. . O

-DOCSTART- X X O

Actins NNS B-NP
show VBP O
two CD O
different JJ O
forms NNS O
of IN O
N-terminal JJ O
processing NN O
dependent JJ O
on IN O
their PRP$ O
N-terminal JJ O
sequence NN O
. . O

-DOCSTART- X X O

JPEG NNP O
53 CD O
, , O
resulting VBG O
in IN O
a DT O
compression NN O
ratio NN O
of IN O
1:21 CD O
, , O
does VBZ O
not RB O
compromise VB O
the DT O
diagnostic JJ O
performance NN O
in IN O
general JJ O
. . O

-DOCSTART- X X O

Like IN O
their PRP$ O
yeast NN O
counterpart NN O
, , O
the DT O
mouse NN O
GCN2 IN B-NP
isoforms NNS O
contain VBP O
HisRS-related JJ B-NP
sequences NNS I-NP
juxtaposed VBD O
to TO O
the DT O
kinase NN O
catalytic JJ O
domain NN O
. . O

-DOCSTART- X X O

Five CD O
women NNS O
( -LRB- O
15.6 CD O
% NN O
) -RRB- O
met VBD O
criteria NNS O
for IN O
PMS. NNP O

-DOCSTART- X X O

MBI NNP O
and CC O
MMBI NNP O
showed VBD O
similar JJ O
Cmax NN O
values NNS O
, , O
but CC O
the DT O
former JJ O
disappeared VBD O
slower RBR O
in IN O
the DT O
serum NN O
than IN O
the DT O
latter NN O
and CC O
resulted VBD O
in IN O
its PRP$ O
larger JJR O
AUC NNP O
values NNS O
. . O

-DOCSTART- X X O

Another DT O
long JJ O
insertion NN O
in IN O
the DT O
cathepsin NN B-NP
X NNP I-NP
amino IN I-NP
acid JJ I-NP
sequence NN I-NP
forms NNS O
a DT O
beta-hairpin NN O
pointing VBG O
away RB O
from IN O
the DT O
active JJ O
site NN O
. . O

-DOCSTART- X X O

Transfection NN O
experiments NNS O
demonstrated VBD O
that IN O
the DT O
5'-flanking JJ O
region NN O
(-1894 . O
to TO O
+37 CD O
) -RRB- O
of IN O
the DT O
mStaf JJ B-NP
gene NN I-NP
drives NNS O
transcription NN O
in IN O
mouse NN O
NMuMG NN O
cells NNS O
and CC O
that IN O
a DT O
construct VB O
containing VBG O
a DT O
fragment NN O
from IN O
-387 NN O
to TO O
+37 CD O
showed VBD O
the DT O
highest JJS O
transcriptional JJ O
activity NN O
. . O

-DOCSTART- X X O

Pretreatment NNP O
of IN O
cells NNS O
or CC O
mouse NN O
skin NN O
with IN O
antisense JJ O
oligonucleotides NNS O
of IN O
PKCzeta NNP B-NP
impaired VBN O
UV-induced JJ O
activation NN O
of IN O
AP-1 NNP B-NP
in IN O
JB6 NNP O
cells NNS O
as RB O
well RB O
as IN O
in IN O
AP-1-luciferase NN B-NP
transgenic JJ O
mice NNS O
. . O

-DOCSTART- X X O

The DT O
level NN O
of IN O
subclinical JJ O
infection NN O
was VBD O
75 CD O
% NN O
among IN O
seropositive JJ O
dogs NNS O
. . O

-DOCSTART- X X O

METHODS NNP O
: : O
The DT O
former JJ O
group NN O
included VBD O
patients NNS O
who WP O
had VBD O
been VBN O
treated VBN O
with IN O
at IN O
least JJS O
four CD O
PGE1 NNP O
alpha-ciclodestrina NN O
, , O
short-term JJ O
treatment NN O
cycles NNS O
per IN O
year NN O
while IN O
the DT O
latter NN O
was VBD O
a DT O
historical JJ O
reference NN O
group NN O
managed VBD O
without IN O
prostaglandins NNS O
. . O

-DOCSTART- X X O

The DT O
rrd1,2delta JJ B-NP
mutant NN I-NP
was VBD O
partially RB O
rescued VBN O
by IN O
inactivation NN O
of IN O
HOG1 NNP B-NP
or CC O
PBS2 NNP B-NP
, , O
suggesting VBG O
an DT O
interaction NN O
between IN O
the DT O
RRD NNP B-NP
genes NNS I-NP
and CC O
the DT O
Hog1p NNP B-NP
signal NN I-NP
transduction NN I-NP
pathway NN I-NP
. . O

-DOCSTART- X X O

Members NNS O
of IN O
the DT O
JAK/Tyk JJ B-NP
family NN O
of IN O
tyrosine NN B-NP
kinases NNS I-NP
mediate JJ O
phosphorylation NN O
of IN O
STAT3 NNP B-NP
at IN O
Tyr705 CD O
during IN O
CNTF NNP B-NP
signaling NN O
; : O
however RB O
, , O
the DT O
kinase NN O
responsible JJ O
for IN O
phosphorylation NN O
at IN O
STAT3 NNP B-NP
Tyr727 NNP O
appears VBZ O
to TO O
depend VB O
on IN O
both CC O
the DT O
extracellular JJ O
stimulus NN O
and CC O
the DT O
cellular JJ O
context NN O
. . O

-DOCSTART- X X O

In IN O
vivo RB O
, , O
CARbeta/RXRalpha NNP B-NP
activated VBD O
transcription NN O
from IN O
an DT O
HD-PPRE NNP B-NP
luciferase NN B-NP
reporter NN I-NP
construct VB I-NP
. . O

-DOCSTART- X X O

Thus RB O
, , O
SOX8 PRP B-NP
is VBZ O
a DT O
good JJ O
candidate NN O
gene NN O
contributing VBG O
to TO O
the DT O
mental JJ O
retardation NN O
phenotype NN O
seen VBN O
in IN O
ATR-16 DT O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
genome JJ O
organization NN O
of IN O
the DT O
mite-transmitted JJ O
wheat NN O
streak NN O
mosaic NN O
virus NN O
( -LRB- O
WSMV) NNP O
appears VBZ O
to TO O
parallel VB O
that DT O
of IN O
members NNS O
of IN O
the DT O
Potyviridae NNP O
with IN O
monopartite JJ O
genomes NNS O
, , O
but CC O
there EX O
are VBP O
substantial JJ O
amino IN O
acid NN O
dissimilarities NNS O
with IN O
other JJ O
potyviral JJ O
polyproteins NNS O
. . O

-DOCSTART- X X O

The DT O
two-hybrid JJ O
assay NN O
was VBD O
then RB O
performed VBN O
using VBG O
full-length JJ O
genes NNS O
of IN O
CI NNP B-NP
, , O
HC-Pro NNP B-NP
, , O
P1 NNP B-NP
, , O
P3 NNP B-NP
, , O
and CC O
CP CD B-NP
, , O
but CC O
no DT O
heterologous JJ O
interactions NNS O
were VBD O
detected VBN O
. . O

-DOCSTART- X X O

Diverse VB O
endogenous JJ O
light NN O
chains NNS O
contribute VBP O
to TO O
basement NN O
membrane NN O
reactivity NN O
in IN O
nonautoimmune JJ O
mice NNS O
transgenic JJ O
for IN O
an DT O
anti-laminin JJ B-NP
Ig NNP B-NP
heavy JJ I-NP
chain NN I-NP
. . O

-DOCSTART- X X O

Patch NNP O
test NN O
results NNS O
obtained VBN O
with IN O
corticosteroid JJ O
allergic NN O
patients NNS O
tested VBD O
with IN O
a DT O
large JJ O
corticosteroid JJ O
series NN O
validated VBN O
the DT O
earlier JJR O
classification NN O
of IN O
corticosteroid JJ O
molecules NNS O
in IN O
four CD O
groups NNS O
of IN O
cross-reacting JJ O
molecules NNS O
: : O
i IN O
.e NN O
. . O
, , O
group NN O
A DT O
( -LRB- O
hydrocortisone NN O
type NN O
) -RRB- O
, , O
group NN O
B NNP O
( -LRB- O
acetonides NNS O
) -RRB- O
, , O
group NN O
C NNP O
( -LRB- O
betamethasone NN O
type-non NN O
esterified VBN O
) -RRB- O
and CC O
group NN O
D NN O
(esters NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Mechanisms NNS O
of IN O
tachyphylaxis NNS O
in IN O
regional JJ O
anesthesia NN O
of IN O
long JJ O
duration NN O

-DOCSTART- X X O

An DT O
increase NN O
in IN O
the DT O
level NN O
of IN O
serum NN O
enzymes NNS O
, , O
such JJ O
as IN O
aspartate NN B-NP
transaminase NN I-NP
, , O
alkaline NN B-NP
phosphatase NN I-NP
, , O
creatine JJ B-NP
phosphokinase NN I-NP
, , O
lactate NN B-NP
dehydrogenase NN I-NP
after IN O
D. NNP O
russelli NNP O
venom NN O
injection NN O
in IN O
albino NN O
rats NNS O
is VBZ O
indicative JJ O
of IN O
cell NN O
or CC O
tissue NN O
damage NN O
. . O

-DOCSTART- X X O

The DT O
partial JJ O
farm NN O
budget NN O
highlighted VBD O
the DT O
importance NN O
of IN O
reducing VBG O
sub-clinical JJ O
lesions NNS O
in IN O
a DT O
feedlot NN O
. . O

-DOCSTART- X X O

Surprisingly RB O
, , O
3 CD O
full-length JJ B-NP
murine NN I-NP
survivin NN I-NP
cDNA NN I-NP
clones NNS O
were VBD O
isolated VBN O
, , O
predicting VBG O
the DT O
existence NN O
of IN O
3 CD O
distinct JJ O
survivin JJ B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
stabilization NN O
of IN O
the DT O
hairpin NN O
reduced VBD O
the DT O
amount NN O
of IN O
tRNA NN O
primer NN O
that WDT O
is VBZ O
annealed VBN O
to TO O
the DT O
PBS. NNP O

-DOCSTART- X X O

Ischemia-induced JJ O
biphasic JJ O
arrhythmias NNS O
were VBD O
suppressed VBN O
in IN O
both DT O
zatebradine NN O
and CC O
propranolol NN O
groups NNS O
. . O

-DOCSTART- X X O

No DT O
definite JJ O
conclusions NNS O
are VBP O
possible JJ O
because IN O
of IN O
the DT O
small JJ O
number NN O
of IN O
patients NNS O
involved VBN O
in IN O
this DT O
phase NN O
II NNP O
trial NN O
. . O

-DOCSTART- X X O

Two CD O
distinct JJ O
Salmonella NNP B-NP
fimbrins NNS I-NP
, , O
AgfA NNP B-NP
and CC O
SefA NNP B-NP
, , O
comprising VBG O
thin JJ O
aggregative JJ O
fimbriae NNS O
SEF17 . B-NP
and CC O
SEF14 NNP B-NP
, , O
respectively RB O
, , O
were VBD O
each DT O
genetically RB O
engineered VBN O
to TO O
carry VB O
PT3 NNP B-NP
, , O
an DT O
alpha-helical JJ O
16-amino JJ O
acid NN O
Leishmania NN O
T-cell NN O
epitope NN O
derived VBN O
from IN O
the DT O
metalloprotease NN B-NP
gp63 NN B-NP
. . O

-DOCSTART- X X O

In IN O
marked JJ O
contrast NN O
to TO O
AgfA NNP B-NP
, , O
none NN O
of IN O
the DT O
chimeric JJ B-NP
SefA NNP I-NP
proteins NNS I-NP
were VBD O
expressed VBN O
or CC O
assembled VBN O
into IN O
fimbriae NNS O
. . O

-DOCSTART- X X O

Productive JJ O
growth NN O
of IN O
phage NN O
P22 NN O
in IN O
wild-type JJ O
Salmonella NNP O
typhimurium NN O
correlates VBZ O
with IN O
the DT O
presence NN O
of IN O
Abc2 NNP B-NP
, , O
but CC O
is VBZ O
independent JJ O
of IN O
the DT O
absolute JJ O
level NN O
of IN O
ATP-dependent JJ B-NP
nuclease NN I-NP
activity NN O
, , O
suggesting VBG O
a DT O
qualitative JJ O
change NN O
in IN O
the DT O
nature NN O
of IN O
Abc2-modified JJ B-NP
RecBCD NNP B-NP
nuclease NN I-NP
activity NN O
relative JJ O
to TO O
the DT O
native JJ O
enzyme NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
we PRP O
investigated VBD O
the DT O
molecular JJ O
mechanisms NNS O
underlying VBG O
the DT O
inducible JJ O
expression NN O
of IN O
the DT O
flt-1 JJ B-NP
gene NN I-NP
during IN O
the DT O
activation NN O
of IN O
THP-1 JJ O
cells NNS O
. . O

-DOCSTART- X X O

Dermatology NNP O
is VBZ O
no DT O
exception NN O
. . O

-DOCSTART- X X O

4 CD O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
of IN O
a DT O
novel NN O
human NN B-NP
I-mfa NNP I-NP
domain-containing JJ I-NP
protein NN I-NP
that IN O
differently RB O
regulates VBZ O
human JJ O
T-cell NN O
leukemia NN O
virus NN O
type NN O
I PRP O
and CC O
HIV-1 PRP$ O
expression NN O
. . O

-DOCSTART- X X O

With IN O
chemical NN O
shift NN O
imaging NN O
, , O
the DT O
signal NN O
intensity NN O
decreased VBD O
on IN O
the DT O
out-of-phase JJ O
images NNS O
in IN O
six CD O
of IN O
seven CD O
(86 CD O
% NN O
) -RRB- O
patients NNS O
with IN O
APA NNP O
and CC O
in IN O
eight CD O
of IN O
nine CD O
(89 CD O
% NN O
) -RRB- O
patients NNS O
with IN O
BAH. NNP O

-DOCSTART- X X O

For IN O
each DT O
night NN O
, , O
the DT O
diary NN O
allowed VBD O
the DT O
subjective JJ O
measurement NN O
of IN O
bedtime NN O
, , O
wake NN O
time NN O
, , O
time NN O
in IN O
bed NN O
( -LRB- O
TIB NN O
) -RRB- O
, , O
sleep VB O
efficiency NN O
, , O
number NN O
of IN O
minutes NNS O
of IN O
wake NN O
after IN O
sleep NN O
onset NN O
( -LRB- O
WASO NNP O
) -RRB- O
, , O
alertness NN O
on IN O
awakening JJ O
, , O
and CC O
percentage NN O
of IN O
morning NN O
needing VBG O
an DT O
alarm NN O
( -LRB- O
or CC O
a DT O
person NN O
functioning VBG O
as IN O
one CD O
) -RRB- O
. . O

-DOCSTART- X X O

Acad NNP O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
previously RB O
demonstrated VBN O
that IN O
expression NN O
of IN O
the DT O
gene NN O
for IN O
the DT O
reproductive JJ O
neuropeptide NN O
, , O
GnRH NNP B-NP
, , O
is VBZ O
repressed VBN O
by IN O
the DT O
glutamate/NO/cyclic JJ O
GMP JJ O
(cGMP NN O
) -RRB- O
signal NN O
transduction NN O
pathway NN O
through IN O
cGMP-dependent JJ B-NP
protein NN I-NP
kinase NN I-NP
in IN O
the DT O
hypothalamic JJ O
GnRH-secreting JJ B-NP
neuronal JJ O
cell NN O
line NN O
GT1-7. . O

-DOCSTART- X X O

Extreme JJ O
potency NN O
of IN O
botulinum NN B-NP
toxin NN I-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
c-Src JJ B-NP
activated JJ O
by IN O
isoproterenol NN O
led VBN O
to TO O
tyrosine NN O
phosphorylation NN O
of IN O
Shc NNP B-NP
and CC O
subsequent JJ O
Erk NNP B-NP
activation NN O
, , O
but CC O
not RB O
tyrosine JJ O
phosphorylation NN O
of IN O
cortactin NN B-NP
or CC O
Stat3 NNP B-NP
. . O

-DOCSTART- X X O

For IN O
wild JJ O
type NN O
MutT NNP B-NP
and CC O
its PRP$ O
E53D NNP B-NP
and CC O
E44D NNP B-NP
mutants NNS I-NP
, , O
plots NNS O
of IN O
log(k( JJ O
cat NN O
) -RRB- O
) -RRB- O
versus FW O
pH PRP O
exhibited VBD O
a DT O
limiting VBG O
slope NN O
of IN O
1 CD O
on IN O
the DT O
ascending VBG O
limb NN O
and CC O
then RB O
a DT O
hump NN O
, , O
i IN O
.e NN O
. . O
, , O
a DT O
sharply RB O
defined VBN O
maximum NN O
near IN O
pH NN O
8 CD O
followed VBN O
by IN O
a DT O
plateau NN O
, , O
yielding VBG O
apparent JJ O
pK( JJ O
a DT O
) -RRB- O
values NNS O
of IN O
7.6 CD O
+/ NNS O
- : O
0.3 CD O
and CC O
8.4 CD O
+/ NNS O
- : O
0.4 CD O
for IN O
an DT O
essential JJ O
base NN O
and CC O
a DT O
nonessential JJ O
acid NN O
catalyst NN O
, , O
respectively RB O
, , O
in IN O
the DT O
active JJ O
quaternary JJ O
MutT-Mg( JJ B-NP
2+)-dGTP-Mg( JJ O
2+ JJ O
) -RRB- O
complex NN O
. . O

-DOCSTART- X X O

Structural JJ O
changes NNS O
in IN O
the DT O
kinetically RB O
more RBR O
damaged JJ O
E44D NNP O
mutant NN O
detected VBD O
in IN O
( -LRB- O
1)H-(15)N JJ O
HSQC NN O
spectra NN O
were VBD O
largely RB O
limited VBN O
to TO O
the DT O
loop NN O
I-helix NNP O
I PRP O
motif RB O
, , O
suggesting VBG O
that IN O
Glu-44 NNP O
stabilizes VBZ O
the DT O
active JJ O
site NN O
region NN O
. . O

-DOCSTART- X X O

After IN O
i PRP O
.v. . O

-DOCSTART- X X O

The DT O
emerging VBG O
view NN O
based VBN O
on IN O
studies NNS O
in IN O
yeast NN O
is VBZ O
that IN O
each DT O
class NN O
of IN O
snoRNPs NNS O
is VBZ O
composed VBN O
of IN O
a DT O
unique JJ O
set NN O
of IN O
proteins NNS O
. . O

-DOCSTART- X X O

Activation NN O
of IN O
a DT O
CRE-dependent JJ O
junB NN B-NP
promoter/chloramphenicol NN I-NP
acetyltransferase NN B-NP
( -LRB- O
CAT NN B-NP
) -RRB- O
reporter NN O
gene NN O
by IN O
the DT O
BCR NNP B-NP
was VBD O
also RB O
blocked VBN O
by IN O
SB203580 CD O
. . O

-DOCSTART- X X O

We PRP O
present JJ O
evidence NN O
that IN O
the DT O
upstream RB O
open JJ O
reading NN O
frame NN O
(uORF NN O
) -RRB- O
represses VBZ O
the DT O
translation NN O
of IN O
the DT O
downstream JJ O
major JJ O
open JJ O
reading NN O
frame NN O
( -LRB- O
mORF NN O
) -RRB- O
. . O

-DOCSTART- X X O

Ras-GRF1 DT B-NP
transiently RB O
expressed VBN O
with IN O
v-Src NN B-NP
was VBD O
tyrosine-phosphorylated JJ O
and CC O
showed VBD O
significant JJ O
GEF NNP B-NP
activity NN O
toward IN O
Rac NNP B-NP
, , O
but CC O
not RB O
Rho NNP B-NP
and CC O
Cdc42 NNP B-NP
, , O
which WDT O
was VBD O
comparable JJ O
with IN O
that DT O
induced VBN O
by IN O
Gbetagamma NNP B-NP
. . O

-DOCSTART- X X O

EMSA NNP O
showed VBD O
that IN O
nuclear JJ O
proteins NNS O
from IN O
PC12 NN O
but CC O
not RB O
C6 NNP O
or CC O
Rat2 NNP O
cells NNS O
bind VBP O
the DT O
CRE NNP O
as IN O
a DT O
complex NN O
containing VBG O
activating JJ B-NP
transcription NN I-NP
factor NN I-NP
( -LRB- I-NP
ATF)-4 NNP I-NP
and CC O
CCAAT NNP B-NP
enhancer-binding JJ I-NP
protein NN I-NP
beta NN I-NP
, , O
while IN O
both DT O
PC12 NNP O
and CC O
C6 NNP O
cell NN O
nuclear JJ O
extracts NNS O
were VBD O
recruited VBN O
by IN O
the DT O
CCAAT-box NN O
as IN O
a DT O
complex NN O
containing VBG O
nuclear JJ B-NP
factor NN I-NP
Y PRP I-NP
. . O

-DOCSTART- X X O

Despite IN O
resolution NN O
of IN O
the DT O
solid JJ O
portion NN O
of IN O
the DT O
tumor NN O
, , O
serial JJ O
MRI NNP O
showed VBD O
enlargement NN O
of IN O
a DT O
bilobar NN O
tumor NN O
cyst NN O
3 CD O
years NNS O
after IN O
the DT O
original JJ O
diagnosis NN O
. . O

-DOCSTART- X X O

LPO NNP O
and CC O
SOD NNP B-NP
levels NNS O
were VBD O
measured VBN O
at IN O
five CD O
points NNS O
before IN O
and CC O
during IN O
the DT O
operation NN O
. . O

-DOCSTART- X X O

Second JJ O
, , O
when WRB O
the DT O
NBF1+R NNP B-NP
protein NN I-NP
, , O
the DT O
NBF2 NNP B-NP
protein NN I-NP
, , O
and CC O
a DT O
mixture NN O
of IN O
the DT O
two CD O
proteins NNS O
were VBD O
folded VBN O
separately RB O
and CC O
analyzed VBN O
by IN O
molecular JJ O
sieve NN O
chomatography NN O
, , O
the DT O
mixture NN O
was VBD O
found VBN O
to TO O
elute VB O
prior RB O
to TO O
either DT O
NBF1+R NNP B-NP
or CC O
NBF2 NNP B-NP
. . O

-DOCSTART- X X O

Sulfhydryl NNP O
titration NN O
with IN O
iodoacetamide JJ O
, , O
monitored VBN O
by IN O
quantitating VBG O
the DT O
residual JJ O
thiols NNS O
after IN O
reaction NN O
with IN O
a DT O
maleimide JJ O
derivative NN O
of IN O
biotin NN O
, , O
revealed VBD O
a DT O
striking JJ O
difference NN O
in IN O
the DT O
apparent JJ O
pK( NN O
a DT O
) -RRB- O
values NNS O
of IN O
the DT O
cysteines NNS O
at IN O
the DT O
two CD O
splice NN O
junctions NNS O
. . O

-DOCSTART- X X O

After IN O
nitric JJ O
oxide NN O
inhalation NN O
, , O
the DT O
results NNS O
showed VBD O
moderate JJ O
increases NNS O
in IN O
PaO2 NNP O
and CC O
SaO2 NNP O
( -LRB- O
P NNP O
> NN O
0.05 CD O
) -RRB- O
and CC O
a DT O
significant JJ O
decrease NN O
in IN O
Qs/ NNP O
Q NNP O
tau VBD O
ratio NN O
( -LRB- O
P NNP O
< NN O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
results NNS O
showed VBD O
that IN O
MIP NNP O
, , O
MMIF NNP O
, , O
FIC NNP O
, , O
Wimax NNP O
, , O
P0.1 NNP O
and CC O
minute NN O
ventilation NN O
( -LRB- O
Vr NNP O
) -RRB- O
were VBD O
significantly RB O
increased VBN O
after IN O
administration NN O
of IN O
methylphenidatum NN O
and CC O
aminophylline NN O
. . O

-DOCSTART- X X O

It PRP O
has VBZ O
also RB O
been VBN O
shown VBN O
that IN O
a DT O
variety NN O
of IN O
extracellular JJ O
factors NNS O
stimulate VB O
a DT O
pair NN O
of IN O
MAPK NN O
p44 NNS B-NP
and CC O
MAPK NNP O
p42 NN B-NP
of IN O
MAPK NNP B-NP
family NN I-NP
members NNS I-NP
. . O

-DOCSTART- X X O

Covalent JJ O
modification NN O
of IN O
the DT O
transactivator NN O
protein NN O
IE2-p86 . B-NP
of IN O
human JJ O
cytomegalovirus NN O
by IN O
conjugation NN O
to TO O
the DT O
ubiquitin-homologous JJ B-NP
proteins NNS I-NP
SUMO-1 JJ B-NP
and CC O
hSMT3b JJ B-NP
. . O

-DOCSTART- X X O

73 CD O
:658-666 CD O
, , O
1999 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
interaction NN O
between IN O
U(L)3 NNP O
. . O

-DOCSTART- X X O

Protamine NNP B-NP
and CC O
heparin NN O
doses NNS O
, , O
their PRP$ O
sum NN O
( -LRB- O
Sigma-dose NNP O
) -RRB- O
and CC O
differential JJ O
( -LRB- O
Delta-dose NN O
) -RRB- O
doses VBZ O
, , O
and CC O
activated VBD O
clotting VBG O
times NNS O
were VBD O
tabulated VBN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
a DT O
common JJ O
mechanism NN O
has VBZ O
been VBN O
identified VBN O
to TO O
coordinate VB O
the DT O
growth NN O
- : O
and CC O
FC-dependent JJ O
expression NN O
of IN O
caveolin NN B-NP
. . O

-DOCSTART- X X O

Expression NN O
in IN O
early JJ O
postnatal JJ O
pituitary NN O
and CC O
in IN O
pre-somatotrophic JJ O
cells NNS O
suggests VBZ O
that IN O
Zn-16 NNP B-NP
could MD O
play VB O
a DT O
role NN O
in IN O
pituitary JJ O
development NN O
prior RB O
to TO O
somatotroph NN O
differentiation NN O
. . O

-DOCSTART- X X O

The DT O
CCAAT NN O
core NN O
sequence NN O
mutants NNS O
in IN O
which WDT O
both DT O
CIII NNP O
and CC O
CI/CII NNP O
were VBD O
abolished VBN O
, , O
also RB O
increased VBD O
the DT O
promoter NN O
activity NN O
. . O

-DOCSTART- X X O

Deglutition NN O
is VBZ O
considered VBN O
to TO O
be VB O
immature JJ O
in IN O
infants NNS O
and CC O
to TO O
mature VB O
postnatally RB O
. . O

-DOCSTART- X X O

This DT O
repression NN O
does VBZ O
not RB O
require VB O
the DT O
PU.1 NNP B-NP
transactivation NN O
or CC O
PEST NN O
domains NNS O
and CC O
cannot MD O
be VB O
reversed VBN O
by IN O
p300 DT B-NP
expression NN O
. . O

-DOCSTART- X X O

First RB O
, , O
human JJ O
erythroid NN O
K562 IN O
cells NNS O
stably RB O
integrated VBN O
with IN O
various JJ O
HS-40 JJ B-NP
mutants NNS I-NP
cis VBD O
linked VBN O
to TO O
a DT O
human JJ B-NP
alpha-globin NN I-NP
promoter-growth NN I-NP
hormone NN B-NP
hybrid JJ O
gene NN O
were VBD O
analyzed VBN O
by IN O
genomic JJ O
footprinting NN O
and CC O
expression NN O
analysis NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
addition NN O
of IN O
purified VBN O
CBP NNP B-NP
to TO O
the DT O
nuclear JJ O
extracts NNS O
of IN O
T47D NNP O
cells NNS O
markedly RB O
stimulated VBN O
progesterone NN O
- : O
and CC O
PR-dependent JJ B-NP
transcription NN O
from IN O
a DT O
nucleosome-free JJ O
, , O
progesterone JJ O
response NN O
element NN O
( -LRB- O
PRE)-linked JJ O
reporter NN O
DNA NNP O
template NN O
. . O

-DOCSTART- X X O

Its PRP$ O
cognate NN O
binding JJ O
protein NN O
, , O
REST/NRSF NNP B-NP
, , O
is VBZ O
an DT O
essential JJ O
transcription NN O
factor NN O
; : O
its PRP$ O
null NN O
mutations NNS O
result VBP O
in IN O
embryonic JJ O
lethality NN O
, , O
and CC O
its PRP$ O
dominant JJ O
negative JJ O
mutants NNS O
produce VBP O
aberrant JJ O
expression NN O
of IN O
neuron-specific JJ O
genes NNS O
. . O

-DOCSTART- X X O

Finally RB O
, , O
the DT O
mechanism NN O
of IN O
ASK1 NNP B-NP
activation NN O
involves VBZ O
, , O
in IN O
part NN O
, , O
homo-oligomerization NN O
. . O

-DOCSTART- X X O

OUTCOME NNP O
: : O
Acetylcholine NN B-NP
receptor NN I-NP
antibodies NNS I-NP
and CC O
single-fibre JJ O
electromyogram NN O
were VBD O
useful JJ O
in IN O
the DT O
diagnosis NN O
of IN O
myasthenia NN O
gravis NN O
. . O

-DOCSTART- X X O

Two CD O
other JJ O
patients NNS O
underwent JJ O
PRFR. NNP O

-DOCSTART- X X O

Characterization NN O
of IN O
the DT O
5'-flanking JJ O
region NN O
of IN O
the DT O
human JJ B-NP
multidrug NN I-NP
resistance NN I-NP
protein NN I-NP
2 CD I-NP
( -LRB- O
MRP2 NN B-NP
) -RRB- O
gene NN O
and CC O
its PRP$ O
regulation NN O
in IN O
comparison NN O
withthe IN O
multidrug JJ B-NP
resistance NN I-NP
protein NN I-NP
3 CD I-NP
( -LRB- O
MRP3 IN B-NP
) -RRB- O
gene NN O
. . O

-DOCSTART- X X O

Of IN O
the DT O
153 CD O
patients NNS O
studied VBD O
, , O
CK-MB DT B-NP
results NNS O
were VBD O
positive JJ O
in IN O
91 CD O
( -LRB- O
59 CD O
% NN O
) -RRB- O
patients NNS O
; : O
ECG NNP O
revealed VBD O
AMI NNP O
in IN O
72 CD O
( -LRB- O
47 CD O
% NN O
) -RRB- O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
MIB NNP O
on IN O
the DT O
dose-response NN O
curve NN O
of IN O
externally RB O
applied VBN O
noradrenaline NN O
was VBD O
also RB O
studied VBN O
. . O

-DOCSTART- X X O

Linearized VBN O
overall JJ O
infection NN O
rates NNS O
( -LRB- O
events/100 NN O
patient-days NNS O
) -RRB- O
were VBD O
2.05 CD O
+/ NNS O
- : O
0.33 CD O
( -LRB- O
heart-lung NN O
) -RRB- O
and CC O
2.34 CD O
+/ NNS O
- : O
0.34 CD O
( -LRB- O
double-lung NN O
; : O
P NNP O
= SYM O
NS NNS O
) -RRB- O
at IN O
3 CD O
months NNS O
. . O

-DOCSTART- X X O

Static NNP O
and CC O
dynamic JJ O
compliance NN O
was VBD O
measured VBN O
after IN O
induction NN O
of IN O
anesthesia NN O
, , O
before RB O
and CC O
immediately RB O
after IN O
filtration NN O
in IN O
the DT O
operating NN O
theater NN O
, , O
1 CD O
hour NN O
after IN O
return NN O
to TO O
the DT O
pediatric JJ O
intensive JJ O
care NN O
unit NN O
, , O
and CC O
24 CD O
hours NNS O
after IN O
the DT O
operation NN O
. . O

-DOCSTART- X X O

KFC NNP B-NP
, , O
a DT O
Ste20-like JJ B-NP
kinase NN I-NP
with IN O
mitogenic JJ O
potential JJ O
and CC O
capability NN O
to TO O
activate VB O
the DT O
SAPK/JNK NNP B-NP
pathway NN O
. . O

-DOCSTART- X X O

TIP30 NN B-NP
has VBZ O
an DT O
intrinsic JJ O
kinase NN O
activity NN O
required VBD O
for IN O
up-regulation NN O
of IN O
a DT O
subset NN O
of IN O
apoptotic JJ O
genes NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
mapped VBN O
the DT O
human JJ B-NP
STAG3 NNP I-NP
gene NN I-NP
to TO O
the DT O
7q22 JJ O
region NN O
of IN O
chromosome NN O
7 CD O
; : O
six CD O
human JJ B-NP
STAG3-related JJ I-NP
genes NNS I-NP
have VBP O
also RB O
been VBN O
mapped VBN O
: : O
two CD O
at IN O
7q22 CD O
near IN O
the DT O
functional JJ O
gene NN O
, , O
one CD O
at IN O
7q11.22 CD O
, , O
and CC O
three CD O
at IN O
7q11.23 CD O
, , O
two CD O
of IN O
them PRP O
flanking VBG O
the DT O
breakpoints NNS O
commonly RB O
associated VBN O
with IN O
the DT O
Williams-Beuren NNP B-NP
syndrome NN I-NP
( -LRB- I-NP
WBS NNP I-NP
) -RRB- I-NP
deletion NN I-NP
. . O

-DOCSTART- X X O

In IN O
experiment NN O
2 CD O
the DT O
rats NNS O
had VBD O
free JJ O
access NN O
to TO O
two CD O
bottles NNS O
, , O
one CD O
of IN O
which WDT O
contained VBD O
tap NN O
water NN O
, , O
and CC O
the DT O
other JJ O
contained VBN O
either CC O
an DT O
ethanol NN O
( -LRB- O
6 CD O
% NN O
) -RRB- O
or CC O
a DT O
sucrose NN O
( -LRB- O
5 CD O
% NN O
) -RRB- O
solution NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
In IN O
this DT O
group NN O
of IN O
patients NNS O
, , O
male JJ O
gender NN O
( -LRB- O
P NNP O
= SYM O
0. . O

-DOCSTART- X X O

Selective NNP O
visual JJ O
attention NN O
involves VBZ O
dynamic JJ O
interplay NN O
between IN O
attentional JJ O
control NN O
systems NNS O
and CC O
sensory JJ O
brain NN O
structures NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
a1 JJ O
isoform NN O
is VBZ O
expressed VBN O
most RBS O
heavily RB O
in IN O
brain NN O
and CC O
heart NN O
, , O
a2 NN O
in IN O
liver NN O
and CC O
kidney NN O
, , O
and CC O
a3 NN O
in IN O
liver NN O
, , O
lung NN O
, , O
heart NN O
, , O
brain NN O
, , O
spleen JJ O
, , O
and CC O
kidney NN O
. . O

-DOCSTART- X X O

During IN O
the DT O
cloning NN O
by IN O
reverse JJ B-NP
transcriptase-polymerase NN I-NP
chain NN O
reaction NN O
of IN O
the DT O
human JJ B-NP
HIF-1alpha NNP I-NP
subunit NN I-NP
, , O
we PRP O
isolated VBD O
two CD O
cDNA NNS O
clones NNS O
which WDT O
corresponded VBD O
to TO O
alternative JJ O
splicing NN O
of IN O
the DT O
HIF-1alpha NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

To TO O
assess VB O
the DT O
relationship NN O
between IN O
G(q)/G( JJ B-NP
11 CD B-NP
) -RRB- I-NP
function NN O
with IN O
the DT O
phosphatidylinositol NN B-NP
3-kinase JJ I-NP
dependent JJ O
pathway NN O
, , O
expression NN O
of IN O
a DT O
dominant-interfering JJ O
p85 NN B-NP
regulatory JJ I-NP
subunit NN I-NP
, , O
as RB O
well RB O
as IN O
wortmannin NN O
treatment NN O
inhibited VBN O
insulin-stimulated JJ B-NP
but CC O
not RB O
G(q)/Q209L-stimulated JJ B-NP
GLUT4-EGFP JJ B-NP
translocation NN O
. . O

-DOCSTART- X X O

In IN O
endemic JJ O
BL NNPS O
, , O
the DT O
RB2/p130 NNP B-NP
gene NN O
is VBZ O
mutated VBN O
in IN O
most JJS O
of IN O
the DT O
cases NNS O
, , O
and CC O
the DT O
protein NN O
is VBZ O
restricted VBN O
to TO O
the DT O
cytoplasm NN O
. . O

-DOCSTART- X X O

Together RB O
, , O
these DT O
data NNS O
identify VBP O
ERK2 PRP B-NP
as IN O
a DT O
specific JJ O
and CC O
direct JJ O
target NN O
of IN O
HePTP NNP B-NP
and CC O
are VBP O
consistent JJ O
with IN O
a DT O
model NN O
in IN O
which WDT O
HePTP NNP B-NP
negatively RB O
regulates VBZ O
ERK2 JJ B-NP
activity NN O
as IN O
part NN O
of IN O
a DT O
feedback NN O
mechanism NN O
. . O

-DOCSTART- X X O

Strontium NN O
nitrate JJ O
mixed JJ O
with IN O
glycolic JJ O
acid NN O
, , O
in IN O
comparison NN O
with IN O
glycolic JJ O
acid NN O
alone RB O
, , O
markedly NN O
( -LRB- O
p<0.01 NN O
) -RRB- O
shortened VBD O
the DT O
duration NN O
of IN O
the DT O
irritation NN O
sensation NN O
from IN O
24.4+/-4.1 CD O
( -LRB- O
mean+/-SEM) NN O
min NN O
to TO O
8.9+/-3.7 CD O
( -LRB- O
mean+/-SEM) NN O
min NN O
, , O
and CC O
significantly RB O
( -LRB- O
p<0.05 NNS O
) -RRB- O
reduced VBD O
the DT O
mean JJ O
magnitude NN O
of IN O
the DT O
irritation NN O
sensation NN O
at IN O
all DT O
time NN O
points NNS O
( -LRB- O
overall JJ O
) -RRB- O
. . O

-DOCSTART- X X O

Analysis NNP O
of IN O
1 CD O
Mb NN O
of IN O
published VBN O
sequence NN O
from IN O
the DT O
region NN O
of IN O
conserved VBN O
synteny NN O
on IN O
human JJ O
chromosome NN O
5q31-q33 CC O
identified VBD O
45 CD O
gene NN O
candidates NNS O
, , O
including VBG O
35 CD O
expressed VBN O
genes NNS O
in IN O
the DT O
human JJ B-NP
IL-4 NN I-NP
cytokine NN I-NP
gene NN I-NP
cluster NN I-NP
. . O

-DOCSTART- X X O

Human NNP B-NP
AP-2rep NN I-NP
repressed VBD O
both DT O
reporter NN O
expression NN O
from IN O
a DT O
transiently RB O
transfected VBN O
AP-2alpha NNP B-NP
promoter NN I-NP
and CC O
the DT O
endogenous JJ O
AP-2alpha NNP B-NP
gene NN I-NP
and CC O
inversely RB O
was VBD O
negatively RB O
regulated VBN O
by IN O
AP-2alpha NNP B-NP
. . O

-DOCSTART- X X O

Clb/Cdc28 CC B-NP
kinases NNS O
promote VBP O
nuclear JJ O
export NN O
of IN O
the DT O
replication NN B-NP
initiator NN I-NP
proteins VBZ I-NP
Mcm2-7. . I-NP

-DOCSTART- X X O

Alternatively RB O
, , O
PC12-E2 JJ O
cells NNS O
were VBD O
submitted VBN O
to TO O
treatment NN O
with IN O
antibodies NNS O
to TO O
the DT O
fibroblast JJ B-NP
growth NN I-NP
factor NN I-NP
( -LRB- I-NP
FGF NN I-NP
) -RRB- I-NP
receptor NN I-NP
, , O
inhibitors NNS O
of IN O
the DT O
nonreceptor NN B-NP
tyrosine NN I-NP
kinase NN I-NP
p59(fyn NN B-NP
) -RRB- O
, , O
PLC NNP B-NP
, , O
PKC NNP B-NP
and CC O
MEK NNP B-NP
and CC O
an DT O
activator NN O
of IN O
PKC NNP B-NP
, , O
phorbol-12-myristate-13-acetate NN O
( -LRB- O
PMA NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Cooperative JJ O
roles NNS O
of IN O
Bozozok/Dharma NNP B-NP
and CC O
Nodal-related JJ B-NP
proteins NNS I-NP
in IN O
the DT O
formation NN O
of IN O
the DT O
dorsal JJ O
organizer NN O
in IN O
zebrafish NN O
. . O

-DOCSTART- X X O

Thiopentone DT O
sodium NN O
administered VBN O
at IN O
30 CD O
and CC O
10 CD O
min NN O
before IN O
or CC O
5 CD O
, , O
10 CD O
and CC O
15 CD O
min NN O
after IN O
exposure NN O
to TO O
NOC-5 NNP O
, , O
but CC O
not RB O
thereafter RB O
, , O
significantly RB O
attenuated VBD O
NO-induced NNP O
neurotoxicity NN O
compared VBN O
with IN O
controls NNS O
. . O

-DOCSTART- X X O

We PRP O
also RB O
show VBP O
that IN O
zygotically RB O
activated VBN O
Xretpos NNP O
transcripts NNS O
are VBP O
restricted VBN O
to TO O
ventro-posterior JJ O
specific JJ O
regions NNS O
and CC O
induced VBN O
by IN O
UV-irradiation NN O
and CC O
BMP-4 JJ B-NP
overexpression NN O
in IN O
cycloheximide-dependent JJ O
way NN O
. . O
genesis NN O
26 CD O
:198-207 CD O
, , O
2000 CD O
. . O

-DOCSTART- X X O

In IN O
all DT O
other JJ O
cases NNS O
, , O
vestibular JJ O
neurectomy NN O
or CC O
chemical NN O
vestibular JJ O
labyrinthectomy NN O
, , O
by IN O
means NNS O
of IN O
intratympanic JJ O
low JJ O
concentration NN O
gentamicin NNS O
( -LRB- O
20 CD O
mg/mL NN O
) -RRB- O
, , O
are VBP O
indicated VBN O
. . O

-DOCSTART- X X O

However RB O
, , O
when WRB O
, , O
where WRB O
and CC O
how WRB O
the DT O
DSPP NNP B-NP
is VBZ O
cleaved VBN O
into IN O
DSP NNP B-NP
and CC O
DPP NNP B-NP
is VBZ O
not RB O
clear JJ O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
TCR NNP B-NP
signaling VBG O
induces VBZ O
AP-1 JJ B-NP
binding NN O
to TO O
this DT O
site NN O
and CC O
regulates VBZ O
the DT O
fasl NN B-NP
promoter NN I-NP
function NN O
in IN O
a DT O
fashion NN O
dependent JJ O
on IN O
NF-kappaB NNP B-NP
binding NN O
. . O

-DOCSTART- X X O

Approximately RB O
20 CD O
% NN O
of IN O
ALCLs NNP O
that WDT O
express VBP O
ALK NNP B-NP
do VBP O
not RB O
contain VB O
the DT O
t( JJ O
2;5 CD O
) -RRB- O
, , O
suggesting VBG O
that IN O
other JJ O
genetic JJ O
abnormalities NNS O
can MD O
result VB O
in IN O
aberrant JJ O
ALK NNP B-NP
expression NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
expected VBD O
decreases NNS O
in IN O
ATIC NNP B-NP
enzymatic JJ O
function NN O
in IN O
ATIC-ALK-containing DT B-NP
lymphomas NNS O
may MD O
render VB O
these DT O
tumors NNS O
more RBR O
sensitive JJ O
to TO O
antifolate VB O
drugs NNS O
such JJ O
as IN O
methotrexate NN O
. . O

-DOCSTART- X X O

Manganese JJ O
ions NNS O
were VBD O
found VBN O
to TO O
be VB O
essential JJ O
for IN O
autophosphorylation NN O
of IN O
BGLF4 NNP B-NP
, , O
and CC O
magnesium NN O
can MD O
stimulate VB O
the DT O
activity NN O
. . O

-DOCSTART- X X O

The DT O
Mif1 NNP B-NP
5' VBD I-NP
flanking VBG I-NP
region NN I-NP
contains VBZ O
a DT O
functional JJ O
ER NNP O
stress-responsive JJ O
element NN O
which WDT O
is VBZ O
sufficient JJ O
for IN O
induction NN O
by IN O
tunicamycin NN O
. . O

-DOCSTART- X X O

Rigid JJ O
point NN O
feature NN O
registration NN O
using VBG O
mutual JJ O
information NN O
. . O

-DOCSTART- X X O

PURPOSE NN O
: : O
A DT O
two-generation JJ O
consanguineous JJ O
Pakistani JJ O
family NN O
with IN O
autosomal JJ O
recessive JJ O
Leber NNP O
congenital NN O
amaurosis NN O
(LCA NNP O
, , O
MIM JJ O
204,000 CD O
) -RRB- O
and CC O
keratoconus NN O
was VBD O
identified VBN O
. . O

-DOCSTART- X X O

Ste18p NNP B-NP
was VBD O
targeted VBN O
to TO O
the DT O
plasma NN O
membrane NN O
even RB O
in IN O
the DT O
absence NN O
of IN O
prenylation NN O
or CC O
thioacylation NN O
. . O

-DOCSTART- X X O

An DT O
amino-acid JJ O
sequence NN O
comparison NN O
revealed VBD O
that IN O
Bacillus NNP B-NP
YM55-1 NNP I-NP
aspartase NN I-NP
shared VBD O
71 CD O
% NN O
homology NN O
with IN O
Bacillus NNP B-NP
subtilis NNS I-NP
aspartase NN I-NP
and CC O
49 CD O
% NN O
with IN O
Escherichia NNP O
coli NNS O
and CC O
Pseudomonas NNS B-NP
fluorescens NNS I-NP
aspartases NNS I-NP
. . O

-DOCSTART- X X O

Collectively RB O
, , O
the DT O
results NNS O
suggest VBP O
that IN O
ARF NN B-NP
binding NN O
to TO O
Mdm2 NNP B-NP
induces VBZ O
a DT O
conformational JJ O
change NN O
that IN O
facilitates NNS O
nucleolar JJ O
import NN O
of IN O
the DT O
ARF-Mdm2 NN B-NP
complex NN O
and CC O
p53-dependent JJ B-NP
cell NN O
cycle NN O
arrest NN O
. . O

-DOCSTART- X X O

Cyclin NNP B-NP
A DT I-NP
expression NN O
is VBZ O
repressed VBN O
in IN O
quiescent JJ O
cells NNS O
by IN O
E2F NNP B-NP
acting VBG O
in IN O
conjunction NN O
with IN O
its PRP$ O
pocket NN O
protein NN O
partners NNS O
Rb NN B-NP
, , O
p107 VBD B-NP
, , O
and CC O
p130 VBD B-NP
; : O
however RB O
, , O
v-Jun JJ B-NP
overrides IN O
this DT O
control NN O
, , O
causing VBG O
phosphorylated JJ O
Rb NN B-NP
and CC O
proliferation-specific JJ O
E2F-p107 JJ B-NP
complexes NNS O
to TO O
persist VB O
after IN O
mitogen NN O
withdrawal NN O
. . O

-DOCSTART- X X O

D-cyclin-cdk JJ B-NP
activity NN O
is VBZ O
required VBN O
for IN O
Rb NNP B-NP
phosphorylation NN O
in IN O
v-Jun-transformed JJ B-NP
cells NNS O
, , O
since IN O
ectopic JJ O
expression NN O
of IN O
the DT O
cdk4 CD B-NP
- : O
and CC O
cdk6-specific JJ B-NP
inhibitor JJ O
p16(INK4A NN B-NP
) -RRB- O
inhibits VBZ O
both DT O
DNA NNP O
synthesis NN O
and CC O
cell NN O
proliferation NN O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
A DT O
valve-like JJ O
mechanism NN O
formed VBN O
by IN O
the DT O
capsulorhexis NNS O
rim VBP O
partially RB O
adhered VBN O
to TO O
the DT O
IOL NNP O
optic NN O
can MD O
occur VB O
postoperatively RB O
. . O

-DOCSTART- X X O

The DT O
protein NN O
first RB O
identified VBN O
by IN O
the DT O
monoclonal JJ B-NP
antibody NN I-NP
Q18 . I-NP
is VBZ O
encoded VBN O
by IN O
a DT O
gene NN O
located VBN O
in IN O
57A CD O
on IN O
polytene NN O
chromosomes NNS O
and CC O
has VBZ O
been VBN O
consequently RB O
named VBN O
Hrb57A. . B-NP

-DOCSTART- X X O

3' JJ O
RNA NNP O
boundary NN O
experiments NNS O
indicate VBP O
that IN O
the DT O
5' JJ O
structure NN O
reduces VBZ O
the DT O
number NN O
of IN O
( -LRB- O
G/U)AG NN O
repeats NNS O
required VBN O
for IN O
stable JJ O
TRAP-trp JJ B-NP
leader NN O
RNA NNP O
association NN O
. . O

-DOCSTART- X X O

The DT O
AtERF NNP B-NP
genes NNS I-NP
were VBD O
differentially RB O
regulated VBN O
by IN O
ethylene NN O
and CC O
by IN O
abiotic JJ O
stress NN O
conditions NNS O
, , O
such JJ O
as IN O
wounding VBG O
, , O
cold JJ O
, , O
high JJ O
salinity NN O
, , O
or CC O
drought NN O
, , O
via IN O
ETHYLENE-INSENSITIVE2 NNP B-NP
( -LRB- O
EIN2)-dependent JJ B-NP
or CC O
-independent JJ O
pathways NNS O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
the DT O
response NN O
rates NNS O
and CC O
toxicity NN O
of IN O
two CD O
regimens NNS O
containing VBG O
granulocyte-macrophage-colony JJ B-NP
stimulating JJ I-NP
factor NN I-NP
( -LRB- O
GM-CSF NNP B-NP
) -RRB- O
in IN O
combination NN O
with IN O
interleukin-2 JJ B-NP
( -LRB- O
IL-2 NN B-NP
) -RRB- O
in IN O
the DT O
treatment NN O
of IN O
patients NNS O
with IN O
metastatic JJ O
renal JJ O
cell NN O
carcinoma NN O
. . O

-DOCSTART- X X O

Electrophoretic NNP O
mobility NN O
shift NN O
assays VBZ O
revealed VBN O
that IN O
Sp1 NNP B-NP
binds NNS O
to TO O
two CD O
different JJ O
regions NNS O
in IN O
the DT O
proximal JJ O
promoter NN O
, , O
a DT O
typical JJ O
Sp1 JJ B-NP
site NN I-NP
located VBN O
at IN O
(-38 CD O
; : O
-33 JJ O
) -RRB- O
and CC O
a DT O
G/C-rich JJ O
region NN O
between IN O
(-67 CD O
; : O
-62 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Fgd3 . B-NP
and CC O
FGD1 JJ B-NP
share NN O
a DT O
high JJ O
degree NN O
of IN O
sequence NN O
identity NN O
that IN O
spans NNS O
>560 VBP O
contiguous JJ O
amino IN O
acid NN O
residues NNS O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
of IN O
mouse NN B-NP
thioredoxin NN I-NP
reductases NNS I-NP
. . O

-DOCSTART- X X O

The DT O
HPLC NNP O
method NN O
involves VBZ O
an DT O
octadecylsilane NN O
column NN O
at IN O
55 CD O
degrees NNS O
C NN O
, , O
a DT O
mixture NN O
of IN O
water-acetonitrile-orthophosphoric JJ O
acid NN O
( -LRB- O
779:220:1 CD O
, , O
v/v RB O
) -RRB- O
as IN O
mobile JJ O
phase NN O
and CC O
detection NN O
at IN O
226 CD O
nm NN O
. . O

-DOCSTART- X X O

Eight CD O
patients NNS O
received VBD O
1.5 CD O
mg NN O
of IN O
adefovir JJ O
dipivoxil NN O
per IN O
kg NN O
of IN O
body NN O
weight NN O
, , O
and CC O
six CD O
patients NNS O
received VBD O
3.0 CD O
mg NN O
of IN O
adefovir JJ O
dipivoxil NN O
per IN O
kg NN O
. . O

-DOCSTART- X X O

To TO O
determine VB O
if IN O
CYC2 PRP B-NP
is VBZ O
found VBN O
in IN O
a DT O
complex JJ O
with IN O
previously RB O
identified VBN O
trypanosome DT B-NP
cdc2-related JJ I-NP
kinases NNS I-NP
( -LRB- O
CRKs NNP B-NP
) -RRB- O
, , O
the DT O
CYC2 NNP B-NP
gene NN I-NP
was VBD O
fused VBN O
to TO O
the DT O
TY NN B-NP
epitope NN I-NP
tag NN O
, , O
integrated VBN O
into IN O
the DT O
trypanosome JJ O
genome NN O
, , O
and CC O
expressed VBD O
under IN O
inducible JJ O
control NN O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
indicate VBP O
the DT O
involvement NN O
of IN O
Sp1 NNP B-NP
and CC O
an DT O
Inr NNP O
in IN O
non-cell-specific JJ O
regulation NN O
and CC O
a DT O
Kruppel-like JJ B-NP
transcription NN I-NP
factor NN I-NP
and CC O
Sp1 NNP B-NP
in IN O
the DT O
cell-specific JJ O
regulation NN O
of IN O
the DT O
LTC( NNP B-NP
4)S NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

The DT O
newly RB O
defined VBN O
region NN O
contains VBZ O
an DT O
intron NN O
that WDT O
may MD O
be VB O
alternatively RB O
spliced VBN O
and CC O
seven CD O
polyadenylation NN O
signal NN O
sequences NNS O
. . O

-DOCSTART- X X O

Most RBS O
likely JJ O
they PRP O
might MD O
represent VB O
regulatory JJ O
RNAs NNS O
or CC O
transcribed VBN O
transposable JJ O
elements NNS O
. . O

-DOCSTART- X X O

Although IN O
MAP NNP B-NP
( -LRB- I-NP
mitogen-activated JJ I-NP
protein NN I-NP
) -RRB- I-NP
kinases NNS I-NP
are VBP O
implicated VBN O
in IN O
cell NN O
proliferation NN O
and CC O
differentiation NN O
in IN O
many JJ O
cell NN O
types NNS O
, , O
the DT O
role NN O
of IN O
MAP NNP B-NP
kinases NNS I-NP
in IN O
cardiac JJ O
hypertrophy NN O
remains VBZ O
unclear JJ O
. . O

-DOCSTART- X X O

Transfection NN O
with IN O
a DT O
CSF-1R JJ B-NP
expression NN O
plasmid NN O
permitted VBN O
CSF-1-dependent JJ B-NP
activation NN O
of IN O
the DT O
signalling NN O
pathway NN O
targeting VBG O
an DT O
Ets/AP1 NNP B-NP
( -LRB- O
activator NN B-NP
protein NN I-NP
1 CD I-NP
) -RRB- O
element NN O
in IN O
the DT O
uPA NNP B-NP
promoter NN I-NP
that WDT O
has VBZ O
been VBN O
shown VBN O
previously RB O
to TO O
be VB O
a DT O
target NN O
of IN O
oncogenic JJ B-NP
ras NNS I-NP
and CC O
protein NN O
kinase NN O
C NNP O
pathways NNS O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
urokinase NN B-NP
plasminogen NN I-NP
activator NN I-NP
gene NN I-NP
transcription NN O
in IN O
the DT O
RAW264 NNP O
murine NN O
macrophage NN O
cell NN O
line NN O
by IN O
macrophage NN B-NP
colony-stimulating NN I-NP
factor NN I-NP
( -LRB- O
CSF-1 NN B-NP
) -RRB- O
is VBZ O
dependent JJ O
upon IN O
the DT O
level NN O
of IN O
cell-surface NN O
receptor NN O
. . O

-DOCSTART- X X O

Coactivation NNP O
of IN O
endogenous JJ O
or CC O
exogenous JJ O
G(q)-coupled JJ B-NP
receptors NNS I-NP
with IN O
the DT O
delta-opioid JJ B-NP
receptor NN I-NP
produced VBD O
strong JJ O
stimulations NNS O
of IN O
PLCbeta NNP B-NP
and CC O
such JJ O
responses NNS O
could MD O
be VB O
partially RB O
blocked VBN O
by IN O
pertussis NN B-NP
toxin NN I-NP
. . O

-DOCSTART- X X O

Patients NNS O
enrolled VBD O
in IN O
the DT O
Integrilin NNP O
to TO O
Minimize NNP O
Platelet NNP O
Aggregation NNP O
and CC O
Coronary JJ O
Thrombosis-II NNP O
( -LRB- O
IMPACT-II NNP O
) -RRB- O
trial NN O
were VBD O
analyzed VBN O
. . O

-DOCSTART- X X O

The DT O
Wnt NNP B-NP
signaling VBG O
pathway NN O
functions NNS O
reiteratively RB O
during IN O
animal NN O
development NN O
to TO O
control VB O
cell NN O
fate NN O
decisions NNS O
. . O

-DOCSTART- X X O

The DT O
two CD O
contiguous JJ O
IGF2 NN B-NP
( -LRB- O
human JJ B-NP
insulin-like NN I-NP
growth NN I-NP
factor NN I-NP
II NNP I-NP
) -RRB- O
and CC O
H19 CD B-NP
genes NNS I-NP
are VBP O
reciprocally RB O
imprinted VBN O
in IN O
both DT O
human JJ O
and CC O
mouse NN O
. . O

-DOCSTART- X X O

The DT O
asymmetric JJ O
methylation NN O
was VBD O
associated VBN O
with IN O
tissue-specific JJ O
disruption NN O
of IN O
H19 NNP B-NP
genomic JJ O
imprinting NN O
in IN O
fetal NN O
brain NN O
. . O

-DOCSTART- X X O

Early RB O
treatment NN O
mechanics NNS O
of IN O
the DT O
Class NNP O
II NNP O
division NN O
2 CD O
malocclusion NN O
. . O

-DOCSTART- X X O

Among IN O
mammalian JJ B-NP
HSFs NNP I-NP
, , O
HSF1 NNP B-NP
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
important JJ O
for IN O
regulation NN O
of IN O
the DT O
heat-induced JJ O
stress NN O
gene NN O
expression NN O
, , O
whereas IN O
the DT O
function NN O
of IN O
HSF2 NNP B-NP
in IN O
stress NN O
response NN O
is VBZ O
unclear JJ O
. . O

-DOCSTART- X X O

They PRP O
share VBP O
many JJ O
downstream NN O
targets NNS O
, , O
including VBG O
remodeling NN O
of IN O
the DT O
actin NN B-NP
cytoskeleton NN O
, , O
activation NN O
of IN O
p70(S6 NNS B-NP
) -RRB- I-NP
kinase NN I-NP
and CC O
c-jun JJ B-NP
N-terminal JJ I-NP
kinase NN I-NP
( -LRB- O
JNK) NNP B-NP
, , O
and CC O
regulation NN O
of IN O
transcription NN O
and CC O
cell NN O
proliferation NN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
activated JJ O
Cdc42 JJ B-NP
results NNS O
in IN O
the DT O
translocation NN O
of IN O
PKClambda NNP B-NP
from IN O
the DT O
nucleus NN O
into IN O
the DT O
cytosol NN O
, , O
and CC O
Cdc42 NNP B-NP
and CC O
PKClambda NNP B-NP
colocalize NN O
at IN O
the DT O
plasma NN O
membrane NN O
and CC O
in IN O
the DT O
cytoplasm NN O
. . O

-DOCSTART- X X O

To TO O
understand VB O
whether IN O
Shc NNP B-NP
localization NN O
in IN O
membrane NN O
rafts NNS O
is VBZ O
sufficient JJ O
to TO O
regulate VB O
Shc NNP B-NP
function NN O
, , O
we PRP O
constructed VBD O
a DT O
Shc NN B-NP
chimera NN I-NP
containing VBG O
the DT O
Ras NNP B-NP
membrane NN I-NP
localization NN I-NP
motif NN I-NP
at IN O
the DT O
C-terminus NN O
. . O

-DOCSTART- X X O

Southern JJ O
blotting NN O
and CC O
single JJ O
strand JJ O
conformation NN O
polymorphism NN O
analyses NNS O
did VBD O
not RB O
show VB O
tumor-specific JJ O
alterations NNS O
of IN O
this DT O
gene NN O
in IN O
gliomas NNS O
and CC O
RT-PCR JJ O
studies NNS O
showed VBD O
expression NN O
in IN O
glioma NN O
cell NN O
lines NNS O
, , O
suggesting VBG O
that IN O
ANOVA NNP B-NP
is VBZ O
not RB O
the DT O
chromosome NN O
19q IN O
glioma NN O
tumor NN O
suppressor NN O
gene NN O
. . O

-DOCSTART- X X O

RegA NNP B-NP
is VBZ O
a DT O
positive JJ O
yet CC O
nonessential JJ O
regulator NN O
of IN O
tol-oprL JJ B-NP
expression NN O
. . O

-DOCSTART- X X O

Enzyme NNP B-NP
I PRP I-NP
of IN O
the DT O
phosphoenolpyruvate JJ B-NP
:sugar NN I-NP
phosphotransferase NN I-NP
system NN O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
these DT O
data NNS O
, , O
we PRP O
conclude VBP O
that IN O
transcription NN O
of IN O
prgX NN B-NP
is VBZ O
initiated VBN O
from IN O
the DT O
Qa NNP B-NP
promoter NN I-NP
in IN O
prgQ NN B-NP
, , O
and CC O
PrgX NNP B-NP
autoregulates VBZ O
its PRP$ O
transcription NN O
either CC O
by IN O
mediating VBG O
transcriptional JJ O
readthrough JJ O
or CC O
increasing VBG O
mRNA JJ O
stability NN O
. . O

-DOCSTART- X X O

Molecular JJ O
mimicry NN O
of IN O
human JJ O
cytokine NN O
and CC O
cytokine JJ O
response NN O
pathway NN O
genes NNS O
by IN O
KSHV. NNP O

-DOCSTART- X X O

By IN O
electrophoresis NN O
mobility NN O
shift NN O
assays IN O
using VBG O
probes NNS O
corresponding JJ O
to TO O
different JJ O
segments NNS O
of IN O
the DT O
putative JJ O
human JJ B-NP
c-myb NN I-NP
intron IN I-NP
1 CD I-NP
transcription NN I-NP
pause NN I-NP
region NN I-NP
and CC O
nuclear JJ O
extracts NNS O
from IN O
myeloid JJ O
leukemia NN O
HL NNP O
60 CD O
and CC O
fibroblast JJ O
WI IN O
38 CD O
cells NNS O
, , O
we PRP O
detected VBD O
a DT O
HL-60-specific JJ O
DNA-protein NNP O
complex NN O
with IN O
a DT O
123-bp JJ O
fragment NN O
containing VBG O
binding NN O
sites NNS O
for IN O
the DT O
interferon NN B-NP
regulatory JJ I-NP
factors NNS I-NP
( -LRB- O
IRFs NN B-NP
) -RRB- O
nuclear JJ O
proteins NNS O
. . O

-DOCSTART- X X O

STUDY NNP O
DESIGN NNP O
: : O
Fine JJ O
needle NN O
aspiration NN O
cytologic NN O
smears VBZ O
from IN O
21 CD O
cases NNS O
of IN O
invasive JJ O
lobular NN O
carcinoma NN O
( -LRB- O
ILC NNP O
) -RRB- O
of IN O
breast NN O
were VBD O
subjected VBN O
to TO O
detailed JJ O
cytomorphologic NN O
analysis NN O
. . O

-DOCSTART- X X O

A DT O
new JJ O
technique NN O
to TO O
create VB O
an DT O
artificial JJ O
stenosis NN O
in IN O
the DT O
native JJ O
LAD NN O
using VBG O
a DT O
hemoclip NN O
. . O

-DOCSTART- X X O

Dll3 DT B-NP
is VBZ O
mutated VBN O
in IN O
the DT O
X-ray-induced JJ O
mouse NN B-NP
mutant NN I-NP
pudgy NN I-NP
( -LRB- O
pu NN B-NP
) -RRB- O
, , O
causing VBG O
a DT O
variety NN O
of IN O
vertebrocostal JJ O
defects NNS O
similar JJ O
to TO O
SD NNP O
phenotypes NNS O
. . O

-DOCSTART- X X O

Invertases NNS B-NP
are VBP O
responsible JJ O
for IN O
the DT O
breakdown NN O
of IN O
sucrose NN O
to TO O
fructose VB O
and CC O
glucose VB O
. . O

-DOCSTART- X X O

To TO O
investigate VB O
the DT O
molecular JJ O
mechanisms NNS O
of IN O
this DT O
Tax-mediated JJ B-NP
inhibition NN O
, , O
we PRP O
analyzed VBD O
its PRP$ O
effect NN O
on IN O
the DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
myogenic JJ O
MyoD NNP B-NP
protein NN I-NP
, , O
which WDT O
was VBD O
used VBN O
as IN O
a DT O
paradigm NN O
of IN O
bHLH JJ B-NP
factors NNS I-NP
. . O

-DOCSTART- X X O

The DT O
cell NN O
cycle NN O
and CC O
transcriptional JJ O
defects NNS O
caused VBN O
by IN O
taf17(slm7-1 NN B-NP
) -RRB- O
are VBP O
consistent JJ O
with IN O
the DT O
role NN O
of IN O
TAF(II NNP B-NP
)s NNP I-NP
as IN O
modulators NNS O
of IN O
transcriptional JJ O
activation NN O
and CC O
may MD O
reflect VB O
a DT O
role NN O
for IN O
TAF17 NNP B-NP
in IN O
regulating VBG O
activation NN O
by IN O
SBF NNP B-NP
and CC O
MBF. NNP B-NP

-DOCSTART- X X O

Extracellular-regulated JJ B-NP
kinase NN I-NP
( -LRB- O
ERK) NNP B-NP
activation NN O
and CC O
molecular JJ O
coupling NN O
of IN O
the DT O
adaptor NN O
proteins VBZ O
p130 DT B-NP
Crk-associated JJ B-NP
substrate NN I-NP
( -LRB- O
CAS NNP B-NP
) -RRB- O
and CC O
c-CrkI JJ B-NP
I PRP I-NP
( -LRB- O
Crk NNP B-NP
) -RRB- O
represent VBP O
two CD O
distinct JJ O
pathways NNS O
that WDT O
induce VB O
cell NN O
invasion NN O
and CC O
protect VB O
cells NNS O
from IN O
apoptosis NN O
in IN O
a DT O
three-dimensional JJ O
collagen NN B-NP
matrix NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
residue NN O
266 CD O
serves VBZ O
as IN O
a DT O
"protein NN O
sensor NN O
" '' O
of IN O
altered JJ O
minor JJ O
groove NN O
interactions NNS O
and CC O
identifies VBZ O
which WDT O
base NN O
pair NN O
interactions NNS O
are VBP O
altered VBN O
by IN O
these DT O
lesions NNS O
. . O

-DOCSTART- X X O

The DT O
recombinant JJ O
enzymes NNS O
exist VBP O
as IN O
monomers NNS O
. . O

-DOCSTART- X X O

A DT O
pathway NN O
for IN O
regulation NN O
of IN O
B NNP B-NP
lymphocyte NN I-NP
antigen RB I-NP
receptor-induced JJ I-NP
calcium NN O
flux NN O
. . O

-DOCSTART- X X O

We PRP O
now RB O
describe VBP O
a DT O
second JJ O
RIM NNP B-NP
protein NN I-NP
, , O
called VBD O
RIM2 NNP B-NP
, , O
that WDT O
is VBZ O
highly RB O
homologous JJ O
to TO O
RIM1 VB B-NP
and CC O
also RB O
expressed VBN O
primarily RB O
in IN O
brain NN O
. . O

-DOCSTART- X X O

Scanning VBG O
mutations NNS O
throughout IN O
the DT O
AC NNP O
element NN O
interfered VBN O
with IN O
induction NN O
but CC O
allowed VBD O
us PRP O
to TO O
define VB O
five CD O
overlapping VBG O
sites NNS O
for IN O
regulatory JJ O
factors NNS O
in IN O
AC NNP O
and CC O
to TO O
design VB O
probes NNS O
binding NN O
just RB O
one CD O
or CC O
two CD O
factors NNS O
. . O

-DOCSTART- X X O

The DT O
substrates NNS O
for IN O
glycan NN O
synthesis NN O
in IN O
the DT O
lumen NNS O
of IN O
the DT O
Golgi NNP O
are VBP O
nucleotide JJ O
sugars NNS O
that WDT O
must MD O
be VB O
transported VBN O
from IN O
the DT O
cytosol NN O
by IN O
specific JJ O
membrane-bound NN O
transporters NNS O
. . O

-DOCSTART- X X O

Synaptic JJ O
targeting VBG O
of IN O
the DT O
postsynaptic JJ B-NP
density NN I-NP
protein NN I-NP
PSD-95 DT I-NP
mediated VBN O
by IN O
a DT O
tyrosine-based JJ O
trafficking NN O
signal NN O
. . O

-DOCSTART- X X O

Bites NNS O
by IN O
two CD O
species NNS O
of IN O
adders NNS O
( -LRB- O
Vipera NNP O
aspis VBD O
and CC O
Vipera NNP O
berus NN O
) -RRB- O
can MD O
lead VB O
to TO O
extensive JJ O
swelling VBG O
with IN O
multiorgan JJ O
failure NN O
. . O

-DOCSTART- X X O

Both DT O
normal JJ O
and CC O
transforming JJ O
PCPH NNP B-NP
proteins NNS I-NP
have VBP O
guanosine NN B-NP
diphosphatase NN I-NP
activity NN O
but CC O
only RB O
the DT O
oncoprotein NNP O
cooperates NNS O
with IN O
Ras NNP B-NP
in IN O
activating VBG O
extracellular JJ B-NP
signal-regulated JJ I-NP
kinase NN I-NP
ERK1 NNP B-NP
. . O

-DOCSTART- X X O

Paxillin NNP B-NP
acts VBZ O
as IN O
an DT O
adaptor NN O
molecule NN O
in IN O
integrin NN B-NP
signaling NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
analysis NN O
of IN O
deletion NN O
promoter-reporter NN O
constructs NNS O
found VBD O
that IN O
the DT O
basal JJ O
activity NN O
of IN O
P2 NNP O
resided VBD O
in IN O
the DT O
proximal JJ O
region NN O
of IN O
P2 NNP O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
the DT O
transcription NN O
of IN O
c-IAP2 JJ B-NP
promoter NN I-NP
was VBD O
strongly RB O
up-regulated JJ O
when WRB O
CD40 PRP B-NP
or CC O
Epstein-Barr NNP B-NP
virus NN I-NP
latent JJ I-NP
membrane NN I-NP
protein NN I-NP
1 CD I-NP
was VBD O
overexpressed VBN O
. . O

-DOCSTART- X X O

These DT O
studies NNS O
identify VBP O
several JJ O
of IN O
the DT O
signal-transduction NN O
events NNS O
involved VBN O
in IN O
the DT O
apoptosis NN O
of IN O
malignant JJ O
B NNP O
cells NNS O
that WDT O
transpire VBP O
following VBG O
ligation NN O
of IN O
CD20 NNP B-NP
by IN O
anti-CD20 DT B-NP
antibodies NNS I-NP
in IN O
the DT O
presence NN O
of IN O
Fc-receptor-expressing JJ B-NP
cells NNS O
or CC O
secondary JJ O
goat NN O
anti-(mouse NN B-NP
Ig NNP I-NP
) -RRB- I-NP
antibodies NNS I-NP
and CC O
which WDT O
may MD O
contribute VB O
to TO O
the DT O
tumor NN O
regressions NNS O
observed VBN O
in IN O
mouse NN O
models NNS O
and CC O
clinical JJ O
trials NNS O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Treatment NNP O
of IN O
sepsis NN O
with IN O
the DT O
platelet-activating NN B-NP
factor NN I-NP
antagonist NN O
BB-882 CC O
offers VBZ O
no DT O
advantage NN O
over IN O
placebo NN O
on IN O
survival NN O
, , O
hemodynamic JJ O
status NN O
, , O
respiratory JJ O
function NN O
, , O
or CC O
organ NN O
failure NN O
scores NNS O
. . O

-DOCSTART- X X O

Recently RB O
, , O
identical JJ O
RBE NNP B-NP
sequences NNS I-NP
have VBP O
been VBN O
identified VBN O
at IN O
other JJ O
locations NNS O
in IN O
the DT O
human JJ O
genome NN O
. . O

-DOCSTART- X X O

EM NN O
analysis NN O
demonstrated VBN O
that IN O
only RB O
one CD O
Rep-DNA NNP B-NP
complex NN I-NP
was VBD O
formed VBN O
on IN O
ch-19 JJ O
target NN O
DNA NN O
. . O

-DOCSTART- X X O

In IN O
vivo FW O
dimethyl NN O
sulfate NN O
footprinting NN O
of IN O
the DT O
cyclin NN B-NP
E NNP I-NP
promoter NN I-NP
revealed VBD O
several JJ O
regions NNS O
of IN O
protection NN O
and CC O
hypersensitivity NN O
that WDT O
were VBD O
unique JJ O
to TO O
infected JJ O
cells NNS O
. . O

-DOCSTART- X X O

A DT O
total NN O
of IN O
194 CD O
STSs NN O
map NN O
to TO O
this DT O
interval NN O
of IN O
3 CD O
Mb NN O
, , O
giving VBG O
an DT O
average JJ O
marker NN O
resolution NN O
of IN O
approximately RB O
one CD O
per IN O
15 CD O
kb NN O
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
We PRP O
determined VBD O
an DT O
odds NNS O
ratio NN O
( -LRB- O
OR JJ O
) -RRB- O
, , O
as IN O
a DT O
measure NN O
of IN O
the DT O
relative JJ O
risk NN O
of IN O
being VBG O
exposed VBN O
to TO O
a DT O
potential JJ O
interaction NN O
, , O
comparing VBG O
the DT O
use NN O
of IN O
the DT O
H2-receptor NNP B-NP
antagonist NN O
, , O
cimetidine NN O
, , O
with IN O
that DT O
of IN O
the DT O
noninteracting JJ O
agents NNS O
ranitidine VBP O
, , O
famotidine JJ O
and CC O
nizatidine JJ O
in IN O
users NNS O
and CC O
nonusers NNS O
of IN O
warfarin NN O
, , O
phenytoin NN O
and CC O
theophylline NN O
. . O

-DOCSTART- X X O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
, , O
at IN O
least JJS O
at IN O
high JJ O
temperature NN O
, , O
a DT O
critical JJ O
minimal JJ O
level NN O
of IN O
Ypt JJ B-NP
protein NN I-NP
prenylation NN O
is VBZ O
required VBN O
for IN O
maintaining VBG O
vesicle NN O
polarization NN O
. . O

-DOCSTART- X X O

The DT O
second JJ O
functional JJ O
pair NN O
of IN O
CreA NNP B-NP
sites NNS I-NP
is VBZ O
located VBN O
between IN O
the DT O
two CD O
transcription NN O
initiation NN O
sites NNS O
. . O

-DOCSTART- X X O

The DT O
'Newcastle NNP O
' POS O
model NN O
, , O
which WDT O
is VBZ O
based VBN O
on IN O
Hotelling NNP O
's POS O
T2 NNP O
statistic NN O
, , O
proved VBD O
to TO O
be VB O
more RBR O
sensitive JJ O
and CC O
diagnosed VBD O
a DT O
systematic JJ O
displacement NN O
for IN O
three CD O
prostate NN O
patients NNS O
. . O

-DOCSTART- X X O

After IN O
phosphorylation NN O
, , O
STAT NNP B-NP
proteins NNS I-NP
are VBP O
transported VBN O
into IN O
the DT O
nucleus JJ O
and CC O
exhibit NN O
transcriptional JJ O
activity NN O
. . O

-DOCSTART- X X O

Overexpression IN O
of IN O
mcl-1 NN B-NP
is VBZ O
sufficient JJ O
to TO O
protect VB O
against IN O
apoptosis NN O
, , O
while IN O
transfection NN O
of IN O
a DT O
mcl-1 JJ B-NP
antisense NN O
plasmid NN O
causes VBZ O
cell NN O
death NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
although IN O
multiple JJ O
senescence NN O
pathways NNS O
are VBP O
activated VBN O
in IN O
response NN O
to TO O
a DT O
ras JJ B-NP
oncogene NN I-NP
, , O
inactivation NN O
of IN O
TGFbeta1 DT B-NP
secretion NN O
or CC O
response NN O
is VBZ O
sufficient JJ O
to TO O
block VB O
the DT O
senescence NN O
program NN O
. . O

-DOCSTART- X X O

In IN O
this DT O
study NN O
, , O
the DT O
abilities NNS O
of IN O
constitutive JJ O
and CC O
conditional JJ O
forms NNS O
of IN O
the DT O
three CD O
Raf NNP B-NP
kinases NNS I-NP
to TO O
abrogate VB O
the DT O
cytokine NN O
dependency NN O
of IN O
FDC-P1 JJ O
cells NNS O
were VBD O
examined VBN O
. . O

-DOCSTART- X X O

The DT O
complete JJ O
cDNA NN O
sequence NN O
of IN O
human JJ B-NP
betaV NN I-NP
spectrin NN I-NP
is VBZ O
available JJ O
from IN O
GenBank( NNP O
TM) NNP O
as IN O
accession NN O
number NN O
. . O

-DOCSTART- X X O

Transactivation NN O
of IN O
naturally RB O
occurring VBG O
HIV-1 PRP$ B-NP
long JJ I-NP
terminal NN I-NP
repeats NNS I-NP
by IN O
the DT O
JNK NNP B-NP
signaling VBG O
pathway NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
show VBP O
that IN O
the DT O
alpha-helix NN O
domain NN O
of IN O
p57( JJ B-NP
Kip2 NNP B-NP
) -RRB- O
, , O
which WDT O
is VBZ O
conserved VBN O
in IN O
the DT O
Cip/Kip NNP B-NP
proteins VBZ O
, , O
is VBZ O
implicated VBN O
in IN O
protein-protein NN O
interaction NN O
and CC O
confers VBZ O
a DT O
specific JJ O
regulatory JJ O
mechanism NN O
, , O
outside IN O
of IN O
their PRP$ O
Cdk-inhibitory JJ B-NP
activity NN O
, , O
by IN O
which WDT O
the DT O
p57( JJ B-NP
Kip2 NNP B-NP
) -RRB- O
family NN O
members NNS O
positively RB O
act VB O
on IN O
myogenic JJ O
differentiation NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
was VBD O
carried VBN O
out RP O
to TO O
analyze VB O
PRL NNP B-NP
secretion NN O
in IN O
metastatic JJ O
prostate NN O
cancer NN O
patients NNS O
both DT O
at IN O
basal JJ O
conditions NNS O
and CC O
in IN O
response NN O
to TO O
L-Dopa NNP O
and CC O
metoclopramide NN O
, , O
which WDT O
represents VBZ O
the DT O
most RBS O
classical JJ O
inhibitory NN O
and CC O
stimulatory JJ O
tests NNS O
for IN O
PRL NNP B-NP
secretion NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Intra-operative JJ O
ultrasound NN O
( -LRB- O
IOUS) NNP O
has VBZ O
been VBN O
widely RB O
used VBN O
in IN O
an DT O
attempt NN O
to TO O
overcome VB O
these DT O
difficulties NNS O
, , O
but CC O
is VBZ O
limited VBN O
by IN O
its PRP$ O
two-dimensional JJ O
nature NN O
, , O
inter-user NN O
variability NN O
, , O
and CC O
image NN O
obliteration NN O
with IN O
ablative JJ O
or CC O
resectional JJ O
techniques NNS O
. . O

-DOCSTART- X X O

Hailey-Hailey JJ O
disease NN O
is VBZ O
caused VBN O
by IN O
mutations NNS O
in IN O
ATP2C1 NNP B-NP
encoding VBG O
a DT O
novel NN O
Ca( NNP O
2+ VBD O
) -RRB- O
pump NN O
. . O

-DOCSTART- X X O

Hex NNP B-NP
is VBZ O
expressed VBN O
in IN O
the DT O
developing VBG O
liver NN O
coincident NN O
with IN O
the DT O
forkhead/winged JJ B-NP
helix NN B-NP
transcription NN O
factor NN O
, , O
Hepatocyte NNP B-NP
Nuclear NNP I-NP
Factor NNP I-NP
3beta NNP I-NP
( -LRB- O
HNF3beta NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
clinical JJ O
stage NN O
was VBD O
I PRP O
( -LRB- O
T1N0M0 DT O
) -RRB- O
, , O
and CC O
S2 NNP O
sleeve NN O
segmentectomy NN O
with IN O
lymph NN O
node NN O
dissection NN O
( -LRB- O
R NN O
2 CD O
b NN O
) -RRB- O
was VBD O
performed VBN O
. . O

-DOCSTART- X X O

Benztropine NNP O
for IN O
venlafaxine-induced JJ O
night NN O
sweats VBZ O
. . O

-DOCSTART- X X O

A DT O
cause NN O
of IN O
increase NN O
of IN O
alkaline NN B-NP
phosphatase NN I-NP
in IN O
children NNS O

-DOCSTART- X X O

Viral NNP O
cell-to-cell JJ O
movement NN O
of IN O
PVX NNP B-NP
CP CD I-NP
mutant NN I-NP
was VBD O
complemented VBN O
in IN O
Nicotiana NNP O
tabacum NN O
cv. . O

-DOCSTART- X X O

Induction NN O
of IN O
CD86 NNP B-NP
expression NN O
by IN O
stimulation NN O
of IN O
U937 JJ O
cells NNS O
with IN O
IFN-gamma NNP B-NP
revealed VBD O
the DT O
presence NN O
of IN O
two CD O
functional JJ O
GAS NNP B-NP
( -LRB- O
gamma-interferon NN B-NP
activation NN I-NP
site NN I-NP
) -RRB- O
elements NNS O
. . O

-DOCSTART- X X O

Significantly RB O
, , O
two CD O
proximal JJ O
GATA-1-binding JJ B-NP
sites NNS I-NP
(-118/-113 JJ O
and CC O
-98/-93 JJ O
) -RRB- O
and CC O
a DT O
region NN O
located VBN O
within IN O
-518 CD O
to TO O
-315bp VB O
of IN O
the DT O
mouse NN B-NP
ALAS2 NN I-NP
promoter NN I-NP
were VBD O
essential JJ O
for IN O
transcriptional JJ O
activation NN O
during IN O
chemically RB O
induced VBN O
differentiation NN O
of IN O
MEL NNP O
cells NNS O
, , O
implying VBG O
their PRP$ O
importance NN O
in IN O
conferring VBG O
erythroid JJ O
specificity NN O
to TO O
the DT O
ALAS2 NNP B-NP
transcriptional JJ O
activation NN O
. . O

-DOCSTART- X X O

SNAP-23 NN B-NP
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
the DT O
regulation NN O
of IN O
vesicle NN O
trafficking NN O
in IN O
mammalian JJ O
cells NNS O
. . O

-DOCSTART- X X O

IgM NNP B-NP
and CC O
IgG NNP B-NP
anti NNS I-NP
A DT I-NP
and CC O
anti JJ B-NP
B NNP I-NP
antibody NN I-NP
status NN O
of IN O
100 CD O
antenatal JJ O
O NNP O
group NN O
mothers NNS O
( -LRB- O
who WP O
had VBD O
non JJ O
O NNP O
group NN O
husbands NNS O
) -RRB- O
were VBD O
studied VBN O
. . O

-DOCSTART- X X O

Retroviral NNP O
transduction NN O
of IN O
T/T( JJ B-NP
L NNP I-NP
) -RRB- I-NP
causes VBZ O
a DT O
rapidly RB O
fatal JJ O
myeloproliferative JJ O
disease NN O
in IN O
a DT O
murine NN O
bone NN O
marrow NN O
transplant NN O
( -LRB- O
BMT NNP O
) -RRB- O
model NN O
, , O
whereas IN O
T/T( JJ B-NP
F NN I-NP
) -RRB- I-NP
causes VBZ O
a DT O
long-latency NN O
, , O
pre-B-cell JJ O
lymphoblastic JJ O
lymphoma NN O
. . O

-DOCSTART- X X O

Ab-MLV NNP O
strains NNS O
expressing VBG O
P70/S2 NNP B-NP
failed VBD O
to TO O
transform VB O
NIH NNP O
3T3 IN O
cells NNS O
and CC O
demonstrated VBD O
a DT O
greatly RB O
reduced VBN O
capacity NN O
to TO O
mediate VB O
signaling VBG O
events NNS O
associated VBN O
with IN O
the DT O
Ras-dependent NNP B-NP
mitogen-activated JJ B-NP
protein NN I-NP
( -LRB- I-NP
MAP NNP I-NP
) -RRB- I-NP
kinase NN I-NP
pathway NN O
. . O

-DOCSTART- X X O

The DT O
p53-homolog NN B-NP
p73beta NN B-NP
also RB O
activated VBD O
the DT O
PIG3 NNP B-NP
promoter NN I-NP
, , O
but CC O
in IN O
contrast NN O
to TO O
p53 NN B-NP
, , O
the DT O
proline-rich JJ O
domain NN O
of IN O
p73beta JJ B-NP
( -LRB- I-NP
residues NNS I-NP
81-113 NN I-NP
) -RRB- I-NP
was VBD O
dispensable JJ O
to TO O
induce VB O
the DT O
PIG3 NN B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Results NNS O
from IN O
transient JJ O
assays IN O
using VBG O
these DT O
mutants NNS O
showed VBD O
that IN O
the DT O
DE1 NNP O
received VBD O
signals NNS O
from IN O
phytochromes NNS B-NP
A DT I-NP
and CC I-NP
B NNP I-NP
, , O
demonstrating NN O
that IN O
this DT O
element NN O
is VBZ O
indeed RB O
a DT O
light-responsive JJ O
element NN O
. . O

-DOCSTART- X X O

Co-immunoprecipitation NN O
and CC O
DNA NNP O
affinity NN O
chromatography NN O
prove VBP O
that IN O
Sp1 NNP B-NP
heterodimerizes VBZ O
with IN O
ZBP-89 CD B-NP
when WRB O
bound VBN O
to TO O
the DT O
silencer NN O
element NN O
to TO O
yield VB O
a DT O
DNA-protein NN O
complex NN O
whose WP$ O
mobility NN O
is VBZ O
indistinguishable JJ O
from IN O
that DT O
displayed VBN O
by IN O
HeLa NNP O
nuclear JJ O
extract VB O
in IN O
band NN O
shift NN O
assays VBZ O
. . O

-DOCSTART- X X O

The DT O
ZNF274 NNP B-NP
gene NN I-NP
is VBZ O
mapped VBN O
distal JJ O
to TO O
marker NN O
RP NNP O
S28 CD O
1 CD O
in IN O
the DT O
human JJ O
chromosome NN O
19qter IN O
region NN O
, , O
by IN O
RH NNP O
mapping NN O
. . O

-DOCSTART- X X O

We PRP O
report VBP O
here RB O
on IN O
the DT O
molecular JJ O
nature NN O
of IN O
an DT O
EMS-induced JJ O
mutant NN O
, , O
mn1-89 CD B-NP
, , O
a DT O
leaky JJ O
semidominant JJ O
allele NN O
of IN O
the DT O
Miniature1 NNP B-NP
( -LRB- O
Mn1 NN B-NP
) -RRB- O
seed NN O
locus NN O
that IN O
encodes VBZ O
a DT O
seed-specific JJ B-NP
cell NN I-NP
wall NN I-NP
invertase NN I-NP
, , O
INCW2 NNP B-NP
. . O

-DOCSTART- X X O

Identification NN O
of IN O
a DT O
novel NN O
E2F3 NNP B-NP
product NN I-NP
suggests VBZ O
a DT O
mechanism NN O
for IN O
determining VBG O
specificity NN O
of IN O
repression NN O
by IN O
Rb JJ B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

In IN O
DNase NN B-NP
I PRP I-NP
footprinting POS O
protection NN O
analysis NN O
, , O
both DT O
SFRE NNP B-NP
and CC O
ERE NNP O
regions NNS O
were VBD O
protected VBN O
by IN O
glutathione NN B-NP
S-transferase-ERRalpha1 JJ I-NP
fusion NN O
protein NN O
. . O

-DOCSTART- X X O

We PRP O
examine VBP O
current JJ O
models NNS O
of IN O
the DT O
effects NNS O
of IN O
aging VBG O
on IN O
mean JJ O
response NN O
time NN O
and CC O
show VB O
how WRB O
they PRP O
might MD O
be VB O
reinterpreted VBN O
. . O

-DOCSTART- X X O

The DT O
median JJ O
levels NNS O
of IN O
particles NNS O
with IN O
50 CD O
% NN O
cut-off NN O
aerodynamic JJ O
diameters NNS O
of IN O
10 CD O
( -LRB- O
PM10 NNP O
) -RRB- O
and CC O
2.5 CD O
microm NN O
( -LRB- O
PM2.5 CD O
) -RRB- O
were VBD O
170 CD O
( -LRB- O
range NN O
103-613 CD O
) -RRB- O
and CC O
95 CD O
( -LRB- O
range NN O
61-218 CD O
) -RRB- O
micro JJ O
x NN O
m-3 NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Specific JJ O
and CC O
heritable JJ O
genetic JJ O
interference NN O
by IN O
double-stranded JJ O
RNA NNP O
in IN O
Arabidopsis NNP O
thaliana NN O
. . O

-DOCSTART- X X O

Two CD O
additional JJ O
cis-acting NN O
sequences NNS O
, , O
conserved VBN O
in IN O
both DT O
the DT O
region NN O
1 CD O
and CC O
3 CD O
promoters NNS O
, , O
were VBD O
identified VBN O
, , O
suggesting VBG O
a DT O
role NN O
for IN O
these DT O
sequences NNS O
in IN O
the DT O
coordinate VBP O
regulation NN O
of IN O
transcription NN O
from IN O
these DT O
promoters NNS O
. . O

-DOCSTART- X X O

Purple NNP O
photosynthetic JJ O
bacteria NNS O
are VBP O
capable JJ O
of IN O
generating VBG O
cellular JJ O
energy NN O
from IN O
several JJ O
sources NNS O
, , O
including VBG O
photosynthesis NN O
, , O
respiration NN O
, , O
and CC O
H( JJ O
2 CD O
) -RRB- O
oxidation NN O
. . O

-DOCSTART- X X O

An DT O
analysis NN O
of IN O
synthetic JJ O
peptides NNS O
revealed VBD O
a DT O
minimal JJ O
CTD NN O
sequence NN O
that WDT O
is VBZ O
sufficient JJ O
to TO O
bind NN O
to TO O
the DT O
second JJ O
Rsp5 NNP B-NP
WW NNP I-NP
domain NN I-NP
( -LRB- O
Rsp5 CC B-NP
WW2 NNP I-NP
) -RRB- O
in IN O
vitro NN O
and CC O
in IN O
yeast NN O
two-hybrid JJ O
assays RB O
. . O

-DOCSTART- X X O

METHOD NNP O
: : O
The DT O
sample NN O
of IN O
subjects NNS O
was VBD O
drawn VBN O
from IN O
the DT O
Suffolk NNP O
County NNP O
Mental NNP O
Health NNP O
Project NNP O
, , O
a DT O
longitudinal JJ O
epidemiologic NN O
study NN O
of IN O
first-hospitalized JJ O
subjects NNS O
with IN O
psychotic JJ O
disorders NNS O
; : O
the DT O
present JJ O
study NN O
focused VBD O
on IN O
patients NNS O
with IN O
schizophrenic JJ O
disorders NNS O
. . O

-DOCSTART- X X O

Marrow NNP O
dysplasia NN O
is VBZ O
a DT O
major JJ O
characteristic JJ O
of IN O
patients NNS O
with IN O
myelodysplastic JJ O
syndrome NN O
( -LRB- O
MDS NNP O
) -RRB- O
, , O
along IN O
with IN O
marrow NN O
blastosis NN O
, , O
cytopenia NN O
and CC O
cytogenetic JJ O
anomalies NNS O
. . O

-DOCSTART- X X O

How WRB O
plants NNS O
respond VBP O
to TO O
attack VB O
by IN O
the DT O
range NN O
of IN O
herbivores NNS O
and CC O
pathogens NNS O
that WDT O
confront VBP O
them PRP O
in IN O
the DT O
field NN O
is VBZ O
the DT O
subject NN O
of IN O
considerable JJ O
research NN O
by IN O
both DT O
molecular JJ O
biologists NNS O
and CC O
ecologists NNS O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
The DT O
probability NN O
of IN O
cardiopulmonary JJ O
complications NNS O
increases VBZ O
significantly RB O
when WRB O
patients NNS O
develop VBP O
class NN O
1 CD O
HELLP NNP O
syndrome NN O
. . O

-DOCSTART- X X O

The DT O
rate-limiting NN O
step NN O
for IN O
telomerase NN B-NP
activity NN O
seems VBZ O
to TO O
be VB O
the DT O
expression NN O
of IN O
the DT O
catalytic JJ O
subunit NN O
of IN O
the DT O
enzyme NN O
, , O
encoded VBN O
by IN O
the DT O
human JJ B-NP
telomerase NN I-NP
reverse NN I-NP
transcriptase NN I-NP
(hTERT NN O
) -RRB- O
gene NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
control NN O
group NN O
, , O
platelet NN O
markers NNS O
increased VBD O
1 CD O
h NN O
after IN O
surgery NN O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
element NN O
proximal NN O
to TO O
the DT O
transcription NN O
start NN O
site NN O
is VBZ O
dependent JJ O
on IN O
the DT O
SRE-1 NN O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
mitochondrial JJ O
single-stranded JJ O
DNA-binding JJ O
protein NN O
gene NN O
expression NN O
links NNS O
nuclear JJ O
and CC O
mitochondrial JJ O
DNA NN O
replication NN O
in IN O
drosophila NN O
. . O

-DOCSTART- X X O

They PRP O
are VBP O
present JJ O
in IN O
many JJ O
kinds NNS O
of IN O
living VBG O
things NNS O
, , O
but CC O
their PRP$ O
functions NNS O
, , O
especially RB O
those DT O
in IN O
humans NNS O
, , O
are VBP O
unclear JJ O
. . O

-DOCSTART- X X O

Transduction NN O
of IN O
the DT O
human JJ O
leukemic JJ O
cell NN O
line NN O
K562 IN O
showed VBD O
that IN O
viral JJ O
MRP1-PG13 JJ B-NP
supernatants NNS O
routinely RB O
transfer VB O
the DT O
MRP1 NNP B-NP
gene NN I-NP
to TO O
approximately RB O
35 CD O
% NN O
of IN O
target NN O
K562 IN O
cells NNS O
, , O
of IN O
which WDT O
at IN O
least JJS O
one CD O
third JJ O
are VBP O
capable JJ O
of IN O
proliferating VBG O
in IN O
the DT O
presence NN O
of IN O
otherwise RB O
toxic JJ O
concentrations NNS O
of IN O
etoposide NN O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
an DT O
AfsA JJ B-NP
homologue NN I-NP
( -LRB- O
BarX NNP B-NP
) -RRB- O
from IN O
Streptomyces NNP O
virginiae NN O
as IN O
a DT O
pleiotropic NN O
regulator NN O
controlling VBG O
autoregulator NN O
biosynthesis NN O
, , O
virginiamycin JJ O
biosynthesis NN O
and CC O
virginiamycin RB O
M1 JJ O
resistance NN O
. . O

-DOCSTART- X X O

Given VBN O
its PRP$ O
relative JJ O
longevity NN O
on IN O
the DT O
Web NNP O
, , O
TIE NNP O
researchers NNS O
have VBP O
been VBN O
in IN O
a DT O
unique JJ O
position NN O
to TO O
observe VB O
trends NNS O
in IN O
telemedicine NN O
. . O

-DOCSTART- X X O

The DT O
structural JJ O
study NN O
of IN O
peptides NNS O
belonging VBG O
to TO O
the DT O
terminal NN O
domains VBZ O
of IN O
histone NN B-NP
H1 PRP I-NP
can MD O
be VB O
considered VBN O
as IN O
a DT O
step NN O
toward IN O
the DT O
understanding NN O
of IN O
the DT O
function NN O
of IN O
H1 NNP B-NP
in IN O
chromatin NN O
. . O

-DOCSTART- X X O

Cerebral JJ O
vasculitis NN O
secondary JJ O
to TO O
Crohn NNP O
's POS O
disease NN O
seems VBZ O
to TO O
be VB O
a DT O
very RB O
rare JJ O
phenomenon NN O
. . O

-DOCSTART- X X O

SELECTION NNP O
CRITERIA NNP O
: : O
Randomised NNP O
and CC O
possibly RB O
randomised JJ O
trials NNS O
using VBG O
acupuncture NN O
to TO O
treat VB O
asthma NN O
and CC O
asthma-like JJ O
symptoms NNS O
. . O

-DOCSTART- X X O

To TO O
test VB O
the DT O
hypothesis NN O
that IN O
progestin-mediated JJ O
increases NNS O
in IN O
resting VBG O
core NN O
temperature NN O
and CC O
the DT O
core NN O
temperature NN O
threshold NN O
for IN O
sweating VBG O
onset NN O
are VBP O
counteracted VBN O
by IN O
estrogen NN O
, , O
we PRP O
studied VBD O
eight CD O
women NNS O
( -LRB- O
24 CD O
+/ NN O
- : O
2 CD O
yr NN O
) -RRB- O
at IN O
27 CD O
degrees NNS O
C NN O
rest NN O
, , O
during IN O
20 CD O
min NN O
of IN O
passive JJ O
heating NN O
( -LRB- O
35 CD O
degrees NNS O
C) NN O
, , O
and CC O
during IN O
40 CD O
min NN O
of IN O
exercise NN O
at IN O
35 CD O
degrees NNS O
C. NNP O

-DOCSTART- X X O

These DT O
studies NNS O
suggest VBP O
an DT O
additional JJ O
component NN O
or CC O
cellular JJ O
environment NN O
is VBZ O
required VBN O
for IN O
SPRK NNP B-NP
activation NN O
by IN O
Cdc42 NNP B-NP
. . O

-DOCSTART- X X O

Jkappa NNP B-NP
DNA-binding NN I-NP
sites NNS I-NP
were VBD O
not RB O
required VBN O
for IN O
this DT O
activation NN O
, , O
and CC O
a DT O
mutant JJ B-NP
EBNA-3C JJ I-NP
protein NN I-NP
unable JJ O
to TO O
bind NN O
Jkappa NNP B-NP
activated VBD O
transcription NN O
as IN O
efficiently RB O
as IN O
wild-type JJ B-NP
EBNA-3C JJ I-NP
, , O
indicating VBG O
that IN O
EBNA-3C NNP B-NP
can MD O
regulate VB O
transcription NN O
through IN O
a DT O
mechanism NN O
that WDT O
is VBZ O
independent JJ O
of IN O
Jkappa NNP B-NP
. . O

-DOCSTART- X X O

Thus RB O
, , O
both DT O
YY1 NNP B-NP
and CC O
CDP NNP B-NP
appear VBP O
to TO O
be VB O
negative JJ O
regulators NNS O
of IN O
the DT O
differentiation-induced JJ O
HPV-6 NNP B-NP
E1 NNP I-NP
promoter NN I-NP
and CC O
thereby RB O
the DT O
HPV JJ O
life NN O
cycle NN O
. . O

-DOCSTART- X X O

Sequential JJ O
cleavage NN O
by IN O
metallopeptidases NNS B-NP
and CC O
proteasomes NNS O
is VBZ O
involved VBN O
in IN O
processing VBG O
HIV-1 PRP$ B-NP
ENV NNP I-NP
epitope NN I-NP
for IN O
endogenous JJ O
MHC NNP B-NP
class NN I-NP
I PRP I-NP
antigen RB I-NP
presentation NN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
show VBP O
that IN O
p65 DT B-NP
binds NNS O
to TO O
these DT O
targets NNS O
with IN O
almost RB O
equal JJ O
affinity NN O
and CC O
that IN O
different JJ O
residues NNS O
have VBP O
variable JJ O
roles NNS O
in IN O
binding JJ O
different JJ O
kappaB NN B-NP
targets NNS I-NP
. . O

-DOCSTART- X X O

Transcriptional NNP O
regulation NN O
of IN O
the DT O
yeast NN B-NP
PHO8 DT I-NP
promoter NN I-NP
in IN O
comparison NN O
to TO O
the DT O
coregulated JJ O
PHO5 CD B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
characterized VBD O
cis-elements NNS O
of IN O
the DT O
human JJ B-NP
PCI NNP I-NP
gene NN I-NP
required VBD O
for IN O
expression NN O
in IN O
the DT O
hepatoma-derived JJ O
cell NN O
line NN O
, , O
HepG2 IN O
cells NNS O
, , O
and CC O
also RB O
evaluated VBN O
rat NN B-NP
PCI NN I-NP
mRNA NN I-NP
expression NN O
, , O
particularly RB O
on IN O
the DT O
effect NN O
of IN O
androgen NN O
in IN O
rat NN O
reproductive VBG O
tissues NNS O
. . O

-DOCSTART- X X O

Mutational JJ O
analysis NN O
of IN O
mammalian JJ B-NP
translation NN I-NP
initiation NN I-NP
factor NN I-NP
5 CD I-NP
(eIF5 CD O
) -RRB- O
: : O
role NN O
of IN O
interaction NN O
between IN O
the DT O
beta JJ O
subunit NN O
of IN O
eIF2 NN B-NP
and CC O
eIF5 VB B-NP
in IN O
eIF5 DT B-NP
function NN O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

This DT O
activity NN O
is VBZ O
stimulated VBN O
by IN O
complex JJ O
formation NN O
with IN O
the DT O
other JJ O
eIF2B NN B-NP
subunits NNS I-NP
. . O

-DOCSTART- X X O

Our PRP$ O
analysis NN O
of IN O
nonsense NN O
mutations NNS O
indicates VBZ O
that IN O
the DT O
C NNP O
terminus NN O
of IN O
eIF2Bepsilon NN B-NP
( -LRB- I-NP
residues NNS I-NP
518 CD I-NP
to TO I-NP
712 CD I-NP
) -RRB- I-NP
is VBZ O
required VBN O
for IN O
both DT O
catalytic JJ O
activity NN O
and CC O
interaction NN O
with IN O
eIF2 NN B-NP
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Physiologic NNP O
pacing VBG O
provides VBZ O
little JJ O
benefit NN O
over IN O
ventricular JJ O
pacing NN O
for IN O
the DT O
prevention NN O
of IN O
stroke NN O
or CC O
death NN O
due JJ O
to TO O
cardiovascular JJ O
causes NNS O
. . O

-DOCSTART- X X O

Among IN O
non-cirrhotics NNS O
, , O
lack NN O
of IN O
portal JJ O
vein NN O
visualisation NN O
had VBD O
a DT O
90 CD O
% NN O
sensitivity NN O
, , O
88 CD O
% NN O
specificity NN O
, , O
94 CD O
% NN O
negative JJ O
predictive JJ O
value NN O
, , O
and CC O
83 CD O
% NN O
positive JJ O
predictive JJ O
value NN O
in IN O
the DT O
diagnosis NN O
of IN O
pre-sinusoidal JJ O
portal JJ O
hypertension NN O
. . O

-DOCSTART- X X O

D5/D1(CT) JJ B-NP
or CC O
D5/D1D(CT) JJ B-NP
tail NN O
substitution NN O
mutants NNS O
displayed VBD O
a DT O
rank NN O
order NN O
of IN O
potency NN O
and CC O
agonist JJ O
affinities NNS O
virtually RB O
mimicking VBG O
wild-type JJ B-NP
( -LRB- I-NP
wt NN I-NP
) -RRB- I-NP
D1 IN I-NP
receptors NNS I-NP
, , O
as IN O
indexed JJ O
by IN O
both DT O
ligand NN O
binding NN O
and CC O
dopamine-stimulated JJ O
cAMP JJ O
accumulation NN O
assays VBZ O
, , O
and CC O
, , O
similar JJ O
to TO O
wt VB O
D1 NNP B-NP
receptors NNS I-NP
, , O
did VBD O
not RB O
exhibit NN O
receptor NN O
constitutive JJ O
activity NN O
or CC O
responsiveness NN O
to TO O
inverse VB O
agonists NNS O
. . O

-DOCSTART- X X O

Stat NNP B-NP
activation NN O
in IN O
response NN O
to TO O
GH NNP B-NP
and CC O
IL-6 NNP B-NP
was VBD O
determined VBN O
by IN O
reporter NN O
gene NN O
induction NN O
. . O

-DOCSTART- X X O

HFA NNP O
134a CD O
had VBD O
a DT O
greater JJR O
tendency NN O
to TO O
take VB O
up RP O
moisture NN O
from IN O
the DT O
environment NN O
than IN O
did VBD O
HFA NNP O
227 CD O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Abnormal JJ O
color NN O
perception NN O
was VBD O
found VBN O
in IN O
32 CD O
% NN O
of IN O
the DT O
epilepsy NN O
patients NNS O
treated VBD O
with IN O
vigabatrin NN O
monotherapy NN O
and CC O
28 CD O
% NN O
of IN O
the DT O
epilepsy NN O
patients NNS O
treated VBD O
with IN O
carbamazepine NN O
monotherapy NN O
. . O

-DOCSTART- X X O

Mitogen-activated JJ B-NP
protein NN I-NP
( -LRB- I-NP
MAP NNP I-NP
) -RRB- I-NP
kinase NN I-NP
phosphatase-3 NN I-NP
( -LRB- O
MKP-3 NN B-NP
) -RRB- O
is VBZ O
a DT O
dual JJ O
specificity NN O
phosphatase NN O
that WDT O
inactivates VBZ O
extracellular JJ B-NP
signal-regulated JJ I-NP
kinase NN I-NP
( -LRB- O
ERK) NNP B-NP
MAP NNP B-NP
kinases NNS I-NP
. . O

-DOCSTART- X X O

Consistent NN O
with IN O
this DT O
, , O
we PRP O
show VBP O
that IN O
peptides NNS O
representing VBG O
docking NN O
sites NNS O
within IN O
the DT O
target NN O
substrates NNS O
Elk-1 : B-NP
and CC O
p90( JJ B-NP
rsk NN B-NP
) -RRB- O
inhibit VBP O
ERK-dependent JJ B-NP
activation NN O
of IN O
MKP-3 NN B-NP
. . O

-DOCSTART- X X O

When WRB O
the DT O
entire JJ O
diet NN O
consisted VBD O
of IN O
SBF NNP O
, , O
voluntary JJ O
feed NN O
intake NN O
was VBD O
reduced VBN O
, , O
indicating VBG O
that IN O
SBF NNP O
should MD O
not RB O
be VB O
fed VBN O
to TO O
ponies NNS O
as IN O
the DT O
sole JJ O
dietary NN O
ingredient NN O
. . O

-DOCSTART- X X O

Hepatitis NNP O
C NNP O
virus NN O
infection NN O
and CC O
lymphoproliferative JJ O
diseases NNS O
in IN O
France NNP O
: : O
a DT O
national JJ O
study NN O
. . O

-DOCSTART- X X O

C. NNP O
elegans NNS O
KLP-11/OSM-3/KAP-1 . B-NP
: : O
orthologs NNS O
of IN O
the DT O
sea NN B-NP
urchin IN I-NP
kinesin-II JJ I-NP
, , O
and CC O
mouse NN O
KIF3A/KIFB/KAP3 IN B-NP
kinesin NN B-NP
complexes NNS O
. . O

-DOCSTART- X X O

Flavonoids NNS O
from IN O
Brosimum NNP O
acutifolium NN O
. . O

-DOCSTART- X X O

The DT O
C NNP O
terminus NN O
of IN O
TRBP NNP B-NP
binds NNS O
to TO O
CBP/p300 VB B-NP
and CC O
DRIP130 VB B-NP
, , O
a DT O
component NN O
of IN O
the DT O
DRIP/TRAP/ARC NNP B-NP
complex NN O
, , O
which WDT O
suggests VBZ O
that IN O
TRBP NNP B-NP
may MD O
activate VB O
transcription NN O
by IN O
means NNS O
of IN O
such JJ O
interactions NNS O
. . O

-DOCSTART- X X O

The DT O
patients NNS O
who WP O
presented VBD O
with IN O
mucocutaneous JJ O
disease NN O
also RB O
had VBD O
low JJ O
CD4+ NNP B-NP
T NNP O
lymphocyte NN O
counts NNS O
, , O
and CC O
most JJS O
of IN O
them PRP O
had VBD O
AIDS NNP O
defining NN O
illnesses VBZ O
. . O

-DOCSTART- X X O

Double-blind NNP O
, , O
placebo-controlled JJ O
trial NN O
. . O

-DOCSTART- X X O

Here RB O
, , O
it PRP O
is VBZ O
shown VBN O
that IN O
TAFII250 NNP B-NP
, , O
the DT O
largest JJS O
subunit NN O
of IN O
TFIID NNP B-NP
, , O
contains VBZ O
two CD O
tandem NN O
bromodomain NN O
modules NNS O
that WDT O
bind VBP O
selectively RB O
to TO O
multiply VB O
acetylated VBN O
histone NN B-NP
H4 IN I-NP
peptides NNS I-NP
. . O

-DOCSTART- X X O

Endostatin NNP O
treatment NN O
for IN O
10 CD O
minutes NNS O
or CC O
24 CD O
hours NNS O
induced VBN O
tyrosine NN O
phosphorylation NN O
of IN O
Shb NNP B-NP
and CC O
formation NN O
of IN O
multiprotein JJ O
complexes NNS O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
analogs NNS O
of IN O
vitamin NN O
D3 NNS O
have VBP O
been VBN O
investigated VBN O
in IN O
a DT O
number NN O
of IN O
trials NNS O
showing VBG O
improvement NN O
of IN O
psoriasis NN O
. . O

-DOCSTART- X X O

The DT O
transcript NN O
was VBD O
initially RB O
identified VBN O
as IN O
a DT O
partial JJ O
cDNA NN O
sequence NN O
in IN O
the DT O
course NN O
of IN O
constructing VBG O
a DT O
transcript NN O
map NN O
of IN O
the DT O
region NN O
between IN O
markers NNS O
D11S1765 CD B-NP
and CC O
uteroglobin RB B-NP
known VBN O
to TO O
encompass VB O
the DT O
gene NN O
causing VBG O
Best NNP O
disease NN O
. . O

-DOCSTART- X X O

Iodine NNP O
deficiency NN O
disorders NNS O
in IN O
Bangladesh NNP O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Soluble JJ O
CD23 IN B-NP
levels NNS O
were VBD O
significantly RB O
higher JJR O
in IN O
women NNS O
with IN O
endometriosis NN O
before IN O
treatment NN O
than IN O
in IN O
ten CD O
normal JJ O
controls NNS O
. . O

-DOCSTART- X X O

To TO O
isolate VB O
this DT O
gene NN O
, , O
a DT O
P-1 JJ O
artificial JJ O
chromosome NN O
( -LRB- O
PAC NNP O
) -RRB- O
library NN O
was VBD O
screened VBN O
with IN O
a DT O
full JJ B-NP
length NN I-NP
UGT2B7 IN I-NP
probe NN O
and CC O
a DT O
clone NN O
of IN O
approximately RB O
100 CD O
kb NN O
in IN O
length NN O
was VBD O
isolated VBN O
. . O

-DOCSTART- X X O

Age NNP O
>/ NNP O
= SYM O
50 CD O
years NNS O
( -LRB- O
odds NNS O
ratio NN O
[OR] NNS O
, , O
14.1 CD O
) -RRB- O
, , O
BMI NNP O
>/ VBD O
= SYM O
28 CD O
kg/m( JJ O
2 CD O
) -RRB- O
( -LRB- O
OR NN O
, , O
5.7 CD O
) -RRB- O
, , O
triglycerides VBZ O
>/ IN O
= SYM O
1.7 CD O
mmol/L NNS O
( -LRB- O
OR NN O
, , O
5 CD O
) -RRB- O
, , O
and CC O
alanine JJR B-NP
aminotransferase FW I-NP
( -LRB- O
ALT) NN B-NP
>/ NN O
= SYM O
2N FW O
( -LRB- O
OR NN O
, , O
4.6 CD O
) -RRB- O
were VBD O
independently RB O
associated VBN O
with IN O
septal JJ O
fibrosis NN O
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
show VBP O
that IN O
the DT O
zinc NN B-NP
finger NN I-NP
protein NN I-NP
Gis1 NNP I-NP
acts VBZ O
as IN O
a DT O
dosage-dependent JJ O
suppressor NN O
of IN O
the DT O
rim15Delta NN B-NP
defect NN O
in IN O
nutrient JJ O
limitation-induced JJ O
transcriptional JJ O
derepression NN O
of IN O
SSA3 NNP B-NP
. . O

-DOCSTART- X X O

To TO O
begin VB O
to TO O
characterize VB O
the DT O
role NN O
of IN O
the DT O
RNA NNP O
subunits NNS O
in IN O
enzyme JJ O
function NN O
and CC O
substrate JJ O
specificity NN O
, , O
we PRP O
swapped VBD O
two CD O
hairpin JJ O
structures NNS O
( -LRB- O
MRP3 NNS O
and CC O
P3 NNS O
) -RRB- O
between IN O
RNase NNP B-NP
MRP NNP I-NP
RNA NNP I-NP
and CC O
RNase NNP B-NP
P NNP I-NP
RNA NNP I-NP
of IN I-NP
S. NNP I-NP
cerevisiae NNS I-NP
. . O

-DOCSTART- X X O

Similarly RB O
, , O
comparison NN O
of IN O
percentage NN O
reductions NNS O
of IN O
heart NN O
rate NN O
at IN O
supine NN O
, , O
sitting VBG O
and CC O
exercise NN O
by IN O
repeated JJ O
measure NN O
analysis NN O
showed VBD O
the DT O
Malays NNP O
to TO O
have VB O
significantly RB O
higher JJR O
change NN O
compared VBN O
to TO O
the DT O
Chinese JJ O
( -LRB- O
p NN O
= SYM O
0.040 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Mucin NNP B-NP
gene NN I-NP
expression NN O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
altered VBN O
in IN O
many JJ O
intestinal JJ O
diseases NNS O
and CC O
especially RB O
cancers NNS O
of IN O
the DT O
gastrointestinal JJ O
tract NN O
. . O

-DOCSTART- X X O

The DT O
experimentally NN O
mapped VBD O
regions NNS O
of IN O
RPB5 DT B-NP
involved VBN O
in IN O
these DT O
interactions NNS O
correspond VBP O
to TO O
distinct JJ O
and CC O
surface-exposed JJ O
alpha-helical JJ O
structures NNS O
. . O

-DOCSTART- X X O

The DT O
model NN O
indicates VBZ O
that IN O
a DT O
0.076 CD O
% NN O
reduction NN O
in IN O
cigarette NN O
consumption NN O
is VBZ O
associated VBN O
with IN O
the DT O
availability NN O
of IN O
nicotine JJ O
patches NNS O
after IN O
1992 CD O
. . O

-DOCSTART- X X O

The DT O
tryptase NN B-NP
locus NN I-NP
also RB O
contains VBZ O
at IN O
least JJS O
four CD O
tryptase-like JJ B-NP
pseudogenes NNS I-NP
, , O
including VBG O
mastin NN B-NP
, , O
a DT O
gene NN O
expressed VBD O
in IN O
dogs NNS O
but CC O
not RB O
in IN O
humans NNS O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
This DT O
study NN O
was VBD O
conducted VBN O
to TO O
assess VB O
the DT O
relative JJ O
roles NNS O
of IN O
99mTc-sestamibi NNP O
scintimammography NN O
and CC O
sonography NN O
in IN O
the DT O
evaluation NN O
of IN O
breast NN O
lesions NNS O
that WDT O
are VBP O
indeterminate JJ O
or CC O
suspicious JJ O
on IN O
mammography NN O
or CC O
clinical JJ O
examination NN O
. . O

-DOCSTART- X X O

Mutational JJ O
analyses NNS O
showed VBD O
that IN O
in-frame JJ O
stop NN O
codons VBZ O
introduced VBN O
into IN O
five CD O
of IN O
seven CD O
RNA NNP B-NP
2 CD I-NP
ORFs NNP I-NP
did VBD O
not RB O
affect VB O
accumulation NN O
of IN O
progeny NN O
LIYV NNP B-NP
RNA NNP I-NP
1 CD I-NP
or CC O
RNA NNP B-NP
2 CD I-NP
, , O
confirming VBG O
that IN O
RNA NNP B-NP
2 CD I-NP
does VBZ O
not RB O
encode VB O
proteins NNS O
necessary JJ O
for IN O
LIYV NNP O
RNA NNP O
replication NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Fournier NNP O
's POS O
gangrene NN O
occurs VBZ O
worldwide RB O
. . O

-DOCSTART- X X O

IL-2 NN B-NP
is VBZ O
accepted VBN O
as IN O
a DT O
standard JJ O
treatment NN O
used VBN O
alone RB O
, , O
or CC O
in IN O
combination NN O
with IN O
chemotherapy NN O
or CC O
biotherapy NN O
in IN O
the DT O
management NN O
of IN O
metastatic JJ O
melanoma NN O
and CC O
metastatic JJ O
renal JJ O
cell NN O
carcinoma NN O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
expression NN O
of IN O
antisense JJ B-NP
Ha-Ras NNP I-NP
or CC O
dominant JJ B-NP
negative JJ I-NP
Raf-1 NN I-NP
abrogated VBD O
the DT O
mitogenic JJ O
effect NN O
of IN O
TGF-beta1 NNP B-NP
in IN O
TSU-Pr1 NNP O
, , O
and CC O
the DT O
TGF-beta1 JJ B-NP
inhibition NN O
of IN O
DU145 NNP O
was VBD O
switched VBN O
to TO O
stimulation NN O
by IN O
V12Ha-Ras JJ B-NP
transfection NN O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
our PRP$ O
data NNS O
suggest VBP O
that IN O
prostate NN O
carcinomas NNS O
with IN O
the DT O
Ras/MAPK NNP B-NP
pathway NN O
activation NN O
might MD O
have VB O
a DT O
selective JJ O
growth NN O
advantage NN O
by IN O
autocrine NN O
TGF-beta1 JJ B-NP
production NN O
. . O

-DOCSTART- X X O

In IN O
experiment NN O
2 CD O
, , O
no DT O
difference NN O
in IN O
gastric JJ O
emptying JJ O
of IN O
40 CD O
% NN O
peptone NN O
or CC O
25 CD O
% NN O
glucose NN O
was VBD O
found VBN O
between IN O
rats NNS O
receiving VBG O
TPN NNP O
and CC O
those DT O
receiving VBG O
intragastric JJ O
nutrition NN O
for IN O
10 CD O
to TO O
12 CD O
days NNS O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
H-NS NNP B-NP
negative JJ O
regulation NN O
operated VBN O
only RB O
in IN O
the DT O
absence NN O
of IN O
Fur NNP B-NP
. . O

-DOCSTART- X X O

Thus RB O
, , O
SAG NNP B-NP
appears VBZ O
to TO O
control VB O
cell NN O
cycle NN O
progression NN O
in IN O
yeast NN O
by IN O
promoting VBG O
ubiquitination NN O
and CC O
degradation NN O
of IN O
cell NN O
cycle NN O
regulatory JJ O
proteins NNS O
. . O

-DOCSTART- X X O

It PRP O
brings VBZ O
about IN O
fatigue NN O
, , O
negative JJ O
moods NNS O
, , O
and CC O
impaired JJ O
health NN O
, , O
sleep NN O
, , O
safety NN O
, , O
and CC O
working VBG O
capacity NN O
. . O

-DOCSTART- X X O

This DT O
demonstrates VBZ O
that IN O
treatment NN O
of IN O
the DT O
graft NN O
recipient NN O
for IN O
a DT O
relatively RB O
short JJ O
period NN O
during IN O
and CC O
after IN O
surgery NN O
has VBZ O
a DT O
favorable JJ O
effect NN O
on IN O
the DT O
survival NN O
of IN O
grafted VBN O
dopaminergic JJ O
neurons NNS O
. . O

-DOCSTART- X X O

The DT O
relationships NNS O
among IN O
blood NN O
concentrations NNS O
of IN O
thyroid DT O
hormones NNS O
and CC O
selenium NN O
, , O
zinc NN O
, , O
retinol NN O
, , O
and CC O
alpha-tocopherol NN O
were VBD O
studied VBN O
in IN O
44 CD O
healthy JJ O
Northern JJ O
Italian JJ O
oldest-old JJ O
subjects NNS O
( -LRB- O
age NN O
range NN O
, , O
90-107 JJ O
yr NN O
) -RRB- O
, , O
selected VBN O
by IN O
the DT O
criteria NNS O
of IN O
the DT O
SENIEUR NNP O
protocol NN O
. . O

-DOCSTART- X X O

Investigations NNS O
using VBG O
hippocampal JJ O
slices NNS O
maintained VBN O
in IN O
vitro NN O
have VBP O
demonstrated VBN O
that IN O
bursts NNS O
of IN O
oscillatory JJ O
field NN O
potentials NNS O
in IN O
the DT O
gamma NN O
frequency NN O
range NN O
( -LRB- O
30-80 JJ O
Hz NN O
) -RRB- O
are VBP O
followed VBN O
by IN O
a DT O
slower JJR O
oscillation NN O
in IN O
the DT O
beta NN O
1 CD O
range NN O
( -LRB- O
12-20 JJ O
Hz NN O
) -RRB- O
. . O

-DOCSTART- X X O

Karger NNP O
AG NNP O
, , O
Basel NNP O

-DOCSTART- X X O

Urinary JJ O
LTE4 NNP O
increased VBD O
after IN O
both DT O
challenges NNS O
the DT O
rise NN O
being VBG O
higher RBR O
following VBG O
oral JJ O
as IN O
compared VBN O
to TO O
inhalation NN O
provocation NN O
( -LRB- O
p=0.0001 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Basal NNP O
FVR NNP O
was VBD O
reduced VBN O
by IN O
approximately RB O
18 CD O
% NN O
by IN O
ERT NNP O
and CC O
HRT NNP O
, , O
but CC O
FVR NNP O
responses NNS O
to TO O
noradrenaline JJ O
, , O
angiotensin IN B-NP
II NNP I-NP
, , O
acetylcholine NN O
and CC O
nitroprusside NN O
were VBD O
unaffected JJ O
. . O

-DOCSTART- X X O

Transfection NN O
of IN O
cDNAs NNS O
for IN O
three CD O
mutant JJ O
enzymes NNS O
into IN O
FPGS-null JJ B-NP
Chinese JJ O
hamster NN O
ovary JJ O
cells NNS O
restored VBN O
a DT O
reduced JJ O
level NN O
of IN O
clonal JJ O
growth NN O
, , O
whereas IN O
a DT O
T339I JJ O
mutant JJ O
supported VBN O
growth NN O
at IN O
a DT O
level NN O
comparable JJ O
to TO O
that DT O
of IN O
the DT O
wild-type JJ O
enzyme NN O
. . O

-DOCSTART- X X O

SETTING NNP O
: : O
University NNP O
of IN O
Paris NNP O
VII NNP O
hospital.Patient( NN O
s VBZ O
) -RRB- O
: : O
Nine CD O
women NNS O
had VBD O
embolization NN O
for IN O
symptomatic JJ O
myoma NN O
, , O
with IN O
12 CD O
pregnancies NNS O
observed VBN O
. . O

-DOCSTART- X X O

Improving VBG O
fissure NN O
sealant NN O
quality NN O
: : O
mechanical JJ O
preparation NN O
and CC O
filling VBG O
level NN O
. . O

-DOCSTART- X X O

The DT O
protein NN O
encoded VBN O
by IN O
the DT O
fruA NN B-NP
transcript NN I-NP
is VBZ O
well RB O
conserved VBN O
with IN O
the DT O
D. NNP B-NP
melanogaster NN I-NP
type NN I-NP
A DT I-NP
protein NN I-NP
, , O
particularly RB O
the DT O
BTB NNP B-NP
protein-protein-binding NN I-NP
domain NN O
, , O
which WDT O
is VBZ O
encoded VBN O
by IN O
exons NNS O
I PRP O
and CC O
II NNP O
and CC O
is VBZ O
100 CD O
% NN O
conserved VBN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
the DT O
mouse NN O
ortholog NN O
( -LRB- O
Mharp/Smarcal1 NNP B-NP
) -RRB- O
was VBD O
cloned VBN O
, , O
and CC O
the DT O
Caenorhabditis NNP O
elegans NNS O
ortholog NN O
( -LRB- O
CEHARP NNP B-NP
) -RRB- O
was VBD O
identified VBN O
in IN O
the DT O
GenBank NNP O
database NN O
. . O

-DOCSTART- X X O

ECP NNP B-NP
and CC O
tryptase VB B-NP
levels NNS O
in IN O
serum NN O
were VBD O
measured VBN O
before IN O
and CC O
after IN O
the DT O
last JJ O
oral JJ O
challenge NN O
. . O

-DOCSTART- X X O

For IN O
an DT O
unsupervised JJ O
program NN O
, , O
the DT O
costs NNS O
were VBD O
estimated VBN O
at IN O
$ $ O
311 CD O
for IN O
the DT O
first JJ O
year NN O
and CC O
$ $ O
73 CD O
for IN O
all DT O
additional JJ O
years NNS O
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
such JJ O
a DT O
putative JJ O
RNA NNP O
- : O
binding JJ O
domain NN O
suggests VBZ O
a DT O
mechanism NN O
for IN O
the DT O
observed JJ O
autoregulation NN O
of IN O
bacteriophage JJ O
T4 NNP B-NP
DNA NNP I-NP
polymerase NN I-NP
synthesis NN O
by IN O
binding NN O
to TO O
its PRP$ O
own JJ O
mRNA NN O
. . O

-DOCSTART- X X O

Deletion NNP O
and CC O
mutational JJ O
analyses NNS O
revealed VBD O
two CD O
positive JJ O
cis-regulatory JJ O
elements NNS O
in IN O
this DT O
region NN O
that WDT O
are VBP O
essential JJ O
for IN O
CSX1 NNP B-NP
expression NN O
in IN O
cardiomyocytes NNS O
. . O

-DOCSTART- X X O

Functional JJ O
studies NNS O
which WDT O
introduced VBD O
a DT O
mutation NN O
in IN O
the DT O
AP2 NNP B-NP
core NN I-NP
binding NN I-NP
region NN I-NP
as RB O
well RB O
as IN O
cotransfection NN O
experiments NNS O
using VBG O
an DT O
AP2 NNP B-NP
expression NN O
vector NN O
revealed VBD O
that IN O
AP2 NNP B-NP
exerts VBZ O
a DT O
repressive JJ O
role NN O
on IN O
the DT O
HGF NNP B-NP
gene NN I-NP
promoter NN I-NP
activity NN O
. . O

-DOCSTART- X X O

Using VBG O
adenoviral JJ O
transfer NN O
of IN O
IkappaBalpha NNP B-NP
( -LRB- O
IkappaBalpha NN B-NP
overexpression NN O
) -RRB- O
, , O
the DT O
production NN O
of IN O
TNF-alpha NNP B-NP
induced VBN O
by IN O
whole JJ O
GBS NNP O
was VBD O
inhibited VBN O
by IN O
only RB O
20 CD O
% NN O
. . O

-DOCSTART- X X O

The DT O
pJR NN O
vectors NNS O
differ VBP O
among IN O
them PRP O
in IN O
: : O
( -LRB- O
a DT O
) -RRB- O
the DT O
selectable JJ O
marker NN O
( -LRB- O
Saccharomyces NNP O
cerevisiae NN O
LEU NNP B-NP
2 CD I-NP
gene NN I-NP
, , O
which WDT O
complements VBZ O
S. NNP B-NP
pombe VB I-NP
leu1 VB I-NP
- : I-NP
gene NN I-NP
and CC O
S. NNP O
pombe VBD O
ura4+ JJ B-NP
and CC O
his3+ JJ B-NP
genes NNS I-NP
) -RRB- O
; : O
( -LRB- O
b NN O
) -RRB- O
the DT O
thiamine-repressible JJ O
nmt1 NN B-NP
promoter NN I-NP
( -LRB- O
3X JJ O
, , O
41X JJ O
and CC O
81X JJ O
with IN O
extremely RB O
high JJ O
, , O
moderate JJ O
or CC O
low JJ O
transcription NN O
efficiency NN O
, , O
respectively RB O
) -RRB- O
; : O
and CC O
( -LRB- O
c NN O
) -RRB- O
the DT O
multiple JJ O
cloning NN O
site NN O
( -LRB- O
two CD O
multiple JJ O
cloning NN O
sites NNS O
, , O
with IN O
12 CD O
restriction NN O
sites NNS O
each DT O
) -RRB- O
. . O

-DOCSTART- X X O

Franz NNP O
Schubert--his NNP O
life NN O
, , O
music NN O
and CC O
diseases NNS O

-DOCSTART- X X O

The DT O
results NNS O
suggest VBP O
that IN O
the DT O
role NN O
of IN O
S. NNP O
argyrostoma NN O
in IN O
the DT O
dissemination NN O
of IN O
Trichinella NNP O
larvae NNS O
in IN O
nature NN O
is VBZ O
limited JJ O
in IN O
comparison NN O
to TO O
the DT O
role NN O
played VBD O
by IN O
mammals NNS O
with IN O
scavenger NN O
and CC O
cannibalistic JJ O
behavior NN O
. . O

-DOCSTART- X X O

The DT O
equilibrium NN O
dissociation NN O
binding NN O
constant JJ O
for IN O
the DT O
interaction NN O
of IN O
TnrA NNP B-NP
with IN O
the DT O
nrgAB NN B-NP
promoter NN I-NP
fragment NN I-NP
was VBD O
7.7 CD O
nM NN O
under IN O
the DT O
conditions NNS O
used VBN O
here RB O
. . O

-DOCSTART- X X O

These DT O
results NNS O
demonstrate VBP O
that IN O
N-glycans NNS O
flanking VBG O
the DT O
receptor-binding JJ O
site NN O
of IN O
the DT O
HA NNP B-NP
molecule NN I-NP
are VBP O
potent JJ O
regulators NNS O
of IN O
influenza NN O
virus NN O
growth NN O
, , O
with IN O
the DT O
glycan NN O
at IN O
Asn149 DT O
being VBG O
dominant JJ O
and CC O
that IN O
at IN O
Asn123 NNP O
being VBG O
less RBR O
effective JJ O
. . O

-DOCSTART- X X O

All DT O
were VBD O
tested VBN O
for IN O
serum NN O
ferritin NN B-NP
( -LRB- O
SF) NNP B-NP
, , O
hemoglobin NN B-NP
( -LRB- O
Hb NN B-NP
) -RRB- O
level NN O
and CC O
asked VBD O
for IN O
detailed JJ O
histories NNS O
of IN O
donations NNS O
and CC O
iron NN O
supplementation NN O
. . O

-DOCSTART- X X O

We PRP O
further RB O
studied VBD O
the DT O
effects NNS O
of IN O
SIE-1 JJ B-NP
hypermethylation NN O
on IN O
p21WAF1 DT B-NP
induction NN O
by IN O
STAT NNP B-NP
activation NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
pRb(-) JJ B-NP
SAOS-2 JJ O
cell NN O
line NN O
transiently VBZ O
transfected VBN O
with IN O
a DT O
reporter NN O
plasmid NN O
containing VBG O
six CD O
tal-1 JJ B-NP
binding JJ I-NP
site NN I-NP
, , O
pRb JJ B-NP
enhances NNS O
the DT O
transcriptional JJ O
activity NN O
of IN O
tal-1-E12-Lmo2 JJ B-NP
and CC O
tal-1-E12-Lmo2-Ldb1 JJ B-NP
complexes NNS O
but CC O
not RB O
that IN O
of IN O
a DT O
tal-1-E12 JJ B-NP
heterodimer NN O
. . O

-DOCSTART- X X O

This DT O
effect NN O
was VBD O
not RB O
seen VBN O
in IN O
conjunction NN O
with IN O
oxycodone NN O
, , O
a DT O
morphine-like JJ B-NP
mu-receptor NN I-NP
agonist NN O
. . O

-DOCSTART- X X O

Neurofibromatosis NN O
of IN O
the DT O
breast NN O
in IN O
a DT O
patient NN O
with IN O
Morbus NNP O
von NNP O
Recklinghausen NNP O

-DOCSTART- X X O

In IN O
the DT O
premating JJ O
period NN O
male JJ O
rate NN O
of IN O
aggression NN O
was VBD O
not RB O
significantly RB O
correlated VBN O
with IN O
testosterone NN O
level NN O
. . O

-DOCSTART- X X O

Prevention NNP O
, , O
differential JJ O
diagnosis NN O
and CC O
therapy NN O
of IN O
travel NN O
diarrhea NN O

-DOCSTART- X X O

This DT O
study NN O
shows VBZ O
that IN O
C/EBPbeta NNP B-NP
is VBZ O
the DT O
predominant JJ O
C/EBP NNP B-NP
isoform NN I-NP
found VBD O
in IN O
activated JJ O
stellate JJ O
cells NNS O
and CC O
that IN O
increased VBN O
C/EBPbeta JJ B-NP
protein NN I-NP
and CC O
C/EBPbeta NN B-NP
binding NN O
to TO O
a DT O
proximal JJ O
C/EBP NNP B-NP
binding NN I-NP
site NN I-NP
in IN O
the DT O
promoter NN O
mediates VBZ O
the DT O
activating JJ O
effect NN O
of IN O
acetaldehyde NN O
. . O

-DOCSTART- X X O

Mutation NN O
analysis NN O
demonstrates VBZ O
that IN O
the DT O
motif NN O
TCCCCT NNP O
is VBZ O
critical JJ O
for IN O
PyRo1 NNP B-NP
interaction NN O
. . O

-DOCSTART- X X O

After IN O
two CD O
successive JJ O
rounds NNS O
of IN O
selection NN O
by IN O
focus NN O
formation NN O
assay NN O
, , O
a DT O
transforming NN O
ribozyme NN O
(Rz007 IN O
) -RRB- O
was VBD O
identified VBN O
. . O

-DOCSTART- X X O

G. NNP O
, , O
and CC O
Hyde NNP O
, , O
C. NNP O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
proteasome JJ O
inhibition NN O
leads VBZ O
to TO O
upregulation NN O
of IN O
specific JJ O
members NNS O
of IN O
transcription NN O
factor NN O
families NNS O
controlling VBG O
cellular JJ O
stress NN O
response NN O
and CC O
proliferation NN O
. . O

-DOCSTART- X X O

The DT O
ATR-X NNP O
syndrome NN O
results NNS O
from IN O
mutations NNS O
of IN O
the DT O
XH2 NNP B-NP
gene NN I-NP
, , O
located VBN O
on IN O
the DT O
X NNP O
chromosome NN O
( -LRB- O
Xq13.3 CD O
) -RRB- O
and CC O
coding VBG O
for IN O
a DT O
transacting NN O
factor NN O
which WDT O
regulates VBZ O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

AIMS NNP O
: : O
To TO O
evaluate VB O
the DT O
role NN O
of IN O
environmental JJ O
intra-uterine JJ O
factors NNS O
in IN O
determining VBG O
the DT O
birthweights NNS O
of IN O
twins NNS O
with IN O
increased VBN O
susceptibility NN O
to TO O
diabetes NNS O
and CC O
discordant JJ O
for IN O
abnormal JJ O
responses NNS O
to TO O
the DT O
oral JJ O
glucose NN O
tolerance NN O
test NN O
( -LRB- O
OGTT NNP O
) -RRB- O
and CC O
verify VB O
the DT O
possible JJ O
association NN O
of IN O
within-pair PRP$ O
birthweight NN O
differences NNS O
and CC O
metabolic JJ O
abnormalities NNS O
in IN O
adult JJ O
life NN O
. . O

-DOCSTART- X X O

In IN O
NASCIS NNP O
III NNP O
, , O
a DT O
randomization NN O
imbalance NN O
occurred VBD O
that IN O
allocated VBN O
a DT O
disproportionate JJ O
number NN O
of IN O
patients NNS O
with IN O
no DT O
motor NN O
deficit NN O
( -LRB- O
and CC O
therefore RB O
no DT O
chance NN O
for IN O
recovery NN O
) -RRB- O
to TO O
the DT O
lower JJR O
dose NN O
control NN O
group NN O
. . O

-DOCSTART- X X O

Penicillin NNP B-NP
acylase NN I-NP
( -LRB- O
PA NNP B-NP
) -RRB- O
from IN O
Escherichia NNP O
coli NNS O
ATCC11105 CC O
is VBZ O
a DT O
periplasmic JJ O
heterodimer NN O
consisting VBG O
of IN O
a DT O
24 CD O
kDa CD O
small JJ O
subunit NN O
and CC O
a DT O
65 CD O
kDa JJ O
large JJ O
subunit NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
isolated VBN O
and CC O
functionally RB O
characterized VBD O
the DT O
mouse NN O
gene NN O
for IN O
the DT O
C2 NNP O
subunit NN O
of IN O
the DT O
20S CD B-NP
proteasome JJ I-NP
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
as IN O
in IN O
the DT O
human JJ O
gene NN O
, , O
the DT O
3' JJ O
end NN O
of IN O
the DT O
Cacna1f JJ B-NP
gene NN I-NP
maps NNS O
within IN O
5 CD O
kb NN O
of IN O
the DT O
5' JJ O
end NN O
of IN O
the DT O
mouse NN B-NP
synaptophysin NN I-NP
gene NN I-NP
in IN O
a DT O
region NN O
orthologous JJ O
to TO O
Xp11.23 CD O
. . O

-DOCSTART- X X O

With IN O
the DT O
human JJ B-NP
Rhotekin NNP I-NP
cDNA NN I-NP
as IN O
a DT O
probe NN O
, , O
Northern NNP O
hybridization NN O
revealed VBD O
that IN O
a DT O
4.0-kb JJ O
transcript NN O
was VBD O
expressed VBN O
at IN O
a DT O
high JJ O
level NN O
in IN O
prostate NN O
and CC O
at IN O
a DT O
middle JJ O
level NN O
in IN O
13 CD O
of IN O
16 CD O
tissues NNS O
examined VBD O
, , O
but CC O
it PRP O
cannot MD O
be VB O
detected VBN O
in IN O
liver NN O
and CC O
lung NN O
tissues NNS O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
mainly RB O
transcribed VBN O
in IN O
neural JJ O
structures NNS O
and CC O
in IN O
developing VBG O
organs NNS O
characterized VBN O
by IN O
epithelial-mesenchymal JJ O
interactions NNS O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
The DT O
alpha2-adrenergic JJ O
antagonist NN O
idazoxan NN O
increases NNS O
glucose-induced JJ O
sympathetic JJ O
activity NN O
but CC O
not RB O
energy NN O
expenditure NN O
in IN O
obese JJ O
subjects NNS O
. . O

-DOCSTART- X X O

ID-PaGIA DT O
diphtheria NN B-NP
toxin NN I-NP
polymer NN O
particle NN O
diagnostic JJ O
agent NN O
manufactured VBN O
by IN O
DiaMed NNP O
AG NNP O
, , O
Switzerland NNP O
, , O
was VBD O
tried VBN O
at IN O
bacteriological JJ O
laboratory NN O
of IN O
Institute NNP O
of IN O
Childhood NNP O
Infections NNP O
in IN O
St NNP O
. . O

-DOCSTART- X X O

Next JJ O
, , O
we PRP O
show VBP O
that IN O
two CD O
EMS-induced JJ O
mutations NNS O
, , O
previously RB O
shown VBN O
to TO O
interact VB O
genetically RB O
with IN O
zipper( NN O
Ebr NN B-NP
) -RRB- O
, , O
disrupt VB O
the DT O
RhoA NNP B-NP
locus NN I-NP
. . O

-DOCSTART- X X O

Therefore RB O
, , O
the DT O
results NNS O
indicate VBP O
that IN O
repeated VBN O
exposure NN O
to TO O
amphetamine VB O
or CC O
apomorphine VB O
overcomes NNS O
the DT O
context-dependent JJ O
component NN O
of IN O
sensitization NN O
of IN O
amphetamine NN O
- : O
or CC O
apomorphine-induced JJ O
stereotyped JJ O
behavior NN O
. . O

-DOCSTART- X X O

Topics NNS O
reviewed VBN O
here RB O
include VBP O
: : O
data NNS O
supporting VBG O
the DT O
association NN O
of IN O
myositis NN O
with IN O
cancer NN O
and CC O
the DT O
appropriate JJ O
evaluations NNS O
for IN O
malignancy NN O
in IN O
a DT O
myositis NN O
patient NN O
; : O
an DT O
approach NN O
to TO O
the DT O
assessment NN O
of IN O
patients NNS O
with IN O
dermatomyositis NN O
sine NN O
myositis NN O
; : O
the DT O
usefulness NN O
of IN O
the DT O
clinicopathological JJ O
and CC O
serological JJ O
classifications NNS O
; : O
a DT O
discussion NN O
of IN O
whether IN O
childhood NN O
and CC O
adult NN O
myositis NN O
are VBP O
the DT O
same JJ O
or CC O
different JJ O
entities NNS O
; : O
a DT O
review NN O
of IN O
those DT O
prognostic JJ O
factors NNS O
to TO O
consider VB O
in IN O
the DT O
clinical JJ O
management NN O
of IN O
myositis NN O
patients NNS O
; : O
current JJ O
approaches NNS O
and CC O
their PRP$ O
limitations NNS O
for IN O
assessing VBG O
disease NN O
activity NN O
and CC O
damage NN O
. . O

-DOCSTART- X X O

The DT O
science NN O
of IN O
tissue NN O
engineering NN O
. . O

-DOCSTART- X X O

Acquired VBN O
bile NN O
duct NN O
blockage NN O
: : O
entry NN O
of IN O
hepatobiliary JJ O
agent NN O
into IN O
an DT O
intrahepatic JJ O
abscess NN O
. . O

-DOCSTART- X X O

The DT O
outer JJ O
diameter NN O
and CC O
the DT O
thickness NN O
of IN O
the DT O
rotor NN O
are VBP O
60 CD O
mm CD O
and CC O
8 CD O
mm CD O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Both DT O
the DT O
MVBF NNP O
and CC O
the DT O
maximum JJ O
EMG NNP O
activity NN O
in IN O
the DT O
right JJ O
masseter NN O
and CC O
the DT O
left JJ O
anterior JJ O
temporalis NN O
muscles NNS O
were VBD O
significantly RB O
decreased VBN O
during IN O
muscle NN O
pain NN O
when WRB O
the DT O
subjects NNS O
bit NN O
on IN O
the DT O
painful JJ O
side NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
There EX O
is VBZ O
a DT O
relation NN O
in IN O
the DT O
topography NN O
of IN O
some DT O
visual JJ O
field NN O
areas NNS O
assessed VBN O
by IN O
SWAP NNP O
and CC O
the DT O
inferotemporal JJ O
neuroretinal JJ O
rim NN O
area NN O
, , O
which WDT O
may MD O
play VB O
a DT O
role NN O
in IN O
the DT O
diagnosis NN O
and CC O
follow-up NN O
of IN O
suspected JJ O
glaucoma NN O
. . O

-DOCSTART- X X O

The DT O
total JJ O
alkaloids NNS O
contained VBN O
in IN O
the DT O
peel NN O
of IN O
Atzimba NNP O
, , O
Lopez NNP O
, , O
Marciana NNP O
, , O
Montsama NNP O
, , O
Murca NNP O
, , O
and CC O
Puebla NNP O
was VBD O
lower JJR O
than IN O
the DT O
limits NNS O
recommended VBD O
for IN O
food NN O
safety NN O
. . O

-DOCSTART- X X O

The DT O
detection NN O
success NN O
rate NN O
was VBD O
determined VBN O
for IN O
different JJ O
markers NNS O
using VBG O
this DT O
MEK. NNP B-NP

-DOCSTART- X X O

ACE-2 NNP B-NP
has VBZ O
a DT O
hydrophobic JJ O
C NNP O
terminus NN O
of IN O
H NNP O
type NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
a DT O
pTyr317 JJ B-NP
Shc NNP I-NP
phosphopeptide NN I-NP
selectively RB O
recognized VBD O
Grb2 NNP B-NP
, , O
Sos1 NNP B-NP
, , O
SHIP NNP B-NP
, , O
and CC O
the DT O
p85 NN B-NP
subunit NN I-NP
of IN O
phosphatidylinositol NN B-NP
3' CD I-NP
kinase NN I-NP
from IN O
mast NN O
cells NNS O
, , O
as RB O
characterized VBN O
by IN O
mass NN O
spectrometry NN O
. . O

-DOCSTART- X X O

Although IN O
increased JJ O
expression NN O
of IN O
the DT O
HMG-I/Y JJ B-NP
proteins NNS I-NP
is VBZ O
associated VBN O
with IN O
cellular JJ O
proliferation NN O
, , O
neoplastic JJ O
transformation NN O
, , O
and CC O
several JJ O
human JJ O
cancers NNS O
, , O
the DT O
role NN O
of IN O
these DT O
proteins NNS O
in IN O
the DT O
pathogenesis NN O
of IN O
malignancy NN O
remains VBZ O
unclear JJ O
. . O

-DOCSTART- X X O

The DT O
naltrexone/lofexidine NN O
combination NN O
was VBD O
associated VBN O
with IN O
a DT O
more RBR O
rapid JJ O
resolution NN O
of IN O
the DT O
opiate JJ O
withdrawal NN O
syndrome NN O
than IN O
a DT O
7-day JJ O
lofexidine-only JJ O
treatment NN O
schedule NN O
, , O
without IN O
substantial JJ O
increases NNS O
in IN O
withdrawal NN O
symptoms NNS O
or CC O
hypotensive JJ O
side-effects NNS O
. . O

-DOCSTART- X X O

The DT O
first JJ O
symptoms NNS O
of IN O
enzootic JJ O
calcinosis NN O
were VBD O
noted VBN O
in IN O
March NNP O
1998 CD O
, , O
when WRB O
some DT O
of IN O
the DT O
cows NNS O
developed VBD O
locomotor NN O
abnormalities NNS O
. . O

-DOCSTART- X X O

Transcriptional NNP O
regulation NN O
of IN O
the DT O
mouse NN B-NP
cytosolic JJ I-NP
chaperonin NN I-NP
subunit NN I-NP
gene NN I-NP
Ccta/t-complex JJ B-NP
polypeptide NN I-NP
1 CD I-NP
by IN O
selenocysteine JJ B-NP
tRNA NN I-NP
gene NN I-NP
transcription NN I-NP
activating VBG I-NP
factor NN I-NP
family NN I-NP
zinc NN I-NP
finger NN I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

The DT O
unfolded JJ O
protein NN O
response NN O
regulates VBZ O
multiple JJ O
aspects NNS O
of IN O
secretory NN O
and CC O
membrane NN O
protein NN O
biogenesis NN O
and CC O
endoplasmic JJ O
reticulum NN O
quality NN O
control NN O
. . O

-DOCSTART- X X O

PNRC NNP B-NP
: : O
a DT O
proline-rich JJ O
nuclear JJ O
receptor NN O
coregulatory JJ O
protein NN O
that IN O
modulates NNS O
transcriptional JJ O
activation NN O
of IN O
multiple JJ O
nuclear JJ O
receptors NNS O
including VBG O
orphan VBN O
receptors NNS O
SF1 . B-NP
( -LRB- O
steroidogenic JJ B-NP
factor NN I-NP
1 CD I-NP
) -RRB- O
and CC O
ERRalpha1 NNP B-NP
(estrogen NN O
related VBN B-NP
receptor NN I-NP
alpha-1 NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

However RB O
, , O
there EX O
is VBZ O
still RB O
a DT O
subset NN O
of IN O
tumors NNS O
that IN O
displayed VBN O
no DT O
changes NNS O
in IN O
these DT O
genes NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
shown VBN O
that IN O
the DT O
epidural NN O
( -LRB- O
EPI NNP O
) -RRB- O
delivery NN O
of IN O
morphine NN O
encapsulated VBN O
in IN O
multivesicular JJ O
liposomes NNS O
( -LRB- O
DepoFoam NNP O
drug NN O
delivery NN O
system NN O
) -RRB- O
produces VBZ O
a DT O
sustained JJ O
clearance NN O
of IN O
morphine NN O
and CC O
a DT O
prolonged JJ O
analgesia NN O
. . O

-DOCSTART- X X O

Following VBG O
EPI-C0401 NNP O
, , O
but CC O
not RB O
saline NN O
or CC O
DepoFoam NNP O
vehicle NN O
, , O
there EX O
were VBD O
transient JJ O
( -LRB- O
< RB O
72 CD O
hr NN O
) -RRB- O
decreases VBZ O
in IN O
food NN O
consumption NN O
, , O
arousal JJ O
, , O
hindlimb JJ O
muscle NN O
tone NN O
, , O
and CC O
body NN O
temperature NN O
. . O

-DOCSTART- X X O

Bailey NNP O
Instruments NNP O
and CC O
Owen NNP O
Mumford NNP O
filaments NNS O
were VBD O
the DT O
most RBS O
accurate JJ O
with IN O
100 CD O
% NN O
buckling NN O
within IN O
+/-1.0 CD O
g NN O
of IN O
10 CD O
g NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
water NN O
deprivation NN O
for IN O
19 CD O
h NN O
on IN O
renal JJ O
Na NNP O
excretion NN O
of IN O
conscious JJ O
adrenalectomized JJ O
( -LRB- O
ADX NN O
) -RRB- O
sheep NN O
maintained VBD O
on IN O
a DT O
constant JJ O
intravenous JJ O
infusion NN O
of IN O
aldosterone NN O
and CC O
cortisol NN O
( -LRB- O
ADX-constant JJ O
steroid NN O
sheep) NN O
was VBD O
investigated VBN O
. . O

-DOCSTART- X X O

Neither DT O
is VBZ O
it PRP O
a DT O
major JJ O
cause NN O
of IN O
rehydration-induced JJ O
renal JJ O
Na NNP O
retention NN O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Rheumatic JJ O
fever NN O
in IN O
the DT O
Nazareth NNP O
area NN O
is VBZ O
still RB O
manifest JJ O
. . O

-DOCSTART- X X O

Antithrombin NNP B-NP
III NNP I-NP
deficiency NN O
: : O
when WRB O
substitute NN O
, , O
when WRB O
heparin NN O
? . O
Thrombosis DT O
ABC NNP O
, , O
3 CD O
: : O
The DT O
role NN O
of IN O
antithrombin JJ B-NP
III NNP I-NP

-DOCSTART- X X O

Specific JJ O
class NN B-NP
I PRP I-NP
and CC I-NP
II NNP I-NP
histone NN I-NP
deacetylases NNS I-NP
( -LRB- O
HDACs NNS B-NP
) -RRB- O
interact NN O
in IN O
vivo NN O
with IN O
BCoR NNP B-NP
, , O
suggesting VBG O
that IN O
BCoR NNP B-NP
may MD O
functionally RB O
link VB O
these DT O
two CD O
classes NNS O
of IN O
HDACs NNP B-NP
. . O

-DOCSTART- X X O

After IN O
screening VBG O
the DT O
Berkeley NNP O
Drosophila NNP O
Genome NNP O
Project NNP O
database NN O
with IN O
sequences NNS O
from IN O
a DT O
recently RB O
characterized VBN O
Leu-rich NNP B-NP
repeats-containing NN I-NP
G NNP I-NP
protein-coupled JJ I-NP
receptor NN I-NP
( -LRB- O
LGR NN B-NP
) -RRB- O
from IN O
Drosophila NNP O
( -LRB- O
DLGR-1 NN B-NP
) -RRB- O
, , O
we PRP O
identified VBD O
a DT O
second JJ O
gene NN O
for IN O
a DT O
different JJ O
LGR NN B-NP
( -LRB- O
DLGR-2 NN B-NP
) -RRB- O
and CC O
cloned VBD O
its PRP$ O
cDNA NN O
. . O

-DOCSTART- X X O

Degenerate JJ O
primers NNS O
homologous JJ O
to TO O
highly RB O
conserved JJ O
regions NNS O
of IN O
known VBN O
CYP3A IN B-NP
sequences NNS I-NP
were VBD O
used VBN O
for IN O
initial JJ O
RT-PCRs NNS O
. . O

-DOCSTART- X X O

Methyllevamisole NNP O
was VBD O
used VBN O
as IN O
the DT O
internal JJ O
standard NN O
. . O

-DOCSTART- X X O

Resistance NN O
ratios NNS O
for IN O
the DT O
other JJ O
field NN O
strains NNS O
obtained VBN O
by IN O
comparison NN O
with IN O
the DT O
R5 NNP O
strain NN O
ranged VBD O
from IN O
24.5 CD O
to TO O
239 CD O
for IN O
topical JJ O
application NN O
and CC O
from IN O
1.2 CD O
to TO O
9.8 CD O
for IN O
the DT O
glass NN O
jar NN O
method NN O
. . O

-DOCSTART- X X O

Only RB O
transcripts NNS O
specific JJ O
for IN O
TSGF-2 NN B-NP
are VBP O
detected VBN O
in IN O
ovary JJ O
and CC O
testes NNS O
tissues NNS O
of IN O
adults NNS O
as RB O
well RB O
as IN O
in IN O
puparia NN O
, , O
while IN O
neither DT O
gene NN O
is VBZ O
expressed VBN O
during IN O
the DT O
larval JJ O
developmental JJ O
stages NNS O
. . O

-DOCSTART- X X O

Reliability NNP O
of IN O
cervical JJ O
range NN O
of IN O
motion NN O
using VBG O
the DT O
OSI NNP O
CA NNP O
6000 CD O
spine JJ O
motion NN O
analyser NN O
on IN O
asymptomatic JJ O
and CC O
symptomatic JJ O
subjects NNS O
. . O

-DOCSTART- X X O

Since IN O
the DT O
RINX NNP B-NP
gene NN I-NP
is VBZ O
likely JJ O
an DT O
ortholog NN O
of IN O
the DT O
goldfish NN B-NP
Vsx1 NNP I-NP
gene NN I-NP
, , O
it PRP O
has VBZ O
been VBN O
named VBN O
VSX1 NNP B-NP
by IN O
the DT O
Human NNP O
Gene NNP O
Nomenclature NNP O
Committee NNP O
. . O

-DOCSTART- X X O

The DT O
chromosomal NN O
localization NN O
on IN O
distal JJ O
chromosome NN O
7 CD O
places NNS O
it PRP O
in IN O
a DT O
cluster NN O
of IN O
imprinted JJ O
genes NNS O
, , O
flanked VBN O
by IN O
the DT O
previously RB O
described VBN O
Tapa1 NNP B-NP
and CC O
Kcnq1 NNP B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

Activation NN O
of IN O
PKA NNP B-NP
by IN O
8-bromo-cyclic JJ O
AMP NNP O
or CC O
forskolin NN O
, , O
and CC O
inhibition NN O
of IN O
PKC NNP B-NP
by IN O
calphostin NN O
C NNP O
, , O
resulted VBD O
in IN O
a DT O
significant JJ O
decrease NN O
in IN O
3TP JJ B-NP
activity NN O
as RB O
well RB O
as IN O
in IN O
vitro NN O
ERK NNP B-NP
kinase NN I-NP
activity NN O
in IN O
CRAC. NNP O

-DOCSTART- X X O

Double NNP O
mutant JJ O
analysis NN O
suggests VBZ O
that IN O
Rad54p NNP B-NP
and CC O
Mus81p MD B-NP
act VB O
in IN O
one CD O
pathway NN O
for IN O
the DT O
repair NN O
of IN O
, , O
or CC O
tolerance NN O
to TO O
, , O
UV-induced JJ O
DNA NNP O
damage NN O
. . O

-DOCSTART- X X O

The DT O
measurement NN O
of IN O
NO DT O
in IN O
biological JJ O
systems NNS O
using VBG O
chemiluminescence NN O
. . O

-DOCSTART- X X O

Atorvastatin NNP O
was VBD O
the DT O
most JJS O
cost-effective JJ O
HMG-CoA NNP B-NP
reductase NN I-NP
inhibitor NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
although IN O
E NNP O
domains NNS O
of IN O
these DT O
two CD O
receptors NNS O
are VBP O
much RB O
less RBR O
conserved VBN O
, , O
replacement NN O
of IN O
this DT O
domain NN O
in IN O
rtER NNP B-NP
by IN O
its PRP$ O
human JJ O
counterpart NN O
resulted VBD O
in IN O
higher JJR O
estradiol NN O
sensitivity NN O
but CC O
no DT O
increase NN O
in IN O
the DT O
magnitude NN O
of IN O
transactivation NN O
. . O

-DOCSTART- X X O

G-DNA NNP O
is VBZ O
a DT O
four-stranded JJ O
DNA NN O
structure NN O
with IN O
diverse JJ O
putative JJ O
biological JJ O
roles NNS O
. . O

-DOCSTART- X X O

The DT O
effectiveness NN O
of IN O
NRT NNP O
appears VBZ O
to TO O
be VB O
largely RB O
independent JJ O
of IN O
the DT O
intensity NN O
of IN O
additional JJ O
support NN O
provided VBD O
to TO O
the DT O
smoker NN O
. . O

-DOCSTART- X X O

8 CD O
% NN O
(95 CD O
% NN O
CI NNP O
, , O
21.3-44.3 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
the DT O
action NN O
of IN O
GLP-1 NN B-NP
at IN O
the DT O
CRE NNP O
was VBD O
not RB O
blocked VBN O
by IN O
cotransfection NN O
with IN O
M1-CREB NNP B-NP
, , O
an DT O
isoform NN O
that IN O
lacks VBZ O
a DT O
consensus NN O
serine NN O
residue NN O
serving VBG O
as IN O
substrate JJ O
for IN O
PKA-mediated JJ B-NP
phosphorylation NN O
. . O

-DOCSTART- X X O

Because IN O
all DT O
PDGFbetaR NNP B-NP
fusions NNS I-NP
described VBD O
thus RB O
far RB O
result VB O
in IN O
splicing NN O
to TO O
a DT O
common JJ O
exon NN O
of IN O
this DT O
gene NN O
, , O
we PRP O
performed VBD O
5'-rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends VBZ O
PCR JJ O
on IN O
patient JJ O
RNA NNP O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
In IN O
essential JJ O
hypertension NN O
an DT O
acute JJ O
protein NN O
load NN O
induces VBZ O
a DT O
decrease NN O
in IN O
GFR NNP O
that WDT O
may MD O
normalize VB O
under IN O
antihypertensive JJ O
treatment NN O
. . O

-DOCSTART- X X O

The DT O
carboxyl-terminal JJ O
proline-rich JJ O
domain NN O
of IN O
SOS1 NNP B-NP
is VBZ O
involved VBN O
in IN O
the DT O
interaction NN O
with IN O
the DT O
PLC-gamma1 NNP B-NP
SH3 NNP B-NP
domain NN I-NP
. . O

-DOCSTART- X X O

Six CD O
distinct JJ O
Ets NNS B-NP
mRNAs NNS I-NP
were VBD O
identified VBN O
: : O
Ets2 NNP B-NP
, , O
Fli1 NNP B-NP
, , O
GABPalpha NNP B-NP
, , O
SAP1 NNP B-NP
, , O
Elk1 NNP B-NP
, , O
and CC O
PE1 NNP B-NP
. . O

-DOCSTART- X X O

A DT O
2 CD O
kb NN O
transcript NN O
was VBD O
isolated VBN O
from IN O
brain NN O
that WDT O
encodes VBZ O
a DT O
approximately RB O
57 CD O
kDa JJ O
protein NN O
; : O
the DT O
predicted VBN O
protein NN O
contains VBZ O
the DT O
known VBN O
N-terminal NNP B-NP
Ets NNP I-NP
domain NN I-NP
of IN O
PE1 NNP B-NP
and CC O
a DT O
novel NN O
C-terminal NNP O
domain NN O
with IN O
signficant JJ O
homology NN O
to TO O
murine NN B-NP
ERF. . I-NP

-DOCSTART- X X O

Intravenous JJ O
versus JJ O
oral JJ O
administration NN O
of IN O
amitriptyline JJ O
in IN O
patients NNS O
with IN O
major JJ O
depression NN O
. . O

-DOCSTART- X X O

Deletion NNP O
of IN O
the DT O
RVH NNP B-NP
domain NN I-NP
resulted VBD O
in IN O
loss NN O
of IN O
Ca( NNP O
2+)-dependent JJ O
activation NN O
. . O

-DOCSTART- X X O

Erythema NNP O
exsudativum NN O
multiforme VBD O
induced VBN O
by IN O
granulocyte JJ B-NP
colony-stimulating JJ I-NP
factor NN I-NP
in IN O
an DT O
allogeneic JJ O
peripheral JJ O
blood NN O
stem VBP O
cell NN O
donor NN O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
now RB O
well RB O
accepted VBN O
that IN O
the DT O
p53 NN B-NP
C-terminus NN I-NP
plays VBZ O
a DT O
central JJ O
role NN O
in IN O
controlling VBG O
the DT O
activity NN O
of IN O
the DT O
wild-type JJ O
molecule NN O
. . O

-DOCSTART- X X O

The DT O
transcription NN O
factor NN O
Jun NNP B-NP
(c-Jun NNP O
) -RRB- O
functions VBZ O
as IN O
a DT O
recipient NN O
of IN O
extracellular JJ O
growth NN O
signals NNS O
and CC O
converts VBZ O
them PRP O
into IN O
patterns NNS O
of IN O
gene NN O
expression NN O
. . O

-DOCSTART- X X O

Developmental NNP O
toxicity NN O
of IN O
the DT O
class NN O
III NNP O
antiarrhythmic JJ O
agent NN O
almokalant RB O
in IN O
mice NNS O
. . O

-DOCSTART- X X O

This DT O
compound NN O
is VBZ O
the DT O
main JJ O
bioactive JJ O
metabolite NN O
of IN O
trimebutine NN O
II NNP O
( -LRB- O
Debridat NN O
, , O
CAS NNP O
39133-31-8 CD O
) -RRB- O
, , O
an DT O
antispasmodic JJ O
widely RB O
used VBN O
for IN O
intestinal JJ O
diseases NNS O
since IN O
1969 CD O
. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
its PRP$ O
effect NN O
in IN O
augmenting VBG O
the DT O
neutrophil JJ O
response NN O
to TO O
eccentric JJ O
exercise NN O
, , O
vitamin NN O
E NNP O
causes VBZ O
a DT O
greater JJR O
increase NN O
in IN O
circulating VBG O
creatine JJ B-NP
kinase JJ I-NP
activity NN O
, , O
perhaps RB O
indicating VBG O
increased VBN O
skeletal JJ O
muscle NN O
repair NN O
. . O

-DOCSTART- X X O

This DT O
enabled VBD O
the DT O
formation NN O
of IN O
stem-loop JJ O
templates NNS O
with IN O
the DT O
fusion NN O
point NN O
of IN O
the DT O
chimeric JJ O
transcript NN O
in IN O
the DT O
loop NN O
and CC O
the DT O
use NN O
of IN O
MLL NNP B-NP
primers NNS O
in IN O
two-sided JJ O
PCR. . O

-DOCSTART- X X O

Measurements NNS O
were VBD O
compared VBN O
with IN O
two CD O
computerised JJ O
treatment NN O
planning NN O
systems--Theraplan NN O
VO5B NNP O
and CC O
ADAC NNP O
Pinnacle3 NNP O
V4.0b NNP O
. . O

-DOCSTART- X X O

Activation NN O
was VBD O
biphasic JJ O
; : O
peaking VBG O
at IN O
5-10 CD O
min NN O
and CC O
24 CD O
h NN O
after IN O
treatment NN O
. . O

-DOCSTART- X X O

Partial JJ O
correction NN O
of IN O
anemia NN O
with IN O
recombinant JJ B-NP
human JJ I-NP
erythropoietin NN I-NP
likely JJ O
reduces VBZ O
left VBN O
ventricular JJ O
mass NN O
and CC O
volume NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
demonstrated VBD O
that IN O
the DT O
PFA-100 CD O
analyzer NN O
can MD O
accurately RB O
assess VB O
vWF-dependent JJ B-NP
platelet NN O
function NN O
and CC O
detect VB O
other JJ O
platelet NN O
defects NNS O
under IN O
high JJ O
shear NN O
stress NN O
in IN O
complex JJ O
patient NN O
populations NNS O
. . O

-DOCSTART- X X O

We PRP O
recently RB O
reported VBD O
the DT O
molecular JJ O
cloning NN O
of IN O
a DT O
PL NNP B-NP
scramblase NN I-NP
of IN O
human JJ O
( -LRB- O
HuPLSCR1 IN B-NP
) -RRB- O
and CC O
mouse NN O
origin NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Using VBG O
an DT O
oligomer NN O
duplex NN O
5'-A(GGGTTA JJ O
)( NN O
5)-3'/5'-(TAACCC)( JJ O
5)T-3' JJ O
as IN O
a DT O
template-primer NN O
, , O
we PRP O
show VBP O
that IN O
both DT O
the DT O
Klenow NNP B-NP
fragment NN I-NP
of IN I-NP
Escherichia NNP I-NP
coli NNS I-NP
DNA NNP I-NP
polymerase NN I-NP
I PRP I-NP
and CC O
HIV NNP B-NP
reverse NN I-NP
transcriptase NN I-NP
could MD O
expand VB O
telomere JJ O
DNA NN O
sequences NNS O
as RB O
well RB O
, , O
giving VBG O
products NNS O
greater JJR O
than IN O
the DT O
size NN O
of IN O
the DT O
template JJ O
DNA NN O
. . O

-DOCSTART- X X O

Mutations NNS O
in IN O
the DT O
RP2 NNP B-NP
locus NN I-NP
at IN I-NP
Xp11.3 CD I-NP
were VBD O
found VBN O
in IN O
a DT O
further JJ O
10-20 CD O
% NN O
of IN O
XLRP NNP O
patients NNS O
, , O
as IN O
predicted VBN O
from IN O
linkage NN O
studies NNS O
. . O

-DOCSTART- X X O

Subsequently RB O
, , O
HD NNP O
inhibited VBD O
healing NN O
because IN O
it PRP O
significantly RB O
delayed VBD O
epithelialization NN O
and CC O
caused VBD O
protracted VBN O
inflammation NN O
. . O

-DOCSTART- X X O

The DT O
effectiveness NN O
of IN O
the DT O
haemodialysate NN O
Solcoseryl NNP O
for IN O
second-intention NN O
wound NN O
healing NN O
in IN O
horses NNS O
and CC O
ponies NNS O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
were VBD O
reinforced VBN O
by IN O
an DT O
analysis NN O
that WDT O
was VBD O
restricted VBN O
to TO O
living VBG O
donor NN O
transplants NNS O
without IN O
acute JJ O
rejection NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
further RB O
support VBP O
an DT O
important JJ O
role NN O
for IN O
CBF2 NNP B-NP
in IN O
mediating VBG O
EBNA2 NNP B-NP
transactivation NN O
; : O
they PRP O
identify VBP O
the DT O
hnRNP JJ B-NP
protein NN I-NP
AUF1 IN I-NP
as IN O
a DT O
major JJ O
component NN O
of IN O
CBF2 NNP B-NP
and CC O
are VBP O
also RB O
the DT O
first JJ O
evidence NN O
of IN O
a DT O
cis-acting JJ O
sequence NN O
other JJ O
than IN O
a DT O
CBF1 JJ B-NP
binding JJ I-NP
element NN I-NP
that WDT O
is VBZ O
able JJ O
to TO O
confer VB O
responsiveness NN O
to TO O
EBNA2 NNP B-NP
. . O

-DOCSTART- X X O

The DT O
genome NN O
of IN O
the DT O
human JJ O
herpesvirus NN O
8 CD O
( -LRB- O
HHV-8 CC O
) -RRB- O
contains VBZ O
a DT O
cluster NN O
of IN O
open JJ O
reading NN O
frames NNS O
( -LRB- O
ORFs NNS O
) -RRB- O
encoding VBG O
proteins NNS O
with IN O
homology NN O
to TO O
the DT O
cellular JJ O
transcription NN O
factors NNS O
of IN O
the DT O
interferon NN B-NP
regulatory JJ I-NP
factor NN I-NP
( -LRB- O
IRF NN B-NP
) -RRB- O
family NN O
. . O

-DOCSTART- X X O

Despite IN O
these DT O
limitations NNS O
the DT O
CHIME JJ O
monitor NN O
provides VBZ O
an DT O
opportunity NN O
to TO O
record VB O
physiological JJ O
data NNS O
previously RB O
unavailable JJ O
in IN O
the DT O
home NN O
. . O

-DOCSTART- X X O

CREST NNP O
syndrome NN O
; : O
a DT O
changing VBG O
clinical JJ O
significance NN O

-DOCSTART- X X O

Troglitazone NN O
also RB O
induced VBD O
an DT O
endogenous JJ B-NP
PPARgamma NNP I-NP
target NN I-NP
gene NN I-NP
in IN O
T24 CD O
cells NNS O
, , O
adipocyte-type JJ B-NP
fatty JJ I-NP
acid NN I-NP
binding JJ I-NP
protein NN I-NP
(A-FABP) NN O
, , O
the DT O
expression NN O
of IN O
which WDT O
correlates VBZ O
with IN O
bladder NN O
cancer NN O
differentiation NN O
. . O

-DOCSTART- X X O

The DT O
RS447 CD B-NP
human JJ B-NP
megasatellite NN I-NP
tandem NN I-NP
repetitive JJ I-NP
sequence NN I-NP
encodes VBZ O
a DT O
novel NN O
deubiquitinating VBG O
enzyme NN O
with IN O
a DT O
functional JJ O
promoter NN O
. . O

-DOCSTART- X X O

Previous JJ O
experience NN O
and CC O
contextual JJ O
cues NNS O
are VBP O
essential JJ O
elements NNS O
in IN O
the DT O
generation NN O
of IN O
a DT O
subjective JJ O
prediction NN O
. . O

-DOCSTART- X X O

To TO O
characterize VB O
this DT O
effect NN O
, , O
we PRP O
looked VBD O
for IN O
targets NNS O
of IN O
NS1 NNP B-NP
influenza NN I-NP
virus NN I-NP
protein NN I-NP
among IN O
cellular JJ O
translation NN O
factors NNS O
. . O

-DOCSTART- X X O

( -LRB- O
iii NN O
) -RRB- O
In IN O
these DT O
cells NNS O
, , O
PKCbeta NNP B-NP
plays VBZ O
a DT O
unique JJ O
Ras-independent JJ B-NP
role NN O
in IN O
mediating VBG O
insulin NN B-NP
but CC O
not RB O
EGF NNP B-NP
or CC O
other JJ O
growth NN O
factor NN O
mitogenic JJ O
signals NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
it PRP O
is VBZ O
not RB O
known VBN O
whether IN O
the DT O
recently RB O
identified VBN O
isoforms NNS O
Vav2 VBP B-NP
and CC O
Vav3 NNP B-NP
, , O
which WDT O
are VBP O
broadly RB O
expressed VBN O
, , O
can MD O
couple NN O
with IN O
similar JJ O
classes NNS O
of IN O
receptors NNS O
, , O
nor CC O
is VBZ O
it PRP O
known VBN O
whether IN O
all DT O
Vav NNP B-NP
isoforms VBZ I-NP
possess VB O
identical JJ O
functional JJ O
activities NNS O
. . O

-DOCSTART- X X O

Transcriptional NNP O
regulation NN O
of IN O
fbp1 CD B-NP
promoter NN I-NP
constructs NNS I-NP
containing VBG O
only RB O
UAS1 JJ O
or CC O
UAS2 NNP O
confirms VBZ O
that IN O
the DT O
PKA NNP B-NP
and CC O
MAPK NNP B-NP
regulation NN O
is VBZ O
targeted VBN O
to TO O
both DT O
sites NNS O
. . O

-DOCSTART- X X O

X-ray NN O
crystallographic JJ O
data NNS O
show VBP O
that IN O
the DT O
PLZF NNP B-NP
BTB/POZ NNP B-NP
domain NN O
forms VBZ O
an DT O
obligate NN O
homodimer NN O
via IN O
an DT O
extensive JJ O
interface NN O
. . O

-DOCSTART- X X O

The DT O
ability NN O
of IN O
SMRT NNP B-NP
to TO O
associate VB O
with IN O
these DT O
transcription NN O
factors NNS O
and CC O
thereby RB O
to TO O
mediate JJ O
repression NN O
is VBZ O
strongly RB O
inhibited VBN O
by IN O
activation NN O
of IN O
tyrosine NN B-NP
kinase NN I-NP
signaling VBG O
pathways NNS O
, , O
such JJ O
as IN O
that DT O
represented VBN O
by IN O
the DT O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

Patients NNS O
were VBD O
randomly RB O
assigned VBN O
to TO O
treatment NN O
with IN O
the DT O
ACE NNP B-NP
inhibitor NN O
perindopril NN O
( -LRB- O
and CC O
the DT O
diuretic JJ O
indapamide NN O
for IN O
those DT O
with IN O
no DT O
definite JJ O
indication NN O
for IN O
or CC O
contraindication NN O
to TO O
treatment NN O
with IN O
a DT O
diuretic JJ O
) -RRB- O
or CC O
matching VBG O
placebo( NN O
s VBZ O
) -RRB- O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
reveals VBZ O
that IN O
the DT O
newly RB O
discovered VBN O
oasA2 JJ B-NP
gene NN I-NP
represents VBZ O
a DT O
pseudogene NN O
that WDT O
is VBZ O
still RB O
transcribed VBN O
, , O
but CC O
is VBZ O
not RB O
functionally RB O
translated VBN O
. . O

-DOCSTART- X X O

Two CD O
distinct JJ O
recessive JJ O
susceptibility NN O
loci NNS O
for IN O
vasculitis NNS O
were VBD O
mapped VBN O
on IN O
chromosome NN O
( -LRB- O
Chr NNP O
) -RRB- O
4 CD O
at IN O
D4Mit89 CD B-NP
and CC O
D4Mit147 CD B-NP
in IN O
both DT O
progenies NNS O
. . O

-DOCSTART- X X O

TNF-alpha NNP B-NP
induced VBD O
a DT O
dose NN O
- : O
and CC O
time-dependent NN O
increase NN O
in IN O
cyclooxygenase-2 NN B-NP
( -LRB- O
COX-2 NN B-NP
) -RRB- O
expression NN O
and CC O
PGE2 NN O
formation NN O
in IN O
human JJ O
NCI-H292 NNP O
epithelial NN O
cells NNS O
. . O

-DOCSTART- X X O

Mis3 NNP B-NP
is VBZ O
needed VBN O
for IN O
the DT O
formation NN O
of IN O
18S DT B-NP
ribosome JJ I-NP
RNA NNP I-NP
, , O
and CC O
may MD O
hence RB O
direct VB O
the DT O
level NN O
of IN O
proteins NNS O
required VBN O
for IN O
the DT O
coupling NN O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Vitrectomy NNP O
for IN O
vitreous JJ O
hemorrhage NN O
in IN O
Terson NNP O
syndrome NN O
is VBZ O
a DT O
safe JJ O
and CC O
effective JJ O
procedure NN O
, , O
offering VBG O
a DT O
rapid JJ O
and CC O
prolonged JJ O
improvement NN O
in IN O
vision NN O
. . O

-DOCSTART- X X O

RNA NNP O
in IN O
situ FW O
hybridization NN O
on IN O
brain NN O
sections NNS O
of IN O
normal JJ O
human JJ O
embryos NNS O
revealed VBD O
a DT O
strong JJ O
labeling NN O
in IN O
restricted JJ O
areas NNS O
of IN O
the DT O
cerebral JJ O
cortex NN O
. . O

-DOCSTART- X X O

To TO O
facilitate VB O
manipulation NN O
of IN O
large JJ O
genomic JJ O
sequences NNS O
, , O
we PRP O
developed VBD O
a DT O
method NN O
of IN O
converting VBG O
Escherichia NNP O
coli NNS O
P1 . O
artificial NN O
chromosomes NNS O
( -LRB- O
PACs NNS O
) -RRB- O
into IN O
yeast NN O
artificial JJ O
chromosomes NNS O
(YACs NNS O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
degenerate JJ O
DNA NN O
transposon NN O
, , O
Pat NNP B-NP
, , O
was VBD O
identified VBN O
in IN O
the DT O
genomes NNS O
of IN O
various JJ O
wild-type JJ O
strains NNS O
of IN O
the DT O
filamentous JJ O
fungus NN O
Podospora NNP O
anserina NN O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
presence NN O
of IN O
Tax NNP B-NP
I PRP I-NP
increased VBD O
the DT O
extent NN O
and CC O
altered VBD O
the DT O
profile NN O
of IN O
proteins NNS O
binding JJ O
TRE-2 NN B-NP
in IN O
vivo NN O
. . O

-DOCSTART- X X O

A DT O
2.3-kb JJ O
full-length JJ O
cDNA NN O
clone NN O
of IN O
an DT O
Atlantic NNP B-NP
halibut CC I-NP
Mx NNP I-NP
gene NN I-NP
was VBD O
isolated VBN O
from IN O
a DT O
liver NN O
cDNA NN O
library NN O
. . O

-DOCSTART- X X O

Once RB O
HIT NNP O
II NNP O
is VBZ O
suspected VBN O
, , O
heparin NN O
( -LRB- O
and CC O
low-molecular-weight JJ O
heparins NNS O
) -RRB- O
should MD O
be VB O
stopped VBN O
immediately RB O
. . O

-DOCSTART- X X O

The DT O
reduced VBN O
efficiency NN O
in IN O
the DT O
glycosylase NN B-NP
activity NN O
is VBZ O
also RB O
reflected VBN O
in IN O
a DT O
reduced VBN O
ability NN O
of IN O
S120K NNP B-NP
MutY NNP I-NP
to TO O
prevent VB O
DNA NNP O
mutations NNS O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

METHODS NNS O
AND CC O
RESULTS NNS O
: : O
We PRP O
prospectively RB O
compared VBD O
the DT O
automated JJ O
measurements NNS O
of IN O
left JJ O
ventricular JJ O
ejection NN O
fraction NN O
( -LRB- O
LVEF NN O
) -RRB- O
and CC O
volumes NNS O
from IN O
rest-injected JJ O
gated VBN O
Technetium NN O
99m FW O
( -LRB- O
Tc99m NN O
) -RRB- O
perfusion NN O
SPECT NNP O
with IN O
equilibrium NN O
radionuclide NN O
angiocardiography NN O
( -LRB- O
ERNA NNP O
) -RRB- O
in IN O
62 CD O
patients NNS O
and CC O
the DT O
assessment NN O
of IN O
regional JJ O
function NN O
with IN O
echocardiography NN O
in IN O
22 CD O
patients NNS O
. . O

-DOCSTART- X X O

The DT O
2 CD O
cDNAs NN O
differed VBD O
in IN O
the DT O
length NN O
of IN O
their PRP$ O
respective JJ O
3' JJ O
untranslated JJ O
regions NNS O
, , O
of IN O
577 CD O
bp NN O
in IN O
Cp.F6 NNP B-NP
and CC O
72 CD O
bp NN O
in IN O
Cp.F10 NNP B-NP
, , O
in IN O
both DT O
of IN O
which WDT O
a DT O
putative JJ O
polyadenylation NN O
signal NN O
was VBD O
identified VBN O
. . O

-DOCSTART- X X O

The DT O
spacing NN O
of IN O
the DT O
essential JJ O
N-terminal JJ O
domain NN O
( -LRB- O
END NNP O
) -RRB- O
relative JJ O
to TO O
the DT O
HFD NNP B-NP
can MD O
be VB O
changed VBN O
significantly RB O
without IN O
an DT O
apparent JJ O
effect NN O
on IN O
Cse4p JJ B-NP
function NN O
. . O

-DOCSTART- X X O

In IN O
invertebrates NNS O
, , O
Fhit NNP B-NP
is VBZ O
encoded VBN O
as IN O
a DT O
fusion NN O
protein NN O
with IN O
Nit NNP B-NP
, , O
a DT O
member NN O
of IN O
the DT O
nitrilase NN B-NP
superfamily NN I-NP
. . O

-DOCSTART- X X O

The DT O
manifestations NNS O
often RB O
include VBP O
a DT O
moderate JJ O
thrombocytopenia NN O
and CC O
, , O
less RBR O
commonly RB O
, , O
hemolysis NN O
. . O

-DOCSTART- X X O

A DT O
beta2 CD B-NP
RARE NNP I-NP
reporter NN I-NP
construct VB I-NP
in IN O
which WDT O
the DT O
methylation-susceptible JJ O
cytosines NNS O
in IN O
the DT O
sense NN O
strand NN O
were VBD O
replaced VBN O
by IN O
thymine DT O
displayed VBN O
marked JJ O
loss NN O
of IN O
activity NN O
in IN O
a DT O
replicated JJ O
chromatin-dependent NN O
manner NN O
. . O

-DOCSTART- X X O

Multiparity NNP O
had VBD O
a DT O
protective JJ O
effect NN O
with IN O
0.66 CD O
less JJR O
risk NN O
(95 CD O
% NN O
CI NNP O
0.44-0.99 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Picture NN O
the DT O
smell NN O
. . O

-DOCSTART- X X O

The DT O
aim NN O
of IN O
our PRP$ O
study NN O
was VBD O
to TO O
evaluate VB O
the DT O
level NN O
of IN O
oxidative JJ O
stress NN O
in IN O
healthy JJ O
controls NNS O
( -LRB- O
CTL NN O
) -RRB- O
compared VBN O
with IN O
CRF NNP O
and CC O
HD NNP O
patients NNS O
before IN O
( -LRB- O
pre-HD JJ O
) -RRB- O
and CC O
after IN O
( -LRB- O
post-HD NN O
) -RRB- O
the DT O
dialysis NN O
session NN O
, , O
carried VBD O
out RP O
on IN O
a DT O
high JJ O
biocompatible JJ O
polyacrylonitrile NN O
membrane NN O
AN69 NNP O
. . O

-DOCSTART- X X O

Taken VBN O
together RB O
, , O
they PRP O
uphold VBP O
the DT O
emerging VBG O
concern NN O
that IN O
women NNS O
with IN O
ER( JJ B-NP
+ NN I-NP
) -RRB- I-NP
cancers NNS O
may MD O
not RB O
benefit VB O
significantly RB O
from IN O
endocrine NN O
treatment NN O
if IN O
the DT O
tumors NNS O
also RB O
overexpress IN O
HER-2 NNP B-NP
. . O

-DOCSTART- X X O

Promoter NNP O
activity NN O
was VBD O
dose-dependently RB O
inhibited VBN O
by IN O
cotransfection NN O
with IN O
either DT O
ras NNS B-NP
or CC O
mos NN B-NP
oncogenes NNS I-NP
, , O
but CC O
oncogene NNP O
inhibition NN O
was VBD O
reversed VBN O
and CC O
the DT O
overall JJ O
activity NN O
increased VBN O
when WRB O
cells NNS O
were VBD O
treated VBN O
with IN O
the DT O
MAP NNP B-NP
kinase NN I-NP
kinase NN I-NP
( -LRB- O
MKK) NNP B-NP
inhibitor IN O
PD98059 CD O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
expression NN O
of IN O
Cktsf1b1 NNP B-NP
, , O
a DT O
gene NN O
associated VBN O
with IN O
early JJ O
development NN O
and CC O
cell NN O
transformation NN O
, , O
is VBZ O
sensitive JJ O
to TO O
MKK NNP B-NP
levels NNS O
and CC O
may MD O
be VB O
regulated VBN O
via IN O
multiple JJ O
transcription NN O
factor NN O
complexes NNS O
. . O

-DOCSTART- X X O

Functional JJ O
magnetic JJ O
resonance NN O
imaging NN O
( -LRB- O
fMRI NN O
) -RRB- O
has VBZ O
been VBN O
increasingly RB O
used VBN O
in IN O
studying VBG O
human JJ O
brain NN O
function NN O
given VBN O
its PRP$ O
non-invasive JJ O
feature NN O
and CC O
good JJ O
spatial JJ O
resolution NN O
. . O

-DOCSTART- X X O

After IN O
declamping VBG O
of IN O
the DT O
aorta NN O
, , O
there EX O
were VBD O
also RB O
severe JJ O
edema NN O
, , O
local JJ O
fibre JJ O
necrosis NN O
, , O
and CC O
adhesion NN O
of IN O
leucocytes NNS O
, , O
whereas IN O
muscle NN O
fibre JJ O
areas NNS O
became VBD O
3,935.18 CD O
micro JJ O
531 CD O
microm( JJ O
2 CD O
) -RRB- O
for IN O
type NN O
I PRP O
and CC O
5,804 VB O
+/ JJ O
- : O
1,075 CD O
microm( NN O
2 CD O
) -RRB- O
for IN O
type NN O
II NNP O
. . O

-DOCSTART- X X O

The DT O
results NNS O
indicate VBP O
that IN O
the DT O
relationship NN O
between IN O
comprehension NN O
and CC O
production NN O
is VBZ O
different JJ O
at IN O
different JJ O
stages NNS O
in IN O
development NN O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
found VBN O
that DT O
increase NN O
in IN O
the DT O
RH NNP O
level NN O
boosts VBZ O
the DT O
current JJ O
values NNS O
by IN O
2-3 CD O
orders NNS O
of IN O
magnitude NN O
; : O
contrariwise NN O
, , O
the DT O
voltage NN O
values NNS O
rise VB O
by IN O
about IN O
three CD O
times NNS O
with IN O
drop NN O
in IN O
the DT O
RH. NNP O

-DOCSTART- X X O

The DT O
tumor-suppressor JJ B-NP
protein NN I-NP
p53 NN I-NP
is VBZ O
involved VBN O
in IN O
maintaining VBG O
genomic JJ O
stability NN O
. . O

-DOCSTART- X X O

Abrogation NN O
of IN O
p53 NN B-NP
function NN O
by IN O
E6 NNP B-NP
resulted VBD O
in IN O
an DT O
increase NN O
in IN O
the DT O
spontaneous JJ O
mutation NN O
frequencies NNS O
at IN O
the DT O
heterozygous JJ O
thymidine NN B-NP
kinase NN I-NP
( -LRB- O
TK) NNP B-NP
locus NN O
but CC O
not RB O
at IN O
the DT O
hemizygous JJ O
hypoxanthine NN B-NP
phosphoribosyl NN I-NP
transferase NN I-NP
( -LRB- O
HPRT NNP B-NP
) -RRB- O
locus NN O
. . O

-DOCSTART- X X O

The DT O
importance NN O
of IN O
this DT O
new JJ O
epidemiological JJ O
profile NN O
of IN O
schistosomiasis NN O
in IN O
the DT O
State NNP O
of IN O
Pernambuco NNP O
relies VBZ O
on IN O
the DT O
fact NN O
that IN O
it PRP O
can MD O
be VB O
related VBN O
with IN O
the DT O
drastic JJ O
human JJ O
interference NN O
on IN O
the DT O
environment NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
No DT O
significant JJ O
deformation NN O
in IN O
vertebral JJ O
artery NN O
flow NN O
was VBD O
noted VBN O
in IN O
the DT O
flexion-distraction NN O
Stage NN O
I PRP O
injuries NNS O
within IN O
the DT O
physiologic NN O
range NN O
of IN O
cervical JJ O
flexion NN O
. . O

-DOCSTART- X X O

The DT O
human JJ O
cDNA NN O
clone NN O
NFBD1 NNP O
( -LRB- O
previously RB O
designated VBN O
KIAA0170 NNP O
) -RRB- O
encodes VBZ O
a DT O
novel JJ O
protein NN O
( -LRB- O
2089 CD O
amino IN O
acids NNS O
in IN O
length NN O
; : O
calculated VBN O
molecular JJ O
mass NN O
226,440 CD O
D) NNP O
with IN O
possible JJ O
BRCT NN B-NP
domains VBZ I-NP
at IN O
its PRP$ O
carboxy NN O
terminus IN O
(amino NNP O
acid NN O
residues NNS O
1894-2089 CD O
) -RRB- O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Neither DT O
basal NN O
FSH NNP B-NP
level NN O
nor CC O
stimulated VBD O
FSH NNP B-NP
level NN O
alone RB O
were VBD O
statistically RB O
significant JJ O
predictors NNS O
of IN O
IVF NNP O
success NN O
; : O
however RB O
, , O
no DT O
patient NN O
with IN O
a DT O
day NN O
3 CD O
FSH NNP B-NP
level NN O
> IN O
11.1 CD O
mIU/ml NN O
or CC O
a DT O
stimulated VBN O
day NN O
10 CD O
FSH NNP B-NP
level NN O
> , O
13.5 CD O
mIU/ml NN O
conceived VBD O
and CC O
carried VBD O
a DT O
pregnancy NN O
. . O

-DOCSTART- X X O

Parathyroid NNP B-NP
hormone NN I-NP
regulation NN O
of IN O
bone NN B-NP
sialoprotein NN I-NP
( -LRB- O
BSP) NNP B-NP
gene NN O
transcription NN O
is VBZ O
mediated VBN O
through IN O
a DT O
pituitary-specific JJ B-NP
transcription NN I-NP
factor-1 NN I-NP
( -LRB- O
Pit-1 NN B-NP
) -RRB- O
motif NN O
in IN O
the DT O
rat NN B-NP
BSP NNP I-NP
gene NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Linking VBG O
continuous JJ O
community-based JJ O
morbidity NN O
recording NN O
of IN O
influenza-like JJ O
illness NN O
( -LRB- O
ILI NN O
) -RRB- O
with IN O
virological JJ O
sampling NN O
has VBZ O
consistently RB O
proved VBN O
its PRP$ O
value NN O
as IN O
one CD O
of IN O
the DT O
earliest JJS O
indicators NNS O
of IN O
circulating VBG O
influenza NN O
activity NN O
. . O

-DOCSTART- X X O

The DT O
muskox NN O
is VBZ O
a DT O
new JJ O
host NN O
record NN O
for IN O
T. NNP O
gondii NNP O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
here RB O
that IN O
this DT O
difference NN O
is VBZ O
due JJ O
to TO O
the DT O
presence NN O
of IN O
a DT O
Mot3 NNP B-NP
binding NN I-NP
site NN I-NP
in IN O
OpA. NNP B-NP

-DOCSTART- X X O

The DT O
article NN O
deals VBZ O
with IN O
the DT O
diagnosing NN O
and CC O
correction NN O
of IN O
reversible JJ O
ischemia NN O
of IN O
the DT O
intestine NN O
. . O

-DOCSTART- X X O

Functional JJ O
recognition NN O
of IN O
5' JJ O
splice NN O
site NN O
by IN O
U4/U6.U5 DT B-NP
tri-snRNP JJ O
defines NNS O
a DT O
novel NN O
ATP-dependent NNP O
step NN O
in IN O
early JJ O
spliceosome JJ O
assembly NN O
. . O

-DOCSTART- X X O

As IN O
control NN O
, , O
the DT O
cells NNS O
were VBD O
transfected VBN O
with IN O
DNA NN O
mixtures NNS O
containing VBG O
vector NN O
mU6-C1 JJ O
or CC O
mU6-C2 JJ O
. . O

-DOCSTART- X X O

In IN O
the DT O
lattice NN O
, , O
23 CD O
% NN O
of IN O
the DT O
sites NNS O
are VBP O
occupied VBN O
, , O
95 CD O
% NN O
of IN O
the DT O
atoms NNS O
are VBP O
in IN O
the DT O
lowest JJS O
energy NN O
magnetic JJ O
sublevel NN O
, , O
and CC O
37 CD O
% NN O
are VBP O
in IN O
the DT O
lowest JJS O
3D NN O
vibrational JJ O
state NN O
. . O

-DOCSTART- X X O

Regarding VBG O
" `` O
the DT O
relation NN O
between IN O
sexual JJ O
orientation NN O
and CC O
penile NN O
size NN O
, , O
" '' O
by IN O
A. NN O

-DOCSTART- X X O

This DT O
slope NN O
was VBD O
further JJ O
significantly RB O
decreased VBD O
at IN O
5 CD O
min NN O
ischemia NN O
(-26.5 CD O
+/ NNS O
- : O
8.8 CD O
microm/mmHg NN O
) -RRB- O
but CC O
returned VBD O
toward IN O
control NN O
values NNS O
in IN O
short-term JJ O
hibernating NN O
myocardium NN O
at IN O
90 CD O
min NN O
ischemia NN O
(-17.2 CD O
+/ NNS O
- : O
6.6 CD O
microm/mmHg NN O
) -RRB- O
. . O

-DOCSTART- X X O

Whereas IN O
both DT O
MAP NNP O
and CC O
MSNA NNP O
increase NN O
during IN O
SHG NNP O
, , O
the DT O
transition NN O
from IN O
SHG NNP O
to TO O
PHI NNP O
is VBZ O
characterized VBN O
by IN O
a DT O
transient JJ O
reduction NN O
in IN O
MAP NNP O
but CC O
sustained VBD O
elevation NN O
in IN O
MSNA NNP O
, , O
facilitating VBG O
separation NN O
of IN O
these DT O
factors NNS O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
Standard NNP O
Reference NNP O
Material NNP O
1846 CD O
, , O
Infant NNP O
Formula NNP O
, , O
gave VBD O
a DT O
mean JJ O
value NN O
of IN O
0.95 CD O
+/ NNS O
- : O
0.088 CD O
mg NN O
vitamin NN O
K/kg NNP O
( -LRB- O
K NNP O
or CC O
K1 NNP O
? . O
) -RRB- O
( -LRB- O
n NN O
= SYM O
31 CD O
) -RRB- O
with IN O
a DT O
coefficient NN O
of IN O
variation NN O
of IN O
9.26 CD O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
recently RB O
discovered VBN O
that IN O
CCAAAT/enhancer-binding JJ B-NP
protein-beta NN I-NP
( -LRB- O
C/EBP-beta NN B-NP
) -RRB- O
induces VBZ O
gene NN O
transcription NN O
through IN O
a DT O
novel NN O
IFN NNP B-NP
response NN I-NP
element NN I-NP
called VBD O
the DT O
gamma-IFN-activated JJ B-NP
transcriptional JJ I-NP
element NN I-NP

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
demonstrated VBN O
that IN O
the DT O
STORP NNP B-NP
gene NN I-NP
has VBZ O
a DT O
ubiquitous JJ O
pattern NN O
of IN O
expression NN O
similar JJ O
to TO O
that DT O
of IN O
the DT O
PML NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
TLE NN O
patients NNS O
the DT O
NAA NNP O
: : O
Cr NNP O
ratios NNS O
were VBD O
reduced VBN O
in IN O
the DT O
seizure NN O
focus NN O
, , O
while IN O
in IN O
the DT O
FLE JJ O
patients NNS O
they PRP O
were VBD O
not RB O
always RB O
reduced VBN O
in IN O
the DT O
seizure NN O
focus NN O
. . O

-DOCSTART- X X O

The DT O
psychologic NN O
factors NNS O
associated VBN O
wth IN O
serious JJ O
illness NN O
, , O
terminal NN O
prognoses NNS O
, , O
and CC O
dying VBG O
complicate VB O
the DT O
scenario NN O
even RB O
more RBR O
as IN O
compared VBN O
with IN O
that DT O
of IN O
nonmalignant JJ O
pain NN O
. . O

-DOCSTART- X X O

However RB O
, , O
if IN O
the DT O
spatial JJ O
resolution NN O
is VBZ O
not RB O
critical JJ O
and CC O
interest NN O
is VBZ O
to TO O
compare VB O
a DT O
pathologic JJ O
area NN O
with IN O
a DT O
contralateral JJ O
VOI NN O
, , O
then RB O
the DT O
acquisition NN O
of IN O
two CD O
single-voxel JJ O
spectra NN O
may MD O
be VB O
preferred VBN O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
the DT O
amplitude NN O
of IN O
the DT O
cortical JJ O
evoked JJ O
potentials NNS O
(amplitude NN O
of IN O
the DT O
N2/P2 JJ O
peak NN O
) -RRB- O
increased VBN O
from IN O
5.1 CD O
+/ CD O
- : O
0.7 CD O
microV NN O
at IN O
5 CD O
mA NN O
to TO O
16.3 CD O
+/ CD O
- : O
1.1 CD O
microV NN O
at IN O
20 CD O
mA NN O
. . O

-DOCSTART- X X O

While IN O
mutations NNS O
in IN O
K-Rev NNP B-NP
that IN O
inactivate JJ O
any DT O
one CD O
of IN O
these DT O
properties NNS O
also RB O
blocked VBD O
K-Rev-dependent JJ B-NP
nuclear JJ O
RNA NN O
export NN O
, , O
several JJ O
K-Rev NNP B-NP
mutants NNS I-NP
were VBD O
comparable JJ O
to TO O
wild JJ O
type NN O
when WRB O
assayed VBN O
for IN O
any DT O
of IN O
these DT O
individual JJ O
activities NNS O
yet RB O
nevertheless RB O
defective JJ O
for IN O
RNA NNP O
export NN O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
In IN O
the DT O
current JJ O
study NN O
the DT O
authors NNS O
reported VBD O
on IN O
PPB NNP O
cases NNS O
from IN O
a DT O
national JJ O
retrospective JJ O
search NN O
performed VBN O
in IN O
18 CD O
Italian JJ O
Associations NNS O
for IN O
Pediatric NNP O
Hematology NNP O
and CC O
Oncology NNP O
centers NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggest VBP O
that IN O
Cdc42p NNP B-NP
is VBZ O
in IN O
fact NN O
required VBN O
for IN O
pheromone NN O
response NN O
and CC O
that DT O
interaction NN O
with IN O
the DT O
PAK NNP B-NP
Ste20p NNP B-NP
is VBZ O
critical JJ O
for IN O
that DT O
role NN O
. . O

-DOCSTART- X X O

Deletion NNP O
of IN O
an DT O
intergenic JJ O
DNA-binding NN O
site NN O
for IN O
this DT O
complex NN O
from IN O
a DT O
human JJ B-NP
beta-globin NN I-NP
locus NN I-NP
construct VB I-NP
results NNS O
in IN O
delayed VBN O
human JJ B-NP
gamma NN I-NP
- : I-NP
to TO I-NP
beta-globin NN I-NP
switching NN O
in IN O
transgenic NN O
mice NNS O
, , O
suggesting VBG O
that IN O
the DT O
PYR NN B-NP
complex JJ I-NP
acts NNS O
to TO O
facilitate VB O
the DT O
switch NN O
. . O

-DOCSTART- X X O

Studies NNS O
suggest VBP O
that IN O
the DT O
DGOR NN O
without IN O
acid NN O
reflux NN O
may MD O
result VB O
in IN O
symptoms NNS O
but CC O
unless IN O
acid JJ O
reflux NN O
is VBZ O
present JJ O
simultaneously RB O
, , O
it PRP O
does VBZ O
not RB O
cause VB O
oesophagitis NN O
. . O

-DOCSTART- X X O

Symptoms NNS O
, , O
however RB O
, , O
appear VBP O
to TO O
correlate VB O
poorly RB O
with IN O
oesophagitis NN O
; : O
hence RB O
, , O
severe JJ O
symptoms NNS O
do VBP O
not RB O
indicate VB O
there EX O
is VBZ O
greater JJR O
oesophageal JJ O
damage NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
demonstrate VBP O
Ras NNP B-NP
- : O
and CC O
Raf-independent NNP B-NP
ERK NNP B-NP
MAPK NNP O
activation NN O
maintains VBZ O
cell NN O
viability NN O
following VBG O
heat NN O
shock NN O
. . O

-DOCSTART- X X O

Three CD O
cDNAs NNS O
encoding VBG O
basic JJ B-NP
leucine NN I-NP
zipper NN I-NP
( -LRB- I-NP
bZIP)-type JJ I-NP
ABRE-binding JJ I-NP
proteins NNS I-NP
were VBD O
isolated VBN O
by IN O
using VBG O
the DT O
yeast NN O
one-hybrid JJ O
system NN O
and CC O
were VBD O
designated VBN O
AREB1 NN B-NP
, , O
AREB2 NN B-NP
, , O
and CC O
AREB3 NN B-NP
( -LRB- O
ABA-responsive JJ B-NP
element NN I-NP
binding JJ I-NP
protein NN I-NP
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
the DT O
PMR NNP O
target NN O
area NN O
but CC O
not RB O
in IN O
the DT O
nontreated JJ O
area NN O
an DT O
improvement NN O
in IN O
regional JJ O
myocardial JJ O
flow NN O
reserve NN O
occurs VBZ O
in IN O
wall NN O
segments NNS O
with IN O
initially RB O
severely RB O
or CC O
moderately RB O
reduced JJ O
stress NN O
perfusion NN O
. . O

-DOCSTART- X X O

For IN O
this DT O
purpose NN O
, , O
a DT O
segment NN O
of IN O
dxr NN B-NP
was VBD O
amplified VBN O
from IN O
Synechococcus NNP O
leopoliensis NN O
SAUG NNP O
1402-1 CD O
DNA NNP O
via IN O
PCR NNP O
using VBG O
oligonucleotides NNS O
for IN O
conserved JJ O
regions NNS O
. . O

-DOCSTART- X X O

Perceptual JJ O
learning NN O
for IN O
a DT O
pattern NN O
discrimination NN O
task NN O
. . O

-DOCSTART- X X O

The DT O
detector NN O
has VBZ O
the DT O
advantage NN O
of IN O
finding VBG O
both DT O
ST JJS O
segment NN O
deviations NNS O
and CC O
entire JJ O
ST-T JJ O
complex JJ O
changes NNS O
thereby RB O
providing VBG O
a DT O
wider JJR O
characterization NN O
of IN O
the DT O
potential JJ O
ischemic JJ O
events NNS O
. . O

-DOCSTART- X X O

Primary JJ O
adrenal JJ O
hypersensitivity NN O
to TO O
ACTH DT B-NP
drive NN O
in IN O
obesity NN O
has VBZ O
also RB O
been VBN O
suggested VBN O
. . O

-DOCSTART- X X O

Multiple NNP O
transcription NN O
start NN O
sites NNS O
were VBD O
revealed VBN O
by IN O
primer JJ O
extension NN O
analysis NN O
of IN O
the DT O
mouse NN O
gene NN O
, , O
and CC O
transfection NN O
constructs NNS O
containing VBG O
the DT O
prospective JJ O
promoter NN O
generated VBN O
transcriptional JJ O
activity NN O
comparable JJ O
to TO O
that DT O
of IN O
the DT O
SV40 NNP B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

From IN O
two CD O
inhibitor NN O
scaffolds NNS O
, , O
we PRP O
have VBP O
identified VBN O
potent JJ O
and CC O
selective JJ O
inhibitors NNS O
for IN O
sensitized JJ O
kinases NNS O
from IN O
five CD O
distinct JJ O
subfamilies NNS O
. . O

-DOCSTART- X X O

To TO O
determine VB O
whether IN O
interaction NN O
of IN O
arsenite NN O
with IN O
the DT O
hormone-binding JJ O
domain NN O
results NNS O
in IN O
receptor NN O
activation NN O
, , O
COS-1 JJ O
cells NNS O
were VBD O
transiently RB O
cotransfected VBN O
with IN O
the DT O
chimeric JJ B-NP
receptors NNS I-NP
GAL-ER NNP I-NP
, , O
which WDT O
contains VBZ O
the DT O
hormone-binding JJ O
domain NN O
of IN O
ERalpha NNP B-NP
and CC O
the DT O
DNA-binding JJ O
domain NN O
of IN O
the DT O
transcription NN O
factor NN O
GAL4 NNP B-NP
, , O
and CC O
a DT O
GAL4-responsive JJ B-NP
CAT NN B-NP
reporter NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

By IN O
progressive JJ O
5'-deletion JJ O
studies NNS O
, , O
we PRP O
have VBP O
identified VBN O
a DT O
248-bp JJ O
DNA NN O
fragment NN O
(-1018 . O
to TO O
-771 JJ O
, , O
relative JJ O
to TO O
the DT O
translation NN O
start NN O
site NN O
) -RRB- O
at IN O
the DT O
5'-flanking JJ O
region NN O
of IN O
the DT O
human JJ B-NP
GnRHR NNP I-NP
gene NN I-NP
that WDT O
is VBZ O
responsible JJ O
for IN O
the DT O
GnRHa-mediated JJ O
down-regulation NN O
of IN O
human JJ B-NP
GnRHR NNP I-NP
promoter NN I-NP
activity NN O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
day NN O
of IN O
diagnosis NN O
of IN O
periventricular JJ O
echodensities NNS O
was VBD O
3 CD O
+/ CD O
- : O
2 CD O
days NNS O
( -LRB- O
range NN O
1-11 JJ O
days NNS O
) -RRB- O
, , O
and CC O
of IN O
cystic JJ O
PVL NNP O
21 CD O
+/ NNS O
- : O
8 CD O
days NNS O
( -LRB- O
range NN O
2-47 JJ O
days NNS O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
group NN O
B NNP O
37 CD O
MBq NN O
in IN O
150 CD O
microL NNS O
of IN O
99mTc-HSA DT O
nanocolloid NN O
was VBD O
additionally RB O
injected VBN O
intradermally RB O
18 CD O
h NN O
before IN O
surgery NN O
(3-6 NN O
aliquots NNS O
injected VBD O
perilesionally RB O
) -RRB- O
. . O

-DOCSTART- X X O

AGO1 NNP B-NP
is VBZ O
similar JJ O
to TO O
QDE-2 DT B-NP
required VBN O
for IN O
quelling NN O
and CC O
RDE-1 NN B-NP
required VBN O
for IN O
RNAi NNP O
. . O

-DOCSTART- X X O

We PRP O
could MD O
demonstrate VB O
the DT O
involvement NN O
of IN O
cAMP-dependent JJ B-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
PKA NN B-NP
) -RRB- O
in IN O
the DT O
phosphorylation NN O
of IN O
CDC25Mm NNP B-NP
in IN O
fibroblasts NNS O
overexpressing VBG O
this DT O
RasGEF NN B-NP
as RB O
well RB O
as IN O
in IN O
mouse NN O
brain NN O
synaptosomal NN O
membranes NNS O
. . O

-DOCSTART- X X O

We PRP O
find VBP O
that DT O
3T1-3T2 JJ O
mixing NN O
has VBZ O
a DT O
pronounced JJ O
effect NN O
on IN O
the DT O
line NN O
shape NN O
and CC O
radiative JJ O
decay NN O
rate NN O
of IN O
emission NN O
from IN O
the DT O
3T2 JJ O
state NN O
and CC O
that IN O
the DT O
extent NN O
of IN O
mixing NN O
depends VBZ O
critically RB O
on IN O
the DT O
magnitude NN O
of IN O
nontetrahedral JJ O
distortions NNS O
. . O

-DOCSTART- X X O

Concurrently RB O
, , O
we PRP O
monitored VBD O
weather NN O
conditions NNS O
and CC O
used VBN O
time-activity NN O
budget NN O
data NNS O
of IN O
free-living JJ O
birds NNS O
and CC O
laboratory NN O
data NNS O
on IN O
resting VBG O
metabolic JJ O
rate NN O
to TO O
construct VB O
time-activity NN O
laboratory NN O
( -LRB- O
TAL NN O
) -RRB- O
estimates NNS O
of IN O
daily JJ O
energy NN O
expenditure NN O
( -LRB- O
DEE NN O
) -RRB- O
and CC O
to TO O
partition VB O
the DT O
verdins NNS O
' POS O
energy NN O
budget NN O
into IN O
thermoregulatory JJ O
, , O
activity NN O
and CC O
basal JJ O
components NNS O
. . O

-DOCSTART- X X O

L/H NNP O
>0.61 CD O
( -LRB- O
chi( NN O
2 CD O
)=10.8 CD O
; : O
P NNP O
:<0.001 CD O
) -RRB- O
and CC O
a DT O
restrictive JJ O
filling NN O
pattern NN O
( -LRB- O
chi( NN O
2 CD O
)=3.6 CD O
; : O
P NNP O
:<0.05 CD O
) -RRB- O
were VBD O
independent JJ O
predictors NNS O
of IN O
events NNS O
. . O

-DOCSTART- X X O

The DT O
high JJ O
selectivity NN O
of IN O
arrestins NNS B-NP
for IN O
this DT O
particular JJ O
functional JJ O
form NN O
of IN O
receptor NN O
ensures VBZ O
their PRP$ O
timely JJ O
binding NN O
and CC O
dissociation NN O
. . O

-DOCSTART- X X O

When WRB O
cotransfected VBN O
in IN O
fibroblasts NNS O
with IN O
a DT O
C/EBP NNP B-NP
alpha NN I-NP
expression NN O
vector RB O
, , O
reporter NN O
gene NN O
expression NN O
increased VBD O
3-fold JJ O
only RB O
in IN O
the DT O
wild-type JJ O
constructs NNS O
. . O

-DOCSTART- X X O

Nature NN O
398 CD O
, , O
828-830 CD O
) -RRB- O
that IN O
the DT O
amino JJ O
acid NN O
sequences NNS O
of IN O
peptide NN O
fragments NNS O
obtained VBN O
from IN O
a DT O
polypeptide NN O
found VBN O
in IN O
a DT O
complex JJ O
of IN O
proteins NNS O
that WDT O
alters NNS O
chromatin NN O
structure NN O
( -LRB- O
ARC NNP B-NP
) -RRB- O
are VBP O
identical JJ O
to TO O
portions NNS O
of IN O
the DT O
deduced VBN O
open JJ O
reading NN O
frame NN O
of IN O
TIG-1 NN B-NP
mRNA NN I-NP
. . O

-DOCSTART- X X O

Abnormalities NNS O
of IN O
plasma NN B-NP
cholecystokinin NN I-NP
were VBD O
observed VBN O
only RB O
in IN O
patients NNS O
with IN O
delayed JJ O
gastric JJ O
emptying JJ O
. . O

-DOCSTART- X X O

5 CD O
( -LRB- O
Sunset NNP O
Yellow NNP O
FCF NNP O
) -RRB- O
were VBD O
determined VBN O
using VBG O
liquid JJ O
chromatography/mass NN O
spectrometry NN O
(LC/MS NNS O
) -RRB- O
with IN O
electrospray NN O
ionization NN O
. . O

-DOCSTART- X X O

Polysome NNP O
and CC O
40S CD B-NP
ribosome JJ I-NP
fractions NNS O
were VBD O
severely RB O
decreased VBN O
in IN O
the DT O
krr1 NN B-NP
mutant JJ I-NP
and CC O
Kri1p-depleted JJ B-NP
cells NNS O
. . O

-DOCSTART- X X O

They PRP O
also RB O
negatively RB O
modulate VB O
the DT O
PI NNP B-NP
3-kinase JJ I-NP
catalytic JJ O
activity NN O
but CC O
to TO O
different JJ O
extents NNS O
, , O
dependent JJ O
on IN O
the DT O
unique JJ O
N-terminal JJ O
structure NN O
of IN O
each DT O
isoform NN O
. . O

-DOCSTART- X X O

Cam NNP B-NP
kinase NN I-NP
II NNP I-NP
induces VBZ O
in IN O
vivo JJ O
phosphorylation NN O
of IN O
Smad2 NNP B-NP
and CC O
Smad4 NNP B-NP
and CC O
, , O
to TO O
a DT O
lesser JJR O
extent NN O
, , O
Smad3 NNP B-NP
. . O

-DOCSTART- X X O

Recombinant NNP B-NP
BRI1-KD NNP I-NP
autophosphorylated VBD O
on IN O
serine NN O
( -LRB- O
Ser NN O
) -RRB- O
and CC O
threonine CD O
( -LRB- O
Thr NNP O
) -RRB- O
residues VBZ O
with IN O
p-Ser JJ O
predominating NN O
. . O

-DOCSTART- X X O

Flow NNP O
cytomery NN O
was VBD O
used VBN O
for IN O
cell NN O
cycle NN O
analysis NN O
. . O

-DOCSTART- X X O

Cost-effectiveness NN O
of IN O
interferon NN B-NP
beta-1b JJ I-NP
in IN O
slowing VBG O
multiple JJ O
sclerosis NN O
disability NN O
progression NN O
. . O

-DOCSTART- X X O

Hyperactivation NNP O
of IN O
Cdc2 NNP B-NP
in IN O
fission NN O
yeast NN O
causes VBZ O
cells NNS O
to TO O
undergo VB O
a DT O
lethal JJ O
premature JJ O
mitosis NN O
called VBD O
mitotic JJ O
catastrophe NN O
. . O

-DOCSTART- X X O

Cells NNP O
differentiate VBP O
in IN O
response NN O
to TO O
various JJ O
extracellular JJ O
stimuli NNS O
. . O

-DOCSTART- X X O

Transforming VBG B-NP
growth NN I-NP
factor-beta1 FW I-NP
( -LRB- O
TGF-beta1 NN B-NP
) -RRB- O
can MD O
act VB O
as IN O
a DT O
tumor NN O
suppressor NN O
or CC O
a DT O
tumor NN O
promoter NN O
depending VBG O
on IN O
the DT O
characteristics NNS O
of IN O
the DT O
malignant JJ O
cell NN O
. . O

-DOCSTART- X X O

Mn2+ JJ O
increased VBD O
both DT O
the DT O
junction NN O
binding NN O
and CC O
cleaving JJ O
activities NNS O
of IN O
the DT O
mutant JJ O
proteins NNS O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
an DT O
in IN O
vitro NN O
pull-down NN O
assay NN O
showed VBD O
that IN O
Os;CycH;1 NNP B-NP
specifically RB O
bound VBD O
to TO O
R2 VB B-NP
but CC O
not RB O
to TO O
other JJ O
rice NN B-NP
CDKs NNS I-NP
. . O

-DOCSTART- X X O

Overexpression IN O
of IN O
Trdpm1 NNP B-NP
in IN O
a DT O
dpm1( JJ B-NP
+ NN I-NP
) -RRB- I-NP
: : O
:his7/dpm1( JJ O
+ NNS B-NP
) -RRB- I-NP
S.pombe NNP O
diploid JJ O
resulted VBD O
in IN O
a DT O
4-fold JJ O
increase NN O
in IN O
specific JJ O
DPM NNP B-NP
synthase NN I-NP
activity NN O
. . O

-DOCSTART- X X O

The DT O
LMW NNP B-NP
FGF-2 NNP I-NP
up-regulated CC O
the DT O
PKC NNP B-NP
epsilon NN I-NP
levels NNS O
by IN O
1.6-fold JJ O
; : O
by IN O
contrast NN O
the DT O
HMW NNP B-NP
isoform NN I-NP
down-regulated CC O
the DT O
level NN O
of IN O
this DT O
PKC NNP B-NP
isotype NN I-NP
by IN O
about IN O
3-fold JJ O
and CC O
increased VBD O
the DT O
amount NN O
of IN O
PKC JJ B-NP
delta NN I-NP
by IN O
1.7-fold JJ O
. . O

-DOCSTART- X X O

Helicobacter NNP O
pylori NN O
and CC O
stomach NN O
diseases NNS O
:from IN O
clinical JJ O
point NN O
of IN O
view NN O

-DOCSTART- X X O

2000 CD O
update NN O
of IN O
recommendations NNS O
for IN O
the DT O
use NN O
of IN O
hematopoietic JJ B-NP
colony-stimulating JJ I-NP
factors NNS I-NP
: : O
evidence-based JJ O
, , O
clinical JJ O
practice NN O
guidelines NNS O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
, , O
Arix NNP B-NP
and CC O
NBPhox NNP B-NP
form VBP O
DNA-independent JJ O
multimers NNS O
and CC O
exhibit NN O
cooperative JJ O
binding NN O
to TO O
the DT O
DB1 JJ B-NP
regulatory JJ I-NP
element NN I-NP
, , O
which WDT O
contains VBZ O
two CD O
homeodomain JJ B-NP
recognition NN I-NP
sites NNS I-NP
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
from IN O
this DT O
study NN O
that IN O
Arix NNP B-NP
and CC O
NBPhox NNP B-NP
exhibit VBP O
indistinguishable JJ O
and CC O
independent JJ O
transcriptional JJ O
regulatory JJ O
properties NNS O
on IN O
the DT O
DBH NNP B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

An DT O
increase NN O
in IN O
hypothalamic JJ O
expression NN O
of IN O
at IN O
least JJS O
two CD O
of IN O
the DT O
erbB NN B-NP
receptors NNS I-NP
is VBZ O
initiated VBN O
before IN O
the DT O
pubertal JJ O
augmentation NN O
of IN O
gonadal JJ O
steroid NN O
secretion NN O
and CC O
is VBZ O
completed VBN O
on IN O
the DT O
day NN O
of IN O
the DT O
first JJ O
preovulatory NN O
surge NN O
of IN O
gonadotropins NNS B-NP
. . O

-DOCSTART- X X O

Dsh NN B-NP
is VBZ O
required VBN O
for IN O
two CD O
different JJ O
pathways NNS O
, , O
the DT O
Wnt NNP B-NP
pathway NN O
and CC O
planar NN O
polarity NN O
pathway NN O
in IN O
Drosophila NNP O
. . O

-DOCSTART- X X O

Methyl NNP O
formate NN O
was VBD O
used VBN O
as IN O
the DT O
solvent NN O
of IN O
biodegradable JJ O
oligoesters NNS O
for IN O
the DT O
fabrication NN O
of IN O
microspheres NNS O
with IN O
encapsulated JJ O
bovine NN B-NP
serum NN I-NP
albumin NN I-NP
( -LRB- O
BSA NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
small JJ B-NP
monomeric JJ I-NP
GTP-binding JJ I-NP
proteins NNS I-NP
of IN O
the DT O
RAB NNP B-NP
subfamily NN I-NP
are VBP O
key JJ O
regulatory JJ O
elements NNS O
of IN O
the DT O
machinery NN O
that WDT O
controls VBZ O
membrane NN O
traffic NN O
in IN O
eukaryotic JJ O
cells NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
loss NN O
of IN O
methylation NN O
also RB O
greatly RB O
reduced VBN O
the DT O
association NN O
of IN O
another DT O
yeast NN O
B-type JJ O
subunit NN O
, , O
Rts1p NNP B-NP
. . O

-DOCSTART- X X O

The DT O
subjects NNS O
were VBD O
diagnosed VBN O
on IN O
the DT O
basis NN O
of IN O
DSM-IV NNP O
pathological JJ O
gambling NN O
criteria NNS O
and CC O
completed VBD O
the DT O
Turkish JJ O
Version NNP O
of IN O
South NNP O
Oaks NNP O
Gambling NNP O
Screen NNP O
( -LRB- O
SOGS) NNP O
. . O

-DOCSTART- X X O

Lys( JJ O
193 CD O
) -RRB- O
and CC O
Arg( JJ O
194 CD O
) -RRB- O
, , O
located VBN O
at IN O
the DT O
COOH-terminal JJ O
end NN O
of IN O
HD NNP B-NP
, , O
are VBP O
essential JJ O
for IN O
dimerization NN O
. . O

-DOCSTART- X X O

When WRB O
BFDS NNP O
was VBD O
taken VBN O
as IN O
the DT O
reference NN O
, , O
W/A NNP O
Z NNP O
scores NNS O
showed VBD O
consistent JJ O
positive JJ O
increments NNS O
, , O
from IN O
birth NN O
in IN O
girls NNS O
and CC O
1 CD O
mo NN O
in IN O
boys NNS O
. . O

-DOCSTART- X X O

These DT O
probable JJ O
border NN O
sequences NNS O
are VBP O
closely RB O
related VBN O
to TO O
those DT O
of IN O
other JJ O
known VBN O
T-regions NNS O
and CC O
define VB O
a DT O
second JJ O
T-region NN O
of IN O
pTiChry5 NN O
, , O
called VBD O
T-right JJ O
( -LRB- O
TR NN O
) -RRB- O
, , O
that WDT O
confers VBZ O
production NN O
of IN O
the DT O
Amadoriopines NNP O
. . O

-DOCSTART- X X O

High-mobility-group JJ B-NP
protein NN I-NP
I PRP I-NP
can MD O
modulate VB O
binding NN O
of IN O
transcription NN O
factors NNS O
to TO O
the DT O
U5 NNP B-NP
region NN I-NP
of IN O
the DT O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
proviral NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Another DT O
cis-acting JJ O
element NN O
, , O
exonic JJ O
splicing NN O
suppressor NN O
1 CD O
( -LRB- O
ESS1 NNP O
) -RRB- O
, , O
represses VBZ O
use NN O
of IN O
the DT O
nt JJ O
3225 CD O
3' CD O
splice NN O
site NN O
. . O

-DOCSTART- X X O

LMP2A DT B-NP
enhances NNS O
Lyn NNP B-NP
and CC O
Syk NNP B-NP
ubiquitination NN O
in IN O
vivo NN O
in IN O
a DT O
fashion NN O
that WDT O
depends VBZ O
on IN O
the DT O
activity NN O
of IN O
Nedd4 NNP B-NP
family NN O
members NNS O
and CC O
correlates NNS O
with IN O
destabilization NN O
of IN O
the DT O
Lyn NNP B-NP
tyrosine NN I-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
, , O
however RB O
, , O
were VBD O
obtained VBN O
for IN O
Z NN O
itself PRP O
and CC O
not RB O
for IN O
[ JJ O
Z] NNP O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
In IN O
the DT O
pregnant JJ O
group NN O
, , O
serum NN O
PP14 NNP B-NP
concentrations NNS O
were VBD O
markedly RB O
increased VBN O
after IN O
ET NNP O
, , O
and CC O
a DT O
significant JJ O
difference NN O
between IN O
the DT O
pregnant JJ O
group NN O
and CC O
the DT O
nonpregnant JJ O
group NN O
was VBD O
observed VBN O
8 CD O
days NNS O
following VBG O
ET NNP O
( -LRB- O
p NN O
< JJ O
0.01 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Thromboelastography NNP O
is VBZ O
a DT O
test NN O
that WDT O
could MD O
potentially RB O
correlate VB O
with IN O
the DT O
degree NN O
of IN O
anticoagulation NN O
produced VBN O
by IN O
low JJ O
molecular JJ O
weight NN O
heparin NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
provide VBP O
direct JJ O
evidence NN O
for IN O
differential JJ O
susceptibility NN O
to TO O
endonuclease-mediated DT O
mRNA NN O
decay NN O
resulting VBG O
from IN O
the DT O
differential JJ O
affinity NN O
of IN O
a DT O
RNA-binding JJ O
protein NN O
for IN O
cis-acting JJ O
stability NN O
determinants NNS O
. . O

-DOCSTART- X X O

Aspirin NNP O
causes VBZ O
peptic JJ O
ulcers NNS O
predominately RB O
by IN O
reducing VBG O
gastric JJ B-NP
mucosal NN I-NP
cyclooxygenase NN I-NP
( -LRB- O
COX NNP B-NP
) -RRB- O
activity NN O
and CC O
prostaglandin NN O
synthesis NN O
. . O

-DOCSTART- X X O

A DT O
total NN O
of IN O
1060 CD O
clones NNS O
were VBD O
randomly RB O
selected VBN O
for IN O
sequencing NN O
of IN O
one CD O
end NN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
a DT O
hybrid JJ O
protein NN O
containing VBG O
the DT O
cytoplasmic JJ O
C-terminal JJ O
half NN O
of IN O
UhpB NNP B-NP
fused VBD O
to TO O
glutathione NN B-NP
S-transferase NN I-NP
( -LRB- O
GST NNP B-NP
) -RRB- O
also RB O
interfered VBD O
with IN O
Uhp NNP B-NP
signaling VBG O
. . O

-DOCSTART- X X O

The DT O
gene NN O
is VBZ O
separated VBN O
into IN O
four CD O
exons NNS O
by IN O
three CD O
short JJ O
introns NNS O
, , O
and CC O
the DT O
open JJ O
reading NN O
frame NN O
consists VBZ O
of IN O
6660 CD O
base NN O
pairs NNS O
( -LRB- O
bp NN O
) -RRB- O
capable JJ O
of IN O
encoding VBG O
a DT O
polypeptide NN O
of IN O
2220 CD O
amino IN O
acid NN O
residues NNS O
. . O

-DOCSTART- X X O

Like IN O
the DT O
p190-B JJ B-NP
exon NN O
, , O
the DT O
first JJ O
exon NN O
of IN O
p190-A JJ B-NP
is VBZ O
extremely RB O
large JJ O
( -LRB- O
3.7 CD O
kb NN O
in IN O
length NN O
) -RRB- O
, , O
encoding VBG O
both DT O
the DT O
GTPase NNP B-NP
and CC O
middle JJ O
domains NNS O
( -LRB- O
residues NNS O
1-1228 CD O
) -RRB- O
, , O
but CC O
not RB O
the DT O
remaining VBG O
GAP NNP B-NP
domain NN I-NP
, , O
suggesting VBG O
a DT O
high JJ O
conservation NN O
of IN O
genomic JJ O
structure NN O
between IN O
two CD O
p190 JJ B-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

The DT O
entire JJ O
human JJ B-NP
teneurin-1 NN I-NP
( -LRB- O
TEN1 NNP B-NP
) -RRB- O
gene NN O
is VBZ O
contained VBN O
in IN O
eight CD O
PAC NNP O
clones NNS O
representing VBG O
part NN O
of IN O
the DT O
chromosomal NN O
locus NN O
Xq25 CD O
. . O

-DOCSTART- X X O

The DT O
plexiform NN O
neurofibroma NN O
and CC O
multiple JJ O
localized JJ O
neurofibromas NNS O
are VBP O
characteristic JJ O
of IN O
NF1 NNP B-NP
. . O

-DOCSTART- X X O

In IN O
general JJ O
lookback NN O
, , O
all DT O
patients NNS O
who WP O
received VBD O
blood NN O
before IN O
being VBG O
tested VBN O
for IN O
hepatitis NN O
C NNP O
are VBP O
advised VBN O
to TO O
undergo VB O
testing NN O
. . O

-DOCSTART- X X O

It PRP O
contained VBD O
seven CD O
extra JJ O
amino IN O
acids NNS O
of IN O
FVVLNL NNP O
Q NNP O
; : O
this DT O
short JJ O
stretch NN O
of IN O
extra JJ O
sequence NN O
was VBD O
found VBN O
between IN O
Gln( JJ O
421 CD O
) -RRB- O
and CC O
Phe( JJ O
422 CD O
) -RRB- O
within IN O
the DT O
SET NNP B-NP
( -LRB- O
Suvar3-9 NNP B-NP
, , O
Enhancer-of-zeste NNP B-NP
, , O
Trithorax NNP B-NP
) -RRB- O
interacting NN O
domain NN O
( -LRB- O
SID NNP O
) -RRB- O
of IN O
rMTM. VBG B-NP

-DOCSTART- X X O

MED1 NNP B-NP
has VBZ O
a DT O
weak JJ O
glycosylase NN B-NP
activity NN O
on IN O
the DT O
mutagenic JJ O
adduct NN O
3,N( IN O
4)-ethenocytosine CD O
, , O
a DT O
metabolite NN O
of IN O
vinyl NN O
chloride NN O
and CC O
ethyl NN O
carbamate NN O
. . O

-DOCSTART- X X O

Among IN O
the DT O
total JJ O
CDSs NNS O
, , O
8.8 CD O
% NN O
match NN O
sequences NNS O
of IN O
proteins NNS O
found VBN O
only RB O
in IN O
Bacillus NNP O
subtilis NNS O
and CC O
66.7 CD O
% NN O
are VBP O
widely RB O
conserved VBN O
in IN O
comparison NN O
with IN O
the DT O
proteins NNS O
of IN O
various JJ O
organisms NNS O
, , O
including VBG O
B.subtilis NNP O
. . O

-DOCSTART- X X O

Tobramycin-loaded JJ O
SLN NNP O
administered VBN O
i IN O
.v. NNP O
showed VBD O
a DT O
prolonged JJ O
circulation NN O
time NN O
compared VBN O
to TO O
the DT O
i NN O
.v. , O
administered VBN O
tobramycin DT O
solution NN O
. . O

-DOCSTART- X X O

Bacteriol NNP O
. . O

-DOCSTART- X X O

Terminal JJ B-NP
deoxynucleotidyl NN I-NP
transferase-mediated JJ I-NP
nick NN O
end NN O
labeling VBG O
assays DT O
revealed VBN O
that IN O
hormonal JJ O
activation NN O
of IN O
the DT O
PAX3 NNP B-NP
repressors NNS I-NP
induced VBD O
extensive JJ O
apoptosis NN O
that IN O
correlated JJ O
with IN O
down-regulation NN O
of IN O
BCL-X( JJ B-NP
L NNP I-NP
) -RRB- I-NP
expression NN O
. . O

-DOCSTART- X X O

VEGF NNP B-NP
promoter NN I-NP
activity NN O
in IN O
transient NN O
transfections NNS O
was VBD O
decreased VBN O
by IN O
either DT O
pharmacological JJ O
or CC O
genetic JJ O
inhibition NN O
of IN O
EGFR NNP B-NP
, , O
Ras NNP B-NP
, , O
or CC O
phosphatidylinositol NN B-NP
3'-kinase JJ I-NP
[PI( NN B-NP
3 CD I-NP
) -RRB- I-NP
kinase] NN I-NP
. . O

-DOCSTART- X X O

Epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
receptor NN I-NP
transcriptionally RB O
up-regulates . O
vascular JJ B-NP
endothelial JJ I-NP
growth NN I-NP
factor NN I-NP
expression NN O
in IN O
human JJ O
glioblastoma NN O
cells NNS O
via IN O
a DT O
pathway NN O
involving VBG O
phosphatidylinositol NN B-NP
3'-kinase JJ I-NP
and CC O
distinct JJ O
from IN O
that DT O
induced VBN O
by IN O
hypoxia NN O
. . O

-DOCSTART- X X O

Stress-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
1 CD I-NP
( -LRB- O
SAPK1 NN B-NP
) -RRB- O
, , O
also RB O
called VBD O
c-Jun JJ B-NP
N-terminal JJ I-NP
kinase NN I-NP
( -LRB- O
JNK) NNP B-NP
, , O
becomes VBZ O
activated VBN O
in IN O
vivo JJ O
in IN O
response NN O
to TO O
pro-inflammatory JJ O
cytokines NNS O
or CC O
cellular JJ O
stresses VBZ O
. . O

-DOCSTART- X X O

Combined VBN O
intravenous JJ O
and CC O
intra-arterial JJ O
recombinant JJ O
tissue NN B-NP
plasminogen NN I-NP
activator NN I-NP
in IN O
acute JJ O
ischemic JJ O
stroke NN O
. . O

-DOCSTART- X X O

To TO O
begin VB O
to TO O
understand VB O
this DT O
role NN O
, , O
we PRP O
overexpressed VBD O
ATF-2 NNP B-NP
in IN O
a DT O
human JJ O
cancer NN O
cell NN O
line NN O
. . O

-DOCSTART- X X O

Signal NNP O
transduction NN O
via IN O
modulation NN O
of IN O
phosphorylation NN O
after IN O
selective JJ O
inhibition NN O
of IN O
protein NN B-NP
phosphatase NN I-NP
( -LRB- I-NP
PP NNP I-NP
) -RRB- I-NP
1 CD I-NP
and/or CC O
PP2A NNP B-NP
appears VBZ O
to TO O
play VB O
a DT O
role NN O
in IN O
okadaic JJ O
acid NN O
( -LRB- O
OA)-mediated JJ O
effects NNS O
. . O

-DOCSTART- X X O

NF-kappaB NNP B-NP
is VBZ O
a DT O
redox-sensitive JJ O
transcription NN O
factor NN O
known VBN O
to TO O
be VB O
activated VBN O
by IN O
oxidative JJ O
stress NN O
as RB O
well RB O
as IN O
chemical NN O
and CC O
biological JJ O
reductants NNS O
. . O

-DOCSTART- X X O

What WP O
to TO O
look VB O
for IN O
during IN O
a DT O
compliance NN O
review NN O
: : O
10 CD O
common JJ O
mistakes NNS O
made VBN O
by IN O
SNFs NNP O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
EBCT NN O
technology NN O
allows VBZ O
minimally RB O
invasive JJ O
evaluation NN O
of IN O
intramyocardial JJ O
microcirculatory JJ O
function NN O
and CC O
permits VBZ O
assessment NN O
of IN O
microvascular JJ O
BV NN O
distribution NN O
in IN O
different JJ O
functional JJ O
components NNS O
. . O

-DOCSTART- X X O

SSF JJ O
experiments NNS O
were VBD O
carried VBN O
out RP O
in IN O
bench-scale JJ O
bioreactors NNS O
( -LRB- O
equipped VBN O
with IN O
CO2 NNP O
and CC O
volatile JJ O
organic JJ O
traps NNS O
) -RRB- O
containing VBG O
a DT O
mixture NN O
of IN O
lignocellulosic JJ O
materials NNS O
and CC O
a DT O
radiolabeled JJ O
pesticide NN O
. . O

-DOCSTART- X X O

Characterization NNP O
of IN O
a DT O
Xenopus NNP B-NP
laevis NN I-NP
CXC NNP I-NP
chemokine NN I-NP
receptor NN I-NP
4 CD I-NP
: : O
implications NNS O
for IN O
hematopoietic JJ O
cell NN O
development NN O
in IN O
the DT O
vertebrate JJ O
embryo NN O
. . O

-DOCSTART- X X O

Abbreviations NNS O
: : O
CAS NNP B-NP
, , O
CRK-associated JJ B-NP
substrate NN I-NP
; : O
CH NNP B-NP
, , O
calponin-homology NN B-NP
domain NN I-NP
; : O
CSK NNP B-NP
, , O
C-terminal JJ B-NP
SRC NNP I-NP
kinase NN I-NP
; : O
E6 NNP B-NP
, , O
Papillomavirus NNP B-NP
E6 NNP I-NP
protein NN I-NP
; : O
FAK NNP B-NP
, , O
focal JJ B-NP
adhesion NN I-NP
kinase NN I-NP
; : O
GIT NNP B-NP
, , O
GRK NNP B-NP
interacter NN I-NP
; : O
GPCR NNP B-NP
, , O
heterotrimeric-G-protein-coupled JJ B-NP
receptor NN I-NP
; : O
GRK NNP B-NP
, , O
G-protein-coupled-receptor NNP B-NP
kinase NN I-NP
; : O
MAPK NNP B-NP
, , O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
ERK NNP B-NP
, , O
p38 VBD B-NP
, , O
JNK) NNP B-NP
; : O
PAK NNP B-NP
, , O
p21-activated JJ B-NP
kinase NN I-NP
; : O
PBS NNP B-NP
, , O
paxillin-binding JJ B-NP
subdomain NN I-NP
; : O
PIX NNP B-NP
, , O
PAK-interacting JJ B-NP
exchange NN I-NP
factor NN I-NP
; : O
PKL NNP B-NP
, , O
paxillin VBG B-NP
kinase NN I-NP
linker NN I-NP
; : O
POR1 NNP B-NP
, , O
partner NN B-NP
of IN I-NP
Rac NNP I-NP
; : O
PS NNP O
, , O
phosphoserine NN O
; : O
PT NNP O
, , O
phosphothreonine NN O
; : O
PY NNP O
, , O
phosphotyrosine NN O
; : O
RTK NNP B-NP
, , O
growth NN B-NP
factor NN I-NP
receptor NN I-NP
tyrosine NN I-NP
kinase NN I-NP
; : O
SH NNP B-NP
, , O
SRC-homology NNP B-NP
domain NN I-NP
. . O

-DOCSTART- X X O

There EX O
were VBD O
122 CD O
cases NNS O
of IN O
tuberculosis NN O
over IN O
an DT O
average JJ O
10.3 CD O
yr NN O
of IN O
follow-up JJ O
( -LRB- O
crude JJ O
annual JJ O
incidence NN O
, , O
76.2/100,000 CD O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggested VBD O
that IN O
BACH1t NNP B-NP
recruits VBZ O
BACH1 NNP B-NP
to TO O
the DT O
nucleus NN O
through IN O
BTB NNP B-NP
domain-mediated JJ O
interaction NN O
. . O

-DOCSTART- X X O

The DT O
U17/U16 NNP B-NP
and CC O
the DT O
U16+ JJ B-NP
gene NN I-NP
products NNS I-NP
transactivated VBN O
the DT O
HIV NNP B-NP
LTR. NNP I-NP

-DOCSTART- X X O

Transcription NN O
of IN O
the DT O
six CD O
EBNA NNP B-NP
genes NNS I-NP
, , O
which WDT O
are VBP O
expressed VBN O
in IN O
EBV-immortalized JJ O
primary JJ O
B NNP O
cells NNS O
, , O
arises VBZ O
from IN O
one CD O
of IN O
two CD O
promoters NNS O
, , O
Cp NNP B-NP
and CC O
Wp NNP B-NP
, , O
located VBN O
near IN O
the DT O
left JJ O
end NN O
of IN O
the DT O
viral JJ O
genome NN O
. . O

-DOCSTART- X X O

The DT O
Cili-2 NN B-NP
sequences NNS I-NP
possess VBP O
similarity NN O
to TO O
the DT O
RNaseH NNP B-NP
domain NN I-NP
of IN O
Lian-Aa1 NNP B-NP
, , O
a DT O
mosquito NN B-NP
non-LTR JJ I-NP
retrotransposon NN I-NP
. . O

-DOCSTART- X X O

There EX O
was VBD O
a DT O
weak JJ O
significant JJ O
correlation NN O
between IN O
TGF NNP B-NP
beta NN I-NP
1 CD I-NP
levels NNS O
and CC O
normal JJ O
cell NN O
radiosensitivity NN O
( -LRB- O
lymphocyte JJ O
SF2 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Acute NNP O
feasibility NN O
and CC O
safety NN O
of IN O
a DT O
smoking NN O
reduction NN O
strategy NN O
for IN O
smokers NNS O
with IN O
schizophrenia NN O
. . O

-DOCSTART- X X O

Tightly RB O
ordered VBD O
proteasomal JJ O
degradation NN O
of IN O
proteins NNS O
critical JJ O
for IN O
cell NN O
cycle NN O
control NN O
implies VBZ O
a DT O
role NN O
of IN O
the DT O
proteasome JJ O
in IN O
maintaining VBG O
cell NN O
proliferation NN O
and CC O
cell NN O
survival NN O
. . O

-DOCSTART- X X O

The DT O
sixth JJ O
nucleotide NN O
was VBD O
bulged VBN O
out RP O
to TO O
allow VB O
stacking NN O
of IN O
this DT O
U.G NNP O
pair NN O
on IN O
the DT O
adjacent JJ O
helical JJ O
region NN O
. . O

-DOCSTART- X X O

Functional JJ O
analysis NN O
of IN O
the DT O
mutant JJ B-NP
desmin NN I-NP
in IN O
SW13 JJ O
(vim-) JJ O
cells NNS O
showed VBD O
aggregation IN O
of IN O
abnormal JJ O
coarse JJ O
clumps NNS O
of IN O
desmin NN B-NP
positive JJ O
material NN O
dispersed VBD O
throughout IN O
the DT O
cytoplasm NN O
. . O

-DOCSTART- X X O

Patients NNS O
with IN O
lesions NNS O
affecting VBG O
the DT O
PRC NNP O
but CC O
sparing VBG O
the DT O
PHC NNP O
, , O
and CC O
patients NNS O
with IN O
lesions NNS O
affecting VBG O
both DT O
PRC NNP O
and CC O
PHC NNP O
, , O
performed VBD O
an DT O
oculomotor NN O
delayed VBN O
response NN O
task NN O
with IN O
unpredictably JJ O
varied JJ O
memory NN O
delays NNS O
of IN O
up RB O
to TO O
30 CD O
s VBZ O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
26 CD O
amino IN O
acid NN O
residues NNS O
, , O
K69 NNP O
, , O
D88 CD O
, , O
E94 NNP O
, , O
D134 NNP O
, , O
R154 NNP O
, , O
K169 NNP O
, , O
H197 CD O
, , O
D233 CD O
, , O
G235 NNP O
, , O
G236 NNP O
, , O
G237 NNP O
, , O
F238 CD O
, , O
E274 NNP O
, , O
G276 NNP O
, , O
R277 CD O
, , O
Y278 CD O
, , O
K294 NNP O
, , O
Y323 NNP O
, , O
Y331 NNP O
, , O
D332 NNP O
, , O
C360 NNP O
, , O
D361 NNP O
, , O
D364 NNP O
, , O
G387 NNP O
, , O
Y389 CD O
, , O
and CC O
F397 CD O
( -LRB- O
mouse NN O
ODC JJ B-NP
numbering NN O
) -RRB- O
, , O
all DT O
of IN O
which WDT O
are VBP O
implicated VBN O
in IN O
the DT O
formation NN O
of IN O
the DT O
pyridoxal JJ O
phosphate-binding JJ O
domain NN O
and CC O
the DT O
substrate-binding JJ O
domain NN O
and CC O
in IN O
dimer NN O
stabilization NN O
with IN O
the DT O
eukaryotic JJ O
ODCs NNS B-NP
, , O
were VBD O
also RB O
conserved VBN O
in IN O
S. NNP O
ruminantium NNP O
LDC NNP B-NP
. . O

-DOCSTART- X X O

The DT O
Psc2 NNP B-NP
cDNA NN I-NP
contained VBD O
an DT O
open JJ O
reading NN O
frame NN O
homologous JJ O
to TO O
CP2 DT B-NP
family NN I-NP
proteins VBZ I-NP
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
Shh NNP B-NP
can MD O
drive VB O
continued VBN O
cycling NN O
in IN O
immature JJ O
, , O
proliferating VBG O
CGNPs NNS O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
npm3 NN B-NP
, , O
which WDT O
is VBZ O
usually RB O
coactivated VBN O
with IN O
fgf8 CD B-NP
by IN O
MMTV NNP O
insertion NN O
,was VBD O
not RB O
up-regulated JJ O
by IN O
androgens NNS O
in IN O
SC-3 JJ O
cells NNS O
. . O

-DOCSTART- X X O

Experiments NNS O
with IN O
epitope-tagged JJ O
proteins NNS O
show VBP O
that DT O
UEV1A NNP B-NP
is VBZ O
a DT O
nuclear JJ O
protein NN O
, , O
whereas IN O
both DT O
Kua NNP B-NP
and CC O
Kua-UEV NNP B-NP
localize VBP O
to TO O
cytoplasmic JJ O
structures NNS O
, , O
indicating VBG O
that IN O
the DT O
Kua NNP B-NP
domain NN I-NP
determines VBZ O
the DT O
cytoplasmic JJ O
localization NN O
of IN O
Kua-UEV. NNP B-NP

-DOCSTART- X X O

Stoichiometric NNP O
phosphorylation NN O
of IN O
human JJ B-NP
p53 NN I-NP
at IN O
Ser315 NNP O
stimulates NNS O
p53-dependent JJ B-NP
transcription NN O
. . O
p53 NN B-NP
protein NN I-NP
activity NN O
as IN O
a DT O
transcription NN O
factor NN O
can MD O
be VB O
activated VBN O
in IN O
vivo NN O
by IN O
antibodies NNS O
that WDT O
target VBP O
its PRP$ O
C-terminal JJ O
negative JJ O
regulatory JJ O
domain NN O
suggesting VBG O
that IN O
cellular JJ O
enzymes NNS O
that IN O
target NN O
this DT O
domain NN O
may MD O
play VB O
a DT O
role NN O
in IN O
stimulating VBG O
p53-dependent JJ B-NP
gene NN O
expression NN O
. . O

-DOCSTART- X X O

The DT O
Tax/IKKgamma NNP B-NP
interaction NN O
serves VBZ O
to TO O
recruit VB O
Tax NNP B-NP
to TO O
the DT O
IKK NNP B-NP
catalytic JJ I-NP
subunits NNS I-NP
, , O
IKKalpha NNP B-NP
and CC O
IKKbeta NNP B-NP
, , O
and CC O
this DT O
recruitment NN O
appears VBZ O
to TO O
be VB O
an DT O
essential JJ O
mechanism NN O
by IN O
which WDT O
Tax NNP B-NP
stimulates VBZ O
the DT O
activity NN O
of IN O
IKK. NNP B-NP

-DOCSTART- X X O

An DT O
anchored VBN O
AFLP- NNP O
and CC O
retrotransposon-based JJ O
map NN O
of IN O
diploid JJ O
Avena NNP O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
we PRP O
identified VBD O
a DT O
novel JJ O
type NN O
of IN O
inhibitory JJ O
domain NN O
in IN O
the DT O
N-terminal JJ O
60 CD O
amino IN O
acids NNS O
of IN O
IRF-1 NN B-NP
which WDT O
strongly RB O
inhibits VBZ O
its PRP$ O
transcriptional JJ O
activity NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
spatial JJ O
and CC O
temporal JJ O
smoothing NN O
on IN O
stimulated VBN O
brillouin IN O
scattering VBG O
in IN O
the DT O
independent-hot-spot NN O
model NN O
limit NN O
The DT O
influence NN O
of IN O
laser NN O
beam NN O
smoothing VBG O
on IN O
stimulated VBN O
Brillouin NNP O
backscattering NN O
( -LRB- O
SBBS NNP O
) -RRB- O
is VBZ O
studied VBN O
analytically RB O
in IN O
the DT O
limit NN O
of IN O
the DT O
independent JJ O
hot JJ O
spot NN O
model NN O
. . O

-DOCSTART- X X O

Simultaneous JJ O
determination NN O
of IN O
theophylline NN O
and CC O
its PRP$ O
metabolites NNS O
by IN O
HPLC NNP O
] SYM O
A DT O
high JJ O
performance NN O
liquid NN O
chromatography NN O
( -LRB- O
HPLC NNP O
) -RRB- O
method NN O
has VBZ O
been VBN O
developed VBN O
for IN O
the DT O
simultaneous JJ O
determination NN O
of IN O
theophylline NN O
and CC O
its PRP$ O
metabolites NNS O
, , O
with IN O
caffeine NN O
and CC O
its PRP$ O
metabolites NNS O
. . O

-DOCSTART- X X O

Ten CD O
males NNS O
performed VBN O
both DT O
test NN O
conditions NNS O
and CC O
oxygen NN O
uptake NN O
VO2 NN O
, , O
heart NN O
rate NN O
, , O
minute NN O
ventilation NN O
VE CD O
, , O
perceived VBN O
exertion NN O
and CC O
spinal JJ O
shrinkage NN O
were VBD O
recorded VBN O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
SPT NNP O
is VBZ O
more RBR O
useful JJ O
than IN O
WST NNP O
in IN O
differentiating VBG O
patients NNS O
predisposed VBD O
to TO O
aspiration NN O
. . O

-DOCSTART- X X O

Studied VBN O
groups NNS O
were VBD O
( -LRB- O
1 CD O
) -RRB- O
untreated JJ O
control NN O
, , O
n RB O
= SYM O
12 CD O
; : O
( -LRB- O
2 CD O
) -RRB- O
FK-1 NN O
, , O
n RB O
= SYM O
8 CD O
; : O
( -LRB- O
3 CD O
) -RRB- O
FK-3 NN O
, , O
n RB O
= SYM O
8. CD O

-DOCSTART- X X O

DNA NNP O
binding NN O
and CC O
glutathione NN B-NP
S-transferase NN I-NP
pull-down NN O
assays RB O
demonstrate VBP O
that IN O
binding NN O
requires VBZ O
Elk-1(1-212 NNP B-NP
) -RRB- I-NP
but CC O
not RB O
the DT O
C-terminal JJ O
transactivation NN O
domain NN O
. . O

-DOCSTART- X X O

Unexpectedly RB O
, , O
ALK7 IN B-NP
signaling VBG O
produced VBN O
a DT O
remarkable JJ O
change NN O
in IN O
cell NN O
morphology NN O
characterized VBN O
by IN O
cell NN O
flattening NN O
and CC O
elaboration NN O
of IN O
blunt JJ O
, , O
short JJ O
cell NN O
processes NNS O
. . O

-DOCSTART- X X O

The DT O
swa2-1 JJ B-NP
allele NN I-NP
recovered VBD O
from IN O
the DT O
original JJ O
screen NN O
carries VBZ O
a DT O
point NN O
mutation NN O
in IN O
its PRP$ O
tetratricopeptide NN O
repeat NN O
( -LRB- O
TPR NNP O
) -RRB- O
domain NN O
, , O
a DT O
motif NN O
not RB O
found VBN O
in IN O
auxilin NN B-NP
but CC O
known VBN O
in IN O
other JJ O
proteins NNS O
to TO O
mediate VB O
interaction NN O
with IN O
heat-shock JJ B-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

Transformation NN O
of IN O
the DT O
sconC3 NN B-NP
mutant NN I-NP
with IN O
sconB+ NN B-NP
restores VBZ O
the DT O
wild-type JJ O
phenotype NN O
. . O

-DOCSTART- X X O

The DT O
non-homologous JJ O
sequences NNS O
in IN O
the DT O
5' JJ O
untranslated JJ O
regions NNS O
might MD O
be VB O
acquired VBN O
at IN O
or CC O
after IN O
transcription NN O
during IN O
retrotransposition NN O
of IN O
the DT O
ATLN NNP O
elements NNS O
. . O

-DOCSTART- X X O

The DT O
time NN O
course NN O
of IN O
RNA1 NNP B-NP
replication NN O
and CC O
RNA3 JJ B-NP
synthesis NN O
in IN O
induced JJ O
yeast NN O
paralleled VBD O
that IN O
in IN O
yeast NN O
transfected VBN O
with IN O
natural JJ O
FHV NNP O
virion NN O
RNA NNP O
. . O

-DOCSTART- X X O

The DT O
transcription NN O
and CC O
alternative JJ O
splicing NN O
of IN O
human JJ B-NP
ORL1 NNP I-NP
and CC O
GAIP NNP B-NP
are VBP O
cell-type JJ O
specific JJ O
. . O

-DOCSTART- X X O

The DT O
extraction NN O
was VBD O
subsequently RB O
rated VBN O
as IN O
'easy JJ O
' '' O
or CC O
'difficult JJ O
'.Taking JJ O
Pell-Gregory JJ O
class NN O
C NNP O
as IN O
a DT O
predictor NN O
of IN O
a DT O
'difficult JJ O
' '' O
extraction NN O
, , O
specificity NN O
was VBD O
88 CD O
% NN O
but CC O
sensitivity NN O
was VBD O
low JJ O
at IN O
15 CD O
% NN O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
16S DT B-NP
rRNA NNP I-NP
gene NN I-NP
sequence NN I-NP
analysis NN O
, , O
the DT O
11 CD O
species NNS O
having VBG O
two CD O
tuf JJ B-NP
genes NNS I-NP
all DT O
have VBP O
a DT O
common JJ O
ancestor NN O
, , O
while IN O
the DT O
six CD O
species NNS O
having VBG O
only RB O
one CD O
copy NN O
diverged VBN O
from IN O
the DT O
enterococcal JJ O
lineage NN O
before IN O
that DT O
common JJ O
ancestor NN O
. . O

-DOCSTART- X X O

Nevertheless RB O
, , O
protein NN B-NP
kinase NN I-NP
A DT I-NP
stimulation NN O
induces VBZ O
CREMalpha NNP B-NP
to TO O
activate VB O
the DT O
complex JJ O
native JJ O
promoter NN O
in IN O
the DT O
phosphoenolpyruvate JJ B-NP
carboxykinase NN I-NP
( -LRB- O
PEPCK) NNP B-NP
gene NN O
. . O

-DOCSTART- X X O

Another DT O
putative JJ O
HNF3 JJ B-NP
site NN I-NP
in IN O
close JJ O
apposition NN O
to TO O
a DT O
NF1/CTF NNP B-NP
site NN O
was VBD O
localized VBN O
upstream RB O
of IN O
the DT O
silencer-like JJ O
element NN O
. . O

-DOCSTART- X X O

DNase NN B-NP
I PRP I-NP
genomic JJ O
footprinting NN O
revealed VBD O
that IN O
the DT O
c-Myb JJ B-NP
site NN I-NP
is VBZ O
occupied VBN O
in IN O
a DT O
tissue-specific JJ O
fashion NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
c-Myb NN B-NP
regulates VBZ O
the DT O
RAG-2 NN B-NP
promoter NN I-NP
in IN O
T NNP O
cells NNS O
by IN O
binding JJ O
to TO O
this DT O
consensus NN B-NP
c-Myb NN I-NP
binding JJ I-NP
site NN I-NP
. . O

-DOCSTART- X X O

A DT O
recently RB O
reported VBN O
new JJ O
member NN O
of IN O
the DT O
Vav NNP B-NP
family NN I-NP
proteins VBZ I-NP
, , O
Vav3 NNP B-NP
has VBZ O
been VBN O
identified VBN O
as IN O
a DT O
Ros NNP B-NP
receptor NN B-NP
protein NN I-NP
tyrosine NN I-NP
kinase NN I-NP
( -LRB- O
RPTK) NN B-NP
interacting JJ O
protein NN O
by IN O
yeast NN O
two-hybrid JJ O
screening NN O
. . O

-DOCSTART- X X O

Induced NNP O
expression NN O
of IN O
Rnd3 NNP B-NP
is VBZ O
associated VBN O
with IN O
transformation NN O
of IN O
polarized JJ O
epithelial NN O
cells NNS O
by IN O
the DT O
Raf-MEK-extracellular NNP B-NP
signal-regulated JJ O
kinase NN O
pathway NN O
. . O

-DOCSTART- X X O

The DT O
activity NN O
of IN O
the DT O
transcription NN B-NP
factor NN I-NP
CREB NNP I-NP
is VBZ O
regulated VBN O
by IN O
extracellular JJ O
stimuli NNS O
that WDT O
result VBP O
in IN O
its PRP$ O
phosphorylation NN O
at IN O
a DT O
critical JJ O
serine NN O
residue NN O
, , O
Ser133 NNP O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Average JJ O
age NN O
at IN O
symptom NN O
onset NN O
was VBD O
41.2 CD O
years NNS O
. . O

-DOCSTART- X X O

When WRB O
10 CD O
fields NNS O
were VBD O
analysed VBN O
, , O
a DT O
strong JJ O
relationship NN O
was VBD O
found VBN O
between IN O
the DT O
presence NN O
of IN O
bacteria NNS O
on IN O
Gram NNP O
staining NN O
and CC O
the DT O
final JJ O
diagnosis NN O
of IN O
VAP NNP O
( -LRB- O
for IN O
PSB NNP O
and CC O
PTC NNP O
respectively RB O
: : O
sensitivity NN O
74 CD O
and CC O
81 CD O
% NN O
, , O
specificity NN O
94 CD O
and CC O
100 CD O
% NN O
, , O
positive JJ O
predictive NN O
value NN O
91 CD O
and CC O
100 CD O
% NN O
, , O
negative JJ O
predictive JJ O
value NN O
82 CD O
and CC O
88 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
objectives NNS O
of IN O
the DT O
present JJ O
study NN O
were VBD O
to TO O
evaluate VB O
the DT O
effects NNS O
of IN O
adding VBG O
Equex NNP O
to TO O
a DT O
TRIS-extender NN O
, , O
diluting VBG O
the DT O
semen NNS O
in IN O
1 CD O
or CC O
2 CD O
steps NNS O
, , O
freezing VBG O
according VBG O
to TO O
2 CD O
methods NNS O
, , O
thawing NN O
at IN O
2 CD O
rates NNS O
, , O
and CC O
the DT O
interactions NNS O
between IN O
these DT O
treatments NNS O
, , O
on IN O
the DT O
post-thaw NN O
survival NN O
of IN O
dog NN O
spermatozoa NNS O
at IN O
38 CD O
degrees NNS O
C. NNP O

-DOCSTART- X X O

This DT O
study NN O
is VBZ O
a DT O
further JJ O
and CC O
more RBR O
extensive JJ O
validation NN O
of IN O
the DT O
clinician NN O
rated VBN O
NIMH-LCM-p. NNP O

-DOCSTART- X X O

The DT O
Aie1 NNP B-NP
locus NN I-NP
was VBD O
mapped VBN O
to TO O
mouse NN O
chromosome NN O
7A2-A3 . O
by IN O
fluorescent JJ O
in IN O
situ FW O
hybridization NN O
. . O

-DOCSTART- X X O

Psychiatric NNP O
disorders NNS O
in IN O
children NNS O
and CC O
adolescents NNS O
carry VBP O
considerable JJ O
morbidity NN O
, , O
impede NN O
development NN O
, , O
and CC O
carry VBP O
a DT O
significant JJ O
mortality NN O
by IN O
suicide NN O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
and CC O
expression NN O
of IN O
human JJ B-NP
UDP-d-Xylose JJ I-NP
:proteoglycan JJ I-NP
core NN I-NP
protein NN I-NP
beta-d-xylosyltransferase NN B-NP
and CC O
its PRP$ O
first JJ O
isoform NN B-NP
XT-II NNP I-NP
. . O

-DOCSTART- X X O

Thyrotoxicosis PRP$ O
due JJ O
to TO O
amiodarone DT O
is VBZ O
difficult JJ O
to TO O
treat VB O
and CC O
is VBZ O
further RB O
complicated VBN O
by IN O
the DT O
pro-arrhythmic JJ O
potential NN O
of IN O
thyrotoxicosis NN O
and CC O
the DT O
fading NN O
antiarrhythmic JJ O
effect NN O
after IN O
amiodarone JJ O
withdrawal NN O
. . O

-DOCSTART- X X O

We PRP O
describe VBP O
the DT O
identification NN O
and CC O
initial JJ O
characterization NN O
of IN O
neurobeachin NN B-NP
, , O
a DT O
neuron-specific JJ O
multidomain JJ O
protein NN O
of IN O
327 CD O
kDa NN O
with IN O
a DT O
high-affinity NN O
binding NN O
site NN O
( -LRB- O
K(d NNP O
) -RRB- O
, , O
10 CD O
nm NN O
) -RRB- O
for IN O
the DT O
type NN B-NP
II NNP I-NP
regulatory JJ I-NP
subunit NN I-NP
of IN I-NP
protein NN I-NP
kinase NN I-NP
A DT I-NP
( -LRB- O
PKA NN B-NP
RII NNP I-NP
) -RRB- O
. . O

-DOCSTART- X X O

Children NNS O
with IN O
ADD NNP O
showed VBD O
an DT O
attenuated VBN O
frontal JJ O
CNV-1 JJ O
amplitude NN O
and CC O
a DT O
trend NN O
towards IN O
increased VBN O
CNV-1 NN O
and CC O
CNV-2 JJ O
occipital NN O
amplitudes NNS O
. . O

-DOCSTART- X X O

Overexpression IN O
of IN O
c-Myc JJ B-NP
in IN O
serum-starved JJ O
human JJ O
or CC O
mouse NN O
embryonic JJ O
cells NNS O
leads VBZ O
to TO O
apoptosis VB O
which WDT O
is VBZ O
significantly RB O
reduced VBN O
in IN O
the DT O
presence NN O
of IN O
growth NN O
factor-containing NN O
serum NN O
. . O
c-Myc-induced '' B-NP
apoptosis NN O
appears VBZ O
to TO O
be VB O
deficient JJ O
in IN O
bax-null JJ B-NP
as IN O
compared VBN O
with IN O
bax-wild-type JJ B-NP
mouse NN O
embryonic NN O
fibroblasts NNS O
. . O

-DOCSTART- X X O

Antimicrobial JJ O
Susceptibility NN O
of IN O
Klebsiella NNP O
pneumoniae NNS O
Producing VBG O
Extended-Spectrum JJ B-NP
beta-lactamase NN I-NP
( -LRB- O
ESBL NNP B-NP
) -RRB- O
Isolated NNP O
in IN O
Hospitals NNS O
in IN O
Brazil NNP O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Our PRP$ O
results NNS O
suggest VBP O
that IN O
AIF NNP O
peak NN O
saturation NN O
leads VBZ O
to TO O
a DT O
significant JJ O
systematic JJ O
error NN O
in IN O
the DT O
determination NN O
of IN O
CBV NNP O
and CC O
CBF NNP O
values NNS O
and CC O
has VBZ O
necessarily RB O
to TO O
be VB O
taken VBN O
into IN O
account NN O
for IN O
dynamic JJ O
contrast-enhanced JJ O
MR NNP O
perfusion NN O
studies NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
transfection NN O
of IN O
cells NNS O
with IN O
the DT O
spacer-RING NN O
domain NN O
alone RB O
suppressed VBN O
the DT O
antiapoptotic JJ O
function NN O
of IN O
the DT O
N-terminal JJ O
BIR NNP B-NP
domain NN O
of IN O
c-IAP1 JJ B-NP
and CC O
induced JJ O
apoptosis NN O
. . O

-DOCSTART- X X O

The DT O
determination NN O
of IN O
the DT O
double JJ O
bounds NNS O
in IN O
blood NN O
serum NN O
lipids NNS O
by IN O
titration NN O
with IN O
ozone NN O
: : O
the DT O
pathophysiology NN O
and CC O
diagnostic JJ O
significance NN O
] IN O
In IN O
this DT O
article NN O
the DT O
method NN O
of IN O
definition NN O
of IN O
double JJ O
binders NNS O
in IN O
lipids NNS O
of IN O
blood NN O
serum NN O
in IN O
patients NNS O
with IN O
different JJ O
diseases NNS O
basically RB O
atherosclerosis . O
and CC O
ischemic JJ O
heart NN O
disease NN O
, , O
with IN O
use NN O
titration NN O
by IN O
ozone NN O
is VBZ O
given VBN O
. . O

-DOCSTART- X X O

Acoust NNP O
. . O

-DOCSTART- X X O

MS NNP O
characteristics NNS O
of IN O
coumarins NNS O
, , O
psoralens NNS O
and CC O
polymethoxylated VBN O
flavones NNS O
with IN O
different JJ O
substitution NN O
patterns NNS O
were VBD O
determined VBN O
on IN O
the DT O
basis NN O
of IN O
the DT O
response NN O
obtained VBN O
with IN O
the DT O
APcI NNP O
interface NN O
. . O

-DOCSTART- X X O

T NNP O
cells NNS O
express VBP O
two CD O
isoforms NNS O
of IN O
S6k1 NNP B-NP
: : O
a DT O
70 CD O
kDa NN O
cytoplasmic JJ O
kinase NN O
and CC O
an DT O
85 CD O
kDa NN O
isoform NN O
that WDT O
has VBZ O
a DT O
classic JJ O
nuclear JJ O
localisation NN O
. . O

-DOCSTART- X X O

A DT O
prospectively NN O
gated VBD O
2D DT O
axial JJ O
sequence NN O
with IN O
velocity NN O
encoding NN O
in IN O
the DT O
craniocaudal JJ O
direction NN O
in IN O
the DT O
cervical JJ O
region NN O
was VBD O
set VBN O
at IN O
a DT O
velocity NN O
of IN O
+/ CD O
- : O
10 CD O
cm/s NN O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
subsequently RB O
shown VBN O
that IN O
Tip60 NNP B-NP
had VBD O
histone NN B-NP
acetyltransferase NN I-NP
( -LRB- O
HAT NN B-NP
) -RRB- O
activity NN O
. . O

-DOCSTART- X X O

Our PRP$ O
data NNS O
show VBP O
that IN O
multiple JJ O
MLSN1 NNP B-NP
transcripts NNS I-NP
, , O
both DT O
constitutively RB O
expressed VBN O
and CC O
inducible JJ O
, , O
are VBP O
present JJ O
in IN O
cultured JJ O
pigmented JJ O
melanoma NN O
cells NNS O
, , O
and CC O
suggest VBP O
that IN O
MLSN1 JJ B-NP
expression NN O
can MD O
be VB O
regulated VBN O
at IN O
the DT O
level NN O
of IN O
both DT O
transcription NN O
and CC O
mRNA NN O
processing NN O
. . O

-DOCSTART- X X O

Copyright NNP O
2000 CD O
Academic NNP O
Press NNP O
. . O

-DOCSTART- X X O

Plectin NNP B-NP
and CC O
desmoplakin FW B-NP
have VBP O
GSR-containing JJ O
domains NNS O
at IN O
their PRP$ O
C-termini NN O
and CC O
we PRP O
further RB O
demonstrate VBP O
that IN O
the DT O
GSR-containing JJ O
domain NN O
of IN O
plectin NN B-NP
, , O
but CC O
not RB O
desmoplakin JJ B-NP
, , O
can MD O
bind NN O
to TO O
MTs NNP O
in IN O
vivo RB O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
in IN O
contrast NN O
to TO O
SRC1 NNP B-NP
, , O
direct JJ O
binding NN O
of IN O
CBP NNP B-NP
to TO O
the DT O
estrogen NN B-NP
receptor NN I-NP
is VBZ O
weak JJ O
, , O
suggesting VBG O
that IN O
SRC1 JJ B-NP
functions NNS O
primarily RB O
as IN O
an DT O
adaptor NN O
to TO O
recruit VB O
CBP NNP B-NP
and CC O
p300 VBD B-NP
. . O

-DOCSTART- X X O

Since IN O
MEK NNP B-NP
acts VBZ O
as IN O
a DT O
cytoplasmic JJ O
anchor NN O
for IN O
the DT O
ERKs NNP B-NP
, , O
the DT O
lack NN O
of IN O
a DT O
MEK NNP B-NP
interaction NN O
resulted VBD O
in IN O
the DT O
aberrant JJ O
nuclear JJ O
localization NN O
of IN O
ERK2-Delta19-25 DT B-NP
mutants NNS O
in IN O
serum-starved JJ O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
the DT O
risk NN O
factors NNS O
for IN O
background NN O
diabetic NN O
retinopathy NN O
( -LRB- O
BDR) NNP O
and CC O
PDR NNP O
by IN O
following VBG O
394 CD O
Japanese JJ O
patients NNS O
with IN O
early-onset JJ O
type NN O
2 CD O
diabetes NN O
diagnosed VBD O
before IN O
30 CD O
years NNS O
of IN O
age NN O
( -LRB- O
mean VBP O
age NN O
27 CD O
, , O
mean JJ O
blood NN O
pressure NN O
at IN O
entry NN O
116/73 CD O
mm CD O
Hg NN O
) -RRB- O
. . O

-DOCSTART- X X O

Of IN O
the DT O
21 CD O
quadrants NNS O
positive JJ O
in IN O
the DT O
controls NNS O
, , O
17 CD O
were VBD O
correlated VBN O
with IN O
previously RB O
detected VBN O
jaw NN O
pathoses NNS O
. . O

-DOCSTART- X X O

Previous JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
the DT O
pro-inflammatory JJ O
cytokines NNS O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
and CC O
interferon NN B-NP
gamma NN I-NP
reduce VB O
the DT O
expression NN O
of IN O
the DT O
cystic JJ B-NP
fibrosis NN I-NP
transmembrane NN I-NP
conductance NN I-NP
regulator NN I-NP
( -LRB- O
CFTR NNP B-NP
) -RRB- O
gene NN O
( -LRB- O
CFTR NNP B-NP
) -RRB- O
in IN O
HT-29 NNP O
and CC O
T84 NNP O
cells NNS O
by IN O
acting VBG O
post-transcriptionally RB O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
RhoA NNP B-NP
is VBZ O
required VBN O
to TO O
maintain VB O
adhesion NN O
in IN O
stationary JJ O
cells NNS O
, , O
but CC O
is VBZ O
also RB O
critical JJ O
for IN O
cell NN O
spreading VBG O
and CC O
migration NN O
[3] NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
show VBP O
in IN O
mouse NN O
fibroblasts NNS O
stably RB O
transformed VBN O
by IN O
v-Src NN B-NP
that IN O
mRNA NN O
and CC O
protein NN O
levels NNS O
of IN O
p21 NN B-NP
( -LRB- O
WAF1/CIP1 NNP B-NP
) -RRB- O
, , O
cyclin NN B-NP
D1 NNP I-NP
, , O
and CC O
cyclin NN B-NP
E NNP I-NP
are VBP O
elevated VBN O
. . O

-DOCSTART- X X O

ORFA NNS O
and CC O
ccdA NNS B-NP
were VBD O
constitutively RB O
cotranscribed VBN O
as IN O
determined VBN O
by IN O
primer JJ O
extension NN O
analysis NN O
. . O

-DOCSTART- X X O

Mouse NN B-NP
Impact NN I-NP
is VBZ O
a DT O
paternally RB O
expressed VBN O
gene NN O
encoding VBG O
an DT O
evolutionarily RB O
conserved JJ O
protein NN O
of IN O
unknown JJ O
function NN O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
high JJ O
COUP-TFI JJ B-NP
expression NN O
impeded VBD O
the DT O
neuronal JJ O
differentiation NN O
of IN O
P19 CD O
cells NNS O
induced VBN O
with IN O
RA NNP O
, , O
resulting VBG O
in IN O
cell NN O
cultures NNS O
lacking VBG O
neurons NNS O
. . O

-DOCSTART- X X O

Because IN O
PET NNP O
is VBZ O
also RB O
useful JJ O
for IN O
the DT O
pretreatment NN O
and CC O
follow-up JJ O
evaluation NN O
, , O
the DT O
use NN O
of IN O
stereotactic JJ O
PET NN O
in IN O
these DT O
patients NNS O
can MD O
enable VB O
an DT O
accurate JJ O
comparison NN O
of IN O
PET-based JJ O
metabolic JJ O
data NNS O
with IN O
MR-based JJ O
anatomical JJ O
data NNS O
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
describe VBP O
the DT O
isolation NN O
of IN O
MdPin1 NNP B-NP
, , O
a DT O
Pin1 NNP B-NP
homologue NN O
from IN O
the DT O
plant NN O
species NN O
apple NN O
( -LRB- O
Malus JJ O
domestica NN O
) -RRB- O
and CC O
show VB O
that IN O
it PRP O
has VBZ O
the DT O
same JJ O
phosphorylation-specific JJ O
substrate NN O
specificity NN O
and CC O
can MD O
be VB O
inhibited VBN O
by IN O
juglone NN O
in IN O
vitro NN O
, , O
as RB O
is VBZ O
the DT O
case NN O
for IN O
Pin1 NNP B-NP
. . O

-DOCSTART- X X O

Differential JJ O
association NN O
of IN O
products NNS O
of IN O
alternative JJ O
transcripts NNS O
of IN O
the DT O
candidate NN O
tumor NN B-NP
suppressor NN I-NP
ING1 NNS I-NP
with IN O
the DT O
mSin3/HDAC1 JJ B-NP
transcriptional JJ O
corepressor NN O
complex NN O
. . O

-DOCSTART- X X O

These DT O
and CC O
other JJ O
data NNS O
presented VBN O
suggest VBP O
that IN O
TAg JJ B-NP
're-models NNS O
' POS O
host NN O
cell NN O
transcription NN O
factors NNS O
that WDT O
are VBP O
used VBN O
early RB O
in IN O
viral JJ O
infection NN O
, , O
and CC O
thereby RB O
mimics VB O
an DT O
event NN O
that WDT O
naturally RB O
occurs VBZ O
during IN O
transformation NN O
. . O

-DOCSTART- X X O

ORFK10.5 CD B-NP
encodes VBZ O
a DT O
protein NN O
, , O
latency-associated JJ B-NP
nuclear JJ I-NP
antigen NN I-NP
2 CD I-NP
( -LRB- O
LANA2 NN B-NP
) -RRB- O
, , O
which WDT O
is VBZ O
expressed VBN O
in IN O
KSHV-infected DT O
hematopoietic JJ O
tissues NNS O
, , O
including VBG O
PEL NNP O
and CC O
CD NNP O
but CC O
not RB O
KS NNP O
lesions NNS O
. . O

-DOCSTART- X X O

As IN O
hypothesized VBN O
, , O
believers NNS O
showed VBD O
relatively RB O
higher JJR O
right JJ O
hemispheric NN O
activation NN O
and CC O
reduced VBD O
hemispheric JJ O
asymmetry NN O
of IN O
functional JJ O
complexity NN O
. . O

-DOCSTART- X X O

Presently RB O
four CD O
unique JJ O
variants NNS O
carrying VBG O
distinct JJ O
GAF NNP B-NP
sequences NNS I-NP
in IN O
the DT O
N-terminal JJ O
region NN O
have VBP O
been VBN O
identified VBN O
. . O

-DOCSTART- X X O

The DT O
present JJ O
findings NNS O
revealed VBD O
that IN O
the DT O
rib-2 JJ B-NP
protein NN I-NP
was VBD O
a DT O
unique JJ O
alpha1,4-N-acetylglucosaminyltransferase NN B-NP
involved VBN O
in IN O
the DT O
biosynthetic JJ O
initiation NN O
and CC O
elongation NN O
of IN O
heparan NN O
sulfate NN O
. . O

-DOCSTART- X X O

Inhibition NN O
of IN O
the DT O
Mek/Erk NNP B-NP
pathway NN O
in IN O
Rat1/ras NNP O
cells NNS O
, , O
using VBG O
the DT O
Mek NNP B-NP
inhibitor NN O
, , O
PD98059 NNP O
, , O
resulted VBD O
in IN O
complete JJ O
cytoskeletal NN O
recovery NN O
, , O
indistinguishable JJ O
from IN O
that DT O
induced VBN O
by IN O
HR12 NNP O
. . O

-DOCSTART- X X O

Addition NN O
of IN O
synthetic JJ O
tyrosine-phosphorylated JJ O
peptides NNS O
derived VBN O
from IN O
betac JJ O
cytoplasmic JJ O
tyrosines NNS O
prior RB O
to TO O
GM-CSF NNP B-NP
stimulation NN O
inhibited VBD O
the DT O
in IN O
vitro NN O
activation NN O
of IN O
STAT5 NNP B-NP
. . O

-DOCSTART- X X O

MAIN NNP O
OUTCOME NNP O
MEASURES NNP O
: : O
Percentage NN O
change NN O
in IN O
the DT O
apnea-hypopnea NN O
index NN O
( -LRB- O
AHI NNP O
; : O
apnea DT O
events NNS O
+ VBP O
hypopnea NNS O
events NNS O
per IN O
hour NN O
of IN O
sleep) NN O
and CC O
odds NNS O
of IN O
developing VBG O
moderate-to-severe JJ O
SDB NNP O
( -LRB- O
defined VBN O
by IN O
an DT O
AHI JJ O
> NN O
or CC O
=15 CD O
events NNS O
per IN O
hour NN O
of IN O
sleep) NN O
, , O
with IN O
respect NN O
to TO O
change VB O
in IN O
weight NN O
. . O

-DOCSTART- X X O

This DT O
article NN O
reviews VBZ O
recent JJ O
information NN O
on IN O
the DT O
frequency NN O
, , O
characteristics NNS O
, , O
and CC O
possible JJ O
pathogenic JJ O
mechanisms NNS O
of IN O
the DT O
vasculitides NNS O
occurring VBG O
in IN O
patients NNS O
with IN O
the DT O
main JJ O
connective JJ O
tissue NN O
diseases NNS O
. . O

-DOCSTART- X X O

Tec NNP B-NP
kinase NN I-NP
signaling VBG O
in IN O
T NNP O
cells NNS O
is VBZ O
regulated VBN O
by IN O
phosphatidylinositol NN B-NP
3-kinase JJ I-NP
and CC O
the DT O
Tec NNP B-NP
pleckstrin NN B-NP
homology NN I-NP
domain NN I-NP
. . O

-DOCSTART- X X O

The DT O
structure NN O
of IN O
the DT O
free JJ O
SH2 NNP B-NP
domain NN I-NP
has VBZ O
been VBN O
compared VBN O
to TO O
that DT O
of IN O
the DT O
SH2 NNP B-NP
complexed VBN O
with IN O
a DT O
doubly RB O
phosphorylated VBN O
peptide NN O
derived VBN O
from IN O
polyomavirus NN B-NP
middle NN I-NP
T NNP I-NP
antigen NN I-NP
( -LRB- O
MT NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
identified VBN O
three CD O
binding JJ O
sites NNS O
for IN O
protein NN O
complexes NNS O
: : O
a DT O
palindrome NN O
, , O
a DT O
direct JJ O
repeat NN O
, , O
and CC O
a DT O
C+T NNP O
sequence NN O
that IN O
corresponds NNS O
to TO O
seven CD O
GAGA NNP O
motifs NNS O
on IN O
the DT O
transcribed JJ O
strand NN O
. . O

-DOCSTART- X X O

Nucleotide NNP O
sequence NN O
, , O
genome JJ O
organization NN O
and CC O
phylogenetic JJ O
analysis NN O
of IN O
pineapple NN O
mealybug NN O
wilt-associated JJ O
virus-2 NN O
. . O

-DOCSTART- X X O

Increased VBN O
levels NNS O
of IN O
anticardiolipin DT B-NP
immunoglobulin NN I-NP
G NNP I-NP
may MD O
also RB O
cause VB O
bleeding VBG O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Prevalence NNP O
of IN O
obesity NN O
( -LRB- O
BM NNP O
I PRP O
SDS>2.0) NNP O
was VBD O
<2 CD O
% NN O
at IN O
diagnosis NN O
, , O
but CC O
increased VBD O
to TO O
16 CD O
% NN O
at IN O
3y NN O
. . O

-DOCSTART- X X O

Bupropion NNP O
to TO O
aid VB O
smoking NN O
cessation NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
determine VB O
and CC O
compare VB O
interleukin-6 NN B-NP
( -LRB- O
IL-6 NN B-NP
) -RRB- O
levels NNS O
in IN O
gingival NN O
crevicular JJ O
fluid NN O
( -LRB- O
GCF NN O
) -RRB- O
and CC O
clinical JJ O
periodontal JJ O
findings NNS O
in IN O
patients NNS O
with IN O
rheumatoid NNP O
arthritis NN O
(RA NN O
) -RRB- O
and CC O
adult NN O
periodontitis NN O
( -LRB- O
AP NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Studies NNS O
are VBP O
necessary JJ O
to TO O
assess VB O
the DT O
source NN O
of IN O
contamination NN O
and CC O
potential JJ O
role NN O
of IN O
MRSA-contaminated JJ O
milk NN O
in IN O
the DT O
transmission NN O
of IN O
MRSA NNP O
to TO O
neonates NNS O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
Trypanosoma NNP O
vivax NN O
on IN O
pregnancy NN O
of IN O
Yankasa NNP O
sheep NN O
and CC O
the DT O
results NNS O
of IN O
homidum NN O
chloride NN O
chemotherapy NN O
. . O

-DOCSTART- X X O

Depending VBG O
on IN O
treatment NN O
exposures NNS O
, , O
this DT O
at-risk JJ O
population NN O
may MD O
experience VB O
life-threatening JJ O
late JJ O
effects NNS O
, , O
such JJ O
as IN O
cirrhosis NN O
secondary JJ O
to TO O
hepatitis NNP O
C NNP O
or CC O
late-onset JJ O
anthracycline-induced JJ O
cardiomyopathy NN O
, , O
or CC O
life-changing NN O
late JJ O
effects NNS O
, , O
such JJ O
as IN O
cognitive JJ O
dysfunction NN O
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
locus-specific JJ O
residues NNS O
throughout IN O
the DT O
entire JJ O
promoter NN O
region NN O
strongly RB O
suggests VBZ O
that IN O
the DT O
various JJ O
HLA NNP B-NP
class NN I-NP
I PRP I-NP
loci VBP I-NP
are VBP O
differentially RB O
regulated VBN O
. . O

-DOCSTART- X X O

Because IN O
the DT O
number NN O
of IN O
parameters NNS O
required VBN O
by IN O
a DT O
Volterra NNP O
series NN O
grows VBZ O
rapidly RB O
with IN O
both DT O
the DT O
length NN O
of IN O
its PRP$ O
memory NN O
and CC O
the DT O
order NN O
of IN O
its PRP$ O
nonlinearity NN O
, , O
methods NNS O
for IN O
identifying VBG O
these DT O
models NNS O
from IN O
measurements NNS O
of IN O
input/output NN O
data NNS O
are VBP O
limited VBN O
to TO O
low-order JJ O
systems NNS O
with IN O
relatively RB O
short JJ O
memories NNS O
. . O

-DOCSTART- X X O

The DT O
standard JJ O
method NN O
for IN O
calculating VBG O
the DT O
composite JJ O
score NN O
on IN O
the DT O
S-B NNP O
IV NNP O
excludes VBZ O
subtests NNS O
with IN O
a DT O
raw JJ O
score NN O
of IN O
0, NN O
which WDT O
overestimates VBZ O
cognitive JJ O
functioning NN O
in IN O
young JJ O
biologically RB O
high JJ O
risk NN O
children NNS O
. . O

-DOCSTART- X X O

Validity NNP O
of IN O
NIR NNP O
spectroscopy NN O
for IN O
quantitatively RB O
measuring VBG O
muscle NN O
oxidative JJ O
metabolic JJ O
rate NN O
in IN O
exercise NN O
. . O

-DOCSTART- X X O

Previous JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
tissue-restricted JJ O
transcription NN O
factors NNS O
including VBG O
PU.1 NNP B-NP
and CC O
PU.1 NNP B-NP
interaction NN I-NP
partner NN I-NP
( -LRB- O
PIP NN B-NP
) -RRB- O
function NN O
synergistically RB O
with IN O
c-Fos JJ B-NP
plus CC O
c-Jun JJ B-NP
to TO O
stimulate VB O
the DT O
kappaE3'-enhancer NN B-NP
in IN O
3T3 CD O
cells NNS O
. . O

-DOCSTART- X X O

An DT O
int6 NN B-NP
deletion NN I-NP
( -LRB- O
int6Delta NN B-NP
) -RRB- O
mutant NN O
was VBD O
viable JJ O
but CC O
grew VBD O
slowly RB O
in IN O
minimal JJ O
medium NN O
. . O

-DOCSTART- X X O

We PRP O
produced VBD O
transgenic JJ O
plants NNS O
expressing VBG O
the DT O
antisense JJ B-NP
Arabidopsis NNP I-NP
HD NNP I-NP
( -LRB- O
AtHD1 NNP B-NP
) -RRB- O
gene NN O
. . O

-DOCSTART- X X O

We PRP O
used VBD O
the DT O
Toshiba NNP O
IIDR NNP O
system NN O
, , O
which WDT O
is VBZ O
composed VBN O
of IN O
an DT O
X-ray NN O
TV NN O
system NN O
and CC O
a DT O
digital JJ O
image NN O
managing VBG O
circuit NN O
. . O

-DOCSTART- X X O

[18F]( JJ O
+)-4-fluorobenzyltrozamicol NN O
( -LRB- O
FBT) NNP O
, , O
which WDT O
selectively RB O
binds VBZ O
to TO O
the DT O
vesicular JJ O
acetylcholine NN B-NP
transporter NN I-NP
in IN O
the DT O
presynaptic JJ O
cholinergic JJ O
neuron NN O
, , O
has VBZ O
previously RB O
been VBN O
shown VBN O
to TO O
be VB O
a DT O
useful JJ O
ligand NN O
for IN O
the DT O
study NN O
of IN O
cholinergic JJ O
terminal NN O
density NN O
in IN O
the DT O
basal NN O
ganglia NN O
with IN O
PET. NN O

-DOCSTART- X X O

LH/CG NN B-NP
receptor NN I-NP
activation NN O
of IN O
ARNO NN B-NP
is VBZ O
not RB O
mediated VBN O
by IN O
activation NN O
of IN O
phosphatidylinositol NN B-NP
3-kinase JJ I-NP
( -LRB- O
PI JJ B-NP
3-kinase NN I-NP
) -RRB- O
or CC O
by IN O
G NNP B-NP
protein NN I-NP
beta NN I-NP
gamma NN I-NP
subunits NNS I-NP
. . O

-DOCSTART- X X O

Changes NNS O
in IN O
stimulation NN O
levels NNS O
over IN O
time NN O
in IN O
nucleus JJ O
22 CD O
cochlear NN O
implant NN O
users NNS O
. . O

-DOCSTART- X X O

A DT O
marked JJ O
decrease NN O
in IN O
the DT O
type NN B-NP
1 CD I-NP
insulin-like JJ I-NP
growth NN I-NP
factor NN I-NP
( -LRB- I-NP
IGF NN I-NP
) -RRB- I-NP
receptor NN I-NP
( -LRB- O
IGF-IR NN B-NP
) -RRB- O
occurs VBZ O
in IN O
prostate NN O
epithelial NN O
cells NNS O
during IN O
transformation NN O
from IN O
the DT O
benign JJ O
to TO O
the DT O
metastatic JJ O
state NN O
. . O

-DOCSTART- X X O

The DT O
P69 NNP O
cell NN O
line NN O
was VBD O
derived VBN O
by IN O
immortalization NN O
of IN O
human JJ O
primary JJ O
prostate NN O
epithelial NN O
cells NNS O
with IN O
simian JJ B-NP
virus-40 NN I-NP
T NNP I-NP
antigen NN I-NP
and CC O
is VBZ O
rarely RB O
tumorigenic JJ O
. . O

-DOCSTART- X X O

Because IN O
the DT O
high-density NN B-NP
lipoprotein NN I-NP
receptor NN I-NP
( -LRB- O
HDL-R NN B-NP
) -RRB- O
is VBZ O
a DT O
key JJ O
element NN O
in IN O
cholesterol NN O
homeostasis NN O
and CC O
a DT O
potential JJ O
therapeutic JJ O
target NN O
for IN O
hypercholesterolemic JJ O
drugs NNS O
, , O
an DT O
understanding NN O
of IN O
HDL-R NNP B-NP
regulation NN O
is VBZ O
essential JJ O
. . O

-DOCSTART- X X O

To TO O
understand VB O
the DT O
molecular JJ O
regulation NN O
of IN O
these DT O
genes NNS O
in IN O
thyroid JJ O
cells NNS O
, , O
the DT O
effect NN O
of IN O
thyroid DT B-NP
transcription NN I-NP
factor NN I-NP
1 CD I-NP
( -LRB- O
TTF-1 NN B-NP
) -RRB- O
and CC O
the DT O
paired VBN B-NP
domain-containing JJ I-NP
protein NN I-NP
8 CD I-NP
( -LRB- O
Pax-8 CD B-NP
) -RRB- O
on IN O
the DT O
transcriptional JJ O
activity NN O
of IN O
the DT O
deiodinase JJ B-NP
promoters NNS I-NP
were VBD O
studied VBN O
. . O

-DOCSTART- X X O

Regional NNP O
blood NN O
blow NN O
was VBD O
measured VBN O
by IN O
means NNS O
of IN O
microspheres NNS O
in IN O
predefined JJ O
regions NNS O
of IN O
the DT O
C6 NNP O
, , O
T11 NNP O
, , O
and CC O
L6 NNP O
vertebrae NNS O
. . O

-DOCSTART- X X O

The DT O
mechanism NN O
of IN O
ligand-activated JJ O
estrogen NN B-NP
receptor NN I-NP
alpha NN I-NP
( -LRB- O
ERalpha)-dependent JJ B-NP
activation NN O
of IN O
gene NN O
expression NN O
through IN O
the DT O
SRE NNP O
was VBD O
determined VBN O
by IN O
mutational JJ O
analysis NN O
of IN O
the DT O
promoter NN O
, , O
analysis NN O
of IN O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
( -LRB- O
MAPK) NNP B-NP
pathway NN O
activation NN O
by IN O
E2 NNP O
, , O
and CC O
transforming VBG B-NP
growth NN I-NP
factor NN I-NP
alpha NN I-NP
( -LRB- O
TGF-alpha NN B-NP
) -RRB- O
as IN O
a DT O
positive JJ O
control NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Under IN O
current JJ O
immunization NN O
practices NNS O
, , O
the DT O
authors NNS O
estimate VBP O
that IN O
nearly RB O
13,000 CD O
Asian JJ O
and CC O
Pacific JJ O
Islander NNP O
children NNS O
living VBG O
in IN O
the DT O
United NNP O
States NNPS O
today NN O
will MD O
become VB O
infected VBN O
with IN O
HBV NNP O
in IN O
the DT O
future NN O
, , O
resulting VBG O
in IN O
more JJR O
than IN O
600 CD O
liver NN O
carcinoma NN O
deaths NNS O
. . O

-DOCSTART- X X O

A DT O
novel JJ O
approach NN O
was VBD O
developed VBN O
for IN O
identifying VBG O
transcription NN O
factor NN O
activities NNS O
associated VBN O
with IN O
NGF-activated JJ B-NP
, , O
but CC O
not RB O
EGF-activated JJ B-NP
, , O
signaling VBG O
, , O
using VBG O
random JJ O
oligonucleotide JJ O
clones NNS O
from IN O
a DT O
DNA NNP O
recognition NN O
library NN O
to TO O
isolate VB O
specific JJ O
DNA NN O
binding JJ O
proteins NNS O
from IN O
PC12 DT O
nuclear JJ O
extracts NNS O
. . O

-DOCSTART- X X O

NGF NN B-NP
elicits NNS O
a DT O
more RBR O
delayed JJ O
and CC O
sustained JJ O
ERK NN B-NP
phosphorylation NN O
than IN O
EGF NNP B-NP
, , O
consistent JJ O
with IN O
previous JJ O
reports NNS O
. . O

-DOCSTART- X X O

NGF NN B-NP
, , O
but CC O
not RB O
EGF NNP B-NP
, , O
enhances VBZ O
the DT O
upper JJ O
bands NNS O
, , O
corresponding JJ O
to TO O
phosphorylated JJ B-NP
Fra-2 NNP I-NP
. . O

-DOCSTART- X X O

Workload NNP O
, , O
UAPs NNP O
, , O
and CC O
you PRP O
. . O

-DOCSTART- X X O

Adding VBG O
10 CD O
mmol JJ O
SDS/l NNP O
led VBD O
to TO O
transient JJ O
inhibition NN O
of IN O
acidification NN O
, , O
metal NN O
solubilization NN O
and CC O
sulfur NN O
oxidation NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
investigated VBN O
the DT O
role NN O
of IN O
NGF NNP B-NP
in IN O
regulating VBG O
gene NN O
transcription NN O
in IN O
PC12 NN O
and CC O
INS-1 JJ O
cells NNS O
, , O
in IN O
order NN O
to TO O
define VB O
if IN O
there EX O
are VBP O
NGF-regulated JJ B-NP
genes NNS O
per IN O
se NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
indicate VBP O
that IN O
the DT O
SmSmad2 NNP B-NP
responds NNS O
to TO O
the DT O
TGF-beta JJ B-NP
signals NNS O
by IN O
interaction NN O
with IN O
receptor NN B-NP
I PRP I-NP
, , O
which WDT O
phosphorylates VBZ O
it PRP O
, , O
whereupon IN O
it PRP O
translocates VBZ O
into IN O
the DT O
nucleus NN O
presumably RB O
to TO O
regulate VB O
target NN O
gene NN O
transcription NN O
and CC O
consequently RB O
elicit VB O
a DT O
specific JJ O
TGF-beta JJ B-NP
effect NN O
. . O

-DOCSTART- X X O

Naltrexone NNP O
hydrochloride NN O
is VBZ O
a DT O
synthetic JJ O
opioid NN B-NP
receptor NN I-NP
antagonist NN O
recently RB O
used VBN O
in IN O
efforts NNS O
to TO O
provide VB O
rapid JJ O
opioid NN O
detoxification NN O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
Thyroid DT O
status NN O
was VBD O
measured VBN O
at IN O
baseline NN O
( -LRB- O
1990-93 CD O
) -RRB- O
, , O
through IN O
assessment NN O
of IN O
serum NN O
antibodies NNS O
to TO O
thyroid VB B-NP
peroxidase NN I-NP
( -LRB- O
TPO-Abs NNP B-NP
, , O
positive JJ O
: : O
>10 JJ O
IU/ml NN O
) -RRB- O
, , O
serum NN B-NP
TSH NNS I-NP
levels NNS O
, , O
and CC O
when WRB O
TSH NNP B-NP
was VBD O
abnormal JJ O
( -LRB- O
<0.4 CD O
or CC O
>4.0 CD O
mU/l NN O
) -RRB- O
, , O
serum NN B-NP
thyroxin NN I-NP
levels NNS O
( -LRB- O
T4 NN O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
suggest VBP O
that IN O
ventriculopleural JJ O
shunting NN O
should MD O
be VB O
considered VBN O
as IN O
the DT O
preferred JJ O
alternative NN O
to TO O
peritoneal JJ O
drainage NN O
in IN O
children NNS O
with IN O
intra-abdominal JJ O
adhesions NNS O
or CC O
with IN O
a DT O
history NN O
of IN O
recent JJ O
peritoneal NN O
infection NN O
. . O

-DOCSTART- X X O

Derivation NNP O
and CC O
initial JJ O
characterization NN O
of IN O
a DT O
mouse NN O
mammary NN O
tumor NN O
cell NN O
line NN O
carrying VBG O
the DT O
polyomavirus NN B-NP
middle NN I-NP
T NNP I-NP
antigen NN I-NP
: : O
utility NN O
in IN O
the DT O
development NN O
of IN O
novel NN O
cancer NN O
therapeutics NNS O
. . O

-DOCSTART- X X O

Long-range JJ O
comparison NN O
of IN O
human JJ B-NP
and CC I-NP
mouse NN I-NP
SCL NNP I-NP
loci NNS I-NP
: : O
localized JJ O
regions NNS O
of IN O
sensitivity NN O
to TO O
restriction NN O
endonucleases NNS O
correspond JJ O
precisely RB O
with IN O
peaks NNS O
of IN O
conserved JJ O
noncoding JJ O
sequences NNS O
. . O

-DOCSTART- X X O

The DT O
utilities NNS O
measured VBD O
in IN O
our PRP$ O
study NN O
can MD O
be VB O
applied VBN O
directly RB O
to TO O
quality-of-life NN O
determinations NNS O
in IN O
clinical JJ O
trials NNS O
of IN O
adjuvant JJ O
IFN NNP B-NP
alpha-2b NN I-NP
to TO O
measure VB O
the DT O
net JJ O
benefit NN O
of IN O
therapy NN O
. . O

-DOCSTART- X X O

Structure NN O
of IN O
the DT O
EMAPII NNP B-NP
domain NN I-NP
of IN O
human JJ B-NP
aminoacyl-tRNA NNS I-NP
synthetase NN I-NP
complex NN I-NP
reveals VBZ O
evolutionary JJ O
dimer NN O
mimicry NN O
. . O

-DOCSTART- X X O

Hypomorphic JJ O
dSLBP JJ B-NP
alleles NNS I-NP
support VBP O
zygotic JJ O
development NN O
but CC O
cause NN O
female NN O
sterility NN O
. . O

-DOCSTART- X X O

We PRP O
mapped VBD O
the DT O
DGCR6 NNP B-NP
gene NN I-NP
to TO O
chromosome NN O
22q11 CD O
within IN O
a DT O
low JJ O
copy NN O
repeat NN O
, , O
termed VBD O
sc11.1a JJ O
, , O
and CC O
identified VBD O
a DT O
second JJ O
copy NN O
of IN O
the DT O
gene NN O
, , O
DGCR6L NNP B-NP
, , O
within IN O
the DT O
duplicate NN O
locus NN O
, , O
termed VBD O
sc11.1b JJ O
. . O

-DOCSTART- X X O

Nerve NNP B-NP
growth NN I-NP
factor NN I-NP
( -LRB- O
NGF NN B-NP
) -RRB- O
and CC O
retinoic JJ O
acid NN O
(RA NN O
) -RRB- O
exert VBP O
important JJ O
actions NNS O
on IN O
PC12 JJ O
cells NNS O
. . O

-DOCSTART- X X O

Recruitment NN O
of IN O
an DT O
RNA NNP B-NP
polymerase NN I-NP
II NNP I-NP
complex NN I-NP
is VBZ O
mediated VBN O
by IN O
the DT O
constitutive JJ O
activation NN O
domain NN O
in IN O
CREB NNP B-NP
, , O
independently RB O
of IN O
CREB NNP B-NP
phosphorylation NN O
. . O

-DOCSTART- X X O

The DT O
region NN O
containing VBG O
both DT O
serines NNS O
is VBZ O
homologous JJ O
to TO O
the DT O
N-terminal JJ O
destruction NN O
box NN O
of IN O
IkappaBalpha NNP B-NP
, , I-NP
-beta JJ I-NP
, , I-NP
and CC I-NP
-epsilon NN I-NP
. . O

-DOCSTART- X X O

This DT O
function NN O
requires VBZ O
not RB O
only RB O
the DT O
kinase NN O
domain NN O
of IN O
Csk NNP B-NP
, , O
but CC O
also RB O
its PRP$ O
Src NNP B-NP
homology NN I-NP
3 CD I-NP
( -LRB- O
SH3 NN B-NP
) -RRB- O
and CC O
SH2 NNP B-NP
regions NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
we PRP O
showed VBD O
that IN O
ERSF NNP B-NP
including VBG O
NF-Y NNP B-NP
and CC O
ATF6alpha NNP B-NP
and/or CC I-NP
beta JJ I-NP
and CC O
capable JJ O
of IN O
binding NN O
to TO O
ERSE NNP O
is VBZ O
indeed RB O
formed VBN O
when WRB O
the DT O
cellular JJ O
UPR NNP O
is VBZ O
activated VBN O
. . O

-DOCSTART- X X O

The DT O
observed JJ O
phenotypes NNS O
may MD O
be VB O
explained VBN O
by IN O
( -LRB- O
i NN O
) -RRB- O
a DT O
selective JJ O
disruption NN O
of IN O
very-low-density NN B-NP
lipoprotein NN I-NP
secretion NN O
due JJ O
to TO O
decreased VBN O
expression NN O
of IN O
genes NNS O
encoding VBG O
apolipoprotein VB B-NP
B NNP I-NP
and CC O
microsomal JJ B-NP
triglyceride NN I-NP
transfer NN I-NP
protein NN I-NP
, , O
( -LRB- O
ii NNS O
) -RRB- O
an DT O
increase NN O
in IN O
hepatic JJ O
cholesterol NN O
uptake NN O
due JJ O
to TO O
increased JJ O
expression NN O
of IN O
the DT O
major JJ O
high-density NN B-NP
lipoprotein NN I-NP
receptor NN I-NP
, , O
scavenger NN B-NP
receptor NN I-NP
BI JJR I-NP
, , O
and CC O
( -LRB- O
iii NN O
) -RRB- O
a DT O
decrease NN O
in IN O
bile NN O
acid NN O
uptake NN O
to TO O
the DT O
liver NN O
due JJ O
to TO O
down-regulation NN O
of IN O
the DT O
major JJ O
basolateral JJ B-NP
bile NN I-NP
acid NN I-NP
transporters NNS I-NP
sodium NN I-NP
taurocholate VBP I-NP
cotransporter JJ I-NP
protein NN I-NP
and CC O
organic JJ B-NP
anion NN I-NP
transporter NN I-NP
protein NN I-NP
1 CD I-NP
. . O

-DOCSTART- X X O

These DT O
effects NNS O
were VBD O
not RB O
seen VBN O
with IN O
SHIP2 NNP B-NP
possessing VBG O
a DT O
mutation NN O
in IN O
the DT O
SH2 NNP B-NP
domain NN I-NP
( -LRB- O
R47G) NNP B-NP
. . O

-DOCSTART- X X O

The DT O
gonadotrope-specific JJ O
and CC O
regulated JJ O
expression NN O
of IN O
the DT O
GnRH NN B-NP
receptor NN I-NP
( -LRB- O
GnRH-R NN B-NP
) -RRB- O
gene NN O
is VBZ O
dependent JJ O
on IN O
multiple JJ O
transcription NN O
factors NNS O
that WDT O
interact NN O
with IN O
the DT O
noncanonical JJ B-NP
GnRH-R NNP I-NP
activating NN I-NP
sequence NN I-NP
( -LRB- O
GRAS NNP B-NP
) -RRB- O
, , O
the DT O
activator NN B-NP
protein-1 NN I-NP
( -LRB- O
AP-1 NN B-NP
) -RRB- O
element NN O
, , O
and CC O
the DT O
steroidogenic JJ B-NP
factor-1 NN I-NP
( -LRB- O
SF-1 NN B-NP
) -RRB- O
binding NN O
site NN O
. . O

-DOCSTART- X X O

Methylation NNP O
at IN O
both DT O
cytosine NN O
residues NNS O
in IN O
the DT O
E2F JJ B-NP
element NN O
( -LRB- O
( -LRB- O
m)CG( NN O
m)CG) NN O
generated VBD O
a DT O
new JJ O
methylcytosine-specific JJ O
DNA-protein NNP O
complex NN O
. . O

-DOCSTART- X X O

As RB O
well RB O
, , O
IFN-gamma-induced JJ B-NP
expression NN O
of IN O
IRF-1 NNP B-NP
and CC O
its PRP$ O
binding NN O
to TO O
the DT O
IRF NNP B-NP
element NN I-NP
is VBZ O
inhibited VBN O
. . O

-DOCSTART- X X O

This DT O
molecule NN O
, , O
wH22xeGFP JJ B-NP
, , O
consists VBZ O
of IN O
the DT O
entire JJ B-NP
humanized JJ I-NP
anti-FcgammaR NN I-NP
I PRP I-NP
mAb VBP I-NP
H22 PRP B-NP
with IN O
eGFP DT B-NP
genetically RB O
fused VBN O
to TO O
the DT O
C-terminal JJ O
end NN O
of IN O
each DT O
CH3 JJ B-NP
domain NN I-NP
. . O
wH22xeGFP '' B-NP
binds NNS O
within IN O
the DT O
ligand-binding JJ O
region NN O
by IN O
its PRP$ O
Fc JJ B-NP
end NN O
, , O
as RB O
well RB O
as IN O
outside IN O
the DT O
ligand-binding JJ O
region NN O
by IN O
its PRP$ O
Fab NNP B-NP
ends NNS O
, , O
thereby RB O
cross-linking JJ O
FcgammaRI. . B-NP

-DOCSTART- X X O

Transient NNP O
transfections NNS O
showed VBD O
that IN O
a DT O
single JJ O
mutation NN O
( -LRB- O
556M JJ O
) -RRB- O
decreased VBD O
TBLV NNP B-NP
enhancer NN I-NP
activity NN O
at IN O
least JJS O
20-fold JJ O
in IN O
two CD O
different JJ O
T-cell NN O
lines NNS O
. . O

-DOCSTART- X X O

Vector NNP O
stocks NNS O
containing VBG O
envelope NN B-NP
proteins VBZ I-NP
from IN O
three CD O
different JJ O
SIVmac NNP O
clones NNS O
, , O
namely RB O
, , O
SIVmac239 NNP O
(T-lymphocyte NNP O
tropic NN O
[T-tropic] NN O
) -RRB- O
, , O
SIVmac316 FW O
( -LRB- O
macrophage NN O
tropic NN O
[M-tropic] NN O
) -RRB- O
, , O
and CC O
SIVmac1A11 NNP O
( -LRB- O
dualtropic NN O
) -RRB- O
, , O
were VBD O
tested VBN O
. . O

-DOCSTART- X X O

Both DT O
Z NN B-NP
and CC O
R NN B-NP
expression NN O
resulted VBD O
in IN O
PML NNP O
dispersion NN O
in IN O
EBV-positive JJ O
cells NNS O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
the DT O
activity NN O
of IN O
IkappaB NNP B-NP
kinase FW I-NP
( -LRB- O
IKK-beta NN B-NP
) -RRB- O
, , O
which WDT O
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
NF-kappaB NNP B-NP
activation NN O
through IN O
IkappaB NNP B-NP
phosphorylation NN O
, , O
was VBD O
largely RB O
enhanced VBN O
in IN O
paclitaxel-treated JJ O
cells NNS O
, , O
detected VBN O
as IN O
IkappaBalpha NNP B-NP
phosphorylation NN O
. . O

-DOCSTART- X X O

Immunofluorescence NNP O
studies NNS O
in IN O
C2C12 DT O
myotubes NNS O
show VBP O
that IN O
Smad2 NNP B-NP
and CC O
MEF2A NNP B-NP
co-localise NN O
in IN O
the DT O
nucleus NN O
of IN O
multinuclear JJ O
myotubes NNS O
during IN O
differentiation NN O
. . O

-DOCSTART- X X O

Rapid NNP O
evolution NN O
of IN O
the DT O
DNA-binding JJ O
site NN O
in IN O
LAGLIDADG NNP B-NP
homing JJ I-NP
endonucleases NNS I-NP
. . O

-DOCSTART- X X O

Southern JJ O
blot NN O
analysis NN O
of IN O
genomic JJ O
DNA NN O
from IN O
somatic JJ O
cell NN O
hybrids NNS O
showed VBD O
that DT O
endothelial-TACC-related JJ B-NP
cDNA NN I-NP
maps NNS O
to TO O
chromosome NN O
10 CD O
. . O

-DOCSTART- X X O

Copyright NNP O
2001 CD O
Academic NNP O
Press NNP O
. . O

-DOCSTART- X X O

Mental NNP O
rotation NN O
of IN O
paired VBN O
figures NNS O
engendered VBN O
activation NN O
in IN O
the DT O
left JJ O
superior JJ O
parietal NN O
lobule NN O
and CC O
the DT O
right JJ O
frontal JJ O
medial JJ O
gyrus NN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
reported VBD O
the DT O
identification NN O
of IN O
three CD O
corresponding JJ O
alternative NN O
first JJ O
exons NNS O
and CC O
an DT O
intronic JJ O
promoter NN O
in IN O
the DT O
human JJ B-NP
PDE5A NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
work NN O
, , O
the DT O
complete JJ O
genome NN O
sequences NNS O
of IN O
Pyrococcus NNP O
horikoshii NNS O
and CC O
Pyrococcus NNP O
abyssi NNS O
, , O
two CD O
species NNS O
in IN O
a DT O
genus NN O
of IN O
hyperthermophilic JJ O
archaeon NN O
(archaebacterium NN O
) -RRB- O
, , O
were VBD O
compared VBN O
to TO O
detect VB O
large JJ O
genome NN O
polymorphisms NNS O
linked VBN O
with IN O
restriction-modification NN O
gene NN O
homologs NNS O
. . O

-DOCSTART- X X O

This DT O
animal NN O
model NN O
of IN O
dystonia NN O
appears VBZ O
to TO O
be VB O
a DT O
model NN O
of IN O
NAD NNP O
in IN O
man NN O
from IN O
the DT O
viewpoint NN O
of IN O
treatment-response NN O
. . O

-DOCSTART- X X O

Peripheral JJ O
and CC O
preemptive JJ O
opioid JJ O
antinociception NN O
in IN O
a DT O
mouse NN O
visceral JJ O
pain NN O
model NN O
. . O

-DOCSTART- X X O

Twenty-six CD O
( -LRB- O
55 CD O
% NN O
) -RRB- O
(95 CD O
% NN O
CI NNP O
, , O
41-69 CD O
% NN O
) -RRB- O
patients NNS O
experienced VBD O
> NNP O
or CC O
=grade NNP O
3 CD O
acute JJ O
toxicity NN O
(RTOG) NN O
. . O

-DOCSTART- X X O

No DT O
'TATA' JJ O
motif NN O
was VBD O
identified VBN O
near IN O
either CC O
the DT O
GABPalpha NNP B-NP
or CC O
ATPsynCF6 DT B-NP
transcription NN O
start VB O
sites NNS O
. . O

-DOCSTART- X X O

Significantly RB O
higher JJR O
lung NN O
function NN O
parameters NNS O
were VBD O
obtained VBN O
in IN O
extubated JJ O
recipients NNS O
of IN O
LPD NNP O
preserved VBD O
grafts NNS O
2 CD O
weeks NNS O
after IN O
TX NNP O
. . O

-DOCSTART- X X O

Acquired VBN O
antithrombin JJ B-NP
deficiency NN O
in IN O
sepsis NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
we PRP O
have VBP O
isolated VBN O
a DT O
genomic JJ O
fragment NN O
containing VBG O
the DT O
most JJS O
distal JJ O
5' JJ O
sequences NNS O
of IN O
the DT O
major JJ O
GGT NNP B-NP
mRNA NN I-NP
in IN O
HepG2 CD O
cells NNS O
. . O

-DOCSTART- X X O

Increased VBN O
erythropoietin NN B-NP
synthesis NN O
in IN O
patients NNS O
with IN O
COLD NNP O
or CC O
left VBN O
heart NN O
failure NN O
is VBZ O
related VBN O
to TO O
alterations NNS O
in IN O
renal JJ O
haemodynamics NNS O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
herpes PRP$ B-NP
simplex JJ I-NP
virus NN I-NP
type NN I-NP
2 CD I-NP
US3 NN I-NP
affects VBZ O
the DT O
Cdc42/Rac NNP B-NP
pathway NN O
and CC O
attenuates VBZ O
c-Jun JJ B-NP
N-terminal JJ I-NP
kinase NN I-NP
activation NN O
. . O

-DOCSTART- X X O

If IN O
you PRP O
think VBP O
education NN O
is VBZ O
expensive--try JJ O
ignorance--Bok NN O
's POS O
Law NN O
. . O

-DOCSTART- X X O

To TO O
the DT O
best JJS O
of IN O
our PRP$ O
knowledge NN O
, , O
SNTCS NNP O
is VBZ O
highly RB O
malignant JJ O
. . O

-DOCSTART- X X O

High-affinity NNP O
binding NN O
of IN O
NF-1 NNP B-NP
to TO O
PSE-B NNP B-NP
, , O
but CC O
not RB O
to TO O
PSE-A NNP B-NP
, , O
was VBD O
confirmed VBN O
by IN O
competition NN O
of IN O
DNA-protein NNP O
interactions NNS O
by IN O
using VBG O
NF-1 JJ B-NP
DNA NNP O
elements NNS O
and CC O
antibodies NNS O
. . O

-DOCSTART- X X O

Coexpression NN O
of IN O
the DT O
p120(ctn NN B-NP
) -RRB- O
protein NN O
with IN O
an DT O
N-terminal JJ O
deletion NN O
, , O
which WDT O
eliminates VBZ O
some DT O
potential JJ O
tyrosine NN O
phosphorylation NN O
sites NNS O
, , O
or CC O
the DT O
protein NN O
with IN O
a DT O
single JJ O
amino JJ O
acid NN O
substitution NN O
(tyrosine NN O
at IN O
217 CD O
to TO O
phenylalanine VB O
) -RRB- O
resulted VBD O
in IN O
an DT O
increase NN O
in IN O
the DT O
aggregation NN O
of IN O
v-Src-transformed JJ B-NP
EL NNP O
and CC O
EalphaCL NNP O
cells NNS O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
p73 PRP B-NP
can MD O
transcriptionally RB O
inhibit VB O
a DT O
number NN O
of IN O
cellular JJ O
and CC O
viral JJ O
promoters NNS O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
pulmonary JJ O
vein NN O
stenosis NN O
after IN O
radiofrequency NN O
ablation NN O
for IN O
atrial JJ O
fibrillation NN O
using VBG O
MRI. . O

-DOCSTART- X X O

Tumor NN O
cell NN O
lines NNS O
transduced VBN O
at IN O
an DT O
MOI NN O
of IN O
8 CD O
for IN O
3 CD O
days NNS O
led VBN O
to TO O
>90 CD O
% NN O
gene NN O
transfer NN O
efficiency NN O
. . O

-DOCSTART- X X O

Finally RB O
, , O
we PRP O
compared VBD O
the DT O
differential JJ O
screening NN O
techniques NNS O
in IN O
terms NNS O
of IN O
sensitivity NN O
, , O
efficiency NN O
and CC O
occurrence NN O
of IN O
false JJ O
positives NNS O
. . O

-DOCSTART- X X O

To TO O
investigate VB O
the DT O
effects NNS O
of IN O
exogenous JJ O
hyaluronic JJ O
acid NN O
, , O
the DT O
development NN O
of IN O
port-site JJ O
metastasis NN O
was VBD O
examined VBN O
using VBG O
mouse NN O
adenocarcinoma NN O
cell-line NN O
colon NN O
26 CD O
cells NNS O
. . O

-DOCSTART- X X O

Cytomegalovirus NNP O
, , O
Chlamydia NNP O
pneumoniae NNS O
, , O
and CC O
Helicobacter NNP O
pylori NN O
IgG NNP B-NP
antibodies NNS I-NP
and CC O
restenosis NN O
after IN O
stent JJ O
implantation NN O
: : O
an DT O
angiographic JJ O
and CC O
intravascular JJ O
ultrasound JJ O
study NN O
. . O

-DOCSTART- X X O

Architecture NNP O
and CC O
anatomy NN O
of IN O
the DT O
genomic JJ O
locus NN O
encoding VBG O
the DT O
human JJ O
leukemia-associated JJ O
transcription NN O
factor NN O
RUNX1/AML1 NNP B-NP
. . O

-DOCSTART- X X O

In IN O
this DT O
paper NN O
the DT O
tyrosine NN O
dephosphorylating VBG O
enzymes NNS O
, , O
the DT O
protein-tyrosine NN B-NP
phosphatases NNS I-NP
( -LRB- O
PTPs NNS B-NP
) -RRB- O
, , O
are VBP O
studied VBN O
which WDT O
can MD O
be VB O
grouped VBN O
into IN O
two CD O
subfamilies NNS O
, , O
the DT O
soluble JJ B-NP
PTPs NNS I-NP
and CC O
the DT O
receptor NN B-NP
PTPs NNS I-NP
( -LRB- O
RPTPs NNS B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
Ig-related JJ B-NP
, , O
typical JJ O
metazoan NN O
, , O
module NN O
is VBZ O
classified VBN O
to TO O
the DT O
disulphide NN O
lacking VBG O
Ig NNP B-NP
members NNS I-NP
and CC O
represents VBZ O
the DT O
phylogenetic JJ O
earliest JJS O
member NN O
of IN O
this DT O
group NN O
. . O

-DOCSTART- X X O

While IN O
these DT O
results NNS O
are VBP O
consistent JJ O
with IN O
previously RB O
reported VBN O
effects NNS O
of IN O
the DT O
C-terminal JJ O
domain NN O
on IN O
nucleotide JJ O
binding NN O
, , O
they PRP O
also RB O
demonstrate VBP O
that IN O
interactions NNS O
with IN O
the DT O
N-terminal JJ O
domains NNS O
are VBP O
necessary JJ O
to TO O
inhibit VB O
proton NN O
transport NN O
. . O

-DOCSTART- X X O

By IN O
analyzing VBG O
5'-deletion JJ O
insulin NN B-NP
promoter-reporter NN I-NP
constructs NNS I-NP
in IN O
transient JJ O
transfections NNS O
of IN O
clonal JJ O
INS-1 NN B-NP
beta-cells NNS I-NP
, , O
we PRP O
located VBD O
activating VBG O
Hh-responsive JJ B-NP
regions NNS O
within IN O
the DT O
rat NN B-NP
insulin NN I-NP
I PRP I-NP
promoter NN I-NP
that WDT O
include VBP O
the DT O
glucose-response NN O
elements NNS O
Far RB O
( -LRB- O
E2 NNS O
) -RRB- O
and CC O
Flat NNP O
( -LRB- O
A2/A3 NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
androgen NN B-NP
receptor NN I-NP
( -LRB- O
AR NN B-NP
) -RRB- O
amino-terminus CC O
imposes VBZ O
androgen-specific JJ O
regulation NN O
of IN O
AR NN B-NP
gene NN I-NP
expression NN O
via IN O
an DT O
exonic JJ O
enhancer NN O
. . O

-DOCSTART- X X O

An DT O
additional JJ O
9 CD O
patients NNS O
achieved VBD O
normal JJ O
levels NNS O
with IN O
adjunctive JJ O
drug NN O
therapy NN O
. . O

-DOCSTART- X X O

By IN O
Caveman NNP O
. . O

-DOCSTART- X X O

Corneal NNP O
scrapping NN O
and CC O
deep JJ O
stromal JJ O
biopsy NN O
were VBD O
obtained VBN O
and CC O
stained VBN O
for IN O
microscopic JJ O
evaluation NN O
with IN O
periodic JJ O
acid-Schiff NN O
, , O
Giemsa NNP O
, , O
and CC O
Gomori NNP O
's POS O
methenamine NN O
silver NN O
stains NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
indicate VBP O
that IN O
BACM NNP O
has VBZ O
antiplaque JJ O
and CC O
stronger JJR O
antidegradation IN O
effects NNS O
than IN O
GLCM. NNP O

-DOCSTART- X X O

Susceptibility NN O
to TO O
ischemia-induced DT O
arrhythmias NNS O
was VBD O
lower JJR O
in IN O
1-week JJ O
diabetics NNS O
: : O
only RB O
42 CD O
% NN O
of IN O
diabetic JJ O
hearts NNS O
exhibited VBD O
ventricular JJ O
tachycardia NN O
(VT NN O
) -RRB- O
and CC O
16 CD O
% NN O
had VBD O
short JJ O
episodes NNS O
of IN O
ventricular JJ O
fibrillation NN O
(VF NN O
) -RRB- O
as IN O
compared VBN O
to TO O
VT VB O
100 CD O
% NN O
and CC O
VF NNP O
70 CD O
% NN O
( -LRB- O
including VBG O
sustained VBN O
VF RB O
36 CD O
% NN O
) -RRB- O
in IN O
the DT O
non-diabetics NNS O
( -LRB- O
P<0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
picture NN O
is VBZ O
emerging VBG O
showing VBG O
a DT O
gradient NN O
of IN O
function NN O
among IN O
p53 NN B-NP
, , O
p73 VBD B-NP
, , O
p63 VBD B-NP
ranging VBG O
from IN O
tumor NN O
suppression NN O
to TO O
development NN O
. . O

-DOCSTART- X X O

This DT O
could MD O
lead VB O
to TO O
subsequent JJ O
outbreaks NNS O
if IN O
Babesia NNP O
carrier NN O
animals NNS O
were VBD O
to TO O
be VB O
introduced VBN O
into IN O
the DT O
herd NN O
. . O

-DOCSTART- X X O

Contagious JJ O
bovine NN O
pleuropneumonia NN O
is VBZ O
a DT O
major JJ O
threat NN O
for IN O
cattle NNS O
in IN O
Africa NNP O
. . O

-DOCSTART- X X O

The DT O
increase NN O
in IN O
number NN O
of IN O
terminal JJ O
hairs NNS O
, , O
which WDT O
are VBP O
defined VBN O
as IN O
hairs NNS O
more RBR O
than IN O
60 CD O
microm NN O
in IN O
diameter NN O
, , O
in IN O
the DT O
designated VBN O
area NN O
( -LRB- O
0.5 CD O
cm NN O
square NN O
= SYM O
0.25 CD O
cm2 JJ O
area NN O
) -RRB- O
of IN O
the DT O
procyanidin NN O
B-2 NN O
group NN O
subjects NNS O
after IN O
the DT O
6-month JJ O
trial NN O
was VBD O
significantly RB O
greater JJR O
than IN O
that DT O
of IN O
the DT O
placebo NN O
control NN O
group NN O
subjects NNS O
( -LRB- O
procyanidin NN O
B-2 NN O
, , O
1.99 CD O
+/ NNS O
- : O
2.58 CD O
( -LRB- O
mean VB O
+/ JJ O
- : O
SD NNP O
)/0.25 CD O
cm2 NN O
; : O
placebo NN O
, , O
-0.82 JJ O
+/ NNS O
- : O
3.40 CD O
( -LRB- O
mean VB O
+/ JJ O
- : O
SD NNP O
)/0.25 CD O
cm2 NN O
; : O
P NNP O
< NNP O
0.02 CD O
, , O
two-sample JJ O
t JJ O
test NN O
) -RRB- O
. . O

-DOCSTART- X X O

Ectopic JJ O
expression NN O
of IN O
the DT O
dominant JJ B-NP
mutant JJ I-NP
Lg3 JJ I-NP
allele NN I-NP
is VBZ O
believed VBN O
to TO O
cause VB O
the DT O
phenotype NN O
. . O

-DOCSTART- X X O

High NNP O
plasma NN B-NP
AVP NNP I-NP
levels NNS O
observed VBD O
in IN O
the DT O
two CD O
cases NNS O
suggest VBP O
that IN O
SSRIs NNP O
stimulate VB O
AVP NNP B-NP
secretion NN O
, , O
thereby RB O
causing VBG O
SIADH. . O

-DOCSTART- X X O

Thus RB O
, , O
in IN O
T47D JJ O
breast NN O
carcinoma NN O
cells NNS O
, , O
IL-6 CC B-NP
acts VBZ O
in IN O
synergy NN O
with IN O
EGF NN B-NP
receptor NN I-NP
autocrine NN O
activity NN O
to TO O
signal VB O
through IN O
the DT O
MAPK/PI3K NNP B-NP
pathways NNS O
. . O

-DOCSTART- X X O

For IN O
immunological JJ O
methods NNS O
, , O
identification NN O
of IN O
such JJ O
antigens NNS O
with IN O
intermolecular JJ O
variability NN O
, , O
e.g. FW O
, , O
the DT O
structural JJ O
aescin NN O
analogs NNS O
, , O
is VBZ O
of IN O
unknown JJ O
validity NN O
. . O

-DOCSTART- X X O

Most JJS O
patients NNS O
harboring VBG O
metronidazole JJ O
- : O
and CC O
clarithromycin-resistant JJ O
strains NNS O
were VBD O
eradicated VBN O
at IN O
an DT O
equal JJ O
rate NN O
by IN O
each DT O
of IN O
the DT O
three CD O
regimens NNS O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
During IN O
the DT O
stabilization NN O
period NN O
, , O
PaCO2 NNP O
( -LRB- O
mean VB O
+/ JJ O
- : O
SD NN O
) -RRB- O
was VBD O
33 CD O
+/ NN O
- : O
5 CD O
mm CD O
Hg NNP O
,and CC O
arrhythmias NNS O
were VBD O
not RB O
detected VBN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Previous JJ O
studies NNS O
have VBP O
indicated VBN O
that IN O
the DT O
60-, JJ O
30-, JJ O
28 CD O
- : O
and CC O
12-item JJ O
versions NNS O
of IN O
the DT O
General NNP O
Health NNP O
Questionnaire NNP O
( -LRB- O
GHQ NN O
) -RRB- O
are VBP O
liable JJ O
to TO O
retest VB O
effects NNS O
, , O
especially RB O
when WRB O
administered VBN O
multiple JJ O
times NNS O
with IN O
short JJ O
intervals NNS O
. . O

-DOCSTART- X X O

Decreased JJ O
serum NN B-NP
ceruloplasmin NN I-NP
and CC O
copper NN O
levels NNS O
in IN O
cervical JJ O
dystonia NN O
. . O

-DOCSTART- X X O

A DT O
microsporidian NN O
, , O
Nosema NNP O
algerae NNS O
Vavra NNP O
and CC O
undeen NNP O
, , O
was VBD O
found VBN O
parasitizing JJ O
larvae NNS O
and CC O
adults NNS O
of IN O
a DT O
laboratory NN O
colony NN O
of IN O
Culex NNP O
pipiens NNS O
L. NNP O
originated VBD O
from IN O
Gharbia NNP O
Governorate NNP O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
and CC O
characterization NN O
of IN O
OsPSK NNP B-NP
, , O
a DT O
gene NN O
encoding VBG O
a DT O
precursor NN O
for IN O
phytosulfokine-alpha NN B-NP
, , O
required VBN O
for IN O
rice NN O
cell NN O
proliferation NN O
. . O

-DOCSTART- X X O

Plasma NNP O
DHE NNP O
concentration NN O
rose VBD O
promptly RB O
above IN O
5 CD O
ng/ml NN O
after IN O
the DT O
application NN O
of IN O
the DT O
PSA NNP O
tape NN O
onto IN O
the DT O
damaged JJ O
skin NN O
in IN O
hairless JJ O
rat NN O
. . O

-DOCSTART- X X O

Implications NNS O
in IN O
biomonitoring NN O
of IN O
the DT O
observed JJ O
accumulation NN O
patterns NNS O
, , O
especially RB O
in IN O
the DT O
different JJ O
tissues NNS O
of IN O
Posidonia NNP O
oceanica NN O
, , O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
Xlim-1 CC B-NP
not RB O
only RB O
contains VBZ O
a DT O
unique JJ O
tyrosine-rich JJ O
activation NN O
domain NN O
but CC O
also RB O
contains VBZ O
a DT O
negative JJ O
regulatory JJ O
domain NN O
in IN O
CT239-403 NNP O
, , O
suggesting VBG O
a DT O
complex JJ O
regulatory JJ O
mechanism NN O
underlying VBG O
the DT O
transcriptional JJ O
activity NN O
of IN O
Xlim-1 NN B-NP
in IN O
the DT O
organizer NN O
. . O

-DOCSTART- X X O

After IN O
allowing VBG O
time NN O
for IN O
absorption NN O
, , O
participants NNS O
completed VBD O
a DT O
bridge NN O
simulator NN O
task NN O
. . O

-DOCSTART- X X O

Anti-nucleolin NNP B-NP
mAb NN I-NP
was VBD O
used VBN O
to TO O
confirm VB O
the DT O
antigenic JJ O
properties NNS O
of IN O
this DT O
p95 NN B-NP
component NN I-NP
. . O

-DOCSTART- X X O

Substitutions NNS O
in IN O
the DT O
YFV NNP B-NP
Ag-binding NNP B-NP
region NN I-NP
( -LRB- O
ABR NN B-NP
) -RRB- O
occur VBP O
at IN O
four CD O
of IN O
the DT O
eight CD O
highly RB O
conserved VBN O
residues NNS O
that WDT O
are VBP O
essential JJ O
for IN O
binding NN O
of IN O
peptide-Ag NN O
in IN O
the DT O
class NN O
Ia NNP O
molecules NNS O
. . O

-DOCSTART- X X O

Similarly RB O
, , O
curcumin NN O
( -LRB- O
diferuloylmethane NN O
) -RRB- O
, , O
an DT O
anti-inflammatory JJ O
agent NN O
, , O
suppressed VBN O
OSM-stimulated JJ B-NP
STAT1 NNP B-NP
phosphorylation NN O
, , O
DNA-binding JJ O
activity NN O
of IN O
STAT1 NNP B-NP
, , O
and CC O
c-Jun JJ B-NP
N-terminal JJ I-NP
kinase NN I-NP
activation NN O
without IN O
affecting VBG O
JAK1 JJ B-NP
, , O
JAK2 NNP B-NP
, , O
JAK3 NNP B-NP
, , O
ERK1/2 NNP B-NP
, , O
and CC O
p38 VBD B-NP
phosphorylation NN O
. . O

-DOCSTART- X X O

A DT O
cDNA NN O
clone NN O
encoding VBG O
C2H2-type JJ B-NP
zinc NN I-NP
finger NN I-NP
protein NN I-NP
, , O
SCOF-1 NN B-NP
, , O
was VBD O
isolated VBN O
from IN O
soybean NN O
. . O

-DOCSTART- X X O

Apart RB O
from IN O
antimicrobial JJ O
properties NNS O
, , O
recent JJ O
data NNS O
indicate VBP O
that IN O
PMN NNP O
also RB O
exert VB O
anti-inflammatory JJ O
effects NNS O
by IN O
stimulation NN O
and CC O
release NN O
of IN O
cytokine NN O
antagonists NNS O
such JJ O
as IN O
interleukin-1 NN B-NP
receptor NN I-NP
antagonist NN I-NP
( -LRB- O
IL-1ra NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
purpose NN O
of IN O
this DT O
investigation NN O
was VBD O
to TO O
study VB O
the DT O
morphological JJ O
characteristics NNS O
of IN O
the DT O
fibrous JJ O
tissue NN O
capsule NN O
resulting VBG O
from IN O
the DT O
implantation NN O
of IN O
aluminum NN O
calcium NN O
phosphate NN O
( -LRB- O
ALCAP NNP O
) -RRB- O
and CC O
hydroxyapetite JJ O
( -LRB- O
HA NNP O
) -RRB- O
bioceramics NNS O
. . O

-DOCSTART- X X O

Before IN O
PO3 DT O
administration NN O
, , O
more JJR O
than IN O
half DT O
( -LRB- O
57.4 CD O
% NN O
) -RRB- O
of IN O
the DT O
patients NNS O
received VBD O
only RB O
1 CD O
or CC O
2 CD O
antituberculous JJ O
drugs NNS O
(ethambutole NN O
and CC O
ethionamide NN O
or CC O
ethambutole NN O
and CC O
oprofloxacin NN O
) -RRB- O
. . O

-DOCSTART- X X O

Can MD O
survival NN O
be VB O
prolonged VBN O
for IN O
patients NNS O
with IN O
hormone-resistant JJ O
prostate NN O
cancer NN O
? . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
the DT O
transfected VBN O
receptors NNS O
were VBD O
associated VBN O
with IN O
antagonism NN O
of IN O
activator NN B-NP
protein NN I-NP
1 CD I-NP
( -LRB- O
AP-1 NN B-NP
) -RRB- O
activity NN O
. . O

-DOCSTART- X X O

Recent JJ O
studies NNS O
using VBG O
isolated JJ O
rat NN O
adipocytes NNS O
and CC O
chemically RB O
synthesized VBN O
PIG NNP O
compounds VBZ O
point NN O
to TO O
IRS NNP B-NP
1/3 CD I-NP
tyrosine NN O
phosphorylation NN O
by IN O
p59Lyn JJ B-NP
kinase NN I-NP
as IN O
the DT O
site NN O
of IN O
cross-talk NN O
, , O
the DT O
negative JJ O
regulation NN O
of IN O
which WDT O
by IN O
interaction NN O
with IN O
caveolin NN B-NP
is VBZ O
apparently RB O
abrogated VBN O
by IN O
PIG. NNP O

-DOCSTART- X X O

RESULTS NNS O
: : O
The DT O
parameters NNS O
SF2 NNP O
and CC O
plating VBG O
efficiency NN O
were VBD O
stable JJ O
throughout IN O
the DT O
4-year JJ O
test NN O
period NN O
. . O

-DOCSTART- X X O

VE-DEF NNP O
animals NNS O
had VBD O
significantly RB O
higher JJR O
( -LRB- O
p NN O
< JJ O
0.05 CD O
) -RRB- O
levels NNS O
of IN O
myocardial JJ O
lipid JJ O
peroxidation NN O
and CC O
lower JJR O
( -LRB- O
p NN O
< JJ O
0.05 CD O
) -RRB- O
protein NN O
thiols NNS O
following VBG O
I-R JJ O
compared VBN O
to TO O
the DT O
CON NN O
animals NNS O
. . O

-DOCSTART- X X O

The DT O
child NN O
left VBD O
behind RB O
. . O

-DOCSTART- X X O

The DT O
contrasting JJ O
effects NNS O
of IN O
dopaminergic JJ O
stimulation NN O
on IN O
the DT O
motor NN O
performance NN O
and CC O
on IN O
some DT O
aspects NNS O
of IN O
cognitive NN O
processing NN O
suggest VBP O
the DT O
existence NN O
of IN O
complex JJ O
interactions NNS O
within IN O
pre NN O
- : O
and CC O
postsynaptic JJ O
brain NN B-NP
dopamine NN I-NP
receptors NNS I-NP
, , O
and CC O
an DT O
intervention NN O
of IN O
segregated JJ O
basal NN O
ganglia-prefrontal JJ O
cortex NN O
loops NNS O
in IN O
motor NN O
and CC O
cognitive NN O
behaviour NN O
. . O

-DOCSTART- X X O

HexA71 PRP B-NP
negatively RB O
affects VBZ O
RpoS NNP B-NP
, , O
as IN O
the DT O
levels NNS O
of IN O
this DT O
alternative JJ O
sigma NN B-NP
factor NN I-NP
are VBP O
higher RBR O
in IN O
the DT O
HexA NNP B-NP
- : I-NP
mutant JJ I-NP
than IN O
in IN O
the DT O
HexA+ NNP B-NP
strain NN O
. . O

-DOCSTART- X X O

Multiple JJ O
copies NNS O
of IN O
rsmB+ NNP B-NP
DNA NNP I-NP
, , O
on IN O
the DT O
other JJ O
hand NN O
, , O
stimulate VB O
exoenzyme NN O
production NN O
by IN O
relieving VBG O
the DT O
negative JJ O
effects NNS O
of IN O
a DT O
chromosomal NN O
copy NN O
of IN O
hexA+ NN B-NP
. . O

-DOCSTART- X X O

0 CD O
% NN O
) -RRB- O
and CC O
IL-12 NN B-NP
( -LRB- O
42.6 CD O
% NN O
vs. FW O

-DOCSTART- X X O

Systematic JJ O
review NN O
of IN O
diagnostic JJ O
tests NNS O
for IN O
vaginal JJ O
trichomoniasis NN O
. . O

-DOCSTART- X X O

More RBR O
importantly RB O
, , O
this DT O
fusion NN O
converted VBD O
a DT O
less RBR O
effective JJ O
vaccine NN O
into IN O
one CD O
with IN O
significant JJ O
potency NN O
against IN O
established VBN O
E7-expressing JJ B-NP
metastatic JJ O
tumors NNS O
. . O

-DOCSTART- X X O

We PRP O
compared VBN O
previously RB O
the DT O
methylation NN O
status NN O
between IN O
normal JJ O
liver NN O
and CC O
liver NN O
tumors NNS O
in IN O
SV40 DT B-NP
T/t NNP I-NP
antigen NN I-NP
transgenic NN O
mice NNS O
( -LRB- O
MT-D2 JJ O
mice NNS O
) -RRB- O
using VBG O
Restriction NNP O
Landmark NNP O
Genomic NNP O
Scanning NNP O
for IN O
Methylation NNP O
( -LRB- O
RLGS-M) JJ O
and CC O
identified VBN O
several JJ O
loci/spots NNS O
that WDT O
appeared VBD O
to TO O
be VB O
methylated VBN O
frequently RB O
in IN O
liver NN O
tumors NNS O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
revealed VBN O
that IN O
mlt NN B-NP
1 CD I-NP
is VBZ O
normally RB O
expressed VBN O
in IN O
brain NN O
, , O
spleen JJ O
, , O
stom NN O
ach NN O
, , O
and CC O
liver NN O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
N18TG-2 JJ O
cells NNS O
with IN O
a DT O
demethylating NN O
agent NN O
, , O
5-aza-deoxycytidine JJ O
, , O
resulted VBD O
in IN O
an DT O
expression NN O
of IN O
mlt NN B-NP
1 CD I-NP
, , O
indicating VBG O
that IN O
the DT O
repression NN O
of IN O
mlt NN B-NP
1 CD I-NP
is VBZ O
attributable JJ O
to TO O
methylation NN O
Thus RB O
, , O
mlt NN B-NP
1 CD I-NP
is VBZ O
a DT O
novel NN O
target NN O
gene NN O
that WDT O
is VBZ O
silenced VBN O
by IN O
methylation NN O
during IN O
liver NN O
tumorigenesis NN O
initiated VBN O
by IN O
SV40 DT B-NP
T NNP I-NP
antigen NN I-NP
. . O

-DOCSTART- X X O

These DT O
results NNS O
suggested VBD O
a DT O
critical JJ O
role NN O
for IN O
tyrosine FW O
residue JJ O
1229 CD O
in IN O
the DT O
regulation NN O
of IN O
L1 NNP B-NP
endocytosis NN O
. . O

-DOCSTART- X X O

We PRP O
conclude VBP O
that IN O
RPMS NNP B-NP
acts VBZ O
as IN O
a DT O
negative JJ O
regulator NN O
of IN O
EBNA2 NNP B-NP
and CC O
Notch NNP B-NP
activity NN O
through IN O
its PRP$ O
interactions NNS O
with IN O
the DT O
CBF1-associated JJ B-NP
corepressor NN I-NP
complex NN I-NP
. . O

-DOCSTART- X X O

Folate NNP O
metabolism NN O
in IN O
the DT O
human JJ O
malaria NN O
parasite NN O
Plasmodium NN O
falciparum NN O
is VBZ O
an DT O
essential JJ O
activity NN O
for IN O
cell NN O
growth NN O
and CC O
replication NN O
, , O
and CC O
the DT O
target NN O
of IN O
an DT O
important JJ O
class NN O
of IN O
therapeutic JJ O
agents NNS O
in IN O
widespread JJ O
use NN O
. . O

-DOCSTART- X X O

Retinoids NNS O
participate VB O
in IN O
the DT O
onset NN O
of IN O
differentiation NN O
, , O
apoptosis NN O
and CC O
the DT O
inhibition NN O
of IN O
growth NN O
in IN O
a DT O
wide JJ O
variety NN O
of IN O
normal JJ O
and CC O
cancerous JJ O
cells NNS O
. . O

-DOCSTART- X X O

Transactivation NN O
of IN O
oIFNtau NNP B-NP
enhancer-reporter NN O
constructs NNS O
was VBD O
primarily RB O
regulated VBN O
by IN O
three CD O
regions NNS O
containing VBG O
AP-1 NNP B-NP
site NN I-NP
, , O
GATA NNP B-NP
like IN I-NP
sequence NN I-NP
and CC O
site( NN O
s VBZ O
) -RRB- O
unidentified JJ O
. . O

-DOCSTART- X X O

Drosophila NNP B-NP
Menin1 NNP I-NP
gene NN I-NP
transcripts NNS I-NP
use VBP O
alternative JJ O
polyadenylation NN O
sites NNS O
resulting VBG O
in IN O
4.3 CD O
and CC O
5-kb JJ O
messages NNS O
. . O

-DOCSTART- X X O

Sequence NN O
analysis NN O
indicates VBZ O
that IN O
RBP21 NNP B-NP
shares NNS O
homology RB O
with IN O
other JJ O
retinoblastoma-binding JJ B-NP
proteins NNS I-NP
in IN O
the DT O
pRb-binding JJ B-NP
motif NN I-NP
LxCxE NN O
at IN O
the DT O
C-terminal JJ O
region NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
the DT O
consensus NN O
amino IN O
acid NN O
motif NN O
for IN O
serine NN B-NP
threonine CD I-NP
receptor NN I-NP
kinases NNS I-NP
was VBD O
also RB O
present JJ O
. . O

-DOCSTART- X X O

OsBBPI NNP B-NP
was VBD O
found VBN O
to TO O
be VB O
rapidly RB O
induced VBN O
in IN O
rice NN O
seedling NN O
leaf NN O
in IN O
response NN O
to TO O
cut VB B-NP
, , O
exogenous JJ O
jasmonic JJ O
acid NN O
( -LRB- O
JA VBN O
) -RRB- O
, , O
and CC O
two CD O
potent JJ O
protein NN B-NP
phosphatase NN I-NP
2A IN I-NP
( -LRB- O
PP2A NN B-NP
) -RRB- O
inhibitors NNS O
, , O
cantharidin NN O
( -LRB- O
CN) NNP O
and CC O
endothall NN O
( -LRB- O
EN) NNP O
, , O
in IN O
a DT O
light/dark-, JJ O
time NN O
- : O
and CC O
dose-dependent JJ O
manner NN O
; : O
this DT O
induction NN O
was VBD O
completely RB O
inhibited VBN O
by IN O
cycloheximide NN O
( -LRB- O
CHX NNP O
) -RRB- O
, , O
indicating VBG O
a DT O
requirement NN O
for IN O
de FW O
novo FW O
protein NN O
synthesis NN O
in IN O
its PRP$ O
induction NN O
. . O

-DOCSTART- X X O

Copyright NNP O
2000 CD O
John NNP O
Wiley NNP O
& CC O
Sons NNP O
, , O
Ltd. NNP O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
chlordiazepoxide NN O
( -LRB- O
2.5-15.0mg/kg JJ O
) -RRB- O
, , O
a DT O
full JJ O
benzodiazepine NN B-NP
receptor NN I-NP
agonist NN O
, , O
and CC O
bretazenil NN O
( -LRB- O
5.0-30.0mg/kg JJ O
) -RRB- O
, , O
a DT O
partial JJ O
benzodiazepine NN B-NP
receptor NN I-NP
agonist NN O
, , O
were VBD O
examined VBN O
in IN O
the DT O
murine NN O
elevated VBD O
plus-maze NN O
paradigm NN O
. . O

-DOCSTART- X X O

However RB O
, , O
plasmids NNS O
carrying VBG O
the DT O
yeast NN B-NP
TyrRS NNP I-NP
gene NN I-NP
could MD O
not RB O
be VB O
stably RB O
maintained VBN O
in IN O
E. NNP O
coli NNS O
. . O

-DOCSTART- X X O

In IN O
mammalian JJ O
tissue NN O
culture NN O
cells NNS O
, , O
overexpression IN O
of IN O
any DT O
of IN O
the DT O
four CD O
mouse NN O
deltex NN O
homologs VBZ O
suppressed VBN O
the DT O
transcriptional JJ O
activity NN O
of IN O
E47 NNP B-NP
, , O
a DT O
basic JJ B-NP
helix-loop-helix NN I-NP
( -LRB- I-NP
bHLH) JJ I-NP
protein NN I-NP
, , O
in IN O
a DT O
manner NN O
similar JJ O
to TO O
suppression NN O
by IN O
an DT O
activated JJ O
form NN O
of IN O
human JJ B-NP
Notch1 NNP I-NP
or CC O
human JJ B-NP
DTX1 NN I-NP
. . O

-DOCSTART- X X O

Multiparous JJ O
women NNS O
presented VBD O
higher JJR O
BMI NNS O
( -LRB- O
P NNP O
= SYM O
0.01 CD O
) -RRB- O
and CC O
PBF NNP O
( -LRB- O
P NNP O
= SYM O
0.03 CD O
) -RRB- O
compared VBN O
with IN O
primi- NNS O
and CC O
nulliparous JJ O
groups NNS O
. . O

-DOCSTART- X X O

Fluorimetric JJ O
determination NN O
of IN O
methylmercury NN O
as IN O
an DT O
ion-association NN O
complex NN O
with IN O
rhodamine NN O
B NNP O
in IN O
the DT O
presence NN O
of IN O
iodide NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
central JJ O
role NN O
of IN O
the DT O
Notch-CBF1/RBP-Jkappa NNP B-NP
signaling VBG O
pathway NN O
in IN O
cell NN O
fate NN O
decisions NNS O
renders VBD O
it PRP O
susceptible JJ O
to TO O
pathways NNS O
of IN O
viral JJ O
replication NN O
and CC O
oncogenic JJ O
conversion NN O
. . O

-DOCSTART- X X O

Using VBG O
a DT O
novel NN O
method NN O
combining VBG O
chromatin NN O
immunoprecipitation NN O
and CC O
genomic JJ O
array NN O
hybridization NN O
, , O
we PRP O
have VBP O
identified VBN O
a DT O
460-kb JJ B-NP
CENP-A-binding JJ I-NP
DNA NNP I-NP
domain NN I-NP
of IN O
a DT O
neocentromere JJ O
derived VBN O
from IN O
the DT O
20p12 CD O
region NN O
of IN O
an DT O
invdup NN O
( -LRB- O
20p JJ O
) -RRB- O
human JJ O
marker NN O
chromosome NN O
. . O

-DOCSTART- X X O

Prophylactic NNP O
lymph NN O
node NN O
dissection NN O
or CC O
radiation NN O
therapy NN O
to TO O
the DT O
nodal NN O
chain NN O
may MD O
decrease VB O
local JJ O
recurrence NN O
but CC O
does VBZ O
not RB O
consistently RB O
affect VB O
overall JJ O
survival NN O
. . O

-DOCSTART- X X O

We PRP O
can MD O
classify VB O
antibiotics NNS O
into IN O
two CD O
groups NNS O
based VBN O
on IN O
initial JJ O
bactericidal JJ O
activity NN O
against IN O
P. NNP O
aeruginosa NN O
; : O
one CD O
class NN O
is VBZ O
antibiotics NNS O
having VBG O
rapid JJ O
initial JJ O
killing NN O
such JJ O
as IN O
AMK, NNP O
IPM NNP O
and CC O
PAPM NNP O
, , O
the DT O
other JJ O
is VBZ O
CAZ NNP O
, , O
MEPM NNP O
showing VBG O
slow JJ O
initial JJ O
killing NN O
. . O

-DOCSTART- X X O

In IN O
Klinefelter NNP O
's POS O
syndrome NN O
( -LRB- O
47XXY JJ O
) -RRB- O
, , O
serum NN O
testosterone NN O
levels NNS O
are VBP O
at IN O
the DT O
lower JJR O
end NN O
of IN O
the DT O
normal JJ O
range NN O
and CC O
dihydrotestosterone NN O
levels NNS O
are VBP O
low JJ O
. . O

-DOCSTART- X X O

The DT O
histamine NN B-NP
H1 IN I-NP
receptor NN I-NP
antagonists NNS O
( -LRB- O
antihistamines NNS O
) -RRB- O
are VBP O
an DT O
important JJ O
class NN O
of IN O
medications NNS O
used VBN O
for IN O
the DT O
relief NN O
of IN O
common JJ O
symptoms NNS O
associated VBN O
with IN O
hyperhistaminic NN O
conditions NNS O
occurring VBG O
in IN O
children NNS O
and CC O
adults NNS O
. . O

-DOCSTART- X X O

Conclusion NNP O
: : O
The DT O
Lp( JJ B-NP
a DT I-NP
) -RRB- I-NP
levels NNS O
in IN O
these DT O
children NNS O
were VBD O
the DT O
lower JJR O
ever RB O
reported VBD O
. . O

-DOCSTART- X X O

AIMS NNP O
: : O
To TO O
establish VB O
a DT O
baseline NN O
and CC O
intraindividual JJ O
fluctuations NNS O
of IN O
the DT O
tumour NN O
markers NNS O
CEA NNP B-NP
, , O
CA NNP B-NP
50 CD I-NP
and CC O
CA NNP B-NP
242 CD I-NP
in IN O
patients NNS O
cured VBD O
from IN O
colorectal NN O
cancer NN O
, , O
and CC O
to TO O
test VB O
the DT O
hypothesis NN O
that IN O
serum NN O
concentrations NNS O
and CC O
intraindividual JJ O
fluctuations NNS O
do VBP O
not RB O
differ VB O
from IN O
the DT O
concentrations NNS O
in IN O
cancer-free JJ O
individuals NNS O
. . O

-DOCSTART- X X O

The DT O
homologous JJ O
active-site JJ O
framework NN O
of IN O
these DT O
enzymes NNS O
with IN O
distinct JJ O
structures NNS O
suggests VBZ O
convergent JJ O
evolution NN O
of IN O
a DT O
common JJ O
catalytic NN O
mechanism NN O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
RhoA NNP B-NP
can MD O
initiate VB O
a DT O
linear JJ O
kinase NN O
cascade NN O
leading VBG O
to TO O
the DT O
activation NN O
of IN O
ERK6 NNP B-NP
( -LRB- O
p38 NN B-NP
gamma NN I-NP
) -RRB- O
, , O
a DT O
recently RB O
identified VBN O
member NN O
of IN O
the DT O
p38 NNS B-NP
family NN I-NP
of IN O
MAPKs NNP O
. . O

-DOCSTART- X X O

We PRP O
show VBP O
that IN O
several JJ O
heme-responsive JJ O
mechanisms NNS O
combine VB O
to TO O
regulate VB O
DAN/TIR NNP B-NP
gene NN O
expression NN O
. . O

-DOCSTART- X X O

In IN O
strains NNS O
lacking VBG O
tup11 NN B-NP
and CC O
tup12 NN B-NP
, , O
the DT O
atf1-pcr1 JJ B-NP
transcriptional JJ O
activator NN O
continues VBZ O
to TO O
play VB O
a DT O
central JJ O
role NN O
in IN O
fbp1-lacZ JJ B-NP
expression NN O
; : O
however RB O
, , O
spc1 VBD B-NP
MAPK NNP I-NP
phosphorylation NN O
of IN O
atf1 NN B-NP
is VBZ O
no RB O
longer RB O
essential JJ O
for IN O
its PRP$ O
activation NN O
. . O

-DOCSTART- X X O

In IN O
vitro NN O
binding NN O
studies NNS O
demonstrate VBP O
that IN O
eIF-5A DT B-NP
is VBZ O
required VBN O
for IN O
efficient JJ O
interaction NN O
of IN O
Rev-NES NNP B-NP
with IN O
CRM1/exportin1 NNP B-NP
and CC O
that DT O
eIF-5A JJ B-NP
interacts NNS O
with IN O
the DT O
nucleoporins NNS O
CAN/nup214 NNP B-NP
, , O
nup153 CD B-NP
, , O
nup98 CD B-NP
, , O
and CC O
nup62 NN B-NP
. . O

-DOCSTART- X X O

Structural JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
class NN B-NP
I PRP I-NP
major VBP I-NP
histocompatibility NN I-NP
complex NN I-NP
( -LRB- O
MHC)-restricted JJ B-NP
peptide-specific JJ O
T NNP B-NP
cell NN I-NP
receptor NN I-NP
(TCR)-alpha/betas NNS I-NP
make VBP O
multiple JJ O
contacts NNS O
with IN O
the DT O
alpha1 NN O
and CC O
alpha2 NN O
helices NNS O
of IN O
the DT O
MHC NNP B-NP
, , O
but CC O
it PRP O
is VBZ O
unclear JJ O
which WDT O
or CC O
how WRB O
many JJ O
of IN O
these DT O
interactions NNS O
contribute VBP O
to TO O
functional JJ O
binding NN O
. . O

-DOCSTART- X X O

Mice NNP O
homozygous NN O
for IN O
the DT O
dlg JJ B-NP
mutation NN O
exhibit NN O
growth NN O
retardation NN O
in IN O
utero NN O
, , O
have VBP O
hypoplasia NN O
of IN O
the DT O
premaxilla NN O
and CC O
mandible JJ O
, , O
have VBP O
a DT O
cleft JJ O
secondary JJ O
palate NN O
, , O
and CC O
die VBP O
perinatally RB O
. . O

-DOCSTART- X X O

A DT O
single JJ O
base NN O
change NN O
( -LRB- O
A8G NN O
) -RRB- O
in IN O
either DT O
sequence NN O
reduces VBZ O
hnRNP RB B-NP
A2 DT I-NP
binding NN O
and CC O
, , O
in IN O
the DT O
case NN O
of IN O
A2RE-2 NNP B-NP
, , O
inhibits VBZ O
RNA NNP O
transport NN O
. . O

-DOCSTART- X X O

TaqMan DT O
analysis NN O
of IN O
gene NN O
expression NN O
following VBG O
chronic JJ O
FA NNP O
treatment NN O
showed VBD O
neither CC O
a DT O
decrease NN O
in IN O
the DT O
amount NN O
of IN O
leptin NN B-NP
receptor NN I-NP
( -LRB- O
Ob-R NN B-NP
) -RRB- O
mRNA NN O
, , O
nor CC O
an DT O
increase NN O
in IN O
the DT O
negative JJ O
regulators NNS O
of IN O
STAT NNP B-NP
signalling NN O
, , O
SOCS3 JJ B-NP
( -LRB- O
suppressors NNS B-NP
of IN I-NP
cytokine JJ I-NP
signalling NN I-NP
) -RRB- O
or CC O
cytokine NN B-NP
inducible JJ I-NP
sequence NN I-NP
( -LRB- O
CIS NNP B-NP
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
mutant JJ O
receptors NNS O
, , O
as RB O
well RB O
as IN O
sBMPR-IA JJ B-NP
, , O
were VBD O
expressed VBN O
as IN O
fusion NN O
proteins NNS O
with IN O
thioredoxin NN B-NP
in IN O
Escherichia NNP O
coli NNS O
, , O
and CC O
purified VBN O
using VBG O
reverse NN O
phase NN O
high JJ O
performance NN O
liquid NN O
chromatography NN O
( -LRB- O
RP-HPLC NNP O
) -RRB- O
after IN O
digestion NN O
with IN O
enterokinase NN B-NP
. . O

-DOCSTART- X X O

The DT O
authors NNS O
undertook VBP O
a DT O
retrospective JJ O
analysis NN O
of IN O
pathology NN O
with IN O
quantification NN O
of IN O
the DT O
percentage NN O
of IN O
papillary NN O
serous JJ O
component NN O
( -LRB- O
% NN O
PSC NNP O
) -RRB- O
and CC O
p53 NN B-NP
expression NN O
. . O

-DOCSTART- X X O

Cloning NNP O
and CC O
characterization NN O
of IN O
the DT O
murine NN B-NP
beta( NN I-NP
3 CD I-NP
) -RRB- I-NP
integrin NN I-NP
gene NN I-NP
promoter NN O
: : O
identification NN O
of IN O
an DT O
interleukin-4 JJ B-NP
responsive JJ I-NP
element NN I-NP
and CC O
regulation NN O
by IN O
STAT-6 NNP B-NP
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Although IN O
the DT O
levels NNS O
of IN O
oxLDL NNP B-NP
antibodies NNS I-NP
might MD O
be VB O
modified VBN O
in IN O
early JJ O
hypertension NN O
, , O
once RB O
advanced VBD O
coronary JJ O
artery NN O
disease NN O
has VBZ O
developed VBN O
the DT O
presence NN O
of IN O
hypertension NN O
does VBZ O
not RB O
affect VB O
anti-oxLDL JJ B-NP
levels NNS O
. . O

-DOCSTART- X X O

GafChromic NNP O
( -LRB- O
MD-55-2 NN O
) -RRB- O
radiochromic JJ O
film NN O
has VBZ O
become VBN O
increasingly RB O
popular JJ O
for IN O
medical JJ O
applications NNS O
and CC O
has VBZ O
proven VBN O
to TO O
be VB O
useful JJ O
for IN O
brachytherapy NN O
dosimetry NN O
. . O

-DOCSTART- X X O

Cis-acting JJ O
CCAAT JJ O
elements NNS O
are VBP O
frequently RB O
found VBN O
in IN O
eukaryotic JJ O
promoter NN O
regions NNS O
. . O

-DOCSTART- X X O

Twenty-five CD O
patients NNS O
also RB O
received VBD O
PET NNP O
examinations NNS O
during IN O
the DT O
staging NN O
procedures NNS O
. . O

-DOCSTART- X X O

The DT O
Gap69C NNP B-NP
is VBZ O
a DT O
single-copy JJ O
gene NN O
producing VBG O
a DT O
major JJ O
2.1-kb JJ O
mRNA NN O
throughout IN O
development NN O
, , O
but CC O
its PRP$ O
amount NN O
is VBZ O
decreased VBN O
in IN O
larvae NNS O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
To TO O
investigate VB O
the DT O
association NN O
between IN O
complete JJ O
congenital NN O
heart NN O
block NN O
(CCHB) NN O
in IN O
the DT O
fetus NN O
and CC O
adult NN O
disease NN O
. . O

-DOCSTART- X X O

Two CD O
families NNS O
with IN O
concordant NN O
inheritance NN O
of IN O
DNAH9 NNP B-NP
alleles NNS I-NP
in IN O
affected JJ O
individuals NNS O
were VBD O
observed VBN O
. . O

-DOCSTART- X X O

Efficacy NN O
of IN O
first-generation NN O
Cavermap NNP O
to TO O
verify VB O
location NN O
and CC O
function NN O
of IN O
cavernous JJ O
nerves NNS O
during IN O
radical JJ O
prostatectomy NN O
: : O
a DT O
multi-institutional JJ O
evaluation NN O
by IN O
experienced JJ O
surgeons NNS O
. . O

-DOCSTART- X X O

The DT O
( -LRB- O
two-motif JJ O
) -RRB- O
domain NN O
fold NN O
contains VBZ O
a DT O
pair NN O
of IN O
calcium NN O
binding NN O
sites NNS O
very RB O
similar JJ O
to TO O
those DT O
found VBN O
in IN O
a DT O
two-domain JJ B-NP
prokaryotic JJ I-NP
betagamma-crystallin NN I-NP
fold NN I-NP
family NN I-NP
member NN I-NP
, , O
Protein NNP B-NP
S. NNP I-NP

-DOCSTART- X X O

Deletional NNP O
analyses NNS O
of IN O
VDR NNP B-NP
indicated VBD O
that IN O
GRIP1 NNP B-NP
and CC O
RAC3 NNP B-NP
required VBD O
an DT O
intact JJ O
VDR NN B-NP
activation NN O
function NN O
( -LRB- O
AF-2 JJ O
) -RRB- O
domain NN O
for IN O
efficient JJ O
interaction NN O
as RB O
well RB O
as IN O
additional JJ O
but CC O
distinct JJ O
regions NNS O
of IN O
the DT O
VDR. NNP B-NP

-DOCSTART- X X O

Only RB O
nine CD O
patients NNS O
were VBD O
offered VBN O
surgery NN O
( -LRB- O
six CD O
were VBD O
resected VBN O
and CC O
three CD O
were VBD O
found VBN O
inoperable JJ O
) -RRB- O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
promoter NN O
region NN O
contains VBZ O
several JJ O
potential JJ O
cis-regulatory JJ O
elements NNS O
such JJ O
as IN O
Sp1 NNP B-NP
, , O
early JJ B-NP
growth NN I-NP
response-1 NN I-NP
, , O
activator NN B-NP
protein-2 NN I-NP
, , O
MyoD NNP B-NP
, , O
p300 VBD B-NP
, , O
nuclear JJ B-NP
factor-kappaB NN I-NP
, , O
myeloid JJ B-NP
zinc NN I-NP
finger NN I-NP
protein-1 NN I-NP
, , O
caudal-related JJ B-NP
homeobox NN I-NP
( -LRB- I-NP
Cdx NN I-NP
) -RRB- I-NP
gene NN I-NP
A DT I-NP
, , O
and CC O
Cdx NNP B-NP
protein-2 NN I-NP
binding NN I-NP
sites NNS I-NP
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
interaction NN O
of IN O
Tat NNPS B-NP
with IN O
the DT O
components NNS O
of IN O
this DT O
rel/AP1 JJ B-NP
cooperative JJ O
complex NN O
seems VBZ O
to TO O
induce VB O
quantitative JJ O
and CC O
qualitative JJ O
alterations NNS O
of IN O
this DT O
complex JJ O
as IN O
activation NN O
progresses NNS O
, , O
resulting VBG O
in IN O
a DT O
decrease NN O
of IN O
IL-2 NNP B-NP
gene NN I-NP
transcription NN O
. . O

-DOCSTART- X X O

2001 CD O
. . O

-DOCSTART- X X O

Adjuvant NNP O
and CC O
neoadjuvant JJ O
treatment NN O
of IN O
breast NN O
cancer NN O
. . O

-DOCSTART- X X O

Unlike IN O
other JJ O
progenitor NN O
cells NNS O
of IN O
the DT O
brain NN O
, , O
SVZa NNP O
progenitor NN O
cells NNS O
have VBP O
the DT O
capacity NN O
to TO O
divide VB O
even RB O
though IN O
they PRP O
express VBP O
a DT O
neuronal JJ O
phenotype NN O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
the DT O
soluble JJ O
forms NNS O
of IN O
ATF6 NNP B-NP
and CC O
the DT O
G13 JJ B-NP
gene NN I-NP
product NN I-NP
are VBP O
unable JJ O
to TO O
bind NN O
to TO O
several JJ O
point NN O
mutants NNS O
of IN O
the DT O
cis-acting JJ O
ER NNP O
stress NN O
response NN O
element NN O
in IN O
vitro NN O
that WDT O
hardly RB O
respond VBP O
to TO O
ER NNP O
stress NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

The DT O
present JJ O
study NN O
was VBD O
initiated VBN O
to TO O
explore VB O
the DT O
potential NN O
of IN O
a DT O
hybrid JJ O
biological JJ O
reactor NN O
, , O
combining VBG O
trickling NN O
filter NN O
( -LRB- O
TF NN O
) -RRB- O
and CC O
activated JJ O
sludge NN O
process NN O
( -LRB- O
ASP) NNP O
, , O
to TO O
treat VB O
wastewater NN O
containing VBG O
trichloroethylene NN O
(TCE NN O
) -RRB- O
at IN O
ambient JJ O
temperature NN O
at IN O
different JJ O
hydraulic JJ O
retention NN O
time NN O
( -LRB- O
HRT NNP O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
DNA NNP O
strand JJ O
exchange NN O
reactions NNS O
using VBG O
oligonucleotides NNS O
, , O
we PRP O
found VBD O
that IN O
Rec2 NNP B-NP
exhibited VBD O
a DT O
pairing NN O
bias NN O
that WDT O
is VBZ O
opposite JJ O
that IN O
of IN O
RecA NNP B-NP
. . O

-DOCSTART- X X O

Anecdotal JJ O
observations NNS O
scattered VBN O
throughout IN O
the DT O
literature NN O
have VBP O
often RB O
provided VBN O
clues NNS O
to TO O
underlying JJ O
variations NNS O
in IN O
humans NNS O
' POS O
ability NN O
to TO O
handle VB O
dietary JJ O
chemicals NNS O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
ace2Delta NN O
cells NNS O
reveals VBZ O
that IN O
Ace2p NN B-NP
is VBZ O
required VBN O
for IN O
cell NN O
separation NN O
but CC O
not RB O
for IN O
polarized JJ O
growth NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
presented VBD O
here RB O
show VB O
that DT O
AR1 NN B-NP
of IN O
the DT O
promoter-proximal JJ O
CAP NNP B-NP
subunit NN I-NP
was VBD O
required VBN O
for IN O
papBA NN B-NP
transcription NN O
even RB O
in IN O
the DT O
absence NN O
of IN O
the DT O
histone-like JJ B-NP
protein NN I-NP
H-NS. . B-NP

-DOCSTART- X X O

A. NN O
, , O
Slatkin NNP O
, , O
D. NNP O

-DOCSTART- X X O

RESULTS NNS O
: : O
A DT O
significant JJ O
correlation NN O
( -LRB- O
p NN O
< JJ O
0.001 CD O
) -RRB- O
was VBD O
observed VBN O
for IN O
mean JJ O
wall NN O
thickness NN O
and CC O
vessel NN O
wall NN O
area NN O
between IN O
MRI NNP O
and CC O
histopathology NN O
( -LRB- O
r NN O
= SYM O
0.87 CD O
and CC O
r NN O
= SYM O
0.85 CD O
, , O
respectively RB O
) -RRB- O
. . O

-DOCSTART- X X O

SIP1 NNS B-NP
( -LRB- O
Smad JJ B-NP
interacting NN I-NP
protein NN I-NP
1 CD I-NP
) -RRB- O
and CC O
deltaEF1 JJ B-NP
( -LRB- O
delta-crystallin NN B-NP
enhancer NN I-NP
binding JJ I-NP
factor NN I-NP
) -RRB- O
are VBP O
structurally RB O
similar JJ O
transcriptional JJ O
repressors NNS O
. . O

-DOCSTART- X X O

Nucleotide NNP O
sequence NN O
, , O
transcription NN O
map NN O
, , O
and CC O
mutation NN O
analysis NN O
of IN O
the DT O
13q14 CD O
chromosomal NN O
region NN O
deleted VBN O
in IN O
B-cell JJ O
chronic NN O
lymphocytic JJ O
leukemia NN O
. . O

-DOCSTART- X X O

Requirements NNS O
for IN O
the DT O
nuclear-cytoplasmic JJ O
translocation NN O
of IN O
infected-cell JJ B-NP
protein NN I-NP
0 CD I-NP
of IN O
herpes PRP$ O
simplex JJ O
virus NN O
1 CD O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
cytomegalovirus NN I-NP
( -LRB- I-NP
HCMV) IN I-NP
major JJ I-NP
immediate-early JJ I-NP
protein NN I-NP
IE2 NN I-NP
is VBZ O
a DT O
nuclear JJ O
phosphoprotein NN O
that WDT O
is VBZ O
believed VBN O
to TO O
be VB O
a DT O
key JJ O
regulator NN O
in IN O
both DT O
lytic JJ O
and CC O
latent JJ O
infections NNS O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
To TO O
determine VB O
whether IN O
RSTD NNP O
predicts VBZ O
coronary JJ O
anatomy NN O
during IN O
acute JJ O
coronary JJ O
occlusion NN O
. . O

-DOCSTART- X X O

Atheroma NNP O
appears VBZ O
as IN O
a DT O
very RB O
low JJ O
signal NN O
intensity NN O
area NN O
on IN O
2-dimensional JJ O
time-of-flight NN O
( -LRB- O
TOF NN O
) -RRB- O
magnetic JJ O
resonance NN O
( -LRB- O
MR NNP O
) -RRB- O
images NNS O
, , O
and CC O
its PRP$ O
components NNS O
have VBP O
various JJ O
signal NN O
intensities NNS O
on IN O
spin-echo NN O
( -LRB- O
SE NNP O
) -RRB- O
images NNS O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
now RB O
tested VBN O
all DT O
known VBN O
mammalian JJ B-NP
Groucho NNP I-NP
family NN I-NP
members NNS I-NP
for IN O
their PRP$ O
ability NN O
to TO O
interact VB O
specifically RB O
with IN O
individual JJ O
Tcf/Lef JJ B-NP
family NN O
members NNS O
. . O

-DOCSTART- X X O

Nephrotoxicity NN O
after IN O
orthotopic JJ O
liver NN O
transplantation NN O
in IN O
cyclosporin NN O
A DT O
and CC O
FK NNP O
506-treated JJ O
patients NNS O
. . O

-DOCSTART- X X O

Compared VBN O
with IN O
normal JJ O
control NN O
subjects NNS O
, , O
all DT O
74 CD O
TOF NN O
patients NNS O
had VBD O
decreased VBN O
systolic JJ O
and CC O
diastolic JJ O
myocardial JJ O
velocities NNS O
and CC O
a DT O
longer RBR O
isovolumic JJ O
relaxation NN O
time NN O
. . O

-DOCSTART- X X O

Mutational JJ O
analysis NN O
showed VBD O
that IN O
the DT O
U-box NNP O
, , O
like IN O
the DT O
RING NNP O
finger NN O
in IN O
other JJ O
proteins NNS O
, , O
forms NNS O
the DT O
physical JJ O
basis NN O
for IN O
the DT O
interaction NN O
with IN O
E2 NNP B-NP
enzymes NNS I-NP
. . O

-DOCSTART- X X O

Fetal NNP O
lung NN O
volume NN O
: : O
estimation NN O
at IN O
MR NNP O
imaging-initial JJ O
results NNS O
. . O

-DOCSTART- X X O

Of IN O
its PRP$ O
gene NN O
products NNS O
, , O
E6 NNP B-NP
binds NNS O
to TO O
and CC O
inactivates NNS O
p53 NN B-NP
tumor NN I-NP
suppressor NN I-NP
protein NN I-NP
by IN O
ubiquitin/proteasome-dependent JJ B-NP
degradation NN O
. . O

-DOCSTART- X X O

In IN O
mouse NN O
, , O
Mmip1 NNP B-NP
( -LRB- O
Mad JJ B-NP
member NN I-NP
interacting JJ I-NP
protein NN I-NP
1 CD I-NP
) -RRB- O
and CC O
Smc3 JJ B-NP
share NN O
99 CD O
% NN O
sequence NN O
identity NN O
and CC O
are VBP O
products NNS O
of IN O
the DT O
same JJ O
gene NN O
. . O

-DOCSTART- X X O

In IN O
SN-48 DT O
neuronal JJ O
cells NNS O
that WDT O
express VBP O
MR NNP B-NP
, , O
GR CD B-NP
, , O
and CC O
5-HT1A JJ B-NP
receptors NNS I-NP
, , O
deletion NN O
or CC O
inactivation NN O
of IN O
the DT O
nGRE NN O
( -LRB- O
negative JJ O
GRE NNP O
) -RRB- O
eliminated VBD O
negative JJ O
regulation NN O
of IN O
the DT O
rat NN B-NP
5-HT1A JJ I-NP
or CC O
heterologous JJ O
promoters NNS O
by IN O
corticosteroids NNS O
, , O
whereas IN O
its PRP$ O
inclusion NN O
conferred VBD O
corticosteroid-induced JJ O
inhibition NN O
to TO O
a DT O
heterologous JJ O
promoter NN O
. . O

-DOCSTART- X X O

Both DT O
pancreatic JJ O
and CC O
intestinal JJ O
cell NN O
lines NNS O
were VBD O
found VBN O
to TO O
express VB O
a DT O
number NN O
of IN O
POU NNP B-NP
( -LRB- O
OCT JJ B-NP
binding NN O
) -RRB- O
homeodomain JJ O
proteins NNS O
examined VBN O
by IN O
electrophoretic JJ O
mobility NN O
shift NN O
assay NN O
. . O

-DOCSTART- X X O

The DT O
v-Src JJ B-NP
SH3 NNP B-NP
domain NN I-NP
facilitates VBZ O
a DT O
cell NN O
adhesion-independent NN O
association NN O
with IN O
focal JJ B-NP
adhesion NN I-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

A DT O
20-base JJ O
pair NN O
oligonucleotide NN O
containing VBG O
this DT O
nonamer NN O
confers VBZ O
up-regulation RP O
by IN O
hypoxia NN O
and CC O
inhibition NN O
by IN O
unsaturated JJ O
fatty JJ O
acids NNS O
when WRB O
placed VBN O
upstream RB O
of IN O
a DT O
heterologous JJ O
promoter NN O
in IN O
a DT O
lacZ JJ B-NP
reporter NN I-NP
construct VB I-NP
. . O

-DOCSTART- X X O

Exchanging VBG O
the DT O
human JJ O
propeptide NN O
in IN O
this DT O
chimera NN O
with IN O
either CC O
the DT O
murine NN B-NP
MIC-1 NN I-NP
or CC O
TGF-beta1 DT B-NP
propeptide NN I-NP
resulted VBD O
in IN O
secretion NN O
of IN O
the DT O
unprocessed JJ O
, , O
monomeric JJ O
chimera NN O
, , O
suggesting VBG O
a DT O
specific JJ O
interaction NN O
between IN O
the DT O
human JJ B-NP
MIC-1 NN I-NP
propeptide NN I-NP
and CC O
mature JJ O
peptide NN O
. . O

-DOCSTART- X X O

Radiolabeled VBN O
biantennary JJ O
N-glycans NNS O
synthesized VBN O
by IN O
Pro(-)5Lec20 NNP O
were VBD O
proportionately RB O
less JJR O
ricin-bound NN O
than IN O
similar JJ O
species NNS O
from IN O
parental JJ O
CHO NNP O
cells NNS O
, , O
and CC O
Lec20 NNP O
cell NN O
extracts NNS O
had VBD O
a DT O
markedly NN O
reduced VBN O
ability NN O
to TO O
transfer VB O
Gal NNP O
to TO O
GlcNAc-terminating NNP O
acceptors NNS O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
that IN O
the DT O
SOCS NNP B-NP
box NN I-NP
interacted VBN O
with IN O
Cullin-2 NNP B-NP
and CC O
promoted VBD O
ubiquitination NN O
of IN O
TEL-JAK2 NNP B-NP
. . O

-DOCSTART- X X O

Neuron-specific JJ B-NP
Bcl-2 JJ I-NP
homology NN I-NP
3 CD I-NP
domain-only JJ I-NP
splice NN I-NP
variant NN I-NP
of IN O
Bak NNP B-NP
is VBZ O
anti-apoptotic JJ O
in IN O
neurons NNS O
, , O
but CC O
pro-apoptotic JJ O
in IN O
non-neuronal JJ O
cells NNS O
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
SB203580 PRP O
inhibited VBD O
LPS-induced JJ O
activation NN O
of IN O
Sp1 NNP B-NP
, , O
as RB O
well RB O
as IN O
the DT O
promoter NN O
activity NN O
in IN O
cells NNS O
transfected VBN O
with IN O
a DT O
plasmid NN O
containing VBG O
the DT O
Sp1 JJ B-NP
consensus NN O
sequence NN O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
mutational JJ O
data NNS O
and CC O
possible JJ O
mRNA NN O
structure NN O
, , O
we PRP O
hypothesized VBD O
about IN O
the DT O
effect NN O
of IN O
mRNA JJ O
structure NN O
on IN O
translation NN O
of IN O
the DT O
two CD O
major JJ O
C/EBPepsilon NN B-NP
isoforms VBZ I-NP
: : O
p32 VB B-NP
and CC O
p30 VB B-NP
. . O

-DOCSTART- X X O

Biol NNP O
. . O

-DOCSTART- X X O

The DT O
size NN O
of IN O
the DT O
infarct NN O
was VBD O
determined VBN O
using VBG O
the DT O
creatine JJ B-NP
kinase NN I-NP
integral NN O
method NN O
. . O

-DOCSTART- X X O

SELECTION NNP O
CRITERIA NNP O
: : O
Randomised JJ O
controlled JJ O
trials NNS O
of IN O
cabergoline NN O
versus NN O
placebo NN O
in IN O
patients NNS O
with IN O
a DT O
clinical JJ O
diagnosis NN O
of IN O
idiopathic JJ O
Parkinson NNP O
's POS O
disease NN O
and CC O
long-term JJ O
complications NNS O
of IN O
levodopa NN O
therapy NN O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
Using VBG O
icodextrin-based JJ O
instead RB O
of IN O
glucose-based JJ O
PD NNP O
fluids NNS O
can MD O
largely RB O
reduce VB O
the DT O
formation NN O
of IN O
Amadori NNP O
albumin NN B-NP
and CC O
AG NNP O
Es NNP O
. . O

-DOCSTART- X X O

In IN O
contrast NN O
, , O
exogenous JJ B-NP
PTHrP1-34 NNP I-NP
and CC I-NP
1-86 CD I-NP
peptides NNS I-NP
did VBD O
not RB O
significantly RB O
affect VB O
IL-8 DT B-NP
production NN O
; : O
moreover RB O
, , O
PTHrP-neutralizing JJ B-NP
antibodies NNS I-NP
did VBD O
not RB O
inhibit VB O
the DT O
production NN O
of IN O
IL-8 DT B-NP
by IN O
transfected VBN O
PTHrP. . B-NP

-DOCSTART- X X O

Unusual JJ O
two-domain JJ B-NP
arginine NN I-NP
kinases NNS I-NP
( -LRB- O
AKs NN B-NP
) -RRB- O
arose VBD O
independently RB O
at IN O
least JJS O
two CD O
times NNS O
during IN O
molecular JJ O
evolution NN O
of IN O
phosphagen NN B-NP
kinases NNS I-NP
: : O
AKs NNS B-NP
from IN O
the DT O
primitive JJ O
sea NN O
anemone NN O
Anthopleurura NNP O
japonicus NNP O
and CC O
from IN O
the DT O
clam NN O
Pseudocardium NN O
sachalinensis NN O
. . O

-DOCSTART- X X O

Baseline NNP O
MBF NNP O
in IN O
females NNS O
was VBD O
significantly RB O
( -LRB- O
P<0.001 NNS O
) -RRB- O
higher JJR O
than IN O
in IN O
males NNS O
. . O

-DOCSTART- X X O

Phase NN O
II NNP O
study NN O
of IN O
paclitaxel NN O
and CC O
oral JJ O
etoposide NN O
in IN O
patients NNS O
with IN O
locally RB O
advanced JJ O
or CC O
metastatic JJ O
non-small JJ O
cell NN O
lung NN O
cancer NN O
. . O

-DOCSTART- X X O

Oral NNP O
supplementation NN O
of IN O
L-arginine NNP O
significantly RB O
increased VBD O
plasma NN O
L-citrulline NN O
, , O
which WDT O
indicated VBD O
enhancement NN O
of IN O
NO DT O
production NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
WASP NNP B-NP
activates NNS O
transcription NN O
following VBG O
TCR NNP B-NP
stimulation NN O
in IN O
a DT O
manner NN O
that WDT O
is VBZ O
independent JJ O
of IN O
its PRP$ O
role NN O
in IN O
Arp2/3-directed JJ B-NP
actin NN B-NP
polymerization NN O
. . O

-DOCSTART- X X O

Two CD O
independent JJ O
transgenic JJ O
lines NNS O
were VBD O
produced VBN O
, , O
and CC O
both DT O
showed VBD O
expression NN O
of IN O
the DT O
Gus NNP B-NP
gene NN I-NP
specifically RB O
in IN O
the DT O
endosperm NN O
during IN O
mid-development NN O
( -LRB- O
first RB O
detected VBN O
10-12 CD O
d NN O
after IN O
anthesis NN O
) -RRB- O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
demonstrate VBP O
that IN O
native JJ B-NP
MRCK NNP I-NP
exists VBZ O
in IN O
high-molecular-weight JJ O
complexes NNS O
. . O

-DOCSTART- X X O

These DT O
data NNS O
define VB O
a DT O
conserved JJ O
pathway NN O
wherein WRB O
sequential JJ O
histone NN B-NP
modifications NNS O
establish VBP O
a DT O
"histone NN O
code NN O
" '' O
essential JJ O
for IN O
the DT O
epigenetic JJ O
inheritance NN O
of IN O
heterochromatin NN O
assembly NN O
. . O

-DOCSTART- X X O

Regression NN O
analyses NNS O
showed VBD O
that IN O
SOREMP NNP O
dream NN O
occurrences NNS O
were VBD O
significantly RB O
related VBN O
to TO O
the DT O
amount NN O
of IN O
REM NNP O
sleep NN O
, , O
while IN O
NREMP NNP O
dream NN O
occurrences NNS O
were VBD O
related VBN O
to TO O
arousals NNS O
from IN O
NREM NNP O
sleep. . O

-DOCSTART- X X O

9.7 CD O
(95 CD O
% NN O
CI NNP O
: : O
9.6-9.7 CD O
) -RRB- O
micromol/L NN O
among IN O
women NNS O
( -LRB- O
P NNP O
= SYM O
0.003 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Three CD O
patients NNS O
received VBD O
additional JJ O
cycles NNS O
of IN O
5-fluorouracil JJ O
+/ NNS O
- : O
leucovorin NN O
as IN O
maintenance NN O
chemotherapy NN O
.RESULTS VBZ O
: : O
Thirty CD O
males NNS O
and CC O
21 CD O
females NNS O
with IN O
a DT O
median JJ O
age NN O
of IN O
55 CD O
years NNS O
( -LRB- O
range NN O
31--73 JJ O
years NNS O
) -RRB- O
were VBD O
treated VBN O
. . O

-DOCSTART- X X O

Secretion NNP O
of IN O
interleukin-8 NNS B-NP
, , O
RANTES NNS B-NP
, , O
macrophage NN B-NP
inflammatory JJ I-NP
protein NN I-NP
1alpha VBD I-NP
, , O
and CC O
10-kappaDa JJ B-NP
IFN-gamma-inducible JJ I-NP
protein NN I-NP
were VBD O
increased VBN O
in IN O
differentiating VBG O
keratinocytes NNS O
by IN O
E6 NNP B-NP
. . O

-DOCSTART- X X O

Herein RB O
PPARgamma NNP B-NP
, , O
liganded VBN O
by IN O
either DT O
natural JJ O
( -LRB- O
15d-PGJ( JJ O
2 CD O
) -RRB- O
and CC O
PGD( JJ O
2 CD O
) -RRB- O
) -RRB- O
or CC O
synthetic JJ O
ligands NNS O
( -LRB- O
BRL49653 NN O
and CC O
troglitazone NN O
) -RRB- O
, , O
selectively RB O
inhibited JJ O
expression NN O
of IN O
the DT O
cyclin NN B-NP
D1 NNP I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Here RB O
we PRP O
demonstrate VBP O
that IN O
the DT O
Ras-activated NNP B-NP
Raf-MEK-extracellular NNP B-NP
signal-regulated JJ B-NP
kinase NN I-NP
( -LRB- O
ERK) NNP B-NP
signaling VBG O
pathway NN O
can MD O
specifically RB O
control VB O
the DT O
expression NN O
of IN O
individual JJ O
integrin NN B-NP
subunits NNS I-NP
in IN O
a DT O
variety NN O
of IN O
human JJ O
and CC O
mouse NN O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

Children NNS O
who WP O
developed VBD O
lower JJR O
respiratory JJ O
tract NN O
infections NNS O
or CC O
PCP NNP O
had VBD O
increased VBN O
rates NNS O
of IN O
decline NN O
of IN O
CD4 NNP B-NP
cell NN O
counts VBZ O
during IN O
the DT O
first JJ O
6 CD O
months NNS O
of IN O
life NN O
. . O

-DOCSTART- X X O

The DT O
reproductive JJ O
effects NNS O
of IN O
the DT O
administration NN O
of IN O
4-chloro-2-methylphenoxyacetic JJ O
acid NN O
(MCPA NN O
) -RRB- O
to TO O
rats NNS O
were VBD O
evaluated VBN O
through IN O
two CD O
generations NNS O
, , O
from IN O
prior RB O
to TO O
mating NN O
, , O
throughout IN O
mating NN O
, , O
to TO O
gestation NN O
and CC O
lactation NN O
. . O

-DOCSTART- X X O

Coexposure NN O
to TO O
FP NNP O
also RB O
resulted VBD O
in IN O
a DT O
more RBR O
pronounced JJ O
and CC O
sustained JJ O
activation NN O
of IN O
the DT O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
kinase/extracellular JJ I-NP
signal-regulated JJ B-NP
protein NN I-NP
kinase NN I-NP
cascade NN O
after IN O
PMA NNP O
treatment NN O
, , O
although IN O
disruption NN O
of IN O
this DT O
pathway NN O
by IN O
the DT O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
kinase NN I-NP
1 CD I-NP
inhibitor NN O
U0126 CC O
did VBD O
not RB O
prevent VB O
potentiation NN O
of IN O
apoptosis NN O
. . O

-DOCSTART- X X O

Also RB O
, , O
the DT O
EWS NNP B-NP
protein NN I-NP
stimulates NNS O
transcription NN O
mediated VBN O
by IN O
the DT O
COOH-terminal JJ O
transactivation NN O
domain NN O
of IN O
the DT O
cofactor NN O
CREB-binding JJ B-NP
protein NN I-NP
( -LRB- O
CBP) NN B-NP
. . O

-DOCSTART- X X O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
have VBP O
determined VBN O
the DT O
ICBP90 NNP B-NP
gene NN I-NP
structure NN O
by IN O
screening NN O
of IN O
a DT O
human JJ O
placenta NN O
genomic JJ O
library NN O
and CC O
PCR NN O
analysis NN O
. . O

-DOCSTART- X X O

Tumor-like JJ O
accumulation NN O
on IN O
Tl-201 JJ O
SPECT NNP O
in IN O
subacute JJ O
hemorrhagic NN O
cerebral NN O
infarction NN O
. . O

-DOCSTART- X X O

Its PRP$ O
transcription NN O
in IN O
vitro NN O
by IN O
pol NN B-NP
III NNP I-NP
requires VBZ O
the DT O
same JJ O
factors NNS O
as IN O
the DT O
U6 NNP B-NP
gene NN I-NP
with IN O
the DT O
major JJ O
exception NN O
that IN O
the DT O
modified VBN O
TATA-box NN O
of IN O
this DT O
construct VB O
only RB O
interacts NNS O
with IN O
a DT O
TATA-binding JJ B-NP
protein NN I-NP
( -LRB- O
TBP NNP B-NP
) -RRB- O
mutant JJ O
( -LRB- O
TBP-DR2 NN B-NP
) -RRB- O
but CC O
not RB O
with IN O
TBP NNP B-NP
wild-type JJ I-NP
( -LRB- O
TBPwt NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

HSF NNP B-NP
binds NNS O
DNA NNP O
as IN O
a DT O
trimer NN O
, , O
and CC O
additional JJ O
trimers NNS O
can MD O
bind NN O
DNA NNP O
co-operatively NN O
. . O

-DOCSTART- X X O

We PRP O
also RB O
demonstrate VBP O
that IN O
the DT O
spo20( JJ B-NP
+ NN I-NP
) -RRB- I-NP
gene NN I-NP
product NN I-NP
is VBZ O
structurally RB O
homologous JJ O
to TO O
Saccharomyces NNP B-NP
cerevisiae NNS I-NP
Sec14 NNP I-NP
, , O
the DT O
major JJ O
phosphatidylinositol NN O
transfer NN O
protein NN O
of IN O
budding VBG O
yeast NN O
. . O

-DOCSTART- X X O

There EX O
was VBD O
no DT O
evidence NN O
of IN O
linkage NN O
disequilibrium NN O
between IN O
the DT O
polymorphic JJ O
site NN O
in IN O
the DT O
B NNP O
cell NN O
specific NN O
promoter NN O
and CC O
those DT O
in IN O
the DT O
3' JJ O
UTR. . O

-DOCSTART- X X O

In IN O
conclusion NN O
, , O
tube NN O
size NN O
estimated VBN O
by IN O
Cole NNP O
's POS O
formula NN O
tends VBZ O
to TO O
be VB O
smaller JJR O
than IN O
practically RB O
appropriate JJ O
tube NN O
size NN O
for IN O
pediatric JJ O
cardiac NN O
anesthesia NN O
, , O
and CC O
therefore RB O
we PRP O
suggest VBP O
new JJ O
formula NN O
to TO O
estimate VB O
the DT O
tube NN O
size NN O
. . O

-DOCSTART- X X O

An DT O
F222W:W21F NNP B-NP
rGST NNP I-NP
A1-1 NNP I-NP
double JJ I-NP
mutant NN I-NP
provides VBZ O
a DT O
direct JJ O
fluorescence NN O
probe NN O
of IN O
changes NNS O
in IN O
the DT O
environment NN O
of IN O
the DT O
C-terminal JJ O
residue NN O
. . O

-DOCSTART- X X O

The DT O
recessive JJ O
hos1 NN B-NP
mutation NN O
causes VBZ O
enhanced JJ O
induction NN O
of IN O
the DT O
CBF NNP B-NP
transcription NN I-NP
factors NNS I-NP
by IN O
low JJ O
temperature NN O
as RB O
well RB O
as IN O
of IN O
their PRP$ O
downstream NN O
cold-responsive JJ O
genes NNS O
. . O

-DOCSTART- X X O

Stable JJ O
transfection NN O
of IN O
human JJ B-NP
CHOP NNP I-NP
cDNA NN I-NP
into IN O
mammary JJ O
carcinoma NN O
cells NNS O
demonstrated VBN O
that IN O
CHOP NNP B-NP
functioned VBD O
not RB O
as IN O
a DT O
mediator NN O
of IN O
hGH-stimulated JJ B-NP
mitogenesis NN O
but CC O
rather RB O
enhanced VBD O
the DT O
protection NN O
from IN O
apoptosis NN O
afforded VBN O
by IN O
hGH NNS B-NP
in IN O
a DT O
p38 JJ B-NP
MAPK-dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

Instead RB O
, , O
affective JJ O
flattening NN O
was VBD O
associated VBN O
with IN O
both DT O
dopamine NN B-NP
receptor NN I-NP
sensitivity NN O
and CC O
psychomotor NN O
slowing NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
reveal VBP O
a DT O
complex JJ O
network NN O
of IN O
interactions NNS O
between IN O
GTPases NNS B-NP
in IN O
the DT O
ARF NN B-NP
family NN I-NP
and CC O
their PRP$ O
effectors NNS O
and CC O
reveal VB O
a DT O
potential NN O
for IN O
cross-talk NN O
not RB O
demonstrated VBD O
previously RB O
. . O

-DOCSTART- X X O

With IN O
NEU NNP B-NP
overexpression NNP O
, , O
nodal JJ O
control NN O
decreased VBD O
from IN O
72 CD O
% NN O
to TO O
34 CD O
% NN O
( -LRB- O
p NN O
= SYM O
.008 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Using VBG O
RACE NNP O
techniques NNS O
we PRP O
have VBP O
cloned VBN O
and CC O
sequenced VBN O
one CD O
of IN O
the DT O
hamster NN O
liver NN O
3-hydroxy-hexobarbital JJ B-NP
dehydrogenases NNS I-NP
which WDT O
catalyze VBP O
not RB O
only RB O
cyclic JJ O
alcohols NNS O
but CC O
also RB O
17beta-hydroxy-steroids NNS O
and CC O
3alpha-hydroxysteroids NNS O
. . O

-DOCSTART- X X O

An DT O
association NN O
was VBD O
demonstrated VBN O
between IN O
the DT O
expression NN O
of IN O
aberrantly RB O
and/or CC O
alternatively RB O
spliced VBD O
mdm2 CD B-NP
mRNAs NNS I-NP
and CC O
a DT O
lack NN O
of IN O
progesterone NN B-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

We PRP O
find VBP O
that IN O
our PRP$ O
response NN O
function NN O
is VBZ O
well RB O
approximated VBN O
by IN O
the DT O
GSER NNP O
only RB O
within IN O
a DT O
particular JJ O
frequency NN O
range NN O
determined VBN O
by IN O
the DT O
material NN O
parameters NNS O
of IN O
both DT O
the DT O
bead NN O
and CC O
the DT O
network NN O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
mCTR NN B-NP
mRNAs NNS I-NP
has VBZ O
revealed VBN O
that IN O
the DT O
three CD O
alternative JJ O
promoters NNS O
give VBP O
rise NN O
to TO O
at IN O
least JJS O
seven CD O
mCTR JJ B-NP
isoforms NNS I-NP
in IN O
the DT O
5' JJ O
region NN O
of IN O
the DT O
gene NN O
and CC O
generate VB O
5'-untranslated JJ O
regions NNS O
of IN O
very RB O
different JJ O
lengths NNS O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
3' JJ O
terminus NN O
modifications NNS O
on IN O
mRNA NNS O
functional JJ O
decay NN O
during IN O
in IN O
vitro NN O
protein NN O
synthesis NN O
. . O

-DOCSTART- X X O

A DT O
comprehensive JJ O
neuropsychological JJ O
battery NN O
was VBD O
administered VBN O
to TO O
48 CD O
veterans NNS O
with IN O
Gulf NNP O
War NNP O
Illness NNP O
( -LRB- O
GWI NN O
) -RRB- O
characterized VBN O
by IN O
severe JJ O
fatigue NN O
( -LRB- O
GV-F) NNP O
and CC O
39 CD O
healthy JJ O
veterans NNS O
( -LRB- O
GV-H) NN O
. . O

-DOCSTART- X X O

Reverse NN O
transcription-PCR JJ O
analysis NN O
of IN O
mRNA NNS O
from IN O
patients NNS O
shows NNS O
that IN O
each DT O
of IN O
these DT O
five CD O
mutations NNS O
results NNS O
in IN O
aberrant JJ O
splicing NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Coronary JJ O
mortality NN O
during IN O
the DT O
median JJ O
follow-up JJ O
time NN O
of IN O
17 CD O
months NNS O
was VBD O
6-fold JJ O
higher JJR O
in IN O
the DT O
highest JJS O
tertile NN O
for IN O
CRP NNP B-NP
and CC O
IL-6 NNP B-NP
and CC O
3.5-fold DT O
higher JJR O
in IN O
the DT O
highest JJS O
tertile NN O
for IN O
fibrinogen NN B-NP
and CC O
TNF-alpha NNP B-NP
than IN O
in IN O
the DT O
respective JJ O
combined VBN O
lower JJR O
tertiles NNS O
. . O

-DOCSTART- X X O

The DT O
relationship NN O
of IN O
the DT O
factor NN B-NP
V NNP I-NP
Leiden NNP I-NP
mutation NN I-NP
or CC O
the DT O
deletion-deletion NN O
polymorphism NN O
of IN O
the DT O
angiotensin NN B-NP
converting VBG I-NP
enzyme JJ I-NP
to TO O
postoperative VB O
thromboembolic IN O
events NNS O
following VBG O
total JJ O
joint JJ O
arthroplasty NN O
. . O

-DOCSTART- X X O

Sural JJ O
nerve NN O
biopsy NN O
showed VBD O
mild JJ O
thickening NN O
of IN O
the DT O
perineurium NN O
, , O
vascular JJ O
alterations NNS O
with IN O
inflammatory JJ O
cell NN O
infiltration NN O
in IN O
the DT O
perineurium NN O
, , O
and CC O
remarkable JJ O
loss NN O
of IN O
large JJ O
and CC O
small JJ O
myelinated JJ O
fibers NNS O
. . O

-DOCSTART- X X O

To TO O
examine VB O
transcriptional JJ O
regulation NN O
of IN O
the DT O
rat NN B-NP
eIF4E JJ I-NP
gene NN I-NP
, , O
2.1 CD O
kB NN O
of IN O
the DT O
rat NN B-NP
eIF4E NN I-NP
promoter NN I-NP
region NN I-NP
was VBD O
cloned VBN O
and CC O
the DT O
contribution NN O
of IN O
specific JJ O
elements NNS O
in IN O
regulating NN O
transcription NN O
was VBD O
determined VBN O
in IN O
primary JJ O
cultures NNS O
of IN O
rat NN O
cardiocytes NNS O
and CC O
in IN O
a DT O
murine NN O
C( IN O
2)C( JJ O
12 CD O
) -RRB- O
myoblast JJ O
cell NN O
line NN O
. . O

-DOCSTART- X X O

When WRB O
this DT O
CCAAT NN O
box NN O
was VBD O
inserted VBN O
into IN O
a DT O
heterologous JJ O
promoter NN O
construct VB O
, , O
OA NNP O
induction NN O
was VBD O
dependent JJ O
on IN O
an DT O
intact JJ O
CCAAT NN O
box NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
remaining VBG O
case NN O
, , O
the DT O
aneurysm NN O
originated VBD O
from IN O
the DT O
proximal JJ O
end NN O
of IN O
the DT O
associated VBN O
A1 NNP O
fenestration NN O
. . O

-DOCSTART- X X O

Raes NNP O
, , O
P. NNP O

-DOCSTART- X X O

We PRP O
used VBD O
a DT O
rev- NNS B-NP
and CC O
RRE-defective JJ B-NP
HIV NNP O
type NN O
1 CD O
( -LRB- O
HIV-1 NN O
) -RRB- O
molecular JJ O
clone NN O
in IN O
complementation NN O
experiments NNS O
to TO O
establish VB O
a DT O
method NN O
for IN O
the DT O
rapid JJ O
isolation NN O
of IN O
posttranscriptional JJ O
regulatory JJ O
elements NNS O
from IN O
the DT O
mammalian JJ O
genome NN O
by IN O
selecting VBG O
for IN O
rescue NN O
of IN O
virus NN O
replication NN O
. . O

-DOCSTART- X X O

A DT O
novel NN O
myeloid-restricted VBD O
zebrafish NN O
CCAAT/enhancer-binding JJ B-NP
protein NN I-NP
with IN O
a DT O
potent JJ O
transcriptional JJ O
activation NN O
domain NN O
. . O

-DOCSTART- X X O

Recently RB O
, , O
we PRP O
discovered VBD O
that IN O
alanine DT O
substitutions NNS O
of IN O
the DT O
active JJ O
center NN O
cleft VBD O
residues NNS O
significantly RB O
impair VB O
the DT O
depurinating NN O
and CC O
ribosome JJ O
inhibitory JJ O
activity NN O
of IN O
PAP. NNP B-NP

-DOCSTART- X X O

SH2D1A JJ B-NP
protein NN I-NP
levels NNS O
are VBP O
up-regulated JJ O
by IN O
CD40 DT B-NP
cross-linking JJ O
and CC O
down-regulated JJ O
by IN O
B NNP B-NP
cell NN I-NP
receptor NN I-NP
ligation NN O
. . O

-DOCSTART- X X O

A DT O
novel JJ O
potential JJ O
effector NN O
of IN O
M-Ras NNP B-NP
and CC O
p21 VBD B-NP
Ras NNP I-NP
negatively RB O
regulates VBZ O
p21 DT B-NP
Ras-mediated NNP I-NP
gene NN O
induction NN O
and CC O
cell NN O
growth NN O
. . O

-DOCSTART- X X O

The DT O
mice NNS O
are VBP O
phenotypically RB O
normal JJ O
and CC O
do VBP O
not RB O
develop VB O
spontaneous JJ O
tumors NNS O
at IN O
an DT O
early JJ O
age NN O
, , O
in IN O
contrast NN O
to TO O
knock-out NN O
( -LRB- O
p53(-/-) NN B-NP
) -RRB- O
strains NNS O
with IN O
a DT O
defective JJ O
p53 NN B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
C-terminal JJ O
region NN O
of IN O
Crk NNP B-NP
contains VBZ O
negative JJ O
regulatory JJ O
elements NNS O
important JJ O
for IN O
both DT O
Abl NNP B-NP
and CC O
FAK NNP B-NP
dependent JJ O
signal NN O
pathways NNS O
, , O
and CC O
offers VBZ O
a DT O
paradigm NN O
for IN O
an DT O
autoinhibitory JJ O
region NN O
in IN O
the DT O
SH3 NNP B-NP
linker/C-terminal JJ O
SH3 NNP B-NP
domain NN O
. . O

-DOCSTART- X X O

Further RB O
, , O
the DT O
osteo-retentive JJ O
ability NN O
of IN O
the DT O
hydroxyapatite NN O
in IN O
the DT O
sockets NNS O
was VBD O
seen VBN O
to TO O
be VB O
close JJ O
to TO O
significance NN O
( -LRB- O
after IN O
six CD O
months NNS O
width JJ O
differences NNS O
, , O
in IN O
the DT O
canine CD O
region NN O
: : O
P NNP O
= SYM O
0.059 CD O
, , O
LHS NNP O
, , O
and CC O
P NNP O
= SYM O
0.065 CD O
, , O
RHS) NNP O
. . O

-DOCSTART- X X O

Nearly RB O
all DT O
isolates NNS O
of IN O
S. NNP O
intermedius NN O
and CC O
most JJS O
isolates NNS O
of IN O
S. NNP O
constellatus NN O
, , O
but CC O
only RB O
19 CD O
% NN O
of IN O
those DT O
of IN O
S. NNP O
anginosus NN O
, , O
were VBD O
associated VBN O
with IN O
abscess NN O
. . O

-DOCSTART- X X O

DESIGN NNP O
: : O
Retrospective JJ O
study NN O
. . O

-DOCSTART- X X O

Human JJ O
brain NN O
cDNA NN O
library NN O
screening NN O
and CC O
5' JJ O
rapid JJ O
amplification NN O
of IN O
cDNA NN O
ends VBZ O
yielded VBN O
full-length JJ B-NP
DENTT NNP I-NP
cDNA NN I-NP
containing VBG O
an DT O
1899-bp JJ O
open JJ O
reading NN O
frame NN O
encoding VBG O
a DT O
predicted VBN O
633-amino-acid JJ O
protein NN O
with IN O
four CD O
potential JJ O
nuclear JJ O
localization NN O
signals NNS O
( -LRB- O
NLSs NN O
) -RRB- O
and CC O
two CD O
coiled-coil NN O
regions NNS O
. . O

-DOCSTART- X X O

Rapamycin NNP O
( -LRB- O
FRAP/mTOR NN B-NP
inhibitor NN O
) -RRB- O
blocked VBD O
4E-BP1 JJ B-NP
phosphorylation NN O
causing VBG O
a DT O
predominance NN O
of IN O
the DT O
alpha NN O
( -LRB- O
hypophosphorylated VBN O
) -RRB- O
band NN O
. . O

-DOCSTART- X X O

Far NNP O
Western JJ O
blot NN O
analysis NN O
suggested VBN O
that IN O
the DT O
tandem NN O
SH2 IN B-NP
domains NNS I-NP
of IN O
SHP2 NNP B-NP
bind NN O
to TO O
Gab1 NNP B-NP
in IN O
a DT O
specific JJ O
orientation NN O
, , O
in IN O
which WDT O
the DT O
N-SH2 JJ B-NP
domain NN I-NP
binds NNS O
to TO O
phosphotyrosine FW O
( -LRB- O
Tyr( NN O
P))-627 NN O
and CC O
the DT O
C-SH2 JJ B-NP
domain NN I-NP
binds NNS O
to TO O
Tyr( NNP O
P)-659 NNP O
. . O

-DOCSTART- X X O

Molecular JJ O
cloning NN O
, , O
genomic JJ O
mapping NN O
, , O
and CC O
expression NN O
of IN O
two CD O
secretor NN B-NP
blood NN I-NP
group NN I-NP
alpha NN I-NP
( -LRB- I-NP
1,2)fucosyltransferase CD I-NP
genes NNS I-NP
differentially RB O
regulated VBN O
in IN O
mouse NN O
uterine NN O
epithelium NN O
and CC O
gastrointestinal JJ O
tract NN O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
found VBN O
that IN O
intrathecal JJ O
administration NN O
( -LRB- O
i.t JJ O
. . O
) -RRB- O
of IN O
D2 NN B-NP
receptor NN I-NP
agonist JJ O
LY171555 CD O
or CC O
D1/D2 CD B-NP
receptor NN I-NP
agonist JJ O
apomorphine NN O
increased VBN O
pain NN O
threshold NN O
and CC O
had VBD O
a DT O
potentiating JJ O
effect NN O
on IN O
AA NNP O
. . O

-DOCSTART- X X O

After IN O
all DT O
doses NNS O
of IN O
d-amphetamine NN O
, , O
responding VBG O
occurred VBN O
largely RB O
on IN O
the DT O
saline NN O
key NN O
under IN O
both DT O
schedules NNS O
. . O

-DOCSTART- X X O

Intravenous JJ O
L-carnitine JJ O
treatment NN O
increased VBN O
plasma NN O
carnitine NN O
concentrations NNS O
, , O
improved VBN O
patient-assessed JJ O
fatigue NN O
, , O
and CC O
may MD O
prevent VB O
the DT O
decline NN O
in IN O
peak NN O
exercise NN O
capacity NN O
in IN O
hemodialysis NN O
patients NNS O
. . O

-DOCSTART- X X O

Elevated JJ O
expression NN O
of IN O
full-length JJ B-NP
UhpB NNP I-NP
or CC O
of IN O
a DT O
soluble JJ O
hybrid JJ O
protein NN O
, , O
GST-Bc NNP B-NP
, , O
which WDT O
is VBZ O
glutathione NN B-NP
S-transferase JJ I-NP
( -LRB- O
GST NN B-NP
) -RRB- O
fused VBN O
to TO O
the DT O
cytoplasmic JJ O
C-terminal JJ O
portion NN O
of IN O
UhpB NNP B-NP
, , O
results NNS O
in IN O
complete JJ O
blockage NN O
of IN O
uhpT JJ B-NP
expression NN O
in IN O
a DT O
uhp( JJ B-NP
+ NN I-NP
) -RRB- I-NP
strain NN O
. . O

-DOCSTART- X X O

Examination NN O
of IN O
various JJ O
promoter NN O
deletion NN O
mutants NNS O
indicated VBD O
that IN O
SF-1 JJ B-NP
acts NNS O
through IN O
the DT O
proximal JJ O
promoter NN O
region NN O
and CC O
upstream RB O
promoter NN O
sequences NNS O
. . O

-DOCSTART- X X O

Consistent JJ O
effects NNS O
on IN O
pVHL JJ B-NP
function NN O
were VBD O
observed VBN O
for IN O
all DT O
mutations NNS O
within IN O
each DT O
subclass NN O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
this DT O
analysis NN O
, , O
we PRP O
propose VBP O
that IN O
the DT O
interactions NNS O
of IN O
Sos NNP B-NP
with IN O
the DT O
switch NN O
1 CD O
and CC O
switch NN O
2 CD O
regions NNS O
of IN O
Ras NNP B-NP
have VBP O
distinct JJ O
functional JJ O
consequences NNS O
: : O
the DT O
interaction NN O
with IN O
switch NN O
2 CD O
mediates VBZ O
the DT O
anchoring NN O
of IN O
Ras NNP B-NP
to TO O
Sos NNP B-NP
, , O
whereas IN O
the DT O
interaction NN O
with IN O
switch NN O
1 CD O
leads VBZ O
to TO O
disruption NN O
of IN O
the DT O
nucleotide-binding JJ O
site NN O
and CC O
GDP NNP O
dissociation NN O
. . O

-DOCSTART- X X O

Bandshift JJ O
experiments NNS O
demonstrate VBP O
that IN O
BmHR3A NNP B-NP
binds NNS O
specifically RB O
to TO O
RORE NNP B-NP
( -LRB- O
Retinoic NNP B-NP
acid-related CC I-NP
Orphan NNP I-NP
receptor NN I-NP
Response NN I-NP
Element)-like JJ I-NP
sequences NNS O
in IN O
the DT O
promoters NNS O
of IN O
both DT O
genes NNS O
, , O
thus RB O
suggesting VBG O
a DT O
direct JJ O
role NN O
for IN O
BmHR3A NNP B-NP
in IN O
regulating VBG O
the DT O
expression NN O
of IN O
BmGATAbeta NNP B-NP
and CC O
ESP NNP B-NP
genes NNS I-NP
during IN O
vitellogenesis NN O
. . O

-DOCSTART- X X O

Here RB O
, , O
we PRP O
identify VBP O
Rsc3 JJ B-NP
and CC O
Rsc30 JJ B-NP
as IN O
novel JJ O
components NNS O
of IN O
the DT O
essential JJ O
yeast NN B-NP
remodeler NN I-NP
RSC NNP I-NP
complex NN I-NP
. . O

-DOCSTART- X X O

Three CD O
of IN O
the DT O
proteins NNS O
involved VBN O
in IN O
checkpoint NN O
signaling NN O
, , O
Rad1 NNP B-NP
, , O
Hus1 NNP B-NP
, , O
and CC O
Rad9 NNP B-NP
, , O
have VBP O
been VBN O
shown VBN O
to TO O
interact VB O
by IN O
immunoprecipitation NN O
and CC O
yeast NN O
two-hybrid JJ O
studies NNS O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
the DT O
hypothesis NN O
that IN O
evolutionarily RB O
conserved VBN O
regions NNS O
are VBP O
functionally RB O
important JJ O
and CC O
likely JJ O
to TO O
interact VB O
with IN O
coactivators NNS O
, , O
we PRP O
compared VBD O
the DT O
amino JJ O
acid NN O
sequence NN O
of IN O
C/EBPalpha NNP B-NP
from IN O
different JJ O
species NNS O
( -LRB- O
frog NN O
to TO O
human JJ O
) -RRB- O
and CC O
identified VBD O
four CD O
highly RB O
conserved VBN O
regions NNS O
( -LRB- O
CR1-CR4 NN O
) -RRB- O
within IN O
the DT O
transactivation NN O
domain NN O
. . O

-DOCSTART- X X O

Of IN O
the DT O
patients NNS O
in IN O
each DT O
regimen NN O
who WP O
reached VBD O
study NN O
end NN O
points NNS O
, , O
17 CD O
of IN O
29 CD O
( -LRB- O
59 CD O
% NN O
) -RRB- O
were VBD O
in IN O
regimen NNS O
A DT O
, , O
11 CD O
of IN O
20 CD O
( -LRB- O
55 CD O
% NN O
) -RRB- O
were VBD O
in IN O
regimen NNS O
B NNP O
, , O
and CC O
28 CD O
of IN O
43 CD O
( -LRB- O
65 CD O
% NN O
) -RRB- O
were VBD O
in IN O
regimen NNS O
C NNP O
met VBD O
the DT O
treatment NN O
success NN O
criterion NN O
. . O

-DOCSTART- X X O

Early RB O
indicators NNS O
of IN O
the DT O
effect NN O
of IN O
a DT O
breast NN O
cancer NN O
screening VBG O
program NN O
for IN O
low-income JJ O
women NNS O
. . O

-DOCSTART- X X O

Percentages NNS O
of IN O
recovery NN O
for IN O
overload JJ O
and CC O
dilution NN O
tests NNS O
were VBD O
between IN O
87 CD O
and CC O
120 CD O
% NN O
. . O

-DOCSTART- X X O

One CD O
of IN O
the DT O
conserved JJ O
RNA NNP O
subdomains NNS O
, , O
designated VBN O
P3 NNP B-NP
, , O
has VBZ O
previously RB O
been VBN O
shown VBN O
to TO O
be VB O
required VBN O
for IN O
nucleolar JJ O
localization NN O
. . O

-DOCSTART- X X O

Measurements NNS O
were VBD O
obtained VBN O
: : O
( -LRB- O
i NN O
) -RRB- O
just RB O
after IN O
the DT O
traumatic JJ O
exposure NN O
( -LRB- O
D0 NN O
) -RRB- O
; : O
( -LRB- O
ii NNS O
) -RRB- O
3 CD O
days NNS O
after IN O
this DT O
first JJ O
measurement NN O
( -LRB- O
D3 NN O
) -RRB- O
; : O
and CC O
( -LRB- O
iii NN O
) -RRB- O
30 CD O
days NNS O
after IN O
( -LRB- O
D30 NN O
) -RRB- O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
present VBP O
evidence NN O
that IN O
the DT O
distal JJ O
half NN O
( -LRB- O
Stem NN O
2 CD O
) -RRB- O
of IN O
the DT O
conserved VBN O
base-paired JJ O
stem NN O
structure NN O
found VBD O
in IN O
all DT O
hY JJ B-NP
RNAs NNP I-NP
also RB O
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
the DT O
export NN O
process NN O
. . O

-DOCSTART- X X O

PACAP NNP B-NP
mRNA NN I-NP
was VBD O
widely RB O
expressed VBN O
in IN O
most RBS O
human JJ O
tissues NNS O
; : O
in IN O
transfected JJ O
cells NNS O
, , O
PACAP NNP B-NP
was VBD O
diffusely JJ O
expressed VBN O
in IN O
the DT O
cytoplasm NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
provide VBP O
the DT O
first JJ O
evidence NN O
for IN O
the DT O
involvement NN O
of IN O
GCN1-GCN2 JJ B-NP
interaction NN O
in IN O
activation NN O
of IN O
GCN2 NNP B-NP
per IN O
se NN O
. . O

-DOCSTART- X X O

The DT O
radial JJ O
forearm NN O
flap NN O
is VBZ O
used VBN O
most RBS O
commonly RB O
, , O
however RB O
the DT O
lateral JJ O
arm NN O
flap NN O
may MD O
be VB O
the DT O
flap NN O
of IN O
choice NN O
in IN O
certain JJ O
situations NNS O
. . O

-DOCSTART- X X O

By IN O
comparison NN O
, , O
in IN O
nontumorigenic JJ O
Ad5 IN O
cells NNS O
, , O
class NN O
I PRP O
expression NN O
is VBZ O
high JJ O
due JJ O
to TO O
negligible JJ O
binding NN O
of IN O
COUP-TF NNP B-NP
and CC O
strong JJ O
binding NN O
of IN O
NF-kappaB. NNP B-NP

-DOCSTART- X X O

As IN O
an DT O
application NN O
of IN O
reverse NN O
genetics NNS O
, , O
we PRP O
introduced VBD O
one CD O
nucleotide JJ O
change NN O
(UCU NN O
to TO O
ACU) NNP O
to TO O
immediate JJ O
downstream NN O
of IN O
the DT O
RNA-editing JJ O
site NN O
of IN O
the DT O
V NNP B-NP
gene NN I-NP
in IN O
the DT O
full-length JJ O
hPIV2 NN O
cDNA NN O
and CC O
were VBD O
able JJ O
to TO O
obtain VB O
infectious JJ O
viruses NNS O
[rPIV2V(-) JJ O
] SYM O
from IN O
the DT O
cDNA NN O
. . O

-DOCSTART- X X O

In IN O
regards NNS O
to TO O
the DT O
latter JJ O
activity NN O
, , O
it PRP O
has VBZ O
been VBN O
shown VBN O
that IN O
S3 DT B-NP
contains VBZ O
vigorous JJ O
N-glycosylase JJ B-NP
activity NN O
for IN O
the DT O
removal NN O
of IN O
8-oxoguanine CD O
residues NNS O
in IN O
DNA NN O
that WDT O
leaves VBZ O
baseless JJ O
sites NNS O
in IN O
their PRP$ O
places NNS O
. . O

-DOCSTART- X X O

The DT O
improved JJ O
CSF NNP O
outflow NN O
conductance NN O
may MD O
increase VB O
the DT O
intracranial JJ O
compliance NN O
and CC O
thereby RB O
dampen VB O
a DT O
pathological JJ O
ICP NNP O
waveform NN O
. . O

-DOCSTART- X X O

The DT O
cyclins NNS B-NP
bind VBP O
to TO O
and CC O
activate VB O
the DT O
CDK NNP B-NP
, , O
which WDT O
leads VBZ O
to TO O
phosphorylation NN O
( -LRB- O
and CC O
then RB O
inhibition IN O
) -RRB- O
of IN O
the DT O
tumor NN O
suppressor NN O
protein NN O
, , O
pRb NN B-NP
. . O
pRb '' B-NP
controls VBZ O
commitment NN O
to TO O
progress VB O
from IN O
the DT O
G1 NNP O
to TO O
S NNP O
phase NN O
, , O
at IN O
least JJS O
in IN O
part NN O
by IN O
repressing VBG O
the DT O
activity NN O
of IN O
the DT O
E2F NNP B-NP
transcription NN I-NP
factors NNS I-NP
known VBN O
to TO O
promote VB O
cell NN O
proliferation NN O
. . O

-DOCSTART- X X O

Additional JJ O
education NN O
and CC O
research NN O
is VBZ O
needed VBN O
to TO O
provide VB O
further JJ O
direction NN O
for IN O
intervention NN O
and CC O
incorporation NN O
into IN O
practice NN O
. . O

-DOCSTART- X X O

The DT O
difference NN O
of IN O
hardness NN O
over IN O
time NN O
of IN O
composite JJ O
specimens NNS O
was VBD O
measured VBN O
using VBG O
Knoop NNP O
hardness NN O
measurements NNS O
taken VBN O
at IN O
the DT O
top JJ O
and CC O
bottom JJ O
surfaces NNS O
of IN O
resin NN O
specimens NNS O
made VBN O
in IN O
a DT O
Teflon NNP O
mold NN O
the DT O
same JJ O
dimensions NNS O
as IN O
the DT O
cavity NN O
prepared VBD O
in IN O
dentin NN O
. . O

-DOCSTART- X X O

An DT O
18-kb JJ O
genomic JJ O
clone NN O
including VBG O
sequences NNS O
encoding VBG O
for IN O
the DT O
two CD O
GHS-R JJ B-NP
variants NNS I-NP
was VBD O
isolated VBN O
. . O

-DOCSTART- X X O

In IN O
Ka13 NNP O
cells NNS O
, , O
CoCl( JJ O
2 CD O
) -RRB- O
stimulated VBN O
expression NN O
of IN O
a DT O
luciferase NN B-NP
reporter NN I-NP
gene NN I-NP
under IN O
the DT O
control NN O
of IN O
a DT O
15-kilobase JJ B-NP
pair NN I-NP
mouse NN I-NP
ho-1 NN I-NP
promoter NN I-NP
( -LRB- O
pHO15luc JJ B-NP
) -RRB- O
. . O

-DOCSTART- X X O

Members NNS O
of IN O
the DT O
AP-1 JJ B-NP
superfamily NN I-NP
of IN I-NP
basic-leucine JJ I-NP
zipper NN I-NP
factors NNS I-NP
bind VBP O
to TO O
the DT O
StRE. NNP O

-DOCSTART- X X O

Like IN O
the DT O
consensus NN B-NP
mammalian NN I-NP
LHbeta NNP I-NP
gene NN I-NP
, , O
the DT O
5'-flanking JJ O
region NN O
of IN O
the DT O
gpLH/CGbeta NNP B-NP
gene NN O
contains VBZ O
a DT O
single JJ O
TATA NNP O
sequence NN O
37 CD O
bp NN O
upstream RB O
of IN O
the DT O
translation NN O
start NN O
codon NN O
. . O

-DOCSTART- X X O

This DT O
shows VBZ O
that IN O
in IN O
situations NNS O
of IN O
separated JJ O
breaks NNS O
, , O
NHEJ NNP O
deficiency NN O
leads VBZ O
to TO O
genomic JJ O
rearrangements NNS O
, , O
in IN O
agreement NN O
with IN O
chromosomal NN O
studies NNS O
. . O

-DOCSTART- X X O

Foxp1 NNP B-NP
and CC O
Foxp2 NNP B-NP
are VBP O
expressed VBN O
at IN O
high JJ O
levels NNS O
in IN O
the DT O
lung NN O
as RB O
early RB O
as IN O
E12.5 DT O
of IN O
mouse NN O
development NN O
with IN O
Foxp2 NNP B-NP
expression NN O
restricted VBN O
to TO O
the DT O
airway NN O
epithelium NN O
. . O

-DOCSTART- X X O

Molecular JJ O
analysis NN O
of IN O
the DT O
pRA2 NN O
partitioning NN O
region NN O
: : O
ParB NNP B-NP
autoregulates NNS O
parAB NN B-NP
transcription NN O
and CC O
forms NNS O
a DT O
nucleoprotein NN O
complex NN O
with IN O
the DT O
plasmid NN O
partition NN O
site NN O
, , O
parS. . B-NP

-DOCSTART- X X O

Several JJ O
dozen NN O
HIF-1 NN B-NP
targets NNS I-NP
are VBP O
known VBN O
, , O
including VBG O
the DT O
gene NN O
encoding VBG O
vascular JJ B-NP
endothelial JJ I-NP
growth NN I-NP
factor NN I-NP
(VEGF NN O
) -RRB- O
. . O

-DOCSTART- X X O

We PRP O
previously RB O
reported VBD O
that IN O
Tax NNP B-NP
induced VBD O
cell NN O
cycle NN O
progression NN O
from IN O
G0/G1 DT O
phase NN O
to TO O
S NNP O
and CC O
G2/M NNP O
phases NNS O
in IN O
human JJ O
T-cell NN O
line NN O
Kit NN O
225 CD O
cells NNS O
. . O

-DOCSTART- X X O

Here RB O
, , O
the DT O
PEX5-TPR JJ B-NP
domains NNS O
from IN O
human NN O
, , O
tobacco NN O
, , O
and CC O
nematode NN O
were VBD O
inserted VBN O
into IN O
a DT O
TPR-less JJ O
yeast NN O
Pex5p NNP B-NP
construct VB O
to TO O
generate VB O
Pex5p JJ B-NP
chimaeras NNS O
. . O

-DOCSTART- X X O

HIV-1 JJ O
and CC O
hepatitis NN O
B NNP O
virus NN O
infections NNS O
in IN O
adolescents NNS O
lodged VBN O
in IN O
security NN O
institutes NNS O
of IN O
Buenos NNP O
Aires NNP O
. . O

-DOCSTART- X X O

Immunofixation NNP O
experiments NNS O
of IN O
C4A NNP B-NP
and CC O
C4B NNP B-NP
demonstrate VBP O
> RB O
41 CD O
allotypes NNS O
in IN O
the DT O
two CD O
classes NNS O
of IN O
proteins NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
course NN O
of IN O
screening NN O
for IN O
transcription NN O
factors NNS O
which WDT O
interact NN O
with IN O
the DT O
human JJ B-NP
myeloperoxidase NN I-NP
( -LRB- O
MPO NNP B-NP
) -RRB- O
promoter NN O
we PRP O
, , O
for IN O
the DT O
first JJ O
time NN O
, , O
identified VBN O
and CC O
cloned VBD O
the DT O
cDNA NN O
and CC O
genomic JJ O
DNA NN O
for IN O
human JJ B-NP
HBP1 NNP I-NP
( -LRB- O
HMG-Box NN B-NP
containing VBG I-NP
protein NN I-NP
1 CD I-NP
) -RRB- O
, , O
a DT O
member NN O
of IN O
the DT O
high JJ B-NP
mobility NN I-NP
group NN I-NP
of IN I-NP
non-histone JJ I-NP
chromosomal JJ I-NP
proteins NNS I-NP
. . O

-DOCSTART- X X O

In IN O
contrast NN O
the DT O
human JJ O
and CC O
mouse NN B-NP
BCNT JJ I-NP
proteins NNS I-NP
contain VBP O
one CD O
repeat NN O
unit NN O
and CC O
lack NN O
the DT O
RTE-1-derived JJ B-NP
portion NN O
. . O

-DOCSTART- X X O

Molecular JJ O
identification NN O
of IN O
smg-4 NN B-NP
, , O
required VBN O
for IN O
mRNA NN O
surveillance NN O
in IN O
C. NNP O
elegans NNS O
. . O

-DOCSTART- X X O

The DT O
first JJ O
hypothesis NN O
was VBD O
supported VBN O
in IN O
the DT O
sense NN O
that IN O
stimulus NN O
differences NNS O
might MD O
affect VB O
behaviour RB O
even RB O
without IN O
their PRP$ O
successful JJ O
attentive NN O
processing NN O
in IN O
normal JJ O
participants NNS O
. . O

-DOCSTART- X X O

CSR NNP O
is VBZ O
directed VBN O
to TO O
specific JJ O
heavy JJ O
chain NN O
isotypes NNS O
by IN O
cytokines NNS O
and CC O
B NNP O
cell NN O
activators NNS O
that WDT O
induce VB O
transcription NN O
from IN O
the DT O
unrearranged JJ O
, , O
or CC O
germline NN O
( -LRB- O
GL) NNP O
, , O
C( NNP B-NP
H) NNP I-NP
region NN I-NP
genes NNS I-NP
. . O

-DOCSTART- X X O

In IN O
this DT O
manuscript NN O
we PRP O
demonstrate VBP O
that IN O
two CD O
tandem NN B-NP
Ets NNS I-NP
sites NNS I-NP
in IN O
the DT O
mouse NN B-NP
GL NN I-NP
alpha NN I-NP
promoter NN I-NP
bind NN O
the DT O
transcription NN B-NP
factors NNS I-NP
Elf-1 JJ I-NP
and CC O
PU.1 JJ B-NP
, , O
and CC O
that IN O
the DT O
3' JJ O
site NN O
is VBZ O
essential JJ O
for IN O
expression NN O
of IN O
a DT O
luciferase NN B-NP
reporter NN I-NP
gene NN I-NP
driven VBN O
by IN O
the DT O
GL NNP B-NP
alpha NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

Cell NNP O
. . O

-DOCSTART- X X O

The DT O
proportion NN O
of IN O
the DT O
biopsies NNS O
found VBD O
to TO O
be VB O
seropositive JJ O
for IN O
HBs NNP B-NP
antigen NN I-NP
was VBD O
27.9 CD O
% NN O
, , O
and CC O
these DT O
showed VBD O
either DT O
MGN NNP O
or CC O
MPGN NNP O
pattern NN O
. . O

-DOCSTART- X X O

This DT O
domain NN O
without IN O
the DT O
canonical NN O
anticodon IN O
loop NN O
or CC O
the DT O
tyrosine NN O
anticodon RB O
acts VBZ O
as IN O
an DT O
anchor NN O
for IN O
TyrRS NNP B-NP
interaction NN O
leading VBG O
to TO O
a DT O
better JJR O
efficiency NN O
of IN O
tyrosylation NN O
. . O

-DOCSTART- X X O

In IN O
summary NN O
, , O
we PRP O
conclude VBP O
that IN O
the DT O
adenoviral JJ O
oncoprotein NNP O
E1A NNP B-NP
activates VBZ O
transcription NN O
from IN O
the DT O
endogenous JJ O
AP-2alpha NNP B-NP
gene NN I-NP
, , O
an DT O
effect NN O
that WDT O
involves VBZ O
transcriptional JJ O
derepression NN O
of IN O
the DT O
AP-2alpha NNP B-NP
promoter NN I-NP
by IN O
interaction NN O
of IN O
E1A NNP B-NP
with IN O
the DT O
AP-2rep JJ B-NP
corepressor NN O
CtBP1 NNP B-NP
. . O

-DOCSTART- X X O

SERS NNS O
spectra NN O
were VBD O
obtained VBN O
by IN O
vacuum NN O
evaporation NN O
and CC O
casting NN O
of IN O
p-NTP JJ O
onto IN O
silver JJ O
island NN O
films NNS O
, , O
and CC O
also RB O
from IN O
colloidal JJ O
silver JJ O
solutions NNS O
. . O

-DOCSTART- X X O

Copyright NNP O
2001 CD O
Academic NNP O
Press NNP O
. . O

-DOCSTART- X X O

The DT O
core NN O
promoter NN O
of IN O
human JJ B-NP
thioredoxin NN I-NP
reductase NN I-NP
1 CD I-NP
: : O
cloning NN O
, , O
transcriptional JJ O
activity NN O
, , O
and CC O
Oct-1 NNP B-NP
, , O
Sp1 NNP B-NP
, , O
and CC O
Sp3 DT B-NP
binding NN O
reveal VB O
a DT O
housekeeping-type NN O
promoter NN O
for IN O
the DT O
AU-rich NNP O
element-regulated JJ O
gene NN O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
show VBP O
that DT O
phosphorylation-induced JJ O
loss NN O
of IN O
the DT O
protein NN O
kinase NN O
activity NN O
of IN O
DNA-PK NNP B-NP
is VBZ O
restored VBN O
by IN O
the DT O
addition NN O
of IN O
the DT O
purified VBN O
catalytic JJ O
subunit NN O
of IN O
either DT O
protein NN B-NP
phosphatase NN I-NP
1 CD I-NP
or CC O
protein NN B-NP
phosphatase NN I-NP
2A IN I-NP
( -LRB- O
PP2A NN B-NP
) -RRB- O
and CC O
that IN O
this DT O
reactivation NN O
is VBZ O
blocked VBN O
by IN O
the DT O
potent JJ O
protein NN O
phosphatase NN O
inhibitor NN O
, , O
microcystin NN O
. . O

-DOCSTART- X X O

The DT O
first JJ O
exon NN O
( -LRB- O
exon JJ O
1A IN O
) -RRB- O
that WDT O
corresponded VBD O
to TO O
the DT O
5'-untranslated JJ O
region NN O
of IN O
the DT O
GHR NNP B-NP
1A NNP I-NP
mRNA NN I-NP
was VBD O
15,250 CD O
bp NN O
upstream RB O
from IN O
exon NN O
2 CD O
in IN O
the DT O
GHR NNP B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

These DT O
corrections NNS O
do VBP O
not RB O
involve VB O
sequences NNS O
predicted VBD O
to TO O
function VB O
as IN O
transcription NN O
factor NN O
binding VBG O
sites NNS O
. . O

-DOCSTART- X X O

FLP NNP B-NP
and CC O
Cre NNP B-NP
recombinase NN I-NP
function NN O
in IN O
Xenopus NNP O
embryos NNS O
. . O

-DOCSTART- X X O

A DT O
method NN O
of IN O
three-station DT O
three-dimensional JJ O
magnetic JJ O
resonance NN O
( -LRB- O
MR NNP O
) -RRB- O
angiography NN O
of IN O
the DT O
lower JJR O
extremities NNS O
with IN O
segmented JJ O
volume NN O
acquisition NN O
is VBZ O
presented VBN O
. . O

-DOCSTART- X X O

Our PRP$ O
previous JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
SHP-1 NNP B-NP
, , O
a DT O
SH2 NNP B-NP
domain-containing NN I-NP
protein-tyrosine NN I-NP
phosphatase NN I-NP
, , O
is VBZ O
expressed VBN O
not RB O
only RB O
in IN O
cells NNS O
of IN O
hematopoietic JJ O
lineages NNS O
, , O
but CC O
also RB O
in IN O
many JJ O
non-hematopoietic JJ O
cells NNS O
under IN O
the DT O
control NN O
of IN O
an DT O
alternative JJ O
tissue-specific JJ O
promoter NN O
, , O
P1 NNP O
. . O

-DOCSTART- X X O

Unexpectedly RB O
, , O
Arg1-expressing JJ B-NP
COS1 NNP O
cells NNS O
showed VBD O
no DT O
significant JJ O
proteinase NN O
activity NN O
to TO O
various JJ O
synthesized JJ O
substrates NNS O
under IN O
neutral JJ O
or CC O
acidic JJ O
conditions NNS O
in IN O
this DT O
study NN O
. . O

-DOCSTART- X X O

ORF1 CD O
( -LRB- O
1029 CD O
bp NN O
; : O
EMBL NNP O
databank NN O
, , O
Accession NNP O
No. NN O

-DOCSTART- X X O

In IN O
the DT O
meantime NN O
, , O
one CD O
has VBZ O
succeeded VBN O
to TO O
establish VB O
the DT O
deammonification NN O
processes NNS O
in IN O
a DT O
continuous JJ O
flow NN O
moving-bed JJ O
pilot NN O
plant NN O
. . O

-DOCSTART- X X O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
evaluate VB O
simplified VBN O
methods NNS O
for IN O
estimation NN O
of IN O
Technetium NNP O
Tc NNP O
99m IN O
(99mTc)-pentetate NNP O
and CC O
orthoiodohippurate NN O
I PRP O
131 CD O
( -LRB- O
131I-OIH) JJ O
plasma NN O
clearance NN O
in IN O
dogs NNS O
and CC O
cats NNS O
with IN O
1 CD O
and CC O
2 CD O
blood NN O
samples NNS O
. . O

-DOCSTART- X X O

Interventions NNS O
aimed VBN O
at IN O
these DT O
specific JJ O
mediators NNS O
and CC O
processes NNS O
may MD O
be VB O
successful JJ O
in IN O
reducing VBG O
the DT O
very JJ O
significant JJ O
human NN O
and CC O
economic JJ O
costs NNS O
of IN O
vascular JJ O
access NN O
dysfunction NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
stonin NN B-NP
2 CD I-NP
binds NNS O
to TO O
the DT O
C2B NNP O
domains NNS O
of IN O
synaptotagmins NNS B-NP
I PRP I-NP
and CC I-NP
II NNP I-NP
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
N63S NNP O
mutation NN O
in IN O
the DT O
wild-type JJ B-NP
VP5 NNP I-NP
background NN O
increased VBD O
the DT O
interaction NN O
, , O
as IN O
judged VBN O
by IN O
the DT O
beta-galactosidase JJ B-NP
activity NN O
, , O
by IN O
a DT O
factor NN O
of IN O
9 CD O
relative JJ O
to TO O
when WRB O
the DT O
PR7 NNP O
mutation NN O
was VBD O
present JJ O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
severe JJ O
vision NN O
loss NN O
can MD O
be VB O
seen VBN O
with IN O
interferon NN B-NP
alfa-2b-associated JJ I-NP
retinopathy NN O
. . O

-DOCSTART- X X O

SKP1-SnRK JJ B-NP
protein NN O
kinase NN O
interactions NNS O
mediate JJ O
proteasomal JJ O
binding NN O
of IN O
a DT O
plant NN O
SCF NN B-NP
ubiquitin IN I-NP
ligase NN I-NP
. . O

-DOCSTART- X X O

PATIENTS NNS O
AND CC O
METHODS NNS O
: : O
Between IN O
June NNP O
1991 CD O
and CC O
December NNP O
1996 CD O
, , O
we PRP O
administered VBN O
the DT O
nucleoside JJ O
analog NN O
2-chlorodeoxyadenosine JJ O
(2-CDA NN O
) -RRB- O
to TO O
73 CD O
children NNS O
with IN O
primary JJ O
AML NNP O
and CC O
20 CD O
children NNS O
with IN O
secondary JJ O
AML NNP O
or CC O
myelodysplastic JJ O
syndrome NN O
( -LRB- O
MDS NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Experimental JJ O
study NN O
of IN O
ta TO O
chengchi VB O
tang NN O
decoction NN O
for IN O
relieving VBG O
lung NN O
injury NN O
during IN O
acute JJ O
necrotizing JJ O
pancreatitis NN O
] RB O
The DT O
objectives NNS O
of IN O
the DT O
study NN O
were VBD O
to TO O
investigate VB O
the DT O
changes NNS O
of IN O
leukocyte NN O
adhesiveness NN O
and CC O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
( -LRB- O
TNF NN B-NP
) -RRB- O
in IN O
the DT O
early JJ O
stage NN O
of IN O
acute JJ O
necrotizing JJ O
pancreatitis NN O
( -LRB- O
ANP NNP O
) -RRB- O
, , O
to TO O
go VB O
further RB O
into IN O
the DT O
relation NN O
of IN O
those DT O
changes NNS O
to TO O
lung NN O
injury NN O
of IN O
ANP NNP O
, , O
and CC O
to TO O
evaluate VB O
the DT O
prohibitive JJ O
effect NN O
of IN O
ta TO O
chengchi VB O
tang NN O
Decoction NNP O
on IN O
leukocyte NN O
adhesion NN O
and CC O
TNF NNP B-NP
secretion NN O
. . O

-DOCSTART- X X O

A DT O
variety NN O
of IN O
receptor-mediated JJ O
signaling NN O
pathways NNS O
are VBP O
controlled VBN O
by IN O
both DT O
positive JJ O
and CC O
negative JJ O
extracellular JJ O
regulators NNS O
. . O

-DOCSTART- X X O

Reciprocally RB O
, , O
HMGI-C JJ B-NP
expression NN O
also RB O
coordinately RB O
enhances VBZ O
PIAS3-mediated JJ B-NP
repression NN O
of IN O
STAT3-dependent JJ B-NP
transactivation NN O
. . O

-DOCSTART- X X O

Additional JJ O
deletion NN O
mutations NNS O
revealed VBD O
a DT O
new JJ O
, , O
67-amino-acid JJ O
functional JJ O
domain NN O
within IN O
the DT O
proline-rich JJ O
region NN O
of IN O
SLP-76 NNP B-NP
, , O
which WDT O
we PRP O
have VBP O
termed VBN O
the DT O
P-1 JJ O
domain NN O
. . O

-DOCSTART- X X O

Finally RB O
, , O
profiling NN O
of IN O
a DT O
gcn4Delta NN B-NP
mutant NN I-NP
uncovered VBD O
an DT O
alternative NN O
induction NN O
pathway NN O
operating VBG O
at IN O
many JJ O
Gcn4p JJ B-NP
target NN I-NP
genes NNS I-NP
in IN O
histidine-starved JJ O
cells NNS O
. . O

-DOCSTART- X X O

Evidence NN O
from IN O
a DT O
Northern NNP O
hybridization NN O
indicated VBD O
that IN O
jadM JJ B-NP
expression NN O
is VBZ O
correlated VBN O
with IN O
jadomycin NNP B-NP
B NNP I-NP
synthesis NN O
. . O

-DOCSTART- X X O

Right RB O
LHR JJ O
(R-LHR NN O
) -RRB- O
provided VBD O
the DT O
best JJS O
interobserver NN O
and CC O
intraobserver NN O
reproducibility NN O
. . O

-DOCSTART- X X O

Online NNP O
teaching NN O
: : O
design NN O
and CC O
techniques NNS O
. . O

-DOCSTART- X X O

The DT O
application NN O
of IN O
the DT O
biotechnology NN O
at IN O
the DT O
plants NNS O
for IN O
treatment NN O
of IN O
the DT O
surface NN O
storm NN O
waters NNS O
from IN O
the DT O
industrial JJ O
zone NN O
Telychka NNP O
of IN O
the DT O
city NN O
of IN O
Kyiv NNP O
has VBZ O
allowed VBN O
the DT O
content NN O
of IN O
petroleum NN O
in IN O
water NN O
dropped VBD O
to TO O
the DT O
Dnieper NN O
to TO O
be VB O
constantly RB O
reduced VBN O
50-100 CD O
times NNS O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
of IN O
RNAs NNP O
from IN O
a DT O
number NN O
of IN O
mouse NN O
tissues NNS O
reveals VBZ O
that IN O
Atp6i NNP B-NP
is VBZ O
expressed VBN O
predominantly RB O
in IN O
osteoclasts NNS O
, , O
and CC O
this DT O
predominant JJ O
expression NN O
was VBD O
confirmed VBN O
by IN O
reverse-transcription NN O
polymerase NN O
chain NN O
reaction NN O
(RT-PCR JJ O
) -RRB- O
assay NN O
and CC O
immunohistochemical JJ O
analysis NN O
. . O

-DOCSTART- X X O

Indeed RB O
, , O
mutation NN O
of IN O
two CD O
of IN O
these DT O
motifs NNS O
, , O
known VBN O
to TO O
be VB O
important JJ O
to TO O
regulation NN O
of IN O
sid1 NN B-NP
, , O
altered VBN O
the DT O
differential JJ O
regulation NN O
of IN O
sid2 NN B-NP
by IN O
iron NN O
. . O

-DOCSTART- X X O

Guidelines NNS O
for IN O
performing VBG O
a DT O
routine JJ O
spiral NN O
assay NN O
are VBP O
presented VBN O
, , O
and CC O
alternative JJ O
test NN O
methods NNS O
intended VBN O
to TO O
overcome VB O
a DT O
variety NN O
of IN O
technical JJ O
difficulties NNS O
( -LRB- O
such JJ O
as IN O
restricted JJ O
sample NN O
availability NN O
, , O
sample NN O
viscosity NN O
or CC O
volatility NN O
, , O
etc. FW O
) -RRB- O
are VBP O
recommended VBN O
. . O

-DOCSTART- X X O

In IN O
conclusion NN O
, , O
obesity NN O
, , O
alcohol NN O
intake NN O
, , O
and CC O
multimetabolic JJ O
disorders NNS O
were VBD O
determined VBN O
to TO O
be VB O
independent JJ O
predictors NNS O
for IN O
the DT O
development NN O
of IN O
hyperuricemia NN O
. . O

-DOCSTART- X X O

Fans NNS O
in IN O
tunnels NNS O
and CC O
open JJ O
windows NNS O
at IN O
aboveground JJ O
locations NNS O
appeared VBD O
to TO O
greatly RB O
reduce VB O
the DT O
likelihood NN O
of IN O
high JJ O
PH3 JJ O
concentrations NNS O
in IN O
enclosed VBN O
areas NNS O
. . O

-DOCSTART- X X O

The DT O
first JJ O
case NN O
of IN O
HCV NNP O
seroconversion NN O
in IN O
Portugal NNP O
after IN O
the DT O
introduction NN O
of IN O
HCV NNP O
NAT NNP O
screening NN O
. . O

-DOCSTART- X X O

The DT O
co-existence NN O
of IN O
TE NNP B-NP
domains VBZ I-NP
within IN O
modular JJ O
PKSs NNS B-NP
along RB O
with IN O
physically RB O
separated VBN O
, , O
monofunctional JJ O
TEs NNS B-NP
( -LRB- O
TE VB B-NP
IIs NNP I-NP
) -RRB- O
has VBZ O
been VBN O
reported VBN O
for IN O
a DT O
number NN O
of IN O
modular JJ O
polyketide NN O
and CC O
non-ribosomal JJ B-NP
peptide NN I-NP
synthases NNS I-NP
( -LRB- O
NRPS) NNP B-NP
. . O

-DOCSTART- X X O

To TO O
gain VB O
an DT O
understanding NN O
of IN O
the DT O
mGSTM2 NN B-NP
regulation NN O
, , O
we PRP O
have VBP O
also RB O
cloned VBN O
and CC O
analyzed VBD O
its PRP$ O
promoter NN O
region NN O
. . O

-DOCSTART- X X O

SELECTION NN O
CRITERIA NN O
: : O
All DT O
randomised JJ O
controlled JJ O
trials NNS O
comparing VBG O
IUSs NNS O
with IN O
other JJ O
forms NNS O
of IN O
reversible JJ O
contraceptives NNS O
and CC O
reporting VBG O
on IN O
pre-determined JJ O
outcomes NNS O
in IN O
women NNS O
of IN O
reproductive JJ O
years NNS O
. . O

-DOCSTART- X X O

OBJECTIVES NNS O
: : O
The DT O
objective NN O
of IN O
this DT O
review NN O
was VBD O
to TO O
compare VB O
the DT O
effectiveness NN O
, , O
safety NN O
and CC O
acceptability NN O
of IN O
the DT O
diaphragm NN O
with IN O
and CC O
without IN O
spermicide NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
are VBP O
reassuring VBG O
and CC O
we PRP O
therefore RB O
advise VBP O
that IN O
in IN O
patients NNS O
undergoing VBG O
free JJ O
jejunum NN O
flap NN O
reconstruction NN O
of IN O
the DT O
hypopharyngo-esophageal JJ O
tract NN O
voice NN O
restoration NN O
should MD O
be VB O
attempted VBN O
by IN O
placing VBG O
a DT O
voice NN O
prosthesis NN O
through IN O
a DT O
secondary JJ O
tracheo-esophageal NN O
puncture NN O
and CC O
providing VBG O
intensive JJ O
speech NN O
training NN O
. . O

-DOCSTART- X X O

Hypercalcemia NNP O
associated VBN O
with IN O
elevated JJ O
serum NN B-NP
PTH DT I-NP
concentration NN O
indicating VBG O
primary JJ O
hyperparathyroidism NN O
was VBD O
found VBN O
in IN O
7 CD O
BC JJ O
patients NNS O
( -LRB- O
7 CD O
% NN O
) -RRB- O
and CC O
in IN O
none NN O
of IN O
healthy JJ O
women NNS O
or CC O
patients NNS O
with IN O
thyroid JJ O
cancer NN O
. . O

-DOCSTART- X X O

In IN O
Saccharomyces NNP O
cerevisiae NN O
, , O
entry NN O
into IN O
mitosis NN O
requires VBZ O
activation NN O
of IN O
the DT O
cyclin-dependent JJ B-NP
kinase NN I-NP
Cdc28 . B-NP
in IN O
its PRP$ O
cyclin NN B-NP
B NNP I-NP
( -LRB- O
Clb)-associated JJ B-NP
form NN O
. . O

-DOCSTART- X X O

We PRP O
investigated VBD O
the DT O
production NN O
of IN O
hyaluronan NN O
( -LRB- O
HA NNP O
) -RRB- O
and CC O
its PRP$ O
effect NN O
on IN O
cell NN O
motility NN O
in IN O
cells NNS O
expressing VBG O
the DT O
v-src JJ B-NP
mutants NNS I-NP
. . O

-DOCSTART- X X O

We PRP O
used VBD O
stored VBN O
plasma NN O
samples NNS O
from IN O
409 CD O
patients NNS O
in IN O
the DT O
National NNP O
Institute NNP O
of IN O
Neurological NNP O
Diseases NNP O
and CC O
Stroke NNP O
( -LRB- O
NINDS NNS O
) -RRB- O
tissue NN B-NP
plasminogen NN I-NP
activator NN I-NP
(t-PA NN O
) -RRB- O
Stroke JJ O
Trial NN O
to TO O
examine VB O
the DT O
relationship NN O
between IN O
an DT O
apolipoprotein NN B-NP
( -LRB- I-NP
Apo NNP I-NP
) -RRB- I-NP
E2 NNP I-NP
or CC O
an DT O
Apo NNP B-NP
E4 NNP I-NP
phenotype NN O
and CC O
a DT O
favorable JJ O
outcome NN O
3 CD O
months NNS O
after IN O
stroke NN O
, , O
the DT O
risk NN O
of IN O
intracerebral JJ O
hemorrhage NN O
, , O
and CC O
the DT O
response NN O
to TO O
intravenous JJ O
t-PA JJ B-NP
therapy NN O
. . O

-DOCSTART- X X O

NIRS NNP O
was VBD O
used VBN O
for IN O
the DT O
quantitative JJ O
measurement NN O
of IN O
muscle NN O
O( JJ O
2 CD O
) -RRB- O
consumption NN O
( -LRB- O
mV.O( JJ O
2 CD O
) -RRB- O
) -RRB- O
and CC O
forearm JJ O
blood NN O
flow NN O
( -LRB- O
FBF NN O
) -RRB- O
in IN O
78 CD O
healthy JJ O
subjects NNS O
. . O

-DOCSTART- X X O

No DT O
dominant JJ O
clinical JJ O
factor NN O
of IN O
risk NN O
was VBD O
found VBN O
, , O
but CC O
multiple JJ O
regression NN O
analysis NN O
identified VBN O
age NN O
, , O
body NN O
surface NN O
area NN O
, , O
valve NN O
size NN O
, , O
shop NN O
order NN O
fracture NN O
rate NN O
, , O
and CC O
manufacturing NN O
period NN O
as IN O
risk NN O
factors NNS O
for IN O
OSF. NNP O

-DOCSTART- X X O

In IN O
this DT O
report NN O
this DT O
technique NN O
was VBD O
applied VBN O
to TO O
human JJ O
breast NN O
carcinoma NN O
MDA-MB231 . O
cells NNS O
overexpressing VBG O
human JJ B-NP
MPG NNP I-NP
in IN O
order NN O
to TO O
assess VB O
whether IN O
up-regulation NN O
of IN O
the DT O
initial JJ O
step NN O
in IN O
BER NNP O
alters IN O
the DT O
activity NN O
of IN O
selected VBN O
other JJ O
BER NN O
( -LRB- O
hOGG1 NN B-NP
and CC O
APE/ref-1 NN B-NP
) -RRB- O
or CC O
direct JJ O
reversal NN O
( -LRB- O
MGMT NNP B-NP
) -RRB- O
repair NN O
activities NNS O
. . O

-DOCSTART- X X O

Colorectal NNP O
cancer NN O
was VBD O
shown VBN O
to TO O
disproportionately RB O
overburden JJ O
Ashkenazi NNP O
Jews NNPS O
, , O
who WP O
may MD O
also RB O
be VB O
at IN O
increased VBN O
risk NN O
for IN O
ovarian JJ O
, , O
pancreatic JJ O
and CC O
stomach NN O
cancer NN O
, , O
and CC O
non-Hodgkin JJ O
's POS O
lymphoma NN O
. . O

-DOCSTART- X X O

Influence NN O
of IN O
compression NN O
therapy NN O
on IN O
symptoms NNS O
following VBG O
soft JJ O
tissue NN O
injury NN O
from IN O
maximal JJ O
eccentric JJ O
exercise NN O
. . O

-DOCSTART- X X O

Keratoconjunctivitis NNP O
sicca NN O
appears VBZ O
to TO O
be VB O
a DT O
common JJ O
ocular JJ O
complication NN O
and CC O
all DT O
children NNS O
with IN O
JRA NNP O
should MD O
be VB O
screened VBN O
for IN O
it PRP O
with IN O
a DT O
comprehensive JJ O
battery NN O
of IN O
tests NNS O
. . O

-DOCSTART- X X O

In IN O
conclusion NN O
, , O
primary JJ O
chemotherapy NN O
based VBN O
on IN O
high JJ O
dose NN O
MTX NNP O
and CC O
ara-C NN O
is VBZ O
highly RB O
efficient JJ O
in IN O
PCNSL. NNP O

-DOCSTART- X X O

Reovirus NN O
mRNAs NNS O
are VBP O
efficiently RB O
translated VBN O
within IN O
host NN O
cells NNS O
despite IN O
the DT O
absence NN O
of IN O
3' JJ O
polyadenylated JJ O
tails NNS O
. . O

-DOCSTART- X X O

Myasthenia NNP O
gravis NN O
is VBZ O
an DT O
autoimmune JJ O
disease NN O
resulting VBG O
from IN O
the DT O
production NN O
of IN O
antibodies NNS O
against IN O
the DT O
ACh NNP B-NP
receptors NNS I-NP
of IN O
the DT O
neuromuscular JJ O
synapse NN O
. . O

-DOCSTART- X X O

Using VBG O
the DT O
postural JJ O
and CC O
force NN O
data NNS O
as IN O
input NN O
to TO O
a DT O
3-D JJ O
biomechanical JJ O
model NN O
, , O
the DT O
lumbosacral JJ O
spinal JJ O
compression NN O
was VBD O
calculated VBN O
. . O

-DOCSTART- X X O

Angina NNP O
( -LRB- O
Q NN O
) -RRB- O
persistence NN O
showed VBD O
marked JJ O
associations NNS O
with IN O
previous JJ O
myocardial JJ O
infarction NN O
, , O
diagnosed VBD O
angina NN O
, , O
electrocardiogram NN O
ischemia NN O
, , O
and CC O
subsequent JJ O
major JJ O
ischemic JJ O
heart NN O
disease NN O
events NNS O
from IN O
Q5 DT O
onward NNP O
. . O

-DOCSTART- X X O

To TO O
assess VB O
more RBR O
specific JJ O
PKA-dependent JJ B-NP
mediation NN O
of IN O
LH NNP B-NP
's POS I-NP
contribution NN O
to TO O
combined JJ O
hormonal JJ O
drive NN O
, , O
the DT O
LDL NNP B-NP
receptor NN I-NP
(-1076 . I-NP
to TO I-NP
+11 JJ I-NP
bp NN I-NP
) -RRB- I-NP
reporter NN I-NP
plasmid NN O
was VBD O
cotransfected VBN O
with IN O
a DT O
full-sequence JJ B-NP
rabbit NN I-NP
muscle NN I-NP
protein NN I-NP
kinase NN I-NP
inhibitor NN I-NP
( -LRB- O
PKI NN B-NP
) -RRB- O
minigene NN O
driven VBN O
constitutively RB O
by IN O
a DT O
Rous JJ B-NP
sarcoma NN I-NP
virus NN I-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

To TO O
investigate VB O
the DT O
convergent JJ O
role NN O
of IN O
the DT O
insulin/IGF-I JJ B-NP
effector NN O
pathway NN O
mediating VBG O
bihormonal JJ O
stimulation NN O
of IN O
LDL NNP B-NP
receptor NN I-NP
promoter NN I-NP
expression NN O
, , O
transfected VBN O
granulosa-luteal JJ O
cells NNS O
were VBD O
pretreated VBN O
for IN O
30 CD O
min NN O
with IN O
two CD O
specific JJ O
inhibitors NNS O
of IN O
phophatidylinositol NN B-NP
3-kinase JJ I-NP
, , O
wortmannin JJ O
( -LRB- O
100 CD O
nM NN O
) -RRB- O
and CC O
LY NNP O
294002 CD O
( -LRB- O
10 CD O
microM) NN O
, , O
or CC O
of IN O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
kinase NN I-NP
, , O
PD NNP O
98059 CD O
( -LRB- O
50 CD O
microM) NN O
, , O
U0126 NNP O
( -LRB- O
10 CD O
microM) NN O
, , O
or CC O
the DT O
latter NN O
's POS O
inactive JJ O
derivative JJ O
, , O
U0124 FW O
( -LRB- O
10 CD O
microM NN O
) -RRB- O
. . O

-DOCSTART- X X O

These DT O
studies NNS O
demonstrate VBP O
that IN O
site-specific JJ O
recognition NN O
of IN O
the DT O
bxd NN B-NP
PRE JJ I-NP
by IN O
d(GA JJ O
)( JJ O
n NN O
) -RRB- O
repeat VBP O
binding JJ O
activities NNS O
mediates NNS O
PcG-dependent JJ B-NP
silencing NN O
. . O

-DOCSTART- X X O

Our PRP$ O
findings NNS O
further RB O
our PRP$ O
understanding NN O
of IN O
how WRB O
ZBP-89 DT B-NP
modulates NNS O
cell NN O
proliferation NN O
and CC O
reveals VBZ O
a DT O
novel NN O
mechanism NN O
by IN O
which WDT O
the DT O
p53 NN B-NP
protein NN I-NP
is VBZ O
stabilized VBN O
. . O

-DOCSTART- X X O

A DT O
computerized JJ O
method NN O
of IN O
determining VBG O
the DT O
focal JJ O
point NN O
of IN O
electrical JJ O
activity NN O
in IN O
the DT O
pallidum NN O
of IN O
parkinsonian JJ O
patients NNS O
was VBD O
developed VBN O
using VBG O
on-line JJ O
quantitative JJ O
physiological JJ O
data NNS O
analysis NN O
. . O

-DOCSTART- X X O

Isolated NNP O
Systolic NNP O
Hypertension NNP O
: : O
An DT O
Update NN O
. . O

-DOCSTART- X X O

Arterial JJ O
blood NN O
gas NN O
tensions NNS O
were VBD O
similar JJ O
across IN O
all DT O
ventilation NN O
modes NNS O
. . O

-DOCSTART- X X O

As IN O
expected VBN O
, , O
homologous JJ B-NP
loxP NNS I-NP
sequences NNS I-NP
efficiently RB O
underwent IN O
Cre-mediated JJ B-NP
recombination NN O
. . O

-DOCSTART- X X O

The DT O
N-terminal JJ O
portion NN O
of IN O
Notch(IC NNP B-NP
) -RRB- I-NP
inhibited VBD O
p50 DT B-NP
DNA NNP O
binding NN O
and CC O
interacted VBD O
specifically RB O
with IN O
p50 DT B-NP
subunit NN I-NP
, , O
not RB O
p65 IN B-NP
of IN O
NF-kappaB. NNP B-NP

-DOCSTART- X X O

Conformational JJ O
changes NNS O
of IN O
the DT O
ferric JJ B-NP
uptake NN I-NP
regulation NN I-NP
protein NN I-NP
upon IN O
metal NN O
activation NN O
and CC O
DNA NN O
binding NN O
; : O
first JJ O
evidence NN O
of IN O
structural JJ O
homologies NNS O
with IN O
the DT O
diphtheria NN B-NP
toxin NN I-NP
repressor NN I-NP
. . O

-DOCSTART- X X O

As IN O
a DT O
complement NN O
to TO O
genome-wide JJ O
mapping NN O
and CC O
sequencing NN O
efforts NNS O
, , O
it PRP O
is VBZ O
often RB O
important JJ O
to TO O
generate VB O
detailed JJ O
maps NNS O
and CC O
sequence NN O
data NNS O
for IN O
specific JJ O
regions NNS O
of IN O
interest NN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
the DT O
screen NN O
for IN O
toxic JJ O
p53 NN B-NP
mutants NNS I-NP
in IN O
yeast NN O
can MD O
identify VB O
novel NN O
p53 NN B-NP
variants NNS O
that WDT O
may MD O
be VB O
useful JJ O
in IN O
dissecting VBG O
p53 NN B-NP
regulated VBN O
cellular JJ O
responses NNS O
and CC O
in IN O
developing VBG O
p53-based JJ B-NP
cancer NN O
therapies NNS O
. . O

-DOCSTART- X X O

Since IN O
the DT O
latter NN O
is VBZ O
very RB O
small JJ O
for IN O
physiological JJ O
flows NNS O
, , O
the DT O
result NN O
is VBZ O
that IN O
alpha NN O
< VBD O
1 CD O
even RB O
at IN O
relatively RB O
high JJ O
values NNS O
of IN O
the DT O
Reynolds NNP O
number NN O
( -LRB- O
i FW O
.e FW O
. . O
, , O
for IN O
non-negligible JJ O
inertia NN O
) -RRB- O
and CC O
we PRP O
validate VBP O
our PRP$ O
perturbation NN O
theory NN O
results NNS O
by IN O
comparison NN O
with IN O
a DT O
numerical JJ O
integration NN O
of IN O
the DT O
full JJ O
model NN O
. . O

-DOCSTART- X X O

Cells NNP O
lacking VBG O
p116 NNS B-NP
exhibit VBP O
a DT O
striking JJ O
defect NN O
in IN O
the DT O
formation NN O
of IN O
these DT O
macropinocytic JJ O
structures NNS O
, , O
a DT O
concomitant JJ O
reduction NN O
in IN O
the DT O
rate NN O
of IN O
fluid JJ O
phase NN O
pinocytosis NN O
, , O
a DT O
significant JJ O
decrease NN O
in IN O
the DT O
efficiency NN O
of IN O
chemotactic NN O
aggregation NN O
, , O
and CC O
a DT O
decrease NN O
in IN O
cellular JJ O
F-actin NN B-NP
content NN O
. . O

-DOCSTART- X X O

The DT O
validity NN O
of IN O
the DT O
FPS-R NNP O
was VBD O
further RB O
supported VBN O
by IN O
strong JJ O
positive JJ O
correlations NNS O
with IN O
the DT O
VAS NNP O
( -LRB- O
r=0.92 NN O
, , O
N=45 NNP O
) -RRB- O
and CC O
the DT O
CAS NNP O
( -LRB- O
r=0.84 CD O
, , O
N=45 NNP O
) -RRB- O
in IN O
this DT O
clinical JJ O
sample NN O
. . O

-DOCSTART- X X O

The DT O
Van NNP O
der NN O
Hoeve NNP O
's POS O
syndrome NN O
lesions NNS O
as IN O
poorly RB O
mineralized VBN O
, , O
with IN O
low JJ O
calcium NN O
salt NN O
and CC O
apparent JJ O
increase NN O
of IN O
phosphates NNS O
. . O

-DOCSTART- X X O

A DT O
5-month-old JJ O
infant NN O
with IN O
persistent JJ O
congenital NN O
stridor NN O
and CC O
acute JJ O
respiratory NN O
distress NN O
is VBZ O
presented VBN O
. . O

-DOCSTART- X X O

DESIGN NNP O
: : O
A DT O
retrospective JJ O
chart NN O
review NN O
of IN O
9,322 CD O
patients NNS O
undergoing VBG O
surgical JJ O
procedures NNS O
in IN O
the DT O
period NN O
January NNP O
1993 CD O
to TO O
December NNP O
1998 CD O
. . O

-DOCSTART- X X O

Biochemical JJ O
experiments NNS O
have VBP O
shown VBN O
that IN O
CopG NNP B-NP
co-operatively JJ O
associates NNS O
to TO O
its PRP$ O
target NN O
DNA NN O
at IN O
low JJ O
protein NN O
:DNA NN O
ratios NNS O
, , O
completely RB O
protecting VBG O
four CD O
helical JJ O
turns NNS O
on IN O
the DT O
same JJ O
face NN O
of IN O
the DT O
double JJ O
helix NN O
in IN O
both DT O
directions NNS O
from IN O
the DT O
inverted JJ O
repeat NN O
that IN O
constitutes VBZ O
the DT O
CopG NNP B-NP
primary JJ O
target NN O
. . O

-DOCSTART- X X O

We PRP O
demonstrated VBD O
that IN O
, , O
under IN O
serum-starved JJ O
conditions NNS O
, , O
KMS-11 NN O
and CC O
OPM-2 JJ O
cells NNS O
express VBP O
appreciable JJ O
levels NNS O
of IN O
phosphorylated JJ O
FGFR3 NNS B-NP
mutants NNS I-NP
indicating VBG O
a DT O
constitutive JJ O
activation NN O
of IN O
the DT O
Y373C NNP B-NP
and CC I-NP
K650E NNP I-NP
receptors NNS I-NP
; : O
the DT O
addition NN O
of IN O
the DT O
aFGF NN B-NP
ligand NN I-NP
further RB O
increased VBD O
the DT O
level NN O
of IN O
receptor NN O
phosphorylation NN O
. . O

-DOCSTART- X X O

[figure NN O
: : O
see VB O
text NN O
] IN O
The DT O
Stille NNP O
coupling NN O
reaction NN O
has VBZ O
been VBN O
performed VBN O
in IN O
1-butyl-3-methylimidazolium JJ O
tetrafluoroborate NN O
( -LRB- O
BMIM NNP O
BF4 NNP O
) -RRB- O
, , O
a DT O
room-temperature NN O
ionic JJ O
liquid JJ O
(RTIL NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
students NNS O
who WP O
had VBD O
abnormal JJ O
urine NN O
screening NN O
results NNS O
at IN O
the DT O
first JJ O
time NN O
received VBD O
a DT O
second JJ O
urine NN O
analysis NN O
10 CD O
to TO O
15 CD O
days NNS O
later RB O
to TO O
confirm VB O
the DT O
abnormal JJ O
urine NN O
analysis NN O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
laminin NN B-NP
beta2 IN I-NP
chain NN I-NP
gene NN I-NP
expression NN O
in IN O
human JJ O
cancer NN O
cell NN O
lines NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
when WRB O
directed VBN O
to TO O
the DT O
nucleosome JJ O
by IN O
fusion NN O
to TO O
core NN B-NP
histone NN I-NP
H2A . I-NP
or CC O
H2B PRP B-NP
, , O
the DT O
non-histone JJ O
tail NN O
forms NNS O
an DT O
MCB NNP O
that IN O
appears VBZ O
identical JJ O
to TO O
that DT O
of IN O
the DT O
endogenous JJ O
protein NN O
. . O

-DOCSTART- X X O

These DT O
data NNS O
suggest VBP O
that IN O
proper JJ O
direct JJ O
binding NN O
of IN O
Nhp2p NNP B-NP
to TO O
H/ACA NNP B-NP
snoRNAs NN I-NP
is VBZ O
required VBN O
for IN O
the DT O
assembly NN O
of IN O
H/ACA NNP B-NP
snoRNPs NNPS I-NP
and CC O
hence RB O
for IN O
the DT O
stability NN O
of IN O
some DT O
of IN O
their PRP$ O
components NNS O
. . O

-DOCSTART- X X O

SIT NN B-NP
( -LRB- O
SHP2-interacting JJ B-NP
transmembrane NN I-NP
adaptor NN I-NP
protein NN I-NP
) -RRB- O
is VBZ O
a DT O
recently RB O
identified VBN O
transmembrane NN O
adaptor IN O
protein NN O
, , O
which WDT O
is VBZ O
expressed VBN O
in IN O
lymphocytes NNS O
. . O

-DOCSTART- X X O

In IN O
35 CD O
of IN O
those DT O
patients NNS O
DD NNP O
was VBD O
measured VBN O
also RB O
with IN O
microlatex NN O
tests--Tinaquant NN O
and CC O
BC NNP O
d-dimer NN O
. . O

-DOCSTART- X X O

Ileal NNP O
digestibilities NNS O
of IN O
DM NNP O
, , O
OM NNP O
, , O
CP CD O
, , O
total JJ O
dietary NN O
fiber NN O
( -LRB- O
TDF) NNP O
, , O
fat JJ O
and CC O
gross JJ O
energy NN O
( -LRB- O
GE NNP O
) -RRB- O
were VBD O
lower JJR O
( -LRB- O
P NNP O
< NN O
0.05 CD O
) -RRB- O
for IN O
dogs NNS O
fed VBN O
diets NNS O
containing VBG O
supplemental JJ O
fiber NN O
compared VBN O
with IN O
dogs NNS O
fed VBN O
the DT O
control NN O
diet NN O
. . O

-DOCSTART- X X O

Together RB O
these DT O
data NNS O
imply VBP O
that IN O
the DT O
HFV NNP B-NP
R NN I-NP
region NN I-NP
acts VBZ O
in IN O
the DT O
nucleus JJ O
to TO O
modify VB O
the DT O
cytoplasmic JJ O
fate NN O
of IN O
target NN O
HFV IN O
mRNA NN O
. . O

-DOCSTART- X X O

These DT O
TxRE NNP B-NP
contain VBP O
cyclic JJ O
AMP-responsive JJ O
elements NNS O
( -LRB- O
CRE) NN O
, , O
but CC O
, , O
remarkably RB O
, , O
the DT O
"TGACGTCA NNP O
" `` O
consensus NN O
is VBZ O
never RB O
strictly RB O
conserved VBN O
in IN O
any DT O
viral JJ O
strain NN O
( -LRB- O
e NN O
.g. NNP O
,AGACGTCA NNP O
, , O
TGACGGCA NNP O
, , O
TGACCTCA NNP O
) -RRB- O
. . O

-DOCSTART- X X O

And CC O
, , O
most RBS O
importantly RB O
, , O
reconstitution NN O
of IN O
a DT O
consensus NN O
CRE RB O
, , O
within IN O
the DT O
21-bp JJ O
enhancers NNS O
increases NNS O
binding NN O
of IN O
CREB/ATF NNP B-NP
proteins VBZ O
but CC O
abrogates VBZ O
basal JJ O
repression NN O
of IN O
LTR-directed JJ O
transcription NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Site-directed JJ O
mutagenesis NN O
of IN O
CAR NNP B-NP
revealed VBD O
that IN O
CAR NNP B-NP
residues NNS O
Leu73 NNP O
and CC O
Lys121 NNP O
and/or CC O
Lys123 CD O
are VBP O
critical JJ O
contact NN O
residues NNS O
, , O
with IN O
Tyr80 NNP O
and CC O
Tyr83 NNP O
being VBG O
peripherally RB O
involved VBN O
in IN O
the DT O
binding NN O
interaction NN O
with IN O
the DT O
Ad5 NNP B-NP
, , I-NP
Ad9 NNP I-NP
, , I-NP
Ad12 NNP I-NP
, , I-NP
and CC I-NP
Ad41L NNP I-NP
fiber NN I-NP
knobs NNS I-NP
. . O

-DOCSTART- X X O

This DT O
subfamily NN O
of IN O
genes NNS O
all DT O
have VBP O
a DT O
single JJ O
ATP-binding JJ O
domain NN O
at IN O
the DT O
N-terminus NNP O
and CC O
a DT O
single JJ O
C-terminal JJ O
set NN O
of IN O
transmembrane NN O
segments NNS O
. . O

-DOCSTART- X X O

Tolerance NN O
in IN O
renal JJ O
transplantation NN O
after IN O
allogeneic DT O
bone NN O
marrow NN O
transplantation-6-year JJ O
follow-up NN O
. . O

-DOCSTART- X X O

The DT O
promoter NN O
activity NN O
of IN O
the DT O
proximal JJ O
region NN O
was VBD O
found VBN O
to TO O
be VB O
restricted VBN O
to TO O
a DT O
subset NN O
of IN O
prestalk NN O
cells NNS O
. . O

-DOCSTART- X X O

Thus RB O
, , O
replication NN O
fork NN O
movement NN O
near IN O
HML NNP B-NP
pauses VBZ O
at IN O
a DT O
silent JJ O
origin NN O
which WDT O
is VBZ O
competent JJ O
for IN O
replication NN O
initiation NN O
but CC O
kept VBD O
silent JJ O
through IN O
Orc2p NNP B-NP
, , O
a DT O
component NN O
of IN O
the DT O
replication NN O
initiator NN O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
adapter NN O
Gab1 NNP B-NP
may MD O
redirect VB O
c-Met JJ B-NP
signaling VBG O
through IN O
PI3K JJ B-NP
away RB O
from IN O
a DT O
c-Akt/Pak1 JJ B-NP
cell NN O
survival NN O
pathway NN O
. . O

-DOCSTART- X X O

Foreigners NNS O
return NN O
. . O

-DOCSTART- X X O

Long-term JJ O
results NNS O
with IN O
MACOP-B NNP O
and CC O
radiation NN O
therapy NN O
for IN O
aggressive JJ O
lymphomas NNS O
] IN O
BACKGROUND NNP O
: : O
Long-term JJ O
results NNS O
are VBP O
needed VBN O
to TO O
evaluate VB O
chemotherapy NN O
regimens NNS O
and CC O
prognostic JJ O
factors NNS O
in IN O
non-Hodgkin JJ O
's POS O
lymphomas NNS O
( -LRB- O
NHL) NNP O
. . O

-DOCSTART- X X O

At IN O
the DT O
end NN O
of IN O
each DT O
day NN O
of IN O
migration NN O
the DT O
pulmonary JJ O
hemolymph NN O
PO2 NNS O
decreased VBN O
by IN O
1-2.5 CD O
kPa NN O
, , O
but CC O
the DT O
hemocyanin NN O
remained VBD O
saturated VBN O
with IN O
O2 NNP O
and CC O
the DT O
venous JJ O
reserve NN O
was VBD O
largely RB O
unchanged JJ O
( -LRB- O
O2 CD O
> IN O
0.4 CD O
mmol NN O
x NN O
l(-1 NN O
) -RRB- O
) -RRB- O
. . O

-DOCSTART- X X O

DESIGN NNP O
: : O
Prospective JJ O
cohort JJ O
study NN O
with IN O
a DT O
20 CD O
y NN O
follow-up JJ O
period NN O
, , O
the DT O
First NNP O
National NNP O
Health NNP O
and CC O
Examination NNP O
Survey NNP O
( -LRB- O
NHANES NNP O
1 CD O
) -RRB- O
Epidemiologic NNP O
Follow-up NNP O
Study NNP O
( -LRB- O
NHEFS) NNP O
. . O

-DOCSTART- X X O

There EX O
are VBP O
many JJ O
different JJ O
proposals NNS O
for IN O
the DT O
statistical JJ O
analysis NN O
of IN O
data NNS O
to TO O
determine VB O
early JJ O
onset NN O
of IN O
action NN O
. . O

-DOCSTART- X X O

The DT O
assay NN O
herein RB O
described VBN O
allows VBZ O
the DT O
comparison NN O
of IN O
relative JJ O
FGFR NN B-NP
expression NN O
levels NNS O
, , O
both DT O
within IN O
a DT O
single JJ O
RNA NNP O
pool NN O
and CC O
among IN O
multiple JJ O
RNA JJ O
pool NN O
samples NNS O
. . O

-DOCSTART- X X O

The DT O
median JJ O
preoperative JJ O
best-corrected JJ O
visual JJ O
acuity NN O
of IN O
0.08 CD O
( -LRB- O
range NN O
hand NN O
motions/0.003 CD O
to TO O
0.4) CD O
, , O
improved VBN O
by IN O
5 CD O
lines NNS O
to TO O
a DT O
median JJ O
final JJ O
postoperative JJ O
best-corrected JJ O
visual JJ O
acuity NN O
of IN O
0.25 CD O
( -LRB- O
range NN O
0.025-0.5 CD O
) -RRB- O
( -LRB- O
P NNP O
= SYM O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Gimpl NNP O
, , O
F. NNP O

-DOCSTART- X X O

The DT O
present JJ O
chemotherapy NN O
of IN O
AE NNP O
is VBZ O
based VBN O
on IN O
the DT O
administration NN O
of IN O
benzimidazole JJ O
carbamate NN O
derivatives NNS O
, , O
such JJ O
as IN O
mebendazole NN O
and CC O
albendazole NN O
. . O

-DOCSTART- X X O

Topological NNP O
and CC O
mutational JJ O
analysis NN O
of IN O
Saccharomyces NNP B-NP
cerevisiae NN I-NP
Ste14p NNP I-NP
, , O
founding VBG O
member NN O
of IN O
the DT O
isoprenylcysteine NN B-NP
carboxyl NN I-NP
methyltransferase NN I-NP
family NN I-NP
. . O

-DOCSTART- X X O

Hormonal NNP O
regulation NN O
of IN O
multiple JJ O
promoters NNS O
of IN O
the DT O
rat NN B-NP
mitochondrial NN I-NP
glycerol-3-phosphate NN I-NP
dehydrogenase NN I-NP
gene NN I-NP
: : O
identification NN O
of IN O
a DT O
complex JJ O
hormone-response NN O
element NN O
in IN O
the DT O
ubiquitous JJ O
promoter NN O
B. NNP O

-DOCSTART- X X O

BACKGROUND/AIMS NNP O
: : O
Hepatitis NNP O
C NNP O
and CC O
nonalcoholic JJ O
fatty NN O
liver NN O
disease NN O
( -LRB- O
NAFL NNP O
) -RRB- O
are VBP O
the DT O
two CD O
most RBS O
common JJ O
forms NNS O
of IN O
liver NN O
disease NN O
in IN O
the DT O
United NNP O
States NNP O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
show VBP O
that IN O
CVN NNP B-NP
specifically RB O
recognizes VBZ O
with IN O
nanomolar JJ O
affinity NN O
Man( NNP O
9)GlcNAc( JJ O
2 CD O
) -RRB- O
and CC O
the DT O
D1D3 JJ O
isomer NN O
of IN O
Man( NNP O
8)GlcNAc( JJ O
2 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Here RB O
we PRP O
show VBP O
that DT O
independent JJ O
of IN O
uncertainties NNS O
in IN O
the DT O
models NNS O
, , O
terrestrial JJ O
planets NNS O
with IN O
dense JJ O
atmosphere NN O
like IN O
Venus NNP O
can MD O
evolve VB O
into IN O
one CD O
of IN O
only RB O
four CD O
possible JJ O
rotation NN O
states NNS O
. . O

-DOCSTART- X X O

Enantiomer JJ O
separation NN O
of IN O
venlafaxine NN O
and CC O
O-desmethylvenlafaxine JJ O
in IN O
human JJ O
plasma NN O
. . O

-DOCSTART- X X O

They PRP O
consist VBP O
of IN O
at IN O
least JJS O
two CD O
separable JJ O
components NNS O
, , O
one CD O
heat NN O
stable NN O
and CC O
the DT O
other JJ O
heat NN O
labile NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
last JJ O
case NN O
, , O
both DT O
hydroxychloroquine JJ O
, , O
carbamazepine NN O
and CC O
fluvoxamine NN O
had VBD O
a DT O
common JJ O
imputability NN O
which WDT O
was VBD O
plausible JJ O
. . O

-DOCSTART- X X O

We PRP O
investigate VB O
the DT O
reaction NN O
kinetics NNS O
of IN O
small JJ O
spherical JJ O
particles NNS O
with IN O
inertia NN O
, , O
obeying VBG O
coalescence NN O
type NN O
of IN O
reaction NN O
, , O
B+B-->B NNP O
, , O
and CC O
being VBG O
advected VBN O
by IN O
hydrodynamical JJ O
flows NNS O
with IN O
time-periodic JJ O
forcing VBG O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
the DT O
Vp1 NNP B-NP
DBD NNP I-NP
during IN O
infection NN O
was VBD O
investigated VBN O
by IN O
taking VBG O
advantage NN O
of IN O
NLS NNP O
phenotypic NN O
complementation NN O
( -LRB- O
N. NNP O

-DOCSTART- X X O

2 CD O
were VBD O
nonviable JJ O
, , O
and CC O
the DT O
mutant JJ B-NP
Vp1s NNS I-NP
unexpectedly RB O
failed VBD O
to TO O
localize VB O
to TO O
the DT O
nucleus JJ O
though IN O
Vp2 NNP B-NP
and CC O
Vp3 NNP B-NP
did VBD O
, , O
suggesting VBG O
that IN O
the DT O
mutated JJ B-NP
NLS1 NNP I-NP
acted VBD O
as IN O
a DT O
dominant JJ O
signal NN O
for IN O
the DT O
cytoplasmic JJ O
localization NN O
of IN O
Vp1 NNP B-NP
. . O

-DOCSTART- X X O

Fasting VBG O
gastrin NN B-NP
levels NNS O
( -LRB- O
normal JJ O
range NN O
: : O
25-110 JJ O
mU/L NNS O
) -RRB- O
varied VBN O
from IN O
48.78 CD O
mU/L-168.20 CD O
( -LRB- O
mean NN O
: : O
85.23 CD O
mU/L NN O
) -RRB- O
. . O

-DOCSTART- X X O

Such JJ O
knowledge NN O
could MD O
advance VB O
diagnosis NN O
and CC O
treatment NN O
of IN O
the DT O
patient NN O
and CC O
counseling NN O
of IN O
the DT O
affected JJ O
family NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
There EX O
is VBZ O
increasing VBG O
interest NN O
on IN O
the DT O
part NN O
of IN O
investigators NNS O
and CC O
the DT O
public NN O
at IN O
large JJ O
in IN O
finding VBG O
ways NNS O
to TO O
study VB O
and CC O
improve VB O
treatments NNS O
for IN O
the DT O
seriously RB O
mentally RB O
ill JJ O
without IN O
exposing VBG O
such JJ O
individuals NNS O
to TO O
unnecessary JJ O
risks NNS O
. . O

-DOCSTART- X X O

In IN O
the DT O
next JJ O
week NN O
, , O
the DT O
beta-adrenergic JJ O
antagonist NN O
atenolol NN O
was VBD O
added VBN O
at IN O
an DT O
initial JJ O
dose NN O
of IN O
25 CD O
mg/day NN O
and CC O
titrated VBD O
to TO O
50 CD O
mg/day NN O
within IN O
1 CD O
week NN O
. . O

-DOCSTART- X X O

Lack NN O
of IN O
association NN O
between IN O
Kawasaki NNP O
syndrome NN O
and CC O
infection NN O
with IN O
Rickettsia NNP O
conorii NNS O
, , O
Rickettsia NNP O
typhi RB O
, , O
Coxiella NNP O
burnetii NNS O
or CC O
Ehrlichia NNP O
phagocytophila NN O
group NN O
. . O

-DOCSTART- X X O

The DT O
presence NN O
of IN O
AS-oligo NNP O
had VBD O
no DT O
further JJ O
effect NN O
on IN O
the DT O
FSH-mediated JJ B-NP
activation NN O
of IN O
the DT O
EB*-mTf-CAT NN O
construct VB O
but CC O
reduced VBN O
cAMP-mediated JJ O
activation NN O
. . O

-DOCSTART- X X O

This DT O
is VBZ O
a DT O
challenging JJ O
task NN O
insofar RB O
as IN O
direct JJ O
measures NNS O
of IN O
ISF NNP O
glucose NN O
are VBP O
not RB O
readily RB O
available JJ O
. . O

-DOCSTART- X X O

We PRP O
developed VBD O
a DT O
system NN O
for IN O
domain NN O
shuffling VBG O
to TO O
establish VB O
the DT O
function NN O
of IN O
C1 DT B-NP
domains NNS O
from IN O
human JJ B-NP
Raf NNP I-NP
kinase NN I-NP
and CC O
rat NN B-NP
PKC NNP I-NP
eta NN I-NP
in IN O
yeast NN O
. . O

-DOCSTART- X X O

We PRP O
interpret VB O
these DT O
data NNS O
as IN O
further JJ O
evidence NN O
that IN O
interaction NN O
with IN O
a DT O
small JJ B-NP
GTPase NN I-NP
is VBZ O
the DT O
main JJ O
regulatory JJ O
function NN O
of IN O
the DT O
C1 NNP B-NP
domain NN O
in IN O
yeast NN O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
There EX O
is VBZ O
a DT O
considerable JJ O
amount NN O
of IN O
variation NN O
between IN O
the DT O
results NNS O
of IN O
TRA1 NNP O
and CC O
TRA2 NNP O
and CC O
between IN O
the DT O
results NNS O
of IN O
both DT O
TRA NNP O
's POS O
and CC O
the DT O
door-to-door NN O
survey NN O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
Extrusion NN O
cooking NN O
is VBZ O
effective JJ O
for IN O
the DT O
inactivation NN O
of IN O
DON NNP O
but CC O
is VBZ O
of IN O
limited JJ O
value NN O
for IN O
AFB1 NNS B-NP
, , O
even RB O
if IN O
metabisulphite NN O
is VBZ O
added VBN O
. . O

-DOCSTART- X X O

The DT O
differences NNS O
in IN O
the DT O
CPIgG NNP B-NP
, , O
CRP NNP B-NP
, , O
and CC O
fibrinogen NN B-NP
levels NNS O
in IN O
patients NNS O
who WP O
were VBD O
diagnosed VBN O
with IN O
ACS NNP O
versus IN O
those DT O
who WP O
were VBD O
not RB O
( -LRB- O
non-ACS) JJ O
were VBD O
evaluated VBN O
. . O

-DOCSTART- X X O

NaeI NNP B-NP
, , O
a DT O
novel JJ O
DNA NNP B-NP
endonuclease NN I-NP
, , O
shows VBZ O
topoisomerase NN B-NP
and CC O
recombinase NN B-NP
activities NNS O
when WRB O
a DT O
Lys NNP O
residue NN O
is VBZ O
substituted VBN O
for IN O
Leu NNP O
43 CD O
. . O

-DOCSTART- X X O

Mss4 NNP B-NP
also RB O
acts VBZ O
as IN O
a DT O
relatively RB O
inefficient JJ O
guanine IN B-NP
nucleotide JJ I-NP
exchange NN I-NP
factor NN I-NP
( -LRB- O
GEF NN B-NP
) -RRB- O
. . O

-DOCSTART- X X O

She PRP O
has VBZ O
since RB O
developed VBN O
a DT O
positive JJ O
anti-cardiolipin NN B-NP
antibody NN I-NP
but CC O
does VBZ O
not RB O
meet VB O
diagnostic JJ O
criteria NNS O
for IN O
systemic JJ O
lupus NN O
erythematosis NN O
. . O
CONCLUSION NN O
: : O
The DT O
presence NN O
of IN O
known VBN O
autoimmune NN O
disease NN O
in IN O
a DT O
woman NN O
with IN O
POF NNP O
should MD O
not RB O
dissuade VB O
the DT O
clinician NN O
from IN O
evaluating VBG O
for IN O
a DT O
potential JJ O
genetic JJ O
cause NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
aerosol-vapor JJ O
JP-8 CD O
jet NN O
fuel NN O
on IN O
the DT O
functional JJ O
observational JJ O
battery NN O
, , O
and CC O
learning NN O
and CC O
memory NN O
in IN O
the DT O
rat NN O
. . O

-DOCSTART- X X O

We PRP O
randomly RB O
assigned VBN O
1,219 CD O
subjects NNS O
to TO O
receive VB O
either CC O
the DT O
standard NN O
three-times-weekly JJ O
( -LRB- O
TIW NN O
) -RRB- O
interferon NN B-NP
alfa-2b JJ I-NP
dose NN O
( -LRB- O
3 CD O
MIU) NN O
or CC O
the DT O
once-weekly JJ O
( -LRB- O
QW NN O
) -RRB- O
peginterferon NN B-NP
alfa-2b NN I-NP
( -LRB- O
0.5 CD O
, , O
1.0, CD O
or CC O
1.5 CD O
microg/kg NN O
) -RRB- O
. . O

-DOCSTART- X X O

At IN O
cross NN O
purposes NNS O
. . O

-DOCSTART- X X O

Many JJ O
factors NNS O
do VBP O
influence VB O
the DT O
educational JJ O
outcome NN O
in IN O
students NNS O
and CC O
large JJ O
statistical JJ O
power NN O
( -LRB- O
such JJ O
as IN O
meta JJ O
analysis NN O
) -RRB- O
should MD O
be VB O
helpful JJ O
to TO O
eliminate VB O
many JJ O
sources NNS O
of IN O
error NN O
. . O

-DOCSTART- X X O

The DT O
combination NN O
of IN O
ifosfamide NN O
, , O
epirubicin NN O
and CC O
etoposide NN O
( -LRB- O
IEV NN O
) -RRB- O
is VBZ O
an DT O
effective JJ O
salvage NN O
regimen NNS O
for IN O
lymphoproliferative JJ O
disease NN O
. . O

-DOCSTART- X X O

Cardiac NNP O
markers NNS O
troponin FW B-NP
T NNP I-NP
, , O
CK-MB NNP B-NP
mass NN O
and CC O
myoglobin NN B-NP
were VBD O
helpful JJ O
in IN O
the DT O
differential JJ O
diagnosis NN O
of IN O
chest NN O
pain NN O
, , O
even RB O
when WRB O
the DT O
ECG NNP O
was VBD O
unremarkable JJ O
or CC O
nonspecific JJ O
. . O

-DOCSTART- X X O

One CD O
maternal JJ O
death NN O
, , O
reduced VBN O
body NN O
weight NN O
, , O
and CC O
reduced VBD O
weight NN O
gain NN O
were VBD O
noted VBN O
at IN O
the DT O
high JJ O
dose NN O
; : O
confirmed JJ O
pregnancy NN O
rates NNS O
were VBD O
84 CD O
to TO O
100 CD O
% NN O
for IN O
each DT O
group NN O
. . O

-DOCSTART- X X O

Our PRP$ O
results NNS O
demonstrated VBD O
that IN O
50 CD O
% NN O
of IN O
the DT O
hepatic JJ O
artery-alone NN O
ALT NNP O
graft NN O
showed VBD O
almost RB O
normal JJ O
structure NN O
histologically RB O
at IN O
1 CD O
month NN O
after IN O
grafting VBG O
, , O
with IN O
bile NN O
secretion NN O
preserved VBN O
. . O

-DOCSTART- X X O

The DT O
authors NNS O
made VBD O
an DT O
analysis NN O
of IN O
social-economical JJ O
conditions NNS O
limiting VBG O
the DT O
possibilities NNS O
of IN O
rendering VBG O
cardiosurgical JJ O
care NN O
to TO O
children NNS O
. . O

-DOCSTART- X X O

In IN O
mammals NNS O
, , O
the DT O
transcriptional JJ O
repressors NNS O
in IN O
the DT O
Wnt JJ B-NP
pathway NN O
are VBP O
not RB O
well RB O
defined VBN O
. . O

-DOCSTART- X X O

The DT O
human JJ B-NP
ABCG1 NNP I-NP
gene NN I-NP
encodes VBZ O
a DT O
member NN O
of IN O
the DT O
ATP-binding JJ B-NP
cassette NN I-NP
( -LRB- O
ABC NNP B-NP
) -RRB- O
superfamily NN O
of IN O
transporter JJ B-NP
proteins NNS I-NP
and CC O
is VBZ O
highly RB O
induced VBN O
when WRB O
macrophages NNS O
are VBP O
incubated VBN O
with IN O
oxysterols NNS O
. . O

-DOCSTART- X X O

Despite IN O
abundant JJ O
expression NN O
of IN O
NtmybAS NNP B-NP
transcripts NNS I-NP
in IN O
mature JJ O
pollen NN O
, , O
gPAL1 IN B-NP
transcripts NNS I-NP
were VBD O
not RB O
detectable JJ O
in IN O
pollen NN O
. . O

-DOCSTART- X X O

C/EBPbeta NNP B-NP
LIP NNP I-NP
overexpressing IN O
HC11 NNP O
cells NNS O
did VBD O
not RB O
express VB O
beta-casein JJ B-NP
mRNA NNS I-NP
( -LRB- O
mammary NN O
epithelial NN O
cell NN O
differentiation NN O
marker NN O
) -RRB- O
in IN O
response NN O
to TO O
lactogenic JJ O
hormones NNS O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
a DT O
novel NN O
ankyrin-independent JJ B-NP
role NN O
for IN O
LAD-1 NN B-NP
related VBN O
to TO O
FGFR NNP B-NP
signaling NN O
. . O

-DOCSTART- X X O

Competition NN O
electrophoretic JJ O
mobility NN O
shift NN O
and CC O
immunoshift JJ O
assays IN O
confirmed VBN O
that IN O
NF1 NNP B-NP
factors NNS I-NP
present JJ O
in IN O
nuclear JJ O
extracts NNS O
of IN O
HeLa NNP O
and CC O
CV-1 JJ O
cells NNS O
bind VBP O
to TO O
the DT O
BKV-MLP. NNP B-NP

-DOCSTART- X X O

This DT O
study NN O
demonstrates VBZ O
that IN O
inducible JJ O
expression NN O
in IN O
response NN O
to TO O
either DT O
PMA NNP O
or CC O
TPO NNP B-NP
is VBZ O
mediated VBN O
through IN O
the DT O
Ets NNP B-NP
site NN I-NP
in IN O
the DT O
proximal JJ O
promoter NN O
of IN O
GPIX NNP B-NP
and CC O
is VBZ O
dependent JJ O
upon IN O
the DT O
upstream JJ O
activation NN O
of IN O
MAPK/extracellular NNP B-NP
signal-regulated JJ B-NP
kinase NN I-NP
. . O

-DOCSTART- X X O

On IN O
Cox NNP O
proportional JJ O
hazards NNS O
regression NN O
adenocarcinoma FW O
( -LRB- O
P=0.006 NN O
) -RRB- O
, , O
the DT O
development NN O
of IN O
BPF NNP O
( -LRB- O
P=0.003 NN O
) -RRB- O
, , O
older JJR O
age NN O
( -LRB- O
P=0.03 CD O
) -RRB- O
and CC O
higher JJR O
pathological JJ O
stage NN O
( -LRB- O
P=0.02 NN O
) -RRB- O
were VBD O
independent JJ O
adverse JJ O
predictors NNS O
of IN O
survival NN O
. . O

-DOCSTART- X X O

Phosphatidylinositol NNP B-NP
3-kinase JJ I-NP
potentiates NNS O
, , O
but CC O
does VBZ O
not RB O
trigger VB O
, , O
T NNP O
cell NN O
proliferation NN O
mediated VBN O
by IN O
the DT O
IL-2 NN B-NP
receptor NN I-NP
. . O

-DOCSTART- X X O

The DT O
loop NN O
domain NN O
of IN O
heat NN B-NP
shock NN I-NP
transcription NN I-NP
factor NN I-NP
1 CD I-NP
dictates VBZ O
DNA-binding JJ O
specificity NN O
and CC O
responses NNS O
to TO O
heat VB O
stress NN O
. . O

-DOCSTART- X X O

EXAFS NNS O
measurements NNS O
around IN O
the DT O
Ge-K JJ O
edge NN O
have VBP O
been VBN O
carried VBN O
out RP O
for IN O
liquid JJ O
Ge-Si NNP O
alloys NNS O
for IN O
the DT O
first JJ O
time NN O
to TO O
investigate VB O
the DT O
local JJ O
structure NN O
around IN O
a DT O
Ge NNP O
atom NN O
. . O

-DOCSTART- X X O

Progressive JJ O
study NN O
and CC O
robustness NN O
test NN O
of IN O
QSAR NN O
model NN O
based VBN O
on IN O
quantum NN O
chemical NN O
parameters NNS O
for IN O
predicting VBG O
BCF NNP O
of IN O
selected VBN O
polychlorinated VBN O
organic JJ O
compounds NNS O
(PCOCs NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Of IN O
the DT O
six CD O
cases NNS O
of IN O
malignant JJ O
polyposis NN O
, , O
none NN O
were VBD O
identified VBN O
using VBG O
CT NNP O
, , O
and CC O
only RB O
two CD O
were VBD O
diagnosed VBN O
by IN O
small JJ O
bowel NN O
follow-through JJ O
. . O

-DOCSTART- X X O

Using VBG O
the DT O
two-hybrid JJ O
system NN O
, , O
we PRP O
show VBP O
that IN O
nonprenylated JJ O
Rac1 NNP B-NP
interacts NNS O
very RB O
weakly RB O
with IN O
Rho-GDI NNP B-NP
, , O
pointing VBG O
to TO O
the DT O
predominant JJ O
role NN O
of IN O
protein-isoprene JJ O
interaction NN O
in IN O
complex JJ O
formation NN O
. . O

-DOCSTART- X X O

Although IN O
metabolized VBN O
by IN O
the DT O
cytochrome NN B-NP
P-450 . I-NP
( -LRB- O
CYP NNP B-NP
) -RRB- O
system NN O
, , O
venlafaxine NN O
inhibits VBZ O
CYP NNP B-NP
2D6 CD I-NP
and CC I-NP
3A4 CD I-NP
to TO O
a DT O
far RB O
lesser JJR O
extent NN O
than IN O
do VBP O
the DT O
SSRIs NNP O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
the DT O
promoter NN O
sequence NN O
revealed VBD O
the DT O
presence NN O
of IN O
a DT O
major JJ O
transcriptional JJ O
start NN O
site NN O
, , O
a DT O
canonical JJ O
TATA NNP O
box NN O
and CC O
putative JJ O
cis NNPS O
regulatory JJ O
elements NNS O
for IN O
pituitary NN O
specific JJ O
expression NN O
as RB O
well RB O
as IN O
an DT O
E-responsive JJ O
element NN O
. . O

-DOCSTART- X X O

Pitx2 VB B-NP
rescues NNS O
the DT O
GABAergic NNP O
differentiation NN O
defect NN O
and CC O
partially RB O
rescues VBZ O
the DT O
axon NN O
guidance NN O
and CC O
behavioral JJ O
phenotypes NNS O
of IN O
unc-30 JJ B-NP
mutants NNS I-NP
, , O
indicating VBG O
a DT O
high JJ O
degree NN O
of IN O
functional JJ O
conservation NN O
between IN O
these DT O
evolutionarily RB O
related VBN O
genes NNS O
. . O

-DOCSTART- X X O

The DT O
patterns NNS O
of IN O
early JJ O
mRNA NN O
and CC O
protein NN O
expression NN O
in IN O
these DT O
seven CD O
mutants NNS O
were VBD O
examined VBN O
, , O
and CC O
it PRP O
was VBD O
found VBN O
that IN O
mutation NN O
of IN O
the DT O
T'( JJ B-NP
135 CD I-NP
) -RRB- I-NP
acceptor NN O
site NN O
resulted VBN O
in IN O
the DT O
utilization NN O
of IN O
cryptic JJ O
splice NN O
sites NNS O
and CC O
the DT O
generation NN O
of IN O
new JJ O
T' JJ B-NP
species NNS O
. . O

-DOCSTART- X X O

Sixty-one JJ O
cases NNS O
of IN O
cholera NN O
, , O
all DT O
caused VBN O
by IN O
V. NNP O
cholerae NNS O
O1 NNP O
, , O
were VBD O
reported VBN O
. . O

-DOCSTART- X X O

Thus RB O
, , O
BALB/c NNP O
mice NNS O
appear VBP O
to TO O
be VB O
the DT O
most JJS O
appropriate JJ O
strain NN O
of IN O
mice NNS O
to TO O
perform VB O
studies NNS O
on IN O
the DT O
possible JJ O
connection NN O
between IN O
infection NN O
with IN O
T. NNP O
canis NNS O
and CC O
allergic JJ O
asthma NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
the DT O
adenoviral JJ B-NP
12S CD I-NP
E1A JJ I-NP
protein NN I-NP
modulates VBZ O
the DT O
phosphorylation NN O
status NN O
of IN O
p130 NN B-NP
and CC O
p107 VBD B-NP
without IN O
apparent JJ O
changes NNS O
in IN O
the DT O
cell NN O
cycle NN O
dependent JJ O
phosphorylation NN O
of IN O
the DT O
retinoblastoma NN B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

Furthermore RB O
, , O
hormonal JJ O
regulation NN O
of IN O
G( JJ O
1 CD O
) -RRB- O
gene NN O
transcription NN O
can MD O
occur VB O
even RB O
without IN O
additional JJ O
activation NN O
of IN O
the DT O
Mek-Erk1/2 NNP B-NP
pathway NN O
by IN O
estrogen NN B-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

Therefore RB O
, , O
to TO O
understand VB O
how WRB O
ErbB1/ErbB2 NNP B-NP
signaling VBG O
contributes NNS O
to TO O
this DT O
process NN O
, , O
we PRP O
used VBD O
the DT O
ErbB NNP B-NP
kinase NN I-NP
inhibitor IN O
AG1478in NNP O
ErbB2-dependent NNP B-NP
BT-474 NNP O
and CC O
SKBR-3 JJ O
human JJ O
breast NN O
cancer NN O
cells NNS O
. . O

-DOCSTART- X X O

This DT O
plus CC O
the DT O
reduced JJ O
phosphorylation NN O
of IN O
p27 NN B-NP
by IN O
MAPK NNP B-NP
enhanced VBD O
the DT O
stability NN O
of IN O
p27 NN B-NP
that IN O
associated VBN O
with IN O
nuclear JJ B-NP
Cdk2 NN I-NP
at IN O
high JJ O
stoichiometry NN O
and CC O
inhibited VBD O
its PRP$ O
kinase NN O
activity NN O
. . O

-DOCSTART- X X O

ICA NNP O
in IN O
the DT O
reference NN O
solution NN O
was VBD O
characterised VBN O
by IN O
LC NNP O
and CC O
time-of-flight NN O
( -LRB- O
TOF NN O
) -RRB- O
MS NNP O
and CC O
quantified VBN O
by IN O
LC NNP O
chemiluminescent NN O
nitrogen NN O
detection NN O
(LC-CLND) NN O
. . O

-DOCSTART- X X O

Inhibition NN O
of IN O
JNK1 NNP B-NP
and CC O
ERK NNP B-NP
kinase NN O
activities NNS O
either CC O
by IN O
expression NN O
of IN O
the DT O
dominant JJ O
negative JJ O
mutant JJ O
JNK1 NN B-NP
or CC O
by IN O
treatment NN O
with IN O
a DT O
selective JJ O
chemical NN O
inhibitor NN O
of IN O
ERK NNP B-NP
( -LRB- O
PD098059 CD O
) -RRB- O
substantially RB O
abrogates VBZ O
the DT O
UV NN O
induction NN O
of IN O
the DT O
GADD45 NNP B-NP
promoter NN I-NP
. . O

-DOCSTART- X X O

NF-kappaB NNP B-NP
is VBZ O
involved VBN O
in IN O
the DT O
regulation NN O
of IN O
CD154 NNP B-NP
( -LRB- O
CD40 NN B-NP
ligand NN I-NP
) -RRB- O
expression NN O
in IN O
primary JJ O
human JJ O
T NNP O
cells NNS O
. . O

-DOCSTART- X X O

Subacute JJ O
diencephalic NN O
angioencephalopathy NN O
( -LRB- O
SDAE NNP O
) -RRB- O
is VBZ O
a DT O
rare JJ O
and CC O
fatal JJ O
disease NN O
of IN O
unknown JJ O
etiology NN O
that WDT O
involves VBZ O
the DT O
thalami NNS O
bilaterally RB O
. . O

-DOCSTART- X X O

Mutation NN O
of IN O
the DT O
octamer NN O
element NN O
also RB O
significantly RB O
reduced VBD O
the DT O
ability NN O
of IN O
HDAC1 NNP B-NP
to TO O
confer VB O
repression NN O
of IN O
inducible JJ O
HLA-DRA NNP B-NP
promoter NN I-NP
activation NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
single JJ O
case NN O
the DT O
restoration NN O
of IN O
a DT O
structured VBN O
daily JJ O
routine NN O
represents VBZ O
the DT O
presupposition NN O
for IN O
a DT O
cognitive JJ O
therapy NN O
. . O

-DOCSTART- X X O

However RB O
these DT O
search NN O
engines NNS O
respond VBP O
with IN O
such JJ O
cumbersome JJ O
results NNS O
that IN O
domain NN O
specific JJ O
experts NNS O
can MD O
not RB O
tolerate VB O
. . O

-DOCSTART- X X O

From IN O
the DT O
above JJ O
results NNS O
, , O
we PRP O
might MD O
infer VB O
that IN O
the DT O
seizure NN O
type NN O
of IN O
TLE NNP O
and CC O
a DT O
high JJ O
frequency NN O
of IN O
seizure NN O
are VBP O
two CD O
major JJ O
independent JJ O
precipitate NN O
factors NNS O
for IN O
abnormal JJ O
latencies NNS O
of IN O
P300 CD O
in IN O
the DT O
epileptic JJ O
patients NNS O
. . O

-DOCSTART- X X O

Audiological NNP O
findings NNS O
in IN O
pregnancy NN O
. . O

-DOCSTART- X X O

The DT O
isoform NN O
, , O
designated VBN O
HDAC9a NNP B-NP
, , O
is VBZ O
132 CD O
aa JJ O
shorter JJR O
at IN O
the DT O
C NNP O
terminus NN O
than IN O
HDAC9 NNP B-NP
. . O

-DOCSTART- X X O

Pulmonary JJ O
embolectomy NN O
and CC O
lung NN O
transplantation NN O
are VBP O
the DT O
main JJ O
indications NNS O
for IN O
the DT O
use NN O
of IN O
heart-lung-machine NN O
. . O

-DOCSTART- X X O

In IN O
such JJ O
conditions NNS O
, , O
the DT O
following VBG O
kinetic JJ O
reactions NNS O
have VBP O
been VBN O
studied VBN O
: : O
N2( JJ O
A DT O
) -RRB- O
+ NN O
N2( JJ O
A DT O
) -RRB- O
--> JJ O
N2( JJ O
C,B,V' NNS O
) -RRB- O
+ VBP O
N2( JJ O
X NNP O
) -RRB- O
, , O
N2( JJ O
A DT O
) -RRB- O
+ NN O
N2(X JJ O
,V>5 IN O
) -RRB- O
--> : O
N2( JJ O
X NNP O
) -RRB- O
+ , O
N2( NNP O
B NNP O
,V' NNP O
) -RRB- O
in IN O
pure JJ O
N2 NNP O
post-discharges NNS O
and CC O
N2( JJ O
A DT O
) -RRB- O
+ NN O
CH4 IN O
--> JJ O
products NNS O
, , O
C NNP O
+ NNP O
N NNP O
+ NN O
M2 IN O
--> JJ O
CN(B NN O
,V' NNS O
) -RRB- O
+ , O
M2 NNP O
, , O
N2(X JJ O
,V>4 NNS O
) -RRB- O
+ VBP O
CN NNP O
--> , O
N2( JJ O
X NNP O
) -RRB- O
+ JJ O
CN(B,A,V' NNP O
) -RRB- O
, , O
in IN O
N2-1 NN O
% NN O
CH4 IN O
post-discharges NNS O
. . O

-DOCSTART- X X O

The DT O
NAUSICAA NNP O
system NN O
gives VBZ O
a DT O
good JJ O
knowledge NN O
of IN O
LET NNP O
spectra NN O
for IN O
the DT O
first JJ O
time NN O
in IN O
space NN O
dosimetry NN O
. . O

-DOCSTART- X X O

In IN O
order NN O
to TO O
quantify VB O
these DT O
effects NNS O
, , O
tests NNS O
were VBD O
conducted VBN O
in IN O
the DT O
NASA NNP O
MSFC NNP O
Neutral NNP O
Buoyancy NNP O
Simulator NNP O
, , O
in IN O
the DT O
NASA NNP O
KC-135 NN O
in IN O
parabolic JJ O
flight NN O
, , O
and CC O
in IN O
space NN O
with IN O
the DT O
EASE NNP O
program NN O
during IN O
the DT O
Shuttle NNP O
Atlantis NNP O
mission NN O
61-B NN O
. . O

-DOCSTART- X X O

Different JJ O
thermoluminescent NN O
detectors NNS O
( -LRB- O
TLD NN O
) -RRB- O
have VBP O
been VBN O
used VBN O
to TO O
measure VB O
the DT O
contribution NN O
of IN O
the DT O
low JJ O
linear NN O
energy NN O
transfer NN O
component NN O
( -LRB- O
LET NNP O
< NNP O
10 CD O
keV/micrometer NN O
) -RRB- O
and CC O
plastic JJ O
nuclear JJ O
track NN O
detectors NNS O
( -LRB- O
PNTD NN O
) -RRB- O
for IN O
the DT O
high JJ O
linear NN O
energy NN O
tranfer NN O
( -LRB- O
LET NNP O
) -RRB- O
component NN O
. . O

-DOCSTART- X X O

Responses NNS O
of IN O
TLD NNP O
Mg2SiO4:Tb NNP O
and CC O
radiophotoluminescent JJ O
glass NN O
to TO O
heavy JJ O
charged VBN O
particles NNS O
and CC O
space NN O
radiation NN O
. . O

-DOCSTART- X X O

The DT O
absorbed JJ O
dose NN O
was VBD O
measured VBN O
by IN O
combination NN O
of IN O
two CD O
integrating NN O
detectors NNS O
: : O
thermo- DT O
luminescent JJ O
dosemeter NN O
of IN O
Mg2SiO4 NNP O
: : O
Tb NNP O
( -LRB- O
TDMS NNP O
) -RRB- O
and CC O
plastic JJ O
nuclear JJ O
track NN O
detector NN O
( -LRB- O
PNTD NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Six CD O
of IN O
the DT O
gstC' NNP B-NP
mutants NNS I-NP
, , O
primarily RB O
in IN O
the DT O
C-terminal JJ O
half NN O
of IN O
C' FW B-NP
, , O
exhibited VBD O
a DT O
defect NN O
in IN O
the DT O
ability NN O
to TO O
bind NN O
L NNP B-NP
protein NN I-NP
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
Experiments NNS O
testing VBG O
the DT O
new JJ O
catheter NN O
and CC O
comparing VBG O
it PRP O
to TO O
the DT O
existing VBG O
catheter NN O
included VBD O
: : O
( -LRB- O
1 CD O
) -RRB- O
measurement NN O
of IN O
the DT O
laser NN O
output NN O
beam NN O
sizes NNS O
and CC O
divergences NNS O
; : O
( -LRB- O
2 CD O
) -RRB- O
evaluation NN O
of IN O
particulate NN O
matter NN O
generation NN O
during IN O
ablation NN O
of IN O
atherosclerotic JJ O
tissue NN O
; : O
( -LRB- O
3 CD O
) -RRB- O
measurement NN O
of IN O
ablation NN O
hole NN O
sizes NNS O
and CC O
tissue NN O
penetration NN O
rates NNS O
; : O
( -LRB- O
4 CD O
) -RRB- O
histopathologic NN O
examination NN O
of IN O
laser-induced JJ O
in IN O
vivo JJ O
vessel NN O
wall NN O
injury NN O
. . O

-DOCSTART- X X O

A DT O
proposal NN O
of IN O
50 CD O
performance NN O
indicators NNS O
divided VBN O
into IN O
five CD O
different JJ O
groups NNS O
is VBZ O
presented VBN O
here RB O
, , O
namely RB O
structural JJ O
indicators NNS O
, , O
operational JJ O
indicators NNS O
, , O
water NN O
and CC O
service NN O
quality NN O
indicators NNS O
, , O
personnel NNS O
indicators NNS O
and CC O
economic JJ O
indicators NNS O
. . O

-DOCSTART- X X O

Overexpression IN O
of IN O
RORgamma NNP B-NP
has VBZ O
been VBN O
shown VBN O
to TO O
inhibit VB O
T NNP B-NP
cell NN I-NP
receptor-mediated JJ I-NP
apoptosis NN O
in IN O
T NNP O
cell NN O
hybridomas NNS O
and CC O
to TO O
repress VB O
the DT O
induction NN O
of IN O
Fas-ligand NNP B-NP
and CC O
interleukin JJ B-NP
2. . I-NP

-DOCSTART- X X O

Once RB O
ICP NNP O
reaches VBZ O
critical JJ O
values NNS O
( -LRB- O
>30 CD O
mm CD O
Hg NN O
) -RRB- O
herniation NN O
occurs VBZ O
, , O
usually RB O
within IN O
2 CD O
to TO O
5 CD O
days NNS O
. . O

-DOCSTART- X X O

Other JJ O
therapies NNS O
are VBP O
also RB O
available JJ O
, , O
including VBG O
hypertonic JJ O
saline NN O
solution NN O
, , O
THAM NNP O
( -LRB- O
Tris-hydroxy-methyl-aminomethane NN O
) -RRB- O
buffer NN O
, , O
and CC O
high-dose JJ O
barbiturates NNS O
. . O

-DOCSTART- X X O

CYP2C19 DT B-NP
genotype NN I-NP
was VBD O
determined VBN O
by IN O
the DT O
polymerase NN O
chain NN O
reaction-restriction NN O
fragment NN O
length NN O
polymorphism NN O
method NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
indicate VBP O
that IN O
a DT O
more JJR O
differentiated JJ O
diagnosis NN O
of IN O
the DT O
molar JJ O
relationship NN O
will MD O
allow VB O
for IN O
a DT O
more JJR O
causally NN O
directed VBD O
correction NN O
of IN O
Class NNP O
II NNP O
molar JJ O
relationship NN O
. . O

-DOCSTART- X X O

These DT O
analyses NNS O
re-open VBP O
the DT O
question NN O
whether IN O
all PDT O
the DT O
CesA NNP B-NP
genes NNS I-NP
encode VBP O
cellulose JJ B-NP
synthases NNS I-NP
or CC O
whether IN O
some DT O
of IN O
the DT O
sub-class JJ O
members NNS O
may MD O
encode VB O
other JJ O
non-cellulosic JJ B-NP
(1-->4)beta-glycan JJ I-NP
synthases NNS I-NP
in IN O
plants NNS O
. . O

-DOCSTART- X X O

Experience NN O
with IN O
xylene-free JJ O
sections NNS O
since IN O
1995 CD O
at IN O
the DT O
Vrinnevi NNP O
Hospital NNP O
is VBZ O
favorable JJ O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
the DT O
CYP71D20-encoded JJ B-NP
enzyme NN I-NP
activity NN O
was VBD O
capable JJ O
of IN O
converting VBG O
both DT O
5-epi-aristolochene JJ O
and CC O
1-deoxycapsidiol JJ O
to TO O
capsidiol VB O
in IN O
vitro NN O
, , O
consistent JJ O
with IN O
the DT O
notion NN O
that IN O
this DT O
P450 CD B-NP
enzyme NN I-NP
catalyzes NNS O
both DT O
hydroxylations NNS O
of IN O
its PRP$ O
hydrocarbon NN O
substrate NN O
. . O

-DOCSTART- X X O

E2F1-mediated JJ B-NP
transcriptional JJ O
inhibition NN O
of IN O
the DT O
plasminogen NN B-NP
activator NN I-NP
inhibitor IN I-NP
type NN I-NP
1 CD I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Transcriptional NNP O
regulation NN O
of IN O
the DT O
estrogen-inducible JJ O
pS2 JJ B-NP
breast NN B-NP
cancer NN I-NP
marker NN I-NP
gene NN I-NP
by IN O
the DT O
ERR NNP B-NP
family NN I-NP
of IN O
orphan JJ B-NP
nuclear JJ I-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

However RB O
, , O
during IN O
our PRP$ O
work NN O
with IN O
a DT O
replication-deficient JJ O
virus NN O
expressing VBG O
the DT O
ASF/SF2 JJ B-NP
splicing NN O
factor NN O
from IN O
a DT O
progesterone NN O
antagonist-inducible JJ O
gene NN O
cassette NN O
, , O
we PRP O
discovered VBD O
that IN O
ASF/SF2 NNP B-NP
was VBD O
expressed VBN O
at IN O
a DT O
significant JJ O
level NN O
in IN O
the DT O
293 CD O
producer NN O
cell NN O
line NN O
, , O
even RB O
in IN O
the DT O
absence NN O
of IN O
inducer NN O
. . O

-DOCSTART- X X O

DNA NNP O
binding NN O
assays VBZ O
confirmed VBN O
the DT O
interference NN O
of IN O
p30(II NNS B-NP
) -RRB- I-NP
with IN O
the DT O
assembly NN O
of IN O
CREB-Tax-p300/CBP JJ B-NP
multiprotein JJ O
complexes NNS O
on IN O
21-bp JJ O
repeat NN O
oligonucleotides NNS O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Using VBG O
the DT O
presented VBN O
categorical JJ O
structure NN O
as IN O
domain NN O
model NN O
a DT O
prototype NN O
DSS NNP O
for IN O
dipslide NN O
urine NN O
cultures NNS O
has VBZ O
been VBN O
developed VBN O
. . O

-DOCSTART- X X O

E47 JJ B-NP
protein NN I-NP
levels NNS O
remain VBP O
high JJ O
until IN O
the DT O
double JJ O
positive JJ O
developmental JJ O
stage NN O
, , O
at IN O
which WDT O
point NN O
they PRP O
drop VBP O
to TO O
relatively RB O
moderate JJ O
levels NNS O
, , O
and CC O
are VBP O
further RB O
downregulated JJ O
upon IN O
transition NN O
to TO O
the DT O
single JJ O
positive JJ O
stage NN O
. . O

-DOCSTART- X X O

The DT O
dual JJ O
specificity NN O
kinases NNS O
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
( -LRB- I-NP
MAPK) NN I-NP
kinase NN I-NP
( -LRB- I-NP
MKK)7 CD I-NP
and CC O
MKK4 NNP B-NP
are VBP O
the DT O
only JJ O
molecules NNS O
known VBN O
to TO O
directly RB O
activate VB O
the DT O
stress NN O
kinases VBZ O
stress-activated JJ B-NP
protein NN I-NP
kinases NNS I-NP
( -LRB- O
SAPKs NNP B-NP
)/c-Jun NNP O
N-terminal JJ B-NP
kinases NNS I-NP
( -LRB- O
JNKs NN B-NP
) -RRB- O
in IN O
response NN O
to TO O
environmental JJ O
or CC O
mitogenic JJ O
stimuli NNS O
. . O

-DOCSTART- X X O

SAPK/JNK NNP B-NP
activation NN O
was VBD O
completely RB O
abolished VBN O
in IN O
the DT O
absence NN O
of IN O
MKK7 NNS B-NP
, , O
even RB O
though IN O
expression NN O
of IN O
MKK4 NNP B-NP
was VBD O
strongly RB O
upregulated VBN O
in IN O
mkk7(-/-) JJ B-NP
mast NN O
cell NN O
lines NNS O
, , O
and CC O
phosphorylation NN O
of IN O
MKK4 NNP B-NP
occurred VBD O
normally RB O
in IN O
response NN O
to TO O
multiple JJ O
stress NN O
stimuli NNS O
. . O

-DOCSTART- X X O

The DT O
small JJ O
copepod NN O
Pseudonychocamptus NN O
proximus NN O
progressively RB O
replaced VBD O
the DT O
large JJ O
Tisbe NNP O
furcata NN O
in IN O
sand NN O
filters NNS O
during IN O
the DT O
fall NN O
of IN O
1995 CD O
and CC O
was VBD O
responsible JJ O
for IN O
the DT O
large JJ O
increase NN O
in IN O
meiofaunal JJ O
biomass NN O
observed VBD O
after IN O
spring NN O
1996 CD O
. . O

-DOCSTART- X X O

When WRB O
mixed JJ O
with IN O
aqueous JJ O
solutions NNS O
of IN O
TMT-55 CD O
, , O
aqueous JJ O
solutions NNS O
of IN O
either DT O
reagent-grade JJ O
zinc NN O
, , O
cadmium NN O
, , O
or CC O
lead NN O
salts NNS O
precipitate VBP O
crystalline NN O
" `` O
Zn-TMT" JJ O
, , O
amorphous JJ O
or CC O
crystalline NN O
"Cd-TMT JJ O
" '' O
or CC O
amorphous JJ O
" `` O
Pb-TMT JJ O
" '' O
( -LRB- O
M3[S3C3N3]2.nH2O NNP O
, , O
where WRB O
M=Cd2+ NNP O
, , O
Pb2+ NNP O
, , O
and CC O
Zn2+ NNP O
and CC O
n> JJ O
or CC O
= SYM O
0) CD O
that WDT O
may MD O
eventually RB O
crystallize VB O
if IN O
stored VBN O
in IN O
air NN O
. . O

-DOCSTART- X X O

Many JJ O
of IN O
the DT O
important JJ O
genes NNS O
associated VBN O
with IN O
G1 NNP O
regulation NN O
have VBP O
been VBN O
shown VBN O
to TO O
play VB O
a DT O
key JJ O
role NN O
in IN O
proliferation NN O
, , O
differentiation NN O
and CC O
oncogenic JJ O
transformation NN O
and CC O
programmed VBD O
cell NN O
death NN O
( -LRB- O
apoptosis NN O
) -RRB- O
. . O

-DOCSTART- X X O

Thus RB O
, , O
through IN O
a DT O
change NN O
in IN O
conformation NN O
upon IN O
repair NN O
of IN O
the DT O
6RG JJ O
lesion NN O
, , O
MGMT NNP B-NP
switches VBZ O
from IN O
a DT O
DNA NN O
repair NN O
factor NN O
to TO O
a DT O
transcription NN O
regulator NN O
(R-MGMT NN O
) -RRB- O
, , O
enabling VBG O
the DT O
cell NN O
to TO O
sense NN O
as RB O
well RB O
as IN O
respond NN O
to TO O
mutagens NNS O
. . O

-DOCSTART- X X O

Data NNP O
from IN O
in IN O
vitro NN O
splicing NN O
assays VBZ O
, , O
UV NN O
crosslinking NN O
and CC O
RNA-binding JJ O
competition NN O
experiments NNS O
indicates VBZ O
a DT O
strong JJ O
correlation NN O
between IN O
the DT O
binding JJ O
affinities NNS O
of IN O
PSI NNP B-NP
for IN O
the DT O
SELEX NNP O
sequences NNS O
and CC O
their PRP$ O
ability NN O
to TO O
modulate VB O
splicing NN O
of IN O
P NNP B-NP
element NN I-NP
IVS3 . B-NP
in IN O
vitro NN O
. . O

-DOCSTART- X X O

Temperature NNP O
measurement NN O
in IN O
microfluidic JJ O
systems NNS O
using VBG O
a DT O
temperature-dependent JJ O
fluorescent JJ O
dye NN O
. . O

-DOCSTART- X X O

Zarix NNP O
expected VBD O
patient JJ O
enrollment NN O
in IN O
Canadian JJ O
clinical JJ O
sites NNS O
to TO O
begin VB O
in IN O
Spring NNP O
2001 CD O
[397955] CD O
, , O
[405928] CD O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
The DT O
subjects NNS O
in IN O
the DT O
augmented JJ O
feedback NN O
group NN O
significantly RB O
reduced VBD O
their PRP$ O
peak NN O
vertical JJ O
ground NN O
reaction NN O
force NN O
in IN O
both DT O
post-test NN O
conditions NNS O
(2-minute JJ O
post-test NN O
reduction NN O
, , O
0.85+/-0.62 CD O
; : O
1-week JJ O
post-test NN O
reduction NN O
, , O
0.74+/-0.58 CD O
) -RRB- O
as IN O
compared VBN O
to TO O
the DT O
sensory JJ O
, , O
control NN O
I PRP O
, , O
and CC O
control NN O
II NNP O
feedback NN O
groups NNS O
. . O

-DOCSTART- X X O

Use NN O
of IN O
a DT O
dual-pulse JJ O
lithotripter NN O
to TO O
generate VB O
a DT O
localized JJ O
and CC O
intensified VBN O
cavitation NN O
field NN O
. . O

-DOCSTART- X X O

When WRB O
the DT O
blood NN O
clot NN O
is VBZ O
formed VBN O
in IN O
the DT O
vitreous JJ O
cavity NN O
, , O
intravitreal JJ O
injection NN O
of IN O
t-PA NNS B-NP
can MD O
convert VB O
plasminogen NN B-NP
to TO O
plasmin VB B-NP
and CC O
remove VB O
the DT O
clot NN O
. . O

-DOCSTART- X X O

Management NN O
of IN O
postvitrectomy NN O
diabetic NN O
vitreous JJ O
hemorrhage NN O
with IN O
tissue NN B-NP
plasminogen NN I-NP
activator NN I-NP
(t-PA NN O
) -RRB- O
and CC O
volume NN O
homeostatic JJ O
fluid-fluid JJ O
exchanger NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
heat NN O
treatments NNS O
on IN O
the DT O
meltability NN O
of IN O
cheeses NNS O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
Sixty CD O
per IN O
cent NN O
of IN O
African NNP O
Americans NNPS O
exposed VBN O
in IN O
26 CD O
community NN O
outbreaks NNS O
were VBD O
TST RB O
positive JJ O
compared VBN O
to TO O
only RB O
40 CD O
% NN O
of IN O
whites NNS O
following VBG O
comparable JJ O
exposures NNS O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
waiting NN O
time NN O
to TO O
receive VB O
the DT O
pancreas NNS O
transplant NN O
was VBD O
244 CD O
days NNS O
for IN O
SPK NNP O
and CC O
167 CD O
days NNS O
for IN O
PAK NN O
recipients NNS O
( -LRB- O
P NNP O
= SYM O
0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Patients NNS O
with IN O
antibody NN O
peaks NNS O
, , O
defined VBN O
as IN O
fivefold RB O
or CC O
higher JJR O
increase NN O
in IN O
antibody NN O
titer NN O
compared VBN O
to TO O
the DT O
lowest JJS O
antibody NN O
titer NN O
over IN O
the DT O
course NN O
of IN O
GBS NNP O
, , O
had VBD O
higher JJR O
disability NN O
scores NNS O
during IN O
the DT O
first JJ O
two CD O
weeks NNS O
of IN O
GBS NNP O
and CC O
a DT O
worse JJR O
clinical JJ O
outcome NN O
( -LRB- O
anti-GM1 JJ B-NP
IgG NN I-NP
and CC O
anti-GD1a DT B-NP
IgM NNP I-NP
antibody NN I-NP
peaks NNS O
) -RRB- O
and CC O
axonal JJ O
damage NN O
( -LRB- O
anti-GD1a JJ B-NP
IgM NNP I-NP
antibody NN I-NP
peaks NNS O
) -RRB- O
, , O
compared VBN O
to TO O
patients NNS O
without IN O
peak JJ O
antibody NN O
titers NNS O
. . O

-DOCSTART- X X O

Following VBG O
baseline NN O
clinical JJ O
examination NN O
and CC O
initial JJ O
periodontal JJ O
therapy NN O
, , O
32 CD O
patients NNS O
received VBD O
mucogingival JJ O
surgery NN O
with IN O
free JJ O
gingival NN O
grafts NNS O
for IN O
treatment NN O
of IN O
insufficient JJ O
attached VBN O
gingiva NN O
. . O

-DOCSTART- X X O

However RB O
, , O
patients NNS O
with IN O
isolated JJ O
office NN O
hypertension NN O
had VBD O
fewer JJR O
previous JJ O
cardiovascular NN O
complications NNS O
. . O

-DOCSTART- X X O

These DT O
findings NNS O
suggest VBP O
that IN O
an DT O
intracellular JJ O
WT-1/HSAL2 JJ B-NP
pathway NN O
may MD O
play VB O
a DT O
role NN O
in IN O
development NN O
and CC O
hematopoiesis NN O
. . O

-DOCSTART- X X O

ICAM-1 NN B-NP
has VBZ O
been VBN O
suggested VBN O
a DT O
predictor NN O
of IN O
the DT O
onset NN O
of IN O
GO. NNP O

-DOCSTART- X X O

Phosphotyrosyl NNP O
peptides NNS O
block NN O
Stat3-mediated JJ B-NP
DNA NNP O
binding NN O
activity NN O
, , O
gene NN O
regulation NN O
, , O
and CC O
cell NN O
transformation NN O
. . O

-DOCSTART- X X O

Plane NNP O
wave NN O
geometry NN O
is VBZ O
impractical JJ O
for IN O
clinical JJ O
use NN O
but CC O
the DT O
results NNS O
of IN O
this DT O
work NN O
encouraged VBD O
us PRP O
to TO O
further RBR O
develop VB O
the DT O
P3 JJ O
approximation NN O
for IN O
a DT O
spherical JJ O
geometry NN O
, , O
described VBN O
in IN O
this DT O
paper NN O
. . O

-DOCSTART- X X O

The DT O
diagnosis NN O
of IN O
HCV NNP O
arthritis NN O
in IN O
patients NNS O
with IN O
positive JJ O
rheumatoid NN B-NP
factor NN I-NP
and CC O
chronic NN O
inflammatory NN O
polyarthritis NN O
may MD O
be VB O
difficult JJ O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
We PRP O
retrospectively RB O
selected VBD O
13 CD O
TFCD NN O
patients NNS O
who WP O
underwent VBD O
surgery NN O
for IN O
intractable JJ O
epilepsy NN O
with IN O
the DT O
aim NN O
of IN O
removing VBG O
the DT O
magnetic JJ O
resonance NN O
( -LRB- O
MR)-detectable JJ O
lesion NN O
and/or CC O
the DT O
epileptogenic JJ O
zone NN O
defined VBN O
by IN O
stereoelectroencephalographic JJ O
recordings NNS O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
At IN O
latest JJS O
examination NN O
, , O
mean JJ O
UPDRS NNP O
II NNP O
and CC O
III NNP O
scores NNS O
had VBD O
improved VBN O
by IN O
30 CD O
% NN O
( -LRB- O
on IN O
stimulation NN O
, , O
off JJ O
therapy NN O
) -RRB- O
with IN O
mean JJ O
50 CD O
% NN O
reduction NN O
in IN O
daily RB O
off IN O
time NN O
. . O

-DOCSTART- X X O

Endovascular JJ O
aneurysm NN O
repair NN O
with IN O
the DT O
AneuRx NNP O
stent-graft NN O
is VBZ O
safe JJ O
, , O
but CC O
is VBZ O
it PRP O
effective JJ O
? . O

-DOCSTART- X X O

Chronic NNP O
nutritional JJ O
diseases NNS O
of IN O
infectious JJ O
origin NN O
: : O
an DT O
assessment NN O
of IN O
a DT O
nascent JJ O
field NN O
. . O

-DOCSTART- X X O

Drug NN O
interactions NNS O
have VBP O
been VBN O
found VBN O
with IN O
drugs NNS O
that WDT O
compete VBP O
for IN O
the DT O
same JJ O
CYP450 NN B-NP
isoenzymes NNS I-NP
as IN O
statins NNS O
. . O

-DOCSTART- X X O

Because IN O
of IN O
differences NNS O
in IN O
patient JJ O
characteristics NNS O
, , O
control NN O
measurements NNS O
were VBD O
obtained VBN O
from IN O
normal JJ O
muscle NN O
in IN O
all DT O
patients NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
abi1-1 JJ B-NP
gene NN I-NP
product NN I-NP
has VBZ O
no DT O
effect NN O
on IN O
the DT O
ABA NNP O
suppression NN O
of IN O
a DT O
GA-responsive JJ O
alpha-amylase NN B-NP
gene NN I-NP
. . O

-DOCSTART- X X O

In IN O
children NNS O
unable JJ O
to TO O
perform VB O
forced VBN O
expiratory JJ O
maneuvers NNS O
( -LRB- O
n NN O
= SYM O
25 CD O
) -RRB- O
, , O
FOT JJ O
, , O
contrary JJ O
to TO O
the DT O
interrupter NN O
technique NN O
, , O
clearly RB O
identified VBN O
a DT O
subgroup NN O
of IN O
young JJ O
children NNS O
with IN O
high JJ O
resistance NN O
values NNS O
at IN O
baseline NN O
, , O
which WDT O
returned VBD O
to TO O
normal JJ O
after IN O
bronchodilation NN O
. . O

-DOCSTART- X X O

In IN O
budding VBG O
yeast NN O
, , O
this DT O
latter JJ O
checkpoint JJ O
response NN O
involves VBZ O
the DT O
proteins NNS O
Mad1 NNP B-NP
, , I-NP
2 CD I-NP
, , I-NP
3 CD I-NP
, , O
Bub1 NNP B-NP
and CC O
Bub3 NNP B-NP
, , O
whose WP$ O
vertebrate JJ O
counterparts NNS O
localize VBP O
to TO O
unattached JJ O
kinetochores NNS O
. . O

-DOCSTART- X X O

HTLV-1 NN O
decreases VBZ O
Th2 DT O
type NN O
of IN O
immune JJ O
response NN O
in IN O
patients NNS O
with IN O
strongyloidiasis NN O
. . O

-DOCSTART- X X O

However RB O
, , O
the DT O
beta5L JJ O
splice NN O
variant NN O
was VBD O
found VBN O
only RB O
in IN O
the DT O
retina NN O
. . O

-DOCSTART- X X O

PROCEDURE NN O
: : O
Cannulas NNP O
were VBD O
surgically RB O
positioned VBN O
in IN O
the DT O
abomasal JJ O
body NN O
and CC O
pyloric JJ O
antrum NN O
of IN O
each DT O
calf NN O
. . O

-DOCSTART- X X O

Transforming VBG B-NP
growth NN I-NP
factor-beta NN I-NP
( -LRB- O
TGF-beta NN B-NP
) -RRB- O
induced VBN O
growth NN O
arrest NN O
of IN O
cells NNS O
involves VBZ O
regulation NN O
of IN O
the DT O
activities NNS O
of IN O
both DT O
D- NNP B-NP
and CC I-NP
E-type NNP I-NP
cyclin NN I-NP
kinase NN I-NP
complexes NNS I-NP
thought VBD O
to TO O
be VB O
mediated VBN O
primarily RB O
by IN O
the DT O
regulation NN O
of IN O
p15( JJ B-NP
Ink4b NN B-NP
) -RRB- O
and CC O
p27( JJ B-NP
Kip1 NNP B-NP
) -RRB- O
cyclin NN O
kinase NN O
inhibitors NNS O
. . O

-DOCSTART- X X O

Alignment NNP O
of IN O
different JJ O
cDNAs NNS O
of IN O
the DT O
NR5A2 NNP B-NP
( -LRB- O
hB1F NN B-NP
) -RRB- O
gene NN O
with IN O
the DT O
genomic JJ O
sequence NN O
facilitated VBD O
the DT O
delineation NN O
of IN O
its PRP$ O
structural JJ O
organization NN O
, , O
which WDT O
spans VBZ O
over IN O
150 CD O
kb NN O
and CC O
consists VBZ O
of IN O
eight CD O
exons NNS O
interrupted VBN O
by IN O
seven CD O
introns NNS O
. . O

-DOCSTART- X X O

The DT O
genomic JJ O
structure NN O
of IN O
the DT O
human JJ B-NP
SPEC1 NNP I-NP
gene NN I-NP
reveals VBZ O
complex JJ O
splicing NN O
and CC O
close JJ O
promoter NN O
proximity NN O
to TO O
the DT O
AF1q NNP B-NP
translocation NN I-NP
gene NN I-NP
. . O

-DOCSTART- X X O

Hp NNP O
positive JJ O
relatives NNS O
of IN O
gastric JJ O
cancer NN O
had VBD O
a DT O
markedly RB O
higher JJR O
prevalence NN O
of IN O
atrophy NN O
than IN O
those DT O
with IN O
Hp NNP O
negativity NN O
without IN O
cancer NN O
relatives NNS O
( -LRB- O
29 CD O
vs. NN O

-DOCSTART- X X O

Peripheral JJ O
metabolism NN O
of IN O
androgens NNS O
takes VBZ O
place NN O
in IN O
various JJ O
areas NNS O
within IN O
the DT O
pilosebaceous JJ O
unit NN O
, , O
as IN O
indicated VBN O
by IN O
local JJ O
differences NNS O
in IN O
the DT O
activities NNS O
of IN O
aromatase NN B-NP
, , O
5alpha-reductase JJ B-NP
as RB O
well RB O
as IN O
of IN O
the DT O
presence NN O
of IN O
the DT O
androgen NN B-NP
receptors NNS I-NP
. . O

-DOCSTART- X X O

The DT O
uptake NN O
of IN O
fluorine-18 NN O
fluorodeoxyglucose NN O
(F-18 NN O
FDG) NNP O
by IN O
a DT O
malignant JJ O
tumor NN O
depends VBZ O
on IN O
the DT O
blood NN O
glucose NN O
level NN O
. . O

-DOCSTART- X X O

Northern JJ O
blot NN O
analysis NN O
with IN O
one CD O
of IN O
the DT O
PARNAs NNP B-NP
revealed VBD O
a DT O
highly RB O
abundant JJ O
signal NN O
of IN O
approximately RB O
2.0 CD O
kilobases NNS O
(kb NN O
) -RRB- O
present NN O
in IN O
all DT O
cell NN O
lines NNS O
tested VBN O
. . O

-DOCSTART- X X O

This DT O
analysis NN O
supports VBZ O
the DT O
use NN O
of IN O
fluticasone NN O
propionate NN O
88 CD O
microg NN O
twice RB O
daily RB O
as IN O
first-line JJ O
treatment NN O
in IN O
patients NNS O
with IN O
persistent JJ O
asthma NN O
previously RB O
treated VBN O
with IN O
short-acting JJ O
beta2-agonist JJ B-NP
alone JJ O
. . O

-DOCSTART- X X O

By IN O
using VBG O
space-discrete/continuous JJ O
metapopulation NN O
dynamic JJ O
models NNS O
and CC O
computer NN O
simulations NNS O
, , O
we PRP O
show VBP O
that IN O
there EX O
can MD O
be VB O
two CD O
principally RB O
different JJ O
regimes NNS O
of IN O
metapopulation NN O
dynamics NNS O
. . O

-DOCSTART- X X O

Eight CD O
CAD NN O
patients NNS O
who WP O
were VBD O
matched VBN O
to TO O
the DT O
treated VBN O
patients NNS O
for IN O
age NN O
( -LRB- O
+/-3 JJ O
years NNS O
) -RRB- O
, , O
baseline NN O
low JJ B-NP
density NN I-NP
lipoprotein NN I-NP
( -LRB- O
+/-5 JJ O
mg/dL NN O
) -RRB- O
, , O
and CC O
triglycerides VBZ O
( -LRB- O
+/-50 JJ O
mg/dL NN O
) -RRB- O
but CC O
who WP O
had VBD O
never RB O
been VBN O
treated VBN O
with IN O
lipid-lowering JJ O
drugs NNS O
were VBD O
selected VBN O
as IN O
controls NNS O
. . O

-DOCSTART- X X O

The DT O
corresponding JJ O
orifice NN O
voltages NNS O
for IN O
the DT O
three CD O
instruments NNS O
were VBD O
20/50/8 CD O
0 CD O
V NNP O
( -LRB- O
AP NNP O
I PRP O
365 CD O
) -RRB- O
, , O
30/90/130 CD O
V NNP O
( -LRB- O
AP NNP O
I PRP O
2000 CD O
) -RRB- O
and CC O
40/8 CD O
0/120 CD O
V NNP O
( -LRB- O
AP NNP O
I PRP O
3000 CD O
) -RRB- O
. . O

-DOCSTART- X X O

RESULTS NNS O
: : O
A DT O
novel NN O
gene NN O
was VBD O
cloned VBN O
. . O

-DOCSTART- X X O

The DT O
moduli NNS O
of IN O
elasticity NN O
of IN O
the DT O
gray JJ O
and CC O
white JJ O
matter NN O
were VBD O
3.4+/-1.4 CD O
kPa NN O
( -LRB- O
mean VB O
+/ VB O
- : O
standard JJ O
deviation NN O
) -RRB- O
and CC O
3.4+/-0.9 CD O
kPa NN O
in IN O
the DT O
axial NN O
section NN O
, , O
3+/-0.3 JJ O
kPa NN O
and CC O
3.5+/-0.5 CD O
kPa NN O
in IN O
the DT O
frontal JJ O
section NN O
, , O
and CC O
3.5+/-0.9 CD O
kPa NN O
and CC O
2.8+/-0.4 CD O
kPa NN O
in IN O
the DT O
sagittal NN O
section NN O
, , O
respectively RB O
. . O

-DOCSTART- X X O

The DT O
LA NNP O
50s VBD O
derived VBN O
from IN O
this DT O
combined VBN O
data NNS O
when WRB O
compared VBN O
with IN O
our PRP$ O
earlier JJR O
series NN O
from IN O
1965 CD O
to TO O
1970 CD O
also RB O
did VBD O
not RB O
show VB O
a DT O
significant JJ O
change NN O
in IN O
mortality NN O
. . O

-DOCSTART- X X O

Direct JJ O
current JJ O
polarography NN O
and CC O
differential JJ O
pulse NN O
polarographic JJ O
methods NNS O
have VBP O
been VBN O
developed VBN O
for IN O
the DT O
qualitative JJ O
as RB O
well RB O
as IN O
quantitative JJ O
analysis NN O
of IN O
vitamin NN O
B1 NNP O
, , O
B2 NN O
and CC O
B6 NNP O
. . O

-DOCSTART- X X O

Against IN O
gram-positive JJ O
organisms NNS O
, , O
E-4767 NNP O
and CC O
E-5065 NNP O
were VBD O
, , O
in IN O
general JJ O
, , O
eight- CD O
and CC O
fourfold RB O
more RBR O
active JJ O
than IN O
tosufloxacin NNS O
, , O
which WDT O
is VBZ O
the DT O
most RBS O
potent JJ O
of IN O
the DT O
reference NN O
compounds NNS O
. . O

-DOCSTART- X X O

However RB O
, , O
most JJS O
produced VBN O
significant JJ O
alteration NN O
of IN O
small JJ O
intestinal JJ O
permeability NN O
. . O

-DOCSTART- X X O

These DT O
included VBD O
HNF-3 JJ B-NP
beta NN I-NP
, , O
HFH-1 JJ B-NP
, , O
HFH-2 JJ B-NP
, , O
HFH-3 JJ B-NP
, , O
C/EBP NNP B-NP
, , O
and CC O
C/EBP NNP B-NP
beta NN I-NP
, , O
all DT O
of IN O
which WDT O
are VBP O
consistent JJ O
with IN O
the DT O
tissue-specific JJ O
expression NN O
profiles NNS O
of IN O
the DT O
gene NN O
. . O

-DOCSTART- X X O

Managing VBG O
vertigo RB O
and CC O
vertigo RB O
syndromes NNS O
in IN O
the DT O
elderly JJ O

-DOCSTART- X X O

The DT O
MABP NNP O
and CC O
MCBFV NNP O
signals NNS O
were VBD O
bandpass VBG O
filtered VBN O
in IN O
the DT O
very JJ O
low-frequency NN O
range NN O
(VLF NN O
, , O
0.015-0.07 CD O
Hz NNP O
) -RRB- O
, , O
low-frequency NN O
range NN O
( -LRB- O
LF NNP O
, , O
0.07-0.15 CD O
Hz NN O
) -RRB- O
and CC O
high-frequency NN O
range NN O
( -LRB- O
HF NNP O
, , O
0.15-0.40 JJ O
Hz NNP O
) -RRB- O
before IN O
applying VBG O
CCF NN O
for IN O
the DT O
purpose NN O
of IN O
studying VBG O
the DT O
effect NN O
of IN O
different JJ O
bandwidths NNS O
on IN O
the DT O
resulting VBG O
mean JJ O
CCFs NN O
. . O

-DOCSTART- X X O

Treatment NNP O
of IN O
ischemic JJ O
heart NN O
disease NN O
in IN O
the DT O
elderly JJ O

-DOCSTART- X X O

Hepatitis NNP O
B NNP O
and CC O
C NNP O
seroprevalence NN O
rates NNS O
among IN O
high-risk JJ O
adolescents NNS O
are VBP O
lower JJR O
in IN O
El NNP O
Paso NNP O
than IN O
in IN O
other JJ O
similar JJ O
US PRP O
populations NNS O
, , O
presenting VBG O
an DT O
ideal JJ O
climate NN O
for IN O
prevention NN O
programs NNS O
. . O

-DOCSTART- X X O

A DT O
twelfth JJ O
insertion NN O
disrupts NNS O
two CD O
genes NNS O
, , O
Nrk NNP B-NP
, , O
a DT O
"neurospecific JJ B-NP
" `` I-NP
receptor NN I-NP
tyrosine NN I-NP
kinase NN I-NP
, , O
and CC O
Tpp NNP B-NP
, , O
which WDT O
encodes VBZ O
a DT O
neuropeptidase NN B-NP
. . O

-DOCSTART- X X O

A DT O
peculiar JJ O
people NNS O
: : O
" `` O
the DT O
physiological JJ O
aspects NNS O
of IN O
Mormonism NNP O
1850-1975 CD O
." . O

-DOCSTART- X X O

Not RB O
Available JJ O

-DOCSTART- X X O

This DT O
unique JJ O
work NN O
needs VBZ O
to TO O
be VB O
edited VBN O
critically RB O
and CC O
afterwards RB O
translated VBN O
into IN O
Urdu NNP O
and CC O
other JJ O
languages NNS O
for IN O
the DT O
benefit NN O
of IN O
the DT O
present JJ O
day NN O
students NNS O
and CC O
scholars NNS O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
German JJ O
language NN O
versions NNS O
of IN O
the DT O
QWB-SA NNP O
and CC O
SF-36 NNP O
evaluating VBG O
outcomes NNS O
for IN O
patients NNS O
with IN O
prostate JJ O
disease NN O
. . O

-DOCSTART- X X O

Disciplinary JJ O
action NN O
for IN O
DNA NNP O
violation NN O
. . O

-DOCSTART- X X O

Epithelial NNP O
cytotoxicity NN O
of IN O
combined VBN O
antibiotics NNS O
was VBD O
additive JJ O
, , O
with IN O
no DT O
evidence NN O
of IN O
competition NN O
or CC O
synergism NN O
. . O

-DOCSTART- X X O

Pro-inflammatory JJ O
cytokine NN O
, , O
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
( -LRB- O
TNF-alpha NNP B-NP
) -RRB- O
, , O
produced VBD O
from IN O
adipose DT O
tissues NNS O
in IN O
obese JJ O
subjects NNS O
, , O
is VBZ O
known VBN O
to TO O
play VB O
a DT O
predominant JJ O
role NN O
in IN O
inducing VBG O
insulin NN B-NP
resistance NN O
. . O

-DOCSTART- X X O

She PRP O
drank VBD O
alcohol NN O
once RB O
or CC O
twice RB O
a DT O
week NN O
and CC O
regularly RB O
took VBD O
an DT O
analgesic JJ O
preparation NN O
, , O
containing VBG O
aspirin NN O
and CC O
acetaminophen NN O
, , O
for IN O
alleviation NN O
of IN O
headaches NNS O
. . O

-DOCSTART- X X O

The DT O
most RBS O
important JJ O
risk NN O
factors NNS O
are VBP O
: : O
1 CD O
) -RRB- O
genetic JJ O
; : O
2 CD O
) -RRB- O
Epstein-Barr NNP O
virus NN O
( -LRB- O
infectious JJ O
mononucleosis NN O
) -RRB- O
; : O
3 CD O
) -RRB- O
congenital NN O
and CC O
acquired VBD O
immunodeficiency NN O
; : O
4 CD O
) -RRB- O
occupational JJ O
exposure NN O
( -LRB- O
the DT O
wood NN O
industry NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
most RBS O
important JJ O
finding NN O
, , O
however RB O
, , O
was VBD O
that IN O
IMT NNP O
values NNS O
were VBD O
related VBN O
with IN O
24 CD O
h NN O
SBP NNP O
or CC O
PP NNP O
standard JJ O
deviation NN O
( -LRB- O
P NNP O
< NN O
0.001 CD O
) -RRB- O
, , O
a DT O
measure NN O
of IN O
overall JJ O
SBP NNP O
or CC O
PP NNP O
variability NN O
. . O

-DOCSTART- X X O

The DT O
difference NN O
between IN O
the DT O
patients NNS O
and CC O
the DT O
controls NNS O
was VBD O
statistically RB O
significant JJ O
( -LRB- O
p NN O
= SYM O
0.03 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
crude JJ O
oil NN O
spillage NN O
on IN O
growth NN O
, , O
productivity NN O
and CC O
nutrient JJ O
uptake NN O
of IN O
maize NN O
( -LRB- O
Zea NNP O
mays VBZ O
L. NNP O
) -RRB- O
was VBD O
assessed VBN O
in IN O
a DT O
pot NN O
experiment NN O
using VBG O
an DT O
Evwreni NNP O
manifold NN O
sample NN O
of IN O
a DT O
petroleum NN O
development NN O
company NN O
, , O
which WDT O
had VBD O
a DT O
specific JJ O
gravity NN O
of IN O
0.8778 CD O
. . O

-DOCSTART- X X O

NO DT O
metabolites NNS O
were VBD O
determined VBN O
by IN O
the DT O
measurement NN O
of IN O
nitrate/nitrite JJ O
( -LRB- O
NOx RB O
, , O
micromol/mmol JJ O
creatinine NN O
) -RRB- O
and CC O
cyclic JJ O
guanosine NN O
monophosphate NN O
(cGMP NNP O
, , O
nmol/mmol JJ O
creatinine NN O
) -RRB- O
in IN O
plasma NN O
and CC O
urine NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
base-case NN O
analysis NN O
, , O
total JJ O
direct JJ O
costs NNS O
per IN O
patient NN O
were VBD O
$ $ O
728 CD O
for IN O
zoledronic JJ O
acid NN O
and CC O
$ $ O
776 CD O
for IN O
pamidronate JJ O
. . O

-DOCSTART- X X O

The DT O
diet NN O
of IN O
migrants NNS O
showed VBD O
both DT O
positive JJ O
( -LRB- O
macronutrients NNS O
) -RRB- O
and CC O
negative JJ O
( -LRB- O
micronutrients NNS O
) -RRB- O
differences NNS O
with IN O
the DT O
general JJ O
Dutch JJ O
diet NN O
. . O

-DOCSTART- X X O

C. NNP O
elegans NNS O
embryogenesis NN O
begins VBZ O
with IN O
a DT O
stereotyped JJ O
sequence NN O
of IN O
asymmetric JJ O
cell NN O
divisions NNS O
that WDT O
are VBP O
largely RB O
responsible JJ O
for IN O
establishing VBG O
the DT O
nematode NN O
body NN O
plan NN O
. . O

-DOCSTART- X X O

Finally RB O
, , O
a DT O
chromogenic NN O
method NN O
was VBD O
used VBN O
, , O
based VBN O
on IN O
thrombin DT B-NP
inhibition NN O
and CC O
the DT O
substrate NN O
S-2238. . O

-DOCSTART- X X O

The DT O
5' JJ O
flanking NN O
sequence NN O
of IN O
the DT O
3B NNP B-NP
gene NN I-NP
is VBZ O
extremely RB O
A DT O
+ JJ O
T NNP O
rich JJ O
but CC O
contains VBZ O
five CD O
G/C JJ O
rich JJ O
stretches NNS O
, , O
each DT O
approximately RB O
7bp JJ O
long JJ O
, , O
which WDT O
have VBP O
strong JJ O
sequence NN O
similarity NN O
to TO O
the DT O
G NNP O
boxes NNS O
found VBD O
upstream RB O
of IN O
other JJ O
developmentally NN O
regulated VBN O
Dictyostelium NNP O
genes NNS O
. . O

-DOCSTART- X X O

Considering VBG O
that IN O
the DT O
reactor NN O
is VBZ O
thoroughly RB O
mixed JJ O
during IN O
each DT O
discharge NN O
and CC O
that DT O
LD50 NNP O
= SYM O
0.9 CD O
values NNS O
are VBP O
nearly RB O
independent JJ O
of IN O
E. NNP O
coli NNS O
concentrations NNS O
in IN O
the DT O
range NN O
of IN O
2 CD O
x NN O
10( JJ O
3 CD O
) -RRB- O
< NN O
or CC O
= SYM O
E NNP O
coli/cfu NN O
mL(-1 NN O
) -RRB- O
< , O
or CC O
= SYM O
3 CD O
x NN O
10(6 CD O
) -RRB- O
, , O
we PRP O
ascribe VBP O
the DT O
nonexponential JJ O
Pn NNP O
decay NN O
of IN O
single-strain NN O
E. NNP O
coli NNS O
colonies NNS O
to TO O
a DT O
shielding NN O
phenomenon NN O
where WRB O
inactive JJ O
cells NNS O
protect VBP O
the DT O
successively RB O
smaller JJR O
numbers NNS O
of IN O
viable JJ O
cells NNS O
in IN O
the DT O
EHD. NNP O

-DOCSTART- X X O

In IN O
the DT O
long JJ O
term NN O
, , O
questions NNS O
still RB O
remain VBP O
about IN O
whether IN O
pre-dialysis NN O
rHu NN B-NP
EPO NNP I-NP
either CC O
speeds VBZ O
up RP O
or CC O
delays NNS O
the DT O
onset NN O
of IN O
dialysis NN O
. . O

-DOCSTART- X X O

No DT O
ISREs NNP B-NP
could MD O
be VB O
identified VBN O
in IN O
the DT O
mouse NN O
promoter NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
Ischemic NNP O
heart NN O
disease NN O
is VBZ O
the DT O
primary JJ O
cause NN O
of IN O
morbidity NN O
and CC O
mortality NN O
among IN O
diabetics NNS O
, , O
especially RB O
those DT O
who WP O
became VBD O
ill RB O
at IN O
a DT O
young JJ O
age NN O
. . O

-DOCSTART- X X O

A DT O
38-year-old JJ O
woman NN O
with IN O
ulcerative JJ O
colitis NN O
subsequently RB O
developed VBD O
sarcoidosis NN O
. . O

-DOCSTART- X X O

Cholesteryl NNP B-NP
ester NN I-NP
transfer NN I-NP
protein NN I-NP
and CC O
atherosclerosis NN O
in IN O
Japanese JJ O
subjects NNS O
: : O
a DT O
study NN O
based VBN O
on IN O
coronary JJ O
angiography NN O
. . O

-DOCSTART- X X O

Electrophoretic NNP O
mobility NN O
shift NN O
assays VBZ O
and CC O
coimmunoprecipitation NN O
studies NNS O
suggest VBP O
that IN O
homo- NNS O
and CC O
heterodimerization NN O
occurs VBZ O
between IN O
cKrox JJ B-NP
family NN I-NP
members NNS I-NP
. . O

-DOCSTART- X X O

The DT O
hcKrox NN B-NP
gene NN O
family NN O
regulates VBZ O
multiple JJ O
extracellular JJ O
matrix NN O
genes NNS O
. . O

-DOCSTART- X X O

A DT O
review NN O
of IN O
the DT O
literature NN O
identified VBD O
8 CD O
comprehensive JJ O
clinical JJ O
studies NNS O
, , O
all DT O
of IN O
which WDT O
failed VBD O
to TO O
document VB O
any DT O
relationship NN O
between IN O
NF1 NNP B-NP
and CC O
intracranial JJ O
aneurysms NNS O
. . O

-DOCSTART- X X O

These DT O
utilisation NN O
data NNS O
imply VBP O
annual JJ O
drug NN O
costs NNS O
in IN O
the DT O
range NN O
of IN O
$ $ O
US PRP O
480,000 CD O
to TO O
$ $ O
US PRP O
3,600,000 CD O
for IN O
TNF NNP B-NP
antagonists NNS O
for IN O
RA NNP O
per IN O
1 CD O
million CD O
population NN O
. . O

-DOCSTART- X X O

Under IN O
our PRP$ O
conditions NNS O
, , O
the DT O
combination NN O
O3/UV NNP O
did VBD O
not RB O
improve VB O
the DT O
degradation NN O
rate NN O
obtained VBN O
by IN O
ozonation NN O
. . O

-DOCSTART- X X O

This DT O
study NN O
investigated VBD O
whether IN O
boron NN O
would MD O
enhance VB O
the DT O
ability NN O
of IN O
17beta-estradiol JJ O
( -LRB- O
E2 NN O
) -RRB- O
or CC O
parathyroid NN B-NP
hormone NN I-NP
( -LRB- O
PTH) NN B-NP
to TO O
improve VB O
bone NN O
quality NN O
in IN O
ovariectomized JJ O
OVX NNP O
rats NNS O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
in IN O
the DT O
control NN O
subjects NNS O
rCBF VBP O
increases NNS O
in IN O
regions NNS O
associated VBN O
with IN O
the DT O
meso-striatal JJ O
and CC O
meso-corticolimbic JJ O
circuits NNS O
in IN O
response NN O
to TO O
both DT O
monetary JJ O
reward NN O
and CC O
nonmonetary JJ O
reinforcement NN O
. . O

-DOCSTART- X X O

Doxorubicin NNP O
( -LRB- O
DOX VB O
) -RRB- O
is VBZ O
commonly RB O
used VBN O
for IN O
the DT O
treatment NN O
of IN O
hematological JJ O
and CC O
solid JJ O
tumors NNS O
. . O

-DOCSTART- X X O

The DT O
event NN O
rate NN O
in IN O
patients NNS O
with IN O
chronic JJ O
Irr-rMFP NNP O
or CC O
Un-nrMFP NNP O
was VBD O
markedly RB O
higher JJR O
than IN O
it PRP O
was VBD O
in IN O
those DT O
with IN O
Rev-rMFP NNP O
or CC O
Sta-nrMFP. NNP O

-DOCSTART- X X O

Subtraction NNP O
hybridization NN O
identified VBN O
melanoma NN B-NP
differentiation NN I-NP
associated VBN I-NP
gene-7 JJ I-NP
( -LRB- O
mda-7 NN B-NP
) -RRB- O
, , O
as IN O
a DT O
gene NN O
induced VBN O
during IN O
these DT O
physiological JJ O
changes NNS O
in IN O
human JJ O
melanoma NN O
cells NNS O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
vitamin NN O
D3 IN O
analogues NNS O
have VBP O
a DT O
substantial JJ O
antipsoriatic JJ O
effect NN O
. . O

-DOCSTART- X X O

Hydrocoele NNP O
is VBZ O
common JJ O
in IN O
men NNS O
in IN O
Wuchereria NNP O
bancrofti-endemic JJ O
areas NNS O
, , O
the DT O
treatment NN O
for IN O
which WDT O
is VBZ O
currently RB O
surgical JJ O
intervention NN O
. . O

-DOCSTART- X X O

Growth NN B-NP
hormone NN I-NP
and CC O
insulin-like JJ B-NP
growth NN I-NP
factor NN I-NP
I PRP I-NP
receptors VBD I-NP
in IN O
the DT O
temporomandibular JJ O
joint NN O
of IN O
the DT O
rat NN O
. . O

-DOCSTART- X X O

On IN O
the DT O
other JJ O
hand NN O
, , O
hepatic JJ O
arterial JJ O
infusion NN O
therapy NN O
prolongs VBZ O
the DT O
survival NN O
of IN O
H3 CD O
patients NNS O
only RB O
. . O

-DOCSTART- X X O

In IN O
addition NN O
to TO O
that DT O
, , O
she PRP O
received VBD O
hepatic JJ O
intra-arterial JJ O
infusion NN O
of IN O
levoforinate JJ O
(l-LV NN O
) -RRB- O
250 CD O
mg JJ O
and CC O
5-fluorouracil JJ O
(5-FU) JJ O
500 CD O
mg NN O
for IN O
combined VBN O
multiple JJ O
hepatic JJ O
metastases NNS O
starting VBG O
on IN O
postoperative JJ O
day NN O
14 CD O
, , O
and CC O
these DT O
medications NNS O
were VBD O
administered VBN O
over IN O
48 CD O
hours NNS O
once RB O
weekly RB O
by IN O
infuser NN O
pump NN O
. . O

-DOCSTART- X X O

The DT O
astronaut NN O
crew NN O
operates VBZ O
the DT O
payload NN O
and CC O
documents NNS O
its PRP$ O
operation NN O
. . O

-DOCSTART- X X O

For IN O
these DT O
patients NNS O
the DT O
introduction NN O
of IN O
a DT O
separate JJ O
category NN O
"extended VBD O
oligoarthritis NN O
at IN O
onset JJ O
" `` O
should MD O
be VB O
considered VBN O
to TO O
establish VB O
comparable JJ O
patient JJ O
groups NNS O
. . O

-DOCSTART- X X O

Finally RB O
, , O
there EX O
are VBP O
a DT O
growing VBG O
number NN O
of IN O
arguments NNS O
favouring VBG O
the DT O
use NN O
of IN O
ACE NNP B-NP
inhibitors VBZ O
very RB O
early JJ O
in IN O
patients NNS O
with IN O
diabetes NNS O
mellitus NN O
. . O

-DOCSTART- X X O

Phase NNP O
II NNP O
trial NN O
of IN O
the DT O
anti-G( JJ B-NP
D2 NN I-NP
) -RRB- I-NP
monoclonal JJ I-NP
antibody NN I-NP
3F8 . I-NP
and CC O
granulocyte-macrophage JJ B-NP
colony-stimulating JJ I-NP
factor NN I-NP
for IN O
neuroblastoma NN O
. . O

-DOCSTART- X X O

Eliminating VBG O
any DT O
subset NN O
of IN O
ASCUS NNP O
reduces VBZ O
the DT O
ASCUS/SIL NNP O
ratio NN O
but CC O
also RB O
significantly RB O
diminishes VBZ O
the DT O
sensitivity NN O
of IN O
the DT O
Papanicolaou NNP O
test NN O
. . O

-DOCSTART- X X O

Eliminating VBG O
any DT O
subset NN O
of IN O
ASCUS NNP O
reduces VBZ O
the DT O
ASCUS/SIL NNP O
ratio NN O
but CC O
also RB O
significantly RB O
diminishes VBZ O
the DT O
sensitivity NN O
of IN O
the DT O
Papanicolaou NNP O
test NN O
. . O

-DOCSTART- X X O

Two CD O
nuclear JJ O
medicine NN O
physicians NNS O
blinded VBD O
to TO O
the DT O
surgical JJ O
findings NNS O
interpreted VBD O
all DT O
available JJ O
images NNS O
and CC O
various JJ O
Tc-99m JJ O
MIBI JJ O
image NN O
combinations NNS O
at IN O
15 CD O
minutes NNS O
alone RB O
; : O
15 CD O
minutes NNS O
and CC O
2 CD O
hours NNS O
, , O
15 CD O
minutes NNS O
and CC O
4 CD O
hours NNS O
; : O
and CC O
15 CD O
minutes NNS O
and CC O
2 CD O
and CC O
4 CD O
hours NNS O
each DT O
with IN O
and CC O
without IN O
correlative JJ O
pertechnetate NN O
thyroid VBD O
imaging VBG O
. . O

-DOCSTART- X X O

Is VBZ O
clopidogrel NN O
superior JJ O
to TO O
aspirin NN O
in IN O
secondary JJ O
prevention NN O
of IN O
vascular JJ O
disease NN O
? . O
The DT O
cornerstone NN O
in IN O
clinical JJ O
evidence NN O
of IN O
the DT O
relative JJ O
efficacy NN O
of IN O
thienopyridines NNS O
( -LRB- O
clopidogrel NN O
, , O
ticlopidine NN O
) -RRB- O
versus FW O
aspirin NN O
in IN O
the DT O
secondary JJ O
prevention NN O
of IN O
vascular JJ O
disease NN O
is VBZ O
the DT O
Clopidogrel NNP O
versus NN O
Aspirin NNP O
in IN O
Patients NNP O
at IN O
Risk NNP O
of IN O
Ischaemic NNP O
Events NNS O
trial NN O
. . O

-DOCSTART- X X O

We PRP O
hypothesize VBP O
that IN O
proprioception NN O
may MD O
be VB O
used VBN O
to TO O
calibrate VB O
the DT O
efference NN O
copy NN O
during IN O
development NN O
and CC O
in IN O
response NN O
to TO O
perturbations NNS O
by IN O
signaling VBG O
potential JJ O
mismatches NNS O
between IN O
eye NN O
movement NN O
information NN O
derived VBN O
from IN O
the DT O
efferent NN O
command NN O
and CC O
the DT O
actual JJ O
motion NN O
of IN O
the DT O
eye NN O
transduced VBN O
by IN O
the DT O
proprioceptive JJ O
organs NNS O
. . O

-DOCSTART- X X O

Between IN O
1967 CD O
and CC O
1994 CD O
, , O
495 CD O
patients NNS O
underwent JJ O
surgery NN O
for IN O
primary JJ O
PTC NNP O
at IN O
the DT O
Department NNP O
of IN O
Surgery NNP O
, , O
Helsinki NNP O
University NNP O
Central NNP O
Hospital NNP O
. . O

-DOCSTART- X X O

ISS NNP O
and CC O
the DT O
acute JJ O
physiology NN O
and CC O
chronic JJ O
health NN O
evaluation NN O
( -LRB- O
APACHE NN O
II NNP O
) -RRB- O
calculated VBN O
on IN O
admission NN O
. . O

-DOCSTART- X X O

The DT O
procedure NN O
is VBZ O
less RBR O
aggressive JJ O
and CC O
painful JJ O
than IN O
sternotomy NN O
. . O

-DOCSTART- X X O

Regarding VBG O
gestational JJ O
risk NN O
, , O
3,243 CD O
drugs NNS O
used VBD O
( -LRB- O
34 CD O
% NN O
) -RRB- O
belonged VBN O
to TO O
category NN O
A DT O
risk NN O
, , O
1,923 CD O
( -LRB- O
22.6 CD O
% NN O
) -RRB- O
to TO O
category NN O
B NNP O
, , O
3,798 CD O
( -LRB- O
39.7 CD O
% NN O
) -RRB- O
to TO O
category NN O
C NNP O
, , O
289 CD O
( -LRB- O
3.0 CD O
% NN O
) -RRB- O
to TO O
category NN O
D NNP O
, , O
and CC O
55 CD O
( -LRB- O
0.6 CD O
% NN O
) -RRB- O
to TO O
category NN O
X NNP O
. . O

-DOCSTART- X X O

The DT O
severity NN O
of IN O
clinical JJ O
course NN O
was VBD O
expressed VBN O
by IN O
means NNS O
of IN O
SOFA JJ O
score NN O
( -LRB- O
group NN O
A DT O
0.3-1-1.3 CD O
point NN O
, , O
group NN O
B NNP O
2.2-2.9-2.6 CD O
point NN O
, , O
group NN O
C NNP O
7.4-8.3-7.7 CD O
point NN O
) -RRB- O
and CC O
APACHE NNP O
II NNP O
score NN O
( -LRB- O
group NN O
A DT O
3.7-7.6-8.1 CD O
point NN O
, , O
group NN O
B NNP O
8.6-11.1-10.5 CD O
point NN O
, , O
group NN O
C NNP O
16.3-15.2-14.3 JJ O
point NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
process NN O
has VBZ O
been VBN O
applied VBN O
to TO O
the DT O
river NN O
reclamation NN O
in IN O
Yangpu NNP O
District NNP O
of IN O
Shanghai NNP O
City NNP O
, , O
China NNP O
. . O

-DOCSTART- X X O

Physical JJ O
principles NNS O
in IN O
therapeutic JJ O
apheresis NN O
. . O

-DOCSTART- X X O

These DT O
results NNS O
were VBD O
compared VBN O
with IN O
the DT O
estimates NNS O
of IN O
penetration NN O
from IN O
steady-state JJ O
calculations NNS O
, , O
square JJ O
root NN O
of IN O
time NN O
calculations NNS O
, , O
and CC O
a DT O
biologically RB O
based VBN O
mathematical JJ O
model NN O
. . O

-DOCSTART- X X O

Rind NNP O
et NNP O
al NN O
. . O
's POS O
study NN O
's POS O
main JJ O
conclusions NNS O
were VBD O
not RB O
supported VBN O
by IN O
the DT O
original JJ O
data NNS O
. . O

-DOCSTART- X X O

Of IN O
major JJ O
concern NN O
to TO O
food NN O
processors NNS O
is VBZ O
the DT O
inadvertent JJ O
cross-contact NN O
of IN O
food NN O
products NNS O
with IN O
allergenic JJ O
residues NNS O
, , O
which WDT O
could MD O
result VB O
in IN O
potentially RB O
life-threatening JJ O
reactions NNS O
in IN O
those DT O
with IN O
a DT O
food NN O
allergy NN O
. . O

-DOCSTART- X X O

Lactate NNP O
accumulation NN O
peak NN O
was VBD O
unaffected JJ O
by IN O
supplementation NN O
( -LRB- O
HMB NNP O
, , O
8.1 CD O
+/ CD O
- : O
1.1 CD O
mM NN O
; : O
LEU NNP O
, , O
6.2 CD O
+/ CD O
- : O
0.8 CD O
mM NN O
; : O
CON NNP O
, , O
7.5 CD O
+/ NNS O
- : O
1.3 CD O
mM NN O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
increased JJ O
clearance NN O
observed VBN O
in IN O
young JJ O
infants NNS O
is VBZ O
in IN O
contrast NN O
to TO O
other JJ O
opioids NNS O
. . O

-DOCSTART- X X O

These DT O
results NNS O
were VBD O
robust JJ O
to TO O
changes NNS O
in IN O
the DT O
baseline JJ O
assumptions NNS O
of IN O
the DT O
model NN O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
The DT O
training NN O
of IN O
novices NNS O
using VBG O
MIST-VR JJ O
yields NNS O
quantifiable JJ O
changes NNS O
in IN O
skill NN O
that WDT O
are VBP O
transferable JJ O
to TO O
a DT O
simple JJ O
real JJ O
task NN O
and CC O
are VBP O
similar JJ O
to TO O
the DT O
results NNS O
achieved VBN O
with IN O
conventional JJ O
training NN O
. . O

-DOCSTART- X X O

The DT O
patients NNS O
and CC O
their PRP$ O
families NNS O
were VBD O
closely RB O
questioned VBN O
, , O
and CC O
full JJ O
clinical JJ O
examination NN O
included VBD O
a DT O
test NN O
for IN O
orthostasia NN O
. . O

-DOCSTART- X X O

They PRP O
have VBP O
not RB O
been VBN O
previously RB O
reported VBN O
as IN O
a DT O
reaction NN O
to TO O
i PRP$ O
.v. NNP O
contrast NN O
material NN O
. . O

-DOCSTART- X X O

There EX O
was VBD O
a DT O
statistically RB O
significant JJ O
correlation NN O
between IN O
simultaneous JJ O
weekly JJ O
average NN O
pollen NN O
levels NNS O
in IN O
Philadelphia NNP O
and CC O
in IN O
Cherry NNP O
Hill NNP O
( -LRB- O
Acer NN O
, , O
r( JJ O
p NN O
) -RRB- O
= SYM O
0.987 CD O
, , O
Quercus NNP O
, , O
r( JJ O
p NN O
) -RRB- O
= SYM O
0.645 CD O
, , O
Betula NNP O
, , O
r( JJ O
p NN O
) -RRB- O
= SYM O
0.896 CD O
, , O
Pinus NNP O
, , O
r( JJ O
p NN O
) -RRB- O
= SYM O
0.732 CD O
, , O
Cupressaceae NNP O
, , O
r( JJ O
p NN O
) -RRB- O
= SYM O
0.695 CD O
, , O
Poaceae NNP O
, , O
r( JJ O
p NN O
) -RRB- O
= SYM O
0.950 CD O
, , O
Ambrosia NNP O
, , O
r( JJ O
p NN O
) -RRB- O
= SYM O
0.903 CD O
, , O
and CC O
Rumex NNP O
, , O
r( JJ O
p NN O
) -RRB- O
= SYM O
0.572 CD O
, , O
P NNP O
<0.001 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Encouraged VBN O
by IN O
a DT O
Dutch JJ O
study NN O
using VBG O
etidronate/fluoride NN O
in IN O
corticoid-induced JJ O
osteoporosis NN O
, , O
we PRP O
performed VBD O
a DT O
pilot NN O
study NN O
in IN O
33 CD O
men NNS O
with IN O
severe JJ O
established VBN O
primary JJ O
osteoporosis NN O
giving VBG O
cyclically RB O
etidronate JJ O
for IN O
14 CD O
days NNS O
followed VBN O
by IN O
fluoride NN O
plus CC O
calcium/vitamin NN O
D NNP O
for IN O
76 CD O
days NNS O
. . O

-DOCSTART- X X O

Treadmill NNP O
training NN O
at IN O
least JJS O
for IN O
2 CD O
weeks NNS O
can MD O
reduce VB O
the DT O
infarction NN O
size NN O
and CC O
edema NN O
caused VBN O
by IN O
MCA NNP O
occlusion NNP O
( -LRB- O
P<0.01 NN O
) -RRB- O
. . O

-DOCSTART- X X O

In IN O
order NN O
to TO O
overcome VB O
the DT O
false JJ O
positive JJ O
readings NNS O
that WDT O
are VBP O
possible JJ O
in IN O
sphincter NN O
manometry NN O
, , O
we PRP O
proposed VBD O
to TO O
use VB O
secretin NN B-NP
stimulated VBN O
endoscopic JJ O
ultrasound NN O
( -LRB- O
SSEUS) NNP O
to TO O
measure VB O
pancreatic JJ O
ductal JJ O
response NN O
as IN O
an DT O
adjunctive JJ O
method NN O
to TO O
aid VB O
and CC O
supplement VB O
the DT O
diagnosis NN O
. . O

-DOCSTART- X X O

The DT O
cut-off JJ O
percentage NN O
positivity NN O
value NN O
was VBD O
established VBN O
using VBG O
500 CD O
brucellosis-positive JJ O
and CC O
500 CD O
brucellosis-negative JJ O
serum NN O
samples NNS O
, , O
confirmed VBN O
with IN O
reference NN O
to TO O
the DT O
sample NN O
data NN O
using VBG O
the DT O
indirect JJ O
ELISA NNP O
kit NN O
. . O

-DOCSTART- X X O

An DT O
analysis NN O
of IN O
the DT O
dynamics NNS O
is VBZ O
performed VBN O
of IN O
exactly RB O
solvable JJ O
models NNS O
for IN O
fragile JJ O
and CC O
strong JJ O
glasses NNS O
, , O
exploiting VBG O
the DT O
partitioning NN O
of IN O
the DT O
free-energy JJ O
landscape NN O
in IN O
inherent JJ O
structures NNS O
. . O

-DOCSTART- X X O

Fifty-six CD O
semen NNS O
samples NNS O
were VBD O
included VBN O
in IN O
this DT O
study NN O
; : O
18 CD O
were VBD O
subnormal JJ O
( -LRB- O
G1 NN O
) -RRB- O
and CC O
38 CD O
were VBD O
normal JJ O
( -LRB- O
G2 NN O
) -RRB- O
based VBN O
on IN O
World NNP O
Health NNP O
Organization NNP O
criteria NNS O
, , O
except IN O
for IN O
morphology NN O
, , O
which WDT O
was VBD O
evaluated VBN O
according VBG O
to TO O
strict JJ O
criteria NNS O
. . O

-DOCSTART- X X O

At IN O
this DT O
timepoint NN O
, , O
many JJ O
leucocytes NNS O
in IN O
the DT O
ME NNP O
and CC O
ET NNP O
mucosa NN O
had VBD O
incorporated JJ O
BrdU NNP O
( -LRB- O
between IN O
15 CD O
and CC O
25 CD O
% NN O
within IN O
the DT O
subsets NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Modality-specific JJ O
areas NNS O
( -LRB- O
e NN O
.g. NNP O
, , O
right JJ O
Wernicke NNP O
, , O
left VBD O
fusiform NN O
gyrus NN O
, , O
Broca NNP O
BA44 NNP O
, , O
supramarginal JJ O
gyrus NN O
) -RRB- O
, , O
appear VBP O
to TO O
cope VB O
with IN O
the DT O
computations NNS O
relevant JJ O
to TO O
making VBG O
contact NN O
with IN O
these DT O
more JJR O
abstract JJ O
dimensions NNS O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
no DT O
correlation NN O
between IN O
plasma NN O
COP NNP O
and CC O
body NN O
weight NN O
at IN O
the DT O
same JJ O
age NN O
( -LRB- O
r2 NN O
= SYM O
0.05 CD O
, , O
P NNP O
= SYM O
0.155 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Their PRP$ O
chemical NN O
structures NNS O
were VBD O
elucidated VBN O
as IN O
1 CD O
alpha,2 NN O
alpha-diacetoxy-8 NNS O
beta-isobutanoyloxy- : O
9 CD O
alpha-benzoyloxy-13-(alpha-methyl)butanoyloxy-4 NN O
beta NN O
, , O
6 CD O
beta-dihydroxy-beta-dihydroagarofuran JJ O
( -LRB- O
1 CD O
) -RRB- O
, , O
1 CD O
alpha,2 NN O
alpha-diacetoxy-8 CC O
beta-(beta JJ O
- : O
furancarbonyloxy)-9 JJ O
alpha-benzoyloxy-13-isobutanoyloxy-4 NN O
beta NN O
, , O
6 CD O
beta-dihydroxy-beta-dihydroagarofuran NN O
( -LRB- O
2 CD O
) -RRB- O
and CC O
1 CD O
alpha NN O
, , O
6 CD O
beta NN O
, , O
8 CD O
alpha,13-tetraacetoxy-9 NN O
alpha-benzoyloxy-2 NN O
alpha-hydroxy-beta-dihydroagarofuran NN O
( -LRB- O
3 CD O
) -RRB- O
mainly RB O
by IN O
analyses NNS O
NMR NNP O
and CC O
MS NNP O
spectral JJ O
data NNS O
. . O

-DOCSTART- X X O

Both DT O
toxins NNS O
in IN O
a DT O
dose NN O
10-fold JJ O
surpassing NN O
the DT O
maximum NN O
permissible JJ O
concentration NN O
increased VBN O
activity NN O
of IN O
glutathione NN B-NP
peroxidase NN I-NP
in IN O
brain NN O
tissue NN O
; : O
moreover RB O
, , O
toluene NN O
increased VBD O
chemiluminescence NN O
intensity NN O
, , O
which WDT O
attested VBD O
to TO O
activation NN O
of IN O
free JJ O
radical JJ O
processes NNS O
. . O

-DOCSTART- X X O

The DT O
performance NN O
of IN O
pH-sensitive JJ O
particles NNS O
is VBZ O
attributed VBN O
to TO O
their PRP$ O
ability NN O
to TO O
release VB O
the DT O
drug NN O
selectively RB O
in IN O
the DT O
upper JJ O
part NN O
of IN O
the DT O
intestine NN O
in IN O
a DT O
molecular JJ O
or CC O
amorphous JJ O
form NN O
. . O

-DOCSTART- X X O

Comparison NNP O
of IN O
remnant-like JJ O
lipoprotein NN O
particles NNS O
in IN O
postmenopausal JJ O
women NNS O
with IN O
and CC O
without IN O
coronary JJ O
artery NN O
disease NN O
and CC O
in IN O
men NNS O
with IN O
coronary JJ O
artery NN O
disease NN O
. . O

-DOCSTART- X X O

Because IN O
results NNS O
of IN O
recent JJ O
randomized JJ O
trials NNS O
indicate VBP O
minimal JJ O
efficacy NN O
of IN O
continuing VBG O
MAC NNP O
prophylaxis NNS O
in IN O
patients NNS O
who WP O
respond VBP O
to TO O
potent JJ O
combination NN O
antiretroviral JJ O
therapy NN O
, , O
the DT O
observed JJ O
high JJ O
incidence NN O
of IN O
macrolide-resistant JJ O
bacterial JJ O
colonization NN O
of IN O
the DT O
respiratory JJ O
tract NN O
in IN O
this DT O
trial NN O
supports VBZ O
the DT O
discontinuation NN O
of IN O
macrolide NN O
prophylaxis NNS O
in IN O
all DT O
AIDS NNP O
patients NNS O
whose WP$ O
CD4 NNP B-NP
counts NNS O
have VBP O
risen VBN O
above IN O
100 CD O
cells/microL NN O
. . O

-DOCSTART- X X O

Acute JJ O
stress NN O
in IN O
7 CD O
rats NNS O
also RB O
increased VBD O
the DT O
mean JJ O
amount NN O
of IN O
IL-6 NN B-NP
released VBN O
in IN O
the DT O
urine NN O
by IN O
31.5 CD O
% NN O
from IN O
775.9 CD O
+/ CD O
- : O
69.2 CD O
to TO O
1,021.1 CD O
+/ CD O
- : O
93.3 CD O
pg NN O
./ml NN O
. . O

-DOCSTART- X X O

Patients NNS O
with IN O
CF NNP O
and CC O
meconium NN O
ileus NN O
presented VBD O
a DT O
poor JJ O
nutritional JJ O
status NN O
at IN O
diagnosis NN O
and CC O
a DT O
lower JJR O
survival NN O
rate NN O
compared VBN O
to TO O
the DT O
general JJ O
CF NNP O
population NN O
. . O

-DOCSTART- X X O

( -LRB- O
Cactaceae NN O
) -RRB- O
waste NN O
matter NN O
. . O

-DOCSTART- X X O

Skin NNP O
cancers NNS O
, , O
followed VBN O
by IN O
gastrointestinal JJ O
tract NN O
and CC O
male JJ O
genital JJ O
system NN O
affected VBN O
mostly RB O
older JJR O
age NN O
patients NNS O
. . O

-DOCSTART- X X O

CONCLUSION NN O
: : O
MMF NNP O
(2-3 NN O
g/day NN O
) -RRB- O
is VBZ O
unable JJ O
to TO O
control VB O
the DT O
signs NNS O
of IN O
mucocutaneous JJ O
Adamantiades-Behcet NNP O
's POS O
disease NN O
. . O

-DOCSTART- X X O

In IN O
the DT O
treatment NN O
of IN O
opioid JJ O
naive JJ O
patients NNS O
who WP O
underwent VBD O
surgery NN O
and CC O
received VBD O
opioids NNS O
for IN O
acute JJ O
pain NN O
, , O
oral JJ O
ADL NNP O
8-2698 CD O
( -LRB- O
6.0 CD O
mg NN O
) -RRB- O
improved VBN O
the DT O
management NN O
of IN O
postoperative JJ O
ileus NN O
( -LRB- O
POI NN O
) -RRB- O
by IN O
shortening VBG O
the DT O
time NN O
to TO O
achieve VB O
normal JJ O
bowel NN O
function NN O
and CC O
, , O
ultimately RB O
, , O
hospital NN O
stay NN O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
302 CD O
consecutive JJ O
patients NNS O
with IN O
BS NNP O
and CC O
438 CD O
patients NNS O
with IN O
other JJ O
rheumatological JJ O
conditions NNS O
were VBD O
surveyed VBN O
for IN O
the DT O
presence NN O
or CC O
absence NN O
of IN O
the DT O
features NNS O
of IN O
BS NNP O
by IN O
means NNS O
of IN O
a DT O
standard JJ O
form NN O
which WDT O
had VBD O
been VBN O
prepared VBN O
according VBG O
to TO O
ISG NNP O
criteria NNS O
. . O

-DOCSTART- X X O

Evidence NN O
suggests VBZ O
that IN O
PHACES NNS O
syndrome NN O
is VBZ O
not RB O
a DT O
random JJ O
association NN O
but CC O
a DT O
true JJ O
phakomatosis NN O
; : O
further JJ O
studies NNS O
are VBP O
awaited VBD O
to TO O
shed VB O
light NN O
on IN O
a DT O
possible JJ O
genetic JJ O
background NN O
. . O

-DOCSTART- X X O

A DT O
computer NN O
program NN O
, , O
ACCESS-IAQ NNP O
, , O
is VBZ O
developed VBN O
to TO O
simulate VB O
the DT O
airflow NN O
pattern NN O
, , O
the DT O
time NN O
history NN O
of IN O
the DT O
contaminant JJ O
concentrations NNS O
in IN O
the DT O
occupied JJ O
zone NN O
, , O
and CC O
the DT O
inhalation NN O
exposures NNS O
. . O

-DOCSTART- X X O

Moreover RB O
, , O
a DT O
severe JJ O
decrease NN O
of IN O
antithrombin JJ B-NP
activity NN O
became VBD O
evident JJ O
during IN O
both DT O
experiments NNS O
(eg VBP O
, , O
in IN O
experiment NN O
2 CD O
from IN O
95.6 CD O
+/ JJ O
- : O
4.8 CD O
to TO O
59.2 CD O
+/ CD O
- : O
6.6 CD O
% NN O
) -RRB- O
. . O

-DOCSTART- X X O

Classification NN O
according VBG O
to TO O
the DT O
ILAR NN O
criteria NNS O
was VBD O
possible JJ O
in IN O
321 CD O
patients NNS O
; : O
290 CD O
patients NNS O
had VBD O
a DT O
disease NN O
duration NN O
> , O
or CC O
= SYM O
3 CD O
months NNS O
and CC O
were VBD O
classified VBN O
according VBG O
to TO O
the DT O
EULAR NN O
criteria NNS O
. . O

-DOCSTART- X X O

Described NNP O
X-ray NN O
projection NN O
were VBD O
performed VBN O
in IN O
70 CD O
patients NNS O
. . O

-DOCSTART- X X O

We PRP O
conducted VBD O
a DT O
clinical JJ O
and CC O
pathologic JJ O
review NN O
of IN O
nine CD O
patients NNS O
with IN O
immature JJ O
ovarian JJ O
teratoma NN O
. . O

-DOCSTART- X X O

Pyrethroid NNP O
insecticides NNS O
are VBP O
widely RB O
used VBN O
in IN O
agriculture NN O
and CC O
private JJ O
households NNS O
. . O

-DOCSTART- X X O

The DT O
sorption NN O
mechanisms NNS O
changed VBD O
from IN O
adsorption NN O
to TO O
partition NN O
in IN O
the DT O
process NN O
of IN O
repetitious JJ O
sorption NN O
. . O

-DOCSTART- X X O

Although IN O
the DT O
spatial JJ O
and CC O
temporal JJ O
variability NN O
of IN O
LDF NNP O
signals NNS O
evoked VBN O
by IN O
cerebrocortical JJ O
microflow NN O
is VBZ O
in IN O
the DT O
same JJ O
range NN O
as IN O
with IN O
other JJ O
methods NNS O
and CC O
in IN O
other JJ O
organs NNS O
, , O
LDF NNP O
cerebrocortical JJ O
mapping NN O
is VBZ O
restricted VBN O
by IN O
the DT O
large JJ O
temporal JJ O
and CC O
spatial JJ O
heterogeneity NN O
of IN O
the DT O
cerebrocortical JJ O
vasculature NN O
. . O

-DOCSTART- X X O

The DT O
5-year JJ O
overall JJ O
survival NN O
( -LRB- O
OS NNP O
) -RRB- O
and CC O
progression-free JJ O
survival NN O
( -LRB- O
PFS NNP O
) -RRB- O
rates NNS O
were VBD O
58.9 CD O
% NN O
and CC O
55.4 CD O
% NN O
for IN O
arm NN O
A DT O
and CC O
44.5 CD O
% NN O
and CC O
41.3 CD O
% NN O
for IN O
arm NN O
B NNP O
( -LRB- O
P NNP O
=.007 CD O
and CC O
P NNP O
=.02 CD O
) -RRB- O
, , O
respectively RB O
. . O

-DOCSTART- X X O

Traditional NNP O
surgical JJ O
exploration NN O
was VBD O
followed VBN O
by IN O
survey NN O
with IN O
a DT O
gamma-detecting NN O
probe NN O
. . O

-DOCSTART- X X O

No DT O
effect NN O
of IN O
the DT O
intervention NN O
on IN O
depression NN O
scores NNS O
was VBD O
found VBN O
. . O

-DOCSTART- X X O

IV. NNP O
combined VBD O
sclerosis NN O
and CC O
resorption NN O
of IN O
the DT O
skull NN O
base NN O
( -LRB- O
6 CD O
cases NNS O
, , O
2 CD O
group NN O
I PRP O
lesions VBD O
and CC O
4 CD O
group NN O
II NNP O
lesions NNS O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
quantity NN O
of IN O
each DT O
population NN O
( -LRB- O
L. NNP O
bulgaricus NN O
, , O
S. NNP O
thermophilus POS O
) -RRB- O
was VBD O
then RB O
estimated VBN O
in IN O
the DT O
pellet NN O
by IN O
PyMS NNP O
, , O
and CC O
the DT O
data NNS O
were VBD O
analysed VBN O
by IN O
artificial JJ O
neural JJ O
networks NNS O
( -LRB- O
ANNs NN O
) -RRB- O
. . O

-DOCSTART- X X O

AF NNS B-NP
showed VBD O
a DT O
mixed JJ O
nuclear/cytoplasmic JJ O
pattern NN O
of IN O
expression NN O
in IN O
the DT O
epithelial NN O
, , O
endothelial JJ O
, , O
and CC O
stromal JJ O
component NN O
of IN O
the DT O
normal JJ O
breast NN O
and CC O
benign JJ O
lesions NNS O
, , O
whereas IN O
an DT O
impressive JJ O
loss NN O
of IN O
AF NNS B-NP
expression NN O
was VBD O
noted VBN O
in IN O
in IN O
situ NN O
and CC O
invasive JJ O
breast NN O
cancer NN O
and CC O
tumoral JJ O
stroma NN O
. . O

-DOCSTART- X X O

We PRP O
derive VBP O
joint JJ O
probability NN O
density NN O
distributions NNS O
for IN O
three CD O
key JJ O
uncertain JJ O
properties NNS O
of IN O
the DT O
climate NN O
system NN O
, , O
using VBG O
an DT O
optimal JJ O
fingerprinting NN O
approach NN O
to TO O
compare VB O
simulations NNS O
of IN O
an DT O
intermediate JJ O
complexity NN O
climate NN O
model NN O
with IN O
three CD O
distinct JJ O
diagnostics NNS O
of IN O
recent JJ O
climate NN O
observations NNS O
. . O

-DOCSTART- X X O

Frequency NNP O
of IN O
seeing VBG O
curves NNS O
were VBD O
examined VBN O
for IN O
the DT O
method NN O
most RBS O
similar JJ O
to TO O
FDT. NNP O

-DOCSTART- X X O

Chronic NNP O
graft-versus-host NN O
disease NN O
(cGVHD NN O
) -RRB- O
is VBZ O
a DT O
major JJ O
complication NN O
of IN O
allogeneic DT O
hematopoietic JJ O
cell NN O
transplantation NN O
. . O

-DOCSTART- X X O

Compared VBN O
to TO O
white-on-white JJ O
(W-W) JJ O
perimetry NN O
, , O
SWAP NNP O
is VBZ O
limited VBN O
clinically RB O
by IN O
: : O
greater JJR O
variability NN O
associated VBN O
with IN O
the DT O
estimation NN O
of IN O
threshold NN O
, , O
ocular JJ O
media NNS O
absorption NN O
, , O
increased VBD O
examination NN O
duration NN O
and CC O
an DT O
additional JJ O
learning NN O
effect NN O
. . O

-DOCSTART- X X O

Preservatives NNS O
are VBP O
an DT O
important JJ O
component NN O
of IN O
ophthalmic JJ O
preparations NNS O
, , O
providing VBG O
antimicrobial JJ O
activity NN O
in IN O
the DT O
bottle NN O
and CC O
preventing VBG O
decomposition NN O
of IN O
active JJ O
drug NN O
. . O

-DOCSTART- X X O

Comparative JJ O
analysis NN O
of IN O
various JJ O
techniques NNS O
of IN O
prostatic JJ O
drainage NN O
in IN O
patients NNS O
with IN O
chronic JJ O
obstructive JJ O
prostatitis NN O
] IN O
The DT O
efficacy NN O
of IN O
prostatic JJ O
drainage NN O
using VBG O
transurethral JJ O
vacuum NN O
aspiration NN O
( -LRB- O
Introl-4 JJ O
unit NN O
) -RRB- O
and CC O
transrectal JJ O
pneumovibromassage NN O
( -LRB- O
PVM-R-01 JJ O
) -RRB- O
was VBD O
compared VBN O
in IN O
1511 CD O
patients NNS O
with IN O
chronic JJ O
obstructive JJ O
prostatitis NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
are VBP O
discussed VBN O
in IN O
relation NN O
to TO O
acoustical JJ O
models NNS O
of IN O
sound NN O
propagation NN O
and CC O
physiology NN O
, , O
and CC O
it PRP O
is VBZ O
suggested VBN O
that IN O
height-dependent NN O
degradation NN O
within IN O
a DT O
forest NN O
is VBZ O
an DT O
important JJ O
selection NN O
pressure NN O
for IN O
transmissibility NN O
in IN O
avian JJ O
communication NN O
. . O

-DOCSTART- X X O

Consumption NNP O
of IN O
4 CD O
% NN O
sucrose NN O
was VBD O
not RB O
affected VBN O
by IN O
excitotoxic JJ O
lesions NNS O
of IN O
the DT O
PPTg NNP O
, , O
but CC O
PPTg NNP O
lesioned VBD O
rats NNS O
consumed VBN O
significantly RB O
more RBR O
12 CD O
% NN O
and CC O
20 CD O
% NN O
sucrose NN O
than IN O
sham NN O
controls NNS O
. . O

-DOCSTART- X X O

Mental NNP O
development NN O
is VBZ O
generally RB O
normal JJ O
. . O

-DOCSTART- X X O

In IN O
sterilized VBN O
milk NN O
there EX O
was VBD O
a DT O
slight JJ O
decrease NN O
of IN O
linoleic JJ O
acid NN O
( -LRB- O
C18:2n6 CC O
; : O
-0.7 : O
% NN O
vs. IN O
fresh JJ O
; : O
P NNP O
= SYM O
0.006 CD O
) -RRB- O
and CC O
arachidonic JJ O
acid NN O
( -LRB- O
C20:4n6 CC O
; : O
-2.5 DT O
% NN O
; : O
P NNP O
= SYM O
0.045 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Vitrectomy NNP O
and CC O
removal NN O
of IN O
retained VBN O
lens NN O
fragments VBZ O
restores NNS O
good JJ O
visual JJ O
acuity NN O
and CC O
reduces VBZ O
secondary JJ O
glaucoma NN O
in IN O
the DT O
majority NN O
of IN O
patients NNS O
. . O

-DOCSTART- X X O

Proteomic JJ O
patterns NNS O
of IN O
nipple NN O
aspirate JJ O
fluids NNS O
obtained VBN O
by IN O
SELDI-TOF NNP O
: : O
potential JJ O
for IN O
new JJ O
biomarkers NNS O
to TO O
aid VB O
in IN O
the DT O
diagnosis NN O
of IN O
breast NN O
cancer NN O
. . O

-DOCSTART- X X O

According VBG O
to TO O
the DT O
laboratory NN O
results NNS O
, , O
the DT O
application NN O
of IN O
neural JJ O
network NN O
can MD O
solve VB O
the DT O
problem NN O
successfully RB O
. . O

-DOCSTART- X X O

A DT O
high-efficiency NN O
cross-flow NN O
micronebulizer NN O
interface NN O
for IN O
capillary NN O
electrophoresis NN O
and CC O
inductively RB O
coupled VBN O
plasma NN O
mass NN O
spectrometry NN O
. . O

-DOCSTART- X X O

The DT O
electrodes NNS O
themselves PRP O
do VBP O
not RB O
need VB O
to TO O
be VB O
polished VBN O
prior RB O
to TO O
their PRP$ O
use NN O
but CC O
are VBP O
observed VBN O
to TO O
be VB O
slightly RB O
recessed VBN O
from IN O
the DT O
surrounding VBG O
insulating NN O
surface NN O
. . O

-DOCSTART- X X O

The DT O
experimental JJ O
results NNS O
showed VBD O
that IN O
the DT O
coagulation-electrooxidation NN O
process NN O
could MD O
efficiently RB O
remove VB O
the DT O
color NN O
and CC O
the DT O
COD NN O
from IN O
the DT O
simulated VBN O
dye JJ O
wastewater NN O
. . O

-DOCSTART- X X O

Cyclic NNP O
loading NN O
of IN O
bone NN O
during IN O
normal JJ O
daily JJ O
activity NN O
leads VBZ O
to TO O
the DT O
formation NN O
of IN O
microcracks NNS O
within IN O
the DT O
tissue NN O
matrix NN O
of IN O
compact JJ O
bone NN O
. . O

-DOCSTART- X X O

The DT O
weight-bearing JJ O
surface NN O
of IN O
the DT O
PE NN O
head NN O
became VBD O
smoother JJ O
with IN O
time NN O
after IN O
THA NNP O
, , O
and CC O
the DT O
friction NN O
coefficient NN O
did VBD O
not RB O
differ VB O
significantly RB O
from IN O
that DT O
of IN O
an DT O
unused JJ O
PE NN O
head NN O
. . O

-DOCSTART- X X O

OBJECTIVE CD O
: : O
To TO O
demonstrate VB O
a DT O
lack NN O
of IN O
effect NN O
of IN O
steady-state NN O
concentrations NNS O
of IN O
cilomilast NN O
, , O
a DT O
new JJ O
oral JJ O
phosphodiesterase NN B-NP
4 CD I-NP
inhibitor NN O
for IN O
the DT O
treatment NN O
of IN O
chronic JJ O
obstructive JJ O
pulmonary NN O
disease NN O
, , O
on IN O
warfarin-induced JJ O
anticoagulation NN O
. . O

-DOCSTART- X X O

The DT O
design NN O
principle NN O
based VBN O
on IN O
a DT O
uniform NN O
vibration NN O
mode NN O
is VBZ O
presented VBN O
. . O

-DOCSTART- X X O

Because IN O
the DT O
DPPD NNP B-NP
gene NN I-NP
is VBZ O
not RB O
present JJ O
in IN O
non-tuberculous JJ O
bacilli NNS O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
this DT O
molecule NN O
can MD O
be VB O
an DT O
additional JJ O
tool NN O
for IN O
a DT O
more RBR O
specific JJ O
diagnosis NN O
of IN O
tuberculosis NN O
. . O

-DOCSTART- X X O

Dynamic NNP O
imaging NN O
of IN O
nuclear JJ O
wave NN O
functions NNS O
with IN O
ultrashort NN O
UV NN O
laser NN O
pulses NNS O
. . O

-DOCSTART- X X O

The DT O
General NNP O
Practice NNP O
Research NNP O
Database NNP O
( -LRB- O
GPRD NNP O
) -RRB- O
is VBZ O
the DT O
world NN O
's POS O
largest JJS O
computerized JJ O
database NN O
of IN O
anonymized DT O
longitudinal JJ O
patient NN O
records NNS O
from IN O
general JJ O
practice NN O
and CC O
is VBZ O
a DT O
unique JJ O
public JJ O
health NN O
research NN O
tool NN O
. . O

-DOCSTART- X X O

This DT O
paper NN O
reports VBZ O
the DT O
results NNS O
of IN O
a DT O
laboratory NN O
study NN O
on IN O
aldicarb NN O
and CC O
its PRP$ O
main JJ O
metabolites NNS O
, , O
aldicarb NN O
sulfone NN O
and CC O
aldicarb NN O
sulfoxide NN O
. . O

-DOCSTART- X X O

Only RB O
one CD O
DC NNP O
cardioversion NN O
was VBD O
required VBN O
in IN O
the DT O
HBS NNP O
group NN O
, , O
whereas IN O
2 CD O
DC NN O
in IN O
the DT O
CBC NNP O
group NN O
and CC O
total JJ O
7 CD O
DC NN O
in IN O
the DT O
GIK NNP O
group NN O
. . O

-DOCSTART- X X O

Since IN O
August NNP O
1994 CD O
, , O
the DT O
ENRP NNP O
has VBZ O
retained VBN O
70.3 CD O
metric JJ O
tons NNS O
of IN O
TP NNP O
that IN O
otherwise RB O
would MD O
have VB O
entered VBN O
the DT O
Everglades NNS O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
found VBN O
that IN O
the DT O
disappearance NN O
of IN O
BOD5 NNP O
and CC O
NH3-N NNP O
could MD O
be VB O
approximated VBN O
using VBG O
first-order JJ O
kinetics NNS O
, , O
but CC O
the DT O
kinetics NNS O
of IN O
TP NNP O
removal NN O
were VBD O
unclear JJ O
. . O

-DOCSTART- X X O

It PRP O
was VBD O
found VBN O
that IN O
the DT O
disappearance NN O
of IN O
BOD5 NNP O
and CC O
NH3-N NNP O
could MD O
be VB O
approximated VBN O
using VBG O
first-order JJ O
kinetics NNS O
, , O
but CC O
the DT O
kinetics NNS O
of IN O
TP NNP O
removal NN O
were VBD O
unclear JJ O
. . O

-DOCSTART- X X O

Losses NNS O
of IN O
dichlofluanid NN O
( -LRB- O
54 CD O
% NN O
) -RRB- O
, , O
chlozolinate NN O
( -LRB- O
22 CD O
% NN O
) -RRB- O
, , O
and CC O
etridiazole NN O
( -LRB- O
40 CD O
% NN O
) -RRB- O
, , O
previously RB O
reported VBN O
to TO O
occur VB O
during IN O
ambient JJ O
processing NN O
of IN O
apples NNS O
, , O
were VBD O
reduced VBN O
to TO O
barely RB O
significant JJ O
levels NNS O
( -LRB- O
10 CD O
, , O
17 CD O
, , O
and CC O
14 CD O
% NN O
, , O
respectively RB O
) -RRB- O
by IN O
cryogenic JJ O
processing NN O
. . O

-DOCSTART- X X O

The DT O
TB NNP O
incidence NN O
in IN O
the DT O
" `` O
AIRIN NNP O
" '' O
area NN O
, , O
where WRB O
about RB O
20 CD O
% NN O
TB NN O
patients NNS O
are VBP O
homeless JJ O
, , O
shows VBZ O
highest JJS O
rate NN O
of IN O
above JJ O
1,000/100,000 CD O
. . O

-DOCSTART- X X O

It PRP O
is VBZ O
shown VBN O
that IN O
the DT O
displacement NN O
distribution NN O
measured VBN O
by IN O
q-space NN O
MRI NNP O
in IN O
both DT O
the DT O
large JJ O
displacement NN O
( -LRB- O
i FW O
.e FW O
. . O
, , O
large JJ O
r NN O
) -RRB- O
and CC O
the DT O
long-wavelength NN O
( -LRB- O
i FW O
.e FW O
. . O
, , O
small JJ O
q NN O
) -RRB- O
limits NNS O
is VBZ O
the DT O
same JJ O
3D NN O
Gaussian NNP O
displacement NN O
distribution NN O
assumed VBD O
in IN O
DT-MRI. NNP O

-DOCSTART- X X O

The DT O
procedure NN O
facilitated VBD O
the DT O
retention NN O
of IN O
a DT O
mandibular JJ O
molar NN O
with IN O
a DT O
Class NNP O
III NNP O
FI NNP O
in IN O
a DT O
manner NN O
acceptable JJ O
to TO O
both DT O
the DT O
patient NN O
and CC O
the DT O
clinician NN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
of IN O
our PRP$ O
ten-fold JJ O
cross-validation NN O
experiments NNS O
show VBP O
that IN O
, , O
on IN O
the DT O
average NN O
, , O
the DT O
system NN O
increases VBZ O
the DT O
specificity NN O
from IN O
0.19 CD O
( -LRB- O
0.35 CD O
) -RRB- O
to TO O
0.69 CD O
( -LRB- O
0.74 CD O
) -RRB- O
at IN O
a DT O
sensitivity NN O
level NN O
of IN O
1.0 CD O
( -LRB- O
0.95 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
physical JJ O
characteristics NNS O
of IN O
these DT O
calls NNS O
vary VBP O
among IN O
species NNS O
of IN O
bat NN O
, , O
and CC O
variations NNS O
also RB O
exist VBP O
in IN O
the DT O
timing NN O
and CC O
patterns NNS O
of IN O
respiratory JJ O
muscle NN O
recruitment NN O
during IN O
echolocation NN O
. . O

-DOCSTART- X X O

Clicking VBG O
on IN O
" `` O
Examples NNS O
and CC O
Explanations NNS O
of IN O
APA NNP O
Form NNP O
" '' O
provides VBZ O
a DT O
help NN O
system NN O
with IN O
examples NNS O
of IN O
the DT O
various JJ O
sections NNS O
of IN O
a DT O
review NN O
article NN O
, , O
journal NN O
article NN O
that WDT O
has VBZ O
one CD O
experiment NN O
, , O
or CC O
journal NN O
article NN O
that WDT O
has VBZ O
two CD O
or CC O
more JJR O
experiments NNS O
. . O

-DOCSTART- X X O

The DT O
drug NN O
packets NNS O
contained VBN O
acetyl NN O
aspirin NN O
, , O
acetaminophen RB O
and CC O
chloramphenicol NN O
. . O

-DOCSTART- X X O

Karger NNP O
AG NNP O
, , O
Basel NNP O

-DOCSTART- X X O

AIM:To RB O
understand VB O
the DT O
role NN O
of IN O
nutritional JJ O
status NN O
in IN O
cirrhotic JJ O
patients NNS O
without IN O
clinical JJ O
porto-systemic JJ O
encephalopathy NN O
( -LRB- O
PSE).METHODS NNP O
:Fifty-one : O
non-alcoholic JJ O
patients NNS O
with IN O
cirrhosis NN O
without IN O
PSE NNP O
were VBD O
studied VBN O
prospectively RB O
and CC O
compared VBN O
with IN O
20 CD O
healthy JJ O
volunteers NNS O
. . O

-DOCSTART- X X O

For IN O
instance NN O
, , O
a DT O
total JJ O
SIP NNP O
score NN O
of IN O
an DT O
individual JJ O
patient NN O
of IN O
28.3 CD O
% NN O
( -LRB- O
which WDT O
is VBZ O
taken VBN O
as IN O
an DT O
example NN O
, , O
being VBG O
the DT O
mean JJ O
score NN O
in IN O
the DT O
study NN O
population NN O
) -RRB- O
should MD O
decrease VB O
by IN O
at IN O
least JJS O
9.26 CD O
% NN O
or CC O
approximately RB O
13 CD O
items NNS O
, , O
before IN O
any DT O
improvement NN O
beyond IN O
reproducibility NN O
noise NN O
can MD O
be VB O
detected VBN O
. . O

-DOCSTART- X X O

Group NNP O
I PRP O
comprised VBD O
5 CD O
adult NN O
Collies NNS O
that IN O
received VBN O
at IN O
least JJS O
400 CD O
microg/kg NN O
ivermectin IN O
p.o NN O
. . O
and CC O
were VBD O
presented VBN O
to TO O
the DT O
VMTH NNP O
3 CD O
hours NNS O
after IN O
intoxication NN O
. . O

-DOCSTART- X X O

Patients NNS O
with IN O
a DT O
secondary JJ O
cardiac JJ O
event NN O
had VBD O
more RBR O
common JJ O
Type JJ O
A DT O
behavior NN O
patterns NNS O
and CC O
higher JJR O
Bortner NNP O
scores NNS O
than IN O
patients NNS O
without IN O
a DT O
secondary JJ O
cardiac JJ O
event NN O
. . O

-DOCSTART- X X O

Interestingly RB O
, , O
continuation NN O
of IN O
the DT O
interferon NN B-NP
therapy NN O
in IN O
the DT O
presence NN O
of IN O
a DT O
mild-to-moderate JJ O
exacerbation NN O
of IN O
sarcoidosis NN O
may MD O
be VB O
safe JJ O
in IN O
a DT O
minority NN O
of IN O
patients NNS O
with IN O
noncritical JJ O
organ NN O
involvement NN O
. . O

-DOCSTART- X X O

No DT O
increased VBD O
tumor-related JJ O
mortality NN O
was VBD O
observed VBN O
after IN O
a DT O
mean JJ O
follow-up NN O
of IN O
44 CD O
months NNS O
. . O

-DOCSTART- X X O

Dissociable JJ O
effects NNS O
of IN O
lidocaine NN O
inactivation NN O
of IN O
the DT O
rostral JJ O
and CC O
caudal JJ O
basolateral JJ O
amygdala NN O
on IN O
the DT O
maintenance NN O
and CC O
reinstatement NN O
of IN O
cocaine-seeking JJ O
behavior NN O
in IN O
rats NNS O
. . O

-DOCSTART- X X O

The DT O
population NN O
studied VBD O
comprised VBN O
4472 CD O
men NNS O
and CC O
5212 CD O
women NNS O
aged VBN O
30-74 CD O
years NNS O
, , O
without IN O
coronary JJ O
heart NN O
disease NN O
, , O
who WP O
had VBD O
CRP NNP B-NP
measurements NNS O
in IN O
the DT O
Third NNP O
National NNP O
Health NNP O
and CC O
Nutrition NNP O
Examination NNP O
Survey NNP O
( -LRB- O
NHANES NNP O
III NNP O
) -RRB- O
. . O

-DOCSTART- X X O

Herceptin NNP O
, , O
which WDT O
recognizes VBZ O
the DT O
HER-2/neu NNP B-NP
antigen NN O
and CC O
has VBZ O
similar JJ O
size NN O
( -LRB- O
10 CD O
nm NN O
) -RRB- O
to TO O
G6-(1B4M-Gd JJ O
)( JJ O
256 CD O
) -RRB- O
, , O
accumulated VBN O
and CC O
internalized VBN O
in IN O
the DT O
WIBC-9 NNP O
tumors NNS O
more RBR O
quickly RB O
than IN O
in IN O
the DT O
control NN O
MC-5 CC O
tumors NNS O
that IN O
progress NN O
with IN O
normal JJ O
angiogenesis NN O
. . O

-DOCSTART- X X O

Forty-eight JJ O
pigs NNS O
were VBD O
removed VBN O
from IN O
sows NNS O
at IN O
1 CD O
d NN O
of IN O
age NN O
and CC O
randomly RB O
assigned VBN O
to TO O
one CD O
of IN O
three CD O
treatments NNS O
: : O
1 CD O
) -RRB- O
control NN O
with IN O
lactose NN O
as IN O
the DT O
carbohydrate NN O
source NN O
, , O
2 CD O
) -RRB- O
lactose NN O
replaced VBD O
( -LRB- O
gram NN O
for IN O
gram NN O
) -RRB- O
with IN O
CSS NNP O
( -LRB- O
dextrose NN O
equivalent JJ O
[DE]-20 NN O
) -RRB- O
, , O
and CC O
3 CD O
) -RRB- O
lactose NN O
replaced VBD O
with IN O
DE-42 JJ O
. . O

-DOCSTART- X X O

CONCLUSIONS NNS O
: : O
AMVT NNP O
is VBZ O
rare JJ O
but CC O
a DT O
potentially RB O
lethal JJ O
emergency NN O
disease NN O
. . O

-DOCSTART- X X O

There EX O
was VBD O
no DT O
difference NN O
in IN O
apnea NN O
duration NN O
between IN O
the DT O
supine NN O
and CC O
prone JJ O
positions NNS O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
in IN O
a DT O
large JJ O
animal NN O
model NN O
of IN O
permanent JJ O
focal JJ O
ischemia NN O
in IN O
which WDT O
transfusion NN O
starts VBZ O
30 CD O
min NN O
after IN O
ischemia NN O
, , O
tetrameric JJ O
cross-linked JJ O
hemoglobin NN B-NP
transfusion NN O
can MD O
augment VB O
oxygen NN O
transport NN O
to TO O
the DT O
ischemic JJ O
cortex NN O
, , O
but CC O
the DT O
increase NN O
can MD O
be VB O
delayed VBN O
and CC O
not RB O
necessarily RB O
provide VB O
protection NN O
. . O

-DOCSTART- X X O

Since IN O
the DT O
early JJ O
1980s CD O
there EX O
has VBZ O
been VBN O
increasing VBG O
awareness NN O
of IN O
the DT O
importance NN O
of IN O
quantifying VBG O
health-related JJ O
quality NN O
of IN O
life NN O
( -LRB- O
HRQL NNP O
) -RRB- O
in IN O
patients NNS O
with IN O
chronic JJ O
respiratory NN O
disorders NNS O
included VBD O
in IN O
clinical JJ O
trials NNS O
. . O

-DOCSTART- X X O

They PRP O
were VBD O
randomly RB O
allocated VBN O
to TO O
receive VB O
either DT O
625 CD O
mg NN O
of IN O
calcium NN O
carbonate NN O
( -LRB- O
250 CD O
mg NN O
of IN O
elemental JJ O
calcium NN O
) -RRB- O
at IN O
the DT O
end NN O
of IN O
a DT O
meal NN O
three CD O
times NNS O
a DT O
day NN O
( -LRB- O
group NN O
A NNP O
, , O
n=26 CD O
) -RRB- O
or CC O
calcium NN O
carbonate NN O
in IN O
the DT O
same JJ O
manner NN O
plus CC O
0.625 CD O
mg/day NN O
of IN O
conjugated VBN O
equine JJ O
estrogen NN O
and CC O
5 CD O
mg NN O
medrogestone NN O
acetate NN O
from IN O
day NN O
1-12 CD O
each DT O
month NN O
( -LRB- O
group NN O
B NNP O
, , O
n=30 NN O
) -RRB- O
. . O

-DOCSTART- X X O

TNFalpha NNP B-NP
and CC O
IL-6 DT B-NP
levels NNS O
were VBD O
determined VBN O
in IN O
the DT O
culture NN O
supernatants NNS O
. . O

-DOCSTART- X X O

Therefore RB O
, , O
this DT O
study NN O
has VBZ O
demonstrated VBN O
that IN O
prenatal JJ O
disturbance NN O
can MD O
induce VB O
a DT O
lasting JJ O
change NN O
in IN O
cytokine NN O
biology NN O
, , O
which WDT O
persists VBZ O
well RB O
beyond IN O
the DT O
fetal NN O
and CC O
infant NN O
stage NN O
. . O

-DOCSTART- X X O

The DT O
two-wave JJ O
, , O
1995-1996 CD O
National NNP O
Longitudinal NNP O
Study NNP O
of IN O
Adolescent NNP O
Health NNP O
uses VBZ O
a DT O
measure NN O
of IN O
depressive JJ O
symptomatology NN O
across IN O
a DT O
12-month JJ O
interval NN O
. . O

-DOCSTART- X X O

METHODS NNS O
: : O
9 CD O
cases NNS O
of IN O
conventional JJ O
intermittent JJ O
tissue NN O
expansion NN O
( -LRB- O
CITE NNP O
) -RRB- O
and CC O
9 CD O
cases NNS O
of IN O
continuous JJ O
pressure-controlled JJ O
tissue NN O
expansion NN O
( -LRB- O
CPTE NN O
) -RRB- O
were VBD O
chosen VBN O
for IN O
the DT O
study NN O
. . O

-DOCSTART- X X O

There EX O
was VBD O
a DT O
significant JJ O
effect NN O
of IN O
hematocrit NN O
on IN O
the DT O
General NNP O
Health NNP O
scale NN O
on IN O
the DT O
SF-36 NNP O
( -LRB- O
P NNP O
= SYM O
0.03 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
analytic JJ O
precisions NNS O
, , O
a DT O
+/ NN O
- : O
2 CD O
% NN O
urine-plasma NN O
difference NN O
was VBD O
set VBN O
as IN O
the DT O
cut-off JJ O
value NN O
. . O

-DOCSTART- X X O

A DT O
global JJ O
response NN O
rate NN O
was VBD O
17 CD O
% NN O
(95 CD O
% NN O
confidence NN O
interval NN O
(95 IN O
% NN O
CI) NN O
: : O
2%-32 CD O
% NN O
) -RRB- O
and CC O
the DT O
median JJ O
overall JJ O
survival NN O
was VBD O
12 CD O
months NNS O
. . O

-DOCSTART- X X O

We PRP O
also RB O
studied VBD O
a DT O
new JJ O
parameter NN O
: : O
the DT O
angle NN O
to TO O
maximal JJ O
peak NN O
torque NN O
( -LRB- O
APT NNP O
) -RRB- O
. . O

-DOCSTART- X X O

For IN O
the DT O
2.5 CD O
to TO O
4 CD O
ng/mL NN O
model NN O
, , O
the DT O
AUC NNP O
of IN O
the DT O
ANN NNP O
ROC NNP O
curve NN O
was VBD O
significantly RB O
higher JJR O
than IN O
the DT O
AUCs NNS O
for IN O
percentage NN O
of IN O
free JJ O
PSA NNP B-NP
( -LRB- O
P NNP O
=.0239 CD O
) -RRB- O
, , O
PSA-TZ NNP O
( -LRB- O
P NNP O
=.0204 CD O
) -RRB- O
, , O
and CC O
PSA NNP B-NP
density NN O
and CC O
total JJ O
prostate NN O
volume NN O
( -LRB- O
P NNP O
<.01 CD O
for IN O
both DT O
) -RRB- O
. . O

-DOCSTART- X X O

Potential JJ O
treatments NNS O
include VBP O
dobutamine NN O
, , O
KATP NNP O
channel NN O
activators NNS O
, , O
and CC O
21-aminosteroids NNS O
. . O

-DOCSTART- X X O

Selenium NNP O
is VBZ O
an DT O
essential JJ O
element NN O
for IN O
humans NNS O
, , O
animals NNS O
and CC O
some DT O
species NNS O
of IN O
microorganisms NNS O
. . O

-DOCSTART- X X O

The DT O
GT-foreign-pictures NNS O
showed VBD O
that IN O
the DT O
judgment NN O
of IN O
other JJ O
subjects NNS O
changed VBD O
toward IN O
hedonic JJ O
and CC O
permeability JJ O
directions NNS O
. . O

-DOCSTART- X X O

Emphysematous JJ O
cholecystitis NN O
: : O
sonographic JJ O
findings NNS O
. . O

-DOCSTART- X X O

We PRP O
therefore RB O
applied VBD O
a DT O
radiolabelled JJ O
serumalbumin NN B-NP
method NN O
to TO O
determine VB O
blood NN O
volume NN O
after IN O
haemodilution NN O
with IN O
crosslinked JJ O
or CC O
conjugated VBN O
haemoglobin NN B-NP
, , O
in IN O
comparison NN O
with IN O
a DT O
reference NN O
solution NN O
of IN O
hydroxyethyl NN O
starch NN O
( -LRB- O
HES NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
equilibrium NN O
phosphorus NN O
content NN O
( -LRB- O
EPC0 NN O
) -RRB- O
of IN O
surface NN O
soil NN O
was VBD O
generally RB O
higher JJR O
than IN O
the DT O
SRP NNP O
content NN O
of IN O
drainage NN O
water NN O
, , O
at IN O
one CD O
farm NN O
by IN O
1 CD O
order NN O
of IN O
magnitude NN O
. . O

-DOCSTART- X X O

The DT O
long-term JJ O
prediction NN O
is VBZ O
based VBN O
on IN O
an DT O
algorithm NN O
for IN O
R-R JJ O
interval NN O
estimation NN O
. . O

-DOCSTART- X X O

Despite IN O
considerable JJ O
research NN O
, , O
an DT O
explanation NN O
of IN O
this DT O
effect NN O
has VBZ O
been VBN O
elusive JJ O
. . O

-DOCSTART- X X O

The DT O
structure NN O
has VBZ O
been VBN O
established VBN O
by IN O
a DT O
study NN O
of IN O
its PRP$ O
mono NN O
- : O
and CC O
bidimensional JJ O
NMR NNP O
spectra NN O
and CC O
mass NN O
spectrometry NN O
. . O

-DOCSTART- X X O

We PRP O
argue VBP O
that IN O
this DT O
is VBZ O
the DT O
general JJ O
property NN O
of IN O
QSAR NNP O
models NNS O
developed VBD O
using VBG O
LOO NNP O
cross-validation NN O
. . O

-DOCSTART- X X O

We PRP O
compared VBD O
the DT O
efficacy NN O
and CC O
costs NNS O
of IN O
valacyclovir NN O
in IN O
preventing VBG O
HSV NNP O
reactivation NN O
among IN O
HSV NNP O
seropositive JJ O
autologous JJ O
progenitor NN O
cell NN O
transplantation NN O
( -LRB- O
APCT) NNP O
patients NNS O
with IN O
historical JJ O
controls NNS O
in IN O
whom WP O
intravenous JJ O
acyclovir NN O
or CC O
no DT O
HSV NN O
prophylaxis NNS O
were VBD O
used VBN O
. . O

-DOCSTART- X X O

All DT O
adults NNS O
attending VBG O
the DT O
outpatient NN O
clinics NNS O
of IN O
a DT O
dermatological JJ O
hospital NN O
on IN O
predetermined JJ O
days NNS O
were VBD O
given VBN O
the DT O
12-item JJ O
General NNP O
Health NNP O
Questionnaire NNP O
. . O

-DOCSTART- X X O

Data NNP O
on IN O
prosthesis NN O
use NN O
are VBP O
encouraging VBG O
, , O
although IN O
a DT O
follow-up JJ O
study NN O
is VBZ O
required VBN O
to TO O
determine VB O
the DT O
functional JJ O
outcome NN O
for IN O
prosthesis NN O
users NNS O
and CC O
non-users NNS O
. . O

-DOCSTART- X X O

A DT O
mail NN O
survey NN O
of IN O
Georgia NNP O
members NNS O
of IN O
the DT O
American NNP O
College NNP O
of IN O
Obstetricians NNS O
and CC O
Gynecologists NNS O
was VBD O
conducted VBN O
. . O

-DOCSTART- X X O

HIV-1 PRP$ O
C NNP O
subtype NN O
in IN O
IDUs NNP O
accounted VBD O
for IN O
61.3 CD O
% NN O
. . O

-DOCSTART- X X O

When WRB O
a DT O
plateau NN O
of IN O
enhancement NN O
was VBD O
reached VBN O
, , O
a DT O
single JJ O
lesion NN O
in IN O
each DT O
patient NN O
was VBD O
imaged VBN O
using VBG O
five CD O
different JJ O
continuous JJ O
scanning NN O
modes NNS O
, , O
fundamental JJ O
grey JJ O
scale NN O
( -LRB- O
FGS NNP O
) -RRB- O
; : O
fundamental JJ O
colour NN O
Doppler NN O
(FCD NN O
) -RRB- O
; : O
fundamental JJ O
power NN O
Doppler NNP O
( -LRB- O
FPD NN O
) -RRB- O
; : O
second JJ O
harmonic JJ O
grey NN O
scale NN O
( -LRB- O
HGS NNP O
) -RRB- O
; : O
and CC O
pulse NN O
inversion NN O
mode NN O
( -LRB- O
Pim NNP O
) -RRB- O
using VBG O
an DT O
HDI5000 CD O
scanner NN O
and CC O
C5-2 NN O
probe NN O
( -LRB- O
ATL NNP O
, , O
Bothell NNP O
, , O
WA VBD O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
comparative JJ O
study NN O
of IN O
the DT O
effects NNS O
of IN O
carbamazepine NN O
and CC O
the DT O
NMDA NNP B-NP
receptor NN I-NP
antagonist NN O
remacemide VBP O
on IN O
road NN O
tracking NN O
and CC O
car-following JJ O
performance NN O
in IN O
actual JJ O
traffic NN O
. . O

-DOCSTART- X X O

We PRP O
find VBP O
that IN O
the DT O
measured VBN O
Nusselt NNP O
number NN O
decreased VBN O
about IN O
20 CD O
% NN O
over IN O
the DT O
range NN O
of IN O
Pr NNP O
spanned VBD O
in IN O
the DT O
experiment NN O
. . O

-DOCSTART- X X O

Viral NNP O
and CC O
atypical JJ O
pathogens NNS O
as IN O
causes NNS O
of IN O
type NN O
1 CD O
acute JJ O
exacerbations NNS O
of IN O
chronic JJ O
bronchitis NN O
. . O

-DOCSTART- X X O

Treatment NNP O
for IN O
this DT O
condition NN O
often RB O
involves VBZ O
use NN O
of IN O
a DT O
wax NN O
softening NN O
or CC O
dispersing JJ O
agent NN O
(cerumenolytic NNP O
) -RRB- O
before IN O
syringing NN O
. . O

-DOCSTART- X X O

In IN O
addition NN O
, , O
benzocaine NN O
and CC O
2-phenoxyethanol JJ O
depressed JJ O
complement NN O
activity NN O
and CC O
phagocytosis NN O
, , O
while IN O
MS222 NNP O
and CC O
quinaldine NNP O
sulphate NN O
did VBD O
not RB O
. . O

-DOCSTART- X X O

The DT O
EC(50 NNP O
) -RRB- O
for IN O
suppression NN O
of IN O
long-term JJ O
memory NN O
( -LRB- O
the DT O
concentration NN O
decreasing VBG O
memory NN O
by IN O
50 CD O
% NN O
) -RRB- O
of IN O
fear NN O
conditioning NN O
to TO O
context NN O
was VBD O
2.00 CD O
% NN O
plus/minus CC O
0.01 CD O
% NN O
( -LRB- O
mean JJ O
plus/minus NN O
SEM) NNP O
, , O
and CC O
for IN O
fear NN O
conditioning NN O
to TO O
tone NN O
was VBD O
3.45 CD O
% NN O
plus/minus CC O
0.26 CD O
% NN O
, , O
( -LRB- O
P NNP O
< NN O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
utility NN O
of IN O
such JJ O
analyses NNS O
in IN O
the DT O
design NN O
of IN O
ceramic/substrate JJ O
bilayer NN O
systems NNS O
for IN O
optimal JJ O
resistance NN O
to TO O
lifetime-threatening NN O
damage NN O
is VBZ O
discussed VBN O
. . O

-DOCSTART- X X O

Dementia NNP O
is VBZ O
being VBG O
avoided VBN O
in IN O
NHS NNP O
and CC O
social JJ O
care NN O
. . O

-DOCSTART- X X O

The DT O
use NN O
of IN O
highly RB O
active JJ O
antiretroviral JJ O
therapy NN O
( -LRB- O
HAART NNP O
) -RRB- O
has VBZ O
resulted VBN O
in IN O
significant JJ O
improvements NNS O
in IN O
the DT O
treatment NN O
of IN O
HIV NNP O
infection NN O
, , O
including VBG O
a DT O
decrease NN O
in IN O
the DT O
incidence NN O
and CC O
severity NN O
of IN O
several JJ O
acquired VBN O
immune JJ O
deficiency NN O
syndrome NN O
( -LRB- O
AIDS)-related JJ O
malignancies NNS O
. . O

-DOCSTART- X X O

Time NN O
to TO O
progression NN O
was VBD O
6 CD O
months NNS O
(5-7 : O
months NNS O
) -RRB- O
with IN O
a DT O
median NN O
survival NN O
from IN O
registration NN O
of IN O
9.6 CD O
months NNS O
(95 IN O
% NN O
CI NNP O
8-12 CD O
months NNS O
) -RRB- O
. . O

-DOCSTART- X X O

Heparin NNP O
( -LRB- O
100 CD O
U NNP O
. . O
kg(-1 NN O
) -RRB- O
. . O
day(-1 NN O
) -RRB- O
) -RRB- O
was VBD O
injected VBN O
subcutaneously RB O
to TO O
the DT O
rats NNS O
in IN O
H NNP O
group NN O
while IN O
normal JJ O
saline NN O
to TO O
those DT O
in IN O
N NNP O
group NN O
once IN O
a DT O
day NN O
. . O

-DOCSTART- X X O

MAIN NNP O
OUTCOME NNP O
MEASURE NNP O
: : O
A DT O
positive JJ O
test NN O
result NN O
for IN O
gonococcal JJ O
or CC O
chlamydial JJ O
infection NN O
by IN O
the DT O
ligase NN B-NP
chain NN O
reaction NN O
assay NN O
; : O
secondary JJ O
outcome NN O
measure NN O
was VBD O
a DT O
positive JJ O
test NN O
result NN O
for IN O
human JJ O
immunodeficiency NN O
virus NN O
( -LRB- O
HIV NNP O
) -RRB- O
. . O

-DOCSTART- X X O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
develop VB O
a DT O
reliable JJ O
and CC O
culturally RB O
meaningful JJ O
exercise NN O
self-efficacy NN O
questionnaire NN O
for IN O
older JJR O
Mexican JJ O
American NNP O
women NNS O
. . O

-DOCSTART- X X O

Neutrophil NNP O
:lymphocyte NNP O
ratio NN O
, , O
plasma NN O
haptoglobin NN B-NP
, , O
and CC O
CBG NNP B-NP
levels NNS O
were VBD O
greater JJR O
( -LRB- O
P NNP O
< NN O
0.01 CD O
) -RRB- O
during IN O
the DT O
INITIAL JJ O
period NN O
than IN O
during IN O
the DT O
PRE JJ O
or CC O
POST JJ O
periods NNS O
but CC O
did VBD O
not RB O
differ VB O
between IN O
treatments NNS O
. . O

-DOCSTART- X X O

Adjacent VB O
to TO O
those DT O
lesions NNS O
, , O
and CC O
in IN O
homologous JJ O
contralateral JJ O
structures NNS O
, , O
FMZ NN O
binding NN O
was VBD O
analysed VBN O
in IN O
four CD O
pairs NNS O
of IN O
cortical JJ O
9 CD O
x NN O
9-mm JJ O
regions NNS O
of IN O
interest NN O
( -LRB- O
ROIs NNP O
) -RRB- O
placed VBD O
on IN O
transaxial NN O
and CC O
coronal JJ O
slices NNS O
, , O
respectively RB O
, , O
as RB O
well RB O
as IN O
in IN O
the DT O
lesion NN O
volume NN O
and CC O
its PRP$ O
mirror NN O
region NN O
. . O

-DOCSTART- X X O

Because IN O
a DT O
close JJ O
correlation NN O
between IN O
regional JJ O
decreases NNS O
in IN O
FMZ NNP O
binding NN O
and CC O
spiking NN O
activity NN O
was VBD O
recently RB O
demonstrated VBN O
in IN O
neocortical JJ O
epilepsies NNS O
, , O
abnormal JJ O
peri-lesional JJ O
FMZ NN O
binding NN O
may MD O
bear VB O
some DT O
relation NN O
to TO O
the DT O
mechanisms NNS O
of IN O
epileptogenesis NN O
in IN O
symptomatic JJ O
epilepsies NNS O
. . O

-DOCSTART- X X O

CD NN O
was VBD O
determined VBN O
using VBG O
the DT O
Farnsworth NNP O
D-15 NNP O
method NN O
. . O

-DOCSTART- X X O

Here RB O
is VBZ O
presented VBN O
the DT O
monitoring NN O
of IN O
the DT O
accidental JJ O
spill NN O
on IN O
vertical JJ O
distribution NN O
of IN O
heavy JJ O
metals NNS O
in IN O
the DT O
estuarine NN O
sediments NNS O
. . O

-DOCSTART- X X O

The DT O
large JJ O
fluxes NNS O
of IN O
239+240Pu PRP O
might MD O
be VB O
attributed VBN O
to TO O
episodic JJ O
lateral JJ O
transport NN O
of IN O
particles NNS O
that IN O
flow NN O
down IN O
the DT O
continental JJ O
slope NN O
with IN O
the DT O
nepheloid JJ O
layer NN O
which WDT O
was VBD O
considered VBN O
to TO O
be VB O
significant JJ O
for IN O
239+240Pu CD O
transport NN O
on IN O
the DT O
continental JJ O
slope NN O
in IN O
the DT O
East NNP O
China NNP O
Sea NNP O
. . O

-DOCSTART- X X O

Rigorous JJ O
treatment NN O
protocols NNS O
for IN O
diet NN O
delivery NN O
and CC O
EEN-related JJ O
GI JJ O
adverse JJ O
effects NNS O
were VBD O
applied VBN O
. . O

-DOCSTART- X X O

We PRP O
found VBD O
three CD O
out IN O
of IN O
four CD O
original JJ O
( -LRB- O
Volkan NN O
's POS O
) -RRB- O
groups NNS O
of IN O
linking VBG O
objects NNS O
, , O
but CC O
also RB O
an DT O
additional JJ O
one CD O
, , O
hitherto PRP O
undescribed VBD O
, , O
comprising VBG O
objects NNS O
used VBN O
for IN O
designing VBG O
a DT O
memorial NN O
shrine NN O
to TO O
the DT O
deceased JJ O
. . O

-DOCSTART- X X O

The DT O
range NN O
of IN O
200 CD O
000-300 CD O
000 CD O
spermatozoa/microl NN O
appeared VBD O
to TO O
be VB O
a DT O
reasonable JJ O
compromise NN O
for IN O
both DT O
criteria NNS O
. . O

-DOCSTART- X X O

Gastritis NNP O
score NN O
was VBD O
significantly RB O
lower JJR O
in IN O
nod-/CagA JJ O
- : O
children NNS O
than IN O
in IN O
nod+/CagA NN O
- : O
( -LRB- O
p NN O
=.004 CD O
) -RRB- O
, , O
nod-/CagA+ JJ O
( -LRB- O
p NN O
=.002 NN O
) -RRB- O
and CC O
nod+/CagA+ JJ O
( -LRB- O
p NN O
<.001 CD O
) -RRB- O
, , O
both DT O
in IN O
the DT O
antrum NN O
and CC O
corpus NN O
. . O

-DOCSTART- X X O

The DT O
mean JJ O
thickness NN O
of IN O
the DT O
visceral JJ O
peritoneum NN O
was VBD O
comparable JJ O
in IN O
both DT O
groups NNS O
of IN O
animals NNS O
, , O
but CC O
, , O
macroscopically RB O
, , O
more RBR O
severe JJ O
fibrosis NN O
was VBD O
found VBN O
in IN O
the DT O
peritoneum NN O
of IN O
rats NNS O
exposed VBN O
to TO O
CAPD NNP O
3 CD O
as IN O
compared VBN O
with IN O
animals NNS O
treated VBN O
with IN O
CAPD NNP O
3 CD O
Balance NN O
( -LRB- O
p NN O
< JJ O
0.05 CD O
) -RRB- O
. . O

-DOCSTART- X X O

A DT O
further JJ O
analysis NN O
has VBZ O
been VBN O
performed VBN O
using VBG O
the DT O
series NN O
of IN O
maximum JJ O
intensity NN O
for IN O
fixed JJ O
duration NN O
( -LRB- O
1 CD O
, , O
3 CD O
, , O
6 CD O
, , O
12 CD O
, , O
24 CD O
hrs NNS O
) -RRB- O
and CC O
annual JJ O
daily JJ O
maxima NN O
. . O

-DOCSTART- X X O

BACKGROUND NNP O
: : O
We PRP O
hypothesized VBD O
that IN O
the DT O
postoperative JJ O
serum NN O
level NN O
of IN O
TA90-IC NNP B-NP
, , O
an DT O
immune JJ O
complex NN O
of IN O
a DT O
90-kDa JJ O
tumor-associated JJ O
antigen NN O
and CC O
its PRP$ O
antibody NN O
, , O
might MD O
have VB O
a DT O
significant JJ O
correlation NN O
with IN O
recurrence NN O
and CC O
survival NN O
in IN O
patients NNS O
with IN O
thick JJ O
primary JJ O
melanomas NNS O
. . O

-DOCSTART- X X O

Genetics NNP O
Institute NNP O
has VBZ O
developed VBN O
and CC O
launched VBN O
oprelvekin NNP B-NP
( -LRB- O
rhIL-11 NN B-NP
; : O
Neumega NNP O
) -RRB- O
, , O
a DT O
recombinant JJ O
form NN O
of IN O
human JJ B-NP
IL-11 NN I-NP
. . O

-DOCSTART- X X O

Patients NNS O
subsequently RB O
returned VBD O
to TO O
the DT O
clinic NN O
every DT O
3 CD O
days NNS O
to TO O
have VB O
the DT O
wounds NNS O
checked VBN O
and CC O
dressings NNS O
changed VBD O
. . O

-DOCSTART- X X O

Elements NNS O
that WDT O
are VBP O
fundamental JJ O
to TO O
the DT O
safety NN O
evaluation NN O
of IN O
flavor NN O
ingredients NNS O
include VBP O
exposure NN O
, , O
structural JJ O
analogy NN O
, , O
metabolism NN O
, , O
pharmacokinetics NNS O
and CC O
toxicology NN O
. . O

-DOCSTART- X X O

The DT O
mass-specific JJ O
resting VBG O
minute NN O
ventilation NN O
( -LRB- O
E NNP O
) -RRB- O
and CC O
the DT O
ventilatory NN O
equivalent NN O
(VE/( IN O
O( JJ O
2 CD O
) -RRB- O
) -RRB- O
) -RRB- O
were VBD O
approximately RB O
the DT O
same JJ O
at IN O
the DT O
two CD O
ages NNS O
, , O
with IN O
a DT O
breathing NN O
pattern NN O
significantly RB O
deeper JJR O
and CC O
slower JJR O
at IN O
day NN O
1 CD O
. . O

-DOCSTART- X X O

INTERPRETATION NN O
: : O
It PRP O
is VBZ O
probable JJ O
that IN O
the DT O
cognitive NN O
dissonance NN O
created VBN O
by IN O
more JJR O
health NN O
information NN O
on IN O
smoking NN O
after IN O
1964 CD O
, , O
i IN O
.e NN O
. . O
the DT O
necessary JJ O
motivation NN O
to TO O
quit VB O
, , O
was VBD O
reduced VBN O
as IN O
a DT O
result NN O
of IN O
strategic JJ O
changes NNS O
in IN O
the DT O
amount NN O
and CC O
content NN O
of IN O
advertising NN O
. . O

-DOCSTART- X X O

Nine CD O
cases NNS O
of IN O
GBS NNP O
and CC O
five CD O
of IN O
TM NNP O
reported VBD O
to TO O
the DT O
active JJ O
AFP NNP O
surveillance NN O
were VBD O
not RB O
found VBN O
in IN O
the DT O
hospital NN O
searches NNS O
. . O

-DOCSTART- X X O

The DT O
ability NN O
of IN O
rats NNS O
with IN O
control NN O
or CC O
hippocampal NN O
lesions NNS O
to TO O
learn VB O
an DT O
object-place NN O
, , O
odor-place NN O
, , O
or CC O
object-odor NN O
paired-associate JJ O
task NN O
was VBD O
assessed VBN O
in IN O
a DT O
cheeseboard NN O
maze NN O
apparatus NN O
. . O

-DOCSTART- X X O

The DT O
shift NN O
in IN O
the DT O
earliest JJS O
activation NN O
site NN O
after IN O
administration NN O
of IN O
esmolol NN O
was VBD O
compared VBN O
with IN O
the DT O
shift NN O
after IN O
RFA. NNP O
RESULTS NNS O
: : O
The DT O
heart NN O
rate NN O
at IN O
rest NN O
and CC O
in IN O
drug-free JJ O
state NN O
ranged VBD O
between IN O
95 CD O
and CC O
125 CD O
beats/min NN O
( -LRB- O
mean VB O
99 CD O
+/ NN O
- : O
14 CD O
beats/min NN O
) -RRB- O
. . O

-DOCSTART- X X O

Urine NNP O
samples NNS O
collected VBD O
after IN O
the DT O
administration NN O
of IN O
these DT O
supplements NNS O
can MD O
test VB O
positive JJ O
. . O

-DOCSTART- X X O

Data NNP O
management NN O
in IN O
practice-based JJ O
research NN O
. . O

-DOCSTART- X X O

We PRP O
have VBP O
previously RB O
reported VBN O
reduced JJ O
levels NNS O
of IN O
choline NN B-NP
acetyltransferase NN I-NP
activity NN O
in IN O
the DT O
cerebral JJ O
cortex NN O
of IN O
patients NNS O
who WP O
died VBD O
after IN O
a DT O
head NN O
injury NN O
, , O
demonstrating VBG O
that IN O
there EX O
is VBZ O
a DT O
loss NN O
of IN O
cortical JJ O
cholinergic JJ O
innervation NN O
. . O

-DOCSTART- X X O

After IN O
taking VBG O
smears NNS O
from IN O
lesions NNS O
of IN O
the DT O
oral JJ O
mucosa NN O
( -LRB- O
tongue NN O
, , O
cheeks NNS O
, , O
palate NN O
) -RRB- O
and CC O
the DT O
contiguous JJ O
denture NN O
surface NN O
by IN O
cotton NN O
wool NN O
swabs NNS O
and CC O
inoculating VBG O
them PRP O
onto IN O
Sabouraud NNP O
glucose NN O
agar NN O
and CC O
CHROMagar NNP O
Candida NNP O
, , O
individual JJ O
yeast NN O
species NNS O
were VBD O
identified VBN O
by IN O
a DT O
germ JJ O
tube NN O
, , O
filamentous JJ O
, , O
and CC O
assimilation NN O
tests NNS O
employing VBG O
the DT O
commercial JJ O
kit NN O
AuxaColor NNP O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
pharmacological JJ O
treatment NN O
and CC O
professional JJ O
care NN O
and CC O
support NN O
may MD O
improve VB O
when WRB O
dementia NN O
is VBZ O
detected VBN O
in IN O
an DT O
early JJ O
stage NN O
. . O

-DOCSTART- X X O

Sexually RB O
conditioned VBN O
incentives NNS O
: : O
attenuation NN O
of IN O
motivational JJ O
impact NN O
during IN O
dopamine NN B-NP
receptor NN I-NP
antagonism NN O
. . O

-DOCSTART- X X O

PATIENTS NNS O
AND CC O
METHODS NNS O
: : O
This DT O
study NN O
is VBZ O
a DT O
retrospective JJ O
cohort JJ O
study NN O
of IN O
all DT O
children NNS O
with IN O
cancer NN O
admitted VBN O
to TO O
a DT O
single JJ O
institution NN O
with IN O
fever NN O
and CC O
neutropenia NN O
( -LRB- O
defined VBN O
as IN O
an DT O
absolute JJ O
neutrophil NN O
count NN O
< NN O
500 CD O
cells/mm3 NNS O
) -RRB- O
in IN O
a DT O
1-year JJ O
period NN O
. . O

-DOCSTART- X X O

Concentrations NNS O
of IN O
N( NNP O
O3-)-N NNP O
and CC O
N( NNP O
H3-)-N NNP O
at IN O
Deoprayag NNP O
varied VBD O
from IN O
0.30 CD O
to TO O
0.50 CD O
and CC O
0.02 CD O
to TO O
0.12 CD O
mg/L NN O
, , O
respectively RB O
, , O
depending VBG O
on IN O
season NN O
. . O

-DOCSTART- X X O

Steal NNP O
is VBZ O
a DT O
pathophysiological JJ O
process NN O
in IN O
which WDT O
increased VBD O
blood NN O
flow NN O
through IN O
a DT O
low-resistance JJ O
vascular JJ O
bed NN O
is VBZ O
sufficient JJ O
to TO O
divert VB O
flow NN O
away RB O
from IN O
a DT O
region NN O
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

-DOCSTART- X X O

The DT O
orientations NNS O
of IN O
the DT O
contact NN O
surfaces NNS O
and CC O
their PRP$ O
locations NNS O
relative JJ O
to TO O
the DT O
object NN O
's POS O
center NN O
of IN O
mass NN O
were VBD O
varied VBN O
. . O

-DOCSTART- X X O

The DT O
results NNS O
are VBP O
given VBN O
as IN O
: : O
flux NN O
, , O
number NN O
of IN O
stars NNS O
per IN O
cm3 CD O
, , O
charge NN O
of IN O
the DT O
ions NNS O
, , O
comparison NN O
with IN O
other JJ O
detectors NNS O
( -LRB- O
plastics NNS O
, , O
AgCl NNP O
crystals NNS O
, , O
LiF NNP O
) -RRB- O
, , O
energy NN O
loss NN O
, , O
hit VBD O
region NN O
in IN O
the DT O
biological JJ O
objects NNS O
. . O

-DOCSTART- X X O

Nodal NNP O
domains NNS O
are VBP O
regions NNS O
where WRB O
a DT O
function NN O
has VBZ O
definite JJ O
sign NN O
. . O

-DOCSTART- X X O

DESIGN NNP O
: : O
Prospective JJ O
, , O
randomized JJ O
, , O
double-blind JJ O
, , O
controlled JJ O
trial NN O
. . O

-DOCSTART- X X O

In IN O
patients NNS O
who WP O
respond VBP O
to TO O
quetiapine VB O
, , O
therapy NN O
should MD O
be VB O
continued VBN O
at IN O
the DT O
optimal JJ O
dose NN O
that WDT O
maintains VBZ O
remission NN O
, , O
within IN O
the DT O
range NN O
of IN O
150 CD O
to TO O
750 CD O
mg/d NN O
. . O

-DOCSTART- X X O

Calcimimetic JJ O
agents NNS O
directly RB O
inhibit VBP O
PTH DT B-NP
secretion NN O
by IN O
activating VBG O
the DT O
calcium-sensing NN O
receptor NN O
in IN O
the DT O
parathyroid NN O
glands NNS O
, , O
but CC O
clinical JJ O
experience NN O
with IN O
them PRP O
is VBZ O
limited VBN O
. . O

-DOCSTART- X X O

With IN O
such JJ O
analysis NN O
, , O
one NN O
can MD O
test VB O
hypotheses NNS O
about IN O
the DT O
structure NN O
of IN O
latent JJ O
variability NN O
within IN O
a DT O
given VBN O
data NN O
set NN O
. . O

-DOCSTART- X X O

The DT O
subjects NNS O
were VBD O
shown VBN O
to TO O
be VB O
capable JJ O
of IN O
assessing VBG O
integrally RB O
the DT O
value NN O
of IN O
accelerations NNS O
and CC O
estimating VBG O
it PRP O
with IN O
an DT O
error NN O
of IN O
0.1-0.12 CD O
g NN O
. . O

-DOCSTART- X X O

The DT O
observed JJ O
incidence NN O
rates NNS O
were VBD O
compared VBN O
to TO O
expected VBN O
rates NNS O
in IN O
the DT O
general JJ O
population NN O
. . O

-DOCSTART- X X O

The DT O
only JJ O
predictor NN O
of IN O
response NN O
to TO O
tacrolimus NN O
was VBD O
a DT O
previous JJ O
response NN O
to TO O
cyclosporin NN O
and CC O
prednisone NN O
, , O
either CC O
as IN O
a DT O
complete JJ O
or CC O
partial JJ O
remission NN O
( -LRB- O
remission NN O
rate NN O
75 CD O
% NN O
vs JJ O
15.3 CD O
; : O
P=0.036 CD O
) -RRB- O
. . O

-DOCSTART- X X O

Based VBN O
on IN O
a DT O
morphological JJ O
study NN O
of IN O
the DT O
resin-dentine JJ O
interface NN O
, , O
a DT O
broad JJ O
selection NN O
of IN O
dentine NN O
adhesive NN O
systems NNS O
was VBD O
classified VBN O
following VBG O
their PRP$ O
adhesion-strategy NN O
. . O

-DOCSTART- X X O

Copyright NN O
2002 CD O
American NNP O
Cancer NNP O
Society NNP O
.DOI NNP O
10.1002/cncr.10318 CD O

-DOCSTART- X X O

In IN O
this DT O
study NN O
we PRP O
wanted VBD O
to TO O
assess VB O
the DT O
DR NN O
using VBG O
the DT O
'combined JJ O
test NN O
' '' O
in IN O
an DT O
unselected JJ O
population NN O
of IN O
self-referred JJ O
pregnant JJ O
women NNS O
at IN O
a DT O
false-positive JJ O
rate NN O
( -LRB- O
FPR NN O
) -RRB- O
of IN O
about IN O
5 CD O
% NN O
. . O

-DOCSTART- X X O

As IN O
measured VBN O
by IN O
the DT O
PDQ-39 NNP O
, , O
STN-DBS NNP O
significantly RB O
improves VBZ O
important JJ O
aspects NNS O
of IN O
QoL NNP O
in IN O
patients NNS O
with IN O
advanced JJ O
PD. . O

